FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Kakkar, P
   Madhan, B
AF Kakkar, Prachi
   Madhan, Balaraman
TI Fabrication of keratin-silica hydrogel for biomedical applications
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Hydrogel; Textural analysis; Biocompatibility; Biomaterial; Biomedical
   application; Sol-gel
ID SOL-GEL SYNTHESIS; DRUG-DELIVERY; COLLAGEN SCAFFOLD; MUCOADHESIVE
   PROPERTIES; COMPOSITE SCAFFOLD; BIOMATERIALS; COMPATIBILITY; GELATIN;
   RELEASE; GLASSES
AB In the recent past, keratin has been fabricated into different forms of biomaterials like scaffold, gel, sponge, film etc. In lieu of the myriad advantages of the hydrogels for biomedical applications, a keratin-silica hydrogel was fabricated using tetraethyl orthosilicate (TEOS). Textural analysis shed light on the physical properties of the fabricated hydrogel, inturn enabling the optimization of the hydrogel. The optimized keratin-silica hydrogel was found to exhibit instant springiness, optimum hardness, with ease of spreadability. Moreover, the hydrogel showed excellent swelling with highly porous microarchitecture. MIT assay and DAPI staining revealed that keratin-silica hydrogel was biocompatible with fibroblast cells. Collectively, these properties make the fabricated keratin-silica hydrogel, a suitable dressing material for biomedical applications. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Kakkar, Prachi; Madhan, Balaraman] CSIR, Cent Leather Res Inst, Madras, Tamil Nadu, India.
RP Madhan, B (reprint author), CSIR, Cent Leather Res Inst, Madras, Tamil Nadu, India.
EM bmadhan76@yahoo.co.in
RI Madhan, Balaraman/B-3136-2009
OI Madhan, Balaraman/0000-0002-4198-8452
FU Council of Scientific and Industrial Research (CSIR); CSIR, India [CSC
   0134]
FX The author PK is thankful to the Council of Scientific and Industrial
   Research (CSIR) for providing support in the form of Senior Research
   Fellowship (SRF). The authors are grateful to CSIR, India for providing
   financial assistance under the M2D XII plan Project (CSC 0134).
   CSIR-CLRI communication number 1210.
CR Bottcher H, 1997, J SOL-GEL SCI TECHN, V8, P651
   Brinker C. J., 2013, SOL GEL SCI PHYS CHE
   Carta D, 2007, J NON-CRYST SOLIDS, V353, P1759, DOI 10.1016/j.jnoncrysol.2007.02.008
   Cevher E, 2008, DRUG DELIV, V15, P57, DOI [10.1080/10717540701829234, 10.1080/10717540701829234 ]
   Dawson E, 2008, ADV DRUG DELIVER REV, V60, P215, DOI 10.1016/j.addr.2007.08.037
   De A.R., 2004, GELLED FOOD PRODUCT
   DeLong SA, 2005, BIOMATERIALS, V26, P3227, DOI 10.1016/j.biomaterials.2004.09.021
   DESHPANDE AA, 1992, DRUG DEV IND PHARM, V18, P1225, DOI 10.3109/03639049209046329
   Ferreira Paula, 2006, Rev. Bras. Cienc. Farm., V42, P419, DOI 10.1590/S1516-93322006000300011
   Ganji F, 2010, IRAN POLYM J, V19, P375
   Geckil H, 2010, NANOMEDICINE-UK, V5, P469, DOI [10.2217/nnm.10.12, 10.2217/NNM.10.12]
   Gorji B., 2012, J APPL CHEM RES, V6, P22
   Grover CN, 2012, J MECH BEHAV BIOMED, V10, P62, DOI 10.1016/j.jmbbm.2012.02.028
   Hurler J, 2012, J APPL POLYM SCI, V125, P180, DOI 10.1002/app.35414
   Jackson CL, 1996, CHEM MATER, V8, P727, DOI 10.1021/cm950417h
   Jones DS, 1997, INT J PHARM, V151, P223, DOI 10.1016/S0378-5173(97)04904-1
   Jones DS, 1997, PHARMACEUT RES, V14, P450, DOI 10.1023/A:1012091231023
   Kakkar P, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-596
   Kakkar P, 2014, MAT SCI ENG C-MATER, V45, P343, DOI 10.1016/j.msec.2014.09.021
   Kim JK, 2007, J NANOSCI NANOTECHNO, V7, P3852, DOI 10.1166/jnn.2007.047
   KLEIN CPAT, 1995, BIOMATERIALS, V16, P715, DOI 10.1016/0142-9612(95)99700-V
   Kortesuo P, 2000, BIOMATERIALS, V21, P193, DOI 10.1016/S0142-9612(99)00148-9
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   MAKAREM R, 1991, Biochemical Society Transactions, V19, p380S
   Mather ML, 2010, REGEN MED, V5, P809, DOI 10.2217/RME.10.32
   Moody A., 2006, BR J COMMUNITY NURS, V11
   Mutlu BR, 2013, J MATER CHEM A, V1, P11051, DOI 10.1039/c3ta12303k
   Nassar E.J., 2011, BIOMATERIALS SOL GEL
   Natarajan V, 2013, J BIOMED MATER RES B, V101B, P560, DOI 10.1002/jbm.b.32856
   Nicoll SB, 1997, BIOMATERIALS, V18, P853, DOI 10.1016/S0142-9612(97)00008-2
   Palumbo G, 1997, J MATER SCI-MATER M, V8, P417, DOI 10.1023/A:1018553505001
   Perullini M, 2011, J SOL-GEL SCI TECHN, V59, P174, DOI 10.1007/s10971-011-2478-8
   Perumal S., 2015, J MECH BEHAV BIOMED
   Perumal S, 2014, EUR J PHARM SCI, V52, P26, DOI 10.1016/j.ejps.2013.10.006
   Pickup DM, 2008, MATER RES BULL, V43, P333, DOI 10.1016/j.materresbull.2007.03.005
   Ramadass SK, 2014, ACS APPL MATER INTER, V6, P15015, DOI 10.1021/am502948g
   Rosiak J., 2002, RAD SYNTHESIS MODIFI, V5
   Rouse JG, 2010, MATERIALS, V3, P999, DOI 10.3390/ma3020999
   Sanchez IY, 2010, BIOMEDICAL APPLICATIONS OF HYDROGELS HANDBOOK, P45, DOI 10.1007/978-1-4419-5919-5_3
   Saul JM, 2011, J BIOMED MATER RES A, V98A, P544, DOI 10.1002/jbm.a.33147
   Schmedlen KH, 2002, BIOMATERIALS, V23, P4325, DOI 10.1016/S0142-9612(02)00177-1
   Sezer AD, 2008, BIOL PHARM BULL, V31, P2326, DOI 10.1248/bpb.31.2326
   Shilova OA, 2013, J SOL-GEL SCI TECHN, V68, P387, DOI 10.1007/s10971-013-3026-5
   Shilova O. A., 2011, ADV SCI TECHNOLOGY, V63, P131
   Shilova O. A., 2006, ADV SCI TECHNOL, V45, P793
   Sierpinski P, 2008, BIOMATERIALS, V29, P118, DOI 10.1016/j.biomaterials.2007.08.023
   Sueikovskaya N., 1971, CHEM METHODS PREPARI
   Syverud K, 2015, CELLULOSE, V22, P473, DOI 10.1007/s10570-014-0470-5
   Szeverenyi I, 2008, HUM MUTAT, V29, P351, DOI 10.1002/humu.20652
   Thonhoff JR, 2008, BRAIN RES, V1187, P42, DOI 10.1016/j.brainres.2007.10.046
   Tsvetkova IN, 2008, GLASS PHYS CHEM+, V34, P68, DOI 10.1134/S1087659608010100
   UNGER K, 1983, DRUG DEV IND PHARM, V9, P69, DOI 10.3109/03639048309048546
   VASHIST A, 2013, ORIENT J CHEM, V29, P861
   Verma V, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/2/025007
   WILSON J, 1981, J BIOMED MATER RES, V15, P805, DOI 10.1002/jbm.820150605
   Zeng MF, 2004, J MEMBRANE SCI, V230, P175, DOI 10.1016/j.memsci.2003.11.020
   Zund G, 1999, EUR J CARDIO-THORAC, V15, P519, DOI 10.1016/S1010-7940(99)00068-8
NR 57
TC 9
Z9 9
U1 7
U2 76
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD SEP 1
PY 2016
VL 66
BP 178
EP 184
DI 10.1016/j.msec.2016.04.067
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA DO4FK
UT WOS:000377737000021
PM 27207052
DA 2018-10-20
ER

PT J
AU Abbott, RD
   Kimmerling, EP
   Cairns, DM
   Kaplan, DL
AF Abbott, Rosalyn D.
   Kimmerling, Erica P.
   Cairns, Dana M.
   Kaplan, David L.
TI Silk as a Biomaterial to Support Long-Term Three-Dimensional Tissue
   Cultures
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Review
DE long-term culture; silk; three-dimensional; adipose; liver; cortical
   brain tissue; kidney; bone
ID MESENCHYMAL STEM-CELLS; IN-VITRO CULTURE; ADIPOSE-TISSUE; BONE-MARROW;
   CHONDROGENIC DIFFERENTIATION; MULTIPHOTON MICROSCOPY; ENGINEERING
   SCAFFOLDS; PROTEIN SCAFFOLDS; POROUS SCAFFOLDS; FIBROIN
AB Tissue engineering has broad and diverse impacts on a variety of different applications from tissue regeneration to drug screening. While two-dimensional (2-D) cell culture platforms are suitable for tissue interfaces where planar surfaces are relevant, three dimensional (3-D) tissue models have enhanced relevance and sustainability over 2-D devices. The improvements between 2-D and 3-D functions and sustainability are related to the limitations of 2-D systems to support proper cellular morphology and signaling over time, resulting in cell overgrowth or changes in viability. For sustainable (long-term) cultures, 3-D silk protein scaffolds provide biocompatibility, porous features for transport, robust yet tunable mechanical properties, retain size and open porous structures for extended time frames due to slow proteolytic biodegradation, avoid-specific cell signaling, and require no chemical Cross-linking. Silk degradation can be extended for months to years without premature collapse of structures (that would result in necrosis) to support cell interactions during slow remodeling toward native tissue. Silk can also be fabricated into different material formats, such as hydrogels, tubes, sponges, composites, fibers, microspheres, and thin films, providing versatile platforms and interfaces for a variety of different applications. For sustainable tissue engineering applications, many formats have been used, including silk ionmer hydrogels that have been cultured for up to 8 weeks and porous silk scaffolds that have been cultured for up to 6 months. In this review, :we highlight some of our tissue engineering work related to long-term in vitro cultures. While each tissue engineered system (adipose tissue, cortical brain tissue, intestine, kidney tissue, bone) is unique, they all use silk biomaterials as a base scaffolding material to achieve sustainable cultivation. Sustainability is important for studies that extend past a few weeks to study acute and chronic impacts of treatments, disease models, and other related applications in the field of tissue engineering.
C1 [Abbott, Rosalyn D.; Kimmerling, Erica P.; Cairns, Dana M.; Kaplan, David L.] Tufts Univ, 4 Colby St, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, 4 Colby St, Medford, MA 02155 USA.
EM David.Kaplan@tufts.edu
OI Cairns, Dana/0000-0003-0574-8395
FU National Institutes of Health (Tissue Engineering Resource Center) [P41
   EB002520, F31EB018718]
FX We would like to thank the National Institutes of Health (Tissue
   Engineering Resource Center P41 EB002520 and F31EB018718) for supporting
   our tissue engineering studies.
CR Abbott RD, 2015, METHODS, V84, P84, DOI 10.1016/j.ymeth.2015.03.022
   Abbott RD, 2015, TRENDS BIOTECHNOL, V33, P401, DOI 10.1016/j.tibtech.2015.04.003
   Abrahamsson CK, 2010, TISSUE ENG PT A, V16, P3709, DOI [10.1089/ten.tea.2010.0190, 10.1089/ten.TEA.2010.0190]
   Achilli M, 2010, POLYMERS-BASEL, V2, P664, DOI 10.3390/polym2040664
   Allaf RM, 2013, J BIOMED MATER RES B, V101B, P1050, DOI 10.1002/jbm.b.32915
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Auer JA, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-72
   Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509
   Becker TA, 2001, J BIOMED MATER RES, V54, P76, DOI 10.1002/1097-4636(200101)54:1<76::AID-JBM9>3.0.CO;2-V
   Bellas E, 2013, TISSUE ENG PART C-ME, V19, P745, DOI [10.1089/ten.tec.2012.0620, 10.1089/ten.TEC.2012.0620]
   Bellas E, 2012, MACROMOL BIOSCI, V12, P1627, DOI 10.1002/mabi.201200262
   Breslin S, 2013, DRUG DISCOV TODAY, V18, P240, DOI 10.1016/j.drudis.2012.10.003
   Calabrese R, 2012, BIOMATERIALS, V33, P7375, DOI 10.1016/j.biomaterials.2012.06.043
   Chang T, 2013, BIOMATERIALS, V34, P8607, DOI 10.1016/j.biomaterials.2013.07.066
   Chen Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep13708
   Choi JH, 2010, TISSUE ENG PART C-ME, V16, P1157, DOI 10.1089/ten.TEC.2009.0760
   Choi JH, 2011, METHODS MOL BIOL, V702, P319, DOI 10.1007/978-1-61737-960-4_23
   Choi JH, 2010, TISSUE ENG PART B-RE, V16, P413, DOI [10.1089/ten.teb.2009.0544, 10.1089/ten.TEB.2009.0544]
   Chwalek K, 2015, NAT PROTOC, V10, P1362, DOI 10.1038/nprot.2015.091
   Cloyd JM, 2007, EUR SPINE J, V16, P1892, DOI 10.1007/s00586-007-0443-6
   Datta A, 2001, COMP BIOCHEM PHYS B, V129, P197, DOI 10.1016/S1096-4959(01)00377-3
   DesRochers TM, 2014, ADV DRUG DELIVER REV, V69, P67, DOI 10.1016/j.addr.2013.12.002
   DesRochers TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059219
   Farrell MJ, 2014, J BIOMECH, V47, P2173, DOI 10.1016/j.jbiomech.2013.10.030
   Fernandez P, 2009, INTEGR BIOL, V1, P252, DOI 10.1039/b822897c
   Gaspar Diana Alves, 2012, Biomatter, V2, P167, DOI 10.4161/biom.22170
   Georgakoudi I, 2007, OPT EXPRESS, V15, P1043, DOI 10.1364/OE.15.001043
   Gerlach JC, 2012, TISSUE ENG PART C-ME, V18, P54, DOI [10.1089/ten.tec.2011.0216, 10.1089/ten.TEC.2011.0216]
   Hannouche D, 2001, J BONE JOINT SURG BR, V83B, P157, DOI 10.1302/0301-620X.83B2.12106
   Hayden RS, 2014, BIOMATERIALS, V35, P3794, DOI 10.1016/j.biomaterials.2014.01.034
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hunt NC, 2010, ACTA BIOMATER, V6, P3649, DOI 10.1016/j.actbio.2010.03.026
   Kang JH, 2009, TISSUE ENG PT A, V15, P2227, DOI 10.1089/ten.tea.2008.0469
   Kawasaki N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00799
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   Kim HJ, 2008, BONE, V42, P1226, DOI 10.1016/j.bone.2008.02.007
   Kim Yun-Gi, 2012, Exp Neurobiol, V21, P61, DOI 10.5607/en.2012.21.2.61
   Kundu SC, 2012, BIOPOLYMERS, V97, P455, DOI 10.1002/bip.22024
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5
   Liu K, 2008, BIOMATERIALS, V29, P2183, DOI 10.1016/j.biomaterials.2008.01.021
   Lucero HA, 2006, CELL MOL LIFE SCI, V63, P2304, DOI 10.1007/s00018-006-6149-9
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mabvuure N, 2012, CURR STEM CELL RES T, V7, P287, DOI 10.2174/157488812800793018
   Mandal BB, 2012, P NATL ACAD SCI USA, V109, P7699, DOI 10.1073/pnas.1119474109
   Martin I, 2004, TRENDS BIOTECHNOL, V22, P80, DOI 10.1016/j.tibtech.2003.12.001
   Mauck RL, 2006, OSTEOARTHR CARTILAGE, V14, P179, DOI 10.1016/j.joca.2005.09.002
   Mauney JR, 2007, BIOMATERIALS, V28, P5280, DOI 10.1016/j.biomaterials.2007.08.017
   Mills LA, 2012, J BONE JOINT SURG BR, V94B, P865, DOI 10.1302/0301-620X.94B7.27370
   Moutos FT, 2008, BIORHEOLOGY, V45, P501, DOI 10.3233/BIR-2008-0491
   Nunamaker EA, 2011, J MECH BEHAV BIOMED, V4, P16, DOI 10.1016/j.jmbbm.2010.08.006
   Oragui Emeka, 2011, Open Orthop J, V5 Suppl 2, P267, DOI 10.2174/1874325001105010267
   Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236
   Pan Z, 2012, INTERFACE FOCUS, V2, P366, DOI 10.1098/rsfs.2011.0123
   Quinn KP, 2012, BIOMATERIALS, V33, P5341, DOI 10.1016/j.biomaterials.2012.04.024
   Robling AG, 2006, ANNU REV BIOMED ENG, V8, P455, DOI 10.1146/annurev.bioeng.8.061505.095721
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Saha S, 2013, CELL TISSUE RES, V352, P495, DOI 10.1007/s00441-013-1586-x
   Salter E, 2012, TISSUE ENG PART B-RE, V18, P62, DOI [10.1089/ten.TEB.2011.0209, 10.1089/ten.teb.2011.0209]
   Saotome T, 2015, J MATER CHEM B, V3, P7109, DOI 10.1039/c5tb00939a
   Schmeichel KL, 2003, J CELL SCI, V116, P2377, DOI 10.1242/jcs.00503
   Sistino Joseph J, 2003, J Extra Corpor Technol, V35, P200
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Stark JJ, 2006, J INVEST DERM SYMP P, V11, P93, DOI 10.1038/sj.jidsymp.5650015
   Subramanian B, 2010, TISSUE ENG PT A, V16, P2821, DOI [10.1089/ten.tea.2009.0595, 10.1089/ten.TEA.2009.0595]
   Sun Y, 2008, MICROSC RES TECHNIQ, V71, P140, DOI 10.1002/jemt.20537
   Sundelacruz S, 2013, BIOMATERIALS, V34, P6695, DOI 10.1016/j.biomaterials.2013.05.040
   Tang-Schomer MD, 2014, P NATL ACAD SCI USA, V111, P13811, DOI 10.1073/pnas.1324214111
   Torres V, 2011, BRENNER RECTORS KIDN, P1626, DOI DOI 10.1016/B978-1-4160-6193-9.10045-4
   Wang XM, 2012, INTERFACE FOCUS, V2, P278, DOI 10.1098/rsfs.2012.0016
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Ward A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055696
   Wissink MJB, 2000, THROMB HAEMOSTASIS, V84, P325
   Wlodarska M, 2015, CELL HOST MICROBE, V17, P577, DOI 10.1016/j.chom.2015.04.008
   Woodfield TBF, 2004, BIOMATERIALS, V25, P4149, DOI 10.1016/j.biomaterials.2003.10.056
   Xu Y, 2000, J BIOL CHEM, V275, P38981, DOI 10.1074/jbc.M007668200
   Yamada M, 2012, BIOMATERIALS, V33, P8304, DOI 10.1016/j.biomaterials.2012.07.068
   Zhao F, 2005, BIOTECHNOL BIOENG, V91, P482, DOI 10.1002/bit.20532
NR 80
TC 12
Z9 13
U1 10
U2 78
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD AUG 31
PY 2016
VL 8
IS 34
BP 21861
EP 21868
DI 10.1021/acsami.5b12114
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA DU9CP
UT WOS:000382514100003
PM 26849288
DA 2018-10-20
ER

PT J
AU Mabry, KM
   Schroeder, ME
   Payne, SZ
   Anseth, KS
AF Mabry, Kelly M.
   Schroeder, Megan E.
   Payne, Samuel Z.
   Anseth, Kristi S.
TI Three-Dimensional High-Throughput Cell Encapsulation Platform to Study
   Changes in Cell-Matrix Interactions
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE hydrogel; biomaterial; high-throughput; aortic stenosis; fibroblast;
   extracellular matrix
ID DISEASED AORTIC VALVES; BIOMATERIAL MICROARRAYS; HYDROGELS; CULTURE;
   DIFFERENTIATION; FIBROBLASTS; PHENOTYPE; SUBSTRATE; CUES; CALCIFICATION
AB In their native extracellular microenvironment, cells respond to a complex array of biochemical and mechanical cues that can vary in both time and space. High throughput methods that allow characterization of cell-laden matrices are valuable tools to screen through many combinations of variables, ultimately helping to evolve and test hypotheses related to cell-ECM signaling. Here, we developed a platform for high-throughput encapsulation of cells in peptide-functionalized poly(ethylene glycol) hydrogels. Hydrogels were synthesized using a thiol-ene, photoclick reaction, which allowed the cell matrix environment to be modified in real time. Matrix signals were dynamically altered by in situ tethering of RGDS (0-1.5 mM), a fibronectin-derived adhesive peptide that induced more elongation than RLD or IKVAV, and/or by increasing the matrix modulus (1 to 6 kPa). This method was demonstrated with aortic valvular interstitial cells (VICs), a population of cells responsible for the pathological fibrosis and matrix remodeling that leads to aortic stenosis. VIC response to cell matrix interactions was characterized by quantifying cell morphology and the fraction of cells exhibiting alpha-smooth muscle actin (alpha SMA) stress fibers, a hallmark of the myofibroblast phenotype. VICs elongated in response to RGDS addition, with a dramatic change in morphology within 24 h. Myofibroblast activation was also dependent on RGDS addition, with VICs exhibiting high activation (16-24%) in 1 kPa gels with RGDS. Response to RGDS was path-dependent, with the amount of time exposed to the adhesive ligand important in determining VIC morphology and activation. Although VIC aspect ratios were dependent on the amount of time spent in a stiff vs soft gel, low levels of VIC activation (<= 4%) were observed in any gels cultured in higher modulus (6 kPa vs 1 kPa) microenvironments.
C1 [Mabry, Kelly M.; Payne, Samuel Z.; Anseth, Kristi S.] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80303 USA.
   [Schroeder, Megan E.; Anseth, Kristi S.] Univ Colorado, Dept Mat Sci, Boulder, CO 80303 USA.
   [Anseth, Kristi S.] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80303 USA.
   [Anseth, Kristi S.] Univ Colorado, BioFrontiers Inst, Boulder, CO 80303 USA.
RP Anseth, KS (reprint author), Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80303 USA.; Anseth, KS (reprint author), Univ Colorado, Dept Mat Sci, Boulder, CO 80303 USA.; Anseth, KS (reprint author), Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80303 USA.; Anseth, KS (reprint author), Univ Colorado, BioFrontiers Inst, Boulder, CO 80303 USA.
EM Kristi.Anseth@colorado.edu
FU NIH Pharmaceutical Biotechnology Training Grant; NSF Graduate Research
   Fellowship; Discovery Learning Apprenticeship Program; Howard Hughes
   Medical Institute (HHMI)
FX The authors acknowledge support to K.M.M. from an NIH Pharmaceutical
   Biotechnology Training Grant, support to M.E.S. from an NSF Graduate
   Research Fellowship, support to S.Z.P. from the Discovery Learning
   Apprenticeship Program, and funding from Howard Hughes Medical Institute
   (HHMI). The authors also thank Dr. Kyle Kyburz for providing the RLD
   peptide and Kelly Shekiro for providing the IKVAV peptide.
CR Anderson DG, 2005, BIOMATERIALS, V26, P4892, DOI 10.1016/j.biomaterials.2004.11.052
   Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509
   Banks JM, 2015, ACS BIOMATER SCI ENG, V1, P718, DOI 10.1021/acsbiomaterials.5b00196
   Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282
   Bosse Y, 2009, CIRC-CARDIOVASC GENE, V2, P489, DOI 10.1161/CIRCGENETICS.108.820795
   Celiz AD, 2015, ADV MATER, V27, P4006, DOI 10.1002/adma.201501351
   Ceriotti L, 2009, SOFT MATTER, V5, P1406, DOI 10.1039/b814616k
   Chambers KF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111029
   Chen JH, 2011, CIRC RES, V108, P1510, DOI 10.1161/CIRCRESAHA.110.234237
   Deiss F, 2013, ANAL CHEM, V85, P8085, DOI 10.1021/ac400161j
   Elkayam T, 2006, TISSUE ENG, V12, P1357, DOI 10.1089/ten.2006.12.1357
   Fairbanks BD, 2009, ADV MATER, V21, P5005, DOI 10.1002/adma.200901808
   Gaharwar AK, 2016, ADV MATER, V28, P771, DOI 10.1002/adma.201503918
   Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035
   Gobaa S, 2015, INTEGR BIOL-UK, V7, P1135, DOI 10.1039/c4ib00176a
   Gould ST, 2016, J TISSUE ENG REGEN M, V10, pE443, DOI 10.1002/term.1836
   Gould ST, 2012, ACTA BIOMATER, V8, P3201, DOI 10.1016/j.actbio.2012.05.009
   Gu XX, 2010, J BIOMED MATER RES A, V93A, P1620, DOI 10.1002/jbm.a.32660
   Hem DL, 1998, J BIOMED MATER RES, V39, P266
   Hinton RB, 2006, CIRC RES, V98, P1431, DOI 10.1161/01.RES.0000224114.65109.4e
   Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613
   Hongisto V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077232
   Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015
   Khademhosseini A, 2006, BIOMATERIALS, V27, P5968, DOI 10.1016/j.biomaterials.2006.06.035
   Khetani SR, 2008, NAT BIOTECHNOL, V26, P120, DOI 10.1038/nbt1361
   Leight JL, 2013, BIOMATERIALS, V34, P7344, DOI 10.1016/j.biomaterials.2013.06.023
   Lin C, 2016, DRUG METAB DISPOS, V44, P127, DOI 10.1124/dmd.115.066027
   Mabry KM, 2016, BIOMATERIALS, V74, P31, DOI 10.1016/j.biomaterials.2015.09.035
   Mabry KM, 2015, BIOMATERIALS, V49, P47, DOI 10.1016/j.biomaterials.2015.01.047
   Major J, 1998, J BIOMOL SCREEN, V3, P13, DOI 10.1177/108705719800300102
   Meli L, 2014, STEM CELL RES, V13, P36, DOI 10.1016/j.scr.2014.04.004
   Merryman WD, 2010, J BIOMECH, V43, P87, DOI 10.1016/j.jbiomech.2009.09.013
   Mih JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019929
   Oliveira MB, 2014, ACS APPL MATER INTER, V6, P9488, DOI 10.1021/am5018607
   Quinlan AMT, 2012, J BIOMED MATER RES A, V100A, P2474, DOI 10.1002/jbm.a.34162
   Rabkin-Aikawa E, 2004, J HEART VALVE DIS, V13, P841
   Ranga A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5324
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Schultz KM, 2015, P NATL ACAD SCI USA, V112, pE3757, DOI 10.1073/pnas.1511304112
   Schultz KM, 2013, SOFT MATTER, V9, P1570, DOI 10.1039/c2sm27303a
   Sorensen I, 2011, KIDNEY INT, V80, P1035, DOI 10.1038/ki.2011.214
   Stephens EH, 2011, CARDIOVASC PATHOL, V20, P334, DOI [10.1016/j.carpath.2010.10.002, 10.1016/j.carpath.2010.07.004]
   Tumarkin E, 2011, INTEGR BIOL-UK, V3, P653, DOI 10.1039/c1ib00002k
   Wang AYM, 2001, J AM SOC NEPHROL, V12, P1927
   Wang H, 2013, P NATL ACAD SCI USA, V110, P19336, DOI 10.1073/pnas.1306369110
   Wang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069667
   West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k
   Wirrig EE, 2011, J MOL CELL CARDIOL, V50, P561, DOI 10.1016/j.yjmcc.2010.12.005
   Zhang X, 2015, ACTA BIOMATER, V14, P11, DOI 10.1016/j.actbio.2014.11.042
NR 49
TC 12
Z9 12
U1 3
U2 39
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD AUG 31
PY 2016
VL 8
IS 34
BP 21914
EP 21922
DI 10.1021/acsami.5b11359
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA DU9CP
UT WOS:000382514100008
PM 27050338
DA 2018-10-20
ER

PT J
AU Moreno-Jimenez, I
   Hulsart-Billstrom, G
   Lanham, SA
   Janeczek, AA
   Kontouli, N
   Kanczler, JM
   Evans, ND
   Oreffo, ROC
AF Moreno-Jimenez, Ines
   Hulsart-Billstrom, Gry
   Lanham, Stuart A.
   Janeczek, Agnieszka A.
   Kontouli, Nasia
   Kanczler, Janos M.
   Evans, Nicholas D.
   Oreffo, Richard O. C.
TI The chorioallantoic membrane (CAM) assay for the study of human bone
   regeneration: a refinement animal model for tissue engineering
SO SCIENTIFIC REPORTS
LA English
DT Article
ID IN-VIVO MODEL; CHICK-EMBRYO; STEM-CELLS; ANGIOGENESIS; SCAFFOLDS;
   FRACTURE; SYSTEM; HYDROGELS; NONUNION; MEDICINE
AB Biomaterial development for tissue engineering applications is rapidly increasing but necessitates efficacy and safety testing prior to clinical application. Current in vitro and in vivo models hold a number of limitations, including expense, lack of correlation between animal models and human outcomes and the need to perform invasive procedures on animals; hence requiring new predictive screening methods. In the present study we tested the hypothesis that the chick embryo chorioallantoic membrane (CAM) can be used as a bioreactor to culture and study the regeneration of human living bone. We extracted bone cylinders from human femoral heads, simulated an injury using a drill-hole defect, and implanted the bone on CAM or in vitro control-culture. Micro-computed tomography (mu CT) was used to quantify the magnitude and location of bone volume changes followed by histological analyses to assess bone repair. CAM blood vessels were observed to infiltrate the human bone cylinder and maintain human cell viability. Histological evaluation revealed extensive extracellular matrix deposition in proximity to endochondral condensations (Sox9+) on the CAM-implanted bone cylinders, correlating with a significant increase in bone volume by mu CT analysis (p < 0.01). This human-avian system offers a simple refinement model for animal research and a step towards a humanized in vivo model for tissue engineering.
C1 [Moreno-Jimenez, Ines; Hulsart-Billstrom, Gry; Lanham, Stuart A.; Janeczek, Agnieszka A.; Kanczler, Janos M.; Evans, Nicholas D.; Oreffo, Richard O. C.] Univ Southampton, Inst Dev Sci, Ctr Human Dev Stem Cells & Regenerat Human Dev &, Bone & Joint Res Grp, Tremona Rd, Southampton SO16 6YD, Hants, England.
   [Kontouli, Nasia] Univ Southampton, Somers Canc Res, Canc Sci Unit, Tremona Rd, Southampton SO16 6YD, Hants, England.
RP Oreffo, ROC (reprint author), Univ Southampton, Inst Dev Sci, Ctr Human Dev Stem Cells & Regenerat Human Dev &, Bone & Joint Res Grp, Tremona Rd, Southampton SO16 6YD, Hants, England.
EM richard.oreffo@soton.ac.uk
OI evans, nicholas/0000-0002-3255-4388; Oreffo, Richard/0000-0001-5995-6726
FU National Centre for the Replacement, Reduction and Refinement of Animals
   in Research (NC3Rs) [NC/K500380/1]; Medical Research Council;
   Engineering and Physical Sciences Research Council; Biotechnology and
   Biological Sciences Research Council UK Regenerative Medicine Platform
   Hub Acellular Approaches for Therapeutic Delivery [MR/K026682/1];
   European Union [318553, 262948]; National Centre for the Replacement,
   Refinement and Reduction of Animals in Research (NC3Rs) [NC/K500380/1];
   Engineering and Physical Sciences Research Council [EP/K029150/1];
   Medical Research Council [MR/K026682/1]
FX This study was supported by the National Centre for the Replacement,
   Reduction and Refinement of Animals in Research (NC3Rs) (NC/K500380/1;
   studentship for IMJ). Funding to ROCO from the Medical Research Council,
   the Engineering and Physical Sciences Research Council and Biotechnology
   and Biological Sciences Research Council UK Regenerative Medicine
   Platform Hub Acellular Approaches for Therapeutic Delivery
   (MR/K026682/1) is gratefully acknowledged as well as the European Union
   Seventh Framework Programme under grant agreement no [318553]-SkelGEN
   and Programme Grant, BioDesign (262948). The authors would like to
   express their gratitude to Julia Wells and Carol Roberts for their
   technical support, Dr. Jeroen Hostens and Dr Phil Salmon from Bruker
   MicroCT, Belgium, for their advice in mu CT analysis, Dr Adrian Sherman
   for kindly providing the GFP-eggs for the experiments, Edoardo Scarpa
   and Dr. Ismael Suarez Falcon and for their constructive comments on the
   manuscripts, and Dr. David Gibbs, Dr. Jon I. Dawson, Dr. Vitali
   Goriainov, Juan A. Nunez and Cameron Black for helpful discussions.
CR Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802
   Bellairs R, 2014, ATLAS CHICK DEV
   Borges J, 2003, TISSUE ENG, V9, P441, DOI 10.1089/107632703322066624
   Buschmann J, 2012, INJURY, V43, P1689, DOI 10.1016/j.injury.2012.06.004
   Cantatore FP, 2005, CELL BIOL INT, V29, P583, DOI 10.1016/j.cellbi.2005.03.011
   COBB TK, 1994, FOOT ANKLE, V15, P64, DOI 10.1177/107110079401500202
   DeVolder RJ, 2012, BIOMATERIALS, V33, P7718, DOI 10.1016/j.biomaterials.2012.07.001
   Diaz-Gomez L, 2014, MAT SCI ENG C-MATER, V40, P180, DOI 10.1016/j.msec.2014.03.065
   Diyana W M, 2009, 2009 IEEE International Conference on Signal and Image Processing Applications (ICSIPA 2009), P107, DOI 10.1109/ICSIPA.2009.5478636
   Ebraheim NA, 2013, ORTHOP SURG, V5, P46, DOI 10.1111/os.12017
   FRIEND JV, 1990, TOXICOL IN VITRO, V4, P324, DOI 10.1016/0887-2333(90)90074-4
   Giannoudis PV, 2007, INJURY, V38, pS3, DOI 10.1016/S0020-1383(08)70003-2
   Greek R, 2013, INT J MED SCI, V10, P206, DOI 10.7150/ijms.5529
   Gruber R, 2006, EXP GERONTOL, V41, P1080, DOI 10.1016/j.exger.2006.09.008
   Hadjizadeh A, 2010, J TISSUE ENG REGEN M, V4, P524, DOI 10.1002/term.269
   HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104
   Hancox N. M., 1946, J PHYSL, V106, P279, DOI [10. 1113/jphysiol. 1947. sp004211, DOI 10.1113/JPHYSIOL.1947.SP004211]
   Hankenson KD, 2011, INJURY, V42, P556, DOI 10.1016/j.injury.2011.03.035
   Holzmann P, 2010, ALTEX-ALTERN ANIM EX, V27, P97
   Hopkins DR, 2007, MATRIX BIOL, V26, P508, DOI 10.1016/j.matbio.2007.05.004
   Kanczler JM, 2007, BIOCHEM BIOPH RES CO, V352, P135, DOI 10.1016/j.bbrc.2006.10.187
   Kanczler JM, 2012, TISSUE ENG PART C-ME, V18, P747, DOI 10.1089/ten.tec.2012.0033
   Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342
   Keshaw H, 2010, ACTA BIOMATER, V6, P1158, DOI 10.1016/j.actbio.2009.08.044
   Kunzi-Rapp K, 1999, ARCH DERMATOL RES, V291, P290, DOI 10.1007/s004030050410
   LAFFERTY KJ, 1969, AUST J EXP BIOL MED, V47, P17, DOI 10.1038/icb.1969.3
   Lillico SG, 2005, DRUG DISCOV TODAY, V3, P1
   MACEY LR, 1989, J BONE JOINT SURG AM, V71A, P722, DOI 10.2106/00004623-198971050-00014
   Martinez-Madrid B, 2009, FERTIL STERIL, V91, P285, DOI 10.1016/j.fertnstert.2007.11.026
   Nowak-Sliwinska P, 2014, ANGIOGENESIS, V17, P779, DOI 10.1007/s10456-014-9440-7
   Oryan A, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/1749-799X-9-18
   OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076
   Perel P, 2007, BMJ-BRIT MED J, V334, P197, DOI 10.1136/bmj.39048.407928.BE
   Ribatti D, 2003, BRAIN RES, V989, P9, DOI 10.1016/S0006-8993(03)03225-6
   Ribatti D., 1996, CURR PHARM BIOTECHNO, V1, P73
   Ribatti D, 2006, NAT PROTOC, V1, P85, DOI 10.1038/nprot.2006.13
   Robinson M, 2004, J BONE JOINT SURG AM, V86A, P1359, DOI 10.2106/00004623-200407000-00002
   Russel W, 1959, PRINCIPLES HUMANE EX
   Shah NJ, 2014, P NATL ACAD SCI USA, V111, P12847, DOI 10.1073/pnas.1408035111
   Smith EL, 2014, ACTA BIOMATER, V10, P4186, DOI 10.1016/j.actbio.2014.06.011
   Steffens L, 2009, J CELL MOL MED, V13, P3380, DOI 10.1111/j.1582-4934.2008.00418.x
   Sys G, 2012, CANCER LETT, V326, P69, DOI 10.1016/j.canlet.2012.07.023
   THOMPSON TJ, 1989, J ANAT, V166, P55
   Tuli R, 2003, STEM CELLS, V21, P681, DOI 10.1634/stemcells.21-6-681
   Valdes TI, 2003, J BIOMED MATER RES A, V67A, P215, DOI 10.1002/jbm.a.10055
   Valdes TI, 2002, J BIOMED MATER RES, V62, P273, DOI 10.1002/jbm.10152
   Vargas GE, 2009, ACTA BIOMATER, V5, P374, DOI 10.1016/j.actbio.2008.07.016
   Wall RJ, 2008, THERIOGENOLOGY, V69, P2, DOI 10.1016/j.theriogenology.2007.09.030
   WEBBER DM, 1990, BONE MINER, V11, P127, DOI 10.1016/0169-6009(90)90053-I
   Yang XBB, 2004, TISSUE ENG, V10, P1037, DOI 10.1089/1076327041887718
   Yuasa M, 2014, BONE, V67, P208, DOI 10.1016/j.bone.2014.07.002
NR 51
TC 4
Z9 4
U1 2
U2 11
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD AUG 31
PY 2016
VL 6
AR 32168
DI 10.1038/srep32168
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DU5EY
UT WOS:000382236200001
PM 27577960
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Thuanthong, M
   Sirinupong, N
   Youravong, W
AF Thuanthong, Mantaka
   Sirinupong, Nualpun
   Youravong, Wirote
TI Triple helical structure of acid-soluble collagen derived from Nile
   tilapia skin as affected by extraction temperature
SO JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE
LA English
DT Article
DE acid-soluble collagen; triple helical structure; self-assembly
ID PEPSIN-SOLUBILIZED COLLAGEN; IN-VITRO; OREOCHROMIS-NILOTICUS; PH;
   DENATURATION; GELATIN
AB BACKGROUNDFish skin has become a new source of collagen. It is usually extracted at low temperature. Increasing the extraction temperature can increase the collagen yield. However, high temperature might cause degradation of the triple helical structure of collagen, which is related to its functional biomaterial. This work thus aimed to investigate the effect of extraction temperature on the extraction efficiency and characteristics of acid-soluble collagen (ASC), particularly its triple helical structure.
   RESULTSASC was extracted at 5 1, 15 +/- 1 and 25 +/- 1 degrees C for 0-24 h with 0.3 or 0.5 mol L-1 acetic acid. The results showed that extraction with 0.5 mol L-1 acetic acid gave a higher extraction efficiency than that in 0.3 mol L-1 acetic acid (P < 0.5). Extraction at 25 +/- 1 degrees C for 5 h with 0.5 mol L-1 acetic acid gave a higher extraction efficiency (73.73 +/- 1.28%), which is higher than that of 5 +/- 1 degrees C by about 1.7-fold. All ASC obtained were identified as type I collagen and showed similar physicochemical properties.
   CONCLUSIONThe results showed that extraction temperature strongly affected extraction efficiency. Extraction at 25 degrees C did not affect the triple helical structure, which was confirmed by the results of Fourier transform infrared, circular dichroism spectrum and collagen self-assembly. (c) 2015 Society of Chemical Industry
C1 [Thuanthong, Mantaka; Youravong, Wirote] Prince Songkla Univ, Fac Agroind, Dept Food Technol, Hat Yai, Thailand.
   [Thuanthong, Mantaka; Youravong, Wirote] Songkla Univ, Prince Songkla Univ, Membrane Sci & Technol Res Ctr, Songkhla, Thailand.
   [Sirinupong, Nualpun] Prince Songkla Univ, Nutraceut & Funct Foods Res & Dev Ctr, Hat Yai, Thailand.
RP Youravong, W (reprint author), Prince Songkla Univ, Fac Agroind, Dept Food Technol, Hat Yai, Thailand.
EM wirote.y@psu.ac.th
FU Thailand Research Fund under the Royal Golden Jubilee PhD Program
   [PHD/022/2552]; Graduate School, Prince of Songkla University; Higher
   Education Research Promotion and National Research University Project of
   Thailand, Office of the Higher Education Commission
FX This study was supported by the Thailand Research Fund under the Royal
   Golden Jubilee PhD Program (PHD/022/2552), Graduate School, Prince of
   Songkla University, and the Higher Education Research Promotion and
   National Research University Project of Thailand, Office of the Higher
   Education Commission.
CR Aukkanit N, 2010, J SCI FOOD AGR, V90, P2627, DOI 10.1002/jsfa.4131
   BERGMAN I, 1963, ANAL CHEM, V35, P1961, DOI 10.1021/ac60205a053
   Carvalho ASL, 2003, ARCH BIOCHEM BIOPHYS, V415, P257, DOI 10.1016/S0003-9861(03)00275-3
   Correa DHA, 2009, J BIOCH, V3, P164
   Ding CC, 2013, INT J BIOL MACROMOL, V52, P319, DOI 10.1016/j.ijbiomac.2012.10.003
   Duan R, 2009, FOOD CHEM, V112, P702, DOI 10.1016/j.foodchem.2008.06.020
   Harris JR, 2013, MICRON, V49, P60, DOI 10.1016/j.micron.2013.03.004
   Heu MS, 2010, FOOD SCI BIOTECHNOL, V19, P27, DOI 10.1007/s10068-010-0004-3
   Huang WH, 2011, FOOD CHEM, V128, P968, DOI 10.1016/j.foodchem.2011.03.127
   Jonglareonrak A, 2005, FOOD CHEM, V93, P475, DOI 10.1016/j.foodchem.2004.10.026
   Kittiphattanabawon P, 2010, EUR FOOD RES TECHNOL, V230, P475, DOI 10.1007/s00217-009-1191-0
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Li F, 2009, LWT-FOOD SCI TECHNOL, V42, P945, DOI 10.1016/j.lwt.2008.12.005
   Li H, 2004, FOOD CHEM, V84, P65, DOI 10.1016/S0308-8146(03)00167-5
   Li Y, 2008, THERMOCHIM ACTA, V469, P71, DOI 10.1016/j.tca.2008.01.006
   Liu ZY, 2010, J AGR FOOD CHEM, V58, P1270, DOI 10.1021/jf9032415
   Muiznieks LD, 2013, BBA-MOL BASIS DIS, V1832, P866, DOI 10.1016/j.bbadis.2012.11.022
   Nagai T, 2008, FOOD CHEM, V111, P296, DOI 10.1016/j.foodchem.2008.03.087
   Nalinanon S, 2007, FOOD CHEM, V104, P593, DOI 10.1016/j.foodchem.2006.12.035
   Noitup P, 2006, J FOOD BIOCHEM, V30, P547, DOI 10.1111/j.1745-4514.2006.00081.x
   Nomura Y, 2011, BIOSCI BIOTECH BIOCH, V61, P1919
   Ogawa M, 2003, J AGR FOOD CHEM, V51, P8088, DOI 10.1021/jf034350r
   PAYNE KJ, 1988, BIOPOLYMERS, V27, P1749, DOI 10.1002/bip.360271105
   Potaros T., 2009, Kasetsart Journal, Natural Sciences, V43, P584
   Sae-leaw T, 2013, FOOD CHEM, V141, P2466, DOI 10.1016/j.foodchem.2013.05.049
   Senaratne LS, 2006, BIORESOURCE TECHNOL, V97, P191, DOI 10.1016/j.biortech.2005.02.024
   Tian HL, 2013, COLLOID SURFACE B, V105, P259, DOI 10.1016/j.colsurfb.2013.01.005
   Usha R, 2004, THERMOCHIM ACTA, V409, P201, DOI 10.1016/S0040-6031(03)00335-6
   Veis A, 1994, EXTRACELLULAR MATRIX
   Wang LZ, 2009, J FOOD PROCESS ENG, V32, P743, DOI 10.1111/j.1745-4530.2008.00242.x
   Woo JW, 2008, FOOD HYDROCOLLOID, V22, P879, DOI 10.1016/j.foodhyd.2007.04.015
   Zeng SK, 2009, FOOD CHEM, V116, P879, DOI 10.1016/j.foodchem.2009.03.038
   Zhang ZK, 2006, J SOC LEATH TECH CH, V90, P23
   Zhuang Yongliang, 2009, Journal of Ocean University of China, V8, P171, DOI 10.1007/s11802-009-0171-0
NR 34
TC 2
Z9 2
U1 2
U2 29
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-5142
EI 1097-0010
J9 J SCI FOOD AGR
JI J. Sci. Food Agric.
PD AUG 30
PY 2016
VL 96
IS 11
BP 3795
EP 3800
DI 10.1002/jsfa.7572
PG 6
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
SC Agriculture; Chemistry; Food Science & Technology
GA DR1QU
UT WOS:000379680800022
PM 26676993
DA 2018-10-20
ER

PT J
AU Lorenzetti, M
   Gongadze, E
   Kulkarni, M
   Junkar, I
   Iglic, A
AF Lorenzetti, Martina
   Gongadze, Ekaterina
   Kulkarni, Mukta
   Junkar, Ita
   Iglic, Ales
TI Electrokinetic Properties of TiO2 Nanotubular Surfaces
SO NANOSCALE RESEARCH LETTERS
LA English
DT Article
DE TiO2 nanostructured surfaces; Zeta potential; Surface charge; TiO2
   nanotubes; Anodization
ID TITANIUM-DIOXIDE NANOTUBES; IMPLANT SURFACE; IONIC-STRENGTH;
   AGGREGATION; WETTABILITY; OSTEOBLASTS; ADSORPTION; DIAMETERS; ADHESION
AB Surface charge is one of the most significant properties for the characterisation of a biomaterial, being a key parameter in the interaction of the body implant with the surrounding living tissues. The present study concerns the systematic assessment of the surface charge of electrochemically anodized TiO2 nanotubular surfaces, proposed as coating material for Ti body implants. Biologically relevant electrolytes (NaCl, PBS, cell medium) were chosen to simulate the physiological conditions. The measurements were accomplished as titration curves at low electrolytic concentration (10(-3) M) and as single points at fixed pH but at various electrolytic concentrations (up to 0.1 M). The results showed that all the surfaces were negatively charged at physiological pH. However, the zeta potential values were dependent on the electrolytic conditions (electrolyte ion concentration, multivalence of the electrolyte ions, etc.) and on the surface characteristics (nanotubes top diameter, average porosity, exposed surface area, wettability, affinity to specific ions, etc.). Accordingly, various explanations were proposed to support the different experimental data among the surfaces. Theoretical model of electric double layer which takes into account the asymmetric finite size of ions in electrolyte and orientational ordering of water dipoles was modified according to our specific system in order to interpret the experimental data. Experimental results were in agreement with the theoretical predictions. Overall, our results contribute to enrich the state-of-art on the characterisation of nanostructured implant surfaces at the bio-interface, especially in case of topographically porous and rough surfaces.
C1 [Lorenzetti, Martina; Junkar, Ita] Jozef Stefan Inst, Jamova Cesta 39, Ljubljana 1000, Slovenia.
   [Gongadze, Ekaterina; Kulkarni, Mukta; Iglic, Ales] Univ Ljubljana, Fac Elect Engn, Ljubljana 1000, Slovenia.
RP Iglic, A (reprint author), Univ Ljubljana, Fac Elect Engn, Ljubljana 1000, Slovenia.
EM ales.iglic@fe.uni-lj.si
OI Lorenzetti, Martina/0000-0002-2557-7899
FU Slovenian Research Agency (ARRS) [L7-7566, P2-0232]
FX The authors would like to acknowladge the Slovenian Research Agency
   (ARRS, grant L7-7566) and the grant (P2-0232) for generous financial
   support to carry out this research.
CR Bauer S, 2013, PROG MATER SCI, V58, P261, DOI 10.1016/j.pmatsci.2012.09.001
   Coday BD, 2015, J MEMBRANE SCI, V478, P58, DOI 10.1016/j.memsci.2014.12.047
   Delgado AV, 2007, J COLLOID INTERF SCI, V309, P194, DOI 10.1016/j.jcis.2006.12.075
   DUMONT F, 1990, J COLLOID INTERF SCI, V138, P543, DOI 10.1016/0021-9797(90)90236-H
   EIGEN M, 1954, J PHYS CHEM-US, V58, P702, DOI 10.1021/j150519a007
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Gongadze E, 2015, ELECTROCHIM ACTA, V178, P541, DOI 10.1016/j.electacta.2015.07.179
   Gongadze E, 2012, BIOELECTROCHEMISTRY, V87, P199, DOI 10.1016/j.bioelechem.2011.12.001
   Gongadze E, 2011, INT J NANOMED, V6, P1801, DOI [10.2147/IJN.S21755, 10.2147/IJN.S16982]
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Horvath E, 2014, CHEMPLUSCHEM, V79, P592, DOI 10.1002/cplu.201300426
   Horvath E, 2014, J COLLOID INTERF SCI, V416, P190, DOI 10.1016/j.jcis.2013.10.049
   Kowalski D, 2013, NANO TODAY, V8, P235, DOI 10.1016/j.nantod.2013.04.010
   Kulkarni M, 2015, NANOTECHNOLOGY, V26, DOI 10.1088/0957-4484/26/6/062002
   Kulkarni M, 2014, BIOMATERIAL SURFACE, P111
   Kulkarni M, 2016, BIOPHYS J, V110, p339A, DOI 10.1016/j.bpj.2015.11.1823
   Kulkarni M, 2015, COLLOID SURFACE B, V129, P47, DOI 10.1016/j.colsurfb.2015.03.024
   Kulkarni M, 2015, INT J NANOMED, V10, P1359, DOI 10.2147/IJN.S77492
   Lee K, 2014, CHEM REV, V114, P9385, DOI 10.1021/cr500061m
   Liu W, 2013, COLLOID SURFACE A, V434, P319, DOI 10.1016/j.colsurfa.2013.05.010
   Lorenzetti M, 2015, BIOMED MATER, V10, DOI 10.1088/1748-6041/10/4/045012
   Lorenzetti M, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5521-4
   Mazare A, 2016, CORROS SCI, V103, P215, DOI 10.1016/j.corsci.2015.11.021
   Mendonca G, 2008, BIOMATERIALS, V29, P3822, DOI 10.1016/j.biomaterials.2008.05.012
   Moerke C, 2016, BIOMATERIALS, V76, P102, DOI 10.1016/j.biomaterials.2015.10.030
   Neacsu P, 2014, INT J BIOCHEM CELL B, V55, P187, DOI 10.1016/j.biocel.2014.09.006
   Niecikowska A, 2012, J PHYS CHEM C, V116, P3071, DOI 10.1021/jp211378s
   Oncsik T, 2015, LANGMUIR, V31, P3799, DOI 10.1021/acs.langmuir.5b00225
   Pavlovic M, 2015, J PHYS CHEM C, V119, P24919, DOI 10.1021/acs.jpcc.5b08775
   Ratner B. D., 2001, TITANIUM MED, P1
   Roy P, 2011, ANGEW CHEM INT EDIT, V50, P2904, DOI 10.1002/anie.201001374
   Shekaran A, 2011, BBA-GEN SUBJECTS, V1810, P350, DOI 10.1016/j.bbagen.2010.04.006
   Vinogradov J, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2010JB007593
   WICKE E, 1952, Z ELEKTROCHEM, V56, P551
   Woods DR, 1988, SURFACTANTS CHEM PRO, V19, P369
   Yukselen-Aksoy Y, 2011, ENVIRON EARTH SCI, V62, P697, DOI 10.1007/s12665-010-0556-9
NR 36
TC 7
Z9 7
U1 0
U2 9
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1556-276X
J9 NANOSCALE RES LETT
JI Nanoscale Res. Lett.
PD AUG 25
PY 2016
VL 11
AR 378
DI 10.1186/s11671-016-1594-3
PG 13
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA EH5DL
UT WOS:000391792700001
PM 27562014
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Schrekker, CML
   Sokolovicz, YCA
   Raucci, MG
   Selukar, BS
   Klitzke, JS
   Lopes, W
   Leal, CAM
   de Souza, IOP
   Galland, GB
   dos Santos, JHZ
   Mauler, RS
   Kol, M
   Dagorne, S
   Ambrosio, L
   Teixeira, ML
   Morais, J
   Landers, R
   Fuentefria, AM
   Schrekker, HS
AF Schrekker, Clarissa M. L.
   Sokolovicz, Yuri C. A.
   Raucci, Maria G.
   Selukar, Balaji S.
   Klitzke, Joice S.
   Lopes, William
   Leal, Claudio A. M.
   de Souza, Igor O. P.
   Galland, Griselda B.
   dos Santos, Joao Henrique Z.
   Mauler, Raquel S.
   Kol, Moshe
   Dagorne, Samuel
   Ambrosio, Luigi
   Teixeira, Mario L.
   Morais, Jonder
   Landers, Richard
   Fuentefria, Alexandre M.
   Schrekker, Henri S.
TI Multitask Imidazolium Salt Additives for Innovative Poly(L-lactide)
   Biomaterials: Morphology Control, Candida spp. Biofilm Inhibition, Human
   Mesenchymal Stem Cell Biocompatibility, and Skin Tolerance
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE polylactic acid/poly(L-lactide); imidazolium salt-ionic liquid;
   antibiofilm biomaterial; human mesenchymal stem cell biocompatibility;
   Candida tropicalis; Candida albicans; Candida parapsilosis
ID IONIC LIQUIDS; POLYLACTIC ACID; ANTIBIOFILM ACTIVITY; PHASE-SEPARATION;
   IN-VITRO; SCAFFOLDS; INFECTION; SURFACES; MICROSPHERES; FABRICATION
AB Candida species have great ability to colonize and form biofilms on medical devices, causing infections in human hosts. In this study, poly(L-lactide) films with different imidazolium salt (1-n-hexadecyl-3-methylimidazolium chloride (C(16)MImCl) and 1-n-hexadecyl-3-methylimidazolium methanesulfonate (C(16)MImMeS)) contents were prepared, using the solvent casting process. Poly(L-lactide)-imidazolium salt films were obtained with different surface morphologies (spherical and directional), and the presence of the imidazolium salt in the surface was confirmed. These films with different concentrations of the imidazolium salts C(16)MImCl and C(16)MImMeS presented antibiofilm activity against isolates of Candida tropicalis, Candida parapsilosis, and Candida albicans. The minor antibiofilm concentration assay enabled one to determine that an increasing imidazolium salt content promoted, in general, an increase in the inhibition percentage of biofilm formation. Scanning electron microscopy micrographs confirmed the effective prevention of biofilm formation on the imidazolium salt containing biomaterials. Lower concentrations of the imidazolium salts showed no cytotoxicity, and the poly(L-lactide)-imidazolium salt films presented good cell adhesion and proliferation percentages with human mesenchymal stem cells. Furthermore, no acute microscopic lesions were identified in the histopathological evaluation after contact between the films and pig ear skin. In combination with the good morphological, physicochemical, and mechanical properties, these poly(L-lactide)-based materials with imidazolium salt additives can be considered as promising biomaterials for use in the manufacturing of medical devices.
C1 [Schrekker, Clarissa M. L.; Fuentefria, Alexandre M.] Univ Fed Rio Grande do Sul, Inst Basic Hlth Sci, Porto Alegre, RS, Brazil.
   [Sokolovicz, Yuri C. A.; Selukar, Balaji S.; Klitzke, Joice S.; Leal, Claudio A. M.; Galland, Griselda B.; dos Santos, Joao Henrique Z.; Mauler, Raquel S.; Ambrosio, Luigi; Schrekker, Henri S.] Univ Fed Rio Grande do Sul, Inst Chem, Porto Alegre, RS, Brazil.
   [Lopes, William] Univ Fed Rio Grande do Sul, Dept Mol Biol & Biotechnol, Ctr Biotechnol, Porto Alegre, RS, Brazil.
   [Schrekker, Clarissa M. L.; de Souza, Igor O. P.; Fuentefria, Alexandre M.] Univ Fed Rio Grande do Sul, Fac Pharm, Porto Alegre, RS, Brazil.
   [Morais, Jonder] Univ Fed Rio Grande do Sul, Inst Phys, Porto Alegre, RS, Brazil.
   [Raucci, Maria G.] Natl Res Council Italy, Inst Polymers Composites & Biomat, Naples, Italy.
   [Kol, Moshe] Tel Aviv Univ, Sch Chem, Tel Aviv, Israel.
   [Dagorne, Samuel] Univ Strasbourg, CNRS, Inst Chim Strasbourg, Lab DECOMET, Strasbourg, France.
   [Teixeira, Mario L.] Inst Fed Catarinense, Toxicol & Biochem Lab, Concordia, SC, Brazil.
   [Landers, Richard] Univ Estadual Campinas UNICAMP, Inst Phys Gleb Wataghin, Campinas, SP, Brazil.
RP Fuentefria, AM (reprint author), Univ Fed Rio Grande do Sul, Inst Basic Hlth Sci, Porto Alegre, RS, Brazil.; Schrekker, HS (reprint author), Univ Fed Rio Grande do Sul, Inst Chem, Porto Alegre, RS, Brazil.; Fuentefria, AM (reprint author), Univ Fed Rio Grande do Sul, Fac Pharm, Porto Alegre, RS, Brazil.
EM alexandre.fuentefria@ufrgs.br; henri.schrekker@ufrgs.br
RI Lopes, William/B-5436-2018; Dagorne, Samuel/E-4650-2013; Morais,
   Jonder/E-5022-2013; Mauler, Raquel/L-6614-2014; Inst. of Physics, Gleb
   Wataghin/A-9780-2017
OI Lopes, William/0000-0002-3914-2300; Dagorne, Samuel/0000-0001-7393-286X;
   Morais, Jonder/0000-0002-4143-1208; Lopes, William/0000-0002-6040-3704;
   Teixeira, Mario Lettieri/0000-0003-4546-5584; Schrekker,
   Henri/0000-0002-8173-3841
FU CAPES; CNPq (Science without Borders Special Visiting Scientist
   projects) [402964/2012-8, 400531/2013-5, 405784/2013-9]; FAPERGS; CNPq
FX We acknowledge Corbion Purac for donating PLA and the Center of
   Microscopy and Microanalysis at UFRGS for the SEM and SEM-EDS
   facilities. The Brazilian agencies CAPES, CNPq (Science without Borders
   Special Visiting Scientist projects 402964/2012-8, 400531/2013-5, and
   405784/2013-9), and FAPERGS are acknowledged for financial support.
   H.S.S., J.M., and A.M.F. are grateful to CNPq for the PQ fellowships.
CR Anderson EB, 2010, POLYMER, V51, P2447, DOI 10.1016/j.polymer.2010.02.006
   Belkhir K, 2015, EUR POLYM J, V66, P290, DOI 10.1016/j.eurpolymj.2015.02.025
   Bergamo VZ, 2015, LETT APPL MICROBIOL, V61, P504, DOI 10.1111/lam.12488
   Bergamo VZ, 2015, LETT APPL MICROBIOL, V60, P66, DOI 10.1111/lam.12338
   Bishai M, 2014, EUR POLYM J, V54, P52, DOI 10.1016/j.eurpolymj.2014.01.027
   Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089
   Chen BK, 2013, CHEM ENG J, V215, P886, DOI 10.1016/j.cej.2012.11.078
   Choi SY, 2011, GREEN CHEM, V13, P1527, DOI 10.1039/c1gc15132k
   Coad BR, 2014, BIOTECHNOL ADV, V32, P296, DOI 10.1016/j.biotechadv.2013.10.015
   Cossement D, 2006, APPL SURF SCI, V252, P6636, DOI 10.1016/j.apsusc.2006.02.225
   Costa ACBP, 2013, MYCOSES, V56, P614, DOI 10.1111/myc.12092
   Davachi SM, 2015, POLYM-PLAST TECHNOL, V54, P944, DOI 10.1080/03602559.2014.979507
   DICK IP, 1992, J PHARM PHARMACOL, V44, P640, DOI 10.1111/j.2042-7158.1992.tb05485.x
   Duhring S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00625
   El-Azizi M, 2015, ANN CLIN MICROB ANTI, V14, DOI 10.1186/s12941-015-0083-3
   Fox EP, 2015, MOL MICROBIOL, V96, P1226, DOI 10.1111/mmi.13002
   Garlotta D, 2001, J POLYM ENVIRON, V9, P63, DOI 10.1023/A:1020200822435
   Grumezescu V, 2014, APPL SURF SCI, V302, P262, DOI 10.1016/j.apsusc.2013.09.081
   Hamad K, 2015, EXPRESS POLYM LETT, V9, P435, DOI 10.3144/expresspolymlett.2015.42
   Han X, 2014, MAT SCI ENG C-MATER, V43, P367, DOI 10.1016/j.msec.2014.07.042
   Huang JN, 2015, J SUPERCRIT FLUID, V103, P28, DOI 10.1016/j.supflu.2015.04.019
   Jiang B, 2015, RSC ADV, V5, P50747, DOI 10.1039/c5ra05073a
   Kim SH, 2015, B KOREAN CHEM SOC, V36, P643, DOI 10.1002/bkcs.10125
   Kimura T, 2004, J VET MED SCI, V66, P1147, DOI 10.1292/jvms.66.1147
   Liu LH, 2013, BIOMATERIALS, V34, P1018, DOI 10.1016/j.biomaterials.2012.10.050
   Liu LH, 2012, BIOMATERIALS, V33, P8625, DOI 10.1016/j.biomaterials.2012.08.006
   Liu RH, 2015, J AM CHEM SOC, V137, P2183, DOI 10.1021/ja512567y
   Makarov C, 2013, J MATER SCI-MATER M, V24, P679, DOI 10.1007/s10856-012-4832-y
   Malheiros PD, 2010, FOOD CONTROL, V21, P298, DOI 10.1016/j.foodcont.2009.06.008
   Mi HY, 2013, MAT SCI ENG C-MATER, V33, P4767, DOI 10.1016/j.msec.2013.07.037
   Morace G, 2014, J GLOB ANTIMICROB RE, V2, P254, DOI 10.1016/j.jgar.2014.09.002
   Navale GR, 2015, RSC ADV, V5, P68136, DOI 10.1039/c5ra12854d
   Ohba T, 2015, J PHYS CHEM C, V119, P28424, DOI 10.1021/acs.jpcc.5b09423
   Oncu S, 2014, CLIN NUTR, V33, P360, DOI 10.1016/j.clnu.2013.04.014
   Pannanusorn S, 2013, MYCOSES, V56, P264, DOI 10.1111/myc.12014
   Park J, 2013, CAN VET J, V54, P491
   Pendleton JN, 2015, INT J ANTIMICROB AG, V46, P131, DOI 10.1016/j.ijantimicag.2015.02.016
   Ramage G, 2014, INT J ANTIMICROB AG, V43, P114, DOI 10.1016/j.ijantimicag.2013.10.023
   Raucci Maria G, 2012, J Funct Biomater, V3, P688, DOI 10.3390/jfb3030688
   Riduan SN, 2013, CHEM SOC REV, V42, P9055, DOI 10.1039/c3cs60169b
   Salerno A, 2015, J SUPERCRIT FLUID, V97, P238, DOI 10.1016/j.supflu.2014.10.029
   Sankri A, 2010, CARBOHYD POLYM, V82, P256, DOI 10.1016/j.carbpol.2010.04.032
   Sato G, 2013, J PHYS CHEM B, V117, P9067, DOI 10.1021/jp403195g
   Schrekker HS, 2008, J BRAZIL CHEM SOC, V19, P426, DOI 10.1590/S0103-50532008000300009
   Schrekker HS, 2013, MEDCHEMCOMM, V4, P1457, DOI 10.1039/c3md00222e
   Seddiki SML, 2015, J MYCOL MED, V25, P130, DOI 10.1016/j.mycmed.2015.03.003
   Shameli K, 2010, INT J NANOMED, V5, P573
   Silva-Dias A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00205
   Smiglak M, 2014, CHEM COMMUN, V50, P9228, DOI 10.1039/c4cc02021a
   Thi PTP, 2010, WATER RES, V44, P352, DOI 10.1016/j.watres.2009.09.030
   Trafny EA, 2013, WORLD J MICROB BIOT, V29, P1635, DOI 10.1007/s11274-013-1326-0
   Wang D, 2015, IET NANOBIOTECHNOL, V9, P58, DOI 10.1049/iet-nbt.2013.0011
   Wisplinghoff H, 2014, INT J ANTIMICROB AG, V43, P78, DOI 10.1016/j.ijantimicag.2013.09.005
   Zolghadr AR, 2014, J PHYS CHEM C, V118, P19889, DOI 10.1021/jp506012x
NR 54
TC 2
Z9 2
U1 7
U2 39
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD AUG 24
PY 2016
VL 8
IS 33
BP 21163
EP 21176
DI 10.1021/acsami.6b06005
PG 14
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA DU4JR
UT WOS:000382179400006
PM 27486827
DA 2018-10-20
ER

PT J
AU Singh, YP
   Bhardwaj, N
   Mandal, BB
AF Singh, Yogendra Pratap
   Bhardwaj, Nandana
   Mandal, Biman B.
TI Potential of Agarose/Silk Fibroin Blended Hydrogel for in Vitro
   Cartilage Tissue Engineering
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE silk fibroin; non-mulberry silk; agarose; cartilage; tissue engineering
ID AUTOLOGOUS CHONDROCYTE IMPLANTATION; HUMAN ARTICULAR CHONDROCYTES;
   MESENCHYMAL STEM-CELLS; SILK FIBROIN; PORE-SIZE; CHONDROGENIC
   DIFFERENTIATION; KNEE OSTEOARTHRITIS; BONE-MARROW; SCAFFOLDS; MATRIX
AB An osteoarthritis pandemic has accelerated exploration of various biomaterials for cartilage reconstruction with a special emphasis on silk fibroin from mulberry (Bombyx mori) and non-mulberry (Antheraea assamensis) silk worms. Retention of positive attributes of the agarose standard and nullification of its negatives are central to the current agarose/silk fibroin hydrogel design. In this study, hydrogels of mulberry and non-mulberry silk fibroin blended with agarose were fabricated and evaluated in vitro for two weeks for cartilaginous tissue formation. The fabricated hydrogels were physicochemically characterized and analyzed for cell viability, proliferation, and extra cellular matrix deposition. The amalgamation of silk fibroin with agarose impacted the pore size, as illustrated by field emission scanning electron microscopy studies, swelling behavior, and in vitro degradation of the hydrogels. Fourier transform infrared spectroscopy results indicated the blend formation and confirmed the presence of both components in the fabricated hydrogels. Rheological studies demonstrated enhanced elasticity of blended hydrogels with G' > G ''. Biochemical analysis revealed significantly higher levels of sulfated glycosaminoglycans (sGAGs) and collagen (p <= 0.01) in blended hydrogels. More specifically, the non-mulberry silk fibroin blend showed sGAG and collagen content (similar to 1.5-fold) higher than that of the mulberry blend (p <= 0.05). Histological and immunohistochemical analyses further validated the enhanced deposition of sGAG and collagen, indicating maintenance of chondrogenic phenotype within constructs after two weeks of culture. Real-time PCR analysis further confirmed up-regulation of cartilage-specific aggrecan, sox-9 (similar to 1.5-fold) and collagen type II (similar to 2-fold) marker genes (p <= 0.01) in blended hydrogels. The hydrogels demonstrated immunocompatibility, which was evidenced by minimal in vitro secretion of tumor necrosis factor-alpha (TNF-alpha) by murine macrophages. Taken together, the results suggest promising attributes of blended hydrogels and particularly the non-mulberry silk fibroin/agarose blends as alternative biomaterial for cartilage tissue engineering.
C1 [Singh, Yogendra Pratap; Mandal, Biman B.] Indian Inst Technol Guwahati, Dept Biosci & Bioengn, Biomat & Tissue Engn Lab, Gauhati 781039, Assam, India.
   [Bhardwaj, Nandana] IASST, Div Life Sci, Biol & Chem Sci Sect, Gauhati 781035, Assam, India.
RP Mandal, BB (reprint author), Indian Inst Technol Guwahati, Dept Biosci & Bioengn, Biomat & Tissue Engn Lab, Gauhati 781039, Assam, India.
EM biman.mandal@iitg.ernet.in
OI Singh, Yogendra Pratap/0000-0003-4941-9323; Bhardwaj, Dr.
   Nandana/0000-0002-7747-3661
FU Department of Biotechnology [BT/PR6889/GBD/27/490/2012,
   BT/548/NE/U-EXCEL/2014, BT/Bio-CARe/05/637/2011-12]; Department of
   Science and Technology, Government of India [SB/EMEQ024/2013,
   DST/INT/UK/P-110/2014]
FX B.B.M. wishes to acknowledge the generous funding support from
   Department of Biotechnology (Grants BT/PR6889/GBD/27/490/2012 and
   BT/548/NE/U-EXCEL/2014) and the Department of Science and Technology
   (Grants SB/EMEQ024/2013 and DST/INT/UK/P-110/2014), Government of India.
   N.B. acknowledges the funding support from the Department of
   Biotechnology (Grant BT/Bio-CARe/05/637/2011-12). The authors also
   acknowledge Central Instruments Facility (CIF), IITG for instrumentation
   support. The contribution of Mr. Bibhas Kumar Bhunia (IITG) for his
   valuable suggestions during manuscript preparation is appreciated.
CR Abdel-Sayed P, 2015, NANOMEDICINE-UK, V10, P2893, DOI 10.2217/nnm.15.119
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Baimark Y, 2010, EXPRESS POLYM LETT, V4, P781, DOI 10.3144/expresspolymlett.2010.94
   BELLAMKONDA R, 1995, J BIOMED MATER RES, V29, P663, DOI 10.1002/jbm.820290514
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Bhardwaj N, 2016, J MATER CHEM B, V4, P3670, DOI 10.1039/c6tb00717a
   Bhardwaj N, 2015, INT J BIOL MACROMOL, V81, P31, DOI 10.1016/j.ijbiomac.2015.07.049
   Bhardwaj N, 2012, BIOMATERIALS, V33, P2848, DOI 10.1016/j.biomaterials.2011.12.028
   Bhardwaj N, 2011, BIOMATERIALS, V32, P5773, DOI 10.1016/j.biomaterials.2011.04.061
   Bhat S, 2011, J R SOC INTERFACE, V8, P540, DOI 10.1098/rsif.2010.0455
   Brown J, 2015, ACTA BIOMATER, V11, P212, DOI 10.1016/j.actbio.2014.09.013
   BUSCHMANN MD, 1995, J CELL SCI, V108, P1497
   BUSCHMANN MD, 1992, J ORTHOPAED RES, V10, P745, DOI 10.1002/jor.1100100602
   Cao Z, 2009, BIOMACROMOLECULES, V10, P2954, DOI 10.1021/bm900670n
   Chao PHG, 2010, J BIOMED MATER RES B, V95B, P84, DOI 10.1002/jbm.b.31686
   Chen CH, 2014, MATERIALS, V7, P2104, DOI 10.3390/ma7032104
   Doulabi AH, 2014, MATERIALS, V7, P5327, DOI 10.3390/ma7075327
   Fernandez-Cossio S, 2007, PLAST RECONSTR SURG, V120, P1161, DOI 10.1097/01.prs.0000279475.99934.71
   Forget A, 2013, P NATL ACAD SCI USA, V110, P12887, DOI 10.1073/pnas.1222880110
   Francioli SE, 2010, J BIOMED MATER RES A, V95A, P924, DOI 10.1002/jbm.a.32917
   Gruber HE, 1997, EXP CELL RES, V235, P13, DOI 10.1006/excr.1997.3647
   Gupta Adarsh K., 2015, Scientific Reports, V5, P12706, DOI 10.1038/srep12706
   Gupta P, 2016, ACS APPL MATER INTER, V8, P15874, DOI 10.1021/acsami.6b00783
   Han KS, 2015, MACROMOL RES, V23, P1091, DOI 10.1007/s13233-015-3156-4
   Hinman RS, 2010, ARTHRIT CARE RES, V62, P1190, DOI 10.1002/acr.20199
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Hunter CJ, 2004, TISSUE ENG, V10, P736, DOI 10.1089/1076327041348310
   Kang JH, 2009, TISSUE ENG PT A, V15, P2227, DOI 10.1089/ten.tea.2008.0469
   Kar S, 2013, TISSUE ENG REGEN MED, V10, P200, DOI 10.1007/s13770-012-0008-6
   Kwon H, 2013, ACTA BIOMATER, V9, P6563, DOI 10.1016/j.actbio.2013.01.004
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Le Goff KJ, 2015, CARBOHYD POLYM, V116, P117, DOI 10.1016/j.carbpol.2014.04.085
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Li MZ, 2003, BIOMATERIALS, V24, P357, DOI 10.1016/S0142-9612(02)00326-5
   Liao JF, 2015, SCI REP-UK, V5, DOI 10.1038/srep09879
   Lien SM, 2009, ACTA BIOMATER, V5, P670, DOI 10.1016/j.actbio.2008.09.020
   Lima EG, 2007, OSTEOARTHR CARTILAGE, V15, P1025, DOI 10.1016/j.joca.2007.03.008
   Loeser RF, 2014, MATRIX BIOL, V39, P11, DOI 10.1016/j.matbio.2014.08.007
   Lovett M, 2010, ORGANOGENESIS, V6, P217, DOI [10.4161/org.6.4.13407, 10.4161/org6.4.13407]
   Mahmoud A. A., 2014, MIDDLE E J APPL SCI, V4, P816
   Malicev E, 2009, J ORTHOP RES, V27, P943, DOI 10.1002/jor.20833
   Mandal BB, 2008, BIOTECHNOL BIOENG, V99, P1482, DOI 10.1002/bit.21699
   Mandal BB, 2010, TISSUE ENG PT A, V16, P2391, DOI [10.1089/ten.tea.2009.0206, 10.1089/ten.TEA.2009.0206]
   Mandal BB, 2012, P NATL ACAD SCI USA, V109, P7699, DOI 10.1073/pnas.1119474109
   Mandal BB, 2011, BIOMATERIALS, V32, P639, DOI 10.1016/j.biomaterials.2010.08.115
   Matsiko A, 2015, TISSUE ENG PT A, V21, P486, DOI [10.1089/ten.tea.2013.0545, 10.1089/ten.TEA.2013.0545]
   Mauney JR, 2007, BIOMATERIALS, V28, P5280, DOI 10.1016/j.biomaterials.2007.08.017
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Park SY, 2010, TISSUE ENG PT A, V16, P1271, DOI [10.1089/ten.tea.2009.0328, 10.1089/ten.TEA.2009.0328]
   Piscitelli P, 2012, ARTHRIT CARE RES, V64, P1320, DOI 10.1002/acr.21706
   Priya MV, 2015, J FUNCT BIOMATER, V6, P849, DOI 10.3390/jfb6030849
   Redman S N, 2005, Eur Cell Mater, V9, P23
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Saha S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080004
   Sakai S, 2007, J BIOSCI BIOENG, V103, P22, DOI 10.1263/jbb.103.22
   Selmi TAS, 2008, J BONE JOINT SURG BR, V90B, P597, DOI 10.1302/0301-620X.90B5.20360
   Talukdar B., 2011, INT J PURE APPL SCI, V7, P81
   Tullberg-Reinert H, 1999, HISTOCHEM CELL BIOL, V112, P271, DOI 10.1007/s004180050447
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang HY, 2015, BIOTECHNOL PROGR, V31, P630, DOI 10.1002/btpr.2058
   Wang LM, 2010, BIOMATERIALS, V31, P1612, DOI 10.1016/j.biomaterials.2009.11.024
   Wang XQ, 2008, BIOMATERIALS, V29, P1054, DOI 10.1016/j.biomaterials.2007.11.003
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022
   WHITLEY CB, 1989, CLIN CHEM, V35, P374
   Yodmuang S, 2015, ACTA BIOMATER, V11, P27, DOI 10.1016/j.actbio.2014.09.032
   You RC, 2015, BIOMED MATER, V10, DOI 10.1088/1748-6041/10/1/015003
   Zhang Q, 2014, ACTA BIOMATER, V10, P2005, DOI 10.1016/j.actbio.2013.12.042
NR 70
TC 31
Z9 32
U1 7
U2 79
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD AUG 24
PY 2016
VL 8
IS 33
BP 21236
EP 21249
DI 10.1021/acsami.6b08285
PG 14
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA DU4JR
UT WOS:000382179400014
PM 27459679
DA 2018-10-20
ER

PT J
AU Huang, DX
   Lin, C
   Wen, XJ
   Gu, SY
   Zhao, P
AF Huang, Daoxiang
   Lin, Chao
   Wen, Xuejun
   Gu, Shuying
   Zhao, Peng
TI A Potential Nanofiber Membrane Device for Filling Surgical Residual
   Cavity to Prevent Glioma Recurrence and Improve Local Neural Tissue
   Reconstruction
SO PLOS ONE
LA English
DT Article
ID NERVE GROWTH-FACTOR; GLIOBLASTOMA-MULTIFORME; VASCULOGENIC MIMICRY;
   CANCER RECURRENCE; TEMOZOLOMIDE; CELLS; CHEMOTHERAPY; COMBINATION;
   THERAPY; MICE
AB This study aims to develop a novel device with nanofiber membrane capable of sustained release of temozolomide (TMZ) and neuron growth factor (NGF). An improved bio-availability of TMZ and NGF in surroundings proximal to the device was expected to be attained for a prolonged period of time. The device was developed by integrating TMZ-doped polycaprolactone (PCL) nanofiber (TP) membrane and NGF-coated PCL (NGFP) membrane using sodium alginate hydrogel. TP was prepared by direct electrospinning of TMZ/ PCL. NGFP membrane was developed by layer-by-layer assembling technology. The incorporation of TMZ-doped nanofiber and NGFP nanofiber in the device was confirmed by scanning electron microscopy. The number of NGF layer in NGF-coated PCL membrane could be readily measured with energy spectrum analysis. The in vitro release study showed that TP-NGFP-TP membrane could efficiently liberate TMZ to inhibit the growth of C6 glioma cells, and sufficient NGF to induce the differentiation of PC12 neuron cells over four weeks. Such TP-NGFP-TP membrane device can be employed as a tampon to fill up surgical residual cavity and afford residual glioma removal, structural support, hemostasis, and local neural tissue reconstruction in the surgical treatment of glioma. The study opens a horizon to develop multifunctional biomaterial device for maximized glioma treatment efficacy.
C1 [Huang, Daoxiang; Lin, Chao; Wen, Xuejun; Zhao, Peng] Tongji Univ, Sch Med, Shanghai East Hosp, Inst Biomed Engn & Nanosci,Inst Translat Nanomed, Shanghai, Peoples R China.
   [Gu, Shuying] Tongji Univ, Sch Mat Sci & Engn, Minist Educ, Key Lab Adv Civil Engn Mat, Shanghai, Peoples R China.
   [Huang, Daoxiang; Gu, Shuying] Tongji Univ, Sch Mat Sci & Engn, Inst Nano & Biopolymer Mat, Shanghai, Peoples R China.
RP Zhao, P (reprint author), Tongji Univ, Sch Med, Shanghai East Hosp, Inst Biomed Engn & Nanosci,Inst Translat Nanomed, Shanghai, Peoples R China.; Gu, SY (reprint author), Tongji Univ, Sch Mat Sci & Engn, Minist Educ, Key Lab Adv Civil Engn Mat, Shanghai, Peoples R China.; Gu, SY (reprint author), Tongji Univ, Sch Mat Sci & Engn, Inst Nano & Biopolymer Mat, Shanghai, Peoples R China.
EM gushuying@tongji.edu.cn; zp@tongji.edu.cn
FU Ministry of Science and Technology of the People's Republic of China
   [2014CB964600, 2012CB966300]; National Natural Science Funds of China
   [81271369]; Fundamental Research Funds for the Central Universities
FX This work was supported by the Ministry of Science and Technology of the
   People's Republic of China (2014CB964600 to Dr. Peng Zhao); Ministry of
   Science and Technology of the People's Republic of China (2012CB966300
   to Dr. Xuejun Wen); National Natural Science Funds of China (81271369 to
   Dr. Xuejun Wen); and Fundamental Research Funds for the Central
   Universities (Dr. Peng Zhao).
CR Aloe L, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-239
   Falsini B, 2016, BRAIN, V139, P404, DOI 10.1093/brain/awv366
   Feng XY, 2015, ACS APPL MATER INTER, V7, P27885, DOI 10.1021/acsami.5b09934
   Gonzalez-Astorga B, 2013, EUR J CANCER, V49, pS794
   Goodenberger ML, 2012, CANCER GENET-NY, V205, P613, DOI 10.1016/j.cancergen.2012.10.009
   GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424
   Ju RJ, 2016, INT J NANOMED, V11, P1131, DOI 10.2147/IJN.S94467
   Kaplan JA, 2016, BIOMATERIALS, V76, P273, DOI 10.1016/j.biomaterials.2015.10.060
   Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190
   Liu G., 2006, MOL CANC, V5
   Liu S, 2015, NANOMED-NANOTECHNOL, V11, P1047, DOI 10.1016/j.nano.2015.03.001
   Liu YP, 2015, WORLD J SURG ONCOL, V13, DOI 10.1186/s12957-015-0558-x
   Middleton MR, 2002, INT J CANCER, V100, P615, DOI 10.1002/ijc.10532
   Mustafa AM, 2016, FOOD CHEM, V192, P782, DOI 10.1016/j.foodchem.2015.07.079
   Naito E, 2015, IN VITRO CELL DEV-AN, V51, P1012, DOI 10.1007/s11626-015-9935-6
   Narin S, 2013, FEBS J, V280, P418
   Ni SL, 2014, ANN BIOMED ENG, V42, P214, DOI 10.1007/s10439-013-0903-6
   Okonogi N, 2015, ANTICANCER RES, V35, P1229
   Paw I, 2015, CANCER LETT, V362, P1, DOI 10.1016/j.canlet.2015.03.015
   Reardon DA, 2006, ONCOLOGIST, V11, P152, DOI 10.1634/theoncologist.11-2-152
   Zhu T, 2015, J APPL POLYM SCI, V132
   Zong S, 2015, EUR J PHARM BIOPHARM, V93, P127, DOI 10.1016/j.ejpb.2015.03.029
NR 22
TC 3
Z9 3
U1 3
U2 27
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 22
PY 2016
VL 11
IS 8
AR e0161435
DI 10.1371/journal.pone.0161435
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DT8TP
UT WOS:000381768400057
PM 27548322
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Daniele, M
   Lavelle, V
   Wilkins, M
AF Daniele, Michael
   Lavelle, Veronica
   Wilkins, Michael
TI Biomaterial and bio-nanocomposite thin-films for printed bioelectronics
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 [Daniele, Michael; Wilkins, Michael] NC State Univ, Elect & Comp Engn, Raleigh, NC USA.
   [Daniele, Michael; Lavelle, Veronica] NC State Univ, UNC Chapel Hill, Biomed Engn, Raleigh, NC USA.
EM mdaniel6@ncsu.edu
NR 0
TC 0
Z9 0
U1 1
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 20
PY 2016
VL 252
MA 155
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA VC1TV
UT WOS:000431460404099
DA 2018-10-20
ER

PT J
AU Kisley, L
   Braun, P
   Gruebele, M
   Leckband, D
AF Kisley, Lydia
   Braun, Paul
   Gruebele, Martin
   Leckband, Deborah
TI Fast relaxation imaging of protein structure, stability, and folding in
   biomaterial environments with variable crowding
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 [Braun, Paul; Gruebele, Martin; Leckband, Deborah] Univ Illinois, Urbana, IL 61801 USA.
   [Kisley, Lydia] Univ Illinois, Beckman Inst, Urbana, IL USA.
EM lkisley11@gmail.com
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 20
PY 2016
VL 252
MA 103
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA VC1TV
UT WOS:000431460402454
DA 2018-10-20
ER

PT J
AU Korley, L
   Jordan, A
   Wanasekara, N
AF Korley, LaShanda
   Jordan, Alex
   Wanasekara, Nandula
TI Toward fibrous biomaterial scaffolds: Manufacturing and
   functionalization strategies
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 [Korley, LaShanda; Jordan, Alex; Wanasekara, Nandula] Case Western Reserve Univ, Cleveland, OH 44106 USA.
   [Korley, LaShanda; Jordan, Alex] Ctr Layered Polymer Syst, Cleveland, OH USA.
EM lashanda.korley@case.edu
NR 0
TC 0
Z9 0
U1 1
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 20
PY 2016
VL 252
MA 2
PG 2
WC Chemistry, Multidisciplinary
SC Chemistry
GA VC1TV
UT WOS:000431460403749
DA 2018-10-20
ER

PT J
AU Mees, M
   Toft, C
   McAllister, T
   Curia, S
   Howdle, S
   Hoogenboom, R
AF Mees, Maarten
   Toft, Charles
   McAllister, Thomas
   Curia, Silvio
   Howdle, Steven
   Hoogenboom, Richard
TI Fizzy approach to PEI processing yielding a fluorescent biomaterial
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 [Hoogenboom, Richard] Univ Ghent, Terneuzen, Netherlands.
   [Mees, Maarten] Ugent, Ghent, Belgium.
   [Toft, Charles; McAllister, Thomas; Curia, Silvio; Howdle, Steven] Univ Nottingham, Chem, Nottingham, England.
EM maarten.mees@ugent.be
NR 0
TC 0
Z9 0
U1 1
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 20
PY 2016
VL 252
MA 272
PG 2
WC Chemistry, Multidisciplinary
SC Chemistry
GA VC1TV
UT WOS:000431460404212
DA 2018-10-20
ER

PT J
AU Sala, R
   Kwon, M
   Camargo, E
   Burdick, J
AF Sala, Renata
   Kwon, Michelle
   Camargo, Emerson
   Burdick, Jason
TI Development of thermosensitive poly(N-vinylcaprolactam) as an injectable
   biomaterial
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 [Sala, Renata] Univ Fed Sao Carlos, Chem, Philadelphia, PA USA.
   [Camargo, Emerson] UFSCAR Fed Univ Sao Carlos, Dept Chem, Sao Carlos, SP, Brazil.
   [Burdick, Jason] Univ Penn, 240 Skirkanich Hall, Philadelphia, PA 19104 USA.
   [Sala, Renata; Kwon, Michelle] Univ Penn, Bioengn, Philadelphia, PA 19104 USA.
EM renata.lang89@gmail.com
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 20
PY 2016
VL 252
MA 550
PG 2
WC Chemistry, Multidisciplinary
SC Chemistry
GA VC1TV
UT WOS:000431460404484
DA 2018-10-20
ER

PT J
AU Shah, R
   Rutz, A
AF Shah, Ramille
   Rutz, Alexandra
TI Biomaterial ink synthesis platform for 3D printing customizable,
   cell-laden hydrogels
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 [Shah, Ramille] Northwestern Univ, Mat Sci & Engn & Surg, Chicago, IL 60611 USA.
   [Rutz, Alexandra] Northwestern Univ, Biomed Engn, Chicago, IL 60611 USA.
EM ramille@gmail.com; arutz13@gmail.com
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 20
PY 2016
VL 252
MA 271
PG 2
WC Chemistry, Multidisciplinary
SC Chemistry
GA VC1TV
UT WOS:000431460403330
DA 2018-10-20
ER

PT J
AU Spiller, K
AF Spiller, Kara
TI Novel strategies to modulate the inflammatory response to biomaterial
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 [Spiller, Kara] Drexel Univ, Biomed Engn, Philadelphia, PA 19104 USA.
EM kls35@drexel.edu
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 20
PY 2016
VL 252
MA 449
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA VC1TU
UT WOS:000431460203104
DA 2018-10-20
ER

PT J
AU Karunanithi, P
   Murali, MR
   Samuel, S
   Raghavendran, HRB
   Abbas, AA
   Kamarul, T
AF Karunanithi, Puvanan
   Murali, Malliga Raman
   Samuel, Shani
   Raghavendran, Hanumanantha Rao Balaji
   Abbas, Azlina Amir
   Kamarul, Tunku
TI Three dimensional alginate-fucoidan composite hydrogel augments the
   chondrogenic differentiation of mesenchymal stromal cells
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Mesenchymal stromal cells; Alginate; Fucoidan; Chondrogenesis;
   Cartilage; Microenvironment
ID STEM-CELLS; BONE-MARROW; GENE-EXPRESSION; IN-VITRO; SULFATION; AFFINITY;
   CULTURE; MATRIX; PROLIFERATION; CHONDROCYTES
AB Presence of sulfated polysaccharides like heparan sulphate has often been implicated in the regulation of chondrogenesis. However, recently there has been a plethora of interest in the use of non-animal extracted analogs of heparan sulphate. Here we remodeled alginate (1.5%) by incorporating fucoidan (0.5%), a natural sulphated polysaccharide extracted from seaweeds to form a composite hydrogel (Al-Fu), capable of enhancing chondrogenesis of human mesenchymal stromal cells (hMSCs). We confirmed the efficiency of fucoidan incorporation by FTIR and EDX analysis. Further, its ability to support hMSC attachment and chondrogenic differentiation was confirmed by SEM, biochemical glycosaminoglycan quantification, real-time quantitative PCR and immunocytochemical analyses of chondrogenic markers Sox-9, Collagen II, Aggrecan and COMP. Effect of Al-Fu hydrogel on hMSC hypertrophy was also confirmed by the downregulation of hypertrophic genes Collagen X and Runx2. This composite scaffold can hence be used as a cartilage biomimetic biomaterial to drive hMSC chondrogenesis and for other cartilage repair based therapies. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Karunanithi, Puvanan; Murali, Malliga Raman; Samuel, Shani; Raghavendran, Hanumanantha Rao Balaji; Abbas, Azlina Amir; Kamarul, Tunku] Univ Malaya, Fac Med, NOCERAL, Tissue Engn Grp,Dept Orthopaed Surg, Kuala Lumpur 50603, Malaysia.
   [Samuel, Shani] Univ Malaya, Fac Med, Dept Physiol, Kuala Lumpur 50603, Malaysia.
RP Murali, MR (reprint author), Univ Malaya, Fac Med, NOCERAL, Tissue Engn Grp,Dept Orthopaed Surg, Kuala Lumpur 50603, Malaysia.
EM drmurali@um.edu.my; tkzrea@um.edu.my
RI Malliga Raman, Murali/A-6987-2012; ABBAS, AZLINA/B-5405-2010; Tunku
   Zainol Abidin, Tunku Kamarul Zaman/B-9633-2011
OI Malliga Raman, Murali/0000-0002-5696-4541; ABBAS,
   AZLINA/0000-0003-4423-4653; Tunku Zainol Abidin, Tunku Kamarul
   Zaman/0000-0002-6028-1313
FU University of Malaya [BK034-2014]; MOSTI [02-01-03-SF1114]; HIR-MoE
   research grant initiative [UM.C/625/1/HIR/MOHE/CHAN/03, A000003-50001]
FX This work was supported by University of Malaya's BKP Grant
   (BK034-2014), MOSTI's Science Fund (02-01-03-SF1114) and HIR-MoE
   research grant initiative (Reference number-UM.C/625/1/HIR/MOHE/CHAN/03,
   account number A000003-50001).
CR Ale MT, 2011, MAR DRUGS, V9, P2106, DOI 10.3390/md9102106
   Barry F, 2001, EXP CELL RES, V268, P189, DOI 10.1006/excr.2001.5278
   Bosnakovski D, 2006, BIOTECHNOL BIOENG, V93, P1152, DOI 10.1002/bit.20828
   Caron MMJ, 2013, OSTEOARTHR CARTILAGE, V21, P604, DOI 10.1016/j.joca.2013.01.009
   Chen FH, 2006, NAT CLIN PRACT RHEUM, V2, P373, DOI 10.1038/ncprheum0216
   Dashtdar H., 2016, PEERJ
   Fan LH, 2011, CARBOHYD POLYM, V83, P1797, DOI 10.1016/j.carbpol.2010.10.038
   Fernandes AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062994
   Freeman I, 2008, BIOMATERIALS, V29, P3260, DOI 10.1016/j.biomaterials.2008.04.025
   French MM, 1999, J CELL BIOL, V145, P1103, DOI 10.1083/jcb.145.5.1103
   Ghone NV, 2012, J CELL PHYSIOL, V227, P3701, DOI 10.1002/jcp.24078
   Gibson G, 1997, EXP CELL RES, V233, P372, DOI 10.1006/excr.1997.3576
   Jeon O, 2011, J CONTROL RELEASE, V154, P258, DOI 10.1016/j.jconrel.2011.06.027
   Karus M, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-20
   Kawamura D, 2014, J ORTHOP SCI, V19, P1028, DOI 10.1007/s00776-014-0643-y
   Kim KS, 2003, POLYM-KOREA, V27, P583
   Kim M, 2013, ACTA BIOMATER, V9, P7833, DOI 10.1016/j.actbio.2013.04.041
   Lee HJ, 2008, TISSUE ENG PT A, V14, P1843, DOI 10.1089/ten.tea.2007.0204
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Little CJ, 2014, J FUNCT BIOMATER, V5, P197, DOI 10.3390/jfb5030197
   Ma HL, 2003, J BIOMED MATER RES A, V64A, P273, DOI 10.1002/jbm.a.10370
   MACKIE EJ, 1987, J CELL BIOL, V105, P2569, DOI 10.1083/jcb.105.6.2569
   McBride SH, 2008, TISSUE ENG PT A, V14, P1561, DOI 10.1089/ten.tea.2008.0112
   Mhanna R, 2014, TISSUE ENG PT A, V20, P1454, DOI [10.1089/ten.tea.2013.0544, 10.1089/ten.TEA.2013.0544]
   NAGASAWA K, 1984, J BIOCHEM-TOKYO, V95, P619, DOI 10.1093/oxfordjournals.jbchem.a134650
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Re'em T, 2012, BIOMATERIALS, V33, P751, DOI 10.1016/j.biomaterials.2011.10.007
   Shu ZH, 2015, INFLAMMATION, V38, P1777, DOI 10.1007/s10753-015-0155-8
   Vidal MA, 2008, VET SURG, V37, P713, DOI 10.1111/j.1532-950X.2008.00462.x
   Xu JP, 2008, TISSUE ENG PT A, V14, P667, DOI 10.1089/tea.2007.0272
   Zaucke F, 2001, BIOCHEM J, V358, P17, DOI 10.1042/0264-6021:3580017
   Zhou G, 2006, P NATL ACAD SCI USA, V103, P19004, DOI 10.1073/pnas.0605170103
NR 32
TC 6
Z9 7
U1 8
U2 59
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD AUG 20
PY 2016
VL 147
BP 294
EP 303
DI 10.1016/j.carbpol.2016.03.102
PG 10
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA DM6GR
UT WOS:000376449300035
PM 27178935
DA 2018-10-20
ER

PT J
AU Pezzotti, G
   McEntire, BJ
   Bock, R
   Boffelli, M
   Zhu, WL
   Vitale, E
   Puppulin, L
   Adachi, T
   Yamamoto, T
   Kanamura, N
   Bal, BS
AF Pezzotti, Giuseppe
   McEntire, Bryan J.
   Bock, Ryan
   Boffelli, Marco
   Zhu, Wenliang
   Vitale, Eleonora
   Puppulin, Leonardo
   Adachi, Tetsuya
   Yamamoto, Toshiro
   Kanamura, Narisato
   Bal, B. Sonny
TI Silicon Nitride: A Synthetic Mineral for Vertebrate Biology
SO SCIENTIFIC REPORTS
LA English
DT Article
ID HYDROXYAPATITE SURFACES; ADSORPTION; CERAMICS
AB The remarkable stoichiometric flexibility of hydroxyapatite (HAp) enables the formation of a variety of charged structural sites at the material's surface which facilitates bone remodeling due to binding of biomolecule moieties in zwitterionic fashion. In this paper, we report for the first time that an optimized biomedical grade silicon nitride (Si3N4) demonstrated cell adhesion and improved osteoconductivity comparable to highly defective, non-stoichiometric natural hydroxyapatite. Si3N4's zwitterionic-like behavior is a function of the dualism between positive and negative charged off-stoichiometric sites (i.e., N-vacancies versus silanols groups, respectively). Lattice defects at the biomaterial's surface greatly promote interaction with positively- and negatively-charged functional groups in biomolecules, and result in the biologically effective characteristics of silicon nitride. These findings are anticipated to be a starting point for further discoveries of therapeutic bone-graft substitute materials.
C1 [Pezzotti, Giuseppe; Boffelli, Marco; Vitale, Eleonora] Kyoto Inst Technol, Ceram Phys Lab, Sakyo Ku, Kyoto 6068126, Japan.
   [McEntire, Bryan J.; Bock, Ryan; Bal, B. Sonny] Amedica Corp, 1885 West 2100 South, Salt Lake City, UT 84119 USA.
   [Zhu, Wenliang] Osaka Univ, Dept Med Engn Treatment Bone & Joint Disorders, 2-2 Yamadaoka, Suita, Osaka 5650854, Japan.
   [Puppulin, Leonardo] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Cell Physiol, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.
   [Adachi, Tetsuya; Yamamoto, Toshiro; Kanamura, Narisato] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Dent Med, Kamigyo Ku, Kyoto 6028566, Japan.
   [Bal, B. Sonny] Univ Missouri, Dept Orthopaed Surg, Columbia, MO 65212 USA.
RP Pezzotti, G (reprint author), Kyoto Inst Technol, Ceram Phys Lab, Sakyo Ku, Kyoto 6068126, Japan.
EM pezzotti@kit.ac.jp
CR Bock RM, 2015, ACTA BIOMATER, V26, P318, DOI 10.1016/j.actbio.2015.08.014
   Cappariello A, 2015, BIOMATERIALS, V46, P58, DOI 10.1016/j.biomaterials.2014.12.033
   Gorth DJ, 2012, INT J NANOMED, V7, P4829, DOI 10.2147/IJN.S35190
   KAY MI, 1964, NATURE, V204, P1050, DOI 10.1038/2041050a0
   Liu PS, 2014, ACS APPL MATER INTER, V6, P7141, DOI 10.1021/am501967y
   Pan HH, 2007, LANGMUIR, V23, P8972, DOI 10.1021/la700567r
   Rimola A, 2008, J AM CHEM SOC, V130, P16181, DOI 10.1021/ja806520d
   Rouahi M, 2006, J BIOMED MATER RES A, V78A, P222, DOI 10.1002/jbm.a.30682
   Santos C, 2007, MAT SCI ENG C-BIO S, V27, P148, DOI 10.1016/j.msec.2006.04.003
   Schlenoff JB, 2014, LANGMUIR, V30, P9625, DOI 10.1021/la500057j
   Uskokovic V, 2015, RSC ADV, V5, P36614, DOI 10.1039/c4ra17180b
   Vaccaro AR, 2002, ORTHOPEDICS, V25, pS571
   Weiss L, 1909, Z ANORG CHEM, V65, P38, DOI 10.1002/zaac.19090650107
   Zhu WL, 2015, J PHYS CHEM C, V119, P3279, DOI 10.1021/jp509995c
NR 14
TC 10
Z9 10
U1 0
U2 8
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD AUG 19
PY 2016
VL 6
AR 31717
DI 10.1038/srep31717
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DT7NI
UT WOS:000381673100001
PM 27539146
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Monsees, TK
AF Monsees, Thomas K.
TI Biocompatibility and Anti-Microbiological Activity Characterization of
   Novel Coatings for Dental Implants: A Primer for Non-Biologists
SO FRONTIERS IN MATERIALS
LA English
DT Review
DE medical devices; biomaterial; biocompatibility; implants; coatings; cell
   adhesion; microorganisms
ID CELL-ADHESION; TITANIUM; DIFFERENTIATION; BIOMATERIALS; DEPOSITION;
   MIGRATION; ZIRCONIUM; SURFACES
AB With regard to biocompatibility, the cardinal requirement for dental implants and other medical devices that are in long-term contact with tissue is that the material does not cause any adverse effect to the patient. To warrant stability and function of the implant, proper osseointegration is a further prerequisite. Cells interact with the implant surface as the interface between bulk material and biological tissue. Whereas structuring, deposition of a thin film, or other modifications of the surface are crucial parameters in determining favorable adhesion of cells, corrosion of metal surfaces and release of ions can affect cell viability. Both parameters are usually tested using in vitro cytotoxicity and adhesion assays with bone or fibroblasts cells. For bioactive surface modifications, further tests should be considered for biocompatibility evaluation. Depending on the type of modification, this may include analysis of specific cell functions or the determination of antimicrobial activities. The latter is of special importance as bacteria and yeast present in the oral cavity can be introduced during the implantation process and this may lead to chronic infections and implant failure. An antimicrobial coating of the implant is a way to avoid that. This review describes the essential biocompatibility assays for evaluation of new implant materials required by International Organization for Standardization 10993 and also provides an overview of recent test methods for specific coatings of dental implants.
C1 [Monsees, Thomas K.] Univ Western Cape, Dept Med Biosci, Bellville, South Africa.
RP Monsees, TK (reprint author), Univ Western Cape, Dept Med Biosci, Bellville, South Africa.
EM tmonsees@uwc.ac.za
CR Abraham Celeste M, 2014, Open Dent J, V8, P50, DOI 10.2174/1874210601408010050
   Actis L, 2013, J KOR ASSOC ORAL MAX, V39, P43, DOI 10.5125/jkaoms.2013.39.2.43
   Anil S, 2011, IMPLANT DENTISTRY - A RAPIDLY EVOLVING PRACTICE, P83
   Avila G, 2009, IMPLANT DENT, V18, P17, DOI 10.1097/ID.0b013e318192cb7d
   Bierbaum S, 2006, J BIOMED MATER RES A, V77A, P551, DOI 10.1002/jbm.a.30572
   Bindschadler M, 2007, J CELL SCI, V120, P876, DOI 10.1242/jcs.03395
   Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089
   Chung RJ, 2006, J BIOMED MATER RES B, V76B, P169, DOI 10.1002/jbm.b.30365
   Cohen M, 2004, CHEMBIOCHEM, V5, P1393, DOI 10.1002/cbic.200400162
   Dalby MJ, 2008, J R SOC INTERFACE, V5, P1055, DOI 10.1098/rsif.2008.0016
   Ehrenfest DMD, 2010, TRENDS BIOTECHNOL, V28, P198, DOI 10.1016/j.tibtech.2009.12.003
   Garcia AJ, 2005, J DENT RES, V84, P407, DOI 10.1177/154405910508400502
   Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9
   Hasan J, 2013, TRENDS BIOTECHNOL, V31, P31, DOI 10.1016/j.tibtech.2013.01.017
   Hempel U, 2004, J BIOMED MATER RES B, V71B, P130, DOI 10.1002/jbm.b.30082
   Huang QL, 2016, MAT SCI ENG C-MATER, V67, P195, DOI 10.1016/j.msec.2016.05.051
   Jemat A, 2015, BIOMED RES INT, DOI 10.1155/2015/791725
   Kargupta R, 2014, WIRES NANOMED NANOBI, V6, P475, DOI 10.1002/wnan.1273
   Karlsson J, 2014, NANO LETT, V14, P4220, DOI [10.1021/nl1501564f, 10.1021/nl501564f]
   Kikuchi M, 2013, BIOL PHARM BULL, V36, P1666
   Kim J, 2015, REGEN BIOMATER, V2, P1, DOI 10.1093/rb/rbu019
   Le Guehennec L, 2004, EUROPEAN CELLS MAT, V8, P1, DOI DOI 10.22203/ECM.V008A01
   Lesniewicz A, 2010, INT BIODETER BIODEGR, V64, P81, DOI 10.1016/j.ibiod.2009.09.012
   Lu T, 2012, INTERFACE FOCUS, V2, P325, DOI 10.1098/rsfs.2012.0003
   Meyer U, 2005, Eur Cell Mater, V9, P39
   Monsees TK, 2005, CELLS TISSUES ORGANS, V180, P81, DOI 10.1159/000086749
   Moon KS, 2015, BIOMED RES INT, DOI 10.1155/2015/742192
   Novaes Jr Arthur Belém, 2010, Braz. Dent. J., V21, P471, DOI 10.1590/S0103-64402010000600001
   Ozkucur N, 2010, J BIOMED MATER RES A, V93A, P258, DOI 10.1002/jbm.a.32541
   Oprea WE, 2003, J CRANIOFAC SURG, V14, P292, DOI 10.1097/00001665-200305000-00006
   Ozkucur N, 2009, J BIOMED MATER RES A, V89A, P57, DOI 10.1002/jbm.a.32003
   Patenge N, 2012, BIOFOULING, V28, P267, DOI 10.1080/08927014.2012.671305
   Pye AD, 2009, J HOSP INFECT, V72, P104, DOI 10.1016/j.jhin.2009.02.010
   Rimondini L, 1997, J PERIODONTOL, V68, P556, DOI 10.1902/jop.1997.68.6.556
   Subramanian Balasubramanian, 2015, Int J Nanomedicine, V10 Suppl 1, P17, DOI 10.2147/IJN.S79977
   Sun W, 2016, MAT SCI ENG C-MATER, V63, P506, DOI 10.1016/j.msec.2016.03.016
   van Oirschot BAJA, 2016, ODONTOLOGY, V104, P347, DOI 10.1007/s10266-015-0230-5
   Wetzel C, 2008, SURF COAT TECH, V202, P5728, DOI 10.1016/j.surfcoat.2008.06.134
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027
   Wood MR, 2004, J PROSTHET DENT, V92, P447, DOI 10.1016/j.prosdent.2004.08.003
NR 41
TC 0
Z9 0
U1 0
U2 15
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-8016
J9 FRONT MATER
JI Front. Mater.
PD AUG 18
PY 2016
VL 3
AR UNSP 40
DI 10.3389/fmats.2016.00040
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA EK0VA
UT WOS:000393644000001
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Sarosi, C
   Biris, AR
   Antoniac, A
   Boboia, S
   Alb, C
   Antoniac, I
   Moldovan, M
AF Sarosi, Codruta
   Biris, Alexandru Radu
   Antoniac, Aurora
   Boboia, Stanca
   Alb, Camelia
   Antoniac, Iulian
   Moldovan, Marioara
TI The nanofiller effect on properties of experimental graphene dental
   nanocomposites
SO JOURNAL OF ADHESION SCIENCE AND TECHNOLOGY
LA English
DT Article
DE Graphene; dental nanocomposites; FTIR-ATR Spectroscopy; thermal
   analysis; surface free energy; AFM
ID SURFACE-FREE-ENERGY; FEW-LAYER GRAPHENE; BIOMATERIAL SURFACES; RESIN
   COMPOSITES; CONTACT-ANGLE; ROUGHNESS; ADHESION; MICROSCOPY; POLYMERS
AB The purpose of the present study is to analyze the effect of the new nanofiller type graphene-gold nanoparticles on the surface structure and surface properties of some dental nanocomposites based on BisGMA/triethyleneglicol dimethacrylate matrix. Materials used in our study were three experimental nanocomposites, two of them based on graphene-gold nanoparticles as filler of different percent. As reference material, a commercial dental nanocomposite product named Herculite XRV Ultra was used. FTIR-ATR spectroscopy was used to determine the residual double bonds and the degree of conversion (DC) after 1 and 21days of immersion in distilled water at 37 degrees C. The difference in DC between the experimental materials was statistically analyzed by one tail, paired Student's t-Tests, using Graph Pod. Surface properties were evaluated through surface free energy using contact angle measurement while roughness and topography was assessed using Atomic Force Microscopy (AFM). To determine the amount of filler particles and thermal behavior of organic matrix, the nanocomposites were investigated by thermal analysis. According to the experimental results, the dental nanocomposites with highest percent in graphene-gold nanoparticles present a better value for the surface free energy. AFM investigations reveal differences in the term of roughness properties and suggest that in order to improve the surface properties is necessary to use a higher percent of graphene-gold nanoparticles as filler. The degradation process of major nanocomposites constituents is observed at temperatures between 240 and 620 degrees C. Entire results sustain this, but the future studies in order to evaluate the biological properties of the experimental nanocomposites will be made.
C1 [Sarosi, Codruta; Boboia, Stanca; Moldovan, Marioara] Univ Babes Bolyai, Raluca Ripan Chem Res Inst, Dept Polymer Composites, R-3400 Cluj Napoca, Romania.
   [Biris, Alexandru Radu] Natl Inst Res & Dev Isotop & Mol Technol, Dept Mass Spectrometry Chromatog & Ion Phys, Cluj Napoca, Romania.
   [Antoniac, Aurora; Antoniac, Iulian] Univ Politehn Bucuresti, Fac Mat Sci & Engn, Dept Mat Sci & Phys Met, Bucharest, Romania.
   [Alb, Camelia] Univ Med & Pharm Iuliu Hatieganu, Fac Med Dent, Dept Dent Propaedeut & Esthet, Cluj Napoca, Romania.
RP Sarosi, C (reprint author), Univ Babes Bolyai, Raluca Ripan Chem Res Inst, Dept Polymer Composites, R-3400 Cluj Napoca, Romania.
EM codruta.sarosi@ubbcluj.ro
RI Antoniac, Iulian/D-4802-2014; Moldovan, Marioara/N-6387-2017; Sarosi,
   Codruta/A-5036-2017
OI Antoniac, Iulian/0000-0003-0112-3494; Sarosi,
   Codruta/0000-0003-2960-9832
FU Romanian Ministry of Education and Research, National project
   [PN-II-PT-PCCA-2013-4-1282230/2014]
FX This work was supported by the Romanian Ministry of Education and
   Research, National project [PN-II-PT-PCCA-2013-4-1282230/2014].
CR Asmussen E, 2005, DENT MATER, V21, P1039, DOI 10.1016/j.dental.2004.12.004
   ASMUSSEN E, 1982, SCAND J DENT RES, V90, P490
   Biris AR, 2012, CARBON, V50, P2252, DOI 10.1016/j.carbon.2012.01.043
   Borchers L, 1999, J PROSTHET DENT, V82, P550, DOI 10.1016/S0022-3913(99)70053-3
   da Silva EM, 2008, J APPL ORAL SCI, V16, P161, DOI 10.1590/S1678-77572008000200015
   Della Bona A, 2008, DENT MATER, V24, P1281
   Dreyer DR, 2010, CHEM SOC REV, V39, P228, DOI 10.1039/b917103g
   Emtsev KV, 2009, NAT MATER, V8, P203, DOI [10.1038/NMAT2382, 10.1038/nmat2382]
   Esposito C, 2012, MATERIALS, V5, P2960
   Fan HL, 2010, BIOMACROMOLECULES, V11, P2345, DOI 10.1021/bm100470q
   Ferracane JL, 2011, DENT MATER, V27, P29, DOI 10.1016/j.dental.2010.10.020
   FERRACANE JL, 1984, J DENT RES, V63, P1093, DOI 10.1177/00220345840630081901
   FERRACANE JL, 1994, J ORAL REHABIL, V21, P441, DOI 10.1111/j.1365-2842.1994.tb01158.x
   GOOD RJ, 1992, J ADHES SCI TECHNOL, V6, P1269, DOI 10.1163/156856192X00629
   Grassie N, ENCY POLYM SCI TECHN, V4, P647
   Kakaboura A, 2007, J MATER SCI-MATER M, V18, P155, DOI 10.1007/s10856-006-0675-8
   Kim KS, 2009, NATURE, V457, P706, DOI 10.1038/nature07719
   Lainovic T, 2013, BOSNIAN J BASIC MED, V13, P34
   Lazar MD, 2013, J MATER SCI, V48, P7409, DOI 10.1007/s10853-013-7556-6
   Leprince JG, 2013, DENT MATER, V29, P139, DOI 10.1016/j.dental.2012.11.005
   Li D, 2008, NAT NANOTECHNOL, V3, P101, DOI 10.1038/nnano.2007.451
   Liu DL, 2010, J ADHES SCI TECHNOL, V24, P2383, DOI 10.1163/016942410X508280
   Lupu D, 2004, CARBON, V42, P503, DOI 10.1016/j.carbon.2003.12.034
   Marghalani HY, 2010, J APPL ORAL SCI, V18, P59, DOI 10.1590/S1678-77572010000100011
   Mei L, 2009, EUR J ORAL SCI, V117, P419, DOI 10.1111/j.1600-0722.2009.00648.x
   Namen F, 2008, MATER RES-IBERO-AM J, V11, P239, DOI 10.1590/S1516-14392008000300002
   Pires de Souza Fernanda de Carvalho Panzeri, 2009, Braz. Dent. J., V20, P319, DOI 10.1590/S0103-64402009000400010
   QUIRYNEN M, 1995, J CLIN PERIODONTOL, V22, P1, DOI 10.1111/j.1600-051X.1995.tb01765.x
   Reis AC, 2013, BRAZ DENT J, V24, P599
   Ruttermann S, 2011, ACTA BIOMATER, V7, P1160, DOI 10.1016/j.actbio.2010.10.002
   Sarkar AK, 2014, INT J ENERG RES, V38, P1889, DOI 10.1002/er.3203
   Sen D, 2002, J PROSTHET DENT, V88, P527, DOI 10.1067/mpr.2002.129335
   Sgarbi S. C., 2010, REV CLIN PESQ ODONTO, V6, P223
   Sideridou ID, 2011, DENT MATER, V27, P598, DOI 10.1016/j.dental.2011.02.015
   Soanca A, 2012, DIG J NANOMATER BIOS, V7, P1071
   Stolyarova E, 2007, P NATL ACAD SCI USA, V104, P9209, DOI 10.1073/pnas.0703337104
   Trif M, 2007, J OPTOELECTRON ADV M, V9, P3312
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Zenkiewicz M., 2007, J ACHIEV MAT MANUF E, V24, P137
NR 39
TC 5
Z9 5
U1 2
U2 72
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0169-4243
EI 1568-5616
J9 J ADHES SCI TECHNOL
JI J. Adhes. Sci. Technol.
PD AUG 17
PY 2016
VL 30
IS 16
SI SI
BP 1779
EP 1794
DI 10.1080/01694243.2016.1161969
PG 16
WC Engineering, Chemical; Materials Science, Multidisciplinary; Mechanics
SC Engineering; Materials Science; Mechanics
GA DJ1ED
UT WOS:000373945200007
DA 2018-10-20
ER

PT J
AU Ingole, VH
   Hussein, KH
   Kashale, AA
   Gattu, KP
   Dhanayat, SS
   Vinchurkar, A
   Chang, JY
   Ghule, AV
AF Ingole, Vijay H.
   Hussein, Kamal H.
   Kashale, Anil A.
   Gattu, Ketan P.
   Dhanayat, Swapnali S.
   Vinchurkar, Aruna
   Chang, Jia-Yaw
   Ghule, Anil V.
TI Invitro Bioactivity and Osteogenic Activity Study of Solid State
   Synthesized Nano-Hydroxyapatite using Recycled Eggshell Bio-waste
SO CHEMISTRYSELECT
LA English
DT Article
DE Bioactivity; Eggshell bio-waste; Hydroxyapatite; Orthopaedic;
   Osteogenicity; Solid state synthesis
ID NANOSTRUCTURED CALCIUM PHOSPHATES; NANOCRYSTALLINE HYDROXYAPATITE;
   GENE-EXPRESSION; BONE; NANOPARTICLES; CERAMICS; PAPER; TRANSFECTION;
   BIOMATERIAL; TEMPERATURE
AB Research on hydroxyapatite is experiencing a remarkable increase during the recent years due to its potential biological and biomedical applications. Herein, we have synthesized nano-hydroxyapatite (HAp) by solid state reaction (SSR), wherein recycled eggshell bio-waste as Ca precursor on processing is reacted with synthetic ammonium dihydrogen orthophosphate to form hydroxyapatite (SSHAp). The solid state synthesis reaction is studied by thermogravimetric analysis. The morphology and crystal structure of SSHAp nanoparticles is characterized and found to be spherical and free of aggregation with average crystallite size similar to 10 nm. The SSHAp nanoparticles show large surface area (9.64 m(2)g(-1)). Furthermore, the invitro bio-activity and osteogenic activity of SSHAp is investigated. The osteogenic activity is evaluated by incubating the SSHAp with hFOB cells. The SSHAp is observed to promote appreciable cell attachment and proliferation unlike in control material. While hFOB cells is found to express higher level of osteocalcin, osteopontin, collagen I, osteonectin, BMP-2 and GAPDH on the SSHAp bone graft. The results show that SSHAp nanoparticles graft is bioactive, nontoxic and osteogenic, and has the potential to promote bone therapy applications. The HAp is synthesized using recycled bio-waste contributing to green chemistry, addressing the environmental concerns of recycle and reuse.
C1 [Ingole, Vijay H.; Kashale, Anil A.; Gattu, Ketan P.; Dhanayat, Swapnali S.; Ghule, Anil V.] Dr Babasaheb Ambedkar Marathwada Univ, Dept Nanotechnol, Aurangabad 431004, Maharashtra, India.
   [Hussein, Kamal H.] Gangwon Natl Univ, Stem Cell Inst, Chunchon 200701, Gangwon, South Korea.
   [Hussein, Kamal H.] Gangwon Natl Univ, Coll Vet Med, Chunchon 200701, Gangwon, South Korea.
   [Vinchurkar, Aruna] Dr Babasaheb Ambedkar Marathwada Univ, Govt Inst Sci, Dept Biophys, Aurangabad 431004, Maharashtra, India.
   [Chang, Jia-Yaw] Natl Taiwan Univ Sci & Technol, Dept Chem Engn, Taipei 10607, Taiwan.
   [Ghule, Anil V.] Shivaji Univ, Dept Chem, Green Nanotechnol Lab, Kolhapur 416004, Maharashtra, India.
RP Ghule, AV (reprint author), Dr Babasaheb Ambedkar Marathwada Univ, Dept Nanotechnol, Aurangabad 431004, Maharashtra, India.; Chang, JY (reprint author), Natl Taiwan Univ Sci & Technol, Dept Chem Engn, Taipei 10607, Taiwan.; Ghule, AV (reprint author), Shivaji Univ, Dept Chem, Green Nanotechnol Lab, Kolhapur 416004, Maharashtra, India.
EM jychang@mail.ntust.edu.tw; anighule@gmail.com
RI bagheri, amir/C-3274-2017
FU UGC, New Delhi [RGNF-F1-17.1/2012-13/RGNF-2012-13-SC-MAH-35362,
   41-370/2012 (SR)]; UGC-DAE-CSR, Indore [CSR-I/CRS-48/48]; Ministry of
   Science and Technology, R.O.C. [102-2628-M-011-001-MY3]
FX V.H.I. is thankful to UGC, New Delhi, for a research fellowship (File
   No. RGNF-F1-17.1/2012-13/RGNF-2012-13-SC-MAH-35362). The authors are
   thankful to UGC-DAE-CSR, Indore (Project Ref. No: CSR-I/CRS-48/48) and
   UGC, New Delhi (File No. 41-370/2012 (SR)) for the financial support.
   JYC is thankful to Ministry of Science and Technology, R.O.C. Contract
   No. 102-2628-M-011-001-MY3 for financial support.
CR Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Baler K, 2014, BIOMATER SCI-UK, V2, P1355, DOI 10.1039/c4bm00133h
   Bezzi G, 2003, MATER CHEM PHYS, V78, P816, DOI 10.1016/S0254-0584(02)00392-9
   Bose S, 2003, J AM CERAM SOC, V86, P1055, DOI 10.1111/j.1151-2916.2003.tb03423.x
   Bystrom S, 2000, RESOUR CONSERV RECY, V28, P55, DOI 10.1016/S0921-3449(99)00033-6
   Cengiz B, 2008, COLLOID SURFACE A, V322, P29, DOI 10.1016/j.colsurfa.2008.02.011
   Craighill AL, 1996, RESOUR CONSERV RECY, V17, P75, DOI 10.1016/0921-3449(96)01105-6
   Cunniffe GM, 2010, J BIOMED MATER RES A, V95A, P1142, DOI 10.1002/jbm.a.32931
   D'Elia NL, 2015, NANOSCALE, V7, P18751, DOI 10.1039/c5nr04850h
   Dorozhkin SV, 2012, ACTA BIOMATER, V8, P963, DOI 10.1016/j.actbio.2011.09.003
   Dorozhkin SV, 2010, BIOMATERIALS, V31, P1465, DOI 10.1016/j.biomaterials.2009.11.050
   Ekvall T, 1999, J CLEAN PROD, V7, P281, DOI DOI 10.1016/S0959-6526(99)00149-3
   Gardin C, 2012, INT J MOL SCI, V13, P6452, DOI 10.3390/ijms13056452
   Hage O, 2009, RESOUR CONSERV RECY, V53, P155, DOI 10.1016/j.resconrec.2008.11.003
   Hassanzadeh S, 2015, ACS SUSTAIN CHEM ENG, V3, P177, DOI 10.1021/sc500686j
   Huang Y, 2012, NANOSCALE, V4, P2484, DOI 10.1039/c2nr12072k
   Inuzuka M, 2004, SOLID STATE IONICS, V172, P509, DOI 10.1016/j.ssi.2004.01.054
   Jiang H, 2013, ACS APPL MATER INTER, V5, P12036, DOI 10.1021/am4038432
   Kannan S, 2006, CHEM MATER, V18, P2181, DOI 10.1021/cm052567q
   Krishna DSR, 2007, J MATER SCI-MATER M, V18, P1735, DOI 10.1007/s10856-007-3069-7
   Kumta PN, 2005, ACTA BIOMATER, V1, P65, DOI 10.1016/j.actbio.2004.09.008
   Lim GK, 1997, BIOMATERIALS, V18, P1433, DOI 10.1016/S0142-9612(97)00081-1
   Lin KL, 2011, NANOSCALE, V3, P3052, DOI 10.1039/c1nr10334b
   Liu JB, 2003, CERAM INT, V29, P629, DOI 10.1016/S0272-8842(02)00210-9
   Lu BQ, 2014, CHEM-EUR J, V20, P1242, DOI 10.1002/chem.201304439
   Mahabole MP, 2005, B MATER SCI, V28, P535, DOI 10.1007/BF02706339
   Marchettini N, 2007, WASTE MANAGE, V27, P562, DOI 10.1016/j.wasman.2006.04.007
   Morales JG, 2004, LANGMUIR, V20, P5174, DOI 10.1021/la0363682
   Murray Peter E, 2007, Med Oral Patol Oral Cir Bucal, V12, pE258
   Murugan R, 2005, J CRYST GROWTH, V274, P209, DOI 10.1016/j.jcrysgro.2004.09.069
   Olton D, 2007, BIOMATERIALS, V28, P1267, DOI 10.1016/j.biomaterials.2006.10.026
   Ozdemir T, 2013, CURR PHARM DESIGN, V19, P3446, DOI 10.2174/1381612811319190010
   Pedraza CE, 2008, BIOMATERIALS, V29, P3384, DOI 10.1016/j.biomaterials.2008.04.043
   Pickin J, 2008, RESOUR CONSERV RECY, V53, P79, DOI 10.1016/j.resconrec.2008.09.003
   Poinern G. E. J., 2013, AM J BIOMED ENG, V3, P148
   Poinern GE, 2009, ULTRASON SONOCHEM, V16, P469, DOI 10.1016/j.ultsonch.2009.01.007
   Ramli R.A., 2011, J PHYS SCI, V22, P20
   Rivera EM, 1999, MATER LETT, V41, P128, DOI 10.1016/S0167-577X(99)00118-4
   Rusu VM, 2005, BIOMATERIALS, V26, P5414, DOI 10.1016/j.biomaterials.2005.01.051
   Sarig S, 2002, J CRYST GROWTH, V237, P55, DOI 10.1016/S0022-0248(01)01850-4
   Singh A, 2012, B MATER SCI, V35, P1031, DOI 10.1007/s12034-012-0384-5
   Wan CY, 2011, NANOSCALE, V3, P693, DOI 10.1039/c0nr00650e
   Wang A., 2006, J SPECTR MATH APPL, V2006, P10
   Wang CY, 2004, BIOMATERIALS, V25, P2949, DOI 10.1016/j.biomaterials.2003.09.088
   Wang YJ, 2006, MATER LETT, V60, P3227, DOI 10.1016/j.matlet.2006.02.077
   Wang YJ, 2006, MATER LETT, V60, P1484, DOI 10.1016/j.matlet.2005.11.053
   Webster TJ, 2001, BIOMATERIALS, V22, P1327, DOI 10.1016/S0142-9612(00)00285-4
   Xie JW, 2004, J BIOMED MATER RES A, V71A, P108, DOI 10.1002/jbm.a.30140
   Zhou H, 2011, ACTA BIOMATER, V7, P2769, DOI 10.1016/j.actbio.2011.03.019
NR 49
TC 4
Z9 4
U1 4
U2 12
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 2365-6549
J9 CHEMISTRYSELECT
JI ChemistrySelect
PD AUG 16
PY 2016
VL 1
IS 13
BP 3901
EP 3908
DI 10.1002/slct.201601092
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA EI2FO
UT WOS:000392302300074
DA 2018-10-20
ER

PT J
AU Soon, G
   Pingguan-Murphy, B
   Lai, KW
   Akbar, SA
AF Soon, Ginny
   Pingguan-Murphy, Belinda
   Lai, Khin Wee
   Akbar, Sheikh Ali
TI Review of zirconia-based bioceramic: Surface modification and cellular
   response
SO CERAMICS INTERNATIONAL
LA English
DT Review
DE Zirconia; Ceramic biomaterial; Cellular response; Surface modification;
   ZrO2
ID PARTIALLY-STABILIZED ZIRCONIA; CALCIUM-PHOSPHATE COATINGS; IN-VITRO
   EVALUATION; DIODE-LASER RADIATION; OSTEOBLAST-LIKE CELLS; DENTAL
   IMPLANTS; TITANIUM-ALLOY; WETTABILITY CHARACTERISTICS; BIOACTIVE GLASS;
   HYDROXYAPATITE COATINGS
AB Zirconia is gaining interest as a ceramic biomaterial for implant applications due to its biocompatibility and desirable mechanical properties. At present, zirconia-based ceramic is often seen in the applications of hip replacement and dental implants. This paper briefly reviews different surface modification techniques that have been applied to zirconia such as polishing, sandblasting, etching, biofunctionalization, coating, laser treatment, and ultraviolet light treatment. The cellular response of osteoblast-like cell, osteoblast cell, fibroblast, and epithelial cell to the modified surface is discussed in terms of their adhesion, proliferation, and metabolic activity. The potential of surface modification to make zirconia a successful implant material in the future is highly dependent on the establishment of successful in vitro and in vivo studies. Hence, further effort should be made in order to deepen the understanding of tissue response to the implant and the tissue regeneration process. The review concludes with future prospect of research and further challenges in developing better zirconia bioceramics. (C) 2016 Elsevier Ltd and Techna Group S.r.l. All rights reserved.
C1 [Soon, Ginny; Pingguan-Murphy, Belinda; Lai, Khin Wee] Univ Malaya, Dept Biomed Engn, Kuala Lumpur 50603, Malaysia.
   [Akbar, Sheikh Ali] Ohio State Univ, Dept Mat Sci & Engn, Columbus, OH 43210 USA.
RP Pingguan-Murphy, B (reprint author), Univ Malaya, Dept Biomed Engn, Kuala Lumpur 50603, Malaysia.
EM bpingguan@um.edu.my
RI Pingguan-Murphy, Belinda/B-8332-2010; Lai, Khin Wee/A-2997-2011
OI Pingguan-Murphy, Belinda/0000-0001-5567-1141; Lai, Khin
   Wee/0000-0002-8602-0533
FU UM High Impact Research Grant UM-MOHE UM; Ministry of Higher Education
   Malaysia, University of Malaya [RP040A-15HTM, PG122-2015A,
   C/625/1/HIR/MOHE/ENG/44]
FX This research is supported by UM High Impact Research Grant UM-MOHE UM.
   C/625/1/HIR/MOHE/ENG/44 (Regenerative Biomechanics of Human Body) from
   the Ministry of Higher Education Malaysia, University of Malaya Grant
   number RP040A-15HTM and Postgraduate Research Grant (PG122-2015A).
CR Aboushelib MN, 2013, J PROSTHODONT, V22, P190, DOI 10.1111/j.1532-849X.2012.00920.x
   Aboushellib MN, 2007, J PROSTHET DENT, V98, P379, DOI 10.1016/S0022-3913(07)60123-1
   Aita H, 2009, BIOMATERIALS, V30, P1015, DOI 10.1016/j.biomaterials.2008.11.004
   AKAGAWA Y, 1993, J PROSTHET DENT, V69, P599, DOI 10.1016/0022-3913(93)90289-Z
   ANDREW JE, 1983, APPL PHYS LETT, V43, P717, DOI 10.1063/1.94488
   Ansari HM, 2013, NANO LETT, V13, P2116, DOI 10.1021/nl4005282
   Anselme K, 2010, ACTA BIOMATER, V6, P3824, DOI 10.1016/j.actbio.2010.04.001
   Anselme K, 2000, BIOMATERIALS, V21, P1567, DOI 10.1016/S0142-9612(00)00042-9
   Att W, 2009, BIOMATERIALS, V30, P1273, DOI 10.1016/j.biomaterials.2008.11.024
   Auer JA, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-72
   BAHNERS T, 1993, APPL SURF SCI, V69, P12, DOI 10.1016/0169-4332(93)90474-P
   Balza J.C., 2013, IOP C SER MAT SCI EN
   Barnes D, 2012, J MECH BEHAV BIOMED, V6, P128, DOI 10.1016/j.jmbbm.2011.10.010
   Barrere F, 2003, J MATER SCI-MATER M, V14, P419, DOI 10.1023/A:1023210817683
   Berglundh T, 2003, CLIN ORAL IMPLAN RES, V14, P251, DOI 10.1034/j.1600-0501.2003.00972.x
   Bettinger CJ, 2008, ADV MATER, V20, P99, DOI 10.1002/adma.200702487
   Bosetti M, 2001, BIOMATERIALS, V22, P987, DOI 10.1016/S0142-9612(00)00264-7
   Brett PM, 2004, BONE, V35, P124, DOI 10.1016/j.bone.2004.03.009
   Butz F, 2006, J DENT RES, V85, P560, DOI 10.1177/154405910608500616
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   CHOU LS, 1995, J CELL SCI, V108, P1563
   Chrcanovic BR, 2014, MATER RES-IBERO-AM J, V17, P373, DOI [10.1590/S1516-14392014000200013, 10.1590/S1516-14392014005000042]
   Chrcanovic BR, 2013, MATER RES-IBERO-AM J, V16, P1006, DOI [10.1590/S1516-14392013000500008, 10.1590/S1516-14392013005000067]
   Cochis A, 2013, CLIN ORAL IMPLAN RES, V24, P904, DOI 10.1111/j.1600-0501.2012.02490.x
   DeGroot K., 1981, SCI CERAM, V11, P433
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   Depprich Rita, 2008, Head Face Med, V4, P29, DOI 10.1186/1746-160X-4-29
   DEWIJS FLJA, 1994, J ORAL REHABIL, V21, P11
   Dorozhkin SV, 2013, J MATER SCI-MATER M, V24, P1335, DOI 10.1007/s10856-013-4898-1
   Dubotzky A., 2001, ISTFA 2001. Proceedings of the 27th International Symposium for Testing and Failure Analysis, P83
   Faia-Torres AB, 2014, BIOMATERIALS, V35, P9023, DOI 10.1016/j.biomaterials.2014.07.015
   Forster A, 2014, J DENT, V42, P7, DOI 10.1016/j.jdent.2013.11.008
   FOURNIER B, 1991, J CELL BIOL, V114, P577, DOI 10.1083/jcb.114.3.577
   Frandsen CJ, 2013, MAT SCI ENG C-MATER, V33, P2752, DOI 10.1016/j.msec.2013.02.045
   Gahlert M, 2009, CLIN ORAL IMPLAN RES, V20, P1247, DOI 10.1111/j.1600-0501.2009.01734.x
   Gehrke S.A., 2013, SCI J MED CLIN TRIAL, P34
   Gerberich BG, 2013, BIOTECHNOL J, V8, P73, DOI 10.1002/biot.201200131
   Ghrebi S., 2013, J BIOMED MAT RES A, V101
   Gittens RA, 2011, BIOMATERIALS, V32, P3395, DOI 10.1016/j.biomaterials.2011.01.029
   Gordon DJ, 2010, J BIOMED MATER RES A, V94A, P586, DOI 10.1002/jbm.a.32735
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Hadjidakis DJ, 2006, ANN NY ACAD SCI, V1092, P385, DOI 10.1196/annals.1365.035
   Han SH, 2011, J PERIODONTAL IMPLAN, V41, P227, DOI 10.5051/jpis.2011.41.5.227
   Hanawa T, 2010, JPN DENT SCI REV, V46, P93, DOI 10.1016/j.jdsr.2009.11.001
   Hao L, 2005, MAT SCI ENG C-BIO S, V25, P496, DOI 10.1016/j.msec.2005.03.003
   Hao L, 2005, J MATER SCI-MATER M, V16, P719, DOI 10.1007/s10856-005-2608-3
   Hao L, 2004, J BIOMED MATER RES A, V69A, P748, DOI 10.1002/jbm.a.30055
   Hao L, 2004, J LASER APPL, V16, P55, DOI 10.2351/1.1642634
   Hao L, 2003, MAT SCI ENG C-BIO S, V23, P627, DOI 10.1016/S0928-4931(03)00056-0
   Hao L, 2003, J PHYS D APPL PHYS, V36, P1292, DOI 10.1088/0022-3727/36/11/309
   Hauser-Gerspach I, 2012, CLIN ORAL INVEST, V16, P1049, DOI 10.1007/s00784-011-0603-2
   HEITZ J, 1992, APPL PHYS A-MATER, V55, P391, DOI 10.1007/BF00324090
   HELMER JC, 1969, RES BIOCERAMICS
   Helmus MN, 2008, TOXICOL PATHOL, V36, P70, DOI 10.1177/0192623307310949
   Hempel U, 2010, CLIN ORAL IMPLAN RES, V21, P174, DOI 10.1111/j.1600-0501.2009.01797.x
   HERMAN H, 1988, MRS BULL, V13, P60, DOI DOI 10.1557/S0883769400063715
   Hoffmann O, 2012, INT J ORAL MAX IMPL, V27, P352
   Hoshing Upendra A, 2014, J Conserv Dent, V17, P320, DOI 10.4103/0972-0707.136438
   Hsu SK, 2014, THIN SOLID FILMS, V572, P91, DOI 10.1016/j.tsf.2014.07.068
   Huang MG, 2010, MATH COMPUT MODEL, V52, P2036, DOI 10.1016/j.mcm.2010.01.024
   Iwaya Y, 2008, DENT MATER J, V27, P415, DOI 10.4012/dmj.27.415
   Jaffe WL, 1996, J BONE JOINT SURG AM, V78A, P1918, DOI 10.2106/00004623-199612000-00018
   Kiang JD, 2013, J BIOMED MATER RES A, V101, P2313, DOI 10.1002/jbm.a.34543
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   Kimura Y, 2012, DENT MATER J, V31, P346, DOI 10.4012/dmj.2011-189
   Klinge B, 2006, CLIN ORAL IMPLAN RES, V17, P93, DOI 10.1111/j.1600-0501.2006.001366.x
   Ko HC, 2007, DENT MATER, V23, P1349, DOI 10.1016/j.dental.2006.11.023
   Kobune K, 2014, DENT MATER J, V33, P696, DOI 10.4012/dmj.2014-087
   Kohal RJ, 2013, DENT MATER, V29, P763, DOI 10.1016/j.dental.2013.04.003
   Kohal RJ, 2009, CLIN ORAL IMPLAN RES, V20, P333, DOI 10.1111/j.1600-0501.2008.01656.x
   KOKUBO T, 1992, J MATER SCI-MATER M, V3, P79, DOI 10.1007/BF00705272
   KONDELL PA, 1991, ACTA ODONTOL SCAND, V49, P169, DOI 10.3109/00016359109005903
   Kono M, 2015, DENT MATER J, V34, P537, DOI 10.4012/dmj.2015-010
   Kunzler TP, 2007, BIOMATERIALS, V28, P2175, DOI 10.1016/j.biomaterials.2007.01.019
   Langhoff JD, 2008, INT J ORAL MAX SURG, V37, P1125, DOI 10.1016/j.ijom.2008.09.008
   Laranjeira MS, 2014, SCI TECHNOL ADV MAT, V15, DOI 10.1088/1468-6996/15/2/025001
   Laurens P, 2000, APPL SURF SCI, V154, P211, DOI 10.1016/S0169-4332(99)00443-2
   Lawrence J, 2002, J LASER APPL, V14, P107, DOI 10.2351/1.1471560
   Lawrence J, 2001, MAT SCI ENG A-STRUCT, V303, P142, DOI 10.1016/S0921-5093(00)01851-7
   Lawrence J, 1999, APPL SURF SCI, V138, P388, DOI 10.1016/S0169-4332(98)00431-0
   Lawrence J, 1999, J PHYS D APPL PHYS, V32, P1075, DOI 10.1088/0022-3727/32/10/301
   Lazzara RJ, 1999, INT J PERIODONT REST, V19, P117
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   Linkevicius T, 2008, INT J ORAL MAX IMPL, V23, P449
   Liu XH, 2015, MAT SCI ENG C-MATER, V48, P256, DOI 10.1016/j.msec.2014.12.011
   Liu XM, 2007, BIOMATERIALS, V28, P4535, DOI 10.1016/j.biomaterials.2007.06.016
   Liu YT, 2013, COLLOID SURFACE B, V106, P37, DOI 10.1016/j.colsurfb.2013.01.023
   Mai R, 2012, ANN ANAT, V194, P561, DOI 10.1016/j.aanat.2012.09.004
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Mathieu V, 2014, J BIOMECH, V47, P3, DOI 10.1016/j.jbiomech.2013.09.021
   Meyer U, 2005, Eur Cell Mater, V9, P39
   Mills A, 2008, INT J PHOTOENERGY, DOI 10.1155/2008/470670
   Morra M, 2006, EUR CELLS MATER, V12, P1
   Mustafa K, 2001, CLIN ORAL IMPLAN RES, V12, P515, DOI 10.1034/j.1600-0501.2001.120513.x
   Nothdurft F.P., 2014, CLIN IMPLANT DENT R
   Ogawa T., 2014, INT J ORAL MAXILLOF, V29
   Oliva J, 2007, INT J ORAL MAX IMPL, V22, P430
   Omar O, 2010, J MATER SCI-MATER M, V21, P969, DOI 10.1007/s10856-009-3915-x
   Pae A, 2014, J ADV PROSTHODONT, V6, P96, DOI 10.4047/jap.2014.6.2.96
   Pae A, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/025005
   Pandey AK, 2013, MAT SCI ENG C-MATER, V33, P3923, DOI 10.1016/j.msec.2013.05.032
   Pardun K, 2015, MAT SCI ENG C-MATER, V48, P337, DOI 10.1016/j.msec.2014.12.031
   Pardun K, 2015, CLIN IMPLANT DENT R, V17, P186, DOI 10.1111/cid.12071
   Parikh KS, 2012, MAT SCI ENG C-MATER, V32, P2469, DOI 10.1016/j.msec.2012.07.028
   Park JY, 2013, ANN DERMATOL, V25, P356, DOI 10.5021/ad.2013.25.3.356
   Pelaez-Vargas A, 2011, DENT MATER, V27, P581, DOI 10.1016/j.dental.2011.02.014
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Potiket N, 2004, J PROSTHET DENT, V92, P491, DOI 10.1016/j.prosdent.2004.09.001
   Rauscher MD, 2008, ADV MATER, V20, P1699, DOI 10.1002/adma.200701383
   Rim KT, 2013, SAF HEALTH WORK, V4, P12, DOI 10.5491/SHAW.2013.4.1.12
   Rocchietta I, 2009, CLIN ORAL IMPLAN RES, V20, P844, DOI 10.1111/j.1600-0501.2009.01727.x
   Rubinstein AI, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/6/065101
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Sammons RL, 2005, CLIN ORAL IMPLAN RES, V16, P657, DOI 10.1111/j.1600-0501.2005.01168.x
   Sandhyarani M, 2014, SURF COAT TECH, V238, P58, DOI 10.1016/j.surfcoat.2013.10.039
   Sartoretto SC, 2015, J APPL ORAL SCI, V23, P279, DOI 10.1590/1678-775720140483
   Sawase T, 2008, CLIN ORAL IMPLAN RES, V19, P491, DOI 10.1111/j.1600-0501.2007.01509.x
   Schulte W., 1984, QUINTESSENCE INT, V48, P229
   Schwarz F, 2005, CLIN ORAL INVEST, V9, P111, DOI 10.1007/s00784-005-0305-8
   Schwarz F, 2007, CLIN ORAL IMPLAN RES, V18, P481, DOI 10.1111/j.1600-0501.2007.01341.x
   Sennerby L, 2005, CLIN IMPLANT DENT R, V7, pS13, DOI 10.1111/j.1708-8208.2005.tb00070.x
   Setzer B, 2009, BIOMATERIALS, V30, P979, DOI 10.1016/j.biomaterials.2008.10.054
   Shetty S, 2014, J CLIN EXP HEPATOL, V4, P66, DOI 10.1016/j.jceh.2013.08.001
   Song YG, 2014, J ADV PROSTHODONT, V6, P285, DOI 10.4047/jap.2014.6.4.285
   Speelman J A, 1992, Clin Oral Implants Res, V3, P120, DOI 10.1034/j.1600-0501.1992.030304.x
   Stadlinger B, 2010, INT J ORAL MAX SURG, V39, P585, DOI 10.1016/j.ijom.2010.01.015
   Stanic V, 2002, BIOMATERIALS, V23, P3833, DOI 10.1016/S0142-9612(02)00119-9
   TENGVALL P, 1992, Clinical Materials, V9, P115, DOI 10.1016/0267-6605(92)90056-Y
   Torricelli P, 2001, BIOMATERIALS, V22, P2535, DOI 10.1016/S0142-9612(00)00444-0
   Tuna T, 2015, DENT MATER, V31, pE14, DOI 10.1016/j.dental.2014.10.008
   TURNER CH, 1993, BONE, V14, P595, DOI 10.1016/8756-3282(93)90081-K
   Ueno T, 2011, BIOMATERIALS, V32, P7297, DOI 10.1016/j.biomaterials.2011.06.033
   Viceconti M, 2000, J BIOMECH, V33, P1611, DOI 10.1016/S0021-9290(00)00140-8
   Watanabe H., 1994, ADHES SCI TECHNOL, V6, P1425
   WEISS P, 1945, J EXP ZOOL, V100, P353, DOI 10.1002/jez.1401000305
   Wennerberg A, 2009, CLIN ORAL IMPLAN RES, V20, P172, DOI 10.1111/j.1600-0501.2009.01775.x
   Werner S, 2009, BIOMATERIALS, V30, P2291, DOI 10.1016/j.biomaterials.2009.01.004
   Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Yamano S, 2011, INT J ORAL MAX IMPL, V26, P1247
   Yang YZ, 2005, BIOMATERIALS, V26, P327, DOI 10.1016/j.biomaterials.2004.02.029
   Yasuno K, 2014, J HARD TISSUE BIOL, V23, P93, DOI 10.2485/jhtb.23.93
   Yoshinari M, 2002, MATER TRANS, V43, P2494, DOI 10.2320/matertrans.43.2494
   Yoshinari M, 2011, JPN DENT SCI REV, V47, P89, DOI 10.1016/j.jdsr.2011.03.001
   Yugeswaran S, 2012, J MECH BEHAV BIOMED, V9, P22, DOI 10.1016/j.jmbbm.2011.11.002
   Zeng HT, 2000, J BIOMED MATER RES, V50, P239, DOI 10.1002/(SICI)1097-4636(200005)50:2<239::AID-JBM19>3.0.CO;2-V
   Zhang BK, 2011, J NANOSCI NANOTECHNO, V11, P10740, DOI 10.1166/jnn.2011.3939
   Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320
   Zheng CY, 2011, APPL SURF SCI, V257, P5634, DOI 10.1016/j.apsusc.2011.01.062
   Zhong JP, 2000, J BIOMED MATER RES, V53, P694, DOI 10.1002/1097-4636(2000)53:6<694::AID-JBM12>3.0.CO;2-6
   ZHOU XB, 1994, ACTA METALL MATER, V42, P1155, DOI 10.1016/0956-7151(94)90132-5
   Zile MA, 2011, J BIOMED MATER RES A, V97A, P59, DOI 10.1002/jbm.a.33028
NR 153
TC 18
Z9 19
U1 8
U2 116
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
EI 1873-3956
J9 CERAM INT
JI Ceram. Int.
PD AUG 15
PY 2016
VL 42
IS 11
BP 12543
EP 12555
DI 10.1016/j.ceramint.2016.05.077
PG 13
WC Materials Science, Ceramics
SC Materials Science
GA DQ1HM
UT WOS:000378952100002
DA 2018-10-20
ER

PT J
AU Shruti, S
   Andreatta, F
   Furlani, E
   Marin, E
   Maschio, S
   Fedrizzi, L
AF Shruti, S.
   Andreatta, F.
   Furlani, E.
   Marin, E.
   Maschio, S.
   Fedrizzi, L.
TI Cerium, gallium and zinc containing mesoporous bioactive glass coating
   deposited on titanium alloy
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Mesoporous bioactive glass with Ce2O3; Ga2O3 or ZnO; Ti6Al4 V substrate;
   Polycaprolactone; Dip coating; In vitro bioactivity
ID IN-VITRO; MECHANICAL-PROPERTIES; POLYCAPROLACTONE SCAFFOLDS; CALCIUM;
   RELEASE; HYDROXYAPATITE; REGENERATION; FILMS; VIVO; ION
AB Surface modification is one of the methods for improving the performance of medical implants in biological environment. In this study, cerium, gallium and zinc substituted 80%SiO2-15%CaO-5%P2O5 mesoporous bioactive glass (MBG) in combination with polycaprolactone (PCL) were coated over Ti6Al4V substrates by dip-coating method in order to obtain an inorganic organic hybrid coating (MBG-PCL). Structural characterization was performed using XRD, nitrogen adsorption, SEM-EDXS, FTIR. The MBG-PCL coating uniformly covered the substrate with the thickness found to be more than 1 pin. Glass and polymer phases were detected in the coating along with the presence of biologically potent elements cerium, gallium and zinc. In addition, in vitro bioactivity was investigated by soaking the coated samples in simulated body fluid (SBF) for up to 30 days at 37 degrees C. The apatite-like layer was monitored by FTIR, SEM-EDXS and ICP measurements and it formed in all the samples within 15 days except zinc samples. In this way, an attempt was made to develop a new biomaterial with improved in vitro bioactive response due to bioactive glass coating and good mechanical strength of Ti6Al4V alloy along with inherent biological properties of cerium, gallium and zinc. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Shruti, S.; Andreatta, F.; Furlani, E.; Marin, E.; Maschio, S.; Fedrizzi, L.] Univ Udine, Dipartimento Politecn Ingn & Architettura, Via Cotonificio 108, I-33100 Udine, Italy.
RP Shruti, S (reprint author), Univ Udine, Dipartimento Politecn Ingn & Architettura, Via Cotonificio 108, I-33100 Udine, Italy.
EM biotech.shruti@gmail.com
OI Marin, Elia/0000-0002-0981-7821
FU European Social Fund
FX Financial support through European Social Fund (project DIANET- incoming
   mode) is gratefully acknowledged. The authors wish to thank Prof. L.
   Menabue, Prof. G. Lusvardi and Dr. G. Malavasi of the University of
   Modena and Reggio Emilia for instrument availability and assistance.
CR Arcos D, 2010, ACTA BIOMATER, V6, P2874, DOI 10.1016/j.actbio.2010.02.012
   Aydin Sevinc B, 2010, J BIOMED MATER RES B, V94, P22
   Baghbani F, 2013, B MATER SCI, V36, P1339, DOI 10.1007/s12034-013-0593-6
   Barth N, 2013, PHYSCS PROC, V40, P9, DOI 10.1016/j.phpro.2012.12.002
   BOCKMAN RS, 1986, CALCIFIED TISSUE INT, V39, P376, DOI 10.1007/BF02555174
   BROWN SA, 1988, J BIOMED MATER RES, V22, P321, DOI 10.1002/jbm.820220406
   Brunski JB, 1996, BIOMATERIALS SCI INT, P37
   Catauro M, 2014, MAT SCI ENG C-MATER, V39, P344, DOI 10.1016/j.msec.2014.03.025
   Catauro M, 2013, J APPL BIOMATER FUNC, V11, P172, DOI 10.5301/JABFM.2012.9256
   Gupta R, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034005
   HALL TJ, 1990, BONE MINER, V8, P211, DOI 10.1016/0169-6009(90)90106-P
   Harrington JR, 2006, J VET PHARMACOL THER, V29, P121, DOI 10.1111/j.1365-2885.2006.00723.x
   Hijon N, 2005, CHEM MATER, V17, P1591, DOI 10.1021/cm048755i
   Hua ZL, 2001, J NON-CRYST SOLIDS, V292, P177, DOI 10.1016/S0022-3093(01)00806-7
   Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.3.CO;2-Z
   Ito A, 2002, MAT SCI ENG C-BIO S, V22, P21, DOI 10.1016/S0928-4931(02)00108-X
   Khor HL, 2002, MAT SCI ENG C-BIO S, V20, P71, DOI 10.1016/S0928-4931(02)00015-2
   Kim HW, 2004, J BIOMED MATER RES A, V70A, P467, DOI 10.1002/j.jbm.a.30100
   Kim HW, 2004, BIOMATERIALS, V25, P1279, DOI 10.1016/j.biomaterials.2003.07.003
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Livage J., 2004, FUNCTIONAL HYBRID MA, P387
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Piccirillo A. M., 2011, ATTI ACCAD PELO SFMN, V89
   Piccirillo A. M., 2012, ATTI ACCAD PELO SFMN, V90
   Pilliar M. R., 1984, CRC CRIT R BIOCOMP, V1, P371
   Salinas AJ, 2011, ACTA BIOMATER, V7, P3452, DOI 10.1016/j.actbio.2011.05.033
   Sanchez-Salcedo S, 2014, J MATER CHEM B, V2, P4836, DOI 10.1039/c4tb00403e
   Schubert D, 2006, BIOCHEM BIOPH RES CO, V342, P86, DOI 10.1016/j.bbrc.2006.01.129
   Seregin VV, 2006, BIOMATERIALS, V27, P4745, DOI 10.1016/j.biomaterials.2006.04.031
   Shruti S, 2013, MICROPOR MESOPOR MAT, V180, P92, DOI 10.1016/j.micromeso.2013.06.014
   Shruti S, 2013, ACTA BIOMATER, V9, P4836, DOI 10.1016/j.actbio.2012.09.024
   Shruti S, 2012, J MATER CHEM, V22, P13698, DOI 10.1039/c2jm31767b
   Vallet-Regi M, 1999, J BIOMED MATER RES, V46, P560
   Verma D, 2006, J BIOMED MATER RES A, V77A, P59, DOI 10.1002/jbm.a.30592
   Wu CT, 2008, ACTA BIOMATER, V4, P569, DOI 10.1016/j.actbio.2007.11.005
   Zhai WY, 2012, ACTA BIOMATER, V8, P341, DOI 10.1016/j.actbio.2011.09.008
   Zhang JC, 2010, J RARE EARTH, V28, P138, DOI 10.1016/S1002-0721(09)60067-3
   Zhou YF, 2006, J BIOMED MATER RES A, V78A, P183, DOI 10.1002/jbm.a.30685
NR 38
TC 7
Z9 7
U1 1
U2 62
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD AUG 15
PY 2016
VL 378
BP 216
EP 223
DI 10.1016/j.apsusc.2016.03.209
PG 8
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA DN1IJ
UT WOS:000376819200028
DA 2018-10-20
ER

PT J
AU Ji, JH
   Shin, KS
   Kang, S
   Lee, SH
   Kang, JY
   Kim, S
   Jun, SC
AF Ji, Jae-hoon
   Shin, Kyeong-sik
   Kang, Shinill
   Lee, Soo Hyun
   Kang, Ji Yoon
   Kim, Sinyoung
   Jun, Seong Chan
TI Fundamental monomeric biomaterial diagnostics by radio frequency signal
   analysis
SO BIOSENSORS & BIOELECTRONICS
LA English
DT Article
DE Biosensor; Biomaterial diagnostics; Bio-detection; Label-free;
   Dielectric relaxation; Radio-frequency
ID BOVINE SERUM-ALBUMIN; DIELECTRIC-RELAXATION; ELECTRICAL-PROPERTIES;
   AQUEOUS-SOLUTIONS; CARBON NANOTUBES; GLUCOSE SENSORS; GLASSY STATES;
   LIQUID; TEMPERATURE; MODULATION
AB We present a new diagnostic technique of fundamental monomeric biomaterials that do not rely on any enzyme or chemical reaction. Instead, it only uses radio frequency (RF) signal analysis. The detection and classification of basic biomaterials, such as glucose and albumin, were demonstrated. The device was designed to generate a strong resonance response with glucose solution and fabricated by simple photolithography with PDMS (Polydimethylsiloxane) well. It even was used to detect the level of glucose in mixtures of glucose and albumin and in human serum, and it operated properly and identified the glucose concentration precisely. It has a detection limit about 100 mu M (1.8 mg/dl), and a sensitivity about 58 MHz per 1 mM of glucose and exhibited a good linearity in human blood glucose level. In addition, the intrinsic electrical properties of biomaterials can be investigated by a de-embedding technique and an equivalent circuit analysis. The capacitance of glucose containing samples exhibited bell-shaped Gaussian dispersion spectra around 2.4 GHz. The Albumin solution did not represent a clear dispersion spectra compared to glucose, and the magnitude of resistance and inductance of albumin was higher than that of other samples. Other parameters also represented distinguishable patterns to classify those biomaterials. It leads us to expect future usage of our technique as a pattern-recognizing biosensor. (C) 2016 Published by Elsevier B.V.
C1 [Ji, Jae-hoon; Kang, Shinill; Jun, Seong Chan] Yonsei Univ, Sch Mech Engn, 50 Yonsei Ro, Seoul 120749, South Korea.
   [Ji, Jae-hoon; Shin, Kyeong-sik; Lee, Soo Hyun; Kang, Ji Yoon] Korea Inst Sci & Technol, Nanobiores Ctr, 39-1 Hawolgok Dong, Seoul 136791, South Korea.
   [Kim, Sinyoung] Yonsei Univ, Coll Med, Dept Lab Med, 50 Yonsei Ro, Seoul 120749, South Korea.
RP Jun, SC (reprint author), Yonsei Univ, Sch Mech Engn, 50 Yonsei Ro, Seoul 120749, South Korea.
EM scj@yonsei.ac.kr
FU Priority Research Centers Program [2009-0093823]; Basic Science Research
   Program [2013063062]; Korean Government (MSIP) through the National
   Research Foundation of Korea (NRF) - Ministry of Education, Science and
   Technology (MEST) [2015R1A5A1037668]
FX This work was partially supported by the Priority Research Centers
   Program (2009-0093823), the Basic Science Research Program (Grant no.
   2013063062), the Korean Government (MSIP) (No. 2015R1A5A1037668) through
   the National Research Foundation of Korea (NRF) funded by the Ministry
   of Education, Science and Technology (MEST).
CR Bahshi L, 2009, SMALL, V5, P676, DOI 10.1002/smll.200801403
   Barochi G, 2011, SENSOR ACTUAT B-CHEM, V157, P374, DOI 10.1016/j.snb.2011.04.059
   Bernou C, 2000, SENSOR ACTUAT B-CHEM, V68, P88, DOI 10.1016/S0925-4005(00)00466-4
   CHAN RK, 1986, J PHYS CHEM-US, V90, P6358, DOI 10.1021/j100281a059
   Cole KS, 1941, J CHEM PHYS, V9, P341, DOI 10.1063/1.1750906
   Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062
   DOUMAS BT, 1971, CLIN CHIM ACTA, V31, P87, DOI 10.1016/0009-8981(71)90365-2
   EDEN J, 1980, J CHEM SOC FARAD T 1, V76, P426, DOI 10.1039/f19807600426
   Farrugia A, 2010, TRANSFUS MED REV, V24, P53, DOI 10.1016/j.tmrv.2009.09.005
   Fuchs K, 2001, J PHYS CHEM B, V105, P2036, DOI 10.1021/jp0030084
   GRANT EH, 1968, J PHYS CHEM-US, V72, P4373, DOI 10.1021/j100859a004
   Grenier Katia, 2009, IEEE, V57, P12
   Harper A, 2010, SENSORS-BASEL, V10, P8248, DOI 10.3390/s100908248
   HAVRILIA.S, 1967, POLYMER, V8, P161, DOI 10.1016/0032-3861(67)90021-3
   HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0
   Jun SC, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/8/265
   Kim NY, 2015, BIOSENS BIOELECTRON, V67, P687, DOI 10.1016/j.bios.2014.10.021
   Kim SG, 2013, BIOSENS BIOELECTRON, V50, P362, DOI 10.1016/j.bios.2013.06.034
   Kim YH, 2006, SENSOR ACTUAT B-CHEM, V117, P315, DOI 10.1016/j.snb.2005.11.004
   Lee HJ, 2014, BIOSENS BIOELECTRON, V61, P448, DOI 10.1016/j.bios.2014.05.025
   Lee HJ, 2012, SENSOR ACTUAT B-CHEM, V169, P26, DOI 10.1016/j.snb.2012.01.044
   Li ZX, 2014, SENSOR ACTUAT B-CHEM, V196, P23, DOI 10.1016/j.snb.2014.01.111
   Lyandres O, 2008, DIABETES TECHNOL THE, V10, P257, DOI 10.1089/dia.2007.0288
   Matthaei G., 1980, MICROWAVE FILTERS IM
   MIYAHARA Y, 1985, SENSOR ACTUATOR, V7, P1, DOI 10.1016/0250-6874(85)87001-3
   Moran GR, 2000, CARBOHYD RES, V328, P573, DOI 10.1016/S0008-6215(00)00125-7
   Noel TR, 1996, CARBOHYD RES, V282, P193, DOI 10.1016/0008-6215(95)00388-6
   Oliver NS, 2009, DIABETIC MED, V26, P197, DOI 10.1111/j.1464-5491.2008.02642.x
   Oncley JL, 1942, CHEM REV, V30, P433, DOI 10.1021/cr60097a008
   Park HG, 2014, CURR APPL PHYS, V14, P1553, DOI 10.1016/j.cap.2014.09.006
   Park H, 2014, BIOSENS BIOELECTRON, V54, P141, DOI 10.1016/j.bios.2013.10.053
   Potts RO, 2002, DIABETES METAB RES, V18, pS49, DOI 10.1002/dmrr.210
   Potyrallo RA, 2007, ANAL CHEM, V79, P45, DOI 10.1021/ac061748o
   Rauch D, 2014, SENSOR ACTUAT B-CHEM, V205, P88, DOI 10.1016/j.snb.2014.08.019
   Rossignol J, 2013, SENSOR ACTUAT B-CHEM, V189, P213, DOI 10.1016/j.snb.2013.03.092
   Tanguy NR, 2015, ACS APPL MATER INTER, V7, P11939, DOI 10.1021/acsami.5b01876
   Theodore Jr Peters, 1985, ADV PROTEIN CHEM, V37, P161
   Yang Y, 2010, LAB CHIP, V10, P553, DOI 10.1039/b921502f
   Yoon HS, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/1/015201
NR 39
TC 1
Z9 1
U1 0
U2 24
PU ELSEVIER ADVANCED TECHNOLOGY
PI OXFORD
PA OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON,
   OXFORD OX5 1GB, OXON, ENGLAND
SN 0956-5663
EI 1873-4235
J9 BIOSENS BIOELECTRON
JI Biosens. Bioelectron.
PD AUG 15
PY 2016
VL 82
BP 255
EP 261
DI 10.1016/j.bios.2016.03.016
PG 7
WC Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical;
   Electrochemistry; Nanoscience & Nanotechnology
SC Biophysics; Biotechnology & Applied Microbiology; Chemistry;
   Electrochemistry; Science & Technology - Other Topics
GA DM7MT
UT WOS:000376545400037
PM 27111728
DA 2018-10-20
ER

PT J
AU Rathore, HS
   Sarubala, M
   Ramanathan, G
   Singaravelu, S
   Raja, MD
   Gupta, S
   Sivagnanam, UT
AF Rathore, Hanumant Singh
   Sarubala, M.
   Ramanathan, Giriprasath
   Singaravelu, Sivakumar
   Raja, M. D.
   Gupta, Sanjeev
   Sivagnanam, Uma Tirichurapalli
TI Fabrication of biomimetic porous novel sponge from gum kondagogu for
   wound dressing
SO MATERIALS LETTERS
LA English
DT Article
DE Biomaterials; Biomimetic; Polymeric composites; FTIR
ID TISSUE ENGINEERING APPLICATIONS; DRUG-DELIVERY; COCHLOSPERMUM-GOSSYPIUM;
   SCAFFOLD
AB The present study focused on fabrication of novel sponge by blending natural polymer gum kondagogu (GK) with gelatin (G) which has not been explored so far. The fabricated sponge was characterized by swelling %, porosity, SEM and showed that sponge is porous in nature. TGA showed blended GK-G sponge has good thermal stability and functional group was confirmed by FTIR. Moreover, Sponge was impregnated with ciprofloxacin (CP) drug and shows 95% drug release in 48 h. The in vitro biocompatibility, cell adhesion and proliferation were done using NIH 3T3 fibroblast and Human keratinocytes cell lines, and result showed that sponge is highly biocompatible. CP loaded sponge was evaluated against S. aureus and E. coli and it showed good antimicrobial activities. In conclusion, it could be used as a potential biomaterial for wound dressing. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Rathore, Hanumant Singh; Sarubala, M.; Ramanathan, Giriprasath; Singaravelu, Sivakumar; Raja, M. D.; Sivagnanam, Uma Tirichurapalli] CSIR, Cent Leather Res Inst, Bioprod Lab, Madras, Tamil Nadu, India.
   [Rathore, Hanumant Singh] Nagaland Cent Univ, Dept Biotechnol, Dimapur, Nagaland, India.
   [Gupta, Sanjeev] CSIR, CLRI, Integrated Dev Leather Sect, Madras, Tamil Nadu, India.
RP Sivagnanam, UT (reprint author), CSIR, Cent Leather Res Inst, Bioprod Lab, Madras, Tamil Nadu, India.
EM suma67@gmail.com
RI Tirichurapalli Sivagnanam, uma/E-1325-2017; Ramanathan,
   Giriprasath/E-2019-2017
OI Tirichurapalli Sivagnanam, uma/0000-0002-1401-2569; Ramanathan,
   Giriprasath/0000-0002-2541-6577
FU Council of Scientific and Industrial Research (CSIR), New Delhi, India
   [31/GATE/06(20)/2009-EMR-I]
FX The authors, H. S. Rathore, thanks Council of Scientific and Industrial
   Research (CSIR) (award number 31/GATE/06(20)/2009-EMR-I), New Delhi,
   India for the award of JRF.
CR Boateng JS, 2008, J PHARM SCI-US, V97, P2892, DOI 10.1002/jps.21210
   Chang CH, 2003, BIOMATERIALS, V24, P4853, DOI 10.1016/S0142-9612(03)00383-1
   Chen Pei-ru, 2005, BME, V17, P101
   Dhandayuthapani B., 2011, INT J POLYM SCI, V2011, P19, DOI DOI 10.1155/2011/290602
   Elsner Jonathan J, 2012, Biomatter, V2, P239, DOI 10.4161/biom.22838
   Janaki B, 2000, FOOD CHEM TOXICOL, V38, P523, DOI 10.1016/S0278-6915(00)00037-5
   Kandhasamy S, 2015, RSC ADV, V5, P55075, DOI 10.1039/c5ra07133j
   Khan MN, 2012, J BIOMED MATER RES A, V100A, P3020, DOI 10.1002/jbm.a.34248
   Kumar Ashok, 2014, Journal of Pharmaceutical Investigation, V44, P237, DOI 10.1007/s40005-014-0120-9
   Kumar A, 2012, CARBOHYD POLYM, V90, P637, DOI 10.1016/j.carbpol.2012.05.089
   Nagiah N, 2014, INT J POLYM MATER PO, V63, P583, DOI 10.1080/00914037.2013.854230
   Peter M, 2010, CARBOHYD POLYM, V80, P687, DOI 10.1016/j.carbpol.2009.11.050
   Ragothaman M, 2014, CARBOHYD POLYM, V114, P399, DOI 10.1016/j.carbpol.2014.08.045
   Saravanan P, 2012, MAT SCI ENG C-MATER, V32, P581, DOI 10.1016/j.msec.2011.12.015
   Singaravelu S, 2016, INT J BIOL MACROMOL, V86, P810, DOI 10.1016/j.ijbiomac.2016.02.021
   Singh B, 2008, EUR POLYM J, V44, P3222, DOI 10.1016/j.eurpolymj.2008.07.013
   Stephanie M. Willerth, 2007, ADV DRUG DELIV REV, V59, P325
   Vinod VTP, 2011, COLLOID SURFACE B, V83, P291, DOI 10.1016/j.colsurfb.2010.11.035
   Vinod V. T. P., 2010, Indian Journal of Natural Products and Resources, V1, P181
   Vinod VTP, 2009, FOOD CHEM, V116, P686, DOI 10.1016/j.foodchem.2009.03.009
   Yang J, 2002, J BIOMED MATER RES, V62, P438, DOI 10.1002/jbm.10318
   Zhan J., 2012, J RES UPDATES POLYM, V1, P59, DOI DOI 10.6000/1929-5995.2012.01.02.1
NR 22
TC 3
Z9 3
U1 1
U2 36
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD AUG 15
PY 2016
VL 177
BP 108
EP 111
DI 10.1016/j.matlet.2016.04.185
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA DM7IG
UT WOS:000376532200027
DA 2018-10-20
ER

PT J
AU Rahmati, B
   Sarhan, AAD
   Basirun, WJ
   Abas, WABW
AF Rahmati, B.
   Sarhan, Ahmed A. D.
   Basirun, W. Jeffrey
   Abas, W. A. B. W.
TI Ceramic tantalum oxide thin film coating to enhance the corrosion and
   wear characteristics of Ti-6Al-4V alloy
SO JOURNAL OF ALLOYS AND COMPOUNDS
LA English
DT Article
DE Tantalum oxide; Ti-6Al-4V alloy; Biomaterial; Corrosion; Wear
ID SHAPE-MEMORY ALLOY; BIOMEDICAL APPLICATIONS; TITANIUM-ALLOYS;
   MECHANICAL-PROPERTIES; PVD-COATINGS; SURFACE MODIFICATION; RESISTANCE;
   TI; BIOMATERIALS; BIOCOMPATIBILITY
AB In this research, an attempt is made to study the corrosion and wear behavior of TaO2 thin film coating deposited onto Ti-6Al-4V alloy with the highest adhesion (was achieved in the author's previous experiments using Taguchi statistical method) which leads to increase corrosion resistance, decrease debris generation and improve durability. Accordingly, pure tantalum (Ta) was deposited onto Ti-6Al-4V substrate surface as intermetallic layer then to form a TaO2 thin film, Ta was deposited onto the sample surface in the presence of oxygen by using physical vapor deposition magnetron sputtering (PVDMS). Corrosion testing was carried out in fetal bovine serum (FBS). The corrosion test in FBS medium confirmed that the corrosion resistance of the TaO2 - coated Ti-6Al-4V alloys was significantly higher than the uncoated Ti-6Al-4V substrate due to the decrease in corrosion current density (Icorr) for the coated substrate with high thin-film adhesion. Wear testing was carried out on uncoated and coated Ti-6Al-4V substrates in the presence of FBS medium under 15 N load (natural walking load) at 1.09 m/s (simulated medium walking speed). The tests revealed that the specific wear ratio of TaO2 coating was significantly lower than the uncoated substrate wear ratio. The average friction coefficients obtained were 0.183 and 0.152 for uncoated substrate and TaO2 thin film coating, respectively. So, due to the noticeable corrosion and wear resistance characteristics of the TaO2 coating, it is suggested for hip joint implant. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Rahmati, B.; Sarhan, Ahmed A. D.] Univ Malaya, Dept Mech Engn, Kuala Lumpur 50603, Malaysia.
   [Basirun, W. Jeffrey] Univ Malaya, Dept Chem, Kuala Lumpur 50603, Malaysia.
   [Abas, W. A. B. W.] Univ Malaya, Dept Biomed Engn, Kuala Lumpur 50603, Malaysia.
RP Rahmati, B; Sarhan, AAD (reprint author), Univ Malaya, Dept Mech Engn, Kuala Lumpur 50603, Malaysia.
EM r.bijan@yahoo.com; ah_sarhan@um.edu.my
RI BASIRUN, WAN JEFREY BASIRUN/B-8008-2010; SARHAN, AHMED/B-5307-2010;
   engineering, @UM-2016/I-9329-2016; Sarhan, Ahmed/M-4184-2013
OI SARHAN, AHMED/0000-0001-8474-8347; Sarhan, Ahmed/0000-0001-8474-8347
FU University of Malaya [UM.C/HIR/MOHE/ENG/44]; Institute of Research
   Management & Monitoring (IPPP) from the University of Malaya
   [PG100/2013B, RP005B-13AET]
FX This work was supported by the High Impact Research Grant
   UM.C/HIR/MOHE/ENG/44 & Institute of Research Management & Monitoring
   (IPPP) grants PG100/2013B and RP005B-13AET from the University of
   Malaya.
CR Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833
   Bergmann G, 2001, J BIOMECH, V34, P859, DOI 10.1016/S0021-9290(01)00040-9
   Cheng Y, 2004, SURF COAT TECH, V186, P346, DOI 10.1016/j.surfcoat.2004.01.012
   Ching HA, 2014, SCI TECHNOL ADV MAT, V15, DOI 10.1088/1468-6996/15/1/014402
   Dabbagh A, 2015, J PHARM SCI-US, V104, P2414, DOI 10.1002/jps.24536
   Donkov N, 2011, PROBL ATOM SCI TECH, P131
   El Abedin SZ, 2005, ELECTROCHEM COMMUN, V7, P941, DOI 10.1016/j.elecom.2005.06.007
   Ewald A, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-22
   Farnoush H, 2012, CERAM INT, V38, P4885, DOI 10.1016/j.ceramint.2012.02.079
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Guillemot F, 2005, EXPERT REV MED DEVIC, V2, P741, DOI 10.1586/17434440.2.6.741
   Hacking SA, 2000, J BIOMED MATER RES, V52, P631
   Hallab NJ, 2003, CORROS REV, V21, P183
   Hertl C, 2014, MAT SCI ENG C-MATER, V41, P28, DOI 10.1016/j.msec.2014.03.018
   Hertl C, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/5/054104
   Hollerweger R, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/33/335203
   Lenaerts V., 1990, BIOADHESIVE DRUG DEL
   Lim YM, 2002, CERAM INT, V28, P37, DOI 10.1016/S0272-8842(01)00055-4
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Ma ZW, 2005, BIOMATERIALS, V26, P2527, DOI 10.1016/j.biomaterials.2004.07.026
   Macionczyk F, 2001, SURF COAT TECH, V142, P1084, DOI 10.1016/S0257-8972(01)01096-9
   Mattei L, 2011, TRIBOL INT, V44, P532, DOI 10.1016/j.triboint.2010.06.010
   Mendonca G, 2008, BIOMATERIALS, V29, P3822, DOI 10.1016/j.biomaterials.2008.05.012
   Moseke C, 2011, J MATER SCI-MATER M, V22, P2711, DOI 10.1007/s10856-011-4457-6
   Nie L, 2014, MATER DESIGN, V53, P8, DOI 10.1016/j.matdes.2013.07.008
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   Oliveira NTC, 2009, ACTA BIOMATER, V5, P399, DOI 10.1016/j.actbio.2008.07.010
   Ouyang JH, 2009, WEAR, V266, P96, DOI 10.1016/j.wear.2008.05.002
   Park J. B., 2002, BIOMATERIALS PRINCIP
   Pelletier H, 2002, SURF COAT TECH, V158, P309, DOI 10.1016/S0257-8972(02)00188-3
   Probst J, 2001, SURF COAT TECH, V148, P226, DOI 10.1016/S0257-8972(01)01357-3
   Rahmanifard R, 2016, J ALLOY COMPD, V657, P646, DOI 10.1016/j.jallcom.2015.10.161
   Rahmati B, 2016, CERAM INT, V42, P466, DOI 10.1016/j.ceramint.2015.08.133
   Rahmati B, 2015, CERAM INT, V41, P13055, DOI 10.1016/j.ceramint.2015.07.090
   Rahmati B, 2014, INT J ADV MANUF TECH, V70, P1143, DOI 10.1007/s00170-013-5334-x
   Rautray TR, 2011, PROG MATER SCI, V56, P1137, DOI 10.1016/j.pmatsci.2011.03.002
   Sharma B, 2016, J ALLOY COMPD, V656, P978, DOI 10.1016/j.jallcom.2015.10.053
   Sing SL, 2016, J ALLOY COMPD, V660, P461, DOI 10.1016/j.jallcom.2015.11.141
   Spriano S, 2005, WEAR, V259, P919, DOI 10.1016/j.wear.2005.02.011
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Taddei P, 2003, J MOL STRUCT, V651, P427, DOI 10.1016/S0022-2860(02)00662-2
   Vasilescu E, 2010, MATER CORROS, V61, P947, DOI 10.1002/maco.201005740
   Velten D, 2002, J BIOMED MATER RES, V59, P18, DOI 10.1002/jbm.1212
   Venugopalan R, 2000, BIOMATERIALS, V21, P1669, DOI 10.1016/S0142-9612(00)00049-1
   Wakily H, 2015, MATER LETT, V143, P322, DOI 10.1016/j.matlet.2014.12.092
   Willert HG, 1996, CLIN ORTHOP RELAT R, P51
   WILSON GJ, 1995, ANN THORAC SURG, V60, pS353, DOI 10.1016/0003-4975(95)98967-Y
   Yang XZ, 2009, MATER RES BULL, V44, P947, DOI 10.1016/j.materresbull.2008.09.048
   Zhang WG, 2009, CERAM INT, V35, P1513, DOI 10.1016/j.ceramint.2008.08.009
NR 50
TC 22
Z9 22
U1 4
U2 96
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-8388
EI 1873-4669
J9 J ALLOY COMPD
JI J. Alloy. Compd.
PD AUG 15
PY 2016
VL 676
BP 369
EP 376
DI 10.1016/j.jallcom.2016.03.188
PG 8
WC Chemistry, Physical; Materials Science, Multidisciplinary; Metallurgy &
   Metallurgical Engineering
SC Chemistry; Materials Science; Metallurgy & Metallurgical Engineering
GA DJ6MR
UT WOS:000374328100050
DA 2018-10-20
ER

PT J
AU Moya, JS
   Martinez, A
   Lopez-Piriz, R
   Guitian, F
   Diaz, LA
   Esteban-Tejeda, L
   Cabal, B
   Sket, F
   Fernandez-Garcia, E
   Tomsia, AP
   Torrecillas, R
AF Moya, Jose S.
   Martinez, Arturo
   Lopez-Piriz, Roberto
   Guitian, Francisco
   Diaz, Luis A.
   Esteban-Tejeda, Leticia
   Cabal, Belen
   Sket, Federico
   Fernandez-Garcia, Elisa
   Tomsia, Antoni P.
   Torrecillas, Ramon
TI Histological response of soda-lime glass-ceramic bactericidal rods
   implanted in the jaws of beagle dogs
SO SCIENTIFIC REPORTS
LA English
DT Article
ID BIOACTIVE GLASS; IN-VITRO; CONTROLLABLE DEGRADATION; SCAFFOLDS; BIOCIDE;
   VIVO; NANOPARTICLES; AUGMENTATION; BOROSILICATE; SILICATE
AB Bacterial and fungal infections remain a major clinical challenge. Implant infections very often require complicated revision procedures that are troublesome to patients and costly to the healthcare system. Innovative approaches to tackle infections are urgently needed. We investigated the histological response of novel free P2O5 glass-ceramic rods implanted in the jaws of beagle dogs. Due to the particular percolated morphology of this glass-ceramic, the dissolution of the rods in the animal body environment and the immature bone formation during the fourth months of implantation maintained the integrity of the glass-ceramic rod. No clinical signs of inflammation took place in any of the beagle dogs during the four months of implantation. This new glass-ceramic biomaterial with inherent bactericidal and fungicidal properties can be considered as an appealing candidate for bone tissue engineering.
C1 [Moya, Jose S.; Lopez-Piriz, Roberto; Diaz, Luis A.; Cabal, Belen; Fernandez-Garcia, Elisa; Torrecillas, Ramon] Univ Oviedo, CSIC, Nanomat & Nanotechnol Res Ctr CINN, Avda Vega 4-6, El Entrego 33940, San Martin Del, Spain.
   [Moya, Jose S.; Esteban-Tejeda, Leticia] Inst Mat Sci Madrid ICMM CSIC, Madrid 28049, Spain.
   [Martinez, Arturo; Guitian, Francisco] Univ Santiago Compostela, Galician Inst Ceram, Avda Maestro Mateo, Santiago De Compostela 15782, Spain.
   [Sket, Federico] IMDEA Mat Inst, C Eric Kandel 2, Madrid 28906, Spain.
   [Tomsia, Antoni P.] Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA.
RP Torrecillas, R (reprint author), Univ Oviedo, CSIC, Nanomat & Nanotechnol Res Ctr CINN, Avda Vega 4-6, El Entrego 33940, San Martin Del, Spain.
EM r.torrecillas@cinn.es
RI Sket, Federico/B-4042-2017
OI Cabal, Belen/0000-0002-4102-3810
FU Spanish Ministry of Science and Innovation (MICINN) [MAT2012-38645];
   National Institutes of Health/National Institute of Dental and
   Craniofacial Research (NIH/NIDCR) [1R01DE015633]
FX This work was supported by the Spanish Ministry of Science and
   Innovation (MICINN) under the projects MAT2012-38645. A.P. Tomsia work
   was supported by the National Institutes of Health/National Institute of
   Dental and Craniofacial Research (NIH/NIDCR) Grant No. 1R01DE015633.
CR Barton AJ, 1996, J BIOMED MATER RES, V30, P403, DOI 10.1002/(SICI)1097-4636(199603)30:3<403::AID-JBM15>3.0.CO;2-K
   Cabal B, 2014, SCI REP-UK, V4, DOI 10.1038/srep05440
   Cabal B, 2011, ADV ENG MATER, V13, pB462, DOI 10.1002/adem.201180026
   Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089
   Chen QZ, 2011, ACTA BIOMATER, V7, P3616, DOI 10.1016/j.actbio.2011.06.005
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Devesa L, 1998, ACTA MATER, V46, P2559, DOI 10.1016/S1359-6454(98)80040-2
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Esteban-Tejeda L, 2016, J NON-CRYST SOLIDS, V432, P73, DOI 10.1016/j.jnoncrysol.2015.05.040
   Fu QA, 2010, J BIOMED MATER RES A, V95A, P164, DOI 10.1002/jbm.a.32824
   Fu QA, 2010, J BIOMED MATER RES A, V95A, P172, DOI 10.1002/jbm.a.32823
   Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x
   Gwinn MR, 2006, ENVIRON HEALTH PERSP, V114, P1818, DOI 10.1289/ehp.8871
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Jones JR, 2013, ACTA BIOMATER, V9, P4457, DOI 10.1016/j.actbio.2012.08.023
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001
   Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222
   Laschke MW, 2010, ACTA BIOMATER, V6, P2020, DOI 10.1016/j.actbio.2009.12.004
   Lopez-Esteban S, 2014, J MECH BEHAV BIOMED, V34, P302, DOI 10.1016/j.jmbbm.2014.02.019
   Lopez-Piriz R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140374
   Lyndon JA, 2014, J CONTROL RELEASE, V179, P63, DOI 10.1016/j.jconrel.2014.01.026
   Marcacci M, 2007, TISSUE ENG, V13, P947, DOI 10.1089/ten.2006.0271
   Martinez A, 2010, MAT SCI ENG C-MATER, V30, P763, DOI 10.1016/j.msec.2010.03.012
   Martinez A, 2015, CLIN ORAL IMPLAN RES, V26, P623, DOI 10.1111/clr.12349
   Matl FD, 2008, ANTIMICROB AGENTS CH, V52, P1957, DOI 10.1128/AAC.01438-07
   Miranda M, 2012, J MATER SCI-MATER M, V23, P1655, DOI 10.1007/s10856-012-4642-2
   Miranda M, 2010, INT J MATER RES, V101, P122, DOI 10.3139/146.110256
   Moya JS, 2011, ADV ENG MATER, V13, pB256, DOI 10.1002/adem.201080133
   MOYA JS, 1994, J MATER SCI-MATER M, V5, P529, DOI 10.1007/BF00124885
   Rahaman MN, 2014, MAT SCI ENG C-MATER, V41, P224, DOI 10.1016/j.msec.2014.04.055
   Shkilnyy A, 2012, COLLOID SURFACE B, V93, P202, DOI 10.1016/j.colsurfb.2012.01.005
   Suresh AK, 2013, NANOSCALE, V5, P463, DOI 10.1039/c2nr32447d
   Wang B, 2013, METALLOMICS, V5, P793, DOI 10.1039/c3mt00093a
   Woodruff MA, 2012, MATER TODAY, V15, P430, DOI 10.1016/S1369-7021(12)70194-3
   Yildirim M, 2000, CLIN ORAL IMPLAN RES, V11, P217, DOI 10.1034/j.1600-0501.2000.011003217.x
NR 36
TC 4
Z9 4
U1 2
U2 9
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD AUG 12
PY 2016
VL 6
AR 31478
DI 10.1038/srep31478
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DT2EO
UT WOS:000381293800001
PM 27515388
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Raina, DB
   Isaksson, H
   Teotia, AK
   Lidgren, L
   Tagil, M
   Kumar, A
AF Raina, Deepak Bushan
   Isaksson, Hanna
   Teotia, Arun Kumar
   Lidgren, Lars
   Tagil, Magnus
   Kumar, Ashok
TI Biocomposite macroporous cryogels as potential carrier scaffolds for
   bone active agents augmenting bone regeneration
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE Cryogel; Zoledronic acid; Biocomposite; Bone tissue engineering;
   Biomaterial
ID COLLAGEN-HYDROXYAPATITE SCAFFOLDS; GROWTH-FACTOR DELIVERY; ZOLEDRONIC
   ACID; IN-VITRO; LOCAL TREATMENT; SILK FIBROIN; TISSUE; BIOMATERIALS;
   VIVO; DIFFERENTIATION
AB Osteoinduction can be enhanced by combining scaffolds with bone morphogenic protein-2 (BMP-2). However, BMP's are known to also cause bone resorption. This can be controlled using bisphosphonates like zoledronic acid (ZA). In this study, we produced two different scaffolds containing silk-fibroin, chitosan, agarose and hydroxyapatite (HA) with and without bioactive glass. The aims of the study were to fabricate, physico-chemically characterize and evaluate the carrier properties of the scaffolds for recombinant human BMP-2 (rhBMP-2) and ZA. Scaffolds were characterized using various methods to confirm their composition. During cell-material interactions, both scaffolds exhibited gradual but sustained proliferation of both C2C12 and MSCs for a period of 6 weeks with augmentative effects on their phenotype indicated by elevated levels of alkaline phosphatase (ALP) cuing towards osteogenic differentiation. In-vitro effects of rhBMP-2 and ZA contained within both the scaffolds was assessed on MC3T3 preosteoblast cells and the results show a significant increase in the ALP activity of the cells seeded on scaffolds with rhBMP-2. Further, the scaffold with both HA and bioactive glass was considered for the animal study. In-vitro, this scaffold released nearly 25% rhBMP-2 in 21-days and the addition of ZA did not affect the release. In the animal study, the scaffolds were combined with rhBMP-2 and ZA, rhBMP-2 or implanted alone in an ectopic muscle pouch model. Significantly higher bone formation was observed in the scaffold loaded with both rhBMP-2 and ZA as seen from micro-computed tomography, histomorphometry and energy dispersive X-ray spectroscopy. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Raina, Deepak Bushan; Teotia, Arun Kumar; Kumar, Ashok] Indian Inst Technol, Dept Biol Sci & Bioengn, Ctr Environm Sci & Engn, Kanpur 208016, Uttar Pradesh, India.
   [Raina, Deepak Bushan; Isaksson, Hanna; Lidgren, Lars; Tagil, Magnus] Lund Univ, Dept Orthoped, Clin Sci Lund, S-22185 Lund, Sweden.
   [Isaksson, Hanna] Lund Univ, Dept Biomed Engn, S-22100 Lund, Sweden.
RP Kumar, A (reprint author), Indian Inst Technol, Dept Biol Sci & Bioengn, Ctr Environm Sci & Engn, Kanpur 208016, Uttar Pradesh, India.
EM ashokkum@iitk.ac.in
RI Isaksson, Hanna/L-1340-2015
OI Isaksson, Hanna/0000-0002-9690-8907; Teotia, Arun/0000-0003-0031-6155
FU Department of Biotechnology (DBT), Ministry of Science and Technology,
   Govt. of India [BT/PR14111/PBD/19/220/2010]; Faculty of Medicine Lund
   University, Sweden
FX Department of Biotechnology (DBT), Ministry of Science and Technology,
   Govt. of India is acknowledged for providing research funding for
   research on silk-based biomaterials (project
   #BT/PR14111/PBD/19/220/2010). AK would also like to acknowledge DBT-TATA
   innovation fellowship. LL, MT and DBR thank the foundation for disabled
   people in Skane and the Faculty of Medicine Lund University, Sweden for
   funding the in-vivo study. We would also like to thank Riya Dhar
   (Department of Biological Sciences and Bioengineering, IIT Kanpur) for
   help with in-vitro experiments, Mea Pelkonen (Department of Orthopedics,
   Lund University) for her advice on histology and Gustav Grafstrom (Lund
   University Bioimaging Center, Lund University) for assistance with
   micro-CT analysis.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Amini Ami R., 2012, Critical Reviews in Biomedical Engineering, V40, P363
   Angelova N, 1999, TRENDS BIOTECHNOL, V17, P409, DOI 10.1016/S0167-7799(99)01356-6
   Arrington ED, 1996, CLIN ORTHOP RELAT R, P300
   Babensee JE, 2000, PHARMACEUT RES, V17, P497, DOI 10.1023/A:1007502828372
   Belfrage O, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-240
   Belfrage O, 2011, ACTA ORTHOP, V82, P228, DOI 10.3109/17453674.2011.566138
   Bhat S, 2011, J R SOC INTERFACE, V8, P540, DOI 10.1098/rsif.2010.0455
   Bosemark P, 2015, J ORTHOP RES, V33, P488, DOI 10.1002/jor.22815
   Chang JT, 2003, NEW ENGL J MED, V349, P1676
   Chang MC, 2002, BIOMATERIALS, V23, P4811, DOI 10.1016/S0142-9612(02)00232-6
   Clupper DC, 2004, J MATER SCI-MATER M, V15, P803, DOI 10.1023/B:JMSM.0000032821.32577.fc
   Corazzari I, 2015, POLYM DEGRAD STABIL, V112, P1, DOI 10.1016/j.polymdegradstab.2014.12.006
   Croisier F, 2013, EUR POLYM J, V49, P780, DOI 10.1016/j.eurpolymj.2012.12.009
   Diel Ingo J, 2007, J Support Oncol, V5, P475
   Epstein Nancy E, 2013, Surg Neurol Int, V4, pS343, DOI 10.4103/2152-7806.114813
   Kaneko H, 2000, BONE, V27, P479, DOI 10.1016/S8756-3282(00)00358-6
   Kumar A, 2010, MATER TODAY, V13, P42, DOI 10.1016/S1369-7021(10)70202-9
   Kuznetsov SA, 1997, J BONE MINER RES, V12, P1335, DOI 10.1359/jbmr.1997.12.9.1335
   Lanza R., 2011, PRINCIPLES TISSUE EN
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mathavan N, 2013, BONE, V56, P440, DOI 10.1016/j.bone.2013.06.030
   Mishra R, 2015, INT J BIOL SCI, V11, P1325, DOI 10.7150/ijbs.13139
   Mishra R, 2014, TISSUE ENG PT A, V20, P751, DOI 10.1089/ten.TEA.2013.0072
   Mishra R, 2011, J BIOMAT SCI-POLYM E, V22, P2107, DOI 10.1163/092050610X534230
   Motta A, 2002, MACROMOL CHEM PHYSIC, V203, P1658, DOI 10.1002/1521-3935(200207)203:10/11<1658::AID-MACP1658>3.0.CO;2-3
   Mygind T, 2007, BIOMATERIALS, V28, P1036, DOI 10.1016/j.biomaterials.2006.10.003
   Oryan A, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/1749-799X-9-18
   Quinlan E, 2015, J CONTROL RELEASE, V207, P112, DOI 10.1016/j.jconrel.2015.03.028
   Quinlan E, 2015, J CONTROL RELEASE, V198, P71, DOI 10.1016/j.jconrel.2014.11.021
   Raina DB, 2016, SCI REP-UK, V6, DOI 10.1038/srep26033
   Raina DB, 2014, RSC ADV, V4, P31855, DOI 10.1039/c4ra05547k
   Recum A F, 1996, Tissue Eng, V2, P241, DOI 10.1089/ten.1996.2.241
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Roelofs AJ, 2006, CLIN CANCER RES, V12, p6222S, DOI 10.1158/1078-0432.CCR-06-0843
   Sachlos E, 2003, EUR CELLS MATER, V5, P39
   Schindeler A, 2005, BIOCHEM BIOPH RES CO, V338, P710, DOI 10.1016/j.bbrc.2005.09.198
   Serra J, 2003, J NON-CRYST SOLIDS, V332, P20, DOI 10.1016/j.jnoncrysol.2003.09.013
   Shen JW, 2008, BIOMATERIALS, V29, P513, DOI 10.1016/j.biomaterials.2007.10.016
   Spicer PP, 2012, NAT PROTOC, V7, P1918, DOI 10.1038/nprot.2012.113
   Teotia AK, 2016, ACS APPL MATER INTER, V8, P10775, DOI 10.1021/acsami.6b02145
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   VANHOOF VO, 1994, CRIT REV CL LAB SCI, V31, P197, DOI 10.3109/10408369409084677
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Xia K, 2006, PLOS COMPUT BIOL, V2, P1482, DOI 10.1371/journal.pcbi.0020145
   Yasuda H, 1999, BONE, V25, P109, DOI 10.1016/S8756-3282(99)00121-0
NR 48
TC 5
Z9 5
U1 6
U2 57
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
EI 1873-4995
J9 J CONTROL RELEASE
JI J. Control. Release
PD AUG 10
PY 2016
VL 235
BP 365
EP 378
DI 10.1016/j.jconrel.2016.05.061
PG 14
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA DR1ZF
UT WOS:000379702700033
PM 27252151
DA 2018-10-20
ER

PT J
AU Uebel, LD
   Schmatz, DA
   Kuntzler, SG
   Dora, CL
   Muccillo-Baisch, AL
   Costa, JAV
   de Morais, MG
AF Uebel, Livia da Silva
   Schmatz, Daiane Angelica
   Kuntzler, Suelen Goettems
   Dora, Cristiana Lima
   Muccillo-Baisch, Ana Luiza
   Vieira Costa, Jorge Alberto
   de Morais, Michele Greque
TI Quercetin and curcumin in nanofibers of polycaprolactone and
   poly(hydroxybutyrate-co-hydroxyvalerate): Assessment of in vitro
   antioxidant activity
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE biomaterials; electrospinning; polymer; scaffolds; tissue engineering
AB Polymeric nanofibers are materials that can be used as scaffolds in tissue engineering. Quercetin and curcumin are antioxidants because of scavenge free radicals and chelate metal ions properties, protecting tissues of lipid peroxidation. The objective of this study was to develop a scaffold with potential antioxidant activity that was produced from nanofibers consisting of polycaprolactone (PCL) and a blend of PCL/poly(hydroxybutyrate-co-hydroxyvalerate) (PHB-HV) with the addition of quercetin or curcumin as the bioactive compound. Curcumin and quercetin were integrated into the solution at a concentration of 3%. The electrospun nanofibers were characterized using calorimetry and thermogravimetric analysis, and the addition of bioactive compounds did not alter the thermal properties of the biomaterial. The antioxidant activity of scaffolds with the active compounds was evaluated by hydrate 2,2-diphenyl-2-picrylhydrazyl (DPPH) and 2,2-azinobis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS) methods. The scaffolds with PCL and PCL/PHB-HV blend with quercetin exhibited higher antioxidant activity than curcumin with both methods. (c) 2016 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 2016, 133, 43712.
C1 [Uebel, Livia da Silva; Schmatz, Daiane Angelica; Kuntzler, Suelen Goettems; de Morais, Michele Greque] Fed Univ Rio Grande, Coll Chem & Food Engn, Lab Microbiol & Biochem, Av Italia,Km 8, BR-96203900 Carreiros Rio Grande, RS, Brazil.
   [Dora, Cristiana Lima; Muccillo-Baisch, Ana Luiza] Fed Univ Rio Grande, Inst Biol Sci, Lab Nanotechnol Appl Hlth, Av Italia,Km 8, BR-96203900 Carreiros Rio Grande, RS, Brazil.
   [Vieira Costa, Jorge Alberto] Fed Univ Rio Grande, Coll Chem & Food Engn, Biochem Engn Lab, Av Italia,Km 8, BR-96203900 Carreiros Rio Grande, RS, Brazil.
RP de Morais, MG (reprint author), Fed Univ Rio Grande, Coll Chem & Food Engn, Lab Microbiol & Biochem, Av Italia,Km 8, BR-96203900 Carreiros Rio Grande, RS, Brazil.
EM michele.morais@pq.cnpq.br
RI Costa, Jorge/L-3999-2013
OI Costa, Jorge/0000-0001-8042-7642; Kuntzler, Suelen/0000-0002-4553-5282;
   Morais, Michele/0000-0001-8920-2896
FU Propesp; MCTI; FURG; CNPq
FX The authors acknowledge financial support from Propesp, MCTI, FURG, and
   CNPq.
CR American Society for Testing and Materials, 2013, D385012 ASTM
   American Society for Testing and Materials, 2014, D742608 ASTM
   Beachley V, 2009, MAT SCI ENG C-BIO S, V29, P663, DOI 10.1016/j.msec.2008.10.037
   Bilbao-Sainz C., 2014, EUR POLYM J, V54, P1
   Brahatheeswaran D., 2012, BIOMED MATER, V7, P1
   Chen WM, 2015, COLLOID SURFACE B, V126, P561, DOI 10.1016/j.colsurfb.2014.09.016
   Cullen B., 2004, Patent No. [U. S. 20060159732 A1, 20060159732]
   Frederice R, 2010, J BRAZIL CHEM SOC, V21, P1213, DOI 10.1590/S0103-50532010000700008
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Li C, 2014, COLLOID SURFACE B, V114, P404, DOI 10.1016/j.colsurfb.2013.10.040
   Lu TC, 2012, J APPL POLYM SCI, V123, P209, DOI 10.1002/app.34463
   Machado MLC, 2010, POLIMEROS, V20, P65, DOI 10.1590/S0104-14282010005000011
   Marten E, 2005, POLYM DEGRAD STABIL, V88, P371, DOI 10.1016/j.polymdegradstab.2004.12.001
   Martin A, 1996, DERMATOL SURG, V22, P156, DOI 10.1111/j.1524-4725.1996.tb00499.x
   Miliauskas G, 2004, FOOD CHEM, V85, P231, DOI 10.1016/j.foodchem.2003.05.007
   Munteanu BS, 2014, J NANOPART RES, V16, DOI 10.1007/s11051-014-2643-4
   Parize AL, 2012, QUIM NOVA, V35, P1127, DOI 10.1590/S0100-40422012000600011
   Patricio T, 2013, CHEM ENGINEER TRANS, V32, P1645, DOI 10.3303/CET1332275
   SCHMATZ D. A., 2016, J NANOSCI NANOTECHNO, V15, P1
   Shin BY, 2011, POLYM ENG SCI, V51, P826, DOI 10.1002/pen.21896
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Tonglairoum P, 2015, COLLOID SURFACE B, V126, P18, DOI 10.1016/j.colsurfb.2014.12.009
   Wang XF, 2008, POLYMER, V49, P2755, DOI 10.1016/j.polymer.2008.04.015
   Wu TH, 2008, INT J PHARM, V346, P160, DOI 10.1016/j.ijpharm.2007.06.036
NR 24
TC 3
Z9 3
U1 3
U2 42
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8995
EI 1097-4628
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD AUG 10
PY 2016
VL 133
IS 30
AR 43712
DI 10.1002/app.43712
PG 7
WC Polymer Science
SC Polymer Science
GA DM3QU
UT WOS:000376262100018
DA 2018-10-20
ER

PT J
AU Gonzalez, OM
   Nguyen, KA
AF Gonzalez, Oswaldo M.
   Nguyen, Khoi A.
TI Cocowood Fibrovascular Tissue System-Another Wonder of Plant Evolution
SO FRONTIERS IN PLANT SCIENCE
LA English
DT Article
DE coconut palm stem tissue (cocowood); monocotyledon plant; fibrovascular
   bundle degree of orientation; mechanical efficiency; finite element
   analysis; integral and macroscopic levels of hierarchical structure
ID WIND-TUNNEL MEASUREMENTS; WASHINGTONIA-ROBUSTA; DRAG RELATIONSHIPS;
   STEM; PALMS; COMPOSITES; MECHANICS; ARECACEAE; FIBER; TREES
AB The coconut palm (Cocos nucifera L.) stem tissue (referred to as cocowood in this study) is a complex fibrovascular system that is made up of fibrovascular bundles embedded into a parenchymatous ground tissue. The complex configuration of fibrovascular bundles along with the non-uniform distribution of the material properties likely allow senile coconut stems to optimize their biomechanical performance per unit mass (i.e., mechanical efficiency) and grow into tall, slender, and very flexible plants with minimum resources of biomass and water. For the first time, to the best of the authors' knowledge, this paper examines, from the integral (i.e., stem structure) and macroscopic (i.e., tissue structure) levels of hierarchy, the characteristic triple helix formation depicted by the fibrovascular bundles within the monocotyledon cocowood. The natural course of the tangential orientation of the axial fibrovascular bundles is mapped for the whole cocowood structure by quantifying 264 cocowood discs, corresponding to 41 senile coconut palms estimated to be >70 years old. The observed variations were modeled in this paper by simple equations that partially enabled characterization of the cocowood fibrovascular tissue system. Furthermore, 11 finite element analyses (FEA) were performed over a three dimensional (3D) finite element (FE) model resembling a characteristic coconut palm stem of 25 m in height to analyze the biomaterial reactions produced by the progressive deviation of the tangential fibrovascular bundles on the cocowood mechanical response (i.e., on the material compressive strength and the bending stiffness). The analyses in this study were carried out for the critical wind speed of 23 m/s (i.e.. Gale tornado according to the Fujita tornado scale). For each analysis, the characteristic average maxima degree of orientation of the cocowood fibrovascular bundles was varied from 0 degrees to 51 degrees. The acquired results provided a deep understanding of the cocowood optimum fibrovascular tissue system that denotes the natural evolution of the material through millions of years. The knowledge advanced from this study may also serve as concept generators for innovative biomimetic applications to improve current engineered wood products.
C1 [Gonzalez, Oswaldo M.] Univ Fuerzas Armadas ESPE, Res Dept, Sangolqui, Ecuador.
   [Gonzalez, Oswaldo M.; Nguyen, Khoi A.] Griffith Univ, Griffith Sch Sci & Engn, Gold Coast, Qld, Australia.
RP Gonzalez, OM (reprint author), Univ Fuerzas Armadas ESPE, Res Dept, Sangolqui, Ecuador.; Gonzalez, OM (reprint author), Griffith Univ, Griffith Sch Sci & Engn, Gold Coast, Qld, Australia.
EM omgonzalez@espe.edu.ec
FU ACIAR project [EST/2004/054]; Universidad de las Fuerzas Armadas ESPE in
   Ecuador
FX The authors gratefully acknowledge the constructive comments on this
   paper offered by Professor Luis Cumbal, Professor Jorge Zuniga
   (Universidad de las Fuerzas Armadas ESPE-Ecuador) and Dr. Hongyu Qin
   (Griffith University-Australia). The authors would like to also thank
   the Department of Agriculture and Fisheries (DAF), Queensland
   Government, for supplying the material and data collected during the
   ACIAR project, EST/2004/054 and Universidad de las Fuerzas Armadas ESPE
   in Ecuador for funding us to publish this paper.
CR [Anonymous], 2000, 4676 ASNZS
   Australian/New Zealand Standard, 2011, 11702 ASNZS
   Bahtiar E., 2010, CIVIL ENG DIMENS, V12, P65, DOI [10.9744/ced.12.2.65-72, DOI 10.9744/CED.12.2.65-72]
   Berard P, 2011, J WOOD SCI, V57, P100, DOI 10.1007/s10086-010-1150-1
   Brahmakumar M, 2005, COMPOS SCI TECHNOL, V65, P563, DOI 10.1016/j.compscitech.2004.09.020
   Butterfield B. G., 1997, 3 DIMENSIONAL STRCUT
   Cabrero J., 2010, EL P WORLD C TIMB EN
   Clyne T. W., 1996, INTRO COMPOSITE MAT
   Cullen S., 2002, J ARBORICULT, V28, P237
   De Mirbel C., 1843, C R PARIS, V19, P689
   Fathi L, 2014, HOLZFORSCHUNG, V68, P915, DOI 10.1515/hf-2013-0213
   Fathi L, 2014, WOOD MATER SCI ENG, V9, P214, DOI 10.1080/17480272.2014.887774
   Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001
   Gibson LJ, 2005, J BIOMECH, V38, P377, DOI 10.1016/j.jbiomech.2004.09.027
   Gibson LJ, 2012, J R SOC INTERFACE, V9, P2749, DOI 10.1098/rsif.2012.0341
   GONZALEZ O., 2015, THESIS
   Gonzalez O. M., 2014, P 23 AUSTR C MECH ST, P881
   Gonzalez O. M., 2015, P 4 INT C NAT SCI EN, P529
   Jones R. M., 1999, MECH COMPOSITE MAT
   Killmann W., 1996, COCONUT PALM STEM PR
   Kuo-Huang LL, 2004, IAWA J, V25, P297, DOI 10.1163/22941932-90000367
   Leelavanichkul S, 2004, STRUCT MULTIDISCIP O, V28, P127, DOI 10.1007/s00158-003-0311-x
   MAYHEAD GJ, 1973, AGR METEOROL, V12, P123, DOI 10.1016/0002-1571(73)90013-7
   Meneghini G, 1836, RICERCHE SULLA STRUT
   NIKLAS KJ, 1992, PLANT BIOMECHANICS E
   Piao C, 2008, WOOD FIBER SCI, V40, P3
   Rao GVG, 2008, MAT SCI ENG A-STRUCT, V498, P142, DOI 10.1016/j.msea.2007.11.157
   Rich P.M., 1986, PRINCIPES, V30, P117
   RICH PM, 1987, BOT GAZ, V148, P42, DOI 10.1086/337626
   RICH PM, 1995, AM J BOT, V82, P328, DOI 10.2307/2445578
   Rudnicki M, 2004, CAN J FOREST RES, V34, P666, DOI [10.1139/x03-233, 10.1139/X03-233]
   Ruggeberg M, 2008, P ROY SOC B-BIOL SCI, V275, P2221, DOI 10.1098/rspb.2008.0531
   Ruggeberg M, 2009, NEW PHYTOL, V182, P443, DOI 10.1111/j.1469-8137.2008.02759.x
   Slodicak M, 2006, FOREST ECOL MANAG, V224, P252, DOI 10.1016/j.foreco.2005.12.037
   Speck T, 2011, ANNU REV MATER RES, V41, P169, DOI 10.1146/annurev-matsci-062910-100425
   Strand7, 2005, THEORETICAL MANUAL T
   SUDO S, 1980, IAWA BULL, V1, P161, DOI 10.1163/22941932-90000716
   Thomas R, 2013, AM J BOT, V100, P289, DOI 10.3732/ajb.1200242
   Tomlinson P., 1990, STRUCTURAL BIOL PALM
   Tomlinson P., 1984, CONT PROBLEMS PLANT
   Tomlinson PB, 2006, BOT J LINN SOC, V151, P5, DOI 10.1111/j.1095-8339.2006.00520.x
   Tomlinson PB, 2011, ANATOMY OF PALMS: ARECACEAE - PALMAE, P1, DOI 10.1093/acprof:osobl/9780199558926.001.0001
   Tomlinson PB, 2001, AM J BOT, V88, P797, DOI 10.2307/2657032
   Ugural A C, 2008, MECH MAT
   VOGEL S, 1989, J EXP BOT, V40, P941, DOI 10.1093/jxb/40.8.941
   Vogel Steven, 1996, Journal of Arboriculture, V22, P92
   Vollsinger S, 2005, CAN J FOREST RES, V35, P1238, DOI 10.1139/x05-051
   Winter David P. A., 1997, SIGNA PROCESSING LIN
   Zhang YM, 2012, J MECH BEHAV BIOMED, V15, P70, DOI 10.1016/j.jmbbm.2012.07.006
   ZIMMERMANN MH, 1972, BOT GAZ, V133, P141, DOI 10.1086/336628
NR 50
TC 0
Z9 0
U1 0
U2 9
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1664-462X
J9 FRONT PLANT SCI
JI Front. Plant Sci.
PD AUG 9
PY 2016
VL 7
AR 1141
DI 10.3389/fpls.2016.01141
PG 12
WC Plant Sciences
SC Plant Sciences
GA DS7SG
UT WOS:000380982600001
PM 27555849
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Gallentoft, L
   Pettersson, LME
   Danielsen, N
   Schouenborg, J
   Prinz, CN
   Linsmeier, CE
AF Gallentoft, Lina
   Pettersson, Lina M. E.
   Danielsen, Nils
   Schouenborg, Jens
   Prinz, Christelle N.
   Linsmeier, Cecilia Eriksson
TI Impact of degradable nanowires on long-term brain tissue responses
SO JOURNAL OF NANOBIOTECHNOLOGY
LA English
DT Article
DE Nanowires; Biocompatibility; Neural interfaces; Brain; Biomaterial;
   Foreign body reaction; Tissue responses; Immunohistochemistry;
   Nanomedicine
ID GALLIUM-PHOSPHIDE; SILVER NANOPARTICLES; SILICON NANOWIRES; ARRAYS;
   CELLS; BIOCOMPATIBILITY; BIOMOLECULES; STABILITY; PLATFORM; NEURONS
AB Background: A promising approach to improve the performance of neural implants consists of adding nanomaterials, such as nanowires, to the surface of the implant. Nanostructured interfaces could improve the integration and communication stability, partly through the reduction of the cell-to-electrode distance. However, the safety issues of implanted nanowires in the brain need to be evaluated and understood before nanowires can be used on the surface of implants for long periods of time. To this end we here investigate whether implanted degradable nanowires offer any advantage over non-degradable nanowires in a long-term in vivo study (1 year) with respect to brain tissue responses.
   Results: The tissue response after injection of degradable silicon oxide (SiOx)-coated gallium phosphide nanowires and biostable hafnium oxide-coated GaP nanowires into the rat striatum was compared. One year after nanowire injection, no significant difference in microglial or astrocytic response, as measured by staining for ED1 and glial fibrillary acidic protein, respectively, or in neuronal density, as measured by staining for NeuN, was found between degradable and biostable nanowires. Of the cells investigated, only microglia cells had engulfed the nanowires. The SiOx-coated nanowire residues were primarily seen in aggregated hypertrophic ED1-positive cells, possibly microglial cells that have fused to create multinucleated giant cells. Occasionally, degradable nanowires with an apparently intact shape were found inside single, small ED1-positive cells. The biostable nanowires were found intact in microglia cells of both phenotypes described.
   Conclusion: The present study shows that the degradable nanowires remain at least partly in the brain over long time periods, i.e. 1 year; however, no obvious bio-safety issues for this degradable nanomaterial could be detected.
C1 [Gallentoft, Lina; Pettersson, Lina M. E.; Danielsen, Nils; Schouenborg, Jens; Prinz, Christelle N.; Linsmeier, Cecilia Eriksson] Lund Univ, Fac Med, Dept Expt Med Sci, NRC, Scheelevagen 2, S-22381 Lund, Sweden.
   [Prinz, Christelle N.] Lund Univ, Div Solid State Phys NanoLund, POB 118, S-22100 Lund, Sweden.
RP Gallentoft, L; Prinz, CN; Linsmeier, CE (reprint author), Lund Univ, Fac Med, Dept Expt Med Sci, NRC, Scheelevagen 2, S-22381 Lund, Sweden.; Prinz, CN (reprint author), Lund Univ, Div Solid State Phys NanoLund, POB 118, S-22100 Lund, Sweden.
EM lina.gallentoft@med.lu.se; christelle.prinz@ftf.lth.se;
   cecilia.eriksson_linsmeier@med.lu.se
FU Knut and Alice Wallenberg Foundation [KAW 2004-0119]; Linnaeus grant
   from the Swedish Research Council [600012701]; Crafoord Foundation
   [20120676]; Royal Physiographic Society in Lund
FX This work was funded by the Knut and Alice Wallenberg Foundation
   (project number: KAW 2004-0119), a Linnaeus grant (Project Number:
   600012701) from the Swedish Research Council, The Crafoord Foundation
   (Project Number: 20120676) and The Royal Physiographic Society in Lund.
CR Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233
   Cellot G, 2009, NAT NANOTECHNOL, V4, P126, DOI [10.1038/NNANO.2008.374, 10.1038/nnano.2008.374]
   Elnathan R, 2014, NANO TODAY, V9, P172, DOI 10.1016/j.nantod.2014.04.001
   Feliu N, 2016, CHEM SOC REV, V45, P2440, DOI 10.1039/c5cs00699f
   Gallentoft L, 2015, BIOMATERIALS, V42, P172, DOI 10.1016/j.biomaterials.2014.11.051
   Hallstrom W, 2007, NANO LETT, V7, P2960, DOI 10.1021/nl070728e
   Helmus MN, 2008, TOXICOL PATHOL, V36, P70, DOI 10.1177/0192623307310949
   Hochbaum AI, 2005, NANO LETT, V5, P457, DOI 10.1021/nl047990x
   Hwang SW, 2012, SCIENCE, V337, P1640, DOI 10.1126/science.1226325
   Kaminski M, 2012, J LEUKOCYTE BIOL, V92, P31, DOI 10.1189/jlb.0511241
   Keefer EW, 2008, NAT NANOTECHNOL, V3, P434, DOI 10.1038/nnano.2008.174
   Kim W, 2007, J AM CHEM SOC, V129, P7228, DOI 10.1021/ja071456k
   Kohler P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119340
   Kreyling WG, 2015, NAT NANOTECHNOL, V10, P619, DOI [10.1038/NNANO.2015.111, 10.1038/nnano.2015.111]
   Lee JH, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-36
   Lind G, 2013, SCI REP-UK, V3, DOI 10.1038/srep02942
   Linsmeier CE, 2008, BIOMATERIALS, V29, P4598, DOI 10.1016/j.biomaterials.2008.08.028
   Linsmeier CE, 2009, NANO LETT, V9, P4184, DOI 10.1021/nl902413x
   Patolsky F, 2006, SCIENCE, V313, P1100, DOI 10.1126/science.1128640
   Peled A, 2014, J NANOBIOTECHNOL, V12, DOI 10.1186/1477-3155-12-7
   Persson J, 2007, J BIOMAT SCI-POLYM E, V18, P1301, DOI 10.1163/156856207782177846
   Piret G, 2015, ACS APPL MATER INTER, V7, P18944, DOI 10.1021/acsami.5b03798
   Piret G, 2013, BIOMATERIALS, V34, P875, DOI 10.1016/j.biomaterials.2012.10.042
   Prinz CN, 2015, J PHYS-CONDENS MAT, V27, DOI 10.1088/0953-8984/27/23/233103
   Richards D, 2012, SCANNING, V34, P332, DOI 10.1002/sca.21012
   Robinson JT, 2012, NAT NANOTECHNOL, V7, P180, DOI [10.1038/nnano.2011.249, 10.1038/NNANO.2011.249]
   Rosengren A, 2002, IEEE T BIO-MED ENG, V49, P392, DOI 10.1109/10.991167
   Shalek AK, 2010, P NATL ACAD SCI USA, V107, P1870, DOI 10.1073/pnas.0909350107
   Suyatin DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056673
   Suyatin DB, 2009, J VAC SCI TECHNOL B, V27, P3092, DOI 10.1116/1.3264665
   Tambuyzer BR, 2009, J LEUKOCYTE BIOL, V85, P352, DOI 10.1189/jlb.0608385
   Thelin J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016267
   Timko BP, 2010, IEEE T NANOTECHNOL, V9, P269, DOI 10.1109/TNANO.2009.2031807
   van der Zande M, 2012, ACS NANO, V6, P7427, DOI 10.1021/nn302649p
   Xie C, 2012, NAT NANOTECHNOL, V7, P185, DOI [10.1038/NNANO.2012.8, 10.1038/nnano.2012.8]
   Xie C, 2011, P NATL ACAD SCI USA, V108, P3894, DOI 10.1073/pnas.1015589108
   Xie C, 2010, NANO LETT, V10, P4020, DOI 10.1021/nl101950x
   Zhou W, 2014, NANO LETT, V14, P1614, DOI 10.1021/nl500070h
NR 38
TC 2
Z9 2
U1 4
U2 23
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1477-3155
J9 J NANOBIOTECHNOL
JI J. Nanobiotechnol.
PD AUG 9
PY 2016
VL 14
AR 64
DI 10.1186/s12951-016-0216-7
PG 11
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics
GA DT7NW
UT WOS:000381674500001
PM 27507159
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Tian, LM
   Jiang, QS
   Liu, KK
   Luan, JY
   Naik, RR
   Singamaneni, S
AF Tian, Limei
   Jiang, Qisheng
   Liu, Keng-Ku
   Luan, Jingyi
   Naik, Rajesh R.
   Singamaneni, Srikanth
TI Bacterial Nanocellulose-Based Flexible Surface Enhanced Raman Scattering
   Substrate
SO ADVANCED MATERIALS INTERFACES
LA English
DT Article
ID PLASMONIC NANOSTRUCTURES; SERS DETECTION; GOLD NANORODS; PAPER;
   SPECTROSCOPY; CELLULOSE; PLATFORM; NANOPARTICLES; CHEMISTRY; BIOASSAYS
AB Owing to high purity, simple surface chemistry, and 3D nanofibrous structure, biosynthesized bacterial nanocellulose (BNC) is a highly attractive biomaterial for a wide range of applications. Conventional cellulose-based laboratory filter paper, adsorbed with plasmonic nanostructures can be employed as a flexible surface enhanced Raman scattering (SERS) substrate. In this work, a BNC film-based SERS substrate fabricated by gravity-assisted filtration method is reported. The 3D porous structure of BNC facilitates uniform and dense adsorption of plasmonic nanostructures on the surface and in subsurface regions, which results in large SERS enhancement. Furthermore, significantly lower surface roughness of BNC compared to conventional filter paper results in an excellent uniformity of SERS activity across the entire substrate. Harnessing the smooth surface of BNC, it is shown that BNC-based SERS substrate serves as an ideal platform for collection, detection, and recognition of bacteria. The 3D plasmonic BNC composites demonstrated here are highly attractive for a broad range of applications including sensing, catalysis, and energy harvesting.
C1 [Tian, Limei; Jiang, Qisheng; Liu, Keng-Ku; Luan, Jingyi; Singamaneni, Srikanth] Washington Univ, Inst Mat Sci & Engn, Dept Mech Engn & Mat Sci, St Louis, MO 63130 USA.
   [Naik, Rajesh R.] 711 Human Performance Wing, Dayton, OH 45433 USA.
RP Singamaneni, S (reprint author), Washington Univ, Inst Mat Sci & Engn, Dept Mech Engn & Mat Sci, St Louis, MO 63130 USA.; Naik, RR (reprint author), 711 Human Performance Wing, Dayton, OH 45433 USA.
EM rajesh.naik@us.af.mil; singamaneni@wustl.edu
FU Air Force Office of Scientific Research [FA9550-15-1-0228, 12RX11COR,
   AFRL/711 HPW]
FX The authors acknowledge support from Air Force Office of Scientific
   Research (S.S.- Award No. FA9550-15-1-0228) and (R.R.N. - 12RX11COR) and
   AFRL/711 HPW. The authors thank Nano Research Facility (NRF) at
   Washington University for providing access to electron microscopy
   facilities.
CR Abbas A, 2013, ANAL CHEM, V85, P3977, DOI 10.1021/ac303567g
   Abbas A, 2013, ADV FUNCT MATER, V23, P1789, DOI 10.1002/adfm.201202370
   Anker JN, 2008, NAT MATER, V7, P442, DOI 10.1038/nmat2162
   Camden JP, 2008, ACCOUNTS CHEM RES, V41, P1653, DOI 10.1021/ar800041s
   Campion A, 1998, CHEM SOC REV, V27, P241, DOI 10.1039/a827241z
   CANNON RE, 1991, CRIT REV MICROBIOL, V17, P435, DOI 10.3109/10408419109115207
   Cheng CM, 2010, ANGEW CHEM INT EDIT, V49, P4771, DOI 10.1002/anie.201001005
   Chu HY, 2008, APPL SPECTROSC, V62, P922, DOI 10.1366/000370208785284330
   Derda R, 2009, P NATL ACAD SCI USA, V106, P18457, DOI 10.1073/pnas.0910666106
   El-Sayed MA, 2001, ACCOUNTS CHEM RES, V34, P257, DOI 10.1021/ar960016n
   Fan C, 2011, APPL MICROBIOL BIOT, V92, P1053, DOI 10.1007/s00253-011-3634-3
   Fang X, 2009, APPL PHYS B-LASERS O, V97, P723, DOI 10.1007/s00340-009-3644-3
   Gandra N, 2012, NANO LETT, V12, P2645, DOI 10.1021/nl3012038
   Gatenholm P, 2010, MRS BULL, V35, P208, DOI 10.1557/mrs2010.653
   Golightly RS, 2009, ACS NANO, V3, P2859, DOI 10.1021/nn9013593
   Habibi Y, 2010, CHEM REV, V110, P3479, DOI 10.1021/cr900339w
   Hering K, 2008, ANAL BIOANAL CHEM, V390, P113, DOI 10.1007/s00216-007-1667-3
   Homola J, 2008, CHEM REV, V108, P462, DOI 10.1021/cr068107d
   Huang XH, 2009, ADV MATER, V21, P4880, DOI 10.1002/adma.200802789
   Jain PK, 2008, NANO LETT, V8, P4347, DOI 10.1021/nl8021835
   Jaiswal A, 2014, SMALL, V10, P4287, DOI 10.1002/smll.201401278
   Jonas R, 1998, POLYM DEGRAD STABIL, V59, P101, DOI 10.1016/S0141-3910(97)00197-3
   Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Klemm D, 2011, ANGEW CHEM INT EDIT, V50, P5438, DOI 10.1002/anie.201001273
   Ko H, 2008, SMALL, V4, P1576, DOI 10.1002/smll.200800337
   Lee CH, 2011, ANAL CHEM, V83, P8953, DOI 10.1021/ac2016882
   Lee CH, 2010, ACS APPL MATER INTER, V2, P3429, DOI 10.1021/am1009875
   Li JF, 2010, NATURE, V464, P392, DOI 10.1038/nature08907
   Liu TY, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1546
   Marques PAAP, 2008, J RAMAN SPECTROSC, V39, P439, DOI 10.1002/jrs.1853
   Martinak D., 1997, IEEE P 1997 INT CARN
   Martinez AW, 2007, ANGEW CHEM INT EDIT, V46, P1318, DOI 10.1002/anie.200603817
   Moskovits M, 2005, J RAMAN SPECTROSC, V36, P485, DOI 10.1002/jrs.1362
   Neugebauer U, 2006, CHEMPHYSCHEM, V7, P1428, DOI 10.1002/cphc.200600173
   Orendorff CJ, 2006, J PHYS CHEM B, V110, P3990, DOI 10.1021/jp0570972
   Pardee K, 2014, CELL, V159, P940, DOI 10.1016/j.cell.2014.10.004
   Park M, 2013, BIOCHIP J, V7, P234, DOI 10.1007/s13206-013-7306-5
   Salmon S, 1997, J MACROMOL SCI R M C, VC37, P199
   Schmucker AL, 2016, RSC ADV, V6, P4136, DOI 10.1039/c5ra21977a
   Sengupta A, 2006, ANAL BIOANAL CHEM, V386, P1379, DOI 10.1007/s00216-006-0711-z
   Shoda M, 2005, BIOTECHNOL BIOPROC E, V10, P1, DOI 10.1007/BF02931175
   Stewart ME, 2008, CHEM REV, V108, P494, DOI 10.1021/cr068126n
   Stiles PL, 2008, ANNU REV ANAL CHEM, V1, P601, DOI 10.1146/annurev.anchem.1.031207.112814
   Tian LM, 2016, NANO LETT, V16, P609, DOI 10.1021/acs.nanolett.5b04320
   Tian LM, 2014, J MATER CHEM C, V2, P5438, DOI 10.1039/c4tc00768a
   Tian LM, 2012, LANGMUIR, V28, P17435, DOI 10.1021/la3034534
   Vosgrone T, 2005, CHEMPHYSCHEM, V6, P154, DOI 10.1002/cphc.200400395
   Walter A, 2011, LAB CHIP, V11, P1013, DOI [10.1039/c0lc00536c, 10.1039/c01c00536c]
   Wang YG, 2015, ADV FUNCT MATER, V25, P1434, DOI 10.1002/adfm.201403067
   Wei HR, 2015, SCI REP-UK, V5, DOI 10.1038/srep18131
   YAMANAKA S, 1989, J MATER SCI, V24, P3141, DOI 10.1007/BF01139032
   Yu WW, 2010, ANAL CHEM, V82, P9626, DOI 10.1021/ac102475k
   Zhao WA, 2008, LAB CHIP, V8, P1988, DOI 10.1039/b814043j
   Zhou HB, 2014, ANAL CHEM, V86, P1525, DOI 10.1021/ac402935p
   Zhou Q, 2011, CHEM COMMUN, V47, P4466, DOI 10.1039/c0cc05465h
   Zhu HL, 2014, ENERG ENVIRON SCI, V7, P269, DOI 10.1039/c3ee43024c
NR 57
TC 15
Z9 15
U1 15
U2 73
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2196-7350
J9 ADV MATER INTERFACES
JI Adv. Mater. Interfaces
PD AUG 5
PY 2016
VL 3
IS 15
AR 1600214
DI 10.1002/admi.201600214
PG 8
WC Chemistry, Multidisciplinary; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA DW6SV
UT WOS:000383782400016
DA 2018-10-20
ER

PT J
AU Dickinson, LE
   Gerecht, S
AF Dickinson, Laura E.
   Gerecht, Sharon
TI Engineered Biopolymeric Scaffolds for Chronic Wound Hea
SO FRONTIERS IN PHYSIOLOGY
LA English
DT Review
DE chronic wounds; biopolymeric scaffolds; skin substitutes; acellular
   matrices; matrix remodeling; skin regeneration; inflammatory
ID DIABETIC FOOT ULCERS; VENOUS LEG ULCERS; ENDOTHELIAL GROWTH-FACTOR;
   HUMAN AMNIOTIC MEMBRANE; OXIDIZED REGENERATED CELLULOSE/COLLAGEN;
   EXTRACELLULAR-MATRIX; IN-VITRO; BIOLOGICAL-PROPERTIES; BIOENGINEERED
   SKIN; BLOOD-COAGULATION
AB Skin regeneration requires the coordinated integration of concomitant biological and molecular events in the extracellular wound environment during overlapping phases of inflammation, proliferation, and matrix remodeling. This process is highly efficient during normal wound healing. However, chronic wounds fail to progress through the ordered and reparative wound healing process and are unable to heal, requiring long-term treatment at high costs. There are many advanced skin substitutes, which mostly comprise bioactive dressings containing mammalian derived matrix components, and/or human cells, in clinical use. However, it is presently hypothesized that no treatment significantly outperforms the others. To address this unmet challenge, recent research has focused on developing innovative acellular biopolymeric scaffolds as more efficacious wound healing therapies. These biomaterial-based skin substitutes are precisely engineered and fine-tuned to recapitulate aspects of the wound healing milieu and target specific events in the wound healing cascade to facilitate complete skin repair with restored function and tissue integrity. This mini-review will provide a brief overview of chronic wound healing and current skin substitute treatment strategies while focusing on recent engineering approaches that regenerate skin using synthetic, biopolymeric scaffolds. We discuss key polymeric scaffold design criteria, including degradation, biocompatibility, and microstructure, and how they translate to inductive microenvironments that stimulate cell infiltration and vascularization to enhance chronic wound healing. As healthcare moves toward precision medicine-based strategies, the potential and therapeutic implications of synthetic, biopolymeric scaffolds as tunable treatment modalities for chronic wounds will be considered.
C1 [Dickinson, Laura E.] Gemstone Biotherapeut, Baltimore, MD USA.
   [Gerecht, Sharon] Johns Hopkins Univ, Inst NanoBioTechnol, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA.
RP Gerecht, S (reprint author), Johns Hopkins Univ, Inst NanoBioTechnol, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA.
EM gerecht@jhu.edu
CR Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Azuma Kazuo, 2015, J Funct Biomater, V6, P104, DOI 10.3390/jfb6010104
   Badylak SE, 2002, SEMIN CELL DEV BIOL, V13, P377, DOI 10.1016/S1084-9521(02)00094-0
   Bainbridge P, 2013, J WOUND CARE, V22, P407
   BENEDETTI L, 1993, BIOMATERIALS, V14, P1154, DOI 10.1016/0142-9612(93)90160-4
   BIAGINI G, 1992, ADVANCES IN CHITIN AND CHITOSAN, P16
   Blakytny R, 2006, DIABETIC MED, V23, P594, DOI 10.1111/j.1464-5491.2006.01773.x
   Braun KM, 2006, STEM CELL REV, V2, P221, DOI 10.1007/s12015-006-0050-7
   BURKE JF, 1981, ANN SURG, V194, P413, DOI 10.1097/00000658-198110000-00005
   Caravaggi C, 2011, WOUNDS, V23, P228
   Carter MJ, 2014, VALUE HEALTH, V17, P801, DOI 10.1016/j.jval.2014.08.001
   Cha JS, 2007, CLIN DERMATOL, V25, P73, DOI 10.1016/j.clindermatol.2006.10.002
   Chen WYJ, 1999, WOUND REPAIR REGEN, V7, P79, DOI 10.1046/j.1524-475X.1999.00079.x
   Chou TC, 2003, BIOCHEM BIOPH RES CO, V302, P480, DOI 10.1016/S0006-291X(03)00173-6
   Cullen B, 2002, WOUND REPAIR REGEN, V10, P16, DOI 10.1046/j.1524-475X.2002.10703.x
   Dai TH, 2011, EXPERT REV ANTI-INFE, V9, P857, DOI [10.1586/ERI.11.59, 10.1586/eri.11.59]
   DiDomenico L, 2011, WOUNDS, V23, P184
   Driver VR, 2015, WOUND REPAIR REGEN, V23, P891, DOI 10.1111/wrr.12357
   Dumville JC, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011277.pub2
   Edmonds M, 2009, INT J LOW EXTR WOUND, V8, P11, DOI 10.1177/1534734609331597
   Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701
   Falanga V, 2002, J INVEST DERMATOL, V119, P653, DOI 10.1046/j.1523-1747.2002.01865.x
   Fortunato SJ, 1998, AM J REPROD IMMUNOL, V40, P395, DOI 10.1111/j.1600-0897.1998.tb00424.x
   Galassi G, 2000, BIOMATERIALS, V21, P2183, DOI 10.1016/S0142-9612(00)00147-2
   Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002
   Gould LJ, 2016, ADV WOUND CARE, V5, P19, DOI 10.1089/wound.2014.0595
   Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039
   Hakkinen L, 2004, AM J PATHOL, V164, P229, DOI 10.1016/S0002-9440(10)63113-6
   Hankin Cheryl S, 2012, J Manag Care Pharm, V18, P375
   Hart J, 2002, INT J BIOCHEM CELL B, V34, P1557, DOI 10.1016/S1357-2725(02)00062-6
   Heino J, 2000, MATRIX BIOL, V19, P319, DOI 10.1016/S0945-053X(00)00076-7
   Hodde J P, 1996, Tissue Eng, V2, P209, DOI 10.1089/ten.1996.2.209
   Hodde JP, 2001, ENDOTHELIUM-NEW YORK, V8, P11, DOI 10.3109/10623320109063154
   Hu SS, 2006, WOUND REPAIR REGEN, V14, P427, DOI 10.1111/j.1743-6109.2006.00148.x
   Kelechi TJ, 2012, J AM ACAD DERMATOL, V66, pE209, DOI 10.1016/j.jaad.2011.01.031
   Kirsner RS, 2015, WOUND REPAIR REGEN, V23, P737, DOI 10.1111/wrr.12332
   Kirsner RS, 2015, INT WOUND J, V12, P646, DOI 10.1111/iwj.12185
   Koizumi N, 2000, CURR EYE RES, V20, P173, DOI 10.1076/0271-3683(200003)20:3;1-9;FT173
   Kojima K, 2004, J VET MED SCI, V66, P1595, DOI 10.1292/jvms.66.1595
   Koob TJ, 2013, INT WOUND J, V10, P493, DOI 10.1111/iwj.12140
   Kramer DB, 2012, NEW ENGL J MED, V366, P848, DOI 10.1056/NEJMhle1113918
   Landsman Adam Scott, 2011, Foot Ankle Spec, V4, P29, DOI 10.1177/1938640010387417
   Lauer G, 2000, J INVEST DERMATOL, V115, P12, DOI 10.1046/j.1523-1747.2000.00036.x
   Lerman OZ, 2003, AM J PATHOL, V162, P303, DOI 10.1016/S0002-9440(10)63821-7
   Litwiniuk M, 2016, WOUNDS, V28, P78
   Lockington D., 2014, CAN J OPTHALMOL, V49, P426, DOI [10.1016/j.jcjo.2014.07.005, DOI 10.1016/J.JCJO.2014.07.005]
   Lopez-Valladares MJ, 2010, ACTA OPHTHALMOL, V88, pe211, DOI 10.1111/j.1755-3768.2010.01908.x
   Mamede AC, 2012, CELL TISSUE RES, V349, P447, DOI 10.1007/s00441-012-1424-6
   Marston WA, 2003, DIABETES CARE, V26, P1701, DOI 10.2337/diacare.26.6.1701
   Mayol L, 2014, J MATER SCI-MATER M, V25, P1483, DOI 10.1007/s10856-014-5175-7
   McCarty SM, 2013, ADV WOUND CARE, V2, P438, DOI 10.1089/wound.2012.0370
   Moore MA, 2015, CELL TISSUE BANK, V16, P249, DOI 10.1007/s10561-014-9467-4
   Mustoe TA, 2006, PLAST RECONSTR SURG, V117, p35S, DOI 10.1097/01.prs.0000225431.63010.1b
   Naughton G, 1997, ARTIF ORGANS, V21, P1203
   Nihsen Edith S, 2008, Adv Skin Wound Care, V21, P479, DOI 10.1097/01.ASW.0000323561.14144.19
   O'Meara S, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010182.pub3
   Okamoto Y, 2003, CARBOHYD POLYM, V53, P337, DOI 10.1016/S0144-8617(03)00076-6
   Park CY, 2009, OPHTHAL RES, V41, P112, DOI 10.1159/000187629
   Pastar T., 2008, SURG TECHNOL INT, V17, P105
   PELUSO G, 1994, BIOMATERIALS, V15, P1215, DOI 10.1016/0142-9612(94)90272-0
   Pirone L A, 1992, J Invest Surg, V5, P149, DOI 10.3109/08941939209012431
   Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m
   Rennert RC, 2013, EXPERT OPIN BIOL TH, V13, P1523, DOI 10.1517/14712598.2013.842972
   Reyzelman A, 2009, INT WOUND J, V6, P196, DOI 10.1111/j.1742-481X.2009.00585.x
   Rowan MP, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0961-2
   Sandoval M, 2011, J DRUGS DERMATOL, V10, P75
   Santoro MM, 2005, EXP CELL RES, V304, P274, DOI 10.1016/j.yexcr.2004.10.033
   Scherer SS, 2009, ANN SURG, V250, P322, DOI 10.1097/SLA.0b013e3181ae9d45
   Schultz GS, 2011, WOUND REPAIR REGEN, V19, P134, DOI 10.1111/j.1524-475X.2011.00673.x
   Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x
   Segal HC, 1998, J BIOMATER APPL, V12, P249, DOI 10.1177/088532829801200305
   Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x
   Shen YI, 2015, J INVEST DERMATOL, V135, P2519, DOI 10.1038/jid.2015.182
   Shi L, 2013, INT J BURNS TRAUMA, V3, P173
   Shi L, 2012, INT WOUND J, V9, P44, DOI 10.1111/j.1742-481X.2011.00843.x
   Shultz G., 2003, WOUND REPAIR REGEN, V11, pST, DOI 10.1046/j.l524-475X.11.s2.1.x
   Silini Antonietta R, 2015, Front Bioeng Biotechnol, V3, P162, DOI 10.3389/fbioe.2015.00162
   Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006
   Stern R, 2004, EUR J CELL BIOL, V83, P317, DOI 10.1078/0171-9335-00392
   Stojadinovic O, 2014, WOUND REPAIR REGEN, V22, P220, DOI 10.1111/wrr.12142
   Sun GM, 2011, P NATL ACAD SCI USA, V108, P20976, DOI 10.1073/pnas.1115973108
   Sun G, 2011, BIOMATERIALS, V32, P95, DOI 10.1016/j.biomaterials.2010.08.091
   Sun GM, 2010, J BIOMED MATER RES A, V93A, P1080, DOI 10.1002/jbm.a.32604
   Sweeney IR, 2012, INT WOUND J, V9, P601, DOI 10.1111/j.1742-481X.2011.00923.x
   Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391
   Trabucchi E, 2002, INT J TISSUE REACT, V24, P65
   Tracy LE, 2016, ADV WOUND CARE, V5, P119, DOI 10.1089/wound.2014.0561
   Turner NJ, 2015, ADV WOUND CARE, V4, P490, DOI 10.1089/wound.2014.0604
   Turner NJ, 2004, BIOMATERIALS, V25, P5955, DOI 10.1016/j.biomaterials.2004.02.002
   Ueno H, 2001, ADV DRUG DELIVER REV, V52, P105, DOI 10.1016/S0169-409X(01)00189-2
   Ulrich D, 2011, J WOUND OSTOMY CONT, V38, P522, DOI 10.1097/WON.0b013e31822ad290
   Vaalamo M, 1996, BRIT J DERMATOL, V135, P52
   Valle MF, 2014, WOUND REPAIR REGEN, V22, P193, DOI 10.1111/wrr.12151
   Veves A, 2001, DIABETES CARE, V24, P290, DOI 10.2337/diacare.24.2.290
   von Versen-Hoeynck F, 2008, BIOLOGICALS, V36, P248, DOI 10.1016/j.biologicals.2008.02.001
   Vournakis JN, 2008, J VASC RES, V45, P222, DOI 10.1159/000112544
   Walters Jodi, 2016, Eplasty, V16, pe10
   Werdin Frank, 2009, Eplasty, V9, pe19
   West D., 2002, THE NEW ANGIOTHERAPY, P177
   Whelan MC, 2003, J BIOL CHEM, V278, P327, DOI 10.1074/jbc.M207554200
   Wiegand C, 2010, ARCH DERMATOL RES, V302, P419, DOI 10.1007/s00403-009-1011-1
   Yonehiro L, 2013, WOUNDS, V25, P340
   Zaulyanov L, 2007, CLIN INTERV AGING, V2, P93, DOI 10.2147/ciia.2007.2.1.93
   Zelen CM, 2016, INT WOUND J, V13, P272, DOI 10.1111/iwj.12566
   Zelen CM, 2013, INT WOUND J, V10, P502, DOI 10.1111/iwj.12097
NR 105
TC 12
Z9 13
U1 3
U2 53
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1664-042X
J9 FRONT PHYSIOL
JI Front. Physiol.
PD AUG 5
PY 2016
VL 7
AR 341
DI 10.3389/fphys.2016.00341
PG 12
WC Physiology
SC Physiology
GA DS5BH
UT WOS:000380795000001
PM 27547189
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Tanaka, T
   Matsumura, S
   Furuta, H
   Ikawa, Y
AF Tanaka, Takahiro
   Matsumura, Shigeyoshi
   Furuta, Hiroyuki
   Ikawa, Yoshiya
TI Tecto-GIRz: Engineered Group I Ribozyme the Catalytic Ability of Which
   Can Be Controlled by Self-Dimerization
SO CHEMBIOCHEM
LA English
DT Article
DE autocatalysis; group I ribozymes; ribozymes; RNA modular engineering;
   RNA structures
ID GREEN FLUORESCENT PROTEIN; TERTIARY INTERACTIONS; TETRAHYMENA RIBOZYME;
   RIBONUCLEASE-P; RNA TECTONICS; METAL-ION; INTRON; ARCHITECTURE;
   TETRALOOP; ELEMENTS
AB RNA is a promising biomaterial for self-assembly of nano-sized structures with a wide range of applications in nanotechnology and synthetic biology. Several RNA-based nanostructures have been reported, but most are unrelated to intracellular RNA, which possesses modular structures that are sufficiently large and complex to serve as catalysts to promote sophisticated chemical reactions. In this study, we designed dimeric RNA structures based on the Tetrahymena group I ribozyme. The resulting dimeric RNAs (tecto group I ribozyme; tecto-GIRz) exhibit catalytic ability that depended on controlled dimerization, by which a pair of ribozymes can be activated to perform cleavage and splicing reactions of two distinct substrates. Modular redesign of complex RNA structures affords large ribozymes for use as modules in RNA nanotechnology and RNA synthetic biology.
C1 [Tanaka, Takahiro; Furuta, Hiroyuki] Kyushu Univ, Grad Sch Engn, Dept Chem & Biochem, Nishi Ku, Moto Oka 744, Fukuoka 8190395, Japan.
   [Matsumura, Shigeyoshi; Ikawa, Yoshiya] Toyama Univ, Grad Sch Sci & Engn, Dept Chem, Gofuku 3190, Toyama 9308555, Japan.
RP Ikawa, Y (reprint author), Toyama Univ, Grad Sch Sci & Engn, Dept Chem, Gofuku 3190, Toyama 9308555, Japan.
EM yikawa@sci.u-toyama.ac.jp
RI Ikawa, Yoshiya/G-8759-2016; Furuta, Hiroyuki/B-9505-2008
OI Ikawa, Yoshiya/0000-0002-6814-0443; Furuta, Hiroyuki/0000-0002-3881-8807
FU Ministry of Education, Culture, Sports, Science, and Technology (MEXT),
   Japan [23119005, 15K05561]
FX This work was supported by Grants-in-Aid for Scientific Research on
   Innovative Area "Synthetic Biology" (no. 23119005 to Y.I.) and
   Scientific Research (C) (no. 15K05561 to Y.I.) from the Ministry of
   Education, Culture, Sports, Science, and Technology (MEXT), Japan.
CR Baird NJ, 2005, J MOL BIOL, V352, P712, DOI 10.1016/j.jmb.2005.07.010
   Campbell TB, 1996, BIOCHEMISTRY-US, V35, P11493, DOI 10.1021/bi960510z
   Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678
   Cayrol B, 2009, J AM CHEM SOC, V131, P17270, DOI 10.1021/ja906076e
   Chen CP, 2000, J BIOL CHEM, V275, P17510, DOI 10.1074/jbc.M909662199
   Correll CC, 2003, RNA, V9, P355, DOI 10.1261/rna.2147803
   Doherty EA, 1999, BIOCHEMISTRY-US, V38, P2982, DOI 10.1021/bi982113p
   Furukawa A, 2016, BIOSCI BIOTECH BIOCH, V80, P1386, DOI 10.1080/09168451.2016.1156483
   Geary C, 2008, NUCLEIC ACIDS RES, V36, P1138, DOI 10.1093/nar/gkm1048
   Geary C, 2014, SCIENCE, V345, P799, DOI 10.1126/science.1253920
   Guo F, 2004, MOL CELL, V16, P351, DOI 10.1016/S1097-2765(04)00592-1
   Guo PX, 2010, NAT NANOTECHNOL, V5, P833, DOI [10.1038/nnano.2010.231, 10.1038/NNANO.2010.231]
   Guo PX, 1998, MOL CELL, V2, P149, DOI 10.1016/S1097-2765(00)80124-0
   Hanczyc MM, 1998, RNA, V4, P268
   Ikawa Y, 2003, NUCLEIC ACIDS RES, V31, P1488, DOI 10.1093/nar/gkg225
   Ikawa Y, 2008, ANAL BIOCHEM, V378, P166, DOI 10.1016/j.ab.2008.03.054
   Ishikawa J, 2013, WIRES RNA, V4, P651, DOI 10.1002/wrna.1185
   Ishikawa J, 2011, METHODS, V54, P226, DOI 10.1016/j.ymeth.2010.12.011
   Jaeger L, 2000, ANGEW CHEM INT EDIT, V39, P2521, DOI 10.1002/1521-3773(20000717)39:14<2521::AID-ANIE2521>3.0.CO;2-P
   JAEGER L, 2000, ANGEW CHEM, V112, P2576
   Jaeger L, 2006, CURR OPIN STRUC BIOL, V16, P531, DOI 10.1016/j.sbi.2006.07.001
   Jasinski DL, 2014, ACS NANO, V8, P7620, DOI 10.1021/nn502160s
   Johnson TH, 2005, P NATL ACAD SCI USA, V102, P10176, DOI 10.1073/pnas.0501498102
   JOYCE GF, 1989, NUCLEIC ACIDS RES, V17, P7879, DOI 10.1093/nar/17.19.7879
   Kazantsev AV, 2006, NAT REV MICROBIOL, V4, P729, DOI 10.1038/nrmicro1491
   Lehnert V, 1996, CHEM BIOL, V3, P993, DOI 10.1016/S1074-5521(96)90166-0
   Leontis NB, 2003, CURR OPIN STRUC BIOL, V13, P300, DOI 10.1016/S0959-440X(03)00076-9
   Leontis NB, 2006, CURR OPIN STRUC BIOL, V16, P279, DOI 10.1016/j.sbi.2006.05.009
   Loria A, 1996, RNA, V2, P551
   Naito Y, 1998, RNA, V4, P837, DOI 10.1017/S1355838298972016
   Nasalean L, 2006, NUCLEIC ACIDS RES, V34, P1381, DOI 10.1093/nar/gkl008
   Paige JS, 2011, SCIENCE, V333, P642, DOI 10.1126/science.1207339
   Pan J, 1999, J MOL BIOL, V294, P955, DOI 10.1006/jmbi.1999.3298
   Severcan I, 2010, NAT CHEM, V2, P772, DOI [10.1038/nchem.733, 10.1038/NCHEM.733]
   Severcan I, 2009, NANO LETT, V9, P1270, DOI 10.1021/nl900261h
   Shi XS, 2014, J AM CHEM SOC, V136, P6643, DOI 10.1021/ja413033d
   Shu D, 2004, NANO LETT, V4, P1717, DOI [10.1021/nl0494497, 10.1021/nl04994497]
   Shu D, 2011, NAT NANOTECHNOL, V6, P658, DOI [10.1038/nnano.2011.105, 10.1038/NNANO.2011.105]
   Stahley MR, 2006, CURR OPIN STRUC BIOL, V16, P319, DOI 10.1016/j.sbi.2006.04.005
   Stahley MR, 2005, SCIENCE, V309, P1587, DOI 10.1126/science.1114994
   Tanaka T, 2014, J BIOSCI BIOENG, V117, P407, DOI 10.1016/j.jbiosc.2013.10.008
   Thompson Kristin M, 2002, BMC Biotechnol, V2, P21, DOI 10.1186/1472-6750-2-21
   Torres-Larios A, 2006, CURR OPIN STRUC BIOL, V16, P327, DOI 10.1016/j.sbi.2006.04.002
   VANDERHORST G, 1991, P NATL ACAD SCI USA, V88, P184, DOI 10.1073/pnas.88.1.184
   Vicens Q, 2006, TRENDS BIOCHEM SCI, V31, P41, DOI 10.1016/j.tibs.2005.11.008
   Warner KD, 2014, NAT STRUCT MOL BIOL, V21, P658, DOI 10.1038/nsmb.2865
   Westhof E, 1996, FOLD DES, V1, pR78, DOI 10.1016/S1359-0278(96)00037-5
   WILLIAMSON CL, 1989, NUCLEIC ACIDS RES, V17, P675, DOI 10.1093/nar/17.2.675
   WOODSON SA, 1991, BIOCHEMISTRY-US, V30, P2042, DOI 10.1021/bi00222a006
NR 49
TC 4
Z9 5
U1 1
U2 3
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1439-4227
EI 1439-7633
J9 CHEMBIOCHEM
JI ChemBioChem
PD AUG 3
PY 2016
VL 17
IS 15
BP 1448
EP 1455
DI 10.1002/cbic.201600190
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Medicinal
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA DW4BF
UT WOS:000383586300012
PM 27247120
DA 2018-10-20
ER

PT J
AU Gabriel, M
   Niederer, K
   Frey, H
AF Gabriel, Matthias
   Niederer, Kerstin
   Frey, Holger
TI Wet Chemistry and Peptide Immobilization on Polytetrafluoroethylene for
   Improved Cell-adhesion
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Bioengineering; Issue 114; Polytetrafluoroethylene (PTFE); biomaterial;
   tissue engineering; surface modification; peptide immobilization; REDV;
   endothelial cell; vascular graft; endothelialization; blood contacting
   surfaces
ID SURFACES
AB Endowing materials surface with cell-adhesive properties is a common strategy in biomaterial research and tissue engineering. This is particularly interesting for already approved polymers that have a long standing use in medicine because these materials are well characterized and legal issues associated with the introduction of newly synthesized polymers may be avoided. Polytetrafluoroethylene (PTFE) is one of the most frequently employed materials for the manufacturing of vascular grafts but the polymer lacks cell adhesion promoting features. Endothelialization, i.e., complete coverage of the grafts inner surface with a confluent layer of endothelial cells is regarded key to optimal performance, mainly by reducing thrombogenicity of the artificial interface.
   This study investigates the growth of endothelial cells on peptide-modified PTFE and compares these results to those obtained on unmodified substrate. Coupling with the endothelial cell adhesive peptide Arg-Glu-Asp-Val (REDV) is performed via activation of the fluorin-containing polymer using the reagent sodium naphthalenide, followed by subsequent conjugation steps. Cell culture is accomplished using Human Umbilical Vein Endothelial Cells (HUVECs) and excellent cellular growth on peptide-immobilized material is demonstrated over a two-week period.
C1 [Gabriel, Matthias] Johannes Gutenberg Univ Mainz, Sidra Cardiovasc Res, Mainz, Germany.
   [Niederer, Kerstin; Frey, Holger] Johannes Gutenberg Univ Mainz, Dept Organ Chem, Mainz, Germany.
RP Gabriel, M (reprint author), Johannes Gutenberg Univ Mainz, Sidra Cardiovasc Res, Mainz, Germany.
EM mgabriel@sidra.org
RI Frey, Holger/C-9849-2009
CR Ceylan H, 2011, BIOMATERIALS, V32, P8797, DOI 10.1016/j.biomaterials.2011.08.018
   Chlupac J, 2009, PHYSIOL RES, V58, pS119
   Cleary MA, 2012, TRENDS MOL MED, V18, P394, DOI 10.1016/j.molmed.2012.04.013
   de Mel A, 2008, BIOMACROMOLECULES, V9, P2969, DOI 10.1021/bm800681k
   Doctor H G, 2006, J Minim Access Surg, V2, P110
   Gabriel M, 2006, J BIOMAT SCI-POLYM E, V17, P567, DOI 10.1163/156856206776986288
   Gabriel M, 2006, BIOCONJUGATE CHEM, V17, P548, DOI 10.1021/bc050091v
   Gabriel M, 2012, J BIOMAT SCI-POLYM E, V23, P941, DOI 10.1163/092050611X566793
   Gabriel M, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/3/035007
   Larsen CC, 2006, BIOMATERIALS, V27, P4846, DOI 10.1016/j.biomaterials.2006.05.009
   Lei YF, 2012, J MATER SCI-MATER M, V23, P2761, DOI 10.1007/s10856-012-4736-x
   Lotz A, 2012, PLASMA PROCESS POLYM, V9, P10, DOI 10.1002/ppap.201100121
   Mikulikova R, 2005, BIOMATERIALS, V26, P5572, DOI 10.1016/j.biomaterials.2005.02.010
   Niu GG, 2014, EXPERT OPIN BIOL TH, V14, P403, DOI 10.1517/14712598.2014.880419
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Wang ML, 2010, SERV IND J, V30, P1077, DOI 10.1080/02642060802298368
   Wise SG, 2012, NANOMEDICINE-UK, V7, P1907, DOI [10.2217/NNM.12.161, 10.2217/nnm.12.161]
   Zaghal A, 2012, SURG ONCOL, V21, P207, DOI 10.1016/j.suronc.2012.02.003
   Zdrahala RJ, 1996, J BIOMATER APPL, V10, P309, DOI 10.1177/088532829601000402
NR 19
TC 0
Z9 0
U1 2
U2 12
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD AUG
PY 2016
IS 114
AR e54272
DI 10.3791/54272
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EH4LM
UT WOS:000391742700049
PM 27584937
DA 2018-10-20
ER

PT J
AU Rokosz, K
   Hryniewicz, T
   Dudek, L
   Matysek, D
   Valicek, J
   Harnicarova, M
AF Rokosz, Krzysztof
   Hryniewicz, Tadeusz
   Dudek, L.
   Matysek, Dalibor
   Valicek, Jan
   Harnicarova, Marta
TI SEM and EDS Analysis of Surface Layer Formed on Titanium After Plasma
   Electrolytic Oxidation in H3PO4 with the Addition of Cu(NO3)(2)
SO JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
LA English
DT Article
DE SEM; EDS; Titanium; PEO; MAO
ID MICRO-ARC OXIDATION; SS BIOMATERIAL; XPS; ANTIBACTERIAL; FILMS; ALLOY
AB Plasma Electrolytic Oxidation-PEO (Micro Arc Oxidation-MAO) as a surface layer modification method is increasingly being used for biomaterials. The surface after that oxidation is more biocompatible than that after other electrochemical treatments. The analyses of the titanium surface after PEO treatment show that the thickness of the surface layer is about 10 mu m, and it contains oxygen (43.8 wt%), titanium (26.26 at%) and phosphorus (25.08 wt%) with some amount of copper (4.85 wt%). The depth analysis by a cross section shows there are three phases: the first one is the matrix as a pure titanium, the second one is an amorphous phase consisting of titanium (34.64 wt%), oxygen (42.13 wt%) and phosphorous (23.23 wt%), and the third outer layer composed of titanium (40.98 wt%), oxygen (40.59 wt%), phosphorus (16 wt%) and copper (2.43 wt%).
C1 [Rokosz, Krzysztof; Hryniewicz, Tadeusz; Dudek, L.] Koszalin Univ Technol, Fac Mech Engn, Raclawicka 15-17, PL-75620 Koszalin, Poland.
   [Matysek, Dalibor; Valicek, Jan; Harnicarova, Marta] VSB Tech Univ Ostrava, Fac Min & Geol, 17 Listopadu 15-2172, Ostrava 70833, Czech Republic.
   [Valicek, Jan] VSB Tech Univ Ostrava, Fac Min & Geol, Inst Clean Technol Min & Utilizat Raw Mat Energy, 17 Listopadu 15-2172, Ostrava 70833, Czech Republic.
   [Valicek, Jan] VSB Tech Univ Ostrava, Fac Met & Mat Engn, Reg Mat Sci & Technol Ctr, 17 Listopadu 15-2172, Ostrava 70833, Czech Republic.
   [Harnicarova, Marta] VSB Tech Univ Ostrava, Nanotechnol Ctr, 17 Listopadu 15-2172, Ostrava 70833, Czech Republic.
RP Valicek, J (reprint author), VSB Tech Univ Ostrava, Fac Min & Geol, 17 Listopadu 15-2172, Ostrava 70833, Czech Republic.; Valicek, J (reprint author), VSB Tech Univ Ostrava, Fac Min & Geol, Inst Clean Technol Min & Utilizat Raw Mat Energy, 17 Listopadu 15-2172, Ostrava 70833, Czech Republic.; Valicek, J (reprint author), VSB Tech Univ Ostrava, Fac Met & Mat Engn, Reg Mat Sci & Technol Ctr, 17 Listopadu 15-2172, Ostrava 70833, Czech Republic.
RI Dudek, Lukasz/R-3274-2016; Matysek, Dalibor/N-1737-2018
OI Matysek, Dalibor/0000-0002-1412-1079
FU ICT project [LO1406]; IT4Innovations Centre of Excellence project -
   Structural Funds of the European Union [CZ.1.05/1.1.00/02.0070]; state
   budget of the Czech Republic; project RMTVC [LO1203]
FX This work was partly supported by the ICT project LO1406, the
   IT4Innovations Centre of Excellence project, reg. no.
   CZ.1.05/1.1.00/02.0070 funded by Structural Funds of the European Union
   and state budget of the Czech Republic and the project RMTVC No. LO1203.
CR Hempel F, 2014, SURF COAT TECH, V256, P52, DOI 10.1016/j.surfcoat.2014.01.027
   Hryniewicz T, 2007, T I MET FINISH, V85, P325, DOI 10.1179/174591907X246537
   Hryniewicz T, 2012, APPL SURF SCI, V263, P357, DOI 10.1016/j.apsusc.2012.09.060
   Hryniewicz T, 2010, SURF COAT TECH, V204, P2583, DOI 10.1016/j.surfcoat.2010.02.005
   Hryniewicz T., MATERIALS
   Hryniewicz T, 2014, FRONT MATER, DOI 10.3389/fmats.2014.00003
   Hryniewicz T, 2014, ANTI-CORROS METHOD M, V61, P57, DOI 10.1108/ACMM-03-2013-1249
   Hryniewicz T, 2012, MATER LETT, V83, P69, DOI 10.1016/j.matlet.2012.06.010
   Jelinek M, 2013, MAT SCI ENG C-MATER, V33, P1242, DOI 10.1016/j.msec.2012.12.018
   Mishra G, 2013, J ENVIRON CHEM ENG, V1, P1124, DOI 10.1016/j.jece.2013.08.031
   Rajendran A, 2014, RSC ADV, V4, P61444, DOI 10.1039/c4ra13107j
   Rokosz K., 2014, TECHNICAL GAZETTE, V22, P415
   Rokosz K, 2015, SURF INTERFACE ANAL, V47, P87, DOI 10.1002/sia.5676
   Rokosz K, 2014, TEH VJESN, V21, P799
   Rokosz K, 2014, TEH VJESN, V21, P533
   Simka W, 2013, ELECTROCHIM ACTA, V104, P518, DOI 10.1016/j.electacta.2012.10.130
   Simka W, 2011, ELECTROCHIM ACTA, V56, P8962, DOI 10.1016/j.electacta.2011.07.129
   Simka W, 2011, PRZEM CHEM, V90, P84
   Sowa M, 2013, ELECTROCHIM ACTA, V114, P627, DOI 10.1016/j.electacta.2013.10.047
   Trujillo NA, 2012, MAT SCI ENG C-MATER, V32, P2135, DOI 10.1016/j.msec.2012.05.012
   Yao XH, 2014, APPL SURF SCI, V292, P944, DOI 10.1016/j.apsusc.2013.12.083
   Yu S, 2011, T NONFERR METAL SOC, V21, P573, DOI 10.1016/S1003-6326(11)60753-X
   Zhang XY, 2012, APPL SURF SCI, V258, P10058, DOI 10.1016/j.apsusc.2012.06.074
NR 23
TC 11
Z9 11
U1 2
U2 26
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1533-4880
EI 1533-4899
J9 J NANOSCI NANOTECHNO
JI J. Nanosci. Nanotechnol.
PD AUG
PY 2016
VL 16
IS 8
BP 7814
EP 7817
DI 10.1166/jnn.2016.12558
PG 4
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA EB1CL
UT WOS:000387083900009
DA 2018-10-20
ER

PT J
AU Khorasani, AM
   Gibson, I
   Goldberg, M
   Nomani, J
   Littlefair, G
AF Khorasani, Amir Mahyar
   Gibson, Ian
   Goldberg, Moshe
   Nomani, Junior
   Littlefair, Guy
TI Machinability of Metallic and Ceramic Biomaterials: A Review
SO SCIENCE OF ADVANCED MATERIALS
LA English
DT Review
DE Biomaterial Machining; Machinability; Surface Characteristics
ID TO-CUT MATERIALS; SURFACE-PROPERTIES ROUGHNESS; MACHINING TI-6AL-4V
   ALLOY; MAGNESIUM-CALCIUM ALLOY; FINITE-ELEMENT-ANALYSIS;
   TITANIUM-ALLOYS; STAINLESS-STEEL; BIOMEDICAL APPLICATIONS; CUTTING
   FLUID; THIN-FILMS
AB The machining process is the most common method for metal cutting, especially in the fabrication of biomaterials and artificial implants. In modern industry, the goal of production is to manufacture products at a low cost, with the highest quality in the shortest time. The main focus of the research presented here is to provide a review of the machinability of metallic and ceramic biomaterials in traditional machining processes, such as turning, milling and grinding. Thereafter, machining strategies, machinability and surface characteristics post machining are discussed. To provide a better understanding of the machining process, various cutting tools and fluids are analysed. Finally, the current research gap and directions of prospect investigations are highlighted.
C1 [Khorasani, Amir Mahyar; Gibson, Ian; Goldberg, Moshe; Nomani, Junior; Littlefair, Guy] Deakin Univ, Sch Engn, Geelong, Vic 3216, Australia.
RP Khorasani, AM (reprint author), Deakin Univ, Sch Engn, Geelong, Vic 3216, Australia.
EM mahyar@deakin.edu.au
RI Littlefair, Guy/N-1614-2017
CR Addison O, 2012, DENT MATER, V28, P880, DOI 10.1016/j.dental.2012.04.017
   Akyuz B, 2013, T NONFERR METAL SOC, V23, P2243, DOI 10.1016/S1003-6326(13)62724-7
   Alam K, 2011, MED ENG PHYS, V33, P234, DOI 10.1016/j.medengphy.2010.10.003
   Albakry M, 2004, J DENT, V32, P91, DOI 10.1016/j.jdent.2003.08.006
   [Anonymous], 1989, ASM HDB, V16
   Araujo AC, 2013, INT J MACH TOOL MANU, V67, P28, DOI 10.1016/j.ijmachtools.2012.12.005
   Arifvianto B., 2009, UNPUB, P1
   Asadnia M., 2010, INT J APP ENG RES, V5, P3191
   Augustin G, 2012, INT ORTHOP, V36, P1449, DOI 10.1007/s00264-012-1491-z
   Bagno A, 2004, J MATER SCI-MATER M, V15, P935, DOI 10.1023/B:JMSM.0000042679.28493.7f
   Bansal DG, 2011, WEAR, V271, P2006, DOI 10.1016/j.wear.2010.11.021
   Bermingham MJ, 2012, J MATER PROCESS TECH, V212, P752, DOI 10.1016/j.jmatprotec.2011.10.027
   Best SM, 2008, J EUR CERAM SOC, V28, P1319, DOI 10.1016/j.jeurceramsoc.2007.12.001
   Black G H. J., 1998, HDB BIOMATERIAL PROP
   Braga FJC, 2007, APPL SURF SCI, V253, P9203, DOI 10.1016/j.apsusc.2007.05.048
   Brandao LC, 2008, J MATER PROCESS TECH, V199, P234, DOI 10.1016/j.jmatprotec.2007.07.049
   Cakir O, 2004, J MATER PROCESS TECH, V153, P35, DOI 10.1016/j.jmatprotec.2004.04.190
   Cao YQ, 2001, ENG FAIL ANAL, V8, P325, DOI 10.1016/S1350-6307(00)00024-8
   Celen S, 2012, APPL SURF SCI, V263, P579, DOI 10.1016/j.apsusc.2012.09.112
   Cetin MH, 2011, J CLEAN PROD, V19, P2049, DOI 10.1016/j.jclepro.2011.07.013
   Chan KS, 2006, METALL MATER TRANS A, V37A, P1323, DOI 10.1007/s11661-006-1084-9
   Chang C. J., 2003, SAE TECHNICAL PAPER, DOI [10.4271/2003-01-2870, DOI 10.4271/2003-01-2870]
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Childs T., 2000, METAL MACHINING THEO
   Cotrut CM, 2015, SCI ADV MATER, V7, P1351, DOI 10.1166/sam.2015.2051
   Davim JP, 2008, J MATER PROCESS TECH, V205, P16, DOI 10.1016/j.jmatprotec.2007.11.082
   Davoodi B, 2014, J CLEAN PROD, V68, P234, DOI 10.1016/j.jclepro.2013.12.056
   De Chiffre L, 2007, CIRP ANN-MANUF TECHN, V56, P101, DOI 10.1016/j.cirp.2007.05.026
   de Lacalle LNL, 2006, J MATER PROCESS TECH, V172, P11, DOI [10.1016/j.jmatprotec.2005.08.014, 10.1016/jjmatprotec.2005.08.014]
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   Denkena B, 2007, CIRP ANN-MANUF TECHN, V56, P113, DOI 10.1016/j.cirp.2007.05.029
   Denkena B, 2013, CIRP J MANUF SCI TEC, V6, P22, DOI 10.1016/j.cirpj.2012.07.002
   Denry I, 2008, DENT MATER, V24, P299, DOI 10.1016/j.dental.2007.05.007
   Dhananchezian M, 2011, CRYOGENICS, V51, P34, DOI 10.1016/j.cryogenics.2010.10.011
   Dhar NR, 2006, J MATER PROCESS TECH, V171, P93, DOI 10.1016/j.jmatprotec.2005.06.047
   Dhokey NB, 2012, T INDIAN I METALS, V65, P405, DOI 10.1007/s12666-012-0145-6
   Dong A, 2015, SCI ADV MATER, V7, P319, DOI 10.1166/sam.2015.2024
   Dumitriu S., 2001, POLYM BIOMATERIALS R
   El-Hossainy TM, 2001, MATER MANUF PROCESS, V16, P165, DOI 10.1081/AMP-100104298
   Elahinia MH, 2012, PROG MATER SCI, V57, P911, DOI 10.1016/j.pmatsci.2011.11.001
   Elias CN, 2008, J MECH BEHAV BIOMED, V1, P234, DOI 10.1016/j.jmbbm.2007.12.002
   Elsarnagawy T, 2015, SCI ADV MATER, V7, P396, DOI 10.1166/sam.2015.2251
   Eshet Y, 2006, IEEE T BIO-MED ENG, V53, P1174, DOI 10.1109/TBME.2006.873562
   Ezugwu EO, 2005, INT J MACH TOOL MANU, V45, P1353, DOI 10.1016/j.ijmachtools.2005.02.003
   Ezugwu EO, 1997, J MATER PROCESS TECH, V68, P262, DOI 10.1016/S0924-0136(96)00030-1
   Feng J, 2012, FINITE ELEM ANAL DES, V57, P67, DOI 10.1016/j.finel.2012.03.002
   Feng P, 2015, SCI ADV MATER, V7, P1326, DOI 10.1166/sam.2015.2048
   Ferracane J. L., 2001, MAT DENTISTRY PRINCI
   Feyerabend F, 2009, J BIOMED MATER RES A, V90A, P931, DOI 10.1002/jbm.a.32151
   Filser F, 2001, Int J Comput Dent, V4, P89
   Gaitonde VN, 2009, J MATER ENG PERFORM, V18, P231, DOI 10.1007/s11665-008-9269-6
   Garcia A. J., 2009, FDN REGENERATIVE MED, P368
   Gaspar M, 2013, COMPUT AIDED DESIGN, V45, P1170, DOI 10.1016/j.cad.2013.04.007
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Ginting A, 2006, INT J MACH TOOL MANU, V46, P758, DOI 10.1016/j.ijmachtools.2005.07.035
   Ginting A, 2009, INT J MACH TOOL MANU, V49, P325, DOI 10.1016/j.ijmachtools.2008.10.011
   Groover M. P., 2007, FUNDAMENTALS MODERN
   Gu P, 2002, CIRP ANN-MANUF TECHN, V51, P181, DOI 10.1016/S0007-8506(07)61495-4
   Guo YB, 2010, CIRP ANN-MANUF TECHN, V59, P151, DOI 10.1016/j.cirp.2010.03.051
   Han P., 2013, INT J MECHATRON MANU, V6, P215
   Han PD, 2012, INT J MECH SCI, V65, P157, DOI 10.1016/j.ijmecsci.2012.09.014
   Hermawan H, 2008, POWDER METALL, V51, P38, DOI 10.1179/174329008X284868
   Hirosaki K, 2004, JSME INT J C-MECH SY, V47, P14, DOI 10.1299/jsmec.47.14
   Ho WF, 2008, J MATER SCI-MATER M, V19, P3179, DOI 10.1007/s10856-008-3454-x
   Ho WF, 2010, MATER CHEM PHYS, V121, P465, DOI 10.1016/j.matchemphys.2010.02.009
   Ho WF, 2009, MAT SCI ENG C-BIO S, V29, P36, DOI 10.1016/j.msec.2008.05.004
   Hong SY, 2002, MACH SCI TECHNOL, V6, P235, DOI 10.1081/MST-120005958
   Hort N, 2010, ACTA BIOMATER, V6, P1714, DOI 10.1016/j.actbio.2009.09.010
   Hryniewicz T, 2009, MATERIALS, V2, P129, DOI 10.3390/ma2010129
   Hsu HC, 2010, J MED BIOL ENG, V30, P73
   Hsu HC, 2009, J ALLOY COMPD, V474, P578, DOI 10.1016/j.jallcom.2008.07.003
   Hsu HC, 2009, J ALLOY COMPD, V476, P817, DOI 10.1016/j.jallcom.2008.09.116
   Huang H, 2004, MATER MANUF PROCESS, V19, P159, DOI 10.1081/AMP-120029849
   Ibrahim I, 2015, SCI ADV MATER, V7, P1556, DOI 10.1166/sam.2015.2288
   Jackson Mark J, 2009, International Journal of Nano and Biomaterials, V2, P520, DOI 10.1504/IJNBM.2009.028341
   Jayal AD, 2009, WEAR, V267, P1723, DOI 10.1016/j.wear.2009.06.032
   Joen JY, 2015, SCI ADV MATER, V7, P57, DOI 10.1166/sam.2015.2079
   Jun S, 2015, SCI ADV MATER, V7, P1510, DOI 10.1166/sam.2015.2366
   Jun S, 2015, SCI ADV MATER, V7, P102, DOI 10.1166/sam.2015.2087
   Kalpakjian S. R. S., 2003, MANUFACTURING PROCES
   Karakoca S, 2009, J BIOMED MATER RES B, V91B, P930, DOI 10.1002/jbm.b.31477
   Kasuga T., 2003, MAT SCI FOR UNPUB, P1
   Kazemi RB, 1996, ORAL SURG ORAL MED O, V81, P596, DOI 10.1016/S1079-2104(96)80055-2
   Ke YL, 2009, T NONFERR METAL SOC, V19, P530, DOI 10.1016/S1003-6326(08)60307-6
   Khettabi R, 2013, CIRP J MANUF SCI TEC, V6, P175, DOI 10.1016/j.cirpj.2013.04.001
   Khorasani A. Mahyar, 2012, International Journal of Computational Materials Science and Surface Engineering, V5, P68, DOI 10.1504/IJCMSSE.2012.049055
   Khorasani Amir Mahyar, 2012, International Journal of Machining and Machinability of Materials, V12, P142, DOI 10.1504/IJMMM.2012.048553
   Khorasani A. M., 2013, MILLING MACHINES STR
   Khorasani A. M., 2015, PH D CONFIRMATION RE
   Khorasani A. M., 2014, J MACH FORM TECHNOL, V6, P45
   Khorasani A. M., 2012, ARTIF INTEL RES, V1, P46
   Khorasani AM, 2015, J BIOMATER TISS ENG, V5, P593, DOI 10.1166/JBT.2015.1361
   Khorasani AM, 2013, INT J MODEL SIMUL SC, V4, DOI 10.1142/S1793962313500013
   Khorasani AM, 2013, ARAB J SCI ENG, V38, P1565, DOI 10.1007/s13369-013-0600-7
   Khorasani AM, 2011, INT J ADV MANUF TECH, V55, P457, DOI 10.1007/s00170-010-3060-1
   Kikuchi M, 2003, DENT MATER J, V22, P191, DOI 10.4012/dmj.22.191
   Kikuchi M, 2003, DENT MATER, V19, P375, DOI 10.1016/S0109-5641(02)00080-5
   Kikuchi M, 2008, DENT MATER J, V27, P216, DOI 10.4012/dmj.27.216
   Kikuchi M, 2008, MATER TRANS, V49, P800, DOI 10.2320/matertrans.MRA2007285
   Kim N, 2015, SCI ADV MATER, V7, P1530, DOI 10.1166/sam.2015.2370
   Kim SW, 2001, J MATER PROCESS TECH, V111, P256, DOI 10.1016/S0924-0136(01)00529-5
   Kohal RJ, 2013, DENT MATER, V29, P763, DOI 10.1016/j.dental.2013.04.003
   Kulkarni SS, 2013, J MANUF PROCESS, V15, P666, DOI 10.1016/j.jmapro.2013.09.007
   Kuram E, 2013, J CLEAN PROD, V42, P159, DOI 10.1016/j.jclepro.2012.11.003
   Kurtz SM, 2012, PDL HANDB SER, P1
   Lakes J. P. R. S., 2007, BIOMATERIALS INTRO
   Lee DB, 2015, SCI ADV MATER, V7, P1515, DOI 10.1166/sam.2015.2367
   LEUSCHKE U, 2008, LA METALLURGIA ITALI, P5
   Li KM, 2006, J MANUF SCI E-T ASME, V128, P416, DOI 10.1115/1.2162907
   Li KM, 2007, INT J MACH TOOL MANU, V47, P1292, DOI 10.1016/j.ijmachtools.2006.08.017
   Li XZ, 2015, SCI ADV MATER, V7, P1400, DOI 10.1166/sam.2015.2058
   Liu JC, 2002, J MANUF SCI E-T ASME, V124, P820, DOI 10.1115/1.1511522
   Liu J, 2014, CIRP J MANUF SCI TEC, V7, P55, DOI 10.1016/j.cirpj.2014.01.003
   Liu J, 2007, INT J MACH TOOL MANU, V47, P635, DOI 10.1016/j.ijmachtools.2006.04.008
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Luiz N. E., 2008, J ENG MANUF, V222, P347
   MACHADO AR, 1990, P I MECH ENG B-J ENG, V204, P53, DOI 10.1243/PIME_PROC_1990_204_047_02
   McGinley EL, 2011, DENT MATER, V27, P637, DOI 10.1016/j.dental.2011.03.004
   Mendonca G, 2008, BIOMATERIALS, V29, P3822, DOI 10.1016/j.biomaterials.2008.05.012
   Mirafzal S. H., 2015, J VIB CONTROL, P1
   Mitsuishi M, 2013, CIRP ANN-MANUF TECHN, V62, P585, DOI 10.1016/j.cirp.2013.05.001
   Mohanty S, 2013, J ASIAN CERAM SOC, V1, P274, DOI 10.1016/j.jascer.2013.06.005
   Mohanty S, 2013, CERAM INT, V39, P8985, DOI 10.1016/j.ceramint.2013.04.099
   Mori M, 2012, PROC CIRP, V1, P22, DOI 10.1016/j.procir.2012.04.004
   Muller R, 2005, BIOMATERIALS, V26, P6962, DOI 10.1016/j.biomaterials.2005.05.013
   Nabhani F, 2001, ROBOT CIM-INT MANUF, V17, P99, DOI 10.1016/S0736-5845(00)00042-9
   Nadim K. J. B., 2004, TISSUE ENG, V7, P55
   Nandy AK, 2009, INT J MACH TOOL MANU, V49, P182, DOI 10.1016/j.ijmachtools.2008.08.008
   Neely J. E., 2000, BASIC MACHINE TOOL O
   Ng SH, 2006, J MATER PROCESS TECH, V175, P299, DOI 10.1016/j.jmatprotec.2005.04.055
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Niinomi M, 2008, J ARTIF ORGANS, V11, P105, DOI 10.1007/s10047-008-0422-7
   Niinomi M, 2003, SCI TECHNOL ADV MAT, V4, P445, DOI 10.1016/j.stam.2003.09.002
   Niinomi M, 2012, ACTA BIOMATER, V8, P3888, DOI 10.1016/j.actbio.2012.06.037
   Niinomi T. H. M., 2005, JOM, V57, P18
   Nomani J, 2013, WEAR, V304, P20, DOI 10.1016/j.wear.2013.04.008
   O'Brien W.J, 1997, DENT MAT THEIR SELEC
   Oberg E., 2008, MACHINERYS HDB
   Ohkubo C, 2000, BIOMATERIALS, V21, P421, DOI 10.1016/S0142-9612(99)00206-9
   Ohkubo C, 2006, DENT MATER, V22, P268, DOI 10.1016/j.dental.2005.04.020
   Ohmori H, 2006, CIRP ANN-MANUF TECHN, V55, P597, DOI 10.1016/S0007-8506(07)60491-0
   Okabe T, 2004, JOM-US, V56, P46, DOI 10.1007/s11837-004-0145-z
   Outeiro JC, 2013, PROC CIRP, V8, P487, DOI 10.1016/j.procir.2013.06.138
   Ozcelik B, 2011, TRIBOL INT, V44, P1864, DOI 10.1016/j.triboint.2011.07.012
   Ozel T, 2010, CIRP ANN-MANUF TECHN, V59, P77, DOI 10.1016/j.cirp.2010.03.055
   Ozturk B, 2006, INT J MACH TOOL MANU, V46, P736, DOI 10.1016/j.ijmachtools.2005.07.037
   Park J. B., 2002, BIOMATERIALS PRINCIP
   Paro JA, 2004, J MATER PROCESS TECH, V153, P622, DOI 10.1016/j.jmatprotec.2004.04.100
   Piquard R, 2014, PRECIS ENG, V38, P356, DOI 10.1016/j.precisioneng.2013.11.006
   Polini R, 2004, THIN SOLID FILMS, V469, P161, DOI 10.1016/j.tsf.2004.08.075
   Polishetty A., 2010, INT J MECH MECHATRON, V10, P1
   Ponsonnet L, 2003, MAT SCI ENG C-BIO S, V23, P551, DOI 10.1016/S0928-4931(03)00033-X
   Pramanik Alokesh, 2013, Advanced Materials Research, V651, P338, DOI 10.4028/www.scientific.net/AMR.651.338
   Prymak O, 2005, BIOMATERIALS, V26, P5801, DOI 10.1016/j.biomaterials.2005.02.029
   Pu Z, 2012, INT J MACH TOOL MANU, V56, P17, DOI 10.1016/j.ijmachtools.2011.12.006
   Pu Z, 2011, PROCEDIA ENGINEER, V19, DOI 10.1016/j.proeng.2011.11.113
   Pusavec F., 2009, J ADV PROD ENG MANAG, V3, P58
   Pusavec F, 2010, J CLEAN PROD, V18, P1211, DOI 10.1016/j.jclepro.2010.01.015
   Qin F, 2009, J DENT, V37, P776, DOI 10.1016/j.jdent.2009.06.004
   Rahman M, 2003, INT J ADV MANUF TECH, V21, P787, DOI 10.1007/s00170-002-1394-z
   Rahman M, 2003, JSME INT J C-MECH SY, V46, P107, DOI 10.1299/jsmec.46.107
   Rahman Z. W. M., 2006, JSME INT J, V49, P11
   Ramsden JJ, 2007, CIRP ANN-MANUF TECHN, V56, P687, DOI 10.1016/j.cirp.2007.10.001
   Raos P., 2005, 4 DAAAM INT C ADV TE
   Rivero A, 2006, INT J ADV MANUF TECH, V28, P1, DOI 10.1007/s00170-004-2349-3
   Robinson GM, 2005, J MATER PROCESS TECH, V167, P316, DOI 10.1016/j.jmatprotec.2005.06.016
   Salahshoor M, 2011, J MECH BEHAV BIOMED, V4, P1888, DOI 10.1016/j.jmbbm.2011.06.006
   Salahshoor M, 2011, INT J MACH TOOL MANU, V51, P579, DOI 10.1016/j.ijmachtools.2011.04.004
   Sasahara H, 2008, INT J MACH TOOL MANU, V48, P841, DOI 10.1016/j.ijmachtools.2007.12.002
   Schaefer O, 2013, DENT MATER, V29, P851, DOI 10.1016/j.dental.2013.04.018
   Schey J. A., 2000, INTRO MANUFACTURING
   Schmidt C, 2000, J BIOMED MATER RES, V53, P348, DOI 10.1002/1097-4636(2000)53:4<348::AID-JBM8>3.3.CO;2-S
   Serope Kalpakjian S. S, 2013, MANUFACTURING ENG TE
   Shapira L, 2009, CLIN ORAL IMPLAN RES, V20, P50, DOI 10.1111/j.1600-0501.2008.01594.x
   Sharabian E. Gharezadeh, 2010, J MANUF TECH, V1, P41
   Sharma VS, 2009, INT J MACH TOOL MANU, V49, P435, DOI 10.1016/j.ijmachtools.2008.12.010
   Shashidhara YM, 2010, TRIBOL INT, V43, P1073, DOI 10.1016/j.triboint.2009.12.065
   Shih AJ, 2004, J MANUF SCI E-T ASME, V126, P115, DOI 10.1115/1.1616951
   Shokrani A, 2012, INT J MACH TOOL MANU, V57, P83, DOI 10.1016/j.ijmachtools.2012.02.002
   Silliman E. J. D., 1992, CUTTING GRINDING FLU
   Spriano S, 2005, WEAR, V259, P919, DOI 10.1016/j.wear.2005.02.011
   Sreejith PS, 2000, J MATER PROCESS TECH, V101, P287, DOI 10.1016/S0924-0136(00)00445-3
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Su Y, 2007, INT J MACH TOOL MANU, V47, P927, DOI 10.1016/j.ijmachtools.2006.07.005
   Su Y, 2006, WEAR, V261, P760, DOI 10.1016/j.wear.2006.01.013
   Sul YT, 2003, BIOMATERIALS, V24, P3893, DOI 10.1016/S0142-9612(03)00261-8
   Sun S, 2010, INT J MACH TOOL MANU, V50, P933, DOI 10.1016/j.ijmachtools.2010.08.003
   Taira M, 1997, J ORAL REHABIL, V24, P527, DOI 10.1046/j.1365-2842.1997.00518.x
   Tan LL, 2013, J MATER SCI TECHNOL, V29, P503, DOI 10.1016/j.jmst.2013.03.002
   Timmerhaus K. D., 2007, CRYOGENIC ENG
   Ulutan D, 2011, INT J MACH TOOL MANU, V51, P250, DOI 10.1016/j.ijmachtools.2010.11.003
   Venugopal KA, 2007, WEAR, V262, P1071, DOI 10.1016/j.wear.2006.11.010
   Venugopal KA, 2007, CRYOGENICS, V47, P12, DOI 10.1016/j.cryogenics.2006.08.011
   Vera V, 2013, NEUROCOMPUTING, V109, P94, DOI 10.1016/j.neucom.2012.04.033
   Von Der Hoh N, 2009, ADV ENG MATER, V11, pB47, DOI 10.1002/adem.200800273
   Walker J. R., 2000, MACHINING FUNDAMENTA
   WALTER M, 1994, J DENT, V22, P346, DOI 10.1016/0300-5712(94)90086-8
   Wan YZ, 2008, MATER DESIGN, V29, P2034, DOI 10.1016/j.matdes.2008.04.017
   Wang HY, 2013, CHARACTERIZATION OF BIOMATERIALS, P105, DOI 10.1016/B978-0-12-415800-9.00004-8
   Wang ZG, 2005, INT J MACH TOOL MANU, V45, P105, DOI 10.1016/j.ijmachtools.2004.06.021
   Wang ZY, 2000, WEAR, V239, P168, DOI 10.1016/S0043-1648(99)00361-0
   Watanabe I, 2009, J PROSTHODONT, V18, P152, DOI 10.1111/j.1532-849X.2008.00402.x
   Wen XJ, 1996, BIO-MED MATER ENG, V6, P173
   Whitney E., 1994, CERAMIC CUTTING TOOL
   Whitters CJ, 1999, J DENT, V27, P401, DOI 10.1016/S0300-5712(99)00007-X
   Wylie CM, 2007, DENT MATER, V23, P714, DOI 10.1016/j.dental.2006.06.011
   Yalcin B, 2009, MATER DESIGN, V30, P896, DOI 10.1016/j.matdes.2008.05.037
   Yan David Ping, 2011, International Journal of Machining and Machinability of Materials, V10, P264, DOI 10.1504/IJMMM.2011.043089
   Yan D. P., 2011, SUPPL P MAT FABR PRO, V2, P633
   Yazdi MRS, 2011, EXPERT SYST APPL, V38, P12116, DOI 10.1016/j.eswa.2011.03.002
   Yin L, 2008, J EUR CERAM SOC, V28, P531, DOI 10.1016/j.jeurcerainsoc.2007.07.006
   Yin L., 2011, INT J ABRAS TECHNOL, V4, P204
   Yong YW, 2012, CERAM INT, V38, P6865, DOI 10.1016/j.ceramint.2012.05.087
   Yoshinari M, 2011, JPN DENT SCI REV, V47, P89, DOI 10.1016/j.jdsr.2011.03.001
   Yuan SM, 2011, J MATER PROCESS TECH, V211, P356, DOI 10.1016/j.jmatprotec.2010.10.009
   Zinelis S, 2010, DENT MATER, V26, P295, DOI 10.1016/j.dental.2009.11.079
NR 216
TC 3
Z9 3
U1 3
U2 47
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1947-2935
EI 1947-2943
J9 SCI ADV MATER
JI Sci. Adv. Mater.
PD AUG
PY 2016
VL 8
IS 8
BP 1491
EP 1511
DI 10.1166/sam.2016.2783
PG 21
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA EA3HE
UT WOS:000386491900001
DA 2018-10-20
ER

PT J
AU Tao, G
   Wang, YJ
   Liu, LN
   Chang, HP
   Zhao, P
   He, HW
AF Tao, Gang
   Wang, Yejing
   Liu, Lina
   Chang, Huaipu
   Zhao, Ping
   He, Huawei
TI Preparation and Characterization of Silver Nanoparticles Composited on
   Polyelectrolyte Film Coated Sericin Gel for Enhanced Antibacterial
   Application
SO SCIENCE OF ADVANCED MATERIALS
LA English
DT Article
DE Sericin Gel; Silver Nanoparticles; Polyelectrolyte Film; Antibacterial
   Application
ID SILK PROTEIN SERICIN; IN-SITU SYNTHESIS; BIOMATERIALS; CYTOTOXICITY;
   HYDROGELS; OXIDE; SHAPE
AB Sericin has shown a great potential as a biomaterial in biomedical application due to its good hydrophilicity, reactivity and biodegradability. To solve the adherence and growth of microorganisms on sericin gel, here we prepared a polyelectrolyte film with interactive arrangement of opposite charges poly(dimethyldiallylammonium chloride) (PDDA) and poly(acrylic acid) (PAA) coated on the surface of sericin gel via electrostatic interaction. AgNPs was then synthesized with the assistance of UV in situ on the polyelectrolyte film to endow the antibacterial activity of sericin gel. SEM revealed the polyelectrolyte film could effectively facilitate the high density growth of AgNPs as a 3-D matrix and the modification of polyelectrolyte and AgNPs did not alter the porous characteristics of sericin gel. XRD studies suggested AgNPs synthesized on the polyelectrolytes film coated sericin gel had good crystal structure. DSC analysis showed AgNPs could tightly bind with the polyelectrolytes film and sericin gel, and the binding may improve the melting temperature of AgNPs. Both bacterial inhibition zone and growth curve assay demonstrated the sericin gel coated with AgNPs-polyelectrolytes film had an excellent and long-lasting antibacterial activity. This novel sericin gel has shown great potentials in biomedical application such as wound healing.
C1 [Tao, Gang; Wang, Yejing; Liu, Lina; Zhao, Ping; He, Huawei] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400715, Peoples R China.
   [Wang, Yejing; Chang, Huaipu; He, Huawei] Southwest Univ, Coll Biotechnol, Chongqing Engn & Technol Res Ctr Novel Silk Mat, Chongqing 400715, Peoples R China.
   [He, Huawei] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China.
RP He, HW (reprint author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400715, Peoples R China.; He, HW (reprint author), Southwest Univ, Coll Biotechnol, Chongqing Engn & Technol Res Ctr Novel Silk Mat, Chongqing 400715, Peoples R China.; He, HW (reprint author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China.
EM hehuawei@swu.edu.cn
FU National Basic Research Program of China [2012CB114602]; State Key
   Program of National Natural Science of China [31530071]; National
   Natural Science Foundation of China [31572465, 31402139]; National
   Laboratory of Biomacromolecules [2015kf08]; Fundamental Research Funds
   for the Central Universities [SWU112111, SWU112086, XDJK2013A019,
   XDJK2013C049]; Chongqing Fundamental and Frontier Research Program
   [cstc2013jcyjA0500, cstc2015jcyjBX0035]
FX This work was supported by National Basic Research Program of China (No.
   2012CB114602), State Key Program of National Natural Science of China
   (No. 31530071), National Natural Science Foundation of China (No.
   31572465, 31402139), Open Project Program of National Laboratory of
   Biomacromolecules (No. 2015kf08), Fundamental Research Funds for the
   Central Universities (SWU112111, SWU112086, XDJK2013A019, XDJK2013C049)
   and Chongqing Fundamental and Frontier Research Program
   (cstc2013jcyjA0500, cstc2015jcyjBX0035).
CR Abbasi AR, 2011, ULTRASON SONOCHEM, V18, P282, DOI 10.1016/j.ultsonch.2010.06.002
   Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Aramwit P, 2012, WASTE MANAGE RES, V30, P217, DOI 10.1177/0734242X11404733
   de Lima R, 2012, J APPL TOXICOL, V32, P867, DOI 10.1002/jat.2780
   Ikoba U, 2015, NANOSCALE, V7, P4291, DOI 10.1039/c4nr07682f
   Kundu B, 2012, BIOMATERIALS, V33, P7456, DOI 10.1016/j.biomaterials.2012.06.091
   Lamboni L, 2015, BIOTECHNOL ADV, V33, P1855, DOI 10.1016/j.biotechadv.2015.10.014
   Lee JM, 2003, J CULT HERIT, V4, p157S
   Lee K, 2003, INT J BIOL MACROMOL, V33, P75, DOI 10.1016/S0141-8130(03)00069-2
   Li DC, 2015, BIOSENS BIOELECTRON, V72, P370, DOI 10.1016/j.bios.2015.05.023
   Li N, 2010, CHEM COMMUN, V46, P1520, DOI 10.1039/b920736h
   Li W, 2014, CARBOHYD POLYM, V99, P218, DOI 10.1016/j.carbpol.2013.07.055
   Lu HM, 2009, J PHYS CHEM C, V113, P7598, DOI 10.1021/jp900314q
   Lu Y, 2014, RSC ADV, V4, P33355, DOI 10.1039/c4ra03782k
   Luo WH, 2012, J CHEM PHYS, V136, DOI 10.1063/1.4729910
   Machado G, 2009, J PHYS CHEM C, V113, P19005, DOI 10.1021/jp906018p
   Mandal BB, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/35/355101
   Meng M, 2016, J COLLOID INTERF SCI, V461, P369, DOI 10.1016/j.jcis.2015.09.038
   Padamwar MN, 2004, J SCI IND RES INDIA, V63, P323
   Pal S, 2007, APPL ENVIRON MICROB, V73, P1712, DOI 10.1128/AEM.02218-06
   Peyton SR, 2006, BIOMATERIALS, V27, P4881, DOI 10.1016/j.biomaterials.2006.05.012
   Prucek R, 2011, BIOMATERIALS, V32, P4704, DOI 10.1016/j.biomaterials.2011.03.039
   SCHILLINGER U, 1989, APPL ENVIRON MICROB, V55, P1901
   Sharma M, 2012, J HETEROCYCLIC CHEM, V49, P589, DOI 10.1002/jhet.825
   Song KL, 2015, ACS APPL MATER INTER, V7, P15108, DOI 10.1021/acsami.5b04479
   Syed JA, 2015, COLLOID SURFACE A, V476, P48, DOI 10.1016/j.colsurfa.2015.03.021
   Vinson N, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4884350
   [王群 Wang Qun], 2003, [武汉大学学报. 理学版, Journal of Wuhan University], V49, P725
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wang Z, 2014, SCI REP-UK, V4, DOI 10.1038/srep07064
   Wu JH, 2007, FOOD CHEM, V103, P1255, DOI 10.1016/j.foodchem.2006.10.042
   Yen CW, 2015, LAB CHIP, V15, P1638, DOI 10.1039/c5lc00055f
   Zhan YF, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.41496
   Zhang DS, 2012, J MATER SCI, V47, P5721, DOI 10.1007/s10853-012-6462-7
   Zhang H., 2008, E-POLYMERS, V8, P761
   Zhang KG, 2015, NANOSCALE, V7, P16952, DOI 10.1039/c5nr05718c
   Zhang YQ, 2002, BIOTECHNOL ADV, V20, P91, DOI 10.1016/S0734-9750(02)00003-4
NR 38
TC 9
Z9 9
U1 2
U2 13
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1947-2935
EI 1947-2943
J9 SCI ADV MATER
JI Sci. Adv. Mater.
PD AUG
PY 2016
VL 8
IS 8
BP 1547
EP 1552
DI 10.1166/sam.2016.2996
PG 6
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA EA3HE
UT WOS:000386491900006
DA 2018-10-20
ER

PT J
AU Zo, SM
   Singh, D
   Singh, D
   Han, SS
AF Zo, Sun Mi
   Singh, Deepti
   Singh, Dolly
   Han, Sung Soo
TI Altering Kinetics of Polymerization Can Modulate Mesenchymal Stem Cells
   Interaction with 3D Matrix
SO SCIENCE OF ADVANCED MATERIALS
LA English
DT Article
DE Cell-Matrix Chemistry; Gelatin; Human Mesenchymal Stem Cells; Micro-CT;
   Scaffold; Redox Agent; PLGA
ID COMPOSITE SCAFFOLDS; CHITOSAN; HYDROXYAPATITE; MICROSPHERES;
   BIOMATERIAL; FILMS
AB Aim of regenerative medicine and tissue engineering is to provide an alternative approach to tissue harvesting and in order to achieve this biomaterials play pivotal role as these matrices provide a three-dimensional base to the cells, microenvironment for its differentiation and architecture suitable for extra-cellular matrix synthesis leading to neo-tissue generation. However, depending upon the technique for scaffold fabrication different properties could be imparted on these scaffolds and by altering the chemical reaction could have effect on the bio-functionality of the scaffold. With this aim, we report for the first time effect of using free-radical polymerization agents on PLGA-gelatin scaffold synthesized via freeze-thawing technique. Two sets of PLGA-gelatin matrix was fabricated one without redox agent ammonium persulphate (APS) and N,N',N'-tetramethylethylenediamine (TEMED) (PG) and another scaffold using both these agents (PGAT). Scanning electron microscopy image shows significant difference in pore size and pore architecture in both scaffold with PG showing large closed pores with average pore size of 150 mu m and PGAT matrix shows smaller interconnected and open pores with average pore diameter of 85 mu m. These results were further confirmed by Micro-CT which shows significant difference in the architecture of both the scaffold. Human mesenchymal stem cell cultured on these matrices showed high cellular attachment in both scaffold however, in PG cells were found to be more spindle shaped with high extracellular matrix secretion. Furthermore, hMSCs cultured on PGAT were found to be more circular which indicates more cell-cell interaction than cell-matrix interactions. Goal of this work was to demonstrate that by modulating a simple step during scaffold fabrication can have substantial effect on how cells interacts with these biomimetic.
C1 [Zo, Sun Mi; Singh, Deepti; Singh, Dolly; Han, Sung Soo] Yeungnam Univ, Biomat Lab, Dept Nano Med & Polymer Mat, Kyongsan 712749, South Korea.
RP Han, SS (reprint author), Yeungnam Univ, Biomat Lab, Dept Nano Med & Polymer Mat, Kyongsan 712749, South Korea.
EM sshan@yu.ac.kr
FU Yeungnam university
FX This work was fully supported by 2014 Yeungnam university research
   grant.
CR Ao Q, 2006, J BIOMED MATER RES A, V77A, P11, DOI 10.1002/jbm.a.30593
   Cao WL, 2005, J BIOMAT SCI-POLYM E, V16, P791, DOI 10.1163/1568562053992496
   Cao WL, 2005, J BIOMAT SCI-POLYM E, V16, P1379, DOI 10.1163/156856205774472308
   Ciobanu BC, 2014, MAT SCI ENG C-MATER, V43, P383, DOI 10.1016/j.msec.2014.07.036
   Fay F, 2010, BIOMATERIALS, V31, P4214, DOI 10.1016/j.biomaterials.2010.01.143
   Goddard JM, 2007, PROG POLYM SCI, V32, P698, DOI 10.1016/j.progpolymsci.2007.04.002
   Horst M, 2013, BIOMATERIALS, V34, P1537, DOI 10.1016/j.biomaterials.2012.10.075
   Huang W, 2010, BIOMATERIALS, V31, P4278, DOI 10.1016/j.biomaterials.2010.01.059
   Hwang YS, 2010, J MATER CHEM, V20, P345, DOI 10.1039/b917142h
   Ito A, 2003, J BIOSCI BIOENG, V95, P196, DOI 10.1016/S1389-1723(03)80129-9
   Izadifar Z, 2012, J FUNCT BIOMATER, V3, P799, DOI 10.3390/jfb3040799
   Kong LJ, 2006, EUR POLYM J, V42, P3171, DOI 10.1016/j.eurpolymj.2006.08.009
   Kong LJ, 2005, J BIOMED MATER RES A, V75A, P275, DOI 10.1002/jbm.a.30414
   Lee J.-J., 2007, CURR APPL PHYS, V7, P3740
   Liu J, 2007, BIOMATERIALS, V28, P3236, DOI 10.1016/j.biomaterials.2007.03.022
   Meng ZX, 2010, MAT SCI ENG C-MATER, V30, P1204, DOI 10.1016/j.msec.2010.06.018
   Oh SH, 2006, J MATER SCI-MATER M, V17, P131, DOI 10.1007/s10856-006-6816-2
   Shukla J, 2007, HELL J NUCL MED, V10, P9
   Singh D., 2014, J BIOMED NANOTECHNOL, V10
   Singh D, 2013, J BIOMAT SCI-POLYM E, V24, P1343, DOI 10.1080/09205063.2012.759505
   Song JE, 2013, MACROMOL RES, V21, P1075, DOI 10.1007/s13233-013-1137-z
   Srivastava A, 2010, J MATER SCI-MATER M, V21, P2937, DOI 10.1007/s10856-010-4124-3
   Sung HJ, 2004, BIOMATERIALS, V25, P5735, DOI 10.1016/j.biomaterials.2004.01.066
   Uematsu K, 2005, BIOMATERIALS, V26, P4273, DOI 10.1016/j.biomaterials.2004.10.037
   Villerberghe S. V., 2011, BIOMACROMOLECULES, V12, P1387
   Vishnoi T, 2013, BIOMED RES INT, DOI 10.1155/2013/294679
   Vishnoi T, 2013, J MATER SCI-MATER M, V24, P447, DOI 10.1007/s10856-012-4795-z
   Zhang L, 2006, J BIOMED MATER RES A, V77A, P277, DOI 10.1002/jbm.a.30614
   Zhao F, 2006, BIOMATERIALS, V27, P1859, DOI 10.1016/j.biomaterials.2005.09.031
NR 29
TC 0
Z9 0
U1 1
U2 7
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1947-2935
EI 1947-2943
J9 SCI ADV MATER
JI Sci. Adv. Mater.
PD AUG
PY 2016
VL 8
IS 8
BP 1688
EP 1695
DI 10.1166/sam.2016.2449
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA EA3HE
UT WOS:000386491900025
DA 2018-10-20
ER

PT J
AU Liu, C
   Agarwal, K
   Zhang, YP
   Chowdhury, DR
   Azad, AK
   Cho, JH
AF Liu, Chao
   Agarwal, Kriti
   Zhang, Yuping
   Chowdhury, Dibakar Roy
   Azad, Abul K.
   Cho, Jeong-Hyun
TI Displacement Current Mediated Resonances in Terahertz Metamaterials
SO ADVANCED OPTICAL MATERIALS
LA English
DT Article
DE displacement current; metamaterials; nanopillars; quality factor; split
   ring resonators
ID SPLIT-RING RESONATORS
AB Terahertz metamaterials (THz MMs) have been proven to be good candidates for chemical, biological, temperature, strain, and position sensing. However, currently developed thin-metal-film-based split ring resonator (SRR) MMs have relatively low quality factor (Q-factors), leading to a poor sensitivity, which is one of the obstacles for development of sensors. In order to enhance the Q-factor, novel THz MMs, nanopillar-based MMs, are designed, fabricated, and characterized. The nanopillar-based MMs excite the inductive-capacitive resonance via desplacement currents, showing a significantly enhanced Q-factor around 450, which is about 30 times higher than typical thin-metal-film-based MMs. Nanopillar-based MMs also show 17 times larger frequency shift compared to the metal-film-based MMs when the permittivity of the ambient dielectric properties of the MMs changes. Due to high Q-factor and large frequency shift, the nanopillar-based THz MMs utilizing displacement current have great potential for highly sensitive chemical and biomaterial detection as well as frequency-agile THz devices.
C1 [Liu, Chao; Agarwal, Kriti; Cho, Jeong-Hyun] Univ Minnesota, Dept Elect & Comp Engn, 5-129 Keller Hall,200 Union St SE, Minneapolis, MN 55455 USA.
   [Zhang, Yuping; Azad, Abul K.] Los Alamos Natl Lab, Ctr Integrated Nanotechnol, Mat Phys & Applicat Div, Los Alamos, NM 87545 USA.
   [Chowdhury, Dibakar Roy] Mahindra Ecole Cent Jeedimetla, Hyderabad 500043, Andhra Pradesh, India.
RP Cho, JH (reprint author), Univ Minnesota, Dept Elect & Comp Engn, 5-129 Keller Hall,200 Union St SE, Minneapolis, MN 55455 USA.
EM jcho@umn.edu
OI Azad, Abul/0000-0002-7784-7432
FU University of Minnesota, Twin Cities; Los Alamos National Laboratory
   LDRD Program
FX This material is based upon work supported by a start-up fund at the
   University of Minnesota, Twin Cities. The authors also acknowledge
   support from the Los Alamos National Laboratory LDRD Program. This work
   was performed, in part, at the Center for Integrated Nanotechnologies, a
   U.S. Department of Energy, Office of Basic Energy Sciences Nanoscale
   Science Research Center operated jointly by Los Alamos and Sandia
   National Laboratories.
CR Al-Naib I, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4905478
   Anetsberger G., 2010, THESIS
   Cao W, 2013, SCI REP-UK, V3, DOI 10.1038/srep01766
   Chen JY, 2009, PROG ELECTROMA RES M, V10, P25, DOI 10.2528/PIERM09110507
   Chen T, 2012, SENSORS-BASEL, V12, P2742, DOI 10.3390/s120302742
   Chiam SY, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3079419
   Cho JH, 2014, NANO LETT, V14, P3088, DOI 10.1021/nl500130e
   Cho JH, 2013, NANO LETT, V13, P5740, DOI 10.1021/nl4036498
   Chow T., 2006, INTRO ELECTROMAGNETI
   Chowdhury DR, 2014, OPT EXPRESS, V22, DOI 10.1364/OE.22.019401
   Chowdhury DR, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3667197
   Cong LQ, 2015, ADV OPT MATER, V3, P1537, DOI 10.1002/adom.201500207
   Cong LQ, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4906109
   Cubukcu E, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3194154
   Deibel J. A., 2014, MEMS NANOTECHNOLOGY, V5, P129
   Driscoll T, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2768300
   Fedotov VA, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.147401
   Gil I, 2004, ELECTRON LETT, V40, P1347, DOI 10.1049/el:20046389
   Guney DO, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.125129
   Han J, 2009, J MOD OPTIC, V56, P554, DOI 10.1080/09500340802621785
   Hao T., 2005, ELECTRON LETT, V41, P1
   Hopkins R., 2006, IMAPS 39 INT S MICR, P65
   Ida N., 2000, ENG ELECTROMAGNETICS, V2
   Jackson J. D., 1999, CLASSICAL EELECTRODY
   Jansen C, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3553193
   Jaruwongrungsee K, 2015, PROCEDIA ENGINEER, V120, P163, DOI 10.1016/j.proeng.2015.08.595
   La Spada L., 2011, Progress In Electromagnetics Research B, V34, P205
   Lee DK, 2015, SCI REP-UK, V5, DOI 10.1038/srep15459
   Lee S., 2015, MRS P, V1785, P13
   Melik R, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3250175
   Naqui J, 2012, SENSORS-BASEL, V12, P11790, DOI 10.3390/s120911790
   Ng BH, 2014, ACS PHOTONICS, V1, P1059, DOI 10.1021/ph500272n
   O'Hara JF, 2008, OPT EXPRESS, V16, P1786, DOI 10.1364/OE.16.001786
   Park HR, 2013, NANO LETT, V13, P1782, DOI 10.1021/nl400374z
   Prasad P. N., 2004, INTRO BIOPHOTONICS
   Singh R, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4895595
   Srivastava YK, 2016, ADV OPT MATER, V4, P457, DOI 10.1002/adom.201500504
   Toma A, 2015, NANO LETT, V15, P386, DOI 10.1021/nl503705w
   Torun H, 2014, J APPL PHYS, V116, DOI 10.1063/1.4896261
   Tsakmakidis KL, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.195128
   Xu XL, 2011, NANO LETT, V11, P3232, DOI 10.1021/nl2014982
NR 41
TC 7
Z9 7
U1 0
U2 6
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 2195-1071
J9 ADV OPT MATER
JI Adv. Opt. Mater.
PD AUG
PY 2016
VL 4
IS 8
BP 1302
EP 1309
DI 10.1002/adom.201600196
PG 8
WC Materials Science, Multidisciplinary; Optics
SC Materials Science; Optics
GA DW4FZ
UT WOS:000383599500022
DA 2018-10-20
ER

PT J
AU Mareci, D
   Fernandez-Perez, BM
   Trinca, LC
   Fotea, L
   Souto, RM
AF Mareci, D.
   Fernandez-Perez, B. M.
   Trinca, L. C.
   Fotea, L.
   Souto, R. M.
TI Electrochemical Investigation of the Corrosion Resistance of Ti20Mo
   Alloys in Simulated Physiological Solution with Added Proteins for
   Biomaterial Application
SO INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE
LA English
DT Article
DE Biomaterials; Ti20Mo alloy; Corrosion resistance; Ringer's solution with
   proteins; Potentiodynamic polarization; Electrochemical impedance
   spectroscopy; Scanning electron microscopy
ID TI-TA ALLOYS; BIOMEDICAL APPLICATIONS; IMPEDANCE SPECTROSCOPY;
   TITANIUM-ALLOYS; MECHANICAL-PROPERTIES; MO ALLOYS; BEHAVIOR; FLUORIDE;
   ALBUMIN; WEAR
AB Corrosion behaviour of the studied Ti20Mo alloy together with the currently used metallic biomaterials Ti6A14V, and Ti6A17Nb alloys was investigated for biomedical applications. All the samples were examined using electrochemical techniques: linear polarization curves and electrochemical impedance spectroscopy (EIS) in electrochemical media: Ringer's solution with proteins at 37 degrees C. The passive behaviour for all the Ti samples is observed for Ringer's solution with proteins. The Ti20Mo alloy underwent spontaneous passivation, and exhibited more positive zero current potential (E-ZCP), and lower corrosion current densities (j(corr)) than Ti6A14V, and Ti6A17Nb alloys. The Ti20Mo alloy appears to posses superior corrosion resistance in Ringer's solution with proteins than the Ti6A14V, and Ti6A17Nb biomaterials.
C1 [Mareci, D.] Tech Univ Gheorghe Asachi Iasi, Iasi 700050, Romania.
   [Fernandez-Perez, B. M.; Souto, R. M.] Univ La Laguna, Dept Chem, E-38205 Tenerife, Canary Islands, Spain.
   [Trinca, L. C.; Fotea, L.] Ion Ionescu de la Brad Univ Agr Sci & Vet Med, Dept Sci, Fac Hort, 3 Mihail Sadoveanu Alley, Iasi 700490, Romania.
   [Souto, R. M.] Univ La Laguna, Inst Mat Sci & Nanotechnol, E-38200 Tenerife, Canary Islands, Spain.
RP Trinca, LC (reprint author), Ion Ionescu de la Brad Univ Agr Sci & Vet Med, Dept Sci, Fac Hort, 3 Mihail Sadoveanu Alley, Iasi 700490, Romania.
EM lctrinca@Yahoo.com; rsouto@ull.es
RI TRINCA, LUCIA CARMEN/F-5966-2011
OI TRINCA, LUCIA CARMEN/0000-0001-7381-6658; Souto, Ricardo
   M./0000-0001-9429-5513
FU Romanian National Authority for Scientific Research (CNCS-UEFISCDI)
   [PN-II-ID-PCE-2011-3-0218]; Ministerio de Economia y Competitividad
   (MINECO, Madrid, Spain); European Regional Development Fund (Brussels,
   Belgium) [CTQ2012-36787]
FX The authors are grateful to Prof. Thierry Gloriant (INSA Rennes, France)
   for kindly providing the Ti20Mo alloys used. This work was supported by
   grants from the Romanian National Authority for Scientific Research
   (CNCS-UEFISCDI) under project number PN-II-ID-PCE-2011-3-0218, and from
   the Ministerio de Economia y Competitividad (MINECO, Madrid, Spain) and
   the European Regional Development Fund (Brussels, Belgium) under project
   number CTQ2012-36787. Se agradece la financiacion concedida a la ULL por
   la Consejeria de Economia, Industria, Comercio y Conocimiento,
   cofinanciada en un 85% por el Fondo Social Europeo.
CR Alkhateeb E, 2005, J BIOMED MATER RES A, V75A, P934, DOI 10.1002/jbm.a.30508
   Alves VA, 2009, CORROS SCI, V51, P2473, DOI 10.1016/j.corsci.2009.06.035
   Balamurugan A, 2008, MATER CORROS, V59, P855, DOI 10.1002/maco.200804173
   Bolat G, 2015, CORROS SCI, V98, P170, DOI 10.1016/j.corsci.2015.05.025
   Bolat G, 2013, ELECTROCHIM ACTA, V113, P470, DOI 10.1016/j.electacta.2013.09.116
   Chelariu R, 2014, DIG J NANOMATER BIOS, V9, P1349
   Chelariu R, 2014, ELECTROCHIM ACTA, V137, P280, DOI 10.1016/j.electacta.2014.06.021
   Cvijovic-Alagic I, 2014, CORROS SCI, V83, P245, DOI 10.1016/j.corsci.2014.02.017
   Duarte LT, 2013, CORROS SCI, V72, P35, DOI 10.1016/j.corsci.2013.02.007
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Gill P, 2011, J MATER ENG PERFORM, V20, P819, DOI 10.1007/s11665-011-9874-7
   Gonzalez JEG, 1999, J ELECTROANAL CHEM, V471, P109, DOI 10.1016/S0022-0728(99)00260-0
   Gordin DM, 2008, ADV ENG MATER, V10, P714, DOI 10.1002/adem.200800041
   He G, 2003, BIOMATERIALS, V24, P5115, DOI 10.1016/S0142-9612(03)00440-X
   Ho WF, 1999, BIOMATERIALS, V20, P2115, DOI 10.1016/S0142-9612(99)00114-3
   Huang HH, 2005, DENT MATER, V21, P749, DOI 10.1016/j.dental.2005.01.009
   Ide K, 2003, DENT MATER J, V22, P359, DOI 10.4012/dmj.22.359
   Ingham E, 2000, P I MECH ENG H, V214, P21, DOI 10.1243/0954411001535219
   Izquierdo J, 2014, APPL SURF SCI, V313, P259, DOI 10.1016/j.apsusc.2014.05.201
   Khan MA, 1996, BIOMATERIALS, V17, P2117, DOI 10.1016/0142-9612(96)00029-4
   Khan MA, 1999, BIOMATERIALS, V20, P765, DOI 10.1016/S0142-9612(98)00229-4
   Kim HS, 2007, MAT SCI ENG A-STRUCT, V449, P322, DOI 10.1016/j.msea.2006.02.329
   Kim TI, 1997, BIO-MED MATER ENG, V7, P253
   Korovessis P, 2006, J BONE JOINT SURG AM, V88A, P1183, DOI 10.2106/JBJS.D.02916
   Kovacs P., 1996, MED APPL TITANIUM IT, P163, DOI DOI 10.1520/STP16077S
   MANSFELD F, 1973, J ELECTROCHEM SOC, V120, P515, DOI 10.1149/1.2403489
   Mareci D, 2010, MATER CORROS, V61, P829, DOI 10.1002/maco.201005761
   Mareci D, 2010, MATER CORROS, V61, P768, DOI 10.1002/maco.200905527
   Mareci D, 2015, T NONFERR METAL SOC, V25, P345, DOI 10.1016/S1003-6326(15)63610-X
   Mareci D, 2013, T NONFERR METAL SOC, V23, P3829, DOI 10.1016/S1003-6326(13)62936-2
   Niinomi M, 2003, SCI TECHNOL ADV MAT, V4, P445, DOI 10.1016/j.stam.2003.09.002
   Okazaki Y, 1996, MAT SCI ENG A-STRUCT, V213, P138, DOI 10.1016/0921-5093(96)10247-1
   Pan J, 1996, ELECTROCHIM ACTA, V41, P1143, DOI 10.1016/0013-4686(95)00465-3
   Piazza S, 1998, CORROS SCI, V40, P1087, DOI 10.1016/S0010-938X(98)00009-2
   Raistrick I. D., 1987, THEORY IMPEDANCE SPE, P90
   Rao S, 1997, MAT SCI ENG C-BIO S, V4, P311, DOI 10.1016/S0928-4931(97)00016-7
   Revell PA, 2008, J R SOC INTERFACE, V5, P1263, DOI 10.1098/rsif.2008.0142
   Sousa S. R., 1993, Clinical Materials, V14, P287, DOI 10.1016/0267-6605(93)90015-Y
   Vasilescu C, 2012, CORROS SCI, V65, P431, DOI 10.1016/j.corsci.2012.08.042
   Wang BL, 2009, MATER CORROS, V60, P330, DOI 10.1002/maco.200805120
   Williams D.F., 1981, BIOCOMPATIBILITY CLI, V1
   Zhou YL, 2008, J ALLOY COMPD, V466, P535, DOI 10.1016/j.jallcom.2007.11.090
   Zhou YL, 2008, MAT SCI ENG A-STRUCT, V483-84, P153, DOI 10.1016/j.msea.2006.09.173
   Zhou YL, 2009, MAT SCI ENG C-BIO S, V29, P1061, DOI 10.1016/j.msec.2008.09.012
NR 44
TC 1
Z9 1
U1 2
U2 16
PU ESG
PI BELGRADE
PA BORIVOJA STEVANOVICA 25-7, BELGRADE, 11000, SERBIA
SN 1452-3981
J9 INT J ELECTROCHEM SC
JI Int. J. Electrochem. Sci.
PD AUG
PY 2016
VL 11
IS 8
BP 6922
EP 6932
DI 10.20964/2016.08.24
PG 11
WC Electrochemistry
SC Electrochemistry
GA DY2ES
UT WOS:000384906500043
OA Bronze
DA 2018-10-20
ER

PT J
AU Liu, C
   Wong, HM
   Yeung, KWK
   Tjong, SC
AF Liu, Chen
   Wong, Hoi Man
   Yeung, Kelvin Wai Kwok
   Tjong, Sie Chin
TI Novel Electrospun Polylactic Acid Nanocomposite Fiber Mats with Hybrid
   Graphene Oxide and Nanohydroxyapatite Reinforcements Having Enhanced
   Biocompatibility
SO POLYMERS
LA English
DT Article
DE polylactic acid; electrospinning; graphene oxide; hydroxyapatite;
   nanocomposites; biocompatibility
ID POLY(LACTIC ACID); BIOMEDICAL APPLICATIONS; BIODEGRADABLE POLYMERS;
   MECHANICAL-PROPERTIES; POLY(L-LACTIC ACID); PROTEIN ADSORPTION;
   HYDROXYAPATITE; NANOFIBERS; COMPOSITES; SCAFFOLDS
AB Graphene oxide (GO) and a nanohydroxyapatite rod (nHA) of good biocompatibility were incorporated into polylactic acid (PLA) through electrospinning to form nanocomposite fiber scaffolds for bone tissue engineering applications. The preparation, morphological, mechanical and thermal properties, as well as biocompatibility of electrospun PLA scaffolds reinforced with GO and/or nHA were investigated. Electron microscopic examination and image analysis showed that GO and nHA nanofillers refine the diameter of electrospun PLA fibers. Differential scanning calorimetric tests showed that nHA facilitates the crystallization process of PLA, thereby acting as a nucleating site for the PLA molecules. Tensile test results indicated that the tensile strength and elastic modulus of the electrospun PLA mat can be increased by adding 15 wt % nHA. The hybrid nanocomposite scaffold with 15 wt % nHA and 1 wt % GO fillers exhibited higher tensile strength amongst the specimens investigated. Furthermore, nHA and GO nanofillers enhanced the water uptake of PLA. Cell cultivation, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and alkaline phosphatase tests demonstrated that all of the nanocomposite scaffolds exhibit higher biocompatibility than the pure PLA mat, particularly for the scaffold with 15 wt % nHA and 1 wt % GO. Therefore, the novel electrospun PLA nanocomposite scaffold with 15 wt % nHA and 1 wt % GO possessing a high tensile strength and modulus, as well as excellent cell proliferation is a potential biomaterial for bone tissue engineering applications.
C1 [Liu, Chen; Tjong, Sie Chin] City Univ Hong Kong, Dept Phys & Mat Sci, Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.
   [Wong, Hoi Man; Yeung, Kelvin Wai Kwok] Univ Hong Kong, Li Ka Shing Fac Med, Dept Orthoped & Traumatol, Hong Kong, Hong Kong, Peoples R China.
RP Tjong, SC (reprint author), City Univ Hong Kong, Dept Phys & Mat Sci, Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.
EM cliu266-c@my.cityu.edu.hk; kwhoiman@gmail.com; wkkyeung@hku.hk;
   aptjong@cityu.edu.hk
RI Tjong, S C/C-2924-2013
OI Tjong, S C/0000-0002-8377-3273; Yeung, Kelvin/0000-0003-0887-088X
FU City University of Hong Kong [9667126]
FX This work was fully supported by the Applied Research Grant (No.
   9667126), City University of Hong Kong.
CR Gonzalez JA, 2014, RSC ADV, V4, P16480, DOI 10.1039/c3ra47986b
   Asran AS, 2010, POLYMER, V51, P868, DOI 10.1016/j.polymer.2009.12.046
   BONFIELD W, 1981, BIOMATERIALS, V2, P185, DOI 10.1016/0142-9612(81)90050-8
   Chaudhuri B, 2015, BIOFABRICATION, V7, DOI 10.1088/1758-5090/7/1/015009
   Compton OC, 2012, ACS NANO, V6, P2008, DOI 10.1021/nn202928w
   Depan D, 2011, ACTA BIOMATER, V7, P3432, DOI 10.1016/j.actbio.2011.05.019
   Dong Y, 2015, COMPOS PART A-APPL S, V76, P28, DOI 10.1016/j.compositesa.2015.05.011
   Dubey N, 2015, STEM CELLS INT, DOI 10.1155/2015/804213
   Ferrari AC, 2007, SOLID STATE COMMUN, V143, P47, DOI 10.1016/j.ssc.2007.03.052
   FISCHER EW, 1973, KOLLOID Z Z POLYM, V251, P980, DOI 10.1007/BF01498927
   Goncalves G, 2009, CHEM MATER, V21, P4796, DOI 10.1021/cm901052s
   Goonoo N, 2014, RSC ADV, V4, P31618, DOI 10.1039/c4ra05218h
   Goswami J, 2013, EXPRESS POLYM LETT, V7, P767, DOI 10.3144/expresspolymlett.2013.74
   Hamad K, 2015, EXPRESS POLYM LETT, V9, P435, DOI 10.3144/expresspolymlett.2015.42
   Han Y., 2013, UROLOGY, V81, DOI DOI 10.1016/J.UROLOGY.2012.08.044
   He LX, 2015, RSC ADV, V5, P15070, DOI 10.1039/c5ra00257e
   Huang J, 1997, J MATER SCI-MATER M, V8, P775, DOI 10.1023/A:1018516813604
   HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017
   Jaiswal AK, 2013, MAT SCI ENG C-MATER, V33, P2926, DOI 10.1016/j.msec.2013.03.020
   Jamshidian M, 2010, COMPR REV FOOD SCI F, V9, P552, DOI 10.1111/j.1541-4337.2010.00126.x
   Jiang LX, 2014, EXPRESS POLYM LETT, V8, P133, DOI 10.3144/expresspolymlett.2014.16
   Kimble LD, 2015, EXPRESS POLYM LETT, V9, P300, DOI 10.3144/expresspolymlett.2015.27
   KISTER G, 1995, J RAMAN SPECTROSC, V26, P307, DOI 10.1002/jrs.1250260409
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Koosha M, 2015, RSC ADV, V5, P10479, DOI 10.1039/c4ra13972k
   Kostakova E, 2014, EXPRESS POLYM LETT, V8, P554, DOI 10.3144/expresspolymlett.2014.59
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996
   Lee WC, 2011, ACS NANO, V5, P7334, DOI 10.1021/nn202190c
   Lerf A, 1998, J PHYS CHEM B, V102, P4477, DOI 10.1021/jp9731821
   Li YC, 2010, SYNTHETIC MET, V160, P1912, DOI 10.1016/j.synthmet.2010.07.009
   Liao CZ, 2014, INT J NANOMED, V9, P1299, DOI 10.2147/IJN.S58332
   Liu C, 2015, RSC ADV, V5, P72288, DOI 10.1039/c5ra14155a
   Liu LZ, 2012, NANOSCALE, V4, P5910, DOI 10.1039/c2nr31164j
   Ma HB, 2012, CHINESE SCI BULL, V57, P3051, DOI 10.1007/s11434-012-5336-3
   Ma PM, 2014, POLYMERS-BASEL, V6, P1528, DOI 10.3390/polym6051528
   Manavitehrani I, 2016, POLYMERS-BASEL, V8, DOI 10.3390/polym8010020
   Meng YZ, 1998, J APPL POLYM SCI, V68, P137, DOI 10.1002/(SICI)1097-4628(19980404)68:1<137::AID-APP15>3.0.CO;2-Y
   Meng YZ, 2001, J POLYM SCI POL CHEM, V39, P3218, DOI 10.1002/pola.1304
   Mezghani K, 1998, J POLYM SCI POL PHYS, V36, P1005, DOI 10.1002/(SICI)1099-0488(19980430)36:6<1005::AID-POLB9>3.3.CO;2-L
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Mitra J, 2013, RSC ADV, V3, P11073, DOI 10.1039/c3ra23315d
   Mokhena TC, 2015, EXPRESS POLYM LETT, V9, P839, DOI 10.3144/expresspolymlett.2015.79
   Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896
   Panzavolta S, 2014, CARBON, V78, P566, DOI 10.1016/j.carbon.2014.07.040
   Park E, 1998, MATER LETT, V36, P38, DOI 10.1016/S0167-577X(97)00287-5
   Park S, 2008, ACS NANO, V2, P572, DOI 10.1021/nn700349a
   Perumbilavil S, 2015, APPL PHYS LETT, V107, DOI 10.1063/1.4928124
   Pinto AM, 2013, COLLOID SURFACE B, V104, P229, DOI 10.1016/j.colsurfb.2012.12.006
   Place ES, 2009, CHEM SOC REV, V38, P1139, DOI 10.1039/b811392k
   Poinern GJE, 2011, INT J NANOMED, V6, P2083, DOI 10.2147/IJN.S24790
   Polini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026211
   Rafiq R, 2010, CARBON, V48, P4309, DOI 10.1016/j.carbon.2010.07.043
   Rajesh R, 2015, RSC ADV, V5, P41135, DOI 10.1039/c5ra07015e
   Ramakrishnan S, 2014, RSC ADV, V4, P9743, DOI 10.1039/c3ra46004e
   Raquez JM, 2013, PROG POLYM SCI, V38, P1504, DOI 10.1016/j.progpolymsci.2013.05.014
   Reneker DH, 2008, POLYMER, V49, P2387, DOI 10.1016/j.polymer.2008.02.002
   Ribeiro C, 2011, SCI TECHNOL ADV MAT, V12, DOI 10.1088/1468-6996/12/1/015001
   Neto WAR, 2012, POLYM DEGRAD STABIL, V97, P2037, DOI 10.1016/j.polymdegradstab.2012.03.048
   Rodriguez-Tobias H, 2014, J MATER SCI, V49, P8373, DOI 10.1007/s10853-014-8547-y
   Singh V, 2011, PROG MATER SCI, V56, P1178, DOI 10.1016/j.pmatsci.2011.03.003
   Song JQ, 2015, CARBON, V95, P1039, DOI 10.1016/j.carbon.2015.09.011
   Sonseca A, 2012, POLYM DEGRAD STABIL, V97, P2052, DOI 10.1016/j.polymdegradstab.2012.05.009
   STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424
   Tatavarty R, 2014, CHEM COMMUN, V50, P8484, DOI 10.1039/c4cc02442g
   Thomas V, 2007, BIOMACROMOLECULES, V8, P631, DOI 10.1021/bm060879w
   Tjong SC, 2007, COMPOS SCI TECHNOL, V67, P314, DOI 10.1016/j.compscitech.2006.08.006
   Tjong SC, 2006, MATER CHEM PHYS, V100, P1, DOI 10.1016/j.matchemphys.2005.11.029
   Tong HW, 2011, J APPL POLYM SCI, V120, P1694, DOI 10.1002/app.33302
   Utku FS, 2014, CERAM INT, V40, P15479, DOI 10.1016/j.ceramint.2014.07.004
   Wan CY, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/5/055010
   Wang JL, 2016, POLYMERS-BASEL, V8, DOI 10.3390/polym8040115
   Wang JC, 2011, POLYM INT, V60, P816, DOI 10.1002/pi.3025
   Wang KF, 2012, INTERFACE FOCUS, V2, P259, DOI 10.1098/rsfs.2012.0012
   Wang M, 2013, EVID-BASED COMPL ALT, V2013, P1, DOI DOI 10.1371/J0URNAL.P0NE.0053452
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098
   Wu DF, 2007, J POLYM SCI POL PHYS, V45, P1100, DOI 10.1002/polb.21154
   Xu XL, 2007, EUR POLYM J, V43, P3187, DOI 10.1016/j.eurpolymj.2007.05.024
   Yoon OJ, 2011, COMPOS PART A-APPL S, V42, P1978, DOI 10.1016/j.compositesa.2011.08.023
   Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014
   Zhou YY, 2014, RSC ADV, V4, P16731, DOI 10.1039/c3ra47168c
NR 83
TC 12
Z9 12
U1 8
U2 95
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2073-4360
J9 POLYMERS-BASEL
JI Polymers
PD AUG
PY 2016
VL 8
IS 8
AR 287
DI 10.3390/polym8080287
PG 19
WC Polymer Science
SC Polymer Science
GA DX6UZ
UT WOS:000384520900003
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Christo, S
   Diener, K
   Manavis, J
   Grimbaldeston, M
   Bachhuka, A
   Vasilev, K
   Hayball, J
AF Christo, S.
   Diener, K.
   Manavis, J.
   Grimbaldeston, M.
   Bachhuka, A.
   Vasilev, K.
   Hayball, J.
TI Modulating innate immune responses to biomaterial-induced inflammation
SO EUROPEAN JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT International Congress of Immunology (ICI)
CY AUG 21-26, 2016
CL Melbourne, AUSTRALIA
C1 [Christo, S.; Diener, K.; Hayball, J.] Univ South Australia, Adelaide, SA, Australia.
   [Diener, K.; Hayball, J.] Univ Adelaide, Adelaide, SA, Australia.
   [Manavis, J.; Grimbaldeston, M.] SA Pathol, Adelaide, SA, Australia.
   [Grimbaldeston, M.] Univ South Australia, Ctr Canc Biol, Adelaide, SA, Australia.
   [Bachhuka, A.; Vasilev, K.] Mawson Inst, Adelaide, SA, Australia.
   [Hayball, J.] Univ Adelaide, Sch Med, Adelaide, SA, Australia.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-2980
EI 1521-4141
J9 EUR J IMMUNOL
JI Eur. J. Immunol.
PD AUG
PY 2016
VL 46
SU 1
SI SI
MA 396
BP 427
EP 427
PG 1
WC Immunology
SC Immunology
GA DW4KA
UT WOS:000383610401052
DA 2018-10-20
ER

PT J
AU Kokorev, OV
   Khodorenko, VN
   Radkevich, AA
   Dambaev, GT
   Gunter, VE
AF Kokorev, O. V.
   Khodorenko, V. N.
   Radkevich, A. A.
   Dambaev, G. Ts.
   Gunter, V. E.
TI Development and Differentiation of Mesenchymal Bone Marrow Cells in
   Porous Permeable Titanium Nickelide Implants In Vitro and In Vivo
SO BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Article
DE biomaterial; biocompatibility; titanium nickelide; tissue bioengineering
ID DESIGN
AB We studied the structure of porous permeable titanium nickelide used as the scaffold. In vitro population of the porous scaffold with multipotent mesenchymal stem bone marrow cells on days 7, 14, 21, and 28 was analyzed by scanning electron microscopy. Stage-by-stage histogenesis of the tissues formed from the bone marrow cells in the titanium nickelide scaffold in vivo is described in detail. Using mesenchymal stem cells, we demonstrated that porous permeable titanium nickelide scaffolds are unique incubators for cell cultures applicable for tissue engineering.
C1 [Kokorev, O. V.; Khodorenko, V. N.; Radkevich, A. A.; Dambaev, G. Ts.; Gunter, V. E.] Tomsk Natl Res State Univ, Res Inst Med Shape Memory Mat & Implants, Tomsk, Russia.
RP Kokorev, OV (reprint author), Tomsk Natl Res State Univ, Res Inst Med Shape Memory Mat & Implants, Tomsk, Russia.
EM kokorevov@yandex.ru
RI Hodorenko, Valentina/P-2247-2016; Gunther, Viktor/O-6678-2014
OI Dambaev, Georgi/0000-0002-4472-5949; Kokorev, Oleg/0000-0003-3690-0177
FU Program "D. I. Mendeleev Scientific Foundation", Tomsk State University
   [8.1.42.2015]
FX The study (No. 8.1.42.2015) was supported by the Program "D. I.
   Mendeleev Scientific Foundation", Tomsk State University in 2014-2015.
CR Dambaev GT, 2000, Patent RF, Patent No. 2143867
   Gjunter VE, 2002, Patent RF, Patent No. 2191607
   Gjunter VE, 2000, PISMA ZH TEKH FIZIKI, V26, P12
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Gunter VE, 2012, SHAPE MEMORY MED MAT, V4
   Gunter VE, 2010, SHAPE MEMORY MED MAT, V2
   Gunter VE, 2011, SHAPE MEMORY MED MAT, V1
   Gunter VE, 2012, SHAPE MEMORY MED MAT, V11
   Gunter VE, 2011, SHAPE MEMORY MED MAT, P3
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/nmat2344, 10.1038/NMAT2344]
   Nerem RM, 2007, BIOMATERIALS, V28, P5074, DOI 10.1016/j.biomaterials.2007.07.032
   Prestwich GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004915
   Prestwich Glenn D, 2008, Organogenesis, V4, P42
   Wood KC, 2008, P NATL ACAD SCI USA, V105, P2280, DOI 10.1073/pnas.0706994105
NR 16
TC 0
Z9 0
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0007-4888
EI 1573-8221
J9 B EXP BIOL MED+
JI Bull. Exp. Biol. Med.
PD AUG
PY 2016
VL 161
IS 4
BP 587
EP 592
DI 10.1007/s10517-016-3465-4
PG 6
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DV6JG
UT WOS:000383040200031
PM 27590764
DA 2018-10-20
ER

PT J
AU Chappuis, V
   Cavusoglu, Y
   Gruber, R
   Kuchler, U
   Buser, D
   Bosshardt, DD
AF Chappuis, Vivianne
   Cavusoglu, Yeliz
   Gruber, Reinhard
   Kuchler, Ulrike
   Buser, Daniel
   Bosshardt, Dieter D.
TI Osseointegration of Zirconia in the Presence of Multinucleated Giant
   Cells
SO CLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH
LA English
DT Article
DE biomaterials; endosseous dental implantation; giant cells; macrophages;
   osteogenesis; surface chemistry; titanium; zirconium oxide
ID SURFACE-MODIFIED ZIRCONIA; FOREIGN-BODY REACTION; MACROPHAGE ACTIVATION;
   TITANIUM IMPLANTS; BONE APPOSITION; IN-VITRO; TISSUE; BIOMATERIAL;
   ARCHITECTURE; INFLAMMATION
AB Background: Current strategies to reduce medical device-associated infections propose zirconia as a potential implant material which may limit bacterial adhesion. Because multinucleated giant cells (MNGCs) have been detected on these implant surfaces, concerns have been raised regarding tissue integration.
   Purpose: The present study examined the presence of MNGCs and their subsequent effect upon tissue integration. Surface-modified implants made of yttria-stabilized (TZP) and alumina-toughened zirconia (ATZ) were compared with commercially pure titanium (Ti).
   Materials and Methods: Seven miniature pigs received three implants on either side of the maxilla. After healing periods of 4 and 8 weeks, the tissue response at the implant surfaces was characterized according to three specific parameters: bone-to-implant contact (BIC), MNGC-to-implant contact (MIC), and the peri-implant bone density (BD).
   Results: Despite being present on all tested implant surfaces, MNGCs were not associated with an inflammatory cell infiltrate or with fibrous encapsulation. MNGCs were less numerous on the Ti implants (range: 3.9-5.2%) compared with the ceramic implants (range: 17.6-30.3%, p < .0001). Even though the values of newly formed bone and pristine bone in direct contact with the implant surfaces were high at 4 weeks (tBIC: Ti = 82.3%, TZP = 64.3%, ATZ = 70%), a negative correlation was observed between the presence of MNGCs and newly formed bone at the implant surface (p < .001). Interestingly, the newly formed peri-implant bone density, defined as the percentage of new bone area inside the screw threads (nBD), was not diminished by the presence of MNGCs.
   Conclusions: Differences in the presence of MNGCs and the BIC parameters between Ti and the ceramic implants appear to be a local cellular phenomenon which is restricted to the implant-bone marrow interface and do not affect the peri-implant bone formation. Factors triggering MNGC differentiation and their persistence in response to biomaterial surface need to be investigated in future studies.
C1 [Chappuis, Vivianne; Cavusoglu, Yeliz; Kuchler, Ulrike; Buser, Daniel] Univ Bern, Sch Dent Med, Dept Oral Surg & Stomatol, Freiburgstr 7, CH-3010 Bern, Switzerland.
   [Gruber, Reinhard] Univ Bern, Sch Dent Med, Lab Oral Cell Biol, CH-3010 Bern, Switzerland.
   [Bosshardt, Dieter D.] Univ Bern, Sch Dent Med, Robert K Schenk Lab Oral Histol, CH-3010 Bern, Switzerland.
RP Chappuis, V (reprint author), Univ Bern, Sch Dent Med, Dept Oral Surg & Stomatol, Freiburgstr 7, CH-3010 Bern, Switzerland.
EM vivianne.chappuis@zmk.unibe.ch
RI Bosshardt, Dieter/C-9442-2012; chappuis, vivianne/P-2163-2018
OI Gruber, Reinhard/0000-0001-5400-9009
FU Dentalpoint AG in Switzerland [DP 2013-002]
FX The study was supported by a research grant from Dentalpoint AG in
   Switzerland (DP 2013-002). The authors wish to thank the staff at the
   Surgical Research Unit ESI and at the Clinic for Large Animals for
   excellent handling of the animals; Ms. Claudia Moser and Ms Denise Schar
   for their professional help during surgical procedures; Mr. David Reist
   for the histologic preparation of the specimens; Ms. Silvia Owusu for
   performing the histomorphometric analysis; and Mr. Lukas Martig
   (University of Bern, Institute of Mathematical Statistics and Actuarial
   Science) for statistical advice.
CR Albrektsson T, 2014, CLIN IMPLANT DENT R, V16, P155, DOI 10.1111/cid.12142
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Andreiotelli M, 2009, CLIN ORAL IMPLAN RES, V20, P32, DOI 10.1111/j.1600-0501.2009.01785.x
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Brunner E., 2002, NONPARAMETRIC ANAL L
   Buser D, 2004, J DENT RES, V83, P529, DOI 10.1177/154405910408300704
   Chen SL, 2010, BIOMATERIALS, V31, P3479, DOI 10.1016/j.biomaterials.2010.01.074
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Chung ES, 2009, AM J PATHOL, V175, P1984, DOI 10.2353/ajpath.2009.080515
   Cionca N, 2015, CLIN ORAL IMPLAN RES, V26, P413, DOI 10.1111/clr.12370
   Davison NL, 2014, EUR CELLS MATER, V27, P281, DOI 10.22203/eCM.v027a20
   Davison NL, 2014, EUR CELLS MATER, V27, P296
   Davison NL, 2014, BIOMATERIALS, V35, P7441, DOI 10.1016/j.biomaterials.2014.05.048
   Delgado-Ruiz RA, 2014, CLIN IMPLANT DENT R, V16, P856, DOI 10.1111/cid.12069
   Depprich R, 2014, CLIN IMPLANT DENT R, V16, P124, DOI 10.1111/j.1708-8208.2012.00454.x
   DONATH K, 1992, VIRCHOWS ARCH A, V420, P131, DOI 10.1007/BF02358804
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Gahlert M, 2012, CLIN ORAL IMPLAN RES, V23, P281, DOI 10.1111/j.1600-0501.2011.02157.x
   Godwin JW, 2013, P NATL ACAD SCI USA, V110, P9415, DOI 10.1073/pnas.1300290110
   Han CH, 1998, CLIN ORAL IMPLAN RES, V9, P1, DOI 10.1034/j.1600-0501.1998.090101.x
   Hisbergues M, 2009, J BIOMED MATER RES B, V88B, P519, DOI 10.1002/jbm.b.31147
   Jensen SS, 2015, CLIN ORAL IMPLAN RES, V26, P859, DOI 10.1111/clr.12376
   Jensen SS, 2014, J PERIODONTOL, V85, P1549, DOI 10.1902/jop.2014.140182
   Johansson CB, 1998, INT J ORAL MAX IMPL, V13, P315
   Lughi V, 2010, DENT MATER, V26, P807, DOI 10.1016/j.dental.2010.04.006
   McNally AK, 2011, ADV EXP MED BIOL, V713, P97, DOI 10.1007/978-94-007-0763-4_7
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073
   Nich C, 2013, J BIOMED MATER RES A, V101, P3033, DOI 10.1002/jbm.a.34599
   Roh JD, 2010, P NATL ACAD SCI USA, V107, P4669, DOI 10.1073/pnas.0911465107
   Saulacic N, 2012, EUR CELLS MATER, V23, P273, DOI 10.22203/eCM.v023a21
   Saulacic N, 2014, CLIN IMPLANT DENT R, V16, P313, DOI 10.1111/cid.12070
   Schenk R. K., 1984, PREPARATION CALCIFIE
   Schliephake H, 2010, J CLIN PERIODONTOL, V37, P818, DOI 10.1111/j.1600-051X.2010.01549.x
   Sennerby L, 2005, CLIN IMPLANT DENT R, V7, pS13, DOI 10.1111/j.1708-8208.2005.tb00070.x
   Siddiqi A, 2015, CLIN IMPLANT DENT R, V17, P483, DOI 10.1111/cid.12159
   Spiller KL, 2014, BIOMATERIALS, V35, P4477, DOI 10.1016/j.biomaterials.2014.02.012
   Stadlinger B, 2010, INT J ORAL MAX SURG, V39, P585, DOI 10.1016/j.ijom.2010.01.015
   STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287
   van Amerongen MJ, 2007, AM J PATHOL, V170, P818, DOI 10.2353/ajpath.2007.060547
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
NR 41
TC 12
Z9 13
U1 4
U2 14
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1523-0899
EI 1708-8208
J9 CLIN IMPLANT DENT R
JI Clin. Implant Dent. Relat. Res.
PD AUG
PY 2016
VL 18
IS 4
BP 686
EP 698
DI 10.1111/cid.12375
PG 13
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA DW0WU
UT WOS:000383364500005
PM 26377587
DA 2018-10-20
ER

PT J
AU Grischke, J
   Eberhard, J
   Stiesch, M
AF Grischke, Jasmin
   Eberhard, Joerg
   Stiesch, Meike
TI Antimicrobial dental implant functionalization strategies-A systematic
   review
SO DENTAL MATERIALS JOURNAL
LA English
DT Review
DE Antimicrobial; Anti-adhesion; Antibacterial; Surface functionalization;
   Dental implant
ID MICRO-ARC OXIDATION; STAPHYLOCOCCUS-AUREUS ADHESION; DIFFERENT BIOFILM
   COMPOSITIONS; INFECTION-RESISTANT SURFACES; BONE MORPHOGENETIC
   PROTEIN-2; HYDROXYAPATITE THIN-FILMS; ORAL BACTERIAL ADHESION;
   GRAM-NEGATIVE BACTERIA; IN-VITRO ANTIBACTERIAL; OF-THE-LITERATURE
AB Biofihn formation on dental implant surfaces is a serious threat. Up to 50% of all implants show signs of irreversible tissue destruction. The aim of the present systematic review was to summarize the state of the art of strategies to functionalize antimicrobial dental implant surfaces. We searched the following electronic database: SCOPUS, MEDLINE and GOOGLE SCHOLAR and identified relevant controlled trials that evaluated the efficiency of new biomaterial strategies to modify dental implant surfaces, in such a way that biofilm formation was inhibited. The search yielded 2,990 potentially relevant publications. A total of 142 publications met the inclusion criteria. Analysis found that it may be concluded that silver-implanted surfaces, drug-loaded surfaces, surfaces with antimicrobial peptides, bioactive and biopassive polymer coatings as well as nanoscale or UV-activatable surfaces enhance antimicrobial activity compared to commercial pure titanium.
C1 [Grischke, Jasmin; Eberhard, Joerg; Stiesch, Meike] Hannover Med Sch, Dept Prosthet Dent & Biomed Mat Sci, Carl Neuberg Str 1, D-30625 Hannover, Germany.
RP Grischke, J (reprint author), Hannover Med Sch, Dept Prosthet Dent & Biomed Mat Sci, Carl Neuberg Str 1, D-30625 Hannover, Germany.
EM grischke.jasmin@mh-hannover.de
OI Eberhard, Joerg/0000-0001-8060-2893
CR Ahamed M, 2010, CLIN CHIM ACTA, V411, P1841, DOI 10.1016/j.cca.2010.08.016
   Aita H, 2009, BIOMATERIALS, V30, P1015, DOI 10.1016/j.biomaterials.2008.11.004
   Almaguer-Flores A, 2010, J BIOMED MATER RES B, V92B, P196, DOI 10.1002/jbm.b.31506
   Almaguer-Flores A, 2009, DIAM RELAT MATER, V18, P1179, DOI 10.1016/j.diamond.2009.03.003
   Annunziata M, 2011, J DENT, V39, P720, DOI 10.1016/j.jdent.2011.08.003
   Ao YH, 2010, APPL SURF SCI, V256, P2754, DOI 10.1016/j.apsusc.2009.11.023
   Arciola CR, 2012, BIOMATERIALS, V33, P5967, DOI 10.1016/j.biomaterials.2012.05.031
   Barbour ME, 2009, J BIOMED MATER RES A, V90A, P993, DOI 10.1002/jbm.a.32170
   Bozzini S, 2011, INT J ARTIF ORGANS, V34, P898, DOI 10.5301/ijao.5000047
   Bronk JK, 2014, ACTA BIOMATER, V10, P3354, DOI 10.1016/j.actbio.2014.04.005
   Busscher HJ, 2010, J DENT RES, V89, P657, DOI 10.1177/0022034510368644
   Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528
   Buxadera-Palomero J, 2015, BIOINTERPHASES, V10, DOI 10.1116/1.4913376
   Cabal B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042393
   Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089
   Campoccia D, 2013, BIOMATERIALS, V34, P8018, DOI 10.1016/j.biomaterials.2013.07.048
   Cecchinato D, 2014, CLIN ORAL IMPLAN RES, V25, P791, DOI 10.1111/clr.12209
   Chang YY, 2013, SURF COAT TECH, V231, P224, DOI 10.1016/j.surfcoat.2012.05.084
   Chang YY, 2012, CLIN ORAL INVEST, V16, P95, DOI 10.1007/s00784-010-0504-9
   Chen SF, 2010, POLYMER, V51, P5283, DOI 10.1016/j.polymer.2010.08.022
   Chen W, 2007, J BIOMED MATER RES A, V82A, P899, DOI 10.1002/jbm.a.31197
   Chen W, 2006, BIOMATERIALS, V27, P5512, DOI 10.1016/j.biomaterials.2006.07.003
   Chen X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111579
   Cheng HY, 2015, BIOMATER SCI-UK, V3, P665, DOI 10.1039/c4bm00263f
   Chimutengwende-Gordon M, 2014, BIOINTERPHASES, V9, DOI 10.1116/1.4889977
   Chua PH, 2008, BIOMATERIALS, V29, P1412, DOI 10.1016/j.biomaterials.2007.12.019
   Chung RJ, 2006, J BIOMED MATER RES B, V76B, P169, DOI 10.1002/jbm.b.30365
   Cochis A, 2015, J BIOMED MATER RES A, V103, P1176, DOI 10.1002/jbm.a.35270
   Cortizo MC, 2012, J DENT, V40, P329, DOI 10.1016/j.jdent.2012.01.008
   Das K, 2008, J BIOMED MATER RES B, V87B, P455, DOI 10.1002/jbm.b.31125
   Davidson H, 2015, J BIOMED MATER RES B, V103, P1381, DOI 10.1002/jbm.b.33310
   de Avila ED, 2015, BIOMATERIALS, V67, P84, DOI 10.1016/j.biomaterials.2015.07.030
   De Giglio E, 2013, ANAL BIOANAL CHEM, V405, P805, DOI 10.1007/s00216-012-6293-z
   Della Valle C, 2012, INT J ARTIF ORGANS, V35, P864, DOI 10.5301/ijao.5000161
   Deng JY, 2010, J BIOMATER APPL, V25, P179, DOI 10.1177/0885328209349316
   Eichler M, 2011, BIOMATERIALS, V32, P9168, DOI 10.1016/j.biomaterials.2011.08.063
   Elizabeth E, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/11/115101
   Esposito M, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003815.pub3
   Fang J, 2014, J HARD TISSUE BIOL, V23, P35, DOI 10.2485/jhtb.23.35
   Flores CY, 2010, J COLLOID INTERF SCI, V350, P402, DOI 10.1016/j.jcis.2010.06.052
   Flores CY, 2013, ACS APPL MATER INTER, V5, P3149, DOI 10.1021/am400044e
   Frojd V, 2011, MOL ORAL MICROBIOL, V26, P241, DOI 10.1111/j.2041-1014.2011.00610.x
   Gallardo-Moreno AM, 2009, ACTA BIOMATER, V5, P181, DOI 10.1016/j.actbio.2008.07.028
   Ge X, 2010, J BIOMED MATER RES A, V95A, P588, DOI 10.1002/jbm.a.32862
   Godoy-Gallardo M, 2015, ACS APPL MATER INTER, V7, P5992, DOI 10.1021/acsami.5b00402
   Godoy-Gallardo M, 2015, BIOMACROMOLECULES, V16, P483, DOI 10.1021/bm501528x
   Godoy-Gallardo M, 2014, ACTA BIOMATER, V10, P3522, DOI 10.1016/j.actbio.2014.03.026
   Groessner-Schreiber B, 2004, EUR J ORAL SCI, V112, P516, DOI 10.1111/j.1600-0722.2004.00171.x
   Grossner-Schreiber B, 2001, CLIN ORAL IMPLAN RES, V12, P543, DOI 10.1034/j.1600-0501.2001.120601.x
   Grossner-Schreiber B, 2009, CLIN ORAL IMPLAN RES, V20, P817, DOI 10.1111/j.1600-0501.2009.01729.x
   Gruenheid S, 2012, FEMS MICROBIOL LETT, V330, P81, DOI 10.1111/j.1574-6968.2012.02528.x
   Han IH, 2007, BIOMED MATER, V2, pS91, DOI 10.1088/1748-6041/2/3/S01
   Harris LG, 2004, J MATER SCI-MATER M, V15, P311, DOI 10.1023/B:JMSM.0000021093.84680.bb
   Harris LG, 2004, BIOMATERIALS, V25, P4135, DOI 10.1016/j.biomaterials.2003.11.033
   He S, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0169
   Holmberg KV, 2013, ACTA BIOMATER, V9, P8224, DOI 10.1016/j.actbio.2013.06.017
   Hu H, 2012, ACTA BIOMATER, V8, P904, DOI 10.1016/j.actbio.2011.09.031
   Huang HL, 2013, THIN SOLID FILMS, V549, P108, DOI 10.1016/j.tsf.2013.07.075
   Huang HL, 2013, THIN SOLID FILMS, V528, P151, DOI 10.1016/j.tsf.2012.07.143
   Huang HL, 2010, SURF COAT TECH, V205, P1636, DOI 10.1016/j.surfcoat.2010.07.096
   Huang J, 2011, J MATER SCI-MATER M, V22, P491, DOI 10.1007/s10856-010-4226-y
   Huang Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06172
   Huang Y, 2015, RSC ADV, V5, P17076, DOI 10.1039/c4ra12118j
   Jankovic A, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-014-5333-y
   Jelinek M, 2011, LASER PHYS, V21, P1265, DOI 10.1134/S1054660X11130159
   Jelinek M, 2010, APPL PHYS A-MATER, V101, P615, DOI 10.1007/s00339-010-5911-x
   Jeyachandran YL, 2006, SURF COAT TECH, V201, P3462, DOI 10.1016/j.surfcoat.2006.07.236
   Jeyachandran YL, 2007, MAT SCI ENG C-BIO S, V27, P35, DOI 10.1016/j.msec.2006.01.004
   Ji MK, 2015, J ADV PROSTHODONT, V7, P166, DOI 10.4047/jap.2015.7.2.166
   Jin GD, 2014, BIOMATERIALS, V35, P7699, DOI 10.1016/j.biomaterials.2014.05.074
   Jin GD, 2014, COLLOID SURFACE B, V117, P158, DOI 10.1016/j.colsurfb.2014.02.025
   Jose B, 2005, CHEM BIOL, V12, P1041, DOI 10.1016/j.chembiol.2005.06.013
   Kang MK, 2011, DENT MATER J, V30, P790, DOI 10.4012/dmj.2011-021
   Kang MK, 2012, DENT MATER J, V31, P98, DOI 10.4012/dmj.2011-131
   Kang MK, 2009, THIN SOLID FILMS, V517, P5390, DOI 10.1016/j.tsf.2009.03.157
   Kawabe A, 2014, DENT MATER J, V33, P638, DOI 10.4012/dmj.2014-025
   Kim WH, 2008, SURF INTERFACE ANAL, V40, P202, DOI 10.1002/sia.2809
   Kizuki T, 2014, J MATER SCI-MATER M, V25, P1737, DOI 10.1007/s10856-014-5201-9
   Kos M, 2015, J CRANIO MAXILL SURG, V43, P863, DOI 10.1016/j.jcms.2015.04.018
   Lai CH, 2011, THIN SOLID FILMS, V520, P1525, DOI 10.1016/j.tsf.2011.06.043
   Lee DW, 2012, BONE, V50, P974, DOI 10.1016/j.bone.2012.01.007
   Lee JH, 2013, ACTA ODONTOL SCAND, V71, P168, DOI 10.3109/00016357.2011.654256
   Lee SB, 2010, SURF COAT TECH, V205, pS172, DOI 10.1016/j.surfcoat.2010.07.049
   Li JY, 2015, BIOMED RES INT, DOI 10.1155/2015/909870
   Li JX, 2012, J COAT TECHNOL RES, V9, P223, DOI 10.1007/s11998-009-9221-1
   Li JB, 2011, SURF COAT TECH, V205, P5430, DOI 10.1016/j.surfcoat.2011.06.006
   Li JH, 2014, COLLOID SURFACE B, V113, P134, DOI 10.1016/j.colsurfb.2013.08.030
   Liao JA, 2010, INT J NANOMED, V5, P261
   Liao J, 2010, INT J NANOMED, V5, P337
   Lin DJ, 2013, J BIOMATER APPL, V27, P553, DOI 10.1177/0885328211414942
   Lin NM, 2012, SURF COAT TECH, V209, P212, DOI 10.1016/j.surfcoat.2012.07.046
   Lin NM, 2012, APPL SURF SCI, V258, P7047, DOI 10.1016/j.apsusc.2012.03.163
   Liu H, 2007, BIOMATERIALS, V28, P354, DOI 10.1016/j.biomaterials.2006.08.049
   Liu WW, 2015, NANOMEDICINE-UK, V10, P713, DOI [10.2217/NNM.14.183, 10.2217/nnm.14.183]
   Liu WW, 2014, NANOSCALE, V6, P9050, DOI 10.1039/c4nr01531b
   Lu X, 2011, J R SOC INTERFACE, V8, P529, DOI 10.1098/rsif.2010.0366
   Lv HB, 2014, J DENT, V42, P1464, DOI 10.1016/j.jdent.2014.06.003
   Maddikeri RR, 2008, J BIOMED MATER RES A, V84A, P425, DOI 10.1002/jbm.a.31323
   Marsich E, 2013, ACTA BIOMATER, V9, P5088, DOI 10.1016/j.actbio.2012.10.002
   Massa MA, 2014, MAT SCI ENG C-MATER, V45, P146, DOI 10.1016/j.msec.2014.08.057
   Massaro C, 2002, J MATER SCI-MATER M, V13, P535, DOI 10.1023/A:1015170625506
   Mei SL, 2014, BIOMATERIALS, V35, P4255, DOI 10.1016/j.biomaterials.2014.02.005
   Mindroiu M, 2013, APPL SURF SCI, V276, P401, DOI 10.1016/j.apsusc.2013.03.107
   Mocanu A, 2014, APPL SURF SCI, V298, P225, DOI 10.1016/j.apsusc.2014.01.166
   Mofarrehi M. R., 2012, International Journal of Nano and Biomaterials, V4, P281
   Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1016/j.jclinepi.2010.03.004, 10.1016/j.pain.2009.05.009]
   Mombelli A, 2012, CLIN ORAL IMPLAN RES, V23, P67, DOI 10.1111/j.1600-0501.2012.02541.x
   Monetta T, 2014, PLASMA CHEM PLASMA P, V34, P1247, DOI 10.1007/s11090-014-9566-9
   Monteiro DR, 2009, INT J ANTIMICROB AG, V34, P103, DOI 10.1016/j.ijantimicag.2009.01.017
   Moon SK, 2012, J KOREAN PHYS SOC, V60, P954, DOI 10.3938/jkps.60.954
   Murakami A, 2012, NANOMED-NANOTECHNOL, V8, P374, DOI 10.1016/j.nano.2011.07.001
   Noda I, 2009, J BIOMED MATER RES B, V89B, P456, DOI 10.1002/jbm.b.31235
   Nodal Miyaji F, 2011, BIOCERAMICS DEV APPL, V1, P101
   Norowski PA, 2009, J BIOMED MATER RES B, V88B, P530, DOI 10.1002/jbm.b.31152
   Omori S, 2009, J DENT RES, V88, P957, DOI 10.1177/0022034509343426
   Park SW, 2014, APPL SURF SCI, V303, P140, DOI 10.1016/j.apsusc.2014.02.111
   Pascual A, 2002, CLIN MICROBIOL INFEC, V8, P256, DOI 10.1046/j.1469-0691.2002.00418.x
   Petrini P, 2006, INT J ARTIF ORGANS, V29, P434
   Pfaffenroth C, 2011, MACROMOL BIOSCI, V11, P1515, DOI 10.1002/mabi.201100124
   Popat KC, 2007, BIOMATERIALS, V28, P4880, DOI 10.1016/j.biomaterials.2007.07.037
   Pye AD, 2009, J HOSP INFECT, V72, P104, DOI 10.1016/j.jhin.2009.02.010
   Qiao SC, 2015, INT J NANOMED, V10, P653, DOI 10.2147/IJN.S73467
   Qu J, 2011, J BIOMED MATER RES B, V97B, P40, DOI 10.1002/jbm.b.31784
   Quirynen M, 2002, CLIN ORAL IMPLAN RES, V13, P1, DOI 10.1034/j.1600-0501.2002.130101.x
   Rajendran A, 2014, RSC ADV, V4, P61444, DOI 10.1039/c4ra13107j
   Ren N, 2012, J MATER CHEM, V22, P19151, DOI 10.1039/c2jm32434b
   Rodriguez-Valencia C, 2013, J BIOMED MATER RES A, V101, P853, DOI 10.1002/jbm.a.34387
   Scarano Antonio, 2003, J Oral Implantol, V29, P80, DOI 10.1563/1548-1336(2003)029<0080:BAOTNA>2.3.CO;2
   Schroder K, 2010, MATER SCI FORUM, V638-642, P700, DOI 10.4028/www.scientific.net/MSF.638-642.700
   Schwarz FP, 2011, SURF COAT TECH, V205, P4850, DOI 10.1016/j.surfcoat.2011.04.078
   Sheikh FA, 2010, J CERAM PROCESS RES, V11, P685
   Shi XG, 2015, RSC ADV, V5, P34237, DOI 10.1039/c5ra00804b
   Shi ZL, 2008, J BIOMED MATER RES A, V86A, P865, DOI 10.1002/jbm.a.31648
   Shi ZL, 2009, BIOMACROMOLECULES, V10, P1603, DOI 10.1021/bm900203w
   Shi ZL, 2009, TISSUE ENG PT A, V15, P417, DOI 10.1089/ten.tea.2007.0415
   Shibata Y, 2010, BIOMATERIALS, V31, P8546, DOI 10.1016/j.biomaterials.2010.07.098
   Shirai T, 2011, ACTA BIOMATER, V7, P1928, DOI 10.1016/j.actbio.2010.11.036
   Shtansky DV, 2013, APPL SURF SCI, V285, P331, DOI 10.1016/j.apsusc.2013.07.169
   Shtansky DV, 2010, SURF COAT TECH, V205, P728, DOI 10.1016/j.surfcoat.2010.07.063
   Simchi A, 2011, NANOMED-NANOTECHNOL, V7, P22, DOI 10.1016/j.nano.2010.10.005
   Song DH, 2012, MATER RES BULL, V47, P2994, DOI 10.1016/j.materresbull.2012.04.085
   Song DH, 2011, THIN SOLID FILMS, V519, P7079, DOI 10.1016/j.tsf.2011.01.385
   Song WH, 2009, J BIOMED MATER RES A, V88A, P246, DOI 10.1002/jbm.a.31877
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1
   Subramani K, 2009, INT J ORAL MAX IMPL, V24, P616
   Suketa N, 2005, CLIN IMPLANT DENT R, V7, P105, DOI 10.1111/j.1708-8208.2005.tb00053.x
   Suzuki H, 2007, ENVIRON SCI TECHNOL, V41, P3018, DOI 10.1021/es0625632
   Tanaka Y, 2010, J BIOMED MATER RES A, V95A, P1105, DOI 10.1002/jbm.a.32932
   Teng F, 2014, BIOSCI TRENDS, V8, P260, DOI 10.5582/bst.2014.01035
   Teughels W, 2006, CLIN ORAL IMPLAN RES, V17, P68, DOI 10.1111/j.1600-0501.2006.01353.x
   Tian XH, 2013, INT J NANOMED, V8, P2129, DOI [10.2147/IJN.S47488, 10.2147/IJN.S45742]
   Torrecillas R, 2009, J NANOMATER
   Tsai MT, 2013, THIN SOLID FILMS, V528, P143, DOI 10.1016/j.tsf.2012.05.093
   Tu JJ, 2012, J MATER SCI-MATER M, V23, P2413, DOI 10.1007/s10856-012-4692-5
   Unosson E, 2015, ACTA BIOMATER, V11, P503, DOI 10.1016/j.actbio.2014.09.048
   Vargas-Reus MA, 2012, INT J ANTIMICROB AG, V40, P135, DOI 10.1016/j.ijantimicag.2012.04.012
   Variola F, 2011, NANOSCALE, V3, P335, DOI 10.1039/c0nr00485e
   Vogel K, 2015, SURF INNOV, V3, P27, DOI 10.1680/si.14.00002
   Westas E, 2014, J BIOMED MATER RES A, V102, P1063, DOI 10.1002/jbm.a.34757
   Wiglusz RJ, 2012, J BIOMED NANOTECHNOL, V8, P605, DOI 10.1166/jbn.2012.1424
   Winkel A, 2015, INT J MOL SCI, V16, P4327, DOI 10.3390/ijms16024327
   Wu YY, 2015, SURF COAT TECH, V272, P337, DOI 10.1016/j.surfcoat.2015.03.045
   Yao XH, 2014, APPL SURF SCI, V292, P944, DOI 10.1016/j.apsusc.2013.12.083
   Yeo IS, 2012, INT J ARTIF ORGANS, V35, P762, DOI 10.5301/ijao.5000154
   Yoshinari M, 2000, J BIOMED MATER RES, V52, P388, DOI 10.1002/1097-4636(200011)52:2<388::AID-JBM20>3.0.CO;2-E
   Yoshinari M, 2001, BIOMATERIALS, V22, P2043, DOI 10.1016/S0142-9612(00)00392-6
   Yoshinari M, 2001, BIOMATERIALS, V22, P709, DOI 10.1016/S0142-9612(00)00234-9
   Yoshinari M, 2010, BIOFOULING, V26, P103, DOI 10.1080/08927010903216572
   Yu WQ, 2011, J BIOMED MATER RES B, V99B, P207, DOI 10.1002/jbm.b.31888
   Yucesoy DT, 2015, JOM-US, V67, P754, DOI 10.1007/s11837-015-1350-7
   Yue CX, 2009, SCI CHINA SER E, V52, P2269, DOI 10.1007/s11431-009-0223-0
   ZEYA HI, 1963, SCIENCE, V142, P1085, DOI 10.1126/science.142.3595.1085
   Zhang BGX, 2014, INT J MOL SCI, V15, P11878, DOI 10.3390/ijms150711878
   Zhao BH, 2013, SURF COAT TECH, V228, pS428, DOI 10.1016/j.surfcoat.2012.05.037
   Zhao B, 2014, DENT MATER, V30, P716, DOI 10.1016/j.dental.2014.04.001
   Zhao LZ, 2011, BIOMATERIALS, V32, P5706, DOI 10.1016/j.biomaterials.2011.04.040
   Zhao XB, 2015, J THERM SPRAY TECHN, V24, P401, DOI 10.1007/s11666-014-0179-x
   Zheng XB, 2007, MATER SCI FORUM, V544-545, P841, DOI 10.4028/www.scientific.net/MSF.544-545.841
   Zheng YH, 2012, ADV MATER RES-SWITZ, V586, P39, DOI 10.4028/www.scientific.net/AMR.586.39
   Zhou L, 2015, COLLOID SURFACE B, V128, P552, DOI 10.1016/j.colsurfb.2015.03.008
   Zhu ZY, 2009, MATER SCI FORUM, V620-622, P307, DOI 10.4028/www.scientific.net/MSF.620-622.307
NR 181
TC 7
Z9 7
U1 3
U2 66
PU JAPANESE SOC DENTAL MATERIALS DEVICES
PI TOKYO
PA C/O KOKU HOKEN KYOKAI, 1-43-9 KOMAGOME TS BDG, KOMAGOME, TOSHIMA-KU,
   TOKYO, 170-0003, JAPAN
SN 0287-4547
J9 DENT MATER J
JI Dent. Mater. J.
PD AUG
PY 2016
VL 35
IS 4
BP 545
EP 558
DI 10.4012/dmj.2015-314
PG 14
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA DW8RF
UT WOS:000383922500001
PM 27477219
OA Bronze
DA 2018-10-20
ER

PT J
AU Baghbani, F
   Moztarzadeh, F
   Mozafari, M
   Raz, M
   Rezvani, H
AF Baghbani, Fatemeh
   Moztarzadeh, Fathollah
   Mozafari, Masoud
   Raz, Majid
   Rezvani, Hamideh
TI Production and Characterization of a Ag- and Zn-Doped Glass-Ceramic
   Material and In Vitro Evaluation of Its Biological Effects
SO JOURNAL OF MATERIALS ENGINEERING AND PERFORMANCE
LA English
DT Article; Proceedings Paper
CT International Symposium on Metal-Matrix Composites as part of the
   European Congress on Advanced Materials and Processes (EUROMAT)
CY SEP 20-24, 2015
CL Warsaw, POLAND
SP Federat European Mat Soc
DE antibacterial/antifungal activity; bioactivity; dental biomaterial;
   modified bioactive glass; silver; zinc
ID SILVER IONS; BIOACTIVE GLASS; CELLS; ZINC; MAGNESIUM; SURFACE;
   HYDROXYAPATITES; BIOMATERIALS; MEMBRANE; IMPLANTS
AB Bioactive glasses in the system SiO2-CaO-Na2O-P2O5-MgO with different amounts of zinc (Zn) and silver (Ag) were synthesized by the sol-gel technique and characterized. The bioactivity was studied during in vitro assays: the ability of hydroxycarbonate apatite (HCA) layer to form on the glass surface was examined after contact with simulated body fluid (SBF). The x-ray diffraction, Fourier transform infrared spectroscopy, scanning electron microscopy, and inductively coupled plasma atomic emission spectrometry (ICP) studies were performed after immersion in vitro assays. Also, the antibacterial and antifungal activities of glass samples against Pseudomonas aeruginosa (ATCC 27853), E. coli (ATCC 25922), and Candida albicans were measured by the halo zone test. Introduction of zinc and silver as the trace elements induces several modifications on the observed phenomena at the glass surface and in SBF solution after immersion of the samples. The chemical durability of the glasses, the formation of the silica-rich layer, and the crystallization of the HCA layer were affected. Samples with the higher content of zinc and silver exhibited an excellent antibacterial/antifungal activity.
C1 [Baghbani, Fatemeh; Moztarzadeh, Fathollah; Mozafari, Masoud; Raz, Majid; Rezvani, Hamideh] Amirkabir Univ Technol, Fac Biomed Engn, Biomat Grp, Ctr Excellence, POB 15875-4413, Tehran, Iran.
   [Mozafari, Masoud] Oklahoma State Univ, Sch Mat Sci & Engn, Helmerich Adv Technol Res Ctr, Stillwater, OK 74106 USA.
RP Baghbani, F (reprint author), Amirkabir Univ Technol, Fac Biomed Engn, Biomat Grp, Ctr Excellence, POB 15875-4413, Tehran, Iran.
EM f.baghbani@aut.ac.ir
OI Mozafari, Masoud/0000-0002-0232-352X
CR Aina V, 2009, ACTA BIOMATER, V5, P1211, DOI 10.1016/j.actbio.2008.10.020
   Balamurugan A, 2007, ACTA BIOMATER, V3, P255, DOI 10.1016/j.actbio.2006.09.005
   Baxter L. C., 2002, European Cells & Materials, V4, P1
   BETTGER WJ, 1993, J NUTR BIOCHEM, V4, P194, DOI 10.1016/0955-2863(93)90052-X
   BIGI A, 1993, J INORG BIOCHEM, V49, P69, DOI 10.1016/0162-0134(93)80049-F
   Caleb O., 2006, OHIO RES CLIN REV, V15, P1
   Cao HL, 2010, WIRES NANOMED NANOBI, V2, P670, DOI 10.1002/wnan.113
   Carta D, 2007, J NON-CRYST SOLIDS, V353, P1141, DOI 10.1016/j.jnoncrysol.2006.12.093
   Delben JRJ, 2009, J THERM ANAL CALORIM, V97, P433, DOI 10.1007/s10973-009-0086-4
   Dietrich E, 2008, APPL SURF SCI, V255, P391, DOI 10.1016/j.apsusc.2008.06.094
   Ducy P, 1998, CURR OPIN CELL BIOL, V10, P614, DOI 10.1016/S0955-0674(98)80037-9
   Efrima S, 1998, J PHYS CHEM B, V102, P5947, DOI 10.1021/jp9813903
   Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3
   Gulati K, 2015, J MATER CHEM B, V3, P2553, DOI 10.1039/c4tb01882f
   Gutowska I, 2005, J BIOMED MATER RES A, V75A, P788, DOI 10.1002/jbm.a.30511
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Jallot E, 2005, COLLOID SURFACE B, V42, P205, DOI 10.1016/j.colsurfb.2005.03.001
   Jallot E, 1999, EUR PHYS J-APPL PHYS, V6, P205, DOI 10.1051/epjap:1999172
   Jallot E.J., J ADV MAT IN PRESS
   Jankauskaite V, 2014, MATER SCI-MEDZG, V20, P42, DOI 10.5755/j01.ms.20.1.4397
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Liau SY, 1997, LETT APPL MICROBIOL, V25, P279, DOI 10.1046/j.1472-765X.1997.00219.x
   Liu HR, 2008, J NON-CRYST SOLIDS, V354, P1314, DOI 10.1016/j.jnoncrysol.2007.02.098
   Mayer I, 2000, J CRYST GROWTH, V219, P98, DOI 10.1016/S0022-0248(00)00608-4
   Memarzadeh K, 2015, J BIOMED MATER RES A, V103, P981, DOI 10.1002/jbm.a.35241
   Montjovent MO, 2004, BONE, V35, P1323, DOI 10.1016/j.bone.2004.07.001
   Nunzio S. D., 2004, J EUR CERAM SOC, V24, P2935
   Ohtani A., 1997, VARIOUS ANTIBACTERIA, p[1, 25, 107, 163]
   Oki A, 2004, J BIOMED MATER RES A, V69A, P216, DOI 10.1002/jbm.a.20070
   Okuma T, 2001, NUTRITION, V17, P679, DOI 10.1016/S0899-9007(01)00551-2
   Oudadesse H, 2004, J RADIOANAL NUCL CH, V262, P479, DOI 10.1023/B:JRNC.0000046781.15503.eb
   PAJAMAKI KJJ, 1995, J MATER SCI-MATER M, V6, P14, DOI 10.1007/BF00121240
   Popat KC, 2005, BIOMATERIALS, V26, P4516, DOI 10.1016/j.biomaterials.2004.11.026
   Russell FM, 2006, J CLIN MICROBIOL, V44, P3346, DOI 10.1128/JCM.02631-05
   Saravanapavan P, 2003, J BIOMED MATER RES A, V66A, P110, DOI 10.1002/jbm.a.10532
   SOLIOZ M, 1995, J BIOL CHEM, V270, P9217, DOI 10.1074/jbc.270.16.9217
   Thirumurugan G, 2012, ANTIMICROBIAL AGENTS, P407
   WELLS TNC, 1995, BIOCHEMISTRY-US, V34, P7896, DOI 10.1021/bi00024a014
   Wu F, 2014, ACS APPL MATER INTER, V6, P10005, DOI 10.1021/am502537k
   Zreiqat H, 2002, J BIOMED MATER RES, V62, P175, DOI 10.1002/jbm.10270
NR 43
TC 1
Z9 1
U1 2
U2 14
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1059-9495
EI 1544-1024
J9 J MATER ENG PERFORM
JI J. Mater. Eng. Perform.
PD AUG
PY 2016
VL 25
IS 8
SI SI
BP 3398
EP 3408
DI 10.1007/s11665-016-2156-7
PG 11
WC Materials Science, Multidisciplinary
SC Materials Science
GA DU3WU
UT WOS:000382143800041
DA 2018-10-20
ER

PT J
AU Chiarini, A
   Freddi, G
   Liu, DS
   Armato, U
   Dal Pra, I
AF Chiarini, Anna
   Freddi, Giuliano
   Liu, Daisong
   Armato, Ubaldo
   Dal Pra, Ilaria
TI Biocompatible Silk Noil-Based Three-Dimensional Carded-Needled Nonwoven
   Scaffolds Guide the Engineering of Novel Skin Connective Tissue
SO TISSUE ENGINEERING PART A
LA English
DT Review
ID BOMBYX-MORI SILK; CHITOSAN NANOFIBROUS SCAFFOLDS; FIBROIN COMPOSITE
   NANOFIBERS; CERVICAL-CARCINOMA CELLS; IN-VIVO; VASCULAR GRAFTS;
   EXTRACELLULAR-MATRIX; GROWTH-FACTOR; STEM-CELLS; WATER
AB Retracting hypertrophic scars resulting from healed burn wounds heavily impact on the patients' life quality. Biomaterial scaffolds guiding burned-out skin regeneration could suppress or lessen scar retraction. Here we report a novel silk noil-based three-dimensional (3D) nonwoven scaffold produced by carding and needling with no formic acid exposure, which might improve burn healing. Once wetted, it displays human skin-like physical features and a high biocompatibility. Human keratinocyte-like cervical carcinoma C4-I cells seeded onto the carded-needled nonwovens in vitro quickly adhered to them, grew, and actively metabolized glutamine releasing lactate. As on plastic, they released no proinflammatory IL-1, although secreting tumor necrosis factor-alpha, an inducer of the autocrine mitogen amphiregulin in such cells. Once grafted into interscapular subcutaneous tissue of mice, carded-needled nonwovens guided the afresh assembly of a connective tissue enveloping the fibroin microfibers and filling the interposed voids within 3 months. Fibroblasts and a few poly- or mononucleated macrophages populated the engineered tissue. Besides, its extracellular matrix contained thin sparse collagen fibrils and a newly formed vascular network whose endothelin-1-expressing endothelial cells grew first on the fibroin microfibrils and later expanded into the intervening matrix. Remarkably, no infiltrates of inflammatory leukocytes and no packed collagen fibers bundles among fibroin microfibers, no fibrous capsules at the grafts periphery, and hence no foreign body response was obtained at the end of 3 months of observation. Therefore, we posit that silk noil-based 3D carded-needled nonwoven scaffolds are tools for translational medicine studies as they could guide connective tissue regeneration at deep burn wounds averting scar retraction with good functional results.
C1 [Chiarini, Anna; Armato, Ubaldo; Dal Pra, Ilaria] Univ Verona, Sch Med, Human Histol & Embryol Unit, 8 Str Le Grazie, I-37134 Verona, Italy.
   [Freddi, Giuliano] Innovhub SSI Expt Silk Div, Milan, Italy.
   [Liu, Daisong] Third Mil Med Univ, Burns Inst, Chongqing, Peoples R China.
RP Armato, U (reprint author), Univ Verona, Sch Med, Human Histol & Embryol Unit, 8 Str Le Grazie, I-37134 Verona, Italy.
EM uarmato@me.com
OI Chiarini, Anna/0000-0002-6974-7685; DAL PRA, Ilaria
   Pierpaola/0000-0001-5523-4910
CR Albrecht W., 2003, NONWOVEN FABRICS 2, P141
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Arai T, 2003, J APPL POLYM SCI, V89, P324, DOI 10.1002/app.12081
   ARMATO U, 1986, CELL TISSUE RES, V245, P471
   Armato U., 2011, INT J BURNS TRAUMA, V1, P27
   ASAI M, 1955, J PHYS CHEM-US, V59, P322, DOI 10.1021/j150526a011
   Aytemiz D, 2013, ADV HEALTHC MATER, V2, P361, DOI 10.1002/adhm.201200227
   Baker BM, 2009, EXPERT REV MED DEVIC, V6, P515, DOI [10.1586/erd.09.39, 10.1586/ERD.09.39]
   Baker BM, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3192140
   Bancroft J. D., 1994, MANUAL HISTOLOGICAL, p27 and 43
   BHAT NV, 1980, J APPL POLYM SCI, V25, P921, DOI 10.1002/app.1980.070250518
   Bosmans MWG, 2015, J BEHAV MED, V38, P642, DOI 10.1007/s10865-015-9638-1
   Cai ZX, 2010, INT J MOL SCI, V11, P3529, DOI 10.3390/ijms11093529
   Carlson MW, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-117
   Chiarini A, 2012, J PROTEOME RES, V11, P3996, DOI 10.1021/pr3000464
   Craig CL, 2003, COMP BIOCHEM PHYS B, V135, P721, DOI 10.1016/S1096-4959(03)00114-3
   Dal Pra I, 2003, TISSUE ENG, V9, P1113, DOI 10.1089/10763270360728026
   Dal Pra I, 2005, BIOMATERIALS, V26, P1987, DOI 10.1016/j.biomaterials.2004.06.036
   Dal Pra I., 2013, TISSUE ENG, V19, P316
   Dal Pra I, 2006, INT J MOL MED, V18, P241
   Dalal PK, 2010, INDIAN J PLAST SURG, V43, pS136, DOI 10.4103/0970-0358.70731
   EDANA, WHAT AR NONW
   Fan LP, 2011, ADV MATER RES-SWITZ, V160-162, P1165, DOI 10.4028/www.scientific.net/AMR.160-162.1165
   Fukayama T, 2015, ORGANOGENESIS, V11, P137, DOI 10.1080/15476278.2015.1093268
   Gellynck K, 2008, J MATER SCI-MATER M, V19, P3399, DOI 10.1007/s10856-008-3474-6
   Gotoh Y, 1998, J BIOMED MATER RES, V39, P351, DOI 10.1002/(SICI)1097-4636(19980305)39:3<351::AID-JBM2>3.0.CO;2-I
   Gui-Bo Y, 2010, J BIOMED MATER RES A, V93A, P158, DOI 10.1002/jbm.a.32496
   Hafemann B, 1999, BURNS, V25, P373, DOI 10.1016/S0305-4179(98)00162-4
   Halper J, 2014, ADV EXP MED BIOL, V802, P31, DOI 10.1007/978-94-007-7893-1_3
   He JX, 2011, J MATER SCI, V46, P2938, DOI 10.1007/s10853-010-5169-x
   Holzapfel GA, 2000, BIOMECH PREPRINT SER
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a
   Huang JW, 2011, ADV MATER RES-SWITZ, V175-176, P197, DOI 10.4028/www.scientific.net/AMR.175-176.197
   Jackson P., 1995, IMMUNOCYTOCHEMISTRY, P15
   Jeong L, 2006, INT J BIOL MACROMOL, V38, P140, DOI 10.1016/j.ijbiomac.2006.02.009
   Jeong L, 2014, INT J NANOMED, V9, P5277, DOI 10.2147/IJN.S71295
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Kambe Y, 2016, J BIOMED MATER RES A, V104, P82, DOI 10.1002/jbm.a.35543
   Kawahara Y, 2008, J APPL POLYM SCI, V107, P3681, DOI 10.1002/app.27539
   Kawakami M, 2011, BIO-MED MATER ENG, V21, P53, DOI 10.3233/BME-2011-0656
   Kim JW, 2010, MACROMOL RES, V18, P442, DOI 10.1007/s13233-010-0514-0
   Kluge JA, 2010, J MECH BEHAV BIOMED, V3, P538, DOI 10.1016/j.jmbbm.2010.06.008
   KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8
   Kundu B, 2013, ADV DRUG DELIVER REV, V65, P457, DOI 10.1016/j.addr.2012.09.043
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Li LH, 2011, INT J BIOL MACROMOL, V49, P223, DOI 10.1016/j.ijbiomac.2011.04.018
   Li WL, 2011, ADV MATER RES-SWITZ, V175-176, P105, DOI 10.4028/www.scientific.net/AMR.175-176.105
   Liu HF, 2011, BIOMATERIALS, V32, P3784, DOI 10.1016/j.biomaterials.2011.02.002
   LOTZ B, 1979, BIOCHIMIE, V61, P205, DOI 10.1016/S0300-9084(79)80067-X
   MAGOSHI J, 1979, J POLYM SCI POL PHYS, V17, P515, DOI 10.1002/pol.1979.180170315
   Marelli B, 2012, MACROMOL BIOSCI, V12, P1566, DOI 10.1002/mabi.201200195
   Marelli B, 2010, ACTA BIOMATER, V6, P4019, DOI 10.1016/j.actbio.2010.05.008
   Mathews EH, 2014, NUTRITION, V30, P218, DOI 10.1016/j.nut.2013.07.024
   MCKAY ND, 1983, BIOCHIM BIOPHYS ACTA, V762, P198, DOI 10.1016/0167-4889(83)90071-X
   McLean LM, 2015, J MULTIDISCIP HEALTH, V8, P377, DOI 10.2147/JMDH.S89375
   Meinel AJ, 2009, BIOMATERIALS, V30, P3058, DOI 10.1016/j.biomaterials.2009.01.054
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Mhatre M, 2012, SEX TRANSM DIS, V39, P591, DOI 10.1097/OLQ.0b013e318255aeef
   Min BM, 2006, MACROMOL BIOSCI, V6, P285, DOI 10.1002/mabi.200500246
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   Montagna W., 1974, STRUCTURE FUNCTION S
   Mori H, 2000, J Biotechnol, V74, P95
   Nagano A, 2011, ACTA BIOMATER, V7, P1192, DOI 10.1016/j.actbio.2010.10.032
   Park SY, 2010, TISSUE ENG PT A, V16, P1271, DOI [10.1089/ten.tea.2009.0328, 10.1089/ten.TEA.2009.0328]
   Perez-Rigueiro J, 2000, J APPL POLYM SCI, V75, P1270, DOI 10.1002/(SICI)1097-4628(20000307)75:10<1270::AID-APP8>3.3.CO;2-3
   Pinheiro C, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-751
   Roland CL, 2014, CANCER RES, V74, P5301, DOI 10.1158/0008-5472.CAN-14-0319
   Sahoo S, 2010, J BIOMED MATER RES B, V95B, P19, DOI 10.1002/jbm.b.31678
   Schneider A, 2009, ACTA BIOMATER, V5, P2570, DOI 10.1016/j.actbio.2008.12.013
   Sell SA, 2011, J BIOMAT SCI-POLYM E, V22, P1253, DOI 10.1163/092050610X504251
   Sezutsu H, 2007, BIOSCI BIOTECH BIOCH, V71, P2725, DOI 10.1271/bbb.70326
   Soffer L., 2005, J BIOMAT SCI-POLYM E, V19, P653
   Tohyama S, 2016, CELL METAB, V23, P663, DOI 10.1016/j.cmet.2016.03.001
   Wagner W, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0114-x
   Wang CY, 2012, J BIOMAT SCI-POLYM E, V23, P167, DOI 10.1163/092050610X545805
   Wang CY, 2011, ACTA BIOMATER, V7, P634, DOI 10.1016/j.actbio.2010.09.011
   Wang GL, 2011, IN VITRO CELL DEV-AN, V47, P234, DOI 10.1007/s11626-010-9381-4
   Wang SD, 2011, INT J BIOL MACROMOL, V48, P345, DOI 10.1016/j.ijbiomac.2010.12.008
   Wang SD, 2009, BIOMACROMOLECULES, V10, P2240, DOI 10.1021/bm900416b
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Wei K, 2011, J BIOMED MATER RES A, V97A, P272, DOI 10.1002/jbm.a.33054
   Wharram SE, 2010, MACROMOL BIOSCI, V10, P246, DOI 10.1002/mabi.200900274
   WOODWORTH CD, 1995, P NATL ACAD SCI USA, V92, P2840, DOI 10.1073/pnas.92.7.2840
   Yang YM, 2011, TISSUE ENG PT A, V17, P2231, DOI [10.1089/ten.tea.2010.0633, 10.1089/ten.TEA.2010.0633]
   Yeo IS, 2008, BIOMACROMOLECULES, V9, P1106, DOI 10.1021/bm700875a
   Yoo Chae-Kyung, 2016, Maxillofac Plast Reconstr Surg, V38, P17, DOI 10.1186/s40902-016-0062-4
   Yoon H, 2009, MACROMOL RAPID COMM, V30, P1632, DOI 10.1002/marc.200900264
   Zang MQ, 2011, ACTA BIOMATER, V7, P3422, DOI 10.1016/j.actbio.2011.05.012
   Zhang KH, 2011, INT J MOL SCI, V12, P2187, DOI 10.3390/ijms12042187
   Zhang KH, 2011, J BIOMAT SCI-POLYM E, V22, P1069, DOI 10.1163/092050610X498204
   Zhang KH, 2010, J BIOMED MATER RES A, V95A, P870, DOI 10.1002/jbm.a.32895
   Zhang KH, 2010, J BIOMED MATER RES A, V93A, P984, DOI 10.1002/jbm.a.32504
   Zhang KH, 2010, J BIOMED MATER RES A, V93A, P976, DOI 10.1002/jbm.a.32497
   Zhang XH, 2009, ADV DRUG DELIVER REV, V61, P988, DOI 10.1016/j.addr.2009.07.005
   Zhang XH, 2009, BIOMATERIALS, V30, P3213, DOI 10.1016/j.biomaterials.2009.02.002
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
   Zhou JA, 2010, INT J BIOL MACROMOL, V47, P514, DOI 10.1016/j.ijbiomac.2010.07.010
   Zhou JA, 2010, POLYM DEGRAD STABIL, V95, P1679, DOI 10.1016/j.polymdegradstab.2010.05.025
   ZIELKE HR, 1978, J CELL PHYSIOL, V95, P41
NR 105
TC 5
Z9 5
U1 3
U2 30
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD AUG
PY 2016
VL 22
IS 15-16
BP 1047
EP 1060
DI 10.1089/ten.tea.2016.0124
PG 14
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA DW7CY
UT WOS:000383810000007
PM 27411949
DA 2018-10-20
ER

PT J
AU Douglas, TEL
   Dokupil, A
   Reczynska, K
   Brackman, G
   Krok-Borkowicz, M
   Keppler, JK
   Bozic, M
   Van der Voort, P
   Pietryga, K
   Samal, SK
   Balcaen, L
   van den Bulcke, J
   Van Acker, J
   Vanhaecke, F
   Schwarz, K
   Coenye, T
   Pamula, E
AF Douglas, Timothy E. L.
   Dokupil, Agnieszka
   Reczynska, Katarzyna
   Brackman, Gilles
   Krok-Borkowicz, Malgorzata
   Keppler, Julia K.
   Bozic, Mojca
   Van der Voort, Pascal
   Pietryga, Krzysztof
   Samal, Sangram Keshari
   Balcaen, Lieve
   van den Bulcke, Jan
   Van Acker, Joris
   Vanhaecke, Frank
   Schwarz, Karin
   Coenye, Tom
   Pamula, Elzbieta
TI Enrichment of enzymatically mineralized gellan gum hydrogels with
   phlorotannin-rich Ecklonia cava extract Seanol (R) to endow
   antibacterial properties and promote mineralization
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE polyphenol; hydrogel; mineralization; antibacterial; composite
ID BROWN-ALGAE; IN-VITRO; LIGAND-BINDING; BONE; PHOSPHATASE; BIOMATERIAL;
   POLYPHENOLS; BEHAVIOR; CELLS; RAT
AB Hydrogels offer several advantages as biomaterials for bone regeneration, including ease of incorporation of soluble substances such as mineralization-promoting enzymes and antibacterial agents. Mineralization with calcium phosphate (CaP) increases bioactivity, while antibacterial activity reduces the risk of infection. Here, gellan gum (GG) hydrogels were enriched with alkaline phosphatase (ALP) and/or Seanol (R), a seaweed extract rich in phlorotannins (brown algae-derived polyphenols), to induce mineralization with CaP and increase antibacterial activity, respectively. The sample groups were unmineralized hydrogels, denoted as GG, GG/ALP, GG/Seanol and GG/Seanol/ALP, and hydrogels incubated in mineralization medium (0.1 M calcium glycerophosphate), denoted as GG/ALP_min, GG/Seanol_min and GG/Seanol/ALP_min. Seanol (R) enhanced mineralization with CaP and also increased compressive modulus. Seanol (R) and ALP interacted in a non-covalent manner. Release of Seanol (R) occurred in a burst phase and was impeded by ALP-mediated mineralization. Groups GG/Seanol and GG/ALP/Seanol exhibited antibacterial activity against methicillin-resistant Staphylococcus aureus. GG/Seanol/ALP_min, but not GG/Seanol_min, retained some antibacterial activity. Eluates taken from groups GG/ALP_min, GG/Seanol_min and GG/ALP/Seanol_min displayed comparable cytotoxicity towards MG-63 osteoblast-like cells. These results suggest that enrichment of hydrogel biomaterials with phlorotannin-rich extracts is a promising strategy to increase mineralizability and antibacterial activity.
C1 [Douglas, Timothy E. L.] Univ Ghent, Dept Organ Chem, Krijgslaan 281 S4, B-9000 Ghent, Belgium.
   [Dokupil, Agnieszka; Reczynska, Katarzyna; Krok-Borkowicz, Malgorzata; Pietryga, Krzysztof; Pamula, Elzbieta] AGH Univ Sci & Technol, Fac Materials Sci & Ceram, Dept Biomaterials, Al Mickiewicza 30, PL-30059 Krakow, Poland.
   [Brackman, Gilles; Coenye, Tom] Univ Ghent, Lab Pharmaceut Microbiol, Ottergemsesteenweg 460, B-9000 Ghent, Belgium.
   [Keppler, Julia K.; Schwarz, Karin] Univ Kiel, Inst Human Nutr & Food Sci, Dept Food Technol, Heinrich Hecht Pl 10, D-24118 Kiel, Germany.
   [Bozic, Mojca] Univ Maribor, Fac Mech Engn, Inst Engn Mat & Design, Smetanova 17, SI-2000 Maribor, Slovenia.
   [Van der Voort, Pascal] Univ Ghent, COMOC, Dept Inorgan Chem, Krijgslaan 281 S3, B-9000 Ghent, Belgium.
   [Samal, Sangram Keshari] Univ Ghent, Lab Gen Biochem & Phys Pharm, Harelbekestr 72, B-9000 Ghent, Belgium.
   [Samal, Sangram Keshari] Univ Ghent, Ctr Nano & Biophoton, Harelbekestr 72, B-9000 Ghent, Belgium.
   [Balcaen, Lieve; Vanhaecke, Frank] Univ Ghent, Dept Analyt Chem, Krijgslaan 281 S12, B-9000 Ghent, Belgium.
   [van den Bulcke, Jan; Van Acker, Joris] Univ Ghent, Fac Biosci Engn, Dept Forest & Water Management, Lab Wood Technol Woodlab, Coupure Links 653, B-9000 Ghent, Belgium.
   [Douglas, Timothy E. L.] Univ Ghent, Fac Biosci Engn, Dept Mol Biotechol, Nano & Biophoton Grp, Coupure Links 653, B-9000 Ghent, Belgium.
   [Dokupil, Agnieszka] Inst Chem Proc Coal ICHPW, Ul Zamkowa 1, PL-41803 Zabrze, Poland.
RP Douglas, TEL (reprint author), Univ Ghent, Dept Organ Chem, Krijgslaan 281 S4, B-9000 Ghent, Belgium.; Douglas, TEL (reprint author), Univ Ghent, Fac Biosci Engn, Dept Mol Biotechol, Nano & Biophoton Grp, Coupure Links 653, B-9000 Ghent, Belgium.
EM Timothy.Douglas@UGent.be
RI Van Der Voort, Pascal/D-3800-2012
OI Van Der Voort, Pascal/0000-0002-1248-479X; Balcaen,
   Lieve/0000-0002-1800-6932
FU FWO, Belgium
FX TELD acknowledges FWO, Belgium for a postdoctoral fellowship. Trey
   MacPhee, JP Renew Distributors LLC, San Francisco, CA, USA, is thanked
   for providing Seanol (R). Inne Dhondt, Tom Planckaert and Meike Pfeiler
   are thanked for excellent technical assistance. No ethical approval was
   required for this study. The authors have no conflict of interest.
CR Balboa EM, 2013, FOOD CHEM, V138, P1764, DOI 10.1016/j.foodchem.2012.11.026
   BEERTSEN W, 1992, J CLIN INVEST, V89, P1974, DOI 10.1172/JCI115805
   BRUDER SP, 1990, BONE, V11, P133, DOI 10.1016/8756-3282(90)90061-3
   Cerqueira MT, 2014, ACS APPL MATER INTER, V6, P19668, DOI 10.1021/am504520j
   Choi JG, 2010, FOODBORNE PATHOG DIS, V7, P435, DOI 10.1089/fpd.2009.0434
   Dash M, 2015, J TISSUE ENG REGEN M
   Doi Y, 1996, J BIOMED MATER RES, V31, P43, DOI 10.1002/(SICI)1097-4636(199605)31:1<43::AID-JBM6>3.0.CO;2-Q
   Douglas T.E., 2014, J TISSUE ENG REGEN M
   Douglas TEL, 2014, J TISSUE ENG REGEN M, V8, P906, DOI 10.1002/term.1616
   Douglas TEL, 2014, MATER LETT, V128, P79, DOI 10.1016/j.matlet.2014.03.173
   Eom SH, 2012, FOOD CHEM TOXICOL, V50, P3251, DOI 10.1016/j.fct.2012.06.028
   Filmon R, 2000, J BIOMAT SCI-POLYM E, V11, P849, DOI 10.1163/156856200744057
   Fraser JHE, 1996, BONE, V19, P223, DOI 10.1016/8756-3282(96)00177-9
   Gassling V, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/5/055001
   Gkioni K, 2010, TISSUE ENG PART B-RE, V16, P577, DOI [10.1089/ten.teb.2010.0462, 10.1089/ten.TEB.2010.0462]
   Keppler JK, 2015, J MOL RECOGNIT, V28, P656, DOI 10.1002/jmr.2480
   Keppler JK, 2014, BBA-PROTEINS PROTEOM, V1844, P1083, DOI 10.1016/j.bbapap.2014.02.007
   Keppler JK, 2014, FOOD BIOPHYS, V9, P158, DOI 10.1007/s11483-013-9328-x
   Khang G, 2015, J TISSUE ENG REGEN M, V9, P265, DOI 10.1002/term.1625
   Kim M, 2012, CARBOHYD POLYM, V90, P592, DOI 10.1016/j.carbpol.2012.05.082
   Koutsopoulos S, 2002, J BIOMED MATER RES, V62, P600, DOI 10.1002/jbm.10280
   Li YX, 2011, PROCESS BIOCHEM, V46, P2219, DOI 10.1016/j.procbio.2011.09.015
   Lopes G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031145
   Mody N, 2001, FREE RADICAL BIO MED, V31, P509, DOI 10.1016/S0891-5849(01)00610-4
   MURDIATI TB, 1991, J APPL TOXICOL, V11, P333, DOI 10.1002/jat.2550110506
   Oliveira JT, 2010, J BIOMED MATER RES A, V93A, P852, DOI 10.1002/jbm.a.32574
   PLESHKO N, 1991, BIOPHYS J, V60, P786, DOI 10.1016/S0006-3495(91)82113-0
   RAGAN MA, 1979, MAR CHEM, V7, P265, DOI 10.1016/0304-4203(79)90043-4
   Rowen R J, 2008, TOWNSEND LETT    FEB, P80
   Spoerke ED, 2009, ADV MATER, V21, P425, DOI 10.1002/adma.200802242
   Stern JL, 1996, J CHEM ECOL, V22, P1877, DOI 10.1007/BF02028510
   Sujatha D, 2015, INT BRAZ J UROL, V41, P511, DOI 10.1590/S1677-5538.IBJU.2014.0357
   Suzawa Y, 2010, J BIOMED MATER RES A, V93A, P965, DOI 10.1002/jbm.a.32518
   van de Weert M, 2010, J FLUORESC, V20, P625, DOI 10.1007/s10895-009-0572-x
   Waterhouse A. L., 2001, CURRENT PROTOCOLS FO
   Yamauchi K, 2004, BIOMATERIALS, V25, P5481, DOI 10.1016/j.biomaterials.2003.12.057
   Yeo M, 2012, J MATER CHEM, V22, P3568, DOI 10.1039/c2jm14725d
NR 37
TC 9
Z9 9
U1 5
U2 19
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD AUG
PY 2016
VL 11
IS 4
AR 045015
DI 10.1088/1748-6041/11/4/045015
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DV9UV
UT WOS:000383288600016
PM 27509486
DA 2018-10-20
ER

PT J
AU Przekora, A
   Benko, A
   Blazewicz, M
   Ginalska, G
AF Przekora, Agata
   Benko, Aleksandra
   Blazewicz, Marta
   Ginalska, Grazyna
TI Hybrid chitosan/beta-1,3-glucan matrix of bone scaffold enhances
   osteoblast adhesion, spreading and proliferation via promotion of serum
   protein adsorption
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE curdlan; osteoblast spreading; MC3T3-E1 cells; FTIR-ATR; water contact
   angle; surface energy
ID CHITOSAN-BASED COMPOSITES; CELL ATTACHMENT; FIBRONECTIN; CURDLAN;
   CHITIN; CONFORMATION; RECOGNITION; CHEMISTRY; SURFACES; GROWTH
AB Initial protein adsorption to the material surface is crucial for osteoblast adhesion, survival, and rapid proliferation resulting in intensive new bone formation. The aim of this study was to demonstrate that modification of a chitosan matrix of chitosan/hydroxyapatite (chit/HA) biomaterial for bone tissue engineering applications with linear beta-1,3-glucan (curdlan) leads to promotion of serum protein adsorption to the resultant scaffold (chit/glu/HA) and thus in enhancement of osteoblast adhesion, spreading and proliferation. Fabricated biomaterials were pre-adsorbed with different protein solutions and then protein adsorption and osteoblast behavior on the scaffolds were compared. Moreover, surface chemical composition, wettability and surface energy of biomaterials were compared. Modification of the chitosan matrix with beta-1,3-glucan introduces a greater polarpart in the resultant chitosan/beta-1,3-glucan matrix presumably resulting from more OH groups within the curdlan structure. Moreover, FTIR-ATR results suggest that there might be some sort of chemical interaction between the NH group of chitosan and the OH group of beta-1,3-glucan. As a consequence, the chit/glu/HA scaffold adsorbs significantly more adhesion proteins that are crucial for osteoblasts compared to the chit/HA material, providing a higher density culture of well-spread osteoblasts on its surface. Obtained results revealed that not only is chit/glu/HA biomaterial a promising scaffold for bone tissue engineering applications, but the specific polysaccharide chit/glu matrix itself is promising for use in the biomedical material field to modify various biomaterials in order to enhance osteoblast adhesion and proliferation on their surfaces.
C1 [Przekora, Agata; Ginalska, Grazyna] Med Univ Lublin, Dept Biochem & Biotechnol, Chodzki 1 St, PL-20093 Lublin, Poland.
   [Benko, Aleksandra; Blazewicz, Marta] AGH Univ Sci & Technol, Fac Mat Sci & Ceram, A Mickiewicza 30 Ave, PL-30059 Krakow, Poland.
RP Przekora, A (reprint author), Med Univ Lublin, Dept Biochem & Biotechnol, Chodzki 1 St, PL-20093 Lublin, Poland.
EM agata.przekora@umlub.pl
RI Benko, Aleksandra/S-9310-2017
OI Benko, Aleksandra/0000-0001-7474-3374; Przekora-Kusmierz,
   Agata/0000-0002-6076-1309
FU Ministry of Science and Higher Education in Poland within Medical
   University of Lublin [MNmb2/16, DS2/15]
FX The authors have no conflicts of interest to declare. Financial
   assistance was provided by Ministry of Science and Higher Education in
   Poland within MNmb2/16 and DS2/15 projects of Medical University of
   Lublin. The paper was developed using the equipment purchased within the
   agreement No. POPW.01.03.00-06-010/09-00 Operational Programme
   Development of Eastern Poland 2007-2013, Priority Axis I, Modern
   Economy, Operations 1.3. Innovations Promotion.
CR Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6
   Brevig T, 2005, BIOMATERIALS, V26, P3039, DOI 10.1016/j.biomaterials.2004.09.006
   Brugnerotto J, 2001, POLYMER, V42, P3569, DOI 10.1016/S0032-3861(00)00713-8
   Burmeister JS, 1996, J BIOMED MATER RES, V30, P13, DOI 10.1002/(SICI)1097-4636(199601)30:1<13::AID-JBM3>3.0.CO;2-U
   Cardenas G, 2004, J APPL POLYM SCI, V93, P1876, DOI 10.1002/app.20647
   Chang H.-I., 2011, REGENERATIVE MED TIS, DOI DOI 10.5772/21983
   Daraghmeh N H, 2011, EXCIPIENTS RELATED M, P35
   Ercan B, 2008, NANOTECHNOLOGY TISSU, P151
   Jin HH, 2012, INT J BIOL MACROMOL, V51, P1079, DOI 10.1016/j.ijbiomac.2012.08.027
   Jin Y, 2006, CARBOHYD RES, V341, P90, DOI [10.1016/j.carres.2005.11.003, 10.1016/j.carres.2006.04.005]
   Kalyanasundaram GT, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-31
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Kim E.S., 2001, FIBER POLYM, V2, P64
   Kumirska J, 2010, MAR DRUGS, V8, P1567, DOI 10.3390/md8051567
   Le X., 2013, INT J BIOMATER, V2013
   Lebaron RG, 2000, TISSUE ENG, V6, P85, DOI 10.1089/107632700320720
   LEE JH, 1994, BIOMATERIALS, V15, P705, DOI 10.1016/0142-9612(94)90169-4
   Myung SW, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.11RB01
   Nilsen-Nygaard J, 2015, POLYMERS-BASEL, V7, P552, DOI 10.3390/polym7030552
   Przekora A, 2015, BIOMED MATER, V10, DOI 10.1088/1748-6041/10/1/015009
   Przekora A, 2016, MAT SCI ENG C-MATER, V61, P355, DOI 10.1016/j.msec.2015.12.066
   Przekora A, 2016, MAT SCI ENG C-MATER, V58, P891, DOI 10.1016/j.msec.2015.09.046
   Przekora A, 2014, INT J BIOL MACROMOL, V70, P474, DOI 10.1016/j.ijbiomac.2014.07.035
   Przekora A, 2014, J BIOTECHNOL, V182, P46, DOI 10.1016/j.jbiotec.2014.04.022
   Przekora A, 2014, CENT EUR J BIOL, V9, P634, DOI 10.2478/s11535-014-0297-y
   Ramya R, 2012, INT J SCI RES PUBL, V2, P55
   Rintoul L, 2007, J MATER SCI-MATER M, V18, P1701, DOI 10.1007/s10856-007-3052-3
   Rivera-Chacon DM, 2013, J BIOMED NANOTECHNOL, V9, P1092, DOI 10.1166/jbn.2013.1601
   Rudawska A, 2009, INT J ADHES ADHES, V29, P451, DOI 10.1016/j.ijadhadh.2008.09.008
   Ruoslahti E, 1991, CELL BIOL EXTRACELLU, P346
   Salakhutdinov I, 2008, J NANOMATER, DOI 10.1155/2008/543170
   Schwartz J, 2003, MAT SCI ENG C-BIO S, V23, P395, DOI 10.1016/S0928-4931(02)00310-7
   Scotchford CA, 2002, J BIOMED MATER RES, V59, P84, DOI 10.1002/jbm.1220
   Silva SML, 2012, INFRARED SPECTROSCOPY - MATERIALS SCIENCE, ENGINEERING AND TECHNOLOGY, P43
   Sousa SR, 2008, J BIOMED MATER RES A, V84A, P281, DOI 10.1002/jbm.a.31201
   Sun Y, 2011, CARBOHYD POLYM, V84, P952, DOI 10.1016/j.carbpol.2010.12.055
   Synytsya A, 2014, ANN TRANSL MED, V2
   Tang LP, 2000, BIOMATERIALS ENGINEERING AND DEVICES: HUMAN APPLICATIONS, VOL 1, P3
   TASHIRO K, 1991, J CELL PHYSIOL, V146, P451, DOI 10.1002/jcp.1041460316
   Thakhiew W, 2015, J FOOD ENG, V158, P66, DOI 10.1016/j.jfoodeng.2015.02.027
   Tukulula M, 2015, PHARM RES-DORDR, V32, P2713, DOI 10.1007/s11095-015-1655-9
   Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098
   YAMADA KM, 1991, J BIOL CHEM, V266, P12809
   Zakaria Z, 2012, BIORESOURCES, V7, P5568
   Zhang RR, 2014, BIOMACROMOLECULES, V15, P1079, DOI 10.1021/bm500038g
NR 45
TC 4
Z9 4
U1 6
U2 21
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD AUG
PY 2016
VL 11
IS 4
AR 045001
DI 10.1088/1748-6041/11/4/045001
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DV9UV
UT WOS:000383288600002
PM 27388048
DA 2018-10-20
ER

PT J
AU Xiong, ZC
   Zhu, YJ
   Chen, FF
   Sun, TW
   Shen, YQ
AF Xiong, Zhi-Chao
   Zhu, Ying-Jie
   Chen, Fei-Fei
   Sun, Tuan-Wei
   Shen, Yue-Qin
TI One-Step Synthesis of Silver Nanoparticle-Decorated Hydroxyapatite
   Nanowires for the Construction of Highly Flexible Free-Standing Paper
   with High Antibacterial Activity
SO CHEMISTRY-A EUROPEAN JOURNAL
LA English
DT Article
DE free-standing paper; hydroxyapatite; nanoparticles; nanowires; silver
ID MICROWAVE-HYDROTHERMAL SYNTHESIS; DRUG-DELIVERY; BACTERIAL-INFECTIONS;
   PROTEIN ADSORPTION; PHOSPHATE; NANOCOMPOSITES; BIOMATERIALS; NANORODS;
   THERAPY; RELEASE
AB A highly flexible and free-standing paper with high antibacterial activity made from silver nanoparticle (AgNP)-decorated ultralong hydroxyapatite nanowires (HAPNWs) is reported. The HAPNWs@ AgNPs nanocomposites were obtained from a facile one-step solvothermal process and utilized for the construction of highly flexible and free-standing inorganic paper through a simple vacuum-filtration procedure. The structure and properties of the HAPNWs@ AgNPs paper were characterized in detail. Scanning electron microscope (SEM) and transmission electron microscope (TEM) micrographs show that AgNPs are highly dispersed and stabilized in the nanocomposite and exhibit a narrow particle size distribution. The effects of the concentration of silver nitrate, solvothermal temperature and time on the product were systematically investigated. This method is simple, convenient and reproducible. The as-prepared HAPNWs@ AgNPs paper shows long-time sustained silver-ion release, high antibacterial activity against both Gram-negative and Gram-positive bacteria, and good biocompatibility. Overall, this work provides a novel pathway for the preparation of a new type of highly flexible, freestanding and antibacterial inorganic paper made from silver nanoparticle-decorated hydroxyapatite nanowires for various applications, as a promising functional biomaterial.
C1 [Xiong, Zhi-Chao; Zhu, Ying-Jie; Chen, Fei-Fei; Sun, Tuan-Wei; Shen, Yue-Qin] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
RP Zhu, YJ (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
EM y.j.zhu@mail.sic.ac.cn
FU Science and Technology Commission of Shanghai [15JC1491001]; Shanghai
   Sailing Program [16YF1413000]
FX Financial support from the Science and Technology Commission of Shanghai
   (15JC1491001), and the Shanghai Sailing Program (16YF1413000) is
   gratefully acknowledged.
CR Cason JP, 2000, IND ENG CHEM RES, V39, P4749, DOI 10.1021/ie000147z
   Chaloupka K, 2010, TRENDS BIOTECHNOL, V28, P580, DOI 10.1016/j.tibtech.2010.07.006
   Chen CP, 2012, ADV FUNCT MATER, V22, P780, DOI 10.1002/adfm.201102333
   Chen F, 2015, RSC ADV, V5
   Chen F, 2014, CURR NANOSCI, V10, P465, DOI 10.2174/1573413710666140319233658
   Chen F, 2011, BIOMATERIALS, V32, P9031, DOI 10.1016/j.biomaterials.2011.08.032
   Chen GY, 2016, CHEM REV, V116, P2826, DOI 10.1021/acs.chemrev.5b00148
   Chen W, 2006, BIOMATERIALS, V27, P5512, DOI 10.1016/j.biomaterials.2006.07.003
   Chen WY, 2015, ADV FUNCT MATER, V25, P7189, DOI 10.1002/adfm.201503248
   Chen X, 2016, DALTON T, V45, P1648, DOI 10.1039/c5dt03357h
   Chen X, 2012, MATER LETT, V89, P233, DOI 10.1016/j.matlet.2012.08.115
   Dankovich TA, 2011, ENVIRON SCI TECHNOL, V45, P1992, DOI 10.1021/es103302t
   Eshed M, 2014, ADV FUNCT MATER, V24, P1382, DOI 10.1002/adfm.201302425
   Fu FY, 2015, ACS APPL MATER INTER, V7, P2597, DOI 10.1021/am507639b
   Hancock REW, 2012, NAT REV MICROBIOL, V10, P243, DOI 10.1038/nrmicro2745
   Hao XH, 2015, ACS NANO, V9, P9614, DOI 10.1021/nn507485j
   Hou ZY, 2009, CHEM-EUR J, V15, P6973, DOI 10.1002/chem.200900269
   Jiang YY, 2015, CERAM INT, V41, P6098, DOI 10.1016/j.ceramint.2014.12.122
   Jin GD, 2014, BIOMATERIALS, V35, P7699, DOI 10.1016/j.biomaterials.2014.05.074
   Kumar A, 2008, NAT MATER, V7, P236, DOI 10.1038/nmat2099
   Kumar R, 2005, BIOMATERIALS, V26, P2081, DOI 10.1016/j.biomaterials.2004.05.030
   Lee JS, 2013, ADV MATER, V25, P1173, DOI 10.1002/adma.201203370
   Li JH, 2014, SCI REP-UK, V4, DOI 10.1038/srep04359
   Li ZZ, 2011, J HAZARD MATER, V187, P466, DOI 10.1016/j.jhazmat.2011.01.050
   Lok CN, 2006, J PROTEOME RES, V5, P916, DOI 10.1021/pr0504079
   Lu BQ, 2014, CHEM-EUR J, V20, P1242, DOI 10.1002/chem.201304439
   Lv M, 2010, ADV MATER, V22, P5463, DOI 10.1002/adma.201001934
   Miller KP, 2015, CHEM SOC REV, V44, P7787, DOI 10.1039/c5cs00041f
   Palmer LC, 2008, CHEM REV, V108, P4754, DOI 10.1021/cr8004422
   Panacek A, 2006, J PHYS CHEM B, V110, P16248, DOI 10.1021/jp063826h
   Pinto RJB, 2009, ACTA BIOMATER, V5, P2279, DOI 10.1016/j.actbio.2009.02.003
   Qi C, 2013, CHEM-EUR J, V19, P5332, DOI 10.1002/chem.201203886
   Qi C, 2012, J MATER CHEM, V22, P22642, DOI 10.1039/c2jm35280j
   SHOCKMAN GD, 1983, ANNU REV MICROBIOL, V37, P501, DOI 10.1146/annurev.mi.37.100183.002441
   Tian TF, 2014, ACS APPL MATER INTER, V6, P8542, DOI 10.1021/am5022914
   Venkatesan J, 2014, J BIOMED NANOTECHNOL, V10, P3124, DOI 10.1166/jbn.2014.1893
   Wang RB, 2012, J MATER CHEM, V22, P15227, DOI 10.1039/c2jm00122e
   Wang X, 2005, NATURE, V437, P121, DOI 10.1038/nature03968
   Wigginton NS, 2010, ENVIRON SCI TECHNOL, V44, P2163, DOI 10.1021/es903187s
   Xiao W, 2013, J MATER CHEM B, V1, P3477, DOI 10.1039/c3tb20303d
   Xu ZQ, 2014, EXPERT OPIN INV DRUG, V23, P163, DOI 10.1517/13543784.2014.848853
   Yang H, 2012, J MATER CHEM, V22, P24132, DOI 10.1039/c2jm35621j
   Yu L, 2014, SCI REP-UK, V4, DOI 10.1038/srep04551
   Zhang JY, 2012, IND ENG CHEM RES, V51, P3081, DOI 10.1021/ie202473u
   Zhang QM, 2014, MACROMOLECULES, V47, P8018, DOI 10.1021/ma501997x
   Zhang YG, 2015, MATER LETT, V144, P135, DOI 10.1016/j.matlet.2015.01.031
NR 46
TC 23
Z9 23
U1 6
U2 68
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 0947-6539
EI 1521-3765
J9 CHEM-EUR J
JI Chem.-Eur. J.
PD AUG 1
PY 2016
VL 22
IS 32
BP 11224
EP 11231
DI 10.1002/chem.201601438
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA DV4TS
UT WOS:000382918700020
PM 27347666
DA 2018-10-20
ER

PT J
AU Koshy, ST
   Mooney, DJ
AF Koshy, Sandeep T.
   Mooney, David J.
TI Biomaterials for enhancing anti-cancer immunity
SO CURRENT OPINION IN BIOTECHNOLOGY
LA English
DT Review
ID LYMPH-NODE; CANCER VACCINES; IN-VIVO; SYNTHETIC NANOPARTICLES; LOCALIZED
   IMMUNOTHERAPY; TUMOR MICROENVIRONMENT; ANTITUMOR IMMUNITY;
   DELIVERY-SYSTEMS; DENDRITIC CELLS; SCAFFOLDS
AB Cancer immunotherapy is becoming a standard approach to treat many cancers. However, shortcomings of current methods limit therapeutic benefit in many patients. Rationally designed biomaterial strategies to deliver immune modulatory drugs can potentially show improved safety profiles, while providing multifunctional and spatiotemporally controlled signals to immune cells to improve their anticancer activity. This brief review describes biomaterialsbased strategies that enhance immune cell function at various tissue sites to improve anti-cancer immunity. Continued collaboration between bioengineers, immunologists, industry, and clinicians is required for biomaterial-based immunotherapy strategies to continue moving to the clinic.
C1 [Koshy, Sandeep T.; Mooney, David J.] Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
   [Koshy, Sandeep T.; Mooney, David J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.
   [Koshy, Sandeep T.] Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
RP Mooney, DJ (reprint author), Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA.; Mooney, DJ (reprint author), Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.
EM mooneyd@seas.harvard.edu
FU NIH [R01 EB015498]; HHMI ISRF
FX The authors acknowledge funding from NIH R01 EB015498 to DJM and an HHMI
   ISRF to STK, and thank Rajiv Desai and Alexander Cheung for their
   helpful comments on the manuscript.
CR Ali OA, 2014, CANCER RES, V74, P1670, DOI 10.1158/0008-5472.CAN-13-0777
   Ali OA, 2013, ADV FUNCT MATER, V23, P4621, DOI 10.1002/adfm.201203859
   Ali OA, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000359
   Ali OA, 2009, NAT MATER, V8, P151, DOI [10.1038/NMAT2357, 10.1038/nmat2357]
   Barrett DM, 2014, ANNU REV MED, V65, P333, DOI 10.1146/annurev-med-060512-150254
   Bencherif SA, 2015, NAT COMMUN
   Bencherif SA, 2012, P NATL ACAD SCI USA, V109, P19590, DOI 10.1073/pnas.1211516109
   Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012
   Cheung A.S., 2015, NANO TODAY
   Cruz LJ, 2014, J CONTROL RELEASE, V192, P209, DOI 10.1016/j.jconrel.2014.07.040
   de Titta A, 2013, P NATL ACAD SCI USA, V110, P19902, DOI 10.1073/pnas.1313152110
   Fan YC, 2015, VACCINES, V3, P662, DOI 10.3390/vaccines3030662
   Hanson MC, 2015, J CLIN INVEST, V125, P2532, DOI 10.1172/JCI79915
   Irvine DJ, 2015, CHEM REV, V115, P11109, DOI 10.1021/acs.chemrev.5b00109
   Jeanbart L, 2014, CANCER IMMUNOL RES, V2, P436, DOI 10.1158/2326-6066.CIR-14-0019-T
   Jewell CM, 2011, P NATL ACAD SCI USA, V108, P15745, DOI 10.1073/pnas.1105200108
   John ALS, 2012, NAT MATER, V11, P250, DOI 10.1038/NMAT3222
   Joyce JA, 2015, SCIENCE, V348, P74, DOI 10.1126/science.aaa6204
   Kearney CJ, 2013, NAT MATER, V12, P1004, DOI [10.1038/NMAT3758, 10.1038/nmat3758]
   Kim J, 2015, NAT BIOTECHNOL, V33, P64, DOI 10.1038/nbt.3071
   Koshy ST, 2014, BIOMATERIALS, V35, P2477, DOI 10.1016/j.biomaterials.2013.11.044
   Kwong B, 2013, CANCER RES, V73, P1547, DOI 10.1158/0008-5472.CAN-12-3343
   Kwong B, 2011, BIOMATERIALS, V32, P5134, DOI 10.1016/j.biomaterials.2011.03.067
   Li AV, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006516
   Li Y, 2015, ONCOIMMUNOL
   Liu HP, 2014, NATURE, V507, P519, DOI 10.1038/nature12978
   Liu HP, 2011, ANGEW CHEM INT EDIT, V50, P7052, DOI 10.1002/anie.201101266
   Manolova V, 2008, EUR J IMMUNOL, V38, P1404, DOI 10.1002/eji.200737984
   Mehta NK, 2015, CANCER IMMUNOL RES, V3, P836, DOI 10.1158/2326-6066.CIR-15-0112
   Melief CJM, 2015, J CLIN INVEST, V125, P3401, DOI 10.1172/JCI80009
   Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673
   Moon JJ, 2011, NAT MATER, V10, P243, DOI 10.1038/NMAT2960
   Mueller SN, 2015, MOL PHARMACEUT, V12, P1356, DOI 10.1021/mp500589c
   Nembrini C, 2011, P NATL ACAD SCI USA, V108, pE989, DOI 10.1073/pnas.1104264108
   Pal I, 2011, ADV DRUG DELIVER REV, V63, P909, DOI 10.1016/j.addr.2011.05.018
   Park J, 2012, NAT MATER, V11, P895, DOI [10.1038/NMAT3355, 10.1038/nmat3355]
   Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI 10.1038/nbtl332
   Rosenberg SA, 2015, SCIENCE, V348, P62, DOI 10.1126/science.aaa4967
   Sandoval F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004888
   Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486
   Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971
   Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030
   Singh A, 2014, ADV MATER, V26, P6530, DOI 10.1002/adma.201402105
   Stephan MT, 2012, BIOMATERIALS, V33, P5776, DOI 10.1016/j.biomaterials.2012.04.029
   Stephan MT, 2010, NAT MED, V16, P1035, DOI 10.1038/nm.2198
   Stephan SB, 2015, NAT BIOTECHNOL, V33, P97, DOI 10.1038/nbt.3104
   Swartz MA, 2012, NAT REV CANCER, V12, P210, DOI 10.1038/nrc3186
   Thomas SN, 2014, BIOMATERIALS, V35, P814, DOI 10.1016/j.biomaterials.2013.10.003
   Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001
   Umeki Y, 2015, ADV FUNCT MATER, V25, P5758, DOI 10.1002/adfm.201502139
   Wang AZ, 2012, ANNU REV MED, V63, P185, DOI 10.1146/annurev-med-040210-162544
   Zheng Y, 2013, J CONTROL RELEASE, V172, P426, DOI 10.1016/j.jconrel.2013.05.037
   Zhuang Y, 2012, J CONTROL RELEASE, V159, P135, DOI 10.1016/j.jconrel.2011.12.017
NR 53
TC 33
Z9 34
U1 8
U2 64
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0958-1669
EI 1879-0429
J9 CURR OPIN BIOTECH
JI Curr. Opin. Biotechnol.
PD AUG
PY 2016
VL 40
BP 1
EP 8
DI 10.1016/j.copbio.2016.02.001
PG 8
WC Biochemical Research Methods; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA DT5OE
UT WOS:000381531700002
PM 26896596
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Serban, MA
AF Serban, Monica Andrea
TI Translational biomaterials - the journey from the bench to the market -
   think 'product'
SO CURRENT OPINION IN BIOTECHNOLOGY
LA English
DT Review
ID SYNTHETIC EXTRACELLULAR MATRICES; MEDICAL DEVICES; TISSUE; SMART
AB Biomaterial research has been gaining popularity over the past decades and, in parallel, the number of biomaterial-based therapies has been increasing. There is still however, a disconnection between the number of developed biomaterials and those that make it to the market. In this context, a review of the biomaterial development trends in both industry and academia, specifically of biomaterials that were successfully translated from bench side to the clinic and the market, is warranted.
C1 [Serban, Monica Andrea] Univ Montana, Mat Sci Program, Dept Biomed & Pharmaceut Sci, Missoula, MT 59812 USA.
RP Serban, MA (reprint author), Univ Montana, Mat Sci Program, Dept Biomed & Pharmaceut Sci, Missoula, MT 59812 USA.
EM monica.serban@umontana.edu
CR Akiyama N, 2013, INT J NANOMED, V8, P2629, DOI 10.2147/IJN.S47279
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   [Anonymous], 2013, BIOMATERIALS MARKET
   [Anonymous], K080442 SERISCAFFOLD
   Bayon Y, 2015, J MATER SCI-MATER M, V26, P5562
   Bergsland J, 2014, MED DEVICES-EVID RES, V7, P205, DOI 10.2147/MDER.S43369
   Cobo I, 2015, NAT MATER, V14, P143, DOI [10.1038/NMAT4106, 10.1038/nmat4106]
   Comesana R, 2015, SCI REP-UK, V5, DOI 10.1038/srep10677
   Fargen KM, 2013, J NEUROINTERV SURG, V5, P269, DOI 10.1136/neurintsurg-2012-010400
   Holzapfel BM, 2013, ADV DRUG DELIVER REV, V65, P581, DOI 10.1016/j.addr.2012.07.009
   Jarow JP, 2015, UROL ONCOL-SEMIN ORI, V33, P128, DOI 10.1016/j.urolonc.2014.10.004
   Jewell M, 2015, ANN N Y ACAD SCI
   Meyer RA, 2015, TRENDS BIOTECHNOL, V33, P514, DOI 10.1016/j.tibtech.2015.07.001
   Mortarino E, 2010, A prosthetic device and method of manufacturing the same, Patent No. [WO2010074827, 2010074827]
   Prestwich GD, 2007, ADV ENZYME REGUL, V47, P196, DOI 10.1016/j.advenzreg.2006.12.012
   Prestwich GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004915
   Prestwich GD, 2012, ACTA BIOMATER, V8, P4200, DOI 10.1016/j.actbio.2012.06.043
   Shu XZ, 2006, J BIOMED MATER RES A, V79A, P902, DOI 10.1002/jbm.a.30831
   Sicari BM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008085
   Williams DL, 2013, INT J BIOMATER, V2013
   Wirostko B, 2014, ADV WOUND CARE, V3, P708, DOI 10.1089/wound.2014.0572
   World Health Organization, 2003, MED DEV REG GLOB OV
   Yang G, 2011, ISRN VET SCI, V2012
NR 23
TC 5
Z9 5
U1 1
U2 9
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0958-1669
EI 1879-0429
J9 CURR OPIN BIOTECH
JI Curr. Opin. Biotechnol.
PD AUG
PY 2016
VL 40
BP 31
EP 34
DI 10.1016/j.copbio.2016.02.009
PG 4
WC Biochemical Research Methods; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA DT5OE
UT WOS:000381531700006
PM 26926461
DA 2018-10-20
ER

PT J
AU Piccinini, M
   Prosperi, S
   Preve, E
   Rebaudi, A
   Bucciotti, F
AF Piccinini, Marzio
   Prosperi, Susanna
   Preve, Eleonora
   Rebaudi, Alberto
   Bucciotti, Francesco
TI In Vitro Biocompatibility Assessment and In Vivo Behavior of a New
   Osteoconductive beta TCP Bone Substitute
SO IMPLANT DENTISTRY
LA English
DT Article
DE bone regeneration; bone filler; biomaterial; calcium phosphate
ID TRICALCIUM PHOSPHATE; GRAFT SUBSTITUTES; HYDROXYAPATITE; POROSITY;
   CELLS; PARTICLES; GRANULES; HUMANS; SIZE
AB Objective: Beta-tricalcium phosphate (beta TCP) granules (OsproLife) exhibit a pure crystalline phase and a rough microporous surface for promoting cell adhesion and microsized intragranule porosity for improving wettability and resorption necessary for bone regeneration. OsproLife is a fully resorbable, space-maintaining, and osteoconductive synthetic material for the filling of bone defects. To asses OsproLife properties, a similar synthetic biomaterial, already on the market, has been chosen as reference: Cerasorb has the same chemical composition, but different crystal structure, surface morphology, and granule size. The aim of this study is to compare the properties of OsproLife and Cerasorb.
   Methods: Chemical purity, composition and physical properties, in vitro cytotoxicity, and in vivo bone performance in a rabbit model were analyzed. beta TCP OsproLife granules (test) were compared with Cerasorb (control). Histological and mu CT analyses were performed at 6, 12, and 56 weeks after implantation.
   Results: beta TCP OsproLife and Cerasorb granules result to be both biocompatible and characterized by the same osteoconductivity and resorption rate.
   Conclusion: beta TCP OsproLife granules are a promising bone substitute for dental and orthopedic applications.
C1 [Piccinini, Marzio; Prosperi, Susanna; Preve, Eleonora; Bucciotti, Francesco] Eurocoating SpA, Dept Res & Dev, Cire Pergine Valsugana, Trento, Italy.
   [Rebaudi, Alberto] Int Piezosurg Acad, Parma, Italy.
RP Piccinini, M (reprint author), Eurocoating SpA, Dept Res & Dev, Via Al Dos de la Roda,60 Loc, I-38057 Pergine Valsugana, Trento, Italy.
EM marziopiccinini@eurocoating.it
FU Eurocoating Spa; Provincia Autonoma di Trento (Regional Public
   Authority)
FX This work is part of the "CaP Project" cosponsored by Eurocoating Spa
   and Provincia Autonoma di Trento (Regional Public Authority).
CR Bashir J, 2014, PM&R, V6, P61, DOI 10.1016/j.pmrj.2013.05.007
   Bohner Marc, 2013, Biomatter, V3, DOI 10.4161/biom.25103
   Bohner M, 2010, EUR CELLS MATER, V20, P1
   CHAMBERS TJ, 1982, IMMUNOBIOLOGY, V161, P283, DOI 10.1016/S0171-2985(82)80084-3
   Chissov VI, 2008, B EXP BIOL MED+, V145, P499, DOI 10.1007/s10517-008-0128-0
   Galois Laurent, 2004, Acta Orthop Belg, V70, P598
   Ghanaati S, 2010, ACTA BIOMATER, V6, P4476, DOI 10.1016/j.actbio.2010.07.006
   Hing KA, 2007, SPINE J, V7, P475, DOI 10.1016/j.spinee.2006.07.017
   Jo YJ, 2011, J PERIODONTAL IMPLAN, V41, P67, DOI 10.5051/jpis.2011.41.2.67
   Kasten P, 2008, ACTA BIOMATER, V4, P1904, DOI 10.1016/j.actbio.2008.05.017
   Knabe C, 2008, BIOMATERIALS, V29, P2249, DOI 10.1016/j.biomaterials.2008.01.026
   Komlev VS, 2003, SCI TECHNOL ADV MAT, V4, P503, DOI 10.1016/j.stam.2003.11.007
   Malard O, 1999, J BIOMED MATER RES, V46, P103, DOI 10.1002/(SICI)1097-4636(199907)46:1<103::AID-JBM12>3.0.CO;2-Z
   MISIEK DJ, 1984, J ORAL MAXIL SURG, V42, P150, DOI 10.1016/S0278-2391(84)80025-7
   Moore WR, 2001, AUST NZ J SURG, V71, P354, DOI 10.1046/j.1440-1622.2001.02128.x
   Ogose A, 2005, J BIOMED MATER RES B, V72B, P94, DOI 10.1002/jbm.b.30136
   Okamoto M, 2006, J MATER SCI-MATER M, V17, P327, DOI 10.1007/s10856-006-8232-z
   Oliveira R, 2012, IMPLANT DENT, V21, P422, DOI 10.1097/ID.0b013e3182691873
   Oonishi H, 1999, J BIOMED MATER RES, V44, P31, DOI 10.1002/(SICI)1097-4636(199901)44:1<31::AID-JBM4>3.0.CO;2-9
   Rebaudi A, 2004, INT J PERIODONT REST, V24, P317
   Salgado P. C., 2011, J BIOMATER NANOBIOTE, V2, P318, DOI 10.4236/jbnb.2011.23039
   Tadic D, 2004, BIOMATERIALS, V25, P987, DOI 10.1016/S0142-9612(03)00621-5
   TOMFORD WW, 1990, J BONE JOINT SURG AM, V72A, P1137, DOI 10.2106/00004623-199072080-00003
   Trisi P, 2005, INT J PERIODONT REST, V25, P317
   Trisi P, 2003, INT J PERIODONT REST, V23, P69
NR 25
TC 1
Z9 1
U1 2
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1056-6163
J9 IMPLANT DENT
JI Implant Dent.
PD AUG
PY 2016
VL 25
IS 4
BP 456
EP 463
DI 10.1097/ID.0000000000000442
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA DS6VQ
UT WOS:000380921500002
PM 27455428
DA 2018-10-20
ER

PT J
AU Tremblay, ML
   Xu, LL
   Sarker, M
   Liu, XQ
   Rainey, JK
AF Tremblay, Marie-Laurence
   Xu, Lingling
   Sarker, Muzaddid
   Liu, Xiang-Qin
   Rainey, Jan K.
TI Characterizing Aciniform Silk Repetitive Domain Backbone Dynamics and
   Hydrodynamic Modularity
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE aciniform spidroin (AcSp1); wrapping silk; recombinant spider silk;
   modular proteins; reduced spectral density mapping; hydrodynamics
   characterization; nuclear magnetic resonance spectroscopy; split intein;
   segmental-labelling
ID N-15 NMR RELAXATION; MODEL-FREE APPROACH; MULTIDOMAIN PROTEIN; WRAPPING
   SILK; DISORDERED PROTEINS; FIBROIN GENE; SPLIT INTEIN; SPIDER SILK; DNAE
   GENE; IN-VIVO
AB Spider aciniform (wrapping) silk is a remarkable fibrillar biomaterial with outstanding mechanical properties. It is a modular protein consisting, in Argiope trifasciata, of a core repetitive domain of 200 amino acid units (W units). In solution, the W units comprise a globular folded core, with five alpha-helices, and disordered tails that are linked to form a similar to 63-residue intrinsically disordered linker in concatemers. Herein, we present nuclear magnetic resonance (NMR) spectroscopy-based N-15 spin relaxation analysis, allowing characterization of backbone dynamics as a function of residue on the ps-ns timescale in the context of the single W unit (W-1) and the two unit concatemer (W-2). Unambiguous mapping of backbone dynamics throughout W-2 was made possible by segmental NMR active isotope-enrichment through split intein-mediated trans-splicing. Spectral density mapping for W-1 and W-2 reveals a striking disparity in dynamics between the folded core and the disordered linker and tail regions. These data are also consistent with rotational diffusion behaviour where each globular domain tumbles almost independently of its neighbour. At a localized level, helix 5 exhibits elevated high frequency dynamics relative to the proximal helix 4, supporting a model of fibrillogenesis where this helix unfolds as part of the transition to a mixed alpha-helix/beta-sheet fibre.
C1 [Tremblay, Marie-Laurence; Xu, Lingling; Sarker, Muzaddid; Liu, Xiang-Qin; Rainey, Jan K.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 4R2, Canada.
   [Rainey, Jan K.] Dalhousie Univ, Dept Chem, Halifax, NS B3H 4R2, Canada.
RP Rainey, JK (reprint author), Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 4R2, Canada.; Rainey, JK (reprint author), Dalhousie Univ, Dept Chem, Halifax, NS B3H 4R2, Canada.
EM mltremblay@dal.ca; ln217415@dal.ca; muzaddid.sarker@dal.ca;
   paul.liu@dal.ca; jan.rainey@dal.ca
RI Rainey, Jan/C-1927-2008
OI Rainey, Jan/0000-0003-0793-5573; Tremblay,
   Marie-Laurence/0000-0002-8366-2653
FU Natural Sciences and Engineering Research Council of Canada (NSERC)
   [RGPIN/342034-2012, RGPIN/41823-2015]; Canadian Foundation for
   Innovation; Dalhousie Medical Research Foundation Capital Equipment
   Grant; Dalhousie University through an Atlantic Canada Opportunities
   Agency Grant; Canadian Institutes for Health Research; NSERC
FX Thanks to Bruce Stewart for expert technical assistance; Leo
   Spyracopoulos for helpful discussions; and, Ian Burton, Nadine Merkley,
   and Ray Syvitski for 16.4 T NMR spectrometer support at the National
   Research Council Biological Magnetic Resonance Facility (NRC-BMRF,
   Halifax, NS, Canada) accessed through Dalhousie's Nuclear Magnetic
   Resonance Resource (NMR3). This work was supported by Discovery Grants
   from the Natural Sciences and Engineering Research Council of Canada
   (NSERC; RGPIN/342034-2012 to Jan K. Rainey and RGPIN/41823-2015 to
   Xiang-Qin Liu); key infrastructure was provided through NSERC Research
   Tools and Instruments Grants and a Leaders Opportunity Fund award from
   the Canadian Foundation for Innovation (to Jan K. Rainey); and, a
   Dalhousie Medical Research Foundation Capital Equipment Grant (to Jan K.
   Rainey and Xiang-Qin Liu). The TCI probe for the 16.4 T NMR spectrometer
   at the NRC-BMRF were provided by Dalhousie University through an
   Atlantic Canada Opportunities Agency Grant. Jan K. Rainey is supported
   by a Canadian Institutes for Health Research New Investigator Award and
   Marie-Laurence Tremblay was supported by an NSERC Doctoral Postgraduate
   Scholarship.
CR Bae SH, 2009, J AM CHEM SOC, V131, P6814, DOI 10.1021/ja809687r
   Buchinger E, 2010, PROTEIN SCI, V19, P1534, DOI 10.1002/pro.432
   Busche AEL, 2009, ANGEW CHEM INT EDIT, V48, P6128, DOI 10.1002/anie.200901488
   Buskirk AR, 2004, P NATL ACAD SCI USA, V101, P10505, DOI 10.1073/pnas.0402762101
   CANTOR CR, 1980, BIOPHYSICAL CHEM, V2, P549
   Castaneda CA, 2011, ANGEW CHEM INT EDIT, V50, P11210, DOI 10.1002/anie.201104649
   Cavanagh J., 1996, PROTEIN NMR SPECTROS, P16
   Chaw R.C., 2014, BMC EVOL BIOL
   Cho CH, 1999, J PHYS CHEM B, V103, P1991, DOI 10.1021/jp9842953
   CLORE GM, 1990, J AM CHEM SOC, V112, P4989, DOI 10.1021/ja00168a070
   De Rosa L, 2013, MOLECULES, V18, P440, DOI 10.3390/molecules18010440
   Evans TC, 2000, J BIOL CHEM, V275, P9091, DOI 10.1074/jbc.275.13.9091
   FARROW NA, 1995, J BIOMOL NMR, V6, P153
   Frueh DP, 2013, CURR OPIN STRUC BIOL, V23, P734, DOI 10.1016/j.sbi.2013.06.016
   Fushman D, 2004, PROG NUCL MAG RES SP, V44, P189, DOI 10.1016/j.pnmrs.2004.02.001
   Giriat I, 2003, J AM CHEM SOC, V125, P7180, DOI 10.1021/ja034736i
   Halle B, 2003, P NATL ACAD SCI USA, V100, P12135, DOI 10.1073/pnas.2033320100
   Han JH, 2007, NAT REV MOL CELL BIO, V8, P319, DOI 10.1038/nrm2144
   Hayashi CY, 2004, MOL BIOL EVOL, V21, P1950, DOI 10.1093/molbev/msh204
   Horn Anselm H C, 2015, Front Bioeng Biotechnol, V3, P191, DOI 10.3389/fbioe.2015.00191
   Jones JA, 1997, J BIOMOL NMR, V10, P199, DOI 10.1023/A:1018304117895
   Kaderavek P, 2014, J BIOMOL NMR, V58, P193, DOI 10.1007/s10858-014-9816-4
   Kanwar M, 2013, METHOD ENZYMOL, V523, P369, DOI 10.1016/B978-0-12-394292-0.00017-5
   KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003
   Kikhney AG, 2015, FEBS LETT, V589, P2570, DOI 10.1016/j.febslet.2015.08.027
   Lefevre T, 2011, J MOL BIOL, V405, P238, DOI 10.1016/j.jmb.2010.10.052
   Levitt M, 2009, P NATL ACAD SCI USA, V106, P11079, DOI 10.1073/pnas.0905029106
   Lewis RV, 2006, CHEM REV, V106, P3762, DOI 10.1021/cr010194g
   LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009
   Maciejewski M, 2014, J COMPUT CHEM, V35, P518, DOI 10.1002/jcc.23510
   MITA K, 1994, J MOL EVOL, V38, P583
   Mootz HD, 2003, J AM CHEM SOC, V125, P10561, DOI 10.1021/ja0362813
   Muir TW, 2008, BIOPOLYMERS, V90, P743, DOI 10.1002/bip.21102
   Muona M, 2008, CHEMBIOCHEM, V9, P2958, DOI 10.1002/cbic.200800604
   Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046
   Ortega G, 2013, ADV PROTEIN CHEM STR, V92, P219, DOI 10.1016/B978-0-12-411636-8.00006-7
   Otomo T, 1999, J BIOMOL NMR, V14, P105, DOI 10.1023/A:1008308128050
   Ozawa T, 2001, ANAL CHEM, V73, P2516, DOI 10.1021/ac0013296
   Pickford AR, 2004, CHEM REV, V104, P3557, DOI 10.1021/cr0304018
   Ravera E, 2014, ACCOUNTS CHEM RES, V47, P3118, DOI 10.1021/ar5002318
   Rezaei-Ghaleh N, 2013, ANGEW CHEM INT EDIT, V52, P11410, DOI 10.1002/anie.201305094
   Ryabov YE, 2007, J AM CHEM SOC, V129, P3315, DOI 10.1021/jia067667r
   Sarker M, 2016, BIOCHEMISTRY-US, V55, P3048, DOI 10.1021/acs.biochem.6b00429
   Scott CP, 1999, P NATL ACAD SCI USA, V96, P13638, DOI 10.1073/pnas.96.24.13638
   Skrisovska L, 2010, J BIOMOL NMR, V46, P51, DOI 10.1007/s10858-009-9362-7
   Smith JL, 2015, CURR OPIN STRUC BIOL, V31, P9, DOI 10.1016/j.sbi.2015.02.014
   Southworth MW, 1998, EMBO J, V17, P918, DOI 10.1093/emboj/17.4.918
   Spyracopoulos L, 2006, J BIOMOL NMR, V36, P215, DOI 10.1007/s10858-006-9083-0
   Tjandra N, 1995, J AM CHEM SOC, V117, P12562, DOI 10.1021/ja00155a020
   Tremblay M.L., 2015, SCI REP
   VENABLE RM, 1988, BIOPOLYMERS, V27, P1001, DOI 10.1002/bip.360270609
   Vila-Perello M, 2010, CELL, V143, P191, DOI 10.1016/j.cell.2010.09.031
   Volkmann G, 2010, MOL BIOSYST, V6, P2110, DOI 10.1039/c0mb00034e
   Volkmann G, 2010, J BIOL CHEM, V285, P8605, DOI 10.1074/jbc.M109.060863
   Wagner MJ, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008987
   Walker O, 2004, J MAGN RESON, V168, P336, DOI 10.1016/j.jmr.2004.03.019
   Walsh JD, 2010, BIOPHYS J, V99, P2636, DOI 10.1016/j.bpj.2010.08.036
   Wang SL, 2014, PROG NUCL MAG RES SP, V82, P1, DOI 10.1016/j.pnmrs.2014.07.001
   Weatherbee-Martin N, 2016, BIOMACROMOLECULES, V17, P2737, DOI 10.1021/acs.biomac.6b00857
   Wu H, 1998, P NATL ACAD SCI USA, V95, P9226, DOI 10.1073/pnas.95.16.9226
   Xu LL, 2013, FEBS LETT, V587, P3273, DOI 10.1016/j.febslet.2013.08.024
   Xu LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050227
   Xu LL, 2012, BIOMOL NMR ASSIGN, V6, P147, DOI 10.1007/s12104-011-9344-z
   Yamazaki T, 1998, J AM CHEM SOC, V120, P5591, DOI 10.1021/ja980776o
   Yigit S, 2016, BIOTECHNOL BIOENG, V113, P913, DOI 10.1002/bit.25820
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
NR 66
TC 1
Z9 1
U1 0
U2 12
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD AUG
PY 2016
VL 17
IS 8
AR 1305
DI 10.3390/ijms17081305
PG 18
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA DU6PU
UT WOS:000382337900117
PM 27517921
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Jerban, S
   Elkoun, S
AF Jerban, Saeed
   Elkoun, Said
TI Individual pore and interconnection size analysis of macroporous ceramic
   scaffolds using high-resolution X-ray tomography
SO MATERIALS CHARACTERIZATION
LA English
DT Article
DE Calcium phosphates; Isolating pores; Interconnection; Subvoxelization;
   mu CT limitations
ID FUZZY DISTANCE TRANSFORM; BONE-GRAFT SUBSTITUTES; MICRO-COMPUTED
   TOMOGRAPHY; IN-VIVO BEHAVIOR; PHOSPHATE SCAFFOLDS; TISSUE SCAFFOLDS;
   TRABECULAR BONE; MICROTOMOGRAPHY; GEOMETRY; CELLS
AB The pore interconnection size of beta-tricalcium phosphate scaffolds plays an essential role in the bone repair process. Although, the mu CT technique is widely used in the biomaterial community, it is rarely used to measure the interconnection size because of the lack of algorithms. In addition, discrete nature of the mu CT introduces large systematic errors due to the convex geometry of interconnections. We proposed, verified and validated a novel pore-level algorithm to accurately characterize the individual pores and interconnections. Specifically, pores and interconnections were isolated, labeled, and individually analyzed with high accuracy. The technique was verified thoroughly by visually inspecting and verifying over 3474 properties of randomly selected pores. This extensive verification process has passed a one-percent accuracy criterion. Scanning errors inherent in the discretization, which lead to both dummy and significantly overestimated interconnections, have been examined using computer-based simulations and additional high-resolution scanning. Then accurate correction charts were developed and used to reduce the scanning errors. Only after the corrections, both the mu CT and SEM-based results converged, and the novel algorithm was validated. Material scientists with access to all geometrical properties of individual pores and interconnections, using the novel algorithm, will have a more-detailed and accurate description of the substitute architecture and a potentially deeper understanding of the link between the geometric and biological interaction. (C) 2016 Elsevier Inc All rights reserved.
C1 [Jerban, Saeed; Elkoun, Said] Univ Sherbrooke, Dept Genie Mecan, 2500 Boul Univ, Sherbrooke, PQ J1K 2R1, Canada.
RP Jerban, S; Elkoun, S (reprint author), Univ Sherbrooke, Dept Genie Mecan, 2500 Boul Univ, Sherbrooke, PQ J1K 2R1, Canada.
EM saeed.jerban@usherbrooke.ca; Said.Elkoun@usherbrooke.ca
OI jerban, saeed/0000-0001-6450-2892
FU NSERC; RMS Foundation
FX The authors thank the NSERC and RMS Foundation for their support. The
   authors thank Steve Allen for his efforts in parallelizing codes. The
   authors appreciate Gamal Baroud and Marc Bohner for their supports and
   valuable comments. The authors also thank Pascal Michel for performing
   the SEM measurements. Ahmed Sweedy is thanked for his valuable comments.
CR Ams J.Y., 2007, P INT S SOC COR AN, P1
   Andersson L, 2010, J EUR CERAM SOC, V30, P2547, DOI 10.1016/j.jeurceramsoc.2010.05.003
   Ashworth JC, 2014, MATER TECHNOL, V29, P281, DOI 10.1179/1753555714Y.0000000159
   Atwood RC, 2004, SCRIPTA MATER, V51, P1029, DOI 10.1016/j.scriptamat.2004.08.014
   Bai F, 2010, TISSUE ENG PT A, V16, P3791, DOI 10.1089/ten.TEA.2010.0148
   Baino F, 2016, J EUR CERAM SOC, V36, P2175, DOI 10.1016/j.jeurceramsoc.2016.01.011
   Bashoor-Zadeh M, 2011, ACTA BIOMATER, V7, P4045, DOI 10.1016/j.actbio.2011.07.014
   Bashoor-Zadeh M, 2010, ACTA BIOMATER, V6, P864, DOI 10.1016/j.actbio.2009.08.007
   Beucher S., 1992, OPTICAL ENG, V34, P433
   Bohner M, 2005, BIOMATERIALS, V26, P6099, DOI 10.1016/j.biomaterials.2005.03.026
   Bohner M, 2012, J EUR CERAM SOC, V32, P2663, DOI 10.1016/j.jeurceramsoc.2012.02.028
   Bohner M, 2010, MATER TODAY, V13, P24, DOI 10.1016/S1369-7021(10)70014-6
   Darabi A, 2009, CAN J ELECT COMPUT E, V34, P57, DOI 10.1109/CJECE.2009.5291208
   Digabel H., 1977, 2 S EUR AN QUANT MIC, P85
   Faessel Matthieu, 2009, Image Analysis & Stereology, V28, P195
   Guimaraes L.V., 2000, BIOIN BIOM ENG 2000, P277
   Ho ST, 2006, BIOMATERIALS, V27, P1362, DOI 10.1016/j.biomaterials.2005.08.035
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Hwang SN, 2002, MAGN RESON MED, V47, P948, DOI 10.1002/mrm.10138
   Janicki P, 2011, INJURY, V42, pS77, DOI 10.1016/j.injury.2011.06.014
   Jerban S., 2013, 23 INT RES C INJ OST
   Jerban S., 2015, 25 INT RES C INJ OST
   Jones AC, 2007, BIOMATERIALS, V28, P2491, DOI 10.1016/j.biomaterials.2007.01.046
   Jones AC, 2009, BIOMATERIALS, V30, P1440, DOI 10.1016/j.biomaterials.2008.10.056
   Jones JR, 2010, P I MECH ENG H, V224, P1373, DOI 10.1243/09544119JEIM836
   Jones JR, 2006, PHILOS T ROY SOC A, V364, P263, DOI 10.1098/rsta.2005.1689
   Jones JR, 2007, BIOMATERIALS, V28, P1404, DOI 10.1016/j.biomaterials.2006.11.014
   Jones JR, 2009, J MATER SCI-MATER M, V20, P463, DOI 10.1007/s10856-008-3597-9
   Jones TR, 2005, LECT NOTES COMPUT SC, V3765, P535
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kuboki Y, 2001, J BONE JOINT SURG AM, V83A, pS105
   Kumar A, 2016, J BIOMED MATER RES A, V104, P1343, DOI 10.1002/jbm.a.35664
   Lapczyna H, 2014, EUR CELLS MATER, V28, P299, DOI 10.22203/eCM.v028a21
   Liang Z, 2000, J COLLOID INTERF SCI, V221, P13, DOI 10.1006/jcis.1999.6559
   Lu JX, 1999, J MATER SCI-MATER M, V10, P111, DOI 10.1023/A:1008973120918
   Mangan AP, 1999, IEEE T VIS COMPUT GR, V5, P308, DOI 10.1109/2945.817348
   MEYER F, 1994, SIGNAL PROCESS, V38, P113, DOI 10.1016/0165-1684(94)90060-4
   Moore MJ, 2004, J BIOMED MATER RES A, V71A, P258, DOI 10.1002/jbm.a.30138
   Nune KC, 2016, J BIOMED MATER RES A, V104, P517, DOI 10.1002/jbm.a.35592
   Nune KC, 2015, J BIOMED MATER RES A, V103, P1677, DOI 10.1002/jbm.a.35307
   Reem D, 2009, 2009 6TH INTERNATIONAL SYMPOSIUM ON VORONOI DIAGRAMS (ISVD 2009), P144, DOI 10.1109/ISVD.2009.23
   Renghini C, 2013, J EUR CERAM SOC, V33, P1553, DOI 10.1016/j.jeurceramsoc.2012.10.016
   Renghini C, 2009, ACTA BIOMATER, V5, P1328, DOI 10.1016/j.actbio.2008.10.017
   Ripamonti U, 2009, J CELL MOL MED, V13, P2953, DOI 10.1111/j.1582-4934.2008.00562.x
   Rumpler M, 2008, J R SOC INTERFACE, V5, P1173, DOI 10.1098/rsif.2008.0064
   Saha PK, 2004, IEEE T MED IMAGING, V23, P53, DOI 10.1109/TMI.2003.819925
   Saha PK, 2002, COMPUT VIS IMAGE UND, V86, P171, DOI 10.1006/cviu.2002.0974
   Sheppard A. P., 2006, P INT S SOC COR AN, P1
   Sheppard P.A., 2005, INT S SOC CORE ANAL, P21
   Singh R, 2010, ACTA BIOMATER, V6, P4596, DOI 10.1016/j.actbio.2010.06.027
   Soille P, 2004, MORPHOLOGICAL IMAGE
   Stock SR, 2008, INT MATER REV, V53, P129, DOI 10.1179/174328008X277803
   Van Bael S, 2012, ACTA BIOMATER, V8, P2824, DOI 10.1016/j.actbio.2012.04.001
   VINCENT L, 1991, IEEE T PATTERN ANAL, V13, P583, DOI 10.1109/34.87344
   von Doernberg MC, 2006, BIOMATERIALS, V27, P5186, DOI 10.1016/j.biomaterials.2006.05.051
   Yue S, 2011, ACTA BIOMATER, V7, P2637, DOI 10.1016/j.actbio.2011.02.009
   Yue S, 2010, J MATER SCI-MATER M, V21, P847, DOI 10.1007/s10856-009-3888-9
   Zhang G, 2005, BIOSYST ENG, V92, P135, DOI 10.1016/j.biosystemseng.2005.06.010
   Zhong QF, 2009, COMPUT ELECTRON AGR, V69, P118, DOI 10.1016/j.compag.2009.06.015
NR 59
TC 4
Z9 4
U1 7
U2 16
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1044-5803
EI 1873-4189
J9 MATER CHARACT
JI Mater. Charact.
PD AUG
PY 2016
VL 118
BP 454
EP 467
DI 10.1016/j.matchar.2016.06.030
PG 14
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Materials Science, Characterization & Testing
SC Materials Science; Metallurgy & Metallurgical Engineering
GA DV9WD
UT WOS:000383292000054
DA 2018-10-20
ER

PT J
AU Giambini, H
   Fang, Z
   Zeng, H
   Camp, JJ
   Yaszemski, MJ
   Lu, LC
AF Giambini, Hugo
   Fang, Zhong
   Zeng, Heng
   Camp, Jon J.
   Yaszemski, Michael J.
   Lu, Lichun
TI Noninvasive Failure Load Prediction of Vertebrae with Simulated Lytic
   Defects and Biomaterial Augmentation
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID QUANTITATIVE COMPUTED-TOMOGRAPHY; STRUCTURAL RIGIDITY ANALYSIS;
   FINITE-ELEMENT-ANALYSIS; MECHANICAL-PROPERTIES; TRABECULAR BONE;
   THORACIC VERTEBRAE; SPINE; STRENGTH; VERTEBROPLASTY; METASTASES
AB The spine is the most common site for secondary bone metastases, and clinical management for fractures is based on size and geometry of the defect. About 75% of the bone needs to be damaged before lesions are detectable, so clinical tools should measure changes in both geometry and material properties. Wehave developed an automated, user-friendly, Spine Cancer Assessment (SCA) image-based analysis method that builds on a platform designed for clinical practice providing failure characteristics of vertebrae. The objectives of this study were to (1) validate SCA predictions with experimental failure load outcomes; (2) evaluate the planning capabilities for prophylactic vertebroplasty procedures; and (3) investigate the effect of computed tomography (CT) protocols on predicted failure loads. Twenty-one vertebrae were randomly divided into two groups: (1) simulated defect without treatment (negative control) [n = 9] and (2) with treatment [n = 12]. Defects were created and a polymeric biomaterial was injected into the vertebrae in the treated-defect group. Spines were scanned, reconstructed with two algorithms, and analyzed for fracture loads. To virtually plan for prophylactic intervention, vertebrae with empty lesions were simulated to be augmented with either poly(methyl methacrylate) (PMMA) or a novel bone replacement copolymer, poly(propylene fumarate-co-caprolactone) [P(PF-co-CL)]. Axial rigidities were calculated from the CT images. Failure loads, determined from the cross section with the lowest axial rigidity, were compared with experimental values. Predicted loads correlated well with experimental outcomes (R-2 = 0.73, p < 0.0001). Predictions from negative control specimens highly correlated with measured values (R-2 = 0.90, p < 0.0001). Although a similar correlation was obtained using both algorithms, the smooth reconstruction (B30) tended to underestimate predicted failure loads by similar to 50% compared with the similar to 10% underestimate of the sharp reconstruction (B70). Percent increase in failure loads after virtual vertebroplasty showed a higher increase in samples with PMMA compared with those with copolymer. The SCA method developed in this study calculated failure loads from quantitative computed tomography scans in vertebrae with simulated metastatic lytic defects, with or without treatment, facilitating clinical applicability and providing more reliable guidelines for physicians to select appropriate treatment options. Furthermore, the analysis could accommodate augmentation planning procedures that aimed to determine the optimum material that would increase vertebral body failure load.
C1 [Giambini, Hugo; Fang, Zhong; Zeng, Heng; Yaszemski, Michael J.; Lu, Lichun] Mayo Clin, Dept Orthoped Surg, Rochester, MN USA.
   [Fang, Zhong; Zeng, Heng] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Orthoped, Tongji Med Coll, Wuhan, Peoples R China.
   [Camp, Jon J.] Mayo Clin, Biomed Imaging Resource, Rochester, MN USA.
   [Yaszemski, Michael J.; Lu, Lichun] Mayo Clin, Dept Physiol & Biomed Engn, 200 First St SW, Rochester, MN 55905 USA.
RP Lu, LC (reprint author), Mayo Clin, Dept Physiol & Biomed Engn, 200 First St SW, Rochester, MN 55905 USA.
EM lu.lichun@mayo.edu
FU National Institutes of Health [R01 AR056212]; National Institute of
   Arthritis and Musculoskeletal and Skin Diseases for the Musculoskeletal
   Research Training Program [T32-AR56950]
FX This work was supported by the National Institutes of Health grant R01
   AR056212. The authors also acknowledge the National Institute of
   Arthritis and Musculoskeletal and Skin Diseases for the Musculoskeletal
   Research Training Program T32-AR56950. The content is solely the
   responsibility of the authors and does not necessarily represent the
   official views of the National Institutes of Health.
CR Ahn H, 2006, J SPINAL DISORD TECH, V19, P178, DOI 10.1097/01.bsd.0000172362.15103.e8
   American Academy of Orthopaedic Surgeons, MET BON DIS
   American Cancer Society, 2014, CANC PREV MAN PEOPL
   Anez-Bustillos L, 2014, BONE, V58, P160, DOI 10.1016/j.bone.2013.10.009
   Crawford RP, 2003, BONE, V33, P744, DOI 10.1016/S8756-3282(03)00210-2
   Damron TA, 2016, CLIN ORTHOP RELAT R, V474, P643, DOI 10.1007/s11999-015-4453-0
   Dragomir-Daescu D, 2015, J BIOMECH, V48, P153, DOI 10.1016/j.jbiomech.2014.09.016
   Edelstyn G A, 1967, Clin Radiol, V18, P158, DOI 10.1016/S0009-9260(67)80010-2
   Fang Z, 2014, TISSUE ENG PT A, V20, P1096, DOI [10.1089/ten.tea.2013.0275, 10.1089/ten.TEA.2013.0275]
   Giambini H, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4031572
   Greenlee RT, 2001, CA-CANCER J CLIN, V51, P15, DOI 10.3322/canjclin.51.1.15
   HIPP JA, 1995, CLIN ORTHOP RELAT R, P120
   Hong J, 2004, J ORTHOPAED RES, V22, P479, DOI 10.1016/orthres.2003.09.006
   Kopperdahl DL, 2002, J ORTHOPAED RES, V20, P801, DOI 10.1016/S0736-0266(01)00185-1
   Latif T, 2005, CLIN LYMPHOMA MYELOM, V6, P228, DOI 10.3816/CLM.2005.n.050
   Matsuura Y, 2014, SPINE, V39, pE1291, DOI 10.1097/BRS.0000000000000540
   MCGOWAN DP, 1993, J SPINAL DISORD, V6, P130
   Mirels H, 2003, CLIN ORTHOP RELAT R, pS4, DOI 10.1097/01.blo.0000093045.56370.dd
   Morgan EF, 2003, J BIOMECH, V36, P897, DOI 10.1016/S0021-9290(03)00071-X
   Silva M J, 1993, Eur Spine J, V2, P118, DOI 10.1007/BF00301407
   Snyder BD, 2009, CLIN CANCER RES, V15, P7676, DOI 10.1158/1078-0432.CCR-09-0420
   SNYDER SM, 1991, J ORTHOPAED RES, V9, P422, DOI 10.1002/jor.1100090315
   Taneichi H, 1997, SPINE, V22, P239, DOI 10.1097/00007632-199702010-00002
   Whealan KM, 2000, J BONE JOINT SURG AM, V82A, P1240, DOI 10.2106/00004623-200009000-00004
   Windhagen HJ, 1997, CLIN ORTHOP RELAT R, P313
   WONG DA, 1990, SPINE, V15, P1, DOI 10.1097/00007632-199001000-00001
   Yan J, 2011, J BIOMAT SCI-POLYM E, V22, P489, DOI 10.1163/092050610X487765
NR 27
TC 2
Z9 2
U1 0
U2 1
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
EI 1937-3392
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD AUG
PY 2016
VL 22
IS 8
BP 717
EP 724
DI 10.1089/ten.tec.2016.0078
PG 8
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA DV8IU
UT WOS:000383181500001
PM 27260559
OA Green Published
DA 2018-10-20
ER

PT J
AU Chou, YN
   Wen, TC
   Chang, Y
AF Chou, Ying-Nien
   Wen, Ten-Chin
   Chang, Yung
TI Zwitterionic surface grafting of epoxylated sulfobetaine copolymers for
   the development of stealth biomaterial interfaces
SO ACTA BIOMATERIALIA
LA English
DT Article; Proceedings Paper
CT 2nd International Conference on Bioinspired and Zwitterionic Materials
   (ICBZM)
CY AUG 13-14, 2015
CL Univ Washington, Seattle, WA
SP US Natl Sci Fdn, Off Naval Res, Univ Washington
HO Univ Washington
DE Universal surface grafting; Zwitterionic copolymer; Glycidyl
   methacrylate; Stealth biomaterials; Sulfobetaine
ID BIOMEDICAL APPLICATIONS; POLY(ETHYLENE GLYCOL); BLOOD COMPATIBILITY;
   BIOADHESIVE CONTROL; PROTEIN ADSORPTION; ULTRAVIOLET-OZONE; POLYMER
   HYDROGEL; COATINGS; BRUSHES; PHOSPHORYLCHOLINE
AB Most biomaterials have a lack of a simple, efficient and robust antifouling modification approach that limits their potential for biomedical applications. The challenge is to develop a universal surface grafting solution to meet the antifouling requirement. In this work, a new formulation of zwitterionic sulfobetaine-based copolymer, ploy(glycidyl methacrylate-co-sulfobetaine methacrylate) (poly(GMA-co-SBMA)), is designed as a chemical for grafting onto material and is introduced for the surface zwitterionization of versatile biomaterials, including ceramic, metal, and plastics. The grafting principle used to stabilize the poly(GMA-co-SBMA) on the target surfaces is based the base-induced ring opening reaction between epoxied and hydroxyl groups. A universal surface modification procedure was developed and performed from an optimized sequence of ultra-violet ozone pretreatment and trimethylaminecatalyzed zwitterionization on a selective case of versatile surfaces including silicon wafer, ceramic glass, titanium, steel, and polystyrene. The prepared poly(GMA-co-SBMA) with an optimum PGMA/PSBMA ratio of 0.23 and a molecular weight of 25 kDa exhibited the best resistance to fibrinogen adsorption with over 90% reduction as well as blood cell activation, tissue cell adhesion and bacterial attachment on the zwitterionic copolymer grafted surfaces. The developed antifouling grafting introduces a universal modification method to generate zwitterionic interfaces on versatile biomaterial substrates, providing great potential for application in medical device coating.
   Statement of Significance
   A simple, efficient and robust antifouling modification approach is critical for many scientific interests and industrial applications. In current stage, the existing available zwitterionic modifications suffer from the lack of universal surface grafting solution to achieve the antifouling requirement on versatile biomaterial substrates. In this study, we synthesized and characterized a new zwitterionic sulfobetaine-based copolymer, ploy(glycidyl methacrylate-co-sulfobetaine methacrylate) (poly(GMA-co-SBMA)), which is designed as chemical grafting onto material and introduced for the surface zwitterionization of versatile biomaterials, including ceramic, metal, and plastics. This research have a promising opportunity for the application of stealth biomaterial interfaces on the next generation of medical devices. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Chou, Ying-Nien; Wen, Ten-Chin] Natl Cheng Kung Univ, Dept Chem Engn, Tainan 70101, Taiwan.
   [Chang, Yung] Chung Yuan Christian Univ, R&D Ctr Membrane Technol, Taoyuan 320, Taiwan.
   [Chang, Yung] Chung Yuan Christian Univ, Dept Chem Engn, Taoyuan 320, Taiwan.
   [Chang, Yung] King Saud Univ, Dept Bot & Microbiol, Coll Sci, POB 2455, Riyadh 11451, Saudi Arabia.
RP Wen, TC (reprint author), Natl Cheng Kung Univ, Dept Chem Engn, Tainan 70101, Taiwan.; Chang, Y (reprint author), Chung Yuan Christian Univ, R&D Ctr Membrane Technol, Taoyuan 320, Taiwan.; Chang, Y (reprint author), Chung Yuan Christian Univ, Dept Chem Engn, Taoyuan 320, Taiwan.
EM tcwen@mail.ncku.edu.tw; ychang@cycu.edu.tw
CR Banerjee I, 2011, ADV MATER, V23, P690, DOI 10.1002/adma.201001215
   Cao Z., 2012, ANGEW CHEM, V51, P2656
   Cao ZQ, 2011, ANGEW CHEM INT EDIT, V50, P6102, DOI 10.1002/anie.201100004
   Chae KH, 2007, SENSOR ACTUAT B-CHEM, V124, P153, DOI 10.1016/j.snb.2006.12.012
   Chang Y, 2006, LANGMUIR, V22, P2222, DOI 10.1021/la052692v
   Chang Y, 2013, ADV FUNCT MATER, V23, P1100, DOI 10.1002/adfm.201201386
   Chang Y, 2011, ACS APPL MATER INTER, V3, P1228, DOI 10.1021/am200055k
   Chang Y, 2010, BIOMACROMOLECULES, V11, P1101, DOI 10.1021/bm100093g
   Chang Y, 2009, BIOMACROMOLECULES, V10, P2092, DOI 10.1021/bm900208u
   Chen SF, 2008, ADV MATER, V20, P335, DOI 10.1002/adma.200701164
   Chen YW, 2014, LANGMUIR, V30, P9139, DOI 10.1021/la501396e
   Chou YN, 2015, ACS APPL MATER INTER, V7, P10096, DOI 10.1021/acsami.5b01756
   Gao CL, 2010, BIOMATERIALS, V31, P1486, DOI 10.1016/j.biomaterials.2009.11.025
   Goda T, 2006, POLYMER, V47, P1390, DOI 10.1016/j.polymer.2005.12.043
   Hoffman A. S., 1982, BIOMATERIALS INTERFA, P3
   Holmlin RE, 2001, LANGMUIR, V17, P2841, DOI 10.1021/la0015258
   Hu WH, 2013, BIOSENS BIOELECTRON, V50, P338, DOI 10.1016/j.bios.2013.06.037
   Huang CJ, 2015, ACS APPL MATER INTER, V7, P2415, DOI 10.1021/am507105r
   Huang CJ, 2012, ADV MATER, V24, P1834, DOI 10.1002/adma.201104849
   Huang W, 2005, J POLYM SCI POL CHEM, V43, P2038, DOI 10.1002/pola.20688
   ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355
   Iwasaki Y, 2005, ANAL BIOANAL CHEM, V381, P534, DOI 10.1007/s00216-004-2805-9
   Jiang SY, 2010, ADV MATER, V22, P920, DOI 10.1002/adma.200901407
   KING DE, 1995, J VAC SCI TECHNOL A, V13, P1247, DOI 10.1116/1.579869
   Klein RJ, 2008, LANGMUIR, V24, P8187, DOI 10.1021/la800134u
   Ko YG, 2001, BIOMATERIALS, V22, P2115, DOI 10.1016/S0142-9612(00)00400-2
   Kostina NY, 2012, BIOMACROMOLECULES, V13, P4164, DOI 10.1021/bm301441x
   Ladd J, 2008, BIOMACROMOLECULES, V9, P1357, DOI 10.1021/bm701301s
   Li GZ, 2008, BIOMATERIALS, V29, P4592, DOI 10.1016/j.biomaterials.2008.08.021
   Li LY, 2007, J BIOMAT SCI-POLYM E, V18, P1415, DOI 10.1163/156856207782246795
   Li M, 2012, LANGMUIR, V28, P16408, DOI 10.1021/la303438t
   Liu YS, 2011, BIOMED MICRODEVICES, V13, P769, DOI 10.1007/s10544-011-9547-1
   Morisaku T, 2008, POLYMER, V49, P4652, DOI 10.1016/j.polymer.2008.08.025
   NIWANO M, 1992, J VAC SCI TECHNOL A, V10, P3171, DOI 10.1116/1.577838
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Ratner BD, 2007, BIOMATERIALS, V28, P5144, DOI 10.1016/j.biomaterials.2007.07.035
   Shih YJ, 2010, LANGMUIR, V26, P17286, DOI 10.1021/la103186y
   Sin MC, 2014, POLYM J, V46, P436, DOI 10.1038/pj.2014.46
   Sin MC, 2014, ACS APPL MATER INTER, V6, P861, DOI 10.1021/am4041256
   Sundaram HS, 2014, ACS APPL MATER INTER, V6, P6664, DOI 10.1021/am500362k
   Sundaram HS, 2014, CHEM SCI, V5, P200, DOI 10.1039/c3sc52233d
   Venault A, 2014, ACS APPL MATER INTER, V6, P3201, DOI 10.1021/am404780w
   Wu L, 2012, J APPL POLYM SCI, V124, P2154, DOI 10.1002/app.35233
   Xu FJ, 2009, PROG POLYM SCI, V34, P719, DOI 10.1016/j.progpolymsci.2009.04.005
   Yu BY, 2014, LANGMUIR, V30, P7502, DOI 10.1021/la500917s
   Zhang Z, 2006, J PHYS CHEM B, V110, P10799, DOI 10.1021/jp057266i
   Zhang Z, 2006, LANGMUIR, V22, P10072, DOI 10.1021/la062175d
NR 48
TC 14
Z9 14
U1 15
U2 86
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD AUG
PY 2016
VL 40
BP 78
EP 91
DI 10.1016/j.actbio.2016.03.046
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DT5PJ
UT WOS:000381534800012
PM 27045347
DA 2018-10-20
ER

PT J
AU Kyle, DJT
   Oikonomou, A
   Hill, E
   Vijayaraghavan, A
   Bayat, A
AF Kyle, Daniel J. T.
   Oikonomou, Antonios
   Hill, Ernie
   Vijayaraghavan, Aravind
   Bayat, Ardeshir
TI Fabrication and modelling of fractal, biomimetic, micro and
   nano-topographical surfaces
SO BIOINSPIRATION & BIOMIMETICS
LA English
DT Article
DE biomimetics; fractal micro and nanotopography; implant biocompatibility;
   fabrication and modelling; 3D maskless grayscale photolithography;
   modified deep reactive ion etching; extracellular topographical cues
ID GRAY-SCALE LITHOGRAPHY; SILICON MEMS STRUCTURES; GECKO FOOT-HAIR;
   GRAYSCALE LITHOGRAPHY; DRIE PROCESS; 3D; MECHANOTRANSDUCTION;
   NANOTOPOGRAPHY; ADHESION; BIOCOMPATIBILITY
AB Natural surface topographies are often self-similar with hierarchical features at the micro and nanoscale, which may be mimicked to overcome modern tissue engineering and biomaterial design limitations. Specifically, a cell's microenvironment within the human body contains highly optimised, fractal topographical cues, which directs precise cell behaviour. However, recreating biomimetic, fractal topographies in vitro is not a trivial process and a number of fabrication methods have been proposed but often fail to precisely control the spatial resolution of features at different lengths scales and hence, to provide true biomimetic properties. Here, we propose a method of accurately reproducing the self-similar, micro and nanoscale topography of a human biological tissue into a synthetic polymer through an innovative fabrication process. The biological tissue surface was characterised using atomic force microscopy (AFM) to obtain spatial data in X, Y and Z, which was converted into a grayscale 'digital photomask'. As a result of maskless grayscale optical lithography followed by modified deep reactive ion etching and replica molding, we were able to accurately reproduce the fractal topography of acellular dermal matrix (ADM) into polydimethylsiloxane (PDMS). Characterisation using AFM at three different length scales revealed that the nano and micro-topographical features, in addition to the fractal dimension, of native ADM were reproduced in PDMS. In conclusion, it has been shown that the fractal topography of biological surfaces can be mimicked in synthetic materials using the novel fabrication process outlined, which may be applied to significantly enhance medical device biocompatibility and performance.
C1 [Kyle, Daniel J. T.; Bayat, Ardeshir] Univ Manchester, Manchester Inst Biotechnol, Plast & Reconstruct Surg Res, Manchester, Lancs, England.
   [Kyle, Daniel J. T.; Oikonomou, Antonios; Hill, Ernie] Univ Manchester, Ctr Mesosci & Nanotechnol, Sch Comp Sci, Manchester, Lancs, England.
   [Oikonomou, Antonios; Hill, Ernie; Vijayaraghavan, Aravind] Univ Manchester, Natl Graphene Inst, Manchester, Lancs, England.
   [Vijayaraghavan, Aravind] Univ Manchester, Sch Mat, Manchester, Lancs, England.
RP Bayat, A (reprint author), Univ Manchester, Manchester Inst Biotechnol, Plast & Reconstruct Surg Res, Manchester, Lancs, England.
EM Ardeshir.Bayat@manchester.ac.uk
RI Vijayaraghavan, Aravind/E-1087-2011
OI Vijayaraghavan, Aravind/0000-0001-8289-2337; Hill,
   Ernie/0000-0001-9412-6795
FU Mentor Corporation, USA; Engineering and Physical Sciences Research
   Council (EPSRC) grant [EP/K009451/1]; Engineering and Physical Sciences
   Research Council [EP/K005014/1, EP/K009451/1]
FX This work was funded by Mentor Corporation, USA. Mentor Corporation did
   not take any part in the study design; in the collection, analysis and
   interpretation of data; in the writing of the report; or in the decision
   to submit the paper for publication.; AO and AV acknowledge funding from
   the Engineering and Physical Sciences Research Council (EPSRC) grant
   EP/K009451/1.
CR Anselme K, 2011, INT MATER REV, V56, P243, DOI 10.1179/1743280411Y.0000000001
   Atencia J, 2007, LAB CHIP, V7, P1567, DOI 10.1039/b709369a
   Autumn K, 2005, PROC SPIE, V5804, P291, DOI 10.1117/12.506157
   Autumn K, 2002, P NATL ACAD SCI USA, V99, P12252, DOI 10.1073/pnas.192252799
   Autumn K, 2000, NATURE, V405, P681
   Bar-Cohen Y, 2006, BIOINSPIR BIOMIM, V1, pP1, DOI 10.1088/1748-3182/1/1/P01
   BarCohen Y, 2005, BIOMIMETICS MIMICKIN
   Barthlott W, 2011, BEILSTEIN J NANOTECH, V2, P135, DOI 10.3762/bjnano.2.16
   Basu CB, 2010, PLAST RECONSTR SURG, V126, P1842, DOI 10.1097/PRS.0b013e3181f44674
   Beidaghi M, 2011, ELECTROCHIM ACTA, V56, P9508, DOI 10.1016/j.electacta.2011.08.054
   Campbell M, 2000, NATURE, V404, P53
   Campoccia D, 2013, BIOMATERIALS, V34, P8018, DOI 10.1016/j.biomaterials.2013.07.048
   Chang C, 2005, J MICROMECH MICROENG
   Chen SL, 2010, BIOMATERIALS, V31, P3479, DOI 10.1016/j.biomaterials.2010.01.074
   Dahiya V, 2014, J DENT IMPLANTS, V4, P66
   Dalby MJ, 2005, MED ENG PHYS, V27, P730, DOI 10.1016/j.medengphy.2005.04.005
   Dalby MJ, 2004, EUR J CELL BIOL, V83, P159, DOI 10.1078/0171-9335-00369
   Danilevicius P, 2013, OPT LASER TECHNOL, V45, P518, DOI 10.1016/j.optlastec.2012.05.038
   David L, 2014, BIOINSPIR BIOMIM, V9
   de Mel A, 2008, BIOMACROMOLECULES, V9, P2969, DOI 10.1021/bm800681k
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Fu YQ, 2000, OPT EXPRESS, V7, P141, DOI 10.1364/OE.7.000141
   Gates BD, 2005, CHEM REV, V105, P1171, DOI 10.1021/cr030076o
   Gauvin R, 2011, ACS NANO, V5, P4258, DOI 10.1021/nn201826d
   Geim AK, 2003, NAT MATER, V2, P461, DOI 10.1038/nmat917
   Gerasopoulos K, 2012, ACS NANO, V6, P6422, DOI 10.1021/nn301981p
   GmBh M, 2011, MICROCHEMICALS DAT S
   Guo MX, 2013, MICROSYST TECHNOL, V19, P1097, DOI 10.1007/s00542-012-1720-9
   Harvey AG, 2013, EXPERT REV MED DEVIC, V10, P257, DOI [10.1586/ERD.12.82, 10.1586/erd.12.82]
   Higurashi E, 2009, IEEE J SEL TOP QUANT, V15, P1500, DOI 10.1109/JSTQE.2009.2020812
   Ho AYY, 2011, ACS NANO, V5, P1897, DOI 10.1021/nn103191q
   Hu F, 2003, J VAC SCI TECHNOL B, V21, P2672, DOI [10.1116/1.1627808, 10.1116/1.627808]
   Huh D, 2011, TRENDS CELL BIOL, V21, P745, DOI 10.1016/j.tcb.2011.09.005
   Ito T, 2000, NATURE, V406, P1027, DOI 10.1038/35023233
   Jansen HV, 2010, J MICROMECH MICROENG, V20, DOI 10.1088/0960-1317/20/7/075027
   Kawata S, 2001, NATURE, V412, P697, DOI 10.1038/35089130
   Kim J, 2007, MICROELECTRON ENG, V84, P2859, DOI 10.1016/j.mee.2007.02.015
   Kroese D P, 2013, ARXIV13080399
   Kyle D J T, 2014, INVENTORSIMPLANTS
   Kyle DJT, 2015, BIOMATERIALS, V52, P88, DOI 10.1016/j.biomaterials.2015.02.003
   Lai S, 2003, SCALLOPING MINIMIZAT
   Lake JH, 2011, J MICROELECTROMECH S, V20, P1483, DOI 10.1109/JMEMS.2011.2167664
   Laschi C, 2009, BIOINSPIR BIOMIM, V4, DOI 10.1088/1748-3182/4/1/015006
   Li MT, 2001, APPL PHYS LETT, V78, P3322, DOI 10.1063/1.1375006
   Liu RY, 2014, J BIOMATER TISS ENG, V4, P65, DOI 10.1166/jbt.2014.1138
   McKenna C, 2010, 18 BIENN U GOV IND M
   Mendonca G, 2008, BIOMATERIALS, V29, P3822, DOI 10.1016/j.biomaterials.2008.05.012
   Morgan B, 2004, J MICROELECTROMECH S, V13, P113, DOI 10.1109/JMEMS.2003.823220
   Mosher L, 2009, J MICROELECTROMECH S, V18, P308, DOI 10.1109/JMEMS.2008.2011703
   Mwenifumbo S, 2008, BIOMEDICAL NANOSTRUCTURES, P225
   Nikkhah M, 2012, BIOMATERIALS, V33, P5230, DOI 10.1016/j.biomaterials.2012.03.079
   Peran M, 2013, MATERIALS, V6, P1333, DOI 10.3390/ma6041333
   Qi PK, 2013, SURF COAT TECH, V233, P80, DOI 10.1016/j.surfcoat.2013.02.008
   Quirk M, 2001, SEMICONDUCTOR MANUFA
   Rammohan A, 2011, SENSOR ACTUAT B-CHEM, V153, P125, DOI 10.1016/j.snb.2010.10.021
   Reyzelman A, 2009, INT WOUND J, V6, P196, DOI 10.1111/j.1742-481X.2009.00585.x
   Sjostrom T, 2009, ACTA BIOMATER, V5, P1433, DOI 10.1016/j.actbio.2009.01.007
   Soumya S, 2012, J MATER CHEM, V22, P1904, DOI 10.1039/c1jm14038h
   Stein ML, 2002, J COMPUT GRAPH STAT, V11, P587, DOI 10.1198/106186002466
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Sullivan MP, 2014, BONE JOINT J, V96B, P569, DOI 10.1302/0301-620X.96B5.33606
   Teo BKK, 2013, ACS NANO, V7, P4785, DOI 10.1021/nn304966z
   Totsu K, 2006, SENSOR ACTUAT A-PHYS, V130, P387, DOI 10.1016/j.sna.2005.12.008
   Trask RS, 2007, BIOINSPIR BIOMIM, V2, pP1, DOI 10.1088/1748-3182/2/1/P01
   Varadan VK, 2000, SMART MATER STRUCT, V9, P953, DOI 10.1088/0964-1726/9/6/327
   Waits CM, 2005, SENSOR ACTUAT A-PHYS, V119, P245, DOI 10.1016/j.sna.2004.03.024
   Waits CM, 2003, J MICROMECH MICROENG, V13, P170, DOI 10.1088/0960-1317/13/2/302
   Wang XD, 2007, J MICROMECH MICROENG, V17, P804, DOI 10.1088/0960-1317/17/4/018
   Wang XD, 2008, MICROELECTRON ENG, V85, P1015, DOI 10.1016/j.mee.2008.01.073
   Westerman R, 2014, SPIE MOEMS MEMS
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153
   Yang JL, 2014, ACS NANO, V8, P9941, DOI 10.1021/nn504767g
   Yang JC, 2010, NANO LETT, V10, P3173, DOI 10.1021/nl102078j
   Yu WX, 2003, OPT EXPRESS, V11, P899, DOI 10.1364/OE.11.000899
   Zentgraf T, 2011, NAT NANOTECHNOL, V6, P151, DOI [10.1038/nnano.2010.282, 10.1038/NNANO.2010.282]
   Zervantonakis IK, 2012, P NATL ACAD SCI USA, V109, P13515, DOI 10.1073/pnas.1210182109
   Zhang LG, 2014, ADV MICRO NANOTECHNO
   Zhong KJ, 2014, OPTIK, V125, P2413, DOI 10.1016/j.ijleo.2013.10.082
NR 79
TC 0
Z9 0
U1 6
U2 50
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-3182
EI 1748-3190
J9 BIOINSPIR BIOMIM
JI Bioinspir. Biomim.
PD AUG
PY 2016
VL 11
IS 4
AR 046009
DI 10.1088/1748-3190/11/4/046009
PG 15
WC Engineering, Multidisciplinary; Materials Science, Biomaterials;
   Robotics
SC Engineering; Materials Science; Robotics
GA DU9EI
UT WOS:000382518700015
PM 27454401
OA Other Gold
DA 2018-10-20
ER

PT J
AU Czyz, K
   Marczak, J
   Major, R
   Mzyk, A
   Rycyk, A
   Sarzynski, A
   Strzelec, M
AF Czyz, Krzysztof
   Marczak, Jan
   Major, Roman
   Mzyk, Aldona
   Rycyk, Antoni
   Sarzynski, Antoni
   Strzelec, Marek
TI Selected laser methods for surface structuring of biocompatible
   diamond-like carbon layers
SO DIAMOND AND RELATED MATERIALS
LA English
DT Article; Proceedings Paper
CT Smart Engineering of New Materials Conference
CY JUN 22-25, 2015
CL Lodz, POLAND
SP Lodz Univ Technol, Inst Mat Sci & Engn, Warsaw Univ Technol, Inst Microelectron & Optoelectron, Lodz Univ Technol, Dept Semicond & Optoelectron Dev, Polish Acad Sci, Comm Mat Sci
DE Diamond like carbon; Laser micromachining; Bioengineering; Biomaterial
   scaffolds
ID CELL RESPONSE; INTERFERENCE LITHOGRAPHY; BIOMEDICAL APPLICATIONS;
   AMORPHOUS-CARBON; TOPOGRAPHIC CUES; POLYMER SURFACE; THIN-FILMS;
   NANOSCALE; COATINGS; MICROSCALE
AB Laser based surface structuring methods are among the fastest growing techniques and displace other surface treatments for applications such as marking, change of topography and microstructure. Such changes may lead to controlled modification of material properties, including their biocompatibility. The paper presents two laser techniques - picosecond Direct Laser Writing (DLW) and multi-beam Direct Laser Interference Lithography (DLIL). The purpose of the research was to create different shapes and dimensions of 2D and 3D periodical microstructures on the surface of thin diamond like carbon (DLC) coatings on different substrates. Resulting structures were further tested to find the influence of laser processing on the interaction of created scaffolds with the living cells in the direction of improvement of their directional growth and adhesion. The use of two different patterning methods (DLW and DLIL) allowed creation of structures with periods ranging between sub-microns to tens of microns, with different pattern resolutions, shapes (linear, dotted, crossed, hierarchical) and depths. Preliminary analyses have shown the possibility of high degree of control and improvement in the directional growth of smooth muscle cells and the proliferation of the endothelial cells, cultivated on migration channels created at DLC layers. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Czyz, Krzysztof; Marczak, Jan; Rycyk, Antoni; Sarzynski, Antoni; Strzelec, Marek] Mil Univ Technol, Inst Optoelect, 2 Gen Sylwestra Kaliskiego St, PL-00908 Warsaw, Poland.
   [Major, Roman; Mzyk, Aldona] Polish Acad Sci, Inst Met & Mat Sci, 25 Reymonta St, PL-30059 Krakow, Poland.
RP Strzelec, M (reprint author), Mil Univ Technol, Inst Optoelect, 2 Gen Sylwestra Kaliskiego St, PL-00908 Warsaw, Poland.
EM krzysztof.czyz@wat.edu.pl; jan.marczak@wat.edu.pl; r.major@imim.pl;
   aldonamzyk@googlemail.com; rycykantoni@gmail.com;
   antoni.sarzynski@wat.edu.pl; marek.strzelec@wat.edu.pl
OI Marek, Strzelec/0000-0003-1088-3057
CR Arps J.H., 2004, ENCY BIOMATERIALS BI, P446
   Beke S, 2014, OPT MATER EXPRESS, V4, P2032, DOI 10.1364/OME.4.002032
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Biela SA, 2009, ACTA BIOMATER, V5, P2460, DOI 10.1016/j.actbio.2009.04.003
   Bremus-Koebberling EA, 2012, J LASER APPL, V24, DOI 10.2351/1.4730804
   Brown M., 2010, LASER PRECISION MICR, V135, P91, DOI DOI 10.1007/978-3-642-10523-4_4
   Burrow GM, 2011, MICROMACHINES-BASEL, V2, P221, DOI 10.3390/mi2020221
   Castillo HA, 2011, APPL SURF SCI, V257, P2665, DOI 10.1016/j.apsusc.2010.10.039
   Chu PK, 2006, MATER CHEM PHYS, V96, P253, DOI 10.1016/j.matchemphys.2005.07.048
   Daminelli G, 2006, APPL PHYS A-MATER, V83, P89, DOI 10.1007/s00339-005-3460-5
   Dearnaley G, 2005, SURF COAT TECH, V200, P2518, DOI 10.1016/j.surfcoat.2005.07.077
   Dreier B, 2013, AM J PHYSIOL-CELL PH, V305, pC290, DOI 10.1152/ajpcell.00264.2012
   Ertorer E, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.3.035002
   Fedel M, 2009, J BIOMED MATER RES B, V90B, P338, DOI 10.1002/jbm.b.31291
   Gittard SD, 2010, EXPERT REV MED DEVIC, V7, P343, DOI [10.1586/erd.10.14, 10.1586/ERD.10.14]
   Grigonis A, 2011, ACTA PHYS POL A, V120, P26, DOI 10.12693/APhysPolA.120.26
   Grill A, 1999, DIAM RELAT MATER, V8, P428, DOI 10.1016/S0925-9635(98)00262-3
   Hedberg-Dirk EL, 2010, J NANOMATER, DOI 10.1155/2010/176750
   Hendrikson W, 2016, MACROMOL BIOSCI, V16, P43, DOI 10.1002/mabi.201500270
   Hribar KC, 2014, LAB CHIP, V14, P268, DOI 10.1039/c3lc50634g
   Hu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104502
   Jeon H, 2014, J BIOMED MATER RES B, V102, P1580, DOI 10.1002/jbm.b.33158
   Kim MS, 2008, PROG POLYM SCI, V33, P138, DOI 10.1016/j.progpolymsci.2007.06.001
   Kononenko TV, 2005, DIAM RELAT MATER, V14, P1368, DOI 10.1016/j.diamond.2005.02.009
   Lackner JM, 2004, SURF COAT TECH, V177, P360, DOI 10.1016/j.surfcoat.2003.09.027
   Lackner JM, 2013, COMPUT STRUCT BIOTEC, V6, DOI 10.5936/csbj.201303002
   Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5
   Lee CH, 2011, ANN BIOMED ENG, V39, P3031, DOI 10.1007/s10439-011-0417-z
   Li JA, 2014, J BIOMED MATER RES A, V102, P1950, DOI 10.1002/jbm.a.34867
   Lim JY, 2007, TISSUE ENG, V13, P1879, DOI 10.1089/ten.2006.0154
   Maguire PD, 2005, DIAM RELAT MATER, V14, P1277, DOI 10.1016/j.diamond.2004.12.023
   Marczak J, 2014, PHOTONICS LETT POL, V6, P44, DOI 10.4302/plp.2014.1.16
   Marczak J, 2013, PROC SPIE, V8703, DOI 10.1117/12.2013280
   Marczak J, 2014, OPT APPL, V44, P575, DOI 10.5277/oa140408
   Matsugaki A, 2015, BIOMATERIALS, V37, P134, DOI 10.1016/j.biomaterials.2014.10.025
   Melchels FPW, 2010, BIOMATERIALS, V31, P6121, DOI 10.1016/j.biomaterials.2010.04.050
   Nakamiya T, 2001, DIAM RELAT MATER, V10, P905, DOI 10.1016/S0925-9635(00)00536-7
   Nikkhah M, 2012, BIOMATERIALS, V33, P5230, DOI 10.1016/j.biomaterials.2012.03.079
   Pacelli S, 2016, J MATER CHEM B, V4, P1586, DOI 10.1039/c5tb01686j
   Peterbauer T, 2010, MACROMOL SYMP, V296, P272, DOI 10.1002/masy.201051038
   Pfleging W, 2007, APPL SURF SCI, V253, P9177, DOI 10.1016/j.apsusc.2007.05.047
   Ponche A, 2010, P I MECH ENG H, V224, P1471, DOI 10.1243/09544119JEIM900
   Ranella A, 2010, ACTA BIOMATER, V6, P2711, DOI 10.1016/j.actbio.2010.01.016
   Roch T, 2011, THIN SOLID FILMS, V519, P3756, DOI 10.1016/j.tsf.2011.01.338
   Roch T, 2013, DIAM RELAT MATER, V33, P20, DOI 10.1016/j.diamond.2012.12.002
   Roy RK, 2007, J BIOMED MATER RES B, V83B, P72, DOI 10.1002/jbm.b.30768
   Selimis A, 2015, MICROELECTRON ENG, V132, P83, DOI 10.1016/j.mee.2014.10.001
   Sin DC, 2009, EXPERT REV MED DEVIC, V6, P51, DOI 10.1586/17434440.6.1.51
   Stratakis E, 2009, PROG QUANT ELECTRON, V33, P127, DOI 10.1016/j.pquantelec.2009.06.001
   Tan J, 2004, BIOMATERIALS, V25, P3593, DOI 10.1016/j.biomaterials.2003.10.034
   Ventre M, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0687
   Waugh DG, 2011, APPL SURF SCI, V257, P8798, DOI 10.1016/j.apsusc.2011.04.044
   Waugh DG, 2010, OPT LASER ENG, V48, P707, DOI 10.1016/j.optlaseng.2010.01.005
   Wu XH, 2013, ADV HEALTHC MATER, V2, P326, DOI 10.1002/adhm.201200205
   Yu FY, 2005, BIOMACROMOLECULES, V6, P1160, DOI 10.1021/bm049324w
   Zhou Q, 2013, OPT EXPRESS, V21, P9851, DOI 10.1364/OE.21.009851
   Zhou XT, 2012, ACS APPL MATER INTER, V4, P3888, DOI 10.1021/am301237j
NR 57
TC 3
Z9 3
U1 2
U2 19
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-9635
EI 1879-0062
J9 DIAM RELAT MATER
JI Diam. Relat. Mat.
PD AUG
PY 2016
VL 67
BP 26
EP 40
DI 10.1016/j.diamond.2016.01.013
PG 15
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA DT2QR
UT WOS:000381326000005
DA 2018-10-20
ER

PT J
AU Bociaga, D
   Kaminska, M
   Sobczyk-Guzenda, A
   Jastrzebski, K
   Swiatek, L
   Olejnik, A
AF Bociaga, Dorota
   Kaminska, Marta
   Sobczyk-Guzenda, Anna
   Jastrzebski, Krzysztof
   Swiatek, Lidia
   Olejnik, Anna
TI Surface properties and biological behaviour of Si-DLC coatings
   fabricated by a multi-target DC-RF magnetron sputtering method for
   medical applications
SO DIAMOND AND RELATED MATERIALS
LA English
DT Article; Proceedings Paper
CT Smart Engineering of New Materials Conference
CY JUN 22-25, 2015
CL Lodz, POLAND
SP Lodz Univ Technol, Inst Mat Sci & Engn, Warsaw Univ Technol, Inst Microelectron & Optoelectron, Lodz Univ Technol, Dept Semicond & Optoelectron Dev, Polish Acad Sci, Comm Mat Sci
DE Si-DLC; Biomaterial; Magnetron sputtering; Haemocompatibility;
   Cytotoxicity; Surface free energy
ID DIAMOND-LIKE CARBON; CHEMICAL-VAPOR-DEPOSITION; THIN-FILMS;
   AMORPHOUS-CARBON; IN-VITRO; TRIBOLOGICAL PROPERTIES; BIOMEDICAL
   APPLICATIONS; MECHANICAL-PROPERTIES; STAINLESS-STEEL; BIOCOMPATIBILITY
AB The Si-incorporated diamond-like carbon (DLC) coatings deposited on AISI 316 LVM medical steel using magnetron sputtering method are currently not widely described in the literature, especially in terms of their biological response. Therefore, in this study both the haemocompatibility and cytotoxicity, as well as the surface properties of the Si-DLC films prepared by multi-target DC-RF magnetron sputtering were assessed. According to the XPS analysis the content of Si in the obtained coatings varied from similar to 4 at.% up to similar to 16 at.%. SEM investigations showed that the surface of the Si-DLC coatings is uniform and homogenous without any local defects. The surface energy measurements and FTIR analysis demonstrated that hydrophilicity and polarity of the examined surfaces changes with the varying Si-concentration. The evaluation of biological response towards the deposited coatings revealed that the increasing concentration of Si suppresses the platelet adhesion and decreases their activation level. Moreover, the results of the live/dead test indicated that the examined Si-DLC coatings are not cytotoxic, regardless of the Si concentration. Only a slight decrease in the endothelial cells' proliferation was observed with the growing Si content. Hence, it was concluded that the Si-DLC layer with the Si concentration similar to 16 at% would be the most bio- and haemocompatible. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Bociaga, Dorota; Jastrzebski, Krzysztof; Swiatek, Lidia; Olejnik, Anna] Lodz Univ Technol, Inst Mat Sci & Engn, Div Biomed Engn & Funct Mat, 1-15 Stefanowskiego St, PL-90924 Lodz, Poland.
   [Kaminska, Marta] Lodz Univ Technol, Inst Mat Sci & Engn, Div Biophys, 1-5 Stefanowskiego St, PL-90924 Lodz, Poland.
   [Sobczyk-Guzenda, Anna] Lodz Univ Technol, Inst Mat Sci & Engn, Div Coatings Engn & Nonmetall Mat, 1-15 Stefanowskiego St, PL-90924 Lodz, Poland.
RP Bociaga, D (reprint author), Lodz Univ Technol, Inst Mat Sci & Engn, Div Biomed Engn & Funct Mat, 1-15 Stefanowskiego St, PL-90924 Lodz, Poland.
EM dorota.bociaga1@gmail.com
RI Sobczyk-Guzenda, Anna/T-2089-2018; Kaminska, Marta/T-1949-2018
OI Sobczyk-Guzenda, Anna/0000-0003-1583-4238; Kaminska,
   Marta/0000-0002-3427-0944
CR Alakoski Esa, 2008, Open Orthop J, V2, P43, DOI 10.2174/1874325000802010043
   Allen M, 2001, J BIOMED MATER RES, V58, P319, DOI 10.1002/1097-4636(2001)58:3<319::AID-JBM1024>3.0.CO;2-F
   Anderson D.R., 1974, ANAL SILICONES
   Ban M, 2003, SURF COAT TECH, V162, P1, DOI 10.1016/S0257-8972(02)00572-8
   Bendavid A, 2007, DIAM RELAT MATER, V16, P1616, DOI 10.1016/j.diamond.2007.02.006
   Bociaga D, 2008, DIAM RELAT MATER, V17, P1410, DOI 10.1016/j.diamond.2008.02.014
   Bruinink A, 2005, BIOMATERIALS, V26, P3487, DOI 10.1016/j.biomaterials.2004.09.030
   Calomme M, 2004, J BONE MINER RES, V19, pS449
   Calomme M. R., 2002, Calcified Tissue International, V70, P292
   CARLISLE EM, 1978, NOBEL FDN S, V40, P231
   Castellino M, 2013, ANAL BIOANAL CHEM, V405, P321, DOI 10.1007/s00216-012-6449-x
   Chai F, 2008, ACTA BIOMATER, V4, P1369, DOI 10.1016/j.actbio.2008.04.011
   Charitidis CA, 2010, INT J REFRACT MET H, V28, P51, DOI 10.1016/j.ijrmhm.2009.08.003
   Choi J, 2007, SURF COAT TECH, V201, P8357, DOI 10.1016/j.surfcoat.2006.02.084
   Coates J., 2000, ENCY ANAL CHEM, P1, DOI DOI 10.1002/9780470027318.A5606
   Cousen PJ, 2012, CONTACT DERMATITIS, V66, P55, DOI 10.1111/j.1600-0536.2011.01970.x
   Cui JF, 2012, APPL SURF SCI, V258, P5025, DOI 10.1016/j.apsusc.2012.01.072
   Damasceno JC, 2000, SURF COAT TECH, V133, P247, DOI 10.1016/S0257-8972(00)00932-4
   Dearnaley G, 2005, SURF COAT TECH, V200, P2518, DOI 10.1016/j.surfcoat.2005.07.077
   Eisinger J., 1993, Magnesium Research, V6, P247
   GOODMAN SL, 1989, J BIOMED MATER RES, V23, P105, DOI 10.1002/jbm.820230109
   Goodman SL, 1999, J BIOMED MATER RES, V45, P240, DOI 10.1002/(SICI)1097-4636(19990605)45:3<240::AID-JBM12>3.3.CO;2-3
   Grill A, 2009, ANNU REV MATER RES, V39, P49, DOI 10.1146/annurev-matsci-082908-145305
   Hallab N, 2001, J BONE JOINT SURG AM, V83A, P428, DOI 10.2106/00004623-200103000-00017
   Hasebe T, 2006, J BIOMED MATER RES A, V76A, P86, DOI 10.1002/jbm.a.30512
   Hauert R, 2013, SURF COAT TECH, V233, P119, DOI 10.1016/j.surfcoat.2013.04.015
   Hauert R, 2003, DIAM RELAT MATER, V12, P583, DOI 10.1016/S0925-9635(03)00081-5
   Hunt BJ, 1997, BLOOD COAGUL FIBRIN, V8, P223, DOI 10.1097/00001721-199706000-00003
   Kim HG, 2005, THIN SOLID FILMS, V482, P299, DOI 10.1016/j.tsf.2004.11.164
   Kim HG, 2005, THIN SOLID FILMS, V475, P291, DOI 10.1016/j.tsf.2004.07.052
   Kwok SCH, 2006, DIAM RELAT MATER, V15, P893, DOI 10.1016/j.diamond.2005.10.062
   Leckner J.M., 2010, BHM, V155, P528
   Lee KR, 1997, THIN SOLID FILMS, V308, P263, DOI 10.1016/S0040-6090(97)00411-2
   Linder S, 2002, BIOMATERIALS, V23, P767, DOI 10.1016/S0142-9612(01)00182-X
   LOEPER J, 1979, ATHEROSCLEROSIS, V33, P397, DOI 10.1016/0021-9150(79)90032-7
   Love CA, 2013, TRIBOL INT, V63, P141, DOI 10.1016/j.triboint.2012.09.006
   LUCOVSKY G, 1979, PHYS REV B, V19, P2064, DOI 10.1103/PhysRevB.19.2064
   Mittal K. L., 2008, CONTACT ANGLE WETTAB, V5
   Mohanty M, 2002, BIOMOL ENG, V19, P125, DOI 10.1016/S1389-0344(02)00026-6
   Morshed MM, 2003, J MATER PROCESS TECH, V143, P922, DOI 10.1016/j.jmatprotec.2003.10.003
   Ogwu AA, 2008, J BIOMED MATER RES B, V85B, P105, DOI 10.1002/jbm.b.30922
   Okazaki Y, 2004, BIOMATERIALS, V25, P5913, DOI 10.1016/j.biomaterials.2004.01.064
   Okpalugo TIT, 2006, J BIOMED MATER RES B, V78B, P222, DOI 10.1002/jbm.b.30459
   Okpalugo TIT, 2004, DIAM RELAT MATER, V13, P1088, DOI 10.1016/j.diamond.2003.10.064
   Okpalugo TIT, 2004, J BIOMED MATER RES A, V71A, P201, DOI 10.1002/jbm.a.30104
   Okpalugo TIT, 2004, BIOMATERIALS, V25, P239, DOI 10.1016/S0142-9612(03)00494-0
   Okroj W, 2006, DIAM RELAT MATER, V15, P1535, DOI 10.1016/j.diamond.2005.12.033
   Ong SE, 2007, BIOMATERIALS, V28, P4033, DOI 10.1016/j.biomaterials.2007.05.031
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Randeniya LK, 2009, ACTA BIOMATER, V5, P1791, DOI 10.1016/j.actbio.2009.01.013
   Schroeder A, 2000, BIOMATERIALS, V21, P449, DOI 10.1016/S0142-9612(99)00135-0
   Sen A, 2009, BIOMATERIALS, V30, P1604, DOI 10.1016/j.biomaterials.2008.11.039
   Shanna R, 2008, THIN SOLID FILMS, V516, P5397, DOI 10.1016/j.tsf.2007.07.099
   Silverstein R.M., 1991, SPECTROMETRIC IDENTI, P72
   Soum-Glaude A, 2010, THIN SOLID FILMS, V519, P1266, DOI 10.1016/j.tsf.2010.09.024
   Thorwarth G, 2007, PLASMA PROCESS POLYM, V4, pS364, DOI 10.1002/ppap.200731001
   Voggenreiter G, 2003, BIOMATERIALS, V24, P247, DOI 10.1016/S0142-9612(02)00312-5
   Yang SH, 2002, WEAR, V252, P70, DOI 10.1016/S0043-1648(01)00856-0
NR 58
TC 8
Z9 8
U1 1
U2 22
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-9635
EI 1879-0062
J9 DIAM RELAT MATER
JI Diam. Relat. Mat.
PD AUG
PY 2016
VL 67
BP 41
EP 50
DI 10.1016/j.diamond.2016.01.025
PG 10
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA DT2QR
UT WOS:000381326000006
DA 2018-10-20
ER

PT J
AU Bochicchio, B
   Bracalello, A
   Pepe, A
AF Bochicchio, Brigida
   Bracalello, Angelo
   Pepe, Antonietta
TI Characterization of a Crosslinked Elastomeric-Protein Inspired
   Polypeptide
SO CHIRALITY
LA English
DT Article
DE AFM; circular dichroism; resilin; elastin; SEM
ID POLYPROLINE-II STRUCTURE; SUPRAMOLECULAR ORGANIZATION;
   EXTRACELLULAR-MATRIX; CIRCULAR-DICHROISM; HUMAN TROPOELASTIN; IN-SITU;
   ELASTIN; RESILIN; TRIFLUOROETHANOL; BIOPOLYMERS
AB Materials inspired by natural proteins have a great appeal in tissue engineering for their biocompatibility and similarity to extracellular matrix (ECM). Chimeric polypeptides inspired by elastomeric proteins such as silk, elastin, and collagen are of outstanding interest in the field. A recombinant polypeptide constituted of three different blocks, each of them having sequences derived from elastin, resilin, and collagen proteins, was demonstrated to be a good candidate as biomaterial for its self-assembling characteristics and biocompatibility. Herein, taking advantage of the primary amine functionalities present in the linear polypeptide, we crosslinked it with 1,6-hexamethylene-diisocyanate (HMDI). The characterization of the obtained polypeptide was realized by CD spectroscopy, AFM, and SEM microscopies. The obtained results, although not conclusive, demonstrate that the crosslinked polypeptide gave rise to porous networks, thin nanowires, and films not observable for the linear polypeptide. Chirality 28:606-611, 2016. (c) 2016 Wiley Periodicals, Inc.
C1 [Bochicchio, Brigida; Bracalello, Angelo; Pepe, Antonietta] Univ Basilicata, Dept Sci, Lab Prot Inspired Mat, Via Ateneo Lucano 10, I-85100 Potenza, Italy.
RP Bochicchio, B (reprint author), Univ Basilicata, Dept Sci, Lab Prot Inspired Mat, Via Ateneo Lucano 10, I-85100 Potenza, Italy.
EM brigida.bochicchio@unibas.it
RI Pepe, Antonietta/J-2489-2012
OI Pepe, Antonietta/0000-0002-1285-2273; Bochicchio,
   Brigida/0000-0002-0700-9257
FU Italian Ministry of University and Research (MIUR) (PRIN) [2010 L(SH3K)]
FX We Thank Dr. Neluta Ibris and Mr. Alessandro Laurita (ex-CIGAS,
   University of Basilicata) for AFM and SEM images. Financial support from
   the Italian Ministry of University and Research (MIUR) (PRIN
   2010-Project 2010 L(SH3K)) is gratefully acknowledged.
CR Annabi N, 2010, BIOMATERIALS, V31, P1655, DOI 10.1016/j.biomaterials.2009.11.051
   Asai D, 2012, BIOMATERIALS, V33, P5451, DOI 10.1016/j.biomaterials.2012.03.083
   Bienkiewicz EA, 2000, J MOL BIOL, V297, P119, DOI 10.1006/jmbi.2000.3545
   Bochicchio B, 2002, CHIRALITY, V14, P782, DOI 10.1002/chir.10153
   Bochicchio B, 2008, CHIRALITY, V20, P985, DOI 10.1002/chir.20541
   Bodkin MJ, 1996, BIOPOLYMERS, V39, P43, DOI 10.1002/(SICI)1097-0282(199607)39:1<43::AID-BIP5>3.3.CO;2-5
   Bracalello A, 2011, BIOMACROMOLECULES, V12, P2957, DOI 10.1021/bm2005388
   Buck M, 1998, Q REV BIOPHYS, V31, P297, DOI 10.1017/S003358359800345X
   Chow D, 2008, MAT SCI ENG R, V62, P125, DOI 10.1016/j.mser.2008.04.004
   delsMercato LL, 2008, BIOMACROMOLECULES, V9, P796
   DRAKE AF, 1988, BIOPHYS CHEM, V31, P143, DOI 10.1016/0301-4622(88)80019-X
   Ferreira LA, 2015, INT J MOL SCI, V16, P13528, DOI 10.3390/ijms160613528
   Gosline J, 2002, PHILOS T ROY SOC B, V357, P121, DOI 10.1098/rstb.2001.1022
   Keeley FW, 2002, PHILOS T R SOC B, V357, P185, DOI 10.1098/rstb.2001.1027
   Li L, 2013, ACS MACRO LETT, V2, P635, DOI 10.1021/mz4002194
   Lin YA, 2014, LANGMUIR, V30, P4406, DOI 10.1021/la403559t
   Lyons RE, 2007, PROTEIN ENG DES SEL, V20, P25, DOI 10.1093/protein/gzl050
   Martin L, 2009, BIOMACROMOLECULES, V10, P3015, DOI 10.1021/bm900560a
   Martino M, 2002, BIOMACROMOLECULES, V3, P297, DOI 10.1021/bm010129g
   Mecham RP, 2014, J TISSUE ENG REGEN M, V8, P38
   Nowatzki PJ, 2004, BIOMATERIALS, V25, P1261, DOI 10.1016/S0142-9612(03)000365-5
   Pepe A, 2005, MATRIX BIOL, V24, P96, DOI 10.1016/j.matbio.2005.01.004
   Pepe A, 2008, MATRIX BIOL, V27, P441, DOI 10.1016/j.matbio.2008.02.006
   Pepe A, 2007, NANOMEDICINE-UK, V2, P203, DOI 10.2217/17435889.2.2.203
   Poursaid A, 2015, BIOMATERIALS, V57, P142, DOI 10.1016/j.biomaterials.2015.04.015
   Reiersen H, 2000, PROTEIN ENG, V13, P739, DOI 10.1093/protein/13.11.739
   Samouillan V, 2000, MED BIOL ENG COMPUT, V38, P226, DOI 10.1007/BF02344781
   Sbrana F, 2012, BIOINSPIR BIOMIM, V7, DOI 10.1088/1748-3182/7/4/046007
   Shi ZS, 2002, P NATL ACAD SCI USA, V99, P9190, DOI 10.1073/pnas.112193999
   Shi ZS, 2002, ADV PROTEIN CHEM, V62, P163
   Tamburro AM, 2010, CHEMBIOCHEM, V11, P83, DOI 10.1002/cbic.200900460
   vansLuyn MJ, 1992, BIOMATERIALS, V13, P1017
   WOODY RW, 1992, ADV BIOPHYS CHEM, V2, P37
NR 33
TC 1
Z9 1
U1 1
U2 17
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0899-0042
EI 1520-636X
J9 CHIRALITY
JI Chirality
PD AUG
PY 2016
VL 28
IS 8
BP 606
EP 611
DI 10.1002/chir.22619
PG 6
WC Chemistry, Medicinal; Chemistry, Analytical; Chemistry, Organic;
   Pharmacology & Pharmacy
SC Pharmacology & Pharmacy; Chemistry
GA DS7GH
UT WOS:000380950600005
PM 27403636
DA 2018-10-20
ER

PT J
AU Akturk, O
   Kismet, K
   Yasti, AC
   Kuru, S
   Duymus, ME
   Kaya, F
   Caydere, M
   Hucumenoglu, S
   Keskin, D
AF Akturk, Omer
   Kismet, Kemal
   Yasti, Ahmet C.
   Kuru, Serdar
   Duymus, Mehmet E.
   Kaya, Feridun
   Caydere, Muzaffer
   Hucumenoglu, Sema
   Keskin, Dilek
TI Collagen/gold nanoparticle nanocomposites: A potential skin wound
   healing biomaterial
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Collagen type I; gold nanoparticles; Matriderm (R); biomechanical tests;
   full-thickness wound
ID CAPPED GOLD NANOPARTICLES; AGED HUMAN SKIN; CROSS-LINKING; DERMAL
   SUBSTITUTE; OXIDATIVE STRESS; GROWTH-FACTOR; BURN WOUNDS; TISSUE;
   SCAFFOLD; SIZE
AB In this study, nanocomposite collagen scaffolds incorporating gold nanoparticles (AuNPs) were prepared for wound healing applications. Initially, dose (<20ppm) and size (>20nm) of AuNPs that were not cytotoxic on HaCat keratinocytes and 3T3 fibroblasts were determined. Both collagen sponges and AuNP-incorporated nanocomposites (CS-Au) were cross-linked with glutaraldehyde (CS-X and CS-AuX). Incorporation of AuNPs into cross-linked scaffolds enhanced their stability against enzymatic degradation and increased the tensile strength. Hydrolytic degradation of CS-Au group was also less than CS after seven days. Upon confirming in vitro biocompatibility of the scaffolds with cytotoxicity assays, cell attachment and proliferation tests and the in vivo efficacy for healing of full-thickness skin wounds were investigated by applying CS-X, CS-AuX or a commercial product (Matriderm (R)) onto defect sites and covering with Ioban (R) drapes. Defects were covered only with drapes for untreated control group. The wound areas were examined with histopathological and biomechanical tests after 14 days of operation. CS-AuX group was superior to untreated control and Matriderm (R); it suppressed the inflammation while significantly promoting granulation tissue formation. Inflammatory reaction against CS-AuX was milder than CS-X. Neovascularization was also higher in CS-AuX than other groups, though the result was not significant. Wound closure in CS-X (76%), CS-AuX (69%), and Matriderm (R) (65%) were better than untreated control (45%). CS-AuX group had the highest tensile strength (significantly higher than Matriderm (R)) and modulus (significantly higher than Matriderm (R) and CS-X), indicating a faster course of dermal healing. Further studies are also needed to investigate whether higher loading of AuNPs affects these results positively in a statistically meaningful manner. Overall, their contribution to the enhancement of degradation profiles and mechanical properties, their excellent invitro biocompatibility, and tendency to accelerate wound healing are encouraging the use of AuNPs in collagen sponges as potent skin substitutes in the future.
C1 [Akturk, Omer; Keskin, Dilek] Middle East Tech Univ, Dept Engn Sci, Ankara, Turkey.
   [Kismet, Kemal; Kuru, Serdar; Duymus, Mehmet E.] Ankara Numune Training & Res Hosp, Dept Gen Surg, Ankara, Turkey.
   [Yasti, Ahmet C.] Ankara Numune Hosp, Dept Gen Surg, Ankara, Turkey.
   [Yasti, Ahmet C.] Hitit Univ, Dept Gen Surg, Sch Med, Corum, Turkey.
   [Kaya, Feridun] Ankara Yuksek Ihtisas Training & Res Hosp, Dept Surg Gastroenterol, Ankara, Turkey.
   [Caydere, Muzaffer; Hucumenoglu, Sema] Ankara Numune Training & Res Hosp, Dept Pathol, Ankara, Turkey.
   [Keskin, Dilek] Middle East Tech Univ, Ctr Excellence Biomat & Tissue Engn, BIOMATEN, Ankara, Turkey.
RP Keskin, D (reprint author), Middle East Tech Univ, Dept Engn Sci, Ankara, Turkey.; Kismet, K (reprint author), Ankara Numune Training & Res Hosp, Dept Gen Surg, Ankara, Turkey.; Keskin, D (reprint author), Middle East Tech Univ, Biomat & Tissue Engn Ctr Excellence, Ankara, Turkey.
EM kemalkismet@yahoo.com; dkeskin@metu.edu.tr
FU Scientific and Technological Research Council of Turkey, TUBITAK
   [111M810]; TUBITAK [2120189]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This
   investigation was financially supported by the Scientific and
   Technological Research Council of Turkey, TUBITAK (Project no: 111M810).
   The commercialization potential of the composite scaffolds developed
   here was also investigated with the cooperation of METU and Remoderm
   Medical Ltd Co and with the financial support of TUBITAK (Project no:
   2120189) in the framework of 1512-Entrepreneurship and Multistep R&D
   Funding Program.
CR Agarwal S, 2015, ANALYST, V140, P1166, DOI 10.1039/c4an01935k
   Akalin C, 2014, INT WOUND J, V11, P64, DOI 10.1111/j.1742-481X.2012.01063.x
   Akturk O, 2016, TURK J BIOL, V40, P380, DOI 10.3906/biy-1502-49
   Bhardwaj N, 2015, INTEGR BIOL-UK, V7, P53, DOI 10.1039/c4ib00208c
   Bi L, 2011, J MATER SCI-MATER M, V22, P51, DOI 10.1007/s10856-010-4177-3
   Biedermann T, 2013, EUR J PEDIATR SURG, V23, P375, DOI 10.1055/s-0033-1352529
   Boekema BKHL, 2014, J MATER SCI-MATER M, V25, P423, DOI 10.1007/s10856-013-5075-2
   Castaneda L, 2008, BIOMACROMOLECULES, V9, P3383, DOI 10.1021/bm800793z
   Chang MC, 2002, BIOMATERIALS, V23, P4811, DOI 10.1016/S0142-9612(02)00232-6
   Chen H, 2013, PLOS ONE, V8
   Cozad MJ, 2011, J BIOMED MATER RES A, V99A, P426, DOI 10.1002/jbm.a.33182
   Cui QL, 2014, ACS APPL MATER INTER, V6, P1999, DOI 10.1021/am5000068
   Cui WJ, 2012, NANOMED-NANOTECHNOL, V8, P46, DOI 10.1016/j.nano.2011.05.005
   DAMINK LHHO, 1995, J MATER SCI-MATER M, V6, P460, DOI 10.1007/BF00123371
   Davidenko N, 2012, ACTA BIOMATER, V8, P667, DOI 10.1016/j.actbio.2011.09.033
   Deeken CR, 2011, J BIOMED MATER RES B, V97B, P334, DOI 10.1002/jbm.b.31819
   Duan X, 2006, BIOMATERIALS, V27, P4608, DOI 10.1016/j.biomaterials.2006.04.022
   Ehmann HMA, 2015, CARBOHYD POLYM, V117, P34, DOI 10.1016/j.carbpol.2014.08.116
   Fisher GJ, 2009, AM J PATHOL, V174, P101, DOI 10.2353/ajpath.2009.080599
   FRENS G, 1973, NATURE-PHYS SCI, V241, P20, DOI 10.1038/physci241020a0
   Gaspar A, 2011, J Med Life, V4, P172
   Goodman CM, 2004, BIOCONJUGATE CHEM, V15, P897, DOI 10.1021/bc049951i
   Gopalakrishnan R, 2015, PHYS CHEM CHEM PHYS, V17, P5172, DOI 10.1039/c4cp04969a
   Grant DN, 2011, J MATER SCI-MATER M, V22, P2803, DOI 10.1007/s10856-011-4449-6
   Grant SA, 2014, J BIOMED MATER RES A, V102, P332, DOI 10.1002/jbm.a.34698
   HARPER E, 1980, ANNU REV BIOCHEM, V49, P1063, DOI 10.1146/annurev.bi.49.070180.005215
   Hung HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104019
   Jia L, 2014, MAT SCI ENG C-MATER, V43, P231, DOI 10.1016/j.msec.2014.07.024
   Jimenez PA, 1999, J SURG RES, V81, P238, DOI 10.1006/jsre.1998.5501
   Jung DJ, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-23
   Kimling J, 2006, J PHYS CHEM B, V110, P15700, DOI 10.1021/jp061667w
   Kumari K, 2014, MATER LETT, V79, P199
   Kuroyanagi M, 2014, J BIOMAT SCI-POLYM E, V25, P1133, DOI 10.1080/09205063.2014.920171
   Lai JY, 2013, INT J NANOMED, V8, P4157, DOI 10.2147/IJN.S52731
   Li XN, 2014, ACS NANO, V8, P10682, DOI 10.1021/nn5042625
   Lin C, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/4/045017
   Lin HY, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/2/025009
   Lin YL, 2008, SURG NEUROL, V70, P9, DOI 10.1016/j.surneu.2008.01.057
   Lu SY, 2010, COLLOID SURFACE B, V81, P406, DOI 10.1016/j.colsurfb.2010.06.019
   Manjumeena R, 2015, J BIOMATER APPL, V29, P1039, DOI 10.1177/0885328214550011
   McKeon-Fischer KD, 2011, J TISSUE ENG REGEN M, V5, P560, DOI 10.1002/term.348
   Midwood KS, 2004, INT J BIOCHEM CELL B, V36, P1031, DOI 10.1016/j.biocel.2003.12.003
   Muehlberger T, 2005, J AM ACAD DERMATOL, V52, P583, DOI 10.1016/j.jaad.2004.08.059
   Muthukumar T, 2014, COLLOID SURFACE B, V113, P207, DOI 10.1016/j.colsurfb.2013.09.019
   Neupane MP, 2011, J NANOPART RES, V13, P491, DOI 10.1007/s11051-010-9971-9
   Obaid G, 2015, PHOTOCH PHOTOBIO SCI, V14, P737, DOI 10.1039/c4pp00312h
   Pan Y, 2007, SMALL, V3, P1941, DOI 10.1002/smll.200700378
   Patra HK, 2007, NANOMED-NANOTECHNOL, V3, P111, DOI 10.1016/j.nano.2007.03.005
   Paviolo C, 2015, SMALL, V11, P1638, DOI 10.1002/smll.201402701
   Powell HM, 2006, BIOMATERIALS, V27, P5821, DOI 10.1016/j.biomaterials.2006.07.030
   Quan TH, 2010, J INVEST DERMATOL, V130, P415, DOI 10.1038/jid.2009.224
   Regiel-Futyra A, 2015, ACS APPL MATER INTER, V7, P1087, DOI 10.1021/am508094e
   Roh DH, 2006, J MATER SCI-MATER M, V17, P547, DOI 10.1007/s10856-006-8938-y
   Schaeublin NM, 2011, NANOSCALE, V3, P410, DOI 10.1039/c0nr00478b
   Silveira PCL, 2014, MAT SCI ENG C-MATER, V44, P380, DOI 10.1016/j.msec.2014.08.045
   Silver FH, 2003, SKIN RES TECHNOL, V9, P3, DOI 10.1034/j.1600-0846.2003.00358.x
   Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006
   Spadavecchia J, 2014, ANGEW CHEM INT EDIT, V53, P8363, DOI 10.1002/anie.201403567
   Stipcevic T, 2006, BURNS, V32, P24, DOI 10.1016/j.bums.2005.07.004
   Supp DM, 2005, CLIN DERMATOL, V23, P403, DOI 10.1016/j.clindermatol.2004.07.023
   Tsirogianni AK, 2006, INJURY, V37, pS5, DOI 10.1016/j.injury.2006.02.035
   Wang SG, 2008, CHEM PHYS LETT, V463, P145, DOI 10.1016/j.cplett.2008.08.039
   Wang XG, 2013, ACTA BIOMATER, V9, P7822, DOI 10.1016/j.actbio.2013.04.017
   Wei G, 2007, J PHYS CHEM C, V111, P1976, DOI 10.1021/jp065868b
   Whelove OE, 2011, J BIOMED MATER RES B, V99B, P142, DOI 10.1002/jbm.b.31881
   WINTER GD, 1963, NATURE, V197, P91, DOI 10.1038/197091b0
   WINTER GD, 1962, NATURE, V193, P293, DOI 10.1038/193293a0
   Zhou Y, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-19
NR 68
TC 15
Z9 15
U1 4
U2 36
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD AUG
PY 2016
VL 31
IS 2
BP 283
EP 301
DI 10.1177/0885328216644536
PG 19
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DU8CL
UT WOS:000382440800011
PM 27095659
DA 2018-10-20
ER

PT J
AU Patton, AJ
   Poole-Warren, LA
   Green, RA
AF Patton, Alexander J.
   Poole-Warren, Laura A.
   Green, Rylie A.
TI Mechanisms for Imparting Conductivity to Nonconductive Polymeric
   Biomaterials
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Review
DE biomaterial; conductive composite; conductivity; polymer; tissue
   engineering
ID TISSUE-ENGINEERING SCAFFOLDS; WALL CARBON NANOTUBES; ELECTRICAL
   PERCOLATION-THRESHOLD; TRANSDERMAL DRUG-DELIVERY; IN-SITU
   POLYMERIZATION; TRANSPARENT ELECTRODES; EPOXY COMPOSITES; NEURAL TISSUE;
   POLYURETHANE ELASTOMERS; ORTHOPEDIC APPLICATIONS
AB Traditionally, conductive materials for electrodes are based on high modulus metals or alloys. Development of bioelectrodes that mimic the mechanical properties of the soft, low modulus tissues in which they are implanted is a rapidly expanding field of research. Many polymers exist that more closely match tissue mechanics than metals; however, the majority do not conduct charge. Integrating conductive properties via incorporation of metals and other conductors into nonconductive polymers is a successful approach to producing polymers that can be used in electrical interfacing devices. When combining conductive materials with nonconductive polymer matrices, there is often a tradeoff between the electrical and mechanical properties. This review analyzes the advantages and disadvantages of approaches involving coating or layer formation, composite formation via dispersion of conductive inclusions through polymer matrices, and in situ growth of a conductive network within polymers.
C1 [Patton, Alexander J.; Poole-Warren, Laura A.; Green, Rylie A.] Univ New South Wales, Grad Sch Biomed Engn, Kingston, Tas, Australia.
RP Green, RA (reprint author), Univ New South Wales, Grad Sch Biomed Engn, Kingston, Tas, Australia.
EM r.green@unsw.edu.au
OI Green, Rylie/0000-0003-1569-7288
CR Abedini A, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-474
   Abidian MR, 2012, ADV HEALTHC MATER, V1, P762, DOI 10.1002/adhm.201200182
   Adhikari R, 2008, BIOMATERIALS, V29, P3762, DOI 10.1016/j.biomaterials.2008.06.021
   Aguilar JO, 2010, EXPRESS POLYM LETT, V4, P292, DOI 10.3144/expresspolymlett.2010.37
   Ahmed EM, 2015, J ADV RES, V6, P105, DOI 10.1016/j.jare.2013.07.006
   Anoop-Anand K., 2006, POLYMER, V47, P3976, DOI DOI 10.1016/J.POLYMER.2006.03.079
   Aouada FA, 2006, POLYM TEST, V25, P158, DOI 10.1016/j.polymertesting.2005.11.005
   Ateh DD, 2006, J R SOC INTERFACE, V3, P741, DOI 10.1098/rsif.2006.0141
   Atzet S, 2008, BIOMACROMOLECULES, V9, P3370, DOI 10.1021/bm800686h
   Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   Ayutsede J, 2006, BIOMACROMOLECULES, V7, P208, DOI 10.1021/bm0505888
   Baek S, 2014, J BIOMED MATER RES A, V102, P2743, DOI 10.1002/jbm.a.34945
   Baibarac M, 2006, J NANOSCI NANOTECHNO, V6, P289, DOI 10.1166/jnn.2006.002
   Baker SC, 2006, BIOMATERIALS, V27, P3136, DOI 10.1016/j.biomaterials.2006.01.026
   Balandin AA, 2011, NAT MATER, V10, P569, DOI [10.1038/nmat3064, 10.1038/NMAT3064]
   Balint R, 2014, ACTA BIOMATER, V10, P2341, DOI 10.1016/j.actbio.2014.02.015
   Banerjee A, 2009, BIOMATERIALS, V30, P4695, DOI 10.1016/j.biomaterials.2009.05.050
   Barkoula NM, 2008, POLYM POLYM COMPOS, V16, P101, DOI 10.1177/096739110801600203
   Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928
   Bell JHA, 2012, TISSUE ENG PART B-RE, V18, P116, DOI [10.1089/ten.teb.2011.0498, 10.1089/ten.TEB.2011.0498]
   Bendrea AD, 2011, J BIOMATER APPL, V26, P3, DOI 10.1177/0885328211402704
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P19, DOI 10.1016/s0939-6411(03)00161-9
   Bhana B, 2010, BIOTECHNOL BIOENG, V105, P1148, DOI 10.1002/bit.22647
   Bhattacharyya AR, 2003, POLYMER, V44, P2373, DOI 10.1016/S0032-3861(03)00073-9
   Bichara DA, 2010, J SURG RES, V163, P331, DOI 10.1016/j.jss.2010.03.070
   Bouhadir KH, 2001, BIOTECHNOL PROGR, V17, P945, DOI 10.1021/bp010070p
   Branzoi V, 2009, ELECTROANAL, V21, P557, DOI 10.1002/elan.200804449
   Brown A, 2015, ACTA BIOMATER, V11, P543, DOI 10.1016/j.actbio.2014.09.008
   Bryant SJ, 2004, MACROMOLECULES, V37, P6726, DOI 10.1021/ma0499324
   Butterwick A, 2007, IEEE T BIO-MED ENG, V54, P2261, DOI 10.1109/TBME.2007.908310
   Byrne MT, 2010, ADV MATER, V22, P1672, DOI 10.1002/adma.200901545
   Cadek M, 2004, NANO LETT, V4, P353, DOI 10.1021/nl035009o
   Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109
   Celle C, 2012, NANO RES, V5, P427, DOI 10.1007/s12274-012-0225-2
   Charlton DC, 2008, TISSUE ENG PT A, V14, P207, DOI 10.1089/ten.a.2006.0344
   Chatterjee A, 2007, MATER MANUF PROCESS, V22, P62, DOI 10.1080/10426910601015931
   Cheong GLM, 2014, ACTA BIOMATER, V10, P1216, DOI 10.1016/j.actbio.2013.12.032
   Cohn D, 2005, BIOMATERIALS, V26, P2297, DOI 10.1016/j.biomaterials.2004.07.052
   Coleman JN, 2006, ADV MATER, V18, P689, DOI 10.1002/adma.200501851
   Cooper CA, 2002, COMPOS SCI TECHNOL, V62, P1105, DOI 10.1016/S0266-3538(02)00056-8
   Cornock R, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/2/025002
   Cravino A, 2007, ADV FUNCT MATER, V17, P3906, DOI 10.1002/adfm.200700295
   Cui XY, 2001, J BIOMED MATER RES, V56, P261, DOI 10.1002/1097-4636(200108)56:2<261::AID-JBM1094>3.0.CO;2-I
   Dang ZM, 2012, PROG MATER SCI, V57, P660, DOI 10.1016/j.pmatsci.2011.08.001
   Davidovich-Pinhas M, 2010, CARBOHYD POLYM, V79, P1020, DOI 10.1016/j.carbpol.2009.10.036
   De Giglio E, 1999, J BIOMAT SCI-POLYM E, V10, P845, DOI 10.1163/156856299X00919
   DENDUNNEN WFA, 1993, J MATER SCI-MATER M, V4, P521, DOI 10.1007/BF00120133
   DENDUNNEN WFA, 1993, MICROSURG, V14, P508, DOI 10.1002/micr.1920140808
   Dhar A, 2013, APL MATER, V1, DOI 10.1063/1.4808438
   Diah AWM, 2014, ELECTROPHORESIS, V35, P1976, DOI 10.1002/elps.201400056
   DIAZ AF, 1983, IBM J RES DEV, V27, P342, DOI 10.1147/rd.274.0342
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Du J.-H., 2007, EXPRESS POLYM LETT, V1, P253
   Dvir T, 2011, NAT NANOTECHNOL, V6, P720, DOI [10.1038/nnano.2011.160, 10.1038/NNANO.2011.160]
   Ebbesen TW, 1996, NATURE, V382, P54, DOI 10.1038/382054a0
   Erkamp RQ, 1998, ULTRASONIC IMAGING, V20, P17, DOI 10.1177/016173469802000102
   Fang JY, 2002, J PHARM PHARMACOL, V54, P1329, DOI 10.1211/002235702760345392
   Fischer JE, 1997, PHYS REV B, V55, pR4921, DOI 10.1103/PhysRevB.55.R4921
   Forte G, 2012, TISSUE ENG PT A, V18, P1837, DOI [10.1089/ten.tea.2011.0707, 10.1089/ten.TEA.2011.0707]
   Frazer Robert Q, 2005, J Long Term Eff Med Implants, V15, P629
   Garcia M, 2014, TRAC-TREND ANAL CHEM, V57, P6, DOI 10.1016/j.trac.2014.01.004
   Garnett EC, 2012, NAT MATER, V11, P241, DOI [10.1038/NMAT3238, 10.1038/nmat3238]
   Gayet JC, 1996, J CONTROL RELEASE, V38, P177, DOI 10.1016/0168-3659(95)00118-2
   Gaynor W, 2011, ADV MATER, V23, P2905, DOI 10.1002/adma.201100566
   Gelves GA, 2006, ADV FUNCT MATER, V16, P2423, DOI 10.1002/adfm.200600336
   Giancoli D., 2009, PHYS SCI ENG
   Godier-Furnemont AFG, 2011, P NATL ACAD SCI USA, V108, P7974, DOI 10.1073/pnas.1104619108
   Gong S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4132
   Gouma P, 2006, J MATER RES, V21, P2904, DOI 10.1557/JMR.2006.0353
   Green RA, 2008, J MATER SCI-MATER M, V19, P1625, DOI 10.1007/s10856-008-3376-7
   Green RA, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/1/016009
   Green RA, 2012, MACROMOL BIOSCI, V12, P494, DOI 10.1002/mabi.201100490
   Green RA, 2010, SCI TECHNOL ADV MAT, V11, DOI 10.1088/1468-6996/11/1/014107
   Green RA, 2010, ACTA BIOMATER, V6, P63, DOI 10.1016/j.actbio.2009.06.030
   Green RA, 2009, BIOMATERIALS, V30, P3637, DOI 10.1016/j.biomaterials.2009.03.043
   Griffiths R., 1999, INTRO ELECTRODYNAMIC
   Guimard NK, 2007, PROG POLYM SCI, V32, P876, DOI 10.1016/j.progpolymsci.2007.05.012
   Gupta ND, 2014, J IND ENG CHEM, V20, P3208, DOI 10.1016/j.jiec.2013.11.067
   Haggenmueller R, 2006, MACROMOLECULES, V39, P2964, DOI 10.1021/ma0527698
   Haggenmueller R, 2000, CHEM PHYS LETT, V330, P219, DOI 10.1016/S0009-2614(00)01013-7
   Harada M, 2011, J PHYS CHEM C, V115, P14081, DOI 10.1021/jp203119a
   Hong S, 2007, NAT NANOTECHNOL, V2, P207, DOI 10.1038/nnano.2007.89
   Hsu PC, 2014, J AM CHEM SOC, V136, P10593, DOI 10.1021/ja505741e
   Huang AH, 2010, J BIOMECH, V43, P128, DOI 10.1016/j.jbiomech.2009.09.018
   Huyer LD, 2015, BIOMED MATER, V10, DOI 10.1088/1748-6041/10/3/034004
   INADA Y, 1995, TRENDS BIOTECHNOL, V13, P86, DOI 10.1016/S0167-7799(00)88912-X
   Jalili R, 2012, J MATER CHEM, V22, P25174, DOI 10.1039/c2jm35148j
   Jiang LQ, 2003, J COLLOID INTERF SCI, V260, P89, DOI 10.1016/S0021-9797(02)00176-5
   Jiang S, 2011, J MECH BEHAV BIOMED, V4, P1228, DOI 10.1016/j.jmbbm.2011.04.005
   Jin R., 2010, BIOMED APPL HYDROGEL, V101, P203
   Jones WR, 1999, J BIOMECH, V32, P119, DOI 10.1016/S0021-9290(98)00166-3
   Kaur V., 2013, IOSR J APPL CHEM, V5
   Kikuchi A, 2005, J CONTROL RELEASE, V101, P69, DOI 10.1016/j.jconrel.2004.08.026
   Kim A, 2013, ACS NANO, V7, P1081, DOI 10.1021/nn305491x
   Kim W., 2005, INT C THERM ICT P, V2005, P9
   Kittle C., 1967, AM J PHYS, V35, P547, DOI DOI 10.1119/1.1974177
   Kumar S, 2002, MACROMOLECULES, V35, P9039, DOI 10.1021/ma0205055
   Kuo CK, 2001, BIOMATERIALS, V22, P511, DOI 10.1016/S0142-9612(00)00201-5
   Kurniawan D, 2011, P I MECH ENG H, V225, P1015, DOI 10.1177/0954411911413059
   Lai SCS, 2015, CHEM SCI, V6, P1126, DOI 10.1039/c4sc02792b
   Lamba NMK, 1997, POLYURETHANES BIOMED, V25
   Landers R, 2002, J MATER SCI, V37, P3107, DOI 10.1023/A:1016189724389
   Langley D, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/45/452001
   Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996
   Lee GW, 2008, POLYMER, V49, P1831, DOI 10.1016/j.polymer.2008.02.029
   Lee J, 2012, NANOSCALE, V4, P6408, DOI 10.1039/c2nr31254a
   Leipzig N., 2009, ENCY BIOMATERIALS BI
   Li J, 2007, COMPOS SCI TECHNOL, V67, P296, DOI 10.1016/j.compscitech.2006.08.009
   Li XD, 2004, NANOTECHNOLOGY, V15, P1416, DOI 10.1088/0957-4484/15/11/005
   Li YL, 2005, LANGMUIR, V21, P10702, DOI 10.1021/la0514314
   Li ZS, 2005, BIOMATERIALS, V26, P3919, DOI 10.1016/j.biomaterials.2004.09.062
   Lieleg O, 2011, TRENDS CELL BIOL, V21, P543, DOI 10.1016/j.tcb.2011.06.002
   Lim JR, 2005, ADV MATER, V17, P1488, DOI 10.1002/adma.200401189
   Lim KS, 2013, BIOMATERIALS, V34, P7097, DOI 10.1016/j.biomaterials.2013.06.005
   Lipner J, 2014, J MECH BEHAV BIOMED, V40, P59, DOI 10.1016/j.jmbbm.2014.08.002
   Liu J, 2010, J PHYS CHEM C, V114, P9528, DOI 10.1021/jp102050s
   Liu RC, 2009, CHINESE SCI BULL, V54, P2028, DOI 10.1007/s11434-009-0217-0
   Liu YD, 2011, CARBON, V49, P4466, DOI 10.1016/j.carbon.2011.06.043
   Lo WWM, 1998, AM J NEURORADIOL, V19, P1147
   Long YZ, 2004, APPL PHYS LETT, V85, P1796, DOI 10.1063/1.1796370
   Long YZ, 2003, PHYSICA B, V325, P208, DOI 10.1016/S0921-4526(02)01526-0
   Lu XF, 2011, PROG POLYM SCI, V36, P671, DOI 10.1016/j.progpolymsci.2010.07.010
   Mietta JL, 2016, SOFT MATTER, V12, P422, DOI 10.1039/c5sm02268a
   Luo XL, 2009, ELECTROCHEM COMMUN, V11, P1956, DOI 10.1016/j.elecom.2009.08.027
   Ma PC, 2008, CARBON, V46, P1497, DOI 10.1016/j.carbon.2008.06.048
   Ma PC, 2010, COMPOS PART A-APPL S, V41, P1345, DOI 10.1016/j.compositesa.2010.07.003
   Ma YF, 2008, ACS NANO, V2, P1197, DOI 10.1021/nn800201n
   MACCAGNO TM, 1991, ENG FRACT MECH, V38, P111, DOI 10.1016/0013-7944(91)90076-D
   Mano JF, 2004, COMPOS SCI TECHNOL, V64, P789, DOI 10.1016/j.compscitech.2003.09.001
   Martens P, 2002, POLYMER, V43, P6093, DOI 10.1016/S0032-3861(02)00561-X
   Martin J, 2001, J NON-CRYST SOLIDS, V285, P222, DOI 10.1016/S0022-3093(01)00457-4
   Matyash M, 2014, TISSUE ENG PART C-ME, V20, P401, DOI [10.1089/ten.tec.2013.0252, 10.1089/ten.TEC.2013.0252]
   Mawad D, 2008, BIOMACROMOLECULES, V9, P263, DOI 10.1021/bm700754m
   Maziarz EP, 2000, J AM SOC MASS SPECTR, V11, P659, DOI 10.1016/S1044-0305(00)00134-3
   Merrill DR, 2005, J NEUROSCI METH, V141, P171, DOI 10.1016/j.jneumeth.2004.10.020
   Metters AT, 2000, POLYMER, V41, P3993, DOI 10.1016/S0032-3861(99)00629-1
   Miyagawa H, 2005, J NANOSCI NANOTECHNO, V5, P1593, DOI 10.1166/jnn.2005.181
   Moisala A, 2006, COMPOS SCI TECHNOL, V66, P1285, DOI 10.1016/j.compscitech.2005.10.016
   Moore DR, 2009, NAT NEUROSCI, V12, P686, DOI 10.1038/nn.2326
   MORTIMER JT, 1980, ANN BIOMED ENG, V8, P235, DOI 10.1007/BF02364479
   Mousa WF, 2000, BIOMATERIALS, V21, P2137, DOI 10.1016/S0142-9612(00)00097-1
   Muggli DS, 1999, J BIOMED MATER RES, V46, P271, DOI 10.1002/(SICI)1097-4636(199908)46:2<271::AID-JBM17>3.0.CO;2-X
   Naficy S, 2012, CHEM MATER, V24, P3425, DOI 10.1021/cm301666w
   Normand V, 2000, BIOMACROMOLECULES, V1, P730, DOI 10.1021/bm005583j
   Nuttelman CR, 2002, BIOMATERIALS, V23, P3617, DOI 10.1016/S0142-9612(02)00093-5
   Nyberg T, 2002, BIOMED MICRODEVICES, V4, P43, DOI 10.1023/A:1014219828983
   Okuzaki H, 2009, EUR POLYM J, V45, P256, DOI 10.1016/j.eurpolymj.2008.10.027
   Otero TF, 2007, MAT SCI ENG C-BIO S, V27, P18, DOI 10.1016/j.msec.2005.11.002
   Otero TF, 2004, ELECTROCHIM ACTA, V49, P3719, DOI 10.1016/j.electacta.2004.01.085
   Pang H, 2010, MATER LETT, V64, P2226, DOI 10.1016/j.matlet.2010.07.001
   Papkov D, 2013, ACS NANO, V7, P126, DOI 10.1021/nn303423x
   Park JG, 2002, APPL PHYS LETT, V81, P4625, DOI 10.1063/1.1528281
   Park JH, 2005, J CONTROL RELEASE, V104, P51, DOI 10.1016/j.jconrel.2005.02.002
   Patton AJ, 2015, APL MATER, V3, DOI 10.1063/1.4904820
   Peigney A, 2001, CARBON, V39, P507, DOI 10.1016/S0008-6223(00)00155-X
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Peppas NA, 2000, ANNU REV BIOMED ENG, V2, P9, DOI 10.1146/annurev.bioeng.2.1.9
   Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015
   Potschke P, 2003, POLYMER, V44, P8061, DOI 10.1016/j.polymer.2003.10.003
   Potschke P, 2002, POLYMER, V43, P3247, DOI 10.1016/S0032-3861(02)00151-9
   Qian D., 2000, APPL PHYS LETT, V2868, P4
   Race A, 2007, J BIOMECH, V40, P1002, DOI 10.1016/j.jbiomech.2006.04.003
   Reichert W. M., 2007, INDWELLING NEURAL IM
   Richardson RT, 2007, BIOMATERIALS, V28, P513, DOI 10.1016/j.biomaterials.2006.09.008
   Richardson-Burns SM, 2007, J NEURAL ENG, V4, pL6, DOI 10.1088/1741-2560/4/2/L02
   Rinaudo M., 2006, POLYM INT, V1370, P1361
   Riviere JE, 1997, PHARMACEUT RES, V14, P687, DOI 10.1023/A:1012129801406
   Roberts JJ, 2011, J BIOMED MATER RES B, V99B, P158, DOI 10.1002/jbm.b.31883
   Sainsbury T, 2010, CHEM MATER, V22, P2164, DOI 10.1021/cm902987k
   Sandler JKW, 2003, POLYMER, V44, P5893, DOI 10.1016/S0032-3861(03)00539-1
   Sasaki M, 2014, ADV HEALTHC MATER, V3, P1919, DOI 10.1002/adhm.201400209
   Saunders K. J., 1973, ORGANIC POLYM CHEM
   SCHEINER A, 1990, ANN BIOMED ENG, V18, P407, DOI 10.1007/BF02364157
   Schmedlen KH, 2002, BIOMATERIALS, V23, P4325, DOI 10.1016/S0142-9612(02)00177-1
   Sekine S, 2010, J AM CHEM SOC, V132, P13174, DOI 10.1021/ja1062357
   Sengupta R, 2011, PROG POLYM SCI, V36, P638, DOI 10.1016/j.progpolymsci.2010.11.003
   Serway D., 2002, PRINCIPLES PHYS
   Seyedin S, 2015, ACS APPL MATER INTER, V7, P21150, DOI 10.1021/acsami.5b04892
   Sheu MT, 2001, BIOMATERIALS, V22, P1713, DOI 10.1016/S0142-9612(00)00315-X
   Shoichet MS, 1996, BIOTECHNOL BIOENG, V50, P374, DOI 10.1002/(SICI)1097-0290(19960520)50:4<374::AID-BIT4>3.0.CO;2-I
   Siddiqui NA, 2010, COMPOS PART A-APPL S, V41, P539, DOI 10.1016/j.compositesa.2009.12.011
   Skarja GA, 1998, J BIOMAT SCI-POLYM E, V9, P271, DOI 10.1163/156856298X00659
   Snook GA, 2011, J POWER SOURCES, V196, P1, DOI 10.1016/j.jpowsour.2010.06.084
   Souier T, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-630
   Souier T, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/40/405704
   Spiller KL, 2008, ACTA BIOMATER, V4, P17, DOI 10.1016/j.actbio.2007.09.001
   Stevens MM, 2004, BIOMATERIALS, V25, P887, DOI 10.1016/j.biomaterials.2003.07.002
   Stoller MD, 2008, NANO LETT, V8, P3498, DOI 10.1021/nl802558y
   Stout DA, 2012, INT J NANOMED, V7, P5653, DOI 10.2147/IJN.S34574
   Street G. B., 1985, ACCOUNTS CHEM RES, V1305, P309
   TAMARGO RJ, 1993, CANCER RES, V53, P329
   Tandon N, 2009, NAT PROTOC, V4, P155, DOI 10.1038/nprot.2008.183
   Tank D., 2009, MACROMOLECULES, V42, P7079, DOI DOI 10.1021/MA900137K
   TOURILLON G, 1982, J ELECTROANAL CHEM, V135, P173, DOI 10.1016/0022-0728(82)90015-8
   Tripathi A, 2011, MACROMOL BIOSCI, V11, P22, DOI 10.1002/mabi.201000286
   Tripathi A, 2009, J BIOMED MATER RES A, V90A, P680, DOI 10.1002/jbm.a.32127
   Trottier CM, 2005, J SOC INF DISPLAY, V13, P759, DOI 10.1889/1.2080514
   Velasco-Santos C, 2003, CHEM MATER, V15, P4470, DOI 10.1021/cm034243c
   Vidu R., 2014, FRONT SYST NEUROSCI, V8, P24
   Walsh F. C., 2015, T IMF, V93
   Wang CY, 2011, ADV MATER, V23, P3580, DOI 10.1002/adma.201101067
   Wang Q, 2010, NATURE, V463, P339, DOI 10.1038/nature08693
   Wang XD, 2001, J ORTHOPAED RES, V19, P1021, DOI 10.1016/S0736-0266(01)00047-X
   Wang XS, 2009, INT J MOL SCI, V10, P5257, DOI 10.3390/ijms10125257
   Wanna Y, 2006, J NANOSCI NANOTECHNO, V6, P3893, DOI 10.1166/jnn.2006.675
   WATASE M, 1980, RHEOL ACTA, V19, P220, DOI 10.1007/BF01521934
   Williams DF, 1999, WILLIAMS DICT BIOMAT, V5
   Win KY, 2005, BIOMATERIALS, V26, P2713, DOI 10.1016/j.biomaterials.2004.07.050
   Wischke C, 2008, INT J PHARMACEUT, V364, P298, DOI 10.1016/j.ijpharm.2008.04.042
   WONG JY, 1994, P NATL ACAD SCI USA, V91, P3201, DOI 10.1073/pnas.91.8.3201
   Wong KKH, 2009, CARBON, V47, P2571, DOI 10.1016/j.carbon.2009.05.006
   Woo BH, 2001, PHARMACEUT RES, V18, P1600, DOI 10.1023/A:1013090700443
   Wu H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2941
   Xia YN, 2003, ADV MATER, V15, P353, DOI 10.1002/adma.200390087
   Xie JW, 2009, ADV FUNCT MATER, V19, P2312, DOI 10.1002/adfm.200801904
   Xie XL, 2005, MAT SCI ENG R, V49, P89, DOI 10.1016/j.mser.2005.04.002
   Yamada S., 2015, FRONT BIOENG BIOTECH, V3, P1
   Ye HH, 2004, APPL PHYS LETT, V85, P1775, DOI 10.1063/1.1787892
   Yeganeh H, 2004, EUR POLYM J, V40, P1233, DOI 10.1016/j.eurpolymj.2003.12.013
   Yu MF, 2000, SCIENCE, V287, P637, DOI 10.1126/science.287.5453.637
   Yu X, 2006, J NANOSCI NANOTECHNO, V6, P1939, DOI 10.1166/jnn.2006.332
   Yuan T, 2014, J BIOMED MATER RES B, V102, P337, DOI 10.1002/jbm.b.33011
   Yuan Ye K., 2011, JOVE-J VIS EXP, V55, P1
   Zeng Q., 2008, SOCIETY, V647, P644
   Zhang DQ, 2012, J AM CHEM SOC, V134, P14283, DOI 10.1021/ja3050184
   Zhao Q., 2013, J IND ENG CHEM, V20, P2
   Zhu JM, 2011, EXPERT REV MED DEVIC, V8, P607, DOI [10.1586/ERD.11.27, 10.1586/erd.11.27]
NR 227
TC 0
Z9 0
U1 3
U2 53
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-5187
EI 1616-5195
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD AUG
PY 2016
VL 16
IS 8
BP 1103
EP 1121
DI 10.1002/mabi.201600057
PG 19
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA DS8QI
UT WOS:000381047500001
PM 27188690
DA 2018-10-20
ER

PT J
AU Rodriguez-Perez, E
   Compan, AL
   Pradas, MM
   Martinez-Ramos, C
AF Rodriguez-Perez, E.
   Lloret Compan, A.
   Monleon Pradas, M.
   Martinez-Ramos, C.
TI Scaffolds of Hyaluronic Acid-Poly(Ethyl Acrylate) Interpenetrating
   Networks: Characterization and In Vitro Studies
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE biomaterials; hyaluronic acid; interpenetrating networks (IPN);
   poly(ethyl acrylate); scaffolds
ID ACID HYDROGELS; MECHANICAL-PROPERTIES; CELL-ADHESION; SUBSTRATE;
   SURFACES; BRAIN; DEPOLYMERIZATION; DEGRADATION; ADSORPTION; COPOLYMERS
AB Hyaluronic acid (HA) provides many advantages to regenerative implants through its bioactive properties, but it also has many limitations as a biomaterial if it is not chemically modified. In order to overcome some of these limitations, HA has been combined with poly(ethyl acrylate) in the form of interpenetrating polymeric networks (IPNs), in which the HA network is crosslinked with divinyl sulfone. Scaffolds of this IPN have been produced through a template-leaching methodology, and their properties have been compared with those of single-network scaffolds made of either PEA or crosslinked HA. A fibroblast cell line has been used to assess the in vitro performance of the scaffolds, revealing good cell response and a differentiated behavior on the IPN surface when compared to the individual polymers. Altogether, the results confirm that this type of material offers an interesting microenvironment for cells, which can be further improved toward its potential use in medical implants.
C1 [Rodriguez-Perez, E.; Lloret Compan, A.; Monleon Pradas, M.; Martinez-Ramos, C.] Univ Politecn Valencia, Ctr Biomat & Tissue Engn, E-46022 Valencia, Spain.
   [Monleon Pradas, M.] Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Valencia, Spain.
RP Pradas, MM (reprint author), Univ Politecn Valencia, Ctr Biomat & Tissue Engn, E-46022 Valencia, Spain.; Pradas, MM (reprint author), Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Valencia, Spain.
EM mmonleon@ter.upv.es
OI Rodriguez-Perez, Eduard/0000-0002-3636-4469; ,
   Cristina/0000-0002-6540-4714
FU ERANET-Neuron [PRI-PIMNEU-2011-1372]; CICyT [MAT2011-28791-C03-02]
FX Support of this work through projects PRI-PIMNEU-2011-1372
   (ERANET-Neuron) and CICyT MAT2011-28791-C03-02 is gratefully
   acknowledged. The authors would like to thank PhD. Carmen Antolinos and
   PhD. Keila Alvarado for their assistance in the TMA assay. Assistance
   and advice received from the Electron Microscopy Service at the
   Universitat Politecnica de Valencia is also acknowledged.
CR ABATANGELO G, 1983, J SURG RES, V35, P410, DOI 10.1016/0022-4804(83)90030-6
   Bencherif SA, 2008, BIOMATERIALS, V29, P1739, DOI 10.1016/j.biomaterials.2007.11.047
   Bollyky PL, 2007, J IMMUNOL, V179, P744, DOI 10.4049/jimmunol.179.2.744
   Campbell JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025661
   Chen L, 2004, BIOMACROMOLECULES, V5, P238, DOI 10.1021/bm0344102
   Collin O, 2006, J CELL SCI, V119, P1914, DOI 10.1242/jcs.02838
   Cui FZ, 2006, J MATER SCI-MATER M, V17, P1393, DOI 10.1007/s10856-006-0615-7
   del Barrio JLA, 2015, J BIOMED MATER RES A, V103, P1106, DOI 10.1002/jbm.a.35249
   DOHERTY MM, 1994, INT J PHARM, V111, P205, DOI 10.1016/0378-5173(94)90342-5
   Eng D, 2010, ACTA BIOMATER, V6, P2407, DOI 10.1016/j.actbio.2009.12.049
   Frisch H. L., 1985, BR POLYM J, V17, P149
   Fujii T, 2002, J BIOMECH, V35, P527, DOI 10.1016/S0021-9290(01)00205-6
   Gerisch G, 2004, BIOPHYS J, V87, P3493, DOI 10.1529/biophysj.104.047589
   Ghosh K, 2006, TISSUE ENG, V12, P601, DOI 10.1089/ten.2006.12.601
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   HALL CL, 1994, J CELL BIOL, V126, P575, DOI 10.1083/jcb.126.2.575
   Hou SP, 2005, J NEUROSCI METH, V148, P60, DOI 10.1016/j.jneumeth.2005.04.016
   Ibrahim S, 2010, J BIOMED MATER RES A, V94A, P355, DOI 10.1002/jbm.a.32704
   Ikada Y, 2006, J R SOC INTERFACE, V3, P589, DOI 10.1098/rsif.2006.0124
   Jeon O, 2007, CARBOHYD POLYM, V70, P251, DOI 10.1016/j.carbpol.2007.04.002
   KUJAWA MJ, 1986, DEV BIOL, V113, P10, DOI 10.1016/0012-1606(86)90103-X
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Lord MS, 2009, J BIOMED MATER RES A, V91A, P635, DOI 10.1002/jbm.a.32219
   Martinez-Ramos C, 2008, TISSUE ENG PT A, V14, P1365, DOI 10.1089/ten.tea.2007.0295
   Martinez-Ramos C, 2012, J BIOMED MATER RES A, V100A, P3276, DOI 10.1002/jbm.a.34273
   Mensitieri M, 1996, J MATER SCI-MATER M, V7, P695, DOI 10.1007/BF00123409
   Morra M, 2005, BIOMACROMOLECULES, V6, P1205, DOI 10.1021/bm049346i
   Noble PW, 2002, MATRIX BIOL, V21, P25, DOI 10.1016/S0945-053X(01)00184-6
   Olmedilla MP, 2006, BIOMATERIALS, V27, P1003, DOI 10.1016/j.biomaterials.2005.07.030
   Patel VR, 1996, PHARMACEUT RES, V13, P588, DOI 10.1023/A:1016054306763
   Perng CK, 2011, J SURG RES, V168, P9, DOI 10.1016/j.jss.2009.09.052
   Ramamurthi A, 2002, J BIOMED MATER RES, V60, P196
   Ramamurthi A, 2003, J BIOMED MATER RES A, V66A, P317, DOI 10.1002/jbm.a.10588
   SANZGIRI YD, 1994, INT J PHARM, V107, P91, DOI 10.1016/0378-5173(94)90446-4
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Seidlits SK, 2010, BIOMATERIALS, V31, P3930, DOI 10.1016/j.biomaterials.2010.01.125
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386
   Soria JM, 2007, J BIOMED MATER RES A, V83A, P463, DOI 10.1002/jbm.a.31297
   Sperling H. E., 1981, INTERPENETRATING POL
   Tokita Y, 1997, POLYM DEGRAD STABIL, V55, P159, DOI 10.1016/S0141-3910(96)00128-0
   TURLEY EA, 1984, CANCER METAST REV, V3, P325, DOI 10.1007/BF00051458
   Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200
   Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594
   WEDLOCK DJ, 1983, INT J BIOL MACROMOL, V5, P186, DOI 10.1016/0141-8130(83)90036-3
   WEIGEL PH, 1986, J THEOR BIOL, V119, P219, DOI 10.1016/S0022-5193(86)80076-5
   WEIGEL PH, 1988, INT J TISSUE REACT, V10, P355
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
   Zimmerman E, 2002, BIOPHYS J, V82, P1848, DOI 10.1016/S0006-3495(02)75535-5
NR 49
TC 1
Z9 1
U1 0
U2 14
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-5187
EI 1616-5195
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD AUG
PY 2016
VL 16
IS 8
BP 1147
EP 1157
DI 10.1002/mabi.201600028
PG 11
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA DS8QI
UT WOS:000381047500004
PM 27072058
DA 2018-10-20
ER

PT J
AU Cakmak, S
   Cakmak, AS
   Kaplan, DL
   Gumusderelioglu, M
AF Cakmak, Soner
   Cakmak, Anil S.
   Kaplan, David L.
   Gumusderelioglu, Menemse
TI A Silk Fibroin and Peptide Amphiphile-Based Co-Culture Model for
   Osteochondral Tissue Engineering
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE co-culture; osteochondral model; peptide amphiphile; silk; trophic
   effect
ID MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; HUMAN ARTICULAR
   CHONDROCYTES; DIFFERENTIATION IN-VITRO; OSTEOGENIC DIFFERENTIATION;
   CHONDROGENIC DIFFERENTIATION; EXTRACELLULAR-MATRIX; SUBCHONDRAL BONE;
   MORPHOGENETIC SIGNALS; BIOMATERIAL SCAFFOLDS
AB New biomaterials with the properties of both bone and cartilage extracellular matrices (ECM) should be designed and used with co-culture systems to address clinically applicable osteochondral constructs. Herein, a co-culture model is described based on a trilayered silk fibroin-peptide amphiphile (PA) scaffold cultured with human articular chondrocytes (hACs) and human bone marrow mesenchymal stem cells (hBMSCs) in an osteochondral cocktail medium for the cartilage and bone sides, respectively. The presence of hACs in the co-cultures significantly increases the osteogenic differentiation potential of hBMSCs based on ALP activity, RT-PCR for osteogenic markers, calcium analyses, and histological stainings, whereas hACs produces a significant amount of glycosaminoglycans (GAGs) for the cartilage region, even in the absence of growth factor TGF-beta family in the co-culture medium. This trilayered scaffold with trophic effects offers a promising strategy for the study of osteochondral defects.
C1 [Cakmak, Soner; Gumusderelioglu, Menemse] Hacettepe Univ, Grad Sch Sci & Engn, Div Nanotechnol & Nanomed, TR-06800 Ankara, Turkey.
   [Cakmak, Soner; Cakmak, Anil S.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
   [Cakmak, Anil S.; Gumusderelioglu, Menemse] Hacettepe Univ, Grad Sch Sci & Engn, Div Bioengn, TR-06800 Ankara, Turkey.
   [Gumusderelioglu, Menemse] Hacettepe Univ, Dept Chem Engn, TR-06800 Ankara, Turkey.
   [Cakmak, Soner] Hacettepe Univ, Dept Environm Engn, TR-06800 Ankara, Turkey.
RP Gumusderelioglu, M (reprint author), Hacettepe Univ, Grad Sch Sci & Engn, Div Nanotechnol & Nanomed, TR-06800 Ankara, Turkey.; Gumusderelioglu, M (reprint author), Hacettepe Univ, Grad Sch Sci & Engn, Div Bioengn, TR-06800 Ankara, Turkey.; Gumusderelioglu, M (reprint author), Hacettepe Univ, Dept Chem Engn, TR-06800 Ankara, Turkey.
EM menemse@gmail.com
RI Bayram, Cem/D-7403-2013
OI Bayram, Cem/0000-0001-8717-4668
FU Hacettepe University, Scientific Research Projects Coordination
   Unit-International Scientific Cooperation Development Support [BAB
   6091]; Scientific and Technological Research Council of Turkey
   (TUBITAK); NIH [P41 EB002520]
FX S.C. was supported by the Hacettepe University, Scientific Research
   Projects Coordination Unit, BAB 6091-International Scientific
   Cooperation Development Support. A.S.C. thanks the Scientific and
   Technological Research Council of Turkey (TUBITAK) for providing an
   International Research Fellowship. The work was also supported via the
   NIH (P41 EB002520).
CR Altman G. A., 2010, BIOMATERIALS, V107, P3299
   Amadori S, 2015, MACROMOL BIOSCI, V15, P1535, DOI 10.1002/mabi.201500165
   Baker BM, 2009, EXPERT REV MED DEVIC, V6, P515, DOI [10.1586/erd.09.39, 10.1586/ERD.09.39]
   Beniash E, 2005, ACTA BIOMATER, V1, P387, DOI 10.1016/j.actbio.2005.04.002
   Bhumiratana S, 2011, BIOMATERIALS, V32, P2812, DOI 10.1016/j.biomaterials.2010.12.058
   Bian L, 2011, TISSUE ENG PT A, V17, P1137, DOI [10.1089/ten.tea.2010.0531, 10.1089/ten.TEA.2010.0531]
   Cakmak S., 2013, BIOMED MATER, V8
   Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886
   Chen JN, 2011, BIOMATERIALS, V32, P4793, DOI 10.1016/j.biomaterials.2011.03.041
   Chen KL, 2016, J TISSUE ENG REGEN M, V10, P284, DOI 10.1002/term.1708
   Cheng HW, 2011, BIOMATERIALS, V32, P1526, DOI 10.1016/j.biomaterials.2010.10.021
   Cooke ME, 2011, OSTEOARTHR CARTILAGE, V19, P1210, DOI 10.1016/j.joca.2011.07.005
   Csaki C, 2009, HISTOCHEM CELL BIOL, V131, P251, DOI 10.1007/s00418-008-0524-6
   Fischer J, 2010, ARTHRITIS RHEUM-US, V62, P2696, DOI 10.1002/art.27565
   Frank O, 2002, J CELL BIOCHEM, V85, P737, DOI 10.1002/jcb.10174
   Galler KM, 2010, J AM CHEM SOC, V132, P3217, DOI 10.1021/ja910481t
   Geckil H, 2010, NANOMEDICINE-UK, V5, P469, DOI [10.2217/nnm.10.12, 10.2217/NNM.10.12]
   Gerstenfeld LC, 2003, CONNECT TISSUE RES, V44, P85, DOI 10.1080/03008200390152142
   Gerstenfeld LC, 2002, J BONE MINER RES, V17, P221, DOI 10.1359/jbmr.2002.17.2.221
   Guo H, 2009, ACTA BIOMATER, V5, P268, DOI 10.1016/j.actbio.2008.07.018
   Guo X, 2009, BIOMATERIALS, V30, P2741, DOI 10.1016/j.biomaterials.2009.01.048
   Hofmann S, 2007, BIOMATERIALS, V28, P1152, DOI 10.1016/j.biomaterials.2006.10.019
   HUNTER GK, 1994, BIOCHEM J, V302, P175, DOI 10.1042/bj3020175
   Hwang NS, 2007, J CELL PHYSIOL, V212, P281, DOI 10.1002/jcp.21052
   Hwang NS, 2006, TISSUE ENG, V12, P2695, DOI 10.1089/ten.2006.12.2695
   Hyllested JL, 2002, OSTEOARTHR CARTILAGE, V10, P333, DOI 10.1053/joca.2002.0519
   Jeon O, 2010, TISSUE ENG PT A, V16, P2915, DOI [10.1089/ten.tea.2010.0096, 10.1089/ten.TEA.2010.0096]
   Jiang J, 2005, BIOCHEM BIOPH RES CO, V338, P762, DOI 10.1016/j.bbrc.2005.10.025
   Jiang J, 2010, ANN BIOMED ENG, V38, P2183, DOI 10.1007/s10439-010-0038-y
   Johnstone B, 2013, EUR CELLS MATER, V25, P248, DOI 10.22203/eCM.v025a18
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kawcak CE, 2001, EQUINE VET J, V33, P120
   Kim HJ, 2008, BONE, V42, P1226, DOI 10.1016/j.bone.2008.02.007
   Kim HJ, 2007, MACROMOL BIOSCI, V7, P643, DOI 10.1002/mabi.200700030
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kirkham G. R., 2007, TOPICS TISSUE ENG, V3
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Lai JH, 2013, SCI REP-UK, V3, DOI 10.1038/srep03553
   Maher SA, 2010, J TISSUE ENG REGEN M, V4, P25, DOI 10.1002/term.205
   Mandal BB, 2011, BIOMATERIALS, V32, P639, DOI 10.1016/j.biomaterials.2010.08.115
   MENTE PL, 1994, J ORTHOPAED RES, V12, P637, DOI 10.1002/jor.1100120506
   Meretoja VV, 2012, BIOMATERIALS, V33, P6362, DOI 10.1016/j.biomaterials.2012.05.042
   Mo XT, 2009, BONE, V45, P42, DOI 10.1016/j.bone.2008.07.240
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Murphy MK, 2015, STEM CELLS, V33, P762, DOI 10.1002/stem.1890
   Naseri N, 2016, RSC ADV, V6, P5999, DOI 10.1039/c5ra27246g
   Rajkhowa R, 2010, MACROMOL BIOSCI, V10, P599, DOI 10.1002/mabi.200900358
   Rodrigues MT, 2012, ACTA BIOMATER, V8, P2795, DOI 10.1016/j.actbio.2012.04.013
   Scott CM, 2015, LANGMUIR, V31, P6122, DOI 10.1021/acs.langmuir.5b00196
   Scotti C, 2010, BIOMATERIALS, V31, P2252, DOI 10.1016/j.biomaterials.2009.11.110
   Shah RN, 2010, P NATL ACAD SCI USA, V107, P3293, DOI 10.1073/pnas.0906501107
   Shin H, 2005, BIOMATERIALS, V26, P3645, DOI 10.1016/j.biomaterials.2004.09.050
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Standal T, 2004, EXP ONCOL, V26, P179
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Thompson AD, 2009, TISSUE ENG PT A, V15, P1181, DOI 10.1089/ten.tea.2007.0275
   Tsai MC, 2015, COLLOID SURFACE B, V125, P34, DOI 10.1016/j.colsurfb.2014.11.003
   Tsuchiya K, 2004, MAT SCI ENG C-BIO S, V24, P391, DOI 10.1016/j.msec.2003.12.014
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vines JB, 2012, ACTA BIOMATER, V8, P4053, DOI 10.1016/j.actbio.2012.07.024
   Webber MJ, 2010, J INTERN MED, V267, P71, DOI 10.1111/j.1365-2796.2009.02184.x
   Wu L, 2011, TISSUE ENG PT A, V17, P1425, DOI [10.1089/ten.tea.2010.0517, 10.1089/ten.TEA.2010.0517]
   Yang PJ, 2009, TISSUE ENG PART B-RE, V15, P127, DOI 10.1089/ten.teb.2008.0371
   Ye JH, 2011, BIOMATERIALS, V32, P5065, DOI 10.1016/j.biomaterials.2011.03.053
   Yokoyama A, 2005, CELL TISSUE RES, V322, P289, DOI 10.1007/s00441-005-0010-6
   Zhao J, 2009, BONE, V45, P517, DOI 10.1016/j.bone.2009.05.026
   Zhou M, 2009, BIOMATERIALS, V30, P2523, DOI 10.1016/j.biomaterials.2009.01.010
   zur Nieden NI, 2003, DIFFERENTIATION, V71, P18, DOI 10.1046/j.1432-0436.2003.700602.x
NR 68
TC 2
Z9 2
U1 3
U2 42
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-5187
EI 1616-5195
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD AUG
PY 2016
VL 16
IS 8
BP 1212
EP 1226
DI 10.1002/mabi.201600013
PG 15
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA DS8QI
UT WOS:000381047500010
PM 27139244
DA 2018-10-20
ER

PT J
AU Stadler, N
   Trieb, K
AF Stadler, N.
   Trieb, K.
TI Osteochondritis dissecans of the medial femoral condyle New cell-free
   scaffold as a treatment option
SO ORTHOPADE
LA English
DT Article
DE Osteochondritis dissecans; Knee; Cell-free scaffold; Cartilage;
   Regeneration
ID COMPOSITE MULTILAYERED BIOMATERIAL; KNEE; REGENERATION; LESIONS
AB There is no gold standard in treating osteochondral lesions, which is why the treatment remains very challenging. Osteochondral defects can occur in any joint, but the most common locations are the knee and the ankle. Trauma, repeated microtrauma, avascular necrosis and osteochondritis dissecans (a special type of avascular necrosis) are blamed for the cartilage damage and the damage of adjacent subchondral bone. The self-healing ability of the cartilage is unfortunately very poor; thus, it is necessary to develop new methods of cartilage repair. Unfortunately, few data and long-term survival rates for these new scaffolds are available. We report a case of osteochondritis dissecans treated with a new cell-free scaffold MaioRegen (R) (Fin-Ceramica Faenza Spa, Faenza, Italy).
C1 [Stadler, N.; Trieb, K.] Klinikum Wels Grieskirchen, Dept Orthopaed, Grieskirchnerstr 42, A-4600 Wels, Austria.
RP Stadler, N (reprint author), Klinikum Wels Grieskirchen, Dept Orthopaed, Grieskirchnerstr 42, A-4600 Wels, Austria.
EM nicola.stadler@klinikum-wegr.at
CR Aerssens J, 1998, ENDOCRINOLOGY, V139, P663, DOI 10.1210/en.139.2.663
   Christensen BB, 2015, KNEE SURG SPORTS TRA, V18
   Delcogliano M, 2014, KNEE SURG SPORT TR A, V22, P1260, DOI 10.1007/s00167-013-2717-3
   Dettoni Federico, 2010, Iowa Orthop J, V30, P131
   Gomoll AH, 2012, KNEE SURG SPORT TR A, V20, P450, DOI 10.1007/s00167-011-1780-x
   Kon E, 2014, INJURY, V45, pS121, DOI 10.1016/j.injury.2014.10.035
   Kon E, 2012, KNEE SURG SPORT TR A, V20, P399, DOI 10.1007/s00167-011-1858-5
   Kon E, 2011, AM J SPORT MED, V39, P1180, DOI 10.1177/0363546510392711
   Kon E, 2010, J ORTHOP RES, V28, P116, DOI 10.1002/jor.20958
   Kon E, 2009, KNEE SURG SPORT TR A, V17, P1312, DOI 10.1007/s00167-009-0819-8
   Peterson L, 2000, CLIN ORTHOP RELAT R, P212
   Peterson L, 2003, MASTER TECHNIQUES OR, P353
   Verdonk P, 2015, BONE JOINT J, V97B, P318, DOI 10.1302/0301-620X.97B3.34555
NR 13
TC 2
Z9 2
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0085-4530
EI 1433-0431
J9 ORTHOPADE
JI Orthopade
PD AUG
PY 2016
VL 45
IS 8
BP 701
EP 704
DI 10.1007/s00132-016-3267-4
PG 4
WC Orthopedics
SC Orthopedics
GA DU7OA
UT WOS:000382403000011
PM 27250619
DA 2018-10-20
ER

PT J
AU Head, DA
   Tronci, G
   Russell, SJ
   Wood, DJ
AF Head, David A.
   Tronci, Giuseppe
   Russell, Stephen J.
   Wood, David J.
TI In Silico Modeling of the Rheological Properties of Covalently
   Cross-Linked Collagen Triple Helices
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Article
DE collagen hydrogel; biomimetic design; rheology; in silico modeling
ID NETWORKS; MECHANICS; HYDROGELS; MODULUS; PEPTIDE; ELASTICITY; SCAFFOLDS;
   GELS; DIFFERENTIATION; NANOFIBERS
AB Biomimetic hydrogels based on natural polymers are a promising class of biomaterial, mimicking the natural extra-cellular matrix of biological tissues and providing cues for cell attachment, proliferation, and differentiation. With a view to providing an upstream method to guide subsequent experimental design, the aim of this study was to introduce a mathematical model that described the rheological properties of a hydrogel system based on covalently cross-linked collagen triple helices. In light of their organization, such gels exhibit limited collagen bundling that cannot be described by existing fibril network models. The model presented here treats collagen triple helices as discrete semiflexible polymers, permits full access to metrics for network microstructure, and should provide a comprehensive understanding of the parameter space associated with the development of such multifunctional materials. Triple helical hydrogel networks were experimentally obtained via the reaction of type I collagen with both aromatic and aliphatic diacids. The complex modulus G* was found from rheological testing in linear shear and quantitatively compared to model predictions. In silico data from the computational model successfully described the experimental trends in hydrogel storage modulus with either (i) the concentration of collagen triple helices during the cross-linking reaction or (ii) the type of cross linking segment introduced in resulting hydrogel networks. This approach may pave the way to a step change in the rational design of biomimetic triple helical collagen systems with controlled multifunctionality.
C1 [Head, David A.] Univ Leeds, Sch Comp, Leeds LS2 9JT, W Yorkshire, England.
   [Tronci, Giuseppe; Russell, Stephen J.] Univ Leeds, Sch Design, Nonwovens Res Grp, Leeds LS2 9JT, W Yorkshire, England.
   [Tronci, Giuseppe; Wood, David J.] Univ Leeds, St Jamess Univ Hosp, Sch Dent, Biomat & Tissue Engn Res Grp, Leeds LS9 7TF, W Yorkshire, England.
RP Head, DA (reprint author), Univ Leeds, Sch Comp, Leeds LS2 9JT, W Yorkshire, England.
EM d.head@leeds.ac.uk
OI Tronci, Giuseppe/0000-0002-9426-4220
FU Biomedical Health Research Centre, University of Leeds; Clothworkers'
   Centre for Textile Materials Innovation for Healthcare; Clothworkers'
   Foundation; Engineering and Physical Sciences Research Council
   [EP/K029592/1]
FX D.H. was funded by the Biomedical Health Research Centre, University of
   Leeds. G.T. and S.J.R. wish to thank The Clothworkers' Centre for
   Textile Materials Innovation for Healthcare and the Clothworkers'
   Foundation for financial support.
CR Alberts B., 2008, MOL BIOL CELL
   ALLEN MP, 1987, COMPUTER SIMULATION
   Appelman TP, 2011, BIOMATERIALS, V32, P1508, DOI 10.1016/j.biomaterials.2010.10.017
   Arafat MT, 2015, POLYMER, V77, P102, DOI 10.1016/j.polymer.2015.09.037
   Barnes H. A., 1989, INTRO RHEOLOGY
   Boothroyd S, 2013, FARADAY DISCUSS, V166, P195, DOI 10.1039/c3fd00097d
   Brinkman WT, 2003, BIOMACROMOLECULES, V4, P890, DOI 10.1021/bm0257412
   Broedersz CP, 2014, REV MOD PHYS, V86, P995, DOI 10.1103/RevModPhys.86.995
   Burdick JA, 2011, BIOMATERIALS FOR TISSUE ENGINEERING APPLICATIONS: A REVIEW OF THE PAST AND FUTURE TRENDS, P1, DOI 10.1007/978-3-7091-0385-2_1
   Burdick JA, 2009, TISSUE ENG PT A, V15, P205, DOI 10.1089/ten.tea.2008.0131
   Chang SW, 2014, MATER TODAY, V17, P70, DOI 10.1016/j.mattod.2014.01.019
   Chicurel ME, 1998, CURR OPIN CELL BIOL, V10, P232, DOI 10.1016/S0955-0674(98)80145-2
   Cranford SW, 2013, ADV MATER, V25, P802, DOI 10.1002/adma.201202553
   Dashtimoghadam E, 2014, RSC ADV, V4, P39386, DOI 10.1039/c4ra05246c
   Davidenko N, 2012, ACTA BIOMATER, V8, P667, DOI 10.1016/j.actbio.2011.09.033
   DOI M, 1986, THEORY POLYM DYNAMIC
   Durham E., 2015, BIOMEDICAL TEXTILES
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Feng JC, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.042710
   Fielding SM, 2000, J RHEOL, V44, P323, DOI 10.1122/1.551088
   Gittes F, 1998, PHYS REV E, V58, pR1241, DOI 10.1103/PhysRevE.58.R1241
   Grant CA, 2009, BIOPHYS J, V97, P2985, DOI 10.1016/j.bpj.2009.09.010
   Greenfield MA, 2010, LANGMUIR, V26, P3641, DOI 10.1021/la9030969
   Harley BA, 2007, ACTA BIOMATER, V3, P463, DOI 10.1016/j.aetbio.2006.12.009
   Head DA, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.032705
   Head DA, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.061907
   Head DA, 2011, BMC BIOPHYS, V4, DOI 10.1186/2046-1682-4-18
   Head DA, 2011, SOFT MATTER, V7, P3116, DOI 10.1039/c0sm00888e
   Heussinger C, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.048101
   Huisman EM, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.061902
   Huynh T, 1999, NAT BIOTECHNOL, V17, P1083
   Kim T, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000439
   Koenderink GH, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysLettRev.96.138307
   Kroy K, 1996, PHYS REV LETT, V77, P306, DOI 10.1103/PhysRevLett.77.306
   Licup AJ, 2015, P NATL ACAD SCI USA, V112, P9573, DOI 10.1073/pnas.1504258112
   Lieleg O, 2011, SOFT MATTER, V7, P3307, DOI 10.1039/c0sm01467b
   Lin JT, 2012, ACS APPL MATER INTER, V4, P1050, DOI 10.1021/am201669z
   Lin YC, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.058101
   MACKINTOSH FC, 1995, PHYS REV LETT, V75, P4425, DOI 10.1103/PhysRevLett.75.4425
   Maggs AC, 1998, PHYS REV E, V57, P2091, DOI 10.1103/PhysRevE.57.2091
   Mizuno D, 2007, SCIENCE, V315, P370, DOI 10.1126/science.1134404
   Moghadam MN, 2015, J MECH BEHAV BIOMED, V41, P161, DOI 10.1016/j.jmbbm.2014.10.010
   Morse DC, 1998, MACROMOLECULES, V31, P7044, DOI 10.1021/ma980304u
   Motte S, 2013, BIOPOLYMERS, V99, P35, DOI 10.1002/bip.22133
   Muller KW, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.238102
   Ozbas B, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.268106
   Ozbas B, 2004, MACROMOLECULES, V37, P7331, DOI 10.1021/ma0491762
   Piechocka IK, 2011, BIOMACROMOLECULES, V12, P2797, DOI 10.1021/bm200553x
   Piechocka IK, 2010, BIOPHYS J, V98, P2281, DOI 10.1016/j.bpj.2010.01.040
   Pritchard RH, 2014, SOFT MATTER, V10, P1864, DOI 10.1039/c3sm52769g
   Raif EM, 2005, BONE, V36, P433, DOI 10.1016/j.bone.2004.12.011
   Reithofer MR, 2014, BIOMATERIALS, V35, P7535, DOI 10.1016/j.biomaterials.2014.04.102
   Roberts D, 2012, LANGMUIR, V28, P16196, DOI 10.1021/la303328p
   Rombouts WH, 2013, SOFT MATTER, V9, P6936, DOI 10.1039/c3sm00091e
   Rubinstein M., 2003, POLYM PHYS
   Shayegan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070590
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Steinmetz NJ, 2015, ACTA BIOMATER, V21, P142, DOI 10.1016/j.actbio.2015.04.015
   Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521
   Tang C, 2009, LANGMUIR, V25, P9447, DOI 10.1021/la900653q
   Tassieri M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.198301
   Tronci G., 2013, MRS P, V1498, P145
   Tronci G, 2016, MRS ADV, V1, P533, DOI 10.1557/adv.2015.11
   Tronci G, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1079
   Tronci G, 2013, J MATER CHEM B, V1, P5478, DOI 10.1039/c3tb20218f
   Tronci G, 2013, J MATER CHEM B, V1, P3705, DOI 10.1039/c3tb20720j
   Wilkinson B., 2005, PARALLEL PROGRAMMING
   Yang ZM, 2007, SMALL, V3, P558, DOI 10.1002/smll.200700015
   Zhou T, 2015, ACS APPL MATER INTER, V7, P3253, DOI 10.1021/am507990m
NR 69
TC 0
Z9 0
U1 1
U2 11
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD AUG
PY 2016
VL 2
IS 8
BP 1224
EP 1233
DI 10.1021/acsbiomaterials.6b00115
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA DT1JC
UT WOS:000381236500002
OA Green Published
DA 2018-10-20
ER

PT J
AU Ling, SJ
   Dinjaski, N
   Ebrahimi, D
   Wong, JY
   Kaplan, DL
   Buehler, MJ
AF Ling, Shengjie
   Dinjaski, Nina
   Ebrahimi, Davoud
   Wong, Joyce Y.
   Kaplan, David L.
   Buehler, Markus J.
TI Conformation Transitions of Recombinant Spidroins via Integration of
   Time-Resolved FTIR Spectroscopy and Molecular Dynamic Simulation
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Article
DE spider silk; self-assembly; structure function relationship;
   conformation transition; modeling
ID PROTEIN SECONDARY STRUCTURE; SPIDER SILK PROTEINS;
   INFRARED-SPECTROSCOPY; PROPERTY RELATIONSHIPS; STRUCTURE PREDICTION;
   VIBRATIONAL ANALYSIS; DISORDERED PROTEIN; GLOBULAR-PROTEINS;
   BLOCK-COPOLYMERS; FIBERS
AB Current trends in biomaterial designs require a detailed understanding of structure function relationships to efficiently address specific utilities. As a prototype, spider silk has been widely studied with diversified characterization or simulation methods, exploiting the integration of experimental and modeling approaches to gain insight into structure function relationships. However, the assembly mechanisms of spider silk in natural and non-natural environments remain incompletely understood. In the present study, experimental and simulation approaches were utilized to study assembly mechanisms of recombinant spider silks. Two spider silk constructs, H(AB)(12) and H(AB)(12)NtSp, were produced and studied. Deconvoluted Fourier transform infrared spectroscopy (FTIR) spectra and molecular dynamics simulations, before and after ethanol treatment, were analyzed to quantify secondary structures, and a higher helix content was observed in H(AB)(12)NtSp compared with that in H(AB)(12). Time-resolved FTIR analysis was used to monitor conformation transitions. A higher rate of beta-sheet formation was found in H (AB)(12)NtSp compared with that in H(AB)(12). These results suggest that the N-terminal domain accelerates self-assembly of recombinant spidroins under ethanol treatment. The approaches used in this study provide insights into the function of the N-terminal domain in conformational transitions of spider silks under non-natural conditions as well as fiber formation. This approach should enable more efficient design, synthesis, and preparation of new recombinant spidroin materials with tunable mechanical properties.
C1 [Ling, Shengjie; Ebrahimi, Davoud; Buehler, Markus J.] MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Buehler, Markus J.] MIT, Ctr Mat Sci & Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Buehler, Markus J.] MIT, Ctr Computat Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Ling, Shengjie; Dinjaski, Nina; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Wong, Joyce Y.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
RP Buehler, MJ (reprint author), MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Buehler, MJ (reprint author), MIT, Ctr Mat Sci & Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Buehler, MJ (reprint author), MIT, Ctr Computat Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
EM David.Kaplan@Tufts.edu; mbuehler@mit.edu
RI Wong, Joyce/F-3732-2011
OI Wong, Joyce/0000-0002-3526-6381
FU NIH [U01 EB014976]; Texas Advanced Computing Center [TG-DMR140101,
   TG-MSS090007]
FX We thank the NIH (U01 EB014976) for support of this work. The
   computational resources used for this project have been provided by the
   National Science Foundation through the Extreme Science and Engineering
   Discovery Environment (XSEDE) and the Texas Advanced Computing Center
   under Grant Numbers TG-DMR140101 and TG-MSS090007.
CR Andersson M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001921
   Askarieh G, 2010, NATURE, V465, P236, DOI 10.1038/nature08962
   Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004
   BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118
   Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x
   Buehler MJ, 2008, PROG MATER SCI, V53, P1101, DOI 10.1016/j.pmatsci.2008.06.002
   CAMERON DG, 1984, J TEST EVAL, V12, P78
   CAMERON DG, 1987, APPL SPECTROSC, V41, P539, DOI 10.1366/0003702874448445
   Chen X, 2007, PROTEINS, V68, P223, DOI 10.1002/prot.21414
   Chen X, 2009, SOFT MATTER, V5, P2777, DOI 10.1039/b900908f
   Chiti F, 2002, NAT STRUCT BIOL, V9, P137, DOI 10.1038/nsb752
   Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6
   deJongh HHJ, 1996, ANAL BIOCHEM, V242, P95, DOI 10.1006/abio.1996.0434
   DWIVEDI AM, 1982, MACROMOLECULES, V15, P177, DOI 10.1021/ma00229a035
   Ebrahimi D, 2015, ACS BIOMATER SCI ENG, V1, P864, DOI 10.1021/acsbiomaterials.5b00152
   ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117
   Fu CJ, 2009, CHEM COMMUN, P6515, DOI 10.1039/b911049f
   Ganim Z, 2008, ACCOUNTS CHEM RES, V41, P432, DOI 10.1021/ar700188n
   GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8
   Garnier J, 1996, METHOD ENZYMOL, V266, P540
   Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681
   GIBRAT JF, 1987, J MOL BIOL, V198, P425, DOI 10.1016/0022-2836(87)90292-0
   Gomes SC, 2011, BIOMATERIALS, V32, P4255, DOI 10.1016/j.biomaterials.2011.02.040
   Gronau G, 2012, BIOMATERIALS, V33, P8240, DOI 10.1016/j.biomaterials.2012.06.054
   Hagn F, 2010, NATURE, V465, P239, DOI 10.1038/nature08936
   Hawkins GD, 1996, J PHYS CHEM-US, V100, P19824, DOI 10.1021/jp961710n
   Heidebrecht A, 2015, ADV MATER, V27, P2189, DOI 10.1002/adma.201404234
   Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H
   HOCKNEY RW, 1974, J COMPUT PHYS, V14, P148, DOI 10.1016/0021-9991(74)90010-2
   HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695
   Hu X, 2012, MATER TODAY, V15, P208, DOI 10.1016/S1369-7021(12)70091-3
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   JACKSON M, 1995, CRIT REV BIOCHEM MOL, V30, P95, DOI 10.3109/10409239509085140
   Jacobsen M. M., 2016, COMBINED MODEL UNPUB
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211
   Krishnaji ST, 2013, ADV FUNCT MATER, V23, P241, DOI 10.1002/adfm.201200510
   Kronqvist N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4254
   Kubelka J, 2002, J AM CHEM SOC, V124, P5325, DOI 10.1021/ja012685o
   Li GY, 2001, EUR J BIOCHEM, V268, P6600, DOI 10.1046/j.0014-2956.2001.02614.x
   Lin SC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7892
   Lin Z, 2013, ADV MATER, V25, P1216, DOI 10.1002/adma.201204357
   Lindorff-Larsen K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032131
   Ling SJ, 2014, PHYS CHEM CHEM PHYS, V16, P7741, DOI 10.1039/c4cp00556b
   Ling SJ, 2013, POLYM CHEM-UK, V4, P5401, DOI 10.1039/c3py00508a
   Ling SJ, 2013, BIOMACROMOLECULES, V14, P1885, DOI 10.1021/bm400267m
   Ling SJ, 2011, BIOMACROMOLECULES, V12, P3344, DOI 10.1021/bm2006032
   Ma BY, 2002, PROTEIN SCI, V11, P2335, DOI 10.1110/ps.4270102
   Mercadante D, 2015, J PHYS CHEM B, V119, P7975, DOI 10.1021/acs.jpcb.5b03440
   MOORE WH, 1976, BIOPOLYMERS, V15, P2465, DOI 10.1002/bip.1976.360151211
   NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693
   Patriksson A, 2008, PHYS CHEM CHEM PHYS, V10, P2073, DOI 10.1039/b716554d
   Peng XN, 2005, BIOMACROMOLECULES, V6, P302, DOI 10.1021/bm049598j
   Piana S, 2015, J PHYS CHEM B, V119, P5113, DOI 10.1021/jp508971m
   Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055
   Rabotyagova OS, 2009, BIOMACROMOLECULES, V10, P229, DOI 10.1021/bm800930x
   Ries J, 2014, J AM CHEM SOC, V136, P17136, DOI 10.1021/ja508760a
   Rising A, 2015, NAT CHEM BIOL, V11, P309, DOI [10.1038/nchembio.1789, 10.1038/NCHEMBIO.1789]
   Rising A, 2014, ACTA BIOMATER, V10, P1627, DOI 10.1016/j.actbio.2013.09.030
   Rising A, 2011, CELL MOL LIFE SCI, V68, P169, DOI 10.1007/s00018-010-0462-z
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5
   Silva RAGD, 2002, BIOPOLYMERS, V65, P229, DOI 10.1002/bip.10241
   SUREWICZ WK, 1993, BIOCHEMISTRY-US, V32, P389, DOI 10.1021/bi00053a001
   TIRONI IG, 1995, J CHEM PHYS, V102, P5451, DOI 10.1063/1.469273
   Tokareva O, 2013, MICROB BIOTECHNOL, V6, P651, DOI 10.1111/1751-7915.12081
   Tokareva OS, 2014, J STRUCT BIOL, V186, P412, DOI 10.1016/j.jsb.2014.03.004
   Vanommeslaeghe K, 2012, J CHEM INF MODEL, V52, P3144, DOI 10.1021/ci300363c
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Xia XX, 2010, P NATL ACAD SCI USA, V107, P14059, DOI 10.1073/pnas.1003366107
   Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213
   Yoder G, 1997, J AM CHEM SOC, V119, P10278, DOI 10.1021/ja971392l
   Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40
NR 76
TC 3
Z9 3
U1 5
U2 31
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD AUG
PY 2016
VL 2
IS 8
BP 1298
EP 1308
DI 10.1021/acsbiomaterials.6b00234
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA DT1JC
UT WOS:000381236500009
DA 2018-10-20
ER

PT J
AU Moore, L
   Yang, JY
   Lang, TTH
   Osawa, E
   Lee, DK
   Johnson, WD
   Xi, JZ
   Chow, EKH
   Ho, D
AF Moore, Laura
   Yang, Junyu
   Lang, Thanh T. Ha
   Osawa, Eiji
   Lee, Don-Kenn
   Johnson, William D.
   Xi, Jianzhong
   Chow, Edward Kai-Hua
   Ho, Dean
TI Biocompatibility Assessment of Detonation Nanodiamond in Non-Human
   Primates and Rats Using Histological, Hematologic, and Urine Analysis
SO ACS NANO
LA English
DT Article
DE nanodiamond; biocompatibility; nanomedicine; biomaterial; carbon
ID FLUORESCENT NANODIAMONDS; CLINICAL-CHEMISTRY; REFERENCE VALUES;
   RHESUS-MONKEYS; BREAST-CANCER; STEM-CELLS; IN-VIVO; DELIVERY;
   CYNOMOLGUS; HYDROGELS
AB Detonation nanodiamonds (DNDs) have been widely explored for biomedical applications ranging from cancer therapy to magnetic resonance imaging due to several promising properties. These include faceted surfaces that mediate potent drug binding and water coordination that have resulted in marked enhancements to the efficacy and safety of drug delivery and imaging. In addition, scalable processing of DNDs yields uniform particles. Furthermore, a broad spectrum of biocompatibility studies has shown that DNDs appear to be well-tolerated. Prior to the clinical translation of DNDs for indications that are addressed via intravenous administration, comprehensive assessment of DND safety in both small and large animal preclinical models is needed. This article reports the results of a DND biocompatibility study in both non-human primates and rats. The rat study was performed as a multiple dose subacute investigation in two cohorts that lasted for 2 weeks and included histological, serum, and urine analysis. The non-human primate study was performed as a dual gender, multiple dose, and long-term investigation in both standard/clinically relevant and elevated dosing cohorts that lasted for 6 months and included comprehensive serum, urine, histological, and body weight analysis. The results from these studies indicate that NDs are well-tolerated at clinically relevant doses. Examination of dose-dependent changes in biomarker levels provides important guidance for the downstream in-human validation of DNDs for clinical drug delivery and imaging.
C1 [Moore, Laura] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.
   [Yang, Junyu; Xi, Jianzhong] Peking Univ, Dept Biomed Engn, Beijing 100871, Peoples R China.
   [Lang, Thanh T. Ha] Alverno Clin Labs, Hammond, IN 46324 USA.
   [Osawa, Eiji] Shinshu Univ, Asama Res Extens Ctr, NanoCarbon Res Inst, Ueda, Nagano 3868567, Japan.
   [Lee, Don-Kenn] Univ Calif Los Angeles, Div Oral Biol & Med, UCLA Sch Dent, Los Angeles, CA 90095 USA.
   [Ho, Dean] Univ Calif Los Angeles, Dept Bioengn, UCLA Sch Engn, Los Angeles, CA 90095 USA.
   [Ho, Dean] Univ Calif Los Angeles, Jane & Jerry Weintraub Ctr Reconstruct Biotechnol, Los Angeles, CA 90095 USA.
   [Ho, Dean] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA.
   [Ho, Dean] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA.
   [Johnson, William D.] IIT Res Inst, Life Sci Grp, Chicago, IL 60616 USA.
   [Chow, Edward Kai-Hua] Natl Univ Singapore, Canc Sci Inst Singapore, Yong Loo Lin Sch Med, Singapore 117599, Singapore.
   [Chow, Edward Kai-Hua] Natl Univ Singapore, Dept Pharmacol, Yong Loo Lin Sch Med, Singapore 117600, Singapore.
RP Xi, JZ (reprint author), Peking Univ, Dept Biomed Engn, Beijing 100871, Peoples R China.; Ho, D (reprint author), Univ Calif Los Angeles, Dept Bioengn, UCLA Sch Engn, Los Angeles, CA 90095 USA.; Ho, D (reprint author), Univ Calif Los Angeles, Jane & Jerry Weintraub Ctr Reconstruct Biotechnol, Los Angeles, CA 90095 USA.; Ho, D (reprint author), Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA.; Ho, D (reprint author), Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA.; Chow, EKH (reprint author), Natl Univ Singapore, Canc Sci Inst Singapore, Yong Loo Lin Sch Med, Singapore 117599, Singapore.; Chow, EKH (reprint author), Natl Univ Singapore, Dept Pharmacol, Yong Loo Lin Sch Med, Singapore 117600, Singapore.
EM xi@coe.pku.edu.cn; csikce@nus.edu.sg; dean.ho@ucla.edu
OI Chow, Edward/0000-0002-3075-1898; Yang, Junyu/0000-0002-5964-5335
FU National Cancer Institute [1F30CA174156-01, U54CA151880]; College of
   Engineering, Peking University; NSFC [81325010, 81421004, 31371443];
   National Research Foundation Cancer Science Institute of Singapore RCE
   Main Grant; National Medical Research Council [NMRC CBRGNIG
   NMRC/BNIG/2012/2013]; Ministry of Education Academic Research Fund (MOE
   AcRF) [T1-2012 Oct-11]; Ministry of Education Academic Research Fund
   (Seed Fund Grant) [T1-BSRG 2014-05]; NCIS Yong Siew Yoon Research Grant;
   National Science Foundation CAREER Award [CMMI-1350197]; Center for
   Scalable and Integrated NanoManufacturing [DMI-0327077]; V Foundation
   for Cancer Research Scholars Award; Wallace H. Coulter Foundation
   Translational Research Award; Society for Laboratory Automation and
   Screening Endowed Fellowship; Beckman Coulter Life Sciences; American
   Academy of Implant Dentistry Research Foundation [20150460]; Departments
   of Biomedical Engineering and Mechanical Engineering at Northwestern
   University;  [CMMI-0856492];  [DMR-1343991];  [OISE-1444100]
FX L.M. gratefully acknowledges Drs. Andrew Mazar and Irawati Kandela of
   the Northwestern University Center for Developmental Therapeutics, the
   Mouse Histology and Phenotyping Core at Northwestern University, and Dr.
   Bill Johnson of the Illinois Institute of Technology Research Institute
   (IITRI) for helpful discussions. L.M. also gratefully acknowledges
   funding support from National Cancer Institute Grant 1F30CA174156-01.
   J.X. acknowledges funding support from the College of Engineering,
   Peking University, as well as the NSFC (Grant No. 81325010, 81421004,
   and 31371443). E.K.-H.C. gratefully acknowledges support from the
   National Research Foundation Cancer Science Institute of Singapore RCE
   Main Grant, National Medical Research Council (NMRC CBRGNIG
   NMRC/BNIG/2012/2013), and Ministry of Education Academic Research Fund
   (MOE AcRF Tier 1 T1-2012 Oct-11 and Seed Fund Grant T1-BSRG 2014-05).
   This work is funded by the NCIS Yong Siew Yoon Research Grant through
   donations from the Yong Loo Lin Trust. D.H. gratefully acknowledges
   support from the National Science Foundation CAREER Award
   (CMMI-1350197), Center for Scalable and Integrated NanoManufacturing
   (DMI-0327077), CMMI-0856492, DMR-1343991, OISE-1444100, V Foundation for
   Cancer Research Scholars Award, Wallace H. Coulter Foundation
   Translational Research Award, National Cancer Institute Grant
   U54CA151880 (the content is solely the responsibility of the authors and
   does not necessarily represent the official views of the National Cancer
   Institute or the National Institutes of Health), Society for Laboratory
   Automation and Screening Endowed Fellowship, Beckman Coulter Life
   Sciences and the American Academy of Implant Dentistry Research
   Foundation under Grant No. 20150460. D.H. also gratefully acknowledges
   the Departments of Biomedical Engineering and Mechanical Engineering at
   Northwestern University for their extensive support during the
   administration of this study.
CR Adnan A, 2011, MOL PHARMACEUT, V8, P368, DOI 10.1021/mp1002398
   AOUIDET A, 1990, J CLIN CHEM CLIN BIO, V28, P251
   Barnard AS, 2008, J MATER CHEM, V18, P4038, DOI 10.1039/b809188a
   Barnard AS, 2009, ANALYST, V134, P1751, DOI 10.1039/b908532g
   Chen M, 2009, ACS NANO, V3, P2016, DOI 10.1021/nn900480m
   Chen YN, 2009, XENOTRANSPLANTATION, V16, P496, DOI 10.1111/j.1399-3089.2009.00554.x
   Chow EK, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001713
   Chow EKH, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005872
   Faklaris O, 2009, ACS NANO, V3, P3955, DOI 10.1021/nn901014j
   FISHER B, 1989, J CLIN ONCOL, V7, P572, DOI 10.1200/JCO.1989.7.5.572
   Havlik J, 2013, NANOSCALE, V5, P3208, DOI 10.1039/c2nr32778c
   Heyer S, 2014, ACS NANO, V8, P5757, DOI 10.1021/nn500573x
   Ho DA, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500439
   Hrkach J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003651
   Huang HJ, 2008, ACS NANO, V2, P203, DOI 10.1021/nn7000867
   Huang H, 2007, NANO LETT, V7, P3305, DOI 10.1021/nl071521o
   Hui YY, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/37/374021
   Jinbo T, 1999, VET RES COMMUN, V23, P265, DOI 10.1023/A:1006388602364
   Kim HJ, 2014, ACS NANO, V8, P2998, DOI 10.1021/nn5002968
   Kumari S, 2014, NANOMEDICINE-UK, V9, P427, DOI [10.2217/NNM.13.23, 10.2217/nnm.13.23]
   Lam R, 2008, ACS NANO, V2, P2095, DOI 10.1021/nn800465x
   Lee DK, 2015, ACS NANO, V9, P11490, DOI 10.1021/acsnano.5b05718
   Liang YJ, 2009, ACS NANO, V3, P2288, DOI 10.1021/nn900339s
   Liu JW, 2013, ACS NANO, V7, P7303, DOI 10.1021/nn4029234
   Liu KK, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/31/315106
   Manus LM, 2010, NANO LETT, V10, P484, DOI 10.1021/nl903264h
   MATSUZAWA T, 1994, COMP HAEMATOL INT, V4, P43, DOI 10.1007/BF00368266
   McGuinness LP, 2011, NAT NANOTECHNOL, V6, P358, DOI [10.1038/NNANO.2011.64, 10.1038/nnano.2011.64]
   Mochalin VN, 2013, MOL PHARMACEUT, V10, P3728, DOI 10.1021/mp400213z
   Mochalin VN, 2012, NAT NANOTECHNOL, V7, P11, DOI [10.1038/nnano.2011.209, 10.1038/NNANO.2011.209]
   Mohan N, 2010, NANO LETT, V10, P3692, DOI 10.1021/nl1021909
   Mona J, 2013, DIAM RELAT MATER, V39, P73, DOI 10.1016/j.diamond.2013.08.001
   Moore L, 2014, NANOSCALE, V6, P11712, DOI 10.1039/c4nr02570a
   Moore L, 2013, ADV MATER, V25, P3532, DOI 10.1002/adma.201300343
   Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Perevedentseva E, 2013, NANOMEDICINE-UK, V8, P2041, DOI 10.2217/nnm.13.183
   Rashid MBMA, 2015, JALA-J LAB AUTOM, V20, P423, DOI 10.1177/2211068215579612
   Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF
   Smith AH, 2011, NANOSCALE, V3, P2844, DOI 10.1039/c1nr10278h
   Tisler J, 2009, ACS NANO, V3, P1959, DOI 10.1021/nn9003617
   Toh TB, 2014, MOL PHARMACEUT, V11, P2683, DOI 10.1021/mp5001108
   Wang H, 2012, VET MED-CZECH, V57, P233
   Wang H, 2015, ACS NANO, V9, P3332, DOI 10.1021/acsnano.5b00638
   Wang X, 2014, ACS NANO, V8, P12151, DOI 10.1021/nn503491e
   Weekley B. L., 2003, J AM ASSOC LAB ANIM, V42, P22
   Wu TJ, 2013, NAT NANOTECHNOL, V8, P682, DOI [10.1038/nnano.2013.147, 10.1038/NNANO.2013.147]
   Xing Y, 2011, ACS NANO, V5, P2376, DOI 10.1021/nn200279k
   Xing Z, 2013, TISSUE ENG PT A, V19, P1783, DOI [10.1089/ten.TEA.2012.0336, 10.1089/ten.tea.2012.0336]
   Yuan Y, 2010, DIAM RELAT MATER, V19, P291, DOI 10.1016/j.diamond.2009.11.022
   Yuan Y, 2009, DIAM RELAT MATER, V18, P95, DOI 10.1016/j.diamond.2008.10.031
   Zarrinpar A, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aac5954
   Zhang QW, 2011, BIOMATERIALS, V32, P87, DOI 10.1016/j.biomaterials.2010.08.090
   Zhang XY, 2012, TOXICOL RES-UK, V1, P62, DOI 10.1039/c2tx20006f
NR 54
TC 24
Z9 24
U1 3
U2 30
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1936-0851
EI 1936-086X
J9 ACS NANO
JI ACS Nano
PD AUG
PY 2016
VL 10
IS 8
BP 7385
EP 7400
DI 10.1021/acsnano.6b00839
PG 16
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA DU1HP
UT WOS:000381959100018
PM 27439019
DA 2018-10-20
ER

PT J
AU Basset, C
   Kedidi, S
   Barakat, A
AF Basset, C.
   Kedidi, S.
   Barakat, A.
TI Chemical- and Solvent-Free Mechanophysical Fractionation of Biomass
   Induced by Tribo-Electrostatic Charging: Separation of Proteins and
   Lignin
SO ACS SUSTAINABLE CHEMISTRY & ENGINEERING
LA English
DT Article
DE Biomass; Milling; Electrostatic fractionation; Proteins; Lignin
ID LIGNOCELLULOSIC BIOMASS; FUNCTIONAL-PROPERTIES; ENERGY; YIELD;
   TECHNOLOGY; PRODUCTS; BIOFUELS; PLATFORM; PHYTATE; IMPACT
AB Rapeseed oil cakes are proteo-lignocellulosic residues obtained after oil extraction from rapeseed seed, featuring high protein, carbohydrates, phenolic compounds, and lignin contents. Most often used as an animal diet supplement, its fiber and phenolic part might be valorized for biofuels; biomolecules and biomaterial production proved its fractionation can be achieved without alteration of its nutritional qualities or generation of effluents and wastes. In this study, an innovative dry fractionation technology combining ultrafine miffing (UFM) and electrostatic separation (tES) has been developed for rapeseed oil cake fractionation into protein- and lignin-rich fractions. The physical features as well as the biochemical composition of the produced fraction have been assessed herein. Thanks to UFM tES technology, protein-rich fractions with 38.4% more proteins than in the initial material and lignocellulosic-rich fractions with 80.0% more fibers can be obtained without either external heating or using any additional solvent and catalysts. Boasting a low energy consumption, UFM tES technology compared to conventional methods seems to be suitable for converting oil cakes biomass into ready-to-use fractions for feeding and fiber and phenolic to green platforms molecules and biomaterials
C1 [Basset, C.; Kedidi, S.; Barakat, A.] Univ Montpelier, INRA, Montpellier SupAgro, UMR IATE,CIRAD, F-34060 Montpellier, France.
RP Barakat, A (reprint author), Univ Montpelier, INRA, Montpellier SupAgro, UMR IATE,CIRAD, F-34060 Montpellier, France.
EM barakat@supagro.inra.fr
FU INRA; ANR (ANR LIGNOV)
FX We are grateful to the leaders of the "transformation des vegetaux UMR
   IATE" platform for their help in mechanical fractionation, Mrs.
   Therese-Marie LASSERRE for her help in protein and phytic acid analysis,
   and Mrs. Aurae PUTOIS for her help in phenolic acid analysis. We also
   thank INRA and ANR (ANR LIGNOV 2015) for their financial support.
CR Alonso DM, 2010, GREEN CHEM, V12, P1493, DOI 10.1039/c004654j
   Antoine C, 2004, J CEREAL SCI, V39, P387, DOI 10.1016/j.jcs.2004.02.001
   Barakat A, 2015, CHEMSUSCHEM, V8, P1161, DOI 10.1002/cssc.201403473
   Barakat A, 2015, APPL ENERG, V142, P240, DOI 10.1016/j.apenergy.2014.12.076
   Barakat A, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0138-2
   Barakat A, 2014, APPL ENERG, V113, P97, DOI 10.1016/j.apenergy.2013.07.015
   Berot S, 2005, J CHROMATOGR B, V818, P35, DOI 10.1016/j.jchromb.2004.08.001
   Chuetor S, 2015, GREEN CHEM, V17, P926, DOI 10.1039/c4gc01718h
   Dascalescu L, 1998, PARTICUL SCI TECHNOL, V16, P25, DOI 10.1080/02726359808906782
   Diaz AF, 2004, J ELECTROSTAT, V62, P277, DOI 10.1016/j.elstat.2004.05.005
   Eskibalci MF, 2012, MINER ENG, V31, P90, DOI 10.1016/j.mineng.2012.01.018
   Ghodsvali A, 2005, FOOD RES INT, V38, P223, DOI 10.1016/j.foodres.2004.10.007
   Gonzalez-Perez S, 2002, J AGR FOOD CHEM, V50, P1713, DOI 10.1021/jf011245d
   Gonzalez-Perez S, 2007, J SCI FOOD AGR, V87, P2173, DOI 10.1002/jsfa.2971
   Hemery Y., 2011, J CEREAL SCI, V53
   Hemery Y, 2011, J CEREAL SCI, V53, P1, DOI 10.1016/j.jcs.2010.09.005
   Huber GW, 2006, CHEM REV, V106, P4044, DOI 10.1021/cr068360d
   Jiang W, 2008, J HAZARD MATER, V154, P161, DOI 10.1016/j.jhazmat.2007.10.018
   LATTA M, 1980, J AGR FOOD CHEM, V28, P1313, DOI 10.1021/jf60232a049
   Luterbacher JS, 2014, GREEN CHEM, V16, P4816, DOI [10.1039/C4GC01160K, 10.1039/c4gc01160k]
   Mazumder MK, 2006, CHEM ENG SCI, V61, P2192, DOI 10.1016/j.ces.2005.05.002
   Mueller K, 2010, J FOOD ENG, V99, P49, DOI 10.1016/j.jfoodeng.2010.01.036
   Park S, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-10
   Pelgrom PJM, 2015, J FOOD ENG, V155, P53, DOI 10.1016/j.jfoodeng.2015.01.005
   Petrus L, 2006, GREEN CHEM, V8, P861, DOI 10.1039/b605036k
   Salgado PR, 2012, LWT-FOOD SCI TECHNOL, V45, P65, DOI 10.1016/j.lwt.2011.07.021
   Salgado PR, 2011, J AM OIL CHEM SOC, V88, P351, DOI 10.1007/s11746-010-1673-z
   Schutyser MAI, 2011, TRENDS FOOD SCI TECH, V22, P154, DOI 10.1016/j.tifs.2010.11.006
   Sen S, 2015, GREEN CHEM, V17, P4862, DOI 10.1039/c5gc01066g
   Sheldon RA, 2014, GREEN CHEM, V16, P950, DOI 10.1039/c3gc41935e
   Sluiter A., 2008, NRELTP51042618
   Smets K, 2013, BIOMASS BIOENERG, V57, P180, DOI 10.1016/j.biombioe.2013.07.001
   VAINTRAUB IA, 1988, ANAL BIOCHEM, V175, P227, DOI 10.1016/0003-2697(88)90382-X
   Wang RH, 2010, ENZYME MICROB TECH, V47, P77, DOI 10.1016/j.enzmictec.2010.05.005
   Willfor S, 2009, IND CROP PROD, V29, P571, DOI 10.1016/j.indcrop.2008.11.003
   Wu J, 2009, J HAZARD MATER, V164, P1352, DOI 10.1016/j.jhazmat.2008.09.061
   YANAR DK, 1995, J ELECTROSTAT, V35, P257, DOI 10.1016/0304-3886(94)00044-W
NR 37
TC 3
Z9 3
U1 4
U2 14
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2168-0485
J9 ACS SUSTAIN CHEM ENG
JI ACS Sustain. Chem. Eng.
PD AUG
PY 2016
VL 4
IS 8
BP 4166
EP 4173
DI 10.1021/acssuschemeng.6b00667
PG 8
WC Chemistry, Multidisciplinary; GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY;
   Engineering, Chemical
SC Chemistry; Science & Technology - Other Topics; Engineering
GA DS6CR
UT WOS:000380869800012
DA 2018-10-20
ER

PT J
AU Lateef, A
   Ojo, SA
   Azeez, MA
   Asafa, TB
   Yekeen, TA
   Akinboro, A
   Oladipo, IC
   Gueguim-Kana, EB
   Beukes, LS
AF Lateef, A.
   Ojo, S. A.
   Azeez, M. A.
   Asafa, T. B.
   Yekeen, T. A.
   Akinboro, A.
   Oladipo, I. C.
   Gueguim-Kana, E. B.
   Beukes, L. S.
TI Cobweb as novel biomaterial for the green and eco-friendly synthesis of
   silver nanoparticles
SO APPLIED NANOSCIENCE
LA English
DT Article
DE Cobwebs; Biomaterial; Silver nanoparticles; Antimicrobial; Multi-drug
   resistance; Synergy; Paints
ID ANTIMICROBIAL ACTIVITY; STRUCTURAL-CHARACTERIZATION; EXTRACT; BACTERIA;
   SILK; GOLD; FOOD; WEBS
AB In this study, spider cobweb as a novel biomaterial was used for the green synthesis of silver nanoparticles (AgNPs). The synthesized AgNPs were characterized using UV-Vis spectroscopy, Fourier-transform infrared spectroscopy (FTIR), and transmission electron microscopy. The efficacy of biosynthesized particles as antibacterial agents was evaluated using multidrug resistant clinical bacterial isolates through sensitivity testing with AgNPs and combination of AgNPs with some selected antibiotics. In addition, the potential application of the particles as additives in paints was demonstrated using some bacterial and fungal isolates. The synthesized AgNPs which were dark brown in color displayed maximum absorbance at the wavelength of 436 nm. It was observed that the reaction mixture of 1:40 (extract:AgNO3 solution) at pH of 8.5 produced particles with maximum absorbance at 436 nm. The FTIR spectrum showed peaks at 3298, 2359, 2089, and 1635 cm(-1), indicating that proteins were the capping and stabilization molecules in the synthesis of AgNPs. The particles were spherical in shape with size ranging about 3-50 nm. The energy-dispersive X-ray analysis showed the presence of silver as the most prominent metal, while the selected area electron diffraction pattern conformed to the face-centered cubic phase and crystalline nature of AgNPs. The AgNPs inhibited the growth of several bacterial isolates including S. aureus, E. coli, Klebsiella granulomatis and P. aeruginosa in the range of 10-17 mm at concentration of 100 mu g/ml. It was also demonstrated that AgNPs potentiated the activities of augmentin, ofloxacin and cefixime in the AgNP-antibiotic synergy studies. Similarly, the inclusion of AgNPs as additive in white emulsion paint led to the total inhibition of growth of E. coli, P. aeruginosa, Aspergillus niger and A. fumigatus. To the best of our knowledge, this is the first report of the use of cobweb for the green synthesis of AgNPs. The immense antimicrobial activities of the particles can be explored in the creation of novel products, where it can be used as additive to protect materials against microbial attack.
C1 [Lateef, A.; Ojo, S. A.; Azeez, M. A.; Yekeen, T. A.; Akinboro, A.] Ladoke Akintola Univ Technol, Dept Pure & Appl Biol, PMB 4000, Ogbomosho, Nigeria.
   [Asafa, T. B.] Ladoke Akintola Univ Technol, Dept Mech Engn, PMB 4000, Ogbomosho, Nigeria.
   [Oladipo, I. C.] Ladoke Akintola Univ Technol, Dept Sci Lab Technol, PMB 4000, Ogbomosho, Nigeria.
   [Gueguim-Kana, E. B.] Univ KwaZulu Natal, Sch Life Sci, Dept Microbiol, Private Bag X01, ZA-3209 Pietermaritzburg, South Africa.
   [Beukes, L. S.] Univ KwaZulu Natal, Sch Life Sci, Microscopy & Microanal Unit, Private Bag X01, ZA-3209 Pietermaritzburg, South Africa.
RP Lateef, A (reprint author), Ladoke Akintola Univ Technol, Dept Pure & Appl Biol, PMB 4000, Ogbomosho, Nigeria.
EM agbaje72@yahoo.com
OI Evariste Bosco, GUEGUIM KANA/0000-0002-1598-7851
CR Adewoye S. O., 2004, ENVIRONMENTALIST, V24, P249
   Andrade E, 2008, BJU INT, V102, P835, DOI 10.1111/j.1464-410X.2008.07762.x
   Andrews JM, 2005, J ANTIMICROB CHEMOTH, V56, P60, DOI 10.1093/jac/dki124
   Augustine R, 2014, APPL NANOSCI, V4, P809, DOI 10.1007/s13204-013-0260-7
   Ayedun H, 2013, J ENV CHEM ECOTOXICO, V5, P21
   Bhat R, 2011, BIOINORG CHEM APPL, DOI 10.1155/2011/650979
   Blackledge TA, 2011, ADV INSECT PHYSIOL, V41, P175, DOI 10.1016/B978-0-12-415919-8.00004-5
   Chakraborty D., 2009, EUR C CLIN MICR INF
   CHORTYK OT, 1993, BIOSCI BIOTECH BIOCH, V57, P1355, DOI 10.1271/bbb.57.1355
   CUTLER B, 1980, EXPERIENTIA, V36, P953, DOI 10.1007/BF01953812
   Denver Museum of Nature and Science, 2015, SPID BIOL
   Devi Lamabam Sophiya, 2012, Mycobiology, V40, P27, DOI 10.5941/MYCO.2012.40.1.027
   El-Batal Ahmed I, 2015, Biotechnol Rep (Amst), V5, P31, DOI 10.1016/j.btre.2014.11.001
   Fayaz AM, 2010, NANOMED-NANOTECHNOL, V6, P103, DOI 10.1016/j.nano.2009.04.006
   Glime JM, 2013, BRYOPHYTE ECOLOGY, V2
   Gomes SC, 2010, FUNCTIONALIZED SILK, P1
   Heimer S., 1988, WUNDERBARE WELT SPIN
   Hose GC, 2002, ENVIRON POLLUT, V120, P725, DOI 10.1016/S0269-7491(02)00171-9
   Kaiser JP, 2013, SCI TOTAL ENVIRON, V442, P282, DOI 10.1016/j.scitotenv.2012.10.009
   Kanmani P, 2013, PROCESS BIOCHEM, V48, P1099, DOI 10.1016/j.procbio.2013.05.011
   Kannan RRR, 2013, APPL NANOSCI, V3, P229, DOI 10.1007/s13204-012-0125-5
   Lateef A., 2004, African Journal of Biotechnology, V3, P334
   Lateef A, 2005, ENVIRON MONIT ASSESS, V100, P59, DOI 10.1007/s10661-005-7062-7
   Lateef A, 2015, INT NANO LETT, V5, P29, DOI 10.1007/s40089-014-0133-4
   Lateef A, 2004, WORLD J MICROB BIOT, V20, P167, DOI 10.1023/B:WIBI.0000021752.29468.4e
   Lateef A, 2010, FOOD SCI TECHNOL INT, V16, P389, DOI 10.1177/1082013210366894
   Lateef A, 2007, International Journal of Environment and Health, V1, P551, DOI 10.1504/IJENVH.2007.018572
   Lateef A., 2006, J FOOD SAFETY, V8, P39
   Lateef A, 2015, BIOLOGIA, V70, P411, DOI 10.1515/biolog-2015-0062
   Lewis RJ, 2003, NAT REV DRUG DISCOV, V2, P790, DOI 10.1038/nrd1197
   Mahendra R., 2009, BIOTECHNOLOGY ADV, V27, P76, DOI DOI 10.1016/J.BIOTECHADV.2008.09.002
   Maloney D., 2003, MAINE AGR FOREST EXP, V190, P1
   Mishra A, 2014, BIORESOURCE TECHNOL, V166, P235, DOI 10.1016/j.biortech.2014.04.085
   Mueller NC, 2008, ENVIRON SCI TECHNOL, V42, P4447, DOI 10.1021/es7029637
   Nazeruddin GM, 2014, IND CROP PROD, V60, P212, DOI 10.1016/j.indcrop.2014.05.040
   Novak K, 2001, NAT MED, V7, P155, DOI 10.1038/84588
   Odegaard F, 2000, BIOL J LINN SOC, V71, P583, DOI 10.1006/bijl.2000.0468
   Priyadarshini S, 2013, COLLOID SURFACE B, V102, P232, DOI 10.1016/j.colsurfb.2012.08.018
   Rajarathinam M., 2014, ADV SCI ENG MED, V6, P676
   Rajeshkumar S, 2014, J NANOSTRUCTURE CHEM, V4, DOI 10.1007/s40097-014-0096-z
   Raliya R., 2014, INT NANO LETT, V4, P1
   Roozbahani H., 2014, International Journal of Advanced Biological and Biomedical Research, V2, P2197
   Ruppert Edward E, 2004, INVERTEBRATE ZOOLOGY
   Salem WM, 2014, IND CROP PROD, V62, P228, DOI 10.1016/j.indcrop.2014.08.030
   Shameli K, 2011, INT J NANOMED, V6, P271, DOI 10.2147/IJN.S16043
   Shankar S, 2014, MATER LETT, V137, P75, DOI 10.1016/j.matlet.2014.08.122
   Shanmugam N, 2014, APPL NANOSCI, V4, P881, DOI 10.1007/s13204-013-0271-4
   Shivaji S, 2011, PROCESS BIOCHEM, V46, P1800, DOI 10.1016/j.procbio.2011.06.008
   Thirumurugan A., 2011, INT J NANOMAT BIOSTR, V1, P22
   Tszydel M, 2009, FIBRES TEXT EAST EUR, V17, P7
   Vendrely C, 2007, MACROMOL BIOSCI, V7, P401, DOI 10.1002/mabi.200600255
   Zaki S, 2011, MATER RES BULL, V46, P1571, DOI 10.1016/j.materresbull.2011.06.025
NR 52
TC 19
Z9 19
U1 1
U2 22
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 2190-5509
EI 2190-5517
J9 APPL NANOSCI
JI Appl. Nanosci.
PD AUG
PY 2016
VL 6
IS 6
BP 863
EP 874
DI 10.1007/s13204-015-0492-9
PG 12
WC Nanoscience & Nanotechnology
SC Science & Technology - Other Topics
GA DU1AM
UT WOS:000381937200009
OA Other Gold
DA 2018-10-20
ER

PT J
AU Rodman, RE
   Kellman, RM
AF Rodman, Regina E.
   Kellman, Robert M.
TI Controversies in the Management of the Trauma Patient
SO FACIAL PLASTIC SURGERY CLINICS OF NORTH AMERICA
LA English
DT Article
DE Facial trauma Orbital trauma; Mandibular trauma; Maxillomandibular
   fixation; Condylar fracture; Endoscopic repair; Blowout fractures
ID MANDIBULAR CONDYLAR PROCESS; FLOOR BLOWOUT FRACTURES;
   ZYGOMATICOMAXILLARY COMPLEX FRACTURES; C-ARM SYSTEM; ORBITAL FLOOR; OPEN
   REDUCTION; SUBCONDYLAR FRACTURES; CLOSED TREATMENT; ANGLE FRACTURES;
   COMPUTED-TOMOGRAPHY
AB Facial trauma is a significant cause of morbidity in the United States. Despite the large volume of trauma surgeries at most academic institutions, there is still controversy regarding management of many traumatic injuries. The literature lacks clear-cut best practices for most fractures. In orbital trauma, there is debate about the optimal timing of repair, preferred biomaterial to be used, and the utility of evaluation afterward with intraoperative computed tomographic scan. In repair of mandible fractures, there is debate regarding open versus closed reduction of subcondylar fractures, or alternatively, endoscopic repair.
C1 [Rodman, Regina E.] SUNY Upstate, Facial Plast & Craniofacial Surg, 750 East Adams St, Syracuse, NY 13207 USA.
   [Kellman, Robert M.] SUNY Upstate, Dept Otolaryngol, 750 East Adams St, Syracuse, NY 13207 USA.
RP Rodman, RE (reprint author), SUNY Upstate, Facial Plast & Craniofacial Surg, 750 East Adams St, Syracuse, NY 13207 USA.
EM reginarodman@gmail.com
CR Allareddy V, 2011, J ORAL MAXIL SURG, V69, P2613, DOI 10.1016/j.joms.2011.02.057
   Amrith S, 2010, CRANIOMAX TRAUM REC, V3, P131, DOI 10.1055/s-0030-1262955
   Ansari K, 2011, ARCH FACIAL PLAST S, V13, P266, DOI 10.1001/archfacial.2011.46
   Banks P, 1998, INT J ORAL MAX SURG, V27, P244, DOI 10.1016/S0901-5027(05)80504-1
   Baumann A, 2002, INT J ORAL MAX SURG, V31, P367, DOI 10.1054/ijom.2001.0219
   Bayat M, 2010, BRIT J ORAL MAX SURG, V48, P617, DOI 10.1016/j.bjoms.2009.10.019
   Becker ST, 2010, J CRANIOFAC SURG, V21, P1066, DOI 10.1097/SCS.0b013e3181e62c5f
   Bell RB, 2008, J ORAL MAXIL SURG, V66, P2116, DOI 10.1016/j.joms.2008.05.370
   Ben Simon GJ, 2009, OPHTHAL SURG LAS IM, V40, P141, DOI 10.3928/15428877-20090301-05
   Brucoli M, 2011, J CRANIOFAC SURG, V22, P1387, DOI 10.1097/SCS.0b013e31821cc317
   BRUNEAU M, 2013, NEUROSURGERY S, V73, pONS28
   Bruneau M, 2013, NEUROSURGERY, V73, P24, DOI 10.1227/NEU.0b013e318282a4e3
   Cai EZ, 2012, J CRANIOFAC SURG, V23, P1567, DOI 10.1097/SCS.0b013e318260ef33
   Castellani A, 2002, J ORAL MAXIL SURG, V60, P1413, DOI 10.1053/joms.2002.36094
   Cavusoglu T, 2010, ANN PLAS SURG, V64, P41, DOI 10.1097/SAP.0b013e3181a13d06
   Cho BC, 2012, ARCH PLAST SURG-APS, V39, P190, DOI [10.5999/aps.2012.39.3.190, 10.5999/aps.2012.39.4.301]
   Chowdhury K, 1998, ARCH OTOLARYNGOL, V124, P1398, DOI 10.1001/archotol.124.12.1398
   Cornelius CP, 2010, CRANIOMAX TRAUM REC, V3, P55, DOI 10.1055/s-0030-1254376
   Dal Canto AJ, 2008, OPHTHAL PLAST RECONS, V24, P437, DOI 10.1097/IOP.0b013e31818aac9b
   Dubois L, 2016, INT J ORAL MAX SURG, V45, P41, DOI 10.1016/j.ijom.2015.06.024
   Dubois L, 2015, INT J ORAL MAX SURG, V44, P433, DOI 10.1016/j.ijom.2014.12.003
   Dubois L, 2015, INT J ORAL MAX SURG, V44, P308, DOI 10.1016/j.ijom.2014.12.002
   Eckelt U, 2006, J CRANIO MAXILL SURG, V34, P306, DOI 10.1016/j.jcms.2006.03.003
   Ellis E, 2000, J ORAL MAXIL SURG, V58, P719, DOI 10.1053/joms.2000.7253
   ELLIS E, 1993, J ORAL MAXIL SURG, V51, P969, DOI 10.1016/S0278-2391(10)80036-9
   Ellis E, 2000, J ORAL MAXIL SURG, V58, P260, DOI 10.1016/S0278-2391(00)90047-8
   Ellis E, 2000, J ORAL MAXIL SURG, V58, P27, DOI 10.1016/S0278-2391(00)80010-5
   ELLIS E, 1994, J ORAL MAXIL SURG, V52, P1032, DOI 10.1016/0278-2391(94)90169-4
   Ellis E., 2000, J ORAL MAXILLOFAC SU, V58, P729
   Ethunandan M, 2011, BRIT J ORAL MAX SURG, V49, P142, DOI 10.1016/j.bjoms.2010.03.012
   Fuller Scott C, 2007, Curr Opin Otolaryngol Head Neck Surg, V15, P233, DOI 10.1097/MOO.0b013e3281df2c5f
   Gear AJL, 2005, J ORAL MAXIL SURG, V63, P655, DOI 10.1016/j.joms.2004.02.016
   Gellrich NC, 2002, PLAST RECONSTR SURG, V110, P1417, DOI 10.1097/01.PRS.0000029807.35391.E5
   Gosau M, 2011, CLIN ORAL INVEST, V15, P305, DOI 10.1007/s00784-010-0385-y
   Gulicher D, 2006, INT J ORAL MAX SURG, V35, P224, DOI 10.1016/j.ijom.2005.10.005
   Gunarajah DR, 2013, J ORAL MAXIL SURG, V71, P550, DOI 10.1016/j.joms.2012.10.029
   Harris GJ, 2006, EYE, V20, P1207, DOI 10.1038/sj.eye.6702384
   Harris GJ, 2000, OPHTHALMIC PLAST REC, V16, P179, DOI 10.1097/00002341-200005000-00004
   Hashemi HM, 2011, J ORAL MAXIL SURG, V69, P1411, DOI 10.1016/j.joms.2010.05.070
   Haug RH, 2001, J ORAL MAXIL SURG, V59, P370, DOI 10.1053/joms.2001.21868
   HAWES MJ, 1983, OPHTHALMOLOGY, V90, P1066
   Heiland M, 2005, INT J ORAL MAX SURG, V34, P369, DOI 10.1016/j.ijom.2004.09.010
   Hosal Banu M, 2002, Orbit, V21, P27
   ILANKOVAN V, 1992, BRIT J ORAL MAX SURG, V30, P92, DOI 10.1016/0266-4356(92)90077-V
   Jaquiery C, 2007, INT J ORAL MAX SURG, V36, P193, DOI 10.1016/j.ijom.2006.11.002
   Jordan DR, 1998, OPHTHALMIC PLAST REC, V14, P379, DOI 10.1097/00002341-199811000-00001
   Kellman Robert M, 2004, Facial Plast Surg, V20, P239, DOI 10.1055/s-2004-861780
   Kellman Robert M, 2003, Arch Facial Plast Surg, V5, P244, DOI 10.1001/archfaci.5.3.244
   Kellman RM, 2009, FACIAL PLAST SURG, V25, P23, DOI 10.1055/s-0028-1112228
   Khiabani KS, 2015, J MAXILLOFAC ORAL SU, V14, P363, DOI 10.1007/s12663-014-0644-6
   Kontio RK, 2006, PLAST RECONSTR SURG, V118, P1365, DOI 10.1097/01.prs.0000244519.26368.4c
   Kopp RW, 2016, LARYNGOSCOPE, V126, P596, DOI 10.1002/lary.25671
   Kumar I, 2011, ORAL MAXILLOFAC SURG, V15, P27, DOI 10.1007/s10006-010-0229-6
   Laxenaire A., 1997, Revue de Stomatologie et de Chirurgie Maxillo-Faciale, V98, P96
   Lieger O, 2010, ARCH FACIAL PLAST S, V12, P186, DOI 10.1001/archfacial.2010.26
   Luebbers HT, 2008, J CRANIO MAXILL SURG, V36, P109, DOI 10.1016/j.jcms.2007.09.002
   Luhr H G, 1973, Trans Int Conf Oral Surg, V4, P340
   Marker P, 2000, BRIT J ORAL MAX SURG, V38, P422, DOI 10.1054/bjom.2000.0457
   Matteini C, 2004, J CRANIOFAC SURG, V15, P145, DOI 10.1097/00001665-200401000-00035
   MAURIELLO JA, 1993, OPHTHALMIC PLAST REC, V9, P191, DOI 10.1097/00002341-199309000-00004
   Morris C, 2015, J ORAL MAXIL SURG, V73, p951E1, DOI 10.1016/j.joms.2015.01.001
   Nam SM, 2015, ANN PLAS SURG, V75, P295, DOI 10.1097/SAP.0000000000000011
   NIEDERDELLMANN H, 1987, PLAST RECONSTR SURG, V80, P68, DOI 10.1097/00006534-198707000-00010
   Nowinski D, 2010, J CRANIOFAC SURG, V21, P1054, DOI 10.1097/SCS.0b013e3181e573be
   Nussbaum ML, 2008, J ORAL MAXIL SURG, V66, P1087, DOI 10.1016/j.joms.2008.01.025
   Nyachhyon P, 2011, J NEPAL MED ASSOC, V50, P37
   Saman M, 2014, JAMA FACIAL PLAST SU, V16, P410, DOI 10.1001/jamafacial.2014.543
   Santler G, 1999, J ORAL MAXIL SURG, V57, P392, DOI 10.1016/S0278-2391(99)90276-8
   Schneider M, 2008, J ORAL MAXIL SURG, V66, P2537, DOI 10.1016/j.joms.2008.06.107
   Schramm A, 2009, INT J MED ROBOT COMP, V5, P111, DOI 10.1002/rcs.245
   Shaye DA, 2015, JAMA FACIAL PLAST SU, V17, P113, DOI 10.1001/jamafacial.2014.1343
   Shin JW, 2013, J CRANIOFAC SURG, V24, P703, DOI 10.1097/SCS.0b013e31829026ca
   Shin KH, 2011, J CRANIOFAC SURG, V22, P1426, DOI 10.1097/SCS.0b013e31821cc2cd
   Singh M, 2015, PRS-GLOB OPEN, V3, DOI 10.1097/GOX.0000000000000455
   Spina AM, 2000, MAXILLOFACIAL SURG T
   Stanley R B Jr, 1999, Arch Facial Plast Surg, V1, P19, DOI 10.1001/archfaci.1.1.19
   THADANI V, 1988, J NEUROSURG, V69, P766, DOI 10.3171/jns.1988.69.5.0766
   THERIOT BA, 1987, J ORAL MAXIL SURG, V45, P577, DOI 10.1016/0278-2391(87)90267-9
   Tominaga K, 2006, J ORAL MAXIL SURG, V64, P1510, DOI 10.1016/j.joms.2006.03.038
   VALENTINO J, 1995, OTOLARYNG HEAD NECK, V112, P215, DOI 10.1016/S0194-5998(95)70239-3
   van Hout WMMT, 2014, J CRANIO MAXILL SURG, V42, P1918, DOI 10.1016/j.jcms.2014.07.012
   VandeGriend ZP, 2015, J CRANIOFAC SURG, V26, P112, DOI 10.1097/SCS.0000000000001299
   Verhoeff K, 1998, STRABISMUS, V6, P77
   Villarreal PM, 2004, J ORAL MAXIL SURG, V62, P155, DOI 10.1016/j.joms.2003.08.010
   Wang Ning-Chia, 2010, Chang Gung Med J, V33, P313
   Wilde F, 2013, J ORAL MAXIL SURG, V71, P894, DOI 10.1016/j.joms.2012.10.031
   Yadav K, 2011, ACAD EMERG MED, V18, P313, DOI 10.1111/j.1553-2712.2011.01017.x
   Yan ZP, 2012, J ORAL MAXIL SURG, V70, P1119, DOI 10.1016/j.joms.2011.12.033
   ZIDE MF, 1983, J ORAL MAXIL SURG, V41, P89, DOI 10.1016/0278-2391(83)90214-8
   Zide MF, 2001, J ORAL MAXIL SURG, V59, P375, DOI 10.1053/joms.2001.21869
   ZINS JE, 1983, PLAST RECONSTR SURG, V72, P778, DOI 10.1097/00006534-198312000-00005
NR 91
TC 0
Z9 0
U1 1
U2 2
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 1064-7406
J9 FACIAL PLAST SURG CL
JI Facial Plast. Surg. Clin. N. Am.
PD AUG
PY 2016
VL 24
IS 3
BP 299
EP +
DI 10.1016/j.fsc.2016.03.006
PG 11
WC Surgery
SC Surgery
GA DT1HJ
UT WOS:000381232000008
PM 27400843
DA 2018-10-20
ER

PT J
AU Cheng, WL
   He, JM
   Chen, ML
   Li, DL
   Li, H
   Chen, L
   Cao, Y
   Wang, J
   Huang, YD
AF Cheng, Weilu
   He, Jinmei
   Chen, Menglin
   Li, Dalong
   Li, Hui
   Chen, Lei
   Cao, Ye
   Wang, Jing
   Huang, Yudong
TI Preparation, Functional Characterization and Hemostatic Mechanism
   Discussion for Oxidized Microcrystalline Cellulose and Its Composites
SO FIBERS AND POLYMERS
LA English
DT Article
DE Oxidation; Microcrystalline cellulose; Hemostasis; Antibacterial
   activity
ID TEMPO-MEDIATED OXIDATION; REGENERATED CELLULOSE; NATIVE CELLULOSE;
   COAGULATION; THROMBOSIS; COLLAGEN; SURFACE; PATHWAY; FIBERS; BLOOD
AB Effective and affordable hemostatic materials are of great interests in the development of biomaterials. Lignocellulose, which is a raw material for microcrystalline cellulose, is one of the most economical and readily available polymers in the nature. The oxidized microcrystalline cellulose particles prepared in NO2/CCl4 oxidation system may be a type of affordable, effective and nontoxic hemostatic biomaterial. The FT-IR and C-13 solid state NMR results showed that the hydroxyl groups on C6 of cellulose were highly selectively oxidized. The increase of carboxyl content and Zeta potential of OMCC were highly dependent on the oxidation time at the first 64 h. XRD spectra indicated that the crystallinity changed from 70.01 % (MCC) to 60.63 % (OMCC-96 h), and the particle size decreased to 80 mu m (OMCC-96 h). To composite with oxidized regenerated cellulose gauze, the OMCC-64 h was optimal, based on the dramatically reduced DP value after 64 h oxidization. The results showed this novel composite with negative charge exhibited good hemostatic property and antibacterial activity. The composite was possessed of both the good biocompatibility for mouse endothelial cells in vitro and the superior biodegradation for rabbits in vivo. Moreover, the data of enzyme-linked immunosorbent assay and blood coagulation tests in vitro suggested that the composite could adsorb and activate the platelets, and then the platelet glycoprotein (GPIIb/IIIa) receptor became competent to bind soluble fibrinogen. The composite also greatly accelerated the activation of the blood coagulation factor XII, and promoted the generation of thrombin, so that the extrinsic route of blood coagulation was initiated.
C1 [Cheng, Weilu; He, Jinmei; Li, Dalong; Chen, Lei; Huang, Yudong] Harbin Inst Technol, Sch Chem & Chem Engn, State Key Lab Urban Water Resource & Environm, Harbin 150001, Peoples R China.
   [Cheng, Weilu; Chen, Menglin; Li, Dalong] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus, Denmark.
   [Li, Hui; Cao, Ye; Wang, Jing] Harbin Med Univ, Affiliated Hosp 2, Dept Oral & Maxillofacial Surg, Harbin 150001, Peoples R China.
RP Huang, YD (reprint author), Harbin Inst Technol, Sch Chem & Chem Engn, State Key Lab Urban Water Resource & Environm, Harbin 150001, Peoples R China.
EM ydhuang.hit1@aliyun.com
OI Chen, Menglin/0000-0002-2721-651X
FU Weihai Science and Technology Development Plan Project [2013GNS028];
   China Postdoctoral Science Foundation [2013M541372]
FX This work was financially supported by Weihai Science and Technology
   Development Plan Project (2013GNS028), China Postdoctoral Science
   Foundation Project (2013M541372).
CR Ashton W. H., 1968, United States Patent, Patent No. [3364200, 3,364,200]
   Baker AA, 1998, APPL PHYS A-MATER, V66, pS559, DOI 10.1007/s003390051201
   BANKER GS, 1995, Patent No. 5414079
   Brown AC, 2014, ACTA BIOMATER, V10, P1502, DOI 10.1016/j.actbio.2013.09.008
   Carlsson DO, 2014, RSC ADV, V4, P52289, DOI 10.1039/c4ra11182f
   Cheng WL, 2013, CELLULOSE, V20, P2547, DOI 10.1007/s10570-013-0005-5
   CONRAD CC, 1945, IND ENG CHEM, V37, P592, DOI 10.1021/ie50426a025
   Coseri S, 2013, CARBOHYD POLYM, V93, P207, DOI 10.1016/j.carbpol.2012.03.086
   Cui QY, 2014, RSC ADV, V4, P1630, DOI 10.1039/c3ra44516j
   Edwards JV, 2012, J BIOMATER APPL, V26, P939, DOI 10.1177/0885328210390542
   Eichhorn SJ, 2001, CELLULOSE, V8, P197, DOI 10.1023/A:1013181804540
   Fujisawa S, 2011, CARBOHYD POLYM, V84, P579, DOI 10.1016/j.carbpol.2010.12.029
   Gailani D, 2007, ARTERIOSCL THROM VAS, V27, P2507, DOI 10.1161/ATVBAHA.107.155952
   Gu HB, 2013, FIBER POLYM, V14, P1266, DOI 10.1007/s12221-013-1266-1
   Haafiz MKM, 2014, CARBOHYD POLYM, V103, P119, DOI 10.1016/j.carbpol.2013.11.055
   Isogai A, 2011, NANOSCALE, V3, P71, DOI 10.1039/c0nr00583e
   Kamel S, 2008, EXPRESS POLYM LETT, V2, P758, DOI 10.3144/expresspolymlett.2008.90
   Keshavarzi S, 2013, WOUNDS, V25, P160
   Knight PE, 2009, J PHARM SCI-US, V98, P2160, DOI 10.1002/jps.21587
   Liu H, 2011, CELLULOSE, V18, P67, DOI 10.1007/s10570-010-9464-0
   Mackman N, 2007, ARTERIOSCL THROM VAS, V27, P1687, DOI 10.1161/ATVBAHA.107.141911
   Martina B, 2009, ADV POLYM TECH, V28, P199, DOI 10.1002/adv.20161
   Pinkert A, 2009, CHEM REV, V109, P6712, DOI 10.1021/cr9001947
   Ponni R, 2012, BIORESOURCES, V7, P6077
   Saito T, 2007, BIOMACROMOLECULES, V8, P2485, DOI 10.1021/bm0703970
   Samir MASA, 2005, BIOMACROMOLECULES, V6, P612, DOI 10.1021/bm0493685
   Schonauer C, 2004, EUR SPINE J, V13, pS89, DOI 10.1007/s00586-004-0727-z
   Shi XY, 2016, J BIOMATER APPL, V30, P1092, DOI 10.1177/0885328215618354
   Siro I, 2010, CELLULOSE, V17, P459, DOI 10.1007/s10570-010-9405-y
   Son WK, 2004, BIOMACROMOLECULES, V5, P197, DOI 10.1021/bm034312g
   Wong SS, 2009, CARBOHYD POLYM, V77, P280, DOI 10.1016/j.carbpol.2008.12.038
   Wu QJ, 2007, BIOMACROMOLECULES, V8, P3687, DOI 10.1021/bm701061t
   Wu YD, 2012, CARBOHYD POLYM, V88, P1023, DOI 10.1016/j.carbpol.2012.01.058
NR 33
TC 3
Z9 3
U1 6
U2 52
PU KOREAN FIBER SOC
PI SEOUL
PA KOREA SCIENCE TECHNOLOGY CTR #501 635-4 YEOGSAM-DONG, KANGNAM-GU, SEOUL
   135-703, SOUTH KOREA
SN 1229-9197
EI 1875-0052
J9 FIBER POLYM
JI Fiber. Polym.
PD AUG
PY 2016
VL 17
IS 8
BP 1277
EP 1286
DI 10.1007/s12221-016-6279-0
PG 10
WC Materials Science, Textiles; Polymer Science
SC Materials Science; Polymer Science
GA DU0XL
UT WOS:000381928100020
DA 2018-10-20
ER

PT J
AU Rokosz, K
   Hryniewicz, T
   Raaen, S
AF Rokosz, Krzysztof
   Hryniewicz, Tadeusz
   Raaen, Steinar
TI Development of plasma electrolytic oxidation for improved Ti6Al4V
   biomaterial surface properties
SO INTERNATIONAL JOURNAL OF ADVANCED MANUFACTURING TECHNOLOGY
LA English
DT Article
DE Ti6Al4V alloy; Plasma electrolytic oxidation (PEO) treatment; Micro arc
   oxidation (MAO); Surface layer; SEM; EDS; XPS
ID AISI 316L SS; CORROSION-RESISTANCE; TI-6AL-4V ALLOY; XPS ANALYSIS;
   TITANIUM; LAYERS; ALUMINUM; ANTIBACTERIAL; DEGRADATION; BEHAVIOR
AB In the paper, the scanning electron microscopy (SEM), energy-dispersive X-ray spectroscopy (EDS), and X-ray photoelectron spectroscopy (XPS) results of the Ti6Al4V alloy treated by a novel plasma electrolytic oxidation (PEO) (micro arc oxidation) in the electrolyte containing concentrated phosphoric acid and copper nitrate are presented. The PEO treatment was performed at the voltage of 450 +/- 10 V. The main problem to solve under the experiments was to obtain a porous surface layer composed mainly of titanium phosphates within the copper ions. The performed study has shown that the amount of copper nitrate in 85 % concentrated phosphoric acid should be not less than 1.60 mol/L. The best result in the case of copper (4.3 +/- 0.6 wt%) and phosphorus (19.9 +/- 0.5 wt%) contents in the surface layer was obtained after the PEO treatment in electrolyte with the highest amount of copper nitrate used, i.e., in 3.20 mol/L of Cu(NO3)(2) in H3PO4. Concerning the Ti6Al4V alloy for the use as biomaterial, an interesting characteristic and a great advantage obtained from the proposed PEO treatment is eliminating vanadium and a considerable diminishing of aluminum from the surface coating. Two elements forming Ti6Al4V alloy, vanadium, and aluminum are detrimental for human body. After implantation, vanadium leaking from this biomaterial reveals the carcinogenic effects whereas aluminum has an impact on acceleration and stimulation of Alzheimer's disease. Separation and isolation of the human tissue from the matrix is a crucial task of researchers. The proposed new PEO process fulfills this requirement and may result in great improvement of the biomedical surface characteristics.
C1 [Rokosz, Krzysztof; Hryniewicz, Tadeusz] Koszalin Univ Technol, Div Surface Electrochem & Technol, Fac Mech Engn, Raclawicka 15-17, PL-75620 Koszalin, Poland.
   [Raaen, Steinar] Norwegian Univ Sci & Technol NTNU, Dept Phys, Realfagbygget E3-124 Hogskoleringen 5, NO-7491 Trondheim, Norway.
RP Hryniewicz, T (reprint author), Koszalin Univ Technol, Div Surface Electrochem & Technol, Fac Mech Engn, Raclawicka 15-17, PL-75620 Koszalin, Poland.
EM rokosz@tu.koszalin.pl; Tadeusz.Hryniewicz@tu.koszalin.pl;
   luki6665@gmail.com
CR [Anonymous], 2015, TITANIUM TODAY, P26
   Bellows CG, 1999, CALCIFIED TISSUE INT, V65, P59, DOI 10.1007/s002239900658
   Biesinger MC, 2010, APPL SURF SCI, V257, P887, DOI 10.1016/j.apsusc.2010.07.086
   Browne R.C, 1995, BRIT J IND MED, V2, P57
   Cha PR, 2013, SCI REP-UK, V3, DOI 10.1038/srep02367
   Cho IS, 2008, ADV FUNCT MATER, V18, P2154, DOI 10.1002/adfm.200800167
   DAVIDSON JA, 1994, BIO-MED MATER ENG, V4, P231
   Hempel F, 2014, SURF COAT TECH, V256, P52, DOI 10.1016/j.surfcoat.2014.01.027
   Hryniewicz T, 2012, APPL SURF SCI, V263, P357, DOI 10.1016/j.apsusc.2012.09.060
   Hryniewicz T, 2010, MATER CHEM PHYS, V123, P47, DOI 10.1016/j.matchemphys.2010.03.060
   Hryniewicz T, 2010, SURF COAT TECH, V204, P2583, DOI 10.1016/j.surfcoat.2010.02.005
   Hryniewicz T, 2015, MATERIALS, V8, P205, DOI 10.3390/ma8010205
   Hryniewicz T, 2014, ANTI-CORROS METHOD M, V61, P57, DOI 10.1108/ACMM-03-2013-1249
   Hryniewicz T, 2012, MATER LETT, V83, P69, DOI 10.1016/j.matlet.2012.06.010
   Hryniewicz T, 2011, SURF COAT TECH, V205, P4228, DOI 10.1016/j.surfcoat.2011.03.024
   Hryniewicz T, 2010, MATER CHEM PHYS, V122, P169, DOI 10.1016/j.matchemphys.2010.02.055
   JACOBS JJ, 1991, J BONE JOINT SURG AM, V73A, P1475, DOI 10.2106/00004623-199173100-00005
   Jelinek M, 2013, MAT SCI ENG C-MATER, V33, P1242, DOI 10.1016/j.msec.2012.12.018
   Kirkland NT, 2012, CORROS ENG SCI TECHN, V47, P322, DOI 10.1179/1743278212Y.0000000034
   Kobayashi E, 1988, J MATER SCI-MATER M, V9, P567
   Krewski D, 2007, J TOXICOL ENV HEAL B, V10, P1, DOI 10.1080/10937400701597766
   Krzakala A, 2014, ARCH METALL MATER, V59, P199, DOI 10.2478/amm-2014-0032
   Ku CH, 2002, BIOMATERIALS, V23, P1447, DOI 10.1016/S0142-9612(01)00266-6
   LANDSBERG JP, 1992, NATURE, V360, P65, DOI 10.1038/360065a0
   Laskawiec J, 2002, THEORETICAL APPL ISS
   Li HF, 2015, SCI REP-UK, V5, DOI 10.1038/srep10719
   Mishra G, 2013, J ENVIRON CHEM ENG, V1, P1124, DOI 10.1016/j.jece.2013.08.031
   Persaud-Sharma Dharam, 2012, J Biomim Biomater Tissue Eng, V12, P25, DOI 10.4028/www.scientific.net/JBBTE.12.25
   Rajendran A, 2014, RSC ADV, V4, P61444, DOI 10.1039/c4ra13107j
   Rokicki R, 2015, J MATER ENG PERFORM, V24, P1634, DOI 10.1007/s11665-015-1429-x
   Rokosz K, 2010, CORROSION, V66, DOI 10.5006/1.3360910
   Rokosz K, 2015, SURF COAT TECH, V276, P516, DOI 10.1016/j.surfcoat.2015.06.022
   Rokosz K, 2015, TEH VJESN, V22, P125, DOI 10.17559/TV-20140211130812
   Rokosz K, 2015, SURF INTERFACE ANAL, V47, P87, DOI 10.1002/sia.5676
   Rokosz K, 2014, TEH VJESN, V21, P533
   Rokosz K, 2012, STEEL RES INT, V83, P910, DOI 10.1002/srin.201200046
   SEILER HG, 1998, HDB TOXICITY INORGAN
   Simka W., 2013, HABILITATION SUMMARY, P1
   STATSOFT INC, 2011, STATISTICA DAT AN SO
   Stevens MM, 2008, MATER TODAY, V11, P18, DOI 10.1016/S1369-7021(08)70086-5
   Trujillo NA, 2012, MAT SCI ENG C-MATER, V32, P2135, DOI 10.1016/j.msec.2012.05.012
   Wagner C.D., 2003, NIST STANDARD REFERE
   Wheeler JM, 2010, SURF COAT TECH, V204, P3399, DOI 10.1016/j.surfcoat.2010.04.006
   Yerokhin AL, 1999, SURF COAT TECH, V122, P73, DOI 10.1016/S0257-8972(99)00441-7
   Yerokhin AL, 2000, SURF COAT TECH, V130, P195, DOI 10.1016/S0257-8972(00)00719-2
   Zhang HB, 2014, TISSUE ENG PART B-RE, V20, P492, DOI [10.1089/ten.teb.2013.0452, 10.1089/ten.TEB.2013.0452]
   Zhang JH, 2015, SCI REP-UK, V5, DOI 10.1038/srep13933
NR 47
TC 20
Z9 20
U1 4
U2 41
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0268-3768
EI 1433-3015
J9 INT J ADV MANUF TECH
JI Int. J. Adv. Manuf. Technol.
PD AUG
PY 2016
VL 85
IS 9-12
BP 2425
EP 2437
DI 10.1007/s00170-015-8086-y
PG 13
WC Automation & Control Systems; Engineering, Manufacturing
SC Automation & Control Systems; Engineering
GA DS9LR
UT WOS:000381105100043
OA Other Gold
DA 2018-10-20
ER

PT J
AU Hsu, HH
   Uemura, T
   Yamaguchi, I
   Ikoma, T
   Tanaka, J
AF Hsu, Han-Hsiu
   Uemura, Toshimasa
   Yamaguchi, Isamu
   Ikoma, Toshiyuki
   Tanaka, Junzo
TI Chondrogenic differentiation of human mesenchymal stem cells on fish
   scale collagen
SO JOURNAL OF BIOSCIENCE AND BIOENGINEERING
LA English
DT Article
DE Fish scale collagen; Chondrogenesis; Mesenchymal stem cells;
   Extra-cellular matrix; Tilapia collagen
ID PAGRUS-MAJOR; IN-VITRO; BONE; OSTEOGENESIS; CARTILAGE; MODEL
AB Fish collagen has recently been reported to be a novel biomaterial for cell and tissue culture as an alternative to conventional mammalian collagens such as bovine and porcine collagens. Fish collagen could overcome the risk of zoonosis, such as from bovine spongiform encephalopathy. Among fish collagens, tilapia collagen, the denaturing temperature of which is near 37 degrees C, is appropriate for cell and tissue culture. In this study, we investigated chondrogenic differentiation of human mesenchymal stem cells (hMSCs) cultured on tilapia scale collagen fibrils compared with porcine collagen and non-coated dishes. The collagen fibrils were observed using a scanning electronic microscope. Safranin 0 staining, glycosaminoglycans (GAG) expression, and real-time PCR were examined to evaluate chondrogenesis of hMSCs on each type of collagen fibril. The results showed that hMSCs cultured on tilapia scale collagen showed stronger Safranin 0 staining and higher GAG expression at day 6. Results of real-time PCR indicated that hMSCs cultured on tilapia collagen showed earlier SOX9 expression on day 4 and higher AGGRECAN and COLLAGEN II expression on day 6 compared with on porcine collagen and non-coated dishes. Furthermore, low mRNA levels of bone gammacarboxyglutamate, a specific marker of osteogenesis, showed that tilapia collagen fibrils specifically enhanced chondrogenic differentiation of hMSCs in chondrogenic medium, as well as porcine collagen. Accordingly, tilapia scale collagen may provide an appropriate collagen source for hMSC chondrogenesis in vitro. (C) 2016, The Society for Biotechnology, Japan. All rights reserved.
C1 [Hsu, Han-Hsiu; Uemura, Toshimasa] Natl Inst Adv Ind Sci & Technol, Biotechnol Res Inst Drug Discovery, Dept Life Sci & Biotechnol, 1-1-1 Higashi,Tsukuba Cent 5, Tsukuba, Ibaraki 3058562, Japan.
   [Yamaguchi, Isamu] Taki Chem Co Ltd, 346 Miyanishi, Harima, Hyogo 6750145, Japan.
   [Ikoma, Toshiyuki; Tanaka, Junzo] Tokyo Inst Technol, Dept Met & Ceram Sci, Meguro Ku, S7-6,2-12-1 Ookayama, Tokyo 1528550, Japan.
   [Uemura, Toshimasa] Osaka Univ, Grad Sch Engn, Dept Precis Sci & Technol, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.
RP Uemura, T (reprint author), Natl Inst Adv Ind Sci & Technol, Biotechnol Res Inst Drug Discovery, Dept Life Sci & Biotechnol, 1-1-1 Higashi,Tsukuba Cent 5, Tsukuba, Ibaraki 3058562, Japan.; Uemura, T (reprint author), Osaka Univ, Grad Sch Engn, Dept Precis Sci & Technol, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.
EM uemura@prec.eng.osaka-u.ac.jp
RI Ikoma, Toshiyuki/E-4288-2012
OI Ikoma, Toshiyuki/0000-0003-3154-1777
CR CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Caplan AI, 2005, TISSUE ENG, V11, P1198, DOI 10.1089/ten.2005.11.1198
   Goessler UR, 2006, INT J MOL MED, V17, P301
   Goldring MB, 2012, THER ADV MUSCULOSKEL, V4, P269, DOI 10.1177/1759720X12448454
   Hermann A, 2004, J CELL SCI, V117, P4411, DOI 10.1242/jcs.01307
   Ikoma T, 2003, INT J BIOL MACROMOL, V32, P199, DOI 10.1016/S0141-8130(03)00054-0
   Ikoma T, 2003, J STRUCT BIOL, V142, P327, DOI 10.1016/S1047-8477(03)00053-4
   Karim AA, 2009, FOOD HYDROCOLLOID, V23, P563, DOI 10.1016/j.foodhyd.2008.07.002
   Kelly DJ, 2010, BIRTH DEFECTS RES C, V90, P75, DOI 10.1002/bdrc.20173
   LASH JW, 1974, J EXP ZOOL, V189, P127, DOI 10.1002/jez.1401890112
   Lee PW, 2011, J AGR FOOD CHEM, V59, P12309, DOI 10.1021/jf203277z
   Liu R, 2013, CLIN EXP ALLERGY, V43, P365, DOI 10.1111/cea.12056
   Matsumoto R, 2015, J BIOMED MATER RES A, V103, P2531, DOI 10.1002/jbm.a.35387
   Muralidharan N, 2013, J FOOD SCI TECH MYS, V50, P1106, DOI 10.1007/s13197-011-0440-y
   Nagai T, 2000, FOOD CHEM, V68, P277, DOI 10.1016/S0308-8146(99)00188-0
   NORRIS WD, 1990, J CELL SCI, V95, P255
   Oh HH, 2016, J BIOACT COMPAT POL, V31, P31, DOI 10.1177/0883911515595240
   Sato Y, 2005, BLOOD, V106, P756, DOI 10.1182/blood-2005-02-0572
   Szpak P, 2011, J ARCHAEOL SCI, V38, P3358, DOI 10.1016/j.jas.2011.07.022
   Takagi Y, 2007, J NANOSCI NANOTECHNO, V7, P757, DOI 10.1166/jnn.2007.503
   Tang J, 2015, BIOMED RES INT, DOI 10.1155/2015/139476
   Terada M, 2012, J BIOMED MATER RES B, V100B, P1792, DOI 10.1002/jbm.b.32746
   Vickers SM, 2006, TISSUE ENG, V12, P1345, DOI 10.1089/ten.2006.12.1345
   Yoshikubo H, 2005, LIFE SCI, V76, P2699, DOI 10.1016/j.lfs.2004.10.063
NR 24
TC 7
Z9 8
U1 0
U2 14
PU SOC BIOSCIENCE BIOENGINEERING JAPAN
PI OSAKA
PA OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871,
   JAPAN
SN 1389-1723
EI 1347-4421
J9 J BIOSCI BIOENG
JI J. Biosci. Bioeng.
PD AUG
PY 2016
VL 122
IS 2
BP 219
EP 225
DI 10.1016/j.jbiosc.2016.01.001
PG 7
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA DT9PW
UT WOS:000381835800014
PM 26829997
DA 2018-10-20
ER

PT J
AU Tobaruela, A
   Rojo, FJ
   Paez, JMG
   Bourges, JY
   Herrero, EJ
   Millan, I
   Alvarez, L
   Cordon, A
   Guinea, GV
AF Tobaruela, Almudena
   Javier Rojo, Francisco
   Garcia Paez, Jose Maria
   Yves Bourges, Jean
   Jorge Herrero, Eduardo
   Millan, Isabel
   Alvarez, Lourdes
   Cordon, Angeles
   Guinea, Gustavo V.
TI Indentation hardness: A simple test that correlates with the
   dissipated-energy predictor for fatigue-life in bovine pericardium
   membranes for bioprosthetic heart valves
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Bovine pericardium; Energy dissipated; Fatigue; Hardness; Heart valves
ID COLLAGEN FIBER ORIENTATION; TISSUE; CALCIFICATION; BIOMATERIALS;
   DURABILITY; SELECTION; BEHAVIOR; ARCHITECTURE; REPLACEMENT; CONSUMPTION
AB The aim of this study was to evaluate the variation of hardness with fatigue in calf pericardium, a biomaterial commonly used in bioprosthetic heart valves, and its relationship with the energy dissipated during the first fatigue cycle that has been shown to be a predictor of fatigue-life (Garcia Paez et al., 2006, 2007; Rojo et al., 2010). Fatigue tests were performed in vitro on 24 pericardium specimens cut in a root-to-apex direction. The specimens were subjected to a maximum stress of 1 MPa in blocks of 10, 25, 50, 100, 250, 500, 1000 and 1500 cycles. By means of a modified Shore A hardness test procedure, the hardness of the specimen was measured before and after fatigue tests. Results showed a significant correlation of such hardness with fatigue performance and with the energy dissipated in the first cycle of fatigue, a predictor of pericardium durability. The study showed indentation hardness as a simple and reliable indicator of mechanical performance, one which could be easily implemented in improving tissue selection. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Tobaruela, Almudena; Javier Rojo, Francisco; Yves Bourges, Jean; Guinea, Gustavo V.] Univ Politecn Madrid, Ctr Tecnol Biomed, Madrid 28223, Spain.
   [Tobaruela, Almudena; Javier Rojo, Francisco; Yves Bourges, Jean; Guinea, Gustavo V.] Univ Politecn Madrid, ETSI Caminos Canales & Puertos, Dept Ciencia Mat, E-28040 Madrid, Spain.
   [Garcia Paez, Jose Maria; Jorge Herrero, Eduardo; Millan, Isabel; Alvarez, Lourdes; Cordon, Angeles] Clin Puerta De Hierro, Serv Cirugia Expt & Bioestadist, Madrid 28220, Spain.
RP Tobaruela, A (reprint author), Univ Politecn Madrid, Ctr Tecnol Biomed, Madrid 28223, Spain.
EM almudena.tobaruela@upm.es
RI Rojo Perez, Francisco Javier/F-7710-2016; GUINEA TORTUERO, GUSTAVO
   VICTOR/N-1241-2014
OI Rojo Perez, Francisco Javier/0000-0001-9517-0050; GUINEA TORTUERO,
   GUSTAVO VICTOR/0000-0002-4326-3746; TOBARUELA ARNEDO, MARIA DE LA
   ALMUDENA/0000-0003-1155-2022
FU Ministerio de Economia y Competitividad Spain [MAT2012-36096,
   MAT2012-38412]; Comunidad de Madrid [S2011/BMD-2460]; Fundacion Botin
   and Banco Santander through Santander Universities Global Division
   [SE14005001]
FX This research was funded by Ministerio de Economia y Competitividad
   Spain through projects MAT2012-36096 and MAT2012-38412, by the Comunidad
   de Madrid (Grant S2011/BMD-2460) and by Fundacion Botin and Banco
   Santander through its Santander Universities Global Division (Grant
   SE14005001).
CR [Anonymous], 53505 DIN
   *ASTM, D2240 ASTM
   Braile DM, 1998, J HEART VALVE DIS, V7, P202
   BROOM ND, 1977, J BIOMECH, V10, P707, DOI 10.1016/0021-9290(77)90086-0
   Bustamante-Munguira J, 2014, CIR CARDIOVASC, V21, P271, DOI 10.1016/j.circv.2014.10.005
   Butany J, 2001, J Long Term Eff Med Implants, V11, P115
   Butcher JT, 2011, ADV DRUG DELIVER REV, V63, P242, DOI 10.1016/j.addr.2011.01.008
   Flecher EM, 2008, J CARDIAC SURG, V23, P234, DOI 10.1111/j.1540-8191.2008.00593.x
   Paez JMG, 2007, J MATER SCI-MATER M, V18, P715, DOI 10.1007/s10856-006-0009-x
   Jorge-Herrero E, 2005, J Appl Biomater Biomech, V3, P67
   Kent PD, 1998, CARDIOVASC PATHOL, V7, P9, DOI 10.1016/S1054-8807(97)00040-9
   Lally C, 2004, ANN BIOMED ENG, V32, P1355, DOI 10.1114/B:ABME.0000042224.23927.ce
   LEE YS, 1994, J ELECTRON MICROSC, V43, P131
   Mausner J, 1985, EPIDEMIOLOGY INTRO T, P214
   Mirnajafi A, 2005, BIOMATERIALS, V26, P795, DOI 10.1016/j.biomaterials.2004.03.004
   Paez JMG, 2009, J BIOMED MATER RES A, V89A, P336, DOI 10.1002/jbm.a.31970
   Paez JMG, 2006, J BIOMED MATER RES A, V77A, P839, DOI 10.1002/jbm.a.30650
   Paez JMG, 2001, BIOMATERIALS, V22, P2759
   PURINYA B, 1994, J BIOMECH, V27, P1, DOI 10.1016/0021-9290(94)90027-2
   Rojo FJ, 2010, J BIOMED MATER RES B, V95B, P414, DOI 10.1002/jbm.b.31732
   Sacks M S, 1994, ASAIO J, V40, pM632, DOI 10.1097/00002480-199407000-00075
   Sacks MS, 2002, J BIOMED MATER RES, V62, P359, DOI 10.1002/jbm.10293
   Sacks MS, 1998, ANN BIOMED ENG, V26, P892, DOI 10.1114/1.135
   Sacks MS, 1998, BIOMATERIALS, V19, P1027, DOI 10.1016/S0142-9612(98)00002-7
   SCHOEN FJ, 1986, AM J PATHOL, V123, P134
   SCHOEN FJ, 1987, CIRCULATION, V76, P618, DOI 10.1161/01.CIR.76.3.618
   Sellaro TL, 2007, J BIOMED MATER RES A, V80A, P194, DOI 10.1002/jbm.a.30871
   Sun W, 2004, J BIOMED MATER RES A, V69A, P658, DOI 10.1002/jbm.a.30031
   Tillquist MN, 2011, PATIENT PREFER ADHER, V5, P91, DOI 10.2147/PPA.S16420
   TYERS GFO, 1995, ANN THORAC SURG, V60, pS464
   Vesely I, 2003, CARDIOVASC PATHOL, V12, P277, DOI 10.1016/S1054-8807(03)00075-9
   VESELY I, 1995, ANN THORAC SURG, V60, pS379, DOI 10.1016/0003-4975(95)00261-I
   Vongpatanasin W, 1996, NEW ENGL J MED, V335, P407, DOI 10.1056/NEJM199608083350607
NR 33
TC 1
Z9 1
U1 3
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
EI 1878-0180
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD AUG
PY 2016
VL 61
BP 55
EP 61
DI 10.1016/j.jmbbm.2016.01.010
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DR7LE
UT WOS:000380080400006
PM 26849027
DA 2018-10-20
ER

PT J
AU Takematsu, E
   Cho, K
   Hieda, J
   Nakai, M
   Katsumata, K
   Okada, K
   Niinomi, M
   Matsushita, N
AF Takematsu, E.
   Cho, K.
   Hieda, J.
   Nakai, M.
   Katsumata, K.
   Okada, K.
   Niinomi, M.
   Matsushita, N.
TI Adhesive strength of bioactive oxide layers fabricated on TNTZ alloy by
   three different alkali-solution treatments
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE TNTZ alloy; Tensile strength; Anodization; Hydrothermal-electrochemical
   processing; Adhesive strength; Bioactive oxide layer
ID BIOMEDICAL APPLICATIONS; MECHANICAL-PROPERTIES; SURFACE MODIFICATION;
   TITANIUM-ALLOYS; COATINGS; STRESS; SYSTEM
AB Bioactive oxide layers were fabricated on Ti-29Nb-13Ta-4.6Zr alloy (TNTZ) by three different alkali solution treatments: hydrothermal (H), electrochemical (E), and hydro thermal -electrochemical (HE). The adhesive strength of the oxide layer to the TNTZ substrate was measured to determine whether this process achieves sufficient adhesive strength for implant materials. Samples subjected to the HE process, in which a current of 15 mA/cm(2) was applied at 90 degrees C for 1 h (HE90-1h), exhibited a comparatively higher adhesive strength of approximately 18 MPa while still maintaining a sufficiently high bioactivity. Based on these results, an oxide layer fabricated on TNTZ by HE90-1h is considered appropriate for practical biomaterial application, though thicker oxide layers with many cracks can lead to a reduced adhesive strength. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Takematsu, E.; Matsushita, N.] Tokyo Inst Technol, Dept Electrochem, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268503, Japan.
   [Cho, K.] Osaka Univ, Div Mat & Mfg Sci, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.
   [Hieda, J.] Tokyo Inst Technol, Dept Mech Sci & Technol, Meguro Ku, 2-12-1 O Okayama, Tokyo 1528550, Japan.
   [Nakai, M.; Niinomi, M.] Tohoku Univ, Inst Mat Res, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9858577, Japan.
   [Katsumata, K.] Tokyo Univ Sci, Res Inst Sci & Technol, Photocatalysis Int Res Ctr, 2641 Yamazaki, Noda, Chiba 2788510, Japan.
   [Okada, K.] Tokyo Inst Technol, Meguro Ku, 2-12-1 O Okayama, Tokyo 1528550, Japan.
   [Matsushita, N.] Tokyo Inst Technol, Dept Chem & Mat Sci, Meguro Ku, 2-12-1 O Okayama, Tokyo 1528550, Japan.
RP Matsushita, N (reprint author), Tokyo Inst Technol, Dept Chem & Mat Sci, Meguro Ku, 2-12-1 O Okayama, Tokyo 1528550, Japan.
EM matsushita.n.ab@m.titech.ac.jp
RI Matsushita, Nobuhiro/F-9416-2014; Katsumata, Ken-ichi/E-4576-2014
OI Katsumata, Ken-ichi/0000-0002-3841-5354
FU Collaboration Research Project of Advanced Materials Development and
   Integration of Novel Structured Metallic and Inorganic Materials -
   Ministry of Education, Culture, Sports, Science and Technology, Japan
FX The authors gratefully acknowledge the financial support received from
   the Collaboration Research Project of Advanced Materials Development and
   Integration of Novel Structured Metallic and Inorganic Materials
   supported by Ministry of Education, Culture, Sports, Science and
   Technology, Japan. We also thank Ms. Matsubara for her helpful advice.
CR Akahori T, 2005, J JPN I MET, V69, P530, DOI 10.2320/jinstmet.69.530
   Akahori T, 2007, MATER TRANS, V48, P293, DOI 10.2320/matertrans.48.293
   Fukushima Y, 2013, MATER TRANS, V54, P1343, DOI 10.2320/matertrans.MF201312
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Gerpreela M.A.-H., 2013, J MECH BEHAV BIOMED, V20, P407
   Ito T., 1994, ELECT J R D REV TOYO, V29, P43
   Kim HM, 1997, J MATER SCI-MATER M, V8, P341, DOI 10.1023/A:1018524731409
   Kozuka H, 2003, J SOL-GEL SCI TECHN, V26, P681, DOI 10.1023/A:1020773415962
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Marie O., 2005, MILLER KEANE ENCY DI
   Mohseni E, 2014, INT J ADHES ADHES, V48, P238, DOI 10.1016/j.ijadhadh.2013.09.030
   Nakai M., 2009, MAT T, V50, P150
   Nakano H, 2009, J JPN I MET, V73, P394, DOI 10.2320/jinstmet.73.394
   Niinomi M, 2011, INT J BIOMATER, DOI 10.1155/2011/836587
   Niinomi M, 2002, MATER TRANS, V43, P2970, DOI 10.2320/matertrans.43.2970
   Niinomi M, 2008, MATER TRANS, V49, P2170, DOI 10.2320/matertrans.L-MRA2008828
   Singh G, 2011, SURF COAT TECH, V205, P4814, DOI 10.1016/j.surfcoat.2011.04.064
   Suchanek WL, 1999, REV SCI INSTRUM, V70, P2432, DOI 10.1063/1.1149772
   Sugiyama N, 2009, ACTA BIOMATER, V5, P1367, DOI 10.1016/j.actbio.2008.10.014
   Takematsu E., 2015, MAT SCI ENG C
   Takematsu E., MAT SCI E C IN PRESS
   Tsui YC, 1998, BIOMATERIALS, V19, P2015, DOI 10.1016/S0142-9612(98)00103-3
   Yoshimura M, 2008, MATER SCI ENG B-ADV, V148, P2, DOI 10.1016/j.mseb.2007.09.080
   Zhang H, 2008, PHYS STATUS SOLIDI B, V245, P37, DOI 10.1002/pssb.200743050
   Zheng XB, 2000, BIOMATERIALS, V21, P841, DOI 10.1016/S0142-9612(99)00255-0
NR 25
TC 1
Z9 1
U1 1
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
EI 1878-0180
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD AUG
PY 2016
VL 61
BP 174
EP 181
DI 10.1016/j.jmbbm.2015.12.046
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DR7LE
UT WOS:000380080400017
PM 26866453
DA 2018-10-20
ER

PT J
AU Weisgerber, DW
   Erning, K
   Flanagan, CL
   Hollister, SJ
   Harley, BAC
AF Weisgerber, D. W.
   Erning, K.
   Flanagan, C. L.
   Hollister, S. J.
   Harley, B. A. C.
TI Evaluation of multi-scale mineralized collagen-polycaprolactone
   composites for bone tissue engineering
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Collagen; Polycaprolactone; Biomaterial; Multi-scale; Craniofacial; Bone
ID ENDOTHELIAL GROWTH-FACTOR; GAG SCAFFOLDS; IN-VIVO; GLYCOSAMINOGLYCAN
   SCAFFOLDS; MORPHOGENETIC PROTEIN-2; BIOPHYSICAL PROPERTIES; PCL
   SCAFFOLDS; CROSS-LINKING; PORE-SIZE; OSTEOGENESIS
AB A particular challenge in biomaterial development for treating orthopedic injuries stems from the need to balance bioactive design criteria with the mechanical and geometric constraints governed by the physiological wound environment. Such trade-offs are of particular importance in large craniofacial bone defects which arise from both acute trauma and chronic conditions. Ongoing efforts in our laboratory have demonstrated a mineralized collagen biomaterial that can promote human mesenchymal stem cell osteogenesis in the absence of osteogenic media but that possesses suboptimal mechanical properties in regards to use in loaded wound sites. Here we demonstrate a multi-scale composite consisting of a highly bioactive mineralized collagen-glycosaminoglycan scaffold with micron-scale porosity and a polycaprolactone support frame (PCL) with millimeter-scale porosity. Fabrication of the composite was performed by impregnating the PCL support frame with the mineral scaffold precursor suspension prior to lyophilization. Here we evaluate the mechanical properties, permeability, and bioactivity of the resulting composite. Results indicated that the PCL support frame dominates the bulk mechanical response of the composite resulting in a 6000-fold increase in modulus compared to the mineral scaffold alone. Similarly, the incorporation of the mineral scaffold matrix into the composite resulted in a higher specific surface area compared to the PCL frame alone. The increased specific surface area in the collagen-PCL composite promoted increased initial attachment of porcine adipose derived stem cells versus the PCL construct. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Weisgerber, D. W.] Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA.
   [Erning, K.; Harley, B. A. C.] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA.
   [Harley, B. A. C.] Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA.
   [Flanagan, C. L.; Hollister, S. J.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
   [Hollister, S. J.] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA.
RP Harley, BAC (reprint author), Univ Illinois, Dept Chem & Biomol Engn, Carl R Woese Inst Genom Biol, 110 Roger Adams Lab,600 S Mathews Ave, Urbana, IL 61801 USA.
EM bharley@illinois.edu
FU AO Foundation (Switzerland) [S-14-54H]; U.S. Department of Energy
   [DE-FG02-07ER46453, DE-FG02-07ER46471]
FX The authors would like to acknowledge the generous donation of porcine
   adipose derived stem cells isolated and contributed by Dr. Mathew
   Wheeler (Department of Animal Sciences, UIUC, Urbana, IL), and Karen
   Doty (Veterinary Sciences, UIUC) for sectioning of GMA embedded samples.
   Project S-14-54H was supported by the AO Foundation (Switzerland). This
   research was carried out in part in the Frederick Seitz Materials
   Research Laboratory Central Facilities, University of Illinois, which
   are partially supported by the U.S. Department of Energy under Grants
   DE-FG02-07ER46453 and DE-FG02-07ER46471.
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A
   Alsop AT, 2014, ACTA BIOMATER, V10, P4715, DOI 10.1016/j.actbio.2014.07.002
   BONFIELD W, 1988, J BIOMED ENG, V10, P522, DOI 10.1016/0141-5425(88)90110-0
   Brydone AS, 2010, P I MECH ENG H, V224, P1329, DOI 10.1243/09544119JEIM770
   Caliari SR, 2015, ADV HEALTHC MATER, V4, P831, DOI 10.1002/adhm.201400809
   Caliari SR, 2015, ADV HEALTHC MATER, V4, DOI 10.1002/adhm.201400252
   Caliari SR, 2014, TISSUE ENG PT A, V20, P2463, DOI [10.1089/ten.tea.2013.0400, 10.1089/ten.TEA.2013.0400]
   Caliari SR, 2011, BIOMATERIALS, V32, P5330, DOI 10.1016/j.biomaterials.2011.04.021
   Chen L., 2015, MOL MED REP
   CHOI K, 1990, J BIOMECH, V23, P1103, DOI 10.1016/0021-9290(90)90003-L
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   Dias MR, 2012, J BIOMECH, V45, P938, DOI 10.1016/j.jbiomech.2012.01.019
   Dias MR, 2014, MED ENG PHYS, V36, P448, DOI 10.1016/j.medengphy.2014.02.010
   Hannink G, 2011, INJURY, V42, pS22, DOI 10.1016/j.injury.2011.06.008
   Harley BA, 2007, ACTA BIOMATER, V3, P463, DOI 10.1016/j.aetbio.2006.12.009
   Harley BA, 2010, J BIOMED MATER RES A, V92A, P1066, DOI 10.1002/jbm.a.32361
   Harley BAC, 2008, CHEM ENG J, V137, P102, DOI 10.1016/j.cej.2007.09.009
   Hollister S J, 2005, Orthod Craniofac Res, V8, P162, DOI 10.1111/j.1601-6343.2005.00329.x
   Hollister SJ, 2015, ANN BIOMED ENG, V43, P774, DOI 10.1007/s10439-015-1270-2
   Hu WW, 2009, BIOMATERIALS, V30, P5785, DOI 10.1016/j.biomaterials.2009.06.041
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   Jeong CG, 2011, ACTA BIOMATER, V7, P505, DOI 10.1016/j.actbio.2010.08.027
   Jungreuthmayer C, 2009, TISSUE ENG PT A, V15, P1141, DOI 10.1089/ten.tea.2008.0204
   KARAM GN, 1994, MAT SCI ENG C-BIOMIM, V2, P113, DOI 10.1016/0928-4931(94)90039-6
   KUHNE JH, 1994, ACTA ORTHOP SCAND, V65, P246, DOI 10.3109/17453679408995448
   Kurtz SM, 2007, BIOMATERIALS, V28, P4845, DOI 10.1016/j.biomaterials.2007.07.013
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lee JC, 2015, J CRANIOFAC SURG, V26, P1992, DOI 10.1097/SCS.0000000000001918
   Lipner J, 2014, J MECH BEHAV BIOMED, V40, P59, DOI 10.1016/j.jmbbm.2014.08.002
   Lipowiecki M, 2014, J BIOMED MATER RES A, V102, P4127, DOI 10.1002/jbm.a.35084
   Martin TA, 2011, BIOMATERIALS, V32, P3949, DOI 10.1016/j.biomaterials.2011.02.018
   Mitsak AG, 2011, TISSUE ENG PT A, V17, P1831, DOI [10.1089/ten.TEA.2010.0560, 10.1089/ten.tea.2010.0560]
   Mobasseri SA, 2013, J MATER SCI-MATER M, V24, P1639, DOI 10.1007/s10856-013-4922-5
   O'Brien Fergal J, 2007, Technol Health Care, V15, P3
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   Patel JJ, 2015, TISSUE ENG PART C-ME, V21, P489, DOI [10.1089/ten.tec.2014.0377, 10.1089/ten.TEC.2014.0377]
   Pontius JS, 1998, ENVIRON ECOL STAT, V5, P371, DOI 10.1023/A:1009607905906
   Przekora A, 2014, INT J BIOL MACROMOL, V70, P474, DOI 10.1016/j.ijbiomac.2014.07.035
   Przekora A, 2014, J BIOTECHNOL, V182, P46, DOI 10.1016/j.jbiotec.2014.04.022
   Ren X., 2016, BIOMATERIALS
   Ren X, 2015, BIOMATERIALS, V50, P107, DOI 10.1016/j.biomaterials.2015.01.059
   RHO JY, 1993, J BIOMECH, V26, P111, DOI 10.1016/0021-9290(93)90042-D
   Shen YH, 2008, ACTA BIOMATER, V4, P477, DOI 10.1016/j.actbio.2007.12.011
   Singh S, 2012, J BIOMED MATER RES A, V100A, P720, DOI 10.1002/jbm.a.34010
   Smith MH, 2007, INT J MED ROBOT COMP, V3, P207, DOI 10.1002/rcs.143
   Suarez-Gonzalez D, 2012, BIOMATERIALS, V33, P713, DOI 10.1016/j.biomaterials.2011.09.095
   Temple JP, 2014, J BIOMED MATER RES A, V102, P4317, DOI 10.1002/jbm.a.35107
   Tierney CM, 2009, J BIOMED MATER RES A, V91A, P92, DOI 10.1002/jbm.a.32207
   Weisgerber DW, 2013, J MECH BEHAV BIOMED, V28, P26, DOI 10.1016/j.jmbbm.2013.07.016
   Weisgerber DW, 2015, BIOMATER SCI-UK, V3, P533, DOI [10.1039/c4bm00397g, 10.1039/C4BM00397G]
   Wettergreen MA, 2005, ANN BIOMED ENG, V33, P1333, DOI 10.1007/s10439-005-6744-1
   Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057
   Woodard JR, 2007, BIOMATERIALS, V28, P45, DOI 10.1016/j.biomaterials.2006.08.021
   Xie J., 2015, ACTA BIOMATER
   Zhang HN, 2010, TISSUE ENG PT A, V16, P3441, DOI [10.1089/ten.tea.2010.0132, 10.1089/ten.TEA.2010.0132]
   Zopf D.A., 2014, OTOLARYNGOL HEAD NEC
NR 57
TC 11
Z9 11
U1 1
U2 24
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
EI 1878-0180
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD AUG
PY 2016
VL 61
BP 318
EP 327
DI 10.1016/j.jmbbm.2016.03.032
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DR7LE
UT WOS:000380080400030
PM 27104930
OA Other Gold
DA 2018-10-20
ER

PT J
AU Gong, KM
   Qu, SX
   Liu, YM
   Wang, J
   Zhang, YC
   Jiang, CX
   Shen, R
AF Gong, Kemeng
   Qu, Shuxin
   Liu, Yumei
   Wang, Jing
   Zhang, Yongchao
   Jiang, Chongxi
   Shen, Ru
TI The mechanical and tribological properties of UHMWPE loaded ALN after
   mechanical activation for joint replacements
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE UHMWPE; ALN; Mechanical activation; Fusion defects; Mechanical
   properties; Tribological properties
ID MOLECULAR-WEIGHT POLYETHYLENE; TOTAL HIP-ARTHROPLASTY; WEAR-RESISTANCE;
   ALENDRONATE; OSTEOLYSIS; MECHANOCHEMISTRY; MICROSTRUCTURE; PROSTHESES
AB Ultra-high molecular weight polyethylene (UHMWPE) loaded with alendronate sodium (ALN) has tremendous potential as an orthopeadic biomaterial for joint replacements. However, poor mechanical and tribological properties of UHMWPE-ALN are still obstacle for further application. The purpose of this study was to investigate the effect and mechanism of mechanical activation on mechanical and tribological properties of 1 wt% ALN-loaded UHMWPE (UHMWPE-ALN-ma). In this study, tensile test, small punch test and reciprocating sliding wear test were applied to characterize the mechanical and tribological properties of UHMWPE-ALN-ma. Scanning electron microscopy (SEM), energy dispersive spectroscopy (EDS) and Fourier transform infrared spectroscopy (FTIR) were employed to characterize UHMWPE-ALN-ma. Tensile test and small punch test showed that Young's modulus, tensile strength and work-to-failure (WTF) of UHMWPE-ALN-ma increased significantly compared to those of UHMWPE-ALN. The friction coefficients and wear factors of UHMWPE-ALN-ma both decreased significantly compared to those of UHMWPE-ALN. Mechanical activation obviously reduced type 1 (void) and type 2 (the disconnected and dislocated machining marks) fusion defects of UHMWPE-ALN-ma, which were revealed by SEM images of freeze fracture surfaces after etching and lateral surfaces of specimens after extension to fracture, respectively. It was attributed to peeled-off layers and chain scission of molecular chains of UHMWPE particles after mechanical activation, which were revealed by SEM images and FTIR spectra of UHMWPE-ALN-ma and UHMWPE-ALN, respectively. Moreover, EDS spectra revealed the more homogeneous distribution of ALN in UHMWPE-ALN-ma compared to that of UHMWPE-ALN. The present results showed that mechanical activation was a potential strategy to improve mechanical and tribological properties of UHMWPE-ALN-ma as an orthopeadic biomaterial for joint replacements. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Gong, Kemeng; Qu, Shuxin; Liu, Yumei; Wang, Jing; Zhang, Yongchao; Jiang, Chongxi; Shen, Ru] Southwest Jiaotong Univ, Key Lab Adv Technol Mat, Minist Educ, Sch Mat Sci & Engn, Chengdu 610031, Peoples R China.
RP Qu, SX (reprint author), Southwest Jiaotong Univ, Key Lab Adv Technol Mat, Minist Educ, Sch Mat Sci & Engn, Chengdu 610031, Peoples R China.
EM qushuxin@swjtu.edu.cn
FU National Basic Research Program of China (973 Program) [2012CB933602];
   National Natural Science Foundation of China [51372210, 51203130];
   Research Fund for the Doctoral Program of Higher Education of China
   [20130184110023]; Construction Program for Innovative Research Team of
   University in Sichuan Province [14TD0050]
FX The present study was supported by the National Basic Research Program
   of China (973 Program, 2012CB933602), National Natural Science
   Foundation of China (51372210, 51203130), Research Fund for the Doctoral
   Program of Higher Education of China (20130184110023), and Construction
   Program for Innovative Research Team of University in Sichuan Province
   (14TD0050).
CR [Anonymous], F210206 ASTM
   [Anonymous], F218302 ASTM
   [Anonymous], D63803 ASTM
   *ASTM, F73200 ASTM
   Aziz G, 2015, SURF COAT TECH, V271, P39, DOI 10.1016/j.surfcoat.2015.01.027
   AZUMA Y, 1995, BONE, V16, P235, DOI 10.1016/8756-3282(94)00035-X
   Barbour PSM, 1999, BIOMATERIALS, V20, P2101, DOI 10.1016/S0142-9612(99)00096-4
   Bergstrom JD, 2000, ARCH BIOCHEM BIOPHYS, V373, P231, DOI 10.1006/abbi.1999.1502
   Beyer MK, 2005, CHEM REV, V105, P2921, DOI 10.1021/cr030697h
   Boanini E, 2008, BIOMATERIALS, V29, P790, DOI 10.1016/j.biomaterials.2007.10.040
   Boldyrev VV, 2000, J MATER SYNTH PROCES, V8, P121, DOI 10.1023/A:1011347706721
   Bracco P, 2011, CLIN ORTHOP RELAT R, V469, P2286, DOI 10.1007/s11999-010-1717-6
   Brach Del Prever EM, 2009, J ORTHOP TRAUMATOL, V10, P1, DOI DOI 10.1007/S10195-008-0038-Y
   BUTLER JH, 1995, POLYMER, V36, P1781, DOI 10.1016/0032-3861(95)90924-Q
   Callaghan JJ, 1998, J BONE JOINT SURG AM, V80A, P704, DOI 10.2106/00004623-199805000-00011
   Curi MM, 2011, J ORAL MAXIL SURG, V69, P2465, DOI 10.1016/j.joms.2011.02.078
   Fu J, 2010, POLYMER, V51, P2721, DOI 10.1016/j.polymer.2010.04.003
   Galvin AL, 2005, WEAR, V259, P972, DOI 10.1016/j.wear.2005.02.016
   Garbuz DS, 2008, J BONE JOINT SURG AM, V90A, P1090, DOI 10.2106/JBJS.G.00415
   Huang YF, 2014, BIOMATERIALS, V35, P6687, DOI 10.1016/j.biomaterials.2014.04.077
   Inui M., 2011, ASIAN J ORAL MAXILLO, V23, P204
   Ise K, 2009, J ARTHROPLASTY, V24, P1216, DOI 10.1016/j.arth.2009.05.020
   Jin ZM, 2006, CURR ORTHOPAED, V20, P32, DOI 10.1016/j.cuor.2005.09.005
   Kurtz S. M., 2009, UHMWPE BIOMATERAILS, P485
   Kurtz SM, 1999, BIOMATERIALS, V20, P1659, DOI 10.1016/S0142-9612(99)00053-8
   Lewis G, 2001, BIOMATERIALS, V22, P371, DOI 10.1016/S0142-9612(00)00195-2
   Liu AQ, 2009, J BIOMED MATER RES A, V90A, P496, DOI 10.1002/jbm.a.32120
   Liu XM, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/6/065008
   Milstein DMJ, 2011, ARCH ORAL BIOL, V56, P599, DOI 10.1016/j.archoralbio.2010.11.015
   Mondal T, 2012, MAT SCI ENG C-MATER, V32, P697, DOI 10.1016/j.msec.2012.01.011
   Oonishi H, 1998, J MATER SCI-MATER M, V9, P393, DOI 10.1023/A:1013283513509
   Plumlee K, 2009, WEAR, V267, P710, DOI 10.1016/j.wear.2008.11.028
   Qu S, 2012, J BIOMED MATER RES A, V101, P394
   Senatov FS, 2015, MAT SCI ENG C-MATER, V48, P566, DOI 10.1016/j.msec.2014.12.050
   Senatov FS, 2014, J ALLOY COMPD, V615, pS573, DOI 10.1016/j.jallcom.2013.12.175
   Shanbhag AS, 1997, CLIN ORTHOP RELAT R, P33
   Shen ZH, 2014, MAT SCI ENG C-MATER, V42, P303, DOI 10.1016/j.msec.2014.05.043
   Wu JJ, 2002, BIOMATERIALS, V23, P3773, DOI 10.1016/S0142-9612(02)00117-5
   Xie XL, 2003, BIOMATERIALS, V24, P1889, DOI 10.1016/S0142-9612(02)00610-5
   Yang D, 2012, APPL SURF SCI, V262, P207, DOI 10.1016/j.apsusc.2012.05.012
   Yang D, 2012, MAT SCI ENG C-MATER, V32, P83, DOI 10.1016/j.msec.2011.09.012
   Zhou Z.R., 2015, BIOSURF BIOTRIBOL, V1, P3, DOI DOI 10.1016/J.BSBT.2015.03.001
   Zhu FB, 2010, J ORTHOP RES, V28, P893, DOI 10.1002/jor.21062
NR 43
TC 4
Z9 4
U1 4
U2 24
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
EI 1878-0180
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD AUG
PY 2016
VL 61
BP 334
EP 344
DI 10.1016/j.jmbbm.2016.03.023
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DR7LE
UT WOS:000380080400032
PM 27104932
DA 2018-10-20
ER

PT J
AU Griffin, M
   Nayyer, L
   Butler, PE
   Palgrave, RG
   Seifalian, AM
   Kalaskar, DM
AF Griffin, Michelle
   Nayyer, Leila
   Butler, Peter E.
   Palgrave, Robert G.
   Seifalian, Alexander M.
   Kalaskar, Deepak M.
TI Development of mechano-responsive polymeric scaffolds using
   functionalized silica nano-fillers for the control of cellular functions
SO NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE
LA English
DT Article
DE Fumed silica; Nanoparticles; Polyhedral oligomeric silsesquioxane;
   Hydroxyl and amine functionalization; Mechano-responsive scaffolds
ID SUBSTRATE STIFFNESS; NANOCOMPOSITE; ADHESION; CELLS; NANOPARTICLES;
   FIBROBLASTS; ADSORPTION; BEHAVIOR
AB We demonstrate an efficient method to produce mechano-responsive polymeric scaffolds which can alter cellular functions using two different functionalized (OH and NH2) silica nano-fillers. Fumed silica-hydroxyl and fumed silica-amine nano-fillers were mixed with a biocompatible polymer (POSS-PCU) at various wt% to produce scaffolds. XPS and mechanical testing demonstrate that bulk mechanical properties are modified without changing the scaffold's surface chemistry. Mechanical testing showed significant change in bulk properties of POSS-PCU scaffolds with an addition of silica nanofillers as low as 1% (P < 0.01). Scaffolds modified with NH2 silica showed significantly higher bulk mechanical properties compared to the one modified with the OH group. Enhanced cell adhesion, proliferation and collagen production over 14 days were observed on scaffolds with higher bulk mechanical properties (NH2) compared to those with lower ones (unmodified and OH modified) (P < 0.05) during in vitro analysis. This study provides an effective method of manufacturing mechano-responsive polymeric scaffolds, which can help to customize cellular responses for biomaterial applications. (C) 2016 The Authors. Published by Elsevier Inc.
C1 [Griffin, Michelle; Nayyer, Leila; Butler, Peter E.; Seifalian, Alexander M.; Kalaskar, Deepak M.] UCL, Ctr Nanotechnol & Regenerat Med, Div Surg & Intervent Sci, London, England.
   [Butler, Peter E.] Royal Free London NHS Fdn Trust Hosp, London, England.
   [Palgrave, Robert G.] UCL, Dept Chem, London, England.
RP Kalaskar, DM (reprint author), UCL, Ctr Nanotechnol & Regenerat Med, Div Surg & Intervent Sci, London, England.
EM d.kalaskar@ucl.ac.uk
OI seifalian, Alexander/0000-0002-8334-9376; Palgrave,
   Robert/0000-0003-4522-2486; Butler, Peter/0000-0001-7419-1493
FU Medical Research Council (MRC) and Action Medical Research (AMR)
   [GN2239]; Action Medical Research [2239]; Medical Research Council
   [MC_EX_MR/M003485/1, MC_PC_15014]
FX This study was funded by Medical Research Council (MRC) and Action
   Medical Research (AMR), grant number GN2239.
CR Chaloupka K, 2011, BIOTECHNOL APPL BIOC, V58, P363, DOI 10.1002/bab.53
   Chen C, 2014, ACS APPL MATER INTER, V6, P16106, DOI 10.1021/am504135b
   Chen JC, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt318
   Chen Y, 2013, ADV MATER, V25, P3144, DOI 10.1002/adma.201205292
   Chowdhury F, 2010, NAT MATER, V9, P82, DOI [10.1038/NMAT2563, 10.1038/nmat2563]
   Chrissafis K, 2008, J APPL POLYM SCI, V110, P1739, DOI 10.1002/app.28818
   D'Agostino A, 2011, J MATER SCI-MATER M, V22, P481, DOI 10.1007/s10856-010-4223-1
   de Mel A, 2014, MACROMOL BIOSCI, V14, P307, DOI 10.1002/mabi.201300382
   Dietrich Braun, 2013, METHODS TECHNIQUES S, P140
   Elliott MJ, 2012, LANCET, V380, P994, DOI 10.1016/S0140-6736(12)60737-5
   Fioretta ES, 2012, J BIOMECH, V45, P736, DOI 10.1016/j.jbiomech.2011.11.013
   Fusco S, 2015, ACTA BIOMATER, V23, P63, DOI 10.1016/j.actbio.2015.05.008
   Gaharwar AK, 2013, MAT SCI ENG C-MATER, V33, P1800, DOI 10.1016/j.msec.2012.12.099
   Hopp I, 2013, BIOMATERIALS, V34, P5070, DOI 10.1016/j.biomaterials.2013.03.075
   Leipzig ND, 2009, BIOMATERIALS, V30, P6867, DOI 10.1016/j.biomaterials.2009.09.002
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI DOI 10.1016/S0006-3495(00)76279-5
   Moe AAK, 2012, SMALL, V8, P3050, DOI 10.1002/smll.201200490
   Nayyer L, 2014, NANOMED-NANOTECHNOL, V10, P235, DOI 10.1016/j.nano.2013.06.006
   Schiraldi C, 2004, BIOMATERIALS, V25, P3645, DOI 10.1016/j.biomaterials.2003.10.059
   Seo JH, 2013, ACTA BIOMATER, V9, P5493, DOI 10.1016/j.actbio.2012.10.015
   Sheu MS, 1995, ENCY HDB BIOMATERI A, V1, P865
   Shi ZL, 2014, J TISSUE ENG REGEN M, V8, P50, DOI 10.1002/term.1496
   Trappmann B, 2013, CURR OPIN BIOTECH, V24, P948, DOI 10.1016/j.copbio.2013.03.020
   Vyner MC, 2014, BIOMATERIALS, V35, P9041, DOI 10.1016/j.biomaterials.2014.07.023
   WALSH BJ, 1992, ANAL BIOCHEM, V203, P187, DOI 10.1016/0003-2697(92)90301-M
   Zou H, 2008, CHEM REV, V108, P3893, DOI 10.1021/cr068035q
NR 26
TC 10
Z9 10
U1 1
U2 18
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1549-9634
EI 1549-9642
J9 NANOMED-NANOTECHNOL
JI Nanomed.-Nanotechnol. Biol. Med.
PD AUG
PY 2016
VL 12
IS 6
BP 1725
EP 1733
DI 10.1016/j.nano.2016.02.011
PG 9
WC Nanoscience & Nanotechnology; Medicine, Research & Experimental
SC Science & Technology - Other Topics; Research & Experimental Medicine
GA DT8DF
UT WOS:000381718600024
PM 27013128
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Wang, M
   Lam, RWM
   Abbah, SA
   Hu, T
   Toh, SY
   Cool, S
   Bhakoo, K
   Li, J
   Goh, JCH
   Wong, HK
AF Wang, Ming
   Lam, Raymond W. M.
   Abbah, Sunny A.
   Hu, Tao
   Toh, Soo Y.
   Cool, Simon
   Bhakoo, Kishore
   Li, Jun
   Goh, James C. H.
   Wong, Hee-Kit
TI Heparin-Based Polyelectrolyte Complex Enhances the Therapeutic Efficacy
   of Bone Morphogenetic Protein-2 for Posterolateral Fusion in a Large
   Animal Model
SO SPINE
LA English
DT Article
DE alginate microbead; biomaterial; BMP-2; heparin; heterotopic
   ossification; localization of bone formation; polyelectrolyte complex;
   porcine model; posterolateral fusion; tissue engineering
ID LUMBAR-INTERBODY-FUSION; SPINAL RECONSTRUCTIVE SURGERY; IN-VIVO;
   NONHUMAN PRIMATE; INCORPORATING HEPARIN; BULKING AGENT; ECTOPIC BONE;
   RHBMP-2; CARRIER; COMPLICATIONS
AB Study Design. The study was based on porcine posterolateral fusion model.
   Objective. The study aims to prove that polyelectrolyte complex (PEC) carrier could enhance the efficacy and safety profile of bone morphogenetic protein-2 (BMP-2).
   Summary of Background Data. BMP-2 was introduced to enhance posterolateral fusion; however, extremely high doses of this molecule were often used which contributed to various complications. This was attributed to the poor modulation capacity of the traditional carrier absorbable collagen sponge (ACS). To reduce the efficacious dose of BMP-2 and its associated complications, heparin-based PEC was introduced.
   Methods. L3/L4 and L5/L6 two-level posterolateral spinal fusion was performed on six pigs using two doses of BMP-2 with PEC or ACS: (1) PEC with 800 mu g BMP-2 (n = 2); (2) PEC with 400 Rg BMP-2 (n = 2); (3) ACS with 800 Rg BMP-2 (n = 1); (4) ACS with 400 Rg of BMP-2 (n = 1). The construct was loaded into a rigid bioabsorbable cage for implantation. Fusion rate and quality were assessed 2 months after operation.
   Results. Manual palpation revealed successful fusion in all groups. Radiological fusion score of PEC groups was, however, higher than that of ACS groups. The newly formed bone in PEC groups appeared to be well integrated into the native bone with no overgrowth into the adjacent structure. On comparison, in ACS groups, large gaps were observed between the newly formed bone and the fusion bed with heterotopic ossification into the psoas muscle. The microarchitecture on the newly formed bone in PEC groups was superior to that in ACS groups, which was demonstrated by higher three-dimensional parameters.
   Conclusion. The present study demonstrated that BMP-2 delivered by PEC induced successful posterolateral fusion in porcine model. The efficacy of BMP-2 was improved and bony overgrowth was reduced. The microarchitecture of BMP-2 induced bone tissue was also enhanced by PEC.
C1 [Wang, Ming; Lam, Raymond W. M.; Abbah, Sunny A.; Hu, Tao; Toh, Soo Y.; Cool, Simon; Bhakoo, Kishore; Goh, James C. H.; Wong, Hee-Kit] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Orthopaed Surg, Singapore 117548, Singapore.
   [Cool, Simon] ASTAR, Inst Med Biol, Singapore, Singapore.
   [Bhakoo, Kishore] ASTAR, Singapore Bioimaging Consortium, Singapore, Singapore.
   [Li, Jun] ASTAR, Inst Mat Res & Engn, Singapore, Singapore.
   [Li, Jun; Goh, James C. H.] Natl Univ Singapore, Fac Engn, Dept Bioengn, Singapore 117548, Singapore.
RP Wong, HK (reprint author), Univ Orthopaed Hand & Reconstruct Microsurg Clust, Level 11,NUHS Tower Block,1E Kent Ridge Rd, Singapore 119228, Singapore.
EM heekit_wong@nuhs.edu.sg
RI Li, Jun/B-5308-2008
OI Li, Jun/0000-0003-2982-7960
FU A*STAR BMRC Grant [09/1/21/19/601]
FX A*STAR BMRC Grant 09/1/21/19/601 funds were received in support of this
   work.
CR Abbah SA, 2011, SPINE, V36, P1752, DOI 10.1097/BRS.0b013e31822576a4
   Abbah SA, 2009, BIOMATERIALS, V30, P5086, DOI 10.1016/j.biomaterials.2009.05.067
   Abbah SA, 2013, TISSUE ENG PT A, V19, P350, DOI [10.1089/ten.TEA.2012.0274, 10.1089/ten.tea.2012.0274]
   Abbah SA, 2014, TISSUE ENG PT A, V20, P1679, DOI [10.1089/ten.tea.2013.0593, 10.1089/ten.TEA.2013.0593]
   Abbah SA, 2012, J CONTROL RELEASE, V162, P364, DOI 10.1016/j.jconrel.2012.07.027
   Akamaru T, 2003, SPINE, V28, P429, DOI 10.1097/00007632-200303010-00004
   Barnes B, 2005, SPINE, V30, P1127, DOI 10.1097/01.brs.0000162623.48058.8c
   Benglis D, 2008, NEUROSURGERY, V62, P423, DOI 10.1227/01.neu.0000326030.24220.d8
   Boden SD, 2002, SPINE, V27, P2662, DOI 10.1097/00007632-200212010-00005
   Cahill KS, 2009, JAMA-J AM MED ASSOC, V302, P58, DOI 10.1001/jama.2009.956
   Carragee EJ, 2013, J BONE JOINT SURG AM, V95A, P1537, DOI 10.2106/JBJS.L.01483
   Carragee EJ, 2011, SPINE J, V11, P511, DOI 10.1016/j.spinee.2011.02.013
   Carragee EJ, 2009, SPINE J, V9, P873, DOI 10.1016/j.spinee.2009.09.001
   Egan KP, 2012, HISTOPATHOLOGY, V61, P1168, DOI 10.1111/j.1365-2559.2012.04333.x
   Fischgrund JS, 1997, SPINE, V22, P2807, DOI 10.1097/00007632-199712150-00003
   Grabowski G, 2013, J AM ACAD ORTHOP SUR, V21, P51, DOI 10.5435/JAAOS-21-01-51
   Hoffmann MF, 2013, SPINE J, V13, P1244, DOI 10.1016/j.spinee.2013.06.022
   Hoffmann MF, 2013, J ORTHOP SURG RES, V8, DOI 10.1186/1749-799X-8-1
   Johnson MR, 2011, CLIN ORTHOP RELAT R, V469, P3111, DOI 10.1007/s11999-011-2012-x
   Khan SN, 2014, J SPINAL DISORD TECH, V27, P212, DOI 10.1097/BSD.0b013e3182767c67
   Koo KH, 2013, ARTIF ORGANS, V37, P487, DOI 10.1111/j.1525-1594.2012.01578.x
   Martin GJ, 1999, J SPINAL DISORD, V12, P179, DOI 10.1097/00002517-199906000-00001
   Morisue H, 2006, SPINE, V31, P1194, DOI 10.1097/01.brs.0000217679.46489.1b
   Mroz TE, 2010, SPINE, V35, pS86, DOI 10.1097/BRS.0b013e3181d81ef2
   Papakostidis C, 2008, SPINE, V33, pE680, DOI 10.1097/BRS.0b013e3181844eca
   PARFITT AM, 1988, CALCIFIED TISSUE INT, V42, P284, DOI 10.1007/BF02556360
   PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617
   Ruppert R, 1996, EUR J BIOCHEM, V237, P295, DOI 10.1111/j.1432-1033.1996.0295n.x
   Sasso RC, 2005, J SPINAL DISORD TECH, V18, pS77, DOI 10.1097/01.bsd.0000112045.36255.83
   Seeherman H, 2005, CYTOKINE GROWTH F R, V16, P329, DOI 10.1016/j.cytogfr.2005.05.001
   Suh DY, 2002, SPINE, V27, P353, DOI 10.1097/00007632-200202150-00006
   Takada T, 2003, J BIOL CHEM, V278, P43229, DOI 10.1074/jbc.M300937200
   Tannoury CA, 2014, SPINE J, V14, P552, DOI 10.1016/j.spinee.2013.08.060
   Toth JM, 2009, SPINE, V34, P539, DOI 10.1097/BRS.0b013e3181952695
   Uludag H, 2001, J BONE JOINT SURG AM, V83A, pS128
   Wang JC, 2005, SPINE, V30, pS33, DOI 10.1097/01.brs.0000174559.13749.83
   Wang M, 2015, SPINE, V40, P964, DOI 10.1097/BRS.0000000000000935
   Wang M, 2013, SPINE, V38, P1452, DOI 10.1097/BRS.0b013e31828a3504
   Winn SR, 1999, CLIN ORTHOP RELAT R, pS95
   Wong DA, 2008, SPINE J, V8, P1011, DOI 10.1016/j.spinee.2007.06.014
   Zara JN, 2011, TISSUE ENG PT A, V17, P1389, DOI [10.1089/ten.TEA.2010.0555, 10.1089/ten.tea.2010.0555]
   Zhao BH, 2006, J BIOL CHEM, V281, P23246, DOI 10.1074/jbc.M511039200
NR 42
TC 2
Z9 2
U1 0
U2 7
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0362-2436
EI 1528-1159
J9 SPINE
JI SPINE
PD AUG 1
PY 2016
VL 41
IS 15
BP 1199
EP 1207
DI 10.1097/BRS.0000000000001543
PG 9
WC Clinical Neurology; Orthopedics
SC Neurosciences & Neurology; Orthopedics
GA DS5BN
UT WOS:000380795600010
PM 26953670
DA 2018-10-20
ER

PT J
AU Ma, YX
   Mu, JS
   Zhang, JQ
   Bo, P
AF Ma, Yi-Xiang
   Mu, Jun-Sheng
   Zhang, Jian-Qun
   Bo, Ping
TI Myocardial Patch Formation by Three-Dimensional
   3-Hydroxybutyrate-co-4-Hydroxybutyrate Cultured with Mouse Embryonic
   Stem Cells
SO JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING
LA English
DT Article
DE Mouse Embryonic Stem Cells; Myocardial Patch; Vitamin C;
   Three-Dimensional Culture; 3-Hydroxybutyrate-co-4-Hydroxybutyrate
   Scaffold
ID DIFFERENTIATION; BIOSYNTHESIS; 3-D
AB Stem cell transplantation is considered promising for treating cardiovascular disorders. However, lack of an effective carrier impacts their survival and proliferation. Poly 3-hydroxybutyrate-co-4-hydroxybutyrate [P(3HB-co-4HB)] is a novel polymer biomaterial with excellent physical characteristics. We assessed the suitability of P(3HB-co-4HB) combined with embryonic stem cells (ESCs) for myocardial patch formation. Mouse ESC embryoid bodies (EBs) were induced into cardiomyocytes in the absence (control group) and presence of 0.1 mg/ml vitamin C (vitamin C group). The myocardial patch was observed by confocal and scanning electron microscopy. Staining of cardiomyocyte-specific markers, cTnT and a-actin, was carried out from day 7 of EB formation throughout patch co-culture every two days. Adherent mouse ESCs displayed normal growth and morphology. When cultured as EBs for 3 days, 100% grew on the biofilm and after 7 days cells were present in the 3D biofilm to a depth of 2 mm, with normal cardiomyocyte morphology. Cardiomyocytes were cTnT- and a-actin-positive. EB morphology in both groups was normal, however the differentiation efficiency of the vitamin C group was significantly higher than the control group (p = 0.026, P < 0.05). Furthermore, the induction rates of the control and vitamin C group were 17.8% and 71.1%, respectively. P(3HB-co-4HB) permitted ESC growth and differentiation forming a myocardial patch. Adding vitamin C significantly increased the induction rate of ESCs into cardiomyocytes. P(3HB-co-4HB) is a suitable biomaterial for investigating cardiomyocyte regeneration in patients with myocardial infarction.
C1 [Ma, Yi-Xiang; Mu, Jun-Sheng; Zhang, Jian-Qun; Bo, Ping] Capital Med Univ, Beijing Anzhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Dept Cardiac Surg, Beijing 100029, Peoples R China.
RP Mu, JS (reprint author), Capital Med Univ, Beijing Anzhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Dept Cardiac Surg, Beijing 100029, Peoples R China.
FU Chaoyang District, Beijing Science and Technology Program [SF1417];
   Capital Medical University student technological innovation program
   Beijing Anzhen Hospital Science Research Fund [XSKY2015192, 15P11]
FX 2014 Chaoyang District, Beijing Science and Technology Program (SF1417);
   2015 Capital Medical University student technological innovation program
   (XSKY2015192) 2015 Beijing Anzhen Hospital Science Research Fund
   (15P11).
CR Al Kindi AH, 2011, EUR J CARDIO-THORAC, V39, P241, DOI 10.1016/j.ejcts.2010.03.066
   Blau HM, 2001, CELL, V105, P829, DOI 10.1016/S0092-8674(01)00409-3
   Bradley A, 2002, NATURE, V420, P512, DOI 10.1038/420512a
   Gepstein L, 2010, STEM CELLS, V28, P2151, DOI 10.1002/stem.545
   Jain K, 2014, METHODS MOL BIOL, V1194, P247, DOI 10.1007/978-1-4939-1215-5_13
   Kose GT, 2003, BIOMATERIALS, V24, P4999, DOI 10.1016/S0142-9612(03)00417-4
   Mandel Y, 2012, CIRCULATION, V125, P883, DOI 10.1161/CIRCULATIONAHA.111.045146
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Orlic D, 2002, CIRC RES, V91, P1092, DOI 10.1161/01.RES.0000046045.00846.B0
   Pal R, 2013, J BIOSCI BIOENG, V115, P200, DOI 10.1016/j.jbiosc.2012.08.018
   Roell W, 2007, NATURE, V450, P819, DOI 10.1038/nature06321
   Saito T, 2003, J THORAC CARDIOV SUR, V126, P114, DOI 10.1016/S0022-5223(03)00118-1
   Shi JB, 2015, J BIOMATER TISS ENG, V5, P364, DOI 10.1166/jbt.2015.1328
   Shiba Y, 2012, NATURE, V489, P322, DOI 10.1038/nature11317
   Takahashi T, 2003, CIRCULATION, V107, P1912, DOI 10.1161/01.CIR.0000064899.53876.A3
   Teng CJ, 2006, J THORAC CARDIOV SUR, V132, P628, DOI 10.1016/j.jtcvs.2006.05.034
   Thakor N, 2005, BIORESOURCE TECHNOL, V96, P1843, DOI 10.1016/j.biortech.2005.01.030
   Tobella LM, 2005, J IND MICROBIOL BIOT, V32, P397, DOI 10.1007/s10295-005-0011-1
   Verma V, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/2/025007
NR 19
TC 1
Z9 1
U1 0
U2 2
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2157-9083
EI 2157-9091
J9 J BIOMATER TISS ENG
JI J. Biomater. Tissue Eng.
PD AUG
PY 2016
VL 6
IS 8
BP 629
EP 634
DI 10.1166/jbt.2016.1484
PG 6
WC Cell & Tissue Engineering
SC Cell Biology
GA DT7EB
UT WOS:000381648800005
DA 2018-10-20
ER

PT J
AU Ge, YM
   Li, HL
   Jiang, K
   Xue, YZB
   Tang, B
AF Ge, Y. M.
   Li, H. L.
   Jiang, K.
   Xue, Y. Z. B.
   Tang, B.
TI Fabrication of Nano-Size AB-Type Carbonated Hydroxyapatite Particles
   from Seashells
SO JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING
LA English
DT Article
DE Seashell; Hydrothermal; Carbonate-Substituted Hydroxyapatite
ID SUBSTITUTED HYDROXYAPATITE; HYDROTHERMAL SYNTHESIS;
   MECHANICAL-PROPERTIES; MESOPOROUS STRUCTURE; APATITE COATINGS; B
   CARBONATE; BONE; COMPOSITE; POWDERS; SHELLS
AB Hydroxyapatite (HA) is a commonly used biomaterial for bone grafting. Unfortunately, the lack of carbonate ions in normal HA limits its osseointegration ability. Alternatively, carbonate-substituted hydroxyapatite (CHA) was reported to be a better bone substitution because it has almost the same chemical composition and structure as natural bone minerals. In this study, a novel method was proposed to directly synthesize CHA through one-step hydrothermal exchange from seashells. The morphology and the amount of carbonate-substitution of the fabricated CHA can be well controlled by adjusting the PH during the reaction: with the increasing of PH, the morphology of the final product was transferred from long needle-like to sheet-like and the amount of CO32 substitution increased gradually. The bioactivity of the products was evaluated by CKK-8 assay. It was found that the CHA significantly improved bioactivity compared to the control group, and the needle-like CHA had a better bioactivity than that of the sheet-like CHA.
C1 [Ge, Y. M.; Li, H. L.; Jiang, K.; Xue, Y. Z. B.; Tang, B.] South Univ Sci & Technol China, Dept Mat Sci & Engn, Shenzhen 518055, Guangdong, Peoples R China.
   [Tang, B.] Shenzhen Key Lab Nanoimprint Technol, Shenzhen 518055, Guangdong, Peoples R China.
RP Tang, B (reprint author), South Univ Sci & Technol China, Dept Mat Sci & Engn, Shenzhen 518055, Guangdong, Peoples R China.; Tang, B (reprint author), Shenzhen Key Lab Nanoimprint Technol, Shenzhen 518055, Guangdong, Peoples R China.
RI tang, bin/H-6980-2018
OI tang, bin/0000-0001-5595-0511
FU Natural Science Foundation of China [11202039]; Shenzhen Science and
   Technology Innovation Committee [JCYJ20120830154526544,
   JCYJ20140612140151890]
FX The authors appreciate the financial support from Natural Science
   Foundation of China (project No. 11202039) and Shenzhen Science and
   Technology Innovation Committee (Project Nos. JCYJ20120830154526544,
   JCYJ20140612140151890).
CR Adak M. D., 2011, TRENDS BIOMATER ARTI, V25, P101
   An YL, 2013, PHASE TRANSIT, V86, P391, DOI 10.1080/01411594.2012.678007
   Bang LT, 2014, SCI WORLD J, DOI 10.1155/2014/969876
   Barinov V. Y. B. S. M., 2004, POWDER METALL PROG, V4, P95
   Chen CL, 2011, CRYSTENGCOMM, V13, P1632, DOI 10.1039/c0ce00090f
   Chen F, 2011, CRYSTENGCOMM, V13, P1858, DOI 10.1039/c0ce00574f
   Chudhuri B, 2013, J BIOMATER TISS ENG, V3, P653, DOI 10.1166/jbt.2013.1126
   Dhanalakshmi CP, 2012, J BIOMATER TISS ENG, V2, P314, DOI 10.1166/jbt.2012.1052
   Dorozhkin SV, 2009, MATERIALS, V2, P1975, DOI 10.3390/ma2041975
   Fazel Anvari-Yazdi A., 2013, SCI INT, V5, P132
   Fleet ME, 2005, BIOMATERIALS, V26, P7548, DOI 10.1016/j.biomaterials.2005.05.025
   Fleet ME, 2004, J SOLID STATE CHEM, V177, P3174, DOI 10.1016/j.jssc.2004.04.002
   Fleet ME, 2007, BIOMATERIALS, V28, P916, DOI 10.1016/j.biomaterials.2006.11.003
   Furuichi K, 2006, CHEM MATER, V18, P229, DOI 10.1021/cm052213z
   Garskaite E, 2014, CRYSTENGCOMM, V16, P3950, DOI 10.1039/c4ce00119b
   Gibson IR, 2002, J BIOMED MATER RES, V59, P697, DOI 10.1002/jbm.10044
   Guo YJ, 2013, MAT SCI ENG C-MATER, V33, P3166, DOI 10.1016/j.msec.2013.03.040
   Guo YP, 2009, MICROPOR MESOPOR MAT, V118, P480, DOI 10.1016/j.micromeso.2008.09.024
   Ha SW, 2015, BIOMATERIALS, V65, P32, DOI 10.1016/j.biomaterials.2015.06.039
   Hamza S, 2013, APPL SURF SCI, V264, P485, DOI 10.1016/j.apsusc.2012.10.049
   Ivankovic H, 2010, J MATER SCI-MATER M, V21, P2711, DOI 10.1007/s10856-010-4115-4
   Kee CC, 2013, J MATER SCI TECHNOL, V29, P761, DOI 10.1016/j.jmst.2013.05.016
   Kubota T, 2014, ACTA BIOMATER, V10, P3716, DOI 10.1016/j.actbio.2014.05.007
   Kumar R, 2004, LANGMUIR, V20, P5196, DOI 10.1021/la049304f
   Lafon JP, 2008, J EUR CERAM SOC, V28, P139, DOI 10.1016/j.jeurceramsoc.2007.06.009
   Lala S, 2015, DALTON T, V44, P20087, DOI 10.1039/c5dt03398e
   Landi E, 2003, J EUR CERAM SOC, V23, P2931, DOI 10.1016/S0955-2219(03)00304-2
   Lee SW, 2014, TISSUE ENG REGEN MED, V11, P113, DOI 10.1007/s13770-014-0056-1
   Lemos AF, 2006, J EUR CERAM SOC, V26, P3639, DOI 10.1016/j.jeurceramsoc.2005.12.011
   Lin KL, 2011, J MATER CHEM, V21, P16558, DOI 10.1039/c1jm12514a
   Liu H, 2015, BIOMATERIALS, V49, P103, DOI 10.1016/j.biomaterials.2015.01.017
   Liu XG, 2011, CRYSTENGCOMM, V13, P1959, DOI 10.1039/c0ce00353k
   Macha IJ, 2013, J AUST CERAM SOC, V49, P122
   Markovic D, 2014, VOJNOSANIT PREGL, V71, P462, DOI 10.2298/VSP1405462M
   Milovac D, 2014, MAT SCI ENG C-MATER, V34, P437, DOI 10.1016/j.msec.2013.09.036
   Muller L, 2007, BIOMOL ENG, V24, P462, DOI 10.1016/j.bioeng.2007.07.011
   Narayanan R, 2006, SURF COAT TECH, V200, P4720, DOI 10.1016/j.surfcoat.2005.04.040
   Neira IS, 2009, CRYST GROWTH DES, V9, P466, DOI 10.1021/cg800738a
   Ni M, 2003, BIOMATERIALS, V24, P4323, DOI 10.1016/S0142-9612(03)00236-9
   Pan HH, 2008, J PHYS CHEM B, V112, P7162, DOI 10.1021/jp802739f
   Porter A, 2005, J MATER SCI-MATER M, V16, P899, DOI 10.1007/s10856-005-4424-1
   Ren FZ, 2014, J BIOMED MATER RES A, V102, P496, DOI 10.1002/jbm.a.34720
   Rocha JHG, 2005, BONE, V37, P850, DOI 10.1016/j.bone.2005.06.018
   ROY DM, 1974, NATURE, V247, P220, DOI 10.1038/247220a0
   Ruffini A, 2013, CHEM ENG J, V217, P150, DOI 10.1016/j.cej.2012.11.107
   Santhosh S, 2013, MATER LETT, V97, P121, DOI 10.1016/j.matlet.2013.01.081
   Santhosh S., 2012, INT J BIOMEDICAL NAN, V2, P276
   Spence G, 2008, J BONE JOINT SURG BR, V90B, P1635, DOI 10.1302/0301-620X.90B12.20931
   Tamasan M, 2013, MAT SCI ENG C-MATER, V33, P2569, DOI 10.1016/j.msec.2013.02.019
   Thian ES, 2008, BIOMATERIALS, V29, P1833, DOI 10.1016/j.biomaterials.2008.01.007
   Ueno H, 2010, J AUST CERAM SOC, V46, P14
   Wang GC, 2012, J MATER CHEM, V22, P19081, DOI 10.1039/c2jm34367c
   Wang W. Q. J., 2013, RSC ADV, V3, P1113
   Zhang Y, 2012, MATER LETT, V78, P120, DOI 10.1016/j.matlet.2012.03.055
   Zhou H, 2011, ACTA BIOMATER, V7, P2769, DOI 10.1016/j.actbio.2011.03.019
   Zhu QX, 2015, FRONT MATER SCI, V9, P192, DOI 10.1007/s11706-015-0294-8
   Zou ZY, 2012, J MATER CHEM, V22, P22637, DOI 10.1039/c2jm35430f
   Zou ZY, 2012, ULTRASON SONOCHEM, V19, P1174, DOI 10.1016/j.ultsonch.2012.04.002
   Zyman ZZ, 2013, PROCESS APPL CERAM, V7, P153, DOI 10.2298/PAC1304153Z
NR 59
TC 1
Z9 1
U1 2
U2 26
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2157-9083
EI 2157-9091
J9 J BIOMATER TISS ENG
JI J. Biomater. Tissue Eng.
PD AUG
PY 2016
VL 6
IS 8
BP 635
EP 641
DI 10.1166/jbt.2016.1486
PG 7
WC Cell & Tissue Engineering
SC Cell Biology
GA DT7EB
UT WOS:000381648800006
DA 2018-10-20
ER

PT J
AU He, K
   Wu, Z
   Wen, JC
   Xu, B
   Shao, YK
   Qian, JM
   Zhu, G
   Yao, QY
AF He, Kai
   Wu, Zhen
   Wen, Jianchuan
   Xu, Bo
   Shao, Yikai
   Qian, Jianming
   Zhu, Guan
   Yao, Qiyuan
TI Silk Fibroin Scaffolds Facilitating the Repair of Rat Abdominal Wall
   Defect
SO JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING
LA English
DT Article
DE Silk Fibroin Scaffold; Biomaterial; Abdominal Wall Defect; Abdominal
   Hernia; Rat Model
ID INCISIONAL HERNIA; BIOMEDICAL APPLICATIONS; IN-VITRO; BIOMATERIALS;
   COMPLICATION; CELLS; NANOPARTICLES; OSTEOGENESIS; FABRICATION; SURGERY
AB Silkworm silk fibroin (SF) has been recently explored as a new biomaterial in tissue engineering. Purified SF protein can be molded into various scaffolds with desirable porous structure and mechanical strength to support the attachment and growth of cells and tissues. Here we evaluated the application of a SF scaffold prepared by a freeze-thaw method in the repair of abdominal hernia in rats. This porous SF scaffold was able to support the attachment and proliferation of fibroblasts both in vitro and in vivo. Using a rat model of abdominal wall defect, we observed a growing layer of tissue containing fibroblast cells and collagen on the surface and certain internal region of the grafted SF patches. The accumulation of cells and collagen increased over the time after the implantation, resulting in the increase of the mechanical strength of the grafted patches and the joints between the patch and surrounding tissues. Although inflammatory cells were observable by histological examination, all patches and surrounding tissues remained intact without noticeable medical complications. These observations indicated that the porous SF scaffolds might be further explored as an alternative to the synthetic materials in hernia repair to overcome common complications associated with synthetic materials.
C1 [He, Kai; Wu, Zhen; Xu, Bo; Shao, Yikai; Qian, Jianming; Yao, Qiyuan] Fudan Univ, Huashan Hosp, Dept Surg, Shanghai 200040, Peoples R China.
   [Wen, Jianchuan] Fudan Univ, Dept Macromol Sci, Shanghai 200433, Peoples R China.
   [Zhu, Guan] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathol, College Stn, TX 77843 USA.
RP Yao, QY (reprint author), Fudan Univ, Huashan Hosp, Dept Surg, Shanghai 200040, Peoples R China.; Zhu, G (reprint author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathol, College Stn, TX 77843 USA.
OI Shao, Yikai/0000-0003-1466-752X; Wen, Jianchuan/0000-0002-0993-1042
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Baumann Donald P, 2012, Semin Plast Surg, V26, P18, DOI 10.1055/s-0032-1302461
   Burger JWA, 2005, WORLD J SURG, V29, P1608, DOI 10.1007/s00268-005-7929-3
   Cao ZB, 2013, MAT SCI ENG C-MATER, V33, P3522, DOI 10.1016/j.msec.2013.04.045
   Chen G, 2004, J MATER SCI-MATER M, V15, P671, DOI 10.1023/B:JMSM.0000030208.89523.2a
   Dal Pra I, 2005, BIOMATERIALS, V26, P1987, DOI 10.1016/j.biomaterials.2004.06.036
   Galan TV, 2012, SPINE J, V12, pE1, DOI 10.1016/j.spinee.2012.02.012
   Harkin DG, 2011, BIOMATERIALS, V32, P2445, DOI 10.1016/j.biomaterials.2010.12.041
   Hofbauer C, 1998, SURG ENDOSC-ULTRAS, V12, P1164, DOI 10.1007/s004649900807
   Inouye K, 1998, J BIOCHEM BIOPH METH, V37, P159, DOI 10.1016/S0165-022X(98)00024-4
   Jiang XR, 2010, ACTA CHIM SINICA, V68, P1909
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kasoju N, 2012, ADV HEALTHC MATER, V1, P393, DOI 10.1002/adhm.201200097
   Kundu B, 2014, PROG POLYM SCI, V39, P251, DOI 10.1016/j.progpolymsci.2013.09.002
   Kundu B, 2013, ADV DRUG DELIVER REV, V65, P457, DOI 10.1016/j.addr.2012.09.043
   Li G, 2015, ADV HEALTHC MATER, V4, P1134, DOI 10.1002/adhm.201500002
   Li ZH, 2013, FRONT MATER SCI, V7, P237, DOI 10.1007/s11706-013-0214-8
   Liu X, 2014, J BIOMATER TISS ENG, V4, P1012, DOI 10.1166/jbt.2014.1254
   Lu L, 2000, BIOMATERIALS, V21, P1837, DOI 10.1016/S0142-9612(00)00047-8
   Mandal BB, 2009, BIOMATERIALS, V30, P2956, DOI 10.1016/j.biomaterials.2009.02.006
   Masden Derek, 2011, J Long Term Eff Med Implants, V21, P25
   Mathur AB, 2010, NANOMEDICINE-UK, V5, P807, DOI 10.2217/NNM.10.51
   Mavrodin CI, 2013, CHIRURGIA-BUCHAREST, V108, P414
   McGreevy JM, 2003, SURG ENDOSC, V17, P1778, DOI 10.1007/s00464-002-8851-5
   Novitsky YW, 2013, SURG CLIN N AM, V93, P1211, DOI 10.1016/j.suc.2013.06.014
   O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X
   Oh SH, 2003, BIOMATERIALS, V24, P4011, DOI 10.1016/S0142-9612(03)00284-9
   Rowlands AS, 2007, BIOMATERIALS, V28, P2109, DOI 10.1016/j.biomaterials.2006.12.032
   Seker Duray, 2011, J Long Term Eff Med Implants, V21, P205
   Shankaran V, 2011, ANN SURG, V253, P16, DOI 10.1097/SLA.0b013e3181f9b6e6
   Slater NJ, 2013, AM J SURG, V205, P220, DOI 10.1016/j.amjsurg.2012.05.028
   Slater NJ, 2011, J GASTROINTEST SURG, V15, P1252, DOI 10.1007/s11605-011-1435-8
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Suganya S, 2014, J BIOMATER TISS ENG, V4, P9, DOI 10.1166/jbt.2014.1139
   Unger RE, 2004, BIOMATERIALS, V25, P5137, DOI 10.1016/j.biomaterials.2003.12.040
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   Vallet-Regi M, 2011, ADV MATER, V23, P5177, DOI 10.1002/adma.201101586
   Wang JH, 2015, J BIOMATER TISS ENG, V5, P357, DOI 10.1166/jbt.2015.1323
   Warnock JJ, 2014, PEERJ, V2, DOI 10.7717/peerj.353
   Yang JW, 2015, J BIOMATER APPL, V30, P221, DOI 10.1177/0885328215577296
   Zhou XF, 2014, J BIOMATER TISS ENG, V4, P235, DOI 10.1166/jbt.2014.1161
NR 41
TC 1
Z9 1
U1 0
U2 9
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2157-9083
EI 2157-9091
J9 J BIOMATER TISS ENG
JI J. Biomater. Tissue Eng.
PD AUG
PY 2016
VL 6
IS 8
BP 665
EP 671
DI 10.1166/jbt.2016.1487
PG 7
WC Cell & Tissue Engineering
SC Cell Biology
GA DT7EB
UT WOS:000381648800010
DA 2018-10-20
ER

PT J
AU Ribeiro, N
   Costa-Pinheiro, P
   Henrique, R
   Gomez-Lazaro, M
   Pereira, MP
   Mansur, AAP
   Mansur, HS
   Jeronimo, C
   Sousa, SR
   Monteiro, FJ
AF Ribeiro, Nilza
   Costa-Pinheiro, Pedro
   Henrique, Rui
   Gomez-Lazaro, Maria
   Pereira, Marisa P.
   Mansur, Alexandra A. P.
   Mansur, Herman S.
   Jeronimo, Carmen
   Sousa, Susana R.
   Monteiro, Fernando J.
TI Comprehensive Analysis of Secreted Protein, Acidic and Rich in Cysteine
   in Prostate Carcinogenesis: Development of a 3D Nanostructured Bone-Like
   Model
SO JOURNAL OF BIOMEDICAL NANOTECHNOLOGY
LA English
DT Article
DE SPARC; Prostate Cancer; 3D Bone-Biomimetic Biomaterial; Bone Metastasis;
   Quantum Dots; Gleason Score
ID CANCER CELL-MIGRATION; MATRICELLULAR PROTEIN; SPARC; METASTASIS;
   OSTEONECTIN; GROWTH; EXPRESSION; PROMOTES; COLLAGEN; CDS
AB Most aggressive prostate cancer (PCa) types tend to metastasize frequently to bone and SPARC, a matricellular protein, might participate in such biological processes. The objective of this study was to evaluate the effect of SPARC in prostate carcinogenesis and bone metastization. This was explored assessing the morphology, metabolic activity and SPARC expression of different PCa cell lines resembling different stages of carcinogenesis, using a 3D bone-biomimetic model (collagen nanofibers/nanohydroxyapatite) grafted with SPARC. Our findings highlight distinct cellular behavior depending on cell type and presence of exogenous SPARC. In fact, SPARC addition contributed to the survival and significant growth of a non-bone metastatic PCa cell line (LNCaP) on bone-like biomaterial. Moreover, SPARC expression levels were evaluated in a series of prostatic tissues, comparing normal prostate, pre-neoplastic prostate intraepithelial neoplasias and overtly malignant tumors, and also metastasis to its correspondent primary prostate tumors, ascertaining potential association between SPARC and clinicopathological data. Remarkably, SPARC was overexpressed in patients with higher Gleason Score, indicating tumors with poor prognosis, as well as in metastasis, particularly from bone sites, compared with their respective primary tumors. The results suggest a potential role of SPARC as a clinical target on PCa, due to its association with bone metastization.
C1 [Ribeiro, Nilza; Gomez-Lazaro, Maria; Pereira, Marisa P.; Sousa, Susana R.; Monteiro, Fernando J.] Univ Porto, I3S, Rua Alfredo Allen 208, P-4200135 Oporto, Portugal.
   [Ribeiro, Nilza; Gomez-Lazaro, Maria; Pereira, Marisa P.; Sousa, Susana R.; Monteiro, Fernando J.] Univ Porto, INEB Inst Engn Biomed, Div Biomat, Rua Alfredo Allen 208, P-4200135 Oporto, Portugal.
   [Ribeiro, Nilza; Pereira, Marisa P.; Monteiro, Fernando J.] Univ Porto, Fac Engn, Dept Engn Met & Mat, Rua Roberto Frias, P-4200465 Oporto, Portugal.
   [Costa-Pinheiro, Pedro; Henrique, Rui; Jeronimo, Carmen] Portuguese Oncol Inst, Canc Biol & Epigenet Grp, Res Ctr, Rua Dr Antonio Bernardino Almeida, P-4200072 Oporto, Portugal.
   [Henrique, Rui; Jeronimo, Carmen] Inst Biomed Sci Abel Salazar ICBAS, Dept Pathol & Mol Immunol, Rua Jorge Viterbo Ferreira 228, P-4050313 Oporto, Portugal.
   [Henrique, Rui] Portuguese Oncol Inst, Dept Pathol, Rua Dr Antonio Bernardino Almeida, P-4200072 Oporto, Portugal.
   [Mansur, Alexandra A. P.; Mansur, Herman S.] Univ Fed Minas Gerais, Dept Met & Mat Engn, Ctr Nanosci Nanotechnol & Innovat CeNano2I, Ave Presidente Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
   [Sousa, Susana R.] Inst Politecn Porto, ISEP, Rua Dr Antonio Bernardino de Almeida 431, P-4200072 Oporto, Portugal.
RP Ribeiro, N (reprint author), Univ Porto, I3S, Rua Alfredo Allen 208, P-4200135 Oporto, Portugal.; Ribeiro, N (reprint author), Univ Porto, INEB Inst Engn Biomed, Div Biomat, Rua Alfredo Allen 208, P-4200135 Oporto, Portugal.; Ribeiro, N (reprint author), Univ Porto, Fac Engn, Dept Engn Met & Mat, Rua Roberto Frias, P-4200465 Oporto, Portugal.
EM nribeiro@ineb.up.pt
RI Sousa, Susana/D-5356-2013; Henrique, Rui/I-2757-2013
OI Sousa, Susana/0000-0001-8018-4310; Henrique, Rui/0000-0003-3171-4666;
   Ribeiro, Nilza/0000-0002-9975-5432; Monteiro,
   Fernando/0000-0002-1361-4605; Mansur, Alexandra/0000-0003-1526-2508;
   Jeronimo, Carmen/0000-0003-4186-5345; Gomez Lazaro,
   Maria/0000-0002-8836-396X
FU Fundacao para a Ciencia e a Tecnologia (FCT), Portugal
   [SFRH/BD/69686/2010]; FEDER through Programa Operacional Factores de
   Competitividade - COMPETE [PEst-C/SAU/LA0002/2013]; Brazilian Funding
   Agency CNPq; Brazilian Funding Agency CAPES; Brazilian Funding Agency
   FAPEMIG
FX The financial support of Fundacao para a Ciencia e a Tecnologia (FCT),
   Portugal, for N. Ribeiro's Ph.D. grant (Ref. SFRH/BD/69686/2010), FEDER
   through Programa Operacional Factores de Competitividade - COMPETE and
   within project PEst-C/SAU/LA0002/2013, and Brazilian Funding Agencies
   CNPq, CAPES and FAPEMIG is acknowledged. The provision of nanoHA
   (nanoXIM) by FLUIDINOVA, S.A. (Maia-Portugal) and collagen by Kensey
   Nash (USA) is acknowledged.
CR Aboulaich A, 2012, ACS APPL MATER INTER, V4, P2561, DOI 10.1021/am300232z
   BARAL S, 1986, J AM CHEM SOC, V108, P375, DOI 10.1021/ja00263a005
   Barker TH, 2005, J BIOL CHEM, V280, P36483, DOI 10.1074/jbc.M504663200
   Brekken RA, 2000, MATRIX BIOL, V19, P569, DOI 10.1016/S0945-053X(00)00105-0
   Chen NY, 2007, CANCER RES, V67, P6544, DOI 10.1158/0008-5472.CAN-07-1330
   Chu JH, 2009, PROSTATE, V69, P428, DOI 10.1002/pros.20897
   De S, 2003, J BIOL CHEM, V278, P39044, DOI 10.1074/jbc.M304494200
   Donahue H J, 2004, J Musculoskelet Neuronal Interact, V4, P381
   Eble JN, 2004, PATHOLOGY GENETICS T
   Ellem SJ, 2014, ADV DRUG DELIVER REV, V79-80, P214, DOI 10.1016/j.addr.2014.04.008
   Epstein JI, 2010, J UROLOGY, V183, P433, DOI 10.1016/j.juro.2009.10.046
   Fenouille N, 2011, ONCOGENE, V30, P4887, DOI 10.1038/onc.2011.198
   Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085
   Hall CL, 2006, CANCER RES, V66, P8648, DOI 10.1158/0008-5472.CAN-06-1544
   Jacob K, 1999, CANCER RES, V59, P4453
   Kupprion C, 1998, J BIOL CHEM, V273, P29635, DOI 10.1074/jbc.273.45.29635
   Logothetis CJ, 2005, NAT REV CANCER, V5, P21, DOI 10.1038/nrc1528
   McCabe NP, 2011, NEOPLASIA, V13, P31, DOI 10.1593/neo.10998
   Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865
   Nagaraju GP, 2014, CARCINOGENESIS, V35, P967, DOI 10.1093/carcin/bgu072
   O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x
   Ramon J., 2007, PROSTATE CANC
   RAMSDEN JJ, 1984, J CHEM SOC FARAD T 1, V80, P919, DOI 10.1039/f19848000919
   Rentz TJ, 2007, J BIOL CHEM, V282, P22062, DOI 10.1074/jbc.M700167200
   Ribeiro N, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/3/035015
   Ribeiro N, 2014, J CELL BIOCHEM, V115, P17, DOI 10.1002/jcb.24649
   Rizzi, 2012, PLOS ONE, V7
   Salgado CL, 2014, RSC ADV, V4, P49016, DOI 10.1039/c4ra08247h
   Sariisik E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057706
   Seux M, 2011, ONCOGENE, V30, P3049, DOI 10.1038/onc.2011.25
   Shin M, 2013, PROSTATE, V73, P1159, DOI 10.1002/pros.22664
   Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208
   Sieh S, 2014, BONE, V63, P121, DOI 10.1016/j.bone.2014.02.001
   Smyntyna V, 2007, RADIAT MEAS, V42, P693, DOI 10.1016/j.radmeas.2007.01.068
   Sobel RE, 2005, J UROLOGY, V173, P342, DOI 10.1097/01.ju.0000141580.30910.57
   Sweetwyne MT, 2004, J HISTOCHEM CYTOCHEM, V52, P723, DOI 10.1369/jhc.3A6153.2004
   Tauc J., 1972, Journal of Non-Crystalline Solids, V8-10, P569, DOI 10.1016/0022-3093(72)90194-9
   TERMINE JD, 1981, CELL, V26, P99, DOI 10.1016/0092-8674(81)90037-4
   Thomas R, 2000, CLIN CANCER RES, V6, P1140
   Wang RX, 2005, SEMIN CANCER BIOL, V15, P353, DOI 10.1016/j.semcancer.2005.05.005
   Xu X, 2012, BIOMATERIALS, V33, P9049, DOI 10.1016/j.biomaterials.2012.08.061
   Yang EN, 2007, INT J CANCER, V121, P567, DOI 10.1002/ijc.22706
NR 42
TC 2
Z9 2
U1 0
U2 5
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1550-7033
EI 1550-7041
J9 J BIOMED NANOTECHNOL
JI J. Biomed. Nanotechnol.
PD AUG
PY 2016
VL 12
IS 8
BP 1667
EP 1678
DI 10.1166/jbn.2016.2276
PG 12
WC Nanoscience & Nanotechnology; Materials Science, Biomaterials
SC Science & Technology - Other Topics; Materials Science
GA DT7DY
UT WOS:000381648500007
PM 29342345
DA 2018-10-20
ER

PT J
AU Zhou, P
   Pan, YT
   Wang, Z
   He, CL
   Huang, YX
AF Zhou, Ping
   Pan, Yan-Ting
   Wang, Zhuo
   He, Chun-Lan
   Huang, Yao-Xiong
TI Raman and surface-enhanced Raman spectroscopy on horns and their
   correlation with biomechanical properties
SO JOURNAL OF RAMAN SPECTROSCOPY
LA English
DT Article
DE molecular composition; mechanical properties; degradation products;
   horns of bovid; surface enhanced Raman scattering
ID IDENTIFICATION; ACID
AB Recently horns are considered as potential candidates for various biomedical applications because of their distinct biomechanical properties. We therefore performed Raman spectral analysis and mechanical test on the horns of buffalo, cattle and sheep to obtain information about the molecular compositions in various parts of the horns and their correlation with biomechanical properties. We also developed a surface enhanced Raman spectroscopy (SERS) to trace their degradation products. We found that various parts of the horns have similar overall molecular compositions, but have differences in the bands of C-C-S-S-C-C conformation, -helix and -sheet conformation, especially in the bands of 507-515cm(-1) which reflect the relative sulfur content and the structural conformation of the disulfide linkages. The Raman intensities at the region are highly correlated with the Young's modulus and tensile strength of the horns, indicating that the biomechanical properties of the horns are mainly determined by their disulfide bonds. It also suggests that Raman spectroscopy has the potential to perform non-destructive detection on the mechanical strength of horns. The SERS measurements verified that the main constituents of the degradation products from both the buffalo and sheep horns were amino acids and polypeptides, suggesting that the horns are suitable candidates for biomaterial scaffolds. Copyright (c) 2016 John Wiley & Sons, Ltd.
C1 [Zhou, Ping; Pan, Yan-Ting; Wang, Zhuo; He, Chun-Lan; Huang, Yao-Xiong] Ji Nan Univ, Dept Biomed Engn, Guangzhou 510632, Guangdong, Peoples R China.
RP Huang, YX (reprint author), Ji Nan Univ, Dept Biomed Engn, Guangzhou 510632, Guangdong, Peoples R China.
EM tyxhuang@jnu.edu.cn
FU Chinese National Natural Science Foundation [30940019, 60377043]; Guang
   Dong Provincial Science and Technology Foundation
FX This work was supported partly by the Chinese National Natural Science
   Foundation (Nos. 30940019 and 60377043) and Guang Dong Provincial
   Science and Technology Foundation.
CR Edwards HGM, 1998, SPECTROCHIM ACTA A, V54, P745, DOI 10.1016/S1386-1425(98)00013-4
   KITCHENER A, 1988, J ZOOL, V214, P1, DOI 10.1111/j.1469-7998.1988.tb04983.x
   LEE PC, 1982, J PHYS CHEM-US, V86, P3391, DOI 10.1021/j100214a025
   Lundrigan B, 1996, J MAMMAL, V77, P462, DOI 10.2307/1382822
   Manuszak MA, 1996, J SOC COSMET CHEM, V47, P49
   Mary MB, 2006, SPECTROCHIM ACTA A, V65, P414, DOI 10.1016/j.saa.2005.11.022
   Neugebauer U, 2010, J BIOPHOTONICS, V3, P579, DOI 10.1002/jbio.201000020
   Pandey G., 2008, P 11 INT C EXP 2008
   Pichardo-Molina JL, 2007, LASER MED SCI, V22, P229, DOI 10.1007/s10103-006-0432-8
   Stone N, 2000, LARYNGOSCOPE, V110, P1756, DOI 10.1097/00005537-200010000-00037
   Virkler K, 2008, FORENSIC SCI INT, V181, pE1, DOI 10.1016/j.forsciint.2008.08.004
   Wegst UGK, 2004, PHILOS MAG, V84, P2167, DOI 10.1080/14786430410001680935
   Wu ZJ, 2010, SPECTROSC SPECT ANAL, V30, P971, DOI 10.3964/j.issn.1000-0593(2010)04-0971-04
   XU Yi-ming, 2005, RAMAN SPECTROSCOPY A, P11
   Zhang QB, 2013, MAT SCI ENG C-MATER, V33, P5036, DOI 10.1016/j.msec.2013.08.034
   Zhang QB, 2015, MAT SCI ENG C-MATER, V47, P123, DOI 10.1016/j.msec.2014.11.051
NR 16
TC 1
Z9 1
U1 1
U2 10
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0377-0486
EI 1097-4555
J9 J RAMAN SPECTROSC
JI J. Raman Spectrosc.
PD AUG
PY 2016
VL 47
IS 8
BP 926
EP 932
DI 10.1002/jrs.4926
PG 7
WC Spectroscopy
SC Spectroscopy
GA DS7FX
UT WOS:000380949500008
DA 2018-10-20
ER

PT J
AU Zhang, Y
   He, F
   Li, XL
AF Zhang, Yun
   He, Fu
   Li, Xiaoli
TI Three-dimensional composite hydrogel based on polyamine zirconium oxide,
   alginate and tannic acid with high performance for Pb(II), Hg(II) and
   Cr(VI) trapping
SO JOURNAL OF THE TAIWAN INSTITUTE OF CHEMICAL ENGINEERS
LA English
DT Article
DE Three-dimensional hydrogels; Polyamine zirconium oxide; Tannic acid;
   Alginate; Heavy metal trapping
ID AQUEOUS-SOLUTIONS; HYBRID MATERIAL; METALS REMOVAL; ADSORPTION; LEAD;
   BIOSORPTION; WATER; NANOPARTICLES; CADMIUM; RESIN
AB In this study, preparation of multifunctional polymer hydrogels (Zr-DETA/TS) was achieved via organic inorganic crosslinking to form three-dimensional network structure for application of Pb2+, Hg2+ and CrO42- extraction. The equilibrium data of Pb2+, Hg2+ and CrO42- were best described by the Langmuir isotherm, and the kinetic data were found to follow the pseudo-second-order kinetic model. It was notable that ionic exchange and complexation were the main adsorption mechanism for Pb2+ and Hg2+ while electrostatic attraction, inner-sphere complex and esterification played an important role in CrO42- adsorption. Thus, Zr-DETA/TS hydrogels could be used as a promising biomaterial for Pb2+, Hg2+ and CrO42- removal from wastewaters. (C) 2016 Taiwan Institute of Chemical Engineers. Published by Elsevier B.V. All rights reserved.
C1 [Zhang, Yun; He, Fu] Lanzhou Univ, Coll Chem & Chem Engn, Lanzhou 730000, Peoples R China.
   [Li, Xiaoli] Lanzhou Univ, Coll Resources & Environm Sci, Lanzhou 730000, Peoples R China.
RP Zhang, Y (reprint author), Lanzhou Univ, Coll Chem & Chem Engn, Lanzhou 730000, Peoples R China.
EM zhangyun@lzu.edu.cn
RI zhang, Yun/P-5873-2018
FU National Natural Science Foundation of China [21304040]; Fundamental
   Research Funds for the Central Universities [lzujbky-2015-29]
FX The authors gratefully acknowledge financial supports from the National
   Natural Science Foundation of China (No. 21304040) and Fundamental
   Research Funds for the Central Universities (lzujbky-2015-29).
CR Arica MY, 2004, J HAZARD MATER, V109, P191, DOI 10.1016/j.jhazmat.2004.03.017
   Balaji T, 2005, CHEMOSPHERE, V59, P1169, DOI 10.1016/j.chemosphere.2004.12.007
   Biswas BK, 2008, J HAZARD MATER, V154, P1066, DOI 10.1016/j.jhazmat.2007.11.030
   Dong LJ, 2010, J ENVIRON SCI-CHINA, V22, P225, DOI 10.1016/S1001-0742(09)60097-8
   Dou BL, 2011, CHEM ENG J, V166, P631, DOI 10.1016/j.cej.2010.11.035
   Feng NC, 2011, J HAZARD MATER, V185, P49, DOI 10.1016/j.jhazmat.2010.08.114
   Ferreira LS, 2011, CHEM ENG J, V173, P326, DOI 10.1016/j.cej.2011.07.039
   GOYER RA, 1993, ENVIRON HEALTH PERSP, V100, P177, DOI 10.2307/3431524
   Hu XJ, 2011, J HAZARD MATER, V185, P306, DOI 10.1016/j.jhazmat.2010.09.034
   Jin YJ, 2012, J HAZARD MATER, V227, P461, DOI 10.1016/j.jhazmat.2012.05.004
   Katz S. A., 1994, BIOL ENV CHEM CHROMI
   Kim HN, 2012, CHEM SOC REV, V41, P3210, DOI 10.1039/c1cs15245a
   Li WG, 2012, BIORESOURCE TECHNOL, V113, P106, DOI 10.1016/j.biortech.2011.12.037
   Li W, 2012, CHEM ENG J, V193, P88, DOI 10.1016/j.cej.2012.03.084
   Li XL, 2012, SEP SCI TECHNOL, V47, P729, DOI 10.1080/01496395.2011.626010
   Liu YY, 2011, CHEM ENG J, V173, P792, DOI 10.1016/j.cej.2011.08.054
   Lofrano G, 2016, WATER RES, V92, P22, DOI 10.1016/j.watres.2016.01.033
   Mandal S, 2011, J HAZARD MATER, V192, P899, DOI 10.1016/j.jhazmat.2011.05.099
   Mata YN, 2009, J HAZARD MATER, V163, P555, DOI 10.1016/j.jhazmat.2008.07.015
   Mondal MK, 2009, J ENVIRON MANAGE, V90, P3266, DOI 10.1016/j.jenvman.2009.05.025
   Nguyen ML, 2015, J TAIWAN INST CHEM E, V56, P96, DOI 10.1016/j.jtice.2015.03.033
   Naeem A, 2009, J HAZARD MATER, V172, P124, DOI 10.1016/j.jhazmat.2009.06.155
   Naiya TK, 2009, CHEM ENG J, V148, P68, DOI 10.1016/j.cej.2008.08.002
   Ozacar M, 2008, CHEM ENG J, V143, P32, DOI 10.1016/j.cej.2007.12.005
   Olu-Owolabi BI, 2010, J HAZARD MATER, V184, P731, DOI 10.1016/j.jhazmat.2010.08.100
   Oo CW, 2009, IND CROP PROD, V30, P152, DOI 10.1016/j.indcrop.2009.03.002
   Ozdemir S, 2009, CHEM ENG J, V152, P195, DOI 10.1016/j.cej.2009.04.041
   PERANIEMI S, 1994, FRESEN J ANAL CHEM, V349, P510, DOI 10.1007/BF00323983
   Qiu H, 2015, ACS APPL MATER INTER, V7, P20835, DOI 10.1021/acsami.5b06098
   Shah B, 2014, J HAZARD MATER, V276, P138, DOI 10.1016/j.jhazmat.2014.05.031
   Vukovic GD, 2011, CHEM ENG J, V173, P855, DOI 10.1016/j.cej.2011.08.036
   Wang JH, 2010, J COLLOID INTERF SCI, V349, P293, DOI 10.1016/j.jcis.2010.05.010
   Wang T, 2013, CHEM ENG J, V215, P366, DOI 10.1016/j.cej.2012.11.029
   Wong KK, 2003, CHEMOSPHERE, V50, P23, DOI 10.1016/S0045-6535(02)00598-2
   Wu XL, 2011, DESALINATION, V269, P84, DOI 10.1016/j.desal.2010.10.046
   Wu YW, 2012, APPL SURF SCI, V258, P6772, DOI 10.1016/j.apsusc.2012.03.057
   Xiong CH, 2009, HYDROMETALLURGY, V98, P318, DOI 10.1016/j.hydromet.2009.05.008
   Zabihi M, 2010, J HAZARD MATER, V174, P251, DOI 10.1016/j.jhazmat.2009.09.044
   Zheng YM, 2012, J COLLOID INTERF SCI, V367, P362, DOI 10.1016/j.jcis.2011.10.007
NR 39
TC 5
Z9 5
U1 5
U2 52
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-1070
EI 1876-1089
J9 J TAIWAN INST CHEM E
JI J. Taiwan Inst. Chem. Eng.
PD AUG
PY 2016
VL 65
BP 304
EP 311
DI 10.1016/j.jtice.2016.05.023
PG 8
WC Engineering, Chemical
SC Engineering
GA DS2OX
UT WOS:000380624500029
DA 2018-10-20
ER

PT J
AU Calvo-Guirado, JL
   Aguilar-Salvatierra, A
   Ramirez-Fernandez, MP
   de Val, JEMS
   Delgado-Ruiz, RA
   Gomez-Moreno, G
AF Luis Calvo-Guirado, Jose
   Aguilar-Salvatierra, Antonio
   Ramirez-Fernandez, Maria P.
   Mate Sanchez de Val, Jose E.
   Arcesio Delgado-Ruiz, Rafael
   Gomez-Moreno, Gerardo
TI RETRACTED: Bone response to collagenized xenografts of porcine origin
   (mp3((R))) and a bovine bone mineral grafting (4BONE (TM) XBM) grafts in
   tibia defects: experimental study in rabbits (Retracted article. See
   vol. 29, pg. 818, 2018)
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article; Retracted Publication
DE 4BONE (TM) XBM; biomaterial; bone graft; Mp3; tibia rabbits; xenografts
ID HISTOMORPHOMETRIC ANALYSIS; AUGMENTATION TECHNIQUES; DENTAL IMPLANTS;
   REGENERATION; BIOMATERIALS; SUBSTITUTE; DOGS
AB ObjectivesThis study aimed to carry out the evaluation of bone response of new bone formation to two different xenografts (bovine and porcine) biomaterials inserted in rabbit tibiae.
   Materials and methodsThe study used a total of 20 male New Zealand albino rabbits. They received a total of 40 grafts in the proximal metaphyseal areas of both tibiae. Two biomaterials were evaluated: 20 porcine xenografts, as a bone granulate (OsteoBiol((R)) MP3((R)); Tecnoss srl, Giaveno, Italy), were placed in the proximal metaphyseal area of the right tibia, 20 anorganic bovine bone mineral grafting (4BONE XBM, MIS Implants Inc., BARLEV, Israel) were placed in the left tibia. Following graft insertion, the animals were sacrificed in two groups of 10 animals, after 1 and 4months, respectively. For each group, biomaterials were analyzed: newly formed bone, residual graft materials and the connective tissue. Histomorphometric, EDX analysis and element mapping were performed at 1 and 4months after graft insertion.
   ResultsAt 4months after treatment, the bone defects displayed radiological images that showed complete repair of osseous defects. Histomorphometric evaluation showed that for the porcine xenograft, the study averages for newly formed bone represented 84.232.9%, while bovine matrix was 79.34 +/- 2.1%. For residual graft material, the porcine biomaterial had 11.23 +/- 1.7% and the bovine graft 31.56 +/- 2.3%. Finally, the connective tissue for MP3 was 10.33 +/- 1.8%, while for the 4BONE XBM we obtained 14.34 +/- 2.9%. Element analysis revealed higher percentages of Ca (54 +/- 9%) and P (35 +/- 6%) in the group B than group A and control group (P<0.05).
   ConclusionsDefects of a critical size in a rabbit tibia model can be sealed using a bovine porous biphasic calcium phosphate and MP3 material; this supports new bone formation, creates a bridge between borders, and facilitates bone ingrowth in both biomaterials. Furthermore, this study observed partial dissolution of the mineral phase of four bone graft and complete resorption of porcine MP3 biomaterial and its incorporation into the surrounding bone. Depending on clinical needs, each biomaterial could be useful in daily clinical practice.
C1 [Luis Calvo-Guirado, Jose; Ramirez-Fernandez, Maria P.; Mate Sanchez de Val, Jose E.] Univ Catolica San Antonio Murcia UCAM, Int Dent Res Cathedra, Murcia, Spain.
   [Arcesio Delgado-Ruiz, Rafael] SUNY Stony Brook, Sch Dent Med, Stony Brook, NY 11794 USA.
   [Aguilar-Salvatierra, Antonio; Gomez-Moreno, Gerardo] Univ Granada, Fac Dent, Granada, Spain.
RP Calvo-Guirado, JL (reprint author), C Mozart 4 1 Floor C-D, Murcia 30002, Spain.
EM jlcalvo@ucam.edu
RI Mate Sanchez de Va, Jose Eduardo/R-9750-2018
OI Mate Sanchez de Va, Jose Eduardo/0000-0002-4216-421X; calvo guirado,
   jose luis/0000-0002-4067-2253
CR Aghaloo TL, 2007, INT J ORAL MAX IMPL, V22, P49
   Beitlitum I, 2010, CLIN ORAL IMPLAN RES, V21, P1242, DOI 10.1111/j.1600-0501.2010.01936.x
   Boix D, 2004, J PERIODONTOL, V75, P663, DOI 10.1902/jop.2004.75.5.663
   Guirado JLC, 2013, CLIN IMPLANT DENT R, V15, P143, DOI 10.1111/j.1708-8208.2011.00337.x
   Calvo-Guirado JL, 2014, CLIN ORAL IMPLAN RES, V25, P1228, DOI 10.1111/clr.12258
   Calvo-Guirado JL, 2015, CLIN ORAL IMPLAN RES, V26, P399, DOI 10.1111/clr.12364
   Chazono M, 2004, J BIOMED MATER RES A, V70A, P542, DOI 10.1002/jbm.a.30094
   De Santis E, 2015, CLIN ORAL IMPLAN RES, V26, P516, DOI 10.1111/clr.12434
   El-Mekkawi HA, 2012, ORAL SURG ORAL MED S, V114, P179
   Esposito M, 2006, INT J ORAL MAX IMPL, V21, P696
   Ezirganli S, 2013, CLIN ORAL IMPLAN RES, V24, P312, DOI 10.1111/j.1600-0501.2011.02323.x
   Fan HS, 2007, J NANOSCI NANOTECHNO, V7, P808, DOI 10.1166/jnn.2007.501
   Frenken JWFH, 2010, CLIN ORAL IMPLAN RES, V21, P201, DOI 10.1111/j.1600-0501.2009.01821.x
   Horch HH, 2006, INT J ORAL MAX SURG, V35, P708, DOI 10.1016/j.ijom.2006.03.017
   Kanczler JM, 2008, EUR CELLS MATER, V15, P100, DOI 10.22203/eCM.v015a08
   Kolerman R, 2012, J ORAL MAXIL SURG, V70, P1835, DOI 10.1016/j.joms.2012.04.034
   Legeros RZ, 2003, J MATER SCI-MATER M, V14, P201, DOI 10.1023/A:1022872421333
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Calvo-Guirado JL, 2015, CLIN ORAL IMPLAN RES, V26, P454, DOI 10.1111/clr.12399
   de Val JEMS, 2012, J BIOMED MATER RES A, V100A, P3446, DOI 10.1002/jbm.a.34259
   de Val JEMS, 2014, J BIOMED MATER RES A, V102, P1037, DOI 10.1002/jbm.a.34785
   McAllister BS, 2007, J PERIODONTOL, V78, P377, DOI 10.1902/jop.2007.060048
   Murai Masakazu, 2005, J Oral Sci, V47, P209, DOI 10.2334/josnusd.47.209
   Pekkan G, 2012, J CRANIO MAXILL SURG, V40, pE1, DOI 10.1016/j.jcms.2011.01.018
   Ramirez-Fernandez MP, 2011, CLIN ORAL IMPLAN RES, V22, P767, DOI 10.1111/j.1600-0501.2010.02058.x
   Ramirez-Fernandez MP, 2013, CLIN ORAL IMPLAN RES, V24, P523, DOI 10.1111/j.1600-0501.2011.02414.x
   Sanchez M., 2014, CLIN ORAL IMPLAN RES, DOI [10.1111/clr.12420, DOI 10.1111/CLR.12420]
   Schopper C, 2005, J BIOMED MATER RES B, V74B, P458, DOI 10.1002/jbm.b.30199
   Simion M, 2007, CLIN ORAL IMPLAN RES, V18, P86, DOI 10.1111/j.1600-0501.2006.01291.x
   Soardi CM, 2011, CLIN ORAL IMPLAN RES, V22, P560, DOI 10.1111/j.1600-0501.2010.02034.x
   Wang W, 2009, ACTA BIOMATER, V5, P3132, DOI 10.1016/j.actbio.2009.04.036
NR 31
TC 2
Z9 2
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD AUG
PY 2016
VL 27
IS 8
BP 1039
EP 1046
DI 10.1111/clr.12681
PG 8
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA DS7IX
UT WOS:000380958000017
PM 26434645
DA 2018-10-20
ER

PT J
AU Suska, F
   Kjeller, G
   Tarnow, P
   Hryha, E
   Nyborg, L
   Snis, A
   Palmquist, A
AF Suska, Felicia
   Kjeller, Goran
   Tarnow, Peter
   Hryha, Eduard
   Nyborg, Lars
   Snis, Anders
   Palmquist, Anders
TI Electron Beam Melting Manufacturing Technology for Individually
   Manufactured Jaw Prosthesis: A Case Report
SO JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
LA English
DT Article
ID TI-6AL-4V STRUCTURES; TRABECULAR TITANIUM; BONE INGROWTH; IMPLANTS;
   RECONSTRUCTION; OSSEOINTEGRATION; BIOMATERIAL; OSTEOBLASTS; SCAFFOLDS;
   THICKNESS
AB In the field of maxillofacial reconstruction, additive manufacturing technologies, specifically electron beam melting (EBM), offer clinicians the potential for patient-customized design of jaw prostheses, which match both load-bearing and esthetic demands. The technique allows an innovative, functional design, combining integrated porous regions for bone ingrowth and secondary biological fixation with solid load-bearing regions ensuring the biomechanical performance. A patient-specific mandibular prosthesis manufactured using EBM was successfully used to reconstruct a patient's mandibular defect after en bloc resection. Over a 9-month follow-up period, the patient had no complications. A short operating time, good esthetic outcome, and high level of patient satisfaction as measured by quality-of-life questionnaires-the European Organisation for Research and Treatment of Cancer QLQ-C30 (30-item quality-of-life core questionnaire) and H&N35 (head and neck cancer module)-were reported for this case. Individually planned and designed EBM-produced prostheses may be suggested as a possible future alternative to fibular grafts or other reconstructive methods. However, the role of porosity, the role of geometry, and the optimal combination of solid and porous parts, as well as surface properties in relation to soft tissues, should be carefully evaluated in long-term clinical trials. (C) 2016 American Association of Oral and Maxillofacial Surgeons
C1 [Suska, Felicia; Kjeller, Goran; Snis, Anders] Univ Gothenburg, Sahlgrenska Acad, Dept Oral & Maxillofacial Surg, Gothenburg, Sweden.
   [Suska, Felicia; Palmquist, Anders] Univ Gothenburg, Sahlgrenska Acad, Dept Biomat, Gothenburg, Sweden.
   [Suska, Felicia; Snis, Anders; Palmquist, Anders] BIOMATCELL VINN Excellence Ctr Biomat & Cell Ther, Gothenburg, Sweden.
   [Tarnow, Peter] Univ Gothenburg, Sahlgrenska Acad, Dept Plast Surg, Gothenburg, Sweden.
   [Hryha, Eduard; Nyborg, Lars] Chalmers, Dept Mat & Mfg Technol, Gothenburg, Sweden.
   [Snis, Anders] Arcam AB, Molndal, Sweden.
RP Suska, F (reprint author), Box 412, SE-40530 Gothenburg, Sweden.
EM felicia.suska@biomaterials.gu.se
RI Palmquist, Anders/D-2171-2014
OI Nyborg, Lars/0000-0002-1726-5529
FU Swedish Government Strategic Funding of Materials Science Area of
   Advance; BIOMATCELL VINN Excellence Center of Biomaterials and Cell
   Therapy; Vastra Gotaland Region; Inga Britt and Arne Lundberg
   Foundation; Hjalmar Svensson Foundation; Adlerbertska Foundation
FX Financial support was provided by the Swedish Government Strategic
   Funding of Materials Science Area of Advance, the BIOMATCELL VINN
   Excellence Center of Biomaterials and Cell Therapy, the Vastra Gotaland
   Region, the Inga Britt and Arne Lundberg Foundation, the Hjalmar
   Svensson Foundation, and the Adlerbertska Foundation. The grant
   providers were not involved in the study design, data acquisition,
   interpretation, writing, and submission of the article. A.S. is employed
   by Arcam AB, a company producing machines for electron beam melting.
   This company had no influence on the content of the manuscript.
CR ADELL R, 1981, INT J ORAL MAXILLOF, V10, P387, DOI 10.1016/S0300-9785(81)80077-4
   Biemond JE, 2011, ARCH ORTHOP TRAUM SU, V131, P711, DOI 10.1007/s00402-010-1218-9
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   BRANEMARK P I, 1969, Scandinavian Journal of Plastic and Reconstructive Surgery, V3, P81
   Cannady SB, 2015, FACIAL PLAST SURG CL, V23, P347, DOI 10.1016/j.fsc.2015.04.007
   De Peppo G.M., 2012, SCI WORLDJ, V2012
   Derand P, 2012, CRANIOMAX TRAUM REC, V5, P137, DOI 10.1055/s-0032-1313357
   Disa JJ, 2000, SEMIN SURG ONCOL, V19, P226, DOI 10.1002/1098-2388(200010/11)19:3<226::AID-SSU4>3.0.CO;2-N
   ENGH CA, 1988, CLIN ORTHOP RELAT R, P7
   Frosch KH, 2004, J BIOMED MATER RES A, V68A, P325, DOI 10.1002/jbm.a.20010
   Haslauer CM, 2010, MED ENG PHYS, V32, P645, DOI 10.1016/j.medengphy.2010.04.003
   Hayden RE, 2012, CURR OPIN OTOLARYNGO, V20, P231, DOI 10.1097/MOO.0b013e328355d0f3
   Heinl P, 2008, ACTA BIOMATER, V4, P1536, DOI 10.1016/j.actbio.2008.03.013
   Hirsch DL, 2008, J ORAL MAXIL SURG, V66, P2545, DOI 10.1016/j.joms.2007.08.041
   Jones JR, 2006, BIOMATERIALS, V27, P964, DOI 10.1016/j.biomaterials.2005.07.017
   Kaplan F, 1994, ORTHOPEDIC BASIC SCI, P124
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Keaveny TM, 2001, ANNU REV BIOMED ENG, V3, P307, DOI 10.1146/annurev.bioeng.3.1.307
   Kienapfel H, 1999, J ARTHROPLASTY, V14, P355, DOI 10.1016/S0883-5403(99)90063-3
   Kontio R, 2014, CURR OPIN OTOLARYNGO, V22, P307, DOI 10.1097/MOO.0000000000000065
   LARSSON C, 1994, BIOMATERIALS, V15, P1062, DOI 10.1016/0142-9612(94)90092-2
   Li SJ, 2014, ACTA BIOMATER, V10, P4537, DOI 10.1016/j.actbio.2014.06.010
   Li X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052049
   Lopez-Arcas JM, 2010, J ORAL MAXIL SURG, V68, P2377, DOI 10.1016/j.joms.2009.09.027
   Lopez-Heredia MA, 2008, J BIOMED MATER RES A, V85A, P664, DOI 10.1002/jbm.a.31468
   Marin E, 2010, J MECH BEHAV BIOMED, V3, P373, DOI 10.1016/j.jmbbm.2010.02.001
   Murr LE, 2012, INT J BIOMATER, V2012, DOI DOI 10.1155/2012/245727
   Nagasao T, 2009, INT J ORAL MAX IMPL, V24, P999
   NYBORG L, 1988, SURF INTERFACE ANAL, V12, P110, DOI 10.1002/sia.740120209
   Oikonomou C, 2014, SURF INTERFACE ANAL, V46, P1028, DOI 10.1002/sia.5439
   Palmquist A, 2013, J BIOMATER APPL, V27, P1003, DOI 10.1177/0885328211431857
   Ponader S, 2008, J BIOMED MATER RES A, V84A, P1111, DOI 10.1002/jbm.a.31540
   Ponader S, 2010, J BIOMED MATER RES A, V92A, P56, DOI 10.1002/jbm.a.32337
   Regis M, 2015, MRS BULL, V40, P137, DOI 10.1557/mrs.2015.1
   Rosengren A, 1999, J BIOMED MATER RES, V46, P458, DOI 10.1002/(SICI)1097-4636(19990915)46:4<458::AID-JBM3>3.0.CO;2-I
   Singare S, 2004, MED ENG PHYS, V26, P671, DOI 10.1016/j.medengphy.2004.06.001
   Springer JC, 2014, MED ENG PHYS, V36, P1367, DOI 10.1016/j.medengphy.2014.07.004
   Takushima Akihiko, 2005, Int J Clin Oncol, V10, P234, DOI 10.1007/s10147-005-0504-y
   Thomsen P, 2009, J BIOMED MATER RES B, V90B, P35, DOI 10.1002/jbm.b.31250
   Wang KH, 2011, CURR OPIN OTOLARYNGO, V19, P119, DOI 10.1097/MOO.0b013e328344a569
   Wu SH, 2013, ARTIF ORGANS, V37, pE191, DOI 10.1111/aor.12153
NR 41
TC 0
Z9 2
U1 0
U2 18
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0278-2391
EI 1531-5053
J9 J ORAL MAXIL SURG
JI J. Oral Maxillofac. Surg.
PD AUG
PY 2016
VL 74
IS 8
DI 10.1016/j.joms.2016.03.046
PG 15
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA DS1AF
UT WOS:000380327400031
PM 27178123
DA 2018-10-20
ER

PT J
AU Jin, T
   Stanciulescu, I
AF Jin, Tao
   Stanciulescu, Ilinca
TI Numerical simulation of fibrous biomaterials with randomly distributed
   fiber network structure
SO BIOMECHANICS AND MODELING IN MECHANOBIOLOGY
LA English
DT Article
DE Fibrous biomaterial; Finite element method; Monte Carlo simulation
ID SOFT-TISSUES; MECHANICAL-PROPERTIES; COLLAGEN NETWORKS; AFFINE FIBRIL;
   MODEL; BEHAVIOR; ELASTICITY; MICROSTRUCTURE; KINEMATICS; FRAMEWORK
AB This paper presents a computational framework to simulate the mechanical behavior of fibrous biomaterials with randomly distributed fiber networks. A random walk algorithm is implemented to generate the synthetic fiber network in 2D used in simulations. The embedded fiber approach is then adopted to model the fibers as embedded truss elements in the ground matrix, which is essentially equivalent to the affine fiber kinematics. The fiber-matrix interaction is partially considered in the sense that the two material components deform together, but no relative movement is considered. A variational approach is carried out to derive the element residual and stiffness matrices for finite element method (FEM), in which material and geometric nonlinearities are both included. Using a data structure proposed to record the network geometric information, the fiber network is directly incorporated into the FEM simulation without significantly increasing the computational cost. A mesh sensitivity analysis is conducted to show the influence of mesh size on various simulation results. The proposed method can be easily combined with Monte Carlo (MC) simulations to include the influence of the stochastic nature of the network and capture the material behavior in an average sense. The computational framework proposed in this work goes midway between homogenizing the fiber network into the surrounding matrix and accounting for the fully coupled fiber-matrix interaction at the segment length scale, and can be used to study the connection between the microscopic structure and the macro-mechanical behavior of fibrous biomaterials with a reasonable computational cost.
C1 [Jin, Tao; Stanciulescu, Ilinca] Rice Univ, Dept Civil & Environm Engn, Houston, TX 77005 USA.
RP Stanciulescu, I (reprint author), Rice Univ, Dept Civil & Environm Engn, Houston, TX 77005 USA.
EM ilinca.s@rice.edu
OI Stanciulescu, Ilinca/0000-0003-4515-0363
FU Ken Kennedy Institute program Collaborative Advances in Biomedical
   Computing; John & Ann Doerr Fund for Computational Biomedicine
FX The authors thank Prof. Jane Grande-Allen for useful discussions and
   suggestions. This work was partially funded by the Ken Kennedy Institute
   program Collaborative Advances in Biomedical Computing. Funding for this
   program is made possible by the John & Ann Doerr Fund for Computational
   Biomedicine. Their support is greatly appreciated.
CR Agoram B, 2001, J BIOMECH ENG-T ASME, V123, P362, DOI 10.1115/1.1385843
   Arganda-Carreras I, 2010, MICROSC RES TECHNIQ, V73, P1019, DOI 10.1002/jemt.20829
   Balzani D, 2006, INT J SOLIDS STRUCT, V43, P6052, DOI 10.1016/j.ijsolstr.2005.07.048
   Bonet J, 2008, NONLINEAR CONTINUUM MECHANICS FOR FINITE ELEMENT ANALYSIS, 2ND EDITION, P1, DOI 10.1017/CBO9780511755446
   Carleton JB, 2015, ACTA BIOMATER, V12, P93, DOI 10.1016/j.actbio.2014.09.049
   Chandran PL, 2006, J BIOMECH ENG-T ASME, V128, P259, DOI 10.1115/1.2165699
   Chandran PL, 2008, MULTISCALE MODEL SIM, V7, P22, DOI 10.1137/070689504
   D'Amore A, 2014, J MECH BEHAV BIOMED, V39, P146, DOI 10.1016/j.jmbbm.2014.07.016
   D'Amore A, 2010, BIOMATERIALS, V31, P5345, DOI 10.1016/j.biomaterials.2010.03.052
   Durst CA, 2011, ACTA BIOMATER, V7, P2467, DOI 10.1016/j.actbio.2011.02.018
   Fan R, 2014, J BIOMECH, V47, P2043, DOI 10.1016/j.jbiomech.2014.03.014
   Flanagan Thomas C., 2003, European Cells & Materials, V6, P28
   FUNG YCB, 1967, AM J PHYSIOL, V213, P1532
   Gasser TC, 2006, J R SOC INTERFACE, V3, P15, DOI 10.1098/rsif.2005.0073
   Hasan A, 2014, J BIOMECH, V47, P1949, DOI 10.1016/j.jbiomech.2013.09.023
   Head DA, 2003, PHYS REV LETT, V91
   Heidemann KM, 2015, SOFT MATTER, V11, P343, DOI 10.1039/c4sm01789g
   Holzapfel GA, 2004, J BIOMECH ENG-T ASME, V126, P264, DOI 10.1115/1.1695572
   Holzapfel GA, 2000, J ELASTICITY, V61, P1, DOI 10.1023/A:1010835316564
   Holzapfel GA, 2000, NONLINEAR SOLID MECH
   Huisman EM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.208103
   Huyghe JM, 2012, BIOMECH MODEL MECHAN, V11, P161, DOI 10.1007/s10237-011-0300-8
   Itskov M, 2004, INT J SOLIDS STRUCT, V41, P3833, DOI 10.1016/j.ijsolstr.2004.02.027
   Lake SP, 2012, ANN BIOMED ENG, V40, P2111, DOI 10.1007/s10439-012-0584-6
   LANIR Y, 1983, J BIOMECH, V16, P1, DOI 10.1016/0021-9290(83)90041-6
   Lee CH, 2015, BIOPHYS J, V108, P2074, DOI 10.1016/j.bpj.2015.03.019
   Liu Q, 2013, MAT SCI ENG A-STRUCT, V587, P36, DOI 10.1016/j.msea.2013.07.087
   MACKINTOSH FC, 1995, PHYS REV LETT, V75, P4425, DOI 10.1103/PhysRevLett.75.4425
   Pandolfi A, 2012, MECH MATER, V44, P151, DOI 10.1016/j.mechmat.2011.06.004
   Roeder BA, 2002, J BIOMECH ENG-T ASME, V124, P214, DOI 10.1115/1.1449904
   Schroder J, 2002, WCCM 5 5 WORLD C COM
   Shahsavari AS, 2013, INT J SOLIDS STRUCT, V50, P3332, DOI 10.1016/j.ijsolstr.2013.06.004
   Silver FH, 2001, CRIT REV BIOMED ENG, V29, P279, DOI 10.1615/CritRevBiomedEng.v29.i3.10
   Simha NK, 1999, J BIOMECH, V32, P503, DOI 10.1016/S0021-9290(98)00185-7
   Spanos PD, 2009, J COMPUT THEOR NANOS, V6, P2317, DOI 10.1166/jctn.2009.1288
   Spencer A., 1984, CONTINUUM THEORY MEC
   Stella JA, 2007, J BIOMECH ENG-T ASME, V129, P757, DOI 10.1115/1.2768111
   Stella JA, 2010, ACTA BIOMATER, V6, P2365, DOI 10.1016/j.actbio.2010.01.001
   Stephens EH, 2011, ACTA BIOMATER, V7, P75, DOI 10.1016/j.actbio.2010.07.001
   Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521
   Stylianopoulos T, 2007, COMPUT METHOD APPL M, V196, P2981, DOI 10.1016/j.cma.2006.06.019
   Taylor R.L., 2011, FEAP FINITE ELEMENT
   Tseng H, 2013, ANN BIOMED ENG, V41, P398, DOI 10.1007/s10439-012-0666-5
   Zhang L, 2013, SOFT MATTER, V9, P6398, DOI 10.1039/c3sm50838b
   Zhang L, 2013, J BIOMECH ENG, V135
NR 45
TC 5
Z9 5
U1 0
U2 14
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1617-7959
EI 1617-7940
J9 BIOMECH MODEL MECHAN
JI Biomech. Model. Mechanobiol.
PD AUG
PY 2016
VL 15
IS 4
BP 817
EP 830
DI 10.1007/s10237-015-0725-6
PG 14
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA DR7ZJ
UT WOS:000380117900005
PM 26342926
DA 2018-10-20
ER

PT J
AU Silveira, RK
   Coelho, ARB
   Pinto, FCM
   de Albuquerque, AV
   de Melo, DA
   Aguiar, JLD
AF Silveira, Raquel Kelner
   Barros Coelho, Antonio Roberto
   Morone Pinto, Flavia Cristina
   de Albuquerque, Amanda Vasconcelos
   de Melo Filho, Djalma Agripino
   de Andrade Aguiar, Jose Lamartine
TI Bioprosthetic mesh of bacterial cellulose for treatment of abdominal
   muscle aponeurotic defect in rat model
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID HERNIA REPAIR; WALL DEFECTS; SUGARCANE BIOPOLYMER; INCISIONAL HERNIA;
   ADHESION; MOLASSES; HYDROGEL; FIBROSIS
AB The use of meshes for treatment of hernias continues to draw attention of surgeons and the industry in the search of an ideal prosthesis. The purpose of this work is to use meshes manufactured from bacterial cellulose, evaluate their organic tissue interaction and compare with an expanded polytetrafluorethylene (ePTFE's) prosthesis used to repair acute defect of muscle aponeurotic induced in rats. Forty-five male Wistar rats were classified using the following criteria: (1) surgical repair of acute muscle aponeurotic defect with perforated bacterial cellulose film (PBC; n = 18); (2) compact bacterial cellulose film (CBC; n = 12) and (3) ePTFE; (n = 15). After postoperative period, rectangles (2 x 3 cm) including prosthesis, muscles and peritoneum were collected for biomechanical, histological and stereological analysis. In all cases, the maximum acceptable error probability for rejecting the null hypothesis was 5 %. Between PBC and CBC samples, the variables of strain (P = 0.011) and elasticity (P = 0.035) were statistically different. The same was found between CBC and ePTFE (elasticity, P = 0.000; strain, P = 0.009). PBC differed from CBC for giant cells (P = 0.001) and new blood vessels (P = 0.000). In conclusion, there was biological integration and biomechanical elasticity of PBC; therefore, we think this option should be considered as a new alternative biomaterial for use as a bio prosthesis.
C1 [Silveira, Raquel Kelner; Barros Coelho, Antonio Roberto; de Melo Filho, Djalma Agripino; de Andrade Aguiar, Jose Lamartine] Univ Fed Pernambuco, Ctr Hlth Sci, Dept Surg, UFPE, R Major Joao Ribeiro Pinheiro 245,Apt 310, BR-50740170 Recife, PE, Brazil.
   [Morone Pinto, Flavia Cristina; de Albuquerque, Amanda Vasconcelos] Univ Fed Pernambuco, UFPE, Ctr Hlth Sci, Ctr Expt Surg,Dept Surg, Recife, PE, Brazil.
RP de Albuquerque, AV (reprint author), Univ Fed Pernambuco, UFPE, Ctr Hlth Sci, Ctr Expt Surg,Dept Surg, Recife, PE, Brazil.
EM amandabiocel@gmail.com
FU National Council for Scientific and Technological Development - CNPq
FX National Council for Scientific and Technological Development - CNPq.
CR Aguiar José Lamartine de Andrade, 2007, Acta Cir. Bras., V22, P77, DOI 10.1590/S0102-86502007000700015
   Bachman S, 2008, SURG CLIN N AM, V88, P101, DOI 10.1016/j.suc.2007.11.001
   Bellon JM, 1996, BIOMATERIALS, V17, P2367, DOI 10.1016/S0142-9612(96)00080-4
   BELLON JM, 1995, BIOMATERIALS, V16, P381, DOI 10.1016/0142-9612(95)98855-8
   Bellon JM, 2009, CIR ESPAN, V85, P268, DOI 10.1016/j.ciresp.2009.01.012
   Bilsel Y, 2012, INT J SURG, V10, P317, DOI 10.1016/j.ijsu.2012.05.002
   Binnebosel M, 2011, SEMIN IMMUNOPATHOL, V33, P235, DOI 10.1007/s00281-010-0237-5
   Blatnik J, 2008, AM J SURG, V196, P47, DOI 10.1016/j.amjsurg.2007.06.035
   Cobb WS, 2005, J SURG RES, V129, P231, DOI 10.1016/j.jss.2005.06.015
   Coda A, 2003, Hernia, V7, P29
   Coelho E, 2015, ACTA CIR BRAS, V30, P194, DOI 10.1590/S0102-865020150030000005
   Lima SVC, 2015, UROLOGY, V85, DOI 10.1016/j.urology.2015.02.028
   de Barros-Marques SR, 2012, J VASC SURG, V55, P517, DOI 10.1016/j.jvs.2011.05.047
   de Carvalho AM, 2012, INT BRAZ J UROL, V38, P544, DOI 10.1590/S1677-55382012000400015
   Pita PCD, 2015, ACTA CIR BRAS, V30, P296, DOI 10.1590/S0102-865020150040000009
   de Lucena MT, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5410-x
   Souza ZA, 2007, ACTA CIR BRAS, V22, P147, DOI 10.1590/S0102-86502007000200013
   Falcao SC, 2008, ACTA CIR BRAS, V23, P184, DOI 10.1590/S0102-86502008000200012
   Fragoso AS, 2014, J MATER SCI-MATER M, V25, P229, DOI 10.1007/s10856-013-5056-5
   Germani G, 2011, SEMIN LIVER DIS, V31, P82, DOI 10.1055/s-0031-1272836
   Grevious MA, 2006, CLIN PLAST SURG, V33, P169, DOI 10.1016/j.cps.2005.12.005
   Huang Y, 2013, LIVER INT, V33, P1249, DOI 10.1111/liv.12184
   JENKINS SD, 1983, SURGERY, V94, P392
   Klinge U, 2000, EUR SURG RES, V32, P43, DOI 10.1159/000008740
   Leblebici IM, 2014, BIOMED RES-INDIA, V25, P414
   Pinto FCM, 2016, CARBOHYD POLYM, V137, P556, DOI 10.1016/j.carbpol.2015.10.071
   Paterson-Beedle M, 2000, CARBOHYD POLYM, V42, P375, DOI 10.1016/S0144-8617(99)00179-4
   Putra A, 2008, POLYMER, V49, P1885, DOI 10.1016/j.polymer.2008.02.022
   Rambo CR, 2008, MAT SCI ENG C-BIO S, V28, P549, DOI 10.1016/j.msec.2007.11.011
   Martins AGS, 2013, INT BRAZ J UROL, V39, P408, DOI 10.1590/S1677-5538.IBJU.2013.03.15
   Trabuco EC, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.08.049
   USHER F C, 1958, Am Surg, V24, P969
   Welty G, 2001, Hernia, V5, P142
   Yuki I, 2010, NEURORADIOLOGY, V52, P1017, DOI 10.1007/s00234-010-0657-x
NR 34
TC 3
Z9 3
U1 0
U2 4
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD AUG
PY 2016
VL 27
IS 8
AR 129
DI 10.1007/s10856-016-5744-z
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DR8EJ
UT WOS:000380130900006
PM 27379627
DA 2018-10-20
ER

PT J
AU Sunarso
   Toita, R
   Tsuru, K
   Ishikawa, K
AF Sunarso
   Toita, Riki
   Tsuru, Kanji
   Ishikawa, Kunio
TI A superhydrophilic titanium implant functionalized by ozone gas
   modulates bone marrow cell and macrophage responses
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID BIOACTIVE TITANIUM; PROTEIN ADSORPTION; UV-PHOTOFUNCTIONALIZATION;
   SURFACE-ENERGY; STEM-CELLS; DIFFERENTIATION; ADHESION; IMMUNE;
   BIOMATERIALS; OSTEOBLASTS
AB Bone-forming cells and M phi play key roles in bone tissue repair. In this study, we prepared a superhydrophilic titanium implant functionalized by ozone gas to modulate osteoconductivity and inhibit inflammatory response towards titanium implants. After 24 h of ozone gas treatment, the water contact angle of the titanium surface became zero. XPS analysis revealed that hydroxyl groups were greatly increased, but carbon contaminants were largely decreased 24 h after ozone gas functionalization. Also, ozone gas functionalization did not alter titanium surface topography. Superhydrophilic titanium (O-3-Ti) largely increased the aspect ratio, size and perimeter of cells when compared with untreated titanium (unTi). In addition, O-3-Ti facilitated rat bone marrow derived MSCs differentiation and mineralization evidenced by greater ALP activity and bone-like nodule formation. Interestingly, O-3-Ti did not affect RAW264.7 M phi proliferation. However, naive RAW264.7 M phi cultured on unTi produced a two-fold larger amount of TNF alpha than that on O-3-Ti. Furthermore, O-3-Ti greatly mitigated proinflammatory cytokine production, including TNF alpha and IL-6 from LSP-stimulated RAW264.7 M phi. These results demonstrated that a superhydrophilic titanium prepared by simple ozone gas functionalization successfully increased MSCs proliferation and differentiation, and mitigated proinflammatory cytokine production from both naive and LPS-stimulated M phi. This superhydrophilic surface would be useful as an endosseous implantable biomaterials and as a biomaterial for implantation into other tissues.
C1 [Sunarso; Toita, Riki; Tsuru, Kanji; Ishikawa, Kunio] Kyushu Univ, Fac Dent Sci, Dept Biomat, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.
   [Toita, Riki] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, 1-8-31 Midorigaoka, Ikeda, Osaka 5638577, Japan.
RP Toita, R (reprint author), Kyushu Univ, Fac Dent Sci, Dept Biomat, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.; Toita, R (reprint author), Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, 1-8-31 Midorigaoka, Ikeda, Osaka 5638577, Japan.
EM toita-r@aist.go.jp
RI Toita, Riki/C-5710-2014
OI Toita, Riki/0000-0001-9700-4531; , Sunarso/0000-0003-0035-4821
FU Strategic Promotion of Innovative Research and Development Program
   (S-innovation) from the Japan Agency for Medical Research and
   Development (AMED) [AJ120495]; Ministry of Education, Culture, Sports,
   Science and Technology [15K12531]
FX This work was supported by a the Strategic Promotion of Innovative
   Research and Development Program (S-innovation; No. AJ120495) from the
   Japan Agency for Medical Research and Development (AMED), and
   Grant-in-Aid for Challenging Exploratory Research (No. 15K12531) from
   the Ministry of Education, Culture, Sports, Science and Technology.
CR Aita H, 2009, BIOMATERIALS, V30, P1015, DOI 10.1016/j.biomaterials.2008.11.004
   Batakliev Todor, 2014, Interdiscip Toxicol, V7, P47, DOI 10.2478/intox-2014-0008
   BULANIN KM, 1995, J PHYS CHEM-US, V99, P10294, DOI 10.1021/j100025a034
   Cho SW, 2014, P NATL ACAD SCI USA, V111, P1545, DOI 10.1073/pnas.1315153111
   DAVIS GE, 1992, EXP CELL RES, V200, P242, DOI 10.1016/0014-4827(92)90170-D
   Deng ZJ, 2011, NAT NANOTECHNOL, V6, P39, DOI [10.1038/nnano.2010.250, 10.1038/NNANO.2010.250]
   Elvis A M, 2011, J Nat Sci Biol Med, V2, P66, DOI 10.4103/0976-9668.82319
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978
   Jozefowski S, 2010, INFLAMM RES, V59, P277, DOI 10.1007/s00011-009-0096-5
   Karlsson M, 2005, J BIOL CHEM, V280, P25558, DOI 10.1074/jbc.M503665200
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   LEVENTHAL GS, 1951, J BONE JOINT SURG AM, V33-A, P473, DOI 10.2106/00004623-195133020-00021
   Lumetti S, 2016, J MATER SCI-MATER M, V27, DOI 10.1007/s10856-016-5678-5
   Nasuhoglu D, 2011, J HAZARD MATER, V186, P67, DOI 10.1016/j.jhazmat.2010.10.080
   Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151
   Nishiguchi S, 2001, J BIOMED MATER RES, V54, P198, DOI 10.1002/1097-4636(200102)54:2<198::AID-JBM6>3.0.CO;2-7
   Novak ML, 2013, AM J PATHOL, V183, P1352, DOI 10.1016/j.ajpath.2013.06.034
   Ostberg AK, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5486-3
   Peng R, 2011, BIOMATERIALS, V32, P8048, DOI 10.1016/j.biomaterials.2011.07.035
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Raghavendra S, 2005, INT J ORAL MAX IMPL, V20, P425
   Richter AG, 2013, LANGMUIR, V29, P5167, DOI 10.1021/la3049532
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Schwartz Z, 1997, J PERIODONTAL RES, V32, P166, DOI 10.1111/j.1600-0765.1997.tb01399.x
   Sun LM, 2001, J BIOMED MATER RES, V58, P570, DOI 10.1002/jbm.1056.abs
   Takadama H, 2001, J BIOMED MATER RES, V55, P185, DOI 10.1002/1097-4636(200105)55:2<185::AID-JBM1005>3.3.CO;2-G
   Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062
   Takemoto M, 2005, BIOMATERIALS, V26, P6014, DOI 10.1016/j.biomaterials.2005.03.019
   Tang J, 2010, BIOMATERIALS, V31, P2470, DOI 10.1016/j.biomaterials.2009.12.006
   Tian Y, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5612-2
   Toita R, 2015, J MATER CHEM B, V3, P8738, DOI 10.1039/c5tb01679g
   Tsukimura N, 2011, BIOMATERIALS, V32, P4358, DOI 10.1016/j.biomaterials.2011.03.001
   Tu MG, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5607-z
   Unosson E, 2013, APPL SURF SCI, V285, P317, DOI 10.1016/j.apsusc.2013.08.057
   Valanezhad A, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5548-6
   Yamada M, 2010, ACTA BIOMATER, V6, P4578, DOI 10.1016/j.actbio.2010.07.010
   Yao X, 2013, ADV MATER, V25, P5257, DOI 10.1002/adma.201301762
   Zhao G, 2007, BIOMATERIALS, V28, P2821, DOI 10.1016/j.biomaterials.2007.02.024
   Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320
NR 40
TC 3
Z9 3
U1 1
U2 12
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD AUG
PY 2016
VL 27
IS 8
AR 127
DI 10.1007/s10856-016-5741-2
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DR8EJ
UT WOS:000380130900004
PM 27344451
DA 2018-10-20
ER

PT J
AU Malcolm, RK
   Boyd, PJ
   McCoy, CF
   Murphy, DJ
AF Malcolm, R. Karl
   Boyd, Peter J.
   McCoy, Clare F.
   Murphy, Diarmaid J.
TI Microbicide vaginal rings: Technological challenges and clinical
   development
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE Vaginal rings; HIV microbicides; Antiretrovirals; HIV prevention;
   Controlled release; Adherence; Vaginal drug delivery
ID TENOFOVIR DISOPROXIL FUMARATE; HUMAN-IMMUNODEFICIENCY-VIRUS; IN-VITRO
   RELEASE; REVERSE-TRANSCRIPTASE INHIBITOR; LUBRICATING SILICONE
   BIOMATERIAL; POLYURETHANE INTRAVAGINAL RINGS; HIV PREVENTION TRIALS;
   CAPRISA 004 TRIAL; PREEXPOSURE PROPHYLAXIS; SUSTAINED-RELEASE
AB Vaginal rings (VRs) are flexible, torus-shaped, polymeric devices designed to sustain delivery of pharmaceutical drugs to the vagina for clinical benefit. Following first report in a 1970 patent application, several steroid releasing VR products have since been marketed for use in hormone replacement therapy and contraception. Since 2002, there has been growing interest in the use of VR technology for delivery of drugs that can reduce the risk of sexual acquisition of human immunodeficiency virus type 1 (HIV-1), the causative agent of acquired immunodeficiency syndrome (AIDS). Although no vaginally-administered product has yet been approved for HIV reduction/prevention, extensive research efforts are continuing and a number of VR devices offering sustained release of so-called 'HIV microbicide' compounds are currently being evaluated in late-stage clinical studies. This review article provides an overview of the published scientific literature within this important field of research, focusing primarily on articles published within peer-reviewed journal publications. Many important aspects of microbicide-releasing VR technology are discussed, with a particular emphasis on the technological, manufacturing and clinical challenges that have emerged in recent years. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Malcolm, R. Karl; Boyd, Peter J.; McCoy, Clare F.; Murphy, Diarmaid J.] Queens Univ Belfast, Sch Pharm, Belfast BT9 7BL, Antrim, North Ireland.
RP Malcolm, RK (reprint author), Queens Univ Belfast, Sch Pharm, Belfast BT9 7BL, Antrim, North Ireland.
EM k.malcolm@qub.ac.uk
CR Amico KR, 2013, AIDS BEHAV, V17, P2143, DOI 10.1007/s10461-013-0429-9
   Andrei G, 2011, CELL HOST MICROBE, V10, P379, DOI 10.1016/j.chom.2011.08.015
   [Anonymous], 2009, COMBINATION PRODUCTS
   [Anonymous], 2003, 1099312003 ISO
   Anton PA, 2012, AIDS RES HUM RETROV, V28, P1412, DOI [10.1089/aid.2012.0262, 10.1089/AID.2012.0262]
   Aravantinou M, 2012, AIDS RES HUM RETROV, V28, P1467, DOI [10.1089/AID.2012.0080, 10.1089/aid.2012.0080]
   Arens M, 2000, J CLIN MICROBIOL, V38, P1758
   Ayton RA, 1996, BRIT J OBSTET GYNAEC, V103, P351, DOI 10.1111/j.1471-0528.1996.tb09741.x
   Balzarini J, 2007, LANCET, V369, P787, DOI 10.1016/S0140-6736(07)60202-5
   Balzarini J, 2012, CURR HIV RES, V10, P53, DOI 10.2174/157016212799304652
   Barditch-Crovo P, 2001, ANTIMICROB AGENTS CH, V45, P2733, DOI 10.1128/AAC.45.10.2733-2739.2001
   Barentsen R, 1997, EUR J OBSTET GYN R B, V71, P73, DOI 10.1016/S0301-2115(96)02612-7
   Baum MM, 2015, INT J PHARMACEUT, V495, P579, DOI 10.1016/j.ijpharm.2015.09.028
   Baum MM, 2012, J PHARM SCI-US, V101, P2833, DOI 10.1002/jps.23208
   Beksinska M, 2012, REPROD HEALTH MATTER, V20, P188, DOI 10.1016/S0968-8080(12)40659-0
   Bell SEJ, 2007, J PHARM PHARMACOL, V59, P203, DOI 10.1211/jpp.59.2.0007
   Belletti D, 2012, INT J PHARMACEUT, V436, P753, DOI 10.1016/j.ijpharm.2012.07.070
   BOUNDS W, 1993, EUR J OBSTET GYN R B, V48, P123, DOI 10.1016/0028-2243(93)90252-8
   Boyd P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125682
   Brache V, 2000, STEROIDS, V65, P687, DOI 10.1016/S0039-128X(00)00175-6
   BURTON FG, 1978, CONTRACEPTION, V17, P221, DOI 10.1016/0010-7824(78)90013-6
   Casper F, 1999, Int Urogynecol J Pelvic Floor Dysfunct, V10, P171, DOI 10.1007/s001920050040
   Celum C, 2012, CURR OPIN INFECT DIS, V25, P51, DOI 10.1097/QCO.0b013e32834ef5ef
   Chaowanachan T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061416
   Chen BA, 2015, JAIDS-J ACQ IMM DEF, V70, P242, DOI 10.1097/QAI.0000000000000702
   Chesney MA, 2000, CLIN INFECT DIS, V30, pS171, DOI 10.1086/313849
   Chien Y.W., 1992, NOVEL DRUG DELIVERY
   CHIEN YW, 1974, J PHARM SCI, V63, P365, DOI 10.1002/jps.2600630311
   CHIEN YW, 1975, J PHARM SCI, V64, P1643, DOI 10.1002/jps.2600641011
   Chuchuen O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085124
   Clark JT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088509
   Clark JT, 2012, J CONTROL RELEASE, V163, P240, DOI 10.1016/j.jconrel.2012.08.033
   Clark M.R., 2012, PHARMACOKINETICS TOP, V28
   Clark MR, 2011, DRUG DELIV TRANSL RE, V1, P238, DOI 10.1007/s13346-011-0032-4
   Clark MR, 2012, J PHARM SCI-US, V101, P576, DOI 10.1002/jps.22781
   Clark MR, 2014, PHARMACEUTICS, V6, P616, DOI DOI 10.3390/PHARMACEUTICS6040616
   Crosby RA, 2013, CURR HIV-AIDS REP, V10, P59, DOI 10.1007/s11904-012-0143-7
   Dang NTT, 2013, J PHARM SCI-US, V102, P3725, DOI 10.1002/jps.23684
   Devlin B., 2013, ANTIVIR RES
   Di Fabio S, 2003, AIDS, V17, P1597, DOI 10.1097/01.aids.0000072663.21517.63
   Dieben TOM, 2002, OBSTET GYNECOL, V100, P585, DOI 10.1016/S0029-7844(02)02124-5
   DiMatteo MR, 2004, MED CARE, V42, P200, DOI 10.1097/01.mlr.0000114908.90348.f9
   Dobard C, 2012, J VIROL, V86, P718, DOI 10.1128/JVI.05842-11
   Duncan G.W., 1970, Patent No. [US3545439 A, 3545439]
   FAUNDES A, 1981, CONTRACEPTION, V24, P393, DOI 10.1016/0010-7824(81)90006-8
   Ferguson LM, 2011, THER DELIV, V2, P1535, DOI [10.4155/TDE.11.126, 10.4155/tde.11.126]
   Fernandez-Romero J.A., 2015, TRENDS MICROBIOL, P1
   Fernandez-Romero JA, 2015, ADV DRUG DELIVER REV, V92, P27, DOI 10.1016/j.addr.2014.12.005
   Ferrer RA, 2010, AIDS CARE, V22, P997, DOI 10.1080/09540121003623719
   Fetherston SM, 2013, EUR J PHARM SCI, V48, P406, DOI 10.1016/j.ejps.2012.12.002
   Fetherston SM, 2013, J ANTIMICROB CHEMOTH, V68, P394, DOI 10.1093/jac/dks415
   Fletcher PS, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-46
   Garg Anita B, 2009, Antivir Chem Chemother, V19, P143
   Giannou F.K., 2015, EXPERT REV PHARM OUT, V7167, P1
   Gilliam ML, 2010, OBSTET GYNECOL, V115, P503, DOI 10.1097/AOG.0b013e3181cf45dc
   Giritch A, 2006, P NATL ACAD SCI USA, V103, P14701, DOI 10.1073/pnas.0606631103
   Gorlani A, 2012, AIDS RES HUM RETROV, V28, P198, DOI 10.1089/aid.2011.0133
   Gouws E., 2011, SACEMA Q
   Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205
   Graziottin Alessandra, 2008, Patient Prefer Adherence, V2, P357
   Groenewegen R.J.J., 1999, Patent No. [US 5989581 A, 5989581]
   Gunawardana M., 2014, J PHARM SCI, P1
   Gupta KM, 2008, J PHARM SCI-US, V97, P4228, DOI 10.1002/jps.21331
   Haignere CS, 2000, J ADOLESCENT HEALTH, V26, P392, DOI 10.1016/S1054-139X(99)00090-7
   Han YA, 2007, CONTRACEPTION, V76, P132, DOI 10.1016/j.contraception.2007.04.006
   Haraguchi Y, 1999, ANTIVIR RES, V43, P123, DOI 10.1016/S0166-3542(99)00040-6
   Hardy E, 2007, CONTRACEPTION, V76, P126, DOI 10.1016/j.contraception.2007.04.013
   Harwood B, 2001, SEMIN REPROD MED, V19, P381, DOI 10.1055/s-2001-18646
   Helbling IM, 2011, J CONTROL RELEASE, V149, P258, DOI 10.1016/j.jconrel.2010.10.018
   Hendrix CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055013
   Herrera C, 2012, CURR HIV RES, V10, P42, DOI 10.2174/157016212799304607
   Herrera C, 2009, ANTIMICROB AGENTS CH, V53, P1797, DOI 10.1128/AAC.01096-08
   Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09
   HICKS DR, 1985, LANCET, V2, P1422
   HIGUCHI T, 1963, J PHARM SCI, V52, P1145, DOI 10.1002/jps.2600521210
   Hillier SL, 2005, JAIDS-J ACQ IMM DEF, V39, P1, DOI 10.1097/01.qai.0000159671.25950.74
   Hladik F, 2015, ELIFE, V4, DOI 10.7554/eLife.04525
   Ho PM, 2009, CIRCULATION, V119, P3028, DOI 10.1161/CIRCULATIONAHA.108.768986
   Holt J.D.S., 2015, ANTIMICROB AGENTS CH
   Hsu M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089300
   Huskens D, 2012, MAR DRUGS, V10, P1476, DOI 10.3390/md10071476
   Ingersoll KS, 2008, J BEHAV MED, V31, P213, DOI 10.1007/s10865-007-9147-y
   JENNINGS R, 1993, J ANTIMICROB CHEMOTH, V32, P71, DOI 10.1093/jac/32.1.71
   Joanis C, 2011, CONTRACEPTION, V83, P248, DOI 10.1016/j.contraception.2010.08.002
   Johnson TJ, 2012, ANTIMICROB AGENTS CH, V56, P6272, DOI 10.1128/AAC.01431-12
   Johnson TJ, 2012, ANTIMICROB AGENTS CH, V56, P1291, DOI 10.1128/AAC.05721-11
   Johnson TJ, 2010, EUR J PHARM SCI, V39, P203, DOI 10.1016/j.ejps.2009.11.007
   Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748
   Karim SSA, 2015, NEW ENGL J MED, V373, P530, DOI 10.1056/NEJMoa1410649
   Karim SSA, 2011, LANCET, V378, pE23, DOI 10.1016/S0140-6736(11)61136-7
   Karim SSA, 2011, LANCET, V378, P279, DOI 10.1016/S0140-6736(11)60878-7
   Kashuba ADM, 2015, JAIDS-J ACQ IMM DEF, V69, P264, DOI 10.1097/QAI.0000000000000607
   Katz DF, 2015, ADV DRUG DELIVER REV, V92, P2, DOI 10.1016/j.addr.2015.04.017
   Kearney BP, 2004, CLIN PHARMACOKINET, V43, P595, DOI 10.2165/00003088-200443090-00003
   Keller MJ, 2012, J ANTIMICROB CHEMOTH, V67, P2005, DOI 10.1093/jac/dks151
   Kenney J, 2013, ANTIMICROB AGENTS CH, V57, P4001, DOI 10.1128/AAC.00796-13
   Ketas TJ, 2007, VIROLOGY, V364, P431, DOI 10.1016/j.virol.2007.03.001
   Kiser PF, 2012, J PHARM SCI-US, V101, P1852, DOI 10.1002/jps.23089
   Kiser PF, 2012, AIDS REV, V14, P62
   Kruk ME, 2006, CLIN THER, V28, P1989, DOI 10.1016/j.clinthera.2006.12.011
   Lai JH, 1999, DENT MATER, V15, P450, DOI 10.1016/S0109-5641(99)00074-3
   Langen Tabitha T, 2005, Afr Health Sci, V5, P188
   Lema D, 2014, SCAND J IMMUNOL, V80, P1, DOI 10.1111/sji.12184
   Levendosky K, 2015, ANTIMICROB AGENTS CH, V59, P7290, DOI 10.1128/AAC.01816-15
   Loxley A, 2011, DRUG DELIV TRANSL RE, V1, P247, DOI 10.1007/s13346-011-0031-5
   Lu CT, 2012, CLIN DRUG INVEST, V32, P333, DOI 10.2165/11599910-000000000-00000
   Lyndgaard LB., 2014, J RAMAN SPECTROSC
   MacArthur RD, 2008, CLIN INFECT DIS, V47, P236, DOI 10.1086/589289
   Machado RM, 2015, ADV DRUG DELIVER REV, V92, P14, DOI 10.1016/j.addr.2015.02.003
   Macqueen K.M., 2014, DEBATE ARTICLE INTER, V17, P1
   MacQueen KM, 2014, AIDS BEHAV, V18, P826, DOI 10.1007/s10461-014-0753-8
   Malcolm K, 2003, J CONTROL RELEASE, V91, P355, DOI 10.1016/S0168-3659(03)00260-8
   Malcolm K, 2003, J CONTROL RELEASE, V90, P217, DOI 10.1016/S0168-3659(03)00178-0
   Malcolm RK, 2014, BJOG-INT J OBSTET GY, V121, P62, DOI 10.1111/1471-0528.12852
   Malcolm R.K., 2013, J ANTIMICROB CHEMOTH, P1
   Malcolm R.K., 2002, MICROBICIDES 2002, P115
   Malcolm RK, 2013, CONTRACEPTION, V88, P321, DOI 10.1016/j.contraception.2013.06.009
   Malcolm RK, 2013, J ANTIMICROB CHEMOTH, V68, P678, DOI 10.1093/jac/dks422
   Malcolm RK, 2012, IN J WOMENS HEALTH, V4, P595, DOI 10.2147/IJWH.S36282
   Malcolm RK, 2012, ANTIMICROB AGENTS CH, V56, P2251, DOI 10.1128/AAC.05810-11
   Malcolm RK, 2010, ANTIVIR RES, V88, pS30, DOI 10.1016/j.antiviral.2010.09.003
   Malcolm RK, 2004, J CONTROL RELEASE, V97, P313, DOI 10.1016/j.jconrel.2004.03.029
   Malcolm RK, 2005, J ANTIMICROB CHEMOTH, V56, P954, DOI 10.1093/jac/dki326
   MALKOVSKY M, 1988, LANCET, V1, P645
   Mansoor LE, 2014, AIDS BEHAV, V18, P811, DOI 10.1007/s10461-014-0751-x
   Mansour D, 2012, CONTRACEPTION, V85, P224, DOI 10.1016/j.contraception.2011.08.003
   Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269
   Martinez J, 2006, ANTIVIR RES, V71, P343, DOI 10.1016/j.antiviral.2006.05.013
   Mauck CK, 2008, JAIDS-J ACQ IMM DEF, V49, P64, DOI 10.1097/QAI.0b013e318183a917
   Mc Conville C, 2012, J BIOMED MATER RES B, V100B, P891, DOI 10.1002/jbm.b.31919
   Mc Cullagh SD, 2004, J MATER CHEM, V14, P1093, DOI 10.1039/b313483k
   McConville C, 2015, DRUG DELIV TRANSL RE, V5, P27, DOI 10.1007/s13346-015-0216-4
   McConville C, 2012, DRUG DELIV TRANSL RE, V2, P489, DOI 10.1007/s13346-012-0101-3
   Mcconville C, 2013, J PHARM SCI-US, V102, P1859, DOI 10.1002/jps.23528
   McCormack SM, 2014, CLIN INFECT DIS, V59, pS41, DOI 10.1093/cid/ciu297
   Mesquita PMM, 2012, J ANTIMICROB CHEMOTH, V67, P1730, DOI 10.1093/jac/dks097
   Minnis A.M., 2015, AIDS BEHAV
   MISHELL DR, 1970, AM J OBSTET GYNECOL, V107, P100
   MISHELL DR, 1970, FERTIL STERIL, V21, P99
   Mngadi KT, 2014, AIDS BEHAV, V18, P849, DOI 10.1007/s10461-014-0696-0
   Montgomery ET, 2012, AIDS BEHAV, V16, P1787, DOI 10.1007/s10461-012-0248-4
   Moore JP, 2009, CURR OPIN HIV AIDS, V4, P118, DOI 10.1097/COH.0b013e3283223d46
   Morris GC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116153
   Morrow RJ, 2011, EUR J PHARM BIOPHARM, V77, P3, DOI 10.1016/j.ejpb.2010.10.010
   Moss JA, 2014, ANTIMICROB AGENTS CH, V58, P5125, DOI 10.1128/AAC.02871-14
   Moss JA, 2013, ANTIMICROB AGENTS CH, V57, P3994, DOI 10.1128/AAC.00547-13
   Moss JA, 2012, ANTIMICROB AGENTS CH, V56, P5952, DOI 10.1128/AAC.01198-12
   Moss JA, 2012, AIDS, V26, P707, DOI 10.1097/QAD.0b013e3283509abb
   Moss JA, 2012, ANTIMICROB AGENTS CH, V56, P875, DOI 10.1128/AAC.05662-11
   Moulaei T, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-014-0127-3
   Murphy D.J., 2014, J ANTIMICROB CHEMOTH, P1
   Nachtigall LE, 1995, MATURITAS, V22, pS43, DOI 10.1016/0378-5122(95)00963-9
   Naranbhai V, 2012, J INFECT DIS, V206, P993, DOI 10.1093/infdis/jis465
   Nel A., 2014, AIDS, V1
   Nel A.M., 2014, J AIDS CLIN RES, V05
   Nel A, 2009, JAIDS-J ACQ IMM DEF, V51, P416, DOI 10.1097/QAI.0b013e3181acb536
   Novak A, 2003, CONTRACEPTION, V67, P187, DOI 10.1016/S0010-7824(02)00514-0
   Nuttall J, 2012, ANTIMICROB AGENTS CH, V56, P103, DOI 10.1128/AAC.00597-11
   Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100
   Ouattara LA, 2014, ANTIMICROB AGENTS CH, V58, P2841, DOI 10.1128/AAC.01529-13
   Parikh UM, 2009, J VIROL, V83, P10358, DOI 10.1128/JVI.01073-09
   Pirrone V, 2011, ANTIMICROB AGENTS CH, V55, P1831, DOI 10.1128/AAC.00976-10
   Promadej-Lanier N, 2009, J MED PRIMATOL, V38, P263, DOI 10.1111/j.1600-0684.2009.00354.x
   RADOMSKY ML, 1992, BIOL REPROD, V47, P133, DOI 10.1095/biolreprod47.1.133
   Ramjee G, 2011, FUTURE VIROL, V6, P997, DOI 10.2217/FVL.11.64
   Rastogi R., 2013, ANTIVIR RES, P8
   Ray S, 2001, J URBAN HEALTH, V78, P581, DOI 10.1093/jurban/78.4.581
   Roddy RE, 1998, NEW ENGL J MED, V339, P504, DOI 10.1056/NEJM199808203390803
   Rohan LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009310
   Romano B.J., NONCLINICAL DEV NEED
   Romano J, 2009, AIDS RES HUM RETROV, V25, P483, DOI 10.1089/aid.2008.0184
   Romano J., 2013, ANTIVIR RES, P1
   Romano J, 2008, CURR OPIN HIV AIDS, V3, P558, DOI 10.1097/COH.0b013e328305b96e
   Romano JW, 2012, CURR HIV RES, V10, P9, DOI 10.2174/157016212799304625
   Roseman T J, 1970, J Pharm Sci, V59, P353, DOI 10.1002/jps.2600590317
   Roumen FJME, 2001, HUM REPROD, V16, P469, DOI 10.1093/humrep/16.3.469
   Roumen FJME, 1999, CONTRACEPTION, V59, P59, DOI 10.1016/S0010-7824(98)00145-0
   Saxena B.B., 2012, J PHARM DRUG DELIV R, V01
   Saxena BB, 2009, AIDS, V23, P917, DOI 10.1097/QAD.0b013e32832af57c
   Schader SM, 2011, AIDS, V25, P1585, DOI 10.1097/QAD.0b013e3283491f89
   Schwartz JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025974
   Seibert C, 2004, CURR PHARM DESIGN, V10, P2041, DOI 10.2174/1381612043384312
   Sexton A, 2009, FASEB J, V23, P3590, DOI 10.1096/fj.09-131995
   Shen J, 2012, J PHARM PHARMACOL, V64, P986, DOI 10.1111/j.2042-7158.2012.01482.x
   Sherwood JK, 1996, NAT BIOTECHNOL, V14, P468, DOI 10.1038/nbt0496-468
   Singer R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003936
   Sivin I, 2005, CONTRACEPTION, V71, P122, DOI 10.1016/j.contraception.2004.08.010
   Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5
   Smith JM, 2015, JAIDS-J ACQ IMM DEF, V68, P1, DOI 10.1097/QAI.0000000000000402
   Smith JM, 2013, P NATL ACAD SCI USA, V110, P16145, DOI 10.1073/pnas.1311355110
   Srinivasan P, 2014, J MED PRIMATOL, V43, P364, DOI 10.1111/jmp.12119
   Stafford MK, 1998, J ACQ IMMUN DEF SYND, V17, P327, DOI 10.1097/00042560-199804010-00006
   STEIN ZA, 1990, AM J PUBLIC HEALTH, V80, P460, DOI 10.2105/AJPH.80.4.460
   Steinbach JM, 2015, CELL MOL LIFE SCI, V72, P469, DOI 10.1007/s00018-014-1756-3
   Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450
   Stirratt MJ, 2015, TRANSL BEHAV MED, V5, P470, DOI 10.1007/s13142-015-0315-2
   Teller RS, 2014, PHARM RES-DORDR, V31, P2344, DOI 10.1007/s11095-014-1331-5
   Thurman AR, 2013, IN J WOMENS HEALTH, V5, P695, DOI 10.2147/IJWH.S34030
   Tolley EE, 2010, AIDS BEHAV, V14, P1124, DOI 10.1007/s10461-009-9635-x
   Trussell J, 2011, CONTRACEPTION, V83, P397, DOI 10.1016/j.contraception.2011.01.021
   Tseng A., 2014, BR J CLIN PHARM
   Ugaonkar S. R., 2015, J PHARM SCI
   Ugaonkar SR, 2015, J CONTROL RELEASE, V213, P57, DOI 10.1016/j.jconrel.2015.06.018
   Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8
   Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614
   van der Straten A, 2012, AIDS BEHAV, V16, P1775, DOI 10.1007/s10461-012-0215-0
   van Gelder J, 2002, DRUG METAB DISPOS, V30, P924, DOI 10.1124/dmd.30.8.924
   van Laarhoven JAH, 2002, INT J PHARM, V232, P163, DOI 10.1016/S0378-5173(01)00900-0
   van Laarhoven JAH, 2002, J CONTROL RELEASE, V82, P309, DOI 10.1016/S0168-3659(02)00139-6
   Van Y. Herrewege, SERIES DIARYLTRIAZIN, V482004, P3684
   VANDERWEIJ FW, 1980, MAKROMOL CHEM, V181, P2541
   VARTIAINEN J, 1993, MATURITAS, V17, P129, DOI 10.1016/0378-5122(93)90008-6
   Veazey RS, 2010, J INFECT DIS, V202, P739, DOI 10.1086/655661
   Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833
   Veazey RS, 2005, NATURE, V438, P99, DOI 10.1038/nature04055
   Villinger F., 2014, J AIDS CLIN RES, V5, P50
   WEISBERG E, 1995, CONTRACEPTION, V51, P39, DOI 10.1016/0010-7824(94)00005-H
   Weisberg E, 2000, CONTRACEPTION, V62, P83, DOI 10.1016/S0010-7824(00)00137-2
   Weller SC, 2002, COCHRANE DATABASE SY
   Wensing AMJ, 2010, ANTIVIR RES, V85, P59, DOI 10.1016/j.antiviral.2009.10.003
   Whaley K.J., 2012, CURR TOP MICROBIOL I, P107
   Whaley KJ, 2010, ANTIVIR RES, V88, pS55, DOI 10.1016/j.antiviral.2010.09.006
   Woodsong C, 2014, BJOG-INT J OBSTET GY, V121, P45, DOI 10.1111/1471-0528.12875
   Woodsong C, 2015, CURR OBSTET GYNECOL, V4, P43, DOI 10.1007/s13669-014-0107-6
   Woodsong C, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18505
   Woolfson A.D., 2008, Patent No. [WO/2009/003125, 2009003125]
   Woolfson AD, 2006, INT J PHARM, V325, P82, DOI 10.1016/j.ijpharm.2006.06.026
   Woolfson AD, 2003, J CONTROL RELEASE, V91, P465, DOI 10.1016/S0168-3659(03)00277-3
   Woolfson AD, 1999, J CONTROL RELEASE, V61, P319, DOI 10.1016/S0168-3659(99)00148-0
   Wyatt TL, 1998, J CONTROL RELEASE, V50, P93, DOI 10.1016/S0168-3659(97)00114-4
   Zeitlin L, 2009, P NATL ACAD SCI USA, V106, P6029, DOI 10.1073/pnas.0902239106
   Zhang T, 2011, EUR J PHARM BIOPHARM, V79, P526, DOI 10.1016/j.ejpb.2011.06.007
NR 232
TC 13
Z9 13
U1 3
U2 64
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
EI 1872-8294
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD AUG 1
PY 2016
VL 103
BP 33
EP 56
DI 10.1016/j.addr.2016.01.015
PG 24
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA DR7ML
UT WOS:000380083700004
PM 26829289
OA Green Published
DA 2018-10-20
ER

PT J
AU Chen, M
   Xu, L
   Zhou, Y
   Zhang, Y
   Lang, MD
   Ye, ZY
   Tan, WS
AF Chen, Min
   Xu, Lei
   Zhou, Yan
   Zhang, Yan
   Lang, Meidong
   Ye, Zhaoyang
   Tan, Wen-Song
TI Poly(epsilon-caprolactone)-based substrates bearing pendant small
   chemical groups as a platform for systemic investigation of
   chondrogenesis
SO CELL PROLIFERATION
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; HUMAN ARTICULAR CHONDROCYTES; IN-VITRO
   CHONDROGENESIS; SMALL FUNCTIONAL-GROUPS; CARTILAGE REGENERATION; SURFACE
   MODIFICATION; DIFFERENTIATION; REDIFFERENTIATION; PHENOTYPE; HYDROGELS
AB ObjectivesPhysiochemical properties of biomaterials play critical roles in dictating types of cell behaviour. In this study, a series of poly(epsilon-caprolactone) (PCL)-derived polymers bearing different small chemical groups was employed as a platform to evaluate chondrogenesis of different cell types.
   Materials and methodsThin films were prepared by spin-coating PCL derivatives. Rabbit articular chondrocytes (rACs) and rabbit bone marrow-derived mesenchymal stem cells (rMSCs) were seeded on to the films, and cell adhesion, proliferation, extracellular matrix production and gene expression were evaluated.
   ResultsThe presence of hydrophilic groups (-NH2, -COOH, -OH and -C=O) promoted adhesion and proliferation of primary rACs and rMSCs. On these polymeric films, chondrogenesis of primary rACs depended on culture time. For passaged cells, re-differentiation was induced on these films by chondrogenic induction, but less for cells of passage 5 compared to passage 3. While films with hydrophilic groups favoured chondrocytic gene expression of both types of passaged cells, production of glycosaminoglycans (GAG) was similar for those of passage 3 on all films, and PCL-CH3 film better supported GAG production for cells of passage 5. Under chondrogenic conditions, rMSCs were more efficient at GAG production on PCL and PCL-NH2 films.
   ConclusionsThis study demonstrates that different cells displayed distinct responses to substrate surface chemistry, implying that cell-biomaterial interactions can be developmental stage dependent. This provides a novel perspective for developing biomaterials for cartilage regeneration.
C1 [Chen, Min; Xu, Lei; Zhou, Yan; Ye, Zhaoyang; Tan, Wen-Song] East China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai, Peoples R China.
   [Zhang, Yan; Lang, Meidong] East China Univ Sci & Technol, Sch Mat Sci & Engn, Key Lab Ultrafine Mat, Minist Educ, Shanghai, Peoples R China.
RP Ye, ZY; Tan, WS (reprint author), East China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai, Peoples R China.
EM zhaoyangye@ecust.edu.cn; wstan@ecust.edu.cn
OI Lang, Meidong/0000-0003-2053-9284
FU National Natural Science Foundation of China [31000424, 31170951]; Basic
   Research Project of Shanghai Science and Technology Commission
   [12JC1403101, 15JC1401402]
FX This work was financially supported by the National Natural Science
   Foundation of China (31000424 and 31170951) and the Basic Research
   Project of Shanghai Science and Technology Commission (12JC1403101 and
   15JC1401402).
CR Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Bobick BE, 2009, BIRTH DEFECTS RES C, V87, P351, DOI 10.1002/bdrc.20167
   Bornes TD, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0432-1
   Chen M, 2015, COLLOID SURFACE B, V134, P322, DOI 10.1016/j.colsurfb.2015.07.018
   Cui YL, 2003, BIOMATERIALS, V24, P3859, DOI 10.1016/S0142-9612(03)00209-6
   Curran JM, 2005, BIOMATERIALS, V26, P7057, DOI 10.1016/j.biomaterials.2005.05.008
   Curran JM, 2006, BIOMATERIALS, V27, P4783, DOI 10.1016/j.biomaterials.2006.05.001
   Erickson IE, 2009, TISSUE ENG PT A, V15, P1041, DOI 10.1089/ten.tea.2008.0099
   Goldshmid R, 2015, SCI REP-UK, V5, DOI 10.1038/srep12607
   Gross-Aviv T, 2009, BIOMATERIALS, V30, P770, DOI 10.1016/j.biomaterials.2008.10.026
   Guo L, 2008, BIOMATERIALS, V29, P23, DOI [10.1016/j.biomaterials.2007.08.043, 10.1016/j.biomaterials.2007-08.043]
   Hellingman CA, 2012, J TISSUE ENG REGEN M, V6, pe1, DOI 10.1002/term.502
   Hsu SH, 2006, ARTIF ORGANS, V30, P42, DOI 10.1111/j.1525-1594.2006.00179.x
   Huang AH, 2008, OSTEOARTHR CARTILAGE, V16, P1074, DOI 10.1016/j.joca.2008.02.005
   Huey DJ, 2012, SCIENCE, V338, P917, DOI 10.1126/science.1222454
   Jakob M, 2001, J CELL BIOCHEM, V81, P368, DOI 10.1002/1097-4644(20010501)81:2<368::AID-JCB1051>3.0.CO;2-J
   Keung AJ, 2010, ANNU REV CELL DEV BI, V26, P533, DOI 10.1146/annurev-cellbio-100109-104042
   Lee TJ, 2011, BIOTECHNOL LETT, V33, P829, DOI 10.1007/s10529-010-0488-1
   Lutolf MP, 2009, ADV MATER, V21, P3255, DOI 10.1002/adma.200802582
   Ma ZW, 2003, J BIOMAT SCI-POLYM E, V14, P13, DOI 10.1163/15685620360511119
   Ma ZW, 2003, BIOMATERIALS, V24, P3725, DOI 10.1016/S0142-9612(03)00247-3
   Ma ZW, 2005, BIOMATERIALS, V26, P1253, DOI 10.1016/j.biomaterials.2004.04.031
   Madeira C, 2015, TRENDS BIOTECHNOL, V33, P35, DOI 10.1016/j.tibtech.2014.11.003
   Pelttari K, 2006, ARTHRITIS RHEUM-US, V54, P3254, DOI 10.1002/art.22136
   Phillips JE, 2010, ACTA BIOMATER, V6, P12, DOI 10.1016/j.actbio.2009.07.023
   Redman S N, 2005, Eur Cell Mater, V9, P23
   Rottmar M, 2014, EXP CELL RES, V320, P175, DOI 10.1016/j.yexcr.2013.11.004
   Salinas CN, 2008, BIOMATERIALS, V29, P2370, DOI 10.1016/j.biomaterials.2008.01.035
   Schrobback K, 2011, J ORTHOP RES, V29, P539, DOI 10.1002/jor.21264
   Schulze-Tanzil G, 2002, CELL TISSUE RES, V308, P371, DOI 10.1007/s00441-002-0562-7
   Tallheden T, 2003, J BONE JOINT SURG AM, V85A, P93, DOI 10.2106/00004623-200300002-00012
   Tigli RS, 2009, J TISSUE ENG REGEN M, V3, P348, DOI 10.1002/term.169
   Tsai WB, 2005, J BIOMAT SCI-POLYM E, V16, P699, DOI 10.1163/1568562053992504
   Tsai WB, 2011, ACTA BIOMATER, V7, P4187, DOI 10.1016/j.actbio.2011.07.024
   Varghese S, 2008, MATRIX BIOL, V27, P12, DOI 10.1016/j.matbio.2007.07.002
   Woodfield TBF, 2006, BIOMATERIALS, V27, P1043, DOI 10.1016/j.biomaterials.2005.07.032
   Xu FY, 2015, BIOCHEM ENG J, V103, P68, DOI 10.1016/j.bej.2015.07.003
   Xu FY, 2014, BIOMED RES INT, DOI 10.1155/2014/539789
   Xu L, 2013, STEM CELLS DEV, V22, P1657, DOI 10.1089/scd.2012.0605
   Yang JJ, 2010, TISSUE ENG PT A, V16, P2529, DOI 10.1089/ten.TEA.2009.0647
   Zhang KX, 2015, BIOMATERIALS, V71, P24, DOI 10.1016/j.biomaterials.2015.08.037
NR 41
TC 2
Z9 2
U1 1
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0960-7722
EI 1365-2184
J9 CELL PROLIFERAT
JI Cell Prolif.
PD AUG
PY 2016
VL 49
IS 4
BP 512
EP 522
DI 10.1111/cpr.12272
PG 11
WC Cell Biology
SC Cell Biology
GA DR5ZW
UT WOS:000379981900011
PM 27364032
DA 2018-10-20
ER

PT J
AU Boda, SK
   Bajpai, I
   Basu, B
AF Boda, Sunil Kumar
   Bajpai, Indu
   Basu, Bikramjit
TI Inhibitory effect of direct electric field and HA-ZnO composites on
   S-aureus biofilm formation
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE zinc oxide; direct electric field (DC EF); reactive oxygen species
   (ROS); S. aureus
ID STAINLESS-STEEL; BACTERIA; BIOCOMPOSITES; NANOPARTICLES; INACTIVATION;
   STIMULATION; EPIDERMIDIS; MECHANISM; GROWTH
AB In addressing the issue of prosthetic infection, we demonstrate herein how direct electric field (DC EF) stimulation can effectively inhibit biofilm formation, when pathogenic Staphylococcus aureus (MRSA, USA 300) are grown on HA-xZnO (x=0, 5, 7.5, and 10 wt %) biocomposites in vitro. After bacterial preincubation for 4 h, a low intensity DC EF (1V/cm) was applied for different time periods (t=6, 12, 18, and 24 h). The bacterial viability and biofilm maturation were evaluated by a combination of biochemical assays, fluorescence/confocal microscopy, and flow cytometry. The results confirm a time-dependent and composition-independent decrease in bacterial viability and biofilm formation on HA-xZnO composites w.r.t EF-treated HA. Flow cytometry analysis indicated that 12 h EF application resulted in membrane depolarization of approximate to 35% of S. aureus populations on HA-xZnO composites. The live/dead assay results revealed approximate to 60% decline in viable bacterial numbers with a concomitant 3.5-fold increase in the production of reactive oxygen species (ROS) after 18 h of EF. The loss in bacterial viability and biofilm instability is due to the synergistic bactericidal action of ZnO and EF. Taken together, the use of engineered biomaterial substrate with antimicrobial reinforcement coupled with continuous low intensity EF application can be adopted to treat prosthetic implant associated infection. (c) 2015 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 104B: 1064-1075, 2016.
C1 [Boda, Sunil Kumar; Bajpai, Indu; Basu, Bikramjit] Indian Inst Sci, Mat Res Ctr, Lab Biomat, Bangalore 560012, Karnataka, India.
   [Basu, Bikramjit] Indian Inst Sci, Bioengn Program, Bangalore 560012, Karnataka, India.
   [Bajpai, Indu] Yeungnam Univ, Sch Mat Sci & Engn, Kyongsan 712749, Gyeongbuk, South Korea.
RP Basu, B (reprint author), Indian Inst Sci, Mat Res Ctr, Lab Biomat, Bangalore 560012, Karnataka, India.; Basu, B (reprint author), Indian Inst Sci, Bioengn Program, Bangalore 560012, Karnataka, India.
EM bikram@mrc.iisc.ernet.in
OI Boda, Sunil Kumar/0000-0003-3565-1914
FU Department of Science and Technology; Department of Biotechnology,
   Government of India; Council for Scientific and Industrial Research
   (CSIR)
FX Contract grant sponsor: Department of Science and Technology, Department
   of Biotechnology, Government of India and Council for Scientific and
   Industrial Research (CSIR) (to S.K.B.)
CR Asadi MR, 2014, ADV WOUND CARE, V3, P91, DOI 10.1089/wound.2012.0410
   Ayman H, 2011, T NANOBIOSCI, V10, P133
   Bajpai I, 2014, J BIOMED MATER RES B, V102, P524, DOI 10.1002/jbm.b.33031
   Bajpai I, 2013, J AM CERAM SOC, V96, P2100, DOI 10.1111/jace.12386
   Bandyopadhyay A, 2007, MAT SCI ENG C-BIO S, V27, P14, DOI 10.1016/j.msec.2005.11.004
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   COSTERTON JW, 1994, ANTIMICROB AGENTS CH, V38, P2803, DOI 10.1128/AAC.38.12.2803
   Dalai S, 2012, TOXICOL RES-UK, V1, P116, DOI 10.1039/c2tx00012a
   Del Pozo JL, 2008, INT J ARTIF ORGANS, V31, P786
   Drees KP, 2003, WATER RES, V37, P2291, DOI 10.1016/S0043-1354(03)00009-5
   Dubey AK, 2014, J AM CERAM SOC, V97, P481, DOI 10.1111/jace.12647
   Dubey AK, 2013, J EUR CERAM SOC, V33, P3445, DOI 10.1016/j.jeurceramsoc.2013.07.012
   Dubey AK, 2013, J MATER SCI-MATER M, V24, P1789, DOI 10.1007/s10856-013-4921-6
   Dubey AK, 2011, J BIOMED MATER RES B, V98B, P18, DOI 10.1002/jbm.b.31827
   Gunduz O, 2008, J MATER SCI, V43, P2536, DOI 10.1007/s10853-008-2497-1
   Indu B, 2012, J BIOMED MATER RES B, V100, P2006
   Jain S, 2015, CARBON, V81, P193, DOI 10.1016/j.carbon.2014.09.048
   Liu WK, 1997, J ANTIMICROB CHEMOTH, V39, P687, DOI 10.1093/jac/39.6.687
   McNicholl BP, 2007, WATER RES, V41, P127, DOI 10.1016/j.watres.2006.10.002
   Merritt J.H., 2005, CURR PROTOC MICROB B, V1B, P1, DOI DOI 10.1002/9780471729259.MC01B01S00
   Nagarajan P, 2008, SCI TECHNOL ADV MAT, V9, P35004
   Nath S, 2010, J MATER SCI-MATER M, V21, P1273, DOI 10.1007/s10856-009-3939-2
   Netuschil L, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-2
   Novo D, 1999, CYTOMETRY, V35, P55, DOI 10.1002/(SICI)1097-0320(19990101)35:1<55::AID-CYTO8>3.0.CO;2-2
   Park JC, 2003, APPL ENVIRON MICROB, V69, P2405, DOI 10.1128/AEM.69.4.2405-2408.2003
   Raghupathi KR, 2011, LANGMUIR, V27, P4020, DOI 10.1021/la104825u
   Rolon M, 2006, PARASITOL RES, V99, P103, DOI 10.1007/s00436-006-0126-y
   Saha N, 2012, J BIOMED MATER RES B, V100B, P256, DOI 10.1002/jbm.b.31948
   Saha N, 2010, J BIOMED MATER RES B, V95B, P430, DOI 10.1002/jbm.b.31734
   Shapiro HM, 2000, METHODS, V21, P271, DOI 10.1006/meth.2000.1007
   Singh B, 2011, MAT SCI ENG C-MATER, V31, P1320, DOI 10.1016/j.msec.2011.04.015
   Tagai H, 1980, PREPARATION SYNTHETI
   Tang HY, 2009, J BIOMED MATER RES A, V88A, P454, DOI 10.1002/jbm.a.31788
   Tawakoli PN, 2013, CLIN ORAL INVEST, V17, P841, DOI 10.1007/s00784-012-0792-3
   van der Borden AJ, 2004, J BIOMED MATER RES B, V68B, P160, DOI 10.1002/jbm.b.20015
   Yu JG, 2008, ENVIRON SCI TECHNOL, V42, P4902, DOI 10.1021/es800036n
   Zhang LL, 2008, PROG NAT SCI, V18, P939, DOI 10.1016/j.pnsc.2008.01.026
   Zhou G, 2008, J BIOMED MATER RES A, V85A, P929, DOI 10.1002/jbm.a.31527
NR 38
TC 6
Z9 6
U1 3
U2 22
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD AUG
PY 2016
VL 104
IS 6
BP 1064
EP 1075
DI 10.1002/jbm.b.33455
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DR6ST
UT WOS:000380032300002
PM 26014126
DA 2018-10-20
ER

PT J
AU Stubinger, S
   Drechsler, A
   Burki, A
   Klein, K
   Kronen, P
   von Rechenberg, B
AF Stubinger, Stefan
   Drechsler, Anika
   Burki, Alexander
   Klein, Karina
   Kronen, Peter
   von Rechenberg, Brigitte
TI Titanium and hydroxyapatite coating of polyetheretherketone and carbon
   fiber-reinforced polyetheretherketone: A pilot study in sheep
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE osseointegration; polyetheretherketone; CFR-PEEK; pull-out test; sheep
ID DENTAL IMPLANTS; ANIMAL-MODELS; PEEK IMPLANTS; COATED PEEK; BONE;
   OSSEOINTEGRATION; SURFACES; IMPROVE; BIOMATERIAL; BIOACTIVITY
AB Purpose: The purpose of this study was to evaluate the bone formation capability of polyetheretherketone (PEEK) and carbon fiber-reinforced PEEK (CFR-PEEK) implants coated with different titanium and hydroxyapatite plasma-sprayed layers after 2 and 12 weeks. Methods: In six sheep 108 implants were placed in the pelvis. Altogether six different surface modifications were tested. After 2 and 12 weeks, n=3 implants per group were examined histologically and n=6 implants per group were tested by a pull-out test. Results: Biomechanically (p=0.001) as well as histologically (p>0.05) surface coating of PEEK/CFR-PEEK led to an increase of osseointegration from 2 to 12 weeks. After 12 weeks, coated implants demonstrated significant (p<0.001) higher pull-out values in comparison to uncoated implants. Overall, the double coating (titanium bond layer and hydroxyapatite top layer) showed the most favorable results after 2 and 12 weeks. Conclusions: Plasma-sprayed titanium and hydroxyapatite coatings on PEEK or CFR-PEEK demonstrated a significant improvement of osseointegration. (c) 2015 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 104B: 1182-1191, 2016.
C1 [Stubinger, Stefan; Drechsler, Anika; Klein, Karina; von Rechenberg, Brigitte] Univ Basel, Hightech Res Ctr Craniomaxillofacial Surg, CH-4031 Basel, Switzerland.
   [Stubinger, Stefan; Kronen, Peter; von Rechenberg, Brigitte] Univ Zurich, Vetsuisse Fac, CABMM, CH-8057 Zurich, Switzerland.
   [Burki, Alexander] Univ Bern, Inst Surg Biotechnol & Biomech, CH-3014 Bern, Switzerland.
   [Kronen, Peter] Vet Anaesthesia Serv Int VAS, CH-8400 Winterthur, Switzerland.
RP Stubinger, S (reprint author), Univ Basel, Hightech Res Ctr Craniomaxillofacial Surg, CH-4031 Basel, Switzerland.; Stubinger, S (reprint author), Univ Zurich, Vetsuisse Fac, CABMM, CH-8057 Zurich, Switzerland.
EM stefan.stuebinger@cabmm.uzh.ch
FU Provincia Autonoma of Trento (Eurocoating S.p.A.)
FX Contract grant sponsor: Provincia Autonoma of Trento (Eurocoating
   S.p.A., project "Inspired")
CR Akkan CK, 2014, LASER MED SCI, V29, P1633, DOI 10.1007/s10103-014-1567-7
   Albrektsson T, 2008, AUST DENT J, V53, pS34, DOI 10.1111/j.1834-7819.2008.00039.x
   Andani MT, 2014, ACTA BIOMATER, V10, P4058, DOI 10.1016/j.actbio.2014.06.025
   Aparicio C, 2011, J MECH BEHAV BIOMED, V4, P1672, DOI 10.1016/j.jmbbm.2011.05.005
   Auer JA, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-72
   Barkarmo S, 2013, J BIOMED MATER RES A, V101, P465, DOI 10.1002/jbm.a.34358
   Briem D, 2005, J MATER SCI-MATER M, V16, P671, DOI 10.1007/s10856-005-2539-z
   Devine DM, 2013, J BIOMED MATER RES B, V101B, P591, DOI 10.1002/jbm.b.32861
   Ernst S, 2015, CLIN ORAL IMPLAN RES, V26, P898, DOI 10.1111/clr.12411
   Fauchais P, 2004, J PHYS D APPL PHYS, V37, pR86, DOI 10.1088/0022-3727/37/9/R02
   Glassman AH, 2006, CLIN ORTHOP RELAT R, P64, DOI 10.1097/01.blo.0000246541.41951.20
   Hahn BD, 2013, APPL SURF SCI, V283, P6, DOI 10.1016/j.apsusc.2013.05.073
   Han CM, 2010, BIOMATERIALS, V31, P3465, DOI 10.1016/j.biomaterials.2009.12.030
   Khanuja HS, 2011, J BONE JOINT SURG AM, V93A, P500, DOI 10.2106/JBJS.J.00774
   Kurtz SM, 2007, BIOMATERIALS, V28, P4845, DOI 10.1016/j.biomaterials.2007.07.013
   Landgraeber S, 2014, MEDIAT INFLAMM, DOI 10.1155/2014/185150
   Langhoff JD, 2008, INT J ORAL MAX SURG, V37, P1125, DOI 10.1016/j.ijom.2008.09.008
   Ma R, 2014, INT J MOL SCI, V15, P5426, DOI 10.3390/ijms15045426
   Manzano G, 2014, INT J ORAL MAX IMPL, V29, P311, DOI 10.11607/jomi.2817
   Mardas N, 2014, J INVEST SURG, V27, P32, DOI 10.3109/08941939.2013.817628
   Martins O, 2014, J INVEST SURG, V27, P50, DOI 10.3109/08941939.2013.828805
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Mills LA, 2012, J BONE JOINT SURG BR, V94B, P865, DOI 10.1302/0301-620X.94B7.27370
   Nakahara I, 2012, J ORTHOP RES, V30, P1618, DOI 10.1002/jor.22115
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   Plecko M, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-32
   Poulsson AHC, 2014, BIOMATERIALS, V35, P3717, DOI 10.1016/j.biomaterials.2013.12.056
   Rao PJ, 2014, ORTHOP SURG, V6, P81, DOI 10.1111/os.12098
   Robotti P, 2013, PEEK BIOMATERIAL HDB, V1, P119
   Schwitalla A, 2013, J ORAL IMPLANTOL, V39, P743, DOI 10.1563/AAID-JOI-D-11-00002
   Seong WJ, 2013, CLIN IMPLANT DENT R, V15, P460, DOI 10.1111/j.1708-8208.2011.00357.x
   Stubinger S, 2015, CLIN ORAL IMPLAN RES, V26, P572, DOI 10.1111/clr.12445
   Toth JM, 2006, BIOMATERIALS, V27, P324, DOI 10.1016/j.biomaterials.2005.07.011
   Trisi P, 2011, INT J ORAL MAX IMPL, V26, P837
   Ulivi M, 2013, J ARTHROPLASTY, V28, P1372, DOI 10.1016/j.arth.2012.11.008
   von Rechenberg B, 2000, EQUINE VET J, V32, P140, DOI 10.2746/042516400777591598
   von Salis-Soglio M, 2014, J FUNCT BIOMATER, V5, P135, DOI 10.3390/jfb5030135
   Wang A, 1999, WEAR, V225, P724, DOI 10.1016/S0043-1648(99)00026-5
   Wang S, 2007, ORAL DIS, V13, P530, DOI 10.1111/j.1601-0825.2006.01337.x
   Wennerberg A, 2011, J ORAL REHABIL, V38, P286, DOI 10.1111/j.1365-2842.2010.02170.x
   Zhao Y, 2013, BIOMATERIALS, V34, P9264, DOI 10.1016/j.biomaterials.2013.08.071
NR 41
TC 3
Z9 3
U1 4
U2 42
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD AUG
PY 2016
VL 104
IS 6
BP 1182
EP 1191
DI 10.1002/jbm.b.33471
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DR6ST
UT WOS:000380032300015
PM 26097161
DA 2018-10-20
ER

PT J
AU Lee, JS
   Sohn, JY
   Lim, HC
   Jung, UW
   Choi, SH
AF Lee, Jung-Seok
   Sohn, Joo-Yeon
   Lim, Hyun-Chang
   Jung, Ui-Won
   Choi, Seong-Ho
TI Different bone regeneration patterns in periimplant circumferential gap
   defects grafted with two types of osteoconductive biomaterial
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE bone regeneration; circumferential defect; deproteinized bovine bone
   mineral (DBBM); porous titanium granules (PTG)
ID CONTROLLED CLINICAL-TRIAL; FRESH EXTRACTION SOCKETS; POROUS TITANIUM
   GRANULES; SINUS FLOOR AUGMENTATION; TOOTH EXTRACTION; RIDGE
   PRESERVATION; IMPLANT PLACEMENT; DENTAL IMPLANTS; DOG; SUBSTITUTE
AB This study aimed to determine healing patterns in periimplant gap defect grafted with demineralized bovine bone mineral (DBBM) and porous titanium granules (PTG), which are known to induce a minimal tissue reaction and to undergo minimal biodegradation in healing process. Experiments were performed using a standardized periimplant gap-defect model in dogs with two observational periods: 4 and 8 weeks. Circumferential defects were surgically induced around dental implants on unilateral mandibles in five dogs, and collagen barrier membranes were placed over the DBBM and PTG grafts at two experimental sites and over a nongrafted site. Four weeks later, the same procedures were performed on the contralateral mandible, and the animals allowed to heal for a further 4 weeks, after which they were sacrificed and their mandibles with graft/control sites harvested for histologic evaluation. Both types of grafted biomaterials significantly enhanced the defect fill with newly formed bone, but the bone-to-implant contact (BIC) was significantly increased only at sites that had been grafted with DBBM. The two experimental sites exhibited different healing patterns, with new bone formation being observed on the surface of the DBBM particles throughout the defect, while there was no de novo bone formation on the PTG surface, but rather appositional bone growth from the base and lateral walls of the defect. It has been suggested that gap-defect filling with DBBM around dental implants may enhance both BIC and defect fill; however, the present findings show that defect grafting with PTG enhances only defect fill and not BIC. (c) 2015 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 104B: 1202-1209, 2016.
C1 [Lee, Jung-Seok; Sohn, Joo-Yeon; Jung, Ui-Won; Choi, Seong-Ho] Yonsei Univ, Coll Dent, Res Inst Periodontal Regenerat, Dept Periodontol, Seoul, South Korea.
   [Lim, Hyun-Chang] Kyung Hee Univ, Sch Dent, Dept Periodontol, Seoul, South Korea.
RP Choi, SH (reprint author), Yonsei Univ, Coll Dent, Res Inst Periodontal Regenerat, Dept Periodontol, Seoul, South Korea.
EM shchoi726@yuhs.ac
OI Lim, Hyun-Chang/0000-0001-7695-1708
FU Basic Science Research Program through the National Research Foundation
   of Korea (NRF) - Ministry of Education [NRF-2013R1A1A2060464]
FX Contract grant sponsor: Basic Science Research Program through the
   National Research Foundation of Korea (NRF) funded by the Ministry of
   Education; contract grant number: NRF-2013R1A1A2060464
CR Araujo M, 2009, CLIN ORAL IMPLAN RES, V20, P1, DOI 10.1111/j.1600-0501.2008.01606.x
   Araujo M, 2008, INT J PERIODONT REST, V28, P123
   Araujo MG, 2006, CLIN ORAL IMPLAN RES, V17, P615, DOI 10.1111/j.1600-0501.2006.01317.x
   Araujo MG, 2006, CLIN ORAL IMPLAN RES, V17, P606, DOI 10.1111/j.1600-0501.2006.01315.x
   Araujo MG, 2015, CLIN ORAL IMPLAN RES, V26, P407, DOI 10.1111/clr.12366
   Araujo MG, 2011, CLIN ORAL IMPLAN RES, V22, P1, DOI 10.1111/j.1600-0501.2010.01920.x
   Araujo MG, 2011, CLIN ORAL IMPLAN RES, V22, P9, DOI 10.1111/j.1600-0501.2010.01937.x
   Araujo MG, 2010, CLIN ORAL IMPLAN RES, V21, P445, DOI 10.1111/j.1600-0501.2009.01876.x
   Araujo MG, 2009, CLIN ORAL IMPLAN RES, V20, P545, DOI 10.1111/j.1600-0501.2008.01703.x
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x
   Becker W, 1994, Int J Oral Maxillofac Implants, V9, P31
   Botticelli D, 2003, CLIN ORAL IMPLAN RES, V14, P35, DOI 10.1034/j.1600-0501.2003.140105.x
   Botticelli D, 2003, CLIN ORAL IMPLAN RES, V14, P1, DOI 10.1034/j.1600-0501.2003.140101.x
   Bystedt H, 2009, CLIN IMPLANT DENT R, V11, P101, DOI 10.1111/j.1708-8208.2008.00100.x
   Chen ST, 2014, INT J ORAL MAX IMPL, V29, P186, DOI 10.11607/jomi.2014suppl.g3.3
   Gholami GA, 2012, CLIN ORAL IMPLAN RES, V23, P1198, DOI 10.1111/j.1600-0501.2011.02288.x
   Hammerle CHF, 2012, CLIN ORAL IMPLAN RES, V23, P80, DOI 10.1111/j.1600-0501.2011.02370.x
   Hofman S, 1999, BIOMATERIALS, V20, P1155, DOI 10.1016/S0142-9612(97)00082-3
   Hong JY, 2014, CLIN ORAL IMPLAN RES, V25, pE30, DOI 10.1111/clr.12041
   Jung RE, 2013, J CLIN PERIODONTOL, V40, P90, DOI 10.1111/jcpe.12027
   Jung UW, 2007, CLIN ORAL IMPLAN RES, V18, P171, DOI 10.1111/j.1600-0501.2006.01310.x
   Kim S, 2011, J BIOMED MATER RES B, V99B, P21, DOI 10.1002/jbm.b.31867
   Kim S, 2011, INT J ORAL MAX IMPL, V26, P265
   Lindhe J, 2013, CLIN ORAL IMPLAN RES, V24, P1158, DOI 10.1111/j.1600-0501.2012.02527.x
   Mardas N, 2010, CLIN ORAL IMPLAN RES, V21, P688, DOI 10.1111/j.1600-0501.2010.01918.x
   Mijiritsky E, 2013, BRIT DENT J, V214, DOI 10.1038/sj.bdj.2013.222
   Mladenovic Z, 2013, CLIN ORAL IMPLAN RES, V24, P329, DOI 10.1111/j.1600-0501.2011.02334.x
   Mordenfeld A, 2010, CLIN ORAL IMPLAN RES, V21, P961, DOI 10.1111/j.1600-0501.2010.01939.x
   Orsini G, 2005, J BIOMED MATER RES B, V74B, P448, DOI 10.1002/jbm.b.30196
   Schneider D, 2014, J CLIN PERIODONTOL, V41, P612, DOI 10.1111/jcpe.12246
   Weng D, 2011, EUR J ORAL IMPLANTOL, V4, P59
NR 31
TC 1
Z9 1
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD AUG
PY 2016
VL 104
IS 6
BP 1202
EP 1209
DI 10.1002/jbm.b.33433
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DR6ST
UT WOS:000380032300017
PM 26087247
DA 2018-10-20
ER

PT J
AU Kaur, G
   Pickrell, G
   Sriranganathan, N
   Kumar, V
   Homa, D
AF Kaur, Gurbinder
   Pickrell, Gary
   Sriranganathan, Nammalwar
   Kumar, Vishal
   Homa, Daniel
TI Review and the state of the art: Sol-gel and melt quenched bioactive
   glasses for tissue engineering
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Review
DE bioactive glasses; sol-gel glasses; melt-quench technique; porosity;
   bioactivity; mechanical properties; cytotoxicity; drug delivery
ID IN-VITRO BIOACTIVITY; LIME-PHOSPHOSILICATE GLASSES; BIOGLASS(R)-FILLED
   POLYLACTIDE FOAMS; HIERARCHICAL PORE STRUCTURE; PHOSPHATE LAYER
   FORMATION; MESENCHYMAL STEM-CELLS; DRUG-DELIVERY SYSTEMS; SIMULATED
   BODY-FLUID; CERAMIC SCAFFOLDS; CALCIUM-PHOSPHATE
AB Biomaterial development is currently the most active research area in the field of biomedical engineering. The bioglasses possess immense potential for being the ideal biomaterials due to their high adaptiveness to the biological environment as well as tunable properties. Bioglasses like 45S5 has shown great clinical success over the past 10 years. The bioglasses like 45S5 were prepared using melt-quenching techniques but recently porous bioactive glasses have been derived through sol-gel process. The synthesis route exhibits marked effect on the specific surface area, as well as degradability of the material. This article is an attempt to provide state of the art of the sol-gel and melt quenched bioactive bioglasses for tissue regeneration. Fabrication routes for bioglasses suitable for bone tissue engineering are highlighted and the effect of these fabrication techniques on the porosity, pore-volume, mechanical properties, cytocompatibilty and especially apatite layer formation on the surface of bioglasses is analyzed in detail. Drug delivery capability of bioglasses is addressed shortly along with the bioactivity of mesoporous glasses. (c) 2015 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 104B: 1248-1275, 2016.
C1 [Kaur, Gurbinder; Pickrell, Gary; Kumar, Vishal; Homa, Daniel] Virginia Polytech Inst & State Univ, Dept Mat Sci & Engn, Holden Hall, Blacksburg, VA 24060 USA.
   [Kaur, Gurbinder] Thapar Univ, Sch Phys & Mat Sci, Patiala 147004, Punjab, India.
   [Sriranganathan, Nammalwar] Virginia Polytech Inst & State Univ, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24060 USA.
   [Kumar, Vishal] Sri Guru Granth Sahib World Univ, Fatehgarh Sahib 140406, India.
RP Kaur, G (reprint author), Virginia Polytech Inst & State Univ, Dept Mat Sci & Engn, Holden Hall, Blacksburg, VA 24060 USA.; Kaur, G (reprint author), Thapar Univ, Sch Phys & Mat Sci, Patiala 147004, Punjab, India.
EM gkapds@gmail.com
FU University Grants Commission, New Delhi
   [F.15-1/2013-14/PDFWM-2013-14-GE-PUN-4803 (SA-II)]
FX Contract grant sponsor: University Grants Commission, New Delhi;
   contract grant number: F.15-1/2013-14/PDFWM-2013-14-GE-PUN-4803 (SA-II)
CR Abou Neel EA, 2009, J R SOC INTERFACE, V6, P435, DOI 10.1098/rsif.2008.0348
   Agathopoulos S, 2006, BIOMATERIALS, V27, P1832, DOI 10.1016/j.biomaterials.2005.10.033
   Aina V, 2009, ACTA BIOMATER, V5, P1211, DOI 10.1016/j.actbio.2008.10.020
   Aina V, 2007, CHEM-BIOL INTERACT, V167, P207, DOI 10.1016/j.cbi.2007.03.002
   Alfani D, 1998, Clin Transpl, P205
   Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833
   ANDERSSON OH, 1988, GLASTECH BER-GLASS, V61, P300
   Andrade AL, 2009, J NON-CRYST SOLIDS, V355, P811, DOI 10.1016/j.jnoncrysol.2009.01.015
   [Anonymous], 1991, 99171991E INT ORG ST
   [Anonymous], 2000, 1377912000 BS ISO
   Arcos D, 2009, CHEM MATER, V21, P1000, DOI 10.1021/cm801649z
   Arcos D, 2010, ACTA BIOMATER, V6, P2874, DOI 10.1016/j.actbio.2010.02.012
   Artaki I., 1984, Materials Letters, V2, P448, DOI 10.1016/0167-577X(84)90160-5
   ARTAKI I, 1985, J NON-CRYST SOLIDS, V72, P391, DOI 10.1016/0022-3093(85)90191-7
   Artaki I, 1986, SCI CERAMIC CHEM PRO, P73
   Baino F, 2011, J BIOMED MATER RES A, V97A, P514, DOI 10.1002/jbm.a.33072
   Baino F, 2009, J MATER SCI-MATER M, V20, P2189, DOI 10.1007/s10856-009-3787-0
   Balamurugan A, 2007, ACTA BIOMATER, V3, P255, DOI 10.1016/j.actbio.2006.09.005
   Beezer A. E., 1980, BIOL MICROCALORIMETR
   Bellucci D, 2010, CERAM INT, V36, P2449, DOI 10.1016/j.ceramint.2010.07.009
   Benhayoune H, 2001, J PHYS D APPL PHYS, V34, P141, DOI 10.1088/0022-3727/34/1/321
   BERESFORD JN, 1994, ARCH ORAL BIOL, V39, P941, DOI 10.1016/0003-9969(94)90077-9
   Bini M, 2009, J PHYS CHEM C, V113, P8821, DOI 10.1021/jp810977w
   Blaker JJ, 2003, J BIOMED MATER RES A, V67A, P1401, DOI 10.1002/jbm.a.20055
   Boccaccini AR, 2005, EXPERT REV MED DEVIC, V2, P303, DOI 10.1586/17434440.2.3.303
   Boccaccini AR, 2005, MAT SCI ENG C-BIO S, V25, P23, DOI 10.1016/j.msec.2004.03.002
   Boyd D, 2005, J MATER SCI-MATER M, V16, P843, DOI 10.1007/s10856-005-3578-1
   Branda F, 2002, BIOMATERIALS, V23, P711, DOI 10.1016/S0142-9612(01)00173-9
   Bretcanu O, 2007, GLASS TECHNOL-PART A, V48, P227
   Brink M, 1997, J BIOMED MATER RES, V37, P114, DOI 10.1002/(SICI)1097-4636(199710)37:1<114::AID-JBM14>3.0.CO;2-G
   BRINKER CJ, 1985, J NON-CRYST SOLIDS, V72, P345, DOI 10.1016/0022-3093(85)90189-9
   Bruck AR, 1982, ENGL J MED, V306, P557
   Cai S, 2009, J MATER SCI-MATER M, V20, P351, DOI 10.1007/s10856-008-3591-2
   Cannillo V, 2009, CERAM INT, V35, P3389, DOI 10.1016/j.ceramint.2009.06.011
   CARTER DR, 1976, SCIENCE, V194, P1174, DOI 10.1126/science.996549
   CERVINKA M, 1994, TOXICOL IN VITRO, V8, P783, DOI 10.1016/0887-2333(94)90067-1
   Cevc G, 2004, BBA-BIOMEMBRANES, V1663, P61, DOI 10.1016/j.bbamem.2004.01.006
   CHEN HS, 1976, MATER RES BULL, V11, P49, DOI 10.1016/0025-5408(76)90213-0
   Chen QZ, 2006, J MATER SCI-MATER M, V17, P979, DOI 10.1007/s10856-006-0433-y
   Chen QZ, 2010, ACTA BIOMATER, V6, P4143, DOI 10.1016/j.actbio.2010.04.022
   Chen QZZ, 2006, BIOMATERIALS, V27, P2414, DOI 10.1016/j.biomaterials.2005.11.025
   Chevalier J, 2009, J EUR CERAM SOC, V29, P1245, DOI 10.1016/j.jeurceramsoc.2008.08.025
   CLEMENTI E, 1967, J CHEM PHYS, V47, P1300, DOI 10.1063/1.1712084
   COLBY MW, 1988, J NON-CRYST SOLIDS, V99, P129, DOI 10.1016/0022-3093(88)90465-6
   Coltrain BK, 1992, INFRASTRUCTURE PROCE, P69
   Courtheoux L, 2008, J PHYS CHEM C, V112, P13663, DOI 10.1021/jp8044498
   Davis J.T., 1963, INTERFACIAL PHENOMEN
   de Oliveira AAR, 2011, BIOMED MATER, V8
   Delben JRJ, 2009, J THERM ANAL CALORIM, V97, P433, DOI 10.1007/s10973-009-0086-4
   Deliormanli AM, 2012, J EUR CERAM SOC, V32, P3637, DOI 10.1016/j.jeurceramsoc.2012.05.005
   Domingues ZR, 2004, BIOMATERIALS, V25, P327, DOI 10.1016/S0142-9612(03)00524-6
   Doostmohammadi A, 2011, J MATER SCI-MATER M, V22, P2293, DOI 10.1007/s10856-011-4400-x
   Doostmohammadi A, 2011, CERAM INT, V37, P2311, DOI 10.1016/j.ceramint.2011.03.026
   Du RL, 2006, J BIOMATER APPL, V20, P341, DOI 10.1177/0885328206054535
   Erol M, 2010, CHEM ENG TECHNOL, V33, P1066, DOI 10.1002/ceat.200900495
   Feng XX, 2011, INT J APPL CERAM TEC, V8, P547, DOI 10.1111/j.1744-7402.2010.02596.x
   Ficai F, 2010, COLLOID SURFACE B, V81, P614
   Filho OP, 1996, J BIOMED MATER RES, V30, P509
   FLORY PJ, 1953, PRINCIPLES POLYM CHE
   FONTANA AJ, 1990, THERMOCHIM ACTA, V172, P105, DOI 10.1016/0040-6031(90)80564-F
   Fredholm YC, 2010, J NON-CRYST SOLIDS, V356, P2546, DOI 10.1016/j.jnoncrysol.2010.06.078
   Fricke J, 1988, ULTRASTRUCTURE PROCE
   FUIERER TA, 1994, LANGMUIR, V10, P4721, DOI 10.1021/la00024a054
   Gao TJ, 2001, BIOMATERIALS, V22, P1475, DOI 10.1016/S0142-9612(00)00288-X
   Garcia A, 2009, CHEM MATER, V21, P5474, DOI 10.1021/cm9022776
   Garcia A, 2011, ACTA BIOMATER, V7, P1265, DOI 10.1016/j.actbio.2010.10.006
   Gentile P, 2010, J BIOMAT SCI-POLYM E, V21, P1207, DOI 10.1163/092050609X12481751806213
   Giesen EBW, 2001, J BIOMECH, V34, P799, DOI 10.1016/S0021-9290(01)00030-6
   Goel A, 2013, J MATER CHEM B, V1, P3073, DOI 10.1039/c3tb20163e
   Goel A, 2012, ACTA BIOMATER, V8, P361, DOI 10.1016/j.actbio.2011.08.026
   Groot K., 1983, BIOCERAMICS CALCIUM, P1
   Gross U, 1988, CRC CRITICAL REV BIO, P2
   Hallab NJ, 1995, J LONG-TERM EFF MED, V5, P209
   HENCH L, 1993, INTRO BIOCERAMICS
   Hench L L, 1988, Ann N Y Acad Sci, V523, P54, DOI 10.1111/j.1749-6632.1988.tb38500.x
   HENCH L L, 1972, Journal of Biomedical Materials Research Biomedical Materials Symposium, V2, P117
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HENCH LL, 1990, CHEM REV, V90, P33, DOI 10.1021/cr00099a003
   Hill R, 1996, J MATER SCI LETT, V15, P1122, DOI 10.1007/BF00539955
   Hoffenberg R, 2001, BMJ-BRIT MED J, V323, P22
   Hoffmann F, 2006, ANGEW CHEM INT EDIT, V45, P3216, DOI 10.1002/anie.200503075
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hong YL, 2010, ADV FUNCT MATER, V20, P1503, DOI 10.1002/adfm.200901627
   Hong YL, 2010, ADV MATER, V22, P754, DOI 10.1002/adma.200901656
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Hum J, 2012, J MATER SCI-MATER M, V23, P2317, DOI 10.1007/s10856-012-4580-z
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Iler R. K., 1979, CHEM SILICA
   Iler RK, 1982, SERIES, V194
   Iler RK, 1955, CHEM SILICA
   Irie T, 1997, J PHARM SCI-US, V86, P147, DOI 10.1021/js960213f
   Ito A, 2002, MAT SCI ENG C-BIO S, V22, P21, DOI 10.1016/S0928-4931(02)00108-X
   James AM., 1987, THERMAL ENERGETIC ST, P147
   Jones JR, 2006, BIOMATERIALS, V27, P964, DOI 10.1016/j.biomaterials.2005.07.017
   Kalampounias AG, 2008, J NON-CRYST SOLIDS, V354, P749, DOI 10.1016/j.jnoncrysol.2007.07.076
   Kang XJ, 2011, DALTON T, V40, P1873, DOI 10.1039/c0dt01390k
   Kanzaki N, 2001, J PHYS CHEM B, V105, P1991, DOI 10.1021/jp003295b
   Kapoor S, 2014, ACTA BIOMATER, V10, P3264, DOI 10.1016/j.actbio.2014.03.033
   Kaur G, 2014, SCI REP-UK, V4, DOI 10.1038/srep04392
   Kaur G, 2014, J BIOMED MATER RES A, V102, P254, DOI 10.1002/jbm.a.34690
   Kaur G, 2012, MAT SCI ENG C-MATER, V32, P1941, DOI 10.1016/j.msec.2012.05.034
   KIM CY, 1989, J NON-CRYST SOLIDS, V113, P195, DOI 10.1016/0022-3093(89)90011-2
   KIM CY, 1992, J BIOMED MATER RES, V26, P1147, DOI 10.1002/jbm.820260905
   KLEMPERER WG, 1988, MATER RES SOC S P, V121, P15
   Klemperer WG, 1988, BETTER CERAMICS CHEM, V121
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Kokubo T, 2005, MAT SCI ENG C-BIO S, V25, P97, DOI 10.1016/j.msec.2005.01.002
   KOKUBO T, 1992, J MATER SCI-MATER M, V3, P79, DOI 10.1007/BF00705272
   Kokubo T., 2000, J AUST CERAM SOC, V36, P37
   Laczka M, 2000, J BIOMED MATER RES, V52, P601, DOI 10.1002/1097-4636(20001215)52:4<601::AID-JBM4>3.3.CO;2-9
   Lei B, 2009, J NON-CRYST SOLIDS, V355, P2583, DOI 10.1016/j.jnoncrysol.2009.09.014
   Lei B, 2009, MATER LETT, V63, P1719, DOI 10.1016/j.matlet.2009.04.041
   Leonova E, 2008, J PHYS CHEM C, V112, P5552, DOI 10.1021/jp7107973
   Li HC, 2013, J SOL-GEL SCI TECHN, V67, P56, DOI 10.1007/s10971-013-3050-5
   Li M, 2009, ANAT REC, V292, P1107, DOI 10.1002/ar.20925
   Li P, 2005, KEY ENG MATER, V284, P431
   LI PJ, 1994, J BIOMED MATER RES, V28, P7, DOI 10.1002/jbm.820280103
   LI R, 1991, J APPL BIOMATER, V2, P231, DOI 10.1002/jab.770020403
   Li X, 2008, J MATER CHEM, V18, P4103, DOI 10.1039/b805114c
   Li X, 2008, J BIOMED MATER RES A, V84A, P84, DOI 10.1002/jbm.a.31371
   Li X, 2009, J BIOMED MATER RES B, V89B, P148, DOI 10.1002/jbm.b.31197
   Liang W, 2008, J NON-CRYST SOLIDS, V354, P1690, DOI 10.1016/j.jnoncrysol.2007.10.003
   Liu H, 2007, BIOMATERIALS, V28, P354, DOI 10.1016/j.biomaterials.2006.08.049
   Liu S, 1989, AGING OF GELS
   Liu X, 2009, J MATER SCI-MATER M, V20, P1237, DOI 10.1007/s10856-009-3691-7
   Liu X, 2009, J MATER SCI-MATER M, V20, P365, DOI 10.1007/s10856-008-3582-3
   LOEHRER PJ, 1984, ANN INTERN MED, V100, P704, DOI 10.7326/0003-4819-100-5-704
   Lu HH, 2003, J BIOMED MATER RES A, V64A, P465, DOI 10.1002/jbm.a.10399
   Lu HH, 2000, J BIOMED MATER RES, V51, P80, DOI 10.1002/(SICI)1097-4636(200007)51:1<80::AID-JBM11>3.0.CO;2-6
   Luz GM, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/49/494014
   Lysaght MJ, 2008, TISSUE ENG PT A, V14, P305, DOI 10.1089/tea.2007.0267
   Mackenzie J. D., 1986, SCI CERAMIC CHEM PRO, P113
   Mal NK, 2003, NATURE, V421, P350, DOI 10.1038/nature01362
   Maquet V, 2003, J BIOMED MATER RES A, V66A, P335, DOI 10.1002/jbm.a.10587
   Misra SK, 2010, BIOMATERIALS, V31, P2806, DOI 10.1016/j.biomaterials.2009.12.045
   MONSIGNY M, 1994, ADV DRUG DELIVER REV, V14, P1, DOI 10.1016/0169-409X(94)90003-5
   Mourino V, 2010, J R SOC INTERFACE, V7, P209, DOI 10.1098/rsif.2009.0379
   Mukherjee DP, 2013, CERAM INT, V39, P571, DOI 10.1016/j.ceramint.2012.06.066
   Murphy S, 2010, J MATER SCI-MATER M, V21, P2827, DOI 10.1007/s10856-010-4139-9
   Murphy S, 2009, J MATER SCI-MATER M, V20, P2028
   Navarro M, 2004, J MATER SCI-MATER M, V15, P419, DOI 10.1023/B:JMSM.0000021113.88702.9d
   NICHOLSON JW, 1988, J BIOMED MATER RES, V22, P623, DOI 10.1002/jbm.820220704
   Nielsen FH, 2000, NUTRITION, V16, P512, DOI 10.1016/S0899-9007(00)00324-5
   Noriega AL, 2006, CHEM MATER, V18, P3137
   Noriko K, 2000, J PHYS CHEM B, V104, P4189
   O'Donnell MD, 2008, J NON-CRYST SOLIDS, V354, P3554, DOI 10.1016/j.jnoncrysol.2008.03.034
   O'Donnell MD, 2008, J NON-CRYST SOLIDS, V354, P3561, DOI 10.1016/j.jnoncrysol.2008.03.035
   O'Donnell MD, 2009, J MATER SCI-MATER M, V20, P1611, DOI 10.1007/s10856-009-3732-2
   OGINO M, 1980, J BIOMED MATER RES, V14, P55, DOI 10.1002/jbm.820140107
   OGINO M, 1980, J NON-CRYST SOLIDS, V38-9, P673, DOI 10.1016/0022-3093(80)90514-1
   Oh SA, 2010, J TISSUE ENG, V2010, DOI DOI 10.4061/2010/475260
   OHTSUKI C, 1992, J NON-CRYST SOLIDS, V143, P84, DOI 10.1016/S0022-3093(05)80556-3
   OHURA K, 1992, J MATER SCI-MATER M, V3, P95, DOI 10.1007/BF00705275
   Oki A, 2004, J BIOMED MATER RES A, V69A, P216, DOI 10.1002/jbm.a.20070
   ORCEL G, 1986, J NON-CRYST SOLIDS, V79, P177, DOI 10.1016/0022-3093(86)90045-1
   ORCEL G, 1988, J NON-CRYST SOLIDS, V104, P170, DOI 10.1016/0022-3093(88)90385-7
   Orcel G, 1986, SCI CERAMIC CHEM PRO, P224
   Ostomel TA, 2006, SMALL, V2, P1261, DOI 10.1002/smll.200600177
   OTA K, 1989, TRANSPLANT INT, V2, P61
   Oudadesse H, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/3/035006
   Pazo A, 1998, ACTA MATER, V46, P2551, DOI 10.1016/S1359-6454(98)80039-6
   Pazo A, 1996, SCRIPTA MATER, V34, P1729, DOI 10.1016/1359-6462(96)00048-6
   Peitl O, 2001, J NON-CRYST SOLIDS, V292, P115, DOI 10.1016/S0022-3093(01)00822-5
   PEREIRA MM, 1995, J AM CERAM SOC, V78, P2463, DOI 10.1111/j.1151-2916.1995.tb08686.x
   Perez-Pariente J, 1999, J BIOMED MATER RES, V47, P170, DOI 10.1002/(SICI)1097-4636(199911)47:2<170::AID-JBM6>3.0.CO;2-J
   Pickup DM, 2012, J BIOMATER APPL, V26, P613, DOI 10.1177/0885328210380761
   PIETROKOWSKY P, 1963, REV SCI INSTRUM, V34, P445, DOI 10.1063/1.1718403
   Pirayesh H, 2013, J AM CERAM SOC, V96, P1643, DOI 10.1111/jace.12190
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Ponsonnet L, 2003, MAT SCI ENG C-BIO S, V23, P551, DOI 10.1016/S0928-4931(03)00033-X
   Radin S, 2007, P 53 ANN M ORTH RES, P1596
   Radin S, 2007, BIOMATERIALS, V28, P1721, DOI 10.1016/j.biomaterials.2006.11.035
   Radin S, 2009, BIOMATERIALS, V30, P850, DOI 10.1016/j.biomaterials.2008.09.066
   Rahaman MN, 2005, CERAM ENG SCI PROC, V26, P3
   Rahaman MN, 2011, ACTA BIOMATER, V7, P2355, DOI 10.1016/j.actbio.2011.03.016
   Reilly GC, 2007, BIOMATERIALS, V28, P4091, DOI 10.1016/j.biomaterials.2007.05.038
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Saiz E, 2002, BIOMATERIALS, V23, P3749, DOI 10.1016/S0142-9612(02)00109-6
   Salinas AJ, 2000, BIOMATERIALS, V21, P251, DOI 10.1016/S0142-9612(99)00150-7
   SCHAKENRAAD JM, 1988, CELL BIOPHYS, V13, P75, DOI 10.1007/BF02797367
   Schlickewei W, 2007, MACROMOL SYMP, V253, P10, DOI 10.1002/masy.200750702
   Schmidt H, 1985, GLASS CURRENT ISSUES, P253
   Schmidt H., 1986, SCI CERAMIC CHEM PRO, P87
   Schnappinger D, 1996, ARCH MICROBIOL, V165, P359, DOI 10.1007/s002030050339
   Schneider OD, 2008, J BIOMED MATER RES B, V84B, P350, DOI 10.1002/jbm.b.30878
   Sepulveda P, 2002, J BIOMED MATER RES, V59, P340, DOI 10.1002/jbm.1250
   SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603
   Singh K, 2009, CERAM INT, V35, P3401, DOI 10.1016/j.ceramint.2009.06.006
   Sokolsky-Papkov M, 2007, ADV DRUG DELIVER REV, V59, P187, DOI 10.1016/j.addr.2007.04.001
   Soundrapandian C, 2011, DRUG DEV IND PHARM, V37, P538, DOI 10.3109/03639045.2010.528427
   Stamboulis AG, 2002, ADV ENG MATER, V4, P105, DOI 10.1002/1527-2648(200203)4:3<105::AID-ADEM105>3.3.CO;2-C
   Sullivan A, 2000, J MATER SCI, V35, P1125, DOI 10.1023/A:1004763815097
   Taboas JM, 2003, BIOMATERIALS, V24, P181, DOI 10.1016/S0142-9612(02)00276-4
   Tilocca A, 2010, LANGMUIR, V26, P545, DOI 10.1021/la902548f
   Tolli H, 2010, J MATER SCI-MATER M, V21, P1677, DOI 10.1007/s10856-010-4017-5
   TOPOL LE, 1974, J NON-CRYST SOLIDS, V15, P116, DOI 10.1016/0022-3093(74)90116-1
   Towler MR, 2001, BIOMATERIALS, V22, P1401, DOI 10.1016/S0142-9612(00)00297-0
   UEKAMA K, 1987, CRIT REV THER DRUG, V3, P1
   Uo M, 1998, BIOMATERIALS, V19, P2277, DOI 10.1016/S0142-9612(98)00136-7
   Valerio P, 2004, BIOMATERIALS, V25, P2941, DOI 10.1016/j.biomaterials.2003.09.086
   Vallet Regi M, 2001, J CHEM SOC DA, V2, P97
   Vallet-Regi M, 2002, PHIL T R SOC LOND A, V370, P1400
   Vallet-Regi M, 2007, ANGEW CHEM INT EDIT, V46, P7548, DOI 10.1002/anie.200604488
   Vallet-Regi M, 2006, CHEM-EUR J, V12, P5934, DOI 10.1002/chem.200600226
   VANKEMENADE MJJM, 1987, J COLLOID INTERF SCI, V118, P564, DOI 10.1016/0021-9797(87)90490-5
   Varanasi VG, 2009, ACTA BIOMATER, V5, P3536, DOI 10.1016/j.actbio.2009.05.035
   Vathsala A, 2004, TRANSPLANT P, V36, P1868, DOI 10.1016/j.transproceed.2004.08.132
   Verne E, 2010, ACTA BIOMATER, V6, P229, DOI 10.1016/j.actbio.2009.06.025
   Verrier S, 2004, BIOMATERIALS, V25, P3013, DOI 10.1016/j.biomaterials.2003.09.081
   Vitale-Brovarone C, 2007, ACTA BIOMATER, V3, P199, DOI 10.1016/j.actbio.2006.07.012
   Vitale-Brovarone C, 2012, J MATER SCI-MATER M, V23, P2369, DOI 10.1007/s10856-012-4643-1
   Vitale-Brovarone C, 2009, J MATER SCI-MATER M, V20, P643, DOI 10.1007/s10856-008-3605-0
   Wang M, 2006, AM J BIOCH BIOTECHNO, V2, P80
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Wei J, 2009, BIOMATERIALS, V30, P1080, DOI 10.1016/j.biomaterials.2008.10.046
   Weng J, 2002, BIOMATERIALS, V23, P2623, DOI 10.1016/S0142-9612(01)00393-3
   WEST JK, 1988, MATERIALS RES SOC S, V121, P219
   Williams DF., 1988, ADV BIOMATER, P11
   Wirth C, 2005, MAT SCI ENG C-BIO S, V25, P51, DOI 10.1016/j.msec.2004.06.001
   Wu CT, 2013, J MATER CHEM B, V1, P2710, DOI 10.1039/c3tb20275e
   Wu CT, 2012, INTERFACE FOCUS, V2, P292, DOI 10.1098/rsfs.2011.0121
   Wu CT, 2012, BIOMATERIALS, V33, P2076, DOI 10.1016/j.biomaterials.2011.11.042
   Wu CT, 2011, ACTA BIOMATER, V7, P3563, DOI 10.1016/j.actbio.2011.06.028
   Wu CT, 2011, BIOMATERIALS, V32, P7068, DOI 10.1016/j.biomaterials.2011.06.009
   Wu CT, 2011, ACTA BIOMATER, V7, P1797, DOI 10.1016/j.actbio.2010.12.018
   Wu CT, 2010, J BIOMED MATER RES A, V95A, P476, DOI 10.1002/jbm.a.32873
   Wu CT, 2010, BIOMATERIALS, V31, P3429, DOI 10.1016/j.biomaterials.2010.01.061
   Wu SC, 2009, J MATER SCI-MATER M, V20, P1229, DOI 10.1007/s10856-009-3690-8
   Wu XH, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/3/035006
   Xia W, 2006, J CONTROL RELEASE, V110, P522, DOI 10.1016/j.jconrel.2005.11.002
   Xia W, 2008, EUR J PHARM BIOPHARM, V69, P546, DOI 10.1016/j.ejpb.2007.11.018
   Xia W, 2008, J NON-CRYST SOLIDS, V354, P1338, DOI 10.1016/j.jnoncrysol.2006.10.084
   Xie ZP, 2009, J CONTROL RELEASE, V139, P118, DOI 10.1016/j.jconrel.2009.06.012
   Yamamuro T., 1990, HDB BIOACTIVE CERAMI
   Yan XX, 2006, BIOMATERIALS, V27, P3396, DOI 10.1016/j.biomaterials.2006.01.043
   Yan XX, 2004, ANGEW CHEM INT EDIT, V43, P5980, DOI 10.1002/anie.200460598
   Yang XY, 2012, J NON-CRYST SOLIDS, V358, P1171, DOI 10.1016/j.jnoncrysol.2012.02.005
   Yao AH, 2007, J AM CERAM SOC, V90, P303, DOI 10.1111/j.1551-2916.2006.01358.x
   Yao J, 2005, BIOMATERIALS, V26, P1935, DOI 10.1016/j.biomaterials.2004.06.027
   Yeni YN, 2001, J BIOMECH, V34, P1649, DOI 10.1016/S0021-9290(01)00155-5
   YOLDAS BE, 1975, AM CERAM SOC BULL, V54, P286
   Yu MH, 2013, NANOSCALE, V5, P178, DOI 10.1039/c2nr32145a
   Yun HS, 2008, J BIOMED MATER RES B, V87B, P374, DOI 10.1002/jbm.b.31114
   Yun HS, 2007, CHEM COMMUN, P2139, DOI 10.1039/b702103h
   Yun HS, 2009, MATER CHEM PHYS, V115, P670, DOI 10.1016/j.matchemphys.2009.02.001
   ZARZYCKI J, 1967, PHYS CHEM GLASSES, V8, P11
   Zarzycki J, SPECIAL METHODS OBTA
   Zhang K, 2005, BIOMATERIALS, V26, P4532, DOI 10.1016/j.biomaterials.2004.11.030
   Zhao S, 2010, MICROPOR MESOPOR MAT, V135, P67, DOI 10.1016/j.micromeso.2010.06.012
   Zhu HL, 2011, J BIOMED MATER RES B, V98B, P330, DOI 10.1002/jbm.b.31856
   Zhu M, 2001, J MATER CHEM, V21, P1064
   Zhu YF, 2008, MICROPOR MESOPOR MAT, V112, P494, DOI 10.1016/j.micromeso.2007.10.029
   Zhu YF, 2011, MICROPOR MESOPOR MAT, V143, P311, DOI 10.1016/j.micromeso.2011.03.007
NR 256
TC 30
Z9 30
U1 11
U2 114
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD AUG
PY 2016
VL 104
IS 6
BP 1248
EP 1275
DI 10.1002/jbm.b.33443
PG 28
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DR6ST
UT WOS:000380032300022
PM 26060931
DA 2018-10-20
ER

PT J
AU Aziz, SGG
   Aziz, SGG
   Akbarzadeh, A
AF Aziz, Shiva Gholizadeh-Ghaleh
   Aziz, Sara Gholizadeh-Ghaleh
   Akbarzadeh, Abolfazl
TI The potential of nanofibers in tissue engineering and stem cell therapy
SO ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY
LA English
DT Article
DE biomaterial scaffolds; electrospinning; nanofiber; stem cells
ID OCULAR SURFACE DISORDERS; OSTEOGENIC DIFFERENTIATION; POLYMER
   NANOFIBERS; CORNEAL SURFACE; STROMAL CELLS; SCAFFOLDS; FIBERS;
   PROLIFERATION; FABRICATION; TRANSPLANTATION
AB Electrospinning is a technique in which materials in solution are shaped into continuous nano- and micro-sized fibers. Combining stem cells with biomaterial scaffolds and nanofibers affords a favorable approach for bone tissue engineering, stem cell growth and transfer, ocular surface reconstruction, and treatment of congenital corneal diseases. This review seeks to describe the current examples of the use of scaffolds in stem cell therapy. Stem cells are classified as adult or embryonic stem (ES) cells, and the advantages and drawbacks of each group are detailed. The nanofibers and scaffolds are further classified in Tables I and II, which describe specific examples from the literature. Finally, the current applications of biomaterial scaffolds containing stem cells for tissue engineering applications are presented. Overall, this review seeks to give an overview of the biomaterials available for use in combination with stem cells, and the application of nanofibers in stem cell therapy.
C1 [Aziz, Shiva Gholizadeh-Ghaleh; Akbarzadeh, Abolfazl] Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz 5154853431, Iran.
   [Aziz, Shiva Gholizadeh-Ghaleh] Tabriz Univ Med Sci, Fac Adv Med Sci, Dept Mol Med, Tabriz, Iran.
   [Aziz, Sara Gholizadeh-Ghaleh] Islamic Azad Univ, Dept Food Sci & Technol, Tabriz, Iran.
   [Aziz, Shiva Gholizadeh-Ghaleh; Akbarzadeh, Abolfazl] INSF, Tehran, Iran.
   [Akbarzadeh, Abolfazl] Tabriz Univ Med Sci, Biotechnol Res Ctr, Tabriz, Iran.
RP Akbarzadeh, A (reprint author), Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz 5154853431, Iran.
EM akbarzadehab@tbzmed.ac.ir
RI Gholizadeh-Ghaleh az, Shiva/G-8254-2017
OI Gholizadeh-Ghaleh az, Shiva/0000-0003-1949-4381
FU Department of Molecular Medicine, Faculty of Advanced Medical Sciences,
   Tabriz University of Medical Sciences; Drug Applied Research Center,
   Tabriz University of Medical Sciences
FX The authors thank the Department of Molecular Medicine, Faculty of
   Advanced Medical Sciences, Tabriz University of Medical Sciences, for
   all support provided. This work is funded by a 2015 grant by the Drug
   Applied Research Center, Tabriz University of Medical Sciences.
CR Anton F., 1934, GOOGLE PATENTS
   Badami AS, 2006, BIOMATERIALS, V27, P596, DOI 10.1016/j.biomaterials.2005.05.084
   Bhattarai N, 2005, BIOMATERIALS, V26, P6176, DOI 10.1016/j.biomaterials.2005.03.027
   Binulal NS, 2010, TISSUE ENG PT A, V16, P393, DOI [10.1089/ten.tea.2009.0242, 10.1089/ten.TEA.2009.0242]
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Daraee H, 2014, ARTIF CELL NANOMED B, P1
   Di JC, 2008, CHEM MATER, V20, P3543, DOI 10.1021/cm8006809
   Doshi J., 1993, IND APPL SOC ANN M 1
   Dubois G, 2008, J BIOMED MATER RES B, V87B, P222, DOI 10.1002/jbm.b.31099
   Eatemadi A, 2014, ARTIF CELL NANOMED B, P1
   Eatemadi A., 2014, NANOSCALE RES LETT, V9, P1
   Ekaputra AK, 2009, TISSUE ENG PT A, V15, P3779, DOI [10.1089/ten.tea.2009.0186, 10.1089/ten.TEA.2009.0186]
   Fujihara K, 2005, BIOMATERIALS, V26, P4139, DOI 10.1016/j.biomaterials.2004.09.014
   Guarino V, 2014, EXPERT REV MED DEVIC, V12, P113
   Han YF, 2012, EUR REV MED PHARMACO, V16, P1873
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   He W, 2005, TISSUE ENG, V11, P1574, DOI 10.1089/ten.2005.11.1574
   Hejcl A, 2006, CELL MOL NEUROBIOL, V26, P1111
   Hohman MM, 2001, PHYS FLUIDS, V13, P2201, DOI 10.1063/1.1383791
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Jiang TS, 2010, MOL VIS, V16, P1304
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Ko EK, 2008, TISSUE ENG PT A, V14, P2105, DOI 10.1089/ten.tea.2008.0057
   Lee CH, 2005, BIOMATERIALS, V26, P1261, DOI 10.1016/j.biomaterials.2004.04.037
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Li D, 2004, ADV MATER, V16, P1151, DOI 10.1002/adma.200400719
   Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Li WJ, 2003, J BIOMED MATER RES A, V67A, P1105, DOI 10.1002/jbm.a.10101
   Liang D, 2007, ADV DRUG DELIVER REV, V59, P1392, DOI 10.1016/j.addr.2007.04.021
   Liu HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010707
   Ma YL, 2006, STEM CELLS, V24, P315, DOI 10.1634/stemcells.2005-0046
   Ma ZW, 2005, TISSUE ENG, V11, P1149, DOI 10.1089/ten.2005.11.1149
   Ma ZW, 2005, TISSUE ENG, V11, P101, DOI 10.1089/ten.2005.11.101
   Martinez-Conesa EM, 2012, INVEST OPHTH VIS SCI, V53, P513, DOI 10.1167/iovs.11-7550
   Meinel AJ, 2009, BIOMATERIALS, V30, P3058, DOI 10.1016/j.biomaterials.2009.01.054
   Mellatyar H, 2014, ASIAN PAC J CANCER P, V15, P8693, DOI 10.7314/APJCP.2014.15.20.8693
   Mo XM, 2004, BIOMATERIALS, V25, P1883, DOI 10.1016/j.biomaterials.2003.08.042
   Naik SP, 2003, CHEM MATER, V15, P787, DOI 10.1021/cm020786v
   Nakamura T, 2004, BRIT J OPHTHALMOL, V88, P1280, DOI 10.1136/bjo.2003.038497
   Oh JY, 2008, STEM CELLS, V26, P1047, DOI 10.1634/stemcells.2007-0737
   Rama P, 2001, TRANSPLANTATION, V72, P1478, DOI 10.1097/00007890-200111150-00002
   Reinshagen H, 2011, ACTA OPHTHALMOL, V89, P741, DOI 10.1111/j.1755-3768.2009.01812.x
   Ren L, 2010, MAT SCI ENG C-MATER, V30, P437, DOI 10.1016/j.msec.2009.12.013
   Reneker DH, 1996, NANOTECHNOLOGY, V7, P216, DOI 10.1088/0957-4484/7/3/009
   Riboldi SA, 2005, BIOMATERIALS, V26, P4606, DOI 10.1016/j.biomaterials.2004.11.035
   Ruckh TT, 2010, ACTA BIOMATER, V6, P2949, DOI 10.1016/j.actbio.2010.02.006
   Sahoo S, 2006, TISSUE ENG, V12, P91, DOI 10.1089/ten.2006.12.91
   Schwab IR, 2006, ARCH OPHTHALMOL-CHIC, V124, P1734, DOI 10.1001/archopht.124.12.1734
   Seidi K, 2014, J AIDS CLIN RES, V5, P2
   Shields KJ, 2004, TISSUE ENG, V10, P1510, DOI 10.1089/1076327042500373
   Shih YRV, 2006, STEM CELLS, V24, P2391, DOI 10.1634/stemcells.2006-0253
   Shimazaki J, 2002, OPHTHALMOLOGY, V109, P1285, DOI 10.1016/S0161-6420(02)01089-8
   Shin M, 2004, TISSUE ENG, V10, P33, DOI 10.1089/107632704322791673
   Son WK, 2004, BIOMACROMOLECULES, V5, P197, DOI 10.1021/bm034312g
   Stitzel J, 2006, BIOMATERIALS, V27, P1088, DOI 10.1016/j.biomaterials.2005.07.048
   Tuzlakoglu K, 2005, J MATER SCI-MATER M, V16, P1099, DOI 10.1007/s10856-005-4713-8
   Venugopal J, 2005, TISSUE ENG, V11, P847, DOI 10.1089/ten.2005.11.847
   Widmer MS, 1998, BIOMATERIALS, V19, P1945, DOI 10.1016/S0142-9612(98)00099-4
   Williamson MR, 2004, BIOMATERIALS, V25, P459, DOI 10.1016/S0142-9612(03)00536-2
   Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3
   Yang Y, 2006, TN T TRENS NAN C 200
   Yao L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030842
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Zajicova A, 2010, CELL TRANSPLANT, V19, P1281, DOI 10.3727/096368910X509040
   Zhang HL, 2010, J BIOACT COMPAT POL, V25, P241, DOI 10.1177/0883911509359486
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zhong Shaoping, 2012, Tissue Eng Part B Rev, V18, P77, DOI 10.1089/ten.TEB.2011.0390
NR 68
TC 4
Z9 4
U1 1
U2 24
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2169-1401
EI 2169-141X
J9 ARTIF CELL NANOMED B
JI Artif. Cell. Nanomed. Biotechnol.
PD AUG
PY 2016
VL 44
IS 5
BP 1195
EP 1200
DI 10.3109/21691401.2015.1029627
PG 6
WC Biotechnology & Applied Microbiology; Engineering, Biomedical; Materials
   Science, Biomaterials
SC Biotechnology & Applied Microbiology; Engineering; Materials Science
GA DQ9PR
UT WOS:000379542300001
PM 26042482
DA 2018-10-20
ER

PT J
AU Zhang, Y
   Wang, QS
   Yan, K
   Qi, Y
   Wang, GF
   Cui, YL
AF Zhang, Yi
   Wang, Qiang-Song
   Yan, Kuo
   Qi, Yun
   Wang, Gui-Fang
   Cui, Yuan-Lu
TI Preparation, characterization, and evaluation of genipin crosslinked
   chitosan/gelatin three-dimensional scaffolds for liver tissue
   engineering applications
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE Genipin; scaffolds; liver tissue engineering; 3-D culture; HepG2 cell
   line
ID IN-VITRO; GELATIN SCAFFOLDS; SURFACE MODIFICATION; LINKING AGENT; HEPG2
   CELLS; TRANSPLANTATION; PROLIFERATION; HEPATOCYTES; FABRICATION;
   APOPTOSIS
AB In liver tissue engineering, scaffolds with porous structure desgined to supply nutrient and oxygen exchange for three-dimensional (3-D) cells culture, and maintain liver functions. Meanwhile, genipin, as a natural crosslinker, is widely used to crosslink biomaterials in tissue engineering, with lower cytotoxicity and better biocompatibility. In present study, chitosan/gelatin 3-D scaffolds crosslinked by genipin, glutaraldehyde or 1-(3-dimethylaminopropyl)-3-ethyl-carbodimide hydrochloride (EDC) were prepared and characterized by Fourier-transform infrared (FT-IR) and scanning electron microscopy (SEM). The biocompatibility of chitosan/gelatin scaffolds corsslinked with different crosslinkers was investigated by cell viability, morphology and liver specific functions. The result showed that the 1% and 2% genipin crosslinked chitosan/gelatin scaffolds possess ideal porosity. The genipin crosslinked 3-D scaffolds possessed the best biocompatibility than that of the others, and maintained liver specific functions when HepG2 cells seeded on scaffolds. The cellular morphology of HepG2 cells seeded on scaffolds showed that cells could penetrate into the scaffolds and proliferate significantly. Therefore, genipin crosslinked chitosan/gelatin scaffolds could be a promising biomaterial used in liver tissue engineering. (c) 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 104A: 1863-1870, 2016.
C1 [Zhang, Yi; Yan, Kuo; Wang, Gui-Fang; Cui, Yuan-Lu] Tianjin Univ Tradit Chinese Med, Res Ctr Tradit Chinese Med, Tianjin State Key Lab Modern Chinese Med, Tianjin 300193, Peoples R China.
   [Wang, Qiang-Song] Chinese Acad Med Sci, Inst Biomed Engn, Tianjin Key Lab Biomed Mat, Tianjin 300192, Peoples R China.
   [Wang, Qiang-Song] Peking Union Med Coll, Tianjin 300192, Peoples R China.
   [Qi, Yun] Tianjin Univ, Fac Environm Sci & Engn, Tianjin 300072, Peoples R China.
RP Cui, YL (reprint author), Tianjin Univ Tradit Chinese Med, Res Ctr Tradit Chinese Med, 88 YuQuan Rd, Tianjin 300193, Peoples R China.
EM cuiyl@tju.edu.cn
RI Cui, Yuan-Lu/A-3705-2013
FU National Natural Science Foundation of China [81473542, 31500761];
   Specialized Research Fund for the Doctoral Program of Higher Education
   [20131210110008]; Postdoctoral Science Foundation of China [2014M552639]
FX Contract grant sponsor: National Natural Science Foundation of China;
   contract grant number: 81473542, 31500761,; Contract grant sponsor:
   Specialized Research Fund for the Doctoral Program of Higher Education;
   contract grant number: 20131210110008,; Contract grant sponsor:
   Postdoctoral Science Foundation of China; contract grant number:
   2014M552639
CR Bi L, 2011, J MATER SCI-MATER M, V22, P51, DOI 10.1007/s10856-010-4177-3
   Cai KY, 2008, J MATER SCI-MATER M, V19, P499, DOI 10.1007/s10856-007-3184-5
   Cai KY, 2001, J BIOMAT SCI-POLYM E, V12, P1303, DOI 10.1163/156856202753419240
   Cao HL, 2010, BIOL PHARM BULL, V33, P1343, DOI 10.1248/bpb.33.1343
   Chen HM, 2006, BIOMACROMOLECULES, V7, P2091, DOI 10.1021/bm050862y
   Cheng MY, 2003, BIOMATERIALS, V24, P2871, DOI 10.1016/S0142-9612(03)00117-0
   Coward SM, 2009, ARTIF ORGANS, V33, P1117, DOI 10.1111/j.1525-1594.2009.00821.x
   Cui YL, 2003, BIOMATERIALS, V24, P3859, DOI 10.1016/S0142-9612(03)00209-6
   Dvir-Ginzberg M, 2003, TISSUE ENG, V9, P757, DOI 10.1089/107632703768247430
   Feng ZQ, 2009, BIOMATERIALS, V30, P2753, DOI 10.1016/j.biomaterials.2009.01.053
   Gong HB, 2014, J MATER SCI-MATER M, V25, P113, DOI 10.1007/s10856-013-5061-8
   Guo T, 2006, BIOMATERIALS, V27, P1095, DOI 10.1016/j.biomaterials.2005.08.015
   He JK, 2009, ACTA BIOMATER, V5, P453, DOI 10.1016/j.actbio.2008.07.002
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   Kane BJ, 2006, ANAL CHEM, V78, P4291, DOI 10.1021/ac051856v
   Kelm JM, 2003, BIOTECHNOL BIOENG, V83, P173, DOI 10.1002/bit.10655
   Kim S, 2005, J BIOMED MATER RES B, V75B, P442, DOI 10.1002/jbm.b.30324
   Lee SY, 2015, INT J STEM CELLS, V8, P36, DOI 10.15283/ijsc.2015.8.1.36
   Li KG, 2004, BIOTECHNOL LETT, V26, P879, DOI 10.1023/B:bile.0000025896.61490.6d
   Lien SM, 2008, MAT SCI ENG C-BIO S, V28, P36, DOI 10.1016/j.msec.2006.12.015
   Liu XH, 2009, BIOMATERIALS, V30, P4094, DOI 10.1016/j.biomaterials.2009.04.024
   Lorenzini S, 2007, STEM CELLS, V25, P2383, DOI 10.1634/stemcells.2007-0056
   Mao JS, 2003, BIOMATERIALS, V24, P1621, DOI 10.1016/S0142-9612(02)00549-5
   Mazza G, 2015, SCI REP-UK, V5, DOI 10.1038/srep13079
   Mei N, 2005, J BIOMATER APPL, V19, P323, DOI 10.1177/0885328205048630
   Mirzaei E., 2014, INT J NANOMED, V1, P137, DOI [10.7508/nmj.2014.03.003, DOI 10.7508/NMJ.2014.03.003]
   Mwale F, 2005, TISSUE ENG, V11, P130, DOI 10.1089/ten.2005.11.130
   Nyblom H, 2004, ALCOHOL ALCOHOLISM, V39, P336, DOI 10.1093/alcalc/agh074
   Ranucci CS, 1999, TISSUE ENG, V5, P407, DOI 10.1089/ten.1999.5.407
   Ruan JL, 2013, TISSUE ENG PART C-ME, V19, P794, DOI [10.1089/ten.tec.2012.0460, 10.1089/ten.TEC.2012.0460]
   Sell SA, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/4/045001
   Shen F, 2000, POLYM INT, V49, P1596, DOI 10.1002/1097-0126(200012)49:12<1596::AID-PI553>3.3.CO;2-J
   Shimizu S, 1996, CANCER RES, V56, P2161
   Su ZC, 2014, MAT SCI ENG C-MATER, V45, P374, DOI 10.1016/j.msec.2014.09.022
   Sung HW, 1998, J BIOMED MATER RES, V42, P560, DOI 10.1002/(SICI)1097-4636(19981215)42:4<560::AID-JBM12>3.0.CO;2-I
   Sung HW, 2001, J BIOMED MATER RES, V55, P538, DOI 10.1002/1097-4636(20010615)55:4<538::AID-JBM1047>3.3.CO;2-U
   Thein-Han WW, 2009, ACTA BIOMATER, V5, P3453, DOI 10.1016/j.actbio.2009.05.012
   Wang QS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034122
   Yang YM, 2011, EUR J PHARM BIOPHARM, V79, P519, DOI 10.1016/j.ejpb.2011.06.008
   Zhang Y, 2014, MAT SCI ENG C-MATER, V41, P52, DOI 10.1016/j.msec.2014.03.059
NR 40
TC 10
Z9 11
U1 10
U2 64
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG
PY 2016
VL 104
IS 8
BP 1863
EP 1870
DI 10.1002/jbm.a.35717
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DR2LR
UT WOS:000379736500002
PM 27027247
DA 2018-10-20
ER

PT J
AU Hernandez-Cordova, R
   Mathew, DA
   Balint, R
   Carrillo-Escalante, HJ
   Cervantes-Uc, JM
   Hidalgo-Bastida, LA
   Hernandez-Sanchez, F
AF Hernandez-Cordova, R.
   Mathew, D. A.
   Balint, R.
   Carrillo-Escalante, H. J.
   Cervantes-Uc, J. M.
   Hidalgo-Bastida, L. A.
   Hernandez-Sanchez, F.
TI Indirect three-dimensional printing: A method for fabricating
   polyurethane-urea based cardiac scaffolds
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE indirect 3D printing; rapid prototyping; scaffold fabrication;
   polyurethane-urea; cardiac tissue engineering
ID TISSUE ENGINEERING SCAFFOLDS; 3D CULTURE-SYSTEMS; POLYCAPROLACTONE
   SCAFFOLD; CHAIN EXTENDERS; ELASTOMERS; PUTRESCINE; CYTOCOMPATIBILITY;
   DEGRADATION; HYPOXIA; BONE
AB Biomaterial scaffolds are a key part of cardiac tissue engineering therapies. The group has recently synthesized a novel polycaprolactone based polyurethane-urea copolymer that showed improved mechanical properties compared with its previously published counterparts. The aim of this study was to explore whether indirect three-dimensional (3D) printing could provide a means to fabricate this novel, biodegradable polymer into a scaffold suitable for cardiac tissue engineering. Indirect 3D printing was carried out through printing water dissolvable poly(vinyl alcohol) porogens in three different sizes based on a wood-stack model, into which a polyurethane-urea solution was pressure injected. The porogens were removed, leading to soft polyurethane-urea scaffolds with regular tubular pores. The scaffolds were characterized for their compressive and tensile mechanical behavior; and their degradation was monitored for 12 months under simulated physiological conditions. Their compatibility with cardiac myocytes and performance in novel cardiac engineering-related techniques, such as aggregate seeding and bi-directional perfusion, was also assessed. The scaffolds were found to have mechanical properties similar to cardiac tissue, and good biocompatibility with cardiac myocytes. Furthermore, the incorporated cells preserved their phenotype with no signs of de-differentiation. The constructs worked well in perfusion experiments, showing enhanced seeding efficiency. (c) 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 104A: 1912-1921, 2016.
C1 [Hernandez-Cordova, R.; Carrillo-Escalante, H. J.; Cervantes-Uc, J. M.; Hernandez-Sanchez, F.] Ctr Invest Cient Yucatan AC, Merida, Yucatan, Mexico.
   [Mathew, D. A.; Hidalgo-Bastida, L. A.] Manchester Metropolitan Univ, Sch Healthcare Sci, Manchester, Lancs, England.
   [Balint, R.] Univ Manchester, Sch Mat, Manchester, Lancs, England.
RP Hernandez-Sanchez, F (reprint author), Ctr Invest Cient Yucatan AC, Unidad Mat, Calle 43 130, Merida 97200, Yucatan, Mexico.
EM fhs@cicy.mx
OI Hidalgo-Bastida, Lilia Araida/0000-0003-2652-2395
FU FOMIX [170132]
FX Contract grant sponsor: FOMIX; contract grant number: 170132
CR Akhyari P, 2002, CIRCULATION, V106, pI137, DOI 10.1161/01.cir.0000032893.55215.fc
   Arana M, 2013, ACTA BIOMATER, V9, P6075, DOI 10.1016/j.actbio.2012.12.014
   Barton P, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4044
   Boffito M, 2014, POLYM INT, V63, P2, DOI 10.1002/pi.4608
   Cauich-Rodriaguez JV, 2013, ADV BIOMATERIALS SCI, P51
   Chan V, 2013, ACS NANO, V7, P1830, DOI 10.1021/nn401098c
   Chan-Chan LH, 2013, J MATER SCI-MATER M, V24, P1733, DOI 10.1007/s10856-013-4931-4
   Chan-Chan LH, 2010, ACTA BIOMATER, V6, P2035, DOI 10.1016/j.actbio.2009.12.010
   Chen QZ, 2008, BIOMATERIALS, V29, P47, DOI 10.1016/j.biomaterials.2007.09.010
   Chimenti I, 2011, BIOMATERIALS, V32, P9271, DOI 10.1016/j.biomaterials.2011.08.049
   Chiono V, 2014, INTERFACE FOCUS, V4, DOI 10.1098/rsfs.2013.0045
   Chiu LLY, 2013, CURR OPIN CHEM ENG, V2, P41, DOI 10.1016/j.coche.2013.01.002
   Courtney T, 2006, BIOMATERIALS, V27, P3631, DOI 10.1016/j.biomaterials.2006.02.024
   Fleischer S, 2013, BIOMATERIALS, V34, P8599, DOI 10.1016/j.biomaterials.2013.07.054
   Generali M., 2014, EUR MED J INTERV CAR, V1, P91
   Ghanbarzadeh B, 2013, BIODEGRADATION LIFE, P141
   Gibson L. J., 2010, CELLULAR MAT NATURE
   Godier-Furnemont AFG, 2011, P NATL ACAD SCI USA, V108, P7974, DOI 10.1073/pnas.1104619108
   Guan JJ, 2004, BIOMATERIALS, V25, P85, DOI 10.1016/S0142-9612(03)00476-9
   Guan JJ, 2002, J BIOMED MATER RES, V61, P493, DOI 10.1002/jbm.10204
   Hong Y, 2010, BIOMATERIALS, V31, P4249, DOI 10.1016/j.biomaterials.2010.02.005
   Lebourg M, 2008, J MATER SCI-MATER M, V19, P2047, DOI 10.1007/s10856-007-3282-4
   May-Hernandez L, 2011, J APPL POLYM SCI, V119, P2093, DOI 10.1002/app.32929
   Melchels FPW, 2011, BIOMATERIALS, V32, P2878, DOI 10.1016/j.biomaterials.2011.01.023
   Muller M, 2012, CELL MOL LIFE SCI, V69, P3457, DOI 10.1007/s00018-012-1030-5
   Park J-Y., 2014, EVID-BASED COMPL ALT, V2014, P1, DOI DOI 10.1371/J0URNAL.P0NE.0112678
   PICKOVER C. A., 2008, ARCHIMEDES HAWKING L
   TABOR CW, 1976, ANNU REV BIOCHEM, V45, P285, DOI 10.1146/annurev.bi.45.070176.001441
   Taylor DA, 2014, AM J TRANSPLANT, V14, P2448, DOI 10.1111/ajt.12939
   Volkmer E, 2008, TISSUE ENG PT A, V14, P1331, DOI 10.1089/ten.tea.2007.0231
   Volkmer E, 2012, J MATER SCI-MATER M, V23, P2793, DOI 10.1007/s10856-012-4725-0
   Vrana NE, 2008, MACROMOL SYMP, V269, P106, DOI 10.1002/masy.200850913
   Yeong WY, 2010, ACTA BIOMATER, V6, P2028, DOI 10.1016/j.actbio.2009.12.033
   Yeong WY, 2004, TRENDS BIOTECHNOL, V22, P643, DOI 10.1016/j.tibtech.2004.10.004
NR 34
TC 5
Z9 6
U1 3
U2 83
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG
PY 2016
VL 104
IS 8
BP 1912
EP 1921
DI 10.1002/jbm.a.35721
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DR2LR
UT WOS:000379736500007
PM 26991636
OA Other Gold, Green Published
DA 2018-10-20
ER

PT J
AU Goncalves, C
   Ribeiro, J
   Pereira, T
   Luis, AL
   Mauricio, AC
   Santos, JD
   Lopes, MA
AF Goncalves, C.
   Ribeiro, J.
   Pereira, T.
   Luis, A. L.
   Mauricio, A. C.
   Santos, J. D.
   Lopes, M. A.
TI Preparation and characterization of electrical conductive PVA based
   materials for peripheral nerve tube-guides
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE poly(vinyl alcohol); carbon nanotubes; poly(pyrrole); nerve guide;
   tissue engineering
ID POLY(VINYL ALCOHOL); REGENERATION; CELLS
AB Peripheral nerve regeneration is a serious clinical problem. Presently, there are several nerve tube-guides available in the market, however with some limitations. The goal of this work was the development of a biomaterial with high electrical conductivity to produce tube-guides for nerve regeneration after neurotmesis injuries whenrver an end-to-end suture without tension is not possible. A matrix of poly(vinyl alcohol) (PVA) was used loaded with the following electrical conductive materials: COOH-functionalized multiwall carbon nanotubes (MWCNTs), poly(pyrrole) (PPy), magnesium chloride (MgCl2), and silver nitrate (AgNO3). The tube-guide production was carried out by a freezing/thawing process (physical crosslinking) with a final annealing treatment. After producing the tube-guide for nerve regeneration, the physicochemical characterization was performed. The most interesting results were achieved by loading PVA with 0.05% of PPy or COOH- functionalized CNTs. These tubes combined the electrical conductivity of carbon nanotubes (CNTs) and PPy with the biocompatibility of PVA matrix, with potential clinical application for nerve regeneration. (c) 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 104A: 1981-1987, 2016.
C1 [Goncalves, C.; Santos, J. D.; Lopes, M. A.] Univ Porto, Dept Engn Met & Mat, CEMUC, Fac Engn,FEUP, Rua Dr Roberto Frias S-N, P-4200465 Oporto, Portugal.
   [Ribeiro, J.; Pereira, T.; Luis, A. L.; Mauricio, A. C.] Univ Porto, ICBAS, Dept Clin Vet, Rua Jorge Viterbo Ferreira 228, P-4050313 Oporto, Portugal.
   [Ribeiro, J.; Pereira, T.; Luis, A. L.; Mauricio, A. C.] Inst Ciencias & Tecnol & Agr Alimentares ICETA, CECA, Rua D Manuel 2,Apartado 55142, P-4051401 Oporto, Portugal.
RP Mauricio, AC (reprint author), Univ Porto, ICBAS, Rua Jorge Viterbo Ferreira 228, P-4050313 Oporto, Portugal.
EM ana.colette@hotmail.com
OI Goncalves, Carolina/0000-0002-9165-6560; Lopes, Maria
   A./0000-0003-4105-8148; Mauricio, Ana Colette/0000-0002-0018-9363;
   Santos, Jose Domingos/0000-0002-6871-9850
FU FEDER (COMPETE) [PEst-C/EME/UI0285/2011]; Project "iBone Therapies:
   Terapias inovadoras para a regeneracao ossea"
   [NORTE-01-0247-FEDER-003262]
FX Contract grant sponsor: FEDER (COMPETE); contract grant number:
   PEst-C/EME/UI0285/2011; Contract grant sponsor: Project "iBone
   Therapies: Terapias inovadoras para a regeneracao ossea"; contract grant
   number: NORTE-01-0247-FEDER-003262
CR [Anonymous], 1999, MOW POL ALC MAN
   Chang J. Y., 2010, THESIS
   Chang JY, 2000, ADV POLYM SCI, V153
   Chen L, 2008, J NANOMATER, V2008, P63
   Chen W, 2005, APPL SURF SCI, V252, P1404, DOI 10.1016/j.apsusc.2005.02.138
   de la Cruz EF, 2012, INT J ELECTROCHEM SC, V7, P3577
   Eisazadeh H., 2007, WORLD J CHEM, V2, P67
   Gartner A, 2012, NEURAL REGEN RES, V7, P2247, DOI 10.3969/j.issn.1673-5374.2012.29.002
   Garbassi F, 2002, POLYM SURFACE PHYS T, P161
   Gartner A, 2014, J STEM CELLS REGEN, V10, pP14
   Ghasemi-Mobarakeh L, 2011, J TISSUE ENG REGEN M, V5, pE17, DOI 10.1002/term.383
   Girotto EM, 2002, QUIM NOVA, V25, P639, DOI 10.1590/S0100-40422002000400019
   He C, 2003, SYNTHETIC MET, V139, P539, DOI 10.1016/S0379-6779(03)00360-6
   Hoke A, 2006, NAT CLIN PRACT NEURO, V2, P448, DOI 10.1038/ncpneuro0262
   Hudson TW, 2000, ORTHOP CLIN N AM, V31, P485, DOI 10.1016/S0030-5898(05)70166-8
   Ichihara S, 2008, INJURY, V39, pS29, DOI 10.1016/j.injury.2008.08.029
   Jiang X, 2010, EXP NEUROL, V223, P86, DOI 10.1016/j.expneurol.2009.09.009
   Kakade BA, 2008, J PHYS CHEM C, V112, P3183, DOI 10.1021/jp711657f
   Lakouraj MM, 2005, IRAN POLYM J, V14, P1022
   Luis AL, 2008, TISSUE ENG PT A, V14, P979, DOI 10.1089/ten.tea.2007.0273
   Lundborg G, 2002, J PERIPHER NERV SYST, V7, P139, DOI 10.1046/j.1529-8027.2002.02019.x
   Mansur HS, 2008, MAT SCI ENG C-BIO S, V28, P539, DOI 10.1016/j.msec.2007.10.088
   Oka M, 2000, MEDIDA QUATO PONTAS
   Park JS, 2001, J APPL POLYM SCI, V82, P1816, DOI 10.1002/app.2023
   Schmidt CELJ, 2003, ANNU REV BIOMED ENG, V5, P165
   Gonzalez JS, 2011, THERMOCHIM ACTA, V521, P184, DOI 10.1016/j.tca.2011.04.022
   Tager A., 1972, PHYS CHEM POLYM
   Teh KS, 2008, PROC IEEE MICR ELECT, P363
   Zamri M.F.M.A., 2011, INT J ENG TECHNOLOGY, V11, P20
NR 29
TC 4
Z9 4
U1 3
U2 28
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG
PY 2016
VL 104
IS 8
BP 1981
EP 1987
DI 10.1002/jbm.a.35730
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DR2LR
UT WOS:000379736500013
PM 27027727
DA 2018-10-20
ER

PT J
AU Jansen, MA
   Singh, SS
   Chawla, N
   Franz, NM
AF Jansen, M. Andrew
   Singh, Sudhanshu S.
   Chawla, Nikhilesh
   Franz, Nico M.
TI A multilayer micromechanical model of the cuticle of Curculio longinasus
   Chittenden, 1927 (Coleoptera: Curculionidae)
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article
DE Curculionidae; Beetle cuticle; Chitin; Homogenization; Elastic
   properties; Multilayer
ID MAXWELL HOMOGENIZATION SCHEME; EFFECTIVE ELASTIC PROPERTIES;
   MECHANICAL-PROPERTIES; EXOSKELETAL MICROSTRUCTURE; COMPOSITE-MATERIALS;
   INSECT CUTICLE; ARMS-RACE; DESIGN; MATRIX; PERFORMANCE
AB Curculio longinasus Chittenden, 1927 (Coleoptera: Curculionidae), is a weevil species common throughout the southwestern United States that uses its rostrum- a very slender, curved, beak-like projection of the head-to excavate tunnels in plant organs (such as acorns) for egg laying (oviposition). Once the apical portion of the rostrum has been inserted into the preferred substrate for oviposition, the female begins rotating around the perimeter of the hole, elevating her head by extending the fore-legs, and rotating the head in place in a drilling motion. This action causes significant elastic deformation of the rostrum, which will bend until it becomes completely straight. To better understand the mechanical behavior of the cuticle as it undergoes deformation during the preparation of oviposition sites, we develop a comprehensive micro/macro model of the micromechanical structure and properties of the cuticle, spanning across all cuticular regions, and reliably mirroring the resultant macroscale properties of the cuticle. Our modeling approach relies on the use of multi-scale, hierarchical biomaterial representation, and employs various micromechanical schemata-e.g., Mori-Tanaka, effective field, and Maxwell-to calculate the homogenized properties of representative volume elements at each level in the hierarchy. We describe the configuration and behavior of this model in detail, and discuss the theoretical implications and limitations of this approach with emphasis on future biomechanical and comparative evolutionary research. Our detailed account of this approach can thereby serve as a methodological template for exploring the biomechanical behavior of new insect structures. (C) 2016 Published by Elsevier Inc.
C1 [Jansen, M. Andrew; Franz, Nico M.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA.
   [Singh, Sudhanshu S.] Indian Inst Technol, Dept Mat Sci & Engn, Kanpur 208016, Uttar Pradesh, India.
   [Chawla, Nikhilesh] Arizona State Univ, Sch Engn Matter Energy & Transport, Tempe, AZ USA.
RP Jansen, MA (reprint author), Arizona State Univ, Sch Life Sci, Tempe, AZ USA.
EM entojansen@gmail.com
FU National Science Foundation [DEB-1155984]; United States Department of
   Agriculture-Agricultural Research Service [58-1275-1-335]
FX This research was funded in part by the National Science Foundation
   (DEB-1155984) and the United States Department of
   Agriculture-Agricultural Research Service (Agreement 58-1275-1-335).
CR Aguirre Uribe LA., 1978, THESIS
   BENVENISTE Y, 1987, MECH MATER, V6, P147, DOI 10.1016/0167-6636(87)90005-6
   BLACKWELL J, 1980, J MOL BIOL, V137, P49, DOI 10.1016/0022-2836(80)90156-4
   BOULIGAND Y, 1972, TISSUE CELL, V4, P189, DOI 10.1016/S0040-8166(72)80042-9
   Buryachenko VA, 2008, ACTA MECH, V198, P129, DOI 10.1007/s00707-007-0531-z
   Chen PY, 2008, ACTA BIOMATER, V4, P587, DOI 10.1016/j.actbio.2007.12.010
   Cheng L, 2008, J MATER RES, V23, P2854, DOI 10.1557/JMR.2008.0375
   Cheng L, 2009, J MATER RES, V24, P3253, DOI 10.1557/JMR.2009.0409
   Davis S.R, 2014, THESIS
   Doghri I, 2000, MECH DEFORMABLE SOLI
   Dumont ER, 2009, J THEOR BIOL, V256, P96, DOI 10.1016/j.jtbi.2008.08.017
   Flannigan W. C., 1998, THESIS
   Gibson L. P, 1969, MISC PUBL ENTOMOL SO, V6, P239
   GIRAUDGUILLE MM, 1990, J STRUCT BIOL, V103, P232, DOI 10.1016/1047-8477(90)90041-A
   HEPBURN HR, 1973, J MATER SCI, V8, P618, DOI 10.1007/BF00561216
   Herbert RC, 2000, J EXP BIOL, V203, P2945
   HILL R, 1952, P PHYS SOC LOND A, V65, P349, DOI 10.1088/0370-1298/65/5/307
   Hornschemeyer T, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.12601
   Hughes J, 2004, MOL PHYLOGENET EVOL, V32, P601, DOI 10.1016/j.ympev.2004.02.007
   Hyun S, 2000, J MATER RES, V15, P1985, DOI 10.1557/JMR.2000.0285
   Kachanov M, 2005, INT J SOLIDS STRUCT, V42, P309, DOI 10.1016/j.ijsolstr.2004.06.016
   Kachanov M, 1999, INT J FRACTURE, V97, P1, DOI 10.1023/A:1018345702490
   Kaya M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115531
   Ker RF, 1977, THESIS
   Klocke D, 2011, ACTA BIOMATER, V7, P2935, DOI 10.1016/j.actbio.2011.04.004
   Leopold R. A., 1992, INT J INSECT MORPHOL
   McCullough EL, 2014, P NATL ACAD SCI USA, V111, P14484, DOI 10.1073/pnas.1409585111
   McNamara ME, 2012, P ROY SOC B-BIOL SCI, V279, P1114, DOI 10.1098/rspb.2011.1677
   Moffett M., 1989, NATL GEOGR MAG, V176, P783
   MORI T, 1973, ACTA METALL MATER, V21, P571, DOI 10.1016/0001-6160(73)90064-3
   Morimoto Katsura, 2003, Esakia, V43, P133
   Mura T, 1987, MICROMECHANICS DEFEC, V3
   NEVILLE AC, 1976, J CELL SCI, V21, P73
   Nikolov S, 2011, J MECH BEHAV BIOMED, V4, P129, DOI 10.1016/j.jmbbm.2010.09.015
   Nikolov S, 2010, ADV MATER, V22, P519, DOI 10.1002/adma.200902019
   Oberprieler R., 2014, HDB ZOOL ARTHROPODA, V3, P503
   Raabe D, 2005, ACTA MATER, V53, P4281, DOI 10.1016/j.actamat.2005.05.027
   Reddy JN, 2004, MECH LAMINATED COMPO
   Saadat F, 2012, INT J FRACTURE, V174, P237, DOI 10.1007/s10704-012-9688-0
   Sachs C, 2008, J STRUCT BIOL, V161, P120, DOI 10.1016/j.jsb.2007.09.022
   Sevostianov I, 2005, INT J SOLIDS STRUCT, V42, P455, DOI 10.1016/j.ijsolstr.2004.06.047
   Sevostianov I, 2002, J MECH PHYS SOLIDS, V50, P253, DOI 10.1016/S0022-5096(01)00051-5
   Sevostianov I, 2001, ARCH APPL MECH, V71, P733, DOI 10.1007/s004190100181
   Sevostianov I, 2008, INT J ENG SCI, V46, P211, DOI 10.1016/j.ijengsci.2007.11.003
   Sevostianov I, 2015, MECH MATER, V84, P28, DOI 10.1016/j.mechmat.2015.01.004
   Sevostianov I, 2014, MECH MATER, V75, P45, DOI 10.1016/j.mechmat.2014.03.003
   Sevostianov I, 2013, INT J ENG SCI, V64, P23, DOI 10.1016/j.ijengsci.2012.12.004
   Ting P. C., 1936, Microentomology Stanford University, V1, P93
   Ting P. C., 1933, Mon Bull Dep Agric California Sacramento, V22, P161
   Toju H, 2006, AM NAT, V167, P105, DOI 10.1086/498277
   Toju H, 2008, EVOLUTION, V62, P1086, DOI 10.1111/j.1558-5646.2008.00341.x
   Toju H, 2006, BIOL LETT-UK, V2, P539, DOI 10.1098/rsbl.2006.0514
   van de Kamp T., 2015, ARTHROPOD STRUCT DEV, V45, P14
   van de Kamp T., 2010, ENTOMOLOGIE HEUTE, V22, P191
   Vilchevskaya E, 2015, INT J ENG SCI, V94, P139, DOI 10.1016/j.ijengsci.2015.05.006
   Vincent JFV, 2004, ARTHROPOD STRUCT DEV, V33, P187, DOI 10.1016/j.asd.2004.05.006
   Vincent JFV., 1982, STRUCTURAL BIOMATERI
NR 57
TC 3
Z9 3
U1 0
U2 10
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
EI 1095-8657
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD AUG
PY 2016
VL 195
IS 2
BP 139
EP 158
DI 10.1016/j.jsb.2016.05.007
PG 20
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA DQ8ID
UT WOS:000379452500001
PM 27189867
OA Other Gold
DA 2018-10-20
ER

PT J
AU Sun, RJ
   Guan, YC
   Zhu, Y
AF Sun, Rujian
   Guan, Yingchun
   Zhu, Ying
TI DEVELOPMENT OF LASER SURFACE TECHNOLOGIES FOR ANTI-CORROSION ON
   MAGNESIUM ALLOYS: A REVIEW
SO SURFACE REVIEW AND LETTERS
LA English
DT Article
DE Laser surface melting; laser surface alloying; laser surface cladding;
   laser shock peening; magnesium alloy; anti-corrosion
ID MICRO-ARC OXIDATION; SOL-GEL COATINGS; AL-SI ALLOY;
   CORROSION-RESISTANCE; MG ALLOY; CONVERSION COATINGS; COMPOSITE COATINGS;
   CERAMIC COATINGS; WEAR-RESISTANCE; BASE ALLOY
AB Magnesium (Mg) alloys have been increasingly used in industries and biomaterial fields due to low density, high specific strength and biodegradability. However, poor surface-related properties are major factors that limit their practical applications. This paper mainly focuses on laser-based anti-corrosion technologies for Mg alloys, beginning with a brief review of conventional methods, and then demonstrates the feasibility of laser surface technologies including laser surface melting (LSM), laser surface alloying (LSA), laser surface cladding (LSC) and laser shock peening (LSP) in achieving enhancement of corrosion resistance. The mechanism and capability of each technique in corrosion resistance is carefully discussed. Finally, an outlook of the development of laser surface technology for Mg alloy is further concluded, aiming to serve as a guide for further research both in industry applications and biomedical devices.
C1 [Sun, Rujian; Guan, Yingchun; Zhu, Ying] Beihang Univ, 37 Xueyuan Rd, Beijing 100191, Peoples R China.
   [Guan, Yingchun] Nanyang Technol Univ, 50 Nanyang Ave, Singapore 639798, Singapore.
   [Guan, Yingchun] Singapore Inst Mfg Technol, 71 Nanyang Dr, Singapore 638075, Singapore.
RP Guan, YC (reprint author), Beihang Univ, 37 Xueyuan Rd, Beijing 100191, Peoples R China.; Guan, YC (reprint author), Nanyang Technol Univ, 50 Nanyang Ave, Singapore 639798, Singapore.; Guan, YC (reprint author), Singapore Inst Mfg Technol, 71 Nanyang Dr, Singapore 638075, Singapore.
EM guan0013@e.ntu.edu.sg
FU National Key Basic Research Program of China [2015CB059900]; Beijing
   Natural Science Foundation [3162019]; Fundamental Research Funds for the
   Central Universities from Beihang University [30425901]; A*STAR
   Collaboration Research Project [U09-M-006SU]
FX Support by the National Key Basic Research Program of China with Grant
   No. 2015CB059900, Beijing Natural Science Foundation with Grant No.
   3162019, Fundamental Research Funds for the Central Universities from
   Beihang University with Project Code 30425901 and A*STAR Collaboration
   Research Project with Project Code U09-M-006SU is gratefully
   acknowledged.
CR Abbas G, 2005, APPL SURF SCI, V247, P347, DOI [10.1016/j.apsusc.2005.01.169, 10.1016/J.APSUSC.2005.01.169]
   Altun H, 2006, MATER DESIGN, V27, P1174, DOI 10.1016/j.matdes.2005.02.004
   Ardelean H, 2008, CORROS SCI, V50, P1907, DOI 10.1016/j.corsci.2008.03.015
   Bobzin K, 2013, J THERM SPRAY TECHN, V22, P207, DOI 10.1007/s11666-012-9867-6
   Brunelli K, 2005, CORROS SCI, V47, P989, DOI 10.1016/j.corsci.2004.06.016
   Cai QZ, 2006, SURF COAT TECH, V200, P3727, DOI 10.1016/j.surfcoat.2005.05.039
   Chen CJ, 2007, CORROS ENG SCI TECHN, V42, P130, DOI 10.1179/174327807X196852
   Chen CJ, 2008, LASER ENG, V18, P85
   Chen CJ, 2007, RARE METALS, V26, P420, DOI 10.1016/S1001-0521(07)60239-3
   Chen CJ, 2011, ADV MATER RES-SWITZ, V314-316, P1867, DOI 10.4028/www.scientific.net/AMR.314-316.1867
   [陈长军 Chen Changjun], 2007, [应用激光, Applied Laser], V27, P261
   Chong KZ, 2003, MATER CHEM PHYS, V80, P191, DOI 10.1016/S0254-0584(02)00481-9
   Cui ZQ, 2015, T NONFERR METAL SOC, V25, P1446, DOI 10.1016/S1003-6326(15)63744-X
   Cui ZQ, 2012, J WUHAN UNIV TECHNOL, V27, P1042, DOI 10.1007/s11595-012-0597-x
   Duan HP, 2007, ELECTROCHIM ACTA, V52, P3785, DOI 10.1016/j.electacta.2006.10.066
   Galun R., 1996, 11 INT S GAS FLOW CH, V3092, P744
   Gao YL, 2007, APPL SURF SCI, V253, P5306, DOI 10.1016/j.apsusc.2006.12.001
   Gao YL, 2006, SURF COAT TECH, V201, P2701, DOI 10.1016/j.surfcoat.2006.05.011
   Ge Maozhong, 2010, Chinese Journal of Lasers, V37, P2925, DOI 10.3788/CJL20103711.2925
   Gray JE, 2002, J ALLOY COMPD, V336, P88, DOI 10.1016/S0925-8388(01)01899-0
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Guan YC, 2008, MATER LETT, V62, P4494, DOI 10.1016/j.matlet.2008.08.025
   Guan YC, 2009, J APPL ELECTROCHEM, V39, P1457, DOI 10.1007/s10800-009-9825-2
   Guo HF, 2006, APPL SURF SCI, V252, P7911, DOI 10.1016/j.apsusc.2005.09.067
   Guo HF, 2005, APPL SURF SCI, V246, P229, DOI 10.1016/j.apsusc.2004.11.031
   Guo YB, 2012, CIRP ANN-MANUF TECHN, V61, P583, DOI 10.1016/j.cirp.2012.03.125
   Hou B., 2008, ELECTROMECH ENG, V24, P42
   Hu Q. W., 2001, APPL LASER, V21, P247
   Huang Y. C., 2012, MODERN MAT CORROSION
   Huo HW, 2004, CORROS SCI, V46, P1467, DOI 10.1016/j.corsci.2003.09.023
   Khramov AN, 2006, THIN SOLID FILMS, V514, P174, DOI 10.1016/j.tsf.2006.02.023
   Li J.X., 2013, THESIS
   Li S. Z., 2014, CHIN J LASERS, V40, P1
   Li XC, 2013, MATER SCI TECH-LOND, V29, P626, DOI 10.1179/1743284712Y.0000000166
   Li Y. H., 2013, LASER SHOCK PROCESSI
   Liang J, 2005, SURF COAT TECH, V199, P121, DOI 10.1016/j.surfcoat.2005.03.020
   Liu CC, 2015, APPL SURF SCI, V343, P133, DOI 10.1016/j.apsusc.2015.03.067
   [刘红宾 Liu Hongbin], 2005, [应用激光, Applied Laser], V25, P299
   Liu Y., 2008, ADV MAT SURFACE PROC
   Liu Z. H., 2014, THESIS
   Majumdar JD, 2010, SCRIPTA MATER, V62, P579, DOI 10.1016/j.scriptamat.2009.12.047
   Majumdar JD, 2003, MAT SCI ENG A-STRUCT, V361, P119, DOI 10.1016/S0921-5093(03)00519-7
   Majumdar JD, 2002, LASER ENG, V12, P147, DOI 10.1080/0898150021000039275
   Mondal AK, 2008, SURF COAT TECH, V202, P3187, DOI 10.1016/j.surfcoat.2007.11.030
   Mu WY, 2008, SURF COAT TECH, V202, P4278, DOI 10.1016/j.surfcoat.2008.03.022
   Parco M, 2006, SURF COAT TECH, V201, P3269, DOI 10.1016/j.surfcoat.2006.06.047
   Pardo A, 2009, APPL SURF SCI, V255, P6968, DOI 10.1016/j.apsusc.2009.03.022
   Pokhmurska H, 2008, SURF COAT TECH, V202, P4515, DOI 10.1016/j.surfcoat.2008.04.036
   Qian M. G., 2008, MODERN SURFACE TECHN
   Qian M, 2008, SCI TECHNOL ADV MAT, V9, DOI 10.1088/1468-6996/9/2/025002
   Samant AN, 2009, J EUR CERAM SOC, V29, P969, DOI 10.1016/j.jeurceramsoc.2008.11.010
   Sealy MP, 2010, J MECH BEHAV BIOMED, V3, P488, DOI 10.1016/j.jmbbm.2010.05.003
   Singh A, 2012, JOM-US, V64, P716, DOI 10.1007/s11837-012-0340-2
   Song GL, 1999, ADV ENG MATER, V1, P11, DOI 10.1002/(SICI)1527-2648(199909)1:1<11::AID-ADEM11>3.0.CO;2-N
   Song GL, 2003, ADV ENG MATER, V5, P837, DOI 10.1002/adem.200310405
   Tan Y., 2014, THESIS
   Vilar R, 1999, MATER SCI FORUM, V301, P229, DOI 10.4028/www.scientific.net/MSF.301.229
   Wang AH, 2001, COMPOS SCI TECHNOL, V61, P1549, DOI 10.1016/S0266-3538(01)00054-9
   Wang B, 2010, THESIS
   Wang CS, 2010, SURF COAT TECH, V205, P189, DOI 10.1016/j.surfcoat.2010.06.032
   Wang CS, 2009, APPL SURF SCI, V256, P1609, DOI 10.1016/j.apsusc.2009.09.029
   Wang D, 2009, PROG ORG COAT, V64, P327, DOI 10.1016/j.porgcoat.2008.08.010
   Wang LQ, 2014, MATER CORROS, V65, P820, DOI 10.1002/maco.201307092
   Winzer N, 2005, ADV ENG MATER, V7, P659, DOI 10.1002/adem.200500071
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2008, CURR OPIN SOLID ST M, V12, P63, DOI 10.1016/j.cossms.2009.04.001
   Xi XX, 2007, PHYSICA C, V456, P22, DOI 10.1016/j.physc.2007.01.029
   Xu Kaiddng, 2012, Special Casting & Nonferrous Alloys, V32, P1070
   Xu R. J., 2008, THESIS
   Yue TM, 2008, SURF COAT TECH, V202, P3043, DOI 10.1016/j.surfcoat.2007.11.007
   Yue TM, 2014, MATER RES INNOV, V18, P624, DOI 10.1179/1432891714Z.000000000530
   Yue TM, 2007, J MATER SCI, V42, P6153, DOI 10.1007/s10853-006-1134-0
   Yue TM, 2001, J MATER SCI LETT, V20, P1479, DOI 10.1023/A:1017966111324
   Zeng RC, 2008, ADV ENG MATER, V10, pB3, DOI 10.1002/adem.200800035
   Zhang L., 2014, HUM VACC IMMUNOTHER, V10, P10, DOI DOI 10.1371/J0URNAL.P0NE.0111127
   Zhang L. Q., 2013, CLEAN-SOIL AIR WATER, V41, P1
   Zhang Q. L., 2015, CHIN J LASERS, V42
   Zhang YK, 2010, SURF COAT TECH, V204, P3947, DOI 10.1016/j.surfcoat.2010.03.015
   Zhang Yongkang, 2008, Chinese Journal of Lasers, V35, P1068, DOI 10.3788/CJL20083507.1068
   Zhong Minlin, 2008, Chinese Journal of Lasers, V35, P1653, DOI 10.3788/CJL20083511.1653
   [左铁钏 ZUO Tiechuan], 2009, [机械工程学报, Chinese Journal of Mechanical Engineering], V45, P106
NR 81
TC 2
Z9 3
U1 7
U2 99
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 0218-625X
EI 1793-6667
J9 SURF REV LETT
JI Surf. Rev. Lett.
PD AUG
PY 2016
VL 23
IS 4
AR 1630003
DI 10.1142/S0218625X16300033
PG 17
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA DR0RS
UT WOS:000379615200002
DA 2018-10-20
ER

PT J
AU Korley, JN
   Yazdi, S
   McHugh, K
   Kirk, J
   Anderson, J
   Putnam, D
AF Korley, Julius N.
   Yazdi, Sara
   McHugh, Kevin
   Kirk, James
   Anderson, James
   Putnam, David
TI One-step synthesis, biodegradation and biocompatibility of polyesters
   based on the metabolic synthon, dihydroxyacetone
SO BIOMATERIALS
LA English
DT Article
DE Biodegradation; Biocompatibility; Kinetics; Polyester; Dihydroxyacetone;
   Metabolic synthons; Biomaterial
ID KETAL-PROTECTED DIHYDROXYACETONE; RING-OPENING POLYMERIZATION;
   POLY(OXYETHYLENE) B-BLOCKS; IN-VIVO BIOCOMPATIBILITY; DIBLOCK
   COPOLYMERS; POLY(LACTIC ACID); TISSUE REACTION; BIOMATERIALS;
   DEGRADATION; MICROSPHERES
AB The one-step synthesis of a polyester family containing dihydroxyacetone is described along with a quantitative analysis of in vitro/in vivo degradation kinetics and initial biocompatibility. Polyesters were synthesized by combining dihydroxyacetone, which is a diol found in the eukaryotic glucose metabolic pathway, with even-carbon aliphatic diacids (adipic, suberic, sebacic) represented in the long-chain alpha carboxylic acid metabolic pathway, by Schotten-Baumann acylation. We show that by using a crystalline monomeric form of dihydroxyacetone, well-defined polyesters can be formed in one step without protection and deprotection strategies. Both diacid length and polyester molecular weight were varied to influence polymer physical and thermal properties. Polyesters were generated with number averaged (M-n) molecular weights ranging from 2200-11,500. Polydispersities were consistent with step-growth polymerization and ranged from 2 to 2.6. The melting (T-m) and recrystallization (T-c) temperatures were impacted in an unpredictable manner. Thermal transitions for the polyesters were highest for the adipic acid followed by suberic acid and sebacic acid, respectively. It was shown that the thermal response of the DHA-based polyesters was influenced by both the diacid length and molecular weight. In vitro degradation studies revealed first-order weight loss kinetics, the molecular weight loss followed first order kinetics with 25%-40% of the original mass remaining after 8 weeks. In vivo testing over 16 weeks highlighted that mass loss ranged from similar to 70% to similar to 6% depending upon initial molecular weight and diacid length. Histological analysis revealed rapid resolution of both acute and chronic inflammatory responses, normal foreign body responses were observed and no inflammation was present after week 4. This one-step synthesis proved robust with unique copolymers warranting further study as potential biomaterials. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Korley, Julius N.; Yazdi, Sara; Putnam, David] Cornell Univ, Meinig Sch Biomed Engn, Ithaca, NY 14853 USA.
   [Putnam, David] Cornell Univ, Robert Frederick Smith Sch Chem & Biomol Engn, Ithaca, NY 14853 USA.
   [Anderson, James] Dept Pathol, Cleveland, OH 44106 USA.
   [McHugh, Kevin; Kirk, James] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
RP Putnam, D (reprint author), Cornell Univ, 147 Weill Hall, Ithaca, NY 14850 USA.
EM dap43@cornell.edu
OI McHugh, Kevin/0000-0001-6801-4431; Putnam, David/0000-0002-0794-4915
FU Wallace H. Coulter Foundation; National Science Foundation CAREER Award;
   NSF MRSEC program [DMR-1120296]; Alfred P. Sloan Foundation
FX This work was supported in part from the Wallace H. Coulter Foundation
   and the National Science Foundation CAREER Award. This work made use of
   the Cornell Center for Materials Research Shared Facilities which are
   supported through the NSF MRSEC program (DMR-1120296). J.N.K would also
   like to thank the Alfred P. Sloan Foundation for a Research Fellowship.
   We are grateful to Dr. Stuart Rowan for use of the NMR Facilities and
   valuable discussions, to Dr. LaShanda Korley for laboratory space and
   use of the TA Thermal Analysis suite and to Dr. Ippolita
   Cantuti-Castelvetri for help with the statistical analysis. We thank
   Drs. David Schiraldi and Thomas H. Mourey for their valuable
   contributions.
CR AGRAWAL CM, 1992, BIOMATERIALS, V13, P176, DOI 10.1016/0142-9612(92)90068-Y
   Albertsson A.-C., 2002, DEGRADABLE ALIPHATIC, P1, DOI 10.1007/3-540-45734-8_1
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 1997, ADV DRUG DELIVER REV, V28, P5, DOI 10.1016/S0169-409X(97)00048-3
   ANDERSON JM, 1994, EUR J PHARM BIOPHARM, V40, P1
   BENTLEY PH, 1970, J ORG CHEM, V35, P2082, DOI 10.1021/jo00831a105
   BLUNDELL DJ, 1987, POLYMER, V28, P2248, DOI 10.1016/0032-3861(87)90382-X
   Coulembier O, 2006, PROG POLYM SCI, V31, P723, DOI 10.1016/j.progpolymsci.2006.08.004
   DAVIS L, 1973, BIOORG CHEM, V2, P197, DOI 10.1016/0045-2068(73)90023-0
   ESMANN V, 1968, ACTA CHEM SCAND, V22, P2281, DOI 10.3891/acta.chem.scand.22-2281
   Flory Paul, 1953, PRINCIPLES OF POLYME
   Grayson ACR, 2004, J BIOMAT SCI-POLYM E, V15, P1281, DOI 10.1163/1568562041959991
   Helou M, 2011, POLYM CHEM-UK, V2, P2789, DOI 10.1039/c1py00405k
   Henderson PW, 2010, J BIOMED MATER RES A, V93A, P776, DOI 10.1002/jbm.a.32586
   Holy CE, 1999, BIOMATERIALS, V20, P1177, DOI 10.1016/S0142-9612(98)00256-7
   Hori Y, 1996, MACROMOLECULES, V29, P804, DOI 10.1021/ma951345i
   Jung K, 2008, SPECTROCHIM ACTA A, V69, P1423, DOI 10.1016/j.saa.2007.09.029
   KENLEY RA, 1987, MACROMOLECULES, V20, P2398, DOI 10.1021/ma00176a012
   Lee WK, 2000, LANGMUIR, V16, P3401, DOI 10.1021/la990800r
   Li SM, 1996, J BIOMAT SCI-POLYM E, V7, P817
   Lucke A, 2000, BIOMATERIALS, V21, P2361, DOI 10.1016/S0142-9612(00)00103-4
   Martin O, 2001, POLYMER, V42, P6209, DOI 10.1016/S0032-3861(01)00086-6
   MENEI P, 1993, BIOMATERIALS, V14, P470, DOI 10.1016/0142-9612(93)90151-Q
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   OGAWA Y, 1988, CHEM PHARM BULL, V36, P2576
   Ricapito NG, 2016, CHEM REV, V116, P2664, DOI 10.1021/acs.chemrev.5b00465
   Rodriguez A, 2008, J BIOMED MATER RES A, V85A, P556, DOI 10.1002/jbm.a.31562
   Ronneberger B, 1996, J BIOMED MATER RES, V30, P31
   Ronneberger B, 1997, EUR J PHARM BIOPHARM, V43, P19, DOI 10.1016/S0939-6411(96)00006-9
   Schick C, 2009, ANAL BIOANAL CHEM, V395, P1589, DOI 10.1007/s00216-009-3169-y
   Shanks RA, 2004, J APPL POLYM SCI, V91, P2114, DOI 10.1002/app.13289
   Shipar M. A. H., 2006, Food Chemistry, V97, P231, DOI 10.1016/j.foodchem.2005.03.041
   Simon J, 2012, MACROMOLECULES, V45, P9275, DOI 10.1021/ma302311h
   SOLER C, 1993, BIOCHEM J, V294, P865, DOI 10.1042/bj2940865
   Stryer L., 1995, BIOCHEMISTRY
   Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u
   VISSCHER GE, 1985, J BIOMED MATER RES, V19, P349, DOI 10.1002/jbm.820190315
   Voskerician G, 2004, IEEE T BIO-MED ENG, V51, P627, DOI 10.1109/TBME.2003.821034
   Voskerician G, 2003, BIOMATERIALS, V24, P1959, DOI 10.1016/S0142-9612(02)00565-3
   Voskerician G, 2007, J BIOMED MATER RES A, V82A, P426, DOI 10.1002/jbm.a.31155
   Wang LS, 2014, POLYM BULL, V71, P47, DOI 10.1007/s00289-013-1044-7
   Wang LS, 2004, MACROMOL RAPID COMM, V25, P959, DOI 10.1002/marc.200300319
   Wang YD, 2003, J BIOMED MATER RES A, V66A, P192, DOI 10.1002/jbm.a.10534
   Weiser JR, 2013, ACTA BIOMATER, V9, P8245, DOI 10.1016/j.actbio.2013.05.020
   Weiser JR, 2012, ANAL BIOCHEM, V430, P116, DOI 10.1016/j.ab.2012.08.009
   Weiser JR, 2011, BIOMACROMOLECULES, V12, P977, DOI 10.1021/bm101342p
   YAMAGUCHI K, 1993, J CONTROL RELEASE, V24, P81, DOI 10.1016/0168-3659(93)90169-6
   Zawaneh PN, 2006, BIOMACROMOLECULES, V7, P3245, DOI 10.1021/bm0605457
   Zawaneh PN, 2010, P NATL ACAD SCI USA, V107, P11014, DOI 10.1073/pnas.0811529107
   Zelikin AN, 2006, BIOMACROMOLECULES, V7, P3239, DOI 10.1021/bm060544e
   Zelikin AN, 2005, MACROMOLECULES, V38, P5532, DOI 10.1021/ma050049v
NR 51
TC 6
Z9 6
U1 5
U2 52
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2016
VL 98
BP 41
EP 52
DI 10.1016/j.biomaterials.2016.04.042
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DQ5XK
UT WOS:000379278400004
PM 27179432
OA Other Gold
DA 2018-10-20
ER

PT J
AU da Cunha, CB
   Klumpers, DD
   Koshy, ST
   Weaver, JC
   Chaudhuri, O
   Seruca, R
   Carneiro, F
   Granja, PL
   Mooney, DJ
AF da Cunha, Cristiana Branco
   Klumpers, Darinka D.
   Koshy, Sandeep T.
   Weaver, James C.
   Chaudhuri, Ovijit
   Seruca, Raquel
   Carneiro, Fatima
   Granja, Pedro L.
   Mooney, David J.
TI CD44 alternative splicing in gastric cancer cells is regulated by
   culture dimensionality and matrix stiffness
SO BIOMATERIALS
LA English
DT Article
DE Culture dimensionality; CD44; Alternative splicing; Extracellular matrix
   (ECM); Matrix stiffness
ID EPITHELIAL-MESENCHYMAL TRANSITION; HYPOXIA-INDUCIBLE FACTOR-1;
   TUMOR-METASTASIS; VARIANT ISOFORMS; SOLID STRESS; EXPRESSION; GROWTH;
   3D; TISSUE; 3RD-DIMENSION
AB Two-dimensional (2D) cultures often fail to mimic key architectural and physical features of the tumor microenvironment. Advances in biomaterial engineering allow the design of three-dimensional (3D) cultures within hydrogels that mimic important tumor-like features, unraveling cancer cell behaviors that would not have been observed in traditional 2D plastic surfaces. This study determined how 3D cultures impact CD44 alternative splicing in gastric cancer (GC) cells. In 3D cultures, GC cells lost expression of the standard CD44 isoform (CD44s), while gaining CD44 variant 6 (CD44v6) expression. This splicing switch was reversible, accelerated by nutrient shortage and delayed at lower initial cell densities, suggesting an environmental stress-induced response. It was further shown to be dependent on the hydrogel matrix mechanical properties and accompanied by the upregulation of genes involved in epithelial-mesenchymal transition (EMT), metabolism and angiogenesis. The 3D cultures reported here revealed the same CD44 alternative splicing pattern previously observed in human premalignant and malignant gastric lesions. These findings indicate that fundamental features of 3D cultures such as soluble factors diffusion and mechanical cues influence CD44 expression in GC cells. Moreover, this study provides a new model system to study CD44 dysfunction, whose role in cancer has been in the spotlight for decades. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [da Cunha, Cristiana Branco; Klumpers, Darinka D.; Koshy, Sandeep T.; Mooney, David J.] Harvard Univ, Sch Engn & Appl Sci, 29 Oxford St,319 Pierce Hall, Cambridge, MA 02138 USA.
   [da Cunha, Cristiana Branco; Klumpers, Darinka D.; Koshy, Sandeep T.; Weaver, James C.; Mooney, David J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.
   [da Cunha, Cristiana Branco; Seruca, Raquel; Carneiro, Fatima] Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, P-4200465 Oporto, Portugal.
   [da Cunha, Cristiana Branco; Granja, Pedro L.] Univ Porto INEB, Inst Engn Biomed, P-4150180 Oporto, Portugal.
   [da Cunha, Cristiana Branco; Seruca, Raquel; Carneiro, Fatima; Granja, Pedro L.] Univ Porto i3S, Inst Invest & Inovacao Saude, P-4200135 Oporto, Portugal.
   [da Cunha, Cristiana Branco; Carneiro, Fatima] Univ Porto, FMUP Hosp S Joao, Fac Med, P-4200319 Oporto, Portugal.
   [Klumpers, Darinka D.] Vrije Univ Amsterdam Med Ctr, Res Inst MOVE, Dept Orthoped Surg, NL-1081 HV Amsterdam, Netherlands.
   [Koshy, Sandeep T.] Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
   [Chaudhuri, Ovijit] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA.
   [Granja, Pedro L.] Univ Porto, Fac Engn, Dept Met & Mat Engn, P-4200465 Oporto, Portugal.
   [Granja, Pedro L.] Univ Porto ICBAS, Inst Ciencias Biomed Abel Salazar, P-4050313 Oporto, Portugal.
RP Mooney, DJ (reprint author), Harvard Univ, Sch Engn & Appl Sci, 29 Oxford St,319 Pierce Hall, Cambridge, MA 02138 USA.
EM mooneyd@seas.harvard.edu
RI Carneiro, Fatima/J-6432-2013
OI Carneiro, Fatima/0000-0002-1964-1006; Granja, Pedro/0000-0003-2761-4929;
   Seruca, Raquel/0000-0002-8851-4166; Koshy, Sandeep/0000-0003-2836-5813
FU Portuguese Fundacao para a Ciencia e a Tecnologia (FCT)
   [SFRH/BD/44982/2008]; Calouste Gulbenkian Foundation (FCG);
   Luso-American Development Foundation (FLAD); FCT
   [PTDC/CTM-NAN/120958/2010]
FX We thank Patricia Rogers and Mandy Tam (Harvard University) for
   assistance with FACS, Anabela Ribeiro Nunes (from the Office for Science
   Communication at IBMC,INEB) for designing Fig. 7, and Barbara Gomes
   (IPATIMUP/FMUP) for immunohistochemistry of gastric tumor samples.
   C.B.C. had research fellowships by the Portuguese Fundacao para a
   Ciencia e a Tecnologia (FCT) (ref.: SFRH/BD/44982/2008), Calouste
   Gulbenkian Foundation (FCG) and Luso-American Development Foundation
   (FLAD). The work herein reported was funded by FCT
   (PTDC/CTM-NAN/120958/2010).
CR Anczukow O, 2015, MOL CELL, V60, P105, DOI 10.1016/j.molcel.2015.09.005
   ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A
   Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509
   Banky B., 2012, MOL CANC, V11
   Birgersdotter A, 2005, SEMIN CANCER BIOL, V15, P405, DOI 10.1016/j.semcancer.2005.06.009
   Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328
   Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059
   Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023
   Brown RL, 2011, J CLIN INVEST, V121, P1064, DOI 10.1172/JCI44540
   Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544
   Carneiro F., 2013, MORSON DAWSONS GASTR
   Chaudhuri O, 2014, NAT MATER, V13, P970, DOI [10.1038/NMAT4009, 10.1038/nmat4009]
   Cook LM, 2011, SEMIN CANCER BIOL, V21, P113, DOI 10.1016/j.semcancer.2010.12.005
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Da CL, 2009, WORLD J GASTROENTERO, V15, P4055, DOI 10.3748/wjg.15.4055
   da Cunha CB, 2014, BIOMATERIALS, V35, P8927, DOI 10.1016/j.biomaterials.2014.06.047
   da Cunha CB, 2010, LAB INVEST, V90, P1604, DOI 10.1038/labinvest.2010.155
   Del Monte U, 2009, CELL CYCLE, V8, P505, DOI 10.4161/cc.8.3.7608
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Ehsan SM, 2013, TISSUE ENG PT A, V19, P1433, DOI [10.1089/ten.tea.2012.0587, 10.1089/ten.TEA.2012.0587]
   Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085
   Friedl P, 2012, NAT REV MOL CELL BIO, V13, P743, DOI 10.1038/nrm3459
   Gilkes DM, 2014, NAT REV CANCER, V14, P430, DOI 10.1038/nrc3726
   Gilkes DM, 2013, J BIOL CHEM, V288, P10819, DOI 10.1074/jbc.M112.442939
   Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006
   Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002
   GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L
   Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/j.cell.2011.02.013
   Helmlinger G, 1997, NAT BIOTECHNOL, V15, P778, DOI 10.1038/nbt0897-778
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038
   Jaalouk DE, 2009, NAT REV MOL CELL BIO, V10, P63, DOI 10.1038/nrm2597
   Jiao S, 2014, CANCER CELL, V25, P166, DOI 10.1016/j.ccr.2014.01.010
   Jothy S, 2003, CLIN EXP METASTAS, V20, P195, DOI 10.1023/A:1022931016285
   Kang W, 2011, CLIN CANCER RES, V17, P2130, DOI 10.1158/1078-0432.CCR-10-2467
   Klingbeil P, 2009, MOL CANCER RES, V7, P168, DOI 10.1158/1541-7786.MCR-08-0207
   Kornblihtt AR, 2013, NAT REV MOL CELL BIO, V14, P153, DOI 10.1038/nrm3525
   Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758
   LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31
   Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027
   Li CX, 2006, CANCER RES, V66, P1990, DOI 10.1158/0008-5472.CAN-05-2593
   Louderbough JMV, 2011, MOL CANCER RES, V9, P1573, DOI 10.1158/1541-7786.MCR-11-0156
   Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645
   Nagano O, 2013, ONCOGENE, V32, P5191, DOI 10.1038/onc.2012.638
   Naor D, 2002, CRIT REV CL LAB SCI, V39, P527, DOI 10.1080/10408360290795574
   Naor D, 1997, ADV CANCER RES, V71, P241, DOI 10.1016/S0065-230X(08)60101-3
   Naor D, 2008, SEMIN CANCER BIOL, V18, P260, DOI 10.1016/j.semcancer.2008.03.015
   Padera TP, 2004, NATURE, V427, P695, DOI 10.1038/427695a
   Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236
   Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259
   Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010
   PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064
   Ponta H, 1998, INT J BIOCHEM CELL B, V30, P299, DOI 10.1016/S1357-2725(97)00152-0
   Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004
   Rudzki Z, 1997, J CLIN PATHOL-MOL PA, V50, P57
   Schwartz MA, 2013, SCIENCE, V339, P402, DOI 10.1126/science.1233814
   SCREATON GR, 1992, P NATL ACAD SCI USA, V89, P12160, DOI 10.1073/pnas.89.24.12160
   Spiegelberg D, 2014, TUMOR BIOL, V35, P2053, DOI 10.1007/s13277-013-1272-3
   Stylianopoulos T, 2012, P NATL ACAD SCI USA, V109, P15101, DOI 10.1073/pnas.1213353109
   Tamada M, 2012, CANCER RES, V72, P1438, DOI 10.1158/0008-5472.CAN-11-3024
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Wirtz D, 2011, NAT REV CANCER, V11, P512, DOI 10.1038/nrc3080
   Wong CCL, 2011, P NATL ACAD SCI USA, V108, P16369, DOI 10.1073/pnas.1113483108
   Yae T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1892
   Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006
   Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009
   Zeng Y, 2013, CANCER RES, V73, P4123, DOI 10.1158/0008-5472.CAN-12-1343
   Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023
NR 68
TC 5
Z9 6
U1 4
U2 39
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2016
VL 98
BP 152
EP 162
DI 10.1016/j.biomaterials.2016.04.016
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DQ5XK
UT WOS:000379278400014
PM 27187279
DA 2018-10-20
ER

PT J
AU Bajwa, DS
   Wang, XN
   Sitz, E
   Loll, T
   Bhattacharjee, S
AF Bajwa, Dilpreet S.
   Wang, Xinnan
   Sitz, Evan
   Loll, Tyler
   Bhattacharjee, Sujal
TI Application of bioethanol derived lignin for improving
   physico-mechanical properties of thermoset biocomposites
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Biocomposites; Lignin; Physical and mechanical properties
ID DICARBOXYLIC-ACID CHLORIDES; KRAFT LIGNIN; COMPOSITES; POLYESTERS;
   RESINS
AB Lignin is the most abundant of renewable polymers next to cellulose with a global annual production of 70 million tons, largely produced from pulping and second generation biofuel industries. Low value of industrial lignin makes it an attractive biomaterial for wide range of applications. The study investigated the application of wheat straw and corn stover based lignin derived from ethanol production for use in thermoset biocomposites. The biocomposite matrix constituted a two component low viscosity Araldite (R) LY 8601/Aradur (R) 8602 epoxy resin system and the lignin content varied from 0 to 25% by weight fraction. The analysis of the physical and mechanical properties of the biocomposites show bioethanol derived lignin can improve selective properties such as impact strength, and thermal stability without compromising the modulus and strength attributes. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Bajwa, Dilpreet S.; Wang, Xinnan; Sitz, Evan; Loll, Tyler; Bhattacharjee, Sujal] N Dakota State Univ, Dept Mech Engn, Dolve Hall 111, Fargo, ND 58105 USA.
RP Bajwa, DS (reprint author), N Dakota State Univ, Dept Mech Engn, Dolve Hall 111, Fargo, ND 58105 USA.
EM dilpreet.bajwa@ndsu.edu
OI Bhattacharjee, Sujal/0000-0002-4209-4231
CR [Anonymous], 2012, TASTM TEST STAND
   Bajwa D. S., 2015, J BIOBASED MATER BIO, P9
   BRODER JD, 1990, ADVANCES IN NEW CROPS, P257
   Digbel F. L., 2006, CARBOHYRDATE POLYM, V66, P537
   FELDMAN D, 1991, J APPL POLYM SCI, V42, P1537, DOI 10.1002/app.1991.070420607
   Fox SC, 2010, BIORESOURCES, V5, P990
   Glasser WG, 1998, BIOMASS BIOENERG, V14, P219, DOI 10.1016/S0961-9534(97)10037-X
   GLASSER WG, 1993, J WOOD CHEM TECHNOL, V13, P545, DOI 10.1080/02773819308020533
   Glasser WG, 2000, ACS SYM SER, V742, P216
   Graupner N, 2008, J MATER SCI, V43, P5222, DOI 10.1007/s10853-008-2762-3
   GUO ZX, 1992, POLYM INT, V27, P17, DOI 10.1002/pi.4990270104
   GUO ZX, 1991, EUR POLYM J, V27, P1177, DOI 10.1016/0014-3057(91)90053-Q
   HATAKEYAMA H, 1995, J MACROMOL SCI PURE, VA32, P743, DOI 10.1080/10601329508010285
   International Lignin Institute, 2015, ZON IND DUC CHEM D A, V40A
   Kovrizhnykh LP, 1998, RUSS J APPL CHEM+, V71, P510
   Kubo S, 2005, BIOMACROMOLECULES, V6, P2815, DOI 10.1021/bm050288q
   Lora J. H., 2002, CHEM MODIFICATION PR
   Lora JH, 2002, J POLYM ENVIRON, V10, P39, DOI 10.1023/A:1021070006895
   McCarthy J. L., 2000, LIGNIN HIST BIOL MAT
   Mihai Brebu, 2010, CELL CHEM TECHNOL, V44, P353
   Nonaka Y, 1997, HOLZFORSCHUNG, V51, P183, DOI 10.1515/hfsg.1997.51.2.183
   Paterson R. J., 2012, PLASTIC MOLDABLE LIG
   Setua D. K., 2004, POLYM COMPOSITE, V21, P988
   Sitz ED, 2015, IND CROP PROD, V75, P200, DOI 10.1016/j.indcrop.2015.05.006
   Srubar WV, 2012, POLYMER, V53, P2152, DOI 10.1016/j.polymer.2012.03.036
   Thielemans W, 2005, BIOMACROMOLECULES, V6, P1895, DOI 10.1021/bm0500345
   Thielemans W, 2004, COMPOS PART A-APPL S, V35, P327, DOI 10.1016/j.compositesa.2003.09.011
   Thielemans W, 2002, J APPL POLYM SCI, V83, P323, DOI 10.1002/app.2247
   Thomas Q. H., 2002, PROPERTIES CHEM MODI
   Toriz G, 2002, POLYM COMPOSITE, V23, P806, DOI 10.1002/pc.10478
NR 30
TC 4
Z9 4
U1 1
U2 35
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD AUG
PY 2016
VL 89
BP 265
EP 272
DI 10.1016/j.ijbiomac.2016.04.077
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA DQ1HF
UT WOS:000378951400030
PM 27131732
DA 2018-10-20
ER

PT J
AU Yang, YN
   Li, CY
   Song, W
   Wang, W
   Qian, GY
AF Yang, Ya'nan
   Li, Caiyan
   Song, Wei
   Wang, Wei
   Qian, Guoying
TI Purification, optimization and physicochemical properties of collagen
   from soft-shelled turtle calipash
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Pelodiscus sinensis calipash collagen; Purification optimization;
   Physicochemical properties
ID PEPSIN-SOLUBILIZED COLLAGEN; SOLUBLE COLLAGEN; SKIN; EXTRACTION; BONE;
   BIOMATERIAL; ACID; FISH
AB The present work was to optimize the purification conditions for soft-shelled turtle (Pelodiscus sinensis) calipash collagen (STCC) isolated by pepsin and to explore collagen physicochemical properties for potential biomaterial applications. Single-factor test and orthogonal method L-9 (3(4)) were employed with the STCC recovery yield as indicator. The optimum purification conditions were obtained when NaCl concentration, collagen concentration and purification time were 2 M, 8 g/L, and 24 h, respectively. Purified STCC were characterized by SDS-PAGE, UV scanning, FTIR, solubility, thermal behavior and amino acid analysis. The results showed that STCC contained high hydroxyproline content than that of other fishery skins, belonging to typical type I collagen in form of [alpha(1)(I)]2 alpha(2)(I). FTIR spectra of STCC were quite similar to other aquatic animals' collagens. It has the lowest solubility at pH 6, and when NaCl concentration decreased from 2% to 6% (w/v), solubility dropped. The denaturation temperature (Td) and melting temperature (Tm) were 35.1 degrees C and 105.14 degrees C, respectively. Morphology of STCC depicted as regular and porous network structure by SEM. In general, the results suggested that turtle calipash can be exploited as alternatives to mammalian collagen and could also be used for biomedical applications as a potential new material. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Yang, Ya'nan; Li, Caiyan; Song, Wei; Wang, Wei; Qian, Guoying] Zhejiang Wanli Univ, Coll Biol & Environm Sci, South Qianhu Rd 8, Ningbo 315100, Zhejiang, Peoples R China.
RP Li, CY; Qian, GY (reprint author), Zhejiang Wanli Univ, Coll Biol & Environm Sci, South Qianhu Rd 8, Ningbo 315100, Zhejiang, Peoples R China.
EM licy82@163.com; qiangy@zwu.edu.cn
FU Research Project of Public Welfare Technology Application in Zhejiang
   Province [2014C32072]; Natural Science Foundation for Young Scientists
   of Zhejiang Province [LQ13C190001]; Ningbo Natural Science Foundation
   [2015A610259]; State Oceanic Administration of China [201405015];
   Zhejiang Provincial Top Key Discipline of Biological Engineering
   [ZS2015008]
FX This study was funded by the Research Project of Public Welfare
   Technology Application in Zhejiang Province (No. 2014C32072), the
   Natural Science Foundation for Young Scientists of Zhejiang Province
   (No. LQ13C190001) and the Ningbo Natural Science Foundation (No.
   2015A610259). Dr. Qian was financed by the State Oceanic Administration
   of China (No. 201405015). Mr. Song was also supported by the Zhejiang
   Provincial Top Key Discipline of Biological Engineering (No. ZS2015008).
CR Abraham LC, 2008, J BIOMED MATER RES B, V87B, P264, DOI 10.1002/jbm.b.31078
   Adibzadeh N, 2014, APPL BIOCHEM BIOTECH, V173, P143, DOI 10.1007/s12010-014-0823-4
   Ahmad M, 2011, FOOD CHEM, V127, P508, DOI 10.1016/j.foodchem.2011.01.032
   Cao S.Q., 2014, J CHIN I FOOD SCI TE, V10, P117
   Castro B. L. E., 2010, J BIOMED MATER RES B, V95, P239
   Daniele B., 2008, CLIN ORAL IMPLAN RES, V15, P285
   Duan R, 2009, FOOD CHEM, V112, P702, DOI 10.1016/j.foodchem.2008.06.020
   FAO, 1834, CULT AQ SPEC INF PRO
   Gomez-Guillen MC, 2011, FOOD HYDROCOLLOID, V25, P1813, DOI 10.1016/j.foodhyd.2011.02.007
   Hiram M., 2010, BIORESOURCE TECHNOL, V101, P4212
   Huang YR, 2011, FOOD HYDROCOLLOID, V25, P1507, DOI 10.1016/j.foodhyd.2011.02.011
   Jeevithan E, 2014, PROCESS BIOCHEM, V49, P1767, DOI 10.1016/j.procbio.2014.06.011
   Jeong HS, 2013, BIOTECHNOL BIOPROC E, V18, P1185, DOI 10.1007/s12257-013-0316-2
   Khan S.B., 2013, BIOPROCESS ENG, V14, P436
   Kittiphattanabawon P, 2010, EUR FOOD RES TECHNOL, V230, P475, DOI 10.1007/s00217-009-1191-0
   Kozlowska J, 2015, INT J BIOL MACROMOL, V81, P220, DOI 10.1016/j.ijbiomac.2015.08.002
   Thuy LTM, 2014, FOOD CHEM, V149, P264, DOI 10.1016/j.foodchem.2013.10.094
   Lin YK, 2006, FOOD CHEM, V99, P244, DOI 10.1016/j.foodchem.2005.06.053
   Liu CC, 2011, ADV MATER RES-SWITZ, V152-153, P1788, DOI 10.4028/www.scientific.net/AMR.152-153.1788
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Lu JF, 2010, J FISH CHINA, V34, P981
   Muralidharan N, 2013, J FOOD SCI TECH MYS, V50, P1106, DOI 10.1007/s13197-011-0440-y
   Nagai N, 2009, J BIOMAT SCI-POLYM E, V20, P567, DOI 10.1163/156856209X426394
   Nillesen STM, 2007, BIOMATERIALS, V28, P1123, DOI 10.1016/j.biomaterials.2006.10.029
   Roberta P., 2011, CRYOBIOLOGY, V63, P61
   Sankar S, 2008, INT J BIOL MACROMOL, V42, P6, DOI 10.1016/j.ijbiomac.2007.08.003
   Senaratne LS, 2006, BIORESOURCE TECHNOL, V97, P191, DOI 10.1016/j.biortech.2005.02.024
   Senthil K. M., 2009, J SURG RES, V158, P162
   Song W, 2014, INT J NUTR FOOD SCI, V3, P270
   Takaki K., 2007, PHIL T R SOC B, V362, P1281
   Tamilmozhi S, 2013, FOOD RES INT, V54, P1499, DOI 10.1016/j.foodres.2013.10.002
   Tian Y. T., 2013, JIANGSU AGR SCI, V41, P265
   Veeruraj A, 2015, FOOD HYDROCOLLOID, V43, P708, DOI 10.1016/j.foodhyd.2014.07.025
   Wang C.H., 2012, THESIS, P22
   Wang L, 2014, FOOD HYDROCOLLOID, V38, P104, DOI 10.1016/j.foodhyd.2013.12.002
   Woo JW, 2008, FOOD HYDROCOLLOID, V22, P879, DOI 10.1016/j.foodhyd.2007.04.015
   Wu GuoPing, 2014, Advances in Bioscience and Biotechnology, V5, P642
   Zhang Y, 2007, FOOD CHEM, V103, P906, DOI 10.1016/j.foodchem.2006.09.053
   [赵苍碧 Zhao Cangbi], 2004, [哈尔滨工业大学学报, Journal of Harbin Institute of Technology], V36, P515
NR 39
TC 6
Z9 10
U1 4
U2 30
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD AUG
PY 2016
VL 89
BP 344
EP 352
DI 10.1016/j.ijbiomac.2016.04.048
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA DQ1HF
UT WOS:000378951400039
PM 27106588
DA 2018-10-20
ER

PT J
AU Sionkowska, A
   Kaczmarek, B
   Lewandowska, K
   Grabska, S
   Pokrywcznska, M
   Kloskowski, T
   Drewa, T
AF Sionkowska, Alina
   Kaczmarek, Beata
   Lewandowska, Katarzyna
   Grabska, Sylwia
   Pokrywcznska, Marta
   Kloskowski, Tomasz
   Drewa, Tomasz
TI 3D composites based on the blends of chitosan and collagen with the
   addition of hyaluronic acid
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Collagen; Chitosan; Hyaluronic acid; Composites; Mechanical properties
ID GLYCOSAMINOGLYCANS; SCAFFOLDS; BIOMATERIALS; SKIN; CARTILAGE; MATRICES
AB 3D porous composites based on blends of chitosan, collagen and hyaluronic acid were obtained through the lyophilization process. Mechanical properties, swelling behavior and thermal stability of the blends were studied. Moreover, SEM images were taken and the structure of the blends was studied. Biological properties of the materials obtained were investigated by analyzing of proliferation rate of fibroblast cells incubated with biomaterial extract using MTT assay (3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide).
   The results showed that the properties of 3D composites based on the blends of chitosan and collagen were altered after the addition 1%, 2% and 5% of hyaluronic acid. Mechanical properties and thermal stability of chitosan/collagen blends were improved in the presence of hyaluronic acid in the composite. New 3D materials based on the blends of chitosan, collagen and hyaluronic acid were non-toxic and did not significantly affect cell morphology. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Sionkowska, Alina; Kaczmarek, Beata; Lewandowska, Katarzyna; Grabska, Sylwia] Nicolaus Copernicus Univ Torun, Fac Chem, Dept Chem Biomat & Cosmet, Gagarin 7, PL-87100 Torun, Poland.
   [Pokrywcznska, Marta; Kloskowski, Tomasz; Drewa, Tomasz] Nicolaus Copernicus Univ Torun, Ludwik Rydygier Med Coll Bydgoszcz, Fac Med, Chair Urol,Dept Regenerat Med, Karlowicza 24 St, PL-85092 Bydgoszcz, Poland.
RP Sionkowska, A (reprint author), Nicolaus Copernicus Univ Torun, Fac Chem, Dept Chem Biomat & Cosmet, Gagarin 7, PL-87100 Torun, Poland.
EM as@chem.umk.pl
RI Pokrywczynska, Marta/E-9323-2014; Kaczmarek, Beata/D-6444-2017;
   Kloskowski, Tomasz/D-4353-2014; Sionkowska, Alina/I-5599-2014;
   Lewandowska, Katarzyna/F-4145-2014
OI Kloskowski, Tomasz/0000-0001-5599-9315; Lewandowska,
   Katarzyna/0000-0003-0009-1777; Pokrywczynska, Marta/0000-0003-3259-087X
FU National Science Centre (NCN, Poland) [UMO-2013/11/B/ST8/04444]; COST
   action [MP1301]
FX Financial support from the National Science Centre (NCN, Poland) Grant
   No UMO-2013/11/B/ST8/04444 is gratefully acknowledged. The authors would
   like to thank also the COST action MP1301 for support to this project.
CR Angele P, 2004, BIOMATERIALS, V25, P2831, DOI 10.1016/j.biomaterials.2003.09.066
   Bae SH, 2012, INVEST OPHTH VIS SCI, V53, P2653, DOI 10.1167/iovs.11-9341
   Cen L, 2008, PEDIATR RES, V63, P492, DOI 10.1203/PDR.0b013e31816c5bc3
   Dumitriu S., 2001, POLYM BIOMATERIALS
   Falshaw R, 2000, CARBOHYD POLYM, V41, P357, DOI 10.1016/S0144-8617(99)00103-4
   FREED LE, 1994, BIOTECHNOL BIOENG, V43, P605, DOI 10.1002/bit.260430710
   Im AR, 2010, GLYCOCONJUGATE J, V27, P249, DOI 10.1007/s10719-009-9273-6
   Kawasaki K, 1999, J CELL PHYSIOL, V179, P142, DOI 10.1002/(SICI)1097-4652(199905)179:2<142::AID-JCP4>3.0.CO;2-Q
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Liao J, 2004, ANN BIOMED ENG, V32, P977, DOI 10.1023/B:ABME.0000032460.97278.e9
   Lin YC, 2009, ACTA BIOMATER, V5, P2591, DOI 10.1016/j.actbio.2009.03.038
   Ma ZW, 2005, TISSUE ENG, V11, P101, DOI 10.1089/ten.2005.11.101
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Maksimenko A.V., 2008, PHARM CHEM J, V42, P553
   Nerem R M, 1995, Tissue Eng, V1, P3, DOI 10.1089/ten.1995.1.3
   Papakonstantinou E, 2003, ARCH DERMATOL RES, V295, P138, DOI 10.1007/s00403-003-0413-8
   Park J., 2007, BIOMATERIALS
   Pokrywczynska M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105295
   Ramshaw JAM, 1996, BIOTECHNOL GENET ENG, V13, P335, DOI 10.1080/02648725.1996.10647934
   Saravanan R, 2010, APPL BIOCHEM BIOTECH, V160, P791, DOI 10.1007/s12010-008-8498-3
   Sheu MT, 2001, BIOMATERIALS, V22, P1713, DOI 10.1016/S0142-9612(00)00315-X
   Sionkowska A, 2006, POLYM DEGRAD STABIL, V91, P3026, DOI 10.1016/j.polymdegradstab.2006.08.009
   Sionkowska A, 2014, KEY ENG MATER, V587, P205, DOI 10.4028/www.scientific.net/KEM.587.205
   Sionkowska A, 2013, INT J BIOL MACROMOL, V52, P250, DOI 10.1016/j.ijbiomac.2012.10.002
   Sionkowska A., 2015, KEY ENG MATER, V672, P247
   Sionkowska A, 2014, J MOL LIQ, V199, P318, DOI 10.1016/j.molliq.2014.09.028
   Sionkowska A, 2011, PROG POLYM SCI, V36, P1254, DOI 10.1016/j.progpolymsci.2011.05.003
   Wei GB, 2004, BIOMATERIALS, V25, P4749, DOI 10.1016/j.biomaterials.2003.12.005
   Wolff JJ, 2007, J AM SOC MASS SPECTR, V18, P234, DOI 10.1016/j.jasms.2006.09.020
   Wu YZ, 2008, J MATER SCI-MATER M, V19, P3621, DOI 10.1007/s10856-008-3477-3
   Yang J, 2015, INT J BIOL MACROMOL, V72, P699, DOI 10.1016/j.ijbiomac.2014.09.025
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Zhang LM, 2012, CARBOHYD POLYM, V88, P1445, DOI 10.1016/j.carbpol.2012.02.050
   2003, BIOMATERIALS, V24, P4833, DOI DOI 10.1016/S0142-9612(03)00374-0
NR 34
TC 23
Z9 23
U1 2
U2 27
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD AUG
PY 2016
VL 89
BP 442
EP 448
DI 10.1016/j.ijbiomac.2016.04.085
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA DQ1HF
UT WOS:000378951400051
PM 27151670
DA 2018-10-20
ER

PT J
AU Wathoni, N
   Motoyama, K
   Higashi, T
   Okajima, M
   Kaneko, T
   Arima, H
AF Wathoni, Nasrul
   Motoyama, Keiichi
   Higashi, Taishi
   Okajima, Maiko
   Kaneko, Tatsuo
   Arima, Hidetoshi
TI Physically crosslinked-sacran hydrogel films for wound dressing
   application
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Sacran; Hydrogel films; Wound dressing
ID TRANSDERMAL FILMS; POTENTIAL USE; THIN-FILMS; IN-VIVO; POLYSACCHARIDE;
   FABRICATION; DELIVERY; MEGAMOLECULES; INTERFERON; RELEASE
AB The thin hydrogel films consisting of water-swollen polymer networks can potentially be applied for biomedical fields. Recently, natural polysaccharides have great attentions to be developed as wound healing and protection. In the present study, we newly prepared and characterized a physically crosslinked-hydrogel film composed of a novel megamolecular polysaccharide sacran for wound dressing application. We successfully fabricated a physically crosslinked-sacran hydrogel film by a solvent-casting method. The thickness of a sacran hydrogel film was lower than that of a sodium alginate (Na-alginate) film. Importantly, the swollen ratio of a sacran hydrogel film in water at 24 h was 19-fold, compared to initial weight. Meanwhile, a Na-alginate hydrogel film was completely broken apart after rehydration. Moreover, a sacran hydrogel film did not show any cytotoxicity on NIH3T3 cells, a murine fibroblast cell line. The in vivo skin hydration study revealed that a sacran hydrogel film significantly increased the moisture content on hairless mice skin and considerably improved wound healing ability, compared to control (non-treated), probably due to not only the moisturing effect but also the anti-inflammatory effect of sacran. These results suggest that sacran has the potential properties as a basic biomaterial in a hydrogel film for wound dressing application. (C) 2016 Published by Elsevier B.V.
C1 [Wathoni, Nasrul; Motoyama, Keiichi; Higashi, Taishi; Arima, Hidetoshi] Kumamoto Univ, Grad Sch Pharmaceut Sci, Chuo Ku, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.
   [Wathoni, Nasrul] Padjadjaran State Univ, Fac Pharm, Jatinangor 45363, Indonesia.
   [Okajima, Maiko; Kaneko, Tatsuo] JAIST, 1-1 Asahidai, Noumi, Ishikawa 9231292, Japan.
   [Arima, Hidetoshi] Kumamoto Univ, Program Leading Grad Sch, HIGO Hlth life Sci Interdisciplinary & Glocal Ori, Kumamoto 860, Japan.
RP Arima, H (reprint author), Kumamoto Univ, Program Leading Grad Sch, HIGO Hlth life Sci Interdisciplinary & Glocal Ori, Kumamoto 860, Japan.
EM arimah@gpo.kumamoto-u.ac.jp
RI Kaneko, Tatsuo/I-7743-2018
OI Kaneko, Tatsuo/0000-0001-9794-083X; Wathoni, Nasrul/0000-0002-5985-6909
CR Adamian A A, 2004, Khirurgiia (Mosk), P10
   Aktar B, 2014, POLYMERS-BASEL, V6, P1350, DOI 10.3390/polym6051350
   Andreu V, 2015, MATERIALS, V8, P5154, DOI 10.3390/ma8085154
   Bajpai SK, 2015, INT J BIOL MACROMOL, V79, P76, DOI 10.1016/j.ijbiomac.2015.04.060
   Bektas A, 2014, CHEM PHARM BULL, V62, P144, DOI 10.1248/cpb.c13-00579
   Bigucci F, 2015, CARBOHYD POLYM, V130, P32, DOI 10.1016/j.carbpol.2015.04.067
   CZAJA MJ, 1987, J BIOL CHEM, V262, P13348
   Edwards R, 2004, CURR OPIN INFECT DIS, V17, P91, DOI 10.1097/00001432-200404000-00004
   Fukushima S, 2016, JCDSA, V6, P9
   Gupta A, 2009, J APPL POLYM SCI, V111, P1400, DOI 10.1002/app.28990
   Kirker KR, 2002, BIOMATERIALS, V23, P3661, DOI 10.1016/S0142-9612(02)00100-X
   Koo H, 2009, INT J PHARMACEUT, V374, P58, DOI 10.1016/j.ijpharm.2009.03.010
   Laato M, 2001, ANN CHIR GYNAECOL, V90, P19
   Leitch VD, 2009, IMMUNOL CELL BIOL, V87, P131, DOI 10.1038/icb.2008.72
   Leung V., 2011, J FIBER BIOENG INFOR, V4, P1, DOI DOI 10.3993/JFBI04201101
   Luo YL, 2009, MATER CHEM PHYS, V118, P329, DOI 10.1016/j.matchemphys.2009.07.063
   Manna PJ, 2015, INT J BIOL MACROMOL, V75, P437, DOI 10.1016/j.ijbiomac.2015.01.047
   Mateescu A, 2012, MEMBRANES, V2, DOI 10.3390/membranes2010040
   Mogosanu GD, 2014, INT J PHARMACEUT, V463, P127, DOI 10.1016/j.ijpharm.2013.12.015
   Motoyama K, 2014, CHEM PHARM BULL, V62, P636
   Naficy S, 2014, ACS APPL MATER INTER, V6, P4109, DOI 10.1021/am405708v
   Ngatu NR, 2012, ANN ALLERG ASTHMA IM, V108, P117, DOI 10.1016/j.anai.2011.10.013
   Nguyen NT, 2013, EUR POLYM J, V49, P4201, DOI 10.1016/j.eurpolymj.2013.09.032
   Okajima MK, 2015, RSC ADV, V5, P86723, DOI 10.1039/c5ra18585h
   Okajima MK, 2008, MACROMOLECULES, V41, P4061, DOI 10.1021/ma800307w
   Okajima MK, 2009, MACROMOLECULES, V42, P3057, DOI 10.1021/ma802829x
   Pereira R, 2013, INT J BIOL MACROMOL, V52, P221, DOI 10.1016/j.ijbiomac.2012.09.031
   Shojaee M, 2015, MAT SCI ENG C-MATER, V48, P158, DOI 10.1016/j.msec.2014.11.063
   Sun JH, 2015, ADV FUNCT MATER, V25, P4334, DOI 10.1002/adfm.201501733
   Teramoto N, 2001, J APPL POLYM SCI, V82, P2273, DOI 10.1002/app.2075
   Tsutsumi T, 2007, J CONTROL RELEASE, V119, P349, DOI 10.1016/j.jconrel.2007.03.013
   WINTER GD, 1962, NATURE, V193, P293, DOI 10.1038/193293a0
   Xu FJ, 2006, BIOMATERIALS, V27, P2787, DOI 10.1016/j.biomaterials.2006.01.003
   Yamamoto-Kasai E, 2012, J INVEST DERMATOL, V132, P2109, DOI 10.1038/jid.2012.97
   Zhao KY, 2015, REACT FUNCT POLYM, V87, P7, DOI 10.1016/j.reactfunctpolym.2014.12.001
NR 35
TC 12
Z9 12
U1 4
U2 73
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD AUG
PY 2016
VL 89
BP 465
EP 470
DI 10.1016/j.ijbiomac.2016.05.006
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA DQ1HF
UT WOS:000378951400054
PM 27151668
DA 2018-10-20
ER

PT J
AU Deniz, F
   Ersanli, ET
AF Deniz, Fatih
   Ersanli, Elif Tezel
TI Removal of colorant from simulated wastewater by phyco-composite
   material: Equilibrium, kinetic and mechanism studies in a lab-scale
   application
SO JOURNAL OF MOLECULAR LIQUIDS
LA English
DT Article
DE Colorants; Biosorption; Phyco-remediation; Composite biomaterial
ID CHLORELLA-PYRENOIDOSA; AQUEOUS-SOLUTIONS; CRYSTAL VIOLET; DYE REMOVAL;
   BIOSORPTION; ADSORPTION; BIOMASS; ISOTHERM; SORPTION
AB The biosorption properties of a novel phyco-composite material composed of Spirogyra sp. and Rhizocionium sp. filamentous green algal biomasses for a model colorant (Basic Red 46, Br46) from simulated wastewater were first explored with respect to medium pH, biomaterial quantity, colorant concentration and contact time. The pseudo-second-order model represented the biosorption kinetic data well. Among biosorption isotherm models, Sips model provided the best fit to the equilibrium data. The phyco-composite biosorbent exhibited best performance at pH 9 with maximum biosorption capacity of 55.953 mg g(-1) for Br46. The mean free energy (E) from Dubinin-Radushkevich isotherm equation and the standard Gibbs free energy change (Delta G degrees) revealed a feasible, spontaneous and physical biosorption process. Thus, this novel composite material can be used as a promising biosorbent to remove such unsafe colorants from aqueous media. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Deniz, Fatih] Sinop Univ, Fac Engn & Architecture, Dept Environm Engn, TR-57000 Sinop, Turkey.
   [Ersanli, Elif Tezel] Sinop Univ, Fac Arts & Sci, Dept Biol, TR-57000 Sinop, Turkey.
RP Deniz, F (reprint author), Sinop Univ, Fac Engn & Architecture, Dept Environm Engn, TR-57000 Sinop, Turkey.
EM f_deniz@outlook.com
RI Deniz, Fatih/E-5471-2015
OI Deniz, Fatih/0000-0002-2771-2652
CR Angin D, 2013, APPL SURF SCI, V280, P705, DOI 10.1016/j.apsusc.2013.05.046
   Anirudhan TS, 2011, CHEM ENG J, V168, P678, DOI 10.1016/j.cej.2011.01.056
   Bera A, 2013, APPL SURF SCI, V284, P87, DOI 10.1016/j.apsusc.2013.07.029
   Bhattacharya P, 2014, BIOREMEDIAT J, V18, P56, DOI 10.1080/10889868.2013.847400
   Chen SH, 2015, J ENVIRON MANAGE, V150, P274, DOI 10.1016/j.jenvman.2014.09.014
   CHIEN SH, 1980, SOIL SCI SOC AM J, V44, P265, DOI 10.2136/sssaj1980.03615995004400020013x
   Daneshvar E, 2012, CHEM ENG J, V204, P225, DOI 10.1016/j.cej.2012.07.090
   Dubinin M.M., 1947, P ACAD SCI USSR PHYS, V55, P331
   Fontana KB, 2016, ECOTOX ENVIRON SAFE, V124, P329, DOI 10.1016/j.ecoenv.2015.11.012
   Foo KY, 2010, CHEM ENG J, V156, P2, DOI 10.1016/j.cej.2009.09.013
   Freundlich H, 1906, Z PHYS CHEM-STOCH VE, V57, P385
   Garcia-Rodriguez A, 2015, INT J ENVIRON SCI TE, V12, P2327, DOI 10.1007/s13762-014-0632-x
   Gholami M, 2016, CARBOHYD POLYM, V136, P772, DOI 10.1016/j.carbpol.2015.09.044
   Guler UA, 2016, PROCESS SAF ENVIRON, V99, P194, DOI 10.1016/j.psep.2015.11.006
   Hajahmadi Z, 2015, WATER RESOUR IND, V11, P71, DOI 10.1016/j.wri.2015.07.003
   Ho YS, 2006, J HAZARD MATER, V136, P681, DOI 10.1016/j.jhazmat.2005.12.043
   Hor KY, 2016, J CLEAN PROD, V118, P197, DOI 10.1016/j.jclepro.2016.01.056
   Hu LC, 2012, PHYSICA A, V391, P731, DOI 10.1016/j.physa.2011.08.048
   Hu XJ, 2011, J HAZARD MATER, V185, P306, DOI 10.1016/j.jhazmat.2010.09.034
   Huang J, 2016, COLLOID SURFACE A, V492, P242, DOI 10.1016/j.colsurfa.2015.11.071
   Iqbal M, 2016, ECOL ENG, V88, P265, DOI 10.1016/j.ecoleng.2015.12.041
   Kayalvizhi K, 2015, DESALIN WATER TREAT, V56, P194, DOI 10.1080/19443994.2014.932711
   Khataee AR, 2013, INT BIODETER BIODEGR, V83, P33, DOI 10.1016/j.ibiod.2013.04.004
   Kousha M, 2012, CHEM ENG J, V179, P158, DOI 10.1016/j.cej.2011.10.073
   Lagergren S, 1898, KUNGLIGA SVENSKA VET, V24, P1, DOI DOI 10.1007/BF01501332
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   Lee YC, 2011, BIORESOURCE TECHNOL, V102, P5297, DOI 10.1016/j.biortech.2010.12.103
   Magriotis ZM, 2014, J ENVIRON CHEM ENG, V2, P2199, DOI 10.1016/j.jece.2014.09.012
   Mohan SV, 2008, BIOCHEM ENG J, V38, P61, DOI 10.1016/j.bej.2007.06.014
   Onyancha D, 2008, J HAZARD MATER, V158, P605, DOI 10.1016/j.jhazmat.2008.02.043
   Oubagaranadin JUK, 2010, APPL CLAY SCI, V50, P409, DOI 10.1016/j.clay.2010.09.008
   Pathak VV, 2015, J ENVIRON MANAGE, V163, P270, DOI 10.1016/j.jenvman.2015.08.041
   Rajfur M, 2012, BIOELECTROCHEMISTRY, V87, P65, DOI 10.1016/j.bioelechem.2011.12.007
   Sinha S, 2016, J HAZARD MATER, V306, P386, DOI 10.1016/j.jhazmat.2015.12.011
   SIPS R, 1948, J CHEM PHYS, V16, P490, DOI 10.1063/1.1746922
   Srivastava S, 2015, ECOL ENG, V85, P56, DOI 10.1016/j.ecoleng.2015.10.011
   Tounsadi H, 2015, J ENVIRON CHEM ENG, V3, P822, DOI 10.1016/j.jece.2015.03.022
   Tuzen M, 2010, CHEM ENG J, V158, P200, DOI 10.1016/j.cej.2009.12.041
   Weber WJ, 1963, J SANITARY ENGINEERI, V89, P31, DOI DOI 10.1016/J.DESAL.2010.08.036
   Yu JX, 2009, BIOCHEM ENG J, V45, P145, DOI 10.1016/j.bej.2009.03.007
NR 40
TC 1
Z9 1
U1 0
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-7322
EI 1873-3166
J9 J MOL LIQ
JI J. Mol. Liq.
PD AUG
PY 2016
VL 220
BP 120
EP 128
DI 10.1016/j.molliq.2016.04.081
PG 9
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA DQ1IE
UT WOS:000378953900016
DA 2018-10-20
ER

PT J
AU Romann, J
   Chauton, MS
   Hanetho, SM
   Vebner, M
   Heldal, M
   Thaulow, C
   Vadstein, O
   Tranell, G
   Einarsrud, MA
AF Romann, Julien
   Chauton, Matilde Skogen
   Hanetho, Sidsel M.
   Vebner, Marius
   Heldal, Mikal
   Thaulow, Christian
   Vadstein, Olav
   Tranell, Gabriella
   Einarsrud, Mari-Ann
TI Diatom frustules as a biomaterial: effects of chemical treatment on
   organic material removal and mechanical properties in cleaned frustules
   from two Coscinodiscus species
SO JOURNAL OF POROUS MATERIALS
LA English
DT Article
DE Porous biomaterial; Nanomaterial; Silica frustules; Cleaning protocols;
   Oxidation; Surfactant
ID MARINE DIATOM; CELL-WALL; DRUG-DELIVERY; FLUORESCENCE; POLYAMINES;
   BIOSILICA; CHITIN; RED
AB The three-dimensional structure of silica diatom frustules offers a great potential as nanoporous material for several nanotechnological applications, but the starting point for these applications is the ability to obtain clean frustules with sufficient mechanical strength and intact structure. Here, frustules from the diatoms Coscinodiscus centralis Ehrenberg and Coscinodiscus wailesii Gran et Angst are characterized with respect to their structural integrity, content of residual organic biomaterial and their mechanical properties after two cleaning methods using either hydrogen peroxide as oxidizing agent or a combination of a surfactant (sodium dodecyl sulphate) and a complexing agent. Fluorescence microscopy and energy dispersive spectroscopy (SEM/EDS) analysis revealed clear differences regarding the amount of organic residual within the frustules depending on the cleaning process, with little organic material left after the oxidizing method. This method, however, induced a partial cracking of the frustules suggesting an embrittlement due to the cleaning. Nanoindentation confirmed this and showed that the oxidizing method resulted in more brittle frustules compared to the surfactant/complexing method. More efficient cleaning of organic biomaterial may result in more fragile frustules, and the choice of cleaning method must be based on the planned application.
C1 [Romann, Julien; Tranell, Gabriella; Einarsrud, Mari-Ann] Norwegian Univ Sci & Technol, Dept Mat Sci & Engn, N-7491 Trondheim, Norway.
   [Hanetho, Sidsel M.] SINTEF Mat & Chem, Trondheim, Norway.
   [Vebner, Marius; Thaulow, Christian] Norwegian Univ Sci & Technol, Dept Engn Design & Mat, N-7491 Trondheim, Norway.
   [Chauton, Matilde Skogen; Vadstein, Olav] Norwegian Univ Sci & Technol, Dept Biotechnol, N-7491 Trondheim, Norway.
   [Heldal, Mikal] Univ Bergen, Dept Biol, Post Box 7803, N-5020 Bergen, Norway.
RP Einarsrud, MA (reprint author), Norwegian Univ Sci & Technol, Dept Mat Sci & Engn, N-7491 Trondheim, Norway.
EM mari-ann.einarsrud@ntnu.no
FU Research Council of Norway through the SOLBIOPTA Project [10358700]
FX The Research Council of Norway is acknowledged for financial support
   through the SOLBIOPTA Project (Contract #10358700). Egil S. Erichsen,
   Laboratory for Electron Microscopy, University of Bergen is acknowledged
   for his help in SEM/EDS analysis.
CR Andrews M.P., 2011, P SOC PHOTO-OPT INS, V7946
   Aw MS, 2012, POWDER TECHNOL, V223, P52, DOI 10.1016/j.powtec.2011.04.023
   Blanco S, 2008, J APPL PHYCOL, V20, P445, DOI 10.1007/s10811-007-9292-2
   Brunner E, 2009, J STRUCT BIOL, V168, P539, DOI 10.1016/j.jsb.2009.06.018
   Cohoon G.A., 2015, P SPIE, V9341
   Dasu VV, 2006, MICROBIOL-SGM, V152, P2265, DOI 10.1099/mic.0.28920-0
   De Stefano L, 2009, BIOSENS BIOELECTRON, V24, P1580, DOI 10.1016/j.bios.2008.08.016
   De Tommasi E, 2010, OPT EXPRESS, V18, P12203, DOI 10.1364/OE.18.012203
   Durkin CA, 2009, EUKARYOT CELL, V8, P1038, DOI 10.1128/EC.00079-09
   Ferrara MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103750
   Friedrichs L, 2013, DIATOM RES, V28, P317, DOI 10.1080/0269249X.2013.799525
   Gnanamoorthy P, 2014, J POROUS MAT, V21, P789, DOI 10.1007/s10934-014-9827-2
   Gordon R, 2009, TRENDS BIOTECHNOL, V27, P116, DOI 10.1016/j.tibtech.2008.11.003
   GUILLARD RRL, 1975, CULTURE MARINE INVER, P26, DOI DOI 10.1007/978-1-4615-8714-9_3
   Gulturk E., 2011, J ACHIEV MAT MANUF E, V46, P196
   Ingalls AE, 2010, GEOCHIM COSMOCHIM AC, V74, P104, DOI 10.1016/j.gca.2009.09.012
   Kieu K, 2014, OPT EXPRESS, V22, P15992, DOI 10.1364/OE.22.015992
   Kleinegris DMM, 2010, J APPL PHYCOL, V22, P645, DOI 10.1007/s10811-010-9505-y
   Kroger N, 2000, P NATL ACAD SCI USA, V97, P14133, DOI 10.1073/pnas.260496497
   KROGER N, 1994, EMBO J, V13, P4676, DOI 10.1002/j.1460-2075.1994.tb06791.x
   Lim GW, 2015, J APPL PHYCOL, V27, P763, DOI 10.1007/s10811-014-0356-9
   LORENZEN CJ, 1967, LIMNOL OCEANOGR, V12, P343, DOI 10.4319/lo.1967.12.2.0343
   Losic D, 2006, J NANOSCI NANOTECHNO, V6, P982, DOI 10.1166/jnn.2006.174
   Losic D, 2010, CHEM COMMUN, V46, P6323, DOI 10.1039/c0cc01305f
   Michels J, 2010, J MICROSC-OXFORD, V238, P95, DOI 10.1111/j.1365-2818.2009.03360.x
   Morales LV, 2013, LIMNOL OCEANOGR-METH, V11, P101, DOI 10.4319/lom.2013.11.101
   Nagababu E, 2000, FREE RADICAL BIO MED, V29, P659, DOI 10.1016/S0891-5849(00)00348-8
   Nassif N, 2011, CHEM SOC REV, V40, P849, DOI 10.1039/c0cs00122h
   O'Connor J, 2014, SMALL, V10, P469, DOI 10.1002/smll.201301146
   Romann J, 2015, OPT LETT, V40, P740, DOI 10.1364/OL.40.000740
   Spinde K, 2011, CHEM MATER, V23, P2973, DOI 10.1021/cm200677d
   Sumper M, 2002, SCIENCE, V295, P2430, DOI 10.1126/science.1070026
   Sumper M, 2004, J MATER CHEM, V14, P2059, DOI 10.1039/b401028k
   Suroy M, 2014, DEEP-SEA RES PT I, V86, P21, DOI 10.1016/j.dsr.2014.01.001
   Tang YZ, 2007, APPL ENVIRON MICROB, V73, P2306, DOI 10.1128/AEM.01741-06
   Tesson B., 2013, PLOS ONE, V8
   Tesson B, 2008, ANAL BIOANAL CHEM, V390, P1889, DOI 10.1007/s00216-008-1908-0
   Toster J, 2013, NANOSCALE, V5, P873, DOI 10.1039/c2nr32716c
   Van Eynde E, 2013, PHOTOCH PHOTOBIO SCI, V12, P690, DOI 10.1039/c2pp25229e
   Vasani RB, 2015, J MATER CHEM B, V3, P4325, DOI 10.1039/c5tb00648a
   Vermeulen S, 2012, J APPL PHYCOL, V24, P1253, DOI 10.1007/s10811-011-9770-4
   Wee KM, 2005, J NANOSCI NANOTECHNO, V5, P88, DOI [10.1166/jnn.2005.020, 10.1116/jnn.2005.020]
   Yang WR, 2011, ANALYST, V136, P42, DOI 10.1039/c0an00602e
NR 43
TC 2
Z9 2
U1 3
U2 53
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1380-2224
EI 1573-4854
J9 J POROUS MAT
JI J. Porous Mat.
PD AUG
PY 2016
VL 23
IS 4
BP 905
EP 910
DI 10.1007/s10934-016-0147-6
PG 6
WC Chemistry, Applied; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA DQ4JF
UT WOS:000379169400007
DA 2018-10-20
ER

PT J
AU Zhan, WQ
   Tan, SS
   Lu, F
AF Zhan, Weiqing
   Tan, Shaun S.
   Lu, Feng
TI Adipose-Derived Stem Cell Delivery for Adipose Tissue Engineering:
   Current Status and Potential Applications in a Tissue Engineering
   Chamber Model
SO STEM CELL REVIEWS AND REPORTS
LA English
DT Review
DE ASCs; Adipose tissue engineering; Biomaterial; Tissue engineering
   chamber model; Vascularization
ID FIBROBLAST-GROWTH-FACTOR; PEDICLED FAT FLAP; IN-VIVO;
   EXTRACELLULAR-MATRIX; ANGIOGENIC GROWTH; STROMAL CELLS; BREAST
   RECONSTRUCTION; REGENERATIVE MEDICINE; ENDOTHELIAL-CELLS; COLLAGEN
   MATRIX
AB In reconstructive surgery, there is a clinical need for adequate implants to repair soft tissue defects caused by traumatic injury, tumor resection, or congenital abnormalities. Adipose tissue engineering may provide answers to this increasing demand. This study comprehensively reviews current approaches to adipose tissue engineering, detailing different cell carriers under investigation, with a special focus on the application of adipose-derived stem cells (ASCs). ASCs act as building blocks for new tissue growth and as modulators of the host response. Recent studies have also demonstrated that the implantation of a hollow protected chamber, combined with a vascular pedicle within the fat flaps provides blood supply and enables the growth of large-volume of engineered soft tissue. Conceptually, it would be of value to co-regulate this unique chamber model with adipose-derived stem cells to obtain a greater volume of soft tissue constructs for clinical use. Our review provides a cogent update on these advances and details the generation of possible fat substitutes.
C1 [Zhan, Weiqing; Lu, Feng] Southern Med Univ, Nanfang Hosp, Dept Plast & Cosmet Surg, 1838 Guang Zhou North Rd, Guangzhou, Guang Dong, Peoples R China.
   [Tan, Shaun S.] Tan Tock Seng Hosp, Sect Plast Reconstruct & Aesthet Surg, Dept Gen Surg, Singapore, Singapore.
RP Lu, F (reprint author), Southern Med Univ, Nanfang Hosp, Dept Plast & Cosmet Surg, 1838 Guang Zhou North Rd, Guangzhou, Guang Dong, Peoples R China.
EM ZHANwq1988@gmail.com; shaunnietan@hotmail.com; doctorlufeng@hotmail.com
FU National Natural Science Foundation of China [81471881, 81372083,
   81171834, 81201482]; Key Clinical Specialty Discipline Construction
   Program; Health Collaborative Innovation major projects of Guangzhou
   [7414275040815]
FX This work was supported by National Natural Science Foundation of China
   (81471881, 81372083, 81171834, 81201482), Key Clinical Specialty
   Discipline Construction Program, and Health Collaborative Innovation
   major projects of Guangzhou (7414275040815).
CR Baglioni S, 2009, FASEB J, V23, P3494, DOI 10.1096/fj.08-126946
   Bellas E, 2015, ADV HEALTHC MATER, V4, DOI 10.1002/adhm.201400506
   Bourin P, 2013, CYTOTHERAPY, V15, P641, DOI 10.1016/j.jcyt.2013.02.006
   Brown CFC, 2015, BIOMED MATER, V10, DOI 10.1088/1748-6041/10/4/045010
   Bucky Louis P, 2008, Aesthet Surg J, V28, P313, DOI 10.1016/j.asj.2008.02.004
   Bucky LP, 2008, AESTHET SURG J, V28, P322
   Cao Y, 2006, BIOMATERIALS, V27, P2854, DOI 10.1016/j.biomaterials.2005.12.015
   Chan EC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149799
   Cheung HK, 2014, BIOMATERIALS, V35, P1914, DOI 10.1016/j.biomaterials.2013.11.067
   Choi JS, 2009, J CONTROL RELEASE, V139, P2, DOI 10.1016/j.jconrel.2009.05.034
   Choi YS, 2010, BIOMATERIALS, V31, P2236, DOI 10.1016/j.biomaterials.2009.11.097
   Chung E, 2015, ACTA BIOMATER, V17, P78, DOI 10.1016/j.actbio.2015.01.012
   Cronin KJ, 2004, PLAST RECONSTR SURG, V113, P260, DOI 10.1097/01.PRS.0000095942.71618.9D
   Cuaranta-Monroy I, 2015, METHODS MOL BIOL
   Debels H., 2015, J TISSUE ENG REGENER
   Deng M, 2015, STEM CELLS INT, DOI 10.1155/2015/350718
   Doldere JH, 2011, PLAST RECONSTR SURG, V127, P2283, DOI 10.1097/PRS.0b013e3182131c3e
   Dolderer JH, 2007, TISSUE ENG, V13, P673, DOI 10.1089/ten.2006.0212
   Esmaili S, 2014, TRENDS ENDOCRIN MET, V25, P444, DOI 10.1016/j.tem.2014.06.001
   Eto H, 2012, PLAST RECONSTR SURG, V129, P1081, DOI 10.1097/PRS.0b013e31824a2b19
   Eto H, 2009, PLAST RECONSTR SURG, V124, P1087, DOI 10.1097/PRS.0b013e3181b5a3f1
   Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001
   Findlay MW, 2011, PLAST RECONSTR SURG, V128, P1206, DOI 10.1097/PRS.0b013e318230c5b2
   Findlay MW, 2009, PLAST RECONSTR SURG, V124, P1077, DOI 10.1097/PRS.0b013e3181b59ff6
   Freese KE, 2015, CANCER RES, V75, P1161, DOI 10.1158/0008-5472.CAN-14-2744
   Frye CA, 2006, IN VITRO CELL DEV-AN, V42, P109
   Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09
   Gronthos S, 2011, METHODS MOL BIOL, V702, P109, DOI 10.1007/978-1-61737-960-4_9
   Hillel AT, 2009, TISSUE ENG PT A, V15, P479, DOI 10.1089/ten.tea.2007.0352
   Kahn CR, 2008, SCIENCE, V322, P542, DOI 10.1126/science.1165667
   Kato H, 2010, TISSUE ENG PT A, V16, P2029, DOI [10.1089/ten.tea.2009.0551, 10.1089/ten.TEA.2009.0551]
   Kaully T, 2009, TISSUE ENG PART B-RE, V15, P159, DOI 10.1089/ten.teb.2008.0193
   Kawaguchi N, 1998, P NATL ACAD SCI USA, V95, P1062, DOI 10.1073/pnas.95.3.1062
   Kelly JL, 2006, TISSUE ENG, V12, P2041, DOI 10.1089/ten.2006.12.2041
   Kilroy GE, 2007, J CELL PHYSIOL, V212, P702, DOI 10.1002/jcp.21068
   Lafosse A, 2015, PLAST RECONSTR SURG, V136, P279, DOI 10.1097/PRS.0000000000001437
   Largo RD, 2014, J PLAST RECONSTR AES, V67, P437, DOI 10.1016/j.bjps.2013.11.011
   Lilja HE, 2013, STEM CELLS DEV, V22, P1602, DOI 10.1089/scd.2012.0451
   Lin G, 2008, STEM CELLS DEV, V17, P1053, DOI 10.1089/scd.2008.0117
   Lokmic Z, 2008, TISSUE ENG PART B-RE, V14, P87, DOI 10.1089/teb.2007.0299
   Lokmic Z, 2007, FASEB J, V21, P511, DOI 10.1096/fj.06-6614com
   Mashiko T, 2015, CLIN PLAST SURG, V42, P181, DOI 10.1016/j.cps.2014.12.008
   Matsuda K, 2013, TISSUE ENG PT A, V19, P1327, DOI [10.1089/ten.tea.2012.0391, 10.1089/ten.TEA.2012.0391]
   Nakajima I, 1998, DIFFERENTIATION, V63, P193, DOI 10.1046/j.1432-0436.1998.6340193.x
   Ogura F, 2014, STEM CELLS DEV, V23, P717, DOI 10.1089/scd.2013.0473
   Ozcelik B, 2014, ACTA BIOMATER, V10, P2769, DOI 10.1016/j.actbio.2014.02.019
   Park IS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122776
   Park IS, 2015, BIOCHEM BIOPH RES CO, V462, P171, DOI 10.1016/j.bbrc.2015.04.059
   Patrick Jr C. W., 2001, ANAT REC, V263, P361
   Peng ZS, 2014, TISSUE ENG PART C-ME, V20, P875, DOI [10.1089/ten.tec.2013.0431, 10.1089/ten.TEC.2013.0431]
   Planat-Benard V, 2004, CIRCULATION, V109, P656, DOI 10.1161/01.CIR.0000114522.38265.61
   Rnjak-Kovacina J, 2015, ACS BIOMATER SCI ENG, V1, P260, DOI 10.1021/ab500149p
   Rohringer S, 2014, ANGIOGENESIS, V17, P921, DOI 10.1007/s10456-014-9439-0
   Rojas-Rodriguez R, 2014, METHOD ENZYMOL, V537, P75, DOI 10.1016/B978-0-12-411619-1.00005-7
   Rophael JA, 2007, AM J PATHOL, V171, P2048, DOI 10.2353/ajpath.2007.070066
   Shah FS, 2014, CELLS TISSUES ORGANS, V200, P204, DOI 10.1159/000430088
   Sheikh FA, 2015, J TISSUE ENG REGENER
   Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902
   Stosich MS, 2007, TISSUE ENG, V13, P2881, DOI 10.1089/ten.2007.0078
   Suga H, 2009, STEM CELLS, V27, P238, DOI 10.1634/stemcells.2008-0261
   Ting ACH, 2014, ACTA BIOMATER, V10, P1907, DOI 10.1016/j.actbio.2013.11.019
   Unger RH, 2013, MOL BIOL CELL, V24, P3011, DOI 10.1091/mbc.E12-10-0774
   Vashi AV, 2006, TISSUE ENG, V12, P3035, DOI 10.1089/ten.2006.12.3035
   Walton RL, 2004, MICROSURG, V24, P378, DOI 10.1002/micr.20056
   Wu I, 2012, PLAST RECONSTR SURG, V129, P1247, DOI 10.1097/PRS.0b013e31824ec3dc
   Wu LC, 2008, PLAST RECONSTR SURG, V122, P702, DOI 10.1097/PRS.0b013e3181823c15
   Yap KK, 2013, BIOMATERIALS, V34, P3992, DOI 10.1016/j.biomaterials.2013.02.011
   Yu C, 2013, BIOMATERIALS, V34, P3290, DOI 10.1016/j.biomaterials.2013.01.056
   Zdolsek JM, 2011, J VASC SURG, V53, P435, DOI 10.1016/j.jvs.2010.08.019
   Zhan WQ, 2015, WOUND REPAIR REGEN, V23, P443, DOI 10.1111/wrr.12292
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 71
TC 8
Z9 8
U1 2
U2 24
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 1550-8943
EI 1558-6804
J9 STEM CELL REV REP
JI Stem Cell Rev. Rep.
PD AUG
PY 2016
VL 12
IS 4
BP 484
EP 491
DI 10.1007/s12015-016-9653-9
PG 8
WC Cell & Tissue Engineering; Cell Biology; Medicine, Research &
   Experimental
SC Cell Biology; Research & Experimental Medicine
GA DQ0QS
UT WOS:000378905600010
PM 27075632
DA 2018-10-20
ER

PT J
AU Pumberger, M
   Qazi, TH
   Ehrentraut, MC
   Textor, M
   Kueper, J
   Stoltenburg-Didinger, G
   Winkler, T
   von Roth, P
   Reinke, S
   Borselli, C
   Perka, C
   Mooney, DJ
   Duda, GN
   Geissler, S
AF Pumberger, Matthias
   Qazi, Taimoor H.
   Ehrentraut, M. Christine
   Textor, Martin
   Kueper, Janina
   Stoltenburg-Didinger, Gisela
   Winkler, Tobias
   von Roth, Philipp
   Reinke, Simon
   Borselli, Cristina
   Perka, Carsten
   Mooney, David J.
   Duda, Georg N.
   Geissler, Sven
TI Synthetic niche to modulate regenerative potential of MSCs and enhance
   skeletal muscle regeneration
SO BIOMATERIALS
LA English
DT Article
DE Engineered cell microenvironments; Biomaterial based stem cell niche;
   Trophic factor secretion; Muscle regeneration
ID MESENCHYMAL STEM-CELLS; FIBROBLAST GROWTH-FACTOR; IN-VIVO; MYOGENIC
   DIFFERENTIATION; TERMINAL DIFFERENTIATION; EXTRACELLULAR-MATRIX;
   MUSCULAR-DYSTROPHY; ALGINATE HYDROGELS; MYOBLAST TRANSFER; STROMAL CELLS
AB Severe injury to the skeletal muscle often results in the formation of scar tissue, leading to a decline in functional performance. Traditionally, tissue engineering strategies for muscle repair have focused on substrates that promote myogenic differentiation of transplanted cells. In the current study, the reported data indicates that mesenchymal stromal cells (MSCs) transplanted via porous alginate cryogels promote muscle regeneration by secreting bioactive factors that profoundly influence the function of muscle progenitor cells. These cellular functions, which include heightened resistance of muscle progenitor cells to apoptosis, migration to site of injury, and prevention of premature differentiation are highly desirable in the healing cascade after acute muscle trauma. Furthermore, stimulation of MSCs with recombinant growth factors IGF-1 and VEGF165 was found to significantly enhance their paracrine effects on muscle progenitor cells. Multifunctional alginate cryogels were then utilized as synthetic niches that facilitate local stimulation of seeded MSCs by providing a sustained release of growth factors. In a clinically relevant injury model, the modulation of MSC paracrine signaling via engineered niches significantly improved muscle function by remodeling scar tissue and promoting the formation of new myofibers, outperforming standalone cell or growth factor delivery. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Pumberger, Matthias; Qazi, Taimoor H.; Ehrentraut, M. Christine; Textor, Martin; Kueper, Janina; Winkler, Tobias; von Roth, Philipp; Reinke, Simon; Perka, Carsten; Duda, Georg N.; Geissler, Sven] Charite, Julius Wolff Inst, Augustenburger Pl 1, D-13353 Berlin, Germany.
   [Pumberger, Matthias; Qazi, Taimoor H.; Textor, Martin; Winkler, Tobias; von Roth, Philipp; Reinke, Simon; Borselli, Cristina; Perka, Carsten; Mooney, David J.; Duda, Georg N.; Geissler, Sven] Charite, Berlin Brandenburg Ctr Regenerat Therapies, Augustenburger Pl 1, D-13353 Berlin, Germany.
   [Pumberger, Matthias; Qazi, Taimoor H.; Textor, Martin; Winkler, Tobias; von Roth, Philipp; Reinke, Simon; Borselli, Cristina; Perka, Carsten; Mooney, David J.; Duda, Georg N.; Geissler, Sven] Charite, Berlin Brandenburg Sch Regenerat Therapies, Augustenburger Pl 1, D-13353 Berlin, Germany.
   [Pumberger, Matthias; Textor, Martin; Winkler, Tobias; von Roth, Philipp; Reinke, Simon; Perka, Carsten; Duda, Georg N.; Geissler, Sven] Charite, Ctr Musculoskeletal Surg, Augustenburger Pl 1, D-13353 Berlin, Germany.
   [Stoltenburg-Didinger, Gisela] Charite, Inst Cell Biol & Neurobiol, Charitepl 1, D-10117 Berlin, Germany.
   [Borselli, Cristina; Mooney, David J.; Duda, Georg N.] Harvard Univ, Wyss Inst Biol Inspired Engn, 3 Blackfan Cir, Boston, MA 02115 USA.
   [Borselli, Cristina; Mooney, David J.; Duda, Georg N.] Harvard Univ, John A Paulson Sch Engn & Appl Sci, 29 Oxford St, Cambridge, MA 02138 USA.
RP Geissler, S (reprint author), Charite, Berlin Brandenburg Ctr Regenerat Therapies, Augustenburger Pl 1, D-13353 Berlin, Germany.
EM Sven.Geissler@charite.de
RI GeiSSler, Sven/J-7275-2013; Qazi, Taimoor Hasan/I-7675-2015; Duda,
   Georg/H-2085-2016
OI GeiSSler, Sven/0000-0002-8750-6324; Qazi, Taimoor
   Hasan/0000-0002-3132-9170; Duda, Georg/0000-0001-7605-3908; Kueper,
   Janina/0000-0002-1270-8319
FU BCRT; BSRT - German Federal Ministry of Education and Research (BMBF);
   German Research Foundation (DFG) [GE2512/1-2]; Einstein fellowship;
   Friede Springer Foundation; BSRT [DFG: GSC203]
FX We would like to acknowledge Gabriela Korus and Mario Thiele for
   providing technical assistance with histology, and ImageJ macros,
   respectively. Funding: This work was supported by grants from the BCRT
   and BSRT through funding by the German Federal Ministry of Education and
   Research (BMBF), by a grant (GE2512/1-2) from the German Research
   Foundation (DFG) to SG, and by the award of the Einstein fellowship to
   DJM. THQ wishes to acknowledge funding from the Friede Springer
   Foundation and the BSRT (DFG: GSC203). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR ALLEN RE, 1989, J CELL PHYSIOL, V138, P311, DOI 10.1002/jcp.1041380213
   Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102
   Anastasi S, 1997, J CELL BIOL, V137, P1057, DOI 10.1083/jcb.137.5.1057
   Bencze M, 2012, MOL THER, V20, P2168, DOI 10.1038/mt.2012.189
   Borselli C, 2011, BIOMATERIALS, V32, P8905, DOI 10.1016/j.biomaterials.2011.08.019
   Borselli C, 2010, P NATL ACAD SCI USA, V107, P3287, DOI 10.1073/pnas.0903875106
   Briggs D, 2013, FEBS J, V280, P4281, DOI 10.1111/febs.12273
   Browne S, 2014, J MATER CHEM B, V2, P6692, DOI 10.1039/c4tb00863d
   Burks TN, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-19
   Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886
   Cezar CA, 2015, ADV DRUG DELIVER REV, V84, P188, DOI 10.1016/j.addr.2014.09.008
   Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003
   Choi YH, 2011, HUM GENE THER, V22, P3, DOI 10.1089/hum.2010.211
   CLEGG CH, 1987, J CELL BIOL, V105, P949, DOI 10.1083/jcb.105.2.949
   De Bari C, 2003, J CELL BIOL, V160, P909, DOI 10.1083/jcb.200212064
   Fan Y, 1996, MUSCLE NERVE, V19, P853, DOI 10.1002/(SICI)1097-4598(199607)19:7<853::AID-MUS7>3.0.CO;2-8
   Fishman JM, 2013, TISSUE ENG PART B-RE, V19, P503, DOI [10.1089/ten.teb.2013.0120, 10.1089/ten.TEB.2013.0120]
   Gang EJ, 2004, STEM CELLS, V22, P617, DOI 10.1634/stemcells.22-4-617
   Geback T, 2009, BIOTECHNIQUES, V46, P265, DOI 10.2144/000113083
   Geissler S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.501
   Gharaibeh B, 2012, BIRTH DEFECTS RES C, V96, P82, DOI 10.1002/bdrc.21005
   Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826
   Gunetti M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045538
   Huard J, 2002, J BONE JOINT SURG AM, V84A, P822, DOI 10.2106/00004623-200205000-00022
   Jackson WM, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt111
   Jung S, 2013, REGENERATIVE MEDICINE AND TISSUE ENGINEERING, P453, DOI 10.5772/55542
   Klein O, 2014, PROTEOMICS, V14, P2249, DOI 10.1002/pmic.201400088
   Kong HJ, 2003, BIOMATERIALS, V24, P4023, DOI 10.1016/S0142-9612(03)00295-3
   Krampera M, 2006, BONE, V39, P678, DOI 10.1016/j.bone.2006.04.020
   Leshem Y, 2000, J CELL PHYSIOL, V184, P101, DOI 10.1002/(SICI)1097-4652(200007)184:1<101::AID-JCP11>3.0.CO;2-D
   LINKHART TA, 1980, J SUPRAMOL STR CELL, V14, P483, DOI 10.1002/jss.400140407
   Matziolis G, 2006, TISSUE ENG, V12, P361, DOI 10.1089/ten.2006.12.361
   Meirelles Lda S., 2009, CYTOKINE GROWTH F R, V20, P419
   MENDELL JR, 1995, NEW ENGL J MED, V333, P832, DOI 10.1056/NEJM199509283331303
   Menetrey J, 2000, J BONE JOINT SURG BR, V82B, P131, DOI 10.1302/0301-620X.82B1.8954
   Merritt EK, 2010, TISSUE ENG PT A, V16, P2871, DOI [10.1089/ten.tea.2009.0826, 10.1089/ten.TEA.2009.0826]
   Micah T. Webster, CELL STEM CELL, V18, P243
   Moshaverinia A, 2015, ADV FUNCT MATER, V25, P2296, DOI 10.1002/adfm.201500055
   Murphy Matthew B, 2013, Exp Mol Med, V45, pe54, DOI 10.1038/emm.2013.94
   Natsu K, 2004, TISSUE ENG, V10, P1093, DOI 10.1089/1076327041887754
   Philippou A, 2012, ADV CLIN CHEM, V58, P49, DOI 10.1016/B978-0-12-394383-5.00010-2
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Qazi TH, 2015, BIOMATERIALS, V53, P502, DOI 10.1016/j.biomaterials.2015.02.110
   Rehrnan J., 2004, CIRCULATION, V109, P1292
   Rossi CA, 2011, FASEB J, V25, P2296, DOI 10.1096/fj.10-174755
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Santo VE, 2013, TISSUE ENG PART B-RE, V19, P327, DOI [10.1089/ten.teb.2012.0727, 10.1089/ten.TEB.2012.0727]
   Shin EH, 2014, WOUND REPAIR REGEN, V22, P18, DOI 10.1111/wrr.12163
   Sicari BM, 2014, SCI TRANSL MED, V6, P234, DOI DOI 10.1126/SCITRANSLMED.3008085
   Togel F, 2007, AM J PHYSIOL-RENAL, V292, pF1626, DOI 10.1152/ajprenal.00339.2006
   TREMBLAY JP, 1993, CELL TRANSPLANT, V2, P99, DOI 10.1177/096368979300200203
   Turner NJ, 2012, CELL TISSUE RES, V347, P759, DOI 10.1007/s00441-011-1185-7
   von Bahr L, 2012, STEM CELLS, V30, P1575, DOI 10.1002/stem.1118
   Winkler T, 2012, J TISSUE ENG REGEN M, V6, ps60, DOI 10.1002/term.1542
   Winkler T, 2009, TISSUE ENG PT A, V15, P487, DOI 10.1089/ten.tea.2007.0426
   Xiao ZB, 2013, ADV SKIN WOUND CARE, V26, P266, DOI 10.1097/01.ASW.0000429705.02588.f5
   Yla-Herttuala S, 2003, NAT MED, V9, P694, DOI 10.1038/nm0603-694
NR 58
TC 22
Z9 25
U1 3
U2 50
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2016
VL 99
BP 95
EP 108
DI 10.1016/j.biomaterials.2016.05.009
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DP7HP
UT WOS:000378670100009
PM 27235995
DA 2018-10-20
ER

PT J
AU Midha, S
   Murab, S
   Ghosh, S
AF Midha, Swati
   Murab, Sumit
   Ghosh, Sourabh
TI Osteogenic signaling on silk-based matrices
SO BIOMATERIALS
LA English
DT Review
DE Silk fibroin; Mulberry and non-mulberry; Osteogenic signaling; Bone
   regeneration
ID MESENCHYMAL STEM-CELLS; BONE-MARROW-CELLS; DIFFERENTIATION IN-VITRO;
   FIBROIN SCAFFOLDS; OSTEOBLAST DIFFERENTIATION; MECHANICAL-PROPERTIES;
   ENDOTHELIAL-CELLS; NON-MULBERRY; COMPOSITE SCAFFOLDS; SURFACE-ROUGHNESS
AB Bone tissue engineering has mainly focused on generating 3D grafts to repair bone defects. However, the underlying signaling mechanisms responsible for development of such 3D bone equivalents have largely been ignored. Here we describe the crucial aspects of embryonic osteogenesis and bone development including cell sources and general signaling cascades that guide mesenchymal progenitors towards osteogenic lineage. Drawing from the knowledge of developmental biology, we then review how silk biomaterial can regulate osteogenic signaling by focusing on the expression of cell surface markers, functional genomic information (mRNA) of stem cells cultured on silk matrices. In an attempt to recapitulate exact in vivo microenvironment of osteogenesis, role of scaffold architecture and material chemistry in regulating cellular differentiation is elaborated. The generated knowledge will not only improve our understanding of cell-material interactions but reveal newer strategies beyond a conventional tissue engineering paradigm and open new prospects for developing silk-based therapies against clinically relevant bone disorders. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Midha, Swati; Murab, Sumit; Ghosh, Sourabh] IIT Delhi, Dept Text Technol, New Delhi 110016, India.
RP Ghosh, S (reprint author), IIT Delhi, Dept Text Technol, New Delhi 110016, India.
EM sghosh08@textile.iitd.ac.in
OI /0000-0003-0295-5356
FU Department of Biotechnology, Government of India
   [BT/PR8038/MED/32/303/2013]
FX Funding from Department of Biotechnology, Government of India (Grant No.
   BT/PR8038/MED/32/303/2013).
CR An B, 2013, BIOMATERIALS, V34, P402, DOI 10.1016/j.biomaterials.2012.09.085
   Anam K, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt323
   Asakura T, 2013, BIOMACROMOLECULES, V14, P3731, DOI 10.1021/bm401118m
   Bellis SL, 2011, BIOMATERIALS, V32, P4205, DOI 10.1016/j.biomaterials.2011.02.029
   Betz MW, 2010, BIOMACROMOLECULES, V11, P1160, DOI 10.1021/bm100061z
   Bhumiratana S, 2011, BIOMATERIALS, V32, P2812, DOI 10.1016/j.biomaterials.2010.12.058
   BRUDER SP, 1989, CONNECT TISSUE RES, V20, P65, DOI 10.3109/03008208909023875
   Chang J, 2007, J BIOL CHEM, V282, P30938, DOI 10.1074/jbc.M702391200
   Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929
   Chen J, 2014, MOL BIOL REP, V41, P2161, DOI 10.1007/s11033-014-3065-1
   Chen WC, 2014, DENT MATER, V30, P535, DOI 10.1016/j.dental.2014.02.007
   Chen XF, 2009, TISSUE ENG PT A, V15, P1363, DOI 10.1089/ten.tea.2008.0314
   Chun Kj, 2014, J Dent Biomech, V5, p1758736014520809, DOI 10.1177/1758736014520809
   Cooper DML, 2004, CALCIFIED TISSUE INT, V74, P437, DOI 10.1007/s00223-003-0071-z
   Correia C, 2012, ACTA BIOMATER, V8, P2483, DOI 10.1016/j.actbio.2012.03.019
   CSERJESI P, 1995, DEVELOPMENT, V121, P1099
   Das S, 2015, ACTA BIOMATER, V11, P233, DOI 10.1016/j.actbio.2014.09.023
   Das S, 2013, BIOMACROMOLECULES, V14, P311, DOI 10.1021/bm301193t
   Dastjerdi M. N., 2006, Iranian Biomedical Journal, V10, P133
   Datta A, 2001, COMP BIOCHEM PHYS B, V129, P197, DOI 10.1016/S1096-4959(01)00377-3
   Dubey P, 2015, BIOMACROMOLECULES, V16, P3936, DOI 10.1021/acs.biomac.5b01258
   Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3
   Dvorak MM, 2004, P NATL ACAD SCI USA, V101, P5140, DOI 10.1073/pnas.0306141101
   Epstein SE, 2001, CIRCULATION, V104, P115, DOI 10.1161/01.CIR.104.1.115
   Erickson GM, 2002, ANAT RECORD, V268, P115, DOI 10.1002/ar.10145
   Fan HB, 2008, CELL TRANSPLANT, V17, P1389, DOI 10.3727/096368908787648047
   Frohlich M, 2008, CURR STEM CELL RES T, V3, P254, DOI 10.2174/157488808786733962
   Fuchs S, 2009, BIOMATERIALS, V30, P1329, DOI 10.1016/j.biomaterials.2008.11.028
   Ge ZG, 2009, J BIOMATER APPL, V23, P533, DOI 10.1177/0885328208094301
   Ghanaati S, 2011, BIOMATERIALS, V32, P8150, DOI 10.1016/j.biomaterials.2011.07.041
   Ghorbanian L, 2013, INT J BIOL MACROMOL, V58, P275, DOI 10.1016/j.ijbiomac.2013.04.004
   Ghosh S, 2008, ADV FUNCT MATER, V18, P1883, DOI 10.1002/adfm.200800040
   Giesen EBW, 2001, J BIOMECH, V34, P799, DOI 10.1016/S0021-9290(01)00030-6
   Gil ES, 2011, J BIOMED MATER RES A, V99A, P16, DOI 10.1002/jbm.a.33158
   HALL BK, 1988, AM SCI, V76, P174
   Hall BK, 1995, INT J DEV BIOL, V39, P881
   Hatakeyama W, 2013, INT J MOL MED, V32, P1255, DOI 10.3892/ijmm.2013.1516
   HATORI M, 1995, J BONE MINER RES, V10, P1960, DOI 10.1002/jbmr.5650101216
   Herzog DPE, 2014, BIOMED RES INT, DOI 10.1155/2014/320123
   Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716
   Hoffmeister BK, 2000, MED BIOL ENG COMPUT, V38, P333, DOI 10.1007/BF02347055
   Horton W. A., 1990, GROWTH GENET HORM, V6, P1
   Hu X, 2011, BIOMATERIALS, V32, P8979, DOI 10.1016/j.biomaterials.2011.08.037
   Huang W, 2007, FRONT BIOSCI-LANDMRK, V12, P3068, DOI 10.2741/2296
   Huang XW, 2015, J BIOMED MATER RES B, V103, P1402, DOI 10.1002/jbm.b.33323
   Ilmer M, 2009, TISSUE ENG PT A, V15, P2397, DOI 10.1089/ten.tea.2008.0427
   Jiang XQ, 2009, BIOMATERIALS, V30, P4522, DOI 10.1016/j.biomaterials.2009.05.021
   Jung SR, 2013, NUTR RES, V33, P162, DOI 10.1016/j.nutres.2012.11.006
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Karageorgiou V, 2006, J BIOMED MATER RES A, V78A, P324, DOI 10.1002/jbm.a.30728
   Keaveny TM, 2001, ANNU REV BIOMED ENG, V3, P307, DOI 10.1146/annurev.bioeng.3.1.307
   Khatiwala CB, 2009, J BONE MINER RES, V24, P886, DOI [10.1359/JBMR.081240, 10.1359/jbmr.081240]
   Khoshniat S, 2011, BONE, V48, P894, DOI 10.1016/j.bone.2010.12.002
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   Kim HJ, 2008, BONE, V42, P1226, DOI 10.1016/j.bone.2008.02.007
   Kim J.H., 2013, J TISSUE ENG, V4
   Kim K, 2010, TISSUE ENG PART B-RE, V16, P523, DOI [10.1089/ten.teb.2010.0171, 10.1089/ten.TEB.2010.0171]
   Kirker-Head C, 2007, BONE, V41, P247, DOI 10.1016/j.bone.2007.04.186
   Koebley SR, 2015, BIOMACROMOLECULES, V16, P2796, DOI 10.1021/acs.biomac.5b00732
   Kollmer Melanie, 2013, J Dev Biol Tissue Eng, V5, P18
   Kundu B, 2014, PROG POLYM SCI, V39, P251, DOI 10.1016/j.progpolymsci.2013.09.002
   Lai CF, 2005, J BONE MINER RES, V20, P330, DOI 10.1359/JBMR.041013
   Langenbach F, 2013, STEM CELL RES THER, V4, DOI 10.1186/1757-6512-4-117
   Lee J, 2014, SCI REP-UK, V4, DOI 10.1038/srep05188
   Lee RH, 2004, CELL PHYSIOL BIOCHEM, V14, P311, DOI 10.1159/000080341
   Li C., 2007, EURO CELLS MAT
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200
   Lim JY, 2008, BIOMATERIALS, V29, P1776, DOI 10.1016/j.biomaterials.2007.12.026
   Lin F, 2008, MATER CHEM PHYS, V111, P92, DOI 10.1016/j.matchemphys.2008.03.019
   Lin SS, 2014, J MATER CHEM B, V2, P2622, DOI 10.1039/c4tb00019f
   Lin YC, 2015, J BONE MINER RES, V30, P1255, DOI 10.1002/jbmr.2451
   Liu C, 2013, INT J MED SCI, V10, P1181, DOI 10.7150/ijms.6657
   Lu GZ, 2014, COLLOID SURFACE B, V120, P28, DOI 10.1016/j.colsurfb.2014.03.027
   Lu Q, 2010, ACTA BIOMATER, V6, P1380, DOI 10.1016/j.actbio.2009.10.041
   Ma S, 2005, J Oral Implantol, V31, P61, DOI 10.1563/0-742.1
   Ma XL, 2010, EXPRESS POLYM LETT, V4, P321, DOI 10.3144/expresspolymlett.2010.40
   Major ML, 2007, BIOCHEM BIOPH RES CO, V355, P654, DOI 10.1016/j.bbrc.2007.01.177
   Mandal BB, 2010, TISSUE ENG PT A, V16, P2391, DOI [10.1089/ten.tea.2009.0206, 10.1089/ten.TEA.2009.0206]
   Mandal BB, 2012, P NATL ACAD SCI USA, V109, P7699, DOI 10.1073/pnas.1119474109
   Mandal BB, 2009, ACTA BIOMATER, V5, P2579, DOI 10.1016/j.actbio.2009.02.033
   Mandal BB, 2009, BIOMATERIALS, V30, P5019, DOI 10.1016/j.biomaterials.2009.05.064
   Marelli B, 2014, J MATER CHEM B, V2, P5339, DOI 10.1039/c4tb00477a
   Marelli B, 2012, BIOMATERIALS, V33, P102, DOI 10.1016/j.biomaterials.2011.09.039
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McCudden CR, 2005, CELL MOL LIFE SCI, V62, P551, DOI 10.1007/s00018-004-4462-3
   Meinel L, 2006, BONE, V39, P922, DOI 10.1016/j.bone.2006.04.019
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Meinel L, 2006, BIOMATERIALS, V27, P4993, DOI 10.1016/j.biomaterials.2006.05.021
   Melke J., 2016, ACTA BIOMATER
   Midha S, 2013, ACTA BIOMATER, V9, P9169, DOI 10.1016/j.actbio.2013.07.014
   Mieszawska AJ, 2011, ACTA BIOMATER, V7, P3036, DOI 10.1016/j.actbio.2011.04.016
   Mieszawska AJ, 2010, BIOMATERIALS, V31, P8902, DOI 10.1016/j.biomaterials.2010.07.109
   Ming JF, 2012, MATER CHEM PHYS, V137, P421, DOI 10.1016/j.matchemphys.2012.10.001
   Mizuno M, 2000, J CELL PHYSIOL, V184, P207, DOI 10.1002/1097-4652(200008)184:2<207::AID-JCP8>3.3.CO;2-L
   Morgan AW, 2008, BIOMATERIALS, V29, P2556, DOI 10.1016/j.biomaterials.2008.02.007
   Mottaghitalab F, 2015, J CONTROL RELEASE, V215, P112, DOI 10.1016/j.jconrel.2015.07.031
   Moursi AM, 1997, J CELL SCI, V110, P2187
   Murab S, 2015, BIOMATERIALS, V55, P64, DOI 10.1016/j.biomaterials.2015.03.032
   Murab S, 2013, TISSUE ENG PT A, V19, P1733, DOI [10.1089/ten.TEA.2012.0385, 10.1089/ten.tea.2012.0385]
   Murphy AR, 2008, BIOMATERIALS, V29, P2829, DOI 10.1016/j.biomaterials.2008.03.039
   Naskar D, 2014, SCI REP-UK, V4, DOI 10.1038/srep04745
   OBERLENDER SA, 1994, DEVELOPMENT, V120, P177
   Ohishi M, 2010, J CELL BIOCHEM, V109, P277, DOI 10.1002/jcb.22399
   Orbay H, 2012, STEM CELLS INT, V2012, DOI DOI 10.1155/2012/461718
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Park SH, 2010, BIOMATERIALS, V31, P6162, DOI 10.1016/j.biomaterials.2010.04.028
   Pascu EI, 2013, MAT SCI ENG C-MATER, V33, P4905, DOI 10.1016/j.msec.2013.08.012
   Pei YZ, 2015, ACTA BIOMATER, V13, P168, DOI 10.1016/j.actbio.2014.11.016
   Perez-Rigueiro J, 2000, J APPL POLYM SCI, V75, P1270, DOI 10.1002/(SICI)1097-4628(20000307)75:10<1270::AID-APP8>3.3.CO;2-3
   Perrone GS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4385
   Roberts J.C., 2013, FRONT BIOENG BIOTECH, V1, P13
   Rowlands AS, 2008, AM J PHYSIOL-CELL PH, V295, pC1037, DOI 10.1152/ajpcell.67.2008
   Rubin MR, 2011, J CLIN ENDOCR METAB, V96, P176, DOI 10.1210/jc.2009-2682
   Sahu N, 2015, ADV HEALTHC MATER, V4, P1709, DOI 10.1002/adhm.201500283
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Sengupta S, 2010, BIOMACROMOLECULES, V11, P3592, DOI 10.1021/bm101054q
   Sethi Nilay, 2012, Bonekey Rep, V1, P3, DOI 10.1038/bonekey.2012.2
   Shi PJ, 2013, BIOMACROMOLECULES, V14, P4465, DOI 10.1021/bm401381s
   Shi PJ, 2013, BIOMATERIALS, V34, P5947, DOI 10.1016/j.biomaterials.2013.04.046
   Shih YRV, 2011, J BONE MINER RES, V26, P730, DOI 10.1002/jbmr.278
   Silva SS, 2013, ACTA BIOMATER, V9, P8972, DOI 10.1016/j.actbio.2013.06.044
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Sosic D, 1997, DEV BIOL, V185, P229, DOI 10.1006/dbio.1997.8561
   Sousa BR, 2014, CYTOM PART A, V85A, P43, DOI 10.1002/cyto.a.22402
   Steiner D, 2012, J ORTHOP RES, V30, P1682, DOI 10.1002/jor.22130
   Stoppato M, 2015, ACTA BIOMATER, V25, P16, DOI 10.1016/j.actbio.2015.07.013
   Sun L, 2012, ADV HEALTHC MATER, V1, P729, DOI 10.1002/adhm.201200057
   Szpalski C, 2012, TISSUE ENG PART B-RE, V18, P258, DOI [10.1089/ten.teb.2011.0440, 10.1089/ten.TEB.2011.0440]
   Takacs R, 2013, INT J MOL SCI, V14, P16141, DOI 10.3390/ijms140816141
   Tapp H, 2009, EXP BIOL MED, V234, P1, DOI [10.3181/0805-MR-170, 10.3181/0805/MR-170]
   Tete S, 2008, INT J IMMUNOPATH PH, V21, P309, DOI 10.1177/039463200802100207
   Thimm J, 2005, J BIOL CHEM, V280, P10646, DOI 10.1074/jbc.M412749200
   Tigli RS, 2009, J TISSUE ENG REGEN M, V3, P348, DOI 10.1002/term.169
   Tobita M, 2011, DISCOV MED, V11, P160
   Tsai MT, 2009, J ORTHOP RES, V27, P1169, DOI 10.1002/jor.20862
   Uchida R, 2014, J BIOSCI BIOENG, V118, P333, DOI 10.1016/j.jbiosc.2014.02.016
   Uebersax L, 2006, TISSUE ENG, V12, P3417, DOI 10.1089/ten.2006.12.3417
   Uebersax L, 2013, EUR J PHARM BIOPHARM, V85, P107, DOI 10.1016/j.ejpb.2013.05.008
   Unger RE, 2007, BIOMATERIALS, V28, P3965, DOI 10.1016/j.biomaterials.2007.05.032
   Unger RE, 2015, ADV DRUG DELIVER REV, V94, P116, DOI 10.1016/j.addr.2015.03.012
   Unger RE, 2010, BIOMATERIALS, V31, P6959, DOI 10.1016/j.biomaterials.2010.05.057
   Varanasi VG, 2012, J ORAL IMPLANTOL, V38, P325, DOI 10.1563/AAID-JOI-D-11-00108
   Vetsch JR, 2015, ACTA BIOMATER, V13, P277, DOI 10.1016/j.actbio.2014.11.025
   Wang JN, 2014, MAT SCI ENG C-MATER, V34, P429, DOI 10.1016/j.msec.2013.09.039
   Wang J, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/4/041002
   Wang P, 2014, BONE RES, V2, DOI 10.1038/boneres.2014.17
   Weiss S, 2002, J BONE MINER RES, V17, P1280, DOI 10.1359/jbmr.2002.17.7.1280
   Westhrin M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120374
   Wetterwald A, 1996, BONE, V18, P125, DOI 10.1016/8756-3282(95)00457-2
   Witkowska-Zimny M., 2012, OSTEOGENESIS
   Woo SM, 2011, J BONE MINER RES, V26, P2634, DOI 10.1002/jbmr.465
   Wray LS, 2011, J BIOMED MATER RES B, V99B, P89, DOI 10.1002/jbm.b.31875
   Wu CT, 2011, ACTA BIOMATER, V7, P2229, DOI 10.1016/j.actbio.2010.12.019
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   Zhang J, 2013, MAT SCI ENG C-MATER, V33, P3206, DOI 10.1016/j.msec.2013.03.051
   Zhang WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102371
   Zhang Y, 2012, SCI WORLD J, DOI 10.1100/2012/793823
   Zhang YF, 2012, BIOMATERIALS, V33, P6698, DOI 10.1016/j.biomaterials.2012.06.021
   Zhang YF, 2011, TISSUE ENG PART C-ME, V17, P789, DOI 10.1089/ten.tec.2010.0453
   Zhang YF, 2010, ACTA BIOMATER, V6, P3021, DOI 10.1016/j.actbio.2010.02.030
   Zhang YF, 2010, BIOMATERIALS, V31, P2848, DOI 10.1016/j.biomaterials.2009.12.049
   Zhao J, 2009, BONE, V45, P517, DOI 10.1016/j.bone.2009.05.026
   Zhou H, 2010, J COLLOID INTERF SCI, V342, P620, DOI 10.1016/j.jcis.2009.10.079
NR 165
TC 21
Z9 22
U1 6
U2 80
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2016
VL 97
BP 133
EP 153
DI 10.1016/j.biomaterials.2016.04.020
PG 21
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DO4EY
UT WOS:000377735800012
PM 27163625
DA 2018-10-20
ER

PT J
AU Parreira, RM
   Andrade, TL
   Luz, AP
   Pandolfelli, VC
   Oliveira, IR
AF Parreira, R. M.
   Andrade, T. L.
   Luz, A. P.
   Pandolfelli, V. C.
   Oliveira, I. R.
TI Calcium aluminate cement-based compositions for biomaterial applications
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE Chemically-bonded ceramic; Calcium aluminate cement; Biomaterial;
   Properties
ID MECHANICAL-PROPERTIES; HYDROXYAPATITE NANOCOMPOSITES; ENDODONTIC CEMENT;
   IN-VITRO; BIOCOMPATIBILITY; CERAMICS; VIVO
AB Calcium aluminate cement (CAC) Calcium aluminate cement (CAC) is classified as a hydraulic binder presenting various advantages, such as fast hardening at room temperature and suitable Theological properties, when compared to traditional materials. Based on this, CAC has been investigated as an alternative biomaterial in order to overcome some drawbacks presented by commercial products usually applied in the dentistry (mineral trioxide aggregate=MTA and glass ionomer) and orthopedics (poly methyl methacrylate=PMMA) fields. In this work, the properties of CAC-based compositions containing different amounts of additives (i.e., alumina, zirconia, zinc oxide, hydroxyapatite, tricalcium phosphate, chitosan and collagen) were evaluated and the attained results were compared to those of MTA, PMMA and two glass ionomers (Meron and Vidrion F). The characterization of the selected materials comprised their particle size distribution, as well as the cold crushing strength, apparent porosity, pore size distribution and radiopacity. Plain CAC presented higher crushing strength than the commercial products used in dentistry and the blend of this cement with 4 wt% of additives (alumina, zirconia, zinc oxide, tricalcium phosphate or hydroxyapatite) resulted in improved mechanical performance when compared to PMMA (cement for bone repair). The addition of zinc oxide and hydroxyapatite to CAC also gave rise to samples with low porosity levels and smaller pore sizes after their contact with simulated body fluid solution over 7 days at 37 degrees C. Conversely, collagen and chitosan-containing compositions showed higher porosity and lower mechanical strength. Regarding the radiopacity results, the evaluated compositions presented better results than the commercial products, except for MTA. (C) 2016 Elsevier Ltd and Techna Group S.r.l. All rights reserved.
C1 [Parreira, R. M.; Andrade, T. L.; Oliveira, I. R.] Univ Vale do Paraiba, Inst Res & Dev, Ave Shishima Hifumi 2911, Sao Jose Dos Campos, SP, Brazil.
   [Luz, A. P.; Pandolfelli, V. C.] Univ Fed Sao Carlos, UFSCar, Dept Mat Engn, Rod Washington Luiz,Km 235, BR-13560 Sao Carlos, SP, Brazil.
RP Oliveira, IR (reprint author), Univ Vale do Paraiba, Inst Res & Dev, Ave Shishima Hifumi 2911, Sao Jose Dos Campos, SP, Brazil.
EM ivoneregina.oliveira@gmail.com
FU Fapesp [2013/22502-8, 2014/08988-8]; CNPq [300782/2012-8]
FX The authors are grateful to Fapesp (2013/22502-8, and 2014/08988-8) and
   CNPq (300782/2012-8) for supporting this work.
CR Aguilar FG, 2012, J ENDODONT, V38, P367, DOI 10.1016/j.joen.2011.11.002
   Alvarez-Perez MA, 2009, J NANO RES, V5, P169, DOI 10.4028/www.scientific.net/JNanoR.5.169
   Amaral M. B., 2006, THESIS, P98
   Aminzare M, 2013, CERAM INT, V39, P2197, DOI 10.1016/j.ceramint.2012.09.023
   Azevedo V. V. C., 2007, ELECT MAG MAT PROCES, V23, P27
   Azevedo V. V. C., 2007, REV ELECT MAT E PROC, V2, P35
   Burger C. P., 2010, THESIS, P55
   Camilleri J, 2008, INT ENDOD J, V41, P843, DOI 10.1111/j.1365-2591.2008.01435.x
   Camilleri J, 2010, INT ENDOD J, V43, P21, DOI 10.1111/j.1365-2591.2009.01621.x
   Castro-Raucci Larissa Moreira Spinola de, 2011, Braz. Dent. J., V22, P99, DOI 10.1590/S0103-64402011000200002
   Engqvist H, 2004, BIOMATERIALS, V25, P2781, DOI 10.1016/j.biomaterials.2003.09.053
   Engqvist H, 2008, TRENDS BIOMATER ARTI, V21, P98
   Hejazi MS, 2014, J MECH BEHAV BIOMED, V40, P95, DOI 10.1016/j.jmbbm.2014.08.004
   Ito A, 2000, J BIOMED MATER RES, V50, P178, DOI 10.1002/(SICI)1097-4636(200005)50:2<178::AID-JBM12>3.0.CO;2-5
   Jacobovitz M, 2009, ORAL SURG ORAL MED O, V108, P140, DOI 10.1016/j.tripleo.2009.03.013
   Kishen A, 2008, J ENDODONT, V34, P1515, DOI 10.1016/j.joen.2008.08.035
   Kopanda J.E., 1990, ALUMINA CHEM SCI TEC, P171
   Lachowski K. M., 2012, REV ASS PAUL CIR DEN, V66, P24
   Lee KH, 2009, BIOMATERIALS, V30, P3444, DOI 10.1016/j.biomaterials.2009.03.002
   Liu J., 2013, J PLANT BIOCHEM BIOT, P1
   Liu W., 2011, J BIOMATER APPL, V27, P171
   Loof J., 2008, THESIS, P87
   Moldovan M, 2015, OPEN CHEM, V13, P725, DOI 10.1515/chem-2015-0083
   Oliveira IR, 2016, CERAM INT, V42, P2542, DOI 10.1016/j.ceramint.2015.10.056
   Oliveira IR, 2010, INT ENDOD J, V43, P1069, DOI 10.1111/j.1365-2591.2010.01770.x
   Oliveira I.R., 2014, MAT RES, V17, P1295
   Oliveira IR, 2013, J ENDODONT, V39, P774, DOI 10.1016/j.joen.2013.01.013
   Pandolfelli V. C., 2009, Patent No, Patent No. [W02009067774, 2009067774]
   Rigo ECS, 2004, MAT SCI ENG C-BIO S, V24, P647, DOI 10.1016/j.msec.2004.08.044
   Roemhildt ML, 2003, J MATER SCI-MATER M, V14, P137, DOI 10.1023/A:1022067729008
   ROY DM, 1987, SCIENCE, V235, P651, DOI 10.1126/science.235.4789.651
   Seabra D. E. A., 2013, THESIS, P114
   Tavaria Freni Kekhasharú, 2013, Rev. Bras. Eng. Bioméd., V29, P110, DOI 10.4322/rbeb.2013.002
   Yoshida A, 2004, MATER TRANS, V45, P994, DOI 10.2320/matertrans.45.994
   Yu L, 2013, MAT SCI ENG C-MATER, V33, P3652, DOI 10.1016/j.msec.2013.04.055
NR 35
TC 7
Z9 7
U1 7
U2 47
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
EI 1873-3956
J9 CERAM INT
JI Ceram. Int.
PD AUG 1
PY 2016
VL 42
IS 10
BP 11732
EP 11738
DI 10.1016/j.ceramint.2016.04.092
PG 7
WC Materials Science, Ceramics
SC Materials Science
GA DO4EB
UT WOS:000377733500030
DA 2018-10-20
ER

PT J
AU Bhutto, MA
   Wu, T
   Sun, BB
   EI-Hamshary, H
   Al-Deyab, SS
   Mo, XM
AF Bhutto, M. Aqeel
   Wu, Tong
   Sun, Binbin
   EI-Hamshary, Hany
   Al-Deyab, Salem S.
   Mo, Xiumei
TI Fabrication and characterization of vitamin B5 loaded poly
   (L-lactide-co-caprolactone)/silk fiber aligned electrospun nanofibers
   for schwann cell proliferation
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Electrospinning; Vitamin B5; P (LLA-CL); Schwann cells
ID PERIPHERAL-NERVE REGENERATION; TISSUE ENGINEERING APPLICATIONS;
   SCAFFOLDS; SILK; STIMULATION; BIOMATERIAL; MORPHOLOGY; FILMS
AB Bioengineering strategies for peripheral nerve regeneration have been focusing on the development of alternative treatments for nerve repair. In present study we have blended the Vitamin B5 (50 mg) with 8% P(LLA-CL) and P(LLA-CL)/SF solutions and produced aligned electrospun nanofiber mashes and characterized the material for its physiochemical and mechanical characteristics. The vitamin loaded composites nanofibers showed tensile strength of 8.73 +/- 1.38 and 8.4 +/- 1.37 in P(LLA-CL)/Vt and P(LLA-CL)/SF/Vt nanofibers mashes, respectively. By the addition of vitamin B5 the P(LLA-CL) nanofibers become hydrophilic and the contact angle decreased from 96 degrees to 0 degrees in 6 min of duration. The effect of vitamin B5 on Schwann cells proliferation and viability were analyzed by using MTT assay and the number of cells cultured on vitamin loaded nanofiber mashes was significantly higher than the without vitamin loaded nanofiber samples after 5th day (p<0.05) whereas, P (LLA-CL)/SF/Vt exhibit the consistently highest cell numbers after 7th days culture as compare to P (LLA-CL)/Vt. The in vitro vitamin release behavior was observed in PBS solution and released vitamin was calculated by revers phase HPLC method. The sustain release behavior of vitamin B5 were noted higher in P(LLA-CL)/Vt (80%) nanofibers as compared to P (LLA-CL)/SF/Vt (62%) nanofibers after 24 h. The present work provided a basis for further studies of this novel aligned nanofibrous material in nerve tissue repair or regeneration. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Bhutto, M. Aqeel; Wu, Tong; Sun, Binbin; Mo, Xiumei] Donghua Univ, Coll Chem Chem Engn & Biotechnol, Biomat & Tissue Engn Lab, Shanghai 201620, Peoples R China.
   [EI-Hamshary, Hany; Al-Deyab, Salem S.; Mo, Xiumei] King Saud Univ, Coll Sci, Dept Chem, Riyadh 11451, Saudi Arabia.
   [EI-Hamshary, Hany] Tanta Univ, Fac Sci, Dept Chem, Tanta 31527, Egypt.
RP Mo, XM (reprint author), Donghua Univ, Coll Chem Chem Engn & Biotechnol, Biomat & Tissue Engn Lab, Shanghai 201620, Peoples R China.
EM xmm@dhu.edu.cn
RI mo, xiumei/C-9340-2013; Wu, Tong/E-1302-2018
OI Wu, Tong/0000-0001-8822-1868
FU National Nature Science Foundation of China [31470941, 31271035];
   Science and Technology Commission of Shanghai Municipality [15JC1490100,
   15441905100]; Ph.D. Programs Foundation of Ministry of Education of
   China [20130075110005]; light of textile project [J201404]; Deanship of
   Scientific Research at King Saud University [RGP-201]
FX This research was supported by National Nature Science Foundation of
   China (31470941, 31271035), Science and Technology Commission of
   Shanghai Municipality (15JC1490100, 15441905100), Ph.D. Programs
   Foundation of Ministry of Education of China (20130075110005) and light
   of textile project (J201404), The authors would like to extend their
   sincere appreciation to the Deanship of Scientific Research at King Saud
   University for financial support regarding this research group, project
   no.RGP-201.
CR Bellamkonda RV, 2006, BIOMATERIALS, V27, P3515, DOI 10.1016/j.biomaterials.2006.02.030
   Bhattarai N, 2009, ADV MATER, V21, P2792, DOI 10.1002/adma.200802513
   Bhutto MA, 2016, INT J POLYM MATER PO, V65, P323, DOI 10.1080/00914037.2015.1099104
   Bini TB, 2004, NANOTECHNOLOGY, V15, P1459, DOI 10.1088/0957-4484/15/11/014
   Chen ZG, 2010, ACTA BIOMATER, V6, P372, DOI 10.1016/j.actbio.2009.07.024
   Chew SY, 2008, BIOMATERIALS, V29, P653, DOI 10.1016/j.biomaterials.2007.10.025
   Ciardelli G, 2006, MACROMOL BIOSCI, V6, P13, DOI 10.1002/mabi.200500151
   Dong Y, 2008, INT J PHARM, V350, P166, DOI 10.1016/j.ijpharm.2007.08.043
   Engelking L.R., 2015, TXB VET PHYSL CHEM, P265
   Farokhi M, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.39980
   Gelain F, 2010, J CONTROL RELEASE, V145, P231, DOI 10.1016/j.jconrel.2010.04.026
   Gu XS, 2011, PROG NEUROBIOL, V93, P204, DOI 10.1016/j.pneurobio.2010.11.002
   Hasan N, 2013, J ANAL SCI METHODS I, V3, P24
   He CL, 2011, J BIOMED MATER RES A, V97A, P339, DOI 10.1002/jbm.a.33067
   Jun I, 2009, BIOMATERIALS, V30, P2038, DOI 10.1016/j.biomaterials.2008.12.063
   Ketabchi N., 2016, NEURAL COMPUT APPL
   Li D, 2004, ADV MATER, V16, P1151, DOI 10.1002/adma.200400719
   Nohr D., 2011, ENCY DAIRY SCI, P694
   Park WH, 2004, POLYMER, V45, P7151, DOI 10.1016/j.polymer.2004.08.045
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Rajaram A, 2012, TISSUE ENG PART B-RE, V18, P454, DOI [10.1089/ten.teb.2012.0006, 10.1089/ten.TEB.2012.0006]
   Richards OW, 1936, J BIOL CHEM, V113, P531
   Schiffman JD, 2008, POLYM REV, V48, P317, DOI 10.1080/15583720802022182
   Sheng XY, 2013, INT J BIOL MACROMOL, V56, P49, DOI 10.1016/j.ijbiomac.2013.01.029
   Stokols S, 2004, BIOMATERIALS, V25, P5839, DOI 10.1016/j.biomaterials.2004.01.041
   Subramanian A, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-108
   Sun BB, 2015, IRAN POLYM J, V24, P29, DOI 10.1007/s13726-014-0297-9
   Teo Wee-Eong, 2006, Biotechnology Journal, V1, P918, DOI 10.1002/biot.200600044
   Tomita K, 2009, NEUROSCI LETT, V461, P36, DOI 10.1016/j.neulet.2009.05.075
   Venugopal J, 2008, J BIOMED MATER RES B, V84B, P34, DOI 10.1002/jbm.b.30841
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang CY, 2012, J BIOMAT SCI-POLYM E, V23, P167, DOI 10.1163/092050610X545805
   Wang CY, 2011, ACTA BIOMATER, V7, P634, DOI 10.1016/j.actbio.2010.09.011
   Xie JW, 2008, MACROMOL RAPID COMM, V29, P1775, DOI 10.1002/marc.200800381
   Xu Y, 2014, BIOMATERIALS, V35, P2760, DOI 10.1016/j.biomaterials.2013.12.042
   Yang F, 2004, BIOMATERIALS, V25, P1891, DOI 10.1016/j.biomaterials.2003.08.062
   Zamani F, 2013, FIBER POLYM, V14, P698, DOI 10.1007/s12221-013-0698-y
   Zhang KH, 2014, J BIOMED MATER RES A, V102, P2680, DOI 10.1002/jbm.a.34922
   Zhang KH, 2010, J BIOMED MATER RES A, V93A, P984, DOI 10.1002/jbm.a.32504
   Zhu Y, 2006, ADV FUNCT MATER, V16, P568, DOI 10.1002/adfm.200500624
NR 40
TC 7
Z9 8
U1 4
U2 100
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD AUG 1
PY 2016
VL 144
BP 108
EP 117
DI 10.1016/j.colsurfb.2016.04.013
PG 10
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA DO5QF
UT WOS:000377837200013
PM 27085042
DA 2018-10-20
ER

PT J
AU Klimek, K
   Belcarz, A
   Pazik, R
   Sobierajska, P
   Han, T
   Wiglusz, RJ
   Ginalska, G
AF Klimek, Katarzyna
   Belcarz, Anna
   Pazik, Robert
   Sobierajska, Paulina
   Han, Tomasz
   Wiglusz, Rafal J.
   Ginalska, Grazyna
TI "False" cytotoxicity of ions-adsorbing hydroxyapatite - Corrected method
   of cytotoxicity evaluation for ceramics of high specific surface area
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Calcium phosphate; Cytotoxicity; High specific surface area; Ions
   uptake; Ions supplementation
ID IN-VITRO; MECHANICAL-PROPERTIES; BONE SUBSTITUTE; BIOMATERIALS;
   BIOACTIVITY; ADSORPTION; REACTIVITY; SCAFFOLDS; POROSITY; RELEASE
AB An assessment of biomaterial cytotoxicity is a prerequisite for evaluation of its clinical potential. A material is considered toxic while the cell viability decreases under 70% of the control. However, extracts of certain materials are likely to reduce the cell viability due to the intense ions adsorption from culture medium (e.g. highly bioactive ceramics of high surface area). Thus, the standard ISO 10993-5 procedure is inappropriate for cytotoxicity evaluation of ceramics of high specific surface area because biomaterial extract obtained in this method (ions-depleted medium) is not optimal for cell cultures per se.
   Therefore, a simple test was designed as an alternative to ISO 10993-5 standard for cytotoxicity evaluation of the biomaterials of high surface area and high ions absorption capacity. The method, presented in this paper, included the evaluation of ceramics extract prepared according to corrected procedure. The corrected extract was found not cytotoxic (cell viability above 70%), suggesting that modified method for cytotoxicity evaluation of ions adsorbing ceramics is more appropriate than ISO 10993-5 standard. For such biomaterials, the term "false" cytotoxicity is more suitable. Moreover, it was noted that NRU assay and microscopic observations should be recommended for cytotoxicity evaluation of ceramics of high surface area. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Klimek, Katarzyna; Belcarz, Anna; Ginalska, Grazyna] Med Univ Lublin, Chair & Dept Biochem & Biotechnol, Chodzki 1 Str, PL-20093 Lublin, Poland.
   [Pazik, Robert; Sobierajska, Paulina; Wiglusz, Rafal J.] PAS, Inst Low Temp & Struct Res, Okolna 2, PL-50422 Wroclaw, Poland.
   [Han, Tomasz] Res & Dev Ctr Novasome Sp Zoo, Olsztynska 5, PL-51423 Wroclaw, Poland.
RP Belcarz, A (reprint author), Med Univ Lublin, Chair & Dept Biochem & Biotechnol, Chodzki 1 Str, PL-20093 Lublin, Poland.
OI Belcarz, Anna/0000-0001-9899-5314; Ginalska, Grazyna/0000-0002-9961-4226
FU Ministry of Science and Higher Education in Poland within Medical
   University of Lublin [DS2/14-16]; National Science Centre in course of
   realization of the Project 'Preparation and characterization of
   nanoapatites doped with rare earth ions and their biocomposites'
   [UMO-2012/05/E/ST5/03904]; Operational Program Development of Eastern
   Poland, Priority Axis I, Modern Economy, Operations 1.3. Innovations
   Promotion [POPW.01.03.00-06-010/09-00]
FX This study was partially supported by Ministry of Science and Higher
   Education in Poland within DS2/14-16 project of Medical University of
   Lublin. Financial support of the National Science Centre in course of
   realization of the Project 'Preparation and characterization of
   nanoapatites doped with rare earth ions and their biocomposites' (no.
   UMO-2012/05/E/ST5/03904) is also gratefully acknowledge. The experiments
   were partially developed using the equipment purchased within the
   agreement No. POPW.01.03.00-06-010/09-00 Operational Program Development
   of Eastern Poland 2007-2013, Priority Axis I, Modern Economy, Operations
   1.3. Innovations Promotion.
CR Abdel-Aal EA, 2008, SURF COAT TECH, V202, P5895, DOI 10.1016/j.surfcoat.2008.06.139
   Abdel-Aal EA, 2008, MATER CHEM PHYS, V112, P202, DOI 10.1016/j.matchemphys.2008.05.053
   Abdel-Aal E. A., 2010, International Journal of Nano and Biomaterials, V3, P187, DOI 10.1504/IJNBM.2010.037804
   Abdel-Aal E. A., 2011, International Journal of Nanoparticles, V4, P77, DOI 10.1504/IJNP.2011.038254
   Abdel-Aal E. A., 2011, J ELECTROCHEM PLATIN, V3, P29
   Abdel-Aal E. A., 2013, APPL SURF SCI, V85, P136
   [Anonymous], 2009, 1099352009E ISO
   Belcarz A, 2015, MAT SCI ENG C-MATER, V47, P256, DOI 10.1016/j.msec.2014.11.052
   Borkowski L, 2015, MAT SCI ENG C-MATER, V53, P60, DOI 10.1016/j.msec.2015.04.009
   Brundavanam S., 2015, AM J MAT SCI, V5, P31
   Chai F, 2007, BIOMOL ENG, V24, P510, DOI 10.1016/j.bioeng.2007.08.001
   Chen SB, 2010, GEOCHEM J, V44, P233, DOI 10.2343/geochemj.1.0065
   Delhez R., 1993, RIETVELD METHOD, P132
   Dermience M, 2015, J TRACE ELEM MED BIO, V32, P86, DOI 10.1016/j.jtemb.2015.06.005
   Dvorak MM, 2004, P NATL ACAD SCI USA, V101, P5140, DOI 10.1073/pnas.0306141101
   Fischer J., 2010, ACTA BIOMATER, V6, P1913
   Gille J, 2002, INT ORTHOP, V26, P203, DOI 10.1007/s00264-002-0353-5
   Ginebra MP, 2006, J CONTROL RELEASE, V113, P102, DOI 10.1016/j.jconrel.2006.04.007
   Gustavsson J, 2011, ACTA BIOMATER, V7, P4242, DOI 10.1016/j.actbio.2011.07.016
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   KRESAK M, 1977, J COLLOID INTERF SCI, V59, P283, DOI 10.1016/0021-9797(77)90010-8
   Krisanapiboon A, 2006, J Orthop Surg (Hong Kong), V14, P315
   Laurent F, 2008, J MATER SCI-MATER M, V19, P947, DOI 10.1007/s10856-007-0163-9
   Li ZY, 2007, BIOMATERIALS, V28, P1452, DOI 10.1016/j.biomaterials.2006.11.001
   Liu Y.K., 2009, BIOMED MATER, V4, P1
   Luterotti L., 1990, J APPL CRYSTALLOGR, V23, P246
   Lutterotti L., 1999, IUCR NEWSLETTER CPD, V21, P14
   Malafaya PB, 2009, ACTA BIOMATER, V5, P644, DOI 10.1016/j.actbio.2008.09.017
   Miao SD, 2007, J MATER SCI-MATER M, V18, P2101, DOI 10.1007/s10856-007-3131-5
   Naruporn M., 2010, J METALS MAT MINERAL, V20, P53
   Netz DJA, 2001, INT J PHARM, V213, P117, DOI 10.1016/S0378-5173(00)00659-1
   Ozawa M, 2003, J MATER SCI LETT, V22, P1363, DOI 10.1023/A:1025795529901
   Pasternak K, 2010, J ELEMENTOL, V15, P601
   Przekora A, 2014, CENT EUR J BIOL, V9, P277, DOI 10.2478/s11535-013-0261-2
   RIETVELD HM, 1969, J APPL CRYSTALLOGR, V2, P65, DOI 10.1107/S0021889869006558
   Shetty S, 2010, J PERIODONTOL, V81, P1781, DOI 10.1902/jop.2010.100172
   Sopyan I, 2007, SCI TECHNOL ADV MAT, V8, P116, DOI 10.1016/j.stam.2006.11.017
   Swain SK, 2013, APPL SURF SCI, V286, P99, DOI 10.1016/j.apsusc.2013.09.027
   Tampieri A, 2012, ACTA BIOMATER, V8, P843, DOI 10.1016/j.actbio.2011.09.032
   Wiglusz RJ, 2015, RSC ADV, V5, P27610, DOI 10.1039/c5ra00675a
   Woodard JR, 2007, BIOMATERIALS, V28, P45, DOI 10.1016/j.biomaterials.2006.08.021
   Yang GL, 2009, ORAL SURG ORAL MED O, V107, P782, DOI 10.1016/j.tripleo.2008.12.023
   Yoshikawa M, 2007, MAT SCI ENG C-BIO S, V27, P220, DOI 10.1016/j.msec.2006.05.014
NR 43
TC 6
Z9 6
U1 0
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD AUG 1
PY 2016
VL 65
BP 70
EP 79
DI 10.1016/j.msec.2016.03.105
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA DN1NR
UT WOS:000376833200009
PM 27157729
DA 2018-10-20
ER

PT J
AU Buckholtz, GA
   Reger, NA
   Anderton, WD
   Schimoler, PJ
   Roudebush, SL
   Meng, WS
   Miller, MC
   Gawalt, ES
AF Buckholtz, Gavin A.
   Reger, Nina A.
   Anderton, William D.
   Schimoler, Patrick J.
   Roudebush, Shana L.
   Meng, Wilson S.
   Miller, Mark C.
   Gawalt, Ellen S.
TI Reducing Escherichia coli growth on a composite biomaterial by a surface
   immobilized antimicrobial peptide
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Calcium aluminum oxide; Hydroxyapatite; Composites; Osteoblasts;
   Escherichia coil; Antimicrobial peptide; Inverso-CysHHC10
ID MESENCHYMAL STEM-CELLS; INCREASED OSTEOBLAST ADHESION; MODIFIED CALCIUM
   ALUMINATE; SELF-ASSEMBLED MONOLAYERS; ENE CLICK CHEMISTRY; BONE-GRAFT;
   IN-VITRO; CALVARIAL DEFECT; POROUS CERAMICS; HYDROXYAPATITE
AB A new composite bioceramic consisting of calcium aluminum oxide (CaAlO) and hydroxyapatite (HA) was functionalized with the synthetic antimicrobial peptide Inverso-CysHHC10. CaAlO is a bioceramic that can be mold cast easily and quickly at room temperature. Improved functionality was previously achieved through surface reactions. Here, composites containing 0-5% HA (by mass) were prepared and the elastic modulus and modulus of rupture were mechanically similar to non-load bearing bone. The addition of hydroxyapatite resulted in increased osteoblast attachment (>180%) and proliferation (>140%) on all composites compared to 100% CaAlO. Antimicrobial peptide (AMP) immobilization was achieved using an interfacial alkene-thiol click reaction. The linked AMP persisted on the composite (>99.6% after 24 h) and retained its activity against Escherichia coli based on N-phenylnaphthylamine uptake and bacterial turbidity tests. Overall, this simple scaffold system improves osteoblast activity and reduces bacterial activity. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Buckholtz, Gavin A.; Reger, Nina A.; Gawalt, Ellen S.] Duquesne Univ, Dept Chem & Biochem, Pittsburgh, PA 15282 USA.
   [Anderton, William D.; Schimoler, Patrick J.; Miller, Mark C.] Allegheny Gen Hosp, Orthopaed Biomech Res Lab, Pittsburgh, PA 15212 USA.
   [Roudebush, Shana L.; Meng, Wilson S.] Duquesne Univ, Div Pharmaceut Sci, Pittsburgh, PA 15282 USA.
   [Gawalt, Ellen S.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA.
RP Gawalt, ES (reprint author), Duquesne Univ, Dept Chem & Biochem, Pittsburgh, PA 15282 USA.
EM gawalte@duq.edu
FU CAberTech Inc.; NSF S-STEM program [CHE 1259941]
FX We thank Kenneth McGowan and Bob Cullen of CAberTech Inc. for providing
   the calcium aluminum oxide precursor materials and for funding of this
   work. GAB acknowledges the NSF S-STEM program for financial support (CHE
   1259941).
CR Ambard Alberto J, 2006, J Prosthodont, V15, P321, DOI 10.1111/j.1532-849X.2006.00129.x
   Bagheri M, 2012, BIOCONJUGATE CHEM, V23, P66, DOI 10.1021/bc200367f
   Bagheri M, 2009, ANTIMICROB AGENTS CH, V53, P1132, DOI 10.1128/AAC.01254-08
   Balasundaram G, 2007, J BIOMED MATER RES A, V80A, P602, DOI 10.1002/jbm.a.30954
   Barralet JE, 2002, BIOMATERIALS, V23, P3063, DOI 10.1016/S0142-9612(01)00401-X
   Bhairamadgi NS, 2013, LANGMUIR, V29, P4535, DOI 10.1021/la400007y
   Bohner M, 2001, EUR SPINE J, V10, pS114, DOI 10.1007/s005860100276
   Budiraharjo R, 2012, J COLLOID INTERF SCI, V366, P224, DOI 10.1016/j.jcis.2011.09.072
   Campana V, 2014, J MATER SCI-MATER M, V25, P2445, DOI 10.1007/s10856-014-5240-2
   Champion E, 2013, ACTA BIOMATER, V9, P5855, DOI 10.1016/j.actbio.2012.11.029
   Charriere E, 2001, BIOMATERIALS, V22, P2937, DOI 10.1016/S0142-9612(01)00041-2
   Cherkasov A, 2009, ACS CHEM BIOL, V4, P65, DOI 10.1021/cb800240j
   CHOI K, 1990, J BIOMECH, V23, P1103, DOI 10.1016/0021-9290(90)90003-L
   Clafshenkel WP, 2012, J PINEAL RES, V53, P206, DOI 10.1111/j.1600-079X.2012.00989.x
   Cleophas RTC, 2014, BIOMACROMOLECULES, V15, P3390, DOI 10.1021/bm500899r
   Cleophas RTC, 2014, ACS MACRO LETT, V3, P477, DOI 10.1021/mz5001465
   CURREY JD, 1970, CLIN ORTHOP RELAT R, P210
   Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.3.CO;2-G
   dos Santos EA, 2009, J BIOMED MATER RES A, V89A, P510, DOI 10.1002/jbm.a.31991
   Engqvist H, 2004, BIOMATERIALS, V25, P2781, DOI 10.1016/j.biomaterials.2003.09.053
   Eslaminejad MB, 2007, J TISSUE ENG REGEN M, V1, P417, DOI 10.1002/term.49
   Gallo A, 2013, APPL SURF SCI, V279, P216, DOI 10.1016/j.apsusc.2013.04.072
   Gupta N, 2012, NAT CHEM, V4, P424, DOI 10.1038/NCHEM.1328
   Hasenbein ME, 2002, BIOMATERIALS, V23, P3937, DOI 10.1016/S0142-9612(02)00129-1
   Helander IM, 2000, J APPL MICROBIOL, V88, P213, DOI 10.1046/j.1365-2672.2000.00971.x
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hing KA, 2004, J BIOMED MATER RES A, V68A, P187, DOI 10.1002/jbm.a.10050
   Hu QH, 2007, J MATER CHEM, V17, P4690, DOI 10.1039/b710936a
   Hung IM, 2012, INT J MOL SCI, V13, P13569, DOI 10.3390/ijms131013569
   Janicki P, 2011, INJURY, V42, pS77, DOI 10.1016/j.injury.2011.06.014
   Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05
   Kalita SJ, 2002, J MATER RES, V17, P3042, DOI 10.1557/JMR.2002.0442
   Kempen DHR, 2009, BIOMATERIALS, V30, P2816, DOI 10.1016/j.biomaterials.2009.01.031
   Lee JH, 2010, MACROMOL BIOSCI, V10, P173, DOI 10.1002/mabi.200900169
   Leopold MC, 2002, LANGMUIR, V18, P2239, DOI 10.1021/la011456c
   Liu LY, 2007, LANGMUIR, V23, P11168, DOI 10.1021/la701435x
   Losic D, 2001, LANGMUIR, V17, P3307, DOI 10.1021/la001462t
   Ma YR, 2013, BIOMACROMOLECULES, V14, P665, DOI 10.1021/bm301731h
   Mckay WF, 2007, INT ORTHOP, V31, P729, DOI 10.1007/s00264-007-0418-6
   Miljkovic ND, 2009, J CRANIOFAC SURG, V20, P1538, DOI 10.1097/SCS.0b013e3181b09c13
   Mujeeb A, 2013, ACTA BIOMATER, V9, P4609, DOI 10.1016/j.actbio.2012.08.044
   Palchesko RN, 2014, MAT SCI ENG C-MATER, V40, P398, DOI 10.1016/j.msec.2014.04.017
   Palchesko RN, 2012, J BIOMED MATER RES A, V100A, P1229, DOI 10.1002/jbm.a.33303
   Palchesko RN, 2011, MAT SCI ENG C-MATER, V31, P637, DOI 10.1016/j.msec.2010.12.003
   Raman A, 2007, LANGMUIR, V23, P2284, DOI 10.1021/la063089g
   ROHL L, 1991, J BIOMECH, V24, P1143, DOI 10.1016/0021-9290(91)90006-9
   Salma K., 2010, PROCESS APPL CERAM, V4, P45
   Schlickewei W, 2007, MACROMOL SYMP, V253, P10, DOI 10.1002/masy.200750702
   Shor L, 2007, BIOMATERIALS, V28, P5291, DOI 10.1016/j.biomaterials.2007.08.018
   Shu R, 2003, J BIOMED MATER RES A, V67A, P1196, DOI 10.1002/jbm.a.20021
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Tadic D, 2004, BIOMATERIALS, V25, P987, DOI 10.1016/S0142-9612(03)00621-5
   Thian ES, 2006, BIOMATERIALS, V27, P2692, DOI 10.1016/j.biomaterials.2005.12.019
   UCHIDA A, 1984, J BONE JOINT SURG BR, V66, P269
   UCHIDA A, 1987, J BIOMED MATER RES, V21, P1, DOI 10.1002/jbm.820210106
   Vreuls C, 2010, J MATER CHEM, V20, P8092, DOI 10.1039/c0jm01419b
   Yoshikawa Hideki, 2005, J Artif Organs, V8, P131, DOI 10.1007/s10047-005-0292-1
   Yuan HP, 2010, P NATL ACAD SCI USA, V107, P13614, DOI 10.1073/pnas.1003600107
   Zhang L, 2005, J MATER SCI-MATER M, V16, P213, DOI 10.1007/s10856-005-6682-3
NR 59
TC 7
Z9 7
U1 0
U2 47
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD AUG 1
PY 2016
VL 65
BP 126
EP 134
DI 10.1016/j.msec.2016.04.021
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA DN1NR
UT WOS:000376833200015
PM 27157735
DA 2018-10-20
ER

PT J
AU Ma, DK
   An, G
   Liang, M
   Liu, YG
   Zhang, B
   Wang, YS
AF Ma, Dakun
   An, Gang
   Liang, Min
   Liu, Yugang
   Zhang, Bin
   Wang, Yansong
TI A composited PEG-silk hydrogel combining with polymeric particles
   delivering rhBMP-2 for bone regeneration
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Hydrogel; Bio-composite; BMP-2 sustained release; Bone regeneration
ID MORPHOGENETIC PROTEIN-2; POLYETHYLENE-GLYCOL; FIBROIN SOLUTION;
   SCAFFOLDS; DEFECTS; VEHICLE; RELEASE; SURGERY; CELLS
AB Given the fabulous potential of promoting bone regeneration, BMP-2 has been investigated widely in the bone tissue engineering field. A sophisticated biomaterial loaded with BMP-2, which could avoid the required supraphysiological dose leading to high medical costs and risks of complications, has been considered as a promising strategy to treat non-healing bone defects. In this study, we developed a simple approach to engineer a composited hydrogel consisting polymeric particles (PLA/PLGA) used as a BMP-2 delivery vehicle. Compared with other groups, the introduction of PLA into PEG-silk gels endowed the hydrogel new physicochemical characteristics especially hydrophobicity which inhibited the burst release of BMP-2 and enhanced gel's structural stability. Moreover, such composited gels could stabilize entrapped proteins and maintain their bioactivity fully in vitro. In vivo, the bio-degradability experiment demonstrated this system was biocompatible and the reinforced hydrophobicity significantly decreased degradation rate, and in rat critical-sized cranial defects model, the gel containing PLA promoted the most bone formation. These findings demonstrated the introduction of PLA changed physicochemical features of gels more suitable as a BMP-2 carrier indicated by inducing bone regeneration efficiently in large bone defects at low delivered dose and this system may own translational potential. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Ma, Dakun; An, Gang; Wang, Yansong] Harbin Med Univ, Dept Spine Surg, Affiliated Hosp 1, Harbin 150001, Peoples R China.
   [Liang, Min] Prov Hosp, Dept Orthoped Surg, Harbin 150001, Peoples R China.
   [Liu, Yugang] Hebei Univ Engn, Dept Orthoped Surg, Affiliated Hosp, Handan 056002, Hebei, Peoples R China.
   [Zhang, Bin; Wang, Yansong] Harbin Med Univ, Inst Hard Tissue Dev & Regenerat, Harbin 150001, Peoples R China.
   [Wang, Yansong] China Orthoped Regenerat Med CORMed, Hangzhou 310058, Zhejiang, Peoples R China.
RP Wang, YS (reprint author), Youzheng St, Harbin 150001, Peoples R China.; Zhang, B (reprint author), Xuefu Rd, Harbin 150086, Peoples R China.
EM zhangbhyd@126.com; wangyansong1975@163.com
FU National Nature Science Foundation of China [81271696]
FX This study was supported by the National Nature Science Foundation of
   China (project no. 81271696).
CR Abarrategi A., 2007, BIOMACROMOLECULES, V9, P711
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Bessa PC, 2010, TISSUE ENG PART C-ME, V16, P937, DOI [10.1089/ten.tec.2009.0486, 10.1089/ten.TEC.2009.0486]
   Bishop GB, 2007, INT ORTHOP, V31, P721, DOI 10.1007/s00264-007-0424-8
   Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023
   Farokhi M, 2014, MAT SCI ENG C-MATER, V35, P401, DOI 10.1016/j.msec.2013.11.023
   Fini M, 2005, BIOMATERIALS, V26, P3527, DOI 10.1016/j.biomaterials.2004.09.040
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jeon O, 2008, BIOCHEM BIOPH RES CO, V369, P774, DOI 10.1016/j.bbrc.2008.02.099
   Jo S, 2013, J BIOMED MATER RES A, V101, P892, DOI 10.1002/jbm.a.34354
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim J, 2007, BIOMATERIALS, V28, P1830, DOI 10.1016/j.biomaterials.2006.11.050
   Kim SS, 2007, J BIOMED MATER RES A, V80A, P206, DOI 10.1002/jbm.a.30836
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lin CC, 2009, PHARM RES-DORD, V26, P631, DOI 10.1007/s11095-008-9801-2
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   Lochmann A, 2010, J CONTROL RELEASE, V147, P92, DOI 10.1016/j.jconrel.2010.06.021
   Luca L, 2010, J CONTROL RELEASE, V147, P38, DOI 10.1016/j.jconrel.2010.06.011
   Mandal BB, 2009, BIOMATERIALS, V30, P2826, DOI 10.1016/j.biomaterials.2009.01.040
   Mariner PD, 2013, J ORTHOP RES, V31, P401, DOI 10.1002/jor.22243
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   Mourino V, 2013, EXPERT OPIN DRUG DEL, V10, P1353, DOI 10.1517/17425247.2013.808183
   NGUYEN TT, 1987, CLAY CLAY MINER, V35, P60, DOI 10.1346/CCMN.1987.0350108
   Patterson J, 2010, BIOMATERIALS, V31, P6772, DOI 10.1016/j.biomaterials.2010.05.047
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Seeherman H, 2005, CYTOKINE GROWTH F R, V16, P329, DOI 10.1016/j.cytogfr.2005.05.001
   Seeherman H, 2002, SPINE, V27, pS16, DOI 10.1097/01.BRS.0000020728.34131.03
   Seol YJ, 2004, BIOTECHNOL LETT, V26, P1037, DOI 10.1023/B:BILE.0000032962.79531.fd
   Shekaran A, 2014, BIOMATERIALS, V35, P5453, DOI 10.1016/j.biomaterials.2014.03.055
   Shi PJ, 2013, BIOMACROMOLECULES, V14, P4465, DOI 10.1021/bm401381s
   Soundrapandian C, 2009, AAPS PHARMSCITECH, V10, P1158, DOI 10.1208/s12249-009-9308-0
   Swetha M, 2010, INT J BIOL MACROMOL, V47, P1, DOI 10.1016/j.ijbiomac.2010.03.015
   Van Tomme SR, 2008, INT J PHARM, V355, P1, DOI 10.1016/j.ijpharm.2008.01.057
   Wang XQ, 2008, BIOMATERIALS, V29, P1054, DOI 10.1016/j.biomaterials.2007.11.003
   Wang XQ, 2015, ACTA BIOMATER, V12, P51, DOI 10.1016/j.actbio.2014.10.027
   Yamada H, 2001, MAT SCI ENG C-BIO S, V14, P41, DOI 10.1016/S0928-4931(01)00207-7
   Yang XBB, 2004, TISSUE ENG, V10, P1037, DOI 10.1089/1076327041887718
   YOON ST, 2002, CLIN ORTHOP RELAT R, V395, P33
   Zhong TY, 2012, J BIOMED MATER RES A, V100A, P1983, DOI 10.1002/jbm.a.33307
NR 40
TC 11
Z9 11
U1 5
U2 83
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD AUG 1
PY 2016
VL 65
BP 221
EP 231
DI 10.1016/j.msec.2016.04.043
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA DN1NR
UT WOS:000376833200027
PM 27157747
DA 2018-10-20
ER

PT J
AU Jellali, R
   Duval, JL
   Leclerc, E
AF Jellali, Rachid
   Duval, Jean-Luc
   Leclerc, Eric
TI Analysis of the biocompatibility of perfluoropolyether dimethacrylate
   network using an organotypic method
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Perfluoropolyethers; Organotypic cultures; Liver; Tissue engineering;
   Microstructuration; ECM proteins
ID RECTANGULAR SILICONE MICROCHANNELS; CELL-ADHESION MOLECULES;
   ORGAN-CULTURE METHOD; HIGH-ASPECT-RATIO; SURFACE MODIFICATION;
   MICROFLUIDIC DEVICES; POLYMER SURFACES; FABRICATION; FIBRONECTIN; TISSUE
AB In this work, we have investigated the potential of perfluoropolyether (PFPE) polymers for use in biomaterial applications, especially in cell culture and tissue engineering. PFPE substrates were synthesized by the photocuring of liquid PFPE urethane dimethacrylate. These surfaces were then modified by ECM protein coatings and microstructuration, to promote cell adhesion and migration. The surface properties of PFPE and PDMS (used as a reference) samples were studied by static contact angle measurements and AFM imaging. Both polymer surfaces were hydrophobic, having sessile air-water contact angles superior to 100 degrees. Collagen and fibronectin coatings were found to change the wettability of PFPE and PDMS samples. The biological testing of substrates was done using a liver organotypic culture to evaluate the migration and density of liver cells. The results over seven days of culture demonstrated that the migration and density of cells cultured under untreated PFPE were higher than the migration and density of cells cultured under PDMS. ECM protein coatings enhanced cell migration from liver explants cultured on PFPE or PDMS. Furthermore, these coatings were more efficient in the case of a PFPE sample. From a second series of tests, in which the PFPE was microstructured, it was found that microstructures promoted the formation of a 3D cell layer. These results indicate that PFPE polymers have a potential for use in the development of biomaterials for tissue engineering and cell culture. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Jellali, Rachid; Duval, Jean-Luc; Leclerc, Eric] Univ Technol Compiegne, Lab Biomecan & Bioingn, Univ Paris 04, CNRS,UMR 7338, Compiegne, France.
   [Leclerc, Eric] Univ Tokyo, Lab Integrated Micro Mechatron Syst, Inst Ind Sci, CNRS,UMI 2820,Meguro Ku, 4-6-1 Komaba, Tokyo 1538505, Japan.
RP Jellali, R; Leclerc, E (reprint author), Univ Technol Compiegne, Lab Biomecan & Bioingn, Univ Paris 04, CNRS,UMR 7338, Compiegne, France.
EM rachid.jellali@utc.fr; eric.leclerc@utc.fr
FU ANR (Agence National de la Recherche) [CCDIM-BM03A321R]
FX The authors thank the ANR (Agence National de la Recherche) for the
   financial support of this project (CCDIM-BM03A321R). We thank Frederic
   Nadaud for his technical assistance in SEM and AFM analysis. Finally we
   thank Isabelle Pezron for the contact angle measurements.
CR Ai H, 2003, J NEUROSCI METH, V128, P1, DOI 10.1016/S0165-0270(03)00191-2
   Ameduri B, 2001, PROG POLYM SCI, V26, P105, DOI 10.1016/S0079-6700(00)00044-7
   Bongiovanni R, 2012, POLYM INT, V61, P65, DOI 10.1002/pi.3149
   Brandl F, 2007, BIOMATERIALS, V28, P134, DOI 10.1016/j.biomaterials.2006.09.017
   Brocchini S, 2001, ADV DRUG DELIVER REV, V53, P123, DOI 10.1016/S0169-409X(01)00224-1
   Chan GYN, 2006, BIOMATERIALS, V27, P1287, DOI 10.1016/j.biomaterials.2005.08.005
   CHAUDHURY MK, 1993, J ADHES SCI TECHNOL, V7, P669, DOI 10.1163/156856193X00907
   Chen H, 2008, PROG POLYM SCI, V33, P1059, DOI 10.1016/j.progpolymsci.2008.07.006
   Craighead HG, 2001, CURR OPIN SOLID ST M, V5, P177, DOI 10.1016/S1359-0286(01)00005-5
   Duval JL, 2017, J TISSUE ENG REGEN M, V11, P354, DOI 10.1002/term.1916
   DUVAL JL, 1988, BIOMATERIALS, V9, P155, DOI 10.1016/0142-9612(88)90115-9
   Evans MDM, 2011, BIOMATERIALS, V32, P3158, DOI 10.1016/j.biomaterials.2011.01.047
   Evans MDM, 2001, BIOMATERIALS, V22, P3319, DOI 10.1016/S0142-9612(01)00169-7
   Gentile F, 2010, BIOMATERIALS, V31, P7205, DOI 10.1016/j.biomaterials.2010.06.016
   Gomez M, 2012, MICROELECTRON ENG, V97, P208, DOI 10.1016/j.mee.2012.03.035
   Johnson G, 1999, J BIOMAT SCI-POLYM E, V10, P217, DOI 10.1163/156856299X00144
   Kim TH, 1998, EXP CELL RES, V244, P93, DOI 10.1006/excr.1998.4209
   Koenig AL, 2003, J BIOMED MATER RES A, V64A, P20, DOI 10.1002/jbm.a.10316
   Kurella A, 2005, J BIOMATER APPL, V20, P5, DOI 10.1177/0885328205052974
   Kwon S, 2011, J IND ENG CHEM, V17, P259, DOI 10.1016/j.jiec.2011.02.018
   Leclerc E, 2007, BIOMATERIALS, V28, P1820, DOI 10.1016/j.biomaterials.2006.11.044
   Leclerc E, 2006, BIOMATERIALS, V27, P4109, DOI 10.1016/j.biomaterials.2006.03.031
   Leclerc E, 2010, MAT SCI ENG C-MATER, V30, P1190, DOI 10.1016/j.msec.2010.06.016
   Leclerc E, 2009, MAT SCI ENG C-BIO S, V29, P861, DOI 10.1016/j.msec.2008.07.019
   Lee JH, 1998, J COLLOID INTERF SCI, V205, P323, DOI 10.1006/jcis.1998.5688
   Lensen MC, 2008, PURE APPL CHEM, V80, P2479, DOI 10.1351/pac200880112479
   Lorenz H, 1998, SENSOR ACTUAT A-PHYS, V64, P33, DOI 10.1016/S0924-4247(98)80055-1
   Ma ZW, 2007, COLLOID SURFACE B, V60, P137, DOI 10.1016/j.colsurfb.2007.06.019
   Mashinchian O, 2015, NANOMEDICINE-UK, V10, P829, DOI [10.2217/NNM.14.225, 10.2217/nnm.14.225]
   Peterson SL, 2005, J BIOMED MATER RES A, V72A, P10, DOI 10.1002/jbm.a.30166
   PETITE H, 1995, BIOMATERIALS, V16, P1003, DOI 10.1016/0142-9612(95)94908-4
   Rolland J. P, 2004, ANGEW CHEM, V116, P5920
   Rolland JP, 2004, J AM CHEM SOC, V126, P2322, DOI 10.1021/ja031657y
   Saha N., 2011, J BIOMATER NANOBIOTE, V2, P85, DOI DOI 10.4236/JBNB.2011.21011
   Sahlin E, 2002, ANAL CHEM, V74, P4566, DOI 10.1021/ac025622c
   Sanchez A, 2000, J HEPATOL, V32, P242, DOI 10.1016/S0168-8278(00)80069-0
   Schulte VA, 2010, BIOMATERIALS, V31, P8583, DOI 10.1016/j.biomaterials.2010.07.070
   Schulte VA, 2009, BIOMACROMOLECULES, V10, P2795, DOI 10.1021/bm900631s
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Shao GC, 2012, SENSOR ACTUAT A-PHYS, V178, P230, DOI 10.1016/j.sna.2012.01.034
   SIGOTLUIZARD MF, 1986, IN VITRO CELL DEV B, V22, P234
   Song GB, 2008, MAT SCI ENG C-BIO S, V28, P1467, DOI 10.1016/j.msec.2008.04.005
   STAMATOGLOU SC, 1994, FASEB J, V8, P420
   Sweeney DF, 2008, CLIN EXP OPTOM, V91, P56, DOI 10.1111/j.1444-0938.2007.00198.x
   TAMADA Y, 1994, J BIOMED MATER RES, V28, P783, DOI 10.1002/jbm.820280705
   Toselli M, 2001, POLYMER, V42, P1771, DOI 10.1016/S0032-3861(00)00568-1
   Truong TT, 2007, LANGMUIR, V23, P2898, DOI 10.1021/la062981k
   Vasita R, 2008, CURR TOP MED CHEM, V8, P341
   Ventre M, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0687
   Vitale A, 2013, LANGMUIR, V29, P15711, DOI 10.1021/la402755q
   Vitale A, 2012, EUR POLYM J, V48, P1118, DOI 10.1016/j.eurpolymj.2012.03.016
   Vladkova TG, 2010, INT J POLYM SCI, DOI 10.1155/2010/296094
   Wang L, 2010, J BIOMED MATER RES A, V93A, P1260, DOI 10.1002/jbm.a.32621
   Werner L, 1999, J BIOMED MATER RES, V46, P347
   WOLFF E, 1952, TEX REP BIOL MED, V10, P463
   Wong I, 2009, MICROFLUID NANOFLUID, V7, P291, DOI 10.1007/s10404-009-0443-4
   Xie RZ, 2006, INVEST OPHTH VIS SCI, V47, P574, DOI 10.1167/iovs.05-0872
NR 57
TC 3
Z9 4
U1 3
U2 23
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD AUG 1
PY 2016
VL 65
BP 295
EP 302
DI 10.1016/j.msec.2016.04.057
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA DN1NR
UT WOS:000376833200035
PM 27157755
DA 2018-10-20
ER

PT J
AU Heidari, F
   Razavi, M
   Bahrololoom, ME
   Bazargan-Lari, R
   Vashaee, D
   Kotturi, H
   Tayebi, L
AF Heidari, Fatemeh
   Razavi, Mehdi
   Bahrololoom, Mohammad E.
   Bazargan-Lari, Reza
   Vashaee, Daryoosh
   Kotturi, Hari
   Tayebi, Lobat
TI Mechanical properties of natural chitosan/hydroxyapatite/magnetite
   nanocomposites for tissue engineering applications
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Bending; Compressive; Hardness; Hydroxyapatite; Chitosan; Magnetite
   nano-particles
ID PARTICULATE SOL-GEL; BIOMEDICAL APPLICATIONS; HYDROXYAPATITE/CHITOSAN
   COMPOSITE; ELECTROPHORETIC DEPOSITION; SURFACE MODIFICATION; ORTHOPEDIC
   IMPLANTS; INTERNAL-FIXATION; MAGNESIUM ALLOY; BONE-FRACTURE;
   DRUG-RELEASE
AB Chitosan (CS), hydroxyapatite (HA), and magnetite (Fe3O4) have been broadly employed for bone treatment applications. Having a hybrid biomaterial composed of the aforementioned constituents not only accumulates the useful characteristics of each component, but also provides outstanding composite properties. In the present research, mechanical properties of pure CS, CS/HA, CS/HA/magnetite, and CS/magnetite were evaluated by the measurements of bending strength, elastic modulus, compressive strength and hardness values. Moreover, the morphology of the bending fracture surfaces were characterized using a scanning electron microscope (SEM) and an image analyzer. Studies were also conducted to examine the biological response of the human Mesenchymal Stem Cells (hMSCs) on different composites. We conclude that, although all of these composites possess in vitro biocompatibility, adding hydroxyapatite and magnetite to the chitosan matrix can noticeably enhance the mechanical properties of the pure chitosan. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Heidari, Fatemeh] Univ Yasuj, Sch Engn, Dept Mat Sci & Engn, Yasuj 7591874934, Iran.
   [Razavi, Mehdi] Brunel Univ London, Inst Mat & Mfg, BCAST, Uxbridge UB8 3PH, Middx, England.
   [Razavi, Mehdi] Brunel Univ London, Brunel Inst Bioengn, London UB8 3PH, England.
   [Bahrololoom, Mohammad E.] Shiraz Univ, Sch Engn, Dept Mat Sci & Engn, Shiraz, Iran.
   [Bazargan-Lari, Reza] Islamic Azad Univ, Marvdasht Branch, Dept Mat Sci & Engn, Marvdasht, Iran.
   [Vashaee, Daryoosh] N Carolina State Univ, Dept Elect & Comp Engn, Raleigh, NC 27606 USA.
   [Kotturi, Hari] Univ Cent Oklahoma, Dept Biol, Edmond, OK 73034 USA.
   [Tayebi, Lobat] Marquette Univ, Sch Dent, Dept Dev Sci, Milwaukee, WI 53233 USA.
   [Tayebi, Lobat] Univ Oxford, Dept Engn Sci, Parks Rd, Oxford OX1 3PJ, England.
RP Tayebi, L (reprint author), Marquette Univ, Sch Dent, Dept Dev Sci, Milwaukee, WI 53233 USA.
EM lobat.tayebi@marquette.edu
OI Razavi, Mehdi/0000-0002-3020-6187
FU Research Committee of Shiraz University [86-GR-ENG-62]; Delta Dental;
   National Science Foundation (NSF) [EEC-1160483, ECCS-1351533,
   CMMI-1363485]; AFOSR [FA9550-12-1-0225]; Marquette University Strategic
   Innovation Fund
FX The authors are thankful of the support from the Research Committee of
   Shiraz University (grant no. 86-GR-ENG-62 to M.E. Bahrololoom), Delta
   Dental, National Science Foundation (NSF, grant no. EEC-1160483,
   ECCS-1351533 and CMMI-1363485), AFOSR under contract number
   FA9550-12-1-0225, and Marquette University Strategic Innovation Fund.
CR AKAO M, 1981, J MATER SCI, V16, P809, DOI 10.1007/BF02402799
   Ang TH, 2002, MAT SCI ENG C-BIO S, V20, P35, DOI 10.1016/S0928-4931(02)00010-3
   Bahrololoom ME, 2009, J CERAM PROCESS RES, V10, P129
   Baradaran S, 2014, CARBON, V69, P32, DOI 10.1016/j.carbon.2013.11.054
   Bazargan-Lari R, 2011, J FOOD AGRIC ENVIRON, V9, P892
   Cai X, 2009, ACTA BIOMATER, V5, P2693, DOI 10.1016/j.actbio.2009.03.005
   Danilchenko SN, 2011, J BIOMED MATER RES A, V96A, P639, DOI 10.1002/jbm.a.33017
   DEBOER HH, 1988, CLIN ORTHOP RELAT R, P292
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Donadel K, 2008, MAT SCI ENG C-BIO S, V28, P509, DOI 10.1016/j.msec.2007.06.004
   Ghaemy M, 2012, CARBOHYD POLYM, V90, P1265, DOI 10.1016/j.carbpol.2012.06.069
   Ghafari-Nazari A, 2012, CERAM INT, V38, P5445, DOI 10.1016/j.ceramint.2012.03.055
   Grumezescu AM, 2012, INT J PHARMACEUT, V436, P771, DOI 10.1016/j.ijpharm.2012.07.063
   Gupta KC, 2001, J MATER SCI-MATER M, V12, P753, DOI 10.1023/A:1017976014534
   Heidari F, 2015, CERAM INT, V41, P3094, DOI 10.1016/j.ceramint.2014.10.153
   Hong ZK, 2005, BIOMATERIALS, V26, P6296, DOI 10.1016/j.biomaterials.2005.04.018
   Hu Q., 2002, CHEM J CHINESE U, V24, P528
   Hu QL, 2006, MATER LETT, V60, P368, DOI 10.1016/j.matlet.2005.08.062
   Hu QL, 2001, CHINESE J POLYM SCI, V19, P467
   Hu QL, 2004, BIOMATERIALS, V25, P779, DOI 10.1016/S0142-9612(03)00582-9
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kuo MC, 2002, MAT SCI ENG C-BIO S, V20, P153, DOI 10.1016/S0928-4931(02)00026-7
   Lee JY, 2002, J CONTROL RELEASE, V78, P187, DOI 10.1016/S0168-3659(01)00498-9
   Leukers B, 2005, J MATER SCI-MATER M, V16, P1121, DOI 10.1007/s10856-005-4716-5
   Li BQ, 2002, ACTA POLYM SIN, P828
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Mozafari M, 2012, ELECTROCONDUCTIVE NA
   Nikpour MR, 2012, COMPOS PART B-ENG, V43, P1881, DOI 10.1016/j.compositesb.2012.01.056
   Pu XM, 2013, MATER LETT, V94, P169, DOI 10.1016/j.matlet.2012.12.009
   Rabiee SM, 2015, CERAM INT, V41, P7241, DOI 10.1016/j.ceramint.2015.02.140
   Razavi M., 2014, PHYS SCI INT J, V4, P708, DOI DOI 10.9734/PSIJ/2014/9265
   Razavi M, 2015, MAT SCI ENG C-MATER, V48, P21, DOI 10.1016/j.msec.2014.11.020
   Razavi M, 2014, APPL SURF SCI, V313, P60, DOI 10.1016/j.apsusc.2014.05.130
   Razavi M, 2014, CERAM INT, V40, P9473, DOI 10.1016/j.ceramint.2014.02.020
   Razavi M, 2014, MAT SCI ENG C-MATER, V41, P168, DOI 10.1016/j.msec.2014.04.039
   Razavi M, 2014, SURF INTERFACE ANAL, V46, P387, DOI 10.1002/sia.5465
   Rouhani P, 2013, J ALLOY COMPD, V568, P102, DOI 10.1016/j.jallcom.2013.03.142
   Sabnis S, 1997, POLYM BULL, V39, P67, DOI 10.1007/s002890050121
   Salahinejad E, 2013, CERAM INT, V39, P1271, DOI 10.1016/j.ceramint.2012.07.058
   Salahinejad E, 2012, MATER LETT, V88, P5, DOI 10.1016/j.matlet.2012.08.013
   Salahinejad E, 2012, CERAM INT, V38, P6145, DOI 10.1016/j.ceramint.2012.04.064
   Spence M. L, 1997, BIOM ENG C 1997 P 19, P257
   Teng SH, 2009, J BIOMED MATER RES A, V88A, P569, DOI 10.1002/jbm.a.31897
   VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270
   Verma D, 2008, MAT SCI ENG C-BIO S, V28, P399, DOI 10.1016/j.msec.2007.04.026
   Wan YZ, 2007, MAT SCI ENG C-BIO S, V27, P855, DOI 10.1016/j.msec.2006.10.002
   Wang XH, 2002, BIOMATERIALS, V23, P4167, DOI 10.1016/S0142-9612(02)00153-9
   Wei GB, 2004, BIOMATERIALS, V25, P4749, DOI 10.1016/j.biomaterials.2003.12.005
   Wilson OC, 2008, MAT SCI ENG C-BIO S, V28, P434, DOI 10.1016/j.msec.2007.04.005
   Woodard JR, 2007, BIOMATERIALS, V28, P45, DOI 10.1016/j.biomaterials.2006.08.021
   XIANMIAO C, 2009, MAT SCI ENG C, V29, P29, DOI DOI 10.1016/J.MSEC.2008.05.008
   Yazdimamaghani M, 2015, MAT SCI ENG C-MATER, V49, P436, DOI 10.1016/j.msec.2015.01.041
   Yazdimamaghani M, 2014, MATER LETT, V132, P106, DOI 10.1016/j.matlet.2014.06.036
   Yazdimamaghani M, 2014, MAT SCI ENG C-MATER, V39, P235, DOI 10.1016/j.msec.2014.03.007
   Yazdimamaghani M, 2013, MATERIALS, V6, P3727, DOI 10.3390/ma6093727
   Zhao HX, 2014, MATER LETT, V116, P293, DOI 10.1016/j.matlet.2013.05.082
NR 57
TC 22
Z9 22
U1 4
U2 73
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD AUG 1
PY 2016
VL 65
BP 338
EP 344
DI 10.1016/j.msec.2016.04.039
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA DN1NR
UT WOS:000376833200040
PM 27157760
OA Other Gold
DA 2018-10-20
ER

PT J
AU Sakloetsakun, D
   Preechagoon, D
   Bernkop-Schnurch, A
   Pongjanyakul, T
AF Sakloetsakun, Duangkamon
   Preechagoon, Detpon
   Bernkop-Schnurch, Andreas
   Pongjanyakul, Thaned
TI Chitosan-gum arabic polyelectrolyte complex films: physicochemical,
   mechanical and mucoadhesive properties
SO PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
LA English
DT Article
DE Chitosan; films; gum arabic; mechanical properties; mucoadhesive
   properties; polyelectrolyte complex
ID ALUMINUM SILICATE FILMS; DRUG-DELIVERY; PERMEABILITY; STABILITY;
   POLYSACCHARIDES; MICROSTRUCTURE; MICROCAPSULES; COACERVATION;
   ABSORPTION; STRENGTH
AB By blending chitosan (CS) and gum arabic (GA), a powerful biomaterial complex might be obtained due to the unique properties of CS and the low viscosity and good emulsifying properties of GA. The objectives of this study were to prepare and examine the properties of dispersions and films of CS and GA as a function of the mixing weight ratio, pH value and molecular weight of CS. The dispersions were characterized by turbidity, zeta potential and cytotoxicity and then the dispersions were cast into films. Physicochemical properties of the film were performed. CS-GA dispersions exhibited higher turbidity and a lower zeta potential with an increase in the GA ratio. Continuous films of the CS-GA could be formed at all ratios. CS and GA could molecularly interact via electrostatic forces and intermolecular hydrogen bonding. The CS-GA (1:0.5) films exhibited relatively low water uptake, erosion, water vapor permeability and puncture strength compared to the CS films. Furthermore, the CS-GA films demonstrated good mucoadhesive properties, allowing for adhesion to the mucosal membrane. Based on these results, it could be advantageous to use CS-GA films as film formers for the formulation of coatings and drug delivery systems.
C1 [Sakloetsakun, Duangkamon; Preechagoon, Detpon; Pongjanyakul, Thaned] Khon Kaen Univ, Fac Pharmaceut Sci, Div Pharmaceut Technol, Khon Kaen 40002, Thailand.
   [Bernkop-Schnurch, Andreas] Leopold Franzens Univ Innsbruck, Inst Pharm, Dept Pharmaceut Technol, Ctr Mol Biosci Innsbruck, Innsbruck, Austria.
RP Sakloetsakun, D (reprint author), Khon Kaen Univ, Fac Pharmaceut Sci, Div Pharmaceut Technol, Khon Kaen 40002, Thailand.
EM sduangk@kku.ac.th
FU Khon Kaen University; Faculty of Pharmaceutical Sciences, Khon Kaen
   University
FX This work was financially supported by the Khon Kaen University
   Scholarship for Young Scientists and the Faculty of Pharmaceutical
   Sciences, Khon Kaen University. The authors report no declarations of
   interest.
CR Avadi MR, 2010, NANOMED-NANOTECHNOL, V6, P58, DOI 10.1016/j.nano.2009.04.007
   Bertolini AC, 2001, J AGR FOOD CHEM, V49, P780, DOI 10.1021/jf000436y
   Bigucci F, 2008, EUR J PHARM SCI, V35, P435, DOI 10.1016/j.ejps.2008.09.004
   BODMEIER R, 1994, PHARMACEUT RES, V11, P882, DOI 10.1023/A:1018942127524
   BODMEIER R, 1993, INT J PHARM, V96, P129, DOI 10.1016/0378-5173(93)90220-A
   Bravo-Osuna I, 2006, INT J PHARMACEUT, V316, P170, DOI 10.1016/j.ijpharm.2006.02.037
   BURGESS DJ, 1990, J COLLOID INTERF SCI, V140, P227, DOI 10.1016/0021-9797(90)90338-O
   Butstraen C, 2014, CARBOHYD POLYM, V99, P608, DOI 10.1016/j.carbpol.2013.09.006
   Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   Chen X, 2005, J APPL POLYM SCI, V96, P1267, DOI 10.1002/app.21552
   Coelho S, 2011, J COLLOID INTERF SCI, V363, P450, DOI 10.1016/j.jcis.2011.07.098
   Dodane V, 1998, PHARM SCI TECHNOL TO, V1, P246, DOI 10.1016/S1461-5347(98)00059-5
   Drogoz A, 2007, LANGMUIR, V23, P10950, DOI 10.1021/la7008545
   Espert A, 2004, COMPOS PART A-APPL S, V35, P1267, DOI 10.1016/j.compositesa.2004.04.004
   Espinosa-Andrews H, 2007, BIOMACROMOLECULES, V8, P1313, DOI 10.1021/bm0611634
   Espinosa-Andrews H, 2013, CARBOHYD POLYM, V95, P161, DOI 10.1016/j.carbpol.2013.02.053
   Espinosa-Andrews H, 2010, CARBOHYD POLYM, V79, P541, DOI 10.1016/j.carbpol.2009.08.040
   Felton LA, 2007, AAPS PHARMSCITECH, V8
   Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3
   Hamman JH, 2010, MAR DRUGS, V8, P1305, DOI 10.3390/md8041305
   Hartig SM, 2007, BIOMACROMOLECULES, V8, P265, DOI 10.1021/bm0604754
   HASSAN EE, 1990, PHARMACEUT RES, V7, P491, DOI 10.1023/A:1015812615635
   Jiang H, 2011, J MATER SCI-MATER M, V22, P289, DOI 10.1007/s10856-010-4195-1
   Kanjanabat S, 2011, AAPS PHARMSCITECH, V12, P683, DOI 10.1208/s12249-011-9633-y
   Khunawattanakul W, 2010, INT J PHARMACEUT, V393, P219, DOI 10.1016/j.ijpharm.2010.04.007
   Lankalapalli S, 2009, INDIAN J PHARM SCI, V71, P481, DOI 10.4103/0250-474X.58165
   LEHR CM, 1992, J PHARM PHARMACOL, V44, P402, DOI 10.1111/j.2042-7158.1992.tb03633.x
   Limmatvapirat S, 2004, INT J PHARM, V278, P41, DOI 10.1016/j.ijpharm.2004.02.030
   Luo YC, 2014, INT J BIOL MACROMOL, V64, P353, DOI 10.1016/j.ijbiomac.2013.12.017
   Malviya R., 2009, FABAD J PHARM SCI, V34, P13
   Nunthanid J, 2001, DRUG DEV IND PHARM, V27, P143, DOI 10.1081/DDC-100000481
   Perez CD, 2009, J AGR FOOD CHEM, V57, P6844, DOI 10.1021/jf804019x
   Pongjanyakul T, 2008, INT J PHARM, V346, P1, DOI 10.1016/j.ijpharm.2007.05.058
   Pongjanyakul T, 2007, INT J PHARM, V333, P34, DOI 10.1016/j.ijpharm.2006.09.046
   Pongjanyakul T, 2009, INT J PHARM, V365, P100, DOI 10.1016/j.ijpharm.2008.08.025
   Prodpran T, 2007, INT J BIOL MACROMOL, V41, P605, DOI 10.1016/j.ijbiomac.2007.07.020
   Ravi K.M.N., 2000, J PHARM SCI, V3, P234
   RemunanLopez C, 1997, J CONTROL RELEASE, V44, P215, DOI 10.1016/S0168-3659(96)01525-8
   Rogers TL, 2012, DRUG DEV IND PHARM, V38, P129, DOI 10.3109/03639045.2011.590990
   Rongthong T, 2013, INT J PHARMACEUT, V458, P57, DOI 10.1016/j.ijpharm.2013.10.016
   Sanchez C, 2002, INT J PHARM, V242, P319, DOI 10.1016/S0378-5173(02)00174-6
   Smart JD, 2005, ADV DRUG DELIVER REV, V57, P1556, DOI 10.1016/j.addr.2005.07.001
   TRINH CK, 1993, ANGEW MAKROMOL CHEM, V212, P167, DOI 10.1002/apmc.1993.052120115
   Tsai RY, 2014, CARBOHYD POLYM, V101, P752, DOI 10.1016/j.carbpol.2013.10.008
   Yoo SR, 2011, J SCI FOOD AGR, V91, P2628, DOI 10.1002/jsfa.4502
NR 45
TC 3
Z9 3
U1 3
U2 39
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1083-7450
EI 1097-9867
J9 PHARM DEV TECHNOL
JI Pharm. Dev. Technol.
PD AUG
PY 2016
VL 21
IS 5
BP 590
EP 599
DI 10.3109/10837450.2015.1035727
PG 10
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA DL2KG
UT WOS:000375462900009
PM 25886079
DA 2018-10-20
ER

PT J
AU Cruz-Zuniga, JM
   Soto-Valdez, H
   Peralta, E
   Mendoza-Wilson, AM
   Robles-Burgueno, MR
   Auras, R
   Gamez-Meza, N
AF Cruz-Zuniga, Johana M.
   Soto-Valdez, Herlinda
   Peralta, Elizabeth
   Maria Mendoza-Wilson, Ana
   Refugio Robles-Burgueno, M.
   Auras, Rafael
   Gamez-Meza, Nohemi
TI Development of an antioxidant biomaterial by promoting the
   deglycosylation of rutin to isoquercetin and quercetin
SO FOOD CHEMISTRY
LA English
DT Article
DE Rutin; Quercetin; Isoquercetin; Deglycosylation; Poly(L-lactic acid);
   Antioxidant
ID FILMS; CYCLODEXTRIN; POLYETHYLENE; FLAVONOIDS; RELEASE; SYSTEM; FOOD
AB Quercetin-3-O-rutinoside (rutin), quercetin-3-O-glucoside (isoquercetin) and quercetin have shown antioxidant, cytoprotective, vasoprotective, antiproliferative and antiinflammatory properties. The aim of this work was to determine the conversion of rutin to isoquercetin and quercetin during the production of poly(L-lactic acid) films with potential to deliver these flavonoids toward tissues, pharmaceuticals or food matrices. Three poly(L-lactic acid) formulations with 17.7, 39.6 and 39.1 mg/g of rutin were prepared by the extrusion process. Processing temperatures (130-165 degrees C) promoted the deglycosylation of rutin to produce isoquercetin and subsequently quercetin, identified by high performance liquid chromatography coupled to mass spectrometry. The effect of the process on the antioxidant activity of the films was determined by measuring the capacity to scavenge 2,2 diphenyl-1-picrylhydrazyl radicals. The material with the highest proportion of quercetin showed the highest antioxidant activity which could be used to produce delivering devices of the flavonoids to tissues, pharmaceuticals or food matrices. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Cruz-Zuniga, Johana M.] Univ Autonoma Sinaloa, Gral Angel Flores S-N,Apdo Postal 80000, Culiacan, Sinaloa, Mexico.
   [Soto-Valdez, Herlinda; Peralta, Elizabeth; Maria Mendoza-Wilson, Ana; Refugio Robles-Burgueno, M.] Ctr Invest Alimentac & Desarrollo AC, CTAOV, Apdo Postal 1735, Hermosillo 83304, Sonora, Mexico.
   [Auras, Rafael] Michigan State Univ, Sch Packaging, E Lansing, MI 48824 USA.
   [Gamez-Meza, Nohemi] Univ Sonora, Blvd Luis Encinas & Rosales S-N,Apdo Postal 1658, Hermosillo 83000, Sonora, Mexico.
RP Soto-Valdez, H (reprint author), Ctr Invest Alimentac & Desarrollo AC, CTAOV, Apdo Postal 1735, Hermosillo 83304, Sonora, Mexico.
EM hsoto@ciad.mx
OI Gamez-Meza, Nohemi/0000-0002-2968-0869
FU CONACYT, Mexico [2008-CB-106224]
FX This study was supported by funds from CONACYT (2008-CB-106224), Mexico.
   Thanks to the CONACYT scholarship program for supporting the author
   Johana M. Cruz-Zuniga. We gratefully acknowledge Thitisilp Kijchavengkul
   and Sukeewan Detyothin for their assistance with the determination of
   weight average molecular weights.
CR Agustin-Salazar S, 2014, AUST J GRAPE WINE R, V20, P208, DOI 10.1111/ajgw.12063
   Auras R, 2004, MACROMOL BIOSCI, V4, P835, DOI 10.1002/mabi.200400043
   Buchner N, 2006, RAPID COMMUN MASS SP, V20, P3229, DOI 10.1002/rcm.2720
   Byrne F, 2009, J POLYM ENVIRON, V17, P28, DOI 10.1007/s10924-009-0119-x
   Castangia I, 2014, ACTA BIOMATER, V10, P1292, DOI 10.1016/j.actbio.2013.11.005
   Chiodo SG, 2010, PHYS CHEM CHEM PHYS, V12, P7662, DOI 10.1039/b924521a
   Dias K, 2008, SPECTROCHIM ACTA A, V70, P154, DOI 10.1016/j.saa.2007.07.022
   Erdohan ZO, 2013, J FOOD ENG, V119, P308, DOI 10.1016/j.jfoodeng.2013.05.043
   Iniguez-Franco F., 2012, J AGR FOOD CHEM, V60, P6515
   Koontz JL, 2010, FOOD ADDIT CONTAM A, V27, P1598, DOI 10.1080/19440049.2010.495729
   Kuehni R. G., 2004, COLOR INTRO PRACTICE, P224
   Lasprilla AJR, 2012, BIOTECHNOL ADV, V30, P321, DOI 10.1016/j.biotechadv.2011.06.019
   Lim L., 2010, POLYLACTIC ACID SYNT, P191
   Lin LZ, 2007, J AGR FOOD CHEM, V55, P1084, DOI 10.1021/jf062431s
   Lopez-de-Dicastillo C, 2010, J AGR FOOD CHEM, V58, P10958, DOI 10.1021/jf1022324
   Manzanarez-Lopez F, 2011, J FOOD ENG, V104, P508, DOI 10.1016/j.jfoodeng.2010.12.029
   de Araujo MEMB, 2013, FOOD CHEM, V141, P266, DOI 10.1016/j.foodchem.2013.02.127
   Ortiz-Vazquez H, 2011, POLYM TEST, V30, P463, DOI 10.1016/j.polymertesting.2011.03.006
   Rohn S, 2007, J AGR FOOD CHEM, V55, P1568, DOI 10.1021/jf063221i
   Soto-Valdez H, 2011, J APPL POLYM SCI, V121, P970, DOI 10.1002/app.33687
   Tatraaljai D, 2014, POLYM DEGRAD STABIL, V102, P41, DOI 10.1016/j.polymdegradstab.2014.02.010
   Yang JX, 2008, LWT-FOOD SCI TECHNOL, V41, P1060, DOI 10.1016/j.lwt.2007.06.010
   Zhang S., 2013, FOOD CHEM, V157, P45
NR 23
TC 5
Z9 5
U1 4
U2 65
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0308-8146
EI 1873-7072
J9 FOOD CHEM
JI Food Chem.
PD AUG 1
PY 2016
VL 204
BP 420
EP 426
DI 10.1016/j.foodchem.2016.02.130
PG 7
WC Chemistry, Applied; Food Science & Technology; Nutrition & Dietetics
SC Chemistry; Food Science & Technology; Nutrition & Dietetics
GA DG2FS
UT WOS:000371882700053
PM 26988520
DA 2018-10-20
ER

PT J
AU Oneto, JMM
   Khan, I
   Seebald, L
   Royzen, M
AF Oneto, Jose M. Mejia
   Khan, Irfan
   Seebald, Leah
   Royzen, Maksim
TI In Vivo Bioorthogonal Chemistry Enables Local Hydrogel and Systemic
   Pro-Drug To Treat Soft Tissue Sarcoma
SO ACS CENTRAL SCIENCE
LA English
DT Article
ID HYPOXIA-ACTIVATED PRODRUG; RANDOMIZED PHASE-II; ADJUVANT CHEMOTHERAPY;
   RADIATION-THERAPY; CONVENTIONAL CHEMOTHERAPY; DOXORUBICIN PRODRUGS;
   MEDICAL PROGRESS; CLINICAL-TRIAL; COMBINATION; EXTREMITY
AB The ability to activate drugs only at desired locations avoiding systemic immunosuppression and other dose limiting toxicities is highly desirable. Here we present a new approach, named local drug activation, that uses bioorthogonal chemistry to concentrate and activate systemic small molecules at a location of choice. This method is independent of endogenous cellular or environmental markers and only depends on the presence of a preimplanted biomaterial near a desired site (e.g., tumor). We demonstrate the clear therapeutic benefit with minimal side effects of this approach in mice over systemic therapy using a doxorubicin prodrug against xenograft tumors of a type of soft tissue sarcoma (HT1080).
C1 [Oneto, Jose M. Mejia] Shasqi Inc, 665 Third St,Suite 250, San Francisco, CA 94107 USA.
   [Khan, Irfan; Seebald, Leah; Royzen, Maksim] SUNY Albany, Dept Chem, 1400 Washington Ave, Albany, NY 12222 USA.
RP Oneto, JMM (reprint author), Shasqi Inc, 665 Third St,Suite 250, San Francisco, CA 94107 USA.
EM jose@shasqi.com
CR Aflatoon Kamran, 2003, J Am Acad Orthop Surg, V11, P332
   Agustin E, 2016, CHEM COMMUN, V52, P1405, DOI 10.1039/c5cc05392g
   Albright CF, 2005, MOL CANCER THER, V4, P751, DOI 10.1158/1535-7163.MCT-05-0006
   [Anonymous], 2000, COCHRANE DATABASE SY
   Arndt CAS, 1999, NEW ENGL J MED, V341, P342, DOI 10.1056/NEJM199907293410507
   Baratti D, 2010, ANN SURG ONCOL, V17, P3220, DOI 10.1245/s10434-010-1178-x
   BRAMWELL VH, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003293
   Brennan MF, 2014, ANN SURG, V260, P416, DOI 10.1097/SLA.0000000000000869
   Brooks JSJ, 2015, J SURG ONCOL, V111, P513, DOI 10.1002/jso.23853
   Brudno Y, 2015, CHEMMEDCHEM, V10, P617, DOI 10.1002/cmdc.201402527
   Chawla SP, 2014, J CLIN ONCOL, V32, P3299, DOI 10.1200/JCO.2013.54.3660
   Clark MA, 2005, NEW ENGL J MED, V353, P701, DOI 10.1056/NEJMra041866
   Colombo C, 2015, J SURG ONCOL, V111, P570, DOI 10.1002/jso.23808
   Demetri G. D., J NATL COMPR CANC NE
   Demetri GD, 2016, J CLIN ONCOL, V34, P786, DOI 10.1200/JCO.2015.62.4734
   Devaraj NK, 2012, P NATL ACAD SCI USA, V109, P4762, DOI 10.1073/pnas.1113466109
   Eggermont A M, 2001, Curr Oncol Rep, V3, P359, DOI 10.1007/s11912-001-0090-8
   Frustaci S, 2001, J CLIN ONCOL, V19, P1238, DOI 10.1200/JCO.2001.19.5.1238
   Ganjoo KN, 2011, ONCOLOGY-BASEL, V80, P50, DOI 10.1159/000327739
   Gelderblom H, 2014, EUR J CANCER, V50, P388, DOI 10.1016/j.ejca.2013.10.002
   Gilbert NE, 2009, J AM ACAD ORTHOP SUR, V17, P40, DOI 10.5435/00124635-200901000-00006
   Gronchi A, 2012, J CLIN ONCOL, V30, P850, DOI 10.1200/JCO.2011.37.7218
   Hanaoka H, 2009, ANN NUCL MED, V23, P479, DOI 10.1007/s12149-009-0265-1
   Harrison DJ, 2015, J SURG ONCOL, V111, P648, DOI 10.1002/jso.23844
   Hendifar AE, 2012, CURR TREAT OPTION ON, V13, P299, DOI 10.1007/s11864-012-0197-1
   Holloway CL, 2013, BRACHYTHERAPY, V12, P179, DOI 10.1016/j.brachy.2012.12.002
   Hu ZL, 2010, BIOORG MED CHEM LETT, V20, P853, DOI 10.1016/j.bmcl.2009.12.084
   Judson I, 2001, EUR J CANCER, V37, P870, DOI 10.1016/S0959-8049(01)00050-8
   Koscielniak E, 1997, BONE MARROW TRANSPL, V19, P227, DOI 10.1038/sj.bmt.1700628
   Le Cesne A, 2014, ANN ONCOL, V25, P2425, DOI 10.1093/annonc/mdu460
   Li J, 2014, NAT CHEM BIOL, V10, P1003, DOI 10.1038/nchembio.1656
   Liebner DA, 2015, J SURG ONCOL, V111, P622, DOI 10.1002/jso.23866
   Liu Q, 2012, CANCER CHEMOTH PHARM, V69, P1487, DOI 10.1007/s00280-012-1852-8
   Miller ED, 2015, J SURG ONCOL, V111, P599, DOI 10.1002/jso.23823
   Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893
   Park K, 2014, J CONTROL RELEASE, V174, P219, DOI 10.1016/j.jconrel.2014.01.001
   Rossin R, 2010, ANGEW CHEM INT EDIT, V49, P3375, DOI 10.1002/anie.200906294
   Sborov D, 2015, J SURG ONCOL, V111, P632, DOI 10.1002/jso.23802
   Schwartz GK, 2016, J CLIN ONCOL, V34, P769, DOI 10.1200/JCO.2015.63.5938
   Simkens LHJ, 2015, LANCET, V385, P1843, DOI 10.1016/S0140-6736(14)62004-3
   Tedesco NS, 2016, J AM ACAD ORTHOP SUR, V24, P150, DOI 10.5435/JAAOS-D-15-00074
   Tongu M, 2013, CANCER IMMUNOL IMMUN, V62, P383, DOI 10.1007/s00262-012-1343-0
   van der Graaf WTA, 2012, CURR TREAT OPTION ON, V13, P306, DOI 10.1007/s11864-012-0196-2
   Versteegen RM, 2013, ANGEW CHEM INT EDIT, V52, P14112, DOI 10.1002/anie.201305969
   von Mehren M, 2014, J NATL COMPR CANC NE, V12, P473, DOI 10.6004/jnccn.2014.0053
   Walczak BE, 2013, J AM ACAD ORTHOP SUR, V21, P480, DOI 10.5435/JAAOS-21-08-480
   Wolfson AH, 2005, CURR OPIN ONCOL, V17, P357, DOI 10.1097/01.cco.0000161745.24887.82
   Wolinsky JB, 2012, J CONTROL RELEASE, V159, P14, DOI 10.1016/j.jconrel.2011.11.031
   Yang JC, 1998, J CLIN ONCOL, V16, P197, DOI 10.1200/JCO.1998.16.1.197
   Zhang G, 2016, ACS CENTRAL SCI, V2, P325, DOI 10.1021/acscentsci.6b00024
NR 50
TC 30
Z9 30
U1 3
U2 16
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2374-7943
EI 2374-7951
J9 ACS CENTRAL SCI
JI ACS Central Sci.
PD JUL 27
PY 2016
VL 2
IS 7
BP 476
EP 482
DI 10.1021/acscentsci.6b00150
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA DX9XE
UT WOS:000384749500008
PM 27504494
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Nitta, K
   Kimoto, A
   Watanabe, J
AF Nitta, Kyohei
   Kimoto, Atsushi
   Watanabe, Junji
TI Surface properties of amphiphilic graft copolymer containing different
   oligo segments
SO POLYMER
LA English
DT Article
DE Amphiphilic graft polymer; Surface enrichment; Wettability
ID TRIMETHYLENE CARBONATE COPOLYMERS; RING-OPENING POLYMERIZATION;
   BLOCK-COPOLYMERS; POLY(TRIMETHYLENE CARBONATE); POLY(ETHYLENE GLYCOL);
   BLOOD COMPATIBILITY; DIBLOCK COPOLYMERS; WATER-STRUCTURE; L-LACTIDE;
   ADSORPTION
AB Two types of novel amphiphilic graft copolymers were synthesized by macromonomer method, and the copolymers were composed of 2-hydroxyethyl acrylate (HEA) or 2-methoxyethyl acrylate (MEA) along with macromonomers with amorphous poly(trimethylene carbonate) (PTMC) and biocompatible poly(ethylene glycol) monomethyl ether (mPEG) segments. The copolymers prepared exhibited low glass transition temperatures, where the mobility of the PTMC segment was high at room temperature. The synthesized polymers were further spin-coated onto a glass substrate, and the polymer-coated surfaces were evaluated using static contact angle measurement. The initial contact angle was influenced by change in the composition ratio of the PTMC macromonomer. However, the wettability of the polymer membrane could be rapidly and reversibly changed from hydrophobic to more hydrophilic upon varying its external environment such as its immersion into different solvents. These results indicated that the copolymer containing PTMC and mPEG segments regulated the surface wettability of its main chain polymer and composition ratio of the macromonomer. This change in wettability most likely occurred due to the mobility of the flexible PTMC segments in the copolymer. Therefore, this copolymer with rapid surface responsiveness has the potential to be used as a surface modifier in biomaterial fields. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Nitta, Kyohei] Konan Univ, Grad Sch Nat Sci, Dept Life & Funct Mat Sci, Higashinada Ku, 8-9-1 Okamoto, Kobe, Hyogo 6588501, Japan.
   [Nitta, Kyohei] Japan Soc Promot Sci DC1, Tokyo, Japan.
   [Kimoto, Atsushi; Watanabe, Junji] Konan Univ, Fac Sci & Engn, Dept Chem Funct Mol, Higashinada Ku, 8-9-1 Okamoto, Kobe, Hyogo 6588501, Japan.
RP Watanabe, J (reprint author), Konan Univ, Fac Sci & Engn, Dept Chem Funct Mol, Higashinada Ku, 8-9-1 Okamoto, Kobe, Hyogo 6588501, Japan.
EM junjiknd@konan-u.ac.jp
FU  [2579181]
FX This work was supported by Grant-in-Aid (2579181) for the Japan Society
   for Promotion of Science Fellows.
CR Ajiro H, 2014, POLYMER, V55, P3591, DOI 10.1016/j.polymer.2014.06.011
   Andronova N, 2006, BIOMACROMOLECULES, V7, P1489, DOI 10.1021/bm060081c
   Atthoff B, 2006, BIOMACROMOLECULES, V7, P2401, DOI 10.1021/bm060396s
   Buwalda SJ, 2011, BIOMACROMOLECULES, V12, P2746, DOI 10.1021/bm200515h
   Cai J, 1998, POLYMER, V39, P4409, DOI 10.1016/S0032-3861(97)10346-9
   Cai J., 1997, POLYM INT, V42, P373
   Carstens MG, 2005, LANGMUIR, V21, P11446, DOI 10.1021/la051972t
   Chen T, 2010, PROG POLYM SCI, V35, P94, DOI 10.1016/j.progpolymsci.2009.11.004
   Diaz A, 2014, MAT SCI ENG C-MATER, V42, P517, DOI 10.1016/j.msec.2014.05.069
   Diaz A., 2005, BIOMACROMOLECULES, V6, P514
   Dizman B, 2005, BIOMACROMOLECULES, V6, P514, DOI 10.1021/bm049383+
   Feng YK, 2005, J POLYM SCI POL CHEM, V43, P4819, DOI 10.1002/pola.20929
   Hirata T, 2015, PHYS CHEM CHEM PHYS, V17, P17399, DOI 10.1039/c5cp01972a
   ISHIHARA K, 1992, J BIOMED MATER RES, V26, P1543, DOI 10.1002/jbm.820261202
   Kallrot M, 2006, BIOMATERIALS, V27, P1788, DOI 10.1016/j.biomaterials.2005.10.010
   Kobayashi M, 2012, LANGMUIR, V28, P7212, DOI 10.1021/la301033h
   Lee S, 2008, LANGMUIR, V24, P9479, DOI 10.1021/la801200h
   Leng C, 2015, ACS APPL MATER INTER, V7, P16881, DOI 10.1021/acsami.5b05627
   LU DR, 1991, J BIOMAT SCI-POLYM E, V3, P127, DOI 10.1163/156856291X00232
   Mert O, 2008, LANGMUIR, V24, P749, DOI 10.1021/la701966d
   Morita S, 2014, LANGMUIR, V30, P10698, DOI 10.1021/la502550d
   Nederberg F, 2007, BIOMACROMOLECULES, V8, P3294, DOI 10.1021/bm700895d
   Nederberg F, 2007, BIOMACROMOLECULES, V8, P153, DOI 10.1021/bm060795n
   Nitta K., 2012, T MAT RES SOC JPN, V37, P349
   Nitta K., 2013, T MAT RES SOC JPN, V38, P629
   Otsuka H, 2000, BIOMACROMOLECULES, V1, P39, DOI 10.1021/bm990005s
   Sato K, 2015, MACROMOL BIOSCI, V15, P1296, DOI 10.1002/mabi.201500078
   Srivastava RK, 2007, MACROMOLECULES, V40, P4464, DOI 10.1021/ma0701179
   Steinhauer W, 2013, MACROMOLECULES, V46, P1447, DOI 10.1021/ma302606x
   TAKEI YG, 1994, MACROMOLECULES, V27, P6163, DOI 10.1021/ma00099a035
   Tanaka M, 2004, J BIOMED MATER RES A, V68A, P684, DOI 10.1002/jbm.a.20088
   Terao K, 2012, MAT SCI ENG C-MATER, V32, P988, DOI 10.1016/j.msec.2012.02.026
   Toki I, 2013, J APPL POLYM SCI, V127, P3657, DOI 10.1002/app.37966
   Trinca RB, 2015, EUR POLYM J, V62, P77, DOI 10.1016/j.eurpolymj.2014.11.008
   Tyson T, 2009, BIOMACROMOLECULES, V10, P149, DOI 10.1021/bm801052m
   Vyas MK, 2008, SOFT MATTER, V4, P1024, DOI 10.1039/b801110a
   Wang H, 1998, J POLYM SCI POL CHEM, V36, P695, DOI 10.1002/(SICI)1099-0518(19980415)36:5<695::AID-POLA3>3.0.CO;2-L
   Watanabe J, 2007, MACROMOLECULES, V40, P8731, DOI 10.1021/ma071030q
   Watanabe J, 2008, POLYMER, V49, P3709, DOI 10.1016/j.polymer.2008.06.034
   Zhang R, 2008, LANGMUIR, V24, P5527, DOI 10.1021/la703934u
   Zuo B, 2013, J PHYS CHEM C, V117, P3396, DOI 10.1021/jp3113304
NR 41
TC 1
Z9 1
U1 4
U2 41
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
EI 1873-2291
J9 POLYMER
JI Polymer
PD JUL 25
PY 2016
VL 96
BP 45
EP 53
DI 10.1016/j.polymer.2016.04.055
PG 9
WC Polymer Science
SC Polymer Science
GA DN0BB
UT WOS:000376728300007
DA 2018-10-20
ER

PT J
AU Shin, SR
   Zihlmann, C
   Akbari, M
   Assawes, P
   Cheung, L
   Zhang, KZ
   Manoharan, V
   Zhang, YS
   Yuksekkaya, M
   Wan, KT
   Nikkhah, M
   Dokmeci, MR
   Tang, XW
   Khademhosseini, A
AF Shin, Su Ryon
   Zihlmann, Claudio
   Akbari, Mohsen
   Assawes, Pribpandao
   Cheung, Louis
   Zhang, Kaizhen
   Manoharan, Vijayan
   Zhang, Yu Shrike
   Yuksekkaya, Mehmet
   Wan, Kai-tak
   Nikkhah, Mehdi
   Dokmeci, Mehmet R.
   Tang, Xiaowu (Shirley)
   Khademhosseini, Ali
TI Reduced Graphene Oxide-GelMA Hybrid Hydrogels as Scaffolds for Cardiac
   Tissue Engineering
SO SMALL
LA English
DT Article
ID GELATIN METHACRYLATE HYDROGELS; MYOCARDIAL TISSUE; CARBON NANOTUBES;
   STEM-CELLS; DIFFERENTIATION; FABRICATION; CONSTRUCTS; NANOSHEETS;
   REDUCTION; PROSPECTS
AB Biomaterials currently used in cardiac tissue engineering have certain limitations, such as lack of electrical conductivity and appropriate mechanical properties, which are two parameters playing a key role in regulating cardiac cell behavior. Here, the myocardial tissue constructs are engineered based on reduced graphene oxide (rGO)-incorporated gelatin methacryloyl (GelMA) hybrid hydrogels. The incorporation of rGO into the GelMA matrix significantly enhances the electrical conductivity and mechanical properties of the material. Moreover, cells cultured on composite rGO-GelMA scaffolds exhibit better biological activities such as cell viability, proliferation, and maturation compared to ones cultured on GelMA hydrogels. Cardiomyocytes show stronger contractility and faster spontaneous beating rate on rGO-GelMA hydrogel sheets compared to those on pristine GelMA hydrogels, as well as GO-GelMA hydrogel sheets with similar mechanical property and particle concentration. Our strategy of integrating rGO within a biocompatible hydrogel is expected to be broadly applicable for future biomaterial designs to improve tissue engineering outcomes. The engineered cardiac tissue constructs using rGO incorporated hybrid hydrogels can potentially provide high-fidelity tissue models for drug studies and the investigations of cardiac tissue development and/or disease processes in vitro.
C1 [Shin, Su Ryon; Zihlmann, Claudio; Akbari, Mohsen; Assawes, Pribpandao; Manoharan, Vijayan; Zhang, Yu Shrike; Dokmeci, Mehmet R.; Khademhosseini, Ali] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Biomat Innovat Res Ctr, Cambridge, MA 02139 USA.
   [Shin, Su Ryon; Zihlmann, Claudio; Akbari, Mohsen; Assawes, Pribpandao; Manoharan, Vijayan; Zhang, Yu Shrike; Dokmeci, Mehmet R.; Khademhosseini, Ali] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
   [Shin, Su Ryon; Dokmeci, Mehmet R.; Khademhosseini, Ali] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02139 USA.
   [Akbari, Mohsen] Univ Victoria, Dept Mech Engn, 3800 Finnerty Rd, Victoria, BC V8P 2C5, Canada.
   [Cheung, Louis; Tang, Xiaowu (Shirley)] Univ Waterloo, Dept Chem, 200 Univ Ave West, Waterloo, ON N2L 3G1, Canada.
   [Cheung, Louis; Tang, Xiaowu (Shirley)] Univ Waterloo, Waterloo Inst Nanotechnol, 200 Univ Ave West, Waterloo, ON N2L 3G1, Canada.
   [Zhang, Kaizhen; Wan, Kai-tak] Northeastern Univ, Dept Mech & Ind Engn, Boston, MA 02115 USA.
   [Yuksekkaya, Mehmet] Baskent Univ, Fac Engn, Dept Biomed Engn, Ankara, Turkey.
   [Nikkhah, Mehdi] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85251 USA.
   [Khademhosseini, Ali] King Abdulaziz Univ, Dept Phys, Jeddah 21569, Saudi Arabia.
   [Khademhosseini, Ali] Konkuk Univ, Dept Bioind Technol, Coll Anim Biosci & Technol, Seoul 143701, South Korea.
RP Khademhosseini, A (reprint author), Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Biomat Innovat Res Ctr, Cambridge, MA 02139 USA.; Khademhosseini, A (reprint author), MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA.; Khademhosseini, A (reprint author), Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02139 USA.; Tang, XW (reprint author), Univ Waterloo, Dept Chem, 200 Univ Ave West, Waterloo, ON N2L 3G1, Canada.; Tang, XW (reprint author), Univ Waterloo, Waterloo Inst Nanotechnol, 200 Univ Ave West, Waterloo, ON N2L 3G1, Canada.; Khademhosseini, A (reprint author), King Abdulaziz Univ, Dept Phys, Jeddah 21569, Saudi Arabia.; Khademhosseini, A (reprint author), Konkuk Univ, Dept Bioind Technol, Coll Anim Biosci & Technol, Seoul 143701, South Korea.
EM tangxw@uwaterloo.ca; alik@bwh.harvard.edu
RI Yuksekkaya, Mehmet/P-1760-2016
OI Yuksekkaya, Mehmet/0000-0002-2665-5799; Khademhosseini,
   Ali/0000-0001-6322-8852
FU National Science Foundation [EFRI-12404433]; IMMODGEL [602694]; National
   Institute of Health [EB012597, AR057837, DE021468, HL099073, AI105024,
   AR063745]
FX The authors acknowledge funding from the National Science Foundation
   (Grant No. EFRI-12404433), IMMODGEL (Grant No. 602694), and the National
   Institute of Health (Grant Nos. EB012597, AR057837, DE021468, HL099073,
   AI105024, and AR063745).
CR Ahearne M, 2005, J R SOC INTERFACE, V2, P455, DOI 10.1098/rsif.2005.0065
   Alcon A, 2012, CELL MOL LIFE SCI, V69, P2635, DOI 10.1007/s00018-012-0942-4
   Bitounis D, 2013, ADV MATER, V25, P2258, DOI 10.1002/adma.201203700
   Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020
   Cellot G, 2009, NAT NANOTECHNOL, V4, P126, DOI [10.1038/NNANO.2008.374, 10.1038/nnano.2008.374]
   Chen QZ, 2008, MAT SCI ENG R, V59, P1, DOI 10.1016/j.mser.2007.08.001
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   CLEVELAND JP, 1993, REV SCI INSTRUM, V64, P403, DOI 10.1063/1.1144209
   Coulombe KLK, 2014, ANNU REV BIOMED ENG, V16, P1, DOI 10.1146/annurev-bioeng-071812-152344
   Dreyer DR, 2010, CHEM SOC REV, V39, P228, DOI 10.1039/b917103g
   Dvir T, 2011, NAT NANOTECHNOL, V6, P720, DOI [10.1038/nnano.2011.160, 10.1038/NNANO.2011.160]
   Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316
   Fernandes P. A. L., 2010, SOFT MATTER, V6, P4
   Fernandez-Merino MJ, 2010, J PHYS CHEM C, V114, P6426, DOI 10.1021/jp100603h
   Galano A, 2008, J PHYS CHEM C, V112, P8922, DOI 10.1021/jp801379g
   Gao X., 2014, CARBON, V76, P7
   Ge Y, 2012, J MATER CHEM, V22, P17619, DOI 10.1039/c2jm33173j
   Geim AK, 2009, SCIENCE, V324, P1530, DOI 10.1126/science.1158877
   Guan ZJ, 2004, J CARDIOVASC PHARM, V44, P696, DOI 10.1097/00005344-200412000-00012
   Jin L, 2016, ACS APPL MATER INTER, V8, P5170, DOI 10.1021/acsami.6b00243
   Kanayama I, 2014, INT J NANOMED, V9, P3363, DOI 10.2147/IJN.S62342
   Kassiri Z, 2005, THROMB HAEMOSTASIS, V93, P212, DOI 10.1160/TH04-08-0522
   Kofidis T, 2002, J THORAC CARDIOV SUR, V124, P63, DOI 10.1067/mtc.2002.121971
   Li D, 2008, NAT NANOTECHNOL, V3, P101, DOI 10.1038/nnano.2007.451
   Liu KP, 2011, J MATER CHEM, V21, P12034, DOI 10.1039/c1jm10749f
   Lovat V, 2005, NANO LETT, V5, P1107, DOI 10.1021/nl050637m
   Nichol JW, 2010, BIOMATERIALS, V31, P5536, DOI 10.1016/j.biomaterials.2010.03.064
   Nikkhah M, 2012, BIOMATERIALS, V33, P9009, DOI 10.1016/j.biomaterials.2012.08.068
   Oun AA, 2015, CARBOHYD POLYM, V127, P101, DOI 10.1016/j.carbpol.2015.03.073
   Papadaki M, 2001, AM J PHYSIOL-HEART C, V280, pH168
   Patel M, 2016, ACS APPL MATER INTER, V8, P5160, DOI 10.1021/acsami.5b12324
   Schinwald A, 2012, ACS NANO, V6, P736, DOI 10.1021/nn204229f
   Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800
   Shan CS, 2009, LANGMUIR, V25, P12030, DOI 10.1021/la903265p
   Shi XT, 2012, ADV FUNCT MATER, V22, P751, DOI 10.1002/adfm.201102305
   Shin M, 2004, BIOMATERIALS, V25, P3717, DOI 10.1016/j.biomaterials.2003.10.055
   Shin SR, 2013, ADV MATER, V25, P6385, DOI 10.1002/adma.201301082
   Shin SR, 2013, ACS NANO, V7, P2369, DOI 10.1021/nn305559j
   Shin SR, 2012, ACS NANO, V6, P362, DOI 10.1021/nn203711s
   Takahashi T, 2003, CIRCULATION, V107, P1912, DOI 10.1161/01.CIR.0000064899.53876.A3
   Yang WR, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/41/412001
   Ye K. Yuan, 2011, JOVE-J VIS EXP, V55, P3251
   Yost MJ, 2004, TISSUE ENG, V10, P273, DOI 10.1089/107632704322791916
   You JO, 2011, NANO LETT, V11, P3643, DOI 10.1021/nl201514a
   Zhang DH, 2013, BIOMATERIALS, V34, P5813, DOI 10.1016/j.biomaterials.2013.04.026
   Zhang JL, 2010, CHEM COMMUN, V46, P1112, DOI 10.1039/b917705a
   Zhang Y, 2013, NANOTECHNOL REV, V2, P27, DOI 10.1515/ntrev-2012-0078
   Zhang YB, 2010, ACS NANO, V4, P3181, DOI 10.1021/nn1007176
NR 48
TC 44
Z9 45
U1 23
U2 96
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1613-6810
EI 1613-6829
J9 SMALL
JI Small
PD JUL 20
PY 2016
VL 12
IS 27
BP 3677
EP 3689
DI 10.1002/smll.201600178
PG 13
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA DW1AK
UT WOS:000383374800006
PM 27254107
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Mozdzen, LC
   Thorpe, SD
   Screen, HRC
   Harley, BAC
AF Mozdzen, Laura C.
   Thorpe, Stephen D.
   Screen, Hazel R. C.
   Harley, Brendan A. C.
TI The Effect of Gradations in Mineral Content, Matrix Alignment, and
   Applied Strain on Human Mesenchymal Stem Cell Morphology within Collagen
   Biomaterials
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
ID CYCLIC TENSILE STRAIN; GAG SCAFFOLDS; TENDON FASCICLES; IN-VITRO;
   GLYCOSAMINOGLYCAN SCAFFOLDS; TENOGENIC DIFFERENTIATION; MECHANICAL
   STIMULATION; BIOPHYSICAL PROPERTIES; EXTRACELLULAR-MATRIX; BIOREACTOR
   SYSTEM
AB The tendon-bone junction is a unique, mechanically dynamic, structurally graded anatomical zone, which transmits tensile loads between tendon and bone. Current surgical repair techniques rely on mechanical fixation and can result in high re-failure rates. A new class of collagen biomaterial that contains discrete mineralized and structurally aligned regions linked by a continuous interface to mimic the graded osteotendinous insertion has been recently described. Here the combined influence of graded biomaterial environment and increasing levels of applied strain (0%-20%) on mesenchymal stem cell (MSC) orientation and alignment have been reported. In osteotendinous scaffolds, which contain opposing gradients of mineral content and structural alignment characteristic of the native osteotendinous interface, MSC nuclear, and actin alignment is initially dictated by the local pore architecture, while applied tensile strain enhances cell alignment in the direction of strain. Comparatively, in layered scaffolds that do not contain any structural alignment cues, MSCs are randomly oriented in the unstrained condition, then become oriented in a direction perpendicular to applied strain. These findings provide an initial understanding of how scaffold architecture can provide significant, potentially competitive, feedback influencing MSC orientation under applied strain, and form the basis for future tissue engineering efforts to regenerate the osteotendinous enthesis.
C1 [Mozdzen, Laura C.; Harley, Brendan A. C.] Univ Illinois, Chem & Biomol Engn, 600 S Mathews St, Urbana, IL 61801 USA.
   [Thorpe, Stephen D.; Screen, Hazel R. C.] Queen Mary Univ London, Sch Engn & Mat Sci, Mile End Rd, London E1 4NS, England.
RP Harley, BAC (reprint author), Univ Illinois, Chem & Biomol Engn, 600 S Mathews St, Urbana, IL 61801 USA.
EM bharley@illinois.edu
OI Thorpe, Stephen/0000-0002-4707-7756; Harley, Brendan/0000-0001-5458-154X
FU National Institute of Arthritis and Musculoskeletal and Skin Diseases of
   the National Institutes of Health [R21 AR063331]; National Science
   Foundation [0965918]; University of Illinois via Support for
   Under-Represented Groups in Engineering (SURGE) Fellowship; DuPont
   Science and Engineering Fellowship programs
FX The authors would like to thank Dr. Knight (QMUL) for providing human
   mesenchymal stem cells for this work, and would also like to acknowledge
   Dr. Chavaunne Thorpe and Dr. Dharmesh Patel for their guidance. Research
   reported in this publication was supported by the National Institute of
   Arthritis and Musculoskeletal and Skin Diseases of the National
   Institutes of Health under Award No. R21 AR063331. L.C.M. was in part
   funded via National Science Foundation Grant 0965918 IGERT: Training the
   Next Generation of Researchers in Cellular & Molecular Mechanics and
   BioNanotechnology, which contributed by providing travel support to work
   with the Screen Lab at Queen Mary University of London, UK, where a
   substantial amount of this work took place. L.C.M. also acknowledges
   support from the University of Illinois via the Support for
   Under-Represented Groups in Engineering (SURGE) Fellowship and the
   DuPont Science and Engineering Fellowship programs.
CR Allen JL, 2012, MOL BIOL CELL, V23, P3731, DOI 10.1091/mbc.E12-03-0172
   Anssari-Benam A, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4006812
   Anssari-Benam A, 2011, J MECH BEHAV BIOMED, V4, P1603, DOI 10.1016/j.jmbbm.2011.02.010
   Banks JM, 2014, BIOMATERIALS, V35, P8951, DOI 10.1016/j.biomaterials.2014.07.012
   Berens P, 2009, J STAT SOFTW, V31, P1
   Caliari SR, 2015, ADV HEALTHC MATER, V4, P831, DOI 10.1002/adhm.201400809
   Caliari SR, 2014, TISSUE ENG PT A, V20, P2463, DOI [10.1089/ten.tea.2013.0400, 10.1089/ten.TEA.2013.0400]
   Caliari SR, 2014, ADV HEALTHC MATER, V3, P1086, DOI 10.1002/adhm.201300646
   Caliari SR, 2012, J MECH BEHAV BIOMED, V11, P27, DOI 10.1016/j.jmbbm.2011.12.004
   Caliari SR, 2011, BIOMATERIALS, V32, P5330, DOI 10.1016/j.biomaterials.2011.04.021
   Chandrashekar N, 2012, KNEE, V19, P65, DOI 10.1016/j.knee.2010.11.014
   Chaubaroux C, 2015, TISSUE ENG PART C-ME, V21, P881, DOI [10.1089/ten.tec.2014.0479, 10.1089/ten.TEC.2014.0479]
   Cheng XG, 2014, ACTA BIOMATER, V10, P1360, DOI 10.1016/j.actbio.2013.11.017
   Chew SY, 2007, ADV FUNCT MATER, V17, P1288, DOI 10.1002/adfm.200600441
   Davidenko N, 2012, ACTA BIOMATER, V8, P667, DOI 10.1016/j.actbio.2011.09.033
   Genin GM, 2009, BIOPHYS J, V97, P976, DOI 10.1016/j.bpj.2009.05.043
   Gershlak JR, 2013, BIOCHEM BIOPH RES CO, V439, P161, DOI 10.1016/j.bbrc.2013.08.074
   Giannoni P, 2015, J TISSUE ENG REGEN M, V9, P1182, DOI 10.1002/term.1651
   Gonnerman EA, 2012, BIOMATERIALS, V33, P8812, DOI 10.1016/j.biomaterials.2012.08.051
   Halper J, 2014, ADV EXP MED BIOL, V802, P59, DOI 10.1007/978-94-007-7893-1_5
   Hao J, 2015, ACTA BIOMATER, V20, P1, DOI 10.1016/j.actbio.2015.04.008
   Harley BA, 2007, ACTA BIOMATER, V3, P463, DOI 10.1016/j.aetbio.2006.12.009
   Harley BA, 2010, J BIOMED MATER RES A, V92A, P1078, DOI 10.1002/jbm.a.32387
   Hsieh HY, 2014, LAB CHIP, V14, P482, DOI 10.1039/c3lc50884f
   Jacques P, 2014, ANN RHEUM DIS, V73, P437, DOI 10.1136/annrheumdis-2013-203643
   Joly P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073545
   Kapoor A, 2010, ACTA BIOMATER, V6, P2580, DOI 10.1016/j.actbio.2009.12.047
   Karlon WJ, 1999, ANN BIOMED ENG, V27, P712, DOI 10.1114/1.226
   Kim TH, 2015, BIOMATERIALS, V40, P51, DOI 10.1016/j.biomaterials.2014.11.017
   Kim YT, 2008, BIOMATERIALS, V29, P3117, DOI 10.1016/j.biomaterials.2008.03.042
   Kopf J, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-37
   Kurpinski K, 2006, P NATL ACAD SCI USA, V103, P16095, DOI 10.1073/pnas.0604182103
   Lee JC, 2015, J CRANIOFAC SURG, V26, P1992, DOI 10.1097/SCS.0000000000001918
   Legerlotz K, 2013, SCAND J MED SCI SPOR, V23, P31, DOI 10.1111/j.1600-0838.2011.01410.x
   Levingstone TJ, 2014, ACTA BIOMATER, V10, P1996, DOI 10.1016/j.actbio.2014.01.005
   Li JD, 2016, J BIOMAT SCI-POLYM E, V27, P327, DOI 10.1080/09205063.2015.1128248
   Lynn AK, 2010, J BIOMED MATER RES A, V92A, P1057, DOI 10.1002/jbm.a.32415
   Maeda E, 2013, BIOMED MICRODEVICES, V15, P1067, DOI 10.1007/s10544-013-9798-0
   Marolt D, 2006, BIOMATERIALS, V27, P6138, DOI 10.1016/j.biomaterials.2006.07.015
   Matsiko A, 2015, ADV HEALTHC MATER, V4, P1175, DOI 10.1002/adhm.201500053
   Min HK, 2014, ACTA BIOMATER, V10, P1272, DOI 10.1016/j.actbio.2013.12.031
   Morita Y, 2013, ACTA BIOENG BIOMECH, V15, P71, DOI 10.5277/abb130309
   Murphy CM, 2012, J MECH BEHAV BIOMED, V11, P53, DOI 10.1016/j.jmbbm.2011.11.009
   O'Brien Fergal J, 2007, Technol Health Care, V15, P3
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   Paxton JZ, 2012, TISSUE ENG PT A, V18, P277, DOI [10.1089/ten.tea.2011.0336, 10.1089/ten.TEA.2011.0336]
   Popov C, 2015, BMC MOL BIOL, V16, DOI 10.1186/s12867-015-0036-6
   Qiu Y, 2014, J TISSUE ENG REGEN M
   Ren X, 2015, BIOMATERIALS, V50, P107, DOI 10.1016/j.biomaterials.2015.01.059
   Saber S, 2010, TISSUE ENG PT A, V16, P2085, DOI [10.1089/ten.tea.2010.0032, 10.1089/ten.TEA.2010.0032]
   Screen HRC, 2011, INT J EXP PATHOL, V92, pA11
   Screen HRC, 2010, ADV FUNCT MATER, V20, P738, DOI 10.1002/adfm.200901711
   Screen HRC, 2004, P I MECH ENG H, V218, P109, DOI 10.1243/095441104322984004
   Screen HRC, 2005, BIOCHEM BIOPH RES CO, V336, P424, DOI 10.1016/j.bbro.2005.08.102
   SPILLMANN D, 1994, CURR OPIN STRUC BIOL, V4, P677, DOI 10.1016/S0959-440X(94)90165-1
   Subramony SD, 2013, BIOMATERIALS, V34, P1942, DOI 10.1016/j.biomaterials.2012.11.012
   Thevenaz P, 2011, IEEE T PATTERN ANAL, V33, P382, DOI 10.1109/TPAMI.2010.112
   Tseng LF, 2013, ACTA BIOMATER, V9, P8790, DOI 10.1016/j.actbio.2013.06.043
   Wang T, 2015, J ORTHOP RES, V33, P1888, DOI 10.1002/jor.22960
   Wei ZS, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2907745
   Weisgerber DW, 2013, J MECH BEHAV BIOMED, V28, P26, DOI 10.1016/j.jmbbm.2013.07.016
   Weisgerber DW, 2015, BIOMATER SCI-UK, V3, P533, DOI [10.1039/c4bm00397g, 10.1039/C4BM00397G]
   Wen JH, 2014, NAT MATER, V13, P979, DOI [10.1038/NMAT4051, 10.1038/nmat4051]
   Xu BY, 2012, J CELL PHYSIOL, V227, P2722, DOI 10.1002/jcp.23016
   Xu Y, 2015, BIOMED RES INT, V2015, DOI [10.1155/2015/790804, DOI 10.1155/2015/790804]
   Yamaguchi K, 2006, J BONE JOINT SURG AM, V88A, P1699, DOI 10.2106/JBJS.E.00835
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
   Younesi M, 2014, ADV FUNCT MATER, V24, P5762, DOI 10.1002/adfm.201400828
   Youngstrom DW, 2015, J ORTHOP RES, V33, P911, DOI 10.1002/jor.22848
   Zouani OF, 2013, BIOMATERIALS, V34, P2157, DOI 10.1016/j.biomaterials.2012.12.007
NR 71
TC 7
Z9 7
U1 4
U2 18
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD JUL 20
PY 2016
VL 5
IS 14
BP 1731
EP 1739
DI 10.1002/adhm.201600181
PG 9
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA DV2RT
UT WOS:000382769400003
PM 27245787
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Raftery, RM
   Walsh, DP
   Castano, IM
   Heise, A
   Duffy, GP
   Cryan, SA
   O'Brien, FJ
AF Raftery, Rosanne M.
   Walsh, David P.
   Castano, Irene Mencia
   Heise, Andreas
   Duffy, Garry P.
   Cryan, Sally-Ann
   O'Brien, Fergal J.
TI Delivering Nucleic-Acid Based Nanomedicines on Biomaterial Scaffolds for
   Orthopedic Tissue Repair: Challenges, Progress and Future Perspectives
SO ADVANCED MATERIALS
LA English
DT Article
DE gene-activated scaffolds; orthopedic tissue engineering; non-viral gene
   therapy; RNAi
ID COLLAGEN-BASED SCAFFOLD; MESENCHYMAL STEM-CELLS; HYDROXYAPATITE
   SCAFFOLDS; REGENERATIVE MEDICINE; ACTIVATED SCAFFOLD; MICRORNA DELIVERY;
   GENE-THERAPY; IN-VITRO; THERAPEUTICS; EXPRESSION
AB As well as acting to fill defects and allow for cell infiltration and proliferation in regenerative medicine, biomaterial scaffolds can also act as carriers for therapeutics, further enhancing their efficacy. Drug and protein delivery on scaffolds have shown potential, however, supraphysiological quantities of therapeutic are often released at the defect site, causing off-target side effects and cytotoxicity. Gene therapy involves the introduction of foreign genes into a cell in order to exert an effect; either replacing a missing gene or modulating expression of a protein. State of the art gene therapy also encompasses manipulation of the transcriptome by harnessing RNA interference (RNAi) therapy. The delivery of nucleic acid nanomedicines on biomaterial scaffolds gene-activated scaffolds has shown potential for use in a variety of tissue engineering applications, but as of yet, have not reached clinical use. The current state of the art in terms of biomaterial scaffolds and delivery vector materials for gene therapy is reviewed, and the limitations of current procedures discussed. Future directions in the clinical translation of gene-activated scaffolds are also considered, with a particular focus on bone and cartilage tissue regeneration.
C1 [Raftery, Rosanne M.; Walsh, David P.; Castano, Irene Mencia; Heise, Andreas; Duffy, Garry P.; Cryan, Sally-Ann; O'Brien, Fergal J.] Royal Coll Surg Ireland RCSI, Tissue Engn Res Grp TERG, Dept Anat, 123 St Stephens Green, Dublin 2, Ireland.
   [Raftery, Rosanne M.; Walsh, David P.; Castano, Irene Mencia; Duffy, Garry P.; Cryan, Sally-Ann; O'Brien, Fergal J.] Trinity Coll Dublin, Trinity Ctr Bioengn TCBE, Dublin 2, Ireland.
   [Raftery, Rosanne M.; Walsh, David P.; Castano, Irene Mencia; Duffy, Garry P.; O'Brien, Fergal J.] RCSI, Adv Mat & Bioengn Res Ctr AMBER, Dublin, Ireland.
   [Raftery, Rosanne M.; Walsh, David P.; Castano, Irene Mencia; Duffy, Garry P.; O'Brien, Fergal J.] TCD, Dublin, Ireland.
   [Raftery, Rosanne M.; Walsh, David P.; Cryan, Sally-Ann] Royal Coll Surgeons Ireland, Drug Delivery & Adv Mat Res Team, Sch Pharm, 123 St Stephens Green, Dublin 2, Ireland.
   [Raftery, Rosanne M.; Walsh, David P.; Cryan, Sally-Ann] Natl Univ Ireland Galway, Ctr Res Med Devices CURAM, Galway, Ireland.
RP O'Brien, FJ (reprint author), Royal Coll Surg Ireland RCSI, Tissue Engn Res Grp TERG, Dept Anat, 123 St Stephens Green, Dublin 2, Ireland.; O'Brien, FJ (reprint author), Trinity Coll Dublin, Trinity Ctr Bioengn TCBE, Dublin 2, Ireland.; O'Brien, FJ (reprint author), RCSI, Adv Mat & Bioengn Res Ctr AMBER, Dublin, Ireland.; O'Brien, FJ (reprint author), TCD, Dublin, Ireland.
EM fjobrien@rcsi.ie
RI Heise, Andreas/A-1201-2009
OI Heise, Andreas/0000-0001-5916-8500; O'Brien, Fergal/0000-0003-2030-8005;
   Cryan, Sally-Ann/0000-0002-3941-496X; Duffy, Garry/0000-0002-4994-9511;
   Raftery, Rosanne/0000-0001-7820-0246; Walsh, David/0000-0002-7316-9478
FU Science Foundation Ireland Research Frontiers Programme
   [11/RFP/ENM/3053]; Science Foundation Ireland Investigator Programme
   (IvP) Award [13/IA/1840]; BioAT funding bodies PRTL (Programme for
   Research in Third Level Institutions) Cycle 5; European Regional
   Development Fund (ERDF), part of the European Union Structural Funds
   Programme; European Research Council under the European Community
   [239685]
FX D.P.W. and I.M.C. contributed equally to this work and are listed
   alphabetically by first name. This work was supported by the Science
   Foundation Ireland Research Frontiers Programme (Grant No.
   11/RFP/ENM/3053), Science Foundation Ireland Investigator Programme
   (IvP) Award (Grant No. 13/IA/1840), BioAT funding bodies PRTL (Programme
   for Research in Third Level Institutions) Cycle 5 and European Regional
   Development Fund (ERDF), part of the European Union Structural Funds
   Programme 2007-2013 and the European Research Council under the European
   Community's Seventh Framework Programme (FP7/2007-2013)/ERC grant
   agreement no 239685.
CR Abbasi E, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-247
   Abdallah B, 1996, HUM GENE THER, V7, P1947, DOI 10.1089/hum.1996.7.16-1947
   Ahearne M, 2011, BIOTECHNOL APPL BIOC, V58, P345, DOI 10.1002/bab.45
   Aicher W. K., 2011, ADV DRUG DELIVERY RE, V63, P4
   Akinc A, 2005, J GENE MED, V7, P657, DOI 10.1002/jgm.696
   Alabi CA, 2013, P NATL ACAD SCI USA, V110, P12881, DOI 10.1073/pnas.1306529110
   Almeida H. V., 2015, ADV HEALTHC MATER, V4, P7
   Almeida HV, 2014, ACTA BIOMATER, V10, P4400, DOI 10.1016/j.actbio.2014.05.030
   [Anonymous], 2015, NAT BIOTECHNOL, V33, P119, DOI 10.1038/nbt0215-119d
   [Anonymous], MULT PHAS 1 STUD MRX
   Atala A, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004890
   Atkinson H, 2010, GENETICA, V138, P485, DOI 10.1007/s10709-009-9434-3
   Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137
   Babister JC, 2008, BIOMATERIALS, V29, P58, DOI 10.1016/j.biomaterials.2007.09.006
   Bader A. G., 2010, CANCER RES, V70, P18
   Badylak S. F., 2011, TISSUE ENG PART A, V17, P11
   Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x
   Barry F, 2001, EXP CELL RES, V268, P189, DOI 10.1006/excr.2001.5278
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Bartlett W, 2005, J BONE JOINT SURG BR, V87B, P330, DOI 10.1302/0301-620X.87B3.15552
   Batty L, 2011, ANZ J SURG, V81, P18, DOI 10.1111/j.1445-2197.2010.05495.x
   BCC Research, TISS ENG REG TECHN G
   Beavers KR, 2015, ADV DRUG DELIVER REV, V88, P123, DOI 10.1016/j.addr.2014.12.006
   Behr JP, 1997, CHIMIA, V51, P34
   Betz OB, 2006, J BONE JOINT SURG AM, V88A, P355, DOI 10.2106/JBJS.E.00464
   BLAESE RM, 1995, SCIENCE, V270, P475, DOI 10.1126/science.270.5235.475
   Bleich N. Kimelman, 2012, ADV DRUG DELIVERY RE, V64, P12
   Bleiziffer O, 2007, J CELL MOL MED, V11, P206, DOI 10.1111/j.1582-4934.2007.00027.x
   Bonadio J, 1999, NAT MED, V5, P753, DOI 10.1038/10473
   Bonadio J., 2000, ADV DRUG DELIV REV, V44, P2
   Bose S, 2012, ACTA BIOMATER, V8, P1401, DOI 10.1016/j.actbio.2011.11.017
   Boudreau R. L., 2009, MOL THER, V17, P1
   BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P14
   Buckley C. T., 2010, J BIOMECH, V43, P5
   BUHLEIER E, 1978, SYNTHESIS-STUTTGART, P155
   Butcher JT, 2006, TISSUE ENG, V12, P905, DOI 10.1089/ten.2006.12.905
   Byrne M., 2012, POLYM CHEM, V3, P10
   Byrne M, 2015, MACROMOL RAPID COMM, V36, P1862, DOI 10.1002/marc.201500300
   Byrne M, 2013, BIOMATER SCI-UK, V1, P1223, DOI 10.1039/c3bm60123d
   Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008
   Carragee EJ, 2011, SPINE J, V11, pE1, DOI 10.1016/j.spinee.2010.10.013
   Carreira AC, 2014, ARCH BIOCHEM BIOPHYS, V561, P64, DOI 10.1016/j.abb.2014.07.011
   Castano IM, 2015, J CONTROL RELEASE, V200, P42, DOI 10.1016/j.jconrel.2014.12.034
   Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669
   Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890
   Chen F. M., 2010, BIOMATERIALS, V31, P24
   Chien K. R., 2015, COLD SPRING HARBOR P, V5, P1
   Chim H, 2006, PLAST RECONSTR SURG, V117, P468, DOI 10.1097/01.prs.0000201489.65811.e7
   Clinicaltrials. gov, GEN ACT MATR BON TIS
   Coelho-Castelo A A M, 2006, Genet Vaccines Ther, V4, P1, DOI 10.1186/1479-0556-4-1
   Cohen S. N., 1973, P NATL ACAD SCI USA, V70, P11
   Corsi K, 2003, BIOMATERIALS, V24, P1255, DOI 10.1016/S0142-9612(02)00507-0
   Costa-Pinto AR., 2011, TISSUE ENG PART B-RE, V17, P5
   Cryan S. A., 2004, J DRUG DELIV SCI TEC, V14, P1
   Cryan SA, 2004, EUR J PHARM SCI, V21, P625, DOI 10.1016/j.ejps.2004.01.001
   Cunniffe G. M., 2011, J MINER MET MAT, V63, P4
   Cunniffe G. M., 2010, J BIOMED MATER RES A, V95A, P4
   Cunniffe G. M., 2010, J MATER SCI-MATER M, V21, P8
   Curtin C. M., 2012, ADV MATER, V24, P6
   Curtin C. M., 2015, ADV HEALTHC MATER, V4, P2
   D'Mello SR, 2015, CURR PHARM BIOTECHNO, V16, P655, DOI 10.2174/138920101607150427112753
   Dass CR, 2000, J PHARM PHARMACOL, V52, P731, DOI 10.1211/0022357001774606
   David F., 2015, J TISSUE ENG REGEN M, V9, P10
   Davis ME, 2004, CURR MED CHEM, V11, P179, DOI 10.2174/0929867043456179
   De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274
   Del Valle E. M. M., 2004, PROCESS BIOCHEM, V39, P9
   Deng Y., 2014, EUR CELL MAT, V27
   Diao H., 2009, TISSUE ENG PART A, V15, P9
   Dimitriou R., 2005, INJURY, V36, P12
   DiSilvio L, 2006, INJURY, V37, pS33, DOI 10.1016/j.injury.2006.08.022
   Dufes C., 2005, ADV DRUG DELIVERY RE, V57, P15
   Duffy GP, 2011, EUR CELLS MATER, V21, P15, DOI 10.22203/eCM.v021a02
   ec. europa. eu, GUID QUAL NONCL CLIN
   Elangovan S, 2014, BIOMATERIALS, V35, P737, DOI 10.1016/j.biomaterials.2013.10.021
   Elbashir S. M., 2001, GENE DEV, V15, P2
   Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107
   Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877
   Endo M, 2006, TISSUE ENG, V12, P489, DOI 10.1089/ten.2006.12.489
   English K, 2008, IMMUNOL LETT, V115, P50, DOI 10.1016/j.imlet.2007.10.002
   Eskildsen T, 2011, P NATL ACAD SCI USA, V108, P6139, DOI 10.1073/pnas.1016758108
   Evans C. H., 2013, MAYO CLIN P, V88, P11
   Evans CH, 2014, NAT REV RHEUMATOL, V10, P11, DOI 10.1038/nrrheum.2013.159
   Evans CH, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001493
   Farrell E, 2006, TISSUE ENG, V12, P459, DOI 10.1089/ten.2006.12.459
   fda. gov Food Drug Administration, HUM CELLS TISS CELL, V21
   Feichtinger GA, 2014, EUR CELLS MATER, V27, P166, DOI 10.22203/eCM.v027a13
   FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413
   Ferreira E, 2012, EUR CELLS MATER, V24, P18, DOI 10.22203/eCM.v024a02
   Fischer A, 2010, NAT IMMUNOL, V11, P457, DOI 10.1038/ni0610-457
   Fischer S, 2013, J BIOTECHNOL, V168, P589, DOI 10.1016/j.jbiotec.2013.08.027
   Fitzgerald KA, 2015, J CONTROL RELEASE, V215, P39, DOI 10.1016/j.jconrel.2015.07.020
   Fitzgerald KA, 2015, BIOMATERIALS, V66, P53, DOI 10.1016/j.biomaterials.2015.07.019
   Fitzgerald KA, 2014, EXPERT OPIN THER TAR, V18, P633, DOI 10.1517/14728222.2014.896904
   Friedenstein A., 1970, CELL TISSUE KINET, V3, P4
   Fumoto S., 2013, TARGETED GENE DELIVE
   Gaspar HB, 2004, LANCET, V364, P2181, DOI 10.1016/S0140-6736(04)17590-9
   Gebhart C. L., 2001, J CONTROL RELEASE, V73, P2
   Geiger F, 2005, J BONE MINER RES, V20, P2028, DOI 10.1359/JBMR.050701
   Gerber H. P., 2000, TRENDS CARDIOVAS MED, V10, P5
   Ginn SL, 2013, J GENE MED, V15, P65, DOI 10.1002/jgm.2698
   Gleeson JP, 2010, EUR CELLS MATER, V20, P218
   Gleeson J. P., 2009, Patent, Patent No. [WO2010/084481, 2010084481]
   Godbey W. T., 1999, J CONTROL RELEASE, V60, P2
   Godbey WT, 1999, GENE THER, V6, P1380, DOI 10.1038/sj.gt.3300976
   Godbey WT, 1999, P NATL ACAD SCI USA, V96, P5177, DOI 10.1073/pnas.96.9.5177
   Gonfiotti A, 2014, LANCET, V383, P238, DOI 10.1016/S0140-6736(13)62033-4
   Gonzalez H, 1999, BIOCONJUGATE CHEM, V10, P1068, DOI 10.1021/bc990072j
   Gosain A, 2004, WORLD J SURG, V28, P321, DOI 10.1007/s00268-003-7397-6
   Greber D, 2007, BIOTECHNOL BIOENG, V96, P821, DOI 10.1002/bit.21303
   Griffith F., 1928, J HYG LOND, V27, P2
   Grossin L, 2003, FASEB J, V17, P829, DOI 10.1096/fj.02-0518com
   GUERRY P, 1973, J BACTERIOL, V116, P1064
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267
   Guo PX, 2010, ADV DRUG DELIVER REV, V62, P650, DOI 10.1016/j.addr.2010.03.008
   Hacein-Bey-Abina S., 2003, NEW ENGL J MED, V348, P3
   Hacein-Bey-Abina S., 2002, NEW ENGL J MED, V346, P16
   HAENSLER J, 1993, BIOCONJUGATE CHEM, V4, P85, DOI 10.1021/bc00019a012
   Haleem AM, 2010, CARTILAGE, V1, P253, DOI 10.1177/1947603510366027
   Hamm A, 2002, TISSUE ENG, V8, P235, DOI 10.1089/107632702753725003
   Hammond SM, 2000, NATURE, V404, P293
   Hastings CL, 2012, J CONTROL RELEASE, V161, P73, DOI 10.1016/j.jconrel.2012.04.033
   Hattori T, 2010, DEVELOPMENT, V137, P901, DOI 10.1242/dev.045203
   Haugh M. G., 2010, TISSUE ENG PART C-ME, V16, P5
   Haugh M. G., 2011, TISSUE ENG PART A, V17, P9
   He CX, 2012, BIOTECHNOL APPL BIOC, V59, P163, DOI 10.1002/bab.1001
   He L., 2004, NAT REV GENET, V5, P8
   Hengge UR, 2001, J INVEST DERMATOL, V116, P979, DOI 10.1046/j.1523-1747.2001.01341.x
   Hesse E., 2010, J BIOMED MATER RES A, V94A, P2
   Hu QL, 2013, BIOMATERIALS, V34, P2265, DOI 10.1016/j.biomaterials.2012.12.016
   Hu R, 2010, EXPERT OPIN THER TAR, V14, P1109, DOI 10.1517/14728222.2010.512916
   Huang C. L., 2015, MOL PHARM, V12, P3
   Huang XY, 2013, CHEM SOC REV, V42, P173, DOI 10.1039/c2cs35288e
   Huang YC, 2005, GENE THER, V12, P418, DOI 10.1038/sj.gt.3302439
   Hurst JM, 2010, CLIN SPORT MED, V29, P257, DOI 10.1016/j.csm.2009.12.009
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Ibrahim A. F., 2011, CANCER RES, V71, P15
   Ilina P, 2012, J CONTROL RELEASE, V163, P385, DOI 10.1016/j.jconrel.2012.09.016
   Itaka K, 2007, MOL THER, V15, P1655, DOI 10.1038/sj.mt.6300218
   Jacobsen A, 2013, NAT STRUCT MOL BIOL, V20, P1325, DOI 10.1038/nsmb.2678
   James EN, 2014, ACTA BIOMATER, V10, P3571, DOI 10.1016/j.actbio.2014.04.026
   Janssen H. L. A., 2013, NEW ENGL J MED, V368, P18
   Jayakumar P, 2010, P I MECH ENG H, V224, P1415, DOI 10.1243/09544119JEIM821
   Jensen ED, 2010, BIOFACTORS, V36, P25, DOI 10.1002/biof.72
   Jeon O., 2008, BIOCHEM BIOPH RES CO, V369, P2
   Jo JI, 2008, EUR J PHARM BIOPHARM, V68, P90, DOI 10.1016/j.ejpb.2007.04.021
   Kadlecova Z., 2013, J CONTROL RELEASE, V169, P3
   Kadlecova Z, 2012, MACROMOL BIOSCI, V12, P628, DOI 10.1002/mabi.201100404
   Kanasty R., 2013, NAT MATER, V12, P11
   Kania G, 2005, STEM CELLS, V23, P791, DOI 10.1634/stemcells.2004-0232
   Kawabata K., 1995, PHARM RES, V12, P6
   Kawai M, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-62
   Kay MA, 2001, NAT MED, V7, P33, DOI 10.1038/83324
   Kearney C. J., 2015, ADV HEALTHC MATER, V4, P11
   Keeney M, 2010, BIOMATERIALS, V31, P2893, DOI 10.1016/j.biomaterials.2009.12.041
   Khademhosseini A, 2009, SCI AM, V300, P64, DOI 10.1038/scientificamerican0509-64
   Kiang T, 2004, BIOMATERIALS, V25, P5293, DOI 10.1016/j.biomaterials.2003.12.036
   Koh JT, 2008, J DENT RES, V87, P845, DOI 10.1177/154405910808700906
   Koping-Hoggard M, 2004, GENE THER, V11, P1441, DOI 10.1038/sj.gt.3302312
   Kou LF, 2013, ASIAN J PHARM SCI, V8, P1, DOI 10.1016/j.ajps.2013.07.001
   KukowskaLatallo JF, 1996, P NATL ACAD SCI USA, V93, P4897, DOI 10.1073/pnas.93.10.4897
   Kulkarni M, 2010, TRENDS BIOTECHNOL, V28, P28, DOI 10.1016/j.tibtech.2009.10.003
   Kuo CK, 2001, BIOMATERIALS, V22, P511, DOI 10.1016/S0142-9612(00)00201-5
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee K, 2013, INT J PHARMACEUT, V445, P196, DOI 10.1016/j.ijpharm.2013.01.014
   Lee MS, 2014, J CONTROL RELEASE, V192, P122, DOI 10.1016/j.jconrel.2014.06.049
   Lee S., 2011, REGEN MED, V6, P6
   Lee SH, 2008, J CONTROL RELEASE, V125, P25, DOI 10.1016/j.jconrel.2007.09.011
   Levingstone TJ, 2014, ACTA BIOMATER, V10, P1996, DOI 10.1016/j.actbio.2014.01.005
   Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035
   Li W., 2007, J JILIN I CHEM TECHN, V24, P3
   Li Y., 2013, BIOMATERIALS, V34, P21
   Liang W, 2012, ENDOSOMAL ESCAPE PAT
   Liao YH, 2014, BIOMATERIALS, V35, P4901, DOI 10.1016/j.biomaterials.2014.02.055
   Lin Z, 2006, TISSUE ENG, V12, P1971, DOI 10.1089/ten.2006.12.1971
   Lipchina I., 2011, GENE DEV, V25, P20
   Lonez C, 2008, PROG LIPID RES, V47, P340, DOI 10.1016/j.plipres.2008.03.002
   Lopez-Noriega A, 2014, J CONTROL RELEASE, V187, P158, DOI 10.1016/j.jconrel.2014.05.043
   Lutz R., 2008, CLIN ORAL IMPLAN RES, V19, P6
   Lyons FG, 2014, CLIN ORTHOP RELAT R, V472, P1318, DOI 10.1007/s11999-013-3438-0
   Madry H, 2005, GENE THER, V12, P1171, DOI 10.1038/sj.gt.3302515
   Madry H., 2014, EUR CELLS MATER, V27, P106
   Malafaya P. B., 2007, ADV DRUG DELIVERY RE, V59, P4
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Mariner PD, 2012, J TISSUE ENG REGEN M, V6, P314, DOI 10.1002/term.435
   Martin I., 2014, TISSUE ENG PT A S1, V20, P3
   Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X
   Matsiko A., 2015, ADV HEALTHC MATER, V4, P8
   Matsiko A, 2012, J MECH BEHAV BIOMED, V11, P41, DOI 10.1016/j.jmbbm.2011.11.012
   Mattick JS, 2003, BIOESSAYS, V25, P930, DOI 10.1002/bies.10332
   McCarthy J, 2013, J CONTROL RELEASE, V168, P28, DOI 10.1016/j.jconrel.2013.03.004
   McCormack MP, 2004, NEW ENGL J MED, V350, P913, DOI 10.1056/NEJMra032207
   McIvor RS, 2011, MOL THER, V19, P822, DOI 10.1038/mt.2011.67
   McKiernan PJ, 2013, INT J NANOMED, V8, P3907, DOI 10.2147/IJN.S47551
   Meinel L, 2012, ADV DRUG DELIVER REV, V64, P1111, DOI 10.1016/j.addr.2012.03.016
   Merkel O. M., 2009, MOL PHARM, V6, P4
   Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172
   Michlits W, 2007, WOUND REPAIR REGEN, V15, P360, DOI 10.1111/j.1524-475X.2007.00238.x
   Midoux P., 2009, BRIT J PHARMACOL, V157, P2
   Monaghan M., 2011, ADV DRUG DELIVERY RE, V63, P4
   Monaghan M, 2014, MOL THER, V22, P786, DOI 10.1038/mt.2013.288
   Moore CB, 2010, METHODS MOL BIOL, V629, P139, DOI 10.1007/978-1-60761-657-3_10
   Morimoto S, 2009, BIOCHEM BIOPH RES CO, V390, P87, DOI 10.1016/j.bbrc.2009.09.071
   Morrison C., 2015, NAT BIOTECHNOL, V33, P3
   Mueller MB, 2010, CELLS TISSUES ORGANS, V192, P158, DOI 10.1159/000313399
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Needham CJ, 2014, ACTA BIOMATER, V10, P4103, DOI 10.1016/j.actbio.2014.05.011
   Nelson C. E., 2014, ADV MATER, V26, P4
   Neumann S, 2009, BIOMATERIALS, V30, P6794, DOI 10.1016/j.biomaterials.2009.08.043
   Newkome G. R., 1996, J HETEROCYCLIC CHEM, V33, P5
   Newkome G. R., 1986, J AM CHEM SOC, V108, P4
   NEWKOME GR, 1985, J ORG CHEM, V50, P2003, DOI 10.1021/jo00211a052
   Nguyen MK, 2014, BIOMATERIALS, V35, P6278, DOI 10.1016/j.biomaterials.2014.04.048
   Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5
   O'Brien F. J., 2008, Patent, Patent No. [WO/2008/096334, 2008096334, WO2008/ 096334A2]
   O'Brien F.J., 2011, MATER TODAY, V14, P3
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   Oh N, 2014, INT J NANOMED, V9, P51, DOI 10.2147/IJN.S26592
   Oliveira PH, 2013, TRENDS BIOTECHNOL, V31, P539, DOI 10.1016/j.tibtech.2013.06.001
   Mellet CO, 2011, CHEM SOC REV, V40, P1586, DOI 10.1039/c0cs00019a
   Osawa K, 2010, J GENE MED, V12, P937, DOI 10.1002/jgm.1515
   Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775
   Pan Y, 2012, FEBS J, V279, P1198, DOI 10.1111/j.1742-4658.2012.08512.x
   Park J, 2003, GENE THER, V10, P1089, DOI 10.1038/sj.gt.3301960
   Patil SD, 2005, AAPS J, V7, pE61, DOI 10.1208/aapsj070109
   Peng B, 2015, ADV DRUG DELIVER REV, V88, P108, DOI 10.1016/j.addr.2015.05.014
   Pinto UM, 2012, NAT REV MICROBIOL, V10, P755, DOI 10.1038/nrmicro2882
   Pittenger M, 2009, CELL STEM CELL, V5, P8, DOI 10.1016/j.stem.2009.06.013
   Place E. S., 2009, NAT MATER, V8, P6
   Plank C, 2012, EUR J NANOMED, V4, P17, DOI 10.1515/ejnm-2012-0001
   Puras G, 2013, EUR J PHARM BIOPHARM, V83, P131, DOI 10.1016/j.ejpb.2012.09.010
   Quinlan E., 2015, J TISSUE ENG R UNPUB
   Quinlan E, 2015, J CONTROL RELEASE, V207, P112, DOI 10.1016/j.jconrel.2015.03.028
   Quinlan E, 2015, J CONTROL RELEASE, V198, P71, DOI 10.1016/j.jconrel.2014.11.021
   Raftery R, 2013, MOLECULES, V18, P5611, DOI 10.3390/molecules18055611
   Raftery RM, 2015, J CONTROL RELEASE, V210, P84, DOI 10.1016/j.jconrel.2015.05.005
   Ram-Liebig G, 2015, ADV DRUG DELIVER REV, V82-83, P181, DOI 10.1016/j.addr.2014.11.009
   Raper SE, 2003, MOL GENET METAB, V80, P148, DOI 10.1016/j.ymgme.2003.08.016
   Raya-Rivera A, 2011, LANCET, V377, P1175, DOI 10.1016/S0140-6736(10)62354-9
   Regnstrom K., 2006, PHARM RES, V23, P3
   Robalino J, 2005, J VIROL, V79, P13561, DOI 10.1128/JVI.79.21.13561-13571.2005
   Santos J. L., 2011, CURRENT GENE THERAPY, V11, P1
   Sato M, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-51
   Schagemann JC, 2010, BIOMATERIALS, V31, P2798, DOI 10.1016/j.biomaterials.2009.12.037
   Schoolmeesters A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005605
   Schwarz DS, 2002, MOL CELL, V10, P537, DOI 10.1016/S1097-2765(02)00651-2
   Sheyn D., 2010, ADV DRUG DELIVERY RE, V62, P7
   Shirasawa S, 2006, J CELL BIOCHEM, V97, P84, DOI 10.1002/jcb.20546
   Spicer PP, 2012, NAT PROTOC, V7, P1918, DOI 10.1038/nprot.2012.113
   Sriram M, 2015, INT J BIOL MACROMOL, V74, P404, DOI 10.1016/j.ijbiomac.2014.12.034
   Steinert AF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2195
   Sulistio A, 2012, MACROMOL BIOSCI, V12, P1220, DOI 10.1002/mabi.201200048
   TEMIN HM, 1961, VIROLOGY, V13, P158, DOI 10.1016/0042-6822(61)90049-6
   Tierney E. G., 2012, J CONTROL RELEASE, V158, P2
   Tierney E. G., 2013, J CONTROL RELEASE, V165, P3
   Tierney EG, 2013, ORGANOGENESIS, V9, P22, DOI 10.4161/org.24329
   Tiwari G, 2010, J PHARM BIOALLIED SC, V2, P72, DOI 10.4103/0975-7406.67003
   TOMALIA DA, 1985, POLYM J, V17, pR1
   Tsiridis E, 2007, INJURY, V38, pS11, DOI 10.1016/j.injury.2007.02.006
   Umebayashi M., 2015, BIORES OPEN ACCESS, V4, P1
   van Osch G. J. V. M., 2009, J CELL MOL MED, V13, P5
   van Rooij E., 2012, CIRC RES, V110, P3
   van Rooij E, 2011, CIRC RES, V108, P219, DOI 10.1161/CIRCRESAHA.110.227496
   Villemejane J., 2009, BRIT J PHARMACOL, V157, P2
   Vo TN, 2012, ADV DRUG DELIVER REV, V64, P1292, DOI 10.1016/j.addr.2012.01.016
   Wang J, 2013, ELECTRON J DIFFER EQ, V2013, DOI DOI 10.1155/2013/978398
   Wang ZL, 2015, J INFLAMM-LOND, V12, DOI 10.1186/s12950-014-0046-z
   Williams DF, 2006, TRENDS BIOTECHNOL, V24, P4, DOI 10.1016/j.tibtech.2005.10.006
   Wirth T, 2013, GENE, V525, P162, DOI 10.1016/j.gene.2013.03.137
   WU GY, 1987, J BIOL CHEM, V262, P4429
   Wu K., 2013, ACS APPL MATER INTER, V5, P7
   Yannas IV, 2011, PLAST RECONSTR SURG, V127, p60S, DOI 10.1097/PRS.0b013e318200a44d
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
   Yano K, 2015, REGEN THER, V1, P45, DOI 10.1016/j.reth.2014.10.001
   Yau WWY, 2012, BIOMATERIALS, V33, P2608, DOI 10.1016/j.biomaterials.2011.12.021
   Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763
   Zangi L, 2013, NAT BIOTECHNOL, V31, P898, DOI 10.1038/nbt.2682
   Zhang M. Z., 2009, ADV MATER, V21, P34
   Zhang Y. F., 2009, J CONTROL RELEASE, V136, P3
   Zhao M, 2005, J CELL BIOCHEM, V95, P1, DOI 10.1002/jcb.20411
   ZINDER ND, 1952, J BACTERIOL, V64, P679
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 284
TC 23
Z9 23
U1 2
U2 77
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 0935-9648
EI 1521-4095
J9 ADV MATER
JI Adv. Mater.
PD JUL 20
PY 2016
VL 28
IS 27
SI SI
BP 5447
EP 5469
DI 10.1002/adma.201505088
PG 23
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA DR5WR
UT WOS:000379973600007
PM 26840618
DA 2018-10-20
ER

PT J
AU Wronska, MA
   O'Connor, IB
   Tilbury, MA
   Srivastava, A
   Wall, JG
AF Wronska, Malgorzata A.
   O'Connor, Iain B.
   Tilbury, Maura A.
   Srivastava, Akshay
   Wall, J. Gerard
TI Adding Functions to Biomaterial Surfaces through Protein Incorporation
SO ADVANCED MATERIALS
LA English
DT Article
DE biomaterials; functionalization; peptides; proteins
ID MUSSEL ADHESIVE PROTEIN; GROWTH-FACTOR RECEPTOR; BONE MORPHOGENETIC
   PROTEIN-2; CELL-PENETRATING PEPTIDES; NATIVE CHEMICAL LIGATION;
   ELASTIN-LIKE PROTEIN; ORIENTED COVALENT IMMOBILIZATION; RECOMBINANT
   ESCHERICHIA-COLI; COATED TITANIUM IMPLANTS; MALTOSE-BINDING PROTEIN
AB The concept of biomaterials has evolved from one of inert mechanical supports with a long-term, biologically inactive role in the body into complex matrices that exhibit selective cell binding, promote proliferation and matrix production, and may ultimately become replaced by newly generated tissues in vivo. Functionalization of material surfaces with biomolecules is critical to their ability to evade immunorecognition, interact productively with surrounding tissues and extracellular matrix, and avoid bacterial colonization. Antibody molecules and their derived fragments are commonly immobilized on materials to mediate coating with specific cell types in fields such as stent endothelialization and drug delivery. The incorporation of growth factors into biomaterials has found application in promoting and accelerating bone formation in osteogenerative and related applications. Peptides and extracellular matrix proteins can impart biomolecule- and cell-specificities to materials while antimicrobial peptides have found roles in preventing biofilm formation on devices and implants. In this progress report, we detail developments in the use of diverse proteins and peptides to modify the surfaces of hard biomaterials in vivo and in vitro. Chemical approaches to immobilizing active biomolecules are presented, as well as platform technologies for isolation or generation of natural or synthetic molecules suitable for biomaterial functionalization.
C1 [Wronska, Malgorzata A.; O'Connor, Iain B.; Tilbury, Maura A.; Srivastava, Akshay; Wall, J. Gerard] Natl Univ Ireland, Microbiol, Galway, Ireland.
   [Wronska, Malgorzata A.; O'Connor, Iain B.; Tilbury, Maura A.; Srivastava, Akshay; Wall, J. Gerard] Natl Univ Ireland, Ctr Res Med Devices CURAM, Galway, Ireland.
RP Wall, JG (reprint author), Natl Univ Ireland, Microbiol, Galway, Ireland.; Wall, JG (reprint author), Natl Univ Ireland, Ctr Res Med Devices CURAM, Galway, Ireland.
EM gerard.wall@nuigalway.ie
FU Science Foundation Ireland [13/RC/2073]; European Regional Development
   Fund; European Union [FP7-PEOPLE-2012-IAPP-324514]; NUI Galway College
   of Science
FX Work on biomaterials and protein engineering in J.G.W.'s laboratory is
   supported by Science Foundation Ireland Grant 13/RC/2073, co-funded
   under the European Regional Development Fund; European Union Project
   Grant FP7-PEOPLE-2012-IAPP-324514; and NUI Galway College of Science
   studentships to MW and IBOC.
CR Abdelghani M, 2015, GM CROPS FOOD, V6, P54, DOI 10.1080/21645698.2015.1026524
   Abdemami Baharak, 2011, Avicenna Journal of Medical Biotechnology, V3, P11
   Accardo A, 2014, INT J NANOMED, V9, P1537, DOI 10.2147/IJN.S53593
   Adams DN, 2005, J NEUROBIOL, V62, P134, DOI 10.1002/neu.20075
   Adebowale A. S., 2015, CURR PHARM DES
   Agallou M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00268
   Ahmad ZA, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/980250
   Aizawa M, 2013, BIOL PHARM BULL, V36, P1654
   Akbari V, 2014, J IND MICROBIOL BIOT, V41, P947, DOI 10.1007/s10295-014-1437-0
   Allon AA, 2012, J BIOMED MATER RES A, V100A, P2168, DOI 10.1002/jbm.a.34144
   Amblard M, 2006, MOL BIOTECHNOL, V33, P239, DOI 10.1385/MB:33:3:239
   Andersen DC, 2002, CURR OPIN BIOTECH, V13, P117, DOI 10.1016/S0958-1669(02)00300-2
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   AOTA S, 1994, J BIOL CHEM, V269, P24756
   Appendini P, 1999, J APPL MICROBIOL, V87, P750, DOI 10.1046/j.1365-2672.1999.00921.x
   Aryal R, 2014, ORTHOP SURG, V6, P171, DOI 10.1111/os.12112
   Assenberg R, 2013, CURR OPIN STRUC BIOL, V23, P393, DOI 10.1016/j.sbi.2013.03.008
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   Ayhan H, 1999, J BIOMAT SCI-POLYM E, V10, P109, DOI 10.1163/156856299X00315
   Balasundaram G, 2007, J BIOMED MATER RES A, V80A, P602, DOI 10.1002/jbm.a.30954
   Barber TA, 2007, J BIOMED MATER RES A, V80A, P306, DOI 10.1002/jbm.a.30927
   Barone A, 2014, XENOTRANSPLANTATION, V21, P510, DOI 10.1111/xen.12123
   Bataille L, 2015, PROTEIN EXPRES PURIF, V110, P165, DOI 10.1016/j.pep.2015.03.013
   Batalla P, 2008, BIOMACROMOLECULES, V9, P719, DOI 10.1021/bm7010906
   Batalla P, 2012, J CHROMATOGR A, V1262, P56, DOI 10.1016/j.chroma.2012.08.058
   Bax DV, 2014, BIOMATERIALS, V35, P6797, DOI 10.1016/j.biomaterials.2014.04.082
   Bax DV, 2012, ACTA BIOMATER, V8, P2538, DOI 10.1016/j.actbio.2012.03.023
   Benvenuto P, 2015, LANGMUIR, V31, P5423, DOI 10.1021/acs.langmuir.5b00812
   Bilan R, 2015, BIOCONJUGATE CHEM, V26, P609, DOI 10.1021/acs.bioconjchem.5b00069
   Bilek MMM, 2011, P NATL ACAD SCI USA, V108, P14405, DOI 10.1073/pnas.1103277108
   Blindt R, 2006, J AM COLL CARDIOL, V47, P1786, DOI 10.1016/j.jacc.2005.11.081
   Bononi FC, 2015, METHODS MOL BIOL, V1248, P223, DOI 10.1007/978-1-4939-2020-4_15
   Boumaiza M, 2014, J PEPT SCI, V20, P680, DOI 10.1002/psc.2644
   Boyer C, 2009, CHEM REV, V109, P5402, DOI 10.1021/cr9001403
   Bradbury ARM, 2011, NAT BIOTECHNOL, V29, P245, DOI 10.1038/nbt.1791
   Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098
   Bryksin AV, 2014, ACTA BIOMATER, V10, P1761, DOI 10.1016/j.actbio.2014.01.019
   Bulmus V, 2011, POLYM CHEM-UK, V2, P1463, DOI 10.1039/c1py00039j
   Burzio VA, 1996, ANAL BIOCHEM, V241, P190, DOI 10.1006/abio.1996.0398
   Cai L, 2014, BIOMATER SCI-UK, V2, P757, DOI 10.1039/c3bm60293a
   Calamak S, 2014, MAT SCI ENG C-MATER, V43, P11, DOI 10.1016/j.msec.2014.07.001
   Campos DM, 2014, BIORESEARCH OPEN ACC, V3, P117, DOI 10.1089/biores.2014.0015
   Carberry TP, 2012, CHEM-EUR J, V18, P13678, DOI 10.1002/chem.201202358
   Casteleijn MG, 2013, INT J PHARMACEUT, V440, P39, DOI 10.1016/j.ijpharm.2012.04.005
   Castelli M, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/521231
   Chafekar SM, 2007, CHEMBIOCHEM, V8, P1857, DOI 10.1002/cbic.200700338
   Chan TCY, 2015, ACTA OPHTHALMOL, V93, P689, DOI 10.1111/aos.12754
   Chantson JT, 2006, CHEMMEDCHEM, V1, P1268, DOI 10.1002/cmdc.200600117
   Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94
   Charbonneau C, 2012, MACROMOL BIOSCI, V12, P812, DOI 10.1002/mabi.201100447
   Che YY, 2016, PROTEIN EXPRES PURIF, V119, P45, DOI 10.1016/j.pep.2015.11.006
   Chen C, 2015, INT J NANOMED, V10, P283, DOI 10.2147/IJN.S74746
   Chen F, 2013, J MASS SPECTROM, V48, P807, DOI 10.1002/jms.3224
   Chen MC, 2009, BIOMATERIALS, V30, P79, DOI 10.1016/j.biomaterials.2008.09.006
   Chen RX, 2012, ACTA BIOMATER, V8, P4371, DOI 10.1016/j.actbio.2012.07.029
   Chen RX, 2009, BIOFOULING, V25, P517, DOI 10.1080/08927010902954207
   Chen TF, 2013, METHOD ENZYMOL, V523, P303, DOI 10.1016/B978-0-12-394292-0.00014-X
   Chen WH, 2011, SPINE, V36, P103, DOI 10.1097/BRS.0b013e3181cb46ba
   Choi BH, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-52
   Choi BH, 2012, TISSUE ENG PART C-ME, V18, P71, DOI [10.1089/ten.tec.2011.0384, 10.1089/ten.TEC.2011.0384]
   Choi BH, 2010, BIOMATERIALS, V31, P8980, DOI 10.1016/j.biomaterials.2010.08.027
   Chowdhury SR, 2015, TISSUE ENG PART C-ME, V21, P1135, DOI [10.1089/ten.tec.2015.0015, 10.1089/ten.TEC.2015.0015]
   Chronopoulou E. G., 2001, CURR PROT PROT SCI, V63, P266
   Coad BR, 2013, SURF COAT TECH, V233, P169, DOI 10.1016/j.surfcoat.2013.05.019
   Coad BR, 2012, LANGMUIR, V28, P2710, DOI 10.1021/la204714p
   Collier JH, 2011, BIOMATERIALS, V32, P4198, DOI 10.1016/j.biomaterials.2011.02.030
   Collins T, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-21
   Costa F, 2011, ACTA BIOMATER, V7, P1431, DOI 10.1016/j.actbio.2010.11.005
   Crosnier C, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-76
   Cui S, 2015, DRUG DES DEV THER, V9, P2249, DOI 10.2147/DDDT.S81257
   Cui S, 2014, BIOMED RES INT, DOI 10.1155/2014/428619
   Cunningham C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083678
   Custodio CA, 2010, J TISSUE ENG REGEN M, V4, P316, DOI 10.1002/term.248
   Custodio CA, 2014, ADV HEALTHC MATER, V3, P797, DOI 10.1002/adhm.201300603
   da Costa JP, 2015, APPL MICROBIOL BIOT, V99, P2023, DOI 10.1007/s00253-015-6375-x
   Dalton AC, 2014, PROTEIN SCI, V23, P517, DOI 10.1002/pro.2439
   Damelin M, 2015, PHARM RES-DORDR, V32, P3494, DOI 10.1007/s11095-015-1624-3
   Dang JL, 2015, PROTEIN EXPRES PURIF, V115, P61, DOI 10.1016/j.pep.2015.08.010
   Das P, 2015, BIOPOLYMERS, V104, P480, DOI 10.1002/bip.22655
   Daugherty PS, 2007, CURR OPIN STRUC BIOL, V17, P474, DOI 10.1016/j.sbi.2007.07.004
   DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629
   De Oliveira LG, 2015, J PHARM SCI-US, V104, P3731, DOI 10.1002/jps.24569
   Decristoforo C, 2008, EUR J NUCL MED MOL I, V35, P1507, DOI 10.1007/s00259-008-0757-6
   Deere J, 2004, LANGMUIR, V20, P532, DOI 10.1021/la035358y
   Delfani S, 2015, CLIN EXP VACCINE RES, V4, P99, DOI 10.7774/cevr.2015.4.1.99
   Demain AL, 2009, BIOTECHNOL ADV, V27, P297, DOI 10.1016/j.biotechadv.2009.01.008
   Dendane N, 2012, LANGMUIR, V28, P13336, DOI 10.1021/la3030217
   Dennis MS, 2007, CANCER RES, V67, P254, DOI 10.1158/0008-5472.CAN-06-2531
   Deonarain MP, 2015, EXPERT OPIN DRUG DIS, V10, P463, DOI 10.1517/17460441.2015.1025049
   Desai MS, 2015, WIRES NANOMED NANOBI, V7, P69, DOI 10.1002/wnan.1303
   Desriac F, 2013, MAR DRUGS, V11, P3632, DOI 10.3390/md11103632
   Dettin M, 2006, TISSUE ENG, V12, P3509, DOI 10.1089/ten.2006.12.3509
   Diener KR, 2012, ACTA BIOMATER, V8, P99, DOI 10.1016/j.actbio.2011.09.001
   Diesner SC, 2012, THER DELIV, V3, P377, DOI 10.4155/TDE.11.146
   Dinga JN, 2014, ACTA TROP, V135, P104, DOI 10.1016/j.actatropica.2014.03.007
   Dinis TM, 2015, J MECH BEHAV BIOMED, V41, P43, DOI 10.1016/j.jmbbm.2014.09.029
   Dodev TS, 2014, SCI REP-UK, V4, DOI 10.1038/srep05885
   Doerner A, 2014, FEBS LETT, V588, P278, DOI 10.1016/j.febslet.2013.11.025
   Dong XL, 2014, J ENVIRON SCI-CHINA, V26, P2526, DOI 10.1016/j.jes.2014.04.010
   Dornish M, 2001, ANN NY ACAD SCI, V944, P388
   Drachman DE, 2000, J AM COLL CARDIOL, V36, P2325, DOI 10.1016/S0735-1097(00)01020-2
   Drugmand JC, 2012, BIOTECHNOL ADV, V30, P1140, DOI 10.1016/j.biotechadv.2011.09.014
   Duplantier AJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00143
   Fairbanks BD, 2015, ADV DRUG DELIVER REV, V91, P141, DOI 10.1016/j.addr.2015.05.016
   Fang F, 2005, BIOPHYS J, V89, P1516, DOI 10.1529/biophysj.104.055079
   Fathi A, 2014, BIOMATERIALS, V35, P5425, DOI 10.1016/j.biomaterials.2014.03.026
   Feldman MF, 2005, P NATL ACAD SCI USA, V102, P3016, DOI 10.1073/pnas.0500044102
   Feng SB, 2014, CELL BIOCHEM BIOPHYS, V70, P1913, DOI 10.1007/s12013-014-0151-x
   Ferrari M, 2015, NAT REV RHEUMATOL, V11, P328, DOI 10.1038/nrrheum.2015.17
   Ferrer-Miralles N, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-17
   Ferris DM, 1999, BIOMATERIALS, V20, P2323, DOI 10.1016/S0142-9612(99)00161-1
   Finlay WJJ, 2011, METHODS MOL BIOL, V681, P87, DOI 10.1007/978-1-60761-913-0_6
   Fischer MJE, 2010, METHODS MOL BIOL, V627, P55, DOI 10.1007/978-1-60761-670-2_3
   Foerster A, 2016, J BIOMED MATER RES A, V104, P821, DOI 10.1002/jbm.a.35616
   Francisco AT, 2013, BIOMATERIALS, V34, P7381, DOI 10.1016/j.biomaterials.2013.06.038
   Freire MO, 2011, TISSUE ENG PT A, V17, P2911, DOI 10.1089/ten.tea.2010.0584
   Frenzel A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00217
   Frigerio B, 2013, EUR J CANCER, V49, P2223, DOI 10.1016/j.ejca.2013.01.024
   Fullana MJ, 2012, DRUG DELIV TRANSL RE, V2, P313, DOI 10.1007/s13346-012-0087-x
   Gabriel M, 2006, BIOCONJUGATE CHEM, V17, P548, DOI 10.1021/bc050091v
   Gajbhiye V, 2013, BIOTECHNOL ADV, V31, P552, DOI 10.1016/j.biotechadv.2013.01.005
   Gand Adeline, 2014, Biomatter, V4, pe28823, DOI 10.4161/biom.28823
   Garg T, 2015, J DRUG TARGET, V23, P202, DOI 10.3109/1061186X.2014.992899
   Gautam A, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-74
   Gauthier MA, 2008, CHEM COMMUN, P2591, DOI 10.1039/b719689j
   GENGENBACH TR, 1994, J ADHES SCI TECHNOL, V8, P305, DOI 10.1163/156856194X00267
   Ghosh A, 2014, CHEMMEDCHEM, V9, P2052, DOI 10.1002/cmdc.201402215
   Giguere S, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004074
   Girotti A, 2011, BIOTECHNOL J, V6, P1174, DOI 10.1002/biot.201100116
   Glinel K, 2009, BIOCONJUGATE CHEM, V20, P71, DOI 10.1021/bc800280u
   Godoy-Gallardo M, 2015, BIOMACROMOLECULES, V16, P483, DOI 10.1021/bm501528x
   Godoy-Gallardo M, 2014, ACTA BIOMATER, V10, P3522, DOI 10.1016/j.actbio.2014.03.026
   Gogate PN, 2014, EUR J MED CHEM, V80, P154, DOI 10.1016/j.ejmech.2014.04.041
   Gomez-Lara J, 2011, JACC-CARDIOVASC INTE, V4, P1271, DOI 10.1016/j.jcin.2011.08.016
   de Torre IG, 2015, ACTA BIOMATER, V12, P146, DOI 10.1016/j.actbio.2014.10.029
   Gothard D, 2014, EUR CELLS MATER, V28, P166, DOI 10.22203/eCM.v028a13
   Gray BP, 2014, CHEM REV, V114, P1020, DOI 10.1021/cr400166n
   GRIFFITHS AD, 1994, EMBO J, V13, P3245, DOI 10.1002/j.1460-2075.1994.tb06626.x
   Grover GN, 2010, CURR OPIN CHEM BIOL, V14, P818, DOI 10.1016/j.cbpa.2010.10.008
   Gutierrez SP, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-40
   Hammers CM, 2014, J INVEST DERMATOL, V134, DOI 10.1038/jid.2013.521
   Hansen M, 2008, ADV DRUG DELIVER REV, V60, P572, DOI 10.1016/j.addr.2007.09.003
   Hanson-Manful Paulina, 2013, Methods Mol Biol, V996, P251, DOI 10.1007/978-1-62703-354-1_15
   Heidebrecht A, 2013, ADV APPL MICROBIOL, V82, P115, DOI 10.1016/B978-0-12-407679-2.00004-1
   Hench LL, 2010, J R SOC INTERFACE, V7, pS379, DOI 10.1098/rsif.2010.0151.focus
   Herbel V, 2015, MOLECULES, V20, P14889, DOI 10.3390/molecules200814889
   Hermanson GT, 2008, BIOCONJUGATE TECHNIQUES, 2ND EDITION, P1, DOI 10.1016/B978-0-12-370501-3.00001-1
   Herve V, 2014, J BIOL CHEM, V289, P7211, DOI 10.1074/jbc.M113.507046
   Hilpert K, 2009, CHEM BIOL, V16, P58, DOI 10.1016/j.chembiol.2008.11.006
   Hiob MA, 2013, BIOMATERIALS, V34, P7584, DOI 10.1016/j.biomaterials.2013.06.036
   Hirsh SL, 2013, COLLOID SURFACE B, V103, P395, DOI 10.1016/j.colsurfb.2012.10.039
   Hoang VLT, 2013, CURR PROTEIN PEPT SC, V14, P205
   Hoffmann J, 2008, J BIOMED MATER RES A, V84A, P614, DOI 10.1002/jbm.a.31309
   Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142
   Hortiguela MJ, 2015, POLYM ADVAN TECHNOL, V26, P1394, DOI 10.1002/pat.3619
   Hortiguela MJ, 2013, MAR DRUGS, V11, P881, DOI 10.3390/md11030881
   Howell S, 1998, J MOL RECOGNIT, V11, P200, DOI 10.1002/(SICI)1099-1352(199812)11:1/6<200::AID-JMR423>3.0.CO;2-7
   Hoyer M, 2014, MAT SCI ENG C-MATER, V43, P290, DOI 10.1016/j.msec.2014.07.010
   Hu X., 2012, BIOL INTERACTIONS SU, V21, P90
   Hu XJ, 2006, J PHYS CHEM B, V110, P18703, DOI 10.1021/jp062423e
   Hu XJ, 2013, BIOMACROMOLECULES, V14, P153, DOI 10.1021/bm301518p
   Huang WW, 2015, EXPERT OPIN DRUG DEL, V12, P779, DOI 10.1517/17425247.2015.989830
   Hudlikar MS, 2016, CHEM-EUR J, V22, P1415, DOI 10.1002/chem.201503999
   HUFNAGEL CA, 1954, SURGERY, V35, P673
   Huh JB, 2012, INT J ORAL MAX SURG, V41, P1577, DOI 10.1016/j.ijom.2012.04.005
   Humblot V, 2009, BIOMATERIALS, V30, P3503, DOI 10.1016/j.biomaterials.2009.03.025
   HUMPHRIES MJ, 1986, J CELL BIOL, V103, P2637, DOI 10.1083/jcb.103.6.2637
   Huovinen Tuomas, 2014, BMC Res Notes, V7, P661, DOI 10.1186/1756-0500-7-661
   Hwang B, 2011, BIOCHEM BIOPH RES CO, V408, P89, DOI 10.1016/j.bbrc.2011.03.125
   Hwang DS, 2007, BIOMATERIALS, V28, P4039, DOI 10.1016/j.biomaterials.2007.05.028
   Hwang DS, 2005, BIOTECHNOL PROGR, V21, P965, DOI 10.1021/bp050014e
   Inostroza-Brito KE, 2015, NAT CHEM, V7, P897, DOI [10.1038/NCHEM.2349, 10.1038/nchem.2349]
   Jain A, 2015, FEBS J, V282, P732, DOI 10.1111/febs.13178
   Jain NK, 2015, NANOMED-NANOTECHNOL, V11, P207, DOI 10.1016/j.nano.2014.09.006
   Jana S, 2014, ACTA BIOMATER, V10, P2877, DOI 10.1016/j.actbio.2014.03.014
   Jansson R., 2016, BIOTECHNOL IN PRESS
   JENTOFT N, 1979, J BIOL CHEM, V254, P4359
   Otero-Gonzalez AJ, 2010, FASEB J, V24, P1320, DOI 10.1096/fj.09-143388
   Jia QL, 2014, J IND MICROBIOL BIOT, V41, P1667, DOI 10.1007/s10295-014-1500-x
   Jiang Z, 2012, COLLOID SURFACE B, V90, P227, DOI 10.1016/j.colsurfb.2011.10.037
   Jin HE, 2014, BIOMATERIALS, V35, P9236, DOI 10.1016/j.biomaterials.2014.07.044
   Jo YK, 2014, ACS APPL MATER INTER, V6, P20242, DOI 10.1021/am505784k
   Jones EM, 2015, FRONT CHEM, V3, DOI 10.3389/fchem.2015.00040
   Junka R, 2013, J BIOMATER TISS ENG, V3, P494, DOI 10.1166/jbt.2013.1110
   Kaizong H., 2015, PROTEIN PEPTIDE LETT, V22, P1000
   Kakwere H, 2010, CHEM COMMUN, V46, P2188, DOI 10.1039/b924112d
   Kastellorizios M, 2015, ADV EXP MED BIOL, V865, P93, DOI 10.1007/978-3-319-18603-0_6
   Kaur PJ, 2015, J BIOL CHEM, V290, P9251, DOI 10.1074/jbc.M113.542241
   Khantasup K, 2014, ANTIMICROB AGENTS CH, V58, P2816, DOI 10.1128/AAC.02768-13
   Kim CS, 2011, ADV FUNCT MATER, V21, P4101, DOI 10.1002/adfm.201100710
   Kim DH, 2015, ACTA BIOMATER, V12, P21, DOI 10.1016/j.actbio.2014.10.030
   Kim H, 2014, MAT SCI ENG C-MATER, V40, P324, DOI 10.1016/j.msec.2014.04.012
   Kim SS, 2010, MOL THER, V18, P370, DOI 10.1038/mt.2009.271
   Kim TH, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/2/025008
   KING DS, 1990, INT J PEPT PROT RES, V36, P255
   Knetsch PA, 2015, NUCL MED BIOL, V42, P115, DOI 10.1016/j.nucmedbio.2014.10.001
   Knezevic NZ, 2015, NANOSCALE, V7, P2199, DOI 10.1039/c4nr06114d
   Ko E, 2013, BIOMACROMOLECULES, V14, P3202, DOI 10.1021/bm4008343
   KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0
   Kolaj O, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-9
   KOMORIYA A, 1991, J BIOL CHEM, V266, P15075
   Kono K, 2015, J CONTROL RELEASE, V216, P69, DOI 10.1016/j.jconrel.2015.08.005
   Kovalskaya N, 2009, PROTEIN EXPRES PURIF, V63, P12, DOI 10.1016/j.pep.2008.08.013
   Kowalczynska HM, 2005, J BIOMED MATER RES A, V72A, P228, DOI 10.1002/jbm.a.30238
   Krah S., 2015, IMMUNOPHARMACOL IMMU, P1
   Kuddus M. R., 2016, PROTEIN EXP IN PRESS
   Kuwana Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105325
   Lakra R, 2015, BIOMED MATER, V10, DOI 10.1088/1748-6041/10/6/065015
   Lee DW, 2012, BONE, V50, P974, DOI 10.1016/j.bone.2012.01.007
   Lee H, 2006, P NATL ACAD SCI USA, V103, P12999, DOI 10.1073/pnas.0605552103
   Lee J, 2013, J PERIODONTOL, V84, P415, DOI 10.1902/jop.2012.110369
   Lee JM, 2012, BIOMATERIALS, V33, P8917, DOI 10.1016/j.biomaterials.2012.08.066
   Lee TT, 2015, NAT MATER, V14, P352, DOI [10.1038/NMAT4157, 10.1038/nmat4157]
   Lee WH, 2014, COLLOID SURFACE B, V122, P823, DOI 10.1016/j.colsurfb.2014.07.029
   Lee W, 2014, CURR MICROBIOL, V69, P794, DOI 10.1007/s00284-014-0657-x
   LEEUW ED, 2010, FEBS LETT, V584, P1543
   Lewandrowski KU, 2000, BIOMATERIALS, V21, P757, DOI 10.1016/S0142-9612(99)00179-9
   Li A, 2014, BIOMATERIALS, V35, P8780, DOI 10.1016/j.biomaterials.2014.06.049
   Li F, 2010, PROTEIN PEPTIDE LETT, V17, P585, DOI 10.2174/092986610791112729
   Li GC, 2015, BIOMED ENVIRON SCI, V28, P378, DOI 10.3967/bes2015.053
   Li HB, 2015, BIOTECHNOL BIOPROC E, V20, P234, DOI 10.1007/s12257-014-0562-y
   Li J., 2014, BIOMED RES INT, V2014
   Li JJ, 2015, BIOCONJUGATE CHEM, V26, P2481, DOI 10.1021/acs.bioconjchem.5b00509
   Li LB, 2015, BIOTECHNOL APPL BIOC, V62, P467, DOI 10.1002/bab.1297
   Li Y, 2014, PROTEIN EXPRES PURIF, V95, P182, DOI 10.1016/j.pep.2013.12.011
   Lim KY, 2015, ACTA BIOMATER, V15, P127, DOI 10.1016/j.actbio.2014.12.015
   Liu MF, 2014, BIOMATERIALS, V35, P3697, DOI 10.1016/j.biomaterials.2013.12.099
   Lofblom J, 2011, BIOTECHNOL J, V6, P1115, DOI 10.1002/biot.201100129
   Lohmeyer JA, 2014, J RECONSTR MICROSURG, V30, P227, DOI 10.1055/s-0033-1358788
   London N, 2013, CURR OPIN STRUC BIOL, V23, P894, DOI 10.1016/j.sbi.2013.07.006
   London N, 2010, STRUCTURE, V18, P188, DOI 10.1016/j.str.2009.11.012
   Long K, 2015, J BIOMED MATER RES A, V103, P1159, DOI 10.1002/jbm.a.35268
   Luo YE, 2014, BIOTECHNOL APPL BIOC, V61, P237, DOI 10.1002/bab.1171
   Machado R, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/6/065009
   Machado R, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-11
   Made V, 2014, BEILSTEIN J ORG CHEM, V10, P1197, DOI 10.3762/bjoc.10.118
   Maghdouri-White Y, 2014, MAT SCI ENG C-MATER, V43, P37, DOI 10.1016/j.msec.2014.06.037
   Main H, 2014, CELL MOL LIFE SCI, V71, P3841, DOI 10.1007/s00018-014-1595-2
   Makaraviciute A, 2013, BIOSENS BIOELECTRON, V50, P460, DOI 10.1016/j.bios.2013.06.060
   Marciniuk K, 2014, VACCINE, V32, P1988, DOI 10.1016/j.vaccine.2014.01.027
   Mardirossian M, 2014, CHEM BIOL, V21, P1639, DOI 10.1016/j.chembiol.2014.10.009
   Maria-Neto S, 2015, BBA-BIOMEMBRANES, V1848, P3078, DOI 10.1016/j.bbamem.2015.02.017
   Marshall SH, 2002, BIOTECHNOL ADV, V20, P229, DOI 10.1016/S0734-9750(02)00015-0
   Martinez AW, 2014, ACTA BIOMATER, V10, P26, DOI 10.1016/j.actbio.2013.08.029
   Mas-Moruno C, 2014, ACS APPL MATER INTER, V6, P6525, DOI 10.1021/am5001213
   Mastellos DC, 2015, EUR J CLIN INVEST, V45, P423, DOI 10.1111/eci.12419
   MCCAFFERTY J, 1990, NATURE, V348, P552, DOI 10.1038/348552a0
   McCullum EO, 2010, METHODS MOL BIOL, V634, P103, DOI 10.1007/978-1-60761-652-8_7
   Melchiorri AJ, 2015, BIOMACROMOLECULES, V16, P437, DOI 10.1021/bm501853s
   Miller K. D., 2001, CURR PROTOC CYTOM, V45, P47
   Misson M, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.0891
   Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/nmat2344, 10.1038/NMAT2344]
   Miyao H, 2015, ANAL BIOCHEM, V484, P113, DOI 10.1016/j.ab.2015.05.010
   Moller L, 2013, BEILSTEIN J ORG CHEM, V9, P270, DOI 10.3762/bjoc.9.33
   Mogosanu GD, 2014, INT J PHARMACEUT, V463, P127, DOI 10.1016/j.ijpharm.2013.12.015
   Mohammad H, 2015, CURR PHARM DESIGN, V21, P2073, DOI 10.2174/1381612821666150310102702
   Mohorcic M, 2010, J MATER SCI-MATER M, V21, P2775, DOI 10.1007/s10856-010-4136-z
   Moles E, 2015, J CONTROL RELEASE, V210, P217, DOI 10.1016/j.jconrel.2015.05.284
   Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843
   Mouratou B, 2012, METHODS MOL BIOL, V805, P315, DOI 10.1007/978-1-61779-379-0_18
   Munch J, 2014, NAT REV MICROBIOL, V12, P715, DOI 10.1038/nrmicro3312
   Mushahary D, 2014, COLLOID SURFACE B, V122, P719, DOI 10.1016/j.colsurfb.2014.08.005
   Myllyharju Johanna, 2009, V522, P51, DOI 10.1007/978-1-59745-413-1_3
   Nagai M, 2006, J BIOMATER APPL, V21, P33, DOI 10.1177/0885328206055316
   Naik K, 2015, J NANOSCI NANOTECHNO, V15, P10108, DOI 10.1166/jnn.2015.11688
   Naik N, 2014, ADV HEALTHC MATER, V3, P367, DOI 10.1002/adhm.201300112
   Nam K, 2010, ACTA BIOMATER, V6, P409, DOI 10.1016/j.actbio.2009.06.022
   NARCISO JET, 2012, PHILIPP SCI LETT, V5, P63
   Nazli C, 2012, INT J NANOMED, V7, P1903, DOI 10.2147/IJN.S29442
   Niikura K, 2013, ACS APPL MATER INTER, V5, P3900, DOI 10.1021/am400590m
   Nilsson PH, 2013, BIOMATERIALS, V34, P985, DOI 10.1016/j.biomaterials.2012.10.040
   Nosworthy NJ, 2014, ENZYME MICROB TECH, V54, P20, DOI 10.1016/j.enzmictec.2013.09.012
   Nothdurft FP, 2015, CLIN IMPLANT DENT R, V17, P1237, DOI 10.1111/cid.12253
   O'Dwyer R, 2009, APPL BIOCHEM BIOTECH, V159, P178, DOI 10.1007/s12010-008-8379-9
   Okamoto A, 2014, BIOCHEM BIOPH RES CO, V449, P460, DOI 10.1016/j.bbrc.2014.05.043
   Osborne MJ, 2003, J BIOMOL NMR, V26, P317, DOI 10.1023/A:1024043620972
   Otvos L, 2000, BIOCHEMISTRY-US, V39, P14150, DOI 10.1021/bi0012843
   Pal S., 2016, CURR PROTEIN PEPT SC, V17, P147
   Palchesko RN, 2014, MAT SCI ENG C-MATER, V40, P398, DOI 10.1016/j.msec.2014.04.017
   Palmberger D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034226
   Pane K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146552
   Panteleev P. V., 2015, BIOTECHNOL IN PRESS
   Parhi P, 2015, J COLLOID INTERF SCI, V451, P198, DOI 10.1016/j.jcis.2015.03.049
   Patel N, 1998, FASEB J, V12, P1447
   Patel PR, 2012, BIOMACROMOLECULES, V13, P2546, DOI 10.1021/bm300795y
   Paul AM, 2014, J GEN VIROL, V95, P1712, DOI 10.1099/vir.0.066084-0
   Perez-Puyana V., 2016, J BIOMED A IN PRESS
   Pertile R, 2012, BIOTECHNOL PROGR, V28, P526, DOI 10.1002/btpr.1501
   Petrie TA, 2008, BIOMATERIALS, V29, P2849, DOI 10.1016/j.biomaterials.2008.03.036
   Petrie TA, 2006, BIOMATERIALS, V27, P5459, DOI 10.1016/j.biomaterials.2006.06.027
   Petrie TA, 2009, J CELL MOL MED, V13, P2602, DOI 10.1111/j.1582-4934.2008.00476.x
   Phoenix D. A., 2013, ANTIMICROBIAL PEPTID, P1, DOI DOI 10.1002/9783527652853.CH1
   Pinilla C., 2012, CURR PROTOCOLS IMMUN, V99, P95
   Polini A, 2014, BIOMATER SCI-UK, V2, P1779, DOI 10.1039/c4bm00164h
   Power KA, 2011, ARTHRITIS RHEUM-US, V63, P3876, DOI 10.1002/art.30607
   Price R, 2014, J CONTROL RELEASE, V190, P304, DOI 10.1016/j.jconrel.2014.06.016
   Proks V, 2003, ADV EXP MED BIOL, V534, P191
   Punet X, 2015, REGEN BIOMATER, V2, P167, DOI 10.1093/rb/rbv014
   Punet X, 2013, BIOMACROMOLECULES, V14, P2690, DOI 10.1021/bm4005436
   Puxbaum V, 2015, APPL MICROBIOL BIOT, V99, P2925, DOI 10.1007/s00253-015-6470-z
   Qi PK, 2013, SURF COAT TECH, V233, P80, DOI 10.1016/j.surfcoat.2013.02.008
   Qi XB, 2011, NANOSCALE, V3, P1874, DOI 10.1039/c1nr10024f
   Qiu WG, 2010, BIOMACROMOLECULES, V11, P3219, DOI 10.1021/bm100469w
   Quinlan E, 2015, J CONTROL RELEASE, V207, P112, DOI 10.1016/j.jconrel.2015.03.028
   Rai A, 2016, ACTA BIOMATER, V33, P64, DOI 10.1016/j.actbio.2016.01.035
   Raibaut L, 2015, TOP CURR CHEM, V363, P103, DOI 10.1007/128_2014_609
   Ramshaw JAM, 2014, BIOENGINEERED, V5, P227, DOI 10.4161/bioe.28791
   Rao SQ, 2016, PROTEIN EXPRES PURIF, V118, P113, DOI 10.1016/j.pep.2015.11.005
   Ratzinger G, 2010, J CONTROL RELEASE, V147, P187, DOI 10.1016/j.jconrel.2010.04.017
   Reissmann S, 2014, J PEPT SCI, V20, P760, DOI 10.1002/psc.2672
   Ren XS, 2011, LANGMUIR, V27, P12069, DOI 10.1021/la202438u
   Reulen SWA, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-66
   Ritala A, 2008, PROTEIN EXPRES PURIF, V59, P274, DOI 10.1016/j.pep.2008.02.013
   Rosenblum G, 2014, FEBS LETT, V588, P261, DOI 10.1016/j.febslet.2013.10.016
   Rothe A, 2008, BIOL CHEM, V389, P433, DOI 10.1515/BC.2008.045
   Rotman E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011106
   Ruiz C, 2016, PLANT MOL BIOL, V90, P329, DOI 10.1007/s11103-015-0419-6
   Rutschmann C, 2014, APPL MICROBIOL BIOT, V98, P4445, DOI 10.1007/s00253-013-5447-z
   Saby C, 1998, ELECTROANAL, V10, P1193, DOI 10.1002/(SICI)1521-4109(199811)10:17<1193::AID-ELAN1193>3.3.CO;2-3
   Sadik CD, 2013, J INVEST DERMATOL, V133, P2135, DOI 10.1038/jid.2013.231
   Salis A, 2016, COLLOID SURFACE B, V137, P77, DOI 10.1016/j.colsurfb.2015.04.068
   Sallach RE, 2009, BIOTECHNOL PROGR, V25, P1810, DOI 10.1002/btpr.208
   Samuelson JC, 2011, METHODS MOL BIOL, V705, P195, DOI 10.1007/978-1-61737-967-3_11
   Sandstrom K, 2012, INT J ONCOL, V40, P1525, DOI 10.3892/ijo.2012.1352
   Santiago LY, 2006, BIOMATERIALS, V27, P2962, DOI 10.1016/j.biomaterials.2006.01.011
   Santos CM, 2013, ACS APPL MATER INTER, V5, P12789, DOI 10.1021/am404591n
   Santos NA, 2015, TOXICON, V103, P160, DOI 10.1016/j.toxicon.2015.07.004
   Sarkar T, 2013, APPL BIOCHEM BIOTECH, V170, P1011, DOI 10.1007/s12010-013-0233-z
   Schimmele B, 2005, J MOL BIOL, V352, P229, DOI 10.1016/j.jmb.2005.06.073
   Schrader Eva, 2011, BMC Proc, V5 Suppl 8, pP87, DOI 10.1186/1753-6561-5-S8-P87
   Schuler M, 2009, J BIOMED MATER RES B, V91B, P517, DOI 10.1002/jbm.b.31425
   Schwarz F, 2010, NAT CHEM BIOL, V6, P264, DOI [10.1038/NCHEMBIO.314, 10.1038/nchembio.314]
   Sedaghat A, 2013, CLIN RES CARDIOL, V102, P413, DOI 10.1007/s00392-013-0547-4
   Shen Z, 2005, ANAL CHEM, V77, P797, DOI 10.1021/ac048665w
   Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Singh A, 2014, NAT MATER, V13, P988, DOI [10.1038/NMAT4048, 10.1038/nmat4048]
   SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944
   Smith MEB, 2010, J AM CHEM SOC, V132, P1960, DOI 10.1021/ja908610s
   Smith RJ, 2015, BIOMATERIALS, V51, P303, DOI 10.1016/j.biomaterials.2015.02.025
   Snell KD, 2015, CURR OPIN BIOTECH, V32, P68, DOI 10.1016/j.copbio.2014.11.005
   Song SX, 2009, FASEB J, V23, P1396, DOI 10.1096/fj.08-117002
   Spada S, 2002, EXTREMOPHILES, V6, P301, DOI 10.1007/s00792-001-0257-0
   Spicer CD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5740
   Srivastava A, 2015, MACROMOL BIOSCI, V15, P682, DOI 10.1002/mabi.201400401
   Srivastava A, 2014, PROG POLYM SCI, V39, P308, DOI 10.1016/j.progpolymsci.2013.09.003
   Steiert N, 2014, AESTHET SURG J, V34, P175, DOI 10.1177/1090820X13515878
   Steiner D, 2008, J MOL BIOL, V382, P1211, DOI 10.1016/j.jmb.2008.07.085
   Stoecklin-Wasmer C, 2013, J DENT RES, V92, P773, DOI 10.1177/0022034513496428
   Sun P, 2011, METHODS MOL BIOL, V705, P259, DOI 10.1007/978-1-61737-967-3_16
   Suzuki T, 2001, CIRCULATION, V104, P1188, DOI 10.1161/hc3601.093987
   Swartzlander MD, 2015, BIOMATERIALS, V41, P26, DOI 10.1016/j.biomaterials.2014.11.026
   Tang W, 2014, CHEM SOC REV, V43, P7013, DOI 10.1039/c4cs00139g
   Tatrai P, 2013, J MATER SCI-MATER M, V24, P479, DOI 10.1007/s10856-012-4809-x
   TAYLOR MS, 1994, J APPL BIOMATER, V5, P151, DOI 10.1002/jab.770050208
   Teule F, 2009, NAT PROTOC, V4, P341, DOI 10.1038/nprot.2008.250
   Thorwarth M, 2005, BIOCHEM BIOPH RES CO, V329, P789, DOI 10.1016/j.bbrc.2005.01.157
   Tibbitt MW, 2015, P NATL ACAD SCI USA, V112, P14444, DOI 10.1073/pnas.1516247112
   Tikunova NV, 2009, ACTA NATURAE, V1, P20
   Tsai CW, 2014, ANAL CHEM, V86, P2931, DOI 10.1021/ac4029467
   Unger RE, 2004, BIOMATERIALS, V25, P5137, DOI 10.1016/j.biomaterials.2003.12.040
   Urushida Y, 2007, FEBS J, V274, P4336, DOI 10.1111/j.1742-4658.2007.05965.x
   Valderrama-Rincon JD, 2012, NAT CHEM BIOL, V8, P434, DOI [10.1038/NCHEMBIO.921, 10.1038/nchembio.921]
   van Baal I, 2005, ANGEW CHEM INT EDIT, V44, P5052, DOI 10.1002/anie.200500635
   van Bloois E, 2011, TRENDS BIOTECHNOL, V29, P79, DOI 10.1016/j.tibtech.2010.11.003
   Vasita R, 2008, CURR TOP MED CHEM, V8, P341
   Veiseh O, 2015, NAT MATER, V14, P643, DOI [10.1038/NMAT4290, 10.1038/nmat4290]
   Vidal G, 2013, ACTA BIOMATER, V9, P4935, DOI 10.1016/j.actbio.2012.09.003
   Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009
   Vreuls C, 2010, J MATER CHEM, V20, P8092, DOI 10.1039/c0jm01419b
   VROMAN L, 1980, BLOOD, V55, P156
   WAITE JH, 1981, SCIENCE, V212, P1038, DOI 10.1126/science.212.4498.1038
   Wakelin EA, 2015, ACS APPL MATER INTER, V7, P23029, DOI 10.1021/acsami.5b06395
   Wang KF, 2012, INTERFACE FOCUS, V2, P259, DOI 10.1098/rsfs.2012.0012
   Wark KL, 2006, ADV DRUG DELIVER REV, V58, P657, DOI 10.1016/j.addr.2006.01.025
   Webb K, 2000, CRIT REV BIOMED ENG, V28, P203, DOI 10.1615/CritRevBiomedEng.v28.i12.350
   Wei Q, 2014, ANGEW CHEM INT EDIT, V53, P8004, DOI 10.1002/anie.201400546
   Willcox MDP, 2008, J APPL MICROBIOL, V105, P1817, DOI 10.1111/j.1365-2672.2008.03942.x
   Wilmes M, 2014, INT J MED MICROBIOL, V304, P93, DOI 10.1016/j.ijmm.2013.08.007
   Wilson SS, 2013, J MOL BIOL, V425, P4965, DOI 10.1016/j.jmb.2013.09.038
   Wojtowicz AM, 2010, BIOMATERIALS, V31, P2574, DOI 10.1016/j.biomaterials.2009.12.008
   Won JE, 2015, BIOTECHNOL LETT, V37, P935, DOI 10.1007/s10529-014-1745-5
   Wu GS, 2015, J MATER CHEM B, V3, P2024, DOI 10.1039/c4tb01934b
   Wu HX, 2014, BIOMATERIALS, V35, P5369, DOI 10.1016/j.biomaterials.2014.03.038
   Wu JJ, 2011, LANGMUIR, V27, P13684, DOI 10.1021/la2027237
   Xie H, 2013, ACTA BIOMATER, V9, P7845, DOI 10.1016/j.actbio.2013.04.038
   Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040
   Xu X, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-69
   Yang DH, 2015, J TISSUE ENG REGEN M, V9, P1067, DOI 10.1002/term.1973
   Yang HM, 2015, ANAL CHIM ACTA, V872, P1, DOI 10.1016/j.aca.2015.03.005
   Yang WJ, 2011, LANGMUIR, V27, P7065, DOI 10.1021/la200620s
   Yang YJ, 2014, BIOMACROMOLECULES, V15, P1390, DOI 10.1021/bm500001n
   Yi TH, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0189-x
   Younesi M, 2015, BIOFABRICATION, V7, DOI 10.1088/1758-5090/7/3/035001
   Yu HL, 2015, J BIOTECHNOL, V214, P77, DOI 10.1016/j.jbiotec.2015.09.012
   Yu XH, 2014, RSC ADV, V4, P7185, DOI 10.1039/c3ra44137g
   Yuksel E, 2014, MAT SCI ENG C-MATER, V45, P510, DOI 10.1016/j.msec.2014.10.004
   Zahnd C, 2007, NAT METHODS, V4, P269, DOI 10.1038/NMETH1003
   Zalba S, 2015, J CONTROL RELEASE, V210, P26, DOI 10.1016/j.jconrel.2015.05.271
   Zhang LC, 2015, J IND MICROBIOL BIOT, V42, P1369, DOI 10.1007/s10295-015-1673-y
   Zhang NY, 2011, MABS-AUSTIN, V3, P289, DOI 10.4161/mabs.3.3.15532
   Zhang Y, 2007, MAT SCI ENG C-BIO S, V27, P213, DOI 10.1016/j.msec.2006.03.013
   Zhong YA, 2014, BIOMACROMOLECULES, V15, P1955, DOI 10.1021/bm5003009
   Zhou HY, 2007, BIOORG MED CHEM LETT, V17, P5690, DOI 10.1016/j.bmcl.2007.07.053
   Zhou L, 2009, J BIOSCIENCES, V34, P221, DOI 10.1007/s12038-009-0026-2
   Zhou Y, 2012, NUCLEIC ACIDS RES, V40, P7932, DOI 10.1093/nar/gks568
   Zhou Y, 2007, J MOL BIOL, V371, P934, DOI 10.1016/j.jmb.2007.05.011
   Zhu BF, 2015, BIOMACROMOLECULES, V16, P202, DOI 10.1021/bm501403f
   Zucca P, 2014, MOLECULES, V19, P14139, DOI 10.3390/molecules190914139
NR 409
TC 14
Z9 14
U1 20
U2 190
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 0935-9648
EI 1521-4095
J9 ADV MATER
JI Adv. Mater.
PD JUL 20
PY 2016
VL 28
IS 27
SI SI
BP 5485
EP 5508
DI 10.1002/adma.201504310
PG 24
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA DR5WR
UT WOS:000379973600009
PM 27164952
DA 2018-10-20
ER

PT J
AU O'Neill, HS
   Gallagher, LB
   O'Sullivan, J
   Whyte, W
   Curley, C
   Dolan, E
   Hameed, A
   O'Dwyer, J
   Payne, C
   O'Reilly, D
   Ruiz-Hernandez, E
   Roche, ET
   O'Brien, FJ
   Cryan, SA
   Kelly, H
   Murphy, B
   Duffy, GP
AF O'Neill, Hugh S.
   Gallagher, Laura B.
   O'Sullivan, Janice
   Whyte, William
   Curley, Clive
   Dolan, Eimear
   Hameed, Aamir
   O'Dwyer, Joanne
   Payne, Christina
   O'Reilly, Daniel
   Ruiz-Hernandez, Eduardo
   Roche, Ellen T.
   O'Brien, Fergal J.
   Cryan, Sally Ann
   Kelly, Helena
   Murphy, Bruce
   Duffy, Garry P.
TI Biomaterial-Enhanced Cell and Drug Delivery: Lessons Learned in the
   Cardiac Field and Future Perspectives
SO ADVANCED MATERIALS
LA English
DT Review
DE biomaterials; cardiac tissue engineering; drug delivery; hydrogels; stem
   cell therapy
ID ACUTE MYOCARDIAL-INFARCTION; CHRONIC HEART-FAILURE; LEFT-VENTRICULAR
   FUNCTION; MESENCHYMAL STEM-CELLS; CHRONIC ISCHEMIC CARDIOMYOPATHY;
   GELATIN METHACRYLATE HYDROGELS; RGD MODIFIED ALGINATE;
   EXTRACELLULAR-MATRIX; 6-MINUTE WALK; INTRAMYOCARDIAL INJECTIONS
AB Heart failure is a significant clinical issue. It is the cause of enormous healthcare costs worldwide and results in significant morbidity and mortality. Cardiac regenerative therapy has progressed considerably from clinical and preclinical studies delivering simple suspensions of cells, macromolecule, and small molecules to more advanced delivery methods utilizing biomaterial scaffolds as depots for localized targeted delivery to the damaged and ischemic myocardium. Here, regenerative strategies for cardiac tissue engineering with a focus on advanced delivery strategies and the use of multimodal therapeutic strategies are reviewed.
C1 [O'Neill, Hugh S.; Gallagher, Laura B.; O'Sullivan, Janice; Whyte, William; Curley, Clive; Dolan, Eimear; Hameed, Aamir; O'Dwyer, Joanne; Payne, Christina; O'Reilly, Daniel; Ruiz-Hernandez, Eduardo; O'Brien, Fergal J.; Cryan, Sally Ann; Kelly, Helena; Duffy, Garry P.] Royal Coll Surgeons Ireland, Dept Anat, TERG, 123 St Stephens Green,D02 YN77, Dublin 2, Ireland.
   [O'Neill, Hugh S.; Gallagher, Laura B.; O'Sullivan, Janice; Whyte, William; Curley, Clive; Dolan, Eimear; Hameed, Aamir; O'Dwyer, Joanne; Ruiz-Hernandez, Eduardo; O'Brien, Fergal J.; Cryan, Sally Ann; Murphy, Bruce; Duffy, Garry P.] Trinity Coll Dublin, Trinity Ctr Bioengn TCBE, Dublin 2, Ireland.
   [Whyte, William; Ruiz-Hernandez, Eduardo; O'Brien, Fergal J.; Murphy, Bruce; Duffy, Garry P.] RCSI, Adv Mat & Bioengn Res Ctr AMBER, Dublin, Ireland.
   [Whyte, William; Ruiz-Hernandez, Eduardo; O'Brien, Fergal J.] TCD, Dublin, Ireland.
   [O'Dwyer, Joanne; Payne, Christina; Cryan, Sally Ann; Kelly, Helena] Royal Coll Surgeons Ireland, Sch Pharm, 123 St Stephens Green, Dublin 2, Ireland.
   [Roche, Ellen T.] Natl Univ Ireland, Dept Biomed Engn, Eng 2053,Engn Bldg, Galway, Ireland.
RP Duffy, GP (reprint author), Royal Coll Surgeons Ireland, Dept Anat, TERG, 123 St Stephens Green,D02 YN77, Dublin 2, Ireland.; Duffy, GP (reprint author), Trinity Coll Dublin, Trinity Ctr Bioengn TCBE, Dublin 2, Ireland.; Duffy, GP (reprint author), RCSI, Adv Mat & Bioengn Res Ctr AMBER, Dublin, Ireland.
EM garryduffy@rcsi.ie
RI Hameed, Aamir/C-2144-2017; O'Brien, Fergal/F-9485-2011
OI Hameed, Aamir/0000-0002-9242-6185; O'Brien, Fergal/0000-0003-2030-8005;
   Murphy, Bruce/0000-0002-9071-1193; Dolan, Eimear/0000-0002-6742-8461;
   Cryan, Sally-Ann/0000-0002-3941-496X; Roche, Ellen/0000-0002-8952-2993;
   Duffy, Garry/0000-0002-4994-9511; Kelly, Helena/0000-0003-4925-0759
FU Science Foundation Ireland (SFI) [SFI/12/RC/2278, SFI/13/IA/1840]; BioAT
   funding bodies PRTL (Programme for Research in Third Level Institutions)
   Cycle 5; European Regional Development Fund (ERDF), part of the European
   Union Structural Funds Programme; European Research Council from
   European Union [239685]; AMCARE grant from European Union [604531];
   European Union [645911]
FX This publication has emanated from research supported in part by
   research grants from Science Foundation Ireland (SFI) under Grant Nos.
   SFI/12/RC/2278 and SFI/13/IA/1840, BioAT funding bodies PRTL (Programme
   for Research in Third Level Institutions) Cycle 5 and European Regional
   Development Fund (ERDF), part of the European Union Structural Funds
   Programme 2007-2013, the European Research Council grant agreement no.
   239685 and AMCARE grant agreement no. 604531 both from the European
   Union's Seventh Framework Programme (FP7/2007-2013), and funding from
   the European Union's Horizon 2020 research and innovation programme
   under grant agreement no. 645911.
CR Afzal MR, 2015, CIRC RES, V117, P558, DOI 10.1161/CIRCRESAHA.114.304792
   Ammar KA, 2007, CIRCULATION, V115, P1563, DOI 10.1161/CIRCULATIONAHA.106.666818
   Anastasiadis K, 2012, HIPPOKRATIA, V16, P292
   Anastasiadis K, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-12
   Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Baldasseroni S, 2002, AM HEART J, V143, P398, DOI 10.1067/mhj.2002.121264
   Bartunek J, 2013, J AM COLL CARDIOL, V61, P2329, DOI 10.1016/j.jacc.2013.02.071
   Bastings MMC, 2014, ADV HEALTHC MATER, V3, P70, DOI 10.1002/adhm.201300076
   Baumann L, 2012, J CONTROL RELEASE, V162, P68, DOI 10.1016/j.jconrel.2012.04.049
   Behfar A, 2014, NAT REV CARDIOL, V11, P232, DOI 10.1038/nrcardio.2014.9
   Brafman DA, 2009, STEM CELLS DEV, V18, P1141, DOI 10.1089/scd.2008.0410
   Brown L, 2005, AM J PHYSIOL-HEART C, V289, P973
   Brudno Y, 2013, BIOMATERIALS, V34, P9201, DOI 10.1016/j.biomaterials.2013.08.007
   Bruick RK, 2001, GENE DEV, V15, P2497, DOI 10.1101/gad.931601
   Cahalin LP, 1996, CHEST, V110, P325, DOI 10.1378/chest.110.2.325
   Cai L, 2015, ADV FUNCT MATER, V25, P1344, DOI 10.1002/adfm.201403631
   Canseco DC, 2015, J AM COLL CARDIOL, V65, P892, DOI 10.1016/j.jacc.2014.12.027
   Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653
   Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144
   Castells-Sala C., 2012, J TISSUE ENG REGENER
   Cearbhaill O'E. D., 2014, MAYO CLIN P, V89, P259
   Chachques JC, 2008, ANN THORAC SURG, V85, P901, DOI 10.1016/j.athoracsur.2007.10.052
   Chen YC, 2012, ADV FUNCT MATER, V22, P2027, DOI 10.1002/adfm.201101662
   Christman KL, 2005, BIOMATERIALS, V26, P1139, DOI 10.1016/j.biomaterials.2004.04.025
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Clifford D. M., 2012, COCHRANE DB SYST REV, V2012, P2
   Cohen JE, 2014, CIRC-HEART FAIL, V7, P619, DOI 10.1161/CIRCHEARTFAILURE.113.001273
   Cokol M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.71
   Constantin M, 2014, EUR J PHARM SCI, V62, P86, DOI 10.1016/j.ejps.2014.05.005
   Dobner S, 2009, J CARD FAIL, V15, P629, DOI 10.1016/j.cardfail.2009.03.003
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Dvir T, 2009, P NATL ACAD SCI USA, V106, P14990, DOI 10.1073/pnas.0812242106
   Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507
   Ezzati M, 2015, NAT REV CARDIOL, V12, P508, DOI 10.1038/nrcardio.2015.82
   Fisher SA, 2015, CIRC RES, V116, P1361, DOI 10.1161/CIRCRESAHA.116.304386
   Flaim CJ, 2008, STEM CELLS DEV, V17, P29, DOI 10.1089/scd.2007.0085
   Frey N, 2014, CIRC-CARDIOVASC INTE, V7, P806, DOI 10.1161/CIRCINTERVENTIONS.114.001478
   Gomez-Mauricio RG, 2013, EUR J PHARM BIOPHARM, V84, P29, DOI 10.1016/j.ejpb.2012.11.028
   Gyongyosi M., 2015, CIRC RES, V114
   Hastings CL, 2014, ADV DRUG DELIV REV, V84, P85
   Hastings CL, 2015, ADV DRUG DELIVER REV, V84, P85, DOI 10.1016/j.addr.2014.08.006
   Hofmann M, 2005, CIRCULATION, V111, P2198, DOI 10.1161/01.CIR.0000163546.27639.AA
   Huang NF, 2005, TISSUE ENG, V11, P1860, DOI 10.1089/ten.2005.11.1860
   Ifkovits JL, 2010, P NATL ACAD SCI USA, V107, P11507, DOI 10.1073/pnas.1004097107
   Ilsar I, 2010, J CARD FAIL, V16, pS42, DOI 10.1016/j.cardfail.2010.06.147
   Ingle L, 2005, EUR HEART J, V26, P1742, DOI 10.1093/eurheartj/ehi259
   KANNEL WB, 1994, BRIT HEART J, V72, P3
   Kichula ET, 2014, ANN BIOMED ENG, V42, P1546, DOI 10.1007/s10439-013-0937-9
   Kofidis T, 2004, J THORAC CARDIOV SUR, V128, P571, DOI 10.1016/j.jtcvs.2004.05.021
   Komori M, 2005, ANESTH ANALG, V100, P830, DOI 10.1213/01.ANE.0000144426.18235.5A
   Konertz W, 2001, J CARDIAC SURG, V16, P113, DOI 10.1111/j.1540-8191.2001.tb00495.x
   Koshy ST, 2014, BIOMATERIALS, V35, P2477, DOI 10.1016/j.biomaterials.2013.11.044
   Lakshmanan R, 2012, EXPERT OPIN BIOL TH, V12, P1623, DOI 10.1517/14712598.2012.721770
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lee L. C., 2013, JOVE-J VIS EXP, V74, P50096
   Lee RJ, 2013, CELL TRANSPLANT, V22, P529, DOI 10.3727/096368911X637461
   Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549
   Leor J, 2005, PHARMACOL THERAPEUT, V105, P151, DOI 10.1016/j.pharmthera.2004.10.003
   Leor J, 2009, J AM COLL CARDIOL, V54, P1014, DOI 10.1016/j.jacc.2009.06.010
   Li P., 2015, BIOINFORMATICS, V12, P2007
   Lin RZ, 2013, BIOMATERIALS, V34, P6785, DOI 10.1016/j.biomaterials.2013.05.060
   Liu ZQ, 2012, BIOMATERIALS, V33, P3093, DOI 10.1016/j.biomaterials.2011.12.044
   Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Macfelda K, 2007, ARTIF ORGANS, V31, P4, DOI 10.1111/j.1525-1594.2007.00334.x
   Mann D. L., 2013, MULTICENTER RANDOMIZ
   Martens TP, 2009, CELL TRANSPLANT, V18, P297, DOI 10.3727/096368909788534915
   Mathiasen B., 2015, EUR HEART J
   McGarvey JR, 2014, J PHARMACOL EXP THER, V350, P701, DOI 10.1124/jpet.114.215798
   Mihardja SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010384
   Miyagawa S, 2009, SURG TODAY, V39, P133, DOI 10.1007/s00595-008-3803-x
   Nelson DM, 2011, ACTA BIOMATER, V7, P1, DOI 10.1016/j.actbio.2010.06.039
   Nichol JW, 2010, BIOMATERIALS, V31, P5536, DOI 10.1016/j.biomaterials.2010.03.064
   O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   O'Cearbhaill ED, 2014, MAYO CLIN PROC, V89, P259, DOI 10.1016/j.mayocp.2013.10.020
   Padin-Iruegas ME, 2009, CIRCULATION, V120, P876, DOI 10.1161/CIRCULATIONAHA.109.852285
   Panda NC, 2014, J INTERV CARD ELECTR, V41, P117, DOI 10.1007/s10840-014-9940-9
   Patel AN, 2015, HEART FAIL CLIN, V11, P275, DOI 10.1016/j.hfc.2014.12.006
   Perera S, 2006, J AM GERIATR SOC, V54, P743, DOI 10.1111/j.1532-5415.2006.00701.x
   Perin EC, 2011, CIRC RES, V109, P351, DOI 10.1161/CIRCRESAHA.111.250696
   PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161
   Pozzobon M, 2010, CELL TRANSPLANT, V19, P1247, DOI 10.3727/096368910X505864
   Radisic M, 2013, MAYO CLIN PROC, V88, P884, DOI 10.1016/j.mayocp.2013.05.003
   Rane A. A., 2012, THESIS
   Rane AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021571
   Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0
   Roche ET, 2014, BIOMATERIALS, V35, P6850, DOI 10.1016/j.biomaterials.2014.04.114
   Roul G, 1998, AM HEART J, V136, P449, DOI 10.1016/S0002-8703(98)70219-4
   Ruvinov E, 2011, J CARDIOVASC TRANSL, V4, P559, DOI 10.1007/s12265-011-9288-9
   Ruvinov E, 2011, BIOMATERIALS, V32, P565, DOI 10.1016/j.biomaterials.2010.08.097
   Sabbah HN, 2009, CIRCULATION, V120, pS912
   Sanina C, 2015, CIRC RES, V117, P229, DOI 10.1161/CIRCRESAHA.117.306306
   Seif-Naraghi SB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005503
   Serpooshan V, 2013, BIOMATERIALS, V34, P9048, DOI 10.1016/j.biomaterials.2013.08.017
   Shafy A., 2012, EUR J CARDIO-THORAC, V4, P1211
   Shah MR, 2001, AM J CARDIOL, V88, P987, DOI 10.1016/S0002-9149(01)01975-0
   Sherman Warren, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS57, DOI 10.1038/ncpcardio0446
   Shore S., 2015, JACC-HEART FAIL, V11, P906
   Simpson D, 2007, STEM CELLS, V25, P2350, DOI 10.1634/stemcells.2007-0132
   Sinescu Crina, 2010, J Med Life, V3, P421
   Singelyn JM, 2012, J AM COLL CARDIOL, V59, P751, DOI 10.1016/j.jacc.2011.10.888
   Singelyn JM, 2011, MACROMOL BIOSCI, V11, P731, DOI 10.1002/mabi.201000423
   Singelyn JM, 2010, J CARDIOVASC TRANSL, V3, P478, DOI 10.1007/s12265-010-9202-x
   Spearman BS, 2015, ACTA BIOMATER, V28, P109, DOI 10.1016/j.actbio.2015.09.025
   Swank A. M., 2012, CIRC-HEART FAIL, V111
   Takehara N, 2008, J AM COLL CARDIOL, V52, P1858, DOI 10.1016/j.jacc.2008.06.052
   Templin C, 2011, INT J DEV BIOL, V55, P407, DOI 10.1387/ijdb.103219ct
   Thompson RB, 2004, ANN THORAC SURG, V78, P303, DOI 10.1016/S0003-4975(03)01215-3
   THOMPSON WD, 1992, J PATHOL, V168, P47, DOI 10.1002/path.1711680109
   Toh WS, 2014, MAT SCI ENG C-MATER, V45, P690, DOI 10.1016/j.msec.2014.04.026
   Tous E, 2011, BIOMACROMOLECULES, V12, P4127, DOI 10.1021/bm201198x
   Traverse JH, 2012, J CARDIOVASC TRANSL, V5, P67, DOI 10.1007/s12265-011-9330-y
   Tsur-Gang O, 2009, BIOMATERIALS, V30, P189, DOI 10.1016/j.biomaterials.2008.09.018
   Uriel S., 2008, TISSUE ENG PART C-ME, V15, P309
   Varghese S, 2006, ADV POLYM SCI, P95, DOI 10.1007/12_072
   Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270
   Walters BD, 2014, ACTA BIOMATER, V10, P1488, DOI 10.1016/j.actbio.2013.08.038
   Wang HB, 2014, BIOMATERIALS, V35, P3986, DOI 10.1016/j.biomaterials.2014.01.021
   Wang T, 2009, ACTA BIOMATER, V5, P2939, DOI 10.1016/j.actbio.2009.04.040
   Wei J, 2009, BIOMATERIALS, V30, P1080, DOI 10.1016/j.biomaterials.2008.10.046
   Wenk JF, 2011, ANN THORAC SURG, V92, P935, DOI 10.1016/j.athoracsur.2011.04.089
   Wenk JF, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.4000165
   WHITE HD, 1987, CIRCULATION, V76, P44, DOI 10.1161/01.CIR.76.1.44
   Whyte W., 2015, TISSUE ENG A
   Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9
   Wong ND, 2014, NAT REV CARDIOL, V11, P276, DOI 10.1038/nrcardio.2014.26
   World Health Organization, 2014, GLOB HLTH EST DEATHS
   Yan YS, 2012, ACTA BIOMATER, V8, P2113, DOI 10.1016/j.actbio.2012.02.016
   Yancy CW, 2013, CIRCULATION, V128, P1810, DOI 10.1161/CIR.0b013e31829e8807
   Yoon SJ, 2009, J BIOMED MATER RES B, V91B, P163, DOI 10.1002/jbm.b.31386
   Yu JS, 2010, BIOMATERIALS, V31, P7012, DOI 10.1016/j.biomaterials.2010.05.078
   Yu JS, 2009, J THORAC CARDIOV SUR, V137, P180, DOI 10.1016/j.jtcvs.2008.08.036
   Yu J, 2009, BIOMATERIALS, V30, P751, DOI 10.1016/j.biomaterials.2008.09.059
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
NR 137
TC 17
Z9 17
U1 13
U2 103
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 0935-9648
EI 1521-4095
J9 ADV MATER
JI Adv. Mater.
PD JUL 20
PY 2016
VL 28
IS 27
SI SI
BP 5648
EP 5661
DI 10.1002/adma.201505349
PG 14
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA DR5WR
UT WOS:000379973600016
PM 26840955
DA 2018-10-20
ER

PT J
AU Naqvi, SM
   Vedicherla, S
   Gansau, J
   McIntyre, T
   Doherty, M
   Buckley, CT
AF Naqvi, Syeda M.
   Vedicherla, Srujana
   Gansau, Jennifer
   McIntyre, Tom
   Doherty, Michelle
   Buckley, Conor T.
TI Living Cell Factories - Electrosprayed Microcapsules and Microcarriers
   for Minimally Invasive Delivery
SO ADVANCED MATERIALS
LA English
DT Article
DE electrohydrodynamic; hydrogels; microcarriers; microcapsules; core-shell
ID MESENCHYMAL STEM-CELLS; MICROENCAPSULATED RECOMBINANT CELLS;
   ALGINATE-BASED MICROCAPSULES; SOMATIC GENE-THERAPY; IN-VIVO;
   HYPERTHERMIA APPLICATIONS; COAXIAL ELECTROSPRAY; HYDROGEL COMPOSITE;
   FIBRIN MICROBEADS; PANCREATIC-ISLETS
AB Minimally invasive delivery of living cell factories consisting of cells and therapeutic agents has gained wide attention for next generation biomaterial device systems for multiple applications including musculoskeletal tissue regeneration, diabetes and cancer. Cellular-based microcapsules and microcarrier systems offer several attractive features for this particular purpose. One such technology capable of generating these types of systems is electrohydrodynamic (EHD) spraying. Depending on various parameters, including applied voltage, biomaterial properties (viscosity, conductivity) and needle geometry, complex structures and arrangements can be fabricated for therapeutic strategies. The advances in the use of EHD technology are outlined, specifically in the manipulation of bioactive and dynamic material systems to control size, composition and configuration in the development of minimally invasive micro-scaled biopolymeric systems. The exciting therapeutic applications of this technology, future perspectives and associated challenges are also presented.
C1 [Naqvi, Syeda M.; Vedicherla, Srujana; Gansau, Jennifer; McIntyre, Tom; Doherty, Michelle; Buckley, Conor T.] Trinity Coll Dublin, Trinity Ctr Bioengn, Trinity Biomed Sci Inst, Dublin, Ireland.
   [Naqvi, Syeda M.; Gansau, Jennifer; Buckley, Conor T.] Trinity Coll Dublin, Dept Mech Engn, Sch Engn, Dublin, Ireland.
   [Vedicherla, Srujana; McIntyre, Tom] Trinity Coll Dublin, Sch Med, Dublin, Ireland.
RP Buckley, CT (reprint author), Trinity Coll Dublin, Trinity Ctr Bioengn, Trinity Biomed Sci Inst, Dublin, Ireland.; Buckley, CT (reprint author), Trinity Coll Dublin, Dept Mech Engn, Sch Engn, Dublin, Ireland.
EM conor.buckley@tcd.ie
OI Buckley, Conor/0000-0001-7452-4534
FU Graduate Research Education Programme in Engineering (GREP-Eng), PRTLI
   Cycle 5; European Regional Development Fund; Irish Research Council
   Government of Ireland [202860/13027]; Irish Research Council (IRC)
   [202860, 13027]; Trinity College Dublin MSc in Bioengineering programme;
   Trinity College Dublin Research Capacity Building Grant- Pathfinder
FX S.M.N. and S.V. contributed equally to this work. S.M.N. was supported
   by the Graduate Research Education Programme in Engineering (GREP-Eng),
   PRTLI Cycle 5 funded programme. PRTLI is 50% co-funded under the
   European Regional Development Fund. J.G. was supported by the Irish
   Research Council Government of Ireland Postgraduate Scholarship, Grant
   No: 202860/13027 Irish Research Council (IRC) Project 202860, Award
   13027, S.V. and T.M. were supported through the Trinity College Dublin
   MSc in Bioengineering programme and Trinity College Dublin Research
   Capacity Building Grant- Pathfinder. The authors would like to thank
   Servier Medical Art (www.servier.com) for their image bank used to
   produce Figure 1.
CR Aguado BA, 2012, TISSUE ENG PT A, V18, P806, DOI [10.1089/ten.tea.2011.0391, 10.1089/ten.TEA.2011.0391]
   Aimin C., 1999, CLIN ORTHOP RELAT R, V239, P239
   ALHENDY A, 1995, HUM GENE THER, V6, P165, DOI 10.1089/hum.1995.6.2-165
   Andreu N, 2012, SMALL, V8, P2495, DOI 10.1002/smll.201200138
   Ang KL, 2007, MAT SCI ENG C-BIO S, V27, P347, DOI 10.1016/j.msec.2006.05.027
   Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Bae Y, 2005, BIOCONJUGATE CHEM, V16, P122, DOI 10.1021/bc0498166
   Barnett BP, 2007, NAT MED, V13, P986, DOI 10.1038/nm1581
   Bartolovic K, 2010, ANALYST, V135, P157, DOI 10.1039/b917813a
   Barzegari A, 2012, BIOIMPACTS, V2, P23, DOI 10.5681/bi.2012.003
   Bertolo A, 2012, EUR SPINE J S6, V21, P826
   Bertolo A, 2015, TISSUE ENG PT A, V21, P2618, DOI [10.1089/ten.tea.2015.0029, 10.1089/ten.TEA.2015.0029]
   Bidarra SJ, 2014, ACTA BIOMATER, V10, P1646, DOI 10.1016/j.actbio.2013.12.006
   BISCEGLIE V., 1933, ZEITSCHR KREBSFORSCH, V40, P122
   Bock N, 2010, ACTA BIOMATER, V6, P786, DOI 10.1016/j.actbio.2009.09.017
   Braghirolli DI, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4819747
   Buranapanitkit B, 2004, CLIN ORTHOP RELAT R, P244, DOI 10.1097/01.blo.0000130268.27024.c1
   Cen L, 2008, PEDIATR RES, V63, P492, DOI 10.1203/PDR.0b013e31816c5bc3
   Chan BP, 2007, BIOMATERIALS, V28, P4652, DOI 10.1016/j.biomaterials.2007.07.041
   Chen AKL, 2011, STEM CELL RES, V7, P97, DOI 10.1016/j.scr.2011.04.007
   Chen ZW, 2011, J MICROENCAPSUL, V28, P344, DOI 10.3109/02652048.2011.569764
   Cheng DX, 2008, J BIOMED MATER RES A, V87A, P321, DOI 10.1002/jbm.a.31716
   Chun KW, 2004, BIOTECHNOL PROGR, V20, P1797, DOI 10.1021/bp0496981
   ClaraSanz N. s., 2013, BIOMATERIALS STEM CE, P386
   Dawson E, 2008, ADV DRUG DELIVER REV, V60, P215, DOI 10.1016/j.addr.2007.08.037
   DeVos P, 1996, TRANSPLANTATION, V62, P893, DOI 10.1097/00007890-199610150-00004
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Eftat S, 2008, ADV DRUG DELIVER REV, V60, P114, DOI 10.1016/j.addr.2007.08.033
   Enayati M, 2011, INT J PHARMACEUT, V404, P110, DOI 10.1016/j.ijpharm.2010.11.014
   Farook U, 2009, J R SOC INTERFACE, V6, P271, DOI 10.1098/rsif.2008.0225
   Feng J, 2014, J BIOMATER APPL, V29, P93, DOI 10.1177/0885328213515734
   Gasperini L, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0817
   Gholap S., 2010, INT J PHARM SCI REV, V1, P015
   Goepfert C, 2010, INT J ARTIF ORGANS, V33, P204
   Goosen MFA, 1999, ANN NY ACAD SCI, V875, P84, DOI 10.1111/j.1749-6632.1999.tb08496.x
   Gorodetsky R, 2011, TISSUE ENG PART C-ME, V17, P745, DOI [10.1089/ten.tec.2010.0644, 10.1089/ten.TEC.2010.0644]
   Guo GP, 2015, ULTRASONICS, V58, P43, DOI 10.1016/j.ultras.2014.12.001
   Hernandez RM, 2010, ADV DRUG DELIVER REV, V62, P711, DOI 10.1016/j.addr.2010.02.004
   Hong Y, 2008, J BIOMED MATER RES A, V85A, P628, DOI 10.1002/jbm.a.31603
   Huang CYC, 2004, ANAT REC PART A, V278A, P428, DOI 10.1002/ar.a.20010
   Huang XB, 2012, J BIOSCI BIOENG, V114, P1, DOI 10.1016/j.jbiosc.2012.02.024
   Hunkeler D, 2004, FOCUS BIOTECHNOL, V8A, P389
   Jaworek A, 2007, POWDER TECHNOL, V176, P18, DOI 10.1016/j.powtec.2007.01.035
   Jayasinghe SN, 2007, J MICROENCAPSUL, V24, P430, DOI 10.1080/02652040701369590
   Jayasinghe SN, 2006, SMALL, V2, P216, DOI [10.1002/smll.200500291, 10.1002/sm11.200500291]
   Jayasinghe SN, 2011, ANALYST, V136, P878, DOI 10.1039/c0an00830c
   Joly P, 2009, BIOMICROFLUIDICS, V3, DOI 10.1063/1.3267044
   Kaya M, 2014, ANN BOT-LONDON, V114, P1319, DOI 10.1093/aob/mcu150
   Kelly DJ, 2010, BIRTH DEFECTS RES C, V90, P75, DOI 10.1002/bdrc.20173
   Krall SM, 1998, J AGR FOOD CHEM, V46, P1311, DOI 10.1021/jf970473y
   Lafrance ML, 1999, TISSUE ENG, V5, P153, DOI 10.1089/ten.1999.5.153
   Lao LL, 2004, J MATER SCI-MATER M, V15, P1061, DOI 10.1023/B:JMSM.0000046386.78633.e5
   Lee KY, 2000, NATURE, V408, P998
   Leung A, 2010, BIOCHEM ENG J, V48, P337, DOI 10.1016/j.bej.2009.10.007
   Li BG, 2002, CRYOLETTERS, V23, P47
   Li BY, 2015, J ORTHOP TRANSL, V3, P51, DOI 10.1016/j.jot.2015.02.003
   Liaudanskaya V, 2015, TISSUE ENG PART C-ME, V21, P631, DOI [10.1089/ten.tec.2014.0228, 10.1089/ten.TEC.2014.0228]
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   Loscertales IG, 2002, SCIENCE, V295, P1695, DOI 10.1126/science.1067595
   Ma ML, 2013, ADV HEALTHC MATER, V2, P667, DOI 10.1002/adhm.201200341
   Malda J, 2006, TRENDS BIOTECHNOL, V24, P299, DOI 10.1016/j.tibtech.2006.04.009
   Mao JS, 2004, BIOMATERIALS, V25, P3973, DOI 10.1016/j.biomaterials.2003.10.080
   Martin Y, 2011, TISSUE ENG PART B-RE, V17, P71, DOI 10.1089/ten.TEB.2010.0559
   Massoud TF, 2008, AM J NEURORADIOL, V29, P229, DOI 10.3174/ajnr.A0864
   Mercier NR, 2005, BIOMATERIALS, V26, P1945, DOI 10.1016/j.biomaterials.2004.06.030
   Meyer DE, 2001, J CONTROL RELEASE, V74, P213, DOI 10.1016/S0168-3659(01)00319-4
   Moghadam H, 2010, J APPL POLYM SCI, V118, P1288, DOI 10.1002/app.32302
   Munarin F, 2011, BIOMACROMOLECULES, V12, P568, DOI 10.1021/bm101110x
   Murua A, 2008, J CONTROL RELEASE, V132, P76, DOI 10.1016/j.jconrel.2008.08.010
   Nam JH, 2007, BIOTECHNOL PROGR, V23, P652, DOI 10.1021/bp070007l
   Orive G, 2004, TRENDS BIOTECHNOL, V22, P87, DOI 10.1016/j.tibtech.2003.11.004
   Orive G, 2002, TRENDS BIOTECHNOL, V20, P382, DOI 10.1016/S0167-7799(02)02037-1
   Orive G, 2003, NAT MED, V9, P104, DOI 10.1038/nm0103-104
   OSHEA GM, 1984, BIOCHIM BIOPHYS ACTA, V804, P133, DOI 10.1016/0167-4889(84)90107-1
   Paletta J R J, 2011, Eur Cell Mater, V21, P384
   Patel AS, 2012, INTEGR BIOL-UK, V4, P628, DOI 10.1039/c2ib20033c
   Patel P, 2008, SOFT MATTER, V4, P1219, DOI 10.1039/b718866h
   Perez RA, 2013, J TISSUE ENG REGEN M, V7, P353, DOI 10.1002/term.530
   Pinkse GGM, 2006, DIABETES, V55, P312, DOI 10.2337/diabetes.55.02.06.db04-0195
   Qiu QQ, 2001, IN VITRO CELL DEV-AN, V37, P157
   Rang A, 2014, BIOMATERIALS, V35, P2651, DOI 10.1016/j.biomaterials.2013.12.073
   Ross CJD, 2000, HUM GENE THER, V11, P2117, DOI 10.1089/104303400750001426
   Ross CJD, 2000, EXP NEUROL, V166, P276, DOI 10.1006/exnr.2000.7531
   Sahoo S, 2010, BIOTECHNOL BIOENG, V106, P690, DOI 10.1002/bit.22734
   Sakai D, 2006, BIOMATERIALS, V27, P335, DOI 10.1016/j.biomaterials.2005.06.038
   Sakai S, 2006, J BIOMED MATER RES A, V78A, P394, DOI 10.1002/jbm.a.30676
   Sapir Y, 2012, BIOMATERIALS, V33, P4100, DOI 10.1016/j.biomaterials.2012.02.037
   Schneider S, 2005, DIABETES, V54, P687, DOI 10.2337/diabetes.54.3.687
   Shikani AH, 2004, AM J RHINOL, V18, P105, DOI 10.1177/194589240401800207
   Soon-Shiong P, 1999, ADV DRUG DELIVER REV, V35, P259, DOI 10.1016/S0169-409X(98)00076-3
   Souza GR, 2010, NAT NANOTECHNOL, V5, P291, DOI 10.1038/nnano.2010.23
   Stoyanov JV, 2011, EUR CELLS MATER, V21, P533, DOI 10.22203/eCM.v021a40
   Sugiura S, 2005, BIOMATERIALS, V26, P3327, DOI 10.1016/j.biomaterials.2004.08.029
   SUN AM, 1984, APPL BIOCHEM BIOTECH, V10, P87, DOI 10.1007/BF02783739
   Tam SK, 2006, BIOMATERIALS, V27, P1296, DOI 10.1016/j.biomaterials.2005.08.027
   Tampieri A, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/1/015104
   Thirumala Sreedhar, 2013, Cells, V2, P460, DOI 10.3390/cells2030460
   Uludag H, 2000, ADV DRUG DELIVER REV, V42, P29, DOI 10.1016/S0169-409X(00)00053-3
   Van Raamsdonk JM, 2002, J LAB CLIN MED, V139, P35, DOI 10.1067/mlc.2002.120649
   Wang Y, 2013, J MICROENCAPSUL, V30, P490, DOI 10.3109/02652048.2012.752537
   WONG H, 1991, BIOMAT ARTIF CELL IM, V19, P675, DOI 10.3109/10731199109117846
   Workman VL, 2014, ADV FUNCT MATER, V24, P2648, DOI 10.1002/adfm.201303891
   Xie JW, 2008, J COLLOID INTERF SCI, V317, P469, DOI 10.1016/j.jcis.2007.09.082
   YAMADA KM, 1991, J BIOL CHEM, V266, P12809
   Yunmin Ma, 2015, Open Biomed Eng J, V9, P133, DOI 10.2174/1874120701509010133
   Zhang YG, 2005, CLIN ORTHOP RELAT R, P219, DOI 10.1097/01.blo.0000146534.31120.cf
   Zhao ST, 2014, INTEGR BIOL-UK, V6, P874, DOI 10.1039/c4ib00100a
   Zhou DB, 1997, TRANSPLANTATION, V64, P1112, DOI 10.1097/00007890-199710270-00005
   Zhou Y, 2005, J BIOTECHNOL, V117, P99, DOI 10.1016/j.biotec.2004.11.004
NR 109
TC 11
Z9 11
U1 12
U2 84
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 0935-9648
EI 1521-4095
J9 ADV MATER
JI Adv. Mater.
PD JUL 20
PY 2016
VL 28
IS 27
SI SI
BP 5662
EP 5671
DI 10.1002/adma.201503598
PG 10
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA DR5WR
UT WOS:000379973600017
PM 26695531
DA 2018-10-20
ER

PT J
AU Lin, SH
   Fujitsuka, M
   Majima, T
AF Lin, Shih-Hsun
   Fujitsuka, Mamoru
   Majima, Tetsuro
TI Sequence-Dependent Photocurrent Generation through Long-Distance
   Excess-Electron Transfer in DNA
SO ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
LA English
DT Article
DE DNA; electrochemistry; electron transfer; photochemistry; thin films
ID REDOX POTENTIALS; HOLE TRANSPORT; GOLD ELECTRODE; MECHANISM; ARRAYS
AB Given its well-ordered continuous pi stacking of nucleobases, DNA has been considered as a biomaterial for charge transfer in biosensors. For cathodic photocurrent generation resulting from hole transfer in DNA, sensitivity to DNA structure and base-pair stacking has been confirmed. However, such information has not been provided for anodic photocurrent generation resulting from excess-electron transfer in DNA. In the present study, we measured the anodic photocurrent of a DNA-modified Au electrode. Our results demonstrate long-distance excess-electron transfer in DNA, which is dominated by a hopping mechanism, and the photocurrent generation is sequence dependent.
C1 [Lin, Shih-Hsun; Fujitsuka, Mamoru; Majima, Tetsuro] Osaka Univ, Inst Sci & Ind Res SANKEN, Mihogaoka 8-1, Osaka 5670047, Japan.
RP Fujitsuka, M; Majima, T (reprint author), Osaka Univ, Inst Sci & Ind Res SANKEN, Mihogaoka 8-1, Osaka 5670047, Japan.
EM fuji@sanken.osaka-u.ac.jp; majima@sanken.osaka-u.ac.jp
FU Ministry of Education, Culture, Sports, Science and Technology (MEXT) of
   Japanese Government [25220806, 25288035]
FX We appreciate Dr. Tadao Takada of University of Hyogo for sharing his
   experiences on electrode modification. This work has been partly
   supported by the Grant-in-Aid for Scientific Research (Projects
   25220806, 25288035 and others) from the Ministry of Education, Culture,
   Sports, Science and Technology (MEXT) of Japanese Government.
CR Bhosale R, 2010, CHEM SOC REV, V39, P138, DOI 10.1039/b906115k
   CARELL T, 1995, ANGEW CHEM INT EDIT, V34, P2491, DOI 10.1002/anie.199524911
   Carell T., 1995, ANGEW CHEM, V107, P2697
   Cichon MK, 2002, J AM CHEM SOC, V124, P13984, DOI 10.1021/ja0277733
   Drummond TG, 2003, NAT BIOTECHNOL, V21, P1192, DOI 10.1038/nbt873
   ELEY DD, 1962, T FARADAY SOC, V58, P411, DOI 10.1039/tf9625800411
   Frischmann PD, 2013, CHEM SOC REV, V42, P1847, DOI 10.1039/c2cs35223k
   Giese B, 2004, ANGEW CHEM INT EDIT, V43, P1848, DOI 10.1002/anie.200353264
   Giese B, 1999, ANGEW CHEM INT EDIT, V38, P996, DOI 10.1002/(SICI)1521-3773(19990401)38:7<996::AID-ANIE996>3.0.CO;2-4
   GIESE B, 2004, ANGEW CHEM, V116, P1884
   GIESE B, 1999, ANGEW CHEM, V111, P1050
   Grodick MA, 2015, BIOCHEMISTRY-US, V54, P962, DOI 10.1021/bi501520w
   Kanvah S, 2010, ACCOUNTS CHEM RES, V43, P280, DOI 10.1021/ar900175a
   Kelley SO, 1998, LANGMUIR, V14, P6781, DOI 10.1021/la980874n
   Lewis F. D., 2006, ANGEW CHEM, V118, P8150
   Lewis FD, 2006, ANGEW CHEM INT EDIT, V45, P7982, DOI 10.1002/anie.200603455
   Li GQ, 2015, J PHYS CHEM LETT, V6, P4889, DOI 10.1021/acs.jpclett.5b02154
   Lin SH, 2016, J PHYS CHEM B, V120, P660, DOI 10.1021/acs.jpcb.5b10857
   Lin SH, 2015, CHEM-EUR J, V21, P16190, DOI 10.1002/chem.201503115
   Lin SH, 2015, J PHYS CHEM B, V119, P7994, DOI 10.1021/acs.jpcb.5b03494
   Lin SH, 2014, J PHYS CHEM B, V118, P12186, DOI 10.1021/jp509691f
   Matsui T, 2015, J PHYS CHEM A, V119, P369, DOI 10.1021/jp508308y
   Nakamura M, 2015, CHEM-EUR J, V21, P11788, DOI 10.1002/chem.201501955
   Okamoto A, 2004, J AM CHEM SOC, V126, P14732, DOI 10.1021/ja0449067
   Palecek E, 2012, CHEM REV, V112, P3427, DOI 10.1021/cr200303p
   Seidel CAM, 1996, J PHYS CHEM-US, V100, P5541, DOI 10.1021/jp951507c
   Steel AB, 1998, ANAL CHEM, V70, P4670, DOI 10.1021/ac980037q
   Takada T., 2007, ANGEW CHEM, V119, P6801
   Takada T, 2007, ANGEW CHEM INT EDIT, V46, P6681, DOI 10.1002/anie.200701525
   Tanabe K, 2006, J AM CHEM SOC, V128, P692, DOI 10.1021/ja0568244
   Turbiez M, 2003, J ORG CHEM, V68, P5357, DOI 10.1021/jo0345493
   Wallace SS, 2002, FREE RADICAL BIO MED, V33, P1, DOI 10.1016/S0891-5849(02)00827-4
   Willner I, 2001, ANGEW CHEM INT EDIT, V40, P1861
   Willner I., 2001, ANGEW CHEM, V113, P1913
   Zhan XW, 2011, ADV MATER, V23, P268, DOI 10.1002/adma.201001402
   Zhao WW, 2014, CHEM REV, V114, P7421, DOI 10.1021/cr500100j
NR 36
TC 3
Z9 3
U1 3
U2 21
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1433-7851
EI 1521-3773
J9 ANGEW CHEM INT EDIT
JI Angew. Chem.-Int. Edit.
PD JUL 18
PY 2016
VL 55
IS 30
BP 8715
EP 8717
DI 10.1002/anie.201602850
PG 3
WC Chemistry, Multidisciplinary
SC Chemistry
GA DV9IG
UT WOS:000383253500042
PM 27243800
DA 2018-10-20
ER

PT J
AU Polley, N
   Sarkar, PK
   Chakrabarti, S
   Lemmens, P
   Pal, SK
AF Polley, Nabarun
   Sarkar, Probir Kumar
   Chakrabarti, Subhananda
   Lemmens, Peter
   Pal, Samir Kumar
TI DNA Biomaterial Based Fiber Optic Sensor: Characterization and
   Application for Monitoring in situ Mercury Pollution
SO CHEMISTRYSELECT
LA English
DT Article
DE DNA based Nanomaterials; Nano-sensor; Fiber optic sensor; SPR-sensor;
   NSET-sensor
ID CHEMICAL SENSORS; SILVER NANOPARTICLES; SELECTIVE DETECTION;
   FLUORESCENT; BIOSENSORS; COMPLEX; IONS; FRET; DAPI
AB In recent years considerable efforts have been devoted to utilize DNA based biomaterials for efficient sensor design. The polymeric molecule has high aqueous solubility, thus design of any water based sensor with DNA without rigorous chemical treatment (modification for covalent bonding) is challenging. In the present work we have developed a novel silver-nanoparticle (Ag-NPs) impregnated genomic DNA-lipid (CTAB) complex, which is completely insoluble in water and forms excellent thin film on optical fiber tips. The intact structural as well as functional integrity of the genomic DNA in the thin film is found to be a key factor for its specific affinity to mercury ions in aqueous environments. We have demonstrated that a dip-coated optical fiber tip can work as a fluorescence sensor in addition to a surface plasmon resonance (SPR) type absorption sensor due to nano surface energy transfer (NSET) between the DNA minor-groove binding dye 4', 6-diamidino-2-phenylindole (DAPI) and Ag-NPs. Nanomolar, specific detection of mercury ions with few seconds reaction time is found in this versatile and economic way revealing clearly the advantageous aspects of our work.
C1 [Polley, Nabarun; Sarkar, Probir Kumar; Pal, Samir Kumar] SN Bose Natl Ctr Basic Sci, Dept Chem Biol & Macromol Sci, Block JD,Sect 3, Kolkata 700106, India.
   [Chakrabarti, Subhananda] Indian Inst Technol, Dept Elect Engn, Bombay 400076, Maharashtra, India.
   [Lemmens, Peter] TU Braunschweig, Inst Condensed Matter Phys, Mendelssohnsstr 3, D-38106 Braunschweig, Germany.
RP Pal, SK (reprint author), SN Bose Natl Ctr Basic Sci, Dept Chem Biol & Macromol Sci, Block JD,Sect 3, Kolkata 700106, India.
EM skpal@bose.res.in
FU DST, India; UGC, India under the UGC-RGNF scheme; DST, India
   [DST/TM/SERI/2k11/103, SB/S1/PC-011/2013]; NTH- School "Contacts in
   Nanosystems: Interactions, Control and Quantum Dynamics"; Braunschweig
   International Graduate School of Metrology (IGSM); Metrology for Complex
   Nanosystems [DFG-RTG1952/1]
FX N.P thanks DST, India for Inspire Research Fellowship and P.K.S thanks
   UGC, India for providing fellowship under the UGC-RGNF scheme. We thank
   DST, India for financial grants (DST/TM/SERI/2k11/103,
   SB/S1/PC-011/2013), NTH- School "Contacts in Nanosystems: Interactions,
   Control and Quantum Dynamics", the Braunschweig International Graduate
   School of Metrology (IGSM), and DFG-RTG1952/1, Metrology for Complex
   Nanosystems.
CR Banerjee D, 2008, J PHYS CHEM B, V112, P1016, DOI 10.1021/jp077090f
   Bhavsar K., 2013, J PHYS C SER, V450
   Chaudhuri S, 2015, J PHYS CHEM A, V119, P4162, DOI 10.1021/acs.jpca.5b03021
   Chen GQ, 2015, ANALYST, V140, P5400, DOI 10.1039/c5an00389j
   Crosby JS, 2013, SENSOR ACTUAT B-CHEM, V181, P938, DOI 10.1016/j.snb.2013.02.037
   Deng L, 2013, ANAL CHEM, V85, P8594, DOI 10.1021/ac401408m
   Flores CY, 2010, J COLLOID INTERF SCI, V350, P402, DOI 10.1016/j.jcis.2010.06.052
   KAPUSCINSKI J, 1995, BIOTECH HISTOCHEM, V70, P220, DOI 10.3109/10520299509108199
   Long F, 2011, BIOSENS BIOELECTRON, V26, P4018, DOI 10.1016/j.bios.2011.03.022
   Muhammed MAH, 2008, J PHYS CHEM C, V112, P14324, DOI 10.1021/jp804597r
   Niziol J., 2014, TRANSP OPT NETW ICTO, P1
   Ono A, 2004, ANGEW CHEM INT EDIT, V43, P4300, DOI 10.1002/anie.200454172
   Polley N, 2015, SENSOR ACTUAT B-CHEM, V210, P381, DOI 10.1016/j.snb.2014.12.129
   Pospisilova M, 2015, SENSORS-BASEL, V15, P25208, DOI 10.3390/s151025208
   Ramesh GV, 2011, ACS APPL MATER INTER, V3, P988, DOI 10.1021/am200023w
   Reddy MSP, 2014, OPT EXPRESS, V22, P908, DOI 10.1364/OE.22.000908
   Sarkar PK, 2016, ACS SENSORS, V1, P789, DOI 10.1021/acssensors.6b00153
   Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406
   Sergachev I, 2013, ANALYST, V138, P4066, DOI 10.1039/c3an00248a
   Sergeyev VG, 1999, J AM CHEM SOC, V121, P1780, DOI 10.1021/ja981683+
   Shemer G, 2006, J AM CHEM SOC, V128, P11006, DOI 10.1021/ja0637021
   Shinar J, 2004, ORGANIC LIGHT EMITTI, P1
   Steckl AJ, 2007, NAT PHOTONICS, V1, P3, DOI 10.1038/nphoton.2006.56
   Sui ZM, 2006, PHYSICA E, V33, P308, DOI 10.1016/j.physe.2006.03.151
   Tanaka K, 1996, J AM CHEM SOC, V118, P10679, DOI 10.1021/ja9617855
   Verma R, 2013, ANALYST, V138, P7254, DOI 10.1039/c3an01098h
   Wang XD, 2016, ANAL CHEM, V88, P203, DOI 10.1021/acs.analchem.5b04298
   Wang XD, 2013, ANAL CHEM, V85, P487, DOI 10.1021/ac303159b
   Watson SMD, 2014, NANOSCALE, V6, P4027, DOI 10.1039/c3nr06767j
   Watson SMD, 2013, NANOSCALE, V5, P5349, DOI 10.1039/c3nr00716b
   Wolfbeis OS, 2008, ANAL CHEM, V80, P4269, DOI 10.1021/ac800473b
   Yaney PP, 2005, P SOC PHOTO-OPT INS, V5724, P224, DOI 10.1117/12.593914
   Yin MJ, 2012, ANAL METHODS-UK, V4, P1292, DOI 10.1039/c2ay05791c
   Zhang XB, 2002, ANAL CHEM, V74, P821, DOI 10.1021/ac0109218
NR 34
TC 4
Z9 4
U1 5
U2 15
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 2365-6549
J9 CHEMISTRYSELECT
JI ChemistrySelect
PD JUL 16
PY 2016
VL 1
IS 11
BP 2916
EP 2922
DI 10.1002/slct.201600391
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA EM6KE
UT WOS:000395420600050
DA 2018-10-20
ER

PT J
AU Koppes, AN
   Keating, KW
   McGregor, AL
   Koppes, RA
   Kearns, KR
   Ziemba, AM
   McKay, CA
   Zuidema, JM
   Rivet, CJ
   Gilbert, RJ
   Thompson, DM
AF Koppes, A. N.
   Keating, K. W.
   McGregor, A. L.
   Koppes, R. A.
   Kearns, K. R.
   Ziemba, A. M.
   McKay, C. A.
   Zuidema, J. M.
   Rivet, C. J.
   Gilbert, R. J.
   Thompson, D. M.
TI Robust neurite extension following exogenous electrical stimulation
   within single walled carbon nanotube-composite hydrogels
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Nerve regeneration; Nerve tissue engineering; Nanomaterial; Electrical
   stimulation; SWCNT; Neuron
ID TISSUE ENGINEERING APPLICATIONS; NEURAL STEM-CELLS; CONDUCTING POLYMER;
   NERVE REGENERATION; IN-VITRO; THERMOSENSITIVE HYDROGEL;
   MECHANICAL-PROPERTIES; EXTRACELLULAR-MATRIX; AXON REGENERATION; VOLTAGE
   GRADIENTS
AB The use of exogenous electrical stimulation to promote nerve regeneration has achieved only limited success. Conditions impeding optimized outgrowth may arise from inadequate stimulus presentation due to differences in injury geometry or signal attenuation. Implantation of an electrically-conductive biomaterial may mitigate this attenuation and provide a more reproducible signal. In this study, a conductive nanofiller (single-walled carbon nanotubes [SWCNT]) was selected as one possible material to manipulate the bulk electrical properties of a collagen type I-10% Matrigel (TM) composite hydrogel. Neurite outgrowth within hydrogels (SWCNT or nanofiller-free controls) was characterized to determine if: (1) nanofillers influence neurite extension and (2) electrical stimulation of the nanofiller composite hydrogel enhances neurite outgrowth. Increased SWCNT loading (10-100 mu g/mL) resulted in greater bulk conductivity (up to 1.7-fold) with no significant changes to elastic modulus. Neurite outgrowth increased 3.3 fold in 20 mu g/mL SWCNT loaded biomaterials relative to the nanofiller-free control. Electrical stimulation promoted greater outgrowth (2.9-fold) within SWCNT-free control. The concurrent presentation of electrical stimulation and SWCNT-loaded biomaterials resulted in a 7.0-fold increase in outgrowth relative to the unstimulated, nanofiller-free controls. Local glia residing within the DRG likely contribute, in part, to the observed increases in outgrowth; but it is unknown which specific nanofiller properties influence neurite extension. Characterization of neuronal behavior in model systems, such as those described here, will aid the rational development of biomaterials as well as the appropriate delivery of electrical stimuli to support nerve repair.
   Statement of Significance
   Novel biomedical devices delivering electrical stimulation are being developed to mitigate symptoms of Parkinson's, treat drug-resistant depression, control movement or enhance verve regeneration. Carbon nanotubes and other novel materials are being explored for novel nano-neuro devices based on their unique properties. Neuronal growth on carbon nanotubes has been studied in 2D since the early 2000s demonstrating increased outgrowth, synapse formation and network activity. In this work, single walled carbon nanotubes were selected as one possible electrically-conductive material, dispersed within a 3D hydrogel containing primary neurons; extending previous 2D work to 3D to evaluate outgrowth within nanomaterial composites with electrical stimulation. This is the first study to our knowledge that stimulates neurons in 3D composite nanomaterial-laden hydrogels. Examination of electrically conductive biomaterials may serve to promote regrowth following injury or in long term stimulation. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Thompson, D. M.] Rensselaer Polytech Inst, Dept Biomed Engn, 110 8th St, Troy, NY 12180 USA.
   Ctr Biotechnol & Interdisciplinary Studies, Troy, NY USA.
   [Koppes, A. N.; Koppes, R. A.] Northeastern Univ, Chem Engn, Boston, MA USA.
   [McGregor, A. L.] Cornell Univ, Biomed Engn, Ithaca, NY USA.
   [Zuidema, J. M.] Univ Calif San Diego, Chem & Biochem, San Diego, CA USA.
RP Thompson, DM (reprint author), Rensselaer Polytech Inst, Dept Biomed Engn, 110 8th St, Troy, NY 12180 USA.
EM a.koppes@neu.edu; kevinwkeating@gmail.com; alm58@cornell.edu;
   r.koppes@neu.edu; kearnk2@rpi.edu; ziemba@rpi.edu; mcka0078@gmail.com;
   jzuidema@ucsd.edu; chrisjrivet@gmail.com; gilber2@rpi.edu;
   thompd4@rpi.edu
OI Koppes, Abigail/0000-0003-0433-9290; Zuidema,
   Jonathan/0000-0003-2258-0045; Kearns, Kathryn/0000-0001-9939-4836;
   Ziemba, Alexis M/0000-0001-8947-9617
FU NIH [1R01EB013281]; NSF Award [DMR-0642573]
FX The authors thank funding from the NIH RO1# 1R01EB013281 (DMT) and NSF
   Award # DMR-0642573 (ANK). The authors also thank members of the
   Thompson and Gilbert Lab groups for their support and insight into this
   project. This work was completed in the Center for Biotechnology and
   Interdisciplinary Studies.
CR Abrams GA, 2000, CELL TISSUE RES, V299, P39, DOI 10.1007/s004410050004
   Ahadian S, 2016, ACTA BIOMATER, V31, P134, DOI 10.1016/j.actbio.2015.11.047
   Ahadian S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04271
   Al-Majed AA, 2000, EUR J NEUROSCI, V12, P4381, DOI 10.1046/j.1460-9568.2000.01341.x
   Al-Majed AA, 2000, J NEUROSCI, V20, P2602
   Alpatova AL, 2010, WATER RES, V44, P505, DOI 10.1016/j.watres.2009.09.042
   ARD MD, 1987, J NEUROCYTOL, V16, P539, DOI 10.1007/BF01668507
   Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1
   Behan BL, 2011, J BIOMED MATER RES A, V96A, P46, DOI 10.1002/jbm.a.32939
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Borgens RB, 1999, J NEUROTRAUM, V16, P639, DOI 10.1089/neu.1999.16.639
   Brushart TM, 2005, EXP NEUROL, V194, P221, DOI 10.1016/j.expneuro.2005.02.007
   BUNGE MB, 1989, DEV NEUROSCI-BASEL, V11, P348, DOI 10.1159/000111911
   Byrne EM, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.045502
   Cellot G, 2009, NAT NANOTECHNOL, V4, P126, DOI [10.1038/NNANO.2008.374, 10.1038/nnano.2008.374]
   Chen MC, 2013, ACTA BIOMATER, V9, P5562, DOI 10.1016/j.actbio.2012.10.024
   CORK RJ, 1994, J NEUROBIOL, V25, P1509, DOI 10.1002/neu.480251204
   Cormie P, 2007, NEUROSCI LETT, V411, P128, DOI 10.1016/j.neulet.2006.10.030
   Cregg J. M., 2009, TISSUE ENG PART C-ME, V16, P167
   DAVENPORT RW, 1993, J NEUROBIOL, V24, P89, DOI 10.1002/neu.480240108
   Dewitt DD, 2009, TISSUE ENG PT A, V15, P2785, DOI [10.1089/ten.tea.2008.0406, 10.1089/ten.TEA.2008.0406]
   Fabbro A, 2012, ACS NANO, V6, P2041, DOI 10.1021/nn203519r
   Fukushima T, 2006, SMALL, V2, P554, DOI 10.1002/smll.200500404
   Galvan-Garcia P, 2007, J BIOMAT SCI-POLYM E, V18, P1245, DOI 10.1163/156856207782177891
   Ghasemi-Mobarakeh L, 2011, J TISSUE ENG REGEN M, V5, pE17, DOI 10.1002/term.383
   Gordon T, 2008, NEUROL RES, V30, P1012, DOI 10.1179/174313208X362488
   Gordon T, 2010, EXP NEUROL, V223, P192, DOI 10.1016/j.expneurol.2009.09.020
   Green AA, 2011, ACS NANO, V5, P1459, DOI 10.1021/nn103263b
   Guarino V, 2013, ADV HEALTHC MATER, V2, P218, DOI 10.1002/adhm.201200152
   Harrison BS, 2007, BIOMATERIALS, V28, P344, DOI 10.1016/j.biomaterials.2006.07.044
   HINKLE L, 1981, J PHYSIOL-LONDON, V314, P121, DOI 10.1113/jphysiol.1981.sp013695
   HOTARY KB, 1994, DEV BIOL, V166, P789, DOI 10.1006/dbio.1994.1357
   HOTARY KB, 1990, DEV BIOL, V140, P149, DOI 10.1016/0012-1606(90)90062-N
   Huang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039526
   Huang JH, 2010, GLIA, V58, P622, DOI 10.1002/glia.20951
   Huang YJ, 2012, SMALL, V8, P2869, DOI 10.1002/smll.201200715
   Hwang JY, 2013, NANOSCALE, V5, P487, DOI 10.1039/c2nr31581e
   JAFFE LF, 1979, J EXP ZOOL, V209, P115, DOI 10.1002/jez.1402090114
   Jiang FX, 2008, ANN BIOMED ENG, V36, P1565, DOI 10.1007/s10439-008-9530-z
   Koppes AN, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/4/046002
   Koppes AN, 2014, TISSUE ENG PT A, V20, P494, DOI 10.1089/ten.TEA.2013.0012
   Koppes AN, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046023
   Leach JB, 2007, J NEURAL ENG, V4, P26, DOI 10.1088/1741-2560/4/2/003
   Lee JY, 2009, BIOMATERIALS, V30, P4325, DOI 10.1016/j.biomaterials.2009.04.042
   Li X, 2014, BIOMATERIALS, V35, P5679, DOI 10.1016/j.biomaterials.2014.03.067
   Lovat V, 2005, NANO LETT, V5, P1107, DOI 10.1021/nl050637m
   MacDonald RA, 2008, ACTA BIOMATER, V4, P1583, DOI 10.1016/j.actbio.2008.07.005
   Man AJ, 2011, TISSUE ENG PT A, V17, P2931, DOI 10.1089/ten.tea.2011.0030
   Marchesan S., 2016, NANO TODAY
   Marchesan S, 2015, MATER TODAY, V18, DOI 10.1016/j.mattod.2014.07.009
   Martinelli V, 2012, NANO LETT, V12, P1831, DOI 10.1021/nl204064s
   MCCAIG CD, 1990, J CELL SCI, V95, P605
   MCCAIG CD, 1991, EXP PHYSIOL, V76, P473, DOI 10.1113/expphysiol.1991.sp003514
   McGinnis M E, 1986, Prog Clin Biol Res, V210, P231
   Menaa F., 2014, J TISSUE ENG REGENER
   METCALF MEM, 1994, J EXP ZOOL, V268, P323, DOI 10.1002/jez.1402680408
   Nygaard UC, 2009, TOXICOL SCI, V109, P113, DOI 10.1093/toxsci/kfp057
   Ogata S, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.165409
   Ostrakhovitch EA, 2012, ARCH BIOCHEM BIOPHYS, V528, P21, DOI 10.1016/j.abb.2012.08.006
   Pan LJ, 2012, J NEUROSCI RES, V90, P1335, DOI 10.1002/jnr.22809
   PATEL N, 1982, J NEUROSCI, V2, P483
   Patel S, 2007, NANO LETT, V7, P2122, DOI 10.1021/nl071182z
   Pok S, 2014, ACS NANO, V8, P9822, DOI 10.1021/nn503693h
   Poyato R, 2006, NANOTECHNOLOGY, V17, P1770, DOI 10.1088/0957-4484/17/6/038
   Prabhakaran MP, 2011, J BIOSCI BIOENG, V112, P501, DOI 10.1016/j.jbiosc.2011.07.010
   Qazi TH, 2014, ACTA BIOMATER, V10, P2434, DOI 10.1016/j.actbio.2014.02.023
   Qi FY, 2013, BIOMATERIALS, V34, P1799, DOI 10.1016/j.biomaterials.2012.11.042
   Rad A. Tahmasbi, 2014, J BIOMED MAT RES A
   Raja PMV, 2007, TOXICOL LETT, V169, P51, DOI 10.1016/j.toxlet.2006.12.003
   Rajnicek AM, 1998, DEV BIOL, V203, P412, DOI 10.1006/dbio.1998.9039
   RAJNICEK AM, 1992, EXP PHYSIOL, V77, P229, DOI 10.1113/expphysiol.1992.sp003580
   Ramon-Azcon J, 2013, ADV MATER, V25, P4028, DOI 10.1002/adma.201301300
   Richardson-Burns SM, 2007, J NEURAL ENG, V4, pL6, DOI 10.1088/1741-2560/4/2/L02
   Richardson-Burns SM, 2007, BIOMATERIALS, V28, P1539, DOI 10.1016/j.biomaterials.2006.11.026
   Robinson KR, 2008, DEV NEUROBIOL, V68, P274, DOI 10.1002/dneu.20570
   Saito N, 2014, CHEM REV, V114, P6040, DOI 10.1021/cr400341h
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Seggio AM, 2008, J NEUROSCI METH, V173, P67, DOI 10.1016/j.jneumeth.2008.05.017
   Shapiro S, 2005, J NEUROSURG-SPINE, V2, P3, DOI 10.3171/spi.2005.2.1.0003
   SHI RY, 1995, DEV DYNAM, V202, P101, DOI 10.1002/aja.1002020202
   Sinnott SB, 2001, CRIT REV SOLID STATE, V26, P145, DOI 10.1080/20014091104189
   Smart SK, 2009, PROTEIN SCI, V18, P1987, DOI 10.1002/pro.212
   Stout DA, 2011, ACTA BIOMATER, V7, P3101, DOI 10.1016/j.actbio.2011.04.028
   STUMP RF, 1983, J CELL BIOL, V97, P1226, DOI 10.1083/jcb.97.4.1226
   Sun S, 2004, TISSUE ENG, V10, P1558, DOI 10.1089/1076327042500265
   Sun S, 2006, BIOELECTROCHEMISTRY, V69, P133, DOI 10.1016/j.bioelechem.2005.11.007
   Sundararaghavan HG, 2009, BIOTECHNOL BIOENG, V102, P632, DOI 10.1002/bit.22074
   Thompson DM, 2014, ANNU REV BIOMED ENG, V16, P397, DOI 10.1146/annurev-bioeng-121813-120655
   Tosun Z, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/6/066002
   Voge CM, 2008, J BIOMED MATER RES A, V86A, P269, DOI 10.1002/jbm.a.32029
   Wood MD, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046003
   Zancanela DC, 2016, J MATER SCI-MATER M, V27, DOI 10.1007/s10856-016-5673-x
   Zhang HN, 2013, ACS NANO, V7, P7619, DOI 10.1021/nn402074y
   Zhang JQ, 2014, ADV HEALTHC MATER, V3, P412, DOI 10.1002/adhm.201300033
   Zhang YB, 2010, ACS NANO, V4, P3181, DOI 10.1021/nn1007176
   Zhou J, 2014, SCI REP-UK, V4, DOI 10.1038/srep03733
   Zhou MY, 2015, ADV FUNCT MATER, V25, P4730, DOI 10.1002/adfm.201501434
   Zhu BK, 2006, COMPOS SCI TECHNOL, V66, P548, DOI 10.1016/j.compscitech.2005.05.038
   Zuidema JM, 2014, J BIOMED MATER RES B, V102, P1063, DOI 10.1002/jbm.b.33088
NR 99
TC 19
Z9 19
U1 12
U2 110
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL 15
PY 2016
VL 39
BP 34
EP 43
DI 10.1016/j.actbio.2016.05.014
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DQ1NA
UT WOS:000378966500004
PM 27167609
OA Green Accepted, Other Gold
DA 2018-10-20
ER

PT J
AU Wu, JB
   Zheng, ZZ
   Li, G
   Kaplan, DL
   Wang, XQ
AF Wu, Jianbing
   Zheng, Zhaozhu
   Li, Gang
   Kaplan, David L.
   Wang, Xiaoqin
TI Control of silk microsphere formation using polyethylene glycol (PEG)
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Silk; Polyethylene glycol (PEG); Microspheres; Quantum dots (QDs)
ID IN-VITRO; FIBROIN MICROSPHERES; BIODEGRADABLE MICROSPHERES; PROTEIN
   DELIVERY; DRUG-DELIVERY; QUANTUM DOTS; SCAFFOLDS; FILMS; RELEASE; SYSTEM
AB A one step, rapid method to prepare silk microspheres was developed, with particle size controlled by the addition of polyethylene glycol (PEG). PEG molecular weight (4.0 K-20.0 KDa) and concentration (20-50 wt%), as well as silk concentration (5-20 wt%), were key factors that determined particle sizes varying in a range of 1-100 mu m. Addition of methanol to the PEG-silk combinations increased the content of crystalline 13-sheet in the silk microspheres. To track the distribution and degradation of silk micro spheres in vivo, 3-mercaptopropionic acid (MPA)-coated CdTe quantum dots (QDs) were physically entrapped in the silk microspheres. QDs tightly bound to the 13-sheet domains of silk via hydrophobic interactions, with over 96% of the loaded QDs remaining in the silk microspheres after exhaustive extraction. The fluorescence of QDs-incorporated silk microspheres less stable in cell culture medium than in phosphate buffer solution (PBS) and water. After subcutaneous injection in mice, microspheres prepared from 20% silk (approx. 30 mu m diameter particles) still fluoresced at 24 h, while those prepared from 8% silk (approx. 4 mu m diameter particles) and free QDs were not detectable, reflecting the QDs quenching and particle size effect on microsphere clearance in vivo. The larger microspheres were more resistant to cell internalization and degradation. Since PEG is an FDA-approved polymer, and silk is FDA approved for some medical devices, the methods developed in the present study will be useful in a variety of biomedical applications where simple, rapid and scalable preparation of silk microspheres is required.
   Statement of Significance
   The work is of significance to the biomaterial and controlled release society because it provides a new option for fabricating silk microspheres in one simple step of mixing silk and polyethylene glycol (PEG), with the size and properties of microspheres controllable by PEG molecular weight as well as PEG and silk concentrations. Although fabrication of silk microspheres have been reported previously using spray-drying, liposome-templating, polyvinyl alcohol (PVA) emulsification, etc., applications were hindered due to harsh conditions (temperature, solvents, etc.) and complicated procedures used as well as low yield and less controllable particle size (usually <10 mu m). Since PEG is an FDA-approved polymer, and silk is FDA approved for some medical devices, the methods developed in the present study will be useful in a variety of biomedical applications where simple, rapid and scalable preparation of silk micro spheres is required. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Wu, Jianbing; Zheng, Zhaozhu; Li, Gang; Wang, Xiaoqin] Soochow Univ, Natl Engn Lab Modem Silk, Suzhou 215123, Peoples R China.
   [Kaplan, David L.] Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.; Wang, XQ (reprint author), 199 Renai Rd,Suzhou Ind Pk, Suzhou, Jiangsu, Peoples R China.
EM david.kaplan@tufts.edu; wangxiaoqin@suda.edu.cn
FU Natural Science Foundation of China [51273138, 81271696]; Nature Science
   Foundation of Jiangsu Province [BK 20150371]; Natural Science Foundation
   of Suzhou City Jiangsu Province China [SYN201403]; Start-up Fund of
   Soochow University [14317432]; US NIH [P41 EB002520]; AFOSR
FX The study was financially supported by the Natural Science Foundation of
   China grant (project no. 51273138 and 81271696), the Nature Science
   Foundation of Jiangsu Province (Grant No BK 20150371) and the Natural
   Science Foundation of Suzhou City Jiangsu Province China (Grants No
   SYN201403), Start-up Fund of Soochow University (project no. 14317432),
   and the US NIH P41 EB002520 and the AFOSR.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Baimark Y, 2010, J APPL POLYM SCI, V118, P1127, DOI 10.1002/app.32506
   Ballou B, 2004, BIOCONJUGATE CHEM, V15, P79, DOI 10.1021/bc034153y
   Berkland C, 2002, J CONTROL RELEASE, V82, P137, DOI 10.1016/S0168-3659(02)00136-0
   Brigger I, 2002, ADV DRUG DELIVER REV, V54, P631, DOI 10.1016/S0169-409X(02)00044-3
   Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013
   Cao ZB, 2007, SOFT MATTER, V3, P910, DOI 10.1039/b703139d
   Chiellini F, 2008, NANOMEDICINE-UK, V3, P367, DOI 10.2217/17435889.3.3.367
   Dang JM, 2006, ADV DRUG DELIVER REV, V58, P487, DOI 10.1016/j.addr.2006.03.001
   Freiberg S, 2004, INT J PHARM, V282, P1, DOI 10.1016/j.ijpharm.2004.04.013
   George M, 2006, J CONTROL RELEASE, V114, P1, DOI 10.1016/j.jconrel.2006.04.017
   Herrero V. R., 2014, PROG REIN EYE RES, V42, P27
   Hino T, 2003, J COLLOID INTERF SCI, V266, P68, DOI 10.1016/S0021-9797(03)00584-8
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   Kaniyankandy S, 2010, PHYS CHEM CHEM PHYS, V12, P4210, DOI 10.1039/b921130f
   Kazazi-Hyseni K., 2015, INT J PHARMACEUT, V482, P99
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Lammel A, 2011, BIOMATERIALS, V32, P2233, DOI 10.1016/j.biomaterials.2010.11.060
   Lammel AS, 2010, BIOMATERIALS, V31, P4583, DOI 10.1016/j.biomaterials.2010.02.024
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Lu Q, 2010, ACTA BIOMATER, V6, P1380, DOI 10.1016/j.actbio.2009.10.041
   Lu SZ, 2007, KEY ENG MATER, V342-343, P233, DOI 10.4028/www.scientific.net/KEM.342-343.233
   Lu SZ, 2010, BIOMACROMOLECULES, V11, P143, DOI 10.1021/bm900993n
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Mitropoulos AN, 2014, ADV MATER, V26, P1105, DOI 10.1002/adma.201304244
   Mundargi RC, 2008, J CONTROL RELEASE, V125, P193, DOI 10.1016/j.jconrel.2007.09.013
   Nathwani BB, 2009, IEEE T NANOBIOSCI, V8, P72, DOI 10.1109/TNB.2009.2017295
   Nicolete R, 2007, PROSTAG OTH LIPID M, V83, P121, DOI 10.1016/j.prostaglandins.2006.10.007
   Park JH, 2013, INT J PHARMACEUT, V441, P562, DOI 10.1016/j.ijpharm.2012.10.044
   PARK TG, 1994, J CONTROL RELEASE, V30, P161, DOI 10.1016/0168-3659(94)90263-1
   Pei YZ, 2015, ACTA BIOMATER, V13, P168, DOI 10.1016/j.actbio.2014.11.016
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Rossetti F., 2006, J CONTROL RELEASE, V111, P219
   Selmin F, 2014, POLYM ADVAN TECHNOL, V25, P532, DOI 10.1002/pat.3282
   Shi LB, 2014, BIOMATERIALS, V35, P1519, DOI 10.1016/j.biomaterials.2013.11.025
   Sinha VR, 2003, J CONTROL RELEASE, V90, P261, DOI 10.1016/S0168-3659(03)00194-9
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Tamada Y, 2005, BIOMACROMOLECULES, V6, P3100, DOI 10.1021/bm050431f
   Wang X, 2007, BIOMATERIALS, V28, P4161, DOI 10.1016/j.biomaterials.2007.05.036
   Wang XQ, 2007, J CONTROL RELEASE, V117, P360, DOI 10.1016/j.jconrel.2006.11.021
   Wang XQ, 2015, ACTA BIOMATER, V12, P51, DOI 10.1016/j.actbio.2014.10.027
   Wang XQ, 2010, BIOMATERIALS, V31, P1025, DOI 10.1016/j.biomaterials.2009.11.002
   Wen XG, 2011, INT J PHARMACEUT, V416, P195, DOI 10.1016/j.ijpharm.2011.06.041
   Wenk E, 2008, J CONTROL RELEASE, V132, P26, DOI 10.1016/j.jconrel.2008.08.005
   Working PK, 1997, ACS SYM SER, V680, P45
   Wu XT, 2015, FLUID PHASE EQUILIBR, V403, P36, DOI 10.1016/j.fluid.2015.05.047
   Yu WW, 2003, CHEM MATER, V15, P2854, DOI 10.1021/cm034081k
   Zandstra J, 2014, EUR CELLS MATER, V28, P335, DOI 10.22203/eCM.v028a23
   Zhang JE, 2012, P NATL ACAD SCI USA, V109, P11981, DOI 10.1073/pnas.1206210109
   Zheng ZZ, 2015, J MATER CHEM B, V3, P6509, DOI 10.1039/c5tb00326a
NR 53
TC 8
Z9 8
U1 7
U2 104
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL 15
PY 2016
VL 39
BP 156
EP 168
DI 10.1016/j.actbio.2016.05.019
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DQ1NA
UT WOS:000378966500015
PM 27181879
DA 2018-10-20
ER

PT J
AU Metoki, N
   Rosa, CMR
   Zanin, H
   Marciano, FR
   Eliaz, N
   Lobo, AO
AF Metoki, N.
   Rosa, C. M. R.
   Zanin, H.
   Marciano, F. R.
   Eliaz, N.
   Lobo, A. O.
TI Electrodeposition and biomineralization of nano-beta-tricalcium
   phosphate on graphenated carbon nanotubes
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE Reduced graphene oxide (rGO); Graphenated carbon nanotube (CNT); Calcium
   phosphate (CaP); Tricalcium phosphate (TCP); Biomineralization;
   Electrodeposition
ID SELF-ASSEMBLED MONOLAYERS; SURFACE FUNCTIONAL-GROUP; HYDROXYAPATITE
   COATINGS; IN-VITRO; ELECTROPHORETIC DEPOSITION; ELECTROCHEMICAL
   PROCESSES; MECHANICAL-PROPERTIES; OXIDE COMPOSITE; TITANIUM-ALLOY;
   IMPLANTS
AB Nano-calcium-phosphate (n-CaP) is an attractive, biocompatible material for increasing osteointegration. Among nanomaterials, functionalized carbon-based materials are emerging materials, which have excellent mechanical properties, biocompatibility and chemical stability. These properties may further enhance the n-CaP performance. It has been shown that stoichiometric n-CaP can be electrodeposited on graphene and carbon nanotubes (CNTs) by employing fast and low-cost electrodeposition techniques. Here, we present, for the first time, a crystalline, needle-like nano-beta-tricalcium phosphate (n-beta-TCP) electrodeposited on reduced graphene oxide (rGO) nanosheets. The rGO was grown on CNT, as a composite biomaterial, in a one-step process, followed by electrodeposition of n-CaP. The results show that, in acidic pH, needle-like crystals appear on the surface. It is speculated that the carboxyl (carboxylic acid)/carboxylate functional groups attached directly to the rGO are essential in accelerating OH- formation and deposition of needle-like n-CaP crystals. High-resolution scanning electron microscopy, transmission electron microscopy, energy dispersive X-ray spectroscopy, and X-ray diffraction elucidated homogeneous, highly crystalline, n-CaP (beta-tricalcium phosphate) crystals. This composite presented an excellent in vitro biomineralization after soaking in simulated body fluid. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Metoki, N.; Eliaz, N.] Tel Aviv Univ, Dept Mat Sci & Engn, IL-6997801 Tel Aviv, Israel.
   [Rosa, C. M. R.; Marciano, F. R.; Lobo, A. O.] Univ Vale Paraiba, Inst Res & Dev, Lab Biomed Nanotechnol Nanobio, Av Shishima Hifumi 2911, BR-12244000 Sao Jose Dos Campos, SP, Brazil.
   [Zanin, H.] Univ Vale Paraiba, Inst Res & Dev, Lab Energy Storage & Supply ES&S, Av Shishima Hifumi 2911, BR-12244000 Sao Jose Dos Campos, SP, Brazil.
RP Lobo, AO (reprint author), Univ Vale Paraiba, Inst Res & Dev, Lab Biomed Nanotechnol Nanobio, Av Shishima Hifumi 2911, BR-12244000 Sao Jose Dos Campos, SP, Brazil.
EM aolobo@pq.cnpq.br
RI Lobo, Anderson/B-2893-2011
OI Lobo, Anderson/0000-0002-2544-0438
FU Sao Paulo Research Foundation (FAPESP grant) [2011/17877-7,
   2011/20345-7, 2013/09684-0]; National Council for Scientific and
   Technological Development (CNPq grant) [474090/2013-2]; Brazilian
   Innovation Agency (FINEP grant) [011304280]; Coordination for the
   Improvement of Higher Education Personnel (CAPES grant)
   [88887.095044/2015-00]
FX The authors thank Sao Paulo Research Foundation (FAPESP grant:
   2011/17877-7, 2011/20345-7 and 2013/09684-0), National Council for
   Scientific and Technological Development (CNPq grant: 474090/2013-2),
   Brazilian Innovation Agency (FINEP grant: 011304280) and Coordination
   for the Improvement of Higher Education Personnel (CAPES grant:
   88887.095044/2015-00) for financial support.
CR Baradaran S, 2014, CARBON, V69, P32, DOI 10.1016/j.carbon.2013.11.054
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Chen X, 2004, ANGEW CHEM INT EDIT, V43, P6111, DOI 10.1002/anie.200460620
   Compton OC, 2011, ACS NANO, V5, P4380, DOI 10.1021/nn1030725
   Dorozhkin SV, 2009, MATERIALS, V2, P1975, DOI 10.3390/ma2041975
   Eliaz N, 2005, SURF ENG, V21, P238, DOI 10.1179/174329405X50091
   Eliaz N, 2008, CRYST GROWTH DES, V8, P3965, DOI 10.1021/cg800016h
   Eliaz N, 2007, J BIOMED MATER RES A, V80A, P621, DOI 10.1002/jbm.a.30944
   Eliaz N, 2011, J MATER SCI-MATER M, V22, P1741, DOI 10.1007/s10856-011-4355-y
   Eliaz N, 2009, ACTA BIOMATER, V5, P3178, DOI 10.1016/j.actbio.2009.04.005
   Eliaz N, 2008, ISR J CHEM, V48, P159, DOI 10.1560/IJC.48.3-4.159
   Eliaz N, 2009, J BIOMED MATER RES A, V89A, P270, DOI 10.1002/jbm.a.32129
   Ferrari AC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187401
   Ferrari AC, 2004, PHILOS T ROY SOC A, V362, P2269, DOI 10.1098/rsta.2004.1453
   Kale S, 2000, NAT BIOTECHNOL, V18, P954
   Kang X, 2016, J APPL POLYM SCI, V133
   Lakstein D, 2009, ACTA BIOMATER, V5, P2258, DOI 10.1016/j.actbio.2009.01.033
   Lee JH, 2015, NANOSCALE, V7, P11642, DOI 10.1039/c5nr01580d
   Li M, 2014, CARBON, V67, P185, DOI 10.1016/j.carbon.2013.09.080
   Li M, 2013, APPL SURF SCI, V284, P804, DOI 10.1016/j.apsusc.2013.08.012
   Liao S, 2007, MATER LETT, V61, P3624, DOI 10.1016/j.matlet.2006.12.007
   Liu DP, 2006, J BIOMED MATER RES A, V77A, P763, DOI 10.1002/jbm.a.30641
   Lobo AO, 2010, LANGMUIR, V26, P18308, DOI 10.1021/la1034646
   Lobo AO, 2013, J MATER SCI-MATER M, V24, P1723, DOI 10.1007/s10856-013-4929-y
   Majewski PJ, 2006, MAT SCI ENG A-STRUCT, V420, P13, DOI 10.1016/j.msea.2006.01.022
   Metoki N, 2014, MATER LETT, V119, P24, DOI 10.1016/j.matlet.2013.12.091
   Metoki N, 2014, LANGMUIR, V30, P6791, DOI 10.1021/la404829b
   Mukherjee S, 2014, CERAM INT, V40, P5635, DOI 10.1016/j.ceramint.2013.10.158
   Nair M, 2015, NANOTECHNOLOGY, V26, DOI 10.1088/0957-4484/26/16/161001
   Santos C, 2015, APPL SURF SCI, V345, P387, DOI 10.1016/j.apsusc.2015.03.182
   Shen JF, 2012, CARBON, V50, P2134, DOI 10.1016/j.carbon.2012.01.019
   Siqueira IAWB, 2015, ACS APPL MATER INTER, V7, P9385, DOI 10.1021/acsami.5b01066
   Siqueira IAWB, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5450-2
   Sridhar TM, 2002, CORROS REV, V20, P255
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Tanahashi M, 1997, J BIOMED MATER RES, V34, P305
   Wang H, 2006, BIOMATERIALS, V27, P4192, DOI 10.1016/j.biomaterials.2006.03.034
   Wang H, 2011, MATER LETT, V65, P2455, DOI 10.1016/j.matlet.2011.05.016
   Xiong GY, 2015, MATER CHARACT, V107, P419, DOI 10.1016/j.matchar.2015.07.016
   Yu W, 2015, CERAM INT, V41, P10600, DOI 10.1016/j.ceramint.2015.04.159
   Zanin H, 2015, NANOSCALE, V7, P10218, DOI 10.1039/c4nr07317g
   Zanin H, 2015, APPL SURF SCI, V324, P174, DOI 10.1016/j.apsusc.2014.10.102
   Zhang LL, 2015, CERAM INT, V41, P4930, DOI 10.1016/j.ceramint.2014.12.055
   Zhang XS, 2015, J MECH BEHAV BIOMED, V42, P267, DOI 10.1016/j.jmbbm.2014.11.027
   Zhou K, 2015, CERAM INT, V41, P14029, DOI 10.1016/j.ceramint.2015.07.016
NR 45
TC 4
Z9 4
U1 5
U2 50
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD JUL 15
PY 2016
VL 297
BP 51
EP 57
DI 10.1016/j.surfcoat.2016.04.035
PG 7
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA DO5JS
UT WOS:000377820000007
DA 2018-10-20
ER

PT J
AU Higuita, LP
   Vargas, AF
   Gil, MJ
   Giraldo, LF
AF Higuita, Lina P.
   Vargas, Andres F.
   Gil, Miriam J.
   Giraldo, Luis F.
TI Synthesis and characterization of nanocomposite based on hydroxyapatite
   and monetite
SO MATERIALS LETTERS
LA English
DT Article
DE Biomaterial; Hydroxyapatite; Polyurethane; Composite
ID ENERGY
AB A mixture of hydroxyapatite (HAp) and monetite (DCPA) was synthesized under conditions of precipitation without pH adjustment by varying the ripening time of 0, 32, 76 and 144 h, followed by a hydrothermal process. The prepared samples were characterized by different techniques. It was concluded that the crystallinity and the morphology of the nanoparticles was dependent on the ripening time, hydroxyapatite crystalline phase and needle-like morphology was favored by higher ripening times. Subsequently the sample with a maturation period of 144 hours was incorporated in a polyurethane matrix, and it was observed that nanoparticles increased the dispersive component of the surface free energy of the composite. (c) 2016 Elsevier B.V. All rights reserved.
C1 [Higuita, Lina P.; Vargas, Andres F.; Gil, Miriam J.] Inst Technol, Dept Ciencias Basicas, Grp Quim Basica Aplicada & Ambiente, Metropolitano, Medellin, Colombia.
   [Higuita, Lina P.; Giraldo, Luis F.] Univ Antioquia, Inst Quim, Lab Invest Polimeros, Medellin 1226, Colombia.
RP Higuita, LP (reprint author), Calle 73 76A 354 Medellin, Antioquia, Colombia.
EM lphg08@gmail.com
OI Vargas, Andres Felipe/0000-0001-8743-1687
FU COLCIENCIAS (Colombia); Institute Tecnologico Metropolitano
FX The authors are grateful to COLCIENCIAS (Colombia) and Institute
   Tecnologico Metropolitano for support.
CR Awaja F, 2009, PROG POLYM SCI, V34, P948, DOI 10.1016/j.progpolymsci.2009.04.007
   Cai YB, 2007, J MATER SCI, V42, P5785, DOI 10.1007/s10853-006-0634-2
   Dong ZH, 2009, APPL SURF SCI, V255, P6087, DOI 10.1016/j.apsusc.2009.01.083
   Dorozhkin SV, 2015, CERAM INT, V41, P13913, DOI 10.1016/j.ceramint.2015.08.004
   dos Santos EA, 2008, J MATER SCI-MATER M, V19, P2307, DOI 10.1007/s10856-007-3347-4
   Dulinska-Molak I, 2013, APPL SURF SCI, V270, P553, DOI 10.1016/j.apsusc.2013.01.085
   Estevez M, 2013, J NANOSCI NANOTECHNO, V13, P4446, DOI 10.1166/jnn.2013.7227
   Laschke M. W., 2010, ACTA BIOMATER, V6, P2020
   Li LM, 2015, MATER LETT, V149, P25, DOI 10.1016/j.matlet.2015.02.106
   Martin DJ, 1996, J APPL POLYM SCI, V62, P1377
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Sadat-Shojai M, 2013, ACTA BIOMATER, V9, P7591, DOI 10.1016/j.actbio.2013.04.012
   Sadat-Shojai M, 2012, J CRYST GROWTH, V361, P73, DOI 10.1016/j.jcrysgro.2012.09.010
   Saenz A., 1999, J MATER EDUC, V21, P267
   Wang WS, 2012, WOODH PUBL REV-MECH, P115
NR 15
TC 7
Z9 7
U1 2
U2 22
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD JUL 15
PY 2016
VL 175
BP 169
EP 172
DI 10.1016/j.matlet.2016.04.011
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA DL7WN
UT WOS:000375851200043
DA 2018-10-20
ER

PT J
AU Liu, HW
   Hu, LY
   Feng, WF
AF Liu, Hanwen
   Hu, Linyong
   Feng, Wenfeng
TI Microstructure characterization of the human frontal bone
SO MATERIALS LETTERS
LA English
DT Article
DE Transmission electron microscopy; Microstructure; Bone; Biomaterial
ID TRANSMISSION ELECTRON-MICROSCOPY; CRYSTALS; GROWTH
AB The frontal bone plays a vital role in supporting and protecting the delicate nervous tissue of the brain. Knowledge of microstructure of the frontal bone is of significant importance for craniocerebral and orthopedic operations. Here, through a combined study of X-ray diffraction (XRD) analysis, optical microscopy, scanning electron microscopy (SEM) and transmission electron microscopy (TEM), we systematically investigate the microstructure of human frontal bone from micrometer to atomic scale. It is found that the frontal bone is mainly composed of hydroxylapatite. At the micrometer scale, the frontal bone appears an obvious layered structure with alternately arranged compacted and loose layers. Down to nanometer scale, the frontal bone in principle consists of a bunch of single-crystalline hydroxylapatite whiskers with an average diameter of similar to 10 nm. (c) 2016 Elsevier B.V. All rights reserved.
C1 [Liu, Hanwen] GanZhou Municipal Hosp, Dept Neurosurg, 49 DaGong Rd, Ganzhou 341000, Jiangxi, Peoples R China.
   [Hu, Linyong] GanZhou Municipal Hosp, Dept Orthoped, 49 DaGong Rd, Ganzhou 341000, Jiangxi, Peoples R China.
   [Feng, Wenfeng] Southern Med Univ, Nanfang Hosp, Dept Neurosurg, Guangzhou 510515, Guangdong, Peoples R China.
RP Hu, LY (reprint author), GanZhou Municipal Hosp, Dept Orthoped, 49 DaGong Rd, Ganzhou 341000, Jiangxi, Peoples R China.; Feng, WF (reprint author), Southern Med Univ, Nanfang Hosp, Dept Neurosurg, Guangzhou 510515, Guangdong, Peoples R China.
EM hu_linyong@sohu.com; fengwf1967@163.com
CR Athreya S, 2014, AM J PHYS ANTHROPOL, V153, P69
   BAKER SL, 1946, BIOCHEM J, V40, P391, DOI 10.1042/bj0400391
   BOIVIN G, 1990, ACTA ORTHOP SCAND, V61, P170, DOI 10.3109/17453679009006514
   Canter HI, 2007, J CRANIOFAC SURG, V18, P1508, DOI 10.1097/scs.0b013e31814fb841
   Chang TK, 2011, THEOR APPL FRACT MEC, V56, P148, DOI 10.1016/j.tafmec.2011.11.003
   Chen CL, 2014, ANGEW CHEM INT EDIT, V53, P1543, DOI 10.1002/anie.201307689
   CUISINIER F, 1987, CALCIFIED TISSUE INT, V40, P332, DOI 10.1007/BF02556695
   DAZERT S, 1995, EUR ARCH OTO-RHINO-L, V252, P332
   DODDS RA, 1988, J CLIN PATHOL, V41, P465, DOI 10.1136/jcp.41.4.465
   Drew BR, 2006, LARYNGOSCOPE, V116, P370, DOI 10.1097/01.mlg.0000200581.70571.8a
   Faverani LP, 2015, J CRANIOFAC SURG, V26, pE229, DOI 10.1097/SCS.0000000000001493
   Gordon LM, 2011, NATURE, V469, P194, DOI 10.1038/nature09686
   Gressey B.A., 2003, MINERAL MAG, V67, P1171
   Machida A, 2014, CONGENIT ANOM, V54, P172, DOI 10.1111/cga.12053
   Nudelman F, 2010, NAT MATER, V9, P1004, DOI 10.1038/NMAT2875
   Schwarcz HP, 2014, J STRUCT BIOL, V188, P240, DOI 10.1016/j.jsb.2014.10.005
   Schwarcz HP, 2013, AM J PHYS ANTHROPOL, V150, P246
   YEN PKJ, 1981, J DENT RES, V60, P578
NR 18
TC 1
Z9 1
U1 2
U2 18
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD JUL 15
PY 2016
VL 175
BP 173
EP 176
DI 10.1016/j.matlet.2016.04.032
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA DL7WN
UT WOS:000375851200044
DA 2018-10-20
ER

PT J
AU Gonzalez-Torres, M
   Vargas-Munoz, S
   del Real, A
   Ruiz-Baltazar, AD
   Reyes-Cervantes, E
   Carreon-Castro, MD
   Rodriguez-Talavera, R
AF Gonzalez-Torres, Maykel
   Vargas-Munoz, Susana
   del Real, Alicia
   de Jesus Ruiz-Baltazar, Alvaro
   Reyes-Cervantes, Eric
   del Pilar Carreon-Castro, Ma
   Rodriguez-Talavera, Rogelio
TI Surface modification of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) by
   direct plasma-radiation-induced graft polymerization of
   N-hydroxyethyl-acrylamide
SO MATERIALS LETTERS
LA English
DT Article
DE poly(3-hydroxybutyrate-co-3-hydro-xyvalerate); Hydroxyethyl-acrylamide;
   Plasma; Graft polymerization
ID C-H; POLYHYDROXYALKANOATE; BIOPOLYMERS; DEGRADATION; SCAFFOLDS; FILMS
AB A new type of cell-carrier-scaffold based on the surface modification of poly(3-hydroxybutyrate-co-3hydroxyvalerate) by direct plasma-radiation-induced graft polymerization of N-hydroxyethyl-acrylamide was prepared. Parameters such as the membrane position for plasma treatment, delivering power and exposure time were varied. The yields over the film surfaces, chemical changes, morphology and roughness were surveyed. The results indicate that the tailoring is more favorable at 10 W for 10 minutes because at lower values, low degrees of grafting are obtained, whereas at higher values, there is an increase in the degradation of the film. It was found that the use of 30% v/v of HEAA/ethanol (etching agent) led to the formation of a coral-like structure with a greater average roughness than the pristine biomaterial. Hydrophilicity was slightly increased in the modified surface. (c) 2016 Elsevier B.V. All rights reserved.
C1 [Gonzalez-Torres, Maykel; del Pilar Carreon-Castro, Ma] Univ Nacl Autonoma Mexico, Inst Ciencias Nucl, Dept Quim Radiac & Radioquim, Mexico City 04510, DF, Mexico.
   [Vargas-Munoz, Susana; del Real, Alicia; de Jesus Ruiz-Baltazar, Alvaro; Rodriguez-Talavera, Rogelio] Univ Nacl Autonoma Mexico, Ctr Fis Aplicada & Tecnol Avanzada, Dept Ingn Mol Mat, Queretaro 76230, Mexico.
   [Reyes-Cervantes, Eric] Benemerita Univ Autonoma Puebla, Ctr Univ Vinculac & Transferencia Tecnol, Puebla 72000, Mexico.
RP Gonzalez-Torres, M (reprint author), Univ Nacl Autonoma Mexico, Inst Ciencias Nucl, Dept Quim Radiac & Radioquim, Mexico City 04510, DF, Mexico.
EM mikegcu@gmail.com
RI Rodriguez Talavera, Jose Rogelio/L-1709-2018; Ruiz-Baltazar, Alvaro de
   Jesus/O-1405-2017
OI Rodriguez Talavera, Jose Rogelio/0000-0002-7455-2276; VARGAS MUNOZ,
   SUSANA/0000-0001-9031-4182; Gonzalez Torres, Maykel/0000-0003-3899-4410;
   Ruiz-Baltazar, Alvaro de Jesus/0000-0003-1032-3279
FU DGAPA-CTIC /DGAPA-PAPIIT (Conacyt-Mexico) [IN116716]
FX This research was supported by DGAPA-CTIC /DGAPA-PAPIIT IN116716.
   (Conacyt-Mexico).
CR Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Torres MG, 2015, VIB SPECTROSC, V76, P55, DOI 10.1016/j.vibspec.2014.12.003
   Torres MG, 2015, RADIAT PHYS CHEM, V108, P87, DOI 10.1016/j.radphyschem.2014.12.001
   Guan DH, 2008, APPL SURF SCI, V255, P324, DOI 10.1016/j.apsusc.2008.06.093
   Hayati AN, 2011, MATER LETT, V65, P736, DOI 10.1016/j.matlet.2010.11.004
   Hazer DB, 2012, MAT SCI ENG C-MATER, V32, P637, DOI 10.1016/j.msec.2012.01.021
   Kasalkova NS, 2014, NUCL INSTRUM METH B, V332, P63, DOI 10.1016/j.nimb.2014.02.031
   Kasalkova NS, 2013, NUCL INSTRUM METH B, V307, P642, DOI 10.1016/j.nimb.2012.10.035
   Ke Y, 2014, POLYM DEGRAD STABIL, V105, P59, DOI 10.1016/j.polymdegradstab.2014.03.039
   Keen I, 2006, BIOMACROMOLECULES, V7, P427, DOI 10.1021/bm050497a
   Lao HK, 2007, BIOMACROMOLECULES, V8, P416, DOI 10.1021/bm0609700
   Luk JZ, 2011, POLYMER, V52, P3251, DOI 10.1016/j.polymer.2011.05.048
   Miguel O, 1999, J APPL POLYM SCI, V73, P455, DOI 10.1002/(SICI)1097-4628(19990725)73:4<455::AID-APP1>3.0.CO;2-Y
   Sato H, 2005, J MOL STRUCT, V744, P35, DOI 10.1016/j.molstruc.2004.10.069
   Siow KS, 2006, PLASMA PROCESS POLYM, V3, P392, DOI 10.1002/ppap.200600021
   SUTOR DJ, 1962, NATURE, V195, P68
   Wang YJ, 2007, MATER LETT, V61, P1071, DOI 10.1016/j.matlet.2006.06.042
   Zhang JQ, 2013, POLYM DEGRAD STABIL, V98, P1458, DOI 10.1016/j.polymdegradstab.2013.04.010
   Zinn M, 2001, ADV DRUG DELIVER REV, V53, P5, DOI 10.1016/S0169-409X(01)00218-6
NR 19
TC 2
Z9 2
U1 2
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD JUL 15
PY 2016
VL 175
BP 252
EP 257
DI 10.1016/j.matlet.2016.04.005
PG 6
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA DL7WN
UT WOS:000375851200064
DA 2018-10-20
ER

PT J
AU Palan, CB
   Koparkar, KA
   Bajaj, NS
   Omanwar, SK
AF Palan, C. B.
   Koparkar, K. A.
   Bajaj, N. S.
   Omanwar, S. K.
TI Synthesis and TL/OSL properties of CaSiO3:Ce biomaterial
SO MATERIALS LETTERS
LA English
DT Article
DE Biomaterials; Phosphors; Luminescence; Diffusion
ID LUMINESCENCE; PHOSPHOR; PHOTOLUMINESCENCE; NANOCRYSTALS; MULTICOLOR;
   DOSIMETRY; EU2+
AB The polycrystalline CaSiO3:xCe (x=0.001, 0.002, 0.005) biomaterials were prepared by using solid state diffusion (SSD) method. The structure of CaSiO3:Ce phosphor was confirmed by X-ray diffraction technique. Moreover, photoluminescence (PL), thermoluminescence (TL) and optically stimulated luminescence (OSL) properties were studied. The TL glow curves consist overlapping peaks in temperature range 40-450 degrees C. The peak shape method was adopted for the calculation of the kinetic parameters such as activation energy, frequency factor and shape factor. The OSL sensitivity of CaSiO3:Ce phosphor was 2.8 time than that of OSL sensitivity of Al2O3:C (BARC) phosphor. The minimum detectable dose (MDD) was found to be 43.6 mu Gy corresponding to 3 sigma background. (c) 2016 Elsevier B.V. All rights reserved.
C1 [Palan, C. B.; Koparkar, K. A.; Omanwar, S. K.] Sant Gadge Baba Amravati Univ, Dept Phys, Amravati, India.
   [Bajaj, N. S.] Toshniwal ACS Coll, Sengaon, Hingoli, India.
RP Palan, CB (reprint author), Sant Gadge Baba Amravati Univ, Dept Phys, Amravati, India.
EM chetanpalan27@yahoo.in
RI OMANWAR, SHREENIWAS/N-4490-2015
OI OMANWAR, SHREENIWAS/0000-0002-6750-1059
CR Annalakshmi O, 2012, RADIAT PROT DOSIM, V150, P127, DOI 10.1093/rpd/ncr379
   Cui ZG, 2011, J ALLOY COMPD, V509, P3553, DOI 10.1016/j.jallcom.2010.12.058
   Gai MQ, 2013, J RARE EARTH, V31, P551, DOI 10.1016/S1002-0721(12)60318-4
   HESSE KF, 1984, Z KRISTALLOGR, V168, P93, DOI 10.1524/zkri.1984.168.1-4.93
   Jagadale PN, 2013, MATER SCI-POLAND, V31, P269, DOI 10.2478/s13536-012-0099-8
   Li FF, 2013, DALTON T, V42, P2015, DOI 10.1039/c2dt32295a
   Li FF, 2012, CHEM-EUR J, V18, P11641, DOI 10.1002/chem.201201309
   Palan C., 2016, J LUMIN
   Palan CB, 2016, MATER RES BULL, V76, P216, DOI 10.1016/j.materresbull.2015.12.027
   Palan CB, 2015, B MATER SCI, V38, P1527, DOI 10.1007/s12034-015-0964-2
   Palaspagar R., 2016, J MAT SCI MAT ELECT
   Tao Z., 2014, J SOLID STATE SCI TE, V3, pR71
   Yang LZ, 2008, MATER RES BULL, V43, P2538, DOI 10.1016/j.materresbull.2008.01.013
   Ye S, 2008, J ELECTROCHEM SOC, V155, pJ143, DOI 10.1149/1.2898875
   Zhou L, 2008, J PHYS CHEM SOLIDS, V69, P2877, DOI 10.1016/j.jpcs.2008.07.012
NR 15
TC 8
Z9 8
U1 3
U2 31
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD JUL 15
PY 2016
VL 175
BP 288
EP 290
DI 10.1016/j.matlet.2016.04.006
PG 3
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA DL7WN
UT WOS:000375851200072
DA 2018-10-20
ER

PT J
AU Wang, SH
   Zhang, YY
   Yang, MY
   Ye, LP
   Gong, L
   Qian, QJ
   Shuai, YJ
   You, ZY
   Chen, YY
   Zhong, BX
AF Wang, Shaohua
   Zhang, Yuyu
   Yang, Mingying
   Ye, Lupeng
   Gong, Lu
   Qian, Qiujie
   Shuai, Yajun
   You, Zhengying
   Chen, Yuyin
   Zhong, Boxiong
TI Characterization of Transgenic Silkworm Yielded Biomaterials with
   Calcium-Binding Activity
SO PLOS ONE
LA English
DT Article
ID BOMBYX-MORI SILK; RECOMBINANT PROTEINS; PIGGYBAC TRANSPOSON; FIBROIN;
   TRANSFORMATION; FIBRONECTIN; SCAFFOLDS; SEQUENCE; GLAND
AB Silk fibers have many inherent properties that are suitable for their use in biomaterials. In this study, the silk fibroin was genetically modified by including a Ca-binding sequence, [(AGSGAG)(6)ASEYDYDDDSDDDDEWD](2) from shell nacreous matrix protein. It can be produced as fibers by transgenic silkworm. The Ca-binding activity and mineralization of the transgenic silk fibroin were examined in vitro. The results showed that this transgenic silk fibroin had relatively higher Ca-binding activity than unmodified silk fibroin. The increased Ca-binding activity could promote the usage of silk fibroin as a biomaterial in the pharmaceutical industry. This study shows the possibility of using silk fibroin as a mineralization accelerating medical material by generating genetically modified transgenic silkworm.
C1 [Wang, Shaohua; Zhang, Yuyu; Yang, Mingying; Ye, Lupeng; Qian, Qiujie; Shuai, Yajun; You, Zhengying; Chen, Yuyin; Zhong, Boxiong] Zhejiang Univ, Coll Anim Sci, Hangzhou 310058, Zhejiang, Peoples R China.
   [Gong, Lu] Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.
RP Zhong, BX (reprint author), Zhejiang Univ, Coll Anim Sci, Hangzhou 310058, Zhejiang, Peoples R China.
EM bxzhong@zju.edu.cn
FU Zhejiang Provincial Science and Technology Plans [2012C12910]; National
   Basic Research Program of China [2012CB114601]
FX This work is supported by the Projects of Zhejiang Provincial Science
   and Technology Plans (No. 2012C12910), grants from the National Basic
   Research Program of China (No. 2012CB114601). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Asakura T, 2006, BIOMACROMOLECULES, V7, P1996, DOI 10.1021/bm060155k
   Inoue S, 2005, INSECT BIOCHEM MOLEC, V35, P51, DOI 10.1016/j.jibm.2004.10.002
   Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200
   Kawakami M, 2011, BIO-MED MATER ENG, V21, P53, DOI 10.3233/BME-2011-0656
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   Kong XD, 2004, J CRYST GROWTH, V270, P197, DOI 10.1016/j.jcrysgro.2004.06.007
   Lee WJ, 1996, P NATL ACAD SCI USA, V93, P7888, DOI 10.1073/pnas.93.15.7888
   Li Z, 2015, MOL BIOL REP, V42, P19, DOI 10.1007/s11033-014-3735-z
   Nagano A, 2011, ACTA BIOMATER, V7, P1192, DOI 10.1016/j.actbio.2010.10.032
   Shi P, 2014, INT J NANOMED, V9, P1617, DOI 10.2147/IJN.S53886
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Tamura T, 2000, NAT BIOTECHNOL, V18, P81
   Tanaka T, 2001, J THERM ANAL CALORIM, V64, P645, DOI 10.1023/A:1011575824042
   Teule F, 2012, P NATL ACAD SCI USA, V109, P923, DOI 10.1073/pnas.1109420109
   Tomita M, 2007, TRANSGENIC RES, V16, P449, DOI 10.1007/s11248-007-9087-x
   Wen HX, 2010, MOL BIOL REP, V37, P1815, DOI 10.1007/s11033-009-9615-2
   Xu HF, 2014, TRANSGENIC RES, V23, P697, DOI 10.1007/s11248-014-9826-8
   Yanagisawa S, 2007, BIOMACROMOLECULES, V8, P3487, DOI 10.1021/bm700646f
   Yang M, 2008, BIOMACROMOLECULES, V9, P416, DOI 10.1021/bm700665m
   Yang M, 2008, J BIOMED MATER RES A, V84A, P353, DOI 10.1002/jbm.a.31348
   Yang MY, 2012, INT J MOL SCI, V13, P7762, DOI 10.3390/ijms13067762
   Ye L, 2015, SCI REP, V5
   Zhong BX, 2007, ACTA BIOCH BIOPH SIN, V39, P117, DOI 10.1111/j.1745-7270.2007.00252.x
   Zhou ZH, 2008, J PROTEOME RES, V7, P5103, DOI 10.1021/pr800383r
NR 24
TC 0
Z9 2
U1 1
U2 16
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 14
PY 2016
VL 11
IS 7
AR e0159111
DI 10.1371/journal.pone.0159111
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DR0DZ
UT WOS:000379579500077
PM 27414647
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Roman, MJ
   Decker, EA
   Goddard, JM
AF Roman, Maxine J.
   Decker, Eric A.
   Goddard, Julie M.
TI Retaining Oxidative Stability of Emulsified Foods by Novel Nonmigratory
   Polyphenol Coated Active Packaging
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE biomaterial; catechol; catechin; metal chelator; free radical scavenger;
   lycopene degradation; lipid oxidation
ID IN-WATER EMULSIONS; CONTROLLING LIPID OXIDATION; LOW-DENSITY
   POLYETHYLENE; ANTIOXIDANT PROPERTY; BETA-CAROTENE; FERULIC ACID; IRON;
   FILMS; CHEMISTRY; LYCOPENE
AB Oxidation causes lipid rancidity, discoloration, and nutrient degradation that decrease shelf life of packaged foods. Synthetic additives are effective oxidation inhibitors, but are undesirable to consumers who prefer "clean" label products. The aim of this study was to improve oxidative stability of emulsified foods by a novel nonmigratory polyphenol coated active packaging. Polyphenol coatings were applied to chitosan functionalized polypropylene (PP) by laccase assisted polymerization of catechol and catechin. Polyphenol coated PP exhibited both metal chelating (39.3 +/- 2.5 nmol Fe3+ cm(-2), pH 4.0) and radical scavenging (up to 52.9 +/- 1.8 nmol Trolox eq cm(-2)) capacity, resulting in dual antioxidant functionality to inhibit lipid oxidation and lycopene degradation in emulsions. Nonmigratory polyphenol coated PP inhibited ferric iron promoted degradation better than soluble chelators, potentially by partitioning iron from the emulsion droplet interface. This work demonstrates that polyphenol coatings can be designed for advanced material chemistry solutions in active food packaging.
C1 [Roman, Maxine J.; Decker, Eric A.; Goddard, Julie M.] Univ Massachusetts, Dept Food Sci, 102 Holdsworth Way, Amherst, MA 01003 USA.
   [Decker, Eric A.] King Abdulaziz Univ, Dept Biochem, Bioact Nat Prod Res Grp, Fac Sci, POB 80203, Jeddah 21589, Saudi Arabia.
   [Goddard, Julie M.] Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA.
RP Goddard, JM (reprint author), Univ Massachusetts, Dept Food Sci, 102 Holdsworth Way, Amherst, MA 01003 USA.; Goddard, JM (reprint author), Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA.
EM goddard@cornell.edu
OI Goddard, Julie/0000-0002-3644-0732
FU Peter Salmon Graduate Fellowship (Dept. of Food Science, UMass Amherst);
   Northeast Alliance for Graduate Education and the Professoriate
   Fellowship; Agriculture and Food Research Initiative Grant from the USDA
   National Institute of Food and Agriculture, Improved Processing
   Technologies [2012-67017-30157, A1351]
FX M.J.R. would like to acknowledge the Peter Salmon Graduate Fellowship
   (Dept. of Food Science, UMass Amherst) and Northeast Alliance for
   Graduate Education and the Professoriate Fellowship for their support.
   This project was supported by Agriculture and Food Research Initiative
   Grant No. 2012-67017-30157 from the USDA National Institute of Food and
   Agriculture, Improved Processing Technologies (A1351).
CR Aljawish A, 2014, FOOD CHEM, V161, P279, DOI 10.1016/j.foodchem.2014.03.076
   Aljawish A, 2012, CARBOHYD POLYM, V87, P537, DOI 10.1016/j.carbpol.2011.08.016
   Andjelkovic M, 2006, FOOD CHEM, V98, P23, DOI 10.1016/j.foodchem.2005.05.044
   Apak R, 2016, J AGR FOOD CHEM, V64, P1028, DOI 10.1021/acs.jafc.5b04743
   Arrua D, 2010, J AGR FOOD CHEM, V58, P9228, DOI 10.1021/jf101651y
   Barish JA, 2011, J FOOD SCI, V76, pE586, DOI 10.1111/j.1750-3841.2011.02396.x
   Bastarrachea LJ, 2015, COATINGS, V5, P771, DOI 10.3390/coatings5040771
   Boon CS, 2008, J AGR FOOD CHEM, V56, P1408, DOI 10.1021/jf072929
   Boon CS, 2009, J AGR FOOD CHEM, V57, P2993, DOI 10.1021/jf803747j
   Bou R, 2011, EUR J LIPID SCI TECH, V113, P724, DOI 10.1002/ejlt.201000524
   CARRANO CJ, 1979, J AM CHEM SOC, V101, P5401, DOI 10.1021/ja00512a047
   Cheatham R., 2015, WELLNESS NEWSLETTER
   Decker EA, 1997, NUTR REV, V55, P396
   Dopico-Garcia MS, 2007, J AGR FOOD CHEM, V55, P3225, DOI 10.1021/jf070102+
   Elegir G, 2008, ENZYME MICROB TECH, V43, P84, DOI 10.1016/j.enzmictec.2007.10.003
   Farkas E, 1999, POLYHEDRON, V18, P2391, DOI 10.1016/S0277-5387(99)00144-8
   Fillat A, 2012, CARBOHYD POLYM, V87, P146, DOI 10.1016/j.carbpol.2011.07.030
   FRANKEL EN, 1991, J SCI FOOD AGR, V54, P495, DOI 10.1002/jsfa.2740540402
   Goddard JM, 2007, J FOOD SCI, V72, pE36, DOI 10.1111/j.1750-3841.2006.00203.x
   Gomez-Estaca J, 2014, TRENDS FOOD SCI TECH, V35, P42, DOI 10.1016/j.tifs.2013.10.008
   Hider RC, 2001, METHOD ENZYMOL, V335, P190
   HIDER RC, 1981, J CHEM SOC DALTON, P609, DOI 10.1039/dt9810000609
   Hu M, 2004, J AGR FOOD CHEM, V52, P5272, DOI 10.1021/jf049486j
   Jeon JR, 2013, J MATER CHEM B, V1, P6501, DOI 10.1039/c3tb21161d
   Johnson DR, 2015, J AGR FOOD CHEM, V63, P5055, DOI 10.1021/acs.jafc.5b00796
   Kiokias S, 2014, FOOD CHEM, V150, P280, DOI 10.1016/j.foodchem.2013.10.112
   Koontz J., 2016, OXIDATIVE STABILITY, P479
   Kurisawa M, 2003, MACROMOL BIOSCI, V3, P758, DOI 10.1002/mabi.200300038
   Lopez-Rubio A., 2008, Smart packaging technologies for fast moving consumer goods, P19, DOI 10.1002/9780470753699.ch2
   Lotito SB, 2000, BIOCHEM BIOPH RES CO, V276, P945, DOI 10.1006/bbrc.2000.3571
   Mahoney KW, 2013, J APPL POLYM SCI, V127, P1203, DOI 10.1002/app.37622
   Martell AE, 1974, CRITICAL STABILITY C, V1
   Muriel-Galet V, 2013, J AGR FOOD CHEM, V61, P6720, DOI 10.1021/jf401818u
   Nerin C, 2010, WOODHEAD PUBL FOOD S, P496, DOI 10.1533/9780857090331.3.496
   Nguyen ML, 1999, FOOD TECHNOL-CHICAGO, V53, P38
   Ogiwara Y, 2016, FOOD CHEM, V196, P842, DOI 10.1016/j.foodchem.2015.10.029
   Pei J., 2012, BIORESOURCES, V8, P515, DOI 10.15376/biores.8.1.515-529
   Perron NR, 2009, CELL BIOCHEM BIOPHYS, V53, P75, DOI 10.1007/s12013-009-9043-x
   ROBERTSON G. L., 2012, FOOD PACKAGING PRINC
   Roman M. J., 2015, Journal of Food Science, V80, P1965, DOI 10.1111/1750-3841.12972
   Roman MJ, 2016, COLLOID INTERFAC SCI, V13, P10, DOI 10.1016/j.colcom.2016.06.002
   Roman MJ, 2014, J FOOD PROTECT, V77, P1153, DOI 10.4315/0362-028X.JFP-13-545
   Roman MJ, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.39948
   SHANTHA NC, 1994, J AOAC INT, V77, P421
   Skerget M, 2005, FOOD CHEM, V89, P191, DOI 10.1016/j.foodchem.2004.02.025
   Tian F, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.41231
   Tian F, 2013, J AGR FOOD CHEM, V61, P12397, DOI 10.1021/jf4041832
   Tian F, 2013, FOOD FUNCT, V4, P669, DOI 10.1039/c3fo30360h
   Tian F, 2012, J AGR FOOD CHEM, V60, P7710, DOI 10.1021/jf302377b
   Tovar L, 2005, J AGR FOOD CHEM, V53, P5270, DOI 10.1021/jf050076k
   Upritchard HG, 2011, LANGMUIR, V27, P10587, DOI 10.1021/la202352j
   Waite JH, 2008, NAT MATER, V7, P8, DOI 10.1038/nmat2087
   Wong DE, 2013, J FOOD SCI, V78, pE853, DOI 10.1111/1750-3841.12134
   Woranuch S, 2013, CARBOHYD POLYM, V96, P495, DOI 10.1016/j.carbpol.2013.04.006
   Yu SH, 2015, FOOD HYDROCOLLOID, V44, P491, DOI 10.1016/j.foodhyd.2014.10.022
   Zulueta A, 2009, FOOD CHEM, V114, P310, DOI 10.1016/j.foodchem.2008.09.033
NR 56
TC 1
Z9 1
U1 4
U2 39
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
EI 1520-5118
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD JUL 13
PY 2016
VL 64
IS 27
BP 5574
EP 5582
DI 10.1021/acs.jafc.6b01933
PG 9
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
SC Agriculture; Chemistry; Food Science & Technology
GA DR3HM
UT WOS:000379794300017
PM 27310107
DA 2018-10-20
ER

PT J
AU Baran, T
   Inanan, T
   Mentes, A
AF Baran, Talat
   Inanan, Tulden
   Mentes, Ayfer
TI Synthesis, characterization, and catalytic activity in Suzuki coupling
   and catalase-like reactions of new chitosan supported Pd catalyst
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Biomaterial supported Pd catalyst; Suzuki coupling reaction; Redox
   potential; Microwave irradiation; Solvent-free
ID BASE MODIFIED CHITOSAN; THERMAL-PROPERTIES; METAL-COMPLEXES; HECK
   REACTION; SCHIFF-BASES; PALLADIUM; MICROWAVE; CU(II); WATER; CHITIN
AB The aim of this study is to analyze the synthesis of a new chitosan supported Pd catalyst and examination of its catalytic activity in:
   1. Suzuki coupling reactions by improving a simple, fast, and solvent-free microwave method.
   2. H2O2 decomposition reaction to find out its redox potential.
   Pd catalyst was synthesized using chitosan as a biomaterial and characterized with FTIR, TG/DTG, XRD, H-1 NMR, C-13 NMR, SEM-EDAX, ICP-OES, Uv-vis spectroscopies, and magnetic moment, along with molar conductivity analysis. Biomaterial supported Pd catalyst indicated high activity and long life time as well as excellent turnover number (TON) and turnover frequency (TOF) values in Suzuki reaction. Biomaterial supported Pd catalyst catalyzed H2O2 decomposition reaction with considerable high activity using comparatively small loading catalyst (10 mg). Redox potential of biomaterial supported Pd catalyst was still high without negligible loss (13% decrease) after 10 cycles in reusability tests. As a consequence, eco-friendly biomaterial supported Pd catalyst has superior properties such as high thermal stability, long life time, easy removal from reaction mixture and durability to air, moisture and high temperature. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Baran, Talat; Inanan, Tulden; Mentes, Ayfer] Aksaray Univ, Dept Chem, Fac Sci & Letters, TR-68100 Aksaray, Turkey.
RP Baran, T (reprint author), Aksaray Univ, Dept Chem, Fac Sci & Letters, TR-68100 Aksaray, Turkey.
EM talatbaran_66@hotmail.com; tkalburcu@gmail.com; ayfermentes@yahoo.com
RI University, Aksaray/A-1857-2018; Mentes, Ayfer/F-8710-2011; Science and
   Arts Faculty, Aksaray University/Q-7606-2016
OI MENTES, AYFER/0000-0003-3946-4075; BARAN, TALAT/0000-0003-0206-3841
FU Scientific and Technological Research Council of Turkey (TUBITAK)
   [113Z296]
FX We would like to thank the Scientific and Technological Research Council
   of Turkey (TUBITAK) (Project Number: 113Z296) for financial support.
CR Al-Nahary T.T., 2009, J SAUDI CHEM SOC, V13, P253
   Alonso DA, 2010, CHEM SOC REV, V39, P2891, DOI 10.1039/b821314n
   Anan NA, 2011, CARBOHYD RES, V346, P775, DOI 10.1016/j.carres.2011.01.014
   Antony R, 2013, J MOL STRUCT, V1050, P53, DOI 10.1016/j.molstruc.2013.07.006
   Antony R, 2013, SPECTROCHIM ACTA A, V103, P423, DOI 10.1016/j.saa.2012.09.101
   Baran T, 2015, J MOL CATAL A-CHEM, V407, P47, DOI 10.1016/j.molcata.2015.06.008
   Baran T, 2015, INT J BIOL MACROMOL, V79, P542, DOI 10.1016/j.ijbiomac.2015.05.021
   Baran T, 2015, INT J BIOL MACROMOL, V72, P94, DOI 10.1016/j.ijbiomac.2014.07.029
   Calo V, 2004, ORGANOMETALLICS, V23, P5154, DOI 10.1021/om049586e
   Clark JH, 1999, GREEN CHEM, V1, P1, DOI 10.1039/a807961g
   Cui YC, 2005, POLYM ADVAN TECHNOL, V16, P633, DOI 10.1002/pat.628
   Das P, 2011, APPL ORGANOMET CHEM, V25, P283, DOI 10.1002/aoc.1755
   Demetgul C., 2012, CARBOHYD POLYM, V89, P354
   Demetgul C, 2008, DES MONOMERS POLYM, V11, P565, DOI 10.1163/156855508X363852
   FUJI K, 1993, CHEM REV, V93, P2037, DOI 10.1021/cr00022a005
   Gupta KC, 2008, J MACROMOL SCI A, V45, P53, DOI 10.1080/10601320701683256
   Hajipour AR, 2011, INORG CHIM ACTA, V370, P531, DOI 10.1016/j.ica.2011.01.050
   Karthikeyan P, 2013, TETRAHEDRON LETT, V54, P7193, DOI 10.1016/j.tetlet.2013.10.111
   Kaya M, 2014, BIOTECHNOL BIOPROC E, V19, P58, DOI 10.1007/s12257-013-0488-9
   Kumar S, 2010, J APPL POLYM SCI, V115, P3056, DOI 10.1002/app.31385
   Leonhardt SES, 2010, APPL CATAL A-GEN, V379, P30, DOI 10.1016/j.apcata.2010.02.029
   Li CJ, 2005, CHEM REV, V105, P3095, DOI 10.1021/cr030009u
   Littke AF, 2000, J AM CHEM SOC, V122, P4020, DOI 10.1021/ja0002058
   Liu C, 2015, TETRAHEDRON, V71, P3954, DOI 10.1016/j.tet.2015.04.041
   Liu Y., 2013, ADV MAT RES, V647, P794
   Makha M, 2004, GREEN CHEM, V6, P158, DOI 10.1039/b315204a
   Makhubela BCE, 2011, APPL CATAL A-GEN, V393, P231, DOI 10.1016/j.apcata.2010.12.002
   MIYAURA N, 1995, CHEM REV, V95, P2457, DOI 10.1021/cr00039a007
   Mostafa Sahar I., 2008, Metal-Based Drugs, P723634, DOI 10.1155/2008/723634
   Muzzarelli RAA, 2011, CARBOHYD POLYM, V84, P54, DOI 10.1016/j.carbpol.2010.12.025
   Nuchter M, 2004, GREEN CHEM, V6, P128, DOI 10.1039/b310502d
   Puthiaraj P, 2014, GREEN CHEM, V16, P4223, DOI 10.1039/c4gc00412d
   Sin E, 2010, J MOL CATAL A-CHEM, V315, P99, DOI 10.1016/j.molcata.2009.09.007
   Singh BK, 2008, ORG PROCESS RES DEV, V12, P468, DOI 10.1021/op800047f
   Trimukhe KD, 2009, CARBOHYD POLYM, V75, P63, DOI 10.1016/j.carbpol.2008.06.011
   Varma RS, 1999, GREEN CHEM, V1, P43, DOI 10.1039/a808223e
   Yi SS, 2007, TETRAHEDRON LETT, V48, P6771, DOI 10.1016/j.tetlet.2007.07.093
   Yin X., 2011, POLYM B, V68, P1215
   Zeng MF, 2012, J ORGANOMET CHEM, V704, P29, DOI 10.1016/j.jorganchem.2012.01.003
   Zhang YQ, 2005, CARBOHYD RES, V340, P1914, DOI 10.1016/j.carres.2005.05.005
   Zhu MY, 2013, CATAL SCI TECHNOL, V3, P952, DOI 10.1039/c2cy20562a
NR 41
TC 22
Z9 22
U1 3
U2 94
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JUL 10
PY 2016
VL 145
BP 20
EP 29
DI 10.1016/j.carbpol.2016.03.019
PG 10
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA DK7MH
UT WOS:000375109200003
PM 27106147
DA 2018-10-20
ER

PT J
AU Bagchi, B
   Banerjee, S
   Kool, A
   Thakur, P
   Bhandary, S
   Hoque, NA
   Das, S
AF Bagchi, Biswajoy
   Banerjee, Somtirtha
   Kool, Arpan
   Thakur, Pradip
   Bhandary, Suman
   Hoque, Nur Amin
   Das, Sukhen
TI Synthesis of eucalyptus/tea tree oil absorbed biphasic calcium
   phosphate-PVDF polymer nanocomposite films: a surface active
   antimicrobial system for biomedical application
SO PHYSICAL CHEMISTRY CHEMICAL PHYSICS
LA English
DT Article
ID BIOFILM FORMATION; ANTIBACTERIAL ACTIVITY; DRUG-RELEASE; HYDROXYAPATITE;
   SILVER; NANOPARTICLES; INFECTIONS; BACTERIAL; COMPOSITE; BIOMATERIAL
AB A biocompatible poly(vinylidene) difluoride (PVDF) based film has been prepared by in situ precipitation of calcium phosphate precursors. Such films were surface absorbed with two essential oils namely eucalyptus and tea tree oil. Physico-chemical characterization of the composite film revealed excellent stability of the film with 10% loading of oils in the PVDF matrix. XRD, FTIR and FESEM measurements confirmed the presence of hydroxyapatite and octacalcium phosphate in the PVDF matrix which showed predominantly beta phase. Strong bactericidal activity was observed with very low minimum bactericidal concentration (MBC) values on both E. coli and S. aureus. The composite films also resisted biofilm formation as observed by FESEM. The release of essential oils from the film showed an initial burst followed by a very slow release over a period of 24 hours. Antibacterial action of the film was found to be primarily due to the action of essential oils which resulted in leakage of vital fluids from the microorganisms. Both necrotic and apoptotic morphologies were observed in bacterial cells. Biocompatibility studies with the composite films showed negligible cytotoxicity to mouse mesenchymal and myoblast cells at MBC concentration.
C1 [Bagchi, Biswajoy; Banerjee, Somtirtha; Kool, Arpan; Thakur, Pradip; Hoque, Nur Amin; Das, Sukhen] Jadavpur Univ, Dept Phys, Kolkata 700032, India.
   [Thakur, Pradip] Netaji Nagar Coll Women, Dept Phys, Kolkata 700092, India.
   [Bhandary, Suman] Bose Inst, Div Mol Med, Kolkata 700054, India.
   [Bagchi, Biswajoy] Cent Glass & Ceram Res Inst, Fuel Cell & Battery Div, Kolkata 700032, India.
   [Das, Sukhen] Indian Inst Engn Sci & Technol, Dept Phys, Howrah 711103, W Bengal, India.
RP Bagchi, B; Das, S (reprint author), Jadavpur Univ, Dept Phys, Kolkata 700032, India.
EM biswajoy_ju@rediffmail.com; sdasphysics@gmail.com
OI Bhandary, Suman/0000-0001-6723-4838; Bagchi,
   Biswajoy/0000-0003-3942-5236; Das, Sukhen/0000-0001-8372-3076
FU Council of Scientific and Industrial Research (CSIR); Department of
   Science and Technology (DST), Government of India
FX We are grateful to the Council of Scientific and Industrial Research
   (CSIR) and the Department of Science and Technology (DST), Government of
   India, for financial assistance.
CR Alt V, 2004, BIOMATERIALS, V25, P4383, DOI 10.1016/j.biomaterials.2003.10.078
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Arciola CR, 2012, BIOMATERIALS, V33, P5967, DOI 10.1016/j.biomaterials.2012.05.031
   Arellano-Jimenez MJ, 2009, J PHYS CHEM SOLIDS, V70, P390, DOI 10.1016/j.jpcs.2008.11.001
   Bagchi B, 2013, COLLOID SURFACE B, V108, P358, DOI 10.1016/j.colsurfb.2013.03.019
   Bagchi B, 2012, MAT SCI ENG C-MATER, V32, P1897, DOI 10.1016/j.msec.2012.05.011
   Baranska M, 2005, BIOPOLYMERS, V78, P237, DOI 10.1002/bip.20284
   Barrere F, 2003, J BIOMED MATER RES A, V66A, P779, DOI 10.1002/jbm.a.10454
   Bechert T, 2000, NAT MED, V6, P1053, DOI 10.1038/79568
   Braga Francisco José Correa, 2007, Mat. Res., V10, P247, DOI 10.1590/S1516-14392007000300005
   Carson CF, 2006, CLIN MICROBIOL REV, V19, P50, DOI 10.1128/CMR.19.1.50-62.2006
   Cheng L, 2012, DENT MATER, V28, P561, DOI 10.1016/j.dental.2012.01.005
   Ciobanu CS, 2011, NANOSCALE RES LETT, V6, P1, DOI 10.1186/1556-276X-6-613
   Costa R., 2012, J MATER SCI-MATER M, V24, P395
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Curcic MG, 2012, INT J MOL SCI, V13, P2521, DOI 10.3390/ijms13022521
   De Silva K. T., 1995, MANUAL ESSENTIAL OIL
   Feng QL, 1998, THIN SOLID FILMS, V335, P214, DOI 10.1016/S0040-6090(98)00956-0
   Ginebra MP, 2006, J CONTROL RELEASE, V113, P102, DOI 10.1016/j.jconrel.2006.04.007
   Handa T, 2012, ACTA BIOMATER, V8, P1190, DOI 10.1016/j.actbio.2011.12.002
   Hoque J, 2015, ACS APPL MATER INTER, V7, P1804, DOI 10.1021/am507482y
   Hwang JS, 2006, BIOTECHNOL BIOPROC E, V11, P391, DOI 10.1007/BF02932304
   Juliano C, 2000, J ESSENT OIL RES, V12, P516, DOI 10.1080/10412905.2000.9699578
   Jung BO, 1999, J KOREAN IND ENG CHE, V10, P660
   Kazemzadeh-Narbat M, 2010, BIOMATERIALS, V31, P9519, DOI 10.1016/j.biomaterials.2010.08.035
   Kim TN, 1998, J MATER SCI-MATER M, V9, P129, DOI 10.1023/A:1008811501734
   Kundu B., 2010, J MATER SCI-MATER M, V21, P2569
   Lambert RJW, 2001, J APPL MICROBIOL, V91, P453, DOI 10.1046/j.1365-2672.2001.01428.x
   LAROCHE G, 1995, J BIOMED MATER RES, V29, P1525, DOI 10.1002/jbm.820291209
   Low YKA, 2011, J BIOMAT SCI-POLYM E, V22, P1651, DOI 10.1163/092050610X519471
   Lynch AS, 2008, ANNU REV MED, V59, P415, DOI 10.1146/annurev.med.59.110106.132000
   Martins P, 2014, PROG POLYM SCI, V39, P683, DOI 10.1016/j.progpolymsci.2013.07.006
   Melo MAS, 2013, DENT MATER, V29, P199, DOI 10.1016/j.dental.2012.10.005
   Ming F., 2006, INT J ANTIMICROB AG, V27, P513
   Mututuvari TM, 2013, J BIOMED MATER RES A, V101, P3266, DOI 10.1002/jbm.a.34636
   Nardecchia S, 2012, LANGMUIR, V28, P15937, DOI 10.1021/la3033435
   Nychas G. J. E., 1995, NEW METHODS FOOD PRE, P58, DOI DOI 10.1007/978-1-4615-2105-1_4
   Puvvada N, 2010, NANOSCALE, V2, P2631, DOI 10.1039/c0nr00611d
   Raad I, 1999, SUPPORT CARE CANCER, V7, P386, DOI 10.1007/s005200050297
   Raho Bachir G., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P739, DOI [10.1016/S2221-1691(12)60220-2, 10.1016/S2221-1691(12)00220-2]
   Ribble D, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-12
   Ribeiro C, 2012, RSC ADV, V2, P11504, DOI 10.1039/c2ra21841k
   Ruparelia JP, 2008, ACTA BIOMATER, V4, P707, DOI 10.1016/j.actbio.2007.11.006
   Sadat-Shojai M, 2013, ACTA BIOMATER, V9, P7591, DOI 10.1016/j.actbio.2013.04.012
   Sadlon AE, 2010, ALTERN MED REV, V15, P33
   Salazar H, 2015, COLLOID SURFACE A, V469, P93, DOI 10.1016/j.colsurfa.2014.12.064
   Salwiczek M, 2014, TRENDS BIOTECHNOL, V32, P82, DOI 10.1016/j.tibtech.2013.09.008
   Sara B., 2004, INT J FOOD MICROBIOL, V94, P223, DOI DOI 10.1016/J.IJFOODMICRO.2004.03.022
   Sun SQ, 2008, B MATER SCI, V31, P61, DOI 10.1007/s12034-008-0011-7
   Tarvainen T, 2000, J CONTROL RELEASE, V66, P19, DOI 10.1016/S0168-3659(99)00254-0
   Thakur P, 2015, PHYS CHEM CHEM PHYS, V17, P1368, DOI 10.1039/c4cp04006f
   Turek C, 2013, COMPR REV FOOD SCI F, V12, P40, DOI 10.1111/1541-4337.12006
   Uskokovic V., 2011, ACS APPL MATER INTER, V5, P2422
   Weber N, 2010, ACTA BIOMATER, V6, P3550, DOI 10.1016/j.actbio.2010.03.035
   Westas E, 2014, J BIOMED MATER RES A, V102, P1063, DOI 10.1002/jbm.a.34757
   Yabune T, 2008, APPL ENVIRON MICROB, V74, P5958, DOI 10.1128/AEM.00610-08
   Yeo S. G., 1981, J KOREAN SOC FOOD NU, V24, P293
   Zhao J, 2011, CHEM CENT J, V5, DOI 10.1186/1752-153X-5-40
   Zhong L. W., 2013, J APPL POLYM SCI, P4564
NR 59
TC 2
Z9 2
U1 4
U2 29
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1463-9076
EI 1463-9084
J9 PHYS CHEM CHEM PHYS
JI Phys. Chem. Chem. Phys.
PD JUL 7
PY 2016
VL 18
IS 25
BP 16775
EP 16785
DI 10.1039/c6cp03493d
PG 11
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA DP7WY
UT WOS:000378711100019
PM 27271864
DA 2018-10-20
ER

PT J
AU Tatara, AM
   Mikos, AG
AF Tatara, Alexander M.
   Mikos, Antonios G.
TI Tissue Engineering in Orthopaedics
SO JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
LA English
DT Review
ID MESENCHYMAL STEM-CELLS; COMPOSITE MULTILAYERED BIOMATERIAL; PILOT
   CLINICAL-TRIAL; BONE REGENERATION; FEMORAL-HEAD; OSTEOCHONDRAL
   REGENERATION; STROMAL CELLS; GROWTH-FACTOR; DELIVERY; THERAPY
C1 [Tatara, Alexander M.; Mikos, Antonios G.] Rice Univ, Dept Bioengn, Houston, TX 77005 USA.
   [Mikos, Antonios G.] Rice Univ, Dept Chem & Biomol Engn, Houston, TX USA.
RP Tatara, AM (reprint author), Rice Univ, Dept Bioengn, Houston, TX 77005 USA.
EM tatara@rice.edu; mikos@rice.edu
FU Army, Navy, National Institutes of Health, Air Force, Veterans Affairs,
   and Health Affairs [W81XWH-14-2-0004]; National Institutes of Health
   (NIH) [R01 AR068073]
FX This work was supported by the Army, Navy, National Institutes of
   Health, Air Force, Veterans Affairs, and Health Affairs to support the
   AFIRM II effort, under Award No. W81XWH-14-2-0004. This work was also
   supported by the National Institutes of Health (NIH R01 AR068073).
CR Aarvold A, 2013, SURG-J R COLL SURG E, V11, P319, DOI 10.1016/j.surge.2013.02.008
   Adachi N, 2014, KNEE SURG SPORT TR A, V22, P1241, DOI 10.1007/s00167-013-2521-0
   Al-Nbaheen M, 2013, STEM CELL REV REP, V9, P32, DOI 10.1007/s12015-012-9365-8
   [Anonymous], 2016, INFUSER BON GRAFT
   Aoyama T, 2014, TISSUE ENG PART B-RE, V20, P233, DOI [10.1089/ten.TEB.2014.0090, 10.1089/ten.teb.2014.0090]
   Atala A, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004890
   Ball MD, 2011, CLIN ORTHOP RELAT R, V469, P3085, DOI 10.1007/s11999-011-1895-x
   Banks JM, 2014, BIOMATERIALS, V35, P8951, DOI 10.1016/j.biomaterials.2014.07.012
   Bieback K, 2004, STEM CELLS, V22, P625, DOI 10.1634/stemcells.22-4-625
   Bobyn JD, 2009, J BONE JOINT SURG AM, V91A, P23, DOI 10.2106/JBJS.I.00518
   Burkus JK, 2003, J SPINAL DISORD TECH, V16, P113, DOI 10.1097/00024720-200304000-00001
   Calori GM, 2013, INJURY, V44, pS63, DOI 10.1016/S0020-1383(13)70015-9
   Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008
   Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023
   Chen MC, 2013, ACTA BIOMATER, V9, P5562, DOI 10.1016/j.actbio.2012.10.024
   Davies BM, 2014, J TISSUE ENG, V5, DOI 10.1177/2041731414551764
   De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274
   Delcogliano M, 2014, KNEE SURG SPORT TR A, V22, P1260, DOI 10.1007/s00167-013-2717-3
   Desai Pingal, 2015, HSS J, V11, P104, DOI 10.1007/s11420-015-9432-1
   Di Bella C, 2015, FRONT SURG, V2, DOI 10.3389/fsurg.2015.00039
   Dohan Ehrenfest DM, 2014, MUSCLES LIGAMENTS TE, V4, P3
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Evans CH, 2012, J CELL PHYSIOL, V227, P416, DOI 10.1002/jcp.23031
   Giuliani A, 2013, STEM CELL TRANSL MED, V2, P316, DOI 10.5966/sctm.2012-0136
   Greenwald AS, 2001, J BONE JOINT SURG AM, V83A, P98, DOI 10.2106/00004623-200100022-00007
   Ha CW, 2015, HUM GENE THER CL DEV, V26, P125, DOI 10.1089/humc.2014.145
   Henkel J, 2013, BONE RES, V1, P216, DOI 10.4248/BR201303002
   Hernigou P, 2015, BONE, V70, P102, DOI 10.1016/j.bone.2014.04.034
   Hogan MV, 2015, ARTHROSCOPY, V31, P1017, DOI 10.1016/j.arthro.2014.11.033
   Homma Y, 2013, INJURY, V44, pS46, DOI 10.1016/S0020-1383(13)70011-1
   Hwang DW, 2008, EUR J NUCL MED MOL I, V35, P1887, DOI 10.1007/s00259-008-0751-z
   Hwang JH, 2011, J TISSUE SCI ENG, V2, P103
   Ito H, 2011, MOD RHEUMATOL, V21, P113, DOI 10.1007/s10165-010-0357-8
   Jain RK, 2006, NAT CLIN PRACT ONCOL, V3, P24, DOI 10.1038/ncponc0403
   Jo CH, 2014, STEM CELLS, V32, P1254, DOI 10.1002/stem.1634
   Kang HW, 2016, NAT BIOTECHNOL, V34, P312, DOI 10.1038/nbt.3413
   Kempen DHR, 2009, BIOMATERIALS, V30, P2816, DOI 10.1016/j.biomaterials.2009.01.031
   Kon E, 2014, AM J SPORT MED, V42, P158, DOI 10.1177/0363546513505434
   Kon E, 2011, AM J SPORT MED, V39, P1180, DOI 10.1177/0363546510392711
   Kuroda R, 2014, STEM CELL TRANSL MED, V3, P128, DOI 10.5966/sctm.2013-0106
   Lalu MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047559
   Laurencin CT, 2014, DRUG DISCOV TODAY, V19, P794, DOI 10.1016/j.drudis.2014.01.012
   Lu CH, 2013, BIOTECHNOL ADV, V31, P1695, DOI 10.1016/j.biotechadv.2013.08.015
   Madry H, 2014, Eur Cell Mater, V27, P17
   Madry H, 2014, EUR CELLS MATER, V27, P21
   Mohan N, 2011, TISSUE ENG PT A, V17, P2845, DOI 10.1089/ten.tea.2011.0135
   Mont MA, 2015, J BONE JOINT SURG AM, V97A, P1604, DOI 10.2106/JBJS.O.00071
   Nicolini AP, 2014, CURR REV MUSCULOSKE, V7, P256, DOI 10.1007/s12178-014-9226-y
   Niemansburg SL, 2014, SPINE J, V14, P1029, DOI 10.1016/j.spinee.2013.10.016
   Nogami M, 2012, TRANSPLANTATION, V93, P1221, DOI 10.1097/TP.0b013e3182529b76
   Panagiotis M, 2005, INJURY, V36, pS30, DOI 10.1016/j.injury.2005.10.008
   Panteli M, 2015, J CELL MOL MED, V19, P685, DOI 10.1111/jcmm.12532
   Patel ZS, 2008, BONE, V43, P931, DOI 10.1016/j.bone.2008.06.019
   Qazi TH, 2015, BIOMATERIALS, V53, P502, DOI 10.1016/j.biomaterials.2015.02.110
   Riekstina U, 2008, CYTOTECHNOLOGY, V58, P153, DOI 10.1007/s10616-009-9183-2
   Santoro M, 2014, J CONTROL RELEASE, V190, P210, DOI 10.1016/j.jconrel.2014.04.014
   Schuttler KF, 2015, TECHNOL HEALTH CARE, V23, P403, DOI 10.3233/THC-150917
   Shah SR, 2015, NATL SCI REV, V2, P85, DOI 10.1093/nsr/nwu028
   Shah SR, 2013, CHINESE SCI BULL, V58, P4342, DOI 10.1007/s11434-013-5780-8
   Shah SR, 2013, MATER TODAY, V16, P177, DOI 10.1016/j.mattod.2013.05.003
   Sheth U, 2012, J BONE JOINT SURG AM, V94A, P298, DOI 10.2106/JBJS.K.00154
   Shi M, 2011, CLIN EXP IMMUNOL, V164, P1, DOI 10.1111/j.1365-2249.2011.04327.x
   Si YL, 2011, AGEING RES REV, V10, P93, DOI 10.1016/j.arr.2010.08.005
   Siebers MC, 2005, BIOMATERIALS, V26, P137, DOI 10.1016/j.biomaterials.2004.02.021
   Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643
   Skovrlj B, 2015, SPINE, V40, P1862, DOI 10.1097/BRS.0000000000001126
   Smith L, 2012, CONNECT TISSUE RES, V53, P95, DOI 10.3109/03008207.2011.650804
   Tan Q, 2012, TISSUE ENG PT A, V18, P840, DOI [10.1089/ten.tea.2011.0362, 10.1089/ten.TEA.2011.0362]
   Veronesi F, 2014, J BIOMED MATER RES A, V102, P2448, DOI 10.1002/jbm.a.34896
   Vo TN, 2016, BIOMATERIALS, V83, P1, DOI 10.1016/j.biomaterials.2015.12.026
   Wakitani S, 2011, J TISSUE ENG REGEN M, V5, P146, DOI 10.1002/term.299
   Weiss KR, 2015, CLIN CANCER RES, V21, P2889, DOI 10.1158/1078-0432.CCR-14-3069
   Wen Y, 2013, OR SURG OR MED OR PA, V116, pE324, DOI 10.1016/j.oooo.2012.02.024
   Wood JJ, 2006, J BONE JOINT SURG AM, V88A, P503, DOI 10.2106/JBJS.E.00103
NR 75
TC 13
Z9 16
U1 3
U2 13
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0021-9355
EI 1535-1386
J9 J BONE JOINT SURG AM
JI J. Bone Joint Surg.-Am. Vol.
PD JUL 6
PY 2016
VL 98
IS 13
BP 1132
EP 1139
DI 10.2106/JBJS.16.00299
PG 8
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA DR5ID
UT WOS:000379935800013
PM 27385687
OA Green Published
DA 2018-10-20
ER

PT J
AU Zhu, SC
   Gu, ZP
   Hu, Y
   Dan, WH
   Xiong, SB
AF Zhu, Shichen
   Gu, Zhipeng
   Hu, Yang
   Dan, Weihua
   Xiong, Shanbai
TI Evaluation of alginate dialdehyde as a suitable crosslinker on modifying
   porcine acellular dermal matrix: The aggregation of collagenous fibers
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE biocompatibility; biomaterials; biomedical applications
ID IN-VITRO; 1-ETHYL-3-METHYLIMIDAZOLIUM ACETATE; EXTRACELLULAR-MATRIX;
   STEM-CELLS; TISSUE; SCAFFOLD; LINKING; BIOPOLYMERS; FIBROBLASTS;
   DEGRADATION
AB Porcine acellular dermal matrix (PADM) has been investigated widely as a natural biomaterial. However, the success of PADM has been limited by insufficient stability and poor physicochemical properties. In our work, alginate dialdehyde (ADA) with various oxidation degrees (OD=25%, 45%, and 65%) were explored to modify PADM, while glutaraldehyde (GA), dehydrathermal treatment (DHT), and carbodiimide (EDC) were used as the control. The efficacy of ADA on modifying PADM increased along with the rising of oxidation degree. The ADA (OD=65% and 45%) groups showed better mechanical and thermal stability, crosslink density, and resistance to enzymatic degradation than ADA (OD=25%) and DHT+EDC group. Meanwhile, the structure of PADM crosslinked by ADA (OD=45% and 65%) were maintained largely. Further, ADA (OD=45%) group revealed better cytocompatibility than DHT+EDC, ADA (OD=65%) and GA group. Considering the balance of cytocompatibility and physicochemical behavior, ADA (OD=45%) was more suitable as a natural derived crosslinker to modify PADM in tissue engineering. (c) 2016 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 2016, 133, 43550.
C1 [Zhu, Shichen; Hu, Yang; Xiong, Shanbai] Huazhong Agr Univ, Coll Food Sci & Technol, 1 Shizishan St, Wuhan 430070, Hubei, Peoples R China.
   [Zhu, Shichen; Hu, Yang; Xiong, Shanbai] Huazhong Agr Univ, MOE Key Lab Environm Correlat Dietol, 1 Shizishan St, Wuhan 430070, Hubei, Peoples R China.
   [Zhu, Shichen; Hu, Yang; Xiong, Shanbai] Sub Ctr Wuhan Natl Technol, Wuhan 430070, Peoples R China.
   [Zhu, Shichen; Hu, Yang; Xiong, Shanbai] R&D Staple Freshwater Fish Proc, Wuhan 430070, Peoples R China.
   [Gu, Zhipeng] Sun Yat Sen Univ, Sch Engn, Dept Biomed Engn, Guangzhou 510006, Guangdong, Peoples R China.
   [Dan, Weihua] Sichuan Univ, Dept Biomass Chem & Engn, 24 South Sect 1,Yihuan Rd, Chengdu 610065, Sichuan, Peoples R China.
RP Hu, Y (reprint author), Huazhong Agr Univ, Coll Food Sci & Technol, 1 Shizishan St, Wuhan 430070, Hubei, Peoples R China.; Hu, Y (reprint author), Huazhong Agr Univ, MOE Key Lab Environm Correlat Dietol, 1 Shizishan St, Wuhan 430070, Hubei, Peoples R China.; Hu, Y (reprint author), Sub Ctr Wuhan Natl Technol, Wuhan 430070, Peoples R China.; Hu, Y (reprint author), R&D Staple Freshwater Fish Proc, Wuhan 430070, Peoples R China.
EM huyang@mail.hzau.edu.cn
RI Gu, Zhi peng/E-5108-2013
OI Gu, Zhi peng/0000-0003-4533-6539
FU Fundamental Research Funds for the Central Universities [2662014BQ053,
   2662015QC014]; Natural Science Foundation of Hubei Province
   [2015CFB391]; National Natural Science Foundation of China [21506070,
   51503129]; China Agriculture Research System [CARS-46-23]
FX The financial support of the Fundamental Research Funds for the Central
   Universities (2662014BQ053, 2662015QC014), Natural Science Foundation of
   Hubei Province (2015CFB391), National Natural Science Foundation of
   China (Program NO. 21506070; 51503129), and China Agriculture Research
   System (CARS-46-23) are gratefully acknowledged.
CR Ahmadi A, 2015, BIOMATERIALS, V49, P18, DOI 10.1016/j.biomaterials.2015.01.016
   Aston R, 2015, BIOMACROMOLECULES, V16, P1807, DOI 10.1021/acs.biomac.5b00383
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Balakrishnan B, 2005, BIOMATERIALS, V26, P3941, DOI 10.1016/j.biomaterials.2004.10.005
   Bian DH, 2014, J HARD TISSUE BIOL, V23, P21, DOI 10.2485/jhtb.23.21
   Bottino MC, 2010, J BIOMED MATER RES B, V95B, P276, DOI 10.1002/jbm.b.31711
   Campi G, 2015, ACTA BIOMATER, V23, P309, DOI 10.1016/j.actbio.2015.05.033
   CHEUNG DT, 1985, CONNECT TISSUE RES, V13, P109, DOI 10.3109/03008208509152389
   Ding CC, 2015, CARBOHYD POLYM, V119, P194, DOI 10.1016/j.carbpol.2014.11.057
   Drexler JW, 2011, TISSUE ENG PART C-ME, V17, P9, DOI [10.1089/ten.tec.2009.0754, 10.1089/ten.TEC.2009.0754]
   Fathima NN, 2004, INT J BIOL MACROMOL, V34, P241, DOI 10.1016/j.ijbiomac.2004.05.004
   Fratzl P., 2008, COLLAGEN STRUCTURE M
   Gouveia RM, 2014, BIOMATER SCI-UK, V2, P1222, DOI 10.1039/c4bm00121d
   Gu ZP, 2013, INT J BIOL MACROMOL, V58, P121, DOI 10.1016/j.ijbiomac.2013.03.059
   Gu ZP, 2011, MAT SCI ENG C-MATER, V31, P1593, DOI 10.1016/j.msec.2011.07.012
   He LR, 2013, EUR POLYM J, V49, P2986, DOI 10.1016/j.eurpolymj.2013.05.033
   He LR, 2012, J INORG BIOCHEM, V117, P124, DOI 10.1016/j.jinorgbio.2012.08.017
   Hu Y., 2013, INT J BIOL MACROMO C, V55C, P211
   Hu Y, 2013, J SOC LEATH TECH CH, V97, P200
   Hu Y, 2013, J APPL POLYM SCI, V130, P2245, DOI 10.1002/app.39298
   Jeong SI, 2010, MACROMOL BIOSCI, V10, P934, DOI 10.1002/mabi.201000046
   Jin Y., 2009, TISSUE ENG PART A, V15, P3729
   Liu SY, 2011, TISSUE ENG PT A, V17, P725, DOI [10.1089/ten.tea.2010.0331, 10.1089/ten.TEA.2010.0331]
   Ma J., 2015, J BIOMED MATER RES B, V103, P335
   MCPHERSON J M, 1986, Journal of Biomedical Materials Research, V20, P93, DOI 10.1002/jbm.820200109
   O'Brien F. J., 2011, TISSUE ENG PART A, V17, P1201
   Roessner ED, 2011, J BIOMATER APPL, V25, P413, DOI 10.1177/0885328209347961
   Safandowska M, 2013, INT J BIOL MACROMOL, V53, P32, DOI 10.1016/j.ijbiomac.2012.10.026
   Sarker B, 2014, J MATER CHEM B, V2, P1470, DOI 10.1039/c3tb21509a
   Takitoh T, 2015, J BIOSCI BIOENG, V119, P217, DOI 10.1016/j.jbiosc.2014.07.008
   Vidal CMP, 2014, LANGMUIR, V30, P14887, DOI 10.1021/la5034383
   Wang HJ, 2010, BIOMATERIALS, V31, P4322, DOI 10.1016/j.biomaterials.2010.02.008
   Xu YT, 2013, CARBOHYD POLYM, V95, P148, DOI 10.1016/j.carbpol.2013.03.021
   Xu YT, 2013, CARBOHYD POLYM, V92, P448, DOI 10.1016/j.carbpol.2012.09.096
   Xu ZP, 2015, J MATER CHEM B, V3, P3634, DOI 10.1039/c5tb00226e
   Yahyouche A, 2011, ACTA BIOMATER, V7, P278, DOI 10.1016/j.actbio.2010.08.005
   Zhang M, 2014, CELLULOSE, V21, P3311, DOI 10.1007/s10570-014-0372-6
   Zhang XJ, 2011, TISSUE ENG PART C-ME, V17, P423, DOI [10.1089/ten.tec.2010.0466, 10.1089/ten.TEC.2010.0466]
   Zhang XJ, 2009, BIOMATERIALS, V30, P2666, DOI 10.1016/j.biomaterials.2009.01.018
   Zhao HS, 2011, TISSUE ENG PT A, V17, P765, DOI [10.1089/ten.tea.2010.0196, 10.1089/ten.TEA.2010.0196]
NR 40
TC 2
Z9 2
U1 5
U2 55
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8995
EI 1097-4628
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD JUL 5
PY 2016
VL 133
IS 25
AR 43550
DI 10.1002/app.43550
PG 12
WC Polymer Science
SC Polymer Science
GA DH9YV
UT WOS:000373152800006
DA 2018-10-20
ER

PT J
AU Diomede, F
   Zini, N
   Gatta, V
   Fulle, S
   Merciaro, I
   D'Aurora, M
   La Rovere, RML
   Traini, T
   Pizzicannella, J
   Ballerini, P
   Caputi, S
   Piattelli, A
   Trubiani, O
AF Diomede, F.
   Zini, N.
   Gatta, V.
   Fulle, S.
   Merciaro, I.
   D'Aurora, M.
   La Rovere, R. M. L.
   Traini, T.
   Pizzicannella, J.
   Ballerini, P.
   Caputi, S.
   Piattelli, A.
   Trubiani, O.
TI HUMAN PERIODONTAL LIGAMENT STEM CELLS CULTURED ONTO CORTICO-CANCELLOUS
   SCAFFOLD DRIVE BONE REGENERATIVE PROCESS
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE Stem cells - osteogenesis; dental tissue (periodontal ligament);
   biomaterials - scaffolds; dental - regenerative repair; tissue
   engineering/regenerative medicine; biomaterials - biocompatibility (in
   vivo)
ID PARATHYROID-HORMONE; STROMAL CELLS; ALVEOLAR BONE; OSTEOBLASTS;
   EXPRESSION; BIOMATERIALS; CARTILAGE; DISEASE; ASSAY
AB The purpose of this work was to test, in vitro and in vivo, a new tissue-engineered construct constituted by porcine cortico-cancellous scaffold (Osteobiol Dual Block) (DB) and xeno-free ex vivo culture of human Periodontal Ligament Stem Cells (hPDLSCs). hPDLSCs cultured in xeno-free media formulation preserved the stem cells' morphological features, the expression of stemness and pluripotency markers, and their ability to differentiate into mesenchymal lineage. Transmission electron microscopy analysis suggested that after one week of culture, both noninduced and osteogenic differentiation induced cells joined and grew on DB secreting extracellular matrix (ECM) that in osteogenic induced samples was hierarchically assembled in fibrils. Quantitative RT-PCR (qRT-PCR) showed the upregulation of key genes involved in the bone differentiation pathway in both differentiated and undifferentiated hPDLSCs cultured with DB (hPDLSCs/DB). Functional studies revealed a significant increased response of calcium transients in the presence of DB, both in undifferentiated and differentiated cells stimulated with calcitonin and parathormone, suggesting that the biomaterial could drive the osteogenic differentiation process of hPDLSCs. These data were confirmed by the increase of gene expression of L-type voltage-dependent Ca2+ (VDCCL), subunits alpha 1C and alpha 2D1 in undifferentiated cells in the presence of DB. In vivo implantation of the hPDLSCs/DB living construct in the mouse calvaria evidenced a precocious osteointegration and vascularisation process. Our results suggest consideration of DB as a biocompatible, osteoinductive and osteoconductive biomaterial, making it a promising tool to regulate cell activities in biological environments and for a potential use in the development of new custom-made tissue engineering.
C1 [Diomede, F.; Merciaro, I.; Traini, T.; Pizzicannella, J.; Caputi, S.; Piattelli, A.; Trubiani, O.] Univ G DAnnunzio, Dept Med Oral & Biotechnol Sci, Via Vestini 31, I-66100 Chieti, Italy.
   [Diomede, F.; Merciaro, I.; Trubiani, O.] Univ G DAnnunzio, Lab Stem Cells & Regenerat Med, I-6610 Chieti, Italy.
   [Zini, N.] CNR, Natl Res Council Italy, IGM, Bologna, Italy.
   [Zini, N.] IOR, SC Lab Musculosckeletal Cell Biol, Bologna, Italy.
   [Gatta, V.; D'Aurora, M.; Ballerini, P.] Univ G DAnnunzio, Dept Psychol Hlth & Terr Sci, Chieti, Italy.
   [Fulle, S.; La Rovere, R. M. L.] Univ G DAnnunzio, Dept Neurosci Imaging & Clin Sci, Chieti, Italy.
   [Pizzicannella, J.] Osped San Pio, Lanciano Vasto Chieti ASL02, Vasto, CH, Italy.
RP Trubiani, O (reprint author), Univ G DAnnunzio, Dept Med Oral & Biotechnol Sci, Via Vestini 31, I-66100 Chieti, Italy.; Trubiani, O (reprint author), Univ G DAnnunzio, Lab Stem Cells & Regenerat Med, I-6610 Chieti, Italy.
EM trubiani@unich.it
RI Fulle, Stefania/F-3328-2013
OI Fulle, Stefania/0000-0003-4557-9127; GATTA,
   Valentina/0000-0002-9999-5823
FU OT ex 60 % University of Chieti fund; Ministry of Education, University
   and Research (M.I.U.R.), Rome, Italy [PRIN 20102ZLNJ5]
FX This work has been supported from OT ex 60 % University of Chieti fund,
   and partly by PRIN 20102ZLNJ5 "Stem cells and 3D scaffolds: a novel
   construct in bone regeneration" financed by the Ministry of Education,
   University and Research (M.I.U.R.), Rome, Italy.
CR Amini Ami R, 2011, J Long Term Eff Med Implants, V21, P93
   Banfi A, 2000, EXP HEMATOL, V28, P707, DOI 10.1016/S0301-472X(00)00160-0
   Baroli B, 2009, J PHARM SCI-US, V98, P1317, DOI 10.1002/jps.21528
   Bergh JJ, 2006, AM J PHYSIOL-CELL PH, V290, pC822, DOI 10.1152/ajpcell.00403.2005
   Candeliere GA, 2001, BONE, V28, P351, DOI 10.1016/S8756-3282(01)00410-0
   Chase LG, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt8
   Chen NX, 2000, AM J PHYSIOL-CELL PH, V278, pC989
   Dimitriou R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-66
   Diomede F, 2014, INT ENDOD J, V47, P864, DOI 10.1111/iej.12230
   Egusa H, 2012, J PROSTHODONT RES, V56, P151, DOI 10.1016/j.jpor.2012.06.001
   Eleuterio E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071101
   Greenblatt MB, 2013, ANNU REV CELL DEV BI, V29, P63, DOI 10.1146/annurev-cellbio-101512-122347
   Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002
   Holzwarth JM, 2011, BIOMATERIALS, V32, P9622, DOI 10.1016/j.biomaterials.2011.09.009
   Manescu A, 2016, J PERIODONTAL RES, V51, P112, DOI 10.1111/jre.12289
   Minear S, 2010, J BONE MINER RES, V25, P1196, DOI 10.1002/jbmr.29
   Nanci A, 2006, PERIODONTOL 2000, V40, P11, DOI 10.1111/j.1600-0757.2005.00141.x
   Newmann, 1996, CLIN PERIODONTOLOGY, P31
   Qin L, 2004, TRENDS ENDOCRIN MET, V15, P60, DOI 10.1016/j.tem.2004.01.006
   Reddi AH, 2000, TISSUE ENG, V6, P351, DOI 10.1089/107632700418074
   Rose FRAJ, 2002, BIOCHEM BIOPH RES CO, V292, P1, DOI 10.1006/bbrc.2002.6519
   Salvade A, 2007, CYTOTHERAPY, V9, P427, DOI 10.1080/14653240701341995
   Seo BM, 2005, J DENT RES, V84, P907, DOI 10.1177/154405910508401007
   Sodek J, 2000, PERIODONTOL 2000, V24, P99, DOI 10.1034/j.1600-0757.2000.2240106.x
   SOUCACOS PN, 2008, INJURY S2, V39, pS1
   SUGIMOTO T, 1993, HORM METAB RES, V25, P608, DOI 10.1055/s-2007-1002189
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Trubiani O, 2008, J BIOMED MATER RES A, V87A, P986, DOI 10.1002/jbm.a.31837
   Trubiani O, 2008, J CELL PHYSIOL, V214, P706, DOI 10.1002/jcp.21266
   Trubiani O, 2016, CELL SIGNAL, V28, P1631, DOI 10.1016/j.cellsig.2016.07.012
   Trubiani O, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-015-0253-4
   Trubiani O, 2015, TISSUE ENG PART C-ME, V21, P52, DOI [10.1089/ten.TEC.2014.0024, 10.1089/ten.tec.2014.0024]
   Trubiani O, 2010, EUR CELLS MATER, V20, P72
   Villa I, 2003, AM J PHYSIOL-ENDOC M, V284, pE627, DOI 10.1152/ajpendo.00307.2002
   Wu XW, 2007, ANN NY ACAD SCI, V1116, P29, DOI 10.1196/annals.1402.053
   Zhu WT, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0719-2
   Zwingenberger S, 2014, TISSUE ENG PT A, V20, P810, DOI 10.1089/ten.TEA.2013.0222
NR 37
TC 19
Z9 19
U1 1
U2 8
PU AO RESEARCH INSTITUTE DAVOS-ARI
PI DAVOS
PA CLAVADELERSTRASSE 8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JUL-DEC
PY 2016
VL 32
BP 181
EP 201
DI 10.22203/eCM.v032a12
PG 21
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA EJ3OC
UT WOS:000393120500012
PM 27633707
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Korkut, E
   Torlak, E
   Altunsoy, M
AF Korkut, Emre
   Torlak, Emrah
   Altunsoy, Mustafa
TI Antimicrobial and mechanical properties of dental resin composite
   containing bioactive glass
SO Journal of Applied Biomaterials & Functional Materials
LA English
DT Article
DE Antimicrobial efficacy; Bioactive glass; Biofilm; Mechanical properties;
   Resin composite
ID ANTIBACTERIAL ACTIVITY; IN-VITRO; RESTORATIVE MATERIALS; PARTICULATE
   BIOGLASS(R); ORAL MICROORGANISMS; SURFACE-ROUGHNESS; BACTERIA; BIOFILM;
   CHLORHEXIDINE; NANOPARTICLES
AB Background: The aim of this study was to evaluate the antimicrobial efficacy and mechanical properties of dental resin composites containing different amounts of microparticulate bioactive glass (BAG).
   Methods: Experimental resin composites were prepared by mixing resin matrix (70% BisGMA and 30% TEG-DMA) and inorganic filler with various fractions of BAG to achieve final BAG concentrations of 5, 10 and 30 wt%. Antimicrobial efficacy was assessed in aqueous suspension against Escherichia coli, Staphylococcus aureus and Streptococcus mutans and in biofilm against S. mutans. The effect of incorporation of BAG on the mechanical properties of resin composite was evaluated by measuring the surface roughness, compressive strength and flexural strength.
   Results: Under the dynamic contact condition, viable counts of E. coli, S. aureus and S. mutans in suspensions were reduced up to 78%, 57% and 50%, respectively, after 90 minutes of exposure to disc-shaped composite specimens, depending on the BAG contents. In 2-day-old S. mutans biofilm, incorporation of BAG into composite at ratios of 10% and 30% resulted in 0.8 and 1.4 log reductions in the viable cell counts compared with the BAG-free composite, respectively. The surface roughness values of composite specimens did not show any significant difference (p>0.05) at any concentration of BAG. However, compressive and flexural strengths of composite were decreased significantly with addition of 30% BAG (p<0.05).
   Conclusions: The results demonstrated the successful utilization of BAG as a promising biomaterial in resin composites to provide antimicrobial function.
C1 [Korkut, Emre] Necmettin Erbakan Univ, Dept Pediat Dent, Konya, Turkey.
   [Torlak, Emrah] Necmettin Erbakan Univ, Dept Mol Biol & Genet, TR-4290 Konya, Turkey.
   [Altunsoy, Mustafa] Selcuk Univ, Dept Pediat Dent, Konya, Turkey.
RP Torlak, E (reprint author), Necmettin Erbakan Univ, Dept Mol Biol & Genet, TR-4290 Konya, Turkey.
EM etorlak@konya.edu.tr
OI Korkut, Emre/0000-0001-6976-3071
CR Allan I, 2002, CLIN ORAL IMPLAN RES, V13, P53, DOI 10.1034/j.1600-0501.2002.130106.x
   Allan I, 2001, BIOMATERIALS, V22, P1683, DOI 10.1016/S0142-9612(00)00330-6
   [Anonymous], 2013, E214913A ASTM INT
   Azillah MA, 1998, J DENT, V26, P177, DOI 10.1016/S0300-5712(96)00089-9
   Beyth N, 2012, MICRO NANO TECHNOL, P35, DOI 10.1016/B978-1-4557-78624.00003-1
   Busscher HJ, 2010, J DENT RES, V89, P657, DOI 10.1177/0022034510368644
   Can Say E, 2014, DENT MATER J, V33, P332, DOI 10.4012/dmj.2013-287
   Chatzistavrou X, 2014, ACTA BIOMATER, V10, P3723, DOI 10.1016/j.actbio.2014.04.030
   Chen CY, 2008, COMPOS SCI TECHNOL, V68, P2811, DOI 10.1016/j.compscitech.2008.06.015
   Chen L, 2011, DENT MATER, V27, P1187, DOI 10.1016/j.dental.2011.08.403
   Coraca-Huber DC, 2014, J ORTHOP RES, V32, P175, DOI 10.1002/jor.22463
   Ferracane JL, 2011, DENT MATER, V27, P29, DOI 10.1016/j.dental.2010.10.020
   Martins CHG, 2011, J MATER SCI-MATER M, V22, P1439, DOI 10.1007/s10856-011-4330-7
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   Hu S, 2009, J MATER SCI-MATER M, V20, P281, DOI 10.1007/s10856-008-3564-5
   Imazato S, 2003, DENT MATER, V19, P449, DOI 10.1016/S0109-5641(02)00102-1
   International Organization for Standardization, 2009, 4049 ISO
   International Organization for Standardization, 2010, 99172 ISO
   Khvostenko D, 2013, DENT MATER, V29, P1139, DOI [10.1016/j.dental.7013.08.707, 10.1016/j.dental.2013.08.207]
   Konishi N, 2003, J ORAL REHABIL, V30, P790, DOI 10.1046/j.1365-2842.2003.01129.x
   Lepparanta O, 2008, MAT SCI MAT MED, V19, P547
   Lima FG, 2009, J APPL ORAL SCI, V17, P61, DOI 10.1590/S1678-77572009000100012
   Munukka E, 2008, J MATER SCI-MATER M, V19, P27, DOI 10.1007/s10856-007-3143-1
   Pal S, 2007, APPL ENVIRON MICROB, V73, P1712, DOI 10.1128/AEM.02218-06
   Rathke A, 2010, J MATER SCI-MATER M, V21, P2971, DOI 10.1007/s10856-010-4126-1
   Sadat-Shojai M, 2010, DENT MATER, V26, P471, DOI 10.1016/j.dental.2010.01.005
   Salehi S, 2015, DENT MATER, V31, P195, DOI 10.1016/j.dental.2014.12.004
   Shackelford JF, 1996, INTRO MAT SCI ENG, P632
   Silva Cecy Martins, 2009, Braz. Dent. J., V20, P54, DOI 10.1590/S0103-64402009000100009
   Steinberg D, 2002, J DENT, V30, P47, DOI 10.1016/S0300-5712(01)00058-6
   Stoor P, 1998, ACTA ODONTOL SCAND, V56, P161, DOI 10.1080/000163598422901
   SVANBERG M, 1990, J DENT RES, V69, P861, DOI 10.1177/00220345900690030601
   Syafiuddin T, 1997, BIOMATERIALS, V18, P1051, DOI 10.1016/S0142-9612(97)88072-6
   Thome T, 2015, ADV POLYM MED, P265
   Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x
   WILSON SJ, 1993, J ORAL REHABIL, V20, P311, DOI 10.1111/j.1365-2842.1993.tb01613.x
   Yamamoto K, 1996, DENT MATER, V12, P227, DOI 10.1016/S0109-5641(96)80027-3
   Yli-Urpo H, 2003, ACTA ODONTOL SCAND, V61, P241, DOI 10.1080/00016350310004719
   Zhang JF, 2014, J DENT RES, V93, P1283, DOI 10.1177/0022034514555143
NR 39
TC 3
Z9 3
U1 1
U2 14
PU WICHTIG PUBLISHING
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 2280-8000
J9 J APPL BIOMATER FUNC
JI J. Appl. Biomater. Funct. Mater.
PD JUL-SEP
PY 2016
VL 14
IS 3
BP E296
EP E301
DI 10.5301/jabfm.5000271
PG 6
WC Biophysics; Engineering, Biomedical; Materials Science, Biomaterials
SC Biophysics; Engineering; Materials Science
GA EI9NG
UT WOS:000392834300009
PM 27149938
DA 2018-10-20
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI NATIONAL BIOMATERIAL CONGRESS - SIB JULY 13-15, 2016 vertical bar
   ISCHIA, ITALY Abstracts
SO Journal of Applied Biomaterials & Functional Materials
LA English
DT Article
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WICHTIG PUBLISHING
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 2280-8000
J9 J APPL BIOMATER FUNC
JI J. Appl. Biomater. Funct. Mater.
PD JUL-SEP
PY 2016
VL 14
IS 3
BP E370
EP E393
PG 24
WC Biophysics; Engineering, Biomedical; Materials Science, Biomaterials
SC Biophysics; Engineering; Materials Science
GA EI9NG
UT WOS:000392834300014
DA 2018-10-20
ER

PT J
AU Wang, SY
   Huang, T
   Lai, C
   Xi, TF
   Liao, SB
   Nan, F
AF Wang, Shuaiyan
   Huang, Tao
   Lai, Chen
   Xi, Tingfei
   Liao, Shibo
   Nan, Fang
TI OXIDIZED NANO-BACTERIAL CELLULOSE/SILK FIBROIN COMPOSITE FILMS
SO CELLULOSE CHEMISTRY AND TECHNOLOGY
LA English
DT Article
DE bacterial cellulose; oxidation; silk fibroin; composite
ID TEMPO-MEDIATED OXIDATION; SURFACE FREE-ENERGY; NATIVE CELLULOSE;
   STEM-CELLS; IN-VITRO; SILK; REGENERATION; BIOMATERIAL; HYDROGEL;
   SCAFFOLD
AB In this work, we investigate the oxidation reaction conditions for bacterial cellulose and the physical and chemical properties of the resulting composite product. The C6 primary hydroxyls of the bacterial cellulose were selectively oxidized to form carboxylate groups using 2,2,6,6-tetramethyl piperidine-1-oxyl (TEMPO) as a catalyst. The carboxylate content was determined by conductivity titration. The performance of the composite products generated by the oxidation carboxylate cross-linking reactions with the amino acid of silk fibroin was analyzed using the contact angle, surface free energy, FT-IR, and FE-SEM. In the TEMPO/NaClO2/NaClO system, the C6 hydroxyl groups of bacterial cellulose were successfully oxidized, and the optimal conditions were determined. The surface free energy and polarization components of the oxidized bacterial cellulose (OBC) film were found to have increased compared to the pure BC pellicles. The OBC/SF composite film surface free energy was the highest and was more prone to the adsorption of endothelial cells. Based on this work, the OBC/SF composite materials described here demonstrate the potential for use in medical material applications and will provide the basis for further experiments.
C1 [Wang, Shuaiyan; Huang, Tao; Xi, Tingfei; Nan, Fang] Wenzhou Med Univ, Sch Lab Med & Life Sci, Wenzhou 325035, Peoples R China.
   [Lai, Chen; Xi, Tingfei] Peking Univ, ShenZhen Key Lab Human Tissue Regenerat & Repair, Shenzhen Inst, Shenzhen 518057, Peoples R China.
   [Lai, Chen; Xi, Tingfei] Wenzhou Med Univ, Sch Informat & Engn, Wenzhou 325035, Peoples R China.
RP Xi, TF (reprint author), Wenzhou Med Univ, Sch Lab Med & Life Sci, Wenzhou 325035, Peoples R China.; Xi, TF (reprint author), Peking Univ, ShenZhen Key Lab Human Tissue Regenerat & Repair, Shenzhen Inst, Shenzhen 518057, Peoples R China.; Xi, TF (reprint author), Wenzhou Med Univ, Sch Informat & Engn, Wenzhou 325035, Peoples R China.
EM xitingfei@pku.edu.cn
FU National "Twelfth Five-Year" Plan for Science & Technology Support
   [2012BAI18B06]
FX This study has been supported by the National "Twelfth Five-Year" Plan
   for Science & Technology Support, small diameter artificial blood
   vessels (NO. 2012BAI18B06).
CR Andersson J, 2010, J BIOMED MATER RES A, V94A, P1124, DOI 10.1002/jbm.a.32784
   BAGNALL RD, 1980, J BIOMED MATER RES, V14, P1, DOI 10.1002/jbm.820140102
   Bhattacharya M, 2012, J CONTROL RELEASE, V164, P291, DOI 10.1016/j.jconrel.2012.06.039
   Bodin A, 2010, BIOMATERIALS, V31, P8889, DOI 10.1016/j.biomaterials.2010.07.108
   Brown EE, 2011, CELLULOSE, V18, P631, DOI 10.1007/s10570-011-9500-8
   Cattaneo I, 2013, INT J ARTIF ORGANS, V36, P166, DOI [10.5301/ijao.5000185, 10.5301/IJAO.5000185]
   Ciechanska D, 2004, FIBRES TEXT EAST EUR, V12, P69
   Dugan JM, 2013, ACTA BIOMATER, V9, P4707, DOI 10.1016/j.actbio.2012.08.050
   Enomoto S, 2010, J VASC SURG, V51, P155, DOI 10.1016/j.jvs.2009.09.005
   Fitz-Binder C, 2014, CARBOHYD POLYM, V106, P142, DOI 10.1016/j.carbpol.2014.02.025
   FREDDI G, 1995, J APPL POLYM SCI, V56, P1537, DOI 10.1002/app.1995.070561203
   Gu HG, 2010, REGEN MED, V5, P245, DOI 10.2217/RME.09.89
   Hallab NJ, 2001, TISSUE ENG, V7, P55, DOI 10.1089/107632700300003297
   Harris J., 2010, US Patent, Patent No. 20107709631
   Hutchens SA, 2006, BIOMATERIALS, V27, P4661, DOI 10.1016/j.biomaterials.2006.04.032
   Inouye K, 1998, J BIOCHEM BIOPH METH, V37, P159, DOI 10.1016/S0165-022X(98)00024-4
   Jung R, 2007, KEY ENG MATER, V342-343, P741, DOI 10.4028/www.scientific.net/KEM.342-343.741
   Kowalska-Ludwicka K, 2013, ARCH MED SCI, V9, P527, DOI 10.5114/aoms.2013.33433
   Kumar V., 2010, US Patent, Patent No. 20107662801
   Lai C, 2013, COLLOID POLYM SCI, V291, P2985, DOI 10.1007/s00396-013-3033-7
   Liimatainen H, 2012, BIOMACROMOLECULES, V13, P1592, DOI 10.1021/bm300319m
   Lin R, 2008, FIBER POLYM, V9, P113, DOI 10.1007/s12221-008-0019-z
   Malm CJ, 2012, SCAND CARDIOVASC J, V46, P57, DOI 10.3109/14017431.2011.623788
   Mohammadi H, 2011, P I MECH ENG H, V225, P718, DOI 10.1177/0954411911399826
   Mothe AJ, 2013, BIOMATERIALS, V34, P3775, DOI 10.1016/j.biomaterials.2013.02.002
   Olivares-Navarrete R, 2012, J BONE MINER RES, V27, P1773, DOI 10.1002/jbmr.1628
   Peng S, 2012, POLYM BULL, V68, P415, DOI 10.1007/s00289-011-0550-8
   Petersen N, 2011, APPL MICROBIOL BIOT, V91, P1277, DOI 10.1007/s00253-011-3432-y
   Retegi A, 2012, CELLULOSE, V19, P103, DOI 10.1007/s10570-011-9598-8
   Saferstein L., 2010, US Patent, Patent No. 20107645874
   Saito T, 2006, CARBOHYD POLYM, V65, P435, DOI 10.1016/j.carbpol.2006.01.034
   Saito T, 2005, CARBOHYD POLYM, V61, P414, DOI 10.1016/j.carbpol.2005.05.014
   Saito T, 2004, BIOMACROMOLECULES, V5, P1983, DOI 10.1021/bm0497769
   Saito T, 2010, J WOOD SCI, V56, P227, DOI 10.1007/s10086-009-1092-7
   SCHAKENRAAD JM, 1986, J BIOMED MATER RES, V20, P773, DOI 10.1002/jbm.820200609
   Schumann DA, 2009, CELLULOSE, V16, P877, DOI 10.1007/s10570-008-9264-y
   Shang SM, 2011, CARBOHYD POLYM, V86, P462, DOI 10.1016/j.carbpol.2011.04.064
   Shi Q, 2012, BIOMATERIALS, V33, P6644, DOI 10.1016/j.biomaterials.2012.05.071
   Silva SS, 2010, CRIT REV BIOTECHNOL, V30, P200, DOI 10.3109/07388551.2010.505561
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   TOEI K, 1976, ANAL CHIM ACTA, V83, P59, DOI 10.1016/S0003-2670(01)84631-6
   Torres FG, 2012, J FUNCT BIOMATER, V3, P864, DOI 10.3390/jfb3040864
   VANDERVALK P, 1983, J BIOMED MATER RES, V17, P807, DOI 10.1002/jbm.820170508
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wiegand C, 2006, CELLULOSE, V13, P689, DOI 10.1007/s10570-006-9073-0
   Yang G, 2000, J MEMBRANE SCI, V177, P153, DOI 10.1016/S0376-7388(00)00467-1
   Yang Xiu-xiang, 2012, J BIOMATHEMATICS, V27, P1
NR 47
TC 0
Z9 0
U1 1
U2 11
PU EDITURA ACAD ROMANE
PI BUCURESTI
PA CALEA 13 SEPTEMBRIE NR 13, SECTOR 5, BUCURESTI 050711, ROMANIA
SN 0576-9787
J9 CELL CHEM TECHNOL
JI Cell Chem. Technol.
PD JUL-AUG
PY 2016
VL 50
IS 7-8
BP 853
EP 862
PG 10
WC Materials Science, Paper & Wood
SC Materials Science
GA EI4MV
UT WOS:000392468700016
DA 2018-10-20
ER

PT J
AU Franceschini, G
   Sanchez, AM
   Visconti, G
   Di Leone, A
   D'Archi, S
   Mule, A
   Santoro, A
   Salgarello, M
   Masetti, R
AF Franceschini, Gianluca
   Sanchez, Alejandro Martin
   Visconti, Giuseppe
   Di Leone, Alba
   D'Archi, Sabatino
   Mule, Antonino
   Santoro, Angela
   Salgarello, Marzia
   Masetti, Riccardo
TI Reduction mammoplasty using oxidized regenerated cellulose as a filler
   in breast conservation surgery
SO ANNALI ITALIANI DI CHIRURGIA
LA English
DT Article
DE Breast cancer; Cosmetic results; Oncoplastic surgery; Oxidized
   regenerated cellulose; QUORC technique
ID CONSERVING SURGERY; SURGICAL-TREATMENT; WOUND EXUDATE; CANCER; MATRIX;
   QUADRANTECTOMY; RADIOTHERAPY; MASTECTOMY; LUMPECTOMY; PROTEASES
AB Oncoplastic surgery of the breast has generated great excitement over the past years and has become an integrated component of the surgical treatment of breast cancer.
   Oncoplastic procedures (OPP) associate the best surgical oncologic principles to achieve wide tumor-free margins with the best principles of plastic surgery to optimize cosmetic outcomes. So, a number of conventional mammoplasty techniques have been adapted to allow reconstruction of resection defects with parenchymal flaps using a variety of different approaches. Thanks to these oncoplastic techniques, the role of breast conserving surgery (BCS) has been extended to include a group of patients who would otherwise require mastectomy to achieve adeguate tumor clearance.
   However, even with the use of therapeutic mammoplasties, cosmetic outcomes may result unsatisfying when a large volume of parenchyma has to be removed, particularly in medium size breasts and for tumor localized in unfavourable location as central, inner-upper and lower quadrants.
   Recently, it has been proposed the use of oxidized regenerated cellulose (ORC) as a reconstructive biomaterial to optimize the aesthetic results after OPP.
   The aim of this article is to describe the standard pattern of an innovative surgical oncoplastic technique with ORC, that we have called "QUORC" (QUadrantectomy with Oxidized Regenerated Cellulose), to improve cosmetic results and minimize the possible postoperative complications after therapeutic mammaplasties.
C1 [Franceschini, Gianluca; Sanchez, Alejandro Martin; Visconti, Giuseppe; Di Leone, Alba; D'Archi, Sabatino; Mule, Antonino; Santoro, Angela; Salgarello, Marzia; Masetti, Riccardo] Univ Cattolica Sacro Cuore, Fdn Policlin Agostino Gemelli, Multidisciplinary Breast Ctr, Polo Salute Donna & Bambino,Area Salute Donna, Rome, Italy.
RP Franceschini, G (reprint author), Univ Cattolica Sacro Cuore, Policlin Agostino Gemelli, Largo Agostino Gemelli 8, I-00168 Rome, Italy.
EM gianlucafranceschini70@gmail.com
OI Sanchez, Alejandro Martin/0000-0002-4840-507X
CR Alfieri S, 2011, MINERVA CHIR, V66, P55
   Anderson BO, 2005, LANCET ONCOL, V6, P145, DOI 10.1016/S1470-2045(05)01765-1
   Bassetto F, 2008, AESTHET PLAST SURG, V32, P807, DOI 10.1007/s00266-008-9203-1
   Belov Iuv, 2009, KHIRURGIIA, P10
   Clough KB, 2010, ANN SURG ONCOL, V17, P1375, DOI 10.1245/s10434-009-0792-y
   Cullen B, 2002, INT J BIOCHEM CELL B, V34, P1544, DOI 10.1016/S1357-2725(02)00054-7
   DELAROCHEFORDIERE A, 1992, INT J RADIAT ONCOL, V23, P925, DOI 10.1016/0360-3016(92)90896-P
   Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152
   Franceschini G, 2012, EUR REV MED PHARMACO, V16, P966
   Franceschini G, 2008, EUR REV MED PHARMACO, V12, P387
   Franceschini G, 2012, EUR REV MED PHARM SC
   Franceschini G, 2015, ANN ITAL CHIR, V86, P548
   Franceschini G, 2015, J SURG RES, V198, P237, DOI 10.1016/j.jss.2015.05.012
   Franceschini G, 2015, ANN ITAL CHIR, V86, P89
   Franceschini G, 2014, BREAST J, V20, P447, DOI 10.1111/tbj.12297
   Gago LA, 2003, AM J OBSTET GYNECOL, V189, P1620, DOI 10.1016/j.ajog.2003.08.018
   Giuliani Michela, 2015, Clin Breast Cancer, V15, pe249, DOI 10.1016/j.clbc.2015.03.008
   Habal Petr, 2011, Acta Medica (Hradec Kralove), V54, P153
   Hart J, 2002, INT J BIOCHEM CELL B, V34, P1557, DOI 10.1016/S1357-2725(02)00062-6
   Jeschke MG, 2005, WOUND REPAIR REGEN, V13, P324, DOI 10.1111/j.1067-1927.2005.130316.x
   Krizova P, 2007, J BIOMED MATER RES A, V82A, P274, DOI 10.1002/jbm.a.31060
   Liu SA, 2012, J CHIN MED ASSOC, V75, P176, DOI 10.1016/j.jcma.2012.03.007
   Masetti R, 2006, BREAST J, V12, pS174, DOI 10.1111/j.1075-122X.2006.00331.x
   Masova L, 2003, Sb Lek, V104, P231
   Mills JM, 1997, INT J RADIAT ONCOL, V39, P637, DOI 10.1016/S0360-3016(97)00381-7
   Nahabedian MY, 2009, ONCOPLASTIC SURG BRE
   OLIVOTTO IA, 1989, INT J RADIAT ONCOL, V17, P747, DOI 10.1016/0360-3016(89)90061-8
   Rassu PC, 2016, ANN MED SURG, V5, P57, DOI 10.1016/j.amsu.2015.12.050
   Rassu PC, 2013, ANN ITAL CHIR, V84, P389
   Smeets R, 2008, INT WOUND J, V5, P195, DOI 10.1111/j.1742-481X.2007.00367.x
   Spangler Daniel, 2003, Surg Infect (Larchmt), V4, P255, DOI 10.1089/109629603322419599
   Tanaka S, 2014, BREAST J, V20, P154, DOI 10.1111/tbj.12229
   TAYLOR ME, 1995, INT J RADIAT ONCOL, V31, P753, DOI 10.1016/0360-3016(94)00480-3
   Ulrich D, 2011, J WOUND OSTOMY CONT, V38, P522, DOI 10.1097/WON.0b013e31822ad290
   VERONESI U, 1990, EUR J CANCER, V26, P671, DOI 10.1016/0277-5379(90)90114-9
   Veronesi U., 2002, INT J RADIAT ONCOL, V347, P1227
NR 36
TC 2
Z9 2
U1 3
U2 3
PU EDIZIONI LUIGI POZZI
PI ROME
PA VIA PANAMA 68, 00198 ROME, ITALY
SN 0003-469X
EI 2239-253X
J9 ANN ITAL CHIR
JI Ann. Ital. Chir.
PD JUL-AUG
PY 2016
VL 87
IS 4
BP 292
EP 297
AR PII S0003469X16025380
PG 6
WC Surgery
SC Surgery
GA EG8ZI
UT WOS:000391346000003
DA 2018-10-20
ER

PT J
AU Haverkamp, L
   Parry, K
   Henegouwen, MIV
   van Laarhoven, HW
   Bonenkamp, JJ
   Bisseling, TM
   Siersema, PD
   Sosef, MN
   Stoot, JH
   Beets, GL
   de Steur, WO
   Hartgrink, HH
   Verspaget, HW
   van der Peet, DL
   Plukker, JT
   van Etten, B
   Wijnhoven, BPL
   van Lanschot, JJ
   van Hillegersberg, R
   Ruurda, JP
AF Haverkamp, L.
   Parry, K.
   Henegouwen, M. I. van Berge
   van Laarhoven, H. W.
   Bonenkamp, J. J.
   Bisseling, T. M.
   Siersema, P. D.
   Sosef, M. N.
   Stoot, J. H.
   Beets, G. L.
   de Steur, W. O.
   Hartgrink, H. H.
   Verspaget, H. W.
   van der Peet, D. L.
   Plukker, J. T.
   van Etten, B.
   Wijnhoven, B. P. L.
   van Lanschot, J. J.
   van Hillegersberg, R.
   Ruurda, J. P.
TI Esophageal and Gastric Cancer Pearl: a nationwide clinical biobanking
   project in the Netherlands
SO DISEASES OF THE ESOPHAGUS
LA English
DT Article
DE biobanking; esophageal and gastric cancer; the Netherlands
ID LONG-TERM SURVIVAL; UK BIOBANK; ADENOCARCINOMA; CARDIA; PATTERNS;
   JUNCTION
AB Esophageal and gastric cancer is associated with a poor prognosis since many patients develop recurrent disease. Treatment requires specific expertise and a structured multidisciplinary approach. In the Netherlands, this type of expertise is mainly found at the University Medical Centers (UMCs) and a few specialized nonacademic centers. Aim of this study is to implement a national infrastructure for research to gain more insight in the etiology and prognosis of esophageal and gastric cancer and to evaluate and improve the response on (neoadjuvant) treatment. Clinical data are collected in a prospective database, which is linked to the patients' biomaterial. The collection and storage of biomaterial is performed according to standard operating procedures in all participating UMCs as established within the Parelsnoer Institute. The collected biomaterial consists of tumor biopsies, blood samples, samples of malignant and healthy tissue of the resected specimen and biopsies of recurrence. The collected material is stored in the local biobanks and is encoded to respect the privacy of the donors. After approval of the study was obtained from the Institutional Review Board, the first patient was included in October 2014. The target aim is to include 300 patients annually. In conclusion, the eight UMCs of the Netherlands collaborated to establish a nationwide database of clinical information and biomaterial of patients with esophageal and gastric cancer. Due to the national coverage, a high number of patients are expected to be included. This will provide opportunity for future studies to gain more insight in the etiology, treatment and prognosis of esophageal and gastric cancer.
C1 [Haverkamp, L.; Parry, K.; van Hillegersberg, R.; Ruurda, J. P.] Univ Med Ctr Utrecht, Dept Surg, POB 85500, NL-3508 GA Utrecht, Netherlands.
   [Siersema, P. D.] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands.
   [Henegouwen, M. I. van Berge] Acad Med Ctr, Dept Surg, Amsterdam, Netherlands.
   [van Laarhoven, H. W.] Acad Med Ctr, Dept Med Oncol, Amsterdam, Netherlands.
   [Verspaget, H. W.] Parelsnoer Inst, Amsterdam, Netherlands.
   [van der Peet, D. L.] Vrije Univ Amsterdam Med Ctr, Dept Surg, Amsterdam, Netherlands.
   [Bonenkamp, J. J.] Radboud Univ Nijmegen, Med Ctr, Dept Surg, Nijmegen, Netherlands.
   [Bisseling, T. M.] Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol & Hepatol, Nijmegen, Netherlands.
   [Sosef, M. N.] Atrium Med Ctr Parkstad, Dept Surg, Heerlen, Netherlands.
   [Stoot, J. H.] Orbis Med Ctr, Dept Surg, Sittard, Netherlands.
   [Beets, G. L.] Maastricht Univ, Med Ctr, Dept Surg, Maastricht, Netherlands.
   [de Steur, W. O.; Hartgrink, H. H.] Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands.
   [Plukker, J. T.; van Etten, B.] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Groningen, Netherlands.
   [Wijnhoven, B. P. L.; van Lanschot, J. J.] Erasmus Univ, Med Ctr, Dept Surg, Rotterdam, Netherlands.
RP Ruurda, JP (reprint author), Univ Med Ctr Utrecht, Dept Surg, POB 85500, NL-3508 GA Utrecht, Netherlands.
EM j.p.ruurda@umcutrecht.nl
RI Siersema, Peter/W-3866-2017; Beets, Geerard/G-2682-2013
OI Beets, Geerard/0000-0002-1671-9912
FU Dutch Federation of University Medical Centers; Dutch Government
FX The work described in this study was carried out in the context of the
   Parelsnoer Institute (PSI). PSI is part of and funded by the Dutch
   Federation of University Medical Centers and has received initial
   funding from the Dutch Government (from 2007-2011).
CR [Anonymous], 2004, STAND OP PROC
   Bollschweiler E, 2001, CANCER, V92, P549, DOI 10.1002/1097-0142(20010801)92:3<549::AID-CNCR1354>3.0.CO;2-L
   Coupland VH, 2013, GUT, V62, P961, DOI 10.1136/gutjnl-2012-303008
   Dassen AE, 2013, INT J CANCER, V133, P1859, DOI 10.1002/ijc.28192
   Devesa SS, 1998, CANCER, V83, P2049, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2
   Dikken JL, 2012, EUR J CANCER, V48, P1624, DOI 10.1016/j.ejca.2012.01.009
   Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4
   Ennis DP, 2010, DIS ESOPHAGUS, V23, P1, DOI 10.1111/j.1442-2050.2009.00969.x
   Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516
   Harvey NC, 2013, OSTEOPOROSIS INT, V24, P2903, DOI 10.1007/s00198-013-2508-1
   Howard JM, 2014, BRIT J SURG, V101, P643, DOI 10.1002/bjs.9469
   Integraal Kankercentrum Nederland, 2010, LAND RICHTL VERS 3 0
   Ito H, 2004, J AM COLL SURGEONS, V199, P880, DOI 10.1016/j.jamcollsurg.2004.08.015
   Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006
   Lahiff C, 2014, BRIT J SURG, V101, P55, DOI 10.1002/bjs.9373
   Mariette C, 2002, BRIT J SURG, V89, P1156, DOI 10.1046/j.1365-2168.2002.02185.x
   Mattioli S, 2001, DIS ESOPHAGUS, V14, P104, DOI 10.1046/j.1442-2050.2001.00165.x
   Ollier W, 2005, PHARMACOGENOMICS, V6, P639, DOI 10.2217/14622416.6.6.639
   Peters CJ, 2010, GASTROENTEROLOGY, V139, P1995, DOI 10.1053/j.gastro.2010.05.080
   Siewert JR, 2000, ANN SURG, V232, P353
   Smith DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075362
   Solaymani-Dodaran M, 2004, GUT, V53, P1070, DOI 10.1136/gut.2003.028076
   Tyrrell JS, 2013, INT J EPIDEMIOL, V42, P1714, DOI 10.1093/ije/dyt220
   van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088
   Weaver JMJ, 2014, NAT GENET, V46, P837, DOI 10.1038/ng.3013
   Wouters MWJM, 2009, ANN SURG ONCOL, V16, P1789, DOI 10.1245/s10434-009-0458-9
NR 26
TC 4
Z9 4
U1 0
U2 6
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1120-8694
EI 1442-2050
J9 DIS ESOPHAGUS
JI Dis. Esophagus
PD JUL
PY 2016
VL 29
IS 5
BP 435
EP 441
DI 10.1111/dote.12347
PG 7
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA DW4ON
UT WOS:000383622800005
PM 25824294
OA Green Published
DA 2018-10-20
ER

PT J
AU Tang, XL
   Lyu, YG
   Zhu, YQ
   Hou, W
   Liang, Y
   Dai, JJ
   Cai, SY
   Mei, RB
   Zhang, C
   Fan, QY
AF Tang, Xiaolong
   Lyu, Yanguan
   Zhu, Yongqiang
   Hou, Wei
   Liang, Yong
   Dai, Jingjing
   Cai, Shuyu
   Mei, Renbiao
   Zhang, Chao
   Fan, Qianyan
TI Enhanced Anti-PDL1(+) Cancer Activity of DM1-Loaded-PLA-TPGS
   Nanoparticles Mediated with MPDL3280A
SO JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
LA English
DT Article
DE MPDL3280A; Emtansine (DM1); Programmed Death-1 Ligand (PDL1); Targeting
   Nanoparticles; Drug Delivery
ID TRASTUZUMAB EMTANSINE T-DM1; SERUM-ALBUMIN NANOPARTICLES; TARGETED
   DRUG-DELIVERY; BREAST-CANCER; IN-VITRO; COPOLYMER; CELLS; VIVO
AB Combined with immuno-chemotherapy, a new targeting nano-delivery system was constructed to overcome the side effects of emtansine (DM1). DM1 was first encapsulated into star-shaped PLA-TPGS nanoparticles, and then PDL1-monoclonal antibody (MPDL3280A) was covalently conjugated to DM1-PLA-TPGS nanoparticles (DM1-NPs-MPDL3280A). As a new molecular biomaterial for drug delivery, DM1-NPs-MPDL3280A was evaluated by the anticancer activity against MDA-MB-453 (PDL1(high)) cells in vivo/vitro. Experiments demonstrated that DM1-NPs-MPDL3280A can specifically target PDL1(+) cancer cells. Most strikingly, compared with conventional DM1 and DM1-loaded-PLA-TPGS copolymer NPs (DM1-NPs), DM1-NPs-MPDL3280A showed significantly enhanced cytotoxicity and increased cell apoptosis in PDL1(+) cancer cells. It might be a potential formulation for targeting immuno-chemotherapy to PDL1(+) tumor.
C1 [Tang, Xiaolong; Dai, Jingjing; Cai, Shuyu; Mei, Renbiao; Zhang, Chao] Anhui Univ Sci & Technol, Stem Cell Engn Res Ctr, Huainan 232001, Peoples R China.
   [Tang, Xiaolong; Hou, Wei] Wuhan Univ, Life Sci Coll, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.
   [Lyu, Yanguan] Yangzhou Univ Med Acad, Huaian Matern & Child Healthcare Hosp, Dept Clin Med Lab, Huaian 223002, Peoples R China.
   [Zhu, Yongqiang] Huazhong Univ Sci & Technol, Dept Med Genet, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China.
   [Liang, Yong] Xuzhou Med Coll, Huaian Hosp, Clin Lab, Huaian 223002, Peoples R China.
   [Fan, Qianyan] Antu Hosp Yangpu Dist Shanghai, Clin Lab, Shanghai 200093, Peoples R China.
RP Fan, QY (reprint author), Antu Hosp Yangpu Dist Shanghai, Clin Lab, Shanghai 200093, Peoples R China.
FU Open Research Fund Program of the State Key Laboratory of Virology of
   China [2014KF004]; National High Technology Research and Development
   Program (863 Program) [2011AA02A111]; Infectious Disease Prevention and
   Control Technology major project [2012ZX10004903]
FX The authors are grateful for the Open Research Fund Program of the State
   Key Laboratory of Virology of China (2014KF004), the National High
   Technology Research and Development Program (863 Program)
   (2011AA02A111), and 2011 Infectious Disease Prevention and Control
   Technology major project (2012ZX10004903).
CR Allen T. M., 2014, SCIENCE, V8, P1818
   Barok M, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3621
   Bauzon M, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00074
   Diessner J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.115
   Gal YS, 2014, J NANOSCI NANOTECHNO, V14, P5480, DOI 10.1166/jnn.2014.8430
   Isakoff SJ, 2011, J CLIN ONCOL, V29, P351, DOI 10.1200/JCO.2010.31.6679
   Ji XY, 2013, J BIOMED NANOTECHNOL, V9, P1672, DOI 10.1166/jbn.2013.1665
   Jin L, 2014, THERANOSTICS, V4, P240, DOI 10.7150/thno.6914
   Kim TH, 2013, J NANOSCI NANOTECHNO, V13, P7325, DOI 10.1166/jnn.2013.8084
   Lee CS, 2014, J NANOSCI NANOTECHNO, V14, P5568, DOI 10.1166/jnn.2014.9067
   Ma NN, 2013, J NANOSCI NANOTECHNO, V13, P6485, DOI 10.1166/jnn.2013.7525
   Ma NN, 2013, J NANOSCI NANOTECHNO, V13, P33, DOI 10.1166/jnn.2013.6697
   Mei L, 2009, NANOSCALE RES LETT, V4, P1530, DOI 10.1007/s11671-009-9431-6
   Sanino A, 2014, J BIOMED NANOTECHNOL, V10, P1620, DOI 10.1166/jbn.2014.1833
   Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138
   Sivasubramanian M, 2013, J NANOSCI NANOTECHNO, V13, P7306, DOI 10.1166/jnn.2013.8090
   Sullivan RJ, 2013, CLIN CANCER RES, V19, P5283, DOI 10.1158/1078-0432.CCR-13-2151
   Tang XL, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-420
   Wang ZY, 2014, J BIOMED NANOTECHNOL, V10, P1509, DOI 10.1166/jbn.2014.1844
   Welslau M, 2014, CANCER-AM CANCER SOC, V120, P642, DOI 10.1002/cncr.28465
   Xiao K, 2012, CANCER RES, V72, P2100, DOI 10.1158/0008-5472.CAN-11-3883
   Yamashita-Kashima Y, 2013, ONCOL REP, V30, P1087, DOI 10.3892/or.2013.2547
   Yuan WM, 2014, J BIOMED NANOTECHNOL, V10, P1563, DOI 10.1166/jbn.2014.1837
   Zhang XJ, 2010, MACROMOLECULES, V43, P6671, DOI 10.1021/ma100653u
   Zhao DM, 2010, INT J NANOMED, V5, P669
   Zhao J, 2014, J BIOMED NANOTECHNOL, V10, P1627, DOI 10.1166/jbn.2014.1835
   Zhong J, 2014, CHINESE J CANCER RES, V26, P355, DOI 10.3978/j.issn.1000-9604.2014.06.04
   Zu YG, 2013, INT J NANOMED, V8, P1207, DOI 10.2147/IJN.S40493
   Zu YG, 2009, INT J NANOMED, V4, P321
NR 29
TC 0
Z9 0
U1 1
U2 8
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1533-4880
EI 1533-4899
J9 J NANOSCI NANOTECHNO
JI J. Nanosci. Nanotechnol.
PD JUL
PY 2016
VL 16
IS 7
BP 7055
EP 7063
DI 10.1166/jnn.2016.11355
PG 9
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA EB1HM
UT WOS:000387100400062
DA 2018-10-20
ER

PT J
AU Sadtler, K
   Singh, A
   Wolf, MT
   Wang, XK
   Pardoll, DM
   Elisseeff, JH
AF Sadtler, Kaitlyn
   Singh, Anirudha
   Wolf, Matthew T.
   Wang, Xiaokun
   Pardoll, Drew M.
   Elisseeff, Jennifer H.
TI Design, clinical translation and immunological response of biomaterials
   in regenerative medicine
SO NATURE REVIEWS MATERIALS
LA English
DT Review
ID MESENCHYMAL STEM-CELLS; AUTOLOGOUS CHONDROCYTE TRANSPLANTATION;
   TISSUE-ENGINEERED CORNEA; ANTIGEN-PRESENTING CELLS;
   EXTRACELLULAR-MATRIX; IN-VIVO; INVIVO BIOCOMPATIBILITY; HIGH-THROUGHPUT;
   CARTILAGE REGENERATION; MACROPHAGE ACTIVATION
AB The field of regenerative medicine aims to replace tissues lost as a consequence of disease, trauma or congenital abnormalities. Biomaterials serve as scaffolds for regenerative medicine to deliver cells, provide biological signals and physical support, and mobilize endogenous cells to repair tissues. Sophisticated chemistries are used to synthesize materials that mimic and modulate native tissue microenvironments, to replace form and to elucidate structure-function relationships of cell-material interactions. The therapeutic relevance of these biomaterial properties can only be studied after clinical translation, whereby key parameters for efficacy can be defined and then used for future design. In this Review, we present the development and translation of biomaterials for two tissue engineering targets, cartilage and cornea, both of which lack the ability to self-repair. Finally, looking to the future, we discuss the role of the immune system in regeneration and the potential for biomaterial scaffolds to modulate immune signalling to create a pro-regenerative environment.
C1 [Sadtler, Kaitlyn; Singh, Anirudha; Wolf, Matthew T.; Wang, Xiaokun; Elisseeff, Jennifer H.] Johns Hopkins Univ, Translat Tissue Engn Ctr, Dept Biomed Engn, Baltimore, MD 21287 USA.
   [Sadtler, Kaitlyn; Singh, Anirudha; Wolf, Matthew T.; Wang, Xiaokun; Elisseeff, Jennifer H.] Johns Hopkins Univ, Wilmer Eye Inst, Baltimore, MD 21287 USA.
   [Singh, Anirudha] Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21287 USA.
   [Pardoll, Drew M.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA.
RP Elisseeff, JH (reprint author), Johns Hopkins Univ, Translat Tissue Engn Ctr, Dept Biomed Engn, Baltimore, MD 21287 USA.; Elisseeff, JH (reprint author), Johns Hopkins Univ, Wilmer Eye Inst, Baltimore, MD 21287 USA.
EM jhe@jhu.edu
RI Wang, Xiaokun/D-7461-2018
OI Wang, Xiaokun/0000-0003-1992-4951
FU Bloomberg similar to Kimmel Institute for Cancer Immunotherapy; Hartwell
   Foundation; Jules and Doris Stein Research; Armed Forces Institute of
   Regenerative Medicine (AFIRM) a US Department of Defense
   [W81XWH-11-2-0022]; Maryland Stem Cell Research Fund (MSCRF) [113345]
FX The authors acknowledge M. Frisk for helpful discussions and critical
   review, and the Bloomberg similar to Kimmel Institute for Cancer
   Immunotherapy for support. M.T.W. was supported by a postdoctoral
   fellowship from the Hartwell Foundation. J.H.E was supported by the
   Jules and Doris Stein Research to Prevent Blindness Professorship. This
   work was funded by grants from the Armed Forces Institute of
   Regenerative Medicine (AFIRM), a US Department of Defense grant
   #W81XWH-11-2-0022 and the Maryland Stem Cell Research Fund (MSCRF)
   #113345 awarded to J.H.E.
CR Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559
   Ahn JM, 2014, J PROTEOME RES, V13, P137, DOI 10.1021/pr400792p
   AIELLO LP, 1995, P NATL ACAD SCI USA, V92, P10457, DOI 10.1073/pnas.92.23.10457
   Ali OA, 2011, CURR TOP MICROBIOL, V344, P279, DOI 10.1007/82_2010_69
   Ali OA, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000359
   Almany L, 2005, BIOMATERIALS, V26, P2467, DOI 10.1016/j.biomaterials.2004.06.047
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   APPLE DJ, 1992, SURV OPHTHALMOL, V37, P73, DOI 10.1016/0039-6257(92)90073-3
   Avadhanam VS, 2015, CLIN OPHTHALMOL, V9, P697, DOI 10.2147/OPTH.S27083
   Azarin SM, 2012, BIOMATERIALS, V33, P2041, DOI 10.1016/j.biomaterials.2011.11.070
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Ballios BG, 2010, BIOMATERIALS, V31, P2555, DOI 10.1016/j.biomaterials.2009.12.004
   Banquy X, 2014, J AM CHEM SOC, V136, P6199, DOI 10.1021/ja501770y
   Barbul A, 1988, Prog Clin Biol Res, V266, P161
   Baskin JM, 2007, P NATL ACAD SCI USA, V104, P16793, DOI 10.1073/pnas.0707090104
   BAUER TW, 1991, J BONE JOINT SURG AM, V73A, P1439, DOI 10.2106/00004623-199173100-00001
   Beachley VZ, 2015, NAT METHODS, V12, P1197, DOI 10.1038/nmeth.3619
   Beck JN, 2013, BIOMATERIALS, V34, P9486, DOI 10.1016/j.biomaterials.2013.08.077
   BEDNARZ J, 1995, CORNEA, V14, P372, DOI 10.1097/00003226-199507000-00005
   Bencherif SA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8556
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   BOON T, 1994, ANNU REV IMMUNOL, V12, P337, DOI 10.1146/annurev.immunol.12.1.337
   Borrelli M, 2015, BIOMATERIALS, V42, P112, DOI 10.1016/j.biomaterials.2014.11.038
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034
   Bryers JD, 2012, BIOTECHNOL BIOENG, V109, P1898, DOI 10.1002/bit.24559
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Chehade M, 1997, AUST NZ J OPHTHALMOL, V25, P255, DOI 10.1111/j.1442-9071.1997.tb01512.x
   Chen SB, 2004, J AM CHEM SOC, V126, P410, DOI 10.1021/ja037390k
   Chen W, 2010, INVEST OPHTH VIS SCI, V51, P775, DOI 10.1167/iovs.09-3422
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   CHIRILA TV, 1993, BIOMATERIALS, V14, P26, DOI 10.1016/0142-9612(93)90072-A
   Coburn JM, 2012, P NATL ACAD SCI USA, V109, P10012, DOI 10.1073/pnas.1121605109
   Cole Brian J, 2010, Instr Course Lect, V59, P181
   COLEY WB, 1991, CLIN ORTHOP RELAT R, P3
   Crawford DC, 2012, J BONE JOINT SURG AM, V94A, P979, DOI 10.2106/JBJS.K.00533
   Dahlin RL, 2014, BIOMATERIALS, V35, P7460, DOI 10.1016/j.biomaterials.2014.05.055
   de Boer J, 2004, BONE, V34, P818, DOI 10.1016/j.bone.2004.01.016
   DeForest CA, 2011, NAT CHEM, V3, P925, DOI [10.1038/nchem.1174, 10.1038/NCHEM.1174]
   Dewan AK, 2014, BIOMED RES INT, DOI 10.1155/2014/272481
   DIPIETRO LA, 1995, SHOCK, V4, P233, DOI 10.1097/00024382-199510000-00001
   Elisseeff J, 2000, J BIOMED MATER RES, V51, P164, DOI 10.1002/(SICI)1097-4636(200008)51:2<164::AID-JBM4>3.0.CO;2-W
   Elisseeff J, 1999, P NATL ACAD SCI USA, V96, P3104, DOI 10.1073/pnas.96.6.3104
   Elisseeff Jennifer, 2013, Middle East Afr J Ophthalmol, V20, P38, DOI 10.4103/0974-9233.106385
   Elliott MJ, 2012, LANCET, V380, P994, DOI 10.1016/S0140-6736(12)60737-5
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Epelman S, 2015, NAT REV IMMUNOL, V15, P117, DOI 10.1038/nri3800
   Fagerholm P, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001022
   Fennema E, 2013, TRENDS BIOTECHNOL, V31, P108, DOI 10.1016/j.tibtech.2012.12.003
   Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736
   Flannery CR, 2009, ARTHRITIS RHEUM-US, V60, P840, DOI 10.1002/art.24304
   Foldager CB, 2012, CARTILAGE, V3, P108, DOI 10.1177/1947603511435522
   Fu Y, 2010, CELLS TISSUES ORGANS, V191, P193, DOI 10.1159/000235680
   Gammon JM, 2015, J CONTROL RELEASE, V210, P169, DOI 10.1016/j.jconrel.2015.05.277
   Gaudilliere B., 2014, SCI TRANSL MED, V6, DOI DOI 10.1126/SCITRANSLMED.3009701
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Gobaa S, 2011, NAT METHODS, V8, P949, DOI [10.1038/NMETH.1732, 10.1038/nmeth.1732]
   Godwin JW, 2013, P NATL ACAD SCI USA, V110, P9415, DOI 10.1073/pnas.1300290110
   Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978
   Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023
   Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Hamdy S, 2011, ADV DRUG DELIVER REV, V63, P943, DOI 10.1016/j.addr.2011.05.021
   Haraguchi Y, 2012, NAT PROTOC, V7, P850, DOI 10.1038/nprot.2012.027
   HARRIS WH, 1990, NEW ENGL J MED, V323, P725, DOI 10.1056/NEJM199009133231106
   Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053
   Hillel AT, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002331
   Hori Y, 2008, BIOMATERIALS, V29, P3671, DOI 10.1016/j.biomaterials.2008.05.033
   Hwang NS, 2008, P NATL ACAD SCI USA, V105, P20641, DOI 10.1073/pnas.0809680106
   Jahn S, 2015, MACROMOLECULES, V48, P5059, DOI 10.1021/acs.macromol.5b00327
   Jeng L, 2013, TISSUE ENG PT A, V19, P2267, DOI [10.1089/ten.TEA.2013.0013, 10.1089/ten.tea.2013.0013]
   Jenner E., 1863, ORIGIN VACCINE INOCU
   Jones ARC, 2007, J ORTHOP RES, V25, P283, DOI 10.1002/jor.20325
   Jones ARC, 2009, ARTHRITIS RHEUM-US, V60, P133, DOI 10.1002/art.24143
   Kaul H., TISSUE ENG B, V21, P203
   Khademhosseini A, 2007, BIOMATERIALS, V28, P5087, DOI 10.1016/j.biomaterials.2007.07.021
   Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]
   Kilian KA, 2012, ANGEW CHEM INT EDIT, V51, P4891, DOI 10.1002/anie.201108746
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Konnecke I, 2014, BONE, V64, P155, DOI 10.1016/j.bone.2014.03.052
   Koizumi N, 2000, INVEST OPHTH VIS SCI, V41, P2506
   Kon E, 2015, J ORTHOP SURG RES, V10, DOI 10.1186/s13018-015-0211-y
   Kumar VA, 2015, J AM CHEM SOC, V137, P4823, DOI 10.1021/jacs.5b01549
   Kwong B, 2011, BIOMATERIALS, V32, P5134, DOI 10.1016/j.biomaterials.2011.03.067
   LaBarge MA, 2009, INTEGR BIOL-UK, V1, P70, DOI 10.1039/b816472j
   Lace R, 2015, J MATER SCI, V50, P1523, DOI 10.1007/s10853-014-8707-0
   Ladet S, 2008, NATURE, V452, P76, DOI 10.1038/nature06619
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   Lee CH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009696
   Lee HI, 2010, PROG POLYM SCI, V35, P24, DOI 10.1016/j.progpolymsci.2009.11.002
   Levorson EJ, 2014, ACTA BIOMATER, V10, P1824, DOI 10.1016/j.actbio.2013.12.026
   Li K, 2014, CELL STEM CELL, V14, P228, DOI 10.1016/j.stem.2014.01.006
   Li WL, 2010, TRENDS PHARMACOL SCI, V31, P36, DOI 10.1016/j.tips.2009.10.002
   Liu JS, 2012, TRENDS CELL BIOL, V22, P683, DOI 10.1016/j.tcb.2012.09.004
   Liu QH, 2015, ACTA BIOMATER, V26, P105, DOI 10.1016/j.actbio.2015.08.017
   Liu XH, 2011, NAT MATER, V10, P398, DOI [10.1038/NMAT2999, 10.1038/nmat2999]
   Lloyd AW, 2001, BIOMATERIALS, V22, P769, DOI 10.1016/S0142-9612(00)00237-4
   Lowther G. E., 1992, CONTACT LENSES PROCE
   Luo HL, 2013, BIOMATERIALS, V34, P6748, DOI 10.1016/j.biomaterials.2013.05.045
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Ma J, 2003, CELL MOL LIFE SCI, V60, P2334, DOI 10.1007/s00018-003-3020-0
   Ma XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132705
   Ma Z, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8413
   Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6
   MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016
   Majumdar S, 2016, J BIOMED MATER RES B, V104, P300, DOI 10.1002/jbm.b.33381
   MARCHANT R, 1983, J BIOMED MATER RES, V17, P301, DOI 10.1002/jbm.820170209
   MARCHANT RE, 1984, J BIOMED MATER RES, V18, P1169, DOI 10.1002/jbm.820180917
   MARCHANT RE, 1984, J BIOMED MATER RES, V18, P309, DOI 10.1002/jbm.820180307
   MARCHANT RE, 1986, J BIOMED MATER RES, V20, P37, DOI 10.1002/jbm.820200105
   Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303
   Matzinger P, 2007, NAT IMMUNOL, V8, P11, DOI 10.1038/ni0107-11
   Matzinger P, 2011, NAT REV IMMUNOL, V11, P221, DOI 10.1038/nri2940
   MAZZOLA RF, 1983, PLAST RECONSTR SURG, V72, P408, DOI 10.1097/00006534-198309000-00031
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002
   Merrett K, 2008, INVEST OPHTH VIS SCI, V49, P3887, DOI 10.1167/iovs.07-1348
   Mikos AG, 2006, TISSUE ENG, V12, P3307, DOI 10.1089/ten.2006.12.3307
   MILAUSKAS AT, 1991, ARCH OPHTHALMOL-CHIC, V109, P913, DOI 10.1001/archopht.1991.01080070023006
   Miller JS, 2012, NAT MATER, V11, P768, DOI [10.1038/NMAT3357, 10.1038/nmat3357]
   Moon JJ, 2012, ADV MATER, V24, P3724, DOI 10.1002/adma.201200446
   Morrison RJ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010825
   Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822
   Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958
   Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008
   Murthy KR, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-29
   Naba A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014647
   Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151
   Needham J., 2000, SCI CIVILISATION C 6, V6, P134
   Nicolson PC, 2001, BIOMATERIALS, V22, P3273, DOI 10.1016/S0142-9612(01)00165-X
   Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455
   Obradovic B, 2001, J ORTHOPAED RES, V19, P1089, DOI 10.1016/S0736-0266(01)00030-4
   Otis JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092363
   Pace LA, 2013, BIOMATERIALS, V34, P5907, DOI 10.1016/j.biomaterials.2013.04.024
   Pashuck ET, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002717
   Pasteur L., 1996, GERM THEORY ITS APPL
   Peterson L, 2003, J BONE JOINT SURG AM, V85A, P17, DOI 10.2106/00004623-200300002-00003
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Purcell BP, 2014, NAT MATER, V13, P653, DOI [10.1038/nmat3922, 10.1038/NMAT3922]
   Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955
   Rape AD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9129
   Ratner B. D., 2013, BIOMATERIALS SCI, P41
   Reid B, 2015, J TISSUE ENG REGEN M, V9, P315, DOI 10.1002/term.1688
   Reiffel AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056506
   Reinke S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004754
   Rengarajan J, 2000, IMMUNOL TODAY, V21, P479, DOI 10.1016/S0167-5699(00)01712-6
   RIDLEY H, 1952, BRIT J OPHTHALMOL, V36, P113, DOI 10.1136/bjo.36.3.113
   Rnjak-Kovacina J, 2015, ACS BIOMATER SCI ENG, V1, P260, DOI 10.1021/ab500149p
   Sadtler K, 2016, SCIENCE, V352, P366, DOI 10.1126/science.aad9272
   Saeidi N, 2012, BIOMATERIALS, V33, P7366, DOI 10.1016/j.biomaterials.2012.06.041
   Saraf A, 2009, TISSUE ENG PART C-ME, V15, P333, DOI 10.1089/ten.tec.2008.0422
   Schense JC, 2000, NAT BIOTECHNOL, V18, P415
   Schlundt C., 2015, BONE
   Schmalzried TP, 1999, J BONE JOINT SURG AM, V81A, P115, DOI 10.2106/00004623-199901000-00016
   Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804
   Seror J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7497
   Shafiq MA, 2012, TISSUE ENG PART C-ME, V18, P340, DOI [10.1089/ten.TEC.2011.0072, 10.1089/ten.tec.2011.0072]
   Shah RN, 2010, P NATL ACAD SCI USA, V107, P3293, DOI 10.1073/pnas.0906501107
   Sharma B, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004838
   Silva JM, 2013, J CONTROL RELEASE, V168, P179, DOI 10.1016/j.jconrel.2013.03.010
   Singh A, 2014, NAT MATER, V13, P988, DOI [10.1038/NMAT4048, 10.1038/nmat4048]
   Singh A, 2013, ADV FUNCT MATER, V23, P575, DOI 10.1002/adfm.201201902
   Somoza RA, 2014, TISSUE ENG PART B-RE, V20, P596, DOI [10.1089/ten.teb.2013.0771, 10.1089/ten.TEB.2013.0771]
   Stevens MM, 2005, P NATL ACAD SCI USA, V102, P11450, DOI 10.1073/pnas.0504705102
   Strehin I, 2010, BIOMATERIALS, V31, P2788, DOI 10.1016/j.biomaterials.2009.12.033
   Sugiyama H, 2014, MOL THER, V22, P1544, DOI 10.1038/mt.2014.69
   Sunshine JC, 2014, BIOMATERIALS, V35, P269, DOI 10.1016/j.biomaterials.2013.09.050
   Sunshine JC, 2013, NANOMEDICINE-UK, V8, P1173, DOI [10.2217/NNM.13.98, 10.2217/nnm.13.98]
   Takezawa T, 2004, CELL TRANSPLANT, V13, P463, DOI 10.3727/000000004783983882
   Tan DTH, 2012, LANCET, V379, P1749, DOI 10.1016/S0140-6736(12)60437-1
   Thurston AJ, 2007, ANZ J SURG, V77, P1114, DOI 10.1111/j.1445-2197.2007.04330.x
   Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009
   Uzunalli G, 2014, ACTA BIOMATER, V10, P1156, DOI 10.1016/j.actbio.2013.12.002
   Vegas AJ, 2016, NAT BIOTECHNOL, V34, P345, DOI 10.1038/nbt.3462
   Vunjak-Novakovic G, 2004, ANNU REV BIOMED ENG, V6, P131, DOI 10.1146/annurev.bioeng.6.040803.140037
   Wang DA, 2007, NAT MATER, V6, P385, DOI 10.1038/nmat1890
   Wang S, 2001, BIOMATERIALS, V22, P1157, DOI 10.1016/S0142-9612(00)00356-2
   Warnke PH, 2004, LANCET, V364, P766, DOI 10.1016/S0140-6736(04)16935-3
   Wolf MT, 2015, ADV DRUG DELIVER REV, V84, P208, DOI 10.1016/j.addr.2014.08.011
   Wong BL, 2008, ARTHRITIS RHEUM-US, V58, P2065, DOI 10.1002/art.23548
   Xie XT, 2012, BIOMATERIALS, V33, P7008, DOI 10.1016/j.biomaterials.2012.06.058
   Yaghouti F, 2001, CORNEA, V20, P19, DOI 10.1097/00003226-200101000-00003
   Yang C, 2014, NAT MATER, V13, P645, DOI [10.1038/NMAT3889, 10.1038/nmat3889]
   Zhao HF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111846
NR 194
TC 23
Z9 24
U1 19
U2 71
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2058-8437
J9 NAT REV MATER
JI Nat. Rev. Mater.
PD JUL
PY 2016
VL 1
IS 7
AR UNSP 16040
DI 10.1038/natrevmats.2016.40
PG 17
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA EA0DZ
UT WOS:000386257000003
DA 2018-10-20
ER

PT J
AU Cheng, GG
   Rong, GY
   Wang, XH
   Kang, H
   Jin, Z
   Zhao, K
AF Cheng, Guogang
   Rong, Guangyu
   Wang, Xiaohua
   Kang, Hong
   Jin, Zheng
   Zhao, Kai
TI Effect of Degrees of Substitution on Physicochemical Properties of
   2-Hydroxypropyl Trimethyl Ammonium Chloride Chitosan
SO SCIENCE OF ADVANCED MATERIALS
LA English
DT Article
DE 2-Hydroxypropyl Trimethyl Ammonium Chloride Chitosan; Nanoparticles;
   Degree of Substitution; Water Solubility; Delivery Carrier
ID ANTIBACTERIAL ACTIVITY; DNA DELIVERY; IN-VITRO; NANOPARTICLES;
   DERIVATIVES; MICROSPHERES; CYTOTOXICITY; SOLUBILITY; RELEASE
AB 2-hydroxypropyl trimethyl ammonium chloride chitosan (HACC), a cationic biopolymer derived from chitosan, has been described as a vehicle for gene and drug delivery and an excellent sustainably-released biomedical material for broad applications. This study aimed to explore the relationship between degree of substitution (DS) of HACC and the properties of HACC-sodium tripolyphosphate nanoparticles (HACC-TPP-NPs). A series of the HACCs with different DSs were synthesized by using prior protection of amino group with benzaldehyde. The effect of DSs on water solubility, mean sizes and zeta potentials of the HACCs were determined. It was found that the HACCs had good water solubility which was increased significantly with increasing DS percentage. The DS percentage of HACCs was found to be a critical factor for forming the HACC-TPP-NPs, when their DSs were 60.19% and 68.95%, HACC-TPP-NPs exhibited a spherical outline and uniform size and they were distributed evenly without obvious agglomeration and with the mean size of about 300 nm. The HACCs with 60.19% and 68.95% of DS could be a potential biomaterial as gene and drug delivery, and the HACC-TPP-NPs could be a drug delivery carrier with immense potential in medical applications.
C1 [Cheng, Guogang; Jin, Zheng] Heilongjiang Univ, Coll Chem & Mat Sci, Key Lab Chem Engn Proc & Technol High Efficiency, Harbin 150080, Peoples R China.
   [Zhao, Kai] Univ Jinan, Sch Biol Sci & Technol, Jinan 250022, Peoples R China.
   [Cheng, Guogang; Rong, Guangyu; Wang, Xiaohua; Kang, Hong; Zhao, Kai] Heilongjiang Univ, Sch Life Sci, Key Lab Microbiol, Harbin 150080, Peoples R China.
RP Jin, Z (reprint author), Heilongjiang Univ, Coll Chem & Mat Sci, Key Lab Chem Engn Proc & Technol High Efficiency, Harbin 150080, Peoples R China.; Zhao, K (reprint author), Univ Jinan, Sch Biol Sci & Technol, Jinan 250022, Peoples R China.; Zhao, K (reprint author), Heilongjiang Univ, Sch Life Sci, Key Lab Microbiol, Harbin 150080, Peoples R China.
EM jinzhengdvd@163.com; zybin395@126.com
OI Jin, Zheng/0000-0003-2537-6664; Zhao, Kai/0000-0001-6139-1912
FU National Natural Science Foundation of China [31570929]; Natural Science
   Foundation of Heilongjiang Province of China [ZD2015002]; Innovative
   Research Team for Agricultural Microbiology Fermentation Technology at
   Heilongjiang Provincial University [2012td009]; Changjiang Scholar
   Candidates Program for Provincial Universities in Heilongjiang
   [2014CJHB005]; Scientific and Technological Key Project of Heilongjiang
   Province [GC13B403]; Technological innovation talent Foundation of
   Harbin [2013RFQXJ030]; Project of Graduate Innovative Scientific
   Research Foundation of Heilongjiang University [YJSCX2015-029HLJU]
FX This work was supported in part by the National Natural Science
   Foundation of China (31570929), the Key Program of Natural Science
   Foundation of Heilongjiang Province of China (ZD2015002), the Innovative
   Research Team for Agricultural Microbiology Fermentation Technology at
   Heilongjiang Provincial University (2012td009), the Changjiang Scholar
   Candidates Program for Provincial Universities in Heilongjiang
   (2014CJHB005), the Scientific and Technological Key Project of
   Heilongjiang Province (GC13B403), the Technological innovation talent
   Foundation of Harbin (2013RFQXJ030) and Project of Graduate Innovative
   Scientific Research Foundation of Heilongjiang University
   (YJSCX2015-029HLJU).
CR Butstraen C, 2014, CARBOHYD POLYM, V99, P608, DOI 10.1016/j.carbpol.2013.09.006
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Deng HB, 2013, J BIOMAT SCI-POLYM E, V24, P485, DOI 10.1080/09205063.2012.695711
   Guan M, 2012, NANOMED-NANOTECHNOL, V8, P1172, DOI 10.1016/j.nano.2012.01.009
   Guo AJ, 2014, INT J BIOL MACROMOL, V67, P163, DOI 10.1016/j.ijbiomac.2014.03.024
   Huang M, 2004, PHARM RES, V21, P344, DOI 10.1023/B:PHAM.0000016249.52831.a5
   Jayakumar R, 2010, PROG MATER SCI, V55, P675, DOI 10.1016/j.pmatsci.2010.03.001
   Je JY, 2006, J AGR FOOD CHEM, V54, P6629, DOI 10.1021/jf061310p
   Jin Z, 2013, CHEM ENG J, V221, P331, DOI 10.1016/j.cej.2013.02.011
   Li GF, 2015, APPL BIOCHEM BIOTECH, V175, P3244, DOI 10.1007/s12010-015-1483-8
   Mandavinia GR, 2015, CARBOHYD POLYM, V128, P112, DOI 10.1016/j.carbpol.2015.04.022
   Mi FL, 2002, BIOMATERIALS, V23, P181, DOI 10.1016/S0142-9612(01)00094-1
   Ninan N, 2013, ACS APPL MATER INTER, V5, P11194, DOI 10.1021/am403436y
   NISHIMURA SI, 1991, MACROMOLECULES, V24, P4745, DOI 10.1021/ma00017a003
   Paiva D, 2013, PHYS CHEM CHEM PHYS, V15, P11893, DOI 10.1039/c3cp51215k
   Park JH, 2003, BIOMACROMOLECULES, V4, P1087, DOI 10.1021/bm034094r
   Patil SD, 2005, AAPS J, V7, pE61, DOI 10.1208/aapsj070109
   Portero A, 2002, J MICROENCAPSUL, V19, P797, DOI 10.1080/0265204021000022761
   Quemeneur F, 2008, BIOMACROMOLECULES, V9, P396, DOI 10.1021/bm700943j
   Sato T, 2001, BIOMATERIALS, V22, P2075, DOI 10.1016/S0142-9612(00)00385-9
   Sogias IA, 2008, BIOMACROMOLECULES, V9, P1837, DOI 10.1021/bm800276d
   Wang Q, 2014, CARBOHYD POLYM, V102, P877, DOI 10.1016/j.carbpol.2013.10.071
   Wang XH, 2012, J MATER SCI-MATER M, V23, P1663, DOI 10.1007/s10856-012-4627-1
   Xu T, 2011, CARBOHYD RES, V346, P2445, DOI 10.1016/j.carres.2011.08.002
   Zhao K, 2014, INT J NANOMED, V9, P389, DOI 10.2147/IJN.S54226
NR 25
TC 1
Z9 1
U1 0
U2 9
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1947-2935
EI 1947-2943
J9 SCI ADV MATER
JI Sci. Adv. Mater.
PD JUL
PY 2016
VL 8
IS 7
BP 1433
EP 1439
DI 10.1166/sam.2016.2748
PG 7
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA DZ1PC
UT WOS:000385609300014
DA 2018-10-20
ER

PT J
AU Palumbo, FP
   Harding, KG
   Abbritti, F
   Bradbury, S
   Cech, JD
   Ivins, N
   Klein, D
   Menzinger, G
   Meuleneire, F
   Seratoni, S
   Zolss, C
   Mayer, D
AF Palumbo, Francesco Paolo
   Harding, Keith G.
   Abbritti, Franca
   Bradbury, Sarah
   Cech, Juergen Dietmar
   Ivins, Nicola
   Klein, Dieter
   Menzinger, Gabrielle
   Meuleneire, Frans
   Seratoni, Simone
   Zoelss, Christoph
   Mayer, Dieter
TI New Surfactant-based Dressing Product to Improve Wound Closure Rates of
   Nonhealing Wounds: A European Multicenter Study Including 1036 Patients
SO WOUNDS-A COMPENDIUM OF CLINICAL RESEARCH AND PRACTICE
LA English
DT Article
DE silver sulphadiazine; wound closure; chronic wounds; biofilm;
   surfactant; antimicrobial; silver dressings
ID NEUROPATHIC FOOT ULCERS; VENOUS LEG ULCERS; INJURY; GUIDELINES; CARE
AB Objective. A new surfactant-based biomaterial containing the antimicrobial 1% silver sulfadiazine (SSD) was developed at the University of Virginia (Charlottesville, VA) to improve outcomes for nonhealing wounds. This study's objective was to clinically test the wound care outcomes of the new surfactant-based antimicrobial wound dressing (SAWD) in a multicenter trial. Methods and Materials. This cohort study enrolled 1036 patients with any nonhealing wound of > 3 months duration not responding to standard-of-care treatments from 10 wound care centers in 7 European countries. The SAWD was used for all wound types at all stages of complexity, healing, and severity. Data collection ranged from 6 months to 2 years and measured the percentage of patients achieving wound closure and time to complete closure. Results. Of the 1036 patients, 70% achieved wound closure, 24.6% were still in treatment at data collection, and 5.4% had a therapy change. The majority (56%) of these non-healing wounds achieved wound closure within 11 weeks. Patients were treated with the SAWD for 3 weeks to more than 1 year with no complications or adverse effects from long-term SSD antimicrobial use. Conclusion. Ten centers concluded that the new SAWD provided positive results (improved wound closure rates, reduction of inflammation, pain, and odor), improvements in clinical application (faster and easier dressing change), and improved patient compliance.
C1 [Palumbo, Francesco Paolo] Azienda Osped Univ, Policlin Paolo Giaccone Palermo, Dept Geriatr Surg, Palermo, Sicily, Italy.
   [Harding, Keith G.; Bradbury, Sarah; Ivins, Nicola] Cardiff Univ, Wound Healing Sch Med, Cardiff, S Glam, Wales.
   [Abbritti, Franca] AOG Salvini, Vasc Surg Unit, Garbagnate Milanese, Italy.
   [Cech, Juergen Dietmar; Zoelss, Christoph] Facharztezentrum Graz, Ambulatorien Steiermarkischen Gebietskrankenkasse, Graz, Austria.
   [Klein, Dieter] Stadt Krankenhaus Offenbach, Diabetol DDG, Wound Care Ctr, Offenbach, Germany.
   [Meuleneire, Frans] AZ St Elisabeth Zottegem, Wound Care Ctr, Zottegem, Belgium.
   [Meuleneire, Frans] Wondzorg De Parel Zorg & Dienstenctr, Hillegem, Belgium.
   [Seratoni, Simone] Villa Fiorita Surg Clin, Vulnol Ctr, Prato, Italy.
   [Seratoni, Simone] Villa Fiorita Surg Clin, Unit Gen Surg 2, Prato, Italy.
   [Mayer, Dieter] Univ Zurich Hosp, Clin Cardiovasc Surg, Zurich, Switzerland.
RP Palumbo, FP (reprint author), Div Surg, Via Cantagallo 56, I-59100 Prato, Italy.
EM drpalumbo.studio@gmail.com
OI Mayer, Dieter/0000-0001-5933-7749
CR Birchenough SA, 2008, ANN PLAS SURG, V60, P584, DOI 10.1097/SAP.0b013e3181651661
   Blume P, 2011, WOUND REPAIR REGEN, V19, P302, DOI 10.1111/j.1524-475X.2011.00669.x
   Curry DJ, 2004, J NEUROSURG, V101, P91, DOI 10.3171/ped.2004.101.2.0091
   da Costa RM, 1999, WOUND REPAIR REGEN, V7, P17, DOI 10.1046/j.1524-475X.1999.00017.x
   Fife CE, 2012, WOUNDS, V24, P10
   Gelfand JM, 2002, J INVEST DERMATOL, V119, P1420, DOI 10.1046/j.1523-1747.2002.19629.x
   Hunter RL, 2010, ANN CLIN LAB SCI, V40, P115
   LEE RC, 1992, P NATL ACAD SCI USA, V89, P4524, DOI 10.1073/pnas.89.10.4524
   Mostow EN, 2005, J VASC SURG, V41, P837, DOI 10.1016/j.jvs.2005.01.042
   Phillips TJ, 2000, J AM ACAD DERMATOL, V43, P627, DOI 10.1067/mjd.2000.107496
   Posnett J, 2009, J Wound Care, V18, P154
   Robson MC, 2006, WOUND REPAIR REGEN, V14, P649, DOI 10.1111/j.1524-475X.2006.00174.x
   Rodeheaver G, 2014, US patent, Patent No. [8,871,248 B2, 8871248]
   RODEHEAVER GT, 1975, AM J SURG, V129, P241, DOI 10.1016/0002-9610(75)90231-7
   Sen CK, 2009, WOUND REPAIR REGEN, V17, DOI [10.1111/j.1524-475X.2009.00543.x, DOI 10.1111/J.1524-475X.2009.00543.X]
   Sibbald RG, 2011, ADV SKIN WOUND CARE, V24, P415, DOI 10.1097/01.ASW.0000405216.27050.97
   Snyder RJ, 2010, WOUNDS, P3
   Steed DL, 2008, WOUND REPAIR REGEN, V16, P169, DOI 10.1111/j.1524-475X.2008.00357.x
   Wolcott RD, 2010, J WOUND CARE, V19, P272
   Zenilman J, 2013, AHRQ PUBLICATION
NR 20
TC 6
Z9 6
U1 0
U2 5
PU H M P COMMUNICATIONS
PI MALVERN
PA 83 GENERAL WARREN BLVD, STE 100, MALVERN, PA 19355 USA
SN 1044-7946
EI 1943-2704
J9 WOUNDS
JI Wounds-Compend. Clin. Res. Pract.
PD JUL
PY 2016
VL 28
IS 7
BP 233
EP 240
PG 8
WC Dermatology; Surgery
SC Dermatology; Surgery
GA DZ4ZJ
UT WOS:000385870700004
PM 27428718
DA 2018-10-20
ER

PT J
AU Lausecker, R
   Badilita, V
   Gleissner, U
   Wallrabe, U
AF Lausecker, R.
   Badilita, V.
   Gleissner, U.
   Wallrabe, U.
TI Introducing natural thermoplastic shellac to microfluidics: A green
   fabrication method for point-of-care devices
SO BIOMICROFLUIDICS
LA English
DT Article
ID GLASS-TRANSITION; SUBSTRATE; RELEASE; SOLVENT
AB We present a sustainable fabrication method for cheap point-of-care microfluidic systems, employing hot embossing of natural shellac as a key feature of an energy-efficient fabrication method that exclusively uses renewable materials as consumables. Shellac is a low-cost renewable biomaterial that features medium hydrophilicity (e.g., a water contact angle of ca. 73 degrees) and a high chemical stability with respect to common solvents such as cyclohexane or toluene, rendering it an interesting candidate for low-cost microfluidics and a competitor to well-known systems such as paper-based or polydimethylsiloxane-based microfluidics. Moreover, its high replication accuracy for small features down to 30 mu m lateral feature size and its ability to form smooth surfaces (surface roughness R-a = 29 nm) at low embossing temperatures (glass transition temperature T-g = 42.2 degrees C) enable energy-efficient hot embossing of microfluidic structures. Proof-of-concept for the implementation of shellac hot embossing as a green fabrication method for microfluidic systems is demonstrated through the successful fabrication of a microfluidic test setup and the assessment of its resource consumption. Published by AIP Publishing.
C1 [Lausecker, R.; Wallrabe, U.] Univ Freiburg, Lab Microactuators, Dept Microsyst Engn IMTEK, Georges Koehler Allee 102, D-79110 Freiburg, Germany.
   [Badilita, V.] Karlsruhe Inst Technol KIT, Inst Microstruct Technol IMT, Herman von Helmholtz Pl 1, D-76344 Eggenstein Leopoldshafen, Germany.
   [Gleissner, U.] Univ Freiburg, Dept Microsyst Engn IMTEK, Lab Mat Proc, Georges Koehler Allee 102, D-79110 Freiburg, Germany.
RP Wallrabe, U (reprint author), Univ Freiburg, Lab Microactuators, Dept Microsyst Engn IMTEK, Georges Koehler Allee 102, D-79110 Freiburg, Germany.
EM wallrabe@imtek.uni-freiburg.de
RI Badilita, Vlad/G-2862-2012; Wallrabe, Ulrike/F-5217-2013
FU University of Freiburg
FX The authors want to thank Zhiqiu Lu for providing the cleanroom
   processing of the SU-8 master wafer, Michael Pauls for providing the SEM
   images, SSB Stroever Schellack Bremen for providing the data of the
   energy demand for the fabrication of shellac, and Dr. Bastian Rapp for
   fruitful discussions concerning the capillary forces between shellac and
   PDMS during hot embossing. This work was supported by the Research
   Innovation Fund of the University of Freiburg.
CR Almquist S. G., 1987, OCCASIONAL PAPERS, V179
   Becker H, 2000, SENSOR ACTUAT A-PHYS, V83, P130, DOI 10.1016/S0924-4247(00)00296-X
   Branham MS, 2010, ENVIRON SCI TECHNOL, V44, P4295, DOI 10.1021/es902388b
   Buch K, 2009, DRUG DEV IND PHARM, V35, P694, DOI 10.1080/03639040802563253
   Capello C, 2007, GREEN CHEM, V9, P927, DOI 10.1039/b617536h
   Delamarche E, 1998, J AM CHEM SOC, V120, P500, DOI 10.1021/ja973071f
   Farag Y, 2009, DISSOLUT TECHNOL, V16, P33, DOI 10.14227/DT160209P33
   Ghoshal S, 2009, J MACROMOL SCI A, V46, P975, DOI 10.1080/10601320903158594
   HANCOCK BC, 1995, PHARMACEUT RES, V12, P799, DOI 10.1023/A:1016292416526
   Honda T, 2005, LAB CHIP, V5, P812, DOI 10.1039/b505137a
   Hutchinson JM, 1998, THERMOCHIM ACTA, V324, P165, DOI 10.1016/S0040-6031(98)00532-2
   Irimia-Vladu M, 2013, GREEN CHEM, V15, P1473, DOI 10.1039/c3gc40388b
   Jo BH, 2000, J MICROELECTROMECH S, V9, P76, DOI 10.1109/84.825780
   Lausecker R, 2015, 2015 TRANSDUCERS - 2015 18TH INTERNATIONAL CONFERENCE ON SOLID-STATE SENSORS, ACTUATORS AND MICROSYSTEMS (TRANSDUCERS), P1680, DOI 10.1109/TRANSDUCERS.2015.7181266
   Lee JN, 2003, ANAL CHEM, V75, P6544, DOI 10.1021/ac0346712
   Li X, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.3687398
   Mittelstaedt R., 1994, J MACROMARKETING, V14, P31, DOI [10.1177/027614679401400105, DOI 10.1177/027614679401400105]
   Mueller S, 2010, BIOTECHNOL LETT, V32, P1261, DOI 10.1007/s10529-010-0296-7
   Pearnchob N, 2003, DRUG DEV IND PHARM, V29, P925, DOI 10.1081/DDC-120024188
   Peng LF, 2014, J MICROMECH MICROENG, V24, DOI 10.1088/0960-1317/24/1/013001
   Qussi B, 2005, DRUG DEV IND PHARM, V31, P99, DOI 10.1081/DDC-200044226
   Ren KN, 2013, ACCOUNTS CHEM RES, V46, P2396, DOI 10.1021/ar300314s
   Schmidt M, 2012, INT J LIFE CYCLE ASS, V17, P126, DOI 10.1007/s11367-011-0351-1
   Selimovic S, 2011, LAB CHIP, V11, P2325, DOI 10.1039/c1lc20213h
   Spengler N, 2014, J MICROMECH MICROENG, V24, DOI 10.1088/0960-1317/24/3/034004
   Stauderman S., 2004, P S SOUND SAV AUST T
   The European IPPC Bureau, 2007, REF DOC BEST AV TECH, P211
   Williams ED, 2002, ENVIRON SCI TECHNOL, V36, P5504, DOI 10.1021/es025643o
NR 28
TC 3
Z9 3
U1 3
U2 14
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 1932-1058
J9 BIOMICROFLUIDICS
JI Biomicrofluidics
PD JUL
PY 2016
VL 10
IS 4
AR 044101
DI 10.1063/1.4955062
PG 12
WC Biochemical Research Methods; Biophysics; Nanoscience & Nanotechnology;
   Physics, Fluids & Plasmas
SC Biochemistry & Molecular Biology; Biophysics; Science & Technology -
   Other Topics; Physics
GA DW8MZ
UT WOS:000383911400014
PM 27478525
OA Green Published
DA 2018-10-20
ER

PT J
AU Stalberg, K
   Crona, J
   Razmara, M
   Taslica, D
   Skogseid, B
   Stalberg, P
AF Stalberg, Karin
   Crona, Joakim
   Razmara, Masoud
   Taslica, Diana
   Skogseid, Britt
   Stalberg, Peter
TI An Integrative Genomic Analysis of Formalin Fixed Paraffin-Embedded
   Archived Serous Ovarian Carcinoma Comparing Long-term and Short-term
   Survivors
SO INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
LA English
DT Article
DE Ovarian cancer; Genetics; Survival
ID PROGNOSTIC-FACTORS; COPY-NUMBER; CANCER; PATHOGENESIS; INSTABILITY;
   VALIDATION; MUTATIONS; SAMPLES; IMPACT
AB Objective: This study aimed to perform an integrative genetic analysis of patients with matched serous ovarian cancer having long-term or short-term survival using formalin fixed paraffin-embedded (FFPE) tissue samples.
   Methods: All patients with serous ovarian carcinoma who underwent surgery between 1998 and 2007 at the Department of Gynaecology, Uppsala University Hospital, Sweden were considered. From this cohort, we selected biomaterial from 2 groups of patients with long-term and short-term survival matched for age, stage, histologic grade, and outcome of surgery. Genomic DNA from FFPE sample was analyzed with SNP array and targeted nextgeneration sequencing of 26 genes.
   Results: Forty-three samples (primary tumors and metastases) from 23 patients were selected for genomic profiling, the survival in the subgroups were 134 and 36 months, respectively. We observed a tendency toward increased genomic instability in those with long-term survival with higher proportion of somatic copy number alterations (P = 0.083) and higher average ploidy (P = 0.037). TP53 mutations were found in 50% of the patients. Frequency of TP53 mutations did not differ between the survival groups (P = 0.629).
   Conclusions: We validated both previous genomic findings in ovarian cancer and the proposed association between increased genomic instability and better survival. These results exemplify that analysis of genomic biomarkers is feasible on archived FFPE tissue.
C1 [Stalberg, Karin] Uppsala Univ, Dept Womens & Childrens Hlth, S-75185 Uppsala, Sweden.
   [Crona, Joakim; Stalberg, Peter] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden.
   [Razmara, Masoud; Skogseid, Britt] Uppsala Univ, Dept Med Sci, Uppsala, Sweden.
   [Taslica, Diana] Uppsala Univ, Dept Clin Pathol, Uppsala, Sweden.
RP Stalberg, K (reprint author), Uppsala Univ, Dept Womens & Childrens Hlth, S-75185 Uppsala, Sweden.
EM karin.stalberg@kbh.uu.se
OI Stalberg, Peter/0000-0002-9625-1394
FU Swedish Cancer Foundation; Lions Cancer Fund; Uppsala University
FX This work was supported by the Swedish Cancer Foundation, Lions Cancer
   Fund, and Uppsala University.
CR Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Baldwin LA, 2012, OBSTET GYNECOL, V120, P612, DOI 10.1097/AOG.0b013e318264f794
   Borley J, 2012, BRIT J CANCER, V107, P1069, DOI 10.1038/bjc.2012.376
   Cancer Genome Atlas Research Network, 2011, NATURE, V474, P609, DOI DOI 10.1038/NATURE10166
   Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203
   Crona J, 2015, CLIN CANCER RES, V21, P4451, DOI 10.1158/1078-0432.CCR-14-2854
   De Angelis R, 2014, LANCET ONCOL, V15, P23, DOI 10.1016/S1470-2045(13)70546-1
   Dumenil TD, 2014, GENE CHROMOSOME CANC, V53, P537, DOI 10.1002/gcc.22164
   Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929
   Hovelson DH, 2015, NEOPLASIA, V17, P385, DOI 10.1016/j.neo.2015.03.004
   Jamal-Hanjani M, 2015, ANN ONCOL, V26, P1340, DOI 10.1093/annonc/mdv178
   Kim S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111693
   Kurman RJ, 2014, WHO CLASSIFICATION T
   Kurman RJ, 2011, HUM PATHOL, V42, P918, DOI 10.1016/j.humpath.2011.03.003
   Levanon K, 2008, J CLIN ONCOL, V26, P5284, DOI 10.1200/JCO.2008.18.1107
   Patch AM, 2015, NATURE, V521, P489, DOI 10.1038/nature14410
   Schweiger MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005548
   Thirlwell C, 2010, METHODS, V52, P248, DOI 10.1016/j.ymeth.2010.04.012
   Tingulstad S, 2003, OBSTET GYNECOL, V101, P885, DOI 10.1016/S0029-7844(03)00123-6
   Tuefferd M, 2008, GENE CHROMOSOME CANC, V47, P957, DOI 10.1002/gcc.20599
   Van Allen EM, 2014, NAT MED, V20, P682, DOI 10.1038/nm.3559
   Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144
   Wang ZGC, 2012, CLIN CANCER RES, V18, P5806, DOI 10.1158/1078-0432.CCR-12-0857
   Wimberger P, 2007, GYNECOL ONCOL, V106, P69, DOI 10.1016/j.ygyno.2007.02.026
   Zhang SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113169
NR 25
TC 2
Z9 2
U1 1
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1048-891X
EI 1525-1438
J9 INT J GYNECOL CANCER
JI Int. J. Gynecol. Cancer
PD JUL
PY 2016
VL 26
IS 6
BP 1027
EP 1032
DI 10.1097/IGC.0000000000000721
PG 6
WC Oncology; Obstetrics & Gynecology
SC Oncology; Obstetrics & Gynecology
GA DW9CV
UT WOS:000383953500007
PM 27177282
DA 2018-10-20
ER

PT J
AU Xiao, B
   Rao, F
   Guo, ZY
   Sun, X
   Wang, YG
   Liu, SY
   Wang, AY
   Guo, QY
   Meng, HY
   Zhao, Q
   Peng, J
   Wang, Y
   Lu, SB
AF Xiao, Bo
   Rao, Feng
   Guo, Zhi-yuan
   Sun, Xun
   Wang, Yi-guo
   Liu, Shu-yun
   Wang, Ai-yuan
   Guo, Quan-yi
   Meng, Hao-ye
   Zhao, Qing
   Peng, Jiang
   Wang, Yu
   Lu, Shi-bi
TI Extracellular matrix from human umbilical cord-derived mesenchymal stem
   cells as a scaffold for peripheral nerve regeneration
SO NEURAL REGENERATION RESEARCH
LA English
DT Article
DE nerve regeneration; peripheral nerve regeneration; mesenchymal stem
   cells; extracellular matrix; Schwann cell; dorsal root ganglion neuron;
   niche; neurotropic factors; collagen; laminin; fibronectin; neural
   regeneration
ID NEURITE OUTGROWTH; SCHWANN-CELLS; EXPANSION; DIFFERENTIATION;
   FIBRONECTIN; COMPONENTS; NEURONS; LAMININ
AB The extracellular matrix, which includes collagens, laminin, or fibronectin, plays an important role in peripheral nerve regeneration. Recently, a Schwann cell-derived extracellular matrix with classical biomaterial was used to mimic the neural niche. However, extensive clinical use of Schwann cells remains limited because of the limited origin, loss of an autologous nerve, and extended in vitro culture times. In the present study, human umbilical cord-derived mesenchymal stem cells (hUCMSCs), which are easily accessible and more proliferative than Schwann cells, were used to prepare an extracellular matrix. We identified the morphology and function of hUCMSCs and investigated their effect on peripheral nerve regeneration. Compared with a non-coated dish tissue culture, the hUCMSC-derived extracellular matrix enhanced Schwann cell proliferation, upregulated gene and protein expression levels of brain-derived neurotrophic factor, glial cell-derived neurotrophic factor, and vascular endothelial growth factor in Schwann cells, and enhanced neurite outgrowth from dorsal root ganglion neurons. These findings suggest that the hUCMSC-derived extracellular matrix promotes peripheral nerve repair and can be used as a basis for the rational design of engineered neural niches.
C1 [Xiao, Bo; Sun, Xun; Wang, Yi-guo; Liu, Shu-yun; Wang, Ai-yuan; Guo, Quan-yi; Meng, Hao-ye; Zhao, Qing; Peng, Jiang; Wang, Yu; Lu, Shi-bi] Chinese Peoples Liberat Army Gen Hosp, Inst Orthoped, Beijing, Peoples R China.
   [Xiao, Bo; Sun, Xun; Wang, Yi-guo; Liu, Shu-yun; Wang, Ai-yuan; Guo, Quan-yi; Meng, Hao-ye; Lu, Shi-bi] Beijing Key Lab Regenerat Med Orthoped, Beijing, Peoples R China.
   [Xiao, Bo; Zhao, Qing; Peng, Jiang; Wang, Yu] Neural Regenerat Coinnovat Ctr Jiangsu Prov, Nantong, Jiangsu, Peoples R China.
   [Rao, Feng] Shihezi Univ, Sch Med, Affiliated Hosp 1, Dept Orthoped, Shihezi, Xinjiang Uygur, Peoples R China.
   [Guo, Zhi-yuan] Cangzhou Cent Hosp, Dept Orthoped, Cangzhou, Hebei Province, Peoples R China.
RP Wang, Y; Lu, SB (reprint author), Chinese Peoples Liberat Army Gen Hosp, Inst Orthoped, Beijing, Peoples R China.; Lu, SB (reprint author), Beijing Key Lab Regenerat Med Orthoped, Beijing, Peoples R China.; Wang, Y (reprint author), Neural Regenerat Coinnovat Ctr Jiangsu Prov, Nantong, Jiangsu, Peoples R China.
EM wangwangdian628@126.com; shibilu94@163.com
FU National Natural Science Foundation of China [31170946]; National
   Program on Key Basic Research Project of China (973 Program)
   [2012CB518106, 2014CB542201]; Special Project of the "Twelfth Five-year
   Plan" for Medical Science Development of PLA [BWS13C029]
FX This research was supported by the National Natural Science Foundation
   of China, Grant No. 31170946; the National Program on Key Basic Research
   Project of China (973 Program), Grant No. 2012CB518106 and No.
   2014CB542201; and the Special Project of the "Twelfth Five-year Plan"
   for Medical Science Development of PLA, No. BWS13C029.
CR Armstrong SJ, 2007, TISSUE ENG, V13, P2863, DOI 10.1089/ten.2007.0055
   Brown Justin M, 2009, Neurosurg Focus, V26, pE12, DOI 10.3171/FOC.2009.26.2.E12
   Byron A, 2013, INT J EXP PATHOL, V94, P75, DOI 10.1111/iep.12011
   Chen XD, 2007, J BONE MINER RES, V22, P1943, DOI 10.1359/JBMR.070725
   Chen ZL, 2003, J CELL BIOL, V163, P889, DOI 10.1083/jcb.200307068
   Dellatore SM, 2008, CURR OPIN BIOTECH, V19, P534, DOI 10.1016/j.copbio.2008.07.010
   DELUCA AC, 2015, JOVE J VIS EXP FEB, DOI DOI 10.3791/52543
   Gao XP, 2013, REV NEUROSCIENCE, V24, P443, DOI 10.1515/revneuro-2013-0022
   Gardiner NJ, 2007, MOL CELL NEUROSCI, V35, P249, DOI 10.1016/j.mcn.2007.02.020
   Gonzalez-Perez F, 2013, INT REV NEUROBIOL, V108, P257, DOI 10.1016/B978-0-12-410499-0.00010-1
   Gould LJ, 2016, ADV WOUND CARE, V5, P19, DOI 10.1089/wound.2014.0595
   Gu Y, 2014, BIOMATERIALS, V35, P2253, DOI 10.1016/j.biomaterials.2013.11.087
   Gu Y, 2012, BIOMATERIALS, V33, P6672, DOI 10.1016/j.biomaterials.2012.06.006
   Hoshiba T, 2016, STEM CELLS INT, V2016
   Li JT, 2014, BIOMATERIALS, V35, P642, DOI 10.1016/j.biomaterials.2013.09.099
   Lin CY, 2014, MAT SCI ENG C-MATER, V42, P474, DOI 10.1016/j.msec.2014.05.063
   Loeser RF, 2002, BIORHEOLOGY, V39, P119
   Nagamura-Inoue Tokiko, 2014, World J Stem Cells, V6, P195, DOI 10.4252/wjsc.v6.i2.195
   Pei M, 2011, Eur Cell Mater, V22, P333
   Peng JA, 2011, BRAIN RES BULL, V84, P235, DOI 10.1016/j.brainresbull.2010.12.013
   Plantman S, 2013, BIOMED RES INT, DOI 10.1155/2013/981695
   Prewitz MC, 2013, NAT METHODS, V10, P788, DOI [10.1038/nmeth.2523, 10.1038/NMETH.2523]
   ROGERS SL, 1983, DEV BIOL, V98, P212, DOI 10.1016/0012-1606(83)90350-0
   Wang J, 2009, BRAIN RES, V1262, P7, DOI 10.1016/j.brainres.2009.01.056
   Wang Y, 2012, NEUROSCI LETT, V514, P96, DOI 10.1016/j.neulet.2012.02.066
   Xiong Y, 2015, TISSUE ENG PT A, V21, P1886, DOI [10.1089/ten.TEA.2014.0539, 10.1089/ten.tea.2014.0539]
   Yu WM, 2009, J CELL SCI, V122, P929, DOI 10.1242/jcs.033928
   Zhang WX, 2016, TISSUE ENG PART B-RE, V22, P193, DOI [10.1089/ten.teb.2015.0290, 10.1089/ten.TEB.2015.0290]
   Zhang ZL, 2015, CELL BIOL INT, V39, P291, DOI 10.1002/cbin.10385
NR 29
TC 3
Z9 4
U1 1
U2 20
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1673-5374
EI 1876-7958
J9 NEURAL REGEN RES
JI Neural Regen. Res.
PD JUL
PY 2016
VL 11
IS 7
BP 1172
EP 1179
DI 10.4103/1673-5374.187061
PG 8
WC Cell Biology; Neurosciences
SC Cell Biology; Neurosciences & Neurology
GA DW6YW
UT WOS:000383798300036
PM 27630705
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Hansen, A
   Budde, J
   Prochnow, A
AF Hansen, Anja
   Budde, Joern
   Prochnow, Annette
TI Resource Usage Strategies and Trade-Offs between Cropland Demand, Fossil
   Fuel Consumption, and Greenhouse Gas Emissions-Building Insulation as an
   Example
SO SUSTAINABILITY
LA English
DT Article
DE resource efficiency; environmental sustainability criteria; cropland;
   fossil fuels; greenhouse gas emissions; insulation materials; EPS; hemp;
   SRC; maize silage
ID LIFE-CYCLE ASSESSMENT; LAND-USE CHANGE; ENVIRONMENTAL IMPACTS; STONE
   WOOL; PAPER WOOL; BIOENERGY; ENERGY; SYSTEMS; CHALLENGES; PRODUCTS
AB Bioresources are used in different production systems as materials as well as energy carriers. The same is true for fossil fuel resources. This study explored whether preferential resource usages exist, using a building insulation system as an example, with regard to the following sustainability criteria: climate impact, land, and fossil fuel demand. We considered the complete life cycle in a life cycle assessment-based approach. The criteria were compared for two strategies: one used natural fibers as material and generated production energies from fossil fuels; the other generated production energies from bioenergy carriers and transformed fossil resources into the insulation material. Both strategies finally yielded the same insulation effect. Hence, the energy demand for heating the building was ignored. None of the strategies operated best in all three criteria: While cropland demand was lower in the bioenergy than in the biomaterial system, its fossil fuel demand was higher. Net contribution to climate change was in the same range for both strategies if we considered no indirect changes in land use. Provided that effective recycling concepts for fossil-derived insulations are in place, using bioresources for energy generation was identified as a promising way to mitigate climate change along with efficient resource use.
C1 [Hansen, Anja; Budde, Joern; Prochnow, Annette] Leibniz Inst Agr Engn Potsdam Bornim, Max Eyth Allee 100, D-14469 Potsdam, Germany.
   [Prochnow, Annette] Humboldt Univ, Fac Life Sci, Invalidenstr 42, D-10115 Berlin, Germany.
RP Hansen, A (reprint author), Leibniz Inst Agr Engn Potsdam Bornim, Max Eyth Allee 100, D-14469 Potsdam, Germany.
EM ahansen@atb-potsdam.de; jbudde@atb-potsdam.de; aprochnow@atb-potsdam.de
RI Hansen, Anja/G-6294-2013
OI Hansen, Anja/0000-0002-4402-7040; Budde, Jorn/0000-0002-9124-1541;
   Prochnow, Annette/0000-0003-3528-5272
FU Leibniz-Pakt fur Forschung project "bioenergy planet"; Leibniz
   Association
FX We would like to thank Hans-Jorg Gusovius for his valuable comments and
   discussion about hemp cultivation and market implications in Germany and
   appreciate that several external experts were willing to share their
   market knowledge. This work was partially funded within the Leibniz-Pakt
   fur Forschung project "bioenergy planet". The publication of this
   article was funded by the Open Access fund of the Leibniz Association.
   John L. Grantham improved English grammar and syntax.
CR Alvarenga RAF, 2013, RENEW ENERG, V59, P49, DOI 10.1016/j.renene.2013.03.029
   Arcese G., 2016, INT J LCA
   Ascione F, 2015, SUSTAINABILITY-BASEL, V7, P10809, DOI 10.3390/su70810809
   Audsley E., 2009, LOW CAN WE GO ASSESS
   BBSR, NUTZ BAUT LEB NACH B
   Benoit-Norris C, 2012, SUSTAINABILITY-BASEL, V4, P1946, DOI 10.3390/su4091946
   BfN (Federal Agency for Nature Conservation), GRUNL REP ALL GRUN B
   Bos U., 2010, AKTUALISIERUNG CO2 B, P11
   Bruch C., 2012, COMMUNICATION
   Canadian Hemp Trade Alliance, GROW HEMP SUBP MARK
   Canto-Perello J, 2015, SUSTAINABILITY-BASEL, V7, P6854, DOI 10.3390/su7066854
   Carus M., EUROPEAN HEMP IND CU
   Cherubini F, 2011, BIORESOURCE TECHNOL, V102, P437, DOI 10.1016/j.biortech.2010.08.010
   Colwill J. A., 2011, INT J SUSTAINABLE EN
   Daioglou V, 2015, GCB BIOENERGY, V7, P1321, DOI 10.1111/gcbb.12228
   Danish Energy Agency, EN STAT
   Danner H., HDB OKOLOGISCHE WARM
   De Rosa M, 2016, J CLEAN PROD, V113, P183, DOI 10.1016/j.jclepro.2015.11.097
   Delin S, 2012, SOIL USE MANAGE, V28, P283, DOI 10.1111/j.1475-2743.2012.00417.x
   DIN EN ISO, 2006, 140402006 ISO
   DIN EN ISO, 2006, ENV PROT OCC SAF SAF
   Don A, 2012, GCB BIOENERGY, V4, P372, DOI 10.1111/j.1757-1707.2011.01116.x
   Dornburg V, 2003, J IND ECOL, V7, P93
   Ekvall T, 2005, J CLEAN PROD, V13, P1225, DOI 10.1016/j.jclepro.2005.05.010
   Erlandsson M, 1997, BUILD ENVIRON, V32, P129, DOI 10.1016/S0360-1323(96)00041-8
   European Commission DG for Agriculture and Rural Development EU agriculture, 2012, STAT EC INF
   European Commission-Joint Research Centre, I ENV SUST INT REF L
   Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747
   Feliciano D, 2014, ENVIRON SCI POLICY, V44, P26, DOI 10.1016/j.envsci.2014.07.010
   Finkbeiner M, 2014, BIOMASS BIOENERG, V62, P218, DOI 10.1016/j.biombioe.2014.01.024
   Frischknecht R., OVERVIEW METHODOLOGY
   Fritsche U.R., TREIBHAUSGASBILANZEN
   Graf T., LEITLINIE EFFIZIENTE
   Hannouf M, 2016, INT J LIFE CYCLE ASS, V21, P1059, DOI 10.1007/s11367-016-1136-3
   Hansen A, 2013, BIOMASS BIOENERG, V56, P104, DOI 10.1016/j.biombioe.2013.05.004
   Hischier R., 2010, DOCUMENTATION CHANGE, P320
   ifu, 2011, IFEU UMB VERS 5 5
   IINAS, 2014, GEM GLOB EM MOD INT
   Ingrao C, 2015, RENEW SUST ENERG REV, V51, P29, DOI 10.1016/j.rser.2015.06.002
   IPCC, IPCC GUIDELINES NATL
   ISO-International Organization for Standardization, 2007, 6946 ISO EN
   Jakob M, 2014, OXFORD REV ECON POL, V30, P447, DOI 10.1093/oxrep/gru026
   Jorgensen SV, 2015, INT J LIFE CYCLE ASS, V20, P451, DOI 10.1007/s11367-015-0845-3
   Kauffman NS, 2013, ENERG POLICY, V54, P300, DOI 10.1016/j.enpol.2012.11.036
   Kilpelainen A, 2014, MITIG ADAPT STRAT GL, V19, P955, DOI 10.1007/s11027-013-9454-2
   Kjaer LL, 2016, J CLEAN PROD, V120, P95, DOI 10.1016/j.jclepro.2016.01.048
   KTBL, 2006, EN DAT PLAN EN
   Luhr C., 2013, Journal of Agricultural Science (Toronto), V5, P9
   Mankowski J., 2014, CHEMIK, V10, P901
   Mazor MH, 2011, J IND ECOL, V15, P284, DOI 10.1111/j.1530-9290.2010.00325.x
   Meynard J.M., FREINS LEVIERS DIVER
   Nitsch H., LANDWIRTSCHAFTLICHE
   Pawelzik P, 2013, RESOUR CONSERV RECY, V73, P211, DOI 10.1016/j.resconrec.2013.02.006
   Piemonte V, 2012, ENERG SOURCE PART A, V34, P1995, DOI 10.1080/15567036.2010.497797
   Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a
   Schierhold G., 2013, COMMUNICATION
   Schmidt AC, 2004, INT J LIFE CYCLE ASS, V9, P122, DOI 10.1065/lca2003.12.144.2
   Schmidt AC, 2004, INT J LIFE CYCLE ASS, V9, P53, DOI 10.1065/lca2003.12.144.1
   Schmidt JH, 2015, J CLEAN PROD, V99, P230, DOI 10.1016/j.jclepro.2015.03.013
   Shah DU, 2013, J MATER SCI, V48, P6083, DOI 10.1007/s10853-013-7458-7
   Silvestre JD, 2014, J CLEAN PROD, V66, P37, DOI 10.1016/j.jclepro.2013.10.028
   TLL, BEGL EINF PRAX HANF
   Tonini D., 2015, GCB BIOENERGY
   Verstegen JA, 2016, GCB BIOENERGY, V8, P561, DOI 10.1111/gcbb.12270
   Vogt R., BASISDATEN THG BILAN
   Walter K, 2015, GCB BIOENERGY, V7, P727, DOI 10.1111/gcbb.12177
   Weiss M, 2012, J IND ECOL, V16, pS169, DOI 10.1111/j.1530-9290.2012.00468.x
   Wolf J, 2003, AGR SYST, V76, P841, DOI 10.1016/S0308-521X(02)00077-X
   Wotzel K., OKOBILANZ PKW SEITEN
NR 69
TC 1
Z9 1
U1 2
U2 16
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2071-1050
J9 SUSTAINABILITY-BASEL
JI Sustainability
PD JUL
PY 2016
VL 8
IS 7
AR 613
DI 10.3390/su8070613
PG 24
WC GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY; Environmental Sciences;
   Environmental Studies
SC Science & Technology - Other Topics; Environmental Sciences & Ecology
GA DS4OM
UT WOS:000380760400024
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Graney, PL
   Roohani-Esfahani, SI
   Zreiqat, H
   Spiller, KL
AF Graney, Pamela L.
   Roohani-Esfahani, Seyed-Iman
   Zreiqat, Hala
   Spiller, Kara L.
TI In vitro response of macrophages to ceramic scaffolds used for bone
   regeneration
SO JOURNAL OF THE ROYAL SOCIETY INTERFACE
LA English
DT Article
DE macrophage phenotype; immunomodulation; bone repair; macrophage
   biomaterial interactions
ID FRACTURE REPAIR; GENE-EXPRESSION; CALLUS FORMATION; VIVO;
   DIFFERENTIATION; ANGIOGENESIS; CYTOKINES; DESIGN; VASCULARIZATION;
   POLARIZATION
AB Macrophages, the primary cells of the inflammatory response, are major regulators of healing, and mediate both bone fracture healing and the inflammatory response to implanted biomaterials. However, their phenotypic contributions to biomaterial-mediated bone repair are incompletely understood. Therefore, we used gene expression and protein secretion analysis to investigate the interactions in vitro between primary human monocyte-derived macrophages and ceramic scaffolds that have been shown to have varying degrees of success in promoting bone regeneration in vivo. Specifically, baghdadite (Ca3ZrSi2O9) and strontium hardystonite gahnite (Sr Ca2ZnSi2O7-ZnAl2O4) scaffolds were chosen as two materials that enhanced bone regeneration in vivo in large defects under load compared with clinically used tricalcium phosphate hydroxyapatite (TCP HA). Principal component analysis revealed that the scaffolds differentially regulated macrophage phenotype. Temporal changes in gene expression included shifts in markers of pro-inflammatory M1, anti-inflammatory M2a and pro-remodelling M2c macrophage phenotypes. Of note, TCP HA scaffolds promoted upregulation of many M1-related genes and downregulation of many M2a- and M2c-related genes. Effects of the scaffolds on macrophages were attributed primarily to direct cell scaffold interactions because of only minor changes observed in transwell culture. Ultimately, elucidating macrophage biomaterial interactions will facilitate the design of immunomodulatory biomaterials for bone repair.
C1 [Graney, Pamela L.; Spiller, Kara L.] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Biomat & Regenerat Med Lab, Philadelphia, PA 19104 USA.
   [Roohani-Esfahani, Seyed-Iman; Zreiqat, Hala] Univ Sydney, Sch Aerosp Mech & Mechatron Engn, Biomat & Tissue Engn Res Unit, Sydney, NSW 2026, Australia.
RP Spiller, KL (reprint author), Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Biomat & Regenerat Med Lab, Philadelphia, PA 19104 USA.
EM spiller@drexel.edu
OI Roohani, Iman/0000-0001-6618-8577
FU Australian NHMRC; ARC; Rebecca Cooper Medical Foundation; United States
   NSF-CNIC [1425737]; Koerner Family Fellowship
FX The authors gratefully acknowledge the Australian NHMRC, ARC and the
   Rebecca Cooper Medical Foundation, as well as the United States NSF-CNIC
   support of this work (award no. 1425737). P.L.G. is also the recipient
   of a Koerner Family Fellowship.
CR Alexander KA, 2011, J BONE MINER RES, V26, P1517, DOI 10.1002/jbmr.354
   Bao B, 2003, AM J PHYSIOL-ENDOC M, V285, pE1095, DOI 10.1152/ajpendo.00545.2002
   Bartneck M, 2010, ACTA BIOMATER, V6, P3864, DOI 10.1016/j.actbio.2010.04.025
   Becker M, 2015, SCI REP-UK, V5, DOI 10.1038/srep13351
   Blakney AK, 2012, J BIOMED MATER RES A, V100A, P1375, DOI 10.1002/jbm.a.34104
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Brown BN, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00510
   Carano RAD, 2003, DRUG DISCOV TODAY, V8, P980, DOI 10.1016/S1359-6446(03)02866-6
   Chehroudi B, 2010, J BIOMED MATER RES A, V93A, P724, DOI 10.1002/jbm.a.32587
   Chen ZT, 2014, BIOMATERIALS, V35, P1507, DOI 10.1016/j.biomaterials.2013.11.014
   Cheung Catherine, 2005, Clin Podiatr Med Surg, V22, P631, DOI 10.1016/j.cpm.2005.07.002
   Colnot C, 2003, DEVELOPMENT, V130, P4123, DOI 10.1242/dev.00559
   Duan HM, 2015, P NATL ACAD SCI USA, V112, P13360, DOI 10.1073/pnas.1510176112
   Duvall CL, 2007, J BONE MINER RES, V22, P286, DOI 10.1359/JBMR.061103
   Gentleman E, 2010, BIOMATERIALS, V31, P3949, DOI 10.1016/j.biomaterials.2010.01.121
   GRUNDNES O, 1993, ACTA ORTHOP SCAND, V64, P340, DOI 10.3109/17453679308993640
   Guo R, 2015, BIOMATERIALS, V73, P85, DOI 10.1016/j.biomaterials.2015.09.005
   Hausman MR, 2004, AM J SURG, V187, p44S, DOI 10.1016/S0002-9610(03)00304-0
   Irwin EF, 2008, J BIOMAT SCI-POLYM E, V19, P1363, DOI 10.1163/156856208786052407
   Karnes JM, 2015, BONE, V78, P87, DOI 10.1016/j.bone.2015.05.001
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kon T, 2001, J BONE MINER RES, V16, P1004, DOI 10.1359/jbmr.2001.16.6.1004
   Lakhkar NJ, 2013, ADV DRUG DELIVER REV, V65, P405, DOI 10.1016/j.addr.2012.05.015
   Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018
   Lesman A, 2010, TISSUE ENG PT A, V16, P115, DOI [10.1089/ten.tea.2009.0130, 10.1089/ten.TEA.2009.0130]
   Li JJ, 2016, BIOMED MATER, V11, DOI 10.1088/1748-6041/11/1/015016
   Lu ZF, 2014, TISSUE ENG PT A, V20, P992, DOI [10.1089/ten.tea.2013.0470, 10.1089/ten.TEA.2013.0470]
   Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303
   McDonald MM, 2013, J BONE MINER RES, V28, P1550, DOI 10.1002/jbmr.1889
   Mohammadi H, 2014, J CERAM SCI TECHNOL, V5, P1, DOI 10.4416/JC5T2013-00027
   Mountziaris PM, 2011, TISSUE ENG PART B-RE, V17, P393, DOI [10.1089/ten.TEB.2011.0182, 10.1089/ten.teb.2011.0182]
   Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073
   Nassiri S, 2015, J INVEST DERMATOL, V135, P1700, DOI 10.1038/jid.2015.30
   Obando-Pereda GA, 2014, LIFE SCI, V97, P96, DOI 10.1016/j.lfs.2013.11.008
   Park SH, 2002, J ORTHOPAED RES, V20, P1197, DOI 10.1016/S0736-0266(02)00072-4
   Paula NE, 2008, BIOMATERIALS, V29, P4056, DOI 10.1016/j.biomaterials.2008.07.010
   Pedraza CE, 2008, BONE, V43, P708, DOI 10.1016/j.bone.2008.06.010
   Quinlan E, 2015, BIOMATERIALS, V52, P358, DOI 10.1016/j.biomaterials.2015.02.006
   Raggatt LJ, 2014, AM J PATHOL, V184, P3192, DOI 10.1016/j.ajpath.2014.08.017
   Ramaswamy Y, 2008, BIOMATERIALS, V29, P4392, DOI 10.1016/j.biomaterials.2008.08.006
   Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303
   Roohani-Esfahani SI, 2013, ACTA BIOMATER, V9, P7014, DOI 10.1016/j.actbio.2013.02.039
   Roohani-Esfahani SI, 2012, ACTA BIOMATER, V8, P4162, DOI 10.1016/j.actbio.2012.07.036
   Roohani-Esfahani SI, 2016, SCI REP-UK, V6, DOI 10.1038/srep19468
   Roohani-Esfahani SI, 2013, MATER LETT, V107, P378, DOI 10.1016/j.matlet.2013.06.046
   Santo VE, 2013, TISSUE ENG PART B-RE, V19, P308, DOI [10.1089/ten.teb.2012.0138, 10.1089/ten.TEB.2012.0138]
   Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004
   Schlundt C, 2018, BONE, V106, P78, DOI 10.1016/j.bone.2015.10.019
   Schmidt-Bleek K, 2012, CELL TISSUE RES, V347, P567, DOI 10.1007/s00441-011-1205-7
   Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490
   Spiller KL, 2015, WOUND REPAIR REGEN, V23, pA40
   Spiller KL, 2015, BIOMATERIALS, V37, P194, DOI 10.1016/j.biomaterials.2014.10.017
   Spiller KL, 2014, BIOMATERIALS, V35, P4477, DOI 10.1016/j.biomaterials.2014.02.012
   Vi L, 2015, J BONE MINER RES, V30, P1090, DOI 10.1002/jbmr.2422
   Witherel CE, 2016, WOUND REPAIR REGEN, V24, P514, DOI 10.1111/wrr.12423
   Wu Andy C, 2013, Bonekey Rep, V2, P373, DOI 10.1038/bonekey.2013.107
   Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006
   Zhang WJ, 2013, BIOMATERIALS, V34, P3184, DOI 10.1016/j.biomaterials.2013.01.008
NR 58
TC 5
Z9 6
U1 1
U2 24
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1742-5689
EI 1742-5662
J9 J R SOC INTERFACE
JI J. R. Soc. Interface
PD JUL
PY 2016
VL 13
IS 120
AR 20160346
DI 10.1098/rsif.2016.0346
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DU6VR
UT WOS:000382353200003
PM 27466438
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Ouyang, Z
   Liu, B
   Yasmin-Karim, S
   Sajo, E
   Ngwa, W
AF Ouyang, Zi
   Liu, Bo
   Yasmin-Karim, Sayeda
   Sajo, Erno
   Ngwa, Wilfred
TI Nanoparticle-aided external beam radiotherapy leveraging the Cerenkov
   effect
SO PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS
LA English
DT Article
DE Cerenkov; Titania nanoparticles; EBRT; Tumor sensitization
ID BREAST IRRADIATION APBI; TARGETED RADIOTHERAPY; GOLD NANOPARTICLES;
   RADIATION-THERAPY; TITANIUM-DIOXIDE; REAL-TIME; TISSUE; BRACHYTHERAPY;
   SYSTEM
AB This study investigates the feasibility of exploiting the Cerenkov radiation (CR) present during external beam radiotherapy (EBRT) for significant therapeutic gain, using titanium dioxide (titania) nanoparticles (NPs) delivered via newly designed radiotherapy biomaterials. Using Monte Carlo radiation transport simulations, we calculated the total CR yield inside a tumor volume during EBRT compared to that of the radionuclides. We also considered a novel approach for intratumoral titania delivery using radiotherapy biomaterials (e.g. fiducials) loaded with NPs. The intratumoral distribution/diffusion of titania released from the fiducials was calculated. To confirm the CR induced enhancement in EBRT experimentally, we used 6 MV radiation to irradiate human lung cancer cells with or without titania NPs and performed clonogenic assays. For a radiotherapy biomaterial loaded with 20 mu g/g of 2-nm titania NPs, at least 1 mu g/g could be delivered throughout a tumor sub-volume of 2-cm diameter after 14 days. This concentration level could inflict substantial damage to cancer cells during EBRT. The Monte Carlo results showed the CR yield by 6 MV radiation was higher than by the radionuclides of interest and hence greater damage might be obtained during EBRT. In vitro study showed significant enhancement with 6 MV radiation and titania NPs. These preliminary findings demonstrate a potential new approach that can be used to take advantage of the CR present during megavoltage EBRT to boost damage to cancer cells. The results provide significant impetus for further experimental studies towards the development of nanoparticleaided EBRT powered by the Cerenkov effect. (C) 2016 Associazione Italiana di Fisica Medica. Published by Elsevier Ltd. All rights reserved.
C1 [Ouyang, Zi; Yasmin-Karim, Sayeda; Ngwa, Wilfred] Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Radiat Oncol, 75 Francis St, Boston, MA 02215 USA.
   [Ouyang, Zi; Yasmin-Karim, Sayeda; Ngwa, Wilfred] Harvard Med Sch, 75 Francis St, Boston, MA 02215 USA.
   [Ouyang, Zi; Liu, Bo; Sajo, Erno; Ngwa, Wilfred] Univ Massachusetts, Dept Phys & Appl Phys, Med Phys Program, Lowell, MA USA.
RP Ngwa, W (reprint author), Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Radiat Oncol, 75 Francis St, Boston, MA 02215 USA.; Ngwa, W (reprint author), Harvard Med Sch, 75 Francis St, Boston, MA 02215 USA.
EM wngwa@lroc.harvard.edu
FU NCI NIH HHS [K01 CA172478]
CR Allison J, 2006, IEEE T NUCL SCI, V53, P270, DOI 10.1109/TNS.2006.869826
   Aueviriyavit S, 2012, BIOL TRACE ELEM RES, V149, P123, DOI 10.1007/s12011-012-9403-z
   Capote R, 2006, NDS0484 IAEA INDC
   Cerenkov P, 1934, CR ACAD SCI URSS, V3, P451
   Choi JH, 2014, GUT LIVER, V8, P88, DOI 10.5009/gnl.2014.8.1.88
   Cifter G, 2015, PHYS MEDICA, V31, P1070, DOI 10.1016/j.ejmp.2015.07.138
   Daimon M, 2007, APPL OPTICS, V46, P3811, DOI 10.1364/AO.46.003811
   Dechsakulthorn F, 2007, AATEX, P397
   Einstein A., 1956, INVESTIGATIONS THEOR
   Glaser AK, 2015, PHYS MED BIOL, V60, P6701, DOI 10.1088/0031-9155/60/17/6701
   Glaser AK, 2013, PHYS MED BIOL, V58, P601, DOI 10.1088/0031-9155/58/3/601
   Hall EJ, 2012, RADIOBIOLOGY RADIOLO
   Helo Y, 2014, PHYS MED BIOL, V59, P1963, DOI 10.1088/0031-9155/59/8/1963
   Jarvis LA, 2014, INT J RADIAT ONCOL, V89, P615, DOI 10.1016/j.ijrobp.2014.01.046
   Kotagiri N, 2015, NAT NANOTECHNOL, V10, P370, DOI [10.1038/NNAN0.2015.17, 10.1038/nnano.2015.17]
   Nakata K, 2012, J PHOTOCH PHOTOBIO C, V13, P169, DOI 10.1016/j.jphotochemrev.2012.06.001
   Ngwa W, 2014, NANOMEDICINE-UK, V9, P1063, DOI [10.2217/NNM.14.55, 10.2217/nnm.14.55]
   Ouyang Z, 2016, PHYS MEDICA, V32, P631, DOI 10.1016/j.ejmp.2016.03.014
   Serpone N, 2006, J PHYS CHEM B, V110, P24287, DOI 10.1021/jp065659r
   Sinha N, 2015, INT J RADIAT ONCOL, V91, P385, DOI 10.1016/j.ijrobp.2014.10.001
   Willoughby TR, 2006, INT J RADIAT ONCOL, V65, P528, DOI 10.1016/j.ijrobp.2006.01.050
   Wong C, 2011, P NATL ACAD SCI USA, V108, P2426, DOI 10.1073/pnas.1018382108
NR 22
TC 7
Z9 7
U1 1
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1120-1797
EI 1724-191X
J9 PHYS MEDICA
JI Phys. Medica
PD JUL
PY 2016
VL 32
IS 7
BP 944
EP 947
DI 10.1016/j.ejmp.2016.06.015
PG 4
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA DT6IS
UT WOS:000381588500013
PM 27397906
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Li, Y
   Beitelshees, M
   Fang, L
   Hill, A
   Ahmadi, MK
   Chen, M
   Davidson, BA
   Knight, P
   Smith, RJ
   Andreadis, ST
   Hakansson, AP
   Jones, CH
   Pfeifer, BA
AF Li, Yi
   Beitelshees, Marie
   Fang, Lei
   Hill, Andrew
   Ahmadi, Mahmoud Kamal
   Chen, Mingfu
   Davidson, Bruce A.
   Knight, Paul, III
   Smith, Randall J., Jr.
   Andreadis, Stelios T.
   Hakansson, Anders P.
   Jones, Charles H.
   Pfeifer, Blaine A.
TI In situ pneumococcal vaccine production and delivery through a hybrid
   biological-biomaterial vector
SO SCIENCE ADVANCES
LA English
DT Article
ID STREPTOCOCCUS-PNEUMONIAE; BIOFILM FORMATION; OTITIS-MEDIA; INFECTION;
   DISEASE; PSPA; COLI
AB The type and potency of an immune response provoked during vaccination will determine ultimate success in disease prevention. The basis for this response will be the design and implementation of antigen presentation to the immune system. Whereas direct antigen administration will elicit some form of immunological response, a more sophisticated approach would couple the antigen of interest to a vector capable of broad delivery formats and designed for heightened response. New antigens associated with pneumococcal disease virulence were used to test the delivery and adjuvant capabilities of a hybrid biological-biomaterial vector consisting of a bacterial core electrostatically coated with a cationic polymer. The hybrid design provides (i) passive and active targeting of antigen-presenting cells, (ii) natural and multicomponent adjuvant properties, (iii) dual intracellular delivery mechanisms, and (iv) a simple formulation mechanism. In addition, the hybrid format enables device-specific, or in situ, antigen production and consolidation via localization within the bacterial component of the vector. This capability eliminates the need for dedicated antigen production and purification before vaccination efforts while leveraging the aforementioned features of the overall delivery device. We present the first disease-specific utilization of the vector toward pneumococcal disease highlighted by improved immune responses and protective capabilities when tested against traditional vaccine formulations and a range of clinically relevant Streptococcus pneumoniae strains. More broadly, the results point to similar levels of success with other diseases that would benefit from the production, delivery, and efficacy capabilities offered by the hybrid vector.
C1 [Li, Yi; Beitelshees, Marie; Fang, Lei; Ahmadi, Mahmoud Kamal; Chen, Mingfu; Andreadis, Stelios T.; Jones, Charles H.; Pfeifer, Blaine A.] SUNY Buffalo, Univ Buffalo, Dept Chem & Biol Engn, Buffalo, NY 14260 USA.
   [Hill, Andrew; Jones, Charles H.; Pfeifer, Blaine A.] Abcombi Biosci Inc, Buffalo, NY 14260 USA.
   [Davidson, Bruce A.; Knight, Paul, III] SUNY Buffalo, Univ Buffalo, Dept Anesthesiol, Buffalo, NY 14260 USA.
   [Knight, Paul, III; Hakansson, Anders P.] SUNY Buffalo, Univ Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14260 USA.
   [Smith, Randall J., Jr.; Andreadis, Stelios T.] SUNY Buffalo, Univ Buffalo, Dept Biomed Engn, Buffalo, NY 14260 USA.
   [Andreadis, Stelios T.] Ctr Excellence Bioinformat & Life Sci, Buffalo, NY 14203 USA.
   [Hakansson, Anders P.] Lund Univ, Dept Lab Med, Div Expt Infect Med, SE-20502 Malmo, Sweden.
RP Jones, CH; Pfeifer, BA (reprint author), SUNY Buffalo, Univ Buffalo, Dept Chem & Biol Engn, Buffalo, NY 14260 USA.; Jones, CH; Pfeifer, BA (reprint author), Abcombi Biosci Inc, Buffalo, NY 14260 USA.
EM charles.jones@abcombibio.com; blainepf@buffalo.edu
RI Hakansson, Anders/H-8190-2014
OI Hakansson, Anders/0000-0002-2834-6009; Chen, Mingfu/0000-0002-0169-613X
FU NIH [AI088485, AI117309]; SUNY-Buffalo Schomburg fellowship
FX The authors recognize support from NIH awards AI088485 and AI117309 (to
   B.A.P.) and a SUNY-Buffalo Schomburg fellowship (to C.H.J.).
CR Bakaletz LO, 2012, PAEDIATR RESPIR REV, V13, P154, DOI 10.1016/j.prrv.2012.03.001
   Briles DE, 2000, INFECT IMMUN, V68, P796, DOI 10.1128/IAI.68.2.796-800.2000
   CHONMAITREE T, 1986, PEDIATRICS, V77, P698
   Chung TC, 2015, MOL PHARMACEUT, V12, P1691, DOI 10.1021/acs.molpharmaceut.5b00172
   Davidson BA, 2013, J IMMUNOL, V190, P1714, DOI 10.4049/jimmunol.1202410
   Hausdorff WP, 2015, EXPERT REV VACCINES, V14, P413, DOI 10.1586/14760584.2015.965160
   Jones CH, 2015, BIOMATERIALS, V58, P103, DOI 10.1016/j.biomaterials.2015.04.033
   Jones CH, 2015, BIOMACROMOLECULES, V16, P1534, DOI 10.1021/acs.biomac.5b00062
   Jones CH, 2015, BIOMATERIALS, V37, P333, DOI 10.1016/j.biomaterials.2014.10.037
   Jones CH, 2014, P NATL ACAD SCI USA, V111, P12360, DOI 10.1073/pnas.1411355111
   Jones CH, 2013, MOL PHARMACEUT, V10, P4082, DOI 10.1021/mp400467x
   Marks LR, 2013, MBIO, V4, DOI 10.1128/mBio.00438-13
   Marks LR, 2012, INFECT IMMUN, V80, P2744, DOI 10.1128/IAI.00488-12
   O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6
   Pettigrew MM, 2014, INFECT IMMUN, V82, P4607, DOI 10.1128/IAI.02225-14
   Pettigrew MM, 2011, J CLIN MICROBIOL, V49, P3750, DOI 10.1128/JCM.01186-11
   Plotkin SA, 2005, NAT MED, V11, pS5, DOI 10.1038/nm1209
   Rappuoli R, 2007, NAT BIOTECHNOL, V25, P1361, DOI 10.1038/nbt1207-1361
   Roche H, 2003, INFECT IMMUN, V71, P4498, DOI 10.1128/IAI.71.8.4498-4505.2003
   Roche H, 2003, INFECT IMMUN, V71, P1033, DOI 10.1128/IAI.71.3.1033-1041.2003
   Stevens KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002232
   Tyx RE, 2011, J BACTERIOL, V193, P3512, DOI 10.1128/JB.01410-10
   Zhang HR, 2010, CHEM BIOL, V17, P1232, DOI 10.1016/j.chembiol.2010.09.013
NR 23
TC 5
Z9 5
U1 0
U2 7
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 2375-2548
J9 SCI ADV
JI Sci. Adv.
PD JUL
PY 2016
VL 2
IS 7
AR UNSP e1600264
DI 10.1126/sciadv.1600264
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DT9GQ
UT WOS:000381805300023
PM 27419235
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Chen, ZT
   Klein, T
   Murray, RZ
   Crawford, R
   Chang, J
   Wu, CT
   Xiao, Y
AF Chen, Zetao
   Klein, Travis
   Murray, Rachael Z.
   Crawford, Ross
   Chang, Jiang
   Wu, Chengtie
   Xiao, Yin
TI Osteoimmunomodulation for the development of advanced bone biomaterials
SO MATERIALS TODAY
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; NF-KAPPA-B; BETA-TRICALCIUM PHOSPHATE;
   NECROSIS-FACTOR-ALPHA; MONOCYTES IN-VITRO; INHIBITS OSTEOCLAST
   DIFFERENTIATION; ACUTE INFLAMMATORY RESPONSES; TITANIUM
   SURFACE-TOPOGRAPHY; BIPHASIC CALCIUM-PHOSPHATE; PERIODONTAL-LIGAMENT
   CELLS
AB As direct effector cells for osteogenesis, osteoblastic cells are commonly used for evaluating the in vitro osteogenic capacity of bone biomaterials, and the traditional biological principle for developing bone biomaterials is to directly stimulate osteogenic differentiation. With this principle, most efforts are currently spent on optimizing the bio-mechanical and physicochemical properties to induce osteogenic differentiation of mesenchymal stem cells. This strategy has achieved certain success in the development of bone biomaterials; however, inconsistencies between in vitro and in vivo studies are not uncommon, implying the mechanisms that govern the material's capacity to mediate osteogenesis is not well-understood. Osteoimmunology has revealed the vital role of immune cells in regulating bone dynamics. Neglecting the importance of the immune response is a major shortcoming of the traditional strategy, and may explain inconsistencies between in vitro and in vivo conditions. Here, we proposed osteoimmunomodulation (OIM) in recognition of the importance of the immune response during biomaterial-mediated osteogenesis. Accordingly, we proposed the paradigm shift of bone biomaterials to an osteoimmunomodulatory material and discussed the evaluation strategy for the osteoimmunomodulation property of bone biomaterials. It is the ambition of authors that this review will change traditional methods for bone biomaterials assessment and assist in developing new bone biomaterials with the osteoimmunomodulatory property for orthopedic and dental applications.
C1 [Chen, Zetao; Klein, Travis; Murray, Rachael Z.; Crawford, Ross; Xiao, Yin] Queensland Univ Technol, Inst Hlth & Biomed Innovat, 60 Musk Ave, Brisbane, Qld 4059, Australia.
   [Chang, Jiang; Wu, Chengtie] Chinese Acad Sci, State Key Lab High Performance Ceram & Superfine, Shanghai Inst Ceram, 1295 Dingxi Rd, Shanghai 200050, Peoples R China.
   [Chen, Zetao; Klein, Travis; Crawford, Ross; Chang, Jiang; Wu, Chengtie; Xiao, Yin] Queensland Univ Technol, Australia China Ctr Tissue Engn & Regenerat Med, 60 Musk Ave, Brisbane, Qld 4059, Australia.
RP Xiao, Y (reprint author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, 60 Musk Ave, Brisbane, Qld 4059, Australia.; Wu, CT (reprint author), Chinese Acad Sci, State Key Lab High Performance Ceram & Superfine, Shanghai Inst Ceram, 1295 Dingxi Rd, Shanghai 200050, Peoples R China.; Wu, CT; Xiao, Y (reprint author), Queensland Univ Technol, Australia China Ctr Tissue Engn & Regenerat Med, 60 Musk Ave, Brisbane, Qld 4059, Australia.
EM chengtiewu@mail.sic.ac.cn; yin.xiao@qut.edu.au
RI Murray, Rachael/J-1370-2012
OI Murray, Rachael/0000-0002-4935-7794
FU Q-CAS Biotechnology Fund [GJHZ1505]; Recruitment Program of Global Young
   Talent, China; National High Technology Research and Development Program
   of China (863 Program) [SS2015AA020302]; Natural Science Foundation of
   China [31370963, 81201202, 81190132]; Program of Shanghai Outstanding
   Academic Leaders [15XD1503900]; Innovative Project of SIC, CAS, NHMRC
   [APP1032738]; ARC [DP120103697]
FX Funding for this study was provided by the Q-CAS Biotechnology Fund
   (GJHZ1505), Recruitment Program of Global Young Talent, China (C.W.),
   the National High Technology Research and Development Program of China
   (863 Program, SS2015AA020302), Natural Science Foundation of China
   (Grants 31370963, 81201202 and 81190132), Program of Shanghai
   Outstanding Academic Leaders (15XD1503900), Innovative Project of SIC,
   CAS, NHMRC (APP1032738) and ARC (DP120103697).
CR Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593
   Ainslie KM, 2008, ACS NANO, V2, P1076, DOI 10.1021/nn800071k
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Andersson J, 2002, J IMMUNOL, V168, P5786, DOI 10.4049/jimmunol.168.11.5786
   Arron JR, 2000, NATURE, V408, P535, DOI 10.1038/35046196
   Azevedo MM, 2010, J MATER CHEM, V20, P8854, DOI 10.1039/c0jm01111h
   Berton G, 1999, CELL SIGNAL, V11, P621, DOI 10.1016/S0898-6568(99)00003-0
   Blouin CC, 2004, BLOOD, V103, P1124, DOI 10.1182/blood-2003-07-2427
   Boehler RM, 2011, BIOTECHNIQUES, V51, P239, DOI 10.2144/000113754
   Bohner M, 2012, J EUR CERAM SOC, V32, P2663, DOI 10.1016/j.jeurceramsoc.2012.02.028
   Bonewald Lynda F, 2006, Bonekey Osteovision, V3, P7
   Boyce BF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2165
   Brown BN, 2013, ACTA BIOMATER, V9, P4948, DOI 10.1016/j.actbio.2012.10.025
   Buache E, 2012, ACTA BIOMATER, V8, P3113, DOI 10.1016/j.actbio.2012.04.045
   Caetano-Lopes J, 2009, AUTOIMMUN REV, V8, P250, DOI 10.1016/j.autrev.2008.07.038
   Cardemil C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084932
   CARLISLE EM, 1982, NUTR REV, V40, P210
   CARLISLE EM, 1986, CIBA F SYMP, V121, P123
   CARLISLE EM, 1982, NUTR REV, V40, P193
   CARLISLE EM, 1970, SCIENCE, V167, P279, DOI 10.1126/science.167.3916.279
   Carson JS, 2007, INJURY, V38, pS33, DOI 10.1016/j.injury.2007.02.008
   Chakravarti A, 2009, BLOOD, V114, P1633, DOI 10.1182/blood-2008-09-178301
   Champagne CM, 2002, BONE, V30, P26, DOI 10.1016/S8756-3282(01)00638-X
   Chang J, 2013, P NATL ACAD SCI USA, V110, P9469, DOI 10.1073/pnas.1300532110
   Chang MK, 2008, J IMMUNOL, V181, P1232, DOI 10.4049/jimmunol.181.2.1232
   Chen Y, 2004, TOXICOL IND HEALTH, V20, P21, DOI 10.1191/0748233704th190oa
   Chen YW, 2015, J MATER CHEM B, V3, P7099, DOI 10.1039/c5tb00713e
   Chen Z., 2014, J MAT CHEM B
   Chen ZT, 2015, BIOMATERIALS, V61, P126, DOI 10.1016/j.biomaterials.2015.04.044
   Chen ZT, 2014, J MATER CHEM B, V2, P6030, DOI 10.1039/c4tb00837e
   Chen ZT, 2014, J BIOMED MATER RES A, V102, P2813, DOI 10.1002/jbm.a.34954
   Chen ZF, 2014, J ARTHROPLASTY, V29, P612, DOI 10.1016/j.arth.2013.07.031
   Chiappetta N, 2006, SEMIN ARTHRITIS RHEU, V36, P32, DOI 10.1016/j.semarthrit.2006.03.004
   Collie AMB, 2011, J BIOMED MATER RES A, V96A, P162, DOI 10.1002/jbm.a.32963
   Connell P, 1997, J AM COLL NUTR, V16, P411, DOI 10.1080/07315724.1997.10718706
   Cook Emily A, 2009, Clin Podiatr Med Surg, V26, P589, DOI 10.1016/j.cpm.2009.07.003
   COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473
   Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Day RM, 2005, J BIOMED MATER RES A, V73A, P73, DOI 10.1002/jbm.a.30262
   De A, 2011, ACTA BIOCH BIOPH SIN, V43, P745, DOI 10.1093/abbs/gmr079
   Devlin RD, 1998, J BONE MINER RES, V13, P393, DOI 10.1359/jbmr.1998.13.3.393
   Ding J, 2009, LIFE SCI, V84, P499, DOI 10.1016/j.lfs.2009.01.013
   Dobrovolskaia MA, 2007, NAT NANOTECHNOL, V2, P469, DOI 10.1038/nnano.2007.223
   Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249
   EVANS EM, 1974, J BONE JOINT SURG BR, VB 56, P626
   Feldmann M, 2010, J IMMUNOL, V185, P791, DOI 10.4049/jimmunol.1090051
   Fitzpatrick LA, 2003, P NATL ACAD SCI USA, V100, P6027, DOI 10.1073/pnas.0934373100
   Fouilloux I, 2006, BONE, V38, P59, DOI 10.1016/j.bone.2005.07.026
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Freytes DO, 2013, J CELL BIOCHEM, V114, P220, DOI 10.1002/jcb.24357
   Gaharwar AK, 2013, ADV MATER, V25, P3329, DOI 10.1002/adma.201300584
   Garg K, 2013, BIOMATERIALS, V34, P4439, DOI 10.1016/j.biomaterials.2013.02.065
   Gentleman E, 2010, BIOMATERIALS, V31, P3949, DOI 10.1016/j.biomaterials.2010.01.121
   Giacomelli CE, 1999, J COLLOID INTERF SCI, V220, P13, DOI 10.1006/jcis.1999.6479
   Gilbert L, 2000, ENDOCRINOLOGY, V141, P3956, DOI 10.1210/en.141.11.3956
   Grandjean-Laquerrier A, 2006, BIOMATERIALS, V27, P3195, DOI 10.1016/j.biomaterial.2006.01.024
   Grcevic D, 2000, J IMMUNOL, V165, P4231, DOI 10.4049/jimmunol.165.8.4231
   Gruber R, 2010, WIEN MED WOCHENSCHR, V160, P438, DOI 10.1007/s10354-010-0809-y
   Guihard P, 2015, AM J PATHOL, V185, P765, DOI 10.1016/j.ajpath.2014.11.008
   Guihard P, 2012, STEM CELLS, V30, P762, DOI 10.1002/stem.1040
   Haase H, 2007, BIOMETALS, V20, P579, DOI 10.1007/s10534-006-9029-8
   Hart PH, 1999, J LEUKOCYTE BIOL, V66, P575
   Hellwig-Burgel T, 1999, BLOOD, V94, P1561
   Hess K, 2009, BONE, V45, P367, DOI 10.1016/j.bone.2009.04.252
   Hezi-Yamit A, 2009, J BIOMED MATER RES A, V90A, P133, DOI 10.1002/jbm.a.32057
   Hirota K., 2012, ENDOCYTOSIS PARTICLE
   Hirota K, 2011, COLLOID SURFACE B, V87, P293, DOI 10.1016/j.colsurfb.2011.05.032
   Honda Y, 2006, BIOCHEM BIOPH RES CO, V345, P1155, DOI 10.1016/j.bbrc.2006.05.013
   HSIEH HS, 1980, J NUTR, V110, P1581
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Hung CJ, 2013, J ENDODONT, V39, P1557, DOI 10.1016/j.joen.2013.07.004
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   Junge K, 2012, LANGENBECK ARCH SURG, V397, P255, DOI 10.1007/s00423-011-0780-0
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863
   KEETING PE, 1992, J BONE MINER RES, V7, P1281, DOI 10.1002/jbmr.5650071107
   Keselowsky BG, 2007, BIOMATERIALS, V28, P3626, DOI 10.1016/j.biomaterials.2007.04.035
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Kim J, 2009, EXP HEMATOL, V37, P1445, DOI 10.1016/j.exphem.2009.09.004
   Kim JT, 2009, J MED FOOD, V12, P118, DOI 10.1089/jmf.2007.0647
   Klein-Nulend J, 2013, BONE, V54, P182, DOI 10.1016/j.bone.2012.10.013
   Klinge U, 2002, J SURG RES, V103, P208, DOI 10.1006/jsre.2002.6358
   Kobayashi SD, 2005, ARCH IMMUNOL THER EX, V53, P505
   Kuboki Y, 2002, CONNECT TISSUE RES, V43, P529, DOI 10.1080/03008200290001104
   Langton DJ, 2010, J BONE JOINT SURG BR, V92B, P38, DOI 10.1302/0301-620X.92B1.22770
   Laquerriere P, 2003, BIOMATERIALS, V24, P2739, DOI 10.1016/S0142-9612(03)00089-9
   Laschke MW, 2006, TISSUE ENG, V12, P2093, DOI 10.1089/ten.2006.12.2093
   Lee HS, 2013, J BIOMED MATER RES A, V101, P203, DOI 10.1002/jbm.a.34309
   Li TS, 2002, AM J PHYSIOL-HEART C, V283, pH468, DOI 10.1152/ajpheart.00261.2002
   Li Y, 2007, BLOOD, V109, P3839, DOI 10.1182/blood-2006-07-037994
   Liu Y, 2011, NAT MED, V17, P1594, DOI 10.1038/nm.2542
   Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356
   Ma ML, 2011, ADV MATER, V23, pH189, DOI 10.1002/adma.201100513
   MacLeod RJ, 2007, AM J PHYSIOL-GASTR L, V293, pG403, DOI 10.1152/ajpgi.00119.2007
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   Malard O, 1999, J BIOMED MATER RES, V46, P103, DOI 10.1002/(SICI)1097-4636(199907)46:1<103::AID-JBM12>3.0.CO;2-Z
   Malekshah Abbasali Karimpour, 2006, Indian Journal of Experimental Biology, V44, P189
   Marshall AJ, 2004, ABSTR PAP AM CHEM S, V228, pU386
   McFarland CD, 2000, J BIOMED MATER RES, V49, P200, DOI 10.1002/(SICI)1097-4636(200002)49:2<200::AID-JBM7>3.3.CO;2-C
   McNally AK, 2002, AM J PATHOL, V160, P621, DOI 10.1016/S0002-9440(10)64882-1
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   McNally AK, 2008, J BIOMED MATER RES A, V86A, P535, DOI 10.1002/jbm.a.31658
   McNally AK, 2011, ADV EXP MED BIOL, V713, P97, DOI 10.1007/978-94-007-0763-4_7
   Meguid MHA, 2013, RHEUMATOL INT, V33, P697, DOI 10.1007/s00296-012-2375-7
   Mendonca G, 2008, BIOMATERIALS, V29, P3822, DOI 10.1016/j.biomaterials.2008.05.012
   Miki Y, 2012, J STEROID BIOCHEM, V131, P68, DOI 10.1016/j.jsbmb.2011.12.004
   Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166
   Mokarram N, 2014, ANN BIOMED ENG, V42, P338, DOI 10.1007/s10439-013-0941-0
   Moon JJ, 2012, ADV MATER, V24, P3724, DOI 10.1002/adma.201200446
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/nmat2442, 10.1038/NMAT2442]
   Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905
   Nielsen FH, 2004, J TRACE ELEM EXP MED, V17, P137, DOI 10.1002/jtra.20004
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   Nyangoga H, 2010, ACTA BIOMATER, V6, P3310, DOI 10.1016/j.actbio.2010.01.042
   Oda T, 2006, AM J PHYSIOL-CELL PH, V291, pC104, DOI 10.1152/ajpcell.00614.2005
   Oh JY, 2010, P NATL ACAD SCI USA, V107, P16875, DOI 10.1073/pnas.1012451107
   Oh WK, 2010, ACS NANO, V4, P5301, DOI 10.1021/nn100561e
   OKeefe RJ, 1997, LAB INVEST, V76, P457
   Oliveira R, 2012, IMPLANT DENT, V21, P422, DOI 10.1097/ID.0b013e3182691873
   Ortiz LA, 2007, P NATL ACAD SCI USA, V104, P11002, DOI 10.1073/pnas.0704421104
   Oyewumi MO, 2010, EXPERT REV VACCINES, V9, P1095, DOI [10.1586/erv.10.89, 10.1586/ERV.10.89]
   Pacifici R, 2010, ARCH BIOCHEM BIOPHYS, V503, P41, DOI 10.1016/j.abb.2010.05.027
   Palmqvist P, 2002, J IMMUNOL, V169, P3353, DOI 10.4049/jimmunol.169.6.3353
   Park JK, 2010, ADV MATER, V22, P4857, DOI 10.1002/adma.201002255
   Paula NE, 2008, BIOMATERIALS, V29, P4056, DOI 10.1016/j.biomaterials.2008.07.010
   Pearl JI, 2011, BIOMATERIALS, V32, P5535, DOI 10.1016/j.biomaterials.2011.04.046
   Pettit AR, 2008, BONE, V43, P976, DOI 10.1016/j.bone.2008.08.128
   Pietak AM, 2007, BIOMATERIALS, V28, P4023, DOI 10.1016/j.biomaterials.2007.05.003
   Prockop DJ, 2012, MOL THER, V20, P14, DOI 10.1038/mt.2011.211
   Raes G, 2002, J LEUKOCYTE BIOL, V71, P597
   Refai AK, 2004, J BIOMED MATER RES A, V70A, P194, DOI 10.1002/jbm.a.30075
   Reffitt DM, 2003, BONE, V32, P127, DOI 10.1016/S8756-3282(02)00950-X
   Reinke S., 2013, SCI TRANSL MED, V5, DOI DOI 10.1126/SCITRANSLMED.3004754
   REMES A, 1992, BIOMATERIALS, V13, P731, DOI 10.1016/0142-9612(92)90010-L
   Rice JM, 2003, BIOMATERIALS, V24, P4799, DOI 10.1016/S0142-9612(03)00381-8
   Richardson IG, 2000, CEMENT CONCRETE COMP, V22, P97, DOI 10.1016/S0958-9465(99)00036-0
   Rifas L, 2006, J CELL BIOCHEM, V98, P706, DOI 10.1002/jcb.20933
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Romer P, 2012, ANN ANAT, V194, P208, DOI 10.1016/j.aanat.2011.09.008
   Roldan Cuenya B, 2010, THIN SOLID FILMS, V518, P3127, DOI 10.1016/j.tsf.2010.01.018
   Sarma JV, 2011, CELL TISSUE RES, V343, P227, DOI 10.1007/s00441-010-1034-0
   Schindler OS, 2007, KNEE, V14, P458, DOI 10.1016/j.knee.2007.07.001
   SCUDERI P, 1990, CELL IMMUNOL, V126, P391, DOI 10.1016/0008-8749(90)90330-T
   SHORR E, 1952, Bull Hosp Joint Dis, V13, P59
   SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0
   SILBERSTEIN R, 1991, BONE, V12, P227, DOI 10.1016/8756-3282(91)90068-T
   Sims N. A., 2014, BONEKEY REP, V3
   Smith BS, 2013, BIOMATER SCI-UK, V1, P322, DOI 10.1039/c2bm00079b
   Smith JM, 2013, J MATER CHEM B, V1, P1296, DOI 10.1039/c3tb00408b
   Son JS, 2011, J BIOMED MATER RES A, V99A, P638, DOI 10.1002/jbm.a.33223
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342
   Sugimoto J, 2012, J IMMUNOL, V188, P6338, DOI 10.4049/jimmunol.1101765
   Takayanagi H, 2005, J PERIODONTAL RES, V40, P287, DOI 10.1111/j.1600-0765.2005.00814.x
   Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062
   Takebe J, 2003, J BIOMED MATER RES A, V64A, P207, DOI 10.1002/jbm.a.10275
   Tan YD, 1999, HUM GENE THER, V10, P2153, DOI 10.1089/10430349950017149
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841
   TEUBER SS, 1995, BIOL TRACE ELEM RES, V48, P121, DOI 10.1007/BF02789186
   Theill LE, 2002, ANNU REV IMMUNOL, V20, P795, DOI 10.1146/annurev.immunol.20.100301.064753
   Toben D, 2011, J BONE MINER RES, V26, P113, DOI 10.1002/jbmr.185
   Velard F, 2013, ACTA BIOMATER, V9, P4956, DOI 10.1016/j.actbio.2012.09.035
   Wagner VE, 2004, J BIOMED MATER RES A, V69A, P79, DOI 10.1002/jbm.a.20115
   WAHL SM, 1990, ANN NY ACAD SCI, V593, P188, DOI 10.1111/j.1749-6632.1990.tb16111.x
   Wang JL, 2012, J BIOMED MATER RES B, V100B, P1691, DOI 10.1002/jbm.b.32707
   Weiss L, 1969, Int Rev Cytol, V26, P63, DOI 10.1016/S0074-7696(08)61634-4
   Weyhe D, 2006, WORLD J SURG, V30, P1586, DOI 10.1007/s00268-005-0601-0
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   WOJCIAKSTOTHARD B, 1995, CELL BIOL INT, V19, P485, DOI 10.1006/cbir.1995.1092
   Wright HL, 2009, CURR REV MUSCULOSKE, V2, P56, DOI 10.1007/s12178-009-9046-7
   Wu BC, 2014, J ENDODONT, V40, P1105, DOI 10.1016/j.joen.2013.12.019
   Wu CT, 2015, BIOMATERIALS, V71, P35, DOI 10.1016/j.biomaterials.2015.08.027
   Wu CT, 2014, ACS APPL MATER INTER, V6, P4264, DOI 10.1021/am4060035
   Wu CT, 2013, J MATER CHEM B, V1, P876, DOI 10.1039/c2tb00391k
   Wu CT, 2012, ACTA BIOMATER, V8, P3805, DOI 10.1016/j.actbio.2012.06.023
   Wu CT, 2012, BIOMATERIALS, V33, P2076, DOI 10.1016/j.biomaterials.2011.11.042
   Wu G, 2010, BIOMATERIALS, V31, P7485, DOI 10.1016/j.biomaterials.2010.06.037
   Wu YL, 2008, AUTOIMMUNITY, V41, P183, DOI 10.1080/08916930701693180
   Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   Yamaguchi M, 1998, J TRACE ELEM EXP MED, V11, P119
   Yamaguchi M, 2012, MOL CELL BIOCHEM, V359, P399, DOI 10.1007/s11010-011-1034-8
   Yamashita M, 2010, REGUL PEPTIDES, V162, P99, DOI 10.1016/j.regpep.2010.03.003
   Yang X, 2007, BONE, V41, P928, DOI 10.1016/j.bone.2007.07.022
   Ylostalo JH, 2012, STEM CELLS, V30, P2283, DOI 10.1002/stem.1191
   Yoshitake F, 2008, J BIOL CHEM, V283, P11535, DOI 10.1074/jbc.M607999200
   YUN JK, 1995, J BIOMED MATER RES, V29, P257, DOI 10.1002/jbm.820290217
   Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593
   Zhang LP, 2012, J BIOL CHEM, V287, P6177, DOI 10.1074/jbc.M111.292649
   Zhang ML, 2012, J MATER CHEM, V22, P21686, DOI 10.1039/c2jm34395a
   Zhang Q., 2008, BIOL CHEM, V283, P13491
   Zhang Y., 2013, ANN ORAL MAXILLOFAC, V1, P1, DOI DOI 10.1007/S11365-012-0246-Z
   Zhou HJ, 2012, BIOMATERIALS, V33, P6933, DOI 10.1016/j.biomaterials.2012.06.064
   Zhou XY, 2014, IMMUNOLOGY, V143, P287, DOI 10.1111/imm.12309
   Zhu J, 2007, BLOOD, V109, P3706, DOI 10.1182/blood-2006-08-041384
   Zoli A, 1998, CLIN RHEUMATOL, V17, P378, DOI 10.1007/BF01450895
NR 201
TC 50
Z9 50
U1 19
U2 125
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1369-7021
EI 1873-4103
J9 MATER TODAY
JI Mater. Today
PD JUL-AUG
PY 2016
VL 19
IS 6
BP 304
EP 321
DI 10.1016/j.mattod.2015.11.004
PG 18
WC Materials Science, Multidisciplinary
SC Materials Science
GA DS4OA
UT WOS:000380759200014
OA Other Gold
DA 2018-10-20
ER

PT J
AU Yuan, X
   Smith, RJ
   Guan, HY
   Ionita, CN
   Khobragade, P
   Dziak, R
   Liu, ZP
   Pang, MH
   Wang, CD
   Guan, GQ
   Andreadis, S
   Yang, SY
AF Yuan, Xue
   Smith, Randall J., Jr.
   Guan, Huiyan
   Ionita, Ciprian N.
   Khobragade, Parag
   Dziak, Rosemary
   Liu, Zunpeng
   Pang, Manhui
   Wang, Changdong
   Guan, Guoqiang
   Andreadis, Stelios
   Yang, Shuying
TI Hybrid Biomaterial with Conjugated Growth Factors and Mesenchymal Stem
   Cells for Ectopic Bone Formation
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID ALGINATE-FIBRIN MICROBEADS; REGENERATION; DELIVERY; DIFFERENTIATION;
   ANGIOGENESIS; SCAFFOLD; STIFFNESS; FGF-1; OSTEOGENESIS; STIMULATION
AB Bone is a highly vascularized tissue and efficient bone regeneration requires neovascularization, especially for critical-sized bone defects. We developed a novel hybrid biomaterial comprising nanocalcium sulfate (nCS) and fibrin hydrogel to deliver mesenchymal stem cells (MSCs) and angiogenic factors, vascular endothelial growth factor (VEGF) and fibroblast growth factor 9 (FGF9), to promote neovascularization and bone formation. MSC and growth factor(s)-loaded scaffolds were implanted subcutaneously into mice to examine their angiogenic and osteogenic potential. Micro CT, alkaline phosphatase activity assay, and histological analysis were used to evaluate bone formation, while immunohistochemistry was employed to assess neovessel formation. The presence of fibrin preserved the nCS scaffold structure and promoted de novo bone formation. In addition, the presence of bone morphogenic protein 2-expressing MSC in nCS and fibrin hydrogels improved bone regeneration significantly. While FGF9 alone had no significant effect, the combination FGF9 and VEGF conjugated in fibrin enhanced neovascularization and bone formation more than 4-fold compared to nCS with MSC. Overall, our results suggested that the combination of nCS (to support bone formation) with a fibrin-based VEGF/FGF9 release system (support vascular formation) is an innovative and effective strategy that significantly enhanced ectopic bone formation in vivo.
C1 [Yuan, Xue; Guan, Huiyan; Dziak, Rosemary; Liu, Zunpeng; Wang, Changdong; Yang, Shuying] SUNY Buffalo, Dept Oral Biol, Buffalo, NY USA.
   [Smith, Randall J., Jr.; Ionita, Ciprian N.; Khobragade, Parag; Andreadis, Stelios] SUNY Buffalo, Dept Biomed Engn, Buffalo, NY USA.
   [Guan, Huiyan; Guan, Guoqiang] SUNY Buffalo, Dept Orthodont, Buffalo, NY USA.
   [Ionita, Ciprian N.; Khobragade, Parag] SUNY Buffalo, Toshiba Stroke & Vasc Res Ctr, Buffalo, NY USA.
   [Pang, Manhui] SUNY Buffalo, Clin & Translat Res Ctr, Buffalo, NY USA.
   [Andreadis, Stelios] SUNY Buffalo, Dept Chem & Biol Engn, Buffalo, NY USA.
   [Andreadis, Stelios; Yang, Shuying] SUNY Buffalo, Ctr Excellence Bioinformat & Life Sci, Buffalo, NY USA.
RP Yang, SY (reprint author), SUNY Buffalo, Dept Oral Biol, Buffalo, NY USA.; Andreadis, S (reprint author), SUNY Buffalo, Dept Biomed Engn, Buffalo, NY USA.
EM sandread@buffalo.edu; sy47@buffalo.edu
OI Yuan, Xue/0000-0002-8063-9431
FU National Institute of Dental and Craniofacial Research; National
   Institute of Arthritis and Musculoskeletal and Skin Diseases part of the
   National Institutes of Health [DE023105, AR066101]; Mark Diamond
   Research Fund of the Graduate Student Association at the University at
   Buffalo, The State University of New York [SU-14-17]
FX We thank Dr. Peter J. Bush for technical assistance with scanning
   electron microscopy. This study was partially supported by the National
   Institute of Dental and Craniofacial Research and the National Institute
   of Arthritis and Musculoskeletal and Skin Diseases, part of the National
   Institutes of Health, under Award Numbers DE023105 and AR066101 to S.Y.,
   and the Mark Diamond Research Fund of the Graduate Student Association
   at the University at Buffalo, The State University of New York (Grant
   No. SU-14-17).
CR Ahn SE, 2006, BIOCHEM BIOPH RES CO, V340, P403, DOI 10.1016/j.bbrc.2005.12.020
   Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7
   Breen A, 2009, J BIOMED MATER RES A, V89A, P876, DOI 10.1002/jbm.a.32039
   Cao LY, 2014, BIOMATERIALS, V35, P684, DOI 10.1016/j.biomaterials.2013.10.005
   Carinci F, 2004, J BIOMED MATER RES B, V71B, P260, DOI 10.1002/jbm.b.30133
   Chen WC, 2012, ACTA BIOMATER, V8, P2297, DOI 10.1016/j.actbio.2012.02.021
   Clark RAF, 2000, EXPERT OPIN INV DRUG, V9, P2371, DOI 10.1517/13543784.9.10.2371
   Clark RAF, 2001, ANN NY ACAD SCI, V936, P355
   Ehrbar M, 2005, J CONTROL RELEASE, V101, P93, DOI 10.1016/j.jconrel.2004.07.018
   Ehrbar M, 2004, CIRC RES, V94, P1124, DOI 10.1161/01.RES.0000126411.29641.08
   Evans ND, 2009, EUR CELLS MATER, V18, P1
   Farrara N, 2000, CURR OPIN BIOTECH, V11, P617
   Frontini MJ, 2011, NAT BIOTECHNOL, V29, P421, DOI 10.1038/nbt.1845
   Geer DJ, 2004, TISSUE ENG, V10, P1006, DOI 10.1089/ten.2004.10.1006
   He XN, 2013, TISSUE ENG PT A, V19, P508, DOI [10.1089/ten.tea.2012.0244, 10.1089/ten.TEA.2012.0244]
   He XN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060473
   Kanczler JM, 2008, EUR CELLS MATER, V15, P100, DOI 10.22203/eCM.v015a08
   Knight MN, 2013, ADV WOUND CARE, V2, P306, DOI 10.1089/wound.2012.0420
   Ledoux Dominique, 1992, Progress in Growth Factor Research, V4, P107, DOI 10.1016/0955-2235(92)90026-E
   Li Y, 2013, BIOMATERIALS, V34, P5048, DOI 10.1016/j.biomaterials.2013.03.052
   Liang MS, 2013, BIOMATERIALS, V34, P7281, DOI 10.1016/j.biomaterials.2013.05.073
   Liang MS, 2011, BIOMATERIALS, V32, P8684, DOI 10.1016/j.biomaterials.2011.07.079
   Lv J, 2015, BIOMED MATER, V10, DOI 10.1088/1748-6041/10/3/035013
   Matsuda T, 2013, J BIOMED MATER RES B, V101B, P50, DOI 10.1002/jbm.b.32812
   Michlits W, 2007, WOUND REPAIR REGEN, V15, P360, DOI 10.1111/j.1524-475X.2007.00238.x
   Nguyen LH, 2012, TISSUE ENG PART B-RE, V18, P363, DOI 10.1089/ten.teb.2012.0012
   Pandit AS, 2000, J BIOMATER APPL, V14, P229, DOI 10.1177/088532820001400303
   Pandit AS, 1998, GROWTH FACTORS, V15, P113, DOI 10.3109/08977199809117187
   Park YB, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/5/055007
   Qin YH, 2014, POSTGRAD MED J, V90, P643, DOI 10.1136/postgradmedj-2013-132387
   Reinhart-King CA, 2008, BIOPHYS J, V95, P6044, DOI 10.1529/biophysj.107.127662
   Risau W., 1994, Arzneimittel-Forschung, V44, P416
   Rosenquist TA, 1996, DEV DYNAM, V205, P379, DOI 10.1002/(SICI)1097-0177(199604)205:4<379::AID-AJA2>3.0.CO;2-F
   Rowlands AS, 2008, AM J PHYSIOL-CELL PH, V295, pC1037, DOI 10.1152/ajpcell.67.2008
   Royce SM, 2004, J BIOMAT SCI-POLYM E, V15, P1327, DOI 10.1163/1568562041960016
   Sahni A, 1998, J BIOL CHEM, V273, P7554, DOI 10.1074/jbc.273.13.7554
   Schense JC, 1999, BIOCONJUGATE CHEM, V10, P75, DOI 10.1021/bc9800769
   Shireman PK, 2000, J VASC SURG, V31, P936, DOI 10.1067/mva.2000.106420
   Snyder A, 2004, J CELL BIOCHEM, V93, P224, DOI 10.1002/jcb.20191
   Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221
   Tan ML, 2014, BIOMATERIALS, V35, P7828, DOI 10.1016/j.biomaterials.2014.05.087
   Tee SY, 2011, BIOPHYS J, V100, pL25, DOI 10.1016/j.bpj.2010.12.3744
   TISCHER E, 1989, BIOCHEM BIOPH RES CO, V165, P1198, DOI 10.1016/0006-291X(89)92729-0
   Tonnesen MG, 2000, J INVEST DERM SYMP P, V5, P40, DOI 10.1046/j.1087-0024.2000.00014.x
   Wang WZ, 2012, INT J BIOL SCI, V8, P1310, DOI 10.7150/ijbs.5136
   Wong C, 2003, THROMB HAEMOSTASIS, V89, P573
   Yang SY, 2012, BONE, V51, P407, DOI 10.1016/j.bone.2012.06.021
   Zhang WJ, 2011, BIOMATERIALS, V32, P9415, DOI 10.1016/j.biomaterials.2011.08.047
   Zhou HZ, 2011, BIOMATERIALS, V32, P7503, DOI 10.1016/j.biomaterials.2011.06.045
   Zisch AH, 2004, BIOMATERIALS, V25, P3245, DOI 10.1016/j.biomaterials.2003.10.015
NR 50
TC 6
Z9 6
U1 0
U2 15
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD JUL
PY 2016
VL 22
IS 13-14
BP 928
EP 939
DI 10.1089/ten.tea.2016.0052
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA DS2NE
UT WOS:000380614400003
PM 27269204
OA Green Published
DA 2018-10-20
ER

PT J
AU Toivonen, S
   Malinen, MM
   Kublbeck, J
   Petsalo, A
   Urtti, A
   Honkakoski, P
   Otonkoski, T
AF Toivonen, Sanna
   Malinen, Melina M.
   Kublbeck, Jenni
   Petsalo, Aleksanteri
   Urtti, Arto
   Honkakoski, Paavo
   Otonkoski, Timo
TI Regulation of Human Pluripotent Stem Cell-Derived Hepatic Cell Phenotype
   by Three-Dimensional Hydrogel Models
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID PRIMARY HUMAN HEPATOCYTES; IN-VITRO; EXTRACELLULAR-MATRIX;
   DRUG-METABOLISM; HUMAN-LIVER; NANOFIBRILLAR CELLULOSE; FUNCTIONAL
   HEPATOCYTES; SPHEROID CULTURE; RAT HEPATOCYTES; HEPARG CELLS
AB Human-induced pluripotent stem cell (hiPSC)-derived hepatocytes are anticipated as important surrogates for primary human hepatocytes in applications ranging from basic research to drug discovery and regenerative medicine. Although methods for differentiating hepatocyte-like cells (HLCs) from hiPSCs have developed remarkably, the limited yield of fully functional HLCs is still a major obstacle to their utility. A three-dimensional (3D) culture environment could improve the in vitro hepatic maturation of HLCs. Here we compare 3D hydrogel models of hiPSC-derived HLCs in agarose microwells (3D Petri Dish; 3DPD), nanofibrillar cellulose hydrogels (Growdex; 3DNFC), or animal extracellular matrix-based hydrogels (3D Matrigel; 3DMG). In all the tested 3D biomaterial systems, HLCs formed aggregates. In comparison with twodimensional monolayer culture, 3DPD and 3DMG models showed both phenotypic and functional enhancement in HLCs over 2.5 weeks of 3D culture. Specifically, we found higher hepatocyte-specific gene expression levels and enhanced cytochrome P450 functions. Our work suggests that transferring HLCs into 3D hydrogel systems can expedite the hepatic maturation of HLCs irrespective of the biochemical nature of the 3D hydrogel. Both plant-based nonembedding and animal-based embedding 3D hydrogel models enhanced the maturation.
C1 [Toivonen, Sanna; Otonkoski, Timo] Univ Helsinki, Res Programs Unit, Mol Neurol, Biomedicum Stem Cell Ctr, FIN-00014 Helsinki, Finland.
   [Malinen, Melina M.; Urtti, Arto] Univ Helsinki, Div Pharmaceut Biosci, Ctr Drug Res, Helsinki, Finland.
   [Kublbeck, Jenni; Petsalo, Aleksanteri; Urtti, Arto; Honkakoski, Paavo] Univ Eastern Finland, Fac Hlth Sci, Sch Pharm, Kuopio, Finland.
   [Kublbeck, Jenni; Petsalo, Aleksanteri; Urtti, Arto; Honkakoski, Paavo] Bioctr Kuopio, Kuopio, Finland.
   [Otonkoski, Timo] Univ Helsinki, Cent Hosp, Childrens Hosp, Helsinki, Finland.
RP Toivonen, S (reprint author), Univ Helsinki, Res Programs Unit, Mol Neurol, Biomedicum Stem Cell Ctr, FIN-00014 Helsinki, Finland.
EM sanna.toivonen@helsinki.fi
OI Kublbeck, Jenni/0000-0002-6439-4403; Honkakoski,
   Paavo/0000-0002-4332-3577
FU Finnish funding agency for innovation (TEKES) 3D-liver project
   [2246/31/2011]; UEF Stem Consortium [931051]
FX This study was funded by the Finnish funding agency for innovation
   (TEKES) 3D-liver project (2246/31/2011) and the UEF Stem Consortium
   (931051). We gratefully thank Eila Korhonen and Heli Grym for excellent
   technical support. We would like to thank Jere Weltner and Diego Balboa
   for fruitful discussions and advices.
CR ADEN DP, 1979, NATURE, V282, P615, DOI 10.1038/282615a0
   Ader M, 2014, CURR OPIN CELL BIOL, V31, P23, DOI 10.1016/j.ceb.2014.06.013
   Andersson TB, 2012, EXPERT OPIN DRUG MET, V8, P909, DOI 10.1517/17425255.2012.685159
   Baharvand H, 2006, INT J DEV BIOL, V50, P645, DOI 10.1387/ijdb.052072hb
   BARTH CA, 1982, P NATL ACAD SCI-BIOL, V79, P4985, DOI 10.1073/pnas.79.16.4985
   BENZEEV A, 1988, P NATL ACAD SCI USA, V85, P2161, DOI 10.1073/pnas.85.7.2161
   Berger DR, 2015, HEPATOLOGY, V61, P1370, DOI 10.1002/hep.27621
   Bhattacharya M, 2012, J CONTROL RELEASE, V164, P291, DOI 10.1016/j.jconrel.2012.06.039
   Bierwolf J, 2011, BIOTECHNOL BIOENG, V108, P141, DOI 10.1002/bit.22924
   Brandl F, 2007, BIOMATERIALS, V28, P134, DOI 10.1016/j.biomaterials.2006.09.017
   Cameron K, 2015, STEM CELL REP, V5, P1250, DOI 10.1016/j.stemcr.2015.10.016
   Cayo MA, 2012, HEPATOLOGY, V56, P2163, DOI 10.1002/hep.25871
   Chang TT, 2009, TISSUE ENG PT A, V15, P559, DOI 10.1089/ten.tea.2007.0434
   Cheng X, 2012, CELL STEM CELL, V10, P371, DOI 10.1016/j.stem.2012.02.024
   Dean DM, 2007, FASEB J, V21, P4005, DOI 10.1096/fj.07-8710com
   DeLaForest A, 2011, DEVELOPMENT, V138, P4143, DOI 10.1242/dev.062547
   Dias-da-Silva D, 2015, TOXICOL IN VITRO, V29, P987, DOI 10.1016/j.tiv.2015.04.001
   Du C, 2014, BIOMATERIALS, V35, P6006, DOI 10.1016/j.biomaterials.2014.04.011
   Gaskell H, 2016, TOXICOL RES-UK, V5, P1053, DOI 10.1039/c6tx00101g
   Gerets HHJ, 2012, CELL BIOL TOXICOL, V28, P69, DOI 10.1007/s10565-011-9208-4
   Ghosheh N., 2016, STEM CELLS INT, V22, P2016
   Gieseck RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086372
   Godoy P, 2013, ARCH TOXICOL, V87, P1315, DOI 10.1007/s00204-013-1078-5
   Gridelli B, 2012, LIVER TRANSPLANT, V18, P226, DOI 10.1002/lt.22322
   Gross-Steinmeyer K, 2005, XENOBIOTICA, V35, P419, DOI 10.1080/00498250500137427
   Hay DC, 2008, P NATL ACAD SCI USA, V105, P12301, DOI 10.1073/pnas.0806522105
   Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758
   Jia L, 2007, CURR DRUG METAB, V8, P822, DOI 10.2174/138920007782798207
   Jiang Hu-Lin, 2010, Int J Stem Cells, V3, P69
   Kajiwara M, 2012, P NATL ACAD SCI USA, V109, P12538, DOI 10.1073/pnas.1209979109
   Kanebratt KP, 2008, DRUG METAB DISPOS, V36, P1444, DOI 10.1124/dmd.107.020016
   KLEINMAN HK, 1986, BIOCHEMISTRY-US, V25, P312, DOI 10.1021/bi00350a005
   Klemm D, 2011, ANGEW CHEM INT EDIT, V50, P5438, DOI 10.1002/anie.201001273
   Kublbeck J., 2016, J PHARM SCI, V105
   Kyttala A, 2016, STEM CELL REP, V6, P200, DOI 10.1016/j.stemcr.2015.12.009
   Li LH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150587
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Malinen MM, 2014, BIOMATERIALS, V35, P5110, DOI 10.1016/j.biomaterials.2014.03.020
   Malinen MM, 2012, TISSUE ENG PT A, V18, P2418, DOI [10.1089/ten.tea.2012.0046, 10.1089/ten.TEA.2012.0046]
   Mallanna S. K., 2013, CURR PROTOC STEM CEL, V26
   McClelland R, 2008, TISSUE ENG PT A, V14, P59, DOI 10.1089/ten.a.2007.0058
   McCracken KW, 2011, NAT PROTOC, V6, P1920, DOI 10.1038/nprot.2011.410
   Mehta G, 2012, J CONTROL RELEASE, V164, P192, DOI 10.1016/j.jconrel.2012.04.045
   Miron-Mendoza M, 2010, BIOMATERIALS, V31, P6425, DOI 10.1016/j.biomaterials.2010.04.064
   Moghe PV, 1996, BIOMATERIALS, V17, P373, DOI 10.1016/0142-9612(96)85576-1
   Nagamoto Y, 2012, BIOMATERIALS, V33, P4526, DOI 10.1016/j.biomaterials.2012.03.011
   Oshikata A, 2011, J BIOSCI BIOENG, V111, P590, DOI 10.1016/j.jbiosc.2011.01.006
   Paakko M, 2007, BIOMACROMOLECULES, V8, P1934, DOI 10.1021/bm061215p
   Page JL, 2007, TOXICOL SCI, V97, P384, DOI 10.1093/toxsci/kfm034
   Ramasamy TS, 2013, TISSUE ENG PT A, V19, P360, DOI 10.1089/ten.tea.2012.0190
   Schrader J, 2011, HEPATOLOGY, V53, P1192, DOI 10.1002/hep.24108
   Shan J, 2013, NAT CHEM BIOL, V9, P514, DOI 10.1038/nchembio.1270
   Shlomai A, 2014, P NATL ACAD SCI USA, V111, P12193, DOI 10.1073/pnas.1412631111
   Sidhu JS, 2004, EXP CELL RES, V292, P252, DOI 10.1016/j.yexcr.2003.09.001
   Siegfried G, 2003, CANCER RES, V63, P1458
   Sivertsson L, 2013, STEM CELLS DEV, V22, P581, DOI 10.1089/scd.2012.0202
   Susukida T, 2016, J PHARM SCI-US, V105, P1550, DOI 10.1016/j.xphs.2016.01.013
   Takayama K, 2013, BIOMATERIALS, V34, P1781, DOI 10.1016/j.biomaterials.2012.11.029
   Takayama K, 2012, MOL THER, V20, P127, DOI 10.1038/mt.2011.234
   Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271
   Tanimizu N, 2007, MOL BIOL CELL, V18, P1472, DOI 10.1091/mbc.E06-09-0848
   Toivonen S, 2013, STEM CELL TRANSL MED, V2, P83, DOI 10.5966/sctm.2012-0047
   Tolonen A, 2007, J MASS SPECTROM, V42, P960, DOI 10.1002/jms.1239
   Touboul T, 2010, HEPATOLOGY, V51, P1754, DOI 10.1002/hep.23506
   Trokovic R, 2015, STEM CELL RES, V15, P263, DOI 10.1016/j.scr.2015.05.013
   Vosough M, 2013, STEM CELLS DEV, V22, P2693, DOI 10.1089/scd.2013.0088
   Wang L, 2015, DRUG METAB DISPOS, V43, P367, DOI 10.1124/dmd.114.061580
   Wu FJ, 1999, CELL TRANSPLANT, V8, P233, DOI 10.1177/096368979900800304
   Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971
   Yang Z, 2012, J DIGEST DIS, V13, P168, DOI 10.1111/j.1751-2980.2011.00566.x
   Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424
   Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103
   Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007
   Zhu SY, 2014, NATURE, V508, P93, DOI 10.1038/nature13020
NR 74
TC 2
Z9 2
U1 2
U2 17
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD JUL
PY 2016
VL 22
IS 13-14
BP 971
EP 984
DI 10.1089/ten.tea.2016.0127
PG 14
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA DS2NE
UT WOS:000380614400007
PM 27329070
DA 2018-10-20
ER

PT J
AU Ning, LQ
   Guillemot, A
   Zhao, J
   Kipouros, G
   Chen, XB
AF Ning, Liqun
   Guillemot, Arthur
   Zhao, Jingxuan
   Kipouros, Georges
   Chen, Xiongbiao
TI Influence of Flow Behavior of Alginate-Cell Suspensions on Cell
   Viability and Proliferation
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID TISSUE-ENGINEERING APPLICATIONS; SUBSTRATE STIFFNESS; HYDROGEL
   SCAFFOLDS; SCHWANN-CELLS; BIOFABRICATION; FABRICATION; CONSTRUCTS;
   DAMAGE; ENCAPSULATION; BIOPRINTER
AB Tissue scaffolds with living cells fabricated by three-dimensional bioprinting/plotting techniques are becoming more prevalent in tissue repair and regeneration. In the bioprinting process, cells are subject to process-induced forces (such as shear force) that can result in cell damage and loss of cell function. The flow behavior of the biomaterial solutions that encapsulate living cells in this process plays an important role. This study used a rheometer to examine the flow behavior of alginate solution and alginate-Schwann cell (RSC96), alginate-fibroblast cell (NIH-3T3), and alginate-skeletal muscle cell (L8) suspensions during shearing with respect to effects on cell viability and proliferation. The flow behavior of all the alginate-cell suspensions varied with alginate concentration and cell density and had a significant influence on the viability and proliferation of the cells once sheared as well as on the recovery of the sheared cells. These findings provide a mean to preserve cell viability and/or retain cell proliferation function in the bioprinting process by regulating the flow behavior of cell-biomaterial suspensions and process parameters.
C1 [Ning, Liqun; Zhao, Jingxuan; Chen, Xiongbiao] Univ Saskatchewan, Dept Mech Engn, Coll Engn, 57 Campus Dr, Saskatoon, SK S7N 5A9, Canada.
   [Guillemot, Arthur] Icam Engn Sch, Dept Mech Engn, Paris, France.
   [Kipouros, Georges] Univ Saskatchewan, Dept Chem & Biol Engn, Coll Engn, Saskatoon, SK, Canada.
   [Chen, Xiongbiao] Univ Saskatchewan, Div Biomed Engn, Coll Engn, Saskatoon, SK, Canada.
RP Chen, XB (reprint author), Univ Saskatchewan, Dept Mech Engn, Coll Engn, 57 Campus Dr, Saskatoon, SK S7N 5A9, Canada.
EM xbc719@mail.usask.ca
OI Ning, Liqun/0000-0002-3651-7410
FU Natural Sciences and Engineering Research Council of Canada (NSERC);
   Saskatchewan Health Research Foundation (SHRF)
FX The authors acknowledge financial support from the Natural Sciences and
   Engineering Research Council of Canada (NSERC) and the Saskatchewan
   Health Research Foundation (SHRF). The authors thank Dr. David J.
   Schreyer and Dr. Tuanjie Chang from the College of Medicine at the
   University of Saskatchewan for their help with experiments.
CR Bajaj P, 2014, ANNU REV BIOMED ENG, V16, P247, DOI 10.1146/annurev-bioeng-071813-105155
   Billiet T, 2014, BIOMATERIALS, V35, P49, DOI 10.1016/j.biomaterials.2013.09.078
   Castilho M, 2015, BIOFABRICATION, V7, DOI 10.1088/1758-5090/7/1/015004
   Chang R, 2008, TISSUE ENG PT A, V14, P41, DOI 10.1089/ten.a.2007.0004
   CLOSE RI, 1972, PHYSIOL REV, V52, P129
   Coelho PG, 2015, MED ENG PHYS, V37, P287, DOI 10.1016/j.medengphy.2015.01.004
   Cornock R, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/2/025002
   Desai ES, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024108
   Draget KI, 1997, INT J BIOL MACROMOL, V21, P47, DOI 10.1016/S0141-8130(97)00040-8
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Goncalves EM, 2016, J BIOMED MATER RES B, V104, P1210, DOI 10.1002/jbm.b.33432
   Gu Y, 2012, BIOMATERIALS, V33, P6672, DOI 10.1016/j.biomaterials.2012.06.006
   Gupta R, 2005, J ORTHOP RES, V23, P1232, DOI 10.1016/j.orthres.2004.12.010
   HALL PA, 1990, CELL TISSUE KINET, V23, P505, DOI 10.1111/j.1365-2184.1990.tb01343.x
   Janmey PA, 2007, ANNU REV BIOMED ENG, V9, P1, DOI 10.1146/annurev.bioeng.9.060906.151927
   Kim G, 2011, J MATER CHEM, V21, P6165, DOI 10.1039/c0jm03452e
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee H, 2014, CARBOHYD POLYM, V104, P191, DOI 10.1016/j.carbpol.2014.01.024
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j
   Li M., 2009, TISSUE ENG PART C-ME, V16, P533
   Li MG, 2009, BIOFABRICATION, V1, DOI 10.1088/1758-5082/1/3/032001
   Li MG, 2009, J MANUF SCI E-T ASME, V131, DOI 10.1115/1.3123331
   Li MG, 2011, ARTIF ORGANS, V35, P741, DOI 10.1111/j.1525-1594.2010.01193.x
   Li MG, 2011, BIOTECHNOL PROGR, V27, P1777, DOI 10.1002/btpr.679
   MARTIN RB, 1991, J BIOMECH, V24, P79, DOI 10.1016/0021-9290(91)90379-2
   Mironov V, 2011, CURR OPIN BIOTECH, V22, P667, DOI 10.1016/j.copbio.2011.02.006
   Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958
   Nair Kalyani, 2009, Biotechnology Journal, V4, P1168, DOI 10.1002/biot.200900004
   Nicodemus GD, 2008, TISSUE ENG PT B-REV, V14, P149, DOI 10.1089/ten.teb.2007.0332
   Onoe H, 2013, NAT MATER, V12, P584, DOI [10.1038/NMAT3606, 10.1038/nmat3606]
   Orive G, 2003, NAT MED, V9, P104, DOI 10.1038/nm0103-104
   Ouyang LL, 2015, BIOFABRICATION, V7, DOI 10.1088/1758-5090/7/1/015010
   Ozbolat IT, 2014, ROBOT CIM-INT MANUF, V30, P295, DOI 10.1016/j.rcim.2013.10.005
   Pfister A, 2004, J POLYM SCI POL CHEM, V42, P624, DOI 10.1002/pola.10807
   Rajaram A, 2014, 3D PRINT ADDIT MANUF, V1, P194, DOI 10.1089/3dp.2014.0006
   Rang A, 2014, BIOMATERIALS, V35, P2651, DOI 10.1016/j.biomaterials.2013.12.073
   Sachlos E, 2003, EUR CELLS MATER, V5, P39
   SECOMB TW, 1991, CELL BIOPHYS, V18, P231, DOI 10.1007/BF02989816
   Shim JH, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/8/085014
   Tallawi M, 2015, TISSUE ENG PART B-RE, V21, P157, DOI [10.1089/ten.teb.2014.0383, 10.1089/ten.TEB.2014.0383]
   Tirella A, 2012, BIOTECHNOL PROGR, V28, P1315, DOI 10.1002/btpr.1586
   van Meerloo J, 2011, METHODS MOL BIOL, V731, P237, DOI 10.1007/978-1-61779-080-5_20
   Xiaoyu Tian, 2013, Journal of Biomimetics, Biomaterials, and Tissue Engineering, V17, P1, DOI 10.4028/www.scientific.net/JBBTE.17.1
   Yan KC, 2010, J BIOMECH, V43, P1031, DOI 10.1016/j.jbiomech.2009.12.018
   Zehnder T, 2015, BIOFABRICATION, V7, DOI 10.1088/1758-5090/7/2/025001
   Zhang Y., 2013, J NANOTECHNOL ENG ME, V4, P20902, DOI DOI 10.1115/1.4024398
   Zhu M, 2015, BIOMATER SCI-UK, V3, P1236, DOI 10.1039/c5bm00132c
   Zhu N, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/3/034105
NR 49
TC 8
Z9 8
U1 1
U2 19
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
EI 1937-3392
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD JUL
PY 2016
VL 22
IS 7
BP 652
EP 662
DI 10.1089/ten.tec.2016.0011
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA DS5EG
UT WOS:000380803200004
PM 27166436
DA 2018-10-20
ER

PT J
AU Mpoyi, EN
   Cantini, M
   Reynolds, PM
   Gadegaard, N
   Dalby, MJ
   Salmeron-Sanchez, M
AF Mpoyi, Elie Ngandu
   Cantini, Marco
   Reynolds, Paul M.
   Gadegaard, Nikolaj
   Dalby, Matthew J.
   Salmeron-Sanchez, Manuel
TI Protein Adsorption as a Key Mediator in the Nanotopographical Control of
   Cell Behavior
SO ACS Nano
LA English
DT Article
DE nanotopography; protein adsorption; fibronectin; cellular response;
   biomaterials
ID STEM-CELLS; NANOSCALE TOPOGRAPHY; ADHESION FORMATION; SURFACE;
   DIFFERENTIATION; CYTOSKELETON; MORPHOLOGY; MECHANOTRANSDUCTION;
   MULTIPOTENCY; PHENOTYPE
AB Surface nanotopography is widely employed to control cell behavior and in particular controlled disorder has been shown to be important in cell differentiation/maturation. However, extracellular matrix proteins, such as fibronectin (FN), initially adsorbed on a biomaterial surface are known to mediate the interaction of synthetic materials with cells. In this work, we examine the effect of nanotopography on cell behavior through this adsorbed layer of adhesive proteins using a nanostructured polycarbonate surface comprising 150 nm-diameter pits originally defined using electron beam lithography. We address the effect of this nanopitted surface on FN adsorption and subsequently on cell morphology and behavior using C2C12 myoblasts. Wettability measurements and atomic force microscopy imaging showed that protein is adsorbed both within the interpits spaces and inside the nanopits. Cells responded to this coated nanotopography with the formation of fewer but larger focal adhesions and by mimicking the pit patterns within their cytoskeleton, nanoimprinting, ultimately achieving higher levels of myogenic differentiation compared to a flat control. Both focal adhesion assembly and nanoimprinting were found to be dependent on cell contractility and are adversely affected by the use of blebbistatin. Our results demonstrate the central role of the nanoscale protein interface in mediating cell-nanotopographical interactions and implicate this interface as helping control the mechanotransductive cascade.
C1 [Mpoyi, Elie Ngandu; Cantini, Marco; Reynolds, Paul M.; Gadegaard, Nikolaj; Salmeron-Sanchez, Manuel] Univ Glasgow, Sch Engn, Div Biomed Engn, Glasgow G12 8LT, Lanark, Scotland.
   [Dalby, Matthew J.] Univ Glasgow, Inst Mol Cell & Syst Biol, Ctr Cell Engn, Joseph Black Bldg,Univ Ave, Glasgow G12 8QQ, Lanark, Scotland.
RP Cantini, M; Salmeron-Sanchez, M (reprint author), Univ Glasgow, Sch Engn, Div Biomed Engn, Glasgow G12 8LT, Lanark, Scotland.
EM marco.cantini@glasgow.ac.uk; manuel.salmeron-sanchez@glasgow.ac.uk
OI Reynolds, Paul/0000-0001-7614-0008; Dalby, Matthew/0000-0002-0528-3359;
   Salmeron-Sanchez, Manuel/0000-0002-8112-2100; Cantini,
   Marco/0000-0003-0326-1508
FU ERC through HealInSynergy [306990]; MRC [MR/L022710/1]; EPSRC
   [EP/F500424/1]
FX Financial support from ERC through HealInSynergy (306990) and MRC
   (MR/L022710/1) is acknowledged. EPSRC funding as part of the Doctoral
   Training Centre EP/F500424/1 is also acknowledged.
CR Anselme K, 2010, P I MECH ENG H, V224, P1487, DOI 10.1243/09544119JEIM901
   Berginski Matthew E, 2013, F1000Res, V2, P68, DOI 10.12688/f1000research.2-68.v1
   Biggs MJP, 2007, J MATER SCI-MATER M, V18, P399, DOI 10.1007/s10856-006-0705-6
   Biggs MJP, 2007, J ORTHOP RES, V25, P273, DOI 10.1002/jor.20319
   Biggs MJP, 2009, BIOMATERIALS, V30, P5094, DOI 10.1016/j.biomaterials.2009.05.049
   Campbell Iain D, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a004994
   Chen WQ, 2012, ACS NANO, V6, P4094, DOI 10.1021/nn3004923
   Curtis A, 2001, TRENDS BIOTECHNOL, V19, P97, DOI 10.1016/S0167-7799(00)01536-5
   Curtis ASG, 2006, J R SOC INTERFACE, V3, P393, DOI 10.1098/rsif.2005.0104
   CURTIS ASG, 1964, J NATL CANCER I, V33, P15
   Curtis ASG, 2004, IEEE T NANOBIOSCI, V3, P61, DOI 10.1109/TNB.2004.824276
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalby MJ, 2007, J CELL BIOCHEM, V100, P326, DOI 10.1002/jcb.21058
   Dalby MJ, 2014, NAT MATER, V13, P558, DOI [10.1038/NMAT3980, 10.1038/nmat3980]
   Dalby MJ, 2004, EXP CELL RES, V295, P387, DOI 10.1016/j.yexcr.2004.02.004
   Dalby MJ, 2003, BIOMATERIALS, V24, P927, DOI 10.1016/S0142-9612(02)00427-1
   Gadegaard N, 2003, MACROMOL MATER ENG, V288, P76, DOI 10.1002/mame.200290037
   Gallagher JO, 2002, IEEE T NANOBIOSCI, V1, P24, DOI 10.1109/TNB.2002.806918
   Garcia AJ, 2006, ADV POLYM SCI, P171, DOI 10.1007/12_071
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Gonzalez-Garcia C, 2010, COLLOID SURFACE B, V77, P181, DOI 10.1016/j.colsurfb.2010.01.021
   Hyun YM, 2009, J IMMUNOL, V183, P359, DOI 10.4049/jimmunol.0803388
   Ji LJ, 2012, EUR CELLS MATER, V23, P135, DOI 10.22203/eCM.v023a10
   Karakecili A, 2014, COLLOID SURFACE B, V123, P39, DOI 10.1016/j.colsurfb.2014.08.008
   Lee EA, 2015, J BIOMED MATER RES B, V103, P1258, DOI 10.1002/jbm.b.33308
   McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]
   Perez-Garnes M, 2011, INT J ARTIF ORGANS, V34, P54, DOI 10.5301/IJAO.2011.6316
   Planell JA, 2010, NATO SCI PEACE SEC A, P233, DOI 10.1007/978-90-481-8790-4_12
   Ravichandran Rajeswari, 2009, World J Stem Cells, V1, P55, DOI 10.4252/wjsc.v1.i1.55
   Rico P., 2014, POLYM REGENERATIVE M, P91
   Roach P, 2007, J MATER SCI-MATER M, V18, P1263, DOI 10.1007/s10856-006-0064-3
   Tsimbouri PM, 2012, ACS NANO, V6, P10239, DOI 10.1021/nn304046m
   Tsimbouri P, 2014, J CELL BIOCHEM, V115, P380, DOI 10.1002/jcb.24673
   Vanterpool FA, 2014, BIORESEARCH OPEN ACC, V3, P286, DOI 10.1089/biores.2014.0033
   Vaz R, 2012, CELL TISSUE RES, V348, P569, DOI 10.1007/s00441-012-1364-1
   Wang N, 2001, P NATL ACAD SCI USA, V98, P7765, DOI 10.1073/pnas.141199598
   WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161
   Wood MA, 2008, EXP CELL RES, V314, P927, DOI 10.1016/j.yexcr.2007.10.003
NR 38
TC 23
Z9 23
U1 4
U2 45
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1936-0851
EI 1936-086X
J9 ACS NANO
JI ACS Nano
PD JUL
PY 2016
VL 10
IS 7
BP 6638
EP 6647
DI 10.1021/acsnano.6b01649
PG 10
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA DS2FD
UT WOS:000380576600026
PM 27391047
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Guo, C
   Xue, J
   Tan, Y
   Dong, YS
AF Guo, Chao
   Xue, Juan
   Tan, Ying
   Dong, Yinsheng
TI Fabrication of silver/beta-tricalcium phosphate particle by a simple
   liquid chemical reduction method
SO MICRO & NANO LETTERS
LA English
DT Article
DE silver; X-ray diffraction; calcium compounds; transmission electron
   microscopy; coatings; nanoparticles; nanofabrication;
   silver-beta-tricalcium phosphate particle; liquid chemical reduction
   method; silver nitrate; glucose; reducing agent; silver-beta-TCP
   particle; liquid chemical reduction; beta-TCP; X- ray diffraction
   pattern; metallic silver; silver nanoparticle; thermal stability;
   alpha-TCP; transmission electron microscopy; mean size; size
   distribution; silver nanoparticles; pure beta-TCP particle; coating and;
   coating material; Ag-Ca-3(PO)(4)
ID ALLOWS PREPARATION; GREEN SYNTHESIS; NANOPARTICLES; HYDROXYAPATITE;
   MORPHOLOGY
AB Using beta-tricalcium phosphate (beta-TCP), silver nitrate and glucose as the carrier, silver resource and reducing agent, silver/beta-TCP particle was successfully fabricated by a novel liquid chemical reduction method to overcome the infection problem of beta-TCP. The X-ray diffraction pattern of the as-obtained sample confirmed the existence of metallic silver in the particle. The addition of silver nanoparticle affected the thermal stability of beta-TCP and prevented the transformation from beta-TCP to alpha-TCP. Transmission electron microscopy images and the corresponding calculation result proved the mean size and size distribution of silver nanoparticles in the silver/beta-TCP particle could be controlled by varying the molar ratio between beta-TCP and silver nitrate. Moreover, the mean size and size distribution of silver nanoparticles also could be changed by using different stabilisers. The prepared silver/beta-TCP particle is a potential biomaterial to replace pure beta-TCP particle and utilise for coating material and other applications.
C1 [Guo, Chao] Southeast Univ, Sch Mat Sci & Engn, Nanjing 211189, Jiangsu, Peoples R China.
   Southeast Univ, Jiangsu Key Lab Adv Metall Mat, Nanjing 211189, Jiangsu, Peoples R China.
RP Guo, C (reprint author), Southeast Univ, Sch Mat Sci & Engn, Nanjing 211189, Jiangsu, Peoples R China.
EM 101010759@seu.edu.cn
FU Jiangsu Key Laboratory of Advanced Metallic Materials [BM2007204]
FX This work was supported by Jiangsu Key Laboratory of Advanced Metallic
   Materials (BM2007204).
CR Bergmann C, 2014, CERAM INT, V40, P7931, DOI 10.1016/j.ceramint.2013.12.141
   Chen ZT, 2014, BIOMATERIALS, V35, P8553, DOI 10.1016/j.biomaterials.2014.06.038
   Ewald A, 2011, ACTA BIOMATER, V7, P4064, DOI 10.1016/j.actbio.2011.06.049
   Gerber LC, 2011, POLYM ENG SCI, V51, P71, DOI 10.1002/pen.21779
   Gokcekaya O, 2015, MAT SCI ENG C-MATER, V53, P111, DOI 10.1016/j.msec.2015.04.025
   Guo C, 2012, MICRO NANO LETT, V7, P904, DOI 10.1049/mnl.2012.0383
   Liu S, 2015, INT J APPL CERAM TEC, V12, P294, DOI 10.1111/ijac.12156
   Loher S, 2008, SMALL, V4, P824, DOI 10.1002/smll.200800047
   Matsumoto N, 2009, ACTA BIOMATER, V5, P3157, DOI 10.1016/j.actbio.2009.04.010
   Raveendran P, 2003, J AM CHEM SOC, V125, P13940, DOI 10.1021/ja029267j
   Shayegan A, 2009, DENT TRAUMATOL, V25, P413, DOI 10.1111/j.1600-9657.2009.00799.x
   Stefanic M, 2013, J EUR CERAM SOC, V33, P3455, DOI 10.1016/j.jeurceramsoc.2013.05.015
   Tatsukawa E, 2014, J ORTHOP RES, V32, P189, DOI 10.1002/jor.22514
   Vigneshwaran N, 2006, CARBOHYD RES, V341, P2012, DOI 10.1016/j.carres.2006.04.042
   Zhang YY, 2015, SYNTH REACT INORG M, V45, P411, DOI 10.1080/15533174.2013.841208
NR 15
TC 0
Z9 0
U1 6
U2 21
PU INST ENGINEERING TECHNOLOGY-IET
PI HERTFORD
PA MICHAEL FARADAY HOUSE SIX HILLS WAY STEVENAGE, HERTFORD SG1 2AY, ENGLAND
SN 1750-0443
J9 MICRO NANO LETT
JI Micro Nano Lett.
PD JUL
PY 2016
VL 11
IS 7
BP 391
EP 394
DI 10.1049/mnl.2016.0014
PG 4
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA DS0BG
UT WOS:000380259600013
DA 2018-10-20
ER

PT J
AU Anitua, E
   Muruzabal, F
   de la Fuente, M
   Merayo, J
   Duran, J
   Orive, G
AF Anitua, Eduardo
   Muruzabal, Francisco
   de la Fuente, Maria
   Merayo, Jesus
   Duran, Juan
   Orive, Gorka
TI Plasma Rich in Growth Factors for the Treatment of Ocular Surface
   Diseases
SO CURRENT EYE RESEARCH
LA English
DT Review
DE Cornea; ocular surface; platelet-rich plasma; PRGF; PRP
ID MUCOSAL EPITHELIAL TRANSPLANTATION; AUTOLOGOUS SERUM APPLICATION;
   PERFORATED CORNEAL ULCERS; 3 BLOOD DERIVATIVES; DRY EYE SYNDROME;
   FACTORS PRGF; PENETRATING KERATOPLASTY; RADIAL KERATOTOMY; RISK-FACTORS;
   IN-VITRO
AB Purpose: The purpose of this work is to describe and review the technology of plasma rich in growth factors (PRGF), a novel blood derivative product, in the treatment of ocular surface disorders.Methods: To demonstrate the importance of this technology in the treatment of ocular pathologies, a thorough review of the preclinical and clinical literature results obtained following use of the different therapeutic formulations of PRGF was carried out. A literature search for applications of PGRF plasma in the ophthalmology field was carried out using the PubMed database.Results: PRGF involves the use of patient's own biologically active proteins, growth factors, and biomaterial scaffolds for therapeutic purposes. This procedural technology is gaining interest in regenerative medicine due to its potential to stimulate and accelerate the tissue healing processes. The versatility and biocompatibility of this technology opens the door to a personalized medicine on ocular tissue regeneration. This review discusses the state of the art of the new treatments and technologies developed to promote ocular surface tissue regeneration. The standardized protocol that has been developed to source eye drops from PRGF technology is also described. The preclinical research, together with the most relevant clinical applications are summarized and discussed.Conclusions: The preliminary results suggest that the use of PRGF to enhance ocular tissue regeneration is safe and efficient.
C1 [Anitua, Eduardo; Muruzabal, Francisco; de la Fuente, Maria; Orive, Gorka] Biotechnol Inst BTI, Dept R&D, Vitoria, Spain.
   [Anitua, Eduardo; Orive, Gorka] Fdn Eduardo Anitua, Dept R&D, C Jose Maria Cagigal 19, Vitoria 01005, Spain.
   [Merayo, Jesus] Inst Oftalmol Fernandez Vega, Fdn Invest Oftalmol, Oviedo, Spain.
   [Duran, Juan] Inst Clin Quirurg Oftalmol, Dept R&D, Bilbao, Spain.
   [Duran, Juan] Univ Basque Country, BioCruces Hlth Res Inst, Sch Med & Dent, Dept Ophthalmol, Leioa, Spain.
RP Orive, G (reprint author), Fdn Eduardo Anitua, Dept R&D, C Jose Maria Cagigal 19, Vitoria 01005, Spain.
EM gorka.orive@bti-implant.es
RI Muruzabal, Francisco/N-7814-2018; de la Fuente Pinedo,
   Maria/N-7819-2018; Anitua, Eduardo/O-1154-2018
OI Muruzabal, Francisco/0000-0001-7359-1698; de la Fuente Pinedo,
   Maria/0000-0002-6820-1517; Anitua, Eduardo/0000-0002-8386-5303
CR Alio JL, 2007, OPHTHALMOLOGY, V114, P1286, DOI 10.1016/j.ophtha.2006.10.044
   Alio JL, 2007, OPHTHAL RES, V39, P124, DOI 10.1159/000100933
   Alio JL, 2007, J REFRACT SURG, V23, P617
   Alio JL, 2013, JAMA OPHTHALMOL, V131, P745, DOI 10.1001/jamaophthalmol.2013.2474
   Alio JL, 2013, CORNEA, V32, P619, DOI 10.1097/ICO.0b013e31825a6d9a
   Aloe L, 2008, PHARMACOL RES, V57, P253, DOI 10.1016/j.phrs.2008.01.010
   Anitua E, 2013, EXP EYE RES, V115, P153, DOI 10.1016/j.exer.2013.07.007
   Anitua E, 1999, INT J ORAL MAX IMPL, V14, P529
   Anitua E, 2008, TRENDS PHARMACOL SCI, V29, P37, DOI 10.1016/j.tips.2007.10.010
   Anitua E, 2007, BIOMATERIALS, V28, P4551, DOI 10.1016/j.biomaterials.2007.06.037
   Anitua E, 2012, J CONTROL RELEASE, V157, P29, DOI 10.1016/j.jconrel.2011.07.004
   Anitua E, 2011, INVEST OPHTH VIS SCI, V52, P6066, DOI 10.1167/iovs.11-7302
   Anitua E, 2010, ADV DRUG DELIVER REV, V62, P741, DOI 10.1016/j.addr.2010.01.001
   Blair P, 2009, BLOOD REV, V23, P177, DOI 10.1016/j.blre.2009.04.001
   Marquez EB, 2011, CUTAN OCUL TOXICOL, V30, P7, DOI 10.3109/15569527.2010.498398
   Bonini S, 2000, OPHTHALMOLOGY, V107, P1347, DOI 10.1016/S0161-6420(00)00163-9
   CHILDS CB, 1982, P NATL ACAD SCI-BIOL, V79, P5312, DOI 10.1073/pnas.79.17.5312
   DUA HS, 1994, BRIT J OPHTHALMOL, V78, P401, DOI 10.1136/bjo.78.5.401
   Dupps WJ, 2006, EXP EYE RES, V83, P709, DOI 10.1016/j.exer.2006.03.015
   Fernandez-Barbero JE, 2006, CLIN ORAL IMPLAN RES, V17, P687, DOI 10.1111/j.1600-0501.2006.01179.x
   Fini ME, 2005, CORNEA, V24, pS2, DOI 10.1097/01.ico.0000178743.06340.2c
   Freire V, 2014, CORNEA, V33, P614, DOI 10.1097/ICO.0000000000000109
   Freire V, 2012, INVEST OPHTH VIS SCI, V53, P5571, DOI 10.1167/iovs.11-7340
   Fu Y, 2012, CORNEA, V31, P723, DOI 10.1097/ICO.0b013e31821142ee
   GARANA RMR, 1992, INVEST OPHTH VIS SCI, V33, P3271
   Geerling G, 2004, BRIT J OPHTHALMOL, V88, P1467, DOI 10.1136/bjo.2004.044347
   Geerling G, 2001, INVEST OPHTH VIS SCI, V42, P948
   GIBBLE JW, 1990, TRANSFUSION, V30, P741, DOI 10.1046/j.1537-2995.1990.30891020337.x
   Inatomi T, 2005, CORNEA, V24, pS32, DOI 10.1097/01.ico.0000178739.37083.2c
   Inatomi T, 2006, AM J OPHTHALMOL, V142, P757, DOI 10.1016/j.ajo.2006.06.004
   James SE, 2001, CORNEA, V20, P488, DOI 10.1097/00003226-200107000-00010
   JESTER JV, 1992, INVEST OPHTH VIS SCI, V33, P3255
   Kawashima M, 2007, ARCH OPHTHALMOL-CHIC, V125, P1337, DOI 10.1001/archopht.125.10.1337
   Kinoshita S, 2004, EXP EYE RES, V78, P483, DOI 10.1016/j.exer.2003.09.004
   Klenkler B, 2004, EXP EYE RES, V79, P677, DOI 10.1016/j.exer.2004.07.008
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Leitner GC, 2006, VOX SANG, V91, P135, DOI 10.1111/j.1423-0410.2006.00815.x
   López-García J.S., 2007, Arch Soc Esp Oftalmol, V82, P9
   Lopez-Plandolit S, 2011, CORNEA, V30, P1312, DOI 10.1097/ICO.0b013e31820d86d6
   Lopez-Plandolit S, 2010, CORNEA, V29, P843, DOI 10.1097/ICO.0b013e3181a81820
   Maltseva O, 2001, INVEST OPHTH VIS SCI, V42, P2490
   Marquez De Aracena Del Cid R, 2009, EUR J OPHTHALMOL, V19, P909
   Marx RE, 2004, J ORAL MAXIL SURG, V62, P489, DOI 10.1016/j.joms.2003.12.003
   Mathers William D., 2000, CLAO Journal, V26, P159
   Mietz H, 1996, GRAEF ARCH CLIN EXP, V234, P364, DOI 10.1007/BF00190712
   Mohan RR, 2008, EXP EYE RES, V86, P235, DOI 10.1016/j.exer.2007.10.014
   Moss SE, 2000, ARCH OPHTHALMOL-CHIC, V118, P1264
   Muller LJ, 2003, EXP EYE RES, V76, P521, DOI 10.1016/S0014-4835(03)00050-2
   NASU M, 1984, J PATHOL, V143, P11, DOI 10.1002/path.1711430104
   Netto MV, 2006, EXP EYE RES, V82, P788, DOI 10.1016/j.exer.2005.09.021
   Noble BA, 2004, BRIT J OPHTHALMOL, V88, P647, DOI 10.1136/bjo.2003.026211
   Noecker R, 2001, ADV THER, V18, P205, DOI 10.1007/BF02853166
   Nurden AT, 2008, FRONT BIOSCI-LANDMRK, V13, DOI 10.2741/2947
   Odrljin TM, 1996, BLOOD, V88, P2050
   Orive G, 2004, TRENDS PHARMACOL SCI, V25, P382, DOI 10.1016/j.tips.2004.05.006
   Orive G, 2003, CURR OPIN BIOTECH, V14, P659, DOI 10.1016/j.copbio.2003.10.007
   Paulsen AJ, 2014, AM J OPHTHALMOL, V157, P799, DOI 10.1016/j.ajo.2013.12.023
   Pflugfelder SC, 2002, ADV EXP MED BIOL, V506, P739
   PFLUGFELDER SC, 1986, OPHTHALMOLOGY, V93, P1513
   Rocha GA, 2007, ARCH OPHTHALMOL-CHIC, V125, P1423, DOI 10.1001/archopht.125.10.1423
   Sakimoto T, 2006, LANCET, V367, P1432, DOI 10.1016/S0140-6736(06)68275-5
   Satake Y, 2008, ARCH OPHTHALMOL-CHIC, V126, P23, DOI 10.1001/archopht.126.1.23
   Schnabel LV, 2007, J ORTHOP RES, V25, P230, DOI 10.1002/jor.20278
   Sharma A, 2014, J OPHTHALMOL, DOI 10.1155/2014/781683
   SKUTA GL, 1987, SURV OPHTHALMOL, V32, P149, DOI 10.1016/0039-6257(87)90091-9
   Slavkin HC, 2006, PERIODONTOL 2000, V41, P9, DOI 10.1111/j.1600-0757.2006.00172.x
   Smith JA, 2007, OCUL SURF, V5, P93
   Stern ME, 1998, CORNEA, V17, P584, DOI 10.1097/00003226-199811000-00002
   TAMAKI T, 1981, BIOCHIM BIOPHYS ACTA, V661, P280, DOI 10.1016/0005-2744(81)90016-4
   Tripathi B J, 1989, Lens Eye Toxic Res, V6, P395
   Tsay RC, 2005, J ORAL MAXIL SURG, V63, P521, DOI 10.1016/j.joms.2004.09.012
   Tsubota K, 1999, BRIT J OPHTHALMOL, V83, P390, DOI 10.1136/bjo.83.4.390
   Tsubota K, 1999, OPHTHALMOLOGY, V106, P1984, DOI 10.1016/S0161-6420(99)90412-8
   Vajpayee RB, 2003, BRIT J OPHTHALMOL, V87, P1312, DOI 10.1136/bjo.87.11.1312
   Wan KH, 2015, OCUL SURF, V13, P213, DOI 10.1016/j.jtos.2014.12.006
   Weibrich G, 2004, BONE, V34, P665, DOI 10.1016/j.bone.2003.12.010
   Williams DF, 2006, TRENDS BIOTECHNOL, V24, P4, DOI 10.1016/j.tibtech.2005.10.006
   Wilson SE, 2003, AM J OPHTHALMOL, V136, P530, DOI 10.1016/S0002-9394(02)00085-0
   Zhou XQ, 2014, CORNEA, V33, P760, DOI 10.1097/ICO.0000000000000123
NR 79
TC 6
Z9 6
U1 2
U2 7
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0271-3683
EI 1460-2202
J9 CURR EYE RES
JI Curr. Eye Res.
PD JUL
PY 2016
VL 41
IS 7
BP 875
EP 882
DI 10.3109/02713683.2015.1104362
PG 8
WC Ophthalmology
SC Ophthalmology
GA DR6KL
UT WOS:000380010700001
PM 26828610
DA 2018-10-20
ER

PT J
AU Scarano, A
   Valbonetti, L
   Marchetti, M
   Lorusso, F
   Ceccarelli, M
AF Scarano, Antonio
   Valbonetti, Luca
   Marchetti, Massimiliano
   Lorusso, Felice
   Ceccarelli, Maurizio
TI Soft Tissue Augmentation of the Face With Autologous Platelet-Derived
   Growth Factors and Tricalcium Phosphate. Microtomography Evaluation of
   Mice
SO JOURNAL OF CRANIOFACIAL SURGERY
LA English
DT Article
DE Autologous platelet-derived growth factors; full-face rejuvenation; skin
   rejuvenation; soft tissues augmentation; tricalcium phosphate
ID RICH PLASMA
AB Background: The platelets used in oral, maxillofacial, and plastic surgery are generally grouped as concentrated platelet-rich plasma. The general principle of production consists of a centrifugation, making it possible to eliminate red blood cells, then acellular plasma, to preserve only the concentrated platelets.
   Objective: The aim of the present study was that micro porous tricalcium phosphate (beta-TCP) mixed with autologous platelet-derived growth factors could be an alternative to fat and hyaluronic acid which are widely used for oral and maxillofacial soft tissue augmentation.
   Methods: Ten female, 6 to 8-week-old black-haired mice were selected. On 1 cheek was injected the gel of tricalcium phosphate/autologous platelet-derived growth factors, while on the other cheek, was left empty and was used as control. The animals were killed after 8 weeks. Investigator evaluation was based on microtomography observation and comparison of control and test.
   Results: The microtomography technique demonstrated amorphous radiopaque images projected in the soft tissue parts of each paramedian region of the right cheek, in those sites corresponding to the injection of the gel of tricalcium phosphate/autologous platelet-derived growth factor. Eight weeks after surgery, beta-TCP granules were clearly visible with most remaining within the cheek. The margins of the beta-TCP granules were clear and not diffused within the vicinity of the tissues.
   Conclusion: The results indicate that micro beta-tricalcium phosphate Ca-3(PO4)(2) mixed with autologous platelet-derived growth factors material was able to create a lasting three-dimensional soft tissue augmentation and is a promising biomaterial for soft tissue augmentation as a scaffold for cells.
C1 [Scarano, Antonio; Lorusso, Felice; Ceccarelli, Maurizio] Univ G dAnnunzio, Dept Med Oral & Biotechnol Sci, Chieti, Italy.
   [Scarano, Antonio; Ceccarelli, Maurizio] Univ G dAnnunzio, Cesi Met, Chieti, Italy.
   [Valbonetti, Luca] Univ Roma La Sapienza, Dept Surg Sci, Piazzale Aldo Moro, Rome, Italy.
RP Scarano, A (reprint author), Via Frentani 98-B, I-66100 Chieti, Italy.
EM ascarano@unich.it
RI Scarano, Antonio/F-6961-2017; Lorusso, Felice/A-3906-2017
OI Scarano, Antonio/0000-0003-1374-6146; Lorusso,
   Felice/0000-0002-2660-9231
CR Baeyens W, 2010, Rev Med Brux, V31, P521
   Ceccarelli M, 2010, PHYSL MED LETT, V10, P17
   Evian Cyril I, 2003, Compend Contin Educ Dent, V24, P195
   Fortier LA, 2011, CLIN ORTHOP RELAT R, V469, P2706, DOI 10.1007/s11999-011-1857-3
   Hammond JW, 2009, AM J SPORT MED, V37, P1135, DOI 10.1177/0363546508330974
   Hom DB, 2008, ARCH FACIAL PLAST S, V10, P402, DOI 10.1001/archfaci.10.6.402
   Na JI, 2011, DERMATOL SURG, V37, P463, DOI 10.1111/j.1524-4725.2011.01916.x
   Rutkowski James L, 2008, J Oral Implantol, V34, P25, DOI 10.1563/1548-1336(2008)34[25:AAOARS]2.0.CO;2
   SCARANO A, 2009, ORAL SURG ORAL MED O, V108, P11
   Scarano A, 2012, EUR J INFLAMM, V1, P31
   Scimeca Christy L, 2010, J Diabetes Sci Technol, V4, P1121
   Souza Felix Bravo Bruna, 2015, J Clin Aesthet Dermatol, V8, P42
NR 12
TC 5
Z9 5
U1 2
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1049-2275
EI 1536-3732
J9 J CRANIOFAC SURG
JI J. Craniofac. Surg.
PD JUL
PY 2016
VL 27
IS 5
BP 1212
EP 1214
DI 10.1097/SCS.0000000000002712
PG 3
WC Surgery
SC Surgery
GA DR3HI
UT WOS:000379793500059
PM 27300455
DA 2018-10-20
ER

PT J
AU Hasan, A
   Waters, R
   Roula, B
   Dana, R
   Yara, S
   Alexandre, T
   Paul, A
AF Hasan, Anwarul
   Waters, Renae
   Roula, Boustany
   Dana, Rahbani
   Yara, Seif
   Alexandre, Toubia
   Paul, Arghya
TI Engineered Biomaterials to Enhance Stem Cell-Based Cardiac Tissue
   Engineering and Therapy
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Review
DE angiogenesis; hydrogel; myocardial infarction; nanomedicine; stem cells
ID CARDIOSPHERE-DERIVED CELLS; ISCHEMIA-REPERFUSION MODEL; ACUTE
   MYOCARDIAL-ISCHEMIA; EXTRACELLULAR-MATRIX; INFARCTED MYOCARDIUM;
   HEART-FAILURE; IN-VITRO; COLLAGEN SCAFFOLDS; GELATIN HYDROGEL;
   PROGENITOR CELLS
AB Cardiovascular disease is a leading cause of death worldwide. Since adult cardiac cells are limited in their proliferation, cardiac tissue with dead or damaged cardiac cells downstream of the occluded vessel does not regenerate after myocardial infarction. The cardiac tissue is then replaced with nonfunctional fibrotic scar tissue rather than new cardiac cells, which leaves the heart weak. The limited proliferation ability of host cardiac cells has motivated investigators to research the potential cardiac regenerative ability of stem cells. Considerable progress has been made in this endeavor. However, the optimum type of stem cells along with the most suitable matrix-material and cellular microenvironmental cues are yet to be identified or agreed upon. This review presents an overview of various types of biofunctional materials and biomaterial matrices, which in combination with stem cells, have shown promises for cardiac tissue replacement and reinforcement. Engineered biomaterials also have applications in cardiac tissue engineering, in which tissue constructs are developed in vitro by combining stem cells and biomaterial scaffolds for drug screening or eventual implantation. This review highlights the benefits of using biomaterials in conjunction with stem cells to repair damaged myocardium and give a brief description of the properties of these biomaterials that make them such valuable tools to the field.
C1 [Hasan, Anwarul] Qatar Univ, Dept Mech & Ind Engn, Coll Engn, Doha, Qatar.
   [Hasan, Anwarul; Roula, Boustany; Dana, Rahbani; Yara, Seif; Alexandre, Toubia] Amer Univ Beirut, Biomed Engn, Fac Engn & Architecture, Beirut 11072020, Lebanon.
   [Hasan, Anwarul; Roula, Boustany; Dana, Rahbani; Yara, Seif; Alexandre, Toubia] Amer Univ Beirut, Dept Mech Engn, Fac Engn & Architecture, Beirut 11072020, Lebanon.
   [Hasan, Anwarul] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Ctr Biomed Engn, Cambridge, MA 02139 USA.
   [Hasan, Anwarul] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
   [Waters, Renae; Paul, Arghya] Univ Kansas, Sch Engn, Bioengn Grad Program, BioIntel Res Lab,Dept Chem & Petr Engn, Lawrence, KS 66045 USA.
RP Hasan, A (reprint author), Qatar Univ, Dept Mech & Ind Engn, Coll Engn, Doha, Qatar.; Hasan, A (reprint author), Amer Univ Beirut, Biomed Engn, Fac Engn & Architecture, Beirut 11072020, Lebanon.; Hasan, A (reprint author), Amer Univ Beirut, Dept Mech Engn, Fac Engn & Architecture, Beirut 11072020, Lebanon.; Hasan, A (reprint author), Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Ctr Biomed Engn, Cambridge, MA 02139 USA.; Hasan, A (reprint author), MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA.; Paul, A (reprint author), Univ Kansas, Sch Engn, Bioengn Grad Program, BioIntel Res Lab,Dept Chem & Petr Engn, Lawrence, KS 66045 USA.
EM ahasan@qu.edu.qa; arghyapaul@ku.edu
OI Hasan, MD Anwarul/0000-0001-8380-2233
FU American University of Beirut, Lebanon; National Council for Scientific
   Research (CNRS), Lebanon; Farouk Jabre interdisciplinary research award;
   University of Kansas; National Institute of General Medical Sciences
   (NIGMS) of the NIH [P20GM103638-04]; NIGMS (NIH) [T32-GM008359]
FX Anwarul Hasan acknowledges the startup grant and the University Research
   Board (URB) grant from American University of Beirut, Lebanon, and the
   National Council for Scientific Research (CNRS) grant, Lebanon, as well
   as the Farouk Jabre interdisciplinary research award. Arghya Paul
   acknowledges the University of Kansas New Faculty General Research Fund
   for support and assistance with this work. The authors also acknowledge
   an investigator grant provided by the Institutional Development Award
   (IDeA) from the National Institute of General Medical Sciences (NIGMS)
   of the NIH Award Number P20GM103638-04 (to A.P.). R.W. acknowledges the
   financial support from NIGMS (NIH, T32-GM008359) Biotechnology
   Predoctoral Research Training Program.
CR Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF
   Annabi N, 2013, LAB CHIP, V13, P3569, DOI 10.1039/c3lc50252j
   [Anonymous], 2004, N ENGL J MED, V351, P209
   Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8
   Barbash IM, 2003, CIRCULATION, V108, P863, DOI 10.1161/01.CIR.0000084828.50310.6A
   Barron V, 2003, ANN BIOMED ENG, V31, P1017, DOI 10.1114/1.1603260
   Barthes J, 2014, BIOMED RES INT, DOI 10.1155/2014/921905
   Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1
   Bernal A, 2013, STEM CELL REV REP, V9, P814, DOI 10.1007/s12015-013-9461-4
   Bhattacharya S, 2014, JOVE-J VIS EXP, DOI 10.3791/52010
   Bhuvanalakshmi G, 2014, STEM CELL REV REP, V10, P856, DOI 10.1007/s12015-014-9530-3
   Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181
   Blocki A, 2015, BIOMATERIALS, V53, P12, DOI 10.1016/j.biomaterials.2015.02.075
   Bui QT, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt29
   Bursac N., 2009, ENG MED BIOL MAG, V28, P80
   Camci-Unal G, 2014, NPG ASIA MATER, V6, DOI 10.1038/am.2014.19
   Campbell NG, 2012, J CARDIOVASC TRANSL, V5, P713, DOI 10.1007/s12265-012-9378-3
   Carrier RL, 2002, TISSUE ENG, V8, P175, DOI 10.1089/107632702753724950
   Chen GP, 2002, MACROMOL BIOSCI, V2, P67, DOI 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F
   Cheng H, 2012, BIOMATERIALS, V33, P5004, DOI 10.1016/j.biomaterials.2012.03.065
   Cheng K, 2012, BIOMATERIALS, V33, P5317, DOI 10.1016/j.biomaterials.2012.04.006
   Cimetta E, 2014, EXP BIOL MED, V239, P1255, DOI 10.1177/1535370214530369
   Connell JP, 2013, TISSUE ENG PART B-RE, V19, P368, DOI [10.1089/ten.teb.2012.0561, 10.1089/ten.TEB.2012.0561]
   Correia C, 2014, STEM CELL REV REP, V10, P786, DOI 10.1007/s12015-014-9533-0
   Cutts J, 2015, BIOMARK INSIGHTS, V10, P77, DOI [10.4137/BMIMI.S20313, 10.4137/BMI.S20313]
   Da Silva RMP, 2007, TRENDS BIOTECHNOL, V25, P577, DOI 10.1016/j.tibtech.2007.08.014
   Davidenko N, 2012, ACTA BIOMATER, V8, P667, DOI 10.1016/j.actbio.2011.09.033
   Dawn B, 2005, P NATL ACAD SCI USA, V102, P3766, DOI 10.1073/pnas.0405957102
   Dib N, 2010, JACC-CARDIOVASC INTE, V3, P265, DOI 10.1016/j.jcin.2009.12.013
   Dong F, 2012, CIRCULATION, V126, P314, DOI 10.1161/CIRCULATIONAHA.111.082453
   Eke CC, 1997, AM SURGEON, V63, P417
   Emmert MY, 2014, ADV DRUG DELIVER REV, V69, P254, DOI 10.1016/j.addr.2013.12.004
   Formiga FR, 2014, J CONTROL RELEASE, V173, P132, DOI 10.1016/j.jconrel.2013.10.034
   Formiga FR, 2010, J CONTROL RELEASE, V147, P30, DOI 10.1016/j.jconrel.2010.07.097
   Freed LE, 2009, ADV MATER, V21, P3410, DOI 10.1002/adma.200900303
   Fromstein JD, 2008, TISSUE ENG PT A, V14, P369, DOI 10.1089/tea.2006.0410
   Fukuda K, 2001, ARTIF ORGANS, V25, P187, DOI 10.1046/j.1525-1594.2001.025003187.x
   Gaetani R, 2015, BIOMATERIALS, V61, P339, DOI 10.1016/j.biomaterials.2015.05.005
   Gao JZ, 2001, CELLS TISSUES ORGANS, V169, P12, DOI 10.1159/000047856
   Garbern JC, 2013, CELL STEM CELL, V12, P689, DOI 10.1016/j.stem.2013.05.008
   Gaustad KG, 2004, BIOCHEM BIOPH RES CO, V314, P420, DOI 10.1016/j.bbrc.2003.12.109
   Giridharan GA, 2010, ANAL CHEM, V82, P7581, DOI 10.1021/ac1012893
   Godier-Furnemont AFG, 2011, P NATL ACAD SCI USA, V108, P7974, DOI 10.1073/pnas.1104619108
   Guan JJ, 2011, BIOMATERIALS, V32, P5568, DOI 10.1016/j.biomaterials.2011.04.038
   Guo XM, 2006, CIRCULATION, V113, P2229, DOI 10.1161/CIRCULATIONAHA.105.583039
   Hagege AA, 2006, CIRCULATION, V114, pI108, DOI 10.1161/CIRCULATIONAHA.105.000521
   Halkos ME, 2008, BASIC RES CARDIOL, V103, P525, DOI 10.1007/s00395-008-0741-0
   Hasan A, 2015, ADV SCI, V2, DOI 10.1002/advs.201500122
   Hasan A, 2015, BIOMED MICRODEVICES, V17, DOI 10.1007/s10544-015-9993-2
   Hasan A, 2014, BIOMED RES INT, DOI 10.1155/2014/307519
   Hasan A, 2014, BIOMATERIALS, V35, P7308, DOI 10.1016/j.biomaterials.2014.04.091
   Hasan A, 2014, J BIOMECH, V47, P1949, DOI 10.1016/j.jbiomech.2013.09.023
   Hasan A, 2014, ACTA BIOMATER, V10, P11, DOI 10.1016/j.actbio.2013.08.022
   Heba G, 2001, J PHYSIOL PHARMACOL, V52, P39
   Hernandez RM, 2010, ADV DRUG DELIVER REV, V62, P711, DOI 10.1016/j.addr.2010.02.004
   Herrmann FEM, 2014, J BIOMED MATER RES A, V102, P958, DOI 10.1002/jbm.a.34786
   Huang NF, 2005, TISSUE ENG, V11, P1860, DOI 10.1089/ten.2005.11.1860
   Hufenus R, 2012, MACROMOL MATER ENG, V297, P75, DOI 10.1002/mame.201100063
   Hwang YS, 2009, P NATL ACAD SCI USA, V106, P16978, DOI 10.1073/pnas.0905550106
   Inamdar NK, 2011, CURR OPIN BIOTECH, V22, P681, DOI 10.1016/j.copbio.2011.05.512
   Ishida O, 2015, TRANSL RES, V165, P631, DOI 10.1016/j.trsl.2014.12.005
   Ito H, 2006, J CHEM ENG JPN, V39, P1296, DOI 10.1252/jcej.39.1296
   Iyer RK, 2011, CURR OPIN BIOTECH, V22, P706, DOI 10.1016/j.copbio.2011.04.004
   Joanne P, 2016, BIOMATERIALS, V80, P157, DOI 10.1016/j.biomaterials.2015.11.035
   JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K
   Jordan JE, 1999, CARDIOVASC RES, V43, P860, DOI 10.1016/S0008-6363(99)00187-X
   Jukes J, 2008, ACAD PR SER BIOM ENG, P1, DOI 10.1016/B978-0-12-370869-4.00001-X
   Kang WJ, 2006, J NUCL MED, V47, P1295
   Kim PJ, 2015, CIRC RES, V116, pE40, DOI 10.1161/CIRCRESAHA.116.304668
   Kim SW, 2013, INT J CARDIOL, V168, P1062, DOI 10.1016/j.ijcard.2012.11.003
   Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498
   Kurdi Mazen, 2010, Congest Heart Fail, V16, P132, DOI 10.1111/j.1751-7133.2010.00145.x
   Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327
   Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215
   Lee SH, 2000, NEW ENGL J MED, V342, P626, DOI 10.1056/NEJM200003023420904
   Lee YS, 2015, J CONTROL RELEASE, V205, P128, DOI 10.1016/j.jconrel.2015.01.004
   Li QH, 2011, BASIC RES CARDIOL, V106, P849, DOI 10.1007/s00395-011-0180-1
   Li ZQ, 2012, ACTA BIOMATER, V8, P3586, DOI 10.1016/j.actbio.2012.06.024
   Liu ZW, 2013, ABSTR APPL ANAL, DOI 10.1155/2013/825307
   Lo CY, 2016, BIOMATERIALS, V74, P19, DOI 10.1016/j.biomaterials.2015.09.026
   Lo CY, 2013, BIOMATERIALS, V34, P8213, DOI 10.1016/j.biomaterials.2013.07.033
   Lu TY, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt85
   Matar AA, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-440
   Mauritz C, 2008, CIRCULATION, V118, P507, DOI 10.1161/CIRCULATIONAHA.108.778795
   Mayfield AE, 2014, BIOMATERIALS, V35, P133, DOI 10.1016/j.biomaterials.2013.09.085
   MENASCHE P, 1982, ANN THORAC SURG, V34, P647, DOI 10.1016/S0003-4975(10)60904-6
   Montgomery M, 2014, J CARDIOVASC PHARM T, V19, P382, DOI 10.1177/1074248414528576
   Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679
   Muscari C., 2014, STEM CELLS INT, V2014
   Nguyen DC, 2014, STEM CELL REP, V3, P260, DOI 10.1016/j.stemcr.2014.06.002
   Nian M, 2004, CIRC RES, V94, P1543, DOI 10.1161/01.RES.0000130526.20854.fa
   Nunes SS, 2011, J CARDIOVASC TRANSL, V4, P592, DOI 10.1007/s12265-011-9307-x
   Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100
   Pacelli S., 2016, J MAT CHEM B
   Panda NC, 2014, J INTERV CARD ELECTR, V41, P117, DOI 10.1007/s10840-014-9940-9
   Papadaki M, 2001, AM J PHYSIOL-HEART C, V280, pH168
   Paul A, 2015, NANOMEDICINE-UK, V10, P1371, DOI [10.2217/NNM.15.33, 10.2217/nnm.15.33]
   Paul A, 2014, ACS NANO, V8, P8050, DOI 10.1021/nn5020787
   Paul A, 2012, MOL PHARMACEUT, V9, P2479, DOI 10.1021/mp3000502
   Paul A, 2011, MOL BIOTECHNOL, V48, P116, DOI 10.1007/s12033-010-9352-8
   Penn MS, 2009, CIRC RES, V104, P1133, DOI 10.1161/CIRCRESAHA.109.198929
   Perin Emerson C, 2007, EuroIntervention, V3, P142
   Pok S, 2013, ACTA BIOMATER, V9, P5630, DOI 10.1016/j.actbio.2012.10.032
   Poon C, 2013, IEEE ENG MED BIO, P6224, DOI 10.1109/EMBC.2013.6610975
   Prabhakaran MP, 2014, J BIOMED MATER RES B, V102, P447, DOI 10.1002/jbm.b.33022
   Raake P, 2004, J AM COLL CARDIOL, V44, P1124, DOI 10.1016/j.jacc.2004.05.074
   Rai R, 2013, MAT SCI ENG C-MATER, V33, P3677, DOI 10.1016/j.msec.2013.04.058
   Ravichandran R, 2013, INT J CARDIOL, V167, P1461, DOI 10.1016/j.ijcard.2012.04.045
   Ravichandran R, 2013, MACROMOL BIOSCI, V13, P366, DOI 10.1002/mabi.201200391
   Reis LA, 2012, ACTA BIOMATER, V8, P1022, DOI 10.1016/j.actbio.2011.11.030
   Russo V, 2014, BIOMATERIALS, V35, P3956, DOI 10.1016/j.biomaterials.2014.01.075
   Sarkar D, 2010, BIOMATERIALS, V31, P5266, DOI 10.1016/j.biomaterials.2010.03.006
   Sekiya N, 2013, MOL THER, V21, P662, DOI 10.1038/mt.2012.266
   Sheng CC, 2013, BIOMED RES INT, DOI 10.1155/2013/547902
   Shi CY, 2011, BIOMATERIALS, V32, P2508, DOI 10.1016/j.biomaterials.2010.12.026
   Shimizu T, 2003, BIOMATERIALS, V24, P2309, DOI 10.1016/S0142-9612(03)00110-8
   Shimizu T, 2006, TISSUE ENG, V12, P499, DOI 10.1089/ten.2006.12.499
   Shimizu T., 2011, MYOCARDIAL TISSUE EN, P1
   Shin EJ, 2014, CELLULOSE, V21, P3515, DOI 10.1007/s10570-014-0368-2
   Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209
   Sreerekha PR, 2013, TISSUE ENG PT A, V19, P849, DOI [10.1089/ten.tea.2012.0374, 10.1089/ten.TEA.2012.0374]
   Steinhaus B, 2007, APPL ENVIRON MICROB, V73, P1653, DOI 10.1128/AEM.01827-06
   Tang GM, 2013, ADV MATER SCI ENG, DOI 10.1155/2013/348601
   Tang YL, 2005, J AM COLL CARDIOL, V46, P1339, DOI 10.1016/j.jacc.2005.05.079
   Telukuntla KS, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000338
   Tompkins Joshua D, 2015, [Frontiers in Biology, 生物学前沿], V10, P11
   Tous E, 2011, J CARDIOVASC TRANSL, V4, P528, DOI 10.1007/s12265-011-9291-1
   Tsang KMC, 2015, ADV FUNCT MATER, V25, P977, DOI 10.1002/adfm.201403124
   Verdi J, 2014, J BIOL ENG, V8, DOI 10.1186/1754-1611-8-20
   Vunjak-Novakovic G, 2010, TISSUE ENG PART B-RE, V16, P169, DOI 10.1089/ten.TEB.2009.0352
   Wang HB, 2014, BIOMATERIALS, V35, P3986, DOI 10.1016/j.biomaterials.2014.01.021
   Waters R, 2016, NANOSCALE, V8, P7371, DOI 10.1039/c5nr07806g
   Williams C, 2015, ACTA BIOMATER, V14, P84, DOI 10.1016/j.actbio.2014.11.035
   Wollert KC, 2010, NAT REV CARDIOL, V7, P204, DOI 10.1038/nrcardio.2010.1
   Xu YY, 2014, ACTA BIOMATER, V10, P3449, DOI 10.1016/j.actbio.2014.04.018
   Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22
   Ye XF, 2013, BIOMATERIALS, V34, P10007, DOI 10.1016/j.biomaterials.2013.09.039
   Yoder MC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006692
   Zhang DH, 2013, BIOMATERIALS, V34, P5813, DOI 10.1016/j.biomaterials.2013.04.026
   Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237
   Zhao Q, 2008, ANN THORAC SURG, V86, P1833, DOI 10.1016/j.athoracsur.2008.08.068
   Zhu Wei-Zhong, 2009, Transplant Rev (Orlando), V23, P53, DOI 10.1016/j.trre.2008.05.005
NR 142
TC 12
Z9 12
U1 6
U2 61
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-5187
EI 1616-5195
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD JUL
PY 2016
VL 16
IS 7
BP 958
EP 977
DI 10.1002/mabi.201500396
PG 20
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA DR5AV
UT WOS:000379916300002
PM 26953627
OA Green Published, Green Accepted
DA 2018-10-20
ER

PT J
AU de Barros, CN
   Yamada, ALM
   Junior, RSF
   Barraviera, B
   Hussni, CA
   de Souza, JB
   Watanabe, MJ
   Rodrigues, CA
   Alves, ALG
AF de Barros, Caio Nunes
   Miluzzi Yamada, Ana Lucia
   Junior, Rui Seabra F.
   Barraviera, Benedito
   Hussni, Carlos Alberto
   de Souza, Jaqueline Brandao
   Watanabe, Marcos Jun
   Rodrigues, Celso Antonio
   Garcia Alves, Ana Liz
TI A new heterologous fibrin sealant as a scaffold to cartilage
   repair-Experimental study and preliminary results
SO EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Article
DE Fibrin gel; rattlesnake venom; scaffold; fibrin sealant
ID MESENCHYMAL STEM-CELLS; DURISSUS-TERRIFICUS VENOM; PLATELET-RICH PLASMA;
   GLUE; REGENERATION; MEDICINE; DEFECTS; SURGERY; HORSES; SHEEP
AB Autologous fibrin gel is commonly used as a scaffold for filling defects in articular cartilage. This biomaterial can also be used as a sealant to control small hemorrhages and is especially helpful in situations where tissue reparation capacity is limited. In particular, fibrin can act as a scaffold for various cell types because it can accommodate cell migration, differentiation, and proliferation. Despite knowledge of the advantages of this biomaterial and mastery of the techniques required for its application, the durability of several types of sealant at the site of injury remains questionable. Due to the importance of such data for evaluating the quality and efficiency of fibrin gel formulations on its use as a scaffold, this study sought to analyze the heterologous fibrin sealant developed from the venom of Crotalus durissus terrificus using studies in ovine experimental models. The fibrin gel developed from the venom of this snake was shown to act as a safe, stable, and durable scaffold for up to seven days, without causing adverse side effects. Fibrin gel produced from the venom of the Crotalus durissus terrificus snake possesses many clinical and surgical uses. It presents the potential to be used as a biomaterial to help repair skin lesions or control bleeding, and it may also be used as a scaffold when applied together with various cell types. The intralesional use of the fibrin gel from the venom of this snake may improve surgical and clinical treatments in addition to being inexpensive and adequately consistent, durable, and stable. The new heterologous fibrin sealant is a scaffold candidate to cartilage repair in this study.
C1 [de Barros, Caio Nunes; Miluzzi Yamada, Ana Lucia; Hussni, Carlos Alberto; de Souza, Jaqueline Brandao; Watanabe, Marcos Jun; Rodrigues, Celso Antonio; Garcia Alves, Ana Liz] Sao Paulo State Univ, UNESP Univ Estadual Paulista, Sch Vet Med & Anim Sci, Dept Vet Surg & Anesthesiol, BR-18618970 Botucatu, SP, Brazil.
   [Junior, Rui Seabra F.; Barraviera, Benedito] Sao Paulo State Univ, UNESP Univ Estadual Paulista, Ctr Study Venoms & Venomous Anim, BR-18618970 Botucatu, SP, Brazil.
RP Alves, ALG (reprint author), Sao Paulo State Univ, UNESP Univ Estadual Paulista, Sch Vet Med & Anim Sci, Dept Vet Surg & Anesthesiol, BR-18618970 Botucatu, SP, Brazil.
EM anaalves@fmvz.unesp.br
RI Hussni, Carlos/C-4917-2012; ALVES, ANA LIZ/D-9937-2012
OI Hussni, Carlos/0000-0001-5421-2904; ALVES, ANA LIZ/0000-0001-9092-7819;
   Yamada, Ana Lucia/0000-0003-3856-0196; Barraviera,
   Benedito/0000-0002-9855-5594; Seabra Ferreira Jr,
   Rui/0000-0001-6952-0512
FU FAPESP (Sao Paulo Research Foundation) [2012/03600-6, 2012/04516-9]
FX This study was financially supported by FAPESP (Sao Paulo Research
   Foundation) (2012/03600-6 and 2012/04516-9). Fibrin sealant derived from
   snake venom was kindly supplied by the Center for the Study of Venoms
   and Venomous Animals (CEVAP) of UNESP, its constituents and instructions
   for use are stated in its patents (registration numbers BR1020140114327
   and BR1020140114360). At the time of use, the components were previously
   thawed, reconstituted, mixed, and applied according to the protocol of
   the project (Thomazini-Santos et al., 2001; Barros et al., 2010, 2011;
   Gasparotto et al. 2014; Ferreira Junior, 2014).
CR Allen MJ, 1998, VET SURG, V27, P596, DOI 10.1111/j.1532-950X.1998.tb00536.x
   Barbizan R, 2014, INT J MOL SCI, V15, P19535, DOI 10.3390/ijms151119535
   Barbizan R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105712
   Barbizan R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063260
   Barros LC, 2011, J VENOM ANIM TOXINS, V17, P23, DOI 10.1590/S1678-91992011000100004
   Barros LC, 2009, J TOXICOL ENV HEAL B, V12, P553, DOI 10.1080/10937400903442514
   Benitez SU, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00096
   Berrevoet F, 2007, ACTA CHIR BELG, V107, P504, DOI 10.1080/00015458.2007.11680111
   BRENNAN M, 1991, BLOOD REV, V5, P240, DOI 10.1016/0268-960X(91)90015-5
   Brittberg M, 1997, BIOMATERIALS, V18, P235, DOI 10.1016/S0142-9612(96)00117-2
   Buchta C, 2004, VOX SANG, V86, P257, DOI 10.1111/j.0042-9007.2004.00516.x
   COPLEY A L, 1973, Thrombosis Research, V2, P487, DOI 10.1016/0049-3848(73)90003-0
   Flanagan TC, 2009, TISSUE ENG PT A, V15, P2965, DOI [10.1089/ten.tea.2009.0018, 10.1089/ten.TEA.2009.0018]
   Foster TE, 2009, AM J SPORT MED, V37, P2259, DOI 10.1177/0363546509349921
   Gasparotto VPO, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt467
   ISHIMURA M, 1991, Arthroscopy, V7, P177, DOI 10.1016/0749-8063(91)90106-8
   Izuta Y, 2005, KNEE, V12, P217, DOI 10.1016/j.knee.2001.06.001
   Kon E, 2010, J TISSUE ENG REGEN M, V4, P300, DOI 10.1002/term.243
   Kretlow JD, 2010, TISSUE ENG PT A, V16, P3555, DOI 10.1089/ten.TEA.2010.0471
   LAITAKARI K, 1989, LARYNGOSCOPE, V99, P974
   Leo AJ, 2006, CELLS TISSUES ORGANS, V183, P112, DOI 10.1159/000095985
   LUPINETTI FM, 1985, J THORAC CARDIOV SUR, V90, P502
   Man D, 2001, PLAST RECONSTR SURG, V107, P229, DOI 10.1097/00006534-200101000-00037
   MATRAS H, 1985, J ORAL MAXIL SURG, V43, P605, DOI 10.1016/0278-2391(85)90129-6
   McIlwraith CW, 2005, AM ASS EQUINE PRACT, V51, P65
   Milano G, 2010, OSTEOARTHR CARTILAGE, V18, P971, DOI 10.1016/j.joca.2010.03.013
   Moraes J.R.E., 2004, J. Venom. Anim. Toxins incl. Trop. Dis, V10, P133, DOI 10.1590/S1678-91992004000200003
   Martins Edivaldo Aparecido Nunes, 2007, Cienc. Rural, V37, P784, DOI 10.1590/S0103-84782007000300028
   PALETTA GA, 1992, AM J SPORT MED, V20, P725, DOI 10.1177/036354659202000614
   Peretti GM, 2001, ANN PLAS SURG, V46, P533, DOI 10.1097/00000637-200105000-00013
   Pescatore P, 1998, ENDOSCOPY, V30, P519, DOI 10.1055/s-2007-1001337
   Ringe J, 2002, NATURWISSENSCHAFTEN, V89, P338, DOI 10.1007/s00114-002-0344-9
   Sartorio Filho R., 1998, Journal of Venomous Animals and Toxins, V4, P23
   Stashak T, 1994, CLAUDICACAO EQUINOS, P99
   Thomazini IAS, 1996, THESIS
   Vinatier C, 2009, TRENDS BIOTECHNOL, V27, P307, DOI 10.1016/j.tibtech.2009.02.005
   Yamada A., 2011, THESIS
NR 37
TC 4
Z9 4
U1 1
U2 10
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1535-3702
EI 1535-3699
J9 EXP BIOL MED
JI Exp. Biol. Med.
PD JUL
PY 2016
VL 241
IS 13
BP 1410
EP 1415
DI 10.1177/1535370215597192
PG 6
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DR3GT
UT WOS:000379791400006
PM 26264444
OA Green Published
DA 2018-10-20
ER

PT J
AU Xue, JD
   Gao, J
   Fu, Q
   Feng, C
   Xie, H
AF Xue, Jing-Dong
   Gao, Jing
   Fu, Qiang
   Feng, Chao
   Xie, Hong
TI Seeding cell approach for tissue-engineered urethral reconstruction in
   animal study: A systematic review and meta- analysis
SO EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Review
DE Tissue engineering; urethral reconstruction; animal model;
   cell-seeded/unseeded biomaterial; urethral defect; meta-analysis
ID BLADDER ACELLULAR MATRIX; TUBULARIZED COLLAGEN MATRICES; TRAUMATIC
   BRAIN-INJURY; 1ST 10 PATIENTS; BUCCAL MUCOSA; STEM-CELLS; PUBLICATION
   BIAS; SEARCH FILTER; RABBIT MODEL; URETHROPLASTY
AB We systematically reviewed published preclinical studies to evaluate the effectiveness of cell-seeded tissue engineering approach for urethral reconstruction in an animal model. The outcomes were summarized by success factors in the animal experiments, which evaluate the possibility and feasibility of a clinical application in the future. Preclinical studies of tissue engineering approaches for urethral reconstruction were identified through a systematic search in PubMed, Embase, and Biosis Previews (web of science SP) databases for studies published from 1 January 1980 to 23 November 2014. Primary studies were included if urethral reconstruction was performed using a tissue-engineered biomaterial in any animal species (with the experiment group being a cell-seeded scaffold and the control group being a cell-free scaffold) with histology and urethrography as the outcome measure. A total of 15 preclinical studies were included in our meta-analysis. The histology and urethrography outcome between the experimental and control groups were considered to be the most clinically relevant. Through this systematic approach, our outcomes suggested that applying the cell-seeded biomaterial in creating a neo-urethra was stable and effective. And multi-type cells including epithelial cells as well as smooth muscle cells or fibroblasts seemed to be a better strategy. Stem cells, especially after epithelial differentiation, could be a promising choice for future researches.
C1 [Xue, Jing-Dong; Fu, Qiang; Feng, Chao; Xie, Hong] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Urol, Shanghai 200233, Peoples R China.
   [Gao, Jing] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Obstet & Gynecol, Shanghai 200025, Peoples R China.
RP Xie, H (reprint author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Urol, Shanghai 200233, Peoples R China.
EM drxiehong@163.com
CR Atala A, 1999, J UROLOGY, V162, P1148, DOI 10.1016/S0022-5347(01)68105-9
   Atala A, 2002, UROL CLIN N AM, V29, P485, DOI 10.1016/S0094-0143(02)00033-2
   Baer PC, 2013, J TISSUE ENG REGEN M, V7, P271, DOI 10.1002/term.518
   Baer PC, 2011, STEM CELLS DEV, V20, P1805, DOI 10.1089/scd.2011.0086
   Barbagli G, 2011, J UROLOGY, V186, P375, DOI 10.1016/j.juro.2011.05.012
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Bhargava S, 2008, EUR UROL, V53, P1263, DOI 10.1016/j.eururo.2008.01.061
   Chen F, 1999, UROLOGY, V54, P407, DOI 10.1016/S0090-4295(99)00179-X
   Crossley NA, STROKE, V3, P929
   da Silva LFA, 2014, TISSUE ENG PT A, V20, P1542, DOI [10.1089/ten.tea.2013.0185, 10.1089/ten.TEA.2013.0185]
   De Filippo RE, 2002, J UROLOGY, V168, P1789, DOI 10.1097/01.ju.0000027662.69103.72
   De Filippo RE, 2015, J TISSUE ENG REGEN M, V9, P257, DOI 10.1002/term.1647
   de Vries RBM, 2012, TISSUE ENG PART B-RE, V18, P427, DOI [10.1089/ten.teb.2012.0059, 10.1089/ten.TEB.2012.0059]
   de Vries RBM, 2011, LAB ANIM-UK, V45, P268, DOI 10.1258/la.2011.011056
   Dorin RP, 2008, WORLD J UROL, V26, P323, DOI 10.1007/s00345-008-0316-6
   Egger M, 1997, BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   El Kassaby A, 2008, J UROLOGY, V179, P1432, DOI 10.1016/j.juro.2007.11.101
   El-Kassaby AW, 2003, J UROLOGY, V169, P170, DOI 10.1016/S0022-5347(05)64060-8
   Engel O, 2012, J UROLOGY, V187, pE6, DOI 10.1016/j.juro.2012.02.057
   Feng C, 2011, TISSUE ENG PT A, V17, P3011, DOI [10.1089/ten.tea.2011.0061, 10.1089/ten.TEA.2011.0061]
   Fiala R, 2007, EUR UROL, V51, P1702, DOI 10.1016/j.eururo.2007.01.099
   Fu Q, 2007, BJU INT, V99, P1162, DOI 10.1111/j.1464-410X.2006.06691.x
   Fu Q, 2012, UROLOGY, V79, P246, DOI 10.1016/j.urology.2011.08.043
   Gu GL, 2012, UROL INT, V89, P358, DOI 10.1159/000339745
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Hooijmans CR, 2010, LAB ANIM-UK, V44, P170, DOI 10.1258/la.2010.009117
   Hooijmans CR, 2010, ATLA-ALTERN LAB ANIM, V38, P167
   Ker K, 2009, CNS NEUROSCI THER, V15, P52, DOI 10.1111/j.1755-5949.2008.00069.x
   Leenaars M, 2012, LAB ANIM-UK, V46, P24, DOI 10.1258/la.2011.011087
   Li CL, 2013, TRANSPL P, V45, P3402, DOI 10.1016/j.transproceed.2013.07.055
   Li C, 2008, J UROLOGY, V180, P1538, DOI 10.1016/j.juro.2008.06.013
   Li C, 2013, UROLOGY, V81, P1075, DOI 10.1016/j.urology.2013.01.041
   Li HB, 2014, TISSUE ENG PT A, V20, P774, DOI 10.1089/ten.TEA.2013.0122
   Liu Y, 2009, BIOMATERIALS, V30, P3865, DOI 10.1016/j.biomaterials.2009.04.008
   Long JL, 2010, LARYNGOSCOPE, V120, P125, DOI 10.1002/lary.20719
   Macleod MR, 2004, STROKE, V35, P1203, DOI 10.1161/01.STR.0000125719.25853.20
   MANTEL N, 1959, J NATL CANCER I, V22, P719
   Micol LA, 2012, BIOMATERIALS, V33, P7447, DOI 10.1016/j.biomaterials.2012.06.087
   Moher D, 2010, INT J SURG, V8, P336, DOI 10.1016/j.ijsu.2010.02.007
   Orabi H, 2013, EUR UROL, V63, P531, DOI 10.1016/j.eururo.2012.07.041
   Osman NI, 2015, ADV DRUG DELIVER REV, V82-83, P69, DOI 10.1016/j.addr.2014.10.006
   Palminteri E, 2007, EUR UROL, V51, P1695, DOI 10.1016/j.eururo.2006.12.016
   Parnigotto PP, 2000, UROL RES, V28, P46, DOI 10.1007/s002400050009
   Peng WJ, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0034-0
   Perel P, 2007, BMJ-BRIT MED J, V334, P197, DOI 10.1136/bmj.39048.407928.BE
   Ram-Liebig G, 2012, EUR UROL SUPPL, V11, pE621
   Ram-Liebig G, 2012, EUR UROL SUPPL, V11, pEV8
   Raya-Rivera A, 2011, LANCET, V377, P1175, DOI 10.1016/S0140-6736(10)62354-9
   Sayeg K, 2013, INT BRAZ J UROL, V39, P414, DOI 10.1590/S1677-5538.IBJU.2013.03.16
   Shih EM, 2014, EUR J MED GENET, V57, P453, DOI 10.1016/j.ejmg.2014.03.003
   Sun DC, 2014, J CELL MOL MED, V18, P434, DOI 10.1111/jcmm.12157
   Vesterinen HM, 2014, J NEUROSCI METH, V221, P92, DOI 10.1016/j.jneumeth.2013.09.010
   Xie MK, 2014, J SURG RES, V188, P1, DOI 10.1016/j.jss.2013.11.1102
   Xu YM, 2015, BJU INT, V116, P938, DOI 10.1111/bju.12945
   Xu YM, 2014, UROLOGY, V83, P232, DOI 10.1016/j.urology.2013.08.035
   Xu YM, 2009, WORLD J UROL, V27, P565, DOI 10.1007/s00345-009-0378-0
NR 56
TC 2
Z9 3
U1 0
U2 9
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1535-3702
EI 1535-3699
J9 EXP BIOL MED
JI Exp. Biol. Med.
PD JUL
PY 2016
VL 241
IS 13
BP 1416
EP 1428
DI 10.1177/1535370216640148
PG 13
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DR3GT
UT WOS:000379791400007
PM 27022134
OA Green Published
DA 2018-10-20
ER

PT J
AU Xiao, XC
   Liu, YY
   Guo, MM
   Fei, WD
   Zheng, HY
   Zhang, RR
   Zhang, Y
   Wei, YH
   Zheng, GH
   Li, FZ
AF Xiao, Xuecheng
   Liu, Yangyang
   Guo, Manman
   Fei, Weidong
   Zheng, Hongyue
   Zhang, Rongrong
   Zhang, Yan
   Wei, Yinghui
   Zheng, Guohua
   Li, Fanzhu
TI pH-triggered sustained release of arsenic trioxide by polyacrylic acid
   capped mesoporous silica nanoparticles for solid tumor treatment invitro
   and invivo
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE pH-triggered MSN; arsenic trioxide; sustained release; pharmacokinetics;
   solid tumor
ID ACUTE PROMYELOCYTIC LEUKEMIA; RESPONSIVE DRUG-RELEASE; INTRACELLULAR
   CONTROLLED-RELEASE; DELIVERY-SYSTEM; CANCER-THERAPY; CELLS;
   PHARMACOKINETICS; NANOCARRIERS; CHEMOTHERAPY; DOXORUBICIN
AB Arsenic trioxide (As2O3, ATO), a FDA approved drug for hematologic malignancies, was proved of efficient growth inhibition of cancer cell invitro or solid tumor invivo. However, its effect on solid tumor invivo was hampered by its poor pharmacokinetics and dose-limited toxicity. In this study, a polyacrylic acid capped pH-triggered mesoporous silica nanoparticles was conducted to improve the pharmacokinetics and enhance the antitumor effect of arsenic trioxide. The mesoporous silica nanoparticles loaded with arsenic trioxide was grafted with polyacrylic acid (PAA-ATO-MSN) as a pH-responsive biomaterial on the surface to achieve the release of drug in acidic microenvironment of tumor, instead of burst release action in circulation. The nanoparticles were characterized with uniform grain size (particle sizes of 158.6 +/- 1.3 nm and pore sizes of 3.71 nm, respectively), historically comparable drug loading efficiency (11.42 +/- 1.75%), pH-responsive and strengthened sustained release features. The cell toxicity of amino groups modified mesoporous silica nanoparticles (NH2-MSN) was significantly reduced by capping of polyacrylic acid. In pharmacokinetic studies, the half time (t(1/2)) was prolonged by 1.3 times, and the area under curve) was increased by 2.6 times in PAA-ATO-MSN group compared with free arsenic trioxide group. Subsequently, the antitumor efficacy invitro (SMMC-7721 cell line) and invivo (H22 xenografts) was remarkably enhanced indicated that PAA-ATO-MSN improved the antitumor effect of the drug. These results suggest that the polyacrylic acid capped mesoporous silica nanoparticles (PAA-MSN) will be a promising nanocarrier for improving pharmacokinetic features and enhancing the anti-tumor efficacy of arsenic trioxide.
C1 [Xiao, Xuecheng; Liu, Yangyang; Zheng, Guohua] Hubei Univ Chinese Med, Dept Pharmaceut, Wuhan 430065, Peoples R China.
   [Guo, Manman; Fei, Weidong; Zhang, Rongrong; Zhang, Yan; Wei, Yinghui; Li, Fanzhu] Zhejiang Chinese Med Univ, Dept Pharmaceut, Hangzhou 310053, Zhejiang, Peoples R China.
   [Zheng, Hongyue] Zhejiang Chinese Med Univ, Lib Zhejiang Chinese Med Univ, Hangzhou, Zhejiang, Peoples R China.
RP Zheng, GH (reprint author), Hubei Univ Chinese Med, Dept Pharmaceut, Wuhan 430065, Peoples R China.; Li, FZ (reprint author), Zhejiang Chinese Med Univ, Dept Pharmaceut, Hangzhou 310053, Zhejiang, Peoples R China.
EM zgh1227@sina.com; lifanzhu@zcmu.edu.cn
FU National Science Foundation of China [81274089, 81473361]; Natural
   Science Foundation of Zhejiang Province [LZ13H280001, LY12H28004];
   Science and Technology Innovation Team Project of Zhejiang Province
   [2015R410051]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This study
   was financially supported by the National Science Foundation of China
   (Nos. 81274089 and 81473361), the Natural Science Foundation of Zhejiang
   Province (LZ13H280001 and LY12H28004) and the Science and Technology
   Innovation Team Project of Zhejiang Province (2015R410051).
CR Aw MS, 2013, J BIOMATER APPL, V28, P163, DOI 10.1177/0885328212441846
   Bhattacharyya S, 2012, ACTA BIOMATER, V8, P3429, DOI 10.1016/j.actbio.2012.06.003
   Chen LF, 2014, ACS NANO, V8, P744, DOI 10.1021/nn405398d
   Chen M, 2014, J MATER CHEM B, V2, P428, DOI 10.1039/c3tb21268h
   Chiu HW, 2011, J MOL MED, V89, P927, DOI 10.1007/s00109-011-0763-1
   Deutel B, 2016, EUR J PHARM SCI, V81, P157, DOI 10.1016/j.ejps.2015.10.022
   Douroumis D, 2013, CRIT REV BIOTECHNOL, V33, P229, DOI 10.3109/07388551.2012.685860
   Elsayed A, 2014, INT J PHARMACEUT, V461, P448, DOI 10.1016/j.ijpharm.2013.12.014
   Frohlich E, 2012, INT J NANOMED, V7, P5577, DOI 10.2147/IJN.S36111
   Fujisawa S, 2007, CANCER CHEMOTH PHARM, V59, P485, DOI 10.1007/s00280-006-0288-4
   Gao Q, 2009, J PHYS CHEM C, V113, P12753, DOI 10.1021/jp9043978
   Gok MK, 2016, CARBOHYD POLYM, V136, P63, DOI 10.1016/j.carbpol.2015.08.079
   He QJ, 2011, J MATER CHEM, V21, P5845, DOI 10.1039/c0jm03851b
   Hua HQ, 2011, ASIAN PAC J CANCER P, V12, P61
   Jalvandi J, 2015, J MATER SCI, V50, P7967, DOI 10.1007/s10853-015-9361-x
   Kruk M, 2001, CHEM MATER, V13, P3169, DOI 10.1021/cm0101069
   Lee SM, 2011, ACS NANO, V5, P3961, DOI 10.1021/nn200478m
   Li JM, 2014, ADV HEALTHC MATER, V3, P1230, DOI 10.1002/adhm.201300613
   Li MQ, 2014, BIOMATERIALS, V35, P3851, DOI 10.1016/j.biomaterials.2014.01.018
   Li YL, 2015, PLOS ONE, V10
   Liu B, 2006, CANCER SCI, V97, P675, DOI 10.1111/j.1349-7006.2006.00230.x
   Liu J, 2014, BIOTECHNOL ADV, V32, P693, DOI 10.1016/j.biotechadv.2013.11.009
   Lu J, 2010, SMALL, V6, P1794, DOI 10.1002/smll.201000538
   Luo QY, 2015, J TOXICOL SCI, V40, P349, DOI 10.2131/jts.40.349
   Mamaeva V, 2013, ADV DRUG DELIVER REV, V65, P689, DOI 10.1016/j.addr.2012.07.018
   MATSUMURA Y, 1986, CANCER RES, V46, P6387
   Mishra AK, 2014, J NANOPART RES, V16, DOI 10.1007/s11051-014-2515-y
   Muhammad F, 2014, COLLOID SURFACE B, V123, P506, DOI 10.1016/j.colsurfb.2014.09.046
   Pan LM, 2014, ADV MATER, V26, P6742, DOI 10.1002/adma.201402752
   Peng F, 2013, ANGEW CHEM INT EDIT, V52, P1457, DOI 10.1002/anie.201206737
   Peng HL, 2013, INT J PHARMACEUT, V446, P153, DOI 10.1016/j.ijpharm.2013.01.071
   Shen Y, 2001, LEUKEMIA, V15, P735, DOI 10.1038/sj.leu.2402106
   Sing KSW, 1984, PURE APPL CHEM, V1985, P603, DOI DOI 10.1351/PAC198557040603
   Song XL, 2014, CHEM RES CHINESE U, V30, P326, DOI 10.1007/s40242-014-3306-9
   Soto RJ, 2016, ACS APPL MATER INTER, V8, P2220, DOI 10.1021/acsami.5b10942
   Spizzirri UG, 2015, DRUG DEV IND PHARM, V41, P2006, DOI 10.3109/03639045.2015.1040415
   Sun JT, 2012, MACROMOL RAPID COMM, V33, P811, DOI 10.1002/marc.201100876
   Sweeney CJ, 2010, CANCER CHEMOTH PHARM, V66, P345, DOI 10.1007/s00280-009-1169-4
   Swindell EP, 2013, INORG CHEM, V52, P12292, DOI 10.1021/ic401211u
   Tripathi SK, 2016, COLLOID SURFACE B, V140, P117, DOI 10.1016/j.colsurfb.2015.12.007
   Vivero-Escoto JL, 2009, J AM CHEM SOC, V131, P3462, DOI 10.1021/ja900025f
   Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798
   Xing L, 2012, ADV MATER, V24, P6433, DOI 10.1002/adma.201201742
   Xu YY, 2015, INT J PHARMACEUT, V495, P792, DOI 10.1016/j.ijpharm.2015.09.030
   Yang JM, 1999, J BIOMED MATER RES, V45, P133, DOI 10.1002/(SICI)1097-4636(199905)45:2<133::AID-JBM8>3.3.CO;2-4
   Yu T, 2011, ACS NANO, V5, P5717, DOI 10.1021/nn2013904
   Yuan L, 2011, J PHYS CHEM C, V115, P9926, DOI 10.1021/jp201053d
   Zhang SH, 2016, BIOCHEM BIOPH RES CO, V469, P55, DOI 10.1016/j.bbrc.2015.11.071
   Zhang Z, 2015, ACS APPL MATER INTER, V7, P8404, DOI 10.1021/acsami.5b01213
   Zhu XL, 2014, J BIOMATER APPL, V29, P769, DOI 10.1177/0885328214543211
NR 50
TC 9
Z9 11
U1 8
U2 54
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD JUL
PY 2016
VL 31
IS 1
BP 23
EP 35
DI 10.1177/0885328216637211
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DQ9FH
UT WOS:000379515300003
PM 27059495
DA 2018-10-20
ER

PT J
AU Choung, HW
   Lee, DS
   Lee, JH
   Shon, WJ
   Lee, JH
   Ku, Y
   Park, JC
AF Choung, H. W.
   Lee, D. S.
   Lee, Ji-Hyun
   Shon, W. J.
   Lee, Jong-Ho
   Ku, Y.
   Park, J. C.
TI Tertiary Dentin Formation after Indirect Pulp Capping Using Protein
   CPNE7
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Article
DE dentinogenesis; regeneration; biomaterial(s); epithelial-mesenchymal
   interaction; mineralized tissue; development
ID MINERAL TRIOXIDE AGGREGATE; IN-VITRO; CALCIUM HYDROXIDE; REACTIONARY
   DENTINOGENESIS; STEM-CELLS; DIFFERENTIATION; MTA; RESPONSES; THERAPY;
   TEETH
AB If there is a partial loss of dentin, the exposed dentinal surface should be protected by an indirect pulp capping (IPC) procedure to preserve pulp vitality and prevent symptoms of dentin hypersensitivity. In our previous study, copine7 (CPNE7) induced odontoblast differentiation in vitro and promoted dentin formation in vivo. The aim of this study was to investigate the possibility of IPC therapy using the CPNE7 protein at the exposed dentinal surface and the resulting effects on tertiary dentin formation in a beagle model. CPNE7 promoted mineralization of odontoblasts and had high calcium ion-binding capacity. The in vivo IPC model with canine teeth showed that regeneration of physiologic reactionary dentin with dentinal tubule structures was clearly observed beneath the remaining dentin in the CPNE7 group, whereas irregular features of reparative dentin were generated in the mineral trioxide aggregate (MTA) group. The CPNE7+MTA group also showed typical reactionary dentin without reparative dentin, showing synergistic effects of CPNE7 with MTA. A scanning electron microscopy analysis showed that dentinal tubules beneath the original dentin were occluded by the deposition of peritubular dentin in the CPNE7 and CPNE7+MTA groups, whereas those in the control group were opened. Therefore, CPNE7 may be able to serve as a novel IPC material and improve symptoms of dentin hypersensitivity.
C1 [Choung, H. W.; Lee, D. S.; Lee, Ji-Hyun; Park, J. C.] Seoul Natl Univ, Sch Dent, Dept Oral Histol Dev Biol, 28 Yeongun Dong, Seoul 110749, South Korea.
   [Choung, H. W.; Lee, D. S.; Lee, Ji-Hyun; Shon, W. J.; Lee, Jong-Ho; Ku, Y.; Park, J. C.] Seoul Natl Univ, Dent Res Inst, 28 Yeongun Dong, Seoul 110749, South Korea.
   [Shon, W. J.] Seoul Natl Univ, Sch Dent, Dept Conservat Dent, Seoul, South Korea.
   [Lee, Jong-Ho] Seoul Natl Univ, Sch Dent, Dept Oral & Maxillofacial Surg, Seoul, South Korea.
   [Ku, Y.] Seoul Natl Univ, Sch Dent, Dept Periodontol, Seoul, South Korea.
RP Park, JC (reprint author), Seoul Natl Univ, Sch Dent, Dept Oral Histol Dev Biol, 28 Yeongun Dong, Seoul 110749, South Korea.; Park, JC (reprint author), Seoul Natl Univ, Dent Res Inst, 28 Yeongun Dong, Seoul 110749, South Korea.
EM jcapark@snu.ac.kr
RI Park, Joo Cheol/D-6437-2012
FU Korea Health Technology R&D Project through the Korea Health Industry
   Development Institute - Ministry of Health and Welfare, Republic of
   Korea [HI14C2681]; National Research Foundation of Korea Grant, through
   the Oromaxillofacial Dysfunction Research Center for the Elderly at
   Seoul National University in Korea [2014 050477]
FX This research was supported by a grant from the Korea Health Technology
   R&D Project through the Korea Health Industry Development Institute,
   funded by the Ministry of Health and Welfare, Republic of Korea
   (HI14C2681), and by a National Research Foundation of Korea Grant,
   through the Oromaxillofacial Dysfunction Research Center for the Elderly
   (No. 2014 050477) at Seoul National University in Korea. The authors
   declare no potential conflicts of interest with respect to the
   authorship and/or publication of this article.
CR About I, 2000, EXP CELL RES, V258, P33, DOI 10.1006/excr.2000.4909
   Aeinehchi M, 2003, INT ENDOD J, V36, P225, DOI 10.1046/j.1365-2591.2003.00652.x
   Choung HW, 2013, J MOL HISTOL, V44, P715, DOI 10.1007/s10735-013-9513-8
   Creutz CE, 1998, J BIOL CHEM, V273, P1393, DOI 10.1074/jbc.273.3.1393
   Dababneh RH, 1999, BRIT DENT J, V187, P606, DOI 10.1038/sj.bdj.4800345a
   Davari Ar, 2013, J Dent (Shiraz), V14, P136
   De Rossi A, 2014, J ENDODONT, V40, P1362, DOI 10.1016/j.joen.2014.02.006
   Duque C, 2006, J ORAL REHABIL, V33, P452, DOI 10.1111/j.1365-2842.2005.01585.x
   Filipovic V, 1989, Stomatol Glas Srb, V36, P393
   Gu J, 2015, J ENDODONT, V41, P1056, DOI 10.1016/j.joen.2015.01.010
   Hayashi M, 2011, J DENT, V39, P95, DOI 10.1016/j.jdent.2010.10.012
   He G, 2003, NAT MATER, V2, P552, DOI 10.1038/nmat945
   Kim HS, 2009, ARCH ORAL BIOL, V54, P71, DOI 10.1016/j.archoralbio.2008.09.011
   Lee JH, 2011, BIOMATERIALS, V32, P9696, DOI 10.1016/j.biomaterials.2011.09.007
   Lee W, 2012, ACTA BIOMATER, V8, P2986, DOI 10.1016/j.actbio.2012.04.032
   Liu SY, 2015, J ENDODONT, V41, P652, DOI 10.1016/j.joen.2014.12.009
   Murray PE, 2000, J AM DENT ASSOC, V131, P321, DOI 10.14219/jada.archive.2000.0175
   Murray Peter E, 2002, Dent Update, V29, P172
   Oh HJ, 2015, BIOMATERIALS, V37, P208, DOI 10.1016/j.biomaterials.2014.10.016
   Opal S, 2014, J CLIN PEDIATR DENT, V38, P185, DOI 10.17796/jcpd.38.3.r79r872218284q20
   Pavlica Z, 2000, ACTA VET HUNG, V48, P23, DOI 10.1556/AVet.48.2000.1.3
   Petrou MA, 2014, CLIN ORAL INVEST, V18, P1383, DOI 10.1007/s00784-013-1107-z
   Reston EG, 2009, AUST ENDOD J, V35, P78, DOI 10.1111/j.1747-4477.2008.00131.x
   SMITH AJ, 1995, INT J DEV BIOL, V39, P273
   Thesleff I, 2003, J CELL SCI, V116, P1647, DOI 10.1242/jcs.00410
   Tziafas D, 2000, J DENT, V28, P77, DOI 10.1016/S0300-5712(99)00047-0
NR 26
TC 3
Z9 3
U1 3
U2 14
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0022-0345
EI 1544-0591
J9 J DENT RES
JI J. Dent. Res.
PD JUL
PY 2016
VL 95
IS 8
BP 906
EP 912
DI 10.1177/0022034516639919
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA DQ9US
UT WOS:000379555400010
PM 27013639
DA 2018-10-20
ER

PT J
AU Reddy, PM
   Lakshmi, R
   Dass, FP
   Sasikumar, S
AF Reddy, P. Manohar
   Lakshmi, Ravy
   Dass, Febin Prabhu
   Sasikumar, Swamiappan
TI Synthesis, characterization and formulation of sodium calcium silicate
   bioceramic for drug delivery applications
SO SCIENCE AND ENGINEERING OF COMPOSITE MATERIALS
LA English
DT Article
DE biomaterial; chemical synthesis; Debye-Scherrer powder method; Fourier
   transform infrared spectroscopy (FTIR)
ID IN-VITRO RELEASE; COMPOSITE MICROSPHERES; BONE; HYDROXYAPATITE;
   GENTAMICIN; COATINGS; MICELLES
AB Sodium calcium silicate (Na2CaSiO4) is a bioactive silicate with Na2O, CaO and SiO2 as its basic components, which is similar to that of the composition of bioactive glasses. In the present study, pure sodium calcium silicate was synthesized by rapid combustion technique, and the synthesized sample was characterized by powder X-ray diffraction to check the phase purity. The scaffolds were prepared by varying the ratio of sodium calcium silicate and polyvinyl alcohol, and the apatite-formation ability of the scaffolds was examined by soaking them in a simulated body fluid. The results revealed the formation of hydroxyapatite on the surface of the scaffold after 5 days, which is found to be rapid when compared with the bioactivity of the calcium silicates and calcium magnesium silicates. The scaffolds were also loaded with ciprofloxacin as a model drug and analyzed for its drug release profile using UV spectrophotometer. The release profile did not vary with the change in bioceramic-to-biopolymer ratio, and 60% of the drug was released in 10 days, which is within the appreciable range for a targeted drug delivery system. Moreover, the experimental and simulated values of the release kinetics were compared by applying the existing mathematical model.
C1 [Lakshmi, Ravy; Sasikumar, Swamiappan] VIT Univ, Sch Adv Sci, Mat Chem Div, Vellore 632014, Tamil Nadu, India.
   [Reddy, P. Manohar; Dass, Febin Prabhu] VIT Univ, Sch Biosci & Technol, Bioinformat Div, Vellore 632014, Tamil Nadu, India.
RP Sasikumar, S (reprint author), VIT Univ, Sch Adv Sci, Mat Chem Div, Vellore 632014, Tamil Nadu, India.
EM ssasikumar@vit.ac.in
RI Swamiappan, Sasikumar/M-9921-2016
OI Swamiappan, Sasikumar/0000-0003-2533-4923
FU VIT University
FX The authors thank the administration of VIT University for providing
   financial support. The authors express their sincerest gratitude to
   Prof. R. Vijayaraghavan, Assistant Director, Centre for Excellence in
   Nanomaterials, VIT University, for his continuous support and
   motivation.
CR BARRY BW, 1979, INT J PHARMACEUT, V2, P1, DOI 10.1016/0378-5173(79)90025-5
   Colilla M, 2008, INT J NANOMED, V3, P403
   Enescu D, 2008, CHEM ENG COMMUN, V195, P1269, DOI 10.1080/00986440801958808
   Grassi Mario, 2005, Current Drug Delivery, V2, P97, DOI 10.2174/1567201052772906
   Huang XH, 2009, MATER CHEM PHYS, V115, P1, DOI 10.1016/j.matchemphys.2008.11.066
   Husseini GA, 2000, J CONTROL RELEASE, V69, P43, DOI 10.1016/S0168-3659(00)00278-9
   Husseini GA, 2002, J CONTROL RELEASE, V83, P303, DOI 10.1016/S0168-3659(02)00203-1
   Kashiwazaki H, 2013, J HARD TISSUE BIOL, V22, P337, DOI 10.2485/jhtb.22.337
   Li HY, 2005, J CONTROL RELEASE, V107, P463, DOI 10.1016/j.jconrel.2005.05.019
   Liu XY, 2004, BIOMATERIALS, V25, P1755, DOI 10.1016/j.biomaterials.2003.08.024
   Lopez T, 2011, MATER CHEM PHYS, V126, P922, DOI 10.1016/j.matchemphys.2010.12.011
   Mastrogiacomo M, 2006, BIOMATERIALS, V27, P3230, DOI 10.1016/j.biomaterials.2006.01.031
   Mendez FB, 2011, CERAM INT, V37, P2445
   Perdomo MM, 2009, ACTA BIOMATER, V5, P3057
   Sasikumar S, 2010, J MATER SCI TECHNOL, V26, P1114, DOI 10.1016/S1005-0302(11)60010-8
   Shukla AK, 1996, MAT SCI ENG B-SOLID, V40, P153, DOI 10.1016/0921-5107(96)01651-0
   Siepmann J, 2008, INT J PHARMACEUT, V364, P328, DOI 10.1016/j.ijpharm.2008.09.004
   Singh V, 2008, J LUMIN, V128, P583, DOI 10.1016/j.jlumin.2007.08.014
   Sivakumar M, 2002, BIOMATERIALS, V23, P3175, DOI 10.1016/S0142-9612(02)00066-2
   Tang HY, 2011, INT J PHARMACEUT, V421, P388, DOI 10.1016/j.ijpharm.2011.10.013
   Wang JL, 2012, INT J ANTIMICROB AG, V40, P103, DOI 10.1016/j.ijantimicag.2012.03.010
   Xina R, 2005, BIOMATERIALS, V26, P6477
   Yumoto A, 2011, SCI ENG COMPOS MATER, V18, P265, DOI 10.1515/SECM.2011.051
   Zhao Y, 2009, J SOL-GEL SCI TECHN, V52, P170
   Zhu M, 2011, BIOMATERIALS, V32, P1986, DOI 10.1016/j.biomaterials.2010.11.025
NR 25
TC 0
Z9 0
U1 4
U2 16
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0792-1233
EI 2191-0359
J9 SCI ENG COMPOS MATER
JI Sci. Eng. Compos. Mater.
PD JUL
PY 2016
VL 23
IS 4
BP 375
EP 380
DI 10.1515/secm-2014-0057
PG 6
WC Materials Science, Composites
SC Materials Science
GA DQ9FL
UT WOS:000379515700004
DA 2018-10-20
ER

PT J
AU Khanlou, HM
   Ang, BC
   Barzani, MM
AF Khanlou, Hossein Mohammad
   Ang, Bee Chin
   Barzani, Mohsen Marani
TI Prediction, modeling and characterization of surface texturing by
   sulfuric etchant on nontoxic titanium bio-material using artificial
   neural networks and fuzzy logic systems
SO SCIENCE AND ENGINEERING OF COMPOSITE MATERIALS
LA English
DT Article
DE acid etching; artificial neural networks; characterization; fuzzy logic;
   prediction
ID LID-DRIVEN CAVITY; INFERENCE SYSTEM; ROUGHNESS; ACID; BONE; ANFIS;
   IMPLANTS; WETTABILITY; BIOMATERIAL; TEMPERATURE
AB Multilayer feed forward network, radial biased function network, generalized regression neural network and adaptive network-based fuzzy inference system (ANFIS) were used to predict the surface roughness of Ti-13Zr-13Nb alloy in etching sulfuric acid. Subsequent processes - polishing, sandblasting and acid etching or SLA - were employed to modify the surface. Alumina particles for surface blasting and concentrated sulfuric acid for acid etching were utilized in this experiment. This was performed for three different periods of time (10, 20 and 30 s) and temperature (25, 45 and 60 degrees C). Correspondingly, the Ti-13Zr-13Nb surfaces were evaluated using a field emission scanning electron microscope for roughening and a contact mode profilometer for the average surface roughness (Ra) (nm). Different configurations of neural networks and ANFIS approaches are examined in order to minimize the root mean square error. Consequently, the ANFIS model is selected by dividing the time and temperature into one and three spaces, respectively, using the Gaussian-shaped membership function. A mathematical model is attained from the best approach in terms of root mean square error to realize the relation of the surface roughness of Ti-13Zr-13Nb alloy in etching sulfuric acid and time and temperature as the effective parameters.
C1 [Khanlou, Hossein Mohammad; Ang, Bee Chin; Barzani, Mohsen Marani] Univ Malaya, Dept Mech Engn, Ctr Adv Mat, Kuala Lumpur 50603, Malaysia.
RP Khanlou, HM (reprint author), Univ Malaya, Dept Mech Engn, Ctr Adv Mat, Kuala Lumpur 50603, Malaysia.
EM khanlou2@gmail.com
RI Ang, Bee Chin/B-8227-2010
OI Mohammad Khanlou, Hossein/0000-0003-0896-1714
FU University of Malaya [UMRG_RP022-13AET, FRGS-FP048-2013B]; Postgraduate
   Research Grant (PPP) Program [PG016-2013A]
FX The authors would like to thank the University of Malaya for the
   financial support through the following grants: nos. UMRG_RP022-13AET,
   FRGS-FP048-2013B and Postgraduate Research Grant (PPP) Program No.
   PG016-2013A.
CR Al Jabbari YS, 2012, DENT MATER J, V31, P249, DOI 10.4012/dmj.2011-210
   Aminossadati SM, 2012, INT J THERM SCI, V52, P102, DOI 10.1016/j.ijthermalsci.2011.09.004
   Arlin ML, 2007, J CAN DENT ASSOC, V73, P821
   Azwadi CSN, 2013, NUMER HEAT TR A-APPL, V63, P906, DOI 10.1080/10407782.2013.757154
   Bagno A, 2004, J MATER SCI-MATER M, V15, P935, DOI 10.1023/B:JMSM.0000042679.28493.7f
   Ban S, 2006, DENT MATER, V22, P1115, DOI 10.1016/j.dental.2005.09.007
   Barranco V, 2010, SURF COAT TECH, V204, P3783, DOI 10.1016/j.surfcoat.2010.04.051
   Boyan B. D., 2001, TITANIUM MED, P561
   Carvalho Daniel Rey de, 2010, Braz. Dent. J., V21, P3, DOI 10.1590/S0103-64402010000100001
   Chrcanovic BR, 2013, MATER RES-IBERO-AM J, V16, P1006, DOI [10.1590/S1516-14392013000500008, 10.1590/S1516-14392013005000067]
   Coelho PG, 2009, J BIOMED MATER RES B, V88B, P579, DOI 10.1002/jbm.b.31264
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   Elias CN, 2008, J MECH BEHAV BIOMED, V1, P234, DOI 10.1016/j.jmbbm.2007.12.002
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Herrero-Climent M, 2013, J AM CERAM SOC, P1
   JANG JSR, 1993, IEEE T SYST MAN CYB, V23, P665, DOI 10.1109/21.256541
   Khanlou HM, 2014, NEURAL COMPUT APPL, P1
   KHANLOU HM, 2012, AUST J BASIC APPL SC, V6, P307
   KHANLOU HM, 2012, AUST J BASIC APPL SC, V6, P125
   Kieswetter K, 1996, CRIT REV ORAL BIOL M, V7, P329, DOI 10.1177/10454411960070040301
   Lim YJ, 2001, INT J ORAL MAX IMPL, V16, P333
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Mohanraj M, 2012, RENEW SUST ENERG REV, V16, P1340, DOI 10.1016/j.rser.2011.10.015
   Nazari A, 2012, APPL MATH MODEL, V36, P3903, DOI 10.1016/j.apm.2011.11.032
   Orsini G, 2000, INT J ORAL MAX IMPL, V15, P779
   Patil PP, 2012, EXPERT SYST APPL, V39, P5019, DOI 10.1016/j.eswa.2011.10.010
   Pelaez-Abellan E, 2012, MATER RES-IBERO-AM J, V15, P159, DOI [10.1590/S1516-14392012000100022, 10.1590/S1516-14392012005000002]
   Pereira K, 2010, BRAZ DENT J, V21, P371
   Rupp F, 2004, BIOMATERIALS, V25, P1429, DOI 10.1016/j.biomaterials.2003.08.015
   Schneider GB, 2003, J DENT RES, V82, P372, DOI 10.1177/154405910308200509
   Suganthi XH, 2013, INT J ADV MANUF TECH, V68, P339, DOI 10.1007/s00170-013-4731-5
   Szmukler-Moncler S, 2004, J BIOMED MATER RES B, V69B, P46, DOI 10.1002/jbm.b.20021
   Szmukler-Moncler S, 2004, J BIOMED MATER RES B, V68B, P149, DOI 10.1002/jbm.b.20003
   TAKAGI T, 1985, IEEE T SYST MAN CYB, V15, P116, DOI 10.1109/TSMC.1985.6313399
   Terzi S, 2013, ADV ENG SOFTW, V57, P59, DOI 10.1016/j.advengsoft.2012.11.013
   Wennerberg A, 2009, CLIN ORAL IMPLAN RES, V20, P172, DOI 10.1111/j.1600-0501.2009.01775.x
   WONG M, 1995, J BIOMED MATER RES, V29, P1567, DOI 10.1002/jbm.820291213
   Zaleska A., 2008, RECENT PAT ENG, V2, P157, DOI DOI 10.2174/187221208786306289
   Zareidoost A, 2012, J MATER SCI-MATER M, V23, P1479, DOI 10.1007/s10856-012-4611-9
   Zeinali M, 2013, SMART MAT STRUCT, P22
NR 41
TC 2
Z9 2
U1 0
U2 8
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0792-1233
EI 2191-0359
J9 SCI ENG COMPOS MATER
JI Sci. Eng. Compos. Mater.
PD JUL
PY 2016
VL 23
IS 4
BP 423
EP 433
DI 10.1515/secm-2014-0230
PG 11
WC Materials Science, Composites
SC Materials Science
GA DQ9FL
UT WOS:000379515700011
DA 2018-10-20
ER

PT J
AU Federico, S
   Nochel, U
   Lowenberg, C
   Lendlein, A
   Neffe, AT
AF Federico, Stefania
   Noechel, Ulrich
   Loewenberg, Candy
   Lendlein, Andreas
   Neffe, Axel T.
TI Supramolecular hydrogel networks formed by molecular recognition of
   collagen and a peptide grafted to hyaluronic acid
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Biopolymers; Collagen-binding peptide; Hyaluronic acid; Hydrogels;
   Mechanical properties
ID MECHANICAL-PROPERTIES; EXTRACELLULAR-MATRIX; FUNCTIONALIZED DERIVATIVES;
   CHONDROITIN SULFATE; FIBRIL FORMATION; BROAD RANGE; DECORIN; BINDING;
   CARTILAGE; BIOMATERIALS
AB The extracellular matrix (ECM) is a nano-structured, highly complex hydrogel, in which the macromolecules are organized primarily by non-covalent interactions. Here, in a biomimetic approach, the decorin-derived collagen-binding peptide LSELRLHNN was grafted to hyaluronic acid (HA) in order to enable the formation of a supramolecular hydrogel network together with collagen. The storage modulus of a mixture of collagen and HA was increased by more than one order of magnitude (G' = 157 Pa) in the presence of the HA-grafted peptide compared to a mixture of collagen and HA (G' = 6 Pa). The collagen fibril diameter was decreased, as quantified using electron microscopy, in the presence of the HA-grafted peptide. Here, the peptide mimicked the function of decorin by spatially organizing collagen. The advantage of this approach is that the non-covalent crosslinks between collagen molecules and the HA chains created by the peptide form a reversible and dynamic hydrogel, which could be employed for a diverse range of applications in regenerative medicine.
   Statement of Significance
   Biopolymers of the extracellular matrix (ECM) like collagen or hyaluronan are attractive starting materials for biomaterials. While in biomaterial science covalent crosslinking is often employed, in the native ECM, stabilization and macromolecular organization is primarily based on non-covalent interactions, which allows dynamic changes of the materials. Here, we show that collagen-binding peptides, derived from the small proteoglycan decorin, grafted to hyaluronic acid enable supramolecular stabilization of collagen hydrogels. These hydrogels have storage moduli more than one order of magnitude higher than mixtures of collagen and hyaluronic acid. Furthermore, the peptide supported the structural organization of collagen. Such hydrogels could be employed for a diverse range of applications in regenerative medicine. Furthermore, the rational design helps in the understanding ECM structuring. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Federico, Stefania; Noechel, Ulrich; Loewenberg, Candy; Lendlein, Andreas; Neffe, Axel T.] Helmholtz Zentrum Geesthacht, Inst Biomat Sci, Kantstr 55, D-14513 Teltow, Germany.
   [Federico, Stefania; Noechel, Ulrich; Loewenberg, Candy; Lendlein, Andreas; Neffe, Axel T.] Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies BCRT, Kantstr 55, D-14513 Teltow, Germany.
   [Federico, Stefania; Loewenberg, Candy; Lendlein, Andreas; Neffe, Axel T.] Univ Potsdam, Inst Chem, D-14476 Potsdam, Germany.
RP Neffe, AT (reprint author), Helmholtz Zentrum Geesthacht, Inst Biomat Sci, Kantstr 55, D-14513 Teltow, Germany.; Neffe, AT (reprint author), Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies BCRT, Kantstr 55, D-14513 Teltow, Germany.
EM stefania.federico@crick.ac.uk; ulrich.noechel@hzg.de;
   candy.loewenberg@hzg.de; andreas.lendlein@hzg.de; axel.neffe@hzg.de
RI Lendlein, Andreas/K-9553-2013; Neffe, Axel/H-6997-2013
OI Lendlein, Andreas/0000-0003-4126-4670; Neffe, Axel/0000-0002-5056-3990
FU Helmholtz Association
FX This work was funded by the Helmholtz Association. The funding agency
   did not participate in the study design, the collection, analysis or
   interpretation of data, writing of the report or in the decision to
   submit the paper for publication. The authors thank Michael Schossig and
   Yvonne Pieper for the SEM images and discussion of the analysis, Heike
   Schmidt for help with sample preparation and rheological measurements,
   and Karola Luetzow for additional synthesis.
CR Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   BANNISTER DW, 1969, BIOCHEM J, V113, P419, DOI 10.1042/bj1130419
   BAX A, 1989, ANNU REV BIOCHEM, V58, P223
   Bulpitt P, 1999, J BIOMED MATER RES, V47, P152
   de Wild M, 2013, BIOPHYS J, V105, P200, DOI 10.1016/j.bpj.2013.05.035
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Federico S, 2015, ANGEW CHEM INT EDIT, V54, P10980, DOI 10.1002/anie.201505227
   Gehnan R. A., 1979, J BIOL CHEM, V254, P180
   GELMAN RA, 1980, J BIOL CHEM, V255, P8098
   Ghosh K, 2005, BIOMACROMOLECULES, V6, P2857, DOI 10.1021/bm050361c
   Greene GW, 2012, SOFT MATTER, V8, P9906, DOI 10.1039/c2sm26330k
   Haxaire K, 2003, BIOPOLYMERS, V72, P10, DOI 10.1002/bip.10245
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   Kochhar A, 2014, JAMA FACIAL PLAST SU, V16, P405, DOI 10.1001/jamafacial.2014.480
   Kogan G, 2007, BIOTECHNOL LETT, V29, P17, DOI 10.1007/s10529-006-9219-z
   LAURENT TC, 1992, FASEB J, V6, P2397
   Maxwell CA, 2006, BIOMACROMOLECULES, V7, P2321, DOI 10.1021/bm060250t
   NAKAJIMA N, 1995, BIOCONJUGATE CHEM, V6, P123, DOI 10.1021/bc00031a015
   Neffe AT, 2004, ANGEW CHEM INT EDIT, V43, P2937, DOI 10.1002/anie.200353271
   Neffe AT, 2013, EXPERT REV MED DEVIC, V10, P813, DOI 10.1586/17434440.2013.839209
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   Orgel JPRO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007028
   Paderi JE, 2008, BIOMACROMOLECULES, V9, P2562, DOI 10.1021/bm8006852
   Pins GD, 1997, BIOPHYS J, V73, P2164, DOI 10.1016/S0006-3495(97)78247-X
   POUYANI T, 1994, BIOCONJUGATE CHEM, V5, P339, DOI 10.1021/bc00028a010
   Riesle J, 1998, J CELL BIOCHEM, V71, P313, DOI 10.1002/(SICI)1097-4644(19981201)71:3<313::AID-JCB1>3.0.CO;2-C
   Schante CE, 2011, CARBOHYD POLYM, V85, P469, DOI 10.1016/j.carbpol.2011.03.019
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   SCHONHERR E, 1995, J BIOL CHEM, V270, P8877, DOI 10.1074/jbc.270.15.8877
   Scott PG, 2004, P NATL ACAD SCI USA, V101, P15633, DOI 10.1073/pnas.0402976101
   Segura T, 2005, BIOMATERIALS, V26, P359, DOI 10.1016/j.biomaterials.2004.02.067
   Servaty R, 2001, INT J BIOL MACROMOL, V28, P121, DOI 10.1016/S0141-8130(00)00161-6
   Sharma S, 2013, ACTA BIOMATER, V9, P4618, DOI 10.1016/j.actbio.2012.08.041
   Spencer NJ, 2008, BIOMATERIALS, V29, P1028, DOI 10.1016/j.biomaterials.2007.11.006
   Strauss E, 2009, AM J SPORT MED, V37, P720, DOI 10.1177/0363546508328415
   TANIOKA A, 1976, BIOPOLYMERS, V15, P1505, DOI 10.1002/bip.1976.360150806
   Tenni R, 2002, EUR J BIOCHEM, V269, P1428, DOI 10.1046/j.1432-1033.2002.02784.x
   WEINER S, 1980, NATURE, V287, P820, DOI 10.1038/287820a0
   Yang YL, 2011, BIOMATERIALS, V32, P7932, DOI 10.1016/j.biomaterials.2011.07.018
   Yang YL, 2009, BIOPHYS J, V96, P1566, DOI [10.1016/j.bpj.2008.10.063, 10.1016/j.bpj.20()8.10.063]
NR 40
TC 5
Z9 5
U1 10
U2 79
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL 1
PY 2016
VL 38
BP 1
EP 10
DI 10.1016/j.actbio.2016.04.018
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DQ1LZ
UT WOS:000378963800001
PM 27090592
DA 2018-10-20
ER

PT J
AU Winter, CC
   Katiyar, KS
   Hernandez, NS
   Song, YJ
   Struzyna, LA
   Harris, JP
   Cullen, DK
AF Winter, Carla C.
   Katiyar, Kritika S.
   Hernandez, Nicole S.
   Song, Yeri J.
   Struzyna, Laura A.
   Harris, James P.
   Cullen, D. Kacy
TI Transplantable living scaffolds comprised of micro-tissue engineered
   aligned astrocyte networks to facilitate central nervous system
   regeneration
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Tissue engineering; Living scaffold; Glial cell transplant;
   Biomaterials; Regeneration; Neurotrauma; Neurodegeneration; Traumatic
   brain injury; Cell migration; Axon pathfinding; Neural stem cells
ID SPINAL-CORD-INJURY; ROSTRAL MIGRATORY STREAM; NEURAL STEM-CELLS; NEURITE
   OUTGROWTH; IN-VITRO; SUBSTRATE CURVATURE; SUBVENTRICULAR ZONE; NEURONAL
   MIGRATION; BRAIN-INJURY; TRACT AXONS
AB Neurotrauma, stroke, and neurodegenerative disease may result in widespread loss of neural cells as well as the complex interconnectivity necessary for proper central nervous system function, generally resulting in permanent functional deficits. Potential regenerative strategies involve the recruitment of endogenous neural stem cells and/or directed axonal regeneration through the use of tissue engineered "living scaffolds" built to mimic features of three-dimensional (3-D) in vivo migratory or guidance pathways. Accordingly, we devised a novel biomaterial encasement scheme using tubular hydrogel-collagen micro-columns that facilitated the self-assembly of seeded astrocytes into 3-D living scaffolds consisting of long, cable-like aligned astrocytic networks. Here, robust astrocyte alignment was achieved within a micro-column inner diameter (ID) of 180 mu m or 300-350 mu m but not 1.0 mm, suggesting that radius of curvature dictated the extent of alignment. Moreover, within small ID micro-columns, >70% of the astrocytes assumed a bi-polar morphology, versus similar to 10% in larger micro-columns or planar surfaces. Cell-cell interactions also influenced the aligned architecture, as extensive astrocyte-collagen contraction was achieved at high (9-12 x 10(5) cells/mL) but not lower (2-6 x 10(5) cells/mL) seeding densities. This high density micro-column seeding led to the formation of ultra-dense 3-D "bundles" of aligned bi-polar astrocytes within collagen measuring up to 150 mu m in diameter yet extending to a remarkable length of over 2.5 cm. Importantly, co-seeded neurons extended neurites directly along the aligned astrocytic bundles, demonstrating permissive cues for neurite extension. These transplantable cable-like astrocytic networks structurally mimic the glial tube that guides neuronal progenitor migration in vivo along the rostral migratory stream, and therefore may be useful to guide progenitor cells to repopulate sites of widespread neurodegeneration.
   Statement of Significance
   This manuscript details our development of novel micro-tissue engineering techniques to generate robust networks of longitudinally aligned astrocytes within transplantable micro-column hydrogels. We report a novel biomaterial encasement scheme that facilitated the self-assembly of seeded astrocytes into long, aligned regenerative pathways. These miniature "living scaffold" constructs physically emulate the glial tube - a pathway in the brain consisting of aligned astrocytes that guide the migration of neuronal progenitor cells - and therefore may facilitate directed neuronal migration for central nervous system repair. The small size and self-contained design of these aligned astrocyte constructs will permit minimally invasive transplantation in models of central nervous system injury in future studies. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Winter, Carla C.; Katiyar, Kritika S.; Hernandez, Nicole S.; Song, Yeri J.; Struzyna, Laura A.; Harris, James P.; Cullen, D. Kacy] Univ Penn, Perelman Sch Med, Ctr Brain Injury & Repair, Dept Neurosurg, Philadelphia, PA 19104 USA.
   [Winter, Carla C.; Struzyna, Laura A.] Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, Philadelphia, PA 19104 USA.
   [Winter, Carla C.; Katiyar, Kritika S.; Struzyna, Laura A.; Harris, James P.; Cullen, D. Kacy] Philadelphia Vet Affairs Med Ctr, Philadelphia, PA USA.
   [Katiyar, Kritika S.] Drexel Univ, Sch Biomed Engn, Philadelphia, PA 19104 USA.
   [Hernandez, Nicole S.; Song, Yeri J.; Cullen, D. Kacy] Univ Penn, Perelman Sch Med, Neurosci Grad Grp, Philadelphia, PA 19104 USA.
RP Cullen, DK (reprint author), 105E Hayden Hall 3320 Smith Walk, Philadelphia, PA 19104 USA.
EM dkacy@mail.med.upenn.edu
FU Penn Medicine Neuroscience Center; National Science Foundation
   [DGE-1321851]; National Institutes of Health [T32-NS043126,
   F31-NS090746]; Michael J. Fox Foundation (Therapeutic Pipeline Program)
   [9998]; Department of Veterans Affairs (RRD Merit Review) [B1097-I];
   U.S. Army Medical Research and Materiel Command through the Joint
   Warfighter Medical Research Program [W81XWH-13-207004]; Penn's Center
   for Undergraduate Research Fellowships
FX Financial support was provided by the Penn Medicine Neuroscience Center,
   National Science Foundation (Graduate Research Fellowship DGE-1321851),
   National Institutes of Health (T32-NS043126; F31-NS090746), Michael J.
   Fox Foundation (Therapeutic Pipeline Program #9998), Department of
   Veterans Affairs (RR&D Merit Review #B1097-I), U.S. Army Medical
   Research and Materiel Command through the Joint Warfighter Medical
   Research Program (#W81XWH-13-207004), and Penn's Center for
   Undergraduate Research & Fellowships. We thank Patricia Murphy for
   technical assistance in these studies.
CR Abematsu M., 2012, J CLIN INVEST, P3255
   Alexander JK, 2006, NEURON GLIA BIOL, V2, P93, DOI 10.1017/S1740925X0600010X
   Alonso M, 2008, J NEUROSCI, V28, P11089, DOI 10.1523/JNEUROSCI.3713-08.2008
   Arellano JI, 2011, NATURE, V478, P333, DOI 10.1038/478333a
   Aubin H, 2010, BIOMATERIALS, V31, P6941, DOI 10.1016/j.biomaterials.2010.05.056
   Barry DS, 2013, J ANAT, V222, P203, DOI 10.1111/joa.12006
   Biran R, 2003, EXP NEUROL, V184, P141, DOI 10.1016/S0014-4886(03)00253-X
   Bonfanti L, 2007, PROG NEUROBIOL, V83, P24, DOI 10.1016/j.pneurobio.2006.11.002
   Bradbury EJ, 2011, BRAIN RES BULL, V84, P306, DOI 10.1016/j.brainresbull.2010.06.015
   Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034
   Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3
   Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008
   Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C
   Cullen DK, 2007, J NEUROSCI RES, V85, P3642, DOI 10.1002/jnr.21434
   Cullen DK, 2012, TISSUE ENG PT A, V18, P2280, DOI [10.1089/ten.TEA.2011.0534, 10.1089/ten.tea.2011.0534]
   Cullen D. Kacy, 2011, Critical Reviews in Biomedical Engineering, V39, P201
   Cullen D. Kacy, 2011, Critical Reviews in Biomedical Engineering, V39, P241
   Cullen DK, 2010, BRAIN RES, V1359, P44, DOI 10.1016/j.brainres.2010.08.058
   DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034
   East E, 2010, TISSUE ENG PT A, V16, P3173, DOI 10.1089/ten.tea.2010.0017
   Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6
   Granger N, 2012, BRAIN, V135, P3227, DOI 10.1093/brain/aws268
   Gros T, 2010, BIOMATERIALS, V31, P6719, DOI 10.1016/j.biomaterials.2010.04.035
   Harris JP, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/1/016019
   HATTEN ME, 1990, EXPERIENTIA, V46, P907, DOI 10.1007/BF01939383
   Houle JD, 2006, J NEUROSCI, V26, P7405, DOI 10.1523/JNEUROSCI.1166-06.2006
   Hsiao TW, 2015, BIOMATERIALS, V39, P124, DOI 10.1016/j.biomaterials.2014.10.062
   Huang JH, 2009, TISSUE ENG PT A, V15, P1677, DOI 10.1089/ten.tea.2008.0294
   Irons HR, 2008, J NEURAL ENG, V5, P333, DOI 10.1088/1741-2560/5/3/006
   JOOSTEN EAJ, 1989, NEUROSCIENCE, V31, P439, DOI 10.1016/0306-4522(89)90386-2
   Katiyar K. S., 2016, J TISSUE EN IN PRESS
   Kawano H, 2012, CELL TISSUE RES, V349, P169, DOI 10.1007/s00441-012-1336-5
   KIM SU, 1983, BRAIN RES, V274, P79, DOI 10.1016/0006-8993(83)90522-X
   Ladewig J, 2014, NAT NEUROSCI, V17, P24, DOI 10.1038/nn.3583
   LaPlaca MC, 2010, ARTECH HSE METH BIOE, P187
   Lu P, 2014, NEURON, V83, P789, DOI 10.1016/j.neuron.2014.07.014
   Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020
   McCarthy M. D., 1980, J CELL BIOL, V85, P890
   MORRISON RS, 1981, P NATL ACAD SCI-BIOL, V78, P7205, DOI 10.1073/pnas.78.11.7205
   NEUGEBAUER KM, 1988, J CELL BIOL, V107, P1177, DOI 10.1083/jcb.107.3.1177
   Peretto P, 1997, BRAIN RES BULL, V42, P9, DOI 10.1016/S0361-9230(96)00116-5
   REIER PJ, 1979, BRAIN RES, V164, P61, DOI 10.1016/0006-8993(79)90006-4
   Rivet Christopher J, 2015, Biomatter, V5, pe1005527, DOI 10.1080/21592535.2015.1005527
   Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487
   Shear DA, 2011, RESTOR NEUROL NEUROS, V29, P215, DOI 10.3233/RNN-2011-0593
   Smeal RM, 2005, ANN BIOMED ENG, V33, P376, DOI 10.1007/s10439-005-1740-z
   Smeal RM, 2008, EXP NEUROL, V213, P281, DOI 10.1016/j.expneurol.2008.05.026
   SMITH GM, 1986, J COMP NEUROL, V251, P23, DOI 10.1002/cne.902510103
   Sofroniew MV, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020420
   STOPAK D, 1982, DEV BIOL, V90, P383, DOI 10.1016/0012-1606(82)90388-8
   Struzyna LA, 2015, TISSUE ENG PT A, V21, P2744, DOI [10.1089/ten.tea.2014.0557, 10.1089/ten.TEA.2014.0557]
   Struzyna LA, 2015, NEURAL REGEN RES, V10, P679, DOI 10.4103/1673-5374.156943
   Struzyna LA, 2014, CURR OPIN SOLID ST M, V18, P308, DOI 10.1016/j.cossms.2014.07.004
   Thompson L. H., 2015, NEUROBIOL DIS, P28
   Wang CM, 2011, CELL RES, V21, P1534, DOI 10.1038/cr.2011.83
   Zukor KA, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-1
NR 56
TC 18
Z9 18
U1 5
U2 47
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL 1
PY 2016
VL 38
BP 44
EP 58
DI 10.1016/j.actbio.2016.04.021
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DQ1LZ
UT WOS:000378963800005
PM 27090594
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Beck, EC
   Barragan, M
   Tadros, MH
   Gehrke, SH
   Detamore, MS
AF Beck, Emily C.
   Barragan, Marilyn
   Tadros, Madeleine H.
   Gehrke, Stevin H.
   Detamore, Michael S.
TI Approaching the compressive modulus of articular cartilage with a
   decellularized cartilage-based hydrogel
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Decellularized cartilage; Hydrogel; Compressive modulus
ID EXTRACELLULAR-MATRIX; CROSS-LINKING; TISSUE; CHONDROCYTES; SCAFFOLDS;
   DIFFERENTIATION; REGENERATION; FABRICATION; CONSTRUCTS; REPAIR
AB ECM-based materials are appealing for tissue engineering strategies because they may promote stem cell recruitment, cell infiltration, and cell differentiation without the need to supplement with additional biological factors. Cartilage ECM has recently shown potential to be chondroinductive, particularly in a hydrogel-based system, which may be revolutionary in orthopedic medicine. However, hydrogels composed of natural materials are often mechanically inferior to synthetic materials, which is a major limitation for load-bearing tissue applications. The objective was therefore to create an unprecedented hydrogel derived entirely from native cartilage ECM that was both mechanically more similar to native cartilage tissue and capable of inducing chondrogenesis. Porcine cartilage was decellularized, solubilized, and then methacrylated and UV photocrosslinked to create methacrylated solubilized decellularized cartilage (MeSDCC) gels. Methacrylated gelatin (GelMA) was employed as a control for both biomechanics and bioactivity. Rat bone marrow-derived mesenchymal stem cells were encapsulated in these networks, which were cultured in vitro for 6 weeks, where chondrogenic gene expression, the compressive modulus, swelling, and histology were analyzed. One day after crosslinking, the elastic compressive modulus of the 20% MeSDCC gels was 1070 +/- 150 kPa. Most notably, the stress strain profile of the 20% MeSDCC gels fell within the 95% confidence interval range of native porcine cartilage. Additionally, MeSDCC gels significantly upregulated chondrogenic genes compared to GelMA as early as day 1 and supported extensive matrix synthesis as observed histologically. Given that these gels approached the mechanics of native cartilage tissue, supported matrix synthesis, and induced chondrogenic gene expression, MeSDCC hydro gels may be promising materials for cartilage tissue engineering applications. Future efforts will focus on improving fracture mechanics as well to benefit overall biomechanical performance.
   Statement of Significance
   Extracellular matrix (ECM)-based materials are appealing for tissue engineering strategies because they may promote stem cell recruitment, cell infiltration, and cell differentiation without the need to supplement with additional biological factors. One such ECM-based material, cartilage ECM, has recently shown potential to be chondroinductive; however, hydrogels composed of natural materials are often mechanically inferior to synthetic materials, which is a major limitation for load-bearing tissue applications. Therefore, this work is significant because we were the first to create hydrogels derived entirely from cartilage ECM that had mechanical properties similar to that of native cartilage until hydrogel failure. Furthermore, these hydrogels had a compressive modulus of 1070 +/- 150 kPa, they were chondroinductive, and they supported extensive matrix synthesis. In the current study, we have shown that these new hydrogels may prove to be a promising biomaterial for cartilage tissue engineering applications (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Beck, Emily C.] Univ Kansas, Med Ctr, Dept Surg, Kansas City, KS 66160 USA.
   [Barragan, Marilyn] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA.
   [Tadros, Madeleine H.] Rice Univ, Dept Chem & Biomol Engn, Houston, TX 77005 USA.
   [Gehrke, Stevin H.; Detamore, Michael S.] Univ Kansas, Bioengn Program, Lawrence, KS 66045 USA.
   [Gehrke, Stevin H.; Detamore, Michael S.] Univ Kansas, Dept Chem & Petr Engn, 4163 Learned Hall,1530 W 15th St, Lawrence, KS 66045 USA.
RP Detamore, MS (reprint author), Univ Kansas, Dept Chem & Petr Engn, 4163 Learned Hall,1530 W 15th St, Lawrence, KS 66045 USA.
EM detamore@ku.edu
FU NIH [R01 DE022472, S10 RR024664]; NSF; Major Research Instrumentation
   Grant [0320648]; Kansas Bioscience Authority Rising Star Award
FX We gratefully acknowledge funding support from the NIH (R01 DE022472 to
   C.J.B, S10 RR024664), the NSF for a Graduate Research Fellowship (E.B.)
   and a Major Research Instrumentation Grant (0320648), and the Kansas
   Bioscience Authority Rising Star Award (M.D.). In addition, we are
   thankful for the help of Emi Kiyotake and Francisca Acosta with IHC and
   for the members of the KU Biomaterials and Tissue Engineering Lab who
   helped with porcine cartilage harvesting.
CR Adkisson HD, 2010, AM J SPORT MED, V38, P1324, DOI 10.1177/0363546510361950
   ARMSTRONG CG, 1982, J BONE JOINT SURG AM, V64, P88, DOI 10.2106/00004623-198264010-00013
   Athanasiou KA, 2013, ARTICULAR CARTILAGE, P1
   Beck E. C., 2015, ANN BIOMED ENG, P1
   Benders KEM, 2013, TRENDS BIOTECHNOL, V31, P169, DOI 10.1016/j.tibtech.2012.12.004
   Brigham MD, 2009, TISSUE ENG PT A, V15, P1645, DOI 10.1089/ten.tea.2008.0441
   Burdick JA, 2013, SCI TRANSL MED, V5, DOI DOI 10.1126/SCITRANSLMED.3003997
   Cha MH, 2013, TISSUE ENG PT A, V19, P978, DOI [10.1089/ten.tea.2012.0358, 10.1089/ten.TEA.2012.0358]
   Cheng NC, 2013, TISSUE ENG PT A, V19, P484, DOI [10.1089/ten.tea.2012.0384, 10.1089/ten.TEA.2012.0384]
   Cheng NC, 2011, REGEN MED, V6, P81, DOI [10.2217/rme.10.87, 10.2217/RME.10.87]
   Converse GL, 2012, ACTA BIOMATER, V8, P2722, DOI 10.1016/j.actbio.2012.03.047
   Decaris ML, 2012, TISSUE ENG PT A, V18, P2148, DOI [10.1089/ten.TEA.2011.0677, 10.1089/ten.tea.2011.0677]
   DeKosky BJ, 2010, TISSUE ENG PART C-ME, V16, P1533, DOI 10.1089/ten.tec.2009.0761
   Elisseeff J, 2005, Orthod Craniofac Res, V8, P150, DOI 10.1111/j.1601-6343.2005.00335.x
   Freytes DO, 2008, BIOMATERIALS, V29, P1630, DOI 10.1016/j.biomaterials.2007.12.014
   Garrigues N. W., 2014, J BIOMED MAT RES A
   Gershlak JR, 2013, BIOCHEM BIOPH RES CO, V439, P161, DOI 10.1016/j.bbrc.2013.08.074
   Huang CY, 2005, J BIOMECH, V38, P799, DOI 10.1016/j.jbiomech.2004.05.006
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Khanlari A, 2013, MACROMOLECULES, V46, P9609, DOI 10.1021/ma401838h
   Kheir E, 2011, J BIOMED MATER RES A, V99A, P283, DOI 10.1002/jbm.a.33171
   Kwon JS, 2013, INT J PHARMACEUT, V454, P183, DOI 10.1016/j.ijpharm.2013.06.023
   Levorson EJ, 2014, TISSUE ENG PART C-ME, V20, P358, DOI 10.1089/ten.tec.2013.0288
   Little CJ, 2011, TISSUE ENG PART B-RE, V17, P213, DOI [10.1089/ten.teb.2010.0572, 10.1089/ten.TEB.2010.0572]
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Mansour JM, 2003, KINESIOLOGY MECH PAT, P66
   McLennan A, 2012, BIOS INSTANT NOTES M
   Murphy L, 2012, AM J NURS, V112, pS13, DOI 10.1097/01.NAJ.0000412646.80054.21
   Renth AN, 2012, TISSUE ENG PART B-RE, V18, P341, DOI 10.1089/ten.teb.2012.0080
   Rowland CR, 2013, BIOMATERIALS, V34, P5802, DOI 10.1016/j.biomaterials.2013.04.027
   Schuurman W, 2013, MACROMOL BIOSCI, V13, P551, DOI 10.1002/mabi.201200471
   Schwarz S., 2012, J TISSUE ENG REGENER
   Schwarz S, 2012, TISSUE ENG PT A, V18, P2195, DOI [10.1089/ten.tea.2011.0705, 10.1089/ten.TEA.2011.0705]
   Seif-Naraghi SB, 2010, TISSUE ENG PT A, V16, P2017, DOI 10.1089/ten.TEA.2009.0768
   Seif-Naraghi SB, 2012, ACTA BIOMATER, V8, P3695, DOI 10.1016/j.actbio.2012.06.030
   Sridharan B., 2015, TISSUE ENG
   Sutherland AJ, 2015, ADV HEALTHC MATER, V4, DOI 10.1002/adhm.201400165
   Tatman P. D., 2015, TISSUE ENG
   Villanueva I, 2009, ACTA BIOMATER, V5, P2832, DOI 10.1016/j.actbio.2009.05.039
   Visser J, 2015, TISSUE ENG PT A, V21, P1195, DOI [10.1089/ten.tea.2014.0362, 10.1089/ten.TEA.2014.0362]
   Weiss P, 2010, BIOMEDICAL APPLICATIONS OF HYDROGELS HANDBOOK, P247, DOI 10.1007/978-1-4419-5919-5_13
   Xiao YH, 2013, TISSUE ENG PART B-RE, V19, P403, DOI [10.1089/ten.teb.2012.0461, 10.1089/ten.TEB.2012.0461]
   Yang ZQ, 2010, TISSUE ENG PART C-ME, V16, P865, DOI [10.1089/ten.tec.2009.0444, 10.1089/ten.TEC.2009.0444]
NR 43
TC 17
Z9 17
U1 9
U2 67
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL 1
PY 2016
VL 38
BP 94
EP 105
DI 10.1016/j.actbio.2016.04.019
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DQ1LZ
UT WOS:000378963800009
PM 27090590
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Pham, JT
   Xue, LJ
   del Campo, A
   Salierno, M
AF Pham, Jonathan T.
   Xue, Longjian
   del Campo, Aranzazu
   Salierno, Marcelo
TI Guiding cell migration with microscale stiffness patterns and undulated
   surfaces
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Cell migration; Migration efficiency; Stiffness patterns; Surface
   topography; Focal adhesions
ID CONTACT GUIDANCE; EXTRACELLULAR-MATRIX; MECHANICAL-PROPERTIES;
   ENDOTHELIAL-CELLS; SMOOTH-MUSCLE; ORIENTATION; SUBSTRATE; RIGIDITY;
   MOTILITY; ELASTICITY
AB By placing stiff structures under soft materials, prior studies have demonstrated that cells sense and prefer to position themselves over the stiff structures. However, an understanding of how cells migrate on such surfaces has not been established. Many studies have also shown that cells readily align to surface topography. Here we investigate the influence of these two aspects in directing cell migration on surfaces with 5 and 10 mu m line stiffness patterns (a cellular to subcellular length scale). A simple approach to create flat, stiffness-patterned surfaces by suspending a thin, low modulus polydimethylsiloxane (PDMS) film over a high modulus PDMS structure is presented, as well as a route to add undulations. We confirm that cells are able to sense through the thin film by observation of focal adhesions being positioned on stiff regions. We examine migration by introducing migration efficiency, a quantitative parameter to determine how strongly cells migrate in a certain direction. We found that cells have a preference to align and migrate along stiffness patterns while the addition of undulations boosts this effect, significantly increasing migration efficiency in either case. Interestingly, we found speed to play little role in the migration efficiency and to be mainly influenced by the top layer modulus. Our results demonstrate that both stiffness patterns and surface undulations are important considerations when investigating the interactions of cells with biomaterial surfaces.
   Statement of Significance
   Two common physical considerations for cell-surface interactions include patterned stiffness and patterned topography. However, their relative influences on cell migration behavior have not been established, particularly on cellular to subcellular scale patterns. For stiffness patterning, it has been recently shown that cells tend to position themselves over a stiff structure that is placed under a thin soft layer. By quantifying the directional migration efficiency on such surfaces with and without undulations, we show that migration can be manipulated by flat stiffness patterns, although surface undulations also play a strong role. Our results offer insight on the effect of cellular scale stiffness and topographical patterns on cell migration, which is critical for the development of fundamental cell studies and engineered implants. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Pham, Jonathan T.; Xue, Longjian; Salierno, Marcelo] Max Planck Inst Polymer Res, Ackermannweg 10, D-55128 Mainz, Germany.
   [del Campo, Aranzazu] INM Leibniz Inst New Mat, Campus D2 2, D-66123 Saarbrucken, Germany.
   [del Campo, Aranzazu] Univ Saarland, Campus D2 2, D-66123 Saarbrucken, Germany.
   [Salierno, Marcelo] Univ Buenos Aires, Dept Biol Chem, Sch Sci, IQUIBICEN CONICET,CABA, RA-1053 Buenos Aires, DF, Argentina.
RP Pham, JT; Salierno, M (reprint author), Max Planck Inst Polymer Res, Ackermannweg 10, D-55128 Mainz, Germany.
EM phamj@mpip-mainz.mpg.de; salierno@gmail.com
RI Xue, Longjian/B-4317-2010
OI Xue, Longjian/0000-0001-5512-747X; del Campo,
   Aranzazu/0000-0001-5725-2135
FU Alexander von Humboldt Foundation
FX J.T.P. is grateful for support from a fellowship granted by the
   Alexander von Humboldt Foundation. The authors thank K. Kiefer for help
   with cell experiments, R. Fuchs for help with AFM and B. Berninger for
   providing microscopy facilities.
CR Bai WB, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.066112
   Biela SA, 2009, ACTA BIOMATER, V5, P2460, DOI 10.1016/j.actbio.2009.04.003
   Buxboim A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194116
   Chao PHG, 2014, J MECH BEHAV BIOMED, V38, P232, DOI 10.1016/j.jmbbm.2014.01.008
   Chaudhuri O., 2014, NAT MAT, V13
   Chen EJ, 1996, IEEE T ULTRASON FERR, V43, P191, DOI 10.1109/58.484478
   Cortese B, 2009, ADV FUNCT MATER, V19, P2961, DOI 10.1002/adfm.200900918
   Cox TR, 2011, DIS MODEL MECH, V4, P165, DOI 10.1242/dmm.004077
   Dalton BA, 2001, J BIOMED MATER RES, V56, P195, DOI 10.1002/1097-4636(200108)56:2<195::AID-JBM1084>3.0.CO;2-7
   Davidson P, 2010, ACTA BIOMATER, V6, P2590, DOI 10.1016/j.actbio.2010.01.038
   Degand S, 2014, COLLOID SURFACE A, V442, P164, DOI 10.1016/j.colsurfa.2013.05.024
   Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041
   Driscoll MK, 2014, ACS NANO, V8, P3546, DOI 10.1021/nn406637c
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Evans ND, 2014, J MATER CHEM B, V2, P2345, DOI 10.1039/c3tb21604g
   Fraley SI, 2010, NAT CELL BIOL, V12, P598, DOI 10.1038/ncb2062
   Guvendiren M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1792
   Holthaus MG, 2012, ACTA BIOMATER, V8, P394, DOI 10.1016/j.actbio.2011.07.031
   Hu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104502
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Kim YT, 2008, BIOMATERIALS, V29, P3117, DOI 10.1016/j.biomaterials.2008.03.042
   Kishi K, 2014, DEV BIOL, V395, P299, DOI 10.1016/j.ydbio.2014.09.006
   Kobayashi M, 2015, BIOMATERIALS, V61, P75, DOI 10.1016/j.biomaterials.2015.05.023
   Koser DE, 2015, BIOPHYS J, V108, P2137, DOI 10.1016/j.bpj.2015.03.039
   Kraning-Rush CM, 2012, CELL ADHES MIGR, V6, P274, DOI 10.4161/cam.21076
   Kuo CHR, 2012, ADV MATER, V24, P6059, DOI 10.1002/adma.201202520
   Ladoux B, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/11/116601
   Lam MT, 2008, BIOMATERIALS, V29, P1705, DOI 10.1016/j.biomaterials.2007.12.010
   Leong WS, 2010, BIOCHEM BIOPH RES CO, V401, P287, DOI 10.1016/j.bbrc.2010.09.052
   Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j
   Liu Y, 2008, TRENDS BIOTECHNOL, V26, P201, DOI 10.1016/j.tibtech.2008.01.003
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Lopez JI, 2008, ONCOGENE, V27, P6981, DOI 10.1038/onc.2008.348
   Lovett M, 2010, ORGANOGENESIS, V6, P217, DOI [10.4161/org.6.4.13407, 10.4161/org6.4.13407]
   Lu Pengfei, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a005058
   Maloney JM, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.041923
   Merkel R, 2007, BIOPHYS J, V93, P3314, DOI 10.1529/biophysj.107.111328
   Mohammadi H, 2014, SOFT MATTER, V10, P408, DOI 10.1039/c3sm52729h
   Nicolas A, 2006, BIOPHYS J, V91, P61, DOI 10.1529/biophysj.105.077115
   Peyton SR, 2005, J CELL PHYSIOL, V204, P198, DOI 10.1002/jcp.20274
   Pholpabu P, 2015, BIOMATERIALS, V39, P164, DOI 10.1016/j.biomaterials.2014.10.078
   REPIN VS, 1984, ATHEROSCLEROSIS, V50, P35, DOI 10.1016/0021-9150(84)90006-6
   Saez A, 2007, P NATL ACAD SCI USA, V104, P8281, DOI 10.1073/pnas.0702259104
   Saito AC, 2014, BIOTECHNOL LETT, V36, P391, DOI 10.1007/s10529-013-1368-2
   Salierno MJ, 2016, BIOMATERIALS, V82, P113, DOI 10.1016/j.biomaterials.2015.12.001
   SHIRINSKY VP, 1989, J CELL BIOL, V109, P331, DOI 10.1083/jcb.109.1.331
   Style RW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3728
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   Teixeira AI, 2009, BIOMATERIALS, V30, P4567, DOI 10.1016/j.biomaterials.2009.05.013
   Trappmann B, 2012, NAT MATER, V11, P742, DOI 10.1038/NMAT3387
   Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859
   Uttayarat P, 2005, J BIOMED MATER RES A, V75A, P668, DOI 10.1002/jbm.a.30478
   van Kooten TG, 1998, J BIOMED MATER RES, V43, P1
   Versaevel M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1668
   Vincent LG, 2013, BIOTECHNOL J, V8, P472, DOI 10.1002/biot.201200205
   Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890
   Walboomers XF, 1999, J BIOMED MATER RES, V47, P204, DOI 10.1002/(SICI)1097-4636(199911)47:2<204::AID-JBM10>3.0.CO;2-H
   Wang JHC, 2003, J BIOMECH, V36, P97, DOI 10.1016/S0021-9290(02)00233-6
   Yamaguchi H, 2005, CURR OPIN CELL BIOL, V17, P559, DOI 10.1016/j.ceb.2005.08.002
   Yeong WY, 2010, TISSUE ENG PART C-ME, V16, P1011, DOI [10.1089/ten.tec.2009.0604, 10.1089/ten.TEC.2009.0604]
NR 60
TC 5
Z9 5
U1 7
U2 58
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL 1
PY 2016
VL 38
BP 106
EP 115
DI 10.1016/j.actbio.2016.04.031
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DQ1LZ
UT WOS:000378963800010
PM 27109767
DA 2018-10-20
ER

PT J
AU Chou, SF
   Luo, LJ
   Lai, JY
AF Chou, Shih-Feng
   Luo, Li-Jyuan
   Lai, Jui-Yang
TI Gallic acid grafting effect on delivery performance and antiglaucoma
   efficacy of antioxidant-functionalized intracameral pilocarpine carriers
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Therapeutic delivery carrier; Intracameral pilocarpine administration;
   Antiglaucoma effects; Antioxidant-functionalized biomaterial; Grafting
   amount of gallic acid
ID ENDOTHELIAL-CELL DENSITY; OXIDATIVE STRESS; DRUG-DELIVERY;
   HYALURONIC-ACID; NITRIC-OXIDE; GLAUCOMA; GELATIN; SYSTEM; RELEASE;
   COPOLYMERIZATION
AB Functionalization of therapeutic carrier biomaterials can potentially provide additional benefits in drug delivery for disease treatment. Given that this modification determines final therapeutic efficacy of drug carriers, here, we investigate systematically the role of grafting amount of antioxidant gallic acid (GA) onto GN in situ gelling copolymers made of biodegradable gelatin and thermo-responsive poly(N-isopropylacrylamide) for intracameral delivery of pilocarpine in antiglaucoma treatment. As expected, increasing redox reaction time increased total antioxidant activities and free radical scavenging abilities of synthesized carrier biomaterials. The hydrophilic nature of antioxidant molecules strongly affected physicochemical properties of carrier materials with varying GA grafting amounts, thereby dictating in vitro release behaviors and mechanisms of pilocarpine. In vitro oxidative stress challenges revealed that biocompatible carriers with high GA content alleviated lens epithelial cell damage and reduced reactive oxygen species. Intraocular pressure and pupil diameter in glaucomatous rabbits showed correlations with GA-mediated release of pilocarpine. Additionally, enhanced pharmacological treatment effects prevented corneal endothelial cell loss during disease progression. Increasing GA content increased total antioxidant level and decreased nitrite level in the aqueous humor, suggesting a much improved antioxidant status in glaucomatous eyes. This work significantly highlights the dependence of physicochemical properties, drug release behaviors, and bioactivities on intrinsic antioxidant capacities of therapeutic carrier biomaterials for glaucoma treatment.
   Statement of Significance
   Development of injectable biodegradable polymer depots and functionalization of carrier biomaterials with antioxidant can potentially provide benefits such as improved bioavailability, controlled release pattern, and increased therapeutic effect in intracameral pilocarpine administration for glaucoma treatment. For the first time, this study demonstrated that the biodegradable in situ gelling copolymers can incorporate different levels of antioxidant gallic acid to tailor the structure-property-function relationship of the intracameral drug delivery system. The systematic evaluation fully verified the dependence of phase transition, degradation behavior, drug release mechanism, and antiglaucoma efficacy on intrinsic antioxidant capacities of carrier biomaterials. The report highlights the significant role of grafting amount of gallic acid in optimizing performance of antioxidant-functionalized polymer therapeutics as new drug delivery platforms in disease treatment. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Chou, Shih-Feng; Luo, Li-Jyuan; Lai, Jui-Yang] Chang Gung Univ, Inst Biochem & Biomed Engn, Taoyuan 33302, Taiwan.
   [Chou, Shih-Feng] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
   [Lai, Jui-Yang] Chang Gung Univ, Biomed Engn Res Ctr, Taoyuan 33302, Taiwan.
   [Lai, Jui-Yang] Chang Gung Univ, Mol Med Res Ctr, Taoyuan 33302, Taiwan.
   [Lai, Jui-Yang] Chang Gung Mem Hosp, Ctr Tissue Engn, Taoyuan 33305, Taiwan.
RP Lai, JY (reprint author), Chang Gung Univ, Inst Biochem & Biomed Engn, Taoyuan 33302, Taiwan.
EM jylai@mail.cgu.edu.tw
RI Luo, Li-Jyuan/N-2688-2016
OI Lai, Jui-Yang/0000-0002-9227-8549
FU National Health Research Institutes of Taiwan [NHRI-EX104-10311EC]
FX This work was supported by grant NHRI-EX104-10311EC from the National
   Health Research Institutes of Taiwan.
CR Bae UJ, 2015, MOL MED REP, V12, P2547, DOI 10.3892/mmr.2015.3766
   Cavet ME, 2014, INVEST OPHTH VIS SCI, V55, P5005, DOI 10.1167/iovs.14-14515
   Cho SW, 2009, JPN J OPHTHALMOL, V53, P569, DOI 10.1007/s10384-009-0740-1
   Choudhary S, 2002, FREE RADICAL BIO MED, V32, P360, DOI 10.1016/S0891-5849(01)00810-3
   Curcio M, 2009, J AGR FOOD CHEM, V57, P5933, DOI 10.1021/jf900778u
   FECHTNER RD, 1994, SURV OPHTHALMOL, V39, P23, DOI 10.1016/S0039-6257(05)80042-6
   GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X
   Haefliger IO, 1999, SURV OPHTHALMOL, V43, pS51, DOI 10.1016/S0039-6257(99)00026-0
   Hedberg EL, 2004, J CONTROL RELEASE, V100, P257, DOI 10.1016/j.jconrel.2004.08.020
   Hsiue GH, 2001, BIOMATERIALS, V22, P1763, DOI 10.1016/S0142-9612(00)00336-7
   Huseeb MT, 2016, CARBOHYD POLYM, V136, P750, DOI 10.1016/j.carbpol.2015.09.092
   Iemma F, 2010, J APPL POLYM SCI, V115, P784, DOI 10.1002/app.31067
   Isiklan N, 2013, POLYM BULL, V70, P1065, DOI 10.1007/s00289-012-0876-x
   Izzotti A, 2009, INVEST OPHTH VIS SCI, V50, P5251, DOI 10.1167/iovs.09-3871
   Kaith BS, 2008, INT J POLYM MATER, V57, P54, DOI 10.1080/00914030701328843
   Kang MS, 2008, J MICROBIOL, V46, P744, DOI 10.1007/s12275-008-0235-7
   Kao HJ, 2006, J PHARM PHARMACOL, V58, P179, DOI 10.1211/jpp.58.2.0004
   Kim SH, 2006, TOXICOL SCI, V91, P123, DOI 10.1093/toxsci/kfj063
   Koracevic D, 2001, J CLIN PATHOL, V54, P356, DOI 10.1136/jcp.54.5.356
   Kratz JM, 2008, BIOL PHARM BULL, V31, P903, DOI 10.1248/bpb.31.903
   Lai JY, 2006, BIOMACROMOLECULES, V7, P1836, DOI 10.1021/bm0601575
   Lai JY, 2015, BIOMACROMOLECULES, V16, P2950, DOI 10.1021/acs.biomac.5b00854
   Lai JY, 2014, COLLOID SURFACE B, V122, P277, DOI 10.1016/j.colsurfb.2014.07.009
   Lai JY, 2014, CARBOHYD POLYM, V101, P203, DOI 10.1016/j.carbpol.2013.09.060
   Lai JY, 2014, MAT SCI ENG C-MATER, V34, P334, DOI 10.1016/j.msec.2013.09.026
   Lai JY, 2013, DRUG DES DEV THER, V7, P1273, DOI 10.2147/DDDT.S53759
   Lai JY, 2013, J BIOMED NANOTECHNOL, V9, P2048, DOI 10.1166/jbn.2013.1734
   Lai JY, 2012, J MATER CHEM, V22, P1812, DOI 10.1039/c1jm14211a
   Lai JY, 2012, BIOMATERIALS, V33, P2372, DOI 10.1016/j.biomaterials.2011.11.085
   Lai JY, 2010, J MATER SCI-MATER M, V21, P1899, DOI 10.1007/s10856-010-4035-3
   Lai JY, 2010, BIOMACROMOLECULES, V11, P1387, DOI 10.1021/bm100213f
   Lei KW, 2015, CHEM COMMUN, V51, P6080, DOI 10.1039/c5cc00049a
   Leske MC, 2003, ARCH OPHTHALMOL-CHIC, V121, P48
   Loo AY, 2007, FOOD CHEM, V104, P300, DOI 10.1016/j.foodchem.2006.11.048
   Ollivier FJ, 2003, EXP EYE RES, V76, P671, DOI 10.1016/S0014-4835(03)00055-1
   Raja IS, 2015, COLLOID SURFACE B, V128, P537, DOI 10.1016/j.colsurfb.2015.03.005
   Richer SP, 1998, VISION RES, V38, P2881, DOI 10.1016/S0042-6989(98)00069-8
   Sacca SC, 2007, EXP EYE RES, V84, P389, DOI 10.1016/j.exer.2006.10.008
   Sarchahi AA, 2012, VET OPHTHALMOL, V15, P64, DOI 10.1111/j.1463-5224.2011.00958.x
   Senevirathne M, 2012, CARBOHYD POLYM, V87, P876, DOI 10.1016/j.carbpol.2011.08.080
   Shen WJ, 2015, BIOMACROMOLECULES, V16, P105, DOI 10.1021/bm501220a
   Siemieniuk E, 2008, TOXICOL MECH METHOD, V18, P519, DOI 10.1080/15376510701624001
   Soobrattee MA, 2005, MUTAT RES-FUND MOL M, V579, P200, DOI 10.1016/j.mrfmmm.2005.03.023
   Spizzirri UG, 2009, BIOMACROMOLECULES, V10, P1923, DOI 10.1021/bm900325t
   Suja KP, 2004, J AGR FOOD CHEM, V52, P912, DOI 10.1021/jf0303621
   Tavano L, 2014, COLLOID SURFACE B, V114, P82, DOI 10.1016/j.colsurfb.2013.09.058
   Thakur VK, 2012, J POLYM ENVIRON, V20, P164, DOI 10.1007/s10924-011-0372-7
   Tusi SK, 2011, BIOMATERIALS, V32, P5438, DOI 10.1016/j.biomaterials.2011.04.024
   van Lith R, 2014, BIOMATERIALS, V35, P8113, DOI 10.1016/j.biomaterials.2014.06.004
   Wolfe K, 2003, J AGR FOOD CHEM, V51, P609, DOI 10.1021/jf020782a
   Xie WM, 2002, POLYM BULL, V49, P47, DOI 10.1007/s00289-002-0076-1
   Yang J, 2014, BIOMACROMOLECULES, V15, P3942, DOI 10.1021/bm5010004
   Zhang L, 2015, ACTA BIOMATER, V23, P271, DOI 10.1016/j.actbio.2015.05.005
   Zhang LA, 2011, FITOTERAPIA, V82, P267, DOI 10.1016/j.fitote.2010.10.009
NR 54
TC 9
Z9 9
U1 1
U2 17
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL 1
PY 2016
VL 38
BP 116
EP 128
DI 10.1016/j.actbio.2016.04.035
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DQ1LZ
UT WOS:000378963800011
PM 27130273
DA 2018-10-20
ER

PT J
AU Kawai, N
   Suzuki, S
   Naito, H
   Kushibe, K
   Tojo, T
   Ikada, Y
   Taniguchi, S
AF Kawai, Norikazu
   Suzuki, Shuko
   Naito, Hiroshi
   Kushibe, Keiji
   Tojo, Takashi
   Ikada, Yoshito
   Taniguchi, Shigeki
TI Sealing Effect of Cross-Linked Gelatin Glue in the Rat Lung Air Leak
   Model
SO ANNALS OF THORACIC SURGERY
LA English
DT Article
ID FIBRIN GLUE; PULMONARY RESECTION; SEALANT; LOBECTOMY; EFFICACY; SURGERY;
   SAFETY
AB Background. Air leak is a common problem in pulmonary surgical procedures. In this study, we evaluated the efficacy and safety of gelatin glue (crosslinked with glutaraldehyde) in a rat model of lung air leak.
   Methods. A model of pulmonary fistula was created in the rat lung with the use of a needle. The fistula was then sealed with either gelatin glue (group A), fibrin glue (group B), or fibrin glue with a polyglycolic acid sheet (group C). The seal breaking pressures were measured for each group, and the results were compared. To assess the biocompatibility of the gelatin glue, a model of lung damage was created with incision, and the gelatin glue was applied to seal the wound. Histologic analysis was then performed on the lung tissue.
   Results. The seal breaking pressure in group A (47.88 +/- 6.69 mm Hg) was significantly higher than that in group B (24.67 +/- 3.24 mm Hg, p = 0.0302) or group C (28.67 +/- 3.55 mm Hg, p = 0.0406). Histologically, the gelatin glue adhered firmly to the lung surface, and only localized tissue inflammation was observed.
   Conclusions. The sealing effect of gelatin glue was superior to that of fibrin glue, with or without a polyglycolic acid sheet. In addition, the gelatin glue only caused mild inflammation of the lung and was absorbed without any adverse foreign body response. These findings suggest that gelatin glue may be a therapeutically effective biomaterial for sealing lung wounds and restoring respiratory function. (C) 2016 by The Society of Thoracic Surgeons
C1 [Kawai, Norikazu] Nara Med Univ, Dept Thorac & Cardiovasc Surg, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.
   Nara Med Univ, Dept Med Engn, Kashihara, Nara 6348522, Japan.
   Queensland Eye Inst, South Brisbane, Qld, Australia.
   Nara Prefecture Gen Med Ctr, Dept Thorac Surg, Nara, Japan.
   Kyoto Univ, Kyoto, Japan.
RP Kawai, N (reprint author), Nara Med Univ, Dept Thorac & Cardiovasc Surg, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.
EM kawai30@hotmail.co.jp
FU GUNZE Ltd, Kyoto
FX The authors wish to thank GUNZE Ltd, Kyoto, for providing the gelatin
   glue for this study and a grant to offset study costs.
CR Abolhoda A, 1998, CHEST, V113, P1507, DOI 10.1378/chest.113.6.1507
   Allen MS, 2004, ANN THORAC SURG, V77, P1792, DOI 10.1016/j.athoracsur.2003.10.049
   Fabian T, 2003, ANN THORAC SURG, V75, P1587, DOI 10.1016/S0003-4975(02)04994-9
   Feito BA, 2000, EUR J CARDIO-THORAC, V17, P8, DOI 10.1016/S1010-7940(99)00342-5
   FLEISHER AG, 1990, ANN THORAC SURG, V49, P133, DOI 10.1016/0003-4975(90)90371-C
   Gika Masatoshi, 2007, Interact Cardiovasc Thorac Surg, V6, P12
   Gillinov AM, 2001, J CARDIAC SURG, V16, P255, DOI 10.1111/j.1540-8191.2001.tb00517.x
   Herget GW, 2001, EUR J CARDIO-THORAC, V19, P4, DOI 10.1016/S1010-7940(00)00613-8
   Itano H, 2008, EUR J CARDIO-THORAC, V33, P457, DOI 10.1016/j.ejcts.2007.12.036
   Kawai H, 2012, THORAC CARDIOV SURG, V60, P351, DOI 10.1055/s-0031-1293599
   Kawai H, 2014, NEUROL MED-CHIR, V54, P640, DOI 10.2176/nmc.oa.2014-0005
   Kawai H, 2014, NEUROL RES, V36, P866, DOI 10.1179/1743132814Y.0000000342
   Lang G, 2004, EUR J CARDIO-THORAC, V25, P160, DOI 10.1016/j.ejcts.2003.11.018
   Macchiarini P, 1999, J THORAC CARDIOV SUR, V117, P751, DOI 10.1016/S0022-5223(99)70296-5
   Marta GM, 2010, EUR J CARDIO-THORAC, V38, P683, DOI 10.1016/j.ejcts.2010.03.061
   MATAR AF, 1990, THORAX, V45, P670, DOI 10.1136/thx.45.9.670
   MCCARTHY PM, 1988, ANN THORAC SURG, V45, P203, DOI 10.1016/S0003-4975(10)62438-1
   Nomori H, 1999, ANN THORAC SURG, V67, P212, DOI 10.1016/S0003-4975(98)01184-9
   Pedersen TB, 2012, ANN THORAC SURG, V94, P234, DOI 10.1016/j.athoracsur.2012.03.050
   Suzuki S, 2013, J BIOMATER APPL, V27, P801, DOI 10.1177/0885328211426491
   Tansley P, 2006, J THORAC CARDIOV SUR, V132, P105, DOI 10.1016/j.jtcvs.2006.02.022
   Wong K, 1997, ANN THORAC SURG, V64, P979, DOI 10.1016/S0003-4975(97)00820-5
   Yamashita K, 2015, BIO-MED MATER ENG, V25, P361, DOI 10.3233/BME-151534
NR 23
TC 1
Z9 1
U1 1
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-4975
EI 1552-6259
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PD JUL
PY 2016
VL 102
IS 1
BP 282
EP 286
DI 10.1016/j.athoracsur.2016.02.038
PG 5
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA DP6UL
UT WOS:000378634400066
PM 27209616
DA 2018-10-20
ER

PT J
AU Williams, L
   Fan, K
   Bentley, R
AF Williams, Luke
   Fan, Kathy
   Bentley, Robert
TI Titanium cranioplasty in children and adolescents
SO JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY
LA English
DT Article
DE Cranioplasty; Calvarial reconstruction; Paediatric; Biomaterials;
   Patient specific implants
ID PEDIATRIC CRANIOFACIAL RECONSTRUCTION; CALVARIAL BONE-GRAFT;
   DECOMPRESSIVE CRANIECTOMY; HYDROXYAPATITE CEMENT; CRANIAL DEFECTS; RIGID
   FIXATION; AUTOLOGOUS CRANIOPLASTY; SKULL RECONSTRUCTION; VOLUME
   MAINTENANCE; CLINICAL ARTICLE
AB Full thickness calvarial defects present considerable challenges to reconstructive surgeons. In paediatric cases, the use of biomaterials as a substrate for cranioplasty rather than autologous bone is controversial. Alloplastic cranioplasty in adults is supported by several large case series however long term outcome of biomaterial use in paediatric cases is limited. Retrospective seven year analysis of departmental database and clinical records identified 22 patients aged under 18 who had undergone 23 custom made titanium cranioplasties by a single surgeon using the same technique. Data including patient demographics, reason for craniectomy and complications experienced following surgery was obtained. The mean age at operation was 12 years 9 months. The mean defect size was 44.3 cm(2). No significant complications related to the cranioplasty were recorded in the early post operative period or during long term review (average follow up 4 years 6 months). No cranioplasty implant required removal. This retrospective case series shows that custom made patient specific titanium cranioplasty is a viable alternative to autologous bone as a reconstructive material in paediatric patients under specific circumstances. (C) 2016 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.
C1 [Williams, Luke; Fan, Kathy; Bentley, Robert] Kings Coll Hosp London, Dept Oral & Maxillofacial Surg, London, England.
RP Fan, K (reprint author), Kings Coll Hosp London, Dept Oral & Maxillofacial Surg, London, England.
EM kfan@nhs.net
OI Williams, Luke/0000-0001-8439-5270
CR Barone CM, 1997, J CRANIOFAC SURG, V8, P43, DOI 10.1097/00001665-199701000-00015
   Baumeister S, 2008, PLAST RECONSTR SURG, V122, p195E, DOI 10.1097/PRS.0b013e3181858eee
   Beck J, 2002, J CRANIOFAC SURG, V13, P327, DOI 10.1097/00001665-200203000-00029
   Biskup NI, 2010, J CRANIOFAC SURG, V21, P358, DOI 10.1097/SCS.0b013e3181cf606b
   BLAIR GAS, 1980, CHILD BRAIN, V6, P82
   Blum KS, 1997, PEDIATR NEUROSURG, V26, P33, DOI 10.1159/000121158
   Bowers CA, 2013, J NEUROSURG-PEDIATR, V11, P526, DOI 10.3171/2013.1.PEDS12483
   Bruce JN, 2003, J NEUROSURG, V98, P1203, DOI 10.3171/jns.2003.98.6.1203
   Cheng YK, 2008, J CLIN NEUROSCI, V15, P1115, DOI 10.1016/j.jocn.2007.09.022
   Chim H, 2005, PLAST RECONSTR SURG, V116, P1726, DOI 10.1097/01.prs.0000182386.78775.cd
   Cho YR, 2004, CLIN PLAST SURG, V31, P377, DOI 10.1016/j.cps.2004.03.001
   Choi SH, 1998, PEDIATR NEUROSURG, V29, P324, DOI 10.1159/000028747
   Cohen AJ, 2004, J CRANIOFAC SURG, V15, P469, DOI 10.1097/00001665-200405000-00025
   David L, 2005, J CRANIOFAC SURG, V16, P129, DOI 10.1097/00001665-200501000-00026
   Durham SR, 2003, NEUROSURGERY, V52, P842, DOI 10.1227/01.NEU.0000054220.01.01290.8E
   Eufinger H, 2005, INT CONGR SER, V1281, P827, DOI 10.1016/j.ics.2005.03.074
   Frassanito P, 2012, ACTA NEUROCHIR, V154, P927, DOI 10.1007/s00701-011-1253-5
   FRODEL JL, 1993, ARCH OTOLARYNGOL, V119, P17
   Gosain AK, 2009, PLAST RECONSTR SURG, V123, P319, DOI 10.1097/PRS.0b013e318193478c
   Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163
   Greene AK, 2008, PLAST RECONSTR SURG, V122, P563, DOI 10.1097/PRS.0b013e31817d61c1
   Hanasono MM, 2009, ANN PLAS SURG, V62, P653, DOI 10.1097/SAP.0b013e318184abc7
   HOCKLEY AD, 1991, PEDIATR NEUROSURG, V16, P271
   JACKSON IT, 1986, J ORAL MAXIL SURG, V44, P949, DOI 10.1016/S0278-2391(86)80048-9
   Joffe J, 1999, BRIT J NEUROSURG, V13, P576, DOI 10.1080/02688699943088
   Josan VA, 2005, CHILD NERV SYST, V21, P200, DOI 10.1007/s00381-004-1068-2
   Kosaka M, 2003, J CRANIO MAXILL SURG, V31, P15, DOI 10.1016/S1010-5182(02)00162-2
   Laure B, 2010, PLAST RECONSTR SURG, V126, P1491, DOI 10.1097/PRS.0b013e3181ef8bb1
   Lin AY, 2012, J CRANIOFAC SURG, V23, P67, DOI 10.1097/SCS.0b013e318240c876
   Marchac D, 2008, J PLAST RECONSTR AES, V61, P744, DOI 10.1016/j.bjps.2007.10.055
   Martin KD, 2014, ACTA NEUROCHIR, V156, P813, DOI 10.1007/s00701-014-2021-0
   Matic DB, 2004, J CRANIOFAC SURG, V15, P415, DOI 10.1097/00001665-200405000-00012
   Matsuno A, 2006, ACTA NEUROCHIR, V148, P535, DOI 10.1007/s00701-006-0740-6
   Moreira-Gonzalez A, 2003, J CRANIOFAC SURG, V14, P144, DOI 10.1097/00001665-200303000-00003
   Munro I R, 1981, Ann Plast Surg, V7, P341, DOI 10.1097/00000637-198111000-00001
   Ozaki W, 1998, PLAST RECONSTR SURG, V102, P291, DOI 10.1097/00006534-199808000-00001
   Pang DL, 2005, J NEUROSURG, V102, P36, DOI 10.3171/ped.2005.102.1.0036
   PAPAY FA, 1995, J CRANIOFAC SURG, V6, P309, DOI 10.1097/00001665-199507000-00010
   Payne KFB, 2014, BRIT J ORAL MAX SURG, V52, P7, DOI 10.1016/j.bjoms.2013.03.005
   Piedra MP, 2012, J NEUROSURG-PEDIATR, V10, P268, DOI 10.3171/2012.6.PEDS1268
   Piitulainen JM, 2015, ACTA NEUROCHIR, V157, P681, DOI 10.1007/s00701-015-2363-2
   RESNICK JI, 1990, ANN PLAS SURG, V25, P372, DOI 10.1097/00000637-199011000-00005
   Rogers GF, 2011, PLAST RECONSTR SURG, V127, P1631, DOI 10.1097/PRS.0b013e31821084f0
   Rosenthal AH, 2003, PLAST RECONSTR SURG, V112, P802, DOI 10.1097/01.PRS.0000069713.62687.F5
   Shoakazemi A, 2009, NEUROSURGERY, V65, P505, DOI 10.1227/01.NEU.0000350870.69891.86
   Singh KA, 2010, J CRANIOFAC SURG, V21, P1130, DOI 10.1097/SCS.0b013e3181e482c6
   Stefini R, 2013, SURG NEUROL INT, V4, P12
   Taggard DA, 2001, PEDIATR NEUROSURG, V34, P149, DOI 10.1159/000056010
   Takumi I, 2008, CHILD NERV SYST, V24, P927, DOI 10.1007/s00381-007-0574-4
   Tessier P, 2005, PLAST RECONSTR SURG, V116, p6S, DOI 10.1097/01.prs.0000173862.20563.12
   Tessier P, 2005, PLAST RECONSTR SURG, V116, p92S
   Wehmoller M, 2004, INT CONGR SER, V1268, P667, DOI 10.1016/j.ics.2004.03.112
   WONG L, 1991, PLAST RECONSTR SURG, V88, P395, DOI 10.1097/00006534-199109000-00003
   Wong RK, 2011, J CRANIOFAC SURG, V22, P247, DOI 10.1097/SCS.0b013e3181f7b7db
   YAREMCHUK MJ, 1994, PLAST RECONSTR SURG, V93, P1
   Zins JE, 2010, J CRANIOFAC SURG, V21, P1755, DOI 10.1097/SCS.0b013e3181c34675
NR 56
TC 7
Z9 7
U1 2
U2 12
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 1010-5182
EI 1878-4119
J9 J CRANIO MAXILL SURG
JI J. Cranio-MaxilloFac. Surg.
PD JUL
PY 2016
VL 44
IS 7
BP 789
EP 794
DI 10.1016/j.jcms.2016.03.010
PG 6
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA DQ3HS
UT WOS:000379094000005
PM 27174495
DA 2018-10-20
ER

PT J
AU Ayadi, I
   Ben Ayed, F
AF Ayadi, Ibticem
   Ben Ayed, Foued
TI Mechanical optimization of the composite biomaterial based on the
   tricalcium phosphate, titania and magnesium fluoride
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Biomaterial; Composites; Mechanical properties; Tricalcium phosphate;
   TiO2; MgF2
ID STRUCTURAL PHASE-TRANSITIONS; CALCIUM PHOSPHATES; HIGH-PRESSURE;
   FLUORAPATITE COMPOSITES; ZIRCONIA COMPOSITES; INTERMEDIATE PHASES;
   OPTICAL-PROPERTIES; IN-VITRO; MGF2; SUBSTITUTION
AB The microstructure, the densification and the mechanical properties of the tricalcium phosphate - titania - MgF2 composites were investigated. The effect of MgF2 addition on the performances of the tricalcium phosphate - 40 wt% titania composites is discussed. The mechanical properties were investigated by Brazilian test, Vickers indentation and the ultrasound techniques. The mechanical properties of the tricalcium phosphate - 40 wt% titania composites reached optimum performances after the sintering process at 1200 degrees C for one hour with 4 wt% MgF2. Thus, the highest values of the rupture strength, Vickers hardness, Young's and the shear modulus reached 27 MPa, 360 Hv, 51 GPa and 20 GPa, respectively. The increase of the mechanical properties of the composites is due to the presence of the liquid phase and the formation of a new compound. Thus, the microstructure of the composites reveals the presence of a new lamella form relative to the Mg-2(PO4)F. Beyond 4 wt% MgF2, the performances of the composites are hindered by the exaggerated grain growth and the formation of the bubbles. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Ayadi, Ibticem; Ben Ayed, Foued] Sfax Univ, Natl Sch Engn, Lab Ind Chem, Box 1173, Sfax 3038, Tunisia.
RP Ben Ayed, F (reprint author), Sfax Univ, Natl Sch Engn, Lab Ind Chem, Box 1173, Sfax 3038, Tunisia.
EM benayedfoued@yahoo.fr
CR [Anonymous], 1984, C496 ASTM, P336
   [ASTM-C618-03 ASfTa Materials], 2003, ANN BOOK ASTM STAND
   Ayadi I, 2015, J MECH BEHAV BIOMED, V49, P129, DOI 10.1016/j.jmbbm.2015.05.001
   Azami M, 2011, CERAM INT, V37, P2007, DOI 10.1016/j.ceramint.2011.02.025
   Babu KR, 2011, J SOLID STATE CHEM, V184, P343, DOI 10.1016/j.jssc.2010.11.025
   Ben Ayed F, 2001, J ALLOY COMPD, V322, P238, DOI 10.1016/S0925-8388(01)01200-2
   Ben Ayed F, 2000, J EUR CERAM SOC, V20, P1069, DOI 10.1016/S0955-2219(99)00272-1
   Ben Ayed F, 2008, CERAM INT, V34, P1885, DOI 10.1016/j.ceramint.2007.07.017
   Bernache-Assollant D., 1993, CHIMIE PHYS FRITTAGE
   BIENIAWSKI ZT, 1978, INT J ROCK MECH MIN, V15, P99
   Biswas N., 2013, ISRN BIOMATER, P1
   Bouslama N, 2010, J MECH BEHAV BIOMED, V3, P2, DOI 10.1016/j.jmbbm.2009.01.007
   Bouslama N, 2009, CERAM INT, V35, P1909, DOI 10.1016/j.ceramint.2008.10.030
   Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023
   Caroff F, 1998, BIOMATERIALS, V19, P1451, DOI 10.1016/S0142-9612(98)00057-X
   Carsten J., 1996, BIOMATERIALS, V17, P2065
   Chang CS, 2003, MATER CHEM PHYS, V81, P27, DOI 10.1016/S0254-0584(02)00460-1
   Chen XJ, 2014, J NON-CRYST SOLIDS, V402, P172, DOI 10.1016/j.jnoncrysol.2014.05.025
   Chevalier Y., 2003, TECH INGEN, P1
   Chuang LC, 2011, APPL SURF SCI, V258, P297, DOI 10.1016/j.apsusc.2011.08.055
   Chun Kj, 2014, J Dent Biomech, V5, p1758736014520809, DOI 10.1177/1758736014520809
   Elliott JC, 1994, STRUCTURE CHEM APATI
   Evis Z, 2010, J CERAM PROCESS RES, V11, P701
   Evis Z, 2009, J EUR CERAM SOC, V29, P621, DOI 10.1016/j.jeurceramsoc.2008.07.020
   FARLEY JR, 1983, SCIENCE, V222, P330
   Fathi M.H., 2008, IRAN J PHARM SCI, V4, P201
   Gozalian A, 2011, SCI IRAN, V18, P1614, DOI 10.1016/j.scient.2011.11.014
   Haines J, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.134110
   Hench L.L., 1993, INTRO BIOCERAMICS, P521
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Himesh A., 2007, J MATER SCI-MATER M, V18, P883
   Hosokawa M, 2007, NANOPARTICLE TECHNOL
   KANAZAWA T, 1991, J MATER SCI, V26, P417, DOI 10.1007/BF00576536
   Kanchana V, 2003, J ALLOY COMPD, V352, P60, DOI 10.1016/S0925-8388(02)01158-1
   Kannan S., 2009, J BIOMED MATER RES B, V90, P1552
   Khairoun I, 2002, J BIOMED MATER RES, V60, P633, DOI 10.1002/jbm.10132
   Kim SH, 2006, MATER SCI FORUM, V510-511, P478, DOI 10.4028/www.scientific.net/MSF.510-511.478
   KOTANI S, 1991, J BIOMED MATER RES, V25, P1303, DOI 10.1002/jbm.820251010
   Kusaba K, 2008, SOLID STATE COMMUN, V148, P440, DOI 10.1016/j.ssc.2008.09.017
   LeGeros R. Z., 1995, ENCY HDB BIOMATERI A, V2, P1429
   Lin FH, 2001, BIOMATERIALS, V22, P2981, DOI 10.1016/S0142-9612(01)00044-8
   Manjubala I, 2001, J MATER SCI LETT, V20, P1225, DOI 10.1023/A:1010926923815
   Mazaheri M, 2009, CERAM INT, V35, P685, DOI 10.1016/j.ceramint.2008.02.005
   Nakade O, 1999, ARCH ORAL BIOL, V44, P89, DOI 10.1016/S0003-9969(98)00099-5
   Nath S, 2009, MAT SCI ENG C-BIO S, V29, P97, DOI 10.1016/j.msec.2008.05.019
   Nofar M, 2008, INFRARED PHYS TECHN, V51, P546, DOI 10.1016/j.infrared.2008.06.002
   Otsuka M, 2008, J PHARM SCI-US, V97, P421, DOI 10.1002/jps.21131
   Ozturk H, 2014, J ALLOY COMPD, V609, P185, DOI 10.1016/j.jallcom.2014.04.152
   Ozturk H, 2014, J ALLOY COMPD, V597, P155, DOI 10.1016/j.jallcom.2014.01.221
   Pardun K, 2015, J BIOMATER APPL, V30, P104, DOI 10.1177/0885328215572428
   Ravaglioli A., 1992, BIOCERAMICS MAT PROP, P422
   Sakka S, 2012, IOP CONF SER-MAT SCI, V28, DOI 10.1088/1757-899X/28/1/012028
   Sakka S, 2014, MAT SCI ENG C-MATER, V40, P92, DOI 10.1016/j.msec.2014.03.036
   Sallemi I, 2015, MATER CHEM PHYS, V151, P50, DOI 10.1016/j.matchemphys.2014.11.027
   Seeley Z, 2007, J BIOMED MATER RES A, V82A, P113, DOI 10.1002/jbm.a.31077
   Serre CM, 1998, J BIOMED MATER RES, V42, P626
   Shi D., 2004, BIOMATERIALS TISSUE, P2
   STAINES M, 1981, J MATER SCI, V16, P2551, DOI 10.1007/BF01113595
   Suchanek WL, 2004, J SOLID STATE CHEM, V177, P793, DOI 10.1016/j.jssc.2003.09.012
   Sun XW, 2011, SOLID STATE COMMUN, V151, P1507, DOI 10.1016/j.ssc.2011.07.040
   Vallet-Regi M, 2004, PROG SOLID STATE CH, V32, P1, DOI 10.1016/j.progsolidstchem.2004.07.001
   Varma HK, 2001, MATER LETT, V49, P83, DOI 10.1016/S0167-577X(00)00346-3
   Williams D., 1990, CONCISE ENCY MED DEN, pxvii
   Xue WC, 2008, J MATER SCI-MATER M, V19, P2669, DOI 10.1007/s10856-008-3395-4
   Xue-Nan Gu, 2010, Frontiers of Materials Science in China, V4, P111, DOI 10.1007/s11706-010-0024-1
NR 65
TC 3
Z9 3
U1 0
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
EI 1878-0180
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD JUL
PY 2016
VL 60
BP 568
EP 580
DI 10.1016/j.jmbbm.2016.03.020
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DQ1OA
UT WOS:000378969100052
PM 27058004
DA 2018-10-20
ER

PT J
AU Atesok, K
   Doral, MN
   Karlsson, J
   Egol, KA
   Jazrawi, LM
   Coelho, PG
   Martinez, A
   Matsumoto, T
   Owens, BD
   Ochi, M
   Hurwitz, SR
   Atala, A
   Fu, FH
   Lu, HH
   Rodeo, SA
AF Atesok, Kivanc
   Doral, M. Nedim
   Karlsson, Jon
   Egol, Kenneth A.
   Jazrawi, Laith M.
   Coelho, Paulo G.
   Martinez, Amaury
   Matsumoto, Tomoyuki
   Owens, Brett D.
   Ochi, Mitsuo
   Hurwitz, Shepard R.
   Atala, Anthony
   Fu, Freddie H.
   Lu, Helen H.
   Rodeo, Scott A.
TI Multilayer scaffolds in orthopaedic tissue engineering
SO KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY
LA English
DT Article
DE Orthopaedic tissue engineering; Interface tissue regeneration;
   Multilayer scaffolds; Multi-lineage cell differentiation
ID OSTEOCHONDRAL REGENERATION; BIPHASIC SCAFFOLD; BONE-CEMENT; SHEEP MODEL;
   INTERFACE; TENDON; BIOMATERIAL; REPAIR
AB The purpose of this study was to summarize the recent developments in the field of tissue engineering as they relate to multilayer scaffold designs in musculoskeletal regeneration.
   Clinical and basic research studies that highlight the current knowledge and potential future applications of the multilayer scaffolds in orthopaedic tissue engineering were evaluated and the best evidence collected. Studies were divided into three main categories based on tissue types and interfaces for which multilayer scaffolds were used to regenerate: bone, osteochondral junction and tendon-to-bone interfaces.
   In vitro and in vivo studies indicate that the use of stratified scaffolds composed of multiple layers with distinct compositions for regeneration of distinct tissue types within the same scaffold and anatomic location is feasible. This emerging tissue engineering approach has potential applications in regeneration of bone defects, osteochondral lesions and tendon-to-bone interfaces with successful basic research findings that encourage clinical applications.
   Present data supporting the advantages of the use of multilayer scaffolds as an emerging strategy in musculoskeletal tissue engineering are promising, however, still limited. Positive impacts of the use of next generation scaffolds in orthopaedic tissue engineering can be expected in terms of decreasing the invasiveness of current grafting techniques used for reconstruction of bone and osteochondral defects, and tendon-to-bone interfaces in near future.
C1 [Atesok, Kivanc; Rodeo, Scott A.] Hosp Special Surg, Sports Med & Shoulder Serv, 525 East 71st St, New York, NY 10021 USA.
   [Doral, M. Nedim] Hacettepe Univ, Dept Orthopaed & Traumatol, Sch Med, TR-06100 Ankara, Turkey.
   [Karlsson, Jon] Gothenburg Univ, Sahlgrenska Univ Hosp, Sahlgrenska Acad, Dept Orthopaed, S-43180 Molndal, Sweden.
   [Egol, Kenneth A.] NYU, Dept Orthopaed Surg, Hosp Joint Dis, 303 2nd Ave, New York, NY 10003 USA.
   [Jazrawi, Laith M.; Martinez, Amaury] NYU, Ctr Musculoskeletal Care, Hosp Joint Dis, 333 East 38th St, New York, NY 10016 USA.
   [Coelho, Paulo G.] NYU, Dept Periodontol & Implant Dent, Coll Dent, 345 East 24th St,Room 804s, New York, NY 10010 USA.
   [Matsumoto, Tomoyuki] Kobe Univ, Dept Orthopaed Surg, Grad Sch Med, Chuo Ku, Kobe, Hyogo 6500017, Japan.
   [Owens, Brett D.] Keller Army Hosp, Orthopaed Surg Serv, 900 Washington Rd, New York, NY 10996 USA.
   [Ochi, Mitsuo] Hiroshima Univ, Dept Orthopaed Surg, Sch Biomed Sci, Minamimi Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.
   [Hurwitz, Shepard R.] Univ N Carolina, Dept Orthopaed Surg, Chapel Hill, NC USA.
   [Hurwitz, Shepard R.] Amer Board Orthopaed Surg, 400 Silver Cedar Court, Chapel Hill, NC 27514 USA.
   [Atala, Anthony] Wake Forest Univ, Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA.
   [Fu, Freddie H.] Univ Pittsburgh, Sch Med, Dept Orthopaed Surg, 3471 Fifth Ave,Suite 1011, Pittsburgh, PA 15213 USA.
   [Lu, Helen H.] Columbia Univ, Dept Biomed Engn, New York, NY 10016 USA.
RP Rodeo, SA (reprint author), Hosp Special Surg, Sports Med & Shoulder Serv, 525 East 71st St, New York, NY 10021 USA.
EM kivanc.atesok@utoronto.ca; RodeoS@HSS.edu
RI Bayram, Cem/D-7403-2013
OI Bayram, Cem/0000-0001-8717-4668
CR Akkouch A, 2011, J BIOMED MATER RES A, V96A, P693, DOI 10.1002/jbm.a.33033
   Atesok K, 2014, J BONE JOINT SURG AM, V96A, P513, DOI 10.2106/JBJS.M.00009
   Aydin HM, 2011, ADV ENG MATER, V13, pB511, DOI 10.1002/adem.201180005
   Billstrom GH, 2013, INJURY, V44, pS28, DOI 10.1016/S0020-1383(13)70007-X
   Brophy RH, 2011, J BONE JOINT SURG AM, V93A, P381, DOI [10.2106/JBJS.I.00933, 10.2106/JBJSJ.00933]
   Butscher A, 2011, ACTA BIOMATER, V7, P907, DOI 10.1016/j.actbio.2010.09.039
   Chen GP, 2006, MAT SCI ENG C-BIO S, V26, P118, DOI 10.1016/j.msec.2005.07.024
   Clarke B, 2008, CLIN J AM SOC NEPHRO, V3, pS131, DOI 10.2215/CJN.04151206
   COOPER RR, 1970, J BONE JOINT SURG AM, VA 52, P1
   Crowley C, 2013, CURR STEM CELL RES T, V8, P243, DOI 10.2174/1574888X11308030009
   Ding CM, 2013, BIOMATERIALS, V34, P6706, DOI 10.1016/j.biomaterials.2013.05.038
   FRANZEN A, 1981, BIOCHEM J, V195, P535, DOI 10.1042/bj1950535
   Giannotti S, 2013, CLIN CASES MINER BON, V10, P116, DOI 10.11138/ccmbm/2013.10.2.116
   Han LH, 2010, BIOMED MICRODEVICES, V12, P721, DOI 10.1007/s10544-010-9425-2
   He PF, 2012, BIOMACROMOLECULES, V13, P2692, DOI 10.1021/bm300651q
   ISHIHARA K, 1992, J BIOMED MATER RES, V26, P937, DOI 10.1002/jbm.820260708
   Jiang J, 2010, ANN BIOMED ENG, V38, P2183, DOI 10.1007/s10439-010-0038-y
   Keeney M, 2009, TISSUE ENG PART B-RE, V15, P55, DOI 10.1089/ten.teb.2008.0388
   Kon E, 2010, J TISSUE ENG REGEN M, V4, P300, DOI 10.1002/term.243
   Kon E, 2011, AM J SPORT MED, V39, P1180, DOI 10.1177/0363546510392711
   Kon E, 2010, J ORTHOP RES, V28, P116, DOI 10.1002/jor.20958
   Kurien T, 2013, BONE JOINT J, V95B, P583, DOI 10.1302/0301-620X.95B5.30286
   Lee CH, 2014, TISSUE ENG PT A, V20, P1342, DOI [10.1089/ten.tea.2013.0386, 10.1089/ten.TEA.2013.0386]
   Liu WF, 2010, FDN REGENERATIVE MED, P284
   Lopes MA, 1999, BIOMATERIALS, V20, P2085, DOI 10.1016/S0142-9612(99)00112-X
   Lu HH, 2013, ANNU REV BIOMED ENG, V15, P201, DOI 10.1146/annurev-bioeng-071910-124656
   Lu HH, 2010, ANN BIOMED ENG, V38, P2142, DOI 10.1007/s10439-010-0046-y
   Madry H, 2010, KNEE SURG SPORT TR A, V18, P419, DOI 10.1007/s00167-010-1054-z
   Moffat KL, 2009, CLIN SPORT MED, V28, P157, DOI 10.1016/j.csm.2008.08.006
   Moreau JL, 2009, J BIOMED MATER RES A, V91A, P605, DOI 10.1002/jbm.a.32248
   Newsham-West R, 2007, J ANAT, V210, P318, DOI 10.1111/j.1469-7580.2007.00699.x
   Ng KW, 2004, BIOMATERIALS, V25, P2807, DOI 10.1016/j.biomaterials.2003.09.058
   Nooeaid P, 2012, J CELL MOL MED, V16, P2247, DOI 10.1111/j.1582-4934.2012.01571.x
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   Spalazzi JP, 2008, J BIOMED MATER RES A, V86A, P1, DOI 10.1002/jbm.a.32073
   Woo S. L., 1988, INJURY REPAIR MUSCUL, P133
NR 36
TC 6
Z9 6
U1 3
U2 24
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0942-2056
EI 1433-7347
J9 KNEE SURG SPORT TR A
JI Knee Surg. Sports Traumatol. Arthrosc.
PD JUL
PY 2016
VL 24
IS 7
BP 2365
EP 2373
DI 10.1007/s00167-014-3453-z
PG 9
WC Orthopedics; Sport Sciences; Surgery
SC Orthopedics; Sport Sciences; Surgery
GA DQ4HO
UT WOS:000379165000043
PM 25466277
DA 2018-10-20
ER

PT J
AU Moghadam, PN
   Yarmohamadi, M
   Hasanzadeh, R
   Nuri, S
AF Moghadam, Peyman Najafi
   Yarmohamadi, Mazaher
   Hasanzadeh, Reza
   Nuri, Sirus
TI Preparation of polyurethane wood adhesives by polyols formulated with
   polyester polyols based on castor oil
SO INTERNATIONAL JOURNAL OF ADHESION AND ADHESIVES
LA English
DT Article
DE Castor oil; Dicarboxylic acid; Polyester polyol; Polyurethane wood
   adhesive
ID INTERPENETRATING POLYMER NETWORKS; MECHANICAL-PROPERTIES; RENEWABLE
   RESOURCE; BIOMATERIAL; ELASTOMERS
AB The aim of this work was the synthesis of polyester polyols from renewable sources as one of the important compounds of polymeric polyurethane (PU) adhesives. The polyester polyols were synthesized by condensation polymerization of different dicarboxylic acids with castor oil and the reaction conditions were in agreement with green chemistry principles. The preparation of PU wood adhesives was carried out by the reaction of each obtained polyester polyol with 4, 4'-diphenylmethane diisocyanate (MDI). The adhesive performance was improved by mixing the obtained polyester polyols with polypropylene glycol (PPG 400) and butanediol (BD). Different NCO/OH ratios were used to obtain adhesives with appropriate properties. The structures of the synthesized polyesters and adhesives were characterized by FTIR, thermogravimetric analysis (TGA) and lap shear strength values were also determined in various conditions such as cold water, hot water, acid and alkali solutions. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Moghadam, Peyman Najafi; Hasanzadeh, Reza] Urmia Univ, Fac Chem, Dept Organ Chem, Orumiyeh, Iran.
   [Yarmohamadi, Mazaher; Nuri, Sirus] Urmia Univ, Fac Chem, Dept Appl Chem, Orumiyeh, Iran.
RP Moghadam, PN (reprint author), Urmia Univ, Fac Chem, Dept Organ Chem, Orumiyeh, Iran.
EM p_najafi27@yahoo.com; mazahervasel@yahoo.com; reza.hasanzade7@gmail.com;
   sirousnouri@urmia.ac.ir
OI hasanzadeh, reza/0000-0002-4734-6485
CR Athawale DV, 2003, J MACROMOL SCI C, V43, P1
   Bai S, 1997, POLYMER, V38, P4319, DOI 10.1016/S0032-3861(96)01053-1
   Bartolotta A, 2004, MAT SCI ENG A-STRUCT, V370, P288, DOI 10.1016/j.msea.2003.07.017
   Burhan A, 2014, INT J ADHES ADHES, V49, P90
   Cangemi JM, 2008, POLIMEROS, V18, P201, DOI 10.1590/S0104-14282008000300004
   Cunha F, 2004, MAT RES, V7, P539
   Desai SD, 2003, INT J ADHES ADHES, V23, P393, DOI 10.1016/S0143-7496(03)00070-8
   Dunky M, 1998, INT J ADHES ADHES, V18, P95, DOI 10.1016/S0143-7496(97)00054-7
   Fedorovskaya EA, 1997, COLOR RES APPL, V22, P96, DOI 10.1002/(SICI)1520-6378(199704)22:2<96::AID-COL5>3.3.CO;2-J
   Ferreira P, 2007, INT J BIOL MACROMOL, V40, P144, DOI 10.1016/j.ijbiomac.2006.06.023
   Gopalakrishnan S, 2012, B MATER SCI, V35, P243, DOI 10.1007/s12034-012-0279-5
   Howard T.G., 2002, INT BIODETER BIODEGR, V49, P245
   Ismail AE, 2011, J PET EGYPT, V20, P1
   Jaisankar SN, 1996, POLYM-PLAST TECHNOL, V35, P781, DOI 10.1080/03602559608004060
   Jellinek H. H. G., 1983, DEGRADATION STABILIT, P91
   Kong XH, 2011, INT J ADHES ADHES, V31, P559, DOI 10.1016/j.ijadhadh.2011.05.004
   Lee J, 2006, POLYMER, V47, P3760, DOI 10.1016/j.polymer.2006.03.109
   ligadas GL, 2010, BIOMACROMOLECULES, V11, P2825
   Meier-Westhues U., 2007, POLYURETHANES COATIN
   Mitha MK, 2009, J MATER SCI-MATER M, V20, P203, DOI 10.1007/s10856-008-3518-y
   Mutlu H, 2010, EUR J LIPID SCI TECH, V112, P10, DOI 10.1002/ejlt.200900138
   Ogunniyi DS, 2006, BIORESOURCE TECHNOL, V97, P1086, DOI 10.1016/j.biortech.2005.03.028
   Patel MR, 2009, MATER RES-IBERO-AM J, V12, P385, DOI 10.1590/S1516-14392009000400003
   Phetphaisit CW, 2013, INT J ADHES ADHES, V41, P127, DOI 10.1016/j.ijadhadh.2012.11.007
   Pizzi A, 2006, J ADHES SCI TECHNOL, V20, P829, DOI 10.1163/156856106777638635
   Pizzi A, 2010, WOOD ADHESIVES
   Randall D., 2002, POLYURETHANES BOOK
   Richard Wool P, 2013, NEW POLYM RENEWABLES, P179
   Rodrigues JME, 2005, THERMOCHIM ACTA, V427, P31, DOI 10.1016/j.tca.2004.08.010
   Saunders JH, 1963, POLYURETHANE CHEM TE, P51
   SAUNDERS JH, 1963, POLYURETHANES CHEM 1
   Silva BBR, 2010, INT J ADHES ADHES, V30, P559, DOI 10.1016/j.ijadhadh.2010.07.001
   Singh SP, 2000, P WOOD ADH S LAK TAH
   Somani KP, 2003, INT J ADHES ADHES, V23, P269, DOI 10.1016/S0143-7496(03)00044-7
   Xia Y, 2010, GREEN CHEM, V12, P1893, DOI 10.1039/c0gc00264j
   Yeganeh H, 2004, EUR POLYM J, V40, P1233, DOI 10.1016/j.eurpolymj.2003.12.013
NR 36
TC 9
Z9 10
U1 6
U2 44
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0143-7496
EI 1879-0127
J9 INT J ADHES ADHES
JI Int. J. Adhes. Adhes.
PD JUL
PY 2016
VL 68
BP 273
EP 282
DI 10.1016/j.ijadhadh.2016.04.004
PG 10
WC Engineering, Chemical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA DP4MQ
UT WOS:000378470400032
DA 2018-10-20
ER

PT J
AU Aminabadi, NA
   Satrab, S
   Najafpour, E
   Samiei, M
   Jamali, Z
   Shirazi, S
AF Aminabadi, Naser Asl
   Satrab, Soheil
   Najafpour, Ebrahim
   Samiei, Mohammad
   Jamali, Zahra
   Shirazi, Sajjad
TI A randomized trial of direct pulp capping in primary molars using MTA
   compared to 3Mixtatin: a novel pulp capping biomaterial
SO INTERNATIONAL JOURNAL OF PAEDIATRIC DENTISTRY
LA English
DT Article
ID MINERAL TRIOXIDE AGGREGATE; HUMAN DENTAL-PULP; IN-VITRO; REDUCTASE
   INHIBITOR; PRIMARY TEETH; SIMVASTATIN; CELLS; STATINS; INFLAMMATION;
   PATHWAY
AB ObjectiveThis study aimed to examine the efficacy of 3Mixtatin (a combination of simvastatin and 3Mix antibiotic) as a novel pulp capping biomaterial in DPC of human primary molars.
   MethodsIn this randomized clinical trial, 160 primary molars from 83 healthy children aged 3-6 years were randomly allocated into four groups. Small traumatic non-caries pulpal exposures were treated by DPC using simvastatin, 3Mix, 3Mixtatin, or MTA. Capping materials were covered with hard-setting zinc oxide eugenol (ZOE) cement, and then, teeth were restored with amalgam. Clinical and radiographic examinations were conducted at 2, 6, and 12 months after treatment. The data were compared using chi-square test at a significance level of 0.05.
   ResultsOne hundred and twenty-nine teeth were available for follow-up study. By the end of 12 months, the overall success rates were 93.8% in MTA, 91.9% in 3Mixtatin, 62.5% in 3Mix, and 57.1% in simvastatingroups. No statistically significant difference was found between the outcomes of MTA and 3Mixtatin groups (P > 0.05). 3Mixtatin had statistically superior results compared to 3Mix and simvastatin (P < 0.01).
   ConclusionRadiographic and clinical outcomes in 3Mixtatin group could suggest it as an acceptable alternative in DPC of primary molar teeth.
C1 [Aminabadi, Naser Asl; Satrab, Soheil; Najafpour, Ebrahim] Tabriz Univ Med Sci, Dept Paediat Dent, Fac Dent, Tabriz, East Azerbaijan, Iran.
   [Samiei, Mohammad] Tabriz Univ Med Sci, Dept Endodont, Fac Dent, Tabriz, East Azerbaijan, Iran.
   [Jamali, Zahra] Tabriz Univ Med Sci, Dept Oral Sci, Fac Dent, Tabriz, East Azerbaijan, Iran.
   [Shirazi, Sajjad] Tabriz Univ Med Sci, Student Res Comm, Fac Dent, Tabriz, East Azerbaijan, Iran.
   [Shirazi, Sajjad] Tabriz Univ Med Sci, Dent & Periodontal Res Ctr, Tabriz, East Azerbaijan, Iran.
RP Aminabadi, NA (reprint author), Tabriz Univ Med Sci, Dept Paediat Dent, Fac Dent, Tabriz, East Azerbaijan, Iran.
EM aslaminabadi@gmail.com
RI satrab, soheil/L-4388-2016; jamali, zahra/F-6325-2017; Shirazi,
   Sajjad/L-7133-2017; Asl Aminabadi, Naser/F-6669-2017; aminabadi,
   naser/L-5731-2017; najafpour, ebrahim/F-5924-2017
OI satrab, soheil/0000-0002-4145-2770; jamali, zahra/0000-0002-9214-0574;
   Shirazi, Sajjad/0000-0002-3996-6772; Asl Aminabadi,
   Naser/0000-0002-6624-4994; aminabadi, naser/0000-0002-6624-4994;
   najafpour, ebrahim/0000-0002-9505-4735
FU Tabriz University of Medical Sciences
FX This study was supported and funded by Tabriz University of Medical
   Sciences. The authors would like to thank the staff at the Department of
   Pediatric Dentistry for their assistance, and the parents and children
   for participating in the study.
CR Ahn KS, 2008, INT J CANCER, V123, P1733, DOI 10.1002/ijc.23745
   Aminabadi NA, J CLIN PEDI IN PRESS
   Antoniades C, 2010, CIRCULATION, V122, pS66, DOI 10.1161/CIRCULATIONAHA.109.927376
   Bodem O, 2004, Int J Paediatr Dent, V14, P376, DOI 10.1111/j.1365-263X.2004.00547.x
   Borkar Swati A, 2015, J Conserv Dent, V18, P73, DOI 10.4103/0972-0707.148901
   Bulcao C, 2007, AM J CARDIOVASC DRUG, V7, P219, DOI 10.2165/00129784-200707030-00007
   Burrus D, 2014, INT J PAEDIATR DENT, V36, P240
   Dammaschke T, 2010, CLIN ORAL INVEST, V14, P559, DOI 10.1007/s00784-009-0326-9
   Dammaschke Till, 2008, J Hist Dent, V56, P9
   Desager JP, 1996, CLIN PHARMACOKINET, V31, P348, DOI 10.2165/00003088-199631050-00003
   Fuks A, 2013, PEDIAT DENT INFANCY, P490
   Fuks A, 2013, PEDIAT DENT INFANCY, P333
   Hilton TJ, 2013, J DENT RES, V92, pS16, DOI 10.1177/0022034513484336
   HOSHINO E, 1992, INT ENDOD J, V25, P2, DOI 10.1111/j.1365-2591.1992.tb00941.x
   Hughes A, 2007, CALCIFIED TISSUE INT, V81, P403, DOI 10.1007/s00223-007-9078-1
   Jung IY, 2008, J ENDODONT, V34, P876, DOI 10.1016/j.joen.2008.03.023
   Kaji H, 2008, HORM METAB RES, V40, P746, DOI 10.1055/s-0028-1082051
   Kureishi Y, 2000, NAT MED, V6, P1004
   Lin SK, 2009, J ENDODONT, V35, P657, DOI 10.1016/j.joen.2009.02.004
   Min KS, 2010, J ENDODONT, V36, P447, DOI 10.1016/j.joen.2009.11.021
   Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946
   Murray PE, 2002, DENT MATER, V18, P470, DOI 10.1016/S0109-5641(01)00072-0
   Nair PNR, 2008, INT ENDOD J, V41, P128
   Nie P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097009
   Nyan M, 2010, J BIOMED MATER RES B, V93B, P65, DOI 10.1002/jbm.b.31559
   Okamoto Y, 2009, J ENDODONT, V35, P367, DOI 10.1016/j.joen.2008.11.024
   Parirokh M, 2010, J ENDODONT, V36, P400, DOI 10.1016/j.joen.2009.09.009
   Park JB, 2012, J SURG RES, V174, P278, DOI 10.1016/j.jss.2010.12.029
   Pettiette MT, 2013, J ENDODONT, V39, P1119, DOI 10.1016/j.joen.2013.06.005
   Phumpatrakom P, 2014, J ENDODONT, V40, P399, DOI 10.1016/j.joen.2013.09.027
   Quispe-Salcedo A, 2014, J ENDODONT, V40, P1566, DOI 10.1016/j.joen.2014.05.005
   Sakoda K, 2006, J DENT RES, V85, P520, DOI 10.1177/154405910608500608
   Takushige T, 2004, INT ENDOD J, V37, P132, DOI 10.1111/j.0143-2885.2004.00771.x
   Takushige T, 2009, J LSTR THER, V8, P3
   Tanaka Yoshiya, 2005, Current Drug Targets - Inflammation and Allergy, V4, P325, DOI 10.2174/1568010054022015
   Trairatvorakul C, 2014, INT J PAEDIATR DENT, V24, P23, DOI 10.1111/ipd.12022
   Tuna D, 2008, INT ENDOD J, V41, P273, DOI 10.1111/j.1365-2591.2007.01339.x
   Vij R, 2004, PEDIATR DENT, V26, P214
   Zeiser R, 2007, BLOOD, V110, P4588, DOI 10.1182/blood-2007-08-106005
NR 39
TC 8
Z9 8
U1 0
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0960-7439
EI 1365-263X
J9 INT J PAEDIATR DENT
JI Int. J. Paediatr. Dent.
PD JUL
PY 2016
VL 26
IS 4
BP 281
EP 290
DI 10.1111/ipd.12196
PG 10
WC Dentistry, Oral Surgery & Medicine; Pediatrics
SC Dentistry, Oral Surgery & Medicine; Pediatrics
GA DP6TU
UT WOS:000378632500006
PM 26370520
DA 2018-10-20
ER

PT J
AU Komorowski, P
   Walkowiak-Przybylo, M
   Walkowiak, B
AF Komorowski, Piotr
   Walkowiak-Przybylo, Magdalena
   Walkowiak, Bogdan
TI Early cell response to contact with biomaterial's surface
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE biomaterials; transcriptomics; microarrays; two-dimensional
   electrophoresis; mass spectrometry
ID PARYLENE-C; EXPRESSION; COMPLICATIONS; ARTHROPLASTY; REMOVAL
AB Most biomaterials at present have sufficient mechanical properties; however compliance with standards for biocompatibility is often not sufficient in clinical practice. This may be due to the complexity of biological systems in general and the diversity of individual responses to these materials by implant recipients. Significant improvement of biocompatibility must involve surface modification of implants, which in the future will make it possible to introduce individually selected types of surface modification for individual recipients. The key to this technology seems to be understanding the processes occurring at the site of contact of the implant with the tissue. Processes resulting from the stress generated by the contact of the biomaterial surfaces were observed with endothelial cells line EA.hy926, and it was demonstrated that differently modified surfaces of medical steel (polished medical steel and medical steel coated with Parylene C and nanocrystalline diamond) cause diverse cellular response in cells grown on these surfaces, on both the cellular (cell morphology and cell survival) and molecular (transcriptome and proteome profiles) levels. The herein presented observations are a good starting point not only for further research and the development of far-reaching personalization of medical implants, but also to study the potential use of cells as a specific sensor capable of recognizing different surfaces with which these cells come into contact. (c) 2015 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 104B: 880-893, 2016.
C1 [Komorowski, Piotr; Walkowiak-Przybylo, Magdalena; Walkowiak, Bogdan] Lodz Univ Technol, Inst Mat Sci, Dept Biophys, Lodz, Poland.
   [Komorowski, Piotr; Walkowiak-Przybylo, Magdalena; Walkowiak, Bogdan] BioTechMed Adv Technol Ctr, Lodz, Poland.
   [Komorowski, Piotr; Walkowiak, Bogdan] BioNanoPk Labs Lodz Reg Pk Sci & Technol, Lodz, Poland.
RP Komorowski, P (reprint author), Lodz Univ Technol, Inst Mat Sci, Dept Biophys, Lodz, Poland.; Komorowski, P (reprint author), BioTechMed Adv Technol Ctr, Lodz, Poland.; Komorowski, P (reprint author), BioNanoPk Labs Lodz Reg Pk Sci & Technol, Lodz, Poland.
EM piotr.komorowski@p.lodz.pl
FU Ministry of Science and Higher Education of Poland [N N507 456034]
FX Contract grant sponsor: Ministry of Science and Higher Education of
   Poland; contract grant number: N N507 456034
CR Allen LT, 2003, P NATL ACAD SCI USA, V100, P6331, DOI 10.1073/pnas.1031426100
   [Anonymous], 10993 EN ISO
   Chang TY, 2007, LANGMUIR, V23, P11718, DOI 10.1021/la7017049
   Chatterjee N, 2014, BIOMATERIALS, V35, P1109, DOI 10.1016/j.biomaterials.2013.09.108
   Dinnes DLM, 2007, J BIOMED MATER RES A, V80A, P895, DOI 10.1002/jbm.a.30967
   Favard L, 2013, ORTHOP TRAUMATOL-SUR, V99, pS12, DOI 10.1016/j.otsr.2012.11.010
   Gallagher WM, 2006, BIOMATERIALS, V27, P5871, DOI 10.1016/j.biomaterials.2006.07.040
   Gazicld-Lipman M., 2007, J VAC SOC JPN, V50, P601
   Jakubowski W, 2004, DIAM RELAT MATER, V13, P1761, DOI 10.1016/j.diamond.2004.03.003
   Kaminska M, 2009, ACTA BIOENG BIOMECH, V11, P19
   Kato S, 1997, J BIOMAT SCI-POLYM E, V8, P809, DOI 10.1163/156856297X00335
   Ku CH, 2002, BIOMATERIALS, V23, P4193, DOI 10.1016/S0142-9612(02)00161-8
   McNamara LE, 2012, BIOMATERIALS, V33, P2835, DOI 10.1016/j.biomaterials.2011.11.047
   Mitura S, 1999, CHAOS SOLITON FRACT, V10, P2165, DOI 10.1016/S0960-0779(98)00251-3
   Morris MJ, 2013, KNEE, V20, P218, DOI 10.1016/j.knee.2012.10.019
   Okroj W, 2006, DIAM RELAT MATER, V15, P1535, DOI 10.1016/j.diamond.2005.12.033
   Richards AL, 2012, OPHTHAL PLAST RECONS, V28, P455, DOI 10.1097/IOP.0b013e3182696515
   Timms JF, 2008, PROTEOMICS, V8, P4886, DOI 10.1002/pmic.200800298
   Vos DI, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-147
   Walkowiak B, 2001, NEW PERSPECT BIO, P458
   Walkowiak B, 2012, Patent No. [P-399899, 399899]
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
NR 22
TC 2
Z9 2
U1 0
U2 12
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JUL
PY 2016
VL 104
IS 5
BP 880
EP 893
DI 10.1002/jbm.b.33439
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DP6TL
UT WOS:000378631600004
PM 25951795
DA 2018-10-20
ER

PT J
AU Esfahanizadeh, N
   Motalebi, S
   Daneshparvar, N
   Akhoundi, N
   Bonakdar, S
AF Esfahanizadeh, Nasrin
   Motalebi, Sara
   Daneshparvar, Niloufar
   Akhoundi, Nasrin
   Bonakdar, Shahin
TI Morphology, proliferation, and gene expression of gingival fibroblasts
   on Laser-Lok, titanium, and zirconia surfaces
SO LASERS IN MEDICAL SCIENCE
LA English
DT Article
DE Fibroblasts; Implant abutment; Laser-Lok; Titanium; Zirconia
ID DEFINED BIOMATERIAL SURFACES; CONNECTIVE-TISSUE ATTACHMENT; DENTAL
   IMPLANTS; IN-VITRO; SOFT-TISSUE; HISTOLOGIC EVIDENCE; TREATED TITANIUM;
   OSTEOBLAST; BEHAVIOR; CELLS
AB Soft tissue seal plays a critical role in long-term success of dental implants, and the effects of implant surface treatments such as laser ablation have been a topic of particular interest in this respect. Considering the existing controversy regarding soft tissue behavior in contact with implant surfaces, this study sought to assess the morphology, proliferation, and gene expression of human gingival fibroblasts (HGFs) on different abutment surfaces. In this in vitro, experimental study, HGFs were cultured on 45 discs (Laser-Lok, titanium, and zirconia). Cell morphology, proliferation rate, and interleukin 10 (IL-10), tumor necrosis factor alpha (TNF alpha), fibronectin, and integrin gene expressions were assessed by electron microscopy, methyl thiazol tetrazolium (MTT) assay, and real-time polymerase chain reaction (PCR), respectively. Data were analyzed using ANOVA and the Kruskal-Wallis H test. Fibroblast attachment was noted in all the three groups. Spindle-shaped cells with pseudopod-like processes were more frequently seen in the Laser-Lok group. Cell proliferation was significantly higher in the Laser-Lok group compared to those in the other groups (P = 0.0002). Significant differences were found in the expression of IL-10, TNF alpha, fibronectin, and integrin genes among the groups (P < 0.01). Within the limitations of this study, HGFs on Laser-Lok surfaces had a more mature morphology and greater proliferation and differentiation as compared to those on zirconia and titanium surfaces. This indicates better attachment of these cells to laser-modified surfaces, creating a more efficient soft tissue seal around dental implants.
C1 [Esfahanizadeh, Nasrin; Motalebi, Sara] Islamic Azad Univ, Dent Branch, Dept Periodont, Tehran, Iran.
   [Esfahanizadeh, Nasrin] Univ Tehran Med Sci, Dent Implant Res Ctr, Tehran, Iran.
   [Daneshparvar, Niloufar] 1501 Harvey Rd,586, College Stn, TX 77840 USA.
   [Akhoundi, Nasrin] Islamic Azad Univ, South Tehran Branch, Dept Math, Tehran, Iran.
   [Bonakdar, Shahin] Pasteur Inst Iran, Natl Cell Bank Iran, Tehran, Iran.
RP Daneshparvar, N (reprint author), 1501 Harvey Rd,586, College Stn, TX 77840 USA.
EM nildan89@yahoo.com
OI Bonakdar, Shahin/0000-0001-8759-3790
CR Al Mustafa M, 2015, CLIN ORAL IMPLAN RES, V26, P15, DOI 10.1111/clr.12294
   Alberts B, 2002, MOL BIOL CELL
   Atsuta I, 2014, CLIN IMPLANT DENT R, V16, P772, DOI 10.1111/cid.12043
   Bachle M, 2004, CLIN ORAL IMPLAN RES, V15, P683, DOI 10.1111/j.1600-0501.2004.01054.x
   Baltriukiene D, 2014, J BIOMED MATER RES A, V102, P713, DOI 10.1002/jbm.a.34739
   Berglundh T, 1991, CLIN ORAL IMPLAN RES, V2, P81, DOI 10.1034/j.1600-0501.1991.020206.x
   Bonakdar S, 2010, MAT SCI ENG C-MATER, V30, P636, DOI 10.1016/j.msec.2010.02.017
   Brunette D M, 1988, Int J Oral Maxillofac Implants, V3, P231
   Canullo L, 2014, MED ORAL PATOL ORAL, V19, P177
   Cochran DL, 1977, PERIODONTOL, V68, P186
   Di Giulio M, 2016, CLIN ORAL IMPLAN RES, V27, P918, DOI 10.1111/clr.12659
   Fenner N, 2015, CLIN ORAL IMPLAN RES, DOI [10.1111/clr.12654, DOI 10.1111/CLR.12654]
   Frankova J, 2013, J BIOMED MATER RES A, V101, P2915, DOI 10.1002/jbm.a.34598
   Geurs NC, 2011, CLIN ADV PERIODONTIC, V1, P29, DOI 10.1902/cap.2011.100005
   Gomez-Florit M, 2014, J PERIODONTAL RES, V49, P425, DOI 10.1111/jre.12121
   Gomez-Florit M, 2014, J DENT, V42, P30, DOI 10.1016/j.jdent.2013.11.003
   Grew JC, 2008, J BIOMED MATER RES A, V85A, P326, DOI 10.1002/jbm.a.31378
   Groner-Schreiber B., 2006, CLIN ORAL IMPLAN RES, V17, P736, DOI [10.1111/j.1600-0501.2006.01277.x17092235, DOI 10.1111/J.1600-0501.2006.01277.X]
   Heinrich A, 2008, LASER MED SCI, V23, P55, DOI 10.1007/s10103-007-0460-z
   Kearns VR, 2013, J CLIN PERIODONTOL, V40, P99, DOI 10.1111/jcpe.12025
   Ketabi M, 2013, INT J PERIODONT REST, V33, pE145, DOI 10.11607/prd.1629
   Khosroshahi ME, 2009, LASER MED SCI, V24, P925, DOI 10.1007/s10103-008-0628-1
   Kunzler TP, 2007, BIOMATERIALS, V28, P2175, DOI 10.1016/j.biomaterials.2007.01.019
   Lee DW, 2015, J ADV PROSTHODONT, V7, P138, DOI 10.4047/jap.2015.7.2.138
   Mackay IM, 2002, NUCLEIC ACIDS RES, V30, P1292, DOI 10.1093/nar/30.6.1292
   Meyer U, 2004, BIOMATERIALS, V25, P1959, DOI 10.1016/j.biomaterials.2003.08.070
   Miura S, 2012, J PROSTHODONT RES, V56, P178, DOI 10.1016/j.jpor.2011.11.004
   Nevins M, 2008, INT J PERIODONT REST, V28, P111
   Nevins M, 2013, INT J PERIODONT REST, V33, P261, DOI 10.11607/prd.1773
   Nevins M, 2010, INT J PERIODONT REST, V30, P245
   Newman Michael G., 2012, CARRANZAS CLIN PERIO
   Nothdurft FP, 2014, CLIN IMP DENT RELATE, V16, P640
   Ouyong W, 2011, ANNU REV IMMUNOL, V29, P71
   Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059
   Pecora GE, 2009, IMPLANT DENT, V18, P57, DOI 10.1097/ID.0b013e31818c5a6d
   Ricci JL, 2008, J BIOMED MATER RES A, V85A, P313, DOI 10.1002/jbm.a.31379
   Rutkunas V, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5481-8
   Schartz-Filho HD, 2012, J BIOMED MATER RES A, V100, P2629
   Thoma DS, 2011, J PERIODONTOL, V82, P1453, DOI 10.1902/jop.2010.100737
   Traini T, 2011, QUINTESSENCE INT, V42, P103
   TRYLOVICH DJ, 1992, J PERIODONTOL, V63, P626, DOI 10.1902/jop.1992.63.7.626
   Weiner S, 2008, IMPLANT DENT, V17, P217, DOI 10.1097/ID.0b013e3181779016
   Zhu XL, 2004, BIOMATERIALS, V25, P4087, DOI 10.1016/j.biomaterials.2003.11.011
NR 43
TC 5
Z9 6
U1 0
U2 17
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0268-8921
EI 1435-604X
J9 LASER MED SCI
JI Lasers Med. Sci.
PD JUL
PY 2016
VL 31
IS 5
BP 863
EP 873
DI 10.1007/s10103-016-1927-6
PG 11
WC Engineering, Biomedical; Surgery
SC Engineering; Surgery
GA DP5NB
UT WOS:000378543200007
PM 27025859
DA 2018-10-20
ER

PT J
AU Malakhov, A
   Wen, J
   Zhang, BX
   Wang, H
   Geng, H
   Chen, XD
   Sun, Y
   Yeh, CK
AF Malakhov, A.
   Wen, J.
   Zhang, B-X
   Wang, H.
   Geng, H.
   Chen, X-D
   Sun, Y.
   Yeh, C-K
TI Rechargeable anticandidal denture material with sustained release in
   saliva
SO ORAL DISEASES
LA English
DT Article
DE Candida-associated denture stomatitis; antifungal treatment; drug
   delivery; rechargeable biomaterial
ID CANDIDA-ALBICANS; BIOFILM FORMATION; IN-VITRO; TISSUE CONDITIONERS;
   ANTIFUNGAL ACTIVITY; SILVER-ZEOLITE; DRUG-RELEASE; STOMATITIS;
   MICONAZOLE; RESISTANCE
AB ObjectiveCandida-induced denture stomatitis is a common debilitating problem among denture wearers. Previously, we described the fabrication of a new denture material that released antifungal drugs when immersed in phosphate buffered saline. Here, we use more clinically relevant immersion conditions (human saliva; 37 degrees C) and measure miconazole release and bioactivity.
   Materials and MethodsDisks were prepared by grafting PNVP [poly(N-vinyl-2-pyrrolidinone)] onto PMMA [poly(methylmethacrylate)] using plasma initiation (PMMA-g-PNVP) and then loaded with miconazole. Drug-loaded disks were immersed in 10-100% human saliva (1-30days). Miconazole release was measured and then tested for bioactivity vs miconazole-sensitive and miconazole-resistant Candida isolates.
   ResultsHPLC was used to quantify miconazole levels in saliva. Miconazole-loaded disks released antifungal drug for up to 30days. Higher drug release was found with higher concentrations of saliva, and, interestingly, miconazole solubility was increased with higher saliva concentrations. The released miconazole retained its anticandidal activity. After immersion, the residual miconazole could be quenched and the disks recharged. Freshly recharged disks displayed the same release kinetics and bioactivity as the original disks. Quenched disks could also be charged with chlorhexidine that displayed anticandidal activity.
   ConclusionsThese results suggest that PMMA-g-PNVP is a promising new denture material for long-term management of denture stomatitis.
C1 [Malakhov, A.; Zhang, B-X; Wang, H.; Chen, X-D; Yeh, C-K] South Texas Vet Hlth Care Syst, Educ & Clin Ctr, Geriatr Res, San Antonio, TX 78229 USA.
   [Malakhov, A.; Zhang, B-X; Wang, H.; Chen, X-D; Yeh, C-K] South Texas Vet Hlth Care Syst, Res Serv, Audie L Murphy Div, San Antonio, TX 78229 USA.
   [Malakhov, A.; Zhang, B-X; Wang, H.; Chen, X-D; Yeh, C-K] Univ Texas Hlth Sci Ctr San Antonio, Dept Comprehens Dent, San Antonio, TX 78229 USA.
   [Wen, J.; Sun, Y.] Univ Massachusetts, Dept Chem, Lowell, MA USA.
   [Geng, H.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA.
RP Yeh, CK (reprint author), South Texas Vet Hlth Care Syst, Educ & Clin Ctr, Geriatr Res, San Antonio, TX 78229 USA.; Yeh, CK (reprint author), South Texas Vet Hlth Care Syst, Res Serv, Audie L Murphy Div, San Antonio, TX 78229 USA.
EM yeh@uthscsa.edu
OI Wen, Jianchuan/0000-0002-0993-1042
FU NIH; NIDCR T-32 [DE021084, DE014318]; COSTAR Program; VA Merit Review
   [1I01BX001103]
FX This study was supported by NIH and NIDCR T-32 grants DE021084,
   DE014318, the COSTAR Program, and a VA Merit Review (1I01BX001103). We
   are grateful to Dr. Nathan Wiederhold, Director of the Fungal Testing
   Laboratory (UTHSCSA), for kindly providing the Candida isolates used in
   this study and to Dr. David Dean (Professor, Comprehensive Dentistry,
   UTHSCSA) for his scientific input and careful editing of the manuscript.
   The authors declared no potential conflict of interests with respect to
   the authorship and/or publication of this article.
CR Abe Y, 2004, J ORAL REHABIL, V31, P568, DOI 10.1111/j.1365-2842.2004.01267.x
   ARENDORF TM, 1987, J ORAL REHABIL, V14, P217, DOI 10.1111/j.1365-2842.1987.tb00713.x
   BRODIE RR, 1978, J CHROMATOGR, V155, P209, DOI 10.1016/S0021-9673(00)83955-2
   Cao Z, 2010, J DENT RES, V89, P1517, DOI 10.1177/0022034510379604
   CAVRINI V, 1981, PHARM ACTA HELV, V56, P163
   Chandra J, 2001, J DENT RES, V80, P903, DOI 10.1177/00220345010800031101
   Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001
   Chow C K, 1999, Gerodontology, V16, P110, DOI 10.1111/j.1741-2358.1999.00110.x
   Dorko E, 2005, FOLIA MICROBIOL, V50, P255, DOI 10.1007/BF02931574
   Douglass CW, 2002, J PROSTHET DENT, V87, P5, DOI 10.1067/mpr.2002.121203
   Golecka M, 2006, TRANSPLANT P, V38, P155, DOI 10.1016/j.transproceed.2005.12.078
   Kalachandra S, 2002, J MATER SCI-MATER M, V13, P53, DOI 10.1023/A:1013634518797
   Lamfon H, 2005, FEMS MICROBIOL LETT, V242, P345, DOI 10.1016/j.femsle.2004.11.032
   Lefebvre CA, 2001, J PROSTHET DENT, V85, P352, DOI [10.1067/mpr.2001.115249, 10.1067/mpr.2001.1152491]
   Lin DM, 2003, DENT MATER, V19, P589, DOI 10.1016/S0109-5641(02)00109-4
   MAKSYMIUK AW, 1984, AM J MED, V77, P20
   Matsuura T, 1997, J DENT, V25, P373, DOI 10.1016/S0300-5712(96)00050-4
   MUSIAL C E, 1988, Clinical Microbiology Reviews, V1, P349
   Nikawa H, 2003, J ORAL REHABIL, V30, P243, DOI 10.1046/j.1365-2842.2003.01024.x
   Nikawa H, 1998, J DENT, V26, P299, DOI 10.1016/S0300-5712(97)00026-2
   Pereira-Cenci T, 2008, J APPL ORAL SCI, V16, P86, DOI 10.1590/S1678-77572008000200002
   Perezous LF, 2005, J PROSTHET DENT, V93, P288, DOI 10.1016/j.prosdent.2004.11.015
   Pesci-Bardon C, 2006, Gerodontology, V23, P111, DOI 10.1111/j.1741-2358.2006.00088.x
   QUINN DM, 1985, J ORAL REHABIL, V12, P177, DOI 10.1111/j.1365-2842.1985.tb00633.x
   Ramage G, 2004, ORAL SURG ORAL MED O, V98, P53, DOI 10.1016/j.tripleo.2003.04.002
   Redding S, 2009, ORAL SURG ORAL MED O, V107, P669, DOI 10.1016/j.tripleo.2009.01.021
   Schneid T R, 1992, Spec Care Dentist, V12, P245, DOI 10.1111/j.1754-4505.1992.tb00458.x
   Sun XB, 2013, COLLOID SURFACE B, V110, P96, DOI 10.1016/j.colsurfb.2013.04.043
   tensCate J. M., 2009, J DENT RES, V88, P105
   TRUHLAR MR, 1994, J PROSTHET DENT, V71, P517, DOI 10.1016/0022-3913(94)90193-7
   TURNER A, 1982, J CHROMATOGR, V227, P229, DOI 10.1016/S0378-4347(00)80377-1
   Villar CC, 2013, ORAL DIS, V19, P287, DOI 10.1111/odi.12000
   Webb BC, 1998, AUST DENT J, V43, P45, DOI 10.1111/j.1834-7819.1998.tb00152.x
NR 33
TC 1
Z9 1
U1 0
U2 6
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1354-523X
EI 1601-0825
J9 ORAL DIS
JI Oral Dis.
PD JUL
PY 2016
VL 22
IS 5
BP 391
EP 398
DI 10.1111/odi.12456
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA DP6WA
UT WOS:000378638800007
PM 26855200
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Teligui, L
   Dalmayrac, E
   Corbeau, JJ
   Bouquet, E
   Godon, A
   Denomme, AS
   Binuani, P
   Verron, L
   Boer, C
   Baufreton, C
AF Teligui, Leylah
   Dalmayrac, Emilie
   Corbeau, Jean-Jacques
   Bouquet, Emmanuelle
   Godon, Alban
   Denomme, Anne-Sophie
   Binuani, Partrice
   Verron, Laurence
   Boer, Christa
   Baufreton, Christophe
TI Ex vivo simulation of cardiopulmonary bypass with human blood for
   hemocompatibility testing
SO PERFUSION-UK
LA English
DT Article
DE cardiopulmonary bypass; hemostasis; biosurface; coating; heparin
ID EXTRACORPOREAL-CIRCULATION; HEPARIN; COAGULATION; COMPLEMENT;
   ACTIVATION; BIOCOMPATIBILITY; BIOMATERIAL; GENERATION; COATINGS;
   CIRCUITS
AB Object: Experimental circuits for biomaterial surface testing are frequently limited by the tested blood volume, composition of the circuit, flow conditions and the use of animal blood. This report describes an ex vivo set-up for simulated cardiopulmonary bypass with human blood perfusion. We investigated the clinical generalizability of the observed effects on hematological and metabolic parameters and the hemocompatibility of the system.
   Methods: The simulated cardiopulmonary bypass circuit consisted of a heparin-coated tubing system connected to an oxygenator and a venous reservoir. Normothermic flow of blood obtained from healthy donors was maintained at 2.4 L/min/m(2) by a roller pump. Heparin was dosed to obtain a target activated clotting time (ACT) 500 s. Blood was drawn at baseline and 0, 10, 60 and 120 minutes following the initiation of blood flow to determine hematological and metabolic parameters and the hemocompatibility of the extracorporeal system. Data were analyzed using repeated measures ANOVA.
   Results: Two hours of blood perfusion resulted in a small, but clinically unimportant reduction in hematocrit, whereas hemoglobin levels and red blood cell, platelet and leukocyte counts remained stable. There was a significant increase in ACT throughout the experiment. While pO(2) levels and the pH remained unaltered during the experiment, pCO(2) values decreased from 51 6 mmHg at T0 to 41 +/- 3 mmHg at T120 (p<0.001). Simulated cardiopulmonary bypass induced a two-fold increase in C3a (p=0.001) while tissue factor was decreased from 44 +/- 14 pg/mL at T0 to 38 +/- 13 pg/mL at T120 (p=0.009). Levels of CD40L, prothrombin fragment 1+2, -thromboglobulin and factor VIIa remained stable over time.
   Conclusion: The ex vivo set-up for simulated cardiopulmonary bypass mimicked the clinical cardiosurgical setting. Exposure of fresh donor blood to the extracorporeal circuit showed a good hemocompatibility, indicated by maintained hematological parameters and a mild immune response.
C1 [Teligui, Leylah; Dalmayrac, Emilie; Bouquet, Emmanuelle; Binuani, Partrice; Verron, Laurence; Baufreton, Christophe] Univ Hosp Angers, Dept Cardiac & Thorac Surg, Angers, France.
   [Teligui, Leylah; Boer, Christa] Vrije Univ Amsterdam, Med Ctr, Inst Cardiovasc Res, Dept Anesthesiol, Amsterdam, Netherlands.
   [Corbeau, Jean-Jacques] Univ Hosp Angers, Dept Anesthesiol, Angers, France.
   [Godon, Alban] Univ Hosp Angers, Lab Hematol, Angers, France.
   [Denomme, Anne-Sophie] Univ Hosp Angers, Immunol Lab, Angers, France.
RP Boer, C (reprint author), Vrije Univ Amsterdam, Med Ctr, Dept Anesthesiol, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands.
EM c.boer@vumc.nl
OI Boer, Christa/0000-0002-7781-6951; Denomme-Pichon,
   Anne-Sophie/0000-0002-8986-8222
FU Medtronic France S.A.S.; Boulogne-Billancourt, France
FX All materials for the extracorporeal circuit used in the present
   manuscript were provided by Medtronic France S.A.S.,
   Boulogne-Billancourt, France.
CR Baufreton C, 1998, ANN THORAC SURG, V66, P1837, DOI 10.1016/S0003-4975(98)00726-7
   De Somer Filip, 2007, J Extra Corpor Technol, V39, P285
   Gong J, 1996, J CLIN IMMUNOL, V16, P222, DOI 10.1007/BF01541228
   Jacobs S, 2011, PERFUSION-UK, V26, P496, DOI 10.1177/0267659111415146
   Johnson G, 2013, J BIOMATER APPL, V27, P925, DOI 10.1177/0885328211428525
   Kessler U, 2011, THROMB RES, V128, P477, DOI 10.1016/j.thromres.2011.03.013
   Korn RL, 1996, J THORAC CARDIOV SUR, V111, P1073, DOI 10.1016/S0022-5223(96)70384-7
   LARM O, 1983, BIOMATER ARTIF CELL, V11, P161, DOI 10.3109/10731198309118804
   Mollnes TE, 1998, VOX SANG, V74, P303, DOI 10.1111/j.1423-0410.1998.tb05435.x
   Morizumi S, 2014, J CARDIAC SURG, V29, P35, DOI 10.1111/jocs.12254
   Munch K, 2000, J BIOMAT SCI-POLYM E, V11, P1147, DOI 10.1163/156856200744246
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   Paparella D, 2004, INTENS CARE MED, V30, P1873, DOI 10.1007/s00134-004-2388-0
   PEKNA M, 1993, CLIN EXP IMMUNOL, V91, P404
   Seyfert UT, 2007, J BIOMED BIOTECHNOL, V10, P29464
   Siller-Matula JM, 2008, THROMB HAEMOSTASIS, V100, P397, DOI 10.1160/TH08-02-0103
   Stevens KN, 2002, BIOMOL ENG, V19, P91
   Tayama E, 2000, ARTIF ORGANS, V24, P618, DOI 10.1046/j.1525-1594.2000.06615.x
   Te Velthuis Henk, 1997, Journal of Thoracic and Cardiovascular Surgery, V114, P117, DOI 10.1016/S0022-5223(97)70124-7
   Teligui L, 2014, INTERACT CARDIOV TH, V18, P763, DOI 10.1093/icvts/ivu011
   van Oeveren W, 2012, INT J BIOMATER, DOI 10.1155/2012/673163
   Weber N, 2000, J BIOMATER APPL, V15, P8, DOI 10.1106/DUYU-CEL6-529C-WUL9
   Wendel HP, 1996, IMMUNOPHARMACOLOGY, V32, P128, DOI 10.1016/0162-3109(95)00073-9
NR 23
TC 1
Z9 2
U1 4
U2 8
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0267-6591
EI 1477-111X
J9 PERFUSION-UK
JI Perfusion-UK
PD JUL
PY 2016
VL 31
IS 5
BP 376
EP 383
DI 10.1177/0267659115599454
PG 8
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA DP6DQ
UT WOS:000378587500004
PM 26243277
DA 2018-10-20
ER

PT J
AU Gorgulu, T
   Akcal, A
   Ugurlu, K
AF Gorgulu, Tahsin
   Akcal, Arzu
   Ugurlu, Kemal
TI Use of human nail for reconstruction of the orbital floor: an
   experimental study in rabbits
SO BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY
LA English
DT Article
DE Orbital floor reconstruction; Human nail; Biomaterial; Experimental
ID CREUTZFELDT-JAKOB-DISEASE; CERAMIC IMPLANTS; CRANIAL BONE; GRAFT;
   FRACTURE; AUTOGRAFTS; SURGERY; MESH
AB The orbital floor is the thinnest part of the orbital wall, and in 20% of all maxillofacial injuries it is fractured. Autografts, allografts, and alloplastic materials are used in reconstruction, but there is no consensus about which material is the most appropriate. Nail is a semirigid material that is easy to reshape and is not antigenic. Alloplastic materials, which are used in reconstructions of the orbital floor, have various complications and are expensive. Autografts have donor-site problems, high rates of resorption, and take a long time to do. We created bilateral 10 mm defects in the orbital floors in 18 New Zealand rabbits. We reconstructed the left orbital floors with double-ground human nail while the right orbital floors were left open as controls. The orbital floors were examined macroscopically and microscopically at 4, 8, and 12 weeks postoperatively, and there were no macroscopic signs of infection, inflammation, or extrusion. Forced duction tests showed that it was possible to induce movement of the eyeball for all 18 of the reconstructed sides throughout the observation period, and in 14 of the 18 rabbits on the control sides. Positive forced duction test shows us that orbital muscles are trapped in orbital floor defect and due to this movement of eyeball is restricted. Acute and chronic inflammation, fibrosis, vascularisation, and the presence of foreign body giant cells were evaluated microscopically. Acute inflammation and the presence of foreign body giant cells were recorded as mild, whereas fibrosis, chronic inflammation, and vascularisation were severe, as were epithelialisation on the maxillary sinus side of the nails, calcification, and progression of collagen. We found no signs of resorption of the nails. (C) 2016 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.
C1 [Gorgulu, Tahsin] Bulent Ecevit Univ, Fac Med, Dept Plast Reconstruct & Aesthet Surg, A Blok Kat 3, Kozlu Zonguldak, Turkey.
   [Akcal, Arzu] Akdeniz Univ, Fac Med, Dept Plast Reconstruct & Aesthet Surg, Antalya, Turkey.
RP Gorgulu, T (reprint author), Bulent Ecevit Univ, Fac Med, Dept Plast Reconstruct & Aesthet Surg, A Blok Kat 3, Kozlu Zonguldak, Turkey.
EM tahsinmd@gmail.com
OI Akcal, Arzu/0000-0002-1234-9029
CR Abramov Y, 2007, WOUND REPAIR REGEN, V15, P80, DOI 10.1111/j.1524-475X.2006.00188.x
   Akcal A, 2014, J ORAL MAXIL SURG, V72, P796, DOI 10.1016/j.joms.2013.09.034
   Baumann A, 2002, INT J ORAL MAX SURG, V31, P367, DOI 10.1054/ijom.2001.0219
   BROWN AE, 1993, BRIT J ORAL MAX SURG, V31, P154, DOI 10.1016/0266-4356(93)90114-C
   Burm JS, 1999, PLAST RECONSTR SURG, V103, P1839, DOI 10.1097/00006534-199906000-00005
   GOLDMAN RJ, 1973, AM J OPHTHALMOL, V76, P152, DOI 10.1016/0002-9394(73)90022-6
   HARSHA BC, 1986, J ORAL MAXIL SURG, V44, P11, DOI 10.1016/0278-2391(86)90008-X
   Hoffmann J, 1998, PLAST RECONSTR SURG, V101, P604, DOI 10.1097/00006534-199803000-00006
   Huang F, 1999, Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi, V15, P138
   Johnson PE, 1999, PLAST RECONSTR SURG, V103, P1709, DOI 10.1097/00006534-199905060-00023
   JORDAN DR, 1992, OPHTHALMOLOGY, V99, P1600
   Karsidag S, 2010, J CRANIOFAC SURG, V21, P1843, DOI 10.1097/SCS.0b013e3181f43e9f
   Mathes SJ, 2005, PLASTIC SURG
   MATSUO K, 1989, PLAST RECONSTR SURG, V83, P429, DOI 10.1097/00006534-198903000-00003
   NGUYEN PN, 1992, CLIN PLAST SURG, V19, P87
   ONO I, 1994, SCAND J PLAST RECONS, V28, P193, DOI 10.3109/02844319409015980
   Ozkaya O, 2012, J CRANIOFAC SURG, V23, P1028, DOI 10.1097/SCS.0b013e31824dfa49
   SLADE CS, 1995, INT OPHTHALMOL CLIN, V35, P47, DOI 10.1097/00004397-199503510-00006
   SMITH JD, 1974, ARCH OTOLARYNGOL, V99, P203
   SUGAR AW, 1992, INT J ORAL MAX SURG, V21, P140, DOI 10.1016/S0901-5027(05)80780-5
   Takashima S, 1997, LANCET, V350, P865, DOI 10.1016/S0140-6736(05)62035-1
   Taylor P, 1998, PLAST RECONSTR SURG, V101, P1276, DOI 10.1097/00006534-199804050-00018
   THADANI V, 1988, J NEUROSURG, V69, P766, DOI 10.3171/jns.1988.69.5.0766
   Tuncer S, 2007, J CRANIOFAC SURG, V18, P598, DOI 10.1097/01.scs.0000246735.92095.ef
   ZINS JE, 1995, PLAST RECONSTR SURG, V96, P1444, DOI 10.1097/00006534-199511000-00036
NR 25
TC 0
Z9 0
U1 0
U2 5
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0266-4356
EI 1532-1940
J9 BRIT J ORAL MAX SURG
JI Br. J. Oral Maxillofac. Surg.
PD JUL
PY 2016
VL 54
IS 6
BP 664
EP 668
DI 10.1016/j.bjoms.2016.03.031
PG 5
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA DO9DF
UT WOS:000378083800022
PM 27090026
DA 2018-10-20
ER

PT J
AU Picke, AK
   Salbach-Hirsch, J
   Hintze, V
   Rother, S
   Rauner, M
   Kascholke, C
   Moller, S
   Bernhardt, R
   Rammelt, S
   Pisabarro, MT
   Ruiz-Gomez, G
   Schnabelrauch, M
   Schulz-Siegmund, M
   Hacker, MC
   Scharnweber, D
   Hofbauer, C
   Hofbauer, LC
AF Picke, Ann-Kristin
   Salbach-Hirsch, Juliane
   Hintze, Vera
   Rother, Sandra
   Rauner, Martina
   Kascholke, Christian
   Moeller, Stephanie
   Bernhardt, Ricardo
   Rammelt, Stefan
   Pisabarro, M. Teresa
   Ruiz-Gomez, Gloria
   Schnabelrauch, Matthias
   Schulz-Siegmund, Michaela
   Hacker, Michael C.
   Scharnweber, Dieter
   Hofbauer, Christine
   Hofbauer, Lorenz C.
TI Sulfated hyaluronan improves bone regeneration of diabetic rats by
   binding sclerostin and enhancing osteoblast function
SO BIOMATERIALS
LA English
DT Article
DE Defect healing; Type 2 diabetes mellitus; Glycosaminoglycans (GAG);
   Hyaluronic acid/hyaluronan (HA) sulfate; Sclerostin
ID ARTIFICIAL EXTRACELLULAR MATRICES; GLYCATION END-PRODUCTS; COLLAGEN I;
   OSTEOGENIC DIFFERENTIATION; DEFECT REGENERATION; GENE-EXPRESSION;
   GLYCOSAMINOGLYCANS; MELLITUS; OSTEOCLASTOGENESIS; CELLS
AB Bone fractures in patients with diabetes mellitus heal poorly and require innovative therapies to support bone regeneration. Here, we assessed whether sulfated hyaluronan included in collagen-based scaffold coatings can improve fracture healing in diabetic rats. Macroporous thermopolymerized lactide-based scaffolds were coated with collagen including non-sulfated or sulfated hyaluronan (HA/sHA3) and inserted into 3 mm femoral defects of non-diabetic and diabetic ZDF rats. After 12 weeks, scaffolds coated with collagen/HA or collagen/sHA3 accelerated bone defect regeneration in diabetic, but not in non-diabetic rats as compared to their non-coated controls. At the tissue level, collagen/sHA3 promoted bone mineralization and decreased the amount of non-mineralized bone matrix. Moreover, collagen/sHA3-coated scaffolds from diabetic rats bound more sclerostin in vivo than the respective controls. Binding assays confirmed a high binding affinity of sHA3 to sclerostin. In vitro, sHA3 induced BMP-2 and lowered the RANKL/OPG expression ratio, regardless of the glucose concentration in osteoblastic cells. Both sHA3 and high glucose concentrations decreased the differentiation of osteoclastic cells. In summary, scaffolds coated with collagen/sHA3 represent a potentially suitable biomaterial to improve bone defect regeneration in diabetic conditions. The underlying mechanism involves improved osteoblast function and binding sclerostin, a potent inhibitor of Wnt signaling and osteoblast function. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Picke, Ann-Kristin; Salbach-Hirsch, Juliane; Rauner, Martina; Hofbauer, Lorenz C.] TU Dresden Med Ctr, Dept Med 3, Div Endocrinol Diabet & Metab Bone Dis, D-01307 Dresden, Germany.
   [Hintze, Vera; Rother, Sandra; Bernhardt, Ricardo; Scharnweber, Dieter] Tech Univ Dresden, Max Bergmann Ctr Biomat, Inst Mat Sci, D-01062 Dresden, Germany.
   [Kascholke, Christian; Schulz-Siegmund, Michaela; Hacker, Michael C.] Univ Leipzig, Inst Pharm, Pharmaceut Technol, D-04109 Leipzig, Germany.
   [Moeller, Stephanie; Schnabelrauch, Matthias] INNOVENT eV, Biomat Dept, Jena, Germany.
   [Rammelt, Stefan] TU Dresden Med Ctr, Dept Trauma & Reconstruct Surg, D-01307 Dresden, Germany.
   [Rammelt, Stefan; Scharnweber, Dieter; Hofbauer, Lorenz C.] Ctr Regenerat Therapies Dresden, Dresden, Germany.
   [Pisabarro, M. Teresa; Ruiz-Gomez, Gloria] Tech Univ Dresden, BIOTEC, Struct Bioinformat, D-01062 Dresden, Germany.
   [Hofbauer, Christine] TU Dresden Med Ctr, Univ Ctr Orthoped & Traumatol, D-01307 Dresden, Germany.
   [Hofbauer, Lorenz C.] TU Dresden Med Ctr, Ctr Hlth Aging, D-01307 Dresden, Germany.
RP Hofbauer, LC (reprint author), TU Dresden Med Ctr, Dept Med 3, Div Endocrinol Diabet & Bone Dis, Fetscherstr 74, D-01307 Dresden, Germany.
EM lorenz.hofbauer@uniklinikum-dresden.de
RI Hofbauer, Lorenz/G-2490-2010; Pisabarro, M. Teresa/D-4270-2012
OI Hofbauer, Lorenz/0000-0002-8691-8423; Schulz-Siegmund,
   Michaela/0000-0003-1340-1850; Rother, Sandra/0000-0003-0631-752X
FU Deutsche Forschungsgemeinschaft [DFG BE 5466/2-1]; CRTD Seed Grant
FX We thank Franziska Paul, Tina Dybek, Ina Gloe, Heike Zimmermann, and
   Aline Katzschner for excellent technical assistance. We wish to
   acknowledge grant support from the Deutsche Forschungsgemeinschaft
   [Transregio-67, projects A1, A2, A3, A7, B2, B5, Z3; DFG BE 5466/2-1 to
   RB] and a CRTD Seed Grant to CH and LCH.
CR Bezerra B. D. B., 2011, CLIN ORAL IMPLAN RES, V23, P938
   Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141
   Burghardt AJ, 2010, J CLIN ENDOCR METAB, V95, P5045, DOI 10.1210/jc.2010-0226
   Case D., 2014, AMBER 2014
   CHANG NS, 1994, J LEUKOCYTE BIOL, V55, P778
   Franz S, 2013, ACTA BIOMATER, V9, P5621, DOI 10.1016/j.actbio.2012.11.016
   Garcia-Martin A, 2012, J CLIN ENDOCR METAB, V97, P234, DOI 10.1210/jc.2011-2186
   Gennari L, 2012, J CLIN ENDOCR METAB, V97, P1737, DOI 10.1210/jc.2011-2958
   Hamann C, 2011, AM J PHYSIOL-ENDOC M, V301, P1220
   Hamann C, 2014, ENDOCRINOLOGY, V155, P1197, DOI 10.1210/en.2013-1960
   Hamann C, 2013, J BONE MINER RES, V28, P627, DOI 10.1002/jbmr.1803
   Hamann C, 2012, NAT REV ENDOCRINOL, V8, P297, DOI 10.1038/nrendo.2011.233
   Hempel U, 2014, BIOMED RES INT, DOI 10.1155/2014/938368
   Hintze V, 2014, J TISSUE ENG REGEN M, V8, P314, DOI 10.1002/term.1528
   Hintze V, 2012, ACTA BIOMATER, V8, P2144, DOI 10.1016/j.actbio.2012.03.021
   Hintze V, 2014, BIOMACROMOLECULES, V15, P3083, DOI 10.1021/bm5006855
   Hintze V, 2009, BIOMACROMOLECULES, V10, P3290, DOI 10.1021/bm9008827
   International Diabetes Federation, 2015, IDF DIABETES ATLAS
   Jiao HL, 2015, CURR OSTEOPOROS REP, V13, P327, DOI 10.1007/s11914-015-0286-8
   Kalbitzer L, 2015, J MATER CHEM B, V3, P8902, DOI 10.1039/c5tb01737h
   Kang J, 2015, J PERIODONTAL IMPLAN, V45, P101, DOI 10.5051/jpis.2015.45.3.101
   Kayal RA, 2007, J BONE MINER RES, V22, P560, DOI 10.1359/JBMR.070115
   Kisiel M., 2013, PLOS ONE, V8, P1
   Kliemt S, 2013, J PROTEOME RES, V12, P378, DOI 10.1021/pr300640h
   Korn P., 2013, J BIOMED MATER RES, V102, P2334
   Kunze R, 2010, GLYCOCONJUGATE J, V27, P151, DOI 10.1007/s10719-009-9270-9
   Lee S., 2012, J NANOMATER, DOI [10.1155/2012/217958, DOI 10.1155/2012/217958]
   Leslie WD, 2012, J BONE MINER RES, V27, P2231, DOI 10.1002/jbmr.1759
   Liu ZD, 2007, ACTA ORTHOP, V78, P46, DOI 10.1080/17453670610013411
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Loth R, 2015, ACTA BIOMATER, V26, P82, DOI 10.1016/j.actbio.2015.08.008
   Mariano R, 2010, ORAL SURG ORAL MED O, V109, P72, DOI 10.1016/j.tripleo.2009.08.003
   Martino M. M., 2011, SCI TRANSL MED, V3, DOI DOI 10.1126/SCITRANSLMED.3002614
   Miron A, 2014, MACROMOL BIOSCI, V14, P1783, DOI 10.1002/mabi.201400292
   Nagahata M, 2004, BIOCHEM BIOPH RES CO, V315, P603, DOI 10.1016/j.bbrc.2004.01.098
   Olokoba Abdulfatai B, 2012, Oman Med J, V27, P269, DOI 10.5001/omj.2012.68
   PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617
   Peric M, 2015, BONE, V70, P73, DOI 10.1016/j.bone.2014.07.010
   Picke AK, 2016, BONE, V82, P108, DOI 10.1016/j.bone.2015.06.001
   Reinwald S, 2009, AM J PHYSIOL-ENDOC M, V296, P765, DOI DOI 10.1152/AJPEND0.90937.2008
   Rother S, 2015, ACS APPL MATER INTER, V7, P23787, DOI 10.1021/acsami.5b08419
   Salbach J., 2014, J CELL BIOCHEM, V1111, P1101
   Salbach J, 2012, BIOMATERIALS, V33, P8418, DOI 10.1016/j.biomaterials.2012.08.028
   Salbach J, 2012, J MOL MED, V90, P625, DOI 10.1007/s00109-011-0843-2
   Salbach-Hirsch J, 2015, BIOMATERIALS, V67, P335, DOI 10.1016/j.biomaterials.2015.07.021
   Salbach-Hirsch J, 2013, BIOMATERIALS, V34, P7653, DOI 10.1016/j.biomaterials.2013.06.053
   Santana RB, 2003, DIABETES, V52, P1502, DOI 10.2337/diabetes.52.6.1502
   Santana RB, 2006, INT J ORAL MAX IMPL, V21, P711
   Scheidt H. A., 2013, MAGN RESON MED, V70, P925
   Schnabelrauch M, 2013, CURR MED CHEM, V20, P2501, DOI 10.2174/0929867311320200001
   Schulz MC, 2014, J MATER SCI-MATER M, V25, P247, DOI 10.1007/s10856-013-5066-3
   Schwartz Ann V, 2013, Front Endocrinol (Lausanne), V4, P62, DOI 10.3389/fendo.2013.00062
   Tsourdi E, 2014, J BIOACT COMPAT POL, V29, P474, DOI 10.1177/0883911514546983
   van der Smissen A, 2013, ACTA BIOMATER, V9, P7775, DOI 10.1016/j.actbio.2013.04.023
   van der Smissen A, 2011, BIOMATERIALS, V32, P8938, DOI 10.1016/j.biomaterials.2011.08.025
   Veverka V, 2009, J BIOL CHEM, V284, P10890, DOI 10.1074/jbc.M807994200
   Wittrant Y, 2008, BONE, V42, P1122, DOI 10.1016/j.bone.2008.02.006
   Wojak-Cwik IM, 2013, J BIOMED MATER RES A, V101, P3109, DOI 10.1002/jbm.a.34620
   Yamagishi S, 2011, CURR DRUG TARGETS, V12, P2096, DOI 10.2174/138945011798829456
NR 59
TC 7
Z9 7
U1 5
U2 39
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2016
VL 96
BP 11
EP 23
DI 10.1016/j.biomaterials.2016.04.013
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DO4FI
UT WOS:000377736800002
PM 27131598
DA 2018-10-20
ER

PT J
AU Jamiolkowski, MA
   Pedersen, DD
   Wu, WT
   Antaki, JF
   Wagner, WR
AF Jamiolkowski, Megan A.
   Pedersen, Drake D.
   Wu, Wei-Tao
   Antaki, James F.
   Wagner, William R.
TI Visualization and analysis of biomaterial-centered thrombus formation
   within a defined crevice under flow
SO BIOMATERIALS
LA English
DT Article
DE Platelets; Thrombosis; Red blood cell ghosts; Crevices; Disturbed flow;
   Microscopy
ID VENTRICULAR ASSIST DEVICE; COMPUTATIONAL FLUID-DYNAMICS; WHOLE-BLOOD;
   PLATELET DEPOSITION; GLYCOPROTEIN IIB/IIIA; TUBULAR EXPANSION; PUMP
   THROMBOSIS; SURFACES; ADHESION; MODEL
AB The blood flow pathway within a device, together with the biomaterial surfaces and status of the patient's blood, are well-recognized factors in the development of thrombotic deposition and subsequent embolization. Blood flow patterns are of particular concern for devices such as blood pumps (i.e. ventricular assist devices, VADs) where shearing forces can be high, volumes are relatively large, and the flow fields can be complex. However, few studies have examined the effect of geometric irregularities on thrombus formation on clinically relevant opaque materials under flow. The objective of this study was to quantify human platelet deposition onto Ti6Al4V alloys, as well as positive and negative control surfaces, in the region of defined crevices (similar to 50-150 mu m in width) that might be encountered in many VADs or other cardiovascular devices. To achieve this, reconstituted fresh human blood with hemoglobin depleted red blood cells (to achieve optical clarity while maintaining relevant rheology), long working optics, and a custom designed parallel plate flow chamber were employed. The results showed that the least amount of platelet deposition occurred in the largest crevice size examined, which was counter-intuitive. The greatest levels of deposition occurred in the 90 mu m and 53 mu m crevices at the lower wall shear rate. The results suggest that while crevices may be unavoidable in device manufacturing, the crevice size might be tailored, depending on the flow conditions, to reduce the risk of thromboembolic events. Further, these data might be used to improve the accuracy of predictive models of thrombotic deposition in cardiovascular devices to help optimize the blood flow path and reduce device thrombogenicity. (C) 2016 Published by Elsevier Ltd.
C1 [Jamiolkowski, Megan A.; Pedersen, Drake D.; Wagner, William R.] McGowan Inst Regenerat Med, Pittsburgh, PA USA.
   [Jamiolkowski, Megan A.; Pedersen, Drake D.; Antaki, James F.; Wagner, William R.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA.
   [Wagner, William R.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA.
   [Wagner, William R.] Univ Pittsburgh, Dept Chem Engn, Pittsburgh, PA 15261 USA.
   [Wu, Wei-Tao; Antaki, James F.] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA.
RP Wagner, WR (reprint author), 450 Technol Dr,Suite 300, Pittsburgh, PA 15219 USA.
EM wagnerwr@upmc.edu
RI Antaki, James/S-3051-2016
OI Antaki, James/0000-0002-5430-7353
FU Cardiovascular Bioengineering Training Program (NIH) [T32-HL076124];
   Cellular Approaches to Tissue Engineering and Regenerative Medicine
   (CATER, NIH) [T32-EB0 01026]; ARCS Foundation; NIH [HHSN268200448192C,
   R01 HL089456-01]; McGowan Institute for Regenerative Medicine
FX Support was provided in part by the Cardiovascular Bioengineering
   Training Program (NIH Training Grant T32-HL076124), Cellular Approaches
   to Tissue Engineering and Regenerative Medicine (CATER, NIH Training
   Grant T32-EB0 01026), ARCS Foundation, NIH Contract No.
   HHSN268200448192C, NIH Grant R01 HL089456-01, and the McGowan Institute
   for Regenerative Medicine.
CR Adzic Aleksandar, 2013, Curr Heart Fail Rep, V10, P89, DOI 10.1007/s11897-012-0127-3
   Ahn T, 2001, J KOREAN MED SCI, V16, P31, DOI 10.3346/jkms.2001.16.1.31
   Alemu Y, 2007, ARTIF ORGANS, V31, P677, DOI 10.1111/j.1525-1594.2007.00446.x
   Baumann Kreuziger LM, 2015, J THROMB HAEMOST, V13, P946
   Bluestein D, 2010, ANN BIOMED ENG, V38, P1236, DOI 10.1007/s10439-010-9905-9
   Boyle AJ, 2009, J HEART LUNG TRANSPL, V28, P881, DOI 10.1016/j.healun.2009.05.018
   Broberg M, 2002, J LAB CLIN MED, V139, P163, DOI 10.1067/mlc.2002.121604
   Burgreen GW, 1999, ASAIO J, V45, P328, DOI 10.1097/00002480-199907000-00014
   Eckman PM, 2012, CIRCULATION, V125, P3038, DOI 10.1161/CIRCULATIONAHA.111.040246
   Golanski J, 1996, THROMB RES, V83, P199, DOI 10.1016/0049-3848(96)00129-6
   Goodman PD, 2005, ANN BIOMED ENG, V33, P780, DOI 10.1007/s10439-005-2951-z
   Ha H, 2013, MICROVASC RES, V90, P96, DOI 10.1016/j.mvr.2013.08.008
   Harding SA, 2007, THROMB HAEMOSTASIS, V98, P451, DOI 10.1160/TH06-11-0654
   Henderson A, 2004, THE PARAVIEW GUIDE
   Jamiolkowski MA, 2015, J BIOMED MATER RES A, V103, P1303, DOI 10.1002/jbm.a.35202
   KARINO T, 1979, MICROVASC RES, V17, P238, DOI 10.1016/S0026-2862(79)80002-3
   KARINO T, 1979, MICROVASC RES, V17, P217, DOI 10.1016/S0026-2862(79)80001-1
   Kent NJ, 2010, BIOMED MICRODEVICES, V12, P987, DOI 10.1007/s10544-010-9453-y
   Kirklin JK, 2014, J HEART LUNG TRANSPL, V33, P12, DOI 10.1016/j.healun.2013.11.001
   Kirklin JK, 2013, J HEART LUNG TRANSPL, V32, P141, DOI 10.1016/j.healun.2012.12.004
   Li M, 2012, LAB CHIP, V12, P1355, DOI 10.1039/c2lc21145a
   LINDON JN, 1986, BLOOD, V68, P355
   Linneweber J, 2008, ARTIF ORGANS, V32, P792, DOI 10.1111/j.1525-1594.2008.00632.x
   Lowe GDO, 2003, PATHOPHYSIOL HAEMO T, V33, P455, DOI 10.1159/000083845
   Mandrusov E, 1996, ASAIO J, V42, pM506, DOI 10.1097/00002480-199609000-00038
   Nesbitt W. S., 2009, NAT MED, V15
   Schaller J., 2013, BIOMED ENG BIOMED TE, V58
   Schaub RD, 2000, J BIOMED MATER RES, V49, P460, DOI 10.1002/(SICI)1097-4636(20000315)49:4<460::AID-JBM4>3.0.CO;2-3
   SHEPPECK RA, 1991, BLOOD, V78, P673
   Sherwood JM, 2014, BIOMECH MODEL MECHAN, V13, P259, DOI 10.1007/s10237-012-0449-9
   Sin DC, 2009, EXPERT REV MED DEVIC, V6, P51, DOI 10.1586/17434440.6.1.51
   Slaughter MS, 2010, J CARDIOVASC TRANSL, V3, P618, DOI 10.1007/s12265-010-9222-6
   Song XW, 2004, J FLUID ENG-T ASME, V126, P410, DOI 10.1115/1.1758259
   Starling RC, 2014, NEW ENGL J MED, V370, P33, DOI 10.1056/NEJMoa1313385
   Tamagawa M, 2009, ARTIF ORGANS, V33, P604, DOI 10.1111/j.1525-1594.2009.00782.x
   Taylor J. O., 2014, J BIOMECH ENG, P136
   Timms D, 2005, ARTIF ORGANS, V29, P573, DOI 10.1111/j.1525-1594.2005.29093.x
   Tovar-Lopez FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074123
   United States Food & Drug Administration (FDA)- Safety Communications, 2015, SER ADV EV IMPL LEFT
   Van Dyke M., 1982, ALBUM FLUID MOTION
   WAGNER WR, 1990, J LAB CLIN MED, V116, P636
   Wagner WR, 2000, J BIOMAT SCI-POLYM E, V11, P1239, DOI 10.1163/156856200744183
   Wereley ST, 2010, ANNU REV FLUID MECH, V42, P557, DOI 10.1146/annurev-fluid-121108-145427
   Woolley JR, 2013, ARTIF ORGANS, V38, P447
   Wootton DM, 2001, ANN BIOMED ENG, V29, P321, DOI 10.1114/1.1359449
   Wu JC, 2010, ARTIF ORGANS, V34, P402, DOI 10.1111/j.1525-1594.2009.00875.x
   Yang F, 2015, J THORAC CARDIOV SUR, V150, P938, DOI 10.1016/j.jtcvs.2015.06.049
   Ye SH, 2010, COLLOID SURFACE B, V79, P357, DOI 10.1016/j.colsurfb.2010.04.018
   Ylin W., 2004, ANN BIOMED ENG, V23, P1058
   Zhang Y, 2008, ASAIO J, V54, P150, DOI 10.1097/MAT.0b013e318164137f
   Zhao R, 2008, ANN BIOMED ENG, V36, P1130, DOI 10.1007/s10439-008-9494-z
NR 51
TC 7
Z9 8
U1 0
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2016
VL 96
BP 72
EP 83
DI 10.1016/j.biomaterials.2016.04.022
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DO4FI
UT WOS:000377736800007
PM 27156141
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Yu, J
   Yang, HY
   Li, K
   Lei, JM
   Zhou, LQ
   Huang, C
AF Yu, Jian
   Yang, Hongye
   Li, Kang
   Lei, Jinmei
   Zhou, Liqun
   Huang, Cui
TI A novel application of nanohydroxyapatite/mesoporous silica biocomposite
   on treating dentin hypersensitivity: An in vitro study
SO JOURNAL OF DENTISTRY
LA English
DT Article
DE Dentin hypersensitivity; Mesoporous silica; Hydroxyapatite; Dentinal
   tubule; Microtensile bond strength
ID MESOPOROUS SILICA; DESENSITIZING AGENTS; TUBULE OCCLUSION;
   DRUG-DELIVERY; CITRIC-ACID; HYDROXYAPATITE; CALCIUM; NANOPARTICLES;
   PERMEABILITY; BIOMATERIAL
AB Objectives: To fabricate a nanohydroxyapatite/mesoporous silica nanoparticle (nHAp@MSN) biocomposite and investigate its effectiveness on dentinal tubule occlusion, acid-resistant stability, and microtensile bond strength (MTBS).
   Methods: The nHAp@MSN biocomposite was synthesized and characterized by X-ray diffraction (XRD), Fourier transform infrared (FT-IR) spectroscopy, N-2 adsorption-desorption isotherms, field-emission scanning electron microscopy (FESEM), and high-resolution transmission electron microscopy (HRTEM). Thirty-two simulated sensitive dentin discs were prepared and randomly divided into four groups according to the following treatments (n = 8 each): Group 1, no treatment; Group 2, NovaMin, 15 s x 2; Group 3, MSN, 15 s x 2; Group 4, nHAp@MSN, 15 s x 2. Then, four discs per group were post-treated with 6 wt.% citric acid challenge to test their acid-resistant stability. The effects on dentinal tubule occlusion were observed by FESEM. A self-etch adhesive (G-Bond) was applied to evaluate the MTBS. The cytotoxicity was detected using the Cell Counting Kit-8 (CCK-8) assay.
   Results: Results revealed that the nHAp@MSN biocomposite was successfully fabricated. nHAp@MSN could effectively occlude the dentinal tubules, and the intratubular crystals were tightly associated with the tubular wall. After citric acid attack, nHAp@MSN exhibited the highest acid-resistant stability among the four groups. Moreover, no significant difference in MTBS was noted among the four groups (P > 0.05). CCK-8 assay identified that nHAp@MSN induced no more than 20% cell death even at the highest concentration of 640 mu g/mL.
   Conclusions: The application of the nHAp@MSN biocomposite resulted in efficient dentinal tubule occlusion, acid-resistant stability, and did not compromise immediate bond strength between dentin and self-etch adhesive system. Clinical significance: The nHAp@MSN biocomposite indicates enormous potential as a new strategy for relieving dentin hypersensitivity. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Huang, Cui] Wuhan Univ, State Key Lab Breeding Base Bas Sci Stomatol Hube, Wuhan 430079, Peoples R China.
   [Huang, Cui] Wuhan Univ, Key Lab Oral Biomed, Minist Educ, Sch & Hosp Stomatol, Wuhan 430079, Peoples R China.
RP Huang, C (reprint author), Wuhan Univ, State Key Lab Breeding Base Bas Sci Stomatol Hube, Wuhan 430079, Peoples R China.; Huang, C (reprint author), Wuhan Univ, Key Lab Oral Biomed, Minist Educ, Sch & Hosp Stomatol, Wuhan 430079, Peoples R China.
EM huangcui@whu.edu.cn
FU National Natural Science Foundation of China [81371191]; Fundamental
   Research Funds for the Central Universities [2042015kf1052]
FX This work was financially supported by the National Natural Science
   Foundation of China (No. 81371191) and the Fundamental Research Funds
   for the Central Universities (2042015kf1052).
CR Adebayo OA, 2008, J DENT, V36, P1013, DOI 10.1016/j.jdent.2008.08.011
   Al-Kady AS, 2011, EUR J PHARM BIOPHARM, V77, P66, DOI 10.1016/j.ejpb.2010.10.007
   Andrade GF, 2014, J MATER SCI-MATER M, V25, P2527, DOI 10.1007/s10856-014-5273-6
   Anunziata OA, 2009, MATERIALS, V2, P1508, DOI 10.3390/ma2041508
   Barbour ME, 2003, EUR J ORAL SCI, V111, P428, DOI 10.1034/j.1600-0722.2003.00059.x
   Besinis A, 2012, DENT MATER, V28, P1012, DOI 10.1016/j.dental.2012.05.007
   BRANNSTROM M, 1963, J AM DENT ASSOC, V66, P366
   Burrow MF, 1996, DENT MATER, V12, P302, DOI 10.1016/S0109-5641(96)80038-8
   Chiang YC, 2010, J DENT RES, V89, P236, DOI 10.1177/0022034509357148
   Chiang YC, 2014, ACS NANO, V8, P12502, DOI 10.1021/nn5053487
   Diaz A, 2006, ACTA BIOMATER, V2, P173, DOI 10.1016/j.actbio.2005.12.006
   DOWELL P, 1983, J CLIN PERIODONTOL, V10, P341, DOI 10.1111/j.1600-051X.1983.tb01283.x
   Fu CH, 2013, BIOMATERIALS, V34, P2565, DOI 10.1016/j.biomaterials.2012.12.043
   Fujita K, 2011, J DENT RES, V90, P607, DOI 10.1177/0022034510397837
   Gillam DG, 1999, ENDOD DENT TRAUMATOL, V15, P198
   Hannig M, 2012, Adv Dent Res, V24, P53, DOI 10.1177/0022034512450446
   Hao XH, 2015, ACS NANO, V9, P9614, DOI 10.1021/nn507485j
   Holland GR, 1997, J CLIN PERIODONTOL, V24, P808, DOI 10.1111/j.1600-051X.1997.tb01194.x
   Huang S, 2011, CARIES RES, V45, P460, DOI 10.1159/000331207
   ISHIKAWA K, 1994, J DENT RES, V73, P1197, DOI 10.1177/00220345940730061101
   Kimura Y, 2000, J CLIN PERIODONTOL, V27, P715, DOI 10.1034/j.1600-051x.2000.027010715.x
   Lee BS, 2005, DENT MATER, V21, P511, DOI 10.1016/j.dental.2004.08.002
   Marshall SJ, 2010, DENT MATER, V26, pE11, DOI 10.1016/j.dental.2009.11.157
   PASHLEY DH, 1994, ARCH ORAL BIOL, V39, pS73, DOI 10.1016/0003-9969(94)90191-0
   Pei DD, 2013, EUR J ORAL SCI, V121, P204, DOI 10.1111/eos.12047
   Prati C, 2003, J PERIODONTOL, V74, P428, DOI 10.1902/jop.2003.74.4.428
   Reis C, 2008, DENT MATER, V24, P1608, DOI 10.1016/j.dental.2008.03.027
   Schafer F, 2009, INT DENT J, V59, P321, DOI 10.1922/IDJ_2499Schafer04
   Schmidlin PR, 2013, CLIN ORAL INVEST, V17, pS55, DOI 10.1007/s00784-012-0912-0
   Shi XT, 2008, J MATER SCI-MATER M, V19, P2933, DOI 10.1007/s10856-008-3424-3
   Singal P, 2005, J PERIODONTOL, V76, P351, DOI 10.1902/jop.2005.76.3.351
   Sousa A, 2008, ACTA BIOMATER, V4, P671, DOI 10.1016/j.actbio.2007.11.003
   Tang FQ, 2012, ADV MATER, V24, P1504, DOI 10.1002/adma.201104763
   Tschoppe P, 2011, J DENT, V39, P430, DOI 10.1016/j.jdent.2011.03.008
   Van Meerbeek B, 2011, DENT MATER, V27, P17, DOI 10.1016/j.dental.2010.10.023
   Wang ZJ, 2015, AM J DENT, V28, P128
   Wang ZJ, 2010, J DENT, V38, P400, DOI 10.1016/j.jdent.2010.01.007
   Wiegand A, 2007, J DENT, V35, P21, DOI 10.1016/j.jdent.2006.04.002
   Xu Z, 2008, J DENT, V36, P1005, DOI 10.1016/j.jdent.2008.08.007
   Yang HY, 2014, J DENT, V42, P1115, DOI 10.1016/j.jdent.2014.03.018
   Yang HY, 2013, AM J DENT, V26, P137
   Yang PP, 2011, J MATER CHEM, V21, P5505, DOI 10.1039/c0jm03878d
   Yoshihara K, 2010, ACTA BIOMATER, V6, P3573, DOI 10.1016/j.actbio.2010.03.024
   Zhao DY, 1998, SCIENCE, V279, P548, DOI 10.1126/science.279.5350.548
NR 44
TC 6
Z9 6
U1 8
U2 39
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0300-5712
EI 1879-176X
J9 J DENT
JI J. Dent.
PD JUL
PY 2016
VL 50
BP 21
EP 29
DI 10.1016/j.jdent.2016.04.005
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA DO7PZ
UT WOS:000377975800003
PM 27101767
DA 2018-10-20
ER

PT J
AU ten Harkel, B
   Koopsen, J
   van Putten, SM
   van Veen, H
   Picavet, DI
   de Vries, TJ
   Bank, RA
   Everts, V
AF ten Harkel, Bas
   Koopsen, Jelle
   van Putten, Sander M.
   van Veen, Henk
   Picavet, Daisy I.
   de Vries, Teun J.
   Bank, Ruud A.
   Everts, Vincent
TI Ultrastructural aspects of foreign body giant cells generated on
   different substrates
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article
DE Foreign body giant cell; FBGC; Biomaterial; Collagen; Sealing zone;
   Cross-linking
ID DERMAL SHEEP COLLAGEN; CROSS-LINKING; BIOMATERIALS; DEGRADATION; FUSION
AB Implantation of biomaterials into the body, e.g. for tissue engineering purposes, induces a material dependent inflammatory response called the foreign body reaction (FBR). A hallmark feature of this response is the formation of large multinucleated cells: foreign body giant cells (FBGCs). Biomaterials like cross-linked and non-cross-linked collagen often induce the formation of FBGCs. It is unknown whether different biomaterials result in the formation of different FBGCs. To investigate this, we implanted cross linked and non-cross-linked dermal sheep collagen subcutaneously in mice. After 21 days the implanted material was collected and prepared for ultrastructural analysis. More FBGCs formed on and between implants of cross-linked collagen compared to non-cross-linked material. The ultrastructural aspects of the FBGCs present on the two types of implants proved to be similar. On both materials, they formed long slender protrusions on the basolateral membrane, they were very rich in mitochondria, contained numerous nuclei, and showed signs of the presence of a clear zone facing the implanted material. Similar clear zones, that resemble osteoclastic features, were also seen in FBGCs generated in vitro on bone slices, but these cells did not form a ruffled border. However, similarities in ultrastructure such as the occurrence of slender protrusions and high mitochondrion content were also found in the FBGCs generated in vitro. These data indicate that FBGCs formed on different substrates share many morphological characteristics. The formation of long finger-like protrusions seemed typical for the FBGCs, in vivo as well as in vitro, however the function of these structures needs further analysis. (C) 2016 Elsevier Inc. All rights reserved.
C1 [ten Harkel, Bas; Koopsen, Jelle; Everts, Vincent] Univ Amsterdam, Dept Oral Cell Biol, Acad Ctr Dent Amsterdam ACTA, MOVE Res Inst Amsterdam, Gustav Mahlerlaan 3004, NL-1081 BT Amsterdam, Netherlands.
   [ten Harkel, Bas; Koopsen, Jelle; de Vries, Teun J.; Everts, Vincent] Vrije Univ Amsterdam, Gustav Mahlerlaan 3004, NL-1081 BT Amsterdam, Netherlands.
   [Koopsen, Jelle] AUC, Sci Pk 113, NL-1098 XG Amsterdam, Netherlands.
   [van Putten, Sander M.; Bank, Ruud A.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Hanzepl 1, NL-9713 GZ Groningen, Netherlands.
   [van Veen, Henk; Picavet, Daisy I.] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, Core Facil Cellular Imaging, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.
   [de Vries, Teun J.] Univ Amsterdam, Dept Periodontol, Acad Ctr Dent Amsterdam ACTA, MOVE Res Inst Amsterdam, Gustav Mahlerlaan 3004, NL-1081 BT Amsterdam, Netherlands.
RP ten Harkel, B (reprint author), Univ Amsterdam, Dept Oral Cell Biol, Acad Ctr Dent Amsterdam ACTA, MOVE Res Inst Amsterdam, Gustav Mahlerlaan 3004, NL-1081 BT Amsterdam, Netherlands.; ten Harkel, B (reprint author), Vrije Univ Amsterdam, Gustav Mahlerlaan 3004, NL-1081 BT Amsterdam, Netherlands.
EM b.t.harkel@acta.nl
OI de Vries, Teun/0000-0001-6464-5172; Koopsen, Jelle/0000-0002-5723-6933
FU Dutch government to The Netherlands Institute for Regenerative Medicine
   (NIRM) [1672802]
FX This work was supported by a grant from the Dutch government to The
   Netherlands Institute for Regenerative Medicine (NIRM, grant No.
   1672802).
CR Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Cen L, 2008, PEDIATR RES, V63, P492, DOI 10.1203/PDR.0b013e31816c5bc3
   Chen E.H., 2011, CURRENT TOPICS MEMBR, P235
   DAMINK LHHO, 1995, J MATER SCI-MATER M, V6, P429
   Davison NL, 2014, BIOMATERIALS, V35, P7441, DOI 10.1016/j.biomaterials.2014.05.048
   Delgado LM, 2015, TISSUE ENG PART B-RE, V21, P298, DOI [10.1089/ten.teb.2014.0290, 10.1089/ten.TEB.2014.0290]
   Goodman SB, 2013, BIOMATERIALS, V34, P3174, DOI 10.1016/j.biomaterials.2013.01.074
   Jarman-Smith ML, 2004, J MATER SCI-MATER M, V15, P925, DOI 10.1023/B:JMSM.0000036281.47596.cc
   Khouw I.M., 1999, J BIOMED MATER RES, V50, P259
   McNally AK, 2015, J BIOMED MATER RES A, V103, P1380, DOI 10.1002/jbm.a.35280
   Miyamoto Takeshi, 2011, Keio Journal of Medicine, V60, P101
   Ramshaw JAM, 2009, J MATER SCI-MATER M, V20, P3, DOI 10.1007/s10856-008-3415-4
   ten Harkel B., 2015, PLOS ONE, V10, P1
   van Putten SM, 2013, ACTA BIOMATER, V9, P6502, DOI 10.1016/j.actbio.2013.01.022
   VANDERLAAN JS, 1991, INT J ARTIF ORGANS, V14, P661
   VANWACHEM PB, 1991, BIOMATERIALS, V12, P215, DOI 10.1016/0142-9612(91)90203-M
   VIGNERY A, 1989, J HISTOCHEM CYTOCHEM, V37, P1265, DOI 10.1177/37.8.2546991
   Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050615
   Ye QS, 2011, BIOMATERIALS, V32, P1339, DOI 10.1016/j.biomaterials.2010.09.076
NR 20
TC 1
Z9 1
U1 0
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
EI 1095-8657
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD JUL
PY 2016
VL 195
IS 1
BP 31
EP 40
DI 10.1016/j.jsb.2016.04.016
PG 10
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA DO4ET
UT WOS:000377735300004
PM 27155321
DA 2018-10-20
ER

PT J
AU Passos, MF
   Dias, DRC
   Bastos, GNT
   Jardini, AL
   Benatti, ACB
   Dias, CGBT
   Maciel, R
AF Passos, M. F.
   Dias, D. R. C.
   Bastos, G. N. T.
   Jardini, A. L.
   Benatti, A. C. B.
   Dias, C. G. B. T.
   Maciel Filho, R.
TI pHEMA hydrogels Synthesis, kinetics and in vitro tests
SO JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY
LA English
DT Article
DE pHEMA; Hydrogel; Biomaterial; Calorimetry; Kinetic; In vitro tests
ID POLY(2-HYDROXYETHYL METHACRYLATE) PHEMA; CHEMICAL-VAPOR-DEPOSITION;
   HYALURONIC-ACID; 2-HYDROXYETHYL METHACRYLATE; GRAFT-COPOLYMERIZATION;
   CONTACT-LENS; POLYMERIZATION; NANOCOMPOSITES; DERIVATIVES; DELIVERY
AB Hydrogels of poly (2-hydroxyethyl methacrylate) (pHEMA) are suitable materials for medical applications. Synthesis, structural characterization, kinetic, physical properties and cell viability of these materials are reported in this article. The system was conducted via free radical polymerization in the absence of solvents or cross-linking agents. Hydrogels were obtained with excellent dimensional stability and high thermal stability (738 K), glass transition temperature of approximately 375 K and a degree of swelling of 66 +/- A 4 % in ethanol. The conversion of C=C double bond of the monomer 2-hydroxyethyl methacrylate was confirmed by Fourier transform infrared spectroscopy. Results showed dense and rough morphologies in the pHEMA, presence of high molecular interactions and good resistance to various organic solvents. In vitro tests showed excellent cell viability. The materials did not display cytotoxicity, and cells proliferated and adhered at a satisfactory rate on the hydrogel. These materials have great potential for biomedical application.
   pHEMA hydrogels are materials receiving great attention among researchers due to their ease of synthesis and biomedical application. This article demonstrates a new method of obtaining pHEMA hydrogels by bulk polymerization, in a single processing step and without the use of cross-linking agents. A kinetic study was evaluated, and the results of in vitro tests showed good cell proliferation.
   [GRAPHICS]
   .
C1 [Passos, M. F.; Jardini, A. L.; Benatti, A. C. B.; Maciel Filho, R.] Univ Estadual Campinas, Natl Inst Biofabricat, Sch Chem Engn, Campinas, SP, Brazil.
   [Dias, D. R. C.; Bastos, G. N. T.] Fed Univ Para, Neuroinflammat Lab, Inst Biol Sci, BR-66059 Belem, PA, Brazil.
   [Dias, C. G. B. T.] Fed Univ Para, Sch Mech Engn, Ecocomposites Lab, BR-66059 Belem, PA, Brazil.
RP Passos, MF (reprint author), Univ Estadual Campinas, Natl Inst Biofabricat, Sch Chem Engn, Campinas, SP, Brazil.
EM marcelepassos2004@yahoo.com.br
RI Jardini, Andre Luiz/N-9963-2016
OI Jardini, Andre Luiz/0000-0002-9381-9335; Bueno Benatti, Ana
   Carolina/0000-0002-3510-8439; Passos, Marcele/0000-0002-5616-2127
FU Sao Paulo Research Foundation (FAPESP) [2008/57860-3, 2011/18525-7];
   National Institute of Science and Technology in Biofabrication
   (BIOFABRIS); National Council of Technological and Scientific
   Development (CNPq) [573661/2008-1]
FX The authors gratefully acknowledge the Sao Paulo Research Foundation
   (FAPESP) (FAPESP Process 2008/57860-3 and 2011/18525-7), the National
   Institute of Science and Technology in Biofabrication (BIOFABRIS) and
   the National Council of Technological and Scientific Development (CNPq)
   (Process 573661/2008-1) for financial support.
CR Achilias DS, 2014, J THERM ANAL CALORIM, V116, P1379, DOI 10.1007/s10973-013-3633-y
   Achilias DS, 2010, J THERM ANAL CALORIM, V102, P451, DOI 10.1007/s10973-010-0935-1
   Bach LG, 2012, APPL SURF SCI, V253, P2816
   Campoccia D, 1998, BIOMATERIALS, V19, P2101, DOI 10.1016/S0142-9612(98)00042-8
   Canevarolo JR SV, 2002, CIENCIA POLIMEROS TE, P56
   Canevarolo JR SV, 2002, CIENCIA POLIMEROS TE, P82
   Casimiro MH, 2013, MATER CHEM PHYS, V138, P11, DOI 10.1016/j.matchemphys.2012.11.061
   Chan K, 2005, LANGMUIR, V21, P8930, DOI 10.1021/la051004q
   Garcia-Moreno I, 2005, J PHYS CHEM B, V109, P21618, DOI 10.1021/jp058076a
   He CL, 2011, APPL SURF SCI, V258, P755, DOI 10.1016/j.apsusc.2011.08.074
   Hoffman AS, 2012, ADV DRUG DELIVER REV, V64, P18, DOI 10.1016/j.addr.2012.09.010
   Holmes RL, 2011, POLYMER, V20, P4471
   Hsieh YC, 2010, AEROSOL AIR QUAL RES, V10, P212, DOI 10.4209/aaqr.2009.08.0053
   Huang CW, 1997, J POLYM SCI POL CHEM, V35, P1873
   Jiang YJ, 2014, BIOMATERIALS, V35, P4969, DOI 10.1016/j.biomaterials.2014.03.001
   Kodama Y, 2014, RADIAT PHYS CHEM, V94, P98, DOI 10.1016/j.radphyschem.2013.07.016
   Nguyen MK, 2014, PROG POLYM SCI, V39, P1235, DOI 10.1016/j.progpolymsci.2013.12.001
   Morita S, 2004, VIB SPECTROSC, V35, P15, DOI 10.1016/j.vibspec.2003.11.020
   Morita S, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00010
   Morita S, 2009, VIB SPECTROSC, V51, P28, DOI 10.1016/j.vibspec.2008.09.008
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Nogueira N, 2012, J COLLOID INTERF SCI, V385, P202, DOI 10.1016/j.jcis.2012.06.015
   Palumbo FS, 2015, CARBOHYD POLYM, V122, P408, DOI 10.1016/j.carbpol.2014.11.002
   Passos MF, 2015, CHEM ENGINEER TRANS, V43, P1459, DOI 10.3303/CET1543244
   Patel A, 2011, J BIOACT COMPAT POL, V26, P114, DOI 10.1177/0883911511398713
   Prestwich GD, 1998, J CONTROL RELEASE, V53, P93, DOI 10.1016/S0168-3659(97)00242-3
   Rantuch P., 2014, EUROPEAN J ENV SAFET, V2, P12
   Rezaei SM, 2011, POLYM TEST, V30, P69, DOI 10.1016/j.polymertesting.2010.07.013
   Ribeiro A, 2011, BIOMACROMOLECULES, V12, P701, DOI 10.1021/bm101562v
   Salmieri S, 2015, IND CROP PROD, V70, P64, DOI 10.1016/j.indcrop.2015.02.056
   Sbirrazzuoli N, 2002, THERMOCHIM ACTA, V388, P289, DOI 10.1016/S0040-6031(02)00053-9
   Silvestri B, 2009, J BIOMED MATER RES B, V89B, P369, DOI 10.1002/jbm.b.31225
   Singh A, 2015, CONTACT LENS ANTERIO, V38, P79, DOI 10.1016/j.clae.2014.09.002
   Sun YM, 1997, BIOMATERIALS, V18, P527, DOI 10.1016/S0142-9612(96)00166-4
   Sun YW, 2014, APPL SURF SCI, V320, P818, DOI 10.1016/j.apsusc.2014.09.085
   Tang Q, 2011, CURR APPL PHYS, V11, P945, DOI 10.1016/j.cap.2010.12.035
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
NR 37
TC 6
Z9 6
U1 8
U2 53
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1388-6150
EI 1572-8943
J9 J THERM ANAL CALORIM
JI J. Therm. Anal. Calorim.
PD JUL
PY 2016
VL 125
IS 1
BP 361
EP 368
DI 10.1007/s10973-016-5329-6
PG 8
WC Thermodynamics; Chemistry, Analytical; Chemistry, Physical
SC Thermodynamics; Chemistry
GA DO4YG
UT WOS:000377790200035
DA 2018-10-20
ER

PT J
AU Rossi, AM
   Saidel, WM
   Gravante, CJ
   Sayers, CW
   Shain, DH
AF Rossi, Anthony M.
   Saidel, William M.
   Gravante, Christopher J.
   Sayers, Charlene W.
   Shain, Daniel H.
TI Mechanics of cocoon secretion in a segmented worm (Annelida:
   Hirudinidae)
SO MICRON
LA English
DT Article
DE Clitellate; Reproduction; Biomaterial; Egg case; Operculum; Granule
ID THEROMYZON-TESSULATUM ANNELIDA; AQUATIC LEECH; GLOSSIPHONIIDAE;
   OLIGOCHAETA; ULTRASTRUCTURE; MEMBRANE
AB Clitellate annelids (e.g., segmented earthworms, leeches) secrete proteinaceous cocoons into which eggs are deposited. The process of cocoon production is characterized by the coordinated release of micro granules from secretory cells positioned asymmetrically within the clitellum. Collectively, these assemble into a tubular cocoon sheath that is sealed at either end by globular opercula. By transmission electron microscopy (TEM), we show here that granules destined to the cocoon operculum in the leech, Erpodbdella obscura, display a series of concentric rings surrounding a structureless core with dimensions approximating a single nanoglobule found in the operculum. Upon their channeling to the surface through narrow tubules, granules are secreted into the cocoon lumen where they appear to fragment upon contact with the operculum matrix. The distribution of partial concentric ring structures throughout the operculum suggests that granular fusion causes dynamic fragmentation of outer surface material, which thereafter integrates into operculum nanoglobules and cavities. Other granules within the same secretory cell display a punctate pattern and likely fuse with the cocoon sheath prior to crystallization. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Rossi, Anthony M.; Saidel, William M.; Gravante, Christopher J.; Sayers, Charlene W.; Shain, Daniel H.] Rutgers State Univ, Dept Biol, 315 Penn St, Camden, NJ 08102 USA.
   [Rossi, Anthony M.] NYU, Dept Biol, 100 Washington Sq East, New York, NY 10003 USA.
RP Shain, DH (reprint author), Rutgers State Univ, Dept Biol, 315 Penn St, Camden, NJ 08102 USA.
EM dshain@camden.rutgers.edu
OI Rossi, Anthony/0000-0001-9345-7939
FU NSF [DBI-0216233]
FX Supported by NSF grant DBI-0216233 to DHS.
CR Brumpt E, 1900, MEM SOC ZOOL FR, VXIII, P286
   Coleman J, 2008, J MORPHOL, V269, P812, DOI 10.1002/jmor.10624
   Dimitriu C, 2004, MICRON, V35, P281, DOI 10.1016/j.micron.2003.10.049
   Hess R.T., 1974, TISSUE CELL, V5, P503
   Hirao Y. h., 1965, Journal of the Faculty of Science Hokkaido University Zoology, V15, P625
   KNIGHT DP, 1974, COMP BIOCHEM PHYSIOL, V47, P871, DOI 10.1016/0300-9629(74)90462-9
   Lang SA, 2012, AM MIDL NAT, V167, P384, DOI 10.1674/0003-0031-167.2.384
   Marotta R, 2007, J STRUCT BIOL, V158, P336, DOI 10.1016/j.jsb.2006.12.009
   Mason TA, 2005, AM MIDL NAT, V154, P78, DOI 10.1674/0003-0031(2005)154[0078:CDAHIT]2.0.CO;2
   Mason TA, 2004, FEBS LETT, V561, P167, DOI 10.1016/S0014-5793(04)00167-X
   MORRIS GM, 1983, J MORPHOL, V177, P41, DOI 10.1002/jmor.1051770104
   RICHARDS KS, 1977, J ZOOL, V183, P161
   Rossi AM, 2013, J MORPHOL, V274, P940, DOI 10.1002/jmor.20150
   SAWYER RT, 1984, ZOOL J LINN SOC-LOND, V80, P303, DOI 10.1111/j.1096-3642.1984.tb01980.x
   Sayers CW, 2009, TISSUE CELL, V41, P35, DOI 10.1016/j.tice.2008.05.003
   SHEEHAN DC, 1980, THEORY PRACTICE HIST
   SUZUTANI C, 1977, Journal of the Faculty of Science Hokkaido University Series VI Zoology, V21, P1
   SUZUTANISHIOTA C, 1980, J MORPHOL, V164, P25, DOI 10.1002/jmor.1051640103
   WILKIALIS J, 1980, J ZOOL, V192, P421
NR 19
TC 2
Z9 2
U1 1
U2 14
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0968-4328
J9 MICRON
JI Micron
PD JUL
PY 2016
VL 86
BP 30
EP 35
DI 10.1016/j.micron.2016.04.004
PG 6
WC Microscopy
SC Microscopy
GA DO5JZ
UT WOS:000377820700003
PM 27129037
OA Other Gold
DA 2018-10-20
ER

PT J
AU Park, HJ
   Min, KD
   Lee, MC
   Kim, SH
   Lee, OJ
   Ju, HW
   Moon, BM
   Lee, JM
   Park, YR
   Kim, DW
   Jeong, JY
   Park, CH
AF Park, Hyun Jung
   Min, Kyung Dan
   Lee, Min Chae
   Kim, Soo Hyeon
   Lee, Ok Joo
   Ju, Hyung Woo
   Moon, Bo Mi
   Lee, Jung Min
   Park, Ye Ri
   Kim, Dong Wook
   Jeong, Ju Yeon
   Park, Chan Hum
TI Fabrication of 3D porous SF/-TCP hybrid scaffolds for bone tissue
   reconstruction
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE -TCP; silk fibroin; bio-ceramic; tissue engineering; bone regeneration
ID CALVARIAL DEFECT MODEL; SILK FIBROIN; COMPOSITE SCAFFOLD; IONIC GELS;
   IN-VITRO; CELLS; BIOCOMPATIBILITY; BIOMATERIALS; REGENERATION
AB Bio-ceramic is a biomaterial actively studied in the field of bone tissue engineering. But, only certain ceramic materials can resolve the corrosion problem and possess the biological affinity of conventional metal biomaterials. Therefore, the recent development of composites of hybrid composites and polymers has been widely studied. In this study, we aimed to select the best scaffold of silk fibroin and -TCP hybrid for bone tissue engineering. We fabricated three groups of scaffold such as SF (silk fibroin scaffold), GS (silk fibroin/small granule size of -TCP scaffold) and GM (silk fibroin/medium granule size of -TCP scaffold), and we compared the characteristics of each group. During characterization of the scaffold, we used scanning electron microscopy (SEM) and a Fourier transform infrared spectroscopy (FTIR) for structural analysis. We compared the physiological properties of the scaffold regarding the swelling ratio, water uptake and porosity. To evaluate the mechanical properties, we examined the compressive strength of the scaffold. During in vitro testing, we evaluated cell attachment and cell proliferation (CCK-8). Finally, we confirmed in vivo new bone regeneration from the implanted scaffolds using histological staining and micro-CT. From these evaluations, the fabricated scaffold demonstrated high porosity with good inter-pore connectivity, showed good biocompatibility and high compressive strength and modulus. In particular, the present study indicates that the GM scaffold using -TCP accelerates new bone regeneration of implanted scaffolds. Accordingly, our scaffold is expected to act a useful application in the field of bone tissue engineering. (c) 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 104A: 1779-1787, 2016.
C1 [Park, Hyun Jung; Lee, Min Chae; Kim, Soo Hyeon; Lee, Ok Joo; Ju, Hyung Woo; Moon, Bo Mi; Lee, Jung Min; Park, Ye Ri; Kim, Dong Wook; Jeong, Ju Yeon; Park, Chan Hum] Hallym Univ, Nanobio Regenerat Med Inst, Gangwon 200702, South Korea.
   [Park, Chan Hum] Hallym Univ, Coll Med, Chuncheon Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, Gangwon 200704, South Korea.
   [Min, Kyung Dan] CGbio Corp, Inst Res & Dev, Songnam, South Korea.
RP Park, CH (reprint author), Hallym Univ, Nanobio Regenerat Med Inst, Gangwon 200702, South Korea.; Park, CH (reprint author), Hallym Univ, Coll Med, Chuncheon Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, Gangwon 200704, South Korea.
EM hlpch@paran.com
RI Park, Chan Hum/C-6848-2016
FU Hallym University Research Fund; Ministry for Food, Agriculture,
   Forestry and Fisheries, Republic of Korea [Bio-industry Technology
   Development (1120 07-05-4-SB010)]
FX Contract grant sponsor: Hallym University Research Fund; Contract grant
   sponsor: Ministry for Food, Agriculture, Forestry and Fisheries,
   Republic of Korea; contract grant number: Bio-industry Technology
   Development (1120 07-05-4-SB010)
CR Cao H, 2010, BONE, V46, P386, DOI 10.1016/j.bone.2009.09.031
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   Develioglu H, 2009, DENT MATER J, V28, P396, DOI 10.4012/dmj.28.396
   El-Ghannam A, 2005, EXPERT REV MED DEVIC, V2, P87, DOI 10.1586/17434440.2.1-87
   Hui Fan J, 2014, BIOMED RES INT, V2014
   Ju HW, 2014, J BIOMED MATER RES A, V102, P2713, DOI 10.1002/jbm.a.34947
   Kim SH, 2015, J BIOACT COMPAT POL, V30, P178, DOI 10.1177/0883911514566015
   Lee JH, 2013, J MATER SCI-MATER M, V24, P2117, DOI 10.1007/s10856-013-4967-5
   Lee Y, 1997, J MEMBRANE SCI, V130, P149, DOI 10.1016/S0376-7388(97)00017-3
   Lou T, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-014-5366-2
   Misch CE, 1999, J ORAL MAXIL SURG, V57, P700, DOI 10.1016/S0278-2391(99)90437-8
   Mobini S, 2013, J MED BIOL ENG, V33, P207, DOI 10.5405/jmbe.1065
   Mohd Al Amin Muhamad N, 2009, J NUCL RELATED TECHN, V6, P1
   O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X
   Park CH., 2014, J BIOMED MAT RES A
   Park HJ, 2015, INT J BIOL MACROMOL, V78, P215, DOI 10.1016/j.ijbiomac.2015.03.064
   RICKA J, 1984, MACROMOLECULES, V17, P2916, DOI 10.1021/ma00142a081
   Salinas AJ, 2013, BIOMATER SCI-UK, V1, P40, DOI 10.1039/c2bm00071g
   Spicer PP, 2012, NAT PROTOC, V7, P1918, DOI 10.1038/nprot.2012.113
   TANAKA T, 1980, PHYS REV LETT, V45, P1636, DOI 10.1103/PhysRevLett.45.1636
   Tang X, 2009, J BIOMED MATER RES A, V91A, P166, DOI 10.1002/jbm.a.32212
   Umoh JU, 2009, PHYS MED BIOL, V54, P2147, DOI 10.1088/0031-9155/54/7/020
   Wang J, 1999, CALCIFIED TISSUE INT, V65, P486, DOI 10.1007/s002239900737
   Weinand C, 2006, BONE, V38, P555, DOI 10.1016/j.bone.2005.10.016
   Yang YM, 2007, BIOMATERIALS, V28, P1643, DOI 10.1016/j.biomaterials.2006.12.004
   유경훈, 2010, [Journal of Life Science, 생명과학회지], V20, P1207
NR 26
TC 5
Z9 5
U1 2
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2016
VL 104
IS 7
BP 1779
EP 1787
DI 10.1002/jbm.a.35711
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DO1FW
UT WOS:000377524900022
PM 26999521
DA 2018-10-20
ER

PT J
AU Lotfi, G
   Shokrgozar, MA
   Mofid, R
   Abbas, FM
   Ghanavati, F
   Baghban, AA
   Yavari, SK
   Pajoumshariati, S
AF Lotfi, Ghogha
   Shokrgozar, Mohammad Ali
   Mofid, Rasoul
   Abbas, Fatemeh Mashhadi
   Ghanavati, Farzin
   Baghban, Alireza Akbarzadeh
   Yavari, Seyedeh Kimia
   Pajoumshariati, Seyedramin
TI Biological Evaluation (In Vitro and In Vivo) of Bilayered Collagenous
   Coated (Nano Electrospun and Solid Wall) Chitosan Membrane for
   Periodontal Guided Bone Regeneration
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Chitosan; Collagen; Electrospun nanofiber; Solid wall; MSC
   differentiation; Guided bone regeneration membrane
ID MARROW STROMAL CELLS; OSTEOBLAST DIFFERENTIATION; OSTEOGENIC
   DIFFERENTIATION; TRANSCRIPTION FACTOR; EXTRACELLULAR-MATRIX; TISSUE
   REGENERATION; EXPRESSION; DEFECTS; RATS; COMPOSITES
AB The application of barrier membranes in guided bone regeneration (GBR) has become a commonly used surgical technique in periodontal research. The objectives of this study were to evaluate the in vitro biocompatibility and osteogenic differentiation of mesenchymal stem cells (MSCs) on two different collagenous coatings (nano electrospun fibrous vs. solid wall) of bilayered collagen/chitosan membrane and their histological evaluation on bone regeneration in rabbit calvarial defects. It was found that chitosan-nano electrospun collagen (CNC) membranes had higher proliferation/metabolic activity compared to the chitosan-collagen (CC) and pristine chitosan membranes. The qRT-PCR analysis demonstrated the CNC membranes induced significant expression of osteogenic genes (Osteocalcin, RUNX2 and Col-alpha 1) in MSCs. Moreover, higher calcium content and alkaline phosphatase activity of MSCs were observed compared to the other groups. Histologic and histomorphometric evaluations were performed on the uncovered (negative control) as well as covered calvarial defects of ten adult white rabbits with different membranes (CNC, CC, BioGide (BG, positive control)) at 1 and 2 months after surgery. More bone formation was detected in the defects covered with CNC and BG membranes than those covered by CC and the negative control. No inflammation and residual biomaterial particles were observed on the membrane surface or in the surrounding tissues in the surgical areas. These results suggest that bilayer CNC membrane can have the potential for use as a GBR membrane material facilitating bone formation.
C1 [Lotfi, Ghogha; Mofid, Rasoul; Ghanavati, Farzin] Shahid Beheshti Univ Med Sci, Dent Res Ctr, Tehran, Iran.
   [Lotfi, Ghogha; Mofid, Rasoul] Shahid Beheshti Univ Med Sci, Sch Dent, Dept Periodontol, Tehran, Iran.
   [Shokrgozar, Mohammad Ali; Yavari, Seyedeh Kimia] Pasteur Inst Iran, Natl Cell Bank Iran, Tehran, Iran.
   [Abbas, Fatemeh Mashhadi] Shahid Beheshti Univ Med Sci, Dept Pathol, Tehran, Iran.
   [Baghban, Alireza Akbarzadeh] Shahid Beheshti Univ Med Sci, Sch Rehabil Sci, Prote Res Ctr, Dept Basic Sci, Tehran, Iran.
   [Pajoumshariati, Seyedramin] Shahid Beheshti Univ, Med Plants & Drugs Res Inst, Dept Chem Engn, Tehran 1983963113, Iran.
   [Pajoumshariati, Seyedramin] Univ S Carolina, Dept Chem Engn, Columbia, SC 29208 USA.
RP Pajoumshariati, S (reprint author), Univ S Carolina, Dept Chem Engn, Columbia, SC 29208 USA.
EM pajoumsh@cec.sc.edu
RI shokrgozar, mohammad ali/L-4149-2017
OI shokrgozar, mohammad ali/0000-0001-5123-4155; Mashhadi Abbas,
   Fatemeh/0000-0002-8711-2843
FU Dental Research Center, Shahid Beheshti University of Medical Sciences,
   Tehran, Iran
FX This work was supported by research grant from Dental Research Center,
   Shahid Beheshti University of Medical Sciences, Tehran, Iran. The
   authors thank Dr. Davood Sharifi, an animal researcher at the faculty of
   Veterinary Medicine of Tehran University, for his assistance in the
   study.
CR Allori AC, 2008, TISSUE ENG PART B-RE, V14, P275, DOI 10.1089/ten.teb.2008.0083
   Arpornmaeklong P, 2008, INT J ORAL MAX SURG, V37, P357, DOI 10.1016/j.ijom.2007.11.014
   Arpornmaeklong P, 2007, INT J ORAL MAX SURG, V36, P328, DOI 10.1016/j.ijom.2006.09.023
   Borges GJ, 2009, CLIN ORAL IMPLAN RES, V20, P1105, DOI 10.1111/j.1600-0501.2009.01731.x
   Bottino MC, 2012, DENT MATER, V28, P703, DOI 10.1016/j.dental.2012.04.022
   Bottino MC, 2011, ACTA BIOMATER, V7, P216, DOI 10.1016/j.actbio.2010.08.019
   Boynuegri D, 2009, J BIOMED MATER RES B, V90B, P461, DOI 10.1002/jbm.b.31307
   Bumgardner JD, 2007, IMPLANT DENT, V16, P66, DOI 10.1097/ID.0b013e3180312011
   BUSER D, 1999, PERIODONTOLOGY, P151
   Buser D., 1994, GUIDED BONE REGENERA
   Cai YZ, 2010, J BIOMED MATER RES A, V95A, P49, DOI 10.1002/jbm.a.32816
   Chen JP, 2008, COLLOID SURFACE A, V313, P183, DOI 10.1016/j.colsurfa.2007.04.129
   Chen VJ, 2006, BIOMATERIALS, V27, P3973, DOI 10.1016/j.biomaterials.2006.02.043
   Chen ZG, 2010, ACTA BIOMATER, V6, P372, DOI 10.1016/j.actbio.2009.07.024
   Chen ZG, 2008, CARBOHYD POLYM, V72, P410, DOI 10.1016/j.carbpol.2007.09.018
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0
   Dupoirieux L, 2001, INT J ORAL MAX SURG, V30, P58, DOI 10.1054/ijom.2000.0011
   Franceschi RT, 2003, J CELL BIOCHEM, V88, P446, DOI 10.1002/jcb.10369
   FRANCESCHI RT, 1994, J BONE MINER RES, V9, P843
   Gomes PS, 2011, LAB ANIM-UK, V45, P14, DOI 10.1258/la.2010.010085
   Jayaraman K, 2004, J NANOSCI NANOTECHNO, V4, P52, DOI 10.1166/jnn.2004.078
   Jung UW, 2007, BIOMED MATER, V2, pS101, DOI 10.1088/1748-6041/2/3/S03
   Kalajzic I, 2002, J BONE MINER RES, V17, P15, DOI 10.1359/jbmr.2002.17.1.15
   Klokkevold PR, 1996, J PERIODONTOL, V67, P1170, DOI 10.1902/jop.1996.67.11.1170
   Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958
   Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Kung S, 2011, J PERIODONTAL RES, V46, P126, DOI 10.1111/j.1600-0765.2010.01322.x
   Kuo SM, 2006, J BIOMED MATER RES A, V76A, P408, DOI 10.1002/jbm.a.30534
   Li XM, 2005, POLYM INT, V54, P1034, DOI [10.1002/pi.1804, 10.1002/pi.l804]
   Liao S, 2005, BIOMATERIALS, V26, P7564, DOI 10.1016/j.biomaterials.2005.05.050
   Long MW, 2001, BLOOD CELL MOL DIS, V27, P677, DOI 10.1006/bcmd.2001.0431
   Malette W.G., 1986, CHITIN NATURE TECHNO, P435
   Mathews S, 2011, CELL PROLIFERAT, V44, P537, DOI 10.1111/j.1365-2184.2011.00788.x
   Newman MG, 2011, CARRANZAS CLIN PERIO
   Pajoumshariati S, 2016, ANN BIOMED ENG, V44, P1808, DOI 10.1007/s10439-015-1478-1
   Park H, 2007, BIOMATERIALS, V28, P3217, DOI 10.1016/j.biomaterials.2007.03.030
   Park YJ, 2006, BIOTECHNOL APPL BIOC, V43, P17, DOI 10.1042/BA20050075
   Retzepi M, 2010, CLIN ORAL IMPLAN RES, V21, P567, DOI 10.1111/j.1600-0501.2010.01922.x
   Ryoo HM, 2006, GENE, V366, P51, DOI 10.1016/j.gene.2005.10.011
   Sell SA, 2009, ADV DRUG DELIVER REV, V61, P1007, DOI 10.1016/j.addr.2009.07.012
   Shin SY, 2005, J PERIODONTOL, V76, P1778, DOI 10.1902/jop.2005.76.10.1778
   Sionkowska A, 2004, BIOMATERIALS, V25, P795, DOI 10.1016/S0142-9612(03)00595-7
   Song JH, 2007, J BIOMED MATER RES B, V83B, P248, DOI 10.1002/jbm.b.30790
   Spector JA, 2001, PLAST RECONSTR SURG, V107, P124, DOI 10.1097/00006534-200101000-00018
   Temenoff JS, 2004, J BIOMED MATER RES A, V70A, P235, DOI 10.1002/jbm.a.30064
   Teng SH, 2008, J BIOMED MATER RES B, V87B, P132, DOI 10.1002/jbm.b.31082
   Thein-Han WW, 2008, MATER SCI TECH-LOND, V24, P1062, DOI 10.1179/174328408X341753
   Thirunavukkarasu K, 2000, J BIOL CHEM, V275, P25163, DOI 10.1074/jbc.M000322200
   Timnak A, 2011, J MATER SCI-MATER M, V22, P1555, DOI 10.1007/s10856-011-4316-5
   Woo KM, 2007, BIOMATERIALS, V28, P335, DOI 10.1016/j.biomaterials.2006.06.013
   XIANMIAO C, 2009, MAT SCI ENG C, V29, P29, DOI DOI 10.1016/J.MSEC.2008.05.008
   Young M. F., 2003, Osteoporosis International, V14, P35
   Zhang C, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-37
   Zhu JX, 2001, HISTOCHEM J, V33, P25, DOI 10.1023/A:1017587712914
NR 56
TC 4
Z9 4
U1 5
U2 49
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD JUL
PY 2016
VL 44
IS 7
BP 2132
EP 2144
DI 10.1007/s10439-015-1516-z
PG 13
WC Engineering, Biomedical
SC Engineering
GA DN9YW
UT WOS:000377437600004
PM 26586588
DA 2018-10-20
ER

PT J
AU Stevenson, G
   Rehman, S
   Draper, E
   Hernandez-Nava, E
   Hunt, J
   Haycock, JW
AF Stevenson, G.
   Rehman, S.
   Draper, E.
   Hernandez-Nava, E.
   Hunt, J.
   Haycock, J. W.
TI Combining 3D human in vitro methods for a 3Rs evaluation of novel
   titanium surfaces in orthopaedic applications
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE additive manufacturing; in vitro test; osteoblast; plasma spraying;
   surface topography; titanium alloy
ID BIOACTIVE GLASS SCAFFOLD; HUMAN OSTEOBLASTS; HYDROXYAPATITE COATINGS;
   BIOLOGICAL RESPONSE; NODULE FORMATION; BONE INGROWTH; IMPLANTS; CELLS;
   MINERALIZATION; ALLOY
AB In this study, we report on a group of complementary human osteoblast in vitro test methods for the preclinical evaluation of 3D porous titanium surfaces. The surfaces were prepared by additive manufacturing (electron beam melting [EBM]) and plasma spraying, allowing the creation of complex lattice surface geometries. Physical properties of the surfaces were characterized by SEM and profilometry and 3D in vitro cell culture using human osteoblasts. Primary human osteoblast cells were found to elicit greater differences between titanium sample surfaces than an MG63 osteoblast-like cell line, particularly in terms of cell survival. Surface morphology was associated with higher osteoblast metabolic activity and mineralization on rougher titanium plasma spray coated surfaces than smoother surfaces. Differences in osteoblast survival and metabolic activity on titanium lattice structures were also found, despite analogous surface morphology at the cellular level. 3D confocal microscopy identified osteoblast organization within complex titanium surface geometries, adhesion, spreading, and alignment to the biomaterial strut geometries. Mineralized nodule formation throughout the lattice structures was also observed, and indicative of early markers of bone in-growth on such materials. Testing methods such as those presented are not traditionally considered by medical device manufacturers, but we suggest have value as an increasingly vital tool in efficiently translating pre-clinical studies, especially in balance with current regulatory practice, commercial demands, the 3Rs, and the relative merits of in vitro and in vivo studies. Biotechnol. Bioeng. 2016;113: 1586-1599. (c) 2015 The Authors. Biotechnology and Bioengineering Published by Wiley Periodicals, Inc.
C1 [Stevenson, G.; Rehman, S.; Draper, E.] JRI Orthopaed Ltd, Sheffield, S Yorkshire, England.
   [Hernandez-Nava, E.; Hunt, J.] Univ Sheffield, Mercury Ctr, Sheffield S3 7HQ, S Yorkshire, England.
   [Haycock, J. W.] Univ Sheffield, Dept Mat Sci & Engn, Sheffield S3 7HQ, S Yorkshire, England.
RP Haycock, JW (reprint author), Univ Sheffield, Dept Mat Sci & Engn, Sheffield S3 7HQ, S Yorkshire, England.
EM j.w.haycock@sheffield.ac.uk
OI Hernandez-Nava, Everth/0000-0002-6414-3313
FU JRI Orthopaedics Ltd.; Innovate U.K.; EPSRC; BBSRC; Department of Health
   through the Knowledge Transfer Partnership Scheme, U.K. [KTP008411]
FX Contract grant sponsor: JRI Orthopaedics Ltd.; Contract grant sponsor:
   Innovate U.K. (formerly the Technology Strategy Board); Contract grant
   sponsor: EPSRC; Contract grant sponsor: BBSRC; Contract grant sponsor:
   Department of Health through the Knowledge Transfer Partnership Scheme,
   U.K.; Contract grant number: KTP008411
CR Balani K, 2007, BIOMATERIALS, V28, P618, DOI 10.1016/j.biomaterials.2006.09.013
   Biemond JE, 2011, J MATER SCI-MATER M, V22, P917, DOI 10.1007/s10856-011-4256-0
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Chang YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095590
   DAVID A, 1995, ARCH ORTHOP TRAUM SU, V114, P112, DOI 10.1007/BF00422838
   Eitel E, 2013, FUTURE ADDITIVE MANU
   Georgakoudi I, 2008, TISSUE ENG PART B-RE, V14, P321, DOI 10.1089/ten.teb.2008.0248
   Gittens RA, 2011, BIOMATERIALS, V32, P3395, DOI 10.1016/j.biomaterials.2011.01.029
   Gough JE, 2004, BIOMATERIALS, V25, P2039, DOI 10.1016/j.biomaterials.2003.07.001
   Grigoriou V, 2005, J BIOL CHEM, V280, P1733, DOI 10.1074/jbc.M402550200
   Hearnden V, 2011, METHODS MOL BIOL, V695, P41, DOI 10.1007/978-1-60761-984-0_3
   Heinl P, 2007, ADV ENG MATER, V9, P360, DOI 10.1002/adem.200700025
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Jones JR, 2007, BIOMATERIALS, V28, P1653, DOI 10.1016/j.biomaterials.2006.11.022
   Kienapfel H, 1999, J ARTHROPLASTY, V14, P355, DOI 10.1016/S0883-5403(99)90063-3
   Levine B, 2008, ADV ENG MATER, V10, P788, DOI 10.1002/adem.200800215
   Madhankumar A, 2014, J MATER SCI, V49, P4067, DOI 10.1007/s10853-014-8094-6
   McLaughlin JR, 2011, J ARTHROPLASTY, V26, P9, DOI 10.1016/j.arth.2009.11.021
   Murr LE, 2012, INT J BIOMATER, V2012, DOI DOI 10.1155/2012/245727
   NC3Rs, 2014, CTR REPL REF RED AN
   NJR, 2014, NAT JOINT REG STAT
   Northgate, 2014, COMPL PROT PAT SUPP
   Parthasarathy J, 2010, J MECH BEHAV BIOMED, V3, P249, DOI 10.1016/j.jmbbm.2009.10.006
   Rice JM, 2003, BIOMATERIALS, V24, P4799, DOI 10.1016/S0142-9612(03)00381-8
   Russell W. M. S., 1959, PRINCIPLES HUMANE EX
   Sammons RL, 2011, SURFACE MODIFICATION, P365
   Schmidt C, 2001, J BIOMED MATER RES, V54, P209, DOI 10.1002/1097-4636(200102)54:2<209::AID-JBM7>3.0.CO;2-7
   Stubinger S, 2013, J BIOMED MATER RES B, V101, P1154, DOI 10.1002/jbm.b.32925
   Tan F, 2011, BIOTECHNOL BIOENG, V108, P454, DOI 10.1002/bit.22955
   Thomsen P, 2009, J BIOMED MATER RES B, V90B, P35, DOI 10.1002/jbm.b.31250
   van Noort R, 2012, DENT MATER, V28, P3, DOI 10.1016/j.dental.2011.10.014
   Wang YH, 2006, BIOTECHNOL PROGR, V22, P1697, DOI 10.1021/bp060274b
   Yazici H, 2013, ACTA BIOMATER, V9, P5341, DOI 10.1016/j.actbio.2012.11.004
   Yeung WK, 2013, J BIOMED MATER RES B, V101B, P939, DOI 10.1002/jbm.b.32899
NR 34
TC 4
Z9 4
U1 1
U2 34
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3592
EI 1097-0290
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD JUL
PY 2016
VL 113
IS 7
BP 1586
EP 1599
DI 10.1002/bit.25919
PG 14
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA DO1HA
UT WOS:000377527900021
PM 26702609
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Zhong, QW
   Li, WH
   Su, XP
   Li, G
   Zhou, Y
   Kundu, SC
   Yao, JM
   Cai, YR
AF Zhong, Qiwei
   Li, Wenhua
   Su, Xiuping
   Li, Geng
   Zhou, Ying
   Kundu, Subhas C.
   Yao, Juming
   Cai, Yurong
TI Degradation pattern of porous CaCO3 and hydroxyapatite microspheres in
   vitro and in vivo for potential application in bone tissue engineering
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Hydroxyapatite; Microspheres; Degradation; Injectable composite; Bone
   tissue engineering
ID CALCIUM-PHOSPHATE CEMENT; MESENCHYMAL STEM-CELLS; OSTEOGENIC
   DIFFERENTIATION; MECHANICAL-PROPERTIES; TRICALCIUM PHOSPHATE;
   GROWTH-FACTORS; SILK SERICIN; COMPOSITE; DELIVERY; REGENERATION
AB Despite superior clinical handling, excellent biocompatibility, biodegradation property of calcium phosphate needs to be improved to coincide with the rate of new bone formation. In this study, spherical CaCO3 are fabricated in the presence of the silk sericin and then transformed into porous hydroxyapatite (HAP) microspheres via hydrothermal method. The degradation behavior of obtained CaCO3, HAP and their mixture is first investigated in vitro. The result demonstrates that the weight loss of HAP microspheres are almost 24.3% after immersing in pH 7.40 Tris-HCl buffer solution for 12 weeks, which is far slower than that of spherical CaCO3 (97.5%). The degradation speed of the mixtures depends on the proportion of CaCO3 and HAP. The mixture with higher content of CaCO3 possesses a quicker degradation speed. The obtained CaCO3 and HAP microspheres are injected into subcutaneous tissue of ICR mice with the assistance of sodium alginate. The result in vivo also shows an obvious difference of degradation speed between the obtained CaCO3 and HAP microspheres, implying it is feasible to modulate the degradation property of the mixture through changing the proportion of CaCO3 and HAP The good cytocompatibility of the two kinds of microspheres is proved and a mild inflammation response is observed only at early stage of implantation. The job offers a simple method to modify the degradation properties of biomaterial for potential use in bone tissue engineering. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Zhong, Qiwei; Li, Wenhua; Su, Xiuping; Li, Geng; Zhou, Ying; Yao, Juming; Cai, Yurong] Zhejiang Sci Tech Univ, Key Lab Adv Text Mat & Mfg Technol, Natl Engn Lab Text Fiber Mat & Proc Technol, Minist Educ,Coll Mat & Text, Hangzhou 310018, Peoples R China.
   [Kundu, Subhas C.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
RP Cai, YR (reprint author), Zhejiang Sci Tech Univ, Key Lab Adv Text Mat & Mfg Technol, Natl Engn Lab Text Fiber Mat & Proc Technol, Minist Educ,Coll Mat & Text, Hangzhou 310018, Peoples R China.
EM caiyr@zstu.edu.cn
RI Yao, Juming/N-7886-2014
OI Kundu, Subhas C./0000-0002-7170-2291
FU National Natural Science Foundation of China [51202219, 51372226];
   Zhejiang Provincial Natural Science Foundation of China [LY16E020013];
   Zhejiang Top Priority Discipline of Textile Science and Engineering
FX The authors acknowledge the support of National Natural Science
   Foundation of China (51202219 and 51372226), Zhejiang Provincial Natural
   Science Foundation of China (LY16E020013) and Zhejiang Top Priority
   Discipline of Textile Science and Engineering. SCK is grateful for the
   hospitality provided during his short visit to the laboratory of College
   of Materials and Textiles, Zhejiang Sci-Tech University.
CR He FP, 2012, J BIOMED MATER RES A, V100A, P3239, DOI 10.1002/jbm.a.34265
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Kasuya A, 2012, J ORTHOP RES, V30, P1103, DOI 10.1002/jor.22044
   Kovtun A, 2015, ACTA BIOMATER, V12, P242, DOI 10.1016/j.actbio.2014.10.034
   Kundu B, 2014, PROG POLYM SCI, V39, P251, DOI 10.1016/j.progpolymsci.2013.09.002
   Kurashina K, 2002, BIOMATERIALS, V23, P407, DOI 10.1016/S0142-9612(01)00119-3
   Liao HH, 2000, BIOMATERIALS, V21, P457, DOI 10.1016/S0142-9612(99)00184-2
   Lin HR, 2004, J BIOMED MATER RES B, V71B, P52, DOI 10.1002/b.30065
   Lin LZ, 2014, MATER LETT, V126, P154, DOI 10.1016/j.matlet.2014.04.028
   Link DP, 2009, J BIOMED MATER RES A, V90A, P372, DOI 10.1002/jbm.a.32091
   Liu J, 2013, MATER LETT, V110, P221, DOI 10.1016/j.matlet.2013.08.021
   Lu JX, 2002, J BIOMED MATER RES, V63, P408, DOI 10.1002/jbm.10259
   Miao TX, 2014, J CONTROL RELEASE, V192, P57, DOI 10.1016/j.jconrel.2014.06.029
   Monchau F, 2002, BIOMOL ENG, V19, P143, DOI 10.1016/S1389-0344(02)00023-0
   Murakami K, 2010, BIOMATERIALS, V31, P83, DOI 10.1016/j.biomaterials.2009.09.031
   Ni P, 2014, BIOMATERIALS, V35, P236, DOI 10.1016/j.biomaterials.2013.10.016
   Nicodemus GD, 2008, TISSUE ENG PT B-REV, V14, P149, DOI 10.1089/ten.teb.2007.0332
   Nilsson M, 2004, J BONE JOINT SURG BR, V86B, P120, DOI 10.1302/0301-620X.86B1.14040
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   POUMARAT G, 1993, BIOMATERIALS, V14, P337, DOI 10.1016/0142-9612(93)90051-3
   Ribeiro CC, 2004, BIOMATERIALS, V25, P4363, DOI 10.1016/j.biomaterials.2003.11.028
   Ruhe PQ, 2006, TISSUE ENG, V12, P789, DOI 10.1089/ten.2006.12.789
   Santo VE, 2013, TISSUE ENG PART B-RE, V19, P308, DOI [10.1089/ten.teb.2012.0138, 10.1089/ten.TEB.2012.0138]
   Sui C, 2013, CRYST GROWTH DES, V13, P3201, DOI 10.1021/cg400595s
   Sun XQ, 2013, BIOMATERIALS, V34, P4971, DOI 10.1016/j.biomaterials.2013.03.015
   Tan RW, 2010, POLYM DEGRAD STABIL, V95, P1736, DOI 10.1016/j.polymdegradstab.2010.05.015
   Ventura M, 2014, BIOMATERIALS, V35, P2227, DOI 10.1016/j.biomaterials.2013.11.084
   Walsh WR, 2003, J ORTHOP RES, V21, P655, DOI 10.1016/S0736-0266(03)00012-3
   Wang YY, 2010, POLYM DEGRAD STABIL, V95, P207, DOI 10.1016/j.polymdegradstab.2009.11.023
   Wu J, 2013, MINI-REV MED CHEM, V13, P1501
   Xie CM, 2014, ACS APPL MATER INTER, V6, P8580, DOI 10.1021/am501428e
   Xu HHK, 2005, BIOMATERIALS, V26, P1337, DOI 10.1016/j.biomaterials.2004.04.043
   Yang MY, 2014, BIOMACROMOLECULES, V15, P1185, DOI 10.1021/bm401740x
   Zhang J, 2010, ACTA BIOMATER, V6, P445, DOI 10.1016/j.actbio.2009.07.001
   Zhi H., 2009, BIOMED MATER, V4
NR 35
TC 8
Z9 11
U1 11
U2 70
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD JUL 1
PY 2016
VL 143
BP 56
EP 63
DI 10.1016/j.colsurfb.2016.03.020
PG 8
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA DM9OZ
UT WOS:000376696900007
PM 26998866
DA 2018-10-20
ER

PT J
AU Wang, XW
   Hu, HW
   Wang, WY
   Lee, KI
   Gao, C
   He, L
   Wang, YF
   Lai, CL
   Fei, B
   Xin, JH
AF Wang, Xiaowen
   Hu, Huawen
   Wang, Wenyi
   Lee, Ka I.
   Gao, Chang
   He, Liang
   Wang, Yuanfeng
   Lai, Chuilin
   Fei, Bin
   Xin, John H.
TI Antibacterial modification of an injectable, biodegradable,
   non-cytotoxic block copolymer-based physical gel with body
   temperature-stimulated sol-gel transition and controlled drug release
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Antibacterial modification; MPEG-PCL-DMA-PCL-mPEG block copolymers;
   Sol-gel-sol transition; Crystallinity; Amphiphilic balance
ID PEG-PCL-PEG; THERMOSENSITIVE HYDROGEL; BIOMEDICAL APPLICATIONS;
   MOLECULAR-WEIGHT; CLICK CHEMISTRY; MICELLES; GRAPHENE; COMPOSITE;
   CYCLODEXTRIN; FLUORESCENCE
AB Biomaterials are being extensively used in various biomedical fields; however, they are readily infected with microorganisms, thus posing a serious threat to the public health care. We herein presented a facile route to the antibacterial modification of an important A-B-A type biomaterial using poly (ethylene glycol) methyl ether (mPEG)-poly(epsilon-caprolactone) (PCL)-mPEG as a typical model. Inexpensive, commercial bis(2-hydroxyethyl) methylammonium chloride (DMA) was adopted as an antibacterial unit. The effective synthesis of the antibacterial copolymer mPEG-PCL-similar to similar to similar to-PCL-mPEG (where similar to similar to similar to denotes the segment with DMA units) was well confirmed by FTIR and H-1 NMR spectra. At an appropriate modification extent, the DMA unit could render the copolymer mPEG-PCL-similar to similar to similar to-PCL-mPEG highly antibacterial, but did not largely alter its fascinating intrinsic properties including the thermosensitivity (e.g., the body temperature-induced sol-gel transition), non-cytotoxicity, and controlled drug release. A detailed study on the sol-gel-sol transition behavior of different copolymers showed that an appropriate extent of modification with DMA retained a sol-gel-sol transition, despite the fact that a too high extent caused a loss of sol-gel-sol transition. The hydrophilic and hydrophobic balance between mPEG and PCL was most likely broken upon a high extent of quaternization due to a large disturbance effect of DMA units at a large quantity (as evidenced by the heavily depressed PCL segment crystallinity), and thus the micelle aggregation mechanism for the gel formation could not work anymore, along with the loss of the thermosensitivity. The work presented here is highly expected to be generalized for synthesis of various block copolymers with immunity to microorganisms. Light may also be shed on understanding the phase transition behavior of various multiblock copolymers. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Wang, Xiaowen; Hu, Huawen; Wang, Wenyi; Lee, Ka I.; Gao, Chang; He, Liang; Wang, Yuanfeng; Lai, Chuilin; Fei, Bin; Xin, John H.] Hong Kong Polytech Univ, Inst Text & Clothing, Nanotechnol Ctr, Hong Kong, Hong Kong, Peoples R China.
RP Fei, B; Xin, JH (reprint author), Hong Kong Polytech Univ, Inst Text & Clothing, Nanotechnol Ctr, Hong Kong, Hong Kong, Peoples R China.
EM tcxinjh@polyu.edu.hk
RI fei, bin/A-9594-2009
OI fei, bin/0000-0002-4274-1873; Wang, Yuanfeng/0000-0002-1167-804X; XIN,
   John Haozhong/0000-0001-9965-7421
FU Research Grants Council of the Hong Kong SAR Government [PolyU 5316/10E]
FX We greatly appreciate the PolyU 5316/10E funding from Research Grants
   Council of the Hong Kong SAR Government.
CR Alexander A, 2013, J CONTROL RELEASE, V172, P715, DOI 10.1016/j.jconrel.2013.10.006
   Anzai R, 2015, COLLOID SURFACE B, V127, P292, DOI 10.1016/j.colsurfb.2015.01.028
   Cai MT, 2015, COLLOID SURFACE B, V126, P1, DOI 10.1016/j.colsurfb.2014.12.005
   Chen L, 2015, MACROMOLECULES, V48, P3662, DOI 10.1021/acs.macromol.5b00168
   Chen L, 2014, MACROMOLECULES, V47, P5895, DOI 10.1021/ma501110p
   Cui C, 2015, COLLOID SURFACE B, V129, P137, DOI 10.1016/j.colsurfb.2015.03.040
   Du H, 2014, POLYM CHEM-UK, V5, P4002, DOI 10.1039/c4py00030g
   Ferruti P, 2003, BIOMACROMOLECULES, V4, P181, DOI 10.1021/bm020115q
   Gong CY, 2013, J BIOMED NANOTECHNOL, V9, P1984, DOI 10.1166/jbn.2013.1754
   Gong CY, 2009, J BIOMED MATER RES B, V91B, P26, DOI 10.1002/jbm.b.31370
   Gong CY, 2009, INT J PHARM, V365, P89, DOI 10.1016/j.ijpharm.2008.08.027
   Gou QH, 2015, COLLOID SURFACE B, V126, P26, DOI 10.1016/j.colsurfb.2014.12.012
   Han Q, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5556-6
   Hu HW, 2013, CHEMPLUSCHEM, V78, P1483, DOI 10.1002/cplu.201300124
   Hu HW, 2015, NANO RES, V8, P3992, DOI 10.1007/s12274-015-0902-z
   Hu HW, 2015, CHEM COMMUN, V51, P16699, DOI 10.1039/c5cc05826k
   Hu HW, 2015, J MATER CHEM A, V3, P11157, DOI 10.1039/c5ta00753d
   Hu HW, 2015, APPL CATAL A-GEN, V492, P1, DOI 10.1016/j.apcata.2014.11.041
   Hu HW, 2014, J MATER CHEM A, V2, P11319, DOI 10.1039/c4ta01620c
   Hu HW, 2014, MOLECULES, V19, P7459, DOI 10.3390/molecules19067459
   Hu HW, 2014, NANO RES, V7, P418, DOI 10.1007/s12274-014-0408-0
   Hu HW, 2013, CARBOHYD POLYM, V91, P305, DOI 10.1016/j.carbpol.2012.08.038
   Hu YX, 2015, NANO RES, V8, P611, DOI 10.1007/s12274-015-0732-z
   Hwang MJ, 2005, BIOMACROMOLECULES, V6, P885, DOI 10.1021/bm049347a
   Khodaverdi E, 2015, AAPS PHARMSCITECH, V16, P140, DOI 10.1208/s12249-014-0198-4
   Li F, 2013, J DENT RES, V92, P932, DOI 10.1177/0022034513502053
   Li YL, 2014, POLYMERS-BASEL, V6, P634, DOI 10.3390/polym6030634
   Liu S, 2015, CHEM COMMUN, V51, P5218, DOI 10.1039/c4cc09568e
   Liu X, 2012, POLYM CHEM-UK, V3, P2082, DOI 10.1039/c2py20170d
   Ni P, 2014, BIOMATERIALS, V35, P236, DOI 10.1016/j.biomaterials.2013.10.016
   Ott C, 2011, POLYM CHEM-UK, V2, P2782, DOI 10.1039/c1py00412c
   Ramimoghadam D, 2015, COLLOID SURFACE B, V133, P388, DOI 10.1016/j.colsurfb.2015.02.003
   Sarker B, 2014, J MATER CHEM B, V2, P1470, DOI 10.1039/c3tb21509a
   Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804
   Shen LL, 2015, NANO RES, V8, P491, DOI 10.1007/s12274-014-0651-4
   Sim H. J., 2015, J MAT CHEM B
   Smeets NMB, 2014, CHEM COMMUN, V50, P3306, DOI 10.1039/c3cc48514e
   Sun YN, 2015, CHEM COMMUN, V51, P8512, DOI 10.1039/c4cc10094h
   Tang ZC, 2015, CHEM COMMUN, V51, P14263, DOI 10.1039/c5cc05652g
   Tang ZC, 2015, CHEM COMMUN, V51, P10099, DOI 10.1039/c5cc02659h
   Thomas V, 2009, J BIOMAT SCI-POLYM E, V20, P2129, DOI 10.1163/156856209X410102
   Vercelino R, 2013, J MATER SCI-MATER M, V24, P2157, DOI 10.1007/s10856-013-4973-7
   Vermonden T, 2012, CHEM REV, V112, P2853, DOI 10.1021/cr200157d
   Wang XW, 2015, CATAL COMMUN, V72, P81, DOI 10.1016/j.catcom.2015.09.014
   Wang XW, 2014, SMART MATER STRUCT, V23, DOI 10.1088/0964-1726/23/12/125027
   Wu QJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13553
   Xiao LP, 2014, POLYM CHEM-UK, V5, P2231, DOI 10.1039/c3py01476b
   Yim SL, 2014, CHEM COMMUN, V50, P3064, DOI 10.1039/c3cc49323g
NR 48
TC 6
Z9 6
U1 13
U2 118
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD JUL 1
PY 2016
VL 143
BP 342
EP 351
DI 10.1016/j.colsurfb.2016.02.008
PG 10
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA DM9OZ
UT WOS:000376696900041
PM 27022875
DA 2018-10-20
ER

PT J
AU Ibarra, V
   Appel, AA
   Anastasio, MA
   Opara, EC
   Brey, EM
AF Ibarra, Veronica
   Appel, Alyssa A.
   Anastasio, Mark A.
   Opara, Emmanuel C.
   Brey, Eric M.
TI This paper is a winner in the Undergraduate category for the SFB awards:
   Evaluation of the tissue response to alginate encapsulated islets in an
   omentum pouch model
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE X-ray phase contrast; alginate; biomaterial stability; inflammatory
   response; macrophages
ID MULTIPLE-IMAGE RADIOGRAPHY; LONG-TERM FUNCTION; MACROPHAGE PHENOTYPE;
   REGENERATIVE MEDICINE; RAT PANCREAS; PIG ISLETS; SCAFFOLDS;
   MICROCAPSULES; BIOCOMPATIBILITY; IMPLEMENTATION
AB Islet transplantation is currently in clinical use as a treatment for type I diabetes, but donor shortages and long-term immunosuppression limit broad application. Alginate microcapsules coated with poly-l-ornithine can be used to encapsulate islets in an environment that allows diffusion of glucose, insulin, nutrients, and waste products while inhibiting cells and antibodies. While clinical trials are ongoing using islets encapsulated in alginate microbeads, there are concerns in regards to long-term stability. Evaluation of the local tissue response following implantation provides insight into the underlying mechanisms contributing to biomaterial failure, which can be used to the design of new material strategies. Macrophages play an important role in driving the response. In this study, the stability of alginate microbeads coated with PLO containing islets transplanted in the omentum pouch model was investigated. Biomaterial structure and the inflammatory response were characterized by X-ray phase contrast (XPC) CT imaging, histology, and immunostaining. XPC allowed evaluation of microbead 3D structure and identification of failed and stable microbeads. A robust inflammatory response characterized by high cell density and the presence of pro-inflammatory macrophages was found around the failed grafts. The results obtained provide insight into the local tissue response and possible failure mechanisms for alginate microbeads. (c) 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 104A: 1581-1590, 2016.
C1 [Ibarra, Veronica; Appel, Alyssa A.; Brey, Eric M.] IIT, Dept Biomed Engn, Chicago, IL 60616 USA.
   [Anastasio, Mark A.] Washington Univ, Dept Biomed Engn, St Louis, MO USA.
   [Opara, Emmanuel C.] Wake Forest Inst Regenerat Med, Winston Salem, NC USA.
   [Brey, Eric M.] Vet Affairs Edward Hines Jr Hosp, Res Serv, Ines, IL USA.
RP Brey, EM (reprint author), IIT, Dept Biomed Engn, Chicago, IL 60616 USA.; Brey, EM (reprint author), Vet Affairs Edward Hines Jr Hosp, Res Serv, Ines, IL USA.
EM brey@iit.edu
FU National Science Foundation [CBET-1263994, EEC-1157041, EEC-1461215];
   Veterans Administration [5 I01 BX000418-06]; Armour College of
   Engineering RD program
FX Contract grant sponsor: National Science Foundation; contract grant
   numbers: CBET-1263994, EEC-1157041, EEC-1461215; Contract grant sponsor:
   Veterans Administration; contract grant number: 5 I01 BX000418-06;
   Contract grant sponsor: Armour College of Engineering R&D program
CR Anderson J, 2011, SEMIN IMMUNOPATHOL, V33, P221, DOI 10.1007/s00281-011-0244-1
   Appel AA, 2015, BIOTECHNOL BIOENG, V112, P612, DOI 10.1002/bit.25467
   Appel AA, 2012, TISSUE ENG PART C-ME, V18, P859, DOI [10.1089/ten.tec.2012.0123, 10.1089/ten.TEC.2012.0123]
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Bartneck M, 2012, BIOMATERIALS, V33, P4136, DOI 10.1016/j.biomaterials.2012.02.050
   Brankov JG, 2006, MED PHYS, V33, P278, DOI 10.1118/1.2150788
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Capone SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062032
   Chou CY, 2007, PHYS MED BIOL, V52, P1923, DOI 10.1088/0031-9155/52/7/011
   Darrabie MD, 2005, BIOMATERIALS, V26, P6846, DOI 10.1016/j.biomaterials.2005.05.009
   Dufrane D, 2006, TRANSPLANTATION, V81, P1345, DOI 10.1097/01.tp.0000208610.75997.20
   Field J, 1996, TRANSPLANTATION, V61, P1554, DOI 10.1097/00007890-199605270-00026
   Garg K, 2013, BIOMATERIALS, V34, P4439, DOI 10.1016/j.biomaterials.2013.02.065
   Hillberg AL, 2013, J BIOMED MATER RES B, V101B, P258, DOI 10.1002/jbm.b.32835
   Khanna O, 2010, J BIOMED MATER RES A, V95A, P632, DOI 10.1002/jbm.a.32883
   King A, 2001, J BIOMED MATER RES, V57, P374, DOI 10.1002/1097-4636(20011205)57:3<374::AID-JBM1180>3.0.CO;2-L
   Kollmer M, 2016, TISSUE ENG PART B-RE, V22, P34, DOI 10.1089/ten.teb.2015.0140
   LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35
   McQuilling JP, 2011, TRANSPL P, V43, P3262, DOI 10.1016/j.transproceed.2011.10.030
   Mokarram N, 2012, BIOMATERIALS, V33, P8793, DOI 10.1016/j.biomaterials.2012.08.050
   Moya ML, 2012, J MATER SCI-MATER M, V23, P903, DOI 10.1007/s10856-012-4575-9
   Opara EC, 2010, J INVEST MED, V58, P831, DOI 10.231/JIM.0b013e3181ed3807
   Pareta R, 2014, PANCREAS, V43, P605, DOI 10.1097/MPA.0000000000000107
   Pareta RA, 2013, PATHOBIOLOGY, V80, P194, DOI 10.1159/000345873
   Ponce S, 2006, BIOMATERIALS, V27, P4831, DOI 10.1016/j.biomaterials.2006.05.014
   Robitaille R, 2005, BIOMATERIALS, V26, P4119, DOI 10.1016/j.biomaterials.2004.10.028
   Spiller KL, 2014, BIOMATERIALS, V35, P4477, DOI 10.1016/j.biomaterials.2014.02.012
   Sun JC, 2013, MATERIALS, V6, P1285, DOI 10.3390/ma6041285
   Sun YL, 1996, J CLIN INVEST, V98, P1417, DOI 10.1172/JCI118929
   Tam SK, 2011, ACTA BIOMATER, V7, P1683, DOI 10.1016/j.actbio.2010.12.006
   Uludag H, 2000, ADV DRUG DELIVER REV, V42, P29, DOI 10.1016/S0169-409X(00)00053-3
   Umashankar PR, 2013, J BIOMED MATER RES A, V101, P2202, DOI 10.1002/jbm.a.34535
   Wernick MN, 2003, PHYS MED BIOL, V48, P3875, DOI 10.1088/0031-9155/48/23/006
   Zakrzewski JL, 2014, NAT BIOTECHNOL, V32, P786, DOI 10.1038/nbt.2960
   Zhong Z, 2000, NUCL INSTRUM METH A, V450, P556, DOI 10.1016/S0168-9002(00)00308-9
   Zhu HT, 2015, J ZHEJIANG UNIV-SC B, V16, P329, DOI 10.1631/jzus.B1400310
NR 36
TC 5
Z9 5
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2016
VL 104
IS 7
BP 1581
EP 1590
DI 10.1002/jbm.a.35769
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DO1FW
UT WOS:000377524900002
PM 27144389
OA Green Accepted, Bronze
DA 2018-10-20
ER

PT J
AU Srinivasan, K
   Naula, DP
   Mijares, DQ
   Janal, MN
   LeGeros, RZ
   Zhang, Y
AF Srinivasan, Kritika
   Naula, Diana P.
   Mijares, Dindo Q.
   Janal, Malvin N.
   LeGeros, Racquel Z.
   Zhang, Yu
TI Preservation and promotion of bone formation in the mandible as a
   response to a novel calcium-phosphate based biomaterial in mineral
   deficiency induced low bone mass male versus female rats
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE calcium phosphate biomaterial; mineral deficiency; peak bone mass;
   animal studies; bone mu CT; microradiography
ID POSTMENOPAUSAL WOMEN; COMPUTED-TOMOGRAPHY; CORTICAL BONE;
   MECHANICAL-PROPERTIES; TRICALCIUM PHOSPHATE; OSTEOPOROSIS THERAPY;
   BODY-COMPOSITION; RESIDUAL RIDGE; DENSITY; ZINC
AB Calcium and other trace mineral supplements have previously demonstrated to safely improve bone quality. We hypothesize that our novel calcium-phosphate based biomaterial (SBM) preserves and promotes mandibular bone formation in male and female rats on mineral deficient diet (MD). Sixty Sprague-Dawley rats were randomly assigned to receive one of three diets (n=10): basic diet (BD), MD or mineral deficient diet with 2% SBM. Rats were sacrificed after 6 months. Micro-computed tomography (mu CT) was used to evaluate bone volume and 3D-microarchitecture while microradiography (Faxitron) was used to measure bone mineral density from different sections of the mandible. Results showed that bone quality varied with region, gender and diet. MD reduced bone mineral density (BMD) and volume and increased porosity. SBM preserved BMD and bone mineral content (BMC) in the alveolar bone and condyle in both genders. In the alveolar crest and mandibular body, while preserving more bone in males, SBM also significantly supplemented female bone. Results indicate that mineral deficiency leads to low bone mass in skeletally immature rats, comparatively more in males. Furthermore, SBM administered as a dietary supplement was effective in preventing mandibular bone loss in all subjects. This study suggests that the SBM preparation has potential use in minimizing low peak bone mass induced by mineral deficiency and related bone loss irrespective of gender. (c) 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 104A: 1622-1632, 2016.
C1 [Srinivasan, Kritika; Naula, Diana P.; Mijares, Dindo Q.; LeGeros, Racquel Z.; Zhang, Yu] NYU, Coll Dent, Dept Biomat & Biomimet, 433 First Ave, New York, NY 10010 USA.
   [Janal, Malvin N.] NYU, Coll Dent, Dept Epidemiol & Hlth Promot, 380 Second Ave,Suite 301, New York, NY 10010 USA.
RP Zhang, Y (reprint author), NYU, Coll Dent, Dept Biomat & Biomimet, 433 First Ave, New York, NY 10010 USA.
EM yz21@nyu.edu
FU NIH/NIAMS [R01 AR056208]; NIH/NIDCR [2R01 DE017925]
FX Contract grant sponsor: NIH/NIAMS; contract grant number: R01 AR056208;
   Contract grant sponsor: NIH/NIDCR; contract grant number: 2R01 DE017925
CR [Anonymous], 2000, NIH CONSENSUS STATE, V17, P1
   Bagi CM, 2006, BONE, V38, P136, DOI 10.1016/j.bone.2005.07.028
   Bailey CA, 2008, P NUTR SOC, V67, P9, DOI 10.1017/S0029665108005971
   Becker W, 2000, J PERIODONTOL, V71, P625, DOI 10.1902/jop.2000.71.4.625
   Bischoff-Ferrari HA, 2007, AM J CLIN NUTR, V86, P1780
   Body JJ, 2011, ACTA CLIN BELG, V66, P443, DOI 10.2143/ACB.66.6.2062612
   Bollen AM, 2000, ORAL SURG ORAL MED O, V90, P518, DOI 10.1067/moe.2000.107802
   Bonjour JP, 2009, SALUD PUBLICA MEXICO, V51, pS5
   BONJOUR JP, 1994, OSTEOPOROSIS INT, V4, P7
   Bradney M, 1998, J BONE MINER RES, V13, P1814, DOI 10.1359/jbmr.1998.13.12.1814
   Chou AHK, 2009, KEY ENG MAT, V396-398, P653, DOI 10.4028/www.scientific.net/KEM.396-398.653
   Cilotti A, 2009, CLIN CASES MINER BON, V6, P229
   COLDITZ GA, 1990, JAMA-J AM MED ASSOC, V264, P2648, DOI 10.1001/jama.264.20.2648
   Ebeling PR, 2008, NEW ENGL J MED, V358, P1474, DOI 10.1056/NEJMcp0707217
   Erdogan O, 2007, ORAL SURG ORAL MED O, V104, P738, DOI 10.1016/j.tripleo.2007.04.008
   Faulkner RA, 2003, MED SCI SPORT EXER, V35, P513, DOI 10.1249/01.MSS.0000053724.33480.8B
   Fawell J. K, 2006, FLUORIDE DRINKING WA
   FELSON DT, 1993, NEW ENGL J MED, V329, P1141, DOI 10.1056/NEJM199310143291601
   Heaney RP, 2000, J AM COLL NUTR, V19, p83S, DOI 10.1080/07315724.2000.10718088
   Ho-Pham LT, 2014, J CLIN ENDOCR METAB, V99, P30, DOI 10.1210/jc.2013-3190
   Holahan CM, 2008, INT J ORAL MAX IMPL, V23, P905
   Houari S, 2014, J BONE MINER RES, V29, P1446, DOI 10.1002/jbmr.2153
   Ijuin M, 2002, MATURITAS, V43, P239, DOI 10.1016/S0378-5122(02)00273-6
   Jee W. S. S., 2001, Journal of Musculoskeletal & Neuronal Interactions, V1, P193
   KRIBBS PJ, 1983, J PROSTHET DENT, V50, P719, DOI 10.1016/0022-3913(83)90215-9
   Laib A, 2000, MED BIOL ENG COMPUT, V38, P326, DOI 10.1007/BF02347054
   Lee YK, 2008, KEY ENG MATER, V377, P43, DOI 10.4028/www.scientific.net/KEM.377.43
   LeGeros R Z, 1991, Monogr Oral Sci, V15, P1
   LeGeros RZ, 1971, ADV XRAY ANALYSIS, V14, P57
   Li XJJW, 1992, CELLS MATERIALS S, V1, P25
   Liu CC, 2015, J BONE MINER RES, V30, P670, DOI 10.1002/jbmr.2382
   Mardon J, 2009, PEDIATR RES, V66, P513, DOI 10.1203/PDR.0b013e3181b9b4bb
   Mary Bath-Balogh MJF, 2011, ILLUSTRATED DENTAL E
   Mijares D, 2012, ARCH ORAL BIOL, V57, P1264, DOI 10.1016/j.archoralbio.2012.02.021
   Mijares DQ, 2010, SYNTHETIC BONE MINER
   Moyer-Mileur L, 2001, J CLIN DENSITOM, V4, P313, DOI 10.1385/JCD:4:4:313
   Nakada H, 2013, KEY ENG MATER, V529-530, P341, DOI 10.4028/www.scientific.net/KEM.529-530.341
   Nakada H, 2011, J HARD TISSUE BIOL, V20, P107
   National Osteoporosis Foundation, 2014, 54 MILL AM AFF OST L
   Nielsen FH, 2011, BRIT J NUTR, V106, P1872, DOI 10.1017/S0007114511002352
   Nieves JW, 2005, J BONE MINER RES, V20, P529, DOI 10.1359/JBMR.041005
   Nilsson M, 2012, J BONE MINER RES, V27, P1206, DOI 10.1002/jbmr.1549
   Otsuka M, 2008, J PHARM SCI-US, V97, P421, DOI 10.1002/jps.21131
   Reid IR, 2002, BONE, V31, P547, DOI 10.1016/S8756-3282(02)00864-5
   Rude RK, 2004, J NUTR BIOCHEM, V15, P710, DOI 10.1016/j.jnutbio.2004.08.001
   Sader MS, 2009, J MATER SCI-MATER M, V20, P521, DOI 10.1007/s10856-008-3610-3
   Sakae T, 2013, KEY ENG MATER, V529-530, P337, DOI 10.4028/www.scientific.net/KEM.529-530.337
   SCHAPIRA D, 1991, CELLS MATERIALS S, V1, P181
   Sengupta P., 2011, BIOMED INT, V2, P81
   Singhal S, 2012, GERODONTOLOGY, V29, pE1059, DOI 10.1111/j.1741-2358.2011.00610.x
   Sirimaharaj Wimon, 2008, Journal of the Medical Association of Thailand, V91, P868
   Stoch SA, 2008, CLIN PHARMACOL THER, V83, P172, DOI 10.1038/sj.clpt.6100450
   Suresh E, 2014, RHEUMATOLOGY, V53, P19, DOI 10.1093/rheumatology/ket236
   Taketa T, 2008, J BONE MINER METAB, V26, P143, DOI 10.1007/s00774-007-0808-2
   Teo JCM, 2007, MAT SCI ENG C-BIO S, V27, P333, DOI 10.1016/j.msec.2006.05.003
   Tokudome Y, 2009, J BIOMED MATER RES B, V90B, P229, DOI 10.1002/jbm.b.31277
   Vlasiadis KZ, 2008, MATURITAS, V59, P226, DOI 10.1016/j.maturitas.2008.01.006
   Weat R, 1987, HDB CHEM PHYS, P88
   Weaver CM, 2008, ASIA PAC J CLIN NUTR, V17, P135
   Wells G, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004523.pub3
   Whitaker M, 2012, NEW ENGL J MED, V366, P2048, DOI 10.1056/NEJMp1202619
   Wright NC, 2014, J BONE MINER RES, V29, P2520, DOI 10.1002/jbmr.2269
   Yamada Y, 2008, J BIOMED MATER RES A, V84A, P344, DOI 10.1002/jbm.a.31265
   YAMAGUCHI M, 1986, RES EXP MED, V186, P337, DOI 10.1007/BF01852099
   Yamaguchi M, 2010, MOL CELL BIOCHEM, V338, P241, DOI 10.1007/s11010-009-0358-0
   Ye D, 1994, J W CHINA U MED SCI, V25, P414
   Young D, 2001, OSTEOPOROSIS INT, V12, P506, DOI 10.1007/s001980170097
   Zix J, 2011, SWISS MED WEEKLY, P141
NR 68
TC 1
Z9 1
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2016
VL 104
IS 7
BP 1622
EP 1632
DI 10.1002/jbm.a.35691
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DO1FW
UT WOS:000377524900006
PM 26914814
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Li, R
   Pavuluri, S
   Bruggeman, K
   Long, BM
   Parnell, AJ
   Martel, A
   Parnell, SR
   Pfeffer, FM
   Dennison, AJC
   Nicholas, KR
   Barrow, CJ
   Nisbet, DR
   Williams, RJ
AF Li, Rui
   Pavuluri, Sivapriya
   Bruggeman, Kiara
   Long, Benjamin M.
   Parnell, Andrew J.
   Martel, Anne
   Parnell, Steven R.
   Pfeffer, Frederick M.
   Dennison, Andrew J. C.
   Nicholas, Kevin R.
   Barrow, Colin J.
   Nisbet, David R.
   Williams, Richard J.
TI Coassembled nanostructured bioscaffold reduces the expression of
   proinflammatory cytokines to induce apoptosis in epithelial cancer cells
SO NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE
LA English
DT Article
DE Bionanotechnology; Self-assembly; Cancer; Supramolecular materials;
   Hydrogels; Tissue engineering
ID NF-KAPPA-B; TUMOR PROGRESSION; DRUG-DELIVERY; SELF; CARCINOMA;
   INFLAMMATION; FIBROBLASTS; HYDROGELS; INHIBITION; MOLECULES
AB The local inflammatory environment of the cell promotes the growth of epithelial cancers. Therefore, controlling inflammation locally using a material in a sustained, non-steroidal fashion can effectively kill malignant cells without significant damage to surrounding healthy cells. A promising class of materials for such applications is the nanostructured scaffolds formed by epitope presenting minimalist self-assembled peptides; these are bioactive on a cellular length scale, while presenting as an easily handled hydrogel. Here, we show that the assembly process can distribute an anti- inflammatory polysaccharide, fucoidan, localized to the nanofibers within the scaffold to create a biomaterial for cancer therapy. We show that it supports healthy cells, while inducing apoptosis in cancerous epithelial cells, as demonstrated by the significant down-regulation of gene and protein expression pathways associated with epithelial cancer progression. Our findings highlight an innovative material approach with potential applications in local epithelial cancer immunotherapy and drug delivery. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Li, Rui; Pavuluri, Sivapriya; Long, Benjamin M.; Pfeffer, Frederick M.; Nicholas, Kevin R.; Barrow, Colin J.; Williams, Richard J.] Deakin Univ, Ctr Chem & Biotechnol, Waurn Ponds, Australia.
   [Bruggeman, Kiara; Nisbet, David R.] Australian Natl Univ, Res Sch Engn, Canberra, ACT, Australia.
   [Parnell, Andrew J.] Univ Sheffield, Dept Phys & Astron, Sheffield S10 2TN, S Yorkshire, England.
   [Martel, Anne; Dennison, Andrew J. C.] Inst Laue Langevin, Grenoble, France.
   [Parnell, Steven R.] Indiana Univ, LENS, Bloomington, IN USA.
   [Li, Rui] Chinese Acad Trop Agr Sci, Coconut Res Inst, Wenchang, Hainan, Peoples R China.
   [Pavuluri, Sivapriya; Nicholas, Kevin R.] Deakin Univ, Sch Med, Waurn Ponds, Vic, Australia.
   [Williams, Richard J.] RMIT Univ, Sch Aerosp Mech & Mfg Engn, Melbourne, Vic, Australia.
   [Williams, Richard J.] RMIT Univ, Hlth Innovat Res Inst, Melbourne, Vic, Australia.
   [Dennison, Andrew J. C.] TU Berlin, Inst Chem, Berlin, Germany.
RP Williams, RJ (reprint author), RMIT Univ, Sch Aerosp Mech & Mfg Engn, Melbourne, Vic, Australia.; Williams, RJ (reprint author), RMIT Univ, Hlth Innovat Res Inst, Melbourne, Vic, Australia.
EM Richard.Williams@RMIT.edu.au
RI Parnell, Andrew/F-8969-2011; Pfeffer, Frederick/E-1710-2011; Parnell,
   Steven/J-4574-2013
OI Parnell, Andrew/0000-0001-8606-8644; Pfeffer,
   Frederick/0000-0002-5441-6437; Nisbet, David/0000-0002-1343-0769; Long,
   Benjamin/0000-0002-3248-8851
FU Australian Research Council (ARC) Discovery Project [DP130103131]; ARC
   [LE110100141]; NHMRC Career Development Fellowship [APP1050684]; Alfred
   Deakin Research Fellowship; Australian Microscopy and Microanalysis
   Research Facility (AMMRF); Swedish Research Council VR; Institut
   Laue-Langevin user access programme [8-03-826]
FX This work was funded by an Australian Research Council (ARC) Discovery
   Project (DP130103131). N.M.R. instrumentation was provided through ARC
   funding (LE110100141). D.R.N. was supported by an NHMRC Career
   Development Fellowship (APP1050684). R.J.W. was supported via an Alfred
   Deakin Research Fellowship. Access to the facilities of the Centre for
   Advanced Microscopy (CAM) with funding through the Australian Microscopy
   and Microanalysis Research Facility (AMMRF) is gratefully acknowledged.
   A.J.C.D. was supported by the Swedish Research Council VR. Preliminary
   SANS measurements were performed at the Low Energy Neutron Source,
   Indiana. Access to the D33 instrument was provided by the Institut
   Laue-Langevin user access programme (8-03-826).
CR Adams DJ, 2009, SOFT MATTER, V5, P1856, DOI 10.1039/b901556f
   Bhuniya S, 2006, TETRAHEDRON LETT, V47, P7153, DOI 10.1016/j.tetlet.2006.08.002
   Boekhoven J, 2012, ADV MAT
   Cheng G, 2010, LANGMUIR, V26, P4990, DOI 10.1021/la903678e
   Conde J, 2010, ADV FUNCT MAT
   Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322
   Cox TR, 2011, DIS MODEL MECH, V4, P165, DOI 10.1242/dmm.004077
   Cuzick J, 2009, LANCET ONCOL, V10, P501, DOI 10.1016/S1470-2045(09)70035-X
   Dewhurst R, 2008, MEAS SCI TECHNOL, V19, DOI 10.1088/0957-0233/19/2/020101
   Dias PF, 2005, CANCER CHEMOTH PHARM, V56, P436, DOI 10.1007/s00280-004-0995-7
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025
   Hamill KJ, 2012, J INVEST DERMATOL, V132, P448, DOI 10.1038/jid.2011.297
   Hirst AR, 2010, NAT CHEM, V2, P1089, DOI 10.1038/NCHEM.861
   Javid N, 2013, BIOMACROMOLECULES, V14, P4368, DOI 10.1021/bm401319c
   Jones MK, 1999, NAT MED, V5, P1418
   Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877
   Kim EJ, 2005, BMC GASTROENTEROL, V10, P96
   Kline SR, 2006, J APPL CRYSTALLOGR, V39, P895, DOI 10.1107/S0021889806035059
   Ko SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055795
   Kuang Y, 2013, RSC ADV, V3, P7704, DOI 10.1039/c3ra41523f
   Li R, 2015, RSC ADV, V5, P301, DOI 10.1039/c4ra13266a
   Lin A, 2003, SEMINARS CANC BIOL, P107
   Lirdprapamongkol K., 2010, AM J APPL SCI, V7, P1038
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   Modepalli VN, 2014, BIOPOLYMERS, V102, P197, DOI 10.1002/bip.22469
   Morris KL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2499
   Murakami K, 2010, BIOMATERIALS, V31, P83, DOI 10.1016/j.biomaterials.2009.09.031
   Nakano Y, 1999, JPN J CANCER RES, V90, P858, DOI 10.1111/j.1349-7006.1999.tb00827.x
   Nisbet DR, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-011-0002-x
   Olumi AF, 2006, CANCER RES, V59, P5002
   Park HY, 2014, MOLECULES, V19, P5981, DOI 10.3390/molecules19055981
   Patel MK, 2002, THROMB HAEMOSTASIS, V87, P149
   Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394
   Raeburn J, 2015, CHEM COMMUN, V51, P5170, DOI 10.1039/c4cc08626k
   Rao SK, 2010, J BIOL CHEM, V285, P32512, DOI 10.1074/jbc.M110.150490
   Reuter S, 1999, ANN NY ACAD SCI, V1171, P436
   RHEINWALD JG, 1981, CANCER RES, V41, P1657
   Rodriguez A., 2015, NANO RES, P1
   Rodriguez AL, 2014, J MATER CHEM B, V2, P7771, DOI 10.1039/c4tb01391c
   Rodriguez AL, 2013, SOFT MATTER, V9, P3915, DOI 10.1039/c3sm27758e
   Sayes CM, 2006, TOXICOL SCI, V92, P174, DOI 10.1093/toxsci/kfj197
   Sezer AD, 2007, AAPS PHARMSCITECH, V8, DOI 10.1208/pt0802039
   Smith AM, 2008, ADV MATER, V20, P37, DOI 10.1002/adma.200701221
   Tao JQ, 2014, TUMOR BIOL, V35, P4389, DOI 10.1007/s13277-013-1578-1
   Waseem A, 2010, ORAL ONCOL, V46, P536, DOI 10.1016/j.oraloncology.2010.03.022
   Whitesides GM, 2002, P NATL ACAD SCI USA, V99, P4769, DOI 10.1073/pnas.082065899
   Williams RJ, 2013, AUST J CHEM, V66, P572, DOI 10.1071/CH12557
   Williams RJ, 2011, BIOMATERIALS, V32, P5304, DOI 10.1016/j.biomaterials.2011.03.078
   Williams RJ, 2009, NAT NANOTECHNOL, V4, P19, DOI [10.1038/nnano.2008.378, 10.1038/NNANO.2008.378]
   Wolinsky JB, 2012, J CONTROL RELEASE, V159, P14, DOI 10.1016/j.jconrel.2011.11.031
   Worthington P, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00092
   Yallapu MM, 2011, DRUG DISCOV TODAY, V16, P457, DOI 10.1016/j.drudis.2011.03.004
   Yamamoto Y, 2001, J CLIN INVEST, V107, P135, DOI 10.1172/JCI11914
   Yang ZM, 2009, CHEM COMMUN, V35, P4414
   Yu C, 2013, TISSUE ENG PART C-ME, V19, P829, DOI [10.1089/ten.tec.2012.0693, 10.1089/ten.TEC.2012.0693]
   Zhao F, 2009, CHEM SOC REV, V38, P883, DOI 10.1039/b806410p
   Zhou M, 2009, BIOMATERIALS, V30, P2523, DOI 10.1016/j.biomaterials.2009.01.010
   Zhu C, 2013, EVID-BASED COMPL ALT, DOI 10.1155/2013/692549
NR 62
TC 11
Z9 11
U1 6
U2 38
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1549-9634
EI 1549-9642
J9 NANOMED-NANOTECHNOL
JI Nanomed.-Nanotechnol. Biol. Med.
PD JUL
PY 2016
VL 12
IS 5
BP 1397
EP 1407
DI 10.1016/j.nano.2016.01.009
PG 11
WC Nanoscience & Nanotechnology; Medicine, Research & Experimental
SC Science & Technology - Other Topics; Research & Experimental Medicine
GA DN9OM
UT WOS:000377409100023
PM 26961467
DA 2018-10-20
ER

PT J
AU Avigo, C
   Flori, A
   Armanetti, P
   Di Lascio, N
   Kusmic, C
   Jose, J
   Losi, P
   Soldani, G
   Faita, F
   Menichetti, L
AF Avigo, Cinzia
   Flori, Alessandra
   Armanetti, Paolo
   Di Lascio, Nicole
   Kusmic, Claudia
   Jose, Jithin
   Losi, Paola
   Soldani, Giorgio
   Faita, Francesco
   Menichetti, Luca
TI Strategies for non-invasive imaging of polymeric biomaterial in vascular
   tissue engineering and regenerative medicine using ultrasound and
   photoacoustic techniques
SO POLYMER INTERNATIONAL
LA English
DT Review
DE molecular imaging; ultrasound; photoacustic imaging; regenerative
   medicine; vascular tissue engineering
ID MICRO-ULTRASOUND; CELL THERAPY; LIVING MICE; NANOPARTICLES;
   ANGIOGENESIS; TOMOGRAPHY; SCAFFOLDS; DISEASE; DACRON
AB The ability of new polymeric materials to provide excellent biomechanical properties expanded their potential for biomedical applications enormously. The use of non-invasive imaging modalities could provide crucial information to monitor the efficacy/effectiveness/efficiency of the new materials employed in regenerative' approaches, including scaffolds, hydrogels, self-assembling materials and nanosized structures. The assessment of the morpho-functional and metabolic changes of treated or implanted tissues, the visualization of sites of drug delivery and the real-time check of the in vivo efficacy of therapeutics could be achieved by non-invasive micro- and macro-imaging techniques. The macro- and nano-requirements of these new materials and their behaviour in vivo can be investigated using standard approaches such as computed tomography, MRI and ultrasound techniques and the emerging photoacoustic imaging. This paper presents recent advancements of ultrasonography and the novel photoacoustic technique to monitor the morpho-functional parameters of synthetic polymeric scaffolds and conduits in experimental models. (c) 2016 Society of Chemical Industry
C1 [Avigo, Cinzia; Flori, Alessandra; Armanetti, Paolo; Di Lascio, Nicole; Kusmic, Claudia; Jose, Jithin; Losi, Paola; Soldani, Giorgio; Faita, Francesco; Menichetti, Luca] CNR, Inst Clin Physiol, Via G Moruzzi 1, I-56124 Pisa, Italy.
RP Menichetti, L (reprint author), CNR, Inst Clin Physiol, Via G Moruzzi 1, I-56124 Pisa, Italy.
EM luca.menichetti@ifc.cnr.it
RI Jose, Jithin/F-3412-2017
OI Jose, Jithin/0000-0002-8389-5596; Di Lascio, Nicole/0000-0003-0826-3465;
   Menichetti, Luca/0000-0002-3293-9616
CR Abdulhannan P, 2012, BRIT MED BULL, V104, P21, DOI 10.1093/bmb/lds027
   Agarwal A, 2007, J APPL PHYS, V102, DOI 10.1063/1.2777127
   Appel AA, 2013, BIOMATERIALS, V34, P6615, DOI 10.1016/j.biomaterials.2013.05.033
   Avigo C, 2015, PROC SPIE, V9323, DOI 10.1117/12.2077942
   Beard P, 2011, INTERFACE FOCUS, V1, P602, DOI 10.1098/rsfs.2011.0028
   Byrom MJ, 2010, J VASC SURG, V52, P176, DOI 10.1016/j.jvs.2009.10.080
   Cai X, 2013, MATER TODAY, V16, P67, DOI 10.1016/j.mattod.2013.03.007
   Cai X, 2012, TISSUE ENG PART C-ME, V18, P310, DOI [10.1089/ten.tec.2011.0519, 10.1089/ten.TEC.2011.0519]
   Chen HB, 2015, BIOMED RES INT, DOI 10.1155/2015/757101
   Chen YS, 2011, NANO LETT, V11, P348, DOI 10.1021/nl1042006
   Deshpande N, 2010, ANGIOGENESIS, V13, P175, DOI 10.1007/s10456-010-9175-z
   Di Lascio N, 2015, PROC SPIE, V9323, DOI 10.1117/12.2077947
   El-Brolossy TA, 2008, EUR PHYS J-SPEC TOP, V153, P361, DOI 10.1140/epjst/e2008-00462-0
   Enomoto S, 2010, J VASC SURG, V51, P155, DOI 10.1016/j.jvs.2009.09.005
   Foster FS, 2011, INTERFACE FOCUS, V1, P576, DOI 10.1098/rsfs.2011.0037
   Gnyawali SC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122327
   Hu S, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3281673
   Iwai S, 2005, ANN THORAC SURG, V80, P1821, DOI 10.1016/j.athoracsur.2005.03.139
   Jokerst JV, 2012, ACS NANO, V6, P5920, DOI 10.1021/nn302042y
   Kim K, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2743752
   Lao YQ, 2008, PHYS MED BIOL, V53, P4203, DOI 10.1088/0031-9155/53/15/013
   Lee PC, 2008, OPT EXPRESS, V16, P18605
   Leong-Poi H, 2009, CARDIOVASC RES, V84, P190, DOI 10.1093/cvr/cvp248
   Lepidi S, 2006, EUR J VASC ENDOVASC, V32, P411, DOI 10.1016/j.ejvs.2006.02.012
   Li K, 2014, CHEM SOC REV, V43, P6570, DOI 10.1039/c4cs00014e
   Mallidi S, 2009, P SOC PHOTO-OPT INS
   Martinoli C, 1998, EUR J RADIOL, V27, pS133, DOI 10.1016/S0720-048X(98)00054-0
   Needles A, 2013, IEEE T ULTRASON FERR, V60, P888, DOI 10.1109/TUFFC.2013.2646
   Nguyen PK, 2014, CELL STEM CELL, V14, P431, DOI 10.1016/j.stem.2014.03.009
   Povsic TJ, 2016, CURR CARDIOL REP, V18, DOI 10.1007/s11886-015-0693-6
   Pu KY, 2014, NAT NANOTECHNOL, V9, P233, DOI [10.1038/nnano.2013.302, 10.1038/NNANO.2013.302]
   Rapoport N, 2007, J NATL CANCER I, V99, P1095, DOI 10.1093/jnci/dim043
   Ravi S, 2010, REGEN MED, V5, P107, DOI 10.2217/RME.09.77
   Ravi S, 2009, VASCULAR, V17, pS45, DOI 10.2310/6670.2008.00084
   Rissanen TT, 2008, JACC-CARDIOVASC IMAG, V1, P83, DOI 10.1016/j.jcmg.2007.10.009
   Roll Stephanie, 2008, BMC Surg, V8, P22, DOI 10.1186/1471-2482-8-22
   Shum-Tim D, 1999, ANN THORAC SURG, V68, P2298, DOI 10.1016/S0003-4975(99)01055-3
   SHUMTIM D, 1999, ANN THORAC SURG, V68, P2305
   Takagi H, 2010, J VASC SURG, V52, P232, DOI 10.1016/j.jvs.2010.02.010
   Talukdar Y, 2014, TISSUE ENG PART C-ME, V20, P440, DOI [10.1089/ten.tec.2013.0203, 10.1089/ten.TEC.2013.0203]
   Upputuri PK, 2015, BIOMED RES INT, DOI 10.1155/2015/783983
   van Det RJ, 2009, EUR J VASC ENDOVASC, V37, P457, DOI 10.1016/j.ejvs.2008.11.041
   Wang LV, 2009, NAT PHOTONICS, V3, P503, DOI 10.1038/NPHOTON.2009.157
   Wang XD, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2192804
   Welch AJ, 2011, OPTICAL THERMAL RESPONSE OF LASER-IRRADIATED TISSUE, SECOND EDITION, P1, DOI 10.1007/978-90-481-8831-4
   Wu D, 2014, INT J MOL SCI, V15, P23616, DOI 10.3390/ijms151223616
   Xiang LZ, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2437752
   Yang HW, 2013, BIOMATERIALS, V34, P5651, DOI 10.1016/j.biomaterials.2013.03.085
   Yang SH, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2749185
   Yang S, 2007, MED PHYS, V34, P3294, DOI 10.1118/1.2757088
NR 50
TC 5
Z9 5
U1 3
U2 35
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0959-8103
EI 1097-0126
J9 POLYM INT
JI Polym. Int.
PD JUL
PY 2016
VL 65
IS 7
BP 734
EP 740
DI 10.1002/pi.5113
PG 7
WC Polymer Science
SC Polymer Science
GA DO0WV
UT WOS:000377500300002
DA 2018-10-20
ER

PT J
AU Zanin, H
   Rodrigues, BVM
   Neto, WAR
   Bretas, RES
   Da-Silva, NS
   Marciano, FR
   Lobo, AO
AF Zanin, Hudson
   Manzolli Rodrigues, Bruno Vinicius
   Ribeiro Neto, Wilson Alves
   Suman Bretas, Rosario Elida
   Da-Silva, Newton Soares
   Marciano, Fernanda Roberta
   Lobo, Anderson Oliveira
TI High loading of graphene oxide/multi-walled carbon nanotubes into PDLLA:
   A route towards the design of osteoconductive, bactericidal and
   non-immunogenic 3D porous scaffolds
SO MATERIALS CHEMISTRY AND PHYSICS
LA English
DT Article
DE Polymers; Biomaterials; Nanostructures; Chemical synthesis;
   Electrochemical properties; Composites materials
ID IN-VIVO; POLY(LACTIC ACID); RELEASE CHARACTERISTICS; CELL VIABILITY;
   BONE; COMPOSITE; POLYMERS; OXIDE; OSTEOBLASTS; SURFACE
AB We have prepared a novel 3D porous biomaterial combining poly (DL-lactic acid) (PDLLA) and graphene and multi-walled carbon nanotubes oxides (MWCNTO-GO) composite. PDLLA as control and a high loading of PDLLA/MWCNTO-GO (50/50 w/w) bioscaffolds were prepared and functionalized. MWCNTs were exfoliated to form MWCNTO-GO by oxygen plasma etching. The later was also applied to enhance the scaffolds wettability, attaching oxygen-containing groups on their surfaces. This approach produced a porous architecture observed by scanning electron microscopy and semi-quantified by electrochemical analysis. The later also indicated a notable increase on the conductivity of PDLLA/MWCNTO-GO scaffold compared to MWCNTO-GO free PDLLA (about 5 orders of magnitudes at low frequencies). Thermogravimetric analysis showed that the MWCNTO-GO acted protecting the PDLLA matrix, enhancing its thermal stability. The PDLLA/MWCNTO-GO scaffolds had significant cellular adhesion, did not present cytotoxicity effect, besides reduced bactericidal proliferation and produced mineralized tissues in SBF media. The metallic MWCNTO-GO powder held together by PDLLA polymer opens a whole new branch of applications, including bioelectroanalyses, drug delivery systems and tissue engineering. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Zanin, Hudson; Manzolli Rodrigues, Bruno Vinicius; Marciano, Fernanda Roberta; Lobo, Anderson Oliveira] Univ Vale Paraiba, Inst Res & Dev, Lab Biomed Nanotechnol NANOBIO, Av Shishima Hifumi 2911, BR-12244000 Sao Jose Dos Campos, SP, Brazil.
   [Zanin, Hudson] Univ Vale Paraiba, Inst Res & Dev, Lab Energy Storage & Supply ES&S, Av Shishima Hifumi 2911, BR-12244000 Sao Jose Dos Campos, SP, Brazil.
   [Ribeiro Neto, Wilson Alves; Suman Bretas, Rosario Elida] Univ Fed Sao Carlos, Dept Mat Engn, Rodovia Washington Luis,Km 235,SP-310, Sao Carlos, SP, Brazil.
   [Da-Silva, Newton Soares] Univ Vale Paraiba, Lab Cell Biol & Tissue, Inst Res & Dev, Av Shishima Hifumi 2911, BR-12244000 Sao Jose Dos Campos, SP, Brazil.
RP Lobo, AO (reprint author), Univ Vale Paraiba, Inst Res & Dev, Lab Biomed Nanotechnol NANOBIO, Av Shishima Hifumi 2911, BR-12244000 Sao Jose Dos Campos, SP, Brazil.
EM aolobo@pq.cnpq.br
RI Rodrigues, Bruno/P-5905-2014; Lobo, Anderson/B-2893-2011
OI Lobo, Anderson/0000-0002-2544-0438; Soares da Silva,
   Newton/0000-0001-6452-9278
FU Sao Paulo Research Foundation (FAPESP) [2011/17877-7, 2011/20345-7,
   2013/20054-8, 2014/02163-7, 2015/01259-3]; National Council for
   Scientific and Technological Development (CNPq) [202439/2012-7,
   474090/2013-2]; Brazilian Innovation Agency (FINEP) [0113042800];
   Coordination for the Improvement of Higher Education Personnel (CAPES)
   [88887.095044/2015-00]; FAPESP [2015/08523-8]
FX The authors would like to thank Sao Paulo Research Foundation (FAPESP,
   grants 2011/17877-7, 2011/20345-7, 2013/20054-8, 2014/02163-7 and
   2015/01259-3), National Council for Scientific and Technological
   Development (CNPq grants 202439/2012-7 and 474090/2013-2), Brazilian
   Innovation Agency (FINEP) (Grant 0113042800) and Coordination for the
   Improvement of Higher Education Personnel (CAPES, 88887.095044/2015-00)
   for financial support. B. V. M. R. would also like to thank FAPESP for
   the post-doctoral fellowship (2015/08523-8).
CR An X., 2013, J NANOMATER, V2013, P7
   Barrere F, 2002, BIOMATERIALS, V23, P1921, DOI 10.1016/S0142-9612(01)00318-0
   Bodamyali T, 1998, BIOCHEM BIOPH RES CO, V250, P458, DOI 10.1006/bbrc.1998.9243
   Bushinsky DA, 1996, AM J PHYSIOL-RENAL, V271, pF216
   Cai X, 2012, CHEM-ASIAN J, V7, P1664, DOI 10.1002/asia.201200045
   Cameron RE, 2008, WOODHEAD PUBL MATER, P43, DOI 10.1533/9781845695033.2.43
   Cho M, 2001, AM J PHYSIOL-HEART C, V280, pH2357
   Domun N, 2015, NANOSCALE, V7, P10294, DOI 10.1039/c5nr01354b
   Fredericks DC, 2007, SPINE, V32, P174, DOI 10.1097/01.brs.0000251363.77027.49
   FUKADA E, 1957, J PHYS SOC JPN, V12, P1158, DOI 10.1143/JPSJ.12.1158
   Garlotta D., J POLYM ENV, V9, P63
   Gong YH, 2007, ACTA BIOMATER, V3, P531, DOI 10.1016/j.actbio.2006.12.008
   Goswami J, 2013, EXPRESS POLYM LETT, V7, P767, DOI 10.3144/expresspolymlett.2013.74
   Grinet MAVM, 2014, J MATER CHEM B, V2, P1196, DOI 10.1039/c3tb21525c
   Han HS, 2014, J NANOSCI NANOTECHNO, V14, P4050, DOI 10.1166/jnn.2014.8258
   Hasegawa S, 2005, J BIOMED MATER RES A, V75A, P567, DOI 10.1002/jbm.a.30460
   He LM, 2013, CARBON, V56, P224, DOI 10.1016/j.carbon.2013.01.025
   Heidemann W, 2001, BIOMATERIALS, V22, P2371, DOI 10.1016/S0142-9612(00)00424-5
   Hidalgo IA, 2013, MOL CELL BIOMECH, V10, P85
   Hollanda LM, 2014, MAT SCI ENG C-MATER, V39, P288, DOI 10.1016/j.msec.2014.03.002
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hwang Y, 2013, COMPOS PART A-APPL S, V55, P195, DOI 10.1016/j.compositesa.2013.08.010
   Ivnitski D, 2008, SMALL, V4, P357, DOI 10.1002/smll.200700725
   Jiang X., 2010, CHEM STRUCTURE POLYL, P67, DOI DOI 10.1002/9780470649848.CH6
   Jin C, 2014, BIOL TRACE ELEM RES, V159, P393, DOI 10.1007/s12011-014-0027-3
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kazufumi K., 2009, SMART MATER STRUCT, V18
   Kim IS, 2006, BBA-MOL CELL RES, V1763, P907, DOI 10.1016/j.bbamcr.2006.06.007
   Kingston C, 2014, CARBON, V68, P33, DOI 10.1016/j.carbon.2013.11.042
   Kobashi K, 2008, SENSOR ACTUAT B-CHEM, V134, P787, DOI 10.1016/j.snb.2008.06.035
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kokubo T, 1998, ACTA MATER, V46, P2519, DOI 10.1016/S1359-6454(98)80036-0
   Kumar B, 2012, SENSOR ACTUAT B-CHEM, V161, P621, DOI 10.1016/j.snb.2011.10.077
   Lasprilla AJR, 2012, BIOTECHNOL ADV, V30, P321, DOI 10.1016/j.biotechadv.2011.06.019
   Li JJ, 2010, MAT SCI ENG C-MATER, V30, P795, DOI 10.1016/j.msec.2010.03.011
   Li RJ, 2015, INT J CLIN EXP PATHO, V8, P8057
   Lim HN, 2012, J NON-CRYST SOLIDS, V358, P525, DOI 10.1016/j.jnoncrysol.2011.11.007
   Lin H, 2015, TISSUE ENG PT A, V21, pS197
   Lobo AO, 2012, MATER LETT, V70, P89, DOI 10.1016/j.matlet.2011.11.071
   Mazaheri M, 2014, APPL SURF SCI, V301, P456, DOI 10.1016/j.apsusc.2014.02.099
   Menaa F, 2015, J TISSUE ENG REGEN M, V9, P1321, DOI 10.1002/term.1910
   Okamoto M, 2013, PROG POLYM SCI, V38, P1487, DOI 10.1016/j.progpolymsci.2013.06.001
   Oliveira J.E., 2013, ADV MATER SCI ENG, V2013, P14
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Oyane A, 2003, J BIOMED MATER RES A, V65A, P188, DOI 10.1002/jbm.a.10482
   Palmre V, 2012, CARBON, V50, P4351, DOI 10.1016/j.carbon.2012.04.071
   Pandey H, 2011, NANOSCALE, V3, P4104, DOI 10.1039/c1nr10661a
   Penel G, 1998, CALCIFIED TISSUE INT, V63, P475, DOI 10.1007/s002239900561
   Prasertsung I, 2010, INT J BIOL MACROMOL, V46, P72, DOI 10.1016/j.ijbiomac.2009.11.001
   Quan H, 2012, POLYMER, V53, P4547, DOI 10.1016/j.polymer.2012.07.061
   Ramos SC, 2010, DIAM RELAT MATER, V19, P752, DOI 10.1016/j.diamond.2010.01.044
   Rasal RM, 2010, MACROMOL MATER ENG, V295, P204, DOI 10.1002/mame.200900195
   Rey C, 2007, MATERIALWISS WERKST, V38, P996, DOI 10.1002/mawe.200700229
   Neto WAR, 2012, POLYM DEGRAD STABIL, V97, P2037, DOI 10.1016/j.polymdegradstab.2012.03.048
   Rodrigues BVM, 2016, MAT SCI ENG C-MATER, V59, P782, DOI 10.1016/j.msec.2015.10.075
   Saligheh O, 2013, J POLYM RES, V20, DOI 10.1007/s10965-012-0065-5
   SCHAKENRAAD JM, 1988, CELL BIOPHYS, V13, P75, DOI 10.1007/BF02797367
   Sharifi E, 2016, MAT SCI ENG C-MATER, V59, P533, DOI 10.1016/j.msec.2015.09.037
   Shi GX, 2008, BIOMATERIALS, V29, P3792, DOI 10.1016/j.biomaterials.2008.06.010
   Siqueira IAWB, 2015, ACS APPL MATER INTER, V7, P9385, DOI 10.1021/acsami.5b01066
   Sirivisoot S, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/29/295101
   Supronowicz PR, 2002, J BIOMED MATER RES, V59, P499, DOI 10.1002/jbm.10015
   Tang ZH, 2013, CARBON, V64, P487, DOI 10.1016/j.carbon.2013.07.103
   Tawakkal ISMA, 2014, J FOOD SCI, V79, pR1477, DOI 10.1111/1750-3841.12534
   Tsai HC, 2013, INT J NANOMED, V8, P4427, DOI 10.2147/IJN.S53636
   Ud-Din S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124502
   VANOSS CJ, 1986, J COLLOID INTERF SCI, V111, P378, DOI 10.1016/0021-9797(86)90041-X
   Wang HY, 2009, ACTA BIOMATER, V5, P279, DOI 10.1016/j.actbio.2008.07.017
   Wang K, 2011, NANOSCALE RES LETT, V6, DOI 10.1007/s11671-010-9751-6
   Wepasnick KA, 2011, CARBON, V49, P24, DOI 10.1016/j.carbon.2010.08.034
   Wu CS, 2007, POLYMER, V48, P4449, DOI 10.1016/j.polymer.2007.06.004
   Wu S, 2015, MATER LETT, V161, P716, DOI 10.1016/j.matlet.2015.09.065
   Yaszemski M J, 2003, TISSUE ENG NOVEL DEL
   Yoon IS, 2015, INT J PHARMACEUT, V488, P70, DOI 10.1016/j.ijpharm.2015.04.046
   Zanin H, 2015, NANOSCALE, V7, P10218, DOI 10.1039/c4nr07317g
   Zanin H, 2014, J ELECTROCHEM SOC, V161, pH290, DOI 10.1149/2.011405jes
   Zanin H, 2014, ACS APPL MATER INTER, V6, P990, DOI 10.1021/am4044344
   Zheng XT, 2009, J BIOMED MATER RES B, V91B, P181, DOI 10.1002/jbm.b.31388
   Zou B, 2012, J BIOMED MATER RES A, V100A, P1407, DOI 10.1002/jbm.a.34079
NR 79
TC 4
Z9 4
U1 7
U2 55
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0254-0584
EI 1879-3312
J9 MATER CHEM PHYS
JI Mater. Chem. Phys.
PD JUL 1
PY 2016
VL 177
BP 56
EP 66
DI 10.1016/j.matchemphys.2016.03.040
PG 11
WC Materials Science, Multidisciplinary
SC Materials Science
GA DM9OK
UT WOS:000376695400009
DA 2018-10-20
ER

PT J
AU Velasco-Ortega, E
   Alfonso-Rodriguez, CA
   Monsalve-Guil, L
   Espana-Lopez, A
   Jimenez-Guerra, A
   Garzon, I
   Alaminos, M
   Gil, FJ
AF Velasco-Ortega, E.
   Alfonso-Rodriguez, C. A.
   Monsalve-Guil, L.
   Espana-Lopez, A.
   Jimenez-Guerra, A.
   Garzon, I.
   Alaminos, M.
   Gil, F. J.
TI Relevant aspects in the surface properties in titanium dental implants
   for the cellular viability
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Roughness treatments; Titanium; Wettability; Surface free energy;
   Cellular behavior; Bone index contact
ID OSTEOBLAST-LIKE CELLS; IN-VITRO; BIOMATERIAL SURFACES; FIBROBLAST
   ADHESION; SOLID-SURFACES; ROUGHNESS; PROLIFERATION; DIFFERENTIATION;
   MATRIX; CYTOTOXICITY
AB Roughness and topographical features are the most relevant of the surface properties for a dental implant for its osseointegration. For that reason, we studied the four surfaces more used in titanium dental implants: machined, sandblasted, acid etching and sandblasted plus acid etching. The roughness and wettability (contact angle and surface free energy) was studied by means 3D-interferometric microscope and sessile drop method. Normal human gingival fibroblasts (HGF) were obtained from small oral mucosa biopsies and were used for cell cultures. To analyze cell integrity, we first quantified the total amount of DNA and LDH released from dead cells to the culture medium. Then, LIVE/DEAD assay was used as a combined method assessing cell integrity and metabolism. All experiments were carried out on each cell type cultured on each Ti material for 24 h, 48 h and 72 h. To evaluate the in vivo cell adhesion capability of each Ti surface, the four types of discs were grafted subcutaneously in 5 Wistar rats. Sandblasted surfaces were significantly rougher than acid etching and machined. Wettability and surface free energy decrease when the roughness increases in sand blasted samples. This fact favors the protein adsorption. The DNA released by cells cultured on the four Ti surfaces did not differ from that of positive control cells (p> 0.05). The number of cells per area was significantly lower (p < 0.05) in the sand-blasted surface than in the machined and surface for both cell types (7 +/- 2 cells for HGF and 10 +/- 5 cells for SAOS-2). The surface of the machined-type discs grafted in vivo had a very small area occupied by cells and/or connective tissue (3.5%), whereas 36.6% of the sandblasted plus acid etching surface, 75.9% of sandblasted discs and 59.6% of acid etching discs was covered with cells and connective tissue. Cells cultured on rougher surfaces tended to exhibit attributes of more differentiated osteoblasts than cells cultured on smoother surfaces. These surface properties justify that the sandblasted implants is able to significantly increase bone contact and bone growth with very good osseointegration results in vivo. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Velasco-Ortega, E.; Monsalve-Guil, L.; Espana-Lopez, A.; Jimenez-Guerra, A.] Univ Seville, Fac Dent, Dept Stomatol, Seville, Spain.
   [Alfonso-Rodriguez, C. A.; Garzon, I.; Alaminos, M.] Univ Granada, Fac Med & Dent, Dept Histol, Tissue Engn Grp, Granada, Spain.
   [Gil, F. J.] Univ Politecn Cataluna, Dept Ciencia Mat & Ingn Met, ETSEIB, Biomat Biomech & Tissue Engn Res Grp, Barcelona, Spain.
   [Gil, F. J.] Univ Int Catalunya, Sch Dent, Immaculada 22, Barcelona, Spain.
RP Gil, FJ (reprint author), Univ Int Catalunya, Sch Dent, Immaculada 22, Barcelona, Spain.
EM Xavier.gil@uic.cat
RI Velasco-Ortega, Eugenio/J-5714-2017; ALAMINOS, MIGUEL/N-9960-2016; Gil,
   Fernando/P-4258-2014
OI Velasco-Ortega, Eugenio/0000-0002-0228-484X; ALAMINOS,
   MIGUEL/0000-0003-4876-2672; Gil, Fernando/0000-0001-9816-8618
FU Spanish Government [MAT 2012-30706]
FX The authors are grateful to Spanish Government for the CICYT (Ministerio
   Economia y Competitividad) project MAT 2012-30706.
CR ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   Martin-Piedra MA, 2013, CYTOTHERAPY, V15, P507, DOI 10.1016/j.jcyt.2012.11.017
   Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Aparicio C, 2007, J BIOMED MATER RES A, V82A, P521, DOI 10.1002/jbm.a.31164
   Aparicio C, 2011, MAT SCI ENG C-MATER, V31, P320, DOI 10.1016/j.msec.2010.09.018
   Aparicio C, 2002, J MATER SCI-MATER M, V13, P1105, DOI 10.1023/A:1021173500990
   Bagno A, 2004, J MATER SCI-MATER M, V15, P935, DOI 10.1023/B:JMSM.0000042679.28493.7f
   Bigerelle M, 2005, J BIOMED MATER RES A, V72A, P36, DOI 10.1002/jbm.a.30212
   Boyan BD, 1998, J BIOMED MATER RES, V39, P77, DOI 10.1002/(SICI)1097-4636(199801)39:1<77::AID-JBM10>3.0.CO;2-L
   Buser D., 2001, TITANIUM MED, P875
   Oliveira AC, 2014, EXP BIOL MED, V239, P71, DOI 10.1177/1535370213503274
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1101, DOI 10.1002/jbm.820290910
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   Donath K., 1989, J ORAL PATHOL, V11, P318
   Drelich J, 1997, POL J CHEM, V71, P525
   Eisenbarth E, 2002, BIOMOL ENG, V19, P233, DOI 10.1016/S1389-0344(02)00028-X
   Feller L, 2015, BIOMED RES INT, DOI 10.1155/2015/171945
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   GOOD RJ, 1992, J ADHES SCI TECHNOL, V6, P1269, DOI 10.1163/156856192X00629
   Guillem-Marti J, 2013, CLIN ORAL IMPLAN RES, V24, P770, DOI 10.1111/j.1600-0501.2012.02451.x
   Jayaraman M, 2004, BIOMATERIALS, V25, P625, DOI 10.1016/S0142-9612(03)00571-4
   Kardos TB, 2014, J ORAL IMPLANTOL, V40, P294, DOI 10.1563/AAID-JOI-D-11-00249
   Kim H, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/2/025011
   Lange R, 2002, BIOMOL ENG, V19, P255, DOI 10.1016/S1389-0344(02)00047-3
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Li D., 2006, J BIOMED MATER RES A, V76, P323
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Morra M, 1997, J BIOMAT SCI-POLYM E, V9, P55, DOI 10.1163/156856297X00263
   Ogler O. E., 2015, DENT CLIN N AM, P505
   Pegueroles M, 2008, SURF COAT TECH, V202, P3470, DOI 10.1016/j.surfcoat.2007.12.021
   Pegueroles M, 2010, ACTA BIOMATER, V6, P291, DOI 10.1016/j.actbio.2009.07.030
   Piattelli A, 1998, INT J ORAL MAX IMPL, V13, P805
   Ponsonnet L, 2003, MAT SCI ENG C-BIO S, V23, P551, DOI 10.1016/S0928-4931(03)00033-X
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Richards RG, 1996, INJURY, V27, P38
   Schwartz Z, 1996, J BIOMED MATER RES, V30, P145
   Sheng YJ, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2804425
   Siebers MC, 2005, BIOMATERIALS, V26, P137, DOI 10.1016/j.biomaterials.2004.02.021
   Stoddart MJ, 2011, METHODS MOL BIOL, V740, P1, DOI 10.1007/978-1-61779-108-6_1
   Velasco-Ortega E, 2010, MUTAT RES-GEN TOX EN, V702, P17, DOI 10.1016/j.mrgentox.2010.06.013
   Vijayaraghavan Vasantha, 2012, J Indian Prosthodont Soc, V12, P201, DOI 10.1007/s13191-012-0139-4
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Wang XX, 2001, J BIOMED MATER RES, V54, P172, DOI 10.1002/1097-4636(200102)54:2<172::AID-JBM3>3.0.CO;2-#
   Wennerberg A, 2000, INT J ORAL MAX IMPL, V15, P331
   Wennerberg A, 2010, INT J ORAL MAX IMPL, V25, P63
   Wennerberg A, 2009, CLIN ORAL IMPLAN RES, V20, P172, DOI 10.1111/j.1600-0501.2009.01775.x
   Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024
   Wieland M, 2000, WEAR, V237, P231, DOI 10.1016/S0043-1648(99)00347-6
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Yeo IS, 2008, J BIOMED MATER RES B, V87B, P303, DOI 10.1002/jbm.b.31104
NR 51
TC 16
Z9 17
U1 2
U2 19
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUL 1
PY 2016
VL 64
BP 1
EP 10
DI 10.1016/j.msec.2016.03.049
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA DM7NQ
UT WOS:000376547700001
PM 27127022
DA 2018-10-20
ER

PT J
AU Ye, CR
   Wang, Y
   Su, H
   Yang, P
   Huang, N
   Maitz, MF
   Zhao, AS
AF Ye, Changrong
   Wang, Yan
   Su, Hong
   Yang, Ping
   Huang, Nan
   Maitz, Manfred F.
   Zhao, Anshan
TI Construction of a fucoidan/laminin functional multilayer to direction
   vascular cell fate and promotion hemocompatibility
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Fucoidan; Laminin; Anticoagulation; Cardiovascular implants; Endothelial
   cells; Smooth muscle cells
ID BIOMATERIAL SURFACES; EXTRACELLULAR-MATRIX; IN-VITRO;
   ENDOTHELIALIZATION; HEPARIN; FIBRONECTIN; ADSORPTION; MICROENVIRONMENT;
   ANTICOAGULANT; ANGIOGENESIS
AB Surface biofunctional modification of cardiovascular stents is a versatile approach to reduce the adverse effects after implantation. In this work, a novel multifunctional coating was fabricated by coimmobilization of the sulfated polysaccharide of brown algae fucoidan and laminin to biomimic the vascular intimal conditions in order to support rapid endothelialization, prevent restenosis and improve hemocompatibility. The surface properties of the coating such as hydrophilicity, bonding density of biomolecules and stability were evaluated and optimized. According to the biocompatibility tests, the fucoidan/laminin multilayer coated surface displayed less platelet adhesion with favorable anticoagulant property. In addition, the fucoidan/laminin complex showed function to selectively regulate vascular cells growth behavior. The proliferation of endothelial cells (ECs) on the fucoidan/laminin biofunctional coating was significantly promoted. For the smooth muscle cells (SMC5), inhibitory effects on cell adhesion and proliferation were observed. In conclusion, the fucoidan/laminin biofunctional coating was successfully fabricated with desirable anticoagulant and endothelialization properties which show a promising application in the vascular devices such as vascular stents or grafts surface modification. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Ye, Changrong; Wang, Yan; Su, Hong; Yang, Ping; Huang, Nan; Zhao, Anshan] Southwest Jiaotong Univ, Dept Mat Sci & Engn, Minist Educ, Key Lab Adv Mat Technol, Chengdu 610031, Peoples R China.
   [Maitz, Manfred F.] Max Bergmann Ctr Biomat Dresden, Leibniz Inst Polymer Res Dresden, D-01069 Dresden, Germany.
RP Zhao, AS (reprint author), Southwest Jiaotong Univ, Dept Mat Sci & Engn, Minist Educ, Key Lab Adv Mat Technol, Chengdu 610031, Peoples R China.
RI Maitz, Manfred/E-6749-2010; Umlauf, Ursula/D-3356-2014
OI Maitz, Manfred/0000-0002-0671-048X; 
FU National Natural Science Foundation of China [81330031, 81401522]; Key
   Basic Research Program [2011CB606204]
FX The authors gratefully acknowledge the assistance from Dr Ansha Zhao,
   Xiaohua Zhu, Xin Li and Guoneng Xue, the financial support of National
   Natural Science Foundation of China (81330031, 81401522), Key Basic
   Research Program (2011CB606204).
CR Avci-Adali M, 2008, BIOMATERIALS, V29, P3936, DOI 10.1016/j.biomaterials.2008.07.002
   Bachelet L, 2009, BBA-GEN SUBJECTS, V1790, P141, DOI 10.1016/j.bbagen.2008.10.008
   Baddour LM, 2011, J AM DENT ASSOC, V142, P159, DOI 10.14219/jada.archive.2011.0058
   Beamish JA, 2009, BIOMATERIALS, V30, P6286, DOI 10.1016/j.biomaterials.2009.08.004
   Boisson-Vidal C, 2000, DRUG DEVELOP RES, V51, P216, DOI 10.1002/ddr.2
   Brown BN, 2014, TRANSL RES, V163, P268, DOI 10.1016/j.trsl.2013.11.003
   Durig J, 1997, THROMB RES, V85, P479, DOI 10.1016/S0049-3848(97)00037-6
   Giraux JL, 1998, EUR J CELL BIOL, V77, P352, DOI 10.1016/S0171-9335(98)80094-0
   Gu Z, 2010, BIOMATERIALS, V31, P5455, DOI 10.1016/j.biomaterials.2010.03.050
   Hamerli P, 2003, BIOMATERIALS, V24, P3989, DOI 10.1016/S0142-9612(03)00312-0
   Hook F, 1998, LANGMUIR, V14, P729, DOI 10.1021/la970815u
   Kwak JY, 2014, MAR DRUGS, V12, P851, DOI 10.3390/md12020851
   Lee JH, 2015, STEM CELLS, V33, P1939, DOI 10.1002/stem.1973
   Li GC, 2011, BIOMATERIALS, V32, P4691, DOI 10.1016/j.biomaterials.2011.03.025
   Liu P, 2015, MAT SCI ENG C-MATER, V55, P1, DOI 10.1016/j.msec.2015.05.047
   Lord MS, 2006, BIOMATERIALS, V27, P4856, DOI 10.1016/j.biomaterials.2006.05.037
   Mahapatro A, 2015, MAT SCI ENG C-MATER, V55, P227, DOI 10.1016/j.msec.2015.05.018
   Matou S, 2002, THROMB RES, V106, P213, DOI 10.1016/S0049-3848(02)00136-6
   Mitchell MJ, 2015, BIOMATERIALS, V56, P179, DOI 10.1016/j.biomaterials.2015.03.045
   Molino PJ, 2012, LANGMUIR, V28, P8433, DOI 10.1021/la300692y
   Mustafa A, 2015, INT J CARDIOL, V201, P648, DOI 10.1016/j.ijcard.2014.12.118
   Park HY, 2011, FOOD CHEM TOXICOL, V49, P1745, DOI 10.1016/j.fct.2011.04.020
   Qi PK, 2013, SURF COAT TECH, V233, P80, DOI 10.1016/j.surfcoat.2013.02.008
   Schopka S, 2010, MATERIALS, V3, P638, DOI 10.3390/ma3010638
   Suri CR, 1996, BIOSENS BIOELECTRON, V11, P1199, DOI 10.1016/0956-5663(96)88084-5
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   von der Mark K, 2013, PROG MATER SCI, V58, P327, DOI 10.1016/j.pmatsci.2012.09.002
   Wang J, 2014, APPL SURF SCI, V317, P776, DOI 10.1016/j.apsusc.2014.07.129
   Wang J, 2010, INT J BIOL MACROMOL, V46, P6, DOI 10.1016/j.ijbiomac.2009.10.015
   Wang X, 2013, BIOMATERIALS, V34, P2865, DOI 10.1016/j.biomaterials.2013.01.021
   Wang X, 2014, APPL SURF SCI, V320, P871, DOI 10.1016/j.apsusc.2014.09.004
   Yang ZL, 2012, BIOMATERIALS, V33, P6615, DOI 10.1016/j.biomaterials.2012.06.055
   Zhang MC, 2014, PATHOL RES PRACT, V210, P1026, DOI 10.1016/j.prp.2014.04.004
NR 33
TC 3
Z9 3
U1 2
U2 22
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUL 1
PY 2016
VL 64
BP 236
EP 242
DI 10.1016/j.msec.2016.03.070
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA DM7NQ
UT WOS:000376547700028
PM 27127049
DA 2018-10-20
ER

PT J
AU Iqbal, Y
   Bae, H
   Rhee, I
   Hong, S
AF Iqbal, Yousaf
   Bae, Hongsub
   Rhee, Ilsu
   Hong, Sungwook
TI Magnetic heating of silica-coated manganese ferrite nanoparticles
SO JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS
LA English
DT Article
DE Magnetic heating; Manganese ferrite nanoparticles; Silica coating;
   Magnetic hyperthermia
ID IRON-OXIDE NANOPARTICLES; TARGETED DRUG-DELIVERY; MRI CONTRAST AGENTS;
   SOL-GEL METHOD; COMPOSITE NANOPARTICLES; PHOTOCATALYTIC SHELL; FE3O4
   NANOPARTICLES; BIOMATERIAL SYSTEM; HYPERTHERMIA; CHITOSAN
AB Manganese ferrite nanoparticles were synthesized using the reverse micelle method; these particles were then coated with silica. The silica-coated nanoparticles were spherical in shape, with an average diameter of 14 nm. The inverse spinel crystalline structure was observed through X-ray diffraction patterns. The coating status of silica on the surface of the nanoparticles was confirmed with a Fourier transform infrared spectrometer. The superparamagnetic properties were revealed by the zero coercive force in the hysteresis curve. Controllable heating at a fixed temperature of 42 degrees C was achieved by changing either the concentration of nanoparticles in the aqueous solution or the intensity of the alternating magnetic field. We found that at a fixed field strength of 5.5 kA/m, the 2.6 mg/ml sample showed a saturation temperature of 42 degrees C for magnetic hyperthermia. On the other hand, at a fixed concentration of 3.6 mg/ml, a field intensity of 4.57 Wm satisfied the required temperature of 42 degrees C. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Iqbal, Yousaf; Bae, Hongsub; Rhee, Ilsu] Kyungpook Natl Univ, Dept Phys, Taegu 702701, South Korea.
   [Hong, Sungwook] Daegu Univ, Div Sci Educ, Gyongsan 712714, South Korea.
RP Rhee, I (reprint author), Kyungpook Natl Univ, Dept Phys, Taegu 702701, South Korea.
EM ilrhee@knu.ac.kr
FU National Research Foundation of Korea [2010-0021315]
FX This work was supported by the National Research Foundation of Korea
   (2010-0021315).
CR Ahmad T, 2015, J MAGN MAGN MATER, V381, P151, DOI 10.1016/j.jmmm.2014.12.077
   Ahmad T, 2013, J KOREAN PHYS SOC, V62, P1696, DOI 10.3938/jkps.62.1696
   Ahmad T, 2012, J NANOSCI NANOTECHNO, V12, P5132, DOI 10.1166/jnn.2012.6368
   Ahmad T, 2012, CURR APPL PHYS, V12, P969, DOI 10.1016/j.cap.2011.12.020
   Ahmad T, 2010, J KOREAN PHYS SOC, V57, P1545, DOI 10.3938/jkps.57.1545
   Aslibeiki B, 2012, J MAGN MAGN MATER, V324, P154, DOI 10.1016/j.jmmm.2011.07.057
   Bruni S, 1999, NANOSTRUCT MATER, V11, P573, DOI 10.1016/S0965-9773(99)00335-9
   Carta D, 2008, PHYS CHEM CHEM PHYS, V10, P3108, DOI 10.1039/b800359a
   Chen LY, 2010, J ALLOY COMPD, V497, P221, DOI 10.1016/j.jallcom.2010.03.016
   Depan D., 2013, J BIOMED RES, V2934, P2934
   Do Kim K, 2007, J IND ENG CHEM, V13, P1137
   Dobson J, 2006, DRUG DEVELOP RES, V67, P55, DOI 10.1002/ddr.20067
   Guerrero-Martinez A, 2010, ADV MATER, V22, P1182, DOI 10.1002/adma.200901263
   Hergt R, 2006, J PHYS-CONDENS MAT, V18, pS2919, DOI 10.1088/0953-8984/18/38/S26
   Hong S, 2010, J KOREAN PHYS SOC, V56, P868, DOI 10.3938/jkps.56.868
   Huang HS, 2013, INT J NANOMED, V8, P2521, DOI 10.2147/IJN.S43770
   Iqbal Y., 2015, NEW PHYS SAE MULLI, V65, P147
   Jordan A, 1999, J MAGN MAGN MATER, V194, P185, DOI 10.1016/S0304-8853(98)00558-7
   Jung YI, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-43
   KLIBANOV AL, 1990, FEBS LETT, V268, P235, DOI 10.1016/0014-5793(90)81016-H
   Lewandowska-Lancucka J, 2014, J ALLOY COMPD, V586, P45, DOI 10.1016/j.jallcom.2013.10.039
   McBain SC, 2008, INT J NANOMED, V3, P169
   Misra RDK, 2008, MATER SCI TECH-LOND, V24, P1011, DOI 10.1179/174328408X341690
   Misra RDK, 2011, NANOPLATFORM-BASED MOLECULAR IMAGING, P709
   Misra RDK, 2010, MATER TECHNOL, V25, P118, DOI 10.1179/175355510X12723642365241
   Mojic B, 2012, CERAM INT, V38, P6635, DOI 10.1016/j.ceramint.2012.05.050
   Na HB, 2009, ADV MATER, V21, P2133, DOI 10.1002/adma.200802366
   Nica V, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/20/204115
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rana S, 2005, MAT SCI ENG B-SOLID, V119, P144, DOI 10.1016/j.mseb.2005.02.043
   Rhee Iisu, 2015, New Physics: Sae Mulli, V65, P411, DOI 10.3938/NPSM.65.411
   Rosensweig RE, 2002, J MAGN MAGN MATER, V252, P370, DOI 10.1016/S0304-8853(02)00706-0
   Sahoo B, 2014, J COLLOID INTERF SCI, V431, P31, DOI 10.1016/j.jcis.2014.06.003
   Senpan A, 2009, ACS NANO, V3, P3917, DOI 10.1021/nn900819y
   Wang WW, 2010, MATER LETT, V64, P840, DOI 10.1016/j.matlet.2010.01.034
   Xu W, 2012, PHYS CHEM CHEM PHYS, V14, P12687, DOI 10.1039/c2cp41357d
   Yoo MK, 2007, J BIOMED BIOTECHNOL, DOI 10.1155/2007/94740
NR 38
TC 13
Z9 13
U1 1
U2 109
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-8853
EI 1873-4766
J9 J MAGN MAGN MATER
JI J. Magn. Magn. Mater.
PD JUL 1
PY 2016
VL 409
BP 80
EP 86
DI 10.1016/j.jmmm.2016.02.078
PG 7
WC Materials Science, Multidisciplinary; Physics, Condensed Matter
SC Materials Science; Physics
GA DG8GF
UT WOS:000372320300014
DA 2018-10-20
ER

PT J
AU Atanasov, PA
   Stankova, NE
   Nedyalkov, NN
   Fukata, N
   Hirsch, D
   Rauschenbach, B
   Amoruso, S
   Wang, X
   Kolev, KN
   Valova, EI
   Georgieva, JS
   Armyanov, SA
AF Atanasov, P. A.
   Stankova, N. E.
   Nedyalkov, N. N.
   Fukata, N.
   Hirsch, D.
   Rauschenbach, B.
   Amoruso, S.
   Wang, X.
   Kolev, K. N.
   Valova, E. I.
   Georgieva, J. S.
   Armyanov, St. A.
TI Fs-laser processing of medical grade polydimethylsiloxane (PDMS)
SO APPLIED SURFACE SCIENCE
LA English
DT Article; Proceedings Paper
CT Symposium CC on Laser and Plasma Processing for Advanced Applications in
   Material Science held during the Annual Spring Meeting of the
   European-Materials-Research-Society (E-MRS)
CY MAY 11-15, 2015
CL Lille, FRANCE
SP European Mat Res Soc
DE PDMS-elastomer; IR; VIS and UV fs-laser processing; mu-Raman
   spectrometry; AFM and SEM analyses; Metallization
ID SILICONE-RUBBER; POLY(DIMETHYLSILOXANE); IRRADIATION; FABRICATION
AB Medical grade polydimethylsiloxane (PDMS) elastomer is a biomaterial widely used in medicine and high-tech devices, e.g. MEMS and NEMS. In this work, we report an experimental investigation on femtosecond laser processing of PDMS-elastomer with near infrared (NIR), visible (VIS) and ultraviolet (UV) pulses. High definition trenches are produced by varying processing parameters as laser wavelength, pulse duration, fluence, scanning speed and overlap of the subsequent pulses. The sample surface morphology and chemical composition are investigated by Laser Microscopy, SEM and Raman spectroscopy, addressing the effects of the various processing parameters through comparison with the native materials characteristics. For all the laser pulse wavelengths used, the produced tracks are successfully metalized with Ni via electro-less plating method. We observe a negligible influence of the time interval elapsed between laser treatment and metallization process. Our experimental findings suggest promising perspectives of femtosecond laser pulses in micro- and nano-fabrication of hi-tech PDMS devices. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Atanasov, P. A.; Stankova, N. E.; Nedyalkov, N. N.] Bulgarian Acad Sci, Inst Elect, 72 Tsaridradsko Shose Blvd, Sofia 1784, Bulgaria.
   [Fukata, N.] Natl Inst Mat Sci, Int Ctr Mat NanoArchitecton MANA, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.
   [Hirsch, D.; Rauschenbach, B.] Leibniz Inst Surface Modificat IOM, Permoserstr 15, D-04318 Leipzig, Germany.
   [Amoruso, S.; Wang, X.] Univ Naples Federico II, Dipartmento Fis, Via Cintia, I-80126 Naples, Italy.
   [Amoruso, S.; Wang, X.] Complesso Univ Monte S Angelo, CNR SPIN, Via Cintia, I-80126 Naples, Italy.
   [Kolev, K. N.; Valova, E. I.; Georgieva, J. S.; Armyanov, St. A.] Bulgarian Acad Sci, Rostislaw Kaischew Inst Phys Chem, Acad G Bonchev Str,Block 11, Sofia 1113, Bulgaria.
RP Atanasov, PA (reprint author), Bulgarian Acad Sci, Inst Elect, 72 Tsaridradsko Shose Blvd, Sofia 1784, Bulgaria.
EM paatanas@ie.bas.bg
RI amoruso, salvatore/E-3941-2012; WANG, Xuan/F-1243-2011
OI amoruso, salvatore/0000-0002-1011-3215; WANG, Xuan/0000-0002-0830-0898
CR [Anonymous], 2009, CURR OPIN SOLID STAT, P1
   [Anonymous], 2004, SIL COMP SIL SIL
   Atanasov PA, 2014, J APPL PHYS, V116, DOI 10.1063/1.4887812
   Curtis J M, 2004, BIOMATERIALS SCI
   Dicara C, 2003, P SOC PHOTO-OPT INS, V5147, P255, DOI 10.1117/12.537694
   Dupas-Bruzek C, 2009, APPL SURF SCI, V255, P8715, DOI 10.1016/j.apsusc.2009.06.025
   Ferrari AC, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.121405
   Ferrari AC, 2007, SOLID STATE COMMUN, V143, P47, DOI 10.1016/j.ssc.2007.03.052
   Graubner VM, 2002, APPL SURF SCI, V197, P786, DOI 10.1016/S0169-4332(02)00415-4
   Guo L, 2013, IEEE T BIOMED CIRC S, V7, P1, DOI 10.1109/TBCAS.2012.2192932
   HajjHassan M, 2008, SENSORS-BASEL, V8, P6704, DOI 10.3390/s8106704
   Hassler C, 2011, J POLYM SCI POL PHYS, V49, P18, DOI 10.1002/polb.22169
   Hermanson G T, 1992, IMMOBILIZED AFFINITY, P454
   Lacour SP, 2010, MED BIOL ENG COMPUT, V48, P945, DOI 10.1007/s11517-010-0644-8
   Laude L, 2008, US Patent, Patent No. [US 2008/ 10305320 A1, 200810305320]
   Laude L D, 1997, US Patent No, Patent No. 5599592
   Makamba H, 2003, ELECTROPHORESIS, V24, P3607, DOI 10.1002/elps.200305627
   McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C
   Okoshi M, 2005, OPT LETT, V30, P2730, DOI 10.1364/OL.30.002730
   Palma C, 1999, APPL SURF SCI, V138, P24, DOI 10.1016/S0169-4332(98)00382-1
   Stankova NE, 2015, APPL SURF SCI, V336, P321, DOI 10.1016/j.apsusc.2014.12.121
NR 21
TC 9
Z9 9
U1 1
U2 39
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD JUN 30
PY 2016
VL 374
BP 229
EP 234
DI 10.1016/j.apsusc.2015.11.175
PG 6
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA DL9BV
UT WOS:000375937300036
DA 2018-10-20
ER

PT J
AU Burke, KA
   Brenckle, MA
   Kaplan, DL
   Omenetto, FG
AF Burke, Kelly A.
   Brenckle, Mark A.
   Kaplan, David L.
   Omenetto, Fiorenzo G.
TI Evaluation of the Spectral Response of Functionalized Silk Inverse Opals
   as Colorimetric Immunosensors
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE silk fibroin; immunosensor; inverse opal; biopolymer; antibody; antigen;
   biosensor; photonic crystals
ID SURFACE-PLASMON RESONANCE; QUARTZ-CRYSTAL MICROBALANCE;
   MONOCLONAL-ANTIBODIES; FIBROIN; BIOSENSOR; STERILIZATION; SENSORS;
   BIOMATERIAL; PROTEINS; ADHESIVE
AB Regenerated silk fibroin is a high molecular weight protein obtained by purifying the cocoons of the Expose to domesticated silkworm, Bombyx mori. This report exploits the analyte aqueous processing and tunable beta sheet secondary structure of regenerated silk to produce nanostructures (i.e., inverse opals) that can be used as colorimetric immunosensors. Such sensors would enable direct detection of antigens by changes in reflectance spectra induced by binding events within the nanostructure. Silk inverse opals were prepared by solution casting and annealing in a humidified atmosphere to render the silk insoluble. Next, antigen sensing capabilities were imparted to silk through a three step synthesis: coupling of avidin to silk surfaces, coupling of biotin to antibodies, and lastly antibody attachment to silk through avidin biotin interactions. Varying the antibody enables detection of different antigens, as demonstrated using different protein antigens: antibodies, red fluorescent protein, and the beta subunit of cholera toxin. Antigen binding to sensors induces a red shift in the opal reflectance spectra, while sensors not exposed to antigen showed either no shift or a slight blue shift. This work constitutes a first step for the design of biopolymer-based optical systems that could directly detect antigens using commercially available reagents and environmentally friendly chemistries.
C1 [Burke, Kelly A.; Brenckle, Mark A.; Kaplan, David L.; Omenetto, Fiorenzo G.] Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
   [Omenetto, Fiorenzo G.] Tufts Univ, Dept Phys, 4 Colby St, Medford, MA 02155 USA.
   [Burke, Kelly A.] Univ Connecticut, Dept Chem & Biomol Engn, Storrs, CT 06269 USA.
   [Burke, Kelly A.] Univ Connecticut, Polymer Program, Storrs, CT 06269 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.; Omenetto, FG (reprint author), 4 Colby St,Sci & Technol Ctr Room 229, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu; fiorenzo.omenetto@tufts.edu
FU Air Force Office of Scientific Research [FA9550-14-1-0015, 32 CFR 168a];
   National Institutes of Health [NIH P41 EB002520]; Ruth Kirschstein
   Postdoctoral Fellowship [F32-DK093194]; Department of Defense
FX The authors wish to thank the Air Force Office of Scientific Research
   (FA9550-14-1-0015), as well as the National Institutes of Health for
   funding support in the form of the Tissue Engineering Resource Center
   (NIH P41 EB002520) and a Ruth Kirschstein Postdoctoral Fellowship
   awarded to K.A.B. (F32-DK093194). M.A.B. would like to acknowledge
   support from the Department of Defense, Air Force Office of Scientific
   Research in the form of a National Defense Science and Engineering
   Graduate (NDSEG) Fellowship, 32 CFR 168a.
CR Amsden JJ, 2009, OPT EXPRESS, V17, P21271, DOI 10.1364/OE.17.021271
   Arugula MA, 2014, MEAS SCI TECHNOL, V25, DOI 10.1088/0957-0233/25/3/032001
   Bini E, 2004, J MOL BIOL, V335, P27, DOI 10.1016/j.jmb.2003.10.043
   Boriskina SV, 2010, OPT EXPRESS, V18, P14568, DOI 10.1364/OE.18.014568
   Burke KA, 2016, BIOMACROMOLECULES, V17, P237, DOI 10.1021/acs.biomac.5b01330
   Byrne B, 2009, SENSORS-BASEL, V9, P4407, DOI 10.3390/s90604407
   Cheng CI, 2012, CHEM SOC REV, V41, P1947, DOI 10.1039/c1cs15168a
   Conroy PJ, 2009, SEMIN CELL DEV BIOL, V20, P10, DOI 10.1016/j.semcdb.2009.01.010
   Cronin-Golomb M, 2012, J POLYM SCI POL PHYS, V50, P257, DOI 10.1002/polb.23003
   de Moraes MA, 2014, J BIOMED MATER RES B, V102, P869, DOI 10.1002/jbm.b.33069
   Diao YY, 2013, ADV FUNCT MATER, V23, P5373, DOI 10.1002/adfm.201203672
   Gil ES, 2014, MACROMOL BIOSCI, V14, P257, DOI 10.1002/mabi.201300321
   Gonzalez M, 1999, BIOMOL ENG, V16, P67, DOI 10.1016/S1050-3862(99)00041-8
   Hao RZ, 2009, BIOSENS BIOELECTRON, V24, P1330, DOI 10.1016/j.bios.2008.07.071
   Healy DA, 2007, TRENDS BIOTECHNOL, V25, P125, DOI 10.1016/j.tibtech.2007.01.004
   Hock B, 1997, ANAL CHIM ACTA, V347, P177, DOI 10.1016/S0003-2670(97)00167-0
   Hofmann S, 2014, ACTA BIOMATER, V10, P308, DOI 10.1016/j.actbio.2013.08.035
   Homola J, 2008, CHEM REV, V108, P462, DOI 10.1021/cr068107d
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Hu X, 2013, ADV FUNCT MATER, V23, P3875, DOI 10.1002/adfm.201202685
   Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a
   Justino CIL, 2015, TRAC-TREND ANAL CHEM, V68, P2, DOI 10.1016/j.trac.2015.03.006
   KARLSSON R, 1991, J IMMUNOL METHODS, V145, P229, DOI 10.1016/0022-1759(91)90331-9
   Kim S, 2013, OPT EXPRESS, V21, P8897, DOI 10.1364/OE.21.008897
   Kim S, 2012, NAT PHOTONICS, V6, P817, DOI [10.1038/NPHOTON.2012.264, 10.1038/nphoton.2012.264]
   Kuralay F, 2011, TALANTA, V85, P1330, DOI 10.1016/j.talanta.2011.06.012
   Kurland NE, 2013, ADV MATER, V25, P6207, DOI 10.1002/adma.201302823
   Lawrence BD, 2008, BIOMACROMOLECULES, V9, P1214, DOI 10.1021/bm701235f
   Lee SY, 2010, P NATL ACAD SCI USA, V107, P12086, DOI 10.1073/pnas.1002849107
   Lu Q, 2011, ACTA BIOMATER, V7, P2782, DOI 10.1016/j.actbio.2011.03.001
   Luong JHT, 2008, BIOTECHNOL ADV, V26, P492, DOI 10.1016/j.biotechadv.2008.05.007
   Mayer KM, 2008, ACS NANO, V2, P687, DOI 10.1021/nn7003734
   Miller PR, 2012, TALANTA, V88, P739, DOI 10.1016/j.talanta.2011.11.046
   Mondia JP, 2010, ADV MATER, V22, P4596, DOI 10.1002/adma.201001238
   Murphy AR, 2009, J MATER CHEM, V19, P6443, DOI 10.1039/b905802h
   Pal RK, 2015, ACS APPL MATER INTER, V7, P8809, DOI 10.1021/acsami.5b01380
   Piliarik M, 2010, BIOSENS BIOELECTRON, V26, P1656, DOI 10.1016/j.bios.2010.08.063
   Pohanka M, 2007, SENSORS-BASEL, V7, P341, DOI 10.3390/s7030341
   Rnjak-Kovacina J, 2015, MACROMOL BIOSCI, V15, P861, DOI 10.1002/mabi.201500013
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Serban MA, 2010, BIOMACROMOLECULES, V11, P3406, DOI 10.1021/bm100925s
   Shen ZH, 2007, ANAL CHEM, V79, P2312, DOI 10.1021/ac061986j
   Shukla AA, 2007, J CHROMATOGR B, V848, P28, DOI 10.1016/j.jchromb.2006.09.026
   Shukla AA, 2010, TRENDS BIOTECHNOL, V28, P253, DOI 10.1016/j.tibtech.2010.02.001
   Swinerd VM, 2007, SOFT MATTER, V3, P1377, DOI 10.1039/b711975e
   Tao H, 2012, P NATL ACAD SCI USA, V109, P19584, DOI 10.1073/pnas.1209056109
   Tao H, 2012, ADV MATER, V24, P1067, DOI 10.1002/adma.201103814
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang XQ, 2011, MACROMOL BIOSCI, V11, P100, DOI 10.1002/mabi.201000173
   Wang X, 2014, TRENDS ENVIRON ANAL, V2, P25, DOI 10.1016/j.teac.2014.04.001
   Wang YT, 2010, SENSOR ACTUAT B-CHEM, V146, P381, DOI 10.1016/j.snb.2010.02.032
   WILCHEK M, 1988, ANAL BIOCHEM, V171, P1, DOI 10.1016/0003-2697(88)90120-0
   Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078
NR 53
TC 9
Z9 9
U1 16
U2 61
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD JUN 29
PY 2016
VL 8
IS 25
BP 16218
EP 16226
DI 10.1021/acsami.6b02215
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA DQ1UB
UT WOS:000378984800041
PM 27322909
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Zilm, ME
   Chen, L
   Sharma, V
   McDannald, A
   Jain, M
   Ramprasad, R
   Wei, M
AF Zilm, M. E.
   Chen, L.
   Sharma, V.
   McDannald, A.
   Jain, M.
   Ramprasad, R.
   Wei, M.
TI Hydroxyapatite substituted by transition metals: experiment and theory
SO PHYSICAL CHEMISTRY CHEMICAL PHYSICS
LA English
DT Article
ID IRON-OXIDE NANOPARTICLES; CALCIUM-HYDROXYAPATITE; DOPED HYDROXYAPATITE;
   DFT; STRONTIUM; MANGANESE; DENSITY; BONE; EPR; CERAMICS
AB Bioceramics are versatile materials for hard tissue engineering. Hydroxyapatite (HA) is a widely studied biomaterial for bone grafting and tissue engineering applications. The crystal structure of HA allows for a wide range of substitutions, which allows for tailoring materials properties. Transition metals and lanthanides are of interest since substitution in HA can result in magnetic properties. In this study, experimental results were compared to theoretical calculations of HA substituted with a transition metal. Calculation of a 10 atomic percent substitution of a transition metal ion Mn2+, Fe2+, and Co2+ substituted HA samples lead to magnetic moments of 5, 4, and 3 Bohr magnetons, respectively. Hydroxyapatite substituted by transition metals (MHA) was fabricated through an ion exchange procedure and characterized with X-ray diffraction, Fourier transform infra-red spectroscopy (FTIR), X-ray photoelectron spectroscopy, and vibrating sample magnetometer, and results were compared to theoretical calculations. All the substitutions resulted in phase-pure M(2+)HA with lattice parameters and FTIR spectra in good agreement with calculations. Magnetic measurements revealed that the substitution of Mn2+ has the greatest effect on the magnetic properties of HA followed by the substitution of Fe2+ and then Co2+. The present work underlines the power of synergistic theoretical-experimental work in guiding the rational design of materials.
C1 [Zilm, M. E.; Chen, L.; Sharma, V.; McDannald, A.; Ramprasad, R.; Wei, M.] Univ Connecticut, Dept Mat Sci & Engn, Storrs, CT 06269 USA.
   [Jain, M.] Univ Connecticut, Dept Phys, Storrs, CT USA.
RP Wei, M (reprint author), Univ Connecticut, Dept Mat Sci & Engn, Storrs, CT 06269 USA.
EM meiwei@engr.uconn.edu
OI sharma, vinit/0000-0002-0577-5716
FU NSF [CBET-1133883, CBET-1347130, DMR 1310149]; NSF GK-12 program
   [0947869]
FX The authors would like to thank NSF grants (CBET-1133883 and
   CBET-1347130) and NSF GK-12 program (0947869) for their support. For
   magnetic measurements, author MJ acknowledges the support of NSF grant
   DMR 1310149.
CR Astala R, 2006, CHEM MATER, V18, P413, DOI 10.1021/cm051989x
   Astala R, 2005, CHEM MATER, V17, P4125, DOI 10.1021/cm050523b
   Bae YJ, 2008, BIOL TRACE ELEM RES, V124, P28, DOI 10.1007/s12011-008-8119-6
   Bhat SS, 2014, CRYST GROWTH DES, V14, P3131, DOI 10.1021/cg5004269
   Biktagirov T, 2014, J PHYS CHEM A, V118, P1519, DOI 10.1021/jp410900m
   Boanini E, 2010, ACTA BIOMATER, V6, P1882, DOI 10.1016/j.actbio.2009.12.041
   BORODKO YG, 1976, CHEM PHYS LETT, V42, P264, DOI 10.1016/0009-2614(76)80360-0
   Bose S, 2013, TRENDS BIOTECHNOL, V31, P594, DOI 10.1016/j.tibtech.2013.06.005
   Briggs D., 1983, PRACTICAL SURFACE AN
   Chandra VS, 2012, ACS APPL MATER INTER, V4, P1200, DOI 10.1021/am300140q
   Chappell HF, 2007, J MATER SCI-MATER M, V18, P829, DOI 10.1007/s10856-006-0001-5
   de Leeuw NH, 2002, PHYS CHEM CHEM PHYS, V4, P3865, DOI 10.1039/b203114k
   Ellis DE, 2006, PHYS CHEM CHEM PHYS, V8, P967, DOI 10.1039/b509254j
   Fiorentini V, 1996, J PHYS-CONDENS MAT, V8, P6525, DOI 10.1088/0953-8984/8/36/005
   Gafurov M, 2015, PHYS CHEM CHEM PHYS, V17, P20331, DOI 10.1039/c5cp01986a
   Gafurov M, 2014, APPL MAGN RESON, V45, P1189, DOI 10.1007/s00723-014-0572-0
   Issa B, 2013, INT J MOL SCI, V14, P21266, DOI 10.3390/ijms141121266
   Jiang M, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.224107
   Khachani M, 2010, APPL CATAL A-GEN, V388, P113, DOI 10.1016/j.apcata.2010.08.043
   Kramer E, 2014, CERAM INT, V40, P13471, DOI 10.1016/j.ceramint.2014.05.072
   Kramer ER, 2013, J MATER SCI, V48, P665, DOI 10.1007/s10853-012-6779-2
   Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169
   Landi E, 2003, J EUR CERAM SOC, V23, P2931, DOI 10.1016/S0955-2219(03)00304-2
   Larson A. C., 2000, LOS ALAMOS NATL LAB, P86
   Laurencin D, 2011, BIOMATERIALS, V32, P1826, DOI 10.1016/j.biomaterials.2010.11.017
   Li Y, 2012, J MATER SCI, V47, P754, DOI 10.1007/s10853-011-5851-7
   Lindsay D, 2011, NAT CHEM, V3, P494, DOI 10.1038/nchem.1053
   Ma XY, 2008, BIOMATERIALS, V29, P257, DOI 10.1016/j.biomaterials.2007.10.001
   Matsunaga K, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.014102
   Mayer I, 2010, J INORG BIOCHEM, V104, P1107, DOI 10.1016/j.jinorgbio.2010.06.009
   MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.13.5188
   Na HB, 2009, ADV MATER, V21, P2133, DOI 10.1002/adma.200802366
   Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201
   Panseri S, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-32
   Patel N, 2002, J MATER SCI-MATER M, V13, P1199, DOI 10.1023/A:1021114710076
   Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865
   POSNER AS, 1958, ACTA CRYSTALLOGR, V11, P308, DOI 10.1107/S0365110X58000815
   Rico H, 2000, EUR J OBSTET GYN R B, V90, P97, DOI 10.1016/S0301-2115(99)00223-7
   Rulis P, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.155104
   Soenen SJH, 2011, BIOMATERIALS, V32, P195, DOI 10.1016/j.biomaterials.2010.08.075
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Terra J, 2010, PHYS CHEM CHEM PHYS, V12, P15490, DOI 10.1039/c0cp01032d
   Terra J, 2009, PHYS CHEM CHEM PHYS, V11, P568, DOI 10.1039/b802841a
   Toby BH, 2001, J APPL CRYSTALLOGR, V34, P210, DOI 10.1107/S0021889801002242
   Veiseh O, 2010, ADV DRUG DELIVER REV, V62, P284, DOI 10.1016/j.addr.2009.11.002
   Veselinovic L, 2010, J APPL CRYSTALLOGR, V43, P320, DOI 10.1107/S0021889809051395
   Webster TJ, 2004, BIOMATERIALS, V25, P2111, DOI 10.1016/j.biomaterials.2003.09.001
   Williams R. J. P., 1968, ROY I CHEM REV, V1, P13
   Xu HY, 2011, BIOMATERIALS, V32, P9758, DOI 10.1016/j.biomaterials.2011.08.076
   Xue WC, 2006, J BIOMED MATER RES A, V79A, P804, DOI 10.1002/jbm.a.30815
   Yin SX, 2010, PHYS CHEM CHEM PHYS, V12, P156, DOI 10.1039/b915171k
   Zeglinski J, 2012, PHYS CHEM CHEM PHYS, V14, P3435, DOI 10.1039/c2cp23163h
   Zhou H, 2011, ACTA BIOMATER, V7, P2769, DOI 10.1016/j.actbio.2011.03.019
   Zhu WH, 2004, CHEM PHYS LETT, V396, P38, DOI 10.1016/j.cplett.2004.08.006
   Zilm ME, 2014, J MATER CHEM B, V2, P7176, DOI 10.1039/c4tb00925h
NR 55
TC 14
Z9 14
U1 3
U2 45
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1463-9076
EI 1463-9084
J9 PHYS CHEM CHEM PHYS
JI Phys. Chem. Chem. Phys.
PD JUN 28
PY 2016
VL 18
IS 24
BP 16457
EP 16465
DI 10.1039/c6cp00474a
PG 9
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA DS8TS
UT WOS:000381056500047
PM 27264723
DA 2018-10-20
ER

PT J
AU Knaack, GL
   McHail, DG
   Borda, G
   Koo, B
   Peixoto, N
   Cogan, SF
   Dumas, TC
   Pancrazio, JJ
AF Knaack, Gretchen L.
   McHail, Daniel G.
   Borda, German
   Koo, Beomseo
   Peixoto, Nathalia
   Cogan, Stuart F.
   Dumas, Theodore C.
   Pancrazio, Joseph J.
TI In vivo Characterization of Amorphous Silicon Carbide As a Biomaterial
   for Chronic Neural Interfaces
SO FRONTIERS IN NEUROSCIENCE
LA English
DT Article
DE amorphous silicon carbide; neuroprosthetic device; neural electrode;
   foreign body response; neuroinflammatory response; in vivo models
ID CENTRAL-NERVOUS-SYSTEM; BRAIN-TISSUE; MICROELECTRODE ARRAYS;
   CEREBRAL-CORTEX; DEVICES; RESPONSES; IMPLANTS; STENT
AB Implantable microelectrode arrays (MEAs) offer clinical promise for prosthetic devices by enabling restoration of communication and control of artificial limbs. While proof-of-concept recordings from MEAs have been promising, work in animal models demonstrates that the obtained signals degrade over time. Both material robustness and tissue response are acknowledged to have a role in device lifetime. Amorphous Silicon carbide (a-SiC), a robust material that is corrosion resistant, has emerged as an alternative encapsulation layer for implantable devices. We systematically examined the impact of a-SiC coating on Si probes by immunohistochemical characterization of key markers implicated in tissue-device response. After implantation, we performed device capture immunohistochemical labeling of neurons, astrocytes, and activated microglia/macrophages after 4 and 8 weeks of implantation. Neuron loss and microglia activation were similar between Si and a-SiC coated probes, while tissue implanted with a-SiC displayed a reduction in astrocytes adjacent to the probe. These results suggest that a-SiC has a similar biocompatibility profile as Si, and may be suitable for implantable MEA applications as a hermetic coating to prevent material degradation.
C1 [Knaack, Gretchen L.; McHail, Daniel G.; Dumas, Theodore C.] George Mason Univ, Krasnow Inst Adv Study, Dept Mol Neurosci, Fairfax, VA 22030 USA.
   [Knaack, Gretchen L.; Pancrazio, Joseph J.] Quantitat Sci Solut, Arlington, VA USA.
   [Borda, German; Koo, Beomseo] George Mason Univ, Dept Bioengn, Fairfax, VA 22030 USA.
   [Peixoto, Nathalia] George Mason Univ, Dept Elect & Comp Engn, Fairfax, VA 22030 USA.
   [Cogan, Stuart F.; Pancrazio, Joseph J.] Univ Texas Dallas, Dept Bioengn, Richardson, TX 75083 USA.
RP Pancrazio, JJ (reprint author), Quantitat Sci Solut, Arlington, VA USA.; Pancrazio, JJ (reprint author), Univ Texas Dallas, Dept Bioengn, Richardson, TX 75083 USA.
EM joseph.pancrazio@utdallas.edu
FU Defense Advanced Research Projects Agency (DARPA) MTO under the Space
   and Naval Warfare Systems Center, Pacific Grant [N66001-12-1-4026]
FX We are grateful to Dr. William Shain (University of Washington, Seattle,
   WA, USA) for sharing the device capture histology method and Dr. Jeffrey
   Capadona (Case Western Reserve University and Louis Stokes Cleveland VA
   Medical Center, Cleveland 011, USA) for providing custom software for
   image analysis. This work was sponsored by the Defense Advanced Research
   Projects Agency (DARPA) MTO under the auspices of Dr. Jack Judy through
   the Space and Naval Warfare Systems Center, Pacific Grant/Contract No.
   N66001-12-1-4026 (to JP). The sponsor did not have a role in the design,
   analysis, or writing of the study.
CR ALEXANDER GB, 1954, J PHYS CHEM-US, V58, P453, DOI 10.1021/j150516a002
   Amon M, 1996, J MATER SCI-MATER M, V7, P273, DOI 10.1007/BF00058566
   Azemi E, 2011, BIOMATERIALS, V32, P681, DOI 10.1016/j.biomaterials.2010.09.033
   Bardehle S, 2013, NAT NEUROSCI, V16, P580, DOI 10.1038/nn.3371
   Barrese JC, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/2/026003
   Barrese JC, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/6/066014
   Bertrand OF, 1998, J AM COLL CARDIOL, V32, P562, DOI 10.1016/S0735-1097(98)00289-7
   Biran R, 2005, EXP NEUROL, V195, P115, DOI 10.1016/j.expneurol.2005.04.020
   Bjornsson CS, 2006, J NEURAL ENG, V3, P196, DOI 10.1088/1741-2560/3/3/002
   Cogan SF, 2003, J BIOMED MATER RES A, V67A, P856, DOI 10.1002/jbm.a.10152
   Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6
   Frewin CL, 2011, IEEE ENG MED BIO, P2957, DOI 10.1109/IEMBS.2011.6090582
   Hamm CW, 2003, CATHETER CARDIO INTE, V60, P375, DOI 10.1002/ccd.10656
   Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970
   Hsu JM, 2007, THIN SOLID FILMS, V516, P34, DOI 10.1016/j.tsf.2007.04.050
   Iliescu C, 2008, SENSOR ACTUAT B-CHEM, V129, P404, DOI 10.1016/j.snb.2007.08.043
   Jansson D, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-104
   Kandel ER, 2000, PRINCIPLES NEUROSCIE
   Kane SR, 2013, IEEE T BIO-MED ENG, V60, P2153, DOI 10.1109/TBME.2013.2248152
   Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009
   Kim YT, 2004, BIOMATERIALS, V25, P2229, DOI 10.1016/j.biomaterials.2003.09.010
   Kozai TDY, 2012, NAT MATER, V11, P1065, DOI [10.1038/NMAT3468, 10.1038/nmat3468]
   Kozai TDY, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/6/066001
   Liu X, 1999, IEEE Trans Rehabil Eng, V7, P315
   McConnell GC, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/5/055005
   Nguyen JK, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/5/056014
   Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015
   Potter KA, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/046020
   Prasad A, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/5/056015
   Ransohoff RM, 2012, NAT REV IMMUNOL, V12, P623, DOI 10.1038/nri3265
   Rousche PJ, 1998, J NEUROSCI METH, V82, P1, DOI 10.1016/S0165-0270(98)00031-4
   SELLA C, 1993, SURF COAT TECH, V60, P577, DOI 10.1016/0257-8972(93)90156-I
   Skaper SD, 2012, FASEB J, V26, P3103, DOI 10.1096/fj.11-197194
   STENSAAS SS, 1976, ACTA NEUROPATHOL, V35, P187
   Stice P, 2007, J NEURAL ENG, V4, P42, DOI 10.1088/1741-2560/4/2/005
   Stice P, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046004
   Szarowski DH, 2003, BRAIN RES, V983, P23, DOI 10.1016/S0006-8993(03)03023-3
   Turner JN, 1999, EXP NEUROL, V156, P33, DOI 10.1006/exnr.1998.6983
   Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996
   Williams JC, 1999, BRAIN RES PROTOC, V4, P303, DOI 10.1016/S1385-299X(99)00034-3
   Winslow BD, 2010, BIOMATERIALS, V31, P1558, DOI 10.1016/j.biomaterials.2009.11.049
   Woolley AJ, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026007
   Woolley AJ, 2011, J NEUROSCI METH, V201, P67, DOI 10.1016/j.jneumeth.2011.07.012
   Zorman C. A., 2009, SILICON CARBIDE MAT
NR 44
TC 5
Z9 5
U1 3
U2 14
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1662-453X
J9 FRONT NEUROSCI-SWITZ
JI Front. Neurosci.
PD JUN 28
PY 2016
VL 10
AR 301
DI 10.3389/fnins.2016.00301
PG 12
WC Neurosciences
SC Neurosciences & Neurology
GA DQ7NS
UT WOS:000379395000001
PM 27445672
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Datta, SS
   Steinberg, AP
   Ismagilov, RF
AF Datta, Sujit S.
   Steinberg, Asher Preska
   Ismagilov, Rustem F.
TI Polymers in the gut compress the colonic mucus hydrogel
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE hydrogel; biophysics; biomaterials; polymers; mucus
ID HOST-MICROBIAL INTERACTIONS; POLYETHYLENE-GLYCOL; POLY(ETHYLENE GLYCOL);
   POLY(ACRYLIC ACID); LIGHT-SCATTERING; IN-VIVO;
   POLY(N-ISOPROPYLACRYLAMIDE) GEL; AUREOBASIDIUM-PULLULANS;
   PSEUDOMONAS-AERUGINOSA; INTRINSIC-VISCOSITY
AB Colonic mucus is a key biological hydrogel that protects the gut from infection and physical damage and mediates host-microbe interactions and drug delivery. However, little is known about how its structure is influenced by materials it comes into contact with regularly. For example, the gut abounds in polymers such as dietary fibers or administered therapeutics, yet whether such polymers interact with the mucus hydrogel, and if so, how, remains unclear. Although several biological processes have been identified as potential regulators of mucus structure, the polymeric composition of the gut environment has been ignored. Here, we demonstrate that gut polymers do in fact regulate mucus hydrogel structure, and that polymer-mucus interactions can be described using a thermodynamic model based on Flory-Huggins solution theory. We found that both dietary and therapeutic polymers dramatically compressed murine colonic mucus ex vivo and in vivo. This behavior depended strongly on both polymer concentration and molecular weight, in agreement with the predictions of our thermodynamic model. Moreover, exposure to polymer-rich luminal fluid from germ-free mice strongly compressed the mucus hydrogel, whereas exposure to luminal fluid from specific-pathogen-free mice-whose microbiota degrade gut polymers-did not; this suggests that gut microbes modulate mucus structure by degrading polymers. These findings highlight the role of mucus as a responsive biomaterial, and reveal a mechanism of mucus restructuring that must be integrated into the design and interpretation of studies involving therapeutic polymers, dietary fibers, and fiber-degrading gut microbes.
C1 [Datta, Sujit S.; Steinberg, Asher Preska; Ismagilov, Rustem F.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.
   [Ismagilov, Rustem F.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.
RP Ismagilov, RF (reprint author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.; Ismagilov, RF (reprint author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.
EM rustem.admin@caltech.edu
OI Datta, Sujit/0000-0003-2400-1561
FU Defense Advanced Research Projects Agency Biological Robustness in
   Complex Settings [HR0011-15-C-0093]; National Science Foundation (NSF)
   Emerging Frontiers in Research and Innovation Award [1137089]; NSF
   Graduate Research Fellowship [DGE-1144469]
FX We thank Said Bogatyrev, Andres Collazo, Elaine Hsiao, Julia Kornfield,
   Octavio Mondragon-Palomino, Ahmad Omar, Alexandre Persat, David Tirrell,
   Zhen-Gang Wang, and David Weitz for useful discussions; the Beckman
   Institute Biological Imaging Facility, the Broad Animal Facility, and
   the Church Animal Facility for experimental resources; the veterinary
   technicians at the California Institute of Technology for experimental
   assistance; Jennifer R. Keeffe for assistance with dynamic light
   scattering measurements; Dorothy Pan for assistance with gel permeation
   chromatography measurements; and Natasha Shelby for contributions to
   writing and editing this manuscript. This work was supported in part by
   Defense Advanced Research Projects Agency Biological Robustness in
   Complex Settings Contract HR0011-15-C-0093, National Science Foundation
   (NSF) Emerging Frontiers in Research and Innovation Award Grant 1137089,
   and NSF Graduate Research Fellowship DGE-1144469 (to A.P.S.).
CR ADACHI H, 1982, POLYM J, V14, P985, DOI 10.1295/polymj.14.985
   Aksoy N, 2002, TURK J MED SCI, V32, P373
   Ambort D, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a014159
   Ambort D, 2012, P NATL ACAD SCI USA, V109, P5645, DOI 10.1073/pnas.1120269109
   American Veterinary Medical Association, 2013, AVMA GUID EUTH AN 20
   Atuma C, 2001, AM J PHYSIOL-GASTR L, V280, pG922
   BANSIL R, 1995, ANNU REV PHYSIOL, V57, P635, DOI 10.1146/annurev.ph.57.030195.003223
   Barcelo A, 2000, GUT, V46, P218, DOI 10.1136/gut.46.2.218
   BEDNAR B, 1984, MACROMOLECULES, V17, P1634, DOI 10.1021/ma00138a037
   Bergstrom KSB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000902
   BOYER RF, 1945, J CHEM PHYS, V13, P363, DOI 10.1063/1.1724050
   Brandup J, 1975, POLYM HDB
   BROCHARD F, 1981, J PHYS-PARIS, V42, P505, DOI 10.1051/jphys:01981004203050500
   Brownlee IA, 2003, P NUTR SOC, V62, P245, DOI 10.1079/PNS2003206
   BULIGA GS, 1987, INT J BIOL MACROMOL, V9, P71, DOI 10.1016/0141-8130(87)90029-8
   Button B, 2012, SCIENCE, V337, P937, DOI 10.1126/science.1223012
   Cai L., 2012, THESIS
   CHEN HL, 1982, MACROMOLECULES, V15, P1445, DOI 10.1021/ma00233a047
   Cone RA, 2009, ADV DRUG DELIVER REV, V61, P75, DOI 10.1016/j.addr.2008.09.008
   DEVANAND K, 1991, MACROMOLECULES, V24, P5943, DOI 10.1021/ma00022a008
   DiPalma JA, 2000, AM J GASTROENTEROL, V95, P446
   DIPALMA JA, 1989, AM J GASTROENTEROL, V84, P1008
   Dobrynin AV, 2005, PROG POLYM SCI, V30, P1049, DOI 10.1016/j.progpolymsci.2005.07.006
   Dondi F, 2012, THEORETICAL ADV CHRO
   Engevik MA, 2015, AM J PHYSIOL-GASTR L, V308, pG510, DOI 10.1152/ajpgi.00091.2014
   Fischer J, 2008, J PHYS CHEM B, V112, P13561, DOI 10.1021/jp805770q
   FLORY PJ, 1953, PRINCIPLES POLYM CHE
   Georgiades P, 2014, BIOPOLYMERS, V101, P366, DOI 10.1002/bip.22372
   Gustafsson JK, 2012, AM J PHYSIOL-GASTR L, V302, pG430, DOI [10.1152/ajpgi.00405.2011., 10.1152/ajpgi.00405.2011]
   Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054
   Heneghan J, 2012, GERMFREE RES BIOL EF
   Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259
   HOVERSTAD T, 1986, J NUTR, V116, P1772
   ISHIDAO T, 1993, MACROMOLECULES, V26, P7361, DOI 10.1021/ma00078a036
   ISHIDAO T, 1995, FLUID PHASE EQUILIBR, V104, P119, DOI 10.1016/0378-3812(94)02643-F
   ITO T, 1989, BIOPHYS J, V56, P707, DOI 10.1016/S0006-3495(89)82717-1
   Jakobsson HE, 2015, EMBO REP, V16, P164, DOI 10.15252/embr.201439263
   JENTOFT N, 1990, TRENDS BIOCHEM SCI, V15, P291, DOI 10.1016/0968-0004(90)90014-3
   Johansson MEV, 2015, CELL HOST MICROBE, V18, P582, DOI 10.1016/j.chom.2015.10.007
   Johansson MEV, 2014, GUT, V63, P281, DOI 10.1136/gutjnl-2012-303207
   Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107
   Johansson MEV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012238
   Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105
   KATO T, 1984, MACROMOLECULES, V17, P1726, DOI 10.1021/ma00139a016
   Kawaguchi S, 1997, POLYMER, V38, P2885, DOI 10.1016/S0032-3861(96)00859-2
   Kayaman N, 1997, POLYM GELS NETW, V5, P167, DOI 10.1016/S0966-7822(96)00039-1
   Khanvilkar K, 2001, ADV DRUG DELIVER REV, V48, P173, DOI 10.1016/S0169-409X(01)00115-6
   KIEFER J, 1993, COLLOID POLYM SCI, V271, P253, DOI 10.1007/BF00652365
   Kienberger F., 2000, Single Molecules, V1, P123, DOI 10.1002/1438-5171(200006)1:2<123::AID-SIMO123>3.3.CO;2-V
   Kim JH, 2000, BIOTECHNOL LETT, V22, P987, DOI 10.1023/A:1005681019573
   Kobayashi K, 2002, GUT, V51, P169, DOI 10.1136/gut.51.2.169
   Lai SK, 2007, P NATL ACAD SCI USA, V104, P1482, DOI 10.1073/pnas.0608611104
   Lai SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004294
   Lai SK, 2009, ADV DRUG DELIVER REV, V61, P86, DOI 10.1016/j.addr.2008.09.012
   Lazaridou A, 2002, ENZYME MICROB TECH, V31, P122, DOI 10.1016/S0141-0229(02)00082-0
   Lentle RG, 2011, PHYS PROCESSES DIGES, P232
   Li H, 2009, SMART HYDROGEL MODELLING, P1, DOI 10.1007/978-3-642-02368-2
   Li H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9292
   Lidell ME, 2006, P NATL ACAD SCI USA, V103, P9298, DOI 10.1073/pnas.0600623103
   Lieleg O, 2010, BIOPHYS J, V98, P1782, DOI 10.1016/j.bpj.2010.01.012
   LOESCHE WJ, 1969, J BACTERIOL, V99, P520
   Lotfy S, 2009, INT J BIOL MACROMOL, V44, P57, DOI 10.1016/j.ijbiomac.2008.10.002
   Macfarlane S, 2006, ALIMENT PHARM THERAP, V24, P701, DOI 10.1111/j.1365-2036.2006.03042.x
   Maisel K, 2015, J CONTROL RELEASE, V209, P280, DOI 10.1016/j.jconrel.2015.04.040
   Matsui H, 2006, P NATL ACAD SCI USA, V103, P18131, DOI 10.1073/pnas.0606428103
   Mestecky J, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P1
   MIJNLIEFF PF, 1978, J POLYM SCI POL PHYS, V16, P245, DOI 10.1002/pol.1978.180160206
   MIKKELSEN A, 1985, BIOPOLYMERS, V24, P1683, DOI 10.1002/bip.360240904
   MOMII T, 1989, MACROMOLECULES, V22, P1384, DOI 10.1021/ma00193a063
   NISHI S, 1985, MACROMOLECULES, V18, P1519, DOI 10.1021/ma00150a001
   Olmsted SS, 2001, BIOPHYS J, V81, P1930, DOI 10.1016/S0006-3495(01)75844-4
   Pal S, 2010, INT J BIOL MACROMOL, V47, P623, DOI 10.1016/j.ijbiomac.2010.08.009
   Perez-Vilar J, 2007, AM J RESP CELL MOL, V36, P183, DOI 10.1165/rcmb.2006-0291TR
   PHILIPPOVA OE, 1994, MACROMOLECULES, V27, P2398, DOI 10.1021/ma00087a006
   Philippova OE, 2013, MACROMOLECULES, V46, P9359, DOI 10.1021/ma401945z
   Poon W. C. K., 2006, SOFT CONDENSED MATTE
   Prasitnok K, 2013, PHYS CHEM CHEM PHYS, V15, P17093, DOI 10.1039/c3cp52958d
   Quillin ML, 2000, ACTA CRYSTALLOGR D, V56, P791, DOI 10.1107/S090744490000679X
   Raynal BDE, 2003, J BIOL CHEM, V278, P28703, DOI 10.1074/jbc.M304632200
   RUBINSTEIN M, 1994, PHYS REV LETT, V73, P2776, DOI 10.1103/PhysRevLett.73.2776
   Rubinstein M., 2003, POLYM PHYS
   Saunders BR, 1997, MACROMOLECULES, V30, P482, DOI 10.1021/ma961277f
   SELLERS LA, 1991, BIOCHIM BIOPHYS ACTA, V1115, P174, DOI 10.1016/0304-4165(91)90027-E
   Sheehan JK, 2000, BIOCHEM J, V347, P37, DOI 10.1042/0264-6021:3470037
   Shimotoyodome A, 2001, DIGEST DIS SCI, V46, P1482, DOI 10.1023/A:1010644021888
   SHOGREN R, 1989, BIOCHEMISTRY-US, V28, P5525, DOI 10.1021/bi00439a029
   Sing CE, 2013, MACROMOLECULES, V46, P5053, DOI 10.1021/ma400372p
   Sobota JA, 2006, MOL BIOL CELL, V17, P5038, DOI 10.1091/mbc.E06-07-0626
   Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051
   SPIRO RG, 1970, ANNU REV BIOCHEM, V39, P599, DOI 10.1146/annurev.bi.39.070170.003123
   Stephen A. M., 2006, FOOD POLYSACCHARIDES
   Sun JL, 2010, MOLECULES, V15, P5162, DOI 10.3390/molecules15085162
   Szycher M., 1991, HIGH PERFORMANCE BIO
   Tanford C., 1961, PHYS CHEM MACROMOLEC
   Valentine MT, 2004, BIOPHYS J, V86, P4004, DOI 10.1529/biophysj.103.037812
   VASILEVSKAYA VV, 1992, MACROMOLECULES, V25, P384, DOI 10.1021/ma00027a059
   Verdugo P., 2012, COLD SPRING HARB PER, V2
   Wang YY, 2008, ANGEW CHEM INT EDIT, V47, P9726, DOI 10.1002/anie.200803526
   Waters DJ, 2010, MACROMOLECULES, V43, P6861, DOI 10.1021/ma101070s
   White DR, 2003, J CHROMATOGR A, V997, P79, DOI 10.1016/S0021-9673(03)00626-5
   Wiley B. J., 1993, Journal of Environmental Polymer Degradation, V1, P3, DOI 10.1007/BF01457648
   Wu LC, 2004, GASTROENTEROLOGY, V126, P488, DOI 10.1053/j.gastro.2003.11.011
   Ziebacz N, 2011, SOFT MATTER, V7, P7181, DOI 10.1039/c0sm01357a
   Zindl CL, 2013, P NATL ACAD SCI USA, V110, P12768, DOI 10.1073/pnas.1300318110
NR 104
TC 6
Z9 6
U1 3
U2 23
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JUN 28
PY 2016
VL 113
IS 26
BP 7041
EP 7046
DI 10.1073/pnas.1602789113
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DQ2LI
UT WOS:000379033400038
PM 27303035
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Han, FY
   Thurecht, KJ
   Whittaker, AK
   Smith, MT
AF Han, Felicity Y.
   Thurecht, Kristofer J.
   Whittaker, Andrew K.
   Smith, Maree T.
TI Bioerodable PLGA-Based Microparticles for Producing Sustained-Release
   Drug Formulations and Strategies for Improving Drug Loading
SO FRONTIERS IN PHARMACOLOGY
LA English
DT Review
DE PLGA microparticles; drug delivery system; hydrophilic molecule;
   biodegradation mechanisms; tuneable release; microfluidics;
   supercritical carbon dioxide; hydrogel template
ID SUPERCRITICAL CARBON-DIOXIDE; DOUBLE-WALLED MICROSPHERES; HYDROGEL
   TEMPLATE METHOD; DOUBLE EMULSION METHOD; ONE-STEP FABRICATION; IN-VITRO
   EVALUATION; WATER-SOLUBLE DRUG; GLYCOLIC ACID PLGA; DELIVERY-SYSTEMS;
   SOLVENT EXTRACTION/EVAPORATION
AB Poly(lactic-co-glycolic acid) (PLGA) is the most widely used biomaterial for microencapsulation and prolonged delivery of therapeutic drugs, proteins and antigens. PLGA has excellent biodegradability and biocompatibility and is generally recognized as safe by international regulatory agencies including the United States Food and Drug Administration and the European Medicines Agency. The physicochemical properties of PLGA may be varied systematically by changing the ratio of lactic acid to glycolic acid. This in turn alters the release rate of microencapsulated therapeutic molecules from PLGA microparticle formulations. The obstacles hindering more widespread use of PLGA for producing sustained-release formulations for clinical use include low drug loading, particularly of hydrophilic small molecules, high initial burst release and/or poor formulation stability. In this review, we address strategies aimed at overcoming these challenges. These include use of low temperature double-emulsion methods to increase drug-loading by producing PLGA particles with a small volume for the inner water phase and a suitable pH of the external phase. Newer strategies for producing PLGA particles with high drug loading and the desired sustained -release profiles include fabrication of multi layered microparticles, nanoparticles-in-microparticles, use of hydrogel templates, as well as coaxial electrospray, microfluidics, and supercritical carbon dioxide methods. Another recent strategy with promise for producing particles with well-controlled and reproducible sustained -release profiles involves complexation of PLGA with additives such as polyethylene glycol, poly(ortho esters), chitosan, alginate, caffeic acid, hyaluronic acid, and silicon dioxide.
C1 [Han, Felicity Y.; Smith, Maree T.] Univ Queensland, Ctr Integrated Preclin Drug Dev, Brisbane, Qld, Australia.
   [Thurecht, Kristofer J.; Whittaker, Andrew K.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia.
   [Thurecht, Kristofer J.] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia.
   [Thurecht, Kristofer J.; Whittaker, Andrew K.] ARC Ctr Excellence Convergent BioNano Sci & Techn, Brisbane, Qld, Australia.
   [Smith, Maree T.] Univ Queensland, Sch Pharm, Brisbane, Qld, Australia.
RP Smith, MT (reprint author), Univ Queensland, Ctr Integrated Preclin Drug Dev, Brisbane, Qld, Australia.; Smith, MT (reprint author), Univ Queensland, Sch Pharm, Brisbane, Qld, Australia.
EM maree.smith@uq.edu.au
FU National Health and Medical Research Council (NHMRC) [APP1107723]
FX FH is supported by a postdoctoral fellowship funded by a National Health
   and Medical Research Council (NHMRC) grant, APP1107723.
CR Abulateefeh SR, 2016, AAPS PHARMSCITECH, V17, P891, DOI 10.1208/s12249-015-0413-y
   Acharya G, 2010, J CONTROL RELEASE, V146, P201, DOI 10.1016/j.jconrel.2010.03.024
   Acharya G, 2010, J CONTROL RELEASE, V141, P314, DOI 10.1016/j.jconrel.2009.09.032
   Anderson JM, 2012, ADV DRUG DELIVER REV, V64, P72, DOI 10.1016/j.addr.2012.09.004
   Anderson JM, 1997, ADV DRUG DELIVER REV, V28, P5, DOI 10.1016/S0169-409X(97)00048-3
   Ansari T., 2012, ELIXIR PHARM, V47, P8821
   Barrow WW, 2004, CURR PHARM DESIGN, V10, P3275, DOI 10.2174/1381612043383197
   Baxendale A, 2011, INT J PHARMACEUT, V413, P147, DOI 10.1016/j.ijpharm.2011.04.053
   BODMEIER R, 1988, INT J PHARM, V43, P179, DOI 10.1016/0378-5173(88)90073-7
   Budisa Nediljko, 2014, Life-Basel, V4, P331, DOI 10.3390/life4030331
   Cai CF, 2009, J MICROENCAPSUL, V26, P334, DOI 10.1080/02652040802354707
   Chaisri Wasana, 2009, Current Drug Delivery, V6, P69
   Champeau M, 2015, J CONTROL RELEASE, V209, P248, DOI 10.1016/j.jconrel.2015.05.002
   Chaudhari KR, 2010, J MICROENCAPSUL, V27, P303, DOI 10.3109/02652040903191818
   Chemmunique, 1980, THE HLB SYST
   Cho DID, 2015, J MICROELECTROMECH S, V24, P10, DOI 10.1109/JMEMS.2014.2368071
   COHEN S, 1991, PHARMACEUT RES, V8, P713, DOI 10.1023/A:1015841715384
   Curley J, 1996, ANESTHESIOLOGY, V84, P1401, DOI 10.1097/00000542-199606000-00017
   Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043
   Dawes GJS, 2009, J MATER SCI-MATER M, V20, P1089, DOI 10.1007/s10856-008-3666-0
   Della Porta G, 2013, J BIOMAT SCI-POLYM E, V24, P1831, DOI 10.1080/09205063.2013.807457
   deMello AJ, 2006, NATURE, V442, P394, DOI 10.1038/nature05062
   Dhanda DS, 2013, J CONTROL RELEASE, V168, P239, DOI 10.1016/j.jconrel.2013.03.027
   Draheim C, 2015, PHARM RES-DORDR, V32, P2609, DOI 10.1007/s11095-015-1647-9
   Dunne M, 2000, BIOMATERIALS, V21, P1659, DOI 10.1016/S0142-9612(00)00040-5
   Engineer C, 2010, TRENDS BIOMATER ARTI, V24, P131, DOI DOI 10.1016/J.CHERD.2010.06.013
   Falco N, 2012, IND ENG CHEM RES, V51, P8616, DOI 10.1021/ie300482n
   Feng SB, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.41943
   Feng SS, 2007, NANOMEDICINE-UK, V2, P333, DOI 10.2217/17435889.2.3.333
   Fredenberg S, 2011, INT J PHARMACEUT, V415, P34, DOI 10.1016/j.ijpharm.2011.05.049
   Freiberg S, 2004, INT J PHARM, V282, P1, DOI 10.1016/j.ijpharm.2004.04.013
   Freitas S, 2005, J CONTROL RELEASE, V102, P313, DOI 10.1016/j.jconrel.2004.10.015
   Fu X, 2005, J MICROENCAPSUL, V22, P705, DOI 10.1080/02652040500162196
   Gasparini G, 2010, COLLOID SURFACE B, V75, P557, DOI 10.1016/j.colsurfb.2009.09.035
   Govender T, 1999, J CONTROL RELEASE, V57, P171, DOI 10.1016/S0168-3659(98)00116-3
   Graves RA, 2004, INT J PHARMACEUT, V270, P251, DOI 10.1016/j.ijpharm.2003.10.019
   Han FY, 2015, J PHARM SCI-US, V104, P2334, DOI 10.1002/jps.24497
   Hillery AM, 2005, DRUG DELIVERY TARGET
   Houchin ML, 2009, J APPL POLYM SCI, V114, P2848, DOI 10.1002/app.30813
   Howdle SM, 2001, CHEM COMMUN, P109, DOI 10.1039/b008188o
   Huang Y, 2014, LANGMUIR, V30, P7304, DOI 10.1021/la5011488
   Hung LH, 2010, LAB CHIP, V10, P1820, DOI 10.1039/c002866e
   Hwisa N. T., 2013, VRI BIOL MED CHEM, V1, P8, DOI [10.14259/bmc.v1i1.29, DOI 10.14259/BMC.V1I1.29]
   Ito F, 2011, COLLOID SURFACE A, V384, P368, DOI 10.1016/j.colsurfa.2011.04.017
   Jordan F, 2010, J CONTROL RELEASE, V141, P153, DOI 10.1016/j.jconrel.2009.09.013
   Joung Yoon Ki, 2011, [Biomaterials Research, 생체재료학회지], V15, P78
   Kamaly N, 2016, CHEM REV, V116, P2602, DOI 10.1021/acs.chemrev.5b00346
   Kapoor DN, 2015, THER DELIV, V6, P41, DOI [10.4155/tde.14.91, 10.4155/TDE.14.91]
   Kim HK, 2006, J CONTROL RELEASE, V112, P167, DOI 10.1016/j.jconrel.2006.02.004
   Klose D, 2008, INT J PHARMACEUT, V354, P95, DOI 10.1016/j.ijpharm.2007.10.030
   Klose D, 2006, INT J PHARMACEUT, V314, P198, DOI 10.1016/j.ijpharm.2005.07.031
   Koushik K, 2004, PHARM RES-DORDR, V21, P524, DOI 10.1023/B:PHAM.0000019308.25479.a4
   LANGER R, 1986, CHEMTECH, V16, P108
   Lee YS, 2013, EUR J PHARM BIOPHARM, V83, P168, DOI 10.1016/j.ejpb.2012.10.016
   Lee YH, 2011, COLLOID SURFACE B, V82, P104, DOI 10.1016/j.colsurfb.2010.08.022
   Leo E, 2004, INT J PHARM, V278, P133, DOI 10.1016/j.ijpharm.2004.03.002
   Leon RAL, 2015, PART PART SYST CHAR, V32, P567, DOI 10.1002/ppsc.201400229
   Li WX, 2015, RSC ADV, V5, P23181, DOI 10.1039/c4ra17153e
   Liggins RT, 2004, INFLAMM RES, V53, P363, DOI 10.1007/s00011-004-1273-1
   Lim MPA, 2013, BIOMATER SCI-UK, V1, P486, DOI 10.1039/c3bm00175j
   Lu Y, 2014, INT J PHARMACEUT, V461, P258, DOI 10.1016/j.ijpharm.2013.11.058
   Mahboubian A, 2010, IRAN J PHARM RES, V9, P369
   Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377
   Malavia N, 2015, INVEST OPHTH VIS SCI, V56
   Mao SR, 2007, INT J PHARM, V334, P137, DOI 10.1016/j.ijpharm.2006.10.036
   Na XM, 2012, ACS MACRO LETT, V1, P697, DOI 10.1021/mz200222d
   Nafissi-Varcheh N, 2011, IRAN J PHARM RES, V10, P203
   Nan KH, 2014, ACTA BIOMATER, V10, P3505, DOI 10.1016/j.actbio.2014.04.024
   Navaei A, 2014, DRUG DEV IND PHARM, V40, P701, DOI 10.3109/03639045.2013.777734
   Nie ZH, 2006, J AM CHEM SOC, V128, P9408, DOI 10.1021/ja060882n
   Nijsen JFW, 2002, CURR MED CHEM, V9, P73, DOI 10.2174/0929867023371454
   Park KM, 2014, FOOD CHEM, V161, P53, DOI 10.1016/j.foodchem.2014.03.125
   Reinhold SE, 2013, MACROMOL BIOSCI, V13, P1700, DOI 10.1002/mabi.201300323
   Riahi R, 2015, CURR OPIN CHEM ENG, V7, P101, DOI 10.1016/j.coche.2014.12.001
   Sanna V, 2015, INT J BIOL MACROMOL, V72, P531, DOI 10.1016/j.ijbiomac.2014.08.053
   Selmin Francesca, 2015, J Funct Biomater, V6, P1, DOI 10.3390/jfb6010001
   SHAH SS, 1992, J CONTROL RELEASE, V18, P261, DOI 10.1016/0168-3659(92)90171-M
   Shi M, 2003, J CONTROL RELEASE, V89, P167, DOI 10.1016/S0168-3659(02)00493-5
   Siegel SJ, 2006, EUR J PHARM BIOPHARM, V64, P287, DOI 10.1016/j.wjpb.2006.06.009
   Siepmann J, 2004, J CONTROL RELEASE, V96, P123, DOI 10.1016/j.jconrel.2004.01.011
   Sosnik A, 2015, ADV COLLOID INTERFAC, V223, P40, DOI 10.1016/j.cis.2015.05.003
   Syrett JA, 2010, POLYM CHEM-UK, V1, P978, DOI 10.1039/c0py00104j
   Thote AJ, 2005, NANOMED-NANOTECHNOL, V1, P85, DOI 10.1016/j.nano.2004.12.001
   Varde NK, 2004, EXPERT OPIN BIOL TH, V4, P35, DOI 10.1517/eobt.4.1.35.25256
   Viry L, 2012, J MATER CHEM, V22, P11347, DOI 10.1039/c2jm31069d
   Wan F, 2016, INT J PHARMACEUT, V498, P82, DOI 10.1016/j.ijpharm.2015.12.025
   Wang H, 2015, BIOMATERIALS, V72, P74, DOI 10.1016/j.biomaterials.2015.08.048
   Wang J, 2002, J CONTROL RELEASE, V82, P289, DOI 10.1016/S0168-3659(02)00137-2
   Xie H, 2012, LANGMUIR, V28, P4459, DOI 10.1021/la2042185
   Xu QB, 2009, SMALL, V5, P1575, DOI 10.1002/smll.200801855
   Yang YY, 2000, J CONTROL RELEASE, V69, P81, DOI 10.1016/S0168-3659(00)00291-1
   Yuan S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132609
   Yun-Seok R., 2010, PHARM TECH S, V2010, P1
   Zamani M, 2014, INT J PHARMACEUT, V473, P134, DOI 10.1016/j.ijpharm.2014.07.006
   Zhang LL, 2012, EXPERT REV MED DEVIC, V9, P595, DOI [10.1586/erd.12.58, 10.1586/ERD.12.58]
   Zhang Y, 2013, ADV DRUG DELIVER REV, V65, P104, DOI 10.1016/j.addr.2012.10.003
   Zheng CH, 2010, DRUG DELIV, V17, P77, DOI 10.3109/10717540903509001
   Zheng W, 2009, INT J PHARMACEUT, V374, P90, DOI 10.1016/j.ijpharm.2009.03.015
NR 98
TC 29
Z9 33
U1 20
U2 175
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1663-9812
J9 FRONT PHARMACOL
JI Front. Pharmacol.
PD JUN 28
PY 2016
VL 7
AR 185
DI 10.3389/fphar.2016.00185
PG 11
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA DP7OI
UT WOS:000378688300001
PM 27445821
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Rossi, B
   Campia, P
   Merlini, L
   Brasca, M
   Pastori, N
   Farris, S
   Melone, L
   Punta, C
   Galante, YM
AF Rossi, Bianca
   Campia, Paola
   Merlini, Luca
   Brasca, Milena
   Pastori, Nadia
   Farris, Stefano
   Melone, Lucio
   Punta, Carlo
   Galante, Yves M.
TI An aerogel obtained from chemo-enzymatically oxidized fenugreek
   galactomannans as a versatile delivery system
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Galactomannans; Fenugreek; Laccase oxidation; Aerogel; Lysozyme;
   Delivery system
ID GALACTOSE-CONTAINING POLYSACCHARIDES; TEMPO-MEDIATED OXIDATION;
   ANTIBACTERIAL ACTIVITY; SELECTIVE OXIDATION; FTIR SPECTROSCOPY; GREEN
   CHEMISTRY; GUAR GUM; CELLULOSE; OXIDASE; LACCASE
AB We describe a new aerogel obtained from laccase-oxidized galactomannans of the leguminous plant fenugreek (Trigonella foenum-graecum) and suggest its potential practical use.
   Laccase/TEMPO oxidation of fenugreek in aqueous solution caused a viscosity increase of over 15-fold. A structured, elastic, stable hydrogel was generated, due to formation of carbonyl groups from primary OH of galactose side units and subsequent establishment of hemiacetalic bonds with available free hydroxyl groups.
   Upon lyophilization of this hydrogel, a water-insoluble aerogel was obtained (EOLFG), capable of up taking aqueous or organic solvents over 20 times its own weight. The material was characterized by scanning electron microscopy, FT-IR, elemental analysis and C-13 CP-MAS NMR spectroscopy and its mechanical properties were investigated.
   To test the EOLFG as a delivery system, the anti-microbial enzyme lysozyme was used as model active principle. Lysozyme was added before or after formation of the aerogel, entrapped or absorbed in the gel, retained and released in active form, as proven by its hydrolytic glycosidase activity on lyophilized Micrococcus lysodeikticus cells wall peptidoglycans.
   This new biomaterial, composed of a chemo-enzymatically modified plant polysaccharide, might represent a versatile, biocompatible "delivery system" of active principles in food and non-food products. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Rossi, Bianca; Merlini, Luca; Galante, Yves M.] CNR, Ist Chim Riconoscimento Mol, Via Mario Bianco 9, I-20131 Milan, Italy.
   [Campia, Paola; Brasca, Milena] CNR, Ist Sci Prod Alimentari, Via Celoria 2, I-20131 Milan, Italy.
   [Pastori, Nadia; Melone, Lucio; Punta, Carlo] Politecn Milan, Dept Chem Mat & Chem Engn G Natta, Piazza Leonardo da Vinci 32, I-20133 Milan, Italy.
   [Pastori, Nadia; Melone, Lucio; Punta, Carlo] Politecn Milan, Local Unit INSTM, Piazza Leonardo da Vinci 32, I-20133 Milan, Italy.
   [Melone, Lucio] Univ E Campus, Via Isimbardi 10, I-22060 Novedrate, Como, Italy.
   [Farris, Stefano] Univ Milan, Dept Food Environm & Nutr Sci, DeFENS, PackLAB,Unimi Food Packaging Lab, ViaCeloria 2, I-20133 Milan, Italy.
RP Galante, YM (reprint author), CNR, Ist Chim Riconoscimento Mol, Via Mario Bianco 9, I-20131 Milan, Italy.; Melone, L; Punta, C (reprint author), Politecn Milan, Dept Chem Mat & Chem Engn G Natta, Piazza Leonardo da Vinci 32, I-20133 Milan, Italy.; Melone, L; Punta, C (reprint author), Politecn Milan, Local Unit INSTM, Piazza Leonardo da Vinci 32, I-20133 Milan, Italy.; Melone, L (reprint author), Univ E Campus, Via Isimbardi 10, I-22060 Novedrate, Como, Italy.
EM bianca.rossi@polimi.it; paola.campia@ispa.cnr.it;
   luca.merlini@icrm.cnr.it; milena.brasca@ispa.cnr.it;
   nadia.pastori@polimi.it; stefano.farris@unimi.it;
   lucio.melone@polimi.it; carlo.punta@polimi.it; yves.galante@icrm.cnr.it
RI Brasca, Milena/C-4049-2009; Farris, Stefano/J-3257-2016; Punta,
   Carlo/C-2657-2008
OI Brasca, Milena/0000-0002-8821-0787; Punta, Carlo/0000-0002-7239-9554;
   Merlini, Luca/0000-0002-9856-1185; Farris, Stefano/0000-0002-6423-8443
FU program Suschem Lombardia: prodotti e processi chimici sostenibili per
   l'industria lombarda. Accordo Quadro Regione Lombardia-CNR [18096/RCC];
   Cariplo Foundation [2014-0478]; MIUR (PRIN) [2010PFLRJR_005]
FX This project was supported by the program Suschem Lombardia: prodotti e
   processi chimici sostenibili per l'industria lombarda. Accordo Quadro
   Regione Lombardia-CNR, 16/07/2012 (protocol no. 18096/RCC), by Cariplo
   Foundation (grant 2014-0478) and by MIUR (PRIN 2010-2011, PROxi project
   2010PFLRJR_005).
CR Abidi N, 2014, CARBOHYD POLYM, V100, P9, DOI 10.1016/j.carbpol.2013.01.074
   Alcalde M, 2006, TRENDS BIOTECHNOL, V24, P281, DOI 10.1016/j.tibtech.2005.04.002
   Avila M, 2014, INT J FOOD MICROBIOL, V172, P70, DOI 10.1016/j.ijfoodmicro.2013.12.002
   Baldaro E, 2012, COLOR TECHNOL, V128, P315, DOI 10.1111/j.1478-4408.2012.00382.x
   Bornscheuer UT, 2012, NATURE, V485, P185, DOI 10.1038/nature11117
   Bragd PL, 2004, TOP CATAL, V27, P49, DOI 10.1023/B:TOCA.0000013540.69309.46
   Brasca M, 2013, MOLECULES, V18, P6008, DOI 10.3390/molecules18056008
   Brummer Y, 2003, FOOD HYDROCOLLOID, V17, P229, DOI 10.1016/S0268-005X(02)00054-1
   Carrillo W, 2014, J FOOD PROTECT, V77, P1732, DOI 10.4315/0362-028X.JFP-14-009
   Chen WS, 2011, SOFT MATTER, V7, P10360, DOI 10.1039/c1sm06179h
   Cheng HN, 2012, POLYMERS-BASEL, V4, P1311, DOI 10.3390/polym4021311
   Cheng Y, 2002, MACROMOLECULES, V35, P10155, DOI 10.1021/ma020887e
   Cheroni S, 2010, ENZYME MICROB TECH, V47, P348, DOI 10.1016/j.enzmictec.2010.08.001
   Crescenzi V, 2004, BIOMACROMOLECULES, V5, P537, DOI 10.1021/bm034387k
   Daas PJH, 2002, J AGR FOOD CHEM, V50, P4282, DOI 10.1021/jf011399t
   Daas PJH, 2000, CARBOHYD RES, V329, P609, DOI 10.1016/S0008-6215(00)00209-3
   Daniel JR, 1994, ULLMANNS ENCY IND A, VA25, P1
   Delagrave S, 2001, PROTEIN ENG, V14, P261, DOI 10.1093/protein/14.4.261
   Delagrave S, 2002, US Patent, Patent No. [6.498.026 B2, 6498026]
   Delattre C, 2015, CARBOHYD POLYM, V116, P34, DOI 10.1016/j.carbpol.2014.04.054
   Deszczynski M, 2003, CARBOHYD POLYM, V53, P85, DOI 10.1016/S0144-8617(02)00327-2
   Ding B, 2008, CARBOHYD RES, V343, P3112, DOI 10.1016/j.carres.2008.09.005
   Donnelly MJ, 1999, METH BIOTEC, V10, P79
   Elboutachfaiti R, 2011, CARBOHYD POLYM, V84, P1, DOI 10.1016/j.carbpol.2010.10.063
   Fabbrini M, 2002, J MOL CATAL B-ENZYM, V16, P231, DOI 10.1016/S1381-1177(01)00067-4
   FROLLINI E, 1995, CARBOHYD POLYM, V27, P129, DOI 10.1016/0144-8617(95)00021-X
   Galante YA, 2003, CURR ORG CHEM, V7, P1399, DOI 10.2174/1385272033486468
   Ghafar A, 2015, EUR POLYM J, V71, P171, DOI 10.1016/j.eurpolymj.2015.07.046
   HALL LD, 1980, CARBOHYD RES, V81, pC10, DOI 10.1016/S0008-6215(00)85669-4
   Jetten J.M., 2000, WO Patent, Patent No. [00/50463, 0050463]
   Kulys J, 2005, J MOL CATAL B-ENZYM, V37, P79, DOI 10.1016/j.molcatb.2005.09.010
   Lavazza M, 2011, J BIOTECHNOL, V156, P108, DOI 10.1016/j.jbiotec.2011.08.029
   Leppanen AS, 2010, CARBOHYD RES, V345, P2610, DOI 10.1016/j.carres.2010.09.026
   Li Shuang, 2012, Comput Struct Biotechnol J, V2, pe201209017, DOI 10.5936/csbj.201209017
   Liyanage S, 2015, IND CROP PROD, V74, P388, DOI 10.1016/j.indcrop.2015.05.013
   Marzorati M, 2005, GREEN CHEM, V7, P310, DOI 10.1039/b416668j
   Mathur MK, 2011, IND GALACTOMANNAN PO
   MCCLEARY BV, 1985, CARBOHYD RES, V139, P237
   Melone L, 2013, J PHOTOCH PHOTOBIO A, V261, P53, DOI 10.1016/j.jphotochem.2013.04.004
   Merlini L, 2015, J BIOTECHNOL, V198, P31, DOI 10.1016/j.jbiotec.2015.01.023
   Mikkonen KS, 2014, RSC ADV, V4, P11884, DOI 10.1039/c3ra47440b
   Mitrus M., 2009, THERMOPLASTIC STARCH, P1
   Morozova OV, 2007, APPL BIOCHEM MICRO+, V43, P523, DOI 10.1134/S0003683807050055
   Murlidhar Meghwal, 2012, Journal of Food Processing and Technology, V3, P181
   Murthy P. S., 2010, U.S. Patent, Patent No. [7,815,946, 7815946]
   Narain R., 2011, ENG CARBOHYDRATE BAS
   Nestl BM, 2011, CURR OPIN CHEM BIOL, V15, P187, DOI 10.1016/j.cbpa.2010.11.019
   NIKUPAAVOLA ML, 1988, BIOCHEM J, V254, P877, DOI 10.1042/bj2540877
   Olsson AM, 2004, CARBOHYD RES, V339, P813, DOI 10.1016/j.carres.2004.01.005
   Parikka K, 2015, J MOL CATAL B-ENZYM, V120, P47, DOI 10.1016/j.molcatb.2015.06.006
   Parikka K, 2012, BIOMACROMOLECULES, V13, P2418, DOI 10.1021/bm300679a
   Parikka K, 2010, J AGR FOOD CHEM, V58, P262, DOI 10.1021/jf902930t
   Parikka K, 2009, CARBOHYD RES, V344, P14, DOI 10.1016/j.carres.2008.08.020
   Prajapati VD, 2013, INT J BIOL MACROMOL, V60, P83, DOI 10.1016/j.ijbiomac.2013.05.017
   Riva S, 2006, TRENDS BIOTECHNOL, V24, P219, DOI 10.1016/j.tibtech.2006.03.006
   Rodgers CJ, 2010, TRENDS BIOTECHNOL, V28, P63, DOI 10.1016/j.tibtech.2009.11.001
   Silvetti T, 2010, J I BREWING, V116, P33, DOI 10.1002/j.2050-0416.2010.tb00395.x
   Sittikijyothin W, 2005, CARBOHYD POLYM, V59, P339, DOI 10.1016/j.carbpol.2004.10.005
   Takahashi H, 2011, J FOOD PROTECT, V74, P994, DOI 10.4315/0362-028X.JFP-10-406
   Tavernier ML, 2008, CARBOHYD RES, V343, P2687, DOI 10.1016/j.carres.2008.06.002
   Tiwari BK, 2009, J AGR FOOD CHEM, V57, P5987, DOI 10.1021/jf900668n
   Viikari L., 1999, WO Patent, Patent No. [99/23240, 9923240]
   Viikari L., 1999, WO Patent, Patent No. [99/23117, 923117]
   Wei YX, 2015, J FOOD ENG, V166, P21, DOI 10.1016/j.jfoodeng.2015.05.015
   Witayakran S, 2009, ADV SYNTH CATAL, V351, P1187, DOI 10.1002/adsc.200800775
   Yoshitomi T, 2012, ACTA BIOMATER, V8, P1323, DOI 10.1016/j.actbio.2011.11.029
   Yoshitomi T, 2011, BIOMATERIALS, V32, P8021, DOI 10.1016/j.biomaterials.2011.07.014
NR 67
TC 8
Z9 8
U1 5
U2 74
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JUN 25
PY 2016
VL 144
BP 353
EP 361
DI 10.1016/j.carbpol.2016.02.007
PG 9
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA DI9NX
UT WOS:000373830700042
PM 27083827
OA Green Published
DA 2018-10-20
ER

PT J
AU Gu, Q
   Tomaskovic-Crook, E
   Lozano, R
   Chen, Y
   Kapsa, RM
   Zhou, Q
   Wallace, GG
   Crook, JM
AF Gu, Qi
   Tomaskovic-Crook, Eva
   Lozano, Rodrigo
   Chen, Yu
   Kapsa, Robert M.
   Zhou, Qi
   Wallace, Gordon G.
   Crook, Jeremy M.
TI Functional 3D Neural Mini-Tissues from Printed Gel-Based Bioink and
   Human Neural Stem Cells
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
DE 3D bioprinting; 3D human neural tissue; cell encapsulation; human stem
   cells; polysaccharide bioink
ID MAGNETIC-RESONANCE ELASTOGRAPHY; BIOMEDICAL APPLICATIONS; BRAIN;
   ENCAPSULATION; CONSTRUCTS; NEURONS
AB Direct-write printing of stem cells within biomaterials presents an opportunity to engineer tissue for in vitro modeling and regenerative medicine. Here, a first example of constructing neural tissue by printing human neural stem cells that are differentiated in situ to functional neurons and supporting neuroglia is reported. The supporting biomaterial incorporates a novel clinically relevant polysaccharide-based bioink comprising alginate, carboxymethyl-chitosan, and agarose. The printed bioink rapidly gels by stable cross-linking to form a porous 3D scaffold encapsulating stem cells for in situ expansion and differentiation. Differentiated neurons form synaptic contacts, establish networks, are spontaneously active, show a bicuculline-induced increased calcium response, and are predominantly gamma-aminobutyric acid expressing. The 3D tissues will facilitate investigation of human neural development, function, and disease, and may be adaptable for engineering other 3D tissues from different stem cell types.
C1 [Gu, Qi; Tomaskovic-Crook, Eva; Lozano, Rodrigo; Chen, Yu; Kapsa, Robert M.; Wallace, Gordon G.; Crook, Jeremy M.] Univ Wollongong, AIIM Facil, ARC Ctr Excellence Elect Sci, Intelligent Polymer Res Inst, Innovation Campus,Squires Way, Fairy Meadow, NSW 2519, Australia.
   [Gu, Qi; Zhou, Qi] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China.
   [Tomaskovic-Crook, Eva; Crook, Jeremy M.] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW 2522, Australia.
   [Kapsa, Robert M.] Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia.
   [Crook, Jeremy M.] Univ Melbourne, St Vincents Hosp, Dept Surg, Fitzroy, Vic 3065, Australia.
RP Wallace, GG; Crook, JM (reprint author), Univ Wollongong, AIIM Facil, ARC Ctr Excellence Elect Sci, Intelligent Polymer Res Inst, Innovation Campus,Squires Way, Fairy Meadow, NSW 2519, Australia.; Crook, JM (reprint author), Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW 2522, Australia.; Crook, JM (reprint author), Univ Melbourne, St Vincents Hosp, Dept Surg, Fitzroy, Vic 3065, Australia.
EM gwallace@uow.edu.au; jcrook@uow.edu.au
RI Wallace, Gordon/H-1123-2011
OI Wallace, Gordon/0000-0002-0381-7273; Crook, Jeremy/0000-0002-6415-1639;
   Tomaskovic-Crook, Eva/0000-0002-7818-9013
FU Australian Research Council (ARC) Centre of Excellence Scheme
   [CE140100012]; Australian National Fabrication Facility (ANFF)-Materials
   Node; ARC through an ARC Laureate Fellowship [FL110100196]; Consejo
   Nacional de Ciencia y Tecnologia (CONACYT, Mexico); National Basic
   Research Program of China [2012CBA01300]
FX J.M.C., G.G.W., Q.Z., and R.K. conceived the study. J.M.C., Q.G., and
   E.T.C. planned and/or executed experiments. R.L. and Y.C. provided
   technical support and guidance with data interpretation for diffusion
   studies and SEM, respectively. J.M.C. wrote the paper with contributions
   from Q.G. and E.T.C. All authors commented on the paper. J.M.C. and
   G.G.W. supervised all aspects of the work. The authors wish to
   acknowledge funding from the Australian Research Council (ARC) Centre of
   Excellence Scheme (CE140100012), the use of facilities at the University
   of Wollongong Electron Microscopy Centre, support of the Australian
   National Fabrication Facility (ANFF)-Materials Node, and assistance
   provided by Dr. Johnson Chung with bioink and gel characterization, Dr.
   Xiao Liu and Dr. Zhilian Yue with bioprinting, Mr. Aaron Waters with
   COMSOL modeling, and Dr. Kerry Gilmore for critically reviewing the
   paper. Prof. Gordon Wallace acknowledges the support of the ARC through
   an ARC Laureate Fellowship (FL110100196), and Mr. Rodrigo Lozano
   acknowledges the support of the Consejo Nacional de Ciencia y Tecnologia
   (CONACYT, Mexico). Professor Qi Zhou acknowledges the support of the
   National Basic Research Program of China (2012CBA01300). The
   acknowledgements section of this article was changed on 22.06.2016.
CR Ahearne M., 2008, TOPICS TISSUE ENG, P1
   Billiet T, 2014, BIOMATERIALS, V35, P49, DOI 10.1016/j.biomaterials.2013.09.078
   CARMAN PC, 1954, PROC R SOC LON SER-A, V222, P109, DOI 10.1098/rspa.1954.0056
   Cave JW, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00016
   Chueh BH, 2010, BIOMED MICRODEVICES, V12, P145, DOI 10.1007/s10544-009-9369-6
   Chung JHY, 2013, BIOMATER SCI-UK, V1, P763, DOI 10.1039/c3bm00012e
   Cohen DL, 2011, TISSUE ENG PART C-ME, V17, P239, DOI [10.1089/ten.tec.2010.0093, 10.1089/ten.TEC.2010.0093]
   Crank J., 1975, MATH DIFFUSION
   Green MA, 2008, NMR BIOMED, V21, P755, DOI 10.1002/nbm.1254
   Jeon O, 2013, ADV FUNCT MATER, V23, P4765, DOI 10.1002/adfm.201300529
   Kruse SA, 2008, NEUROIMAGE, V39, P231, DOI 10.1016/j.neuroimage.2007.08.030
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Li RH, 1996, BIOTECHNOL BIOENG, V50, P365, DOI 10.1002/(SICI)1097-0290(19960520)50:4<365::AID-BIT3>3.0.CO;2-J
   Lozano R, 2015, BIOMATERIALS, V67, P264, DOI 10.1016/j.biomaterials.2015.07.022
   Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958
   Ouyang LL, 2015, BIOFABRICATION, V7, DOI 10.1088/1758-5090/7/4/044101
   Pati F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4935
   Patrulea V, 2015, EUR J PHARM BIOPHARM, V97, P417, DOI 10.1016/j.ejpb.2015.08.004
   Pfrieger FW, 1997, SCIENCE, V277, P1684, DOI 10.1126/science.277.5332.1684
   RADOMSKI MW, 1990, P NATL ACAD SCI USA, V87, P10043, DOI 10.1073/pnas.87.24.10043
   Rutz AL, 2015, ADV MATER, V27, P1607, DOI 10.1002/adma.201405076
   Shin SR, 2012, ACS NANO, V6, P362, DOI 10.1021/nn203711s
   Sivashankari PR, 2016, INT J BIOL MACROMOL, V93, P1382, DOI 10.1016/j.ijbiomac.2016.02.043
   Taylor Z, 2004, J BIOMECH, V37, P1263, DOI 10.1016/j.jbiomech.2003.11.027
   Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657
   Upadhyaya L, 2013, CARBOHYD POLYM, V91, P452, DOI 10.1016/j.carbpol.2012.07.076
   WEINSTEIN DE, 1991, J CELL BIOL, V112, P1205, DOI 10.1083/jcb.112.6.1205
   Xu ZNS, 2013, J ULTRAS MED, V32, P485, DOI 10.7863/jum.2013.32.3.485
NR 28
TC 43
Z9 44
U1 17
U2 132
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD JUN 22
PY 2016
VL 5
IS 12
BP 1429
EP 1438
DI 10.1002/adhm.201600095
PG 10
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA DQ9SU
UT WOS:000379550400006
PM 27028356
OA Bronze
DA 2018-10-20
ER

PT J
AU Glynn, JJ
   Hinds, MT
AF Glynn, Jeremy J.
   Hinds, Monica T.
TI Bioactive Anti-Thrombotic Modification of Decellularized Matrix for
   Vascular Applications
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
DE coagulation; decellularized biomaterial; heparin; platelets;
   thrombomodulin
ID SMALL-INTESTINAL SUBMUCOSA; ACTIVATED PROTEIN-C; NEOINTIMAL HYPERPLASIA;
   IN-VITRO; GRAFTS; HEPARIN; MODEL; VALVE; THROMBOSIS; HEMOCOMPATIBILITY
AB The decellularized matrix derived from porcine small intestinal submucosa (SIS) is a widely used biomaterial being investigated for numerous applications. Currently, thrombus deposition and neointimal hyperplasia have limited the use of SIS in some vascular applications. To limit these detrimental processes, this work applies bioactive, endothelial-inspired properties to the material. SIS is modified with the endothelial cell membrane protein thrombomodulin and the glycosaminoglycan heparin to facilitate protein C activation and anticoagulant activity, respectively. Modifying SIS with thrombomodulin alone enables robust activated protein C (APC) generation, and thrombomodulin activity is maintained after prolonged exposure to fluid shear and blood plasma. Heparin-modified SIS has a potent anticoagulant activity. When both modifications are applied sequentially, SIS modified first with thrombomodulin then with heparin retains the full activity of each individual modification. Tubular SIS devices are connected to a baboon arteriovenous shunt to quantify thrombus deposition on these materials. After being exposed to flowing whole blood for 60 min, SIS devices modified first with thrombomodulin then with heparin have significantly less platelet accumulation compared to unmodified SIS devices. These studies demonstrate that modifying SIS with thrombomodulin and heparin confers APC generation and anticoagulant activity that results in reduced thrombogenesis.
C1 [Glynn, Jeremy J.; Hinds, Monica T.] Oregon Hlth & Sci Univ, Dept Biomed Engn, Mail Code CH13B,3303 SW Bond Ave, Portland, OR 97239 USA.
RP Hinds, MT (reprint author), Oregon Hlth & Sci Univ, Dept Biomed Engn, Mail Code CH13B,3303 SW Bond Ave, Portland, OR 97239 USA.
EM hindsm@ohsu.edu
OI Glynn, Jeremy/0000-0003-1961-9121
FU National Science Foundation [DGE-0925180]; American Heart Association
   Predoctoral Fellowship [14PRE20380042]; NIH [R01HL103728, OD011092]
FX The authors gratefully acknowledge the technical support provided by
   Jennifer Greisel. Additionally, the authors appreciate the donation of
   SIS from Cook Biotech, and financial support from the National Science
   Foundation Graduate Research Fellowship DGE-0925180, the American Heart
   Association Predoctoral Fellowship 14PRE20380042, as well as funding
   from NIH Grant R01HL103728. Operation of the Oregon National Primate
   Research Center was supported by NIH grant OD011092. These sponsors did
   not have any involvement in designing or performing the experiments or
   in writing the manuscript.
CR Anderson DEJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115163
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Begovac PC, 2003, EUR J VASC ENDOVASC, V25, P432, DOI 10.1053/ejvs.2002.1909
   Cutiongco MFA, 2015, ACTA BIOMATER, V25, P97, DOI 10.1016/j.actbio.2015.07.039
   Esmon CT, 2003, CHEST, V124, p26S, DOI 10.1378/chest.124.3_suppl.26S
   Fallon AM, 2014, J THORAC CARDIOV SUR, V148, P333, DOI 10.1016/j.jtcvs.2013.10.048
   Gasper PM, 2012, P NATL ACAD SCI USA, V109, P21216, DOI 10.1073/pnas.1218414109
   Glynn JJ, 2016, J BIOMED MATER RES B, V104, P1610, DOI 10.1002/jbm.b.33507
   Glynn JJ, 2015, ACTA BIOMATER, V14, P96, DOI 10.1016/j.actbio.2014.11.038
   Glynn JJ, 2015, TISSUE ENG PT A, V21, P174, DOI [10.1089/ten.tea.2014.0032, 10.1089/ten.TEA.2014.0032]
   Griffin JH, 2007, J THROMB HAEMOST, V5, P73, DOI 10.1111/j.1538-7836.2007.02491.x
   Griffin JH, 2015, BLOOD, V125, P2898, DOI 10.1182/blood-2015-02-355974
   Hanson SR, 1998, AM HEART J, V135, pS132, DOI 10.1016/S0002-8703(98)70241-8
   HANSON SR, 1985, ARTERIOSCLEROSIS, V5, P595, DOI 10.1161/01.ATV.5.6.595
   HANSON SR, 1980, J LAB CLIN MED, V95, P289
   Hinds MT, 2008, J BIOMED MATER RES A, V86A, P804, DOI 10.1002/jbm.a.31672
   Hodde J P, 1996, Tissue Eng, V2, P209, DOI 10.1089/ten.1996.2.209
   Kocsis JF, 2000, J LONG-TERM EFF MED, V10, P19
   Lantz G C, 1993, J Invest Surg, V6, P297, DOI 10.3109/08941939309141619
   Li JM, 2004, J VASC SURG, V39, P1074, DOI 10.1016/j.jvs.2003.12.030
   Lin PH, 2004, J VASC SURG, V39, P1322, DOI 10.1016/j.jvs.2004.01.046
   Lukovic D, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5580-6
   Mann KG, 2009, HAMOSTASEOLOGIE, V29, P7
   Mann KG, 2003, ARTERIOSCL THROM VAS, V23, P17, DOI 10.1161/01.ATV.0000046238.23903.FC
   Matheny RG, 2000, J HEART VALVE DIS, V9, P769
   Matsusaki M, 2008, J BIOMED MATER RES A, V84A, P1, DOI 10.1002/jbm.a.31460
   Mosnier LO, 2007, BLOOD, V109, P3161, DOI 10.1182/blood-2006-09-003004
   Pavcnik D, 2002, J VASC SURG, V35, P598, DOI 10.1067/mva.2002.118825
   Pavcnik D, 2008, VASC MED, V13, P75, DOI 10.1177/1358863X07083474
   Pavcnik D, 2009, CARDIOVASC INTER RAD, V32, P106, DOI 10.1007/s00270-008-9449-7
   Quint C, 2011, P NATL ACAD SCI USA, V108, P9214, DOI 10.1073/pnas.1019506108
   Qureshi SH, 2009, BIOCHEMISTRY-US, V48, P8261, DOI 10.1021/bi900921t
   Rau JC, 2007, J THROMB HAEMOST, V5, P102, DOI 10.1111/j.1538-7836.2007.02516.x
   Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8
   SANDUSKY GE, 1992, AM J PATHOL, V140, P317
   Smith RJ, 2015, BIOMATERIALS, V51, P303, DOI 10.1016/j.biomaterials.2015.02.025
   Toyota N, 2002, J VASC INTERV RADIOL, V13, P489, DOI 10.1016/S1051-0443(07)61529-2
   van Oeveren W, 2002, ARTIF ORGANS, V26, P506, DOI 10.1046/j.1525-1594.2002.06872.x
   Vartanian KB, 2008, BIOCHEM BIOPH RES CO, V371, P787, DOI 10.1016/j.bbrc.2008.04.167
   Weitz JI, 1997, NEW ENGL J MED, V337, P688, DOI 10.1056/NEJM199709043371007
   Wissink MJB, 2001, BIOMATERIALS, V22, P151, DOI 10.1016/S0142-9612(00)00164-2
   Wong G, 2008, J VASC SURG, V47, P608, DOI 10.1016/j.jvs.2007.11.025
NR 43
TC 3
Z9 3
U1 2
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD JUN 22
PY 2016
VL 5
IS 12
BP 1439
EP 1446
DI 10.1002/adhm.201600020
PG 8
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA DQ9SU
UT WOS:000379550400007
PM 27072858
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Razafiarison, T
   Silvan, U
   Meier, D
   Snedeker, JG
AF Razafiarison, Tojo
   Silvan, Unai
   Meier, Daniela
   Snedeker, Jess G.
TI Surface-Driven Collagen Self-Assembly Affects Early Osteogenic Stem Cell
   Signaling
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
DE collagen monomer; hydrophobicity; nanotopographical cue;
   polydimethylsiloxane; stem cell
ID SUBSTRATE STIFFNESS AFFECTS; FOCAL ADHESION KINASE; SUPRAMOLECULAR
   ORGANIZATION; EXTRACELLULAR-MATRIX; DIFFERENTIATION;
   POLYDIMETHYLSILOXANE; BEHAVIOR; POLY(DIMETHYLSILOXANE); FIBRONECTIN;
   INTERPLAY
AB This study reports how extracellular matrix (ECM) ligand self-assembly on biomaterial surfaces and the resulting nanoscale architecture can drive stem cell behavior. To isolate the biological effects of surface wettability on protein deposition, folding, and ligand activity, a polydimethylsiloxane (PDMS)-based platform was developed and characterized with the ability to tune wettability of elastomeric substrates with otherwise equivalent topology, ligand loading, and mechanical properties. Using this platform, markedly different assembly of covalently bound type I collagen monomers was observed depending on wettability, with hydrophobic substrates yielding a relatively rough layer of collagen aggregates compared to a smooth collagen layer on more hydrophilic substrates. Cellular and molecular investigations with human bone marrow stromal cells revealed higher osteogenic differentiation and upregulation of focal adhesion-related components on the resulting smooth collagen layer coated substrates. The initial collagen assembly driven by the PDMS surface directly affected 11 integrin/discoidin domain receptor 1 signaling, activation of the extracellular signal-regulated kinase/mitogen activated protein kinase pathway, and ultimately markers of osteogenic stem cell differentiation. We demonstrate for the first time that surface-driven ligand assembly on material surfaces, even on materials with otherwise identical starting topographies and mechanical properties, can dominate the biomaterial surface-driven cell response.
C1 [Razafiarison, Tojo; Silvan, Unai; Meier, Daniela; Snedeker, Jess G.] Univ Zurich, Balgrist Univ Hosp, Dept Orthoped, Lengghalde 5, CH-8008 Zurich, Switzerland.
   [Razafiarison, Tojo; Silvan, Unai; Snedeker, Jess G.] Swiss Fed Inst Technol, Lab Orthoped Biomech, Lengghalde 5, CH-8008 Zurich, Switzerland.
RP Snedeker, JG (reprint author), Univ Zurich, Balgrist Univ Hosp, Dept Orthoped, Lengghalde 5, CH-8008 Zurich, Switzerland.
EM snedeker@ethz.ch
RI Snedeker, Jess/C-2105-2009
OI Snedeker, Jess/0000-0002-8115-0275; Silvan, Unai/0000-0003-0757-3621
FU Swiss National Science Foundation [31003A-138221]
FX This work was generously supported by the Swiss National Science
   Foundation (Grant No. 31003A-138221). The authors thank Stefania
   Wunderli for protocols for RT-PCR and Barbara Schar for her help
   designing Figure 1. All figures in this manuscript were exchanged for
   versions of higher resolution on 22.06.2016.
CR Arshi A, 2013, SCI TECHNOL ADV MAT, V14, DOI 10.1088/1468-6996/14/2/025003
   Ataollahi F, 2015, J BIOMED MATER RES A, V103, P2203, DOI 10.1002/jbm.a.35186
   Ayala R, 2011, BIOMATERIALS, V32, P3700, DOI 10.1016/j.biomaterials.2011.02.004
   Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6
   Bartalena G, 2012, SOFT MATTER, V8, P673, DOI 10.1039/c1sm06250f
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Benoit DSW, 2007, BIOMATERIALS, V28, P66, DOI 10.1016/j.biomaterials.2006.08.033
   Bhadriraju K, 2009, BIOMATERIALS, V30, P6687, DOI 10.1016/j.biomaterials.2009.08.036
   Brown XQ, 2005, BIOMATERIALS, V26, P3123, DOI 10.1016/j.biomaterials.2004.08.009
   Carter EM, 2009, CURR OPIN PEDIATR, V21, P46, DOI 10.1097/MOP.0b013e32832185c5
   Chen WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083394
   Choi H, 2014, EXP DERMATOL, V23, P172, DOI 10.1111/exd.12343
   Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359
   Dowling DP, 2011, J BIOMATER APPL, V26, P327, DOI 10.1177/0885328210372148
   Dupont-Gillain CC, 2005, COLLOID SURFACE B, V43, P179, DOI 10.1016/j.colsurfb.2004.12.022
   Dupont-Gillain CC, 2004, J MATER SCI-MATER M, V15, P347, DOI 10.1023/B:JMSM.0000021100.71256.29
   Eddington DT, 2006, SENSOR ACTUAT B-CHEM, V114, P170, DOI 10.1016/j.snb.2005.04.037
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Eroshenko N, 2013, J BIOL ENG, V7, DOI 10.1186/1754-1611-7-7
   Evans ND, 2009, EUR CELLS MATER, V18, P1
   Frith JE, 2012, J CELL SCI, V125, P317, DOI 10.1242/jcs.087916
   Fuard D, 2008, MICROELECTRON ENG, V85, P1289, DOI 10.1016/j.mee.2008.02.004
   Gutekunst SB, 2014, BEILSTEIN J NANOTECH, V5, P1393, DOI 10.3762/bjnano.5.152
   Harjanto D, 2010, ORG BIOMOL CHEM, V8, P299, DOI 10.1039/b913064k
   Hoemann CD, 2009, PATHOL BIOL, V57, P318, DOI 10.1016/j.patbio.2008.06.004
   KADLER K, 1994, PROTEIN PROFILE, V1, P519
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Kim MS, 2007, TISSUE ENG, V13, P2095, DOI 10.1089/ten.2006.0062
   Kuddannaya S, 2013, ACS APPL MATER INTER, V5, P9777, DOI 10.1021/am402903e
   Kulangara K, 2012, BIOMATERIALS, V33, P4998, DOI 10.1016/j.biomaterials.2012.03.053
   Li BJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02425
   Li JJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep03910
   Lund A W, 2009, Open Stem Cell J, V1, P40
   MacQueen L, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0179
   Michael KE, 2003, LANGMUIR, V19, P8033, DOI 10.1021/la034810a
   Coelho NM, 2010, EUR CELLS MATER, V19, P262, DOI 10.22203/eCM.v019a25
   Narayanan B, 2014, LANGMUIR, V30, P1343, DOI 10.1021/la4043364
   Palchesko RN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051499
   Park JY, 2010, BIOCHIP J, V4, P230, DOI 10.1007/s13206-010-4311-9
   Prager-Khoutorsky M, 2011, NAT CELL BIOL, V13, P1457, DOI 10.1038/ncb2370
   Prauzner-Bechcicki S, 2015, J MECH BEHAV BIOMED, V41, P13, DOI 10.1016/j.jmbbm.2014.09.020
   Rosa AL, 2014, J CELL BIOCHEM, V115, P540, DOI 10.1002/jcb.24688
   Ruiz PA, 2011, J BIOL CHEM, V286, P12912, DOI 10.1074/jbc.M110.143693
   Salasznyk RM, 2007, EXP CELL RES, V313, P22, DOI 10.1016/j.yexcr.2006.09.013
   Schaap-Oziemlak AM, 2014, RSC ADV, V4, P53307, DOI 10.1039/c4ra07915a
   Seo JH, 2013, ACTA BIOMATER, V9, P5493, DOI 10.1016/j.actbio.2012.10.015
   Sharma RI, 2010, BIOMATERIALS, V31, P7695, DOI 10.1016/j.biomaterials.2010.06.046
   Shi YL, 2013, MOL MED REP, V7, P419, DOI 10.3892/mmr.2012.1213
   Stalder G. K. A. F., 2006, COLLOID SURF A, V286, P92
   Takeuchi Y, 1997, J BIOL CHEM, V272, P29309, DOI 10.1074/jbc.272.46.29309
   Taubenberger AV, 2010, BIOMATERIALS, V31, P2827, DOI 10.1016/j.biomaterials.2009.12.051
   Toworfe GK, 2004, J BIOMED MATER RES A, V71A, P449, DOI 10.1002/jbm.a.30164
   Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]
   Tsai KS, 2010, J BIOMED MATER RES A, V94A, P673, DOI 10.1002/jbm.a.32693
   Valamehr B, 2008, P NATL ACAD SCI USA, V105, P14459, DOI 10.1073/pnas.0807235105
   Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9
   Wang CZ, 2006, MOL BIOL CELL, V17, P2839, DOI 10.1091/mbc.E05-11-1068
   Wang PY, 2012, ACTA BIOMATER, V8, P519, DOI 10.1016/j.actbio.2011.09.030
   Wen JH, 2014, NAT MATER, V13, P979, DOI [10.1038/NMAT4051, 10.1038/nmat4051]
   Wu CC, 2011, SURF COAT TECH, V205, P3182, DOI 10.1016/j.surfcoat.2010.11.036
   Wu M, 2014, COLLOID SURFACE B, V116, P700, DOI 10.1016/j.colsurfb.2013.11.010
   Xie J, 2014, ACTA BIOMATER, V10, P2463, DOI 10.1016/j.actbio.2014.01.031
   Xu HF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052209
   Yao MJ, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/2/025012
   Yao X, 2013, BIOMATERIALS, V34, P9001, DOI 10.1016/j.biomaterials.2013.08.013
   Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031
   Zhang WJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02332
NR 67
TC 7
Z9 7
U1 5
U2 34
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD JUN 22
PY 2016
VL 5
IS 12
BP 1481
EP 1492
DI 10.1002/adhm.201600128
PG 12
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA DQ9SU
UT WOS:000379550400011
PM 27125602
DA 2018-10-20
ER

PT J
AU Ventre, M
   Netti, PA
AF Ventre, Maurizio
   Netti, Paolo A.
TI Engineering Cell Instructive Materials To Control Cell Fate and
   Functions through Material Cues and Surface Patterning
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE adhesion; cytoskeleton; topography; material stiffness; patterning;
   differentiation
ID MESENCHYMAL STEM-CELLS; EXTRACELLULAR-MATRIX; FOCAL ADHESIONS;
   NANOSCALE; DIFFERENTIATION; SUBSTRATE; BIOMATERIALS; MIGRATION; LINEAGE;
   TISSUE
AB Mastering the interaction between cells and extracellular environment is a fundamental prerequisite in order to engineer functional biomaterial interfaces able to instruct cells with specific commands. Such advanced biomaterials might find relevant application in prosthesis design, tissue engineering, diagnostics and stem cell biology. Because of the highly complex, dynamic, and multifaceted context, a thorough understanding of the cell-material crosstalk has not been achieved yet; however, a variety of material features including biological cues, topography, and mechanical properties have been proved to impact the strength and the nature of the cell-material interaction, eventually affecting cell fate and functions. Although the nature of these three signals may appear very different, they are equated by their participation in the same materialcytoskeleton crosstalk pathway as they regulate cell adhesion events. In this work we present recent and relevant findings on the material-induced cell responses, with a particular emphasis on how the presentation of biochemical/biophysical signals modulates cell behavior. Finally, we summarize and discuss the literature data to draw out unifying elements concerning cell recognition of and reaction to signals displayed by material surfaces.
C1 [Netti, Paolo A.] Univ Naples Federico II, Dept Chem Mat & Ind Prod Engn, Ple Tecchio 80, I-80125 Naples, Italy.
   Univ Naples Federico II, Interdisciplinary Res Ctr Biomat, Ple Tecchio 80, I-80125 Naples, Italy.
   Ist Italiano Tecnol, Ctr Adv Biomat Hlth Care CRIB, Lgo Barsanti & Matteucci 53, I-80125 Naples, Italy.
RP Netti, PA (reprint author), Univ Naples Federico II, Dept Chem Mat & Ind Prod Engn, Ple Tecchio 80, I-80125 Naples, Italy.
EM nettipa@unina.it
OI NETTI, PAOLO/0000-0002-2435-7181
CR Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014
   Bacharouche J, 2013, ACS NANO, V7, P3457, DOI 10.1021/nn400356p
   Battista E, 2015, BIOMATERIALS, V45, P72, DOI 10.1016/j.biomaterials.2014.12.012
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Biela SA, 2009, ACTA BIOMATER, V5, P2460, DOI 10.1016/j.actbio.2009.04.003
   Bierbaum Susanne, 2012, Biomatter, V2, P132, DOI 10.4161/biom.20921
   Biggs MJP, 2010, NANOMED-NANOTECHNOL, V6, P619, DOI 10.1016/j.nano.2010.01.009
   Cameron AR, 2011, BIOMATERIALS, V32, P5979, DOI 10.1016/j.biomaterials.2011.04.003
   Causa F, 2010, LANGMUIR, V26, P9875, DOI 10.1021/la100207q
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chowdhury F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015655
   Christman KL, 2008, J AM CHEM SOC, V130, P16585, DOI 10.1021/ja803676r
   Comoglio PM, 2003, CURR OPIN CELL BIOL, V15, P565, DOI 10.1016/S0955-0674(03)00096-6
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalby MJ, 2014, NAT MATER, V13, P558, DOI [10.1038/NMAT3980, 10.1038/nmat3980]
   del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912
   Diez M, 2011, ADV ENG MATER, V13, pB395, DOI 10.1002/adem.201080122
   Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   Fusco S, 2015, ACTA BIOMATER, V23, P63, DOI 10.1016/j.actbio.2015.05.008
   Geiger B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005033
   George PA, 2009, BIOMATERIALS, V30, P4732, DOI 10.1016/j.biomaterials.2009.05.039
   Gerecht S, 2007, BIOMATERIALS, V28, P4068, DOI 10.1016/j.biomaterials.2007.05.027
   Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035
   Glass R, 2003, NANOTECHNOLOGY, V14, P1153, DOI 10.1088/0957-4484/14/10/314
   Guarnieri D, 2010, ACTA BIOMATER, V6, P2532, DOI 10.1016/j.actbio.2009.12.050
   Guillemette MD, 2009, INTEGR BIOL, V1, P196, DOI 10.1039/b820208g
   Guvendiren M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1792
   HARRIS AK, 1980, SCIENCE, V208, P177, DOI 10.1126/science.6987736
   Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Iannone M, 2015, NANO LETT, V15, P1517, DOI 10.1021/nl503737k
   Jansen KA, 2015, BBA-MOL CELL RES, V1853, P3043, DOI 10.1016/j.bbamcr.2015.05.007
   Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621
   Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Kim DH, 2010, P NATL ACAD SCI USA, V107, P565, DOI 10.1073/pnas.0906504107
   Kim DH, 2009, BIOMATERIALS, V30, P5433, DOI 10.1016/j.biomaterials.2009.06.042
   Lamers E, 2010, EUR CELLS MATER, V20, P329
   Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125
   Lee MR, 2010, BIOMATERIALS, V31, P4360, DOI 10.1016/j.biomaterials.2010.02.012
   Li Y, 2011, BIOPHYS J, V100, P1902, DOI 10.1016/j.bpj.2011.03.008
   Loesberg WA, 2007, BIOMATERIALS, V28, P3944, DOI 10.1016/j.biomaterials.2007.05.030
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Mammoto T, 2010, DEVELOPMENT, V137, P1407, DOI 10.1242/dev.024166
   Mason B., 2012, ENG BIOMATERIALS REG, P19, DOI DOI 10.1007/978-1-4614-1080-5_2
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   MASSIA SP, 1991, J BIOMED MATER RES, V25, P223, DOI 10.1002/jbm.820250209
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]
   Natale CF, 2014, BIOMATERIALS, V35, P2743, DOI 10.1016/j.biomaterials.2013.12.023
   Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Park JS, 2011, BIOMATERIALS, V32, P3921, DOI 10.1016/j.biomaterials.2011.02.019
   Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957
   Peng R, 2011, BIOMATERIALS, V32, P8048, DOI 10.1016/j.biomaterials.2011.07.035
   Peyton SR, 2006, BIOMATERIALS, V27, P4881, DOI 10.1016/j.biomaterials.2006.05.012
   Peyton SR, 2005, J CELL PHYSIOL, V204, P198, DOI 10.1002/jcp.20274
   Piner RD, 1999, SCIENCE, V283, P661, DOI 10.1126/science.283.5402.661
   Raynor JE, 2009, BIOINTERPHASES, V4, pFA3, DOI 10.1116/1.3089252
   Rianna C, 2015, ACS APPL MATER INTER, V7, P16984, DOI 10.1021/acsami.5b02080
   Schvartzman M, 2011, NANO LETT, V11, P1306, DOI 10.1021/nl104378f
   Shahal T, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0023-0
   Smith JT, 2004, LANGMUIR, V20, P8279, DOI 10.1021/la0489763
   Ventre M, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0687
   Ventre M, 2012, J R SOC INTERFACE, V9, P2017, DOI 10.1098/rsif.2012.0308
   Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594
   Wu JD, 2012, INTERFACE FOCUS, V2, P337, DOI 10.1098/rsfs.2011.0124
   Yao X, 2013, BIOMATERIALS, V34, P930, DOI 10.1016/j.biomaterials.2012.10.052
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
   Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031
   Zhernenkov M, 2015, ACS APPL MATER INTER, V7, P11857, DOI 10.1021/acsami.5b01453
NR 74
TC 23
Z9 23
U1 3
U2 50
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD JUN 22
PY 2016
VL 8
IS 24
SI SI
BP 14896
EP 14908
DI 10.1021/acsami.5b08658
PG 13
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA DP6CP
UT WOS:000378584800002
PM 26693600
DA 2018-10-20
ER

PT J
AU Modulevsky, DJ
   Cuerrier, CM
   Pelling, AE
AF Modulevsky, Daniel J.
   Cuerrier, Charles M.
   Pelling, Andrew E.
TI Biocompatibility of Subcutaneously Implanted Plant-Derived Cellulose
   Biomaterials
SO PLOS ONE
LA English
DT Article
ID 3D CELL-CULTURE; IN-VIVO BIOCOMPATIBILITY; BACTERIAL CELLULOSE;
   MECHANICAL-PROPERTIES; RESORBABLE BIOMATERIALS; BIOMEDICAL APPLICATIONS;
   REGENERATIVE MEDICINE; ELECTROSPUN SCAFFOLDS; DECELLULARIZED MATRIX;
   EXTRACELLULAR-MATRIX
AB There is intense interest in developing novel biomaterials which support the invasion and proliferation of living cells for potential applications in tissue engineering and regenerative medicine. Decellularization of existing tissues have formed the basis of one major approach to producing 3D scaffolds for such purposes. In this study, we utilize the native hypanthium tissue of apples and a simple preparation methodology to create implantable cellulose scaffolds. To examine biocompatibility, scaffolds were subcutaneously implanted in wild-type, immunocompetent mice (males and females; 6-9 weeks old). Following the implantation, the scaffolds were resected at 1, 4 and 8 weeks and processed for histological analysis (H&E, Masson's Trichrome, anti-CD31 and anti-CD45 antibodies). Histological analysis revealed a characteristic foreign body response to the scaffold 1 week post-implantation. However, the immune response was observed to gradually disappear by 8 weeks post-implantation. By 8 weeks, there was no immune response in the surrounding dermis tissue and active fibroblast migration within the cellulose scaffold was observed. This was concomitant with the deposition of a new collagen extracellular matrix. Furthermore, active blood vessel formation within the scaffold was observed throughout the period of study indicating the pro-angiogenic properties of the native scaffolds. Finally, while the scaffolds retain much of their original shape they do undergo a slow deformation over the 8-week length of the study. Taken together, our results demonstrate that native cellulose scaffolds are biocompatible and exhibit promising potential as a surgical biomaterial.
C1 [Modulevsky, Daniel J.; Cuerrier, Charles M.; Pelling, Andrew E.] Univ Ottawa, Ctr Interdisciplinary NanoPhys, Ottawa, ON, Canada.
   [Modulevsky, Daniel J.; Pelling, Andrew E.] Univ Ottawa, Dept Biol, Ottawa, ON, Canada.
   [Cuerrier, Charles M.; Pelling, Andrew E.] Univ Ottawa, Dept Phys, Ottawa, ON K1N 6N5, Canada.
   [Pelling, Andrew E.] Univ Ottawa, Inst Sci Soc & Policy, Ottawa, ON, Canada.
   [Pelling, Andrew E.] Univ Western Australia, Sch Anat Physiol & Human Biol, SymbioticA, Perth, WA 6009, Australia.
RP Pelling, AE (reprint author), Univ Ottawa, Ctr Interdisciplinary NanoPhys, Ottawa, ON, Canada.; Pelling, AE (reprint author), Univ Ottawa, Dept Biol, Ottawa, ON, Canada.; Pelling, AE (reprint author), Univ Ottawa, Dept Phys, Ottawa, ON K1N 6N5, Canada.; Pelling, AE (reprint author), Univ Ottawa, Inst Sci Soc & Policy, Ottawa, ON, Canada.; Pelling, AE (reprint author), Univ Western Australia, Sch Anat Physiol & Human Biol, SymbioticA, Perth, WA 6009, Australia.
EM a@pellinglab.net
FU Natural Sciences and Engineering Resource Council (NSERC) Discovery
   Grant [RGPIN-2014-04978]; University of Ottawa Faculty Development Fund;
   "Fonds de Recherche du Quebec - Sante" (FRQS); Canada Research Chairs
   Program [950-229071]
FX This study was funded by a Natural Sciences and Engineering Resource
   Council (NSERC) Discovery Grant (#RGPIN-2014-04978) and the University
   of Ottawa Faculty Development Fund. D.J.M. was supported by a graduate
   student fellowship from the "Fonds de Recherche du Quebec - Sante"
   (FRQS). C.M.C. was supported by a postdoctoral training award from the
   "Fonds de Recherche du Quebec - Sante" (FRQS). A.E.P. would like to
   acknowledge generous support from the Canada Research Chairs Program
   (#950-229071). The funders had no role in study design, datacollection
   and analysis, decision to publish, or preparation of the manuscript.
CR Abou Neel EA, 2014, J DENT, V42, P915, DOI 10.1016/j.jdent.2014.05.008
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Andrade FK, 2013, J BIOACT COMPAT POL, V28, P97, DOI 10.1177/0883911512467643
   Andrade FK, 2011, J BIOMED MATER RES A, V98A, P554, DOI 10.1002/jbm.a.33148
   [Anonymous], WHY ORG EYE TISS DON
   [Anonymous], 2011, COMPR BIOM ONL VERS, V1
   Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7
   Anseth KS, 2012, DYNAMIC MICROENVIRON, V4, P1
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Backdahl H, 2006, BIOMATERIALS, V27, P2141, DOI 10.1016/j.biomaterials.2005.10.026
   Badylak SF, 2011, ANN REV
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Bae H, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003688
   Bagno A, 2004, J MATER SCI-MATER M, V15, P935, DOI 10.1023/B:JMSM.0000042679.28493.7f
   Bai F, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/1/015007
   Baker BM, 2008, BIOMATERIALS, V29, P2348, DOI 10.1016/j.biomaterials.2008.01.032
   Bao G, 2003, NAT MATER, V2, P715, DOI 10.1038/nmat1001
   Baptista PM, 2011, HEPATOLOGY, V53, P604, DOI 10.1002/hep.24067
   Baptista PM, 2009, IEEE ENG MED BIO, P6526, DOI 10.1109/IEMBS.2009.5333145
   BEGUIN P, 1994, FEMS MICROBIOL REV, V13, P25, DOI 10.1016/0168-6445(94)90099-X
   Behravesh E, 1999, CLIN ORTHOP RELAT R, pS118
   Bhardwaj N, 2015, MACROMOL BIOSCI, V15, P153, DOI 10.1002/mabi.201400335
   Bhattacharya M, 2012, J CONTROL RELEASE, V164, P291, DOI 10.1016/j.jconrel.2012.06.039
   Blakeney BA, 2011, BIOMATERIALS, V32, P1583, DOI 10.1016/j.biomaterials.2010.10.056
   Bohner M, 2010, MATER TODAY, V13, P24, DOI 10.1016/S1369-7021(10)70014-6
   Brown EE, 2013, BIOMACROMOLECULES, V14, P1063, DOI 10.1021/bm3019467
   Campoli G, 2013, MATER DESIGN, V49, P957, DOI 10.1016/j.matdes.2013.01.071
   Cancedda R, 2007, BIOMATERIALS, V28, P4240, DOI 10.1016/j.biomaterials.2007.06.023
   Cervantes TM, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0413
   Chang HI, 2011, REGENERATIVE MEDICINE AND TISSUE ENGINEERING - CELLS AND BIOMATERIALS, P569
   Chen QZ, 2013, PROG POLYM SCI, V38, P584, DOI 10.1016/j.progpolymsci.2012.05.003
   Cornwell Kevin G, 2009, Clin Podiatr Med Surg, V26, P507, DOI 10.1016/j.cpm.2009.08.001
   Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d
   de Guzman RC, 2011, BIOMATERIALS, V32, P8205, DOI 10.1016/j.biomaterials.2011.07.054
   Derda R, 2009, P NATL ACAD SCI USA, V106, P18457, DOI 10.1073/pnas.0910666106
   Dong WJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep18266
   Dugan JM, 2013, NANOMEDICINE-UK, V8, P287, DOI [10.2217/NNM.12.211, 10.2217/nnm.12.211]
   Dugan JM, 2013, ACTA BIOMATER, V9, P4707, DOI 10.1016/j.actbio.2012.08.050
   Entcheva E, 2004, BIOMATERIALS, V25, P5753, DOI 10.1016/j.biomaterials.2004.01.024
   Tischer PCSF, 2010, BIOMACROMOLECULES, V11, P1217, DOI 10.1021/bm901383a
   Gibson LJ, 2012, J R SOC INTERFACE, V9, P2749, DOI 10.1098/rsif.2012.0341
   Gottenbos B, 2002, J MATER SCI-MATER M, V13, P717, DOI 10.1023/A:1016175502756
   Gu L, 2016, NAT REV CANCER, V16, P56, DOI 10.1038/nrc.2015.3
   Guillaume O, 2016, J MATER SCI-MATER M, V27, DOI 10.1007/s10856-015-5648-3
   Guyette JP, 2016, CIRC RES, V118, P56, DOI 10.1161/CIRCRESAHA.115.306874
   Hattori N, 2014, MOVEMENT DISORD, V29, P185, DOI 10.1002/mds.25740
   Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570
   Hsu SH, 2015, WOUND REPAIR REGEN, V23, P57, DOI 10.1111/wrr.12239
   ISHIHARA K, 1995, J BIOMED MATER RES, V29, P181, DOI 10.1002/jbm.820290207
   ISHIHARA K, 1992, BIOMATERIALS, V13, P145, DOI 10.1016/0142-9612(92)90062-S
   Isogai N, 2004, TISSUE ENG, V10, P673, DOI 10.1089/1076327041348527
   Jones KS, 2008, SEMIN IMMUNOL, V20, P130, DOI 10.1016/j.smim.2007.11.005
   Kar M, 2016, BIOMATERIALS, V77, P186, DOI 10.1016/j.biomaterials.2015.11.018
   Kim MS, 2007, BIOMATERIALS, V28, P5137, DOI 10.1016/j.biomaterials.2007.08.014
   Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Lee Daniel K, 2007, J Foot Ankle Surg, V46, P451, DOI 10.1053/j.jfas.2007.05.007
   Lee J-S, 2014, BIOFABRICATION, V6
   Lemons J E, 1986, J Arthroplasty, V1, P143
   Liao HT, 2015, PLAST RECONSTR SURG, V135, p313E, DOI 10.1097/PRS.0000000000001105
   Lin N, 2014, EUR POLYM J, V59, P302, DOI 10.1016/j.eurpolymj.2014.07.025
   Lu Y, 2014, TAPPI J, V13, P47
   Lv S, 2010, NATURE, V465, P69, DOI 10.1038/nature09024
   Mannoor MS, 2013, NANO LETT, V13, P2634, DOI 10.1021/nl4007744
   Mao AS, 2015, P NATL ACAD SCI USA, V112, P14452, DOI 10.1073/pnas.1508520112
   Maurer MM, 2015, MATERIALS, V8, P2794, DOI 10.3390/ma8052794
   McBane JE, 2011, BIOMATERIALS, V32, P6034, DOI 10.1016/j.biomaterials.2011.04.048
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Metcalfe AD, 2007, J R SOC INTERFACE, V4, P413, DOI 10.1098/rsif.2006.0179
   MIYAMOTO T, 1989, J BIOMED MATER RES, V23, P125, DOI 10.1002/jbm.820230110
   Modulevsky DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097835
   MOTEGI K, 1984, J MAXILLOFAC SURG, V12, P21, DOI 10.1016/S0301-0503(84)80205-2
   Nakayama KH, 2010, TISSUE ENG PT A, V16, P2207, DOI 10.1089/ten.TEA.2009.0602
   Neumeister MW, 2006, PLAST RECONSTR SURG, V117, P116, DOI 10.1097/01.prs.0000195071.01699.ce
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   Nimeskern L, 2013, J MECH BEHAV BIOMED, V22, P12, DOI 10.1016/j.jmbbm.2013.03.005
   O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X
   Onuki Yoshinori, 2008, J Diabetes Sci Technol, V2, P1003
   Orlando G, 2011, TRANSPLANTATION, V91, P1310, DOI 10.1097/TP.0b013e318219ebb5
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Page H, 2013, CELL TISSUE RES, V352, P123, DOI 10.1007/s00441-012-1441-5
   Pashuck ET, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002717
   Pertile RAN, 2012, J BIOMAT SCI-POLYM E, V23, P1339, DOI 10.1163/092050611X581516
   Phipps MC, 2012, BIOMATERIALS, V33, P524, DOI 10.1016/j.biomaterials.2011.09.080
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Pomerantseva I, 2016, TISSUE ENG PT A, V22, P197, DOI [10.1089/ten.tea.2015.0173, 10.1089/ten.TEA.2015.0173]
   Puschmann TB, 2013, GLIA, V61, P432, DOI 10.1002/glia.22446
   Rai R, 2011, MAT SCI ENG R, V72, P29, DOI 10.1016/j.mser.2010.11.002
   Ratner B. D., 2004, BIOMATERIALS SCI INT
   Raya-Rivera A, 2011, LANCET, V377, P1175, DOI 10.1016/S0140-6736(10)62354-9
   Raya-Rivera AM, 2014, LANCET, V384, P329, DOI 10.1016/S0140-6736(14)60542-0
   Ren X, 2015, NAT BIOTECHNOL, V33, P1097, DOI 10.1038/nbt.3354
   Rickert D, 2003, CLIN HEMORHEOL MICRO, V28, P175
   Saini M, 2015, WORLD J CLIN CASES, V3, P52, DOI 10.12998/wjcc.v3.i1.52
   Salzberg CA, 2006, ANN PLAS SURG, V57, P1, DOI 10.1097/01.sap.0000214873.13102.9f
   Santerre JP, 2005, BIOMATERIALS, V26, P7457, DOI 10.1016/j.biomaterials.2005.05.079
   Schumann DA, 2009, CELLULOSE, V16, P877, DOI 10.1007/s10570-008-9264-y
   Shieh SJ, 2004, BIOMATERIALS, V25, P1545, DOI 10.1016/S0142-9612(03)00501-5
   Shue Li, 2012, Biomatter, V2, P271, DOI 10.4161/biom.22948
   Sieminski AL, 2000, BIOMATERIALS, V21, P2233, DOI 10.1016/S0142-9612(00)00149-6
   Sittinger M, 1996, BIOMATERIALS, V17, P237, DOI 10.1016/0142-9612(96)85561-X
   Song JJ, 2011, TRENDS MOL MED, V17, P424, DOI 10.1016/j.molmed.2011.03.005
   Soto-Gutierrez A, 2011, TISSUE ENG PART C-ME, V17, P677, DOI 10.1089/ten.tec.2010.0698
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Sterling JA, 2014, CURR OSTEOPOROS REP, V12, P48, DOI 10.1007/s11914-014-0187-2
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Torres FG, 2012, J FUNCT BIOMATER, V3, P864, DOI 10.3390/jfb3040864
   Trindade R, 2016, CLIN IMPLANT DENT R, V18, P192, DOI 10.1111/cid.12274
   Wang X., 2013, ADV BIOMATER SCI APP, P112, DOI DOI 10.5772/53461
   WATANABE K, 1993, CYTOTECHNOLOGY, V13, P107, DOI 10.1007/BF00749937
   Xiao X, 2015, SCI REP-UK, V5, DOI 10.1038/srep09409
   Xu JW, 2005, PLAST RECONSTR SURG, V115, P1633, DOI 10.1097/01.PRS.0000161465.21513.5D
   Zhao RG, 2011, ACTA BIOMATER, V7, P1220, DOI 10.1016/j.actbio.2010.11.004
   Zhou LB, 2011, TISSUE ENG PT A, V17, P1573, DOI 10.1089/ten.tea.2010.0627
NR 117
TC 15
Z9 15
U1 5
U2 35
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 21
PY 2016
VL 11
IS 6
AR e0157894
DI 10.1371/journal.pone.0157894
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DP0WU
UT WOS:000378212400059
PM 27328066
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Jastrzebska, K
   Felcyn, E
   Kozak, M
   Szybowicz, M
   Buchwald, T
   Pietralik, Z
   Jesionowski, T
   Mackiewicz, A
   Dams-Kozlowska, H
AF Jastrzebska, Katarzyna
   Felcyn, Edyta
   Kozak, Maciej
   Szybowicz, Miroslaw
   Buchwald, Tomasz
   Pietralik, Zuzanna
   Jesionowski, Teofil
   Mackiewicz, Andrzej
   Dams-Kozlowska, Hanna
TI The method of purifying bioengineered spider silk determines the silk
   sphere properties
SO SCIENTIFIC REPORTS
LA English
DT Article
ID PROTEIN SECONDARY STRUCTURE; HUMAN CYSTATIN-C; NEPHILA-CLAVIPES;
   DRUG-DELIVERY; DRAGLINE SILK; FIBROIN; MICROSPHERES; RELEASE; FIBER;
   NANOPARTICLES
AB Bioengineered spider silks are a biomaterial with great potential for applications in biomedicine. They are biocompatible, biodegradable and can self-assemble into films, hydrogels, scaffolds, fibers, capsules and spheres. A novel, tag-free, bioengineered spider silk named MS2(9x) was constructed. It is a 9-mer of the consensus motif derived from MaSp2-the spidroin of Nephila clavipes dragline silk. Thermal and acidic extraction methods were used to purify MS2(9x). Both purification protocols gave a similar quantity and quality of soluble silk; however, they differed in the secondary structure and zeta potential value. Spheres made of these purified variants differed with regard to critical features such as particle size, morphology, zeta potential and drug loading. Independent of the purification method, neither variant of the MS2(9x) spheres was cytotoxic, which confirmed that both methods can be used for biomedical applications. However, this study highlights the impact that the applied purification method has on the further biomaterial properties.
C1 [Jastrzebska, Katarzyna; Mackiewicz, Andrzej; Dams-Kozlowska, Hanna] Poznan Univ Med Sci, Chair Med Biotechnol, PL-61688 Poznan, Poland.
   [Jastrzebska, Katarzyna] Adam Mickiewicz Univ, NanoBioMed Ctr, PL-61614 Poznan, Poland.
   [Felcyn, Edyta; Mackiewicz, Andrzej] BioContract Sp Zoo, PL-61051 Poznan, Poland.
   [Kozak, Maciej; Pietralik, Zuzanna] Adam Mickiewicz Univ, Dept Macromol Phys, PL-61614 Poznan, Poland.
   [Kozak, Maciej] Adam Mickiewicz Univ, Joint Lab SAXS Studies, PL-61614 Poznan, Poland.
   [Szybowicz, Miroslaw; Buchwald, Tomasz] Poznan Univ Tech, Fac Tech Phys, PL-60965 Poznan, Poland.
   [Jesionowski, Teofil] Poznan Univ Tech, Inst Chem Technol & Engn, Fac Chem Technol, PL-60965 Poznan, Poland.
   [Mackiewicz, Andrzej; Dams-Kozlowska, Hanna] Greater Poland Canc Ctr, Dept Diagnost & Canc Immunol, PL-61688 Poznan, Poland.
RP Dams-Kozlowska, H (reprint author), Poznan Univ Med Sci, Chair Med Biotechnol, PL-61688 Poznan, Poland.; Dams-Kozlowska, H (reprint author), Greater Poland Canc Ctr, Dept Diagnost & Canc Immunol, PL-61688 Poznan, Poland.
EM hanna.dams-kozlowska@wco.pl
RI Buchwald, Tomasz/B-3356-2014; Jesionowski, Teofil/N-1623-2014;
   Szybowicz, Miroslaw/H-6283-2013
OI Buchwald, Tomasz/0000-0003-1837-402X; Szybowicz,
   Miroslaw/0000-0001-8933-571X; Dams-Kozlowska, Hanna/0000-0003-2349-419X
FU HARMONIA3 grant from the National Science Centre (Poland)
   [2012/06/M/ST4/00036]; National Science Centre, Poland
   [2014/15/B/NZ7/00903]; International PhD Projects Programme Foundation
   for Polish Science within the European Regional Development Fund
FX KJ was supported by the International PhD Projects Programme Foundation
   for Polish Science operated within the Innovative Economy Operational
   Programme (IE OP) 2007-2013 within the European Regional Development
   Fund. MK and ZP were partially supported by HARMONIA3 grant (Project No.
   2012/06/M/ST4/00036) from the National Science Centre (Poland). The
   project was partially supported by grant from The National Science
   Centre, Poland (2014/15/B/NZ7/00903).
CR Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029
   Bini E, 2006, BIOMACROMOLECULES, V7, P3139, DOI 10.1021/bm0607877
   Blum C, 2012, BIONANOSCIENCE, V2, P67, DOI 10.1007/s12668-012-0036-7
   Breslauer DN, 2010, BIOMACROMOLECULES, V11, P643, DOI 10.1021/bm901209u
   Brooks AE, 2005, BIOMACROMOLECULES, V6, P3095, DOI 10.1021/bm050421e
   Chen MJ, 2012, J BIOMED MATER RES A, V100A, P203, DOI 10.1002/jbm.a.33265
   Dams-Kozlowska H, 2013, J BIOMED MATER RES A, V101, P456, DOI 10.1002/jbm.a.34353
   Florczak A, 2014, BIOMACROMOLECULES, V15, P2971, DOI 10.1021/bm500591p
   GATENBY AA, 1990, TRENDS BIOTECHNOL, V8, P354, DOI 10.1016/0167-7799(90)90224-L
   Germershaus O, 2014, BIOMATERIALS, V35, P3427, DOI 10.1016/j.biomaterials.2013.12.083
   Hagn F, 2012, J PEPT SCI, V18, P357, DOI 10.1002/psc.2417
   Hedhammar M, 2008, BIOCHEMISTRY-US, V47, P3407, DOI 10.1021/bi702432y
   Heim M, 2010, CHEM SOC REV, V39, P156, DOI 10.1039/b813273a
   Hijirida DH, 1996, BIOPHYS J, V71, P3442, DOI 10.1016/S0006-3495(96)79539-5
   HINMAN MB, 1992, J BIOL CHEM, V267, P19320
   Huemmerich D, 2004, BIOCHEMISTRY-US, V43, P13604, DOI 10.1021/bi048983q
   Janowski R, 2001, NAT STRUCT BIOL, V8, P316, DOI 10.1038/86188
   Jansson R, 2014, BIOMACROMOLECULES, V15, P1696, DOI 10.1021/bm500114e
   Kluge JA, 2008, TRENDS BIOTECHNOL, V26, P244, DOI 10.1016/j.tibtech.2008.02.006
   Kundu J, 2010, INT J PHARMACEUT, V388, P242, DOI 10.1016/j.ijpharm.2009.12.052
   Lammel A, 2008, CHEMSUSCHEM, V1, P413, DOI 10.1002/cssc.200800030
   Lammel A, 2011, BIOMATERIALS, V32, P2233, DOI 10.1016/j.biomaterials.2010.11.060
   Lammel AS, 2010, BIOMATERIALS, V31, P4583, DOI 10.1016/j.biomaterials.2010.02.024
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Lefevre T, 2007, BIOMACROMOLECULES, V8, P2342, DOI 10.1021/bm7005517
   Lefevre T, 2007, BIOPHYS J, V92, P2885, DOI 10.1529/biophysj.106.100339
   Mello CM, 2004, BIOMACROMOLECULES, V5, P1849, DOI 10.1021/bm049815g
   Milanova D, 2011, ELECTROPHORESIS, V32, P3286, DOI 10.1002/elps.201100210
   Ostner G, 2013, J BIOL CHEM, V288, P16438, DOI 10.1074/jbc.M113.469593
   Rabotyagova OS, 2009, BIOMACROMOLECULES, V10, P229, DOI 10.1021/bm800930x
   Rammensee S, 2008, P NATL ACAD SCI USA, V105, P6590, DOI 10.1073/pnas.0709246105
   Rising A, 2014, ACTA BIOMATER, V10, P1627, DOI 10.1016/j.actbio.2013.09.030
   Rising A, 2011, CELL MOL LIFE SCI, V68, P169, DOI 10.1007/s00018-010-0462-z
   Schacht K, 2014, CURR OPIN BIOTECH, V29, P62, DOI 10.1016/j.copbio.2014.02.015
   Scheibel T, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-14
   Seib FP, 2013, ADV HEALTHC MATER, V2, P1606, DOI 10.1002/adhm.201300034
   Slotta UK, 2008, ANGEW CHEM INT EDIT, V47, P4592, DOI 10.1002/anie.200800683
   Spiess K, 2010, MACROMOL BIOSCI, V10, P998, DOI 10.1002/mabi.201000071
   Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879
   Tokareva O, 2013, MICROB BIOTECHNOL, V6, P651, DOI 10.1111/1751-7915.12081
   Wahlbom M, 2007, J BIOL CHEM, V282, P18318, DOI 10.1074/jbc.M611368200
   Wang XQ, 2007, J CONTROL RELEASE, V117, P360, DOI 10.1016/j.jconrel.2006.11.021
   Wang XQ, 2010, BIOMATERIALS, V31, P1025, DOI 10.1016/j.biomaterials.2009.11.002
   Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853
NR 44
TC 9
Z9 9
U1 2
U2 31
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUN 17
PY 2016
VL 6
AR 28106
DI 10.1038/srep28106
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DO8NW
UT WOS:000378041300001
PM 27312998
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Zheng, K
   Chen, Y
   Huang, WW
   Lin, YN
   Kaplan, DL
   Fan, YM
AF Zheng, Ke
   Chen, Ying
   Huang, Wenwen
   Lin, Yinan
   Kaplan, David L.
   Fan, Yimin
TI Chemically Functionalized Silk for Human Bone Marrow-Derived Mesenchymal
   Stem Cells Proliferation and Differentiation
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE silk fibroin; oxidation; carboxyl groups; serine; mesenchymal stern
   cells
ID TEMPO-MEDIATED OXIDATION; OSTEOGENIC-DIFFERENTIATION; BIOMATERIAL
   SCAFFOLDS; FIBROIN FILMS; STROMAL CELLS; SPIDER SILK; IN-VITRO;
   PROTEINS; FIBERS; HYDROXYAPATITE
AB To produce biocompatible, mechanically robust, and conductive materials for bone tissue engineering, chemical oxidation using sodium hyprochlorite (NaClO) was utilized to introduce carboxyl groups onto silk fibroin (SF). A final carboxyl content of 1.09 mM/g SF was obtained, corresponding to similar to 47% of the primary hydroxymethyl groups on the silk. Interestingly, both infrared (IR) spectroscopy and circular dichroism (CD) spectra demonstrated that the resulting oxidized silk (OxSF) self-assembled into beta-sheet structures under aqueous conditions and this contributed to the mechanical properties of the as-prepared silk-based scaffolds and the mineralized OxSF scaffolds (M-OxSF). The OxSF scaffolds had a compressive modulus of 211 +/- 75 KPa in the hydrated state, 10 times higher than that of the SF scaffolds, and the modulus of the M-OxSF scaffolds was increased to 758 +/- 189 KPa. Human bone marrow-derived mesenchymal stem cells (hMSCs) grown on the scaffolds during osteogenesis showed that the OxSF scaffolds supported the proliferation and differentiation of hMSCs in vitro.
C1 [Zheng, Ke; Fan, Yimin] Nanjing Forestry Univ, Coll Chem Engn, Jiangsu Key Lab Biomass Based Green Fuel & Chem, Nanjing 210037, Jiangsu, Peoples R China.
   [Zheng, Ke; Chen, Ying; Huang, Wenwen; Lin, Yinan; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
RP Fan, YM (reprint author), Nanjing Forestry Univ, Coll Chem Engn, Jiangsu Key Lab Biomass Based Green Fuel & Chem, Nanjing 210037, Jiangsu, Peoples R China.; Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.com; fanyimin@njfu.edu.cn
RI Huang, Wenwen/H-5352-2018
OI Huang, Wenwen/0000-0001-8175-9083
FU National Forestry Public Welfare Industry Research Project [201304609];
   Foundation for Innovation Training of Graduate Student of Jiangsu
   Province [KYZZ15_0250]; National Natural Science Foundation of China
   [31100426]; Specialized Research Fund for the Doctoral Program of the
   Higher Education of China [20133204110008]; Priority Academic Program
   Development of Jiangsu Higher Education Institutions (PAPD)
FX This research was supported by the National Forestry Public Welfare
   Industry Research Project (No. 201304609), the Foundation for Innovation
   Training of Graduate Student of Jiangsu Province (No. KYZZ15_0250), the
   National Natural Science Foundation of China (No. 31100426), the
   Specialized Research Fund for the Doctoral Program of the Higher
   Education of China (No. 20133204110008) and the Priority Academic
   Program Development of Jiangsu Higher Education Institutions (PAPD).
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A
   An B, 2011, BIOMACROMOLECULES, V12, P2375, DOI 10.1021/bm200463e
   Bai LQ, 2008, APPL SURF SCI, V254, P2988, DOI 10.1016/j.apsusc.2007.10.049
   BAKER RWR, 1947, BIOCHEM J, V41, P337, DOI 10.1042/bj0410337
   Bhumiratana S, 2011, BIOMATERIALS, V32, P2812, DOI 10.1016/j.biomaterials.2010.12.058
   Boyd R N, 1992, ORGANIC CHEM
   BROWN CH, 1950, Q J MICROSC SCI, V91, P331
   CHEN YH, 1972, BIOCHEMISTRY-US, V11, P4120, DOI 10.1021/bi00772a015
   Correia C, 2012, ACTA BIOMATER, V8, P2483, DOI 10.1016/j.actbio.2012.03.019
   Fan YM, 2009, CARBOHYD POLYM, V77, P832, DOI 10.1016/j.carbpol.2009.03.008
   Forsyth WR, 2002, PROTEINS, V48, P388, DOI 10.1002/prot.10174
   Gholipourmalekabadi M, 2015, BIOTECHNOL APPL BIOC, V62, P441, DOI 10.1002/bab.1285
   Hawkins CL, 2003, AMINO ACIDS, V25, P259, DOI 10.1007/s00726-003-0016-x
   HAZAN A, 1975, COMP BIOCHEM PHYS B, V51, P457, DOI 10.1016/0305-0491(75)90038-3
   Hu X, 2011, BIOMATERIALS, V32, P8979, DOI 10.1016/j.biomaterials.2011.08.037
   Hu YH, 2002, J BIOMED MATER RES, V59, P563, DOI 10.1002/jbm.1269
   Jiang J, 2013, BIOTECHNOL LETT, V35, P657, DOI 10.1007/s10529-012-1121-2
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jones GL, 2009, BIOMATERIALS, V30, P5376, DOI 10.1016/j.biomaterials.2009.07.028
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kenney JM, 2002, EUR J BIOCHEM, V269, P4159, DOI 10.1046/j.1432-1033.2002.03112.x
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Kim HJ, 2008, BONE, V42, P1226, DOI 10.1016/j.bone.2008.02.007
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   KREJCHI MT, 1994, SCIENCE, V265, P1427, DOI 10.1126/science.8073284
   Kundu B, 2014, PROG POLYM SCI, V39, P251, DOI 10.1016/j.progpolymsci.2013.09.002
   Lee YJ, 2013, BIOMATERIALS, V34, P5059, DOI 10.1016/j.biomaterials.2013.03.051
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Lin LX, 2015, J BIOSCI BIOENG, V119, P591, DOI 10.1016/j.jbiosc.2014.10.009
   Ling SJ, 2011, BIOMACROMOLECULES, V12, P3344, DOI 10.1021/bm2006032
   Lu Q, 2010, MACROMOL BIOSCI, V10, P289, DOI 10.1002/mabi.200900258
   Mandal BB, 2012, P NATL ACAD SCI USA, V109, P7699, DOI 10.1073/pnas.1119474109
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   Mieszawska AJ, 2010, BIOMATERIALS, V31, P8902, DOI 10.1016/j.biomaterials.2010.07.109
   Mobini S, 2013, J BIOMED MATER RES A, V101, P2392, DOI 10.1002/jbm.a.34537
   Mou ZL, 2013, MATER LETT, V105, P189, DOI 10.1016/j.matlet.2013.03.130
   Murphy AR, 2008, BIOMATERIALS, V29, P2829, DOI 10.1016/j.biomaterials.2008.03.039
   Murphy AR, 2009, J MATER CHEM, V19, P6443, DOI 10.1039/b905802h
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Rockwood DN, 2011, ACTA BIOMATER, V7, P144, DOI 10.1016/j.actbio.2010.07.020
   Romero IS, 2013, ACS APPL MATER INTER, V5, P553, DOI 10.1021/am301844c
   Saito T, 2004, BIOMACROMOLECULES, V5, P1983, DOI 10.1021/bm0497769
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Surmenev RA, 2014, ACTA BIOMATER, V10, P557, DOI 10.1016/j.actbio.2013.10.036
   Takeuchi A, 2005, J ROY SOC INTERFACE, V2, P373, DOI 10.1098/rsif.2005.0052
   Thimm BW, 2011, ACTA BIOMATER, V7, P2218, DOI 10.1016/j.actbio.2011.02.004
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wenk E, 2010, BIOMATERIALS, V31, P1403, DOI 10.1016/j.biomaterials.2009.11.006
   Wongpanit P, 2007, EUR POLYM J, V43, P4123, DOI 10.1016/j.eurpolymj.2007.07.004
   Wray LS, 2011, J BIOMED MATER RES B, V99B, P89, DOI 10.1002/jbm.b.31875
   Yoo CR, 2008, INT J BIOL MACROMOL, V42, P324, DOI 10.1016/j.ijbiomac.2007.12.004
   Zhang WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102371
   Zhang WJ, 2014, EUR CELLS MATER, V27, P1
   Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078
NR 56
TC 6
Z9 6
U1 7
U2 52
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD JUN 15
PY 2016
VL 8
IS 23
BP 14406
EP 14413
DI 10.1021/acsami.6b03518
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA DP0QT
UT WOS:000378195000015
PM 27177120
DA 2018-10-20
ER

PT J
AU Ashokkumar, M
   Chipara, AC
   Narayanan, NT
   Anumary, A
   Sruthi, R
   Thanikaivelan, P
   Vajtai, R
   Mani, SA
   Ajayan, PM
AF Ashokkumar, Meiyazhagan
   Chipara, Alin Cristian
   Narayanan, Narayanan Tharangattu
   Anumary, Ayyappan
   Sruthi, Radhakrishnan
   Thanikaivelan, Palanisamy
   Vajtai, Robert
   Mani, Sendurai A.
   Ajayan, Pulickel M.
TI Three-Dimensional Porous Sponges from Collagen Biowastes
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE collagen; skin wastes; porous sponge; environmental applications; cell
   viability
ID IRON-OXIDE NANOPARTICLES; CARBON NANOTUBES; CROSS-LINKING; SCAFFOLDS;
   FIBERS; OIL; BIOMATERIAL; CHROMIUM; DELIVERY; WASTE
AB Three-dimensional, functional, and porous scaffolds can find applications in a variety of fields. Here we report the synthesis of hierarchical and interconnected porous sponges using a simple freeze-drying technique, employing collagen extracted from animal skin wastes and superparamagnetic iron oxide nanoparticles. The ultralightweight, high-surface-area sponges exhibit excellent mechanical stability and enhanced absorption of organic contaminants such as oils and dye molecules. Additionally, these biocomposite sponges display significant cellular biocompatibility, which opens new prospects in biomedical uses. The approach highlights innovative ways of transforming biowastes into advanced hybrid materials using simple and scalable synthesis techniques.
C1 [Ashokkumar, Meiyazhagan; Chipara, Alin Cristian; Anumary, Ayyappan; Sruthi, Radhakrishnan; Vajtai, Robert; Ajayan, Pulickel M.] Rice Univ, Dept Mat Sci & NanoEngn, Houston, TX 77005 USA.
   [Narayanan, Narayanan Tharangattu] Ctr Interdisciplinary Sci TCIS, Tata Inst Fundamental Res, Hyderabad 500075, Andhra Pradesh, India.
   [Anumary, Ayyappan; Thanikaivelan, Palanisamy] CSIR, Adv Mat Lab, Ctr Leather Apparel & Accessories Dev CLAD, Cent Leather Res Inst, Chennai 600020, Tamil Nadu, India.
   [Mani, Sendurai A.] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA.
RP Ashokkumar, M; Ajayan, PM (reprint author), Rice Univ, Dept Mat Sci & NanoEngn, Houston, TX 77005 USA.
EM ma37@rice.edu; ajayan@rice.edu
RI Mani, Sendurai/A-7244-2009
OI Mani, Sendurai/0000-0002-5918-4276; Meiyazhagan,
   AshokKumar/0000-0002-9765-4347
FU USIEF, India; Air Force Office of Scientific Research [AFOSR
   FA9550-13-1-0084]; Fred L. Hartley Family Foundation; CSIR, India under
   ZERIS Project [CSC0103]
FX M.A. thanks USIEF, India for the Fulbright-Doctoral and Professional
   Research (DPR) Fellowship, Air Force Office of Scientific Research,
   (Grant No. AFOSR FA9550-13-1-0084), and Fred L. Hartley Family
   Foundation for financial assistance. P.T. is grateful for financial
   support from CSIR, India under ZERIS Project (CSC0103).
CR Alliraja C, 2015, RSC ADV, V5, P20939, DOI 10.1039/c4ra16181e
   Anderson ML, 2003, NANO LETT, V3, P1321, DOI 10.1021/nl034543t
   Anumary A, 2013, SOFT MATER, V11, P181, DOI 10.1080/1539445X.2012.617634
   Ashokkumar M, 2012, CARBON, V50, P5574, DOI 10.1016/j.carbon.2012.08.006
   Chen GP, 2000, ADV MATER, V12, P455, DOI 10.1002/(SICI)1521-4095(200003)12:6<455::AID-ADMA455>3.0.CO;2-C
   Choi SJ, 2011, ACS APPL MATER INTER, V3, P4552, DOI 10.1021/am201352w
   Covington AD, 1997, CHEM SOC REV, V26, P111, DOI 10.1039/cs9972600111
   DAMINK LHHO, 1995, J BIOMED MATER RES, V29, P149, DOI 10.1002/jbm.820290203
   Deng DH, 2008, LANGMUIR, V24, P368, DOI 10.1021/la702831m
   Faivre D, 2010, NAT NANOTECHNOL, V5, P562, DOI 10.1038/nnano.2010.159
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Gelinsky M, 2008, CHEM ENG J, V137, P84, DOI 10.1016/j.cej.2007.09.029
   Gough JE, 2002, J BIOMED MATER RES, V61, P121, DOI 10.1002/jbm.10145
   Gui XC, 2010, ADV MATER, V22, P617, DOI 10.1002/adma.200902986
   Hirata E, 2009, J BIOMED MATER RES B, V90B, P629, DOI 10.1002/jbm.b.31327
   Hofmann S, 2007, BIOMATERIALS, V28, P1152, DOI 10.1016/j.biomaterials.2006.10.019
   Kinneberg K. R. C., 2011, THESIS
   LAKES R, 1993, NATURE, V361, P511, DOI 10.1038/361511a0
   Laurent S, 2014, EXPERT OPIN DRUG DEL, V11, P1449, DOI 10.1517/17425247.2014.924501
   Lee CK, 2009, ANGEW CHEM INT EDIT, V48, P5116, DOI 10.1002/anie.200804788
   Lee SB, 2004, BIOMATERIALS, V25, P2309, DOI 10.1016/j.biomaterials.2003.09.016
   Meiyazhagan A, 2015, MATER CHEM PHYS, V157, P8, DOI 10.1016/j.matchemphys.2015.03.005
   Moura FCC, 2009, APPL CATAL B-ENVIRON, V90, P436, DOI 10.1016/j.apcatb.2009.04.003
   Munster S, 2013, P NATL ACAD SCI USA, V110, P12197, DOI 10.1073/pnas.1222787110
   Munoz JA, 2002, ENVIRON SCI TECHNOL, V36, P3405, DOI 10.1021/es020017c
   Narayanan TN, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/5/055607
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   PETITE H, 1990, J BIOMED MATER RES, V24, P179, DOI 10.1002/jbm.820240205
   Ramay HR, 2003, BIOMATERIALS, V24, P3293, DOI 10.1016/S0142-9612(03)00171-6
   Shakespeare P, 2001, BURNS, V27, P517, DOI 10.1016/S0305-4179(01)00017-1
   Sheu MT, 2001, BIOMATERIALS, V22, P1713, DOI 10.1016/S0142-9612(00)00315-X
   Shi B., 2000, PLANT POLYPHENOLS, P73
   Sreeram KJ, 2003, RESOUR CONSERV RECY, V38, P185, DOI 10.1016/S0921-3449(02)00151-9
   Svagan AJ, 2008, ADV MATER, V20, P1263, DOI 10.1002/adma.200701215
   Thanikaivelan P, 2012, SCI REP-UK, V2, DOI 10.1038/srep00230
   Usha R, 2000, THERMOCHIM ACTA, V356, P59, DOI 10.1016/S0040-6031(00)00518-9
   Wang S, 2011, J MATER SCI-MATER M, V22, P1195, DOI 10.1007/s10856-011-4297-4
   WEADOCK KS, 1995, J BIOMED MATER RES, V29, P1373, DOI 10.1002/jbm.820291108
   Yannas I., 1995, ELECT ENG HDB, P1619
NR 40
TC 7
Z9 7
U1 1
U2 33
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD JUN 15
PY 2016
VL 8
IS 23
BP 14836
EP 14844
DI 10.1021/acsami.6b04582
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA DP0QT
UT WOS:000378195000065
PM 27219483
DA 2018-10-20
ER

PT J
AU Stipniece, L
   Salma-Ancane, K
   Rjabovs, V
   Juhnevica, I
   Turks, M
   Narkevica, I
   Berzina-Cimdina, L
AF Stipniece, Liga
   Salma-Ancane, Kristine
   Rjabovs, Vitalijs
   Juhnevica, Inna
   Turks, Maris
   Narkevica, Inga
   Berzina-Cimdina, Liga
TI Development of functionalized hydroxyapatiteipoly(vinyl alcohol)
   composites
SO JOURNAL OF CRYSTAL GROWTH
LA English
DT Article
DE Microgranules; In situ synthesis; Spray drying; Hydroxyapatite;
   Poly(vinyl alcohol)
ID POLY(VINYL ALCOHOL); CELLULOSE NANOCRYSTALS; BIOCOMPOSITE SCAFFOLDS;
   MECHANICAL-PROPERTIES; POLYVINYL-ALCOHOL; DRUG-DELIVERY; BIOMATERIAL;
   TEMPERATURE; HYDROGEL; ACID
AB Based on the well-known pharmaceutical excipient potential of poly(vinyl alcohol) (PVA) and clinical success of hydroxyapatite (HAp), the objective of this work was to fabricate functionalized composite microgranules. PVA was modified with succinic anhydride to introduce carboxyl groups (-COOH), respectively, by reaction between the-OH groups of PVA and succinic anhydride, for attachment of drug molecules. For the first time, the functionalized composite microgranules containing HAp/PVA in the ratio of 1:1 were prepared through in situ precipitation of HAp in modified PVA aqueous solutions followed by spray drying of obtained suspensions. The microgranules were characterized by Fourier transform infrared spectroscopy (FT-IR), X-ray diffraction (XRD), field emission scanning electron microscopy (FE-SEM), and differential scanning calorimetry (DSC). The presence of -COOH groups was verified by FT-IR, and the amount of functional groups added to PVA molecules (averaging 15 mol%) was determined by nuclear magnetic resonance spectroscopy (NMR). DSC results showed that modification with -COOH groups slightly decreased the thermal stability of PVA. FT-IR and XRD analysis confirmed that the resulting composites contain mainly nanocrystalline HAp and PVA. Moreover, the images taken by FE-SEM revealed that the microgranules consisted of nanosized HAp crystallites homogenously embedded in the PVA matrix. DSC measurements indicated that decomposition mechanism of the HAp/PVA differs from that of pure PVA and occurs at lower temperatures. However, the presence of HAp had minor influence on the thermal decomposition of the PVA modified with succinic anhydride. The investigation of composite microgranules confirmed interaction and integration between the HAp and PVA. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Stipniece, Liga; Salma-Ancane, Kristine; Narkevica, Inga; Berzina-Cimdina, Liga] Riga Tech Univ, Inst Gen Chem Engn, Fac Mat Sci & Appl Chem, Rudolfs Cimdins Riga Biomat Innovat & Dev Ctr RTU, Pulka 3, LV-1007 Riga, Latvia.
   [Rjabovs, Vitalijs; Turks, Maris] Riga Tech Univ, Inst Technol Organ Chem, Fac Mat Sci & Appl Chem, Paula Valdena 3-7, LV-1048 Riga, Latvia.
   [Juhnevica, Inna] Riga Tech Univ, Fac Mat Sci & Appl Chem, Inst Silicate Mat, Paula Valdena 3-7, LV-1048 Riga, Latvia.
RP Stipniece, L (reprint author), Riga Tech Univ, Inst Gen Chem Engn, Fac Mat Sci & Appl Chem, Rudolfs Cimdins Riga Biomat Innovat & Dev Ctr RTU, Pulka 3, LV-1007 Riga, Latvia.
EM liga.stipniece@rtu.lv
OI Rjabovs, Vitalijs/0000-0003-4302-7804; Stipniece,
   Liga/0000-0001-5472-7684
FU European Social Fund within the project "Involvement of new scientist
   group for synergistic investigation to development of nanostructured
   composite materials for bone tissue regeneration"
   [2013/0007/1DP/1.1.1.2.0/13/APIA/VIAA/024]
FX This work has been supported by European Social Fund within the project
   "Involvement of new scientist group for synergistic investigation to
   development of nanostructured composite materials for bone tissue
   regeneration" No. 2013/0007/1DP/1.1.1.2.0/13/APIA/VIAA/024.
CR Abal-hay A., 2014, CERAM INT, V40, P4995
   Alves MH, 2011, MACROMOL BIOSCI, V11, P1293, DOI 10.1002/mabi.201100145
   Baker MI, 2012, J BIOMED MATER RES B, V100B, P1451, DOI 10.1002/jbm.b.32694
   Balgova Z, 2013, CENT EUR J CHEM, V11, P1403, DOI 10.2478/s11532-013-0283-7
   Cai X, 2009, ACTA BIOMATER, V5, P2693, DOI 10.1016/j.actbio.2009.03.005
   Cannan RK, 1938, J AM CHEM SOC, V60, P2314, DOI 10.1021/ja01277a012
   Chua CK, 2004, J MATER SCI-MATER M, V15, P1113, DOI 10.1023/B:JMSM.0000046393.81449.a5
   Chung YS, 2007, J APPL POLYM SCI, V104, P3240, DOI 10.1002/app.25949
   Costa Vilma Conceição, 2007, Mat. Res., V10, P21, DOI 10.1590/S1516-14392007000100006
   Dhandayuthapani B, 2011, INT J POLYM SCI, DOI 10.1155/2011/290602
   Dinga B., 2005, POLYMER, V45, P1895
   Drouet C, 2013, BIOMED RES INT, DOI 10.1155/2013/490946
   DUNCAN R, 1994, CLIN PHARMACOKINET, V27, P290, DOI 10.2165/00003088-199427040-00004
   Fundueanu G, 2010, ACTA BIOMATER, V6, P3899, DOI 10.1016/j.actbio.2010.04.026
   Goldberg M, 2007, J BIOMAT SCI-POLYM E, V18, P241, DOI 10.1163/156856207779996931
   Guirguis OW, 2012, NAT SCI, V4, P57, DOI DOI 10.4236/NS.2012.41009
   Han XZ, 2009, DESALINATION, V240, P21, DOI 10.1016/j.desal.2008.01.047
   Hayami T, 2007, MATER LETT, V61, P2667, DOI 10.1016/j.matlet.2006.10.019
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Iqbal N, 2012, CURR APPL PHYS, V12, P755, DOI 10.1016/j.cap.2011.11.003
   Kumar A, 2014, CELLULOSE, V21, P3409, DOI 10.1007/s10570-014-0339-7
   Kumar A, 2014, MATER LETT, V129, P61, DOI 10.1016/j.matlet.2014.05.038
   Lin XY, 2004, MATER LETT, V58, P3569, DOI 10.1016/j.matlet.2004.06.044
   Mansur HS, 2008, MAT SCI ENG C-BIO S, V28, P539, DOI 10.1016/j.msec.2007.10.088
   Pan YS, 2009, WEAR, V266, P699, DOI 10.1016/j.wear.2008.08.012
   Parrish B, 2005, J AM CHEM SOC, V127, P7404, DOI 10.1021/ja050310n
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Raj M. Sundar, 2013, INDIAN J SCI TECH S5, V6, pS4653
   Roche KJ, 2015, J CRYST GROWTH, V409, P80, DOI 10.1016/j.jcrysgro.2014.10.002
   Sadjadi MS, 2010, MATER CHEM PHYS, V124, P217, DOI 10.1016/j.matchemphys.2010.06.022
   Sanchez-Chaves M, 1998, POLYMER, V39, P2751, DOI 10.1016/S0032-3861(97)00601-0
   Singh A, 2012, B MATER SCI, V35, P1031, DOI 10.1007/s12034-012-0384-5
   Stipniece L, 2014, CERAM INT, V40, P3261, DOI 10.1016/j.ceramint.2013.09.110
   Tang CY, 2009, CERAM INT, V35, P2171, DOI 10.1016/j.ceramint.2008.11.028
   Tsetsekou A, 2014, MAT SCI ENG C-MATER, V43, P555, DOI 10.1016/j.msec.2014.07.011
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Zhou ZF, 2007, J APPL POLYM SCI, V103, P848, DOI 10.1002/app.25190
NR 37
TC 5
Z9 5
U1 6
U2 50
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-0248
EI 1873-5002
J9 J CRYST GROWTH
JI J. Cryst. Growth
PD JUN 15
PY 2016
VL 444
BP 14
EP 20
DI 10.1016/j.jcrysgro.2016.03.029
PG 7
WC Crystallography; Materials Science, Multidisciplinary; Physics, Applied
SC Crystallography; Materials Science; Physics
GA DM6EO
UT WOS:000376443600003
DA 2018-10-20
ER

PT J
AU Castano, IM
   Curtin, CM
   Duffy, GP
   O'Brien, FJ
AF Castano, Irene Mencia
   Curtin, Caroline M.
   Duffy, Garry P.
   O'Brien, Fergal J.
TI Next generation bone tissue engineering: non-viral miR-133a inhibition
   using collagen-nanohydroxyapatite scaffolds rapidly enhances
   osteogenesis
SO SCIENTIFIC REPORTS
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; OSTEOBLAST DIFFERENTIATION; POSITIVE REGULATION;
   ADIPOSE-TISSUE; DELIVERY; REGENERATION; TRANSFECTION; DEFECTS; MIRNAS;
   REPAIR
AB Bone grafts are the second most transplanted materials worldwide at a global cost to healthcare systems valued over $30 billion every year. The influence of microRNAs in the regenerative capacity of stem cells offers vast therapeutic potential towards bone grafting; however their efficient delivery to the target site remains a major challenge. This study describes how the functionalisation of porous collagen-nanohydroxyapatite (nHA) scaffolds with miR-133a inhibiting complexes, delivered using non-viral nHA particles, enhanced human mesenchymal stem cell-mediated osteogenesis through the novel focus on a key activator of osteogenesis, Runx2. This study showed enhanced Runx2 and osteocalcin expression, as well as increased alkaline phosphatase activity and calcium deposition, thus demonstrating a further enhanced therapeutic potential of a biomaterial previously optimised for bone repair applications. The promising features of this platform offer potential for a myriad of applications beyond bone repair and tissue engineering, thus presenting a new paradigm for microRNA-based therapeutics.
C1 [Castano, Irene Mencia; Curtin, Caroline M.; Duffy, Garry P.; O'Brien, Fergal J.] RCSI, Dept Anat, Tissue Engn Res Grp, 123 St Stephens Green, Dublin 2, Ireland.
   [Castano, Irene Mencia; Curtin, Caroline M.; Duffy, Garry P.; O'Brien, Fergal J.] Coll Green, TCD, Trinity Ctr Bioengn, Dublin 2, Ireland.
   [Castano, Irene Mencia; Curtin, Caroline M.; Duffy, Garry P.; O'Brien, Fergal J.] RCSI, Adv Mat & Bioengn Res AMBER Ctr, Dublin 2, Ireland.
   [Castano, Irene Mencia; Curtin, Caroline M.; Duffy, Garry P.; O'Brien, Fergal J.] TCD, Dublin 2, Ireland.
RP O'Brien, FJ (reprint author), RCSI, Dept Anat, Tissue Engn Res Grp, 123 St Stephens Green, Dublin 2, Ireland.; O'Brien, FJ (reprint author), Coll Green, TCD, Trinity Ctr Bioengn, Dublin 2, Ireland.; O'Brien, FJ (reprint author), RCSI, Adv Mat & Bioengn Res AMBER Ctr, Dublin 2, Ireland.; O'Brien, FJ (reprint author), TCD, Dublin 2, Ireland.
EM fjobrien@rcsi.ie
RI O'Brien, Fergal/F-9485-2011
OI O'Brien, Fergal/0000-0003-2030-8005; Duffy, Garry/0000-0002-4994-9511
FU BioAT; European Regional Development Fund (ERDF); European Union
   Structural Funds Programme; European Research Council (ERC) Grant
   [239685]
FX This work was supported by the BioAT funding bodies PRTL (Programme for
   Research in Third Level Institutions) Cycle 5 and European Regional
   Development Fund (ERDF), part of the European Union Structural Funds
   Programme 2007-2013. Support funding also included the European Research
   Council (ERC) Grant Agreement no. 239685. The authors are thankful to
   Integra LifeSciences Corporation for providing the collagen for the
   scaffold synthesis, Ms. Georgina Shaw and Dr. J. Mary Murphy at NUI
   Galway for kindly providing hMSCs.
CR Beavers KR, 2015, ADV DRUG DELIVER REV, V88, P123, DOI 10.1016/j.addr.2014.12.006
   Castano IM, 2015, J CONTROL RELEASE, V200, P42, DOI 10.1016/j.jconrel.2014.12.034
   Clark EA, 2014, STEM CELLS, V32, P1074, DOI 10.1002/stem.1623
   Cunniffe GM, 2010, J BIOMED MATER RES A, V95A, P1142, DOI 10.1002/jbm.a.32931
   Cunniffe GM, 2010, J MATER SCI-MATER M, V21, P2293, DOI 10.1007/s10856-009-3964-1
   Curtin CM, 2015, ADV HEALTHC MATER, V4, P223, DOI 10.1002/adhm.201400397
   Curtin CM, 2012, ADV MATER, V24, P749, DOI 10.1002/adma.201103828
   Deng Y, 2014, EUR CELLS MATER, V27, P13, DOI 10.22203/eCM.v027a02
   Deng Y, 2013, BIOMATERIALS, V34, P6717, DOI 10.1016/j.biomaterials.2013.05.042
   Duffy GP, 2009, TISSUE ENG PT A, V15, P2459, DOI [10.1089/ten.tea.2008.0341, 10.1089/ten.TEA.2008.0341]
   Elmore J. C., 2010, MARKET TECHNOLOGY RE
   Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455
   Gleeson JP, 2010, EUR CELLS MATER, V20, P218
   Gordeladze JO, 2010, ILAR J, V51, P42, DOI 10.1093/ilar.51.1.42
   Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267
   Hassan MQ, 2012, J BIOL CHEM, V287, P42084, DOI 10.1074/jbc.M112.377515
   Hu R, 2010, EXPERT OPIN THER TAR, V14, P1109, DOI 10.1517/14728222.2010.512916
   James EN, 2014, ACTA BIOMATER, V10, P3571, DOI 10.1016/j.actbio.2014.04.026
   Jensen ED, 2010, BIOFACTORS, V36, P25, DOI 10.1002/biof.72
   Kim KM, 2014, CURR OPIN PHARMACOL, V16, P133, DOI 10.1016/j.coph.2014.05.001
   Kim YJ, 2009, J BONE MINER RES, V24, P816, DOI 10.1359/JBMR.081230
   Kwong FNK, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2436
   Li H, 2009, J CLIN INVEST, V119, P3666, DOI 10.1172/JCI39832
   Li JG, 2014, ADV MATER, V26, P8217, DOI 10.1002/adma.201403877
   Li Y, 2013, BIOMATERIALS, V34, P5048, DOI 10.1016/j.biomaterials.2013.03.052
   Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105
   Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200
   Liao XB, 2013, ENDOCRINOLOGY, V154, P3344, DOI 10.1210/en.2012-2236
   Liao YH, 2014, BIOMATERIALS, V35, P4901, DOI 10.1016/j.biomaterials.2014.02.055
   Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315
   Mariner P. D., 2011, J TISSUE ENG REGEN M, V6, P314
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Nguyen MK, 2014, BIOMATERIALS, V35, P6278, DOI 10.1016/j.biomaterials.2014.04.048
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   Pedraza CE, 2008, BIOMATERIALS, V29, P3384, DOI 10.1016/j.biomaterials.2008.04.043
   Qureshi AT, 2013, BIOMATERIALS, V34, P7799, DOI 10.1016/j.biomaterials.2013.07.004
   Raftery RM, 2016, ADV MATER, V28, P5447, DOI 10.1002/adma.201505088
   Schoolmeesters A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005605
   Sriram M, 2015, INT J BIOL MACROMOL, V74, P404, DOI 10.1016/j.ijbiomac.2014.12.034
   Tierney E. G., 2011, J CONTROL RELEASE, V158, P304
   Wu KM, 2013, ACS APPL MATER INTER, V5, P2733, DOI 10.1021/am400374c
   Yang XC, 2008, TISSUE ENG PT A, V14, P71, DOI 10.1089/ten.a.2007.0102
NR 42
TC 17
Z9 18
U1 3
U2 18
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUN 14
PY 2016
VL 6
AR 27941
DI 10.1038/srep27941
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DO5NM
UT WOS:000377829800001
PM 27297802
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Vishali, S
   Rashmi, P
   Karthikeyan, R
AF Vishali, S.
   Rashmi, P.
   Karthikeyan, R.
TI Evaluation of wasted biomaterial, crab shells (Portunus sanguinolentus),
   as a coagulant, in paint effluent treatment
SO DESALINATION AND WATER TREATMENT
LA English
DT Article
DE Portunus sanguinolentus; Crab shell; Paint effluent; Coagulation; Eluate
ID ELECTROCHEMICAL TREATMENT; INDUSTRIAL EFFLUENTS; AQUEOUS-SOLUTIONS;
   WATER; CHITOSAN; BIOSORPTION; REMOVAL; PARTICLES; ALUMINUM; CHITIN
AB The ability of the wasted biomaterial crab shells, Portunus sanguinolentus, as a coagulant, in the treatment of simulated water-based paint industry effluent was evaluated. The treatment process was conducted in conventional jar test. The FTIR spectrum values endorse the existence of chitosan in P. sanguinolentus. The leverage of variables such as time (min), eluent type (deionized water, NaCl, and BaCl2), eluent concentration (1-5N), coagulant dose (1-6g), coagulant volume (20-100mL), initial pH (5-10), and initial concentration (3,100, 4,224, 5,650, 6,258, and 7,693mg/L named as sample number 1-5, respectively) were investigated in terms of color, chemical oxygen demand, and turbidity. The optimized value of the above-mentioned variables were examined and the values are 20min of slow mixing, 15min of settling course, 3N NaCl as an eluent, and 100mL of 3g crab shells eluate to treat 1L of effluent under basic pH. The maximum removal efficiency was identified for higher initial concentration effluent, sample 5. The results were compared with conventional coagulant alum and ferric chloride from previous studies. The wasted biomaterial crab shells could act as propitious surrogate for conventional coagulants.
C1 [Vishali, S.; Rashmi, P.] SRM Univ, Dept Chem Engn, Madras 603203, Tamil Nadu, India.
   [Karthikeyan, R.] AAMEC, Kovilvenni 614403, Thanjavur, India.
RP Vishali, S (reprint author), SRM Univ, Dept Chem Engn, Madras 603203, Tamil Nadu, India.
EM meet.vishali@gmail.com; rashmi_p30@yahoo.com; drrkarthi@yahoo.com
CR Ahmad AL, 2011, CHEM ENG J, V173, P879, DOI 10.1016/j.cej.2011.07.070
   Ahmad A. L., 2006, CHEM ENG J, P9
   Akyol A, 2012, DESALINATION, V285, P91, DOI 10.1016/j.desal.2011.09.039
   APHA, 1995, STAND METH EX WAST W
   Bolat Y, 2010, PAK VET J, V30, P227
   Brugnerotto J, 2001, POLYMER, V42, P3569, DOI 10.1016/S0032-3861(00)00713-8
   Chi FH, 2006, J POLYM ENVIRON, V14, P411, DOI 10.1007/s10924-006-0027-2
   Dahiya S, 2008, BIORESOURCE TECHNOL, V99, P179, DOI 10.1016/j.biortech.2006.11.011
   Flaten TP, 2001, BRAIN RES BULL, V55, P187, DOI 10.1016/S0361-9230(01)00459-2
   George T. S., 2011, WORLD J SCI TECHNOL, V1, P3
   Korbahti BK, 2007, J HAZARD MATER, V148, P83, DOI 10.1016/j.jhazmat.2007.02.005
   Korbahti BK, 2009, CHEM ENG J, V148, P444, DOI 10.1016/j.cej.2008.09.019
   Kumar R, 2013, CHEM ENG J, V226, P377, DOI 10.1016/j.cej.2013.04.063
   Meyssami B, 2005, BIORESOURCE TECHNOL, V96, P303, DOI 10.1016/j.biortech.2004.04.014
   Palpandi C., 2009, INT J MED MED SCI, V5, P198
   Patel H, 2012, J SAUDI CHEM SOC, V16, P131, DOI 10.1016/j.jscs.2010.12.003
   Rizzo L, 2008, SEP PURIF TECHNOL, V62, P79, DOI 10.1016/j.seppur.2007.12.020
   Sciban M. B., 2006, APTEFF, V37, P1
   Sciban M, 2009, BIORESOURCE TECHNOL, V100, P6639, DOI 10.1016/j.biortech.2009.06.047
   Shazly M. A. E. L., 2010, AM EURASIAN J AGR EN, V8, P597
   Shuguang L., 2007, J HAZARD MATER, V149, P208
   Verma AK, 2012, J ENVIRON MANAGE, V93, P154, DOI 10.1016/j.jenvman.2011.09.012
   Vijayaraghavan K, 2005, J HAZARD MATER, V119, P251, DOI 10.1016/j.jhazmat.2004.12.017
   Vijayaraghavan K, 2011, DESALINATION, V266, P195, DOI 10.1016/j.desal.2010.08.026
   Vijayaraghavan K, 2010, CHEM ENG J, V163, P337, DOI 10.1016/j.cej.2010.08.012
   Vishali S, 2014, SEP SCI TECHNOL, V49, P2510, DOI 10.1080/01496395.2014.931098
   Vishali S., 2014, DESALIN WATER TREAT, DOI [10.1080/19443994.2014.945487, DOI 10.1080/19443994.2014.945487]
   Yin CY, 2010, PROCESS BIOCHEM, V45, P1437, DOI 10.1016/j.procbio.2010.05.030
   Zemmouri H, 2012, PROCEDIA ENGINEER, V33, P254, DOI 10.1016/j.proeng.2012.01.1202
NR 29
TC 6
Z9 6
U1 0
U2 16
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1944-3994
EI 1944-3986
J9 DESALIN WATER TREAT
JI Desalin. Water Treat.
PD JUN 14
PY 2016
VL 57
IS 28
BP 13157
EP 13165
DI 10.1080/19443994.2015.1055812
PG 9
WC Engineering, Chemical; Water Resources
SC Engineering; Water Resources
GA DG1GH
UT WOS:000371813600025
DA 2018-10-20
ER

PT J
AU Izquierdo, J
   Gonzalez-Marrero, MB
   Bozorg, M
   Fernandez-Perez, BM
   Vasconcelos, HC
   Santana, JJ
   Souto, RM
AF Izquierdo, J.
   Gonzalez-Marrero, M. B.
   Bozorg, M.
   Fernandez-Perez, B. M.
   Vasconcelos, H. C.
   Santana, J. J.
   Souto, R. M.
TI Multiscale electrochemical analysis of the corrosion of titanium and
   nitinol for implant applications
SO ELECTROCHIMICA ACTA
LA English
DT Article
DE Ti alloys; corrosion resistance; passive layers; potentiodynamic
   polarization; scanning electrochemical microscopy; biomaterials
ID SIMULATED PHYSIOLOGICAL SOLUTIONS; SHAPE-MEMORY ALLOYS; BIOMEDICAL
   APPLICATIONS; PITTING CORROSION; METALLIC BIOMATERIALS; LOCALIZED
   CORROSION; HYDROGEN-PEROXIDE; CHLORIDE SOLUTION; PRECURSOR SITES; ZRTI
   ALLOYS
AB Surface electrochemical activity of titanium and nitinol biomaterials in naturally aerated Ringer's physiological solution was investigated using potentiodynamic polarization and scanning electrochemical microscopy (SECM) techniques. SECM was operated in feedback and redox competition modes as a function of potential applied to the substrate. The kinetics of the electron transfer rate on both materials was characterized by mathematical modelling of the Z-approach curves monitored under feedback conditions. The rate constant values greatly depended on the characteristics of the passive layers formed over the metals under potentiostatic control. A more insulating film was found on nitinol when biased at low polarizations, resulting in smaller tip current increments during tip approach to the investigated surface under positive feedback and competition operation modes. However, at higher anodic polarizations, nitinol passive layers experience breakdown, and therefore tip current values reflect the release of metal cations from the biomaterial surface. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Izquierdo, J.; Gonzalez-Marrero, M. B.; Bozorg, M.; Fernandez-Perez, B. M.; Souto, R. M.] Univ La Laguna, Dept Chem, POB 456, E-38200 Tenerife, Canary Islands, Spain.
   [Izquierdo, J.; Souto, R. M.] Univ La Laguna, Inst Mat Sci & Nanotechnol, POB 456, E-38200 Tenerife, Canary Islands, Spain.
   [Vasconcelos, H. C.] Azores Univ, Dept Technol Sci & Dev, P-9501801 Ponta Delgada, Sao Miguel, Portugal.
   [Santana, J. J.] Univ Las Palmas Gran Canaria, Dept Proc Engn, E-35017 Las Palmas Gran Canaria, Canary Islands, Spain.
RP Souto, RM (reprint author), Univ La Laguna, Dept Chem, POB 456, E-38200 Tenerife, Canary Islands, Spain.
EM rsouto@ull.es
RI Santana Rodriguez, Juan Jose/C-4040-2008
OI Santana Rodriguez, Juan Jose/0000-0002-3030-2195; /0000-0001-5935-870X;
   Izquierdo Perez, Javier/0000-0003-3287-9403; Souto, Ricardo
   M./0000-0001-9429-5513
FU Spanish Ministry of Economy and Competitiveness (MINECO, Madrid, Spain)
   [CTQ2012-36787]; European Regional Development Fund (Brussels, Belgium)
   [CTQ2012-36787]; Spanish Ministry of Education (Programa de Formacion de
   Personal Investigador, Madrid, Spain); Obra Social La Caixa - Fundacion
   Cajacanarias (Santa Cruz de Tenerife, Spain)
FX This work was supported by the Spanish Ministry of Economy and
   Competitiveness (MINECO, Madrid, Spain), jointly with the European
   Regional Development Fund (Brussels, Belgium), under Grant
   CTQ2012-36787. The award of Research Training Grants to J.I. by the
   Spanish Ministry of Education (Programa de Formacion de Personal
   Investigador, Madrid, Spain), and to B.M.F.-P. by Obra Social La Caixa -
   Fundacion Cajacanarias (Santa Cruz de Tenerife, Spain) are greatly
   acknowledged.
CR ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   Alkhateeb E, 2005, J BIOMED MATER RES A, V75A, P934, DOI 10.1002/jbm.a.30508
   Alves VA, 2009, CORROS SCI, V51, P2473, DOI 10.1016/j.corsci.2009.06.035
   Assis S.L.d., 2006, ELECTROCHIM ACTA, V51, P1815, DOI DOI 10.1016/J.ELECTACTA.2005.02.121
   Azumi K, 2001, CORROS SCI, V43, P533, DOI 10.1016/S0010-938X(00)00105-0
   Bard A. J, 2012, SCANNING ELECTROCHEM
   Bard A.J., 2001, ELECTROCHEMICAL METH
   BASAME SB, 1995, J PHYS CHEM-US, V99, P16430, DOI 10.1021/j100044a034
   Basame SB, 1998, J PHYS CHEM B, V102, P9812, DOI 10.1021/jp982088x
   Bolat G, 2013, ELECTROCHIM ACTA, V113, P470, DOI 10.1016/j.electacta.2013.09.116
   Bolat G, 2013, ELECTROCHIM ACTA, V88, P447, DOI 10.1016/j.electacta.2012.10.026
   Bolz A, 1996, TEX HEART I J, V23, P162
   Burstein GT, 2005, BIOMATERIALS, V26, P245, DOI 10.1016/j.biomaterials.2004.02.023
   Carroll WM, 2003, J BIOMED MATER RES A, V67A, P1123, DOI 10.1002/jbm.a.10099
   CASILLAS N, 1994, J ELECTROCHEM SOC, V141, P636, DOI 10.1149/1.2054783
   CASILLAS N, 1993, J ELECTROCHEM SOC, V140, pL142, DOI 10.1149/1.2220897
   Chan CW, 2012, CORROS SCI, V56, P158, DOI 10.1016/j.corsci.2011.11.020
   Chelariu R, 2014, ELECTROCHIM ACTA, V137, P280, DOI 10.1016/j.electacta.2014.06.021
   Cheng XL, 2005, BIOMATERIALS, V26, P7350, DOI 10.1016/j.biomaterials.2005.05.047
   Ciurescu G, 2012, INT J ELECTROCHEM SC, V7, P7404
   Cornut R, 2008, J ELECTROANAL CHEM, V621, P178, DOI 10.1016/j.jelechem.2007.09.021
   Es-Souni M, 2005, ANAL BIOANAL CHEM, V381, P557, DOI 10.1007/s00216-004-2888-3
   Fan F.-R. F., 2012, SCANNING ELECTROCHEM
   Garfias-Mesias LF, 1998, J ELECTROCHEM SOC, V145, P2005, DOI 10.1149/1.1838590
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Hallab NJ, 2003, J BIOMED MATER RES A, V65A, P311, DOI 10.1002/jbm.a.10429
   HOAR TP, 1966, PROC R SOC LON SER-A, V294, P486, DOI 10.1098/rspa.1966.0220
   Huang WM, 2013, ADV DRUG DELIVER REV, V65, P515, DOI 10.1016/j.addr.2012.06.004
   Izquierdo J, 2014, J ELECTROANAL CHEM, V728, P148, DOI 10.1016/j.jelechem.2014.06.009
   Izquierdo J, 2014, APPL SURF SCI, V313, P259, DOI 10.1016/j.apsusc.2014.05.201
   Izquierdo J, 2014, ELECTROCHIM ACTA, V134, P167, DOI 10.1016/j.electacta.2014.04.161
   Izquierdo J, 2012, PROG ORG COAT, V74, P526, DOI 10.1016/j.porgcoat.2012.01.019
   Izquierdo J, 2010, ELECTROCHIM ACTA, V55, P8791, DOI 10.1016/j.electacta.2010.08.020
   Lamaka S. V., 2010, MICROSCOPY SCI TECHN, V3, P2162
   Li YH, 2014, MATERIALS, V7, P1709, DOI 10.3390/ma7031709
   Maho A, 2014, ELECTROCHIM ACTA, V116, P78, DOI 10.1016/j.electacta.2013.11.008
   Mansfeld F., 1993, 26 SOL SCHLUMB, V4, P41
   Milosev I, 2012, MAT SCI ENG C-MATER, V32, P1068, DOI 10.1016/j.msec.2011.08.022
   Milosev I, 2012, MAT SCI ENG C-MATER, V32, P1087, DOI 10.1016/j.msec.2011.11.007
   Niinomi M, 2012, ACTA BIOMATER, V8, P3888, DOI 10.1016/j.actbio.2012.06.037
   Pan J, 1996, J BIOMED MATER RES, V30, P393
   PAN J, 1994, J BIOMED MATER RES, V28, P113, DOI 10.1002/jbm.820280115
   Pan J., 1996, THESIS ROYAL I TECHN
   Pourbaix M, 1966, ATLAS ELECTROCHEMICA
   Pust SE, 2007, J ELECTROCHEM SOC, V154, pC508, DOI 10.1149/1.2754080
   Pust SE, 2007, ADV MATER, V19, P878, DOI 10.1002/adma.200601446
   Rajan GP, 2005, J BIOMED MATER RES B, V72B, P305, DOI 10.1002/jbm.b.30165
   Rosalbino F, 2011, J MATER SCI-MATER M, V22, P1293, DOI 10.1007/s10856-011-4301-z
   Ruhlig D, 2008, ANALYST, V133, P1700, DOI 10.1039/b804718a
   Santana JJ, 2010, ELECTROCHIM ACTA, V55, P4488, DOI 10.1016/j.electacta.2010.02.091
   Schiff N, 2002, BIOMATERIALS, V23, P1995, DOI 10.1016/S0142-9612(01)00328-3
   Schulte A, 2004, MAT SCI ENG A-STRUCT, V378, P523, DOI 10.1016/j.msea.2003.10.354
   Schulte A., 2002, Materials Science Forum, V394-395, P145
   Shabalovskaya SA, 2009, BIOMATERIALS, V30, P3662, DOI 10.1016/j.biomaterials.2009.03.034
   Shih CC, 2005, J BIOMED MATER RES A, V74A, P325, DOI 10.1002/ibm.a.30255
   Wallinder D, 1999, CORROS SCI, V41, P275
   Wang BL, 2009, MATER CORROS, V60, P330, DOI 10.1002/maco.200805120
   Yang P, 2004, SURF COAT TECH, V177, P747, DOI 10.1016/j.surfcoat.2003.08.016
   Yeum B., 2001, ELECTROCHEMICAL IMPE
   Zhu RK, 2008, ANAL CHEM, V80, P1437, DOI 10.1021/ac701796u
   Zhu RK, 2007, CHEM MATER, V19, P2533, DOI 10.1021/cm070023d
NR 61
TC 5
Z9 5
U1 5
U2 33
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0013-4686
EI 1873-3859
J9 ELECTROCHIM ACTA
JI Electrochim. Acta
PD JUN 10
PY 2016
VL 203
BP 366
EP 378
DI 10.1016/j.electacta.2016.01.146
PG 13
WC Electrochemistry
SC Electrochemistry
GA DM1UV
UT WOS:000376133200041
DA 2018-10-20
ER

PT J
AU Oprych, KM
   Whitby, RLD
   Mikhalovsky, SV
   Tomlins, P
   Adu, J
AF Oprych, Karen M.
   Whitby, Raymond L. D.
   Mikhalovsky, Sergey V.
   Tomlins, Paul
   Adu, Jimi
TI Repairing Peripheral Nerves: Is there a Role for Carbon Nanotubes?
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
DE carbon nanotubes; nerve regeneration; nerve repair conduits; neurons;
   tissue scaffold
ID ELECTRICAL-STIMULATION PROMOTES; CONDUCTIVE POLYPYRROLE/CHITOSAN
   POLYMERS; ENHANCE NEURITE OUTGROWTH; ROOT GANGLIA NEURONS; NEURAL
   STEM-CELLS; IN-VITRO; AXON REGENERATION; NERVOUS-SYSTEM; SCIATIC-NERVE;
   GROWTH-FACTOR
AB Peripheral nerve injury continues to be a major global health problem that can result in debilitating neurological deficits and neuropathic pain. Current state-of-the-art treatment involves reforming the damaged nerve pathway using a nerve autograft. Engineered nerve repair conduits can provide an alternative to the nerve autograft avoiding the inevitable tissue damage caused at the graft donor site. Commercially available nerve repair conduits are currently only considered suitable for repairing small nerve lesions; the design and performance of engineered conduits requires significant improvements to enable their use for repairing larger nerve defects. Carbon nanotubes (CNTs) are an emerging novel material for biomedical applications currently being developed for a range of therapeutic technologies including scaffolds for engineering and interfacing with neurological tissues. CNTs possess a unique set of physicochemical properties that could be useful within nerve repair conduits. This progress report aims to evaluate and consolidate the current literature pertinent to CNTs as a biomaterial for supporting peripheral nerve regeneration. The report is presented in the context of the state-of-the-art in nerve repair conduit design; outlining how CNTs may enhance the performance of next generation peripheral nerve repair conduits.
C1 [Oprych, Karen M.] UCL, Inst Neurol, Dept Brain Repair & Rehabil, Queen Sq, London WC1N 3BG, England.
   [Whitby, Raymond L. D.; Mikhalovsky, Sergey V.] Nazarbayev Univ, Sch Engn, Astana 010000, Kazakhstan.
   [Mikhalovsky, Sergey V.; Adu, Jimi] Univ Brighton, Sch Pharm & Biomol Sci, Brighton BN2 4GJ, E Sussex, England.
RP Oprych, KM (reprint author), UCL, Inst Neurol, Dept Brain Repair & Rehabil, Queen Sq, London WC1N 3BG, England.; Adu, J (reprint author), Univ Brighton, Sch Pharm & Biomol Sci, Brighton BN2 4GJ, E Sussex, England.
EM k.gladwin@ucl.ac.uk; j.adu@brighton.ac.uk
FU University of Brighton; National Physical Laboratory; Engineering and
   Physical Sciences Research Council [GR/T18387/01]; University College
   London/University College London Hospitals Biomedical Research Center -
   National Institute for Health Research
FX This work was supported by funds from the following organizations:
   University of Brighton, the National Physical Laboratory, Engineering
   and Physical Sciences Research Council (GR/T18387/01) and University
   College London/University College London Hospitals Biomedical Research
   Center which receives funding from the National Institute for Health
   Research.
CR Abu-Rub MT, 2011, SOFT MATTER, V7, P2770, DOI 10.1039/c0sm01062f
   Agarwal S, 2010, LANGMUIR, V26, P2244, DOI 10.1021/la9048743
   Ahn HS, 2015, ACTA BIOMATER, V13, P324, DOI 10.1016/j.actbio.2014.11.026
   Al-Jamal KT, 2011, P NATL ACAD SCI USA, V108, P10952, DOI 10.1073/pnas.1100930108
   Al-Majed AA, 2004, CELL MOL NEUROBIOL, V24, P379, DOI 10.1023/B:CEMN.0000022770.66463.f7
   Al-Majed AA, 2000, J NEUROSCI, V20, P2602
   Anava S, 2009, BIOPHYS J, V96, P1661, DOI 10.1016/j.bpj.2008.10.058
   Arslantunali D, 2014, J BIOMED MATER RES A, V102, P828, DOI 10.1002/jbm.a.34727
   Arthur-Farraj PJ, 2012, NEURON, V75, P633, DOI 10.1016/j.neuron.2012.06.021
   Ayutsede J, 2006, BIOMACROMOLECULES, V7, P208, DOI 10.1021/bm0505888
   Bardi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080964
   Bareket-Keren Lilach, 2012, Front Neural Circuits, V6, P122, DOI 10.3389/fncir.2012.00122
   Beduer A, 2012, LANGMUIR, V28, P17363, DOI 10.1021/la304278n
   Bell JHA, 2012, TISSUE ENG PART B-RE, V18, P116, DOI [10.1089/ten.teb.2011.0498, 10.1089/ten.TEB.2011.0498]
   Belyanskaya L, 2009, NEUROTOXICOLOGY, V30, P702, DOI 10.1016/j.neuro.2009.05.005
   Bhattacharyya S, 2008, BIOMACROMOLECULES, V9, P505, DOI 10.1021/bm7009976
   Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400
   Borgens RB, 1999, J NEUROTRAUM, V16, P639, DOI 10.1089/neu.1999.16.639
   Borgens RB, 1999, NEUROSCIENCE, V91, P251, DOI 10.1016/S0306-4522(98)00584-3
   Bremus-Koebberling EA, 2012, J LASER APPL, V24, DOI 10.2351/1.4730804
   Brooks DN, 2012, MICROSURG, V32, P1, DOI 10.1002/micr.20975
   Brushart T.M., 2011, NERVE REPAIR
   Cai D, 2005, NAT METHODS, V2, P449, DOI 10.1038/NMETH761
   CARBONETTO S, 1987, J NEUROSCI, V7, P610
   Chae SY, 2003, CHEM MATER, V15, P3326, DOI 10.1021/cm030171d
   Chao T, 2013, ANN NEUROL, V73, P210, DOI 10.1002/ana.23781
   Chen MB, 2006, ANN PLAS SURG, V57, P462, DOI 10.1097/01.sap.0000237577.07219.b6
   Chen YS, 2011, BIOMEDICINE-TAIWAN, V1, P33, DOI 10.1016/j.biomed.2011.10.006
   Chen YY, 2005, J NEUROPATH EXP NEUR, V64, P613, DOI 10.1097/01.jnen.0000171650.94341.46
   Chew SY, 2007, ADV FUNCT MATER, V17, P1288, DOI 10.1002/adfm.200600441
   Cho YN, 2010, J BIOMED MATER RES A, V95A, P510, DOI 10.1002/jbm.a.32841
   Collins PC, 2001, SCIENCE, V292, P706, DOI 10.1126/science.1058782
   Corey JM, 2007, J BIOMED MATER RES A, V83A, P636, DOI 10.1002/jbm.a.31285
   de Winter F, 2013, EUR J PHARMACOL, V719, P145, DOI 10.1016/j.ejphar.2013.04.057
   Deister C, 2007, J BIOMAT SCI-POLYM E, V18, P983, DOI 10.1163/156856207781494377
   Edwards SL, 2009, BIOMATERIALS, V30, P1725, DOI 10.1016/j.biomaterials.2008.12.031
   Eggers R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071076
   English AW, 2007, DEV NEUROBIOL, V67, P158, DOI 10.1002/neu.20339
   Esawi AMK, 2007, MATER DESIGN, V28, P2394, DOI 10.1016/j.matdes.2006.09.022
   Fan L, 2012, NANO LETT, V12, P3668, DOI 10.1021/nl301428w
   FORDHOLEVINSKI T, 1986, DEV BRAIN RES, V28, P121, DOI 10.1016/0165-3806(86)90071-4
   Gabay T, 2005, PHYSICA A, V350, P611, DOI 10.1016/j.physa.2004.11.007
   Gaillard C, 2011, J PEPT SCI, V17, P139, DOI 10.1002/psc.1290
   Galvan-Garcia P, 2007, J BIOMAT SCI-POLYM E, V18, P1245, DOI 10.1163/156856207782177891
   Gattazzo F., 2014, J BIOMED MAT RES B
   Georgiou M, 2013, BIOMATERIALS, V34, P7335, DOI 10.1016/j.biomaterials.2013.06.025
   Ghasemi-Mobarakeh L, 2011, J TISSUE ENG REGEN M, V5, pE17, DOI 10.1002/term.383
   Gheith MK, 2006, ADV MATER, V18, P2975, DOI 10.1002/adma.200600878
   Gheith MK, 2005, ADV MATER, V17, P2663, DOI 10.1002/adma.200500366
   GhoshMitra S, 2012, ADV DRUG DELIVER REV, V64, P110, DOI 10.1016/j.addr.2011.12.013
   Gladwin KM, 2013, ADV HEALTHC MATER, V2, P728, DOI 10.1002/adhm.201200233
   Gordon T, 2008, NEUROL RES, V30, P1012, DOI 10.1179/174313208X362488
   Gordon T, 2010, EXP NEUROL, V223, P192, DOI 10.1016/j.expneurol.2009.09.020
   Haastert K, 2006, NEUROBIOL DIS, V21, P138, DOI 10.1016/j.nbd.2005.06.020
   Haastert-Talini K., 2011, NEUROTRAUMA, V28, P661
   Hall S, 2005, J BONE JOINT SURG BR, V87B, P1309, DOI 10.1302/0301-620X.87B10.16700
   Hanein Y, 2010, PHYS STATUS SOLIDI B, V247, P2635, DOI 10.1002/pssb.201000109
   Heath CA, 1998, TRENDS BIOTECHNOL, V16, P163, DOI 10.1016/S0167-7799(97)01165-7
   Heister E, 2009, CARBON, V47, P2152, DOI 10.1016/j.carbon.2009.03.057
   Hoffman-Kim D, 2010, ANNU REV BIOMED ENG, V12, P203, DOI 10.1146/annurev-bioeng-070909-105351
   Hrkach J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003651
   Hu H, 2004, NANO LETT, V4, P507, DOI 10.1021/nl035193d
   Hu H, 2005, J PHYS CHEM B, V109, P4285, DOI 10.1021/jp0441137
   Huang JH, 2010, J BIOMED MATER RES A, V93A, P164, DOI 10.1002/jbm.a.32511
   Huang YC, 2011, J BIOMED MATER RES A, V99A, P86, DOI 10.1002/jbm.a.33164
   Huang YJ, 2012, SMALL, V8, P2869, DOI 10.1002/smll.201200715
   Hwang JY, 2013, NANOSCALE, V5, P487, DOI 10.1039/c2nr31581e
   Jang MJ, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/23/235102
   Jiang X, 2010, EXP NEUROL, V223, P86, DOI 10.1016/j.expneurol.2009.09.009
   Jin GZ, 2011, NEUROSCI LETT, V501, P10, DOI 10.1016/j.neulet.2011.06.023
   Johansson F, 2006, BIOMATERIALS, V27, P1251, DOI [10.1016/j.biomaterials.2005.07.047, 10.1016/j.niomaterials.2005.07.047]
   Kabiri M, 2012, BIOTECHNOL LETT, V34, P1357, DOI 10.1007/s10529-012-0889-4
   Kagan VE, 2010, NAT NANOTECHNOL, V5, P354, DOI [10.1038/NNANO.2010.44, 10.1038/nnano.2010.44]
   Kam NWS, 2004, J AM CHEM SOC, V126, P6850, DOI 10.1021/ja0486059
   Kateb B, 2007, NEUROIMAGE, V37, pS9, DOI 10.1016/j.neuroimage.2007.03.078
   Keefer EW, 2008, NAT NANOTECHNOL, V3, P434, DOI 10.1038/nnano.2008.174
   Kehoe S, 2012, INJURY, V43, P553, DOI 10.1016/j.injury.2010.12.030
   Kim JA, 2012, INTEGR BIOL-UK, V4, P587, DOI 10.1039/c2ib20017a
   Koh HS, 2008, BIOMATERIALS, V29, P3574, DOI 10.1016/j.biomaterials.2008.05.014
   Konofaos P, 2013, J RECONSTR MICROSURG, V29, P149, DOI 10.1055/s-0032-1333316
   Kotchey GP, 2013, ADV DRUG DELIVER REV, V65, P1921, DOI 10.1016/j.addr.2013.07.007
   Kotwal A, 2001, BIOMATERIALS, V22, P1055, DOI 10.1016/S0142-9612(00)00344-6
   Lahiri D, 2009, ACS APPL MATER INTER, V1, P2470, DOI 10.1021/am900423q
   Landers J, 2014, ADV HEALTHC MATER, V3, P1745, DOI 10.1002/adhm.201400042
   Lee AC, 2003, EXP NEUROL, V184, P295, DOI 10.1016/S0014-4886(03)00258-9
   Lee JY, 2009, BIOMATERIALS, V30, P4325, DOI 10.1016/j.biomaterials.2009.04.042
   Lee YS, 2011, POLYMERS-BASEL, V3, P413, DOI 10.3390/polym3010413
   LEIN PJ, 1989, DEV BIOL, V136, P330, DOI 10.1016/0012-1606(89)90260-1
   LEMMON V, 1992, J NEUROSCI, V12, P818
   Lewitus DY, 2011, ADV FUNCT MATER, V21, P2624, DOI 10.1002/adfm.201002429
   Li GN, 2008, TISSUE ENG PT B-REV, V14, P33, DOI 10.1089/teb.2007.0181
   LIESI P, 1985, EMBO J, V4, P2505, DOI 10.1002/j.1460-2075.1985.tb03963.x
   Lin MY, 2013, HAND CLIN, V29, P331, DOI 10.1016/j.hcl.2013.04.003
   Liopo AV, 2006, J NANOSCI NANOTECHNO, V6, P1365, DOI 10.1166/jnn.2006.155
   Liu J, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/19/195101
   Liu Z, 2008, P NATL ACAD SCI USA, V105, P1410, DOI 10.1073/pnas.0707654105
   Liu Z, 2009, NANO RES, V2, P85, DOI 10.1007/s12274-009-9009-8
   Lovat V, 2005, NANO LETT, V5, P1107, DOI 10.1021/nl050637m
   Lu Y, 2010, BIOMATERIALS, V31, P5169, DOI 10.1016/j.biomaterials.2010.03.022
   LUNDBORG G, 1982, EXP NEUROL, V76, P361, DOI 10.1016/0014-4886(82)90215-1
   Ma HY, 2015, NANOTECHNOLOGY, V26, DOI 10.1088/0957-4484/26/2/025701
   MacDonald RA, 2005, J BIOMED MATER RES A, V74A, P489, DOI 10.1002/jbm.a.30386
   MacDonald RA, 2008, ACTA BIOMATER, V4, P1583, DOI 10.1016/j.actbio.2008.07.005
   Malarkey EB, 2008, NANO LETT, V8, P3538, DOI 10.1021/nl8017912
   Malarkey EB, 2009, NANO LETT, V9, P264, DOI 10.1021/nl802855c
   Mason MRJ, 2011, CURR GENE THER, V11, P75
   Matsumoto K, 2000, BRAIN RES, V868, P315, DOI 10.1016/S0006-8993(00)02207-1
   Matsumoto K, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/11/115101
   Matsumoto K, 2007, J BIOSCI BIOENG, V103, P216, DOI 10.1263/jbb.103.216
   Mattson MP, 2000, J MOL NEUROSCI, V14, P175, DOI 10.1385/JMN:14:3:175
   Mazzatenta A, 2007, J NEUROSCI, V27, P6931, DOI 10.1523/JNEUROSCI.1051-07.2007
   McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004
   MCCAIG CD, 1986, J PHYSIOL-LONDON, V375, P55, DOI 10.1113/jphysiol.1986.sp016105
   McCullen SD, 2007, MACROMOLECULES, V40, P997, DOI 10.1021/ma061735c
   Meng L, 2013, SMALL, V9, P1786, DOI 10.1002/smll.201201388
   Menorca RMG, 2013, HAND CLIN, V29, P317, DOI 10.1016/j.hcl.2013.04.002
   MERLE M, 1989, MICROSURG, V10, P130, DOI 10.1002/micr.1920100213
   Mikael PE, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/3/035001
   Mottaghitalab F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074417
   Nguyen QT, 2002, NAT NEUROSCI, V5, P861, DOI 10.1038/nn905
   Ni YC, 2005, J NANOSCI NANOTECHNO, V5, P1707, DOI 10.1166/jnn.2005.189
   Nimmagadda A, 2006, J BIOMED MATER RES A, V76A, P614, DOI 10.1002/jbm.a.30577
   NURCOMBE V, 1992, PHARMACOL THERAPEUT, V56, P247, DOI 10.1016/0163-7258(92)90019-V
   Owens CM, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/4/045007
   Pan LL, 2012, COLLOID SURFACE B, V93, P226, DOI 10.1016/j.colsurfb.2012.01.011
   Pantarotto D, 2004, ANGEW CHEM INT EDIT, V43, P5242, DOI 10.1002/anie.200460437
   PATEL N, 1982, J NEUROSCI, V2, P483
   Podesta JE, 2009, SMALL, V5, P1176, DOI 10.1002/smll.200801572
   Qi FY, 2013, BIOMATERIALS, V34, P1799, DOI 10.1016/j.biomaterials.2012.11.042
   Raivich G, 2007, BRAIN RES REV, V53, P287, DOI 10.1016/j.brainresrev.2006.09.005
   Ren JF, 2012, BIOMATERIALS, V33, P3324, DOI 10.1016/j.biomaterials.2012.01.025
   Richardson JA, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046015
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Rivers TJ, 2002, ADV FUNCT MATER, V12, P33, DOI 10.1002/1616-3028(20020101)12:1<33::AID-ADFM33>3.0.CO;2-E
   Roberts MJ, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/3/036013
   ROGERS SL, 1983, DEV BIOL, V98, P212, DOI 10.1016/0012-1606(83)90350-0
   Romano NH, 2015, ACTA BIOMATER, V11, P48, DOI 10.1016/j.actbio.2014.10.008
   RUEGG UT, 1984, NEUROSCI LETT, V49, P319, DOI 10.1016/0304-3940(84)90309-4
   Ruiter GCW, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/FOC.2009.26.2.E5
   Russier J, 2011, NANOSCALE, V3, P893, DOI 10.1039/c0nr00779j
   Saeed K, 2007, J APPL POLYM SCI, V104, P1957, DOI 10.1002/app.25901
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V69, P149, DOI 10.1016/S0168-3659(00)00296-0
   Sato Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02516
   Schlosshauer B, 2006, NEUROSURGERY, V59, P740, DOI 10.1227/01.NEU.0000235197.36789.42
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Shapiro S, 2005, J NEUROSURG-SPINE, V2, P3, DOI 10.3171/spi.2005.2.1.0003
   Shi JJ, 2010, NANO LETT, V10, P3223, DOI 10.1021/nl102184c
   Shi XF, 2008, J BIOMED MATER RES A, V86A, P813, DOI 10.1002/jbm.a.31671
   Shi XF, 2006, BIOMACROMOLECULES, V7, P2237, DOI 10.1021/bm060391v
   Shin MK, 2008, SENSOR ACTUAT B-CHEM, V134, P122, DOI 10.1016/j.snb.2008.04.021
   Shin SR, 2012, ACS NANO, V6, P362, DOI 10.1021/nn203711s
   Shokrgozar MA, 2011, J BIOMED NANOTECHNOL, V7, P276, DOI 10.1166/jbn.2011.1284
   Shoval Asaf, 2009, Front Neuroeng, V2, P4, DOI 10.3389/neuro.16.004.2009
   Singh R, 2006, P NATL ACAD SCI USA, V103, P3357, DOI 10.1073/pnas.0509009103
   Singh S, 2003, ADV FUNCT MATER, V13, P868, DOI 10.1002/adfm.200304411
   Song M, 2007, ANN BIOMED ENG, V35, P1812, DOI 10.1007/s10439-007-9348-0
   Sorkin R, 2006, J NEURAL ENG, V3, P95, DOI 10.1088/1741-2560/3/2/003
   Sorkin R, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/1/015101
   Szynkaruk M, 2013, TISSUE ENG PART B-RE, V19, P83, DOI [10.1089/ten.TEB.2012.0275, 10.1089/ten.teb.2012.0275]
   Tan W, 2010, IEEE T NANOBIOSCI, V9, P111, DOI 10.1109/TNB.2010.2043367
   Tannemaat MR, 2008, EUR J NEUROSCI, V28, P1467, DOI 10.1111/j.1460-9568.2008.06452.x
   Tasis D, 2006, CHEM REV, V106, P1105, DOI 10.1021/cr050569o
   Thompson BC, 2009, CARBON, V47, P1282, DOI 10.1016/j.carbon.2009.01.013
   TOMASELLI KJ, 1987, J CELL BIOL, V105, P2347, DOI 10.1083/jcb.105.5.2347
   Tonge DA, 1997, EXP NEUROL, V146, P81, DOI 10.1006/exnr.1997.6498
   Tosun Z, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/6/066002
   VALENTINI RF, 1992, BIOMATERIALS, V13, P183, DOI 10.1016/0142-9612(92)90069-Z
   Varro P, 2013, ACTA BIOL HUNG, V64, P137, DOI 10.1556/ABiol.64.2013.2.1
   Vitale F, 2015, ACS NANO, V9, P4465, DOI 10.1021/acsnano.5b01060
   Voge CM, 2008, J BIOMED MATER RES A, V86A, P269, DOI 10.1002/jbm.a.32029
   Wang AJ, 2007, BIOTECHNOL LETT, V29, P1697, DOI 10.1007/s10529-007-9460-0
   WANG GY, 1992, BRAIN RES, V570, P116, DOI 10.1016/0006-8993(92)90571-P
   Wang HB, 2010, ACTA BIOMATER, V6, P2970, DOI 10.1016/j.actbio.2010.02.020
   Wang K, 2006, NANO LETT, V6, P2043, DOI 10.1021/nl061241t
   Wang SF, 2005, BIOMACROMOLECULES, V6, P3067, DOI 10.1021/bm050378v
   Wang SF, 2010, INT J POLYM SCI, DOI 10.1155/2010/138686
   Wang XD, 2004, J BIOMED MATER RES A, V68A, P411, DOI 10.1002/jbm.a.20065
   Webster TJ, 2004, NANOTECHNOLOGY, V15, P48, DOI 10.1088/0957-4484/15/1/009
   Weigel S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050714
   Wen XJ, 2006, J BIOMED MATER RES A, V76A, P626, DOI 10.1002/jbm.a.30520
   Wong BS, 2013, ADV DRUG DELIVER REV, V65, P1964, DOI 10.1016/j.addr.2013.08.005
   Wood M, 2006, BIOELECTROMAGNETICS, V27, P328, DOI 10.1002/bem.20214
   Wood MD, 2009, ACTA BIOMATER, V5, P959, DOI 10.1016/j.actbio.2008.11.008
   Wu D, 2012, NEUROSCI LETT, V507, P72, DOI 10.1016/j.neulet.2011.11.056
   Xie JW, 2010, NANOSCALE, V2, P35, DOI 10.1039/b9nr00243j
   Xie JW, 2009, ADV FUNCT MATER, V19, P2312, DOI 10.1002/adfm.200801904
   Xie JW, 2009, ACS NANO, V3, P1151, DOI 10.1021/nn900070z
   Xie JN, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/10/105101
   Xie JN, 2006, SMART MATER STRUCT, V15, pN85, DOI 10.1088/0964-1726/15/4/N02
   Xu HX, 2014, BIOMATERIALS, V35, P225, DOI 10.1016/j.biomaterials.2013.10.002
   Yang ST, 2007, J PHYS CHEM C, V111, P17761, DOI 10.1021/jp070712c
   Yildirim ED, 2008, J BIOMED MATER RES B, V87B, P406, DOI 10.1002/jbm.b.31118
   Yu WW, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/16/165102
   Zhang RF, 2013, ACS NANO, V7, P6156, DOI 10.1021/nn401995z
   Zhang X, 2005, SENSOR ACTUAT B-CHEM, V106, P843, DOI 10.1016/j.snb.2004.10.039
   Zhang Z, 2007, ARTIF ORGANS, V31, P13, DOI 10.1111/j.1525-1594.2007.00335.x
   Zhao M, 1999, P NATL ACAD SCI USA, V96, P4942, DOI 10.1073/pnas.96.9.4942
   Zhao XC, 2012, ENVIRON INT, V40, P244, DOI 10.1016/j.envint.2011.12.003
   Zhao Y, 2011, J PHYS CHEM A, V115, P9536, DOI 10.1021/jp112324d
   Zhou HH, 2013, ACTA BIOMATER, V9, P6439, DOI 10.1016/j.actbio.2013.01.042
   Zhu W, 2014, NANOMEDICINE-UK, V9, P859, DOI [10.2217/NNM.14.36, 10.2217/nnm.14.36]
NR 201
TC 7
Z9 7
U1 1
U2 47
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD JUN 8
PY 2016
VL 5
IS 11
BP 1253
EP 1271
DI 10.1002/adhm.201500864
PG 19
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA DP6XE
UT WOS:000378642100001
PM 27027923
OA Other Gold
DA 2018-10-20
ER

PT J
AU Domingues, RMA
   Chiera, S
   Gershovich, P
   Motta, A
   Reis, RL
   Gomes, ME
AF Domingues, Rui M. A.
   Chiera, Silvia
   Gershovich, Pavel
   Motta, Antonella
   Reis, Rui L.
   Gomes, Manuela E.
TI Enhancing the Biomechanical Performance of Anisotropic Nanofibrous
   Scaffolds in Tendon Tissue Engineering: Reinforcement with Cellulose
   Nanocrystals
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
DE anisotropic alignment; cellulose nanocrystals; mechanical properties;
   nanofibrous scaffolds; tendon tissue engineering
ID STEM-CELL DIFFERENTIATION; MECHANICAL-PROPERTIES; IN-VIVO; TENOGENIC
   DIFFERENTIATION; HUMAN MSCS; NANOCOMPOSITE; DEGRADATION; ALIGNMENT;
   CHITOSAN; REPAIR
AB Anisotropically aligned electrospun nanofibrous scaffolds based on natural/synthetic polymer blends have been established as a reasonable compromise between biological and biomechanical performance for tendon tissue engineering (TE) strategies. However, the limited tensile properties of these biomaterials restrict their application in this field due to the load-bearing nature of tendon/ligament tissues. Herein, the use of cellulose nanocrystals (CNCs) as reinforcing nanofillers in aligned electrospun scaffolds based on a natural/synthetic polymer blend matrix, poly-epsilon-caprolactone/chitosan (PCL/CHT) is reported. The incorporation of small amounts of CNCs (up to 3 wt%) into tendon mimetic nanofiber bundles has a remarkable biomaterial-toughing effect (85% +/- 5%, p < 0.0002) and raises the scaffolds mechanical properties to tendon/ligament relevant range (sigma = 39.3 +/- 1.9 MPa and E = 540.5 +/- 83.7 MPa, p < 0.0001). Aligned PCL/CHT/CNC nanocomposite fibrous scaffolds meet not only the mechanical requirements for tendon TE applications but also provide tendon mimetic extracellular matrix (ECM) topographic cues, a key feature for maintaining tendon cell's morphology and behavior. The strategy proposed here may be extended to other anisotropic aligned nanofibrous scaffolds based on natural/synthetic polymer blends and enable the full exploitation of the advantages provided by their tendon mimetic fibrous structures in tendon TE.
C1 [Domingues, Rui M. A.; Gershovich, Pavel; Reis, Rui L.; Gomes, Manuela E.] Univ Minho, Headquarters European Inst Excellence Tissue Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, Avepk Parque Ciencia & Tecnol, P-4805017 Barco, Guimaraes, Portugal.
   [Domingues, Rui M. A.; Gershovich, Pavel; Reis, Rui L.; Gomes, Manuela E.] ICVS 3Bs PT Associate Lab, Braga, Portugal.
   [Chiera, Silvia; Motta, Antonella] Univ Trento, Dept Ind Engn, I-38123 Trento, Italy.
   [Chiera, Silvia; Motta, Antonella] Univ Trento, Biotech Res Ctr, I-38123 Trento, Italy.
   [Chiera, Silvia; Motta, Antonella] European Inst Excellence Tissue Engn & Regenerat, I-38123 Trento, Italy.
RP Gomes, ME (reprint author), Univ Minho, Headquarters European Inst Excellence Tissue Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, Avepk Parque Ciencia & Tecnol, P-4805017 Barco, Guimaraes, Portugal.; Gomes, ME (reprint author), ICVS 3Bs PT Associate Lab, Braga, Portugal.
EM megomes@dep.uminho.pt
RI Gomes, Manuela/B-6282-2009; Reis, Rui L./A-8938-2008; Domingues,
   Rui/G-3893-2011; Group, 3Bs/E-4374-2012
OI Gomes, Manuela/0000-0002-2036-6291; Reis, Rui L./0000-0002-4295-6129;
   Domingues, Rui/0000-0002-3654-9906; Group, 3Bs/0000-0002-5195-3456;
   Motta, Antonella/0000-0003-4893-6863; Chiera, Silvia/0000-0003-0920-6577
FU North Portugal Regional Operational Programme (ON.2 - O Novo Norte)
   under the National Strategic Reference Framework (NSRF), through the
   European Regional Development Fund (ERDF)
   [RL1-ABMR-NORTE-01-0124-FEDER-000016]; Project POLARIS - EU-FP7
   [REGPOT-2012-2013-1-316331]
FX The authors acknowledge the financial support from the Project
   RL1-ABMR-NORTE-01-0124-FEDER-000016 cofinanced by North Portugal
   Regional Operational Programme (ON.2 - O Novo Norte), under the National
   Strategic Reference Framework (NSRF), through the European Regional
   Development Fund (ERDF) and from Project POLARIS financed by EU-FP7
   (REGPOT-2012-2013-1-316331).
CR Araki J, 2013, SOFT MATTER, V9, P4125, DOI 10.1039/c3sm27514k
   Ayres C, 2006, BIOMATERIALS, V27, P5524, DOI 10.1016/j.biomaterials.2006.06.014
   Barber J, 2011, TISSUE ENG PART A, V19, P1265
   Bosworth LA, 2013, J MATER SCI-MATER M, V24, P1605, DOI 10.1007/s10856-013-4911-8
   Chen HS, 2013, CELL TRANSPLANT, V22, P677, DOI 10.3727/096368912X655118
   Cooper A, 2010, J MATER CHEM, V20, P8904, DOI 10.1039/c0jm01841d
   Domingues R. M. A., 2015, TENDON REGENERATION, P259
   Domingues RMA, 2015, BIOCONJUGATE CHEM, V26, P1571, DOI 10.1021/acs.bioconjchem.5b00209
   Domingues RMA, 2014, BIOMACROMOLECULES, V15, P2327, DOI 10.1021/bm500524s
   Gaspar D, 2015, ADV DRUG DELIVER REV, V84, P240, DOI 10.1016/j.addr.2014.11.023
   Habibi Y, 2008, J MATER CHEM, V18, P5002, DOI 10.1039/b809212e
   Habibi Y, 2010, CHEM REV, V110, P3479, DOI 10.1021/cr900339w
   He X, 2014, BIOMACROMOLECULES, V15, P618, DOI 10.1021/bm401656a
   Kannus P, 2000, SCAND J MED SCI SPOR, V10, P312, DOI 10.1034/j.1600-0838.2000.010006312.x
   Kean T, 2010, ADV DRUG DELIVER REV, V62, P3, DOI 10.1016/j.addr.2009.09.004
   Kishore V, 2012, BIOMATERIALS, V33, P2137, DOI 10.1016/j.biomaterials.2011.11.066
   LaCroix AS, 2013, J APPL PHYSIOL, V115, P43, DOI 10.1152/japplphysiol.01449.2012
   Lee J, 2012, MACROMOL RES, V20, P76, DOI 10.1007/s13233-012-0008-3
   Leung M, 2013, J MATER CHEM B, V1, P6516, DOI 10.1039/c3tb20825g
   Lin N, 2009, J APPL POLYM SCI, V113, P3417, DOI 10.1002/app.30308
   Liu CF, 2011, TISSUE ENG PART B-RE, V17, P165, DOI [10.1089/ten.TEB.2010.0662, 10.1089/ten.teb.2010.0662]
   Lomas A., 2015, TENDON REGENERATION, P225
   Lomas A. J., 2015, ADV DRUG DEL REV, V85, P257
   McNeilly CM, 1996, J ANAT, V189, P593
   Mo YF, 2015, COLLOID SURFACE B, V132, P177, DOI 10.1016/j.colsurfb.2015.05.029
   Moffat K. L., 2008, TISSUE ENG PART A, V15, P115
   Moon RJ, 2011, CHEM SOC REV, V40, P3941, DOI 10.1039/c0cs00108b
   Pooyan P, 2013, POLYMER, V54, P2105, DOI 10.1016/j.polymer.2013.01.030
   Ralphs JR, 2002, MATRIX BIOL, V21, P67, DOI 10.1016/S0945-053X(01)00179-2
   Raspanti M, 2002, ARCH HISTOL CYTOL, V65, P37, DOI 10.1679/aohc.65.37
   Richardson SH, 2007, MOL CELL BIOL, V27, P6218, DOI 10.1128/MCB.00261-07
   Roman M., 2015, Industrial Biotechnology, V11, P25
   Roozbahani F, 2013, J NANOMATER, DOI 10.1155/2013/641502
   Scherrer P., 1918, GOTTINGER NACHRICHTE, V2, P98
   Schiele NR, 2015, J ORTHOP RES, V33, P874, DOI 10.1002/jor.22880
   Sheng LB, 2014, J MACROMOL SCI B, V53, P820, DOI 10.1080/00222348.2013.861311
   Shi QF, 2012, CARBOHYD POLYM, V90, P301, DOI 10.1016/j.carbpol.2012.05.042
   Signini R, 1999, POLYM BULL, V42, P159, DOI 10.1007/s002890050448
   Subramony SD, 2013, BIOMATERIALS, V34, P1942, DOI 10.1016/j.biomaterials.2012.11.012
   Sun HF, 2006, BIOMATERIALS, V27, P1735, DOI 10.1016/j.biomaterials.2005.09.019
   van den Berg O, 2007, BIOMACROMOLECULES, V8, P1353, DOI 10.1021/bm061104q
   Van der Schueren L, 2012, CARBOHYD POLYM, V88, P1221, DOI 10.1016/j.carbpol.2012.01.085
   Wanasekara N. D., 2015, J MATER SCI, V51, P218
   Wang JHC, 2006, J BIOMECH, V39, P1563, DOI 10.1016/j.jbiomech.2005.05.011
   Wang XF, 2013, PROG MATER SCI, V58, P1173, DOI 10.1016/j.pmatsci.2013.05.001
   Wong SC, 2008, POLYMER, V49, P4713, DOI 10.1016/j.polymer.2008.08.022
   Xu Y, 2014, BIOMATERIALS, V35, P2760, DOI 10.1016/j.biomaterials.2013.12.042
   Yang X, 2013, BIOMACROMOLECULES, V14, P4447, DOI 10.1021/bm401364z
   Yin Z, 2010, BIOMATERIALS, V31, P2163, DOI 10.1016/j.biomaterials.2009.11.083
   Younesi M, 2014, ADV FUNCT MATER, V24, P5762, DOI 10.1002/adfm.201400828
   Zhou CJ, 2013, ACS APPL MATER INTER, V5, P3847, DOI 10.1021/am4005072
   Zhu J, 2010, BIOMATERIALS, V31, P6952, DOI 10.1016/j.biomaterials.2010.05.058
   Zoppe JO, 2009, ACS APPL MATER INTER, V1, P1996, DOI 10.1021/am9003705
NR 53
TC 14
Z9 14
U1 8
U2 69
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD JUN 8
PY 2016
VL 5
IS 11
BP 1364
EP 1375
DI 10.1002/adhm.201501048
PG 12
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA DP6XE
UT WOS:000378642100011
PM 27059281
DA 2018-10-20
ER

PT J
AU Zhu, BW
   Wang, H
   Leow, WR
   Cai, YR
   Loh, XJ
   Han, MY
   Chen, XD
AF Zhu, Bowen
   Wang, Hong
   Leow, Wan Ru
   Cai, Yurong
   Loh, Xian Jun
   Han, Ming-Yong
   Chen, Xiaodong
TI Silk Fibroin for Flexible Electronic Devices
SO ADVANCED MATERIALS
LA English
DT Review
ID FIELD-EFFECT TRANSISTORS; THIN-FILM TRANSISTORS; 25TH ANNIVERSARY
   ARTICLE; RESISTIVE SWITCHING MEMORIES; STRETCHABLE ELECTRONICS;
   EPIDERMAL ELECTRONICS; TRANSIENT ELECTRONICS; ORGANIC ELECTRONICS;
   MEMRISTIVE DEVICES; ENERGY HARVESTERS
AB Flexible electronic devices are necessary for applications involving unconventional interfaces, such as soft and curved biological systems, in which traditional silicon-based electronics would confront a mechanical mismatch. Biological polymers offer new opportunities for flexible electronic devices by virtue of their biocompatibility, environmental benignity, and sustainability, as well as low cost. As an intriguing and abundant biomaterial, silk offers exquisite mechanical, optical, and electrical properties that are advantageous toward the development of next-generation biocompatible electronic devices. The utilization of silk fibroin is emphasized as both passive and active components in flexible electronic devices. The employment of biocompatible and biosustainable silk materials revolutionizes state-of-the-art electronic devices and systems that currently rely on conventional semiconductor technologies. Advances in silk-based electronic devices would open new avenues for employing biomaterials in the design and integration of high-performance biointegrated electronics for future applications in consumer electronics, computing technologies, and biomedical diagnosis, as well as human-machine interfaces.
C1 [Zhu, Bowen; Wang, Hong; Leow, Wan Ru; Cai, Yurong; Chen, Xiaodong] Nanyang Technol Univ, Sch Mat Sci & Engn, 50 Nanyang Ave, Singapore 639798, Singapore.
   [Loh, Xian Jun; Han, Ming-Yong] ASTAR, Inst Mat Res & Engn, 3 Res Link, Singapore 117602, Singapore.
RP Chen, XD (reprint author), Nanyang Technol Univ, Sch Mat Sci & Engn, 50 Nanyang Ave, Singapore 639798, Singapore.
EM chenxd@ntu.edu.sg
RI Wang, Hong/I-9598-2017; Chen, Xiaodong/A-4537-2009
OI Wang, Hong/0000-0002-0213-3523; Chen, Xiaodong/0000-0002-3312-1664; Loh,
   Xian Jun/0000-0001-8118-6502
FU National Research Foundation, Prime Minister's Office, Singapore, under
   its Competitive Research Programme Funding Scheme [NRF-CRP13-2014-02];
   National Research Foundation, Prime Minister's Office, Singapore, under
   its Competitive Research Programme Funding Scheme (CREATE Progamme on
   Nanomaterials for Energy and Water Management); NTU-A*STAR Silicon
   Technologies Center of Excellence [11235100003]
FX The authors thank the financial support from the National Research
   Foundation, Prime Minister's Office, Singapore, under its Competitive
   Research Programme Funding Scheme (NRF-CRP13-2014-02 and CREATE Progamme
   on Nanomaterials for Energy and Water Management), and NTU-A*STAR
   Silicon Technologies Center of Excellence under the program grant No.
   11235100003.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Arico AS, 2005, NAT MATER, V4, P366, DOI 10.1038/nmat1368
   Barr MC, 2011, ADV MATER, V23, P3500, DOI 10.1002/adma.201101263
   Baude PF, 2003, APPL PHYS LETT, V82, P3964, DOI 10.1063/1.1579554
   Bauer S, 2014, ADV MATER, V26, P149, DOI 10.1002/adma.201303349
   Bettinger CJ, 2007, ADV MATER, V19, P2847, DOI 10.1002/adma.200602487
   Bettinger CJ, 2010, POLYM INT, V59, P563, DOI 10.1002/pi.2827
   Bettinger CJ, 2010, ADV MATER, V22, P651, DOI 10.1002/adma.200902322
   Biswal M, 2013, ENERG ENVIRON SCI, V6, P1249, DOI 10.1039/c3ee22325f
   Bourzac K, 2015, NATURE, V519, pS4, DOI 10.1038/519S4a
   Cabana J, 2010, ADV MATER, V22, pE170, DOI 10.1002/adma.201000717
   Cao Q, 2009, ADV MATER, V21, P29, DOI 10.1002/adma.200801995
   Capelli R, 2011, ORG ELECTRON, V12, P1146, DOI 10.1016/j.orgel.2011.04.005
   Chang JW, 2011, ADV MATER, V23, P4077, DOI 10.1002/adma.201102124
   Cheng Y., 2014, J R SOC INTERFACE, V11, P8
   Choi Y, 2013, FIBER POLYM, V14, P2006, DOI 10.1007/s12221-013-2006-2
   Currie HA, 2011, ADV FUNCT MATER, V21, P2889, DOI 10.1002/adfm.201100249
   Dagdeviren C, 2013, SMALL, V9, P3398, DOI 10.1002/smll.201300146
   Eder F, 2004, APPL PHYS LETT, V84, P2673, DOI 10.1063/1.1690870
   Fei X, 2013, BIOMACROMOLECULES, V14, P4483, DOI 10.1021/bm4014149
   Fei X, 2013, NANOSCALE, V5, P7991, DOI 10.1039/c3nr01872e
   Fei X, 2013, J MATER CHEM B, V1, P213, DOI 10.1039/c2tb0001/b
   Forrest SR, 2004, NATURE, V428, P911, DOI 10.1038/nature02498
   Franklin AD, 2015, SCIENCE, V349, DOI 10.1126/science.aab2750
   Gelinck GH, 2004, NAT MATER, V3, P106, DOI 10.1038/nmat1061
   Gogurla N, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/34/345202
   Hagen JA, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2197973
   Hamedi M, 2007, NAT MATER, V6, P357, DOI [10.1038/nmat1884, 10.1038/nma11884]
   Hammock ML, 2013, ADV MATER, V25, P5997, DOI 10.1002/adma.201302240
   He YD, 2011, ADV MATER, V23, P5502, DOI 10.1002/adma.201103592
   Hota MK, 2012, ADV FUNCT MATER, V22, P4493, DOI 10.1002/adfm.201200073
   Hou JH, 2015, ACS NANO, V9, P2556, DOI 10.1021/nn506394r
   Hsieh CY, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4813075
   Hu X, 2012, MATER TODAY, V15, P208, DOI 10.1016/S1369-7021(12)70091-3
   Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a
   Huang X, 2014, SMALL, V10, P3083, DOI 10.1002/smll.201400483
   Hubler A, 2011, ADV ENERGY MATER, V1, P1018, DOI 10.1002/aenm.201100394
   Hwang SW, 2015, ADV MATER, V27, P47, DOI 10.1002/adma.201403051
   Hwang SW, 2014, ADV MATER, V26, P1992, DOI 10.1002/adma.201304821
   Hwang SW, 2013, ADV FUNCT MATER, V23, P4087, DOI 10.1002/adfm.201300127
   Hwang SW, 2013, ADV MATER, V25, P3526, DOI 10.1002/adma.201300920
   Hwang SW, 2012, SCIENCE, V337, P1640, DOI 10.1126/science.1226325
   Irimia-Vladu M, 2014, CHEM SOC REV, V43, P588, DOI 10.1039/c3cs60235d
   Irimia-Vladu M, 2012, MATER TODAY, V15, P340, DOI 10.1016/S1369-7021(12)70139-6
   Irimia-Vladu M, 2011, J MATER CHEM, V21, P1350, DOI 10.1039/c0jm02444a
   Irimia-Vladu M, 2010, ADV FUNCT MATER, V20, P4069, DOI 10.1002/adfm.201001031
   Itaka K, 2006, ADV MATER, V18, P1713, DOI 10.1002/adma.200502752
   Jang KI, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5779
   Jeong HM, 2011, NANO LETT, V11, P2472, DOI 10.1021/nl2009058
   Jeong JW, 2013, ADV MATER, V25, P6839, DOI 10.1002/adma.201301921
   Jiang CY, 2007, ADV FUNCT MATER, V17, P2229, DOI 10.1002/adfm.200601136
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Jung MW, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/28/285302
   Kaltenbrunner M, 2013, NATURE, V499, P458, DOI 10.1038/nature12314
   Kang SK, 2014, ADV FUNCT MATER, V24, P4427, DOI 10.1002/adfm.201304293
   Karakawa M, 2007, MACROMOL RAPID COMM, V28, P1479, DOI 10.1002/marc.200700186
   Kharlampieva E, 2010, ACS NANO, V4, P7053, DOI 10.1021/nn102456w
   Kharlampieva E, 2010, ADV FUNCT MATER, V20, P840, DOI 10.1002/adfm.200901774
   Kim BJ, 2013, SMALL, V9, P3784, DOI 10.1002/smll.201300522
   Kim C, 2007, SCIENCE, V318, P76, DOI 10.1126/science.1146458
   Kim DH, 2008, SCIENCE, V320, P507, DOI 10.1126/science.1154367
   Kim DH, 2012, MRS BULL, V37, P226, DOI 10.1557/mrs.2012.36
   Kim DH, 2011, SCIENCE, V333, P838, DOI 10.1126/science.1206157
   Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/NMAT2745, 10.1038/nmat2745]
   Kim DH, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3238552
   Kim J., 2014, NAT COMMUN, V5
   Kim J, 2015, SMALL, V11, P906, DOI 10.1002/smll.201402495
   Kim KD, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2213010
   Kim S, 2014, NAT NANOTECHNOL, V9, P306, DOI [10.1038/nnano.2014.47, 10.1038/NNANO.2014.47]
   Kim TI, 2013, SCIENCE, V340, P211, DOI 10.1126/science.1232437
   Kim YJ, 2007, CARBON, V45, P2116, DOI 10.1016/j.carbon.2007.05.026
   Klauk H, 2010, CHEM SOC REV, V39, P2643, DOI 10.1039/b909902f
   Ko Y, 2011, ACS NANO, V5, P9918, DOI 10.1021/nn2036939
   Koh LD, 2015, PROG POLYM SCI, V46, P86, DOI 10.1016/j.progpolymsci.2015.02.001
   Kundu SC, 2008, PROG POLYM SCI, V33, P998, DOI 10.1016/j.progpolymsci.2008.08.002
   Kurland NE, 2013, ADV MATER, V25, P6207, DOI 10.1002/adma.201302823
   Kwon DH, 2010, NAT NANOTECHNOL, V5, P148, DOI [10.1038/NNANO.2009.456, 10.1038/nnano.2009.456]
   Liang B, 2014, NANOSCALE, V6, P4264, DOI 10.1039/c3nr06057h
   Lin DM, 2012, ADV MATER, V24, P6088, DOI 10.1002/adma.201201888
   Liu LL, 2014, ADV MATER, V26, P4855, DOI 10.1002/adma.201401513
   Liu Q, 2012, ADV MATER, V24, P1844, DOI 10.1002/adma.201104104
   Liu YQ, 2014, ACS APPL MATER INTER, V6, P20670, DOI 10.1021/am504163r
   Maiti UN, 2014, ADV MATER, V26, P40, DOI 10.1002/adma.201303265
   Mannoor MS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1767
   Mannsfeld SCB, 2010, NAT MATER, V9, P859, DOI [10.1038/nmat2834, 10.1038/NMAT2834]
   McEvoy MA, 2015, SCIENCE, V347, DOI 10.1126/science.1261689
   Meng FB, 2014, SMALL, V10, P277, DOI 10.1002/smll.201300810
   Meng FB, 2011, SMALL, V7, P3016, DOI 10.1002/smll.201101494
   Mukherjee C, 2013, PHYS STATUS SOLIDI A, V210, P1797, DOI 10.1002/pssa.201329109
   Muller C, 2011, ADV MATER, V23, P898, DOI 10.1002/adma.201003601
   Muskovich M, 2012, ADV HEALTHC MATER, V1, P248, DOI 10.1002/adhm.201200071
   Niu ZQ, 2013, ADV MATER, V25, P4035, DOI 10.1002/adma.201301332
   Niu ZQ, 2013, ADV MATER, V25, P1058, DOI 10.1002/adma.201204003
   Nogi M, 2008, ADV MATER, V20, P1849, DOI 10.1002/adma.200702559
   Nomura K, 2004, NATURE, V432, P488, DOI 10.1038/nature03090
   Omenetto FG, 2008, NAT PHOTONICS, V2, P641, DOI 10.1038/nphoton.2008.207
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Pang C., 2014, ADV MATER, V27, P634
   Park J, 2004, APPL PHYS LETT, V85, P3283, DOI 10.1063/1.1805703
   Pereira RFP, 2015, MACROMOL MATER ENG, V300, P1171, DOI 10.1002/mame.201400276
   Qi DP, 2015, ADV MATER, V27, P3145, DOI 10.1002/adma.201405807
   Qi N, 2015, RSC ADV, V5, P50878, DOI 10.1039/c5ra03501e
   Qian WJ, 2014, ENERG ENVIRON SCI, V7, P379, DOI 10.1039/c3ee43111h
   Qie L, 2012, ADV MATER, V24, P2047, DOI 10.1002/adma.201104634
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Rogers JA, 2010, SCIENCE, V327, P1603, DOI 10.1126/science.1182383
   Sahu V, 2015, ELECTROCHIM ACTA, V160, P244, DOI 10.1016/j.electacta.2015.02.019
   Sawa A, 2008, MATER TODAY, V11, P28, DOI 10.1016/S1369-7021(08)70119-6
   Schwartz G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2832
   Sekitani T, 2008, SCIENCE, V321, P1468, DOI 10.1126/science.1160309
   Sekitani T, 2010, ADV MATER, V22, P2228, DOI 10.1002/adma.200904054
   Sheng WQ, 2015, NANOTECHNOLOGY, V26, DOI 10.1088/0957-4484/26/11/115603
   Shi LL, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4862198
   Siegel AC, 2010, ADV FUNCT MATER, V20, P28, DOI 10.1002/adfm.200901363
   Siegel AC, 2009, LAB CHIP, V9, P2775, DOI 10.1039/b905832j
   Simon P, 2008, NAT MATER, V7, P845, DOI 10.1038/nmat2297
   Sirringhaus H, 1999, NATURE, V401, P685, DOI 10.1038/44359
   Sokolov A. N., 2011, ACCOUNTS CHEM RES, V45, P361
   Someya T, 2004, P NATL ACAD SCI USA, V101, P9966, DOI 10.1073/pnas.0401918101
   Stadler P, 2007, ORG ELECTRON, V8, P648, DOI 10.1016/j.orgel.2007.05.003
   Street RA, 2009, ADV MATER, V21, P2007, DOI 10.1002/adma.200803211
   Strukov DB, 2008, NATURE, V453, P80, DOI 10.1038/nature06932
   Sun XN, 2010, J MATER CHEM, V20, P2599, DOI 10.1039/b921449f
   Tang YX, 2015, CHEM SOC REV, V44, P5926, DOI 10.1039/c4cs00442f
   Tang-Schomer MD, 2014, ADV FUNCT MATER, V24, P1938, DOI 10.1002/adfm.201303196
   Tansil NC, 2012, ADV MATER, V24, P1388, DOI 10.1002/adma.201104118
   Tansil NC, 2011, ADV MATER, V23, P1463, DOI 10.1002/adma.201003860
   Tao H, 2014, P NATL ACAD SCI USA, V111, P17385, DOI 10.1073/pnas.1407743111
   Tao H, 2012, ADV MATER, V24, P2824, DOI 10.1002/adma.201104477
   Tao H, 2012, ADV MATER, V24, P1067, DOI 10.1002/adma.201103814
   Tao H, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3486157
   Tarascon JM, 2001, NATURE, V414, P359, DOI 10.1038/35104644
   Thompson SE, 2006, MATER TODAY, V9, P20, DOI 10.1016/S1369-7021(06)71539-5
   Tobjork D, 2011, ADV MATER, V23, P1935, DOI 10.1002/adma.201004692
   Tsai CL, 2012, ORG ELECTRON, V13, P3315, DOI 10.1016/j.orgel.2012.10.007
   Tsai LS, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4841595
   Uenuma M, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/21/215201
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Veres J, 2004, CHEM MATER, V16, P4543, DOI 10.1021/cm049598q
   Wang CH, 2011, ADV MATER, V23, P1630, DOI 10.1002/adma.201004071
   Wang H, 2015, ADV MATER, V27, P7670, DOI 10.1002/adma.201405728
   Wang H, 2015, ADV FUNCT MATER, V25, P3825, DOI 10.1002/adfm.201501389
   Wang H, 2013, ADV MATER, V25, P5498, DOI 10.1002/adma.201301983
   Wang H, 2014, ADV MATER, V26, P3638, DOI 10.1002/adma.201305682
   Wang H, 2013, ACS NANO, V7, P5131, DOI 10.1021/nn400731g
   Wang JC, 2012, J MATER CHEM, V22, P23710, DOI 10.1039/c2jm34066f
   Wang T, 2012, ADV FUNCT MATER, V22, P435, DOI 10.1002/adfm.201101011
   Wang T, 2011, CRYST GROWTH DES, V11, P2164, DOI 10.1021/cg101410u
   Wang XW, 2014, ADV MATER, V26, P1336, DOI 10.1002/adma.201304248
   Wang Y, 2014, ORG ELECTRON, V15, P3476, DOI 10.1016/j.orgel.2014.09.042
   Waser R, 2007, NAT MATER, V6, P833, DOI 10.1038/nmat2023
   Waser R, 2009, ADV MATER, V21, P2632, DOI 10.1002/adma.200900375
   Webb RC, 2013, NAT MATER, V12, P938, DOI [10.1038/NMAT3755, 10.1038/nmat3755]
   Wen YG, 2011, CHEM REV, V111, P3358, DOI 10.1021/cr1001904
   Xu XJ, 2012, ADV FUNCT MATER, V22, P4139, DOI 10.1002/adfm.201200316
   Yang JJS, 2013, NAT NANOTECHNOL, V8, P13, DOI [10.1038/nnano.2012.240, 10.1038/NNANO.2012.240]
   Yang YC, 2013, NANOSCALE, V5, P10076, DOI 10.1039/c3nr03472k
   Yao HB, 2014, ADV MATER, V26, P163, DOI 10.1002/adma.201303470
   Yin GF, 2011, J COLLOID INTERF SCI, V363, P393, DOI 10.1016/j.jcis.2011.07.009
   Yin L, 2014, ADV FUNCT MATER, V24, P645, DOI 10.1002/adfm.201301847
   Yin SY, 2013, ADV FUNCT MATER, V23, P2972, DOI 10.1002/adfm.201203491
   Yoon MH, 2005, J AM CHEM SOC, V127, P10388, DOI 10.1021/JA052488f
   You XQ, 2014, SENSOR ACTUAT B-CHEM, V202, P1357, DOI 10.1016/j.snb.2014.04.079
   Yumusak C, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3278592
   Yun YS, 2014, MACROMOL RES, V22, P509, DOI 10.1007/s13233-014-2071-4
   Yun YS, 2013, ADV MATER, V25, P1993, DOI 10.1002/adma.201204692
   Zang Y., 2015, NAT COMMUN, V6
   Zhai YP, 2011, ADV MATER, V23, P4828, DOI 10.1002/adma.201100984
   Zhang LL, 2009, CHEM SOC REV, V38, P2520, DOI 10.1039/b813846j
   Zhang XL, 2013, ACTA BIOMATER, V9, P6974, DOI 10.1016/j.actbio.2013.03.004
   Zheng GY, 2013, MRS BULL, V38, P320, DOI 10.1557/mrs.2013.59
   Zhu BW, 2014, SMALL, V10, P3625, DOI 10.1002/smll.201401207
   Zhu XJ, 2012, ADV MATER, V24, P3941, DOI 10.1002/adma.201201506
   Zhu YW, 2011, SCIENCE, V332, P1537, DOI 10.1126/science.1200770
   Zschieschang U, 2011, ADV MATER, V23, P654, DOI 10.1002/adma.201003374
NR 175
TC 88
Z9 89
U1 75
U2 434
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 0935-9648
EI 1521-4095
J9 ADV MATER
JI Adv. Mater.
PD JUN 8
PY 2016
VL 28
IS 22
SI SI
BP 4250
EP 4265
DI 10.1002/adma.201504276
PG 16
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA DN5PV
UT WOS:000377123500006
PM 26684370
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Safonov, VG
AF Safonov, Vladimir G.
TI Beaver trapping in Russia and Belarus and problems of resources
   management
SO RUSSIAN JOURNAL OF THERIOLOGY
LA English
DT Article
DE Eurasian beaver; North American beaver; population dynamics; trapping
   regulation; management; ecosystem; Russia; Belarus
AB In the Soviet Union experimental kill trapping (removal trapping) of Eurasian beaver began in 1960 in the Kirov region, and since 1963 the limited kill trapping was also permitted throughout Russia and Belarus. Regular trapping allowed obtaining large amounts of biomaterial, which significantly widened our knowledge on the general population ecology of beavers and on their behaviour during the under-ice period when observation is limited. The current decrease in demand for furs requires the realization of scientifically sound measures for beaver management based on ecological priorities.
C1 [Safonov, Vladimir G.] Russian Res Inst Game Management & Fur Farming, Dept Anim Ecol, Preobrazhenskaya Str 79, Kirov 610000, Russia.
RP Safonov, VG (reprint author), Russian Res Inst Game Management & Fur Farming, Dept Anim Ecol, Preobrazhenskaya Str 79, Kirov 610000, Russia.
EM safonov.vniioz@mail.ru
CR BARABASH-NIKIFOROV I. I., 1961, TR KHOPERSK GOS ZAPOVEDNIKA, V5, P3
   Borodina M.A., 1960, T OKSKOGO GOSZAPOVED, V3, P41
   BOYCE MS, 1981, J APPL ECOL, V18, P749, DOI 10.2307/2402366
   Danilov PI, 2015, RUSS J ECOL+, V46, P272, DOI 10.1134/S1067413615030029
   Danilov P. I., 2007, BEAVERS RUSSIAN EURO
   Durka W, 2005, MOL ECOL, V14, P3843, DOI 10.1111/j.1365-294X.2005.02704.x
   Emelyanov A. V., 2012, SYSTEM RES ECOLOGY R
   Halley D, 2012, BALT FOR, V18, P168
   Helgen K.M., 2005, MAMMALS SPECIES WORL, V2, P842
   Khlyap L. A., 2011, Russian Journal of Biological Invasions, V2, P293, DOI 10.1134/S2075111711040059
   Korth William W., 2001, Journal of Mammalian Evolution, V8, P279, DOI 10.1023/A:1014468732231
   Kudryashov V.S., 1980, BIOL OSNOVY OKHOTNIC, P45
   Larson J.S., 1983, Acta Zoologica Fennica, P91
   Lavrov L. S., 1983, ACTA ZOOL FENN, V174, P87
   Lavsund S., 1977, 26 I SCOGSZ SKOGSH, P8
   Litvinov V.F., 2012, POPULATION ECOLOGY B
   MILISHNIKOV AN, 1994, GENETIKA+, V30, P529
   Milishnikov AN, 2001, RUSS J GENET+, V37, P108, DOI 10.1023/A:1009039113581
   Nitsche K.-A., 2003, MOEGLICHKEITEN MASSN
   Nolet BA, 1998, BIOL CONSERV, V83, P165, DOI 10.1016/S0006-3207(97)00066-9
   NOVAK M, 1987, WILD FURBEARER MANAG, P283
   Odum E. P., 1975, FUNDAMENTALS ECOLOGY
   Oleynikov A. Yu., 2013, RUSSIAN J BIOL INVAS, V4, P180
   Owens R., 1968, FOREST FARMER, V28, P12
   PARSONS G, 1978, NEW YORK FISH GAME J, V25, P23
   SAFONOV V. G., 1966, BYUL MOSK OBSHCHEST ISPYT PRIR OTD BIOL, V71, P5
   SAFONOV V. G., 1964, SB NAUCH TEKH INFORM VSES NAUCH ISSLED DJST ZHIVOTN SYR YA PUSHNINY, V10, P42
   Safonov V.G., 1971, T KIROVSKOGO SELSKOK, V28, P25
   Safonov V.G., 1965, SBORNIK NAUCHNO TEKH, V12, P26
   Safonov V.G., 1962, OKHOTA OKHOTNICHYE K, P24
   Safonov V.G., 1962, SBORNIK NAUCHNO TEKH, V4, P3
   Saveljev A.P., 2003, THESIS
   Senn H, 2014, EVOL APPL, V7, P645, DOI 10.1111/eva.12162
   Vostokov E.K., 2014, BEAVER IN BELARUS
   [Зарубин Б.Е. Zarubin B.E.], 2015, [Аграрная наука Евро-Северо-Востока, Agrarnaya nauka Evro-Severo-Vostoka], P70
   Zarubin B.E., 2015, BEAV GEN VAR LANDSC, P72
   Zharkov I.V., 1968, THESIS
   Zurowski W., 1983, Acta Zoologica Fennica, P85
NR 38
TC 0
Z9 0
U1 1
U2 3
PU KMK SCIENTIFIC PRESS LTD, MOSCOW STATE UNIV
PI MOSCOW
PA ZOOLOGICAL MUSEUM, BOLSHAYA NIKITSKAYA STREET 6, MOSCOW, 00000, RUSSIA
SN 1682-3559
J9 RUSS J THERIOL
JI Russ. J. Theriol.
PD JUN 6
PY 2016
VL 15
IS 1
BP 2
EP 7
PG 6
WC Zoology
SC Zoology
GA DO3LQ
UT WOS:000377683500002
DA 2018-10-20
ER

PT J
AU Ozmen, Y
AF Ozmen, Yilmaz
TI Si3N4 as a biomaterial and its tribo-characterization under water
   lubrication
SO LUBRICATION SCIENCE
LA English
DT Article
DE silicon nitride; water lubrication; biomaterial; total joint
   replacements; friction; wear
ID TOTAL HIP-ARTHROPLASTY; SILICON-NITRIDE; JOINT REPLACEMENTS;
   LOW-FRICTION; WEAR; CERAMICS; IMPLANTS; ALUMINA; LAYER; MICROSTRUCTURE
AB Hip implant wear is recognised as the main cause of hip implant failure therefore has been widely investigated both experimentally and clinically, demonstrating the coexistence of abrasive, adhesive, fatigue and corrosive wear. Many clinical in vivo and bulk material wear rate data from published literature have been presented for non-oxide ceramic implants. Several studies have shown that the coefficient of friction of self-mated silicon nitride in water decreases from an initially high value to about 0.002 after a certain run-in period. Since the worn surfaces become extremely smooth, the low friction is attributed to the initiation of hydrodynamic lubrication by a thin water film at the interface. The possibility of mixed lubrication, i.e. hydrodynamic lubrication by water and boundary lubrication due to the presence of colloidal silica on the wearing surfaces, has also been proposed.
   Influence of load, speed and surface roughness on the duration of the run-in period of silicon nitride under water lubrication was investigated in this study. The results confirmed that a low coefficient of friction is obtained following a run-in period when a wear scar of sufficient size is developed to reduce the contact stress. The run-in period, during which the coefficient of friction is fairly high, is shorter for smoother surfaces and at higher loads and speeds. The striations that appeared to be associated with the high-friction spikes can be formed as a result of surface film breakdown. Although the results are consistent with the proposed mechanisms of hydrodynamic lubrication or mixed lubrication, it is proposed that the low-friction behaviour may also be related to fundamental interactions between two hard and elastically deforming surfaces covered with hydrogen-terminated oxide films. Copyright (C) 2016 John Wiley & Sons, Ltd.
C1 [Ozmen, Yilmaz] Pamukkale Univ, Dept Biomed Engn, TR-20070 Denizli, Turkey.
RP Ozmen, Y (reprint author), Pamukkale Univ, Dept Biomed Engn, TR-20070 Denizli, Turkey.
EM yilmaz.ozmen@gmail.com
FU DARPA
FX The author is grateful to Dr. Said Jahanmir, who guided and supported
   this project, for his enthusiastic encouragement and his tremendous
   contribution to tribology. The tribochemically polished disks were
   supplied by Professor T.E. Fischer at Stevens Institute of Technology.
   This project was supported by DARPA.
CR Adachi K, 2000, WEAR, V245, P84, DOI 10.1016/S0043-1648(00)00468-3
   AKAZAWA M, 1988, WEAR, V124, P123, DOI 10.1016/0043-1648(88)90239-6
   Bal BS, 2012, ACTA BIOMATER, V8, P2889, DOI 10.1016/j.actbio.2012.04.031
   Bal BS, 2008, J BIOMED MATER RES B, V87B, P447, DOI 10.1002/jbm.b.31123
   Bal BS, 2009, J ARTHROPLASTY, V24, P110, DOI 10.1016/j.arth.2008.01.300
   Bal BS, 2011, ADV CERAMICS ELECT M, DOI [10.5772/19381, DOI 10.5772/19381.ISBN:978-953-307-350-7]
   Buford A, 2004, MATER DESIGN, V25, P385, DOI 10.1016/j.matdes.2003.11.010
   Chen CY, 2013, TRIBOL LETT, V51, P127, DOI 10.1007/s11249-013-0153-7
   Chen CY, 2012, APPL PHYS A-MATER, V107, P345, DOI 10.1007/s00339-012-6822-9
   Chen M, 2002, TRIBOL INT, V35, P129, DOI 10.1016/S0301-679X(01)00105-0
   Ferreira V, 2012, WEAR, V296, P656, DOI 10.1016/j.wear.2012.07.030
   FISCHER TE, 1985, WEAR, V105, P29, DOI 10.1016/0043-1648(85)90004-3
   Hah SR, 1995, TRIBOCHEMICAL FINISH, V4
   Hanawa T, 2004, MAT SCI ENG C-BIO S, V24, P745, DOI 10.1016/j.msec.2004.08.018
   HOWLETT CR, 1989, CLIN ORTHOP RELAT R, P293
   Huang W, 2011, WEAR, V270, P682, DOI 10.1016/j.wear.2011.01.033
   Jahanmir S, 2004, TRIBOL LETT, V17, P409, DOI 10.1023/B:TRIL.0000044489.44053.be
   Jahanmir S, 2002, P I MECH ENG J-J ENG, V216, P371, DOI 10.1243/135065002762355307
   JAHANMIR S, 1988, TRIBOL T, V31, P32, DOI 10.1080/10402008808981795
   Kato K, 2002, WEAR, V253, P1097, DOI 10.1016/S0043-1648(02)00240-5
   Kotzar G, 2002, BIOMATERIALS, V23, P2737, DOI 10.1016/S0142-9612(02)00007-8
   Kristensen BW, 2001, BRAIN RES, V896, P1, DOI 10.1016/S0006-8993(00)03304-7
   Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222
   Laarz E, 2000, J AM CERAM SOC, V83, P2394
   Landgraeber S, 2008, BIOMATERIALS, V29, P3444, DOI 10.1016/j.biomaterials.2008.04.044
   LaVan DA, 2003, NAT BIOTECHNOL, V21, P1184, DOI 10.1038/nbt876
   Litwin W, 2015, TRIBOL INT, V82, P153, DOI 10.1016/j.triboint.2014.10.002
   Ma LR, 2012, CHINESE SCI BULL, V57, P2062, DOI 10.1007/s11434-012-5031-4
   Mattei L, 2011, TRIBOL INT, V44, P532, DOI 10.1016/j.triboint.2010.06.010
   Mazzocchi M, 2008, J MATER SCI-MATER M, V19, P2881, DOI 10.1007/s10856-008-3417-2
   Muratov VA, 1998, TRIBOL INT, V31, P601, DOI 10.1016/S0301-679X(98)00081-4
   Neumann A, 2006, OTOLARYNG HEAD NECK, V134, P923, DOI 10.1016/j.otohns.2006.01.022
   Neumann A, 2006, HNO, V54, P937, DOI 10.1007/s00106-006-1397-4
   Neumann A, 2004, LARYNGO RHINO OTOL, V83, P845, DOI 10.1055/s-2004-825739
   Oloffson J., 2011, THESIS, P66
   Olofsson Johanna, 2012, Biomatter, V2, P94, DOI 10.4161/biom.20710
   Pettersson M, 2013, J MECH BEHAV BIOMED, V25, P41, DOI 10.1016/j.jmbbm.2013.05.002
   Rahaman MN, 2007, J AM CERAM SOC, V90, P1965, DOI 10.1111/j.1551-2916.2007.01725.x
   Ratoi M, 1999, TRIBOL T, V42, P479, DOI 10.1080/10402009908982244
   Saito T, 2001, WEAR, V247, P223, DOI 10.1016/S0043-1648(00)00539-1
   Sargeant A, 2006, MATER DESIGN, V27, P287, DOI 10.1016/j.matdes.2004.10.028
   Sargeant A, 2007, MATER DESIGN, V28, P155, DOI 10.1016/j.matdes.2005.05.018
   SASAKI S, 1989, WEAR, V134, P185, DOI 10.1016/0043-1648(89)90068-9
   Silva CCG, 2004, MAT SCI ENG C-BIO S, V24, P643, DOI 10.1016/j.msec.2004.08.007
   Sonntag R, 2012, ACTA BIOMATER, V8, P2434, DOI 10.1016/j.actbio.2012.03.029
   Sorrell CC, 2004, T 7 WORLD BIOM C
   Takadoum J, 1998, J EUR CERAM SOC, V18, P553, DOI 10.1016/S0955-2219(97)00157-X
   Tokoro M, 2009, WEAR, V267, P2167, DOI 10.1016/j.wear.2009.04.009
   Wong PL, 2003, TRIBOL LETT, V14, P197, DOI 10.1023/A:1022320531293
   Xu JG, 2000, WEAR, V245, P61, DOI 10.1016/S0043-1648(00)00466-X
   Xu JG, 1997, WEAR, V205, P55, DOI 10.1016/S0043-1648(96)07283-3
   Zhou YS, 1997, WEAR, V210, P171, DOI 10.1016/S0043-1648(97)00066-5
   Zhou YS, 1997, MAT SCI ENG C-BIOMIM, V5, P125, DOI 10.1016/S0928-4931(97)00032-5
NR 53
TC 3
Z9 3
U1 0
U2 11
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0954-0075
EI 1557-6833
J9 LUBR SCI
JI Lubr. Sci.
PD JUN
PY 2016
VL 28
IS 4
BP 243
EP 254
DI 10.1002/ls.1329
PG 12
WC Engineering, Chemical; Engineering, Mechanical
SC Engineering
GA DW5XZ
UT WOS:000383722300004
DA 2018-10-20
ER

PT J
AU Banlunara, W
   Songsiripadapboon, S
   Jiemsirilers, S
   Saravari, O
   Kashima, DP
   Thunyakitpisal, N
   Brikshavana, P
   Srisuwan, P
   Rupunt, T
   Thunyakitpisal, P
AF Banlunara, Wijit
   Songsiripadapboon, Siriporn
   Jiemsirilers, Sirithan
   Saravari, Onusa
   Kashima, Dujreutai Pongkao
   Thunyakitpisal, Nonglax
   Brikshavana, Pasakorn
   Srisuwan, Phanitnan
   Rupunt, Thitima
   Thunyakitpisal, Pasutha
TI Pulp-dentin Complex Response to RU-HBM1, a Novel Resin Modified Glass
   Ionomer Cement Prototype, in Deep Cavity Preparation of Porcine Teeth
SO THAI JOURNAL OF VETERINARY MEDICINE
LA English
DT Article
DE animal study; biocompatibility; histopathology; reactionary dentin; RMGI
ID REACTIONARY DENTINOGENESIS; CALCIUM HYDROXIDE; BIOCOMPATIBILITY; LINERS
AB The objective of this study was to evaluate the response of the pulp-dentin complex to Research Unit-Herbal Medicine, Biomaterial and Material 1 (RU-HBM1), a resin-modified glass ionomer (RMGI) cement prototype, in deep cavity of porcine teeth compared with commercial RMGIs. Six 14-week-old pigs were used in this study. Deep class V cavity was created on the buccal surface of canine, premolar, and molar teeth. The teeth were randomly lined with the design cement bases: RU-HBM1, Vitrebond (TM) (VB), or GC-Gold Label Light-Cured Universal Restorative (GC). After that, the cavity walls were treated with 30% phosphoric acid and washed. Then, a bonding agent was applied and the cavities were restored using light-cured resin-based material (Filtek (TM) Z250XT, 3M ESPE). The teeth were extracted at 7, 30, and 70 days post-operation, sectioned and stained for histopathological evaluation. Data were collected and analyzed using SPSS program. It was found that the RU-HBM1, VB, and GC groups had no inflammatory reaction at all time points of observation except one sample in the VB group had mild reaction at day 7. Reactionary dentin formation was detected in all groups at 30 and 70 days post-treatment. Normal pulp tissue pattern and cellular organization were observed in all groups at all time points of observation. There was no significant difference in the overall histopathological scores of the RU-HBM1, VB, and GC groups at all time points of evaluation (p>0.05). In condusion, RU-HBM1, a novel resin-modified glass ionomer cement prototype, is biocompatible for deep cavity prepared in intact teeth.
C1 [Banlunara, Wijit] Chulalongkorn Univ, Dept Pathol, Fac Vet Sci, Bangkok 10330, Thailand.
   [Banlunara, Wijit; Songsiripadapboon, Siriporn; Jiemsirilers, Sirithan; Kashima, Dujreutai Pongkao; Thunyakitpisal, Nonglax; Srisuwan, Phanitnan; Rupunt, Thitima; Thunyakitpisal, Pasutha] Chulalongkorn Univ, Res Unit Herbal Med Biomat & Mat Dent Treatment, Bangkok 10330, Thailand.
   [Songsiripadapboon, Siriporn] Chulalongkorn Univ, Fac Dent, Dept Pediat Dent, Bangkok 10330, Thailand.
   [Jiemsirilers, Sirithan; Saravari, Onusa; Kashima, Dujreutai Pongkao] Chulalongkorn Univ, Dept Mat Sci, Fac Sci, Bangkok 10330, Thailand.
   [Brikshavana, Pasakorn] Chulalongkorn Univ, Dept Surg, Fac Vet Sci, Bangkok 10330, Thailand.
   [Thunyakitpisal, Pasutha] Chulalongkorn Univ, Fac Dent, Dept Anat, Bangkok 10330, Thailand.
RP Thunyakitpisal, P (reprint author), Chulalongkorn Univ, Res Unit Herbal Med Biomat & Mat Dent Treatment, Bangkok 10330, Thailand.; Thunyakitpisal, P (reprint author), Chulalongkorn Univ, Fac Dent, Dept Anat, Bangkok 10330, Thailand.
EM pthunyak@yahoo.com
FU Thai Government Research Fund; National Research University Project,
   Office of Higher Education Commission [WCU-030-AM-57]
FX We would like to thank Professor Visaka Limwong, Associate Professor Dr.
   Dolly Methatharathip, and Dr. Kevin Tompkins for their valuable
   suggestions. This project was supported by Thai Government Research Fund
   and National Research University Project, Office of Higher Education
   Commission (WCU-030-AM-57).
CR Costa CAD, 2007, J BIOMED MATER RES B, V81B, P175, DOI 10.1002/jbm.b.30651
   Bleicher F, 2014, EXP CELL RES, V325, P65, DOI 10.1016/j.yexcr.2013.12.012
   Couve E, 2014, J DENT RES, V93, P788, DOI 10.1177/0022034514539507
   Croll Theodore P, 2002, Pediatr Dent, V24, P423
   Darvell B. W., 2009, MAT SCI DENT, P214
   de Souza Costa CA, 2003, DENT MATER, V19, P739
   Costa CAD, 2006, DENT MATER, V22, P954, DOI 10.1016/j.dental.2005.10.007
   Duque C, 2006, J ORAL REHABIL, V33, P452, DOI 10.1111/j.1365-2842.2005.01585.x
   Faraco Junior Italo Medeiros, 2004, Braz. Dent. J., V15, P104, DOI 10.1590/S0103-64402004000200004
   Ibarra-Montano E. L., 2015, J APPL SOLUTION CHEM, V4, P7
   Khoroushi M, 2012, OPER DENT, V37, P54, DOI 10.2341/11-137-L
   Kruthkul K, 2012, VALUE CREATION MED D
   Leites AB, 2011, OPER DENT, V36, P448, DOI 10.2341/10-321-L
   Mickenautsch S, 2010, DENT MATER, V26, P761, DOI 10.1016/j.dental.2010.03.021
   MITRA SB, 1994, DENT MATER, V10, P78, DOI 10.1016/0109-5641(94)90044-2
   MOUNT GJ, 1994, OPER DENT, V19, P82
   Mousavinasab Majid, 2008, J Calif Dent Assoc, V36, P51
   Nicholson JW, 2008, DENT MATER, V24, P1702, DOI 10.1016/j.dental.2008.04.005
   Pameijer Cornelis H, 2015, J Clin Dent, V26, P23
   Shayegan A, 2009, DENT TRAUMATOL, V25, P413, DOI 10.1111/j.1600-9657.2009.00799.x
   Shen C., 2013, PHILIPS SCI DENT MAT, P307
   Shimada Y, 2004, OPER DENT, V29, P23
   Tarim B, 1998, QUINTESSENCE INT, V29, P535
   Thunyakitpisal P., 2015, JDAT, V65, P189
   Uzzaman MA, 2005, DENT MATER J, V24, P178
   Volk J, 2009, DENT MATER, V25, P1556, DOI 10.1016/j.dental.2009.07.009
   Watana J. C., 2002, RESTORATIVE DENT MAT, P125
   Yano J, 2011, J APPL ORAL SCI, V19, P218, DOI 10.1590/S1678-77572011000300007
NR 28
TC 0
Z9 0
U1 0
U2 2
PU CHULALONGKORN UNIV
PI BANGKOK
PA FAC VETERINARY SCI, HENRI DUNANT RD, BANGKOK, 10330, THAILAND
SN 0125-6491
J9 THAI J VET MED
JI Thai J. Vet. Med.
PD JUN
PY 2016
VL 46
IS 2
BP 185
EP 193
PG 9
WC Veterinary Sciences
SC Veterinary Sciences
GA EB2NJ
UT WOS:000387198800001
DA 2018-10-20
ER

PT J
AU Chang, TJ
   Wang, LB
   Zhao, KX
   Ge, Y
   He, M
   Li, G
AF Chang, Tianjun
   Wang, Libo
   Zhao, Kexu
   Ge, Yu
   He, Meng
   Li, Gang
TI Duplex Identification of Staphylococcus aureus by Aptamer and Gold
   Nanoparticles
SO JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
LA English
DT Article
DE Aptamer; Gold Nanoparticle; Biomaterial; Pathogenic Bacterium; Molecular
   Recognition
ID COLORIMETRIC DETECTION; RAPID DETECTION; BACTERIA; AGGREGATION;
   APTASENSORS; PATHOGENS; SELECTION; PROTEINS; PROGRESS; LIGANDS
AB Staphylococcus aureus is the top common pathogen causing infections and food poisoning. Identification of S. aureus is crucial for the disease diagnosis and regulation of food hygiene. Herein, we report an aptamer-AuNPs based method for duplex identification of S. aureus. Using AuNPs as an indicator, SA23, an aptamer against S. aureus, can well identify its target from Escherichia coli, Listeria monocytogenes and Pseudomonas aeruginosa. Furthermore, we find citrate-coated AuNPs can strongly bind to S. aureus, but not bind to Salmonella enterica and Proteus mirabilis, which leads to different color changes in salt solution. This colorimetric response is capable of distinguishing S. aureus from S. enteritidis and P. mirabilis. Thus, using the aptasensor and AuNPs together, S. aureus can be accurately identified from the common pathogens. This duplex identification system is a promising platform for simple visual identification of S. aureus. Additionally, in the aptasensing process, bacteria are incubated with aptamers and then be removed before the aptamers adding to AuNPs, which may avoid the interactions between bacteria and AuNPs. This strategy can be potentially applied in principle to detect other cells by AuNPs-based aptasensors.
C1 [Chang, Tianjun; Zhao, Kexu; Ge, Yu; He, Meng; Li, Gang] Henan Polytech Univ, Inst Resources & Environm, Jiaozuo 454000, Peoples R China.
   [Wang, Libo] Henan Polytech Univ, Inst Mat Sci & Engn, Jiaozuo 454000, Peoples R China.
RP Chang, TJ; Li, G (reprint author), Henan Polytech Univ, Inst Resources & Environm, Jiaozuo 454000, Peoples R China.
RI Chang, Tianjun/F-4460-2016
OI Chang, Tianjun/0000-0003-2030-9868
FU Henan Polytechnic University [B2013-068]
FX We gratefully acknowledge the financial support from the Doctoral
   Program of Henan Polytechnic University (Grant Numbers B2013-068). We
   also thank Dr. Dongyan Li for the helpful discussion.
CR Bing T, 2010, BIOSENS BIOELECTRON, V25, P1487, DOI 10.1016/j.bios.2009.11.003
   Cao XX, 2009, NUCLEIC ACIDS RES, V37, P4621, DOI 10.1093/nar/gkp489
   Chang TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062348
   Cheng JC, 2006, CLIN CHEM, V52, P1997, DOI 10.1373/clinchem.2006.069286
   Cho EJ, 2009, ANNU REV ANAL CHEM, V2, P241, DOI 10.1146/annurev.anchem.1.031207.112851
   DIRIENZO JM, 1978, ANNU REV BIOCHEM, V47, P481, DOI 10.1146/annurev.bi.47.070178.002405
   ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0
   GRABAR KC, 1995, ANAL CHEM, V67, P735, DOI 10.1021/ac00100a008
   Hayden SC, 2012, J AM CHEM SOC, V134, P6920, DOI 10.1021/ja301167y
   He XX, 2014, J BIOMED NANOTECHNOL, V10, P1359, DOI 10.1166/jbn.2014.1828
   Hennekinne JA, 2012, FEMS MICROBIOL REV, V36, P815, DOI 10.1111/j.1574-6976.2011.00311.x
   Iliuk AB, 2011, ANAL CHEM, V83, P4440, DOI 10.1021/ac201057w
   Li HX, 2004, P NATL ACAD SCI USA, V101, P14036, DOI 10.1073/pnas.0406115101
   Li ZX, 2014, J NANOSCI NANOTECHNO, V14, P905, DOI 10.1166/jnn.2014.8743
   Lin MH, 2013, ADV MATER, V25, P3490, DOI 10.1002/adma.201301333
   Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806
   Mei HC, 2012, ANAL CHEM, V84, P7323, DOI 10.1021/ac300281u
   Nakayama T, 2014, BIOSENS BIOELECTRON, V60, P175, DOI 10.1016/j.bios.2014.03.074
   Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174
   Niu KL, 2014, J NANOSCI NANOTECHNO, V14, P5151, DOI 10.1166/jnn.2014.8703
   Paniel N, 2013, METHODS, V64, P229, DOI 10.1016/j.ymeth.2013.07.001
   Shangguan D, 2006, P NATL ACAD SCI USA, V103, P11838, DOI 10.1073/pnas.0602615103
   Shen SF, 2011, J BIOMED NANOTECHNOL, V7, P691, DOI 10.1166/jbn.2011.1329
   Sung YJ, 2013, BIOSENS BIOELECTRON, V43, P432, DOI 10.1016/j.bios.2012.12.052
   Torres-Chavolla E, 2009, BIOSENS BIOELECTRON, V24, P3175, DOI 10.1016/j.bios.2008.11.010
   TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121
   Velasco V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097617
   Verma MS, 2014, BIOSENS BIOELECTRON, V61, P386, DOI 10.1016/j.bios.2014.05.045
   Wang S, 2014, ANAL CHEM, V86, P8261, DOI 10.1021/ac501657g
   Wu WH, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-658
   Xi ZJ, 2014, J BIOMED NANOTECHNOL, V10, P3043, DOI 10.1166/jbn.2014.1979
   Zhang SY, 2014, ACS APPL MATER INTER, V6, P21184, DOI 10.1021/am506112u
   Zhao W, 2008, CHEMBIOCHEM, V9, P2363, DOI 10.1002/cbic.200800282
NR 33
TC 9
Z9 10
U1 4
U2 39
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1533-4880
EI 1533-4899
J9 J NANOSCI NANOTECHNO
JI J. Nanosci. Nanotechnol.
PD JUN
PY 2016
VL 16
IS 6
BP 5513
EP 5519
DI 10.1166/jnn.2016.11656
PG 7
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA DZ8MG
UT WOS:000386123900011
PM 27427591
DA 2018-10-20
ER

PT J
AU Dong, JM
   Yu, HF
   Xiao, XY
   Li, Y
   Wu, CY
   Wen, J
   Tan, YS
   Chang, CG
   Zheng, WX
AF Dong Jinmei
   Yu Hongfa
   Xiao Xueying
   Li Ying
   Wu Chengyou
   Wen Jing
   Tan Yongshan
   Chang Chenggong
   Zheng Weixin
TI Effects of Calcination Temperature of Boron-Containing Magnesium Oxide
   Raw Materials on Properties of Magnesium Phosphate Cement as a
   Biomaterial
SO JOURNAL OF WUHAN UNIVERSITY OF TECHNOLOGY-MATERIALS SCIENCE EDITION
LA English
DT Article
DE magnesium phosphate bone cement; boron-containing magnesium oxide;
   calcination temperature
ID RAPID REPAIR; CONCRETE; CERAMICS; ADHESIVE; STRENGTH; BINDER
AB A new magnesium phosphate bone cement (MPBC) was prepared as a byproduct of boron-containing magnesium oxide (B-MgO) after extracting Li2CO3 from salt lakes. We analyzed the elementary composition of the B-MgO raw materials and the effects of calcination temperature on the performance of MPBC. The phase composition and microstructure of the B-MgO raw materials and the hydration products (KMgPO4 center dot 6H(2)O) of MPBC were analyzed by X-ray diffraction and scanning electron microscopy. The results showed that ionic impurities and the levels of toxic elements were sufficiently low in B-MgO raw materials to meet the medical requirements for MgO (Chinese Pharmacopeia, 2010 Edition) and for hydroxyapatite surgical implants (GB23101.1-2008). The temperature of B-MgO calcination had a marked influence on the hydration and hardening of MPBC pastes. Increasing calcination temperature prolonged the time required for the MPBC slurry to set, significantly decreased the hydration temperature, and prolonged the time required to reach the highest hydration temperature. However, the compressive strength of hardened MPBC did not increase with higher calcination temperatures. In the 900-1 000 degrees C temperature range, the hardened MPBC had a higher compressive strength. Imaging analysis suggested that the setting time and the highest hydration temperature of MPBC pastes were dependent on the size and crystal morphology of the B-MgO materials. The production and microstructure compactness of KMgPO4 center dot 6H(2)O, the main hydration product, determined the compressive strength.
C1 [Dong Jinmei; Yu Hongfa; Xiao Xueying; Li Ying; Wu Chengyou; Wen Jing; Tan Yongshan; Chang Chenggong; Zheng Weixin] Chinese Acad Sci, Qinghai Inst Salt Lakes, Xining 810008, Peoples R China.
   [Yu Hongfa] Qinghai Univ, Civil Engn Inst, Xining 810016, Peoples R China.
   [Yu Hongfa] Nanjing Univ Aeronaut & Astronaut, Dept Civil Engn, Nanjing 210016, Peoples R China.
RP Yu, HF (reprint author), Chinese Acad Sci, Qinghai Inst Salt Lakes, Xining 810008, Peoples R China.; Yu, HF (reprint author), Qinghai Univ, Civil Engn Inst, Xining 810016, Peoples R China.; Yu, HF (reprint author), Nanjing Univ Aeronaut & Astronaut, Dept Civil Engn, Nanjing 210016, Peoples R China.
EM dongda839@163.com; yuhongfa@nuaa.edu.cn
FU National Natural Science Foundation of China [21276264]; Qinghai
   Province Science and Technology Department [2013-G-208]
FX Funded by the National Natural Science Foundation of China (No.21276264)
   and the Qinghai Province Science and Technology
   Department(No.2013-G-208)
CR Bruker, 2006, BRUK AXS 2006
   EUBANK WR, 1951, J AM CERAM SOC, V34, P225, DOI 10.1111/j.1151-2916.1951.tb11644.x
   Fang H S, 2009, GB2310112008ISO
   Gulotta LV, 2008, AM J SPORT MED, V36, P1290, DOI 10.1177/0363546508314396
   Jiang Q Y, 2011, J WUHAN UNIV TECHNOL, V23, P32
   Mestres G, 2011, ACTA BIOMATER, V7, P1853, DOI 10.1016/j.actbio.2010.12.008
   Moseke C, 2011, J MATER SCI-MATER M, V22, P2591, DOI 10.1007/s10856-011-4442-0
   Soudee E, 2002, CEMENT CONCRETE RES, V32, P153, DOI 10.1016/S0008-8846(01)00647-0
   State Pharmacopoeia Commission, 2010, PHARM PEOPL REP CH 2
   Wagh AS, 2003, J AM CERAM SOC, V86, P1838, DOI 10.1111/j.1151-2916.2003.tb03569.x
   Wang AJ, 2013, MAT SCI ENG C-MATER, V33, P5058, DOI 10.1016/j.msec.2013.08.031
   Waselau M, 2007, AM J VET RES, V68, P370, DOI 10.2460/ajvr.68.4.370
   Wu F, 2008, ACTA BIOMATER, V4, P1873, DOI 10.1016/j.actbio.2008.06.020
   Yang Q, 2000, MATER STRUCT, V33, P229, DOI 10.1007/BF02479332
   Yang QB, 2002, CEMENT CONCRETE RES, V32, P165, DOI 10.1016/S0008-8846(01)00651-2
   Yang QB, 1999, CEMENT CONCRETE RES, V29, P389, DOI 10.1016/S0008-8846(98)00230-0
NR 16
TC 2
Z9 2
U1 2
U2 17
PU JOURNAL WUHAN UNIV TECHNOLOGY
PI WUHAN
PA WUHAN UNIV TECHNOLOGY, WUHAN 430070, PEOPLES R CHINA
SN 1000-2413
EI 1993-0437
J9 J WUHAN UNIV TECHNOL
JI J. Wuhan Univ. Technol.-Mat. Sci. Edit.
PD JUN
PY 2016
VL 31
IS 3
BP 671
EP 676
DI 10.1007/s11595-016-1427-3
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA DY3YF
UT WOS:000385033600032
DA 2018-10-20
ER

PT J
AU Dordevic, L
   Najman, S
   Vasiljevic, P
   Miljkovic, M
   Ignjatovic, N
   Uskokovic, D
   Plavsic, M
AF Dordevic, Ljubisa
   Najman, Stevo
   Vasiljevic, Perica
   Miljkovic, Miroslav
   Ignjatovic, Nenad
   Uskokovic, Dragan
   Plavsic, Milenko
TI SCANNING ELECTRON MICROSCOPY ANALYSIS OF CHANGES OF
   HYDROXIAPATITE/POLY-L-LACTIDE WITH DIFFERENT MOLECULAR WEIGHT OF PLLA
   AFTER INTRAPERITONEAL IMPLANTATION
SO ACTA VETERINARIA-BEOGRAD
LA English
DT Article
DE calcium hydroxiapatite; poly-L-lactide; implant; mouse; peritoneum;
   collagen; SEM
ID COMPOSITE BIOMATERIALS; HAP/PLLA COMPOSITE; BONE; REGENERATION;
   SCAFFOLDS
AB Implantation of a biomaterial is one of the important trends in solving the problem of bone tissue loss. Calcium hydroxiapatite (HAp), as the most representative bone component is a serious candidate for such implantations. The synthetic polymer poly-L-lactide (PLLA) in HAp/PLLA is often used as a polymeric material, with a role in the substitution of bone tissue collagen fibers. Fibers of PLLA may strengthen HAp and its good bioresorption provides space for tissue remodeling. Differences in porosity, microstructure, compressive consistency as well as bioresorbility of HAp/PLLA may be achieved by using PLLA with different molecular weights. In this study HAp/PLLA composites with PLLA of different molecular weights (50,000; 160,000 and 430,000) were implanted in mouse peritoneum in order to examine the influence of the molecular weight of PLLA on morphology changes. Microstructural changes of biomaterial (HAp/PLLA) surface were analyzed one week, three weeks and four months after their implantation using Scanning Electron Microscopy. The results showed a significant difference in tissue reactions on the applied biocomposites, depending on their molecular weight. The most intense proliferation of cells was induced by HAp/PLLA 50,000 compared to HAp/PLLA 430,000 and HAp/PLLA 160,000. In the vicinity of HAp/PLLA 430,000 abundant erythrocytes were observed. The differences in biological reactions on the examined biocomposites are significant for their practical applications. HAp/PLLA composite biomaterials of different types and resorption rates require specific designing and programming to become suitable for particular purposes in an organism.
C1 [Dordevic, Ljubisa; Vasiljevic, Perica] Univ Nis, Fac Sci & Math, Dept Biol Ecol, Nish, Serbia.
   [Najman, Stevo; Miljkovic, Miroslav] Univ Nis, Sci Res Ctr Biomed, Fac Med, Nish, Serbia.
   [Ignjatovic, Nenad; Uskokovic, Dragan] Serbian Acad Arts & Sci, Inst Tech Sci, Belgrade, Serbia.
   [Plavsic, Milenko] Natl Acad Engn Serbia, Belgrade, Serbia.
RP Dordevic, L (reprint author), Univ Nis, Fac Sci & Math, Dept Biol Ecol, Nish, Serbia.
EM ljupce@pmf.ni.ac.rs
RI Ignjatovic, Nenad/C-4489-2008; Uskokovic, Dragan/B-4129-2008
OI Ignjatovic, Nenad/0000-0002-5749-094X; Uskokovic,
   Dragan/0000-0002-0421-4968; Vasiljevic, Perica/0000-0003-0006-7187
FU Ministry of Education, Science and Technological Development of Republic
   of Serbia [III 41017, III 45004]
FX This study was supported by the Ministry of Education, Science and
   Technological Development of Republic of Serbia, Project Grants III
   41017 and III 45004.
CR Angelova N, 1999, TRENDS BIOTECHNOL, V17, P409, DOI 10.1016/S0167-7799(99)01356-6
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Gao CD, 2014, INT J MOL SCI, V15, P4714, DOI 10.3390/ijms15034714
   Ignjatovic N, 1999, BIOMATERIALS, V20, P809, DOI 10.1016/S0142-9612(98)00234-8
   Ignjatovic N, 2001, BIOMATERIALS, V22, P571, DOI 10.1016/S0142-9612(00)00215-5
   Keating JF, 2001, J BONE JOINT SURG BR, V83B, P3, DOI 10.1302/0301-620X.83B1.11952
   KURASHINA K, 1995, BIOMATERIALS, V16, P119, DOI 10.1016/0142-9612(95)98273-H
   Lazic Z, 2014, ACTA VET-BEOGRAD, V64, P477, DOI 10.2478/acve-2014-0045
   MainilVarlet P, 1997, J BIOMED MATER RES, V36, P360, DOI 10.1002/(SICI)1097-4636(19970905)36:3<360::AID-JBM11>3.0.CO;2-I
   Mansourizadeh F, 2013, MOL BIOL RES COMMUN, V2, P1
   Najman S, 2004, BIO-MED MATER ENG, V14, P61
   Najman S., 2003, FACTA U, V10, P131
   Nejati E, 2009, MAT SCI ENG C-BIO S, V29, P942, DOI 10.1016/j.msec.2008.07.038
   Persson M, 2014, COLLOID SURFACE B, V121, P409, DOI 10.1016/j.colsurfb.2014.06.029
   Podlaha J, 2014, ACTA VET-BEOGRAD, V64, P426, DOI 10.2478/acve-2014-0040
   Ripamonti U, 1996, MRS BULL, V21, P36
   Wang Z, 2016, SCI REPORTS, V9, P20770
   Yanagida H, 2011, J ARTIF ORGANS, V14, P331, DOI 10.1007/s10047-011-0594-4
NR 18
TC 0
Z9 0
U1 0
U2 6
PU DE GRUYTER OPEN LTD
PI WARSAW
PA BOGUMILA ZUGA 32A ST, 01-811 WARSAW, POLAND
SN 0567-8315
EI 1820-7448
J9 ACTA VET-BEOGRAD
JI Acta Vet.-Beogr.
PD JUN
PY 2016
VL 66
IS 2
BP 234
EP 244
DI 10.1515/acve-2016-0020
PG 11
WC Veterinary Sciences
SC Veterinary Sciences
GA DY0ER
UT WOS:000384770600008
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Ricklin, D
   Lambris, JD
AF Ricklin, Daniel
   Lambris, John D.
TI New milestones ahead in complement-targeted therapy
SO SEMINARS IN IMMUNOLOGY
LA English
DT Review
DE Complement; Inflammation; Therapeutics; Immune modulation
ID PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; C3 INHIBITOR CP40; ALTERNATIVE
   PATHWAY; FACTOR-H; IN-VITRO; PHARMACOKINETIC PROPERTIES; BIOMATERIAL
   SURFACES; RHEUMATOID-ARTHRITIS; MACULAR DEGENERATION; CONVERTASE
   INHIBITOR
AB The complement system is a powerful effector arm of innate immunity that typically confers protection from microbial intruders and accumulating debris. In many clinical situations, however, the defensive functions of complement can turn against host cells and induce or exacerbate immune, inflammatory, and degenerative conditions. Although the value of inhibiting complement in a therapeutic context has long been recognized, bringing complement-targeted drugs into clinical use has proved challenging. This important milestone was finally reached a decade ago, yet the clinical availability of complement inhibitors has remained limited. Still, the positive long-term experience with complement drugs and their proven effectiveness in various diseases has reinvigorated interest and confidence in this approach. Indeed, a broad variety of clinical candidates that act at almost any level of the complement activation cascade are currently in clinical development, with several of them being evaluated in phase 2 and phase 3 trials. With antibody-related drugs dominating the panel of clinical candidates, the emergence of novel small-molecule, peptide, protein, and oligonucleotide-based inhibitors offers new options for drug targeting and administration. Whereas all the currently approved and many of the proposed indications for complement-targeted inhibitors belong to the rare disease spectrum, these drugs are increasingly being evaluated for more prevalent conditions. Fortunately, the growing experience from preclinical and clinical use of therapeutic complement inhibitors has enabled a more evidence-based assessment of suitable targets and rewarding indications as well as related technical and safety considerations. This review highlights recent concepts and developments in complement-targeted drug discovery, provides an overview of current and emerging treatment options, and discusses the new milestones ahead on the way to the next generation of clinically available complement therapeutics. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Ricklin, Daniel; Lambris, John D.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.
RP Ricklin, D; Lambris, JD (reprint author), Univ Penn, Perelman Sch Med, Stellar Chance Labs 401, 422 Curie Blvd, Philadelphia, PA 19104 USA.
EM ricklin@upenn.edu; lambris@upenn.edu
FU National Institutes of Health [AI068730, AI030040]; National Science
   Foundation [1423304]; European Community's Seventh Framework Programme
   (DIREKT) [602699]
FX We thank Dr. Deborah McClellan for her excellent editorial assistance.
   This work was supported by grants for the National Institutes of Health
   (AI068730, AI030040) and the National Science Foundation (1423304) and
   by funding from the European Community's Seventh Framework Programme,
   under grant agreement number 602699 (DIREKT).
CR Abdel-Magid AF, 2012, ACS MED CHEM LETT, V3, P781, DOI 10.1021/ml300233n
   Abe T, 2012, J IMMUNOL, V189, P5442, DOI 10.4049/jimmunol.1202339
   Anderson K., 2016, ARVO ANN M SEATTL WA
   BAKER BR, 1969, J MED CHEM, V12, P408, DOI 10.1021/jm00303a016
   Barratt-Due A, 2013, J IMMUNOL, V191, P819, DOI 10.4049/jimmunol.1201909
   Barratt-Due A, 2012, IMMUNOBIOLOGY, V217, P1047, DOI 10.1016/j.imbio.2012.07.019
   Berends ETM, 2015, MOL IMMUNOL, V65, P328, DOI 10.1016/j.molimm.2015.01.020
   Biglarnia AR, 2015, ADV EXP MED BIOL, V865, P211, DOI 10.1007/978-3-319-18603-0_13
   Boross P., 2016, ALT C 2016 INN HOST
   Brennan F.H., 2016, SEMIN IMMUNOL
   Brennan FH, 2015, J NEUROSCI, V35, P6517, DOI 10.1523/JNEUROSCI.5218-14.2015
   Cagliani R., 2016, MOL ECOL
   Chehoud C, 2013, P NATL ACAD SCI USA, V110, P15061, DOI 10.1073/pnas.1307855110
   Chen S, 2011, AM J TRANSPLANT, V11, P2057, DOI 10.1111/j.1600-6143.2011.03646.x
   Cooper DKC, 2015, INT J SURG, V23, P211, DOI 10.1016/j.ijsu.2015.06.068
   Coyle D, 2014, MED DECIS MAKING, V34, P1016, DOI 10.1177/0272989X14539731
   Crowley M., 2016, ARVO 2016 ANN M SEAT
   DeAngelis RA, 2012, IMMUNOBIOLOGY, V217, P1097, DOI 10.1016/j.imbio.2012.07.012
   DeZern AE, 2014, EXP HEMATOL, V42, P857, DOI 10.1016/j.exphem.2014.06.007
   Ekdahl KN, 2011, ADV DRUG DELIVER REV, V63, P1042, DOI 10.1016/j.addr.2011.06.012
   Flohr S., 2014, [No title captured], Patent No. [W02014002052 (A1), 2014002052]
   Fonseca MI, 2009, J IMMUNOL, V183, P1375, DOI 10.4049/jimmunol.0901005
   Fremeaux-Bacchi V, 2015, KIDNEY INT, V88, P967, DOI 10.1038/ki.2015.253
   Fridkis-Hareli M, 2011, BLOOD, V118, P4705, DOI 10.1182/blood-2011-06-359646
   Gavriilaki E., 2015, BLOOD, V126, P275
   Georgoutsou-Spyridonos M, 2015, J IMMUNOL, V195, P3946, DOI 10.4049/jimmunol.1500966
   Grossman T.R., 2015, IMMUNOBIOLOGY
   Grossman T.R., 2015, ANTISENSE THERAPIES
   Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102
   Hajishengallis G, 2015, ADV EXP MED BIOL, V865, P57, DOI 10.1007/978-3-319-18603-0_4
   Hajishengallis G, 2013, SEMIN IMMUNOL, V25, P65, DOI 10.1016/j.smim.2013.04.004
   Hamad OA, 2015, THROMB HAEMOSTASIS, V114, P1207, DOI 10.1160/TH15-02-0162
   Harris CL, 2012, TRENDS IMMUNOL, V33, P513, DOI 10.1016/j.it.2012.06.001
   Hebecker M, 2013, J IMMUNOL, V191, P912, DOI 10.4049/jimmunol.1300269
   Hepburn NJ, 2007, J BIOL CHEM, V282, P8292, DOI 10.1074/jbc.M609858200
   Hillmen P, 2016, AM J HEMATOL, V91, pE16, DOI 10.1002/ajh.24280
   Hillmen P, 2013, BRIT J HAEMATOL, V162, P62, DOI 10.1111/bjh.12347
   Hoehlig K, 2013, MOL THER, V21, P2236, DOI 10.1038/mt.2013.178
   Holers M, 2012, IMMUNOBIOLOGY, V217, P1210, DOI 10.1016/j.imbio.2012.08.232
   Holers V.M., 2015, IMMUNOBIOLOGY
   Holers VM, 2013, ADV EXP MED BIOL, V735, P137, DOI 10.1007/978-1-4614-4118-2_9
   Hovland A, 2015, ATHEROSCLEROSIS, V241, P480, DOI 10.1016/j.atherosclerosis.2015.05.038
   Huang YJ, 2014, CHEMMEDCHEM, V9, P2223, DOI 10.1002/cmdc.201402212
   Huber-Lang M, 2013, SEMIN IMMUNOL, V25, P73, DOI 10.1016/j.smim.2013.05.006
   Johnson L., 2016, ANT FAB TREATM AG RE
   Jore MM, 2016, NAT STRUCT MOL BIOL, V23, P378, DOI 10.1038/nsmb.3196
   Katschke KJ, 2012, J BIOL CHEM, V287, P12886, DOI 10.1074/jbc.M112.345082
   Katschke KJ, 2009, J BIOL CHEM, V284, P10473, DOI 10.1074/jbc.M809106200
   Kolev M, 2014, NAT REV IMMUNOL, V14, P811, DOI 10.1038/nri3761
   Lachmann PJ, 2016, CLIN EXP IMMUNOL, V183, P150, DOI 10.1111/cei.12714
   Lachmann PJ, 2009, SCAND J IMMUNOL, V69, P471, DOI 10.1111/j.1365-3083.2009.02258.x
   Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439
   Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824
   Loschi M., 2015, AM J HEMATOL
   Loyet KM, 2014, J PHARMACOL EXP THER, V351, P527, DOI 10.1124/jpet.114.215921
   Macedo ACL, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00055
   Maekawa T., 2016, J CLIN PERIODONTOL
   Maekawa T, 2014, J IMMUNOL, V192, P6020, DOI 10.4049/jimmunol.1400569
   Mamidi S, 2015, IMMUNOBIOLOGY
   Markiewski MM, 2008, NAT IMMUNOL, V9, P1225, DOI 10.1038/ni.1655
   Marsh JE, 2001, ARCH IMMUNOL THER EX, V49, pS41
   Mastellos DC, 2015, EUR J CLIN INVEST, V45, P423, DOI 10.1111/eci.12419
   Mastellos DC, 2014, EXPERT REV HEMATOL, V7, P583, DOI 10.1586/17474086.2014.953926
   Melis JPM, 2015, MOL IMMUNOL, V67, P117, DOI 10.1016/j.molimm.2015.01.028
   Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00262
   Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00257
   Mojcik CF, 2004, ANN RHEUM DIS, V63, P301
   Morgan BP, 2015, NAT REV DRUG DISCOV, V14, P857, DOI 10.1038/nrd4657
   Morgan BP, 2015, EXPERT REV CLIN IMMU, V11, P1109, DOI 10.1586/1744666X.2015.1074039
   Muller-Eberhard H J, 1968, Adv Immunol, V8, P1, DOI 10.1016/S0065-2776(08)60464-2
   Najaan N., SUBCUTANEOUSLY ADM I
   Nester CM, 2015, MOL IMMUNOL, V67, P31, DOI 10.1016/j.molimm.2015.03.246
   Nester CM, 2013, CURR OPIN PEDIATR, V25, P225, DOI 10.1097/MOP.0b013e32835df4a3
   Nilsson PH, 2013, BIOMATERIALS, V34, P985, DOI 10.1016/j.biomaterials.2012.10.040
   Nishimura J, 2014, NEW ENGL J MED, V370, P632, DOI 10.1056/NEJMoa1311084
   Nordmaj MA, 2015, FASEB J, V29, P4945, DOI 10.1096/fj.15-277103
   Noris M, 2012, NAT REV NEPHROL, V8, P622, DOI 10.1038/nrneph.2012.195
   Paixao-Cavalcante D, 2014, J IMMUNOL, V192, P4844, DOI 10.4049/jimmunol.1303131
   Patel H, 2006, J AM SOC NEPHROL, V17, P1102, DOI 10.1681/ASN.200610116
   Pio R, 2013, SEMIN IMMUNOL, V25, P54, DOI 10.1016/j.smim.2013.04.001
   Qu HC, 2013, IMMUNOBIOLOGY, V218, P496, DOI 10.1016/j.imbio.2012.06.003
   Qu H, 2009, MOL IMMUNOL, V47, P185, DOI 10.1016/j.molimm.2009.08.032
   Rafail S, 2015, J IMMUNOL, V194, P1285, DOI 10.4049/jimmunol.1402354
   Regillo C.D., 2013, 117 ANN AAO M NEW OR
   Reis ES, 2015, CLIN IMMUNOL, V161, P225, DOI 10.1016/j.clim.2015.08.009
   Reis ES, 2015, IMMUNOBIOLOGY, V220, P476, DOI 10.1016/j.imbio.2014.10.026
   Ricklin D., 2016, NATURE REV NEPHROLOG
   Ricklin D, 2007, NAT BIOTECHNOL, V25, P1265, DOI 10.1038/nbt1342
   Ricklin D, 2016, IMMUNOBIOLOGY, V221, P740, DOI 10.1016/j.imbio.2015.06.012
   Ricklin D, 2013, J IMMUNOL, V190, P3839, DOI 10.4049/jimmunol.1203200
   Ricklin D, 2013, J IMMUNOL, V190, P3831, DOI 10.4049/jimmunol.1203487
   Ricklin D, 2013, ADV EXP MED BIOL, V735, P1, DOI 10.1007/978-1-4614-4118-2_1
   Ricklin D, 2012, IMMUNOBIOLOGY, V217, P1057, DOI 10.1016/j.imbio.2012.07.016
   Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923
   Risitano A.M., 2016, AM J HEMATOL
   Risitano A.M., 2015, ASH 57 ANN M EXP ORL
   Risitano AM, 2014, BLOOD, V123, P2094, DOI 10.1182/blood-2013-11-536573
   de Cordoba SR, 2012, IMMUNOBIOLOGY, V217, P1034, DOI 10.1016/j.imbio.2012.07.021
   Roguska M, 2014, INVEST OPHTH VIS SCI, V55
   Rother RP, 2007, NAT BIOTECHNOL, V25, P1256, DOI 10.1038/nbt1344
   Ruseva MM, 2015, P NATL ACAD SCI USA, V112, P14319, DOI 10.1073/pnas.1513698112
   Sacks SH, 2012, NAT REV IMMUNOL, V12, P431, DOI 10.1038/nri3225
   Sahelijo L, 2015, BLOOD, V126, P4777
   Sahu A, 2000, IMMUNOPHARMACOLOGY, V49, P133, DOI 10.1016/S0162-3109(00)80299-4
   Schmidt CQ, 2016, IMMUNOBIOLOGY, V221, P503, DOI 10.1016/j.imbio.2015.12.009
   Schmidt CQ, 2013, J IMMUNOL, V190, P5712, DOI 10.4049/jimmunol.1203548
   Scott D., 2015, IMMUNOBIOLOGY
   Silasi-Mansat R., 2015, J CELL MOL MED
   Silasi-Mansat R, 2010, BLOOD, V116, P1002, DOI 10.1182/blood-2010-02-269746
   SR E., 2006, J IMMUNOL, V63, P155
   Szebeni J, 2014, MOL IMMUNOL, V61, P163, DOI 10.1016/j.molimm.2014.06.038
   Taylor RP, 2014, METHODS, V65, P18, DOI 10.1016/j.ymeth.2013.07.027
   Vadrevu SK, 2014, CANCER RES, V74, P3454, DOI 10.1158/0008-5472.CAN-14-0157
   van der Veen S, 2014, INFECT IMMUN, V82, P1157, DOI 10.1128/IAI.01183-13
   van Lookeren Campagne M., 2015, IMMUNOBIOLOGY
   Vergunst CE, 2007, RHEUMATOLOGY, V46, P1773, DOI 10.1093/rheumatology/kem222
   Vogel CW, 2014, MOL IMMUNOL, V61, P191, DOI 10.1016/j.molimm.2014.06.035
   Wang JX, 2016, CLIN IMMUNOL, V162, P37, DOI 10.1016/j.clim.2015.11.002
   Woodruff TM, 2011, MOL IMMUNOL, V48, P1631, DOI 10.1016/j.molimm.2011.04.014
   Wu MA, 2016, EXPERT OPIN PHARMACO, V17, P27, DOI 10.1517/14656566.2016.1104300
   Wu YQ, 2011, J IMMUNOL, V186, P4269, DOI 10.4049/jimmunol.1003802
   Xiao F, 2016, BRIT J PHARMACOL, V173, P575, DOI 10.1111/bph.13388
   Zeerleder S, 2011, SEMIN THROMB HEMOST, V37, P362, DOI 10.1055/s-0031-1276585
   Zhang YZ, 2015, IMMUNOBIOLOGY, V220, P993, DOI 10.1016/j.imbio.2015.04.001
   Zhang YZ, 2013, J AM SOC NEPHROL, V24, P1820, DOI 10.1681/ASN.2013010045
   Zipfel PF, 2015, MOL IMMUNOL, V67, P21, DOI 10.1016/j.molimm.2015.03.012
NR 126
TC 25
Z9 25
U1 0
U2 11
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1044-5323
J9 SEMIN IMMUNOL
JI Semin. Immunol.
PD JUN
PY 2016
VL 28
IS 3
BP 208
EP 222
DI 10.1016/j.smim.2016.06.001
PG 15
WC Immunology
SC Immunology
GA DT9TQ
UT WOS:000381845600002
PM 27321574
OA Green Accepted, Other Gold
DA 2018-10-20
ER

PT J
AU Ekdahl, KN
   Huang, S
   Nilsson, B
   Teramura, Y
AF Ekdahl, Kristina N.
   Huang, Shan
   Nilsson, Bo
   Teramura, Yuji
TI Complement inhibition in biomaterial- and biosurface-induced
   thromboinflammation
SO SEMINARS IN IMMUNOLOGY
LA English
DT Review
DE Biomaterials; Coagulation; Complement; Inflammation; Platelets;
   Therapeutic medicine
ID CONTACT ACTIVATION; HUMAN BLOOD; TISSUE FACTOR; ENDOTHELIAL-CELLS;
   FACTOR-XII; FACTOR-H; ISLET TRANSPLANTATION; ALTERNATIVE PATHWAY;
   PROTEIN ADSORPTION; PLATELET-ADHESION
AB Therapeutic medicine today includes a vast number of procedures involving the use of biomaterials, transplantation of therapeutic cells or cell clusters, as well as of solid organs. These treatment modalities are obviously of great benefit to the patient, but also present a great challenge to the innate immune system, since they involve direct exposure of non-biological materials, cells of non-hematological origin as well as endothelial cells, damaged by ischemia-perfusion in solid organs to proteins and cells in the blood. The result of such an exposure may be an inappropriate activation of the complement and contact/kallikrein systems, which produce mediators capable of triggering the platelets and PMNs and monocytes, which can ultimately result in thrombotic and inflammatory (i.e., a thrombo-inflammatory) response to the treatment modality. In this concept review, we give an overview of the mechanisms of recognition within the innate immunity system, with the aim to identify suitable points for intervention. Finally, we discuss emerging and promising techniques for surface modification of biomaterials and cells with specific inhibitors in order to diminish thromboinflammation and improve clinical outcome. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Ekdahl, Kristina N.; Nilsson, Bo; Teramura, Yuji] Uppsala Univ, Rudbeck Lab C5 3, Dept Immunol Genet & Pathol IGP, SE-75185 Uppsala, Sweden.
   [Ekdahl, Kristina N.; Huang, Shan] Linnaeus Univ, Linnaeus Ctr Biomat Chem, SE-39182 Kalmar, Sweden.
   [Teramura, Yuji] Univ Tokyo, Dept Bioengn, Bunkyo Ku, 7-3-1Hongo, Tokyo 1138656, Japan.
RP Teramura, Y (reprint author), Uppsala Univ, Rudbeck Lab C5 3, Dept Immunol Genet & Pathol IGP, SE-75185 Uppsala, Sweden.
EM teramura@bioeng.t.u-tokyo.ac.jp
RI Nilsson Ekdahl, Kristina/B-5301-2012; Nilsson, Bo/B-3102-2012
OI Nilsson, Bo/0000-0003-0057-2730
FU Swedish Research Council (VR) [2013-65X-05647-34-4]; European
   Community's Seventh Framework Programme (DIRECT) [602699]; Swedish
   Foundation for International Cooperation in Research and Higher
   Education (STINT); Bilateral Joint Research Projects (Japan-Sweden) of
   the Japan Society for the Promotion of Science (JSPS); Linnus University
FX We thank Dr. Deborah McClellan for excellent editorial assistance. This
   work was supported by grant 2013-65X-05647-34-4 from the Swedish
   Research Council (VR), the European Community's Seventh Framework
   Programme under the grant agreement no 602699 (DIRECT), the Swedish
   Foundation for International Cooperation in Research and Higher
   Education (STINT), the Bilateral Joint Research Projects (Japan-Sweden)
   of the Japan Society for the Promotion of Science (JSPS), and faculty
   grants from the Linnus University.
CR Andersson J, 2006, J BIOMED MATER RES A, V76A, P25, DOI 10.1002/jbm.a.30377
   Andersson J, 2005, BIOMATERIALS, V26, P1477, DOI 10.1016/j.biomaterials.2004.05.011
   Andersson J, 2002, J IMMUNOL, V168, P5786, DOI 10.4049/jimmunol.168.11.5786
   Andersson J, 2001, BIOMATERIALS, V22, P2435, DOI 10.1016/S0142-9612(00)00431-2
   Arnebrant T, 1995, ACS SYM SER, V602, P239
   Asif S., 2016, ACTA BIOMATER
   Back J, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4399
   Back J, 2010, BIOCHEM BIOPH RES CO, V391, P11, DOI 10.1016/j.bbrc.2009.10.123
   Back J, 2009, BIOMATERIALS, V30, P6573, DOI 10.1016/j.biomaterials.2009.07.052
   Bennet W, 1999, DIABETES, V48, P1907, DOI 10.2337/diabetes.48.10.1907
   Bennet W, 2000, TRANSPLANTATION, V69, P711
   Biglarnia AR, 2011, TRANSPL INT, V24, pE61, DOI 10.1111/j.1432-2277.2011.01290.x
   Blitz A, 2014, ANN CARDIOTHORAC SUR, V3, P450, DOI 10.3978/j.issn.2225-319X.2014.09.10
   Brass LF, 2003, CHEST, V124, p18S, DOI 10.1378/chest.124.3_suppl.18S
   Cattaneo M, 1999, ARTERIOSCL THROM VAS, V19, P2281, DOI 10.1161/01.ATV.19.10.2281
   Cavalli A, 2010, MINERVA UROL NEFROL, V62, P1
   Christensen K, 2001, BIOMATERIALS, V22, P349, DOI 10.1016/S0142-9612(00)00190-3
   Colman R., 2006, CONTACT ACTIVATION K
   de Agostini A, 1984, J Clin Invest, V73, P1542
   Dobo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020036
   Ekdahl KN, 2011, ADV DRUG DELIVER REV, V63, P1042, DOI 10.1016/j.addr.2011.06.012
   Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507
   Engberg AE, 2015, BIOMATERIALS, V36, P55, DOI 10.1016/j.biomaterials.2014.09.011
   Engberg AE, 2011, J BIOMED MATER RES A, V97A, P74, DOI 10.1002/jbm.a.33030
   Engberg AE, 2009, BIOMATERIALS, V30, P2653, DOI 10.1016/j.biomaterials.2009.01.001
   Golias Ch, 2007, Hippokratia, V11, P124
   Gustafson EK, 2011, TRANSPLANTATION, V91, P632, DOI 10.1097/TP.0b013e31820ae459
   Hamad OA, 2008, J THROMB HAEMOST, V6, P1413, DOI 10.1111/j.1538-7836.2008.03034.x
   Hamad O.A., 2015, THROMB HAEMOST, V2015
   Hamad OA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012889
   Hamad OA, 2010, J IMMUNOL, V184, P2686, DOI 10.4049/jimmunol.0902810
   Hess K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035690
   HESSING M, 1990, J IMMUNOL, V144, P204
   HORBETT TA, 1993, CARDIOVASC PATHOL, V2, pS137
   Huang S, 2016, BIOMATERIALS, V77, P111, DOI 10.1016/j.biomaterials.2015.10.067
   Ikeda K, 1997, THROMB HAEMOSTASIS, V77, P394
   ISHIHARA K, 1992, J BIOMED MATER RES, V26, P1543, DOI 10.1002/jbm.820261202
   Ishihara K, 1999, BIOMATERIALS, V20, P1553, DOI 10.1016/S0142-9612(98)00206-3
   Iwasaki Y, 2012, SCI TECHNOL ADV MAT, V13, DOI 10.1088/1468-6996/13/6/064101
   Joseph K, 2001, THROMB HAEMOSTASIS, V85, P119
   Kozarcanin H., 2015, J THROMB HAEMOST
   Krarup A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000623
   Krarup A, 2008, BBA-PROTEINS PROTEOM, V1784, P1294, DOI 10.1016/j.bbapap.2008.03.020
   Mandi F., 2002, BLOOD, V99, P3585, DOI DOI 10.1182/BL00D.V99.10.3585
   Marcus AJ, 1997, J CLIN INVEST, V99, P1351, DOI 10.1172/JCI119294
   Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006
   Miyamoto T, 2011, CURR OPIN NEPHROL HY, V20, P662, DOI 10.1097/MNH.0b013e32834ad504
   Moberg L, 2002, LANCET, V360, P2039, DOI 10.1016/S0140-6736(02)12020-4
   Moll G, 2012, STEM CELLS, V30, P1565, DOI 10.1002/stem.1111
   Moll G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021703
   Murakami Y, 2005, J BIOMAT SCI-POLYM E, V16, P381, DOI 10.1163/1568562053654095
   Murphy DA, 2015, TRANSFUS MED REV, V29, P90, DOI 10.1016/j.tmrv.2014.12.001
   Nagahashi K, 2015, COLLOID SURFACE B, V134, P384, DOI 10.1016/j.colsurfb.2015.07.040
   Nakanishi K, 2001, J BIOSCI BIOENG, V91, P233, DOI 10.1016/S1389-1723(01)80127-4
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   Nilsson B, 2010, TRENDS IMMUNOL, V31, P32, DOI 10.1016/j.it.2009.09.005
   Nilsson PH, 2013, BIOMATERIALS, V34, P985, DOI 10.1016/j.biomaterials.2012.10.040
   Nilsson PH, 2010, BIOMATERIALS, V31, P4484, DOI 10.1016/j.biomaterials.2010.02.036
   NILSSON UR, 1993, MOL IMMUNOL, V30, P211, DOI 10.1016/0161-5890(93)90050-L
   Osterud Bjarne, 2012, Front Biosci (Elite Ed), V4, P289
   Punjabi Prakash P, 2013, Glob Cardiol Sci Pract, V2013, P249, DOI 10.5339/gcsp.2013.32
   Ricklin D, 2013, J IMMUNOL, V190, P3839, DOI 10.4049/jimmunol.1203200
   Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923
   Ritis K, 2006, J IMMUNOL, V177, P4794, DOI 10.4049/jimmunol.177.7.4794
   Schmidt CQ, 2008, CLIN EXP IMMUNOL, V151, P14, DOI 10.1111/j.1365-2249.2007.03553.x
   Serruto D, 2010, NAT REV MICROBIOL, V8, P393, DOI 10.1038/nrmicro2366
   Simard T, 2014, CAN J CARDIOL, V30, P35, DOI 10.1016/j.cjca.2013.09.012
   SIMS PJ, 1991, IMMUNOL TODAY, V12, P338, DOI 10.1016/0167-5699(91)90012-I
   Singh A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055852
   Snyder TA, 2007, J BIOMED MATER RES A, V81A, P85, DOI 10.1002/jbm.a.31006
   Tedesco F, 1997, J EXP MED, V185, P1619, DOI 10.1084/jem.185.9.1619
   Tengvall P, 1997, J BIOMED MATER RES, V35, P81, DOI 10.1002/(SICI)1097-4636(199704)35:1<81::AID-JBM8>3.0.CO;2-I
   Teramura Y, 2007, BIOMATERIALS, V28, P4818, DOI 10.1016/j.biomaterials.2007.07.050
   Teramura Y, 2010, SOFT MATTER, V6, P1081, DOI 10.1039/b913621e
   Tillou X, 2010, KIDNEY INT, V78, P152, DOI 10.1038/ki.2010.75
   Tsai WB, 1999, J BIOMED MATER RES, V44, P130, DOI 10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9
   Vogler EA, 2009, BIOMATERIALS, V30, P1857, DOI 10.1016/j.biomaterials.2008.12.041
   Wettero J, 2001, J BIOMED MATER RES, V57, P550, DOI 10.1002/1097-4636(20011215)57:4<550::AID-JBM1201>3.0.CO;2-T
   Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755
   Wu YQ, 2011, J IMMUNOL, V186, P4269, DOI 10.4049/jimmunol.1003802
   Zhuo R, 2007, BIOMATERIALS, V28, P4355, DOI 10.1016/j.biomaterials.2007.06.019
NR 81
TC 4
Z9 4
U1 1
U2 16
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1044-5323
EI 1096-3618
J9 SEMIN IMMUNOL
JI Semin. Immunol.
PD JUN
PY 2016
VL 28
IS 3
BP 268
EP 277
DI 10.1016/j.smim.2016.04.006
PG 10
WC Immunology
SC Immunology
GA DT9TQ
UT WOS:000381845600007
PM 27211838
DA 2018-10-20
ER

PT J
AU Girard, J
   Joset, N
   Crochet, A
   Tan, M
   Holzheu, A
   Brunetto, PS
   Fromm, KM
AF Girard, Jerome
   Joset, Nathalie
   Crochet, Aurelien
   Tan, Milene
   Holzheu, Anja
   Brunetto, Priscilla S.
   Fromm, Katharina M.
TI Synthesis of New Polyether Ether Ketone Derivatives with Silver Binding
   Site and Coordination Compounds of Their Monomers with Different Silver
   Salts
SO POLYMERS
LA English
DT Article
DE PEEK; antimicrobial polymer coating; silver coordination polymer
ID IMPLANT; BENZOPHENONE; REPLACEMENT; COMPOSITES; POLYMERS; MATRIX; STATE;
   PEEK
AB Polyether ether ketone (PEEK) is a well-known polymer used for implants and devices, especially spinal ones. To overcome the biomaterial related infection risks, 4-4-difluorobenzophenone, the famous PEEK monomer, was modified in order to introduce binding sites for silver ions, which are well known for their antimicrobial activity. The complexation of these new monomers with different silver salts was studied. Crystal structures of different intermediates were obtained with a linear coordination between two pyridine groups and the silver ions in all cases. The mechanical and thermal properties of different new polymers were characterized. The synthesized PEEKN5 polymers showed similar properties than the PEEK ones whereas the PEEKN7 polymers showed similar thermal properties but the mechanical properties are not as good as the ones of PEEK. To improve these properties, these polymers were complexed with silver nitrate in order to cross-link with silver ions. The presence of ionic silver in the polymer was then confirmed by thermogravimetric analysis (TGA) and X-ray powder diffraction (XRPD). Finally, a silver-based antimicrobial compound was successfully coated on the surface of PEEKN5.
C1 [Girard, Jerome; Joset, Nathalie; Tan, Milene; Holzheu, Anja; Brunetto, Priscilla S.; Fromm, Katharina M.] Univ Fribourg, Dept Chem, Chemin Musee 9, CH-1700 Fribourg, Switzerland.
   [Crochet, Aurelien] Univ Fribourg, Dept Phys, Fribourg Ctr Nanomat, FriMat, Chemin Musee 3, CH-1700 Fribourg, Switzerland.
RP Fromm, KM (reprint author), Univ Fribourg, Dept Chem, Chemin Musee 9, CH-1700 Fribourg, Switzerland.
EM jerome.girard@outlook.com; nathalie.joset@givaudan.com;
   aurelien.crochet@unifr.ch; milene.tan@unifr.ch; anja.holzheu@unifr.ch;
   priscilla.brunetto@unifr.ch; katharina.fromm@unifr.ch
OI Crochet, Aurelien/0000-0002-4763-2764
FU Swiss National Science Foundation; University of Fribourg; Fribourg
   Center for Nanomaterials (FriMat)
FX The authors thank Sandeep Kumar and the Adolphe Merkle Institute for DMA
   measurement. The Swiss National Science Foundation, the University of
   Fribourg, and Fribourg Center for Nanomaterials (FriMat) for financial
   and technical support.
CR Barton AJ, 1996, J BIOMED MATER RES, V30, P403, DOI 10.1002/(SICI)1097-4636(199603)30:3<403::AID-JBM15>3.0.CO;2-K
   BLANC E, 1991, J APPL CRYSTALLOGR, V24, P1035, DOI 10.1107/S002188989100835X
   Brunetto PS, 2011, MATERIALS, V4, P355, DOI 10.3390/ma4020355
   Burla MC, 2005, J APPL CRYSTALLOGR, V38, P381, DOI 10.1107/S002188980403225X
   Corvelli AA, 1999, J MATER SCI, V34, P2421, DOI 10.1023/A:1004562732460
   COSIER J, 1986, J APPL CRYSTALLOGR, V19, P105, DOI 10.1107/S0021889886089835
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Diez-Pascual AM, 2011, MATER CHEM PHYS, V130, P126, DOI 10.1016/j.matchemphys.2011.06.019
   Eckhardt S, 2013, CHEM REV, V113, P4708, DOI 10.1021/cr300288v
   ETTER MC, 1990, ACCOUNTS CHEM RES, V23, P120, DOI 10.1021/ar00172a005
   Fromm KM, 2013, APPL ORGANOMET CHEM, V27, P683, DOI 10.1002/aoc.3047
   Fromm KM, 2011, NAT CHEM, V3, P178, DOI 10.1038/nchem.970
   Girard J, 2013, CR CHIM, V16, P550, DOI 10.1016/j.crci.2013.04.010
   Gordon O, 2010, ANTIMICROB AGENTS CH, V54, P4208, DOI 10.1128/AAC.01830-09
   Gors H. G., 1989, U. S. Patent, Patent No. [4814508 A, 4814508]
   Govaert L., 2003, PLYMEREN KETEN KUNST
   HOFFMANN R, 1970, J PHYS CHEM-US, V74, P415, DOI 10.1021/j100697a030
   JOHANSSON M, 1993, J POLYM SCI POL CHEM, V31, P619, DOI 10.1002/pola.1993.080310304
   Kamm O, 1922, ORG SYNTH, V2, P5
   Lai YH, 2007, MAT SCI ENG A-STRUCT, V458, P158, DOI 10.1016/j.msea.2007.01.085
   MAGINN SJ, 1994, ACTA CRYSTALLOGR C, V50, P254, DOI 10.1107/S0108270193007437
   Mano JF, 2004, COMPOS SCI TECHNOL, V64, P789, DOI 10.1016/j.compscitech.2003.09.001
   Papilloud S, 2002, FOOD ADDIT CONTAM, V19, P168, DOI 10.1080/02652030110084800
   PAULIK F, 1985, THERMOCHIM ACTA, V92, P787, DOI 10.1016/0040-6031(85)85995-5
   SEFERIS JC, 1986, POLYM COMPOSITE, V7, P158, DOI 10.1002/pc.750070305
   Sheldrick G. M., 1997, SHELX 97
   Slenters TV, 2010, MATERIALS, V3, P3407, DOI 10.3390/ma3053407
   Staniland P. A., 1986, Patent No. [EP0184458 A2, 0184458]
   Steiner T, 2002, ANGEW CHEM INT EDIT, V41, P48, DOI 10.1002/1521-3773(20020104)41:1<48::AID-ANIE48>3.0.CO;2-U
   Varisco M, 2014, CHEMMEDCHEM, V9, P1221, DOI 10.1002/cmdc.201400072
   Vaudaux P, 2001, J ANTIMICROB CHEMOTH, V47, P163, DOI 10.1093/jac/47.2.163
   Wei J, 2010, POLYM ADVAN TECHNOL, V21, P656, DOI 10.1002/pat.1486
   WEIKERT RJ, 1991, J MED CHEM, V34, P1630, DOI 10.1021/jm00109a015
   Wu LL, 2011, CHEM-EUR J, V17, P4774, DOI 10.1002/chem.201003631
NR 34
TC 1
Z9 1
U1 4
U2 29
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2073-4360
J9 POLYMERS-BASEL
JI Polymers
PD JUN
PY 2016
VL 8
IS 6
DI 10.3390/polym8060208
PG 16
WC Polymer Science
SC Polymer Science
GA DR4GV
UT WOS:000379860500006
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Wen, B
   Kuhn, L
   Charles, L
   Pendrys, D
   Shafer, D
   Freilich, M
AF Wen, Bo
   Kuhn, Liisa
   Charles, Lyndon
   Pendrys, David
   Shafer, David
   Freilich, Martin
TI Comparison of bone morphogenetic protein-2 delivery systems to induce
   supracrestal bone guided by titanium implants in the rabbit mandible
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE biomaterial scaffold; BMP-2; dental implant; vertical supracrestal bone
   growth
ID GROWTH; AUGMENTATION; MATRIX; MODEL; RAT; REGENERATION; MODULATION;
   MINIPIG; BMP-2; DOG
AB Objective: To compare the ability of three non-glycosylated/rhBMP-2 (BMP-2) delivery systems to induce supracrestal bone.
   Material and methods: Thirty-six custom SLActive dental implants were partially embedded in transverse orientation into the posterior mandibles of 18 adult rabbits with the head of the implant located 3 mm supracrestal. Delivery of BMP-2 (30 mu g) from the following materials was studied: (1) Ti implant + BMP-2 with hydroxyapatite (HA)-coated collagen (Col/HA) scaffold, (2) Ti implant with Col/HA infused with PEG hydrogel + BMP-2, or (3) Ti implant with HA/beta-TCP/PEG hydrogel scaffold + BMP-2. Scaffolds were secured with a metal "umbrella." Non-BMP-2 contralateral controls were included. MicroCT imaging and histological analysis was performed after 10 weeks to assess new supracrestal bone formation. in vitro BMP-2 release studies were conducted.
   Results: All treatment groups displayed new supracrestal bone formation. Ti + BMP-2 with Col/HA (3.0 +/- 0.2 mm) and Ti with Col/HA/PEG hydrogel I BMP-2 (2.7 +/- 0.4 mm) had significantly greater (P < 0.05) outcomes than without BMP-2. Maximum bone volume occurred in the Ti implant with HA/beta-TCP/PEG hydrogel scaffold BMP-2 group.
   Conclusions: The use of an implant system composed of a partially inserted Ti implant, adjacent scaffold and scaffold stabilizer resulted in the formation of new supracrestal bone across all test groups with and without BMP-2. Delivery of BMP-2 directly from the Ti implant increased bone height, BIC and bone volume as compared to no BMP-2 when a Col/HA was used, but did not improve performance of the HA/beta-TCP/PEG scaffold.
C1 [Wen, Bo] Nanjing Univ, Dept Oral & Maxillofacial Surg, Div Implant Dent, Affiliated Stomatol Hosp,Med Sch, Nanjing, Jiangsu, Peoples R China.
   [Kuhn, Liisa; Charles, Lyndon; Pendrys, David; Freilich, Martin] Univ Connecticut, Sch Dent Med, Dept Reconstruct Sci, Ctr Regenerat Med & Skeletal Dev, Farmington, CT 06032 USA.
   [Shafer, David] Univ Connecticut, Sch Dent Med, Dept Craniofacial Sci, Div Oral & Maxillofacial Surg, Farmington, CT 06032 USA.
RP Freilich, M (reprint author), Univ Connecticut, Sch Dent Med, Dept Reconstruct Sci, 263 Farmington Ave, Farmington, CT 06032 USA.
EM freilich@uchc.edu
FU Institut Straumann AG, Basel, Switzerland
FX This study was supported by a grant from Institut Straumann AG, Basel,
   Switzerland. Experimental titanium implants, scaffold stabilizing
   devices and PEG hydrogel scaffolds were also provided by Institut
   Straumann. The authors greatly appreciate the assistance and
   professional expertise of Dr. Michel Hard, Mr. Marcel Obrecht and Dr.
   Aart Molenberg. We thank Ms. Denise Ortiz for her assistance in
   conducting biostatistical analysis and manuscript preparation. We also
   thank Dr. Peter Hotschansky of the Hans-Knoll-Institut, Jena, Germany
   for the gift of ng/rhBMP-2.
CR Catros S, 2013, INT J ORAL MAX IMPL, V28, P432, DOI 10.11607/jomi.2782
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Donos N, 2002, CLIN ORAL IMPLAN RES, V13, P175, DOI 10.1034/j.1600-0501.2002.130208.x
   Elbert DL, 2001, BIOMACROMOLECULES, V2, P430, DOI 10.1021/bm0056299
   Fittkau MH, 2005, BIOMATERIALS, V26, P167, DOI 10.1016/j.biomaterials.2004.02.012
   Freilich M, 2008, BONE, V43, P781, DOI 10.1016/j.bone.2008.05.021
   Freilich M, 2012, CLIN ORAL IMPLAN RES, V23, P751, DOI 10.1111/j.1600-0501.2011.02199.x
   Freilich M, 2009, CLIN ORAL IMPLAN RES, V20, P201, DOI 10.1111/j.1600-0501.2008.01615.x
   Hall J, 2007, J CLIN PERIODONTOL, V34, P444, DOI 10.1111/j.1600-051X.2007.01064.x
   Jung RE, 2008, CLIN ORAL IMPLAN RES, V19, P188, DOI 10.1111/j.1600-0501.2007.01431.x
   Jung RE, 2007, CLIN ORAL IMPLAN RES, V18, P319, DOI 10.1111/j.1600-0501.2007.01342.x
   Leknes KN, 2008, CLIN ORAL IMPLAN RES, V19, P1027, DOI 10.1111/j.1600-0501.2008.01567.x
   Lutolf MP, 2001, BIOCONJUGATE CHEM, V12, P1051, DOI 10.1021/bc015519e
   Nicolau P, 2013, CLIN IMPLANT DENT R, V15, P600, DOI 10.1111/j.1708-8208.2011.00418.x
   Rengachary Setti S, 2002, Neurosurg Focus, V13, pe2
   Roos-Jansaker AM, 2002, CLIN ORAL IMPLAN RES, V13, P455, DOI 10.1034/j.1600-0501.2002.130502.x
   Sachse A, 2005, BONE, V37, P699, DOI 10.1016/j.bone.2005.06.011
   SAMPATH TK, 1990, J BIOL CHEM, V265, P13198
   Schmitt JM, 1999, J ORTHOPAED RES, V17, P269, DOI 10.1002/jor.1100170217
   Schmoekel H, 2004, J ORTHOPAED RES, V22, P376, DOI 10.1016/S0736-0266(03)00188-8
   Schwarz F, 2007, CLIN ORAL INVEST, V11, P245, DOI 10.1007/s00784-007-0110-7
   Seeherman H, 2002, SPINE, V27, pS16, DOI 10.1097/01.BRS.0000020728.34131.03
   Simion M, 1994, Int J Periodontics Restorative Dent, V14, P496
   Vasak C, 2014, CLIN ORAL IMPLAN RES, V25, P1378, DOI 10.1111/clr.12277
   Wen B, 2011, J BIOMED MATER RES B, V97B, P315, DOI 10.1002/jbm.b.31817
   Wikesjo UME, 2008, J CLIN PERIODONTOL, V35, P1001, DOI 10.1111/j.1600-051X.2008.01321.x
   Woo BH, 2001, PHARMACEUT RES, V18, P1747, DOI 10.1023/A:1013382832091
NR 27
TC 5
Z9 5
U1 1
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD JUN
PY 2016
VL 27
IS 6
BP 676
EP 685
DI 10.1111/clr.12645
PG 10
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA DR5BE
UT WOS:000379917200008
PM 26183057
DA 2018-10-20
ER

PT J
AU Choi, W
   Lee, S
   Kim, SH
   Jang, JH
AF Choi, Wuyong
   Lee, Slgirim
   Kim, Seung-Hyun
   Jang, Jae-Hyung
TI Polydopamine Inter-Fiber Networks: New Strategy for Producing Rigid,
   Sticky, 3D Fluffy Electrospun Fibrous Polycaprolactone Sponges
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE 3D fibers; delivery vehicles; electrospun fibers; polydopamine; tissue
   engineering scaffolds
ID ENGINEERING COMPLEX TISSUES; NANOFIBROUS SCAFFOLDS; STEM-CELLS; CELLULAR
   INFILTRATION; OXIDATIVE STRESS; DELIVERY; REGENERATION; HYDROGEL;
   SURFACES; COATINGS
AB Designing versatile 3D interfaces that can precisely represent a biological environment is a prerequisite for the creation of artificial tissue structures. To this end, electrospun fibrous sponges, precisely mimicking an extracellular matrix and providing highly porous interfaces, have capabilities that can function as versatile physical cues to regenerate various tissues. However, their intrinsic features, such as sheet-like, thin, and weak structures, limit the design of a number of uses in tissue engineering applications. Herein, a highly facile methodology capable of fabricating rigid, sticky, spatially expanded fluffy electrospun fibrous sponges is proposed. A bio-inspired adhesive material, poly(dopamine) (pDA), is employed as a key mediator to provide rigidity and stickiness to the 3D poly(e-caprolactone) (PCL) fibrous sponges, which are fabricated using a coaxial electrospinning with polystyrene followed by a selective leaching process. The iron ion induced oxidation of dopamine into pDA networks interwoven with PCL fibers results in significant increases in the rigidity of 3D fibrous sponges. Furthermore, the exposure of catecholamine groups on the fiber surfaces promotes the stable attachment of the sponges on wet organ surfaces and triggers the robust immobilization of biomolecules (e.g., proteins and gene vectors), demonstrating their potential for 3D scaffolds as well as drug delivery vehicles. Because fibrous structures are ubiquitous in the human body, these rigid, sticky, 3D fibrous sponges are good candidates for powerful biomaterial systems that functionally mimic a variety of tissue structures.
C1 [Choi, Wuyong; Lee, Slgirim; Kim, Seung-Hyun; Jang, Jae-Hyung] Yonsei Univ, Dept Chem & Biomol Engn, Seoul 120749, South Korea.
RP Jang, JH (reprint author), Yonsei Univ, Dept Chem & Biomol Engn, Seoul 120749, South Korea.
EM j-jang@yonsei.ac.kr
FU National Research Foundation of Korea (NRF) grant through the Active
   Polymer Center for Pattern Integration [2007-0056091]; Ministry of
   Science, ICT & Future Planning (MSIP) [NRF-2015R1A2A2A03003553]
FX This work was supported by the National Research Foundation of Korea
   (NRF) grant through the Active Polymer Center for Pattern Integration
   (2007-0056091) and NRF-2015R1A2A2A03003553 funded by the Ministry of
   Science, ICT & Future Planning (MSIP).
CR Blakeney BA, 2011, BIOMATERIALS, V32, P1583, DOI 10.1016/j.biomaterials.2010.10.056
   Bonino CA, 2012, SMALL, V8, P1928, DOI 10.1002/smll.201101791
   Bosworth LA, 2013, J MATER SCI-MATER M, V24, P1605, DOI 10.1007/s10856-013-4911-8
   Byun E, 2014, CHEM COMMUN, V50, P2869, DOI 10.1039/c3cc49043b
   Cheng Q, 2013, BIOMACROMOLECULES, V14, P1349, DOI 10.1021/bm302000n
   Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI [10.1038/nnano.2010.246, 10.1038/NNANO.2010.246]
   Holzwarth U, 2011, NAT NANOTECHNOL, V6, P534, DOI 10.1038/nnano.2011.145
   Howard D, 2008, J ANAT, V213, P66, DOI 10.1111/j.1469-7580.2008.00878.x
   Jang JH, 2011, MOL THER, V19, P667, DOI 10.1038/mt.2010.287
   Jiao YP, 2006, J APPL POLYM SCI, V101, P1515, DOI 10.1002/app.22291
   Jin G, 2015, ANGEW CHEM INT EDIT, V54, P7587, DOI 10.1002/anie.201502177
   Jin G, 2014, BIOMED MICRODEVICES, V16, P793, DOI 10.1007/s10544-014-9883-z
   Jones DC, 2000, J NEUROCHEM, V74, P2296, DOI 10.1046/j.1471-4159.2000.0742296.x
   Kim E, 2014, ACS APPL MATER INTER, V6, P8288, DOI 10.1021/am5011095
   Kim E, 2012, ANGEW CHEM INT EDIT, V51, P5598, DOI 10.1002/anie.201201495
   Kim K, 2015, BIOMATERIALS, V52, P161, DOI 10.1016/j.biomaterials.2015.02.010
   Kim TG, 2008, ACTA BIOMATER, V4, P1611, DOI 10.1016/j.actbio.2008.06.008
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lee H, 2009, ADV MATER, V21, P431, DOI 10.1002/adma.200801222
   Lee S, 2014, ACS APPL MATER INTER, V6, P1082, DOI 10.1021/am404627r
   Leong MF, 2009, J BIOMED MATER RES A, V91A, P231, DOI 10.1002/jbm.a.32208
   Li L., 2014, BIOMATERIALS C, V37C, P218
   Liang D, 2007, ADV DRUG DELIVER REV, V59, P1392, DOI 10.1016/j.addr.2007.04.021
   Liu YD, 2014, ACTA BIOMATER, V10, P5074, DOI 10.1016/j.actbio.2014.08.036
   Lotharius J, 2001, ANN NEUROL, V49, P79, DOI 10.1002/1531-8249(200101)49:1<79::AID-ANA11>3.0.CO;2-D
   Mikos AG, 2006, TISSUE ENG, V12, P3307, DOI 10.1089/ten.2006.12.3307
   Navaei-Nigjeh M, 2014, J BIOMED MATER RES A, V102, P2533, DOI 10.1002/jbm.a.34921
   Nisbet DR, 2009, J BIOMATER APPL, V24, P7, DOI 10.1177/0885328208099086
   Park JP, 2015, CHEM MATER, V27, P105, DOI 10.1021/cm503425d
   Shabani I, 2012, BIOCHEM BIOPH RES CO, V423, P50, DOI 10.1016/j.bbrc.2012.05.069
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Sun B, 2012, NANOSCALE, V4, P2134, DOI 10.1039/c2nr11782g
   Wang YM, 2014, ACS APPL MATER INTER, V6, P2958, DOI 10.1021/am405556x
   Wittmer CR, 2011, ADV FUNCT MATER, V21, P4232, DOI 10.1002/adfm.201100755
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Zhang H, 2013, BIOMATERIALS, V34, P2202, DOI 10.1016/j.biomaterials.2012.12.005
   Zhong SP, 2012, TISSUE ENG PART B-RE, V18, P77, DOI 10.1089/ten.teb.2011.0390
NR 37
TC 6
Z9 6
U1 11
U2 88
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-5187
EI 1616-5195
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD JUN
PY 2016
VL 16
IS 6
BP 824
EP 835
DI 10.1002/mabi.201500375
PG 12
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA DR5AM
UT WOS:000379915300004
PM 26855375
DA 2018-10-20
ER

PT J
AU Wisotzki, EI
   Friedrich, RP
   Weidt, A
   Alexiou, C
   Mayr, SG
   Zink, M
AF Wisotzki, Emilia I.
   Friedrich, Ralf P.
   Weidt, Astrid
   Alexiou, Christoph
   Mayr, Stefan G.
   Zink, Mareike
TI Cellular Response to Reagent-Free Electron-Irradiated Gelatin Hydrogels
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE crosslinking; cytotoxicity; electron irradiation; gelatin; hydrogels
ID CROSS-LINKING; FUNCTIONAL-GROUPS; FLOW-CYTOMETRY; GAMMA-RAYS; COLLAGEN;
   APOPTOSIS; CELLS; SUBSTRATE; STIFFNESS; GLUTARALDEHYDE
AB As a biomaterial, it is well established that gelatin exhibits low cytotoxicity and can promote cellular growth. However, to circumvent the potential toxicity of chemical crosslinkers, reagent-free crosslinking methods such as electron irradiation are highly desirable. While high energy irradiation has been shown to exhibit precise control over the degree of crosslinking, these hydrogels have not been thoroughly investigated for biocompatibility and degradability. Here, NIH 3T3 murine fibroblasts are seeded onto irradiated gelatin hydrogels to examine the hydrogel's influence on cellular viability and morphology. The average projected area of cells seeded onto the hydrogels increases with irradiation dose, which correlates with an increase in the hydrogel's shear modulus up to 10 kPa. Cells on these hydrogels are highly viable and exhibits normal cell cycles, particularly when compared to those grown on glutaraldehyde crosslinked gelatin hydrogels. However, proliferation is reduced on both types of crosslinked samples. To mimic the response of the hydrogels in physiological conditions, degradability is monitored in simulated body fluid to reveal strongly dose-dependent degradation times. Overall, given the low cytotoxicity, influence on cellular morphology and variability in degradation times of the electron irradiated gelatin hydrogels, there is significant potential for application in areas ranging from regenerative medicine to mechanobiology.
C1 [Wisotzki, Emilia I.; Mayr, Stefan G.] Leibniz Inst Surface Modificat IOM, Permoserstr 15, D-04318 Leipzig, Germany.
   [Wisotzki, Emilia I.; Weidt, Astrid; Mayr, Stefan G.; Zink, Mareike] Univ Leipzig, Fac Phys & Earth Sci, Linnestr 5, D-04103 Leipzig, Germany.
   [Friedrich, Ralf P.; Alexiou, Christoph] Univ Hosp Erlangen, SEON, Else Kroner Fresenius Stiftung Professorship, ENT Clin, Erlangen, Germany.
RP Wisotzki, EI; Mayr, SG (reprint author), Leibniz Inst Surface Modificat IOM, Permoserstr 15, D-04318 Leipzig, Germany.; Wisotzki, EI; Mayr, SG (reprint author), Univ Leipzig, Fac Phys & Earth Sci, Linnestr 5, D-04103 Leipzig, Germany.; Friedrich, RP (reprint author), Univ Hosp Erlangen, SEON, Else Kroner Fresenius Stiftung Professorship, ENT Clin, Erlangen, Germany.
EM emilia.wisotzki@iom-leipzig.de; ralf.friedrich@uk-erlangen.de;
   stefan.mayr@iom-leipzig.de
RI Friedrich, Ralf/R-2580-2016; Zink, Mareike/D-8454-2016
OI Zink, Mareike/0000-0002-3603-3483
FU European Union; Free State of Saxony [SAB 100121467]; National Sciences
   and Engineering Research Council of Canada (NSERC) via a PGS D; Deutsche
   Forschungsgemeinschaft (DFG) [SPP 1681, AL 552/5, MA 2432/6]
FX The authors acknowledge Dr. U. Decker for his assistance with FTIR
   measurements, Dr. W. Knolle and R. Konecziey for electron irradiation,
   as well as F. Engert and B. Heyart for their contributions to this work.
   Grateful acknowledgement is given to Prof. J. A. Kas, as part of this
   work was performed within his labs. The project was funded in part by
   the European Union and the Free State of Saxony (SAB 100121467). Funding
   was also provided from the National Sciences and Engineering Research
   Council of Canada (NSERC) via a PGS D and the Deutsche
   Forschungsgemeinschaft (DFG) via Priority program SPP 1681
   "Feldgesteuerte Partikel-Matrix-Wechselwirkungen: Erzeugung,
   skalenubergreifende Modellierung und Anwendung magnetischer
   Hybrid-Materialien," grant numbers AL 552/5 and MA 2432/6.
CR Allenstein U, 2013, ACTA BIOMATER, V9, P5845, DOI 10.1016/j.actbio.2012.10.040
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Beal G. D., 1928, J AM PHARM ASSOC, V17, P261
   Bessho M, 2007, B CHEM SOC JPN, V80, P979, DOI 10.1246/bcsj.80.979
   Bhat R, 2009, FOOD CHEM, V113, P1160, DOI 10.1016/j.foodchem.2008.08.039
   Bohm I, 2006, ROFO-FORTSCHR RONTG, V178, P263, DOI 10.1055/s-2005-858791
   BORRAS A, 1972, AM J OPHTHALMOL, V73, P390, DOI 10.1016/0002-9394(72)90067-0
   Brodsky B., 2005, BIOPOLYMERS ONLINE
   Cataldo F., 2007, J RADIOANAL NUCL CH, V275, P125
   Chan TR, 2015, ACTA BIOMATER, V15, P164, DOI 10.1016/j.actbio.2015.01.005
   Demchenko A. P., 2012, Experimental Oncology, V34, P263
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Dubruel P, 2007, BIOMACROMOLECULES, V8, P338, DOI 10.1021/bm0606869
   Friess W, 1996, BIOMATERIALS, V17, P2289, DOI 10.1016/0142-9612(96)00047-6
   HARRINGT.WF, 1970, BIOCHEMISTRY-US, V9, P3714, DOI 10.1021/bi00821a010
   HAUSCHKA SD, 1966, P NATL ACAD SCI USA, V55, P119, DOI 10.1073/pnas.55.1.119
   HUANGLEE LLH, 1990, J BIOMED MATER RES, V24, P1185, DOI 10.1002/jbm.820240905
   Jayakrishnan A, 1996, BIOMATERIALS, V17, P471, DOI 10.1016/0142-9612(96)82721-9
   Jiang B, 2006, BIOMATERIALS, V27, P15, DOI 10.1016/j.biomaterials.2005.05.091
   Justice BA, 2009, DRUG DISCOV TODAY, V14, P102, DOI 10.1016/j.drudis.2008.11.006
   KOZLOV PV, 1983, POLYMER, V24, P651, DOI 10.1016/0032-3861(83)90001-0
   Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096
   MIYAZAWA T, 1958, J CHEM PHYS, V29, P611, DOI 10.1063/1.1744547
   Mohammadi H, 2014, BIOMATERIALS, V35, P1138, DOI 10.1016/j.biomaterials.2013.10.059
   Munoz LE, 2013, AUTOIMMUNITY, V46, P336, DOI 10.3109/08916934.2012.755960
   Paguirigan A, 2006, LAB CHIP, V6, P407, DOI 10.1039/b517524k
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   PEZRON I, 1990, J POLYM SCI POL PHYS, V28, P1823, DOI 10.1002/polb.1990.090281013
   Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11
   Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238
   SCHOR SL, 1979, J CELL SCI, V38, P267
   Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386
   Terao K, 2003, J BIOMAT SCI-POLYM E, V14, P1197, DOI 10.1163/156856203322553437
   TOMODA Y, 1961, J POLYM SCI, V54, P321, DOI 10.1002/pol.1961.1205416005
   Tsuda M., 1960, B SOC SCI PHOTOGR JP, V1960, P18
   van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R
   VANLUYN MJA, 1992, BIOMATERIALS, V13, P1017, DOI 10.1016/0142-9612(92)90153-F
   Webb K, 1998, J BIOMED MATER RES, V41, P422, DOI 10.1002/(SICI)1097-4636(19980905)41:3<422::AID-JBM12>3.0.CO;2-K
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wisotzki EI, 2014, J MATER CHEM B, V2, P4297, DOI 10.1039/c4tb00429a
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
NR 41
TC 6
Z9 6
U1 0
U2 10
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-5187
EI 1616-5195
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD JUN
PY 2016
VL 16
IS 6
BP 914
EP 924
DI 10.1002/mabi.201500408
PG 11
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA DR5AM
UT WOS:000379915300012
PM 26937853
DA 2018-10-20
ER

PT J
AU Abe, T
   Iiyoshi, R
   Ito, K
   Takahashi, Y
   Sato, K
   Matsuzaka, A
   Sonoki, T
   Ito, Y
AF Abe, Tomomi
   Iiyoshi, Ryota
   Ito, Kyosuke
   Takahashi, Yutaka
   Sato, Kohei
   Matsuzaka, Atsushi
   Sonoki, Tomonori
   Ito, Yukihiro
TI Difference of saccharification yields between organs and growth stages
   in rice
SO PLANT BIOTECHNOLOGY
LA English
DT Article
DE Saccharification; straw; rice
ID ARABIDOPSIS-THALIANA; EXO-GLUCANASE; SWITCHGRASS; BIOFUELS; ETHANOL;
   TISSUE; STRAW; SUGAR
AB Saccharification is a key step in the efficient production of biofuels and biomaterials from cellulosic biomass. We examined saccharification yields from leaf blades, leaf sheaths and stems at several growth stages in rice. We found that saccharification yields were high before heading and reduced after heading in all three organs examined. Stems showed highest saccharification yields at all growth stages examined, and leaf blades showed lowest saccharification yields. Differences of saccharification yields between rice cultivars were also observed. Our results indicate that saccharification yields are different between rice organs. This suggests that the proportion of organs is one of the determinants of saccharification yields of rice straws, and thus it will be a breeding target for biofuel and biomaterial crops with high saccharification yields. Our results also suggest that the harvesting stage is critical for high saccharification yields.
C1 [Abe, Tomomi; Ito, Kyosuke; Takahashi, Yutaka; Matsuzaka, Atsushi; Ito, Yukihiro] Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi 9818555, Japan.
   [Iiyoshi, Ryota; Sonoki, Tomonori] Hirosaki Univ, Fac Agr & Life Sci, Hirosaki, Aomori 0368560, Japan.
   [Sato, Kohei; Ito, Yukihiro] Tohoku Univ, Exploring Germinat & Growth Program Young Scienti, Sendai, Miyagi 9818555, Japan.
   [Takahashi, Yutaka] Northern Akita Reg Dev Bur, Kitaakita, Akita 0183393, Japan.
   [Sato, Kohei] Iwate Univ, Fac Agr, Morioka, Iwate 0208550, Japan.
RP Ito, Y (reprint author), Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi 9818555, Japan.; Ito, Y (reprint author), Tohoku Univ, Exploring Germinat & Growth Program Young Scienti, Sendai, Miyagi 9818555, Japan.
EM yukito@bios.tohoku.ac.jp
OI Sonoki, Tomonori/0000-0002-8671-2935
FU Japan Society for the Promotion of Science (JSPS) [23658003]; Japan
   Science and Technology Agency (JST)
FX This study was supported by a Grant-in-Aid for Challenging Exploratory
   Research (JSPS KAKENHI Grant Number 23658003) from the Japan Society for
   the Promotion of Science (JSPS) and Future Scientist Program from the
   Japan Science and Technology Agency (JST).
CR Alper H, 2009, NAT REV MICROBIOL, V7, P715, DOI 10.1038/nrmicro2186
   Berthet S, 2011, PLANT CELL, V23, P1124, DOI 10.1105/tpc.110.082792
   Bhandari HS, 2014, GCB BIOENERGY, V6, P26, DOI 10.1111/gcbb.12053
   Chen F, 2007, NAT BIOTECHNOL, V25, P759, DOI 10.1038/nbt1316
   Fu CX, 2011, P NATL ACAD SCI USA, V108, P3803, DOI 10.1073/pnas.1100310108
   Furukawa K, 2014, TRANSGENIC RES, V23, P531, DOI 10.1007/s11248-014-9786-z
   Furukawa T, 2013, J BIOSCI BIOENG, V116, P616, DOI 10.1016/j.jbiosc.2013.05.007
   Hendriks ATWM, 2009, BIORESOURCE TECHNOL, V100, P10, DOI 10.1016/j.biortech.2008.05.027
   Ishii T, 2001, PLANT PHYSIOL, V126, P1698, DOI 10.1104/pp.126.4.1698
   Nigorikawa M, 2012, RICE, DOI 10.1186/1939-8433-5-14
   Rancour DM, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00266
   Sainz MB, 2009, IN VITRO CELL DEV-PL, V45, P314, DOI 10.1007/s11627-009-9210-1
   Sato S, 2001, PLANT CELL PHYSIOL, V42, P251, DOI 10.1093/pcp/pce045
   Shen H, 2012, NEW PHYTOL, V193, P121, DOI 10.1111/j.1469-8137.2011.03922.x
   Sumiyoshi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078269
   Sumner JB, 1921, J BIOL CHEM, V47, P5
   Taylor LE, 2008, TRENDS BIOTECHNOL, V26, P413, DOI 10.1016/j.tibtech.2008.05.002
   Zhang H, 2014, GCB BIOENERGY, V6, P90, DOI 10.1111/gcbb.12060
NR 18
TC 0
Z9 0
U1 0
U2 3
PU JAPANESE SOC PLANT CELL & MOLECULAR BIOLOGY
PI NARA
PA NARA INST SCI & TECH, GRAD SCH BIOMEDICAL SCIENCES, NARA, 630-0101,
   JAPAN
SN 1342-4580
J9 PLANT BIOTECHNOL-NAR
JI Plant Biotechnol.
PD JUN
PY 2016
VL 33
IS 2
BP 105
EP +
DI 10.5511/plantbiotechnology.16.0502a
PG 7
WC Biotechnology & Applied Microbiology; Plant Sciences
SC Biotechnology & Applied Microbiology; Plant Sciences
GA DR5QV
UT WOS:000379958400006
OA Bronze
DA 2018-10-20
ER

PT J
AU Niespodziana, K
   Jurczyk, K
   Jurczyk, M
AF Niespodziana, K.
   Jurczyk, K.
   Jurczyk, M.
TI SYNTHESIS OF NITI BASED NANOCOMPOSITES REINFORCED BY HA ADDITION
SO ARCHIVES OF METALLURGY AND MATERIALS
LA English
DT Article
DE biomaterial; NiTi; hydroxyapatite; nanocomposite; mechanical alloying
ID ALLOY
AB NiTi alloy is well known for its unique properties, such as good ductility at room temperature, good corrosion resistance and also thermal shape memory effects. On the other hand hydroxyapatite has a combination of desirable properties, such as low density and excellent compatibility with the bone which used as ceramic reinforced phases can change the properties and thermal stability of the NiTi alloy.
   In this study, the NiTi alloy matrix shape memory composite reinforced by hydroxyapatite particles was successfully fabricated using mechanical alloying and powder metallurgical process. The structural evaluation of milled and heat treated powders was studied by X-ray diffraction, scanning electron microscopy and transmission electron microscopy. The differential scanning calorimetry was used to measure the phase transformation temperatures. The porosity, Vickers' hardness and corrosion resistance of the TiNi-HA composites were investigated. The results show that the increase of the weight ratio of hydroxyapatite causes increase the porosity and decrease the corrosion resistance. The fabricated NiTi alloy matrix composite possesses lower density and higher Vickers' hardness as the pure NiTi shape memory alloy, yet still exhibiting the shape memory effect.
C1 [Niespodziana, K.; Jurczyk, M.] Poznan Univ Tech, Inst Mat Sci & Engn, 5 M Sklodowska Curie Str, PL-60965 Poznan, Poland.
   [Jurczyk, K.] Poznan Univ Med Sci, Dept Conservat Dent & Periodontol, 70 Bukowska Str, PL-60812 Poznan, Poland.
RP Niespodziana, K (reprint author), Poznan Univ Tech, Inst Mat Sci & Engn, 5 M Sklodowska Curie Str, PL-60965 Poznan, Poland.
EM katarzyna.niespodziana@put.poznan.pl
RI Niespodziana, Kasia/N-7507-2013; Jurczyk, Mieczyslaw/F-8616-2014
OI Niespodziana, Kasia/0000-0001-9827-9879; Jurczyk,
   Mieczyslaw/0000-0001-5989-8298
CR BENJAMIN JS, 1976, SCI AM, V234, P40, DOI 10.1038/scientificamerican0576-40
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Jiang HJ, 2013, MATER LETT, V100, P74, DOI 10.1016/j.matlet.2013.02.113
   Kaczmarek M, 2014, J BIOMED MATER RES A, V102, P1316, DOI 10.1002/jbm.a.34808
   Neikov O.D., 2009, HDB NONFERROUS METAL
   Niespodziana K, 2010, MATER CHEM PHYS, V123, P160, DOI 10.1016/j.matchemphys.2010.03.076
   Wei ZG, 1998, J MATER SCI, V33, P3743, DOI 10.1023/A:1004692329247
   Wever DJ, 1997, BIOMATERIALS, V18, P1115, DOI 10.1016/S0142-9612(97)00041-0
   Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014
NR 9
TC 0
Z9 0
U1 0
U2 7
PU POLSKA AKAD NAUK, POLISH ACAD SCIENCES, INST METALL & MATER SCI PAS
PI WARSZAWA
PA PL, 00-901 WARSZAWA, POLAND
SN 1733-3490
EI 2300-1909
J9 ARCH METALL MATER
JI Arch. Metall. Mater.
PD JUN
PY 2016
VL 61
IS 2
BP 577
EP 580
DI 10.1515/amm-2016-0098
PG 4
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA DQ9GR
UT WOS:000379518900017
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Basiaga, M
   Staszuk, M
   Walke, W
   Tanski, T
   Kajzer, W
AF Basiaga, M.
   Staszuk, M.
   Walke, W.
   Tanski, T.
   Kajzer, W.
TI POTENTIOSTATIC, POTENTIODYNAMIC AND IMPEDANCE STUDY OF TiO2 LAYERS
   DEPOSITED OF 316 LVM STEEL USED FOR CORONARY STENTS
SO ARCHIVES OF METALLURGY AND MATERIALS
LA English
DT Article
DE AISI 316LVM; TiO2 layer; ALD method; coronary stents; corrosion
   resistance
ID STAINLESS-STEEL; CORROSION-RESISTANCE; COATINGS
AB The objective of the study is assessment of suitability of the ALD method for application of a TiO2 layer on surface of 316LVM steel used for production of vessel stents. Selection of the appropriate process parameters for application of the layer affects its electrochemical properties, which largely determine resistance of the biomaterial to corrosion in the blood environment, thus affecting its hemocompatibility. To assess resistance of the AISI 316LVM steel with modified surface to corrosion, voltammetric and impedance measurements were conducted. The proposed variant of surface processing allows safe deformation of the TiO2 layer without its delamination.
C1 [Basiaga, M.; Walke, W.; Kajzer, W.] Silesian Tech Univ, Fac Biomed Engn, 40 Roosevelta Str, PL-41800 Zabrze, Poland.
   [Staszuk, M.; Tanski, T.] Silesian Tech Univ, Fac Mech Engn, 18a Konarskiego Str, PL-44100 Gliwice, Poland.
RP Basiaga, M (reprint author), Silesian Tech Univ, Fac Biomed Engn, 40 Roosevelta Str, PL-41800 Zabrze, Poland.
EM marcin.basiaga@polsl.pl
RI Tanski, Tomasz/F-8944-2014
OI Tanski, Tomasz/0000-0003-4024-1231; Staszuk, Marcin/0000-0003-3637-9713;
   Kajzer, Wojciech/0000-0001-9285-1272
FU National Science Centre [2014/13/D/ST8/03230]
FX The project was funded by the National Science Centre allocated on the
   basis of the decision No. 2014/13/D/ST8/03230.
CR Aarik L, 2013, THIN SOLID FILMS, V542, P100, DOI 10.1016/j.tsf.2013.06.074
   Basiaga M, 2016, MATERIALWISS WERKST, V47, P512, DOI 10.1002/mawe.201600527
   Basiaga M, 2016, MATER TEHNOL, V50, P153, DOI 10.17222/mit.2014.241
   Basiaga M, 2014, ADV INTELL SYST, V284, P411, DOI 10.1007/978-3-319-06596_39
   Kajzer A, 2015, ACTA BIOENG BIOMECH, V17, P35, DOI 10.5277/ABB-00140-2014-02
   Kiel M, 2010, ADV INTEL SOFT COMPU, V69, P447
   Kumagai H, 2011, J CRYST GROWTH, V314, P146, DOI 10.1016/j.jcrysgro.2010.12.003
   Lim BS, 2003, NAT MATER, V2, P749, DOI 10.1038/nmat1000
   Marin E, 2012, THIN SOLID FILMS, V522, P283, DOI 10.1016/j.tsf.2012.08.023
   Martin E., 2015, MATER CORROS, V66, P909
   Saleem MR, 2012, THIN SOLID FILMS, V520, P5442, DOI 10.1016/j.tsf.2012.04.008
   Shan CX, 2008, SURF COAT TECH, V202, P2399, DOI 10.1016/j.surfcoat.2007.08.066
   Walke W., INT C ADV COMP ENG E
   Walke W, 2014, ADV INTELL SYST, V284, P403, DOI 10.1007/978-3-319-06596_38
   Wang L, 2015, APPL SURF SCI, V340, P113, DOI 10.1016/j.apsusc.2015.02.191
NR 15
TC 0
Z9 0
U1 1
U2 4
PU POLSKA AKAD NAUK, POLISH ACAD SCIENCES, INST METALL & MATER SCI PAS
PI WARSZAWA
PA PL, 00-901 WARSZAWA, POLAND
SN 1733-3490
EI 2300-1909
J9 ARCH METALL MATER
JI Arch. Metall. Mater.
PD JUN
PY 2016
VL 61
IS 2
BP 821
EP 824
DI 10.1515/amm-2016-0138
PG 4
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA DQ9GR
UT WOS:000379518900057
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Affeld, K
   Schaller, J
   Wolken, T
   Krabatsch, T
   Kertzscher, U
AF Affeld, Klaus
   Schaller, Jens
   Woelken, Thies
   Krabatsch, Thomas
   Kertzscher, Ulrich
TI Role of flow for the deposition of platelets
SO BIOINTERPHASES
LA English
DT Article
ID STAGNATION POINT FLOW; SHEAR; TRANSPORT; ACCUMULATION; COATINGS;
   ADHESION; PUMPHEAD; THROMBUS; SURFACES; RATES
AB Implants inside the cardiovascular system are subjected to blood flow. Platelet deposition usually takes place, eventually leading to thrombus formation. Tests must be performed in order to select a suitable biomaterial, but no generally accepted test method exists for biomaterials in contact with blood. At a first glance, the flow appears to play only a minor role in the complex interaction between platelets and biomaterials. However, experiments and models have indeed demonstrated the importance of flow. Flow is the mechanism by which platelets are transported to the site of deposition, enabling deposition and forming the shape of a growing thrombus. This interaction is investigated here by means of two experimental models. The first model generates the simplest shear flow, the plane Couette flow. It serves to quantify the role of the shear rate. The second model, the stagnation point flow model, features a more complex shear flow. This model is used to understand the influence of a changing flow field along the wall over which the platelets travel. The platelet deposition is observed using the two experimental models, and a numerical model is developed to reproduce and simulate the experimental results. In the numerical model, the movement of platelets is computed with a combination of convective and stochastic movements due to diffusion. The combined motion brings some platelets close to the wall. The deposition of the platelet at the wall is modeled by a stochastic model. Probability determines whether the individual platelet deposits or flows onwards. This probability is the product of three different probabilities, which are the properties of the platelet, the wall, and the flow. The results of the models are compared with the experimental results and are used to understand the experiments. (C) 2016 American Vacuum Society.
C1 [Affeld, Klaus; Schaller, Jens; Woelken, Thies; Kertzscher, Ulrich] Charite Univ Med Berlin, Inst Lab Med Klin Chem & Pathobiochem, Lab Biofluidmech, Augustenburger Pl 1 Forum 4, D-13353 Berlin, Germany.
   [Krabatsch, Thomas] Deutsch Herzzentrum Berlin, DHZB, Augustenburger Pl 1, D-13353 Berlin, Germany.
RP Affeld, K (reprint author), Charite Univ Med Berlin, Inst Lab Med Klin Chem & Pathobiochem, Lab Biofluidmech, Augustenburger Pl 1 Forum 4, D-13353 Berlin, Germany.
EM Klaus.affeld@charite.de
FU German Research Foundation (DFG)
FX This work is funded by the German Research Foundation (DFG). The
   photograph of Fig. 1 was contributed by Friedrich Kaufmann (DHZB-German
   Heart Center Berlin). Rainer Haag and Tobias Becherer (Freie Universitat
   Berlin) developed the Polyglycerol coatings used for the experiments
   depicted in Fig. 15. Torsten Kragh (Department of Transfusion Medicine,
   Cell Therapeutics and Hemostasis, Medical Center of the University of
   Munich, Germany) performed the experiments with blood flowing over glass
   covered with collagen, with vWF, and with polyurethane, likewise in Fig.
   15.
CR AFFELD K, 1995, ARTIF ORGANS, V19, P597, DOI 10.1111/j.1525-1594.1995.tb02387.x
   Affeld K., 2014, BIOMED TECH, V59, ps11
   Affeld K, 2013, J BIOMECH, V46, P430, DOI 10.1016/j.jbiomech.2012.10.030
   Alston RP, 2005, BRIT J ANAESTH, V94, P699, DOI 10.1093/bja/aei128
   BALDAUF W, 1978, PATHOL RES PRACT, V163, P9, DOI 10.1016/S0344-0338(78)80107-1
   Bark DL, 2013, BIOPHYS J, V105, P502, DOI 10.1016/j.bpj.2013.05.049
   Bark DL, 2012, BIOTECHNOL BIOENG, V109, P2642, DOI 10.1002/bit.24537
   Becherer T, 2015, ANAL CHIM ACTA, V867, P47, DOI 10.1016/j.aca.2015.01.048
   Casa LDC, 2015, J VASC SURG, V61, P1068, DOI 10.1016/j.jvs.2014.12.050
   Dattilio Frank M, 2006, Neuropsychiatr Dis Treat, V2, P111
   Hoger K, 2013, EUR J PHARM BIOPHARM, V85, P756, DOI 10.1016/j.ejpb.2013.04.005
   Hund SJ, 2009, PHYS MED BIOL, V54, P6415, DOI 10.1088/0031-9155/54/20/024
   Jamiolkowski MA, 2015, J BIOMED MATER RES A, V103, P1303, DOI 10.1002/jbm.a.35202
   Jung F, 2013, CLIN HEMORHEOL MICRO, V53, P97, DOI 10.3233/CH-2012-1579
   Kragh T, 2015, MICROFLUID NANOFLUID, V19, P155, DOI 10.1007/s10404-015-1557-5
   PETSCHEK H, 1968, T AM SOC ART INT ORG, V14, P256
   Rastan AJ, 2006, INT J ARTIF ORGANS, V29, P1121
   Ruggeri ZM, 2006, BLOOD, V108, P1903, DOI 10.1182/blood-2006-04-011551
   Sorensen E. N., 2002, THESIS
   Stutz B, 2003, SCI AM, V289, P76, DOI 10.1038/scientificamerican0703-76
   TURITTO VT, 1975, T AM SOC ART INT ORG, V21, P593
   Virchow R., 1856, GESAMMELTE ABHANDLUN
   Wellnhofer E, 2010, ATHEROSCLEROSIS, V213, P475, DOI 10.1016/j.atherosclerosis.2010.09.007
   Wootton DM, 2001, ANN BIOMED ENG, V29, P321, DOI 10.1114/1.1359449
   ZYDNEY AL, 1988, PHYSICOCHEM HYDRODYN, V10, P77
NR 25
TC 0
Z9 0
U1 1
U2 10
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 1934-8630
EI 1559-4106
J9 BIOINTERPHASES
JI Biointerphases
PD JUN
PY 2016
VL 11
IS 2
AR 029804
DI 10.1116/1.4944383
PG 9
WC Biophysics; Materials Science, Biomaterials
SC Biophysics; Materials Science
GA DR0FF
UT WOS:000379582700049
PM 26984235
DA 2018-10-20
ER

PT J
AU Cornelius, RM
   Macri, J
   Cornelius, KM
   Brash, JL
AF Cornelius, Rena M.
   Macri, Joseph
   Cornelius, Katherine M.
   Brash, John L.
TI Lipoprotein interactions with a polyurethane and a polyethylene
   oxide-modified polyurethane at the plasma-material interface
SO BIOINTERPHASES
LA English
DT Article
ID AMPHIPHILIC TRIBLOCK COPOLYMERS; SURFACE MODIFYING ADDITIVES;
   APOLIPOPROTEIN-A-I; HIGH-DENSITY-LIPOPROTEIN; PEO-COPOLYMER/POLYURETHANE
   BLENDS; PROTEIN ADSORPTION; BIOMATERIAL SURFACES; PLATELET-ADHESION;
   POLYMER SURFACES; BLOOD-PLASMA
AB Lipoproteins [high density lipoprotein (HDL), low density lipoprotein (LDL), and very low density lipoprotein (VLDL)] are present in blood in relatively high concentrations, and, given their importance in cardiovascular disease, the interactions of these species with blood contacting biomaterials and their possible role in thrombogenesis is of interest. In the present communication, quantitative data on the adsorption of apolipoprotein AI, apolipoprotein AII (the main protein components of HDL), and apolipoprotein B (the main protein component of LDL and VLDL), as well as the lipoproteins themselves from plasma to a biomedical grade polyurethane (PU) with and without a copolymer additive that contains polyethylene oxide (PEO) segments, were investigated. Adsorption from some binary solutions was also studied. Significant quantities of the apolipoproteins were found to adsorb from plasma to the PU, while adsorption to the PEO material was more than 90% lower, demonstrating strong protein resistance of the latter material. In contrast, significant quantities of the lipoproteins were found to adsorb to the PEO as well as to the PU material. From these and previously published results, it is concluded that the protein layer formed on the PU surface from plasma (and by extension from blood) contains apolipoproteins and lipoproteins in addition to other plasma proteins; the layer formed on the PEO surface, however, appears to contain minimal quantities of plasma proteins (including free apolipoproteins) but significant quantities of lipoproteins. (C) 2016 American Vacuum Society.
C1 [Cornelius, Rena M.] McMaster Univ, Dept Chem Engn, 1280 Main St West, Hamilton, ON L8S 4L7, Canada.
   [Macri, Joseph] McMaster Univ, Dept Pathol & Mol Med, 1280 Main St West, Hamilton, ON L8S 4L7, Canada.
   [Cornelius, Katherine M.] McMaster Univ, Dept Biol, 1280 Main St West, Hamilton, ON L8S 4L7, Canada.
   [Brash, John L.] McMaster Univ, Dept Chem Engn, Sch Biomed Engn, 1280 Main St West, Hamilton, ON L8S 4L7, Canada.
RP Brash, JL (reprint author), McMaster Univ, Dept Chem Engn, Sch Biomed Engn, 1280 Main St West, Hamilton, ON L8S 4L7, Canada.
EM brashjl@mcmaster.ca
FU Natural Sciences and Engineering Research Council (NSERC) of Canada
FX Financial support from the Natural Sciences and Engineering Research
   Council (NSERC) of Canada is gratefully acknowledged.
CR Ajees AA, 2006, P NATL ACAD SCI USA, V103, P2126, DOI 10.1073/pnas.0506877103
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Banerjee I, 2011, ADV MATER, V23, P690, DOI 10.1002/adma.201001215
   Capriotti AL, 2012, J PROTEOMICS, V75, P1924, DOI 10.1016/j.jprot.2012.01.003
   Cavigiolio G, 2010, J BIOL CHEM, V285, P18847, DOI 10.1074/jbc.M109.098434
   Cedervall T, 2007, ANGEW CHEM INT EDIT, V46, P5754, DOI 10.1002/anie.200700465
   Cornelius RM, 2015, LANGMUIR, V31, P12087, DOI 10.1021/acs.langmuir.5b02688
   Cornelius RM, 2011, J BIOMED MATER RES A, V99A, P109, DOI 10.1002/jbm.a.33169
   Cornelius RM, 2002, BIOMATERIALS, V23, P3583, DOI 10.1016/S0142-9612(02)00083-2
   Docter D, 2014, NAT PROTOC, V9, P2030, DOI 10.1038/nprot.2014.139
   Florentin M, 2008, CURR OPIN CARDIOL, V23, P370, DOI 10.1097/HCO.0b013e3283043806
   Frazier RA, 2000, BIOMATERIALS, V21, P957, DOI 10.1016/S0142-9612(99)00270-7
   Futamura K, 2008, LANGMUIR, V24, P10340, DOI 10.1021/la801017h
   Gossmann R, 2015, EUR J PHARM BIOPHARM, V93, P80, DOI 10.1016/j.ejpb.2015.03.021
   Graham I, 2007, ATHEROSCLEROSIS, V194, P1, DOI 10.1016/j.atherosclerosis.2007.08.024
   Gunkel G, 2013, J AM CHEM SOC, V135, P7047, DOI 10.1021/ja402126t
   He Y, 2008, LANGMUIR, V24, P10358, DOI 10.1021/la8013046
   Horbett T. A., 2012, ACS S SERIES, V1120
   Jansch M, 2012, INT J PHARMACEUT, V428, P125, DOI 10.1016/j.ijpharm.2012.01.060
   Jiang SY, 2010, ADV MATER, V22, P920, DOI 10.1002/adma.200901407
   Jin ZL, 2010, J BIOMED MATER RES A, V95A, P1223, DOI 10.1002/jbm.a.32935
   Johs A, 2006, J BIOL CHEM, V281, P19732, DOI 10.1074/jbc.M601688200
   Knetsch MLW, 2006, BIOMATERIALS, V27, P2813, DOI 10.1016/j.biomaterials.2005.12.025
   KNIGHT LC, 1981, THROMB HAEMOSTASIS, V46, P593
   Kumar S, 2013, CHEM COMMUN, V49, P90, DOI 10.1039/c2cc36284h
   Lazarovits J, 2015, CHEM COMMUN, V51, P2756, DOI 10.1039/c4cc07644c
   Liu XL, 2014, J MATER CHEM B, V2, P5718, DOI 10.1039/c4tb00881b
   Lyman D. J., 1971, THROMB DIATH HAEMO, V42, P109
   Morra M, 2000, J BIOMAT SCI-POLYM E, V11, P547, DOI 10.1163/156856200743869
   Pierce Chemical Company, 1993, IODO GEN IOD REAG
   Pollard RD, 2013, BIOCHEMISTRY-US, V52, P9470, DOI 10.1021/bi401080k
   Ren CL, 2008, J PHYS CHEM B, V112, P16238, DOI 10.1021/jp8080904
   Riedel T, 2013, LANGMUIR, V29, P3388, DOI 10.1021/la304886r
   Salvador-Morales C, 2006, MOL IMMUNOL, V43, P193, DOI 10.1016/j.molimm.2005.02.006
   Salvador-Morales C, 2009, BIOMATERIALS, V30, P2231, DOI 10.1016/j.biomaterials.2009.01.005
   Schottler S, 2016, NAT NANOTECHNOL, V11, P372, DOI [10.1038/NNANO.2015.330, 10.1038/nnano.2015.330]
   Sempf K, 2013, EUR J PHARM BIOPHARM, V85, P53, DOI 10.1016/j.ejpb.2012.11.030
   Tan J, 2008, J BIOMED MATER RES A, V85A, P862, DOI 10.1002/jbm.a.31548
   Tan J, 2008, J BIOMED MATER RES A, V85A, P873, DOI 10.1002/jbm.a.31554
   Tan J, 2008, J APPL POLYM SCI, V108, P1617, DOI 10.1002/app.27098
   Tan J, 2013, J BIOMAT SCI-POLYM E, V24, P497, DOI 10.1080/09205063.2012.690286
   Tan J, 2009, J BIOMED MATER RES A, V90A, P196, DOI 10.1002/jbm.a.32074
   Tenzer S, 2013, NAT NANOTECHNOL, V8, P772, DOI 10.1038/nnano.2013.181
   Tsai WB, 2002, J BIOMED MATER RES, V60, P348, DOI 10.1002/jbm.10048
   Vogler EA, 2012, BIOMATERIALS, V33, P1201, DOI 10.1016/j.biomaterials.2011.10.059
   Walkey CD, 2014, ACS NANO, V8, P2439, DOI 10.1021/nn406018q
   Wang LCH, 2006, J ETHNOPHARMACOL, V103, P103, DOI 10.1016/j.jep.2005.07.010
   Yang W, 2009, LANGMUIR, V25, P11911, DOI 10.1021/la9015788
   Zhang Z, 2008, BIOMACROMOLECULES, V9, P2686, DOI 10.1021/bm800407r
NR 49
TC 2
Z9 2
U1 6
U2 22
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 1934-8630
EI 1559-4106
J9 BIOINTERPHASES
JI Biointerphases
PD JUN
PY 2016
VL 11
IS 2
AR 029810
DI 10.1116/1.4953867
PG 6
WC Biophysics; Materials Science, Biomaterials
SC Biophysics; Materials Science
GA DR0FF
UT WOS:000379582700055
PM 27306077
DA 2018-10-20
ER

PT J
AU Hugoni, L
   Montano-Machado, V
   Yang, ML
   Pauthe, E
   Mantovani, D
   Santerre, JP
AF Hugoni, Ludivine
   Montano-Machado, Vanessa
   Yang, Meilin
   Pauthe, Emmanuel
   Mantovani, Diego
   Santerre, J. Paul
TI Fibronectin adsorption on surface-modified polyetherurethanes and their
   differentiated effect on specific blood elements related to inflammatory
   and clotting processes
SO BIOINTERPHASES
LA English
DT Article
ID HYDROPHOBIC IONIC POLYURETHANE; FOREIGN-BODY REACTION; MODIFYING
   MACROMOLECULES; PLASMA FIBRONECTIN; PLATELET-ADHESION; SEGMENTED
   POLYURETHANES; FIBRINOGEN ADSORPTION; PROTEIN ADSORPTION; CELL-ADHESION;
   IN-VITRO
AB After the introduction of a medical device into the body, adhesive proteins such as fibronectin (Fn) will adsorb to the surface of the biomaterial. Monocytes (MCs) will interact with these adsorbed proteins, and adopt either a proinflammatory and/or prowound healing phenotype, thereby influencing many blood interaction events including thrombogenesis. In this work, Fn adsorption as well as subsequent MC response and thrombus formation were investigated on two surfaces-modified polyetherurethanes (PEUs) using different surface modifiers: an anionic/dihydroxyl oligomeric (ADO) additive, known to enable cell adhesion, and a fluorinated polypropylene oxide oligomer (PPO), known to reduce platelet adhesion. Results indicated that at 24 h of MC culture, PEU-ADO and PEU-PPO promoted an anti-inflammatory character relative to the base PEU. Longer clotting times, based on a free hemoglobin assay, were also found on the two surface-modified PEUs relative to the native one, suggesting their potential for the reduction of thrombus formation. In presence of a Fn monolayer, the surface-modified PEUs conserved a lower thrombogenic character than the base PEU, and was however significantly decreased when compared to prior protein adsorption. Furthermore, Fn coatings increased the MC production levels of tumor necrosis factor-a and interleukin-10 at 24 h, while not affecting the anti-inflammatory effect of the modifications relative to the base PEU. This finding was most prominent on PEU-PPO, suggesting that the interaction of the adsorbed Fn with blood cells was different for the two additives. Hence, the results highlighted differentiating effects of Fn adsorption on specific blood activating processes related to inflammatory and thrombotic responses. (C) 2016 American Vacuum Society.
C1 [Hugoni, Ludivine; Montano-Machado, Vanessa; Mantovani, Diego] Univ Laval, Lab Biomat & Bioengn, Dept Min Met Mater Engn, CRC 1, Quebec City, PQ G1A 0V6, Canada.
   [Hugoni, Ludivine; Montano-Machado, Vanessa; Mantovani, Diego] CHU Quebec, Res Ctr, Quebec City, PQ G1A 0V6, Canada.
   [Hugoni, Ludivine; Montano-Machado, Vanessa; Pauthe, Emmanuel] Univ Cergy Pontoise, Lab ERRMECe, 2 Ave Adolphe Chauvin, F-95302 Cergy Pontoise, France.
   [Hugoni, Ludivine; Yang, Meilin; Santerre, J. Paul] Univ Toronto, Fac Dent, Toronto, ON M5G 1G6, Canada.
   [Santerre, J. Paul] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada.
RP Santerre, JP (reprint author), Univ Toronto, Fac Dent, Toronto, ON M5G 1G6, Canada.; Santerre, JP (reprint author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada.
EM paul.santerre@dentistry.utoronto.ca
OI Mantovani, Diego/0000-0001-9672-895X
FU NSERC CREATE Program in Regenerative Medicine; NSERC; CIHR; Fonds Samuel
   de Champlain; FQRS; FQRNT; CONACYT, Mexico; FRQ-Sante; FRQ-Nature et
   Technologies
FX L.H. was awarded with a M.Sc. Scholarship from NSERC CREATE Program in
   Regenerative Medicine (www.ncprm.ulaval.ca), NSERC, CIHR, Fonds Samuel
   de Champlain, FQRS, and FQRNT. V.M.M. was awarded with a Ph.D.
   Scholarship from CONACYT, Mexico. This work was partially supported by
   FRQ-Sante and FRQ-Nature et Technologies. The authors would like to
   thank Pascale Chevallier, Kyle Battiston and Lucie Levesque for their
   technical assistance, help, and guidance all along the project.
CR Alves CM, 2010, SOFT MATTER, V6, P4135, DOI 10.1039/c002972f
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Andrade J. D., 1985, SURFACE INTERFACIAL, P249
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Asanuma Y, 2013, COLLOID SURFACE B, V108, P239, DOI 10.1016/j.colsurfb.2013.02.042
   BAIER RE, 1972, B NEW YORK ACAD MED, V48, P257
   Battiston KG, 2012, BIOMATERIALS, V33, P8316, DOI 10.1016/j.biomaterials.2012.08.014
   Baujard-Lamotte L, 2008, COLLOID SURFACE B, V63, P129, DOI [10.1016/j.colsurfb.2007.11.015, 10.1016/j.coisurfb.2007.11.015]
   Bergkvist M, 2003, J BIOMED MATER RES A, V64A, P349, DOI 10.1002/jbm.a.10423
   BEVILACQUA MP, 1981, J EXP MED, V153, P42, DOI 10.1084/jem.153.1.42
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P457, DOI 10.1002/jbm.820260404
   Claiborne TE, 2012, EXPERT REV MED DEVIC, V9, P577, DOI [10.1586/ERD.12.51, 10.1586/erd.12.51]
   Dadsetan M, 2004, J BIOMED MATER RES A, V71A, P439, DOI 10.1002/jbm.a.30165
   DETTRE RH, 1965, J PHYS CHEM-US, V69, P1507, DOI 10.1021/j100889a012
   Ernsting MJ, 2007, J BIOMED MATER RES A, V83A, P759, DOI 10.1002/jbm.a.31370
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Galtayries A, 2006, SURF INTERFACE ANAL, V38, P186, DOI 10.1002/sia.2295
   Gretzer C, 2006, J BIOMAT SCI-POLYM E, V17, P669, DOI 10.1163/156856206777346340
   Guignot C, 2001, NUCL INSTRUM METH B, V185, P100, DOI 10.1016/S0168-583X(01)00850-3
   HORBETT TA, 1993, CARDIOVASC PATHOL, V2, pS137
   Jahangir AR, 2002, J BIOMED MATER RES, V60, P135, DOI 10.1002/jbm.10033
   Kakkos SK, 2007, J VASC SURG, V45, P974, DOI 10.1016/j.jvs.2007.01.011
   Kao WJ, 2001, J BIOMED MATER RES, V55, P79, DOI 10.1002/1097-4636(200104)55:1<79::AID-JBM110>3.3.CO;2-Q
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Levi M, 2004, CIRCULATION, V109, P2698, DOI 10.1161/01.CIR.0000131660.51520.9A
   Lopez-Donaire ML, 2014, J APPL POLYM SCI, V131, DOI [10.1002/APP.40328, 10.1002/app.40328]
   MarcosFernandez A, 1997, MACROMOLECULES, V30, P3584, DOI 10.1021/ma9619039
   Marois Y, 2000, BIOCOMPATIBILITY POL
   Massa TM, 2007, J BIOMED MATER RES A, V81A, P178, DOI 10.1002/jbm.a.30936
   Mathieu E, 2014, J BIOMAT SCI-POLYM E, V25, P1159, DOI 10.1080/09205063.2014.923367
   McBane JE, 2011, BIOMATERIALS, V32, P3584, DOI 10.1016/j.biomaterials.2011.01.069
   McBane JE, 2009, J BIOMED MATER RES A, V91A, P1150, DOI 10.1002/jbm.a.32261
   McBane JE, 2009, BIOMATERIALS, V30, P5497, DOI 10.1016/j.biomaterials.2009.07.010
   McCloskey CB, 2002, MACROMOLECULES, V35, P924, DOI 10.1021/ma010283v
   Mickelson JK, 1996, J AM COLL CARDIOL, V28, P345, DOI 10.1016/0735-1097(96)00164-7
   Montano-Machado V, 2015, BIOMATTER, V5, DOI 10.4161/21592535.2014.979679
   Park HD, 2006, MACROMOL RES, V14, P73, DOI 10.1007/BF03219071
   Poulouin L, 1999, PROTEIN EXPRES PURIF, V17, P146, DOI 10.1006/prep.1999.1103
   Rampersad SN, 2012, SENSORS-BASEL, V12, P12347, DOI 10.3390/s120912347
   RINDER HM, 1991, BLOOD, V78, P1730
   Rumbaut RE, 2010, PLATELET VESSEL WALL
   RYU GH, 1995, ASAIO J, V41, pM384, DOI 10.1097/00002480-199507000-00036
   Scopelliti PE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011862
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   Sudhakaran PR, 2007, GLYCOCONJUGATE J, V24, P49, DOI 10.1007/s10719-006-9011-2
   Szycher M, 1999, SZYCHERS HDB POLYURE
   TAKAHARA A, 1991, J BIOMED MATER RES, V25, P1095, DOI 10.1002/jbm.820250905
   Tan DS, 2012, APPL SURF SCI, V258, P2697, DOI 10.1016/j.apsusc.2011.10.120
   Tang YW, 1996, J APPL POLYM SCI, V62, P1133, DOI 10.1002/(SICI)1097-4628(19961121)62:8<1133::AID-APP1>3.0.CO;2-J
   Tang YW, 1997, J BIOMED MATER RES, V35, P371, DOI 10.1002/(SICI)1097-4636(19970605)35:3<371::AID-JBM11>3.0.CO;2-I
   Thevenot P, 2008, CURR TOP MED CHEM, V8, P270
   THURLOW PJ, 1990, BRIT J HAEMATOL, V75, P549, DOI 10.1111/j.1365-2141.1990.tb07797.x
   TINGEY KG, 1991, LANGMUIR, V7, P2471, DOI 10.1021/la00059a013
   VANFURTH R, 1979, BLOOD, V54, P485
   Vanterpool FA, 2014, BIORESEARCH OPEN ACC, V3, P286, DOI 10.1089/biores.2014.0033
   Venkatraman S, 2008, PROG POLYM SCI, V33, P853, DOI 10.1016/j.progpolymsci.2008.07.001
   WANG CB, 1983, MACROMOLECULES, V16, P775, DOI 10.1021/ma00239a014
   Wang J, 2005, SURF COAT TECH, V196, P307, DOI 10.1016/j.surfcoat.2004.08.161
   Yang L, 2009, J BIOMED MATER RES A, V91A, P1089, DOI 10.1002/jbm.a.32331
   YASUDA H, 1991, LANGMUIR, V7, P2394, DOI 10.1021/la00058a070
   ZOGRAFI G, 1984, INT J PHARM, V22, P159, DOI 10.1016/0378-5173(84)90019-X
NR 61
TC 1
Z9 1
U1 0
U2 22
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 1934-8630
EI 1559-4106
J9 BIOINTERPHASES
JI Biointerphases
PD JUN
PY 2016
VL 11
IS 2
AR 029809
DI 10.1116/1.4950887
PG 14
WC Biophysics; Materials Science, Biomaterials
SC Biophysics; Materials Science
GA DR0FF
UT WOS:000379582700054
PM 27246517
DA 2018-10-20
ER

PT J
AU Modic, M
   Mozetic, M
AF Modic, Martina
   Mozetic, Miran
TI In vitro screening procedure for characterization of thrombogenic
   properties of plasma treated surfaces
SO BIOINTERPHASES
LA English
DT Article
ID B COLORIMETRIC ASSAY; PLATELET-ADHESION; BLOOD COMPATIBILITY; VASCULAR
   GRAFTS; SHAPE CHANGE; HEMOCOMPATIBILITY; BIOMATERIALS; COAGULATION;
   POLYETHYLENE; ACTIVATION
AB Estimation of thrombogenic surface properties is an important aspect of hemocompatibility studies. To improve our understanding of interaction between blood and biomaterial surfaces, there is a need to employ standardized methods that are both effective and efficient. This contribution details a systematic approach for the in vitro analysis of plasma modified polymer surfaces and human blood platelet interaction, following the recently introduced ISO 10933-4 guidelines. A holistic multistep process is presented that considers all aspects of testing procedure, including blood collection, platelet function testing, and incubation parameters, right through to a comparison and evaluation of the different methods and analysis available. In terms of detection and analysis, confocal light microscopy is shown to offer many advantages over the widely used scanning electron microscopy technique; this includes simpler, less-invasive sample preparation, and less time-consuming analysis procedure. On the other hand, as an alternative to microscopy techniques, toxicology sulforhodamine B based assay (TOX assay) was also evaluated. It has been shown that the assay could be used for rapid estimation of relative concentration of blood platelets on the surface of plasma treated materials, especially when samples do not allow the implementation of microscopy techniques. (C) 2016 American Vacuum Society.
C1 [Modic, Martina; Mozetic, Miran] Jozef Stefan Inst, Dept Surface Engn & Optoelect, Jamova Cesta 39, Ljubljana 1000, Slovenia.
RP Modic, M (reprint author), Jozef Stefan Inst, Dept Surface Engn & Optoelect, Jamova Cesta 39, Ljubljana 1000, Slovenia.
EM martina.modic@ijs.si
FU Slovenian Research Agency [L7-6782]
FX Financial support from the Slovenian Research Agency (Grant No. L7-6782)
   is gratefully acknowledged. Special thanks to Department of Hematology
   of the University Medical Centre Ljubljana for providing blood and
   equipment for assessing platelet function and especially Helena
   Podgornik and Tadej Pajic for their help and advice on the choice of
   used methods. The authors would also like to thank Rok Kostanjsek from
   Biotechnical Faculty from University of Ljubljana for SEM analysis.
CR ALLEN RD, 1979, J CELL BIOL, V83, P126, DOI 10.1083/jcb.83.1.126
   Barbucci R, 2002, BIOMATERIALS, V23, P1967, DOI 10.1016/S0142-9612(01)00323-4
   Briede JJ, 2003, J THROMB HAEMOST, V1, P559, DOI 10.1046/j.1538-7836.2003.00077.x
   Byrom MJ, 2013, ANN CARDIOTHORAC SUR, V2, P435, DOI 10.3978/j.issn.2225-319X.2013.05.04
   Choi JW, 2003, ANN CLIN LAB SCI, V33, P79
   Desmet T, 2009, BIOMACROMOLECULES, V10, P2351, DOI 10.1021/bm900186s
   Ferraz N, 2008, J MATER SCI-MATER M, V19, P3115, DOI 10.1007/s10856-008-3449-7
   Frank RD, 2000, J BIOMED MATER RES, V52, P374, DOI 10.1002/1097-4636(200011)52:2<374::AID-JBM18>3.3.CO;2-Q
   GOODMAN SL, 1989, J BIOMED MATER RES, V23, P105, DOI 10.1002/jbm.820230109
   Harrison P, 2005, BLOOD REV, V19, P111, DOI 10.1016/j.blre.2004.05.002
   Humpolicek P, 2015, COLLOID SURFACE B, V133, P278, DOI 10.1016/j.colsurfb.2015.06.008
   Iwasaki Y, 1996, J BIOMAT SCI-POLYM E, V8, P151, DOI 10.1163/156856296X00228
   Jing X, 2015, MAT SCI ENG C-MATER, V49, P40, DOI 10.1016/j.msec.2014.12.060
   Jung F, 2013, CLIN HEMORHEOL MICRO, V53, P97, DOI 10.3233/CH-2012-1579
   Junkar I, 2015, OPEN CHEM, V13, P490, DOI 10.1515/chem-2015-0061
   Junkar I, 2009, VACUUM, V84, P83, DOI 10.1016/j.vacuum.2009.04.011
   Lee JH, 1998, J BIOMED MATER RES, V41, P304, DOI 10.1002/(SICI)1097-4636(199808)41:2<304::AID-JBM16>3.0.CO;2-K
   Lippi G, 2012, SEMIN THROMB HEMOST, V38, P565, DOI 10.1055/s-0032-1315961
   Mackie I, 2013, INT J LAB HEMATOL, V35, P1, DOI 10.1111/ijlh.12004
   Massa TM, 2005, BIOMATERIALS, V26, P7367, DOI 10.1016/j.biomaterials.2005.05.063
   Morent R, 2011, PLASMA PROCESS POLYM, V8, P171, DOI 10.1002/ppap.201000153
   Mrowietz C, 2005, CLIN HEMORHEOL MICRO, V32, P89
   MURPHY S, 1971, J CLIN INVEST, V50, P370, DOI 10.1172/JCI106504
   Murugesan R, 2008, J APPL PHYS, V103, DOI 10.1063/1.2908200
   PACKHAM MA, 1988, P SOC EXP BIOL MED, V189, P261
   Papazisis KT, 1997, J IMMUNOL METHODS, V208, P151, DOI 10.1016/S0022-1759(97)00137-3
   Ratner BD, 2007, BIOMATERIALS, V28, P5144, DOI 10.1016/j.biomaterials.2007.07.035
   Resmi KR, 2004, THROMB RES, V114, P121, DOI 10.1016/j.thromres.2004.05.014
   Roy RK, 2009, ACTA BIOMATER, V5, P249, DOI 10.1016/j.actbio.2008.07.031
   Savion N, 2006, PATHOPHYSIOL HAEMO T, V35, P83, DOI 10.1159/000093548
   Solouk A, 2011, BIOTECHNOL APPL BIOC, V58, P311, DOI 10.1002/bab.50
   Spijker HT, 2002, BIOMATERIALS, V23, P757, DOI 10.1016/S0142-9612(01)00181-8
   Stevens KN, 2009, ACS APPL MATER INTER, V1, P2049, DOI 10.1021/am900390h
   Stevens KNJ, 2009, BIOMATERIALS, V30, P3682, DOI 10.1016/j.biomaterials.2009.03.054
   Toes GJ, 1999, BIOMATERIALS, V20, P1951, DOI 10.1016/S0142-9612(99)00100-3
   Vasiljevic J, 2013, MATER TEHNOL, V47, P379
   Venkatraman S, 2008, PROG POLYM SCI, V33, P853, DOI 10.1016/j.progpolymsci.2008.07.001
   Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179
   Vroman L, 2008, COLLOID SURFACE B, V62, P1, DOI 10.1016/j.colsurfb.2007.11.017
   Wang J, 2005, SURF COAT TECH, V196, P307, DOI 10.1016/j.surfcoat.2004.08.161
NR 40
TC 0
Z9 0
U1 1
U2 4
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 1934-8630
EI 1559-4106
J9 BIOINTERPHASES
JI Biointerphases
PD JUN
PY 2016
VL 11
IS 2
AR 029808
DI 10.1116/1.4948808
PG 9
WC Biophysics; Materials Science, Biomaterials
SC Biophysics; Materials Science
GA DR0FF
UT WOS:000379582700053
PM 27154919
DA 2018-10-20
ER

PT J
AU Reviakine, I
   Braune, S
AF Reviakine, Ilya
   Braune, Steffen
TI Preface: In Focus Issue on Blood-Biomaterial Interactions
SO BIOINTERPHASES
LA English
DT Editorial Material
C1 [Reviakine, Ilya] Karlsruhe Inst Technol, Inst Funct Interfaces IFG, Hermann von Helmholtz Pl 1, D-76344 Eggenstein Leopoldshafen, Germany.
   [Reviakine, Ilya] Univ Washington, Dept Bioengn, Seattle, WA 98105 USA.
   [Braune, Steffen] Helmholtz Zentrum Geesthacht, Inst Biomat Sci, Dept Biointerface Engn, Kantstr 55, D-14513 Teltow, Germany.
RP Reviakine, I (reprint author), Karlsruhe Inst Technol, Inst Funct Interfaces IFG, Hermann von Helmholtz Pl 1, D-76344 Eggenstein Leopoldshafen, Germany.; Reviakine, I (reprint author), Univ Washington, Dept Bioengn, Seattle, WA 98105 USA.
RI Braune, Steffen/D-2315-2015; Reviakine, Ilya/B-2631-2013
OI Reviakine, Ilya/0000-0002-3448-5072
CR Blok SLJ, 2016, BIOINTERPHASES, V11, DOI 10.1116/1.4941850
   Cornelius RM, 2016, BIOINTERPHASES, V11, DOI 10.1116/1.4953867
   Farrugia BL, 2016, BIOINTERPHASES, V11, DOI 10.1116/1.4952450
   Ghanbari H, 2016, BIOINTERPHASES, V11, DOI 10.1116/1.4939036
   Gupta S, 2016, BIOINTERPHASES, V11, DOI 10.1116/1.4947047
   Jung F, 2016, BIOINTERPHASES, V11, DOI 10.1116/1.4938557
   Reviakine I, 2016, BIOINTERPHASES, V11, DOI 10.1116/1.4952652
   Szott LM, 2016, BIOINTERPHASES, V11, DOI 10.1116/1.4944586
   Tronic EH, 2016, BIOINTERPHASES, V11, DOI 10.1116/1.4943618
NR 9
TC 3
Z9 3
U1 2
U2 5
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 1934-8630
EI 1559-4106
J9 BIOINTERPHASES
JI Biointerphases
PD JUN
PY 2016
VL 11
IS 2
AR 029501
DI 10.1116/1.4954646
PG 1
WC Biophysics; Materials Science, Biomaterials
SC Biophysics; Materials Science
GA DR0FF
UT WOS:000379582700039
PM 27936810
OA Other Gold
DA 2018-10-20
ER

PT J
AU Tang, JX
AF Tang, Jay X.
TI Measurements of fluid viscosity using a miniature ball drop device
SO REVIEW OF SCIENTIFIC INSTRUMENTS
LA English
DT Article
ID VISCOMETER; MICRORHEOLOGY
AB This paper describes measurement of fluid viscosity using a small ball drop device. It requires as little as 100 mu l of fluid. Each measurement can be performed in seconds. The experiment is designed to yield reliable viscosity values by operating at properly chosen tilt angles and with calibration using well-characterized Newtonian fluids such as mixtures of glycerol and water. It also yields dynamical viscosity of non-Newtonian fluids at moderate shear rates. The device is easy to assemble and it allows for the measurement of viscosity even when the fluid samples are too small to measure using most commercial viscometers or rheometers. Therefore, the technique is particularly useful in characterizing biological fluids such as solutions of proteins, DNA, and polymers frequently used in biomaterial applications. Published by AIP Publishing.
C1 [Tang, Jay X.] Brown Univ, Dept Phys, Providence, RI 02912 USA.
RP Tang, JX (reprint author), Brown Univ, Dept Phys, Providence, RI 02912 USA.
FU National Science Foundation's Fluid Physics program [CBET 1438033]
FX A number of undergraduate students in a freshman seminar course
   participated in the experiment. Mr. Dean Hudek of Physics Instructional
   Support designed the sample racks and provided valuable technical
   assistance. Other colleagues in the author's department, particularly
   Professor Humphrey Maris, offered helpful comments and proofread the
   manuscript. Funding by the National Science Foundation's Fluid Physics
   program (Award No. CBET 1438033) is gratefully acknowledged.
CR Addas KM, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.021503
   Almog Y, 1997, PHYS FLUIDS, V9, P16, DOI 10.1063/1.869158
   Ambari A., 1985, PHYS FLUIDS, V85, P1559
   Brizard M, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1851471
   CHO YI, 1984, J NON-NEWTON FLUID, V15, P61, DOI 10.1016/0377-0257(84)80028-2
   Crocker JC, 2000, PHYS REV LETT, V85, P888, DOI 10.1103/PhysRevLett.85.888
   FAXEN H, 1923, ARK MATEMATIK ASTRON, V17, P1
   GOLDMAN AJ, 1967, CHEM ENG SCI, V22, P637, DOI 10.1016/0009-2509(67)80047-2
   GOTTLIEB M, 1979, J NON-NEWTON FLUID, V6, P97, DOI 10.1016/0377-0257(79)87008-1
   Happel J., 1983, LOW REYNOLDS NUMBER, P318
   Larson R. G., 1999, STRUCTURE RHEOLOGY C
   Mason TG, 1997, PHYS REV LETT, V79, P3282, DOI 10.1103/PhysRevLett.79.3282
   McFarlane NL, 2010, LANGMUIR, V26, P13823, DOI 10.1021/la101907s
   PANIKER NV, 1972, J LAB CLIN MED, V80, P282
   POLLARD TD, 1982, METHOD CELL BIOL, V24, P301
   Srivastava N, 2005, ANAL CHEM, V77, P383, DOI 10.1021/ac0494681
   SWANK RL, 1954, REV SCI INSTRUM, V25, P1020, DOI 10.1063/1.1770901
   Tang JX, 1999, BIOPHYS J, V76, P2208, DOI 10.1016/S0006-3495(99)77376-5
   Tanner R. I., 1963, FLUID MECH, V17, P161
   Wagner O, 2001, BIOCHEM J, V355, P771, DOI 10.1042/bj3550771
   Yuan P., 2008, AM LAB, V40
NR 21
TC 2
Z9 2
U1 2
U2 8
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 0034-6748
EI 1089-7623
J9 REV SCI INSTRUM
JI Rev. Sci. Instrum.
PD JUN
PY 2016
VL 87
IS 5
AR 054301
DI 10.1063/1.4948314
PG 8
WC Instruments & Instrumentation; Physics, Applied
SC Instruments & Instrumentation; Physics
GA DQ4QE
UT WOS:000379187600078
PM 27250443
OA Bronze
DA 2018-10-20
ER

PT J
AU Raman, R
   Clay, NE
   Sen, S
   Melhem, M
   Qin, E
   Kong, H
   Bashir, R
AF Raman, Ritu
   Clay, Nicholas E.
   Sen, Sanjeet
   Melhem, Molly
   Qin, Ellen
   Kong, Hyunjoon
   Bashir, Rashid
TI 3D printing enables separation of orthogonal functions within a hydrogel
   particle
SO BIOMEDICAL MICRODEVICES
LA English
DT Article
DE Hydrogel; Polyethylene glycol; Stereolithography; 3D printing;
   Biomaterial
ID STEREOLITHOGRAPHY; MICROPARTICLES; ANISOTROPY
AB Multifunctional particles with distinct physiochemical phases are required by a variety of applications in biomedical engineering, such as diagnostic imaging and targeted drug delivery. This motivates the development of a repeatable, efficient, and customizable approach to manufacturing particles with spatially segregated bioactive moieties. This study demonstrates a stereolithographic 3D printing approach for designing and fabricating large arrays of biphasic poly (ethylene glycol) diacrylate (PEGDA) gel particles. The fabrication parameters governing the physical and biochemical properties of multi-layered particles are thoroughly investigated, yielding a readily tunable approach to manufacturing customizable arrays of multifunctional particles. The advantage in spatially organizing functional epitopes is examined by loading superparamagnetic iron oxide nanoparticles (SPIONs) and bovine serum albumin (BSA) in separate layers of biphasic PEGDA gel particles and examining SPION-induced magnetic resonance (MR) contrast and BSA-release kinetics. Particles with spatial segregation of functional moieties have demonstrably higher MR contrast and BSA release. Overall, this study will contribute significant knowledge to the preparation of multifunctional particles for use as biomedical tools.
C1 [Raman, Ritu] Univ Illinois, Dept Mech Sci & Engn, 1206 W Green St, Urbana, IL 61801 USA.
   [Raman, Ritu; Bashir, Rashid] Univ Illinois, Micro & Nanotechnol Lab, 208 North Wright St, Urbana, IL 61801 USA.
   [Clay, Nicholas E.; Sen, Sanjeet; Qin, Ellen; Kong, Hyunjoon] Univ Illinois, Dept Chem & Biomol Engn, 600 South Mathews Ave, Urbana, IL 61801 USA.
   [Melhem, Molly; Bashir, Rashid] Univ Illinois, Dept Bioengn, 1270 Digital Comp Lab,MC-278, Urbana, IL 61801 USA.
RP Bashir, R (reprint author), Univ Illinois, Micro & Nanotechnol Lab, 208 North Wright St, Urbana, IL 61801 USA.; Bashir, R (reprint author), Univ Illinois, Dept Bioengn, 1270 Digital Comp Lab,MC-278, Urbana, IL 61801 USA.
EM rbashir@illinois.edu
FU National Science Foundation (NSF) Science and Technology Center EBICS
   [CBET-0939511]; National Institute of Health [1R01 HL109192]; NSF
   Graduate Research Fellowship [DGE-1144245]; NSF CMMB IGERT at UIUC
   [0965918]; Dow Graduate Fellowship
FX We acknowledge Boris Odintsov for his assistance in MR imaging. This
   work was funded by the National Science Foundation (NSF) Science and
   Technology Center EBICS (Grant CBET-0939511) and National Institute of
   Health (1R01 HL109192 to H.K). R.R was funded by an NSF Graduate
   Research Fellowship (Grant DGE-1144245) and NSF CMMB IGERT at UIUC
   (Grant 0965918). N.C. was funded by a Dow Graduate Fellowship.
CR Annabi N., 2013, ADV MAT
   Arcaute K, 2011, STEREOLITHOGRAPHY: MATERIALS, PROCESSES AND APPLICATIONS, P299, DOI 10.1007/978-0-387-92904-0_12
   Bartolo P. J., 2011, STEREOLITHOGRAPHY MA, P1
   Bhaskar S, 2010, SMALL, V6, P404, DOI 10.1002/smll.200901306
   Cha C, 2009, ADV FUNCT MATER, V19, P3056, DOI 10.1002/adfm.200900865
   Chan V, 2010, LAB CHIP, V10, P2062, DOI 10.1039/c004285d
   Jeong J. H, 2012, ADV MATER, V24, P58
   Jeong J. H., 2012, ADV MATER, V24, P1
   Kanesaraj Ramasamy R, 2015, ADV HEALTHC MATER, P1
   Lai MH, 2015, NANOSCALE, V7, P6737, DOI 10.1039/c5nr00736d
   Li B, 2016, ACS APPL MATER INTER, V8, P4158, DOI 10.1021/acsami.5b11883
   Melchels FPW, 2010, BIOMATERIALS, V31, P6121, DOI 10.1016/j.biomaterials.2010.04.050
   Neiman JAS, 2015, BIOTECHNOL BIOENG, V112, P777, DOI 10.1002/bit.25494
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Raman R., 2015, ESSENTIALS 3D BIOFAB, P89, DOI DOI 10.1016/B978-0-12-800972-7.00006-2
   RITGER P L, 1987, Journal of Controlled Release, V5, P23, DOI 10.1016/0168-3659(87)90034-4
   Roh KH, 2005, NAT MATER, V4, P759, DOI 10.1038/nmat1486
   Shah B. R. K., 2009, ADV MATER, V729, P1949
   Shevchenko EV, 2008, ADV MATER, V20, P4323, DOI 10.1002/adma.200702994
   Stampfl J, 2011, STEREOLITHOGRAPHY: MATERIALS, PROCESSES AND APPLICATIONS, P161, DOI 10.1007/978-0-387-92904-0_7
   Yang SK, 2012, LAB CHIP, V12, P2097, DOI 10.1039/c2lc90046g
NR 21
TC 2
Z9 2
U1 1
U2 41
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1387-2176
EI 1572-8781
J9 BIOMED MICRODEVICES
JI Biomed. Microdevices
PD JUN
PY 2016
VL 18
IS 3
AR 49
DI 10.1007/s10544-016-0068-9
PG 7
WC Engineering, Biomedical; Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA DP7PK
UT WOS:000378691100009
PM 27215416
DA 2018-10-20
ER

PT J
AU Galan-Marin, C
   Rivera-Gomez, C
   Garcia-Martinez, A
AF Galan-Marin, Carmen
   Rivera-Gomez, Carlos
   Garcia-Martinez, Antonio
TI Use of Natural-Fiber Bio-Composites in Construction versus Traditional
   Solutions: Operational and Embodied Energy Assessment
SO MATERIALS
LA English
DT Article
DE life cycle assessment; operational energy; embodied energy; natural
   composites; natural fibers; sustainability; load bearing walls
ID LIFE-CYCLE ENERGY; RESIDENTIAL BUILDINGS; EMISSIONS; REDUCTION; INDIA;
   NEED
AB During the last decades natural polymers have become more and more frequent to replace traditional inorganic stabilizers in building materials. The purpose of this research is to establish a comparison between the most conventional building material solutions for load-bearing walls and a type of biomaterial. This comparison will focus on load-bearing walls as used in a widespread type of twentieth century dwelling construction in Europe and still used in developing countries nowadays. To carry out this analysis, the structural and thermal insulation characteristics of different construction solutions are balanced. The tool used for this evaluation is the life cycle assessment throughout the whole lifespan of these buildings. This research aims to examine the environmental performance of each material assessed: fired clay brick masonry walls (BW), concrete block masonry walls (CW), and stabilized soil block masonry walls (SW) stabilized with natural fibers and alginates. These conventional and new materials are evaluated from the point of view of both operational and embodied energy.
C1 [Galan-Marin, Carmen; Rivera-Gomez, Carlos; Garcia-Martinez, Antonio] Univ Seville, Inst Architecture & Construct Sci, E-41012 Seville, Spain.
RP Galan-Marin, C (reprint author), Univ Seville, Inst Architecture & Construct Sci, E-41012 Seville, Spain.
EM cgalan@us.es; crivera@us.es; agarcia6@us.es
RI Galan-Marin, Carmen/M-9023-2014
OI Galan-Marin, Carmen/0000-0003-1929-3280
FU project PANEL of the Direccion General de Investigacion, Tecnologia y
   Empresa. Consejeria de Economia, Innovacion, Ciencia y Empleo., Junta de
   Andalucia [TEP-1988]
FX This research project and the costs to publish in open access have been
   partially funded by the TEP-1988 project PANEL of the 2012 call of the
   Direccion General de Investigacion, Tecnologia y Empresa. Consejeria de
   Economia, Innovacion, Ciencia y Empleo., Junta de Andalucia.
CR [Anonymous], ECOINVENT DAT
   [Anonymous], 2011, SPAHOUSEC PROJECT AN, P1
   Arena AP, 2003, BUILD ENVIRON, V38, P359, DOI 10.1016/S0360-1323(02)00056-2
   Asif M, 2007, BUILD ENVIRON, V42, P1391, DOI 10.1016/j.buildenv.2005.11.023
   Barber A., 2006, LIFE CYCLE ASSESSMEN
   Blengini GA, 2009, BUILD ENVIRON, V44, P319, DOI 10.1016/j.buildenv.2008.03.007
   Brown NWO, 2014, BUILD ENVIRON, V79, P46, DOI 10.1016/j.buildenv.2014.04.018
   Cabeza LF, 2014, RENEW SUST ENERG REV, V29, P394, DOI 10.1016/j.rser.2013.08.037
   Chen TY, 2001, ENERGY, V26, P323, DOI 10.1016/S0360-5442(01)00006-8
   Chung WS, 2009, APPL ENERG, V86, P1902, DOI 10.1016/j.apenergy.2009.02.001
   CIPECAD, 2015, CYPE ING S A
   CTE_DB-HE, COD TECN ED DOC BAS
   De Miranda F., INVENTARIO CICLO VID
   Devi LP, 2014, ENERG BUILDINGS, V80, P247, DOI 10.1016/j.enbuild.2014.05.034
   Eder P., 2009, 23775EN2009 EUR JRC
   Fitzmaurice R, 1958, MANUAL STABILISED SO
   Galan-Marin C, 2010, J BIOBASED MATER BIO, V4, P121, DOI 10.1166/jbmb.2010.1076
   Garcia-Martinez A., 2010, THESIS
   Guan L., 2015, PROCEDIA ENG, V121, P653
   Hendriks C.F., 2002, ADV BUILD TECHNOL, VII, P1399
   Huberman N, 2008, ENERG BUILDINGS, V40, P837, DOI 10.1016/j.enbuild.2007.06.002
   Ibn-Mohammed T, 2013, ENERG BUILDINGS, V66, P232, DOI 10.1016/j.enbuild.2013.07.026
   Iddon CR, 2013, ENERG BUILDINGS, V67, P479, DOI 10.1016/j.enbuild.2013.08.041
   ISO, 2006, 14044 ISO
   ISO (International Organization for Standardization), 2006, 14040 ISO
   Jollands M., 2014, ENERGY BUILD, V84, P33
   Kellenberger D., 2004, 7 SWISS CTR LIF CYCL
   Koesling M, 2015, ENERG BUILDINGS, V108, P330, DOI 10.1016/j.enbuild.2015.09.012
   Ortiz O, 2010, APPL ENERG, V87, P673, DOI 10.1016/j.apenergy.2009.08.002
   Ortiz O, 2009, BUILD ENVIRON, V44, P584, DOI 10.1016/j.buildenv.2008.05.004
   Praseeda KI, 2016, ENERG BUILDINGS, V110, P211, DOI 10.1016/j.enbuild.2015.09.072
   Resurreccion EP, 2012, BIORESOURCE TECHNOL, V126, P298, DOI 10.1016/j.biortech.2012.09.038
   Sartori I, 2007, ENERG BUILDINGS, V39, P249, DOI 10.1016/j.enbuild.2006.07.001
   Shukla A, 2009, RENEW ENERG, V34, P755, DOI 10.1016/j.renene.2008.04.002
   Stephan A, 2016, APPL ENERG, V161, P445, DOI 10.1016/j.apenergy.2015.10.023
   Stephan A, 2012, ENERG BUILDINGS, V55, P592, DOI 10.1016/j.enbuild.2012.09.008
   Thormark C, 2006, BUILD ENVIRON, V41, P1019, DOI 10.1016/j.buildenv.2005.04.026
   Thormark C, 2002, BUILD ENVIRON, V37, P429, DOI 10.1016/S0360-1323(01)00033-6
   Vazquez M., 2001, INF CONSTR, V52, P29
   Venkatarama R., 2003, ENERGY BUILD, V35, P129
   Walker P, 2000, P 6 INT SEM STRUCT M, P27
   WALKER PJ, 1995, CEMENT CONCRETE COMP, V17, P301, DOI 10.1016/0958-9465(95)00019-9
   Yildiz A, 2009, APPL ENERG, V86, P1939, DOI 10.1016/j.apenergy.2008.12.010
   Zhu JJ, 2013, HABITAT INT, V37, P148, DOI 10.1016/j.habitatint.2011.12.006
NR 44
TC 4
Z9 4
U1 3
U2 28
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD JUN
PY 2016
VL 9
IS 6
AR 465
DI 10.3390/ma9060465
PG 17
WC Materials Science, Multidisciplinary
SC Materials Science
GA DP6TB
UT WOS:000378630600064
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Rabadan-Ros, R
   Velasquez, PA
   Meseguer-Olmo, L
   De Aza, PN
AF Rabadan-Ros, Ruben
   Velasquez, Pablo A.
   Meseguer-Olmo, Luis
   De Aza, Piedad N.
TI Morphological and Structural Study of a Novel Porous Nurse's A Ceramic
   with Osteoconductive Properties for Tissue Engineering
SO MATERIALS
LA English
DT Article
DE bioceramics; calcium silicophosphate; scanning electron microscopy;
   mu-Raman spectroscopy; bone response; biocompatibility
ID ALPHA-TRICALCIUM PHOSPHATE; IN-VITRO; DICALCIUM SILICATE; BLOCK GRAFT;
   RAMAN; VIVO; TCP; PROLIFERATION; BIOCERAMICS; ADSORPTION
AB The characterization process of a new porous Nurse's A ceramic and the physico chemical nature of the remodeled interface between the implant and the surrounding bone were studied after in vivo implantation. Scaffolds were prepared by a solid-state reaction and implanted in New Zealand rabbits. Animals were sacrificed on days 15, 30, and 60. The porous biomaterial displayed biocompatible, bioresorbable, and osteoconductive capacity. The degradation processes of implants also encouraged osseous tissue ingrowths into the material's pores, and drastically changed the macro-and microstructure of the implants. After 60 healing days, the resorption rates were 52.62% +/- 1.12% for the ceramic and 47.38% +/- 1.24% for the residual biomaterial. The elemental analysis showed a gradual diffusion of the Ca and Si ions from the materials into the newly forming bone during the biomaterial's resorption process. The energy dispersive spectroscopy (EDS) analysis of the residual ceramic revealed some particle categories with different mean Ca/P ratios according to size, and indicated various resorption process stages. Since osteoconductive capacity was indicated for this material and bone ingrowth was possible, it could be applied to progressively substitute an implant.
C1 [Rabadan-Ros, Ruben] UCAM Univ Catolica San Antonio Murcia, Grp Invest Regenerac & Reparac Tejidos, Murcia 30107, Spain.
   [Velasquez, Pablo A.; De Aza, Piedad N.] Univ Miguel Hernandez, Inst Bioingn, Avda Univ S-N, Alicante 03202, Spain.
   [Meseguer-Olmo, Luis] UCAM Catholic Univ Murcia, Arrixaca Univ Hosp, Serv Orthopaed, Murcia 30120, Spain.
RP De Aza, PN (reprint author), Univ Miguel Hernandez, Inst Bioingn, Avda Univ S-N, Alicante 03202, Spain.
EM rubenrabadanros@gmail.com; pavelasquez@umh.es; lmeseguer.doc@gmail.com;
   piedad@umh.es
RI Velasquez, Pablo/O-5857-2015; De Aza, Piedad/A-7621-2015
OI Velasquez, Pablo/0000-0002-5142-4992; De Aza,
   Piedad/0000-0001-9316-4407; Rabadan-Ros, Ruben/0000-0003-2990-4620;
   Meseguer-Olmo, Luis/0000-0003-3858-8148
FU Spanish Ministry of Economy and Competitiveness (MINECO)
   [MAT2013-48426-C2-2-R]
FX Part of this work has been supported by Spanish Ministry of Economy and
   Competitiveness (MINECO) contract grant number: MAT2013-48426-C2-2-R.
CR Aguiar H, 2008, J NON-CRYST SOLIDS, V354, P5004, DOI 10.1016/j.jnoncrysol.2008.07.033
   Antonakos A, 2007, BIOMATERIALS, V28, P3043, DOI 10.1016/j.biomaterials.2007.02.028
   BAIER RE, 1977, ANN NY ACAD SCI, V283, P17, DOI 10.1111/j.1749-6632.1977.tb41750.x
   Beltrame F, 2005, BIOTECHNOL BIOENG, V92, P189, DOI 10.1002/bit.20591
   Bohner M, 2009, BIOMATERIALS, V30, P6403, DOI 10.1016/j.biomaterials.2009.08.007
   Bonino F, 2008, J RAMAN SPECTROSC, V39, P260, DOI 10.1002/jrs.1860
   BREEMHAAR W, 1984, BIOMATERIALS, V5, P269, DOI 10.1016/0142-9612(84)90071-1
   Calvo-Guirado J. L., 2015, CLIN ORAL IMPLAN RES, V26, P154
   Calvo-Guirado JL, 2014, CLIN ORAL IMPLAN RES, V25, P1228, DOI 10.1111/clr.12258
   CARLISLE EM, 1970, SCIENCE, V167, P279, DOI 10.1126/science.167.3916.279
   Carrodeguas RG, 2008, KEY ENG MATER, V361-363, P237
   Chevalier J, 2009, J EUR CERAM SOC, V29, P1245, DOI 10.1016/j.jeurceramsoc.2008.08.025
   De Aza P.N., 2016, CLIN ORAL IMPLANT RE
   De Aza PN, 2014, MATERIALS, V7, P2395, DOI 10.3390/ma7042395
   de Aza PN, 2013, MICROSC MICROANAL, V19, P1350, DOI 10.1017/S1431927613001864
   deAza PN, 1997, CHEM MATER, V9, P916, DOI 10.1021/cm9604266
   Garcia-Paez IH, 2014, J MECH BEHAV BIOMED, V30, P1, DOI 10.1016/j.jmbbm.2013.10.011
   Hadjicharalambous Chrystalleni, 2015, Front Bioeng Biotechnol, V3, P175, DOI 10.3389/fbioe.2015.00175
   Ibanez J, 2007, J RAMAN SPECTROSC, V38, P61, DOI 10.1002/jrs.1599
   Jugdaohsingh R, 2004, J BONE MINER RES, V19, P297, DOI 10.1359/JBMR.0301225
   KOCHWA S, 1977, ANN NY ACAD SCI, V283, P37, DOI 10.1111/j.1749-6632.1977.tb41751.x
   Kumar A., 2015, J APPL BIOMATER FUNC, V30, P1168
   Lazary A, 2007, BIOMATERIALS, V28, P393, DOI 10.1016/j.biomaterials.2006.09.002
   Lugo GJ, 2015, J EUR CERAM SOC, V35, P3693, DOI 10.1016/j.jeurceramsoc.2015.04.036
   Lugo GJ, 2016, CERAM INT, V42, P673, DOI 10.1016/j.ceramint.2015.08.164
   Martinez IM, 2012, MAT SCI ENG C-MATER, V32, P878, DOI 10.1016/j.msec.2012.02.006
   Martinez IM, 2011, CERAM INT, V37, P2527, DOI 10.1016/j.ceramint.2011.03.062
   Mate-Sanchez de Val J. E., 2016, CLIN ORAL IMPLANT RE
   de Val JEMS, 2012, J BIOMED MATER RES A, V100A, P3446, DOI 10.1002/jbm.a.34259
   de Val JEMS, 2012, CERAM INT, V38, P1563, DOI 10.1016/j.ceramint.2011.09.042
   Reid JW, 2006, BIOMATERIALS, V27, P2916, DOI 10.1016/j.biomaterials.2006.01.007
   Remy C, 1997, J AM CERAM SOC, V80, P413
   Ros-Tarraga P., 2016, MATERIALS
   Rubio V, 2011, J AM CERAM SOC, V94, P4459, DOI 10.1111/j.1551-2916.2011.04716.x
   Sayer M, 2003, BIOMATERIALS, V24, P369, DOI 10.1016/S0142-9612(02)00327-7
   SCHWARZ K, 1973, P NATL ACAD SCI USA, V70, P1608, DOI 10.1073/pnas.70.5.1608
   Serena S, 2015, CERAM INT, V41, P9411, DOI 10.1016/j.ceramint.2015.03.319
   Velasquez P, 2013, J BIOMED MATER RES A, V101, P1943, DOI 10.1002/jbm.a.34495
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
NR 39
TC 10
Z9 10
U1 1
U2 10
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD JUN
PY 2016
VL 9
IS 6
AR 474
DI 10.3390/ma9060474
PG 14
WC Materials Science, Multidisciplinary
SC Materials Science
GA DP6TB
UT WOS:000378630600073
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Recha-Sancho, L
   Moutos, FT
   Abella, J
   Guilak, F
   Semino, CE
AF Recha-Sancho, Lourdes
   Moutos, Franklin T.
   Abella, Jordi
   Guilak, Farshid
   Semino, Carlos E.
TI Dedifferentiated Human Articular Chondrocytes Redifferentiate to a
   Cartilage-Like Tissue Phenotype in a
   Poly(epsilon-Caprolactone)/Self-Assembling Peptide Composite Scaffold
SO MATERIALS
LA English
DT Article
DE cartilage tissue engineering; 3D cell culture; human chondrocytes; cell
   differentiation; biomimetic materials
ID MOUSE EMBRYONIC FIBROBLASTS; IN-VITRO; CHONDROGENIC PHENOTYPE;
   REGENERATIVE MEDICINE; WOVEN SCAFFOLDS; GENE-EXPRESSION; GELS AFFECTS;
   STEM-CELLS; MATRIX; HYDROGEL
AB Adult articular cartilage has a limited capacity for growth and regeneration and, with injury, new cellular or biomaterial-based therapeutic platforms are required to promote repair. Tissue engineering aims to produce cartilage-like tissues that recreate the complex mechanical and biological properties found in vivo. In this study, a unique composite scaffold was developed by infiltrating a three-dimensional (3D) woven microfiber poly (epsilon-caprolactone) (PCL) scaffold with the RAD16-I self-assembling nanofibers to obtain multi-scale functional and biomimetic tissue-engineered constructs. The scaffold was seeded with expanded dedifferentiated human articular chondrocytes and cultured for four weeks in control and chondrogenic growth conditions. The composite constructs were compared to control constructs obtained by culturing cells with 3D woven PCL scaffolds or RAD16-I independently. High viability and homogeneous cell distribution were observed in all three scaffolds used during the term of the culture. Moreover, gene and protein expression profiles revealed that chondrogenic markers were favored in the presence of RAD16-I peptide (PCL/RAD composite or alone) under chondrogenic induction conditions. Further, constructs displayed positive staining for toluidine blue, indicating the presence of synthesized proteoglycans. Finally, mechanical testing showed that constructs containing the PCL scaffold maintained the initial shape and viscoelastic behavior throughout the culture period, while constructs with RAD16-I scaffold alone contracted during culture time into a stiffer and compacted structure. Altogether, these results suggest that this new composite scaffold provides important mechanical requirements for a cartilage replacement, while providing a biomimetic microenvironment to re-establish the chondrogenic phenotype of human expanded articular chondrocytes.
C1 [Recha-Sancho, Lourdes; Semino, Carlos E.] Ramon Llull Univ, IQS Sch Engn, Bioengn Dept, Tissue Engn Lab, Via Augusta 390, Barcelona 08017, Spain.
   [Moutos, Franklin T.; Guilak, Farshid] Cytex Therapeut Inc, Durham, NC 27705 USA.
   [Guilak, Farshid] Washington Univ, Dept Orthopaed Surg, St Louis, MO 63110 USA.
   [Guilak, Farshid] Shriners Hosp Children St Louis, St Louis, MO 63110 USA.
   [Abella, Jordi] Ramon Llull Univ, Inst Quim Sarria, Dept Analyt Chem, Via Augusta 390, Barcelona 08017, Spain.
RP Semino, CE (reprint author), Ramon Llull Univ, IQS Sch Engn, Bioengn Dept, Tissue Engn Lab, Via Augusta 390, Barcelona 08017, Spain.
EM lourdesrechas@iqs.url.edu; frank.moutos@cytextherapeutics.com;
   jordi.abella@iqs.url.edu; guilak@wustl.edu; carlos.semino@iqs.url.edu
OI Abella, Jordi/0000-0002-5854-7514; Guilak, Farshid/0000-0001-7380-0330
FU AO Foundation, Exploratory Research Collaborative Research Program Acute
   Cartilage Injury/lesion/defect (CRP ACI) under the project Bioactive and
   biomimetic scaffolds for cartilage regeneration (BIOCART); OSTEOCHON3D;
   NIH [AR50245, AR48852, AG15768, AR48182, AG46927]; ESF [2015FI_B2 00109]
FX This study was supported in part by grants from AO Foundation,
   Exploratory Research Collaborative Research Program Acute Cartilage
   Injury/lesion/defect (CRP ACI) under the project Bioactive and
   biomimetic scaffolds for cartilage regeneration (BIOCART) and
   OSTEOCHON3D and grants from the NIH (AR50245, AR48852, AG15768, AR48182,
   AG46927). We thank the SUR of DEC of Catalan Government and the ESF for
   the pre-doctoral fellowship 2015FI_B2 00109 to Lourdes Recha Sancho. We
   also thank the Materials Science Laboratory of IQS-School of Engineering
   for kindly helping us with the DMA analysis and Scientific and
   Technological Centers of Barcelona University for the scanning electron
   microscopy service. Finally, we thank Maria Pilar Armengol from the
   Genomic Unit of the IGTP for her help with the quantitative PCR.
CR Alemany-Ribes M, 2013, TISSUE ENG PT A, V19, P1665, DOI [10.1089/ten.tea.2012.0661, 10.1089/ten.TEA.2012.0661]
   Asnaghi MA, 2011, J APPL BIOMATER BIOM, V9, P73, DOI 10.5301/JABB.2011.8562
   Bauge C, 2014, AGING DIS, V5, P394, DOI 10.14336/AD.2014.0500394
   Bobick BE, 2009, BIRTH DEFECTS RES C, V87, P351, DOI 10.1002/bdrc.20167
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Bussmann B.M., 2013, J TISSUE ENG REGEN M
   Cals FLJ, 2012, J TISSUE ENG REGEN M, V6, P68, DOI 10.1002/term.399
   Castells-Sala C., 2013, J BIOCHIP TISSUE C S, V2, P1
   Chiang HS, 2009, J FORMOS MED ASSOC, V108, P87, DOI 10.1016/S0929-6646(09)60039-5
   Chung C, 2008, ADV DRUG DELIVER REV, V60, P243, DOI 10.1016/j.addr.2007.08.027
   Cucchiarini M, 2014, Eur Cell Mater, V27, P12
   Darling EM, 2005, J ORTHOP RES, V23, P425, DOI 10.1016/j.orthres.2004.08.008
   Darnell MC, 2013, BIOMATERIALS, V34, P8042, DOI 10.1016/j.biomaterials.2013.06.061
   Degano IR, 2009, BIOMATERIALS, V30, P1156, DOI 10.1016/j.biomaterials.2008.11.021
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fernandez-Muinos T, 2015, ACTA BIOMATER, V16, P35, DOI 10.1016/j.actbio.2015.01.008
   Fernandez-Muinos T, 2014, TISSUE ENG PT A, V20, P1145, DOI 10.1089/ten.tea.2013.0369
   Freed LE, 2009, ADV MATER, V21, P3410, DOI 10.1002/adma.200900303
   Garcia-Giralt N, 2008, J BIOMED MATER RES A, V85A, P1082, DOI 10.1002/jbm.a.31670
   Garreta E, 2006, TISSUE ENG, V12, P2215, DOI 10.1089/ten.2006.12.2215
   Genove E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012
   Genove E, 2009, J CELL MOL MED, V13, P3387, DOI 10.1111/j.1582-4934.2009.00970.x
   Girotto D, 2003, BIOMATERIALS, V24, P3265, DOI 10.1016/S0142-9612(03)00160-1
   Grad S, 2006, TISSUE ENG, V12, P3171, DOI 10.1089/ten.2006.12.3171
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   Guilak F, 2014, J BIOMECH, V47, P1933, DOI 10.1016/j.jbiomech.2014.04.019
   Huang MH, 2006, J APPL POLYM SCI, V102, P1681, DOI 10.1002/app.24196
   Hunziker EB, 2015, OSTEOARTHR CARTILAGE, V23, P334, DOI 10.1016/j.joca.2014.12.011
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Johnstone B, 2013, EUR CELLS MATER, V25, P248, DOI 10.22203/eCM.v025a18
   Kim M, 2011, BIOMATERIALS, V32, P7883, DOI 10.1016/j.biomaterials.2011.07.015
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Kock L, 2012, CELL TISSUE RES, V347, P613, DOI 10.1007/s00441-011-1243-1
   Lee SH, 2007, ADV DRUG DELIVER REV, V59, P339, DOI 10.1016/j.addr.2007.03.016
   LEFEBVRE V, 1990, BIOCHIM BIOPHYS ACTA, V1051, P266, DOI 10.1016/0167-4889(90)90132-W
   Li QY, 2016, BIOMATERIALS, V75, P37, DOI 10.1016/j.biomaterials.2015.10.011
   Liao IC, 2013, ADV FUNCT MATER, V23, P5833, DOI 10.1002/adfm.201300483
   Mari-Buye N, 2013, TISSUE ENG PT A, V19, P870, DOI [10.1089/ten.TEA.2012.0077, 10.1089/ten.tea.2012.0077]
   Matson JB, 2012, CHEM COMMUN, V48, P26, DOI 10.1039/c1cc15551b
   Miot S, 2005, BIOMATERIALS, V26, P2479, DOI 10.1016/j.biomaterials.2004.06.048
   Moutos FT, 2008, BIORHEOLOGY, V45, P501, DOI 10.3233/BIR-2008-0491
   Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822
   Moutos FT, 2010, TISSUE ENG PT A, V16, P1291, DOI [10.1089/ten.tea.2009.0480, 10.1089/ten.TEA.2009.0480]
   Moutos FT, 2010, MACROMOL BIOSCI, V10, P1355, DOI 10.1002/mabi.201000124
   Nava M.M., 2012, BIOMED RES INT, V2012
   Nava MM, 2015, BIOMED MATER, V10, DOI 10.1088/1748-6041/10/1/015012
   Quinatana L, 2009, TISSUE ENG PT A, V15, P45, DOI 10.1089/ten.tea.2007.0296
   Recha-Sancho L, 2016, J BIOMED MATER RES A, V104, P1694, DOI 10.1002/jbm.a.35699
   Rohner D, 2003, J BIOMED MATER RES B, V66B, P574, DOI 10.1002/jbm.b.10037
   Semino CE, 2008, J DENT RES, V87, P606, DOI 10.1177/154405910808700710
   Semino CE, 2004, TISSUE ENG, V10, P643, DOI 10.1089/107632704323061997
   Semino CE, 2003, J BIOMED BIOTECHNOL, P164, DOI 10.1155/S1110724303208019
   Sieminski AL, 2008, J BIOMED MATER RES A, V87A, P494, DOI 10.1002/jbm.a.31785
   Sieminski AL, 2007, CELL BIOCHEM BIOPHYS, V49, P73, DOI 10.1007/s12013-007-0046-1
   Valonen PK, 2010, BIOMATERIALS, V31, P2193, DOI 10.1016/j.biomaterials.2009.11.092
   Wu Jonathan, 2010, Journal of Nanobiotechnology, V8, P29, DOI 10.1186/1477-3155-8-29
   Yoon DM, 2006, ADV EXP MED BIOL, V585, P67
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
NR 59
TC 5
Z9 5
U1 2
U2 12
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD JUN
PY 2016
VL 9
IS 6
AR 472
DI 10.3390/ma9060472
PG 18
WC Materials Science, Multidisciplinary
SC Materials Science
GA DP6TB
UT WOS:000378630600071
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Gazquez, GC
   Chen, HL
   Veldhuis, SA
   Solmaz, A
   Mota, C
   Boukamp, BA
   van Blitterswijk, CA
   ten Elshof, JE
   Moroni, L
AF Gazquez, Gerard Cadafalch
   Chen, Honglin
   Veldhuis, Sjoerd A.
   Solmaz, Alim
   Mota, Carlos
   Boukamp, Bernard A.
   van Blitterswijk, Clemens A.
   ten Elshof, Johan E.
   Moroni, Lorenzo
TI Flexible Yttrium-Stabilized Zirconia Nanofibers Offer Bioactive Cues for
   Osteogenic Differentiation of Human Mesenchymal Stromal Cells
SO ACS NANO
LA English
DT Article
DE flexible ceramic scaffolds; electrospinning ceramic; surface roughness;
   human mesenchymal stromal cells; osteogenic differentiation
ID STEM-CELLS; MECHANICAL-PROPERTIES; ROBUST FLEXIBILITY; BONE-FORMATION;
   SCAFFOLDS; ELECTROSPUN; TISSUE; HYDROXYAPATITE; BIOMATERIAL; CERAMICS
AB Currently, the main drawback of ceramic scaffolds used in hard tissue regeneration is their low mechanical strength. Stabilized zirconia, especially the tetragonal 3% yttrium-stabilized zirconia (YSZ) phase, has been considered as a bioinert ceramic material with high mechanical strength. In the present work, flexible nanofibrous YSZ scaffolds were prepared by electrospinning. The obtained scaffolds showed remarkable flexibility at the macroscopic scale, while retaining their stiffness at the microscopic scale. The surface nanoroughness of the scaffolds could be tailored by varying the heat treatment method. Our results demonstrate that the osteogenic differentiation and mineralization of seeded human mesenchymal stromal cells were supported by the nanofibrous YSZ scaffolds, in contrast to the well-known bioinert behavior of bulk YSZ. These findings highlight that flexible ceramic scaffolds are an appealing alternative to the current brittle ceramics for bone tissue regeneration applications.
C1 [Gazquez, Gerard Cadafalch; Veldhuis, Sjoerd A.; Solmaz, Alim; Boukamp, Bernard A.; ten Elshof, Johan E.] Univ Twente, Inorgan Mat Sci Grp, MESA Inst Nanotechnol, POB 217, NL-7500 AE Enschede, Netherlands.
   [Chen, Honglin; Mota, Carlos; van Blitterswijk, Clemens A.; Moroni, Lorenzo] MERLN Inst Technol Inspired Regenerat Med, Dept Complex Tissue Regenerat, NL-6200 MD Maastricht, Netherlands.
RP ten Elshof, JE (reprint author), Univ Twente, Inorgan Mat Sci Grp, MESA Inst Nanotechnol, POB 217, NL-7500 AE Enschede, Netherlands.; Moroni, L (reprint author), MERLN Inst Technol Inspired Regenerat Med, Dept Complex Tissue Regenerat, NL-6200 MD Maastricht, Netherlands.
EM j.e.tenelshof@utwente.nl; 1.moroni@maastrichtuniversity.nl
RI Moroni, Lorenzo/D-2826-2014
OI Moroni, Lorenzo/0000-0003-1298-6025; Mota, Carlos/0000-0001-5935-6245
FU China Council Scholarship programme [2011614016]; ADEM Programme; NCRR
   of the NIH [P40RR017447]
FX H.C. thanks the China Council Scholarship programme for financial
   support (grant no. 2011614016). G.C.G. thanks the ADEM Programme for
   financial support. Roy Visser is thanked for assistance in mechanical
   testing, and Aliaksei Vasilevich for help in calculating the cell areas.
   Some of the materials employed in this work were provided by the Texas
   A&M Health Science Center College of Medicine Institute for Regenerative
   Medicine at Scott & White through a grant from NCRR of the NIH (grant
   no. P40RR017447).
CR Adams JW, 1997, J AM CERAM SOC, V80, P903
   Azad AM, 2006, MATER LETT, V60, P67, DOI 10.1016/j.matlet.2005.07.085
   Best SM, 2008, J EUR CERAM SOC, V28, P1319, DOI 10.1016/j.jeurceramsoc.2007.12.001
   Biswas A, 2012, CERAM INT, V38, P883, DOI 10.1016/j.ceramint.2011.07.060
   Chaim R, 2004, J MATER SCI, V39, P3057, DOI 10.1023/B:JMSC.0000025832.93840.b0
   Champion E, 2013, ACTA BIOMATER, V9, P5855, DOI 10.1016/j.actbio.2012.11.029
   Chen HL, 2011, INT J NANOMED, V6, P453, DOI 10.2147/IJN.S17057
   Chen HL, 2011, INT J BIOL MACROMOL, V48, P13, DOI 10.1016/j.ijbiomac.2010.09.019
   Chen YC, 2014, RSC ADV, V4, P2756, DOI 10.1039/c3ra45043k
   Chuah YJ, 2015, ACTA BIOMATER, V23, P52, DOI 10.1016/j.actbio.2015.05.023
   Curtin CM, 2012, ADV MATER, V24, P749, DOI 10.1002/adma.201103828
   Denry I, 2008, DENT MATER, V24, P299, DOI 10.1016/j.dental.2007.05.007
   DiGirolamo CM, 1999, BRIT J HAEMATOL, V107, P275, DOI 10.1046/j.1365-2141.1999.01715.x
   Fernandes H, 2010, TISSUE ENG PT A, V16, P1693, DOI 10.1089/ten.TEA.2009.0341
   Gaharwar AK, 2013, ADV MATER, V25, P3329, DOI 10.1002/adma.201300584
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   Gerstenfeld LC, 1996, J CELL BIOCHEM, V62, P1
   Goldstein A, 1999, J EUR CERAM SOC, V19, P2067, DOI 10.1016/S0955-2219(99)00020-5
   Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002
   Guo M, 2010, J PHYS CHEM C, V114, P916, DOI 10.1021/jp909672r
   Hing KA, 2005, J MATER SCI-MATER M, V16, P467, DOI 10.1007/s10856-005-6988-1
   Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.3.CO;2-Z
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim HW, 2006, ADV FUNCT MATER, V16, P1529, DOI 10.1002/adfm.200500750
   Kim HW, 2004, BIOMATERIALS, V25, P1279, DOI 10.1016/j.biomaterials.2003.07.003
   Kitagawa F, 2013, TISSUE ENG PART C-ME, V19, P438, DOI [10.1089/ten.tec.2012.0166, 10.1089/ten.TEC.2012.0166]
   Lee SH, 2005, MAT SCI ENG A-STRUCT, V398, P77, DOI 10.1016/j.msea.2005.03.014
   Mao X, 2012, RSC ADV, V2, P12216, DOI 10.1039/c2ra22086e
   McNamara LE, 2010, J TISSUE ENG, V1, DOI 10.4061/2010/120623
   Meza LR, 2014, SCIENCE, V345, P1322, DOI 10.1126/science.1255908
   Nandakumar Anandkumar, 2013, Biomatter, V3, DOI 10.4161/biom.23705
   Nandakumar A, 2010, LANGMUIR, V26, P7380, DOI 10.1021/la904406b
   Park SJ, 2010, J SOL-GEL SCI TECHN, V54, P188, DOI 10.1007/s10971-010-2174-0
   Phinney DG, 1999, J CELL BIOCHEM, V75, P424, DOI 10.1002/(SICI)1097-4644(19991201)75:3<424::AID-JCB8>3.3.CO;2-#
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Polini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026211
   Pot SA, 2010, INVEST OPHTH VIS SCI, V51, P1373, DOI 10.1167/iovs.09-4074
   Ramesh S, 2008, CERAM INT, V34, P1603, DOI 10.1016/j.ceramint.2007.04.012
   Scotti C, 2010, P NATL ACAD SCI USA, V107, P7251, DOI 10.1073/pnas.1000302107
   Si Y, 2014, NANOSCALE, V6, P2102, DOI 10.1039/c3nr05879d
   Sundaresan SG, 2007, J APPL PHYS, V101, DOI 10.1063/1.2717016
   Takeuchi K, 2005, J BIOMED MATER RES A, V72A, P296, DOI 10.1002/jbm.a.30227
   Tang MH, 2014, TISSUE ENG PT A, V20, P1295, DOI [10.1089/ten.tea.2013.0211, 10.1089/ten.TEA.2013.0211]
   Wade RJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7639
   Wang J, 2006, J AM CERAM SOC, V89, P1977, DOI 10.1111/j.1551-2916.2006.00976.x
   Wang RY, 2011, J MATER CHEM, V21, P19375, DOI 10.1039/c1jm13979g
   Watari S, 2012, BIOMATERIALS, V33, P128, DOI 10.1016/j.biomaterials.2011.09.058
   Woodard JR, 2007, BIOMATERIALS, V28, P45, DOI 10.1016/j.biomaterials.2006.08.021
   Xi M, 2014, MATER LETT, V120, P219, DOI 10.1016/j.matlet.2014.01.110
   Xie ZP, 1999, J EUR CERAM SOC, V19, P381, DOI 10.1016/S0955-2219(98)00203-9
   Xu SY, 2006, NANOTECHNOLOGY, V17, P4497, DOI 10.1088/0957-4484/17/17/036
   Yuan HP, 2010, P NATL ACAD SCI USA, V107, P13614, DOI 10.1073/pnas.1003600107
   Zakaria SM, 2013, TISSUE ENG PART B-RE, V19, P431, DOI [10.1089/ten.teb.2012.0624, 10.1089/ten.TEB.2012.0624]
   Zamani F, 2013, J MATER SCI-MATER M, V24, P1551, DOI 10.1007/s10856-013-4905-6
NR 55
TC 10
Z9 10
U1 10
U2 60
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1936-0851
EI 1936-086X
J9 ACS NANO
JI ACS Nano
PD JUN
PY 2016
VL 10
IS 6
BP 5789
EP 5799
DI 10.1021/acsnano.5b08005
PG 11
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA DQ1PU
UT WOS:000378973700022
PM 27294434
DA 2018-10-20
ER

PT J
AU Dinjaski, N
   Kaplan, DL
AF Dinjaski, Nina
   Kaplan, David L.
TI Recombinant protein blends: silk beyond natural design
SO CURRENT OPINION IN BIOTECHNOLOGY
LA English
DT Review
ID SPIDER DRAGLINE SILK; ELASTIN-LIKE PROTEIN; ESCHERICHIA-COLI;
   BIOMATERIALS; NANOPARTICLES; TROPOELASTIN; EXPRESSION; POLYMERS;
   COLLAGEN; CONSTRUCTION
AB Recombinant DNA technology and new material concepts are shaping future directions in biomaterial science for the design and production of the next-generation biomaterial platforms. Aside from conventionally used synthetic polymers, numerous natural biopolymers (e.g., silk, elastin, collagen, gelatin, alginate, cellulose, keratin, chitin, polyhydroxyalkanoates) have been investigated for properties and manipulation via bioengineering. Genetic engineering provides a path to increase structural and functional complexity of these biopolymers, and thereby expand the catalog of available biomaterials beyond that which exists in nature. In addition, the integration of experimental approaches with computational modeling to analyze sequence-structure-function relationships is starting to have an impact in the field by establishing predictive frameworks for determining material properties. Herein, we review advances in recombinant DNA mediated protein production and functionalization approaches, with a focus on hybrids or combinations of proteins; recombinant protein blends or 'ecombinamers'. We highlight the potential biomedical applications of fibrous protein recombinamers, such as Silk-Elastin Like Polypeptides (SELPs) and Silk-Bacterial Collagens (SBCs). We also discuss the possibility for the rationale design of fibrous proteins to build smart, stimuli-responsive biomaterials for diverse applications. We underline current limitations with production systems for these proteins and discuss the main trends in systems/synthetic biology that may improve recombinant fibrous protein design and production.
C1 [Dinjaski, Nina; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
EM David.Kaplan@tufts.edu
FU NIH [P41 EB002520]; AFOSR; NSF IGERT program
FX We thank the NIH (P41 EB002520), the AFOSR and the NSF IGERT program for
   support of this work.
CR An B., 2014, FRONT CHEM, V2, P1
   An B, 2013, BIOMATERIALS, V34, P402, DOI 10.1016/j.biomaterials.2012.09.085
   BEDELLHOGAN D, 1993, J BIOL CHEM, V268, P10345
   Bracalello A, 2011, BIOMACROMOLECULES, V12, P2957, DOI 10.1021/bm2005388
   CANDELAS GC, 1990, DEV BIOL, V140, P215, DOI 10.1016/0012-1606(90)90069-U
   Rodrikuez-Cabello JC, 2006, NANOMEDICINE-UK, V1, P267, DOI 10.2217/17435889.1.3.267
   Caves JM, 2010, BIOMATERIALS, V31, P7175, DOI 10.1016/j.biomaterials.2010.05.014
   Collins T, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-21
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P23, DOI 10.1007/s002530050883
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P33, DOI 10.1007/s002530050884
   FAZIO MJ, 1988, J INVEST DERMATOL, V91, P458, DOI 10.1111/1523-1747.ep12476591
   Floss DM, 2010, TRENDS BIOTECHNOL, V28, P37, DOI 10.1016/j.tibtech.2009.10.004
   Gomes S, 2012, PROG POLYM SCI, V37, P1, DOI 10.1016/j.progpolymsci.2011.07.003
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Gronau G, 2012, BIOMATERIALS, V33, P8240, DOI 10.1016/j.biomaterials.2012.06.054
   Gyorgy A, 2015, BIOPHYS J, V109, P639, DOI 10.1016/j.bpj.2015.06.034
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   Hossainy S, 2012, Methods and Compositions for Treating Tissue Using Silk Proteins, Patent No. [US 20130251764 A1, 20130251764]
   Hu XA, 2010, BIOMATERIALS, V31, P8121, DOI 10.1016/j.biomaterials.2010.07.044
   Huang J, 2007, BIOMATERIALS, V28, P2358, DOI 10.1016/j.biomaterials.2006.11.021
   Huemmerich D, 2004, CURR BIOL, V14, P2070, DOI 10.1016/j.cub.2004.11.005
   Hunag W, 2015, EXPERT OPIN DRUG DEL, V12, P779
   Kaplan DL, 2002, ADV DRUG DELIV REV, V54, P1131, DOI DOI 10.1016/S0169-409X(02)00061-3
   Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775
   Kumar VA, 2014, BIOMED MATER, V9, P1
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   LEHRACH H, 1978, P NATL ACAD SCI USA, V75, P5417, DOI 10.1073/pnas.75.11.5417
   Lin YA, 2014, LANGMUIR, V30, P4406, DOI 10.1021/la403559t
   Machado R, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-11
   MacKay JA, 2009, NAT MATER, V8, P993, DOI [10.1038/nmat2569, 10.1038/NMAT2569]
   MARTIN SL, 1995, GENE, V154, P159, DOI 10.1016/0378-1119(94)00848-M
   McDaniel JR, 2013, ANGEW CHEM INT EDIT, V52, P1683, DOI 10.1002/anie.201200899
   Megeed Z, 2002, ADV DRUG DELIVER REV, V54, P1075, DOI 10.1016/S0169-409X(02)00063-7
   Patwardhan SV, 2006, P NATL ACAD SCI USA, V103, P9428
   PRINCE JT, 1995, BIOCHEMISTRY-US, V34, P10879, DOI 10.1021/bi00034a022
   Qiu WG, 2010, BIOMACROMOLECULES, V11, P3219, DOI 10.1021/bm100469w
   Rabotyagova OS, 2009, BIOMACROMOLECULES, V10, P229, DOI 10.1021/bm800930x
   Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335
   SOBEL ME, 1978, J BIOL CHEM, V75, P5846
   Spiess K, 2010, MACROMOL BIOSCI, V10, P998, DOI 10.1002/mabi.201000071
   Tillinghast EK, 1977, J EXP ZOOL, V202, P2113
   Tokareva O, 2013, MICROB BIOTECHNOL, V6, P651, DOI 10.1111/1751-7915.12081
   Tokareva OS, 2014, J BIOMED MATER RES B, V103, P1390
   Wang Q, 2014, ADV FUNCT MATER, V24, P4303, DOI 10.1002/adfm.201304106
   Widmaier DM, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.62
   Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027
   Xia X-X, 2011, BIOMACROMOLECULES, V12, P3844
   Xia XX, 2010, P NATL ACAD SCI USA, V107, P14059, DOI 10.1073/pnas.1003366107
   Xu LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050227
NR 49
TC 18
Z9 18
U1 6
U2 83
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0958-1669
EI 1879-0429
J9 CURR OPIN BIOTECH
JI Curr. Opin. Biotechnol.
PD JUN
PY 2016
VL 39
BP 1
EP 7
DI 10.1016/j.copbio.2015.11.002
PG 7
WC Biochemical Research Methods; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA DP5VI
UT WOS:000378565700003
PM 26686863
OA Other Gold
DA 2018-10-20
ER

PT J
AU Ning, RZ
   Wang, F
   Lin, L
AF Ning, Ruizhi
   Wang, Feng
   Lin, Ling
TI Biomaterial-based microfluidics for cell culture and analysis
SO TRAC-TRENDS IN ANALYTICAL CHEMISTRY
LA English
DT Review
DE Biomaterials; Microfluidic; Cell culture; Organ on chip; Cell
   observation; Cell analysis
ID ON-A-CHIP; IN-VITRO; MASS-SPECTROMETRY; STEM-CELLS; SURFACE
   MODIFICATION; CYTOTOXICITY ASSAY; PROTEIN ADSORPTION; SOFT LITHOGRAPHY;
   TUMOR-CELLS; FABRICATION
AB To make microfluidics more functional and sensitive for biological applications, biomaterials for chip organization and function are key factors that can be controlled. Biomaterials used in microfluidics were found to be more diverse, complicated, and integrated, which were gradually replaced with polymers. Previously, microfluidics involved chemical and biological microanalysis, including biomolecular analysis. We believe that biomaterial-based microplatforms will be used for cell culture and analysis in vitro in future, thus revolutionizing biology and medicine research and applications. In this review, we first describe commonly used biomaterials in microfluidic construction. Then, biomaterials for two-dimensional (2D) and three-dimensional (3D) cell culture on chip, as well as organ-on-chip mimicking, are elaborated. Finally, based on cell observation and analysis, biomaterials with higher sensitivity are selected. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Ning, Ruizhi; Wang, Feng; Lin, Ling] Beijing Univ Chem Technol, State Key Lab Chem Resource Engn, Beijing 100029, Peoples R China.
   [Lin, Ling] Univ Tokyo, Sch Engn, Dept Bioengn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.
RP Lin, L (reprint author), Beijing Univ Chem Technol, State Key Lab Chem Resource Engn, Beijing 100029, Peoples R China.; Lin, L (reprint author), Univ Tokyo, Sch Engn, Dept Bioengn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.
EM lin@icl.t.u-tokyo.ac.jp
FU National Natural Science Foundation of China [51125007]
FX This work was supported by National Natural Science Foundation of China
   (No. 51125007).
CR Agarwal A, 2013, LAB CHIP, V13, P3599, DOI 10.1039/c3lc50350j
   Alessandri K, 2013, P NATL ACAD SCI USA, V110, P14843, DOI 10.1073/pnas.1309482110
   Annabi N, 2013, LAB CHIP, V13, P3569, DOI 10.1039/c3lc50252j
   Bartalena G, 2012, SOFT MATTER, V8, P673, DOI 10.1039/c1sm06250f
   Battle KN, 2014, ANALYST, V139, P1355, DOI 10.1039/c3an02400h
   Biju V, 2014, CHEM SOC REV, V43, P744, DOI 10.1039/c3cs60273g
   Bodas D, 2007, SENSOR ACTUAT B-CHEM, V123, P368, DOI 10.1016/j.snb.2006.08.037
   Booth R, 2012, LAB CHIP, V12, P1784, DOI 10.1039/c2lc40094d
   Caron MMJ, 2012, OSTEOARTHR CARTILAGE, V20, P1170, DOI 10.1016/j.joca.2012.06.016
   Chandrasekaran S, 2011, BIOMATERIALS, V32, P7159, DOI 10.1016/j.biomaterials.2011.06.013
   Chen QS, 2013, SCI REP-UK, V3, DOI 10.1038/srep02433
   Chen QS, 2012, LAB CHIP, V12, P5180, DOI 10.1039/c2lc40858a
   Chung S, 2009, ADV MATER, V21, P4863, DOI 10.1002/adma.200901727
   Dochow S, 2013, ANAL BIOANAL CHEM, V405, P2743, DOI 10.1007/s00216-013-6726-3
   Ertl P, 2014, TRENDS BIOTECHNOL, V32, P245, DOI 10.1016/j.tibtech.2014.03.004
   Gao D, 2013, LAB CHIP, V13, P978, DOI 10.1039/c2lc41215b
   Gao D, 2012, ANAL CHEM, V84, P9230, DOI 10.1021/ac301966c
   Gao D, 2010, ANAL CHIM ACTA, V665, P7, DOI 10.1016/j.aca.2010.03.015
   He QH, 2013, ANAL CHEM, V85, P1327, DOI 10.1021/ac303138x
   He XW, 2014, TRAC-TREND ANAL CHEM, V53, P84, DOI 10.1016/j.trac.2013.09.013
   Henrich D, 2013, MEDIAT INFLAMM, DOI 10.1155/2013/364591
   Hong S, 2012, INTEGR BIOL-UK, V4, P374, DOI 10.1039/c2ib00166g
   Hua X, 2013, ANAL CHIM ACTA, V788, P135, DOI 10.1016/j.aca.2013.06.001
   Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302
   Jung YD, 2014, J MATER CHEM B, V2, P4922, DOI 10.1039/c4tb00476k
   Kang E, 2010, LAB CHIP, V10, P2651, DOI [10.1039/c0lc00005a, 10.1039/c01c00005a]
   Kim C, 2012, LAB CHIP, V12, P2942, DOI 10.1039/c2lc40182g
   Kothapalli CR, 2011, LAB CHIP, V11, P497, DOI [10.1039/c0lc00240b, 10.1039/c01c00240b]
   Kuddannaya S, 2013, ACS APPL MATER INTER, V5, P9777, DOI 10.1021/am402903e
   Larsen EKU, 2013, LAB CHIP, V13, P669, DOI 10.1039/c2lc40750g
   Lee JW, 2013, MOL BIOSYST, V9, P1004, DOI 10.1039/c2mb25431j
   Lee KH, 2014, J BIOMED MATER RES A, V102, P1164, DOI 10.1002/jbm.a.34772
   Lee SA, 2013, LAB CHIP, V13, P3529, DOI 10.1039/c3lc50197c
   Lei KF, 2014, BIOSENS BIOELECTRON, V51, P16, DOI 10.1016/j.bios.2013.07.031
   Leipzig ND, 2011, BIOMATERIALS, V32, P57, DOI 10.1016/j.biomaterials.2010.09.031
   Li Q, 2014, TRAC-TREND ANAL CHEM, V58, P130, DOI 10.1016/j.trac.2014.03.007
   Lin HK, 2010, CLIN CANCER RES, V16, P5011, DOI 10.1158/1078-0432.CCR-10-1105
   Lin L, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3623412
   Lin L, 2011, ANALYST, V136, P4260, DOI 10.1039/c1an15530j
   Liu CS, 2010, ANAL CHEM, V82, P9418, DOI 10.1021/ac102094r
   Liu F, 2014, MICROCHIM ACTA, V181, P663, DOI 10.1007/s00604-014-1171-3
   Liu JJ, 2012, SCI CHINA CHEM, V55, P494, DOI 10.1007/s11426-012-4538-5
   Liu TQ, 2014, BIOMATERIALS, V35, P6060, DOI 10.1016/j.biomaterials.2014.04.047
   Liu W, 2014, ANAL CHEM, V86, P7128, DOI 10.1021/ac501678q
   Luo Y, 2012, ANAL CHEM, V84, P6731, DOI 10.1021/ac301191j
   Mack PJ, 2009, J BIOL CHEM, V284, P8412, DOI 10.1074/jbc.M804524200
   Mo XJ, 2010, BIOMATERIALS, V31, P7455, DOI 10.1016/j.biomaterials.2010.06.020
   Mogi K, 2014, SENSOR ACTUAT B-CHEM, V201, P407, DOI 10.1016/j.snb.2014.05.047
   Mu X, 2014, ANAL CHEM, V86, P5338, DOI 10.1021/ac500247f
   O'Connor RS, 2012, J IMMUNOL, V189, P1330, DOI 10.4049/jimmunol.1102757
   Onoe H, 2013, NAT MATER, V12, P584, DOI [10.1038/NMAT3606, 10.1038/nmat3606]
   Ou JJ, 2009, LAB CHIP, V9, P1926, DOI 10.1039/b821438g
   Ozaydin-Ince G, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/1/016501
   Paguirigan AL, 2008, BIOESSAYS, V30, P811, DOI 10.1002/bies.20804
   Pei Y, 2013, CELLULOSE, V20, P1897, DOI 10.1007/s10570-013-9930-6
   Qin D, 2010, NAT PROTOC, V5, P491, DOI 10.1038/nprot.2009.234
   Rolland JP, 2004, J AM CHEM SOC, V126, P2322, DOI 10.1021/ja031657y
   Roy E, 2011, LAB CHIP, V11, P3193, DOI 10.1039/c1lc20251k
   Sapir Y, 2011, BIOMATERIALS, V32, P1838, DOI 10.1016/j.biomaterials.2010.11.008
   Schmidt S, 2010, ADV FUNCT MATER, V20, P3235, DOI 10.1002/adfm.201000730
   Seiffert S, 2010, SOFT MATTER, V6, P3184, DOI 10.1039/c0sm00071j
   Shin Y, 2012, NAT PROTOC, V7, P1247, DOI 10.1038/nprot.2012.051
   Sun GY, 2012, J MICROELECTROMECH S, V21, P1504, DOI 10.1109/JMEMS.2012.2211574
   Sun TL, 2011, ADV MATER, V23, pH57, DOI 10.1002/adma.201004326
   Sun TL, 2004, ANGEW CHEM INT EDIT, V43, P357, DOI 10.1002/anie.200352565
   Tanzi S, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/11/115008
   TERRY SC, 1979, IEEE T ELECTRON DEV, V26, P1880, DOI 10.1109/T-ED.1979.19791
   Vu TT, 2014, SENSOR ACTUAT B-CHEM, V196, P64, DOI 10.1016/j.snb.2014.01.085
   Thuo MM, 2014, CHEM MATER, V26, P4230, DOI 10.1021/cm501596s
   Tsougeni K, 2012, SENSOR ACTUAT B-CHEM, V161, P216, DOI 10.1016/j.snb.2011.10.022
   van Midwoud PM, 2012, ANAL CHEM, V84, P3938, DOI 10.1021/ac300771z
   Wang J, 2010, LAB CHIP, V10, P1993, DOI 10.1039/c003264f
   Weltin A, 2014, LAB CHIP, V14, P138, DOI 10.1039/c3lc50759a
   Wu DP, 2006, LAB CHIP, V6, P942, DOI 10.1039/b600765a
   Wu J, 2013, LAB CHIP, V13, P1948, DOI 10.1039/c3lc00041a
   Wu J, 2012, LAB CHIP, V12, P3474, DOI 10.1039/c2lc40502d
   Wylie RG, 2011, NAT MATER, V10, P799, DOI [10.1038/NMAT3101, 10.1038/nmat3101]
   Xiao Y, 2014, LAB CHIP, V14, P869, DOI 10.1039/c3lc51123e
   Yakovleva J, 2002, ANAL CHEM, V74, P2994, DOI 10.1021/ac015645b
   Yang DM, 2013, CHEM-EUR J, V19, P2685, DOI 10.1002/chem.201203634
   Yoshii Y, 2011, BIOMATERIALS, V32, P6052, DOI 10.1016/j.biomaterials.2011.04.076
   You JB, 2013, LAB CHIP, V13, P1266, DOI 10.1039/c2lc41266g
   Yu JH, 2011, LAB CHIP, V11, P1286, DOI 10.1039/c0lc00524j
   Zhang L, 2015, RSC ADV, V5, P5638, DOI 10.1039/c4ra15907a
   Zhang YD, 2014, SCI CHINA CHEM, V57, P442, DOI 10.1007/s11426-013-4960-3
   Zhang YR, 2011, ANAL CHEM, V83, P9651, DOI 10.1021/ac202517x
   Zheng CF, 2012, BIOMATERIALS, V33, P5603, DOI 10.1016/j.biomaterials.2012.04.044
   Zhou JW, 2010, ELECTROPHORESIS, V31, P2, DOI 10.1002/elps.200900475
NR 88
TC 9
Z9 11
U1 5
U2 47
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0165-9936
EI 1879-3142
J9 TRAC-TREND ANAL CHEM
JI Trac-Trends Anal. Chem.
PD JUN
PY 2016
VL 80
BP 255
EP 265
DI 10.1016/j.trac.2015.08.017
PG 11
WC Chemistry, Analytical
SC Chemistry
GA DP4EW
UT WOS:000378450000021
DA 2018-10-20
ER

PT J
AU Huang, CJ
   Zhao, LX
   Gu, J
   Nie, DK
   Chen, YN
   Zuo, H
   Huan, W
   Shi, JL
   Chen, J
   Shi, W
AF Huang, Chuanjun
   Zhao, Longxiang
   Gu, Jun
   Nie, Dekang
   Chen, Yinan
   Zuo, Hao
   Huan, Wei
   Shi, Jinlong
   Chen, Jian
   Shi, Wei
TI The migration and differentiation of hUC-MSCsCXCR4/GFP encapsulated in
   BDNF/chitosan scaffolds for brain tissue engineering
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE traumatic brain injury; hUC-MSCs; CXCR4/SDF-1 alpha axis; migration;
   neuronal differentiation
ID MESENCHYMAL STEM-CELLS; BONE-MARROW; IN-VITRO; INJURY; THERAPY;
   TRAFFICKING; EXPRESSION; MODEL; MICE
AB We previously developed a biomaterial scaffold that could effectively provide seed cells to a lesion cavity resulting from traumatic brain injury. However, we subsequently found that few transplanted human umbilical cord mesenchymal stem cells (hUC-MSCs) are able to migrate from the scaffold to the lesion boundary. Stromal derived-cell factor-1 alpha and its receptor chemokine (C-X-C motif) receptor (CXCR) 4 are chemotactic factors that control cell migration and stem cell recruitment to target areas. Given the low expression level of CXCR4 on the hUC-MSC membrane, lentiviral vectors were used to generate hUC-MSCs stably expressing CXCR4 fused to green fluorescent protein (GFP) (hUC-MSCsCXCR4/GFP). We constructed a scaffold in which recombinant human brain-derived neurotrophic factor (BDNF) was linked to chitosan scaffolds with the crosslinking agent genipin (CGB scaffold). The scaffold containing hUC-MSCsCXCR4/GFP was transplanted into the lesion cavity of a rat brain, providing exogenous hUC-MSCs to both lesion boundary and cavity. These results demonstrate a novel strategy for inducing tissue regeneration after traumatic brain injury.
C1 [Huang, Chuanjun; Zhao, Longxiang; Gu, Jun; Chen, Yinan; Zuo, Hao; Huan, Wei; Shi, Jinlong; Chen, Jian; Shi, Wei] Nantong Univ, Affiliated Hosp, Dept Neurosurg, Nantong, Peoples R China.
   [Nie, Dekang] Nantong Univ, Affiliated Hosp 4, Dept Neurosurg, YanCheng City Peoples Hosp 1, Yancheng, Peoples R China.
RP Shi, W (reprint author), Nantong Univ, Affiliated Hosp, Dept Neurosurg, Nantong, Peoples R China.
EM ntshiwei123@163.com
FU National Nature Science Foundation of China [81271368]; Natural Science
   Foundation of Jiangsu Province [BK2012654]
FX The authors thank the Surgical Comprehensive Laboratory at the
   Affiliated Hospital of Nantong University for technical assistance and
   equipment support. This work was supported by the National Nature
   Science Foundation of China (grant no. 81271368) and the Natural Science
   Foundation of Jiangsu Province (grant no. BK2012654).
CR Barbash IM, 2003, CIRCULATION, V108, P863, DOI 10.1161/01.CIR.0000084828.50310.6A
   Brooke G, 2008, STEM CELLS DEV, V17, P929, DOI 10.1089/scd.2007.0156
   Cao ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082949
   Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075
   Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197
   Dazzi F, 2007, CURR OPIN ONCOL, V19, P650, DOI 10.1097/CCO.0b013e3282f0e116
   Guan J, 2013, BIOMATERIALS, V34, P5937, DOI 10.1016/j.biomaterials.2013.04.047
   Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102
   Ji JF, 2004, STEM CELLS, V22, P415, DOI 10.1634/stemcells.22-3-415
   Jiang QS, 2011, CHINESE MED J-PEKING, V124, P1540, DOI 10.3760/cma.j.issn.0366-6999.2011.10.019
   Jiang Q, 2011, NMR BIOMED, V24, P1119, DOI 10.1002/nbm.1667
   Keilhoff G, 2006, CELL MOL NEUROBIOL, V26, P1235, DOI 10.1007/s10571-006-9029-9
   Kim Ju-Yeon, 2010, World J Stem Cells, V2, P34, DOI 10.4252/wjsc.v2.i2.34
   Lee JH, 2011, J NEUROL SCI, V300, P86, DOI 10.1016/j.jns.2010.09.025
   Liang J, 2013, NEUROSCI LETT, V532, P59, DOI 10.1016/j.neulet.2012.11.014
   Lim JY, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt79
   Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9
   Maegele M, 2008, MINIM INVASIV THER, V17, P119, DOI 10.1080/13645700801970087
   McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000
   Murphy JM, 2003, ARTHRITIS RHEUM, V48, P3464, DOI 10.1002/art.11365
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Qiu YY, 2012, CYTOTHERAPY, V14, P285, DOI 10.3109/14653249.2011.651532
   Qu C, 2012, BRAIN RES, V1371, P129
   Shi M, 2007, HAEMATOL-HEMATOL J, V92, P897, DOI 10.3324/haematol.10669
   Shi W, 2012, BIOMATERIALS, V33, P3119, DOI 10.1016/j.biomaterials.2012.01.009
   Son BR, 2006, STEM CELLS, V24, P1254, DOI 10.1634/stemcells.2005-0271
   Sordi V, 2005, BLOOD, V106, P419, DOI 10.1182/blood2004-09-3507
   Wang KZ, 2014, FLEX SERV MANUF J, V26, P387, DOI 10.1007/s10696-012-9153-4
NR 28
TC 2
Z9 2
U1 2
U2 8
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD JUN
PY 2016
VL 11
IS 3
DI 10.1088/1748-6041/11/3/035004
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DP0GQ
UT WOS:000378167700005
PM 27147644
OA Other Gold
DA 2018-10-20
ER

PT J
AU Im, BJ
   Lee, SC
   Lee, MH
   Leesungbok, R
   Ahn, SJ
   Kang, YG
   Lee, DY
   Yoon, JH
   Lee, SW
AF Im, Byung-Jin
   Lee, Sang Cheon
   Lee, Myung-Hyun
   Leesungbok, Richard
   Ahn, Su-Jin
   Kang, Yoon-Goo
   Lee, Do Yun
   Yoon, Joon-Ho
   Lee, Suk Won
TI Promotion of osteoblastic differentiation and osteogenic transcription
   factor expression on a microgroove titanium surface with immobilized
   fibronectin or bone sialoprotein II
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE microgrooves; matrix protein immobilization; fibronectin; bone
   sialoprotein II; osteoblastic differentiation; osteogenic transcription
   factors
ID HUMAN GINGIVAL FIBROBLASTS; HUMAN PRIMARY-CELLS; IN-VITRO;
   QUANTITATIVE-ANALYSIS; ETCHED MICROGROOVES; STEM-CELLS; SUBSTRATA;
   PROLIFERATION; PROTEINS; ADHESION
AB We demonstrate that a composite surface of microgroove titanium (Ti) with immobilized fibronectin (FN) or bone sialoprotein II (BSP2) promotes osteoblastic differentiation and osteogenic transcription factor expression in human bone marrow-derived mesenchymal stem cells (MSCs). Comparisons made between smooth microgrooves, microgrooves with silanization and microgrooves with matrix protein (FN or BSP2)-immobilization Ti surfaces revealed a significant promotion of in vitro osteogenic activity and osteoblastic differentiation at various timelines of culture. An even more significant increase was verified on microgrooves with a matrix protein-immobilization Ti surface in 28 d time-dependent gene expression of the main osteogenic transcription factors, such as ARF4, FRA1, RUNX2, and OSX. As a result, a synergestic effect regarding the promotion of osteogenic transcription factor expression and osteoblastic differentiation in the matrix protein-microgroove Ti composite surface was confirmed. From a multiple regression analysis using various timelines of osteogenic culture as independent variables, day 13 was verified as the most prominent influential timeline for the promotion of osteoblastic differentiation induced by the matrix protein-microgroove Ti composite surface. The FN-or BSP2-microgroove Ti composite surface resulting from silanization can strongly induce the promotion of osteoblastic differentiation in human MSCs. The proposed surface is expected to be useful in the development of a variety of osteogenic biomaterial surfaces.
C1 [Im, Byung-Jin] Kyung Hee Univ, Grad Sch, Dept Dent, Seoul 02447, South Korea.
   [Lee, Sang Cheon] Kyung Hee Univ, Dept Maxillofacial Biomed Engn, Seoul 02447, South Korea.
   [Lee, Sang Cheon] Kyung Hee Univ, Sch Dent, Inst Oral Biol, Seoul 02447, South Korea.
   [Lee, Myung-Hyun] Korea Inst Ceram Engn & Technol, Div Energy & Environm, Jinju 660031, Gyeongsangnam D, South Korea.
   [Leesungbok, Richard; Ahn, Su-Jin; Lee, Suk Won] Kyung Hee Univ, Kyung Hee Univ Hosp Gangdong, Dept Biomat & Prosthodont, Inst Oral Biol,Sch Dent, Seoul 05278, South Korea.
   [Kang, Yoon-Goo] Kyung Hee Univ, Kyung Hee Univ Hosp Gangdong, Inst Oral Biol, Sch Dent,Dept Orthodont, Seoul 05278, South Korea.
   [Lee, Do Yun] ED Dent Clin, Seoul 08310, South Korea.
   [Yoon, Joon-Ho] Ilsan Hosp, Natl Hlth Insurance Med Ctr, Dept Prosthodont, Goyang 10444, Gyeonggi Do, South Korea.
RP Lee, SW (reprint author), Kyung Hee Univ, Kyung Hee Univ Hosp Gangdong, Dept Biomat & Prosthodont, Inst Oral Biol,Sch Dent, Seoul 05278, South Korea.
EM ysprosth@hanmail.net
FU Basic Science Research Program through the National Research Foundation
   of Korea (NRF) - Ministry of Education, Republic of Korea
   [NRF-2015R1D1A1A01057956]
FX This research was supported by the Basic Science Research Program
   through the National Research Foundation of Korea (NRF) funded by the
   Ministry of Education, Republic of Korea (NRF-2015R1D1A1A01057956).
CR Chatakun P, 2014, CELL MOL LIFE SCI, V71, P113, DOI 10.1007/s00018-013-1326-0
   CHEHROUDI B, 1992, CELL MATER, V2, P89
   denBraber ET, 1996, BIOMATERIALS, V17, P1093, DOI 10.1016/0142-9612(96)85910-2
   denBraber ET, 1996, BIOMATERIALS, V17, P2037, DOI 10.1016/0142-9612(96)00032-4
   Eferl R, 2004, EMBO J, V23, P2789, DOI 10.1038/sj.emboj.7600282
   ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102
   Fujisawa R, 2012, FRONT BIOSCI-LANDMRK, V17, P1891, DOI 10.2741/4026
   Ganss B, 1999, CRIT REV ORAL BIOL M, V10, P79, DOI 10.1177/10454411990100010401
   Godoy-Gallardo M, 2016, MAT SCI ENG C-MATER, V59, P524, DOI 10.1016/j.msec.2015.10.051
   Hilbig H, 2007, EUR J MED RES, V12, P6
   Im BJ, 2012, ARCH ORAL BIOL, V57, P898, DOI 10.1016/j.archoralbio.2011.11.013
   Jimbo R, 2007, BIOMATERIALS, V28, P3469, DOI 10.1016/j.biomaterials.2007.04.029
   Kim SY, 2014, BIOMED RES INT, DOI 10.1155/2014/452175
   Kim SY, 2009, CLIN ORAL IMPLAN RES, V20, P262, DOI 10.1111/j.1600-0501.2008.01652.x
   Kim SE, 2010, TISSUE ENG REGEN MED, V7, P202
   Koo KT, 2014, CLIN ORAL IMPLAN RES, V25, P714, DOI 10.1111/clr.12131
   Lee MH, 2013, ARCH ORAL BIOL, V58, P59, DOI 10.1016/j.archoralbio.2012.05.010
   Lee MH, 2012, BIOMATERIALS, V33, P3216, DOI 10.1016/j.biomaterials.2012.01.034
   Lee MH, 2010, TISSUE ENG REGEN MED, V7, P501
   Lee MH, 2010, BIOMATERIALS, V31, P3804, DOI 10.1016/j.biomaterials.2010.01.117
   Lee S W, 2007, J KOREAN ACAD PROSTH, V45, P787
   Lee SW, 2015, COLLOID SURFACE B, V135, P565, DOI 10.1016/j.colsurfb.2015.08.011
   Lee SW, 2012, TISSUE ENG REGEN MED, V9, P75, DOI 10.1007/s13770-012-0020-x
   Lee SW, 2012, J ORAL IMPLANTOL, V38, P11, DOI 10.1563/AAID-JOI-D-09-00144.1
   Lee SW, 2009, CLIN ORAL IMPLAN RES, V20, P458, DOI 10.1111/j.1600-0501.2008.01671.x
   Lee SW, 2009, CLIN ORAL IMPLAN RES, V20, P56, DOI 10.1111/j.1600-0501.2008.01597.x
   Leiss M, 2008, CURR OPIN CELL BIOL, V20, P502, DOI 10.1016/j.ceb.2008.06.001
   Malaval L, 2008, J EXP MED, V205, P1145, DOI 10.1084/jem.20071294
   Middleton CA, 2007, J BIOMED MATER RES A, V83A, P1032, DOI 10.1002/jbm.a.31382
   Mould AP, 1997, J BIOL CHEM, V272, P17283, DOI 10.1074/jbc.272.28.17283
   Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5
   Nanci A, 1998, J BIOMED MATER RES, V40, P324
   O'Toole GC, 2004, J ORTHOPAED RES, V22, P641, DOI 10.1016/j.orthres.2003.09.005
   Park JA, 2010, J ADV PROSTHODONT, V2, P18, DOI [10.4047/jap.2010.2.1.18, 10.4047/jap.2010.2.18-24]
   Park SJ, 2015, J ADV PROSTHODONT, V7, P496, DOI 10.4047/jap.2015.7.6.496
   Perizzolo D, 2001, J BIOMED MATER RES, V56, P494, DOI 10.1002/1097-4636(20010915)56:4<494::AID-JBM1121>3.0.CO;2-X
   Qu J, 1996, Oral Dis, V2, P102
   Seo Jin-Ho, 2015, [The Journal of Korean Academy of Prosthodontics, 대한치과보철학회지], V53, P198, DOI 10.4047/jkap.2015.53.3.198
   Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7
NR 39
TC 0
Z9 0
U1 3
U2 9
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD JUN
PY 2016
VL 11
IS 3
DI 10.1088/1748-6041/11/3/035020
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DP0GQ
UT WOS:000378167700021
PM 27327854
DA 2018-10-20
ER

PT J
AU Kang, MH
   Jang, TS
   Jung, HD
   Kim, SM
   Kim, HE
   Koh, YH
   Song, J
AF Kang, Min-Ho
   Jang, Tae-Sik
   Jung, Hyun-Do
   Kim, Sae-Mi
   Kim, Hyoun-Ee
   Koh, Young-Hag
   Song, Juha
TI Poly(ether imide)-silica hybrid coatings for tunable corrosion behavior
   and improved biocompatibility of magnesium implants
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE hybrid coating; silica; biodegradation; corrosion resistance; magnesium;
   hard tissue engineering
ID IN-VIVO CORROSION; GUIDED BONE REGENERATION; ORTHOPEDIC APPLICATIONS;
   BIOMEDICAL APPLICATIONS; ALLOYS; HYDROXYAPATITE; RESISTANCE; VITRO;
   AZ31; MG
AB Magnesium (Mg) and its alloys have gained considerable attention as a promising biomaterial for bioresorbable orthopedic implants, but the corrosion behavior of Mg-based implants is still the major issue for clinical use. In order to improve the corrosion stability and implant-tissue interfaces of these implants, methods for coating Mg have been actively investigated. In this study, poly(ether imide) (PEI)silica hybrid material was coated on Mg, for the tunable degradation and enhanced biological behavior. Homogeneous PEI-silica hybrid materials with various silica contents were coated on Mg substrates without any cracks, where silica nanoparticles were well dispersed in the PEI matrix without significant particle agglomeration up the 30 vol% silica. The hybrid coatings maintained good adhesion strength of PEI to Mg. The corrosion rate of hybrid-coated Mg was increased along with the increment of the silica content, due to improved hydrophilicity of the hybrid coating layers. Moreover, the biocompatibility of the hybrid-coated Mg specimens was significantly improved, mainly due to the higher Mg ion concentrations associated with faster corrosion, compared to PEI-coated Mg. Therefore, PEI-silica hybrid systems have significant potential as a coating material of Mg for load-bearing orthopedic applications by providing tunable corrosion behavior and enhanced biological performance.
C1 [Kang, Min-Ho; Jang, Tae-Sik; Kim, Sae-Mi; Kim, Hyoun-Ee; Song, Juha] Seoul Natl Univ, Dept Mat Sci & Engn, Seoul 151742, South Korea.
   [Kim, Hyoun-Ee; Song, Juha] Seoul Natl Univ, Adv Inst Convergence Technol, Suwon 443270, South Korea.
   [Koh, Young-Hag] Korea Univ, Sch Biomed Engn, Seoul 136703, South Korea.
   [Jung, Hyun-Do] Korea Inst Ind Technol, Liquid Proc & Casting Technol R&D Grp, Inchon 406840, South Korea.
   [Song, Juha] Nanyang Technol Univ, Sch Chem & Biomed Engn, 70 Nanyang Dr, Singapore 637457, Singapore.
RP Song, J (reprint author), Seoul Natl Univ, Dept Mat Sci & Engn, Seoul 151742, South Korea.; Song, J (reprint author), Seoul Natl Univ, Adv Inst Convergence Technol, Suwon 443270, South Korea.; Song, J (reprint author), Nanyang Technol Univ, Sch Chem & Biomed Engn, 70 Nanyang Dr, Singapore 637457, Singapore.
EM songjuha@ntu.edu.sg
RI Song, Juha/P-1927-2017
OI Song, Juha/0000-0002-3503-680X
FU Young Researcher Program [2015R1C1A2A01056113]; National Research
   Foundation of Korea; Industrial Strategic Technology Development Program
   [10045329]; Ministry of Trade, Industry & Energy (MI, Korea)
FX This research was supported by the Young Researcher Program (Contract
   grant No. 2015R1C1A2A01056113), funded by National Research Foundation
   of Korea, Minister of Science, ICT and Future Planning (MSIP, Korea),
   and the Industrial Strategic Technology Development Program (Contract
   grant No. 10045329, Development of customized implant with porous
   structure for bone replacement), funded by the Ministry of Trade,
   Industry & Energy (MI, Korea).
CR Abdal-hay A, 2013, CERAM INT, V39, P183, DOI 10.1016/j.ceramint.2012.06.008
   Abdal-Hay A, 2012, APPL SURF SCI, V261, P536, DOI 10.1016/j.apsusc.2012.08.051
   Birbilis N, 2009, CORROS SCI, V51, P683, DOI 10.1016/j.corsci.2008.12.012
   Chen YJ, 2014, ACTA BIOMATER, V10, P4561, DOI 10.1016/j.actbio.2014.07.005
   Conceicao TF, 2010, CORROS SCI, V52, P2066, DOI 10.1016/j.corsci.2010.02.027
   da Conceicao TF, 2011, CORROS SCI, V53, P338, DOI 10.1016/j.corsci.2010.09.040
   Diez M, 2016, J MATER SCI-MATER M, V27, DOI 10.1007/s10856-015-5643-8
   Du J, 2015, J BIOMECH, V48, P3486, DOI 10.1016/j.jbiomech.2015.05.014
   Garcia-Gareta E, 2015, BONE, V81, P112, DOI 10.1016/j.bone.2015.07.007
   Ghali E, 2013, J MATER ENG PERFORM, V22, P2875, DOI 10.1007/s11665-013-0730-9
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Hahn BD, 2011, SURF COAT TECH, V205, P3112, DOI 10.1016/j.surfcoat.2010.11.029
   Jang TS, 2012, J BIOMED MATER RES B, V100B, P321, DOI 10.1002/jbm.b.31952
   Jeong H, 2015, SURF COAT TECH, V284, P26, DOI 10.1016/j.surfcoat.2015.10.039
   Jo JH, 2013, J BIOMATER APPL, V28, P617, DOI 10.1177/0885328212468921
   Jo JH, 2012, J BIOMATER APPL, V27, P469, DOI 10.1177/0885328211412633
   Jo JH, 2011, J MATER SCI-MATER M, V22, P2437, DOI 10.1007/s10856-011-4431-3
   Johnson I, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/37/375103
   Jun SH, 2011, J MATER SCI-MATER M, V22, P2757, DOI 10.1007/s10856-011-4458-5
   Jun SH, 2010, ACTA BIOMATER, V6, P302, DOI 10.1016/j.actbio.2009.06.024
   Kim SM, 2014, J BIOMED MATER RES A, V102, P429, DOI 10.1002/jbm.a.34718
   Kim SB, 2013, J BIOMED MATER RES A, V101, P1708, DOI 10.1002/jbm.a.34474
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Lee EJ, 2009, BIOMATERIALS, V30, P743, DOI 10.1016/j.biomaterials.2008.10.025
   Pan YK, 2012, J BIOMED MATER RES B, V100B, P1574, DOI 10.1002/jbm.b.32726
   Pezzato L, 2015, APPL SURF SCI, V357, P1031, DOI 10.1016/j.apsusc.2015.09.107
   Razavi M, 2015, MAT SCI ENG C-MATER, V48, P21, DOI 10.1016/j.msec.2014.11.020
   Romero AI, 2011, J MATER SCI, V46, P4701, DOI 10.1007/s10853-011-5380-4
   Sanchez AHM, 2015, ACTA BIOMATER, V13, P16, DOI 10.1016/j.actbio.2014.11.048
   Scharnagl N, 2009, SURF COAT TECH, V203, P1423, DOI 10.1016/j.surfcoat.2008.11.018
   Song GL, 1999, ADV ENG MATER, V1, P11, DOI 10.1002/(SICI)1527-2648(199909)1:1<11::AID-ADEM11>3.0.CO;2-N
   Staiger M P, 2006, BIOMATERIALS, V27, P728
   Vojtech D, 2011, ACTA BIOMATER, V7, P3515, DOI 10.1016/j.actbio.2011.05.008
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Xu LP, 2012, COLLOID SURFACE B, V93, P67, DOI 10.1016/j.colsurfb.2011.12.009
   Zomorodian A, 2013, ACTA BIOMATER, V9, P8660, DOI 10.1016/j.actbio.2013.02.036
NR 37
TC 7
Z9 8
U1 2
U2 31
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD JUN
PY 2016
VL 11
IS 3
DI 10.1088/1748-6041/11/3/035003
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DP0GQ
UT WOS:000378167700004
PM 27147643
DA 2018-10-20
ER

PT J
AU Smink, AM
   de Haan, BJ
   Paredes-Juarez, GA
   Wolters, AHG
   Kuipers, J
   Giepmans, BNG
   Schwab, L
   Engelse, MA
   van Apeldoorn, AA
   de Koning, E
   Faas, MM
   de Vos, P
AF Smink, Alexandra M.
   de Haan, Bart J.
   Paredes-Juarez, Genaro A.
   Wolters, Anouk H. G.
   Kuipers, Jeroen
   Giepmans, Ben N. G.
   Schwab, Leendert
   Engelse, Marten A.
   van Apeldoorn, Aart A.
   de Koning, Eelco
   Faas, Marijke M.
   de Vos, Paul
TI Selection of polymers for application in scaffolds applicable for human
   pancreatic islet transplantation
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE type 1 diabetes; pancreatic islet transplantation; polymeric scaffold
ID CELL ENCAPSULATION; NERVE GUIDES; MESENCHYMAL TRANSITION;
   INSULIN-SECRETION; DIABETIC MICE; SITE; RAT; TISSUE; REGENERATION;
   IMPROVEMENT
AB The liver is currently the site for transplantation of islets in humans. This is not optimal for islets, but alternative sites in humans are not available. Polymeric scaffolds in surgically accessible areas are a solution. As human donors are rare, the polymers should not interfere with functional survival of human-islets. We applied a novel platform to test the adequacy of polymers for application in scaffolds for human-islet transplantation. Viability, functionality, and immune parameters were included to test poly(D, L-lactide-co-epsilon-caprolactone) (PDLLCL), poly(ethylene oxide terephthalate)/polybutylene terephthalate (PEOT/PBT) block copolymer, and polysulfone.
   The type of polymer influenced the functional survival of human islets. In islets cultured on PDLLCL the glucagon-producing alpha-cells and insulin-producing beta-cells contained more hormone granules than in islets in contact with PEOT/PBT or polysulfone. This was studied with ultrastructural analysis by electron microscopy (nanotomy) during 7 d of culture. PDLLCL was also associated with statistically significant lower release of double-stranded DNA (dsDNA, a so called danger-associate molecular pattern (DAMP)) from islets on PDLLCL when compared to the other polymers. DAMPs support undesired immune responses. Hydrophilicity of the polymers did not influence dsDNA release. Islets on PDLLCL also showed less cellular outgrowth. These outgrowing cells were mainly fibroblast and some beta-cells undergoing epithelial to mesenchymal cell transition. None of the polymers influenced the glucose-stimulated insulin secretion. As PDLLCL was associated with less release of DAMPs, it is a promising candidate for creating a scaffold for human islets. Our study demonstrates that for sensitive, rare cadaveric donor tissue such as pancreatic islets it might be necessary to first select materials that do not influence functionality before proposing the biomaterial for in vivo application. Our presented platform may facilitate this selection of biomaterials.
C1 [Smink, Alexandra M.; de Haan, Bart J.; Paredes-Juarez, Genaro A.; Faas, Marijke M.; de Vos, Paul] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Sect Immunoendocrinol, Hanzepl 1,EA11, NL-9700 GZ Groningen, Netherlands.
   [Wolters, Anouk H. G.; Kuipers, Jeroen; Giepmans, Ben N. G.] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, NL-9700 GZ Groningen, Netherlands.
   [Schwab, Leendert] Polyganics, Groningen, Netherlands.
   [Engelse, Marten A.] Leiden Univ, Med Ctr, Lab Pancreat Islet Isolat, Leiden, Netherlands.
   [van Apeldoorn, Aart A.] Univ Twente, Fac Sci & Technol, Dept Dev BioEngn, POB 217, NL-7500 AE Enschede, Netherlands.
   [de Koning, Eelco] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands.
RP Smink, AM (reprint author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Sect Immunoendocrinol, Hanzepl 1,EA11, NL-9700 GZ Groningen, Netherlands.
EM A.M.SMINK@UMCG.NL
RI Giepmans, Ben/R-4564-2016; de Vos, Paul/A-3170-2013; Paredes,
   Genaro/R-6633-2016
OI Giepmans, Ben/0000-0001-5105-5915; Paredes, Genaro/0000-0002-6621-7830
FU ZonMW [91111.006]
FX This research is part of the Diabetes Cell Therapy Initiative (DCTI)
   (FES 2009 program, Dutch ministry of welfare and sports, and the Dutch
   diabetes research foundation). Nanotomy has been performed in the UMCG
   Microscopy and Imaging Center (UMIC), sponsored by ZonMW grant
   91111.006.
CR Aoki M, 1988, Nihon Naibunpi Gakkai Zasshi, V64, P109
   Balamurugan AN, 2014, AM J TRANSPLANT, V14, P2595, DOI 10.1111/ajt.12872
   Barton FB, 2012, DIABETES CARE, V35, P1436, DOI 10.2337/dc12-0063
   Bavamian S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041535
   Bertleff MJOE, 2005, J HAND SURG-AM, V30A, P513, DOI 10.1016/j.jhsa.2004.12.009
   Bhujbal SV, 2014, ADV DRUG DELIVER REV, V67-68, P142, DOI 10.1016/j.addr.2014.01.010
   Blomeier H, 2006, TRANSPLANTATION, V82, P452, DOI 10.1097/01.tp.0000231708.19937.21
   Buitinga M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064772
   Bulstra SK, 1996, J BONE JOINT SURG BR, V78B, P892, DOI 10.1302/0301-620X78B6.6806
   Cantarelli E, 2011, CURR DIABETES REP, V11, P364, DOI 10.1007/s11892-011-0216-9
   Carlsson PO, 2000, TRANSPLANTATION, V69, P761
   Chase LG, 2007, DIABETES, V56, P3, DOI 10.2337/db06-1165
   Cheung SC, 1997, TRANSPLANT P, V29, P2144, DOI 10.1016/S0041-1345(97)00266-2
   Daoud J, 2010, BIOMATERIALS, V31, P1676, DOI 10.1016/j.biomaterials.2009.11.057
   de Vos P, 2014, ADV DRUG DELIVER REV, V67-68, P15, DOI 10.1016/j.addr.2013.11.005
   Den Dunnen WFA, 1998, J MATER SCI-MATER M, V9, P811, DOI 10.1023/A:1008987910224
   DeVos P, 1996, DIABETES, V45, P1102, DOI 10.2337/diabetes.45.8.1102
   Dufour JM, 2005, TISSUE ENG, V11, P1323, DOI 10.1089/ten.2005.11.1323
   Eden D, 2015, DIABETOLOGIA, V58, P2563, DOI 10.1007/s00125-015-3729-y
   Evans ND, 2006, MATER TODAY, V9, P26, DOI 10.1016/S1369-7021(06)71740-0
   Figliuzzi M, 2005, BIOMATERIALS, V26, P5640, DOI 10.1016/j.biomaterials.2005.02.019
   FRITSCHY WM, 1991, TRANSPLANTATION, V52, P777, DOI 10.1097/00007890-199111000-00004
   Gershengorn MC, 2004, SCIENCE, V306, P2261, DOI 10.1126/science.1101968
   Hakim RM, 1996, KIDNEY INT, V50, P566, DOI 10.1038/ki.1996.350
   Harlan DM, 2009, DIABETES, V58, P2175, DOI 10.2337/db09-0476
   Hosseini-Tabatabaei A, 2015, TRANSPLANTATION, V99, P1341, DOI 10.1097/TP.0000000000000661
   Ichii H, 2005, AM J TRANSPLANT, V5, P1635, DOI 10.1111/j.1600-6143.2005.00913.x
   Ihm SH, 2006, DIABETES, V55, P1361, DOI 10.2337/005-1333
   Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003
   KAGAWA S, 1987, LIFE SCI, V41, P2241, DOI 10.1016/0024-3205(87)90522-4
   KAUFMAN DB, 1990, TRANSPLANTATION, V50, P385, DOI 10.1097/00007890-199009000-00006
   Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215
   Kuipers J, 2015, EXP CELL RES, V33, P202
   Kunstar A, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0464
   Lembert N, 2005, CELL TRANSPLANT, V14, P97, DOI 10.3727/000000005783983232
   Lembert N, 2001, EXP CLIN ENDOCR DIAB, V109, P116, DOI 10.1055/s-2001-14828
   Luis AL, 2007, MICROSURG, V27, P125, DOI 10.1002/micr.20317
   Meek MF, 2008, ANN PLAS SURG, V60, P466, DOI 10.1097/SAP.0b013e31804d441c
   Meek MF, 2009, MICROSURG, V29, P473, DOI 10.1002/micr.20642
   Moberg L, 2002, LANCET, V360, P2039, DOI 10.1016/S0140-6736(02)12020-4
   Ouziel-Yahalom L, 2006, BIOCHEM BIOPH RES CO, V341, P291, DOI 10.1016/j.bbrc.2005.12.187
   Paredes-Juarez G A, 2015, SCI REP, V30, P14623
   Pepper AR, 2015, NAT BIOTECHNOL, V33, P518, DOI 10.1038/nbt.3211
   Ravelli RBG, 2013, SCI REP-UK, V3, DOI 10.1038/srep01804
   Rinastiti M, 2010, J DENT, V38, P29, DOI 10.1016/j.jdent.2009.08.009
   Rokstad AMA, 2014, ADV DRUG DELIVER REV, V67-68, P111, DOI 10.1016/j.addr.2013.07.010
   Sakkers RJB, 1998, J MATER SCI-MATER M, V9, P375, DOI 10.1023/A:1013227428530
   SCHNELL AH, 1988, CELL TISSUE RES, V252, P9
   Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267
   Shapiro AMJ, 2005, THER DRUG MONIT, V27, P35, DOI 10.1097/00007691-200502000-00008
   Smink AM, 2013, DIABETES, V62, P1357, DOI 10.2337/db12-1553
   Sokol E, 2015, J INVEST DERMATOL, V135, P1763, DOI 10.1038/jid.2015.109
   Stagner JI, 2007, J PANCREAS, V8, P628
   Svensson J, 2011, CELL TRANSPLANT, V20, P783, DOI 10.3727/096368910X536527
   Tanaka S, 2013, ENDOCR J, V60, P837, DOI 10.1507/endocrj.EJ13-0222
   Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835
   Uludag H, 2000, ADV DRUG DELIVER REV, V42, P29, DOI 10.1016/S0169-409X(00)00053-3
NR 57
TC 4
Z9 5
U1 3
U2 16
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD JUN
PY 2016
VL 11
IS 3
DI 10.1088/1748-6041/11/3/035006
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DP0GQ
UT WOS:000378167700007
PM 27173149
DA 2018-10-20
ER

PT J
AU Zhang, JJ
   Wang, J
   Zhang, H
   Lin, JH
   Ge, ZG
   Zou, XN
AF Zhang, Jingjing
   Wang, Justin
   Zhang, Hui
   Lin, Jianhao
   Ge, Zigang
   Zou, Xuenong
TI Macroporous interpenetrating network of polyethylene glycol (PEG) and
   gelatin for cartilage regeneration
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE articular cartilage; tissue engineering; interpenetrating network;
   mechanical property; macroporous hydrogel
ID POLY(ETHYLENE GLYCOL); ENGINEERED CARTILAGE; ARTICULAR-CARTILAGE;
   STEM-CELL; PORE-SIZE; HYDROGELS; TISSUE; MATRIX; SCAFFOLD; AGAROSE
AB Poor mechanical properties hinder the application of hydrogels in cartilage tissue engineering. In this study, macroporous interpenetrating network (IPN) hydrogels of gelatin and polyethylene glycol (PEG) were fabricated for use as a functional biomaterial to support chondrocyte culture. The IPN structure enhanced mechanical properties, while the macroporous structure facilitated cell-cell interactions. The hydrogels had pore sizes around 80 mu m with favorable interconnectivity, reduced volume swelling ratios, and nearly unchanged weight swelling ratios with increasing gelatin ratios. More significantly, the Young's modulus increased with increasing gelatin ratio, reaching a 5.3-fold increase (p < 0.01) in IPN-10% over that of the PEG group. Chondrocytes developed elongated and fibroblast morphologies with extensive cell-cell interaction throughout IPN hydrogels, compared with round, isolated aggregates in PEG hydrogels. The glycosaminoglycan (GAG) accumulation was significantly higher in IPN hydrogels than in PEG hydrogels at day 21 and day 28. Additionally, significantly higher gene expressions of collagen II (p < 0.01) and sox-9 (p < 0.01) were found in IPN-10% when compared with other groups. Overall, the macroporous IPN hydrogels showed strong tissue formation abilities and enhanced mechanical properties, demonstrating high potential as scaffolds for cartilage regeneration.
C1 [Zhang, Jingjing] China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing 100700, Peoples R China.
   [Zhang, Jingjing; Zhang, Hui; Ge, Zigang] Peking Univ, Dept Biomed Engn, Coll Engn, Beijing 100871, Peoples R China.
   [Wang, Justin] Univ Calif Los Angeles, Dept Bioengn, Henry Samueli Sch Engn & Appl Sci, Los Angeles, CA 90024 USA.
   [Lin, Jianhao; Ge, Zigang] Peking Univ, Peoples Hosp, Arthrit Clin & Res Ctr, Beijing 100871, Peoples R China.
   [Zou, Xuenong] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Spinal Surg, Orthopaed Res Inst, Guangzhou 510080, Guangdong, Peoples R China.
RP Zhang, JJ (reprint author), China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing 100700, Peoples R China.; Zhang, JJ (reprint author), Peking Univ, Dept Biomed Engn, Coll Engn, Beijing 100871, Peoples R China.
EM zjj4785@163.com; justinw555@ucla.edu; zhangh0424@qq.com;
   jianhao_lin@yahoo.com; gez@pku.edu.cn; zxnong@hotmail.com
RI GE, Zigang/E-3576-2010
OI GE, Zigang/0000-0002-5202-0973
FU National Basic Research Program of China grant (973 Program)
   [2012CB619100]; National Natural Science Foundation of China [81471800]
FX The authors would like to acknowledge the support from the National
   Basic Research Program of China grant (973 Program 2012CB619100) and the
   National Natural Science Foundation of China grant (81471800).
CR Betz MW, 2010, BIOMACROMOLECULES, V11, P1160, DOI 10.1021/bm100061z
   Bian LM, 2013, P NATL ACAD SCI USA, V110, P10117, DOI 10.1073/pnas.1214100110
   Cai W, 2014, MACROMOL MATER ENG, V299, P504
   Daniele MA, 2014, BIOMATERIALS, V35, P1845, DOI 10.1016/j.biomaterials.2013.11.009
   DeKosky BJ, 2010, TISSUE ENG PART C-ME, V16, P1533, DOI 10.1089/ten.tec.2009.0761
   Erickson IE, 2012, ACTA BIOMATER, V8, P3027, DOI 10.1016/j.actbio.2012.04.033
   Erickson IE, 2009, TISSUE ENG PT A, V15, P1041, DOI 10.1089/ten.tea.2008.0099
   Gao GF, 2015, BIOTECHNOL LETT, V37, P2349, DOI 10.1007/s10529-015-1921-2
   Gigout A, 2008, J BIOL CHEM, V283, P31522, DOI 10.1074/jbc.M804234200
   Huang AH, 2008, OSTEOARTHR CARTILAGE, V16, P1074, DOI 10.1016/j.joca.2008.02.005
   Ingavle GC, 2014, BIOMATERIALS, V35, P3558, DOI 10.1016/j.biomaterials.2014.01.002
   Ingber DE, 2003, J CELL SCI, V116, P1397, DOI 10.1242/jcs.00360
   Li C, 2012, J BIOMAT SCI-POLYM E, V23, P405, DOI 10.1163/092050610X551970
   Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048824
   Liao IC, 2013, ADV FUNCT MATER, V23, P5833, DOI 10.1002/adfm.201300483
   Lien SM, 2009, ACTA BIOMATER, V5, P670, DOI 10.1016/j.actbio.2008.09.020
   Lim KS, 2013, BIOMATERIALS, V34, P7097, DOI 10.1016/j.biomaterials.2013.06.005
   Little CJ, 2011, TISSUE ENG PART B-RE, V17, P213, DOI [10.1089/ten.teb.2010.0572, 10.1089/ten.TEB.2010.0572]
   Margadant C, 2007, J CELL SCI, V120, P66, DOI 10.1242/jcs.03301
   Moon JJ, 2009, TISSUE ENG PT A, V15, P579, DOI 10.1089/ten.tea.2008.0196
   Moreira Teixeira L S, 2012, EUR CELLS MATER, V23, P387
   Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Nehrer S, 1997, BIOMATERIALS, V18, P769, DOI 10.1016/S0142-9612(97)00001-X
   Nicodemus GD, 2011, ACTA BIOMATER, V7, P492, DOI 10.1016/j.actbio.2010.08.021
   Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Qiu Y., 2003, AAPS PHARMSCITECH, V4, P406
   Rennerfeldt DA, 2013, BIOMATERIALS, V34, P8241, DOI 10.1016/j.biomaterials.2013.07.052
   Rnjak-Kovacina J, 2014, ADV FUNCT MATER, V24, P2188, DOI 10.1002/adfm.201302901
   Schuh E, 2010, TISSUE ENG PT A, V16, P1281, DOI [10.1089/ten.tea.2009.0614, 10.1089/ten.TEA.2009.0614]
   Simonsson C, 2011, TOXICOL APPL PHARM, V252, P221, DOI 10.1016/j.taap.2011.02.010
   Sridhar BV, 2015, REGEN ENG TRANSL MED, V1, P11, DOI 10.1007/s40883-015-0002-3
   Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859
   Webber RE, 2007, MACROMOLECULES, V40, P2919, DOI 10.1021/ma062924y
   Wolf F, 2008, EUR CELLS MATER, V16, P92, DOI 10.22203/eCM.v016a10
   Yasuda K, 2009, MACROMOL BIOSCI, V9, P307, DOI 10.1002/mabi.200800223
   Zhang JJ, 2015, BIOMED MATER, V10, DOI 10.1088/1748-6041/10/3/035016
   Zhang JJ, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/3/035011
   Zhang JJ, 2013, TISSUE ENG PT A, V19, P2166, DOI [10.1089/ten.tea.2012.0393, 10.1089/ten.TEA.2012.0393]
   Zhang Y, 2012, MACROMOL RAPID COMM, V33, P296, DOI 10.1002/marc.201100695
NR 41
TC 1
Z9 1
U1 6
U2 47
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD JUN
PY 2016
VL 11
IS 3
DI 10.1088/1748-6041/11/3/035014
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DP0GQ
UT WOS:000378167700015
PM 27305040
DA 2018-10-20
ER

PT J
AU Alt, V
   Cheung, WH
   Chow, SKH
   Thormann, U
   Cheung, ENM
   Lips, KS
   Schnettler, R
   Leung, KS
AF Alt, Volker
   Cheung, Wing Hoi
   Chow, Simon K. H.
   Thormann, Ulrich
   Cheung, Edmond N. M.
   Lips, Katrin S.
   Schnettler, Reinhard
   Leung, Kwok-Sui
TI Bone formation and degradation behavior of nanocrystalline
   hydroxyapatite with or without collagen-type 1 in osteoporotic bone
   defects - an experimental study in osteoporotic goats
SO INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED
LA English
DT Article
DE Hydroxyapatite; Collagen; Osteoporosis; Degradation; Biomaterial
ID METAPHYSEAL DEFECTS; MODEL; FRACTURES; REGENERATION; SUBSTITUTES;
   OSTIM(R)
AB The intention of the current work is to assess new bone formation and degradation behavior of nanocrystalline hydroxyapatite with (HA/col-1) or without collagen-type I (HA) in osteoporotic metaphyseal bone defects in goats. After ovariectomy and special low-calcium diet for three months, 3 drill hole defects in the vertebrae of L3, L4, L5, 4 drill hole defects in the right and left iliac crest and 1 drill hole defect at the distal femur were created in three Chinese mountain goats with a total of 24 defects. The defects were either filled with one of the biomaterials or left empty (empty defect control group). After 42 days, the animals were euthanized and the samples were assessed for new bone formation using high-resolution peripheral quantitative computed tomography (HR-pQCT) and histomorphometry with 2 regions of interest. Detail histology, enzymehistochemistry and immunohistochemistry as well as connexin-43 in situ hybridization and transmission electron microscopy were carried out for evaluation of degradation behavior of the materials and cellular responses of the surrounding tissue in respect to the implants. HR-pQCT showed the highest BV/TV ratio (p = 0.008) and smallest trabecular spacing (p = 0.005) for HA compared to the other groups in the region of interest at the interface with 1 mm distance to the initially created defect. The HA/col-1 yielded the highest connectivity density (Conn.D) (p = 0.034) and the highest number of trabeculae (Tb.N) (p = 0.002) compared to the HA and the control group. Histomorphometric analysis for the core region of the initially created defect revealed a statistically higher new bone formation in the HA (p = 0.001) and HA/col-1 group (p = 0.001) compared to the empty defect group including all defect sites. This result was confirmed for site specific analysis with significant higher new bone formation for the HA group for vertebral defects compared to the empty defect group (p = 0.029). For the interface region, no statistically significant differences were found between the three groups (p = 0.08). Histology revealed a good biocompatibility without inflammatory reaction for the HA-and HA/col-1 implants with a higher fragmentation of the HA-implant compared to the HA/col-1 biomaterial and formation of new bone in the region between the biomaterial fragments by osteoblasts. Fragmentation was shown by transmission electron microscopy to be caused by multinuclear osteoclast-like cells with degradation of the implant via intracellular incorporation of degraded implant material particles. In conclusion, both nanoparticulate HA with and without collagen type-1 showed better new bone formation compared to untreated drill hole defects in metaphyseal regions of this osteoporotic Chinese mountain goat model with good biocompatibility. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Alt, Volker; Schnettler, Reinhard] Univ Hosp Giessen Marburg GmbH, Dept Trauma Surg, Campus Giessen, D-35385 Giessen, Germany.
   [Alt, Volker; Thormann, Ulrich; Lips, Katrin S.; Schnettler, Reinhard] Univ Giessen, Lab Expt Trauma Surg Giessen, D-35394 Giessen, Germany.
   [Cheung, Wing Hoi; Chow, Simon K. H.; Cheung, Edmond N. M.; Leung, Kwok-Sui] Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China.
RP Leung, KS (reprint author), Univ Hosp Giessen Marburg GmbH, Dept Trauma Surg Giessen, Campus Giessen,Rudolf Buchheim Str 7, D-35385 Giessen, Germany.
EM volker.alt@chiru.med.uni-giessen.de
RI Cheung, Wing Hoi/J-2150-2018; Chow, Simon/J-1554-2018
OI Cheung, Wing Hoi/0000-0003-3247-8255; Chow, Simon/0000-0003-1742-980X
FU Germany/Hong Kong Joint Research Scheme of the German Academic Research
   Service (Deutscher Akademischer Austauschdienst (DAAD)) - Federal
   Ministry of Education and Reserach of Germany (Bundesministeriums fur
   Bildung und Forschung (BMBF)) [G_HK009/07]
FX The study was sponsored by a travel grant from Germany/Hong Kong Joint
   Research Scheme (Ref: G_HK009/07) of the German Academic Research
   Service (Deutscher Akademischer Austauschdienst (DAAD)) funded by means
   of the Federal Ministry of Education and Reserach of Germany
   (Bundesministeriums fur Bildung und Forschung (BMBF)). The authors thank
   aap Biomaterials, Dieburg, Germany, for the provision of the OSTIM (R)
   and OSTIM (R) + collagen type-I implants.
CR Alt V, 2013, ACTA BIOMATER, V9, P7035, DOI 10.1016/j.actbio.2013.02.002
   Brandt J, 2010, J MATER SCI-MATER M, V21, P283, DOI 10.1007/s10856-009-3859-1
   Busenlechner D, 2008, BIOMATERIALS, V29, P3195, DOI 10.1016/j.biomaterials.2008.04.021
   Canuto RA, 2013, CLIN ORAL IMPLAN RES, V24, P42, DOI 10.1111/j.1600-0501.2011.02363.x
   Chris A.J., 2006, BIOMATERIALS, V27, P1110
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002
   Huber FX, 2008, ZBL CHIR, V133, P577, DOI 10.1055/s-2008-1076873
   Huber FX, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-164
   Leung KS, 2006, J BIOMED MATER RES B, V78B, P153, DOI 10.1002/jbm.b.30467
   Leung KS, 2001, J BONE MINER RES, V16, P2348, DOI 10.1359/jbmr.2001.16.12.2348
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Siu WS, 2004, BONE, V35, P21, DOI 10.1016/j.bone.2004.03.014
   Spies CKG, 2009, ARCH ORTHOP TRAUM SU, V129, P979, DOI 10.1007/s00402-008-0705-8
   Tam KF, 2009, ULTRASOUND MED BIOL, V35, P1109, DOI 10.1016/j.ultrasmedbio.2009.01.001
   Taubenberger V, 2010, BIOMATERIALS, V31, P2827
   Thorwarth M, 2005, J ORAL MAXIL SURG, V63, P1626, DOI 10.1016/j.joms.2005.06.010
   Van Lieshout EMM, 2016, INJURY, V47, pS43, DOI 10.1016/S0020-1383(16)30011-0
   Zaffe D, 2011, J APPL BIOMATER BIOM, V9, P19, DOI 10.5301/JABB.2011.6450
NR 21
TC 6
Z9 6
U1 1
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0020-1383
EI 1879-0267
J9 INJURY
JI Injury-Int. J. Care Inj.
PD JUN
PY 2016
VL 47
SU 2
BP S58
EP S65
DI 10.1016/S0020-1383(16)47010-5
PG 8
WC Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery
SC General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery
GA DP2UK
UT WOS:000378348500010
PM 27338229
DA 2018-10-20
ER

PT J
AU Ozcan, B
   Bayrak, E
   Erisken, C
AF Ozcan, Burak
   Bayrak, Ece
   Erisken, Cevat
TI Characterization of Human Dental Pulp Tissue Under Oscillatory Shear and
   Compression
SO JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME
LA English
DT Article
DE tooth; pulp; regeneration; viscoelastic; compression; biomaterial
ID VISCOELASTIC PROPERTIES; ARTICULAR-CARTILAGE; CROSS-LINKING; STEM-CELLS;
   COLLAGEN; REGENERATION; REPAIR
AB Availability of material as well as biological properties of native tissues is critical for biomaterial design and synthesis for regenerative engineering. Until recently, selection of biomaterials and biomolecule carriers for dental pulp regeneration has been done randomly or based on experience mainly due to the absence of benchmark data for dental pulp tissue. This study, for the first time, characterizes the linear viscoelastic material functions and compressive properties of human dental pulp tissue harvested from wisdom teeth, under oscillatory shear and compression. The results revealed a gel-like behavior of the pulp tissue over the frequency range of 0.1-100 rps. Uniaxial compression tests generated peak normal stress and compressive modulus values of 39.1 +/- 20.4 kPa and 5.5 +/- 2.8 kPa, respectively. Taken collectively, the linear viscoelastic and uniaxial compressive properties of the human dental pulp tissue reported here should enable the better tailoring of biomaterials or biomolecule carriers to be employed in dental pulp regeneration.
C1 [Ozcan, Burak; Bayrak, Ece; Erisken, Cevat] TOBB Univ Econ & Technol, Dept Biomed Engn, Sogutozu Ave 43, TR-06560 Ankara, Turkey.
RP Erisken, C (reprint author), TOBB Univ Econ & Technol, Dept Biomed Engn, Sogutozu Ave 43, TR-06560 Ankara, Turkey.
EM cerisken@etu.edu.tr
RI Erisken, Cevat/P-7850-2014
OI Erisken, Cevat/0000-0002-6337-8022
CR AKIZUKI S, 1986, J ORTHOPAED RES, V4, P379, DOI 10.1002/jor.1100040401
   Aktas S, 2014, J RHEOL, V58, P513, DOI 10.1122/1.4866295
   Cameron AR, 2014, BIOMATERIALS, V35, P1857, DOI 10.1016/j.biomaterials.2013.11.023
   CHAMBON F, 1987, J RHEOL, V31, P683, DOI 10.1122/1.549955
   Couppe C, 2009, J APPL PHYSIOL, V107, P880, DOI 10.1152/japplphysiol.00291.2009
   de Aro AA, 2012, MICRON, V43, P205, DOI 10.1016/j.micron.2011.07.015
   Degirmenbasi N, 2006, COLLOID SURFACE B, V48, P42, DOI 10.1016/j.colsurfb.2006.01.002
   Erisken C, 2015, J ENDODONT, V41, P1711, DOI 10.1016/j.joen.2015.07.005
   Erisken C, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4001884
   Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002
   Goldberg M, 2004, CRIT REV ORAL BIOL M, V15, P13, DOI 10.1177/154411130401500103
   Hargreaves K. M., 2008, J ENDODONT, V34, P51, DOI DOI 10.1016/J.JOEN.2008.02.032
   Haus JM, 2007, J APPL PHYSIOL, V103, P2068, DOI 10.1152/japplphysiol.00670.2007
   HAYES WC, 1978, J BIOMECH, V11, P407, DOI 10.1016/0021-9290(78)90075-1
   Mintz BR, 2014, J BIOMED MATER RES A, V102, P2918, DOI 10.1002/jbm.a.34957
   Murray PE, 2007, J ENDODONT, V33, P377, DOI 10.1016/j.joen.2006.09.013
   Shen ZLL, 2011, BIOPHYS J, V100, P3008, DOI 10.1016/j.bpj.2011.04.052
   Sloan AJ, 2007, ORAL DIS, V13, P151, DOI 10.1111/j.1601-0825.2006.01346.x
   SPIRT AA, 1989, J ORTHOP RES, V7, P43, DOI 10.1002/jor.1100070107
   Yuan ZL, 2011, TISSUE ENG PART B-RE, V17, P373, DOI [10.1089/ten.TEB.2011.0041, 10.1089/ten.teb.2011.0041]
   ZHU WB, 1993, J ORTHOPAED RES, V11, P771, DOI 10.1002/jor.1100110602
NR 21
TC 2
Z9 2
U1 1
U2 5
PU ASME
PI NEW YORK
PA TWO PARK AVE, NEW YORK, NY 10016-5990 USA
SN 0148-0731
EI 1528-8951
J9 J BIOMECH ENG-T ASME
JI J. Biomech. Eng.-Trans. ASME
PD JUN
PY 2016
VL 138
IS 6
AR 061006
DI 10.1115/1.4033437
PG 5
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA DP1OO
UT WOS:000378259500006
PM 27093446
DA 2018-10-20
ER

PT J
AU Ahmed, N
   Schober, J
   Hill, L
   Zustiak, SP
AF Ahmed, Naveed
   Schober, Joseph
   Hill, Lindsay
   Zustiak, Silviya P.
TI Custom Multiwell Plate Design for Rapid Assembly of Photopatterned
   Hydrogels
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID 3-DIMENSIONAL MATRIX STIFFNESS; SUBSTRATE STIFFNESS; TOXINS; TISSUE;
   CELLS; RESPONSIVENESS; ELASTICITY; PLATFORMS; MODULUS; DRUGS
AB The extracellular matrix provides both mechanical support and biochemical cues that influence cellular behavior. Matrix stiffness, in particular, has been found to regulate cellular morphology, motility, proliferation, differentiation, and drug responses among other behaviors. Thus, biomaterial platforms that exhibit wide range of stiffness and are available in a semi high-throughput format such as a multiwell plate would be useful for elucidating cell-substrate relationships. Polyacrylamide (PA) gels have been widely used as cell platforms since they span a range of stiffness between 0.3 and 300 kPa in Young's modulus, which encompasses all soft tissues. However, PA gels are time consuming and labor intensive to prepare, and are not amenable to a multiwell plate format. In this study, we present a novel custom multiwell plate design that allows for a one-step stiffness assay assembly that reduces preparation time and labor intensity by several fold. Gel stiffness is controlled by ultraviolet light intensity and exposure time to achieve a wide stiffness range from a single gel precursor solution. The geometry of the gels is defined by a custom photomask and gel thickness is controlled by spacers. A multiwell plate upper structure is designed similar to a regular multiwell plate such that a gel fits in each well and cells and media are added on top. The upper structure design allows for adequate gas exchange and minimum evaporation. Comparison between cell behaviors seeded in the custom and a standard multiwell plate demonstrated the suitability of the design as a cell culture platform. In summary, we describe and validate a novel custom design for an easy and rapid assembly of photopolymerizable PA-based stiffness assay.
C1 [Ahmed, Naveed; Hill, Lindsay; Zustiak, Silviya P.] St Louis Univ, Dept Biomed Engn, 3507 Lindell Blvd, St Louis, MO 63103 USA.
   [Schober, Joseph] So Illinois Univ, Dept Pharm, Edwardsville, IL 62026 USA.
RP Zustiak, SP (reprint author), St Louis Univ, Dept Biomed Engn, 3507 Lindell Blvd, St Louis, MO 63103 USA.
EM szustiak@slu.edu
FU Saint Louis University
FX This work was funded by start-up funds provided to Dr. Zustiak by Saint
   Louis University as well as by a President's Research Fund (PRF) grant
   and Stroble Award in Health Sciences awarded to Dr. Zustiak by Saint
   Louis University.
CR Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Feng JT, 2013, CLIN HEMORHEOL MICRO, V55, P121, DOI 10.3233/CH-131696
   Gumuscu B, 2015, BIOMACROMOLECULES, V16, P3802, DOI 10.1021/acs.biomac.5b01104
   Herrick WG, 2013, BIOMACROMOLECULES, V14, P2294, DOI 10.1021/bm400418g
   Kloxin AM, 2010, BIOMATERIALS, V31, P1, DOI 10.1016/j.biomaterials.2009.09.025
   Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j
   LI Y, 1993, J APPL POLYM SCI, V50, P1107, DOI 10.1002/app.1993.070500619
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Mih JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019929
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Ramamoorthi K, 2014, CELL MOL BIOENG, V7, P278, DOI 10.1007/s12195-014-0326-y
   Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1
   Semler EJ, 2005, BIOTECHNOL BIOENG, V89, P296, DOI 10.1002/bit.20328
   Stolz M, 2004, BIOPHYS J, V86, P3269, DOI 10.1016/S0006-3495(04)74375-1
   Stoppie N, 2009, J BIOMED MATER RES A, V90A, P792, DOI 10.1002/jbm.a.32145
   Sunyer R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046107
   Syed S, 2015, JOVE-J VIS EXP, V97
   Tilghman RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012905
   Tokuda EY, 2014, BIOMATERIALS, V35, P4310, DOI 10.1016/j.biomaterials.2014.01.063
   Tse J. R., 2010, CURR PROTOC CELL BIO, V47, P10, DOI DOI 10.1002/0471143030.CB1016S47
   WEBER K, 1969, J BIOL CHEM, V244, P4406
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
   Young DA, 2013, BIOMATERIALS, V34, P8581, DOI 10.1016/j.biomaterials.2013.07.103
   Zustiak S., 2012, AICHE S P ANN FALL M
   Zustiak S., 2013, BIOTECHNOL BIOENG, V111, P396
   Zustiak S, 2014, BIOTECHNOL BIOENG, V111, P396, DOI 10.1002/bit.25097
   Zustiak SP, 2010, BIOMACROMOLECULES, V11, P1348, DOI 10.1021/bm100137q
   Zustiak SP, 2016, BIOTECHNOL BIOENG, V113, P443, DOI 10.1002/bit.25709
   Zustiak SP, 2015, MACROMOL BIOSCI, V15, P589, DOI 10.1002/mabi.201400507
NR 30
TC 1
Z9 1
U1 0
U2 7
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
EI 1937-3392
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD JUN
PY 2016
VL 22
IS 6
BP 543
EP 551
DI 10.1089/ten.tec.2015.0522
PG 9
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA DO8LJ
UT WOS:000378034600004
PM 27059131
DA 2018-10-20
ER

PT J
AU Denham, SLW
   Alexander, LF
   Robbin, ML
AF Denham, Stephanie LeeAnn Wilson
   Alexander, Lauren F.
   Robbin, Michelle L.
TI Contrast-Enhanced Ultrasound: Practical Review for the Assessment of
   Hepatic and Renal Lesions
SO ULTRASOUND QUARTERLY
LA English
DT Review
DE microbubble; contrast agents; contrast-enhanced ultrasound; ultrasound
ID FOCAL NODULAR HYPERPLASIA; MICROBUBBLE CONTRAST; DIAGNOSTIC PERFORMANCE;
   HOSPITALIZED-PATIENTS; INITIAL-EXPERIENCE; ACUTE MORTALITY;
   LIVER-LESIONS; UNITED-STATES; BLOOD-FLOW; AGENTS
AB The use of microbubble contrast greatly enhances the ability of ultrasound to delineate structures and therefore aid in diagnosis. Ultrasound microbubble contrast agents are composed of low-solubility gas encapsulated in a biomaterial shell. These agents use the physics of ultrasound imaging to effectively identify and characterize focal hepatic and renal lesions. Not only can contrast agents be used to evaluate multiple phases of lesion contrast enhancement, but ultrasound also allows for real-time study of enhancement patterns. The short half-life and intravascular location of the microbubbles allows for multiple, sequential administrations of contrast to observe enhancement of lesions in different sites. Furthermore, the ability to perform imaging without ionizing radiation and the lack of nephrotoxicity make contrast-enhanced ultrasound an ideal evaluation method for patients who need serial surveillance or in whom imaging options are severely limited because of renal insufficiency. These techniques are widely used in many countries for diagnostic radiological purposes; however, the lack of both Food and Drug Administration approval and reimbursement for noncardiac hospital-based imaging has delayed widespread use in the United States. Despite these limitations, continued research and innovations in ultrasound contrast make it essential to have a working knowledge of the typical enhancement patterns of frequently seen hepatic and renal lesions as these techniques offer an alternative option for contrast imaging.
C1 [Denham, Stephanie LeeAnn Wilson; Robbin, Michelle L.] Univ Alabama Birmingham, Dept Radiol, JTN 331,619 19th St S, Birmingham, AL 35249 USA.
   [Alexander, Lauren F.] Emory Univ Hosp, Dept Radiol & Imaging Sci, 1364 Clifton Rd NE, Atlanta, GA 30322 USA.
RP Denham, SLW (reprint author), Univ Alabama Birmingham, Dept Radiol, JTN 331,619 19th St S, Birmingham, AL 35249 USA.
EM ldenham@uabmc.edu
CR Ascenti G, 2007, RADIOLOGY, V243, P158, DOI 10.1148/radiol.2431051924
   Barr RG, 2014, RADIOLOGY, V271, P133, DOI 10.1148/radiol.13130161
   Barr RG, 2013, J ULTRAS MED, V32, P7
   Bhayana D, 2010, AM J ROENTGENOL, V194, P977, DOI 10.2214/AJR.09.3375
   BOSNIAK MA, 1986, RADIOLOGY, V158, P1
   Bosniak MA, 1997, AM J ROENTGENOL, V169, P819, DOI 10.2214/ajr.169.3.9275903
   Bosniak MA, 2012, RADIOLOGY, V262, P781, DOI 10.1148/radiol.11111595
   Brannigan M, 2004, RADIOGRAPHICS, V24, P921, DOI 10.1148/rg.244035158
   Burns Peter N, 2006, Ultrasound Q, V22, P5
   Burns PN, 2007, RADIOLOGY, V242, P162, DOI 10.1148/radiol.2421051006
   Burns PN, 2000, INVEST RADIOL, V35, P58, DOI 10.1097/00004424-200001000-00007
   Burns PN, 2005, DIAGNOSTIC ULTRASOUN, P55
   CARROLL BA, 1980, INVEST RADIOL, V15, P260, DOI 10.1097/00004424-198005000-00013
   CARROLL BA, 1982, RADIOLOGY, V143, P747, DOI 10.1148/radiology.143.3.7079504
   Claudon M, 2013, ULTRASCHALL MED, V34, P11, DOI 10.1055/s-0032-1325499
   Correas Jean-Michel, 2006, Ultrasound Q, V22, P53
   Correas JM, 2001, EUR RADIOL, V11, P1316, DOI 10.1007/s003300100940
   Cosgrove D, 2006, EUR J RADIOL, V60, P324, DOI 10.1016/j.ejrad.2006.06.022
   Exuzides A, 2010, JACC-CARDIOVASC IMAG, V3, P578, DOI 10.1016/j.jcmg.2010.04.006
   FEINSTEIN SB, 1984, J AM COLL CARDIOL, V3, P14, DOI 10.1016/S0735-1097(84)80424-6
   FEINSTEIN SB, 1984, J AM COLL CARDIOL, V4, P595, DOI 10.1016/S0735-1097(84)80107-2
   Gerst S, 2011, AM J ROENTGENOL, V197, P897, DOI 10.2214/AJR.10.6330
   Goldberg YH, 2012, CARDIOLOGY, V122, P119, DOI 10.1159/000338731
   Gramiak R, 1968, Invest Radiol, V3, P356
   GRAMIAK R, 1969, RADIOLOGY, V92, P939, DOI 10.1148/92.5.939
   Jakobsen JA, 2005, EUR RADIOL, V15, P941, DOI 10.1007/s00330-004-2601-0
   Jang HJ, 2007, RADIOLOGY, V244, P898, DOI 10.1148/radiol.2443061520
   Kaewlai R, 2012, AM J ROENTGENOL, V199, pW17, DOI 10.2214/AJR.11.8144
   Kim TK, 2008, AM J ROENTGENOL, V190, P58, DOI 10.2214/AJR.07.2493
   Main ML, 2007, J AM COLL CARDIOL, V50, P2434, DOI 10.1016/j.jacc.2007.11.006
   Main ML, 2012, CARDIOLOGY, V122, P248, DOI 10.1159/000341246
   Main ML, 2008, AM J CARDIOL, V102, P1742, DOI 10.1016/j.amjcard.2008.08.019
   McCullough PA, 2008, CRIT CARE MED, V36, pS204, DOI 10.1097/CCM.0b013e318168cdc3
   Morel DR, 2000, INVEST RADIOL, V35, P80, DOI 10.1097/00004424-200001000-00009
   Murphy-Lavallee J, 2007, J ULTRAS MED, V26, P1545, DOI 10.7863/jum.2007.26.11.1545
   Neugut AI, 2001, ARCH INTERN MED, V161, P15, DOI 10.1001/archinte.161.1.15
   Paspulati RM, 2006, RADIOL CLIN N AM, V44, P787, DOI 10.1016/j.rcl.2006.10.002
   Piscaglia F, 2006, ULTRASOUND MED BIOL, V32, P1369, DOI 10.1016/j.ultrasmedbio.2006.05.031
   Quaia E, 2007, RADIOL MED, V112, P473, DOI 10.1007/s11547-007-0157-1
   Quaia E, 2004, RADIOLOGY, V232, P420, DOI 10.1148/radiol.2322031401
   Quaia E, 2008, AM J ROENTGENOL, V191, P1239, DOI 10.2214/AJR.07.3546
   Quaia E, 2007, EUR RADIOL, V17, P1995, DOI 10.1007/s00330-007-0623-0
   Robbin ML, 2003, RADIOL CLIN N AM, V41, P963, DOI 10.1016/S0033-8389(03)00070-8
   Sutherland T, 2011, J CLIN ULTRASOUND, V39, P399, DOI 10.1002/jcu.20847
   ter Haar GR, 2002, EUR J RADIOL, V41, P217, DOI 10.1016/S0720-048X(01)00456-9
   Torzilli Guido, 2005, Expert Opin Drug Saf, V4, P399, DOI 10.1517/14740338.4.3.399
   WANLESS IR, 1985, HEPATOLOGY, V5, P1194, DOI 10.1002/hep.1840050622
   Wilson SR, 2000, RADIOLOGY, V215, P153, DOI 10.1148/radiology.215.1.r00ap08153
   Wilson SR, 2001, SEMIN LIVER DIS, V21, P147, DOI 10.1055/s-2001-15342
   Wilson SR, 2010, RADIOLOGY, V257, P24, DOI 10.1148/radiol.10091210
   Wilson SR, 2009, AM J ROENTGENOL, V193, P55, DOI 10.2214/AJR.09.2553
   Xu ZF, 2010, J ULTRAS MED, V29, P709, DOI 10.7863/jum.2010.29.5.709
NR 52
TC 3
Z9 3
U1 1
U2 9
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0894-8771
EI 1536-0253
J9 ULTRASOUND Q
JI Ultrasound Q.
PD JUN
PY 2016
VL 32
IS 2
BP 116
EP 125
DI 10.1097/RUQ.0000000000000182
PG 10
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA DP3RR
UT WOS:000378413100004
PM 27233070
DA 2018-10-20
ER

PT J
AU Zhang, SW
   Guo, YC
   Dong, YL
   Wu, YS
   Cheng, L
   Wang, YY
   Xing, M
   Yuan, Q
AF Zhang, Shiwen
   Guo, Yuchen
   Dong, Yuliang
   Wu, Yunshu
   Cheng, Lei
   Wang, Yongyue
   Xing, Malcolm
   Yuan, Quan
TI A Novel Nanosilver/Nanosilica Hydrogel for Bone Regeneration in Infected
   Bone Defects
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE nanosilica; nanosilver hydrogel; bone defects; infection
ID SILVER NANOPARTICLES; NANOCRYSTALLINE SILVER; COMPOSITE SCAFFOLDS;
   CALVARIAL DEFECTS; MINERAL DENSITY; ANTIBACTERIAL; DELIVERY;
   NANOCOMPOSITES; BIOMATERIALS; MATRIX
AB Treating bone defects in the presence of infection is a formidable clinical challenge. The use of a biomaterial with the dual function of bone regeneration and infection control is a novel therapeutic approach to this problem. In this Study, we fabricated an innovative, dual-function biocomposite hydrogel containing nano silver and nanosilica (nAg/nSiO(2)) particles and evaluated, its characteristics using FT-IR, SEM, swelling ratio, and stiffness assays. The in vitro antibacterial analysis showed that this nAg/nSiO(2) hydrogel inhibited both Gram-positive and Gram-negative bacteria. In addition, this nontoxic material could promote osteogenic differentiation of rat bone marrow stromal cells (BMSCs). We then created infected bone defects in rat calvaria in order to evaluate the function of the hydrogel in vivo. The hydrogel demonstrated effective antibacterial ability while promoting bone regeneration in these defects. Our results indicate that this nAg/nSiO(2) hydrogel has the potential to both control infection and to promote bone healing in contaminated defects.
C1 [Zhang, Shiwen; Guo, Yuchen; Dong, Yuliang; Wu, Yunshu; Cheng, Lei; Wang, Yongyue; Yuan, Quan] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610041, Peoples R China.
   [Zhang, Shiwen; Xing, Malcolm] Univ Manitoba, Fac Engn, Dept Mech Engn, Winnipeg, MB R3E 3P4, Canada.
   [Zhang, Shiwen; Xing, Malcolm] Univ Manitoba, Dept Biochem & Genet, Fac Med, Winnipeg, MB R3E 3P4, Canada.
   [Zhang, Shiwen; Xing, Malcolm] Univ Manitoba, Manitoba Inst Child Hlth, Winnipeg, MB R3E 3P4, Canada.
RP Yuan, Q (reprint author), Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610041, Peoples R China.; Xing, M (reprint author), Univ Manitoba, Fac Engn, Dept Mech Engn, Winnipeg, MB R3E 3P4, Canada.; Xing, M (reprint author), Univ Manitoba, Dept Biochem & Genet, Fac Med, Winnipeg, MB R3E 3P4, Canada.; Xing, M (reprint author), Univ Manitoba, Manitoba Inst Child Hlth, Winnipeg, MB R3E 3P4, Canada.
EM malcolm.xing@umanitoba.ca; yuanquan@scu.edu.cn
FU Program for New Century Excellent Talents in University [NCET-12-0379];
   National Natural Science Foundation of China [NSFC 81571001, 81371173];
   Sichuan Province Youth Fund [2013JQ0017]; State Key Laboratory of Oral
   Diseases
FX This study is supported by Program for New Century Excellent Talents in
   University (NCET-12-0379), National Natural Science Foundation of China
   (NSFC 81571001, 81371173), Sichuan Province Youth Fund (2013JQ0017), and
   open funding from State Key Laboratory of Oral Diseases. S.Z and Q.Y.
   thank Essential Scientific Editing for assistance in preparing the final
   manuscript
CR Anisha BS, 2013, INT J BIOL MACROMOL, V62, P310, DOI 10.1016/j.ijbiomac.2013.09.011
   Arcos D, 2010, ACTA BIOMATER, V6, P2874, DOI 10.1016/j.actbio.2010.02.012
   Beck GR, 2012, NANOMED-NANOTECHNOL, V8, P793, DOI 10.1016/j.nano.2011.11.003
   Besinis A, 2014, NANOTOXICOLOGY, V8, P1, DOI 10.3109/17435390.2012.742935
   Castillo PM, 2008, NANOMEDICINE-UK, V3, P627, DOI 10.2217/17435889.3.5.627
   Chaloupka K, 2010, TRENDS BIOTECHNOL, V28, P580, DOI 10.1016/j.tibtech.2010.07.006
   Chen XQ, 2005, J ORTHOP RES, V23, P816, DOI 10.1016/j.orthres.2005.01.009
   Chun C, 2009, BIOMATERIALS, V30, P6295, DOI 10.1016/j.biomaterials.2009.08.011
   Cousins BG, 2007, J APPL MICROBIOL, V102, P757, DOI 10.1111/j.1365-2672.2006.03124.x
   Depan D, 2011, ACTA BIOMATER, V7, P2163, DOI 10.1016/j.actbio.2011.01.029
   Diefenbeck M, 2006, INJURY, V37, P95, DOI 10.1016/j.injury.2006.04.015
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Dorigato A, 2012, J POLYM ENVIRON, V20, P713, DOI 10.1007/s10924-012-0425-6
   Durao SFO, 2012, INT J ORAL MAX IMPL, V27, P1400
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Ferruti P, 2005, BIOMACROMOLECULES, V6, P2229, DOI 10.1021/bm050210+
   Gaharwar AK, 2013, MAT SCI ENG C-MATER, V33, P1800, DOI 10.1016/j.msec.2012.12.099
   Gomes PS, 2011, LAB ANIM-UK, V45, P14, DOI 10.1258/la.2010.010085
   Gong T, 2015, BONE RES, V3, DOI 10.1038/boneres.2015.29
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Hesaraki S, 2012, J BIOMED MATER RES B, V100B, P1627, DOI 10.1002/jbm.b.32731
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Jugdaohsingh R, 2007, J NUTR HEALTH AGING, V11, P99
   Jugdaohsingh R, 2004, J BONE MINER RES, V19, P297, DOI 10.1359/JBMR.0301225
   Kanellakopoulou K, 2000, DRUGS, V59, P1223, DOI 10.2165/00003495-200059060-00003
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Keeling JJ, 2008, J BONE JOINT SURG AM, V90A, P2643, DOI 10.2106/JBJS.G.01326
   Kluin OS, 2013, EXPERT OPIN DRUG DEL, V10, P341, DOI 10.1517/17425247.2013.751371
   Li JD, 2012, J BIOMAT SCI-POLYM E, V23, P81, DOI 10.1163/092050610X543159
   Madhumathi K, 2009, INT J BIOL MACROMOL, V45, P289, DOI 10.1016/j.ijbiomac.2009.06.009
   Marom R, 2005, J CELL PHYSIOL, V202, P41, DOI 10.1002/jcp.20109
   Mieszawska AJ, 2010, BIOMATERIALS, V31, P8902, DOI 10.1016/j.biomaterials.2010.07.109
   Miyaji F, 1998, J MATER SCI-MATER M, V9, P61, DOI 10.1023/A:1008886729050
   Mohan YM, 2007, POLYMER, V48, P158, DOI 10.1016/j.polymer.2006.10.045
   Mohan YM, 2010, J COLLOID INTERF SCI, V342, P73, DOI 10.1016/j.jcis.2009.10.008
   Montanaro L, 2011, INT J ARTIF ORGANS, V34, P781, DOI 10.5301/ijao.5000052
   Mourino V, 2010, J R SOC INTERFACE, V7, P209, DOI 10.1098/rsif.2009.0379
   Murphy CM, 2010, CELL ADHES MIGR, V4, P377, DOI 10.4161/cam.4.3.11747
   Murphy M, 2015, J NANOMATER, DOI 10.1155/2015/696918
   Nadworny PL, 2008, NANOMED-NANOTECHNOL, V4, P241, DOI 10.1016/j.nano.2008.04.006
   Nair MB, 2011, CURR OPIN BIOTECH, V22, P721, DOI 10.1016/j.copbio.2011.02.005
   Nandi SK, 2009, MAT SCI ENG C-MATER, V29, P2478, DOI 10.1016/j.msec.2009.07.014
   Raasch W, 2001, BRIT J PHARMACOL, V133, P755, DOI 10.1038/sj.bjp.0704153
   Sakamoto Y, 2014, NEUROL MED-CHIR, V54, P647, DOI 10.2176/nmc.oa.2013-0295
   Schexnailder P, 2009, COLLOID POLYM SCI, V287, P1, DOI 10.1007/s00396-008-1949-0
   Schneider Oliver D, 2011, Open Orthop J, V5, P63, DOI 10.2174/1874325001105010063
   Shi JB, 2012, J MATER CHEM, V22, P23952, DOI 10.1039/c2jm34862d
   Simchi A, 2011, NANOMED-NANOTECHNOL, V7, P22, DOI 10.1016/j.nano.2010.10.005
   Sivolella S., 2012, J NANOMATER, V12, P4873
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Srinivasan S, 2013, J BIOMED NANOTECHNOL, V9, P1803, DOI 10.1166/jbn.2013.1658
   Thomas V, 2007, J COLLOID INTERF SCI, V315, P389, DOI 10.1016/j.jcis.2007.06.068
   Tian Y, 2013, J MATER CHEM B, V1, P5264, DOI 10.1039/c3tb20544d
   Wang C, 2004, ADV MATER, V16, P1074, DOI 10.1002/adma.200306516
   Wenke JC, 2011, EXPERT OPIN DRUG DEL, V8, P1555, DOI 10.1517/17425247.2011.628655
   Wright JB, 2002, WOUND REPAIR REGEN, V10, P141, DOI 10.1046/j.1524-475X.2002.10308.x
   Wu CJ, 2010, MATERIALS, V3, P2986, DOI 10.3390/ma3052986
   Yang SB, 2012, SOFT MATTER, V8, P8981, DOI 10.1039/c2sm25123j
   Zhang JC, 2010, CLIN ORAL IMPLAN RES, V21, P321, DOI 10.1111/j.1600-0501.2009.01838.x
   Zhang SW, 2014, J BIOMATER TISS ENG, V4, P875, DOI 10.1166/jbt.2014.1269
   Zheng Z, 2010, BIOMATERIALS, V31, P9293, DOI 10.1016/j.biomaterials.2010.08.041
   Zhong C, 2010, ACTA BIOMATER, V6, P3908, DOI 10.1016/j.actbio.2010.04.011
   Zou H, 2008, CHEM REV, V108, P3893, DOI 10.1021/cr068035q
NR 64
TC 17
Z9 18
U1 4
U2 69
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD JUN 1
PY 2016
VL 8
IS 21
BP 13242
EP 13250
DI 10.1021/acsami.6b01432
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA DN5ZM
UT WOS:000377150400008
PM 27167643
DA 2018-10-20
ER

PT J
AU Wang, HY
   Hua, XW
   Jia, HR
   Li, CC
   Lin, FM
   Chen, Z
   Wu, FG
AF Wang, Hong-Yin
   Hua, Xian-Wu
   Jia, Hao-Ran
   Li, Chengcheng
   Lin, Fengming
   Chen, Zhan
   Wu, Fu-Gen
TI Universal Cell Surface Imaging for Mammalian, Fungal, and Bacterial
   Cells
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Article
DE cell surface-biomaterial interaction; bioimaging; glycol chitosan; cell
   surface engineering; electrostatic interaction
ID GRAM-STAINING TECHNIQUE; PLASMA-MEMBRANE; SACCHAROMYCES-CEREVISIAE;
   ANTIBACTERIAL AGENTS; ESCHERICHIA-COLI; DRUG-DELIVERY; YEAST; PEPTIDES;
   PROTEINS; POLYMERS
AB Because of the distinct surface structures of different cells (mammalian cells, fungi, and bacteria), surface labeling for these cells requires a variety of fluorescent dyes. Besides, fluorescent dyes (especially the commercial ones) for staining Gram-negative bacterial cell walls are still lacking. Herein, a conformation-adjustable glycol chitosan (GC) derivative (GC-PEG cholesterolFITC) with "all-in-one" property was developed to realize universal imaging for plasma membranes of mammalian cells (via hydrophobic interaction) and cell walls of fungal and bacterial cells (via electrostatic interaction). By comparing the different staining behaviors of GC-PEG cholesterol-FITC and three other analogs (GC-PEGFITC, GC-FITC, and cholesterol-PEG-FITC), we have elucidated the different roles the hydrophobic and electrostatic interactions play in the staining performance of these different cells. Such a simple, noncytotoxic, economic, and universal cell surface staining reagent will be very useful for investigating cell surface-related biological events and advancing cell surface engineering of various types of cells.
C1 [Wang, Hong-Yin; Hua, Xian-Wu; Jia, Hao-Ran; Li, Chengcheng; Lin, Fengming; Wu, Fu-Gen] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China.
   [Chen, Zhan] Univ Michigan, Dept Chem, 930 North Univ Ave, Ann Arbor, MI 48109 USA.
RP Wu, FG (reprint author), Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China.; Chen, Z (reprint author), Univ Michigan, Dept Chem, 930 North Univ Ave, Ann Arbor, MI 48109 USA.
EM zhanc@umich.edu; wufg@seu.edu.cn
RI Wu, Fu-Gen/B-1444-2009; Wang, Hong-Yin/C-1423-2014
OI Wu, Fu-Gen/0000-0003-1773-2868; Chen, Zhan/0000-0001-8687-8348
FU National High Technology Research & Development Program of China
   [2015AA020502]; National Natural Science Foundation of China [21303017];
   Natural Science Foundation of Jiangsu Province [KB20130601]; Fundamental
   Research Funds for the Central Universities [2242015R30016]; Six Talents
   Peak Project in Jiangsu Province [2015-SWYY-003]; Scientific Research
   Foundation of Graduate School of Southeast University [YBPY1508];
   Graduate Students' Scientific Research Innovation Project of Jiangsu
   Province Ordinary University [CXZZ13_0122]; University of Michigan
FX This work was supported by grants from the National High Technology
   Research & Development Program of China (2015AA020502), National Natural
   Science Foundation of China (21303017), Natural Science Foundation of
   Jiangsu Province (KB20130601), Fundamental Research Funds for the
   Central Universities (2242015R30016), Six Talents Peak Project in
   Jiangsu Province (2015-SWYY-003), Scientific Research Foundation of
   Graduate School of Southeast University (YBPY1508), and Graduate
   Students' Scientific Research Innovation Project of Jiangsu Province
   Ordinary University (CXZZ13_0122). Z.C. thanks the University of
   Michigan for supporting his sabbatical.
CR Aghamohammadzadeh S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103311
   AI-Saadi A., 2009, J PHYS CHEM C, V113, P15260
   Bai HT, 2015, ANGEW CHEM INT EDIT, V54, P13208, DOI 10.1002/anie.201504566
   Banerjee I, 2011, ADV MATER, V23, P690, DOI 10.1002/adma.201001215
   Bazan SB, 2014, VACCINE, V32, P2591, DOI 10.1016/j.vaccine.2014.03.043
   Boileau AJ, 2010, J NEUROSCI, V30, P4895, DOI 10.1523/JNEUROSCI.5039-09.2010
   Bondar OV, 2012, ACTA NATURAE, V4, P78
   Bugg TDH, 2011, TRENDS BIOTECHNOL, V29, P167, DOI 10.1016/j.tibtech.2010.12.006
   Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119
   Chen WW, 2014, ANGEW CHEM INT EDIT, V53, P13734, DOI 10.1002/anie.201407606
   Chen XY, 2015, CHEM COMMUN, V51, P487, DOI 10.1039/c4cc08681c
   Dalla Pellegrina C., 2005, TOXICOL APPL PHARM, V207, P170, DOI 10.1016/j.taap.2005.01.001
   Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI [10.1038/nnano.2010.246, 10.1038/NNANO.2010.246]
   Emde B, 2014, EUR J HISTOCHEM, V58, P315, DOI 10.4081/ejh.2014.2448
   Ernst AM, 2013, FEBS LETT, V587, P1411, DOI 10.1016/j.febslet.2013.03.019
   Fishov I, 1999, MOL MICROBIOL, V32, P1166, DOI 10.1046/j.1365-2958.1999.01425.x
   Gao WW, 2015, J DRUG TARGET, V23, P619, DOI 10.3109/1061186X.2015.1052074
   Gauvin TJ, 2015, MOL BIOL CELL, V26, P467, DOI 10.1091/mbc.E14-07-1247
   Goldenberg NM, 2010, CANCER RES, V70, P1277, DOI 10.1158/0008-5472.CAN-09-2905
   GREENBERG ML, 1993, J MEMBRANE BIOL, V131, P115, DOI 10.1007/BF02791320
   Guttenplan SB, 2013, MOL MICROBIOL, V87, P211, DOI 10.1111/mmi.12103
   Harbers GM, 2007, CHEM MATER, V19, P4405, DOI 10.1021/cm070509u
   He H, 2015, BIOMACROMOLECULES, V16, P1390, DOI 10.1021/acs.biomac.5b00180
   Holm C, 2003, APPL ENVIRON MICROB, V69, P2857, DOI 10.1128/AEM.69.5.2857-2863.2003
   Jia HR, 2016, BIOCONJUGATE CHEM, V27, P782, DOI 10.1021/acs.bioconjchem.6b00003
   Jung SW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116519
   KARSON EM, 1978, J BIOL CHEM, V253, P6484
   Kuo CW, 2014, J NANOBIOTECHNOL, V12, DOI 10.1186/s12951-014-0054-4
   Lopez-Garcia B, 2015, APPL MICROBIOL BIOT, V99, P8011, DOI 10.1007/s00253-015-6541-1
   MAEDA H, 1967, J BIOCHEM-TOKYO, V62, P276, DOI 10.1093/oxfordjournals.jbchem.a128660
   Makovitzki A, 2006, P NATL ACAD SCI USA, V103, P15997, DOI 10.1073/pnas.0606129103
   Master RN, 2013, ANN NY ACAD SCI, V1277, P1, DOI 10.1111/nyas.12022
   Maurya IK, 2011, PEPTIDES, V32, P1732, DOI 10.1016/j.peptides.2011.06.003
   Figueroa-Lopez AM, 2014, J BASIC MICROB, V54, pS125, DOI 10.1002/jobm.201200594
   Monteiro JM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9055
   Munoz A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054813
   Pereira P, 2013, MACROMOL BIOSCI, V13, P1369, DOI 10.1002/mabi.201300123
   Powers JPS, 2003, PEPTIDES, V24, P1681, DOI 10.1016/j.peptides.2003.08.023
   Rojas E, 2014, P NATL ACAD SCI USA, V111, P7807, DOI 10.1073/pnas.1402591111
   Salje J, 2011, MOL CELL, V43, P478, DOI 10.1016/j.molcel.2011.07.008
   SIZEMORE RK, 1990, APPL ENVIRON MICROB, V56, P2245
   Sun HL, 2015, BIOMACROMOLECULES, V16, P597, DOI 10.1021/bm501652d
   Tada R, 2013, CURR PHARM DESIGN, V19, P3738, DOI 10.2174/1381612811319200012
   Takeo M, 2015, J BIOMAT SCI-POLYM E, V26, P353, DOI 10.1080/09205063.2015.1007414
   Teramura Y, 2010, SOFT MATTER, V6, P1081, DOI 10.1039/b913621e
   Tobinaga K, 2014, J CONTROL RELEASE, V177, P27, DOI 10.1016/j.jconrel.2013.12.024
   Ursell TS, 2014, P NATL ACAD SCI USA, V111, pE1025, DOI 10.1073/pnas.1317174111
   VANLOOSDRECHT MCM, 1987, APPL ENVIRON MICROB, V53, P1893
   VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779
   Wang HY, 2016, J MATER CHEM B, V4, P834, DOI 10.1039/c5tb02183a
   Wang HY, 2015, J MATER CHEM B, V3, P6165, DOI 10.1039/c5tb00930h
   Wang HY, 2015, ACS APPL MATER INTER, V7, P7082, DOI 10.1021/acsami.5b01214
   Wang W, 2012, NAT CHEM, V4, P846, DOI [10.1038/nchem.1434, 10.1038/NCHEM.1434]
   Wenzel M, 2014, P NATL ACAD SCI USA, V111, pE1409, DOI 10.1073/pnas.1319900111
   Yao X, 2013, ADV MATER, V25, P5257, DOI 10.1002/adma.201301762
   Yhee JY, 2014, J CONTROL RELEASE, V193, P202, DOI 10.1016/j.jconrel.2014.05.009
   Yoritsune K, 2013, FEBS LETT, V587, P917, DOI 10.1016/j.febslet.2013.02.016
   Yuan HX, 2014, ADV MATER, V26, P4333, DOI 10.1002/adma.201400636
   Zhao YY, 2010, J AM CHEM SOC, V132, P12349, DOI 10.1021/ja1028843
   Zhou XX, 2015, SCIENCE, V348, P574, DOI 10.1126/science.aaa1511
   Zhu CL, 2011, ADV MATER, V23, P4805, DOI 10.1002/adma.201102850
NR 61
TC 12
Z9 12
U1 6
U2 36
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD JUN
PY 2016
VL 2
IS 6
BP 987
EP 997
DI 10.1021/acsbiomaterials.6b00130
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA DO6WX
UT WOS:000377925300012
DA 2018-10-20
ER

PT J
AU Francis, NL
   Bennett, NK
   Halikere, A
   Pang, ZPP
   Moghe, PV
AF Francis, Nicola L.
   Bennett, Neal K.
   Halikere, Apoorva
   Pang, Zhiping P.
   Moghe, Prabhas V.
TI Self-Assembling Peptide Nanofiber Scaffolds for 3-D Reprogramming and
   Transplantation of Human Pluripotent Stem Cell-Derived Neurons
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Article
DE nanofiber; self-assembling peptide; neuronal reprogramming; brain
   transplantation; human induced pluripotent stem cell; neural tissue
   engineering
ID BRAIN EXTRACELLULAR-MATRIX; NEURAL PRECURSOR CELLS; COMPLEMENTARY
   OLIGOPEPTIDE; FUNCTIONAL-NEURONS; NEURITE OUTGROWTH; RAT-BRAIN;
   IN-VITRO; SURVIVAL; DEATH; LAMININ
AB While cell transplantation presents a potential strategy to treat the functional deficits of neurodegenerative diseases or central nervous system injuries, the poor survival rate of grafted cells in vivo is a major barrier to effective therapeutic treatment. In this study, we investigated the role of a peptide-based nanofibrous scaffold composed of the self assembling peptide RADA16-I to support the reprogramming and maturation of human neurons in vitro and to transplant these neurons in vivo. The induced human neurons were generated via the single transcriptional factor transduction of induced pluripotent stem cells (iPSCs), which are a promising cell source for regenerative therapies. These neurons encapsulated within RADA16-I scaffolds displayed robust neurite outgrowth and demonstrated high levels of functional activity in vitro compared to that of 2-D controls, as determined by live cell calcium imaging. When evaluated in vivo as a transplantation vehicle for adherent, functional networks of neurons, monodisperse RADA16-I microspheres significantly increased survival (over 100-fold greater) compared to the conventional transplantation of unsupported neurons in suspension. The scaffold-encapsulated neurons integrated well in vivo within the injection site, extending neurites several hundred microns long into the host brain tissue. Overall, these results suggest that this biomaterial platform can be used to successfully improve the outcome of cell transplantation and neuro-regenerative therapies.
C1 [Francis, Nicola L.; Bennett, Neal K.; Moghe, Prabhas V.] Rutgers State Univ, Dept Biomed Engn, 599 Taylor Rd, Piscataway, NJ 08854 USA.
   [Halikere, Apoorva; Pang, Zhiping P.] Rutgers Robert Wood Johnson Med Sch, Child Hlth Inst New Jersey, Dept Neurosci & Cell Biol, 89 French St, New Brunswick, NJ 08901 USA.
   [Moghe, Prabhas V.] Rutgers State Univ, Dept Chem & Biochem Engn, 98 Brett Rd, Piscataway, NJ 08854 USA.
RP Moghe, PV (reprint author), Rutgers State Univ, Dept Biomed Engn, 599 Taylor Rd, Piscataway, NJ 08854 USA.; Pang, ZPP (reprint author), Rutgers Robert Wood Johnson Med Sch, Child Hlth Inst New Jersey, Dept Neurosci & Cell Biol, 89 French St, New Brunswick, NJ 08901 USA.; Moghe, PV (reprint author), Rutgers State Univ, Dept Chem & Biochem Engn, 98 Brett Rd, Piscataway, NJ 08854 USA.
EM pangzh@rwjms.rutgers.edu; moghe@rutgers.edu
FU NIH [P41 EB001046, R21 NS095082, T32EB005583]; NSF-IGERT [0801620]
FX Research reported here was supported by NIH P41 EB001046, NIH R21
   NS095082, NIH T32EB005583, and NSF-IGERT grant 0801620. We gratefully
   acknowledge the RUCDR for the gift of the iPSC line used in this study
   and 3-D Matrix for the gift of the RADA16-I self-assembling peptide
   (PuraMatrix).
CR Bakshi A, 2005, BRAIN RES, V1065, P8, DOI 10.1016/j.brainres.2005.09.059
   Baraniak PR, 2010, REGEN MED, V5, P121, DOI 10.2217/RME.09.74
   Bonneh-Barkay D, 2009, BRAIN PATHOL, V19, P573, DOI 10.1111/j.1750-3639.2008.00195.x
   Carlson AL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10862
   Cheng TY, 2013, BIOMATERIALS, V34, P2005, DOI 10.1016/j.biomaterials.2012.11.043
   Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x
   Cooke MJ, 2010, SOFT MATTER, V6, P4988, DOI 10.1039/c0sm00448k
   Cordeiro KK, 2014, EUR J NEUROSCI, V39, P1474, DOI 10.1111/ejn.12541
   Cormier AR, 2013, ACS NANO, V7, P7562, DOI 10.1021/nn401562f
   Deister C, 2007, J BIOMAT SCI-POLYM E, V18, P983, DOI 10.1163/156856207781494377
   Einstein O, 2006, GLIA, V53, P449, DOI 10.1002/glia.20305
   Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103
   FORDHOLEVINSKI T, 1986, DEV BRAIN RES, V28, P121, DOI 10.1016/0165-3806(86)90071-4
   Genove E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012
   Gorman AM, 2008, J CELL MOL MED, V12, P2263, DOI 10.1111/j.1582-4934.2008.00402.x
   Green MA, 2008, NMR BIOMED, V21, P755, DOI 10.1002/nbm.1254
   Guo J, 2007, NANOMED-NANOTECHNOL, V3, P311, DOI 10.1016/j.nano.2007.09.003
   Guo JS, 2009, NANOMED-NANOTECHNOL, V5, P345, DOI 10.1016/j.nano.2008.12.001
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Hwang Onyou, 2013, Exp Neurobiol, V22, P11, DOI 10.5607/en.2013.22.1.11
   Inoue H, 2011, CLIN PHARMACOL THER, V89, P655, DOI 10.1038/clpt.2011.38
   Liu WW, 2013, INTEGR BIOL-UK, V5, P1244, DOI 10.1039/c3ib40131f
   Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016
   Marchionini DM, 2003, J COMP NEUROL, V464, P172, DOI 10.1002/cne.10785
   Nakaji-Hirabayashi T, 2013, BIOCONJUGATE CHEM, V24, P1798, DOI 10.1021/bc400005m
   Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202
   Phillips JB, 2005, TISSUE ENG, V11, P1611, DOI 10.1089/ten.2005.11.1611
   RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0
   Ruoslahti E, 1996, GLYCOBIOLOGY, V6, P489, DOI 10.1093/glycob/6.5.489
   Smetters D, 1999, METHODS, V18, P215, DOI 10.1006/meth.1999.0774
   Srinivasan P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099640
   Swindle-Reilly KE, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/046007
   Takeuchi S, 2005, ADV MATER, V17, P1067, DOI 10.1002/adma.200401738
   Thonhoff JR, 2008, BRAIN RES, V1187, P42, DOI 10.1016/j.brainres.2007.10.046
   Tsuda Y, 2010, LANGMUIR, V26, P2645, DOI [10.1021/la902827y, 10.1021/la002827y]
   Uemura M, 2010, J NEUROSCI RES, V88, P542, DOI 10.1002/jnr.22223
   Vasita R, 2006, INT J NANOMED, V1, P15, DOI 10.2147/nano.2006.1.1.15
   Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797
   Yang YL, 2009, NANO TODAY, V4, P193, DOI 10.1016/j.nantod.2009.02.009
   Yla-Outinen L, 2014, J TISSUE ENG REGEN M, V8, P186, DOI 10.1002/term.1512
   Yokoi H, 2005, P NATL ACAD SCI USA, V102, P8414, DOI 10.1073/pnas.0407843102
   Yu LMY, 2008, MATER TODAY, V11, P36, DOI 10.1016/S1369-7021(08)70088-9
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
   Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029
   Zhang ZX, 2010, BIOTECHNOL BIOPROC E, V15, P545, DOI 10.1007/s12257-009-3076-2
NR 46
TC 12
Z9 12
U1 3
U2 27
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD JUN
PY 2016
VL 2
IS 6
BP 1030
EP 1038
DI 10.1021/acsbiomaterials.6b00156
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA DO6WX
UT WOS:000377925300017
DA 2018-10-20
ER

PT J
AU Kojima, K
   Vacanti, CA
AF Kojima, K.
   Vacanti, C. A.
TI Tissue Engineering in the Trachea (vol 297, pg 44, 2014)
SO ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY
   BIOLOGY
LA English
DT Correction
DE tissue engineering; stem cell; trachea
AB This review summarizes efforts to generate an autologous tissue-engineered trachea (TET) using various biomaterial or cell sources to make tracheal cartilage to form the structural components of a functional tracheal replacement. Biomechanical assessments of the TET showed that the cartilage stiffness was excellent in the nude models; however, the sheep autologous TET did not provide sufficient support and collapsed easily. As a result, tissue engineering technology is still far from allowing the functional recovery of patients who suffer from severe tracheal disease. On the other hand, there are several clinical reports seeding cells to decellularized tissue using tissue engineering techniques. However, the working mechanisms of the tissue-engineered trachea remain unclear. Nevertheless, we believe that the field of tissue engineering has great potential for surmounting these obstacles and allowing us to generate functional tracheal replacements in the near future. (C) 2013 Wiley Periodicals, Inc.
CR Kojima K, 2014, ANAT REC, V297, P44, DOI 10.1002/ar.22799
NR 1
TC 0
Z9 0
U1 0
U2 8
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-8486
EI 1932-8494
J9 ANAT REC
JI Anat. Rec.
PD JUN
PY 2016
VL 299
IS 6
BP 703
EP 703
DI 10.1002/ar.23343
PG 1
WC Anatomy & Morphology
SC Anatomy & Morphology
GA DO2RJ
UT WOS:000377627300001
OA Bronze
DA 2018-10-20
ER

PT J
AU Santo, VE
   Babo, P
   Amador, M
   Correia, C
   Cunha, B
   Coutinho, DF
   Neves, NM
   Mano, JF
   Reis, RL
   Gomes, ME
AF Santo, Vitor E.
   Babo, Pedro
   Amador, Miguel
   Correia, Claudia
   Cunha, Barbara
   Coutinho, Daniela F.
   Neves, Nuno M.
   Mano, Joao F.
   Reis, Rui L.
   Gomes, Manuela E.
TI Engineering Enriched Microenvironments with Gradients of Platelet Lysate
   in Hydrogel Fibers
SO BIOMACROMOLECULES
LA English
DT Article
ID CONTROLLED-RELEASE STRATEGIES; GELLAN GUM HYDROGELS; ADIPOSE STEM-CELLS;
   RICH PLASMA; OSTEOGENIC DIFFERENTIATION; GROWTH-FACTOR; IN-VITRO;
   CARTILAGE TISSUE; BONE; REGENERATION
AB Gradients of physical and chemical cues are characteristic of specific,tissue inicroerrvironments and contribute toward morphogenesis and tissue regeneration upon injury. Recentadvances on microfluiclics and hydrogel inanipulation raised the possibility of generating biomimetic biothaterials enriched with bioactive factors and encapsulating cells following designs specifically tailored for a target application. The novelty of this work relies on the combination of methacrylated gellan gum (MeGG) with platelet lysate (PL), aiming to generate novel advanced 3D PL-enriched photo-cross-linkable hydrogels and overcoming the lack of adhesion sites provided by the native MeGG hydrogels. This combination takes advantage of the availability, enriched growth factor composition, and potential autologous application of PL while simultaneouslypreserving the ability provided by MeGG to tailor mechanical properties, protein release kinetics, and shape of the construct according to the desired goal. Incorporation of PL in the hydrogels significantly improved cellular adhesion and viability in the constructs. The use of mitrolluidic tools allowed the design of a fiber-like hydrogel incorporating a gradient of PL along the length of the fiber. These spatial protein gradients led to the viability and cell number gradients caused by maintenance of human umbilical vein endothelial cells (HUVECs) survival in the fibers toward the PL-enriched sections in comparison with the nonloaded MeGG sections of the fibers. Altogether, we propose a proof of concept strategy to design a PL gradient biomaterial with potential in tissue engineering approaches and analysis of cell-microenvironment interactions.
C1 [Santo, Vitor E.; Babo, Pedro; Amador, Miguel; Coutinho, Daniela F.; Neves, Nuno M.; Mano, Joao F.; Reis, Rui L.; Gomes, Manuela E.] Univ Minho, Headquarters European Inst Excellence Tissue Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, AvePark, P-4806909 Taipas, Guimaraes, Portugal.
   [Santo, Vitor E.; Babo, Pedro; Amador, Miguel; Coutinho, Daniela F.; Neves, Nuno M.; Mano, Joao F.; Reis, Rui L.; Gomes, Manuela E.] ICVS 3Bs PT Govt Associate Lab, P-4710243 Braga, Portugal.
   [Santo, Vitor E.; Correia, Claudia; Cunha, Barbara] Inst Biol Expt & Tecnol, iBET, Apartado 12, P-2780901 Oeiras, Portugal.
RP Santo, VE; Gomes, ME (reprint author), Univ Minho, Headquarters European Inst Excellence Tissue Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, AvePark, P-4806909 Taipas, Guimaraes, Portugal.; Santo, VE; Gomes, ME (reprint author), ICVS 3Bs PT Govt Associate Lab, P-4710243 Braga, Portugal.
EM v.espirito.santo@ibet.pt; megomes@dep.uminho.pt
RI Neves, Nuno/B-4685-2008; Mano, Joao/A-4418-2009; Espirito Santo,
   Vitor/K-7668-2015; Reis, Rui L./A-8938-2008; Group, 3Bs/E-4374-2012;
   Gomes, Manuela/B-6282-2009
OI Neves, Nuno/0000-0003-3041-0687; Mano, Joao/0000-0002-2342-3765;
   Espirito Santo, Vitor/0000-0002-0854-0197; Reis, Rui
   L./0000-0002-4295-6129; Group, 3Bs/0000-0002-5195-3456; Gomes,
   Manuela/0000-0002-2036-6291; Babo, Pedro/0000-0003-4347-599X
FU Fundacao para a Ciencia e a Tecnologia (FCT) under project BIBS
   [PTDC/CVT/102972/2008]; FCT [SFRH/BPD/91072/2012, SFRH/BD/73403/2010]
FX The research leading to these results has received funding from Fundacao
   para a Ciencia e a Tecnologia (FCT) under project BIBS
   (PTDC/CVT/102972/2008). Vitor E. Santo acknowledges his FCT Post-Doc
   Fellowship SFRH/BPD/91072/2012 and Pedro S. Babo acknowledges his FCT
   Ph.D. Grant SFRH/BD/73403/2010.
CR Allazetta S, 2011, CHEM COMMUN, V47, P191, DOI 10.1039/c0cc02377a
   Anitua E, 2004, THROMB HAEMOSTASIS, V91, P4, DOI 10.1160/TH03-07-0440
   Babo P, 2014, INFLAMMATION REGENER, V34
   Biswal D, 2008, BIOMED MICRODEVICES, V10, P213, DOI 10.1007/s10544-007-9127-6
   Blair P, 2009, BLOOD REV, V23, P177, DOI 10.1016/j.blre.2009.04.001
   Brennan MA, 2013, STEM CELL RES THER, V4, DOI [10.1186/scrt307, 10.1186/1757-6512-4-96]
   Lima AC, 2015, STEM CELL REV REP, V11, P161, DOI 10.1007/s12015-014-9548-6
   Chen FM, 2011, J CONTROL RELEASE, V149, P92, DOI 10.1016/j.jconrel.2010.10.021
   Chow LW, 2014, ADV HEALTHC MATER, V3, P1381, DOI 10.1002/adhm.201400032
   Chung BG, 2005, LAB CHIP, V5, P401, DOI 10.1039/b417651k
   Chung BG, 2012, LAB CHIP, V12, P45, DOI 10.1039/c1lc20859d
   Correia C, 2012, TISSUE ENG PT A, V18, P1979, DOI [10.1089/ten.tea.2012.0083, 10.1089/ten.TEA.2012.0083]
   Cosson S, 2009, ADV FUNCT MATER, V19, P3411, DOI 10.1002/adfm.200900968
   Coutinho DF, 2010, BIOMATERIALS, V31, P7494, DOI 10.1016/j.biomaterials.2010.06.035
   Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X
   Dinis TM, 2014, ACS APPL MATER INTER, V6, P16817, DOI 10.1021/am504159j
   Fekete N, 2012, CYTOTHERAPY, V14, P540, DOI 10.3109/14653249.2012.655420
   Gattazzo F, 2014, BBA-GEN SUBJECTS, V1840, P2506, DOI 10.1016/j.bbagen.2014.01.010
   Greiner AM, 2014, BIOMATERIALS, V35, P611, DOI 10.1016/j.biomaterials.2013.09.095
   Guo XL, 2012, BIOMACROMOLECULES, V13, P3262, DOI 10.1021/bm301029a
   Hamcerencu M, 2008, CARBOHYD POLYM, V71, P92, DOI 10.1016/j.carbpol.2007.05.021
   Han YL, 2014, DRUG DISCOV TODAY, V19, P763, DOI 10.1016/j.drudis.2014.01.015
   Huang NF, 2011, ANN BIOMED ENG, V39, P1201, DOI 10.1007/s10439-011-0297-2
   Huh D, 2011, TRENDS CELL BIOL, V21, P745, DOI 10.1016/j.tcb.2011.09.005
   Intini G, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-13
   Jeong GS, 2011, BIOMED MICRODEVICES, V13, P717, DOI 10.1007/s10544-011-9541-7
   Kamei K, 2015, BIOMED MICRODEVICES, V17, DOI 10.1007/s10544-015-9928-y
   Kharkar PM, 2013, CHEM SOC REV, V42, P7335, DOI 10.1039/c3cs60040h
   Kitagawa Y, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/3/035011
   Lacci Kathleen M., 2010, Yale Journal of Biology and Medicine, V83, P1
   Lee KH, 2014, J BIOMED MATER RES A, V102, P1164, DOI 10.1002/jbm.a.34772
   Li Q, 2003, MACROMOLECULES, V36, P2556, DOI 10.1021/ma021190w
   Mak M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020825
   Martineau I, 2004, BIOMATERIALS, V25, P4489, DOI 10.1016/j.biomaterials.2003.11.013
   Matsui M, 2012, ACTA BIOMATER, V8, P1792, DOI 10.1016/j.actbio.2012.01.016
   Mehta S, 2008, J ORTHOP TRAUMA, V22, P433, DOI 10.1097/BOT.0b013e31817e793f
   Messora MR, 2008, J PERIODONTAL RES, V43, P723, DOI 10.1111/j.1600-0765.2008.01084.x
   Metallo CM, 2007, BIOTECHNOL PROGR, V23, P18, DOI 10.1021/bp060350a
   Oliveira JT, 2010, TISSUE ENG PT A, V16, P343, DOI [10.1089/ten.tea.2009.0117, 10.1089/ten.TEA.2009.0117]
   Oliveira JT, 2010, J ORTHOP RES, V28, P1193, DOI 10.1002/jor.21114
   Oliveira SM, 2016, ACTA BIOMATER, V32, P129, DOI 10.1016/j.actbio.2015.12.028
   Oliveira SM, 2015, BIOMATERIALS, V48, P56, DOI 10.1016/j.biomaterials.2015.01.020
   Park JY, 2009, STEM CELLS, V27, P2646, DOI 10.1002/stem.202
   Popa E, 2012, BIOTECHNOL APPL BIOC, V59, P132, DOI 10.1002/bab.1007
   Rada T, 2012, J TISSUE ENG REGEN M, V6, P1, DOI 10.1002/term.388
   Rada T, 2009, J TISSUE ENG REGEN M, V3, P158, DOI 10.1002/term.141
   Rada T, 2011, J TISSUE ENG REGEN M, V5, P655, DOI 10.1002/term.364
   Rada T, 2011, STEM CELL REV REP, V7, P64, DOI 10.1007/s12015-010-9147-0
   Sant S, 2010, CAN J CHEM ENG, V88, P899, DOI 10.1002/cjce.20411
   Santo VE, 2015, ACTA BIOMATER, V19, P56, DOI 10.1016/j.actbio.2015.03.015
   Santo VE, 2013, TISSUE ENG PART B-RE, V19, P327, DOI [10.1089/ten.teb.2012.0727, 10.1089/ten.TEB.2012.0727]
   Santo VE, 2013, TISSUE ENG PART B-RE, V19, P308, DOI [10.1089/ten.teb.2012.0138, 10.1089/ten.TEB.2012.0138]
   Santo VE, 2012, J CONTROL RELEASE, V162, P19, DOI 10.1016/j.jconrel.2012.06.001
   Santo VE, 2012, J TISSUE ENG REGEN M, V6, ps47, DOI 10.1002/term.1519
   Silva-Correia J, 2011, J TISSUE ENG REGEN M, V5, pE97, DOI 10.1002/term.363
   Silva-Correia J, 2013, ADV HEALTHC MATER, V2, P568, DOI 10.1002/adhm.201200256
   van Noort D, 2009, BIOTECHNOL PROGR, V25, P52, DOI [10.1021/bp.171, 10.1002/btpr.171]
   Verhulsel M, 2014, BIOMATERIALS, V35, P1816, DOI 10.1016/j.biomaterials.2013.11.021
   Vickerman V, 2008, LAB CHIP, V8, P1468, DOI 10.1039/b802395f
   Wade RJ, 2015, ADV MATER, V27, P1356, DOI 10.1002/adma.201404993
   Wang L, 2016, CLIM DYNAM, DOI [10.1007/s00382-016-3215-3, DOI 10.1007/S00382-016-3215-3]
NR 61
TC 7
Z9 7
U1 3
U2 37
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JUN
PY 2016
VL 17
IS 6
BP 1985
EP 1997
DI 10.1021/acs.biomac.6b00150
PG 13
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA DO6WS
UT WOS:000377924800009
PM 27203709
DA 2018-10-20
ER

PT J
AU Atyabi, SM
   Sharifi, F
   Irani, S
   Zandi, M
   Mivehchi, H
   Nagheh, Z
AF Atyabi, Seyed Mohammad
   Sharifi, Fereshteh
   Irani, Shiva
   Zandi, Mojgan
   Mivehchi, Houri
   Nagheh, Zahra
TI Cell Attachment and Viability Study of PCL Nano-fiber Modified by Cold
   Atmospheric Plasma
SO CELL BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Tissue engineering; Nano-fiber; Surface modification; Cold plasma
   atmospheric
ID SURFACE MODIFICATION; SCAFFOLDS; PROLIFERATION; NANOTECHNOLOGY; ACID;
   JET
AB The field of tissue engineering is an emerging discipline which applies the basic principles of life sciences and engineering to repair and restore living tissues and organs. The purpose of this study was to investigate the effect of cold and non-thermal plasma surface modification of poly (e-caprolactone) (PCL) scaffolds on fibroblast cell behavior. Nano-fiber PCL was fabricated through electro-spinning technique, and some fibers were then treated by cold and non-thermal plasma. The cell-biomaterial interactions were studied by culturing the fibroblast cells on nano-fiber PCL. Scaffold biocompatibility test was assessed using an inverted microscope. The growth and proliferation of fibroblast cells on nano-fiber PCL were analyzed by MTT viability assay. Cellular attachment on the nanofiber and their morphology were evaluated using scanning electron microscope. The result of cell culture showed that nano-fiber could support the cellular growth and proliferation by developing three-dimensional topography. The present study demonstrated that the nano-fiber surface modification with cold plasma sharply enhanced the fibroblast cell attachment. Thus, cold plasma surface modification greatly raised the bioactivity of scaffolds.
C1 [Atyabi, Seyed Mohammad] Pasteur Inst Iran, Dept Pilot Biotechnol, Tehran, Iran.
   [Sharifi, Fereshteh; Irani, Shiva; Nagheh, Zahra] Islamic Azad Univ, Sci & Res Branch, Dept Biol, Tehran, Iran.
   [Zandi, Mojgan; Mivehchi, Houri] Iran Polymer & Petrochem Inst, Dept Biomat, Tehran, Iran.
RP Irani, S (reprint author), Islamic Azad Univ, Sci & Res Branch, Dept Biol, Tehran, Iran.
EM shi_irani@yahoo.com
OI Irani, Shiva/0000-0002-4202-9931
CR Adams J. C., 2002, METHODS CELL BIOL ME
   Barnes CP, 2007, ADV DRUG DELIVER REV, V59, P1413, DOI 10.1016/j.addr.2007.04.022
   Cheng C, 2006, SURF COAT TECH, V200, P6659, DOI 10.1016/j.surfcoat.2005.09.033
   Chung T., 2009, MAT SCI, V20, P379
   Clark RAF, 2007, J INVEST DERMATOL, V127, P1018, DOI 10.1038/sj.jid.5700715
   Cunha C, 2011, NANOMED-NANOTECHNOL, V7, P50, DOI 10.1016/j.nano.2010.07.004
   Domingos M, 2013, ACTA BIOMATER, V9, P5997, DOI 10.1016/j.actbio.2012.12.031
   Gloria A, 2009, J APPL BIOMATER BIOM, V7, P141
   Hauser J, 2009, J MATER SCI-MATER M, V20, P2541, DOI 10.1007/s10856-009-3826-x
   Jha BS, 2011, ACTA BIOMATER, V7, P203, DOI 10.1016/j.actbio.2010.08.004
   Keck M., 2013, SKIN TISSUE ENG, V13, P13
   Kim H. N., 2012, ADV DRUG DELIVERY RE, V65, P389
   Kim MC, 2003, SURF COAT TECH, V171, P312, DOI 10.1016/S0257-8972(03)00292-5
   Kumar G, 2012, BIOMATERIALS, V33, P4022, DOI 10.1016/j.biomaterials.2012.02.048
   Kumbar SG, 2008, BIOMATERIALS, V29, P4100, DOI 10.1016/j.biomaterials.2008.06.028
   Lee HU, 2008, APPL SURF SCI, V254, P5700, DOI 10.1016/j.apsusc.2008.03.049
   Mahmod G., PLASMA PHYS
   Masao Y., 2009, ENG TECHNOLOGY, V58, P171
   Prabhakaran MP, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/45/455102
   Pramanik S, 2012, SCI TECHNOL ADV MAT, V13, DOI 10.1088/1468-6996/13/4/043002
   Renata A. N. P., 2010, CARBOHYD POLYM, V82, P692
   Santis RD, 2011, J APPL POLYM SCI, V122, P3599
   Sasmazel HT, 2009, NATO SCIENCE PEACE S, P533, DOI 10.1007/978-1-4020-9916-8_55
   Shashurin A, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3020223
   Shi JJ, 2010, NANO LETT, V10, P3223, DOI 10.1021/nl102184c
   Supp D., 2005, CLIN DERMATOL, V4, P203
   Vance RJ, 2004, BIOMATERIALS, V25, P2095, DOI 10.1016/j.biomaterials.2003.08.064
   Yildirim ED, 2008, PLASMA PROCESS POLYM, V5, P58, DOI 10.1002/ppap.200700041
   Yildirim ED, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/1/014109
   Zhu XL, 2008, BIOMACROMOLECULES, V9, P1795, DOI 10.1021/bm800476u
NR 30
TC 6
Z9 6
U1 0
U2 9
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 1085-9195
EI 1559-0283
J9 CELL BIOCHEM BIOPHYS
JI Cell Biochem. Biophys.
PD JUN
PY 2016
VL 74
IS 2
BP 181
EP 190
DI 10.1007/s12013-015-0718-1
PG 10
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA DO5NX
UT WOS:000377830900009
PM 27286857
DA 2018-10-20
ER

PT J
AU Alex, MJ
   Periasamy, P
   Mohan, K
   Sekar, S
   Prabha, KKS
   Venkatachalam, R
AF Alex, Martina Jenitha
   Periasamy, Prabu
   Mohan, Kalirajan
   Sekar, Sankar
   Prabha, Kavitha Kandiah Suriya
   Venkatachalam, Rajendran
TI In situ synthesised TiO2-chitosan-chondroitin 4-sulphate nanocomposites
   for bone implant applications
SO IET NANOBIOTECHNOLOGY
LA English
DT Article
DE titanium compounds; filled polymers; nanocomposites; bone; orthopaedics;
   biomedical materials; sol-gel processing; nanofabrication; particle
   size; swelling; microorganisms; cellular biophysics; nanomedicine;
   prosthetics; in situ synthesised TiO2-chitosan-chondroitin 4-sulphate
   nanocomposites; bone implant applications; artificial materials; in situ
   sol-gel method; particle size; swelling nature; antimicrobial nature;
   microorganisms; Staphylococcus aureus; Escherichia coli; cell viability;
   MG-63; biomaterial; size 30 nm to 50 nm; TiO2
ID TISSUE ENGINEERING APPLICATIONS; COMPOSITE SCAFFOLDS; GROWTH-FACTOR;
   CHITOSAN; NANOPARTICLES; FABRICATION; MEMBRANES; TITANIA; TIO2
AB The artificial materials for bone implant applications are gaining more importance in the recent years. The series titania-chitosan-chondroitin 4-sulphate nanocomposites of three different concentrations (2:1:x, where x- 0.125, 0.25, 0.5) have been synthesised by in situ sol-gel method and characterised by various techniques. The particle size of the nanocomposites ranges from 30-50 nm. The bioactivity, swelling nature, and the antimicrobial nature of the nanocomposites were investigated. The swelling ability and bioactivity of the composites is significantly greater and they possess high zone of inhibition against the microorganisms such as Staphylococcus aureus and Escherichia coli. The cell viability of the nanocomposites were evaluated by using MG-63 and observed the composites possess high cell viability at low concentration. The excellent bioactivity and biocompatibility makes these nanocomposites a promising biomaterial for bone implant applications.
C1 [Alex, Martina Jenitha; Periasamy, Prabu; Mohan, Kalirajan; Sekar, Sankar; Prabha, Kavitha Kandiah Suriya; Venkatachalam, Rajendran] KS Rangasamy Coll Technol, Ctr Nano Sci & Technol, Tiruchengode 637215, Tamil Nadu, India.
RP Periasamy, P (reprint author), KS Rangasamy Coll Technol, Ctr Nano Sci & Technol, Tiruchengode 637215, Tamil Nadu, India.
EM prabukrp@gmail.com
OI VENKATACHALAM, RAJENDRAN/0000-0001-9471-5311
CR Amin KAM, 2012, POLYMERS-BASEL, V4, P590, DOI 10.3390/polym4010590
   Bjornson A, 2005, AM J PHYSIOL-RENAL, V288, pF748, DOI 10.1152/ajprenal.00202.2004
   Hua D, 2007, T NONFERR METAL SOC, V17, pS700
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Di Vona ML, 2007, J MEMBRANE SCI, V296, P156, DOI 10.1016/j.memsci.2007.03.037
   Facca S, 2011, J BIOMED NANOTECHNOL, V7, P482, DOI 10.1166/jbn.2011.1311
   Fisher J. P., 2003, TOPICS TISSUE ENG, P1
   Ganza Gonzalez A., 1999, EUROPEAN J PHARM BIO, V48, P149, DOI [10.1016/S0939-6411(99)00040-5, DOI 10.1016/S0939-6411(99)00040-5]
   He JK, 2009, ACTA BIOMATER, V5, P453, DOI 10.1016/j.actbio.2008.07.002
   Ho MH, 2005, BIOMATERIALS, V26, P3197, DOI 10.1016/j.biomaterials.2004.08.032
   Iouv M, 2008, OSTEOARTHR CARTILAGE, V16, P14, DOI [10.1016/j.joca.2008.06.008, DOI 10.1016/J.JOCA.2008.06.008]
   Jayachandran V., 2012, INT J BIOL MACROMOL, V51, P1033, DOI [10.1016/j.ijbiomac.2012.08.020, DOI 10.1016/J.IJBIOMAC.2012.08.020]
   Jayakumar R, 2011, INT J BIOL MACROMOL, V49, P274, DOI 10.1016/j.ijbiomac.2011.04.020
   Jiang LY, 2008, CARBOHYD POLYM, V74, P680, DOI 10.1016/j.carbpol.2008.04.035
   Jing H., 2012, CARBOHYD POLYM, V90, P122, DOI [10.1016/j.carbpol.2012.04.068, DOI 10.1016/J.CARBPOL.2012.04.068]
   Joana M., 2012, ACTA BIOMATER, V8, P4173, DOI [10.1016/j.actbio.2012.06.040, DOI 10.1016/J.ACTBIO.2012.06.040]
   Kavitha K, 2013, CURR NANOSCI, V9, P308, DOI 10.2174/1573413711309030003
   Kavitha K, 2013, CARBOHYD POLYM, V93, P731, DOI 10.1016/j.carbpol.2012.12.031
   Kavya KC, 2012, J BIOMED NANOTECHNOL, V8, P149, DOI 10.1166/jbn.2012.1363
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Li Z., 2009, J MATER SCI-MATER M, V20, P949
   Lin YS, 2010, J BIOMED NANOTECHNOL, V6, P247, DOI 10.1166/jbn.2010.1122
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Luo YB, 2009, APPL SURF SCI, V255, P6795, DOI 10.1016/j.apsusc.2009.02.074
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Manero J M, 2002, Implant Dent, V11, P170, DOI 10.1097/00008505-200204000-00019
   Maria de la F, 2008, INVEST OPHTH VIS SCI, V49, P2016, DOI [10.1167/iovs.07-1077, DOI 10.1167/IOVS.07-1077]
   Markovic M, 2004, J RES NATL INST STAN, V109, P553, DOI 10.6028/jres.109.042
   Mi FL, 2006, J BIOMED MATER RES A, V76A, P1, DOI 10.1002/jbm.a.30298
   Morimoto M, 2001, BIOMACROMOLECULES, V2, P1133, DOI 10.1021/bm010063p
   Park YJ, 2000, J CONTROL RELEASE, V67, P385, DOI 10.1016/S0168-3659(00)00232-7
   Peter M, 2010, CARBOHYD POLYM, V80, P687, DOI 10.1016/j.carbpol.2009.11.050
   Ramalingam S, 2009, J SOLID STATE ELECTR, V13, P1777, DOI 10.1007/s10008-009-0870-x
   Singla AK, 2001, J PHARM PHARMACOL, V53, P1047, DOI 10.1211/0022357011776441
   Smriti Sharma Vivek P, 2009, J MATER SCI-MATER M, V20, P1427
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Venkatesan J, 2010, MAR DRUGS, V8, P2252, DOI 10.3390/md8082252
   Vitor Santo E., 2010, J SUPERCRIT FLUID, V54, P320, DOI [10.1016/j.supflu.2010.05.021, DOI 10.1016/J.SUPFLU.2010.05.021]
   Williams D, 2004, MATER TODAY, V7, P24, DOI 10.1016/S1369-7021(04)00232-9
   Yang D, 2009, CHEM ENG SCI, V64, P3130, DOI 10.1016/j.ces.2009.03.042
   Yang WJ, 2009, J BIOMED NANOTECHNOL, V5, P591, DOI 10.1166/jbn.2009.1067
   Yeh MK, 2011, ACTA BIOMATER, V7, P3804, DOI 10.1016/j.actbio.2011.06.026
   Yen Lin C., 2007, BIOMATERIALS, V28, P2294, DOI [10.1016/j.biomaterials.2007.01.027, DOI 10.1016/J.BIOMATERIALS.2007.01.027]
   Yuan NY, 2008, DESALINATION, V234, P166, DOI 10.1016/j.desal.2007.09.083
NR 44
TC 3
Z9 3
U1 2
U2 14
PU INST ENGINEERING TECHNOLOGY-IET
PI HERTFORD
PA MICHAEL FARADAY HOUSE SIX HILLS WAY STEVENAGE, HERTFORD SG1 2AY, ENGLAND
SN 1751-8741
EI 1751-875X
J9 IET NANOBIOTECHNOL
JI IET Nanobiotechnol.
PD JUN
PY 2016
VL 10
IS 3
BP 107
EP 113
DI 10.1049/iet-nbt.2015.0023
PG 7
WC Biochemical Research Methods; Nanoscience & Nanotechnology
SC Biochemistry & Molecular Biology; Science & Technology - Other Topics
GA DO5MA
UT WOS:000377826000002
PM 27256888
DA 2018-10-20
ER

PT J
AU Sen, DG
   Najjar, M
   Yimaz, B
   Levasseur, SM
   Kalessan, B
   Quaegebeur, JM
   Bacha, EA
AF Sen, Danielle Gottlieb
   Najjar, Marc
   Yimaz, Betul
   Levasseur, Stephanie M.
   Kalessan, Bindu
   Quaegebeur, Jan M.
   Bacha, Emile A.
TI Aiming to Preserve Pulmonary Valve Function in Tetralogy of Fallot
   Repair: Comparing a New Approach to Traditional Management
SO PEDIATRIC CARDIOLOGY
LA English
DT Article
DE Tetralogy of Fallot; Pulmonary valve; Valve-sparing repair; Transannular
   patch repair
ID RECONSTRUCTION; OUTCOMES; TERM
AB Pulmonary valve (PV) incompetence following transannular patch (TAP) repair of tetralogy of Fallot (TOF) results in long-term morbidity and mortality. Valve-sparing repairs have recently gained recognition; however, they may be associated with residual pulmonary stenosis (PS) in patients with small PV z scores. We sought to determine whether a repair that increases the PV annulus and augments the valve leaflet with a biomaterial would result in annular growth and in longer duration of valve competence compared with TAP. Eighty patients (median age 136 days, range 4-350) who underwent surgical repair of TOF between 2010 and 2014 were included in the study. Patients were divided into three groups based on the PV intervention: balloon dilation/valvotomy (n = 29), valve-sparing transannular repair (VSTAR) (n = 19) and TAP (n = 32). Intraoperative, early postoperative and midterm follow-up echocardiographic data (median 19 months, range 1-59) were obtained. The primary outcomes were the presence and severity of pulmonary regurgitation and/or PS. Compared with TAP, VSTAR patients demonstrated significantly less severe PR with 100 % freedom of severe PR immediately post-op (vs. 0 % in TAP), 60 % at 6 months and 20 % at 20 months. There were no differences in PS between VSTAR and TAP at follow-up. A subgroup analysis of the VSTAR group was performed. PV z scores were calculated and fit to a random effects model. Patient data fit the model closely, predicting a reproducible increase in valve annulus size over time. With better short-term and comparable midterm results, VSTAR may be appropriate for TOF repair in patients with small PV that would conventionally require a TAP.
C1 [Sen, Danielle Gottlieb; Najjar, Marc; Levasseur, Stephanie M.; Kalessan, Bindu; Quaegebeur, Jan M.; Bacha, Emile A.] Columbia Univ, Pediat Cardiac Surg, Morgan Stanley Childrens Hosp New York Presbyteri, New York, NY 10027 USA.
   [Sen, Danielle Gottlieb] New Orleans Childrens Hosp, Pediat Cardiac Surg, New Orleans, LA USA.
   [Yimaz, Betul] Columbia Univ, Morgan Stanley Childrens Hosp New York Presbyteri, Pediat Cardiol, New York, NY USA.
   [Yimaz, Betul] Texas Childrens Hosp, Pediat Cardiol, Houston, TX 77030 USA.
RP Bacha, EA (reprint author), Columbia Univ, Pediat Cardiac Surg, Morgan Stanley Childrens Hosp New York Presbyteri, New York, NY 10027 USA.
EM mn2594@cumc.columbia.edu; eb2709@cumc.columbia.edu
CR Anagnostopoulos P, 2007, J THORAC CARDIOV SUR, V133, P640, DOI 10.1016/j.jtcvs.2006.10.039
   Bacha Emile, 2012, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, V15, P24, DOI 10.1053/j.pcsu.2012.01.006
   Bautista-Hernandez V, 2013, PEDIATR CARDIOL, V34, P918, DOI 10.1007/s00246-012-0574-3
   Brown JW, 2007, J THORAC CARDIOV SUR, V133, P1336, DOI 10.1016/j.jtcvs.2006.12.045
   Geva T, 2013, CIRCULATION, V128, P1855, DOI 10.1161/CIRCULATIONAHA.113.005878
   Horton KD, 2009, J AM SOC ECHOCARDIOG, V22, P776, DOI 10.1016/j.echo.2009.04.027
   Hua ZD, 2011, EUR J CARDIO-THORAC, V40, P1221, DOI 10.1016/j.ejcts.2011.02.035
   Ito H, 2013, INTERACT CARDIOV TH, V16, P802, DOI 10.1093/icvts/ivt095
   MURPHY JG, 1993, NEW ENGL J MED, V329, P593, DOI 10.1056/NEJM199308263290901
   Nath DS, 2010, ANN THORAC SURG, V90, P42, DOI 10.1016/j.athoracsur.2010.03.045
   Ngodgnamthaweesuk M, 2012, ASIAN CARDIOVASC THO, V21, P9
   Stewart RD, 2005, ANN THORAC SURG, V80, P1431, DOI 10.1016/j.athoracsur.2005.04.016
   Sung SC, 2003, ANN THORAC SURG, V75, P303, DOI 10.1016/S0003-4975(02)03926-7
   Valente AM, 2014, HEART, V100, P247, DOI 10.1136/heartjnl-2013-304958
NR 14
TC 10
Z9 10
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0172-0643
EI 1432-1971
J9 PEDIATR CARDIOL
JI Pediatr. Cardiol.
PD JUN
PY 2016
VL 37
IS 5
BP 818
EP 825
DI 10.1007/s00246-016-1355-1
PG 8
WC Cardiac & Cardiovascular Systems; Pediatrics
SC Cardiovascular System & Cardiology; Pediatrics
GA DO3ZX
UT WOS:000377722400003
PM 26921062
DA 2018-10-20
ER

PT J
AU Mariot, P
   Leeflang, MA
   Schaeffer, L
   Zhou, J
AF Mariot, P.
   Leeflang, M. A.
   Schaeffer, L.
   Zhou, J.
TI An investigation on the properties of injection-molded pure iron
   potentially for biodegradable stent application
SO POWDER TECHNOLOGY
LA English
DT Article
DE Iron; Biodegradable material; Metal injection molding; In vitro
   degradation; Corrosion
ID CONGENITAL HEART-DISEASE; FE-MN ALLOYS; CORONARY STENTS;
   MECHANICAL-PROPERTIES; POWDER-METALLURGY; MICRO-NANOPOWDER; POROUS
   TITANIUM; BEHAVIOR; MICROSTRUCTURE; CYTOTOXICITY
AB Metal injection molding (MIM) is a near-net-shape manufacturing process suitable for the production of small size and complex-shape components. As a cost-effective and flexible manufacturing method, it may have distinct advantages over other methods when it comes to the manufacturing of implantable medical devices. However, up till now, the potential for MIM to be employed in the commercial-scale manufacturing of implantable medical devices has been insufficiently exploited. In the present research, an attempt was made to produce porous pure iron, as a metallic degradable biomaterial potentially for stent application, via the MIM route. The effects of iron powder loading and sintering temperature on the porosity, microstructure, mechanical properties, surface properties and in vitro degradation behavior of MIM iron were investigated. The results obtained were compared to those of cast iron. It was found that the amount of porosity retained in the as-sintered specimens had a major effect on their surface and mechanical properties. MIM iron exhibited strengths between those of magnesium alloys and 316 L stainless steel and very high ductility-a specially required property of stent materials. Its degradation rates in Hank's solution were superior to the degradation rate of cast iron. Interestingly, the material made from the feedstock containing 66% of iron powder, above the critical powder loading, showed the highest elongation and a good in vitro degradation rate. In conclusion, MIM is a promising method to be developed as a new route to produce thin-wall tubes for biodegradable stents. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Mariot, P.; Schaeffer, L.] Univ Fed Rio Grande do Sul, Fac Engn, Lab Mech Transformat LdTM, Ave Bento Goncalves 9500,POB 15021, BR-91501970 Porto Alegre, RS, Brazil.
   [Leeflang, M. A.; Zhou, J.] Delft Univ Technol, Dept Biomech Engn, NL-2628 CD Delft, Netherlands.
RP Mariot, P (reprint author), Univ Fed Rio Grande do Sul, Fac Engn, Lab Mech Transformat LdTM, Ave Bento Goncalves 9500,POB 15021, BR-91501970 Porto Alegre, RS, Brazil.
EM paulo.mariot@ufrgs.br; m.a.leeflang@tudelft.nl; schaefer@ufrgs.br;
   J.Zhou@tudelft.nl
RI Zhou, Jie/J-3019-2012
OI Zhou, Jie/0000-0002-6484-9156; Leeflang, Marius
   Alexander/0000-0003-1702-7413
FU Coordination for the Improvement of Higher Education Personnel (CAPES);
   Brazilian government [CAPES/AUX 993/2009]
FX The research was supported by the Coordination for the Improvement of
   Higher Education Personnel (CAPES) and financed by the Brazilian
   government under the project number CAPES/AUX 993/2009.
CR Aggarwal G, 2007, INT J REFRACT MET H, V25, P226, DOI 10.1016/j.ijrmhm.2006.05.005
   [Anonymous], US Patent, Patent No. [US 8303642 B1, 8303642]
   Ashby DT, 2002, CATHETER CARDIO INTE, V56, P83, DOI 10.1002/ccd.10209
   *ASTM, 2001, ANN BOOK ASTM STAND
   ASTM, 2004, ANN BOOK ASTM STAND
   Banerjee D, 2013, ACTA MATER, V61, P844, DOI 10.1016/j.actamat.2012.10.043
   Bowen PK, 2013, MAT SCI ENG C-MATER, V33, P5064, DOI 10.1016/j.msec.2013.08.042
   Capek J, 2014, MAT SCI ENG C-MATER, V35, P21, DOI 10.1016/j.msec.2013.10.014
   Chen G, 2013, MAT SCI ENG A-STRUCT, V582, P117, DOI 10.1016/j.msea.2013.05.082
   Chen LJ, 2009, T NONFERR METAL SOC, V19, P1174, DOI 10.1016/S1003-6326(08)60424-0
   Chen XB, 2009, ACTA BIOMATER, V5, P2290, DOI 10.1016/j.actbio.2009.02.027
   Choi JP, 2015, POWDER TECHNOL, V279, P196, DOI 10.1016/j.powtec.2015.04.014
   Choi JP, 2014, POWDER TECHNOL, V253, P596, DOI 10.1016/j.powtec.2013.11.048
   Demangel C, 2012, MAT SCI ENG C-MATER, V32, P1919, DOI 10.1016/j.msec.2012.05.037
   Fagali NS, 2015, COLLOID SURFACE B, V128, P480, DOI 10.1016/j.colsurfb.2015.02.047
   Gu X., 2009, BIOMATERIALS, V9, P484
   Hausnerova B, 2011, NEW TRENDS AND DEVELOPMENTS IN AUTOMOTIVE SYSTEM ENGINEERING, P129
   Hermawan H, 2008, POWDER METALL, V51, P38, DOI 10.1179/174329008X284868
   Hermawan H, 2013, ACTA BIOMATER, V9, P8585, DOI 10.1016/j.actbio.2013.04.027
   Hermawan H, 2010, ACTA BIOMATER, V6, P1852, DOI 10.1016/j.actbio.2009.11.025
   Huan Z, 2012, APPL SURF SCI, V258, P5244, DOI 10.1016/j.apsusc.2012.02.002
   Huang HH, 2004, BIOMOL ENG, V21, P93, DOI 10.1016/j.bioeng.2004.05.001
   Kafkas F, 2014, J ALLOY COMPD, V617, P359, DOI 10.1016/j.jallcom.2014.07.168
   Kong X, 2012, J MATER PROCESS TECH, V212, P2173, DOI 10.1016/j.jmatprotec.2012.05.023
   Levesque J, 2008, ACTA BIOMATER, V4, P284, DOI 10.1016/j.actbio.2007.09.012
   Li YMM, 2007, J MATER PROCESS TECH, V183, P432, DOI 10.1016/j.jmatprotec.2006.10.039
   Mani G, 2007, BIOMATERIALS, V28, P1689, DOI 10.1016/j.biomaterials.2006.11.042
   Migliavacca F, 2005, MED ENG PHYS, V27, P13, DOI 10.1016/j.medengphy.2004.08.012
   Moravej M, 2010, ACTA BIOMATER, V6, P1726, DOI 10.1016/j.actbio.2010.01.010
   Moravej M, 2011, INT J MOL SCI, V12, P4250, DOI 10.3390/ijms12074250
   Mueller P.P., 2006, BIOMATERIALS, V27, P4955
   MULLINS CE, 1988, CIRCULATION, V77, P188, DOI 10.1161/01.CIR.77.1.188
   Okubo M, 2001, CURR OPIN CARDIOL, V16, P84, DOI 10.1097/00001573-200103000-00002
   OLAUGHLIN MP, 1991, CIRCULATION, V83, P1923, DOI 10.1161/01.CIR.83.6.1923
   PULEO DA, 1995, J APPL BIOMATER, V6, P109, DOI 10.1002/jab.770060205
   Shongwe MB, 2015, J ALLOY COMPD, V649, P824, DOI 10.1016/j.jallcom.2015.07.223
   Song B, 2014, OPT LASER TECHNOL, V56, P451, DOI 10.1016/j.optlastec.2013.09.017
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Suwaidi Jassim Al, 2000, JAMA (Journal of the American Medical Association), V284, P1828
   Waksman R, 2006, CATHETER CARDIOVASC, V68, P606
   Waksman Ron, 2006, J Interv Cardiol, V19, P414, DOI 10.1111/j.1540-8183.2006.00187.x
   Waksman R, 2007, CATHETER CARDIO INTE, V70, P407, DOI 10.1002/ccd.21176
   Yin HQ, 2008, J UNIV SCI TECHNOL B, V15, P480, DOI 10.1016/S1005-8850(08)60090-0
   Zhang EL, 2010, J MATER SCI-MATER M, V21, P2151, DOI 10.1007/s10856-010-4070-0
   Zhu SF, 2009, MAT SCI ENG C-BIO S, V29, P1589, DOI 10.1016/j.msec.2008.12.019
NR 45
TC 7
Z9 7
U1 3
U2 50
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0032-5910
EI 1873-328X
J9 POWDER TECHNOL
JI Powder Technol.
PD JUN
PY 2016
VL 294
BP 226
EP 235
DI 10.1016/j.powtec.2016.02.042
PG 10
WC Engineering, Chemical
SC Engineering
GA DO4BJ
UT WOS:000377726500024
DA 2018-10-20
ER

PT J
AU Berns, EJ
   Alvarez, Z
   Goldberger, JE
   Boekhoven, J
   Kessler, JA
   Kuhn, HG
   Stupp, SI
AF Berns, Eric J.
   Alvarez, Zaida
   Goldberger, Joshua E.
   Boekhoven, Job
   Kessler, John A.
   Kuhn, H. Georg
   Stupp, Samuel I.
TI A tenascin-C mimetic peptide amphiphile nanofiber gel promotes neurite
   outgrowth and cell migration of neurosphere-derived cells
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Self assembly; Tenascin-C mimetic peptide; Peptide amphiphile; Neurite
   growth; Cell migration
ID ALTERNATIVELY SPLICED REGION; SPINAL-CORD-INJURY; PROGENITOR CELLS;
   MONODOMAIN GELS; BETA-1-INTEGRINS; DIFFERENTIATION; BIOMATERIALS;
   GENERATION; SURFACES; NEURONS
AB Biomimetic materials that display natural bioactive signals derived from extracellular matrix molecules like laminin and fibronectin hold promise for promoting regeneration of the nervous system. In this work, we investigated a biomimetic peptide amphiphile (PA) presenting a peptide derived from the extracellular glycoprotein tenascin-C, known to promote neurite outgrowth through interaction with beta 1 integrin. The tenascin-C mimetic PA (TN-C PA) was found to self-assemble into supramolecular nanofibers and was incorporated through co-assembly into PA gels formed by highly aligned nanofibers. TN-C PA content in these gels increased the length and number of neurites produced from neurons differentiated from encapsulated P19 cells. Furthermore, gels containing TN-C PA were found to increase migration of cells out of neurospheres cultured on gel coatings. These bioactive gels could serve as artificial matrix therapies in regions of neuronal loss to guide neural stem cells and promote through biochemical cues neurite extension after differentiation. One example of an important target would be their use as biomaterial therapies in spinal cord injury.
   Statement of Significance
   Tenascin-C is an important extracellular matrix molecule in the nervous system and has been shown to play a role in regenerating the spinal cord after injury and guiding neural progenitor cells during brain development, however, minimal research has been reported exploring the use of biomimetic biomaterials of tenascin-C. In this work, we describe a selfassembling biomaterial system in which peptide amphiphiles present a peptide derived from tenascin-C that promotes neurite outgrowth. Encapsulation of neurons in hydrogels of aligned nanofibers formed by tenascin-C-mimetic peptide amphiphiles resulted in enhanced neurite outgrowth. Additionally, these peptide amphiphiles promoted migration of neural progenitor cells cultured on nanofiber coatings. Tenascin-C biomimetic biomaterials such as the one described here have significant potential in neuroregenerative medicine. (c) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Berns, Eric J.; Stupp, Samuel I.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.
   [Alvarez, Zaida; Boekhoven, Job; Stupp, Samuel I.] Northwestern Univ, Simpson Querrey Inst BioNanotechnol, Chicago, IL 60611 USA.
   [Goldberger, Joshua E.; Stupp, Samuel I.] Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.
   [Kessler, John A.] Northwestern Univ, Dept Neurol, Chicago, IL 60611 USA.
   [Kuhn, H. Georg] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Ctr Brain Repair & Rehabil, S-41390 Gothenburg, Sweden.
   [Stupp, Samuel I.] Northwestern Univ, Dept Mat Sci & Engn, 2220 Campus Dr, Evanston, IL 60208 USA.
   [Stupp, Samuel I.] Northwestern Univ, Dept Med, Chicago, IL 60611 USA.
   [Goldberger, Joshua E.] Ohio State Univ, Dept Chem, Columbus, OH 43210 USA.
RP Stupp, SI (reprint author), Northwestern Univ, Dept Mat Sci & Engn, 2220 Campus Dr, Evanston, IL 60208 USA.
EM eric-berns@u.northwestern.edu; zaida.pinto@northwestern.edu;
   goldberger@chemistry.ohio-state.edu; job.boekhoven@northwestern.edu;
   jakessler@northwestern.edu; Georg.Kuhn@neuro.gu.se;
   s-stupp@northwestern.edu
RI Goldberger, Joshua/F-5484-2011; Stupp, Samuel/B-6737-2009; Goldberger,
   Joshua/N-8963-2016
OI Goldberger, Joshua/0000-0003-4284-604X; Goldberger,
   Joshua/0000-0003-4284-604X; Boekhoven, Job/0000-0002-9126-2430; Kuhn,
   Hans-Georg/0000-0003-4247-5613
FU National Institutes of Health/National Institute of Biomedical Imaging
   And Bioengineering [5R01EB003806-07]; Center for Regenerative
   Nanomedicine at the Simpson Querrey Institute for BioNanotechnology at
   Northwestern; National Institutes of Health [F32EB007131]; U.S. Army
   Research Office; U.S. Army Medical Research and Materiel Command;
   Department of Energy; Frederick S. Upton Foundation; Northwestern
   University; NCI CCSG [P30 CA060553]; U.S. DOE [DE-AC02-06CH11357]
FX This project was supported by National Institutes of Health/National
   Institute of Biomedical Imaging And Bioengineering Award Number
   5R01EB003806-07 and by the Center for Regenerative Nanomedicine at the
   Simpson Querrey Institute for BioNanotechnology at Northwestern. J.E.G.
   received postdoctoral support from the National Institutes of Health
   Award Number F32EB007131. Peptide synthesis was performed in the Peptide
   Synthesis Core Facility and cell culture was performed in the
   Nanomedicine Cleanroom of the Simpson Querrey Institute at Northwestern
   University. The U.S. Army Research Office, the U.S. Army Medical
   Research and Materiel Command, the Department of Energy, the Frederick
   S. Upton Foundation and Northwestern University provided funding to
   develop these facilities. Imaging was performed at the Northwestern
   University Center for Advanced Microscopy generously supported by NCI
   CCSG P30 CA060553 awarded to the Robert H Lurie Comprehensive Cancer
   Center. SEM was performed at the Electron Probe Instrumentation Center
   of the NUANCE Center at Northwestern University, which is supported by
   NSF-NSEC, NSF-MRSEC, Keck Foundation, the State of Illinois, and
   Northwestern University. Use of the Advanced Photon Source, an Office of
   Science User Facility operated for the U.S. Department of Energy (DOE)
   Office of Science by Argonne National Laboratory, was supported by the
   U.S. DOE under Contract No. DE-AC02-06CH11357. The authors acknowledge
   Tammy McGuire for isolation of neural progenitor cells and Dr. Steven
   Weigand for assistance with SAXS experiments.
CR Ahmed I, 2006, J BIOMED MATER RES A, V76A, P851, DOI 10.1002/jbm.a.30587
   Beniash E, 2005, ACTA BIOMATER, V1, P387, DOI 10.1016/j.actbio.2005.04.002
   Berns EJ, 2014, BIOMATERIALS, V35, P185, DOI 10.1016/j.biomaterials.2013.09.077
   Collier JH, 2011, BIOMATERIALS, V32, P4198, DOI 10.1016/j.biomaterials.2011.02.030
   Garcion E, 2004, DEVELOPMENT, V131, P3423, DOI 10.1242/dev.01202
   Goldberger JE, 2011, ANGEW CHEM INT EDIT, V50, P6292, DOI 10.1002/anie.201100202
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Jacques TS, 1998, DEVELOPMENT, V125, P3167
   Leone DP, 2005, J CELL SCI, V118, P2589, DOI 10.1242/jcs.02396
   MacPherson P., 1995, METHODS, V65, P1093
   Matson JB, 2011, CURR OPIN SOLID ST M, V15, P225, DOI 10.1016/j.cossms.2011.08.001
   Meiners S, 2001, J NEUROSCI, V21, P7215, DOI 10.1523/JNEUROSCI.21-18-07215.2001
   Mercado MLT, 2004, J NEUROSCI, V24, P238, DOI 10.1523/JNEUROSCI.4519-03.2004
   Pan LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104335
   Peramo A, 2006, LANGMUIR, V22, P3228, DOI 10.1021/la051166m
   REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Sever M, 2014, BIOMACROMOLECULES, V15, P4480, DOI 10.1021/bm501271x
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Thomas LB, 1996, GLIA, V17, P1
   Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008
   VESCOVI AL, 1993, NEURON, V11, P951, DOI 10.1016/0896-6273(93)90124-A
   Webber MJ, 2010, J INTERN MED, V267, P71, DOI 10.1111/j.1365-2796.2009.02184.x
   Webber MJ, 2013, ISR J CHEM, V53, P530, DOI 10.1002/ijch.201300046
   Yu YM, 2011, NEUROSCIENCE, V183, P238, DOI 10.1016/j.neuroscience.2011.03.043
   Zhang SM, 2010, NAT MATER, V9, P594, DOI [10.1038/nmat2778, 10.1038/NMAT2778]
   Zhang Y, 1997, J NEUROSCI RES, V49, P433
NR 29
TC 14
Z9 14
U1 5
U2 58
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUN
PY 2016
VL 37
BP 50
EP 58
DI 10.1016/j.actbio.2016.04.010
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DN8FM
UT WOS:000377314600006
PM 27063496
OA Green Accepted, Other Gold
DA 2018-10-20
ER

PT J
AU Bishop, CJ
   Majewski, RL
   Guiriba, TRM
   Wilson, DR
   Bhise, NS
   Quinones-Hinojosa, A
   Green, JJ
AF Bishop, Corey J.
   Majewski, Rebecca L.
   Guiriba, Toni-Rose M.
   Wilson, David R.
   Bhise, Nupura S.
   Quinones-Hinojosa, Alfredo
   Green, Jordan J.
TI Quantification of cellular and nuclear uptake rates of polymeric gene
   delivery nanoparticles and DNA plasmids via flow cytometry
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Gene delivery; Nanoparticle; Polymer; Computational modeling; Brain
   cancer
ID POLY(BETA-AMINO ESTERS); MAMMALIAN-CELLS; STEM-CELLS; IN-VIVO; THERAPY;
   POLYETHYLENIMINE; EXPRESSION; VECTOR; BINDING; GLIOBLASTOMA
AB Non-viral, biomaterial-mediated gene delivery has the potential to treat many diseases, but is limited by low efficacy. Elucidating the bottlenecks of plasmid mass transfer can enable an improved understanding of biomaterial structure-function relationships, leading to next-generation rationally designed non-viral gene delivery vectors. As proof of principle, we transfected human primary glioblastoma cells using a poly(beta-amino ester) complexed with eGFP plasmid DNA. The polyplexes transfected 70.6 +/- 0.6% of the cells with 101 +/- 3% viability. The amount of DNA within the cytoplasm, nuclear envelope, and nuclei was assessed at multiple time points using fluorescent dye conjugated plasmid up to 24 h post-transfection using a quantitative multi-well plate-based flow cytometry assay. Conversion to plasmid counts and degradation kinetics were accounted for via quantitative PCR (plasmid degradation rate constants were determined to be 0.62 h(-1) and 0.084 h(-1) for fast and slow phases respectively). Quantitative cellular uptake, nuclear association, and nuclear uptake rate constants were determined by using a four-compartment first order mass-action model. The rate limiting step for these poly(beta-amino ester)/DNA polyplex nanoparticles was determined to be cellular uptake (7.5 x 10(-4)h(-1)) and only 0.1% of the added dose was taken up by the human brain cancer cells, whereas 12% of internalized DNA successfully entered the nucleus (the rate of nuclear internalization of nuclear associated plasmid was 1.1 h(-1)). We describe an efficient new method for assessing cellular and nuclear uptake rates of non-viral gene delivery nanoparticles using flow cytometry to improve understanding and design of polymeric gene delivery nanoparticles.
   Statement of Significance
   In this work, a quantitative high throughput flow cytometry-based assay and computational modeling approach was developed for assessing cellular and nuclear uptake rates of non-viral gene delivery nanoparticles. This method is significant as it can be used to elucidate structure-function relationships of gene delivery nanoparticles and improve their efficiency. This method was applied to a particular type of biodegradable polymer, a poly(beta-amino ester), that transfected human brain cancer cells with high efficacy and without cytotoxicity. A four-compartment first order mass-action kinetics model was found to model the experimental transport data well without requiring external fitting parameters. Quantitative rate constants were identified for the intracellular transport, including DNA degradation rate from polyplexes, cellular uptake rate, and nuclear uptake rate, with cellular uptake identified as the rate-limiting step. (c) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Bishop, Corey J.; Majewski, Rebecca L.; Wilson, David R.; Bhise, Nupura S.; Green, Jordan J.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Translat Tissue Engn Ctr, Baltimore, MD 21231 USA.
   [Guiriba, Toni-Rose M.; Green, Jordan J.] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21231 USA.
   [Quinones-Hinojosa, Alfredo; Green, Jordan J.] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21231 USA.
   [Quinones-Hinojosa, Alfredo; Green, Jordan J.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21231 USA.
   [Green, Jordan J.] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21231 USA.
RP Green, JJ (reprint author), 400 North Broadway Rm 5017, Baltimore, MD 21231 USA.
EM green@jhu.edu
FU NSF [GRF: DGE-0707427]; National Institutes of Health [R01EB016721,
   P30-EY001865]
FX CJB thanks the NSF for a GRF: DGE-0707427. This work was also supported
   in part by the National Institutes of Health (R01EB016721 and a Core
   Grant to the Wilmer Institute, P30-EY001865).
CR ALTON EWFW, 1993, NAT GENET, V5, P135, DOI 10.1038/ng1093-135
   Anderson DG, 2005, MOL THER, V11, P426, DOI 10.1016/j.ymthe.2004.11.015
   Banks GA, 2003, GENE THER, V10, P1766, DOI 10.1038/sj.gt.3302076
   Bishop CJ, 2015, CHEM COMMUN, V51, P12134, DOI 10.1039/c5cc04417k
   Bishop CJ, 2015, ACTA BIOMATER, V11, P393, DOI 10.1016/j.actbio.2014.09.020
   Bishop CJ, 2014, ANN BIOMED ENG, V42, P1557, DOI 10.1007/s10439-013-0932-1
   Bishop CJ, 2013, J AM CHEM SOC, V135, P6951, DOI 10.1021/ja4002376
   BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297
   Carapuca E, 2007, MOL BIOTECHNOL, V37, P120, DOI 10.1007/s12033-007-0007-3
   Chen HH, 2009, NANO TODAY, V4, P125, DOI 10.1016/j.nantod.2009.02.008
   Cohen RN, 2009, J CONTROL RELEASE, V135, P166, DOI 10.1016/j.jconrel.2008.12.016
   Cooper S, 2003, CELL MOL LIFE SCI, V60, P1099, DOI 10.1007/s00018-003-2253-2
   Filareto A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2550
   Guerrero-Cazares H, 2009, METHODS MOL BIOL, V568, P73, DOI 10.1007/978-1-59745-280-9_6
   Howe S.J., 2008, J CLIN INVEST, V118, P3143
   James MB, 2000, MOL THER, V1, P339, DOI 10.1006/mthe.2000.0054
   Keeney M, 2013, ACS NANO, V7, P7241, DOI 10.1021/nn402657d
   Ketola TM, 2013, J PHYS CHEM B, V117, P10405, DOI 10.1021/jp404812a
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Millili PG, 2010, MICROSC RES TECHNIQ, V73, P866, DOI 10.1002/jemt.20839
   Mohyeldin A, 2012, CANCER J, V18, P82, DOI 10.1097/PPO.0b013e3182458b13
   Mullen PM, 2000, BBA-GEN SUBJECTS, V1523, P103, DOI 10.1016/S0304-4165(00)00104-5
   Murphy AM, 2013, TRANSL RES, V161, P339, DOI 10.1016/j.trsl.2012.11.003
   Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046
   Raucher D, 1999, J CELL BIOL, V144, P497, DOI 10.1083/jcb.144.3.497
   Sacramento CB, 2010, BRAZ J MED BIOL RES, V43, P722, DOI 10.1590/S0100-879X2010000800005
   Schaffer DV, 2000, BIOTECHNOL BIOENG, V67, P598, DOI 10.1002/(SICI)1097-0290(20000305)67:5<598::AID-BIT10>3.0.CO;2-G
   Shmueli RB, 2012, NANOMED-NANOTECHNOL, V8, P1200, DOI 10.1016/j.nano.2012.01.006
   Sunshine JC, 2012, MOL PHARMACEUT, V9, P3375, DOI 10.1021/mp3004176
   Sunshine JC, 2011, THER DELIV, V2, P493, DOI 10.4155/TDE.11.14
   Toyoda E, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-30
   Tzeng SY, 2011, BIOMATERIALS, V32, P5402, DOI 10.1016/j.biomaterials.2011.04.016
   Varga CM, 2005, GENE THER, V12, P1023, DOI 10.1038/sj.gt.3302495
   Varga CM, 2001, MOL THER, V4, P438, DOI 10.1006/mthe.2001.0475
   Zhou JB, 2012, NAT MATER, V11, P82, DOI [10.1038/NMAT3187, 10.1038/nmat3187]
   Zhou JY, 2007, PHARM RES, V24, P1079, DOI 10.1007/s11095-006-9229-5
NR 36
TC 18
Z9 18
U1 1
U2 42
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUN
PY 2016
VL 37
BP 120
EP 130
DI 10.1016/j.actbio.2016.03.036
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DN8FM
UT WOS:000377314600013
PM 27019146
OA Green Accepted
DA 2018-10-20
ER

PT J
AU van Oirschot, BAJA
   Eman, RM
   Habibovic, P
   Leeuwenburgh, SCG
   Tahmasebi, Z
   Weinans, H
   Alblas, J
   Meijer, GJ
   Jansen, JA
   van den Beucken, JJJP
AF van Oirschot, Bart A. J. A.
   Eman, Rhandy M.
   Habibovic, Pamela
   Leeuwenburgh, Sander C. G.
   Tahmasebi, Zeinab
   Weinans, Harrie
   Alblas, Jacqueline
   Meijer, Gert J.
   Jansen, John A.
   van den Beucken, Jeroen J. J. P.
TI Osteophilic properties of bone implant surface modifications in a
   cassette model on a decorticated goat spinal transverse process
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Biomaterials; Titanium implant; Surface modifications; Calcium
   phosphate; Goat model
ID CALCIUM-PHOSPHATE COATINGS; IN-VIVO EVALUATION; PLASMA-SPRAYED
   HYDROXYAPATITE; POROUS METAL IMPLANTS; OCTACALCIUM PHOSPHATE; TITANIUM
   IMPLANTS; DENTAL IMPLANTS; ORAL IMPLANTS; HEALING RESPONSE; BIOACTIVE
   GLASS
AB This study comparatively evaluated the osteophilic capacity of 17 different surface modifications (i.e. fourteen different chemical modifications via ceramic coatings and three different physical modifications via surface roughness) for titanium (Ti) surfaces. All surface modifications were subjected to physicochemical analyses and immersion in simulated body fluid (SBF) for coating stability assessment. Subsequently, a bone conduction chamber cassette model on the goat transverse process was used for comparative in vivo analysis based on bone responses to these different surface modifications after twelve weeks. Histological and histomorphometrical analyses in terms of longitudinal bone-to-implant contact percentage (BIC%), relative bone area (BA%) were investigated within each individual channel and maximum bone height (BH). Characterization of the surface modifications showed significant differences in surface chemistry and surface roughness among the surface modifications. Generally, immersion of the coatings in SBF showed net uptake of calcium by thick coatings (>50 mu m; plasma-sprayed and biomimetic coatings) and no fluctuations in the SBF for thin coatings (<50 mu m). The histomorphometrical data set demonstrated that only plasma-sprayed CaP coatings performed superiorly regarding BIC%, BA % and BH compared to un-coated surfaces, irrespective of surface roughness of the latter. In conclusion, this study demonstrated that the deposition of plasma-sprayed CaP coating with high roughness significantly improves the osteophilic capacity of titanium surfaces in a chamber cassette model.
   Statement of Significance
   For the bone implant market, a large number of surface modifications are available on different types of (dental and orthopedic) bone implants. As the implant surface provides the interface at which the biomaterial interacts with the surrounding (bone) tissue, it is of utmost importance to know what surface modification has optimal osteophilic properties. In contrast to numerous earlier studies on bone implant surface modifications with limited number of comparison surfaces, the manuscript by van Oirschot et al. describes the data of in vivo experiments using a large animal model that allows for direct and simultaneous comparison of a large variety of surface modifications, which included both commercially available and experimental surface modifications for bone implants. These data clearly show the superiority of plasma-sprayed hydroxyapatite coatings regarding bone-to-implant contact, bone amount, and bone height. (c) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [van Oirschot, Bart A. J. A.; Leeuwenburgh, Sander C. G.; Jansen, John A.; van den Beucken, Jeroen J. J. P.] Radboudumc, Dept Biomat, Nijmegen, Netherlands.
   [Eman, Rhandy M.; Weinans, Harrie; Alblas, Jacqueline] Univ Med Ctr Utrecht, Dept Orthoped, Utrecht, Netherlands.
   [Habibovic, Pamela; Tahmasebi, Zeinab] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Tissue Regenerat, POB 217, NL-7500 AE Enschede, Netherlands.
   [van Oirschot, Bart A. J. A.; Meijer, Gert J.; Jansen, John A.] Radboudumc, Dept Implantol & Periodontol, Nijmegen, Netherlands.
RP van den Beucken, JJJP (reprint author), Radboudumc, Biomat 309, Philips van Leijdenln 25, NL-6525 EX Nijmegen, Netherlands.
EM jeroen.vandenbeucken@radboudumc.nl
RI Meijer, G.J./H-8073-2014; Jansen, John/H-8055-2014; Leeuwenburgh,
   S.C.G./L-4483-2015; van den beucken, jeroen/N-2910-2013; van Oirschot,
   Bart/P-8203-2015
OI Leeuwenburgh, S.C.G./0000-0003-1471-6133; van den beucken,
   jeroen/0000-0002-0301-1966; Alblas, Jacqueline/0000-0002-2996-9697
FU Dutch Ministry of Economic Affairs, Agriculture and Innovation [P2.04
   BONE-IP]; ReumaFonds [LLP-12]
FX The authors would like to acknowledge Mr. Vincent Cuijpers for his
   assistance with histomorphometrical analyses, and Ms. Natasja van Dijk
   for her assistance with the histological sectioning. We would like to
   thank Editage (www.editage.com) for English language editing. This
   research forms part of the Project P2.04 BONE-IP of the research program
   of the BioMedical Materials institute, co-funded by the Dutch Ministry
   of Economic Affairs, Agriculture and Innovation.
CR Alghamdi HS, 2013, TISSUE ENG PART B-RE, V19, P233, DOI [10.1089/ten.TEB.2012.0400, 10.1089/ten.teb.2012.0400]
   Alghamdi HS, 2013, CLIN ORAL IMPLAN RES, V24, P475, DOI 10.1111/j.1600-0501.2011.02409.x
   Allen PF, 2003, CLIN ORAL IMPLAN RES, V14, P173, DOI 10.1034/j.1600-0501.2003.140206.x
   Barradas AMC, 2012, BIOMATERIALS, V33, P3205, DOI 10.1016/j.biomaterials.2012.01.020
   Barrere F, 2003, J BIOMED MATER RES B, V67B, P655, DOI 10.1002/jbm.b.10057
   Barrere F, 2003, J BIOMED MATER RES A, V66A, P779, DOI 10.1002/jbm.a.10454
   Barrere F, 2001, J MATER SCI-MATER M, V12, P529, DOI 10.1023/A:1011271713758
   Becktor JP, 2004, INT J ORAL MAX IMPL, V19, P107
   Berglundh T, 2007, CLIN ORAL IMPLAN RES, V18, P147, DOI 10.1111/j.1600-0501.2006.01309.x
   Bornstein MM, 2008, CLIN ORAL IMPLAN RES, V19, P233, DOI 10.1111/j.1600-0501.2007.01473.x
   Bosco R, 2013, SURF COAT TECH, V233, P91, DOI 10.1016/j.surfcoat.2013.02.039
   Botticelli D, 2004, J CLIN PERIODONTOL, V31, P820, DOI 10.1111/j.1600-051X.2004.00565.x
   Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658
   Buser D, 2004, J DENT RES, V83, P529, DOI 10.1177/154405910408300704
   Chai YC, 2012, ACTA BIOMATER, V8, P3876, DOI 10.1016/j.actbio.2012.07.002
   Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4
   Christenson EM, 2007, J ORTHOP RES, V25, P11, DOI 10.1002/jor.20305
   Cleries L, 2000, BIOMATERIALS, V21, P967, DOI 10.1016/S0142-9612(99)00240-9
   Daculsi G., 2003, J MAT SCI MAT MED, V14
   Davies John E, 2003, J Dent Educ, V67, P932
   de Jonge LT, 2008, PHARM RES-DORDR, V25, P2357, DOI 10.1007/s11095-008-9617-0
   de Jonge LT, 2009, ACTA BIOMATER, V5, P2773, DOI 10.1016/j.actbio.2009.03.019
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   Dekker RJ, 2005, BIOMATERIALS, V26, P5231, DOI 10.1016/j.biomaterials.2005.01.057
   Esposito M, 1998, EUR J ORAL SCI, V106, P527, DOI 10.1046/j.0909-8836..t01-2-.x
   Fini M, 2004, BIOMED PHARMACOTHER, V58, P487, DOI 10.1016/j.biopha.2004.08.016
   GarciaSanz FJ, 1997, J MATER SCI-MATER M, V8, P861, DOI 10.1023/A:1018549720873
   Gottlander M, 1997, CLIN ORAL IMPLAN RES, V8, P345, DOI 10.1034/j.1600-0501.1997.080501.x
   Habibovic P, 2004, J MATER SCI-MATER M, V15, P373, DOI 10.1023/B:JMSM.0000021104.42685.9f
   Habibovic P, 2005, BIOMATERIALS, V26, P23, DOI 10.1016/j.biomaterials.2004.02.026
   Habibovic P, 2002, J AM CERAM SOC, V85, P517
   Havelin LI, 2000, ACTA ORTHOP SCAND, V71, P337, DOI 10.1080/000164700317393321
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   Hench LL, 1998, J BIOMED MATER RES, V41, P511, DOI 10.1002/(SICI)1097-4636(19980915)41:4<511::AID-JBM1>3.0.CO;2-F
   Itthichaisri C, 2007, J BIOMED MATER RES A, V82A, P777, DOI 10.1002/jbm.a.31191
   JANSEN JA, 1991, J BIOMED MATER RES, V25, P973, DOI 10.1002/jbm.820250805
   JANSEN JA, 1993, J BIOMED MATER RES, V27, P603, DOI 10.1002/jbm.820270507
   Junker R, 2009, CLIN ORAL IMPLAN RES, V20, P185, DOI 10.1111/j.1600-0501.2009.01777.x
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kruyt MC, 2006, BIOMATERIALS, V27, P5099, DOI 10.1016/j.biomaterials.2006.05.048
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Leeuwenburgh SCG, 2004, BIOMATERIALS, V25, P641, DOI 10.1016/S0142-9612(03)00575-1
   Lekholm U, 1999, INT J ORAL MAX IMPL, V14, P639
   Lenth RV, 2007, J ANIM SCI, V85, pE24, DOI 10.2527/jas.2006-449
   Lew D., 1999, J ORAL MAXILLOFAC SU, V1096, P9
   Li YF, 2010, J ORTHOP RES, V28, P578, DOI 10.1002/jor.21050
   Lohmann CH, 2002, J BIOMED MATER RES, V62, P204, DOI 10.1002/jbm.10290
   Mohammadi S, 2004, INT J ORAL MAX IMPL, V19, P498
   Nijhuis AWG, 2010, MACROMOL BIOSCI, V10, P1316, DOI 10.1002/mabi.201000142
   Ostman PO, 2008, CLIN IMPLANT DENT R, V10, P71, DOI 10.1111/j.1708-8208.2007.00069.x
   Oliveira AL, 2007, J BIOMED MATER RES B, V83B, P258, DOI 10.1002/jbm.b.30791
   Ong JL, 2002, INT J ORAL MAX IMPL, V17, P581
   Saravanapavan P, 2004, BIO-MED MATER ENG, V14, P467
   Schaeken H. G., 1999, J BIOMED MATER RES, V28, P1477
   Schouten C, 2010, CLIN ORAL IMPLAN RES, V21, P414, DOI 10.1111/j.1600-0501.2009.01872.x
   Schouten C, 2009, BIOMATERIALS, V30, P6407, DOI 10.1016/j.biomaterials.2009.08.001
   Schwartz-Arad D, 2005, INT J ORAL MAX IMPL, V20, P238
   Shalabi MM, 2006, J DENT RES, V85, P496, DOI 10.1177/154405910608500603
   Siebers MC, 2007, CLIN ORAL IMPLAN RES, V18, P354, DOI 10.1111/j.1600-0501.2006.01314.x
   Sonoyama W, 2002, CLIN ORAL IMPLAN RES, V13, P359, DOI 10.1034/j.1600-0501.2002.130403.x
   ter Brugge PJ, 2002, BIOMATERIALS, V23, P3269, DOI 10.1016/S0142-9612(02)00085-6
   van Oirschot BAJA, 2014, CLIN ORAL IMPLAN RES, V25, P21, DOI 10.1111/clr.12060
   VANDERLUBBE HBM, 1988, STAIN TECHNOL, V63, P171, DOI 10.3109/10520298809107179
   Vercaigne S, 1998, J DENT RES, V77, P769
   WENNERBERG A, 1995, J MATER SCI-MATER M, V6, P302, DOI 10.1007/BF00120275
   Wheeler DL, 2001, J BIOMED MATER RES, V55, P603, DOI 10.1002/1097-4636(20010615)55:4<603::AID-JBM1054>3.0.CO;2-N
   Wilson CE, 2006, BIOMATERIALS, V27, P302, DOI 10.1016/j.biomaterials.2005.06.041
   Wolke JGC, 2005, KEY ENG MAT, V284-286, P187, DOI 10.4028/www.scientific.net/KEM.284-286.187
   Xiropaidis AV, 2005, CLIN ORAL IMPLAN RES, V16, P532, DOI 10.1111/j.1600-0501.2005.01126.x
   Xue WC, 2004, BIOMATERIALS, V25, P415, DOI 10.1016/S0142-9612(03)00545-3
   Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134
   Yuan H., 2010, P NATL ACAD SCI US, V107, P13614
   Yuan HP, 2001, J BIOMED MATER RES, V58, P270, DOI 10.1002/1097-4636(2001)58:3<270::AID-JBM1016>3.0.CO;2-2
NR 73
TC 6
Z9 6
U1 3
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUN
PY 2016
VL 37
BP 195
EP 205
DI 10.1016/j.actbio.2016.03.037
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DN8FM
UT WOS:000377314600020
PM 27019145
DA 2018-10-20
ER

PT J
AU Song, KD
   Li, LY
   Yan, XY
   Zhang, Y
   Li, RP
   Wang, YW
   Wang, L
   Wang, H
   Liu, TQ
AF Song, Kedong
   Li, Liying
   Yan, Xinyu
   Zhang, Yu
   Li, Ruipeng
   Wang, Yiwei
   Wang, Ling
   Wang, Hong
   Liu, Tianqing
TI Fabrication and development of artificial osteochondral constructs based
   on cancellous bone/hydrogel hybrid scaffold
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; CARTILAGE REPAIR; BONE-MARROW; ENGINEERED
   CARTILAGE; DYNAMIC FABRICATION; SPINNER FLASK; ADIPOSE; DIFFERENTIATION;
   REGENERATION; DEFECTS
AB Using tissue engineering techniques, an artificial osteochondral construct was successfully fabricated to treat large osteochondral defects. In this study, porcine cancellous bones and chitosan/gelatin hydrogel scaffolds were used as substitutes to mimic bone and cartilage, respectively. The porosity and distribution of pore size in porcine bone was measured and the degradation ratio and swelling ratio for chitosan/gelatin hydrogel scaffolds was also determined in vitro. Surface morphology was analyzed with the scanning electron microscope (SEM). The physicochemical properties and the composition were tested by using an infrared instrument. A double layer composite scaffold was constructed via seeding adipose-derived stem cells (ADSCs) induced to chondrocytes and osteoblasts, followed by inoculation in cancellous bones and hydrogel scaffolds. Cell proliferation was assessed through Dead/Live staining and cellular activity was analyzed with IpWin5 software. Cell growth, adhesion and formation of extracellular matrix in composite scaffolds blank cancellous bones or hydrogel scaffolds were also analyzed. SEM analysis revealed a super porous internal structure of cancellous bone scaffolds and pore size was measured at an average of 410 +/- 59 mu m while porosity was recorded at 70.6 +/- 1.7 %. In the hydrogel scaffold, the average pore size was measured at 117 +/- 21 mu m and the porosity and swelling rate were recorded at 83.4 +/- 0.8 % and 362.0 +/- 2.4 %, respectively. Furthermore, the remaining hydrogel weighed 80.76 +/- 1.6 % of the original dry weight after hydration in PBS for 6 weeks. In summary, the cancellous bone and hydrogel composite scaffold is a promising biomaterial which shows an essential physical performance and strength with excellent osteochondral tissue interaction in situ. ADSCs are a suitable cell source for osteochondral composite reconstruction. Moreover, the bi-layered scaffold significantly enhanced cell proliferation compared to the cells seeded on either single scaffold. Therefore, a bi-layered composite scaffold is an appropriate candidate for fabrication of osteochondral tissue.
C1 [Song, Kedong; Li, Liying; Yan, Xinyu; Zhang, Yu; Li, Ruipeng; Wang, Ling; Liu, Tianqing] Dalian Univ Technol, Dalian R&D Ctr Stem Cell & Tissue Engn, State Key Lab Fine Chem, Dalian 116024, Peoples R China.
   [Wang, Yiwei] Univ Sydney, ANZAC Res Inst, Burns Res, Concord, NSW 2139, Australia.
   [Wang, Ling] Dalian Med Univ, Affiliated Hosp 1, Dept Oncol, Dalian 116011, Peoples R China.
   [Wang, Hong] Dalian Med Univ, Affiliated Hosp 1, Dept Orthopaed, Dalian 116011, Peoples R China.
RP Song, KD; Wang, L; Liu, TQ (reprint author), Dalian Univ Technol, Dalian R&D Ctr Stem Cell & Tissue Engn, State Key Lab Fine Chem, Dalian 116024, Peoples R China.; Wang, L (reprint author), Dalian Med Univ, Affiliated Hosp 1, Dept Oncol, Dalian 116011, Peoples R China.
EM Kedongsong@dlut.edu.cn; whwl@hotmail.com; liutq@dlut.edu.cn
FU Fok Ying Tung Education Foundation [132027]; National Science Foundation
   of China [31370991/31170945/81271719/81341060]; Joint Open Foundation of
   Natural Science Foundation of Liaoning; Shenyang National Laboratory for
   Materials Science [2015021017]; Fundamental Research Funds for the
   Central Universities, SRF for ROCS, SEM [DUT14YQ106/15GY47/16ZD210]
FX The present work was supported by Fok Ying Tung Education Foundation
   (132027), National Science Foundation of China
   (31370991/31170945/81271719/81341060), the Joint Open Foundation of
   Natural Science Foundation of Liaoning and Shenyang National Laboratory
   for Materials Science (2015021017) and the Fundamental Research Funds
   for the Central Universities (DUT14YQ106/15GY47/16ZD210), SRF for ROCS,
   SEM.
CR Abou-Khalil R, 2015, STEM CELLS, V33, P1501, DOI 10.1002/stem.1945
   Basad Erhan, 2007, Acta Orthop Traumatol Turc, V41 Suppl 2, P79
   Cao S, 2012, BEIJING BIOMED ENG, V31, P478
   Cao YL, 1997, PLAST RECONSTR SURG, V100, P297, DOI 10.1097/00006534-199708000-00001
   Cheng NC, 2012, BIOMATERIALS, V33, P1748, DOI 10.1016/j.biomaterials.2011.11.049
   Chia SL, 2006, TISSUE ENG, V12, P1945, DOI 10.1089/ten.2006.12.1945
   Chien KB, 2013, TISSUE ENG PART C-ME, V19, P417, DOI [10.1089/ten.tec.2012.0383, 10.1089/ten.TEC.2012.0383]
   Damm P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120438
   Enea D, 2015, KNEE, V22, P30, DOI 10.1016/j.knee.2014.10.003
   Faia-Torres AB, 2014, BIOMATERIALS, V35, P9023, DOI 10.1016/j.biomaterials.2014.07.015
   Fields AJ, 2012, SPINE, V37, pE1310, DOI 10.1097/BRS.0b013e318267bcfc
   Filardo G, 2013, ARTHROSCOPY, V29, P174, DOI 10.1016/j.arthro.2012.05.891
   Filova E, 2008, J BIOMED MATER RES B, V87B, P415, DOI 10.1002/jbm.b.31119
   Godzik J, 2015, J NEUROSURG-SPINE, V23, P144, DOI 10.3171/2014.12.SPINE14535
   Ho STB, 2010, TISSUE ENG PT A, V16, P1123, DOI 10.1089/ten.TEA.2009.0471
   Karaoz E, 2013, CYTOTHERAPY, V15, P557, DOI 10.1016/j.jcyt.2013.01.005
   Kawamura S, 1998, ACTA ORTHOP SCAND, V69, P56, DOI 10.3109/17453679809002358
   Khanarian NT, 2012, TISSUE ENG PT A, V18, P533, DOI [10.1089/ten.tea.2011.0279, 10.1089/ten.TEA.2011.0279]
   Lee AY, 2015, RES VET SCI, V100, P115, DOI 10.1016/j.rvsc.2015.03.010
   Lee JW, 2015, CURR PHARM DESIGN, V21, P1606, DOI 10.2174/1381612821666150115125324
   Link DP, 2013, J BIOMED MATER RES A, V101, P3059, DOI 10.1002/jbm.a.34614
   Liu H, 2005, TISSUE ENG, V11, P319, DOI 10.1089/ten.2005.11.319
   Liu X, 2014, ACTA BIOMATER, V10, P4484, DOI 10.1016/j.actbio.2014.06.027
   Lu TF, 2014, APPL BIOCHEM BIOTECH, V174, P719, DOI 10.1007/s12010-014-1128-3
   Luo ZW, 2015, BIOMATERIALS, V52, P463, DOI 10.1016/j.biomaterials.2015.01.001
   Mesimaki K, 2009, INT J ORAL MAX SURG, V38, P201, DOI 10.1016/j.ijom.2009.01.001
   Mohan N, 2011, TISSUE ENG PT A, V17, P2845, DOI 10.1089/ten.tea.2011.0135
   Nooeaid P, 2012, J CELL MOL MED, V16, P2247, DOI 10.1111/j.1582-4934.2012.01571.x
   Perdisa F, 2014, HISTOL HISTOPATHOL, V29, P805, DOI 10.14670/HH-29.805
   Qu XJ, 2013, BIOCHEM BIOPH RES CO, V439, P552, DOI 10.1016/j.bbrc.2013.09.005
   Ren YZ, 2015, MOL CELL BIOCHEM, V400, P135, DOI 10.1007/s11010-014-2269-y
   SAMS AE, 1995, OSTEOARTHR CARTILAGE, V3, P61, DOI 10.1016/S1063-4584(05)80038-X
   Schek RM, 2004, TISSUE ENG, V10, P1376, DOI 10.1089/1076327042500391
   Solchaga LA, 2000, J ORTHOP RES, V18, P773, DOI 10.1002/jor.1100180515
   Song KD, 2016, MAT SCI ENG C-MATER, V62, P787, DOI 10.1016/j.msec.2016.02.036
   Song KD, 2015, MAT SCI ENG C-MATER, V55, P384, DOI 10.1016/j.msec.2015.05.062
   Song KD, 2014, APPL BIOCHEM BIOTECH, V174, P1331, DOI 10.1007/s12010-014-1132-7
   Song KD, 2013, APPL BIOCHEM BIOTECH, V170, P459, DOI 10.1007/s12010-013-0210-6
   Song KD, 2013, MAT SCI ENG C-MATER, V33, P1506, DOI 10.1016/j.msec.2012.12.054
   Song KD, 2012, APPL BIOCHEM BIOTECH, V167, P2381, DOI 10.1007/s12010-012-9764-y
   Steinwachs MR, 2014, ARTHROSC TEC, V3, pE399, DOI 10.1016/j.eats.2014.02.011
   Sterodimas A, 2010, J PLAST RECONSTR AES, V63, P1886, DOI 10.1016/j.bjps.2009.10.028
   Strem Brian M., 2005, Keio Journal of Medicine, V54, P132, DOI 10.2302/kjm.54.132
   Tang C, 2014, TISSUE ENG PT A, V20, P2455, DOI [10.1089/ten.tea.2013.0464, 10.1089/ten.TEA.2013.0464]
   van der Kraan PM, 2012, OSTEOARTHR CARTILAGE, V20, P223, DOI 10.1016/j.joca.2011.12.003
   Wang F, 2008, BIONIC DESIGN INITIA
   Zhu YX, 2008, CELL BIOCHEM FUNCT, V26, P664, DOI 10.1002/cbf.1488
NR 47
TC 6
Z9 6
U1 4
U2 48
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 2016
VL 27
IS 6
AR 114
DI 10.1007/s10856-016-5722-5
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DN9BD
UT WOS:000377373200015
PM 27180235
DA 2018-10-20
ER

PT J
AU Chiang, YC
   Wang, YL
   Lin, PY
   Chen, YY
   Chien, CY
   Lin, HP
   Lin, CP
AF Chiang, Yu-Chih
   Wang, Yin-Lin
   Lin, Po-Yen
   Chen, Yen-Yi
   Chien, Chih-Yu
   Lin, Hong-Ping
   Lin, Chun-Pin
TI A mesoporous biomaterial for biomimetic crystallization in dentinal
   tubules without impairing the bonding of a self-etch resin to dentin
SO JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
LA English
DT Article
DE biomimetic; crystal growth; dentinal tubule; mesoporous materials;
   self-etch adhesive
ID POSTOPERATIVE SENSITIVITY; IN-VITRO; COMPOSITE RESTORATIONS; AMALGAM
   RESTORATIONS; DP-BIOGLASS; DEEP DENTIN; HYPERSENSITIVITY; SYSTEMS; CELLS
AB Background/Purpose: CaCO3@mesoporous silica reacted with phosphoric acid (denoted as CCMS-HP) enables the growth of calcium phosphate crystals in dentinal tubules. This study tested whether CCMS-HP could be used to form a biomimetic barrier on the exposed dentin for prevention of dentin sensitivity without impairing the bonding of Single Bond Universal (SBU) self-etch adhesive to the dentin.
   Methods: Twenty-four dentin disks were prepared and divided into three groups: (1) SBU group (n = 8), in which SBU self-etch adhesive was bonded to the dentin disk directly; (2) CCMS-HP group (n = 8), in which CCMS-HP was applied onto the dentin surface; and (3) CCMS-HP/SBU group (n = 8), in which the dentin surface was first treated with CCMS-HP and then boned by SBU. The permeation depth of crystals into the dentinal tubules was examined and measured with a scanning electron microscope. The shear bonding strength of SBU and CCMS-HP/SBU to dentin was also measured.
   Results: The mean crystal permeation depth was 35.8 +/- 6.9 mu m for the CCMS-HP/SBU group and 33.6 +/- 12.2 mu m for the CCMS-HP group; no significant difference was found between the two groups. Moreover, the mean shear bonding strength was 22.7 +/- 6.7 MPa for the CCMS-HP/SBU group and 23.3 +/- 7.0 MPa for the SBU group. There was also no significant difference between the two groups.
   Conclusion: CCMS-HP can be used to form a biomimetic barrier for prevention of dentin sensitivity because it neither impedes the bonding of SBU to dentin nor impairs the shear bonding strength between the SBU and dentin. Copyright (C) 2016, Formosan Medical Association. Published by Elsevier Taiwan LLC.
C1 [Chiang, Yu-Chih; Wang, Yin-Lin; Chen, Yen-Yi; Lin, Chun-Pin] Natl Taiwan Univ, Sch Dent, Grad Inst Clin Dent, Taipei 10764, Taiwan.
   [Chiang, Yu-Chih; Wang, Yin-Lin; Chen, Yen-Yi; Lin, Chun-Pin] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Taipei 10764, Taiwan.
   [Lin, Po-Yen] Natl Yang Ming Univ, Dept Dent, Sch Dent, Taipei 112, Taiwan.
   [Chien, Chih-Yu] Natl Taiwan Univ, Sch Dent, Grad Inst Oral Biol, Taipei 10764, Taiwan.
   [Lin, Hong-Ping] Natl Cheng Kung Univ, Dept Chem, Tainan 70101, Taiwan.
RP Lin, CP (reprint author), Natl Taiwan Univ Hosp, Dept Dent, 1 Chang Te St, Taipei 10048, Taiwan.
EM pinlin@ntu.edu.tw
FU National Science Council Taiwan [103-2314-B-002-111-MY2,
   NSC101-2314-B-002-098-MY2]; National Taiwan University Hospital
   [100-N1766]
FX This study was partly supported by the funding from the National Science
   Council Taiwan (103-2314-B-002-111-MY2 and NSC101-2314-B-002-098-MY2)
   and the National Taiwan University Hospital (100-N1766). The authors
   also wish to thank the staff of the Core Labs, Department of Medical
   Research, National Taiwan University Hospital, Taipei, Taiwan for
   technical support.
CR Al-Omari WM, 2006, OPER DENT, V31, P165, DOI 10.2341/05-8
   Briso ALF, 2007, OPER DENT, V32, P421, DOI 10.2341/06-141
   Chang HH, 2005, BIOMATERIALS, V26, P745, DOI 10.1016/j.biomaterials.2004.03.021
   Chiang YC, 2010, J DENT RES, V89, P236, DOI 10.1177/0022034509357148
   Chiang YC, 2014, ACS NANO, V8, P12502, DOI 10.1021/nn5053487
   Chiang YC, 2010, COMPOS SCI TECHNOL, V70, P989, DOI 10.1016/j.compscitech.2010.02.017
   Chiang YC, 2010, DENT MATER, V26, P223, DOI 10.1016/j.dental.2009.09.013
   Fok ASL, 2013, DENT MATER, V29, P1108, DOI 10.1016/j.dental.2013.08.198
   GAAFAR H, 1976, ORL J OTO-RHINO-LARY, V38, P350, DOI 10.1159/000275295
   Gordan VV, 1999, OPER DENT, V24, P377
   He CL, 2010, ADV FUNCT MATER, V20, P3568, DOI 10.1002/adfm.201000993
   ISHIKAWA K, 1994, J DENT RES, V73, P1462, DOI 10.1177/00220345940730081101
   Lee BS, 2007, DENT MATER J, V26, P52, DOI 10.4012/dmj.26.52
   Lee BS, 2015, J FORMOS MED ASSOC, V114, P339, DOI 10.1016/j.jfma.2012.12.009
   Lee BS, 2005, DENT MATER J, V24, P562, DOI 10.4012/dmj.24.562
   LeGeros RZ., 1991, MONOGR ORAL SCI
   Love RM, 2002, CRIT REV ORAL BIOL M, V13, P171, DOI 10.1177/154411130201300207
   Mahmoud SH, 2014, J ADHES DENT, V16, P285, DOI 10.3290/j.jad.a31939
   Moretto SG, 2013, J DENT, V41, P675, DOI 10.1016/j.jdent.2013.05.016
   Nakajima M, 1999, J DENT RES, V78, P1298, DOI 10.1177/00220345990780070301
   Pashley DH, 2011, DENT MATER, V27, P1, DOI 10.1016/j.dental.2010.10.016
   PASHLEY DH, 1994, ARCH ORAL BIOL, V39, pS73, DOI 10.1016/0003-9969(94)90191-0
   PASHLEY EL, 1993, DENT MATER, V9, P19, DOI 10.1016/0109-5641(93)90099-C
   Pegado Rafael Eduardo Fernandes, 2010, Eur J Dent, V4, P110
   Reis A, 2015, DENT MATER, V31, P1052, DOI 10.1016/j.dental.2015.06.001
   SEGURA A, 1993, J ORAL REHABIL, V20, P495, DOI 10.1111/j.1365-2842.1993.tb01636.x
   Tanase CE, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/2/025002
   THOMAS HF, 1984, J DENT RES, V63, P1064, DOI 10.1177/00220345840630081101
   van Dijken JWV, 2014, DENT MATER, V30, pE245, DOI 10.1016/j.dental.2014.05.028
   Yoshida Y, 2004, J DENT RES, V83, P454, DOI 10.1177/154405910408300604
   Zhang L, 2014, DENT MATER, V30, P1245, DOI 10.1016/j.dental.2014.08.362
NR 31
TC 2
Z9 3
U1 1
U2 18
PU ELSEVIER TAIWAN
PI TAIPEI
PA RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2,
   TAIPEI, 10449, TAIWAN
SN 0929-6646
EI 1876-0821
J9 J FORMOS MED ASSOC
JI J. Formos. Med. Assoc.
PD JUN
PY 2016
VL 115
IS 6
BP 455
EP 462
DI 10.1016/j.jfma.2016.01.005
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA DO2FK
UT WOS:000377595100011
PM 26860038
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Patel, A
   Xue, YF
   Mukundan, S
   Rohan, LC
   Sant, V
   Stolz, DB
   Sant, S
AF Patel, Akhil
   Xue, Yingfei
   Mukundan, Shilpaa
   Rohan, Lisa C.
   Sant, Vinayak
   Stolz, Donna B.
   Sant, Shilpa
TI Cell-Instructive Graphene-Containing Nanocomposites Induce
   Multinucleated Myotube Formation
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Graphene nanosheet; Myoblast differentiation; Electrospinning;
   Polycaprolactone; Cell-instructive scaffolds; Biologic-free
ID MESENCHYMAL STEM-CELLS; SKELETAL-MUSCLE DIFFERENTIATION; GROWTH-FACTOR;
   OSTEOGENIC DIFFERENTIATION; ELECTRICAL-CONDUCTIVITY; DEGRADATION
   PROPERTIES; MECHANICAL-PROPERTIES; TISSUE REGENERATION; COMPOSITE; OXIDE
AB Myoblast differentiation is a key step in myogenesis and has long been considered to be controlled mainly by biochemical cues such as growth factors. However, the tissue engineering approaches based on biochemical cues demonstrate low reproducibility as a precise spatial control over their bioactivity is challenging. Recently, substrate micro/nano-structure and electro-responsive properties are recognized for their important roles in myoblast differentiation. In this study, we hypothesized that engineering biophysical features such as nano/micro-fibrous structure and conductive properties into a single biomaterial scaffold will instruct the myoblasts to differentiate into multinucleated myotubes even in the absence of differentiation media. We fabricated nanocomposite scaffolds composed of conductive graphene nanosheets and polycaprolactone (PCL), a widely used biocompatible material. The resulting graphene-PCL scaffolds possess excellent conductivity due to graphene nanosheets and great processability, biodegradability and elastic mechanical properties conferred by PCL. Additionally, physicochemical and mechanical properties of nanocomposite scaffolds can be tuned by varying graphene concentration. Further, graphene-PCL nanocomposites and their 8-week degradation products exhibited remarkable cytocompatibility and promoted adhesion and proliferation of C2C12 mouse myoblast cells. Importantly, these nanocomposite scaffolds induced graphene concentration-dependent differentiation of C2C12 cells into multinucleated myotubes even in normal growth media suggesting their cell-instructive potential. Thus, graphene-PCL nanocomposite scaffolds can serve as a strategy to promote skeletal muscle regeneration without biochemical cues.
C1 [Patel, Akhil; Xue, Yingfei; Mukundan, Shilpaa; Rohan, Lisa C.; Sant, Vinayak; Sant, Shilpa] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA.
   [Stolz, Donna B.] Univ Pittsburgh, Sch Med, Ctr Biol Imaging, Pittsburgh, PA 15261 USA.
   [Stolz, Donna B.] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA 15261 USA.
   [Stolz, Donna B.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA.
   [Sant, Shilpa] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15219 USA.
   [Sant, Shilpa] McGowan Inst Regenerat Med, Pittsburgh, PA 15260 USA.
RP Sant, S (reprint author), Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA.
EM shs149@pitt.edu
OI Xue, Yingfei/0000-0002-4551-3702; Patel, Akhil/0000-0001-8915-8995;
   Sant, Shilpa/0000-0002-2017-9584
FU Department of Pharmaceutical Sciences at University of Pittsburgh
FX The authors acknowledge Material Characterization Lab, University of
   Pittsburgh for access to contact angle goniometer and Dr. Tracy Cui lab
   for access to conductivity measurement. SS acknowledges financial
   support (start-up funds) from the Department of Pharmaceutical Sciences
   at University of Pittsburgh.
CR Ahadian S, 2015, BIOMATER SCI-UK, V3, P1449, DOI 10.1039/c5bm00215j
   Ahadian S, 2014, RSC ADV, V4, P9534, DOI 10.1039/c3ra46218h
   Ahmed WW, 2010, BIOMATERIALS, V31, P250, DOI 10.1016/j.biomaterials.2009.09.047
   Alzari V, 2011, J MATER CHEM, V21, P8727, DOI 10.1039/c1jm11076d
   Aryaei A, 2014, J BIOMED MATER RES A, V102, P3282, DOI 10.1002/jbm.a.34993
   Bajaj P., 2014, ADV HEALTHC MATER, V3, P949
   BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y
   Bentzinger C. F., 2012, COLD SPRING HARB PER, V4
   Bonderer LJ, 2008, SCIENCE, V319, P1069, DOI 10.1126/science.1148726
   Bridges Amanda W, 2008, J Diabetes Sci Technol, V2, P984
   Cezar CA, 2016, P NATL ACAD SCI USA, V113, P1534, DOI 10.1073/pnas.1517517113
   Chaudhuri B, 2015, BIOFABRICATION, V7, DOI 10.1088/1758-5090/7/1/015009
   Depan D, 2014, BIOMATER SCI-UK, V2, P1727, DOI 10.1039/c4bm00168k
   Ding X., 2015, ADV HEALTHC MAT
   Ferri P, 2009, J CELL BIOCHEM, V108, P1302, DOI 10.1002/jcb.22360
   Gaharwar AK, 2015, BIOFABRICATION, V7, DOI 10.1088/1758-5090/7/1/015001
   Gawlitta D, 2008, TISSUE ENG PT A, V14, P161, DOI 10.1089/ten.a.2007.0095
   Goenka S, 2014, J CONTROL RELEASE, V173, P75, DOI 10.1016/j.jconrel.2013.10.017
   Gutierrez J, 2010, MOL CELL BIOL, V30, P1634, DOI 10.1128/MCB.01164-09
   Han Y, 2013, ACTA BIOMATER, V9, P9107, DOI 10.1016/j.actbio.2013.06.022
   Hill E, 2006, P NATL ACAD SCI USA, V103, P2494, DOI 10.1073/pnas.0506004103
   Holloway JL, 2014, ACTA BIOMATER, V10, P3581, DOI 10.1016/j.actbio.2014.05.004
   Horsley V, 2004, CELLS TISSUES ORGANS, V176, P67, DOI 10.1159/000075028
   Juhas M, 2013, CURR OPIN BIOTECH, V24, P880, DOI 10.1016/j.copbio.2013.04.013
   Jun I, 2009, BIOMATERIALS, V30, P2038, DOI 10.1016/j.biomaterials.2008.12.063
   KREIDER BL, 1992, SCIENCE, V255, P1700, DOI 10.1126/science.1372755
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lawson MA, 2000, CELLS TISSUES ORGANS, V167, P130, DOI 10.1159/000016776
   Lee J, 2013, J MEMBRANE SCI, V448, P223, DOI 10.1016/j.memsci.2013.08.017
   LI L, 1992, GENE DEV, V6, P676, DOI 10.1101/gad.6.4.676
   Li YF, 2013, P NATL ACAD SCI USA, V110, P12295, DOI 10.1073/pnas.1222276110
   Liu D, 2001, GENE DEV, V15, P2950, DOI 10.1101/gad.925901
   Liu WJ, 2015, ACTA BIOMATER, V21, P217, DOI 10.1016/j.actbio.2015.04.012
   Luo Y, 2015, ACS APPL MATER INTER, V7, P6331, DOI 10.1021/acsami.5b00862
   Mukundan S, 2015, EUR POLYM J, V68, P21, DOI 10.1016/j.eurpolymj.2015.04.026
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Nayak TR, 2011, ACS NANO, V5, P4670, DOI 10.1021/nn200500h
   OLSON EN, 1992, DEV BIOL, V154, P261, DOI 10.1016/0012-1606(92)90066-P
   Ostrovidov S, 2014, TISSUE ENG PART B-RE, V20, P403, DOI [10.1089/ten.teb.2013.0534, 10.1089/ten.TEB.2013.0534]
   Patel A., 2016, ACTA BIOMATER
   Pelipenko J, 2015, INT J PHARMACEUT, V484, P57, DOI 10.1016/j.ijpharm.2015.02.043
   Rossi CA, 2011, FASEB J, V25, P2296, DOI 10.1096/fj.10-174755
   Sant S., 2012, BIOMIMETIC APPROACHE, P471
   Sant S, 2013, ACTA BIOMATER, V9, P5963, DOI 10.1016/j.actbio.2012.11.014
   Santin M., 2013, BIOL RESPONS BIOMATE, V1, P43
   Sanz A, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/10/104209
   Sfeir C., 2014, ACTA BIOMATER
   Soliman S, 2011, J BIOMED MATER RES A, V96A, P566, DOI 10.1002/jbm.a.33010
   Stone V, 2009, CRIT REV TOXICOL, V39, P613, DOI 10.1080/10408440903120975
   Suk JW, 2010, ACS NANO, V4, P6557, DOI 10.1021/nn101781v
   Tomblyn S, 2015, J BIOMED MAT RES B
   Tong ZX, 2011, TISSUE ENG PT A, V17, P2773, DOI [10.1089/ten.tea.2011.0219, 10.1089/ten.TEA.2011.0219]
   Ventre M., 2016, ACS APPL MAT INTERFA
   Warren H, 2014, J POLYM SCI POL PHYS, V52, P864, DOI 10.1002/polb.23497
   Wu N, 2012, J MATER CHEM, V22, P17254, DOI 10.1039/c2jm33114d
   Xavier JR, 2015, ACS NANO, V9, P3109, DOI 10.1021/nn507488s
   Xu AX, 2015, MAT SCI ENG C-MATER, V48, P592, DOI 10.1016/j.msec.2014.12.061
   Xue YF, 2015, EUR POLYM J, V72, P163, DOI 10.1016/j.eurpolymj.2015.09.013
   Yan XR, 2010, J ELECTROSTAT, V68, P458, DOI 10.1016/j.elstat.2010.06.009
   Yang HS, 2016, ADV HEALTHC MATER, V5, P137, DOI 10.1002/adhm.201500003
   Zhang YB, 2010, ACS NANO, V4, P3181, DOI 10.1021/nn1007176
   Zhou TN, 2013, EXPRESS POLYM LETT, V7, P747, DOI 10.3144/expresspolymlett.2013.72
NR 62
TC 9
Z9 9
U1 2
U2 29
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD JUN
PY 2016
VL 44
IS 6
BP 2036
EP 2048
DI 10.1007/s10439-016-1586-6
PG 13
WC Engineering, Biomedical
SC Engineering
GA DN0RO
UT WOS:000376772000015
PM 26983841
DA 2018-10-20
ER

PT J
AU Gao, WW
   Zhang, Y
   Zhang, QZ
   Zhang, LF
AF Gao, Weiwei
   Zhang, Yue
   Zhang, Qiangzhe
   Zhang, Liangfang
TI Nanoparticle-Hydrogel: A Hybrid Biomaterial System for Localized Drug
   Delivery
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Nanomedicine; Nanoparticle; Hydrogel; Hybrid biomaterial; Drug delivery
ID RESISTANT STAPHYLOCOCCUS-AUREUS; BIODEGRADABLE COLLOIDAL GELS; ON-DEMAND
   DRUG; SPINAL-CORD; THERAPEUTIC APPLICATIONS; NANOCOMPOSITE HYDROGELS;
   POLYMERIC NANOPARTICLES; REGENERATIVE MEDICINE; COMBINATION THERAPY;
   CONTROLLED-RELEASE
AB Nanoparticles have offered a unique set of properties for drug delivery including high drug loading capacity, combinatorial delivery, controlled and sustained drug release, prolonged stability and lifetime, and targeted delivery. To further enhance therapeutic index, especially for localized application, nanoparticles have been increasingly combined with hydrogels to form a hybrid biomaterial system for controlled drug delivery. Herein, we review recent progresses in engineering such nanoparticle-hydrogel hybrid system (namely 'NP-gel') with a particular focus on its application for localized drug delivery. Specifically, we highlight four research areas where NP-gel has shown great promises, including (1) passively controlled drug release, (2) stimuli-responsive drug delivery, (3) site-specific drug delivery, and (4) detoxification. Overall, integrating therapeutic nanoparticles with hydrogel technologies creates a unique and robust hybrid biomaterial system that enables effective localized drug delivery.
C1 [Zhang, Liangfang] Univ Calif San Diego, Dept Nanoengn, La Jolla, CA 92093 USA.
   [Zhang, Liangfang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA.
RP Zhang, LF (reprint author), Univ Calif San Diego, Dept Nanoengn, La Jolla, CA 92093 USA.; Zhang, LF (reprint author), Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA.
EM zhang@ucsd.edu
FU National Science Foundation [DMR-1505699]; National Institute of
   Diabetes and Digestive and Kidney Diseases of the National Institutes of
   Health [R01DK095168]
FX This work is supported by the National Science Foundation Grant
   DMR-1505699 and the National Institute of Diabetes and Digestive and
   Kidney Diseases of the National Institutes of Health under Award Number
   R01DK095168.
CR Al Ghanami RC, 2010, SOFT MATTER, V6, P5037, DOI 10.1039/c0sm00059k
   Aryal S, 2011, MOL PHARMACEUT, V8, P1401, DOI 10.1021/mp200243k
   Baumann MD, 2010, BIOMATERIALS, V31, P7631, DOI 10.1016/j.biomaterials.2010.07.004
   Baumann MD, 2009, J CONTROL RELEASE, V138, P205, DOI 10.1016/j.jconrel.2009.05.009
   Bishop KJM, 2009, SMALL, V5, P1600, DOI 10.1002/smll.200900358
   Blanco E, 2015, NAT BIOTECHNOL, V33, P941, DOI 10.1038/nbt.3330
   Caccavo D, 2015, MOL PHARMACEUT, V12, P474, DOI 10.1021/mp500563n
   Chen ML, 2012, ACS NANO, V6, P4835, DOI 10.1021/nn300106t
   Cho EC, 2008, NANO LETT, V8, P168, DOI 10.1021/nl072346e
   Chvatal SA, 2008, BIOMATERIALS, V29, P1967, DOI 10.1016/j.biomaterials.2008.01.002
   Cometa S, 2013, J BIOACT COMPAT POL, V28, P508, DOI 10.1177/0883911513498960
   Conrado RJ, 2008, CURR OPIN BIOTECH, V19, P492, DOI 10.1016/j.copbio.2008.07.006
   Dang TT, 2013, BIOMATERIALS, V34, P5792, DOI 10.1016/j.biomaterials.2013.04.016
   Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614
   DeMuth PC, 2012, ACS NANO, V6, P8041, DOI 10.1021/nn302639r
   DeMuth PC, 2010, ADV MATER, V22, P4851, DOI 10.1002/adma.201001525
   Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI [10.1038/nnano.2010.246, 10.1038/NNANO.2010.246]
   Fairbanks BD, 2009, BIOMATERIALS, V30, P6702, DOI 10.1016/j.biomaterials.2009.08.055
   Fang RH, 2015, ADV DRUG DELIVER REV, V90, P69, DOI 10.1016/j.addr.2015.04.001
   Fang RH, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005386
   Fang Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02811
   Farokhzad OC, 2009, ACS NANO, V3, P16, DOI 10.1021/nn900002m
   Fraylich MR, 2010, J COLLOID INTERF SCI, V344, P61, DOI 10.1016/j.jcis.2009.12.030
   Fuhrer R, 2009, SMALL, V5, P383, DOI 10.1002/smll.200801091
   Fullenkamp DE, 2012, BIOMATERIALS, V33, P3783, DOI 10.1016/j.biomaterials.2012.02.027
   Gao WW, 2014, WIRES NANOMED NANOBI, V6, P532, DOI 10.1002/wnan.1282
   Gao WW, 2014, ACS NANO, V8, P2900, DOI 10.1021/nn500110a
   Gao WW, 2010, MOL PHARMACEUT, V7, P1913, DOI 10.1021/mp100253e
   Gobin AM, 2007, NANO LETT, V7, P1929, DOI 10.1021/nl070610y
   Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591
   Gorwitz RJ, 2008, J INFECT DIS, V197, P179, DOI 10.1086/523767
   Gou ML, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4774
   Grzelczak M, 2010, ACS NANO, V4, P3591, DOI 10.1021/nn100869j
   Gu Z, 2013, ACS NANO, V7, P4194, DOI 10.1021/nn400630x
   Gulsen D, 2005, CURR EYE RES, V30, P1071, DOI 10.1080/02713680500346633
   Gupta P, 2002, DRUG DISCOV TODAY, V7, P569, DOI 10.1016/S1359-6446(02)02255-9
   HIGUCHI T, 1961, J PHARM SCI, V50, P874, DOI 10.1002/jps.2600501018
   Hoare TR, 2008, POLYMER, V49, P1993, DOI 10.1016/j.polymer.2008.01.027
   Hoshino Y, 2012, P NATL ACAD SCI USA, V109, P33, DOI 10.1073/pnas.1112828109
   Hu CMJ, 2015, NATURE, V526, P118, DOI 10.1038/nature15373
   Hu CMJ, 2013, NAT NANOTECHNOL, V8, P933, DOI [10.1038/nnano.2013.254, 10.1038/NNANO.2013.254]
   Hu CMJ, 2013, NAT NANOTECHNOL, V8, P336, DOI [10.1038/nnano.2013.54, 10.1038/NNANO.2013.54]
   Hu CMJ, 2011, P NATL ACAD SCI USA, V108, P10980, DOI 10.1073/pnas.1106634108
   Hu K, 2015, ADV MATER, V27, P2507, DOI 10.1002/adma.201405757
   Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601
   Ilg P, 2013, SOFT MATTER, V9, P3465, DOI 10.1039/c3sm27809c
   Jung HJ, 2013, J CONTROL RELEASE, V165, P82, DOI 10.1016/j.jconrel.2012.10.010
   Kapoor Y, 2008, J COLLOID INTERF SCI, V322, P624, DOI 10.1016/j.jcis.2008.02.028
   Kastrup CJ, 2012, P NATL ACAD SCI USA, V109, P21444, DOI 10.1073/pnas.1217972110
   Kolishetti N, 2010, P NATL ACAD SCI USA, V107, P17939, DOI 10.1073/pnas.1011368107
   Lang N, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006557
   Langer R, 2009, ADV MATER, V21, P3235, DOI 10.1002/adma.200902589
   Laroui H, 2010, GASTROENTEROLOGY, V138, P843, DOI 10.1053/j.gastro.2009.11.003
   Li F, 2011, ANGEW CHEM INT EDIT, V50, P360, DOI 10.1002/anie.201001451
   Li L, 2015, POLYM CHEM-UK, V6, P353, DOI 10.1039/c4py01415d
   Lin CC, 2006, ADV DRUG DELIVER REV, V58, P1379, DOI 10.1016/j.addr.2006.09.004
   Liu TY, 2008, J CONTROL RELEASE, V126, P228, DOI 10.1016/j.jconrel.2007.12.006
   Liu Y, 2013, NAT NANOTECHNOL, V8, P187, DOI [10.1038/nnano.2012.264, 10.1038/NNANO.2012.264]
   Lobatto ME, 2011, NAT REV DRUG DISCOV, V10, P835, DOI 10.1038/nrd3578
   Ma L, 2013, ACS NANO, V7, P9518, DOI 10.1021/nn405674m
   Merino S, 2015, ACS NANO, V9, P4686, DOI 10.1021/acsnano.5b01433
   Messing R, 2011, MACROMOLECULES, V44, P2990, DOI 10.1021/ma102708b
   Mohan YM, 2007, POLYMER, V48, P158, DOI 10.1016/j.polymer.2006.10.045
   Morton SW, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005261
   Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397
   Ninh C, 2014, BIOMATER SCI-UK, V2, P766, DOI 10.1039/c3bm60321k
   Park CG, 2015, MACROMOL RES, V23, P882, DOI 10.1007/s13233-015-3115-0
   Patel RG, 2014, CELL MOL BIOENG, V7, P394, DOI 10.1007/s12195-014-0353-8
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Petros RA, 2010, NAT REV DRUG DISCOV, V9, P615, DOI 10.1038/nrd2591
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Qiu Y, 2001, ADV DRUG DELIVER REV, V53, P321, DOI 10.1016/S0169-409X(01)00203-4
   Qu Y, 2015, NPG ASIA MATER, V7, DOI 10.1038/am.2015.83
   Ramer LM, 2005, SPINAL CORD, V43, P134, DOI 10.1038/sj.sc.3101715
   Ratner BD, 2002, J CONTROL RELEASE, V78, P211, DOI 10.1016/S0168-3659(01)00502-8
   Rattanaruengsrikul V, 2012, J APPL POLYM SCI, V124, P1668, DOI 10.1002/app.35195
   Romero MI, 2001, J NEUROSCI, V21, P8408
   Roux R, 2013, MAT SCI ENG C-MATER, V33, P997, DOI 10.1016/j.msec.2012.12.002
   Saquing CD, 2009, SMALL, V5, P944, DOI 10.1002/smll.200801273
   Satarkar NS, 2008, J CONTROL RELEASE, V130, P246, DOI 10.1016/j.jconrel.2008.06.008
   Sattayasamitsathit S, 2014, SMALL, V10, P2830, DOI 10.1002/smll.201303646
   Schafer-Korting M, 2007, ADV DRUG DELIVER REV, V59, P427, DOI 10.1016/j.addr.2007.04.006
   Schexnailder P, 2009, COLLOID POLYM SCI, V287, P1, DOI 10.1007/s00396-008-1949-0
   Schmaljohann D, 2006, ADV DRUG DELIVER REV, V58, P1655, DOI 10.1016/j.addr.2006.09.020
   Schmid-Wendtner MH, 2006, SKIN PHARMACOL PHYS, V19, P296, DOI 10.1159/000094670
   Schoffelen S, 2012, SOFT MATTER, V8, P1736, DOI 10.1039/c1sm06452e
   Sekine Y, 2012, ADV HEALTHC MATER, V1, P722, DOI 10.1002/adhm.201200175
   Sethi M, 2014, NANOSCALE, V6, P2321, DOI 10.1039/c3nr05961h
   Shi JJ, 2011, ACCOUNTS CHEM RES, V44, P1123, DOI 10.1021/ar200054n
   Shi JJ, 2010, NANO LETT, V10, P3223, DOI 10.1021/nl102184c
   Siepmann J, 2001, ADV DRUG DELIVER REV, V48, P139, DOI 10.1016/S0169-409X(01)00112-0
   Siepmann J, 2011, INT J PHARMACEUT, V418, P6, DOI 10.1016/j.ijpharm.2011.03.051
   Singer AJ, 2014, NEW ENGL J MED, V370, P1039, DOI 10.1056/NEJMra1212788
   Thomas V, 2009, J APPL POLYM SCI, V111, P934, DOI 10.1002/app.29018
   Timko BP, 2011, ANNU REV MATER RES, V41, P1, DOI 10.1146/annurev-matsci-062910-100359
   Wang AZ, 2012, ANNU REV MED, V63, P185, DOI 10.1146/annurev-med-040210-162544
   Wang F, 2015, ADV MATER, V27, P3437, DOI 10.1002/adma.201501071
   Wang HA, 2011, ADV MATER, V23, pH119, DOI 10.1002/adma.201003908
   Wang Q, 2008, ADV MATER, V20, P236, DOI 10.1002/adma.200702099
   Wang Q, 2013, TISSUE ENG PT A, V19, P2586, DOI [10.1089/ten.tea.2013.0075, 10.1089/ten.TEA.2013.0075]
   Wang Q, 2011, J BIOMED MATER RES A, V96A, P520, DOI 10.1002/jbm.a.33000
   Wang SG, 2012, THER DELIV, V3, P1155, DOI 10.4155/TDE.12.103
   Wang YL, 2013, J CONTROL RELEASE, V172, pE90, DOI 10.1016/j.jconrel.2013.08.182
   Wu Z, 2015, NANOSCALE, V7, P13680, DOI 10.1039/c5nr03730a
   Xia LW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3226
   Xiang YQ, 2007, EUR POLYM J, V43, P4178, DOI 10.1016/j.eurpolymj.2007.08.005
   Yan B, 2012, J AM CHEM SOC, V134, P16558, DOI 10.1021/ja308876j
   Yoon YM, 2015, SCI REP-UK, V5, DOI 10.1038/srep13155
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
   Zhang JH, 2010, ADV MATER, V22, P4249, DOI 10.1002/adma.201000755
   Zhang L, 2013, NAT BIOTECHNOL, V31, P553, DOI 10.1038/nbt.2580
   Zhang LF, 2015, ADV DRUG DELIVER REV, V90, P1, DOI 10.1016/j.addr.2015.07.010
   Zhang XB, 2011, NANO LETT, V11, P3239, DOI 10.1021/nl201503e
   Zhao XL, 2006, NEW J CHEM, V30, P915, DOI 10.1039/b601069e
   Zhao XH, 2011, P NATL ACAD SCI USA, V108, P67, DOI 10.1073/pnas.1007862108
   Zhu CH, 2012, ADV FUNCT MATER, V22, P4017, DOI 10.1002/adfm.201201020
   Zhu W, 2010, BIOMACROMOLECULES, V11, P3086, DOI 10.1021/bm100889j
NR 117
TC 23
Z9 23
U1 11
U2 140
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD JUN
PY 2016
VL 44
IS 6
BP 2049
EP 2061
DI 10.1007/s10439-016-1583-9
PG 13
WC Engineering, Biomedical
SC Engineering
GA DN0RO
UT WOS:000376772000016
PM 26951462
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Akhtar, N
   Rahman, MS
   Jamil, HM
   Arifuzzaman, M
   Miah, MM
   Asaduzzaman, SM
AF Akhtar, Naznin
   Rahman, Md. Shaifur
   Jamil, Hossen Mohammad
   Arifuzzaman, Md.
   Miah, M. M.
   Asaduzzaman, S. M.
TI Tissue banking in Bangladesh: 12 years of experience (2003-2014)
SO CELL AND TISSUE BANKING
LA English
DT Article
DE Tissue bank; Guidelines of tissue banking; Tissue allografts; Bone;
   Amniotic membrane; Bangladesh
ID ALLOGRAFT; KERATINOCYTES; SURGERY; BONE; TRANSPLANTATION
AB Tissue Banking and Biomaterial Research Unit (TBBRU), the only tissue bank of Bangladesh, has been established to create an available supply of human tissue allografts for transplantation in Bangladesh. Since its establishment in 2003, TBBRU strictly follows the guidelines of tissue banking setup by the International Atomic Energy Agency, the European Association of Tissue Banks and the American Association of Tissue Banks. Though started serving from earlier, regular supply of tissue allografts from this bank were documented at the end of 2006. From January 2007 to December 2014, 3747 bones and 5772 amniotic sacs were collected from live tissue donors. During this period, 59,489 cc bone allografts and 23,472 pieces of amniotic membrane allografts were processed. In the same period, 58,483 cc bone allografts and 20,786 pieces membrane were supplied to different hospitals throughout the country on the basis of demand. The outcomes of the concerted efforts of tissue banking professionals and physicians were the restoration of health and hope of 3662 patients during the last 8 years.
C1 [Akhtar, Naznin; Rahman, Md. Shaifur; Jamil, Hossen Mohammad; Arifuzzaman, Md.; Asaduzzaman, S. M.] AERE, TBBRU, Dhaka 1349, Bangladesh.
   [Miah, M. M.] Natl Inst Nucl Med & Allied Sci, BSMMU Campus, Dhaka 1000, Bangladesh.
RP Akhtar, N; Asaduzzaman, SM (reprint author), AERE, TBBRU, Dhaka 1349, Bangladesh.
EM nazmbiocu@yahoo.com; sikderasad@yahoo.com
OI Rahman, Md Shaifur/0000-0002-4306-6224; Jamil, Hossen
   Mohammad/0000-0001-8244-8607
FU Ministry of Science and Technology, People's Republic of Bangladesh;
   IAEA
FX We would like to thank Ministry of Science and Technology, People's
   Republic of Bangladesh and IAEA for providing the financial and
   technical support for the development of Tissue Banking and Biomaterial
   Research Unit, Bangladesh. We also like convey the heartiest thanks to
   Prof. Dr. Naiyyum Choudhury, Chairman, Bangladesh Atomic Energy
   Regulatory Authority, Dr. M. Serajul Islam, former Member, Bangladesh
   Atomic Energy commission and Mrs. Azizun Nessa, former Director of TBBRU
   for their support throughout the development of the tissue bank. We
   would like to give special thanks to the personnel of Cobalt-60 gamma
   source at AERE.
CR [Anonymous], 2006, 111372 ISO
   [Anonymous], 2006, 111371 ISO
   Armitage WJ, 2011, TRANSFUS MED HEMOTH, V38, P143, DOI 10.1159/000326632
   Baker Thomas F., 2005, Cell and Tissue Banking, V6, P271, DOI 10.1007/s10561-005-7364-6
   Braye F, 2000, MED BIOL ENG COMPUT, V38, P248, DOI 10.1007/BF02344784
   Chapovsky F, 2005, ARTHROSCOPY, V21, DOI 10.1016/j.arthro.2005.04.005
   Chen HJ, 2000, BRIT J OPHTHALMOL, V84, P826, DOI 10.1136/bjo.84.8.826
   Donati D, 2005, CURR ORTHOPAED, V19, P393, DOI 10.1016/j.cuor.2005.08.001
   Ehrler DM, 2000, CLIN ORTHOP RELAT R, P38
   Feilmeier MR, 2010, MIDDLE EAST AFR J OP, V17, P38, DOI 10.4103/0974-9233.61215
   Heng WL, 2013, CELL TISSUE BANK, V14, P187, DOI 10.1007/s10561-012-9310-8
   Judas F, 2005, TRANSPLANT P, V37, P2799, DOI 10.1016/j.transproceed.2005.05.004
   KUROYANAGI Y, 1993, ANN PLAS SURG, V31, P340, DOI 10.1097/00000637-199310000-00011
   Leon-Villapalos J, 2010, CELL TISSUE BANK, V11, P99, DOI 10.1007/s10561-009-9152-1
   Nather A, 2004, J Orthop Surg (Hong Kong), V12, P184
   Nguyen H, 2011, J ARTHROPLASTY, V26, P303, DOI 10.1016/j.arth.2010.03.032
   Pedraza JM, 2011, CELL SCI THER, V2, P105
   Plunkett MD, 1999, SEMIN THORAC CARDIOV, V2, P95
   Reardon MJ, 1997, CURR OPIN CARDIOL, V12, P114, DOI 10.1097/00001573-199703000-00005
   RONFARD V, 1991, BURNS, V17, P181, DOI 10.1016/0305-4179(91)90099-3
   Toteberg-Harms M, 2009, DEV OPHTHALMOL, V43, P105, DOI 10.1159/000223843
   Vajaradul Yongyudh, 2000, Cell and Tissue Banking, V1, P229, DOI 10.1023/A:1026542730541
   Vloemans AFPM, 2002, BURNS S1, V28, P16
   Zelen CM, 2014, WOUND MED, V4, P1
   Zwitser EW, 2012, CELL TISSUE BANK, V13, P63, DOI 10.1007/s10561-010-9230-4
NR 25
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1389-9333
EI 1573-6814
J9 CELL TISSUE BANK
JI Cell Tissue Banking
PD JUN
PY 2016
VL 17
IS 2
BP 189
EP 197
DI 10.1007/s10561-016-9549-6
PG 9
WC Cell Biology; Engineering, Biomedical
SC Cell Biology; Engineering
GA DN3UD
UT WOS:000376988400002
PM 26915083
DA 2018-10-20
ER

PT J
AU Ricklin, D
   Lambris, JD
AF Ricklin, Daniel
   Lambris, John D.
TI Therapeutic control of complement activation at the level of the central
   component C3
SO IMMUNOBIOLOGY
LA English
DT Article; Proceedings Paper
CT Meeting on Complement-Driver of Inflammation and Therapeutic Target in
   Diverse Diseases
CY FEB, 2015
CL Royal Soc, Chicheley, ENGLAND
HO Royal Soc
DE Complement; C3; Therapeutics; Convertase; Alternative pathway
ID PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; ANTI-FACTOR D; ALTERNATIVE PATHWAY;
   TISSUE-INJURY; PHARMACOKINETIC PROPERTIES; BIOMATERIAL SURFACES; MACULAR
   DEGENERATION; INHIBITOR COMPSTATIN; FACTOR-I; FACTOR-H
AB The increasing recognition of the complement system's association with diseases of the inflammatory spectrum and with biomaterial and transplant-related complications has generated growing interest in the therapeutic modulation of this innate immune cascade. As a central functional hub that largely drives the activation, amplification, and effector generation of the complement response, the plasma protein C3 has long been recognized as an attractive target. While pharmacological modulation of C3 activation may offer a powerful opportunity to interfere with or even prevent complement-driven pathologies, the development of C3 inhibitors has often been accompanied by concerns regarding the safety and feasibility of this approach. Although no C3-targeted inhibitors have thus far been approved for clinical use, several promising concepts and candidates have emerged in recent years. At the same time, experiences from preclinical development and clinical trials are slowly providing a more detailed picture of therapeutic complement inhibition at the level of C3. This review highlights the current therapeutic strategies to control C3 activation and discusses the possibilities and challenges on the road to bringing C3-targeted therapeutics to the clinic. (C) 2015 Elsevier GmbH. All rights reserved.
C1 [Ricklin, Daniel; Lambris, John D.] Univ Penn, Dept Pathol & Lab Med, 401 Stellar Chance,422 Curie Blvd, Philadelphia, PA 19104 USA.
RP Ricklin, D (reprint author), Univ Penn, Dept Pathol & Lab Med, 401 Stellar Chance,422 Curie Blvd, Philadelphia, PA 19104 USA.
EM ricklin@upenn.edu
FU NEI NIH HHS [R01 EY020633]; NIAID NIH HHS [P01 AI068730, N01 AI030040,
   R01 AI030040, R21 AI097805]
CR ALPER CA, 1967, J CLIN INVEST, V46, P2021, DOI 10.1172/JCI105691
   Atkinson C, 2005, J CLIN INVEST, V115, P2444, DOI 10.1172/JCI25208
   Bajic G, 2013, PROTEIN SCI, V22, P204, DOI 10.1002/pro.2200
   Baudino L, 2014, P NATL ACAD SCI USA, V111, P1503, DOI 10.1073/pnas.1316877111
   Berends ETM, 2015, MOL IMMUNOL, V65, P328, DOI 10.1016/j.molimm.2015.01.020
   Botto M, 2009, MOL IMMUNOL, V46, P2774, DOI 10.1016/j.molimm.2009.04.029
   Craik CS, 2011, BIOCHEM J, V435, P1, DOI 10.1042/BJ20100965
   DiLillo DJ, 2006, MOL IMMUNOL, V43, P1010, DOI 10.1016/j.molimm.2005.05.003
   Ekdahl KN, 2011, ADV DRUG DELIVER REV, V63, P1042, DOI 10.1016/j.addr.2011.06.012
   Forneris F, 2010, SCIENCE, V330, P1816, DOI 10.1126/science.1195821
   Fridkis-Hareli M, 2011, BLOOD, V118, P4705, DOI 10.1182/blood-2011-06-359646
   Grumach AS, 2014, MOL IMMUNOL, V61, P110, DOI 10.1016/j.molimm.2014.06.030
   Harboe M, 2004, CLIN EXP IMMUNOL, V138, P439, DOI 10.1111/j.1365-2249.2004.02627.x
   Harboe M, 2009, MOL IMMUNOL, V47, P373, DOI 10.1016/j.molimm.2009.09.005
   Hillmen P, 2013, BRIT J HAEMATOL, V162, P62, DOI 10.1111/bjh.12347
   Holers VM, 2013, ADV EXP MED BIOL, V735, P137, DOI 10.1007/978-1-4614-4118-2_9
   Holz FG, 2013, OPHTHALMOLOGICA, V230, P12
   Huang YJ, 2014, CHEMMEDCHEM, V9, P2223, DOI 10.1002/cmdc.201402212
   Janssen BJC, 2007, J BIOL CHEM, V282, P29241, DOI 10.1074/jbc.M704587200
   Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172
   Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005
   Katschke KJ, 2012, J BIOL CHEM, V287, P12886, DOI 10.1074/jbc.M112.345082
   Katschke KJ, 2009, J BIOL CHEM, V284, P10473, DOI 10.1074/jbc.M809106200
   Kimura Y, 2010, J CLIN INVEST, V120, P3545, DOI 10.1172/JCI41782
   Lachmann PJ, 2009, ADV IMMUNOL, V104, P115, DOI 10.1016/S0065-2776(08)04004-2
   Lay E, 2015, CLIN EXP IMMUNOL, V181, P314, DOI 10.1111/cei.12437
   Lazar HL, 2007, CIRCULATION, V116, pI83, DOI 10.1161/CIRCULATIONAHA.106.677914
   Lesher AM, 2013, MOL IMMUNOL, V56, P191, DOI 10.1016/j.molimm.2013.06.002
   Lesher AM, 2013, J AM SOC NEPHROL, V24, P53, DOI 10.1681/ASN.2012060570
   Li Jennifer S, 2006, Expert Rev Cardiovasc Ther, V4, P649, DOI 10.1586/14779072.4.5.649
   Loyet KM, 2014, J PHARMACOL EXP THER, V351, P527, DOI 10.1124/jpet.114.215921
   Maekawa T, 2014, J IMMUNOL, V192, P6020, DOI 10.4049/jimmunol.1400569
   Mastellos DC, 2015, EUR J CLIN INVEST, V45, P423, DOI 10.1111/eci.12419
   Mastellos DC, 2014, EXPERT REV HEMATOL, V7, P583, DOI 10.1586/17474086.2014.953926
   Medical Research Council, UK CLIN RES NETW STU
   Milder FJ, 2007, NAT STRUCT MOL BIOL, V14, P224, DOI 10.1038/nsmb1210
   Miwa T, 2013, J IMMUNOL, V190, P3552, DOI 10.4049/jimmunol.1202275
   Morgan B. P., 2014, 56 ASH ANN M EXP SAN
   Nagar B, 1998, SCIENCE, V280, P1277, DOI 10.1126/science.280.5367.1277
   Nilsson PH, 2013, BIOMATERIALS, V34, P985, DOI 10.1016/j.biomaterials.2012.10.040
   Paixao-Cavalcante D, 2014, J IMMUNOL, V192, P4844, DOI 10.4049/jimmunol.1303131
   Pauly D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096371
   Qu HC, 2013, IMMUNOBIOLOGY, V218, P496, DOI 10.1016/j.imbio.2012.06.003
   Reis ES, 2015, IMMUNOBIOLOGY, V220, P476, DOI 10.1016/j.imbio.2014.10.026
   Reis ES, 2006, SCAND J IMMUNOL, V63, P155, DOI 10.1111/j.1365-3083.2006.01729.x
   Ricklin D, 2008, ADV EXP MED BIOL, V632, P273, DOI 10.1007/978-0-387-78952-1_20
   Ricklin D, 2013, J IMMUNOL, V190, P3839, DOI 10.4049/jimmunol.1203200
   Ricklin D, 2013, J IMMUNOL, V190, P3831, DOI 10.4049/jimmunol.1203487
   Ricklin D, 2013, ADV EXP MED BIOL, V735, P1, DOI 10.1007/978-1-4614-4118-2_1
   Ricklin D, 2012, IMMUNOBIOLOGY, V217, P1057, DOI 10.1016/j.imbio.2012.07.016
   Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923
   Risitano AM, 2014, BLOOD, V123, P2094, DOI 10.1182/blood-2013-11-536573
   Risitano AM, 2012, BLOOD, V119, P6307, DOI 10.1182/blood-2011-12-398792
   Rooijakkers SHM, 2009, NAT IMMUNOL, V10, P721, DOI 10.1038/ni.1756
   Roversi P, 2011, P NATL ACAD SCI USA, V108, P12839, DOI 10.1073/pnas.1102167108
   Ruseva MM, 2013, J AM SOC NEPHROL, V24, P43, DOI 10.1681/ASN.2012060571
   Sacks S, 2013, ADV EXP MED BIOL, V735, P247, DOI 10.1007/978-1-4614-4118-2_17
   Sacks SH, 2012, NAT REV IMMUNOL, V12, P431, DOI 10.1038/nri3225
   Sahu A, 1996, J IMMUNOL, V157, P884
   Schmidt CQ, 2013, J IMMUNOL, V190, P5712, DOI 10.4049/jimmunol.1203548
   Scott D, 2016, IMMUNOBIOLOGY, V221, P719, DOI 10.1016/j.imbio.2015.05.001
   Vogel CW, 2014, MOL IMMUNOL, V61, P191, DOI 10.1016/j.molimm.2014.06.035
   Wiles J., 2014, 56 ASH ANN M EXP SAN
   Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755
   Wu YQ, 2011, J IMMUNOL, V186, P4269, DOI 10.4049/jimmunol.1003802
   Zhang YZ, 2015, IMMUNOBIOLOGY, V220, P993, DOI 10.1016/j.imbio.2015.04.001
NR 66
TC 14
Z9 14
U1 0
U2 3
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 0171-2985
J9 IMMUNOBIOLOGY
JI Immunobiology
PD JUN
PY 2016
VL 221
IS 6
SI SI
BP 740
EP 746
DI 10.1016/j.imbio.2015.06.012
PG 7
WC Immunology
SC Immunology
GA DN7BP
UT WOS:000377230600008
PM 26101137
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Gao, ZH
   Hu, L
   Liu, GL
   Wei, FL
   Liu, Y
   Liu, ZH
   Fan, ZP
   Zhang, CM
   Wang, JS
   Wang, SL
AF Gao, Z. H.
   Hu, L.
   Liu, G. L.
   Wei, F. L.
   Liu, Y.
   Liu, Z. H.
   Fan, Z. P.
   Zhang, C. M.
   Wang, J. S.
   Wang, S. L.
TI Bio-Root and Implant-Based Restoration as a Tooth Replacement
   Alternative
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Article
DE tissue engineering; stem cell(s); dental implant(s); bioengineering;
   tooth regeneration/transplantation; biomaterial(s)
ID PERIODONTAL-LIGAMENT; DENTAL IMPLANT; PROXIMAL FEMUR; STEM-CELLS;
   REGENERATION; SWINE; THERAPY
AB We previously reported that dental stem cell-mediated bioengineered tooth root (bio-root) regeneration could restore tooth loss in a miniature pig model. As a potential new method for tooth restoration, it is essential to compare this method with the widely used commercial dental implant-based method of tooth restoration. Tooth loss models were created by extracting mandibular incisors from miniature pigs. Allogeneic periodontal ligament stem cells (PDLSCs) and dental pulp stem cells (DPSCs) were isolated and cultured. A PDLSC sheet was prepared by adding 20.0 mu g/mL vitamin C to the culture medium; in addition, a hydroxyapatite tricalcium phosphate (HA/TCP)/DPSC graft was fabricated and cultured in a 3-dimensional culture system. A total of 46 bio-root implantations and 9 dental implants were inserted, and crown restorations were performed 6 mo after implantation. Histological, radiological, biomechanical, and elemental analyses were used to evaluate and compare tissue-engineered bio-roots and dental implants to the natural tooth roots. After 6 mo, both computed tomography scans and histological examinations showed that root-like structures and dentin-like tissues had formed. Three months after crown restoration, clinical assessments revealed that tooth function was equivalent in the regenerated bio-root and the dental implant. Biomechanical testing showed that the bio-roots were similar to natural tooth roots in compressive strength, modulus of elasticity, and torsional force; however, these properties were significantly higher in the dental implants. Elemental analysis revealed a higher similarity in elemental composition between bio-roots and natural tooth roots than between bio-roots and dental implants. However, the dental implant success rate was 100% (9 of 9) and the bio-root success rate was only 22% (10 of 46). Taken together, we showed that an allogeneic HA/TCP/DPSC/PDLSC sheet could successfully build a bio-root with structure and function similar to the natural tooth root; however, tissue engineering procedures must be optimized further to improve the success rate.
C1 [Gao, Z. H.; Hu, L.; Liu, G. L.; Liu, Y.; Liu, Z. H.; Fan, Z. P.; Zhang, C. M.; Wang, J. S.; Wang, S. L.] Capital Med Univ, Sch Stomatol, Beijing Key Lab Tooth Regenerat & Funct Reconstru, Mol Lab Gene Therapy & Tooth Regenerat, Tian Tan Xi Li 4, Beijing 100050, Peoples R China.
   [Wei, F. L.] Shandong Univ, Shandong Prov Key Lab Oral Biomed, Dept Orthodont, Sch Stomatol, Jinan 250100, Peoples R China.
   [Wang, S. L.] Capital Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Beijing 100050, Peoples R China.
RP Wang, SL (reprint author), Capital Med Univ, Sch Stomatol, Beijing Key Lab Tooth Regenerat & Funct Reconstru, Mol Lab Gene Therapy & Tooth Regenerat, Tian Tan Xi Li 4, Beijing 100050, Peoples R China.
EM slwang@ccmu.edu.cn
FU Beijing Municipality Government [PXM2013_014 226_000055,
   PXM2015_014226_000116, PXM2015_014226_0 00055, PXM2015_014226_000052,
   PXM2014_014226_000048, PXM2014_014226_000013, PXM2014_014226_000053,
   Z1211 00005212004, PXM 2013_014226_000021, PXM2013_01422 6_07_000080,
   TJSHG201310025005]
FX This work was supported by grants from Beijing Municipality Government
   grants (Beijing Scholar Program-PXM2013_014 226_000055,
   PXM2015_014226_000116, PXM2015_014226_0 00055, PXM2015_014226_000052,
   PXM2014_014226_000048, PXM2014_014226_000013, PXM2014_014226_000053,
   Z1211 00005212004, PXM 2013_014226_000021, PXM2013_01422 6_07_000080,
   and TJSHG201310025005). The authors thank Dr. Songtao Shi (Department of
   Anatomy and Cell Biology School of Dental Medicine University of
   Pennsylvania, USA) for his insights and thoughtful input. The authors
   declare no potential conflicts of interest with respect to the
   authorship and/or publication of this article.
CR Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Daley GQ, 2008, CELL, V132, P544, DOI 10.1016/j.cell.2008.02.009
   Du J, 2014, J DENT RES, V93, P183, DOI 10.1177/0022034513513026
   Erhart S, 2011, INJURY, V42, P1322, DOI 10.1016/j.injury.2011.04.010
   Gault P, 2010, J CLIN PERIODONTOL, V37, P750, DOI 10.1111/j.1600-051X.2010.01588.x
   Giannobile WV, 2010, J CLIN PERIODONTOL, V37, P747, DOI 10.1111/j.1600-051X.2010.01589.x
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   Ikeda E, 2009, P NATL ACAD SCI USA, V106, P13475, DOI 10.1073/pnas.0902944106
   Kroger H, 1998, CLIN ORTHOP RELAT R, P66
   Liu Y, 2008, STEM CELLS, V26, P1065, DOI 10.1634/stemcells.2007-0734
   Meijer GJ, 1997, J ORAL REHABIL, V24, P85, DOI 10.1046/j.1365-2842.1997.d01-264.x
   Piotrowski B, 2014, MAT SCI ENG C-MATER, V38, P151, DOI 10.1016/j.msec.2014.01.048
   Sahin S, 2002, J DENT, V30, P271, DOI 10.1016/S0300-5712(02)00065-9
   Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0
   Sonoyama W, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000079
   Wang S, 2007, ORAL DIS, V13, P530, DOI 10.1111/j.1601-0825.2006.01337.x
   Wei FL, 2013, STEM CELLS DEV, V22, P1752, DOI 10.1089/scd.2012.0688
   Wei FL, 2012, J CELL PHYSIOL, V227, P3216, DOI 10.1002/jcp.24012
   Wikesjo Ulf M E, 2007, Oral Maxillofac Surg Clin North Am, V19, P535, DOI 10.1016/j.coms.2007.07.004
   Zaky SH, 2009, J DENT RES, V88, P1077, DOI 10.1177/0022034509349926
NR 20
TC 12
Z9 15
U1 0
U2 11
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0022-0345
EI 1544-0591
J9 J DENT RES
JI J. Dent. Res.
PD JUN
PY 2016
VL 95
IS 6
BP 642
EP 649
DI 10.1177/0022034516639260
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA DN3XB
UT WOS:000376996400006
PM 26976131
DA 2018-10-20
ER

PT J
AU Li, Y
   Guo, T
   Zhang, Z
   Yao, Y
   Chang, S
   Nor, JE
   Clarkson, BH
   Ni, L
   Liu, J
AF Li, Y.
   Guo, T.
   Zhang, Z.
   Yao, Y.
   Chang, S.
   Nor, J. E.
   Clarkson, B. H.
   Ni, L.
   Liu, J.
TI Autophagy Modulates Cell Mineralization on Fluorapatite-Modified
   Scaffolds
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Article
DE osteogenesis; tissue engineering; stem cell(s); biomaterial(s); bone
   biology; cell differentiation
ID MESENCHYMAL STEM-CELLS; PROTEIN-DEGRADATION; DIFFERENTIATION; LYSOSOMES;
   CONJUGATE; SURFACES; FUSION
AB As a major intracellular degradation and recycling machinery, autophagy plays an important role in maintaining cellular homeostasis and remodeling during normal development. Our previous study showed that fluorapatite (FA) crystal-coated electrospun polycaprolactone (PCL) was capable of inducing differentiation and mineralization of human dental pulp stem cells. However, how autophagy changes and whether autophagy plays a vital role during these processes is still unknown. In this study, we seeded STEMPRO human adipose-derived stem cells (ASCs) on both PCL+FA and PCL scaffolds to investigate the osteogenic inductive ability of FA crystals and we observed the autophagy changes of these cells. Scanning electron microscopy and fluorescence microscopy images, along with DNA quantitation, showed that both PCL+FA and PCL scaffolds could sustain ASC growth but only the PCL+FA scaffold could sustain cell mineralization. This was confirmed by alkaline phosphatase activity and Alizarin red and Von Kossa staining results. The autophagy RT2 Profiler polymerase chain reaction array analysis showed many autophagy-related genes changes during ASC differentiation. Western blot analysis indicated that several autophagy-related proteins fluctuated during the procedure. Among them, the microtubule-associated protein 1 light chain 3 (LC3)-II protein changes of the ASCs grown on the 2- or 3-dimensional environments at 6 h, 12 h, 1 d, 3 d, 7 d, 14 d, and 21 d reached a peak value at day 7 during osteogenesis. At earlier stages (from day 0 to day 3), the addition of autophagy inhibitors (3-mathyladenine, bafilomycin A1, and NH4Cl) attenuated the expression of osteogenic related markers (osteopontin, alkaline phosphatase activity, Alizarin red, and Von Kossa) compared with the control group. All data indicated that autophagy played an important role in ASC differentiation on the PCL+FA scaffold. Inhibition of autophagy before day 3 strongly inhibited osteogenic differentiation and mineralization of ASCs in the 3-dimensional model. This observation further elucidates the mechanism of autophagy in mesenchymal stem cell osteogenic differentiation.
C1 [Li, Y.; Guo, T.; Zhang, Z.; Yao, Y.; Chang, S.; Nor, J. E.; Clarkson, B. H.; Liu, J.] Univ Michigan, Sch Dent, Dept Cariol Restorat Sci & Endodont, Ann Arbor, MI 48109 USA.
   [Li, Y.] Fourth Mil Med Univ, Dept Oral & Maxillofacial Surg, State Key Lab Mil Stomatol, Xian 710032, Shaanxi, Peoples R China.
   [Guo, T.] Nanjing Jinling Hosp, Dept Stomatol, Nanjing, Jiangsu, Peoples R China.
   [Ni, L.] Fourth Mil Med Univ, Sch Stomatol, Dept Operat Dent & Endodont, Xian 710032, Shaanxi, Peoples R China.
RP Ni, L (reprint author), Fourth Mil Med Univ, Sch Stomatol, Dept Operat Dent & Endodont, Xian 710032, Shaanxi, Peoples R China.; Liu, J (reprint author), Univ Michigan, Dept Cariol Restorat Sci & Endodont, 2310A Dent Sch,1011 N Univ Ave, Ann Arbor, MI 48109 USA.
EM nilx2007@gmail.com; junlc@umich.edu
FU Department of Cariology, Restorative Sciences, and Endodontics at the
   University of Michigan, School of Dentistry
FX This work was supported by the Department of Cariology, Restorative
   Sciences, and Endodontics at the University of Michigan, School of
   Dentistry. The authors declare no potential conflicts of interest with
   respect to the authorship and/or publication of this article.
CR Blommaart EFC, 1997, HISTOCHEM J, V29, P365, DOI 10.1023/A:1026486801018
   Fass E, 2006, J BIOL CHEM, V281, P36303, DOI 10.1074/jbc.M607031200
   Gao C, 2010, NAT CELL BIOL, V12, P781, DOI 10.1038/ncb2082
   Guan JL, 2013, AUTOPHAGY, V9, P830, DOI 10.4161/auto.24132
   Guo T, 2014, J DENT RES, V93, P1290, DOI 10.1177/0022034514547914
   He H, 2003, J BIOL CHEM, V278, P29278, DOI 10.1074/jbc.M303800200
   Huang CP, 2009, LAB CHIP, V9, P1740, DOI 10.1039/b818401a
   Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114
   Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720
   Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845
   Liu F, 2013, J BONE MINER RES, V28, P2414, DOI 10.1002/jbmr.1971
   Liu J, 2012, BIOMATERIALS, V33, P5036, DOI 10.1016/j.biomaterials.2012.03.050
   Liu J, 2010, TISSUE ENG PT A, V16, P2977, DOI [10.1089/ten.tea.2009.0632, 10.1089/ten.TEA.2009.0632]
   Mann SS, 1996, J NEUROSCI RES, V43, P535, DOI 10.1002/(SICI)1097-4547(19960301)43:5<535::AID-JNR3>3.0.CO;2-J
   Mizushima N, 1998, NATURE, V395, P395
   Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381
   Mizushima N, 1999, EMBO J, V18, P3888, DOI 10.1093/emboj/18.14.3888
   Oliver L, 2012, STEM CELLS DEV, V21, P2779, DOI 10.1089/scd.2012.0124
   Pan HZ, 2013, EMBO MOL MED, V5, P327, DOI 10.1002/emmm.201201999
   Pantovic A, 2013, BONE, V52, P524, DOI 10.1016/j.bone.2012.10.024
   Salemi S, 2012, CELL RES, V22, P432, DOI 10.1038/cr.2011.200
   SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889
   SEGLEN PO, 1992, EXPERIENTIA, V48, P158, DOI 10.1007/BF01923509
   Singh R, 2011, CELL METAB, V13, P495, DOI 10.1016/j.cmet.2011.04.004
   Vessoni AT, 2012, STEM CELLS DEV, V21, P513, DOI 10.1089/scd.2011.0526
   Wang XD, 2012, TISSUE ENG PART C-ME, V18, P821, DOI [10.1089/ten.tec.2011.0624, 10.1089/ten.TEC.2011.0624]
   Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102
   Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854
NR 28
TC 4
Z9 4
U1 1
U2 15
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0022-0345
EI 1544-0591
J9 J DENT RES
JI J. Dent. Res.
PD JUN
PY 2016
VL 95
IS 6
BP 650
EP 656
DI 10.1177/0022034516636852
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA DN3XB
UT WOS:000376996400007
PM 26961490
DA 2018-10-20
ER

PT J
AU Litvinov, RI
   Weisel, JW
AF Litvinov, Rustem I.
   Weisel, John W.
TI What Is the Biological and Clinical Relevance of Fibrin?
SO SEMINARS IN THROMBOSIS AND HEMOSTASIS
LA English
DT Article
DE fibrin; fibrinogen; hemostasis; thrombosis; afibrinogenemia;
   hypofibrinogenemia; dysfibrinogenemia
ID RESTRICTED MYH9 INACTIVATION; ACUTE MYOCARDIAL-INFARCTION; FACTOR-XIII;
   SOLUBLE FIBRIN; LIVER-DISEASE; D-DIMER; PLATELET ACTIVATION; MONOMER
   COMPLEX; CLOT FORMATION; HOST-DEFENSE
AB d As our knowledge of the structure and functions of fibrinogen and fibrin has increased tremendously, several key findings have given some people a superficial impression that the biological and clinical significance of these clotting proteins may be less than earlier thought. Most strikingly, studies of fibrinogen knockout mice demonstrated that many of these mice survive to weaning and beyond, suggesting that fibrin(ogen) may not be entirely necessary. Humans with afibrinogenemia also survive. Furthermore, in recent years, the major emphasis in the treatment of arterial thrombosis has been on inhibition of platelets, rather than fibrin. In contrast to the initially apparent conclusions from these results, it has become increasingly clear that fibrin is essential for hemostasis; is a key factor in thrombosis; and plays an important biological role in infection, inflammation, immunology, and wound healing. In addition, fibrinogen replacement therapy has become a preferred, major treatment for severe bleeding in trauma and surgery. Finally, fibrin is a unique biomaterial and is used as a sealant or glue, a matrix for cells, a scaffold for tissue engineering, and a carrier and/or a vector for targeted drug delivery.
C1 [Litvinov, Rustem I.; Weisel, John W.] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.
RP Weisel, JW (reprint author), Univ Penn, 421 Curie Blvd,BRB 2-3,Room 1154, Philadelphia, PA 19104 USA.
EM weisel@mail.med.upenn.edu
RI Litvinov, Rustem/E-5291-2011
OI Litvinov, Rustem/0000-0003-0643-1496
FU NIH [HL090774, U01-HL116330]
FX The authors thank Dr. Lubica Rauova for careful reading of the
   manuscript and valuable suggestions. The work was supported by NIH
   grants HL090774 and U01-HL116330.
CR Ahmad E, 2015, INT J BIOL MACROMOL, V81, P121, DOI 10.1016/j.ijbiomac.2015.07.054
   Aleman MM, 2014, J CLIN INVEST, V124, P3590, DOI 10.1172/JCI75386
   Allen P, 2011, J TISSUE ENG REGEN M, V5, pE74, DOI 10.1002/term.389
   Ariens RAS, 2002, BLOOD, V100, P743, DOI 10.1182/blood.V100.3.743
   Bates SM, 2012, SEMIN THROMB HEMOST, V38, P673, DOI 10.1055/s-0032-1326782
   Bennett JS, 2001, ANN NY ACAD SCI, V936, P340
   Bensaid W, 2003, BIOMATERIALS, V24, P2497, DOI 10.1016/S0142-9612(02)00618-X
   Bhasin N, 2008, J VASC SURG, V48, P1497, DOI 10.1016/j.jvs.2008.07.010
   Bonk Ryan, 2009, J Extra Corpor Technol, V41, P157
   Bornikova L, 2011, J THROMB HAEMOST, V9, P1687, DOI 10.1111/j.1538-7836.2011.04424.x
   Brown AEX, 2009, SCIENCE, V325, P741, DOI 10.1126/science.1172484
   Byrnes JR, 2016, SEMIN THROMB HEMOST, V42, P445, DOI 10.1055/s-0036-1571343
   Byrnes JR, 2015, BLOOD, V126, P1940, DOI 10.1182/blood-2015-06-652263
   Carr ME, 2003, CELL BIOCHEM BIOPHYS, V38, P55, DOI 10.1385/CBB:38:1:55
   Casini A, 2015, J THROMB HAEMOST, V13, P909, DOI 10.1111/jth.12916
   Casini A, 2015, BLOOD, V125, P553, DOI 10.1182/blood-2014-06-582866
   Ciesienski KL, 2013, MOL PHARMACEUT, V10, P1100, DOI 10.1021/mp300610s
   Cines DB, 2014, BLOOD, V123, P1596, DOI 10.1182/blood-2013-08-523860
   Collet JP, 2006, ARTERIOSCL THROM VAS, V26, P2567, DOI 10.1161/01.ATV.0000241589.52950.4c
   Collet JP, 2002, CIRC RES, V90, P428, DOI 10.1161/hh0402.105095
   Cotovio M, 2008, J VET INTERN MED, V22, P1403, DOI 10.1111/j.1939-1676.2008.0178.x
   Davis ME, 2005, CIRC RES, V97, P8, DOI 10.1161/01.RES.0000173376.39447.01
   de Moerloose P, 2013, SEMIN THROMB HEMOST, V39, P585, DOI 10.1055/s-0033-1349222
   de Moerloose P, 2009, SEMIN THROMB HEMOST, V35, P356, DOI 10.1055/s-0029-1225758
   Dear A, 2007, Haematologica, V92, pe111, DOI 10.3324/haematol.11837
   Dikovsky D, 2006, BIOMATERIALS, V27, P1496, DOI 10.1016/j.biomaterials.2005.09.038
   Drew AF, 2001, BLOOD, V97, P3691, DOI 10.1182/blood.V97.12.3691
   Eckly A, 2009, BLOOD, V113, P3182, DOI 10.1182/blood-2008-06-164061
   Ehrlicher A, 2011, NAT MATER, V10, P12, DOI 10.1038/nmat2928
   Flick MJ, 2007, J CLIN INVEST, V117, P3224, DOI 10.1172/JCI30134
   Flick MJ, 2004, J CLIN INVEST, V113, P1596, DOI 10.1172/JCI200420741
   FORRESTER JM, 1995, MED HIST, V39, P477, DOI 10.1017/S0025727300060385
   Fries D, 2010, BRIT J ANAESTH, V105, P116, DOI 10.1093/bja/aeq161
   Fries D, 2013, TRANSFUSION, V53, p91S, DOI 10.1111/trf.12041
   Fries D, 2009, CURR OPIN ANESTHESIO, V22, P267, DOI 10.1097/ACO.0b013e32832678d9
   Gazzeri Roberto, 2015, Surg Technol Int, V26, P364
   Goncalves NR, 2014, NEUROIMAGE, V97, P196, DOI 10.1016/j.neuroimage.2014.04.012
   Haas T, 2008, ANESTH ANALG, V106, P1360, DOI 10.1213/01.ane.0b013e3181684339
   Hamano A, 2002, CLIN CHIM ACTA, V318, P25, DOI 10.1016/S0009-8981(01)00779-3
   Hanss M, 2001, ANN NY ACAD SCI, V936, P89
   Ieko M, 2009, TOHOKU J EXP MED, V219, P25, DOI 10.1620/tjem.219.25
   Innerhofer P, 2013, INJURY, V44, P209, DOI 10.1016/j.injury.2012.08.047
   Itosaka H, 2009, NEUROPATHOLOGY, V29, P248, DOI 10.1111/j.1440-1789.2008.00971.x
   Janmey PA, 2009, J R SOC INTERFACE, V6, P1, DOI 10.1098/rsif.2008.0327
   Jarvis GE, 2003, BRIT J PHARMACOL, V138, P574, DOI 10.1038/sj.bjp.0705095
   Kabrhel C, 2010, ACAD EMERG MED, V17, P589, DOI 10.1111/j.1553-2712.2010.00765.x
   Kasahara K, 2013, BLOOD, V122, P3340, DOI 10.1182/blood-2013-04-491290
   Kasahara K, 2010, BLOOD, V115, P1277, DOI 10.1182/blood-2009-06-227645
   Kim OV, 2014, BIOMATERIALS, V35, P6739, DOI 10.1016/j.biomaterials.2014.04.056
   Ko YP, 2016, SEMIN THROMB HEMOST, V42, P408, DOI 10.1055/s-0036-1579635
   Kolodziej AF, 2012, BIOCONJUGATE CHEM, V23, P548, DOI 10.1021/bc200613e
   Kopec AK, 2016, SEMIN THROMB HEMOST, V42, P397, DOI 10.1055/s-0036-1579655
   Kunishima S, 2010, CURR OPIN HEMATOL, V17, P405, DOI 10.1097/MOH.0b013e32833c069c
   Kurniawan NA, 2014, J THROMB HAEMOST, V12, P1687, DOI 10.1111/jth.12705
   Lam WA, 2011, NAT MATER, V10, P61, DOI [10.1038/nmat2903, 10.1038/NMAT2903]
   Lassila R, 2016, SEMIN THROMB HEMOST, V42, P440, DOI 10.1055/s-0036-1572324
   Law DA, 1999, NATURE, V401, P808, DOI 10.1038/44599
   Leon C, 2007, BLOOD, V110, P3183, DOI 10.1182/blood-2007-03-080184
   Levi M, 2014, SEMIN THROMB HEMOST, V40, P874, DOI 10.1055/s-0034-1395155
   Liebeskind DS, 2011, STROKE, V42, P1237, DOI 10.1161/STROKEAHA.110.605576
   Lisman T, 2016, SEMIN THROMB HEMOST, V42, P389, DOI 10.1055/s-0036-1572327
   Lisman T, 2010, BLOOD, V116, P878, DOI 10.1182/blood-2010-02-261891
   Litvinov RI, 2016, J BIOL CHEM
   Macrae FL, 2016, SEMIN THROMB HEMOST, V42, P344, DOI 10.1055/s-0036-1572353
   Martineau Laurie, 2007, Angiogenesis, V10, P269, DOI 10.1007/s10456-007-9079-8
   MARTINEZ J, 1978, J CLIN INVEST, V61, P535, DOI 10.1172/JCI108964
   Martini J, 2014, TRANSFUSION, V54, P149, DOI 10.1111/trf.12241
   Martini J, 2013, CRIT CARE MED, V41, pE301, DOI 10.1097/CCM.0b013e31828a4520
   Mills JD, 2002, CIRCULATION, V106, P1938, DOI 10.1161/CIR.0000033221.73082.06
   Misaki T, 2008, J ORTHOP SCI, V13, P419, DOI 10.1007/s00776-008-1266-y
   Mosesson MW, 2007, THROMB HAEMOSTASIS, V98, P105, DOI 10.1160/Th07-04-0274
   Muszbek L, 2016, SEMIN THROMB HEMOST, V42, P429, DOI 10.1055/s-0036-1572326
   Muthard RW, 2012, ARTERIOSCL THROM VAS, V32, P2938, DOI 10.1161/ATVBAHA.112.300312
   Nair SA, 2008, ANGEW CHEM INT EDIT, V47, P4918, DOI 10.1002/anie.200800563
   Neerman-Arbez M, 2016, SEMIN THROMB HEMOST, V42, P344
   Neerman-Arbez M, 2016, SEMIN THROMB HEMOST, V42, P356, DOI 10.1055/s-0036-1571340
   Ono A, 2008, BLOOD, V112, P90, DOI 10.1182/blood-2007-12-127001
   Overoye-Chan K, 2008, J AM CHEM SOC, V130, P6025, DOI 10.1021/ja800834y
   PANZER S, 1993, HAEMOSTASIS, V23, P69
   Piechocka IK, 2010, BIOPHYS J, V98, P2281, DOI 10.1016/j.bpj.2010.01.040
   Pluta A, 2010, ADV MED SCI-POLAND, V55, P16, DOI 10.2478/v10039-010-0018-3
   Prasad JM, 2015, BLOOD, V126, P2047, DOI 10.1182/blood-2015-04-639849
   Riopel M, 2015, TISSUE ENG PART B-RE, V21, P34, DOI [10.1089/ten.TEB.2014.0188, 10.1089/ten.teb.2014.0188]
   Samama CM, 2016, SEMIN THROMB HEMOST, V42, P375, DOI 10.1055/s-0036-1572325
   Schroeder V, 2016, SEMIN THROMB HEMOST, V42, P422, DOI 10.1055/s-0036-1571341
   Scognamiglio F, 2015, J BIOMED MAT RES B, DOI 10.1002/jbm.b.33409
   Semeraro N, 2012, THROMB RES, V129, P290, DOI 10.1016/j.thromres.2011.10.013
   Shevchenko RV, 2010, J R SOC INTERFACE, V7, P229, DOI 10.1098/rsif.2009.0403
   Silvain J, 2011, J AM COLL CARDIOL, V57, P1359, DOI 10.1016/j.jacc.2010.09.077
   Skewis LR, 2014, CLIN CHEM, V60, P1174, DOI 10.1373/clinchem.2014.223735
   Stalker TJ, 2014, BLOOD, V124, P1824, DOI 10.1182/blood-2014-01-550319
   Stalker TJ, 2014, CURR OPIN HEMATOL, V21, P410, DOI 10.1097/MOH.0000000000000070
   Stalker TJ, 2013, BLOOD, V121, P1875, DOI 10.1182/blood-2012-09-457739
   SUH TT, 1995, GENE DEV, V9, P2020, DOI 10.1101/gad.9.16.2020
   Undas A, 2008, DIABETES CARE, V31, P1590, DOI 10.2337/dc08-0282
   Undas A, 2016, SEMIN THROMB HEMOST, V42, P381, DOI 10.1055/s-0036-1579636
   Undas A, 2010, THROMB RES, V125, P357, DOI 10.1016/j.thromres.2009.11.013
   Undas A, 2009, BLOOD, V114, P4272, DOI 10.1182/blood-2009-05-222380
   Undas A, 2009, STROKE, V40, P1499, DOI 10.1161/STROKEAHA.108.532812
   Velik-Salchner C, 2007, J THROMB HAEMOST, V5, P1019, DOI 10.1111/j.1538-7836.2007.02481.x
   Weisel JW, 2013, BLOOD, V121, P1712, DOI 10.1182/blood-2012-09-306639
   Wells PS, 2003, NEW ENGL J MED, V349, P1227, DOI 10.1056/NEJMoa023153
   Welsh JD, 2015, J THROMB HAEMOST, V13, P174
   Wufsus AR, 2015, BIOPHYS J, V108, P173, DOI 10.1016/j.bpj.2014.11.007
   Zabczyk M, 2015, INT J CARDIOL, V179, P186, DOI 10.1016/j.ijcard.2014.10.004
   Zhang YF, 2012, BLOOD, V119, P238, DOI 10.1182/blood-2011-06-358853
NR 106
TC 13
Z9 16
U1 4
U2 23
PU THIEME MEDICAL PUBL INC
PI NEW YORK
PA 333 SEVENTH AVE, NEW YORK, NY 10001 USA
SN 0094-6176
EI 1098-9064
J9 SEMIN THROMB HEMOST
JI Semin. Thromb. Hemost.
PD JUN
PY 2016
VL 42
IS 4
BP 333
EP 343
DI 10.1055/s-0036-1571342
PG 11
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA DN7AK
UT WOS:000377227500003
PM 27056152
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Vishwakarma, A
   Bhise, NS
   Evangelista, MB
   Rouwkema, J
   Dokmeci, MR
   Ghaemmaghami, AM
   Vrana, NE
   Khademhosseini, A
AF Vishwakarma, Ajaykumar
   Bhise, Nupura S.
   Evangelista, Marta B.
   Rouwkema, Jeroen
   Dokmeci, Mehmet R.
   Ghaemmaghami, Amir M.
   Vrana, Nihal Engin
   Khademhosseini, Ali
TI Engineering Immunomodulatory Biomaterials To Tune the Inflammatory
   Response
SO TRENDS IN BIOTECHNOLOGY
LA English
DT Review
ID FOREIGN-BODY RESPONSE; MANNOSE RECEPTOR-ACTIVITY; IN-VITRO; MACROPHAGE
   ACTIVATION; SURFACE WETTABILITY; ADAPTIVE IMMUNITY; STEM-CELLS;
   ADHESION; PHENOTYPE; DEXAMETHASONE
AB Current state-of-the-art biomedical implants and tissue engineering methods promise technologies to improve or even restore the function of diseased organs. However, one of the biggest challenges to clinical success is the lack of functional integration. A series of cellular and molecular events following biomaterial implantation poses an important bottleneck for developing breakthrough solutions. With inflammation increasingly recognized as a crucial component influencing regeneration, immunomodulation or immuno-engineering has emerged as a potential solution to overcome this key challenge in regenerative medicine. We postulate possibilities to utilize biomaterial physicochemical modifications to modulate the host inflammatory response and develop strategies for effective biomaterial integration. Biomaterial-based immunomodulation strategies can significantly ameliorate the outcomes of medical implants and tissue engineering therapies.
C1 [Vishwakarma, Ajaykumar; Bhise, Nupura S.; Rouwkema, Jeroen; Dokmeci, Mehmet R.; Khademhosseini, Ali] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Biomat Innovat Res Ctr, Cambridge, MA 02115 USA.
   [Vishwakarma, Ajaykumar; Bhise, Nupura S.; Rouwkema, Jeroen; Dokmeci, Mehmet R.; Khademhosseini, Ali] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02319 USA.
   [Evangelista, Marta B.; Vrana, Nihal Engin] Protip Med, 8 Pl Hop, F-67000 Strasbourg, France.
   [Rouwkema, Jeroen] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Biomech Engn, POB 217, NL-7500 AE Enschede, Netherlands.
   [Ghaemmaghami, Amir M.] Univ Nottingham, Fac Med & Hlth Sci, Sch Life Sci, Div Immunol,Queens Med Ctr, Nottingham NG7 2UH, England.
   [Vrana, Nihal Engin] INSERM, UMR 1121, 11 Rue Humann, F-67085 Strasbourg, France.
   [Khademhosseini, Ali] Harvard Univ, Sch Med, Wyss Inst Biol Inspired Engn, Boston, MA 02155 USA.
   [Khademhosseini, Ali] Konkuk Univ, Dept Bioind Technol, Coll Anim Biosci & Technol, Seoul 143701, South Korea.
   [Khademhosseini, Ali] King Abdulaziz Univ, Dept Phys, Jeddah 21569, Saudi Arabia.
RP Khademhosseini, A (reprint author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Biomat Innovat Res Ctr, Cambridge, MA 02115 USA.; Khademhosseini, A (reprint author), MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02319 USA.; Khademhosseini, A (reprint author), Harvard Univ, Sch Med, Wyss Inst Biol Inspired Engn, Boston, MA 02155 USA.; Khademhosseini, A (reprint author), Konkuk Univ, Dept Bioind Technol, Coll Anim Biosci & Technol, Seoul 143701, South Korea.; Khademhosseini, A (reprint author), King Abdulaziz Univ, Dept Phys, Jeddah 21569, Saudi Arabia.
EM alik@bwh.harvard.edu
OI Rouwkema, Jeroen/0000-0001-9666-9064; Khademhosseini,
   Ali/0000-0001-6322-8852; Ghaemmaghami, Amir/0000-0003-3160-8759
FU European Commission [602694, 606624]; People Programme (Marie Curie
   Actions) under REA grant [622294]
FX This work has received funding from the European Commission 7th
   Framework Programme for research, technological development and
   demonstration under grant agreements 602694 (IMMODGEL) and 606624
   (NanoTi). J.R. was supported by the People Programme (Marie Curie
   Actions) under REA grant agreement 622294 (PreVascIn).
CR Alfarsi MA, 2014, J BIOMED MATER RES A, V102, P60, DOI 10.1002/jbm.a.34666
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson J, 2011, SEMIN IMMUNOPATHOL, V33, P221, DOI 10.1007/s00281-011-0244-1
   Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Bitar D, 2015, WORLD J ORTHOP, V6, P172, DOI 10.5312/wjo.v6.i2.172
   Blaszykowski C, 2014, TRENDS BIOTECHNOL, V32, P61, DOI 10.1016/j.tibtech.2013.11.002
   Boehler RM, 2014, BIOTECHNOL BIOENG, V111, P1210, DOI 10.1002/bit.25175
   Boehler RM, 2011, BIOTECHNIQUES, V51, P239, DOI 10.2144/000113754
   Bridges Amanda W, 2008, J Diabetes Sci Technol, V2, P984
   Bridges AW, 2008, BIOMATERIALS, V29, P4605, DOI 10.1016/j.biomaterials.2008.08.015
   Brodbeck WG, 2005, J BIOMED MATER RES A, V74A, P222, DOI 10.1002/jbm.a.30313
   Broughton G, 2006, PLAST RECONSTR SURG, V117, p12S, DOI 10.1097/01.prs.0000225430.42531.c2
   Brown BN, 2013, ACTA BIOMATER, V9, P4948, DOI 10.1016/j.actbio.2012.10.025
   Brown BN, 2012, ACTA BIOMATER, V8, P978, DOI 10.1016/j.actbio.2011.11.031
   Cantu DA, 2012, STEM CELL TRANSL MED, V1, P740, DOI 10.5966/sctm.2012-0061
   Chang DT, 2009, J BIOMED MATER RES A, V91A, P1210, DOI 10.1002/jbm.a.32218
   Chen SL, 2010, BIOMATERIALS, V31, P3479, DOI 10.1016/j.biomaterials.2010.01.074
   Chen ZT, 2014, BIOMATERIALS, V35, P1507, DOI 10.1016/j.biomaterials.2013.11.014
   Collier TO, 2004, J BIOMED MATER RES A, V69A, P644, DOI 10.1002/jbm.a.30030
   CROSSLEY GH, 1995, CIRCULATION, V92, P2935, DOI 10.1161/01.CIR.92.10.2935
   Damanik FFR, 2014, SCI REP-UK, V4, DOI 10.1038/srep06325
   Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184
   Dimitrova M, 2007, ADV FUNCT MATER, V17, P233, DOI 10.1002/adfm.200600155
   Dohle E, 2014, EUR CELLS MATER, V27, P149, DOI 10.22203/eCM.v027a12
   Esche C, 2005, J INVEST DERMATOL, V125, P615, DOI 10.1111/j.0022-202X.2005.23841.x
   Gonzalez R, 2003, EXP NEUROL, V184, P456, DOI 10.1016/S0014-4886(03)00257-7
   GROTH T, 1994, BIOMATERIALS, V15, P423, DOI 10.1016/0142-9612(94)90220-8
   HENSON PM, 1971, J IMMUNOL, V107, P1535
   Hubbell JA, 2013, NAT MATER, V12, P963, DOI 10.1038/nmat3788
   Hume PS, 2012, BIOMATERIALS, V33, P3615, DOI 10.1016/j.biomaterials.2012.02.009
   Kajahn Jennifer, 2012, Biomatter, V2, P226, DOI 10.4161/biom.22855
   Keane TJ, 2012, BIOMATERIALS, V33, P1771, DOI 10.1016/j.biomaterials.2011.10.054
   Kim DH, 2006, BIOMATERIALS, V27, P3031, DOI 10.1016/j.biomaterials.2005.12.021
   Kim J, 2009, EXP HEMATOL, V37, P1445, DOI 10.1016/j.exphem.2009.09.004
   Kim YK, 2014, ADV HEALTHC MATER, V3, P989, DOI 10.1002/adhm.201300532
   Koedam JA, 2002, MOL CELL ENDOCRINOL, V197, P35, DOI 10.1016/S0303-7207(02)00276-9
   Kou PM, 2012, BIOMATERIALS, V33, P1699, DOI 10.1016/j.biomaterials.2011.10.066
   Kruger P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004651
   Kusaka T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092634
   Lee S, 2011, ACTA BIOMATER, V7, P2337, DOI 10.1016/j.actbio.2011.01.006
   Li GC, 2011, CYTOKINE, V56, P208, DOI 10.1016/j.cyto.2011.06.020
   Lin CC, 2010, J CONTROL RELEASE, V142, P384, DOI 10.1016/j.jconrel.2009.11.022
   Lin CC, 2009, BIOMATERIALS, V30, P4907, DOI 10.1016/j.biomaterials.2009.05.083
   Lu J, 2015, ACTA BIOMATER, V16, P223, DOI 10.1016/j.actbio.2015.01.036
   Luo JC, 2004, EUR J PHARMACOL, V485, P275, DOI 10.1016/j.ejphar.2003.11.038
   MAEDA M, 1986, J BIOMED MATER RES, V20, P25, DOI 10.1002/jbm.820200104
   Martinez Fernando O, 2014, F1000Prime Rep, V6, P13, DOI 10.12703/P6-13
   MATLAGA BF, 1976, J BIOMED MATER RES, V10, P391, DOI 10.1002/jbm.820100308
   McNally AK, 1996, AM J PATHOL, V149, P975
   McWhorter FY, 2013, P NATL ACAD SCI USA, V110, P17253, DOI 10.1073/pnas.1308887110
   Mercanzini A, 2010, J CONTROL RELEASE, V145, P196, DOI 10.1016/j.jconrel.2010.04.025
   Meyer U, 2005, Eur Cell Mater, V9, P39
   Mora-Solano C, 2014, J MATER CHEM B, V2, P2409, DOI 10.1039/c3tb21549k
   Mori R, 2008, J EXP MED, V205, P43, DOI 10.1084/jem.20071412
   Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325
   Mrksich M, 1996, ANNU REV BIOPH BIOM, V25, P55, DOI 10.1146/annurev.bb.25.060196.000415
   Murphy SV, 2013, BIOESSAYS, V35, P163, DOI 10.1002/bies.201200062
   Neacsu P, 2014, INT J BIOCHEM CELL B, V55, P187, DOI 10.1016/j.biocel.2014.09.006
   Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d
   Patil SD, 2007, J CONTROL RELEASE, V117, P68, DOI 10.1016/j.jconrel.2006.10.013
   Rajyalakshmi A, 2011, INT J NANOMED, V6, P1765, DOI 10.2147/IJN.S22763
   Roach P, 2007, J MATER SCI-MATER M, V18, P1263, DOI 10.1007/s10856-006-0064-3
   Rogers TH, 2010, BIOMATERIALS, V31, P594, DOI 10.1016/j.biomaterials.2009.09.077
   Rostam HM, 2015, BIOMATER SCI-UK, V3, P424, DOI 10.1039/c4bm00375f
   SALTHOUSE TN, 1984, J BIOMED MATER RES, V18, P395, DOI 10.1002/jbm.820180407
   Scharp DW, 2014, ADV DRUG DELIVER REV, V67-68, P35, DOI 10.1016/j.addr.2013.07.018
   Shen MC, 2002, J BIOMAT SCI-POLYM E, V13, P367, DOI 10.1163/156856202320253910
   Simms HH, 1997, ANN SURG, V225, P757, DOI 10.1097/00000658-199706000-00013
   STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287
   Swartzlander MD, 2015, BIOMATERIALS, V41, P79, DOI 10.1016/j.biomaterials.2014.11.020
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tsianakas A, 2012, IMMUNOBIOLOGY, V217, P329, DOI 10.1016/j.imbio.2011.10.002
   Udipl K., 2000, J BLOMED MAT RES, V51, P549
   Vegas AJ, 2016, NAT BIOTECHNOL, V34, P345, DOI 10.1038/nbt.3462
   Veiseh O, 2015, NAT MATER, V14, P643, DOI [10.1038/NMAT4290, 10.1038/nmat4290]
   Vishwakarma A., 2014, STEM CELL BIOL TISSU
   Vitte J, 2004, Eur Cell Mater, V7, P52
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wong TS, 2011, NATURE, V477, P443, DOI 10.1038/nature10447
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
   Zandstra J, 2014, EUR CELLS MATER, V28, P335, DOI 10.22203/eCM.v028a23
   Zaveri TD, 2010, BIOMATERIALS, V31, P2999, DOI 10.1016/j.biomaterials.2009.12.055
   Zelikin AN, 2010, ACS NANO, V4, P2494, DOI 10.1021/nn100634r
   Zhang L, 2013, NAT BIOTECHNOL, V31, P553, DOI 10.1038/nbt.2580
   Zhong YH, 2007, BRAIN RES, V1148, P15, DOI 10.1016/j.brainres.2007.02.024
   Zlotnik A, 2012, IMMUNITY, V36, P705, DOI 10.1016/j.immuni.2012.05.008
NR 86
TC 48
Z9 49
U1 11
U2 70
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0167-7799
EI 1879-3096
J9 TRENDS BIOTECHNOL
JI Trends Biotechnol.
PD JUN
PY 2016
VL 34
IS 6
BP 470
EP 482
DI 10.1016/j.tibtech.2016.03.009
PG 13
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA DN1NW
UT WOS:000376833700006
PM 27138899
DA 2018-10-20
ER

PT J
AU Barry, M
   Pearce, H
   Cross, L
   Tatullo, M
   Gaharwar, AK
AF Barry, Mikayla
   Pearce, Hannah
   Cross, Lauren
   Tatullo, Marco
   Gaharwar, Akhilesh K.
TI Advances in Nanotechnology for the Treatment of Osteoporosis
SO CURRENT OSTEOPOROSIS REPORTS
LA English
DT Review
DE Nanotechnology; Osteoporosis; Bioactive nanomaterials; Bone regeneration
ID MESENCHYMAL STEM-CELLS; MESOPOROUS BIOACTIVE NANOCARRIERS; OSTEOGENIC
   DIFFERENTIATION; NANOCOMPOSITE HYDROGELS; BIOMEDICAL APPLICATIONS;
   SILICA NANOPARTICLES; POSTMENOPAUSAL WOMEN; UNITED-STATES; BONE LOSS;
   SCAFFOLDS
AB Osteoporosis is a degenerative bone disease commonly related to aging. With an increase in life expectancies worldwide, the prevalence of the disease is expected to rise. Current clinical therapeutic treatments are not able to offer long-term solutions to counter the bone mass loss and the increased risk of fractures, which are the primary characteristics of the disease. However, the combination of bioactive nanomaterials within a biomaterial scaffold shows promise for the development of a localized, long-term treatment for those affected by osteoporosis. This review summarizes the unique characteristics of engineered nanoparticles that render them applicable for bone regeneration and recaps the current body of knowledge on nanomaterials with potential for osteoporosis treatment and bone regeneration. Specifically, we highlight new developments that are shaping this emerging field and evaluate applications of recently developed nanomaterials for osteoporosis treatment. Finally, we will identify promising new research directions in nanotechnology for bone regeneration.
C1 [Barry, Mikayla; Pearce, Hannah; Cross, Lauren; Gaharwar, Akhilesh K.] Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77841 USA.
   [Tatullo, Marco] Calabrodent Clin, Maxillofacial Unit, I-88900 Crotone, Italy.
   [Tatullo, Marco] Tecnol Res Inst, Regenerat Med Sect, I-88900 Crotone, Italy.
   [Gaharwar, Akhilesh K.] Texas A&M Univ, Dept Mat Sci & Engn, College Stn, TX 77841 USA.
   [Gaharwar, Akhilesh K.] Texas A&M Univ, Ctr Remote Hlth Technol & Syst, College Stn, TX 77843 USA.
RP Gaharwar, AK (reprint author), Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77841 USA.; Gaharwar, AK (reprint author), Texas A&M Univ, Dept Mat Sci & Engn, College Stn, TX 77841 USA.; Gaharwar, AK (reprint author), Texas A&M Univ, Ctr Remote Hlth Technol & Syst, College Stn, TX 77843 USA.
EM gaharwar@tamu.edu
OI Gaharwar, Akhilesh/0000-0002-0284-0201
CR Alghamdi HS, 2014, BIOMATERIALS, V35, P5482, DOI 10.1016/j.biomaterials.2014.03.069
   Bilezikian JP, 2009, AM J MED, V122, P14, DOI 10.1016/j.amjmed.2008.12.003
   Bosco R, 2015, APPL SURF SCI, V328, P516, DOI 10.1016/j.apsusc.2014.12.072
   Cao LY, 2014, BIOMATERIALS, V35, P684, DOI 10.1016/j.biomaterials.2013.10.005
   Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023
   Carrow JK, 2015, MACROMOL CHEM PHYS, V216, P248, DOI 10.1002/macp.201400427
   Chimene D, 2015, ADV MATER, V27, P7261, DOI 10.1002/adma.201502422
   Crowder SW, 2013, NANOSCALE, V5, P4171, DOI 10.1039/c3nr00803g
   Diab DL, 2012, ENDOCRIN METAB CLIN, V41, P487, DOI 10.1016/j.ecl.2012.04.007
   Ehnert S, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-101
   Ehrlich PJ, 2002, OSTEOPOROSIS INT, V13, P688, DOI 10.1007/s001980200095
   El-Fiqi A, 2014, RSC ADV, V4, P4444, DOI 10.1039/c3ra45858j
   Felsenberg D, 2002, J BONE MINER RES, V17, P716
   Francis RM, 1999, CLIN ENDOCRINOL, V50, P411
   Fricain JC, 2013, BIOMATERIALS, V34, P2947, DOI 10.1016/j.biomaterials.2013.01.049
   Gaharwar AK, 2014, TISSUE ENG PT A, V20, P2088, DOI 10.1089/ten.tea.2013.0281
   Gaharwar AK, 2014, BIOTECHNOL BIOENG, V111, P441, DOI 10.1002/bit.25160
   Gaharwar AK, 2013, ADV MATER, V25, P3329, DOI 10.1002/adma.201300584
   Gaharwar AK, 2011, BIOMACROMOLECULES, V12, P1641, DOI 10.1021/bm200027z
   Hu Y, 2010, ADV MATER, V22, P4146, DOI 10.1002/adma.201000854
   Ignjatovic N, 2013, J MATER SCI-MATER M, V24, P343, DOI 10.1007/s10856-012-4793-1
   Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4
   Kang GF, 2012, J MATER CHEM, V22, P21740, DOI 10.1039/c2jm34370c
   Kang MS, 2015, ACTA BIOMATER, V16, P103, DOI 10.1016/j.actbio.2014.12.028
   Karunaratne D. N., 2010, J NATL SCI FOUND SRI, V35, P149
   Kerativitayanan P, 2015, ACTA BIOMATER, V26, P34, DOI 10.1016/j.actbio.2015.08.025
   Kerativitayanan P, 2015, ADV HEALTHC MATER, V4, P1600, DOI 10.1002/adhm.201500272
   Kim T-H, 2015, ACTA BIOMATER
   Lad SP, 2011, SPINE, V36, pE274, DOI 10.1097/BRS.0b013e3182055a6b
   LIBERMAN UA, 1995, NEW ENGL J MED, V333, P1437, DOI 10.1056/NEJM199511303332201
   Lindsay R, 1997, LANCET, V350, P550, DOI 10.1016/S0140-6736(97)02342-8
   Liu Y, 2009, BIOMATERIALS, V30, P6276, DOI 10.1016/j.biomaterials.2009.08.003
   Lozano-Calderon SA, 2014, ORTHOP CLIN N AM, V45, P403, DOI 10.1016/j.ocl.2014.03.006
   Mackey PA, 2015, JNP-J NURSE PRACT, V11, P1011, DOI 10.1016/j.nurpra.2015.08.010
   Manolagas SC, 2010, ENDOCR REV, V31, P266, DOI 10.1210/er.2009-0024
   Nhiem T, 2011, ACTA BIOMATER, V7, P1298, DOI 10.1016/j.actbio.2010.10.004
   Ong KL, 2010, SPINE, V35, P1794, DOI 10.1097/BRS.0b013e3181ecf6e4
   PARFITT AM, 1987, AM J MED, V82, P68, DOI 10.1016/0002-9343(87)90274-9
   Rawat M, 2006, BIOL PHARM BULL, V29, P1790, DOI 10.1248/bpb.29.1790
   Riggs BL, 1998, J BONE MINER RES, V13, P763, DOI 10.1359/jbmr.1998.13.5.763
   Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508
   Saifullah B, 2014, INT J NANOMED, V9, P4749, DOI 10.2147/IJN.S63608
   Saravanan S, 2013, INT J BIOL MACROMOL, V62, P481, DOI 10.1016/j.ijbiomac.2013.09.034
   Schmidt GA, 2010, AM J HEALTH-SYST PH, V67, P994, DOI 10.2146/ajhp090506
   Sowjanya JA, 2013, COLLOID SURFACE B, V109, P294, DOI 10.1016/j.colsurfb.2013.04.006
   Thakur T, 2016, J BIOMED MATER RES A, V104, P879, DOI 10.1002/jbm.a.35621
   Tran PA, 2009, J MATER CHEM, V19, P2653, DOI 10.1039/b814334j
   Tripathi A, 2012, INT J BIOL MACROMOL, V50, P294, DOI 10.1016/j.ijbiomac.2011.11.013
   Webster TJ, 2001, ADV CHEM ENG, V27, P125
   Weitzmann MN, 2015, NANOMED-NANOTECHNOL, V11, P959, DOI 10.1016/j.nano.2015.01.013
   Xavier JR, 2015, ACS NANO, V9, P3109, DOI 10.1021/nn507488s
   Xu AX, 2015, MAT SCI ENG C-MATER, V48, P592, DOI 10.1016/j.msec.2014.12.061
   Zallone A, 2006, ANN NY ACAD SCI, V1068, P173, DOI 10.1196/annals.1346.019
   Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014
NR 54
TC 5
Z9 5
U1 1
U2 21
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1544-2241
J9 CURR OSTEOPOROS REP
JI Curr. Osteoporos. Rep.
PD JUN
PY 2016
VL 14
IS 3
BP 87
EP 94
DI 10.1007/s11914-016-0306-3
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DM8CA
UT WOS:000376587000003
PM 27048473
DA 2018-10-20
ER

PT J
AU Leal, CV
   Martinez, DST
   Mas, BA
   Alves, OL
   Duek, EAR
AF Leal, C. V.
   Martinez, D. S. T.
   Mas, B. A.
   Alves, O. L.
   Duek, E. A. R.
TI Influence of purified multiwalled carbon nanotubes on the mechanical and
   morphological behavior in poly (L-lactic acid) matrix
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Poly (L-lactic acid); Carbon nanotubes; Nanocomposites;
   Cytocompatibility; Toxicity
ID OSTEOBLAST-LIKE CELLS; NONISOTHERMAL CRYSTALLIZATION; BIOMEDICAL
   APPLICATIONS; PLLA NANOCOMPOSITES; IMPACT TOUGHNESS; IN-SITU;
   COMPOSITES; ADHESION; SURFACE; BLENDS
AB Poly (L-latic acid) (PLLA) is a bioresorbable polymer widely used as a biomaterial, but its fragility can limit its use. An alternative is to produce polymer nanocomposites, which can enhance the mechanical properties of polymeric matrix, resulting in a material with differentiated properties. In this work, PLLA based nanocomposites containing 0.25, 0.5 and 1.0 wt% of purified multiwalled carbon nanotubes (p-MWCNTs) were prepared by the solvent casting method. The morphology and mechanical properties results show an improvement in strain at break for 0.25 and 0.5 wt% p-MWCNTs and an increase in stiffness and elastic modulus for all compositions. Nanocomposites presented a p-MWCNTs agglomeration; however, there was a good stress transfer between PLLA and p-MWCNTs, which was confirmed by the increase in the hardness and elastic modulus. Atomic force microscopy analysis indicated an increase in roughness after nanotube addition. The in vitro biological study showed that PLLA/p-MWCNTs nanocomposites are cytocompatible with osteoblasts cells. The capacity of PLLA nanocomposites to stimulate osteogenesis was investigated by alkaline phosphatase (ALP) activity assay. Higher ALP activity was found on osteoblasts cultured on nanocomposites with 0.25 and 0.5 wt% p-MWCNT compared to neat PLLA, confirming that PLLA cytocompatibility was improved on these compositions. Finally, our results showed that by a simple and inexpensive solvent casting method, it is possible to manufacture biofunctional nanocomposites devices with potential for orthopedic applications. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Leal, C. V.; Duek, E. A. R.] Univ Estadual Campinas, Fac Mech Engn, Dept Mat Engn, BR-13083860 Campinas, SP, Brazil.
   [Martinez, D. S. T.; Alves, O. L.] Univ Estadual Campinas, Inst Chem, Solid State Chem Lab, POB 6154, BR-13081970 Campinas, SP, Brazil.
   [Martinez, D. S. T.] Brazilian Ctr Res Energy & Mat CNPEM, Brazilian Nanotechnol Natl Lab LNNano, BR-1308970 Campinas, SP, Brazil.
   [Mas, B. A.; Duek, E. A. R.] Pontifical Catholic Univ Sao Paulo PUCSP, Fac Med Sci, BR-18030095 Sorocaba, SP, Brazil.
RP Leal, CV (reprint author), Univ Estadual Campinas, Fac Mech Engn, Dept Mat Engn, BR-13083860 Campinas, SP, Brazil.
EM lealcv5@gmail.com
RI Martinez, Diego/K-8310-2012; LEAL, CLAUDENETE/S-8592-2018; Alves,
   Oswaldo/J-7124-2012
OI Martinez, Diego/0000-0002-0086-3055; LEAL,
   CLAUDENETE/0000-0002-2223-2297; Alves, Oswaldo/0000-0002-1518-2092
FU CNPq [402280/2013-0, 552120/2011-1]; FAPESP [2008/57867-8]
FX The authors are grateful to CNPq (402280/2013-0 and 552120/2011-1) and
   FAPESP (2008/57867-8) to financial support. DSTM and OLA thank the
   National Institute of Science, Technology and Innovation on Complex
   Functional Materials (INCT-Inomat), Brazilian Nanotubes Network (Rede
   Nanotubos), Brazilian Nanotoxicology Network (Rede Cigenanotox), and
   SisNANO/MCTI (NanoBioss Laboratory). CVL and EARD thank the LAMULT
   Laboratory/Institute of Physics Gleb Wataghin (University of Campinas)
   for AFM analysis.
CR Ajayan PM, 2007, NATURE, V447, P1066, DOI 10.1038/4471066a
   American Society for Testing and Materials-ASTM, 2012, D88212 ASTM
   Andrade NF, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-1761-8
   Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Armentano I, 2010, POLYM DEGRAD STABIL, V95, P2126, DOI 10.1016/j.polymdegradstab.2010.06.007
   Bikiaris D, 2010, MATERIALS, V3, P2884, DOI 10.3390/ma3042884
   Bin T., 2011, THERMOCHIM ACTA, V525, P141, DOI DOI 10.1016/J.TCA.2011.08.003
   Blumenstein R, 2002, INT J ONCOL, V21, P447
   Bruzaud S, 2007, POLYM TEST, V26, P652, DOI 10.1016/j.polymertesting.2007.04.001
   Cassu SN, 2005, QUIM NOVA, V28, P255, DOI 10.1590/S0100-40422005000200017
   Chen K, 2007, J PHYS CHEM B, V111, P12685, DOI 10.1021/jp0759168
   Chrissafis K, 2008, J APPL POLYM SCI, V110, P1739, DOI 10.1002/app.28818
   Datsyuk V, 2008, CARBON, V46, P833, DOI 10.1016/j.carbon.2008.02.012
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Dondero WE, 2006, J POLYM SCI POL PHYS, V44, P864, DOI 10.1002/POLB.20743
   Ellis SJ, 2010, CELL TISSUE RES, V339, P121, DOI 10.1007/s00441-009-0828-4
   Firkowska I, 2008, ADV FUNCT MATER, V18, P3765, DOI 10.1002/adfm.200800760
   Gamez-Perez J, 2011, J APPL POLYM SCI, V120, P896, DOI 10.1002/app.33191
   Harrison BS, 2007, BIOMATERIALS, V28, P344, DOI 10.1016/j.biomaterials.2006.07.044
   He AH, 2004, POLYMER, V45, P8231, DOI 10.1016/j.polymer.2004.08.076
   He YS, 2014, RSC ADV, V4, P12857, DOI 10.1039/c4ra00718b
   Hickey DJ, 2015, ACTA BIOMATER, V14, P175, DOI 10.1016/j.actbio.2014.12.004
   Hirata E, 2012, APPL SURF SCI, V262, P24, DOI 10.1016/j.apsusc.2012.01.012
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   Jain S, 2011, CHEM RES TOXICOL, V24, P2028, DOI 10.1021/tx2003728
   Jana RN, 2010, COMPOS PART A-APPL S, V41, P1524, DOI 10.1016/j.compositesa.2010.06.015
   Jancar J., 2003, HDB POLYPROPYLENE PO, P374
   Kroustalli AA, 2013, ANN BIOMED ENG, V41, P2655, DOI 10.1007/s10439-013-0860-0
   Lacerda L, 2008, NANOMEDICINE-UK, V3, P149, DOI 10.2217/17435889.3.2.149
   Lacerda L, 2008, ADV MATER, V20, P225, DOI 10.1002/adma.200702334
   Lahiri D, 2009, ACS APPL MATER INTER, V1, P2470, DOI 10.1021/am900423q
   Leal CV, 2015, QUIM NOVA, V38, P1153, DOI 10.5935/0100-4042.20150132
   Li JZ, 2015, POLYMER, V63, P179, DOI 10.1016/j.polymer.2015.02.049
   Li WX, 2014, CHEM ENG J, V237, P291, DOI 10.1016/j.cej.2013.10.034
   Li X., 2009, BIOMED MATER, V4, P1
   Lin CL, 2011, COLLOID SURFACE B, V83, P367, DOI 10.1016/j.colsurfb.2010.12.011
   Liu HZ, 2011, J POLYM SCI POL PHYS, V49, P1051, DOI 10.1002/polb.22283
   Mas BA, 2014, MATER RES-IBERO-AM J, V17, P1523, DOI 10.1590/1516-1439.269414
   Mirsalehi SA, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.42052
   Montesano S., 2013, ISRN TISSUE ENG, V2013, P1
   Motta Adriana C., 2006, Polímeros, V16, P26, DOI 10.1590/S0104-14282006000100008
   Mundra RV, 2014, CURR OPIN BIOTECH, V28, P25, DOI 10.1016/j.copbio.2013.10.012
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Ng KW, 2005, TISSUE ENG, V11, P182, DOI 10.1089/ten.2005.11.182
   Nielsen L.E., 1993, MECH PROPERTIES POLY
   Ornagui H.L., 2010, J APPL POLYM SCI, V118, P887
   Papageorgiou DG, 2014, THERMOCHIM ACTA, V590, P181, DOI 10.1016/j.tca.2014.06.030
   Papageorgiou GZ, 2010, THERMOCHIM ACTA, V511, P129, DOI 10.1016/j.tca.2010.08.004
   Park S. J., 2011, INTERFACE SCI COMPOS
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Perez E, 2013, COMPOS PART B-ENG, V52, P72, DOI 10.1016/j.compositesb.2013.03.035
   Pothan LA, 2003, COMPOS SCI TECHNOL, V63, P283, DOI 10.1016/S0266-3538(02)00254-3
   Ramontja J, 2009, MACROMOL MATER ENG, V294, P839, DOI 10.1002/mame.200900197
   Sahoo NG, 2010, PROG POLYM SCI, V35, P837, DOI 10.1016/j.progpolymsci.2010.03.002
   Schadler L, 2007, NAT MATER, V6, P257, DOI 10.1038/nmat1873
   Stefani D, 2011, J HAZARD MATER, V189, P391, DOI 10.1016/j.jhazmat.2011.02.050
   Tang ZB, 2012, J APPL POLYM SCI, V125, P1108, DOI 10.1002/app.34799
   Tavangarian F, 2012, CERAM INT, V38, P6075, DOI 10.1016/j.ceramint.2012.05.038
   Thostenson ET, 2001, COMPOS SCI TECHNOL, V61, P1899, DOI 10.1016/S0266-3538(01)00094-X
   Tian HY, 2012, PROG POLYM SCI, V37, P237, DOI 10.1016/j.progpolymsci.2011.06.004
   Tirrell M, 2002, SURF SCI, V500, P61, DOI 10.1016/S0039-6028(01)01548-5
   Turan D, 2011, J APPL POLYM SCI, V121, P1067, DOI 10.1002/app.33802
   Ulery BD, 2011, J POLYM SCI POL PHYS, V49, P832, DOI 10.1002/polb.22259
   Vardharajula S, 2012, INT J NANOMED, V7, P5361, DOI 10.2147/IJN.S35832
   Wagner HD, 2004, MATER TODAY, V7, P38, DOI 10.1016/S1369-7021(04)00507-3
   Wan YQ, 2005, BIOMATERIALS, V26, P4453, DOI 10.1016/j.biomaterials.2004.11.016
   Wang HF, 2004, J NANOSCI NANOTECHNO, V4, P1019, DOI 10.1166/jnn.2004.146
   Wepasnick KA, 2011, CARBON, V49, P24, DOI 10.1016/j.carbon.2010.08.034
   Wu LP, 2013, POLYM CHEM-UK, V4, P4490, DOI 10.1039/c3py00668a
   Xiao Y, 2010, ACS APPL MATER INTER, V2, P3506, DOI 10.1021/am100692n
   Xu HS, 2009, J POLYM SCI POL PHYS, V47, P2341, DOI 10.1002/polb.21830
   Xu ZH, 2011, ACS APPL MATER INTER, V3, P3744, DOI 10.1021/am200932q
   Yan LA, 2011, NANOSCALE, V3, P362, DOI 10.1039/c0nr00647e
   Yang ST, 2012, THERANOSTICS, V2, P271, DOI 10.7150/thno.3618
   Yang Y.K., 2011, FUNCTIONALIZATION CA
   Yu HY, 2012, CARBOHYD POLYM, V89, P971, DOI 10.1016/j.carbpol.2012.04.053
   Zhang L, 2015, CHEM ENG J, V264, P538, DOI 10.1016/j.cej.2014.11.066
   Zhang QW, 2012, BIOMATERIALS, V33, P5067, DOI 10.1016/j.biomaterials.2012.03.063
   Zhao YY, 2009, COMPOS SCI TECHNOL, V69, P627, DOI 10.1016/j.compscitech.2008.12.008
NR 80
TC 3
Z9 3
U1 4
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
EI 1878-0180
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD JUN
PY 2016
VL 59
BP 547
EP 560
DI 10.1016/j.jmbbm.2016.03.016
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DM9NV
UT WOS:000376693900048
PM 27038896
DA 2018-10-20
ER

PT J
AU Saito, Y
   Kamitakahara, H
   Takano, T
AF Saito, Yasuko
   Kamitakahara, Hiroshi
   Takano, Toshiyuki
TI Preparation of (ruthenium (II) complex)-bound cellulose derivative for
   photocurrent generation system
SO JOURNAL OF WOOD SCIENCE
LA English
DT Article
DE Cellulose; Langmuir Blodgett film; Photoelectro conversion;
   Photosensitizer; Ruthenium complex
ID LANGMUIR-BLODGETT-FILMS; PERFORMANCE; COMPLEXES; RUTHENIUM; RING; DYE
AB 6-0-[Acetylacetonato-bis(2,2'-bipyridine)ruthenium(II)]-2,3-di-0-myristyl cellulose (3) was prepared from 2,3-di-0-myristyl cellulose (1) by two reaction steps in 37.7 % total yield. The LB monolayer film of compound 3 was successfully deposited onto an indium tin oxide electrode by a vertical dipping method and showed photocurrent generation performance in the range of 400-600 nm. Compound 3 was expected as a complementary material of porphyrinbound cellulose derivative for biomaterial-based solar cells.
C1 [Saito, Yasuko; Kamitakahara, Hiroshi; Takano, Toshiyuki] Kyoto Univ, Grad Sch Agr, Div Forest & Biomat Sci, Sakyo Ku, Kitashirakawa Oiwake Cho, Kyoto 6068502, Japan.
RP Takano, T (reprint author), Kyoto Univ, Grad Sch Agr, Div Forest & Biomat Sci, Sakyo Ku, Kitashirakawa Oiwake Cho, Kyoto 6068502, Japan.
EM takatmys@kais.kyoto-u.ac.jp
RI Kamitakahara, Hiroshi/L-6710-2018
OI Kamitakahara, Hiroshi/0000-0002-0130-1919
CR Burke A, 2007, CHEM COMMUN, P234, DOI 10.1039/b609266g
   Edgar KJ, 2001, PROG POLYM SCI, V26, P1605, DOI 10.1016/S0079-6700(01)00027-2
   EDGAR KJ, 1995, MACROMOLECULES, V28, P4122, DOI 10.1021/ma00116a011
   ElHendawy AM, 1997, POLYHEDRON, V16, P3039
   Kang H, 2012, POLYM INT, V62, P338
   Matsumi N, 2008, POLYM J, V40, P400, DOI 10.1295/polymj.PJ2007225
   Nasuno T, 2006, HOLZFORSCHUNG, V60, P201, DOI 10.1515/HF.2006.033
   Numata Y, 2013, CHEM LETT, V42, P1328, DOI 10.1246/cl.130701
   Saito Y, 2016, CARBOHYD RES, V421, P40, DOI 10.1016/j.carres.2015.12.002
   Saito Y, 2014, CELLULOSE, V21, P1885, DOI 10.1007/s10570-014-0176-8
   Saito Y, 2012, CELLULOSE, V19, P2105, DOI 10.1007/s10570-012-9772-7
   Sakakibara K, 2007, MACROMOL RAPID COMM, V28, P1270, DOI 10.1002/marc.200700130
   Sakakibara K, 2010, MACROMOL CHEM PHYS, V211, P2425, DOI 10.1002/macp.201000257
   SULLIVAN BP, 1978, INORG CHEM, V17, P3334, DOI 10.1021/ic50190a006
   Taniguchi T, 1997, CHEM LETT, P295, DOI 10.1246/cl.1997.295
   Vougioukalakis GC, 2011, COORDIN CHEM REV, V255, P2602, DOI 10.1016/j.ccr.2010.11.006
   Wallen SL, 1997, J CHEM SOC FARADAY T, V93, P2391, DOI 10.1039/a701851g
   Wondraczek H, 2011, CARBOHYD POLYM, V83, P1048, DOI 10.1016/j.carbpol.2010.10.014
   Yin JF, 2012, COORDIN CHEM REV, V256, P3008, DOI 10.1016/j.ccr.2012.06.022
   Yoshida Y, 2007, CELLULOSE, V14, P481, DOI 10.1007/s10570-007-9133-0
NR 20
TC 0
Z9 0
U1 1
U2 11
PU SPRINGER JAPAN KK
PI TOKYO
PA CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065,
   JAPAN
SN 1435-0211
EI 1611-4663
J9 J WOOD SCI
JI J. Wood Sci.
PD JUN
PY 2016
VL 62
IS 3
BP 270
EP 275
DI 10.1007/s10086-016-1550-y
PG 6
WC Forestry; Materials Science, Paper & Wood
SC Forestry; Materials Science
GA DM8ZT
UT WOS:000376653700007
DA 2018-10-20
ER

PT J
AU Wang, HL
   Ping, L
   Yu, Q
   Hui, Y
AF Wang Hailei
   Ping, Li
   Yu, Qin
   Hui, Yang
TI Removal of phenol in phenolic resin wastewater by a novel biomaterial:
   the Phanerochaete chrysosporium pellet containing chlamydospore-like
   cells
SO APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
LA English
DT Article
DE Phenol; Chlamydospore-like cell; Metagenomic analysis; Lignin
   peroxidase; Mn-dependent peroxidase
ID YEAST CANDIDA-TROPICALIS; FIXED-BED REACTOR; WHITE-ROT FUNGUS;
   IMMOBILIZED CELLS; FLUIDIZED-BED; DEGRADATION; BIODEGRADATION;
   PEROXIDASE; MICROORGANISMS; NANOPARTICLES
AB A novel biomaterial, the Phanerochaete chrysosporium pellet (CP) composed of chlamydospore-like cells (CLCs), was prepared and its potential in treating phenolic resin wastewater was evaluated. CP possesses higher phenol removal ability in contrast with mycelial pellets of P. chrysosporium, and CLC can be seen as the naturally immobilized enzymes. At shake-flask level, the ideal pH value, temperature, and inoculation quantity of CP for treatment of 1430 mg/l phenol wastewater were pH 4-6, 30 A degrees C, and 5.0 g/l, respectively, and the maximum specific removal rate, 41.1 mg phenol/g CP/h, was obtained in fixed bed reactor (FBR) when the flow rate of wastewater was 3.4 l/h. During the treatment, FBR harbored amounts of bacteria (135 genera) and eukaryotes, as analyzed by metagenomic sequencing. Bacterial pollution not only decreased reactor performance but also had a negative impact on reusability of CP. Hot water treatment (80-85 A degrees C) is effective to inhibit bacterial pollution, and heat resistance of CLC makes the repeated regrowing of CP be feasible. This work presents an innovative and low-cost biomaterial for phenol removal and will be helpful for the practical application of P. chrysosporium in wastewater treatment.
C1 [Wang Hailei; Ping, Li; Yu, Qin] Henan Normal Univ, Coll Life Sci, Xinxiang 453007, Peoples R China.
   [Wang Hailei] Univ Henan Prov, Key Lab Microorganisms & Funct Mol, Xinxiang 453007, Peoples R China.
   [Hui, Yang] Henan Med Coll, Dept Med, Xinzheng 451191, Peoples R China.
RP Wang, HL (reprint author), Henan Normal Univ, Coll Life Sci, Xinxiang 453007, Peoples R China.; Wang, HL (reprint author), Univ Henan Prov, Key Lab Microorganisms & Funct Mol, Xinxiang 453007, Peoples R China.
EM whl@htu.edu.cn
FU National Science Foundation of China [51008119]
FX This work is supported by the National Science Foundation of China (No.
   51008119).
CR Adav SS, 2007, BIOTECHNOL BIOENG, V96, P844, DOI 10.1002/bit.21148
   Ahmaruzzaman M, 2008, ADV COLLOID INTERFAC, V143, P48, DOI 10.1016/j.cis.2008.07.002
   Al-Khalid T, 2012, CRIT REV ENV SCI TEC, V42, P1631, DOI 10.1080/10643389.2011.569872
   Aloke KG, 2011, INT BIODETER BIODEGR, V65, P1052
   ANSELMO AM, 1985, BIOTECHNOL LETT, V7, P889, DOI 10.1007/BF01088011
   APHA (American Public Health Association), 1998, STANDARD METHODS EXA
   Bajaj M, 2008, BIORESOURCE TECHNOL, V99, P8376, DOI 10.1016/j.biortech.2008.02.057
   Banerjee A, 2011, INT BIODETER BIODEGR, V65, P1052, DOI 10.1016/j.ibiod.2011.04.011
   Bayer C, 2010, WATER SCI TECHNOL, V62, P915, DOI 10.2166/wst.2010.368
   Bayramoglu G, 2010, BIORESOURCE TECHNOL, V101, P6615, DOI 10.1016/j.biortech.2010.03.088
   Bayramoglu G, 2009, BIORESOURCE TECHNOL, V100, P2685, DOI 10.1016/j.biortech.2008.12.042
   Begerow D, 2010, APPL MICROBIOL BIOT, V87, P99, DOI 10.1007/s00253-010-2585-4
   Bergauer P, 2005, CHEMOSPHERE, V59, P909, DOI 10.1016/j.chemosphere.2004.11.011
   Bogan BW, 1996, APPL ENVIRON MICROB, V62, P1597
   Busca G, 2008, J HAZARD MATER, V160, P265, DOI 10.1016/j.jhazmat.2008.03.045
   Carbajo JB, 2010, BIODEGRADATION, V21, P603, DOI 10.1007/s10532-010-9328-1
   CARDOSO RB, 2009, PROCESS BIOCHEM, V44, P23
   Carter MR, 1993, SOIL SAMPLING METHOD
   Chen KC, 2002, ENZYME MICROB TECH, V31, P490, DOI 10.1016/S0141-0229(02)00148-5
   Daims H, 2007, APPL MICROBIOL BIOT, V75, P237, DOI 10.1007/s00253-007-0886-z
   Galindez-Mayer J, 2008, BIOCHEM ENG J, V38, P147, DOI 10.1016/j.bej.2007.06.011
   Gao DW, 2010, CRIT REV BIOTECHNOL, V30, P70, DOI 10.3109/07388550903427272
   Godjevargova T, 2000, PROCESS BIOCHEM, V35, P699, DOI 10.1016/S0032-9592(99)00131-4
   Gomez JL, 2006, ENZYME MICROB TECH, V39, P1016, DOI 10.1016/j.enzmictec.2006.02.008
   Gomez M, 2009, J HAZARD MATER, V169, P46, DOI 10.1016/j.jhazmat.2009.03.059
   Hannaford AM, 1999, J IND MICROBIOL BIOT, V22, P121, DOI 10.1038/sj.jim.2900617
   He LM, 2014, MICROB ECOL, V67, P951, DOI 10.1007/s00248-014-0393-6
   Jiang HL, 2006, ENVIRON SCI TECHNOL, V40, P6137, DOI 10.1021/es0609295
   Jiang LC, 2013, J BASIC MICROB, V53, P224, DOI 10.1002/jobm.201100460
   Karigar C, 2006, BIODEGRADATION, V17, P47, DOI 10.1007/s10532-005-3048-y
   KENNES C, 1994, J IND MICROBIOL, V13, P311, DOI 10.1007/BF01569733
   Kibret M, 2000, WATER RES, V34, P1127, DOI 10.1016/S0043-1354(99)00248-1
   Le TH, 2012, BIORESOURCE TECHNOL, V104, P795, DOI 10.1016/j.biortech.2011.10.064
   Leitao AL, 2007, INT BIODETER BIODEGR, V59, P220, DOI 10.1016/j.ibiod.2006.09.009
   Levy I, 2003, BIOTECHNOL BIOENG, V82, P223, DOI 10.1002/bit.10562
   Liu YJ, 2009, BIOCHEM ENG J, V44, P187, DOI 10.1016/j.bej.2008.12.001
   Lobo CC, 2014, WATER SA, V40, P125, DOI 10.4314/wsa.v40i1.15
   Lu DB, 2012, BIODEGRADATION, V23, P209, DOI 10.1007/s10532-011-9500-2
   Nikola L, 2011, J SERB CHEM SOC, V76, P513
   Polaert I, 2005, CHEM ENG SCI, V60, P6354, DOI 10.1016/j.ces.2005.01.030
   Rho D, 2001, BIOTECHNOL BIOENG, V73, P271, DOI 10.1002/bit.1060
   Couto SR, 2006, WORLD J MICROB BIOT, V22, P607, DOI 10.1007/s11274-005-9078-0
   Saitoh T, 2011, J HAZARD MATER, V185, P1369, DOI 10.1016/j.jhazmat.2010.10.057
   Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09
   Seetharam GB, 2003, WATER RES, V37, P436, DOI 10.1016/S0043-1354(02)00290-7
   Shao J, 2007, BIOTECHNOL LETT, V29, P901, DOI 10.1007/s10529-007-9329-2
   STGERMAIN G, 1996, IDENTIFYING FILAMENT
   Su C, 2012, APPL MICROBIOL BIOT, V93, P993, DOI 10.1007/s00253-011-3800-7
   TIEN M, 1983, SCIENCE, V221, P661, DOI 10.1126/science.221.4611.661
   Urek RO, 2005, PROCESS BIOCHEM, V40, P83, DOI 10.1016/j.procbio.2003.11.040
   Wang C, 2008, BIOMED ENVIRON SCI, V21, P474, DOI 10.1016/S0895-3988(09)60005-2
   Wang F, 2012, BIORESOURCE TECHNOL, V110, P120, DOI 10.1016/j.biortech.2012.01.184
   Wang HL, 2005, J ENVIRON SCI, V17, P421
   Wesenberg D, 2003, BIOTECHNOL ADV, V22, P161, DOI 10.1016/j.biotechadv.2003.08.011
   Wu CD, 2001, WATER RES, V35, P3927, DOI 10.1016/S0043-1354(01)00133-6
   Yang YN, 2004, BIORESOURCE TECHNOL, V92, P285, DOI 10.1016/j.biortech.2003.09.011
   Zaushitsyna O, 2013, TOP CATAL, V56, P339
   Zhai ZJ, 2012, J CHEM TECHNOL BIOT, V87, P105, DOI 10.1002/jctb.2689
   ZHOU DQ, 2002, ESSENTIAL MICROBIOLO
NR 59
TC 2
Z9 2
U1 1
U2 41
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0175-7598
EI 1432-0614
J9 APPL MICROBIOL BIOT
JI Appl. Microbiol. Biotechnol.
PD JUN
PY 2016
VL 100
IS 11
BP 5153
EP 5164
DI 10.1007/s00253-016-7353-7
PG 12
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA DM3OG
UT WOS:000376255200038
PM 26860939
DA 2018-10-20
ER

PT J
AU Gramanzini, M
   Gargiulo, S
   Zarone, F
   Megna, R
   Apicella, A
   Aversa, R
   Salvatore, M
   Mancini, M
   Sorrentino, R
   Brunetti, A
AF Gramanzini, Matteo
   Gargiulo, Sara
   Zarone, Fernando
   Megna, Rosario
   Apicella, Antonio
   Aversa, Raffaella
   Salvatore, Marco
   Mancini, Marcello
   Sorrentino, Roberto
   Brunetti, Arturo
TI Combined microcomputed tomography, biomechanical and histomorphometric
   analysis of the peri-implant bone: a pilot study in minipig model
SO DENTAL MATERIALS
LA English
DT Article
DE Dental implant; Insertion torque; Resonance frequency analysis; mu CT;
   Histomorphometry; Minipig model
ID RESONANCE FREQUENCY-ANALYSIS; SINGLE-TOOTH IMPLANTS; BRANEMARK SYSTEM
   IMPLANTS; DENTAL QUANTITATIVE CT; PRIMARY STABILITY; IN-VITRO; INSERTION
   TORQUE; ENDOSSEOUS IMPLANTS; TITANIUM IMPLANTS; TRABECULAR BONE
AB Objectives. To present a practical approach that combines biomechanical tests, microcomputed tomography (mu CT) and histomorphometry, providing quantitative results on bone structure and mechanical properties in a minipig model, in order to investigate the specific response to an innovative dental biomaterial.
   Methods. Titanium implants with innovative three-dimensional scaffolds were inserted in the tibias of 4 minipigs. Primary stability and osseointegration were investigated by means of insertion torque (IT) values, resonance frequency analysis (RFA), bone-to-implant contact (BIC), bone mineral density (BMD) and stereological measures of trabecular bone.
   Results. A significant positive correlation was found between IT and RFA (r = 0.980, p = 0.0001). BMD at the implant sites was 18% less than the reference values (p = 0.0156). Pefi-implant Tb.Th was 50% higher, while Tb.N was 50% lower than the reference zone (p <0.003) and they were negatively correlated (r = -0.897, p = 0.006).
   Significance. mu CT increases evaluation throughput and offers the possibility for qualitative three-dimensional recording of the bone-implant system as well as for non-destructive evaluation of bone architecture and mineral density, in combination with conventional analysis methods. The proposed multimodal approach allows to improve accuracy and reproducibility for peri-implant bone measurements and could support future investigations. (C) 2016 Academy of Dental Materials. Published by Elsevier Ltd. All rights reserved.
C1 [Gramanzini, Matteo; Gargiulo, Sara; Megna, Rosario; Mancini, Marcello] CNR, Inst Biostruct & Bioimaging, Via T De Amicis 95, I-80145 Naples, Italy.
   [Gramanzini, Matteo; Gargiulo, Sara; Brunetti, Arturo] CEINGE Scarl, Via G Salvatore 486, I-80145 Naples, Italy.
   [Zarone, Fernando; Sorrentino, Roberto] Univ Naples Federico II, Sch Med, Dept Neurosci Reprod & Odontostomatol Sci, Via Pansini 5, I-80131 Naples, Italy.
   [Apicella, Antonio; Aversa, Raffaella; Sorrentino, Roberto] Univ Naples 2, Dept Architecture & Ind Design, I-81031 Borgo San Lorenzo, Aversa, Italy.
   [Salvatore, Marco] IRCCS SDN, Via E Gianturco 113, I-80143 Naples, Italy.
   [Brunetti, Arturo] Univ Naples Federico II, Dept Adv Med Sci, Via Pansini 5, I-80145 Naples, Italy.
RP Gramanzini, M (reprint author), CNR, Inst Biostruct & Bioimaging, Via T De Amicis 95, I-80145 Naples, Italy.
EM matteo.gramanzini@ibb.cnr.it; sara.gargiulo@ibb.cnr.it;
   fernandozarone@mac.com; rosario.megna@ibb.cnr.it;
   antonio.apicella@unina2.it; raffaella.aversa@unina2.it;
   marsalva@unina.it; marcello.mancini@ibb.cnr.it; errestino@libero.it;
   brunetti@unina.it
OI Megna, Rosario/0000-0002-5716-2137; Brunetti,
   Arturo/0000-0001-7057-3494; apicella, antonio/0000-0002-5365-6033;
   aversa, raffaella/0000-0003-0672-634X
CR Aerssens J, 1998, ENDOCRINOLOGY, V139, P663, DOI 10.1210/en.139.2.663
   Alm JJ, 2012, J ORTHOP RES, V30, P1019
   Alsaadi G, 2007, J CLIN PERIODONTOL, V34, P359, DOI 10.1111/j.1600-051X.2007.01047.x
   Aversa Raffaella, 2015, Advanced Materials Research, V1088, P487, DOI 10.4028/www.scientific.net/AMR.1088.487
   Aversa R, 2009, DENT MATER, V25, P678, DOI 10.1016/j.dental.2008.10.015
   Beddoe HA., 1978, CALCIF TISSUE RES, V25, P273
   Beer A, 2003, CLIN ORAL IMPLAN RES, V14, P616, DOI 10.1034/j.1600-0501.2003.00932.x
   Berglundh T, 2003, CLIN ORAL IMPLAN RES, V14, P251, DOI 10.1034/j.1600-0501.2003.00972.x
   Bilhan H, 2012, INT J DENT, V2012
   Calandriello Roberto, 2003, Clin Implant Dent Relat Res, V5 Suppl 1, P10, DOI 10.1111/j.1708-8208.2003.tb00011.x
   Cha JY, 2010, AM J ORTHOD DENTOFAC, V137, P73, DOI 10.1016/j.ajodo.2008.03.024
   COLIN SS, 2005, J APPL PHYSIOL, V99, P2369
   CURREY JD, 1995, BIOMATERIALS, V16, P1267, DOI 10.1016/0142-9612(95)98135-2
   da Cunha HA, 2004, INT J ORAL MAX IMPL, V19, P578
   Dagher M, 2014, IMPLANT DENT, V23, P672, DOI 10.1097/ID.0000000000000155
   Davison KS, 2006, SEMIN ARTHRITIS RHEU, V36, P22, DOI 10.1016/j.semarthrit.2006.04.002
   Degidi M, 2010, CLIN IMPLANT DENT R, V21, P213
   Degidi M, 2013, CLIN IMPLANT DENT R, V15, P637, DOI 10.1111/j.1708-8208.2011.00392.x
   Degidi M, 2009, CLIN ORAL IMPLAN RES, V20, P778, DOI 10.1111/j.1600-0501.2008.01599.x
   FELDKAMP LA, 1989, J BONE MINER RES, V4, P3, DOI 10.1002/jbmr.5650040103
   Franchi M, 2005, MICRON, V36, P665, DOI 10.1016/j.micron.2005.05.010
   Friberg B, 1999, Clin Implant Dent Relat Res, V1, P75, DOI 10.1111/j.1708-8208.1999.tb00095.x
   FRIBERG B, 1995, CLIN ORAL IMPLAN RES, V6, P213, DOI 10.1034/j.1600-0501.1995.060403.x
   FRIBERG B, 1995, CLIN ORAL IMPLAN RES, V6, P164, DOI 10.1034/j.1600-0501.1995.060305.x
   FROST HM, 1987, ANAT RECORD, V219, P1, DOI 10.1002/ar.1092190104
   Gahlert M, 2008, EUR CELLS MATER, V16, P34
   Homolka P, 2002, RADIOLOGY, V224, P247, DOI 10.1148/radiol.2241010948
   Horiuchi K, 2000, INT J ORAL MAX IMPL, V15, P824
   Hui E, 2001, Clin Implant Dent Relat Res, V3, P79, DOI 10.1111/j.1708-8208.2001.tb00235.x
   Huwiler MA, 2007, CLIN ORAL IMPLAN RES, V18, P275, DOI 10.1111/j.1600-0501.2007.01336.x
   Ito Y, 2008, CLIN ORAL IMPLAN RES, V19, P9, DOI 10.1111/j.1600-0501.2007.01419.x
   Johansson P, 1994, INT J ORAL MAXILLOF, V9, P279
   Joos U, 2006, INT J ORAL MAX SURG, V35, P783, DOI 10.1016/j.ijom.2006.03.013
   KRAGSTRUP J, 1989, BONE, V10, P421, DOI 10.1016/8756-3282(89)90073-2
   KUHN JL, 1990, J ORTHOPAED RES, V8, P833, DOI 10.1002/jor.1100080608
   LAIBLIN C, 1979, BERL MUNCH TIERARZTL, V92, P124
   Lorenzoni M, 2003, CLIN ORAL IMPLAN RES, V14, P180, DOI 10.1034/j.1600-0501.2003.140207.x
   Calvo-Guirado JL, 2014, CLIN ORAL IMPLAN RES, V25, P352, DOI 10.1111/clr.12134
   Majumdar S, 1998, BONE, V22, P445, DOI 10.1016/S8756-3282(98)00030-1
   Malo P, 2000, Clin Implant Dent Relat Res, V2, P138, DOI 10.1111/j.1708-8208.2000.tb00004.x
   Martinez-Gonzalez JM, 2005, ORAL SURG ORAL MED O, V99, P11, DOI 10.1016/j.tripleo.2004.02.068
   Martiniakova M, 2006, J FORENSIC SCI, V51, P1235, DOI 10.1111/j.1556-4029.2006.00260.x
   Meredith N, 1997, CLIN ORAL IMPLAN RES, V8, P226, DOI 10.1034/j.1600-0501.1997.080309.x
   Meredith N, 1997, CLIN ORAL IMPLAN RES, V8, P234, DOI 10.1034/j.1600-0501.1997.080310.x
   Meredith N, 1996, CLIN ORAL IMPLAN RES, V7, P261, DOI 10.1034/j.1600-0501.1996.070308.x
   Meredith N, 1998, INT J PROSTHODONT, V11, P491
   Meredith N, 1996, MED SCI RES, V24, P191
   Miyamoto I, 2005, BONE, V37, P776, DOI 10.1016/j.bone.2005.06.019
   MOSEKILDE L, 1993, BONE, V14, P379, DOI 10.1016/8756-3282(93)90167-9
   MOSEKILDE L, 1987, CALCIFIED TISSUE INT, V40, P318, DOI 10.1007/BF02556693
   Muller B, 2007, INT J MATER RES, V98, P613, DOI 10.3139/146.101507
   Natali AN, 2004, DENT MATER, V22, p[3, 9]
   Nazarian A, 2009, J BIOMECH, V42, P82, DOI 10.1016/j.jbiomech.2008.09.037
   Neugebauer J, 2006, J PERIODONTOL, V77, P152, DOI 10.1902/jop.2006.040360
   Nikellis I, 2004, INT J ORAL MAX IMPL, V19, P116
   Nkenke E, 2003, CLIN ORAL IMPLAN RES, V14, P601, DOI 10.1034/j.1600-0501.2003.00937.x
   O'Sullivan D, 2000, Clin Implant Dent Relat Res, V2, P85, DOI 10.1111/j.1708-8208.2000.tb00110.x
   Ostman PO, 2006, INT J PROSTHODONT, V19, P77
   Otsuka M, 2013, J BIOMED MATER RES B, V101B, P338, DOI 10.1002/jbm.b.32844
   Ottoni JMP, 2005, INT J ORAL MAX IMPL, V20, P769
   Panseri S, 2013, BONE, V56, P432, DOI 10.1016/j.bone.2013.07.015
   Park YS, 2005, CLIN ORAL IMPLAN RES, V16, P156, DOI 10.1111/j.1600-0501.2004.01083.x
   Rebaudi A, 2011, INT J ORAL MAX IMPL, V26, P1233
   Roberts W E, 1988, J Dent Educ, V52, P804
   ROBERTS WE, 1989, ANGLE ORTHOD, V59, P247
   Romanos GE, 2014, CLIN IMPLANT DENT R, V16, P89, DOI 10.1111/j.1708-8208.2012.00464.x
   Sakoh J, 2006, INT J ORAL MAX IMPL, V21, P560
   Salimov F, 2014, CLIN ORAL IMPLAN RES, V25, P1016, DOI 10.1111/clr.12219
   Scarano A, 2006, CLIN IMPLANT DENT R, V8, P218, DOI 10.1111/j.1708-8208.2006.00022.x
   Schiraldi C, 2004, BIOMATERIALS, V25, P3645, DOI 10.1016/j.biomaterials.2003.10.059
   Schliephake H, 2006, INT J ORAL MAX SURG, V35, P941, DOI 10.1016/j.ijom.2006.05.002
   SEDLIN ED, 1966, ACTA ORTHOP SCAND, V37, P29, DOI 10.3109/17453676608989401
   Sennerby L, 2008, PERIODONTOL 2000, V47, P51, DOI 10.1111/j.1600-0757.2008.00267.x
   Shalabi MM, 2006, CLIN ORAL IMPLAN RES, V17, P172, DOI 10.1111/j.1600-0501.2005.01202.x
   Stadlinger B, 2010, BR J ORAL MAXILLOFAC, V50, P74
   Swain MV, 2009, INT J ORAL SCI, V1, P177, DOI 10.4248/IJOS09031
   Thorwarth M, 2005, J ORAL MAXIL SURG, V63, P1626, DOI 10.1016/j.joms.2005.06.010
   Turkyilmaz I, 2006, J ORAL REHABIL, V33, P754, DOI 10.1111/j.1365-2842.2006.01631.x
   Turkyilmaz I., 2007, J CLIN PERIODONTOL, V34, P716, DOI DOI 10.1111/J.1600-051X.2007.01112.X
   Turkyilmaz Ilser, 2008, BMC Oral Health, V8, P32, DOI 10.1186/1472-6831-8-32
   Velasquez P, 2013, J BIOMED MATER RES A, V101, P1943, DOI 10.1002/jbm.a.34495
   Vozzi G, 2013, J BIOMED MAT RES A, p00A
   Wang S, 2007, ORAL DIS, V13, P530, DOI 10.1111/j.1601-0825.2006.01337.x
NR 83
TC 2
Z9 2
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0109-5641
EI 1879-0097
J9 DENT MATER
JI Dent. Mater.
PD JUN
PY 2016
VL 32
IS 6
BP 794
EP 806
DI 10.1016/j.dental.2016.03.025
PG 13
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA DL8GZ
UT WOS:000375880500012
PM 27063459
DA 2018-10-20
ER

PT J
AU Liu, XM
   Yang, L
   Li, J
   Zhang, YM
   Xu, WJ
   Ren, Y
   Liu, BW
   Yang, BA
   Li, BX
AF Liu, Xiaoming
   Yang, Lin
   Li, Jing
   Zhang, Yuming
   Xu, Weijun
   Ren, Yan
   Liu, Biwang
   Yang, Biao
   Li, Baoxing
TI GS/DBM/PLA porous composite biomaterial for the treatment of infective
   femoral condyle defect in rats
SO EXPERIMENTAL AND THERAPEUTIC MEDICINE
LA English
DT Article
DE bone tissue engineering; infection; bone defect; composite biomaterial
ID DEMINERALIZED BONE-MATRIX; IN-VITRO; GRAFTING MATERIALS; RELEASE;
   REPAIR; REGENERATION; DELIVERY; CEMENT; BIOCOMPATIBILITY; MICROPARTICLES
AB A bone defect resulting from open bone trauma may easily become infected; however, the administration of efficacious systemic antibiotics cannot be performed at safe levels. Previous studies have investigated anti-infective biomaterials that incorporate into bone and facilitate the direct application of high-concentration local antibiotics. In the present study, the effect of a novel porous composite with gentamicin sulfate (GS) in treating infected femoral condyle defects was investigated using a rat model. A novel porous composite biomaterial was prepared based on a supercritical carbon dioxide fluid technique that combined GS, demineralized bone matrix (DBM) and polylactic acid (PLA). A rat femoral condyle fracture model of infection was established. The GS/DBM/PLA composite biomaterial was implanted and its physicochemical characteristics, biocompatibility and ability to facilitate repair of infected bone defect were assessed. The GS/DBM/PLA composite biomaterial maintained the antibiotic activity of GS, with good anti-compression strength, porosity and biocompatibility. The results of the animal experiments indicated that the GS/DBM/PLA composite biomaterial exerted marked anti-infective effects and facilitated bone defect repair, while simultaneously controlling infection. Porous GS/DBM/PLA is therefore a promising composite biomaterial for use in bone tissue engineering.
C1 [Liu, Xiaoming; Li, Baoxing] Southern Med Univ, Guangdong Prov Key Lab Med Biomech, Dept Human Anat, Guangzhou 510515, Guangdong, Peoples R China.
   [Liu, Xiaoming; Li, Jing; Zhang, Yuming; Xu, Weijun; Yang, Biao; Li, Baoxing] China Inst Radiat Protect, 102 Xuefu St, Taiyuan 030006, Shanxi, Peoples R China.
   [Yang, Lin] Zunyi Med Coll, Dept Human Anat, Zhuhai 519041, Guangdong, Peoples R China.
   [Ren, Yan] Shanxi Med Univ, Dept Med Imaging, Taiyuan 030001, Shanxi, Peoples R China.
   [Liu, Biwang] Shanxi Univ, Dept Tradit Chinese Med, Taiyuan 030001, Shanxi, Peoples R China.
RP Li, BX (reprint author), China Inst Radiat Protect, 102 Xuefu St, Taiyuan 030006, Shanxi, Peoples R China.
EM pplxmpp@163.com
FU Shenzhen Governmental Basic Research Grant [JCYJ20120617115010496];
   State Key Laboratory of Bioelectronics of Southeast University (Nanjing,
   China); Doctor Startup Foundation of Zunyi Medical College [F-746]
FX The present study was supported by a grant from the Shenzhen
   Governmental Basic Research Grant (no. JCYJ20120617115010496), the State
   Key Laboratory of Bioelectronics of Southeast University (Nanjing,
   China) and the Doctor Startup Foundation of Zunyi Medical College (no.
   F-746).
CR Agarwal A, 2015, J CLIN ORTHOP TRAUMA, V6, P72
   Ajiboye RM, 2015, EUR SPINE J, V24, P2567, DOI 10.1007/s00586-015-4117-5
   Ambrose CG, 2004, CLIN ORTHOP RELAT R, P293, DOI 10.1097/01.blo.0000126303.41711.a2
   Anal AK, 2005, INT J PHARM, V290, P45, DOI 10.1016/j.ijpharm.2004.11.015
   Bakhshalian N, 2013, INT J ORAL MAX IMPL, V28, P1655, DOI 10.11607/jomi .2833
   Bucholz RW, 2002, CLIN ORTHOP RELAT R, P44
   Buranapanitkit B, 2004, CLIN ORTHOP RELAT R, P244, DOI 10.1097/01.blo.0000130268.27024.c1
   Chen Zhi-Wen, 2008, Zhongguo Gu Shang, V21, P377
   Corden TJ, 2000, BIOMATERIALS, V21, P713, DOI 10.1016/S0142-9612(99)00236-7
   CRANE GM, 1995, NAT MED, V1, P1322, DOI 10.1038/nm1295-1322
   Fong N, 2013, J BIOMED MATER RES B, V101B, P310, DOI 10.1002/jbm.b.32841
   Garcia-Gareta E, 2015, BONE, V81, P112, DOI 10.1016/j.bone.2015.07.007
   Hautaamaki MP, 2008, ACTA ORTHOP, V79, P555, DOI 10.1080/17453670710015571
   Hile DD, 2000, J CONTROL RELEASE, V66, P177, DOI 10.1016/S0168-3659(99)00268-0
   Jimi E, 2012, INT J DENT, DOI 10.1155/2012/148261
   Li XD, 2001, J BONE JOINT SURG BR, V83B, P1063, DOI 10.1302/0301-620X.83B7.11271
   Li ZX, 2012, J BIOMED MATER RES A, V100A, P2537, DOI 10.1002/jbm.a.34185
   Li ZS, 2005, BIOMATERIALS, V26, P3919, DOI 10.1016/j.biomaterials.2004.09.062
   Link DP, 2006, BIOMATERIALS, V27, P4941, DOI 10.1016/j.biomaterials.2006.05.022
   Liu HH, 2010, J BIOMED MATER RES B, V95B, P36, DOI 10.1002/jbm.b.31680
   Makinen TJ, 2005, J ANTIMICROB CHEMOTH, V56, P1063, DOI 10.1093/jac/dki366
   Nofar M, 2013, POLYMER, V54, P2382, DOI 10.1016/j.polymer.2013.02.049
   Pandey M, 2013, INT J POLYM SCI, DOI 10.1155/2013/905471
   Porter NL, 2001, J BIOMED MATER RES, V56, P504, DOI 10.1002/1097-4636(20010915)56:4<504::AID-JBM1122>3.0.CO;2-J
   Quaglino P, 2013, GIORN ITAL DERMAT V, V148, P453
   Roberts TT, 2012, ORGANOGENESIS, V8, P114, DOI 10.4161/org.23306
   Silverman LD, 2007, J ORTHOP RES, V25, P23, DOI 10.1002/jor.20284
   Stiller M, 2014, BIOMATERIALS, V35, P3154, DOI 10.1016/j.biomaterials.2013.12.068
   Tavakol S, 2013, J CRANIOFAC SURG, V24, P2135, DOI 10.1097/SCS.0b013e3182a243d4
   Thomas DB, 2005, CLIN ORTHOP RELAT R, P366, DOI 10.1097/01.blo.0000181144.01306.b0
   Turner TM, 2005, CLIN ORTHOP RELAT R, P97, DOI 10.1097/01.blo.0000175127.37343.0d
   Lima CEVD, 2011, BRAZ ORAL RES, V25, P42, DOI 10.1590/S1806-83242011000100008
   Won YH, 2011, IMPLANT DENT, V20, P460, DOI 10.1097/ID.0b013e31823541e7
   Xu CX, 2010, J BIOMED MATER RES A, V95A, P495, DOI 10.1002/jbm.a.32877
   Yandrapu SK, 2013, MOL PHARMACEUT, V10, P4676, DOI 10.1021/mp400487f
   Yoshikawa T, 1998, BIO-MED MATER ENG, V8, P311
   Zhang HY, 2013, J MECH BEHAV BIOMED, V20, P209, DOI 10.1016/j.jmbbm.2013.01.001
   Zhang HY, 2013, J TRIBOL-T ASME, V135, DOI 10.1115/1.4023802
   Zhang Yu-min, 2006, Nan Fang Yi Ke Da Xue Xue Bao, V26, P1745
   Zheng JP, 2011, J MATER SCI-MATER M, V22, P1063, DOI 10.1007/s10856-011-4269-8
NR 40
TC 2
Z9 2
U1 4
U2 12
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1792-0981
EI 1792-1015
J9 EXP THER MED
JI Exp. Ther. Med.
PD JUN
PY 2016
VL 11
IS 6
BP 2107
EP 2116
DI 10.3892/etm.2016.3219
PG 10
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DM2NA
UT WOS:000376182300005
OA Green Published
DA 2018-10-20
ER

PT J
AU Alvarez-Anorve, LI
   Gaugue, I
   Link, H
   Marcos-Viquez, J
   Diaz-Jimenez, DM
   Zonszein, S
   Bustos-Jaimes, I
   Schmitz-Afonso, I
   Calcagno, ML
   Plumbridge, J
AF Alvarez-Anorve, Laura I.
   Gaugue, Isabelle
   Link, Hannes
   Marcos-Viquez, Jorge
   Diaz-Jimenez, Dana M.
   Zonszein, Sergio
   Bustos-Jaimes, Ismael
   Schmitz-Afonso, Isabelle
   Calcagno, Mario L.
   Plumbridge, Jacqueline
TI Allosteric Activation of Escherichia coli Glucosamine-6-Phosphate
   Deaminase (NagB) In Vivo Justified by Intracellular Amino Sugar
   Metabolite Concentrations
SO JOURNAL OF BACTERIOLOGY
LA English
DT Article
ID GLUCOSAMINE 6-PHOSPHATE DEAMINASE; N-ACETYLGLUCOSAMINE; ADAPTER PROTEIN;
   SMALL RNA; KINETICS; ENZYME; MECHANISM; ISOMERASE; SITE; K-12
AB We have investigated the impact of growth on glucosamine (GlcN) and N-acetylglucosamine (GlcNAc) on cellular metabolism by quantifying glycolytic metabolites in Escherichia coli. Growth on GlcNAc increased intracellular pools of both GlcNAc6P and GlcN6P 10- to 20-fold compared to growth on glucose. Growth on GlcN produced a 100-fold increase in GlcN6P but only a slight increase in GlcNAc6P. Changes to the amounts of downstream glycolytic intermediates were minor compared to growth on glucose. The enzyme glucosamine-6P deaminase (NagB) is required for growth on both GlcN and GlcNAc. It is an allosteric enzyme in E. coli, displaying sigmoid kinetics with respect to its substrate, GlcN6P, and is allosterically activated by GlcNAc6P. The high concentration of GlcN6P, accompanied by the small increase in GlcNAc6P, drives E. coli NagB (NagB(Ec)) into its high activity state, as observed during growth on GlcN (L. I. Alvarez-Anorve, I. Bustos-Jaimes, M. L. Calcagno, and J. Plumbridge, J Bacteriol 191: 6401-6407, 2009, http://dx.doi.org/10.1128/JB.00633-09). The slight increase in GlcNAc6P during growth on GlcN is insufficient to displace NagC, the GlcNAc6P-responsive repressor of the nag genes, from its binding sites, so there is only a small increase in nagB expression. We replaced the gene for the allosteric NagB(Ec) enzyme with that of the nonallosteric, B. subtilis homologue, NagB(Bs). We detected no effects on growth rates or competitive fitness on glucose or the amino sugars, nor did we detect any effect on the concentrations of central metabolites, thus demonstrating the robustness of amino sugar metabolism and leaving open the question of the role of allostery in the regulation of NagB.
   IMPORTANCE
   Chitin, the polymer of N-acetylglucosamine, is an abundant biomaterial, and both glucosamine and N-acetylglucosamine are valuable nutrients for bacteria. The amino sugars are components of numerous essential macromolecules, including bacterial peptidoglycan and mammalian glycosaminoglycans. Controlling the biosynthetic and degradative pathways of amino sugar metabolism is important in all organisms to avoid loss of nitrogen and energy via a futile cycle of synthesis and breakdown. The enzyme glucosamine-6P deaminase (NagB) is central to this control, and N-acetylglucosamine-6P is the key signaling molecule regulating amino sugar utilization in Escherichia coli. Here, we investigate how the metabolic status of the bacteria impacts on the activity of NagB(Ec) and the N-acetylglucosamine-6P-sensitive transcriptional repressor, NagC.
C1 [Alvarez-Anorve, Laura I.; Gaugue, Isabelle; Plumbridge, Jacqueline] Univ Paris Diderot, Sorbonne Paris Cite, CNRS, UMR8261,Inst Biol Phys Chim, Paris, France.
   [Alvarez-Anorve, Laura I.; Marcos-Viquez, Jorge; Diaz-Jimenez, Dana M.; Zonszein, Sergio; Bustos-Jaimes, Ismael; Calcagno, Mario L.] Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim, Lab Fisicoquim & Ingn Prot, Mexico City 04510, Cdmx, Mexico.
   [Link, Hannes] ETH, Inst Mol Syst Biol, Zurich, Switzerland.
   [Schmitz-Afonso, Isabelle] Univ Paris 11, ICSN CNRS UPR2301, LabEx CEBA, Inst Chim Subst Nat, Gif Sur Yvette, France.
   [Gaugue, Isabelle] Inst Curie, CNRS, INSERM, UMR 3215,U 934,Ctr Rech, F-75231 Paris, France.
   [Link, Hannes] Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany.
   [Schmitz-Afonso, Isabelle] Univ Rouen, Normandie Univ, COBRA, CNRS,UMR6014,FR 3038,IRCOF, Mont St Aignan, France.
RP Plumbridge, J (reprint author), Univ Paris Diderot, Sorbonne Paris Cite, CNRS, UMR8261,Inst Biol Phys Chim, Paris, France.
EM jackie.plumbridge@ibpc.fr
RI Schmitz-Afonso, Isabelle/D-2168-2013
OI Schmitz-Afonso, Isabelle/0000-0003-0665-0074; Bustos-Jaimes,
   Ismael/0000-0003-3038-8141
FU DGAPA-PAPIIT-UNAM [IN206009, IN213312]; DGAPA-PASPA-UNAM; Agence
   Nationale de la Recherche (ANR) [ANR-09-BLAN 0399, ANR-11-LABX-0011-01];
   Consejo Nacional de Ciencia y Tecnologia (CONACYT) [99857-Q, 116074];
   Centre National de la Recherche Scientifique (CNRS)
FX This work, including the efforts of Mario Calcagno, was funded by
   DGAPA-PAPIIT-UNAM (IN206009 and IN213312). This work, including the
   efforts of Laura I. Alvarez-Anorve, was funded by DGAPA-PASPA-UNAM. This
   work, including the efforts of Jacqueline A. Plumbridge, was funded by
   Agence Nationale de la Recherche (ANR) (ANR-09-BLAN 0399 and
   ANR-11-LABX-0011-01). This work, including the efforts of Mario
   Calcagno, was funded by Consejo Nacional de Ciencia y Tecnologia
   (CONACYT) (99857-Q and 116074). This work, including the efforts of
   Jacqueline A. Plumbridge, was funded by Centre National de la Recherche
   Scientifique (CNRS).
CR ALTAMIRANO MM, 1994, EUR J BIOCHEM, V220, P409, DOI 10.1111/j.1432-1033.1994.tb18638.x
   Alvarez-Anorve LI, 2011, BBA-PROTEINS PROTEOM, V1814, P1846, DOI 10.1016/j.bbapap.2011.07.010
   Alvarez-Anorve LI, 2009, J BACTERIOL, V191, P6401, DOI 10.1128/JB.00633-09
   Alvarez-Anorve LI, 2005, J BACTERIOL, V187, P2974, DOI 10.1128/JB.187.9.2974-2982.2005
   Arreola R, 2003, FEBS LETT, V551, P63, DOI 10.1016/S0014-5793(03)00896-2
   Baba Tomoya, 2006, Mol Syst Biol, V2
   Bertin Y, 2013, ENVIRON MICROBIOL, V15, P610, DOI 10.1111/1462-2920.12019
   BLANGY D, 1968, J MOL BIOL, V31, P13, DOI 10.1016/0022-2836(68)90051-X
   Buescher JM, 2010, ANAL CHEM, V82, P4403, DOI 10.1021/ac100101d
   Bustos-Jaimes I, 2005, BIOCHEMISTRY-US, V44, P1127, DOI 10.1021/bi048514o
   Bustos-Jaimes I, 2002, J MOL BIOL, V319, P183, DOI 10.1016/S0022-2836(02)00096-7
   Bustos-Jaimes I, 2001, ARCH BIOCHEM BIOPHYS, V394, P156, DOI 10.1006/abbi.2001.2523
   CALCAGNO M, 1984, BIOCHIM BIOPHYS ACTA, V787, P165, DOI 10.1016/0167-4838(84)90076-1
   Cisneros DA, 2004, ARCH BIOCHEM BIOPHYS, V421, P77, DOI 10.1016/j.abb.2003.09.041
   Conway T, 2015, MICROBIOL SPECTR, V3, P3
   Cook P. F., 2007, ENZYME KINETICS MECH
   Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297
   Ferenci T, 2009, J BACTERIOL, V191, P4025, DOI 10.1128/JB.00118-09
   Gaugue I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063025
   Gopel Y, 2014, RNA BIOL, V11, P433, DOI 10.4161/rna.28301
   Gopel Y, 2013, GENE DEV, V27, P552, DOI 10.1101/gad.210112.112
   Horjales E, 1999, STRUCT FOLD DES, V7, P527, DOI 10.1016/S0969-2126(99)80069-0
   Kerfeld CA, 2010, ANNU REV MICROBIOL, V64, P391, DOI 10.1146/annurev.micro.112408.134211
   Kochanowski K, 2013, P NATL ACAD SCI USA, V110, P1130, DOI 10.1073/pnas.1202582110
   Lara-Gonzalez S, 2000, J MOL BIOL, V301, P219, DOI 10.1006/jmbi.2000.3937
   Lara-Lemus R, 1998, BBA-PROTEIN STRUCT M, V1388, P1, DOI 10.1016/S0167-4838(98)00141-1
   Lenski R E, 1991, Biotechnology, V15, P173
   Link H, 2013, NAT BIOTECHNOL, V31, P357, DOI 10.1038/nbt.2489
   Link H, 2012, METHOD MICROBIOL, V39, P127, DOI 10.1016/B978-0-08-099387-4.00005-3
   Liu C, 2008, J MOL BIOL, V379, P73, DOI 10.1016/j.jmb.2008.03.031
   Lopez PJ, 1999, MOL MICROBIOL, V33, P188, DOI 10.1046/j.1365-2958.1999.01465.x
   Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100
   MIDELFORT CF, 1977, BIOCHEMISTRY-US, V16, P1590, DOI 10.1021/bi00627a010
   MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6
   Montero-Moran GM, 2001, BIOCHEMISTRY-US, V40, P10187, DOI 10.1021/bi0105835
   NATARAJAN K, 1993, J BIOL CHEM, V268, P9206
   Oliva G, 1995, STRUCTURE, V3, P1323, DOI 10.1016/S0969-2126(01)00270-2
   Park JT, 2001, J BACTERIOL, V183, P3842, DOI 10.1128/JB.183.13.3842-3847.2001
   Plumbridge J, 1998, MOL MICROBIOL, V27, P369, DOI 10.1046/j.1365-2958.1998.00685.x
   PLUMBRIDGE JA, 1991, MOL MICROBIOL, V5, P2053, DOI 10.1111/j.1365-2958.1991.tb00828.x
   PLUMBRIDGE JA, 1990, J BACTERIOL, V172, P2728, DOI 10.1128/jb.172.5.2728-2735.1990
   Plumbridge J, 2009, J BACTERIOL, V191, P5641, DOI 10.1128/JB.00448-09
   Reaves ML, 2013, NATURE, V500, P237, DOI 10.1038/nature12445
   Steimle PA, 1997, MOL BIOCHEM PARASIT, V84, P149, DOI 10.1016/S0166-6851(96)02790-9
   Tanaka T, 2005, J BACTERIOL, V187, P7038, DOI 10.1128/JB.187.20.7038-7044.2005
   Vincent F, 2005, J BIOL CHEM, V280, P19649, DOI 10.1074/jbc.M502131200
   Volkmer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023126
   WHITE RJ, 1968, BIOCHEM J, V106, P847, DOI 10.1042/bj1060847
   Wiser MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126210
   Xu YF, 2012, NAT CHEM BIOL, V8, P562, DOI [10.1038/NCHEMBIO.941, 10.1038/nchembio.941]
   Yang C, 2006, J BIOL CHEM, V281, P29872, DOI 10.1074/jbc.M60505220
NR 51
TC 3
Z9 3
U1 3
U2 13
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0021-9193
EI 1098-5530
J9 J BACTERIOL
JI J. Bacteriol.
PD JUN
PY 2016
VL 198
IS 11
BP 1610
EP 1620
DI 10.1128/JB.00870-15
PG 11
WC Microbiology
SC Microbiology
GA DM2VN
UT WOS:000376206300009
PM 27002132
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Asdrubali, F
   Bianchi, F
   Cotana, F
   D'Alessandro, F
   Pertosa, M
   Pisello, AL
   Schiavoni, S
AF Asdrubali, F.
   Bianchi, F.
   Cotana, F.
   D'Alessandro, F.
   Pertosa, M.
   Pisello, A. L.
   Schiavoni, S.
TI Experimental thermo-acoustic characterization of innovative common reed
   bio-based panels for building envelope
SO BUILDING AND ENVIRONMENT
LA English
DT Article
DE Common reed; Thermal insulation panels; Innovative bio-based panels;
   Sound insulation; Energy efficiency in buildings; Biomaterial building
   panels
ID PHRAGMITES-COMMUNIS TRIN; LIFE-CYCLE ASSESSMENT; ENERGY ANALYSIS;
   PERFORMANCE; CALIBRATION; CARDBOARD; BIOMASS; MODEL; LCA
AB Natural and bio-based construction materials represent a promising solution for optimizing buildings' environmental sustainability. In this view, the paper presents the multipurpose experimental thermoacoustic characterization of common reed-based building panels. Different geometries, densities, humidity rates and stalk shapes were considered and tested by means of hot-plate, hot-box and impedance tube in-lab experimental benches. The thermal analysis showed that the geometry scarcely affects the thermal conductivity, which is around 0.05 W/mK and, therefore, comparable to other materials already commercialized for the same scope. On the other hand, the acoustic behavior is strongly affected by the stalk configuration, e.g. perpendicular, parallel or combined orientation with respect to the incident wave. In particular, the longitudinal stalk layout showed a significant sound absorption performance. The exhaustive experimental original characterization of such by-product, therefore, showed a very promising overall thermo-acoustic behavior. At the same time, for optimizing the panel field performance, the acoustic requirements should represent the panel design drivers, given the high sensitivity of the panel layout characteristics affecting the acoustic performance. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Asdrubali, F.; Bianchi, F.; Cotana, F.; D'Alessandro, F.; Pertosa, M.; Pisello, A. L.; Schiavoni, S.] Univ Perugia, CIRIAF Inter Univ Res Ctr Environm & Pollut Mauro, Via G Duranti 67, I-06125 Perugia, Italy.
   [Asdrubali, F.] Univ Rome Tre, Dept Engn, Via V Volterra 62, I-00146 Rome, Italy.
   [Cotana, F.; Pisello, A. L.] Univ Perugia, Dept Engn, Via G Duranti 93, I-06125 Perugia, Italy.
   [D'Alessandro, F.] Univ Perugia, Dept Civil & Environm Engn, Via G Duranti 93, I-06125 Perugia, Italy.
RP Pisello, AL (reprint author), Univ Perugia, CIRIAF Inter Univ Res Ctr Environm & Pollut Mauro, Via G Duranti 67, I-06125 Perugia, Italy.; Pisello, AL (reprint author), Univ Perugia, Dept Engn, Via G Duranti 93, I-06125 Perugia, Italy.
EM pisello@crbnet.it
OI D'Alessandro, Francesco/0000-0002-9867-7540; PISELLO, ANNA
   LAURA/0000-0002-4527-6444
FU CIRIAF program for UNESCO
FX The corresponding author acknowledgments are due to the "CIRIAF program
   for UNESCO" in the framework of the UNESCO Chair "Water Resources
   Management and Culture", for supporting her research.
CR Afram A, 2014, BUILD ENVIRON, V72, P343, DOI 10.1016/j.buildenv.2013.11.016
   Allirand JM, 1995, BIOMASS BIOENERG, V9, P441, DOI 10.1016/0961-9534(95)00042-9
   [Anonymous], 1999, 13005 ENV
   [Anonymous], 1991, 8302 ISO
   [Anonymous], 1994, 8990 ISO
   [Anonymous], 1998, 105342 ISO
   [Anonymous], 2009, C42309A ASTM INT
   Ascione F, 2015, ENERG BUILDINGS, V88, P78, DOI 10.1016/j.enbuild.2014.11.058
   Asdrubali F, 2016, BUILD ENVIRON, V95, P145, DOI 10.1016/j.buildenv.2015.09.003
   Asdrubali F, 2012, BUILD ACOUST, V19, P283, DOI 10.1260/1351-010X.19.4.283
   Asdrubali F, 2011, ENERG BUILDINGS, V43, P1618, DOI 10.1016/j.enbuild.2011.03.005
   Asdrubali F., 2008, P AC 08 PAR FRANC 29
   Asdrubali F, 2015, P 22 INT C SOUND VIB
   Asdrubali F., 2010, P ASME ATI UIT C THE
   Asdrubali F, 2015, SUSTAIN MATER TECHNO, V4, P1, DOI 10.1016/j.susmat.2015.05.002
   Azkorra Z, 2015, APPL ACOUST, V89, P46, DOI 10.1016/j.apacoust.2014.09.010
   Baldinelli G, 2014, APPL ENERG, V136, P250, DOI 10.1016/j.apenergy.2014.09.021
   Barreneche C, 2016, RENEW ENERG, V85, P281, DOI 10.1016/j.renene.2015.06.054
   Bevilacqua P, 2015, BUILD ENVIRON, V92, P305, DOI 10.1016/j.buildenv.2015.04.026
   Cabeza LF, 2014, RENEW SUST ENERG REV, V29, P394, DOI 10.1016/j.rser.2013.08.037
   Castaldo V.L., 2015, URBAN CLIM, V14
   Chilekwa V., 2006, P EUR 2006 TAMP FINL
   Cox T. J., 2009, ACOUSTIC ABSORBERS D
   D'Alessandro F, 2015, BUILD ENVIRON, V94, P913, DOI 10.1016/j.buildenv.2015.06.004
   D'Oca S, 2014, ENERGY RES SOC SCI, V3, P131, DOI 10.1016/j.erss.2014.07.015
   European Committee for Standardization, 2001, 12664 EN
   Fouquet M, 2015, BUILD ENVIRON, V90, P51, DOI 10.1016/j.buildenv.2015.03.022
   HASLAM SM, 1972, J ECOL, V60, P585, DOI 10.2307/2258363
   Kobbing JF, 2013, MIRES PEAT, V13
   Lansdown R. V., 2015, IUCN RED LIST THREAT
   Miljan M., 2014, MIRES PEAT, V13, P1
   Oldham DJ, 2011, APPL ACOUST, V72, P350, DOI 10.1016/j.apacoust.2010.12.009
   Rincon L, 2015, EARTHEN ARCHITECTURE: PAST, PRESENT AND FUTURE, P311
   Rosso F, 2014, SUSTAINABILITY-BASEL, V6, P5439, DOI 10.3390/su6085439
   Salata F, 2015, ENERG BUILDINGS, V99, P32, DOI 10.1016/j.enbuild.2015.04.010
   Secchi S, 2016, J BUILD ENG, V5, P1, DOI 10.1016/j.jobe.2015.10.005
   Synnefa A, 2007, ENERG BUILDINGS, V39, P1167, DOI [10.1016/j.enbuild.2007.01.004, 10.1016/j.enbuild.2006.01.004]
   Torgal FP, 2011, ECO-EFFICIENT CONSTRUCTION AND BUILDING MATERIALS, P1
   Trematerra A., 2013, J SUSTAINABLE ARCHIT, V3, P33, DOI DOI 10.5755/J01.SACE.3.4A708
   Venegas R, 2011, J ACOUST SOC AM, V130, P2765, DOI 10.1121/1.3644915
   Woodside W., 1957, ASTM217 SPEC PUB, P32
   Xu XQ, 2014, ENERG BUILDINGS, V68, P312, DOI 10.1016/j.enbuild.2013.09.017
   Yuan SZ, 2002, AM SOC TEST MATER, V1426, P221, DOI 10.1520/STP11015S
NR 43
TC 14
Z9 14
U1 3
U2 21
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0360-1323
EI 1873-684X
J9 BUILD ENVIRON
JI Build. Environ.
PD JUN
PY 2016
VL 102
BP 217
EP 229
DI 10.1016/j.buildenv.2016.03.022
PG 13
WC Construction & Building Technology; Engineering, Environmental;
   Engineering, Civil
SC Construction & Building Technology; Engineering
GA DL2XK
UT WOS:000375498300018
DA 2018-10-20
ER

PT J
AU Girerd, D
   Parratte, S
   Lunebourg, A
   Boureau, F
   Ollivier, M
   Pasquier, G
   Putman, S
   Migaud, H
   Argenson, JN
AF Girerd, D.
   Parratte, S.
   Lunebourg, A.
   Boureau, F.
   Ollivier, M.
   Pasquier, G.
   Putman, S.
   Migaud, H.
   Argenson, J. N.
TI Total knee arthroplasty revision with trabecular tantalum cones:
   Preliminary retrospective study of 51 patients from two centres with a
   minimal 2-year follow-up
SO ORTHOPAEDICS & TRAUMATOLOGY-SURGERY & RESEARCH
LA English
DT Article
DE Revision; Total knee arthroplasty; Knee; Trabecular metal cones;
   Tantalum; Bone defect
ID TIBIAL BONE LOSS; STRUCTURAL ALLOGRAFT; METAPHYSEAL CONES; REPLACEMENT;
   BIOMATERIAL; VALIDATION; OUTCOMES; DEFECTS; STEMS; TKA
AB Background: Successful management of large bone defects is of crucial importance when performing revision total knee arthroplasty (TKA). Trabecular tantalum cones may improve prosthesis fixation via their potential for reconstructing a stable metaphyseal support. The objective of this study was to evaluate the clinical and radiological outcomes and the complications of tantalum cones in revision TKA.
   Hypothesis: Trabecular tantalum cones provide stable and durable metaphyseal reconstruction when used during revision TKA.
   Material and methods: Trabecular Metal (TM) cones (Zimmer, Warsaw, IN, USA) were used for 52 revision TKAs in 51 patients (mean age, 68 +/- 9 years) managed in two centres between 2008 and 2013. A rotating hinge prosthesis was chosen for 38 (73%) knees and a condylar constrained knee prosthesis for 14 (27%) knees, with 37 tibial and 34 femoral cones. The two most common reasons for revision surgery were aseptic loosening (n= 22, 42%) and infection (n=19, 37%). The bone loss was severe in most cases. At each centre, after a mean follow-up of 34 months (range, 24-52 months), two independent observers assessed the Knee Society Score (KSS), range of motion, mechanical axis, and osteo-integration for each patient.
   Results: Mean KSS increased from 46 preoperatively to 77 (P=0.001) at last follow-up and the mean KSS function from 39 to 57 (P=0.007). Mean range of motion improved from 93 degrees (45 degrees-120 degrees) to 110 (65 degrees-130 degrees) (P= 0.001). Mean postoperative mechanical axis was 180 degrees (172 degrees-190 degrees). Radiographic evaluation showed evidence of osteo-integration for all cones. Four revisions were performed for recurrence of infection but none for mechanical failure.
   Discussion: The findings of our study confirm the biomechanical and biological reliability of Trabecular Metal (TM) cones used to fill metaphyseal bone defects during revision TKA. Level of evidence: IV, retrospective therapeutic study. (C) 2016 Elsevier Masson SAS. All rights reserved.
C1 [Girerd, D.; Parratte, S.; Lunebourg, A.; Ollivier, M.; Argenson, J. N.] Univ Aix Marseille, Serv Chirurg Orthoped & Traumatol, Inst Mouvement & Appareil Locomoteur, Hop St Marguerite,CNRS,AMU,UMR 787, 270 Blvd St Marguerite, F-13009 Marseille, France.
   [Boureau, F.; Pasquier, G.; Putman, S.; Migaud, H.] Ctr Hosp Reg Univ, Serv Chirurg Orthoped & Traumatol, Ave Oscar Lambret, F-59037 Lille, France.
   [Boureau, F.; Pasquier, G.; Putman, S.; Migaud, H.] Univ Lille, Rue Paul Duez, F-59000 Lille, France.
RP Parratte, S (reprint author), Univ Aix Marseille, Serv Chirurg Orthoped & Traumatol, Inst Mouvement & Appareil Locomoteur, Hop St Marguerite,CNRS,AMU,UMR 787, 270 Blvd St Marguerite, F-13009 Marseille, France.
EM sebastien@parratte.fr
CR Bauman RD, 2009, CLIN ORTHOP RELAT R, V467, P818, DOI 10.1007/s11999-008-0679-4
   Beckmann NA, 2015, J ARTHROPLASTY, V30, P249, DOI 10.1016/j.arth.2014.09.016
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Boureau F, 2015, ORTHOP TRAUMATOL-SUR, V101, P251, DOI 10.1016/j.otsr.2014.11.020
   Dalury DF, 2013, J ARTHROPLASTY, V28, P120, DOI 10.1016/j.arth.2013.04.051
   Derome P, 2014, J ARTHROPLASTY, V29, P122, DOI 10.1016/j.arth.2013.04.033
   Engh GA, 1998, ORTHOP CLIN N AM, V29, P205, DOI 10.1016/S0030-5898(05)70319-9
   Engh GA, 2007, J BONE JOINT SURG AM, V89A, P2640, DOI 10.2106/JBJS.F00865
   Greidanus NV, 2011, J ARTHROPLASTY, V26, P615, DOI 10.1016/j.arth.2010.04.026
   Howard JL, 2011, J BONE JOINT SURG AM, V93A, P478, DOI 10.2106/JBJS.l.01322
   Huten D, 2013, ORTHOP TRAUMATOL-SUR, V99, pS22, DOI 10.1016/j.otsr.2012.11.009
   INSALL JN, 1989, CLIN ORTHOP RELAT R, P13
   Iorio R, 2008, J BONE JOINT SURG AM, V90A, P1598, DOI 10.2106/JBJS.H.00067
   Kamath AF, 2015, J BONE JOINT SURG AM, V97A, P216, DOI 10.2106/JBJS.N.00540
   Lachiewicz PF, 2012, CLIN ORTHOP RELAT R, V470, P199, DOI 10.1007/s11999-011-1888-9
   Long WJ, 2009, J ARTHROPLASTY, V24, P1086, DOI 10.1016/j.arth.2008.08.011
   Mabry TM, 2007, J ARTHROPLASTY, V22, P56, DOI 10.1016/j.arth.2007.02.008
   Meneghini RM, 2008, J BONE JOINT SURG AM, V90A, P78, DOI 10.2106/JBJS.F.01495
   Ornetti P, 2008, OSTEOARTHR CARTILAGE, V16, P423, DOI 10.1016/j.joca.2007.08.007
   Parratte S, 2007, VANCOMYCIN BONE CEME
   Rao BM, 2013, BONE JOINT J, V95B, P1069, DOI 10.1302/0301-620X.95B8.29194
   Schmitz HCR, 2013, J ARTHROPLASTY, V28, P1556, DOI 10.1016/j.arth.2013.01.028
   Shen C, 2014, J ARTHROPLASTY, V29, P127, DOI [10.1016/j.arth.2013.09.048, 10.1016/j.arth.2013.04.042]
   Singh JA, 2014, RHEUMATOLOGY, V53, P313, DOI 10.1093/rheumatology/ket325
   van Kempen RWTM, 2013, CLIN ORTHOP RELAT R, V471, P2296, DOI 10.1007/s11999-013-2940-8
   Villanueva-Martinez M, 2013, J ARTHROPLASTY, V28, P988, DOI 10.1016/j.arth.2012.09.003
   Vince KG, 2005, ORTHOPEDICS, V28, P999
   Whaley AL, 2003, J ARTHROPLASTY, V18, P592, DOI 10.1016/S0883-5403(03)00200-6
   Wood GC, 2009, CLIN ORTHOP RELAT R, V467, P810, DOI 10.1007/s11999-008-0621-9
NR 30
TC 8
Z9 8
U1 0
U2 2
PU ELSEVIER MASSON
PI MILANO
PA VIA PALEOCAPA 7, 20121 MILANO, ITALY
SN 1877-0568
J9 ORTHOP TRAUMATOL-SUR
JI Orthop. Traumatol.-Surg. Res.
PD JUN
PY 2016
VL 102
IS 4
BP 429
EP 433
DI 10.1016/j.otsr.2016.02.010
PG 5
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA DL4IQ
UT WOS:000375598100003
PM 27052939
OA Bronze
DA 2018-10-20
ER

PT J
AU Wong, ML
   Wong, JL
   Vapniarsky, N
   Griffiths, LG
AF Wong, Maelene L.
   Wong, Janelle L.
   Vapniarsky, Natalia
   Griffiths, Leigh G.
TI In vivo xenogeneic scaffold fate is determined by residual antigenicity
   and extracellular matrix preservation
SO BIOMATERIALS
LA English
DT Article
DE Antigen removal; Decellularization; Xenogeneic scaffold; Extracellular
   matrix; Vascular regenerative medicine; Immune response
ID PORCINE AORTIC-VALVE; SODIUM DODECYL-SULFATE; BOVINE PERICARDIUM;
   CELLULAR REPOPULATION; IMMUNE-RESPONSE; TISSUE; GLUTARALDEHYDE;
   CALCIFICATION; COLLAGEN; REMOVAL
AB The immunological potential of animal-derived tissues and organs is the critical hurdle to increasing their clinical implementation. Glutaraldehyde-fixation cross-links proteins in xenogeneic tissues (e.g., bovine pericardium) to delay immune rejection, but also compromises the regenerative potential of the resultant biomaterial. Unfixed xenogeneic biomaterials in which xenoantigenicity has been ameliorated and native extracellular matrix (ECM) architecture has been maintained have the potential to overcome limitations of current clinically utilized glutaraldehyde-fixed biomaterials. The objective of this work was to determine how residual antigenicity and ECM architecture preservation modulate recipient immune and regenerative responses towards unfixed bovine pericardium (BP) ECM scaffolds. Disruption of ECM architecture during scaffold generation, with either SDS-decellularization or glutaraldehyde-fixation, stimulated recipient foreign body response and resultant fibrotic encapsulation following leporine subpannicular implantation. Conversely, BP scaffolds subjected to stepwise removal of hydrophilic and lipophilic antigens using amidosulfobetaine-14 (ASB-14) maintained native ECM architecture and thereby avoided fibrotic encapsulation. Removal of hydrophilic and lipophilic antigens significantly decreased local and systemic graft-specific, adaptive immune responses and subsequent calcification of BP scaffolds compared to scaffolds undergoing hydrophile removal only. Critically, removal of antigenic components and preservation of ECM architecture with ASB-14 promoted full-thickness recipient non immune cellular repopulation of the BP scaffold. Further, unlike clinically utilized fixed BP, ASB-14-treated scaffolds fostered rapid intimal and medial vessel wall regeneration in a porcine carotid patch angioplasty model. This work highlights the importance of residual antigenicity and ECM architecture preservation in modulating recipient immune and regenerative responses towards xenogeneic biomaterial generation. (C) 2016 Published by Elsevier Ltd.
C1 [Wong, Maelene L.; Wong, Janelle L.; Griffiths, Leigh G.] Univ Calif Davis, Dept Vet Med & Epidemiol, One Shields Ave, Davis, CA 95616 USA.
   [Wong, Maelene L.; Vapniarsky, Natalia] Univ Calif Davis, Dept Biomed Engn, One Shields Ave, Davis, CA 95616 USA.
RP Griffiths, LG (reprint author), Univ Calif Davis, Dept Vet Med & Epidemiol, One Shields Ave, Davis, CA 95616 USA.
EM lggriffiths@ucdavis.edu
FU American Heart Association [11SDG4980023]; NIH [R01HL115205]
FX We thank James Cravotta and Dr. Boaz Arzi for rabbit surgery assistance;
   Dr. Kevin Grayson for pig surgery assistance; Dr. Clare E. Yellowley for
   facility access; Ms. Becky Horn for her polarized light microscopy
   assistance; and Ms. Alycia Cook for technical immunohistochemistry
   assistance. Funding support was received from the American Heart
   Association (11SDG4980023, LGG) and NIH (R01HL115205, LGG).
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Badylak SF, 2014, ANN BIOMED ENG, V42, P1517, DOI 10.1007/s10439-013-0963-7
   Bayrak A, 2010, BIOMATERIALS, V31, P3793, DOI 10.1016/j.biomaterials.2010.01.120
   Brown B. V., 2009, MANUAL CENTRAL AM DI, V1, P1
   Cascalho M, 2001, IMMUNITY, V14, P437, DOI 10.1016/S1074-7613(01)00124-8
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Dohmen PM, 2009, ANN THORAC CARDIOVAS, V15, P362
   Galili U, 2001, BIOCHIMIE, V83, P557, DOI 10.1016/S0300-9084(01)01294-9
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   GOLOMB G, 1987, AM J PATHOL, V127, P122
   Goncalves AC, 2005, J HEART VALVE DIS, V14, P212
   Gratzer PF, 2006, TISSUE ENG, V12, P2975, DOI 10.1089/ten.2006.12.2975
   Harrison RD, 2005, J BIOMED MATER RES A, V75A, P841, DOI 10.1002/jbm.a.30486
   HENRIQUEZ M, 1994, MACROMOLECULES, V27, P6834, DOI 10.1021/ma00101a023
   Ho KJ, 2012, J VASC SURG, V55, P708, DOI 10.1016/j.jvs.2011.10.007
   Hulsmann J, 2012, XENOTRANSPLANTATION, V19, P286, DOI 10.1111/j.1399-3089.2012.00719.x
   Human P, 2001, ANN THORAC SURG, V71, pS385, DOI 10.1016/S0003-4975(01)02492-4
   Janeway C., 2001, IMMUNOBIOLOGY
   Junge K, 2012, LANGENBECK ARCH SURG, V397, P255, DOI 10.1007/s00423-011-0780-0
   Kasimir MT, 2005, THROMB HAEMOSTASIS, V94, P562, DOI 10.1160/TH05-01-0025
   Kim KM, 1999, AM J PATHOL, V154, P843, DOI 10.1016/S0002-9440(10)65331-X
   Kim MS, 2015, EUR J CARDIO-THORAC, V48, P392, DOI 10.1093/ejcts/ezu501
   Krejci J., 2007, International Journal of Cosmetic Science, V29, P121, DOI 10.1111/j.1467-2494.2007.00368.x
   LEVY RJ, 1983, AM J PATHOL, V113, P143
   LEVY RJ, 1986, AM J PATHOL, V122, P71
   Li X, 2011, ANN VASC SURG, V25, P561, DOI 10.1016/j.avsg.2010.11.007
   Manji RA, 2006, CIRCULATION, V114, P318, DOI 10.1161/CIRCULATIONAHA.105.549311
   McMorrow IM, 1997, TRANSPLANTATION, V64, P501, DOI 10.1097/00007890-199708150-00021
   Nam Jinhae, 2012, Korean J Thorac Cardiovasc Surg, V45, P380, DOI 10.5090/kjtcs.2012.45.6.380
   Orenstein SB, 2012, J SURG RES, V176, P423, DOI 10.1016/j.jss.2011.09.031
   Park S, 2009, J KOREAN MED SCI, V24, P1126, DOI 10.3346/jkms.2009.24.6.1126
   Reing JE, 2010, BIOMATERIALS, V31, P8626, DOI 10.1016/j.biomaterials.2010.07.083
   Rodriguez KJ, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-29
   Samouillan V, 1999, J BIOMED MATER RES, V46, P531, DOI 10.1002/(SICI)1097-4636(19990915)46:4<531::AID-JBM11>3.0.CO;2-2
   Samouillan V, 2003, J BIOMED MATER RES A, V64A, P330, DOI 10.1002/jbm.a.10326
   Shinoka T, 1995, ANN THORAC SURG, V60, pS513, DOI 10.1016/0003-4975(95)00733-4
   Swartzlander MD, 2015, BIOMATERIALS, V41, P79, DOI 10.1016/j.biomaterials.2014.11.020
   TRIGLIA D, 1991, IN VITRO CELL DEV B, V27, P239
   Wong ML, 2013, ACTA BIOMATER, V9, P6492, DOI 10.1016/j.actbio.2012.12.034
   Wong ML, 2011, BIOMATERIALS, V32, P8129, DOI 10.1016/j.biomaterials.2011.07.030
   Wright GA, 2009, COMPARATIVE MED, V59, P266
   Xu H, 2009, TISSUE ENG PT A, V15, P1807, DOI 10.1089/ten.tea.2008.0384
   Yang YG, 2007, NAT REV IMMUNOL, V7, P519, DOI 10.1038/nri2099
NR 43
TC 14
Z9 15
U1 4
U2 41
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2016
VL 92
BP 1
EP 12
DI 10.1016/j.biomaterials.2016.03.024
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DL1BF
UT WOS:000375366200001
PM 27031928
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Pan, HT
   Zheng, QX
   Guo, XD
   Wu, YC
   Wu, B
AF Pan, Haitao
   Zheng, Qixin
   Guo, Xiaodong
   Wu, Yongchao
   Wu, Bin
TI Polydopamine-assisted BMP-2-derived peptides immobilization on
   biomimetic copolymer scaffold for enhanced bone induction in vitro and
   in vivo
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Polydopamine; BMP-2; Bone induction; Scaffold; Ectopic bone formation
ID STEM-CELLS; MORPHOGENETIC PROTEIN-2; ALKALINE-PHOSPHATASE; COMPOSITE
   SCAFFOLDS; HYDROXYAPATITE; REGENERATION; COATINGS; TITANIUM;
   OSTEOGENESIS; CONJUGATION
AB In this study, a polydopamine (pDA)-coated PLGA-[Asp-PEG]n scaffold was developed for sustained delivery of bone morphogenetic protein-2 (BMP-2)-derived peptide (designated as P24), and then used to address the hypothesis that P24 peptides delivered from the scaffolds could enhance bone induction in vitro and in vivo. We found pDA coating as compared with physical adsorption could more efficiently mediate the grafting of peptides onto polymer surfaces, and the release of P24 peptides from PLGA-[Asp-PEG]n-pDA-P24 was sustained for about 21 days, while a burst P24 release was observed in initial 4h and almost all peptides were released within 24 h in physisorbed PLGA-[Asp-PEG]n-P24 group. In vitro, significantly greater ALP activity and mRNA expressions of osteo-specific markers of rat-derived mesenchymal stem cells (rMSCs) were observed in the sustained delivery system than those in physisorbed PLGA-[Asp-PEG]n-P24 and unmodified PLGA-[Asp-PEG]n groups. In vivo, ectopic bone formation studies showed that the sustained delivery system could induce bone formation to a much greater extent than physisorbed PLGA-[Asp-PEG]n-P24. Meanwhile, there were no evidences of bone formation in non P24-loaded PLGA-[Asp-PEG]n. It is concluded that PLGA-[Asp-PEG]n-pDA-P24 biomaterial can delivery bioactive P24 peptides in a sustained manner, which can more efficiently promote osteogenic differentiation of rMSCs in vitro and induce ectopic bone formation in vivo, as compared with PLGA-[Asp-PEG]n-P24 delivering P24 in a burst manner. This pDA-coated PLGA-[Asp-PEG]n-pDA-P24 composite promises to be an excellent biomaterial for inducing bone regeneration. Moreover, pDA-mediated catechol functionalization can be an effective, simple technique for developing sustained delivery systems. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Pan, Haitao; Zheng, Qixin; Guo, Xiaodong; Wu, Yongchao; Wu, Bin] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Orthopaed, 1277 Jiefang Dadao, Wuhan 430022, Peoples R China.
RP Wu, B (reprint author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Orthopaed, 1277 Jiefang Dadao, Wuhan 430022, Peoples R China.
EM bin_wu@hust.edu.cn
FU National Natural Science Foundation of China [81000520, 81471271,
   30900292]
FX This research was supported by the National Natural Science Foundation
   of China (81000520, 81471271, 30900292).
CR Barradas AMC, 2011, EUR CELLS MATER, V21, P407, DOI 10.22203/eCM.v021a31
   Baylan N, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/4/045011
   Biazar E, 2015, ARTIF CELL NANOMED B, V43, P112, DOI 10.3109/21691401.2013.848874
   Cai YL, 2014, COLLOID SURFACE B, V116, P681, DOI 10.1016/j.colsurfb.2013.11.004
   Chien CY, 2013, ACS APPL MATER INTER, V5, P6975, DOI 10.1021/am401071f
   Duan ZX, 2007, J HUAZHONG UNIV SCI, V27, P179, DOI 10.1007/s11596-007-0219-6
   Duan ZX, 2008, J HUAZHONG U SCI-MED, V28, P426, DOI 10.1007/s11596-008-0411-3
   Fujisawa R, 1996, BBA-PROTEIN STRUCT M, V1292, P53, DOI 10.1016/0167-4838(95)00190-5
   Guo X., 2007, KEY ENG MATER, V334, P1261
   He XZ, 2012, LANGMUIR, V28, P5387, DOI 10.1021/la205005h
   Ho MH, 2006, MACROMOL BIOSCI, V6, P90, DOI 10.1002/mabi.200500130
   Jeon O, 2007, BIOMATERIALS, V28, P2763, DOI 10.1016/j.biomaterials.2007.02.023
   Kim J, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/1/014107
   Kim SS, 2006, BIOMATERIALS, V27, P1399, DOI 10.1016/j.biomaterials.2005.08.016
   King WJ, 2012, ADV DRUG DELIVER REV, V64, P1239, DOI 10.1016/j.addr.2012.03.004
   Ko E, 2013, BIOMACROMOLECULES, V14, P3202, DOI 10.1021/bm4008343
   Kopecki Z, 2011, J PATHOL, V225, P401, DOI 10.1002/path.2973
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lee H, 2009, ADV MATER, V21, P431, DOI 10.1002/adma.200801222
   Lee YB, 2012, BIOMATERIALS, V33, P8343, DOI 10.1016/j.biomaterials.2012.08.011
   Lin ZY, 2010, J CONTROL RELEASE, V144, P190, DOI 10.1016/j.jconrel.2010.02.016
   Ma JL, 2014, STEM CELL TRANSL MED, V3, P98, DOI 10.5966/sctm.2013-0126
   Mesfin A, 2013, J BONE JOINT SURG AM, V95A, P1546, DOI 10.2106/JBJS.L.01730
   MIKOS AG, 1994, BIOMATERIALS, V15, P55, DOI 10.1016/0142-9612(94)90197-X
   Moore NM, 2011, ACTA BIOMATER, V7, P2091, DOI 10.1016/j.actbio.2011.01.019
   Nandi SK, 2010, INDIAN J MED RES, V132, P15
   Nijhuis AWG, 2013, TISSUE ENG PART C-ME, V19, P610, DOI [10.1089/ten.tec.2012.0313, 10.1089/ten.TEC.2012.0313]
   Nijhuis AG, 2014, J BIOMED MATER RES A, V102, P1102, DOI 10.1002/jbm.a.34776
   Pan HT, 2007, J PEPT SCI, V13, P154, DOI 10.1002/psc.826
   Pan HT, 2014, J BIOMED MATER RES A, V102, P2864, DOI 10.1002/jbm.a.34961
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Seo JP, 2014, VET RES COMMUN, V38, P73, DOI 10.1007/s11259-013-9587-5
   Sonnaert M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136875
   Srinivasan S, 2013, J BIOMED NANOTECHNOL, V9, P1803, DOI 10.1166/jbn.2013.1658
   Wu B, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/4/044111
   Xie J., 2015, ACTA BIOMATER
   Yang K, 2012, BIOMATERIALS, V33, P6952, DOI 10.1016/j.biomaterials.2012.06.067
   Zhang WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102371
   Zhang X., 2013, J TISSUE ENG REGEN M
   Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047
NR 40
TC 12
Z9 13
U1 4
U2 111
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD JUN 1
PY 2016
VL 142
BP 1
EP 9
DI 10.1016/j.colsurfb.2016.01.060
PG 9
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA DK8IE
UT WOS:000375169600001
PM 26924362
DA 2018-10-20
ER

PT J
AU Singh, R
   Kumar, M
   Bishnoi, NR
AF Singh, Rajesh
   Kumar, Mukesh
   Bishnoi, Narsi R.
TI Development of biomaterial for chromium(VI) detoxification using
   Aspergillus flavus system supported with iron
SO ECOLOGICAL ENGINEERING
LA English
DT Article
DE Aspergillus flavus; Biomaterial; Biotransformation; Hexavalent chromium;
   Biosorption
ID HEXAVALENT CHROMIUM; HEAVY-METALS; CHROMATE REDUCTION; FERROUS IRON;
   BIOSORPTION; REMOVAL; BACTERIA; BIOMASS; GROWTH; NIGER
AB This study was aimed to develop the growing Aspergillus flavus biomaterial for Cr(VI) transformation and removal from simulated wastewater. Fe2+ ions have significant implication as it enhanced both chromium removal as well as sticky nature of the biomaterial. The values of Delta, i.e. the differences between the frequencies v(as) and v(s) of carboxyl group 146.59, 139.27, 152.38 by Fe(II), Cr(VI) and mix metalsions (Fe(II) + Cr(VI)) inferred the carboxylate ions bidentate coordination. The highest value in case of mix metals ions (Fe(II) + Cr(VI)) inferred that carboxylate groups have coordinated to surface Fe3+ ions increasingly with greatest bridging character. Heat flow value 31.36 Jg(-1) and 51.02 Jg(-1) in Fe2+ and Cr(VI) amended material respectively indicated that extremely little amount of the free water content was sorbed. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Singh, Rajesh] Cent Univ Gujarat, Sch Environm & Sustainable Dev, Gandhinagar 382030, Gujarat, India.
   [Singh, Rajesh; Kumar, Mukesh; Bishnoi, Narsi R.] Guru Jambheshwar Univ Sci & Technol, Dept Environm Sci & Engn, Hisar 125001, Haryana, India.
RP Singh, R (reprint author), Cent Univ Gujarat, Sch Environm & Sustainable Dev, Gandhinagar 382030, Gujarat, India.
EM rajeshsnain@gmail.com
FU Council of Scientific and Industrial Research (CSIR), New Delhi
FX One of the authors Singh R. is grateful to Council of Scientific and
   Industrial Research (CSIR), New Delhi for awarding Senior Research
   Fellowship.
CR Ahluwalia SS, 2007, BIORESOURCE TECHNOL, V98, P2243, DOI 10.1016/j.biortech.2005.12.006
   Aksu Z, 2007, J HAZARD MATER, V145, P210, DOI 10.1016/j.jhazmat.2006.11.011
   [American Water Works Association(AWWA) Water Environment Federation (WEF) APHA (American Public Health Association)], 2005, STAND METH FORTH EX
   [Anonymous], 2001, PALEONTOLOGICAL STAT
   Babu BV, 2008, ADSORPTION, V14, P85, DOI 10.1007/s10450-007-9057-x
   Bai R.S., 2001, BIORESOURCE TECHNOL, V79, P73, DOI DOI 10.1016/S0960-8524(00)00107-3
   Bakradze Nugzar G, 2003, ScientificWorldJournal, V3, P432
   Contreras EM, 2011, WATER RES, V45, P3034, DOI 10.1016/j.watres.2011.03.011
   Couri S, 2003, BRAZ J MICROBIOL, V34, P16, DOI 10.1590/S1517-83822003000100005
   Donmez G, 2001, WATER RES, V35, P1425, DOI 10.1016/S0043-1354(00)00394-8
   Dossing LN, 2011, CHEM GEOL, V285, P157, DOI 10.1016/j.chemgeo.2011.04.005
   EARY LE, 1988, ENVIRON SCI TECHNOL, V22, P972, DOI 10.1021/es00173a018
   Elangovan R, 2009, BIOCHEM ENG J, V44, P174, DOI 10.1016/j.bej.2008.11.014
   Everitt B S, 1992, APPL MULTIVARIATE DA
   Gikas P, 2009, GLOBAL NEST J, V11, P325
   Hansel CM, 2003, GEOCHIM COSMOCHIM AC, V67, P401, DOI 10.1016/S0016-7037(02)01081-5
   Kapoor A, 1998, BIORESOURCE TECHNOL, V63, P109, DOI 10.1016/S0960-8524(97)00118-1
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Mouedhen G, 2009, J HAZARD MATER, V168, P983, DOI 10.1016/j.jhazmat.2009.02.117
   Puzon GJ, 2005, ENVIRON SCI TECHNOL, V39, P2811, DOI 10.1021/es048967g
   Ribe V, 2012, WASTE MANAGE, V32, P1886, DOI 10.1016/j.wasman.2012.05.011
   Samuel J, 2012, IND ENG CHEM RES, V51, P3740, DOI 10.1021/ie201796s
   Sedlak DL, 1997, GEOCHIM COSMOCHIM AC, V61, P2185, DOI 10.1016/S0016-7037(97)00077-X
   Singh R, 2015, ECOL ENG, V75, P103, DOI 10.1016/j.ecoleng.2014.11.023
   Singh R, 2013, BIORESOURCE TECHNOL, V127, P49, DOI 10.1016/j.biortech.2012.09.056
   Tigini V, 2011, APPL MICROBIOL BIOT, V90, P343, DOI 10.1007/s00253-010-3010-8
   Trunfio G, 2010, IND ENG CHEM RES, V49, P12217, DOI 10.1021/ie101042a
   Viamajala S, 2008, BIOTECHNOL BIOENG, V101, P1150, DOI 10.1002/bit.22020
   Vijayaraghavan K, 2008, BIOTECHNOL ADV, V26, P266, DOI 10.1016/j.biotechadv.2008.02.002
   Wielinga B, 2001, ENVIRON SCI TECHNOL, V35, P522, DOI 10.1021/es001457b
   Xu L, 2011, J HAZARD MATER, V185, P1169, DOI 10.1016/j.jhazmat.2010.10.028
NR 31
TC 8
Z9 8
U1 1
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0925-8574
EI 1872-6992
J9 ECOL ENG
JI Ecol. Eng.
PD JUN
PY 2016
VL 91
BP 31
EP 40
DI 10.1016/j.ecoleng.2016.01.060
PG 10
WC Ecology; Engineering, Environmental; Environmental Sciences
SC Environmental Sciences & Ecology; Engineering
GA DK2TE
UT WOS:000374766500005
DA 2018-10-20
ER

PT J
AU Kumar, A
   Nune, KC
   Misra, RDK
AF Kumar, A.
   Nune, K. C.
   Misra, R. D. K.
TI Biological functionality of extracellular matrix-ornamented
   three-dimensional printed hydroxyapatite scaffolds
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE additive manufacturing; 3D printing; tissue engineering; ECM;
   cytocompatibility
ID MARROW STROMAL CELLS; TISSUE; ADHESION; ANGIOGENESIS; REGENERATION;
   REGULATOR; GROWTH; ORGANS; FATE
AB Three-dimensional (3D) printing is considered an ideally suitable method to fabricate patient specific implantable devices. The approach enabled to produce a porous scaffold with tailored physical, mechanical, and biological properties because of the flexibility to tune the scaffold architecture. The objective of the study described was to elucidate the determining role of cell-laid extracellular matrix (ECM) in impacting biological response. In this regard, to mimic the natural ECM environment or the attributes of the native tissue, a natural ECM analogue surface was produced on the 3D printed and sintered hydroxyapatite (HA) scaffold surface by the mineralized ECM of the osteoblast. This involved the growth of osteoblast on 3D printed scaffolds, followed by differentiation to deposit the mineralized ECM on the biomaterial surface. The cells were removed from the mineralized matrix using freeze-thaw cycles to obtain a decellularized extracellular matrix (dECM) on the biomaterial surface. Subsequently, seeding of osteoblast on dECM-ornamented HA scaffolds led to 3D growth with enhanced expression of prominent proteins, actin and vinculin. Based on preliminary observations of present study, it was underscored that HA scaffolds-ornamented with dECM provided an optimized microenvironment conducive to the growth of 3D structural tissue and favorably promoted biological functionality because of the availability of an environment that promoted cell-cell and cell-scaffold interaction. The primary advantage of dECM is that it enabled constructive remodeling and promoted the formation of tissue in lieu of less functional tissue. The study opens-up a new path for printing of 3D structures suitable to treat segmental bone defects. (c) 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 104A: 1343-1351, 2016.
C1 [Kumar, A.; Nune, K. C.; Misra, R. D. K.] Univ Texas El Paso, Dept Met Mat & Biomed Engn, 500 W Univ Ave, El Paso, TX 79968 USA.
RP Misra, RDK (reprint author), Univ Texas El Paso, Dept Met Mat & Biomed Engn, 500 W Univ Ave, El Paso, TX 79968 USA.
EM dmisra2@utep.edu
CR Bi YM, 2005, J BIOL CHEM, V280, P30481, DOI 10.1074/jbc.M500573200
   Carisey A, 2011, EUR J CELL BIOL, V90, P157, DOI 10.1016/j.ejcb.2010.06.007
   Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651
   COLTON CK, 1995, CELL TRANSPLANT, V4, P415, DOI 10.1016/0963-6897(95)00025-S
   Craighead HG, 2001, CURR OPIN SOLID ST M, V5, P177, DOI 10.1016/S1359-0286(01)00005-5
   DeMali KA, 2004, TRENDS BIOCHEM SCI, V29, P565, DOI 10.1016/j.tibs.2004.09.001
   Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359
   Flynn LE, 2010, BIOMATERIALS, V31, P4715, DOI 10.1016/j.biomaterials.2010.02.046
   FOLKMAN J, 1973, J EXP MED, V138, P745, DOI 10.1084/jem.138.4.745
   Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820
   Gourlay CW, 2005, NAT REV MOL CELL BIO, V6, P583, DOI 10.1038/nrm1682
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Klammert U, 2010, J CRANIO MAXILL SURG, V38, P565, DOI 10.1016/j.jcms.2010.01.009
   Kumar A, 2013, MICROSTRUCTURE DEV B
   Kumar A, 2016, J BIOMATER APPL, V30, P1168, DOI 10.1177/0885328215617058
   Kumar A, 2015, J BIOMED MATER RES A, V103, P791, DOI 10.1002/jbm.a.35198
   Kumar A, 2013, J BIOMED MATER RES A, V101, P2925, DOI 10.1002/jbm.a.34603
   Kumar A, 2013, ACTA MATER, V61, P5198, DOI 10.1016/j.actamat.2013.05.013
   Laschke MW, 2006, TISSUE ENG, V12, P2093, DOI 10.1089/ten.2006.12.2093
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9
   LODISH HB, 2000, MOL CELL BIOL
   Maazouz Y, 2014, J MATER CHEM B, V2, P5378, DOI 10.1039/c4tb00438h
   Malda J, 2004, BIOTECHNOL BIOENG, V86, P9, DOI 10.1002/bit.20038
   Murugan R, 2005, COMPOS SCI TECHNOL, V65, P2385, DOI 10.1016/j.compscitech.2005.07.022
   OSBORN JF, 1980, BIOMATERIALS, V1, P108, DOI 10.1016/0142-9612(80)90009-5
   Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193
   Pati F, 2015, BIOMATERIALS, V37, P230, DOI 10.1016/j.biomaterials.2014.10.012
   Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345
   Pham QP, 2008, BIOMATERIALS, V29, P2729, DOI 10.1016/j.biomaterials.2008.02.025
   Pinney E, 2000, J CELL PHYSIOL, V183, P74, DOI 10.1002/(SICI)1097-4652(200004)183:1<74::AID-JCP9>3.0.CO;2-G
   Place ES, 2009, CHEM SOC REV, V38, P1139, DOI 10.1039/b811392k
   Redick SD, 2000, J CELL BIOL, V149, P521, DOI 10.1083/jcb.149.2.521
   Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009
   Rozario T, 2010, DEV BIOL, V341, P126, DOI 10.1016/j.ydbio.2009.10.026
   RUOSLAHTI E, 1984, CANCER METAST REV, V3, P43, DOI 10.1007/BF00047692
   Seitz H, 2005, J BIOMED MATER RES B, V74B, P782, DOI 10.1002/jbm.b.30291
   Sellaro TL, 2010, TISSUE ENG PT A, V16, P1075, DOI [10.1089/ten.tea.2008.0587, 10.1089/ten.TEA.2008.0587]
   URIST MARSHALL R., 1967, CLIN ORTHOP RELATED RESIN COMPLICATIONS OF ORTHOPAEDIC SURGERY, V53, P243
   Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170
   Wu YC, 2006, BIOMATERIALS, V27, P896, DOI 10.1016/j.biomaterials.2005.07.002
   Wylie RG, 2011, NAT MATER, V10, P799, DOI [10.1038/NMAT3101, 10.1038/nmat3101]
   Yarlagadda PKDV, 2005, BIO-MED MATER ENG, V15, P159
NR 45
TC 14
Z9 14
U1 0
U2 61
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN
PY 2016
VL 104
IS 6
BP 1343
EP 1351
DI 10.1002/jbm.a.35664
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DK7PC
UT WOS:000375117200003
PM 26799466
DA 2018-10-20
ER

PT J
AU Samorezov, JE
   Headley, EB
   Everett, CR
   Alsberg, E
AF Samorezov, Julia E.
   Headley, Emma B.
   Everett, Christopher R.
   Alsberg, Eben
TI Sustained presentation of BMP-2 enhances osteogenic differentiation of
   human adipose-derived stem cells in gelatin hydrogels
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE bone tissue engineering; drug delivery; growth factor; gelatin
   methacrylate; biomaterials
ID BONE MORPHOGENETIC PROTEIN-2; GROWTH-FACTOR DELIVERY; UMBILICAL-CORD
   BLOOD; STROMAL CELLS; CONTROLLED-RELEASE; TISSUE; MARROW; MICROSPHERES;
   FATE; MICROPARTICLES
AB Human adipose-derived stem cells (hASCs) show great potential for healing bone defects. Bone morphogenetic protein-2 (BMP-2) has been reported to stimulate their osteogenic differentiation both in vitro and in vivo. Here, methacrylated gelatin (GelMA) hydrogels were evaluated as a system to deliver BMP-2 to encapsulated hASCs from two different donors, and BMP-2 delivered from the hydrogels was compared to BMP-2 presented exogenously in culture media. GelMA hydrogels were shown to provide sustained, localized presentation of BMP-2 due to electrostatic interactions between the growth factor and biomaterial after an initial burst release. Both donors exhibited similar responses to the loaded and exogenous growth factor; BMP-2 from the hydrogels had a statistically significant effect on hASC osteogenic differentiation compared to exogenous BMP-2. Expression of alkaline phosphatase was accelerated, and cells in hydrogels with loaded BMP-2 deposited more calcium at one, two, and four weeks than cells without BMP-2 or with the growth factor presented in the media. There were no statistically significant differences in calcium content between groups with 25, 50, or 100 mu g/mL loaded BMP-2, suggesting that using a lower growth factor dose may be as effective as a higher loading amount in this system. Taken together, these findings suggest that controlled delivery of BMP-2 from the GelMA enhances its osteogenic bioactivity compared to free growth factor presented in the media. Thus, the GelMA system is a promising biomaterial for BMP-2-mediated hASC osteogenesis. (c) 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 104A: 1387-1397, 2016.
C1 [Samorezov, Julia E.; Headley, Emma B.; Everett, Christopher R.; Alsberg, Eben] Case Western Reserve Univ, Dept Biomed Engn, 10900 Euclid Ave, Cleveland, OH 44106 USA.
   [Alsberg, Eben] Case Western Reserve Univ, Dept Orthopaed Surg, 10900 Euclid Ave, Cleveland, OH 44106 USA.
   [Alsberg, Eben] Case Western Reserve Univ, Natl Ctr Regenerat Med, Div Gen Med Sci, 10900 Euclid Ave, Cleveland, OH 44106 USA.
RP Alsberg, E (reprint author), Case Western Reserve Univ, Dept Biomed Engn, 10900 Euclid Ave, Cleveland, OH 44106 USA.; Alsberg, E (reprint author), Case Western Reserve Univ, Dept Orthopaed Surg, 10900 Euclid Ave, Cleveland, OH 44106 USA.; Alsberg, E (reprint author), Case Western Reserve Univ, Natl Ctr Regenerat Med, Div Gen Med Sci, 10900 Euclid Ave, Cleveland, OH 44106 USA.
EM eben.alsberg@case.edu
OI Alsberg, Eben/0000-0002-3487-4625
FU National Defense Science and Engineering Graduate Fellowship; National
   Science Foundation Graduate Fellowship [R01AR066193, R01AR063194]
FX Contract grant sponsor: National Defense Science and Engineering
   Graduate Fellowship and National Science Foundation Graduate Fellowship
   ( to JES); contract grant numbers: R01AR066193 and R01AR063194 ( to EA)
CR Barnes GL, 1999, J BONE MINER RES, V14, P1805, DOI 10.1359/jbmr.1999.14.11.1805
   Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x
   Benton JA, 2009, TISSUE ENG PT A, V15, P3221, DOI [10.1089/ten.tea.2008.0545, 10.1089/ten.TEA.2008.0545]
   Bieback K, 2007, BIOMEDICAL MAT ENG S, V18, pS71
   BOWENPOPE DF, 1984, BLOOD, V64, P458
   Bramono DS, 2012, BONE, V50, P954, DOI 10.1016/j.bone.2011.12.013
   Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006
   Burdick JA, 2009, TISSUE ENG PT A, V15, P205, DOI 10.1089/ten.tea.2008.0131
   Chatterjee K, 2010, BIOMATERIALS, V31, P5051, DOI 10.1016/j.biomaterials.2010.03.024
   Chen YC, 2012, ADV FUNCT MATER, V22, P2027, DOI 10.1002/adfm.201101662
   Dang PN, ACS BIOMATERIALS SCI
   Dubois SG, 2008, ISOLATION HUMAN ADIP, P69
   EDELMAN ER, 1993, P NATL ACAD SCI USA, V90, P1513, DOI 10.1073/pnas.90.4.1513
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Hou QP, 2008, J PHARM SCI-US, V97, P3972, DOI 10.1002/jps.21310
   Hu XH, 2009, MACROMOL BIOSCI, V9, P1194, DOI 10.1002/mabi.200900275
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Hutton DL, 2013, TISSUE ENG PT A, V19, P2076, DOI [10.1089/ten.tea.2012.0752, 10.1089/ten.TEA.2012.0752]
   Hwang CM, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/3/035003
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   Jeon O, 2015, ADV MATER, V27, P2216, DOI 10.1002/adma.201405337
   Jeon O, 2011, J CONTROL RELEASE, V154, P258, DOI 10.1016/j.jconrel.2011.06.027
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342
   Kim J, 2009, TISSUE ENG PART C-ME, V15, P583, DOI [10.1089/ten.tec.2008.0642, 10.1089/ten.TEC.2008.0642]
   Knippenberg M, 2006, BIOCHEM BIOPH RES CO, V342, P902, DOI 10.1016/j.bbrc.2006.02.052
   Kyllonen L, 2013, GROWTH FACTORS, V31, P141, DOI 10.3109/08977194.2013.817404
   Levi B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011177
   LIAN JB, 1992, CRIT REV ORAL BIOL M, V3, P269, DOI 10.1177/10454411920030030501
   Nguyen MK, 2014, PROG POLYM SCI, V39, P1235, DOI 10.1016/j.progpolymsci.2013.12.001
   MOSSNER E, 1980, H-S Z PHYSIOL CHEM, V361, P543, DOI 10.1515/bchm2.1980.361.1.543
   Nguyen AH, 2015, ACTA BIOMATER, V13, P101, DOI 10.1016/j.actbio.2014.11.028
   Overman JR, 2013, TISSUE ENG PT A, V19, P571, DOI [10.1089/ten.tea.2012.0133, 10.1089/ten.TEA.2012.0133]
   Ovsianikov A, 2011, BIOMACROMOLECULES, V12, P851, DOI 10.1021/bm1015305
   Panetta NJ, 2010, PLAST RECONSTR SURG, V125, P483, DOI 10.1097/PRS.0b013e3181c82d75
   Patel ZS, 2008, ACTA BIOMATER, V4, P1126, DOI 10.1016/j.actbio.2008.04.002
   Puissant N, 2005, BRIT J HAEMATOL, V129, P118, DOI 10.1111/j.1365-2141.2005.05409.x
   Raisz LG, 1999, CLIN CHEM, V45, P1885
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Solorio LD, 2012, STEM CELL TRANSL MED, V1, P632, DOI 10.5966/sctm.2012-0039
   Solorio L, 2010, J TISSUE ENG REGEN M, V4, P514, DOI 10.1002/term.267
   Sutter M, 2007, J CONTROL RELEASE, V119, P301, DOI 10.1016/j.jconrel.2007.03.003
   Tayalia P, 2009, ADV MATER, V21, P3269, DOI 10.1002/adma.200900241
   Tirkkonen L, 2013, EUR CELLS MATER, V25, P144, DOI 10.22203/eCM.v025a10
   Van den Bulcke AI, 2000, BIOMACROMOLECULES, V1, P31, DOI 10.1021/bm990017d
   Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546
   Yamachika E, 2009, J BIOMED MATER RES A, V88A, P599, DOI 10.1002/jbm.a.31833
   Yamamoto M, 2001, J BIOMAT SCI-POLYM E, V12, P77, DOI 10.1163/156856201744461
   YASKO AW, 1992, J BONE JOINT SURG AM, V74A, P659, DOI 10.2106/00004623-199274050-00005
   Zanetti AS, 2013, J BIOMED MATER RES B, V101B, P187, DOI 10.1002/jbm.b.32817
   Zhu M, 2009, J TISSUE ENG REGEN M, V3, P290, DOI 10.1002/term.165
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
   Zuk P, 2011, CONNECT TISSUE RES, V52, P119, DOI 10.3109/03008207.2010.484515
NR 53
TC 6
Z9 6
U1 4
U2 30
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN
PY 2016
VL 104
IS 6
BP 1387
EP 1397
DI 10.1002/jbm.a.35668
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DK7PC
UT WOS:000375117200007
PM 26822338
DA 2018-10-20
ER

PT J
AU Mirsalehi, SA
   Sattari, M
   Khavandi, A
   Mirdamadi, S
   Naimi-Jamal, MR
AF Mirsalehi, Seyed A.
   Sattari, Mohammadali
   Khavandi, Alireza
   Mirdamadi, Shamsodin
   Naimi-Jamal, Mohammad R.
TI Tensile and biocompatibility properties of synthesized
   nano-hydroxyapatite reinforced ultrahigh molecular weight polyethylene
   nanocomposite
SO JOURNAL OF COMPOSITE MATERIALS
LA English
DT Article
DE Biocompatibility; biomaterials; mechanical properties; ultrahigh
   molecular weight polyethylene; nanocomposites
ID BETA-TRICALCIUM PHOSPHATE; HIGH-DENSITY POLYETHYLENE; IN-VITRO;
   BIOMEDICAL APPLICATIONS; EXTRACELLULAR CALCIUM; MECHANICAL-PROPERTIES;
   SLIDING WEAR; COMPOSITES; BONE; PROLIFERATION
AB Ultrahigh molecular weight polyethylene-based nanocomposites reinforced with nano-sized hydroxyapatite particles were fabricated using internal mixer and compression molding with different weight percent of the nano-hydroxyapatite. In this study, first, hydroxyapatite nanoparticles were synthesized by sol-gel. Then, the mechanical and biological properties of nanocomposites were studied by tensile test and proliferation and cell adhesion assays using MG-63 osteoblast cells, respectively. Results of the tensile test showed that incorporation of 50 wt% nano-hydroxyapatite led to a 345.64% and 57.58% increase in Young's modulus and yield strength (compared to the pure ultrahigh molecular weight polyethylene), respectively. The effect of the nano-hydroxyapatite powders on the MG-63 osteoblast cells behavior was compared to those of a composite (positive control) and a negative control samples. Scanning electron microscopy micrographs revealed that cell-biomaterial interaction was carried out on the surface of the nanocomposites with normal phenotypic shape. Results of MTT assay exhibited that all samples are biocompatible.
C1 [Mirsalehi, Seyed A.; Sattari, Mohammadali; Khavandi, Alireza] Iran Univ Sci & Technol, Sch Materials Sci & Engn, Composite Lab, Tehran 1684613114, Iran.
   [Mirdamadi, Shamsodin] Iran Univ Sci & Technol, CEHSAT, Sch Materials Engn, Tehran 1684613114, Iran.
   [Naimi-Jamal, Mohammad R.] Iran Univ Sci & Technol, Dept Chem, Res Lab Green Organ Synth & Polymers, Tehran 1684613114, Iran.
RP Khavandi, A (reprint author), Iran Univ Sci & Technol, Sch Materials Sci & Engn, Composite Lab, Tehran 1684613114, Iran.
EM khavandi@iust.ac.ir
RI Khavandi, Alireza/S-3732-2018; khavandi, alireza/S-6562-2018
OI Naimi-Jamal, Mohammad Reza/0000-0002-8305-7234
CR Abadi MBH, 2010, POLYM COMPOSITE, V31, P1745, DOI 10.1002/pc.20965
   Akhilesh K., 2011, NANOBIOMATERIALS HDB
   Anderson BC, 2002, BIOMATERIALS, V23, P1761, DOI 10.1016/S0142-9612(01)00301-5
   BONFIELD W, 1981, BIOMATERIALS, V2, P185, DOI 10.1016/0142-9612(81)90050-8
   Brandt J, 2010, J MATER SCI-MATER M, V21, P283, DOI 10.1007/s10856-009-3859-1
   Brown PW, 1994, HYDROXYAPATITE RELAT
   COOPER JR, 1993, WEAR, V162, P378, DOI 10.1016/0043-1648(93)90521-M
   Deville S, 2007, ACTA MATER, V55, P1965, DOI 10.1016/j.actamat.2006.11.003
   Dutt RT, 2003, J BIOMED MATER RES A, V67, P1228
   Ehara A, 2003, BIOMATERIALS, V24, P831, DOI 10.1016/S0142-9612(02)00411-8
   Ergun C, 2007, J BIOMED MATER RES A, V80A, P990, DOI 10.1002/jbm.a.30923
   Fang L, 2003, PROCESSING HA UHMWPE
   Fang LM, 2006, BIOMATERIALS, V27, P3701, DOI 10.1016/j.biomaterials.2006.02.023
   Fang LM, 2005, BIOMATERIALS, V26, P3471, DOI 10.1016/j.biomaterials.2004.09.022
   Gergely G, 2010, CENT EUR J CHEM, V8, P375, DOI 10.2478/s11532-010-0004-4
   Gul RM, 2004, POLYM ENG SCI, V44, P1848, DOI 10.1002/pen.20186
   Hashimoto M, 2003, KEY ENG MAT, V240-2, P415, DOI 10.4028/www.scientific.net/KEM.240-242.415
   Hashmi SAR, 2001, WEAR, V247, P9, DOI 10.1016/S0043-1648(00)00513-5
   Homaeigohar SSH, 2005, J BIOMED MATER RES A, V75A, P14, DOI 10.1002/jbm.a.30333
   Ji BH, 2004, J MECH PHYS SOLIDS, V52, P1963, DOI 10.1016/j.jmps.2004.03.006
   Kalantari SM, 2015, J MECH BEHAV BIOMED, V48, P183, DOI 10.1016/j.jmbbm.2015.04.015
   KANATANI M, 1991, BIOCHEM BIOPH RES CO, V181, P1425, DOI 10.1016/0006-291X(91)92098-5
   KNETS IV, 1993, MECH COMPOS MATER, V29, P181, DOI 10.1007/BF00696450
   Krzypow DJ, 2000, BIOMATERIALS, V21, P2081, DOI 10.1016/S0142-9612(00)00138-1
   Lawrence E. N., 1994, MECH PROPERTIES POLY
   Li W, 2014, POLYMER, V55, P1792, DOI 10.1016/j.polymer.2014.02.023
   LOZA J, 1995, BONE, V16, pS341
   Mirsalehi SA, 2015, J APPL POLYM SCI, V132
   Mirsalehi SA, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.42052
   Monchau F, 2002, BIOMOL ENG, V19, P143, DOI 10.1016/S1389-0344(02)00023-0
   Pan YS, 2010, J MATER ENG PERFORM, V19, P1037, DOI 10.1007/s11665-009-9569-5
   Perepechko I, 1981, INTRO POLYM PHYS
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   Rigo ECS, 2004, MAT SCI ENG C-BIO S, V24, P647, DOI 10.1016/j.msec.2004.08.044
   Roy S, 2002, B MATER SCI, V25, P609, DOI 10.1007/BF02707893
   Ruan SL, 2003, POLYMER, V44, P5643, DOI 10.1016/S0032-3861(03)00628-1
   Sattari M, 2014, POLYM TEST, V38, P26, DOI 10.1016/j.polymertesting.2014.06.006
   Supova M, 2009, J MATER SCI-MATER M, V20, P1201, DOI 10.1007/s10856-009-3696-2
   Suzuki T, 2000, J BIOSCI BIOENG, V89, P18, DOI 10.1016/S1389-1723(00)88045-7
   Tong J, 2003, WEAR, V255, P734, DOI 10.1016/S0043-1648(03)00221-7
   Tourani H, 2013, POLYM COMPOSITE, V34, P1961, DOI 10.1002/pc.22603
   Wang M, 2001, BIOMATERIALS, V22, P1311, DOI 10.1016/S0142-9612(00)00283-0
   Wang M, 1998, BIOMATERIALS, V19, P2357, DOI 10.1016/S0142-9612(98)00154-9
   Wang M, 1998, J BIOMED MATER RES, V42, P577, DOI 10.1002/(SICI)1097-4636(19981215)42:4<577::AID-JBM14>3.0.CO;2-2
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Xie XL, 2003, BIOMATERIALS, V24, P1889, DOI 10.1016/S0142-9612(02)00610-5
   Yoshimura M, 1998, J MATER RES, V13, P796, DOI 10.1557/JMR.1998.0101
   Zhou JS, 2005, J APPL POLYM SCI, V96, P2336, DOI 10.1002/app.21534
NR 49
TC 3
Z9 3
U1 1
U2 17
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0021-9983
EI 1530-793X
J9 J COMPOS MATER
JI J. Compos Mater.
PD JUN
PY 2016
VL 50
IS 13
BP 1725
EP 1737
DI 10.1177/0021998315595711
PG 13
WC Materials Science, Composites
SC Materials Science
GA DK6BP
UT WOS:000375006200003
DA 2018-10-20
ER

PT J
AU Bociaga, D
   Jakubowski, W
   Komorowski, P
   Sobczyk-Guzenda, A
   Jedrzejczak, A
   Batory, D
   Olejnik, A
AF Bociaga, Dorota
   Jakubowski, Witold
   Komorowski, Piotr
   Sobczyk-Guzenda, Anna
   Jedrzejczak, Anna
   Batory, Damian
   Olejnik, Anna
TI Surface characterization and biological evaluation of
   silver-incorporated DLC coatings fabricated by hybrid RF PACVD/MS method
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Ag-DLC coatings; Antibacterial properties; Cell viability; Biomaterial;
   Biomedical applications
ID DIAMOND-LIKE CARBON; A-C-H; AMORPHOUS-CARBON; ESCHERICHIA-COLI;
   BACTERIAL ADHESION; IN-VITRO; ANTIBACTERIAL PROPERTIES; BIOMEDICAL
   APPLICATIONS; ANTIBIOTIC-RESISTANCE; MECHANICAL-PROPERTIES
AB Since the biological response of the body towards an implanted material is mainly governed by its surface properties, biomaterials are improved by various kinds of coatings. Their role is to provide good mechanical and biological characteristics, and exclude some disadvantages like post-implantation infections. This phenomenon may be reduced by introduction of silver as an antibacterial agent. This study evaluates the Ag-DLC films synthesized by the hybrid RF PACVD/MS method according to the patent number PL401955-A1 worked out inter alia by the authors. Such tests as XPS, SEM, EDS, AFM, FTIR, Raman and ICP-TOF-MS were used to determine surface properties of the coatings. The obtained results were correlated with the biological response estimated on the basis of cells viability assay (osteoblast cells line Saos-2) and bacterial colonization test (Escherichia coli strain DH5 alpha). Results showed that the hybrid RF PACVD/MS method allows one to get tight coating preventing the diffusion of harmful elements from the metallic substrate. Ag concentration increases with the growing power density, it occurs in metallic state, does not create chemical bonds and is evenly dispersed within the DLC matrix in the form of nanoscale silver clusters. Increasing silver content above 2 at.% improves bactericidal properties, but decreases cell viability (C) 2016 Elsevier B.V. All rights reserved.
C1 [Bociaga, Dorota; Jedrzejczak, Anna; Batory, Damian; Olejnik, Anna] Lodz Univ Technol, Inst Mat Sci & Engn, Div Biomed Engn & Funct Mat, 1-15 Stefanowskiego St, PL-90924 Lodz, Poland.
   [Jakubowski, Witold; Komorowski, Piotr] Lodz Univ Technol, Inst Mat Sci & Engn, Div Biophys, 1-15 Stefanowskiego St, PL-90924 Lodz, Poland.
   [Sobczyk-Guzenda, Anna] Lodz Univ Technol, Inst Mat Sci & Engn, Div Coatings Engn & Nonmetall Mat, 1-15 Stefanowskiego St, PL-90924 Lodz, Poland.
   [Komorowski, Piotr] BioNanoPk Labs Lodz Reg Pk Sci & Technol, 114-116 Dubois St, PL-93465 Lodz, Poland.
RP Bociaga, D (reprint author), Lodz Univ Technol, Inst Mat Sci & Engn, Div Biomed Engn & Funct Mat, 1-15 Stefanowskiego St, PL-90924 Lodz, Poland.
EM dorota.bociagal@gmail.com
RI Jakubowski, Witold/S-1137-2018; Sobczyk-Guzenda, Anna/T-2089-2018
OI Jakubowski, Witold/0000-0003-1751-609X; Sobczyk-Guzenda,
   Anna/0000-0003-1583-4238
FU National Centre for Research and Development
   [ERA-NET/MNT/CARSILA/1/2010]
FX This work was supported by the National Centre for Research and
   Development under grant no. ERA-NET/MNT/CARSILA/1/2010.
CR Allen M, 2001, J BIOMED MATER RES, V58, P319, DOI 10.1002/1097-4636(2001)58:3<319::AID-JBM1024>3.0.CO;2-F
   Almaguer-Flore A., 2011, IMPLANT DENT MOST PR, P263
   Baba K, 2013, VACUUM, V89, P179, DOI 10.1016/j.vacuum.2012.04.015
   Baba K, 2012, ADV MATER SCI ENG, DOI 10.1155/2012/536853
   Batory D, 2008, J MATER SCI, V43, P3385, DOI 10.1007/s10853-007-2393-0
   Batory D., 2014, PL401955A1
   Batory D, 2013, APPL SURF SCI, V275, P303, DOI 10.1016/j.apsusc.2012.12.088
   Bendavid A, 2007, DIAM RELAT MATER, V16, P1616, DOI 10.1016/j.diamond.2007.02.006
   Bociaga D, 2008, DIAM RELAT MATER, V17, P1410, DOI 10.1016/j.diamond.2008.02.014
   Bociaga D, 2015, APPL SURF SCI, V355, P388, DOI 10.1016/j.apsusc.2015.07.117
   Bociaga D, 2010, J NANOSCI NANOTECHNO, V10, P1191, DOI 10.1166/jnn.2010.1850
   Bruinink A, 2005, BIOMATERIALS, V26, P3487, DOI 10.1016/j.biomaterials.2004.09.030
   Bryers JD, 2008, BIOTECHNOL BIOENG, V100, P1, DOI 10.1002/bit.21838
   Camargo SS, 1998, DIAM RELAT MATER, V7, P1155, DOI 10.1016/S0925-9635(98)00165-4
   Campoccia D, 2010, BIOMATERIALS, V31, P6363, DOI 10.1016/j.biomaterials.2010.05.005
   Casiraghi C, 2005, DIAM RELAT MATER, V14, P1098, DOI 10.1016/j.diamond.2004.10.030
   Casiraghi C., 2005, PHYS REV B, V72
   Chai F, 2008, ACTA BIOMATER, V4, P1369, DOI 10.1016/j.actbio.2008.04.011
   Chan YH, 2011, SURF COAT TECH, V206, P1037, DOI 10.1016/j.surfcoat.2011.07.034
   Charitidis CA, 2010, INT J REFRACT MET H, V28, P51, DOI 10.1016/j.ijrmhm.2009.08.003
   Chekan NM, 2009, DIAM RELAT MATER, V18, P1006, DOI 10.1016/j.diamond.2009.02.024
   Choi HW, 2008, DIAM RELAT MATER, V17, P252, DOI 10.1016/j.diamond.2007.12.034
   Choi HW, 2007, THIN SOLID FILMS, V516, P248, DOI 10.1016/j.tsf.2007.06.154
   Cousen PJ, 2012, CONTACT DERMATITIS, V66, P55, DOI 10.1111/j.1600-0536.2011.01970.x
   Cui JF, 2012, APPL SURF SCI, V258, P5025, DOI 10.1016/j.apsusc.2012.01.072
   Dearnaley G, 2005, SURF COAT TECH, V200, P2518, DOI 10.1016/j.surfcoat.2005.07.077
   Dhandapani VS, 2014, SURF COAT TECH, V240, P128, DOI 10.1016/j.surfcoat.2013.12.025
   Endrino JL, 2008, SURF COAT TECH, V202, P3675, DOI 10.1016/j.surfcoat.2008.01.011
   Endrino JL, 2010, IOP CONF SER-MAT SCI, V12, DOI 10.1088/1757-899X/12/1/012012
   Ferrari AC, 2000, PHYS REV B, V61, P14095, DOI 10.1103/PhysRevB.61.14095
   Francz G, 1999, SURF INTERFACE ANAL, V28, P3, DOI 10.1002/(SICI)1096-9918(199908)28:1<3::AID-SIA609>3.0.CO;2-U
   Ghosh T, 2015, FRONT LIFE SCI, V8, P47, DOI 10.1080/21553769.2014.952048
   Grabarczyk J., 2007, J ACHIEV MAT MANUF E, V1-2, P107
   Grill A, 1999, DIAM RELAT MATER, V8, P428, DOI 10.1016/S0925-9635(98)00262-3
   Hallab N, 2001, J BONE JOINT SURG AM, V83A, P428, DOI 10.2106/00004623-200103000-00017
   Hauert R, 2013, SURF COAT TECH, V233, P119, DOI 10.1016/j.surfcoat.2013.04.015
   Hauert R, 2003, DIAM RELAT MATER, V12, P583, DOI 10.1016/S0925-9635(03)00081-5
   Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011
   Hollinger MA, 1996, CRIT REV TOXICOL, V26, P255, DOI 10.3109/10408449609012524
   Ivask A, 2014, ACS NANO, V8, P374, DOI 10.1021/nn4044047
   Jakubowski W, 2008, ADV APPL CERAM, V107, P217, DOI 10.1179/174367608X263395
   Jakubowski W, 2004, DIAM RELAT MATER, V13, P1761, DOI 10.1016/j.diamond.2004.03.003
   Kierek-Pearscon K, 2005, ADV APPL MICROBIOL, V57, P79, DOI 10.1016/S0065-2164(05)57003-5
   Kwok SCH, 2007, DIAM RELAT MATER, V16, P1353, DOI 10.1016/j.diamond.2006.11.001
   Lackner J.M., 2010, MONATSH, V155, P528
   Lambert J. B., 1987, INTRO ORGANIC SPECTR
   Lan WC, 2013, CERAM INT, V39, P4099, DOI 10.1016/j.ceramint.2012.10.264
   Lara HH, 2010, WORLD J MICROB BIOT, V26, P615, DOI 10.1007/s11274-009-0211-3
   Lee W, 2014, BIOMETALS, V27, P1191, DOI 10.1007/s10534-014-9782-z
   Lee YH, 2014, BIOMATERIALS, V35, P4706, DOI 10.1016/j.biomaterials.2014.02.021
   Linder S, 2002, BIOMATERIALS, V23, P767, DOI 10.1016/S0142-9612(01)00182-X
   Love CA, 2013, TRIBOL INT, V63, P141, DOI 10.1016/j.triboint.2012.09.006
   Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2
   Manninen NK, 2013, SURF COAT TECH, V232, P440, DOI 10.1016/j.surfcoat.2013.05.048
   Manninen NK, 2015, SURF COAT TECH, V267, P90, DOI 10.1016/j.surfcoat.2014.12.029
   Marambio-Jones C, 2010, J NANOPART RES, V12, P1531, DOI 10.1007/s11051-010-9900-y
   Marciano FR, 2011, VACUUM, V85, P662, DOI 10.1016/j.vacuum.2010.07.017
   Marciano FR, 2009, DIAM RELAT MATER, V18, P1010, DOI 10.1016/j.diamond.2009.02.014
   Martinez-Gutierrez F, 2012, NANOMED-NANOTECHNOL, V8, P328, DOI 10.1016/j.nano.2011.06.014
   Mohanty M, 2002, BIOMOL ENG, V19, P125, DOI 10.1016/S1389-0344(02)00026-6
   Mohanty S, 2012, NANOMED-NANOTECHNOL, V8, P916, DOI 10.1016/j.nano.2011.11.007
   Morshed MM, 2003, J MATER PROCESS TECH, V143, P922, DOI 10.1016/j.jmatprotec.2003.10.003
   Morzyk-Ociepa B, 2003, SPECTROCHIM ACTA A, V59, P1247, DOI 10.1016/S1386-1425(02)00306-2
   Okazaki Y, 2004, BIOMATERIALS, V25, P5913, DOI 10.1016/j.biomaterials.2004.01.064
   Okpalugo TIT, 2004, BIOMATERIALS, V25, P239, DOI 10.1016/S0142-9612(03)00494-0
   Oktar FN, 2015, CURR TOP MED CHEM, V15, P1583
   Rai MK, 2012, J APPL MICROBIOL, V112, P841, DOI 10.1111/j.1365-2672.2012.05253.x
   Rams TE, 2014, CLIN ORAL IMPLAN RES, V25, P82, DOI 10.1111/clr.12160
   Ren DW, 2013, SURF COAT TECH, V226, P1, DOI 10.1016/j.surfcoat.2013.03.025
   Robertson J, 2002, MAT SCI ENG R, V37, P129, DOI 10.1016/S0927-796X(02)00005-0
   Saito T, 2005, DIAM RELAT MATER, V14, P1116, DOI 10.1016/j.diamond.2004.09.017
   Schembri MA, 2003, MOL MICROBIOL, V48, P253, DOI 10.1046/j.1365-2958.2003.03432.x
   Shanna R, 2008, THIN SOLID FILMS, V516, P5397, DOI 10.1016/j.tsf.2007.07.099
   Sheng XX, 2008, J COLLOID INTERF SCI, V321, P256, DOI 10.1016/j.jcis.2008.02.038
   SILVERSTEIN RM, 1991, SPECTROMETRIC IDENTI
   Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012
   Song F, 2015, J DENT RES, V94, P1027, DOI 10.1177/0022034515587690
   Swieczko-Zurek B., 2008, ADV MAT SCI, V8, P179
   Takeno T, 2013, DIAM RELAT MATER, V39, P20, DOI 10.1016/j.diamond.2013.07.004
   Voggenreiter G, 2003, BIOMATERIALS, V24, P247, DOI 10.1016/S0142-9612(02)00312-5
   Wang CB, 2009, APPL SURF SCI, V256, P1431, DOI 10.1016/j.apsusc.2009.08.103
   Wang QZ, 2013, ELECTROCHIM ACTA, V112, P603, DOI 10.1016/j.electacta.2013.09.022
   Wu YX, 2013, APPL SURF SCI, V284, P165, DOI 10.1016/j.apsusc.2013.07.074
   Yamane K, 2013, CLIN ORAL IMPLAN RES, V24, P1310, DOI 10.1111/j.1600-0501.2012.02574.x
   Zimmerli W, 2006, BEST PRACT RES CL RH, V20, P1045, DOI 10.1016/j.berh.2006.08.003
   Zou CW, 2013, APPL SURF SCI, V286, P137, DOI 10.1016/j.apsusc.2013.09.036
NR 86
TC 13
Z9 13
U1 4
U2 42
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUN 1
PY 2016
VL 63
BP 462
EP 474
DI 10.1016/j.msec.2016.03.013
PG 13
WC Materials Science, Biomaterials
SC Materials Science
GA DK4UW
UT WOS:000374916800052
PM 27040240
DA 2018-10-20
ER

PT J
AU Pollini, M
   Paladini, F
   Sannino, A
   Maffezzoli, A
AF Pollini, Mauro
   Paladini, Federica
   Sannino, Alessandro
   Maffezzoli, Alfonso
TI Development of hybrid cotton/hydrogel yarns with improved absorption
   properties for biomedical applications
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Textile; Hydrogel; Durability; Absorption; Hyperhidrosis; Biomaterial
ID GLASS-IONOMER CEMENTS; FOCAL HYPERHIDROSIS; COTTON FABRICS; HYDROGEL;
   TRANSMISSION; DIAGNOSIS; BEHAVIOR
AB Hyperhidrosis, or excessive sweating, is an overlooked and potentially disabling symptom, which is often seen in social anxiety disorder. In this work an innovative advanced textile material was developed for application in the management of excessive sweating, preparing a drying yarn providing improved comfort Hybrid cotton/hydrogel yarns were obtained by combining cotton with superabsorbent hydrogels through an optimization study focused on the achievement of the most promising product in terms of absorption properties and resistance to washings. Swelling and washing tests were performed using different hydrogels, and the effect of an additional crosslinking on the materials was also evaluated by testing different solutions containing Al3+ and Ca2+ ions. Scanning electron microscopy and infrared spectroscopy analyses were adopted to characterize morphology and chemical structure of the hydrogels undergoing different production processes. The biocompatibility of the hybrid fabrics was demonstrated by 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide colorimetric assay (MTT) through the extract method. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Pollini, Mauro; Paladini, Federica; Sannino, Alessandro; Maffezzoli, Alfonso] Univ Salento, Dept Engn Innovat, Via Monteroni, I-73100 Lecce, Italy.
RP Paladini, F (reprint author), Univ Salento, Dept Engn Innovat, Via Monteroni, I-73100 Lecce, Italy.
EM federica.paladini@unisalento.it
CR Bechara FG, 2007, J AM ACAD DERMATOL, V57, P207, DOI 10.1016/j.jaad.2007.01.035
   Bozaci E, 2015, CARBOHYD POLYM, V134, P128, DOI 10.1016/j.carbpol.2015.07.036
   Brook IM, 1998, BIOMATERIALS, V19, P565, DOI 10.1016/S0142-9612(98)00138-0
   Celino A, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2013.00043
   Cina CS, 1999, QUAL LIFE RES, V8, P693, DOI 10.1023/A:1008968401068
   Das B, 2008, FIBER POLYM, V9, P225, DOI 10.1007/s12221-008-0036-y
   Das S, 2012, INDIAN J FIBRE TEXT, V37, P151
   Davidson JRT, 2002, PROG NEURO-PSYCHOPH, V26, P1327, DOI 10.1016/S0278-5846(02)00297-X
   Eisenach JH, 2005, MAYO CLIN PROC, V80, P657, DOI 10.4065/80.5.657
   Garside P, 2003, STUD CONSERV, V48, P269, DOI 10.1179/sic.2003.48.4.269
   Ghali K, 2002, INT J HEAT MASS TRAN, V45, P3703, DOI 10.1016/S0017-9310(02)00088-1
   Haghi AK, 2004, J THERM ANAL CALORIM, V76, P1035, DOI 10.1023/B:JTAN.0000032288.16502.d2
   Haider A, 2005, CAN MED ASSOC J, V172, P69, DOI 10.1503/cmaj.1040708
   Hornberger J, 2004, J AM ACAD DERMATOL, V51, P274, DOI 10.1016/j.jaad.2003.12.029
   Hu J., 2011, J CONTROL RELEASE
   Ibrahim I.K., 2015, INT J MAT CHEM PHYS, V1, P99
   Kaufmann H, 2003, CLIN AUTON RES, V13, P96, DOI 10.1007/s10286-003-0082-x
   Khalil-Abad MS, 2010, J COLLOID INTERF SCI, V351, P293, DOI 10.1016/j.jcis.2010.07.049
   Kohler R, 2006, MACROMOL SYMP, V244, P89, DOI 10.1002/masy.200651208
   Leung AKC, 1999, INT J DERMATOL, V38, P561, DOI 10.1046/j.1365-4362.1999.00609.x
   Micelli F, 2001, J MATER SCI-MATER M, V12, P151, DOI 10.1023/A:1008974128215
   Mijnhout GS, 2006, NETH J MED, V64, P326
   Noel F, 2012, INT J DERMATOL, V51, P647, DOI 10.1111/j.1365-4632.2011.05307.x
   Onofrei E, 2011, J ENG FIBER FABR, V6, P10
   Paladini F, 2015, MAT SCI ENG C-MATER, V52, P1, DOI 10.1016/j.msec.2015.03.035
   Paladini F, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.40326
   Paladini F, 2013, J MATER SCI-MATER M, V24, P2461, DOI 10.1007/s10856-013-4986-2
   Pena MA, 2007, SEMIN CUTAN MED SURG, V26, P29, DOI 10.1016/j.sder.2006.12.004
   Pollini M, 2013, J COAT TECHNOL RES, V10, P239, DOI 10.1007/s11998-012-9439-1
   Sannino A, 2003, J BIOMED MATER RES A, V67A, P1016, DOI 10.1002/jbm.a.10149
   Schieman C., 2010, EXPERT REV DERMATOL, V5, P31
   Staneva D, 2015, APPL SURF SCI, V345, P72, DOI 10.1016/j.apsusc.2015.03.141
   Vorkamp T, 2010, SURG-J R COLL SURG E, V8, P287, DOI 10.1016/j.surge.2010.06.002
   Wheaton MG, 2011, J PSYCHOPATHOL BEHAV, V33, P393, DOI 10.1007/s10862-010-9211-8
   Yuranova T, 2006, J MOL CATAL A-CHEM, V244, P160, DOI 10.1016/j.molcata.2005.08.059
   Zimehl R, 2000, COLLOID SURFACE A, V163, P55, DOI 10.1016/S0927-7757(99)00430-6
NR 36
TC 7
Z9 8
U1 1
U2 45
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUN 1
PY 2016
VL 63
BP 563
EP 569
DI 10.1016/j.msec.2016.03.027
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA DK4UW
UT WOS:000374916800063
PM 27040251
DA 2018-10-20
ER

PT J
AU Mendes, MWD
   Agreda, CG
   Bressiani, AHA
   Bressiani, JC
AF Mendes, Marcio W. D.
   Agreda, Carola G.
   Bressiani, Ana H. A.
   Bressiani, Jose C.
TI A new titanium based alloy Ti-27Nb-13Zr produced by powder metallurgy
   with biomimetic coating for use as a biomaterial
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Titanium alloy; Ti-Nb-Zr; powder metallurgy; Young's modulus; Apatite
   coating
ID SN-NB ALLOY; MECHANICAL-PROPERTIES; ELASTIC-MODULUS; IN-VITRO; TI;
   TI-13NB-13ZR; IMPLANTS; VIVO; MICROSTRUCTURE; BIOACTIVITY
AB Titanium alloys are widely used in biomedical applications due to their excellent properties such as high strength, good corrosion resistance and biocompatibility. Titanium alloys with alloying elements such as Nb and Zr are biocompatible and have Young's modulus close to that of human bone. To increase the bioactivity of titanium alloy surfaces is used chemical treatment with NaOH followed by immersion in simulated body fluid (SBF). The purpose of this study was to produce the alloy Ti-27Nb-13Zr with low Young's modulus by powder metallurgy using powders produced by the HDH process. The formation of biomimetic coatings on samples immersed in SBF for 3, 7,11 and 15 days was evaluated. Characterization of the coating was performed by diffuse reflectance infrared Fourier transform spectroscopy (DRIFTS) and scanning electron microscope. The microstructure and composition of the alloy were determined using SEM and XRD, while the mechanical properties were evaluated by determining the elastic modulus and the Vickers microhardness. The sintered alloys were composed of of and 13 phases, equiaxed grains and with density around 97.8% of its theoretical density. The Vickers microhardness and elasticity modulus of the alloy were determined and their values indicate that this alloy can be used as a biomaterial. Analysis of the coating revealed the presence of calcium phosphate layers on samples immersed for >3 days in the SBF solution. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Mendes, Marcio W. D.; Agreda, Carola G.; Bressiani, Ana H. A.; Bressiani, Jose C.] Energy & Nucl Res Inst, Mat Sci & Technol Ctr, Ave Lineu Prestes 2242, BR-05508000 Sao Paulo, SP, Brazil.
RP Mendes, MWD (reprint author), Energy & Nucl Res Inst, Mat Sci & Technol Ctr, Ave Lineu Prestes 2242, BR-05508000 Sao Paulo, SP, Brazil.
EM mwdmendes@ipen.com
RI Mendes, Marcio/D-8786-2013; Bressiani, Ana/I-1402-2012
FU Capes; CNPq [307954/2013-7]; FAPESP [2008/57860-3]
FX The authors acknowledge the financial support of Capes (scholarship
   granted to M.W.D. Mendes and C. G. Agreda), CNPq (grant no
   307954/2013-7) and FAPESP (grant no 2008/57860-3).
CR Abdel-Hady M, 2006, SCRIPTA MATER, V55, P477, DOI 10.1016/j.scriptamat.2006.04.022
   Afonso CRM, 2007, MAT SCI ENG C-BIO S, V27, P908, DOI 10.1016/j.msec.2006.11.001
   Agreda CG, 2013, ADV SCI TECH, V86, P28, DOI 10.4028/www.scientific.net/AST.86.28
   Ahmed T, 1996, J MATER SCI, V31, P4267, DOI 10.1007/BF00356449
   Assis C.M., 2005, MAT RES, V8, P207
   Barriobero-Vila P, 2015, J ALLOY COMPD, V626, P330, DOI 10.1016/j.jallcom.2014.11.176
   Bottino MC, 2009, J BIOMED MATER RES A, V88A, P689, DOI 10.1002/jbm.a.31912
   Candioto KCG, 2006, INT J REFRACT MET H, V24, P413, DOI 10.1016/j.ijrmhm.2005.06.001
   Chen R., 2015, MAT SCI ENG R, V87, P1
   Chen YK, 2007, SURF COAT TECH, V202, P494, DOI 10.1016/j.surfcoat.2007.06.015
   Feng B, 2002, BIOMATERIALS, V23, P173, DOI 10.1016/S0142-9612(01)00093-X
   Gabriel SB, 2011, INT J REFRACT MET H, V29, P134, DOI 10.1016/j.ijrmhm.2010.09.006
   Gabriel SB, 2010, MATER RES-IBERO-AM J, V13, P333, DOI 10.1590/S1516-14392010000300009
   He G, 2005, MAT SCI ENG C-BIO S, V25, P290, DOI 10.1016/j.msec.2005.03.001
   Hirschhorn Joel S., 1976, INTRO POWDER METALLU
   Izman S., 2012, TITANIUM ALLOYS ACHI
   Kamitakahara M., 2007, BIOMED MATER, V2, pR 17
   Kim HM, 1997, J MATER SCI-MATER M, V8, P341, DOI 10.1023/A:1018524731409
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Lee K, 2015, ARCH METALL MATER, V60, P1371, DOI 10.1515/amm-2015-0133
   Lutjering G., 2007, TITANIUM
   Majumdar P, 2008, MAT SCI ENG A-STRUCT, V489, P419, DOI 10.1016/j.msea.2007.12.029
   Medeiros W.S., 2008, ARTIF ORGANS, V32, P277
   Muller FA, 2008, DENT MATER, V24, P50, DOI 10.1016/j.dental.2007.02.005
   Ng HP, 2010, MAT SCI ENG A-STRUCT, V527, P7017, DOI 10.1016/j.msea.2010.07.055
   Nouri A, 2010, ACTA BIOMATER, V6, P1630, DOI 10.1016/j.actbio.2009.10.005
   Nouri A, 2008, MAT SCI ENG A-STRUCT, V485, P562, DOI 10.1016/j.msea.2007.10.010
   Rao X., 2011, INT J REFRACT MET H, V29, P27
   Rigo ECS, 2004, MAT SCI ENG C-BIO S, V24, P647, DOI 10.1016/j.msec.2004.08.044
   Simka W, 2013, RSC ADV, V3, P11195, DOI 10.1039/c3ra23256e
   Suryanarayana C, 2001, PROG MATER SCI, V46, P1, DOI 10.1016/S0079-6425(99)00010-9
   Upadhyaya GS, 2002, POWDER METALLURGY TE
   Zhao DP, 2013, J MECH BEHAV BIOMED, V28, P171, DOI 10.1016/j.jmbbm.2013.08.013
NR 35
TC 17
Z9 17
U1 2
U2 59
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUN 1
PY 2016
VL 63
BP 671
EP 677
DI 10.1016/j.msec.2016.03.052
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA DK4UW
UT WOS:000374916800076
PM 27040264
DA 2018-10-20
ER

PT J
AU Wang, JY
   Chen, FL
   Liu, LW
   Qi, CX
   Wang, BJ
   Yan, XJ
   Huang, CY
   Hou, W
   Zhang, MQ
   Chen, Y
   Du, YA
AF Wang, Jingyu
   Chen, Fengling
   Liu, Longwei
   Qi, Chunxiao
   Wang, Bingjie
   Yan, Xiaojun
   Huang, Chenyu
   Hou, Wei
   Zhang, Michael Q.
   Chen, Yang
   Du, Yanan
TI Engineering EMT using 3D micro-scaffold to promote hepatic functions for
   drug hepatotoxicity evaluation
SO BIOMATERIALS
LA English
DT Article
DE EMT; 3D micro-scaffold; Hepatic functions; HDACs; Drug hepatotoxicity
   evaluation
ID EPITHELIAL-MESENCHYMAL TRANSITION; PRIMARY HUMAN HEPATOCYTES;
   GENE-EXPRESSION PATTERNS; BETA-INDUCED APOPTOSIS; EMBRYONIC STEM-CELLS;
   HEPARG CELLS; IN-VITRO; TRANSCRIPTIONAL REGULATION; CANCER CELLS;
   E-CADHERIN
AB Accompanied by decreased hepatic functions, epithelial-mesenchymal transition (EMT) was observed in two dimensional (2D) cultured hepatocytes with elongated morphology, loss of polarity and weakened cell-cell interaction, while upgrading to 3D culture has been considered as significant improvement of its 2D counterpart for hepatocyte maintenance. Here we hypothesize that 3D culture enhances hepatic functions through regulating the EMT status. Biomaterial-engineered EMT was achieved by culturing HepaRG as 3D spheroids (SP-3D) or 3D stretched cells (ST-3D) in non-adherent and adherent micro scaffold respectively. In SP-3D, constrained EMT of HepaRG, a hepatic stem cell line, as represented by increased epithelial markers and decreased mesenchymal markers, was echoed by improved hepatic functions. To investigate the relationship between EMT status and hepatic functions, time-series RNASeq and gene network analysis were used for comparing different cell culture models, which identified histone deacetylases (HDACs) as key mediating factors. Protein analysis confirmed that high HDAC activity was correlated with high expression of Cadherin-1 (CDH1) and hepatic function genes, which were decreased upon HDAC inhibitor treatment in SP-3D, suggesting HDACs may play positive role in regulating EMT and hepatic functions. To illustrate the application of 3D micro-scaffold culture in drug safety evaluation, hepatotoxicity and metabolism assays of two hepatotoxins (i.e. N-acetyl-p-aminophenol and Doxorubicin) were performed and SP-3D showed more biomimetic toxicity response, indicating regulation of EMT as a vital consideration in designing 3D hepatocyte culture configuration. (c) 2016 Elsevier Ltd. All rights reserved.
C1 [Wang, Jingyu; Qi, Chunxiao; Yan, Xiaojun; Du, Yanan] Tsinghua Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Sch Med, Dept Biomed Engn, Beijing 100084, Peoples R China.
   [Chen, Fengling; Zhang, Michael Q.; Chen, Yang] Tsinghua Univ, Bioinformat Div, MOE, Key Lab Bioinformat, Beijing 100084, Peoples R China.
   [Chen, Fengling; Zhang, Michael Q.; Chen, Yang] Tsinghua Univ, TNLIST, Dept Automat, Ctr Synthet & Syst Biol, Beijing 100084, Peoples R China.
   [Liu, Longwei; Wang, Bingjie] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.
   [Huang, Chenyu] Tsinghua Univ, Beijing Tsinghua Changgung Hosp, Med Ctr, Dept Plast Reconstruct & Aesthet Surg, Beijing 102218, Peoples R China.
   [Hou, Wei] Tianjin Second Peoples Hosp, Tianjin 300192, Peoples R China.
   [Hou, Wei] Tianjin Inst Hepatol, Tianjin 300192, Peoples R China.
   [Du, Yanan] China Orthoped Regenerat Med Grp CORMed, Hangzhou 310058, Zhejiang, Peoples R China.
RP Du, YA (reprint author), Tsinghua Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Sch Med, Dept Biomed Engn, Beijing 100084, Peoples R China.; Chen, Y (reprint author), Tsinghua Univ, Bioinformat Div, MOE, Key Lab Bioinformat, Beijing 100084, Peoples R China.; Chen, Y (reprint author), Tsinghua Univ, TNLIST, Dept Automat, Ctr Synthet & Syst Biol, Beijing 100084, Peoples R China.
EM yc@tsinghua.edu.cn; duyanan@tsinghua.edu.cn
RI Huang, Chenyu/I-4410-2018
OI Huang, Chenyu/0000-0001-9521-5650
FU Natural Science Foundation of China [51273106, 81201474, 91019016,
   31361163004, 31301044]; National Basic Research Program of China
   [2012CB316503]; Beijing Municipal Natural Science Foundation [157142090]
FX We greatly thank Prof. Sen Song from Tsinghua University and Tao Yu for
   the help in construction of plasmid containing ALB promoter-EGFP
   sequence. We are grateful to Xiaohui Liu and Xueying Wang for the help
   in LC/MS-LC detection. We thank Qinghai Dai and Bokai Song for the help
   in imaging experiments and all Du-lab members for general help. This
   work is financially supported by Natural Science Foundation of China
   (Grant No: 51273106, 81201474, 91019016, 31361163004, 31301044),
   National Basic Research Program of China (Grant No: 2012CB316503) and
   Beijing Municipal Natural Science Foundation (Grant No: 157142090).
CR ALTER HJ, 1966, BLOOD-J HEMATOL, V27, P297
   Andersson TB, 2012, EXPERT OPIN DRUG MET, V8, P909, DOI 10.1517/17425255.2012.685159
   Nieto MA, 2013, SCIENCE, V342, P708, DOI 10.1126/science.1234850
   Aninat C, 2006, DRUG METAB DISPOS, V34, P75, DOI 10.1124/dmd.105.006759
   [Anonymous], 2008, J Prev Med Public Health, V41, P208
   [Anonymous], 2008, J PREV MED PUBLIC HL, V41, P209
   Bovolenta LA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-405
   Chang TT, 2014, BIOMATERIALS, V35, P2162, DOI 10.1016/j.biomaterials.2013.11.063
   Chang TT, 2009, TISSUE ENG PT A, V15, P559, DOI 10.1089/ten.tea.2007.0434
   CSARDI G, 2006, INT J COMPLEX SYST, V1695, P1695, DOI DOI 10.1080/01621459.1951.10500769
   De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321
   Downing TL, 2013, NAT MATER, V12, P1154, DOI [10.1038/nmat3777, 10.1038/NMAT3777]
   DuFort CC, 2011, NAT REV MOL CELL BIO, V12, P308, DOI 10.1038/nrm3112
   Aguilar-Olivos NE, 2015, MINI-REV MED CHEM, V15, P1187, DOI 10.2174/1389557515666150709115702
   Elaut G, 2007, J PHARMACOL EXP THER, V321, P400, DOI 10.1124/jpet.106.116202
   Elkayam T, 2006, TISSUE ENG, V12, P1357, DOI 10.1089/ten.2006.12.1357
   FARDEL O, 1992, EUR J BIOCHEM, V205, P847, DOI 10.1111/j.1432-1033.1992.tb16849.x
   Flom P. L., 2004, CONNECTIONS, V26, P62
   Franco DL, 2010, J CELL SCI, V123, P3467, DOI 10.1242/jcs.068692
   Gerets HHJ, 2012, CELL BIOL TOXICOL, V28, P69, DOI 10.1007/s10565-011-9208-4
   Godoy P, 2009, HEPATOLOGY, V49, P2031, DOI 10.1002/hep.22880
   Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699
   Guillouzo A, 2007, CHEM-BIOL INTERACT, V168, P66, DOI 10.1016/j.cbi.2006.12.003
   Gunness P, 2013, TOXICOL SCI, V133, P67, DOI 10.1093/toxsci/kft021
   Hewitt NJ, 2007, DRUG METAB REV, V39, P159, DOI 10.1080/03602530601093489
   Hoekstra R, 2013, DRUG METAB DISPOS, V41, P562, DOI 10.1124/dmd.112.049098
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Jain N, 2013, P NATL ACAD SCI USA, V110, P11349, DOI 10.1073/pnas.1300801110
   Kaimori A, 2010, HEPATOLOGY, V52, P1033, DOI 10.1002/hep.23765
   Kawada M, 1998, IN VITRO CELL DEV-AN, V34, P109
   Leite SB, 2012, TOXICOL SCI, V130, P106, DOI 10.1093/toxsci/kfs232
   Li XK, 2014, LAB CHIP, V14, P471, DOI 10.1039/c3lc51103k
   Li YQ, 2014, P NATL ACAD SCI USA, V111, P13511, DOI 10.1073/pnas.1411295111
   Lin RZ, 2006, CELL TISSUE RES, V324, P411, DOI 10.1007/s00441-005-0148-2
   Liu W, 2014, LAB CHIP, V14, P2614, DOI 10.1039/c4lc00081a
   Liu W, 2014, ACTA BIOMATER, V10, P1864, DOI 10.1016/j.actbio.2013.12.008
   Liu ZF, 2014, J CELL MOL MED, V18, P610, DOI 10.1111/jcmm.12209
   Lubberstedt M, 2011, J PHARMACOL TOXICOL, V63, P59, DOI 10.1016/j.vascn.2010.04.013
   Moreau A, 2008, MOL PHARM, V5, P35, DOI 10.1021/mp700103m
   Moreno-Bueno G, 2008, ONCOGENE, V27, P6958, DOI 10.1038/onc.2008.346
   Nelson CM, 2008, J CELL BIOCHEM, V105, P25, DOI 10.1002/jcb.21821
   Ng S, 2006, TISSUE ENG, V12, P2181, DOI 10.1089/ten.2006.12.2181
   O'Connor JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083188
   Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078
   Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004
   Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131
   Pingale SG, 2013, J PHARMACEUTICS, DOI 10.1155/2013/437697
   Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892
   Ramdas NM, 2015, J MOL BIOL, V427, P695, DOI 10.1016/j.jmb.2014.09.008
   Rebelo SP, 2015, ARCH TOXICOL, V89, P1347, DOI 10.1007/s00204-014-1320-9
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Roy KR, 2010, CANCER CHEMOTH PHARM, V65, P903, DOI 10.1007/s00280-009-1097-3
   Schneider D, 2011, BBA-MOL CELL RES, V1813, P2099, DOI 10.1016/j.bbamcr.2011.07.016
   Schulze A, 2012, HEPATOLOGY, V55, P373, DOI 10.1002/hep.24707
   Takayama K, 2012, MOL THER, V20, P127, DOI 10.1038/mt.2011.234
   Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408
   Tobwala S, 2015, EXP BIOL MED, V240, P261, DOI 10.1177/1535370214549520
   Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016
   Treyer A, 2013, COMPR PHYSIOL, V3, P243, DOI 10.1002/cphy.c120009
   Vuoriluoto K, 2011, ONCOGENE, V30, P1436, DOI 10.1038/onc.2010.509
   Wei SC, 2015, NAT CELL BIOL, V17, P678, DOI 10.1038/ncb3157
   Xiong AM, 2008, TISSUE ENG PT A, V14, P995, DOI [10.1089/ten.tea.2007.0087, 10.1089/tea.2007.0087]
   Xu Z., 2013, EMERGING TRENDS CELL, P33
   Yan XJ, 2015, LAB CHIP, V15, P2634, DOI 10.1039/c5lc00313j
   Yao R, 2014, SMALL, V10, P4311, DOI 10.1002/smll.201401040
   Zhao S, 2014, BIOMACROMOLECULES, V15, P2521, DOI 10.1021/bm500388m
NR 66
TC 17
Z9 18
U1 3
U2 72
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2016
VL 91
BP 11
EP 22
DI 10.1016/j.biomaterials.2016.03.001
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DK0OK
UT WOS:000374611900002
PM 26994875
DA 2018-10-20
ER

PT J
AU Gilmour, AD
   Woolley, AJ
   Poole-Warren, LA
   Thomson, CE
   Green, RA
AF Gilmour, A. D.
   Woolley, A. J.
   Poole-Warren, L. A.
   Thomson, C. E.
   Green, R. A.
TI A critical review of cell culture strategies for modelling intracortical
   brain implant material reactions
SO BIOMATERIALS
LA English
DT Review
DE Cell culture; Intracortical implants; Central nervous system wound
   healing; Glial scar; In vitro model
ID CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD-INJURY; FIBRILLARY ACIDIC PROTEIN;
   IN-VITRO MODEL; BIOMATERIAL SURFACE-CHEMISTRY; CHRONIC RECORDING
   FUNCTION; BLOOD-DERIVED MACROPHAGES; NEURAL STEM-CELLS; GLIAL SCAR;
   ELECTRICAL-STIMULATION
AB The capacity to predict in vivo responses to medical devices in humans currently relies greatly on implantation in animal models. Researchers have been striving to develop in vitro techniques that can overcome the limitations associated with in vivo approaches. This review focuses on a critical analysis of the major in vitro strategies being utilized in laboratories around the world to improve understanding of the biological performance of intracortical, brain-implanted microdevices. Of particular interest to the current review are in vitro models for studying cell responses to penetrating intracortical devices and their materials, such as electrode arrays used for brain computer interface (BCI) and deep brain stimulation electrode probes implanted through the cortex. A background on the neural interface challenge is presented, followed by discussion of relevant in vitro culture strategies and their advantages and disadvantages. Future development of 2D culture models that exhibit developmental changes capable of mimicking normal, postnatal development will form the basis for more complex accurate predictive models in the future. Although not within the scope of this review, innovations in 3D scaffold technologies and microfluidic constructs will further improve the utility of in vitro approaches. (c) 2016 Elsevier Ltd. All rights reserved.
C1 [Gilmour, A. D.; Woolley, A. J.; Poole-Warren, L. A.; Green, R. A.] Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia.
   [Thomson, C. E.] Univ Alaska Fairbanks, Dept Vet Med, Fairbanks, AK 99775 USA.
   [Woolley, A. J.] Univ Western Sydney, Sydney, NSW, Australia.
RP Gilmour, AD (reprint author), Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia.
EM a.gilmour@unsw.edu.au
CR ABEMAYOR E, 1989, ENVIRON HEALTH PERSP, V80, P3, DOI 10.2307/3430727
   Achyuta AKH, 2010, MACROMOL BIOSCI, V10, P872, DOI 10.1002/mabi.200900451
   Adeeb N, 2014, BRAIN BEHAV, V4, P105, DOI 10.1002/brb3.207
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Aregueta-Robles U. A., 2014, FRONT NEUROENG, V7, P1
   Astashkina A, 2012, PHARMACOL THERAPEUT, V134, P82, DOI 10.1016/j.pharmthera.2012.01.001
   Ayoub AE, 2003, J NEUROSCI, V23, P7759
   Barnett SC, 2013, NEUROSCIENTIST, V19, P442, DOI 10.1177/1073858412465655
   Barrese JC, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/6/066014
   BELLAMKONDA R, 1995, J NEUROSCI RES, V41, P501, DOI 10.1002/jnr.490410409
   Benavente JJM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090189
   Berghaus LJ, 2010, COMP IMMUNOL MICROB, V33, P443, DOI 10.1016/j.cimid.2009.07.001
   BETHEA CL, 1987, MOL CELL ENDOCRINOL, V50, P211, DOI 10.1016/0303-7207(87)90019-0
   Biran R, 2005, EXP NEUROL, V195, P115, DOI 10.1016/j.expneurol.2005.04.020
   Bjornsson CS, 2006, J NEURAL ENG, V3, P196, DOI 10.1088/1741-2560/3/3/002
   Blaise GA, 2005, TOXICOLOGY, V208, P177, DOI 10.1016/j.tox.2004.11.032
   Braune S, 2013, BIOINTERPHASES, V8, DOI 10.1186/1559-4106-8-33
   Bridges Amanda W, 2008, J Diabetes Sci Technol, V2, P984
   BRISMAR T, 1995, GLIA, V15, P231, DOI 10.1002/glia.440150305
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   Brodbeck WG, 2009, CURR OPIN HEMATOL, V16, P53, DOI 10.1097/MOH.0b013e32831ac52e
   Bronstein JM, 2011, ARCH NEUROL-CHICAGO, V68, P165, DOI 10.1001/archneurol.2010.260
   Bryers JD, 2012, BIOTECHNOL BIOENG, V109, P1898, DOI 10.1002/bit.24559
   Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034
   Busch SA, 2010, J NEUROSCI, V30, P255, DOI 10.1523/JNEUROSCI.3705-09.2010
   Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599
   CHAO CC, 1992, J IMMUNOL, V149, P2736
   Chen HuiLiang, 2005, Chinese Journal of Rabbit Farming, P22
   Chen L, 2004, BIOMACROMOLECULES, V5, P238, DOI 10.1021/bm0344102
   Choi NW, 2007, NAT MATER, V6, P908, DOI 10.1038/nmat2022
   Cogan SF, 2008, ANNU REV BIOMED ENG, V10, P275, DOI 10.1146/annurev.bioeng.10.061807.160518
   COOKSON MR, 1994, TOXICOL IN VITRO, V8, P351, DOI 10.1016/0887-2333(94)90156-2
   Craighead HG, 1998, BIOMED MICRODEVICES, V1, P49, DOI 10.1023/A:1009982306118
   Cullen DK, 2007, ANN BIOMED ENG, V35, P835, DOI 10.1007/s10439-007-9292-z
   Daud N. Mohd, 2014, J ORTHOP TRANSL, V2, P1
   De Faveri Sara, 2014, Front Neuroeng, V7, P7, DOI 10.3389/fneng.2014.00007
   DENISDONINI S, 1984, NATURE, V307, P641, DOI 10.1038/307641a0
   Deverman BE, 2009, NEURON, V64, P61, DOI 10.1016/j.neuron.2009.09.002
   Diemel LT, 2003, J NEUROSCI RES, V74, P858, DOI 10.1002/jnr.10837
   Dobolyi A, 2012, INT J MOL SCI, V13, P8219, DOI 10.3390/ijms13078219
   DRUBIN DG, 1985, J CELL BIOL, V101, P1799, DOI 10.1083/jcb.101.5.1799
   Dunstan RW, 2011, TOXICOL PATHOL, V39, P988, DOI 10.1177/0192623311419163
   Ekdahl KN, 2011, ADV DRUG DELIVER REV, V63, P1042, DOI 10.1016/j.addr.2011.06.012
   ENG LF, 1994, BRAIN PATHOL, V4, P229, DOI 10.1111/j.1750-3639.1994.tb00838.x
   Ereifej ES, 2013, J NEUROSCI METH, V217, P17, DOI 10.1016/j.jneumeth.2013.04.023
   Ereifej ES, 2013, J BIOMED MATER RES A, V101, P1743, DOI 10.1002/jbm.a.34480
   Evans TA, 2014, EXP NEUROL, V254, P109, DOI 10.1016/j.expneurol.2014.01.013
   Fahmy GH, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00129
   Feldmann M., 2014, J BIOL METHODS, V1, P11
   Fennrich Stefan, 1996, Methods in Cell Science, V18, P283, DOI 10.1007/BF00127905
   Fernandez Eduardo, 2014, Front Neuroeng, V7, P24, DOI 10.3389/fneng.2014.00024
   Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195
   Filous AR, 2010, DEV NEUROBIOL, V70, P826, DOI 10.1002/dneu.20820
   Fini M, 2003, J Appl Biomater Biomech, V1, P155
   Fitch MT, 1999, J NEUROSCI, V19, P8182
   Fornasiero EF, 2014, NEUROMETHODS, V86, pVII
   Francis KR, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.22
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Freshney I, 2001, CELL BIOL TOXICOL, V17, P213, DOI 10.1023/A:1012572930721
   Freshney R. I., 2005, CULTURE CELLS TISSUE
   Gao HM, 2002, J NEUROCHEM, V81, P1285, DOI 10.1046/j.1471-4159.2002.00928.x
   Gao J, 2006, P NATL ACAD SCI USA, V103, P16681, DOI 10.1073/pnas.0606237103
   GARCIAABREU J, 1995, J NEUROSCI RES, V40, P471, DOI 10.1002/jnr.490400406
   Geraghty R. J., 2014, BRIT J CANCER, V111, P1, DOI DOI 10.1038/BJC.2014.166
   Gilletti A, 2006, J NEURAL ENG, V3, P189, DOI 10.1088/1741-2560/3/3/001
   Gilmour AD, 2013, TOXICOL ENVIRON CHEM, V95, P1129, DOI 10.1080/02772248.2013.844429
   Goding JA, 2015, J MATER CHEM B, V3, P5058, DOI 10.1039/c5tb00384a
   Goldshmit Y, 2014, BRAIN BEHAV, V4, P187, DOI 10.1002/brb3.172
   Gottlieb DI, 2002, ANNU REV NEUROSCI, V25, P381, DOI 10.1146/annurev.neuro.25.112701.142904
   Green RA, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/5/056017
   Green RA, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/1/016009
   Green RA, 2013, IEEE ENG MED BIO, P6957, DOI 10.1109/EMBC.2013.6611158
   Green RA, 2010, BIOMATERIALS, V31, P886, DOI 10.1016/j.biomaterials.2009.09.099
   Green RA, 2010, ACTA BIOMATER, V6, P63, DOI 10.1016/j.actbio.2009.06.030
   Green RA, 2009, BIOMATERIALS, V30, P3637, DOI 10.1016/j.biomaterials.2009.03.043
   Greene L.A., 1998, CULTURING NERVE CELL
   GREENE LA, 1982, DEV BIOL, V91, P305, DOI 10.1016/0012-1606(82)90037-9
   Gregg JM, 2014, EXP NEUROL, V253, P197
   Groothuis J, 2014, BRAIN STIMUL, V7, P1, DOI 10.1016/j.brs.2013.07.001
   Grotenhuis N, 2014, BRIT J SURG, V101, P983, DOI 10.1002/bjs.9523
   Guillemin GJ, 2004, J LEUKOCYTE BIOL, V75, P388, DOI 10.1189/jlb.0303114
   Gunasekera B, 2015, ACS CHEM NEUROSCI, V6, P68, DOI 10.1021/cn5002864
   Hamby ME, 2006, GLIA, V54, P566, DOI 10.1002/glia.20411
   Harris James P., 2013, Critical Reviews in Biomedical Engineering, V41, P435
   Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483
   He W, 2005, BIOMATERIALS, V26, P2983, DOI 10.1016/j.biomaterials.2004.08.021
   He W., 2014, INT J COMPUT INTEG M, P1, DOI DOI 10.1080/0951192X.2013.874595
   He YR, 2014, STROKE, V45, P2514, DOI 10.1161/STROKEAHA.114.005427
   Hetrick EM, 2007, BIOMATERIALS, V28, P4571, DOI 10.1016/j.biomaterials.2007.06.036
   Hewett JA, 2009, J NEUROCHEM, V110, P1717, DOI 10.1111/j.1471-4159.2009.06288.x
   Holecko MM, 2005, J NEURAL ENG, V2, P97, DOI 10.1088/1741-2560/2/4/005
   Huh D, 2011, TRENDS CELL BIOL, V21, P745, DOI 10.1016/j.tcb.2011.09.005
   Ignatius AA, 1996, BIOMATERIALS, V17, P831, DOI 10.1016/0142-9612(96)81421-9
   Ishikawa M, 1996, Mult Scler, V2, P91
   Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208
   John P. M. S., 1997, J NEUROSCI METH, V75, P171
   Kam L, 2002, BIOMATERIALS, V23, P511, DOI 10.1016/S0142-9612(01)00133-8
   Kam L, 1999, BIOMATERIALS, V20, P2343, DOI 10.1016/S0142-9612(99)00163-5
   Kang K, 2014, GLIA, V62, P1328, DOI 10.1002/glia.22684
   Karumbaiah L, 2013, BIOMATERIALS, V34, P8061, DOI 10.1016/j.biomaterials.2013.07.016
   Kawano H, 2012, CELL TISSUE RES, V349, P169, DOI 10.1007/s00441-012-1336-5
   Keller PJ, 2015, NAT METHODS, V12, P27, DOI 10.1038/nmeth.3214
   KEMPERMANN G, 2006, ADULT NEUROGENESIS S
   Kerstetter A.E., 2012, ISOL CULT SPINAL COR, V814, P93
   Kim S, 2009, EUR J PHARM BIOPHARM, V71, P420, DOI 10.1016/j.ejpb.2008.09.021
   Kim YJ, 2000, BIOMATERIALS, V21, P121, DOI 10.1016/S0142-9612(99)00137-4
   Klapka N, 2006, J NEUROTRAUM, V23, P422, DOI 10.1089/neu.2006.23.422
   Kou PM, 2011, J BIOMED MATER RES A, V96A, P239, DOI 10.1002/jbm.a.32971
   Kozai TDY, 2012, NAT MATER, V11, P1065, DOI [10.1038/NMAT3468, 10.1038/nmat3468]
   Kozai TDY, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/6/066001
   Kunze A, 2011, BIOMATERIALS, V32, P2088, DOI 10.1016/j.biomaterials.2010.11.047
   Kyritsis N, 2014, TRENDS CELL BIOL, V24, P128, DOI 10.1016/j.tcb.2013.08.004
   LAPING NJ, 1994, BRAIN PATHOL, V4, P259, DOI 10.1111/j.1750-3639.1994.tb00841.x
   Leach Jennie B, 2010, Front Neuroeng, V2, P18, DOI 10.3389/neuro.16.018.2009
   Lebedev M, 2014, TRANSL NEUROSCI, V5, P99, DOI 10.2478/s13380-014-0212-z
   Lebedev MA, 2006, TRENDS NEUROSCI, V29, P536, DOI 10.1016/j.tins.2006.07.004
   Lee JY, 2015, RSC ADV, V5, P39228, DOI 10.1039/c5ra03294f
   Lee K, 2004, BIOSENS BIOELECTRON, V20, P404, DOI 10.1016/j.bios.2004.02.005
   Lee KK, 2004, J MICROMECH MICROENG, V14, P32, DOI 10.1088/0960-1317/14/1/305
   Leung BK, 2008, BIOMATERIALS, V29, P3289, DOI 10.1016/j.biomaterials.2008.03.045
   Lewis GP, 2003, INT REV CYTOL, V230, P263, DOI 10.1016/S0074-7696(03)30005-1
   Li XJ, 2012, BIOANALYSIS, V4, P1509, DOI [10.4155/bio.12.133, 10.4155/BIO.12.133]
   Liao LJ, 2008, P NATL ACAD SCI USA, V105, P15281, DOI 10.1073/pnas.0804678105
   Liu W, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-5
   Liu X, 2011, BIOMATERIALS, V32, P7309, DOI 10.1016/j.biomaterials.2011.06.047
   London A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00034
   Magrez A, 2006, NANO LETT, V6, P1121, DOI 10.1021/nl060162e
   Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601
   Maqsood MI, 2013, CELL BIOL INT, V37, P1038, DOI 10.1002/cbin.10137
   Martinez Fernando O, 2014, F1000Prime Rep, V6, P13, DOI 10.12703/P6-13
   Massia SP, 2004, J BIOMED MATER RES A, V68A, P177, DOI 10.1002/jbm.a.20009
   Matsutani S, 1997, GLIA, V20, P1, DOI 10.1002/(SICI)1098-1136(199705)20:1<1::AID-GLIA1>3.0.CO;2-E
   Matyash V, 2010, BRAIN RES REV, V63, P2, DOI 10.1016/j.brainresrev.2009.12.001
   MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890
   McConnell GC, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/5/056003
   MCKEON RJ, 1991, J NEUROSCI, V11, P3398
   Merrill DR, 2005, J NEUROSCI METH, V141, P171, DOI 10.1016/j.jneumeth.2004.10.020
   Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005
   Middeldorp J, 2010, DEVELOPMENT, V137, P313, DOI 10.1242/dev.041632
   Miyazaki I, 1999, NEUROCHEM RES, V24, P857, DOI 10.1023/A:1020953913490
   Morrison B, 2011, STUD MECHANOBIOL TIS, V3, P247, DOI 10.1007/8415_2011_79
   Mosser D.M., 2008, CURRENT PROTOCOLS IM, V83
   Motlagh D, 2006, BIOMATERIALS, V27, P4315, DOI 10.1016/j.biomaterials.2006.04.010
   Naik P, 2012, J PHARM SCI-US, V101, P1337, DOI 10.1002/jps.23022
   Nash B, 2011, J NEUROSCI, V31, P13028, DOI 10.1523/JNEUROSCI.1449-11.2011
   Nash B, 2011, J ANAT, V219, P44, DOI 10.1111/j.1469-7580.2010.01330.x
   Ndubaku U, 2008, ACTA HISTOCHEM, V110, P182, DOI 10.1016/j.acthis.2007.10.003
   Nyga A, 2011, J CELL COMMUN SIGNAL, V5, P239, DOI 10.1007/s12079-011-0132-4
   Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207
   Pilling D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007475
   Polikov VS, 2006, BIOMATERIALS, V27, P5368, DOI 10.1016/j.biomaterials.2006.06.018
   Polikov VS, 2009, J NEUROSCI METH, V181, P170, DOI 10.1016/j.jneumeth.2009.05.002
   Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015
   Poole-Warren LA, 2008, APPL SURF SCI, V255, P519, DOI 10.1016/j.apsusc.2008.06.062
   Potter SM, 2001, J NEUROSCI METH, V110, P17, DOI 10.1016/S0165-0270(01)00412-5
   Ravikumar M, 2014, BIOMATERIALS, V35, P8049, DOI 10.1016/j.biomaterials.2014.05.084
   Reilly JF, 1998, GLIA, V22, P202, DOI 10.1002/(SICI)1098-1136(199802)22:2<202::AID-GLIA11>3.0.CO;2-1
   Ren D, 2003, BRAIN RES BULL, V61, P547, DOI 10.1016/S0361-9230(03)00193-X
   Reuss B, 2003, J NEUROSCI, V23, P6404
   Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591
   ROSE TL, 1990, IEEE T BIO-MED ENG, V37, P1118, DOI 10.1109/10.61038
   ROUSCHE PJ, 1992, ANN BIOMED ENG, V20, P413, DOI 10.1007/BF02368133
   Saneinejad S, 1998, J BIOMED MATER RES, V42, P13, DOI 10.1002/(SICI)1097-4636(199810)42:1<13::AID-JBM3>3.0.CO;2-R
   Saura J, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-26
   Saxena T, 2013, BIOMATERIALS, V34, P4703, DOI 10.1016/j.biomaterials.2013.03.007
   Schachtrup C, 2010, J NEUROSCI, V30, P5843, DOI 10.1523/JNEUROSCI.0137-10.2010
   Schildge S., 2013, JOVE-J VIS EXP, V71, P1
   Schutte RJ, 2009, J BIOMED MATER RES A, V88A, P128, DOI 10.1002/jbm.a.31863
   Schwartz AB, 2004, ANNU REV NEUROSCI, V27, P487, DOI 10.1146/annurev.neuro.27.070203.144233
   Schwarz DA, 2014, NAT METHODS, V11, P670, DOI [10.1038/NMETH.2936, 10.1038/nmeth.2936]
   Seymour JP, 2007, BIOMATERIALS, V28, P3594, DOI 10.1016/j.biomaterials.2007.03.024
   SHANNON RV, 1992, IEEE T BIO-MED ENG, V39, P424, DOI 10.1109/10.126616
   Shapiro LA, 2005, BRAIN RES, V1040, P81, DOI 10.1016/j.brainres.2005.01.098
   Shechter R, 2013, TRENDS MOL MED, V19, P135, DOI 10.1016/j.molmed.2012.11.007
   Shin S, 2007, STEM CELLS, V25, P1298, DOI 10.1634/stemcells.2006-0660
   Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326
   Simons M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a020479
   Singh A, 2003, BIOMATERIALS, V24, P5083, DOI 10.1016/S0142-9612(03)00424-1
   Sivaraman KM, 2013, ADV HEALTHC MATER, V2, P591, DOI 10.1002/adhm.201200282
   SMETANA K, 1993, J MATER SCI-MATER M, V4, P526, DOI 10.1007/BF00120134
   Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8
   Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002
   Sommakia S., 2014, FRONT NEUROENG, V7, P1
   Sommakia S, 2014, CURR OPIN SOLID ST M, V18, P319, DOI 10.1016/j.cossms.2014.07.005
   Sorensen A, 2008, GLIA, V56, P750, DOI 10.1002/glia.20650
   Stacey G, 2001, CELL BIOL TOXICOL, V17, P319, DOI 10.1023/A:1012585300679
   Stroncek J. D., 2008, INDWELLING NEURAL IM, P1
   Suzuki T, 2012, EUR J NEUROSCI, V36, P3653, DOI 10.1111/j.1460-9568.2012.08280.x
   Thelin J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016267
   Thomson CE, 2008, EUR J NEUROSCI, V28, P1518, DOI 10.1111/j.1460-9568.2008.06415.x
   Tresco Patrick A., 2011, Critical Reviews in Biomedical Engineering, V39, P29
   Tsai HH, 2012, SCIENCE, V337, P358, DOI 10.1126/science.1222381
   Turner AMP, 2000, J BIOMED MATER RES, V51, P430, DOI 10.1002/1097-4636(20000905)51:3<430::AID-JBM18>3.0.CO;2-C
   Turner JN, 1999, EXP NEUROL, V156, P33, DOI 10.1006/exnr.1998.6983
   Unsworth CP, 2011, BIOMATERIALS, V32, P6541, DOI 10.1016/j.biomaterials.2011.05.041
   van de Kamp J., 2013, STEM CELLS INT, V2013, DOI DOI 10.1155/2013/892065
   van Duinen V, 2015, CURR OPIN BIOTECH, V35, P118, DOI 10.1016/j.copbio.2015.05.002
   van Oeveren W., 2013, SCIENTIFICA CAIRO, V2013, P1
   VERDERBER L, 1995, INVEST OPHTH VIS SCI, V36, P1137
   Verreck FAW, 2006, J LEUKOCYTE BIOL, V79, P285, DOI 10.1189/jlb.0105015
   VESCOVI AL, 1993, NEURON, V11, P951, DOI 10.1016/0896-6273(93)90124-A
   Wachs FP, 2006, J NEUROPATH EXP NEUR, V65, P358, DOI 10.1097/01.jnen.0000218444.53405.f0
   Wadhwa R, 2006, J CONTROL RELEASE, V110, P531, DOI 10.1016/j.jconrel.2005.10.027
   WAINWRIGHT MS, 1995, J NEUROSCI, V15, P676
   WALIVAARA B, 1994, BIOMATERIALS, V15, P827, DOI 10.1016/0142-9612(94)90038-8
   Wang MO, 2013, BIOMACROMOLECULES, V14, P1321, DOI 10.1021/bm301962f
   Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013
   Weng B, 2012, SYNTHETIC MET, V162, P1375, DOI 10.1016/j.synthmet.2012.05.022
   White RE, 2010, J COMP NEUROL, V518, P1370, DOI 10.1002/cne.22282
   Williams JC, 1999, BRAIN RES PROTOC, V4, P303, DOI 10.1016/S1385-299X(99)00034-3
   Williams JC, 2007, J NEURAL ENG, V4, P410, DOI 10.1088/1741-2560/4/4/007
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Winn SR, 2000, BIOMATERIALS, V21, P2413, DOI 10.1016/S0142-9612(00)00109-5
   Winslow BD, 2010, BIOMATERIALS, V31, P1558, DOI 10.1016/j.biomaterials.2009.11.049
   Woehrling EK, 2011, NEUROTOX RES, V19, P472, DOI 10.1007/s12640-010-9202-2
   Woolley AJ, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026007
   Woolley AJ, 2011, J NEUROSCI METH, V201, P67, DOI 10.1016/j.jneumeth.2011.07.012
   Wu VW, 1998, J NEUROSCI RES, V51, P675, DOI 10.1002/(SICI)1097-4547(19980315)51:6<675::AID-JNR2>3.0.CO;2-8
   Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01
   Xu LY, 2015, BIOMATER SCI-UK, V3, P250, DOI [10.1039/c4bm00245h, 10.1039/C4BM00245H]
   Yang JY, 2005, ACTA BIOMATER, V1, P125, DOI 10.1016/j.actbio.2004.09.006
   Yue ZL, 2011, BIOMATERIALS, V32, P4714, DOI 10.1016/j.biomaterials.2011.03.032
   Zang R., 2012, INT J BIOTECHNOL WEL, V1, P31, DOI DOI 10.6000/1927-3037.2012.01.01.02.
   Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069
   Zhang Y, 2010, CURR OPIN NEUROBIOL, V20, P588, DOI 10.1016/j.conb.2010.06.005
   Zhang YT, 2010, GLIA, V58, P964, DOI 10.1002/glia.20978
   ZHAO QH, 1993, J BIOMED MATER RES, V27, P379, DOI 10.1002/jbm.820270311
   Zhong YH, 2008, J R SOC INTERFACE, V5, P957, DOI 10.1098/rsif.2008.0071
   Zimmerli W, 2014, J INTERN MED, V276, P111, DOI 10.1111/joim.12233
NR 231
TC 9
Z9 10
U1 6
U2 89
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2016
VL 91
BP 23
EP 43
DI 10.1016/j.biomaterials.2016.03.011
PG 21
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DK0OK
UT WOS:000374611900003
PM 26994876
DA 2018-10-20
ER

PT J
AU Rowland, CR
   Colucci, LA
   Guilak, F
AF Rowland, Christopher R.
   Colucci, Lina A.
   Guilak, Farshid
TI Fabrication of anatomically-shaped cartilage constructs using
   decellularized cartilage-derived matrix scaffolds
SO BIOMATERIALS
LA English
DT Article
DE Articular cartilage; Decellularization; Tissue engineering; Mesenchymal
   stem cell; Cell-mediated contraction; Ice-templating
ID MESENCHYMAL STEM-CELLS; COLLAGEN-GLYCOSAMINOGLYCAN SCAFFOLDS;
   ARTICULAR-CARTILAGE; EXTRACELLULAR-MATRIX; CROSS-LINKING; IN-VITRO;
   CHONDROGENIC DIFFERENTIATION; GAG SCAFFOLDS; PORE-SIZE; PROMOTE
   CHONDROGENESIS
AB The native extracellular matrix of cartilage contains entrapped growth factors as well as tissue-specific epitopes for cell-matrix interactions, which make it a potentially attractive biomaterial for cartilage tissue engineering. A limitation to this approach is that the native cartilage extracellular matrix possesses a pore size of only a few nanometers, which inhibits cellular infiltration. Efforts to increase the pore size of cartilage-derived matrix (CDM) scaffolds dramatically attenuate their mechanical properties, which makes them susceptible to cell-mediated contraction. In previous studies, we have demonstrated that collagen crosslinking techniques are capable of preventing cell-mediated contraction in CDM disks. In the current study, we investigated the effects of CDM concentration and pore architecture on the ability of CDM scaffolds to resist cell-mediated contraction. Increasing CDM concentration significantly increased scaffold mechanical properties, which played an important role in preventing contraction, and only the highest CDM concentration (11% wow) was able to retain the original scaffold dimensions. However, the increase in CDM concentration led to a concomitant decrease in porosity and pore size. Generating a temperature gradient during the freezing process resulted in unidirectional freezing, which aligned the formation of ice crystals during the freezing process and in turn produced aligned pores in CDM scaffolds. These aligned pores increased the pore size of CDM scaffolds at all CDM concentrations, and greatly facilitated infiltration by mesenchymal stem cells (MSCs). These methods were used to fabricate of anatomically-relevant CDM hemispheres. CDM hemispheres with aligned pores supported uniform MSC infiltration and matrix deposition. Furthermore, these CDM hemispheres retained their original architecture and did not contract, warp, curl, or splay throughout the entire 28-day culture period. These findings demonstrate that given the appropriate fabrication parameters, CDM scaffolds are capable of maintaining complex structures that support MSC chondrogenesis. (c) 2016 Elsevier Ltd. All rights reserved.
C1 [Rowland, Christopher R.; Colucci, Lina A.; Guilak, Farshid] Washington Univ, Dept Orthopaed Surg, 3210 McKinley Res Bldg, St Louis, MO 63110 USA.
   [Rowland, Christopher R.; Colucci, Lina A.; Guilak, Farshid] Washington Univ, Dept Dev Biol, St Louis, MO 63110 USA.
   [Rowland, Christopher R.; Colucci, Lina A.; Guilak, Farshid] Washington Univ, Dept Biomed Engn, St Louis, MO 63110 USA.
   [Rowland, Christopher R.; Colucci, Lina A.; Guilak, Farshid] St Louis Hosp, Shriners Hosp Children, 3210 McKinley Res Bldg, St Louis, MO 63110 USA.
RP Guilak, F (reprint author), Washington Univ, Dept Orthopaed Surg, 3210 McKinley Res Bldg, St Louis, MO 63110 USA.; Guilak, F (reprint author), St Louis Hosp, Shriners Hosp Children, 3210 McKinley Res Bldg, St Louis, MO 63110 USA.
EM guilak@wustl.edu
OI Rowland, Chris/0000-0003-0228-4054; Guilak, Farshid/0000-0001-7380-0330;
   /0000-0003-1264-3815
FU NIH [P01 CA47741, AR50245, AR48852, AG15768, AR48182, AG46927, OD01070];
   Collaborative Research Center, AO Foundation, Davos, Switzerland;
   Arthritis Foundation; Nancy Taylor Foundation for Chronic Diseases; Lord
   Foundation Grant through the Shared Materials Instrumentation Facility
   (SMIF)
FX We thank Dr. Nelson Chao for providing bone marrow (NIH grant P01
   CA47741), Dr. Brad Estes, Dr. Frank Moutos, and Steven Earp of the Pratt
   Student Shop for assistance in machining the hemisphere molds, and
   Katherine Glass and Jonathan Brunger for assistance with various aspects
   of the project. This work was supported in part by NIH grants AR50245,
   AR48852, AG15768, AR48182, AG46927, OD01070, the Collaborative Research
   Center, AO Foundation, Davos, Switzerland, the Arthritis Foundation, the
   Nancy Taylor Foundation for Chronic Diseases, and the Lord Foundation
   Grant through the Shared Materials Instrumentation Facility (SMIF).
CR Almeida HV, 2015, ADV HEALTHC MATER, V4, P1043, DOI 10.1002/adhm.201400687
   Almeida HV, 2014, ACTA BIOMATER, V10, P4400, DOI 10.1016/j.actbio.2014.05.030
   Benders KEM, 2014, CARTILAGE, V5, P221, DOI 10.1177/1947603514535245
   Bhumiratana S, 2014, P NATL ACAD SCI USA, V111, P6940, DOI 10.1073/pnas.1324050111
   Chang CH, 2014, J BIOMED MATER RES A, V102, P2248, DOI 10.1002/jbm.a.34897
   Chen CC, 2012, J ORTHOP RES, V30, P393, DOI 10.1002/jor.21541
   Cheng CW, 2014, BIOTECHNOL ADV, V32, P462, DOI 10.1016/j.biotechadv.2013.12.012
   Cheng NC, 2013, TISSUE ENG PT A, V19, P484, DOI [10.1089/ten.tea.2012.0384, 10.1089/ten.TEA.2012.0384]
   Cheng NC, 2011, REGEN MED, V6, P81, DOI [10.2217/rme.10.87, 10.2217/RME.10.87]
   Cheng NC, 2009, TISSUE ENG PT A, V15, P231, DOI 10.1089/ten.tea.2008.0253
   Corin KA, 2010, BIOMATERIALS, V31, P4835, DOI 10.1016/j.biomaterials.2010.01.149
   DAYAN D, 1989, HISTOCHEMISTRY, V93, P27, DOI 10.1007/BF00266843
   Deville S, 2007, ACTA MATER, V55, P1965, DOI 10.1016/j.actamat.2006.11.003
   Deville S, 2006, BIOMATERIALS, V27, P5480, DOI 10.1016/j.biomaterials.2006.06.028
   Deville S, 2010, MATERIALS, V3, P1913, DOI 10.3390/ma3031913
   Diekman BO, 2010, TISSUE ENG PT A, V16, P523, DOI [10.1089/ten.tea.2009.0398, 10.1089/ten.TEA.2009.0398]
   Ding M, 1999, J BIOMECH, V32, P323, DOI 10.1016/S0021-9290(98)00176-6
   Elder BD, 2009, BIOMATERIALS, V30, P3749, DOI 10.1016/j.biomaterials.2009.03.050
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Garrigues NW, 2014, J BIOMED MATER RES A, V102, P3998, DOI 10.1002/jbm.a.35068
   Geidobler R, 2013, EUR J PHARM BIOPHARM, V85, P214, DOI 10.1016/j.ejpb.2013.04.014
   Ghanavi P, 2012, CELL TISSUE RES, V347, P643, DOI 10.1007/s00441-012-1323-x
   Gong YY, 2011, BIOMATERIALS, V32, P2265, DOI 10.1016/j.biomaterials.2010.11.078
   Gutierrez MC, 2008, CHEM MATER, V20, P634, DOI 10.1021/cm702028z
   Han EH, 2008, CLIN ORTHOP RELAT R, V466, P1912, DOI 10.1007/s11999-008-0291-7
   Harley BA, 2007, ACTA BIOMATER, V3, P463, DOI 10.1016/j.aetbio.2006.12.009
   Haugh MG, 2011, TISSUE ENG PT A, V17, P1201, DOI [10.1089/ten.tea.2010.0590, 10.1089/ten.TEA.2010.0590]
   Haugh MG, 2010, TISSUE ENG PART C-ME, V16, P887, DOI 10.1089/ten.TEC.2009.0422
   Huber M, 2000, INVEST RADIOL, V35, P573, DOI 10.1097/00004424-200010000-00003
   Huey DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027857
   Hung CT, 2003, J BIOMECH, V36, P1853, DOI 10.1016/S0021-9290(03)00213-6
   Jia SJ, 2012, J BIOSCI BIOENG, V113, P647, DOI 10.1016/j.jbiosc.2011.12.009
   JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772
   Kalson NS, 2010, INT J CLIN PRACT, V64, P1444, DOI 10.1111/j.1742-1241.2010.02420.x
   Kang HJ, 2014, J TISSUE ENG REGEN M, V8, P442, DOI 10.1002/term.1538
   Kheir E, 2011, J BIOMED MATER RES A, V99A, P283, DOI 10.1002/jbm.a.33171
   Korhonen RK, 2002, J BIOMECH, V35, P903, DOI 10.1016/S0021-9290(02)00052-0
   Lee CR, 2001, BIOMATERIALS, V22, P3145, DOI 10.1016/S0142-9612(01)00067-9
   Lu HX, 2010, BIOMATERIALS, V31, P5825, DOI 10.1016/j.biomaterials.2010.04.019
   MacBarb RF, 2014, TISSUE ENG PT A, V20, P3290, DOI [10.1089/ten.tea.2013.0694, 10.1089/ten.TEA.2013.0694]
   Madaghiele M, 2008, J BIOMED MATER RES A, V85A, P757, DOI 10.1002/jbm.a.31517
   Mandal BB, 2013, MACROMOL BIOSCI, V13, P48, DOI 10.1002/mabi.201200230
   Matsiko A, 2015, TISSUE ENG PT A, V21, P486, DOI [10.1089/ten.tea.2013.0545, 10.1089/ten.TEA.2013.0545]
   Moradi A, 2016, J BIOMED MATER RES A, V104, P245, DOI 10.1002/jbm.a.35561
   Moradi A, 2014, SCI TECHNOL ADV MAT, V15, DOI 10.1088/1468-6996/15/6/065001
   Moutos FT, 2010, MACROMOL BIOSCI, V10, P1355, DOI 10.1002/mabi.201000124
   Munch E, 2009, J AM CERAM SOC, V92, P1534, DOI 10.1111/j.1551-2916.2009.03087.x
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   Pawelec KM, 2014, APPL PHYS REV, V1, DOI 10.1063/1.4871083
   Pawelec KM, 2014, MAT SCI ENG C-MATER, V37, P141, DOI 10.1016/j.msec.2014.01.009
   Peretti GM, 1998, J ORTHOPAED RES, V16, P89, DOI 10.1002/jor.1100160115
   Pfeiffer E, 2008, OSTEOARTHR CARTILAGE, V16, P1237, DOI 10.1016/j.joca.2008.02.014
   Philip D, 2005, STEM CELLS, V23, P288, DOI 10.1634/stemcells.2002.0109
   Reddy GK, 1996, CLIN BIOCHEM, V29, P225, DOI 10.1016/0009-9120(96)00003-6
   Rosenzweig DH, 2012, ACTA BIOMATER, V8, P3333, DOI 10.1016/j.actbio.2012.05.032
   Rowland CR, 2013, BIOMATERIALS, V34, P5802, DOI 10.1016/j.biomaterials.2013.04.027
   Schwarz S, 2015, J TISSUE ENG REGEN M, V9, pE239, DOI 10.1002/term.1650
   Schwarz S, 2012, TISSUE ENG PT A, V18, P2195, DOI [10.1089/ten.tea.2011.0705, 10.1089/ten.TEA.2011.0705]
   Shin YS, 2014, INT J PEDIATR OTORHI, V78, P32, DOI 10.1016/j.ijporl.2013.10.014
   Solchaga LA, 2006, TISSUE ENG, V12, P1851, DOI 10.1089/ten.2006.12.1851
   Sung HW, 2003, J BIOMED MATER RES A, V64A, P427, DOI 10.1002/jbm.a.10346
   Sutherland AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121966
   Sutherland AJ, 2015, ADV HEALTHC MATER, V4, DOI 10.1002/adhm.201400165
   Torres DS, 2000, BIOMATERIALS, V21, P1607
   Utomo L, 2015, BIOMED MATER, V10, DOI 10.1088/1748-6041/10/1/015010
   Vickers SM, 2006, TISSUE ENG, V12, P1345, DOI 10.1089/ten.2006.12.1345
   Vickers SM, 2010, J ORTHOP RES, V28, P1184, DOI 10.1002/jor.21113
   Wang ZJ, 2014, GENET MOL RES, V13, P4599, DOI 10.4238/2014.June.18.2
   Wu X, 2010, ACTA BIOMATER, V6, P1167, DOI 10.1016/j.actbio.2009.08.041
   Xue JX, 2012, BIOMATERIALS, V33, P5832, DOI 10.1016/j.biomaterials.2012.04.054
   Yang F, 2006, BIOMATERIALS, V27, P4923, DOI 10.1016/j.biomaterials.2006.05.028
   Yang Q, 2008, BIOMATERIALS, V29, P2378, DOI 10.1016/j.biomaterials.2008.01.037
   Yang Q, 2011, CHINESE MED J-PEKING, V124, P3930, DOI 10.3760/cma.j.issn.0366-6999.2011.23.018
   Yang W, 2014, TRANSPL P, V46, P1247, DOI 10.1016/j.transproceed.2013.11.082
   Yang ZQ, 2010, TISSUE ENG PART C-ME, V16, P865, DOI [10.1089/ten.tec.2009.0444, 10.1089/ten.TEC.2009.0444]
   Zhang H, 2007, ADV MATER, V19, P1529, DOI 10.1002/adma.200700154
   Zhang YY, 2012, BIOMATERIALS, V33, P2926, DOI 10.1016/j.biomaterials.2012.01.006
   Zhao YH, 2013, CHINESE MED J-PEKING, V126, P3130, DOI 10.3760/cma.j.issn.0366-6999.20130212
NR 79
TC 23
Z9 25
U1 5
U2 87
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2016
VL 91
BP 57
EP 72
DI 10.1016/j.biomaterials.2016.03.012
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DK0OK
UT WOS:000374611900005
PM 26999455
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Ghuman, H
   Massensini, AR
   Donnelly, J
   Kim, SM
   Medberry, CJ
   Badylak, SF
   Modo, M
AF Ghuman, Harmanvir
   Massensini, Andre R.
   Donnelly, Julia
   Kim, Sung-Min
   Medberry, Christopher J.
   Badylak, Stephen F.
   Modo, Michel
TI ECM hydrogel for the treatment of stroke: Characterization of the host
   cell infiltrate
SO BIOMATERIALS
LA English
DT Article
DE Biomaterial; Delivery; Extracellular matrix; Injection; Magnetic
   resonance imaging; Stereotactic; Brain; Stroke; Hydrogel; Phenotypes;
   Neural progenitor; Macrophage
ID NEURAL STEM-CELLS; POLY(ETHYLENE GLYCOL)-BASED HYDROGELS; SOLUBILIZED
   EXTRACELLULAR-MATRIX; TERM BEHAVIORAL-ASSESSMENT; PORCINE
   URINARY-BLADDER; FOCAL CEREBRAL-ISCHEMIA; BIOLOGIC SCAFFOLDS; MACROPHAGE
   PHENOTYPE; IN-VIVO; REGENERATIVE MEDICINE
AB Brain tissue loss following stroke is irreversible with current treatment modalities. The use of an acellular extracellular matrix (ECM), formulated to produce a hydrogel in situ within the cavity formed by a stroke, was investigated as a method to replace necrotic debris and promote the infiltration of host brain cells. Based on magnetic resonance imaging measurements of lesion location and volume, different concentrations of ECM (0, 1, 2, 3, 4, 8 mg/mL) were injected at a volume equal to that of the cavity (14 days post stroke). Retention of ECM within the cavity occurred at concentrations >3 mg/mL. A significant cell infiltration into the ECM material in the lesion cavity occurred with an average of similar to 36,000 cells in the 8 mg/mL concentration within 24 h. An infiltration of cells with distances of >1500 mu m into the ECM hydrogel was observed, but the majority of cells were at the tissue/hydrogel boundary. Cells were typically of a microglia, macrophage, or neural and oligodendrocyte progenitor phenotype. At the 8 mg/mL concentration, similar to 60% of infiltrating cells were brain-derived phenotypes and 30% being infiltrating peripheral macrophages, polarizing toward an M2-like anti-inflammatory phenotype. These results suggest that an 8 mg/mL ECM concentration promotes a significant acute endogenous repair response that could potentially be exploited to treat stroke. (c) 2016 Elsevier Ltd. All rights reserved.
C1 [Ghuman, Harmanvir; Massensini, Andre R.; Medberry, Christopher J.; Badylak, Stephen F.; Modo, Michel] Univ Pittsburgh, McGowan Inst Regenerat Med, 3025 East Carson St, Pittsburgh, PA 15203 USA.
   [Ghuman, Harmanvir; Kim, Sung-Min; Medberry, Christopher J.; Badylak, Stephen F.; Modo, Michel] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15203 USA.
   [Massensini, Andre R.; Modo, Michel] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15203 USA.
   [Donnelly, Julia] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15203 USA.
   [Badylak, Stephen F.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15203 USA.
   [Massensini, Andre R.] Univ Fed Minas Gerais, Dept Physiol & Biophys, Belo Horizonte, MG, Brazil.
RP Modo, M (reprint author), Univ Pittsburgh, McGowan Inst Regenerat Med, 3025 East Carson St, Pittsburgh, PA 15203 USA.
EM modomm@upmc.edu
OI Modo, Michel/0000-0003-4436-735X; Ghuman, Harmanvir/0000-0002-9123-7796;
   Badylak, Stephen/0000-0003-3555-0689
FU Department of Health of the Commonwealth of Pennsylvania [4100061184];
   National Institute of Neurological Disorders and Stroke [R01NS08226];
   CAPES Foundation, Brazil; Vertex Pharmaceuticals
FX This study was funded by a seed grant from the Department of Health of
   the Commonwealth of Pennsylvania (4100061184) and the National Institute
   of Neurological Disorders and Stroke (R01NS08226). ARM was supported by
   a Fellowship from CAPES Foundation, Brazil. SFB and MM gratefully
   acknowledge support from Vertex Pharmaceuticals.
CR Agrawal V, 2010, P NATL ACAD SCI USA, V107, P3351, DOI 10.1073/pnas.0905851106
   Ashioti M, 2007, BRAIN RES, V1145, P177, DOI 10.1016/j.brainres.2007.01.111
   Aurand ER, 2014, STEM CELL RES, V12, P11, DOI 10.1016/j.scr.2013.09.013
   Aurand ER, 2012, J FUNCT BIOMATER, V3, P839, DOI 10.3390/jfb3040839
   Aurand ER, 2012, NEUROSCI RES, V72, P199, DOI 10.1016/j.neures.2011.12.005
   Badylak SF, 2014, ANN BIOMED ENG, V42, P1517, DOI 10.1007/s10439-013-0963-7
   Banerjee A, 2009, BIOMATERIALS, V30, P4695, DOI 10.1016/j.biomaterials.2009.05.050
   Beattie AJ, 2009, TISSUE ENG PT A, V15, P1119, DOI 10.1089/ten.tea.2008.0162
   Bible E, 2012, BIOMATERIALS, V33, P2858, DOI 10.1016/j.biomaterials.2011.12.033
   Bible E, 2009, NAT PROTOC, V4, P1440, DOI 10.1038/nprot.2009.156
   Bible E, 2009, BIOMATERIALS, V30, P2985, DOI 10.1016/j.biomaterials.2009.02.012
   Bjugstad KB, 2010, J BIOMED MATER RES A, V95A, P79, DOI 10.1002/jbm.a.32809
   Blakney AK, 2012, J BIOMED MATER RES A, V100A, P1375, DOI 10.1002/jbm.a.34104
   Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904
   Bracher M, 2013, BIOMATERIALS, V34, P6797, DOI 10.1016/j.biomaterials.2013.05.057
   Brown BN, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00510
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Cheeran B, 2009, NEUROREHAB NEURAL RE, V23, P97, DOI 10.1177/1545968308326636
   Crapo PM, 2014, TISSUE ENG PT A, V20, P313, DOI [10.1089/ten.tea.2013.0186, 10.1089/ten.TEA.2013.0186]
   Crapo PM, 2012, BIOMATERIALS, V33, P3539, DOI 10.1016/j.biomaterials.2012.01.044
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Dalise S, 2014, ARCH ITAL BIOL, V152, P190, DOI 10.12871/00039829201442
   Dearth CL, 2016, ACTA BIOMATER, V31, P50, DOI 10.1016/j.actbio.2015.11.043
   Duncan K, 2015, BRAIN RES, V1623, P160, DOI 10.1016/j.brainres.2015.03.007
   Encarnacion A, 2011, J NEUROSCI METH, V196, P247, DOI 10.1016/j.jneumeth.2011.01.010
   Farnebo S, 2014, TISSUE ENG PT A, V20, P1550, DOI [10.1089/ten.tea.2013.0207, 10.1089/ten.TEA.2013.0207]
   Fournier E, 2003, BIOMATERIALS, V24, P3311, DOI 10.1016/S0142-9612(03)00161-3
   Freytes DO, 2008, BIOMATERIALS, V29, P1630, DOI 10.1016/j.biomaterials.2007.12.014
   Gefen A, 2004, J BIOMECH, V37, P1339, DOI 10.1016/j.jbiomech.2003.12.032
   Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114
   Hosseini Y, 2015, INTEGR BIOL-UK, V7, P1432, DOI 10.1039/c5ib00207a
   Hsiao TW, 2015, BIOMATERIALS, V39, P124, DOI 10.1016/j.biomaterials.2014.10.062
   Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208
   Keane TJ, 2012, BIOMATERIALS, V33, P1771, DOI 10.1016/j.biomaterials.2011.10.054
   Leipzig ND, 2009, BIOMATERIALS, V30, P6867, DOI 10.1016/j.biomaterials.2009.09.002
   Ma Y., 2016, PROG NEUROBIOL
   Macaya DJ, 2013, BIOMATERIALS, V34, P3591, DOI 10.1016/j.biomaterials.2012.12.050
   Marcal H, 2012, REGEN MED, V7, P159, DOI [10.2217/RME.12.6, 10.2217/rme.12.6]
   Massensini AR, 2015, ACTA BIOMATER, V27, P116, DOI 10.1016/j.actbio.2015.08.040
   Mauney JR, 2015, ADV DRUG DELIVER REV, V82-83, P77, DOI 10.1016/j.addr.2014.10.016
   Medberry CJ, 2013, BIOMATERIALS, V34, P1033, DOI 10.1016/j.biomaterials.2012.10.062
   Meng FW, 2015, BIOMATERIALS, V46, P131, DOI 10.1016/j.biomaterials.2014.12.044
   Modo M, 2000, J NEUROSCI METH, V104, P99, DOI 10.1016/S0165-0270(00)00329-0
   Modo M, 2013, CURR OPIN NEUROL, V26, P626, DOI 10.1097/WCO.0000000000000031
   Modo Michel, 2009, J Exp Stroke Transl Med, V2, P52
   Mokarram N, 2012, BIOMATERIALS, V33, P8793, DOI 10.1016/j.biomaterials.2012.08.050
   Moreau F, 2012, STROKE, V43, P1837, DOI 10.1161/STROKEAHA.111.647859
   Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152
   Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751
   Piterina AV, 2009, INT J MOL SCI, V10, P4375, DOI 10.3390/ijms10104375
   Plantman S, 2013, BIOMED RES INT, DOI 10.1155/2013/981695
   Roll L, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00219
   Rossetti T., 2016, CELL TRANSPLANT
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Sicari BM, 2014, BIOMATERIALS, V35, P8605, DOI 10.1016/j.biomaterials.2014.06.060
   Simona BR, 2015, BIOMATER SCI-UK, V3, P586, DOI 10.1039/c4bm00416g
   Smith EJ, 2012, STEM CELLS, V30, P785, DOI 10.1002/stem.1024
   Stabenfeldt SE, 2010, TISSUE ENG PT A, V16, P3747, DOI [10.1089/ten.tea.2009.0837, 10.1089/ten.TEA.2009.0837]
   Stille M, 2013, J NEUROSCI METH, V219, P27, DOI 10.1016/j.jneumeth.2013.06.003
   Tate MC, 2002, CELL TRANSPLANT, V11, P283
   Taylor Z, 2004, J BIOMECH, V37, P1263, DOI 10.1016/j.jbiomech.2003.11.027
   Wolf MT, 2014, BIOMATERIALS, V35, P6838, DOI 10.1016/j.biomaterials.2014.04.115
NR 62
TC 23
Z9 26
U1 2
U2 59
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2016
VL 91
BP 166
EP 181
DI 10.1016/j.biomaterials.2016.03.014
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DK0OK
UT WOS:000374611900012
PM 27031811
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Chu, MQ
   Hai, WX
   Zhang, ZY
   Wo, FJ
   Wu, Q
   Zhang, ZF
   Shao, YX
   Zhang, D
   Jin, L
   Shi, DL
AF Chu, Maoquan
   Hai, Wangxi
   Zhang, Zheyu
   Wo, Fangjie
   Wu, Qiang
   Zhang, Zefei
   Shao, Yuxiang
   Zhang, Ding
   Jin, Lu
   Shi, Donglu
TI Melanin nanoparticles derived from a homology of medicine and food for
   sentinel lymph node mapping and photothermal in vivo cancer therapy
SO BIOMATERIALS
LA English
DT Article
DE Natural black sesame melanin; A homology of medicine and food;
   Sheet-like nanoparticles; Sentinel lymph node mapping; Cancer therapy
ID QUANTUM DOTS; INDOCYANINE GREEN; PHOTODYNAMIC THERAPY; BLUE-DYE;
   ANTIOXIDANT ACTIVITY; METHYLENE-BLUE; ISOSULFAN BLUE; SESAME; TEA;
   ANAPHYLAXIS
AB The use of non-toxic or low toxicity materials exhibiting dual functionality for use in sentinel lymph node (SLN) mapping and cancer therapy has attracted considerable attention during the past two decades. Herein, we report that the natural black sesame melanin (BSM) extracted from black sesame seeds (Sesamum indicum L.) shows exciting potential for SLN mapping and cancer photothermal therapy. Aqueous solutions of BSM under neutral and alkaline conditions can assemble into sheet-like nano particles ranging from 20 to 200 nm in size. The BSM nanoparticles were encapsulated by liposomes to improve their water solubility and the encapsulated and bare BSM nanoparticles were both non-toxic to cells. Furthermore, the liposome-encapsulated BSM nanoparticles (liposome-BSM) did not exhibit any long-term toxicity in mice. The liposome-BSM nanoparticles were subsequently used to passively target healthy and tumor-bearing mice SLNs, which were identified by the black color of the nanoparticles. BSM also strongly absorbed light in the near-infrared (NIR) range, which was rapidly converted to heat energy. Human esophagus carcinoma cells (Eca-109) were killed efficiently by liposome-BSM nanocomposites upon NIR laser irradiation. Furthermore, mouse tumor tissues grown from Eca-109 cells were seriously damaged by the photothermal effects of the liposome-BSM nanocomposites, with significant tumor growth suppression compared with controls. Given that BSM is a safe and nutritious biomaterial that can be easily obtained from black sesame seed, the results presented herein represent an important development in the use of natural biomaterials for clinical SLN mapping and cancer therapy. (c) 2016 Elsevier Ltd. All rights reserved.
C1 [Chu, Maoquan; Zhang, Zheyu; Wo, Fangjie; Wu, Qiang; Zhang, Zefei; Shao, Yuxiang; Zhang, Ding; Jin, Lu] Tongji Univ, Sch Life Sci & Technol, Shanghai East Hosp, Res Ctr Translat Med, Shanghai 200092, Peoples R China.
   [Hai, Wangxi] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200240, Peoples R China.
   [Shi, Donglu] Tongji Univ, Sch Med, Shanghai 200092, Peoples R China.
   [Shi, Donglu] Univ Cincinnati, Coll Engn & Appl Sci, Dept Mech & Mat Engn, Mat Sci & Engn Program, Cincinnati, OH 45221 USA.
RP Chu, MQ (reprint author), Tongji Univ, Sch Life Sci & Technol, Shanghai East Hosp, Res Ctr Translat Med, Shanghai 200092, Peoples R China.
EM mqchu98@tongji.edu.cn
FU National Natural Science Foundation of China [31370961]; Nanoscience
   Foundation of Shanghai [13NM1402000]; Program for New Century Excellent
   Talents in University [NCET-07-0618]
FX This work was supported in part by the National Natural Science
   Foundation of China (31370961), the Nanoscience Foundation of Shanghai
   (13NM1402000) and the Program for New Century Excellent Talents in
   University (No. NCET-07-0618).
CR Amr D, 2005, AM SURGEON, V71, P720
   [Anonymous], 2008, NAT REV UROL, V5, P67
   Ballou B, 2007, BIOCONJUGATE CHEM, V18, P389, DOI 10.1021/bc060261j
   Basu P, 2004, NAT BIOTECHNOL, V22, P263, DOI 10.1038/nbt0304-263
   Ben Othman S, 2015, FOOD CHEM, V175, P306, DOI 10.1016/j.foodchem.2014.11.155
   Bezu C, 2011, SURG ONCOL, V20, pE55, DOI 10.1016/j.suronc.2010.10.002
   Brisibe EA, 2009, FOOD CHEM, V115, P1240, DOI 10.1016/j.foodchem.2009.01.033
   Bronze-Uhle ES, 2013, J MOL STRUCT, V1047, P102, DOI 10.1016/j.molstruc.2013.04.061
   Cao YH, 1999, NATURE, V398, P381, DOI 10.1038/18793
   Catarci M, 1998, ANN SURG ONCOL, V5, P580, DOI 10.1007/BF02303825
   Cheng L, 2014, CHEM REV, V114, P10869, DOI 10.1021/cr400532z
   Chu MQ, 2013, BIOMATERIALS, V34, P4078, DOI 10.1016/j.biomaterials.2013.01.086
   Chu MQ, 2013, BIOMATERIALS, V34, P1820, DOI 10.1016/j.biomaterials.2012.11.027
   Chu MQ, 2012, BIOMATERIALS, V33, P7071, DOI 10.1016/j.biomaterials.2012.06.062
   Chung JE, 2014, NAT NANOTECHNOL, V9, P907, DOI [10.1038/NNANO.2014.208, 10.1038/nnano.2014.208]
   Eichler J, 2000, MED ENG PHYS, V22, P307, DOI 10.1016/S1350-4533(00)00037-0
   Erogbogbo F, 2011, ACS NANO, V5, P413, DOI 10.1021/nn1018945
   Garbisa S, 1999, NAT MED, V5, P1216, DOI 10.1038/15145
   Gray J, 2007, PHOTODIAGN PHOTODYN, V4, P151, DOI 10.1016/j.pdpdt.2007.04.003
   Hirsch LR, 2003, P NATL ACAD SCI USA, V100, P13549, DOI 10.1073/pnas.2232479100
   Hong XM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7304
   Hsia SM, 2006, INT J IMPOT RES, V18, P264, DOI 10.1038/sj.ijir.3901405
   Hu A, 2015, SCI REP-UK, V5, DOI 10.1038/srep13429
   Huang XL, 2012, BIOMATERIALS, V33, P4370, DOI 10.1016/j.biomaterials.2012.02.060
   Jangjoo A, 2010, ACTA ONCOL, V49, P877, DOI 10.3109/02841861003769964
   Jankun J, 1997, NATURE, V387, P561, DOI 10.1038/42381
   Jaque D, 2014, NANOSCALE, V6, P9494, DOI 10.1039/c4nr00708e
   Jiang X., 2015, INT J ORAL MAXILLOFA
   Jiang XW, 2012, OR SURG OR MED OR PA, V113, P500, DOI 10.1016/j.oooo.2011.09.007
   Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282
   Kaur IP, 2000, MUTAT RES-GEN TOX EN, V470, P71, DOI 10.1016/S1383-5718(00)00096-6
   Kim S, 2004, NAT BIOTECHNOL, V22, P93, DOI 10.1038/nbt920
   Kobayashi H, 2007, NANO LETT, V7, P1711, DOI 10.1021/nl0707003
   Kuerer HM, 2001, SURGERY, V129, P119, DOI 10.1067/msy.2001.111212
   Leong SPL, 2000, ANN SURG ONCOL, V7, P361, DOI 10.1007/s10434-000-0361-x
   Levenback C, 2001, GYNECOL ONCOL, V83, P276, DOI 10.1006/gyno.2001.6374
   Li GD, 2011, NANOSCALE, V3, P3251, DOI 10.1039/c1nr10284b
   Li LB, 2010, PHOTODIAGN PHOTODYN, V7, P139, DOI 10.1016/j.pdpdt.2010.06.002
   Li WW, 2015, BIOMATERIALS, V45, P18, DOI 10.1016/j.biomaterials.2014.12.037
   Liao MY, 2012, CHEM COMMUN, V48, P5319, DOI 10.1039/c2cc31448g
   Liu Z, 2014, BIOMATERIALS, V35, P4099, DOI 10.1016/j.biomaterials.2014.01.053
   Lyew MA, 2000, ANESTHESIOLOGY, V93, P1145, DOI 10.1097/00000542-200010000-00041
   Ma Y, 2013, BIOMATERIALS, V34, P7706, DOI 10.1016/j.biomaterials.2013.07.007
   MCCULLOCH DG, 1994, PHYS REV B, V50, P5905, DOI 10.1103/PhysRevB.50.5905
   Mizumoto M, 2014, RADIOTHER ONCOL, V113, P54, DOI 10.1016/j.radonc.2014.08.015
   Moon HK, 2009, ACS NANO, V3, P3707, DOI 10.1021/nn900904h
   Muijs CT, 2010, RADIOTHER ONCOL, V97, P165, DOI 10.1016/j.radonc.2010.04.024
   NAMIKI M, 1995, FOOD REV INT, V11, P281, DOI 10.1080/87559129509541043
   Nandi I., 2015, BIOACTIVE CARBOHYDRA, V5, P129
   Ohnishi S, 2005, MOL IMAGING, V4, P172
   Ono E, 2006, P NATL ACAD SCI USA, V103, P10116, DOI 10.1073/pnas.0603865103
   Oomah S., 2010, ALLERGY ASTHMA CL IM, V6, P29
   Pan DPJ, 2010, BIOMATERIALS, V31, P4088, DOI 10.1016/j.biomaterials.2010.01.136
   Panzella L, 2012, J AGR FOOD CHEM, V60, P8895, DOI 10.1021/jf2053096
   Park SH, 2010, FOOD REV INT, V26, P103, DOI 10.1080/87559120903564464
   Pattison DJ, 2008, NAT CLIN PRACT RHEUM, V4, P590, DOI 10.1038/ncprheum0920
   Plante M, 2015, GYNECOL ONCOL, V137, P443, DOI 10.1016/j.ygyno.2015.03.004
   Pons T, 2010, ACS NANO, V4, P2531, DOI 10.1021/nn901421v
   Raaphorst G. P., 1990, INTRO PRACTICAL ASPE, P10
   Rodwell C, 2012, NAT REV CANCER, V12, DOI 10.1038/nrc3288
   Rzyman W, 2006, EJSO, V32, P462, DOI 10.1016/j.ejso.2006.01.005
   Salazar H, 2008, NAT NEUROSCI, V11, P255, DOI 10.1038/nn2056
   Shahidi F, 1997, J AM OIL CHEM SOC, V74, P143, DOI 10.1007/s11746-997-0159-0
   Shahidi F, 2006, FOOD CHEM, V99, P478, DOI 10.1016/j.foodchem.2005.08.009
   Sharker SM, 2015, BIOMATERIALS, V61, P229, DOI 10.1016/j.biomaterials.2015.05.040
   Soltesz EG, 2005, ANN THORAC SURG, V79, P269, DOI 10.1016/j.athoracsur.2004.06.055
   Song KH, 2009, NANO LETT, V9, P183, DOI 10.1021/nl802746w
   Storm F. K., 1992, ARCH SURG-CHICAGO, V127, P392
   Sun Y, 2011, BIOMATERIALS, V32, P2999, DOI 10.1016/j.biomaterials.2011.01.011
   Sunagawa Y., 2015, PHARM NUTR
   Tachibana H, 2004, NAT STRUCT MOL BIOL, V11, P380, DOI 10.1038/nsmb743
   Teknos D, 2008, J NATL MED ASSOC, V100, P1483, DOI 10.1016/S0027-9684(15)31552-2
   Thomas SN, 2014, BIOMATERIALS, V35, P814, DOI 10.1016/j.biomaterials.2013.10.003
   Toma Atsushi, 2002, Gan To Kagaku Ryoho, V29, P2291
   Vaijayanthimala V, 2012, BIOMATERIALS, V33, P7794, DOI 10.1016/j.biomaterials.2012.06.084
   Wahid FN, 2014, J PEDIAT SURG CASE R, V2, P117, DOI 10.1016/j.epsc.2014.02.009
   Wu YF, 2014, COMPLEMENT THER MED, V22, P40, DOI 10.1016/j.ctim.2013.12.010
   Xia L, 2014, BIOMATERIALS, V35, P4146, DOI 10.1016/j.biomaterials.2014.01.068
   Xin C, 2015, J BIOSCI BIOENG, V119, P446, DOI 10.1016/j.jbiosc.2014.09.009
   Xu L.P., 2006, THESIS JIANGNAN U
   Yang K, 2015, BIOMATERIALS, V38, P1, DOI 10.1016/j.biomaterials.2014.10.052
   Yang X, 2015, SCI REP-UK, V5, DOI 10.1038/srep10322
   Yuan A, 2013, J PHARM SCI-US, V102, P6, DOI 10.1002/jps.23356
   Zhang C, 2010, BIOMATERIALS, V31, P1911, DOI 10.1016/j.biomaterials.2009.11.061
   Zhang M, 2008, P NATL ACAD SCI USA, V105, P14773, DOI 10.1073/pnas.0801349105
NR 85
TC 11
Z9 13
U1 19
U2 156
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2016
VL 91
BP 182
EP 199
DI 10.1016/j.biomaterials.2016.03.018
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DK0OK
UT WOS:000374611900013
PM 27031812
DA 2018-10-20
ER

PT J
AU Zabost, E
   Liwinska, W
   Karbarz, M
   Kurek, E
   Lyp, M
   Donten, M
   Stojek, Z
AF Zabost, Ewelina
   Liwinska, Wioletta
   Karbarz, Marcin
   Kurek, Eliza
   Lyp, Marek
   Donten, Mikolaj
   Stojek, Zbigniew
TI Electrochemical examination of ability of dsDNA/PAM composites for
   storing and releasing of doxorubicin
SO BIOELECTROCHEMISTRY
LA English
DT Article
DE DNA electrooxidation; Doxorubicin; Drug delivery system; Polyacrylamide;
   Square wave voltammetry; Switching system
ID NUCLEIC-ACID BASES; DRUG-DELIVERY; SIRNA DELIVERY; DNA; HYDROGELS;
   NANOPARTICLES; TEMPERATURE; DENATURATION; POLYMER; SYSTEMS
AB Composites consisting of ss- and ds-DNA strands and polyacrylamide (PAM) hydrogel have been synthesized. DNA was entrapped non-covalently. The obtained DNA biomaterial exhibited a strong increase in.guanine and adenine anodic currents when temperature reached the physiological level. This increase was related to the unique oligonucleotide structural changes in the composite. The structural alterations in the PAM lattices were employed for the release of the drug accumulated in the composite. Doxorubicin (Dox) was selected as the drug; it was accumulated by intercalation to dsDNA and was slowly released from the dsDNA/PAM system by using a minor temperature increase (up to 40 divided by 45 degrees C) as it is routinely done in hyperthermia. The applied release temperature was either constant or oscillating. The binding strength, the rate of Dox release and the properties of the composite were examined using voltammetry, SEM and ICP-MS. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Zabost, Ewelina; Liwinska, Wioletta; Karbarz, Marcin; Kurek, Eliza; Donten, Mikolaj; Stojek, Zbigniew] Univ Warsaw, Fac Chem, Pasteura 1, PL-02093 Warsaw, Poland.
   [Lyp, Marek] Coll Rehabil, Kasprzaka 49, PL-01234 Warsaw, Poland.
RP Zabost, E (reprint author), Univ Warsaw, Fac Chem, Pasteura 1, PL-02093 Warsaw, Poland.
EM ezabost@chem.uw.edu.pl
FU NCN [2012/05/D/ST5/03464]
FX Support of this work by NCN grant no.: 2012/05/D/ST5/03464 is thankfully
   acknowledged.
CR Agarwal T, 2015, INT J BIOL MACROMOL, V75, P409, DOI 10.1016/j.ijbiomac.2014.12.052
   Baser B., 2010, J APPL POLYM SCI, V120, P1420
   Bird S.P., 2001, ANALYST, V136, P3410
   Campolongo MJ, 2011, J MATER CHEM, V21, P6113, DOI 10.1039/c0jm03854g
   Cheng W., 2015, SCI ENG C, V45, P600
   Costa D., 2010, ADV COLLOID INTERF S, V158, P94
   Costa D, 2010, COLLOID SURFACE A, V354, P28, DOI 10.1016/j.colsurfa.2009.08.009
   Fahlman RP, 2003, NANO LETT, V3, P1073, DOI 10.1021/nl034267i
   Gogoi M, 2014, NANOMEDICINE-UK, V9, P955, DOI [10.2217/NNM.13.90, 10.2217/nnm.13.90]
   Gu FX, 2007, NANO TODAY, V2, P14, DOI 10.1016/S1748-0132(07)70083-X
   Guo WW, 2014, ANGEW CHEM INT EDIT, V53, P10134, DOI 10.1002/anie.201405692
   Gyenes T, 2008, ACTA BIOMATER, V4, P733, DOI 10.1016/j.actbio.2007.12.004
   Hruby M, 2015, EUR POLYM J, V65, P82, DOI 10.1016/j.eurpolymj.2015.01.016
   Huang H., 2010, NANO, V25, P2892
   Huo H, 2015, J COLLOID INTERF SCI, V447, P8, DOI 10.1016/j.jcis.2015.01.043
   Hynek D, 2012, INT J ELECTROCHEM SC, V7, P34
   Islam M., 2015, J MATER CHEM B, V1, P1
   Jeffryes C, 2015, CURR OPIN BIOTECH, V33, P23, DOI 10.1016/j.copbio.2014.10.005
   Kaniewska K, 2013, RSC ADV, V3, P23816, DOI 10.1039/c3ra42405g
   Karbarz M, 2010, SOFT MATTER, V6, P1336, DOI 10.1039/b920809g
   Karbarz M, 2009, ELECTROCHEM COMMUN, V11, P1217, DOI 10.1016/j.elecom.2009.04.005
   Katas H, 2006, J CONTROL RELEASE, V115, P216, DOI 10.1016/j.jconrel.2006.07.021
   Kim JK, 2014, ARCH PHARM RES, V37, P60, DOI 10.1007/s12272-013-0280-6
   Kim SM, 2013, POLYMER, V54, P2138, DOI 10.1016/j.polymer.2013.02.014
   KREMER M, 1994, MACROMOLECULES, V27, P2965, DOI 10.1021/ma00089a012
   Lee J, 2012, NAT NANOTECHNOL, V7, P816, DOI [10.1038/NNANO.2012.211, 10.1038/nnano.2012.211]
   Liao WC, 2010, ELECTROPHORESIS, V31, P2813, DOI 10.1002/elps.201000081
   Liu JW, 2011, SOFT MATTER, V7, P6757, DOI 10.1039/c1sm05284e
   Lu S., 2013, J COLLOID INTERF SCI, V412, P50
   Mackiewicz M, 2015, J MATER CHEM B, V3, P7262, DOI 10.1039/c5tb00907c
   MCFADYEN WD, 1990, BIOCHIM BIOPHYS ACTA, V1048, P50, DOI 10.1016/0167-4781(90)90021-S
   Merino S, 2015, ACS NANO, V9, P4686, DOI 10.1021/acsnano.5b01433
   Mora L, 2009, J CONTROL RELEASE, V140, P69, DOI 10.1016/j.jconrel.2009.08.002
   Nowicka A.M., 2007, BIOELECTROCHEMISTRY, V71, P440
   Nowicka AM, 2011, PHYS CHEM CHEM PHYS, V13, P7500, DOI 10.1039/c0cp02667k
   Oliveira-Brett AM, 2002, TALANTA, V56, P959, DOI 10.1016/S0039-9140(01)00656-7
   Palecek E, 2005, PERSP BIOANAL, V1, P1
   PALECEK E, 1965, J MOL BIOL, V11, P839, DOI 10.1016/S0022-2836(65)80040-7
   Palecek E, 2012, CHEM REV, V112, P3427, DOI 10.1021/cr200303p
   Piedade JAP, 2002, BIOELECTROCHEMISTRY, V56, P81, DOI 10.1016/S1567-5394(02)00013-0
   POLTEV VI, 1991, J BIOMOL STRUCT DYN, V9, P101, DOI 10.1080/07391102.1991.10507896
   Privalova AM, 2015, J NANOSCI NANOTECHNO, V15, P4806, DOI 10.1166/jnn.2015.10508
   Qiaoling L., 2014, APTAMER CONJUGATED N
   RITGER P L, 1987, Journal of Controlled Release, V5, P23, DOI 10.1016/0168-3659(87)90034-4
   Roberts A.G., 2013, METHOD MOL BIOL, V1054, P1
   Samain F, 2015, CURR OPIN CHEM BIOL, V26, P72, DOI 10.1016/j.cbpa.2015.02.009
   Sanson C, 2010, J CONTROL RELEASE, V147, P428, DOI 10.1016/j.jconrel.2010.07.123
   Shelkovsky VS, 2002, EUR PHYS J D, V20, P421, DOI 10.1140/epjd/e2002-00144-9
   Shim MS, 2013, ANGEW CHEM INT EDIT, V52, P6926, DOI 10.1002/anie.201209633
   Syed SN, 2013, J AM CHEM SOC, V135, P5399, DOI 10.1021/ja311873t
   Tsung-Hua J., 2008, RECENT PATENTS MAT S, V1, P29
   Varga N., 2015, MICROPOR MESOPOR MAT, V2013, P134
   Wang F, 2015, ANGEW CHEM INT EDIT, V54, P1098, DOI 10.1002/anie.201404652
   Wang J, 1998, BIOELECTROCH BIOENER, V45, P33, DOI 10.1016/S0302-4598(98)00075-0
   Xiong XL, 2013, MACROMOL RAPID COMM, V34, P1271, DOI 10.1002/marc.201300411
   Ye L, 2014, J MATER CHEM B, V2, P5746, DOI 10.1039/c4tb00719k
   Zabost E, 2014, ELECTROCHEM COMMUN, V42, P50, DOI 10.1016/j.elecom.2014.02.011
   Zabost E, 2012, PHYS CHEM CHEM PHYS, V14, P3408, DOI 10.1039/c2cp23824a
   Zabost E, 2009, PHYS CHEM CHEM PHYS, V11, P8933, DOI 10.1039/b906752c
   Zhu YY, 2015, J NANOSCI NANOTECHNO, V15, P4753, DOI 10.1166/jnn.2015.10298
   Zou H, 2015, J MATER CHEM B, V3, P260, DOI 10.1039/c4tb01518e
NR 61
TC 4
Z9 4
U1 2
U2 38
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1567-5394
EI 1878-562X
J9 BIOELECTROCHEMISTRY
JI Bioelectrochemistry
PD JUN
PY 2016
VL 109
BP 1
EP 8
DI 10.1016/j.bioelechem.2015.12.001
PG 8
WC Biochemistry & Molecular Biology; Biology; Biophysics; Electrochemistry
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Biophysics; Electrochemistry
GA DI3SI
UT WOS:000373418400001
PM 26764570
DA 2018-10-20
ER

PT J
AU Lim, PN
   Lam, RN
   Zheng, YF
   Thian, ES
AF Lim, P. N.
   Lam, R. N.
   Zheng, Y. F.
   Thian, E. S.
TI Magnesium-calcium/hydroxyapatite (Mg-Ca/HA) composites with enhanced
   bone differentiation properties for orthopedic applications
SO MATERIALS LETTERS
LA English
DT Article
DE Hydroxyapatite; Magnesium-calcium; Composites; Stem cells
ID IN-VITRO; OSTEOBLASTIC CELLS; ALLOYS; HYDROXYAPATITE; BEHAVIOR
AB Mg-1Ca/HA composites were produced by blending magnesium-calcium (1 wt%) (Mg-1Ca) alloys with 5, 10 and 15 wt% of hydroxyapatite (HA). Morphology, elemental and phase composition of Mg-1Ca/HA composites were examined. Biocompatibility assessments were also performed using an indirect contact method by culturing human adipose mesenchymal stem cells (hASCs) in the extracts of Mg-1Ca alloy, Mg-1Ca/HA composites and Dulbecco's modified eagle's medium. Mg-1Ca/HA composites could promote cell proliferation and at the same time, enhanced collagen type I (COL I) and osteocalcin (OCN) expressions of hASCs. Among the Mg-1Ca/HA composites, 10 wt% of HA is the optimum amount to be added into Mg-1Ca alloy for enhanced bioactivity, thus emerging as a potential biomaterial for orthopedic fixation. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Lim, P. N.; Lam, R. N.; Thian, E. S.] Natl Univ Singapore, Dept Mech Engn, 9 Engn Dr 1, Singapore 117576, Singapore.
   [Zheng, Y. F.] Peking Univ, Coll Engn, Dept Mat Sci & Engn, Beijing 100871, Peoples R China.
RP Thian, ES (reprint author), Natl Univ Singapore, Dept Mech Engn, 9 Engn Dr 1, Singapore 117576, Singapore.; Zheng, YF (reprint author), Peking Univ, Coll Engn, Dept Mat Sci & Engn, Beijing 100871, Peoples R China.
EM yfzheng@pku.edu.cn; mpetes@nus.edu.sg
RI Zheng, Yufeng/A-4146-2010
OI Zheng, Yufeng/0000-0002-7402-9979
FU Ministry of Education Academic Research Fund (Singapore)
   [MOE2013-T2-1-074]; National Basic Research Program of China (973
   Program) [2012CB619102]; National Science Fund for Distinguished Young
   Scholars [51225101]; National Natural Science Foundation of China
   [51431002, 31170909]; Beijing Municipal Science and Technology Project
   [Z141100002814008]
FX This work was supported by the Ministry of Education Academic Research
   Fund (Singapore) Project number MOE2013-T2-1-074, and the National Basic
   Research Program of China (973 Program) (Grant no. 2012CB619102),
   National Science Fund for Distinguished Young Scholars (Grant no.
   51225101), National Natural Science Foundation of China (Grant nos.
   51431002 and 31170909), Beijing Municipal Science and Technology Project
   (Z141100002814008).
CR Cha PR, 2013, SCI REP-UK, V3, DOI 10.1038/srep02367
   Chua BW, 1999, COMPOS STRUCT, V47, P595, DOI 10.1016/S0263-8223(00)00031-3
   Dorozhkin SV, 2010, J FUNCT BIOMATER, V1, P22, DOI 10.3390/jfb1010022
   Dou YN, 2014, PROG NAT SCI-MATER, V24, P433, DOI 10.1016/j.pnsc.2014.08.001
   Hott M, 1997, J BIOMED MATER RES, V37, P508, DOI 10.1002/(SICI)1097-4636(19971215)37:4<508::AID-JBM9>3.0.CO;2-P
   Landi E, 2008, J MATER SCI-MATER M, V19, P239, DOI 10.1007/s10856-006-0032-y
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Lim PN, 2014, ACS APPL MATER INTER, V6, P17082, DOI 10.1021/am504716g
   Lim PN, 2012, J BIOMED MATER RES B, V100B, P285, DOI 10.1002/jbm.b.31951
   Salahshoor M, 2012, MATERIALS, V5, P135, DOI 10.3390/ma5010135
   Shu R, 2003, J BIOMED MATER RES A, V67A, P1196, DOI 10.1002/jbm.a.20021
   Xu LP, 2009, BIOMATERIALS, V30, P1512, DOI 10.1016/j.biomaterials.2008.12.001
   Zheng YF, 2010, ACTA BIOMATER, V6, P1783, DOI 10.1016/j.actbio.2009.10.009
   Zreiqat H, 2002, J BIOMED MATER RES, V62, P175, DOI 10.1002/jbm.10270
NR 14
TC 11
Z9 11
U1 10
U2 56
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD JUN 1
PY 2016
VL 172
BP 193
EP 197
DI 10.1016/j.matlet.2016.03.005
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA DI1WU
UT WOS:000373288500048
DA 2018-10-20
ER

PT J
AU Lee, JW
   Soman, P
   Park, JH
   Chen, SC
   Cho, DW
AF Lee, Jin Woo
   Soman, Pranav
   Park, Jeong Hun
   Chen, Shaochen
   Cho, Dong-Woo
TI A Tubular Biomaterial Construct Exhibiting a Negative Poisson's Ratio
SO PLOS ONE
LA English
DT Article
ID SMALL-INTESTINAL SUBMUCOSA; VASCULAR GRAFTS; BIODEGRADABLE POLYMER;
   PULMONARY-ARTERY; AUXETIC BEHAVIOR; BLOOD-VESSEL; HOLY-GRAIL; IN-VITRO;
   GROWTH; MODEL
AB Developing functional small-diameter vascular grafts is an important objective in tissue engineering research. In this study, we address the problem of compliance mismatch by designing and developing a 3D tubular construct that has a negative Poisson's ratio v(xy) (NPR). NPR constructs have the unique ability to expand transversely when pulled axially, thereby resulting in a highly-compliant tubular construct. In this work, we used projection stereolithography to 3D-print a planar NPR sheet composed of photosensitive poly(ethylene) glycol diacrylate biomaterial. We used a step-lithography exposure and a stitch process to scale up the projection printing process, and used the cut-missing rib unit design to develop a centimeter-scale NPR sheet, which was rolled up to form a tubular construct. The constructs had Poisson's ratios of -0.6 <= -v(xy) <= -0.1. The NPR construct also supports higher cellular adhesion than does the construct that has positive v(xy). Our NPR design offers a significant advance in the development of highly-compliant vascular grafts.
C1 [Lee, Jin Woo] Gachon Univ, Sch Med, Dept Mol Med, 7-45 Songdo Dong, Inchon 406840, South Korea.
   [Soman, Pranav] Syracuse Univ, Dept Biomed & Chem Engn, 318 Browne Hall, Syracuse, NY 13244 USA.
   [Park, Jeong Hun; Cho, Dong-Woo] Pohang Univ Sci & Technol POSTECH, Dept Mech Engn, San 31, Pohang 790781, Gyeongbuk, South Korea.
   [Chen, Shaochen] Univ Calif San Diego, Dept NanoEngn, 9500 Gilman Dr,Atkinson Hall,MC-0448, La Jolla, CA 92093 USA.
RP Cho, DW (reprint author), Pohang Univ Sci & Technol POSTECH, Dept Mech Engn, San 31, Pohang 790781, Gyeongbuk, South Korea.; Chen, SC (reprint author), Univ Calif San Diego, Dept NanoEngn, 9500 Gilman Dr,Atkinson Hall,MC-0448, La Jolla, CA 92093 USA.
EM chen168@eng.ucsd.edu; dwcho@postech.ac.kr
FU National Institutes of Health [EB012597, EB017876]; National Research
   Foundation of Korea (NRF) [2014R1A1A2A16054777, 2010-0018294]; Korea
   Health Industry Development Institute (KHIDI) [HI14C3228]
FX This study was supported by the National Institutes of Health (EB012597
   and EB017876, http://www.nih.gov/) to SC; National Research Foundation
   of Korea (NRF)(2014R1A1A2A16054777, http://www.nrf.re.kr/) to JWL;
   National Research Foundation of Korea (NRF) (2010-0018294,
   http://www.nrf.re.kr/) to D-WC; Korea Health Industry Development
   Institute (KHIDI) (HI14C3228, http://www.khidi.or.kr/) to JWL.; We
   greatly appreciate the financial support from National Institutes of
   Health (EB012597 and EB017876) to S.C, National Research Foundation
   (NRF) of Korea (No. 2014R1A1A2A16054777 & No. 2010-0018294) and the
   Korea Health Industry Development Institute (KHIDI) (HI14C3228). And We
   also appreciate the donation of human turbinate mesenchymal stromal
   cells from Prof. Sung-Won Kim (Seoul Saint Mary Hospital).
CR Association AH, 2003, BIOST FACTSH CARD PR
   Badylak SF, 1998, J BIOMAT SCI-POLYM E, V9, P863, DOI 10.1163/156856298X00208
   BASSIOUNY HS, 1992, J VASC SURG, V15, P708, DOI 10.1016/0741-5214(92)90019-5
   Buckmann T, 2012, ADV MATER, V24, P2710, DOI 10.1002/adma.201200584
   CANHAM PB, 1991, CONNECT TISSUE RES, V26, P121, DOI 10.3109/03008209109152168
   Chaouat M, 2006, BIOMATERIALS, V27, P5546, DOI 10.1016/j.biomaterials.2006.06.032
   Conte MS, 1998, FASEB J, V12, P43
   COURTMAN DW, 1994, J BIOMED MATER RES, V28, P655, DOI 10.1002/jbm.820280602
   Dahl SLM, 2003, CELL TRANSPLANT, V12, P659, DOI 10.3727/000000003108747136
   Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z
   Eisenstadt MM, 1971, INTRO MECH PROPERTIE
   EVANS KE, 1991, NATURE, V353, P124, DOI 10.1038/353124a0
   Fozdar DY, 2011, ADV FUNCT MATER, V21, P2712, DOI 10.1002/adfm.201002022
   Fozdar DY, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/21/215303
   Fung Y, 1993, BIOMECHANICS MECH PR, P321
   Gaspar N, 2005, ACTA MATER, V53, P2439, DOI 10.1016/j.actamat.2005.02.006
   Gibson L.J., 1997, CELLULAR SOLIDS STRU, P510
   GIBSON LJ, 1982, P ROY SOC LOND A MAT, V382, P25, DOI 10.1098/rspa.1982.0087
   GLAGOV S, 1979, ARTERY, V5, P295
   Hoerstrup SP, 2002, ANN THORAC SURG, V74, P46, DOI 10.1016/S0003-4975(02)03649-4
   Hoerstrup SP, 2001, EUR J CARDIO-THORAC, V20, P164, DOI 10.1016/S1010-7940(01)00706-0
   Huynh T, 1999, NAT BIOTECHNOL, V17, P1083
   Isenberg BC, 2006, CIRC RES, V98, P25, DOI 10.1161/01.RES.0000196867.12470.84
   Kakisis JD, 2005, J VASC SURG, V41, P349, DOI 10.1016/j.jvs.2004.12.026
   Kannan RY, 2005, BIOMATERIALS, V26, P1857, DOI 10.1016/j.biomaterials.2004.07.006
   Kim BS, 1999, EXP CELL RES, V251, P318, DOI 10.1006/excr.1999.4595
   Kurane A, 2007, BIOMATERIALS, V28, P2830, DOI 10.1016/j.biomaterials.2007.02.031
   L'Heureux N, 1998, FASEB J, V12, P47
   Masters IG, 1996, COMPOS STRUCT, V35, P403, DOI 10.1016/S0263-8223(96)00054-2
   Mooney DT, 1996, BIOMATERIALS, V17, P115, DOI 10.1016/0142-9612(96)85756-5
   Ounpuu S, 2000, EUR HEART J, V21, P880, DOI 10.1053/euhj.1999.1880
   Perler BA, 1995, J VASC INTERV RADIOL, V6, pS111, DOI 10.1016/S1051-0443(95)71259-3
   Popov EP, 1990, ENG MECH SOLIDS, P82
   Rashid ST, 2004, BIOMATERIALS, V25, P1627, DOI 10.1016/S0142-9612(03)00522-2
   Robotin-Johnson MC, 1998, J THORAC CARDIOV SUR, V116, P805, DOI 10.1016/S0022-5223(98)00436-X
   SANDUSKY GE, 1992, AM J PATHOL, V140, P317
   Shin'oka T, 2001, NEW ENGL J MED, V344, P532, DOI 10.1056/NEJM200102153440717
   Shum-Tim D, 1999, ANN THORAC SURG, V68, P2298, DOI 10.1016/S0003-4975(99)01055-3
   Smith CW, 2000, ACTA MATER, V48, P4349, DOI 10.1016/S1359-6454(00)00269-X
   Soletti L, 2011, J BIOMED MATER RES A, V96A, P436, DOI 10.1002/jbm.a.32997
   Pranav S, 2012, BIOMATERIALS, V33, P7064, DOI 10.1016/j.biomaterials.2012.06.012
   Soman P, 2012, ACTA BIOMATER, V8, P2587, DOI 10.1016/j.actbio.2012.03.035
   Soman P, 2012, SOFT MATTER, V8, P4946, DOI 10.1039/c2sm07354d
   Sung HW, 1997, ARTIF ORGANS, V21, P50
   Teebken OE, 2002, EUR J VASC ENDOVASC, V23, P475, DOI 10.1006/ejvs.2002.1654
   Timmins LH, 2010, AM J PHYSIOL-HEART C, V298, pH1537, DOI 10.1152/ajpheart.00891.2009
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   Wake MC, 1996, CELL TRANSPLANT, V5, P465, DOI 10.1016/0963-6897(96)00025-5
   Watanabe M, 2001, TISSUE ENG, V7, P429, DOI 10.1089/10763270152436481
   WOLINSKY H, 1964, CIRC RES, V14, P400, DOI 10.1161/01.RES.14.5.400
   Zund G, 1998, EUR J CARDIO-THORAC, V13, P160, DOI 10.1016/S1010-7940(97)00309-6
NR 51
TC 1
Z9 1
U1 1
U2 22
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 27
PY 2016
VL 11
IS 5
AR e0155681
DI 10.1371/journal.pone.0155681
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DN2GV
UT WOS:000376883000005
PM 27232181
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Abhyankar, VV
   Wu, MY
   Koh, CY
   Hatch, AV
AF Abhyankar, Vinay V.
   Wu, Meiye
   Koh, Chung-Yan
   Hatch, Anson V.
TI A Reversibly Sealed, Easy Access, Modular (SEAM) Microfluidic
   Architecture to Establish In Vitro Tissue Interfaces
SO PLOS ONE
LA English
DT Article
ID ORGANS-ON-CHIPS; PEPTIDE-AMPHIPHILE NANOFIBERS; CELL-CULTURE;
   EXTRACELLULAR-MATRIX; MOLECULAR-MECHANISMS; DRUG DISCOVERY; MEMBRANES;
   DEVICES; MICROFABRICATION; PURIFICATION
AB Microfluidic barrier tissue models have emerged as advanced in vitro tools to explore interactions with external stimuli such as drug candidates, pathogens, or toxins. However, the procedures required to establish and maintain these systems can be challenging to implement for end users, particularly those without significant in-house engineering expertise. Here we present a module-based approach that provides an easy-to-use workflow to establish, maintain, and analyze microscale tissue constructs. Our approach begins with a removable culture insert that is magnetically coupled, decoupled, and transferred between standalone, prefabricated microfluidic modules for simplified cell seeding, culture, and downstream analysis. The modular approach allows several options for perfusion including standard syringe pumps or integration with a self-contained gravity-fed module for simple cell maintenance. As proof of concept, we establish a culture of primary human microvascular endothelial cells (HMVEC) and report combined surface protein imaging and gene expression after controlled apical stimulation with the bacterial endotoxin lipopolysaccharide (LPS). We also demonstrate the feasibility of incorporating hydrated biomaterial interfaces into the microfluidic architecture by integrating an ultra-thin (<1 mu m), self-assembled hyaluronic acid/peptide amphiphile culture membrane with brain-specific Young's modulus (similar to 1kPa). To highlight the importance of including biomimetic interfaces into microscale models we report multi-tiered readouts from primary rat cortical cells cultured on the self-assembled membrane and compare a panel of mRNA targets with primary brain tissue signatures. We anticipate that the modular approach and simplified operational workflows presented here will enable a wide range of research groups to incorporate microfluidic barrier tissue models into their work.
C1 [Abhyankar, Vinay V.; Wu, Meiye; Koh, Chung-Yan; Hatch, Anson V.] Sandia Natl Labs, Dept Biotechnol & Bioengn, Livermore, CA 94551 USA.
   [Abhyankar, Vinay V.] Univ Texas Arlington, Res Inst, Biol Microsyst, Ft Worth, TX 76118 USA.
RP Abhyankar, VV; Hatch, AV (reprint author), Sandia Natl Labs, Dept Biotechnol & Bioengn, Livermore, CA 94551 USA.; Abhyankar, VV (reprint author), Univ Texas Arlington, Res Inst, Biol Microsyst, Ft Worth, TX 76118 USA.
EM vinay.abhyankar@gmail.com; ahatch@sandia.gov
OI Abhyankar, Vinay/0000-0002-8462-3920
FU Laboratory Directed Research and Development (LDRD) at Sandia National
   Laboratories; Defense Threat Reduction Agency Joint Science and
   Technology Office for Chemical and Biological Defense (IAA) [DTRA
   10027IA-3167]; NIAID [R01AI98853]; US Department of Energy
   [DE-AC04-94AL85000]
FX This work was funded under Laboratory Directed Research and Development
   (LDRD) at Sandia National Laboratories and by the Defense Threat
   Reduction Agency Joint Science and Technology Office for Chemical and
   Biological Defense (IAA number DTRA 10027IA-3167). CK was supported by
   NIAID grant R01AI98853. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.; Sandia National Laboratories is a multi-program laboratory
   operated by Sandia Corporation, a Lockheed Martin Company, for the US
   Department of Energy under contract DE-AC04-94AL85000. Illustrations
   contained vector art designed by Freepik. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Abaci HE, 2015, LAB CHIP, V15, P882, DOI 10.1039/c4lc00999a
   Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824
   Andonegui G, 2003, J CLIN INVEST, V111, P1011, DOI 10.1172/JCI200316510
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Beebe DJ, 2000, P NATL ACAD SCI USA, V97, P13488, DOI 10.1073/pnas.250273097
   Beniash E, 2005, ACTA BIOMATER, V1, P387, DOI 10.1016/j.actbio.2005.04.002
   Berry SM, 2014, INTEGR BIOL-UK, V6, P224, DOI 10.1039/c3ib40136g
   Bhatia SN, 2014, NAT BIOTECHNOL, V32, P760, DOI 10.1038/nbt.2989
   Bhattacharya J, 2013, ANNU REV PHYSIOL, V75, P593, DOI 10.1146/annurev-physiol-030212-183756
   Bruggeman LA, 2012, CELL MOL BIOENG, V5, P194, DOI 10.1007/s12195-012-0221-3
   Capito RM, 2008, SCIENCE, V319, P1812, DOI 10.1126/science.1154586
   Carvajal D, 2010, SOFT MATTER, V6, P1816, DOI 10.1039/b923903k
   Chosewood LC, 2009, BIOSAFETY MICROBIOLO, Vxxii
   Chow LW, 2011, BIOMATERIALS, V32, P1574, DOI 10.1016/j.biomaterials.2010.10.048
   Delmas P, 2011, NAT REV NEUROSCI, V12, P139, DOI 10.1038/nrn2993
   Domansky K, 2013, LAB CHIP, V13, P3956, DOI 10.1039/c3lc50558h
   Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z
   Engler A. J., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P335
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   Esch MB, 2015, LAB CHIP, V15, P2269, DOI 10.1039/c5lc00237k
   Esch MB, 2014, ADV DRUG DELIVER REV, V69, P158, DOI 10.1016/j.addr.2013.12.003
   Esch MB, 2012, BIOMED MICRODEVICES, V14, P895, DOI 10.1007/s10544-012-9669-0
   Freed LE, 2009, ADV MATER, V21, P3410, DOI 10.1002/adma.200900303
   Frohlich EM, 2013, LAB CHIP, V13, P2311, DOI 10.1039/c3lc50199j
   Fuerstman MJ, 2007, LAB CHIP, V7, P1479, DOI 10.1039/b706549c
   Gaver DP, 1998, BIOPHYS J, V75, P721, DOI 10.1016/S0006-3495(98)77562-9
   Geetha T, 2013, J BIOL CHEM
   Ghaemmaghami AM, 2012, DRUG DISCOV TODAY, V17, P173, DOI 10.1016/j.drudis.2011.10.029
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   Hatch AV, 2006, ANAL CHEM, V78, P4976, DOI 10.1021/ac0600454
   Herr AE, 2007, P NATL ACAD SCI USA, V104, P5268, DOI 10.1073/pnas.0607254104
   Hinsby AM, 2004, FRONT BIOSCI, V9, P2227, DOI 10.2741/1393
   Huh D, 2013, NAT PROTOC, V8, P2135, DOI 10.1038/nprot.2013.137
   Huh D, 2012, LAB CHIP, V12, P2156, DOI 10.1039/c2lc40089h
   Huh D, 2011, TRENDS CELL BIOL, V21, P745, DOI 10.1016/j.tcb.2011.09.005
   Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302
   Huynh J, 2013, CELL MOL BIOENG, V6
   Ismagilov RF, 2001, ANAL CHEM, V73, P5207, DOI 10.1021/ac010502a
   Kang E, 2013, ADV MATER, V25, P2167, DOI 10.1002/adma.201204619
   Kim HJ, 2012, LAB CHIP, V12, P2165, DOI 10.1039/c2lc40074j
   Krump-Konvalinkova V, 2001, LAB INVEST, V81, P1717
   Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673
   Lin CC, 2010, JALA-J LAB AUTOM, V15, P253, DOI 10.1016/j.jala.2010.01.013
   Lu JT, 2007, BIOMATERIALS, V28, P1486, DOI 10.1016/j.biomaterials.2006.11.023
   Miller FD, 2001, NEURON, V32, P767, DOI 10.1016/S0896-6273(01)00529-3
   Miller JJ, 2015, J MICROMECHANICS MIC, V25
   NAKAYAMA M, 1995, J NEUROSCI, V15, P5238
   Nan L, 2014, LAB CHIP, V14, P1060, DOI 10.1039/c3lc51133b
   Rehfeldt F, 2007, ADV DRUG DELIVER REV, V59, P1329, DOI 10.1016/j.addr.2007.08.007
   Reichen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052246
   Richert L, 2004, BIOMACROMOLECULES, V5, P1908, DOI 10.1021/bm0498023
   Ruoslahti E, 1996, GLYCOBIOLOGY, V6, P489, DOI 10.1093/glycob/6.5.489
   Soofi SS, 2009, J STRUCT BIOL, V167, P216, DOI 10.1016/j.jsb.2009.05.005
   Sung JH, 2010, LAB CHIP, V10, P446, DOI 10.1039/b917763a
   Temiz Y, 2015, MICROELECTRON ENG, V132, P156, DOI 10.1016/j.mee.2014.10.013
   Toepke MW, 2006, LAB CHIP, V6, P1484, DOI 10.1039/b612140c
   Van Heirstraeten L, 2014, LAB CHIP, V14, P1519, DOI 10.1039/c3lc51339d
   Verbist B, 2015, DRUG DISCOV TODAY, V20, P505, DOI 10.1016/j.drudis.2014.12.014
   Verhulsel M, 2014, BIOMATERIALS, V35, P1816, DOI 10.1016/j.biomaterials.2013.11.021
   Wang JD, 2012, ANN BIOMED ENG, V40, P1862, DOI 10.1007/s10439-012-0562-z
   Wang TW, 2009, ACTA BIOMATER, V5, P2371, DOI 10.1016/j.actbio.2009.03.033
   Zhang JH, 2002, NAT GENET, V30, P416, DOI 10.1038/ng859
   Zhang P, 2000, IMMUNOL REV, V173, P39, DOI 10.1034/j.1600-065X.2000.917306.x
   Zhu XY, 2004, ANALYST, V129, P1026, DOI 10.1039/b407623k
NR 65
TC 4
Z9 4
U1 3
U2 28
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 26
PY 2016
VL 11
IS 5
AR e0156341
DI 10.1371/journal.pone.0156341
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DN2GQ
UT WOS:000376882500118
PM 27227828
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Yue, W
   Yan, F
   Zhang, YL
   Liu, SL
   Hou, SP
   Mao, GC
   Liu, N
   Ji, Y
AF Yue, Wei
   Yan, Feng
   Zhang, Yue-Lin
   Liu, Shu-Ling
   Hou, Shu-Ping
   Mao, Guo-Chao
   Liu, Ning
   Ji, Yong
TI Differentiation of Rat Bone Marrow Mesenchymal Stem Cells Into
   Neuron-Like Cells In Vitro and Co-Cultured with Biological Scaffold as
   Transplantation Carrier
SO MEDICAL SCIENCE MONITOR
LA English
DT Article
DE Adult Stem Cells; Bone Marrow Cells; Tissue Engineering
ID TRAUMATIC BRAIN-INJURY; NERVE REGENERATION; CHITOSAN
AB Background: Autograft and allograft transplantation are used to prompt the regeneration of axons after nerve injury. However, the poor self-regeneration caused by the glial scar and growth inhibitory factors after neuronal necrosis limit the efficacy of these methods. The purpose of this study was to develop a new chitosan porous scaffold for cell seeding.
   Material/Methods: The bone marrow mesenchymal stem cells (BMSCs) and tissue-engineered biomaterial scaffold compound were constructed and co-cultured in vitro with the differentiated BMSCs of Wistar rats and chitosan scaffold in a 3D environment. The purity of the third-generation BMSCs culture was identified using flow cytometry and assessment of induced neuronal differentiation. The scaffolds were prepared by the freeze-drying method. The internal structure of scaffolds and the change of cells' growth and morphology were observed under a scanning electron microscope. The proliferation of cells was detected with the MTT method.
   Results: On day 5 there was a significant difference in the absorbance value of the experimental group (0.549 +/- 0.0256) and the control group (0.487 +/- 0.0357) (P>0.05); but on day 7 there was no significant difference in the proliferation of the experimental group (0.751 +/- 0.011) and the control group and (0.78 +/- 0.017) (P>0.05).
   Conclusions: Tissue engineering technology can provide a carrier for cells seeding and is expected to become an effective method for the regeneration and repair of nerve cells. Our study showed that chitosan porous scaffolds can be used for such purposes.
C1 [Yue, Wei; Liu, Shu-Ling; Ji, Yong] Tianjin Huanhu Hosp, Dept Neurol, Tianjin, Peoples R China.
   [Yan, Feng; Zhang, Yue-Lin; Mao, Guo-Chao] Xi An Jiao Tong Univ, Shanxi Prov Peoples Hosp, Affiliate Hosp 3, Dept Neurosurg, Xian 710049, Shaanxi, Peoples R China.
   [Hou, Shu-Ping] Tianjin Med Univ Gen Hosp, Dept Dermatovenereol, Tianjin, Peoples R China.
   [Liu, Ning] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Xian 710049, Shaanxi, Peoples R China.
RP Zhang, YL (reprint author), Xi An Jiao Tong Univ, Shanxi Prov Peoples Hosp, Affiliate Hosp 3, Dept Neurosurg, Xian 710049, Shaanxi, Peoples R China.
EM yuelinzhang111@163.com
CR Amado S, 2008, BIOMATERIALS, V29, P4409, DOI 10.1016/j.biomaterials.2008.07.043
   Andelic N, 2013, LANCET NEUROL, V12, P28, DOI [10.1016/S1474-4422(12)20294-6, 10.1016/S1474-4422(12)70294-6]
   Danilevicius P, 2015, APPL SURF SCI, V336, P2, DOI 10.1016/j.apsusc.2014.06.012
   Gulbake A, 2012, EXPERT OPIN DRUG DEL, V9, P713, DOI 10.1517/17425247.2012.682148
   Huang R, 2015, BIOMATERIALS, V53, P58, DOI 10.1016/j.biomaterials.2015.02.076
   Kong L, 2007, J BIOMATER APPL, V22, P223, DOI 10.1177/0885328206073706
   Kuroda S, 2011, J STEM CELLS REGEN, V7, P2
   Lee B.-Y., 2015, BIOMEDICAL PHYS ENG, V1
   Liu CZ, 2008, J BIOMED MATER RES B, V85B, P519, DOI 10.1002/jbm.b.30975
   Liu QF, 2015, PHARM RES-DORDR, V32, P22, DOI 10.1007/s11095-014-1441-0
   Nawrotek K, 2016, CARBOHYD POLYM, V136, P764, DOI 10.1016/j.carbpol.2015.09.105
   Rocamonde B, 2016, BRAIN INJURY, V10, P1
   Santander-Ortega MJ, 2011, COLLOID SURFACE B, V82, P571, DOI 10.1016/j.colsurfb.2010.10.019
   Shen Q, 2016, CELL PHYSIOL BIOCHEM, V38, P748, DOI 10.1159/000443031
   Shen ZS, 2015, RSC ADV, V5, P55640, DOI 10.1039/c5ra06835e
   Uchida H, 2016, STEM CELLS, V34, P160, DOI 10.1002/stem.2206
   Wang LC, 2014, MAR DRUGS, V12, P4984, DOI 10.3390/md12094984
   Wang W, 2008, J BIOMED MATER RES A, V84A, P557, DOI 10.1002/jbm.a.31536
   Yada RY, 2014, COMPR REV FOOD SCI F, V13, P730, DOI 10.1111/1541-4337.12076
NR 19
TC 1
Z9 2
U1 1
U2 9
PU INT SCIENTIFIC LITERATURE, INC
PI SMITHTOWN
PA 361 FOREST LANE, SMITHTOWN, NY 11787 USA
SN 1643-3750
J9 MED SCI MONITOR
JI Med. Sci. Monitor
PD MAY 26
PY 2016
VL 22
BP 1766
EP 1772
DI 10.12659/MSM.898441
PG 7
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DN0EU
UT WOS:000376738000001
PM 27225035
OA Green Published
DA 2018-10-20
ER

PT J
AU Kuppusamy, S
   Thavamani, P
   Megharaj, M
   Venkateswarlu, K
   Lee, YB
   Naidu, R
AF Kuppusamy, Saranya
   Thavamani, Palanisami
   Megharaj, Mallavarapu
   Venkateswarlu, Kadiyala
   Lee, Yong Bok
   Naidu, Ravi
TI Potential of Melaleuca diosmifolia as a novel, non-conventional and
   low-cost coagulating adsorbent for removing both cationic and anionic
   dyes
SO JOURNAL OF INDUSTRIAL AND ENGINEERING CHEMISTRY
LA English
DT Article
DE Adsorption; Anionic dye; Cationic dyes; Coagulation; Melaleuca
   diosmifolia; Wastewater treatment
ID HEXAVALENT CHROMIUM REMOVAL; EFFECTIVE NATURAL COAGULANT;
   AQUEOUS-SOLUTION; MALACHITE GREEN; METHYLENE-BLUE; WATER-TREATMENT; SEED
   GUM; ADSORPTION; WASTE; KINETICS
AB The potential of dried twigs of Melaleuca diosmifolia as a novel biosorbent for removing three cationic dyes, methylene blue (MB), acridine orange (AO) and malachite green (MG), and an anionic dye, eriochrome black T (EB) was evaluated in a batch adsorption process. Notably, the biosorbent removed 77-99% of both cationic and anionic dyes in a wide ranging pH of 2-10, and the reactions were endothermic. The dye adsorption equilibria were rapidly attained within 3 h. The monolayer adsorption capacity of the sorbent added at 5 g L-1 was 119.05, 126.8, 116.28 and 94.34 mg g(-1) for MB, AO, MG and EB, respectively. The water extract obtained from the plant material induced fast decolourization of both categories of dyes followed by gradual flocculation, indicating its potential as a natural coagulant. Gas chromatographic analysis also indicated that the main electrostatic attraction between 1,8-cineole, 1-p-methene-8-thiol and furfural compounds of the biomaterial, and dye molecules resulted in the formation of initial supramolecular complexes which further progressed into strong aggregates, leading to precipitation of dye-biomaterial complexes. Subsequently, the overall complex mechanism of dye removal was confirmed to be a combined process of adsorption and coagulation. Consistent with the batch studies, using selected plant material in real environmental water samples also resulted in effective dye removal, highlighting its potential for use in wastewater treatment. (C) 2016 The Korean Society of Industrial and Engineering Chemistry. Published by Elsevier B.V. All rights reserved.
C1 [Kuppusamy, Saranya; Lee, Yong Bok] Gyeongsang Natl Univ, Inst Agr & Life Sci, Jinju 660701, South Korea.
   [Kuppusamy, Saranya; Megharaj, Mallavarapu; Naidu, Ravi] Univ S Australia, Ctr Environm Risk Assessment & Remediat, Mawson Lakes, SA 5095, Australia.
   [Kuppusamy, Saranya; Thavamani, Palanisami; Megharaj, Mallavarapu; Naidu, Ravi] Cooperat Res Ctr Contaminat Assessment & Remediat, POB 486, Salisbury South, SA 5106, Australia.
   [Thavamani, Palanisami; Megharaj, Mallavarapu; Naidu, Ravi] Univ Newcastle, Fac Sci & Informat Technol, Global Ctr Environm Remediat, Callaghan, NSW 2308, Australia.
   [Venkateswarlu, Kadiyala] Sri Krishnadevaraya Univ, Dept Microbiol, Anantapur 515055, Andhra Pradesh, India.
RP Kuppusamy, S (reprint author), Gyeongsang Natl Univ, Inst Agr & Life Sci, Jinju 660701, South Korea.
EM saran.miles2go@gmail.com
RI Kuppusamy, Saranya/L-3912-2017; Mallavarapu, Megharaj/D-3408-2011
OI Kuppusamy, Saranya/0000-0002-6271-7475; Mallavarapu,
   Megharaj/0000-0002-6230-518X
FU Australian Government, University of South Australia (UniSA);
   Cooperative Research Centre for Contamination Assessment and Remediation
   of Environment (CRC CARE)
FX SK thank the Australian Government, University of South Australia
   (UniSA) and Cooperative Research Centre for Contamination Assessment and
   Remediation of Environment (CRC CARE) for the International Postgraduate
   Research Scholarship (IPRS) and CRC CARE top-up fellowship during PhD.
CR Bapr CA, 2006, J HAZARD MATER, V135, P232
   Barka N, 2011, J TAIWAN INST CHEM E, V42, P320, DOI 10.1016/j.jtice.2010.07.004
   Bazrafshan E., 2012, J BIOTECHNOL, V11, P16661
   Beach ES, 2011, CATAL SCI TECHNOL, V1, P437, DOI 10.1039/c0cy00070a
   Beltran-Heredia J, 2009, IND ENG CHEM RES, V48, P6512, DOI 10.1021/ie9004833
   Bhatti H. N., 2015, J ANIM PLANT SCI, V25, P248
   Cengiz S, 2008, BIORESOURCE TECHNOL, V99, P2357, DOI 10.1016/j.biortech.2007.05.011
   Duran C, 2011, J CHEM ENG DATA, V56, P2136, DOI 10.1021/je101204j
   El-Latif M.M.A., 2010, J AM SCI, V6, P267
   Hamdaoui O, 2008, CHEM ENG J, V143, P73, DOI 10.1016/j.cej.2007.12.018
   Jeon JR, 2009, CHEMOSPHERE, V77, P1090, DOI 10.1016/j.chemosphere.2009.08.036
   Kuppusamy S, 2016, PROCESS SAF ENVIRON, V100, P173, DOI 10.1016/j.psep.2016.01.009
   Kuppusamy S, 2016, IND CROP PROD, V83, P630, DOI 10.1016/j.indcrop.2015.12.060
   Kuppusamy S, 2016, WATER AIR SOIL POLL, V227, DOI 10.1007/s11270-016-2760-z
   Kuppusamy S, 2016, REV ENVIRON CONTAM T, V236, P117, DOI 10.1007/978-3-319-20013-2_2
   Kuppusamy S, 2016, REV ENVIRON CONTAM T, V236, P1, DOI 10.1007/978-3-319-20013-2_1
   Lakshmi UR, 2009, J ENVIRON MANAGE, V90, P710, DOI 10.1016/j.jenvman.2008.01.002
   Lata H, 2007, DYES PIGMENTS, V74, P653, DOI 10.1016/j.dyepig.2006.04.007
   Lee JW, 2006, DYES PIGMENTS, V69, P196, DOI 10.1016/j.dyepig.2005.03.008
   Leopoldini M, 2006, J AGR FOOD CHEM, V54, P3078, DOI [10.1021/jf053180a, 10.1021/jp053180a]
   Malik R, 2007, WASTE MANAGE, V27, P1129, DOI 10.1016/j.wasman.2006.06.009
   Mallampati R, 2012, RSC ADV, V2, P9914, DOI 10.1039/c2ra21108d
   Miller SM, 2008, ENVIRON SCI TECHNOL, V42, P4274, DOI 10.1021/es7025054
   Ozer A, 2007, J HAZARD MATER, V146, P262, DOI 10.1016/j.jhazmat.2006.12.016
   Royer B, 2009, J HAZARD MATER, V164, P1213, DOI 10.1016/j.jhazmat.2008.09.028
   Sadaf S, 2015, J TAIWAN INST CHEM E, V47, P160, DOI 10.1016/j.jtice.2014.10.001
   Safarik I, 2005, J MAGN MAGN MATER, V293, P371, DOI 10.1016/j.jmmm.2005.02.033
   Salleh MAM, 2011, DESALINATION, V280, P1, DOI 10.1016/j.desal.2011.07.019
   Sanchez-Martin J, 2010, CHEM ENG J, V165, P851, DOI 10.1016/j.cej.2010.10.030
   Sanghi R, 2002, GREEN CHEM, V4, P252, DOI 10.1039/b200067a
   Sanghi R, 2006, J ENVIRON MANAGE, V81, P36, DOI 10.1016/j.jenvman.2005.09.015
   Sharma P, 2010, DESALINATION, V259, P249, DOI 10.1016/j.desal.2010.03.044
   Sivaraj R, 2001, WASTE MANAGE, V21, P105, DOI 10.1016/S0956-053X(00)00076-3
   Sonawane GH, 2009, DESALINATION, V247, P430, DOI 10.1016/j.desal.2009.01.006
   Yagub MT, 2014, ADV COLLOID INTERFAC, V209, P172, DOI 10.1016/j.cis.2014.04.002
   Yan MQ, 2008, WATER RES, V42, P3361, DOI 10.1016/j.watres.2008.04.017
   Yani S, 2014, FUEL, V133, P341, DOI 10.1016/j.fuel.2014.05.030
NR 37
TC 9
Z9 10
U1 3
U2 14
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1226-086X
EI 1876-794X
J9 J IND ENG CHEM
JI J. Ind. Eng. Chem.
PD MAY 25
PY 2016
VL 37
BP 198
EP 207
DI 10.1016/j.jiec.2016.03.021
PG 10
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA DO4FL
UT WOS:000377737100027
DA 2018-10-20
ER

PT J
AU Nayyer, L
   Jell, G
   Esmaeili, A
   Birchall, M
   Seifalian, AM
AF Nayyer, Leila
   Jell, Gavin
   Esmaeili, Ali
   Birchall, Martin
   Seifalian, Alexander M.
TI A Biodesigned Nanocomposite Biomaterial for Auricular Cartilage
   Reconstruction
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
DE auricular cartilage; biomaterial; Medpor; nanocomposite scaffold;
   POSS-PCU
ID GROWTH-FACTOR-BETA; POROUS POLYETHYLENE IMPLANTS; IN-VITRO;
   PROTEIN-ADSORPTION; EAR RECONSTRUCTION; FIBROTIC RESPONSE; MODIFIED
   TITANIUM; WOUND REPAIR; SURFACE; MACROPHAGE
AB Current biomaterials for auricular replacement are associated with high rates of infection and extrusion. The development of new auricular biomaterials that mimic the mechanical properties of native tissue and promote desirable cellular interactions may prevent implant failure. A porous 3D nanocomposite scaffold (NS) based on POSS-PCU (polyhedral oligomeric silsesquioxane nanocage into polycarbonate based urea-urethane) is developed with an elastic modulus similar to native ear. In vitro biological interactions on this NS reveal greater protein adsorption, increased fibroblast adhesion, proliferation, and collagen production compared with Medpor (the current synthetic auricular implant). In vivo, the POSS-PCU with larger pores (NS2; 150-250 m) have greater tissue ingrowth (approximate to 5.8x and approximate to 1.4 x increase) than the POSS-PCU with smaller pores (NS1; 100-50 m) and when compared to Medpor (>100 m). The NS2 with the larger pores demonstrates a reduced fibrotic encapsulation compared with NS1 and Medpor (approximate to 4.1x and approximate to 1.6x, respectively; P < 0.05). Porosity also influences the amount of neovascularization within the implants, with no blood vessel observed in NS1 (12 weeks postimplantation). The lack of chronic inflammatory response for all materials may indicate that the elastic modulus and pore size of the implant scaffold could be important design considerations for influencing fibrotic responses to auricular and other soft tissue implants.
C1 [Nayyer, Leila; Jell, Gavin; Esmaeili, Ali; Seifalian, Alexander M.] UCL, Div Surg & Intervent Sci, Mortimer St, London WC1E 6BT, England.
   [Birchall, Martin] UCL, Ear Inst, Mortimer St, London WC1E 6BT, England.
   [Esmaeili, Ali; Seifalian, Alexander M.] Royal Free Hampstead NHS Trust Hosp, Dept Plast & Reconstruct Surg, London NW3 2QG, England.
RP Jell, G (reprint author), UCL, Div Surg & Intervent Sci, Mortimer St, London WC1E 6BT, England.
EM g.jell@ucl.ac.uk
RI Jell, Gavin/C-4893-2009
FU UCL Ear Institute; Royal Free Hospital; HMRC [X6243, 501724]; Medical
   Research Council [MR/K026453/1, G1001539]; National Institute for Health
   Research [NF-SI-0513-10089]
FX The authors acknowledge A. Darbyshire for polymer material synthesis.
   The authors would like to acknowledge the Northwick Park Hospital
   Institute for assistance in the in vivo histology and IHC staining
   works, T. Jorgensenat from Falmouth University for use of the 3D
   printing facilities, and M. Durran for assistance in the glass-mould
   design. This research was financially supported by a generous gift from
   Hana Thalova to UCL Ear Institute and the Royal Free Hospital charity
   with HMRC No: X6243 and project No: 501724;
   http://www.ucl.ac.uk/ear/research/microtia/gift. Requests for materials
   should be addressed to A.M.S. The authors declare no competing financial
   interests in relation to the content of this paper.
CR Ahmed M., 2013, J BIOMED MAT RES B
   Ahmed M, 2014, BIOMATERIALS, V35, P9033, DOI 10.1016/j.biomaterials.2014.07.008
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Arora PD, 1999, AM J PATHOL, V154, P871, DOI 10.1016/S0002-9440(10)65334-5
   Bai F, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/1/015007
   Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x
   BERGHAUS A, 1985, ARCH OTOLARYNGOL, V111, P154
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Brunner G, 2004, THROMB HAEMOSTASIS, V92, P253, DOI 10.1160/TH04-05-0324
   CARDONA MA, 1992, J BIOMED MATER RES, V26, P851, DOI 10.1002/jbm.820260703
   Cenzi R, 2005, J CRANIOFAC SURG, V16, P526, DOI 10.1097/01.scs.0000168761.46700.dc
   Cha C, 2011, ACTA BIOMATER, V7, P3719, DOI 10.1016/j.actbio.2011.06.017
   Chaloupka K, 2011, BIOTECHNOL APPL BIOC, V58, P363, DOI 10.1002/bab.53
   Choritz L, 2010, INVEST OPHTH VIS SCI, V51, P4047, DOI 10.1167/iovs.09-4759
   Collier TO, 2002, J BIOMED MATER RES, V60, P487, DOI 10.1002/jbm.10043
   COX NH, 1987, Q J MED, V64, P661
   Davis P K, 1971, Br J Plast Surg, V24, P405, DOI 10.1016/S0007-1226(71)80099-1
   DIPIETRO LA, 1995, SHOCK, V4, P233, DOI 10.1097/00024382-199510000-00001
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   FERRARA N, 1989, BIOCHEM BIOPH RES CO, V161, P851, DOI 10.1016/0006-291X(89)92678-8
   Gerlach RC, 2013, OR SURG OR MED OR PA, V115, pE44, DOI 10.1016/j.oooo.2012.05.020
   Goreham RV, 2013, RSC ADV, V3, P10309, DOI 10.1039/c3ra23193c
   Guduru D, 2011, INT J ARTIF ORGANS, V34, P963, DOI [10.5301/ijao.5000012, 10.5301/IJAO.5000012]
   Harris J, 1996, J MED GENET, V33, P809, DOI 10.1136/jmg.33.10.809
   Henriksen TF, 2005, ANN PLAS SURG, V54, P343, DOI 10.1097/01.sap.0000151459.07978.fa
   Henry JA, 2009, ACTA BIOMATER, V5, P29, DOI 10.1016/j.actbio.2008.08.020
   Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613
   Hohman MH, 2014, ANN OTO RHINOL LARYN, V123, P135, DOI 10.1177/0003489414523710
   Hu XF, 2013, TISSUE ENG PT A, V19, P1919, DOI [10.1089/ten.tea.2012.0218, 10.1089/ten.TEA.2012.0218]
   Jell G, 2009, FUNDAMENTALS TISSUE, P469
   Jiang L, 2014, SPINAL CORD, V52, P145, DOI 10.1038/sc.2013.132
   Johnson R, 1997, Biomed Sci Instrum, V34, P47
   Jungebluth P, 2011, LANCET, V378, P1997, DOI 10.1016/S0140-6736(11)61715-7
   Kam KR, 2014, TISSUE ENG PT A, V20, P130, DOI [10.1089/ten.tea.2012.0772, 10.1089/ten.TEA.2012.0772]
   Kannan RY, 2006, BIOMATERIALS, V27, P1971, DOI 10.1016/j.biomaterials.2005.10.006
   Kao WYJ, 1999, BIOMATERIALS, V20, P2213, DOI 10.1016/S0142-9612(99)00152-0
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kopf BS, 2015, J BIOMED MATER RES A, V103, P2661, DOI 10.1002/jbm.a.35401
   Lavenus S, 2010, NANOMEDICINE-UK, V5, P937, DOI 10.2217/NNM.10.54
   Le SJ, 2010, DIFFERENTIATION, V79, P232, DOI 10.1016/j.diff.2010.03.001
   Lee S, 2011, ACTA BIOMATER, V7, P2337, DOI 10.1016/j.actbio.2011.01.006
   Li J, 2003, MICROSC RES TECHNIQ, V60, P107, DOI 10.1002/jemt.10249
   Li ZD, 2007, HEPATOLOGY, V46, P1246, DOI 10.1002/hep.21792
   Luquetti DV, 2011, BIRTH DEFECTS RES A, V91, P813, DOI 10.1002/bdra.20836
   MacDonald DE, 2002, BIOMATERIALS, V23, P1269, DOI 10.1016/S0142-9612(01)00317-9
   MERRITT K, 1979, J BIOMED MATER RES, V13, P101, DOI 10.1002/jbm.820130111
   MUSTOE TA, 1987, SCIENCE, V237, P1333, DOI 10.1126/science.2442813
   NAKAI H, 1979, BRIT J PLAST SURG, V32, P261, DOI 10.1016/0007-1226(79)90076-6
   Nayyer L, 2014, NANOMED-NANOTECHNOL, V10, P235, DOI 10.1016/j.nano.2013.06.006
   NEEL HB, 1983, ARCH OTOLARYNGOL, V109, P427
   RAPALA K, 1991, EUR SURG RES, V23, P261, DOI 10.1159/000129163
   Ratner B. D., 2004, BIOMATERIALS SCI INT
   Refai AK, 2004, J BIOMED MATER RES A, V70A, P194, DOI 10.1002/jbm.a.30075
   Reinisch JF, 2009, FACIAL PLAST SURG, V25, P181, DOI 10.1055/s-0029-1239448
   Roach P, 2006, J AM CHEM SOC, V128, P3939, DOI 10.1021/ja056278e
   Romo T, 2009, ANN PLAS SURG, V62, P384, DOI 10.1097/SAP.0b013e31819fae51
   ROSEN HM, 1991, PLAST RECONSTR SURG, V88, P1076, DOI 10.1097/00006534-199112000-00020
   RUBIN PAD, 1994, OPHTHALMOLOGY, V101, P1697
   Sclafani AP, 1997, PLAST RECONSTR SURG, V99, P41, DOI 10.1097/00006534-199701000-00007
   SHANBHAG A, 1990, ANN PLAS SURG, V24, P32, DOI 10.1097/00000637-199001000-00006
   Shephard P, 2004, AM J PATHOL, V164, P2055, DOI 10.1016/S0002-9440(10)63764-9
   Silver JH, 1999, BIOMATERIALS, V20, P1533, DOI 10.1016/S0142-9612(98)00173-2
   Tinsley D. M., 1994, OPHTHALMOLOGY, V4, P77
   VANROYEN BJ, 1986, PLAST RECONSTR SURG, V78, P360, DOI 10.1097/00006534-198609000-00013
   Wang K, 2015, BIOMATERIALS, V54, P63, DOI 10.1016/j.biomaterials.2015.03.019
   Webster T. J., 2000, KEY ENG MATER, V192-1, P321
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01
   Zhang Q, 2009, PLAST RECONSTR SURG, V123, P849, DOI 10.1097/PRS.0b013e318199f057
NR 69
TC 5
Z9 5
U1 3
U2 40
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD MAY 25
PY 2016
VL 5
IS 10
BP 1203
EP 1212
DI 10.1002/adhm.201500968
PG 10
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA DO1HE
UT WOS:000377528300012
PM 26992039
DA 2018-10-20
ER

PT J
AU Manchineella, S
   Thrivikraman, G
   Khanum, KK
   Ramamurthy, PC
   Basu, B
   Govindaraju, T
AF Manchineella, Shivaprasad
   Thrivikraman, Greeshma
   Khanum, Khadija K.
   Ramamurthy, Praveen C.
   Basu, Bikramjit
   Govindaraju, T.
TI Pigmented Silk Nanofibrous Composite for Skeletal Muscle Tissue
   Engineering
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
DE biomaterials; electroactive and antioxidant scaffolds; electrospinning;
   myogenesis; silk; melanin composite
ID OXIDATIVE STRESS; STEM-CELLS; IN-VITRO; BIOMEDICAL APPLICATIONS;
   CONDUCTIVE NANOFIBERS; DRUG-DELIVERY; FIBER MATS; DIFFERENTIATION;
   FIBROIN; SCAFFOLDS
AB Skeletal muscle tissue engineering (SMTE) employs designed biomaterial scaffolds for promoting myogenic differentiation of myoblasts to functional myotubes. Oxidative stress plays a significant role in the biocompatibility of biomaterials as well as in the fate of myoblasts during myogenesis and is also associated with pathological conditions such as myotonic dystrophy. The inherent electrical excitability of muscle cells inspired the use of electroactive scaffolds for SMTE. Conducting polymers attracted the attention of researchers for their use in muscle tissue engineering. However, poor biocompatibility, biodegradability and development of oxidative stress associated immunogenic response limits the extensive use of synthetic conducting polymers for SMTE. In order to address the limitations of synthetic polymers, intrinsically electroactive and antioxidant silk fibroin/melanin composite films and electrospun fiber mats were fabricated and evaluated as scaffolds for promoting myogenesis in vitro. Melanin incorporation modulated the thermal stability, electrical conductivity of scaffolds, fiber alignment in electrospun mats and imparted good antioxidant properties to the scaffolds. The composite electrospun scaffolds promoted myoblast assembly and differentiation into uniformly aligned high aspect ratio myotubes. The results highlight the significance of scaffold topography along with conductivity in promoting myogenesis and the potential application of silk nanofibrous composite as electoractive platform for SMTE.
C1 [Manchineella, Shivaprasad; Govindaraju, T.] Jawaharlal Nehru Ctr Adv Sci Res, Bioorgan Chem Lab, New Chem Unit, Bengaluru 560064, Karnataka, India.
   [Thrivikraman, Greeshma; Basu, Bikramjit] Indian Inst Sci, Mat Res Ctr, Lab Biomat, Bengaluru 560012, Karnataka, India.
   [Khanum, Khadija K.; Ramamurthy, Praveen C.] Indian Inst Sci, Dept Mat Engn, Organ Nano Elect Lab, Bengaluru 560012, Karnataka, India.
RP Govindaraju, T (reprint author), Jawaharlal Nehru Ctr Adv Sci Res, Bioorgan Chem Lab, New Chem Unit, Bengaluru 560064, Karnataka, India.
EM tgraju@jncasr.ac.in
RI T, Govindaraju/H-1471-2012; Manchineella, Shivaprasad/J-6726-2012
OI T, Govindaraju/0000-0002-9423-4275; Manchineella,
   Shivaprasad/0000-0002-8773-5426; T, Greeshma/0000-0002-0870-5369
FU JNCASR, the Department of Biotechnology (DBT), Government of India under
   Innovative Young Biotechnologist Award (IYBA) [BT/03/IYBA/2010];
   DST-SERB/health sciences, Government of India; Council of Scientific and
   Industrial Research (CSIR), India
FX S.M. and G.T. contributed equally to this work. The authors thank Prof.
   C. N. R. Rao, FRS, for his constant support and JNCASR, the Department
   of Biotechnology (DBT), Government of India, for a research grant
   (BT/03/IYBA/2010) under Innovative Young Biotechnologist Award (IYBA)
   2010. G.T. and B.B. greatly acknowledge the financial support from
   DST-SERB/health sciences, Government of India. The Council of Scientific
   and Industrial Research (CSIR), India, is greatly acknowledged for
   awarding research fellowship to S.M.
CR Amiraliyan N, 2010, POLYM SCI SER A+, V52, P407, DOI 10.1134/S0965545X10040097
   Angammana CJ, 2011, IEEE T IND APPL, V47, P1109, DOI 10.1109/TIA.2011.2127431
   Balint R, 2014, ACTA BIOMATER, V10, P2341, DOI 10.1016/j.actbio.2014.02.015
   Barbieri Elena, 2012, J Signal Transduct, V2012, P982794, DOI 10.1155/2012/982794
   Bettinger CJ, 2009, BIOMATERIALS, V30, P3050, DOI 10.1016/j.biomaterials.2009.02.018
   Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Bothma JP, 2008, ADV MATER, V20, P3539, DOI 10.1002/adma.200703141
   Broda CR, 2011, J BIOMED MATER RES A, V98A, P509, DOI 10.1002/jbm.a.33128
   Burattini S, 2004, EUR J HISTOCHEM, V48, P223
   Canton M, 2014, J MUSCLE RES CELL M, V35, P23, DOI 10.1007/s10974-014-9380-2
   Chen MC, 2013, ACTA BIOMATER, V9, P5562, DOI 10.1016/j.actbio.2012.10.024
   Chuysinuan P, 2012, ACS APPL MATER INTER, V4, P3031, DOI 10.1021/am300404v
   Cirilo G., 2012, ANTIOXIDANT POLYM SY
   d'Ischia M, 2015, PIGM CELL MELANOMA R, V28, P520, DOI 10.1111/pcmr.12393
   d'Ischia M, 2014, ACCOUNTS CHEM RES, V47, P3541, DOI 10.1021/ar500273y
   Das S, 2015, ACTA BIOMATER, V11, P233, DOI 10.1016/j.actbio.2014.09.023
   Essick EE, 2010, OXID MED CELL LONGEV, V3, P168, DOI 10.4161/oxim.3.3.12106
   Fitzmaurice SD, 2011, SKIN PHARMACOL PHYS, V24, P113, DOI 10.1159/000322643
   Hardy JG, 2015, MACROMOL RAPID COMM, V36, P1884, DOI 10.1002/marc.201500233
   He CL, 2014, J MATER CHEM B, V2, P7828, DOI 10.1039/c4tb01464b
   Higuchi A, 2013, CHEM REV, V113, P3297, DOI 10.1021/cr300426x
   Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a
   Jain S, 2013, BIOMATERIALS, V34, P9252, DOI 10.1016/j.biomaterials.2013.08.057
   Ju KY, 2011, BIOMACROMOLECULES, V12, P625, DOI 10.1021/bm101281b
   Kai D, 2013, J MATER CHEM B, V1, P2305, DOI 10.1039/c3tb00151b
   Kasoju N, 2012, J BIOMED MATER RES B, V100B, P1854, DOI 10.1002/jbm.b.32753
   Khanum KK, 2015, RSC ADV, V5, P60419, DOI 10.1039/c5ra06468f
   Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/NMAT2745, 10.1038/nmat2745]
   Kim DW, 2015, BIOMATERIALS, V70, P48, DOI 10.1016/j.biomaterials.2015.08.025
   Kim E, 2014, BIOMACROMOLECULES, V15, P1653, DOI 10.1021/bm500026x
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   Kim SH, 2015, J CONTROL RELEASE, V206, P101, DOI 10.1016/j.jconrel.2015.03.026
   Kim YJ, 2013, P NATL ACAD SCI USA, V110, P20912, DOI 10.1073/pnas.1314345110
   Ku SH, 2012, BIOMATERIALS, V33, P6098, DOI 10.1016/j.biomaterials.2012.05.018
   Kulkarni A, 2010, POLYM-PLAST TECHNOL, V49, P427, DOI 10.1080/03602550903414019
   Kundu B, 2014, PROG POLYM SCI, V39, P251, DOI 10.1016/j.progpolymsci.2013.09.002
   Kundu S., 2014, SILK BIOMATERIALS TI
   Lawson MA, 2000, CELLS TISSUES ORGANS, V167, P130, DOI 10.1159/000016776
   Li Z., 2013, ONE DIMENSIONAL NANO
   Liu WE, 2011, BIOMATERIALS, V32, P1796, DOI 10.1016/j.biomaterials.2010.11.029
   Matheson LA, 2004, J CELL PHYSIOL, V199, P8, DOI 10.1002/jcp.10412
   McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004
   MCGINNESS J, 1974, SCIENCE, V183, P853, DOI 10.1126/science.183.4127.853
   Meechaisue C, 2007, BIOMED MATER, V2, P181, DOI 10.1088/1748-6041/2/3/003
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   Mitra J, 2013, CARBON, V65, P140, DOI 10.1016/j.carbon.2013.08.008
   Mostert AB, 2012, P NATL ACAD SCI USA, V109, P8943, DOI 10.1073/pnas.1119948109
   O'Brien F. J., 2006, MATER TODAY, V14, P88
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Parker ST, 2009, ADV MATER, V21, P2411, DOI 10.1002/adma.200801580
   Pham-Huy Lien Ai, 2008, Int J Biomed Sci, V4, P89
   Poltawski L, 2009, PHYS THER REV, V14, P104, DOI 10.1179/174328809X405973
   Potter-Baker KA, 2015, ACS MACRO LETT, V4, P275, DOI 10.1021/mz500743a
   Qazi TH, 2015, BIOMATERIALS, V53, P502, DOI 10.1016/j.biomaterials.2015.02.110
   Qazi TH, 2014, BIOMATERIALS, V35, P9068, DOI 10.1016/j.biomaterials.2014.07.020
   Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Seib FP, 2013, ISR J CHEM, V53, P756, DOI 10.1002/ijch.201300083
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Sirivisoot S, 2011, INT J NANOMED, V6, P2483, DOI 10.2147/IJN.S24073
   Solano F., 2014, NEW J SCI, V2014, DOI [10. 1155/2014/498276, DOI 10.1155/2014/498276]
   Tansil NC, 2012, ADV MATER, V24, P1388, DOI 10.1002/adma.201104118
   Tao H, 2012, ADV MATER, V24, P2824, DOI 10.1002/adma.201104477
   Thrivikraman G, 2013, BIOMATERIALS, V34, P7073, DOI 10.1016/j.biomaterials.2013.05.076
   Uyar T, 2008, POLYMER, V49, P5336, DOI 10.1016/j.polymer.2008.09.025
   Vallejo-Giraldo C, 2014, DRUG DISCOV TODAY, V19, P88, DOI 10.1016/j.drudis.2013.07.022
   van Lith R, 2014, BIOMATERIALS, V35, P8113, DOI 10.1016/j.biomaterials.2014.06.004
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wattamwar PP, 2010, ADV FUNCT MATER, V20, P147, DOI 10.1002/adfm.200900839
   Wolf MT, 2015, ADV DRUG DELIVER REV, V84, P208, DOI 10.1016/j.addr.2014.08.011
   Xu JZ, 2014, COLLOID SURFACE B, V123, P907, DOI 10.1016/j.colsurfb.2014.10.041
   Zhang F, 2012, BIOMACROMOLECULES, V13, P798, DOI 10.1021/bm201719s
   Zhou J, 2014, ACS APPL MATER INTER, V6, P21813, DOI 10.1021/am502278b
NR 74
TC 16
Z9 17
U1 8
U2 66
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD MAY 25
PY 2016
VL 5
IS 10
BP 1222
EP 1232
DI 10.1002/adhm.201501066
PG 11
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA DO1HE
UT WOS:000377528300014
PM 27226037
DA 2018-10-20
ER

PT J
AU Zou, YW
   Qin, JB
   Huang, ZB
   Yin, GF
   Pu, XM
   He, D
AF Zou, Yuanwen
   Qin, Jiabang
   Huang, Zhongbing
   Yin, Guangfu
   Pu, Ximing
   He, Da
TI Fabrication of Aligned Conducting PPy-PLLA Fiber Films and Their
   Electrically Controlled Guidance and Orientation for Neurites
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE aligned conducting fibers; PPy-PLLA; electrical controlled guidance;
   neurites orientation; nerve regeneration
ID STIMULATING ELECTRODES; NERVE REGENERATION; BONE REGENERATION; GROWTH;
   POLYPYRROLE; NANOFIBERS; OUTGROWTH; POLYMER; BIOMATERIALS; EXTENSION
AB Electrically conductive biomaterial scaffolds have great potential in a neural tissue regeneration. In this work, an aligned conductive fibrous scaffold was prepared by electrospinning PLLA on rotating collector and chemical oxidation polymerization of pyrrole (PPy) codoped with poly(glutamic acid)/dodecyl benzenesulfonic acid sodium. The characterization results of composition, structure and mechanics of fiber films show that the existence of weak polar van der Waals' force between PPy coating and PLLA fibers. The resistivity of aligned rough PPy-PLLA fiber film (about 800 nm of fiber diameter) at the perpendicular and parallel directions is 0.971 and 0.874 Omega m, respectively. Aligned rough PPy-PLLA fiber film could guide the extension of 68% PC12 neurites along the direction of fiber axis. Under electrostimulation (ES) of 100, 200, and 400 mV/cm, median neurite lengths of differentiated PC12 on aligned fiber-films are 128, 149, and 141 pm, respectively. Furthermore, under ES of 100, 200, and 400 mV/cm, the alignment rate of neurite along the electropotential direction (angle between neurite and electropotential direction <= 10 degrees) on random fibers film are 17, 23, and 28%, respectively, and the alignment rate of neurites along the fiber axis (angle between neurite and fiber axis <= 10 degrees) on aligned fibers film reach to 76, 83, and 79%, respectively, indicating that the combination of ES and rough conducting aligned structure could adjust the alignment of cellular neurites along the direction of the fiber axis or electropotential.
C1 [Zou, Yuanwen; Qin, Jiabang; Huang, Zhongbing; Yin, Guangfu; Pu, Ximing; He, Da] Sichuan Univ, Coll Mat Sci & Engn, Chengdu 610065, Peoples R China.
RP Huang, ZB (reprint author), Sichuan Univ, Coll Mat Sci & Engn, Chengdu 610065, Peoples R China.
EM zbhuang@scu.edu.cn
FU National Natural Science Foundation of China [51273122, 51173120,
   51202151]
FX This work has been supported by the National Natural Science Foundation
   of China (Projects 51273122, 51173120, and 51202151).
CR Amillo S, 1995, MICROSURG, V16, P621, DOI 10.1002/micr.1920160908
   Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Boland ED, 2001, ABSTR PAP AM CHEM S, V222, pU344
   Burnette DT, 2008, DEV CELL, V15, P163, DOI 10.1016/j.devcel.2008.05.016
   Chang YJ, 2013, BBA-GEN SUBJECTS, V1830, P4130, DOI 10.1016/j.bbagen.2013.04.007
   Chougule M. A., 2011, SOFT NANOSCI LETT, V1, P6, DOI [10.4236/snl.2011.11002, DOI 10.4236/SNL.2011.11002]
   Cogan SF, 2008, ANNU REV BIOMED ENG, V10, P275, DOI 10.1146/annurev.bioeng.10.061807.160518
   Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631
   CRAGGS MD, 1986, MED BIOL ENG COMPUT, V24, P424, DOI 10.1007/BF02442699
   DOSHI J, 1995, J ELECTROSTAT, V35, P151, DOI 10.1016/0304-3886(95)00041-8
   FAWCETT JW, 1990, ANNU REV NEUROSCI, V13, P43, DOI 10.1146/annurev.neuro.13.1.43
   Ghosh P, 2015, COLLOID SURFACE B, V125, P160, DOI 10.1016/j.colsurfb.2014.11.031
   Ghosh P, 2014, RSC ADV, V4, P19516, DOI 10.1039/c4ra01971g
   Gomez N, 2007, ADV FUNCT MATER, V17, P1645, DOI 10.1002/adfm.200600669
   Gomez N, 2007, J BIOMED MATER RES A, V81A, P135, DOI 10.1002/jbm.a.31047
   Guimard NK, 2007, PROG POLYM SCI, V32, P876, DOI 10.1016/j.progpolymsci.2007.05.012
   Hsiao CW, 2013, BIOMATERIALS, V34, P1063, DOI 10.1016/j.biomaterials.2012.10.065
   Kotwal A, 2001, BIOMATERIALS, V22, P1055, DOI 10.1016/S0142-9612(00)00344-6
   Lee JY, 2009, BIOMATERIALS, V30, P4325, DOI 10.1016/j.biomaterials.2009.04.042
   Millesi H, 2000, HAND CLIN, V16, P73
   PATEL N, 1982, J NEUROSCI, V2, P483
   PATEL NB, 1984, J NEUROSCI, V4, P2939
   Rafique J, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2768871
   Sanghvi AB, 2005, NAT MATER, V4, P496, DOI 10.1038/nmat1397
   Schaefer AW, 2002, J CELL BIOL, V158, P139, DOI 10.1083/jcb.200203038
   SCHINDLER A, 1979, J POLYM SCI POL CHEM, V17, P2593, DOI 10.1002/pol.1979.170170831
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Song HK, 2006, BIOMATERIALS, V27, P473, DOI 10.1016/j.biomaterials.2005.06.030
   Suter DM, 2011, PROG NEUROBIOL, V94, P91, DOI 10.1016/j.pneurobio.2011.04.002
   Suter DM, 2000, J NEUROBIOL, V44, P97, DOI 10.1002/1097-4695(200008)44:2<97::AID-NEU2>3.0.CO;2-U
   Weiland JD, 2002, IEEE T BIO-MED ENG, V49, P1574, DOI 10.1109/TBME.2002.805487
   Xie JW, 2009, ADV FUNCT MATER, V19, P2312, DOI 10.1002/adfm.200801904
   Xie JW, 2009, BIOMATERIALS, V30, P354, DOI 10.1016/j.biomaterials.2008.09.046
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yu QZ, 2011, MATER SCI ENG B-ADV, V176, P913, DOI 10.1016/j.mseb.2011.05.017
   Zeng JW, 2013, COLLOID SURFACE B, V110, P450, DOI 10.1016/j.colsurfb.2013.05.012
   Zhang JM, 2005, MACROMOLECULES, V38, P8012, DOI 10.1021/ma051232r
NR 38
TC 13
Z9 15
U1 8
U2 75
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD MAY 25
PY 2016
VL 8
IS 20
BP 12576
EP 12582
DI 10.1021/acsami.6b00957
PG 7
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA DN1KX
UT WOS:000376825800002
PM 27172537
DA 2018-10-20
ER

PT J
AU Li, CY
   Chaung, W
   Mozayan, C
   Chabra, R
   Wang, P
   Narayan, RK
AF Li, Chunyan
   Chaung, Wayne
   Mozayan, Cameron
   Chabra, Ranjeev
   Wang, Ping
   Narayan, Raj K.
TI A New Approach for On-Demand Generation of Various Oxygen Tensions for
   In Vitro Hypoxia Models
SO PLOS ONE
LA English
DT Article
ID CELL-CULTURE; MICROFLUIDIC DEVICES; HYDROGEN-PEROXIDE; STEM-CELLS;
   GRADIENTS; INJURY; ALPHA; MICROENVIRONMENT; MACROPHAGES; ISCHEMIA
AB The development of in vitro disease models closely mimicking the functions of human disease has captured increasing attention in recent years. Oxygen tensions and gradients play essential roles in modulating biological systems in both physiologic and pathologic events. Thus, controlling oxygen tension is critical for mimicking physiologically relevant in vivo environments for cell, tissue and organ research. We present a new approach for on-demand generation of various oxygen tensions for in vitro hypoxia models. Proof-of-concept prototypes have been developed for conventional cell culture microplate by immobilizing a novel oxygen-consuming biomaterial on the 3D-printed insert. For the first time, rapid (similar to 3.8 minutes to reach 0.5% O-2 from 20.9% O-2) and precisely controlled oxygen tensions/gradients (2.68 mmHg per 50 mu m distance) were generated by exposing the biocompatible biomaterial to the different depth of cell culture media. In addition, changing the position of 3D-printed inserts with immobilized biomaterials relative to the cultured cells resulted in controllable and rapid changes in oxygen tensions (<130 seconds). Compared to the current technologies, our approach allows enhanced spatiotemporal resolution and accuracy of the oxygen tensions. Additionally, it does not interfere with the testing environment while maintaining ease of use. The elegance of oxygen tension manipulation introduced by our new approach will drastically improve control and lower the technological barrier of entry for hypoxia studies. Since the biomaterials can be immobilized in any devices, including microfluidic devices and 3D-printed tissues or organs, it will serve as the basis for a new generation of experimental models previously impossible or very difficult to implement.
C1 [Li, Chunyan; Chabra, Ranjeev; Narayan, Raj K.] Feinstein Inst Med Res, Cushing Neuromonitoring Lab, Manhasset, NY USA.
   [Li, Chunyan; Mozayan, Cameron; Narayan, Raj K.] Hofstra Northwell Sch Med, Dept Neurosurg, Manhasset, NY USA.
   [Chaung, Wayne; Wang, Ping] Feinstein Inst Med Res, Ctr Translat Res, Manhasset, NY USA.
RP Li, CY (reprint author), Feinstein Inst Med Res, Cushing Neuromonitoring Lab, Manhasset, NY USA.; Li, CY (reprint author), Hofstra Northwell Sch Med, Dept Neurosurg, Manhasset, NY USA.
EM cli11@nshs.edu
FU Department of Neurosurgery at Northwell Health; U.S. Department of
   Defense [W81XWH-10-1-0978]
FX This work was supported in part by the Department of Neurosurgery at
   Northwell Health and U.S. Department of Defense (W81XWH-10-1-0978). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Adler M, 2010, LAB CHIP, V10, P388, DOI 10.1039/b920401f
   Allen CB, 2001, AM J PHYSIOL-LUNG C, V281, pL1021
   Allen JW, 2003, BIOTECHNOL BIOENG, V82, P253, DOI 10.1002/bit.10569
   Au AK, 2014, LAB CHIP, V14, P1294, DOI 10.1039/c3lc51360b
   Benam KH, 2015, ANNU REV PATHOL-MECH, V10, P195, DOI 10.1146/annurev-pathol-012414-040418
   Bhatia SN, 2014, NAT BIOTECHNOL, V32, P760, DOI 10.1038/nbt.2989
   Bickler PE, 2015, NEUROSCIENCE, V310, P306, DOI 10.1016/j.neuroscience.2015.09.021
   Brennan MD, 2014, LAB CHIP, V14, P4305, DOI 10.1039/c4lc00853g
   Byrne MB, 2014, TRENDS BIOTECHNOL, V32, P556, DOI 10.1016/j.tibtech.2014.09.006
   Carreau A, 2011, J CELL MOL MED, V15, P1239, DOI 10.1111/j.1582-4934.2011.01258.x
   Chang CW, 2014, LAB CHIP, V14, P3762, DOI 10.1039/c4lc00732h
   Genbacev O, 1997, SCIENCE, V277, P1669, DOI 10.1126/science.277.5332.1669
   Gross BC, 2014, ANAL CHEM, V86, P3240, DOI 10.1021/ac403397r
   Hopkins AM, 2015, PROG NEUROBIOL, V125, P1, DOI 10.1016/j.pneurobio.2014.11.003
   Huang QY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061345
   Huh D, 2011, TRENDS CELL BIOL, V21, P745, DOI 10.1016/j.tcb.2011.09.005
   Hung SP, 2012, J ORTHOP RES, V30, P260, DOI 10.1002/jor.21517
   Lee WH, 2009, ARCH PHARM RES, V32, P421, DOI 10.1007/s12272-009-1316-9
   Lo JF, 2010, LAB CHIP, V10, P2394, DOI 10.1039/c004660d
   Martou G, 2006, J APPL PHYSIOL, V101, P1335, DOI 10.1152/japplphysiol.00278.2006
   Miksa M, 2007, MOL MED, V13, P553, DOI 10.2119/2007-00019.Miksa
   Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007
   Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706
   Mueller S, 2009, ADV MED SCI-POLAND, V54, P121, DOI 10.2478/v10039-009-0042-3
   Nistico R, 2008, BRIT J PHARMACOL, V153, P1022, DOI 10.1038/sj.bjp.0707587
   Peng CC, 2013, LAB CHIP, V13, P3239, DOI 10.1039/c3lc50388g
   Polinkovsky M, 2009, LAB CHIP, V9, P1073, DOI 10.1039/b816191g
   SCANNELL G, 1993, J SURG RES, V54, P281, DOI 10.1006/jsre.1993.1044
   Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021
   Skolimowski M, 2010, LAB CHIP, V10, P2162, DOI 10.1039/c003558k
   Suda T, 2011, CELL STEM CELL, V9, P298, DOI 10.1016/j.stem.2011.09.010
   Takeda N, 2010, GENE DEV, V24, P491, DOI 10.1101/gad.1881410
   Waldbaur A, 2011, ANAL METHODS-UK, V3, P2681, DOI 10.1039/c1ay05253e
   WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510
   Wang L, 2013, LAB CHIP, V13, P695, DOI [10.1039/c2lc40661f, 10.1039/C2LC40661F]
   Yu X, 2012, J MOL CELL CARDIOL, V53, P848, DOI 10.1016/j.yjmcc.2012.10.002
NR 36
TC 3
Z9 3
U1 1
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 24
PY 2016
VL 11
IS 5
AR e0155921
DI 10.1371/journal.pone.0155921
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DN2FY
UT WOS:000376880700028
PM 27219067
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Clifford, R
   Sparks, M
   Hosford, E
   Ong, A
   Richesson, D
   Fraser, S
   Kwak, Y
   Miller, S
   Julius, M
   McGann, P
   Lesho, E
AF Clifford, Robert
   Sparks, Michael
   Hosford, Eve
   Ong, Ana
   Richesson, Douglas
   Fraser, Susan
   Kwak, Yoon
   Miller, Sonia
   Julius, Michael
   McGann, Patrick
   Lesho, Emil
TI Correlating Cleaning Thoroughness with Effectiveness and Briefly
   Intervening to Affect Cleaning Outcomes: How Clean Is Cleaned?
SO PLOS ONE
LA English
DT Article
ID RESISTANT STAPHYLOCOCCUS-AUREUS; DISINFECTION TISSUE DISPENSERS;
   COMPARING SURFACE DISINFECTION; CARE-ASSOCIATED INFECTIONS;
   EVIDENCE-BASED DESIGN; HOSPITAL ROOM; CLINICAL-PRACTICE; OVERWEIGHT;
   PARADIGM; PITFALLS
AB Objectives
   The most efficient approach to monitoring and improving cleaning outcomes remains unresolved. We sought to extend the findings of a previous study by determining whether cleaning thoroughness (dye removal) correlates with cleaning efficacy (absence of molecular or cultivable biomaterial) and whether one brief educational intervention improves cleaning outcomes.
   Design
   Before-after trial.
   Setting
   Newly built community hospital.
   Intervention
   90 minute training refresher with surface-specific performance results.
   Methods
   Dye removal, measured by fluorescence, and biomaterial removal and acquisition, measured with culture and culture-independent PCR-based assays, were clandestinely assessed for eight consecutive months. At this midpoint, results were presented to the cleaning staff (intervention) and assessments continued for another eight consecutive months.
   Results
   1273 surfaces were sampled before and after terminal room cleaning. In the short-term, dye removal increased from 40.3% to 50.0% (not significant). For the entire study period, dye removal also improved but not significantly. After the intervention, the number of rooms testing positive for specific pathogenic species by culturing decreased from 55.6% to 36.6% (not significant), and those testing positive by PCR fell from 80.6% to 53.7%(P = 0.016). For nonspecific biomaterial on surfaces: a) removal of cultivable Gram-negatives (GN) trended toward improvement (P = 0.056); b) removal of any cultivable growth was unchanged but acquisition (detection of biomaterial on post-cleaned surfaces that were contaminant-free before cleaning) worsened (P = 0.017); c) removal of PCR-based detection of bacterial DNA improved (P = 0.046), but acquisition worsened (P = 0.003); d) cleaning thoroughness and efficacy were not correlated.
   Conclusion
   At this facility, a minor intervention or minimally more aggressive cleaning may reduce pathogen-specific contamination, but not without unintended consequences.
C1 [Clifford, Robert; Sparks, Michael; Hosford, Eve; Ong, Ana; Richesson, Douglas; Kwak, Yoon; Julius, Michael; McGann, Patrick; Lesho, Emil] Walter Reed Army Inst Res, Multidrug Resistant Organism Repository & Surveil, Silver Spring, MD USA.
   [Fraser, Susan; Miller, Sonia] Ft Belvoir Community Hosp, Dept Infect Dis & Infect Control, Ft Belvoir, VA USA.
RP Lesho, E (reprint author), Walter Reed Army Inst Res, Multidrug Resistant Organism Repository & Surveil, Silver Spring, MD USA.
EM carolinelesho@yahoo.com
OI Mc Gann, Patrick/0000-0003-1548-9438
FU U.S. Army Medical Command; Department of Defense Global Emerging
   Infection Surveillance and Response System
FX This work was funded by the U.S. Army Medical Command and the Department
   of Defense Global Emerging Infection Surveillance and Response System.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Baron RB, 2011, ARCH INTERN MED, V171, P321, DOI 10.1001/archinternmed.2011.5
   Bogusz A., 2013, Healthcare Infection, V18, P3, DOI 10.1071/HI12063
   Boyce JM, 2007, J HOSP INFECT, V65, P50, DOI 10.1016/S0195-6701(07)60015-2
   Carling PC, 2015, INFECT CONT HOSP EP, V36, P850, DOI 10.1017/ice.2015.84
   Carling PC, 2014, INFECT CONT HOSP EP, V35, P1349, DOI 10.1086/678424
   Caselli E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148857
   Clifford RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048558
   DHHS, 2013, NATIONAL ACTION PLAN
   Force USPST, 2009, ANN INTERN MED, V150, P551
   Guh H, ENVIRONMENTAL EVALUA
   Han JH, 2015, ANN INTERN MED, V163, P598, DOI 10.7326/M15-1192
   Kampf G, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-37
   Kupfahl C, 2015, INFECT CONT HOSP EP, V36, P1362, DOI 10.1017/ice.2015.176
   Lesho E, 2015, INFECT CONT HOSP EP, V36, P1130, DOI 10.1017/ice.2015.151
   Livorsi DJ, 2015, INFECT CONT HOSP EP, V36, P1335, DOI 10.1017/ice.2015.174
   Manian FA, 2011, INFECT CONT HOSP EP, V32, P667, DOI 10.1086/660357
   Mitchell BG, 2015, J HOSP INFECT, V91, P211, DOI 10.1016/j.jhin.2015.08.005
   Otter JA, 2011, J HOSP INFECT, V79, P189, DOI 10.1016/j.jhin.2011.04.028
   Overballe-Petersen S, 2013, P NATL ACAD SCI USA, V110, P19860, DOI 10.1073/pnas.1315278110
   Post RE, 2011, ARCH INTERN MED, V171, P316, DOI 10.1001/archinternmed.2010.549
   Rupp ME, 2013, INFECT CONT HOSP EP, V34, P100, DOI 10.1086/668779
   Sattar SA, 2010, AM J INFECT CONTROL, V38, pS34, DOI 10.1016/j.ajic.2010.04.207
   Septimus E, 2014, INFECT CONT HOSP EP, V35, P797, DOI [10.1086/676535, 10.1017/S0899823X00193808]
   Smith PW, 2014, INFECT CONT HOSP EP, V35, P564, DOI 10.1086/675839
   Stewart M, 2014, INFECT CONT HOSP EP, V35, P1505, DOI 10.1086/678595
   Vandini A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108598
   Zimring C, 2013, INFECT CONT HOSP EP, V34, P514, DOI 10.1086/670220
NR 27
TC 4
Z9 4
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 19
PY 2016
VL 11
IS 5
AR e0155779
DI 10.1371/journal.pone.0155779
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DM4BR
UT WOS:000376291100100
PM 27196635
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Farago, S
   Lucconi, G
   Perteghella, S
   Vigani, B
   Tripodo, G
   Sorrenti, M
   Catenacci, L
   Boschi, A
   Faustini, M
   Vigo, D
   Chlapanidas, T
   Marazzi, M
   Torre, ML
AF Farago, Silvio
   Lucconi, Giulia
   Perteghella, Sara
   Vigani, Barbara
   Tripodo, Giuseppe
   Sorrenti, Milena
   Catenacci, Laura
   Boschi, Alessandra
   Faustini, Massimo
   Vigo, Daniele
   Chlapanidas, Theodora
   Marazzi, Mario
   Torre, Maria Luisa
TI A dry powder formulation from silk fibroin microspheres as a topical
   auto-gelling device
SO PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
LA English
DT Article
DE Alginate; microparticles; poloxamer; polyethylene glycol; silk fibroin;
   spray-drying; wound healing
ID CONFORMATION TRANSITION KINETICS; DRUG-DELIVERY; HYALURONIC-ACID;
   BIOMATERIAL; TISSUE; SPECTROSCOPY; HYDROGELS; THERAPY; RELEASE; SPHERES
AB With the aim of establishing the formulation of a new hydrophilic auto-gelling medical device for biomedical applications, fibroin-based microspheres were prepared. The proposed microspheres were produced by a cost-effective and industrially scalable technique, such as the spray-drying. Spray-dried silk fibroin microspheres were obtained and the effects of different hydrophilic polymer on the process yield, microsphere morphology and conformation transition of fibroin were evaluated. The final auto-gelling formulations were obtained by adding calcium gluconate (as a calcium source for alginate crosslinking) to the prepared microspheres and tested by an in vitro gelling test. This study showed that the combination of fibroin with sodium alginate and poloxamer produced the most promising auto-gelling formulation for specific biomedical applications, such as the treatment of pressure ulcers.
C1 [Farago, Silvio; Boschi, Alessandra] Innovhub, Stn Sperimentali Ind, Silk Div, Milan, Italy.
   [Lucconi, Giulia; Perteghella, Sara; Vigani, Barbara; Tripodo, Giuseppe; Sorrenti, Milena; Catenacci, Laura; Chlapanidas, Theodora; Torre, Maria Luisa] Univ Pavia, Dept Drug Sci, Via Taramelli 12, I-27100 Pavia, Italy.
   [Faustini, Massimo; Vigo, Daniele] Univ Milan, Dept Vet Sci & Publ Hlth, Milan, Italy.
   [Marazzi, Mario] Osped Niguarda Ca Granda, Struttura Semplice Tissue Therapy, Milan, Italy.
RP Chlapanidas, T (reprint author), Univ Pavia, Dept Drug Sci, Via Taramelli 12, I-27100 Pavia, Italy.
EM theodora.chlapanidas@unipv.it
RI VIGO, DANIELE/L-4868-2017; Tripodo, Giuseppe/C-7232-2011; faustini,
   massimo/K-6595-2017
OI VIGO, DANIELE/0000-0002-6292-4992; Tripodo,
   Giuseppe/0000-0001-5462-5629; faustini, massimo/0000-0003-2182-1003;
   Perteghella, Sara/0000-0003-1128-7636; TORRE, MARIA
   LUISA/0000-0001-8062-6836
FU Eurostars project [E!5227]
FX This work was supported by Eurostars project application E!5227
   FIBROSPHERE. The authors thank Eng. Marzio Sorlini (SUPSI - University
   of Applied Sciences and Arts of Southern Switzerland, Innovative
   Technologies Department) for their precious support during all the steps
   of the research project.
CR Chen X, 2001, BIOPHYS CHEM, V89, P25, DOI 10.1016/S0301-4622(00)00213-1
   Chen X, 2007, PROTEINS, V68, P223, DOI 10.1002/prot.21414
   Chlapanidas T, 2013, INT J IMMUNOPATH PH, V26, P43, DOI 10.1177/03946320130260S106
   Chlapanidas T, 2011, TISSUE ENG PT A, V17, P1725, DOI 10.1089/ten.tea.2010.0636
   Chlapanidas T, 2013, INT J BIOL MACROMOL, V58, P47, DOI 10.1016/j.ijbiomac.2013.03.054
   Chung TW, 2011, J TAIWAN INST CHEM E, V42, P592, DOI 10.1016/j.jtice.2010.11.003
   Dumortier G, 2006, PHARM RES, V23, P2709, DOI 10.1007/s11095-006-9104-4
   Dyakonov T, 2012, J DRUG DELIV, DOI 10.1155/2012/490514
   Fortunati D, 2014, AMINO ACIDS, V46, P1751, DOI 10.1007/s00726-014-1732-0
   Gaetani P, 2008, TISSUE ENG PT A, V14, P1415, DOI 10.1089/ten.tea.2007.0330
   Ghidoni I, 2008, CYTOTECHNOLOGY, V58, P49, DOI 10.1007/s10616-008-9161-0
   Hino Tomoaki, 2000, Pharmacy and Pharmacology Communications, V6, P335
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Innocente F, 2009, CIRCULATION, V120, pS37, DOI 10.1161/CIRCULATIONAHA.109.848242
   Kundu B, 2013, ADV DRUG DELIVER REV, V65, P457, DOI 10.1016/j.addr.2012.09.043
   Lawrence BD, 2008, J MATER SCI, V43, P6967, DOI 10.1007/s10853-008-2961-y
   Ling SJ, 2012, MATER LETT, V81, P13, DOI 10.1016/j.matlet.2012.04.136
   Liu TL, 2010, J ZHEJIANG UNIV-SC B, V11, P10, DOI 10.1631/jzus.B0900163
   Lu SZ, 2009, BIOMACROMOLECULES, V10, P1032, DOI 10.1021/bm800956n
   Min SJ, 2012, J BIOMAT SCI-POLYM E, V23, P97, DOI 10.1163/092050610X543609
   Ming JF, 2014, POLYM ENG SCI, V54, P129, DOI 10.1002/pen.23542
   Mitropoulos AN, 2014, ADV MATER, V26, P1105, DOI 10.1002/adma.201304244
   Nottelet B, 2009, J BIOMED MATER RES A, V89A, P865, DOI 10.1002/jbm.a.32023
   Pajardi G, 2016, INT WOUND J, V13, P44, DOI 10.1111/iwj.12223
   Palumbo FS, 2006, CARBOHYD POLYM, V66, P379, DOI 10.1016/j.carbpol.2006.03.023
   Pitarresi G, 2007, EUR POLYM J, V43, P3953, DOI 10.1016/j.eurpolymj.2007.06.027
   Pitarresi G, 2006, BIOMACROMOLECULES, V7, P1302, DOI 10.1021/bm050697m
   Pritchard EM, 2011, EXPERT OPIN DRUG DEL, V8, P797, DOI 10.1517/17425247.2011.568936
   Pritchard EM, 2010, J CONTROL RELEASE, V144, P159, DOI 10.1016/j.jconrel.2010.01.035
   Qiang L, 2004, J MATER SCI-MATER M, V15, P1193, DOI 10.1007/s10856-004-5918-y
   Qin YM, 2008, POLYM ADVAN TECHNOL, V19, P6, DOI 10.1002/pat.960
   Qu J.Q., 2013, J BIOMATER NANOBIOTE, V4, P84
   Roche ET, 2014, BIOMATERIALS, V35, P6850, DOI 10.1016/j.biomaterials.2014.04.114
   Roh DH, 2006, J MATER SCI-MATER M, V17, P547, DOI 10.1007/s10856-006-8938-y
   Teuschl AH, 2014, ACTA BIOMATER, V10, P2506, DOI 10.1016/j.actbio.2014.02.012
   Tripodo G, 2012, MATER RES SOC SYMP P, V1403, P21, DOI 10.1557/opl.2012.223
   Tripodo G, 2011, MACROMOL SYMP, V309-310, P49, DOI 10.1002/masy.201100058
   Um IC, 2001, INT J BIOL MACROMOL, V29, P91, DOI 10.1016/S0141-8130(01)00159-3
   Vasconcelos A, 2008, BIOMACROMOLECULES, V9, P1299, DOI 10.1021/bm7012789
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang XQ, 2010, BIOMATERIALS, V31, P1025, DOI 10.1016/j.biomaterials.2009.11.002
   Wenk E, 2008, J CONTROL RELEASE, V132, P26, DOI 10.1016/j.jconrel.2008.08.005
   Wenk E, 2011, J CONTROL RELEASE, V150, P128, DOI 10.1016/j.jconrel.2010.11.007
   Wischke C, 2011, MACROMOL BIOSCI, V11, P1637, DOI 10.1002/mabi.201100226
   Xie MK, 2013, J SURG RES, V184, P774, DOI 10.1016/j.jss.2013.04.016
   Yeo JH, 2003, EUR POLYM J, V39, P1195, DOI 10.1016/S0014-3057(02)00359-2
   Yoo MK, 2004, INT J BIOL MACROMOL, V34, P263, DOI 10.1016/j.ijbiomac.2004.06.002
NR 47
TC 5
Z9 5
U1 2
U2 54
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1083-7450
EI 1097-9867
J9 PHARM DEV TECHNOL
JI Pharm. Dev. Technol.
PD MAY 18
PY 2016
VL 21
IS 4
BP 453
EP 462
DI 10.3109/10837450.2015.1022784
PG 10
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA DG2XL
UT WOS:000371934000008
PM 25757645
DA 2018-10-20
ER

PT J
AU Garbayo, E
   Gavira, JJ
   de Yebenes, MG
   Pelacho, B
   Abizanda, G
   Lana, H
   Blanco-Prieto, MJ
   Prosper, F
AF Garbayo, Elisa
   Jose Gavira, Juan
   Garcia de Yebenes, Manuel
   Pelacho, Beatriz
   Abizanda, Gloria
   Lana, Hugo
   Jose Blanco-Prieto, Maria
   Prosper, Felipe
TI Catheter-based Intramyocardial Injection of FGF1 or NRG1-loaded MPs
   Improves Cardiac Function in a Preclinical Model of Ischemia-Reperfusion
SO SCIENTIFIC REPORTS
LA English
DT Article
ID ELEVATION MYOCARDIAL-INFARCTION; FIBROBLAST GROWTH FACTOR-2;
   CORONARY-ARTERY-DISEASE; HEART-FAILURE; STEM-CELLS; PLGA MICROPARTICLES;
   DOUBLE-BLIND; SWINE MODEL; FACTOR-I; DELIVERY
AB Cardiovascular protein therapeutics such as neuregulin (NRG1) and acidic-fibroblast growth factor (FGF1) requires new formulation strategies that allow for sustained bioavailability of the drug in the infarcted myocardium. However, there is no FDA-approved injectable protein delivery platform due to translational concerns about biomaterial administration through cardiac catheters. We therefore sought to evaluate the efficacy of percutaneous intramyocardial injection of poly(lactic-co-glycolic acid) microparticles (MPs) loaded with NRG1 and FGF1 using the NOGA MYOSTAR injection catheter in a porcine model of ischemia-reperfusion. NRG1- and FGF1-loaded MPs were prepared using a multiple emulsion solvent-evaporation technique. Infarcted pigs were treated one week after ischemia-reperfusion with MPs containing NRG1, FGF1 or non-loaded MPs delivered via clinically-translatable percutaneous transendocardial-injection. Three months post-treatment, echocardiography indicated a significant improvement in systolic and diastolic cardiac function. Moreover, improvement in bipolar voltage and decrease in transmural infarct progression was demonstrated by electromechanical NOGA-mapping. Functional benefit was associated with an increase in myocardial vascularization and remodeling. These findings in a large animal model of ischemia-reperfusion demonstrate the feasibility and efficacy of using MPs as a delivery system for growth factors and provide strong evidence to move forward with clinical studies using therapeutic proteins combined with catheter-compatible biomaterials.
C1 [Garbayo, Elisa; Lana, Hugo; Jose Blanco-Prieto, Maria] Univ Navarra, Sch Pharm, Dept Pharm & Pharmaceut Technol, E-31080 Pamplona, Spain.
   [Garbayo, Elisa; Jose Gavira, Juan; Garcia de Yebenes, Manuel; Pelacho, Beatriz; Abizanda, Gloria; Lana, Hugo; Jose Blanco-Prieto, Maria; Prosper, Felipe] Inst Invest Sanitaria Navarra IDISNA, Pamplona, Spain.
   [Jose Gavira, Juan; Garcia de Yebenes, Manuel; Pelacho, Beatriz; Abizanda, Gloria; Prosper, Felipe] Univ Navarra Clin, Hematol Cardiol & Cell Therapy, Pamplona, Spain.
   [Jose Gavira, Juan; Garcia de Yebenes, Manuel; Pelacho, Beatriz; Abizanda, Gloria; Prosper, Felipe] Univ Navarra, Fdn Appl Med Res, E-31080 Pamplona, Spain.
RP Blanco-Prieto, MJ (reprint author), Univ Navarra, Sch Pharm, Dept Pharm & Pharmaceut Technol, E-31080 Pamplona, Spain.; Blanco-Prieto, MJ; Prosper, F (reprint author), Inst Invest Sanitaria Navarra IDISNA, Pamplona, Spain.
EM mjblanco@unav.es; fprosper@unav.es
RI Prosper, Felipe/H-6859-2017; Garbayo, Elisa/V-1740-2017
OI Prosper, Felipe/0000-0001-6115-8790; Garbayo, Elisa/0000-0003-2049-4143;
   Blanco-prieto, Maria J/0000-0003-0710-899X
FU Spanish Ministry of Sciences and Innovations [JCI-2011-10737]; Spanish
   Ministry of Economy and Competitiveness [SAF2013-42528-R]; Instituto de
   Salud Carlos III (ISCIII) [PI10/01621, PI13/02144, CP09/00333,
   ISCIII-RETIC RD12/0019/0031, PLE2009-0116]; EU FPVII program (INELPY);
   UTE project CIMA
FX We acknowledge the technical assistance of Hanspeter Fischer and Stijn
   Kramer with NOGA mapping procedures and analysis. The study was funded
   through the support from the Spanish Ministry of Sciences and
   Innovations (JCI-2011-10737), Spanish Ministry of Economy and
   Competitiveness (SAF2013-42528-R), the Instituto de Salud Carlos III
   (ISCIII) PI10/01621, PI13/02144, CP09/00333 and ISCIII-RETIC
   RD12/0019/0031, PLE2009-0116 and INNPACTO Procardio, the EU FPVII
   program (INELPY), and the "UTE project CIMA".
CR Abizaid A, 2010, CIRC-CARDIOVASC INTE, V3, P384, DOI 10.1161/CIRCINTERVENTIONS.109.891192
   Arana M, 2014, BIOMATERIALS, V35, P143, DOI 10.1016/j.biomaterials.2013.09.083
   Awada H. K., 2015, BIOMATERIALS, V82, P94
   Beohar N, 2010, J AM COLL CARDIOL, V56, P1287, DOI 10.1016/j.jacc.2010.05.039
   Bergmann MW, 2011, EUR J HEART FAIL, V13, P560, DOI 10.1093/eurjhf/hfr002
   Callans DJ, 1999, CIRCULATION, V100, P1744, DOI 10.1161/01.CIR.100.16.1744
   Chang MY, 2013, J CONTROL RELEASE, V170, P287, DOI 10.1016/j.jconrel.2013.04.022
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Eckhouse SR, 2014, SCI TRANSL MED, V6, P223
   Emmert MY, 2013, BIOMATERIALS, V34, P2428, DOI 10.1016/j.biomaterials.2012.12.021
   Engel FB, 2006, P NATL ACAD SCI USA, V103, P15546, DOI 10.1073/pnas.0607382103
   Formiga FR, 2013, EUR J PHARM BIOPHARM, V85, P665, DOI 10.1016/j.ejpb.2013.02.017
   Formiga FR, 2014, J CONTROL RELEASE, V173, P132, DOI 10.1016/j.jconrel.2013.10.034
   Formiga FR, 2010, J CONTROL RELEASE, V147, P30, DOI 10.1016/j.jconrel.2010.07.097
   Galindo CL, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000773
   Garbern JC, 2011, BIOMATERIALS, V32, P2407, DOI 10.1016/j.biomaterials.2010.11.075
   Goodfriend AC, 2015, J BIOMED MATER RES A, V103, P1761, DOI 10.1002/jbm.a.35313
   Guo HD, 2012, BIOCHEM BIOPH RES CO, V424, P105, DOI 10.1016/j.bbrc.2012.06.080
   Gyongyosi M, 2011, NAT REV CARDIOL, V8, P393, DOI 10.1038/nrcardio.2011.64
   Hastings CL, 2015, ADV DRUG DELIVER REV, V84, P85, DOI 10.1016/j.addr.2014.08.006
   Henry TD, 2003, CIRCULATION, V107, P1359, DOI 10.1161/01.CIR.0000061911.47710.8A
   Itoh N, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00247
   Jabbour A, 2011, EUR J HEART FAIL, V13, P83, DOI 10.1093/eurjhf/hfq152
   Jain RA, 2000, BIOMATERIALS, V21, P2475, DOI 10.1016/S0142-9612(00)00115-0
   Gavira JJ, 2010, EUR HEART J, V31, P1013, DOI 10.1093/eurheartj/ehp342
   Kerut EK, 2004, ECHOCARDIOGR-J CARD, V21, P439, DOI 10.1111/j.0742-2822.2004.04003.x
   Krause K, 2009, HEART, V95, P1145, DOI 10.1136/hrt.2008.155077
   Lam MT, 2012, EXPERT REV CARDIOVAS, V10, P1039, DOI [10.1586/erc.12.99, 10.1586/ERC.12.99]
   Lichtman J.H., 2014, CIRCULATION, V131, pe29, DOI DOI 10.1161/CIR.0000000000000152
   Lin Y., 2012, LASER OPTOELECTRONIC, V4, P109
   Lin YD, 2010, CIRCULATION, V122, pS132, DOI 10.1161/CIRCULATIONAHA.110.939512
   Liu XF, 2006, J AM COLL CARDIOL, V48, P1438, DOI 10.1016/j.jacc.2006.05.057
   Mazo M, 2012, CELL TRANSPLANT, V21, P2723, DOI 10.3727/096368912X638847
   Meller J, 1979, Adv Intern Med, V24, P331
   Menasche P, 2009, CIRCULATION, V119, P2735, DOI 10.1161/CIRCULATIONAHA.108.812693
   Minguell Jose J, 2011, Acute Card Care, V13, P40, DOI 10.3109/17482941.2010.551134
   Nagaoka K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132451
   Odiete O, 2012, CIRC RES, V111, P1376, DOI 10.1161/CIRCRESAHA.112.267286
   Onuma Y, 2011, CIRC J, V75, P509, DOI 10.1253/circj.CJ-10-1135
   Palmen M, 2004, J AM COLL CARDIOL, V44, P1113, DOI 10.1016/j.jacc.2004.05.067
   Pascual-Gil S, 2015, J CONTROL RELEASE, V220, P388, DOI 10.1016/j.jconrel.2015.10.058
   Pavo N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113245
   Rane AA, 2011, J AM COLL CARDIOL, V58, P2615, DOI 10.1016/j.jacc.2011.11.001
   Ripa RS, 2006, CIRCULATION, V113, P1983, DOI 10.1161/CIRCULATIONAHA.105.610469
   Rupert CE, 2015, BIOMARK INSIGHTS, V10, P1, DOI [10.4137/BMIMI.S20061, 10.4137/BMI.S20061]
   Segers VFM, 2011, CIRC RES, V109, P910, DOI 10.1161/CIRCRESAHA.111.249052
   Seif-Naraghi SB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005503
   Simon-Yarza T, 2013, INT J PHARMACEUT, V454, P784, DOI 10.1016/j.ijpharm.2013.04.015
   Simons M, 2002, CIRCULATION, V105, P788, DOI 10.1161/hc0802.104407
   Singelyn JM, 2012, J AM COLL CARDIOL, V59, P751, DOI 10.1016/j.jacc.2011.10.888
   Smits PC, 2003, J AM COLL CARDIOL, V42, P2063, DOI 10.1016/j.jacc.2003.06.017
   Udelson JE, 2000, CIRCULATION, V102, P1605, DOI 10.1161/01.CIR.102.14.1605
   Voors AA, 2010, EUR HEART J, V31, P2593, DOI 10.1093/eurheartj/ehq304
   Vu TD, 2015, BIOMATERIALS, V45, P27, DOI 10.1016/j.biomaterials.2014.12.013
   Weidemann F, 2002, AM J PHYSIOL-HEART C, V283, pH792, DOI 10.1152/ajpheart.00025.2002
   Wolf T, 2001, J AM COLL CARDIOL, V37, P1590, DOI 10.1016/S0735-1097(01)01209-8
   Yutzey KE, 2015, NATURE, V520, P445, DOI 10.1038/520445a
   Zhang H., 2014, BLOOD, V1
   Zohlnhofer Dietlind, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS106, DOI 10.1038/ncpcardio0745
NR 59
TC 10
Z9 10
U1 4
U2 12
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAY 17
PY 2016
VL 6
AR 25932
DI 10.1038/srep25932
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DL8PP
UT WOS:000375904200001
PM 27184924
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Bodenberger, N
   Paul, P
   Kubiczek, D
   Walther, P
   Gottschalk, KE
   Rosenau, F
AF Bodenberger, Nicholas
   Paul, Patrick
   Kubiczek, Dennis
   Walther, Paul
   Gottschalk, Kay-Eberhard
   Rosenau, Frank
TI A Novel Cheap and Easy to Handle Protein Hydrogel for 3D Cell Culture
   Applications: A High Stability Matrix with Tunable Elasticity and Cell
   Adhesion Properties
SO CHEMISTRYSELECT
LA English
DT Article
DE Biomaterial; cell adhesion; tunable elasticity; AFM; cancer cell
ID HUMAN SERUM-ALBUMIN; CLICK CHEMISTRY; CROSS-LINKING; STEM-CELLS;
   CHONDROGENIC DIFFERENTIATION; INJECTABLE HYDROGEL; BINDING-SPECIFICITY;
   ALGINATE HYDROGELS; DRUG-DELIVERY; SCAFFOLDS
AB Modern hydrogels have a high potential for cell culture applications due to their ability to form 3D architectures resembling the natural environment of the cell. A new cheap, robust and cell compatible hydrogel consisting of chemically crosslinked human serum albumin is presented. The protein gels polymerize within minutes, have high pH and temperature stabilities and combine biocompatibility and biodegradability. Pore size and elasticity were investigated by atomic force microscopy and revealed an adjustable elasticity. Pore sizes were investigated using cryo-scanning electron microscopy. To evaluate biocompatibility, hydrogels were incubated with human breast cancer cells and adenocarcinomic human alveolar basal epithelial cells under 2D and 3D conditions and both cell lines showed high survival rates. All results indicate the versatility of the new material to be used as a simple, robust system with high mechanical and chemical stability and a broad range of possible applications.
C1 [Bodenberger, Nicholas; Kubiczek, Dennis; Rosenau, Frank] Univ Ulm, Fac Nat Sci, Ctr Pharmaceut, Albert Einstein Allee 11, D-89069 Ulm, Germany.
   [Paul, Patrick; Gottschalk, Kay-Eberhard] Univ Ulm, Fac Nat Sci, Inst Expt Phys, Albert Einstein Allee 11, D-89069 Ulm, Germany.
   [Walther, Paul] Univ Ulm, Cent Facil Elect Microscopy, Albert Einstein Allee 11, D-89069 Ulm, Germany.
RP Rosenau, F (reprint author), Univ Ulm, Fac Nat Sci, Ctr Pharmaceut, Albert Einstein Allee 11, D-89069 Ulm, Germany.
EM frank.rosenau@uni-ulm.de
FU Baden-Wurttemberg Stiftung
FX Nicholas Bodenberger thanks the Baden-Wurttemberg Stiftung for funding
   his work and supporting the project. Special thanks go to Cornelia
   Lee-Thedieck and Annamarija Raic for inspiring discussions.
CR Ahmed EM, 2015, J ADV RES, V6, P105, DOI 10.1016/j.jare.2013.07.006
   Annabi N, 2010, TISSUE ENG PART B-RE, V16, P371, DOI 10.1089/ten.TEB.2009.0639
   Balakrishnan B, 2005, BIOMATERIALS, V26, P3941, DOI 10.1016/j.biomaterials.2004.10.005
   Banerjee A, 2009, BIOMATERIALS, V30, P4695, DOI 10.1016/j.biomaterials.2009.05.050
   Bellis SL, 2011, BIOMATERIALS, V32, P4205, DOI 10.1016/j.biomaterials.2011.02.029
   Calvert P, 2009, ADV MATER, V21, P743, DOI 10.1002/adma.200800534
   Chung C, 2012, BIOMACROMOLECULES, V13, P3912, DOI 10.1021/bm3015279
   Crescenzi V, 2007, BIOMACROMOLECULES, V8, P1844, DOI 10.1021/bm0700800
   Crompton KE, 2007, BIOMATERIALS, V28, P441, DOI 10.1016/j.biomaterials.2006.08.044
   De Boisseson MR, 2004, J COLLOID INTERF SCI, V273, P131, DOI 10.1016/j.jcis.2003.12.064
   Dimitriadis EK, 2002, BIOPHYS J, V82, P2798, DOI 10.1016/S0006-3495(02)75620-8
   Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075
   Gil ES, 2004, PROG POLYM SCI, V29, P1173, DOI 10.1016/j.progpolymsci.2004.08.003
   Hirose M, 2010, MAT SCI ENG C-MATER, V30, P664, DOI 10.1016/j.msec.2010.02.020
   Hoare TR, 2008, POLYMER, V49, P1993, DOI 10.1016/j.polymer.2008.01.027
   Hong SM, 2015, ADV MATER, V27, P4035, DOI [10.1002/adma.201501099, 10.1002/adma.201570182]
   Hoshikawa A, 2006, TISSUE ENG, V12, P2333, DOI 10.1089/ten.2006.12.2333
   Huang HZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059482
   Jirasek A, 2006, PHYS MED BIOL, V51, P1891, DOI 10.1088/0031-9155/51/7/018
   Komatsu T, 2004, BBA-GEN SUBJECTS, V1675, P21, DOI 10.1016/j.bbagen.2004.08.010
   Li XY, 2012, BIOTECHNOL PROGR, V28, P856, DOI 10.1002/btpr.1526
   Li Yuting, 2015, ScientificWorldJournal, V2015, P685690, DOI 10.1155/2015/685690
   Lin ST, 2014, SOFT MATTER, V10, P7519, DOI 10.1039/c4sm01039f
   Lu SY, 2011, SOFT MATTER, V7, P10763, DOI 10.1039/c1sm06053h
   Ludwig T, 2008, PFLUG ARCH EUR J PHY, V456, P29, DOI 10.1007/s00424-007-0398-9
   Missirlis D, 2014, BIOMACROMOLECULES, V15, P195, DOI 10.1021/bm4014827
   Nicodemus GD, 2008, TISSUE ENG PT B-REV, V14, P149, DOI 10.1089/ten.teb.2007.0332
   Nwe K, 2009, CANCER BIOTHER RADIO, V24, P289, DOI 10.1089/cbr.2008.0626
   Parikka K, 2012, FOOD HYDROCOLLOID, V26, P212, DOI 10.1016/j.foodhyd.2011.05.012
   Park H, 2009, BIOMACROMOLECULES, V10, P541, DOI 10.1021/bm801197m
   Patenaude M, 2014, BIOMACROMOLECULES, V15, P781, DOI 10.1021/bm401615d
   PIERSCHBACHER MD, 1987, J BIOL CHEM, V262, P17294
   PRICE JS, 1975, J BACTERIOL, V124, P1574
   Purcell BP, 2014, NAT MATER, V13, P653, DOI [10.1038/nmat3922, 10.1038/NMAT3922]
   Raic A, 2014, BIOMATERIALS, V35, P929, DOI 10.1016/j.biomaterials.2013.10.038
   Raja STK, 2015, SCI REP-UK, V5, DOI 10.1038/srep15977
   Ross AM, 2012, SMALL, V8, P336, DOI 10.1002/smll.201100934
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Satya Prakash S., 2010, INT J NANOMED, P525
   Sawicki LA, 2014, BIOMATER SCI-UK, V2, P1612, DOI 10.1039/c4bm00187g
   Sung KE, 2009, BIOMATERIALS, V30, P4833, DOI 10.1016/j.biomaterials.2009.05.043
   Tada D, 2005, J BIOSCI BIOENG, V100, P551, DOI 10.1263/hbb.100.551
   Tanaka H, 2004, J CELL BIOCHEM, V93, P454, DOI 10.1002/jcb.20171
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Van Vlierberghe S, 2011, BIOMACROMOLECULES, V12, P1387, DOI 10.1021/bm200083n
   Walther P, 2003, J MICROSC-OXFORD, V212, P34, DOI 10.1046/j.1365-2818.2003.01236.x
   Yamashita S, 2014, RADIAT PHYS CHEM, V101, P53, DOI 10.1016/j.radphyschem.2014.04.004
   Yang F, 2014, INT J MOL SCI, V15, P3580, DOI 10.3390/ijms15033580
   Yu F, 2014, POLYM CHEM-UK, V5, P1082, DOI 10.1039/c3py00869j
   Zhu JM, 2011, EXPERT REV MED DEVIC, V8, P607, DOI [10.1586/ERD.11.27, 10.1586/erd.11.27]
NR 50
TC 3
Z9 3
U1 0
U2 14
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 2365-6549
J9 CHEMISTRYSELECT
JI ChemistrySelect
PD MAY 16
PY 2016
VL 1
IS 7
BP 1353
EP 1360
DI 10.1002/slct.201600206
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA EM6DJ
UT WOS:000395402700008
DA 2018-10-20
ER

PT J
AU Feyen, DAM
   Gaetani, R
   Deddens, J
   van Keulen, D
   van Opbergen, C
   Poldervaart, M
   Alblas, J
   Chamuleau, S
   van Laake, LW
   Doevendans, PA
   Sluijter, JPG
AF Feyen, Dries A. M.
   Gaetani, Roberto
   Deddens, Janine
   van Keulen, Danielle
   van Opbergen, Chantal
   Poldervaart, Michelle
   Alblas, Jacqueline
   Chamuleau, Steven
   van Laake, Linda W.
   Doevendans, Pieter A.
   Sluijter, Joost P. G.
TI Gelatin Microspheres as Vehicle for Cardiac Progenitor Cells Delivery to
   the Myocardium
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
ID STEM-CELLS; INTRACORONARY INJECTION; EXTRACELLULAR-MATRIX; MOUSE MODEL;
   INFARCTION; HEART; TRANSPLANTATION; HYDROGEL; DIFFERENTIATION;
   CARDIOMYOCYTES
AB Inadequate cell retention and survival in cardiac stem cell therapy seems to be reducing the therapeutic effect of the injected stem cells. In order to ameliorate their regenerative effects, various biomaterials are being investigated for their potential supportive properties. Here, gelatin microspheres (MS) are utilized as microcarriers to improve the delivery and therapeutic efficacy of cardiac progenitor cells (CPCs) in the ischemic myocardium. The gelatin MS, generated from a water-in-oil emulsion, are able to accommodate the attachment of CPCs, thereby maintaining their cardiogenic potential. In a mouse model of myocardial infarction, we demonstrated the ability of these microcarriers to substantially enhance cell engraftment in the myocardium as indicated by bioluminescent imaging and histological analysis. However, despite an observed tenfold increase in CPC numbers in the myocardium, echocardiography, and histology reveals that mice treated with MS-CPCs show marginal improvement in cardiac function compared to CPCs only. Overall, a straightforward and translational approach is developed to increase the retention of stem cells in the ischemic myocardium. Even though the current biomaterial setup with CPCs as cell source does not translate into improved therapeutic action, coupling this developed technology with stem cell-derived cardiomyocytes can lead to an effective remuscularization therapy.
C1 [Feyen, Dries A. M.; Gaetani, Roberto; Deddens, Janine; van Keulen, Danielle; van Opbergen, Chantal; Chamuleau, Steven; van Laake, Linda W.; Doevendans, Pieter A.; Sluijter, Joost P. G.] Univ Med Ctr Utrecht, Dept Cardiol DH&L, NL-3584 CX Utrecht, Netherlands.
   [Gaetani, Roberto] Univ Roma La Sapienza, Inst Pasteur, Cenci Bolognetti Fdn, Dept Mol Med, I-00161 Rome, Italy.
   [Poldervaart, Michelle; Alblas, Jacqueline] Univ Med Ctr Utrecht, Dept Orthoped, NL-3584 CX Utrecht, Netherlands.
   [Doevendans, Pieter A.; Sluijter, Joost P. G.] Interuniv Cardiol Inst Netherlands, NL-3511 EP Utrecht, Netherlands.
   [Sluijter, Joost P. G.] Univ Med Ctr Utrecht, Expt Cardiol Lab, Dept Cardiol DH&L, Heidelberglaan 100,Room G03-642, NL-3584 CX Utrecht, Netherlands.
RP Sluijter, JPG (reprint author), Univ Med Ctr Utrecht, Dept Cardiol DH&L, NL-3584 CX Utrecht, Netherlands.; Sluijter, JPG (reprint author), Interuniv Cardiol Inst Netherlands, NL-3511 EP Utrecht, Netherlands.; Sluijter, JPG (reprint author), Univ Med Ctr Utrecht, Expt Cardiol Lab, Dept Cardiol DH&L, Heidelberglaan 100,Room G03-642, NL-3584 CX Utrecht, Netherlands.
EM j.sluijter@umcutrecht.nl
OI Alblas, Jacqueline/0000-0002-2996-9697; Sluijter,
   Joost/0000-0003-2088-9102
FU Project SMARTCARE of the BioMedical Materials institute [P1.04]; Dutch
   Ministry of Economic Affairs, Agriculture and Innovation; Netherlands
   CardioVascular Research Initiative (CVON): The Dutch Heart Foundation,
   Dutch Federation of University Medical Centers; Netherlands Organization
   for Health Research and Development; Royal Netherlands Academy of
   Sciences; HLSU grant "cardiac microtissues"
FX D.A.M.F. and R.G. contributed equally to this work. This research forms
   part of the Project P1.04 SMARTCARE of the BioMedical Materials
   institute, co-funded by the Dutch Ministry of Economic Affairs,
   Agriculture and Innovation and the Netherlands CardioVascular Research
   Initiative (CVON): The Dutch Heart Foundation, Dutch Federation of
   University Medical Centers, the Netherlands Organization for Health
   Research and Development, and the Royal Netherlands Academy of Sciences.
   Financial support via a HLSU grant "cardiac microtissues" is
   appreciated.
CR Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Danoviz ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012077
   Ellison GM, 2011, J AM COLL CARDIOL, V58, P977, DOI 10.1016/j.jacc.2011.05.013
   Feyen D, 2013, CARDIOVASC RES, V99, P83, DOI 10.1093/cvr/cvt078
   Hirt MN, 2014, CIRC RES, V114, P354, DOI 10.1161/CIRCRESAHA.114.300522
   Hoshino K, 2006, GENE THER, V13, P1320, DOI 10.1038/sj.gt.3302793
   Ivaska J, 2000, CELL MOL LIFE SCI, V57, P16, DOI 10.1007/s000180050496
   Iwakura A, 2006, CIRCULATION, V113, P1605, DOI 10.1161/CIRCULATIONAHA.105.553925
   Kofidis T, 2005, CIRCULATION, V112, pI173, DOI 10.1161/CIRCULATIONAHA.104.526178
   Leor J, 2009, J AM COLL CARDIOL, V54, P1014, DOI 10.1016/j.jacc.2009.06.010
   Liu J, 2011, J CELL MOL MED, V15, P1474, DOI 10.1111/j.1582-4934.2010.01104.x
   Lu WN, 2009, TISSUE ENG PT A, V15, P1437, DOI 10.1089/ten.tea.2008.0143
   NEWTON JM, 1977, J PHARM PHARMACOL, V29, P294, DOI 10.1111/j.2042-7158.1977.tb11315.x
   Perin EC, 2003, CIRCULATION, V107, P2294, DOI 10.1161/01.CIR.0000070596.30552.8B
   Poldervaart MT, 2014, J CONTROL RELEASE, V184, P58, DOI 10.1016/j.jconrel.2014.04.007
   Poldervaart MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072610
   Ptaszek LM, 2012, LANCET, V379, P933, DOI 10.1016/S0140-6736(12)60075-0
   Radisic M, 2013, MAYO CLIN PROC, V88, P884, DOI 10.1016/j.mayocp.2013.05.003
   Rane AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021571
   Sasajima T, 1997, ARTIF ORGANS, V21, P287
   Singelyn JM, 2012, J AM COLL CARDIOL, V59, P751, DOI 10.1016/j.jacc.2011.10.888
   Sluijter JPG, 2010, ARTERIOSCL THROM VAS, V30, P859, DOI 10.1161/ATVBAHA.109.197434
   Sluijter JPG, 2004, J VASC RES, V41, P546, DOI 10.1159/000081972
   Smits AM, 2009, NAT PROTOC, V4, P232, DOI 10.1038/nprot.2008.229
   Smits AM, 2009, CARDIOVASC RES, V83, P527, DOI 10.1093/cvr/cvp146
   Spinale FG, 2002, CIRC RES, V90, P520, DOI 10.1161/01.RES.0000013290.12884.A3
   Steingen C, 2008, J MOL CELL CARDIOL, V44, P1072, DOI 10.1016/j.yjmcc.2008.03.010
   Terrovitis J, 2009, J AM COLL CARDIOL, V54, P1619, DOI 10.1016/j.jacc.2009.04.097
   Tous E, 2011, J CARDIOVASC TRANSL, V4, P528, DOI 10.1007/s12265-011-9291-1
   van Laake LW, 2007, NAT PROTOC, V2, P2551, DOI 10.1038/nprot.2007.371
   van Mil A, 2013, J MOL MED, V91, P1001, DOI 10.1007/s00109-013-1017-1
   Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270
   Wall ST, 2010, J BIOMED MATER RES A, V95A, P1055, DOI 10.1002/jbm.a.32904
   Wang T, 2009, ACTA BIOMATER, V5, P2939, DOI 10.1016/j.actbio.2009.04.040
   Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023
   Zheng Y, 2005, BONE MARROW TRANSPL, V35, P137, DOI 10.1038/sj.bmt.1704751
NR 37
TC 9
Z9 9
U1 0
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD MAY 11
PY 2016
VL 5
IS 9
BP 1071
EP 1079
DI 10.1002/adhm.201500861
PG 9
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA DO1HB
UT WOS:000377528000009
PM 26913710
DA 2018-10-20
ER

PT J
AU Wu, CT
   Xia, LG
   Han, PP
   Mao, LX
   Wang, JC
   Zhai, D
   Fang, B
   Chang, J
   Xiao, Y
AF Wu, Chengtie
   Xia, Lunguo
   Han, Pingping
   Mao, Lixia
   Wang, Jiacheng
   Zhai, Dong
   Fang, Bing
   Chang, Jiang
   Xiao, Yin
TI Europium-Containing Mesoporous Bioactive Glass Scaffolds for Stimulating
   in Vitro and in Vivo Osteogenesis
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE Eu-containing mesoporous bioactive glass; scaffolds; bone tissue
   engineering; biolabeling; bone regeneration
ID PRO-ANGIOGENIC PROPERTIES; MARROW STROMAL CELLS; HYDROXYAPATITE
   NANOPARTICLES; DOPED HYDROXYAPATITE; HYDROXIDE NANORODS;
   GENE-EXPRESSION; HYALURONIC-ACID; DRUG-DELIVERY; STEM-CELLS; BONE
AB Bone tissue engineering offers a possible strategy for regenerating large bone defects, in which how to design beneficial scaffolds for accelerating bone formation remains significantly challenging. Europium, as an important rare earth element, has been used as a solid-state lighting material. However, there are few reports on whether Eu can be used for labeling bone tissue engineering scaffolds, and its biological effect on bone cells and bone tissue regeneration is unknown. In this study, we incorporated Eu into mesoporous bioactive glass (Eu-MBG) scaffolds by an in situ cotemplate method to achieve a bifunctional biomaterial with biolabeling and bone regeneration. The prepared Eu-MBG scaffolds have highly interconnective large pores (300-500 pm), a high specific surface area (140-290 m(2)/g), and well-ordered mesopores (5 nm) as well as uniformly distributed Eu. The incorporation of 2-5 mol % Eu into MBG scaffolds gives them a luminescent property. The in vitro degradation of Eu-MBG scaffolds has a functional effect on the change of the luminescence intensity. In addition, Eu-MBG can be used for labeling bone marrow stromal cells (BMSCs) in vitro and still presents a distinct luminescence signal in deep bone tissues in vivo to label new bone tissue via release of Eu ions. Furthermore, the incorporation of different contents of Eu (1, 2, and 5 mol %) into MBG scaffolds significantly enhances the osteogenic gene expression of BMSCs in the scaffolds. The Eu- and Si-containing ionic products released from Eu-MBG scaffolds distinctly promote the osteogenic differentiation of BMSCs. Critically sized femur defects in ovariectomized (OVX) rats are created to simulate an osteoporotic phenotype. The results show that Eu-MBG scaffolds significantly stimulate new bone formation in osteoporotic bone defects when compared to MBG scaffolds alone and Eu may be involved in the acceleration of bone regeneration in OVX rats. Our study for the first time reports that the incorporation of the rare earth element Eu into bioscaffolds has the ability to accelerate bone regeneration in vivo, and thus, the prepared Eu-MBG scaffolds possess bifunctional properties with biolabeling and bone regeneration.
C1 [Wu, Chengtie; Wang, Jiacheng; Zhai, Dong; Chang, Jiang] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
   [Xia, Lunguo; Mao, Lixia; Fang, Bing] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9,Ctr Craniofacial Orthodont, Dept Oral & Craniomaxillofacial Sci, Shanghai 200011, Peoples R China.
   [Han, Pingping; Xiao, Yin] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4059, Australia.
RP Wu, CT; Chang, J (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.; Fang, B (reprint author), Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9,Ctr Craniofacial Orthodont, Dept Oral & Craniomaxillofacial Sci, Shanghai 200011, Peoples R China.
EM chengtiewu@mail.sic.ac.cn; braces_dr@hotmail.com; jchang@mail.sic.ac.acn
OI Han, Pingping/0000-0001-7546-1635; Xiao, Yin/0000-0003-1785-3491
FU Recruitment Program of Global Young Talent, China; National High
   Technology Research and Development Program of China (863 Program)
   [SS2015AA020302]; Natural Science Foundation of China [31370963,
   81190132]; Program of Shanghai Outstanding Academic Leaders
   [15XD1503900]; Key Research Program of the Chinese Academy of Sciences
   [KGZD-EW-T06]
FX We acknowledge the support of the Recruitment Program of Global Young
   Talent, China (C.W.), the National High Technology Research and
   Development Program of China (863 Program, Grant SS2015AA020302), the
   Natural Science Foundation of China (Grants 31370963 and 81190132), the
   Program of Shanghai Outstanding Academic Leaders (Grant 15XD1503900),
   and the Key Research Program of the Chinese Academy of Sciences (Grant
   KGZD-EW-T06).
CR [Anonymous], 2009, 1099352009 ISO
   Barta CA, 2007, DALTON T, P5019, DOI 10.1039/b705123a
   Bunzli JCG, 2010, CHEM REV, V110, P2729, DOI 10.1021/cr900362e
   Chen F, 2012, BIOMATERIALS, V33, P6447, DOI 10.1016/j.biomaterials.2012.05.059
   Chen F, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-67
   De Jong WH, 2008, BIOMATERIALS, V29, P1912, DOI 10.1016/j.biomaterials.2007.12.037
   DENHOLLANDER W, 1991, BIOMATERIALS, V12, P569, DOI 10.1016/0142-9612(91)90053-D
   Dillip GR, 2014, J PHYS CHEM SOLIDS, V75, P8, DOI 10.1016/j.jpcs.2013.07.008
   Fan Y, 2011, J COLLOID INTERF SCI, V357, P280, DOI 10.1016/j.jcis.2011.01.109
   Fan Y, 2009, J PHYS CHEM C, V113, P7826, DOI 10.1021/jp900515x
   Gbureck U, 2007, ADV FUNCT MATER, V17, P3940, DOI 10.1002/adfm.200700019
   Gerhardt LC, 2011, BIOMATERIALS, V32, P4096, DOI 10.1016/j.biomaterials.2011.02.032
   Ghosh S, 2008, ADV FUNCT MATER, V18, P1883, DOI 10.1002/adfm.200800040
   Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021
   Guo BL, 2015, REGEN BIOMATER, V2, P47, DOI 10.1093/rb/rbu016
   Han PP, 2014, BIOMATER SCI-UK, V2, P1230, DOI 10.1039/c4bm00111g
   Han YC, 2010, CURR NANOSCI, V6, P178, DOI 10.2174/157341310790945632
   Hayashi H, 1988, Nihon Shishubyo Gakkai Kaishi, V30, P1
   Hench LL, 2010, J R SOC INTERFACE, V7, pS379, DOI 10.1098/rsif.2010.0151.focus
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hou ZY, 2011, ADV FUNCT MATER, V21, P2356, DOI 10.1002/adfm.201100193
   Kim K, 2008, ACTA BIOMATER, V4, P783, DOI 10.1016/j.actbio.2008.02.010
   Kim TG, 2012, ADV FUNCT MATER, V22, P2446, DOI 10.1002/adfm.201103083
   Lee KH, 2013, J AM CERAM SOC, V96, P503, DOI 10.1111/jace.12057
   Li B, 2009, BIOMATERIALS, V30, P6768, DOI 10.1016/j.biomaterials.2009.08.038
   Li G, 2015, ADV APPL CERAM, V114, P164, DOI 10.1179/1743676114Y.0000000210
   Lu JX, 2002, J BIOMED MATER RES, V63, P408, DOI 10.1002/jbm.10259
   Martin JR, 2014, BIOMATERIALS, V35, P3766, DOI 10.1016/j.biomaterials.2014.01.026
   Martins AM, 2009, TISSUE ENG PT A, V15, P1953, DOI 10.1089/ten.tea.2008.0023
   Mathews S, 2011, BIOCHEM BIOPH RES CO, V414, P270, DOI 10.1016/j.bbrc.2011.09.071
   Mawani Y, 2014, J INORG BIOCHEM, V132, P52, DOI 10.1016/j.jinorgbio.2013.12.004
   Mawani Y, 2013, DALTON T, V42, P5999, DOI 10.1039/c2dt32373g
   Mendonca G, 2009, INT J ORAL MAX IMPL, V24, P205
   Miao GH, 2014, J SOL-GEL SCI TECHN, V69, P250, DOI 10.1007/s10971-013-3209-0
   Mordon S, 1998, MICROVASC RES, V55, P146, DOI 10.1006/mvre.1998.2068
   Park JK, 2011, ADV FUNCT MATER, V21, P2906, DOI 10.1002/adfm.201100612
   Patra CR, 2008, ADV MATER, V20, P753, DOI 10.1002/adma.200701611
   Patra CR, 2009, TOXICOL APPL PHARM, V240, P88, DOI 10.1016/j.taap.2009.07.009
   Salinas AJ, 2011, ACTA BIOMATER, V7, P3452, DOI 10.1016/j.actbio.2011.05.033
   Shaat SKK, 2014, J ALLOY COMPD, V587, P600, DOI 10.1016/j.jallcom.2013.11.001
   Shruti S, 2013, ACTA BIOMATER, V9, P4836, DOI 10.1016/j.actbio.2012.09.024
   Stambouli W, 2013, J LUMIN, V138, P201, DOI 10.1016/j.jlumin.2013.01.019
   Sui BY, 2014, ACS APPL MATER INTER, V6, P3528, DOI 10.1021/am4056886
   Tapec R, 2002, J NANOSCI NANOTECHNO, V2, P405, DOI 10.1166/jnn.2002.114
   Wang YF, 2016, REGEN BIOMATER, V3, P33, DOI 10.1093/rb/rbv025
   Wennerberg A, 2011, INT J ORAL MAX IMPL, V26, P1161
   Wu CT, 2015, CARBON, V93, P116, DOI 10.1016/j.carbon.2015.04.048
   Wu CT, 2014, J CONTROL RELEASE, V193, P282, DOI 10.1016/j.jconrel.2014.04.026
   Wu CT, 2014, ACS APPL MATER INTER, V6, P4264, DOI 10.1021/am4060035
   Wu CT, 2013, ACTA BIOMATER, V9, P9159, DOI 10.1016/j.actbio.2013.06.026
   Wu CT, 2013, BIOMATERIALS, V34, P422, DOI 10.1016/j.biomaterials.2012.09.066
   Wu CT, 2012, J MATER CHEM, V22, P12288, DOI 10.1039/c2jm30566f
   Wu CT, 2012, BIOMATERIALS, V33, P2076, DOI 10.1016/j.biomaterials.2011.11.042
   Wu CT, 2011, ACTA BIOMATER, V7, P3563, DOI 10.1016/j.actbio.2011.06.028
   Wu CT, 2011, BIOMATERIALS, V32, P7068, DOI 10.1016/j.biomaterials.2011.06.009
   Wu CT, 2010, BIOMATERIALS, V31, P3429, DOI 10.1016/j.biomaterials.2010.01.061
   Wu Y, 2014, ADV FUNCT MATER, V24, P4473, DOI 10.1002/adfm.201304304
   Xia LG, 2014, BIOMATERIALS, V35, P8514, DOI 10.1016/j.biomaterials.2014.06.028
   Yang PP, 2008, BIOMATERIALS, V29, P4341, DOI 10.1016/j.biomaterials.2008.07.042
   Yang PP, 2012, CHEM SOC REV, V41, P3679, DOI 10.1039/c2cs15308d
   Zhang HB, 2014, TISSUE ENG PART B-RE, V20, P492, DOI [10.1089/ten.teb.2013.0452, 10.1089/ten.TEB.2013.0452]
NR 61
TC 11
Z9 11
U1 14
U2 128
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD MAY 11
PY 2016
VL 8
IS 18
BP 11342
EP 11354
DI 10.1021/acsami.6b03100
PG 13
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA DL3GA
UT WOS:000375521000020
PM 27096527
DA 2018-10-20
ER

PT J
AU Maleki, H
   Rai, A
   Pinto, S
   Evangelista, M
   Cardoso, RMS
   Paulo, C
   Carvalheiro, T
   Paiva, A
   Imani, M
   Simchi, A
   Duraes, L
   Portugal, A
   Ferreira, L
AF Maleki, Hajar
   Rai, Akhilesh
   Pinto, Sandra
   Evangelista, Marta
   Cardoso, Renato M. S.
   Paulo, Cristiana
   Carvalheiro, Tiago
   Paiva, Artur
   Imani, Mohammad
   Simchi, Abdolreza
   Duraes, Luisa
   Portugal, Antonio
   Ferreira, Lino
TI High Antimicrobial Activity and Low Human Cell Cytotoxicity of
   Core-Shell Magnetic Nanoparticles Functionalized with an Antimicrobial
   Peptide
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE antimicrobial peptide; cecropin melittin; magnetic nanoparticles;
   core-shell nanoparticles; human cell biocompatibility
ID IRON-OXIDE NANOPARTICLES; AMPHIPATHIC PEPTIDES; GOLD NANOPARTICLES;
   ANTIBACTERIAL; SELECTIVITY; CARBOXYFLUORESCEIN; MECHANISMS; MEMBRANES;
   MELITTIN; DELIVERY
AB Superparamagnetic iron oxide nanoparticles (SPIONs) functionalized with antimicrobial agents are promising infection-targeted therapeutic platforms when coupled with external magnetic stimuli. These antimicrobial nanoparticles (NPs) may offer advantages in fighting intracellular pathogens as well as biomaterial-associated infections. This requires the development of NPs with high antimicrobial activity without interfering with the biology of mammalian cells. Here, we report the preparation of biocompatible antimicrobial SPION@gold core-shell NPs based on covalent immobilization of the antimicrobial peptide (AMP) cecropin melittin (CM) (the conjugate is named AMP-NP). The minimal inhibitory concentration (MIC) of the AMP-NP for Escherichia coli was 0.4 mu g/mL, 10-times lower than the MIC of soluble CM. The antimicrobial activity of CM depends on the length of the spacer between the CM and the NP. AMP-NPs are taken up by endothelial (between 60 and 170 pg of NPs per cell) and macrophage (between 18 and 36 pg of NPs per cell) cells and accumulate preferentially in endolysosomes. These NPs have no significant cytotoxic and pro-inflammatory activities for concentrations up to 200 mu g/mL (at least 100 times higher than the MIC of soluble CM). Our results in membrane models suggest that the selectivity of AMP-NPs for bacteria and not eukaryotic membranes is due to their membrane compositions. The AMP-NPs developed here open new opportunities for infection-site targeting.
C1 [Maleki, Hajar; Duraes, Luisa; Portugal, Antonio] Univ Coimbra, Dept Chem Engn, CIEPQPF, P-3030790 Coimbra, Portugal.
   [Rai, Akhilesh; Pinto, Sandra; Evangelista, Marta; Cardoso, Renato M. S.; Paulo, Cristiana; Ferreira, Lino] Biocant Biotechnol Innovat Ctr, P-3060197 Cantanhede, Portugal.
   [Rai, Akhilesh; Pinto, Sandra; Evangelista, Marta; Cardoso, Renato M. S.; Paulo, Cristiana; Ferreira, Lino] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, P-3004517 Coimbra, Portugal.
   [Carvalheiro, Tiago; Paiva, Artur] Portuguese Inst Blood & Transplantat, Blood & Transplantat Ctr Coimbra, P-3041861 Coimbra, Portugal.
   [Imani, Mohammad] Iran Polymer & Petrochem Inst, Novel Drug Delivery Syst Dept, Tehran 1311514977, Iran.
   [Simchi, Abdolreza] Sharif Univ Technol, Dept Mat Sci & Engn, Tehran 1136511155, Iran.
   [Simchi, Abdolreza] Sharif Univ Technol, Inst Nanosci & Nanotechnol, Tehran 1136511155, Iran.
   [Paiva, Artur] Univ Hosp Coimbra, Pathol Serv, Flow Cytometry Unit, P-3001301 Coimbra, Portugal.
RP Ferreira, L (reprint author), Biocant Biotechnol Innovat Ctr, P-3060197 Cantanhede, Portugal.; Ferreira, L (reprint author), Univ Coimbra, CNC Ctr Neurosci & Cell Biol, P-3004517 Coimbra, Portugal.
EM lino@biocant.pt
RI Duraes, Luisa/B-5176-2012; maleki, hajar/A-9926-2016
OI Duraes, Luisa/0000-0003-3336-2449; maleki, hajar/0000-0002-2813-4700;
   Carvalheiro, Tiago/0000-0002-3187-2288; Rai,
   Akhilesh/0000-0001-5352-5415; Portugal, Antonio/0000-0002-7520-4767;
   ferreira, lino/0000-0001-8985-9302; Paiva, Artur/0000-0002-6562-5859
FU FEDER through the Program COMPETE; Portuguese fund through FCT
   [PTDC/Qui-Qui/105000/2008]; COMPETE [Centro-07-ST24-FEDER-002008]; FCT
   [SFRH/BPD/73211/2010]
FX This work was funded by FEDER through the Program COMPETE and by
   Portuguese fund through FCT in the context of the project
   PTDC/Qui-Qui/105000/2008. The work was also funded by COMPETE in the
   context of the project "Stem cell based platforms for Regenerative and
   Therapeutic Medicine" (Centro-07-ST24-FEDER-002008). A.R. wishes to
   thank FCT for a BPD fellowship (SFRH/BPD/73211/2010).
CR Armstead AL, 2011, INT J NANOMED, V6, P3281, DOI 10.2147/IJN.S27285
   Arruebo M, 2007, NANO TODAY, V2, P22, DOI 10.1016/S1748-0132(07)70084-1
   Aslam M, 2004, J MATER CHEM, V14, P1795, DOI 10.1039/b402823f
   BARBET J, 1984, BIOCHIM BIOPHYS ACTA, V772, P347, DOI 10.1016/0005-2736(84)90152-4
   Bhargava K, 2004, BIOPHYS J, V86, P329, DOI 10.1016/S0006-3495(04)74108-9
   Bini RA, 2012, J MAGN MAGN MATER, V324, P534, DOI 10.1016/j.jmmm.2011.08.035
   Boal AK, 2004, CHEM MATER, V16, P3252, DOI 10.1021/cm0495865
   Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x
   Briones E, 2008, J CONTROL RELEASE, V125, P210, DOI 10.1016/j.jconrel.2007.10.027
   Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528
   Cho EC, 2011, NAT NANOTECHNOL, V6, P385, DOI [10.1038/nnano.2011.58, 10.1038/NNANO.2011.58]
   Corot C, 2006, ADV DRUG DELIVER REV, V58, P1471, DOI 10.1016/j.addr.2006.09.013
   Ferreira L., 2007, Medical Devices and Coatings with Non-Leaching Antimicrobial Peptides, Patent No. [W02007095393 A2, 2007095393, WO 2007095393 A2]
   Gabriel M, 2006, BIOCONJUGATE CHEM, V17, P548, DOI 10.1021/bc050091v
   Glukhov E, 2005, J BIOL CHEM, V280, P33960, DOI 10.1074/jbc.M507042200
   Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267
   Hashizaki K, 2006, CHEM PHARM BULL, V54, P80, DOI 10.1248/cpb.54.80
   Hopp L., 1995, PERSPECT RESP NURS, V6, P8
   Ibrahim EH, 2000, CHEST, V118, P146, DOI 10.1378/chest.118.1.146
   KATSU T, 1989, BIOCHIM BIOPHYS ACTA, V983, P135, DOI 10.1016/0005-2736(89)90226-5
   Khdary NH, 2014, RSC ADV, V4, P50114, DOI 10.1039/c4ra09341k
   Kumar CSSR, 2010, J PHYS CHEM LETT, V1, P3141, DOI 10.1021/jz101202a
   LEE CCY, 1979, ANAL BIOCHEM, V94, P60, DOI 10.1016/0003-2697(79)90790-5
   Lee WR, 2005, J AM CHEM SOC, V127, P16090, DOI 10.1021/ja053659j
   Lyon JL, 2004, NANO LETT, V4, P719, DOI 10.1021/nl035253f
   Maleki H, 2012, J MAGN MAGN MATER, V324, P3997, DOI 10.1016/j.jmmm.2012.06.045
   MATSUZAKI K, 1995, BIOCHEMISTRY-US, V34, P3423, DOI 10.1021/bi00010a034
   McHenry AJ, 2012, BBA-BIOMEMBRANES, V1818, P3019, DOI 10.1016/j.bbamem.2012.07.021
   MERRIFIELD RB, 1995, P NATL ACAD SCI USA, V92, P3449, DOI 10.1073/pnas.92.8.3449
   Pedrosa J, 2015, MATER CHEM PHYS, V163, P88, DOI 10.1016/j.matchemphys.2015.07.018
   Robinson I, 2010, NANOSCALE, V2, P2624, DOI 10.1039/c0nr00621a
   Skerlavaj B, 1999, FEBS LETT, V463, P58, DOI 10.1016/S0014-5793(99)01600-2
   STEINER H, 1981, NATURE, V292, P246, DOI 10.1038/292246a0
   Subbiandoss G, 2012, ACTA BIOMATER, V8, P2047, DOI 10.1016/j.actbio.2012.03.002
   Taylor EN, 2009, INT J NANOMED, V4, P145
   Teply BA, 2008, BIOMATERIALS, V29, P1216, DOI 10.1016/j.biomaterials.2007.11.018
   Tiozzo E, 1998, BIOCHEM BIOPH RES CO, V249, P202, DOI 10.1006/bbrc.1998.9114
   Vestal CR, 2002, J AM CHEM SOC, V124, P14312, DOI 10.1021/ja0274709
   Wang YQ, 2009, NANOSCALE RES LETT, V4, P684, DOI 10.1007/s11671-009-9298-6
   Yilmaz A, 2013, EUR HEART J, V34, P462, DOI 10.1093/eurheartj/ehs366
   Yount NY, 2009, P NATL ACAD SCI USA, V106, P14972, DOI 10.1073/pnas.0904465106
   Zhao Y, 2005, J AM CHEM SOC, V127, P7328, DOI 10.1021/ja050432f
   Ziegler A, 2008, ADV DRUG DELIVER REV, V60, P580, DOI 10.1016/j.addr.2007.10.005
NR 43
TC 17
Z9 17
U1 7
U2 60
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD MAY 11
PY 2016
VL 8
IS 18
BP 11366
EP 11378
DI 10.1021/acsami.6b03355
PG 13
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA DL3GA
UT WOS:000375521000022
PM 27074633
DA 2018-10-20
ER

PT J
AU Al-Ta'ii, HMJ
   Amin, YM
   Periasamy, V
AF Al-Ta'ii, Hassan Maktuff Jaber
   Amin, Yusoff Mohd
   Periasamy, Vengadesh
TI Humidity influenced capacitance and resistance of an Al/DNA/Al Schottky
   diode irradiated by alpha particles
SO SCIENTIFIC REPORTS
LA English
DT Article
ID VOLTAGE CHARACTERISTICS; NANOMEMBRANE DIODES; PLASTIC SUBSTRATE;
   CHARGE-TRANSPORT; THIN-FILM; DNA; SENSORS; HYPERSENSITIVITY;
   FABRICATION; EXTRACTION
AB Deoxyribonucleic acid or DNA based sensors, especially as humidity and alpha particle sensors have become quite popular in recent times due to flexible and highly optimizable nature of this fundamental biomaterial. Application of DNA electronics allow for more sensitive, accurate and effective sensors to be developed and fabricated. In this work, we examined the effect of different humidity conditions on the capacitive and resistive response of Aluminum (Al)/DNA/Al Schottky barrier structure when bombarded by time-dependent dosages of alpha particles. Based on current-voltage profiles, which demonstrated rectifying behaviours, Schottky diode parameters such as ideality factor, barrier height and series resistance was calculated. Results observed generally pointed towards a decrease in the resistance value from the pristine to the radiated structures. It was also demonstrated that under the effect of humidity, the capacitance of the DNA thin film increased from 0.05894 to 92.736 nF, with rising relative humidity level. We also observed the occurrence of the hypersensitivity phenomena after alpha irradiation between 2 to 4 min by observing a drop in the series resistance, crucial in the study of DNA damage and repair mechanisms. These observations may also suggest the exciting possibility of utilizing Al/DNA/Al Schottky diodes as potentially sensitive humidity sensors.
C1 [Al-Ta'ii, Hassan Maktuff Jaber; Periasamy, Vengadesh] Univ Malaya, Dept Phys, Low Dimens Mat Res Ctr, Fac Sci, Kuala Lumpur 50603, Malaysia.
   [Al-Ta'ii, Hassan Maktuff Jaber] Univ Al Muthanna, Dept Phys, Fac Sci, Samawah 66001, Iraq.
   [Amin, Yusoff Mohd] Univ Malaya, Dept Phys, Fac Sci, Kuala Lumpur 50603, Malaysia.
RP Al-Ta'ii, HMJ; Periasamy, V (reprint author), Univ Malaya, Dept Phys, Low Dimens Mat Res Ctr, Fac Sci, Kuala Lumpur 50603, Malaysia.; Al-Ta'ii, HMJ (reprint author), Univ Al Muthanna, Dept Phys, Fac Sci, Samawah 66001, Iraq.
EM hassankirkukly@gmail.com; vengadeshp@um.edu.my
RI PERIASAMY, VENGADESH/B-9993-2010
FU FRGS [FP004-2013A]; UMRG [RG321-15AFR]; Ministry of Higher Education and
   Scientific Research of Iraq;  [PG202-2014B]
FX Financial assistance provided by the PG202-2014B, FRGS (FP004-2013A) and
   UMRG (RG321-15AFR) grants are greatly appreciated. The first author
   would like to thank the Ministry of Higher Education and Scientific
   Research of Iraq for the financial assistance provided for his PhD
   study.
CR Ahmad Z, 2008, PHYSICA E, V41, P18, DOI 10.1016/j.physe.2008.05.018
   Ahmad Z, 2013, SENSORS-BASEL, V13, P3615, DOI 10.3390/s130303615
   Al-Ta'ii H., 2015, PLOS ONE, V11
   Al-Ta'ii H. M. J., 2015, J APPL PHYS, V118
   Armitage NP, 2004, PHYS STATUS SOLIDI B, V241, P69, DOI 10.1002/pssb.200303603
   Aydogan S, 2008, MAT SCI SEMICON PROC, V11, P53, DOI 10.1016/j.mssp.2008.11.004
   Aziz F., 2012, MEAS SCI TECHNOL, V23
   Azmer MI, 2015, MEASUREMENT, V61, P180, DOI 10.1016/j.measurement.2014.10.048
   Bi H., 2013, SCI REP, V3, P1
   Bonea A, 2012, J OPTOELECTRON ADV M, V14, P511
   Cerreta A, 2013, EUR POLYM J, V49, P1916, DOI 10.1016/j.eurpolymj.2013.03.026
   Chani MTS, 2012, PHYSICA E, V45, P77, DOI 10.1016/j.physe.2012.07.012
   Chen HJ, 2010, SENSOR ACTUAT B-CHEM, V150, P487, DOI [10.1016/j.snb.2010.07.038, 10.1016/jsob.2010.07.038]
   Chen W.-C., 2014, J PHYS D, V47
   CHEUNG SK, 1986, APPL PHYS LETT, V49, P85, DOI 10.1063/1.97359
   CHIU SM, 1982, BIOCHIM BIOPHYS ACTA, V699, P15, DOI 10.1016/0167-4781(82)90166-X
   Cubero OF, 1999, PLANT SYST EVOL, V216, P243, DOI 10.1007/BF01084401
   Cvetkovic NV, 2012, MICROELECTRON ENG, V100, P47, DOI 10.1016/j.mee.2012.07.110
   Farag AAM, 2011, SYNTHETIC MET, V161, P32, DOI 10.1016/j.synthmet.2010.10.030
   Farahani H, 2014, SENSORS-BASEL, V14, P7881, DOI 10.3390/s140507881
   Gupta RK, 2012, SOL ENERGY, V86, P1539, DOI 10.1016/j.solener.2012.02.015
   Ha DH, 2002, CHEM PHYS LETT, V355, P405, DOI 10.1016/S0009-2614(02)00142-2
   Hassan M, 2009, J RAFIDEN SCI, V20, P113
   Hibbett D., 2013, FORENSIC D N A MINIP
   Huang JR, 2007, SENSOR ACTUAT A-PHYS, V133, P467, DOI 10.1016/j.sna.2006.04.020
   Imtiaj A., 2011, Micologia Aplicada International, V23, P1
   Jo YS, 2003, J KOREAN PHYS SOC, V43, P909
   Joiner MC, 1996, MUTAT RES-FUND MOL M, V358, P171, DOI 10.1016/S0027-5107(96)00118-2
   Karatas S, 2004, VACUUM, V74, P45, DOI 10.1016/j.vacuum.2003.11.006
   Karimov K.S., 2012, J SEMICOND, V33
   Karimov K. S., 2015, CHINESE PHYS B, V24
   Kleine-Ostmann T., 2006, APPL PHYS LETT, P88
   Knapp F. R., 2016, RADIOPHARMACEUTICALS, p[3, 40]
   KULWICKI BM, 1991, J AM CERAM SOC, V74, P697, DOI 10.1111/j.1151-2916.1991.tb06911.x
   Kumemura M, 2007, CHEMPHYSCHEM, V8, P1875, DOI 10.1002/cphc.200700268
   Leveritt III J. M., 2009, J CHEM PHYS, V131
   Li Y, 2004, TALANTA, V62, P707, DOI 10.1016/j.talanta.2003.09.011
   Lin CY, 2011, ORG ELECTRON, V12, P1777, DOI 10.1016/j.orgel.2011.07.006
   Ma DL, 2014, ACCOUNTS CHEM RES, V47, P3614, DOI 10.1021/ar500310z
   Maeda M, 2008, J RADIAT RES, V49, P171, DOI 10.1269/jrr.07093
   MASUDA H, 1995, SCIENCE, V268, P1466, DOI 10.1126/science.268.5216.1466
   Mogera U., 2014, SCI REP, V4, P1
   Otsuka Y, 2002, JPN J APPL PHYS 1, V41, P891, DOI 10.1143/JJAP.41.891
   Paul A, 2013, IEEE SENS J, V13, P1806, DOI 10.1109/JSEN.2012.2234451
   Qin GX, 2013, IEEE ELECTR DEVICE L, V34, P160, DOI 10.1109/LED.2012.2228464
   Ramaprasad AT, 2010, SENSOR ACTUAT B-CHEM, V148, P117, DOI 10.1016/j.snb.2010.05.044
   Reddy VR, 2011, J ALLOY COMPD, V509, P8001, DOI 10.1016/j.jallcom.2011.05.055
   Rittersma ZM, 2002, SENSOR ACTUAT A-PHYS, V96, P196, DOI 10.1016/S0924-4247(01)00788-9
   Seo JH, 2013, MICROELECTRON ENG, V110, P40, DOI 10.1016/j.mee.2013.05.001
   Steckl AJ, 2007, NAT PHOTONICS, V1, P3, DOI 10.1038/nphoton.2006.56
   Stetter JR, 2003, J ELECTROCHEM SOC, V150, pS11, DOI 10.1149/1.1539051
   Sze S. M., 2006, PHYS SEMICONDUCTOR D
   Tabata H, 2003, SYNTHETIC MET, V133, P469, DOI 10.1016/S0379-6779(02)00386-7
   Taniguchi M, 2003, JPN J APPL PHYS 1, V42, P6629, DOI 10.1143/JJAP.42.6629
   TRAVERSA E, 1995, SENSOR ACTUAT B-CHEM, V23, P135, DOI 10.1016/0925-4005(94)01268-M
   Tugluoglu N, 2012, CURR APPL PHYS, V12, P1529, DOI 10.1016/j.cap.2012.04.027
   Tuukkanen S., 2005, APPL PHYS LETT, V87
   Varghese OK, 2003, J NANOSCI NANOTECHNO, V3, P277, DOI 10.1166/jnn.2003.158
   Wang SR, 2013, SENSOR ACTUAT B-CHEM, V182, P467, DOI 10.1016/j.snb.2013.03.042
   Yamada M, 2008, POLYM J, V40, P327, DOI 10.1295/polymj.PJ2007215
   Yamahata C, 2008, BIOPHYS J, V94, P63, DOI 10.1529/biophysj.107.115980
   Yaworski B., 1968, HDB PHYS
   Zhang YY, 2008, SENSOR ACTUAT B-CHEM, V135, P317, DOI 10.1016/j.snb.2008.08.042
NR 63
TC 6
Z9 6
U1 1
U2 13
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAY 10
PY 2016
VL 6
AR 25519
DI 10.1038/srep25519
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DL2AY
UT WOS:000375436100001
PM 27160654
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Golberg, K
   Emuna, N
   Vinod, TP
   van Moppes, D
   Marks, RS
   Arad, SM
   Kushmaro, A
AF Golberg, Karina
   Emuna, Noa
   Vinod, T. P.
   van Moppes, Dorit
   Marks, Robert S.
   Arad, Shoshana Malis
   Kushmaro, Ariel
TI Novel Anti-Adhesive Biomaterial Patches: Preventing Biofilm with Metal
   Complex Films (MCF) Derived from a Microalgal Polysaccharide
SO ADVANCED MATERIALS INTERFACES
LA English
DT Article
ID PSEUDOMONAS-AERUGINOSA; SWARMING MOTILITY; STREPTOCOCCUS-MUTANS;
   ANTIMICROBIAL ACTIVITY; VIRULENCE FACTORS; STAINLESS-STEEL; RED
   MICROALGAE; BACTERIAL; INHIBITION; NANOPARTICLES
AB Biofilm matrices formed by irreversibly surface-anchored bacteria cause significant economic damage in the industrial and biomedical environments. The ubiquity of biofilms promotes increased investment in the development of technologies that will impede bacteria-surface association. Certain surface topographical fabrications may aid in preventing colonization. Herein, algalsecreted polysaccharide (Ps) biomaterial patches and metal complex films (MCF) are examined for their anti-Acinetobacter baumannii and anti-Pseudomonas aeruginosa biofilm properties. Ps moderately reduces biofilm formation; the Cu-MCF coating has significant anti-biofim activity while Zn-MCF had no effect. A mechanistic examination of these effects shows a two-fold greater coverage of the anti-adhesive surface of Cu-MCF than that of the control due to the induction of swarming motility, thus impeding bacterial transformation to the irreversibly attached state. Chemical compositions of the coatings and the interactions between coating components are examined using X-ray photoelectron spectroscopy (XPS) and Fourier transform infrared (FTIR) spectrometry. Cu-MCF surface morphology comprises protruding needle-like structures up to 100 nm in height that are lacking in both the Ps and the Zn-MCF. Their presence in an aqueous solution is yet unproven and role in preventing their bacterial attachment open to speculation. The present study highlights the need to generate novel biomaterials that integrate naturally occurring anti-adhesive polymers with specific metal ions to improve the chemical, physical and biological properties of these anti-adhesive surfaces. Cu-MCF complexes fabricated with thermal and pressure stability to prevent metal ion leakage hold promise for a broad spectrum of industrial and medical anti-biofilm applications.
C1 [Golberg, Karina; Emuna, Noa; van Moppes, Dorit; Marks, Robert S.; Arad, Shoshana Malis; Kushmaro, Ariel] Ben Gurion Univ Negev, Avram & Stella Goldstein Goren Dept Biotechnol En, POB 653, IL-8410501 Beer Sheva, Israel.
   [Vinod, T. P.] Ben Gurion Univ Negev, Dept Chem, IL-8410501 Beer Sheva, Israel.
   [Marks, Robert S.; Kushmaro, Ariel] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore.
   [Marks, Robert S.; Kushmaro, Ariel] Ben Gurion Univ Negev, Ilse Katz Ctr Meso & Nanoscale Sci & Technol, POB 653, IL-8410501 Beer Sheva, Israel.
RP Kushmaro, A (reprint author), Ben Gurion Univ Negev, Avram & Stella Goldstein Goren Dept Biotechnol En, POB 653, IL-8410501 Beer Sheva, Israel.
EM arielkus@bgu.ac.il
OI T. P., Vinod/0000-0001-5815-5230
FU Singapore National Research Foundation under the CREATE program:
   Nanomaterials for Energy and Water Management; Levi Eshkol scholarship
   from the Israeli Ministry of Science and Technology; Shimona Geresh
   award
FX This work was supported by the Singapore National Research Foundation
   under the CREATE program: Nanomaterials for Energy and Water Management;
   a Levi Eshkol scholarship from the Israeli Ministry of Science and
   Technology and Shimona Geresh award. The authors also thank Bar
   Piglanski and Juergen Jopp for technical support.
CR ALLISON C, 1992, INFECT IMMUN, V60, P4740
   [Anonymous], 2012, NIST XRAY PHOT SPECT
   Arad S, 2006, LANGMUIR, V22, P7313, DOI 10.1021/la060600x
   Asuri P, 2007, SMALL, V3, P50, DOI 10.1002/smll.200600312
   Atkinson S, 2009, J R SOC INTERFACE, V6, P959, DOI 10.1098/rsif.2009.0203
   Beamson G., 1993, SURF INTERFACE ANAL, V20, P267
   Bearinger JP, 2003, NAT MATER, V2, P259, DOI 10.1038/nmat851
   Bendaoud M, 2011, J BACTERIOL, V193, P3879, DOI 10.1128/JB.00311-11
   Birkenhauer E, 2014, JOVE-J VIS EXP, DOI 10.3791/52327
   Boles BR, 2005, MOL MICROBIOL, V57, P1210, DOI 10.1111/j.1365-2958.2005.04743.x
   Bosch TCG, 2013, ANNU REV MICROBIOL, V67, P499, DOI 10.1146/annurev-micro-092412-155626
   Braithwaite RA, 2005, ADV MAR BIOL, V47, P215
   Brochardt SA, 2001, APPL ENVIRON MICROB, V67, P3174
   Caiazza NC, 2004, J BACTERIOL, V186, P4476, DOI 10.1128/JB.186.14.4476-4485.2004
   Carte Brad K., 1993, Current Opinion in Biotechnology, V4, P275, DOI 10.1016/0958-1669(93)90095-E
   CERVANTES C, 1994, FEMS MICROBIOL REV, V14, P121
   Christensen BB, 1999, METHOD ENZYMOL, V310, P20
   Cloete TE, 2001, WATER SA, V27, P21
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   de la Fuente-Nunez C, 2012, ANTIMICROB AGENTS CH, V56, P2696, DOI 10.1128/AAC.00064-12
   Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063
   Efimenko K, 2009, ACS APPL MATER INTER, V1, P1031, DOI 10.1021/am9000562
   Eshed M, 2014, ADV FUNCT MATER, V24, P1382, DOI 10.1002/adfm.201302425
   Eshed M, 2012, LANGMUIR, V28, P12288, DOI 10.1021/la301432a
   Falagas ME, 2007, INT J ANTIMICROB AG, V29, P630, DOI 10.1016/j.ijantimicag.2006.12.012
   Faundez G, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-19
   Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415
   Francolini I, 2010, FEMS IMMUNOL MED MIC, V59, P227, DOI 10.1111/j.1574-695X.2010.00665.x
   Fraser GM, 1999, CURR OPIN MICROBIOL, V2, P630, DOI 10.1016/S1369-5274(99)00033-8
   Gaddy JA, 2009, FUTURE MICROBIOL, V4, P273, DOI 10.2217/FMB.09.5
   Gao GZ, 2011, BIOMATERIALS, V32, P3899, DOI 10.1016/j.biomaterials.2011.02.013
   GERESH S, 1991, BIORESOURCE TECHNOL, V38, P195, DOI 10.1016/0960-8524(91)90154-C
   Giesbers M, 2013, LANGMUIR, V29, P4782, DOI 10.1021/la400445s
   Givskov M, 1996, J BACTERIOL, V178, P6618, DOI 10.1128/jb.178.22.6618-6622.1996
   Hattori T, 1998, J NAT PROD, V61, P823, DOI 10.1021/np970527y
   Hentzer M, 2002, MICROBIOL-SGM, V148, P87, DOI 10.1099/00221287-148-1-87
   Hofmann S., 2013, AUGER XRAY PHOTOELEC
   Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011
   Huleihel M, 2001, J APPL PHYCOL, V13, P127, DOI 10.1023/A:1011178225912
   INGRAM LO, 1990, CRIT REV BIOTECHNOL, V9, P305
   Jayaraman A, 2008, ANNU REV BIOMED ENG, V10, P145, DOI 10.1146/annurev.bioeng.10.061807.160536
   Jiang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018514
   Kielemoes J, 2001, LETT APPL MICROBIOL, V33, P148, DOI 10.1046/j.1472-765X.2001.00967.x
   Kim JS, 2007, BIOTECHNOL BIOPROC E, V12, P308, DOI 10.1007/BF02931109
   Leal MC, 2013, TRENDS BIOTECHNOL, V31, P555, DOI 10.1016/j.tibtech.2013.06.004
   Lee SY, 2007, POLYM ADVAN TECHNOL, V18, P562, DOI 10.1002/pat.918
   LIPPERT B, 1992, BIOMETALS, V5, P195, DOI 10.1007/BF01061218
   Loke MF, 2007, FEMS IMMUNOL MED MIC, V50, P231, DOI 10.1111/j.1574-695X.2007.00248.x
   LOPEZ GP, 1991, SURF INTERFACE ANAL, V17, P267, DOI 10.1002/sia.740170508
   Lutay N, 2011, APPL BIOCHEM BIOTECH, V164, P1, DOI 10.1007/s12010-010-9109-7
   Lynch AS, 2008, ANNU REV MED, V59, P415, DOI 10.1146/annurev.med.59.110106.132000
   Mansouri J, 2010, J MATER CHEM, V20, P4567, DOI 10.1039/b926440j
   Matsui MS, 2003, APPL BIOCHEM BIOTECH, V104, P13, DOI 10.1385/ABAB:104:1:13
   Merritt JH, 2007, J BACTERIOL, V189, P8154, DOI 10.1128/JB.00585-07
   Nabet A, 1997, APPL SPECTROSC, V51, P466, DOI 10.1366/0003702971940701
   Neal AL, 2008, ECOTOXICOLOGY, V17, P362, DOI 10.1007/s10646-008-0217-x
   Nies DH, 1999, APPL MICROBIOL BIOT, V51, P730, DOI 10.1007/s002530051457
   Nikolic GS, 2008, RUSS J COORD CHEM+, V34, P322, DOI 10.1134/S1070328408050023
   Nikolic G. S., 2011, NEW ANAL APPROACHES, P15
   O'Loughlin CT, 2013, P NATL ACAD SCI USA, V110, P17981, DOI 10.1073/pnas.1316981110
   O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49
   Overhage J, 2008, J BACTERIOL, V190, P2671, DOI 10.1128/JB.01659-07
   Qin ZQ, 2009, MICROBIOL-SGM, V155, P2148, DOI 10.1099/mic.0.028001-0
   RAMUS J, 1972, J PHYCOL, V8, P97, DOI 10.1111/j.0022-3646.1972.00097.x
   Ren D, 2002, LETT APPL MICROBIOL, V34, P293, DOI 10.1046/j.1472-765x.2002.01087.x
   Rendueles O, 2013, ENVIRON MICROBIOL, V15, P334, DOI 10.1111/j.1462-2920.2012.02810.x
   Rozalski A, 1997, MICROBIOL MOL BIOL R, V61, P65
   RUGGIERI MR, 1987, J UROLOGY, V138, P423, DOI 10.1016/S0022-5347(17)43177-6
   Ruparelia JP, 2008, ACTA BIOMATER, V4, P707, DOI 10.1016/j.actbio.2007.11.006
   Saeki Yoji, 1994, Bulletin of Tokyo Dental College, V35, P9
   Sayem S M Abu, 2011, Microb Cell Fact, V10, P74, DOI 10.1186/1475-2859-10-74
   Schultz MP, 2011, BIOFOULING, V27, P87, DOI 10.1080/08927014.2010.542809
   Schumacher JF, 2007, BIOFOULING, V23, P55, DOI 10.1080/08927010601136957
   Shrout JD, 2006, MOL MICROBIOL, V62, P1264, DOI 10.1111/j.1365-2958.2006.05421.x
   Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3
   Tannin-Spitz T, 2005, J APPL PHYCOL, V17, P215, DOI 10.1007/s10811-005-0679-7
   Tenke P, 2004, INT J ANTIMICROB AG, V23, pS67, DOI 10.1016/j.ijantimicag.2003.12.007
   Valle J, 2006, P NATL ACAD SCI USA, V103, P12558, DOI 10.1073/pnas.0605399103
   Verstraeten N, 2008, TRENDS MICROBIOL, V16, P496, DOI 10.1016/j.tim.2008.07.004
   Wai SN, 1998, APPL ENVIRON MICROB, V64, P3648
   Wu C, 2013, J APPL MICROBIOL, V115, P30, DOI 10.1111/jam.12197
   Yano A, 2012, ARCH ORAL BIOL, V57, P711, DOI 10.1016/j.archoralbio.2012.01.001
NR 82
TC 2
Z9 2
U1 6
U2 31
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2196-7350
J9 ADV MATER INTERFACES
JI Adv. Mater. Interfaces
PD MAY 6
PY 2016
VL 3
IS 9
AR 1500486
DI 10.1002/admi.201500486
PG 11
WC Chemistry, Multidisciplinary; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA DQ0JN
UT WOS:000378885300002
DA 2018-10-20
ER

PT J
AU Dragostin, OM
   Samal, SK
   Dash, M
   Lupascu, F
   Panzariu, A
   Tuchilus, C
   Ghetu, N
   Danciu, M
   Dubruel, P
   Pieptu, D
   Vasile, C
   Tatia, R
   Profire, L
AF Dragostin, Oana Maria
   Samal, Sangram Keshari
   Dash, Mamoni
   Lupascu, Florentina
   Panzariu, Andreea
   Tuchilus, Cristina
   Ghetu, Nicolae
   Danciu, Mihai
   Dubruel, Peter
   Pieptu, Dragos
   Vasile, Cornelia
   Tatia, Rodica
   Profire, Lenuta
TI New antimicrobial chitosan derivatives for wound dressing applications
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Chitosan derivative; Membrane; Biomaterial; Healing activity
ID ANTIBACTERIAL ACTIVITY; COMPOSITE SPONGES; SURFACE-ENERGY;
   CELL-ADHESION; WATER; SULFONAMIDES; WETTABILITY; TECHNOLOGY; POLYMERS;
   CHITIN
AB Chitosan is a non-toxic, biocompatible, biodegradable natural cationic polymer known for its low imunogenicity, antimicrobial, antioxidant effects and wound-healing activity. To improve its therapeutic potential, new chitosan-sulfonamide derivatives have been designed to develop new wound dressing biomaterials. The structural, morphological and physico-chemical properties of synthesized chitosan derivatives were analyzed by FT-IR, H-1 NMR spectroscopy, scanning electron microscopy, swelling ability and porosity. Antimicrobial, in vivo testing and biodegradation behavior have been also performed. The chitosan derivative membranes showed improved swelling and biodegradation rate, which are important characteristics required for the wound healing process. The antimicrobial assay evidenced that chitosan-based sulfadiazine, sulfadimethoxine and sulfamethoxazole derivatives were the most active. The MTT assay showed that some of chitosan derivatives are nontoxic. Furthermore, the in vivo study on burn wound model induced in Wistar rats demonstrated an improved healing effect and enhanced epithelialization of chitosan-sulfonamide derivatives compared to neat chitosan. The obtained results strongly recommend the use of some of the newly developed chitosan derivatives as antimicrobial wound dressing biomaterials. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Dragostin, Oana Maria; Lupascu, Florentina; Panzariu, Andreea; Profire, Lenuta] Univ Med & Pharm Grigore T Popa Iasi, Dept Pharmaceut Chem, Fac Pharm, 16 Univ St, Iasi 700115, Romania.
   [Samal, Sangram Keshari] Univ Ghent, Ctr Nano & Biophoton, Lab Gen Biochem & Phys Pharm, Ottergemsesteenweg 460, B-9000 Ghent, Belgium.
   [Dash, Mamoni; Dubruel, Peter] Univ Ghent, Polymer Chem & Biomat Res Grp, Krijgslaan 281,S4 Bis, B-9000 Ghent, Belgium.
   [Tuchilus, Cristina] Univ Med & Pharm Grigore T Popa Iasi, Dept Microbiol, Fac Med, 16 Univ St, Iasi 700115, Romania.
   [Ghetu, Nicolae; Pieptu, Dragos] Univ Med & Pharm Grigore T Popa Iasi, Dept Plast Surg, Fac Med, 16 Univ St, Iasi 700115, Romania.
   [Danciu, Mihai] Univ Med & Pharm Grigore T Popa Iasi, Dept Morphopathol, Fac Med, 16 Univ St, Iasi 700115, Romania.
   [Vasile, Cornelia] Petni Poni Inst Macromol Chem, Dept Phys Chem Polymers, 41A Grigore Ghica Voda Alley, Iasi 700487, Romania.
   [Tatia, Rodica] Natl Inst Res & Dev Biol Sci, 296 Splaiul Independentei, Bucharest 060031, Romania.
RP Profire, L (reprint author), Univ Med & Pharm Grigore T Popa Iasi, Dept Pharmaceut Chem, Fac Pharm, 16 Univ St, Iasi 700115, Romania.
EM lenuta.profire@umfiasi.ro
RI Dash, Mamoni/H-5450-2013; Pieptu, Dragos/N-3173-2017; Danciu,
   Mihai/N-5012-2016; Profire, Lenuta/H-4514-2016
OI Dash, Mamoni/0000-0001-6930-6495; Pieptu, Dragos/0000-0001-8742-7581; 
FU POSDRU [159/1.5/S/136893]; Romanian National Authority for Scientific
   Research, CNCS-UEFISCDI [PN-II-ID-PCE-2011-3-0906]; Romanian UEFISCDI
   [164/2012 BIONANOMED]
FX The research was funded by POSDRU grant no. 159/1.5/S/136893 grant with
   title "Parteneriat strategic pentru cresterea calitatii cercetarii
   stiintifice din universitatile medicale prin acordarea de burse
   doctorale si postdoctorale-DocMed.Net_2.0" (partially) and by a grant of
   the Romanian National Authority for Scientific Research, CNCS-UEFISCDI,
   project number PN-II-ID-PCE-2011-3-0906". The authors thank also to
   Romanian UEFISCDI for the financial support given through the research
   project 164/2012 BIONANOMED.
CR Aider M, 2010, LWT-FOOD SCI TECHNOL, V43, P837, DOI 10.1016/j.lwt.2010.01.021
   Anisha BS, 2013, CARBOHYD POLYM, V92, P1470, DOI 10.1016/j.carbpol.2012.10.058
   Arpornmaeklong P, 2008, INT J ORAL MAX SURG, V37, P357, DOI 10.1016/j.ijom.2007.11.014
   Avadi MR, 2004, EUR POLYM J, V40, P1355, DOI 10.1016/j.europolymj.2004.02.015
   Baran ET, 2012, MAT SCI ENG C-MATER, V32, P1314, DOI 10.1016/j.msec.2012.02.015
   Batista MKS, 2006, CARBOHYD POLYM, V64, P299, DOI 10.1016/j.carbpol.2005.11.040
   Clinical Laboratory Standards Institute, 2012, 22 INF S, V32
   Dash M, 2011, PROG POLYM SCI, V36, P981, DOI 10.1016/j.progpolymsci.2011.02.001
   Dias AMA, 2013, J SUPERCRIT FLUID, V74, P34, DOI 10.1016/j.supflu.2012.12.007
   Dragostin O. M., 2015, CARBOHYDRATE P UNPUB
   Dutta PK, 2002, J MACROMOL SCI-POL R, VC42, P307, DOI 10.1081/MC-120006451
   European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society for Clinical Microbiology and Infectious Diseases (ESCMID), 2000, CLIN MICROBIOL INFEC, V6, P509
   Feng YW, 2011, CARBOHYD POLYM, V83, P1169, DOI 10.1016/j.carbpol.2010.09.026
   Gallaher CM, 2000, J NUTR, V130, P2753
   Gethin G. T., 2007, WOUNDS UK, V3, P52
   Giri TK, 2012, ACTA PHARM SIN B, V2, P439, DOI 10.1016/j.apsb.2012.07.004
   Gomes JRB, 2005, TETRAHEDRON, V61, P2705, DOI 10.1016/j.tet.2005.01.034
   Gupta A, 2009, WATER RES, V43, P3862, DOI 10.1016/j.watres.2009.05.040
   Hallab NJ, 2001, TISSUE ENG, V7, P55, DOI 10.1089/107632700300003297
   Ignatova M, 2013, MACROMOL BIOSCI, V13, P860, DOI 10.1002/mabi.201300058
   Jones V, 2006, BRIT MED J, V332, P777, DOI 10.1136/bmj.332.7544.777
   Kolodynska D, 2012, CHEM ENG J, V179, P33, DOI 10.1016/j.cej.2011.10.028
   Kremer E, 2006, J INORG BIOCHEM, V100, P1167, DOI 10.1016/j.jinorgbio.2006.01.042
   Kumar PTS, 2012, ACS APPL MATER INTER, V4, P2618, DOI 10.1021/am300292v
   Kumirska J, 2011, POLYMERS-BASEL, V3, P1875, DOI 10.3390/polym3041875
   Lin YC, 2009, ACTA BIOMATER, V5, P2591, DOI 10.1016/j.actbio.2009.03.038
   Liu X, 2011, ADV POLYM SCI, V244, P81, DOI 10.1007/12_2011_118
   Lonnroth Emma Christin, 2005, Int J Occup Saf Ergon, V11, P131
   Ma GP, 2008, CARBOHYD POLYM, V74, P121, DOI 10.1016/j.carbpol.2008.01.028
   Mallick S, 2012, ACS APPL MATER INTER, V4, P1313, DOI 10.1021/am201586w
   Martins AF, 2014, INT J MOL SCI, V15, P20800, DOI 10.3390/ijms151120800
   Mazyala E. J, 2008, THESIS U STELLENBOSC
   O'Brien F. J., 2005, EFFECT PORE SIZE CEL
   Okamoto Y, 2003, CARBOHYD POLYM, V53, P337, DOI 10.1016/S0144-8617(03)00076-6
   Ozturk E, 2006, J APPL POLYM SCI, V101, P1602, DOI 10.1002/app.23563
   Paul W., 2004, TRENDS BIOMATERIALS, V18, P18
   Pillai CKS, 2009, PROG POLYM SCI, V34, P641, DOI 10.1016/j.progpolymsci.2009.04.001
   Rotta J, 2009, MAT SCI ENG C-BIO S, V29, P619, DOI 10.1016/j.msec.2008.10.032
   Samal SK, 2014, RSC ADV, V4, P53547, DOI 10.1039/c4ra10070k
   Samal SK, 2014, MACROMOL BIOSCI, V14, P991, DOI 10.1002/mabi.201300513
   Samal SK, 2012, CHEM SOC REV, V41, P7147, DOI 10.1039/c2cs35094g
   Sashiwa H, 2003, MACROMOL BIOSCI, V3, P231, DOI 10.1002/mabi.200390029
   Shabalovskaya SA, 2013, MAT SCI ENG C-MATER, V33, P127, DOI 10.1016/j.msec.2012.08.018
   Sionkowska A, 2013, J MOL LIQ, V178, P5, DOI 10.1016/j.molliq.2012.10.042
   Wang JP, 2009, WATER RES, V43, P5267, DOI 10.1016/j.watres.2009.08.040
   Xie YJ, 2007, CARBOHYD POLYM, V69, P142, DOI 10.1016/j.carbpol.2006.09.010
   Yang CY, 2010, EUR CELLS MATER, V20, P415
   Yang JM, 2008, MAT SCI ENG C-BIO S, V28, P150, DOI 10.1016/j.msec.2007.01.011
   Yang TC, 2005, INT J FOOD MICROBIOL, V97, P237, DOI 10.1016/S0168-1605(03)00083-7
   Zahid H. C., 2009, TRANSITION METAL CHE, V34, P153
   Zhong Z., 2007, CARBOHYD RES, V343, P566
NR 51
TC 27
Z9 27
U1 6
U2 248
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD MAY 5
PY 2016
VL 141
BP 28
EP 40
DI 10.1016/j.carbpol.2015.12.078
PG 13
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA DD5JT
UT WOS:000369960400004
PM 26876993
DA 2018-10-20
ER

PT J
AU Nieto-Suarez, M
   Lopez-Quintela, MA
   Lazzari, M
AF Nieto-Suarez, Marina
   Arturo Lopez-Quintela, M.
   Lazzari, Massimo
TI Preparation and characterization of crosslinked chitosan/gelatin
   scaffolds by ice segregation induced self-assembly
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Chitosan; Gelatin; Hydrogel; Scaffold; Unidirectional freezing;
   Biomaterial
ID BIOMEDICAL APPLICATIONS; GELATIN SCAFFOLDS; CONTROLLED-RELEASE;
   COMPOSITE FILMS; DRUG-DELIVERY; HYDROGELS; CHITIN; LINKING; MORPHOLOGY;
   GELS
AB Chitosan and gelatin are biodegradable and biocompatible polymers which may be used in the preparation of 3D scaffolds with applications in biomedicine. Chitosan/gelatin scaffolds crosslinked with glutaraldehyde were prepared by ice segregation induced self-assembly (ISISA); a unidirectional freezing at -196 degrees C followed freeze-drying to produce macroporous materials with a well-patterned structure. This process may be included within the green chemistry by the preparation of the porous structures without using organic solvents, moreover is a versatile, non-difficult and cheap process.
   The scaffolds prepared by ISISA were characterized by scanning electron microscopy, attenuated total reflectance Fourier transform infrared spectroscopy, thermal gravimetric analysis, differential scanning calorimetry, and their stability was evaluated by degree swelling and degradation tests. The scaffolds present properties as high porosity, high degree swelling and good stability which make them suitable of applications as biomaterials. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Nieto-Suarez, Marina; Lazzari, Massimo] Univ Santiago de Compostela, Ctr Res Biol Chem & Mol Mat CIQUS, Campus Vida, Santiago De Compostela 15782, Spain.
   [Nieto-Suarez, Marina; Arturo Lopez-Quintela, M.] Univ Santiago de Compostela, Dept Phys Chem, Fac Chem, Santiago De Compostela 15782, Spain.
RP Nieto-Suarez, M (reprint author), Univ Santiago de Compostela, Ctr Res Biol Chem & Mol Mat CIQUS, Campus Vida, Santiago De Compostela 15782, Spain.; Nieto-Suarez, M (reprint author), Univ Santiago de Compostela, Dept Phys Chem, Fac Chem, Santiago De Compostela 15782, Spain.
EM m.nieto@usc.es
RI lazzari, massimo/E-8799-2013
OI lazzari, massimo/0000-0003-1300-6711; Lopez-Quintela, M.
   Arturo/0000-0002-4842-8028
FU Xunta de Galicia [GRC2013-044]
FX This research work was supported by the Xunta de Galicia through grant
   GRC2013-044. M.N.S. thanks to the Xunta de Galicia for "Isidro Parga
   Pondal" research contract. The authors also thank Manuel Gomez (Optics
   Faculty-USC) for measurements of the mechanical properties
CR Alizadeh M, 2013, MAT SCI ENG C-MATER, V33, P3958, DOI 10.1016/j.msec.2013.05.039
   Attawia MA, 1999, J BIOMED MATER RES, V48, P322, DOI 10.1002/(SICI)1097-4636(1999)48:3<322::AID-JBM17>3.0.CO;2-U
   Avetta P, 2014, J MATER CHEM B, V2, P5287, DOI 10.1039/c4tb00236a
   Balakrishnan B, 2011, CHEM REV, V111, P4453, DOI 10.1021/cr100123h
   Cheng MY, 2003, BIOMATERIALS, V24, P2871, DOI 10.1016/S0142-9612(03)00117-0
   Chiono V, 2008, J MATER SCI-MATER M, V19, P889, DOI 10.1007/s10856-007-3212-5
   Choi YS, 2001, J MATER SCI-MATER M, V12, P67, DOI 10.1023/A:1026765321117
   Contri RV, 2014, MAT SCI ENG C-MATER, V42, P234, DOI 10.1016/j.msec.2014.05.001
   Deville S, 2006, SCIENCE, V311, P515, DOI 10.1126/science.1120937
   Farris S, 2010, J AGR FOOD CHEM, V58, P998, DOI 10.1021/jf9031603
   Ferrer ML, 2006, CHEM MATER, V18, P554, DOI 10.1021/cm052087z
   Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x
   Garcia MA, 2006, STARCH-STARKE, V58, P453, DOI 10.1002/star.200500484
   Guan JJ, 2005, BIOMATERIALS, V26, P3961, DOI 10.1016/j.biomaterials.2004.10.018
   Gutierrez MC, 2007, ADV FUNCT MATER, V17, P3505, DOI 10.1002/adfm.200700093
   Gutierrez MC, 2007, CHEM MATER, V19, P1968, DOI 10.1021/cm062882s
   Gutierrez MC, 2006, ADV MATER, V18, P1137, DOI 10.1002/adma.200502550
   Guvendiren M, 2012, SOFT MATTER, V8, P260, DOI 10.1039/c1sm06513k
   Hamidi M, 2008, ADV DRUG DELIVER REV, V60, P1638, DOI 10.1016/j.addr.2008.08.002
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hoffman AS, 2012, ADV DRUG DELIVER REV, V64, P18, DOI 10.1016/j.addr.2012.09.010
   Hopkins AM, 2013, ADV FUNCT MATER, V23, P5140, DOI 10.1002/adfm.201300435
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   Ikeda T, 2014, BIOMED RES INT, V2014, DOI [10.1155/2014/786892, DOI 10.1155/2014/786892]
   Jayakumar R, 2010, CARBOHYD POLYM, V82, P227, DOI 10.1016/j.carbpol.2010.04.074
   Kim H, 2011, J BIOMED MATER RES A, V97A, P395, DOI 10.1002/jbm.a.33070
   Kuijpers AJ, 2000, J BIOMAT SCI-POLYM E, V11, P225, DOI 10.1163/156856200743670
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Kurita K, 2000, CARBOHYD POLYM, V42, P19, DOI 10.1016/S0144-8617(99)00127-7
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lopez-Perez PM, 2010, J MATER CHEM, V20, P483, DOI 10.1039/b911854c
   Monteiro OAC, 1999, INT J BIOL MACROMOL, V26, P119, DOI 10.1016/S0141-8130(99)00068-9
   Mukai SR, 2005, CARBON, V43, P1563, DOI 10.1016/j.carbon.2004.12.029
   Mukai SR, 2003, MICROPOR MESOPOR MAT, V63, P43, DOI 10.1016/S1387-1811(03)00430-X
   Muzzarelli RAA, 2012, CARBOHYD POLYM, V87, P995, DOI 10.1016/j.carbpol.2011.09.063
   Muzzarelli RAA, 2011, CARBOHYD POLYM, V83, P1433, DOI 10.1016/j.carbpol.2010.10.044
   Muzzarelli RAA, 2009, CARBOHYD POLYM, V76, P167, DOI 10.1016/j.carbpol.2008.11.002
   Nieto M, 2010, SOFT MATTER, V6, P3533, DOI 10.1039/c0sm00079e
   Olad A, 2014, CERAM INT, V40, P10061, DOI 10.1016/j.ceramint.2014.04.010
   Ostrowska-Czubenko J, 2009, CARBOHYD POLYM, V77, P590, DOI 10.1016/j.carbpol.2009.01.036
   Pal K, 2007, J MATER SCI-MATER M, V18, P1889, DOI 10.1007/s10856-007-3061-2
   Pawlak A, 2003, THERMOCHIM ACTA, V396, P153, DOI 10.1016/S0040-6031(02)00523-3
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Pillai CKS, 2009, PROG POLYM SCI, V34, P641, DOI 10.1016/j.progpolymsci.2009.04.001
   Pradal C, 2011, J MATER CHEM, V21, P2330, DOI 10.1039/c0jm03080e
   Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m
   RATNER BD, 1976, ACS SYM SER, P1
   Rigozzi S, 2013, J BIOMECH, V46, P813, DOI 10.1016/j.jbiomech.2012.11.017
   Rinaudo M, 2008, POLYM INT, V57, P397, DOI 10.1002/pi.2378
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Sarem M, 2013, CARBOHYD POLYM, V93, P635, DOI 10.1016/j.carbpol.2012.11.099
   She B., 2008, POLYM DEGRADATION ST, V93, P1316
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Smitha B, 2005, EUR POLYM J, V41, P1859, DOI 10.1016/j.eurpolymj.2005.02.018
   Suwanchawalit C, 2009, J MATER CHEM, V19, P8478, DOI 10.1039/b912698h
   Tseng HJ, 2013, J TISSUE ENG REGEN M, V7, P20, DOI 10.1002/term.492
   Verma V, 2007, BIOTECHNOL BIOENG, V96, P392, DOI 10.1002/bit.21111
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   Wu X, 2010, ACTA BIOMATER, V6, P1167, DOI 10.1016/j.actbio.2009.08.041
   Yan L. P., 2010, J BIOMEDICAL MAT R A, V2, P465
   Yeul VS, 2013, J POLYM ENVIRON, V21, P606, DOI 10.1007/s10924-012-0458-x
NR 62
TC 28
Z9 28
U1 7
U2 215
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD MAY 5
PY 2016
VL 141
BP 175
EP 183
DI 10.1016/j.carbpol.2015.12.064
PG 9
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA DD5JT
UT WOS:000369960400021
PM 26877010
DA 2018-10-20
ER

PT J
AU He, XL
   Zhang, J
   Wang, WB
   Xuan, WP
   Wang, XZ
   Zhang, QL
   Smith, CG
   Luo, JK
AF He, Xingli
   Zhang, Jian
   Wang, Wenbo
   Xuan, Weipeng
   Wang, Xiaozhi
   Zhang, Qilong
   Smith, Charles G.
   Luo, Jikui
TI Transient Resistive Switching Devices Made from Egg Albumen Dielectrics
   and Dissolvable Electrodes
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE egg albumen; proteins; memristors; bipolar switch; dissolvability
ID NONVOLATILE MEMORY; GOLD NANOPARTICLES; CHICKEN ALBUMIN; PROTEIN;
   TRANSISTOR; NANODEVICES; MEMRISTOR; FILMS; ZNO
AB Egg albumen as the dielectric, and dissolvable Mg and W as the top and bottom electrodes are used to fabricate water-soluble memristors. 4 X 4 cross-bar configuration memristor devices show a bipolar resistive switching, behavior with a high to low resistance ratio in the range of 1 X 10(2) to 1 X 10(4), higher than most other biomaterial-based memristors, and a retention time over 10(4) s without any sign of deterioration, demonstrating its high stability and reliability. Metal filaments accompanied by hopping conduction are believed to be responsible for the switching behavior of the memory devices. The Mg and W electrodes, and albumen film all can be dissolved in water within 72 h, showing their transient characteristics. This work demonstrates a new way to fabricate biocompatible and dissolvable electronic devices by using cheap, abundant, and 100% natural materials for the forthcoming bioelectronics era as well as for environmental sensors when the Internet of things takes off.
C1 [He, Xingli; Wang, Wenbo; Xuan, Weipeng; Wang, Xiaozhi; Luo, Jikui] Zhejiang Univ, Coll Informat Sci & Elect Engn, Hangzhou 310027, Zhejiang, Peoples R China.
   [Zhang, Jian; Zhang, Qilong] Zhejiang Univ, Dept Mat Sci & Engn, Hangzhou 310027, Zhejiang, Peoples R China.
   [He, Xingli] Fujian Univ Technol, Coll Informat Sci & Engn, Fuzhou 350118, Peoples R China.
   [He, Xingli; Smith, Charles G.] Univ Cambridge, Cavendish Lab, JJ Thomson Ave, Cambridge CB3 0HE, England.
   [Luo, Jikui] Univ Bolton, Inst Mat Res & Innovat, Deane Rd, Bolton BL3 5AB, England.
RP Wang, XZ; Luo, JK (reprint author), Zhejiang Univ, Coll Informat Sci & Elect Engn, Hangzhou 310027, Zhejiang, Peoples R China.; Luo, JK (reprint author), Univ Bolton, Inst Mat Res & Innovat, Deane Rd, Bolton BL3 5AB, England.
EM xw224@zju.edu.cn; jl2@bolton.ac.uk
FU NSFC [61274037, 61301046]; Research Fund for the Doctoral Program of
   Higher Education of China [20120101110031, 20120101110054]
FX This work was supported by NSFC (Grants 61274037 and 61301046), and
   Research Fund for the Doctoral Program of Higher Education of China
   (Grants 20120101110031 and 20120101110054). The authors also acknowledge
   the Innovation Platform of Micro/Nanodevices and Integration System,
   Zhejiang University.
CR BORSOOK H, 1953, ADV PROTEIN CHEM, V8, P127, DOI 10.1016/S0065-3233(08)60092-3
   Byun JY, 2013, LAB CHIP, V13, P886, DOI 10.1039/c2lc41137g
   Chang JW, 2011, ADV MATER, V23, P4077, DOI 10.1002/adma.201102124
   Chang YC, 2014, ACS APPL MATER INTER, V6, P5413, DOI 10.1021/am500815n
   Chen C, 2012, J APPL PHYS, V111, DOI 10.1063/1.3672811
   Chen G, 2012, ADV MATER, V24, P3515, DOI 10.1002/adma.201201595
   Chen IT, 2013, SCI REP-UK, V3, DOI 10.1038/srep01505
   Chen Y. C., 2015, SCI REP, V5, P10022
   Chen YS, 2012, NAT NANOTECHNOL, V7, P197, DOI [10.1038/nnano.2012.7, 10.1038/NNANO.2012.7]
   Dagdeviren C, 2013, SMALL, V9, P3398, DOI 10.1002/smll.201300146
   de la Rica R, 2010, CHEM SOC REV, V39, P3499, DOI 10.1039/b917574c
   Fujisaki Y, 2014, ADV FUNCT MATER, V24, P1657, DOI 10.1002/adfm.201303024
   GRINBERG AA, 1989, IEEE T ELECTRON DEV, V36, P1162, DOI 10.1109/16.24363
   Hota MK, 2012, ADV FUNCT MATER, V22, P4493, DOI 10.1002/adfm.201200073
   Hubbard RE, 2010, ENCY LIFE SCI ELS, DOI [10. 1002/9780470015902. a0003011. pub2, DOI 10.1002/9780470015902.A0003011.PUB2, 10.1002/9780470015902.a0003011.pub2]
   Hung YC, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3671153
   Hwang SW, 2014, ACS NANO, V8, P5843, DOI 10.1021/nn500847g
   Hwang SW, 2013, ADV FUNCT MATER, V23, P4087, DOI 10.1002/adfm.201300127
   Hwang SW, 2012, SCIENCE, V337, P1640, DOI 10.1126/science.1226325
   Irimia-Vladu M, 2010, ORG ELECTRON, V11, P1974, DOI 10.1016/j.orgel.2010.09.007
   Jeong DS, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/7/076502
   Kiy M, 2002, APPL PHYS LETT, V80, P1198, DOI 10.1063/1.1449527
   Lin ZF, 2014, LAB CHIP, V14, P2505, DOI 10.1039/c4lc00223g
   Mandal B, 2014, RSC ADV, V4, P13854, DOI 10.1039/c3ra45997g
   Meng FB, 2014, SMALL, V10, P277, DOI 10.1002/smll.201300810
   Meng FB, 2011, SMALL, V7, P3016, DOI 10.1002/smll.201101494
   Mohanty N, 2008, NANO LETT, V8, P4469, DOI 10.1021/nl802412n
   Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920
   Petsko G. A., 2004, PROTEIN STRUCTURE FU
   Puskas J. E., 2013, INTRO POLYM CHEM
   Sela M., 1959, BIOCHIM BIOPHYS ACTA, V36, P417
   Wang H, 2013, ADV MATER, V25, P5498, DOI 10.1002/adma.201301983
   Xu D, 1997, PROTEIN ENG, V10, P999, DOI 10.1093/protein/10.9.999
   Yang JJ, 2008, NAT NANOTECHNOL, V3, P429, DOI 10.1038/nnano.2008.160
   Yang YC, 2009, NANO LETT, V9, P1636, DOI 10.1021/nl900006g
   Yin L, 2014, ADV FUNCT MATER, V24, P645, DOI 10.1002/adfm.201301847
   Zhang J, 2014, APPL PHYS A-MATER, V116, P663, DOI 10.1007/s00339-014-8324-4
   Zhang J, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4774400
   Zhu HL, 2013, ENERG ENVIRON SCI, V6, P2105, DOI 10.1039/c3ee40492g
NR 39
TC 30
Z9 30
U1 11
U2 73
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD MAY 4
PY 2016
VL 8
IS 17
BP 10954
EP 10960
DI 10.1021/acsami.5b10414
PG 7
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA DL3FX
UT WOS:000375520700036
PM 27052437
DA 2018-10-20
ER

PT J
AU Luvizuto, ER
   Tangl, S
   Dobsak, T
   Reich, K
   Gruber, R
   Sonoda, CK
   Okamoto, R
AF Luvizuto, Eloa R.
   Tangl, Stefan
   Dobsak, Toni
   Reich, Karoline
   Gruber, Reinhard
   Sonoda, Celso K.
   Okamoto, Roberta
TI Effect of recombinant PDGF-BB on bone formation in the presence of
   beta-tricalcium phosphate and bovine bone mineral matrix: a pilot study
   in rat calvarial defects
SO BMC ORAL HEALTH
LA English
DT Article
DE Bone substitutes; Bone formation; Bone regeneration; Bone augmentation;
   Platelet-derived growth factor-BB; Rat calvaria defects; beta-tricalcium
   phosphate; Demineralized bovine bone mineral; Histomorphometry; Graft
   consolidation
ID GROWTH-FACTOR-BB; VERTICAL RIDGE AUGMENTATION; CLINICAL-APPLICATIONS;
   RHPDGF-BB; BLOCK; MODEL; BIOLOGY
AB Background: Supplementation of bone substitutes with recombinant platelet-derived growth factor-BB (PDGF-BB) can enhance bone regeneration. The aim of the study was to evaluate the effect of PDGF-BB on bone formation in the presence of beta-tricalcium phosphate and bovine bone mineral matrix in a rat calvaria defect model.
   Methods: The authors examined 5 mm rat calvarial defects treated with beta-tricalcium phosphate (TCP) or demineralized bovine bone mineral (DBBM) with and without 0.3 mg/ml recombinant PDGF-BB. Calvaria defects were randomly divided into the following treatment groups (n = 5); TCP; TCP plus PDGF-BB; DBBM; DBBM plus PDGF-BB; and untreated empty control. After 45 days, bone formation was evaluated by histomorphometry and fluorescence microscopy.
   Results: The authors report that the area of newly formed bone was similar between the empty controls and the two bone substitutes, TCP and DBBM. Supplementation of TCP and DBBM with PDGF-BB had no significant impact on bone formation. Fluorochrome staining revealed no visible changes in the pattern of bone formation in defects filled with TCP and DBBM, irrespective of PDGF-BB. Furthermore, supplementation with PDGF-BB did not influence biomaterial degradation.
   Conclusions: The authors concluded that PDGF-BB had no impact on bone formation and degradation of bone substitutes in the respective rodent models. Thus, possible beneficial effects of PDGF-BB may require other model situations.
C1 [Luvizuto, Eloa R.; Sonoda, Celso K.] Univ Estadual Paulista, UNESP, Aracatuba Dent Sch, Dept Surg, Sao Paulo, Brazil.
   [Luvizuto, Eloa R.; Sonoda, Celso K.] Univ Estadual Paulista, UNESP, Aracatuba Dent Sch, Integrated Clin, Sao Paulo, Brazil.
   [Tangl, Stefan; Dobsak, Toni; Reich, Karoline] Med Univ Vienna, Div Oral Surg, Karl Donath Lab Hard Tissue & Biomat Res, Vienna, Austria.
   [Tangl, Stefan; Dobsak, Toni; Reich, Karoline] Austrian Cluster Tissue Regenerat, Vienna, Austria.
   [Gruber, Reinhard] Univ Bern, Sch Dent Med, Dept Prevent Restorat & Pediat Dent, Bern, Switzerland.
   [Gruber, Reinhard] Med Univ Vienna, Dept Oral Biol, Vienna, Austria.
   [Okamoto, Roberta] Univ Estadual Paulista, UNESP, Aracatuba Dent Sch, Dept Anat, Sao Paulo, Brazil.
RP Gruber, R (reprint author), Univ Bern, Sch Dent Med, Dept Prevent Restorat & Pediat Dent, Bern, Switzerland.; Gruber, R (reprint author), Med Univ Vienna, Dept Oral Biol, Vienna, Austria.
EM reinhard.gruber@meduniwien.ac.at
OI Gruber, Reinhard/0000-0001-5400-9009; Tangl, Stefan/0000-0002-9023-4745
FU FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)
   [2012/15181-8]
FX This research was supported by FAPESP (Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo) project number 2012/15181-8.
CR Al-Zube L, 2009, J ORTHOP RES, V27, P1074, DOI 10.1002/jor.20842
   Choo T, 2013, CLIN ORAL IMPLAN RES, V24, P158, DOI 10.1111/j.1600-0501.2011.02345.x
   Christersson A, 2015, J ORTHOP SURG RES, V10, DOI 10.1186/s13018-015-0174-z
   Daniels TR, FOOT ANKLE INT
   Graham S, 2009, EXPERT OPIN INV DRUG, V18, P1633, DOI 10.1517/13543780903241607
   Hollinger JO, 2008, J BONE JOINT SURG AM, V90A, P48, DOI 10.2106/JBJS.G.01231
   Hollinger JO, 2008, J ORTHOP RES, V26, P83, DOI 10.1002/jor.20453
   Kaigler D, 2011, EXPERT OPIN BIOL TH, V11, P375, DOI 10.1517/14712598.2011.554814
   Khojasteh A, 2014, J BIOMED MATER RES B, V102, P1771, DOI 10.1002/jbm.b.33156
   Lee YM, J PERIODONTOL
   Lieberman JR, 2002, J BONE JOINT SURG AM, V84A, P1032, DOI 10.2106/00004623-200206000-00022
   Lioubavina-Hack N, J CLIN PERIODONTOL
   Luvizuto ER, 2011, BIOMATERIALS, V32, P3855, DOI 10.1016/j.biomaterials.2011.01.076
   Moore DC, 2009, J BONE JOINT SURG AM, V91A, P1973, DOI 10.2106/JBJS.H.00540
   Nevins ML, 2014, INT J PERIODONT REST, V34, P157, DOI 10.11607/prd.1743
   Okamoto T, 1994, Braz Dent J, V5, P85
   Polo-Corrales L, 2014, J NANOSCI NANOTECHNO, V14, P15, DOI 10.1166/jnn.2014.9127
   Simion M, 2006, INT J PERIODONT REST, V26, P415
   Simion M, 2009, INT J PERIODONT REST, V29, P245
   Tsuchiya N, 2014, J ORAL SCI, V56, P23, DOI 10.2334/josnusd.56.23
   Xu L, 2012, J MATER SCI-MATER M, V23, P1073, DOI 10.1007/s10856-012-4558-x
NR 21
TC 0
Z9 0
U1 0
U2 3
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1472-6831
J9 BMC ORAL HEALTH
JI BMC Oral Health
PD MAY 4
PY 2016
VL 16
AR 52
DI 10.1186/s12903-016-0210-3
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA DL7FX
UT WOS:000375807100001
PM 27145819
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Hulsen, DJW
   Geurts, J
   van Gestel, NAP
   van Rietbergen, B
   Arts, JJ
AF Hulsen, D. J. W.
   Geurts, J.
   van Gestel, N. A. P.
   van Rietbergen, B.
   Arts, J. J.
TI Mechanical behaviour of Bioactive Glass granules and morselized
   cancellous bone allograft in load bearing defects
SO JOURNAL OF BIOMECHANICS
LA English
DT Article
DE Bioactive Glass; Bone allograft; Mechanical behaviour; Load-bearing
   defects; Confined compression
ID FRONTAL-SINUS OBLITERATION; CALCIUM-PHOSPHATE CEMENT; TIBIAL PLATEAU
   FRACTURE; CHRONIC OTITIS-MEDIA; IN-VITRO; CHRONIC OSTEOMYELITIS; GRAFT
   SUBSTITUTES; AUTOGENOUS BONE; AUTOLOGOUS BONE; HUMAN OSTEOBLASTS
AB Bioactive Glass (BAG) granules are osteoconductive and possess unique antibacterial properties for a synthetic biomaterial. To assess the applicability of BAG granules in load-bearing defects, the aim was to compare mechanical behaviour of graft layers consisting of BAG granules and morselized cancellous bone allograft in different volume mixtures under clinically relevant conditions.
   The graft layers were mechanically tested, using two mechanical testing modalities with simulated physiological loading conditions: highly controllable confined compression tests (CCT) and more clinically realistic in situ compression tests (ISCT) in cadaveric porcine bone defects. Graft layer impaction strain, residual strain, aggregate modulus, and creep strain were determined in CCT. Graft layer porosity was determined using micro computed tomography. The ISCT was used to determine graft layer subsidence in bone environment.
   ANOVA showed significant differences (p < 0.001) between different graft layer compositions. True strains absolutely decreased for increasing BAG content: impaction strain -0.92 (allograft) to -0.39 (BAG), residual strain -0.12 to -0.01, and creep strain -0.09 to 0.00 respectively. Aggregate modulus increased with increasing BAG content from 116 to 653 MPa. Porosity ranged from 66% (pure allograft) to 15% (pure BAG). Subsidence was highest for allograft, and remarkably low for a 1:1 BAG-allograft volume mixture.
   Both BAG granules and allograft morsels as stand-alone materials exhibit suboptimal mechanical behaviour for load-bearing purpose. BAG granules are difficult to handle and less porous, whereas allograft subsides and creeps. A 1:1 volume mixture of BAG and allograft is therefore proposed as the best graft material in load-bearing defects. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Hulsen, D. J. W.; Geurts, J.; Arts, J. J.] Maastricht Univ, Med Ctr, Res Sch CAPHRI, Dept Orthopaed Surg, NL-6200 MD Maastricht, Netherlands.
   [Hulsen, D. J. W.; van Gestel, N. A. P.; van Rietbergen, B.; Arts, J. J.] Eindhoven Univ Technol, Fac Biomed Engn, Dept Orthopaed Biomech, POB 513, NL-5600 MB Eindhoven, Netherlands.
   [Hulsen, D. J. W.] Jeroen Bosch Ziekenhuis, MICT Dept, Shertogenbosch, Netherlands.
   [van Gestel, N. A. P.] Eindhoven Univ Technol, Inst Complex Mol Syst, POB 513, NL-5600 MB Eindhoven, Netherlands.
RP Hulsen, DJW (reprint author), Maastricht Univ, Med Ctr, Dept Orthopaed Surg, POB 5800, NL-6202 AZ Maastricht, Netherlands.
EM d.hulsen@jbz.nl
OI Arts, Jacobus/0000-0002-2947-8564; van Gestel,
   Nicole/0000-0003-0162-490X
FU BonAlive Biomaterials Ltd.
FX The Radboudumc orthopaedic department (Nijmegen, Netherlands) is kindly
   acknowledged for lending the test setup. This research was sponsored in
   kind (materials) by BonAlive Biomaterials Ltd.
CR Aitasalo K, 2000, KEY ENG MAT, V192-1, P877
   Aitasalo K, 2001, J ORAL MAXIL SURG, V59, P1390, DOI 10.1053/joms.2001.27524
   Andersson O. H., 1992, NEW TRENDS BONE GRAF, P127
   ANDERSSON OH, 1990, J NON-CRYST SOLIDS, V119, P290, DOI 10.1016/0022-3093(90)90301-2
   ANDERSSON OH, 1990, J MATER SCI-MATER M, V1, P219, DOI 10.1007/BF00701080
   ANDERSSON OH, 1991, J BIOMED MATER RES, V25, P1019, DOI 10.1002/jbm.820250808
   Arts JJC, 2005, P I MECH ENG H, V219, P257, DOI 10.1243/095441105X34266
   Benoit Benoit, 2009, J Orthop Surg Res, V4, P37, DOI 10.1186/1749-799X-4-37
   Blom AW, 2002, P I MECH ENG H, V216, P265, DOI 10.1243/09544110260138754
   Brodt MD, 1998, J ORTHOPAED RES, V16, P43, DOI 10.1002/jor.1100160108
   Conejero JA, 2007, J CRANIOFAC SURG, V18, P1290, DOI 10.1097/scs.0b013e3180f610c7
   Coraca-Huber DC, 2014, J ORTHOP RES, V32, P175, DOI 10.1002/jor.22463
   Drago L, 2014, FUTURE MICROBIOL, V9, P593, DOI 10.2217/fmb.14.20
   Drago L, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-584
   Eldridge JDJ, 1997, J ARTHROPLASTY, V12, P535, DOI 10.1016/S0883-5403(97)90176-5
   Frantzen J, 2011, J SPINAL DISORD TECH, V24, P455, DOI 10.1097/BSD.0b013e31822a20c6
   Fu Q, 2011, MAT SCI ENG C-MATER, V31, P1245, DOI 10.1016/j.msec.2011.04.022
   Gergely I, 2014, ACTA MICROBIOL IMM H, V61, P145, DOI 10.1556/AMicr.61.2014.2.5
   Giesen EBW, 2001, J BIOMECH, V34, P799, DOI 10.1016/S0021-9290(01)00030-6
   Gough JE, 2004, J BIOMED MATER RES A, V68A, P640, DOI 10.1002/jbm.a.20075
   Gough JE, 2004, BIOMATERIALS, V25, P2039, DOI 10.1016/j.biomaterials.2003.07.001
   Gunn JM, 2013, ACTA ODONTOL SCAND, V71, P1238, DOI 10.3109/00016357.2012.757642
   Heikkila JT, 2011, J MATER SCI-MATER M, V22, P1073, DOI 10.1007/s10856-011-4272-0
   HEIKKILA JT, 1993, ACTA ORTHOP SCAND, V64, P678, DOI 10.3109/17453679308994597
   HEIKKILA JT, 1995, ACTA ORTHOP SCAND, V66, P463, DOI 10.3109/17453679508995588
   Keaveny T. M., 2003, STANDARD HDB BIOMEDI, V8, p[1, 23]
   Lepparanta O, 2008, J MATER SCI-MATER M, V19, P547, DOI 10.1007/s10856-007-3018-5
   Lindfors NC, 2010, BONE, V47, P212, DOI 10.1016/j.bone.2010.05.030
   Lindfors NC, 2010, J BIOMED MATER RES B, V94B, P157, DOI 10.1002/jbm.b.31636
   Lindfors NC, 2009, J BIOMED MATER RES B, V90B, P131, DOI 10.1002/jbm.b.31263
   Loty C, 2001, J BONE MINER RES, V16, P231, DOI 10.1359/jbmr.2001.16.2.231
   MATSUDA T, 1987, BIOMATERIALS, V8, P275, DOI 10.1016/0142-9612(87)90115-3
   McAndrew J, 2013, IRISH J MED SCI, V182, P509, DOI 10.1007/s11845-012-0895-5
   McDonald E, 2011, J ORTHOP TRAUMA, V25, P90, DOI 10.1097/BOT.0b013e3181e3e28f
   Munukka E, 2008, J MATER SCI-MATER M, V19, P27, DOI 10.1007/s10856-007-3143-1
   Peltola M, 1998, HEAD NECK-J SCI SPEC, V20, P315, DOI 10.1002/(SICI)1097-0347(199807)20:4<315::AID-HED6>3.0.CO;2-1
   Peltola M, 2006, HEAD NECK-J SCI SPEC, V28, P834, DOI 10.1002/hed.20436
   Peltola MJ, 2008, J ORAL MAXIL SURG, V66, P1699, DOI 10.1016/j.joms.2007.11.020
   Rantakokko J, 2012, SCAND J SURG, V101, P66, DOI 10.1177/145749691210100113
   Romano CL, 2014, BONE JOINT J, V96B, P845, DOI 10.1302/0301-620X.96B6.33014
   Sanzana ES, 2014, J BIOMED MATER RES A, V102, P1767, DOI 10.1002/jbm.a.34845
   Sarin J, 2012, ANN OTO RHINOL LARYN, V121, P563, DOI 10.1177/000348941212100901
   Silvola JT, 2012, OTOLARYNG HEAD NECK, V147, P119, DOI 10.1177/0194599812438168
   Stoor P, 2010, ANN OTO RHINOL LARYN, V119, P377, DOI 10.1177/000348941011900603
   Turunen T, 2004, CLIN ORAL IMPLAN RES, V15, P135, DOI 10.1111/j.1600-0501.2004.00989.x
   van Gestel NAP, 2015, BIOMED RES INT, DOI 10.1155/2015/684826
   Veitch SW, 2010, J TRAUMA, V68, P980, DOI 10.1097/TA.0b013e3181b16e3d
   Verdonschot N, 2001, J BIOMED MATER RES, V58, P599, DOI 10.1002/jbm.1058
   VROUWENVELDER WCA, 1992, BIOMATERIALS, V13, P382, DOI 10.1016/0142-9612(92)90044-O
   VROUWENVELDER WCA, 1993, J BIOMED MATER RES, V27, P465, DOI 10.1002/jbm.820270407
   Walschot LHB, 2010, J BIOMED MATER RES B, V95B, P131, DOI 10.1002/jbm.b.31692
   Waselau M., 2012, J TISSUE ENG, V23
   Welch RD, 2003, J BONE JOINT SURG AM, V85A, P222, DOI 10.2106/00004623-200302000-00007
   Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   Yeni YN, 2001, J BIOMECH, V34, P1649, DOI 10.1016/S0021-9290(01)00155-5
   Yetkinler DN, 2001, J ORTHOP TRAUMA, V15, P197, DOI 10.1097/00005131-200103000-00009
   Zhang D, 2010, J BIOMED MATER RES A, V93A, P475, DOI 10.1002/jbm.a.32564
   Zhou Z. H., 2010, Journal of Medical Engineering & Technology, V34, P285, DOI 10.3109/03091901003753041
NR 60
TC 2
Z9 2
U1 2
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0021-9290
EI 1873-2380
J9 J BIOMECH
JI J. Biomech.
PD MAY 3
PY 2016
VL 49
IS 7
BP 1121
EP 1127
DI 10.1016/j.jbiomech.2016.02.047
PG 7
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA DM0RB
UT WOS:000376052400019
PM 26972764
DA 2018-10-20
ER

PT J
AU Lassenberger, A
   Bixner, O
   Gruenewald, T
   Lichtenegger, H
   Zirbs, R
   Reimhult, E
AF Lassenberger, Andrea
   Bixner, Oliver
   Gruenewald, Tilman
   Lichtenegger, Helga
   Zirbs, Ronald
   Reimhult, Erik
TI Evaluation of High-Yield Purification Methods on Monodisperse
   PEG-Grafted Iron Oxide Nanoparticles
SO LANGMUIR
LA English
DT Article
ID CORE-SHELL NANOPARTICLES; MAGNETIC NANOPARTICLES; POLYETHYLENE-GLYCOL;
   BIOMEDICAL APPLICATIONS; HYDRODYNAMIC RADIUS; FUNCTIONALIZATION;
   PEGYLATION; THERAPY; DESIGN; FE3O4
AB Fundamental research on nanoparticle (NP) interactions and development of next-generation biomedical NP applications relies on synthesis of monodisperse, functional, coreshell nanoparticles free of residual dispersants with truly homogeneous and controlled physical properties. Still, synthesis and purification of e.g. such superparamagnetic iron oxide NPs remain a challenge. Comparing the success of different methods is marred by the sensitivity of analysis methods to the purity of the product. We synthesize monodisperse, oleic acid (OA)-capped, Fe3O4 NPs in the superparamagnetic size range (310 nm). Ligand exchange of OA for poly(ethylene glycol) (PEG) was performed with the PEG irreversibly grafted to the NP surface by a nitrodopamine (NDA) anchor. Four different methods were investigated to remove excess ligands and residual OA: membrane centrifugation, dialysis, size exclusion chromatography, and precipitation combined with magnetic decantation. Infrared spectroscopy and thermogravimetric analysis were used to determine the purity of samples after each purification step. Importantly, only magnetic decantation yielded pure NPs at high yields with sufficient grafting density for biomedical applications (similar to 1 NDA-PEG(5 kDa)/nm(2), irrespective of size). The purified NPs withstand challenging tests such as temperature cycling in serum and long-term storage in biological buffers. Dynamic light scattering, transmission electron microscopy, and small-angle X-ray scattering show stability over at least 4 months also in serum. The successful synthesis and purification route is compatible with any conceivable functionalization for biomedical or biomaterial applications of PEGylated Fe3O4 NPs.
C1 [Lassenberger, Andrea; Bixner, Oliver; Zirbs, Ronald; Reimhult, Erik] Univ Nat Resources & Life Sci, Inst Biol Inspired Mat, Dept Nanobiotechnol, Muthgasse 11, A-1190 Vienna, Austria.
   [Gruenewald, Tilman; Lichtenegger, Helga] Inst Phys & Mat Sci, Dept Mat Sci & Proc Engn, Peter Jordan Str 82, A-1190 Vienna, Austria.
RP Reimhult, E (reprint author), Univ Nat Resources & Life Sci, Inst Biol Inspired Mat, Dept Nanobiotechnol, Muthgasse 11, A-1190 Vienna, Austria.
EM Erik.reimhult@boku.ac.at
RI Reimhult, Erik/C-6011-2013; Grunewald, Tilman A./I-5453-2018
OI Reimhult, Erik/0000-0003-1417-5576; Grunewald, Tilman
   A./0000-0002-5621-605X
FU European Research Council under the European Union's Seventh Framework
   Programme/ERC [310034]; BMWFW IGS BioNanoTech
FX The research leading to these results received funding from the European
   Research Council under the European Union's Seventh Framework Programme
   (FP/2007-2013)/ERC Grant Agreement no. 310034 and BMWFW IGS BioNanoTech.
CR Amstad E, 2011, NANOSCALE, V3, P2819, DOI 10.1039/c1nr10173k
   Amstad E, 2009, NANO LETT, V9, P4042, DOI 10.1021/nl902212q
   Bixner O, 2015, LANGMUIR, V31, P9198, DOI 10.1021/acs.langmuir.5b01833
   Boni A, 2015, NANOSCALE, V7, P7307, DOI 10.1039/c5nr01148e
   Boyer C, 2010, NPG ASIA MATER, V2, P23, DOI 10.1038/asiamat.2010.6
   Bronstein LM, 2007, CHEM MATER, V19, P3624, DOI 10.1021/cm062948j
   Burda C, 2005, CHEM REV, V105, P1025, DOI 10.1021/cr030063a
   Cornard JP, 2005, CHEM PHYS, V309, P239, DOI 10.1016/j.chemphys.2004.09.020
   Davis K, 2014, LANGMUIR, V30, P10918, DOI 10.1021/la502204g
   El-Faham A, 2009, CHEM-EUR J, V15, P9404, DOI 10.1002/chem.200900615
   FINGER LW, 1986, PHYS CHEM MINER, V13, P215, DOI 10.1007/BF00308271
   Frey NA, 2009, CHEM SOC REV, V38, P2532, DOI 10.1039/b815548h
   Gillich T, 2013, ACS NANO, V7, P316, DOI 10.1021/nn304045q
   Grunewald TA, 2015, CHEM MATER, V27, P4763, DOI 10.1021/acs.chemmater.5b01488
   Halbreich A, 1998, BIOCHIMIE, V80, P379, DOI 10.1016/S0300-9084(00)80006-1
   Hong RY, 2008, BIOCHEM ENG J, V42, P290, DOI 10.1016/j.bej.2008.07.009
   Hyeon T, 2001, J AM CHEM SOC, V123, P12798, DOI 10.1021/ja016812s
   Jokerst JV, 2011, NANOMEDICINE-UK, V6, P715, DOI [10.2217/nnm.11.19, 10.2217/NNM.11.19]
   Jun YW, 2008, ANGEW CHEM INT EDIT, V47, P5122, DOI 10.1002/anie.200701674
   Kang SM, 2009, MACROMOL RES, V17, P259, DOI 10.1007/BF03218689
   Lacava LM, 2001, BIOPHYS J, V80, P2483, DOI 10.1016/S0006-3495(01)76217-0
   Lak A, 2013, NANOSCALE, V5, P11447, DOI 10.1039/c3nr02197a
   Lattuada M, 2007, LANGMUIR, V23, P2158, DOI 10.1021/la062092x
   Lee H, 2008, BIOPHYS J, V95, P1590, DOI 10.1529/biophysj.108.133025
   Lewin M, 2000, NAT BIOTECHNOL, V18, P410
   Linegar KL, 2010, COLLOID J+, V72, P279, DOI 10.1134/S1061933X10020195
   Ling DS, 2013, SMALL, V9, P1450, DOI 10.1002/smll.201202111
   Liu DF, 2011, ADV FUNCT MATER, V21, P1498, DOI 10.1002/adfm.201001658
   Lu AH, 2007, ANGEW CHEM INT EDIT, V46, P1222, DOI 10.1002/anie.200602866
   McCarthy JR, 2008, ADV DRUG DELIVER REV, V60, P1241, DOI 10.1016/j.addr.2008.03.014
   Mondini S, 2012, NANOSCALE, V4, P5356, DOI 10.1039/c2nr31276j
   Na HB, 2012, ACS NANO, V6, P389, DOI 10.1021/nn203735b
   Namdeo M, 2008, J NANOSCI NANOTECHNO, V8, P3247, DOI 10.1166/jnn.2008.399
   NAPOLITANO A, 1992, TETRAHEDRON, V48, P8515, DOI 10.1016/S0040-4020(01)86599-6
   Pankhurst Q. A., 2009, J PHYS D, V42
   Park J, 2007, ANGEW CHEM INT EDIT, V46, P4630, DOI 10.1002/anie.200603148
   Pittet MJ, 2006, NAT PROTOC, V1, P73, DOI 10.1038/nprot.2006.11
   Roonasi P, 2009, APPL SURF SCI, V255, P5891, DOI 10.1016/j.apsusc.2009.01.031
   Sahoo Y, 2001, LANGMUIR, V17, P7907, DOI 10.1021/la010703+
   Saville SL, 2012, J MATER CHEM, V22, P24909, DOI 10.1039/c2jm34902g
   Stone RC, 2014, J MATER CHEM B, V2, P4789, DOI 10.1039/c4tb00198b
   Tassa C, 2011, ACCOUNTS CHEM RES, V44, P842, DOI 10.1021/ar200084x
   WEISSLEDER R, 1990, RADIOLOGY, V175, P489, DOI 10.1148/radiology.175.2.2326474
   WEISSLEDER R, 1987, AM J ROENTGENOL, V149, P723, DOI 10.2214/ajr.149.4.723
   Xie J, 2007, ADV MATER, V19, P3163, DOI 10.1002/adma.200701975
   Ziebacz N, 2011, SOFT MATTER, V7, P7181, DOI 10.1039/c0sm01357a
   Zirbs R, 2015, NANOSCALE, V7, P11216, DOI 10.1039/c5nr02313k
NR 47
TC 12
Z9 12
U1 1
U2 54
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD MAY 3
PY 2016
VL 32
IS 17
BP 4259
EP 4269
DI 10.1021/acs.langmuir.6b00919
PG 11
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA DL3FY
UT WOS:000375520800015
PM 27046133
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Li, LL
   Li, X
   Chen, L
   Sun, P
   Hao, N
   Jiang, B
AF Li, Lili
   Li, Xia
   Chen, Lu
   Sun, Peng
   Hao, Na
   Jiang, Bo
TI Morphology, proliferation, alignment, and new collagen synthesis of
   mesenchymal stem cells on a microgrooved collagen membrane
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE topographic cues; collagen; Microgrooves; oriented growth; MSC
ID TISSUE ENGINEERING SCAFFOLDS; OSTEOBLAST-LIKE CELLS; FIBRILLAR COLLAGEN;
   CONTACT GUIDANCE; THIN-FILMS; IN-VITRO; GROWTH; LAYERS; SUBSTRATA;
   DIFFERENTIATION
AB Abstract
   The topographic cues of the extracellular matrix may have significant effects upon cellular behavior, such as adhesion, spreading, migration, proliferation, differentiation, and in particular, morphology and orientation. In this study, we examined the effects of microgrooved collagen membrane (MCM) on mesenchymal stem cell (MSC) behavior. The MCM (9 mu m in periodicity, and 1-2 mu m in depth) was fabricated on an untreated (nonpolar) and smooth polystyrene substrate, based on the absorption and self-assembly properties of collagen on the polystyrene substrate. Methyl thiazolyl tetrazolium assay revealed that cell proliferation on the MCM was enhanced compared with the smooth collagen membrane at day 2. Qualitative observation of MSC behavior using confocal laser scanning microscopy and scanning electron microscopy showed that MSCs grew with a highly elongated morphology and were aligned strictly along the direction of the microgrooves. Additionally, scanning electron microscopy revealed the oriented cells produced a collagenous matrix on the MCM that had a preferential orientation, whereas the collagenous matrix produced by randomly oriented MSCs on the smooth collagen membrane was disorganized. Future studies should investigate the fabrication of oriented topographical substrates, based on the natural biomaterial collagen, to guide cell alignment and oriented growth along definite directions. These substrates may help produce aligned collagenous matrices that could have good potential for the production of tissue substitutes.
C1 [Li, Lili; Li, Xia; Chen, Lu; Sun, Peng; Hao, Na; Jiang, Bo] Sichuan Univ, Natl Engn Res Ctr Biomat, Chengdu 610064, Peoples R China.
   [Sun, Peng] Sichuan Univ, Inst Nucl Sci & Technol, Key Lab Radiat Phys & Technol, Minist Educ, Chengdu 610064, Peoples R China.
RP Jiang, B (reprint author), Sichuan Univ, Natl Engn Res Ctr Biomat, Chengdu 610064, Peoples R China.
EM bjiang@scu.edu.cn
FU National Natural Science Foundation of China [81301934]
FX This work was supported by National Natural Science Foundation of China
   [grant number 81301934].
CR Alaerts JA, 2001, BIOMATERIALS, V22, P1635, DOI 10.1016/S0142-9612(00)00321-5
   Anene-Nzelu CG, 2013, LAB CHIP, V13, P4124, DOI 10.1039/c3lc50730k
   Bettinger CJ, 2006, BIOMATERIALS, V27, P2558, DOI 10.1016/j.biomaterials.2005.11.029
   Biran R, 2003, EXP NEUROL, V184, P141, DOI 10.1016/S0014-4886(03)00253-X
   Browne MM, 2004, SURF SCI, V553, P155, DOI 10.1016/j.susc.2004.01.046
   BRUNETTE DM, 1986, EXP CELL RES, V164, P11, DOI 10.1016/0014-4827(86)90450-7
   CLARK P, 1990, DEVELOPMENT, V108, P635
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   denBraber ET, 1996, BIOMATERIALS, V17, P1093, DOI 10.1016/0142-9612(96)85910-2
   Dupont-Gillain CC, 2004, PROG COLL POL SCI S, V128, P98
   Dupont-Gillain CC, 2005, COLLOID SURFACE B, V43, P179, DOI 10.1016/j.colsurfb.2004.12.022
   Dupont-Gillain CC, 2003, SURF SCI, V539, P145, DOI 10.1016/S0039-6028(03)00779-9
   Elliott JT, 2007, BIOMATERIALS, V28, P576, DOI 10.1016/j.biomaterials.2006.09.023
   Friedl P, 1998, MICROSC RES TECHNIQ, V43, P369, DOI 10.1002/(SICI)1097-0029(19981201)43:5<369::AID-JEMT3>3.0.CO;2-6
   Gamboa JR, 2013, COLLOID SURFACE B, V104, P318, DOI 10.1016/j.colsurfb.2012.11.035
   Guo ZZ, 2015, J BIOMAT SCI-POLYM E, V26, P989, DOI 10.1080/09205063.2015.1065598
   Gurdak E, 2006, COLLOID SURFACE B, V52, P76, DOI 10.1016/j.colsurfb.2006.07.011
   Harrison RG, 1911, SCIENCE, V34, P279, DOI 10.1126/science.34.870.279
   He J, 2012, J BIOMED MATER RES A, V100A, P1706, DOI 10.1002/jbm.a.34121
   Huang NF, 2006, NANO LETT, V6, P537, DOI 10.1021/nl060060o
   Jacquemart I, 2004, J COLLOID INTERF SCI, V278, P63, DOI 10.1016/j.jcis.2004.05.040
   Lanfer B, 2009, BIOMATERIALS, V30, P5950, DOI 10.1016/j.biomaterials.2009.07.039
   Lee MR, 2010, BIOMATERIALS, V31, P4360, DOI 10.1016/j.biomaterials.2010.02.012
   Matsuzaka K, 1999, BIOMATERIALS, V20, P1293, DOI 10.1016/S0142-9612(99)00029-0
   Meinel AJ, 2009, BIOMATERIALS, V30, P3058, DOI 10.1016/j.biomaterials.2009.01.054
   Murugan R, 2007, TISSUE ENG, V13, P1845, DOI 10.1089/ten.2006.0078
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Ricci JL, 2008, J BIOMED MATER RES A, V85A, P313, DOI 10.1002/jbm.a.31379
   Sang L, 2010, CARBOHYD POLYM, V82, P1264, DOI 10.1016/j.carbpol.2010.07.005
   Tan J, 2004, BIOMATERIALS, V25, P3593, DOI 10.1016/j.biomaterials.2003.10.034
   Vernon RB, 2005, BIOMATERIALS, V26, P3131, DOI 10.1016/j.biomateriasl.2004.08.011
   Walboomers XF, 1999, J BIOMED MATER RES, V47, P204, DOI 10.1002/(SICI)1097-4636(199911)47:2<204::AID-JBM10>3.0.CO;2-H
   Walboomers XF, 1998, BIOMATERIALS, V19, P1861, DOI 10.1016/S0142-9612(98)00093-3
   Wang DY, 2007, J BIOMED MATER RES B, V80B, P447, DOI 10.1002/jbm.b.30616
   Wang JHC, 2000, J BIOMECH, V33, P729, DOI 10.1016/S0021-9290(00)00013-0
   Wang JHC, 2003, J BIOMECH, V36, P97, DOI 10.1016/S0021-9290(02)00233-6
   WEISS P, 1945, J EXP ZOOL, V100, P353, DOI 10.1002/jez.1401000305
   Whitehouse C, 2005, ANGEW CHEM INT EDIT, V44, P1965, DOI [10.1002/(ISSN)1521-3773, DOI 10.1002/(ISSN)1521-3773]
   Yang JY, 2009, J BIOMED MATER RES A, V90A, P629, DOI 10.1002/jbm.a.32130
   Zhou XT, 2012, ACS APPL MATER INTER, V4, P3888, DOI 10.1021/am301237j
   Zhu BS, 2005, TISSUE ENG, V11, P825, DOI 10.1089/ten.2005.11.825
   Zhu BS, 2004, BIOMATERIALS, V25, P4215, DOI 10.1016/j.biomaterials.2003.11.020
   Zuyderhoff EM, 2012, LANGMUIR, V28, P2007, DOI 10.1021/la203842q
NR 43
TC 1
Z9 1
U1 2
U2 25
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PD MAY 2
PY 2016
VL 27
IS 7
BP 581
EP 598
DI 10.1080/09205063.2015.1136919
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA DH8AH
UT WOS:000373015000003
PM 26723935
DA 2018-10-20
ER

PT J
AU Vishwanath, V
   Pramanik, K
   Biswas, A
AF Vishwanath, Varshini
   Pramanik, Krishna
   Biswas, Amit
TI Optimization and evaluation of silk fibroin-chitosan freeze-dried porous
   scaffolds for cartilage tissue engineering application
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE silk fibroin; Tissue engineering; biocompatibility; chitosan; scaffolds;
   optimization
ID MESENCHYMAL STEM-CELLS; UMBILICAL-CORD BLOOD; NANOFIBROUS SCAFFOLD;
   BLEND SCAFFOLDS; REGENERATION; DIFFERENTIATION; ADHESION; DELIVERY; BONE
AB Silk fibroin/chitosan blend has been reported to be an attractive biomaterial that provides a 3D porous structure with controllable pore size and mechanical property suitable for tissue engineering applications. However, there is no systematic study for optimizing the ratio of silk fibroin (SF) and chitosan (CS) which seems to influence the scaffold property to a great extent. The present research, therefore, investigates the effect of blend ratio of SF and CS on scaffold property and establishes the optimum value of blend ratio. Among the various blends, the scaffolds with blend ratio of SF/CS (80:20) were found to be superior. The scaffold possesses pore size in the range 71-210 mu m and porosity of 82.2 +/- 1.3%. The compressive strength of the scaffold was measured as 190 +/- 0.2kPa. The cell supportive property of the scaffold in terms of cell attachment, cell viability, and proliferation was confirmed by cell culture study using mesenchymal stem cells derived from umbilical cord blood. Furthermore, the assessment of glycosaminoglycan secretion on the scaffolds indicates its potentiality toward cartilage tissue regeneration.
C1 [Vishwanath, Varshini; Pramanik, Krishna; Biswas, Amit] Natl Inst Technol, Dept Biotechnol & Med Engn, Rourkela, India.
RP Biswas, A (reprint author), Natl Inst Technol, Dept Biotechnol & Med Engn, Rourkela, India.
EM amitb79@nitrkl.ac.in
RI Biswas, Amit/O-7144-2017; Pramanik, Krishna/M-3729-2018
OI Pramanik, Krishna/0000-0002-5676-7740
FU Department of Biotechnology, Government of India [BT/01/COE/09/13]
FX This work was supported by the Department of Biotechnology, Government
   of India for providing research fellowship to one of the authors
   [Sanction order no.: BT/01/COE/09/13 Date: 09-06-2010].
CR Altman AM, 2010, ACTA BIOMATER, V6, P1388, DOI 10.1016/j.actbio.2009.10.034
   Altman AM, 2009, STEM CELLS, V27, P250, DOI 10.1634/stemcells.2008-0178
   Bhardwaj N, 2012, BIOMATERIALS, V33, P2848, DOI 10.1016/j.biomaterials.2011.12.028
   Bhardwaj N, 2011, BIOMATERIALS, V32, P5773, DOI 10.1016/j.biomaterials.2011.04.061
   Bhardwaj N, 2011, CARBOHYD POLYM, V85, P325, DOI 10.1016/j.carbpol.2011.02.027
   Bieback K, 2004, STEM CELLS, V22, P625, DOI 10.1634/stemcells.22-4-625
   Chen JP, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-170
   Chen X, 1997, J POLYM SCI POL PHYS, V35, P2293, DOI 10.1002/(SICI)1099-0488(199710)35:14<2293::AID-POLB9>3.0.CO;2-X
   Chung C, 2008, ADV DRUG DELIVER REV, V60, P243, DOI 10.1016/j.addr.2007.08.027
   Gobin AS, 2005, J BIOMED MATER RES A, V74A, P465, DOI 10.1002/jbm.a.30382
   Han KS, 2015, MACROMOL RES, V12, P1091
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Hwang SH, 2014, TISSUE ENG REGEN MED, V11, P414, DOI 10.1007/s13770-014-4042-4
   Iwasa J, 2009, KNEE SURG SPORT TR A, V17, P561, DOI 10.1007/s00167-008-0663-2
   Kang SW, 2006, J BIOMAT SCI-POLYM E, V17, P925, DOI 10.1163/156856206777996862
   Kock L, 2012, CELL TISSUE RES, V347, P613, DOI 10.1007/s00441-011-1243-1
   Koga H, 2009, KNEE SURG SPORT TR A, V17, P1289, DOI 10.1007/s00167-009-0782-4
   Kweon H, 2001, J APPL POLYM SCI, V80, P928, DOI 10.1002/app.1172
   Lee SH, 2007, ADV DRUG DELIVER REV, V59, P339, DOI 10.1016/j.addr.2007.03.016
   Luangbudnark W, 2012, SCI WORLD J, DOI 10.1100/2012/697201
   Lucia LA, 2009, NANOSCIENCE TECHNOLO, P297
   Mekala NK, 2012, TISSUE ENG REGEN MED, V9, P259, DOI 10.1007/s13770-012-0359-z
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Panda N, 2015, MAT SCI ENG C-MATER, V48, P521, DOI 10.1016/j.msec.2014.12.010
   Panda N, 2014, J BIOMAT SCI-POLYM E, V25, P1440, DOI 10.1080/09205063.2014.943548
   Park H, 2005, BIOMATERIALS, V26, P7095, DOI 10.1016/j.biomaterials.2005.05.083
   Pati F, 2013, J BIOMED MATER RES A, V101, P2526, DOI 10.1002/jbm.a.34559
   Peter M, 2010, CARBOHYD POLYM, V80, P687, DOI 10.1016/j.carbpol.2009.11.050
   She Z-D, 2009, FRONT MAT SCI CHINA, V3, P241, DOI DOI 10.1007/S11706-009-0048-6
   She ZD, 2008, POLYM DEGRAD STABIL, V93, P1316, DOI 10.1016/j.polymdegradstab.2008.04.001
   Siddiqui N, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.41534
   Siddiqui N, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.41025
   Vinatier C, 2009, CURR STEM CELL RES T, V4, P318, DOI 10.2174/157488809789649205
   Zang MQ, 2011, ACTA BIOMATER, V7, P3422, DOI 10.1016/j.actbio.2011.05.012
   Zeng SG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128658
   Zhang Q, 2014, ACTA BIOMATER, V10, P2005, DOI 10.1016/j.actbio.2013.12.042
NR 36
TC 11
Z9 11
U1 5
U2 43
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PD MAY 2
PY 2016
VL 27
IS 7
BP 657
EP 674
DI 10.1080/09205063.2016.1148303
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA DH8AH
UT WOS:000373015000008
PM 26830046
DA 2018-10-20
ER

PT J
AU Tostanoski, LH
   Gosselin, EA
   Jewell, CM
AF Tostanoski, Lisa H.
   Gosselin, Emily A.
   Jewell, Christopher M.
TI Engineering Tolerance Using Biomaterials to Target and Control Antigen
   Presenting Cells
SO DISCOVERY MEDICINE
LA English
DT Article
ID REGULATORY T-CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS;
   TOLEROGENIC DENDRITIC CELLS; LYMPH-NODE MICROENVIRONMENT; NANOPARTICLE
   DELIVERY; TRANSPLANT TOLERANCE; ALLOGRAFT SURVIVAL; IMMUNE SIGNALS;
   INDUCTION; MICROPARTICLES
AB Autoimmune diseases occur when cells of the adaptive immune system incorrectly recognize and attack "self" tissues. Importantly, the proliferation and differentiation of these cells is triggered and controlled by interactions with antigen presenting cells (APCs), such as dendritic cells. Thus, modulating the signals transduced by APCs (e.g., cytokines, costimulatory surface proteins) has emerged as a promising strategy to promote tolerance for diseases such as multiple sclerosis, type 1 diabetes, and lupus. However, many approaches have been hindered by non-specific activity of immunosuppressive or immunoregulatory cues, following systemic administration of soluble factors via traditional injections routes (e.g., subcutaneous, intravenous). Biomaterials offer a unique opportunity to control the delivery of tolerogenic signals in vivo via properties such as controlled particle size, tunable release kinetics, and co-delivery of multiple classes of cargo. In this review, we highlight recent reports that exploit these properties of biomaterials to target APCs and promote tolerance via three strategies, i) passive or active targeting of particulate carriers to APCs, ii) biomaterial-mediated control over antigen localization and processing, and iii) targeted delivery of encapsulated or adsorbed immunomodulatory signals. These reports represent exciting advances toward the goal of more effective therapies for autoimmune diseases, without the broad suppressive effects associated with current clinically-approved therapies.
C1 [Tostanoski, Lisa H.; Gosselin, Emily A.; Jewell, Christopher M.] Univ Maryland, Fischell Dept Bioengn, 8228 Paint Branch Dr, College Pk, MD 20742 USA.
   [Jewell, Christopher M.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, 685 West Baltimore St, Baltimore, MD 21201 USA.
   [Jewell, Christopher M.] Marlene & Stewart Greenebaum Canc Ctr, 22 S Greene St, Baltimore, MD 21201 USA.
RP Jewell, CM (reprint author), Univ Maryland, Fischell Dept Bioengn, 8228 Paint Branch Dr, College Pk, MD 20742 USA.; Jewell, CM (reprint author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, 685 West Baltimore St, Baltimore, MD 21201 USA.; Jewell, CM (reprint author), Marlene & Stewart Greenebaum Canc Ctr, 22 S Greene St, Baltimore, MD 21201 USA.
EM cmjewell@umd.edu
OI Tostanoski, Lisa/0000-0001-9255-5684
FU National Multiple Sclerosis Society Award [RG-1501-02968, PP2103]; NSF
   CAREER Award [1351688]; Maryland Innovation Initiative; Damon Runyon
   Foundation [DRR3415]; Young Investigator of the Alliance for Cancer Gene
   Therapy [15051543]; Melanoma Research Alliance [348963]
FX This work was supported in part by the National Multiple Sclerosis
   Society Award # RG-1501-02968 and # PP2103, NSF CAREER Award # 1351688,
   and the Maryland Innovation Initiative. L.H.T. is a NSF Graduate Fellow
   (# DGE1322106). C.M.J. is a Damon Runyon-Rachleff Innovator supported by
   the Damon Runyon Foundation (# DRR3415), and a Young Investigator of the
   Alliance for Cancer Gene Therapy (# 15051543) and the Melanoma Research
   Alliance (# 348963).
CR Andorko JI, 2015, AAPS J, V17, P323, DOI 10.1208/s12248-014-9708-2
   Andorko JI, 2015, ACTA BIOMATER
   Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290
   Bluestone JA, 2015, J CLIN INVEST, V125, P2250, DOI 10.1172/JCI78089
   Bryant J, 2014, BIOMATERIALS, V35, P8887, DOI 10.1016/j.biomaterials.2014.06.044
   Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159
   Chalmers SA, 2015, DISCOV MED, V20, P43
   Chiu YC, 2015, ACS BIOMATER SCI ENG, V1, P1200, DOI 10.1021/acsbiomaterials.5b00375
   Dane KY, 2011, J CONTROL RELEASE, V156, P154, DOI 10.1016/j.jconrel.2011.08.009
   Foged C, 2005, INT J PHARM, V298, P315, DOI 10.1016/j.ijpharm.2005.03.035
   Gammon JM, 2015, J CONTROL RELEASE, V210, P169, DOI 10.1016/j.jconrel.2015.05.277
   Getts DR, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007563
   Getts DR, 2012, NAT BIOTECHNOL, V30, P1217, DOI 10.1038/nbt.2434
   Griffith TS, 2011, IMMUNITY, V35, P456, DOI 10.1016/j.immuni.2011.08.011
   Grimm AJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep15907
   Hlavaty KA, 2015, CLIN IMMUNOL, V160, P14, DOI 10.1016/j.clim.2015.03.013
   Hudalla GA, 2014, NAT MATER, V13, P829, DOI [10.1038/NMAT3998, 10.1038/nmat3998]
   Hunter Z, 2014, ACS NANO, V8, P2148, DOI 10.1021/nn405033r
   Irvine DJ, 2013, NAT MATER, V12, P978, DOI [10.1038/NMAT3775, 10.1038/nmat3775]
   Jewell CM, 2011, P NATL ACAD SCI USA, V108, P15745, DOI 10.1073/pnas.1105200108
   Jhunjhunwala S, 2009, J CONTROL RELEASE, V133, P191, DOI 10.1016/j.jconrel.2008.10.011
   Jones CH, 2015, DISCOV MED, V19, P447
   Kontos S, 2013, P NATL ACAD SCI USA, V110, pE60, DOI 10.1073/pnas.1216353110
   Kwon YJ, 2005, P NATL ACAD SCI USA, V102, P18264, DOI 10.1073/pnas.0509541102
   Lewis JS, 2015, CLIN IMMUNOL, V160, P90, DOI 10.1016/j.clim.2015.03.023
   Lewis JS, 2012, BIOMATERIALS, V33, P7221, DOI 10.1016/j.biomaterials.2012.06.049
   Liu HP, 2014, NATURE, V507, P519, DOI 10.1038/nature12978
   Look M, 2013, J CLIN INVEST, V123, P1741, DOI 10.1172/JCI65907
   Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432
   Lutterotti A, 2014, EXPERT OPIN INV DRUG, V23, P9, DOI 10.1517/13543784.2014.844788
   Maldonado RA, 2015, P NATL ACAD SCI USA, V112, pE156, DOI 10.1073/pnas.1408686111
   Maldonado RA, 2010, ADV IMMUNOL, V108, P111, DOI 10.1016/S0065-2776(10)08004_1
   Manicassamy S, 2011, IMMUNOL REV, V241, P206, DOI 10.1111/j.1600-065X.2011.01015.x
   Mankia K, 2015, DISCOV MED, V20, P129
   Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132
   Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588
   Northrup L, 2016, ADV DRUG DELIVER REV, V98, P86, DOI 10.1016/j.addr.2015.10.020
   Northrup L, 2014, AAPS J, V16, P1204, DOI 10.1208/s12248-014-9671-y
   Osorio F, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00535
   Peine KJ, 2014, MOL PHARMACEUT, V11, P828, DOI 10.1021/mp4005172
   Pereira BD, 2015, DISCOV MED, V20, P111
   Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI 10.1038/nbtl332
   Salmond RJ, 2011, EUR J IMMUNOL, V41, P2137, DOI 10.1002/eji.201141523
   Shao K, 2015, ACS NANO, V9, P16, DOI 10.1021/nn5062029
   Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106
   Shirali AC, 2011, AM J TRANSPLANT, V11, P2582, DOI 10.1111/j.1600-6143.2011.03725.x
   Singh A, 2014, ADV MATER, V26, P6530, DOI 10.1002/adma.201402105
   Soroosh P, 2013, J EXP MED, V210, P775, DOI 10.1084/jem.20121849
   Sunshine JC, 2014, BIOMATERIALS, V35, P269, DOI 10.1016/j.biomaterials.2013.09.050
   Sunshine JC, 2013, NANOMEDICINE-UK, V8, P1173, DOI [10.2217/NNM.13.98, 10.2217/nnm.13.98]
   Taner T, 2005, AM J TRANSPLANT, V5, P228, DOI 10.1046/j.1600-6143.2004.00673.x
   Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546
   Tsai SE, 2010, IMMUNITY, V32, P568, DOI 10.1016/j.immuni.2010.03.015
   van Broekhoven CL, 2004, CANCER RES, V64, P4357, DOI 10.1158/0008-5472.CAN-04-0138
   Wang C, 2015, CELL, V163, DOI 10.1016/j.cell.2015.10.068
   Zhang PP, 2015, ACS NANO, V9, P6465, DOI 10.1021/acsnano.5b02153
NR 56
TC 11
Z9 12
U1 0
U2 6
PU DISCOVERY MEDICINE
PI TIMONIUM
PA 10 GERARD AVE, STE 201, TIMONIUM, MD 21093 USA
SN 1539-6509
EI 1944-7930
J9 DISCOV MED
JI Discov. Med.
PD MAY
PY 2016
VL 21
IS 117
BP 403
EP 410
PG 8
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DX2JY
UT WOS:000384196200008
PM 27355336
DA 2018-10-20
ER

PT J
AU Sentineri, R
   Lombardi, T
   Celauro, A
   Stacchi, C
AF Sentineri, Rosario
   Lombardi, Teresa
   Celauro, Andrea
   Stacchi, Claudio
TI Nasal Floor Elevation with Transcrestal Hydrodynamic Approach Combined
   with Dental Implant Placement: A Case Report
SO INTERNATIONAL JOURNAL OF PERIODONTICS & RESTORATIVE DENTISTRY
LA English
DT Article
ID ANTERIOR MAXILLA; RECONSTRUCTION; AUGMENTATION
AB Severe atrophy of the anterior maxilla represents a major challenge for the clinician when planning an implant-supported rehabilitation. Several surgical options are available for augmenting bone volume in this area, including onlay or interpositional bone grafts, guided bone regeneration, distraction osteogenesis, and nasal floor augmentation. This case report describes a novel approach to nasal floor elevation using ultrasonic instruments to prepare the implant sites followed by transcrestal hydrodynamic nasal mucosa elevation and grafting with a collagenized xenogeneic biomaterial. This minimally invasive technique allowed for vertical augmentation of the atrophic anterior maxilla together with implant placement in a single-stage surgery.
C1 [Celauro, Andrea] Univ Genoa, Sch Dent, Dent, Genoa, Italy.
   [Stacchi, Claudio] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy.
RP Stacchi, C (reprint author), Univ Trieste, Dept Odontol & Stomatol, Piazza Ospitale 1, I-34100 Trieste, Italy.
EM claudio@stacchi.it
OI STACCHI, CLAUDIO/0000-0003-4017-4980; Lombardi,
   Teresa/0000-0002-0334-6029
CR Adell R, 1985, TISSUE INTEGRATED PR, P226
   CAWOOD JI, 1988, INT J ORAL MAX SURG, V17, P232, DOI 10.1016/S0901-5027(88)80047-X
   Chiapasco M, 2009, INT J ORAL MAX IMPL, V24, P237
   El-Ghareeb M, 2012, J ORAL MAXIL SURG, V70, pE235, DOI 10.1016/j.joms.2011.09.032
   Gaggl A, 2005, INT J ORAL MAX SURG, V34, P37, DOI 10.1016/j.ijom.2004.03.008
   Garg A K, 1997, Dent Implantol Update, V8, P49
   Hising P, 2001, INT J ORAL MAX IMPL, V16, P90
   JENSEN J, 1994, J ORAL MAXIL SURG, V52, P210, DOI 10.1016/0278-2391(94)90283-6
   Keller E E, 1987, Int J Oral Maxillofac Implants, V2, P155
   Lorean A, 2014, INT J ORAL MAX IMPL, V29, P705, DOI 10.11607/jomi.3565
   Lundgren S, 1997, INT J ORAL MAX SURG, V26, P428, DOI 10.1016/S0901-5027(97)80007-0
   Mazor Z, 2012, CLIN IMPLANT DENT R, V14, P768, DOI 10.1111/j.1708-8208.2010.00312.x
   Merli M, 2013, INT J PERIODONT REST, V33, P129, DOI 10.11607/prd.1175
   Nystrom E, 2009, INT J ORAL MAX SURG, V38, P111, DOI 10.1016/j.ijom.2008.10.008
   Orsini G, 2011, INT J PERIODONT REST, V31, P535
   SAILER HF, 1989, J CRANIO MAXILL SURG, V17, P299, DOI 10.1016/S1010-5182(89)80057-5
   Schlee Markus, 2006, Implant Dent, V15, P334, DOI 10.1097/01.id.0000247859.86693.ef
   Sentineri R, 2011, J OSTEOL BIOMAT, V2, P69
   Stacchi C, 2013, CLIN IMPLANT DENT R, V15, P188, DOI 10.1111/j.1708-8208.2011.00341.x
   Troedhan A, 2014, J ORAL MAXILLOFAC SU, V72, p1503 e1
   Waldhorn Theodor, 2008, Schweiz Monatsschr Zahnmed, V118, P301
NR 21
TC 0
Z9 0
U1 0
U2 0
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0198-7569
EI 1945-3388
J9 INT J PERIODONT REST
JI Int. J. Periodontics Restor. Dent.
PD MAY-JUN
PY 2016
VL 36
IS 3
BP 357
EP 361
DI 10.11607/prd.2540
PG 5
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA DW7VX
UT WOS:000383862000008
PM 27100805
OA Bronze
DA 2018-10-20
ER

PT J
AU Istrate, B
   Mareci, D
   Munteanu, C
   Stanciu, S
   Crimu, CI
   Trinca, LC
   Kamel, E
AF Istrate, Bogdan
   Mareci, Daniel
   Munteanu, Corneliu
   Stanciu, Sergiu
   Crimu, Carmen-Iulia
   Trinca, Lucia Carmen
   Kamel, Earar
TI IN VITRO ELECTROCHEMICAL PROPERTIES OF BIODEGRADABLE YSZ-COATED MgCa
   ALLOY
SO ENVIRONMENTAL ENGINEERING AND MANAGEMENT JOURNAL
LA English
DT Article
DE EIS; MgCa alloy; plasma spraying; SEM; YSZ-coated
ID AZ91 MAGNESIUM ALLOY; LOW-POWER PLASMA; CORROSION BEHAVIOR; RINGERS
   SOLUTION; CA ALLOYS; BIOMATERIAL; RESISTANCE; COATINGS; ALBUMIN
AB Zirconia (ZrO2) as a ceramic biomaterial facilitates the osteoconductivity in new bone formation around implant. Surface characterization before and after electrochemical testing was performed used scanning electron microscopy (SEM). The electrochemical properties of the yttrium oxide stabilized zirconium oxide (YSZ) coated and uncoated MgCa sample with the open circuit potential at different immersion time in Ringer's solution were studied by electrochemical impedance spectroscopy (EIS). Equivalent circuits (ECs) were used to modeling EIS data, in order to characterize YSZ-coated and uncoated MgCa surface. The polarization resistance of the YSZ coated and uncoated MgCa decreases with the immersion time. However, after 2-days immersion in Ringer's solution the corrosion resistance presenteded bigger value for the uncoated (360 Omega cm(2)) than YSZ coated (140 Omega cm(2)) MgCa alloy. The present study, showed that electrochemical determinations can be a usefull tool to characterize such alloys. Knowledge of in vitro corrosion behaviour of these alloys may lead to a better undersanding of any biologically adverse effects in vivo.
C1 [Istrate, Bogdan; Munteanu, Corneliu; Crimu, Carmen-Iulia] Gheorghe Asachi Tech Univ Iasi, Fac Mech Engn, 43 D Mangeron St, Iasi 700050, Romania.
   [Mareci, Daniel] Gheorghe Asachi Tech Univ Iasi, Fac Chem Engn & Environm Protect, Iasi 700050, Romania.
   [Stanciu, Sergiu] Gheorghe Asachi Tech Univ Iasi, Fac Mat Sci & Engn, 41 D Mangeron St, Iasi 700050, Romania.
   [Trinca, Lucia Carmen] Ion Ionescu de la Brad Univ Agr Sci & Vet Med, Iasi 700490, Romania.
   [Kamel, Earar] Dunarea de Jos Univ Galati, Fac Med, Dent Med, Al I Cuza 35 St, Galati, Romania.
RP Munteanu, C (reprint author), Gheorghe Asachi Tech Univ Iasi, Fac Mech Engn, 43 D Mangeron St, Iasi 700050, Romania.
EM cornelmun@gmail.com
RI Bogdan, Istrate/P-5182-2014; TRINCA, LUCIA CARMEN/F-5966-2011
OI Bogdan, Istrate/0000-0003-0817-3523; TRINCA, LUCIA
   CARMEN/0000-0001-7381-6658
CR [Anonymous], 1999, G190 ASTM
   Bender S, 2007, MATER CORROS, V58, P977, DOI 10.1002/maco.200704091
   Bozzini B, 2011, J MATER SCI-MATER M, V22, P193, DOI 10.1007/s10856-010-4187-1
   Chen J, 2008, ELECTROCHEM COMMUN, V10, P577, DOI 10.1016/j.elecom.2008.01.027
   Crimu C, 2015, MATER CORROS, V66, P649, DOI 10.1002/maco.201407980
   Eliezer A, 2010, ADV MATER RES-SWITZ, V95, P17, DOI 10.4028/www.scientific.net/AMR.95.17
   Ghali E, 2004, J MATER ENG PERFORM, V13, P517, DOI 10.1361/10599490420665
   Gray JE, 2002, J ALLOY COMPD, V336, P88, DOI 10.1016/S0925-8388(01)01899-0
   Ilich JZ, 2000, J AM COLL NUTR, V19, P715, DOI 10.1080/07315724.2000.10718070
   Li N, 2013, J MATER SCI TECHNOL, V29, P489, DOI 10.1016/j.jmst.2013.02.005
   Li T, 2015, MATER CORROS, V66, P7, DOI 10.1002/maco.201307528
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Liu CL, 2007, J MATER RES, V22, P1806, DOI 10.1557/JMR.2007.0241
   Liu XB, 2011, ELECTROCHIM ACTA, V56, P2582, DOI 10.1016/j.electacta.2010.12.030
   Mareci D, 2016, MAT SCI ENG C-MATER, V60, P402, DOI 10.1016/j.msec.2015.11.069
   Mareci D, 2010, ENVIRON ENG MANAG J, V9, P81
   Mareci D, 2009, ENVIRON ENG MANAG J, V8, P397
   Mareci D, 2009, ENVIRON ENG MANAG J, V8, P29, DOI 10.30638/eemj.2009.004
   Mareci D, 2008, ENVIRON ENG MANAG J, V7, P701, DOI 10.30638/eemj.2008.093
   Morks MF, 2006, MATER LETT, V60, P1049, DOI 10.1016/j.matlet.2005.10.073
   Morks MF, 2005, SURF COAT TECH, V199, P66, DOI 10.1016/j.surfcoat.2005.02.159
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Pompa L, 2015, MAT SCI ENG C-MATER, V49, P761, DOI 10.1016/j.msec.2015.01.017
   Popa MV, 2010, QUIM NOVA, V33, P1892, DOI 10.1590/S0100-40422010000900014
   Romas M, 2015, ENVIRON ENG MANAG J, V14, P2719
   Rosemann P, 2013, MATER CORROS, V64, P714, DOI 10.1002/maco.201206590
   Shaw B.A., 2003, CORROSION RESISTANCE
   Shi ZM, 2010, CORROS SCI, V52, P579, DOI 10.1016/j.corsci.2009.10.016
   Song GL, 2005, ADV ENG MATER, V7, P563, DOI 10.1002/adem.200500013
   Song YW, 2008, MATER LETT, V62, P3276, DOI 10.1016/j.matlet.2008.02.048
   Tie D, 2014, MATER CORROS, V65, P569, DOI 10.1002/maco.201206903
   Virtanen S, 2011, MATER SCI ENG B-ADV, V176, P1600, DOI 10.1016/j.mseb.2011.05.028
   Wang H, 2007, ADV ENG MATER, V9, P967, DOI 10.1002/adem.200700200
   Witte F, 2007, BIOMATERIALS, V28, P2163, DOI 10.1016/j.biomaterials.2006.12.027
   Xin YC, 2009, SURF COAT TECH, V203, P2554, DOI 10.1016/j.surfcoat.2009.02.074
   Zeng RC, 2006, T NONFERR METAL SOC, V16, pS763, DOI 10.1016/S1003-6326(06)60297-5
   Zeng RC, 2015, CORROS SCI, V96, P23, DOI 10.1016/j.corsci.2015.03.018
NR 38
TC 20
Z9 20
U1 0
U2 6
PU GH ASACHI TECHNICAL UNIV IASI
PI IASI
PA 71 MANGERON BLVD, IASI, 700050, ROMANIA
SN 1582-9596
EI 1843-3707
J9 ENVIRON ENG MANAG J
JI Environ. Eng. Manag. J.
PD MAY
PY 2016
VL 15
IS 5
BP 955
EP 963
PG 9
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA DT1WZ
UT WOS:000381274100002
DA 2018-10-20
ER

PT J
AU Rajabinejad, H
   Buciscanu, II
   Maier, SS
AF Rajabinejad, Hossein
   Buciscanu, Ingrid-Ioana
   Maier, Stelian-Sergiu
TI PRACTICAL WAYS OF EXTRACTING KERATIN FROM KERATINOUS WASTES AND
   BY-PRODUCTS: A REVIEW
SO ENVIRONMENTAL ENGINEERING AND MANAGEMENT JOURNAL
LA English
DT Article; Proceedings Paper
CT 6th International Conference on Biomaterials, Tissue Engineering and
   Medical Devices (BiomMed)
CY SEP 17-20, 2014
CL Constanta, ROMANIA
DE biopolymer; biomaterial; keratin solubilization; keratinous wastes;
   renewable resources
ID CARBOXYMETHYLATED FEATHER KERATINS; REGENERATED WOOL KERATIN;
   BACILLUS-PUMILUS A1; IONIC LIQUIDS; CHICKEN FEATHERS; HAIR KERATIN;
   AMINO-ACID; ENZYMATIC-HYDROLYSIS; ALKALINE-HYDROLYSIS; PROTEIN
   HYDROLYSATE
AB Renewable resources, biopolymers and bio-based materials are keywords of the sustainable development and environmental sustainability concepts. Biopolymers, the green alternatives to fossil fuel based polymers, have already found different feasible applications, from consumer goods to regenerative medicine. Keratin is the biopolymer contained in the skin derivatives and appendages and is one of the the proteins with the most sophisticated architecture nature could produce. It is found in huge quantities in materials regarded as by-products or wastes with negative environmental impact but with high potential, for which it is desirable to develop valorization solutions. The increased interest towards biopolymers and renewable resources determined a large body of research and practical work concerning keratin extraction from different sources and regeneration into useful products. It is the aim of this paper to review the conventional chemical pathways and environmentally friendly alternatives for keratin solubilization as it regards the mechanisms, process parameters, characteristics of the obtained keratin forms, environmental and economical aspects. Current and possible applications of the solubilized keratin forms are also shortly reviewed.
C1 [Rajabinejad, Hossein] Gheorghe Asachi Tech Univ Iasi, SMDTex Doctorate Programme, 67 Prof Dr Docent Dimitrie Mangeron Blvd, Iasi 700050, Romania.
   [Buciscanu, Ingrid-Ioana; Maier, Stelian-Sergiu] Gheorghe Asachi Tech Univ Iasi, Fac Text Leather & Ind Management, 71A Prof Dr Docent Dimitrie Mangeron Blvd, Iasi 700050, Romania.
RP Maier, SS (reprint author), Gheorghe Asachi Tech Univ Iasi, Fac Text Leather & Ind Management, 71A Prof Dr Docent Dimitrie Mangeron Blvd, Iasi 700050, Romania.
EM smaier@ch.tuiasi.ro
RI Buciscanu, Ingrid-Ioana/F-8711-2017
CR ALEXANDER P, 1950, BIOCHEM J, V46, P27, DOI 10.1042/bj0460027
   ALEXANDER P, 1950, NATURE, V166, P396, DOI 10.1038/166396a0
   Alexander P., 1952, Patent No. [No. 2622036, 2622036]
   ALEXANDER P, 1963, WOOL ITS CHEM PHYS
   Alibardi L, 2013, ANN ANAT, V195, P189, DOI 10.1016/j.aanat.2012.08.005
   Anker CA, 1972, US patent, Patent No. 3642498
   [Anonymous], 2007, United States Patent, Patent No. 7297342
   Arivithamani N, 2014, CLEAN TECHNOL ENVIR, V16, P1207, DOI 10.1007/s10098-014-0718-7
   BAILEY JL, 1959, J BIOL CHEM, V234, P1733
   Benson Heather A. E., 2005, Current Drug Delivery, V2, P23, DOI 10.2174/1567201052772915
   Blanchard C. R., 1999, US Pat, Patent No. [US5932552 A, 5932552, 5,932,552]
   Bragulla HH, 2009, J ANAT, V214, P516, DOI 10.1111/j.1469-7580.2009.01066.x
   BROWN CH, 1950, NATURE, V166, P439, DOI 10.1038/166439a0
   Burnett L., 2013, Patent No. [025940 A1, 025940]
   Cardamone JM, 2010, J MOL STRUCT, V969, P97, DOI 10.1016/j.molstruc.2010.01.048
   CASTINO F, 1974, HISTOCHEMISTRY, V39, P93, DOI 10.1007/BF02428555
   Cavello IA, 2013, PROCESS BIOCHEM, V48, P972, DOI 10.1016/j.procbio.2013.03.012
   Chen JY, 2014, MATERIALS, V7, P6158, DOI 10.3390/ma7096158
   Cilurzo F, 2013, POLYM ADVAN TECHNOL, V24, P1025, DOI 10.1002/pat.3168
   Cole R.D., 1967, METHOD ENZYMOL, V11, P206
   Converti A, 2015, ENVIRON ENG MANAG J, V14, P1231
   COOPERMAN ES, 1973, COSMET PERFUM, V88, P19
   CORFIELD MC, 1958, BIOCHEM J, V68, P348, DOI 10.1042/bj0680348
   Coulombe PA, 2013, ENCY BIOL CHEM, P665
   CREWTHER W. G. R. D. B. FRASER, 1965, ADVANCE PROTEIN CHEM, V20, P191, DOI 10.1016/S0065-3233(08)60390-3
   DALEV P, 1990, BIOTECHNOL LETT, V12, P71, DOI 10.1007/BF01028496
   de Guzman RC, 2011, BIOMATERIALS, V32, P8205, DOI 10.1016/j.biomaterials.2011.07.054
   DOUTHWAITE FJ, 1993, TEXT RES J, V63, P177, DOI 10.1177/004051759306300308
   EARLAND C, 1956, BIOCHIM BIOPHYS ACTA, V22, P405, DOI 10.1016/0006-3002(56)90048-8
   Erra P, 1997, TEXT RES J, V67, P397, DOI 10.1177/004051759706700602
   Eslahi N, 2013, PREP BIOCHEM BIOTECH, V43, P624, DOI 10.1080/10826068.2013.763826
   Fakhfakh N, 2013, J APPL MICROBIOL, V115, P424, DOI 10.1111/jam.12246
   Fakhfakh N, 2011, PROCESS BIOCHEM, V46, P1731, DOI 10.1016/j.procbio.2011.05.023
   FAN X, 2008, THESIS
   Fellahi S., 2014, J BIOPROCESSING BIOT, V4, P181, DOI [10.4172/2155-9821.1000181, DOI 10.4172/2155-9821.1000181]
   Feughelman M., 1997, MECH PROPERTIES STRU
   Fleischner A.M., 1989, US Patent, Patent No. 4818520
   FLORENCE TM, 1980, BIOCHEM J, V189, P507, DOI 10.1042/bj1890507
   Fontoura R, 2014, NEW BIOTECHNOL, V31, P506, DOI 10.1016/j.nbt.2014.07.002
   Fraser RDB, 2008, J STRUCT BIOL, V162, P1, DOI 10.1016/j.jsb.2008.01.011
   FUCHS E, 1983, CELL, V34, P332, DOI 10.1016/0092-8674(83)90367-7
   Fujii T., 2013, J BIOL MACROMOLECULE, V13, P92
   Gallstedt M., 2011, BIOPOLYMERS NEW MAT, P107
   Ghosh A, 2014, POLYM DEGRAD STABIL, V108, P108, DOI 10.1016/j.polymdegradstab.2014.06.007
   GILLESPIE J, 1961, BIOCHEM J, V79, P280, DOI 10.1042/bj0790280
   Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871
   Gonzalez A, 2011, J FOOD ENG, V106, P331, DOI 10.1016/j.jfoodeng.2011.05.030
   Gousterova A, 2005, LETT APPL MICROBIOL, V40, P335, DOI 10.1111/j.1472-765X.2005.01692.x
   Gousterova A, 2003, BIOTECHNOL BIOTECHNO, V17, P140
   Gupta R, 2006, APPL MICROBIOL BIOT, V70, P21, DOI 10.1007/s00253-005-0239-8
   Hamasaki S, 2008, MAT SCI ENG C-BIO S, V28, P1250, DOI 10.1016/j.msec.2007.11.008
   HARRAP BS, 1964, BIOCHEM J, V92, P19, DOI 10.1042/bj0920019
   Hill P, 2010, BIOMATERIALS, V31, P585, DOI 10.1016/j.biomaterials.2009.09.076
   Hsiung D.Y., 1972, US Patent, Patent No. 3644084
   Ianelli M., 2011, MICROWAVE HEATING TO, P53
   Idris A, 2014, ACS SUSTAIN CHEM ENG, V2, P1888, DOI 10.1021/sc500229a
   Idris A, 2014, GREEN CHEM, V16, P2857, DOI 10.1039/c4gc00213j
   Idris A, 2013, GREEN CHEM, V15, P525, DOI 10.1039/c2gc36556a
   Ignatova Z, 1999, CAN J MICROBIOL, V45, P217, DOI 10.1139/cjm-45-3-217
   Istrate D, 2013, POLYM DEGRAD STABIL, V98, P542, DOI 10.1016/j.polymdegradstab.2012.12.001
   Jones LN, 2007, INT FIBER SCI TECHNO, V16, P331
   Kalbarg S.M., 2003, US Patent App, Patent No. 0175845
   Katoh K, 2004, BIOMATERIALS, V25, P2265, DOI 10.1016/j.biomaterials.2003.09.021
   Katritzky AR, 2003, MAGN RESON CHEM, V41, P37, DOI 10.1002/mrc.1110
   Kelly R.J., 2006, US Patent, Patent No. 7148327
   Kelly R.J., 2012, US Patent, Patent No. 8124735
   Kelly R.J., 2010, US Patent, Patent No. 7767756
   Ki CS, 2007, J MEMBRANE SCI, V302, P20, DOI 10.1016/j.memsci.2007.06.003
   Kilpelainen I, 2007, J AGR FOOD CHEM, V55, P9142, DOI 10.1021/jf071692e
   Kim WK, 2000, POULTRY SCI, V79, P528, DOI 10.1093/ps/79.4.528
   Kornillowicz-Kowalska T, 2011, WASTE MANAGE, V31, P1689, DOI 10.1016/j.wasman.2011.03.024
   Kornillowicz-Kowalska Teresa, 1997, Acta Mycologica, V32, P51
   Kreplak L, 2004, BIOPHYS J, V87, P640, DOI 10.1529/biophysj.103.036749
   KUNERT J, 1989, J BASIC MICROB, V29, P597, DOI 10.1002/jobm.3620290909
   Lane B.E., 2002, CONNECTIVE TISSUE AN, P329
   Lee SH, 2010, ACS SYM SER, V1038, P115
   LEE SJ, 2007, MANUAL BIOMATERIALS, P141
   Li JS, 2013, FOOD CHEM TOXICOL, V57, P338, DOI 10.1016/j.fct.2013.03.047
   Li R, 2013, J APPL POLYM SCI, V127, P2648, DOI 10.1002/app.37527
   Liu XY, 2011, MATER LETT, V65, P2489, DOI 10.1016/j.matlet.2011.05.017
   Maclaren J.A., 1981, WOOL SCI CHEM REACTI, P219
   Marmer WN, 2006, J AM LEATHER CHEM AS, V101, P408
   Meng ZJ, 2012, INT J BIOL MACROMOL, V51, P440, DOI 10.1016/j.ijbiomac.2012.05.030
   Mokrejs P., 2011, Rasayan Journal of Chemistry, V4, P728
   Mokrejs P, 2011, WASTE MANAGE RES, V29, P260, DOI 10.1177/0734242X10370378
   Moshy R.J., 1961, US Patent, Patent No. 2993794
   NACHTIGAL J, 1970, TEXT RES J, V40, P454, DOI 10.1177/004051757004000511
   NAGAI Y, 1970, AGR BIOL CHEM TOKYO, V34, P16, DOI 10.1080/00021369.1970.10859572
   NAGAI Y, 1970, AGR BIOL CHEM TOKYO, V34, P1676, DOI 10.1080/00021369.1970.10859823
   Nakamura A, 2002, BIOL PHARM BULL, V25, P569, DOI 10.1248/bpb.25.569
   Nakata R, 2015, J BIOSCI BIOENG, V120, P111, DOI 10.1016/j.jbiosc.2014.12.005
   NOISHIKI Y, 1982, KOBUNSHI RONBUNSHU, V39, P221, DOI 10.1295/koron.39.221
   Nomura Y, 2002, BIOSCI BIOTECH BIOCH, V66, P1382, DOI 10.1271/bbb.66.1382
   Nunez F, 2011, MICROCIRCULATION, V18, P663, DOI 10.1111/j.1549-8719.2011.00135.x
   O'DONNELL I. J., 1959, AUSTRALIAN JOUR BIOL SCI, V12, P294
   ODONNELL IJ, 1964, AUST J BIOL SCI, V17, P973, DOI 10.1071/BI9640973
   OERTEL RP, 1977, BIOPOLYMERS, V16, P2329, DOI 10.1002/bip.1977.360161017
   Ohba R, 2003, FOOD SCI TECHNOL RES, V9, P91, DOI 10.3136/fstr.9.91
   Onifade AA, 1998, BIORESOURCE TECHNOL, V66, P1, DOI 10.1016/S0960-8524(98)00033-9
   Ozaki Y, 2014, MAT SCI ENG C-MATER, V42, P146, DOI 10.1016/j.msec.2014.05.018
   Pasupuleti VK, 2010, PROTEIN HYDROLYSATES IN BIOTECHNOLOGY, P11, DOI 10.1007/978-1-4020-6674-0_2
   Plowman JE, 2003, J CHROMATOGR B, V787, P63, DOI 10.1016/S1570-0232(02)00211-8
   Poole AJ, 2011, J POLYM ENVIRON, V19, P995, DOI 10.1007/s10924-011-0365-6
   PRICE VH, 1967, J INVEST DERMATOL, V49, P297, DOI 10.1038/jid.1967.139
   Ramnani P, 2005, CAN J MICROBIOL, V51, P191, DOI 10.1139/W04-123
   Ramnani P, 2007, WORLD J MICROB BIOT, V23, P1537, DOI 10.1007/s11274-007-9398-3
   Reddy N, 2014, J CLEAN PROD, V65, P561, DOI 10.1016/j.jclepro.2013.09.046
   Reichl S, 2009, BIOMATERIALS, V30, P6854, DOI 10.1016/j.biomaterials.2009.08.051
   ROBBINS C, 1971, J SOC COSMET CHEM, V22, P339
   Robbins C.R., 2012, CHEM PHYS BEHAV HUMA, P205
   Rouette H.K., 2001, ENCY TEXTILE FINISHI, P2696
   Rouse JG, 2010, MATERIALS, V3, P999, DOI 10.3390/ma3020999
   Sahoo DK, 2012, APPL BIOCHEM BIOTECH, V167, P1040, DOI 10.1007/s12010-011-9527-1
   Sanderson W.R., 2002, HDB GREEN CHEM TECHN, P258
   Sando L, 2010, J BIOMED MATER RES A, V95A, P901, DOI 10.1002/jbm.a.32913
   SAVIGE WE, 1964, TETRAHEDRON LETT, P3289
   Schrooyen P.M., 2007, US Patent, Patent No. 7169896
   Schrooyen PMM, 2000, J AGR FOOD CHEM, V48, P4326, DOI 10.1021/jf9913155
   Schrooyen PMM, 2001, J AGR FOOD CHEM, V49, P221, DOI 10.1021/jf0004154
   Schrooyen PMM, 2001, J COLLOID INTERF SCI, V240, P30, DOI 10.1006/jcis.2001.7673
   Selmin Francesca, 2012, Results Pharma Sci, V2, P72, DOI 10.1016/j.rinphs.2012.10.001
   Shi B, 2003, J AM LEATHER CHEM AS, V98, P185
   Srinivasan B, 2010, J BIOMED MATER RES B, V92B, P5, DOI 10.1002/jbm.b.31483
   Sun P, 2009, J HAZARD MATER, V170, P786, DOI 10.1016/j.jhazmat.2009.05.034
   SWAN JM, 1961, AUST J CHEM, V14, P69, DOI 10.1071/CH9610069
   SWAN JM, 1957, NATURE, V180, P643, DOI 10.1038/180643a0
   Syed DG, 2009, BIORESOURCE TECHNOL, V100, P1868, DOI 10.1016/j.biortech.2008.09.047
   Tachibana A, 2002, J BIOTECHNOL, V93, P165, DOI 10.1016/S0168-1656(01)00395-9
   TAKIUCHI I, 1983, Journal of Dermatology (Tokyo), V10, P327
   Tam J.P., 1992, US Patent, Patent No. 5144006
   Tanabe T, 2002, BIOMATERIALS, V23, P817, DOI 10.1016/S0142-9612(01)00187-9
   Tang L, 2012, EXP DERMATOL, V21, P458, DOI 10.1111/j.1600-0625.2012.01505.x
   THOMPSON EO, 1961, BIOCHIM BIOPHYS ACTA, V53, P447, DOI 10.1016/0006-3002(61)90471-1
   Tiwary E., 2012, J BIOPROCESS BIOTECH, V2, DOI [10.4172/2155-9821.100012\3, DOI 10.4172/2155-9821.1000123, 10.4172/2155-9821.1000123]
   Tonin C, 2006, BIOMACROMOLECULES, V7, P3499, DOI 10.1021/bm060597w
   Tsuda Y, 2014, ANIM SCI J, V85, P180, DOI 10.1111/asj.12093
   Van Dyke M.E., 2001, US Patent No, Patent No. 6316598
   VanDyke M.E., 2011, US Patent No, Patent No. 7892573
   VanDyke M.E., 2012, US Patent No, Patent No. 8258093
   Vasconcelos A, 2008, BIOMACROMOLECULES, V9, P1299, DOI 10.1021/bm7012789
   Vasconcelos A, 2011, APPL MICROBIOL BIOT, V90, P445, DOI 10.1007/s00253-011-3135-4
   Vesela M, 2009, BIOTECHNOL BIOPROC E, V14, P84, DOI [10.1007/s12257-008-0083-7, 10.1007/S12257-008-0083-7]
   Wang X, 1997, POULTRY SCI, V76, P491, DOI 10.1093/ps/76.3.491
   Wang YX, 2012, PROCESS BIOCHEM, V47, P896, DOI 10.1016/j.procbio.2012.02.013
   WOLFRAM L J, 1970, Journal of the Society of Cosmetic Chemists, V21, P875
   Wolfram L.J., 1971, US Patent, No, Patent No. 3567363
   WOLFRAM LJ, 1966, TEXT RES J, V36, P947, DOI 10.1177/004051756603601102
   Wrzesniewska-Tosik K, 2007, FIBRES TEXT EAST EUR, V15, P106
   Xie HB, 2005, GREEN CHEM, V7, P606, DOI 10.1039/b502547h
   Xu HL, 2014, J MATER SCI, V49, P7513, DOI 10.1007/s10853-014-8457-z
   Xu SM, 2013, MAT SCI ENG C-MATER, V33, P648, DOI 10.1016/j.msec.2012.10.011
   Yamada M., 1994, US Patent, Patent No. 5276138
   YAMASHOJI S, 1979, AGR BIOL CHEM TOKYO, V43, P1505, DOI 10.1080/00021369.1979.10863656
   Yamauchi K, 1996, J BIOMED MATER RES, V31, P439, DOI 10.1002/(SICI)1097-4636(199608)31:4<439::AID-JBM1>3.0.CO;2-M
   Yang X, 2007, CHINESE SCI BULL, V52, P2876, DOI 10.1007/s11434-007-0418-3
   Yang X, 2009, J COLLOID INTERF SCI, V336, P756, DOI 10.1016/j.jcis.2009.04.050
   Yin J, 2007, BIOMACROMOLECULES, V8, P800, DOI 10.1021/bm060811g
   Yin XC, 2013, BIOMATER SCI-UK, V1, P528, DOI 10.1039/c3bm00158j
   Zhang J, 2013, POWDER TECHNOL, V246, P356, DOI 10.1016/j.powtec.2013.05.037
   Zhou LT, 2014, ENVIRON SCI POLLUT R, V21, P5730, DOI 10.1007/s11356-014-2513-8
   Zoccola M, 2015, WASTE BIOMASS VALORI, V6, P891, DOI 10.1007/s12649-015-9393-0
   Zoccola M, 2012, TEXT RES J, V82, P2006, DOI 10.1177/0040517512452948
   Zoccola M, 2009, J MOL STRUCT, V938, P35, DOI 10.1016/j.molstruc.2009.08.036
NR 163
TC 1
Z9 1
U1 4
U2 18
PU GH ASACHI TECHNICAL UNIV IASI
PI IASI
PA 71 MANGERON BLVD, IASI, 700050, ROMANIA
SN 1582-9596
EI 1843-3707
J9 ENVIRON ENG MANAG J
JI Environ. Eng. Manag. J.
PD MAY
PY 2016
VL 15
IS 5
BP 1131
EP 1147
PG 17
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA DT1WZ
UT WOS:000381274100024
DA 2018-10-20
ER

PT J
AU Deo, VK
   Kato, T
   Park, EY
AF Deo, Vipin Kumar
   Kato, Tatsuya
   Park, Enoch Y.
TI Virus-Like Particles Displaying Recombinant Short-Chain Fragment Region
   and Interleukin 2 for Targeting Colon Cancer Tumors and Attracting
   Macrophages
SO JOURNAL OF PHARMACEUTICAL SCIENCES
LA English
DT Article
DE bilayer; biomaterials; biotechnology; cancer chemotherapy; colon;
   nanoparticles; proteins; protein delivery; site-specific delivery;
   targeted drug delivery
ID ALPHA-RECEPTOR; DRUG-DELIVERY; FORCE-FIELD; GAG; IMMUNOTHERAPY;
   PLATFORM; UPDATE
AB Functionalized virus-like particles (VLPs) can target with specificity as drug delivery systems and can attract macrophages for the destruction of cancer cells. Here, the group antigen capsid protein from the Rous sarcoma virus was used to prepare VLPs, functionalized by displaying glycoleinositol phosphate-anchored recombinant single chain fragment variable (rscFv) and hemagglutinin transmembrane region anchored recombinant human interleukin-2 (rhIL2) (designated as VLP-rscFv-rhIL2s) in silkworms. The rscFv specifically binds the tumor-associated glycoprotein 72 that is expressed at the surface of colon cancer cells. VLP-rscFv-rhIL2 was affinity purified and had a smooth particle size with a diameter of 50 nm. Calcein-AM-packaged VLP-rscFv-rhIL2s successfully targeted cancer cells as a model for drug delivery system. VLP-rscFv-rhIL2 bound with colon cancer cells that attracted macrophages (human monocytic cell line-1 cells) in chemotaxis chamber assays compared with negative controls. The macrophages secreted tumor necrosis factor-a, a cytokine that is necessary to destroy cancer cells. These results demonstrate the potential of VLP-rscFv-rhIL2 as an intelligent nano biomaterial that is capable of attracting macrophages. (C) 2016 American Pharmacists Association (R). Published by Elsevier Inc. All rights reserved.
C1 [Deo, Vipin Kumar] Shizuoka Univ, Coll Global Interdisciplinary Studies, Biotechnol Lab, Shizuoka 4228529, Japan.
   [Kato, Tatsuya; Park, Enoch Y.] Shizuoka Univ, Res Inst Green Sci & Technol, Biotechnol Lab, Shizuoka 4228529, Japan.
RP Park, EY (reprint author), Shizuoka Univ, Res Inst Green Sci & Technol, Biotechnol Lab, Shizuoka 4228529, Japan.
EM park.enoch@shizuoka.ac.jp
RI Kato, Tatsuya/E-3095-2010
OI Kato, Tatsuya/0000-0001-7990-2557
CR Bergstrom SE, 2013, IMMUNOLOGY, V140, P441, DOI 10.1111/imm.12154
   Bertrand N, 2014, ADV DRUG DELIVER REV, V66, P2, DOI 10.1016/j.addr.2013.11.009
   Boder ET, 2012, NATURE, V484, P463, DOI 10.1038/484463a
   Deo VK, 2015, MOL PHARMACEUT, V12, P839, DOI 10.1021/mp500860x
   Deo VK, 2014, PHARM RES-DORDR, V31, P2166, DOI 10.1007/s11095-014-1316-4
   Deo VK, 2013, J BIOTECHNOL, V165, P69, DOI 10.1016/j.jbiotec.2013.02.013
   Dwyer PJ, 2014, J PHYS CHEM A, V118, P11583, DOI 10.1021/jp506601e
   Goerner M, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-8
   Hank JA, 2009, CLIN CANCER RES, V15, P5923, DOI 10.1158/1078-0432.CCR-08-2963
   Kato T, 2015, PHARM RES-DORDR, V32, P3699, DOI 10.1007/s11095-015-1730-2
   Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q
   Lee S, 2011, CAMERON-CLEGG GOVERNMENT: COALITION POLITICS IN AN AGE OF AUSTERITY, P3
   Maksimenko A, 2014, ACS NANO, V8, P2018, DOI 10.1021/nn500517a
   Pokorski JK, 2011, MOL PHARMACEUT, V8, P29, DOI 10.1021/mp100225y
   Rao BM, 2003, PROTEIN ENG, V16, P1081, DOI 10.1093/protein/gzg111
   Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5
   SABZEVARI H, 1994, P NATL ACAD SCI USA, V91, P9626, DOI 10.1073/pnas.91.20.9626
   Shao K, 2015, ACS NANO, V9, P16, DOI 10.1021/nn5062029
   Sim GC, 2014, CYTOKINE GROWTH F R, V25, P377, DOI 10.1016/j.cytogfr.2014.07.018
   TANIGUCHI T, 1983, NATURE, V302, P305, DOI 10.1038/302305a0
   TEODORCZYKINJEYAN JA, 1992, CLIN EXP IMMUNOL, V90, P36
   Vazquez-Lombardi R, 2013, ANTIBODIES, V2, P426, DOI 10.3390/antib2030426
   Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893
   Watanabe T, 2012, INT J CLIN ONCOL, V17, P1, DOI 10.1007/s10147-011-0315-2
   Xiang Y, 1997, J VIROL, V71, P2083
   Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213
NR 26
TC 3
Z9 3
U1 1
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3549
EI 1520-6017
J9 J PHARM SCI-US
JI J. Pharm. Sci.
PD MAY
PY 2016
VL 105
IS 5
BP 1614
EP 1622
DI 10.1016/j.xphs.2016.02.011
PG 9
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology &
   Pharmacy
SC Pharmacology & Pharmacy; Chemistry
GA DT8TZ
UT WOS:000381769800005
PM 27037014
DA 2018-10-20
ER

PT J
AU Arias, SL
   Shetty, AR
   Senpan, A
   Echeverry-Rendon, M
   Reece, LM
   Allain, JP
AF Arias, Sandra L.
   Shetty, Akshath R.
   Senpan, Angana
   Echeverry-Rendon, Monica
   Reece, Lisa M.
   Allain, Jean Paul
TI Fabrication of a Functionalized Magnetic Bacterial Nanocellulose with
   Iron Oxide Nanoparticles
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Bioengineering; Issue 111; Gluconacetobacter xylinus; bacterial
   cellulose; iron oxide nanoparticles; blood vessel; biomaterial
ID BLOOD-VESSELS; CELLULOSE
AB In this study, bacterial nanocellulose (BNC) produced by the bacteria Gluconacetobacter xylinus is synthesized and impregnated in situ with iron oxide nanoparticles (IONP) (Fe3O4) to yield a magnetic bacterial nanocellulose (MBNC). The synthesis of MBNC is a precise and specifically designed multi-step process. Briefly, bacterial nanocellulose (BNC) pellicles are formed from preserved G. xylinus strain according to our experimental requirements of size and morphology. A solution of iron(III) chloride hexahydrate (FeCl3 center dot 6H(2)O) and iron(II) chloride tetrahydrate (FeCl2 center dot 4H(2)O) with a 2:1 molar ratio is prepared and diluted in deoxygenated high purity water. A BNC pellicle is then introduced in the vessel with the reactants. This mixture is stirred and heated at 80 degrees C in a silicon oil bath and ammonium hydroxide (14%) is then added by dropping to precipitate the ferrous ions into the BNC mesh. This last step allows forming in situ magnetite nanoparticles (Fe3O4) inside the bacterial nanocellulose mesh to confer magnetic properties to BNC pellicle. A toxicological assay was used to evaluate the biocompatibility of the BNC-IONP pellicle. Polyethylene glycol (PEG) was used to cover the IONPs in order to improve their biocompatibility. Scanning electron microscopy (SEM) images showed that the IONP were located preferentially in the fibril interlacing spaces of the BNC matrix, but some of them were also found along the BNC ribbons. Magnetic force microscope measurements performed on the MBNC detected the presence magnetic domains with high and weak intensity magnetic field, confirming the magnetic nature of the MBNC pellicle. Young's modulus values obtained in this work are also in a reasonable agreement with those reported for several blood vessels in previous studies.
C1 [Arias, Sandra L.; Allain, Jean Paul] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA.
   [Shetty, Akshath R.; Allain, Jean Paul] Univ Illinois, Dept Nucl Plasma & Radiol Engn, Urbana, IL 61801 USA.
   [Senpan, Angana; Allain, Jean Paul] Univ Illinois, Micro & Nanotechnol Lab, Urbana, IL 61801 USA.
   [Echeverry-Rendon, Monica] Univ Antioquia, Program Study & Control Trop Dis PECET, Medellin, Antioquia, Colombia.
   [Reece, Lisa M.] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA.
   [Reece, Lisa M.] Univ Texas Med Branch, WHO Collaborating Ctr Vaccine Res Evaluat & Train, Galveston, TX 77555 USA.
   [Allain, Jean Paul] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA.
RP Allain, JP (reprint author), Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA.; Allain, JP (reprint author), Univ Illinois, Dept Nucl Plasma & Radiol Engn, Urbana, IL 61801 USA.; Allain, JP (reprint author), Univ Illinois, Micro & Nanotechnol Lab, Urbana, IL 61801 USA.; Allain, JP (reprint author), Univ Illinois, Beckman Inst, Urbana, IL 61801 USA.
EM allain@illinois.edu
OI Allain, Jean Paul/0000-0003-1348-262X
FU Department of Defense [W81XWH-11-2-0067]
FX This work was funded by Department of Defense under contract No.
   W81XWH-11-2-0067
CR Azqueta A, 2013, ARCH TOXICOL, V87, P949, DOI 10.1007/s00204-013-1070-0
   Barud HS, 2015, J APPL PHYS, V117, DOI 10.1063/1.4917261
   Bodin A, 2007, BIOTECHNOL BIOENG, V97, P425, DOI 10.1002/bit.21314
   Cai Z, 2010, CELLULOSE, V17, P83, DOI 10.1007/s10570-009-9362-5
   Chan-Park MB, 2009, J BIOMED MATER RES A, V88A, P1104, DOI 10.1002/jbm.a.32318
   Fu LN, 2013, MAT SCI ENG C-MATER, V33, P2995, DOI 10.1016/j.msec.2013.03.026
   Illes E, 2015, J MAGN MAGN MATER, V380, P132, DOI 10.1016/j.jmmm.2014.10.146
   Karimi A, 2014, ARTERY RES, V8, P51, DOI 10.1016/j.artres.2014.02.001
   Martson M, 1999, BIOMATERIALS, V20, P1989, DOI 10.1016/S0142-9612(99)00094-0
   Olsson RT, 2010, NAT NANOTECHNOL, V5, P584, DOI [10.1038/nnano.2010.155, 10.1038/NNANO.2010.155]
   Saxena IM, 2013, PERSPECT NANOTECHNOL, P1
   Scherner M, 2014, J SURG RES, V189, P340, DOI 10.1016/j.jss.2014.02.011
   Torre B, 2011, SCI REP-UK, V1, DOI 10.1038/srep00202
   Torrisi V, 2014, BIOMACROMOLECULES, V15, P3171, DOI 10.1021/bm500832q
   Ulbricht J, 2014, BIOMATERIALS, V35, P4848, DOI 10.1016/j.biomaterials.2014.02.029
   Wu W, 2008, NANOSCALE RES LETT, V3, P397, DOI 10.1007/s11671-008-9174-9
   Zaborowska M, 2010, ACTA BIOMATER, V6, P2540, DOI 10.1016/j.actbio.2010.01.004
NR 17
TC 2
Z9 2
U1 3
U2 27
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD MAY
PY 2016
IS 111
AR e52951
DI 10.3791/52951
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DS0BJ
UT WOS:000380259900004
PM 27285589
OA Green Published
DA 2018-10-20
ER

PT J
AU Aires, MD
   Treter, J
   Braz, DC
   Krug, C
   Macedo, AJ
   Alves, C
AF Aires, Michelle de Medeiros
   Treter, Janine
   Braz, Danilo Cavalcante
   Krug, Cristiano
   Macedo, Alexandre Jose
   Alves Junior, Clodomiro
TI Influence of Oxynitrided Surface in the Production of a Less Susceptible
   Titanium Surface to Skin-Borne Bacterial Adhesion
SO ARTIFICIAL ORGANS
LA English
DT Article; Proceedings Paper
CT 12th International Conference on Pediatric Mechanical Circulatory
   Support Systems and Pediatric Cardiopulmonary Perfusion
CY MAY 18-21, 2016
CL Columbia Univ Med Ctr, New York Presbyterian, Vivian & Seymour Milstein
   Fa, New York, NY
HO Columbia Univ Med Ctr, New York Presbyterian, Vivian & Seymour Milstein Fa
DE Plasma; Staphylococcus epidermidis; Biofilm; Titanium
ID STAPHYLOCOCCAL ADHESION; COATINGS; BIOMATERIALS; INFECTIONS; TOPOGRAPHY;
   ROUGHNESS; BIOFILMS; BEHAVIOR
AB There is a growing quest for an ideal biomaterial that shows appropriate cellular response and is not susceptible to microbial adhesion. In this study, commercial grade II titanium was submitted to RF/DC plasma surface modification at 2.2 mbar, using gas mixtures of argon, nitrogen, and oxygen at proportions 4: 1: 2 and 4: 1: 3. The surfaces were physically and chemically characterized. In order to evaluate bacterial response, the surfaces were exposed to Staphylococcus epidermidis. Oxynitrided samples, although having a higher roughness as compared with untreated samples, exhibited lower bacterial growth. This observation is probably due to the formation of different crystalline phases of nitrides and oxides caused by plasma treatment. The surface with highest contact angle and highest surface tension showed lower bacterial adhesion. These results were confirmed by scanning electron microscopy. The role of nitrogen in reducing bacterial adhesion is clear when this material is compared with untreated titanium, on which only an oxide film is present.
C1 [Aires, Michelle de Medeiros; Braz, Danilo Cavalcante; Alves Junior, Clodomiro] Univ Fed Rio Grande do Norte, Lab Plasma, BR-59072970 Natal, RN, Brazil.
   [Treter, Janine; Macedo, Alexandre Jose] Univ Fed Rio Grande do Sul, Biofilms & Microbial Div Lab, Ctr Biotechnol, BR-90046900 Porto Alegre, RS, Brazil.
   [Treter, Janine; Macedo, Alexandre Jose] Univ Fed Rio Grande do Sul, Coll Pharm, BR-90046900 Porto Alegre, RS, Brazil.
   [Krug, Cristiano] Univ Fed Rio Grande do Sul, Inst Phys, BR-90046900 Porto Alegre, RS, Brazil.
RP Aires, MD (reprint author), Univ Fed Rio Grande do Norte, Lab Plasma, BR-59072970 Natal, RN, Brazil.
EM michellemaires@gmail.com
RI Alves Junior, Clodomiro/B-7578-2009
OI Alves Junior, Clodomiro/0000-0002-5547-5922
CR Antoci V, 2008, BIOMATERIALS, V29, P4684, DOI 10.1016/j.biomaterials.2008.08.016
   Araujo EA, 2010, QUIM NOVA, Vv, P1940
   BRIDGETT MJ, 1992, BIOMATERIALS, V13, P411, DOI 10.1016/0142-9612(92)90159-L
   Chandra J, 2005, APPL ENVIRON MICROB, V71, P8795, DOI 10.1128/AEM.71.12.8795-8801.2005
   Costa THC, 2008, MATERIA-BRAZIL, V13, P65, DOI 10.1590/S1517-70762008000100008
   Darouiche RO, 2001, CLIN INFECT DIS, V33, P1567, DOI 10.1086/323130
   Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008
   Deshmukh RR, 2003, MATER RES INNOV, V7, P283, DOI 10.1007/s10019-003-0265-z
   Gosheger G, 2004, BIOMATERIALS, V25, P5547, DOI 10.1016/j.biomaterials.2004.01.008
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   Karunakaran E, 2011, APPL MICROBIOL BIOT, V90, P1869, DOI 10.1007/s00253-011-3293-4
   Kim WH, 2008, SURF INTERFACE ANAL, V40, P202, DOI 10.1002/sia.2809
   Koerner RJ, 2002, BIOMATERIALS, V23, P2835, DOI 10.1016/S0142-9612(01)00404-5
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Locatelli Claudete Inês, 2004, Arq. Bras. Oftalmol., V67, P241, DOI 10.1590/S0004-27492004000200011
   Lu X, 2004, BIOMATERIALS, V25, P1779, DOI 10.1016/j.biomaterials.2003.08.028
   Oner D, 2000, LANGMUIR, V16, P7777, DOI 10.1021/la000598o
   Otto Michael, 2009, NAT REV MICROBIOL, V7, P555
   Pascual A, 2002, CLIN MICROBIOL INFEC, V8, P256, DOI 10.1046/j.1469-0691.2002.00418.x
   Poortinga AT, 2001, BIOPHYS CHEM, V91, P273, DOI 10.1016/S0301-4622(01)00177-6
   Puckett SD, 2010, BIOMATERIALS, V31, P706, DOI 10.1016/j.biomaterials.2009.09.081
   Quirynen M, 1996, Int J Oral Maxillofac Implants, V11, P169
   Rino JP, 1999, PHYS REV B, V59, P6643, DOI 10.1103/PhysRevB.59.6643
   Sa JC, 2009, SURF COAT TECH, V203, P1765, DOI 10.1016/j.surfcoat.2008.12.017
   Sadiqali C, 2010, J APPL BIOMED, V8, P55
   SHIRKHANZADEH M, 1995, NANOSTRUCT MATER, V5, P33, DOI 10.1016/0965-9773(95)00006-Z
   Trentin DD, 2011, J ETHNOPHARMACOL, V137, P327, DOI 10.1016/j.jep.2011.05.030
   Treter J, 2011, SCI MICROBIAL PATHOG, V2, P693
   Truong VK, 2010, BIOMATERIALS, V31, P3674, DOI 10.1016/j.biomaterials.2010.01.071
   Wall I, 2009, BONE, V45, P17, DOI 10.1016/j.bone.2009.03.662
   Whitehead KA, 2006, FOOD BIOPROD PROCESS, V84, P253, DOI 10.1205/fbp06035
   WHITEHEAD SA, 1995, J ORAL REHABIL, V22, P421, DOI 10.1111/j.1365-2842.1995.tb00795.x
   Windecker S, 2005, CIRCULATION, V111, P2617, DOI 10.1161/CIRCULASTIONAHA.104.486647
   Wu Y, 2011, BIOMATERIALS, V32, P951, DOI 10.1016/j.biomaterials.2010.10.001
   Zhao LZ, 2009, J BIOMED MATER RES B, V91B, P470, DOI 10.1002/jbm.b.31463
NR 35
TC 4
Z9 4
U1 0
U2 6
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0160-564X
EI 1525-1594
J9 ARTIF ORGANS
JI Artif. Organs
PD MAY
PY 2016
VL 40
IS 5
BP 521
EP 526
DI 10.1111/aor.12581
PG 6
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA DP5MX
UT WOS:000378542800019
PM 26611366
DA 2018-10-20
ER

PT J
AU Maeda, NT
   Yoshimoto, M
   Allegrini, S
   Bressiani, AHD
AF Maeda, Nancy Tiaki
   Yoshimoto, Marcelo
   Allegrini Junior, Sergio
   de Almeida Bressiani, Ana Helena
TI Hydroxyapatite Dome for Bone Neoformation in Rabbit Tibia
SO INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS
LA English
DT Article
DE bone neoformation; dome barrier; hydroxyapatite; osteoconduction
ID BETA-TRICALCIUM PHOSPHATE; FLUOROCHROME LABELS; SUBSTITUTES;
   REGENERATION; ALLOGRAFT; GRAFTS
AB Purpose: To evaluate supracortical bone neoformation with the use of hydroxyapatite (HA) hollow domes specially manufactured for osteogenesis promotion. Materials and Methods: Nine New Zealand rabbits were selected and 18 domes were placed, divided into three groups according to the iller: control (blood clot), vitamin complex, and particulate beta-tricalcium phosphate (beta-TCP). The healing period was 8 weeks, hence fluorescent markers were applied. After healing, the samples were embedded in resin to prepare slides for light and fluorescence microscopic evaluation of the amount of neoformed bone tissue. Energy dispersive spectroscopy was also used for chemical analysis of the material inside the domes. Results: The quality of neoformed bone tissue with active bone remodeling areas was observed. As a iller, beta-TCP showed higher bone formation (14.1%), better quality of neoformed bone tissue with organized structures, and an area of mineralized tissue in the dome. Bone neoformation inside the dome filled with blood clot confirmed the osteoconductive property of HA, as indicated by the migration of osteogenic cells from the blood clot, without the action of another biomaterial (mean area of bone formation for blood clot iller = 7.5%). Bone neoformation was not favored in samples filled with vitamin complex because of the difficulty of blood penetration through the material. Conclusion: HA domes performed well as a scaffold for bone neoformation over the cortical bone of rabbits, and this is based on maintenance of good stability and good integration with bone tissue. beta-TCP presented higher values of neoformed bone area compared with the blood clot. HA domes have osteoconductive properties, especially when filled with blood clot, because of the migration of osteogenic cells without action of any other biomaterial. In domes filled with vitamin complex, no bone formation was noted because of the absence of resorption.
C1 [Maeda, Nancy Tiaki] IPEN USP, Nucl & Energy Res Inst, Sao Paulo, SP, Brazil.
   [Yoshimoto, Marcelo; Allegrini Junior, Sergio] Univ Ibirapuera, Grad Masters Program Biodentistry, Sao Paulo, SP, Brazil.
   [Yoshimoto, Marcelo; Allegrini Junior, Sergio; de Almeida Bressiani, Ana Helena] IPEN USP, Nucl & Energy Res Inst, Dept Biomat, Sao Paulo, SP, Brazil.
RP Maeda, NT (reprint author), Av Prof Lineu Prestes,2242 Cidade Univ, BR-05508000 Sao Paulo, SP, Brazil.
EM nancymaeda@yahoo.com.br
RI Bressiani, Ana/I-1402-2012
CR Allegrini S, 2006, ANN ANAT, V188, P143, DOI 10.1016/j.aanat.2005.08.019
   Allegrini SJ, 2003, THESIS
   [Anonymous], 2009, 109935 ISO
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Beck TJ, 1997, THESIS
   BECKER W, 1994, J PERIODONTOL, V65, P1128, DOI 10.1902/jop.1994.65.12.1128
   Buser D, 2004, INT J ORAL MAX IMPL, V19, P43
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Horch HH, 2006, INT J ORAL MAX SURG, V35, P708, DOI 10.1016/j.ijom.2006.03.017
   ISO, 2012, ISO 10993 12 BIOL 12
   Jensen SS, 2009, INT J ORAL MAX IMPL, V24, P218
   Jensen SS, 2006, CLIN ORAL IMPLAN RES, V17, P237, DOI 10.1111/j.1600-0501.2005.01257.x
   KONIG JB, 2002, ANN ANAT, V184, P241
   LeGeros R Z, 1991, Monogr Oral Sci, V15, P1
   Lopes C. A. E, 2003, THESIS
   Maliska AM, 2013, SCANNING ELECT MICRO
   McAllister BS, 2007, J PERIODONTOL, V78, P377, DOI 10.1902/jop.2007.060048
   MELLONIG JT, 1992, J PERIODONTOL, V63, P979, DOI 10.1902/jop.1992.63.12.979
   NAGAHARA K, 1992, International Journal of Oral and Maxillofacial Implants, V7, P72
   Nasr HF, 1999, PERIODONTOL 2000, V19, P74, DOI 10.1111/j.1600-0757.1999.tb00148.x
   Nishimura I, 2004, CLIN ORAL IMPLAN RES, V15, P293, DOI 10.1111/j.1600-0501.2004.01001.x
   O'Brien FJ, 2002, J BIOMECH, V35, P523, DOI 10.1016/S0021-9290(01)00200-7
   Ribeiro C., 2003, THESIS
   Salles MB, 2007, THESIS
   Salles MB, 2001, THESIS
   Saska S, 2009, INT J ORAL MAX SURG, V38, P180, DOI 10.1016/j.ijom.2008.12.004
   Shermak MA, 1998, PLAST RECONSTR SURG, V102, P309, DOI 10.1097/00006534-199808000-00003
   Stevenson S, 1999, ORTHOP CLIN N AM, V30, P543, DOI 10.1016/S0030-5898(05)70107-3
   SUN TC, 1992, BONE, V13, P443, DOI 10.1016/8756-3282(92)90088-E
   van Gaalen SM, 2010, TISSUE ENG PART B-RE, V16, P209, DOI [10.1089/ten.teb.2009.0503, 10.1089/ten.TEB.2009.0503]
   Yoshimoto M, 2004, J ORAL MAXIL SURG, V62, P131, DOI 10.1016/j.joms.2004.03.011
   Zairopoulos GG, 2007, J PERIODONTOL, V78, P2216
   Zerbo IR, 2005, BIOMATERIALS, V26, P1445, DOI 10.1016/j.biomaterials.2004.05.003
   Zimmermann G, 2011, INJURY, V42, pS16, DOI 10.1016/j.injury.2011.06.199
NR 35
TC 0
Z9 0
U1 1
U2 5
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0882-2786
EI 1942-4434
J9 INT J ORAL MAX IMPL
JI Int. J. Oral Maxillofac. Implants
PD MAY-JUN
PY 2016
VL 31
IS 3
BP 571
EP 579
DI 10.11607/jomi.4412
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA DP8JF
UT WOS:000378743600016
PM 27183066
OA Bronze
DA 2018-10-20
ER

PT J
AU Di Lorenzo, A
   Bloise, N
   Meneghini, S
   Sureda, A
   Tenore, GC
   Visai, L
   Arciola, CR
   Daglia, M
AF Di Lorenzo, Arianna
   Bloise, Nora
   Meneghini, Silvia
   Sureda, Antoni
   Tenore, Gian Carlo
   Visai, Livia
   Arciola, Carla Renata
   Daglia, Maria
TI Effect of Winemaking on the Composition of Red Wine as a Source of
   Polyphenols for Anti-Infective Biomaterials
SO MATERIALS
LA English
DT Article
DE red wine; winemaking process; metabolite profiling; polyphenols;
   anti-infective biomaterials
ID STREPTOCOCCUS-MUTANS; GALLIC ACID; ANTIBACTERIAL ACTIVITY; NATURAL
   ANTIOXIDANTS; PHENOLIC COMPOSITION; MICRO-OXYGENATION; ORAL
   STREPTOCOCCI; RESVERATROL; BIOFILM; GRAPES
AB Biomaterials releasing bactericides have currently become tools for thwarting medical device-associated infections. The ideal anti-infective biomaterial must counteract infection while safeguarding eukaryotic cell integrity. Red wine is a widely consumed beverage to which many biological properties are ascribed, including protective effects against oral infections and related bone (osteoarthritis, osteomyelitis, periprosthetic joint infections) and cardiovascular diseases. In this study, fifteen red wine samples derived from grapes native to the Oltrepo Pavese region (Italy), obtained from the winemaking processes of "Bonarda dell'Oltrepo Pavese" red wine, were analyzed alongside three samples obtained from marc pressing. Total polyphenol and monomeric anthocyanin contents were determined and metabolite profiling was conducted by means of a chromatographic analysis. Antibacterial activity of wine samples was evaluated against Streptococcus mutans, responsible for dental caries, Streptococcus salivarius, and Streptococcus pyogenes, two oral bacterial pathogens. Results highlighted the winemaking stages in which samples exhibit the highest content of polyphenols and the greatest antibacterial activity. Considering the global need for new weapons against bacterial infections and alternatives to conventional antibiotics, as well as the favorable bioactivities of polyphenols, results point to red wine as a source of antibacterial substances for developing new anti-infective biomaterials and coatings for biomedical devices.
C1 [Di Lorenzo, Arianna; Meneghini, Silvia; Daglia, Maria] Univ Pavia, Dept Drug Sci, Med Chem & Pharmaceut Technol Sect, Vle Taramelli 12, I-27100 Pavia, Italy.
   [Bloise, Nora; Visai, Livia] Univ Pavia, UdR INSTM, CHT, Dept Mol Med, Viale Taramelli 3-b, I-27100 Pavia, Italy.
   [Sureda, Antoni] Univ Balearic Isl, Res Grp Community Nutr & Oxidat Stress, E-07122 Palma De Mallorca, Balearic Island, Spain.
   [Sureda, Antoni] Univ Balearic Isl, CIBEROBN Physiopathol Obes & Nutr, E-07122 Palma De Mallorca, Balearic Island, Spain.
   [Tenore, Gian Carlo] Univ Naples Federico II, Dept Pharmaceut & Toxicol Chem, Via D Montesano 49, I-80131 Naples, Italy.
   [Visai, Livia] S Maugeri Fdn, IRCCS, Dept Occupat Med Toxicol & Environm Risks, Via S Boezio 28, I-27100 Pavia, Italy.
   [Arciola, Carla Renata] Rizzoli Orthopaed Inst, Res Unit Implant Infect, Via Barbiano 1-10, I-40136 Bologna, Italy.
   [Arciola, Carla Renata] Univ Bologna, Dept Expt Diagnost & Specialty Med DIMES, Via San Giacomo 14, I-40126 Bologna, Italy.
RP Daglia, M (reprint author), Univ Pavia, Dept Drug Sci, Med Chem & Pharmaceut Technol Sect, Vle Taramelli 12, I-27100 Pavia, Italy.; Arciola, CR (reprint author), Rizzoli Orthopaed Inst, Res Unit Implant Infect, Via Barbiano 1-10, I-40136 Bologna, Italy.; Arciola, CR (reprint author), Univ Bologna, Dept Expt Diagnost & Specialty Med DIMES, Via San Giacomo 14, I-40126 Bologna, Italy.
EM arianna.dilorenzo01@universitadipavia.it; nora.bloise@unipv.it;
   silvia.meneghini01@universitadipavia.it; tosugo@hotmail.com;
   gctenore@unina.it; livia.visai@unipv.it; carlarenata.arciola@ior.it;
   maria.daglia@unipv.it
RI Sureda Gomila, Antonio/L-7191-2014; Bloise, Nora/M-5699-2016
OI Sureda Gomila, Antonio/0000-0003-2101-616X; Bloise,
   Nora/0000-0002-6000-5036; Daglia, Maria/0000-0002-4870-7713; ,
   Antoni/0000-0001-8656-6838
FU project entitled "Esperienze di Riso e Vino nella terra dei Longobardi e
   dei Visconti" [11527-3/12/2014]; Spanish Ministry of Health, Social
   Services and Equality [CIBEROBN-CB12/03/30038]; "5 per mille" grants for
   Health Research
FX The research leading to these results has received funding from the
   project entitled "Esperienze di Riso e Vino nella terra dei Longobardi e
   dei Visconti" approved by Regione Lombardia (Dds n. 11527-3/12/2014).
   The authors would like to thank the vineyard "I Doria di Montalto"
   (Montalto Pavese, PV) and especially Daniele Manini for providing wine
   samples and giving us technical support for writing the Materials and
   Method Section, and Alessandra Leoni for the collection of wine samples.
   Antoni Sureda was supported by the Spanish Ministry of Health, Social
   Services and Equality (CIBEROBN-CB12/03/30038). Carla Renata Arciola
   acknowledges the financial contribution of "5 per mille" grants for
   Health Research to the Rizzoli Orthopedic Institute of Bologna.
CR Altiok D, 2010, J MATER SCI-MATER M, V21, P2227, DOI 10.1007/s10856-010-4065-x
   [Anonymous], 2009, M07A10 CLIN LAB STAN
   Baiano A., 2015, CRIT REV FOOD SCI NU
   Bandela V, 2015, J CLIN DIAGN RES, V9, pZE01, DOI 10.7860/JCDR/2015/14275.6874
   Baranac JM, 1997, J AGR FOOD CHEM, V45, P1694, DOI 10.1021/jf9606114
   da Silva ACB, 2008, BRAZ J MICROBIOL, V39, P648, DOI 10.1590/S1517-83822008000400009
   Borazan AA, 2013, FOOD CHEM, V138, P389, DOI 10.1016/j.foodchem.2012.10.099
   Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089
   Carillo M., 2011, ELECTRON J BIOTECHN, V14, P7
   Castillo-Munoz N, 2007, J AGR FOOD CHEM, V55, P992, DOI 10.1021/jf062800k
   Choubey S, 2015, PHARM PAT ANAL, V4, P305, DOI [10.4155/PPA.15.14, 10.4155/ppa.15.14]
   Cote CD, 2015, NAT MED, V21, P498, DOI 10.1038/nm.3821
   Csiszar A, 2006, AM J PHYSIOL-HEART C, V291, pH1694, DOI 10.1152/ajpheart.00340.2006
   Daglia M, 2007, J AGR FOOD CHEM, V55, P5038, DOI 10.1021/jf070352q
   Daglia M, 2014, CURR PHARM BIOTECHNO, V15, P362, DOI 10.2174/138920101504140825120737
   Daglia M, 2012, CURR OPIN BIOTECH, V23, P174, DOI 10.1016/j.copbio.2011.08.007
   Moreira MD, 2011, J FOOD SCI, V76, pM54, DOI 10.1111/j.1750-3841.2010.01910.x
   Deng QA, 2011, J FOOD SCI, V76, pE309, DOI 10.1111/j.1750-3841.2011.02090.x
   Di Lorenzo A, 2016, MOL NUTR FOOD RES, V60, P566, DOI 10.1002/mnfr.201500567
   Duarte S, 2006, FEMS MICROBIOL LETT, V257, P50, DOI 10.1111/j.1574-6968.2006.00147.x
   Ehrlich GD, 2014, J APPL BIOMATER FUNC, V12, P13, DOI 10.5301/jabfm.5000203
   Escot S, 2001, AUST J GRAPE WINE R, V7, P153, DOI 10.1111/j.1755-0238.2001.tb00204.x
   Ferreira C, 2014, ANTIMICROB AGENTS CH, V58, P6197, DOI 10.1128/AAC.00093-14
   Frette XC, 2012, PLANTA MED, V78, P1281
   Ginjom IR, 2010, J AGR FOOD CHEM, V58, P10133, DOI 10.1021/jf100822n
   Giovinazzo G, 2015, PLANT FOOD HUM NUTR, V70, P454, DOI 10.1007/s11130-015-0518-1
   Gomez-Plaza E, 2011, FOOD CHEM, V125, P1131, DOI 10.1016/j.foodchem.2010.10.034
   Guo XF, 2012, MOLECULES, V17, P3794, DOI 10.3390/molecules17043794
   Haslam E, 1996, J NAT PROD, V59, P205, DOI 10.1021/np960040+
   Ivanova V, 2011, FOOD BIOPROCESS TECH, V4, P1512, DOI 10.1007/s11947-011-0566-y
   Cejudo-Bastante MJ, 2011, FOOD CHEM, V124, P727, DOI 10.1016/j.foodchem.2010.06.067
   KANNER J, 1994, J AGR FOOD CHEM, V42, P64, DOI 10.1021/jf00037a010
   Lachman J., 2009, INT J WINE RES, V101, P101
   Lagerweij MD, 2015, CURR ORAL HLTH REP, V2, P212
   Lee J, 2005, J AOAC INT, V88, P1269
   Leech MT, 2015, BEST PRACT RES CL RH, V29, P189, DOI 10.1016/j.berh.2015.03.001
   Leifert WR, 2008, NUTR RES, V28, P729, DOI 10.1016/j.nutres.2008.09.001
   Lemos JAC, 2005, CURR ISSUES MOL BIOL, V7, P95
   Leung E, 2011, B WORLD HEALTH ORGAN, V89, P390, DOI 10.2471/BLT.11.088435
   Lopez-Velez M, 2003, CRIT REV FOOD SCI, V43, P233, DOI 10.1080/10408690390826509
   Lupoae P, 2015, J OLEO SCI, V64, P1111, DOI 10.5650/jos.ess15023
   Malekinejad H, 2012, AVICENNA J PHYTOMEDI, V2, P188
   Marchese A, 2014, FOOD RES INT, V63, P182, DOI 10.1016/j.foodres.2014.01.036
   Mattivi F, 2002, ANN NY ACAD SCI, V957, P37, DOI 10.1111/j.1749-6632.2002.tb02904.x
   Mink PJ, 2007, AM J CLIN NUTR, V85, P895
   Moreno-Arribas MV, 2008, FOOD CHEM, V109, P149, DOI 10.1016/j.foodchem.2007.12.040
   Munoz-Gonzalez I, 2014, J AGR FOOD CHEM, V62, P4731, DOI 10.1021/jf501768p
   Nabavi SF, 2015, CURR MED CHEM, V22, P51
   Nabavi SF, 2015, CURR PHARM BIOTECHNO, V16, P891, DOI 10.2174/1389201016666150610160652
   Nabavi SF, 2015, NUTRIENTS, V7, P7729, DOI 10.3390/nu7095359
   Nabavi SM, 2015, FOOD CHEM, V173, P339, DOI 10.1016/j.foodchem.2014.10.042
   Nabavi SM, 2013, MOL CELL BIOCHEM, V372, P233, DOI 10.1007/s11010-012-1464-y
   Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011
   Percival RS, 2006, EUR J ORAL SCI, V114, P343, DOI 10.1111/j.1600-0722.2006.00386.x
   Pereira V, 2013, MOLECULES, V18, P2997, DOI 10.3390/molecules18032997
   Peroval C, 2002, J AGR FOOD CHEM, V50, P3977, DOI 10.1021/jf0116449
   Preserova J, 2015, J FOOD SCI TECH MYS, V52, P6405, DOI 10.1007/s13197-014-1644-8
   Ribereau-Gayon P., 1998, TRATTATO DI ENOLOGIA, VII
   Riihinen KR, 2014, FITOTERAPIA, V97, P78, DOI 10.1016/j.fitote.2014.05.012
   Sadat Sajadi Fatemeh, 2015, J Dent Res Dent Clin Dent Prospects, V9, P49, DOI 10.15171/joddd.2015.010
   Saini R, 2014, J FOOD SCI TECH MYS, V51, P3369, DOI 10.1007/s13197-012-0836-3
   SCALBERT A, 1991, PHYTOCHEMISTRY, V30, P3875, DOI 10.1016/0031-9422(91)83426-L
   Sileika TS, 2013, ANGEW CHEM INT EDIT, V52, P10766, DOI 10.1002/anie.201304922
   Soobrattee MA, 2006, BIOFACTORS, V27, P19, DOI 10.1002/biof.5520270103
   Vazquez ES, 2010, EUR FOOD RES TECHNOL, V231, P789, DOI 10.1007/s00217-010-1332-5
   Stauder M, 2010, J AGR FOOD CHEM, V58, P11662, DOI 10.1021/jf1031839
   Sun BS, 2011, J AGR FOOD CHEM, V59, P6550, DOI 10.1021/jf201383e
   van Loveren C, 2012, EUR J NUTR, V51, P15, DOI 10.1007/s00394-012-0323-7
   Zoellner H, 2011, SEMIN THROMB HEMOST, V37, P181, DOI 10.1055/s-0031-1273082
NR 69
TC 3
Z9 3
U1 3
U2 25
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD MAY
PY 2016
VL 9
IS 5
AR 316
DI 10.3390/ma9050316
PG 19
WC Materials Science, Multidisciplinary
SC Materials Science
GA DP6SG
UT WOS:000378628500011
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Edgar, L
   McNamara, K
   Wong, T
   Tamburrini, R
   Katari, R
   Orlando, G
AF Edgar, Lauren
   McNamara, Kyle
   Wong, Theresa
   Tamburrini, Riccardo
   Katari, Ravi
   Orlando, Giuseppe
TI Heterogeneity of Scaffold Biomaterials in Tissue Engineering
SO MATERIALS
LA English
DT Review
DE biomaterials; extracellular matrix scaffold; decellularized organs;
   natural polymer; synthetic polymer
ID MESENCHYMAL STEM-CELLS; REGENERATIVE MEDICINE APPROACH;
   GENTAMICIN-COLLAGEN SPONGE; HYALURONIC-ACID; BIOMEDICAL APPLICATIONS;
   CARTILAGE REGENERATION; ORGAN-TRANSPLANTATION; BIOLOGICAL-PROPERTIES;
   BONE REGENERATION; MATRIX SCAFFOLDS
AB Tissue engineering (TE) offers a potential solution for the shortage of transplantable organs and the need for novel methods of tissue repair. Methods of TE have advanced significantly in recent years, but there are challenges to using engineered tissues and organs including but not limited to: biocompatibility, immunogenicity, biodegradation, and toxicity. Analysis of biomaterials used as scaffolds may, however, elucidate how TE can be enhanced. Ideally, biomaterials should closely mimic the characteristics of desired organ, their function and their in vivo environments. A review of biomaterials used in TE highlighted natural polymers, synthetic polymers, and decellularized organs as sources of scaffolding. Studies of discarded organs supported that decellularization offers a remedy to reducing waste of donor organs, but does not yet provide an effective solution to organ demand because it has shown varied success in vivo depending on organ complexity and physiological requirements. Review of polymer-based scaffolds revealed that a composite scaffold formed by copolymerization is more effective than single polymer scaffolds because it allows copolymers to offset disadvantages a single polymer may possess. Selection of biomaterials for use in TE is essential for transplant success. There is not, however, a singular biomaterial that is universally optimal.
C1 [Edgar, Lauren; McNamara, Kyle; Wong, Theresa; Tamburrini, Riccardo; Katari, Ravi; Orlando, Giuseppe] Wake Forest Sch Med, 1 Med Ctr Blvd Winston Salem, Winston Salem, NC 27157 USA.
RP Orlando, G (reprint author), Wake Forest Sch Med, 1 Med Ctr Blvd Winston Salem, Winston Salem, NC 27157 USA.
EM laedgar@wakehealth.edu; kmcnamar@wakehealth.edu; twong@wakehealth.edu;
   rtamburr@wakehealth.edu; rkatari@wakehealth.edu; gorlando@wakehealth.edu
OI Edgar, Lauren/0000-0003-2923-7952; ORLANDO, GIUSEPPE/0000-0002-9584-6927
CR Ahn S, 2010, TISSUE ENG PART C-ME, V16, P813, DOI 10.1089/ten.tec.2009.0511
   Aladini F., 2016, J PEPT SCI
   Amiel GE, 2006, TISSUE ENG, V12, P2355, DOI 10.1089/ten.2006.12.2355
   Anisha BS, 2013, CARBOHYD POLYM, V92, P1470, DOI 10.1016/j.carbpol.2012.10.058
   Anitha A, 2009, CARBOHYD POLYM, V78, P672, DOI 10.1016/j.carbpol.2009.05.028
   Badylak SF, 2012, LANCET, V379, P943, DOI 10.1016/S0140-6736(12)60073-7
   Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743
   Bao J, 2011, CELL TRANSPLANT, V20, P753, DOI 10.3727/096368910X536572
   Batchelder CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143849
   Bennett-Guerrero E, 2010, JAMA-J AM MED ASSOC, V304, P755, DOI 10.1001/jama.2010.1152
   Bhrany AD, 2006, TISSUE ENG, V12, P319, DOI 10.1089/ten.2006.12.319
   Bottcher-Haberzeth S, 2010, BURNS, V36, P450, DOI 10.1016/j.burns.2009.08.016
   Bogan S.L., 2016, J CELL BIOCH
   Bolland F, 2007, BIOMATERIALS, V28, P1061, DOI 10.1016/j.biomaterials.2006.10.005
   Brown MB, 2005, J EUR ACAD DERMATOL, V19, P308, DOI 10.1111/j.1468-3083.2004.01180.x
   Caliari SR, 2011, BIOMATERIALS, V32, P8990, DOI 10.1016/j.biomaterials.2011.08.035
   Chahal S, 2015, RSC ADV, V5, P29497, DOI 10.1039/c4ra17087c
   Chen J, 2015, ACS APPL MATER INTER, V7, P28273, DOI 10.1021/acsami.5b10829
   Chen S, 2013, J MATER SCI, V48, P6567, DOI 10.1007/s10853-013-7453-z
   Chuang TH, 2009, TISSUE ENG PT A, V15, P2837, DOI [10.1089/ten.tea.2008.0394, 10.1089/ten.TEA.2008.0394]
   Claase MB, 2003, BIOMACROMOLECULES, V4, P57, DOI 10.1021/bm0256045
   Claase MB, 2003, J BIOMED MATER RES A, V64A, P291, DOI 10.1002/jbm.a.10418
   Connor RE, 2007, POLYM REV, V47, P9, DOI 10.1080/15583720601109552
   Cui L, 2009, BIOMATERIALS, V30, P2683, DOI 10.1016/j.biomaterials.2009.01.045
   Cullen LE, 2005, TREE PHYSIOL, V25, P563, DOI 10.1093/treephys/25.5.563
   Curran MP, 2010, DRUG AGING, V27, P925, DOI 10.2165/11205920-000000000-00000
   Dai WD, 2010, BIOMATERIALS, V31, P2141, DOI 10.1016/j.biomaterials.2009.11.070
   Dash TK, 2012, J CONTROL RELEASE, V158, P15, DOI 10.1016/j.jconrel.2011.09.064
   Del Gaudio C, 2014, J BIOMED MATER RES A, V102, P2427, DOI 10.1002/jbm.a.34883
   Deng CM, 2007, CARBOHYD POLYM, V69, P583, DOI 10.1016/j.carbpol.2007.01.014
   Domingues R.M.A., 2016, ADV HEALTHC MAT
   dos Santos KSCR, 2006, INT J PHARMACEUT, V310, P37, DOI 10.1016/j.ijpharm.2005.11.019
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Durselen L, 2001, J BIOMED MATER RES, V58, P666, DOI 10.1002/jbm.1067
   Ekholm E, 2005, ACTA BIOMATER, V1, P535, DOI 10.1016/j.actbio.2005.05.003
   Entcheva E, 2004, BIOMATERIALS, V25, P5753, DOI 10.1016/j.biomaterials.2004.01.024
   Fan HB, 2006, BIOMATERIALS, V27, P4573, DOI 10.1016/j.biomaterials.2006.04.013
   Ferretti M, 2006, TISSUE ENG, V12, P2657, DOI 10.1089/ten.2006.12.2657
   Fishman JM, 2013, P NATL ACAD SCI USA, V110, P14360, DOI 10.1073/pnas.1213228110
   Fratzl P., 2008, STRUCTURE MECH
   Galler K M, 2011, Adv Dent Res, V23, P333, DOI 10.1177/0022034511405326
   Gifford S, 2015, REGEN MED, V10, P913, DOI 10.2217/rme.15.60
   Hou QP, 2004, J MATER CHEM, V14, P1915, DOI 10.1039/b401791a
   Hsieh FY, 2015, BIOMATERIALS, V71, P48, DOI 10.1016/j.biomaterials.2015.08.028
   Isogai N, 2005, J BIOMED MATER RES A, V74A, P408, DOI 10.1002/jbm.a.30343
   Jacobs IN, 2016, LARYNGOSCOPE, V126, pS5, DOI 10.1002/lary.25676
   Jastrzebska K, 2015, REP PRACT ONCOL RADI, V20, P87, DOI 10.1016/j.rpor.2014.11.010
   Jayakumar R, 2011, BIOTECHNOL ADV, V29, P322, DOI 10.1016/j.biotechadv.2011.01.005
   Kang HW, 2016, NAT BIOTECHNOL, V34, P312, DOI 10.1038/nbt.3413
   Katari R, 2014, NEPHRON EXP NEPHROL, V126, P119, DOI 10.1159/000360684
   Katari Ravi S, 2014, Adv Surg, V48, P137
   Kavanaugh TE, 2016, J MATER SCI-MATER M, V27, DOI 10.1007/s10856-015-5654-5
   Keeley FW, 2002, PHILOS T R SOC B, V357, P185, DOI 10.1098/rstb.2001.1027
   Kew SJ, 2011, ACTA BIOMATER, V7, P3237, DOI 10.1016/j.actbio.2011.06.002
   Kim G, 2011, J MATER CHEM, V21, P6165, DOI 10.1039/c0jm03452e
   Kim J, 2008, INT J BIOL MACROMOL, V42, P41, DOI 10.1016/j.ijbiomac.2007.09.002
   Kim J, 2007, BIOMATERIALS, V28, P1830, DOI 10.1016/j.biomaterials.2006.11.050
   Kim KS, 2011, ACTA BIOMATER, V7, P666, DOI 10.1016/j.actbio.2010.09.030
   Kitahara H., 2016, INTERACT CARDIOVASC
   Kovalenko VI, 2010, RUSS CHEM REV+, V79, P231, DOI 10.1070/RC2010v079n03ABEH004065
   Kumar MS, 2010, J SURG RES, V158, P162, DOI 10.1016/j.jss.2008.07.006
   Kumbar SG, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/6/065005
   Kundu B, 2014, PROG POLYM SCI, V39, P251, DOI 10.1016/j.progpolymsci.2013.09.002
   Lai GJ, 2014, CARBOHYD POLYM, V111, P288, DOI 10.1016/j.carbpol.2014.04.094
   Hai LV, 2015, CELLULOSE, V22, P1789, DOI 10.1007/s10570-015-0633-z
   Leach JB, 2004, J BIOMED MATER RES A, V70A, P74, DOI 10.1002/jbm.a.30063
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Liao JF, 2014, J BIOMED NANOTECHNOL, V10, P3085, DOI 10.1166/jbn.2014.1934
   Liu XH, 2012, MACROMOL BIOSCI, V12, P911, DOI 10.1002/mabi.201100466
   Liu XH, 2011, NAT MATER, V10, P398, DOI [10.1038/NMAT2999, 10.1038/nmat2999]
   Lou T, 2013, INT J BIOL MACROMOL, V61, P353, DOI 10.1016/j.ijbiomac.2013.07.025
   Madhavan NK, 2010, BIORESOURCE TECHNOL, V101, P8493, DOI DOI 10.1016/J.BI0RTECH.2010.05.092
   Mahmood TA, 2006, J BIOMED MATER RES A, V79A, P216, DOI 10.1002/jbm.a.30830
   Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133
   Mazza G, 2015, SCI REP, V5
   Mendes SC, 2003, TISSUE ENG, V9, pS91, DOI 10.1089/10763270360697003
   Mirmalek-Sani A, 2013, BIOMATERIALS, V34, P5488
   Mironov V, 2003, TRENDS BIOTECHNOL, V21, P157, DOI 10.1016/S0167-7799(03)00033-7
   Muller FA, 2006, BIOMATERIALS, V27, P3955, DOI 10.1016/j.biomaterials.2006.02.031
   Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958
   Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004
   Neves SC, 2011, BIOMATERIALS, V32, P1068, DOI 10.1016/j.biomaterials.2010.09.073
   Nichols JE, 2012, J CELL BIOCHEM, V113, P2185, DOI 10.1002/jcb.24112
   No HK, 2002, INT J FOOD MICROBIOL, V74, P65, DOI 10.1016/S0168-1605(01)00717-6
   Nukavarapu SP, 2008, BIOMACROMOLECULES, V9, P1818, DOI 10.1021/bm800031t
   O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X
   O'Neill JD, 2013, ANN THORAC SURG, V96, P1046, DOI 10.1016/j.athoracsur.2013.04.022
   Oerlemans AJM, 2014, REGEN MED, V9, P113, DOI [10.2217/RME.13.89, 10.2217/rme.13.89]
   Orabi H., 2013, SCI WORLD J, V2013
   Orlando G, 2013, ANN SURG, V258, P221, DOI 10.1097/SLA.0b013e31829c79cf
   Orlando G, 2013, BIOMATERIALS, V34, P5915, DOI 10.1016/j.biomaterials.2013.04.033
   Orlando G, 2013, GUT, V62, P774, DOI 10.1136/gutjnl-2011-301111
   Orlando G, 2012, ANN SURG, V255, P867, DOI 10.1097/SLA.0b013e318243a4db
   Orlando G, 2011, TRANSPLANTATION, V91, P1310, DOI 10.1097/TP.0b013e318219ebb5
   Orlando Giuseppe, 2011, Transpl Int, V24, P223, DOI 10.1111/j.1432-2277.2010.01182.x
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Park H, 2007, BIOMATERIALS, V28, P3217, DOI 10.1016/j.biomaterials.2007.03.030
   Patterson J, 2010, BIOMATERIALS, V31, P6772, DOI 10.1016/j.biomaterials.2010.05.047
   Peloso A., 2015, ANN SURG
   Peloso A, 2015, TRANSPLANTATION, V99, P1807, DOI 10.1097/TP.0000000000000811
   Petrosyan A, 2015, CELLR4, V1, pe1401
   Polykandriotis E, 2010, J CELL MOL MED, V14, P2350, DOI 10.1111/j.1582-4934.2010.01169.x
   Rath S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141802
   Rhee SH, 2000, J MATER SCI-MATER M, V11, P449, DOI 10.1023/A:1008992009826
   Robertson MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090406
   Rolandi M, 2014, ADV COLLOID INTERFAC, V207, P216, DOI 10.1016/j.cis.2014.01.019
   Ryan AJ, 2015, BIOMATERIALS, V73, P296, DOI 10.1016/j.biomaterials.2015.09.003
   Saidi RF, 2012, WORLD J SURG, V36, P2909, DOI 10.1007/s00268-012-1748-0
   Salvatori M, 2015, XENOTRANSPLANTATION, V22, P1, DOI 10.1111/xen.12122
   Lopes MS, 2012, PROCEDIA ENGINEER, V42, P1402, DOI 10.1016/j.proeng.2012.07.534
   Scioli MG, 2016, J TISSUE ENG REGEN M
   Seeberger PH, 2003, CURR OPIN CHEM BIOL, V7, P715, DOI 10.1016/j.cbpa.2003.10.014
   Shin H, 2003, BIOMATERIALS, V24, P3201, DOI 10.1016/S0142-9612(03)00168-6
   Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833
   Singh N, 2016, NANOSCALE, V8, P8288, DOI 10.1039/c5nr06595j
   Smith MT, 2014, FEBS LETT, V588, P2755, DOI 10.1016/j.febslet.2014.05.062
   Song JJ, 2013, NAT MED, V19, P646, DOI 10.1038/nm.3154
   Soto-Gutierrez A, 2011, TISSUE ENG PART C-ME, V17, P677, DOI 10.1089/ten.tec.2010.0698
   Sreejalekshmi KG, 2011, J BIOMED MATER RES A, V96A, P477, DOI 10.1002/jbm.a.32980
   Steffens D, 2015, REGEN MED, V10, P975, DOI 10.2217/rme.15.58
   Sung HW, 1999, J BIOMED MATER RES, V46, P520
   Tan Aaron, 2013, Critical Reviews in Biomedical Engineering, V41, P495
   Tharanathan RN, 2003, CRIT REV FOOD SCI, V43, P61, DOI 10.1080/10408690390826455
   Thevenot PT, 2010, BIOMATERIALS, V31, P3997, DOI 10.1016/j.biomaterials.2010.01.144
   Thurber AE, 2015, BIOMATERIALS, V71, P145, DOI 10.1016/j.biomaterials.2015.08.039
   Toh WS, 2012, BIOMATERIALS, V33, P3835, DOI 10.1016/j.biomaterials.2012.01.065
   Tokareva O, 2014, ACTA BIOMATER, V10, P1612, DOI 10.1016/j.actbio.2013.08.020
   Totonelli G, 2012, BIOMATERIALS, V33, P3401, DOI 10.1016/j.biomaterials.2012.01.012
   Ueno H, 2001, ADV DRUG DELIVER REV, V52, P105, DOI 10.1016/S0169-409X(01)00189-2
   Ulery BD, 2011, J POLYM SCI POL PHYS, V49, P832, DOI 10.1002/polb.22259
   Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170
   Vacanti CA, 2006, TISSUE ENG, V12, P1137, DOI 10.1089/ten.2006.12.1137
   Varga M, 2014, ARCH MED SCI, V10, P283, DOI 10.5114/aoms.2014.42580
   Veit G, 2006, J BIOL CHEM, V281, P3494, DOI 10.1074/jbc.M509333200
   Vellayappan MV, 2015, INT J NANOMED, V10, P2785, DOI 10.2147/IJN.S80121
   Visscher D.O., 2016, TISSUE ENG C
   Wan YZ, 2007, MAT SCI ENG C-BIO S, V27, P855, DOI 10.1016/j.msec.2006.10.002
   Weber FE, 2002, INT J ORAL MAX SURG, V31, P60, DOI 10.1054/ijom.2001.0154
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Xu YD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120244
   Yagi H, 2013, CELL TRANSPLANT, V22, P231, DOI 10.3727/096368912X654939
   Yahyaei H, 2016, MAT SCI ENG C-MATER, V61, P293, DOI 10.1016/j.msec.2015.12.048
   Zambon Joao Paulo, 2014, World J Nephrol, V3, P24, DOI 10.5527/wjn.v3.i3.24
   Zant E, 2016, ACTA BIOMATER, V31, P80, DOI 10.1016/j.actbio.2015.12.014
   Zhang KX, 2015, BIOMATERIALS, V71, P24, DOI 10.1016/j.biomaterials.2015.08.037
   Zhong SP, 2005, BIOMACROMOLECULES, V6, P2998, DOI 10.1021/bm050318p
   Zhou H, 2012, ACTA BIOMATER, V8, P1999, DOI 10.1016/j.actbio.2012.01.031
NR 148
TC 5
Z9 5
U1 3
U2 60
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD MAY
PY 2016
VL 9
IS 5
AR 332
DI 10.3390/ma9050332
PG 21
WC Materials Science, Multidisciplinary
SC Materials Science
GA DP6SG
UT WOS:000378628500027
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Gallo, J
   Panacek, A
   Prucek, R
   Kriegova, E
   Hradilova, S
   Hobza, M
   Holinka, M
AF Gallo, Jiri
   Panacek, Ales
   Prucek, Robert
   Kriegova, Eva
   Hradilova, Sarka
   Hobza, Martin
   Holinka, Martin
TI Silver Nanocoating Technology in the Prevention of Prosthetic Joint
   Infection
SO MATERIALS
LA English
DT Review
DE prosthetic joint infection; biomaterial-associated infection;
   anti-adhesive; anti-biofilm; antibacterial surface treatment; silver
   nanocoating; silver nanoparticles
ID ANTIBACTERIAL MULTILAYER FILMS; DOPED HYDROXYAPATITE COATINGS;
   ORTHOPEDIC BIOFILM INFECTIONS; SURGICAL SITE INFECTIONS; GRAM-NEGATIVE
   BACTERIA; IN-VITRO CYTOTOXICITY; HUMAN HEPATOMA-CELLS;
   PSEUDOMONAS-AERUGINOSA; STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI
AB Prosthetic joint infection (PJI) is a feared complication of total joint arthroplasty associated with increased morbidity and mortality. There is a growing body of evidence that bacterial colonization and biofilm formation are critical pathogenic events in PJI. Thus, the choice of biomaterials for implanted prostheses and their surface modifications may significantly influence the development of PJI. Currently, silver nanoparticle (AgNP) technology is receiving much interest in the field of orthopaedics for its antimicrobial properties and a strong anti-biofilm potential. The great advantage of AgNP surface modification is a minimal release of active substances into the surrounding tissue and a long period of effectiveness. As a result, a controlled release of AgNPs could ensure antibacterial protection throughout the life of the implant. Moreover, the antibacterial effect of AgNPs may be strengthened in combination with conventional antibiotics and other antimicrobial agents. Here, our main attention is devoted to general guidelines for the design of antibacterial biomaterials protected by AgNPs, its benefits, side effects and future perspectives in PJI prevention.
C1 [Gallo, Jiri; Hobza, Martin; Holinka, Martin] Palacky Univ, Fac Med & Dent, Dept Orthopaed, IP Pavlova 6, Olomouc 77900, Czech Republic.
   [Panacek, Ales; Prucek, Robert; Hradilova, Sarka] Palacky Univ, Reg Ctr Adv Technol & Mat, Slechtitelu 27, Olomouc 78371, Czech Republic.
   [Kriegova, Eva] Palacky Univ, Fac Med & Dent, Dept Immunol, Hnevotinska 3, Olomouc 77900, Czech Republic.
RP Gallo, J (reprint author), Palacky Univ, Fac Med & Dent, Dept Orthopaed, IP Pavlova 6, Olomouc 77900, Czech Republic.
EM jiri.gallo@volny.cz; ales.panacek@upol.cz; robert.prucek@upol.cz;
   eva.kriegova@email.cz; sarka.hradilova@upol.cz; martinhobza@gmail.com;
   mholinka@seznam.cz
OI Hobza, Martin/0000-0002-2208-6189; Holinka, Martin/0000-0001-9180-4458;
   Gallo, Jiri/0000-0002-7424-8653
FU Ministry of Health of the Czech Republic [AZV VES 15-27726A]
FX Funding was obtained from the Ministry of Health of the Czech Republic
   (AZV VES 15-27726A).
CR Afkhami F, 2015, J DENT, V43, P1573, DOI 10.1016/j.jdent.2015.08.012
   Agarwala M, 2014, J BIOMED MATER RES B, V102, P1223, DOI 10.1002/jbm.b.33106
   Aggarwal VK, 2014, J KNEE SURG, V27, P399, DOI 10.1055/s-0033-1364102
   Ahmed RA, 2014, APPL SURF SCI, V292, P390, DOI 10.1016/j.apsusc.2013.11.150
   Albers CE, 2013, NANOTOXICOLOGY, V7, P30, DOI 10.3109/17435390.2011.626538
   Perez-Diaz MA, 2015, MAT SCI ENG C-MATER, V55, P360, DOI 10.1016/j.msec.2015.05.036
   Albrecht MA, 2006, GREEN CHEM, V8, P417, DOI 10.1039/b517131h
   Albrekt AS, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-5
   Ali K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131178
   Alijanipour P, 2014, J KNEE SURG, V27, P251, DOI 10.1055/s-0034-1376332
   Ammons MCB, 2011, INT WOUND J, V8, P268, DOI 10.1111/j.1742-481X.2011.00781.x
   An YH, 1996, J HOSP INFECT, V33, P93, DOI 10.1016/S0195-6701(96)90094-8
   An YH, 1996, J ORTHOPAED RES, V14, P846, DOI 10.1002/jor.1100140526
   Ansari MA, 2014, J BASIC MICROB, V54, P688, DOI 10.1002/jobm.201300748
   Antoci V, 2007, CLIN ORTHOP RELAT R, P81, DOI 10.1097/BLO.0b013e3181123a50
   Antoci V, 2007, J ORTHOP RES, V25, P858, DOI 10.1002/jor.20348
   Antonelli M, 2012, J HOSP INFECT, V82, P101, DOI 10.1016/j.jhin.2012.07.010
   Arciola CR, 2015, ADV EXP MED BIOL, V830, P29, DOI 10.1007/978-3-319-11038-7_2
   Arora S, 2009, TOXICOL APPL PHARM, V236, P310, DOI 10.1016/j.taap.2009.02.020
   Asare N, 2012, TOXICOLOGY, V291, P65, DOI 10.1016/j.tox.2011.10.022
   AshaRani PV, 2009, ACS NANO, V3, P279, DOI 10.1021/nn800596w
   Funez AA, 2013, TOXICOL MECH METHOD, V23, P153, DOI 10.3109/15376516.2012.762081
   Bai L, 2015, APPL SURF SCI, V355, P32, DOI 10.1016/j.apsusc.2015.07.064
   Bai Y, 2016, J MATER SCI-MATER M, V27, DOI 10.1007/s10856-015-5646-5
   Baker C, 2005, J NANOSCI NANOTECHNO, V5, P244, DOI 10.1166/jnn.2005.034
   Barros J, 2013, INT MICROBIOL, V16, P191, DOI 10.2436/20.1501.01.193
   Bedair H, 2015, CLIN ORTHOP RELAT R, V473, P2300, DOI 10.1007/s11999-015-4174-4
   Bellucci D, 2016, J BIOMED MATER RES A, V104, P1030, DOI 10.1002/jbm.a.35619
   Bemer P, 2014, J CLIN MICROBIOL, V52, P3583, DOI 10.1128/JCM.01459-14
   Benito N, 2014, J ORTHOP RES, V32, P633, DOI 10.1002/jor.22581
   Berend KR, 2013, CLIN ORTHOP RELAT R, V471, P510, DOI 10.1007/s11999-012-2595-x
   Bernthal NM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012580
   Besinis A, 2014, NANOTOXICOLOGY, V8, P745, DOI 10.3109/17435390.2013.825343
   Birla SS, 2009, LETT APPL MICROBIOL, V48, P173, DOI 10.1111/j.1472-765X.2008.02510.x
   Bock RM, 2015, ACTA BIOMATER, V26, P318, DOI 10.1016/j.actbio.2015.08.014
   Braem A, 2015, COLLOID SURFACE B, V126, P481, DOI 10.1016/j.colsurfb.2014.12.054
   Brennan SA, 2015, BONE JOINT J, V97B, P582, DOI 10.1302/0301-620X.97B5.33336
   Brown AN, 2012, APPL ENVIRON MICROB, V78, P2768, DOI 10.1128/AEM.06513-11
   Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528
   Busscher HJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002440
   Cabiscol E, 2000, INT MICROBIOL, V3, P3, DOI DOI 10.2436/IM.V3I1.9235
   Campoccia D, 2012, INT J ARTIF ORGANS, V35, P800, DOI 10.5301/ijao.5000140
   Cao HL, 2011, BIOMATERIALS, V32, P693, DOI 10.1016/j.biomaterials.2010.09.066
   Carlson C, 2008, J PHYS CHEM B, V112, P13608, DOI 10.1021/jp712087m
   Chagnot C, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00303
   Chairuangkitti P, 2013, TOXICOL IN VITRO, V27, P330, DOI 10.1016/j.tiv.2012.08.021
   Chan ELK, 2015, CLIN COSMET INVESTIG, V7, P65, DOI 10.2147/CCIDE.S68874
   Chen CY, 2008, MATER LETT, V62, P3607, DOI 10.1016/j.matlet.2008.04.008
   Chen XN, 2012, EUR CELLS MATER, V24, P237, DOI 10.22203/eCM.v024a17
   Chen XY, 2013, SURF COAT TECH, V216, P158, DOI 10.1016/j.surfcoat.2012.11.049
   Chen Y, 2011, APPL ENVIRON MICROB, V77, P5065, DOI 10.1128/AEM.00502-11
   Cheng H, 2014, J BIOMED MATER RES A, V102, P3488, DOI 10.1002/jbm.a.35019
   Chennell P, 2013, INT J PHARMACEUT, V455, P298, DOI 10.1016/j.ijpharm.2013.07.014
   Choi O, 2008, ENVIRON SCI TECHNOL, V42, P4583, DOI 10.1021/es703238h
   Choi OY, 2010, WATER RES, V44, P6095, DOI 10.1016/j.watres.2010.06.069
   Chua PH, 2008, BIOMATERIALS, V29, P1412, DOI 10.1016/j.biomaterials.2007.12.019
   Cipriano AF, 2014, J BIOMED NANOTECHNOL, V10, P2977, DOI 10.1166/jbn.2014.1927
   Corvec S, 2012, INT J ARTIF ORGANS, V35, P923, DOI 10.5301/ijao.5000168
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Costerton W, 2003, J CLIN INVEST, V112, P1466, DOI 10.1172/JCI20365
   Cui L, 2013, ANAL CHEM, V85, P5436, DOI 10.1021/ac400245j
   De Angelis G, 2015, INFECTION, V43, P629, DOI 10.1007/s15010-015-0806-6
   De Giglio E, 2013, ANAL BIOANAL CHEM, V405, P805, DOI 10.1007/s00216-012-6293-z
   De Matteis V, 2015, NANOMED-NANOTECHNOL, V11, P731, DOI 10.1016/j.nano.2014.11.002
   Della Valle C, 2012, INT J ARTIF ORGANS, V35, P864, DOI 10.5301/ijao.5000161
   Dong W, 2013, J NANOSCI NANOTECHNO, V13, P6782, DOI 10.1166/jnn.2013.7757
   Drago L, 2014, CLIN ORTHOP RELAT R, V472, P3311, DOI 10.1007/s11999-014-3558-1
   Drake PL, 2005, ANN OCCUP HYG, V49, P575, DOI 10.1093/annhyg/mei019
   Durgalakshmi D, 2015, J NANOSCI NANOTECHNO, V15, P4285, DOI 10.1166/jnn.2015.9724
   Dziendzikowska K, 2012, J APPL TOXICOL, V32, P920, DOI 10.1002/jat.2758
   Ehrlich GD, 2005, CLIN ORTHOP RELAT R, P59, DOI 10.1097/01.blo.0000175125.60214.a4
   Eichenberger EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141436
   Elizabeth E, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/11/115101
   Nunez-Anita RE, 2014, INT J NANOMED, V9, P3999, DOI 10.2147/IJN.S63064
   Esfandiari N, 2014, J BIOMED MATER RES A, V102, P2625, DOI 10.1002/jbm.a.34934
   Eto S., 2015, J ARTHROPLAST
   Fabrega J, 2009, ENVIRON SCI TECHNOL, V43, P9004, DOI 10.1021/es901706j
   Fayaz AM, 2010, NANOMED-NANOTECHNOL, V6, P103, DOI 10.1016/j.nano.2009.04.006
   Filova E, 2015, INT J NANOMED, V10, P7145, DOI 10.2147/IJN.S87474
   Florschutz AV, 2015, J AM ACAD ORTHOP SUR, V23, pS8, DOI 10.5435/JAAOS-D-14-00447
   Follmann HDM, 2012, BIOMACROMOLECULES, V13, P3711, DOI 10.1021/bm3011962
   Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161
   Franci G, 2015, MOLECULES, V20, P8856, DOI 10.3390/molecules20058856
   Frankova J., 2016, J APPL BIOMATER FUNC
   Fu JH, 2006, J BIOMED MATER RES A, V79A, P665, DOI 10.1002/jbm.a.30819
   Fufa O, 2015, BIOINTERFACE RES APP, V5, P1011
   Funao H, 2016, SCI REP-UK, V6, DOI 10.1038/srep23238
   Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010
   Galandakova A., 2015, HUM EXP TOXICOL
   Gallo J, 2008, NEW MICROBIOL, V31, P97
   Gallo J, 2014, INT J MOL SCI, V15, P13849, DOI 10.3390/ijms150813849
   Gao A, 2014, BIOMATERIALS, V35, P4223, DOI 10.1016/j.biomaterials.2014.01.058
   Gardner AB, 2013, BIOMED RES INT, DOI 10.1155/2013/732182
   Garza-Ocanas L, 2010, METALLOMICS, V2, P204, DOI 10.1039/b916107d
   Gatin L, 2015, ORTHOP TRAUMATOL-SUR, V101, P851, DOI 10.1016/j.otsr.2015.08.007
   Getzlaf MA, 2016, J ORTHOP RES, V34, P177, DOI 10.1002/jor.23068
   Ghosh S, 2015, J NANOMATER, DOI 10.1155/2015/562938
   Ghosh S, 2012, INT J NANOMED, V7, P483, DOI 10.2147/IJN.S24793
   Glinel K, 2012, ACTA BIOMATER, V8, P1670, DOI 10.1016/j.actbio.2012.01.011
   Gottenbos B, 2003, BIOMATERIALS, V24, P2707, DOI 10.1016/S0142-9612(03)00083-8
   Grainger DW, 2013, BIOMATERIALS, V34, P9237, DOI 10.1016/j.biomaterials.2013.08.043
   GRISTINA AG, 1989, MED PROG TECHNOL, V14, P205
   Guimond-Lischer S, 2016, BIOINTERPHASES, V11, DOI 10.1116/1.4943225
   Gupta A, 1999, NAT MED, V5, P183, DOI 10.1038/5545
   HAEFELI C, 1984, J BACTERIOL, V158, P389
   Haenle M, 2011, J MATER SCI-MATER M, V22, P381, DOI 10.1007/s10856-010-4204-4
   Harrasser N, 2015, AMB EXPRESS, V5, DOI 10.1186/s13568-015-0162-z
   He T, 2010, J BIOMED MATER RES A, V95A, P454, DOI 10.1002/jbm.a.32872
   Hickok NJ, 2012, ADV DRUG DELIVER REV, V64, P1165, DOI 10.1016/j.addr.2012.03.015
   Higgins DM, 2009, AM J PATHOL, V175, P161, DOI 10.2353/ajpath.2009.080962
   Hizal F, 2015, ACS APPL MATER INTER, V7, P20304, DOI 10.1021/acsami.5b05947
   Hoene A., 2013, BIOMED MAT, V8
   Holinka J, 2013, BONE JOINT J, V95B, P678, DOI 10.1302/0301-620X.95B5.31216
   Holzapfel BM, 2013, ADV DRUG DELIVER REV, V65, P581, DOI 10.1016/j.addr.2012.07.009
   Hsiao IL, 2015, ENVIRON SCI TECHNOL, V49, P3813, DOI 10.1021/es504705p
   Hu H, 2012, ACTA BIOMATER, V8, P904, DOI 10.1016/j.actbio.2011.09.031
   Huang WJ, 2013, INT J BIOL MACROMOL, V53, P26, DOI 10.1016/j.ijbiomac.2012.10.024
   Humphreys H, 2012, J HOSP INFECT, V81, P71, DOI 10.1016/j.jhin.2012.03.007
   Huotari K, 2015, ACTA ORTHOP, V86, P321, DOI 10.3109/17453674.2015.1035173
   Hussain S.M., 2004, P 13 INT WORKSH IN V, P975
   Hwang IS, 2012, J MED MICROBIOL, V61, P1719, DOI 10.1099/jmm.0.047100-0
   Illingworth Kenneth David, 2013, J Bone Joint Surg Am, V95, pe50, DOI 10.2106/JBJS.L.00596
   Ionita D, 2011, J BIOSCI BIOENG, V112, P630, DOI 10.1016/j.jbiosc.2011.07.022
   Ivanova EP, 2010, LANGMUIR, V26, P1973, DOI 10.1021/la902623c
   Jaiswal S, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-014-5367-1
   Johansson H, 2013, TOXICOL IN VITRO, V27, P1163, DOI 10.1016/j.tiv.2012.05.019
   Johansson H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-399
   Kamath AF, 2015, J ARTHROPLASTY, V30, P1492, DOI 10.1016/j.arth.2015.03.035
   Kapadia BH, 2016, LANCET, V387, P386, DOI 10.1016/S0140-6736(14)61798-0
   Kasemets K, 2014, TOXICOL LETT, V229, pS193, DOI 10.1016/j.toxlet.2014.06.657
   Kawata K, 2009, ENVIRON SCI TECHNOL, V43, P6046, DOI 10.1021/es900754q
   Keller L, 2015, MATERIALS, V8, P6863, DOI 10.3390/ma8105342
   Ketabchi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092080
   Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001
   Kim S, 2009, TOXICOL IN VITRO, V23, P1076, DOI 10.1016/j.tiv.2009.06.001
   Knetsch MLW, 2011, POLYMERS-BASEL, V3, P340, DOI 10.3390/polym3010340
   Koseki H, 2013, INT J NANOMED, V8, P593, DOI 10.2147/IJN.S39201
   Kremer AN, 2012, J CLIN MICROBIOL, V50, P3249, DOI 10.1128/JCM.00885-12
   Kurtz SM, 2012, J ARTHROPLASTY, V27, P61, DOI 10.1016/j.arth.2012.02.022
   Kvitek L, 2008, J PHYS CHEM C, V112, P5825, DOI 10.1021/jp711616v
   Kwon HB, 2009, ANN DERMATOL, V21, P308, DOI 10.5021/ad.2009.21.3.308
   Lara HH, 2010, WORLD J MICROB BIOT, V26, P615, DOI 10.1007/s11274-009-0211-3
   Laverty G, 2013, FUTURE MICROBIOL, V8, P509, DOI [10.2217/FMB.13.7, 10.2217/fmb.13.7]
   Lemcke Johannes, 2012, Acta Neurochir Suppl, V114, P347, DOI 10.1007/978-3-7091-0956-4_67
   Lemire JA, 2013, NAT REV MICROBIOL, V11, P371, DOI 10.1038/nrmicro3028
   LewisOscar F, 2015, BIOFOULING, V31, P379, DOI 10.1080/08927014.2015.1048686
   Li BY, 2011, CLIN ORTHOP RELAT R, V469, P3262, DOI 10.1007/s11999-010-1690-0
   Li P, 2005, NANOTECHNOLOGY, V16, P1912, DOI 10.1088/0957-4484/16/9/082
   Li WR, 2011, BIOMETALS, V24, P135, DOI 10.1007/s10534-010-9381-6
   Li WR, 2010, APPL MICROBIOL BIOT, V85, P1115, DOI 10.1007/s00253-009-2159-5
   Li XZ, 1997, J BACTERIOL, V179, P6127, DOI 10.1128/jb.179.19.6127-6132.1997
   Lindgren V, 2014, INFECT CONT HOSP EP, V35, P1491, DOI 10.1086/678600
   Liu JY, 2010, ACS NANO, V4, P6903, DOI 10.1021/nn102272n
   Liu W, 2010, NANOTOXICOLOGY, V4, P319, DOI 10.3109/17435390.2010.483745
   Liu Y., 2016, ACS NANO
   Liu YS, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/17/175501
   Loeschner K, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-18
   Lok CN, 2006, J PROTEOME RES, V5, P916, DOI 10.1021/pr0504079
   Ludecke C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084837
   Ma Z., 2015, INT ORTHOP
   Maoz G, 2015, CLIN ORTHOP RELAT R, V473, P453, DOI 10.1007/s11999-014-3780-x
   Markowska K, 2014, J MED MICROBIOL, V63, P849, DOI 10.1099/jmm.0.068833-0
   Martinez-Castanon GA, 2008, J NANOPART RES, V10, P1343, DOI 10.1007/s11051-008-9428-6
   Mastronardi E, 2014, SENSORS-BASEL, V14, P3156, DOI 10.3390/s140203156
   Mayr M, 2009, AM J KIDNEY DIS, V53, P890, DOI 10.1053/j.ajkd.2008.08.028
   McHugh SM, 2015, SURG-J R COLL SURG E, V13, P52, DOI 10.1016/j.surge.2014.10.003
   McMurray CL, 2015, J MED MICROBIOL, V64, P1489, DOI 10.1099/jmm.0.000182
   Mei SL, 2014, BIOMATERIALS, V35, P4255, DOI 10.1016/j.biomaterials.2014.02.005
   Mejia E, 2015, AORN J, V101, P213, DOI 10.1016/j.aorn.2014.03.017
   Min J, 2014, BIOMATERIALS, V35, P2507, DOI 10.1016/j.biomaterials.2013.12.009
   Mohanty S, 2012, NANOMED-NANOTECHNOL, V8, P916, DOI 10.1016/j.nano.2011.11.007
   Molleman B, 2015, LANGMUIR, V31, P13361, DOI 10.1021/acs.langmuir.5b03686
   Muhsin TM, 2014, WORLD J MICROB BIOT, V30, P2081, DOI 10.1007/s11274-014-1634-z
   Mukherjee SG, 2012, TOXICOL IN VITRO, V26, P238, DOI 10.1016/j.tiv.2011.12.004
   Muszanska AK, 2014, BIOMACROMOLECULES, V15, P2019, DOI 10.1021/bm500168s
   Naqvi SZH, 2013, INT J NANOMED, V8, DOI 10.2147/IJN.S49284
   Navratilova Z, 2012, TISSUE ANTIGENS, V80, P444, DOI 10.1111/tan.12001
   Necula BS, 2012, ACTA BIOMATER, V8, P4191, DOI 10.1016/j.actbio.2012.07.005
   Neoh KG, 2011, ACS APPL MATER INTER, V3, P2808, DOI 10.1021/am200646t
   Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2
   Nishitani K, 2015, J ORTHOP RES, V33, P1311, DOI 10.1002/jor.22907
   Norowski PA, 2011, IMPLANT DENT, V20, P56, DOI 10.1097/ID.0b013e3182087ac4
   Pajarinen J, 2014, J MATER CHEM B, V2, P7094, DOI [10.1039/c4tb01005a, 10.1039/C4TB01005A]
   Pal S, 2007, APPL ENVIRON MICROB, V73, P1712, DOI 10.1128/AEM.02218-06
   Palanisamy NK, 2014, J NANOBIOTECHNOL, V12, DOI 10.1186/1477-3155-12-2
   Panacek A., 2015, MOLECULES, V21
   Panacek A, 2006, J PHYS CHEM B, V110, P16248, DOI 10.1021/jp063826h
   Panacek A, 2016, COLLOID SURFACE B, V142, P392, DOI 10.1016/j.colsurfb.2016.03.007
   Panacek A, 2013, COLLOID SURFACE B, V110, P191, DOI 10.1016/j.colsurfb.2013.04.031
   Pandit V, 2013, TISSUE ENG PT A, V19, P2452, DOI [10.1089/ten.tea.2012.0644, 10.1089/ten.TEA.2012.0644]
   Park EJ, 2010, TOXICOL IN VITRO, V24, P872, DOI 10.1016/j.tiv.2009.12.001
   Park MVDZ, 2011, BIOMATERIALS, V32, P9810, DOI 10.1016/j.biomaterials.2011.08.085
   Parvizi J, 2007, EXPERT REV MED DEVIC, V4, P55, DOI 10.1586/17434440.4.1.55
   Pauksch L, 2014, ACTA BIOMATER, V10, P439, DOI 10.1016/j.actbio.2013.09.037
   Peulen TO, 2011, ENVIRON SCI TECHNOL, V45, P3367, DOI 10.1021/es103450g
   Poncin-Epaillard F, 2013, MAT SCI ENG C-MATER, V33, P1152, DOI 10.1016/j.msec.2012.12.020
   Potara M, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/13/135101
   Qin H, 2014, BIOMATERIALS, V35, P9114, DOI 10.1016/j.biomaterials.2014.07.040
   Rajiv S, 2015, INT FORUM ALLERGY RH, V5, P283, DOI 10.1002/alr.21459
   Rapsch K, 2014, BIOCONJUGATE CHEM, V25, P308, DOI 10.1021/bc4004469
   Ratner B. D., 2013, BIOMATERIALS SCI INT, P259
   Ratner B. D., 2013, BIOMATERIALS SCI INT, P588
   Renoud P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039367
   Rezapoor M, 2015, J ARTHROPLASTY, V30, P902, DOI 10.1016/j.arth.2015.02.044
   Richtera L, 2015, MATERIALS, V8, P2994, DOI 10.3390/ma8062994
   Rizzello L, 2014, CHEM SOC REV, V43, P1501, DOI 10.1039/c3cs60218d
   Roach P, 2007, J MATER SCI-MATER M, V18, P1263, DOI 10.1007/s10856-006-0064-3
   Rodriguez-Cano A, 2014, SURF COAT TECH, V245, P66, DOI 10.1016/j.surfcoat.2014.02.041
   Rodriguez-Valencia C, 2013, J BIOMED MATER RES A, V101, P853, DOI 10.1002/jbm.a.34387
   Romano CL, 2015, J ORTHOP SURG RES, V10, DOI 10.1186/s13018-015-0294-5
   Ruden S, 2009, ANTIMICROB AGENTS CH, V53, P3538, DOI 10.1128/AAC.01106-08
   Rujanapun N, 2015, TOXICOL IN VITRO, V29, P1982, DOI 10.1016/j.tiv.2015.08.005
   Saidin S, 2013, MAT SCI ENG C-MATER, V33, P4715, DOI 10.1016/j.msec.2013.07.026
   Saleh NB, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00677
   Sambale F., 2015, J NANOMATER
   Sathiyanarayanan G, 2013, COLLOID SURFACE B, V102, P13, DOI 10.1016/j.colsurfb.2012.07.032
   Scavone M, 2016, MATERIALS, V9, DOI 10.3390/ma9010037
   Scherr TD, 2014, METHODS MOL BIOL, V1106, P173, DOI 10.1007/978-1-62703-736-5_16
   Schlinkert P, 2015, J NANOBIOTECHNOL, V13, DOI 10.1186/s12951-014-0062-4
   Secinti KD, 2011, J CLIN NEUROSCI, V18, P391, DOI 10.1016/j.jocn.2010.06.022
   Shahbazzadeh D, 2011, IRAN J FISH SCI, V10, P487
   Shahverdi AR, 2007, NANOMED-NANOTECHNOL, V3, P168, DOI 10.1016/j.nano.2007.02.001
   Sharma VK, 2009, ADV COLLOID INTERFAC, V145, P83, DOI 10.1016/j.cis.2008.09.002
   Shchukin D, 2013, SCIENCE, V341, P1458, DOI 10.1126/science.1242895
   Shchukin DG, 2007, SMALL, V3, P926, DOI 10.1002/smll.200700064
   Shi YY, 2016, J MATER SCI-MATER M, V27, DOI 10.1007/s10856-015-5634-9
   Shida T, 2013, INT J NANOMED, V8, P3955, DOI 10.2147/IJN.S51994
   Silver S, 2003, FEMS MICROBIOL REV, V27, P341, DOI 10.1016/S0168-6445(03)00047-0
   Silver S, 2006, J IND MICROBIOL BIOT, V33, P627, DOI 10.1007/s10295-006-0139-7
   Singh AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025029
   Singh R, 2013, INT J NANOMED, V8, P4277, DOI 10.2147/IJN.S48913
   Smekalova M, 2016, VET J, V209, P174, DOI 10.1016/j.tvjl.2015.10.032
   Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012
   Spaan AN, 2013, ANNU REV MICROBIOL, V67, P629, DOI 10.1146/annurev-micro-092412-155746
   Stallard CP, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0031-0
   Stoehr LC, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-36
   Stoodley P., 2013, BIOMATERIALS SCI INT, P565
   Stoodley P, 2011, CURR ORTHOP PRACT, V22, P558, DOI 10.1097/BCO.0b013e318230efcf
   Sussman EM, 2015, J APPL TOXICOL, V35, P631, DOI 10.1002/jat.3104
   Taglietti A, 2014, BIOMATERIALS, V35, P1779, DOI 10.1016/j.biomaterials.2013.11.047
   Tan HL, 2013, INT J MOL SCI, V14, P1854, DOI 10.3390/ijms14011854
   Tande AJ, 2014, CLIN MICROBIOL REV, V27, P302, DOI 10.1128/CMR.00111-13
   Taraszkiewicz A, 2013, BIOMED RES INT, DOI 10.1155/2013/150653
   Thallinger B, 2013, BIOTECHNOL J, V8, P97, DOI 10.1002/biot.201200313
   Thevenot P, 2008, CURR TOP MED CHEM, V8, P270
   Thomas R, 2015, J PHOTOCH PHOTOBIO B, V149, P68, DOI 10.1016/j.jphotobiol.2015.04.034
   Thornley Patrick, 2015, CMAJ Open, V3, pE338, DOI 10.9778/cmajo.20150012
   Tian B, 2016, J MECH BEHAV BIOMED, V61, P345, DOI 10.1016/j.jmbbm.2016.04.002
   Tian XH, 2013, INT J NANOMED, V8, P2129, DOI [10.2147/IJN.S47488, 10.2147/IJN.S45742]
   Tran Phong A, 2011, Int J Nanomedicine, V6, P1553, DOI 10.2147/IJN.S21729
   Truong VK, 2010, BIOMATERIALS, V31, P3674, DOI 10.1016/j.biomaterials.2010.01.071
   Tsaras G, 2012, INFECT CONT HOSP EP, V33, P1207, DOI 10.1086/668421
   Tsuchiya H, 2012, J ORTHOP SCI, V17, P595, DOI 10.1007/s00776-012-0247-3
   Unosson E, 2015, ACTA BIOMATER, V11, P503, DOI 10.1016/j.actbio.2014.09.048
   van der Zande M, 2012, ACS NANO, V6, P7427, DOI 10.1021/nn302649p
   Vertelov GK, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/35/355707
   Vidlak D., 2016, INFECT IMMUN
   Voigt J, 2015, ANTIMICROB AGENTS CH, V59, P6696, DOI 10.1128/AAC.01331-15
   Wafa H, 2015, BONE JOINT J, V97B, P252, DOI 10.1302/0301-620X.97B2.34554
   Walter MS, 2014, DENT MATER, V30, P200, DOI 10.1016/j.dental.2013.11.006
   Wang JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082745
   Webster TJ, 2012, ACTA BIOMATER, V8, P4447, DOI 10.1016/j.actbio.2012.07.038
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Witso E, 2015, ACTA ORTHOP, V86, P277, DOI 10.3109/17453674.2015.1042320
   Wong CL, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00094
   Wu DM, 2014, J ENDODONT, V40, P285, DOI 10.1016/j.joen.2013.08.022
   Xie CM, 2014, ACS APPL MATER INTER, V6, P8580, DOI 10.1021/am501428e
   Xu HY, 2012, BIOMETALS, V25, P45, DOI 10.1007/s10534-011-9482-x
   Yang H, 2009, J APPL TOXICOL, V29, P69, DOI 10.1002/jat.1385
   Yazici H, 2016, ACS APPL MATER INTER, V8, P5070, DOI 10.1021/acsami.5b03697
   Yilmaz C, 2013, J BONE JOINT SURG AM, V95A, P117, DOI 10.2106/JBJS.K.01135
   Yu Q, 2015, ACTA BIOMATER, V16, P1, DOI 10.1016/j.actbio.2015.01.018
   Yu Q, 2013, ACS APPL MATER INTER, V5, P9295, DOI 10.1021/am4022279
   Yue C, 2015, EUR CELLS MATER, V29, P303, DOI 10.22203/eCM.v029a23
   Yue CX, 2015, J BIOMED MATER RES A, V103, P3590, DOI 10.1002/jbm.a.35502
   Yue CX, 2014, BIOMATERIALS, V35, P2580, DOI 10.1016/j.biomaterials.2013.12.036
   Zaborowska M., 2014, J BIOMED MAT RES B
   Zan XJ, 2010, BIOMACROMOLECULES, V11, P1082, DOI 10.1021/bm100048q
   Zhang M, 2016, ACS APPL MATER INTER, V8, P8834, DOI 10.1021/acsami.6b01396
   Zhang TL, 2014, YONSEI MED J, V55, P283, DOI 10.3349/ymj.2014.55.2.283
   Zhang XM, 2013, MAT SCI ENG C-MATER, V33, P2816, DOI 10.1016/j.msec.2013.03.010
   Zhao CJ, 2013, APPL SURF SCI, V280, P8, DOI 10.1016/j.apsusc.2013.04.057
   Zhao C, 2013, LANGMUIR, V29, P1517, DOI 10.1021/la304511s
   Zheng D, 2013, J COLLOID INTERF SCI, V406, P238, DOI 10.1016/j.jcis.2013.05.060
   Zhong X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146957
   Zhou B, 2014, COLLOID SURFACE B, V116, P432, DOI 10.1016/j.colsurfb.2014.01.016
   Zhou XD, 2015, GENE, V563, P76, DOI 10.1016/j.gene.2015.03.005
   Zhu H, 2014, CHEM COMMUN, V50, P3900, DOI 10.1039/c3cc47818a
   Zhu Y, 2015, J HOSP INFECT, V89, P82, DOI 10.1016/j.jhin.2014.10.008
   Zimmerli W, 2011, SEMIN IMMUNOPATHOL, V33, P295, DOI 10.1007/s00281-011-0275-7
   Zou J, 2014, J NANOBIOTECHNOL, V12, DOI 10.1186/s12951-014-0052-6
NR 291
TC 9
Z9 9
U1 4
U2 60
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD MAY
PY 2016
VL 9
IS 5
AR UNSP 337
DI 10.3390/ma9050337
PG 30
WC Materials Science, Multidisciplinary
SC Materials Science
GA DP6SG
UT WOS:000378628500032
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Pfeifer, CG
   Berner, A
   Koch, M
   Krutsch, W
   Kujat, R
   Angele, P
   Nerlich, M
   Zellner, J
AF Pfeifer, Christian G.
   Berner, Arne
   Koch, Matthias
   Krutsch, Werner
   Kujat, Richard
   Angele, Peter
   Nerlich, Michael
   Zellner, Johannes
TI Higher Ratios of Hyaluronic Acid Enhance Chondrogenic Differentiation of
   Human MSCs in a Hyaluronic Acid-Gelatin Composite Scaffold
SO MATERIALS
LA English
DT Article
DE composite scaffold; hyaluronic acid; gelatin; chondrogenesis; human
   mesenchymal stem cells
ID MESENCHYMAL STEM-CELLS; AUTOLOGOUS CHONDROCYTE IMPLANTATION;
   ARTICULAR-CARTILAGE REPAIR; PORE-SIZE; TISSUE; MATRIX; KNEE;
   TRANSPLANTATION; HYDROGELS; DEFECTS
AB Mesenchymal stem cells (MSCs) seeded on specific carrier materials are a promising source for the repair of traumatic cartilage injuries. The best supportive carrier material has not yet been determined. As natural components of cartilage's extracellular matrix, hyaluronic acid and collagen are the focus of biomaterial research. In order to optimize chondrogenic support, we investigated three different scaffold compositions of a hyaluronic acid (HA)-gelatin based biomaterial. Methods: Human MSCs (hMSCs) were seeded under vacuum on composite scaffolds of three different HA-gelatin ratios and cultured in chondrogenic medium for 21 days. Cell-scaffold constructs were assessed at different time points for cell viability, gene expression patterns, production of cartilage-specific extracellular matrix (ECM) and for (immuno-) histological appearance. The intrinsic transforming growth factor beta (TGF-beta) uptake of empty scaffolds was evaluated by determination of the TGF-beta concentrations in the medium over time. Results: No significant differences were found for cell seeding densities and cell viability. hMSCs seeded on scaffolds with higher ratios of HA showed better cartilage-like differentiation in all evaluated parameters. TGF-beta uptake did not differ between empty scaffolds. Conclusion: Higher ratios of HA support the chondrogenic differentiation of hMSCs seeded on a HA-gelatin composite scaffold.
C1 [Pfeifer, Christian G.; Berner, Arne; Koch, Matthias; Krutsch, Werner; Kujat, Richard; Angele, Peter; Nerlich, Michael; Zellner, Johannes] Univ Med CentreRegensburg, Dept Trauma Surg, Franz Josef Strauss Allee 11, D-93053 Regensburg, Germany.
   [Angele, Peter] Straubing Regensburg, Sporthopaedicum, Hildegard von Bingen Str 1, D-93053 Regensburg, Germany.
RP Pfeifer, CG (reprint author), Univ Med CentreRegensburg, Dept Trauma Surg, Franz Josef Strauss Allee 11, D-93053 Regensburg, Germany.
EM christian.pfeifer@ukr.de; arne.berner@ukr.de; matthias.koch@ukr.de;
   werner.krutsch@ukr.de; richard.kujat@ukr.de;
   peter.angele@sporthopaedicum.de; michael.nerlich@ukr.de;
   johannes.zellner@ukr.de
FU Clinic and Policlinic for Trauma Surgery, University Medical Center
   Regensburg
FX We want to highly acknowledge technical support of Daniela Drenkard.
   This study was funded by intramural funding of the Clinic and Policlinic
   for Trauma Surgery, University Medical Center Regensburg.
CR Al-Munajjed AA, 2008, J MATER SCI-MATER M, V19, P2859, DOI 10.1007/s10856-008-3422-5
   Angele P, 1999, TISSUE ENG, V5, P545, DOI 10.1089/ten.1999.5.545
   Angele P, 2008, J BIOMED MATER RES A, V85A, P445, DOI 10.1002/jbm.a.31480
   Angele P, 2009, J BIOMED MATER RES A, V91A, P416, DOI 10.1002/jbm.a.32236
   Basad E, 2010, KNEE SURG SPORT TR A, V18, P519, DOI 10.1007/s00167-009-1028-1
   BENEDETTI L, 1993, BIOMATERIALS, V14, P1154, DOI 10.1016/0142-9612(93)90160-4
   Bergemann C., 2015, INT J BIOMATER, V2015
   Bian LM, 2013, P NATL ACAD SCI USA, V110, P10117, DOI 10.1073/pnas.1214100110
   Bosserhoff AK, 2003, BIOMATERIALS, V24, P3229, DOI 10.1016/S0142-9612(03)00184-4
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Burdick JA, 2005, BIOMACROMOLECULES, V6, P386, DOI 10.1021/bm049508a
   Dienstknecht T, 2010, B EXP BIOL MED+, V150, P157, DOI 10.1007/s10517-010-1092-z
   Erickson IE, 2009, OSTEOARTHR CARTILAGE, V17, P1639, DOI 10.1016/j.joca.2009.07.003
   Erickson IE, 2012, ACTA BIOMATER, V8, P3027, DOI 10.1016/j.actbio.2012.04.033
   Filardo G, 2013, ARTHROSCOPY, V29, P174, DOI 10.1016/j.arthro.2012.05.891
   Grigolo B, 2001, BIOMATERIALS, V22, P2417, DOI 10.1016/S0142-9612(00)00429-4
   Harris JD, 2011, OSTEOARTHR CARTILAGE, V19, P779, DOI 10.1016/j.joca.2011.02.010
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Johnstone B, 2013, EUR CELLS MATER, V25, P248, DOI 10.22203/eCM.v025a18
   Kim IL, 2015, TISSUE ENG PT A, V21, P2680, DOI 10.1089/ten.tea.2015.0150
   Kim IL, 2011, BIOMATERIALS, V32, P8771, DOI 10.1016/j.biomaterials.2011.08.073
   KUJAWA MJ, 1986, DEV BIOL, V114, P504, DOI 10.1016/0012-1606(86)90214-9
   Lisignoli G, 2006, J BIOMED MATER RES A, V77A, P497, DOI 10.1002/jbm.a.30632
   Matsiko A, 2015, TISSUE ENG PT A, V21, P486, DOI [10.1089/ten.tea.2013.0545, 10.1089/ten.TEA.2013.0545]
   Mithoefer K, 2009, AM J SPORT MED, V37, P2053, DOI 10.1177/0363546508328414
   MOW VC, 1992, BIOMATERIALS, V13, P67, DOI 10.1016/0142-9612(92)90001-5
   Mueller MB, 2008, ARTHRITIS RHEUM-US, V58, P1377, DOI 10.1002/art.23370
   Nejadnik H, 2010, AM J SPORT MED, V38, P1110, DOI 10.1177/0363546509359067
   Niemeyer P, 2008, AM J SPORT MED, V36, P2091, DOI 10.1177/0363546508322131
   Nuernberger S, 2011, BIOMATERIALS, V32, P1032, DOI 10.1016/j.biomaterials.2010.08.100
   Park YD, 2003, BIOMATERIALS, V24, P893, DOI 10.1016/S0142-9612(02)00420-9
   Peterson L, 2003, J BONE JOINT SURG AM, V85A, P17, DOI 10.2106/00004623-200300002-00003
   Pietschmann MF, 2012, AM J SPORT MED, V40, P68, DOI 10.1177/0363546511424396
   Rutjes AWS, 2012, ANN INTERN MED, V157, P180, DOI 10.7326/0003-4819-157-3-201208070-00473
   Zellner J, 2015, ORTHOP RES REV, V7, P149, DOI 10.2147/ORR.S65569
   Zellner J, 2013, J BIOMED MATER RES B, V101, P1133, DOI 10.1002/jbm.b.32922
   Zellner J, 2010, J BIOMED MATER RES A, V94A, P1150, DOI 10.1002/jbm.a.32796
   Zhu H, 2006, STEM CELLS, V24, P928, DOI 10.1634/stemcells.2005-0186
NR 39
TC 5
Z9 5
U1 2
U2 8
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD MAY
PY 2016
VL 9
IS 5
AR 381
DI 10.3390/ma9050381
PG 15
WC Materials Science, Multidisciplinary
SC Materials Science
GA DP6SG
UT WOS:000378628500076
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Rokosz, K
   Hryniewicz, T
   Matysek, D
   Raaen, S
   Valicek, J
   Dudek, L
   Harnicarova, M
AF Rokosz, Krzysztof
   Hryniewicz, Tadeusz
   Matysek, Dalibor
   Raaen, Steinar
   Valicek, Jan
   Dudek, Lukasz
   Harnicarova, Marta
TI SEM, EDS and XPS Analysis of the Coatings Obtained on Titanium after
   Plasma Electrolytic Oxidation in Electrolytes Containing Copper Nitrate
SO MATERIALS
LA English
DT Article
DE titanium; plasma electrolytic oxidation (PEO); micro arc oxidation
   (MAO); copper nitrate; Scanning Electron Microscopy (SEM); Energy
   Dispersive X-ray Spectroscopy (EDS); X-ray Photoelectron Spectroscopy
   (XPS)
ID HIGH-CURRENT-DENSITY; MICRO-ARC OXIDATION; PURE TITANIUM;
   CORROSION-RESISTANCE; SURFACE MODIFICATION; STAINLESS-STEEL; SS
   BIOMATERIAL; ANTIBACTERIAL; CU; LAYERS
AB In the paper, the Scanning Electron Microscopy (SEM) with Energy Dispersive X-ray Spectroscopy (EDS) and X-ray Photoelectron Spectroscopy (XPS) results of the surface layer formed on pure titanium after plasma electrolytic oxidation (micro arc oxidation) at the voltage of 450 V are shown. As an electrolyte, the mixture of copper nitrate Cu(NO3)(2) (10-600 g/L) in concentrated phosphoric acid H3PO4 (98 g/mol) was used. The thickness of the obtained porous surface layer equals about 10 mu m, and it consists mainly of titanium phosphates and oxygen with embedded copper ions as a bactericidal agent. The maximum percent of copper in the PEO surface layer was equal to 12.2 +/- 0.7 wt % (7.6 +/- 0.5 at %), which is the best result that the authors obtained. The top surface layer of all obtained plasma electrolytic oxidation (PEO) coatings consisted most likely mainly of Ti-3(PO4)(4)center dot nH(3)PO(4) and Cu-3(PO4)(2)center dot nH(3)PO(4) with a small addition of CuP2, CuO and Cu2O.
C1 [Rokosz, Krzysztof; Hryniewicz, Tadeusz; Dudek, Lukasz] Koszalin Univ Technol, Fac Mech Engn, Div Surface Electrochem & Technol, Raclawicka 15-17, PL-75620 Koszalin, Poland.
   [Matysek, Dalibor] Koszalin Univ Technol, Fac Mech Engn, Div Surface Electrochem & Technol, Raclawicka 15-17, PL-75620 Koszalin, Poland.
   [Raaen, Steinar] VSB Tech Univ Ostrava, Fac Min & Geol, Inst Geol Engn, Ostrava 70833, Czech Republic.
   [Valicek, Jan; Harnicarova, Marta] Norwegian Univ Sci & Technol NTNU, Dept Phys, Realfagbygget E3-124,Hogskoleringen 5, NO-7491 Trondheim, Norway.
   [Valicek, Jan] VSB Tech Univ Ostrava, Fac Min & Geol, Inst Phys, Ostrava 70833, Czech Republic.
   [Valicek, Jan] VSB Tech Univ Ostrava, Fac Min & Geol, Inst Clean Technol Min & Utilizat Raw Mat Energy, Ostrava 70833, Czech Republic.
   VSB Tech Univ Ostrava, Fac Met & Mat Engn, Reg Mat Sci & Technol Ctr, Ostrava 70833, Czech Republic.
RP Hryniewicz, T (reprint author), Koszalin Univ Technol, Fac Mech Engn, Div Surface Electrochem & Technol, PL-75620 Koszalin, Poland.
EM rokosz@tu.koszalin.pl; Tadeusz.Hryniewicz@tu.koszalin.pl;
   dalibor.matysek@vsb.cz; steinar.raaen@ntnu.no; jan.valicek@vsb.cz;
   Lukasz.Dudek@tu.koszalin.pl; marta.harnicarova@vsb.cz
RI Dudek, Lukasz/R-3274-2016; Matysek, Dalibor/N-1737-2018
OI Matysek, Dalibor/0000-0002-1412-1079
FU Student Grant Competition (SGC) project [SP2016/94]; project of
   Institute of Clean Technologies for Mining and Utilization of Raw
   Materials for Energy Use [LO1406]; project Regional Materials Science
   and Technology Centre (RMTVC) [LO1203]
FX The plasma electrolytic oxidation (PEO) experiments on CP titanium Grade
   2 were performed at the Division of Surface Electrochemistry and
   Technology, Koszalin University of Technology, Poland. SEM and EDS were
   done at Vysoka skola banska-Technicka Univerzita Ostrava (VSB-TUO),
   Czech Republic; the research was elaborated partly in the framework of
   the project of Institute of Clean Technologies for Mining and
   Utilization of Raw Materials for Energy Use, Registration Number LO1406,
   the project Regional Materials Science and Technology Centre (RMTVC) No.
   LO1203 and Student Grant Competition (SGC) project SP2016/94. XPS
   studies were performed in the Department of Physics, Norges
   teknisk-naturvitenskapelige universitet (NTNU) Trondheim, Norway.
CR Aliasghari S, 2014, APPL SURF SCI, V316, P463, DOI 10.1016/j.apsusc.2014.08.037
   Baszkiewicz J, 2005, VACUUM, V78, P143, DOI 10.1016/j.vacuum.2005.01.017
   Biesinger MC, 2010, APPL SURF SCI, V257, P887, DOI 10.1016/j.apsusc.2010.07.086
   Hempel F, 2014, SURF COAT TECH, V256, P52, DOI 10.1016/j.surfcoat.2014.01.027
   Hryniewicz T, 2007, T I MET FINISH, V85, P325, DOI 10.1179/174591907X246537
   Hryniewicz T, 2012, APPL SURF SCI, V263, P357, DOI 10.1016/j.apsusc.2012.09.060
   Hryniewicz T, 2010, SURF COAT TECH, V204, P2583, DOI 10.1016/j.surfcoat.2010.02.005
   Hryniewicz T, 2015, MATERIALS, V8, P205, DOI 10.3390/ma8010205
   Hryniewicz T, 2014, FRONT MATER, DOI 10.3389/fmats.2014.00003
   Hryniewicz T, 2014, ANTI-CORROS METHOD M, V61, P57, DOI 10.1108/ACMM-03-2013-1249
   Hryniewicz T, 2012, MATER LETT, V83, P69, DOI 10.1016/j.matlet.2012.06.010
   Jelinek M, 2013, MAT SCI ENG C-MATER, V33, P1242, DOI 10.1016/j.msec.2012.12.018
   Krupa D, 2010, SURF COAT TECH, V205, P1743, DOI 10.1016/j.surfcoat.2010.05.015
   Laurindo CAH, 2014, MAT SCI ENG C-MATER, V37, P223, DOI 10.1016/j.msec.2014.01.006
   Mishra G, 2013, J ENVIRON CHEM ENG, V1, P1124, DOI 10.1016/j.jece.2013.08.031
   Park TE, 2013, SURF COAT TECH, V235, P706, DOI 10.1016/j.surfcoat.2013.08.051
   Rajendran A, 2014, RSC ADV, V4, P61444, DOI 10.1039/c4ra13107j
   Rokosz K., 2016, WORLD SCI NEWS, V35, P44
   Rokosz K, 2015, TEH VJESN, V22, P415, DOI 10.17559/TV-20140722110711
   Rokosz K, 2015, SURF INTERFACE ANAL, V47, P87, DOI 10.1002/sia.5676
   Rokosz K, 2014, TEH VJESN, V21, P799
   Rokosz K, 2014, TEH VJESN, V21, P533
   Rudnev VS, 2015, SURF COAT TECH, V269, P23, DOI 10.1016/j.surfcoat.2015.01.073
   Shin KR, 2011, J ALLOY COMPD, V509, pS478, DOI 10.1016/j.jallcom.2011.02.056
   Shin KR, 2010, MATER LETT, V64, P2714, DOI 10.1016/j.matlet.2010.08.069
   Simka W, 2013, ELECTROCHIM ACTA, V104, P518, DOI 10.1016/j.electacta.2012.10.130
   Simka W, 2011, ELECTROCHIM ACTA, V56, P8962, DOI 10.1016/j.electacta.2011.07.129
   Simka W, 2011, PRZEM CHEM, V90, P84
   Sowa M, 2013, ELECTROCHIM ACTA, V114, P627, DOI 10.1016/j.electacta.2013.10.047
   STATSOFT INC, 2011, STATISTICA DAT AN SO
   Stojadinovic S, 2013, APPL SURF SCI, V265, P226, DOI 10.1016/j.apsusc.2012.10.183
   Stojadinovic S, 2011, SURF COAT TECH, V206, P575, DOI 10.1016/j.surfcoat.2011.07.090
   Teker D, 2015, MAT SCI ENG C-MATER, V48, P579, DOI 10.1016/j.msec.2014.12.058
   Trujillo NA, 2012, MAT SCI ENG C-MATER, V32, P2135, DOI 10.1016/j.msec.2012.05.012
   Truong VK, 2010, BIOMATERIALS, V31, P3674, DOI 10.1016/j.biomaterials.2010.01.071
   Wagner C.D., NIST XRAY PHOTOELECT
   Yao XH, 2014, APPL SURF SCI, V292, P944, DOI 10.1016/j.apsusc.2013.12.083
   Yu S, 2011, T NONFERR METAL SOC, V21, P573, DOI 10.1016/S1003-6326(11)60753-X
   Zhang W, 2008, APPL SURF SCI, V254, P5216, DOI 10.1016/j.apsusc.2008.02.047
   Zhang XY, 2012, APPL SURF SCI, V258, P10058, DOI 10.1016/j.apsusc.2012.06.074
   Zhu W, 2013, J MATER SCI TECHNOL, V29, P237, DOI 10.1016/j.jmst.2012.12.015
NR 41
TC 18
Z9 18
U1 4
U2 60
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD MAY
PY 2016
VL 9
IS 5
AR 318
DI 10.3390/ma9050318
PG 12
WC Materials Science, Multidisciplinary
SC Materials Science
GA DP6SG
UT WOS:000378628500013
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Ravindranathan, S
   Koppolu, BP
   Smith, SG
   Zaharoff, DA
AF Ravindranathan, Sruthi
   Koppolu, Bhanu Prasanth
   Smith, Sean G.
   Zaharoff, David A.
TI Effect of Chitosan Properties on Immunoreactivity
SO MARINE DRUGS
LA English
DT Article
DE chitosan; immunoreactivity; endotoxin; immune response
ID ORAL INSULIN DELIVERY; DENDRITIC CELLS; DRUG-DELIVERY; MEDIATED
   STIMULATION; DEACETYLATED CHITIN; MACROPHAGE FUNCTION; ACTIVATION;
   DERIVATIVES; SCAFFOLDS; BIOCOMPATIBILITY
AB Chitosan is a widely investigated biopolymer in drug and gene delivery, tissue engineering and vaccine development. However, the immune response to chitosan is not clearly understood due to contradicting results in literature regarding its immunoreactivity. Thus, in this study, we analyzed effects of various biochemical properties, namely degree of deacetylation (DDA), viscosity/polymer length and endotoxin levels, on immune responses by antigen presenting cells (APCs). Chitosan solutions from various sources were treated with mouse and human APCs (macrophages and/or dendritic cells) and the amount of tumor necrosis factor- (TNF-) released by the cells was used as an indicator of immunoreactivity. Our results indicate that only endotoxin content and not DDA or viscosity influenced chitosan-induced immune responses. Our data also indicate that low endotoxin chitosan (<0.01 EU/mg) ranging from 20 to 600 cP and 80% to 97% DDA is essentially inert. This study emphasizes the need for more complete characterization and purification of chitosan in preclinical studies in order for this valuable biomaterial to achieve widespread clinical application.
C1 [Ravindranathan, Sruthi; Koppolu, Bhanu Prasanth; Smith, Sean G.; Zaharoff, David A.] Univ Arkansas, Dept Biomed Engn, Fayetteville, AR 72701 USA.
RP Zaharoff, DA (reprint author), Univ Arkansas, Dept Biomed Engn, Fayetteville, AR 72701 USA.
EM ravindra@uark.edu; bkoppolu@uark.edu; sgs004@uark.edu; zaharoff@uark.edu
OI Ravindranathan, Sruthi/0000-0003-0451-7931
FU NCI NIH HHS [K22 CA131567, R15 CA176648, R01 CA172631]
CR Agnihotri SA, 2004, J CONTROL RELEASE, V100, P5, DOI 10.1016/j.jconrel.2004.08.010
   Al Rubeaan K, 2016, EXPERT OPIN DRUG DEL, V13, P223, DOI 10.1517/17425247.2016.1107543
   Azab AK, 2007, J BIOMED MATER RES A, V83A, P414, DOI 10.1002/jbm.a.31256
   Bao HQ, 2011, SMALL, V7, P1569, DOI 10.1002/smll.201100191
   Barbosa JN, 2010, J BIOMED MATER RES A, V93A, P20, DOI 10.1002/jbm.a.32499
   Bhardwaj N, 2012, BIOMATERIALS, V33, P2848, DOI 10.1016/j.biomaterials.2011.12.028
   Bueter CL, 2011, J BIOL CHEM, V286, P35447, DOI 10.1074/jbc.M111.274936
   Casettari L, 2014, J CONTROL RELEASE, V190, P189, DOI 10.1016/j.jconrel.2014.05.003
   Charernsriwilaiwat N, 2012, INT J PHARMACEUT, V427, P379, DOI 10.1016/j.ijpharm.2012.02.010
   Chen CL, 2008, BIOMATERIALS, V29, P2173, DOI 10.1016/j.biomaterials.2008.01.023
   Dai TH, 2011, EXPERT REV ANTI-INFE, V9, P857, DOI [10.1586/ERI.11.59, 10.1586/eri.11.59]
   Dang QF, 2016, CARBOHYD POLYM, V136, P516, DOI 10.1016/j.carbpol.2015.09.084
   Dang YB, 2011, CARBOHYD POLYM, V83, P1075, DOI 10.1016/j.carbpol.2010.08.071
   Feng J, 2004, BIOCHEM BIOPH RES CO, V317, P414, DOI 10.1016/j.bbrc.2004.03.048
   Gan Q, 2007, COLLOID SURFACE B, V59, P24, DOI 10.1016/j.colsurfb.2007.04.009
   Han YP, 2005, INT IMMUNOPHARMACOL, V5, P1533, DOI 10.1016/j.intimp.2005.04.015
   INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693
   Jana S, 2012, J MATER CHEM, V22, P6291, DOI [10.1039/C2JM16676C, 10.1039/c2jm16676c]
   Koppolu BP, 2014, BIOMATERIALS, V35, P4382, DOI 10.1016/j.biomaterials.2014.01.078
   Koppolu B, 2013, BIOMATERIALS, V34, P2359, DOI 10.1016/j.biomaterials.2012.11.066
   Kumar M, 2002, HUM GENE THER, V13, P1415, DOI 10.1089/10430340260185058
   Kweon DK, 2003, BIOMATERIALS, V24, P1595, DOI 10.1016/S0142-9612(02)00566-5
   Levengood SKL, 2014, J MATER CHEM B, V2, P3161, DOI 10.1039/c4tb00027g
   Lieder R, 2013, ACTA BIOMATER, V9, P4771, DOI 10.1016/j.actbio.2012.08.043
   Lih E, 2012, ACTA BIOMATER, V8, P3261, DOI 10.1016/j.actbio.2012.05.001
   Lu HD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084703
   Luo YC, 2014, INT J BIOL MACROMOL, V64, P353, DOI 10.1016/j.ijbiomac.2013.12.017
   Mao SR, 2004, INT J PHARM, V281, P45, DOI 10.1016/j.ijpharm.2004.05.019
   Mehrotra A, 2011, CHEM PHARM BULL, V59, P315, DOI 10.1248/cpb.59.315
   MORRISON DC, 1978, AM J PATHOL, V93, P526
   Moura LIF, 2014, ACTA BIOMATER, V10, P843, DOI 10.1016/j.actbio.2013.09.040
   Mukhopadhyay P, 2014, CARBOHYD POLYM, V112, P627, DOI 10.1016/j.carbpol.2014.06.045
   Nettles DL, 2002, TISSUE ENG, V8, P1009, DOI 10.1089/107632702320934100
   NISHIMURA K, 1986, VACCINE, V4, P151, DOI 10.1016/0264-410X(86)90002-2
   NISHIMURA K, 1987, VACCINE, V5, P136, DOI 10.1016/0264-410X(87)90061-2
   Park JH, 2010, ADV DRUG DELIVER REV, V62, P28, DOI 10.1016/j.addr.2009.10.003
   PELUSO G, 1994, BIOMATERIALS, V15, P1215, DOI 10.1016/0142-9612(94)90272-0
   Raftery R, 2013, MOLECULES, V18, P5611, DOI 10.3390/molecules18055611
   Risbud MV, 2000, J CONTROL RELEASE, V68, P23, DOI 10.1016/S0168-3659(00)00208-X
   Riva R, 2011, ADV POLYM SCI, V244, P19, DOI 10.1007/12_2011_137
   Ruel-Gariepy E, 2002, J CONTROL RELEASE, V82, P373, DOI 10.1016/S0168-3659(02)00146-3
   Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555
   Smith SG, 2015, CANCER IMMUNOL IMMUN, V64, P689, DOI 10.1007/s00262-015-1672-x
   SUZUKI K, 1984, MICROBIOL IMMUNOL, V28, P903, DOI 10.1111/j.1348-0421.1984.tb00746.x
   van der Lubben IM, 2001, EUR J PHARM SCI, V14, P201, DOI 10.1016/S0928-0987(01)00172-5
   VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270
   Vasiliev YM, 2015, EXPERT REV VACCINES, V14, P37, DOI 10.1586/14760584.2015.956729
   Villiers C, 2009, MOL CELL PROTEOMICS, V8, P1252, DOI 10.1074/mcp.M800589-MCP200
   Vo JL, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/21624011.2014.968001
   Wang BL, 2012, CARBOHYD POLYM, V90, P8, DOI 10.1016/j.carbpol.2012.03.080
   Yao WJ, 2013, MOL PHARMACEUT, V10, P2904, DOI 10.1021/mp4000053
   Yuan YL, 2011, MATERIALS, V4, P1399, DOI 10.3390/ma4081399
NR 52
TC 8
Z9 8
U1 1
U2 11
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1660-3397
J9 MAR DRUGS
JI Mar. Drugs
PD MAY
PY 2016
VL 14
IS 5
AR 91
DI 10.3390/md14050091
PG 12
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA DO7RV
UT WOS:000377981400010
PM 27187416
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Kadakia, PU
   Jain, E
   Hixon, KR
   Eberlin, CT
   Sell, SA
AF Kadakia, P. U.
   Jain, E.
   Hixon, K. R.
   Eberlin, C. T.
   Sell, S. A.
TI Sonication induced silk fibroin cryogels for tissue engineering
   applications
SO MATERIALS RESEARCH EXPRESS
LA English
DT Article
DE cryogel; silk fibroin; ultrasonication; tissue engineering; scaffold
ID BIOCOMPOSITE CRYOGELS; SCAFFOLDS; PROTEIN; BIOMATERIAL; TRANSITION;
   ULTRASOUND; MORPHOLOGY; BEHAVIOR; GELATION
AB In this study, we report a method to form macroporous silk fibroin (SF) scaffolds through a combination of ultrasonication followed by cryogelation at subzero temperatures. The resultant sonication induced SF cryogels encompassed larger pore sizes (151 +/- 56 mu m) and higher mechanical stability (127.15 +/- 24.71 kPa) than their hydrogel counterparts made at room temperature. Furthermore, the addition of dopants like Manuka honey and bone char in SF cryogels did not affect cryogel synthesis but decreased the pore size in a concentration dependent manner. With no crack propagation at 50% strain and promising stability under cyclic loads, mineralization and cellular infiltration potential were analyzed for bone tissue engineering purposes. Although the scaffolds showed limited mineralization, encouraging cellular infiltration results yield promise for other tissue engineering applications. The use of mild processing conditions, a simplistic procedure, and the lack of organic solvents or chemical cross-linkers renders the combination of sonication and cryogelation as an attractive fabrication technique for 3D SF macroporous scaffolds.
C1 [Kadakia, P. U.; Jain, E.; Hixon, K. R.; Eberlin, C. T.; Sell, S. A.] St Louis Univ, Dept Biomed Engn, St Louis, MO 63103 USA.
RP Sell, SA (reprint author), St Louis Univ, Dept Biomed Engn, St Louis, MO 63103 USA.
EM ssell@slu.edu
OI Hixon, Katherine/0000-0002-3094-5537
CR Ak F, 2013, BIOMACROMOLECULES, V14, P719, DOI 10.1021/bm3018033
   Bardelang D, 2008, J AM CHEM SOC, V130, P3313, DOI 10.1021/ja711342y
   Barthes J, 2014, BIOMED RES INT, DOI 10.1155/2014/921905
   Chen X, 2007, PROTEINS, V68, P223, DOI 10.1002/prot.21414
   Dragan ES, 2015, METHODS MOL BIOL, V1286, P239, DOI 10.1007/978-1-4939-2447-9_20
   Giesche H, 2006, PART PART SYST CHAR, V23, P9, DOI 10.1002/ppsc.200601009
   ISHIDA M, 1990, MACROMOLECULES, V23, P88, DOI 10.1021/ma00203a017
   Jain E, 2013, NAT PROTOC, V8, P821, DOI 10.1038/nprot.2013.027
   Jiang P, 2006, MATER LETT, V60, P919, DOI 10.1016/j.matlet.2005.10.056
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Kathuria N, 2009, ACTA BIOMATER, V5, P406, DOI 10.1016/j.actbio.2008.07.009
   Kim BS, 1999, NAT BIOTECHNOL, V17, P979, DOI 10.1038/13671
   Kim U J, 2005, BIOMATERIALS, V26, P2775, DOI DOI 10.1016/J.BIOMATERIALS.2004.07.044
   Kumar A, 2010, MATER TODAY, V13, P42, DOI 10.1016/S1369-7021(10)70202-9
   Kundu B, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/5/055003
   Kwon SM, 2009, J NANOSCI NANOTECHNO, V9, P7204, DOI 10.1166/jnn.2009.1616
   Li MZ, 2002, POLYM ADVAN TECHNOL, V13, P605, DOI 10.1002/pat.159
   Li MZ, 2001, J APPL POLYM SCI, V79, P2192, DOI 10.1002/1097-4628(20010321)79:12<2192::AID-APP1027>3.0.CO;2-0
   Lozinsky VI, 2001, BIOSEPARATION, V10, P163, DOI 10.1023/A:1016386902611
   Lu Q, 2011, ACTA BIOMATER, V7, P2394, DOI 10.1016/j.actbio.2011.02.032
   Lusby P E, 2002, J Wound Ostomy Continence Nurs, V29, P295, DOI 10.1067/mjw.2002.129073
   Mandal BB, 2008, MACROMOL BIOSCI, V8, P807, DOI 10.1002/mabi.200800113
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   Mishra R, 2014, J COLLOID INTERF SCI, V431, P139, DOI 10.1016/j.jcis.2014.05.040
   Mishra R, 2011, J BIOMAT SCI-POLYM E, V22, P2107, DOI 10.1163/092050610X534230
   Mo CL, 2009, BIOMACROMOLECULES, V10, P2724, DOI 10.1021/bm900452u
   Mottaghitalab F, 2015, J CONTROL RELEASE, V215, P112, DOI 10.1016/j.jconrel.2015.07.031
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Oyane A, 2003, J BIOMED MATER RES A, V65, P188
   Paulusse JMJ, 2006, J POLYM SCI POL CHEM, V44, P5445, DOI 10.1002/pola.21646
   Rezaee A, 2009, B ENVIRON CONTAM TOX, V82, P732, DOI 10.1007/s00128-009-9690-z
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Rnjak-Kovacina J, 2015, ACS BIOMATER SCI ENG, V1, P260, DOI 10.1021/ab500149p
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Rodriguez Isaac A, 2013, Cells, V2, P244, DOI 10.3390/cells2020244
   Rodriguez IA, 2012, INT J BIOMATER, DOI 10.1155/2012/159484
   Samal SK, 2013, MACROMOL MATER ENG, V298, P1201, DOI 10.1002/mame.201200377
   Tamada Y, 2005, BIOMACROMOLECULES, V6, P3100, DOI 10.1021/bm050431f
   Tretinnikov ON, 2001, LANGMUIR, V17, P7406, DOI 10.1021/la010791y
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang XQ, 2008, BIOMATERIALS, V29, P1054, DOI 10.1016/j.biomaterials.2007.11.003
   Yan LP, 2012, ACTA BIOMATER, V8, P289, DOI 10.1016/j.actbio.2011.09.037
   YOSHIMIZU H, 1990, J APPL POLYM SCI, V40, P127, DOI 10.1002/app.1990.070400111
   Yucel T, 2009, BIOPHYS J, V97, P2044, DOI 10.1016/j.bpj.2009.07.028
NR 45
TC 6
Z9 6
U1 6
U2 28
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 2053-1591
J9 MATER RES EXPRESS
JI Mater. Res. Express
PD MAY
PY 2016
VL 3
IS 5
AR 055401
DI 10.1088/2053-1591/3/5/055401
PG 15
WC Materials Science, Multidisciplinary
SC Materials Science
GA DO5GT
UT WOS:000377812300025
DA 2018-10-20
ER

PT J
AU Witherel, CE
   Graney, PL
   Freytes, DO
   Weingarten, MS
   Spiller, KL
AF Witherel, Claire E.
   Graney, Pamela L.
   Freytes, Donald O.
   Weingarten, Michael S.
   Spiller, Kara L.
TI Response of human macrophages to wound matrices in vitro
SO WOUND REPAIR AND REGENERATION
LA English
DT Article
ID CROSS-LINKING; SKIN WOUNDS; PHENOTYPE; SCAFFOLDS; CELLS;
   VASCULARIZATION; REGENERATION; SPONGES; REPAIR; MODEL
AB Chronic wounds remain a major burden to the global healthcare system. Myriad wound matrices are commercially available but their mechanisms of action are poorly understood. Recent studies have shown that macrophages are highly influenced by their microenvironment, but it is not known how different biomaterials affect this interaction. Here, it was hypothesized that human macrophages respond differently to changes in biomaterial properties in vitro with respect to phenotype, including pro-inflammatory M1, anti-inflammatory M2a, known for facilitating extracellular matrix deposition and proliferation, and M2c, which has recently been associated with tissue remodeling. Using multiple donors, it was found that collagen scaffolds cross-linked with 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide and N-hydroxysuccinimide (EDC/NHS) promoted the least inflammatory phenotype in primary human macrophages compared with scaffolds cross-linked with formaldehyde or glutaraldehyde. Importantly, gene expression analysis trends were largely conserved between donors, especially TNFa (M1), CCL22 (M2a), and MRC1 (M2a). Then the response of primary and THP1 monocyte-derived macrophages to four commercially available wound matrices were comparedIntegra Dermal Regeneration Template (Integra), PriMatrix Dermal Repair Scaffold (PriMatrix), AlloMend Acellular Dermal Matrix (AlloMend), and Oasis Wound Matrix (Oasis). Gene expression trends were different between primary and THP1 monocyte-derived macrophages for all six genes analyzed in this study. Finally, the behavior of primary macrophages cultured onto the wound matrices over time was analyzed. Integra and Oasis caused down-regulation of M2a markers CCL22 and TIMP3. PriMatrix caused up-regulation of TNFa (M1) and CD163 (M2c) and down-regulation of CCL22 and TIMP3 (both M2a). AlloMend caused up-regulation in CD163 (M2c). Lastly, Oasis promoted the largest increase in the combinatorial M1/M2 score, defined as the sum of M1 genes divided by the sum of M2 genes. This preliminary study suggested that biomaterials influenced the wound microenvironment to affect macrophage phenotype.
C1 [Witherel, Claire E.; Graney, Pamela L.; Spiller, Kara L.] Drexel Univ, Sch Biomed Engn, Biomat & Regenerat Med Lab, Philadelphia, PA 19104 USA.
   [Freytes, Donald O.] New York Stem Cell Fdn, New York, NY USA.
   [Freytes, Donald O.] Univ N Carolina, Joint Dept Biomed Engn, Chapel Hill, NC 27599 USA.
   [Freytes, Donald O.] N Carolina State Univ, Raleigh, NC 27695 USA.
   [Weingarten, Michael S.] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA.
RP Spiller, KL (reprint author), Drexel Univ, Sch Biomed Engn, Biomat & Regenerat Med Lab, Philadelphia, PA 19104 USA.
EM spiller@drexel.edu
FU Integra LifeSciences
FX CEW would like to thank to Integra LifeSciences for their generous
   support via the Integra LifeSciences Doctoral Scholarship. Additionally,
   the authors would like to thank Justin Levrock for his technical
   assistance with SEM, and Bryan Vayda and Timothy Brockman for training
   and assistance with residual testing.
CR BORATYNSKI J, 1990, ANAL BIOCHEM, V184, P259, DOI 10.1016/0003-2697(90)90677-2
   Brown BN, 2012, ACTA BIOMATER, V8, P978, DOI 10.1016/j.actbio.2011.11.031
   Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010
   Haugh MG, 2011, TISSUE ENG PT A, V17, P1201, DOI [10.1089/ten.tea.2010.0590, 10.1089/ten.TEA.2010.0590]
   Hermanson GT, 2013, BIOCONJUGATE TECHNIQUES, 3RD EDITION, P229, DOI 10.1016/B978-0-12-382239-0.00003-0
   Knipper JA, 2015, IMMUNITY, V43, P803, DOI 10.1016/j.immuni.2015.09.005
   Kuijpers AT, 1982, ANAL CHEM, V55, P391
   Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018
   Lei QP, 2004, J CHROMATOGR B, V813, P103, DOI 10.1016/j.jchromb.2004.09.015
   Lolmede K, 2009, J LEUKOCYTE BIOL, V85, P779, DOI 10.1189/jlb.0908579
   Mirza RE, 2013, DIABETES, V62, P2579, DOI 10.2337/db12-1450
   Moiemen NS, 2006, PLAST RECONSTR SURG, V117, p160S, DOI 10.1097/01.prs.0000222609.40461.68
   Nassiri S, 2015, J INVEST DERMATOL, V135, P1700, DOI 10.1038/jid.2015.30
   Neill JSA, 2013, AM J CLIN PATHOL, V140, P248, DOI 10.1309/AJCPMF3B9XJAKXKM
   Qin ZY, 2012, ATHEROSCLEROSIS, V221, P2, DOI 10.1016/j.atherosclerosis.2011.09.003
   Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x
   Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110
   Snyder DL, 2012, HCPR0610 US DEP HLTH
   Spiller KL, 2015, WOUND REPAIR REGEN, V23, pA40
   Spiller KL, 2015, BIOMATERIALS, V37, P194, DOI 10.1016/j.biomaterials.2014.10.017
   Spiller KL, 2014, BIOMATERIALS, V35, P4477, DOI 10.1016/j.biomaterials.2014.02.012
   Spiller KL, 2015, EXP CELL RES
   Tan GK, 2014, ACTA BIOMATER, V10, P2684, DOI 10.1016/j.actbio.2014.02.025
   Troidl C, 2013, CURR VASC PHARMACOL, V11, P5, DOI 10.2174/157016113804547629
   Ulubayram K, 2002, J BIOMAT SCI-POLYM E, V13, P1203, DOI 10.1163/156856202320892966
   Willenborg S, 2012, BLOOD, V120, P613, DOI 10.1182/blood-2012-01-403386
   Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354
   Xue J, 2015, NAT COMMUN, V6, P1
   Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006
   Ye QS, 2010, BIOMATERIALS, V31, P9192, DOI 10.1016/j.biomaterials.2010.08.049
NR 30
TC 12
Z9 12
U1 1
U2 17
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1067-1927
EI 1524-475X
J9 WOUND REPAIR REGEN
JI Wound Repair Regen.
PD MAY-JUN
PY 2016
VL 24
IS 3
BP 514
EP 524
DI 10.1111/wrr.12423
PG 11
WC Cell Biology; Dermatology; Medicine, Research & Experimental; Surgery
SC Cell Biology; Dermatology; Research & Experimental Medicine; Surgery
GA DO0XA
UT WOS:000377500900005
PM 26874797
DA 2018-10-20
ER

PT J
AU Essoua, GGE
   Blanchet, P
   Landry, V
   Beauregard, R
AF Essoua, Gatien Geraud Essoua
   Blanchet, Pierre
   Landry, Veronic
   Beauregard, Robert
TI Pine Wood Treated with a Citric Acid and Glycerol Mixture: Biomaterial
   Performance Improved by a Bio-byproduct
SO BIORESOURCES
LA English
DT Article
DE Wood impregnation; Citric acid; Glycerol; Wood technical performance;
   Environmentally friendly treatment; By-product valorization
ID INFRARED-SPECTROSCOPY; CHEMICAL-REACTION; ROT FUNGI; BIODEGRADATION;
   STABILITY; COATINGS; PINASTER; DECAY; FTIR
AB Wood material is a good reservoir for biogenic carbon storage. The use of wood material for outdoor products such as siding in the building construction sector presents limits. These limits are bound to the nature of wood material (hygroscopic property and anatomical structure). They are responsible for the dimensional variation associated with moisture content variations. Fungal attacks and coating layers adhesion on wood surface, are other problems. This research investigated the feasibility of impregnation with environmentally friendly chemicals, i.e., a citric acid-glycerol mixture (CA-G). The anti-swelling efficiency (ASE), hardness, biodegradation, and coating adhesion tests were performed on softwood specimens. ASE results were up to 53%. The equilibrium moisture content of the treated specimens was less than half of the untreated ones. FTIR spectroscopy showed bands at 1720 to 1750 cm(-1), indicating the presence of ester bonds, and scanning electron microscopy images confirmed the polymerization and condensation of treatment solution inside the wood structure. Hardness and decay resistance were increased; however, treatment reduces coating adhesion. In conclusion, CA-G represents a promising eco-responsible solution for improving the technical performance of outdoor wood products.
C1 [Essoua, Gatien Geraud Essoua; Blanchet, Pierre; Landry, Veronic; Beauregard, Robert] Univ Laval, Dept Wood & Forest Sci, 2325 Rue Univ, Quebec City, PQ G1V 0A6, Canada.
   [Landry, Veronic] FPInnovat, G1P 4R4,319 Rue Franquet, Quebec City, PQ G1P 4R4, Canada.
RP Blanchet, P (reprint author), Univ Laval, Dept Wood & Forest Sci, 2325 Rue Univ, Quebec City, PQ G1V 0A6, Canada.
EM Pierre.Blanchet@sbf.ulaval.ca
RI Blanchet, Pierre/C-2455-2014; Landry, Veronic/S-6062-2017; Beauregard,
   Robert/S-3978-2016
OI Blanchet, Pierre/0000-0002-6348-0289; Beauregard,
   Robert/0000-0002-0781-7625
FU National Science and Engineering Research Council of Canada;
   FPInnovations [RDCPJ 386935]
FX The authors would like to acknowledge the National Science and
   Engineering Research Council of Canada and FPInnovations for funding
   this research (RDCPJ 386935).
CR American Society for Testing And Materials, 2014, D2395 ASTM
   Anand PM, 2011, NEW BIOTECHNOL, V1, P1, DOI DOI 10.1016/J.NBT.2011.05.010
   [Anonymous], 2009, D4541 ASTM
   [Anonymous], 2002, 4624 ISO
   [Anonymous], 2000, 1534 ISO
   [Anonymous], 2012, E10 AWPA
   Arnold M., 2010, PRAS 7 INT WOODC C R
   Barone JR, 2007, POLYM DEGRAD STABIL, V92, P859, DOI 10.1016/j.polymdegradstab.2007.01.030
   BENDER ML, 1960, CHEM REV, V60, P53, DOI 10.1021/cr60203a005
   Bodirlau R, 2009, ROM J PHYS, V54, P93
   Brioude Michel de Meireles, 2007, Mat. Res., V10, P335, DOI 10.1590/S1516-14392007000400003
   Budhavaram N. K., 2008, ASABE M PROV RI, DOI 10.13031/2013.24910
   Cai X., 2007, THESIS LAVAL U QUEBE
   Chang ST, 2001, POLYM DEGRAD STABIL, V71, P261, DOI 10.1016/S0141-3910(00)00171-3
   Essoua GGE, 2015, BIORESOURCES, V10, P6830
   GOLDSTEIN IS, 1959, IND ENG CHEM, V51, P1313, DOI 10.1021/ie50598a042
   Green W. D., 2006, FPTRN0303 USDA FOR S
   Guerrero P, 2015, J CLEAN PROD, V100, P179, DOI 10.1016/j.jclepro.2015.03.049
   Halpern JM, 2014, J BIOMED MATER RES A, V102, P1467, DOI 10.1002/jbm.a.34821
   Hasan M., 2012, P 6 EUR C WOOD MOD L, P63
   Hernandez RE, 2008, WOOD FIBER SCI, V40, P459
   Hill CAS, 2006, WOOD MODIFICATION CH, DOI [10.1002/0470021748, DOI 10.1002/0470021748]
   Holser RA, 2008, J BIOBASED MATER BIO, V2, P94, DOI 10.1166/jbmb.2008.205
   INOUE M, 1993, WOOD FIBER SCI, V25, P404
   Korkut S, 2008, BIORESOURCE TECHNOL, V99, P1861, DOI 10.1016/j.biortech.2007.03.038
   Li GY, 2011, CARBOHYD POLYM, V85, P560, DOI 10.1016/j.carbpol.2011.03.014
   Lukowsky D, 2002, HOLZ ROH WERKST, V60, P349, DOI 10.1007/s00107-002-0324-y
   Maminski M., 2011, 2 INT C ENV ENG APPL, P13
   Nelson G. L., 1995, ASTM SPECIAL TECHNIC, P513
   Nkeuwa WN, 2014, J COAT TECHNOL RES, V11, P283, DOI 10.1007/s11998-013-9551-x
   NORIMOTO M, 1992, WOOD FIBER SCI, V24, P25
   OWEN NL, 1989, APPL SPECTROSC, V43, P451, DOI 10.1366/0003702894202760
   Ozdemir T, 2015, ADV MATER SCI ENG, DOI 10.1155/2015/525496
   Pagliaro M, 2008, RSC GREEN CHEM SER, P1
   Pandey KK, 2003, INT BIODETER BIODEGR, V52, P151, DOI 10.1016/S0964-8305(03)00052-0
   Panshin AJ, 1964, TXB WOOD TECHNOLOGY
   Paukszta D, 2015, J COMPOS MATER, V49, P1369, DOI 10.1177/0021998314534096
   Podgorski L., 2010, IRG 41 ANN M BIARR F
   PRAMANICK D, 1988, POLYM BULL, V19, P365
   Ross Robert J., 2010, GTR190 USDA FOR SERV
   Rosu D, 2016, J CLEAN PROD, V112, P1175, DOI 10.1016/j.jclepro.2015.07.092
   Roussel C, 2001, HOLZFORSCHUNG, V55, P57, DOI 10.1515/HF.2001.009
   ROWELL RM, 1984, ADV CHEM SER, P175
   Sebe G, 2000, HOLZFORSCHUNG, V54, P474, DOI 10.1515/HF.2000.080
   Sebe G, 2004, HOLZFORSCHUNG, V58, P511, DOI 10.1515/HF.2004.078
   Shang J, 2013, BIORESOURCES, V8, P6066
   Siau JF, 1984, SPRINGER SERIES WOOD
   Teaca CA, 2013, BIORESOURCES, V8, P1478
   Trenkel-Amoroso J., 2008, THESIS OREGONS STATE
   URAKI Y, 1994, J WOOD CHEM TECHNOL, V14, P429, DOI 10.1080/02773819408003106
   Van Acker J., 1999, 9930206 IRGWP, DOI International Research Group on Wood Preservation
   Weaver J. W., 1960, Forest Products Journal, V10, P306
   Wen Z., 2012, NEW USES CRUDE GLYCE
   Westin M., 2004, 0440288 IRGWP
   Yang FX, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-13
   Yang Q, 2013, BIORESOURCES, V8, P487
   Yong F. L., 2010, WORLD ACAD SCI ENG T, V4, P67, DOI [10.1016/j.ibiod.2011.08.009, DOI 10.1016/J.IBIOD.2011.08.009]
NR 57
TC 4
Z9 4
U1 0
U2 21
PU NORTH CAROLINA STATE UNIV DEPT WOOD & PAPER SCI
PI RALEIGH
PA CAMPUS BOX 8005, RALEIGH, NC 27695-8005 USA
SN 1930-2126
J9 BIORESOURCES
JI BioResources
PD MAY
PY 2016
VL 11
IS 2
BP 3049
EP 3072
PG 24
WC Materials Science, Paper & Wood
SC Materials Science
GA DL6YT
UT WOS:000375786700009
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Hortensius, RA
   Harley, BAC
AF Hortensius, Rebecca A.
   Harley, Brendan A. C.
TI Naturally derived biomaterials for addressing inflammation in tissue
   regeneration
SO EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Review
DE Chitosan; decellularized matrix; amniotic membrane; inflammation; tissue
   regeneration; biomaterial
ID COLLAGEN-GAG SCAFFOLDS; FETAL WOUND REPAIR; AMNIOTIC MEMBRANE
   TRANSPLANTATION; DECELLULARIZED PERICARDIAL BIOMATERIAL; OCULAR SURFACE
   RECONSTRUCTION; HEALING IN-VIVO; SCAR FORMATION; EXTRACELLULAR-MATRIX;
   CROSS-LINKING; GROWTH-FACTOR
AB Tissue regeneration strategies have traditionally relied on designing biomaterials that closely mimic features of the native extracellular matrix (ECM) as a means to potentially promote site-specific cellular behaviors. However, inflammation, while a necessary component of wound healing, can alter processes associated with successful tissue regeneration following an initial injury. These processes can be further magnified by the implantation of a biomaterial within the wound site. In addition to designing biomaterials to satisfy biocompatibility concerns as well as to replicate elements of the composition, structure, and mechanics of native tissue, we propose that ECM analogs should also include features that modulate the inflammatory response. Indeed, strategies that enhance, reduce, or even change the temporal phenotype of inflammatory processes have unique potential as future pro-regenerative analogs. Here, we review derivatives of three natural materials with intrinsic anti-inflammatory properties and discuss their potential to address the challenges of inflammation in tissue engineering and chronic wounds.
C1 [Hortensius, Rebecca A.] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA.
   [Harley, Brendan A. C.] Univ Illinois, Dept Chem & Biol Engn, Urbana, IL 61801 USA.
   [Harley, Brendan A. C.] Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA.
RP Hortensius, RA (reprint author), Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA.
EM ralyons2@illinois.edu
FU NSF Graduate Research Fellowship [DGE 11-44245 FLLW]; University of
   Illinois Graduate Dissertation Fellowship; National Science Foundation
   [1105300]; National Institute of Arthritis and Musculoskeletal and Skin
   Diseases of the National Institutes of Health [R03 AR062811]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: The
   authors wish to acknowledge funding provided by the NSF Graduate
   Research Fellowship DGE 11-44245 FLLW (RAH), University of Illinois
   Graduate Dissertation Fellowship (RAH), the National Science Foundation
   under Grant No. 1105300 (BACH), and the National Institute of Arthritis
   and Musculoskeletal and Skin Diseases of the National Institutes of
   Health under Award Number R03 AR062811 (BACH).
CR ADZICK NS, 1994, ANN SURG, V220, P10, DOI 10.1097/00000658-199407000-00003
   Ariganello MB, 2011, BIOMATERIALS, V32, P439, DOI 10.1016/j.biomaterials.2010.09.004
   Ariganello MB, 2010, J BIOMED MATER RES A, V93A, P280, DOI 10.1002/jbm.a.32554
   ARMSTRONG JR, 1995, DEV BIOL, V169, P242, DOI 10.1006/dbio.1995.1141
   Azuara-Blanco A, 1999, BRIT J OPHTHALMOL, V83, P399, DOI 10.1136/bjo.83.4.399
   Azuma Kazuo, 2015, J Funct Biomater, V6, P33, DOI 10.3390/jfb6010033
   Badylak SF, 2014, ANN BIOMED ENG, V42, P1517, DOI 10.1007/s10439-013-0963-7
   Bentzen SM, 2006, NAT REV CANCER, V6, P702, DOI 10.1038/nrc1950
   Beredjiklian PK, 2003, ANN BIOMED ENG, V31, P1143, DOI 10.1114/1.1616931
   Bota PCS, 2010, J BIOMED MATER RES A, V95A, P649, DOI 10.1002/jbm.a.32893
   Boucard N, 2007, BIOMATERIALS, V28, P3478, DOI 10.1016/j.biomaterials.2007.04.021
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Bruyere O, 2008, OSTEOARTHR CARTILAGE, V16, P254, DOI 10.1016/j.joca.2007.06.011
   Bullard KM, 2003, WORLD J SURG, V27, P54, DOI 10.1007/s00268-002-6737-2
   Bullers SJ, 2014, TISSUE ENG PT A, V20, P2390, DOI [10.1089/ten.tea.2013.0628, 10.1089/ten.TEA.2013.0628]
   Caliari SR, 2011, BIOMATERIALS, V32, P5330, DOI 10.1016/j.biomaterials.2011.04.021
   Cao HQ, 2010, J BIOMED MATER RES A, V93A, P1151, DOI 10.1002/jbm.a.32609
   Cass DL, 1997, J PEDIATR SURG, V32, P411, DOI 10.1016/S0022-3468(97)90593-5
   Chen HJ, 2000, BRIT J OPHTHALMOL, V84, P826, DOI 10.1136/bjo.84.8.826
   Chen Q, 2006, EUR J PHARMACOL, V541, P1, DOI 10.1016/j.ejphar.2006.03.044
   Chung MJ, 2012, INT IMMUNOPHARMACOL, V12, P453, DOI 10.1016/j.intimp.2011.12.027
   Colwell AS, 2006, PLAST RECONSTR SURG, V117, P2292, DOI 10.1097/01.prs.0000219340.47232.eb
   Colwell AS, 2005, ADV BIOCHEM ENG BIOT, V93, P83, DOI 10.1007/b99972
   Cooper LJ, 2005, CORNEA, V24, P722, DOI 10.1097/01.ico.0000154237.49112.29
   Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184
   Elsaesser AF, 2014, TISSUE ENG PT A, V20, P1668, DOI [10.1089/ten.tea.2013.0365, 10.1089/ten.TEA.2013.0365]
   Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701
   Fairbairn NG, 2014, J PLAST RECONSTR AES, V67, P662, DOI 10.1016/j.bjps.2014.01.031
   Farrell E, 2006, TISSUE ENG, V12, P459, DOI 10.1089/ten.2006.12.459
   Fishman JM, 2013, P NATL ACAD SCI USA, V110, P14360, DOI 10.1073/pnas.1213228110
   French KM, 2012, ACTA BIOMATER, V8, P4357, DOI 10.1016/j.actbio.2012.07.033
   Friedman AJ, 2013, J INVEST DERMATOL, V133, P1231, DOI 10.1038/jid.2012.399
   Gittes C, 2000, J PEDIATR SURG, V35, P872
   Gordon A, 2008, WOUND REPAIR REGEN, V16, P70, DOI 10.1111/j.1524-475X.2007.00326.x
   Harley BA, 2004, CELLS TISSUES ORGANS, V176, P153, DOI 10.1159/000075035
   Harley BA, 2007, BIOPHYS J, V93, P2911, DOI 10.1529/biophysj.106.095471
   Harley BAC, 2008, BIOPHYS J, V95, P4013, DOI 10.1529/biophysj.107.122598
   Haugh MG, 2011, TISSUE ENG PT A, V17, P1201, DOI [10.1089/ten.tea.2010.0590, 10.1089/ten.TEA.2010.0590]
   Holladay C, 2011, MOL THER, V19, P969, DOI 10.1038/mt.2010.311
   Holladay CA, 2012, BIOMATERIALS, V33, P1303, DOI 10.1016/j.biomaterials.2011.10.019
   Hortensius RA, 2016, J BIOMED MATER RES A, V104, P1332, DOI 10.1002/jbm.a.35663
   Hortensius RA, 2013, BIOMATERIALS, V34, P7645, DOI 10.1016/j.biomaterials.2013.06.056
   Hsu M, 2001, PLAST RECONSTR SURG, V107, P1787, DOI 10.1097/00006534-200106000-00023
   Hsu M, 2001, PLAST RECONSTR SURG, V107, P95
   Jayakumar R, 2011, BIOTECHNOL ADV, V29, P322, DOI 10.1016/j.biotechadv.2011.01.005
   Keane TJ, 2017, J BIOMED MATER RES B, V105, P291, DOI 10.1002/jbm.b.33556
   Kim H, 2013, ARCH PLAST SURG-APS, V40, P11, DOI 10.5999/aps.2013.40.1.11
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Kim MM, 2006, FEBS LETT, V580, P2661, DOI 10.1016/j.febslet.2006.04.015
   Koch Holger, 2015, Front Bioeng Biotechnol, V3, P89, DOI 10.3389/fbioe.2015.00089
   Koob TJ, 2013, INT WOUND J, V10, P493, DOI 10.1111/iwj.12140
   Larson BJ, 2010, PLAST RECONSTR SURG, V126, P1172, DOI 10.1097/PRS.0b013e3181eae781
   Lee SH, 2009, BIOORG MED CHEM LETT, V19, P6655, DOI 10.1016/j.bmcl.2009.10.007
   Liechty KW, 1998, J SURG RES, V77, P80, DOI 10.1006/jsre.1998.5345
   Liechty KW, 2000, J PEDIATR SURG, V35, P866, DOI 10.1053/jpsu.2000.6868
   Liechty KW, 2000, CYTOKINE, V12, P671, DOI 10.1006/cyto.1999.0598
   LONGAKER MT, 1991, ANN SURG, V213, P292, DOI 10.1097/00000658-199104000-00003
   LONGAKER MT, 1994, ANN SURG, V219, P65, DOI 10.1097/00000658-199401000-00011
   LORENZ HP, 1993, ANN SURG, V217, P391, DOI 10.1097/00000658-199304000-00011
   LORENZ HP, 1992, DEVELOPMENT, V114, P253
   MALAK TM, 1993, PLACENTA, V14, P385, DOI 10.1016/S0143-4004(05)80460-6
   Mazza G, 2015, SCI REP-UK, V5, DOI 10.1038/srep13079
   McDade JK, 2013, ACTA BIOMATER, V9, P7191, DOI 10.1016/j.actbio.2013.02.021
   Medberry CJ, 2013, BIOMATERIALS, V34, P1033, DOI 10.1016/j.biomaterials.2012.10.062
   MERKEL JR, 1988, P SOC EXP BIOL MED, V187, P493
   MURPHY GF, 1990, LAB INVEST, V62, P305
   Murphy WL, 2000, BIOMATERIALS, V21, P2521, DOI 10.1016/S0142-9612(00)00120-4
   Muzzarelli RAA, 2009, CARBOHYD POLYM, V76, P167, DOI 10.1016/j.carbpol.2008.11.002
   Naik-Mathuria B, 2007, J PEDIATR SURG, V42, P166, DOI 10.1016/j.jpedsurg.2006.09.058
   Ngo DH, 2014, ADV FOOD NUTR RES, V73, P15, DOI 10.1016/B978-0-12-800268-1.00002-0
   Niknejad H, 2008, EUR CELLS MATER, V15, P88
   Novak ML, 2013, AM J PATHOL, V183, P1352, DOI 10.1016/j.ajpath.2013.06.034
   Nowocin AK, 2013, J TISSUE ENG REGEN M, V10, pE23
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   Oliveira MI, 2012, EUR CELLS MATER, V24, P136, DOI 10.22203/eCM.v024a10
   Oliveira MI, 2012, EUR CELLS MATER, V24, P52
   Olutoye OO, 2005, PEDIATR RES, V58, P1290, DOI 10.1203/01.pdr.0000184326.01884.bc
   Olutoye OO, 1996, J PEDIATR SURG, V31, P91, DOI 10.1016/S0022-3468(96)90326-7
   Pangestuti R, 2011, INT J BIOL MACROMOL, V49, P599, DOI 10.1016/j.ijbiomac.2011.06.014
   Peranteau WH, 2008, J INVEST DERMATOL, V128, P1852, DOI 10.1038/sj.jid.5701232
   Pinkerton MC, 1942, LANCET, V1, P70
   PRUDDEN JF, 1970, AM J SURG, V119, P560, DOI 10.1016/0002-9610(70)90175-3
   Qiao Y, 2011, INT IMMUNOPHARMACOL, V11, P121, DOI 10.1016/j.intimp.2010.10.016
   Raghavan SS, 2012, TISSUE ENG PT A, V18, P796, DOI [10.1089/ten.tea.2011.0422, 10.1089/ten.TEA.2011.0422]
   Reing JE, 2009, TISSUE ENG PT A, V15, P605, DOI 10.1089/ten.tea.2007.0425
   Rhett JM, 2008, TRENDS BIOTECHNOL, V26, P173, DOI 10.1016/j.tibtech.2007.12.007
   Samandari MH, 2004, ORAL SURG ORAL MED O, V97, P574, DOI 10.1016/j.tripleo.2003.10.031
   SHAH M, 1994, J CELL SCI, V107, P1137
   Shukla SK, 2013, INT J BIOL MACROMOL, V59, P46, DOI 10.1016/j.ijbiomac.2013.04.043
   SOMASUND.K, 1970, J PATHOL, V100, P81, DOI 10.1002/path.1711000202
   Soo C, 2003, AM J PATHOL, V163, P2459, DOI 10.1016/S0002-9440(10)63601-2
   Spiller KL, 2015, BIOMATERIALS, V37, P194, DOI 10.1016/j.biomaterials.2014.10.017
   Taghiabadi E, 2015, CELL J, V16, P476
   Torres DS, 2000, BIOMATERIALS, V21, P1607
   TROENSEGAARDHANSEN E, 1950, LANCET, V258, P859
   Tseng SCG, 1998, ARCH OPHTHALMOL-CHIC, V116, P431, DOI 10.1001/archopht.116.4.431
   Ueno H, 1999, BIOMATERIALS, V20, P1407, DOI 10.1016/S0142-9612(99)00046-0
   Umashankar PR, 2013, J BIOMED MATER RES A, V101, P2202, DOI 10.1002/jbm.a.34535
   Wang QS, 2014, J BIOMED MATER RES A, V102, P4098, DOI 10.1002/jbm.a.35083
   Weisgerber DW, 2015, BIOMATER SCI-UK, V3, P533, DOI [10.1039/c4bm00397g, 10.1039/C4BM00397G]
   Willett NJ, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4476
   Wilshaw SP, 2006, TISSUE ENG, V12, P2117, DOI 10.1089/ten.2006.12.2117
   Xia WS, 2011, FOOD HYDROCOLLOID, V25, P170, DOI 10.1016/j.foodhyd.2010.03.003
   Xing Q, 2015, TISSUE ENG PART C-ME, V21, P77, DOI [10.1089/ten.tec.2013.0666, 10.1089/ten.TEC.2013.0666]
   Yannas I., 2001, TISSUE ORGAN REGENER
   Yannas IV, 2013, BIOMATERIALS, V34, P321, DOI 10.1016/j.biomaterials.2012.10.006
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
   Yousef M, 2012, PHARMACOL RES, V66, P66, DOI 10.1016/j.phrs.2012.03.013
   Yuan ZM, 2014, BIOMATER SCI-UK, V2, P502, DOI 10.1039/c3bm60198f
   Zgheib C, 2014, ADV WOUND CARE, V3, P344, DOI 10.1089/wound.2013.0456
   Zilla P, 2004, BIOTECHNOL APPL BIOC, V40, P57, DOI 10.1042/BA20030211
NR 111
TC 9
Z9 9
U1 2
U2 31
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1535-3702
EI 1535-3699
J9 EXP BIOL MED
JI Exp. Biol. Med.
PD MAY
PY 2016
VL 241
IS 10
BP 1015
EP 1024
DI 10.1177/1535370216648022
PG 10
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DN6PJ
UT WOS:000377197400001
PM 27190254
OA Green Accepted, Green Published
DA 2018-10-20
ER

PT J
AU Chow, LW
   Fischer, JF
AF Chow, Lesley W.
   Fischer, Jacob F.
TI Creating biomaterials with spatially organized functionality
SO EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Review
DE Biomaterials; extracellular matrix; tissue engineering; regenerative
   medicine; translational; biomedical
ID PEPTIDE-AMPHIPHILE NANOFIBERS; CLICK-BASED HYDROGELS; STEM-CELL FATE;
   EXTRACELLULAR-MATRIX; REGENERATIVE MEDICINE; 3-DIMENSIONAL HYDROGELS;
   CARTILAGE REGENERATION; TISSUE CONSTRUCTS; FIBROUS SCAFFOLDS;
   MICROENVIRONMENTS
AB Biomaterials for tissue engineering provide scaffolds to support cells and guide tissue regeneration. Despite significant advances in biomaterials design and fabrication techniques, engineered tissue constructs remain functionally inferior to native tissues. This is largely due to the inability to recreate the complex and dynamic hierarchical organization of the extracellular matrix components, which is intimately linked to a tissue's biological function. This review discusses current state-of-the-art strategies to control the spatial presentation of physical and biochemical cues within a biomaterial to recapitulate native tissue organization and function.
C1 [Chow, Lesley W.] Lehigh Univ, Dept Mat Sci & Engn, Bethlehem, PA 18015 USA.
   [Chow, Lesley W.; Fischer, Jacob F.] Lehigh Univ, Bioengn Program, Bethlehem, PA 18015 USA.
RP Chow, LW (reprint author), Lehigh Univ, Dept Mat Sci & Engn, Bethlehem, PA 18015 USA.; Chow, LW (reprint author), Lehigh Univ, Bioengn Program, Bethlehem, PA 18015 USA.
EM lesley.chow@lehigh.edu
FU Lehigh University
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This work
   was supported by startup funds from Lehigh University. The authors have
   no other relevant affiliations or financial involvement with any
   organization or entity with a financial interest in or financial
   conflict with the subject matter or materials discussed in the
   manuscript. The authors acknowledge Dr E. Thomas Pashuck for useful
   discussions and editing the manuscript.
CR Abbah SA, 2015, ADV HEALTHC MATER, V4, P2488, DOI 10.1002/adhm.201500004
   Ahadian S, 2015, BIOCONJUGATE CHEM, V26, P1984, DOI 10.1021/acs.bioconjchem.5b00360
   Aizawa Y, 2010, ADV MATER, V22, P4831, DOI 10.1002/adma.201001855
   Azagarsamy MA, 2013, ACS MACRO LETT, V2, P5, DOI 10.1021/mz300585q
   Bae H, 2014, J TISSUE ENG REGEN M, V8, P1, DOI 10.1002/term.1494
   Bajaj P, 2014, ANNU REV BIOMED ENG, V16, P247, DOI 10.1146/annurev-bioeng-071813-105155
   Bandyopadhyay A, 2015, MRS BULL, V40, P108, DOI 10.1557/mrs.2015.3
   Bitton R, 2014, SMALL, V10, P500, DOI 10.1002/smll.201300254
   Boekhoven J, 2013, ANGEW CHEM INT EDIT, V52, P12077, DOI 10.1002/anie.201306278
   Bonzani IC, 2006, CURR OPIN CHEM BIOL, V10, P568, DOI 10.1016/j.cbpa.2006.09.009
   Burdick JA, 2004, LANGMUIR, V20, P5153, DOI 10.1021/la049298n
   Burdick JA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2271
   Caldwell DJ, 2013, ADV HEALTHC MATER, V2, P673, DOI 10.1002/adhm.201200346
   Caliari SR, 2015, ADV HEALTHC MATER, V4, P831, DOI 10.1002/adhm.201400809
   Caliari SR, 2014, ADV HEALTHC MATER, V3, P1086, DOI 10.1002/adhm.201300646
   Caliari SR, 2011, BIOMATERIALS, V32, P5330, DOI 10.1016/j.biomaterials.2011.04.021
   Capito RM, 2008, SCIENCE, V319, P1812, DOI 10.1126/science.1154586
   Carvajal D, 2010, SOFT MATTER, V6, P1816, DOI 10.1039/b923903k
   Charras G, 2014, NAT REV MOL CELL BIO, V15, P813, DOI 10.1038/nrm3897
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chow LW, 2014, ADV HEALTHC MATER, V3, P1381, DOI 10.1002/adhm.201400032
   Chow LW, 2011, BIOMATERIALS, V32, P1574, DOI 10.1016/j.biomaterials.2010.10.048
   Colosi C, 2016, ADV MATER, V28, P677, DOI 10.1002/adma.201503310
   Custodio CA, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0065-3
   Custodio CA, 2014, ADV HEALTHC MATER, V3, P797, DOI 10.1002/adhm.201300603
   Davey SK, 2015, TISSUE ENG PART C-ME, V21, P1188, DOI [10.1089/ten.tec.2015.0179, 10.1089/ten.TEC.2015.0179]
   DeForest CA, 2012, ANGEW CHEM INT EDIT, V51, P1816, DOI 10.1002/anie.201106463
   DeForest CA, 2011, NAT CHEM, V3, P925, DOI [10.1038/nchem.1174, 10.1038/NCHEM.1174]
   DeForest CA, 2010, CHEM MATER, V22, P4783, DOI 10.1021/cm101391y
   Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI [10.1038/nnano.2010.246, 10.1038/NNANO.2010.246]
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Gasiorowski JZ, 2011, BIOMACROMOLECULES, V12, P3549, DOI 10.1021/bm200763y
   Guven S, 2015, TRENDS BIOTECHNOL, V33, P269, DOI 10.1016/j.tibtech.2015.02.003
   Guvendiren M, 2013, ADV HEALTHC MATER, V2, P155, DOI 10.1002/adhm.201200105
   Harrison RH, 2015, ADV FUNCT MATER, V25, P5748, DOI 10.1002/adfm.201501277
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   Highley CB, 2015, ADV MATER, V27, P5075, DOI 10.1002/adma.201501234
   Hinton TJ, 2015, SCI ADV, V1
   Hu J, 2014, PLOS ONE, V9
   Hudalla GA, 2014, NAT MATER, V13, P829, DOI [10.1038/NMAT3998, 10.1038/nmat3998]
   Huebsch N, 2015, NAT MATER, V14, P1269, DOI [10.1038/NMAT4407, 10.1038/nmat4407]
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Janson IA, 2015, J BIOMED MATER RES A, V103, P1246, DOI 10.1002/jbm.a.35254
   Jia XQ, 2009, MACROMOL BIOSCI, V9, P140, DOI 10.1002/mabi.200800284
   Kesti M, 2015, ADV FUNCT MATER, V25, P7397
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]
   Kidoaki A, 2008, J BIOTECHNOL, V133, P225, DOI 10.1016/j.jbiotec.2007.08.015
   Kim DH, 2012, J CELL BIOL, V197, P351, DOI 10.1083/jcb.201108062
   Kim J, 2016, ADV MATER, V28, P132, DOI 10.1002/adma.201503950
   Kyburz KA, 2015, ANN BIOMED ENG, V43, P489, DOI 10.1007/s10439-015-1297-4
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee TT, 2015, NAT MATER, V14, P352, DOI [10.1038/NMAT4157, 10.1038/nmat4157]
   Leong KF, 2008, J MECH BEHAV BIOMED, V1, P140, DOI 10.1016/j.jmbbm.2007.11.002
   Liu S, 2015, CHEM COMMUN, V51, P5218, DOI 10.1039/c4cc09568e
   Loo YH, 2015, NANO LETT, V15, P6919, DOI 10.1021/acs.nanolett.5b02859
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mandrycky C, 2016, BIOTECHNOL ADV, V34, P422, DOI 10.1016/j.biotechadv.2015.12.011
   Marklein RA, 2010, SOFT MATTER, V6, P136, DOI 10.1039/b916933d
   Matson JB, 2011, CURR OPIN SOLID ST M, V15, P225, DOI 10.1016/j.cossms.2011.08.001
   Matson JB, 2012, CHEM COMMUN, V48, P26, DOI 10.1039/c1cc15551b
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McClendon MT, 2012, BIOMATERIALS, V33, P5713, DOI 10.1016/j.biomaterials.2012.04.040
   McCullen SD, 2012, TISSUE ENG PT A, V18, P2073, DOI [10.1089/ten.tea.2011.0606, 10.1089/ten.TEA.2011.0606]
   Mosiewicz KA, 2013, NAT MATER, V12, P1071, DOI 10.1038/NMAT3766
   Mouw JK, 2014, NAT REV MOL CELL BIO, V15, P771, DOI 10.1038/nrm3902
   Nguyen LH, 2011, BIOMATERIALS, V32, P1
   Oliveira SM, 2015, BIOMATERIALS, V48, P56, DOI 10.1016/j.biomaterials.2015.01.020
   Pashuck ET, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002717
   Pati F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4935
   Pedron S, 2015, ADV MATER, V27, P1567, DOI 10.1002/adma.201404896
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Rice JJ, 2013, ADV HEALTHC MATER, V2, P57, DOI 10.1002/adhm.201200197
   Rodell CB, 2015, BIOCONJUGATE CHEM, V26, P2279, DOI 10.1021/acs.bioconjchem.5b00483
   Seidi A, 2011, ACTA BIOMATER, V7, P1441, DOI 10.1016/j.actbio.2011.01.011
   Shukla A, 2016, ACS APPL MATER INTER, V8, P21883, DOI 10.1021/acsami.5b08978
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Steele JAM, 2014, ACTA BIOMATER, V10, P2065, DOI 10.1016/j.actbio.2013.12.030
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Stevens MM, 2008, MATER TODAY, V11, P18, DOI 10.1016/S1369-7021(08)70086-5
   Sundararaghavan HG, 2011, BIOMACROMOLECULES, V12, P2344, DOI 10.1021/bm200415g
   Tang W, 2014, CHEM SOC REV, V43, P7013, DOI 10.1039/c4cs00139g
   Tayi AS, 2014, BIOMACROMOLECULES, V15, P1323, DOI 10.1021/bm401877s
   Tibbitt MW, 2015, P NATL ACAD SCI USA, V112, P14444, DOI 10.1073/pnas.1516247112
   Velichko YS, 2012, ADV FUNCT MATER, V22, P369, DOI 10.1002/adfm.201101538
   Wade RJ, 2015, ADV MATER, V27, P1356, DOI 10.1002/adma.201404993
   Wylie RG, 2011, NAT MATER, V10, P799, DOI [10.1038/NMAT3101, 10.1038/nmat3101]
   Zhang H, 2014, ACS MACRO LETT, V3, P727, DOI 10.1021/mz5002993
   Zhang SM, 2010, NAT MATER, V9, P594, DOI [10.1038/nmat2778, 10.1038/NMAT2778]
NR 91
TC 2
Z9 2
U1 0
U2 36
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1535-3702
EI 1535-3699
J9 EXP BIOL MED
JI Exp. Biol. Med.
PD MAY
PY 2016
VL 241
IS 10
BP 1025
EP 1032
DI 10.1177/1535370216648023
PG 8
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DN6PJ
UT WOS:000377197400002
PM 27190258
OA Green Published
DA 2018-10-20
ER

PT J
AU Tengood, JE
   Levy, RJ
   Stachelek, SJ
AF Tengood, Jillian E.
   Levy, Robert J.
   Stachelek, Stanley J.
TI The use of CD47-modified biomaterials to mitigate the immune response
SO EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Review
DE CD47; signal regulatory protein alpha; biomaterials; inflammation
ID ALVEOLAR MACROPHAGE PHAGOCYTOSIS; HEMATOPOIETIC STEM-CELLS; FOREIGN-BODY
   REACTION; SURFACTANT PROTEIN-A; IN-VIVO; INFLAMMATORY RESPONSE;
   CARDIOPULMONARY BYPASS; SIRP-ALPHA; DENDRITIC CELLS; POLY(CARBONATE
   URETHANE)
AB Addressing the aberrant interactions between immune cells and biomaterials represents an unmet need in biomaterial research. Although progress has been made in the development of bioinert coatings, identifying and targeting relevant cellular and molecular pathways can provide additional therapeutic strategies to address this major healthcare concern. To that end, we describe the immune inhibitory motif, receptor-ligand pairing of signal regulatory protein alpha and its cognate ligand CD47 as a potential signaling pathway to enhance biocompatibility. The goals of this article are to detail the known roles of CD47-signal regulatory protein alpha signal transduction pathway and to describe how immobilized CD47 can be used to mitigate the immune response to biomaterials. Current applications of CD47-modified biomaterials will also be discussed herein.
C1 [Tengood, Jillian E.; Levy, Robert J.; Stachelek, Stanley J.] Childrens Hosp Philadelphia, Dept Pediat, Div Cardiol, Philadelphia, PA 19104 USA.
   [Tengood, Jillian E.; Levy, Robert J.; Stachelek, Stanley J.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.
RP Stachelek, SJ (reprint author), Childrens Hosp Philadelphia, Dept Pediat, Div Cardiol, Philadelphia, PA 19104 USA.; Stachelek, SJ (reprint author), Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.
EM stachelek@email.chop.edu
FU American Heart Association [14POST18830039]; NIH [R21 EB015612]; William
   J. Rashkind Endowment; Kibel Foundation; Erin's Fund of Children's
   Hospital of Philadelphia
FX Support for JTH is from the American Heart Association (14POST18830039).
   Support for SJS is from NIH R21 EB015612. Support for RJL is from the
   William J. Rashkind Endowment, Erin's Fund of the Children's Hospital of
   Philadelphia and The Kibel Foundation. The CD47 technology is licensed
   to SIRP Biological Coatings Inc. of which RJL and SJS are co-founders
   and equity shareholders.
CR Almeida CR, 2014, ACTA BIOMATER, V10, P613, DOI 10.1016/j.actbio.2013.10.035
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson J, 2011, SEMIN IMMUNOPATHOL, V33, P221, DOI 10.1007/s00281-011-0244-1
   Bajaj G, 2012, PLOS ONE, V7
   Bartoszewicz ZP, 1999, J NEUROCHEM, V72, P1688, DOI 10.1046/j.1471-4159.1999.721688.x
   Bellinger DC, 2003, J DEV BEHAV PEDIATR, V24, P169, DOI 10.1097/00004703-200306000-00007
   Bendszus M, 2002, ARCH NEUROL-CHICAGO, V59, P1090, DOI 10.1001/archneur.59.7.1090
   Brooke GP, 1998, EUR J IMMUNOL, V28, P1
   BRUCK SD, 1982, MED PROG TECHNOL, V9, P1
   Bruns H, 2015, CLIN CANCER RES, V21, P2075, DOI 10.1158/1078-0432.CCR-14-2696
   CAMPBELL IG, 1992, CANCER RES, V52, P5416
   Chao MP, 2011, CANCER RES, V71, P1374, DOI 10.1158/0008-5472.CAN-10-2238
   Christenson EM, 2006, J BIOMED MATER RES A, V76A, P480, DOI 10.1002/jbm.a.30506
   Christenson EM, 2004, J BIOMED MATER RES A, V70A, P245, DOI 10.1002/jbm.a.30067
   Dadsetan M, 2003, J CONTROL RELEASE, V93, P259, DOI 10.1016/j.jconrel.2003.08.010
   Edmunds LH, 1998, ANN THORAC SURG, V66, pS12, DOI 10.1016/S0003-4975(98)00967-9
   Edris B, 2012, P NATL ACAD SCI USA, V109, P6656, DOI 10.1073/pnas.1121629109
   Finley MJ, 2013, BIOMATERIALS, V34, P8640, DOI 10.1016/j.biomaterials.2013.07.088
   Finley MJ, 2012, BIOMATERIALS, V33, P5803, DOI 10.1016/j.biomaterials.2012.04.051
   Gao WW, 2013, ADV MATER, V25, P3549, DOI 10.1002/adma.201300638
   Gaynor J William, 2004, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, V7, P133, DOI 10.1053/j.pcsu.2004.02.007
   Goda T, 2015, ACS APPL MATER INTER, V7, P27440, DOI 10.1021/acsami.5b09325
   Hagnerud S, 2006, J IMMUNOL, V176, P5772, DOI 10.4049/jimmunol.176.10.5772
   Hill GE, 1996, INT ANESTHESIOL CLIN, V34, P95, DOI 10.1097/00004311-199603420-00009
   Hogue CW, 2006, ANESTH ANALG, V103, P21, DOI 10.1213/01.ANE.0000220035.82989.79
   Hu CMJ, 2014, NANOSCALE, V6, P65, DOI 10.1039/c3nr05444f
   Hu CMJ, 2013, NANOSCALE, V5, P2664, DOI 10.1039/c3nr00015j
   Hu CMJ, 2011, P NATL ACAD SCI USA, V108, P10980, DOI 10.1073/pnas.1106634108
   INABA K, 1990, International Reviews of Immunology, V6, P197, DOI 10.3109/08830189009056630
   Isenberg JS, 2008, ARTERIOSCL THROM VAS, V28, P615, DOI 10.1161/ATVBAHA.107.158154
   Isenberg JS, 2007, J BIOL CHEM, V282, P15404, DOI 10.1074/jbc.M701638200
   Jakel A, 2010, IMMUNOBIOLOGY, V215, P551, DOI 10.1016/j.imbio.2009.09.005
   Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046
   Janssen WJ, 2008, AM J RESP CRIT CARE, V178, P158, DOI 10.1164/rccm.200711-1661OC
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Jenney CR, 1999, J BIOMED MATER RES, V44, P206, DOI 10.1002/(SICI)1097-4636(199902)44:2<206::AID-JBM11>3.0.CO;2-D
   Jiang PH, 1999, J BIOL CHEM, V274, P559, DOI 10.1074/jbc.274.2.559
   Kim D, 2012, LEUKEMIA, V26, P2538, DOI 10.1038/leu.2012.141
   KRAAL G, 1992, INT REV CYTOL, V132, P31, DOI 10.1016/S0074-7696(08)62453-5
   Kyle DJT, 2015, BIOMATERIALS, V52, P88, DOI 10.1016/j.biomaterials.2015.02.003
   Landis Clive, 2007, J Extra Corpor Technol, V39, P281
   Levy JH, 2008, ANESTH ANALG, V106, P392, DOI [10.1213/ane.0b013e318160e0d, 10.1213/ane.0b013e3181602e0d]
   Levy JH, 2003, ANN THORAC SURG, V75, pS715, DOI 10.1016/S0003-4975(02)04701-X
   Li J, 2015, BIOMATERIALS, V47, P51, DOI 10.1016/j.biomaterials.2015.01.005
   Luther SA, 2002, J IMMUNOL, V169, P424, DOI 10.4049/jimmunol.169.1.424
   Maitz MF, 2010, J BIOMED MATER RES A, V94A, P905, DOI 10.1002/jbm.a.32780
   McCracken MN, 2015, CLIN CANCER RES, V21, P3597, DOI 10.1158/1078-0432.CCR-14-2520
   McGuinness J, 2008, SURG-J R COLL SURG E, V6, P162, DOI 10.1016/S1479-666X(08)80113-8
   Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588
   Narizhneva NV, 2005, FASEB J, V19, P1158, DOI 10.1096/fj.04-3310fje
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   Nygren H, 1997, J LAB CLIN MED, V129, P35, DOI 10.1016/S0022-2143(97)90159-1
   OKEREKE CS, 1995, TOXICOL LETT, V80, P61, DOI 10.1016/0378-4274(95)03334-H
   Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051
   Palaniyar N, 2003, ANN NY ACAD SCI, V1010, P471, DOI 10.1196/annals.1299.085
   Rebres RA, 2005, J CELL PHYSIOL, V205, P182, DOI 10.1002/jcp.20379
   ROBISON SH, 1994, ENVIRON MOL MUTAGEN, V23, P312, DOI 10.1002/em.2850230409
   Rodriguez PL, 2013, SCIENCE, V339, P971, DOI 10.1126/science.1229568
   Saito Y, 2010, BLOOD, V116, P3517, DOI 10.1182/blood-2010-03-277244
   Sato-Hashimoto M, 2011, J IMMUNOL, V187, P291, DOI 10.4049/jimmunol.1100528
   Saumet A, 2002, BIOCHEM J, V363, P473, DOI 10.1042/0264-6021:3630473
   Schagat TL, 2001, J IMMUNOL, V166, P2727, DOI 10.4049/jimmunol.166.4.2727
   SCHUBERT MA, 1995, J BIOMED MATER RES, V29, P337, DOI 10.1002/jbm.820290309
   Shahan TA, 1999, CANCER RES, V59, P4584
   Shinohara M, 2006, CANCER SCI, V97, P889, DOI 10.1111/j.1349-7006.2006.00245.x
   Slee JB, 2014, POLYMERS-BASEL, V6, P2526, DOI 10.3390/polym6102526
   Smadja DM, 2011, ARTERIOSCL THROM VAS, V31, P551, DOI 10.1161/ATVBAHA.110.220624
   Sperling C, 2004, BIOMATERIALS, V25, P5101, DOI 10.1016/j.biomaterials.2003.12.014
   Sperling C, 2007, BIOMATERIALS, V28, P3617, DOI 10.1016/j.biomaterials.2007.04.041
   Stachelek SJ, 2007, J BIOMED MATER RES A, V82A, P1004, DOI 10.1002/jbm.a.31215
   Stachelek SJ, 2011, BIOMATERIALS, V32, P4317, DOI 10.1016/j.biomaterials.2011.02.053
   Stachelek SJ, 2010, J BIOMED MATER RES A, V94A, P751, DOI 10.1002/jbm.a.32755
   Steinman RM, 1997, IMMUNOL REV, V156, P25, DOI 10.1111/j.1600-065X.1997.tb00956.x
   Stevens KNJ, 2007, J BIOMED BIOTECHNOL, DOI 10.1155/2007/29464
   STOKES K, 1990, Journal of Biomaterials Science Polymer Edition, V1, P207
   STOKES K, 1995, J BIOMATER APPL, V9, P321, DOI 10.1177/088532829500900402
   Subramanian S, 2006, TRANSFUS CLIN BIOL, V13, P31, DOI 10.1016/j.tracli.2006.02.009
   Subramanian S, 2006, BLOOD, V107, P2548, DOI 10.1182/blood-2005-04-1463
   Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527
   Toutouzas K, 2013, CURR VASC PHARMACOL, V11, P379
   Tsai RK, 2008, J CELL BIOL, V180, P989, DOI 10.1083/jcb.200708043
   Tsai RK, 2010, BLOOD CELL MOL DIS, V45, P67, DOI [10.1016/j.hcmd.2010.02.016, 10.1016/j.bcmd.2010.02.016]
   Ueda M, 2010, BIOMATERIALS, V31, P6394, DOI 10.1016/j.biomaterials.2010.05.006
   van den Berg TK, 2008, TRENDS IMMUNOL, V29, P203, DOI 10.1016/j.it.2008.02.004
   Vandivier RW, 2002, J IMMUNOL, V169, P3978, DOI 10.4049/jimmunol.169.7.3978
   Weber N, 2002, BIOMATERIALS, V23, P429, DOI 10.1016/S0142-9612(01)00122-3
   Wiggins MJ, 2001, J BIOMED MATER RES, V58, P302
   Wisniewski N, 2002, AM J PHYSIOL-ENDOC M, V282, pE1316, DOI 10.1152/ajpendo.00259.2001
   Wisniewski N, 2001, J BIOMED MATER RES, V57, P513, DOI 10.1002/1097-4636(20011215)57:4<513::AID-JBM1197>3.0.CO;2-E
   Yoo JW, 2010, CURR PHARM DESIGN, V16, P2298, DOI 10.2174/138161210791920496
   Zhang L, 2013, NAT BIOTECHNOL, V31, P553, DOI 10.1038/nbt.2580
   ZUCKER MB, 1985, ARTERIOSCLEROSIS, V5, P2, DOI 10.1161/01.ATV.5.1.2
NR 92
TC 5
Z9 5
U1 2
U2 12
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1535-3702
EI 1535-3699
J9 EXP BIOL MED
JI Exp. Biol. Med.
PD MAY
PY 2016
VL 241
IS 10
BP 1033
EP 1041
DI 10.1177/1535370216647130
PG 9
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DN6PJ
UT WOS:000377197400003
PM 27190273
OA Green Published
DA 2018-10-20
ER

PT J
AU Garash, R
   Bajpai, A
   Marcinkiewicz, BM
   Spiller, KL
AF Garash, Reham
   Bajpai, Anamika
   Marcinkiewicz, Brandon M.
   Spiller, Kara L.
TI Drug delivery strategies to control macrophages for tissue repair and
   regeneration
SO EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Review
DE Biomaterials; macrophage; drugs; wound; repair
ID FOREIGN-BODY RESPONSE; GIANT-CELL FORMATION; IN-VITRO; ANTIINFLAMMATORY
   MONOCYTES; LOCALIZED DELIVERY; ATHLETIC INJURIES; RECRUITMENT AGENT;
   BONE REGENERATION; DUAL RELEASE; SPINAL-CORD
AB Tissue repair and regeneration is a complex process. Our bodies have an excellent capacity to regenerate damaged tissues in many situations. However, tissue healing is impaired in injuries that exceed a critical size or are exacerbated by chronic inflammatory diseases like diabetes. In these instances, biomaterials and drug delivery strategies are often required to facilitate tissue regeneration by providing physical and biochemical cues. Inflammation is the body's response to injury. It is critical for wound healing and biomaterial integration and vascularization, as long as the timing is well controlled. For example, chronic inflammation is well known to impair healing in chronic wounds. In this review, we highlight the importance of a well-controlled inflammatory response, primarily mediated by macrophages in tissue repair and regeneration and discuss various strategies designed to promote regeneration by controlling macrophage behavior. These strategies include temporally controlled delivery of anti-inflammatory drugs, delivery of macrophages as cellular therapy, controlled release of cytokines that modulate macrophage phenotype, and the design of nanoparticles that exploit the inherent phagocytic behavior of macrophages. A clear outcome of this review is that a deeper understanding of the role and timing of complex macrophage phenotypes or activation states is required to fully harness their abilities with drug delivery strategies.
C1 [Garash, Reham; Bajpai, Anamika; Marcinkiewicz, Brandon M.; Spiller, Kara L.] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Biomat & Regenerat Med Lab, Philadelphia, PA 19104 USA.
RP Spiller, KL (reprint author), Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Biomat & Regenerat Med Lab, Philadelphia, PA 19104 USA.
EM Spiller@drexel.edu
FU NHLBI [1R01 HL130037-01]; Drexel-Coulter Translational Research
   Partnership
FX Work in the laboratory of KLS is supported by NHLBI 1R01 HL130037-01 and
   the Drexel-Coulter Translational Research Partnership.
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075
   Awojoodu AO, 2013, P NATL ACAD SCI USA, V110, P13785, DOI 10.1073/pnas.1221309110
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   BAKKER D, 1988, BIOMATERIALS, V9, P14, DOI 10.1016/0142-9612(88)90064-6
   Bartneck M, 2010, ACS NANO, V4, P3073, DOI 10.1021/nn100262h
   Camacho N, 2015, LUBRICANTS, V3, P597, DOI 10.3390/lubricants3030597
   Champion JA, 2009, PHARM RES-DORD, V26, P244, DOI 10.1007/s11095-008-9626-z
   CHONN A, 1992, J BIOL CHEM, V267, P18759
   Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184
   Fijn R, 2003, PHARM WORLD SCI, V25, P138, DOI 10.1023/A:1024830213832
   Ghanaati S, 2011, BIOMATERIALS, V32, P8150, DOI 10.1016/j.biomaterials.2011.07.041
   Glass GE, 2011, P NATL ACAD SCI USA, V108, P1585, DOI 10.1073/pnas.1018501108
   Godwin JW, 2013, P NATL ACAD SCI USA, V110, P9415, DOI 10.1073/pnas.1300290110
   Harel-Adar T, 2011, P NATL ACAD SCI USA, V108, P1827, DOI 10.1073/pnas.1015623108
   He CB, 2010, BIOMATERIALS, V31, P3657, DOI 10.1016/j.biomaterials.2010.01.065
   Hetrick EM, 2007, BIOMATERIALS, V28, P4571, DOI 10.1016/j.biomaterials.2007.06.036
   Hirose N, 2008, CELL TRANSPLANT, V17, P211, DOI 10.3727/000000008783906919
   Hisatome T, 2005, BIOMATERIALS, V26, P4550, DOI 10.1016/j.biomaterials.2004.11.032
   Hsu CW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131643
   Huang HJ, 2008, ACS NANO, V2, P203, DOI 10.1021/nn7000867
   Ihn H, 2002, J IMMUNOL, V168, P1895, DOI 10.4049/jimmunol.168.4.1895
   Jetten N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102994
   Jones MK, 1999, NAT MED, V5, P1418
   KAO WYJ, 1995, J BIOMED MATER RES, V29, P1267, DOI 10.1002/jbm.820291014
   Keeler GD, 2015, ACTA BIOMATER, V12, P11, DOI 10.1016/j.actbio.2014.10.022
   Khallou-Laschet J, 2010, PLOS ONE, V5, pe8852
   Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009
   Kim YH, 2016, J BIOMED MATER RES A, V104, P942, DOI 10.1002/jbm.a.35635
   Kim YH, 2014, BIOMATERIALS, V35, P214, DOI 10.1016/j.biomaterials.2013.09.103
   Knipper JA, 2015, IMMUNITY, V43, P803, DOI 10.1016/j.immuni.2015.09.005
   Koh TJ, 2011, EXPERT REV MOL MED, V13, pe2
   Krieger JR, 2016, BIOMATERIALS, V77, P280, DOI 10.1016/j.biomaterials.2015.10.045
   Kyriakides TR, 2004, AM J PATHOL, V165, P2157, DOI 10.1016/S0002-9440(10)63265-8
   Kzhyshkowska J, 2015, J LEUKOCYTE BIOL, V98, P953, DOI 10.1189/jlb.5VMR0415-166R
   Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018
   Leidi M, 2009, J IMMUNOL, V182, P4415, DOI 10.4049/jimmunol.0713732
   Leor J, 2006, CIRCULATION, V114
   Li SX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061799
   Long J, 2002, J BONE JOINT SURG AM, V84A, P1763, DOI 10.2106/00004623-200210000-00004
   Lu JY, 2013, KIDNEY INT, V84, P745, DOI 10.1038/ki.2013.135
   MAHESHWARI RK, 1991, J CELL PHYSIOL, V146, P164, DOI 10.1002/jcp.1041460121
   Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201
   Mehallo CJ, 2006, CLIN J SPORT MED, V16, P170, DOI 10.1097/00042752-200603000-00015
   Meijer C, 2000, LIVER, V20, P66, DOI 10.1034/j.1600-0676.2000.020001066.x
   Milde R, 2015, CELL REP, V13, P1937, DOI 10.1016/j.celrep.2015.10.065
   Mirza R, 2009, AM J PATHOL, V175, P2454, DOI 10.2353/ajpath.2009.090248
   Mirza RE, 2014, DIABETES, V63, P1103, DOI 10.2337/db13-0927
   Mirza RE, 2013, DIABETES, V62, P2579, DOI 10.2337/db12-1450
   Mokarram N, 2012, BIOMATERIALS, V33, P8793, DOI 10.1016/j.biomaterials.2012.08.050
   Mosqueira VCF, 2001, BIOMATERIALS, V22, P2967, DOI 10.1016/S0142-9612(01)00043-6
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Mou Xiaodun, 2011, J Diabetes Sci Technol, V5, P619
   Nassiri S, 2015, TISSUE REGENERATION, P65
   Nassiri S, 2015, J INVEST DERMATOL, V135, P1700, DOI 10.1038/jid.2015.30
   Nichols AW, 2005, CLIN J SPORT MED, V15, P370
   Pajarinen J, 2015, J BIOMED MATER RES A, V103, P1339, DOI 10.1002/jbm.a.35278
   Pentecost A.E., 2016, MICROSCALE TECHNOLOG, P291
   Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118
   Pountos I, 2012, SCI WORLD J, DOI 10.1100/2012/606404
   Raggatt LJ, 2014, AM J PATHOL, V184, P3192, DOI 10.1016/j.ajpath.2014.08.017
   Rapalino O, 1998, NAT MED, V4, P814, DOI 10.1038/nm0798-814
   Reeves ARD, 2015, BIOMATERIALS, V73, P272, DOI 10.1016/j.biomaterials.2015.09.027
   Rodriguez A, 2009, J BIOMED MATER RES A, V90A, P106, DOI 10.1002/jbm.a.32050
   Roh JD, 2010, P NATL ACAD SCI USA, V107, P4669, DOI 10.1073/pnas.0911465107
   Rybalko V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145550
   Saito A, 2003, INT ARCH ALLERGY IMM, V132, P168, DOI 10.1159/000073718
   SATO N, 1990, J INVEST DERMATOL, V95, pS85, DOI 10.1111/1523-1747.ep12874809
   Schlundt C., 2015, BONE
   Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490
   Spiller K., 2014, ANN BIOMED ENG, V43, P616
   Spiller KL, 2015, WOUND REPAIR REGEN, V23, pA40
   Spiller KL, 2015, BIOMATERIALS, V37, P194, DOI 10.1016/j.biomaterials.2014.10.017
   Spiller KL, 2014, BIOMATERIALS, V35, P4477, DOI 10.1016/j.biomaterials.2014.02.012
   Spiller KL, 2015, EXP CELL RES
   Stevens KR, 2002, J BIOMAT SCI-POLYM E, V13, P1353, DOI 10.1163/15685620260449741
   Torihashi S, 2000, HISTOCHEM CELL BIOL, V113, P73, DOI 10.1007/s004180050009
   Vacanti NM, 2012, BIOMACROMOLECULES, V13, P3031, DOI 10.1021/bm300520u
   van Amerongen MJ, 2007, AM J PATHOL, V170, P818, DOI 10.2353/ajpath.2007.060547
   Veiseh O, 2015, NAT MATER, V14, P643, DOI [10.1038/NMAT4290, 10.1038/nmat4290]
   Volpert OV, 1998, J EXP MED, V188, P1039, DOI 10.1084/jem.188.6.1039
   Wang Y, 2007, KIDNEY INT, V72, P290, DOI 10.1038/sj.ki.5002275
   Wood S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091574
   Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006
   Yu T, 2015, BIOMATERIALS REGENER, P17
   Yu T, 2016, J BIOMAT SCI-POLYM E, V27, P721, DOI 10.1080/09205063.2016.1155881
   Zuloff-Shani A, 2010, ARCH GERONTOL GERIAT, V51, P268, DOI 10.1016/j.archger.2009.11.015
NR 87
TC 13
Z9 14
U1 1
U2 29
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1535-3702
EI 1535-3699
J9 EXP BIOL MED
JI Exp. Biol. Med.
PD MAY
PY 2016
VL 241
IS 10
BP 1054
EP 1063
DI 10.1177/1535370216649444
PG 10
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DN6PJ
UT WOS:000377197400005
PM 27190256
OA Green Published
DA 2018-10-20
ER

PT J
AU Farhadi, SA
   Hudalla, GA
AF Farhadi, Shaheen A.
   Hudalla, Gregory A.
TI Engineering galectin-glycan interactions for immunotherapy and
   immunomodulation
SO EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Review
DE Biomaterial; bionanoscience; engineering; immunology; immunobiology;
   glycan
ID TUMOR-INFILTRATING LYMPHOCYTES; GALACTOSIDE-BINDING LECTIN;
   T-CELL-ACTIVATION; EXTRACELLULAR-MATRIX; DENDRITIC CELLS; RECOGNITION
   RECEPTORS; SOLUBLE GALECTIN-1; PANCREATIC-CANCER; IMMUNE PRIVILEGE;
   APOPTOSIS
AB Galectins, a 15-member family of soluble carbohydrate-binding proteins, are receiving increasing interest as therapeutic targets for immunotherapy and immunomodulation due to their role as extracellular signals that regulate innate and adaptive immune cell phenotype and function. However, different galectins can have redundant, synergistic, or antagonistic signaling activity in normal immunological responses, such as resolution of inflammation and induction of antigen-specific tolerance. In addition, certain galectins can be hijacked to promote progression of immunopathologies, such as tumor immune privilege, metastasis, and viral infection, while others can inhibit these processes. Thus, eliciting a desired immunological outcome will likely necessitate therapeutics that can precisely enhance or inhibit particular galectin-glycan interactions. Multivalency is an important determinant of the affinity and specificity of natural galectin-glycan interactions, and is emerging as a key design element for therapeutics that can effectively manipulate galectin bioactivity. This minireview surveys current molecular and biomaterial engineering approaches to create therapeutics that can stabilize galectin multivalency or recapitulate natural glycan multivalency (i.e. the glycocluster effect). In particular, we highlight examples of using natural and engineered multivalent galectins for immunosuppression and immune tolerance, with a particular emphasis on treating autoimmune diseases or avoiding transplant rejection. In addition, we present examples of multivalent inhibitors of galectin-glycan interactions to maintain or restore T-cell function, with a particular emphasis on promoting antitumor immunity. Finally, we discuss emerging opportunities to further engineer galectin-glycan interactions for immunotherapy and immunomodulation.
C1 [Farhadi, Shaheen A.; Hudalla, Gregory A.] Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL 32611 USA.
RP Hudalla, GA (reprint author), Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL 32611 USA.
EM ghudalla@bme.ufl.edu
FU National Science Foundation CAREER award [DMR-1455201]
FX This work was supported by a National Science Foundation CAREER award to
   G.A.H. (DMR-1455201).
CR Andre S, 2001, CHEMBIOCHEM, V2, P822, DOI 10.1002/1439-7633(20011105)2:11<822::AID-CBIC822>3.0.CO;2-W
   Auvynet C, 2013, GLYCOBIOLOGY, V23, P32, DOI 10.1093/glycob/cws128
   Banh A, 2011, CANCER RES, V71, P4423, DOI 10.1158/0008-5472.CAN-10-4157
   Baum LG, 2003, CLIN IMMUNOL, V109, P295, DOI 10.1016/j.clim.2003.08.003
   Beer MV, 2013, ADV HEALTHC MATER, V2, P306, DOI 10.1002/adhm.201200080
   Belardi B, 2012, J AM CHEM SOC, V134, P9549, DOI 10.1021/ja301694s
   Belitsky JM, 2007, CHEM BIOL, V14, P1140, DOI 10.1016/j.chembiol.2007.09.007
   Belo AI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065957
   Bernardi A, 2013, CHEM SOC REV, V42, P4709, DOI 10.1039/c2cs35408j
   Blanchard H, 2014, AUST J CHEM, V67, P1763, DOI 10.1071/CH14362
   Blois SM, 2007, NAT MED, V13, P1450, DOI 10.1038/nm1680
   Blois SM, 2015, J REPROD IMMUNOL, V108, P33, DOI 10.1016/j.jri.2014.12.001
   Branson TR, 2013, CHEM SOC REV, V42, P4613, DOI 10.1039/c2cs35430f
   Cedeno-Laurent F, 2012, BLOOD, V119, P3534, DOI 10.1182/blood-2011-12-396457
   Cedeno-Laurent F, 2012, J IMMUNOL, V188, P3127, DOI 10.4049/jimmunol.1103433
   Cedeno-Laurent F, 2012, CLIN IMMUNOL, V142, P107, DOI 10.1016/j.clim.2011.09.011
   Cedeno-Laurent F, 2012, J INVEST DERMATOL, V132, P410, DOI 10.1038/jid.2011.335
   Cedeno-Laurent F, 2010, J IMMUNOL, V185, P4659, DOI 10.4049/jimmunol.1000715
   Chen HY, 2009, P NATL ACAD SCI USA, V106, P14496, DOI 10.1073/pnas.0903497106
   Chernyy ES, 2011, BIOCHEMISTRY-MOSCOW+, V76, P958, DOI 10.1134/S0006297911080128
   CHO MJ, 1995, J BIOL CHEM, V270, P5207, DOI 10.1074/jbc.270.10.5207
   Chung CD, 2000, J IMMUNOL, V165, P3722, DOI 10.4049/jimmunol.165.7.3722
   Collins BE, 2004, CURR OPIN CHEM BIOL, V8, P617, DOI 10.1016/j.cbpa.2004.10.004
   Compagno D, 2014, CURR MOL MED, V14, P630, DOI 10.2174/1566524014666140603101953
   Cooper DNW, 1999, GLYCOBIOLOGY, V9, P979, DOI 10.1093/glycob/9.10.979
   Cousin JM, 2015, BEILSTEIN J ORG CHEM, V11, P739, DOI 10.3762/bjoc.11.84
   Crocker PR., 2001, MAMMALIAN CARBOHYDRA
   Dahms NM, 2008, GLYCOBIOLOGY, V18, P664, DOI 10.1093/glycob/cwn061
   Dalotto-Moreno T, 2013, CANCER RES, V73, P1107, DOI 10.1158/0008-5472.CAN-12-2418
   Demotte N, 2014, CLIN CANCER RES, V20, P1823, DOI 10.1158/1078-0432.CCR-13-2459
   Demotte N, 2010, CANCER RES, V70, P7476, DOI 10.1158/0008-5472.CAN-10-0761
   Dettin L, 2003, BIOL REPROD, V68, P51, DOI 10.1095/biolreprod.102.006361
   Di Lella S, 2011, BIOCHEMISTRY-US, V50, P7842, DOI 10.1021/bi201121m
   Drickamer K, 2015, CURR OPIN STRUC BIOL, V34, P26, DOI 10.1016/j.sbi.2015.06.003
   Ebrahim AH, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.09.12
   Elola MT, 2015, BIOCHEM J, V469, P1, DOI 10.1042/BJ20150461
   Fettis MM, 2016, J MATER CHEM B, V4, P3054, DOI 10.1039/c5tb02446c
   Fontaniella B, 2004, PLANT PHYSIOL BIOCH, V42, P773, DOI 10.1016/j.plaphy.2004.09.003
   Fulcher JA, 2006, J IMMUNOL, V177, P216, DOI 10.4049/jimmunol.177.1.216
   Gauthier L, 2002, P NATL ACAD SCI USA, V99, P13014, DOI 10.1073/pnas.202323999
   Gauthier S, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-105
   Giudicelli V, 1997, GLYCOBIOLOGY, V7, pR8
   Grigorian A, 2009, IMMUNOL REV, V230, P232, DOI 10.1111/j.1600-065X.2009.00796.x
   He JL, 2004, J BIOL CHEM, V279, P4705, DOI 10.1074/jbc.M311183200
   Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364
   Horlacher T, 2010, CHEMBIOCHEM, V11, P1563, DOI 10.1002/cbic.201000020
   Huang ML, 2016, EXP BIOL MED, V241, P1042, DOI 10.1177/1535370216647811
   Ilarregui JM, 2009, NAT IMMUNOL, V10, P981, DOI 10.1038/ni.1772
   Ishida K, 2003, OCUL IMMUNOL INFLAMM, V11, P91, DOI 10.1076/ocii.11.2.91.15914
   Ito K, 2012, CANCER METAST REV, V31, P763, DOI 10.1007/s10555-012-9388-2
   Ito K, 2012, CLIN EXP METASTAS, V29, P561, DOI 10.1007/s10585-012-9471-7
   Ito K, 2011, ANGIOGENESIS, V14, P293, DOI 10.1007/s10456-011-9213-5
   Kaltner H, 1998, ACTA ANAT, V161, P162
   Kanasty R, 2013, NAT MATER, V12, P967, DOI [10.1038/NMAT3765, 10.1038/nmat3765]
   Kang CW, 2015, SCI REP-UK, V5, DOI 10.1038/srep15659
   Kouo T, 2015, CANCER IMMUNOL RES, V3, P412, DOI 10.1158/2326-6066.CIR-14-0150
   Kuwabara I, 1996, J IMMUNOL, V156, P3939
   Leppanen A, 2005, J BIOL CHEM, V280, P5549, DOI 10.1074/jbc.m412019200
   Liu FT, 2012, ANN NY ACAD SCI, V1253, P80, DOI 10.1111/j.1749-6632.2011.06386.x
   Liu SD, 2008, BLOOD, V112, P120, DOI 10.1182/blood-2007-09-114181
   Lundquist JJ, 2002, CHEM REV, V102, P555, DOI 10.1021/cr000418f
   Macauley MS, 2014, NAT REV IMMUNOL, V14, P653, DOI 10.1038/nri3737
   MacKinnon AC, 2008, J IMMUNOL, V180, P2650, DOI 10.4049/jimmunol.180.4.2650
   Mascanfroni ID, 2011, INT IMMUNOPHARMACOL, V11, P833, DOI 10.1016/j.intimp.2011.01.021
   McDonald DM, 2015, FRONT CHEM, V3, DOI 10.3389/fchem.2015.00060
   Mercier S, 2008, VIROLOGY, V371, P121, DOI 10.1016/j.virol.2007.09.034
   Merlin J, 2011, ONCOGENE, V30, P2514, DOI 10.1038/onc.2010.631
   Michel AK, 2014, CHEMBIOCHEM, V15, P2106, DOI 10.1002/cbic.201402134
   Miller MC, 2009, BIOCHEM J, V421, P211, DOI 10.1042/BJ20090265
   Minko T, 2004, ADV DRUG DELIVER REV, V56, P491, DOI 10.1016/j.addr.2003.10.017
   Miura T, 2004, CELL DEATH DIFFER, V11, P1076, DOI 10.1038/sj.cdd.4401462
   Moiseeva EP, 2003, BBA-GEN SUBJECTS, V1619, P125, DOI 10.1016/S0304-4165(02)00447-6
   Morelli L, 2011, EUR J ORG CHEM, P5723, DOI 10.1002/ejoc.201100296
   Motran CC, 2008, EUR J IMMUNOL, V38, P3015, DOI 10.1002/eji.200838295
   Nabi IR, 2015, J CELL SCI, V128, P2213, DOI 10.1242/jcs.151159
   Nelson A, 2004, J AM CHEM SOC, V126, P11914, DOI 10.1021/ja0491073
   Nishi N, 2008, GLYCOBIOLOGY, V18, P1065, DOI 10.1093/glycob/cwn089
   Norling LV, 2009, J ENDOCRINOL, V201, P169, DOI 10.1677/JOE-08-0512
   Panjwani N, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.09.09
   PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0
   Perone MJ, 2009, J IMMUNOL, V182, P2641, DOI 10.4049/jimmunol.0800839
   Rabinovich G, 1999, J EXP MED, V190, P385, DOI 10.1084/jem.190.3.385
   Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536
   Restuccia A, 2016, J MATER CHEM B, V4, P1569, DOI 10.1039/c5tb01780g
   Restuccia A, 2015, CELL MOL BIOENG, V8, P471, DOI 10.1007/s12195-015-0399-2
   Rubinstein N, 2004, CANCER CELL, V5, P241, DOI 10.1016/S1535-6108(04)00024-8
   Ruvolo PP, 2015, BIOCHIM BIOPHYS ACTA, V1863, P562
   Santucci L, 2003, GASTROENTEROLOGY, V124, P1381, DOI 10.1016/S0016-5085(03)00267-1
   Sharon N, 2004, GLYCOBIOLOGY, V14, p53R, DOI 10.1093/glycob/cwh122
   St-Pierre C, 2012, ANTIMICROB AGENTS CH, V56, P154, DOI 10.1128/AAC.05595-11
   St-Pierre C, 2011, J VIROL, V85, P11742, DOI 10.1128/JVI.05351-11
   Stannard KA, 2010, CANCER LETT, V299, P95, DOI 10.1016/j.canlet.2010.08.005
   Starossom SC, 2012, IMMUNITY, V37, P249, DOI 10.1016/j.immuni.2012.05.023
   Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200
   Stowell SR, 2015, METHODS MOL BIOL, V1207, P51, DOI 10.1007/978-1-4939-1396-1_3
   Stowell SR, 2009, J BIOL CHEM, V284, P4989, DOI 10.1074/jbc.M808925200
   Tandon R, 2014, AIDS RES HUM RETROV, V30, P654, DOI [10.1089/aid.2014.0004, 10.1089/AID.2014.0004]
   Tang D, 2015, TUMOR BIOL, V36, P5617, DOI 10.1007/s13277-015-3233-5
   Thiemann S, 2016, ANNU REV IMMUNOL, V34, P91
   Thiemann S, 2015, J BIOL CHEM, V290, P22662, DOI 10.1074/jbc.M115.644799
   Thijssen VL, 2014, GLYCOBIOLOGY, V24, P915, DOI 10.1093/glycob/cwu048
   Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1489
   Toscano MA, 2006, J IMMUNOL, V176, P6323, DOI 10.4049/jimmunol.176.10.6323
   van der Leij J, 2007, MOL IMMUNOL, V44, P506, DOI 10.1016/j.molimm.2006.02.011
   Vasta GR, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00199
   Vasta GR, 2012, ADV EXP MED BIOL, V946, P21, DOI 10.1007/978-1-4614-0106-3_2
   Vella M, 2015, EXPERT OPIN BIOL TH, V15, P529, DOI 10.1517/14712598.2015.993375
   Vespa GNR, 1999, J IMMUNOL, V162, P799
   Weisman A, 2015, ADV DRUG DELIVER REV, V90, P81, DOI 10.1016/j.addr.2015.05.011
   Xu GS, 2010, INT IMMUNOPHARMACOL, V10, P643, DOI 10.1016/j.intimp.2010.03.001
   Yamamoto K, 2009, BIOL PHARM BULL, V32, P767, DOI 10.1248/bpb.32.767
   Yan XB, 2015, BIOMACROMOLECULES, V16, P1827, DOI 10.1021/acs.biomac.5b00413
NR 112
TC 4
Z9 4
U1 1
U2 25
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1535-3702
EI 1535-3699
J9 EXP BIOL MED
JI Exp. Biol. Med.
PD MAY
PY 2016
VL 241
IS 10
BP 1074
EP 1083
DI 10.1177/1535370216650055
PG 10
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DN6PJ
UT WOS:000377197400007
PM 27229902
OA Green Published
DA 2018-10-20
ER

PT J
AU Ogle, ME
   Segar, CE
   Sridhar, S
   Botchwey, EA
AF Ogle, Molly E.
   Segar, Claire E.
   Sridhar, Sraeyes
   Botchwey, Edward A.
TI Monocytes and macrophages in tissue repair: Implications for
   immunoregenerative biomaterial design
SO EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Review
DE Monocyte; macrophage; biomaterial; regeneration; wound healing;
   inflammation
ID SKELETAL-MUSCLE INJURY; POLY(ETHYLENE GLYCOL)-BASED HYDROGELS; ACUTE
   MYOCARDIAL-INFARCTION; COLLATERAL ARTERY GROWTH; FOREIGN-BODY REACTION;
   VIVO HOST RESPONSE; IN-VIVO; CIRCULATING MONOCYTES; RESIDENT
   MACROPHAGES; ANTIINFLAMMATORY MONOCYTES
AB Monocytes and macrophages play a critical role in tissue development, homeostasis, and injury repair. These innate immune cells participate in guiding vascular remodeling, stimulation of local stem and progenitor cells, and structural repair of tissues such as muscle and bone. Therefore, there is a great interest in harnessing this powerful endogenous cell source for therapeutic regeneration through immunoregenerative biomaterial engineering. These materials seek to harness specific subpopulations of monocytes/macrophages to promote repair by influencing their recruitment, positioning, differentiation, and function within a damaged tissue. Monocyte and macrophage phenotypes span a continuum of inflammatory (M1) to anti-inflammatory or pro-regenerative cells (M2), and their heterogeneous functions are highly dependent on microenvironmental cues within the injury niche. Increasing evidence suggests that division of labor among subpopulations of monocytes and macrophages could allow for harnessing regenerative functions over inflammatory functions of myeloid cells; however, the complex balance between necessary functions of inflammatory versus regenerative myeloid cells remains to be fully elucidated. Historically, biomaterial-based therapies for promoting tissue regeneration were designed to minimize the host inflammatory response; although, recent appreciation for the roles that innate immune cells play in tissue repair and material integration has shifted this paradigm. A number of opportunities exist to exploit known signaling systems of specific populations of monocytes/macrophages to promote repair and to better understand the biological and pathological roles of myeloid cells. This review seeks to outline the characteristics of distinct populations of monocytes and macrophages, identify the role of these cells within diverse tissue injury niches, and offer design criteria for immunoregenerative biomaterials given the intrinsic inflammatory response to their implantation.
C1 [Ogle, Molly E.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   Emory Univ, Atlanta, GA 30332 USA.
RP Ogle, ME (reprint author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
EM molly.ogle@bme.gatech.edu
FU NIH [5R01AR056445]; American Heart Association [15PRE25090024]; P.E.O.
   Scholar Award
FX This work was supported by NIH 5R01AR056445, American Heart Association
   Grant 15PRE25090024 (CES), and P.E.O. Scholar Award (CES).
CR Alexander KA, 2011, J BONE MINER RES, V26, P1517, DOI 10.1002/jbmr.354
   Ancuta P, 2003, J EXP MED, V197, P1701, DOI 10.1084/jem.20022156
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075
   Arnold L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9972
   Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883
   Avraham-Davidi I, 2013, J EXP MED, V210, P2611, DOI 10.1084/jem.20120690
   Awojoodu AO, 2014, BLOOD, V124, P1941, DOI 10.1182/blood-2014-01-543652
   Awojoodu AO, 2013, P NATL ACAD SCI USA, V110, P13785, DOI 10.1073/pnas.1221309110
   Bai F, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/1/015007
   Bartneck M, 2012, BIOMATERIALS, V33, P4136, DOI 10.1016/j.biomaterials.2012.02.050
   Bergmann CE, 2006, J LEUKOCYTE BIOL, V80, P59, DOI 10.1189/jlb.0206087
   Blakney AK, 2012, J BIOMED MATER RES A, V100A, P1375, DOI 10.1002/jbm.a.34104
   Bota PCS, 2010, J BIOMED MATER RES A, V95A, P649, DOI 10.1002/jbm.a.32893
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Cao HQ, 2010, J BIOMED MATER RES A, V93A, P1151, DOI 10.1002/jbm.a.32609
   Carlin LM, 2013, CELL, V153, P362, DOI 10.1016/j.cell.2013.03.010
   Champagne CM, 2002, BONE, V30, P26, DOI 10.1016/S8756-3282(01)00638-X
   Champion JA, 2006, P NATL ACAD SCI USA, V103, P4930, DOI 10.1073/pnas.0600997103
   Chang MK, 2008, J IMMUNOL, V181, P1232, DOI 10.4049/jimmunol.181.2.1232
   Chen SL, 2010, BIOMATERIALS, V31, P3479, DOI 10.1016/j.biomaterials.2010.01.074
   Cho SW, 2014, P NATL ACAD SCI USA, V111, P1545, DOI 10.1073/pnas.1315153111
   Collison JL, 2015, J IMMUNOL, V195, P1162, DOI 10.4049/jimmunol.1401806
   Crane MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086660
   Dal-Secco D, 2015, J EXP MED, V212, P447, DOI 10.1084/jem.20141539
   Deng B, 2012, J IMMUNOL, V189, P3669, DOI 10.4049/jimmunol.1103180
   Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249
   Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019
   Fantin A, 2010, BLOOD, V116, P829, DOI 10.1182/blood-2009-12-257832
   Fereol S, 2006, CELL MOTIL CYTOSKEL, V63, P321, DOI 10.1002/cm.20130
   Garg K, 2013, BIOMATERIALS, V34, P4439, DOI 10.1016/j.biomaterials.2013.02.065
   Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419
   Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2
   Getts DR, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007563
   Ginhoux F, 2016, NAT IMMUNOL, V17, P34, DOI 10.1038/ni.3324
   Godwin JW, 2013, P NATL ACAD SCI USA, V110, P9415, DOI 10.1073/pnas.1300290110
   Goncalves R, 2011, J EXP MED, V208, P1253, DOI 10.1084/jem.20101751
   Goodman SB, 2007, BIOMATERIALS, V28, P5044, DOI 10.1016/j.biomaterials.2007.06.035
   Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733
   Gref R, 2000, COLLOID SURFACE B, V18, P301, DOI 10.1016/S0927-7765(99)00156-3
   Griffith CK, 2005, TISSUE ENG, V11, P257, DOI 10.1089/ten.2005.11.257
   Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036
   Hanna RN, 2011, NAT IMMUNOL, V12, P778, DOI 10.1038/ni.2063
   Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004
   Heil M, 2004, CIRC RES, V94, P671, DOI 10.1161/01.RES.0000122041.73808.B5
   Heil M, 2002, AM J PHYSIOL-HEART C, V283, pH2411, DOI 10.1152/ajpheart.01098.2001
   Hettinger J, 2013, NAT IMMUNOL, V14, P821, DOI 10.1038/ni.2638
   Hoefer IE, 2004, CIRC RES, V94, P1179, DOI 10.1161/01.RES.0000126922.18222.F0
   Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011
   Hoffman AS, 2013, ADV DRUG DELIVER REV, V65, P10, DOI 10.1016/j.addr.2012.11.004
   Hsu CW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131643
   Ito WD, 1997, CIRC RES, V80, P829
   Jay SM, 2010, BIOMATERIALS, V31, P3054, DOI 10.1016/j.biomaterials.2010.01.014
   Jenkins SJ, 2013, J EXP MED, V210, P2477, DOI 10.1084/jem.20121999
   Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Knipper JA, 2015, IMMUNITY, V43, P803, DOI 10.1016/j.immuni.2015.09.005
   Krieger JR, 2016, BIOMATERIALS, V77, P280, DOI 10.1016/j.biomaterials.2015.10.045
   Kusaka T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092634
   Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018
   Lavine KJ, 2014, P NATL ACAD SCI USA, V111, P16029, DOI 10.1073/pnas.1406508111
   Lee TT, 2015, NAT MATER, V14, P352, DOI [10.1038/NMAT4157, 10.1038/nmat4157]
   Leuschner F, 2012, J EXP MED, V209, P123, DOI 10.1084/jem.20111009
   Li L, 2012, J BIOL CHEM, V287, P25353, DOI 10.1074/jbc.M112.349126
   Lu HY, 2011, FASEB J, V25, P358, DOI 10.1096/fj.10-171579
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Lynn AD, 2011, ACTA BIOMATER, V7, P123, DOI 10.1016/j.actbio.2010.07.033
   Lynn AD, 2010, J BIOMED MATER RES A, V93A, P941, DOI 10.1002/jbm.a.32595
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   Majmudar MD, 2013, CIRCULATION, V127, P2038, DOI 10.1161/CIRCULATIONAHA.112.000116
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303
   McWhorter FY, 2013, P NATL ACAD SCI USA, V110, P17253, DOI 10.1073/pnas.1308887110
   Melgar-Lesmes P, 2015, J HEPATOL, V63, P917, DOI 10.1016/j.jhep.2015.05.011
   Mokarram N, 2012, BIOMATERIALS, V33, P8793, DOI 10.1016/j.biomaterials.2012.08.050
   Moldovan NI, 2000, CIRC RES, V87, P378
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   MUTSAERS SE, 1988, J LEUKOCYTE BIOL, V44, P17
   Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885
   Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346
   Nassiri S, 2015, J INVEST DERMATOL, V135, P1700, DOI 10.1038/jid.2015.30
   Nickerson MM, 2009, ANGIOGENESIS, V12, P355, DOI 10.1007/s10456-009-9157-1
   Ogle ME, 2014, ACTA BIOMATER, V10, P4704, DOI 10.1016/j.actbio.2014.08.007
   Padmanabhan J, 2014, ACS NANO, V8, P4366, DOI 10.1021/nn501874q
   PASSLICK B, 1989, BLOOD, V74, P2527
   Patel NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041024
   Patterson J, 2011, BIOMATERIALS, V32, P1301, DOI 10.1016/j.biomaterials.2010.10.016
   Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989
   Phelps EA, 2013, BIOMATERIALS, V34, P4602, DOI 10.1016/j.biomaterials.2013.03.012
   Pinto AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036814
   Raggatt LJ, 2014, AM J PATHOL, V184, P3192, DOI 10.1016/j.ajpath.2014.08.017
   Reeves ARD, 2015, BIOMATERIALS, V73, P272, DOI 10.1016/j.biomaterials.2015.09.027
   Rettig L, 2010, BLOOD, V115, P4533, DOI 10.1182/blood-2009-11-247817
   Riedel T, 2013, LANGMUIR, V29, P3388, DOI 10.1021/la304886r
   Ruparelia N, 2015, EUR HEART J, V36, P1923, DOI 10.1093/eurheartj/ehv195
   Rzeniewicz K, 2015, P NATL ACAD SCI USA, V112, pE1461, DOI 10.1073/pnas.1417100112
   Saclier M, 2013, STEM CELLS, V31, P384, DOI 10.1002/stem.1288
   Sanders JE, 2000, J BIOMED MATER RES, V52, P231, DOI 10.1002/1097-4636(200010)52:1<231::AID-JBM29>3.0.CO;2-E
   Schlundt C, 2018, BONE, V106, P78, DOI 10.1016/j.bone.2015.10.019
   Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070
   Sinder BP, 2015, J BONE MINER RES, V30, P2140, DOI 10.1002/jbmr.2735
   Sironi M, 2006, J LEUKOCYTE BIOL, V80, P342, DOI 10.1189/jlb.1005586
   Slaney CY, 2011, IMMUNOL CELL BIOL, V89, P7, DOI 10.1038/icb.2010.110
   Spiller KL, 2016, EXP CELL RES, V347, P1, DOI 10.1016/j.yexcr.2015.10.017
   Spiller KL, 2015, BIOMATERIALS, V37, P194, DOI 10.1016/j.biomaterials.2014.10.017
   Spiller KL, 2014, BIOMATERIALS, V35, P4477, DOI 10.1016/j.biomaterials.2014.02.012
   Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160
   Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410
   Swartzlander MD, 2015, BIOMATERIALS, V41, P26, DOI 10.1016/j.biomaterials.2014.11.026
   Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202
   TABATA Y, 1988, BIOMATERIALS, V9, P356, DOI 10.1016/0142-9612(88)90033-6
   Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549
   Underhill DM, 2012, NAT REV IMMUNOL, V12, P492, DOI 10.1038/nri3244
   van Amerongen MJ, 2007, AM J PATHOL, V170, P818, DOI 10.2353/ajpath.2007.060547
   VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415
   Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011
   Veiseh O, 2015, NAT MATER, V14, P643, DOI [10.1038/NMAT4290, 10.1038/nmat4290]
   Vi L, 2015, J BONE MINER RES, V30, P1090, DOI 10.1002/jbmr.2422
   Winkler IG, 2010, BLOOD, V116, P4815, DOI 10.1182/blood-2009-11-253534
   Wolf MT, 2014, BIOMATERIALS, V35, P6838, DOI 10.1016/j.biomaterials.2014.04.115
   Wu Andy C, 2013, Bonekey Rep, V2, P373, DOI 10.1038/bonekey.2013.107
   Xie H, 2014, NAT MED, V20, P1270, DOI 10.1038/nm.3668
   Xing ZQ, 2010, DIS MODEL MECH, V3, P451, DOI 10.1242/dmm.003186
   Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001
   Yrlid U, 2006, J IMMUNOL, V176, P4155, DOI 10.4049/jimmunol.176.7.4155
   Zhao WM, 2016, FASEB J, V30, P380, DOI 10.1096/fj.14-270090
NR 126
TC 47
Z9 49
U1 9
U2 38
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1535-3702
EI 1535-3699
J9 EXP BIOL MED
JI Exp. Biol. Med.
PD MAY
PY 2016
VL 241
IS 10
BP 1084
EP 1097
DI 10.1177/1535370216650293
PG 14
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DN6PJ
UT WOS:000377197400008
PM 27229903
OA Green Published, Green Accepted
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Lewis, JS
   Allen, RP
AF Lewis, Jamal S.
   Allen, Riley P.
TI An introduction to biomaterial-based strategies for curbing autoimmunity
SO EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Review
DE Immuno-engineering; biomaterials; autoimmune disease; particulate;
   immunotherapy; tolerogenic
ID REGULATORY T-CELLS; TOLEROGENIC DENDRITIC CELLS; PLASMA-PROTEIN
   ADSORPTION; INFLAMMATORY-DISEASES; NEGATIVE SELECTION;
   CROSS-PRESENTATION; POLYMER PARTICLES; IMMUNE-SYSTEM; LYMPH-NODES;
   EX-VIVO
AB Recently, scientists have made significant progress in the development of immunotherapeutics that correct aberrant, autoimmune responses. Yet, concerns about the safety, efficacy, and wide scale applicability continue to hinder use of contemporary, immunology-based strategies. There is a clear need for therapies that finely control molecular and cellular elements of the immune system. Biomaterial engineers have taken up this challenge to develop therapeutics with selective spatial and temporal control of immune cells. In this review, we introduce the immunology of autoimmune disorders, survey the current therapeutic strategies for autoimmune diseases, and highlight the ongoing research efforts to engineer the immune system using biomaterials, for positive therapeutic outcomes in treatment of autoimmune disorders.
C1 [Lewis, Jamal S.; Allen, Riley P.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.
RP Lewis, JS (reprint author), Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.
EM jamlewis@ucdavis.edu
FU National Institutes of Health [R43DK100132]
FX JSL gratefully acknowledges the grant support from the National
   Institutes of Health (award - R43DK100132).
CR Aarvak T, 2000, RHEUMATOLOGY, V39, P513, DOI 10.1093/rheumatology/39.5.513
   Andrews S., 2010, BLOOD, V115, P4
   Azar ST, 1999, CLIN DIAGN LAB IMMUN, V6, P306
   Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767
   Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156
   Brunstein CG, 2011, BLOOD, V117, P1061, DOI 10.1182/blood-2010-07-293795
   Brusko TM, 2005, DIABETES, V54, P1407, DOI 10.2337/diabetes.54.5.1407
   Butoescu N, 2009, BIOMATERIALS, V30, P1772, DOI 10.1016/j.biomaterials.2008.12.017
   Candon S, 2004, J IMMUNOL, V172, P2917, DOI 10.4049/jimmunol.172.5.2917
   Castro JE, 1996, IMMUNITY, V5, P617, DOI 10.1016/S1074-7613(00)80275-7
   Champion JA, 2009, PHARM RES-DORD, V26, P244, DOI 10.1007/s11095-008-9626-z
   Charlton B, 1995, CURR OPIN IMMUNOL, V7, P793, DOI 10.1016/0952-7915(95)80050-6
   Chatenoud L, 2007, NAT REV IMMUNOL, V7, P622, DOI 10.1038/nri2134
   Chen CR, 2003, J CLIN INVEST, V111, P1897, DOI 10.1172/JCI200317069
   De Temmerman ML, 2011, DRUG DISCOV TODAY, V16, P569, DOI 10.1016/j.drudis.2011.04.006
   Dinarello CA, 2003, VACCINE, V21, pS24, DOI 10.1016/S0264-410X(03)00196-8
   Forrester JV, 2008, MUCOSAL IMMUNOL, V1, P372, DOI 10.1038/mi.2008.27
   Giannoukakis N, 2013, IMMUNOTHERAPY-UK, V5, P569, DOI [10.2217/IMT.13.50, 10.2217/imt.13.50]
   Giannoukakis N, 2011, DIABETES CARE, V34, P2026, DOI 10.2337/dc11-0472
   Gref R, 2000, COLLOID SURFACE B, V18, P301, DOI 10.1016/S0927-7765(99)00156-3
   GREF R, 1994, SCIENCE, V263, P1600, DOI 10.1126/science.8128245
   Horwitz DA, 2004, SEMIN IMMUNOL, V16, P135, DOI 10.1016/j.smim.2003.12.009
   IMBACH P, 1990, AM J PEDIAT HEMATOL, V12, P134
   Jewell CM, 2011, P NATL ACAD SCI USA, V108, P15745, DOI 10.1073/pnas.1105200108
   Jiang WL, 2005, ADV DRUG DELIVER REV, V57, P391, DOI 10.1016/j.addr.2004.09.003
   Jilek S, 2004, PHARM RES, V21, P8
   Kamradt T, 2001, NEW ENGL J MED, V344, P655, DOI 10.1056/NEJM200103013440907
   Kang ZH, 2013, NAT NEUROSCI, V16, P1401, DOI 10.1038/nn.3505
   Keselowsky BG, 2011, HUM VACCINES, V7, P37, DOI 10.4161/hv.7.1.12916
   Kourtis IC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061646
   Lacasse FX, 1998, PHARMACEUT RES, V15, P312, DOI 10.1023/A:1011935222652
   Lapadula G, 2014, INT J IMMUNOPATH PH, V27, P33, DOI 10.1177/03946320140270S103
   Lewis JS, 2014, J MATER CHEM B, V2, P2562, DOI 10.1039/c3tb21460e
   Lewis JS, 2014, MRS BULL, V39, P25, DOI 10.1557/mrs.2013.310
   Lewis JS, 2012, BIOMATERIALS, V33, P7221, DOI 10.1016/j.biomaterials.2012.06.049
   Liu Y, 2013, J MATER CHEM B, V1, P3888, DOI 10.1039/c3tb20383b
   Longhi MS, 2004, J HEPATOL, V41, P31, DOI 10.1016/j.hep.2004.03.008
   Look M, 2013, J CLIN INVEST, V123, P1741, DOI 10.1172/JCI65907
   Maddur MS, 2012, AM J PATHOL, V181, P8, DOI 10.1016/j.ajpath.2012.03.044
   Marek-Trzonkowska N, 2012, DIABETES CARE, V35, P1817, DOI 10.2337/dc12-0038
   Mccarthy DP, 2012, METHOD MOL BIOL, V900, P1
   Munier S, 2005, COLLOID SURFACE B, V43, P163, DOI 10.1016/j.colsurfb.2005.05.001
   Munir H, 2015, STEM CELLS DEV, V24, P2091, DOI 10.1089/scd.2015.0008
   Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173
   Nelson BH, 2004, J IMMUNOL, V172, P3983, DOI 10.4049/jimmunol.172.7.3983
   Neoh KG, 2011, POLYM CHEM-UK, V2, P747, DOI 10.1039/c0py00266f
   Noack M, 2014, AUTOIMMUN REV, V13, P668, DOI 10.1016/j.autrev.2013.12.004
   NOSSAL GJV, 1994, CELL, V76, P229, DOI 10.1016/0092-8674(94)90331-X
   O'Shea JJ, 2014, CELL, V157, P227, DOI 10.1016/j.cell.2014.03.010
   Ostrov BE, 2015, IMMUNOL INVEST, V44, P777, DOI 10.3109/08820139.2015.1093912
   Osuji N, 2005, LEUKEMIA LYMPHOMA, V46, P723, DOI 10.1080/10428190500052156
   Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261
   Patterson H, 2014, CLIN EXP IMMUNOL, V176, P1, DOI 10.1111/cei.12248
   Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297
   Reddy ST, 2006, J CONTROL RELEASE, V112, P26, DOI 10.1016/j.jconrel.2006.01.006
   Rouse M, 2013, IMMUNOBIOLOGY, V218, P674, DOI 10.1016/j.imbio.2012.08.269
   Sheng Y, 2009, BIOMATERIALS, V30, P2340, DOI 10.1016/j.biomaterials.2008.12.070
   Shu S, 2006, CANCER METAST REV, V25, P233, DOI 10.1007/s10555-006-8503-7
   Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040
   Suwandi JS, 2015, CLIN EXP RHEUMATOL, V33, pS97
   Suzuki K, 2009, J EXP MED, V206, P1485, DOI 10.1084/jem.20090209
   Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139
   Tran KK, 2009, BIOMATERIALS, V30, P1356, DOI 10.1016/j.biomaterials.2008.11.034
   Tsai SE, 2010, IMMUNITY, V32, P568, DOI 10.1016/j.immuni.2010.03.015
   Virgolini L, 2004, BIOMED PHARMACOTHER, V58, P299, DOI 10.1016/j.biopha.2004.04.006
   von Boehmer H, 2009, EUR J IMMUNOL, V39, P2313, DOI 10.1002/eji.200939575
   VONBOEHMER H, 1988, ANNU REV IMMUNOL, V6, P309, DOI 10.1146/annurev.immunol.6.1.309
   Vrolix K, 2010, AUTOIMMUNITY, V43, P380, DOI 10.3109/08916930903518073
   Waeckerle-Men Y, 2004, J IMMUNOL METHODS, V287, P109, DOI 10.1016/j.jim.2004.01.010
   Wang NX, 2012, BIOTECHNOL BIOENG, V109, P1835, DOI 10.1002/bit.24431
   Yang YW, 2008, BIOMATERIALS, V29, P2516, DOI 10.1016/j.biomaterials.2008.02.015
   Yarkoni Y, 2010, IMMUNOL REV, V237, P249, DOI 10.1111/j.1600-065X.2010.00936.x
   Yoo JW, 2011, NAT REV DRUG DISCOV, V10, P521, DOI 10.1038/nrd3499
   Yoon YM, 2015, SCI REP-UK, V5, DOI 10.1038/srep13155
   Yoshida M, 2004, J BIOMED MATER RES A, V71A, P45, DOI 10.1002/jbm.a.30131
   Zhang X, 2013, J IMMUNOL, V191, P5867, DOI 10.4049/jimmunol.1301926
NR 76
TC 3
Z9 4
U1 0
U2 12
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1535-3702
EI 1535-3699
J9 EXP BIOL MED
JI Exp. Biol. Med.
PD MAY
PY 2016
VL 241
IS 10
BP 1107
EP 1115
DI 10.1177/1535370216650294
PG 9
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DN6PJ
UT WOS:000377197400010
PM 27229905
OA Green Published
DA 2018-10-20
ER

PT J
AU Mewhort, HEM
   Turnbull, JD
   Satriano, A
   Chow, K
   Flewitt, JA
   Andrei, AC
   Guzzardi, DG
   Svystonyuk, DA
   White, JA
   Fedak, PWM
AF Mewhort, Holly E. M.
   Turnbull, Jeannine D.
   Satriano, Alessandro
   Chow, Kelvin
   Flewitt, Jacqueline A.
   Andrei, Adin-Cristian
   Guzzardi, David G.
   Svystonyuk, Daniyil A.
   White, James A.
   Fedak, Paul W. M.
TI Epicardial infarct repair with bioinductive extracellular matrix
   promotes vasculogenesis and myocardial recovery
SO JOURNAL OF HEART AND LUNG TRANSPLANTATION
LA English
DT Article
DE heart failure; myocardial infarction; extracellular matrix;
   angiogenesis; cardiac MRI; ischemia-reperfusion
ID PARACRINE MECHANISM; HEART-DISEASE; CELL; REGENERATION; SCAFFOLD;
   INJURY; ECM
AB BACKGROUND: Infarcted myocardium can remodel after successful reperfusion, resulting in left ventricular dilation and heart failure. Epicardial infarct repair (EIR) using a bioinductive extracellular matrix (ECM) biomaterial is a novel surgical approach to promote endogenous myocardial repair and functional recovery after myocardial infarction. Using a pre-clinical porcine model of coronary ischemia-reperfusion, we assessed the effects of EIR on regional functional recovery, safety, and possible mechanisms of benefit.
   METHODS: An ECM biomaterial (CorMatrix ECM) was applied to the epicardium after 75 minutes of coronary ischemia in a porcine model. Following ischemia-reperfusion injury, animals were randomly assigned in 2:1 fashion to EIR (n = 8) or sham treatment (n = 4). Serial cardiac magnetic resonance imaging was performed on normal (n = 4) and study animals at baseline (1 week) and 6 weeks after treatment. Myocardial function and tissue characteristics were assessed.
   RESULTS: Functional myocardial recovery was significantly increased by EIR compared with sham treatment (change in regional myocardial contraction at 6 weeks, 28.6 +/- 14.0% vs 4.2 +/- 13.5% wall thickening, p < 0.05). Animals receiving EIR had reduced adhesions compared with animals receiving sham treatment (1.44 +/- 0.51 vs 3.08 +/- 0.89, p < 0.05). Myocardial fibrosis was not increased, and EIR did not cause myocardial constriction, as left ventricular compliance by passive pressure distention at matched volumes was similar between groups (13.9 +/- 4.0 mm Hg in EIR group vs 16.0 +/- 5.2 mm Hg in sham group, p = 0.61). Animals receiving EIR showed evidence of vasculogenesis in the region of functional recovery.
   CONCLUSIONS: In addition to the beneficial effects of successful reperfusion, EIR using a bioinductive ECM enhances myocardial repair and functional recovery. Clinical translation of EIR early after myocardial infarction as an adjunct to surgical revascularization may be warranted in the future. (C) 2016 The Authors. Published by Elsevier Inc. on behalf of International Society for Heart and Lung Transplantation. All rights reserved.
C1 [Mewhort, Holly E. M.; Turnbull, Jeannine D.; Guzzardi, David G.; Svystonyuk, Daniyil A.; Fedak, Paul W. M.] Univ Calgary, Div Cardiac Surg, Calgary, AB, Canada.
   [Satriano, Alessandro; Flewitt, Jacqueline A.; White, James A.] Univ Calgary, Dept Cardiac Sci, Stephenson Cardiovasc MR Ctr, Libin Cardiovasc Inst Alberta, Calgary, AB, Canada.
   [Chow, Kelvin] Univ Alberta, Dept Biomed Engn, Edmonton, AB, Canada.
   [Andrei, Adin-Cristian; Fedak, Paul W. M.] Northwestern Univ, Bluhin Cardiovasc Inst, Chicago, IL 60611 USA.
RP Fedak, PWM (reprint author), C880,1403-29 St NW, Calgary, AB T2N 2T9, Canada.
EM paul.fedak@gmail.com
OI Fedak, Paul/0000-0003-0658-9381; Andrei,
   Adin-Cristian/0000-0001-8129-3981
FU Alberta Innovates [201201075]
CR Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Baicu CF, 2003, AM J PHYSIOL-HEART C, V284, pH122, DOI 10.1152/ajpheart.00233.2002
   Balmer GM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5054
   Bayomy AF, 2012, LIFE SCI, V91, P823, DOI 10.1016/j.lfs.2012.08.034
   Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000
   Bock-Marquette I, 2009, J MOL CELL CARDIOL, V46, P728, DOI 10.1016/j.yjmcc.2009.01.017
   Burkhoff D, 2005, AM J PHYSIOL-HEART C, V289, pH501, DOI 10.1152/ajpheart.00138.2005
   Chow K, 2014, MAGN RESON MED, V71, P2082, DOI 10.1002/mrm.24878
   Daly KA, 2009, TISSUE ENG PT A, V15, P3877, DOI 10.1089/ten.TEA.2009.0089
   Fazel S, 2005, J THORAC CARDIOV SUR, V130, P1310, DOI 10.1016/j.jtcvs.2005.07.012
   Fedak PWM, 2012, CIRC-HEART FAIL, V5, P349, DOI 10.1161/CIRCHEARTFAILURE.111.965889
   Fedak PWM, 2010, CARDIOVASC RES, V87, P8, DOI 10.1093/cvr/cvq124
   Fedak PWM, 2005, J THORAC CARDIOV SUR, V130, P1430, DOI 10.1016/j.jtcvs.2005.05.055
   Go AS, 2013, CIRCULATION, V127, P143, DOI 10.1161/CIR.0b013e318282ab8f
   Kim RJ, 2000, NEW ENGL J MED, V343, P1445, DOI 10.1056/NEJM200011163432003
   Konertz WF, 2003, ANN THORAC SURG, V76, P1270, DOI 10.1016/S0003-4975(03)00733-1
   Mercer SE, 2013, DEV BIOL, V382, P457, DOI 10.1016/j.ydbio.2013.08.002
   Mewhort HEM, 2014, J THORAC CARDIOV SUR, V147, P1650, DOI 10.1016/j.jtcvs.2013.08.005
   Morita M, 2011, ANN THORAC SURG, V92, P617, DOI 10.1016/j.athoracsur.2011.04.051
   Murphy-Ullrich JE, 2001, J CLIN INVEST, V107, P785, DOI 10.1172/JCI12609
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Satriano A, 2015, J BIOMECH, V48, P354, DOI 10.1016/j.jbiomech.2014.11.016
   Scholl FG, 2010, WORLD J PEDIATR CONG, V1, P132, DOI 10.1177/2150135110362092
   Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383
   Smart N, 2012, FUTUR CARDIOL, V8, P53, DOI [10.2217/fca.11.87, 10.2217/FCA.11.87]
   Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188
   van Wijk B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044692
   Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327
   Walther T, 2002, CIRCULATION S1, V106, pI23
   Witt RG, 2013, EUR J CARDIO-THORAC, V44, P72, DOI 10.1093/ejcts/ezs638
   Zaidi AH, 2014, J THORAC CARDIOVASC, V148, pe1
   Zhou B, 2011, J CLIN INVEST, V121, P1894, DOI 10.1172/JCI45529
NR 33
TC 4
Z9 4
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1053-2498
EI 1557-3117
J9 J HEART LUNG TRANSPL
JI J. Heart Lung Transplant.
PD MAY
PY 2016
VL 35
IS 5
BP 661
EP 670
DI 10.1016/j.healun.2016.01.012
PG 10
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery;
   Transplantation
SC Cardiovascular System & Cardiology; Respiratory System; Surgery;
   Transplantation
GA DN3HB
UT WOS:000376951900018
PM 26987597
OA Other Gold
DA 2018-10-20
ER

PT J
AU Diculescu, VC
   Chiorcea-Paquim, AM
   Oliveira-Brett, AM
AF Diculescu, Victor Constantin
   Chiorcea-Paquim, Ana-Maria
   Oliveira-Brett, Ana Maria
TI Applications of a DNA-electrochemical biosensor
SO TRAC-TRENDS IN ANALYTICAL CHEMISTRY
LA English
DT Review
DE DNA-electrochemical biosensor; Voltammetry; G-quadruplex; DNA oxidative
   damage; Protein; Drug; Metal ion; Pollutant; Free radical; Radiation
ID ATOMIC-FORCE MICROSCOPY; IN-SITU EVALUATION; DOPED DIAMOND ELECTRODE;
   GLASSY-CARBON ELECTRODE; VOLTAMMETRIC CHARACTERIZATION; OXIDATIVE
   DAMAGE; NUCLEIC-ACIDS; QUADRUPLEX NANOSTRUCTURES; PYROLYTIC-GRAPHITE;
   ANODIC VOLTAMMETRY
AB As carrier of genetic information, DNA is one of the most important intracellular targets that undergo modification and damage upon interaction with endogenous and exogenous factors. DNA is an excellent biomaterial for the construction of new devices, in nanotechnology and biosensor technology, for evaluation of DNA interaction with a broad range of chemical compounds and biomolecules, essential from a biological and a medical point of view.
   This review discusses recent advances on the design and applications of DNA-electrochemical biosensors that use DNA direct electrochemistry as a detection platform. AFM and voltammetric characterization of new bottom up immobilisation procedures of self-assembled nanostructures based on DNA single- and double-stranded, G-quadruplex, and i-motif configurations are presented, relevant for the development of new DNA-electrochemical biosensor devices. The applications of DNA-electrochemical biosensors, for the label-free detection of interactions with proteins, pharmaceutical compounds, metal ions and metal complexes, pollutants, free radicals, and electromagnetic radiation, were revisited. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Diculescu, Victor Constantin; Chiorcea-Paquim, Ana-Maria; Oliveira-Brett, Ana Maria] Univ Coimbra, Dept Chem, P-3000 Coimbra, Portugal.
RP Oliveira-Brett, AM (reprint author), Univ Coimbra, Dept Chem, P-3000 Coimbra, Portugal.
EM brett@ci.uc.pt
RI Diculescu, Victor/D-4132-2012; Chiorcea Paquim, Ana Maria/F-5036-2013
OI Diculescu, Victor/0000-0003-0719-8016; Chiorcea Paquim, Ana
   Maria/0000-0002-0605-5147
FU Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BPD/92726/2013,
   PTDC/SAU-BMA/118531/2010, PTDC/QEQ-MED/0586/2012,
   PTDC/DTP-FTO/0191/2012]; CEMUC-R (Research Unit 285); FEDER funds
   through the program COMPETE - Programa Operacional Factores de
   Competitividade; European Community Fund FEDER
FX Financial support from Fundacao para a Ciencia e a Tecnologia (FCT),
   grant SFRH/BPD/92726/2013 (A.-M. Chiorcea-Paquim), projects
   PTDC/SAU-BMA/118531/2010, PTDC/QEQ-MED/0586/2012,
   PTDC/DTP-FTO/0191/2012, and CEMUC-R (Research Unit 285), (co-financed by
   the European Community Fund FEDER), and FEDER funds through the program
   COMPETE - Programa Operacional Factores de Competitividade, is
   gratefully acknowledged.
CR Aydogdu G, 2014, SENSOR ACTUAT B-CHEM, V197, P211, DOI 10.1016/j.snb.2014.02.083
   Babula P, 2012, INT J ELECTROCHEM SC, V7, P7349
   BRABEC V, 1978, J ELECTROANAL CHEM, V88, P373, DOI 10.1016/S0022-0728(78)80125-9
   Brett AMO, 2005, BIOELECTROCHEMISTRY, V67, P181, DOI 10.1016/j.bioelechem.2004.06.008
   Brett AMO, 2005, BIOELECTROCHEMISTRY, V66, P117, DOI 10.1016/j.bioelechem.2004.05.009
   Brett AMO, 1997, J ELECTROANAL CHEM, V429, P95
   Chiorcea AM, 2004, BIOELECTROCHEMISTRY, V63, P229, DOI 10.1016/j.bioelechem.2003.09.029
   Paquim AMC, 2006, BIOPHYS CHEM, V121, P131, DOI 10.1016/j.bpc.2005.12.017
   Chiorcea-Paquim AM, 2009, ELECTROCHIM ACTA, V54, P1978, DOI 10.1016/j.electacta.2008.07.032
   Chiorcea-Paquim AM, 2006, ANAL CHEM, V78, P8256, DOI 10.1021/ac061040+
   Chiorcea-Paquim AM, 2013, GUANINE QUARTETS: STRUCTURE AND APPLICATION, P100, DOI 10.1039/9781849736954-00100
   Chiorcea-Paquim AM, 2015, ANAL CHEM, V87, P6141, DOI 10.1021/acs.analchem.5b00743
   Chiorcea-Paquim AM, 2014, ELECTROCHEM COMMUN, V45, P71, DOI 10.1016/j.elecom.2014.05.019
   Chiorcea-Paquim AM, 2014, ELECTROCHIM ACTA, V126, P162, DOI 10.1016/j.electacta.2013.07.150
   Chiorcea-Paquim AM, 2013, ELECTROCHIM ACTA, V110, P599, DOI 10.1016/j.electacta.2013.03.103
   Chiorcea-Paquim AM, 2013, PHYS CHEM CHEM PHYS, V15, P9117, DOI 10.1039/c3cp50866h
   Diculescu VC, 2006, ELECTROANAL, V18, P1963, DOI 10.1002/elan.200603602
   Corduneanu O, 2010, ANAL CHEM, V82, P1245, DOI 10.1021/ac902127d
   Corduneanu O, 2009, TALANTA, V77, P1843, DOI 10.1016/j.talanta.2008.10.046
   de Vasconcellos MC, 2016, J ELECTROANAL CHEM, V765, P168, DOI 10.1016/j.jelechem.2015.09.040
   Del Carlo M, 2012, BIOSENS BIOELECTRON, V31, P270, DOI 10.1016/j.bios.2011.10.030
   Deppman A, 2004, BRAZ J PHYS, V34, P958, DOI 10.1590/S0103-97332004000500068
   Diculescu VC, 2005, SENSORS-BASEL, V5, P377, DOI 10.3390/s5060377
   Diculescu VC, 2016, BIOELECTROCHEMISTRY, V107, P50, DOI 10.1016/j.bioelechem.2015.10.004
   Diculescu VC, 2013, BIOSENSORS AND CANCER, P187
   Diculescu VC, 2010, J NUCLEIC ACIDS, DOI 10.4061/2010/841932
   Diculescu VC, 2011, J ELECTROANAL CHEM, V656, P159, DOI 10.1016/j.jelechem.2010.11.037
   Dogan-Topal B, 2014, SENSOR ACTUAT B-CHEM, V194, P185, DOI 10.1016/j.snb.2013.12.088
   Enache TA, 2009, ELECTROCHEM COMMUN, V11, P1342, DOI 10.1016/j.elecom.2009.04.017
   Fojta M, 2000, BIOSENS BIOELECTRON, V15, P107, DOI 10.1016/S0956-5663(00)00070-1
   Hlavata L, 2015, MICROCHIM ACTA, V182, P1715, DOI 10.1007/s00604-015-1502-z
   Hlavata L, 2012, ELECTROCHIM ACTA, V71, P134, DOI 10.1016/j.electacta.2012.03.119
   Jalalvand AR, 2015, INT J BIOL MACROMOL, V79, P1004, DOI 10.1016/j.ijbiomac.2015.05.047
   Kara HES, 2014, BIOELECTROCHEMISTRY, V99, P17, DOI 10.1016/j.bioelechem.2014.06.002
   Katz E, 2005, PERSP BIOANAL, V1, P195, DOI 10.1016/S1871-0069(05)01005-0
   Kurbanoglu S, 2015, ELECTROCHIM ACTA, V169, P233, DOI 10.1016/j.electacta.2015.04.087
   Kuzin Y, 2015, ELECTROANAL, V27, P2800, DOI 10.1002/elan.201500312
   Lopes IC, 2012, ANALYST, V137, P1904, DOI 10.1039/c2an16017j
   Oliveira A.M., 2003, LANGMUIR, V19, P3830
   Oliveira A.M., 2003, ELECTROCHEM COMMUN, V5, P178
   Oliveira A.M. Brett, 2007, COMPREHENSIVE ANAL C, P413
   Oliveira SCB, 2008, BIOELECTROCHEMISTRY, V72, P53, DOI 10.1016/j.bioelechem.2007.11.004
   Oliveira SCB, 2009, BIOELECTROCHEMISTRY, V76, P201, DOI 10.1016/j.bioelechem.2009.03.003
   Oliveira SCB, 2012, LANGMUIR, V28, P4896, DOI 10.1021/la300070x
   Oliveira SCB, 2010, ANAL BIOANAL CHEM, V398, P1633, DOI 10.1007/s00216-010-4051-7
   Oliveira SCB, 2010, ELECTROCHIM ACTA, V55, P4599, DOI 10.1016/j.electacta.2010.03.016
   Oliveira SCB, 2010, J ELECTROANAL CHEM, V648, P60, DOI 10.1016/j.jelechem.2010.06.020
   Oliveira-Brett AM, 2006, MED ENG PHYS, V28, P963, DOI 10.1016/j.medengphy.2006.05.009
   Oliveira-Brett A. M., 2006, ENCY SENSORS, V3, P301
   Oliveira-Brett AM, 2004, BIOELECTROCHEMISTRY, V64, P143, DOI 10.1016/j.bioelechem.2004.05.002
   Oliveira-Brett AM, 2004, BIOELECTROCHEMISTRY, V64, P133, DOI 10.1016/j.bioelechem.2004.05.003
   Oliveira-Brett AM, 2002, J ELECTROANAL CHEM, V538, P267, DOI 10.1016/S0022-0728(02)00944-0
   Oliveira-Brett AM, 2002, TALANTA, V56, P959, DOI 10.1016/S0039-9140(01)00656-7
   Oliveira-Brett AM, 2004, ANAL BIOCHEM, V332, P321, DOI 10.1016/j.ab.2004.06.021
   OLIVEIRABRETT AM, 1999, COMPREHENSIVE CHEM K, V37, P91
   Palecek E, 2002, TALANTA, V56, P809, DOI 10.1016/S0039-9140(01)00649-X
   Palecek E, 2012, CHEM REV, V112, P3427, DOI 10.1021/cr200303p
   Paquim AMC, 2004, BIOSENS BIOELECTRON, V20, P933, DOI 10.1016/j.bios.2004.06.018
   Paquim AMC, 2006, ELECTROCHIM ACTA, V51, P5037, DOI 10.1016/j.electacta.2006.03.041
   Piedade JAP, 2006, ANAL BIOCHEM, V355, P39, DOI 10.1016/j.ab.2006.05.022
   Piedade JAP, 2002, BIOELECTROCHEMISTRY, V56, P81, DOI 10.1016/S1567-5394(02)00013-0
   Pontinha ADR, 2013, BIOELECTROCHEMISTRY, V89, P50, DOI 10.1016/j.bioelechem.2012.08.005
   Qiu YY, 2011, J HAZARD MATER, V190, P480, DOI 10.1016/j.jhazmat.2011.03.071
   Pontinha ADR, 2014, ANAL CHEM, V86, P5851, DOI 10.1021/ac500624z
   Pontinha ADR, 2011, PHYS CHEM CHEM PHYS, V13, P5227, DOI 10.1039/c0cp02377a
   Santarino IB, 2014, ELECTROANAL, V26, P1304, DOI 10.1002/elan.201300488
   Santos PVF, 2012, ELECTROANAL, V24, P547, DOI 10.1002/elan.201100516
   Soleymani L., 2009, ANGEW CHEM, V121, P8609, DOI DOI 10.1002/ANGE.200902439
   Soleymani L, 2009, NAT NANOTECHNOL, V4, P844, DOI [10.1038/nnano.2009.276, 10.1038/NNANO.2009.276]
   Tang WW, 2014, TALANTA, V127, P262, DOI 10.1016/j.talanta.2014.03.069
   Tome LIN, 2015, ANAL CHIM ACTA, V898, P28, DOI 10.1016/j.aca.2015.09.049
   Vacek J, 2007, ELECTROANAL, V19, P2093, DOI 10.1002/elan.200703917
   Vacek J, 2013, CHEM-BIOL INTERACT, V205, P173, DOI 10.1016/j.cbi.2013.07.006
NR 73
TC 28
Z9 28
U1 16
U2 107
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0165-9936
EI 1879-3142
J9 TRAC-TREND ANAL CHEM
JI Trac-Trends Anal. Chem.
PD MAY
PY 2016
VL 79
SI SI
BP 23
EP 36
DI 10.1016/j.trac.2016.01.019
PG 14
WC Chemistry, Analytical
SC Chemistry
GA DM9RR
UT WOS:000376703900004
DA 2018-10-20
ER

PT J
AU Nor, FM
   Lee, HY
   Lim, JY
   Kurniawan, D
AF Nor, Fethma M.
   Lee, Ho Yong
   Lim, Joong Yeon
   Kurniawan, Denni
TI Strain rate and temperature effects on elastic properties of
   polycaprolactone/starch composite
SO E-POLYMERS
LA English
DT Article
DE composite; mechanical properties; strain rate; temperature
ID SCAFFOLDS; DESIGN; DEFORMATION; FABRICATION; POLYMERS; BEHAVIOR; STRESS;
   BLENDS; BONE
AB Composite of polycaprolactone (PCL) and starch is a potential biomaterial for tissue engineering scaffolds. During implantation, its mechanical properties might be compromised considering the various strain rates it is subjected to and that human body temperature is close to polycaprolactone's melting temperature. This study aims at revealing the effect of strain rate and temperature to the elastic properties of polycaprolactone-starch composite. Tensile test at strain rates of 5, 0.1, and 0.01 mm/min at ambient and body temperatures were performed. It was revealed that strain rate as well as temperature readily have significant effects on the composite's elastic properties. Such effects have similar trends with that of PCL homopolymer which is used as the composite's matrix. Further analysis on the consequence of the finding was performed by applying the behavior to a finite element model of a porous scaffold and it was found that the discrepancy in elastic properties throughout the construct is even greater.
C1 [Nor, Fethma M.; Lee, Ho Yong; Lim, Joong Yeon; Kurniawan, Denni] Dongguk Univ, Dept Mech Robot & Energy Engn, Seoul, South Korea.
   [Kurniawan, Denni] Univ Teknol Malaysia, Fac Mech Engn, Skudai, Malaysia.
RP Kurniawan, D (reprint author), Dongguk Univ, Dept Mech Robot & Energy Engn, Seoul, South Korea.; Kurniawan, D (reprint author), Univ Teknol Malaysia, Fac Mech Engn, Skudai, Malaysia.
EM denni@utm.my
RI Kurniawan, Denni/C-2703-2008
OI Kurniawan, Denni/0000-0002-4179-0454
FU Dongguk University, Korea; Universiti Teknologi Malaysia
FX Financial supports from the Dongguk University, Korea, as well as
   Universiti Teknologi Malaysia through this collaborative work are
   gratefully acknowledged.
CR Avella M, 2000, POLYMER, V41, P3875, DOI 10.1016/S0032-3861(99)00663-1
   Baas E, 2010, J BIOMECH, V43, P733, DOI 10.1016/j.jbiomech.2009.10.016
   Boyce MC, 2000, POLYMER, V41, P2183, DOI 10.1016/S0032-3861(99)00406-1
   Chen TT, 2015, E-POLYMERS, V15, P3, DOI 10.1515/epoly-2014-0158
   ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B
   Ghavimi SAA, 2015, POLYM TEST, V43, P94, DOI 10.1016/j.polymertesting.2015.02.012
   Hobeika S, 2000, MACROMOLECULES, V33, P1827, DOI 10.1021/ma9910484
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   KOENIG MF, 1995, POLYMER, V36, P1877, DOI 10.1016/0032-3861(95)90934-T
   Kurniawan D, 2011, P I MECH ENG H, V225, P1015, DOI 10.1177/0954411911413059
   Kweon DK, 2004, J APPL POLYM SCI, V92, P1716, DOI 10.1002/app.20130
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Lu Z, 2002, SOLID MECH APPL, V87, P41
   Nor FM, 2012, P I MECH ENG H, V226, P693, DOI 10.1177/0954411912452988
   Ohashi F, 2002, POLYM ENG SCI, V42, P1046, DOI 10.1002/pen.11011
   Rajagopalan S, 2006, MED IMAGE ANAL, V10, P693, DOI 10.1016/j.media.2006.06.001
   Richeton J, 2006, INT J SOLIDS STRUCT, V43, P2318, DOI 10.1016/j.ijsolstr.2005.06.040
   Sanz-Herrera JA, 2010, J BIOMECH, V43, P2480, DOI 10.1016/j.jbiomech.2010.05.027
   Schuckert KH, 2009, TISSUE ENG PT A, V15, P493, DOI 10.1089/ten.tea.2008.0033
   Shapiro JM, 2014, ACTA MECH SINICA-PRC, V30, P7, DOI 10.1007/s10409-014-0025-x
   Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Yeong WY, 2010, ACTA BIOMATER, V6, P2028, DOI 10.1016/j.actbio.2009.12.033
NR 23
TC 0
Z9 0
U1 1
U2 16
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 1618-7229
J9 E-POLYMERS
JI e-Polymers
PD MAY
PY 2016
VL 16
IS 3
BP 217
EP 223
DI 10.1515/epoly-2015-0261
PG 7
WC Polymer Science
SC Polymer Science
GA DM7CX
UT WOS:000376513000006
DA 2018-10-20
ER

PT J
AU Chung, EJ
AF Chung, Eun Ji
TI Targeting and therapeutic peptides in nanomedicine for atherosclerosis
SO EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Review
DE Peptides; nanoparticles; atherosclerosis; micelles; inflammation;
   biomaterial
ID DENSITY-LIPOPROTEIN NANOPARTICLES; APOLIPOPROTEIN-A-I; VASCULAR
   INFLAMMATION; AMPHIPHILE MICELLES; ANTITUMOR-ACTIVITY; CONTRAST AGENTS;
   VIVO EFFICACY; DISEASE; CHOLESTEROL; DELIVERY
AB Peptides in atherosclerosis nanomedicine provide structural, targeting, and therapeutic functionality and can assist in overcoming delivery barriers of traditional pharmaceuticals. Moreover, their inherent biocompatibility and biodegradability make them especially attractive as materials intended for use in vivo. In this review, an overview of nanoparticle-associated targeting and therapeutic peptides for atherosclerosis is provided, including peptides designed for cellular targets such as endothelial cells, monocytes, and macrophages as well as for plaque components such as collagen and fibrin. An emphasis is placed on recent advances in multimodal strategies and a discussion on current challenges and barriers for clinical applicability is presented.
C1 [Chung, Eun Ji] Univ So Calif, Los Angeles, CA 90089 USA.
RP Chung, EJ (reprint author), Univ So Calif, Los Angeles, CA 90089 USA.
EM eunchung@usc.edu
FU University of Southern California, National Heart, Lung, and Blood
   Institute (NHLBI) [K99HL124279]; Chicago Biomedical Consortium
   Postdoctoral Research Grant
FX The author would like to acknowledge the financial support from the
   University of Southern California, National Heart, Lung, and Blood
   Institute (NHLBI), K99HL124279, and the Chicago Biomedical Consortium
   Postdoctoral Research Grant.
CR American Heart Association, 2014, WHAT IS CARD DIS
   Bandeira-Melo C, 2005, J PHARMACOL EXP THER, V313, P1416, DOI 10.1124/jpet.104.080473
   Bentzon JF, 2010, CURR OPIN LIPIDOL, V21, P434, DOI 10.1097/MOL.0b013e32833ded6a
   Bruckman MA, 2014, NANO LETT, V14, P1551, DOI 10.1021/nl404816m
   Chacko AM, 2011, CURR OPIN COLLOID IN, V16, P215, DOI 10.1016/j.cocis.2011.01.008
   Chamberlain AM, 2008, BLOOD, V112, P2675, DOI 10.1182/blood-2008-05-157412
   Chen W, 2013, JACC-CARDIOVASC IMAG, V6, P373, DOI 10.1016/j.jcmg.2012.06.016
   Chen W, 2008, CONTRAST MEDIA MOL I, V3, P233, DOI 10.1002/cmmi.257
   Chung EJ, 2014, J CELL SCI THER, V5, P181, DOI DOI 10.4172/2157-7013.1000181
   Chung EJ, 2015, ADV HEALTHC MATER, V4, P2408, DOI 10.1002/adhm.201500126
   Chung EJ, 2015, ADV HEALTHC MATER, V4, DOI 10.1002/adhm.201400336
   Chung EJ, 2014, BIOMATERIALS, V35, P1249, DOI 10.1016/j.biomaterials.2013.10.064
   Cormode DP, 2009, BIOCONJUGATE CHEM, V20, P937, DOI 10.1021/bc800520d
   Damiano MG, 2013, ADV DRUG DELIVER REV, V65, P649, DOI 10.1016/j.addr.2012.07.013
   Eraso LH, 2011, VASC MED, V16, P145, DOI 10.1177/1358863X10392474
   Fang Y, 2012, ARTERIOSCL THROM VAS, V32, P979, DOI 10.1161/ATVBAHA.111.244053
   Fredman G, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1065
   Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80
   Howard MD, 2014, ANNU REV PHARMACOL, V54, P205, DOI 10.1146/annurev-pharmtox-011613-140002
   Jonas A, 2008, N COMP BIOC, P485, DOI 10.1016/B978-044453219-0.50019-2
   Kamaly N, 2013, P NATL ACAD SCI USA, V110, P6506, DOI 10.1073/pnas.1303377110
   Kanwar RK, 2012, NANOMEDICINE-UK, V7, P899, DOI [10.2217/nnm.12.57, 10.2217/NNM.12.57]
   Kashiwagi M, 2010, ATHEROSCLEROSIS, V212, P171, DOI 10.1016/j.atherosclerosis.2010.05.004
   Kelly KA, 2005, CIRC RES, V96, P327, DOI 10.1161/01.RES.0000155722.17881.dd
   Kelly KA, 2006, MOL IMAGING BIOL, V8, P201, DOI 10.1007/s11307-006-0043-6
   Kheirolomoom A, 2015, ACS NANO, V9, P8885, DOI 10.1021/acsnano.5b02611
   Kuo CH, 2014, J MATER CHEM B, V2, P8142, DOI 10.1039/c4tb00977k
   Kusunose J, 2014, J DRUG TARGET, V22, P48, DOI 10.3109/1061186X.2013.837468
   Kusunose J, 2013, ANN BIOMED ENG, V41, P89, DOI 10.1007/s10439-012-0634-0
   La M, 2001, FASEB J, V15, P2247, DOI 10.1096/fj.01-0196com
   Laakkonen P, 2004, P NATL ACAD SCI USA, V101, P9381, DOI 10.1073/pnas.0403317101
   Lee GY, 2011, J CONTROL RELEASE, V155, P211, DOI 10.1016/j.jconrel.2011.07.010
   Lewis DR, 2011, WIRES NANOMED NANOBI, V3, P400, DOI 10.1002/wnan.145
   Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353
   Lobatto ME, 2011, NAT REV DRUG DISCOV, V10, P835, DOI 10.1038/nrd3578
   Luehmann HP, 2014, J NUCL MED, V55, P629, DOI 10.2967/jnumed.113.132001
   Marrache S, 2013, P NATL ACAD SCI USA, V110, P9445, DOI 10.1073/pnas.1301929110
   Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399
   Michalska M, 2012, ARTERIOSCL THROM VAS, V32, P2350, DOI 10.1161/ATVBAHA.112.255224
   Mlinar LB, 2014, BIOMATERIALS, V35, P8678, DOI 10.1016/j.biomaterials.2014.06.054
   Moghimi SM, 2005, FASEB J, V19, P311, DOI 10.1096/fj.04-2747rev
   Nahrendorf M, 2006, CIRCULATION, V114, P1504, DOI 10.1161/CIRCULATIONAHA.106.646380
   Nahrendorf M, 2009, ARTERIOSCL THROM VAS, V29, P1444, DOI 10.1161/ATVBAHA.109.193086
   Najafi-Shoushtari SH, 2010, SCIENCE, V328, P1566, DOI 10.1126/science.1189123
   National Heart Lung Blood Institute, 2015, WHAT IS ATH
   Navab M, 2006, NAT CLIN PRACT CARD, V3, P540, DOI 10.1038/ncpcardio0661
   Pan H, 2013, FASEB J, V27, P255, DOI 10.1096/fj.12-218081
   Park Y, 2008, J CONTROL RELEASE, V128, P217, DOI 10.1016/j.jconrel.2008.03.019
   Peters D, 2009, P NATL ACAD SCI USA, V106, P9815, DOI 10.1073/pnas.0903369106
   Psarros C, 2012, MATURITAS, V73, P52, DOI 10.1016/j.maturitas.2011.12.014
   Raha S, 2011, WIRES NANOMED NANOBI, V3, P269, DOI 10.1002/wnan.121
   Redwine LS, 1999, CLIN IMMUNOL, V93, P124, DOI 10.1006/clim.1999.4771
   Schiener M, 2014, TRENDS MOL MED, V20, P271, DOI 10.1016/j.molmed.2013.12.001
   Southworth R, 2009, NANOMED-NANOTECHNOL, V5, P359, DOI 10.1016/j.nano.2008.12.002
   Srinivasan R, 2010, J BIOMED MATER RES A, V93A, P1004, DOI 10.1002/jbm.a.32549
   Staff MC, 1998, ARTERIOSCLEROSIS
   Starmans LWE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119257
   Starmans LWE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057335
   Swirski FK, 2006, P NATL ACAD SCI USA, V103, P10340, DOI 10.1073/pnas.0604260103
   Tang J, 2012, CURR CARDIOVASC IMAG, V5, P19, DOI 10.1007/s12410-011-9120-6
   Uchida M, 2011, ACS NANO, V5, P2493, DOI 10.1021/nn102863y
   UZIELY B, 1995, J CLIN ONCOL, V13, P1777, DOI 10.1200/JCO.1995.13.7.1777
   Webber MJ, 2010, J INTERN MED, V267, P71, DOI 10.1111/j.1365-2796.2009.02184.x
   Westein E, 2013, DRUG DEVELOP RES, V74, P460, DOI 10.1002/ddr.21103
   Wickline SA, 2007, J MAGN RESON IMAGING, V25, P667, DOI 10.1002/jmri.20866
   Wilson HM, 2010, J CELL MOL MED, V14, P2055, DOI 10.1111/j.1582-4934.2010.01121.x
   WILSON PWF, 1988, ARTERIOSCLEROSIS, V8, P737, DOI 10.1161/01.ATV.8.6.737
   Zhao YN, 2014, J LIPID RES, V55, P2053, DOI 10.1194/jlr.M049262
   Zhao YN, 2013, J AM CHEM SOC, V135, P13414, DOI 10.1021/ja404714a
NR 69
TC 8
Z9 9
U1 2
U2 24
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1535-3702
EI 1535-3699
J9 EXP BIOL MED
JI Exp. Biol. Med.
PD MAY
PY 2016
VL 241
IS 9
BP 891
EP 898
DI 10.1177/1535370216640940
PG 8
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DM5JA
UT WOS:000376383300002
PM 27022138
OA Green Published, Green Accepted
DA 2018-10-20
ER

PT J
AU Farris, E
   Brown, DM
   Ramer-Tait, AE
   Pannier, AK
AF Farris, Eric
   Brown, Deborah M.
   Ramer-Tait, Amanda E.
   Pannier, Angela K.
TI Micro- and nanoparticulates for DNA vaccine delivery
SO EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Review
DE DNA vaccine; biomaterials; transfection; vaccination; oral delivery
ID MUCOSAL ANTIBODY-RESPONSES; B SURFACE-ANTIGEN; GENE DELIVERY; PLASMID
   DNA; CHITOSAN NANOPARTICLES; IMMUNE-RESPONSE; HEPATITIS-B; IN-VIVO;
   IMMUNOLOGICAL EFFECTIVENESS; POLYMERIC NANOPARTICLES
AB DNA vaccination has emerged as a promising alternative to traditional protein-based vaccines for the induction of protective immune responses. DNA vaccines offer several advantages over traditional vaccines, including increased stability, rapid and inexpensive production, and flexibility to produce vaccines for a wide variety of infectious diseases. However, the immunogenicity of DNA vaccines delivered as naked plasmid DNA is often weak due to degradation of the DNA by nucleases and inefficient delivery to immune cells. Therefore, biomaterial-based delivery systems based on micro- and nanoparticles that encapsulate plasmid DNA represent the most promising strategy for DNA vaccine delivery. Microparticulate delivery systems allow for passive targeting to antigen presenting cells through size exclusion and can allow for sustained presentation of DNA to cells through degradation and release of encapsulated vaccines. In contrast, nanoparticle encapsulation leads to increased internalization, overall greater transfection efficiency, and the ability to increase uptake across mucosal surfaces. Moreover, selection of the appropriate biomaterial can lead to increased immune stimulation and activation through triggering innate immune response receptors and target DNA to professional antigen presenting cells. Finally, the selection of materials with the appropriate properties to achieve efficient delivery through administration routes conducive to high patient compliance and capable of generating systemic and local (i.e. mucosal) immunity can lead to more effective humoral and cellular protective immune responses. In this review, we discuss the development of novel biomaterial-based delivery systems to enhance the delivery of DNA vaccines through various routes of administration and their implications for generating immune responses.
C1 [Farris, Eric; Pannier, Angela K.] Univ Nebraska, Dept Biol Syst Engn, Lincoln, NE 68588 USA.
   [Brown, Deborah M.] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA.
   [Brown, Deborah M.] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE 68588 USA.
   [Ramer-Tait, Amanda E.] Univ Nebraska, Dept Food Sci & Technol, Lincoln, NE 68588 USA.
   [Pannier, Angela K.] Univ Nebraska, Nebraska Ctr Mat & Nanosci, Lincoln, NE 68588 USA.
   [Pannier, Angela K.] Univ Nebraska, Ctr Nanohybrid Funct Mat, Lincoln, NE 68588 USA.
   [Pannier, Angela K.] Univ Nebraska, Med Ctr, Mary & Dick Holland Regenerat Med Program, 600 S 42nd St, Omaha, NE 68198 USA.
RP Pannier, AK (reprint author), Univ Nebraska, Dept Biol Syst Engn, Lincoln, NE 68588 USA.; Pannier, AK (reprint author), Univ Nebraska, Nebraska Ctr Mat & Nanosci, Lincoln, NE 68588 USA.; Pannier, AK (reprint author), Univ Nebraska, Ctr Nanohybrid Funct Mat, Lincoln, NE 68588 USA.; Pannier, AK (reprint author), Univ Nebraska, Med Ctr, Mary & Dick Holland Regenerat Med Program, 600 S 42nd St, Omaha, NE 68198 USA.
EM apannier2@unl.edu
OI Ramer-Tait, Amanda/0000-0003-0950-7548
FU Nebraska Research Initiative; University of Nebraska-Lincoln Tobacco
   Settlement Funds; National Science Foundation [CBET-1254415]; Center for
   Nanohybrid Functional Materials (NSF) [EPS-1004094]; American Heart
   Association [10SDG2640217]; University of Nebraska Foundation (Layman
   Funds); National Institute of General Medical Sciences of the National
   Institutes of Health [P20GM104320]; Crohn's and Colitis Foundation of
   America [3578]; Nebraska Corn Board; UNL Research Council
   Interdisciplinary Seed Grant; UNL Research Council-Tobacco Settlement
   Funds Biomedical Seed Grant; USDA CSREES-Nebraska [NEB-21-146,
   NEB-26-211]
FX The Nebraska Research Initiative, University of Nebraska-Lincoln Tobacco
   Settlement Funds, National Science Foundation (CBET-1254415), Center for
   Nanohybrid Functional Materials (NSF EPS-1004094), American Heart
   Association (#10SDG2640217), the University of Nebraska Foundation
   (Layman Funds), National Institute of General Medical Sciences of the
   National Institutes of Health (P20GM104320), the Crohn's and Colitis
   Foundation of America (#3578), and the Nebraska Corn Board, UNL Research
   Council Interdisciplinary Seed Grant, UNL Research Council-Tobacco
   Settlement Funds Biomedical Seed Grant and USDA CSREES-Nebraska
   [NEB-21-146 and NEB-26-211] are acknowledged for funding this work.
CR Anderson RJ, 2007, VACCINE, V25, pB24, DOI 10.1016/j.vaccine.2007.05.030
   Asthana GS, 2014, BIOMED RES INT, V17
   Barbon CM, 2010, VACCINE, V28, P7852, DOI 10.1016/j.vaccine.2010.09.078
   Beloor J, 2015, SMALL, V11, P2069, DOI 10.1002/smll.201402933
   Bhavsar MD, 2008, AAPS PHARMSCITECH, V9, P288, DOI 10.1208/s12249-007-9021-9
   Bhowmik T, 2012, J DRUG TARGET, V20, P364, DOI 10.3109/1061186X.2012.662686
   Bivas-Benita M, 2003, INT J PHARM, V266, P17, DOI 10.1016/S0378-5173(03)00377-6
   Bueter CL, 2011, J BIOL CHEM, V286, P35447, DOI 10.1074/jbc.M111.274936
   Carvalho JA, 2010, EXPERT REV VACCINES, V9, P175, DOI 10.1586/ERV.09.158
   Chai DF, 2014, HUM VACC IMMUNOTHER, V10, P1284, DOI 10.4161/hv.28333
   Channarong S, 2011, AAPS PHARMSCITECH, V12, P192, DOI 10.1208/s12249-010-9559-9
   Chen K, 2010, IMMUNITY, V33, P479, DOI 10.1016/j.immuni.2010.09.013
   Csaba N, 2009, INT J PHARMACEUT, V382, P205, DOI 10.1016/j.ijpharm.2009.07.028
   Deering RP, 2014, EXPERT OPIN DRUG DEL, V11, P885, DOI 10.1517/17425247.2014.901308
   DeMuth PC, 2013, NAT MATER, V12, P367, DOI [10.1038/nmat3550, 10.1038/NMAT3550]
   Doroud D, 2011, J CONTROL RELEASE, V153, P154, DOI 10.1016/j.jconrel.2011.04.011
   Dudhani AR, 2010, CARBOHYD POLYM, V81, P243, DOI 10.1016/j.carbpol.2010.02.026
   Eratalay A, 2010, J MICROENCAPSUL, V27, P48, DOI 10.3109/02652040902937666
   FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413
   Forrest ML, 2003, BIOCONJUGATE CHEM, V14, P934, DOI 10.1021/bc034014g
   Gao SS, 2013, VACCINE, V31, P5754, DOI 10.1016/j.vaccine.2013.08.053
   Glenn Gregory M, 2003, Expert Rev Vaccines, V2, P253, DOI 10.1586/14760584.2.2.253
   Gold MJ, 2016, EUR J IMMUNOL, V46, P122, DOI 10.1002/eji.201545628
   Hashida M, 1998, J CONTROL RELEASE, V53, P301, DOI 10.1016/S0168-3659(97)00263-0
   Hong XY, 2013, DRUG DES DEV THER, V7, P945, DOI 10.2147/DDDT.S44401
   Hu Y, 2015, POLYM CHEM-UK, V6, P373, DOI 10.1039/c4py01394h
   Ingolotti M, 2010, EXPERT REV VACCINES, V9, P747, DOI [10.1586/erv.10.57, 10.1586/ERV.10.57]
   Jain S, 2005, IMMUNOL LETT, V101, P41, DOI 10.1016/j.imlet.2005.04.002
   Jiang HL, 2008, BIOMATERIALS, V29, P1931, DOI 10.1016/j.biomaterials.2007.12.025
   Jones DH, 1997, VACCINE, V15, P814, DOI 10.1016/S0264-410X(96)00266-6
   Josefsberg JO, 2012, BIOTECHNOL BIOENG, V109, P1443, DOI 10.1002/bit.24493
   Kim NW, 2014, J CONTROL RELEASE, V179, P11, DOI 10.1016/j.jconrel.2014.01.016
   Kim Sae-Hae, 2012, Immune Netw, V12, P165, DOI 10.4110/in.2012.12.5.165
   Kim TH, 2006, MOL CANCER THER, V5, P1723, DOI 10.1158/1535-7163.MCT-06-0540
   Kim YC, 2013, J CONTROL RELEASE, V172, P579, DOI 10.1016/j.jconrel.2013.04.016
   Kines RC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120797
   Kiyono H, 2004, NAT REV IMMUNOL, V4, P699, DOI 10.1038/nri1439
   Koping-Hoggard M, 2001, GENE THER, V8, P1108, DOI 10.1038/sj.gt.3301492
   Kumru OS, 2014, BIOLOGICALS, V42, P237, DOI 10.1016/j.biologicals.2014.05.007
   Kurisawa M, 2000, J CONTROL RELEASE, V69, P127, DOI 10.1016/S0168-3659(00)00297-2
   Kutzler MA, 2008, NAT REV GENET, V9, P776, DOI 10.1038/nrg2432
   Langer B, 2013, BIOLISTIC DNA DELIVE, P371
   Layek B, 2015, J CONTROL RELEASE, V207, P143, DOI 10.1016/j.jconrel.2015.04.014
   Lee D, 2006, J NANOSCI NANOTECHNO, V6, P2860, DOI 10.1166/jnn.2006.465
   Lee PW, 2010, BIOMATERIALS, V31, P2425, DOI 10.1016/j.biomaterials.2009.11.100
   Levine MM, 2011, VACCINE, V29, pD116, DOI 10.1016/j.vaccine.2011.11.090
   Li A, 2011, BIOMATERIALS, V32, P469, DOI 10.1016/j.biomaterials.2010.08.107
   Liu MA, 2011, IMMUNOL REV, V239, P62, DOI 10.1111/j.1600-065X.2010.00980.x
   Liu WG, 2003, BIOCONJUGATE CHEM, V14, P782, DOI 10.1021/bc020051g
   Liu XM, 2005, BIOMATERIALS, V26, P109, DOI 10.1016/j.biomaterials.2004.02.013
   Lonez C, 2014, NANOMED-NANOTECHNOL, V10, P775, DOI 10.1016/j.nano.2013.12.003
   Lu HD, 2011, INT J PHARMACEUT, V420, P358, DOI 10.1016/j.ijpharm.2011.08.046
   Luo YC, 2012, J AGR FOOD CHEM, V60, P836, DOI 10.1021/jf204194z
   Lynn DM, 2000, J AM CHEM SOC, V122, P10761, DOI 10.1021/ja0015388
   Matijevic M, 2011, CELL IMMUNOL, V270, P62, DOI 10.1016/j.cellimm.2011.04.005
   Mehta SK, 2011, COLLOID SURFACE A, V375, P219, DOI 10.1016/j.colsurfa.2010.12.014
   Nanda RK, 2014, BIOLOGICALS, V42, P153, DOI 10.1016/j.biologicals.2014.01.002
   Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777
   Nguyen DN, 2009, ADV MATER, V21, P847, DOI 10.1002/adma.200801478
   O'Hagan DT, 2004, IMMUNOL REV, V199, P191, DOI 10.1111/j.0105-2896.2004.00153.x
   O'Neill MJ, 2011, DRUG DISCOV TODAY, V16, P203, DOI 10.1016/j.drudis.2011.01.003
   Oliveira CR, 2012, SCI WORLD J, DOI 10.1100/2012/938457
   Page DT, 2001, DRUG DISCOV TODAY, V6, P92, DOI 10.1016/S1359-6446(00)01600-7
   Parris N, 2005, J AGR FOOD CHEM, V53, P4788, DOI 10.1021/jf040492p
   Peng YX, 2015, J NANOSCI NANOTECHNO, V15, P2619, DOI 10.1166/jnn.2015.9252
   Perche F, 2011, NANOMED-NANOTECHNOL, V7, P445, DOI 10.1016/j.nano.2010.12.010
   Prabha S, 2002, INT J PHARM, V244, P105, DOI 10.1016/S0378-5173(02)00315-0
   Reddy KS, 2012, J GENE MED, V14, P348, DOI 10.1002/jgm.2622
   Regier MC, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-44
   Sadeghi AMM, 2008, EUR J PHARM BIOPHARM, V70, P270, DOI 10.1016/j.ejpb.2008.03.004
   Sawaengsak C, 2014, INT J PHARMACEUT, V473, P113, DOI 10.1016/j.ijpharm.2014.07.005
   Shuaibu MN, 2011, VACCINE, V29, P3239, DOI 10.1016/j.vaccine.2011.02.033
   Singh M, 2000, P NATL ACAD SCI USA, V97, P811, DOI 10.1073/pnas.97.2.811
   Srinivas R, 2012, BIOMATERIALS, V33, P6220, DOI 10.1016/j.biomaterials.2012.05.006
   Stachyra A, 2014, ACTA BIOCHIM POL, V61, P515
   Tahamtan A, 2014, J BIOMED SCI, V21, DOI 10.1186/s12929-014-0069-z
   Tang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055077
   Umthong S, 2015, J MICROBIOL BIOTECHN, V25, P526, DOI 10.4014/jmb.1408.08007
   Uto Tomofumi, 2013, Results Immunol, V3, P1, DOI 10.1016/j.rinim.2012.11.002
   VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703
   Vangasseri DP, 2006, MOL MEMBR BIOL, V23, P385, DOI 10.1080/09687860600790537
   Walters AA, 2015, J PHARM PHARMACOL, V67, P400, DOI 10.1111/jphp.12367
   Wang DA, 2010, VACCINE, V28, P3134, DOI 10.1016/j.vaccine.2010.02.058
   Wang HJ, 2005, J CONTROL RELEASE, V105, P120, DOI 10.1016/j.jconrel.2005.03.014
   Wang J, 2014, BIOMATERIALS, V35, P466, DOI 10.1016/j.biomaterials.2013.09.060
   Xu W, 2004, VACCINE, V22, P3603, DOI 10.1016/j.vaccine.2004.03.033
   Yang B, 2014, HUM VACC IMMUNOTHER, V10, P3153, DOI 10.4161/21645515.2014.980686
   Yao WJ, 2013, MOL PHARMACEUT, V10, P2904, DOI 10.1021/mp4000053
   Ye T, 2014, VACCINE, V32, P4457, DOI 10.1016/j.vaccine.2014.06.050
   Zhang J, 2013, BIOMATERIALS, V34, P3667, DOI 10.1016/j.biomaterials.2013.01.079
   Zhang YQ, 2014, FOOD CHEM, V142, P269, DOI 10.1016/j.foodchem.2013.07.058
   Zhao K, 2011, VACCINE, V29, P8549, DOI 10.1016/j.vaccine.2011.09.029
   Zhao K, 2010, J MICROENCAPSUL, V27, P178, DOI 10.3109/02652040903059239
NR 93
TC 10
Z9 11
U1 3
U2 38
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1535-3702
EI 1535-3699
J9 EXP BIOL MED
JI Exp. Biol. Med.
PD MAY
PY 2016
VL 241
IS 9
BP 919
EP 929
DI 10.1177/1535370216643771
PG 11
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DM5JA
UT WOS:000376383300005
PM 27048557
OA Green Published
DA 2018-10-20
ER

PT J
AU Rosch, JC
   Hollmann, EK
   Lippmann, ES
AF Rosch, Jonah C.
   Hollmann, Emma K.
   Lippmann, Ethan S.
TI In vitro selection technologies to enhance biomaterial functionality
SO EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Review
DE Biomaterial; in vitro selection; biomedical engineering; phage; aptamer;
   peptides
ID SPINAL-CORD-INJURY; ENDOTHELIAL GROWTH-FACTOR; MESENCHYMAL STEM-CELLS;
   CONTROLLED PROTEIN RELEASE; PHAGE DISPLAY LIBRARY; TISSUE ENGINEERING
   SCAFFOLDS; SCIATIC-NERVE REGENERATION; HIGH-AFFINITY APTAMERS;
   RECEPTOR-BINDING; EXPONENTIAL ENRICHMENT
AB Cells make decisions and fate choices based in part on cues they receive from their external environment. Factors that affect the interpretation of these cues include the soluble proteins that are present at any given time, the cell surface receptors that are available to bind these proteins, and the relative affinities of the soluble proteins for their cognate receptors. Researchers have identified many of the biological motifs responsible for the high-affinity interactions between proteins and their receptors, and subsequently incorporated these motifs into biomaterials to elicit control over cell behavior. Common modes of control include localized sequestration of proteins to improve bioavailability and direct inhibition or activation of a receptor by an immobilized peptide or protein. However, naturally occurring biological motifs often possess promiscuous affinity for multiple proteins and receptors or lack programmable actuation in response to dynamic stimuli, thereby limiting the amount of control they can exert over cellular decisions. These natural motifs only represent a small fraction of the biological diversity that can be assayed by in vitro selection strategies, and the discovery of "artificial'' motifs with varying affinity, specificity, and functionality could greatly expand the repertoire of engineered biomaterial properties. This minireview provides a brief summary of classical and emerging techniques in peptide phage display and nucleic acid aptamer selections and discusses prospective applications in the areas of cell adhesion, angiogenesis, neural regeneration, and immune modulation.
C1 [Rosch, Jonah C.; Hollmann, Emma K.; Lippmann, Ethan S.] Vanderbilt Univ, Dept Chem & Biomol Engn, 221 Kirkland Hall, Nashville, TN 37235 USA.
RP Lippmann, ES (reprint author), Vanderbilt Univ, Dept Chem & Biomol Engn, 221 Kirkland Hall, Nashville, TN 37235 USA.
EM ethan.s.lippmann@vanderbilt.edu
FU College of Engineering at Vanderbilt University
FX The authors are grateful for financial support from the College of
   Engineering at Vanderbilt University.
CR Ahmad KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027051
   Akdis M, 2011, J ALLERGY CLIN IMMUN, V127, P701, DOI 10.1016/j.jaci.2010.11.050
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Baird GS, 2010, AM J CLIN PATHOL, V134, P529, DOI 10.1309/AJCPFU4CG2WGJJKS
   Battig MR, 2014, BIOMATERIALS, V35, P8040, DOI 10.1016/j.biomaterials.2014.06.001
   Battig MR, 2012, J AM CHEM SOC, V134, P12410, DOI 10.1021/ja305238a
   Belair DG, 2014, CHEM COMMUN, V50, P15651, DOI 10.1039/c4cc04317k
   Boehler RM, 2014, BIOTECHNOL BIOENG, V111, P1210, DOI 10.1002/bit.25175
   Boehler RM, 2011, BIOTECHNIQUES, V51, P239, DOI 10.2144/000113754
   Brammer LA, 2008, ANAL BIOCHEM, V373, P88, DOI 10.1016/j.ab.2007.10.015
   Briquez PS, 2015, ADV WOUND CARE, V4, P479, DOI 10.1089/wound.2014.0603
   Brudno Y, 2014, P NATL ACAD SCI USA, V111, P12722, DOI 10.1073/pnas.1413027111
   Burdick JA, 2006, BIOMATERIALS, V27, P452, DOI 10.1016/j.biomaterials.2005.06.034
   Cao LZ, 2012, P NATL ACAD SCI USA, V109, P7251, DOI 10.1073/pnas.1118088109
   Charras G, 2014, NAT REV MOL CELL BIO, V15, P813, DOI 10.1038/nrm3897
   Chen NC, 2012, BIOMATERIALS, V33, P1353, DOI 10.1016/j.biomaterials.2011.10.062
   Cho M, 2010, P NATL ACAD SCI USA, V107, P15373, DOI 10.1073/pnas.1009331107
   COLOTTA F, 1993, SCIENCE, V261, P472, DOI 10.1126/science.8332913
   DeForest CA, 2015, NAT MATER, V14, P523, DOI [10.1038/nmat4219, 10.1038/NMAT4219]
   DeForest CA, 2012, ANGEW CHEM INT EDIT, V51, P1816, DOI 10.1002/anie.201106463
   DeForest CA, 2009, NAT MATER, V8, P659, DOI [10.1038/NMAT2473, 10.1038/nmat2473]
   Deng Y, 2013, ACTA BIOMATER, V9, P8840, DOI 10.1016/j.actbio.2013.07.017
   Derda R, 2010, ANGEW CHEM INT EDIT, V49, P5301, DOI 10.1002/anie.201001143
   Derda R, 2010, J AM CHEM SOC, V132, P1289, DOI 10.1021/ja906089g
   Donaghue IE, 2014, J CONTROL RELEASE, V190, P219, DOI 10.1016/j.jconrel.2014.05.040
   Douglas SM, 2012, SCIENCE, V335, P831, DOI 10.1126/science.1214081
   Ehrlich M, 2012, FEBS LETT, V586, P1885, DOI 10.1016/j.febslet.2012.01.040
   Ehrlich M, 2011, CELL SIGNAL, V23, P1424, DOI 10.1016/j.cellsig.2011.04.004
   ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0
   Ezquerro IJ, 2003, CYTOKINE, V22, P12, DOI 10.1016/S1043-4666(03)00101-7
   Fairbrother WJ, 1998, BIOCHEMISTRY-US, V37, P17754, DOI 10.1021/bi981931e
   Fan TH, 2011, SOFT MATTER, V7, P9326, DOI 10.1039/c1sm05802a
   Fleming JC, 2008, EXP NEUROL, V214, P147, DOI 10.1016/j.expneurol.2008.04.024
   Gaddes ER, 2015, BIOMACROMOLECULES, V16, P1382, DOI 10.1021/acs.biomac.5b00165
   Germeroth L, 2003, THROMB HAEMOSTASIS, V90, P501
   Ghivizzani SC, 1998, P NATL ACAD SCI USA, V95, P4613, DOI 10.1073/pnas.95.8.4613
   Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004
   Gopinath SCB, 2007, ANAL BIOANAL CHEM, V387, P171, DOI 10.1007/s00216-006-0826-2
   Gower RM, 2014, BIOMATERIALS, V35, P2024, DOI 10.1016/j.biomaterials.2013.11.036
   Gupta S, 2014, J BIOL CHEM, V289, P8706, DOI 10.1074/jbc.M113.532580
   Hayashi G, 2007, J AM CHEM SOC, V129, P8678, DOI 10.1021/ja071298x
   Hermida N, 2009, CARDIOVASC RES, V81, P601, DOI 10.1093/cvr/cvn315
   Hetian Lei, 2002, Journal of Biological Chemistry, V277, P43137, DOI 10.1074/jbc.M203103200
   Huang CJ, 2010, BIOSENS BIOELECTRON, V25, P1761, DOI 10.1016/j.bios.2009.12.029
   Humphrey JD, 2014, NAT REV MOL CELL BIO, V15, P802, DOI 10.1038/nrm3896
   Hynes NE, 2013, NAT REV MOL CELL BIO, V14, P393, DOI 10.1038/nrm3581
   Impellitteri NA, 2012, BIOMATERIALS, V33, P3475, DOI 10.1016/j.biomaterials.2012.01.032
   JELLINEK D, 1994, BIOCHEMISTRY-US, V33, P10450, DOI 10.1021/bi00200a028
   Jing M, 2013, ANAL CHEM, V85, P10761, DOI 10.1021/ac401875h
   Johnson PJ, 2010, SOFT MATTER, V6, P5127, DOI 10.1039/c0sm00173b
   Johnson PJ, 2010, J BIOMED MATER RES A, V92A, P152, DOI 10.1002/jbm.a.32343
   Jones KS, 2008, SEMIN IMMUNOL, V20, P130, DOI 10.1016/j.smim.2007.11.005
   Kim MJ, 2013, BIOMATERIALS, V34, P7236, DOI 10.1016/j.biomaterials.2013.06.019
   Klim JR, 2010, NAT METHODS, V7, P989, DOI 10.1038/NMETH.1532
   KOIVUNEN E, 1994, J CELL BIOL, V124, P373, DOI 10.1083/jcb.124.3.373
   KOIVUNEN E, 1993, J BIOL CHEM, V268, P20205
   Kricker JA, 2003, ENDOCRINOLOGY, V144, P2807, DOI 10.1210/en.2002-221086
   Lee AC, 2003, EXP NEUROL, V184, P295, DOI 10.1016/S0014-4886(03)00258-9
   Lee JS, 2010, ACTA BIOMATER, V6, P21, DOI 10.1016/j.actbio.2009.08.003
   Lee ST, 2010, BIOMATERIALS, V31, P1219, DOI 10.1016/j.biomaterials.2009.10.054
   Li LL, 2014, P NATL ACAD SCI USA, V111, P17099, DOI 10.1073/pnas.1420105111
   Li LY, 2011, P NATL ACAD SCI USA, V108, P11745, DOI 10.1073/pnas.1101454108
   Li LY, 2010, MOL BIOSYST, V6, P2392, DOI 10.1039/c0mb00115e
   Li SH, 2015, SCI REP-UK, V5, DOI 10.1038/srep14297
   Li SH, 2015, ANGEW CHEM INT EDIT, V54, P5957, DOI 10.1002/anie.201500397
   Li SH, 2013, BIOMATERIALS, V34, P460, DOI 10.1016/j.biomaterials.2012.09.040
   Lin CC, 2009, ADV FUNCT MATER, V19, P2325, DOI 10.1002/adfm.200900107
   Lin CC, 2009, BIOMATERIALS, V30, P4907, DOI 10.1016/j.biomaterials.2009.05.083
   LINDAHL U, 1978, ANNU REV BIOCHEM, V47, P385, DOI 10.1146/annurev.bi.47.070178.002125
   Liu MZ, 2010, BIOORG MED CHEM LETT, V20, P2964, DOI 10.1016/j.bmcl.2010.02.109
   Lou XH, 2009, P NATL ACAD SCI USA, V106, P2989, DOI 10.1073/pnas.0813135106
   Madl CM, 2014, BIOMACROMOLECULES, V15, P445, DOI 10.1021/bm401726u
   Manz BN, 2010, NAT REV MOL CELL BIO, V11, P342, DOI 10.1038/nrm2883
   Martino MM, 2014, SCIENCE, V343, P885, DOI 10.1126/science.1247663
   Martino MM, 2013, P NATL ACAD SCI USA, V110, P4563, DOI 10.1073/pnas.1221602110
   Martino MM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002614
   Martino MM, 2010, FASEB J, V24, P4711, DOI 10.1096/fj.09-151282
   Martino MM, 2009, BIOMATERIALS, V30, P1089, DOI 10.1016/j.biomaterials.2008.10.047
   Martino MM, 2015, FRONT BIOENG BIOTECH, V3, P1
   Matochko WL, 2012, METHODS, V58, P47, DOI 10.1016/j.ymeth.2012.07.006
   McCall JD, 2012, DRUG DELIV TRANSL RE, V2, P305, DOI 10.1007/s13346-012-0090-2
   McCreedy DA, 2014, BIOMATER SCI-UK, V2, P1672, DOI 10.1039/c4bm00106k
   Meyer C, 2014, RNA BIOL, V11, P57, DOI 10.4161/rna.27447
   Miller T, 2014, ACTA BIOMATER, V10, P1705, DOI 10.1016/j.actbio.2013.09.039
   Mittelberger F, 2015, RNA BIOL, V12, P1043, DOI 10.1080/15476286.2015.1079681
   MOORADIAN DL, 1989, J CELL BIOCHEM, V41, P189, DOI 10.1002/jcb.240410404
   Mosiewicz KA, 2013, NAT MATER, V12, P1071, DOI 10.1038/NMAT3766
   Mothe AJ, 2013, BIOMATERIALS, V34, P3775, DOI 10.1016/j.biomaterials.2013.02.002
   Mueller TD, 2012, FEBS LETT, V586, P1846, DOI 10.1016/j.febslet.2012.02.043
   Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355
   Orive G, 2009, NAT REV NEUROSCI, V10, P682, DOI 10.1038/nrn2685
   Ouellet E, 2015, BIOTECHNOL BIOENG, V112, P1506, DOI 10.1002/bit.25581
   Ozer A, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.34
   Palomo J, 2015, CYTOKINE, V76, P25, DOI 10.1016/j.cyto.2015.06.017
   PASQUALINI R, 1995, J CELL BIOL, V130, P1189, DOI 10.1083/jcb.130.5.1189
   Pedersen RO, 2013, BIOMACROMOLECULES, V14, P4157, DOI 10.1021/bm4011722
   Piossek C, 1999, J BIOL CHEM, V274, P5612, DOI 10.1074/jbc.274.9.5612
   Qian JR, 2009, ANAL CHEM, V81, P5490, DOI 10.1021/ac900759k
   Rebollo IR, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku940
   Richards E, 2014, BIOMACROMOLECULES, V15, P4561, DOI 10.1021/bm501347s
   Ruckman J, 1998, J BIOL CHEM, V273, P20556, DOI 10.1074/jbc.273.32.20556
   Sacchi V, 2014, P NATL ACAD SCI USA, V111, P6952, DOI 10.1073/pnas.1404605111
   Sahni A, 1998, J BIOL CHEM, V273, P7554, DOI 10.1074/jbc.273.13.7554
   Sahni V, 2010, NAT REV NEUROL, V6, P363, DOI 10.1038/nrneurol.2010.73
   Sahni V, 2010, J NEUROSCI, V30, P1839, DOI 10.1523/JNEUROSCI.4459-09.2010
   Saito A, 2003, BBA-PROTEINS PROTEOM, V1651, P60, DOI 10.1016/S1570-9639(03)00235-8
   Sakiyama SE, 1999, FASEB J, V13, P2214
   Salinas CN, 2008, BIOMATERIALS, V29, P2370, DOI 10.1016/j.biomaterials.2008.01.035
   Sandvig A, 2004, GLIA, V46, P225, DOI 10.1002/glia.10315
   SHAW JP, 1991, NUCLEIC ACIDS RES, V19, P747, DOI 10.1093/nar/19.4.747
   Soontornworajit B, 2011, BIOMATERIALS, V32, P6839, DOI 10.1016/j.biomaterials.2011.05.074
   Soontornworajit B, 2010, BIOMACROMOLECULES, V11, P2724, DOI [10.1021/bm1007741, 10.1021/bm100774t]
   Soontornworajit B, 2010, SOFT MATTER, V6, P4255, DOI 10.1039/c0sm00206b
   Soontornworajit B, 2010, CHEM COMMUN, V46, P1857, DOI 10.1039/b924909e
   Stoltenburg R, 2007, BIOMOL ENG, V24, P381, DOI 10.1016/j.bioeng.2007.06.001
   't Hoen P.A., 2012, ANAL BIOCHEM, V421, P622, DOI DOI 10.1016/J.AB.2011.11.005
   Taylor SJ, 2006, J CONTROL RELEASE, V113, P226, DOI 10.1016/j.jconrel.2006.05.005
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121
   Ullman CG, 2011, BRIEF FUNCT GENOMICS, V10, P125, DOI 10.1093/bfgp/elr010
   Vaught JD, 2010, J AM CHEM SOC, V132, P4141, DOI 10.1021/ja908035g
   Vodnik M, 2011, MOLECULES, V16, P790, DOI 10.3390/molecules16010790
   Wang JP, 2014, ANGEW CHEM INT EDIT, V53, P4796, DOI 10.1002/anie.201309334
   Wang JP, 2011, P NATL ACAD SCI USA, V108, P6909, DOI 10.1073/pnas.1014753108
   Wilems TS, 2015, ACTA BIOMATER, V28, P23, DOI 10.1016/j.actbio.2015.09.018
   Willerth SM, 2007, J BIOMED MATER RES A, V80A, P13, DOI 10.1002/jbm.a.30844
   Wirkner M, 2011, CHEMBIOCHEM, V12, P2623, DOI 10.1002/cbic.201100437
   Wood MD, 2009, ACTA BIOMATER, V5, P959, DOI 10.1016/j.actbio.2008.11.008
   Wrighton PJ, 2014, P NATL ACAD SCI USA, V111, P18126, DOI 10.1073/pnas.1409525111
   YAYON A, 1993, P NATL ACAD SCI USA, V90, P10643, DOI 10.1073/pnas.90.22.10643
   You MX, 2014, J AM CHEM SOC, V136, P1256, DOI 10.1021/ja4114903
   Yuen WW, 2010, P NATL ACAD SCI USA, V107, P17933, DOI 10.1073/pnas.1001192107
   Yufa R, 2015, ANAL CHEM, V87, P1411, DOI 10.1021/ac5044187
   Zeisberg M, 2013, AM J PHYSIOL-CELL PH, V304, pC216, DOI 10.1152/ajpcell.00328.2012
   Zhang WY, 2012, ANAL CHEM, V84, P350, DOI 10.1021/ac2026942
   Zhang ZY, 2012, J AM CHEM SOC, V134, P15716, DOI 10.1021/ja307717w
   Zhu Z, 2014, ANAL CHEM, V86, P5881, DOI 10.1021/ac501423g
NR 137
TC 3
Z9 3
U1 1
U2 33
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1535-3702
EI 1535-3699
J9 EXP BIOL MED
JI Exp. Biol. Med.
PD MAY
PY 2016
VL 241
IS 9
BP 962
EP 971
DI 10.1177/1535370216647182
PG 10
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DM5JA
UT WOS:000376383300009
PM 27188514
OA Green Published
DA 2018-10-20
ER

PT J
AU Cao, S
   Wang, Y
   Cao, L
   Wang, Y
   Lin, BP
   Lan, W
   Cao, BC
AF Cao, Shuai
   Wang, Ye
   Cao, Lin
   Wang, Yu
   Lin, Bingpeng
   Lan, Wei
   Cao, Baocheng
TI Preparation and antimicrobial assay of ceramic brackets coated with TiO2
   thin films
SO KOREAN JOURNAL OF ORTHODONTICS
LA English
DT Article
DE Biomaterial science; Esthetics; Ceramic brackets; Antibacterial
ID SOL-GEL METHOD; PHOTOCATALYTIC TITANIUM-OXIDE; STAINLESS-STEEL;
   ANTIBACTERIAL PROPERTIES; IN-VITRO; LACTOBACILLUS-ACIDOPHILUS;
   ORTHODONTIC TREATMENT; BIOCOMPATIBILITY; NANOCOMPOSITE; NANOPARTICLES
AB Objective: Different methods have been utilized to prevent enamel demineralization and other complications during orthodontic treatment.-However, none of these methods can offer long-lasting and effective prevention of orthodontic complications or interventions after complications occur. Considering the photocatalytic effect of TiO2 on organic compounds, we hoped to synthesize a novel bracket with a TiO2 thin film to develop a photocatalytic antimicrobial effect. Methods: The sol-gel dip coating method was used to prepare TiO2 thin films on ceramic bracket surfaces. Twenty groups of samples were composed according to the experimental parameters. Crystalline structure and surface morphology were characterized by X-ray diffraction and scanning electron microscopy, respectively; film thickness was examined with a surface ellipsometer. The photocatalytic properties under ultraviolet (UV) light irradiation were analyzed by evaluating the degradation ratio of methylene blue (MB) at a certain time. Antibacterial activities of selected thin films were also tested against Lactobacillus acidophilus and Candida albicans. Results: Films with 5 coating layers annealed at 700 degrees C showed the greatest photocatalytic activity in terms of MB decomposition under UV light irradiation. TiO2 thin films with 5 coating layers annealed at 700 degrees C exhibited the greatest antimicrobial activity under UV-A light irradiation. Conclusions: These results provide promising guidance in prevention of demineralization by increasing antimicrobial activities of film coated brackets.
C1 [Cao, Shuai; Wang, Ye; Cao, Lin; Wang, Yu; Lin, Bingpeng; Cao, Baocheng] Lanzhou Univ, Sch Dent, Dept Orthodont, Lanzhou 730000, Peoples R China.
   [Lan, Wei] Lanzhou Univ, Sch Phys Sci & Technol, Dept Phys, Lanzhou 730000, Peoples R China.
RP Cao, BC (reprint author), Lanzhou Univ, Sch Dent, Dept Orthodont, Lanzhou 730000, Peoples R China.
EM caobch@lzu.edu.cn
FU Natural Science Foundation of Gansu Province [1208RJZA236, 1208RJZA199];
   Beijing research program [D121100001812002]
FX The authors would like to acknowledge the financial support provided by
   the Natural Science Foundation of Gansu Province (No. 1208RJZA236; No.
   1208RJZA199), Beijing research program (No. D121100001812002).
CR Akpan UG, 2010, APPL CATAL A-GEN, V375, P1, DOI 10.1016/j.apcata.2009.12.023
   BALASUBRAMANIAN K, 1993, APPL OPTICS, V32, P5594, DOI 10.1364/AO.32.005594
   Barrocas B, 2013, APPL SURF SCI, V264, P111, DOI 10.1016/j.apsusc.2012.09.136
   Bishara S E, 1997, Semin Orthod, V3, P178, DOI 10.1016/S1073-8746(97)80068-0
   Calderon-Moreno JM, 2014, CERAM INT, V40, P2209, DOI 10.1016/j.ceramint.2013.07.139
   Cao S, 2014, APPL SURF SCI, V309, P119, DOI 10.1016/j.apsusc.2014.04.198
   CHATTERJEE R, 1979, ARCH ORAL BIOL, V24, P97, DOI 10.1016/0003-9969(79)90056-6
   Chen Y, 2011, ARCH ORAL BIOL, V56, P16, DOI 10.1016/j.archoralbio.2010.08.006
   Chen YJ, 2006, APPL CATAL B-ENVIRON, V69, P24, DOI 10.1016/j.apcatb.2006.05.002
   Choi JY, 2007, J BIOMED MATER RES B, V80B, P353, DOI 10.1002/jbm.b.30604
   Chun MJ, 2007, ANGLE ORTHOD, V77, P483, DOI 10.2319/052406-211
   Cui CX, 2005, MATER LETT, V59, P3144, DOI 10.1016/j.matlet.2005.05.037
   Eissaa OE, 2013, TANTA DENT J, V10, P86, DOI DOI 10.1016/J.TDJ.2013.08.007
   ELIADES T, 1994, AM J ORTHOD DENTOFAC, V105, P10, DOI 10.1016/S0889-5406(94)70094-X
   Fu T, 2012, VACUUM, V86, P1402, DOI 10.1016/j.vacuum.2012.01.017
   FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0
   Ghamsari MS, 2008, MATER LETT, V62, P361, DOI 10.1016/j.matlet.2007.05.053
   GORELICK L, 1982, AM J ORTHOD DENTOFAC, V81, P93, DOI 10.1016/0002-9416(82)90032-X
   Hou Y.-Q., 2003, APPL SURF SCI, V218, P98
   Kaplan R, 2016, APPL CATAL B-ENVIRON, V181, P465, DOI 10.1016/j.apcatb.2015.08.027
   Karunakaran C, 2011, MAT SCI SEMICON PROC, V14, P133, DOI 10.1016/j.mssp.2011.01.017
   Kumar AM, 2013, CERAM INT, V39, P5639, DOI 10.1016/j.ceramint.2012.12.080
   Lee H, 2012, PROG ORG COAT, V74, P758, DOI 10.1016/j.porgcoat.2011.09.024
   Malengreaux CM, 2012, CHEM ENG J, V195, P347, DOI 10.1016/j.cej.2012.04.076
   Maness PC, 1999, APPL ENVIRON MICROB, V65, P4094
   Mattsson A, 2013, J SOLID STATE CHEM, V199, P212, DOI 10.1016/j.jssc.2012.12.018
   Mechiakh R, 2007, OPT MATER, V30, P645, DOI 10.1016/j.optmat.2007.02.047
   Nakaruk A, 2010, J SOL-GEL SCI TECHN, V55, P328, DOI 10.1007/s10971-010-2257-y
   Nejand BA, 2011, APPL SURF SCI, V257, P10434, DOI 10.1016/j.apsusc.2011.06.124
   Ogaard B., 2008, SEMIN ORTHOD, V14, P183, DOI DOI 10.1053/J.SODO.2008.03.003
   Ozyildiz F, 2010, BIOTECHNOL BIOPROC E, V15, P680
   Poma AM, 2010, J BIOTECHNOL, V150, pS466, DOI 10.1016/j.jbiotec.2010.09.691
   Pomoni K, 2008, J NON-CRYST SOLIDS, V354, P4448, DOI 10.1016/j.jnoncrysol.2008.06.069
   Richter AE, 2011, AM J ORTHOD DENTOFAC, V139, P657, DOI 10.1016/j.ajodo.2009.06.037
   Sayilkan F, 2009, J HAZARD MATER, V162, P1309, DOI 10.1016/j.jhazmat.2008.06.043
   SCHEIE AA, 1984, SCAND J DENT RES, V92, P211
   Shah AG, 2011, ANGLE ORTHOD, V81, P1028, DOI 10.2319/021111-101.1
   Sharma SK, 2009, J ALLOY COMPD, V471, P244, DOI 10.1016/j.jallcom.2008.03.058
   Singh P, 2010, PHYSICA B, V405, P1258, DOI 10.1016/j.physb.2009.11.061
   Tavares CJ, 2008, THIN SOLID FILMS, V517, P1161, DOI 10.1016/j.tsf.2008.06.024
   Tufekci E, 2011, ANGLE ORTHOD, V81, P206, DOI 10.2319/051710-262.1
   Wang HF, 2011, J MATER SCI TECHNOL, V27, P309, DOI 10.1016/S1005-0302(11)60067-4
   Wang XM, 2012, APPL SURF SCI, V258, P8241, DOI 10.1016/j.apsusc.2012.05.028
   Zhou L., 2009, MATER CHEM PHYS, V117, P522
NR 44
TC 1
Z9 1
U1 0
U2 15
PU KOREAN ASSOC ORTHODONTISTS
PI SEOUL
PA 603 TRAPALACE II, 1327 SEOCHO-DONG, SEOCHO-GU, SEOUL, 137-070, SOUTH
   KOREA
SN 2234-7518
EI 2005-372X
J9 KOREAN J ORTHOD
JI Korean J. Orthod.
PD MAY
PY 2016
VL 46
IS 3
BP 146
EP 154
DI 10.4041/kjod.2016.46.3.146
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA DM9VI
UT WOS:000376713400004
PM 27226960
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Safronova, TV
   Knot'ko, AV
   Shatalova, TB
   Evdokimov, PV
   Putlyaev, VI
   Kostin, MS
AF Safronova, T. V.
   Knot'ko, A. V.
   Shatalova, T. B.
   Evdokimov, P. V.
   Putlyaev, V. I.
   Kostin, M. S.
TI Calcium Phosphate Ceramic Based on Powder Synthesized From a
   Mixed-Anionic Solution
SO GLASS AND CERAMICS
LA English
DT Article
DE brushite; monetite; amorphous calcium pyrophosphate; ceramic;
   thermo-hydrolysis; calcium pyrophosphate; tricalcium phosphate;
   biomaterial
ID HYDROPHOSPHATE; ACETATE
AB Ceramic based on calcium phosphates is obtained from powders synthesized from water solutions of calcium nitrate, ammonium hydrophosphate, and ammonium pyrophosphate as well as from a mixed-anionic solution containing simultaneously ammonium pyro- and orthophosphate in the molar ratio (NH4)(2)HPO4/(NH4)(4)P2O7 = 1. The ceramic obtained contains biocompatible bioresorbable phases and can be used to make implants used in regenerative methods for the treatment of bone tissue defects. This represents the first time synthesis from mixed-anionic solutions is used to obtain powders of calcium phosphates with significant quantities of each anion.
C1 [Safronova, T. V.; Knot'ko, A. V.; Shatalova, T. B.; Evdokimov, P. V.; Putlyaev, V. I.; Kostin, M. S.] Moscow MV Lomonosov State Univ, Moscow, Russia.
RP Safronova, TV (reprint author), Moscow MV Lomonosov State Univ, Moscow, Russia.
EM t3470641@yandex.ru
RI Safronova, Tatiana/D-7285-2012; Shatalova, Tatiana/T-2059-2017
OI Safronova, Tatiana/0000-0002-9799-5029; Shatalova,
   Tatiana/0000-0002-4304-8624
FU Russian Science Foundation [15-19-00103]
FX The research was supported by the Russian Science Foundation under Grant
   No. 15-19-00103.
CR EANES ED, 1970, CALC TISS RES, V5, P133, DOI 10.1007/BF02017543
   Gibson IR, 2002, J MATER SCI-MATER M, V13, P685, DOI 10.1023/A:1015793927364
   Gibson IR, 1999, J BIOMED MATER RES, V44, P422, DOI 10.1002/(SICI)1097-4636(19990315)44:4<422::AID-JBM8>3.0.CO;2-#
   Kannan S, 2006, J AM CERAM SOC, V89, P2757, DOI 10.1111/j.1551-2916.2006.01158.x
   Koutsoukos P. G., 2000, P 2 INT C PHOSPH REC, P12
   Miao SD, 2006, KEY ENG MAT, V309-311, P565, DOI 10.4028/www.scientific.net/KEM.309-311.565
   Pietak AM, 2007, BIOMATERIALS, V28, P4023, DOI 10.1016/j.biomaterials.2007.05.003
   RAJENDRAN S, 1988, J MATER SCI, V23, P1805, DOI 10.1007/BF01115724
   Safronova TV, 2007, GLASS CERAM+, V64, P102, DOI 10.1007/s10717-007-0027-2
   Safronova TV, 2013, NANOSYST-PHYS CHEM M, V4, P24
   Safronova TV, 2013, GLASS CERAM+, V70, P65, DOI 10.1007/s10717-013-9510-0
   Safronova TV, 2011, GLASS CERAM+, V68, P131, DOI 10.1007/s10717-011-9338-4
   Safronova T. V., 2015, IAN SSSR NEORG MATER, V51, P1269
   Safronova T. V., 2013, STEKLO KERAM, P34
   Safronova TV, 2013, PROCESS APPL CERAM, V7, P9, DOI 10.2298/PAC1301009S
   Safronova TV, 2009, CENT EUR J CHEM, V7, P184, DOI 10.2478/s11532-009-0016-0
NR 16
TC 4
Z9 4
U1 1
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0361-7610
EI 1573-8515
J9 GLASS CERAM+
JI Glass Ceram.
PD MAY
PY 2016
VL 73
IS 1-2
BP 25
EP 31
DI 10.1007/s10717-016-9819-6
PG 7
WC Materials Science, Ceramics
SC Materials Science
GA DM1GN
UT WOS:000376093500007
DA 2018-10-20
ER

PT J
AU Ramanathan, M
   Patil, MS
   Epur, R
   Kumta, PN
AF Ramanathan, Madhumati
   Patil, Mitali S.
   Epur, Rigved
   Kumta, Prashant N.
TI Tartrate Resistant Acid Phosphatase Assisted Degradation of Single-Wall
   Carbon Nanotubes (SWCNTs)
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Article
DE carbon nanotubes; biodegradation; tartrate resistant acid phosphatase;
   bone marker
ID BIOMEDICAL APPLICATIONS; CRYSTAL-STRUCTURES; IN-VIVO; BONE; COMPOSITES;
   IMPLANTS; PROLIFERATION; OSTEOBLASTS; SCIENCE
AB In this study, we explored the capability of tartrate resistant acid phosphatase (TRAcP), a bone resorption marker, to degrade carboxylated single-walled carbon nano tubes (C-SWCNTs). Optical observations and Raman and high-resolution transmission electron microscopy studies show that the enzyme contributes to the degradation of C-SWCNTs, although the degradation is not complete. Molecular modeling implemented to investigate the binding sites for carboxylated and pristine SWCNTs to TRAcP elucidate the varying proximity of SWCNTs to the binuclear iron active site and the active site residues of TRAcP, which is clearly dependent upon the degree of carboxylation introduced into the SWCNT model. The modeling results presented provide justification to the propensity of TRAcP to degrade the C-SWCNTs alluding to the possibility of C-SWCNTs to be used as a potential degradable biomaterial for use in therapeutic applications of mineralized tissue related conditions.
C1 [Ramanathan, Madhumati; Patil, Mitali S.; Kumta, Prashant N.] Univ Pittsburgh, Swanson Sch Engn, Dept Bioengn, 3700 OHara St, Pittsburgh, PA 15261 USA.
   [Epur, Rigved; Kumta, Prashant N.] Univ Pittsburgh, Swanson Sch Engn, Dept Mech Engn & Mat Sci, 3700 OHara St, Pittsburgh, PA 15261 USA.
   [Kumta, Prashant N.] Univ Pittsburgh, Swanson Sch Engn, Dept Chem & Petr Engn, 3700 OHara St, Pittsburgh, PA 15261 USA.
   [Kumta, Prashant N.] Univ Pittsburgh, Sch Dent Med, Dept Oral Biol, 3501 Terrace St, Pittsburgh, PA USA.
RP Kumta, PN (reprint author), Univ Pittsburgh, Swanson Sch Engn, Dept Bioengn, 3700 OHara St, Pittsburgh, PA 15261 USA.; Kumta, PN (reprint author), Univ Pittsburgh, Swanson Sch Engn, Dept Mech Engn & Mat Sci, 3700 OHara St, Pittsburgh, PA 15261 USA.; Kumta, PN (reprint author), Univ Pittsburgh, Swanson Sch Engn, Dept Chem & Petr Engn, 3700 OHara St, Pittsburgh, PA 15261 USA.
EM pkumta@pitt.edu
FU NSF-ERC [EEC-0812348]; Swanson School of Engineering, University of
   Pittsburgh; NSF-CBET [0933153]
FX The authors acknowledge the partial financial assistance of NSF-ERC
   Grant EEC-0812348 in supporting this work. The authors also acknowledge
   the financial support of the Swanson School of Engineering, University
   of Pittsburgh, whereas P.N.K. acknowledges the Edward R. Weidlein Chair
   Professorship, the Center for Complex Engineered Multifunctional
   Materials (CCEMM) of the Swanson School of Engineering, and NSF-CBET
   Grant 0933153 for support of use of equipment and accessories needed for
   this research.
CR Allen BL, 2009, J AM CHEM SOC, V131, P17194, DOI 10.1021/ja9083623
   Balani K, 2007, BIOMATERIALS, V28, P618, DOI 10.1016/j.biomaterials.2006.09.013
   Bianco A, 2005, CHEM COMMUN, P571, DOI 10.1039/b410943k
   BURSTONE MS, 1959, J HISTOCHEM CYTOCHEM, V7, P39, DOI 10.1177/7.1.39
   Ciombor Deborah McK, 2005, Foot Ankle Clin, V10, P579, DOI 10.1016/j.fcl.2005.06.006
   Coleman JN, 2006, CARBON, V44, P1624, DOI 10.1016/j.carbon.2006.02.038
   Giannona S, 2007, J NANOSCI NANOTECHNO, V7, P1679, DOI 10.1166/jnn.2007.454
   Harrison BS, 2007, BIOMATERIALS, V28, P344, DOI 10.1016/j.biomaterials.2006.07.044
   Herrera-Herrera AV, 2012, ANAL CHIM ACTA, V734, P1, DOI 10.1016/j.aca.2012.04.035
   Kagan VE, 2010, NAT NANOTECHNOL, V5, P354, DOI [10.1038/NNANO.2010.44, 10.1038/nnano.2010.44]
   Klabunde T, 1996, J MOL BIOL, V259, P737, DOI 10.1006/jmbi.1996.0354
   Kraus T, 2012, ACTA BIOMATER, V8, P1230, DOI 10.1016/j.actbio.2011.11.008
   Lacerda L, 2006, ADV DRUG DELIVER REV, V58, P1460, DOI 10.1016/j.addr.2006.09.015
   Newman P, 2013, NANOMED-NANOTECHNOL, V9, P1139, DOI 10.1016/j.nano.2013.06.001
   Oddie GW, 2000, BONE, V27, P575, DOI 10.1016/S8756-3282(00)00368-9
   Pan LL, 2012, COLLOID SURFACE B, V93, P226, DOI 10.1016/j.colsurfb.2012.01.011
   Roldo M, 2013, ANNU REP PROG CHEM C, V109, P10, DOI 10.1039/c3pc90010j
   Sinha N, 2005, IEEE T NANOBIOSCI, V4, P180, DOI 10.1109/TNB.2005.850478
   Sirivisoot S, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/29/295101
   Sitharaman B, 2008, BONE, V43, P362, DOI 10.1016/j.bone.2008.04.013
   Strater N, 2005, J MOL BIOL, V351, P233, DOI 10.1016/j.jmb.2005.04.014
   Supronowicz PR, 2002, J BIOMED MATER RES, V59, P499, DOI 10.1002/jbm.10015
   Thostenson ET, 2001, COMPOS SCI TECHNOL, V61, P1899, DOI 10.1016/S0266-3538(01)00094-X
   Tian FR, 2006, TOXICOL IN VITRO, V20, P1202, DOI 10.1016/j.tiv.2006.03.008
   Trojanowicz M, 2006, TRAC-TREND ANAL CHEM, V25, P480, DOI 10.1016/j.trac.2005.11.008
   Wang J, 2005, ELECTROANAL, V17, P7, DOI 10.1002/elan.200403113
   Webster TJ, 2011, NANOTECHNOLOGY ENABLED IN SITU SENSORS FOR MONITORING HEALTH, P1, DOI 10.1007/978-1-4419-7291-0
   Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028
   Wong HM, 2010, BIOMATERIALS, V31, P2084, DOI 10.1016/j.biomaterials.2009.11.111
   Yang WR, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/41/412001
   Zanello LP, 2006, NANO LETT, V6, P562, DOI 10.1021/nl051861e
NR 31
TC 1
Z9 1
U1 1
U2 11
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD MAY
PY 2016
VL 2
IS 5
BP 712
EP 721
DI 10.1021/acsbiomaterials.5b00462
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA DL8LN
UT WOS:000375893600002
DA 2018-10-20
ER

PT J
AU Huyer, LD
   Zhang, BY
   Korolj, A
   Montgomery, M
   Drecun, S
   Conant, G
   Zhao, YM
   Reis, L
   Radisic, M
AF Huyer, Locke Davenport
   Zhang, Boyan
   Korolj, Anastasia
   Montgomery, Miles
   Drecun, Stasja
   Conant, Genevieve
   Zhao, Yimu
   Reis, Lewis
   Radisic, Milica
TI Highly Elastic and Moldable Polyester Biomaterial for Cardiac Tissue
   Engineering Applications
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Article
DE elastomer; regenerative medicine; tunable properties; biodegradable;
   microfabrication; cross-linkable
ID VENTRICULAR FREE-WALL; CONTRACTILE FUNCTION; MYOCARDIUM; ELASTOMERS;
   STIFFNESS; MEDICINE; SCAFFOLD; STRAIN
AB Polyester biomaterials are used in tissue engineering as scaffolds for implantation of tissues developed in vitro. An ideal biodegradable elastomer for cardiac tissue engineering exhibits a relatively low Young's modulus, with high elongation and tensile strength. Here we describe a novel polyester biomaterial that exhibits improved elastic properties for cardiac tissue engineering applications. We synthesized poly(octamethylene maleate (anhydride) 1,2,4-butanetricarboxylate) (124 polymer) prepolymer gel in a one-step polycondensation reaction. The prepolymer was then molded as desired and exposed to ultraviolet (UV) light to produce a cross-linked elastomer. 124 polymer exhibited highly elastic properties under aqueous conditions that were tunable according to the UV light exposure, monomer composition, and porosity of the cured elastomer. Its elastomeric properties fell within the range of adult heart myocardium, but they could also be optimized for higher elasticity for weaker immature constructs. The polymer showed relatively stable degradation characteristics, both hydrolytically and in a cellular environment, suggesting maintenance of material properties as a scaffold support for potential tissue implants. When assessed for cell interaction, this polymer supported rat cardiac cell attachment in vitro as well as comparable acute in vivo host response when compared to poly(L-lactic acid) control. This suggests the potential applicability of this material as an elastomer for cardiac tissue engineered constructs.
C1 [Huyer, Locke Davenport; Zhang, Boyan; Korolj, Anastasia; Montgomery, Miles; Conant, Genevieve; Zhao, Yimu; Reis, Lewis; Radisic, Milica] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada.
   [Huyer, Locke Davenport; Zhang, Boyan; Korolj, Anastasia; Montgomery, Miles; Conant, Genevieve; Reis, Lewis; Radisic, Milica] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.
   [Drecun, Stasja] Univ Toronto, Human Biol, Toronto, ON, Canada.
RP Radisic, M (reprint author), Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada.; Radisic, M (reprint author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.
EM m.radisic@utoronto.ca
FU NSERC Steacie Fellowship; Canadian Institutes of Health Research (CIHR)
   [MOP-126027, MOP-137107]; NSERC Discovery Grant [RGPIN 326982-10];
   National Institutes of Health [2R01 HL076485]; Canadian Foundation for
   Innovation [19119]; Ontario Research Fund; CIHR Canadian Graduate
   Scholarships Masters; NSERC Vanier Graduate Scholarships; Ontario
   Graduate Scholarships
FX This work is funded by the NSERC Steacie Fellowship to M.R, Canadian
   Institutes of Health Research (CIHR) Operating Grants (MOP-126027 and
   MOP-137107), NSERC Discovery Grant (RGPIN 326982-10), and National
   Institutes of Health Grant 2R01 HL076485. The authors acknowledge the
   Canadian Foundation for Innovation, Project 19119, and the Ontario
   Research Fund for funding of the Centre for Spectroscopic Investigation
   of Complex Organic Molecules and Polymers. L.D.H. is supported by CIHR
   Canadian Graduate Scholarships Masters. M.M. is supported by NSERC
   Vanier Graduate Scholarships. G.C. is supported by Ontario Graduate
   Scholarships.
CR Arias V, 2014, BIOMACROMOLECULES, V15, P391, DOI 10.1021/bm401667b
   Bouten CVC, 2011, ADV DRUG DELIVER REV, V63, P221, DOI 10.1016/j.addr.2011.01.007
   Chan B., 2008, EUR SPINE J, V17, P467, DOI DOI 10.1007/S00586-008-0745-3
   Chen QZ, 2013, PROG POLYM SCI, V38, P584, DOI 10.1016/j.progpolymsci.2012.05.003
   CHUONG CJ, 1991, AM J PHYSIOL, V260, pH1224
   Coirault C, 1998, J APPL PHYSIOL, V85, P1762
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Gupta B, 2007, PROG POLYM SCI, V32, P455, DOI 10.1016/j.progpolymsci.2007.01.005
   Hoshi RA, 2009, ADV MATER, V21, P188, DOI 10.1002/adma.200801132
   Huyer LD, 2015, BIOMED MATER, V10, DOI 10.1088/1748-6041/10/3/034004
   Jawad H, 2008, BRIT MED BULL, V87, P31, DOI 10.1093/bmb/ldn026
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Marsano A, 2010, BIOTECHNOL PROGR, V26, P1382, DOI 10.1002/btpr.435
   MASSEY V, 1953, BIOCHEM J, V55, P172, DOI 10.1042/bj0550172
   Montgomery D.C., 2011, ENG STAT
   Montgomery M, 2014, J CARDIOVASC PHARM T, V19, P382, DOI 10.1177/1074248414528576
   Nagueh SF, 2004, CIRCULATION, V110, P155, DOI 10.1161/01.CIR.0000135591.37759.AF
   Nijst CLE, 2007, BIOMACROMOLECULES, V8, P3067, DOI 10.1021/bm070423u
   Nunes SS, 2013, NAT METHODS, V10, P781, DOI [10.1038/NMETH.2524, 10.1038/nmeth.2524]
   Omens JH, 1998, PROG BIOPHYS MOL BIO, V69, P559, DOI 10.1016/S0079-6107(98)00025-X
   Park H, 2005, IN VITRO CELL DEV-AN, V41, P188
   Radisic M, 2007, PHILOS T R SOC B, V362, P1357, DOI 10.1098/rstb.2007.2121
   Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101
   Rappaport D, 2006, ULTRASOUND MED BIOL, V32, P1181, DOI 10.1016/j.ultrasmedbio.2006.05.005
   Reis LA, 2016, J TISSUE ENG REGEN M, V10, P11, DOI 10.1002/term.1944
   SACKS MS, 1993, J BIOMECH ENG-T ASME, V115, P202, DOI 10.1115/1.2894122
   Tran RT, 2010, SOFT MATTER, V6, P2449, DOI 10.1039/c001605e
   Ulery BD, 2011, J POLYM SCI POL PHYS, V49, P832, DOI 10.1002/polb.22259
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Weis SM, 2000, CIRC RES, V87, P663, DOI 10.1161/01.RES.87.8.663
   Zhang BY, 2016, NAT MATER, V15, P669, DOI [10.1038/NMAT4570, 10.1038/nmat4570]
   Zhang BY, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500423
   Zhao YM, 2014, CAN J CARDIOL, V30, P1307, DOI 10.1016/j.cjca.2014.08.027
NR 33
TC 17
Z9 17
U1 5
U2 47
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD MAY
PY 2016
VL 2
IS 5
BP 780
EP 788
DI 10.1021/acsbiomaterials.5b00525
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA DL8LN
UT WOS:000375893600009
DA 2018-10-20
ER

PT J
AU Wang, W
   Dang, M
   Zhang, ZP
   Hu, J
   Eyster, TW
   Ni, LX
   Ma, PX
AF Wang, Wei
   Dang, Ming
   Zhang, Zhanpeng
   Hu, Jiang
   Eyster, Thomas W.
   Ni, Longxing
   Ma, Peter X.
TI Dentin regeneration by stem cells of apical papilla on injectable
   nanofibrous microspheres and stimulated by controlled BMP-2 release
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Stem cells of apical papilla (SCAP); Nanofibrous microspheres (NF-MS);
   Odontogenic differentiation; Bone morphogenetic protein-2 (BMP-2);
   Controlled delivery
ID BONE MORPHOGENETIC PROTEIN-2; IN-VIVO; ODONTOGENIC DIFFERENTIATION;
   OSTEOGENIC DIFFERENTIATION; AMPUTATED PULP; PDGF-BB; TISSUE; SCAFFOLDS;
   DELIVERY; MICROCARRIERS
AB The aim of this study was to investigate the effects of PLLA nanofibrous microspheres (NF-MS) as a cell delivery carrier in combination with controlled release of BMP-2 from PLGA microspheres on the induction of odontogenic differentiation of human stem cells of apical papilla (SCAP). Injectable NF-MS, which mimic the physical architecture of collagen fibers on the nano scale, were fabricated by combining thermally-induced phase separation techniques with an emulsification process. SCAP cultured in a mono layer or cultured on NF-MS in spinner flasks were treated with 100 ng/ml BMP-2 in vitro. Odontogenic differentiation was characterized by measuring alkaline phosphatase activity, odontogenic gene expression levels, calcium content, and dentin sialophosphoprotein accumulation. The results demonstrated that BMP-2 enhanced human SCAP odontogenic differentiation both in monolayer culture and on 3D NF-MS in spinner flask culture in vitro. We also developed and tested a system combining NF-MS with controlled BMP-2 release for dentin regeneration in vivo. The results indicate that controlled release of BMP-2 promoted more mineralization and osteodentin formation compared to a BSA-releasing control in a dose-dependent and time-dependent manner. In summary, the NF-MS combined with controlled release of BMP-2 provides an excellent microenvironment for SCAP to regenerate dentin tissue.
   Statement of Significance
   Tooth lesion and loss affect masticatory efficiency, speaking function, facial aesthetics and even psychological health. Current treatments depend on "inert" restorative materials, which do not have the healing capacity and may lead to the failure of the restorations over a long term. The aim of this study was to develop an injectable biomaterial and desired growth factor delivery system to support stem cells for mineralized dental tissue regeneration. The study showed that novel injectable and biodegradable nanofibrous microspheres and controlled release of BMP-2 synergistically induce the odontogenic differentiation of human stem cells from the apical papilla and mineralized tissue regeneration, demonstrating the potential of living dental tissue repair. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Wang, Wei; Hu, Jiang; Eyster, Thomas W.; Ma, Peter X.] Univ Michigan, Dept Biol & Mat Sci, 1011 North Univ Ave,Room 2211, Ann Arbor, MI 48109 USA.
   [Wang, Wei; Ni, Longxing] Fourth Mil Med Univ, Sch Stomatol, Dept Operat Dent & Endodont, State Key Lab Mil Stomatol, Xian 710032, Peoples R China.
   [Dang, Ming; Ma, Peter X.] Univ Michigan, Macromol Sci & Engn Ctr, Ann Arbor, MI 48109 USA.
   [Zhang, Zhanpeng; Ma, Peter X.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
   [Ma, Peter X.] Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA.
RP Ma, PX (reprint author), Univ Michigan, Dept Biol & Mat Sci, 1011 North Univ Ave,Room 2211, Ann Arbor, MI 48109 USA.; Ni, LX (reprint author), Fourth Mil Med Univ, Sch Stomatol, Dept Operat Dent & Endodont, State Key Lab Mil Stomatol, Xian 710032, Peoples R China.
EM Longxing_Ni@hotmail.com; mapx@umich.edu
FU US NIH [NIDCR DE022327, DE015384]; US DOD [W81XWH-12-2-0008]; US NSF
   [DMR-1206575]; NSF of China (NSFC) [31500786]; Chinese Scholarship
   Council
FX This study was conducted in the Polymeric Biomaterials and Tissue
   Engineering Laboratory at the University of Michigan with the financial
   support from the US NIH (NIDCR DE022327 and DE015384: PXM), US DOD
   (W81XWH-12-2-0008: PXM), US NSF (DMR-1206575: PXM), and NSF of China
   (NSFC No 31500786: WW). WW was partially supported by a fellowship from
   the Chinese Scholarship Council to conduct research at the University of
   Michigan under the joint advisement of PXM and LN.
CR Babensee JE, 2000, PHARMACEUT RES, V17, P497, DOI 10.1023/A:1007502828372
   Boerckel JD, 2011, BIOMATERIALS, V32, P5241, DOI 10.1016/j.biomaterials.2011.03.063
   Casagrande L, 2010, J DENT RES, V89, P603, DOI 10.1177/0022034510364487
   Dreifke MB, 2013, J BIOMED MATER RES A, V101, P2436, DOI 10.1002/jbm.a.34521
   Fang JJ, 2014, ACTA BIOMATER, V10, P276, DOI 10.1016/j.actbio.2013.09.002
   Francisco AT, 2013, BIOMATERIALS, V34, P7381, DOI 10.1016/j.biomaterials.2013.06.038
   Friedlander LT, 2009, INT ENDOD J, V42, P955, DOI 10.1111/j.1365-2591.2009.01622.x
   Goldberg M, 2001, Adv Dent Res, V15, P91
   Gupte MJ, 2012, J DENT RES, V91, P227, DOI 10.1177/0022034511417441
   Huang GTJ, 2009, J DENT RES, V88, P792, DOI 10.1177/0022034509340867
   Huang GTJ, 2010, TISSUE ENG PT A, V16, P605, DOI 10.1089/ten.TEA.2009.0518
   Huang GTJ, 2009, REGEN MED, V4, P697, DOI 10.2217/RME.09.45
   Iohara K, 2004, J DENT RES, V83, P590, DOI 10.1177/154405910408300802
   Jayasuriya AC, 2010, J BIOMED MATER RES A, V93A, P1280, DOI 10.1002/jbm.a.32623
   Jin QM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001729
   Kirker-Head CA, 2000, ADV DRUG DELIVER REV, V43, P65, DOI 10.1016/S0169-409X(00)00078-8
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Li G, 2005, J ORTHOP RES, V23, P680, DOI 10.1016/j.orthres.2004.12.005
   Liu XH, 2011, NAT MATER, V10, P398, DOI [10.1038/NMAT2999, 10.1038/nmat2999]
   Lovelace TW, 2011, J ENDODONT, V37, P133, DOI 10.1016/j.joen.2010.10.009
   Ma PX, 2008, ADV DRUG DELIVER REV, V60, P184, DOI 10.1016/j.addr.2007.08.041
   Malda J, 2006, TRENDS BIOTECHNOL, V24, P299, DOI 10.1016/j.tibtech.2006.04.009
   Martin Y, 2011, TISSUE ENG PART B-RE, V17, P71, DOI 10.1089/ten.TEB.2010.0559
   Mckay WF, 2007, INT ORTHOP, V31, P729, DOI 10.1007/s00264-007-0418-6
   NAKASHIMA M, 1994, ARCH ORAL BIOL, V39, P1085, DOI 10.1016/0003-9969(94)90062-0
   Nakashima M, 2003, NAT BIOTECHNOL, V21, P1025, DOI 10.1038/nbt864
   NAKASHIMA M, 1994, DEV BIOL, V162, P18, DOI 10.1006/dbio.1994.1063
   Nakashima M, 2005, CYTOKINE GROWTH F R, V16, P369, DOI 10.1016/j.cytogfr.2005.02.011
   NAKASHIMA M, 1994, J DENT RES, V73, P1515, DOI 10.1177/00220345940730090601
   Rao Subramaniam M, 2013, N Am J Med Sci, V5, P161, DOI 10.4103/1947-2714.109175
   Saito T, 2004, J ENDODONT, V30, P205, DOI 10.1097/00004770-200404000-00005
   Smith LA, 2009, TISSUE ENG PT A, V15, P1855, DOI 10.1089/ten.tea.2008.0227
   Smith LA, 2009, BIOMATERIALS, V30, P2516, DOI 10.1016/j.biomaterials.2009.01.009
   Sonoyama W, 2008, J ENDODONT, V34, P166, DOI 10.1016/j.joen.2007.11.021
   Sonoyama W, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000079
   Tasli PN, 2014, APPL BIOCHEM BIOTECH, V172, P3016, DOI 10.1007/s12010-013-0706-0
   Thomadakis G, 1999, EUR J ORAL SCI, V107, P368, DOI 10.1046/j.0909-8836.1999.eos107508.x
   Wang J, 2011, BIOMATERIALS, V32, P7822, DOI 10.1016/j.biomaterials.2011.04.034
   Wang J, 2010, ACTA BIOMATER, V6, P3856, DOI 10.1016/j.actbio.2010.04.009
   Wei GB, 2004, BIOMATERIALS, V25, P345, DOI 10.1016/S0142-9612(03)00528-3
   Wei GB, 2006, J CONTROL RELEASE, V112, P103, DOI 10.1016/j.jconrel.2006.01.011
   Wei GB, 2007, BIOMATERIALS, V28, P2087, DOI 10.1016/j.biomaterials.2006.12.028
   Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098
   Woo KM, 2007, BIOMATERIALS, V28, P335, DOI 10.1016/j.biomaterials.2006.06.013
   Woo KM, 2009, TISSUE ENG PT A, V15, P2155, DOI 10.1089/ten.tea.2008.0433
   Wozney JM, 1998, CLIN ORTHOP RELAT R, P26
   YANG LJ, 1993, CLIN ORTHOP RELAT R, P305
   Zhao M, 2002, J BONE MINER RES, V17, P1441, DOI 10.1359/jbmr.2002.17.8.1441
   Zheng LQ, 2011, BIOMATERIALS, V32, P7053, DOI [10.1016/j.biomaterials.2011.06.094, 10.1016/j.biomaterials.2011.06.004]
NR 49
TC 17
Z9 17
U1 6
U2 62
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2016
VL 36
BP 63
EP 72
DI 10.1016/j.actbio.2016.03.015
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DL8JJ
UT WOS:000375888000005
PM 26971664
OA Other Gold, Green Accepted
DA 2018-10-20
ER

PT J
AU Bilem, I
   Chevallier, P
   Plawinski, L
   Sone, ED
   Durrieu, MC
   Laroche, G
AF Bilem, I.
   Chevallier, P.
   Plawinski, L.
   Sone, E. D.
   Durrieu, M. C.
   Laroche, G.
TI RGD and BMP-2 mimetic peptide crosstalk enhances osteogenic commitment
   of human bone marrow stem cells
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Stem cells; Biomimetic materials; Bone tissue engineering; Mimetic
   peptides; Surface modification
ID OSTEOBLAST DIFFERENTIATION; MORPHOGENETIC PROTEIN-2; IN-VIVO;
   SURFACE-DENSITY; GROWTH-FACTORS; STROMAL CELLS; BIOMATERIALS; ADHESION;
   MATRIX; SCAFFOLDS
AB Human bone marrow mesenchymal stem cells (hBMSCs) commitment and differentiation are dictated by bioactive molecules sequestered within their Extra Cellular Matrix (ECM). One common approach to mimic the physiological environment is to functionalize biomaterial surfaces with ECM-derived peptides able to recruit stem cells and trigger their linage-specific differentiation. The objective of this work was to investigate the effect of RGD and BMP-2 ligands crosstalk and density on the extent of hBMSCs osteogenic commitment, without recourse to differentiation medium. RGD peptide promotes cell adhesion via cell transmembrane integrin receptors, while BMP-2 peptide, corresponding to residues 73-92 of Bone Morphogenetic Protein-2, was shown to induce hBMSCs osteoblast differentiation. The immobilization of peptides on aminated glass was ascertained by X-ray Photoelectron Spectroscopy (XPS), the density of grafted peptides was quantified by fluorescence microscopy and the surface roughness was evaluated using Atomic Force Microscopy (AFM). The osteogenic commitment of hBMSCs cultured on RGD and/or BMP-2 surfaces was characterized by immunohistochemistry using STRO-1 as specific stem cells marker and Runx-2 as an earlier osteogenic marker. Biological results showed that the osteogenic commitment of hBMSCs was enhanced on bifunctionalized surfaces as compared to surfaces containing BMP-2, while on RGD surfaces cells mainly preserved their sternness character. These results demonstrated that RGD and BMP-2 mimetic peptides act synergistically to enhance hBMSCs osteogenesis without supplementing the media with osteogenic factors. These findings contribute to the development of biomimetic materials, allowing a deeper understanding of signaling pathways that govern the transition of stem cells towards the osteoblastic lineage.
   Statement of Significance
   For a long time, scientists thought that the differentiation of Mesenchymal Stem Cells (MSCs) into bone cells was dictated by growth factors. This manuscript shed light on other ligands that play a crucial role in regulating MSCs fate. In concrete terms, it was demonstrated that the osteoinductive effect of BMP-2 peptide is 2 folds improved in the presence of adhesive RGD peptide. Compared to previous works highlighting this synergistic cooperation between RGD and BMP-2 peptides, the main strength of this work lies to the use of primitive human cells (hMSCs) and well-defined biomimetic material surfaces (controlled surface roughness and peptide densities). This work provides valuable insights to develop custom-designed in vitro cell culture models, capable of targeting the desired cell response. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Bilem, I.; Chevallier, P.; Laroche, G.] Univ Laval, Dept Genie Mines Met & Mat, Ctr Rech Mat Avances, Lab Ingn Surface, 1065 Ave Med, Quebec City, PQ G1V 0A6, Canada.
   [Bilem, I.; Chevallier, P.; Laroche, G.] Univ Quebec, Ctr Rech Ctr Hosp, Hop St Francois dAssise, 10 Rue Espinay, Quebec City, PQ G1L 3L5, Canada.
   [Plawinski, L.; Durrieu, M. C.] Univ Bordeaux, CNRS, CBMN, Inst Chem & Biol Membranes & Nanoobjects,UMR5248, Bordeaux Inp, France.
   [Sone, E. D.] Univ Toronto, Dept Mat Sci & Engn, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada.
   [Sone, E. D.] Univ Toronto, Fac Dent, Toronto, ON M5S 3G9, Canada.
RP Laroche, G (reprint author), Univ Laval, Dept Genie Mines Met & Mat, Ctr Rech Mat Avances, Lab Ingn Surface, 1065 Ave Med, Quebec City, PQ G1V 0A6, Canada.; Durrieu, MC (reprint author), Univ Bordeaux, CNRS, CBMN, Inst Chem & Biol Membranes & Nanoobjects,UMR5248, Bordeaux Inp, France.
EM Ibrahim.bilem.1@ulaval.ca; Pascale.Chevallier@crchudequebec.ulaval.ca;
   l.plawinski@cbmn.u-bordeaux.fr; eli.sone@utoronto.ca;
   marie-christine.durrieu@inserm.fr; Gaetan.Laroche@gmn.ulaval.ca
RI DURRIEU, Marie-Christine/I-4358-2016
OI DURRIEU, Marie-Christine/0000-0003-0583-9289
FU NSERC - Canada CREATE Program of Regenerative Medecine (NCPRM); National
   Research and Engineering Research Council of Canada
FX I. Bilem acknowledges funding from the NSERC - Canada CREATE Program of
   Regenerative Medecine (NCPRM). The authors also express their gratitude
   to Andree-Anne Guay-Begin for her assistance for XPS analyses. This
   research was supported by the National Research and Engineering Research
   Council of Canada (G.L.).
CR Amini Ami R., 2012, Critical Reviews in Biomedical Engineering, V40, P363
   Banwell EF, 2009, NAT MATER, V8, P596, DOI [10.1038/nmat2479, 10.1038/NMAT2479]
   BAYLINK DJ, 1993, J BONE MINER RES, V8, pS565
   Blyth K, 2005, NAT REV CANCER, V5, P376, DOI 10.1038/nrc1607
   Boivin MC, 2013, J BIOMED MATER RES A, V101, P694, DOI 10.1002/jbm.a.34367
   Bucci-Sabattini V, 2010, ORAL SURG ORAL MED O, V109, P217, DOI 10.1016/j.tripleo.2009.09.007
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Burkus JK, 2004, ORTHOPEDICS, V27, P723
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Chen WQ, 2012, ACS NANO, V6, P4094, DOI 10.1021/nn3004923
   Chevallier P, 2001, J PHYS CHEM B, V105, P12490, DOI 10.1021/jp011607k
   Chollet C, 2012, MACROMOL BIOSCI, V12, P1648, DOI 10.1002/mabi.201200167
   Collier JH, 2011, BIOMATERIALS, V32, P4198, DOI 10.1016/j.biomaterials.2011.02.030
   Cui HG, 2010, BIOPOLYMERS, V94, P1, DOI 10.1002/bip.21328
   Elmengaard B, 2005, BIOMATERIALS, V26, P3521, DOI 10.1016/j.biomaterials.2004.09.039
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   FRIEDENSTEIN AJ, 1987, CELL TISSUE KINET, V20, P263, DOI 10.1111/j.1365-2184.1987.tb01309.x
   Gauvreau V, 2004, BIOCONJUGATE CHEM, V15, P1146, DOI 10.1021/bc049858u
   Guicheux J, 2003, J BONE MINER RES, V18, P2060, DOI 10.1359/jbmr.2003.18.11.2060
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   He XZ, 2008, LANGMUIR, V24, P12508, DOI 10.1021/la802447v
   Hoesli CA, 2014, BIOMATERIALS, V35, P879, DOI 10.1016/j.biomaterials.2013.09.076
   Horii A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000190
   Hsiong SX, 2009, TISSUE ENG PT A, V15, P263, DOI 10.1089/ten.tea.2007.0411
   Jensen EC, 2013, ANAT REC, V296, P378, DOI 10.1002/ar.22641
   Jun JH, 2010, J BIOL CHEM, V285, P36410, DOI 10.1074/jbc.M110.142307
   Jung JP, 2009, BIOMATERIALS, V30, P2400, DOI 10.1016/j.biomaterials.2009.01.033
   Kim Y, 2014, BIOMATER SCI-UK, V2, P1110, DOI 10.1039/c3bm60333d
   Knippenberg M, 2006, BIOCHEM BIOPH RES CO, V342, P902, DOI 10.1016/j.bbrc.2006.02.052
   Koepsel JT, 2012, J MATER CHEM, V22, P19474, DOI 10.1039/c2jm32242k
   Lai CF, 2005, J BONE MINER RES, V20, P330, DOI 10.1359/JBMR.041013
   Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000
   Lu L, 2000, BIOMATERIALS, V21, P1837, DOI 10.1016/S0142-9612(00)00047-8
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mante Francis K, 2004, J Oral Implantol, V30, P343, DOI 10.1563/0.667.1
   Mata A, 2010, BIOMATERIALS, V31, P6004, DOI 10.1016/j.biomaterials.2010.04.013
   Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200
   Miyazono K, 1999, BONE, V25, P91, DOI 10.1016/S8756-3282(99)00113-1
   Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009
   Moon JH, 1996, LANGMUIR, V12, P4621, DOI 10.1021/la9604339
   Mooney DJ, 2008, CELL STEM CELL, V2, P205, DOI 10.1016/j.stem.2008.02.005
   Moore NM, 2011, ACTA BIOMATER, V7, P2091, DOI 10.1016/j.actbio.2011.01.019
   Narayanan K, 2004, J BIOL CHEM, V279, P44294, DOI 10.1074/jbc.M403511200
   O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X
   Pallu S, 2003, PEPTIDES, V24, P1349, DOI 10.1016/j.peptides.2003.09.003
   Papathanasiou I, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3805
   Park JS, 2010, BIOMATERIALS, V31, P6239, DOI 10.1016/j.biomaterials.2010.05.002
   Porte-Durrieu MC, 2004, BIOMATERIALS, V25, P4837, DOI 10.1016/j.biomaterials.2003.11.037
   Porte-Durrieu MC, 1999, J BIOMED MATER RES, V46, P368
   Rezania A, 2000, J BIOMED MATER RES, V52, P595, DOI 10.1002/1097-4636(20001215)52:4<595::AID-JBM3>3.0.CO;2-3
   Sabbatier G., 2015, MACROMOL BIOSCI
   Saito A, 2003, BBA-PROTEINS PROTEOM, V1651, P60, DOI 10.1016/S1570-9639(03)00235-8
   Schuldiner M, 2000, P NATL ACAD SCI USA, V97, P11307, DOI 10.1073/pnas.97.21.11307
   Secchi AG, 2007, J BIOMED MATER RES A, V83A, P577, DOI 10.1002/jbm.a.31007
   Senta H, 2009, CYTOKINE GROWTH F R, V20, P213, DOI 10.1016/j.cytogfr.2009.05.006
   Su JL, 2010, J BIOL CHEM, V285, P31325, DOI 10.1074/jbc.M109.087122
   Suzawa M, 2002, J BONE MINER RES, V17, P240, DOI 10.1359/jbmr.2002.17.2.240
   Suzuki Y, 2000, J BIOMED MATER RES, V50, P405, DOI 10.1002/(SICI)1097-4636(20000605)50:3<405::AID-JBM15>3.0.CO;2-Z
   Takahashi Y, 2005, BIOMATERIALS, V26, P4856, DOI 10.1016/j.biomaterials.2005.01.012
   Takeuchi Y, 1997, J BIOL CHEM, V272, P29309, DOI 10.1074/jbc.272.46.29309
   Tang N, 2009, J CELL MOL MED, V13, P2448, DOI 10.1111/j.1582-4934.2008.00569.x
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Vallieres K, 2007, LANGMUIR, V23, P9745, DOI 10.1021/la701323q
   van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910
   Wan Mei, 2005, Biochemical and Biophysical Research Communications, V328, P651, DOI 10.1016/j.bbrc.2004.11.067
   Weber D, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-6
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Zhang HN, 2009, BIOMATERIALS, V30, P4063, DOI 10.1016/j.biomaterials.2009.04.015
   Zhou M, 2009, BIOMATERIALS, V30, P2523, DOI 10.1016/j.biomaterials.2009.01.010
   Zouani OF, 2013, BIOL OPEN, V2, P872, DOI 10.1242/bio.20134986
   Zouani OF, 2010, BIOMATERIALS, V31, P8245, DOI 10.1016/j.biomaterials.2010.07.042
NR 71
TC 14
Z9 16
U1 8
U2 78
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2016
VL 36
BP 132
EP 142
DI 10.1016/j.actbio.2016.03.032
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DL8JJ
UT WOS:000375888000011
PM 27000551
DA 2018-10-20
ER

PT J
AU Patil, PS
   Fountas-Davis, N
   Huang, H
   Evancho-Chapman, MM
   Fulton, JA
   Shriver, LP
   Leipzig, ND
AF Patil, Pritam S.
   Fountas-Davis, Natalie
   Huang, He
   Evancho-Chapman, M. Michelle
   Fulton, Judith A.
   Shriver, Leah P.
   Leipzig, Nic D.
TI Fluorinated methacrylamide chitosan hydrogels enhance collagen synthesis
   in wound healing through increased oxygen availability
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Chitosan; Perfluorocarbons; Oxygen delivery; Metabolomics; Wound healing
ID NITRIC-OXIDE SYNTHASE; TISSUE SURVIVAL; DRUG-DELIVERY; CELL-CULTURE;
   IN-VIVO; METABOLISM; ARGININE; METABOLOMICS; MACROPHAGES; THERAPY
AB In this study, methacrylamide chitosan modified with perfluorocarbon chains (MACF) is used as the base material to construct hydrogel dressings for treating dermal wounds. MACF hydrogels saturated with oxygen (+O-2) are examined for their ability to deliver and sustain oxygen, degrade in a biological environment, and promote wound healing in an animal model. The emerging technique of metabolomics is used to understand how MACF + O-2 hydrogel dressings improve wound healing. Results indicate that MACF treatment facilitates oxygen transport rate that is two orders of magnitude greater than base MAC hydro gels. MACF hydrogel dressings are next tested in an in vivo splinted rat excisional wound healing model. Histological analysis reveals that MACF + O-2 dressings improve re-epithelialization (p < 0.0001) and synthesis of collagen over controls (p < 0.01). Analysis of endogenous metabolites in the wounds using global metabolomics demonstrates that MACF + O-2 dressings promotes a regenerative metabolic process directed toward hydroxyproline and collagen synthesis, with confirmation of metabolite levels within this pathway. The results of this study confirm that increased oxygen delivery through the application of MACF + O-2 hydrogels enhances wound healing and metabolomics analyses provides a powerful tool to assess wound healing physiology.
   Statement of Significance
   This work presents the first application of a novel class of oxygen delivering biomaterials (methacrylamide chitosan modified with perfluorocarbon chains (MACF)) as a hydrogel wound dressing. This manuscript also contains strong focus on the biochemical benefits of MACF dressings on underlying mechanisms vital to successful wound healing. In this vein, this manuscript presents the application of applied metabolomics (tandem mass spectroscopy) to uncover biomaterial interactions with wound healing mechanisms. We believe the approaches described in this manuscript will be of great interest to biomedical scientists and particularly to researchers studying wound healing, metabolomics, applied biomaterials and regenerative medicine. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Patil, Pritam S.; Fountas-Davis, Natalie; Leipzig, Nic D.] Univ Akron, Dept Chem & Biomol Engn, 200 East Buchtel Common, Akron, OH 44325 USA.
   [Huang, He; Shriver, Leah P.] Univ Akron, Dept Chem, Akron, OH 44325 USA.
   [Evancho-Chapman, M. Michelle] Summa Akron City Hosp, Akron, OH 44304 USA.
   [Fulton, Judith A.] Akron Gen Med Ctr, Akron, OH 44307 USA.
RP Leipzig, ND (reprint author), Univ Akron, Dept Chem & Biomol Engn, 200 East Buchtel Common, Akron, OH 44325 USA.
EM nl21@uakron.edu
FU National Institute of General Medical Sciences of the National
   Institutes of Health [R15GM104851]; AB SCIEX Young Investigator Award
FX We would like to acknowledge funding from the National Institute of
   General Medical Sciences of the National Institutes of Health under
   award number R15GM104851 to PSP, NFD, JF and NDL. We would also like to
   acknowledge support from AB SCIEX Young Investigator Award, to LPS.
   Parag Joshi is acknowledged for assistance with histology and
   accompanying analyses. We want to thank Jack Gillespie for glasswork and
   Frank Pelc for regular troubleshooting and setup, Bethany Noble for her
   help and expertise in animal care, Karen Day at the University of Akron
   Vivarium for her expertise and guidance, and Kelly Bondor for assistance
   with dermal fibroblast isolation and culture. Also, we want to thank
   Carla Giai and Nick Callow for help with the oxygen sensors and
   experimental setup and Dr. William Landis for use of histology
   equipment. Finally, we would like to thank group members Hang Li,
   Aleesha McCormick, Trevor Ham, and Ashley Wilkinson for assistance with
   analyses.
CR ABERCROMBIE M, 1954, J EMBRYOL EXP MORPH, V2, P264
   Arieli Y, 2014, RESP PHYSIOL NEUROBI, V197, P29, DOI 10.1016/j.resp.2014.03.006
   BENNER P, 1984, NOVICE EXPERT
   Benton HP, 2015, ANAL CHEM, V87, P884, DOI 10.1021/ac5025649
   Bo Y, 2014, TOXICOL MECH METHOD, V24, P461, DOI 10.3109/15376516.2014.939321
   Borisov SM, 2008, ANAL CHEM, V80, P9435, DOI 10.1021/ac801521v
   Carlson MA, 2003, J SURG RES, V110, P304, DOI 10.1006/jsre.2002.6602
   Castro CI, 2010, ARTIF ORGANS, V34, P622, DOI 10.1111/j.1525-1594.2009.00944.x
   Chen SC, 2004, J CONTROL RELEASE, V96, P285, DOI 10.1016/j.jconrel.2004.02.002
   DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9
   Dettmer K, 2007, MASS SPECTROM REV, V26, P51, DOI 10.1002/mas.20108
   Dreifke MB, 2015, MAT SCI ENG C-MATER, V48, P651, DOI 10.1016/j.msec.2014.12.068
   El-Gayar S, 2003, J IMMUNOL, V171, P4561, DOI 10.4049/jimmunol.171.9.4561
   Fonder MA, 2008, J AM ACAD DERMATOL, V58, P185, DOI 10.1016/j.jaad.2007.08.048
   Gajendrareddy PK, 2005, BRAIN BEHAV IMMUN, V19, P217, DOI 10.1016/j.bbi.2004.09.003
   German JB, 2005, METABOLOMICS, V1, P3, DOI 10.1007/s11306-005-1102-8
   Ghosh K, 2006, TISSUE ENG, V12, P601, DOI 10.1089/ten.2006.12.601
   Gordillo GM, 2013, ADV WOUND CARE, V2, P1, DOI 10.1089/wound.2012.0367
   Gordillo GM, 2009, INT J LOW EXTR WOUND, V8, P105, DOI 10.1177/1534734609335149
   Gordillo GM, 2003, AM J SURG, V186, P259, DOI 10.1016/S0002-9610(03)00211-3
   Gorres KL, 2010, CRIT REV BIOCHEM MOL, V45, P106, DOI 10.3109/10409231003627991
   Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125
   HAMAGUCHI K, 1960, J BIOCHEM-TOKYO, V48, P351, DOI 10.1093/oxfordjournals.jbchem.a127179
   HANKIEWICZ J, 1974, CLIN CHIM ACTA, V57, P205, DOI 10.1016/0009-8981(74)90398-2
   Harrison BS, 2007, BIOMATERIALS, V28, P4628, DOI 10.1016/j.biomaterials.2007.07.003
   HECKER M, 1995, FEBS LETT, V359, P251, DOI 10.1016/0014-5793(95)00039-C
   Igwegbe I, 2015, ADV SKIN WOUND CARE, V28, P206, DOI 10.1097/01.ASW.0000462327.30245.ae
   Kalkhof S, 2014, BIOMED RES INT, DOI 10.1155/2014/934848
   Ladizinsky D, 2010, WOUNDS, V22, P294
   LATTES A, 1994, ARTIF CELL BLOOD SUB, V22, P1007, DOI 10.3109/10731199409138798
   Li H, 2013, J CHROMATOGR A, V1275, P9, DOI 10.1016/j.chroma.2012.12.023
   Li ZQ, 2012, BIOMATERIALS, V33, P5914, DOI 10.1016/j.biomaterials.2012.05.012
   Lin Li-Chen, 2006, J Nurs Res, V14, P219
   Lowe KC, 1998, TRENDS BIOTECHNOL, V16, P272, DOI 10.1016/S0167-7799(98)01205-0
   Lu L, 2000, BIOMATERIALS, V21, P1837, DOI 10.1016/S0142-9612(00)00047-8
   Meyer A, 2012, BIOTECHNOL PROGR, V28, P171, DOI 10.1002/btpr.712
   Mirza RE, 2015, J PATHOL, V236, P433, DOI 10.1002/path.4548
   Oh SH, 2009, BIOMATERIALS, V30, P757, DOI 10.1016/j.biomaterials.2008.09.065
   Otto GP, 2012, CRIT CARE, V16, DOI 10.1186/cc11205
   Phang JM, 2015, CURR OPIN CLIN NUTR, V18, P71, DOI 10.1097/MCO.0000000000000121
   Pilarek M, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-50
   Poon L, 2014, CARBOHYD POLYM, V109, P92, DOI 10.1016/j.carbpol.2014.02.086
   Pusateri AE, 2003, J TRAUMA, V54, P177, DOI 10.1097/01.TA.0000032512.04647.C6
   Quan TH, 2013, J INVEST DERMATOL, V133, P658, DOI 10.1038/jid.2012.364
   Rath M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00532
   Riess JG, 2006, ARTIF CELL BLOOD SUB, V34, P567, DOI 10.1080/10731190600973824
   Ruiz Matute A. I., 2013, Food Hydrocolloids, V33, P245
   Schaper S.J. W., 2007, HEART PHYSL PATHOPHY
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Schreml S, 2010, BRIT J DERMATOL, V163, P257, DOI 10.1111/j.1365-2133.2010.09804.x
   Sen CK, 2009, WOUND REPAIR REGEN, V17, P1, DOI 10.1111/j.1524-475X.2008.00436.x
   Shavaleev NM, 2006, INORG CHEM, V45, P9410, DOI 10.1021/ic061283k
   Singh DK, 2000, J MACROMOL SCI R M C, VC40, P69, DOI 10.1081/MC-100100579
   Sood A, 2014, ADV WOUND CARE, V3, P511, DOI 10.1089/wound.2012.0401
   Sood RF, 2015, WOUND REPAIR REGEN, V23, P423, DOI 10.1111/wrr.12299
   Togami K, 2015, BIOL PHARM BULL, V38, P270, DOI 10.1248/bpb.b14-00659
   Tzafriri AR, 2005, CLIN CANCER RES, V11, P826
   Wang JP, 2011, ACS APPL MATER INTER, V3, P67, DOI 10.1021/am100862h
   Ward CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072485
   Wijekoon A, 2013, ACTA BIOMATER, V9, P5653, DOI 10.1016/j.actbio.2012.10.034
   Wu D., 2011, JOVE-J VIS EXP, P2899
   Zhao X., 2015, ADV HEALTHCARE MAT, V5
NR 62
TC 6
Z9 6
U1 7
U2 56
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2016
VL 36
BP 164
EP 174
DI 10.1016/j.actbio.2016.03.022
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DL8JJ
UT WOS:000375888000014
PM 27000552
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Crichton, ML
   Archer-Jones, C
   Meliga, S
   Edwards, G
   Martin, D
   Huang, H
   Kendall, MAF
AF Crichton, Michael L.
   Archer-Jones, Cameron
   Meliga, Stefano
   Edwards, Grant
   Martin, Darren
   Huang, Han
   Kendall, Mark A. F.
TI Characterising the material properties at the interface between skin and
   a skin vaccination microprojection device
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Skin; Microneedles; Material testing; Material strength; Puncture
ID POLYMER MICRONEEDLES; DRUG-DELIVERY; STRUCTURAL-CHARACTERIZATION;
   FABRICATION; STRENGTH
AB The rapid emergence of micro-devices for biomedical applications over the past two decades has introduced new challenges for the materials used in the devices. Devices like microneedles and the Nanopatch, require sufficient strength to puncture skin often with sharp-slender micro-scale profiles, while maintaining mechanical integrity. For these technologies we sought to address two important questions: 1) On the scale at which the device operates, what forces are required to puncture the skin? And 2) What loads can the projections/microneedles withstand prior to failure. First, we used custom fabricated nanoindentation micro-probes to puncture skin at the micrometre scale, and show that puncture forces are 0.25-1.75 mN for fresh mouse skin, in agreement with finite element simulations for our device. Then, we used two methods to perform strength tests of Nanopatch projections with varied aspect ratios. The first method used a nanoindenter to apply a force directly on the top or on the side of individual silicon projections (110 ism in length, 10 Ism base radius), to measure the force of fracture. Our second method used an Instron to fracture full rows of projections and characterise a range of projection designs (with the method verified against previous nanoindentation experiments). Finally, we used Cryo-Scanning Electron Microscopy to visualise projections in situ in the skin to confirm the behaviour we quantified, qualitatively.
   Statement of Significance
   Micro-device development has proliferated in the past decade, including devices that interact with tissues for biomedical outcomes. The field of microneedles for vaccine delivery to skin has opened new material challenges both in understanding tissue material properties and device material. In this work we characterise both the biomaterial properties of skin and the material properties of our microprojection vaccine delivery device. This study directly measures the micro-scale puncture properties of skin, whilst demonstrating clearly how these relate to device design. This will be of strong interest to those in the field of biomedical microdevices. This includes work in the field of wearable and semi implantable devices, which will require clear understanding of tissue behaviour and material characterisation. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Crichton, Michael L.; Archer-Jones, Cameron; Meliga, Stefano; Edwards, Grant; Martin, Darren; Kendall, Mark A. F.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld 4072, Australia.
   [Crichton, Michael L.; Kendall, Mark A. F.] Univ Queensland, ARC Ctr Excellence Convergent Bionano Sci & Techn, Brisbane, Qld 4072, Australia.
   [Huang, Han] Univ Queensland, Sch Mech & Min Engn, Brisbane, Qld 4072, Australia.
   [Kendall, Mark A. F.] Univ Queensland, Diamantina Inst, Princess Alexandra Hosp, Brisbane, Qld 4102, Australia.
   [Kendall, Mark A. F.] Univ Queensland, Fac Med & Biomed Sci, Royal Brisbane & Womens Hosp, Herston, Qld 4006, Australia.
RP Kendall, MAF (reprint author), Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld 4072, Australia.
EM m.kendall@uq.edu.au
RI Kendall, Mark/M-4122-2017
OI Martin, Darren/0000-0002-8537-6765; Crichton,
   Michael/0000-0002-3683-802X
FU Queensland state Nirap grant; ARC Future Fellowship; University of
   Queensland Endeavour IPRS
FX We thank all members of Prof Kendall, Prof Martin and Prof Huang's
   groups at the University of Queensland. This work is funded by a
   Queensland state Nirap grant, an ARC Future Fellowship and a University
   of Queensland Endeavour IPRS. We thank Hysitron for providing a
   nanoindenter probe mount and the Queensland University of Technology
   AMMRF node for FIB assistance. This work was performed in part at the
   Queensland Node of the Australian National Fabrication Facility. A
   company established under the National Collaborative Research
   Infrastructure Strategy to provide nano and microfabrication facilities
   for Australia's researchers.
CR Chu LY, 2010, J PHARM SCI-US, V99, P4228, DOI 10.1002/jps.22140
   Crichton ML, 2013, BIOMATERIALS, V34, P2087, DOI 10.1016/j.biomaterials.2012.11.035
   Crichton ML, 2011, BIOMATERIALS, V32, P4670, DOI 10.1016/j.biomaterials.2011.03.012
   Crichton ML, 2010, BIOMATERIALS, V31, P4562, DOI 10.1016/j.biomaterials.2010.02.022
   Davis SP, 2004, J BIOMECH, V37, P1155, DOI 10.1016/j.jbiomech.2003.12.010
   Fernando GJP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010266
   Fischer-Cripps A., 2004, NANOINDENTATION
   Hirobe S, 2015, BIOMATERIALS, V57, P50, DOI 10.1016/j.biomaterials.2015.04.007
   Jenkins D., 2012, RSC ADV
   Kendall M, 2004, J BIOMECH, V37, P1733, DOI 10.1016/j.jbiomech.2004.01.032
   Kendall MAF, 2007, BIOMATERIALS, V28, P4968, DOI 10.1016/j.biomaterials.2007.08.006
   Khanna P, 2010, PROCEDIA ENGINEER, V5, P977, DOI 10.1016/j.proeng.2010.09.272
   Li CG, 2015, LAB CHIP, V15, P382, DOI 10.1039/c4lc00937a
   Loizidou EZ, 2015, EUR J PHARM BIOPHARM, V89, P224, DOI 10.1016/j.ejpb.2014.11.023
   McNeilly CL, 2014, J CONTROL RELEASE, V196, P252, DOI 10.1016/j.jconrel.2014.09.028
   Meliga S. C., 2012, 7 AUSTR C APPL MECH, P331
   Meliga SC, 2013, J MULTIDISCIPL ENG, V10, P173
   Mukundan V., 2009, J MICROELECTROMECHAN, V18, P405, DOI DOI 10.1109/JMEMS.2009.2039697
   O'Mahony C, 2014, BIOMED MICRODEVICES, V16, P333, DOI 10.1007/s10544-014-9836-6
   Park JH, 2006, PHARM RES, V23, P1008, DOI 10.1007/s11095-006-0028-9
   Park JH, 2005, J CONTROL RELEASE, V104, P51, DOI 10.1016/j.jconrel.2005.02.002
   Prow TW, 2010, SMALL, V6, P1776, DOI 10.1002/smll.201000331
   Raja WK, 2013, SMALL, V9, P3704, DOI 10.1002/smll.201202075
   SMITH WG, 1988, COMPUT STRUCT, V28, P677, DOI 10.1016/0045-7949(88)90011-9
   Suwito W, 1999, J APPL PHYS, V85, P3519, DOI 10.1063/1.369711
   WILDNAUER RH, 1971, J INVEST DERMATOL, V56, P72, DOI 10.1111/1523-1747.ep12292018
NR 26
TC 4
Z9 4
U1 0
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2016
VL 36
BP 186
EP 194
DI 10.1016/j.actbio.2016.02.039
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DL8JJ
UT WOS:000375888000016
PM 26956913
DA 2018-10-20
ER

PT J
AU Stefani, I
   Cooper-White, JJ
AF Stefani, I.
   Cooper-White, J. J.
TI Development of an in-process UV-crosslinked, electrospun PCL/aPLA-co-TMC
   composite polymer for tubular tissue engineering applications
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Electrospinning; Core-shell structured fibres; In-situ crosslinking;
   Vascular scaffold; Tissue engineering
ID MESENCHYMAL STEM-CELLS; SMOOTH-MUSCLE-CELLS; VASCULAR GRAFTS;
   POLY(TRIMETHYLENE CARBONATE-CO-L-LACTIDE); NANOFIBROUS SCAFFOLDS;
   MECHANICAL-PROPERTIES; ELASTOMERIC SCAFFOLD; POLYCAPROLACTONE; VITRO;
   RESPONSES
AB Cardiovascular diseases remain the largest cause of death worldwide, and half of these deaths are the result of failure of the vascular system. Tissue engineering promises to provide new, and potentially more effective therapeutic strategies to replace damaged or degenerated vessels with functional vessels. However, these engineered vessels have substantial performance criteria, including vessel-like tubular shape, structure and mechanical property slate. Further, whether implanted without or with prior in vitro culture, such tubular scaffolds must provide a suitable environment for cell adhesion and growth and be of sufficient porosity to permit cell colonization. This study investigates the fabrication of slowly degradable, composite tubular polymer scaffolds made from polycaprolactone (PCL) and acrylated L-lactide-co-trimethylene carbonate (aPLA-co-TMC). The addition of acrylate groups permits the 'in-process' formation of crosslinks between aPLA-co-TMC chains during electrospinning of the composite system, exemplifying a novel process to produce multicomponent, elastomeric electrospun polymer scaffolds. Although PCL and aPLA-co-TMC were miscible in a co-solvent, a criteria for electrospinning, due to thermodynamic incompatibility of the two polymers as melts, solvent evaporation during electrospinning drove phase separation of these two systems, producing 'core-shell' fibres, with the core being composed of PCL, and the shell of crosslinked elastomeric aPLA-co-TMC. The resulting elastic fibrous scaffolds displayed burst pressures and suture retention strengths comparable with human arteries. Cytocompatibility testing with human mesenchymal stem cells confirmed adhesion to, and proliferation on the three-dimensional fibrous network, as well as alignment with highly-organized fibres. This new processing methodology and resulting mechanically-robust composite scaffolds hold significant promise for tubular tissue engineering applications.
   Statement of Significance
   Autologous small diameter blood vessel grafts are unsuitable solutions for vessel repair. Engineered solutions such as tubular biomaterial scaffolds however have substantial performance criteria to meet, including vessel-like tubular shape, structure and mechanical property slate. We detail herein an innovative methodology to co-electrospin and 'in-process' crosslink composite mixtures of Poly( caprolactone) and a newly synthesised acrylated-Poly(lactide-co-trimethylene-carbonate) to create elastomeric, core shell nanofibrous porous scaffolds in a one-step process. This novel composite system can be used to make aligned scaffolds that encourage stem cell adhesion, growth and morphological control, and produce robust tubular scaffolds of tunable internal diameter and wall thickness that possess mechanical properties approaching those of native vessels, ideal for future applications in the field of vessel tissue engineering. (C) Crown Copyright 2016 Published by Elsevier Ltd. on behalf of Acta Materialia Inc. All rights reserved.
C1 [Stefani, I.] Politecn Milan, Giulio Natta Dept Chem Mat & Chem Engn, I-20133 Milan, Italy.
   [Stefani, I.; Cooper-White, J. J.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Tissue Engn & Microfluid Lab, Brisbane, Qld 4072, Australia.
   [Cooper-White, J. J.] Univ Queensland, Sch Chem Engn, Brisbane, Qld 4072, Australia.
   [Cooper-White, J. J.] CSIRO, Biomed Mfg, Mfg Flagship, Clayton, Vic 3169, Australia.
RP Cooper-White, JJ (reprint author), Univ Queensland, Australian Inst Bioengn & Nanotechnol, St Lucia, Qld 4072, Australia.
EM i.stefani@uq.edu.au; j.cooperwhite@uq.edu.au
RI Stefani, Ilaria/B-6392-2015
OI Stefani, Ilaria/0000-0003-3648-8688; Cooper-White,
   Justin/0000-0002-1920-8229
FU Australian Research Council [DP140104217]; Australian Institute for
   Bioengineering and Nanotechnology
FX We also would like to acknowledge the funding provided by the Australian
   Research Council (grant ID: DP140104217) and the Australian Institute
   for Bioengineering and Nanotechnology.
CR Agarwal S, 2010, MACROMOL RAPID COMM, V31, P1317, DOI 10.1002/marc.201000021
   Agarwal S, 2009, ADV MATER, V21, P3343, DOI 10.1002/adma.200803092
   Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559
   Alwan A., 2011, WHO LIB CATALOGUING, V2, P161
   Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Camarero-Espinosa S., 2015, BIOMATERIALS, V74, P42
   Catto V, 2014, ISRN VASC MED, V2014, P1, DOI [10.1155/2014/923030, DOI 10.1155/2014/923030]
   Catto V, 2015, MAT SCI ENG C-MATER, V54, P101, DOI 10.1016/j.msec.2015.05.003
   Cipitria A, 2011, J MATER CHEM, V21, P9419, DOI 10.1039/c0jm04502k
   Cleary MA, 2012, TRENDS MOL MED, V18, P394, DOI 10.1016/j.molmed.2012.04.013
   Conklin B.S., 2002, MED ENG PHYS, V24, P10
   Couet F, 2007, MACROMOL BIOSCI, V7, P701, DOI 10.1002/mabi.200700002
   Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003
   Dahlin RL, 2011, TISSUE ENG PART B-RE, V17, P349, DOI [10.1089/ten.teb.2011.0238, 10.1089/ten.TEB.2011.0238]
   Dargaville BL, 2013, ACTA BIOMATER, V9, P6885, DOI 10.1016/j.actbio.2013.02.009
   Dargaville BL, 2011, BIOMACROMOLECULES, V12, P3856, DOI 10.1021/bm201291e
   Elnakady YA, 2015, SCI ADV MATER, V7, P407, DOI 10.1166/sam.2015.2252
   Ercolani E, 2015, J TISSUE ENG REGEN M, V9, P861, DOI 10.1002/term.1697
   Hasan A, 2014, ACTA BIOMATER, V10, P11, DOI 10.1016/j.actbio.2013.08.022
   Huang AH, 2014, CELL MOL LIFE SCI, V71, P2103, DOI 10.1007/s00018-013-1546-3
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Ichim TE, 2010, CELL IMMUNOL, V260, P75, DOI 10.1016/j.cellimm.2009.10.006
   James R, 2011, METHODS MOL BIOL, V726, P243, DOI 10.1007/978-1-61779-052-2_16
   Kamoun E.A., 2014, ARAB J CHEM
   KOENIG MF, 1995, POLYMER, V36, P1877, DOI 10.1016/0032-3861(95)90934-T
   Konig G, 2009, BIOMATERIALS, V30, P1542, DOI 10.1016/j.biomaterials.2008.11.011
   Lin-Vien D., 1991, HDB INFRARED RAMAN C
   Liu S.Q., 1998, J BIOMCHEM ENG, V120, P8
   Pashneh-Tala S., 2015, TISSUE ENG B
   Patra S, 2013, J BIOMATER TISS ENG, V3, P289, DOI 10.1166/jbt.2013.1087
   Pellegata A.F., 2013, BIOMED RES INT
   Prichard HL, 2011, J CARDIOVASC TRANSL, V4, P674, DOI 10.1007/s12265-011-9306-y
   Rathore A, 2012, WIRES NANOMED NANOBI, V4, P257, DOI 10.1002/wnan.1166
   Salacinski HJ, 2001, J BIOMATER APPL, V15, P241, DOI 10.1106/NA5T-J57A-JTDD-FD04
   Sarkar S, 2005, ACTA BIOMATER, V1, P93, DOI 10.1016/j.actbio.2004.08.003
   Seifu DG, 2013, NAT REV CARDIOL, V10, P410, DOI 10.1038/nrcardio.2013.77
   Stewart SFC, 2004, ANN BIOMED ENG, V32, P991, DOI 10.1023/B:ABME.0000032462.56207.65
   Subbiah T, 2005, J APPL POLYM SCI, V96, P557, DOI 10.1002/app.21481
   Van Landuyt KL, 2015, DENT MATER, V31, P916, DOI 10.1016/j.dental.2015.04.016
   Wenddorff J.H., 2012, ELECTROSPINNING MAT
   Zaniboni A, 2015, AM J PHYSIOL-CELL PH, V309, pC320, DOI 10.1152/ajpcell.00049.2015
NR 41
TC 11
Z9 12
U1 12
U2 124
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2016
VL 36
BP 231
EP 240
DI 10.1016/j.actbio.2016.03.013
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DL8JJ
UT WOS:000375888000020
PM 26969522
DA 2018-10-20
ER

PT J
AU Li, JY
   Zhai, D
   Lv, F
   Yu, QQ
   Ma, HS
   Yin, JB
   Yi, ZF
   Liu, MY
   Chang, J
   Wu, CT
AF Li, Jinyan
   Zhai, Dong
   Lv, Fang
   Yu, Qingqing
   Ma, Hongshi
   Yin, Jinbo
   Yi, Zhengfang
   Liu, Mingyao
   Chang, Jiang
   Wu, Chengtie
TI Preparation of copper-containing bioactive glass/eggshell membrane
   nanocomposites for improving angiogenesis, antibacterial activity and
   wound healing
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Wound healing; Copper-containing bioactive glass; Nanocoating;
   Angiogenesis; Antibacterial activity
ID PULSED-LASER DEPOSITION; EGGSHELL MEMBRANE; GLASS SCAFFOLDS;
   CELL-ADHESION; ION RELEASE; IN-VITRO; NANOPARTICLES; REGENERATION;
   BIOMATERIAL; CAPACITY
AB Effectively stimulating angiogenesis and avoiding wound infection are great challenges in wound care management. Designing new healing dressings with requisite angiogenic capacity and antibacterial performance is of particular significance. In order to achieve this aim, we prepared a copper (Cu)-containing bioactive glass nanocoating (40-50 nm) with uniform nanostructure on natural eggshell membrane (Cu-BG/ESM) by the pulsed laser deposition (PLD) technique. The surface physicochemical properties including hydrophilicity and hardness of ESM were significantly improved after depositing Cu-BG nanocoatings. Meanwhile, 5Cu-BG/ESM films containing 5 mol% Cu stimulated proangiogenesis by improving vascular endothelial growth factor (VEGF) and hypoxia-inducible factor (HIF)-1 alpha protein secretion as well as angiogenesis-related gene expression (VEGF, VEGF receptor 2 (KDR) and endothelial nitric oxide (eNos)) of human umbilical vein endothelial cells (HUVECs). When used to treat full-thickness skin defects in mice, 5Cu-BG/ESM films enhanced the healing quality as confirmed by the significantly improved angiogenesis (as indicated by CD31 expression) and formation of continuous and uniform epidermis layer in vivo. Furthermore, 5Cu-BG/ESM films could maintain a sustained release of Cu2+ ions and distinctly inhibited the viability of bacteria (Escherichia coli). The results indicate that Cu2+ ions released from Cu-BG/ESM nanocomposite films play an important role for improving both angiogenesis and antibacterial activity and the prepared nanocomposite films combined Cu-containing BG nanocoatings with ESM are a promising biomaterial for wound healing application.
   Statement of Significance
   Designing new healing dressings with requisite angiogenic capacity and antibacterial performance is of particular significance in wound care management. In our study, we successfully prepared copper containing bioactive glass/eggshell membrane (Cu-BG/ESM) nanocomposites with uniform bioactive glass nanocoatings by using pulsed laser deposition (PLD) technology. Due to the deposited Cu-BG nanocoatings on the surface of ESM, Cu-BG/ESM nanocomposites possessed significantly improved physicochemical and biological properties, including surface hydrophilicity, hardness, antibacterial ability, angiogenesis rate in vitro and wound healing quality in vivo as compared to pure ESM and BG/ESM films. Our study showed that prepared nanocoatings on Cu-BG/ESM nanocomposites offer a beneficial carrier for sustained release of Cu2+ ions which played a key role for improving both angiogenesis and antibacterial activity. The prepared nanocomposites combined Cu-containing BG nanocoatings with ESM are a promising biomaterial for wound healing application. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Li, Jinyan; Zhai, Dong; Yu, Qingqing; Ma, Hongshi; Chang, Jiang; Wu, Chengtie] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
   [Lv, Fang; Yi, Zhengfang; Liu, Mingyao] E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China.
   [Lv, Fang; Yi, Zhengfang; Liu, Mingyao] E China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China.
   [Yin, Jinbo] Shanghai Univ, Dept Polymer Mat, 333 Nanchen Rd, Shanghai 200444, Peoples R China.
RP Wu, CT (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.; Yi, ZF (reprint author), E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China.; Yi, ZF (reprint author), E China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China.
EM zfyi@bio.ecnu.edu.cn; chengtiewu@mail.sic.ac.cn
FU Recruitment Program of Global Young Talent, China; National High
   Technology Research and Development Program of China (863 Program)
   [SS2015AA020302]; Natural Science Foundation of China [31370963,
   81190132, 81272463]; Program of Shanghai Outstanding Academic Leaders
   [15XD1503900]; Chinese Academy of Sciences [KGZD-EW-T06]
FX Funding for this study was provided by the Recruitment Program of Global
   Young Talent, China (Dr. Wu), the National High Technology Research and
   Development Program of China (863 Program, SS2015AA020302), Natural
   Science Foundation of China (Grant 31370963, 81190132, 81272463),
   Program of Shanghai Outstanding Academic Leaders (15XD1503900) and Key
   Research Program of Chinese Academy of Sciences (Grant KGZD-EW-T06).
   Authors thank for Prof. Renkui Zheng's assistance for preparing PLD
   nanocoatings.
CR Aguirre A, 2012, EUR CELLS MATER, V24, P90, DOI 10.22203/eCM.v024a07
   Ahlborn G, 2006, J FOOD PROTECT, V69, P729, DOI 10.4315/0362-028X-69.4.729
   Bonilla JJA, 2015, WORLD J MICROB BIOT, V31, P1801, DOI 10.1007/s11274-015-1933-z
   Bacakova L, 2011, BIOTECHNOL ADV, V29, P739, DOI 10.1016/j.biotechadv.2011.06.004
   Balaz M, 2014, ACTA BIOMATER, V10, P3827, DOI 10.1016/j.actbio.2014.03.020
   Barralet J, 2009, TISSUE ENG PT A, V15, P1601, DOI 10.1089/ten.tea.2007.0370
   Cai H, 2015, J MATER CHEM C, V3, P5307, DOI 10.1039/c5tc00475f
   Chatterjee AK, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/13/135101
   Devi PS, 2012, RSC ADV, V2, P11578, DOI 10.1039/c2ra21053c
   Eisenhawer B, 2013, NANO LETT, V13, P873, DOI 10.1021/nl3033075
   Gentleman E, 2010, BIOMATERIALS, V31, P3949, DOI 10.1016/j.biomaterials.2010.01.121
   Gorustovich AA, 2010, TISSUE ENG PART B-RE, V16, P199, DOI [10.1089/ten.teb.2009.0416, 10.1089/ten.TEB.2009.0416]
   Goyal A, 2014, J ALLOY COMPD, V583, P214, DOI 10.1016/j.jallcom.2013.08.115
   Grzybowski J, 1999, INT J PHARM, V184, P179, DOI 10.1016/S0378-5173(99)00064-2
   Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039
   Haider A, 2015, ADV MATER SCI ENG, DOI 10.1155/2015/165257
   Harper D., 2014, SURGERY, V32, P445
   Huang Y, 2015, J MATER SCI, V50, P1688, DOI 10.1007/s10853-014-8730-1
   Jaiswal S, 2012, COLLOID SURFACE B, V94, P170, DOI 10.1016/j.colsurfb.2012.01.035
   Kaur G, 2014, J BIOMED MATER RES A, V102, P254, DOI 10.1002/jbm.a.34690
   Ku SH, 2010, BIOMATERIALS, V31, P2535, DOI 10.1016/j.biomaterials.2009.12.020
   Laurencin CT, 2014, DRUG DISCOV TODAY, V19, P794, DOI 10.1016/j.drudis.2014.01.012
   Law AYS, 2013, MOL CELL ENDOCRINOL, V374, P73, DOI 10.1016/j.mce.2013.04.024
   Li Z, 2013, BIOMATERIALS, V34, P7616, DOI 10.1016/j.biomaterials.2013.06.059
   Lin C, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/4/045017
   Liu AX, 2008, ACTA BIOMATER, V4, P1005, DOI 10.1016/j.actbio.2008.02.013
   Matsumoto S, 2013, PRS-GLOB OPEN, V1, DOI 10.1097/GOX.0b013e3182a88787
   Miguez-Pacheco V, 2015, ACTA BIOMATER, V13, P1, DOI 10.1016/j.actbio.2014.11.004
   Park K, 2012, KOREAN J FOOD SCI AN, V32, P308, DOI 10.5851/kosfa.2012.32.3.308
   Rahaman MN, 2011, ACTA BIOMATER, V7, P2355, DOI 10.1016/j.actbio.2011.03.016
   Rossi Ana Cláudia, 2014, Int. J. Odontostomat., V8, P289, DOI 10.4067/S0718-381X2014000200023
   Seo CH, 2011, BIOMATERIALS, V32, P9568, DOI 10.1016/j.biomaterials.2011.08.077
   Shevchenko RV, 2010, J R SOC INTERFACE, V7, P229, DOI 10.1098/rsif.2009.0403
   Tan Q, 2014, J TISSUE ENG REGEN M, V8, P195, DOI 10.1002/term.1513
   Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]
   Valarmathi MT, 2009, BIOMATERIALS, V30, P1098, DOI 10.1016/j.biomaterials.2008.10.044
   Wu CT, 2013, BIOMATERIALS, V34, P422, DOI 10.1016/j.biomaterials.2012.09.066
   Wu CT, 2012, BIOMATERIALS, V33, P2076, DOI 10.1016/j.biomaterials.2011.11.042
   Xu H, 2015, NANOSCALE, V7, P18446, DOI 10.1039/c5nr04802h
   Yang HS, 2011, EXP MOL MED, V43, P622, DOI 10.3858/emm.2011.43.11.070
   Yildirimer L, 2012, TRENDS BIOTECHNOL, V30, P638, DOI 10.1016/j.tibtech.2012.08.004
   Zhai WY, 2012, ACTA BIOMATER, V8, P341, DOI 10.1016/j.actbio.2011.09.008
   Zhang FB, 2014, J CRYST GROWTH, V387, P96, DOI 10.1016/j.jcrysgro.2013.11.022
   Zhao SC, 2015, ACTA BIOMATER, V14, P185, DOI 10.1016/j.actbio.2014.12.010
NR 44
TC 39
Z9 39
U1 20
U2 168
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2016
VL 36
BP 254
EP 266
DI 10.1016/j.actbio.2016.03.011
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DL8JJ
UT WOS:000375888000022
PM 26965395
DA 2018-10-20
ER

PT J
AU Fuoco, C
   Cannata, S
   Gargioli, C
AF Fuoco, Claudia
   Cannata, Stefano
   Gargioli, Cesare
TI Could a functional artificial skeletal muscle be useful in muscle
   wasting?
SO CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
LA English
DT Review
DE biomaterial scaffold; muscle tissue wasting; myogenic stem; progenitor
   cells; skeletal muscle tissue engineering
ID IN-VIVO; EXTRACELLULAR-MATRIX; STEM-CELLS; ELECTRICAL-STIMULATION;
   DYSTROPHIC MUSCLE; ENGINEERED MUSCLE; SATELLITE CELL; TISSUE;
   REGENERATION; DIFFERENTIATION
AB Purpose of reviewRegardless of the underlying cause, skeletal muscle wasting is detrimental for a person's life quality, leading to impaired strength, locomotion, and physiological activity. Here, we propose a series of studies presenting tissue engineering-based approaches to reconstruct artificial muscle in vitro and in vivo.Recent findingsSkeletal muscle tissue engineering is attracting more and more attention from scientists, clinicians, patients, and media, thanks to the promising results obtained in the last decade with animal models of muscle wasting. The use of novel and refined biomimetic scaffolds mimicking three-dimensional muscle environment, thus supporting cell survival and differentiation, in combination with well characterized myogenic stem/progenitor cells, revealed the noteworthy potential of these technologies for creating artificial skeletal muscle tissue. In vitro, the production of three-dimensional muscle structures offer the possibility to generate a drug-screening platform for patient-specific pharmacological treatment, opening new frontiers in the development of new compounds with specific therapeutic actions. In vivo, three-dimensional artificial muscle biomimetic constructs offer the possibility to replace, in part or entirely, wasted muscle by means of straight reconstruction and/or by enhancing endogenous regeneration.SummaryReports of tissue engineering approaches for artificial muscle building appeared in large numbers in the specialized press lately, advocating the suitability of this technology for human application upon scaling up and a near future applicability for medical care of muscle wasting.Video abstracthttp://links.lww.com/COCN/A9
C1 [Fuoco, Claudia; Cannata, Stefano; Gargioli, Cesare] Univ Roma Tor Vergata, Dept Biol, Via Ric Sci Snc, I-00133 Rome, Italy.
RP Gargioli, C (reprint author), Univ Roma Tor Vergata, Dept Biol, Via Ric Sci Snc, I-00133 Rome, Italy.
EM cesare.gargioli@uniroma2.it
FU European Research Council [N322749 DEPTH]; Uncovering Excellence Grant
   [MDESMPLAT]
FX This work has been supported by grants from: the European Research
   Council [N322749 DEPTH] and Uncovering Excellence Grant 2014
   [MDESMPLAT].
CR Alexakis C, 2007, AM J PHYSIOL-CELL PH, V293, pC661, DOI 10.1152/ajpcell.00061.2007
   Badylak Stephen F, 2015, Acta Biomater, V23 Suppl, pS17, DOI 10.1016/j.actbio.2015.07.016
   Bentzinger CF, 2013, EMBO REP, V14, P1062, DOI 10.1038/embor.2013.182
   Birbrair A, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00245
   Biressi S, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00140
   Carosio S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01420
   Cezar CA, 2015, ADV DRUG DELIVER REV, V84, P188, DOI 10.1016/j.addr.2014.09.008
   Christ GJ, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00053
   Cittadella Vigodarzere G, 2014, FRONT PHYSIOL, V5, P421
   Corona BT, 2012, TISSUE ENG PT A, V18, P1213, DOI [10.1089/ten.tea.2011.0614, 10.1089/ten.TEA.2011.0614]
   Cossu G, 2015, EMBO MOL MED, V7, P1513, DOI 10.15252/emmm.201505636
   Costamagna D, 2015, CURR GENE THER, V15, P348, DOI 10.2174/1566523215666150630121024
   De Lisio M, 2015, J APPL PHYSIOL, V119, P900, DOI 10.1152/japplphysiol.01112.2014
   Flaibani M, 2009, TISSUE ENG PT A, V15, P2447, DOI 10.1089/ten.tea.2008.0301
   Fuoco C, 2015, EMBO MOL MED, V7, P411, DOI 10.15252/emmm.201404062
   Fuoco C, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00203
   Fuoco C, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-24
   Gargioli C, 2008, NAT MED, V14, P973, DOI 10.1038/nm.1852
   Grasman JM, 2015, ACTA BIOMATER, V25, P2, DOI 10.1016/j.actbio.2015.07.038
   Grogan BF, 2011, J AM ACAD ORTHOP SUR, V19, pS35, DOI 10.5435/00124635-201102001-00007
   Handschin C, 2015, ADV DRUG DELIVER REV, V82-83, P168, DOI 10.1016/j.addr.2014.10.021
   Heher P, 2015, ACTA BIOMATER, V24, P251, DOI 10.1016/j.actbio.2015.06.033
   Hurd SA, 2015, BIOMATERIALS, V49, P9, DOI 10.1016/j.biomaterials.2015.01.027
   Ito A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04781
   Juhas M, 2016, METHODS, V99, P81, DOI 10.1016/j.ymeth.2015.10.002
   Juhas M, 2014, P NATL ACAD SCI USA, V111, P5508, DOI 10.1073/pnas.1402723111
   Kajbafzadeh AM, 2016, ANN BIOMED ENG, V44, P1773, DOI 10.1007/s10439-015-1468-3
   Karbalaeikhani A, 2015, ARCH BONE JT SURG-AB, V3, P193
   Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109
   Liao H, 2009, TISSUE ENG PART B-RE, V15, P319, DOI 10.1089/ten.teb.2009.0092
   Londono R, 2015, ANN BIOMED ENG, V43, P577, DOI 10.1007/s10439-014-1103-8
   Madden L, 2015, ELIFE, V4, DOI 10.7554/eLife.04885
   Merritt EK, 2010, TISSUE ENG PT A, V16, P1395, DOI [10.1089/ten.tea.2009.0226, 10.1089/ten.TEA.2009.0226]
   Ostrovidov S, 2015, STEM CELL REV REP, V11, P866, DOI 10.1007/s12015-015-9618-4
   Ostrovidov S, 2014, BIOMATERIALS, V35, P6268, DOI 10.1016/j.biomaterials.2014.04.021
   Parmar N, 2014, REGEN MED, V9, P831, DOI [10.2217/RME.14.56, 10.2217/rme.14.56]
   Piccoli M, 2015, BIOMATERIALS, V74, P1
   Pinheiro CHJ, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00141
   Porzionato A, 2015, INT J MOL SCI, V16, P14808, DOI 10.3390/ijms160714808
   Qazi TH, 2015, BIOMATERIALS, V53, P502, DOI 10.1016/j.biomaterials.2015.02.110
   Rizzi Roberto, 2012, Muscles Ligaments Tendons J, V2, P230
   Rossi CA, 2011, FASEB J, V25, P2296, DOI 10.1096/fj.10-174755
   Salcedo L, 2014, STEM CELL TRANSL MED, V3, P760, DOI 10.5966/sctm.2013-0157
   Shandalov Y, 2015, METHODS, V84, P70, DOI 10.1016/j.ymeth.2015.03.021
   Sicari BM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008085
   Tidball JG, 2011, COMPR PHYSIOL, V1, P2029, DOI 10.1002/cphy.c100092
   Wood LK, 2014, J APPL PHYSIOL, V117, P363, DOI 10.1152/japplphysiol.00256.2014
NR 47
TC 3
Z9 3
U1 2
U2 25
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1363-1950
EI 1473-6519
J9 CURR OPIN CLIN NUTR
JI Curr. Opin. Clin. Nutr. Metab. Care
PD MAY
PY 2016
VL 19
IS 3
BP 182
EP 187
DI 10.1097/MCO.0000000000000271
PG 6
WC Endocrinology & Metabolism; Nutrition & Dietetics
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA DK2KR
UT WOS:000374743900003
PM 26910194
DA 2018-10-20
ER

PT J
AU Chew, BH
   Lange, D
AF Chew, Ben H.
   Lange, Dirk
TI Advances in ureteral stent development
SO CURRENT OPINION IN UROLOGY
LA English
DT Review
DE biomaterial; stent; ureter; urolithiasis
ID QUALITY-OF-LIFE; EXPERIENCE; MORBIDITY; REMOVAL; METAL
AB Purpose of review
   Ureteral stents are commonly used in urology, but there is no perfect ureteral stent. This review documents developing ureteral technologies and strategies over the past 2 years. This area has some progressive advances in the foreseeable future.
   Recent findings
   Publications from 2014 and 2015 from a PubMed search with the words 'ureter' and 'stent' in the title were reviewed. Topics that affected patient symptoms from stents include selecting the proper length of stent, patient education regarding stent symptoms, and how the stent is removed. Stent extraction strings have been studied and not increased the incidence of infection or pain. There have been several publications examining antirefluxing ureteral stents that reduced vesicoureteral reflux during micturition and infection of transplanted kidneys. Other novel methods of removing a stent include new biodegradable ureteral stents and metal beads attached to the stent used in tandem with a magnetic catheter. Several new metal and mesh stents were described for use in patients with malignant ureteral obstruction. Last, new stent coatings with antimicrobial peptides have also been described.
   Summary
   The search continues for the perfect stent and there has been promising progress over the past 2 years.
C1 [Chew, Ben H.; Lange, Dirk] Univ British Columbia, Dept Urol Sci, Level 6,2775 Laurel St, Vancouver, BC V5Z 1M9, Canada.
RP Chew, BH (reprint author), Univ British Columbia, Dept Urol Sci, Level 6,2775 Laurel St, Vancouver, BC V5Z 1M9, Canada.
EM ben.chew@ubc.ca
FU Boston Scientific Corporation; Cook Medical; ADVA-Tec/Poly-Med Inc.;
   Urotech
FX B.H.C. is a consultant for the following companies: ADVA-Tec/Poly-Med
   Inc., Bard Medical, Boston Scientific Corporation, Cook Medical, and
   Olympus Medical. He is also a lecturer/instructor for Boston Scientific
   Corporation, Cook Medical, and Olympus Medical. D.L. is a consultant for
   the following companies: Bard Medical, Boston Scientific Corporation,
   Cook Medical, and Urotech. Both authors received financial/study grants
   from Boston Scientific Corporation, Cook Medical, ADVA-Tec/Poly-Med
   Inc., and Urotech.
CR Abt D, 2015, INT J UROL, V22, P679, DOI 10.1111/iju.12782
   Abt D, 2015, KOREAN J UROL, V56, P370, DOI 10.4111/kju.2015.56.5.370
   Acelam PA, 2015, RES REP UROL, V7, P117, DOI 10.2147/RRU.S87860
   Althaus AB, 2015, J UROLOGY, V193, P2011, DOI 10.1016/j.juro.2014.12.087
   Ay N, 2015, INT J CLIN EXP MED, V8, P16340
   Barnes KT, 2014, BJU INT, V113, P605, DOI 10.1111/bju.12541
   Barros AA, 2015, INT J PHARMACEUT, V495, P651, DOI 10.1016/j.ijpharm.2015.08.040
   Barros AA, 2015, J BIOMED MATER RES B, V103, P608, DOI 10.1002/jbm.b.33237
   Bourdoumis A, 2014, J ENDOUROL, V28, P96, DOI 10.1089/end.2013.0332
   Chow PM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135566
   Chow PM, 2014, J ENDOUROL, V28, P729, DOI 10.1089/end.2013.0792
   Chung HH, 2014, CARDIOVASC INTER RAD, V37, P463, DOI 10.1007/s00270-013-0675-2
   Elsamra SE, 2015, INT J UROL, V22, P629, DOI 10.1111/iju.12795
   Gultekinoglu M, 2015, ACTA BIOMATER, V21, P44, DOI 10.1016/j.actbio.2015.03.037
   Kim HW, 2015, J ENDOUROL
   Loh-Doyle JC, 2015, J ENDOUROL, V29, P35, DOI 10.1089/end.2014.0402
   Soria F, 2015, UROLOGY, V86, P417, DOI 10.1016/j.urology.2015.05.020
   Vogt B, 2015, WORLD J UROL, V33, P1061, DOI 10.1007/s00345-014-1394-2
   Wang J, 2014, UROLOGY, V84, P960, DOI 10.1016/j.urology.2014.06.024
   Yu K, 2015, ACS APPL MAT INTERFA
NR 20
TC 4
Z9 5
U1 1
U2 18
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0963-0643
EI 1473-6586
J9 CURR OPIN UROL
JI Curr. Opin. Urol.
PD MAY
PY 2016
VL 26
IS 3
BP 277
EP 282
DI 10.1097/MOU.0000000000000275
PG 6
WC Urology & Nephrology
SC Urology & Nephrology
GA DK2SE
UT WOS:000374763900011
PM 26840739
DA 2018-10-20
ER

PT J
AU Wiacek, AE
   Terpilowski, K
   Jurak, M
   Worzakowska, M
AF Wiacek, Agnieszka Ewa
   Terpilowski, Konrad
   Jurak, Malgorzata
   Worzakowska, Marta
TI Effect of low-temperature plasma on chitosan-coated PEEK polymer
   characteristics
SO EUROPEAN POLYMER JOURNAL
LA English
DT Article
DE Polyetheretherketone; Low-temperature plasma; Chitosan film; Contact
   angle; Apparent surface energy; Wettability
ID SURFACE FREE-ENERGY; VAN-DER-WAALS; THERMAL-DECOMPOSITION;
   MOLECULAR-WEIGHT; BIOMATERIALS; WETTABILITY; PYROLYSIS; MECHANISM;
   ADHESION; FIBERS
AB Low-temperature plasma effect on changes of physicochemical properties of plastic polymer polyetheretherketone (PEEK) was investigated. Despite extensive use of PEEK, information about adhesion to this polymer is limited. The adhesive and energetic properties of biomaterial and after chitosan modification were studied by contact angles measurements and surface free energy evaluation using the acid-base LWAB theory and contact angle hysteresis (CAH) model. Modification by chitosan can enhance antibacterial properties, native haemostatic and the polymer biocompatibility. Plasma modification led to variation in surface chemistry and morphology determined by an optical profilometer. After air/nitrogen plasma treatment a relatively hydrophobic character of PEEK was changed into more hydrophilic, significant differences in the wettability of sample were observed. Though, practically no differences in thermal and mechanical properties were noticed. The profilometer pictures showed an increase in the surface roughness of plasma modified PEEK due to the formation of additional polar groups with oxygen and nitrogen on the surface. Plasma treated polyetheretherketone surfaces had better adhesive features. Novel and stable chitosan-coated PEEK biomaterials were prepared applicable for different industries, mainly pharmacy and reconstructive medicine. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Wiacek, Agnieszka Ewa; Terpilowski, Konrad; Jurak, Malgorzata] Marie Curie Sklodowska Univ, Dept Interfacial Phenomena, Fac Chem, PL-20031 Lublin, Poland.
   [Worzakowska, Marta] Marie Curie Sklodowska Univ, Dept Polymer Chem, Fac Chem, Lublin, Poland.
RP Wiacek, AE (reprint author), Marie Curie Sklodowska Univ, Dept Interfacial Phenomena, Fac Chem, PL-20031 Lublin, Poland.
EM a.wiacek@poczta.umcs.lublin.pl
OI Terpilowski, Konrad/0000-0002-8078-3644
FU European Regional Development Fund [POIG.02.01.00-06-024/09]; Marie
   Curie Initial Training Network "Complex Wetting Phenomena" [607861]
FX The research was carried out with the equipment purchased thanks to the
   financial support of the European Regional Development Fund in the
   framework of the Polish Innovation Economy Operational Program (contract
   no. POIG.02.01.00-06-024/09 Center of Functional Nanomaterials)
   www.cnf.umcs.lublin.pl.; Support from Marie Curie Initial Training
   Network "Complex Wetting Phenomena" (Project number 607861) is highly
   appreciated.
CR [Anonymous], 2005, THERMAL ANAL POLYMER, V53
   Awaja F, 2009, PROG POLYM SCI, V34, P948, DOI 10.1016/j.progpolymsci.2009.04.007
   Bismarck A, 2008, POLYM ENG SCI, V48, P1971, DOI 10.1002/pen.21103
   Chibowski E, 2003, ADV COLLOID INTERFAC, V103, P149, DOI 10.1016/S0001-8686(02)00093-3
   Dash M., 2011, PROGR POLYM SCI, V26, P981
   Denes FS, 2004, PROG POLYM SCI, V29, P815, DOI 10.1016/j.progpolymsci.2004.05.001
   Ding Z, 2004, BIOMATERIALS, V25, P1059, DOI 10.1016/S0142-9612(03)00615-X
   Dodane V, 1998, PHARM SCI TECHNOL TO, V1, P246, DOI 10.1016/S1461-5347(98)00059-5
   Furuike T, 2015, FIBERS, V3, P380, DOI 10.3390/fib3040380
   Gil'man AB, 2003, HIGH ENERG CHEM+, V37, P17, DOI 10.1023/A:1021957425359
   HAY JN, 1987, POLYMER, V28, P2047, DOI 10.1016/0032-3861(87)90039-5
   Hegemann D, 2003, NUCL INSTRUM METH B, V208, P281, DOI 10.1016/S0168-583X(03)00644-X
   Hegemann D., 2001, Plasmas and Polymers, V6, P221, DOI 10.1023/A:1014461932094
   Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410
   Huang M, 2004, PHARM RES, V21, P344, DOI 10.1023/B:PHAM.0000016249.52831.a5
   Kaminska A, 2002, EUR POLYM J, V38, P1915, DOI 10.1016/S0014-3057(02)00059-9
   Kuo MC, 2005, MATER CHEM PHYS, V90, P185, DOI 10.1016/j.matchemphys.2004.10.009
   Lommatzsch U., 2007, PLASMA PROCESS POLYM, V4, P1041
   Mark H.F., 1985, ENCY POLYM SCI ENG, V1, P490
   Mi F.-L., 2003, BIOMATERIALS, V24, P5035
   Miao JJ, 2012, LANGMUIR, V28, P4396, DOI 10.1021/la3000137
   Murari A, 2003, VACUUM, V72, P327, DOI 10.1016/j.vacuum.2003.08.011
   Nair KCM, 2001, COMPOS SCI TECHNOL, V61, P2519
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Patel P, 2010, POLYM DEGRAD STABIL, V95, P709, DOI 10.1016/j.polymdegradstab.2010.01.024
   Patela P., 2010, POLYM DEGRAD STABIL, V96, P12
   Perng LH, 1999, POLYMER, V40, P7321, DOI 10.1016/S0032-3861(99)00006-3
   Rochford ETJ, 2014, COLLOID SURFACE B, V113, P213, DOI 10.1016/j.colsurfb.2013.09.012
   Slepicka P, 2013, EXPRESS POLYM LETT, V7, P535, DOI 10.3144/expresspolymlett.2013.50
   Steen ML, 2001, CHEM MATER, V13, P2749, DOI 10.1021/cm010452q
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Tokura S, 1997, MACROMOL SYMP, V120, P1, DOI 10.1002/masy.19971200103
   Tsai CJ, 1997, RAPID COMMUN MASS SP, V11, P1987, DOI 10.1002/(SICI)1097-0231(199712)11:18<1987::AID-RCM100>3.0.CO;2-Q
   Udpa N, 2013, TISSUE ENG PT A, V19, P2713, DOI [10.1089/ten.tea.2012.0739, 10.1089/ten.TEA.2012.0739]
   VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270
   VANOSS CJ, 1993, COLLOID SURFACE A, V78, P1, DOI 10.1016/0927-7757(93)80308-2
   VANOSS CJ, 1986, J COLLOID INTERF SCI, V111, P378, DOI 10.1016/0021-9797(86)90041-X
   VANOSS CJ, 1988, CHEM REV, V88, P927, DOI 10.1021/cr00088a006
   Wang XH, 2006, J BIOACT COMPAT POL, V21, P39, DOI 10.1177/0883911506060201
   Wiacek AE, 2016, POLYM TEST, V50, P325, DOI 10.1016/j.polymertesting.2016.01.020
   Wiacek AE, 2015, COLLOID SURFACE A, V480, P351, DOI 10.1016/j.colsurfa.2015.01.085
   Wiacek AE, 2015, FOOD HYDROCOLLOID, V48, P228, DOI 10.1016/j.foodhyd.2015.02.005
   Williams TS, 2013, REV ADHES ADHES, V1, P46, DOI 10.7569/RAA.2013.097302
   Zhang SN, 2011, COLLOID SURFACE A, V374, P88, DOI 10.1016/j.colsurfa.2010.11.013
NR 44
TC 10
Z9 10
U1 8
U2 61
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0014-3057
EI 1873-1945
J9 EUR POLYM J
JI Eur. Polym. J.
PD MAY
PY 2016
VL 78
BP 1
EP 13
DI 10.1016/j.eurpolymj.2016.02.024
PG 13
WC Polymer Science
SC Polymer Science
GA DL3CK
UT WOS:000375511600001
DA 2018-10-20
ER

PT J
AU Pieretti, EF
   das Neves, MDM
AF Pieretti, Eurico Felix
   Martins das Neves, Mauricio David
TI Influence of Laser Marks on the Electrochemical Behaviour of the ASTM
   F139 Stainless Steel for Biomedical Application
SO INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE
LA English
DT Article
DE Biomedical engineering; biointerfaces; laser engraving; electrochemistry
ID CORROSION-RESISTANCE; PITTING CORROSION; SURFACE-ROUGHNESS; OXIDE-FILMS;
   ALBUMIN
AB The aim of this work is to evaluate the effect of a laser marking technique on the microstructure and chemical composition at the surface of the ASTM F139 stainless steel and the influence of the surface modifications on its corrosion resistance. This is one of the most frequently used biomaterial for prosthesis manufacture. The laser effect on the corrosion resistance has been evaluated by electrochemical techniques, specifically electrochemical impedance spectroscopy. It was found that the laser marking reduces the corrosion resistance by modification of the microstructure and surface chemical composition affecting the surface passive layer, comparatively to the unmarked material. The surface and chemical composition was analyzed by scanning electron microscope coupled to a high-resolution field emission gun (SEM-FEG) and transmission electron microscopy (TEM) with microanalysis. TEM in areas affected by laser engraving showed a very high density of dislocations suggesting the presence of residual stresses induced by laser, decreasing the corrosion resistance of the stainless steel. Aluminum and silicon oxide inclusions were conveyed into the surface exposed to the corrosive electrolyte by melting the metallic matrix surrounding them during the incidence of the laser beam. The corrosive attack of this stainless steel matrix surrounding the oxide inclusions creates micro crevices, promoting pitting corrosion. This is the mechanism proposed to explain the increased susceptibility to localized corrosion associated to the areas affected by the laser marking process.
C1 [Pieretti, Eurico Felix; Martins das Neves, Mauricio David] Inst Pesquisas Energet & Nucl IPEN CNEN, Ave Prof Lineu Prestes 2242,Cidade Univ, BR-05422970 Sao Paulo, SP, Brazil.
RP Pieretti, EF (reprint author), Inst Pesquisas Energet & Nucl IPEN CNEN, Ave Prof Lineu Prestes 2242,Cidade Univ, BR-05422970 Sao Paulo, SP, Brazil.
EM efpieretti@usp.br
OI Neves, Mauricio/0000-0002-1304-2117
FU CNPq [350798/2014-1, 459565/2013-3]
FX The authors acknowledge CNPq for the financial support, under grant
   number Process: 350798/2014-1, Project: 459565/2013-3; the Instituto de
   Ortopedia e Traumatologia of the Hospital das Clinicas da Faculdade de
   Medicina da Universidade de Sao Paulo and Dr. I. Costa, PhD.
CR Anderson J. M., 2001, MAT RES, V31, P81
   Asteman H, 2002, OXID MET, V57, P193, DOI 10.1023/A:1014877600235
   BLACK J, 1984, BIOMATERIALS, V5, P11, DOI 10.1016/0142-9612(84)90061-9
   Cheng XQ, 2009, INT J MIN MET MATER, V16, P170, DOI 10.1016/S1674-4799(09)60029-7
   Da Cunha Belo M, 1999, ELECTROCHIM ACTA, V44, P2473
   Dowling NJE, 1999, CORROSION, V55, P187, DOI 10.5006/1.3283979
   Hakiki NE, 2000, CORROS SCI, V42, P687, DOI 10.1016/S0010-938X(99)00082-7
   Hong T, 1997, CORROS SCI, V39, P1665, DOI 10.1016/S0010-938X(97)00072-3
   Leone C., 2010, J MAT PROC TEC, V210, P1293
   Mudali UK, 2002, CORROS SCI, V44, P2183, DOI 10.1016/S0010-938X(02)00035-5
   Okasaki Y., 2002, BIOMATERIALS, V23, P2071
   Patrikar RA, 2004, APPL SURF SCI, V228, P213, DOI 10.1016/j.apsusc.2004.01.010
   Pieretti EF, 2014, INT J ELECTROCHEM SC, V9, P3828
   Pieretti EF, 2014, ELECTROCHIM ACTA, V124, P150, DOI 10.1016/j.electacta.2013.10.137
   Pieretti EF, 2014, INT J ELECTROCHEM SC, V9, P2435
   Pieretti EF, 2015, INT J ELECTROCHEM SC, V10, P1221
   Pieretti EF, 2013, ELECTROCHIM ACTA, V114, P838, DOI 10.1016/j.electacta.2013.05.101
   Pourbaix M., 1963, CORROS SCI, V3, P239
   Punckt C, 2004, SCIENCE, V305, P1133, DOI 10.1126/science.1101358
   Qi J, 2003, J MATER PROCESS TECH, V139, P273, DOI 10.1016/S0924-0136(03)00234-6
   SCHMUKI P, 1995, J ELECTROCHEM SOC, V142, P1705, DOI 10.1149/1.2048644
   Shahryari A, 2008, MAT SCI ENG C-BIO S, V28, P94, DOI 10.1016/j.msec.2007.09.002
   Shih CC, 2004, CORROS SCI, V46, P427, DOI 10.1016/S0010-938X(03)00148-3
   Virtanen S, 2008, ACTA BIOMATER, V4, P468, DOI 10.1016/j.actbio.2007.12.003
NR 24
TC 6
Z9 6
U1 1
U2 16
PU ESG
PI BELGRADE
PA BORIVOJA STEVANOVICA 25-7, BELGRADE, 11000, SERBIA
SN 1452-3981
J9 INT J ELECTROCHEM SC
JI Int. J. Electrochem. Sci.
PD MAY
PY 2016
VL 11
IS 5
BP 3532
EP 3541
PG 10
WC Electrochemistry
SC Electrochemistry
GA DL6LG
UT WOS:000375750100021
DA 2018-10-20
ER

PT J
AU Sarmiento-Bustos, E
   Rodriguez-Diaz, RA
   Colin, J
   Molina-Ocampo, A
   Gaona-Jimenez, S
   Bahena-Medina, LA
AF Sarmiento-Bustos, E.
   Rodriguez-Diaz, R. A.
   Colin, J.
   Molina-Ocampo, A.
   Gaona-Jimenez, S.
   Bahena-Medina, L. A.
TI Optimized In-vitro Corrosion Assessment of a FeAl intermetallic Compound
   Modified with Ag in Artificial Human Media
SO INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE
LA English
DT Article
DE Corrosion; Fe-Al alloy; Hanks' solution; biomaterial; noise;
   polarization curve
ID IRON ALUMINIDE INTERMETALLICS; RAY PHOTOELECTRON-SPECTROSCOPY;
   PHYSIOLOGICAL SOLUTION; METALLIC BIOMATERIALS; BEHAVIOR; ALLOY; NI; CR
AB This article presents an assessment about the effect of the addition of silver on the corrosion performance of the intermetallic alloy Fe40Al (at. %) in a biomimetic environment that simulates the biological human body fluid. In the present work, an in-vitro corrosion assessment of Fe40Al based alloys was performed, since the electrochemical parameters of Fe40Al and Fe40Al2.5Ag alloys were compared. According to the polarization curves, the corrosion current density of Fe40Al2.5Ag alloy resulted minor than that of binary Fe40Al alloy; however, according to the measurements of the linear polarization resistance, the current density of the ternary alloy resulted higher than that of the binary FeAl based alloy. This behavior is ascribed to the enhancement of the protective character of the Al-oxide layer of the Fe40Al aluminide, while the exposed time in the Hanks' solution had elapsed.
C1 [Sarmiento-Bustos, E.] Univ Tecnol Emiliano Zapata Estado Morelos, Ave Univ Tecnol 1, Emiliano Zapata 62760, Morelos, Mexico.
   [Rodriguez-Diaz, R. A.; Gaona-Jimenez, S.; Bahena-Medina, L. A.] Univ Politecn Estado Morelos, Blvd Cuauhnahuac 566, Jiutepec 62574, Morelos, Mexico.
   [Colin, J.] Univ Autonoma Estado Morelos, Fac Ciencias Quim & Ingn, Ave Univ 1001, Cuernavaca 62209, Morelos, Mexico.
   [Rodriguez-Diaz, R. A.; Molina-Ocampo, A.] Univ Autonoma Estado Morelos, Ctr Invest Ingn & Ciencias Aplicada IICBA, Ave Univ 1001, Cuernavaca 62209, Morelos, Mexico.
RP Rodriguez-Diaz, RA (reprint author), Univ Politecn Estado Morelos, Blvd Cuauhnahuac 566, Jiutepec 62574, Morelos, Mexico.; Rodriguez-Diaz, RA (reprint author), Univ Autonoma Estado Morelos, Ctr Invest Ingn & Ciencias Aplicada IICBA, Ave Univ 1001, Cuernavaca 62209, Morelos, Mexico.
EM rdiaz.unam@gmail.com
FU PRODEP; CONACyT
FX The authors express their gratitude to PRODEP and CONACyT for their
   financial support provided for the development and accomplishment of
   this research.
CR Arenas MA, 2000, BR CORROS J, V35, P1
   Arrieta-Gonzalez CD, 2011, INT J ELECTROCHEM SC, V6, P4016
   Castaneda IE, 2011, INT J ELECTROCHEM SC, V6, P404
   Chaturvedi T P, 2009, Indian J Dent Res, V20, P91
   Chen QZ, 2015, MAT SCI ENG R, V87, P1, DOI 10.1016/j.mser.2014.10.001
   Concha-Guzman L., 2015, OMNIASCIENCE MONOGRA
   Hanawa T, 2002, SCI TECHNOL ADV MAT, V3, P289, DOI 10.1016/S1468-6996(02)00028-1
   Huape-Padilla E, 2015, INT J ELECTROCHEM SC, V10, P2141
   Jez M, 2014, J SOLID STATE ELECTR, V18, P1635, DOI 10.1007/s10008-014-2387-1
   Kubaschewski O., 2013, IRON BINARY PHASE DI
   [Luo Lin 骆琳], 2014, [硅酸盐学报, Journal of the Chinese Ceramic Society], V42, P574
   Mansfeld F, 2009, J SOLID STATE ELECTR, V13, P515, DOI 10.1007/s10008-008-0652-x
   McCabe JF, 2008, APPL DENT MAT
   Menchaca-Campos C., 2013, RECENT PATENTS CORRO, V3, P12
   Milosev I, 2000, BIOMATERIALS, V21, P2103, DOI 10.1016/S0142-9612(00)00145-9
   Milosev I, 2000, J BIOMED MATER RES, V52, P404, DOI 10.1002/1097-4636(200011)52:2<404::AID-JBM22>3.0.CO;2-Z
   Okamoto H, 2010, PHASE DIAGRAMS BINAR
   POURBAIX M, 1984, BIOMATERIALS, V5, P122, DOI 10.1016/0142-9612(84)90046-2
   Pourbaix M., 2012, LECT ELECTROCHEMICAL
   Ramirez-Arteaga MA, 2014, INT J ELECTROCHEM SC, V9, P161
   Rodriguez-Diaz RA, 2013, INT J ELECTROCHEM SC, V8, P958
   Rosalbino F, 2014, CORROS SCI, V85, P394, DOI 10.1016/j.corsci.2014.04.054
   Senderowski C, 2015, MATERIALS, V8, P1108, DOI 10.3390/ma8031108
   Upadhyay D, 2006, MAT SCI ENG A-STRUCT, V432, P1, DOI 10.1016/j.msea.2006.05.003
   Zaid B, 2008, CORROS SCI, V50, P1841, DOI 10.1016/j.corsci.2008.03.006
   Zamanzade M, 2016, MAT SCI ENG A-STRUCT, V652, P370, DOI 10.1016/j.msea.2015.11.088
   Zamanzade M, 2016, CRYSTALS, V6, DOI 10.3390/cryst6010010
   Zamanzade M, 2014, ACTA MATER, V69, P210, DOI 10.1016/j.actamat.2014.01.042
   Zamanzade M, 2014, CORROS SCI, V78, P223, DOI 10.1016/j.corsci.2013.10.002
   Zarkevich N. A., 2003, PHYS REV B, V67
NR 30
TC 0
Z9 0
U1 0
U2 5
PU ESG
PI BELGRADE
PA BORIVOJA STEVANOVICA 25-7, BELGRADE, 11000, SERBIA
SN 1452-3981
J9 INT J ELECTROCHEM SC
JI Int. J. Electrochem. Sci.
PD MAY
PY 2016
VL 11
IS 5
BP 4136
EP 4148
PG 13
WC Electrochemistry
SC Electrochemistry
GA DL6LG
UT WOS:000375750100069
DA 2018-10-20
ER

PT J
AU Muhonen, V
   Salonius, E
   Haaparanta, AM
   Jarvinen, E
   Paatela, T
   Meller, A
   Hannula, M
   Bjorkman, M
   Pyhalto, T
   Ella, V
   Vasara, A
   Toyras, J
   Kellomaki, M
   Kiviranta, I
AF Muhonen, Virpi
   Salonius, Eve
   Haaparanta, Anne-Marie
   Jarvinen, Elina
   Paatela, Teemu
   Meller, Anna
   Hannula, Markus
   Bjorkman, Mimmi
   Pyhalto, Tuomo
   Ella, Ville
   Vasara, Anna
   Toyras, Juha
   Kellomaki, Minna
   Kiviranta, Ilkka
TI Articular Cartilage Repair With Recombinant Human Type II
   Collagen/Polylactide Scaffold in a Preliminary Porcine Study
SO JOURNAL OF ORTHOPAEDIC RESEARCH
LA English
DT Article
DE cartilage repair; recombinant type II collagen; polylactide; scaffold;
   ACI
ID AUTOLOGOUS CHONDROCYTE IMPLANTATION; MESENCHYMAL STEM-CELLS;
   OSTEOCHONDRAL DEFECTS; SUBCHONDRAL BONE; COLLAGEN GEL; IMAGE-ANALYSIS;
   KNEE; MODEL; LESIONS; RABBIT
AB The purpose of this study was to investigate the potential of a novel recombinant human type II collagen/polylactide scaffold (rhCo-PLA) in the repair of full-thickness cartilage lesions with autologous chondrocyte implantation technique (ACI). The forming repair tissue was compared to spontaneous healing (spontaneous) and repair with a commercial porcine type I/III collagen membrane (pCo). Domestic pigs (4-month-old, n = 20) were randomized into three study groups and a circular full-thickness chondral lesion with a diameter of 8 mm was created in the right medial femoral condyle. After 3 weeks, the chondral lesions were repaired with either rhCo-PLA or pCo together with autologous chondrocytes, or the lesion was only debrided and left untreated for spontaneous repair. The repair tissue was evaluated 4 months after the second operation. Hyaline cartilage formed most frequently in the rhCo-PLA treatment group. Biomechanically, there was a trend that both treatment groups resulted in better repair tissue than spontaneous healing. Adverse subchondral bone reactions developed less frequently in the spontaneous group (40%) and the rhCo-PLA treated group (50%) than in the pCo control group (100%). However, no statistically significant differences were found between the groups. The novel rhCo-PLA biomaterial showed promising results in this proof-of-concept study, but further studies will be needed in order to determine its effectiveness in articular cartilage repair. (C) 2015 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.
C1 [Muhonen, Virpi; Salonius, Eve; Jarvinen, Elina; Paatela, Teemu; Vasara, Anna; Kiviranta, Ilkka] Univ Helsinki, Dept Orthopaed & Traumatol, Helsinki, Finland.
   [Haaparanta, Anne-Marie; Hannula, Markus; Ella, Ville; Kellomaki, Minna] Tampere Univ Technol, Dept Elect & Commun Engn, FIN-33101 Tampere, Finland.
   [Haaparanta, Anne-Marie; Hannula, Markus; Ella, Ville; Kellomaki, Minna] BioMediTech, Tampere, Finland.
   [Paatela, Teemu; Pyhalto, Tuomo; Vasara, Anna; Kiviranta, Ilkka] Helsinki Univ Hosp, Dept Orthopaed & Traumatol, Helsinki, Finland.
   [Meller, Anna] Univ Helsinki, Lab Anim Ctr, Helsinki, Finland.
   [Bjorkman, Mimmi; Toyras, Juha] Univ Eastern Finland, Dept Appl Phys, Kuopio, Finland.
   [Toyras, Juha] Kuopio Univ Hosp, Dept Clin Neurophysiol, SF-70210 Kuopio, Finland.
RP Salonius, E (reprint author), Univ Helsinki, Dept Orthopaed & Traumatol, Helsinki, Finland.
EM eve.salonius@helsinki.fi
OI Hannula, Markus Ilkka Juhana/0000-0002-4485-8004; Paatela,
   Teemu/0000-0002-6389-051X; Kellomaki, Minna/0000-0003-4321-1820
FU Finnish Funding Agency for Innovation (Tekes) [40091/09, 40113/13]
FX Grant sponsor: Finnish Funding Agency for Innovation (Tekes); Grant
   numbers: 40091/09, 40113/13.
CR Ahsan T, 1999, OSTEOARTHR CARTILAGE, V7, P29, DOI 10.1053/joca.1998.0160
   Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Bentley G, 2003, J BONE JOINT SURG BR, V85B, P223, DOI 10.1302/0301-620X.85B2.13543
   Biant LC, 2014, AM J SPORT MED, V42, P2178, DOI 10.1177/0363546514539345
   Bos PK, 2001, OSTEOARTHR CARTILAGE, V9, P382, DOI 10.1053/joca.2000.0399
   Brittberg M, 2003, J BONE JOINT SURG AM, V85A, P58, DOI 10.2106/00004623-200300002-00008
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Crawford DC, 2009, AM J SPORT MED, V37, P1334, DOI 10.1177/0363546509333011
   de Vries-van Melle ML, 2014, TISSUE ENG PT A, V20, P23, DOI [10.1089/ten.tea.2013.0080, 10.1089/ten.TEA.2013.0080]
   Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023
   Haaparanta AM, 2008, J APPL BIOMATER BIOM, V6, P89
   Haaparanta AM, 2014, J MATER SCI-MATER M, V25, P1129, DOI 10.1007/s10856-013-5129-5
   Harris JD, 2010, J BONE JOINT SURG AM, V92A, P2220, DOI 10.2106/JBJS.J.00049
   Heiskanen A, 2007, STEM CELLS, V25, P197, DOI 10.1634/stemcells.2006-0444
   Hurtig MB, 2011, CARTILAGE, V2, P137, DOI 10.1177/1947603511401905
   Jones CW, 2008, J ORTHOP RES, V26, P292, DOI 10.1002/jor.20502
   Julkunen P, 2007, J BIOMECH, V40, P1862, DOI 10.1016/j.jbiomech.2006.07.026
   Kon E, 2011, AM J SPORT MED, V39, P1668, DOI 10.1177/0363546511404675
   Korhonen RK, 2003, J BIOMECH, V36, P1373, DOI 10.1016/S0021-9290(03)00069-1
   Kosiur JR, 2014, J BONE JOINT SURG AM, V96A, DOI 10.2106/JBJS.M.01041
   Laasanen MS, 2006, OSTEOARTHR CARTILAGE, V14, P258, DOI 10.1016/j.joca.2005.09.011
   Lansman S, 2006, J CRANIOFAC SURG, V17, P1121
   Mainil-Varlet P, 2003, J BONE JOINT SURG AM, V85A, P45, DOI 10.2106/00004623-200300002-00007
   Makela JTA, 2012, OSTEOARTHR CARTILAGE, V20, P1268, DOI 10.1016/j.joca.2012.07.016
   Niemeyer P, 2014, INT ORTHOP, V38, P2065, DOI 10.1007/s00264-014-2368-0
   Nooeaid P, 2012, J CELL MOL MED, V16, P2247, DOI 10.1111/j.1582-4934.2012.01571.x
   Orth P, 2013, EUR CELLS MATER, V25, P299, DOI 10.22203/eCM.v025a21
   Parenteau BR, 2011, ACTA BIOMATER, V7, P3757, DOI [10.1016/j.actbio.2011.06.020, DOI 10.1016/J.ACTBIO.2011.06.020]
   Pulkkinen HJ, 2013, OSTEOARTHR CARTILAGE, V21, P481, DOI 10.1016/j.joca.2012.12.004
   Pulkkinen HJ, 2010, OSTEOARTHR CARTILAGE, V18, P1077, DOI 10.1016/j.joca.2010.05.004
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Schneider U, 2011, AM J SPORT MED, V39, P2558, DOI 10.1177/0363546511423369
   Scranton PE, 2001, FOOT ANKLE INT, V22, P380, DOI 10.1177/107110070102200504
   SHAPIRO F, 1993, J BONE JOINT SURG AM, V75A, P532, DOI 10.2106/00004623-199304000-00009
   Sharma B, 2013, SCI TRANSL MED, V5, P167, DOI DOI 10.1126/SCITRANSLMED.3004838
   Spees JL, 2004, MOL THER, V9, P747, DOI 10.1016/j.y,the.2004.02.012
   Spiller KL, 2011, TISSUE ENG PART B-RE, V17, P281, DOI [10.1089/ten.teb.2011.0077, 10.1089/ten.TEB.2011.0077]
   Swindle M., 2007, SWINE LAB SURG ANEST
   Tew SR, 2000, ARTHRITIS RHEUM-US, V43, P215, DOI 10.1002/1529-0131(200001)43:1<215::AID-ANR26>3.0.CO;2-X
   Vanlauwe J, 2011, AM J SPORT MED, V39, P2566, DOI 10.1177/0363546511422220
   Vasara AI, 2006, OSTEOARTHR CARTILAGE, V14, P1066, DOI 10.1016/j.joca.2006.04.003
   Vasara AI, 2004, CALCIFIED TISSUE INT, V74, P107, DOI 10.1007/s00223-002-2153-8
   Vasiliadis HS, 2010, AM J SPORT MED, V38, P943, DOI 10.1177/0363546509358266
   WAKITANI S, 1989, J BONE JOINT SURG BR, V71, P74
NR 44
TC 4
Z9 4
U1 1
U2 10
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0736-0266
EI 1554-527X
J9 J ORTHOP RES
JI J. Orthop. Res.
PD MAY
PY 2016
VL 34
IS 5
BP 745
EP 753
DI 10.1002/jor.23099
PG 9
WC Orthopedics
SC Orthopedics
GA DL4JX
UT WOS:000375602200003
PM 26573959
OA Bronze
DA 2018-10-20
ER

PT J
AU Illien-Junger, S
   Sedaghatpour, DD
   Laudier, DM
   Hecht, AC
   Qureshi, SA
   Iatridis, JC
AF Illien-Juenger, Svenja
   Sedaghatpour, Dillon D.
   Laudier, Damien M.
   Hecht, Andrew C.
   Qureshi, Sheeraz A.
   Iatridis, James C.
TI Development of a bovine decellularized extracellular matrix-biomaterial
   for nucleus pulposus regeneration
SO JOURNAL OF ORTHOPAEDIC RESEARCH
LA English
DT Article
DE intervertebral disc; decellularization; nucleus pulposus replacement;
   extracellular matrix biomaterial; tissue engineering
ID MESENCHYMAL STEM-CELLS; INTERVERTEBRAL DISC DEGENERATION; IN-VITRO;
   REPAIR; TRANSPLANTATION; SCAFFOLDS; THERAPIES; HYDROGELS; DISEASES;
   SURGERY
AB Painful intervertebral disc (IVD) degeneration is a common cause for spinal surgery. There is a clinical need to develop injectable biomaterials capable of promoting IVD regeneration, yet many available biomaterials do not mimic the native extracellular matrix (ECM) or promote matrix production. This study aimed to develop a decellularized injectable bovine ECM material that maintains structural and compositional features of native tissue and promotes nucleus pulposus (NP) cell (NPC) and mesenchymal stem cell (MSC) adaption. Injectable decellularized ECM constructs were created using 3 NP tissue decellularization methods (con.A: sodium deoxycholate, con.B: sodium deoxycholate & sodium dodecyl sulfate, con.C: sodium deoxycholate, sodium dodecyl sulfate & TritonX-100) and evaluated for protein, microstructure, and for cell adaptation in 21 day human NPC and MSC culture experiments. Con.A was most efficient at DNA depletion, preserved best collagen microstructure and content, and maintained the highest glycosaminoglycan (GAG) content. NPCs in decellularized constructs of con.A&B demonstrated newly synthesized GAG production, which was apparent from halos of GAG staining surrounding seeded NPCs. Con.A also promoted MSC adaption with high cell viability and ECM production. The injectable decellularized NP biomaterial that used sodium deoxycholate without additional decellularization steps maintained native NP tissue structure and composition closest to natural ECM and promoted cellular adaptation of NP cells and MSCs. This natural decellularized biomaterial warrants further investigation for its potential as an injectable cell seeded supplement to augment NP replacement biomaterials and deliver NPCs or MSCs. (c) 2015 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 34:876-888, 2016.
C1 [Illien-Juenger, Svenja; Sedaghatpour, Dillon D.; Laudier, Damien M.; Hecht, Andrew C.; Qureshi, Sheeraz A.; Iatridis, James C.] Icahn Sch Med Mt Sinai, Leni & Peter W May Dept Orthopaed, New York, NY 10029 USA.
RP Illien-Junger, S (reprint author), Icahn Sch Med Mt Sinai, Leni & Peter W May Dept Orthopaed, New York, NY 10029 USA.
EM Svenja.illien-junger@mssm.edu
OI Iatridis, James/0000-0002-2186-0590; Illien-Junger,
   Svenja/0000-0001-9895-0693
FU National Institute of Arthritis and Musculoskeletal and Skin Diseases of
   the National Institutes of Health [R01 AR057397]; AO Exploratory
   Research Board of AO Foundation
FX Grant sponsor: National Institute of Arthritis and Musculoskeletal and
   Skin Diseases of the National Institutes of Health; Grant number: R01
   AR057397; Grant sponsor: AO Exploratory Research Board of AO Foundation.
CR Abbott RD, 2012, J ORTHOP RES, V30, P482, DOI 10.1002/jor.21534
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Bosnakovski D, 2006, BIOTECHNOL BIOENG, V93, P1152, DOI 10.1002/bit.20828
   Boubriak OA, 2013, J ANAT, V222, P341, DOI 10.1111/joa.12022
   Chan LKY, 2013, ACTA BIOMATER, V9, P5262, DOI 10.1016/j.actbio.2012.09.005
   Chan SCW, 2013, SPINE J, V13, P273, DOI 10.1016/j.spinee.2012.12.007
   COURTMAN DW, 1994, J BIOMED MATER RES, V28, P655, DOI 10.1002/jbm.820280602
   Fakouri B, 2015, CLIN ORTHOP RELAT R, V473, P1957, DOI 10.1007/s11999-014-3904-3
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Feng GJ, 2012, TISSUE ENG PT A, V18, P2231, DOI [10.1089/ten.tea.2011.0747, 10.1089/ten.TEA.2011.0747]
   Fitzpatrick JC, 2010, INT J BIOMATER, V2010, DOI DOI 10.1155/2010/620503
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Guillaume O, 2015, J BIOMATER APPL, V29, P1230, DOI 10.1177/0885328214557905
   HANLEY EN, 1989, J BONE JOINT SURG AM, V71A, P719, DOI 10.2106/00004623-198971050-00013
   Hu JQ, 2015, MOL MED REP, V12, P5701, DOI 10.3892/mmr.2015.4139
   Huang YC, 2014, NAT REV RHEUMATOL, V10, P561, DOI 10.1038/nrrheum.2014.91
   Hudson KD, 2013, CURR OPIN BIOTECH, V24, P872, DOI 10.1016/j.copbio.2013.04.012
   Iatridis JC, 2013, SPINE J, V13, P243, DOI 10.1016/j.spinee.2012.12.002
   Jiang WC, 2014, BIOMATERIALS, V35, P3607, DOI 10.1016/j.biomaterials.2014.01.024
   Kim CH, 2013, SPINE, V38, P581, DOI 10.1097/BRS.0b013e318274f9a7
   Kirzner Yakira, 2012, J Long Term Eff Med Implants, V22, P73
   Laudier D, 2007, J ORTHOP RES, V25, P390, DOI 10.1002/jor.20304
   Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223
   Li H, 2013, CELLS TISSUES ORGANS, V198, P266, DOI 10.1159/000356505
   Loupasis GA, 1999, SPINE, V24, P2313, DOI 10.1097/00007632-199911150-00005
   Martin BI, 2007, SPINE, V32, P382, DOI 10.1097/01.brs.0000254104.55716.46
   Mern DS, 2014, J TISSUE ENG REGEN M, V8, P925, DOI 10.1002/term.1583
   Mochida J, 2015, EUR CELLS MATER, V29, P202, DOI 10.22203/eCM.v029a15
   Price AP, 2015, TISSUE ENG PART C-ME, V21, P94, DOI [10.1089/ten.tec.2013.0756, 10.1089/ten.TEC.2013.0756]
   Reing JE, 2010, BIOMATERIALS, V31, P8626, DOI 10.1016/j.biomaterials.2010.07.083
   Sakai D, 2015, NAT REV RHEUMATOL, V11, P243, DOI 10.1038/nrrheum.2015.13
   Sanchez PL, 2015, BIOMATERIALS, V61, P279, DOI 10.1016/j.biomaterials.2015.04.056
   Scarritt Michelle E, 2015, Front Bioeng Biotechnol, V3, P43, DOI 10.3389/fbioe.2015.00043
   Schwarz S, 2012, TISSUE ENG PT A, V18, P2195, DOI [10.1089/ten.tea.2011.0705, 10.1089/ten.TEA.2011.0705]
   Song JJ, 2013, NAT MED, V19, P646, DOI 10.1038/nm.3154
   Stapleton TW, 2008, TISSUE ENG PT A, V14, P505, DOI 10.1089/tea.2007.0233
   Teebken OE, 2009, EUR J VASC ENDOVASC, V37, P92, DOI 10.1016/j.ejvs.2008.10.012
   Thomas JD, 2010, ACTA BIOMATER, V6, P1319, DOI 10.1016/j.actbio.2009.10.024
   Vavken P, 2009, J ORTHOP RES, V27, P1612, DOI 10.1002/jor.20932
   Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2
   Wang Z, 2015, GENE, V564, P1, DOI 10.1016/j.gene.2015.03.022
   Watanabe T, 2010, J ORTHOP RES, V28, P623, DOI 10.1002/jor.21036
   Weymann A, 2015, ARTIF ORGANS, V39, P1024, DOI 10.1111/aor.12481
   Wuertz K, 2009, BIOCHEM BIOPH RES CO, V379, P824, DOI 10.1016/j.bbrc.2008.12.145
   Xu HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086723
   Yang SH, 2008, SPINE, V33, P1951, DOI 10.1097/BRS.0b013e31817e6974
   Yang XL, 2009, EUR SPINE J, V18, P1564, DOI 10.1007/s00586-009-1092-8
NR 47
TC 11
Z9 11
U1 3
U2 26
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0736-0266
EI 1554-527X
J9 J ORTHOP RES
JI J. Orthop. Res.
PD MAY
PY 2016
VL 34
IS 5
BP 876
EP 888
DI 10.1002/jor.23088
PG 13
WC Orthopedics
SC Orthopedics
GA DL4JX
UT WOS:000375602200017
PM 26509556
OA Green Accepted, Bronze
DA 2018-10-20
ER

PT J
AU Manferdini, C
   Cavallo, C
   Grigolo, B
   Fiorini, M
   Nicoletti, A
   Gabusi, E
   Zini, N
   Pressato, D
   Facchini, A
   Lisignoli, G
AF Manferdini, C.
   Cavallo, C.
   Grigolo, B.
   Fiorini, M.
   Nicoletti, A.
   Gabusi, E.
   Zini, N.
   Pressato, D.
   Facchini, A.
   Lisignoli, G.
TI Specific inductive potential of a novel nanocomposite biomimetic
   biomaterial for osteochondral tissue regeneration
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE biomimetic materials; composite; mesenchymal stromal cells; osteogenic
   differentiation; chondrogenic differentiation; osteochondral lesions
ID 1,4-BUTANEDIOL DIGLYCIDYL ETHER; MARROW STROMAL CELLS; COMPOSITE
   MULTILAYERED BIOMATERIAL; MESENCHYMAL STEM-CELLS; DERMAL SHEEP COLLAGEN;
   CROSS-LINKING; CHONDROGENIC DIFFERENTIATION; BILAYERED SCAFFOLD; BONE;
   DESIGN
AB Osteochondral lesions require treatment to restore the biology and functionality of the joint. A novel nanostructured biomimetic gradient scaffold was developed to mimic the biochemical and biophysical properties of the different layers of native osteochondral structure. The present results show that the scaffold presents important physicochemical characteristics and can support the growth and differentiation of mesenchymal stromal cells (h-MSCs), which adhere and penetrate into the cartilaginous and bony layers. H-MSCs grown in chondrogenic or osteogenic medium decreased their proliferation during days 14-52 on both scaffold layers and in medium without inducing factors used as controls. Both chondrogenic and osteogenic differentiation of h-MSCs occurred from day 28 and were increased on day 52, but not in the control medium. Safranin O staining and collagen type II and proteoglycans immunostaining confirmed that chondrogenic differentiation was specifically induced only in the cartilaginous layer. Conversely, von Kossa staining, osteocalcin and osteopontin immunostaining confirmed that osteogenic differentiation occurred on both layers. This study shows the specific potential of each layer of the biomimetic scaffold to induce chondrogenic or osteogenic differentiation of h-MSCs. These processes depended mainly on the media used but not the biomaterial itself, suggesting that the local milieu is fundamental for guiding cell differentiation. Copyright (c) 2013 John Wiley & Sons, Ltd.
C1 [Manferdini, C.; Grigolo, B.; Facchini, A.; Lisignoli, G.] Ist Ortoped Rizzoli, SC Lab Immunoreumatol & Rigeneraz Tissutale, Bologna, Italy.
   [Manferdini, C.; Cavallo, C.; Grigolo, B.; Gabusi, E.; Facchini, A.; Lisignoli, G.] Ist Ortoped Rizzoli, Lab RAMSES, Bologna, Italy.
   [Fiorini, M.; Nicoletti, A.; Pressato, D.] Fin Ceram Faenza SpA, Faenza, RA, Italy.
   [Zini, N.] CNR IGM, IOR, Bologna, Italy.
   [Facchini, A.] Univ Bologna, Dipartimento Med Interna & Gastroenterol, I-40126 Bologna, Italy.
RP Lisignoli, G (reprint author), SC Lab Immunoreumatol & Rigeneraz Tissutale, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM gina.lisignoli@ior.it
RI Grigolo, Brunella/J-5417-2016
OI Grigolo, Brunella/0000-0002-3990-6745; manferdini,
   cristina/0000-0002-6648-6061; ZINI, NICOLETTA/0000-0002-4442-7079;
   Cavallo, Carola/0000-0002-2913-856X
FU Rizzoli Orthopaedic Institute; MIUR; RFO University of Bologna
FX Funding for the study was provided by Rizzoli Orthopaedic Institute
   (Ricerca Corrente and 'Cinque per mille'), MIUR and the RFO University
   of Bologna.
CR AHMED SA, 1994, J IMMUNOL METHODS, V170, P211
   Barker MK, 2001, RHEUMATOLOGY, V40, P274, DOI 10.1093/rheumatology/40.3.274
   CAVALLARO JF, 1994, BIOTECHNOL BIOENG, V43, P781, DOI 10.1002/bit.260430813
   Chen WC, 2013, J TISSUE ENG REGEN M, V7, P665, DOI 10.1002/term.1463
   Erisken C, 2011, TISSUE ENG PT A, V17, P1239, DOI [10.1089/ten.tea.2009.0693, 10.1089/ten.TEA.2009.0693]
   Grigolo B, 2011, J BIOL REGUL HOMEOST, V25, P3
   Hench L.L., 2002, FUTURE STRATEGIES TI, P3
   Hollister SJ, 2002, BIOMATERIALS, V23, P4095, DOI 10.1016/S0142-9612(02)00148-5
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Kim HW, 2005, J BIOMED MATER RES A, V75A, P629, DOI 10.1002/jbm.a.30463
   Kon E, 2010, INJURY, V41, P693, DOI 10.1016/j.injury.2009.11.014
   Kon E, 2011, AM J SPORT MED, V39, P1180, DOI 10.1177/0363546510392711
   Kon E, 2010, J ORTHOP RES, V28, P116, DOI 10.1002/jor.20958
   Kon E, 2009, KNEE SURG SPORT TR A, V17, P1312, DOI 10.1007/s00167-009-0819-8
   Kon E, 2008, SPORTS MED ARTHROSC, V16, P221, DOI 10.1097/JSA.0b013e31818cdbc5
   Li J, 2009, TISSUE ENG PT A, V15, P2481, DOI 10.1089/ten.TEA.2008.0463
   Lisignoli G, 2005, BIOMATERIALS, V26, P5677, DOI 10.1016/j.biomaterials.2005.02.031
   Lisignoli G, 2002, BIOMATERIALS, V23, P1043, DOI 10.1016/S0142-9612(01)00216-2
   Lozano LF, 2003, J MATER SCI, V38, P4777, DOI 10.1023/A:1027483220584
   Manferdini C, 2010, BIOMATERIALS, V31, P3986, DOI 10.1016/j.biomaterials.2010.01.148
   Nicoletti A, 2013, J MATER SCI-MATER M, V24, P17, DOI 10.1007/s10856-012-4782-4
   Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034
   Qu D, 2011, J BIOMED MATER RES B, V96B, P9, DOI 10.1002/jbm.b.31697
   Roveri N, 2003, MAT SCI ENG C-BIO S, V23, P441, DOI 10.1016/S0928-4931(02)00318-1
   Tampieri A, 2006, Patent No. [WO 2006/092718, 2006092718]
   Tampieri A, 2008, BIOMATERIALS, V29, P3539, DOI 10.1016/j.biomaterials.2008.05.008
   Tampieri A, 2008, KEY ENG MATER, V361-363, P927, DOI 10.4028/www.scientific.net/KEM.361-363.927
   Tampieri A, 2011, TRENDS BIOTECHNOL, V29, P526, DOI 10.1016/j.tibtech.2011.04.011
   Venugopal B, 2012, J BIOMED MATER RES A, V100A, P1427, DOI 10.1002/jbm.a.34082
   Wang JL, 2012, J BIOMED MATER RES A, V100A, P1438, DOI 10.1002/jbm.a.34081
   Whang K, 1999, TISSUE ENG, V5, P35, DOI 10.1089/ten.1999.5.35
   Yuan T, 2010, BIOTECHNOL PROGR, V26, P1749, DOI 10.1002/btpr.484
   Zeeman R, 1999, J BIOMED MATER RES, V46, P424, DOI 10.1002/(SICI)1097-4636(19990905)46:3<424::AID-JBM16>3.0.CO;2-R
   Zeeman R, 2000, J BIOMED MATER RES, V51, P541, DOI 10.1002/1097-4636(20000915)51:4<541::AID-JBM1>3.3.CO;2-G
   Zhang Z., 2012, J SOC LEATHER TECHNO, V90, P23
NR 35
TC 6
Z9 6
U1 0
U2 13
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD MAY
PY 2016
VL 10
IS 5
BP 374
EP 391
DI 10.1002/term.1723
PG 18
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA DL8BT
UT WOS:000375865100004
PM 23495253
DA 2018-10-20
ER

PT J
AU Stach, S
   Sapota, W
   Wrobel, Z
   Talu, S
AF Stach, Sebastian
   Sapota, Wiktoria
   Wrobel, Zygmunt
   Talu, Stefan
TI Assessment of Possibilities of Ceramic Biomaterial Fracture Surface
   Reconstruction Using Laser Confocal Microscopy and Long Working Distance
   Objective Lenses
SO MICROSCOPY RESEARCH AND TECHNIQUE
LA English
DT Article
DE confocal microscopy; fracture; long working distance; stereometry;
   surface morphology
ID SCANNING MICROSCOPY
AB A numerical description of fracture is an important step in the search of the correlation between specific micromechanisms of decohesion and material characteristics designated with the use of fracture mechanics methods. This issue is essential for the proper orientation of the search for basic relationships between chemical composition, technology, structure, and properties of materials. It often happens that fracture surfaces are well developed, which can significantly hinder or even prevent the measurement and reconstruction of the tested material surface geometry. In this article, comparative measurements of a biomaterial surface were performed using laser confocal microscopy. To this end, short working distance lenses dedicated to a focused UV laser beam and long working distance objective lenses were used. The article includes a quantitative comparative analysis and interpretation of the obtained results. (C) 2016 Wiley Periodicals, Inc.
C1 [Stach, Sebastian; Sapota, Wiktoria; Wrobel, Zygmunt] Univ Silesia, Dept Biomed Comp Syst, Inst Informat, Fac Comp Sci & Mat Sci, PL-41205 Sosnowiec, Poland.
   [Talu, Stefan] Tech Univ Cluj Napoca, Fac Mech Engn, Dept AET, Discipline Descript Geometry & Engn Graph, 103-105 B Dul Muncii St, Cluj Napoca 400641, Cluj, Romania.
RP Talu, S (reprint author), Tech Univ Cluj Napoca, Fac Mech Engn, Dept AET, Discipline Descript Geometry & Engn Graph, 103-105 B Dul Muncii St, Cluj Napoca 400641, Cluj, Romania.
EM stefan_ta@yahoo.com
OI Stach, Sebastian/0000-0001-7054-700X
CR BRUTKOWSKI W, 2013, KOSMOS, V62, P171
   Conn PM, 2010, TECHNIQUES CONFOCAL
   Cwajna J, 2001, MATER CHARACT, V46, P183, DOI 10.1016/S1044-5803(01)00122-X
   Davidson M.W., 2002, ENCY IMAGING SCI TEC, P1106
   Dudek A, 2011, ARCH METALL MATER, V56, P135, DOI 10.2478/v10172-011-0015-y
   Freiman SW, 2012, FRACTURE BRITTLE MAT, DOI [10.1002/9781118147757.ch6, DOI 10.1002/9781118147757.CH6]
   I.S.O, 2016, 2517822012 ISO
   Kelsall RW, 2009, NANOTECHNOLOGIES
   Moore D. R., 2001, ESIS PUBLICATION, V28
   Paddock SW, 2000, MOL BIOTECHNOL, V16, P127, DOI 10.1385/MB:16:2:127
   Pawlus P., 2006, SURFACE TOPOGRAPHY M
   PLUTA M, 1982, OPTICAL MICROSCOPY
   Price RL, 2011, BASIC CONFOCAL MICROSCOPY, P181, DOI 10.1007/978-0-387-78175-4_9
   Quinn GD, 2007, NIST SPECIAL PUBLICA, V960-16
   Quinn GD, 2008, MICROSC ANAL, V22, P21
   Ren F, 2005, INT J APPL CERAM TEC, V2, P200, DOI 10.1111/j.1744-7402.2005.02022.x
   Stach S, 2011, KEY ENG MATER, V465, P271, DOI 10.4028/www.scientific.net/KEM.465.271
   Stach S, 2009, MATER CHARACT, V60, P1151, DOI 10.1016/j.matchar.2009.02.013
   Synak R, 2013, ELECT INFORM TECHNOL, V54, P46
   Szczotok A, 2005, MATER SCI-POLAND, V23, P559
   Talu Stefan, 2015, MICRO NANOSCALE CHAR
   YAO N, 2005, HDB MICROSCOPY NANOT
NR 22
TC 1
Z9 1
U1 0
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1059-910X
EI 1097-0029
J9 MICROSC RES TECHNIQ
JI Microsc. Res. Tech.
PD MAY
PY 2016
VL 79
IS 5
BP 385
EP 392
DI 10.1002/jemt.22641
PG 8
WC Anatomy & Morphology; Biology; Microscopy
SC Anatomy & Morphology; Life Sciences & Biomedicine - Other Topics;
   Microscopy
GA DJ9RR
UT WOS:000374551100006
PM 26918261
DA 2018-10-20
ER

PT J
AU Lappalainen, OP
   Haapea, M
   Serpi, R
   Lehtonen, S
   Ylikontiola, L
   Korpi, J
   Serlo, W
   Sandor, GKB
AF Lappalainen, Olli-Pekka
   Haapea, Marianne
   Serpi, Raisa
   Lehtonen, Siri
   Ylikontiola, Leena
   Korpi, Jarkko
   Serlo, Willy
   Sandor, George K. B.
TI Iron-labeled adipose stem cells and neovascularization in rabbit
   calvarial critical-sized defects
SO ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY
LA English
DT Article
ID IN-VIVO; BONE REGENERATION; OXIDE; TRACKING; NANOPARTICLES;
   ANGIOGENESIS; MODEL; MRI
AB Objective. The aim of this study was to evaluate the presence of iron-labeled adipose stem cells at the 2-week time point and vascular changes at the 2-week and 6-week time points using two different types of scaffolds.
   Study Design. This study included 22 White New Zealand adult male rabbits. In six rabbits, full-thickness calvarial criticalsized defects were filled with autogenous adipose stem cells labeled with iron oxide seeded onto two scaffolds, namely, solid bioactive glass (BAG) or porous tricalcium phosphate granules (TCP) used on reciprocal sides of the skull. Eleven rabbits were implanted with adipose stem celleseeded scaffolds without iron labeling for analysis of vascular changes. Five defects were left empty as negative control defects. The specimens were analyzed histologically at the 2-week and 6-week time points.
   Results. The TCP group showed significantly more vascularity compared with the BAG group. A greater number of labeled stem cells were identified in the TCP group compared with the BAG group, but the difference was not statistically significant.
   Conclusions. This study revealed the differences in stem cell distribution and revascularization of the calvarial defect, which may be biomaterial dependent.
C1 [Lappalainen, Olli-Pekka] Univ Oulu, Med Res Ctr, Res Grp Tissue Engn, Oral & Maxillofacial Surg, Oulu, Finland.
   [Haapea, Marianne] Oulu Univ Hosp, Dept Radiol, Oulu, Finland.
   [Serpi, Raisa] Univ Oulu, Fac Biochem & Mol Med, Oulu Ctr Cell Matrix Res, Bioctr Oulu, Oulu, Finland.
   [Lehtonen, Siri] Univ Oulu, Dept Internal Med, Resp Res Unit, Dept Anat & Cell Biol,Canc Res & Translat Med Res, Kajaanintie 50, SF-90220 Oulu, Finland.
   [Lehtonen, Siri] Oulu Univ Hosp, Med Res Ctr, Oulu, Finland.
   [Ylikontiola, Leena; Korpi, Jarkko] Oulu Univ Hosp, Cleft Lip & Palate Program, Oulu, Finland.
   [Ylikontiola, Leena; Korpi, Jarkko] Univ Oulu, Med Res Ctr, Oulu, Finland.
   [Serlo, Willy] Univ Oulu, Oulu Univ Hosp, Med Res Ctr,PEDEGO Res Ctr, Pediat Surg,Dept Children & Adolescents,Div Pedia, Oulu, Finland.
   [Sandor, George K. B.] Univ Oulu, Med Res Ctr, Tissue Engn & Oral & Maxillofacial Surg, Oulu, Finland.
   [Sandor, George K. B.] Oulu Univ Hosp, Oulu, Finland.
   [Sandor, George K. B.] Univ Tampere, Inst Biosci & Med Technol, BioMediTech, Res, FIN-33101 Tampere, Finland.
RP Sandor, GKB (reprint author), Univ Oulu, Dept Oral & Maxillofacial Surg, POB 5281, FIN-90014 Oulu, Finland.
EM sandor_george@hotmail.com
OI Haapea, Marianne/0000-0002-3989-9354; Serpi, Raisa/0000-0002-8207-4673
FU Finnish Medical Association Duodecim, Helsinki, Finland; Emil Aaltonen
   Foundation, Tampere, Finland; Pohjois-Pohjanmaan Sairaanhoitopiiri
   (Northern Ostrobothnia Hospital District); Stiftelsen Alma and K.A.
   Snellman Foundation, Oulu, Finland; ITI Foundation (ITI) [619-2009]
FX This study was generously funded by the Finnish Medical Association
   Duodecim, Helsinki, Finland; the Emil Aaltonen Foundation, Tampere,
   Finland; the VTR grant funds from the Pohjois-Pohjanmaan
   Sairaanhoitopiiri (Northern Ostrobothnia Hospital District), the
   Stiftelsen Alma and K.A. Snellman Foundation, Oulu, Finland; and by the
   ITI Foundation (ITI Grant number 619-2009).
CR Alestalo K, 2015, SCAND CARDIOVASC J, V49, P82, DOI 10.3109/14017431.2015.1018311
   Amsalem Y, 2007, CIRCULATION, V116, pI38, DOI 10.1161/CIRCULATIONAHA.106.680231
   Bai F, 2010, TISSUE ENG PT A, V16, P3791, DOI 10.1089/ten.TEA.2010.0148
   Balakumaran A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011462
   Banyard DA, 2015, PLAST RECONSTR SURG, V135, P1740, DOI 10.1097/PRS.0000000000001272
   Beaumont M, 2010, NMR BIOMED, V23, P48, DOI 10.1002/nbm.1425
   BERGGREN A, 1982, J BONE JOINT SURG AM, V64, P73, DOI 10.2106/00004623-198264010-00012
   Clokie CML, 2002, J CRANIOFAC SURG, V13, P111, DOI 10.1097/00001665-200201000-00026
   Delgado-Ruiz RA, 2015, CLIN ORAL IMPLANTS R
   Fok TCO, 2008, ORAL SURG ORAL MED O, V105, P417, DOI 10.1016/j.tripleo.2007.07.015
   Hansen L, 2014, SCAND J CLIN LAB INV, V74, P437, DOI 10.3109/00365513.2014.900698
   Hauger O, 2006, RADIOLOGY, V238, P200, DOI 10.1148/radiol.2381041668
   Hussain SM, 2005, TOXICOL IN VITRO, V19, P975, DOI 10.1016/j.tiv.2005.06.034
   Ittrich H, 2007, J MAGN RESON IMAGING, V25, P1179, DOI 10.1002/jmri.20925
   Jan Ahmed M A, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, P144, DOI 10.1016/j.tripleo.2005.08.032
   Korchinski DJ, 2015, MAGN RESON INSIGHTS, V8, P15, DOI 10.4137/MRI.S23557
   LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X
   Leucht P, 2015, J AM ACAD ORTHOP SUR, V23, P67, DOI 10.5435/JAAOS-23-01-67
   Mesimaki K, 2009, INT J ORAL MAX SURG, V38, P201, DOI 10.1016/j.ijom.2009.01.001
   Ohnishi S, 2007, INT J HEMATOL, V86, P17, DOI 10.1532/IJH97.07041
   Piitulainen JM, 2015, WORLD NEUROSURG, V83, P708, DOI 10.1016/j.wneu.2015.01.014
   Politi LS, 2007, STEM CELLS, V25, P2583, DOI 10.1634/stemcells.2007-0037
   Sandor GK, 2014, STEM CELL TRANSL MED, V3, P530, DOI 10.5966/sctm.2013-0173
   Sandor GK, 2013, J ORAL MAXIL SURG, V71, P938, DOI 10.1016/j.joms.2012.11.014
   Schwarz F, 2015, J NEUROSURG, V25, P1
   Shen WB, 2015, CELL TRANSPL
   Singh N, 2010, NANO REV EXP, V1, DOI 10.3402/nano.v1i0.5358
   Valimaki VV, 2006, SCAND J SURG, V95, P95
   von der Haar K, 2015, APPL MICROBIOL BIOT, V99, P9907, DOI 10.1007/s00253-015-6965-7
   Wolff J, 2015, IMPLANT DENT, V24, P552, DOI 10.1097/ID.0000000000000320
   Xiao X, 2015, SCI REP-UK, V5, DOI 10.1038/srep09409
   Yamahara K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001666
   Yu M, 2012, INT J MOL SCI, V13, P5554, DOI 10.3390/ijms13055554
NR 33
TC 1
Z9 1
U1 4
U2 12
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 2212-4403
EI 1528-395X
J9 OR SURG OR MED OR PA
JI Oral Surg. Oral Med. Oral Pathol. Oral Radiol.
PD MAY
PY 2016
VL 121
IS 5
BP E104
EP E110
DI 10.1016/j.oooo.2016.01.006
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA DL4LN
UT WOS:000375608100002
PM 27017402
DA 2018-10-20
ER

PT J
AU Filip, D
   Macocinschi, D
   Paslaru, E
   Tuchilus, CG
   Vlad, S
AF Filip, Daniela
   Macocinschi, Doina
   Paslaru, Elena
   Tuchilus, Cristina G.
   Vlad, Stelian
TI Surface characterization and antimicrobial properties of sodium
   deoxycholate-based poly(ester ether)urethane ionomer biomaterials
SO REACTIVE & FUNCTIONAL POLYMERS
LA English
DT Article
DE Polyurethane ionomers; Sodium deoxycholate; Biomaterial; Surface
   characterization; Antibacterial
ID CONTACT-ANGLE; BIOMEDICAL APPLICATIONS; BLOOD COMPATIBILITY; BILE-SALTS;
   ACID; POLYMERS; SORPTION; ENERGY; BIOCOMPATIBILITY; POLYURETHANES
AB New sodium deoxycholate-based poly( ester ether)urethane ionomers have been obtained for the development of biomedical materials. Wettability, surface tension parameters, surface morphology, roughness, water sorption and/or desorption properties, and antimicrobial efficiency were determined for the obtained polyurethane biomembranes. Contact angle analysis evidenced that the synthesized polyurethane ionomers are hydrophilic due to orientation and amount of ionic bile salt moieties towards surface. The values of interfacial tension demonstrate biocompatible qualities for these polyurethanes. SEM microphotographs show that the resulted morphologies of polyurethane ionomers are different due to the diverse polyether co-soft segments which determine the supramolecular architecture, ionic interactions between bile salt moiety and polyether segments. AFM images evidence lamellar arrangement at the sub-micron scale and the nanophase separated morphology for these polyurethanes. The estimated moisture diffusion coefficients are dependent on a range of moisture transport mechanisms in the porous membranes and the moisture content of the polyurethanes. The monolayer sorption and average pore size values were estimated by applying BET and GAB models. GAB model could not be applied in the case of high water uptake polyurethane samples. The synthesized biocidal polyurethanes are effective at inactivation of tested bacteria: Staphylococcus aureus, Sarcina lutea, Escherichia coli, except Pseudomonas aeruginosa. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Filip, Daniela; Macocinschi, Doina; Paslaru, Elena; Vlad, Stelian] Petru Poni Inst Macromol Chem, Aleea Gr Ghica Voda 41A, Iasi 700487, Romania.
   [Tuchilus, Cristina G.] Gr T Popa Univ Med & Pharm, Fac Med, Dept Microbiol, 16 Univ St, Iasi 700115, Romania.
RP Filip, D (reprint author), Petru Poni Inst Macromol Chem, Aleea Gr Ghica Voda 41A, Iasi 700487, Romania.
EM dare67ro@yahoo.com
RI Paslaru, Elena/O-4402-2014; Vlad, Stelian/C-3430-2011
OI Paslaru, Elena/0000-0003-1409-9913; Vlad, Stelian/0000-0002-5895-438X
FU Unitatea Executiva pentru Finantarea Invatamantului Superior, a
   Cercetarii, Dezvoltarii si Inovarii-UEFISCDI [BIONANOMED 164/2012]
FX The authors gratefully acknowledge the financial support given by
   Unitatea Executiva pentru Finantarea Invatamantului Superior, a
   Cercetarii, Dezvoltarii si Inovarii-UEFISCDI through research project
   BIONANOMED 164/2012.
CR ANDERSON RB, 1946, J AM CHEM SOC, V68, P686, DOI 10.1021/ja01208a049
   Arslan N, 2006, J STORED PROD RES, V42, P112, DOI 10.1016/j.jspr.2005.01.001
   Balik CM, 1996, MACROMOLECULES, V29, P3025, DOI 10.1021/ma9509467
   Brunauer S, 1940, J AM CHEM SOC, V62, P1723, DOI 10.1021/ja01864a025
   Chen SF, 2010, POLYMER, V51, P5283, DOI 10.1016/j.polymer.2010.08.022
   Clinical and Laboratory Standards Institute, 2014, M100S20 CLSI
   Crank J., 1975, MATH DIFFUSION
   De Boer J. H., 1968, DYNAMICAL CHARACTER
   Diamond T, 1991, HPB Surg, V4, P81, DOI 10.1155/1991/48672
   Faibish RS, 2002, J COLLOID INTERF SCI, V256, P341, DOI 10.1006/jcis.2002.8612
   Filip D, 2014, J NANOPART RES, V16, DOI 10.1007/s11051-014-2710-x
   Filip D, 2016, J APPL POLYM SCI, V133, DOI 10.1002/app.42921
   Gautrot JE, 2006, ANGEW CHEM INT EDIT, V45, P6872, DOI 10.1002/anie.200602096
   Gonzalez-Paz RJ, 2013, REACT FUNCT POLYM, V73, P690, DOI 10.1016/j.reactfunctpolym.2013.02.005
   Gouin S, 2000, MACROMOLECULES, V33, P5379, DOI 10.1021/ma991364i
   Grassy F., 2000, POLYM SURFACES PHYS
   Guggenheim E. A, 1966, APPL STAT MECH
   Hallab NJ, 2001, TISSUE ENG, V7, P55, DOI 10.1089/107632700300003297
   Herrera-Gomez A, 2001, J APPL PHYS, V89, P5431, DOI 10.1063/1.1365427
   Janvier F, 2013, J MECH BEHAV BIOMED, V18, P100, DOI 10.1016/j.jmbbm.2012.11.008
   Jiang GC, 2010, REACT FUNCT POLYM, V70, P175, DOI 10.1016/j.reactfunctpolym.2009.11.010
   Kalble D. H., 1969, J ADHESION, V1, P102
   Korley LTJ, 2006, POLYMER, V47, P3073, DOI 10.1016/j.polymer.2006.02.093
   Kwok SCH, 2005, DIAM RELAT MATER, V14, P78, DOI 10.1016/j.diamond.2004.07.019
   Lelah MD, 1993, POLYURETHANES MED
   Liu J, 2011, POLYMER, V52, P4619, DOI 10.1016/j.polymer.2011.08.001
   Macocinschi D, 2015, J BIOACT COMPAT POL, V30, P509, DOI 10.1177/0883911515581508
   Macocinschi D, 2009, J MATER SCI-MATER M, V20, P775, DOI 10.1007/s10856-008-3626-8
   MARSHALL SE, 1987, J MED VET MYCOL, V25, P307
   MAURYA KK, 1992, J MATER SCI, V27, P6357, DOI 10.1007/BF00576285
   Melia E., 2005, POLYM PREPR, V46, P166
   Menzies KL, 2010, OPTOMETRY VISION SCI, V87, P387, DOI 10.1097/OPX.0b013e3181da863e
   Merritt ME, 2009, J MED MICROBIOL, V58, P1533, DOI 10.1099/jmm.0.014092-0
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Plank H., 1987, PROGR BIOMEDICAL ENG, V3
   Rankl M, 2003, COLLOID SURFACE B, V30, P177, DOI 10.1016/S0927-7765(03)00085-7
   RUCKENSTEIN E, 1986, BIOMATERIALS, V7, P403, DOI 10.1016/0142-9612(86)90028-1
   RUCKENSTEIN E, 1984, J COLLOID INTERF SCI, V101, P436, DOI 10.1016/0021-9797(84)90055-9
   Silver JH, 1999, BIOMATERIALS, V20, P1533, DOI 10.1016/S0142-9612(98)00173-2
   Skopinska-Wisniewska J, 2009, APPL SURF SCI, V255, P8286, DOI 10.1016/j.apsusc.2009.05.127
   Straube J., 2006, MOISTURE MAT
   SUNG JY, 1993, DIGEST DIS SCI, V38, P2104, DOI 10.1007/BF01297092
   Timmermann EO, 2003, COLLOID SURFACE A, V220, P235, DOI 10.1016/S0927-7757(03)00059-1
   Van Oss C. J., 1994, INTERFACIAL FORCES A
   VANOSS CJ, 1988, CHEM REV, V88, P927, DOI 10.1021/cr00088a006
   VANOSS CJ, 1988, LANGMUIR, V4, P884, DOI 10.1021/la00082a018
   Vermette P, 2001, TISSUE ENG INTELLIGE, V6
   Wang YX, 2004, PHARM RES, V21, P1362, DOI 10.1023/B:PHAM.0000036909.41843.18
   Xu H, 2013, PROG ORG COAT, V76, P924, DOI 10.1016/j.porgcoat.2013.02.013
   Yuan Y., 2013, SURFACE SCI TECHNIQU, V51, DOI DOI 10.1007/978-3-642-34243-11
   Zhang JW, 2009, SCI CHINA SER B, V52, P849, DOI 10.1007/s11426-009-0124-x
   Zuluaga F, 1999, POLYM BULL, V42, P41, DOI 10.1007/s002890050432
NR 52
TC 7
Z9 8
U1 1
U2 31
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1381-5148
EI 1873-166X
J9 REACT FUNCT POLYM
JI React. Funct. Polym.
PD MAY
PY 2016
VL 102
BP 70
EP 81
DI 10.1016/j.reactfunctpolym.2016.02.011
PG 12
WC Chemistry, Applied; Engineering, Chemical; Polymer Science
SC Chemistry; Engineering; Polymer Science
GA DL6GI
UT WOS:000375737300010
DA 2018-10-20
ER

PT J
AU Klotz, BJ
   Gawlitta, D
   Rosenberg, AJWP
   Malda, J
   Melchels, FPW
AF Klotz, Barbara J.
   Gawlitta, Debby
   Rosenberg, Antoine J. W. P.
   Malda, Jos
   Melchels, Ferry P. W.
TI Gelatin-Methacryloyl Hydrogels: Towards Biofabrication-Based Tissue
   Repair
SO TRENDS IN BIOTECHNOLOGY
LA English
DT Review
ID MESENCHYMAL STEM-CELLS; GROWTH-FACTOR RELEASE; CROSS-LINKING; BIOMEDICAL
   APPLICATIONS; CARTILAGE CONSTRUCTS; DELIVERY VEHICLE; AQUEOUS-SOLUTION;
   LADEN HYDROGELS; FABRICATION; PHOTOPOLYMERIZATION
AB Research over the past decade on the cell-biomaterial interface has shifted to the third dimension. Besides mimicking the native extracellular environment by 3D cell culture, hydrogels offer the possibility to generate well-defined 3D biofabricated tissue analogs. In this context, gelatin-methacryloyl (gelMA) hydrogels have recently gained increased attention. This interest is sparked by the combination of the inherent bioactivity of gelatin and the physicochemical tailorability of photo-crosslinkable hydrogels. GeIMA is a versatile matrix that can be used to engineer tissue analogs ranging from vasculature to cartilage and bone. Convergence of biological and biofabrication approaches is necessary to progress from merely proving cell functionality or construct shape fidelity towards regenerating tissues. GeIMA has a critical pioneering role in this process and could be used to accelerate the development of clinically relevant applications.
C1 [Klotz, Barbara J.; Gawlitta, Debby; Rosenberg, Antoine J. W. P.] Univ Med Ctr Utrecht, Dept Oral & Maxillofacial Surg & Special Dent Car, PO 85500, NL-3508 GA Utrecht, Netherlands.
   [Malda, Jos; Melchels, Ferry P. W.] Univ Med Ctr Utrecht, Dept Orthopaed, POB 85500, NL-3508 GA Utrecht, Netherlands.
   [Malda, Jos] Univ Utrecht, Fac Vet Med, Dept Equine Sci, Yalelaan 112, NL-3584 CM Utrecht, Netherlands.
   [Melchels, Ferry P. W.] Heriot Watt Univ, Inst Biol Chem Biophys & Bioengn, Sch Engn & Phys Sci, Edinburgh EH14 4AS, Midlothian, Scotland.
RP Malda, J (reprint author), Univ Med Ctr Utrecht, Dept Orthopaed, POB 85500, NL-3508 GA Utrecht, Netherlands.; Malda, J (reprint author), Univ Utrecht, Fac Vet Med, Dept Equine Sci, Yalelaan 112, NL-3584 CM Utrecht, Netherlands.
EM j.malda@umcutrecht.nl
OI Malda, Jos/0000-0002-9241-7676
FU Dutch Arthritis Foundation; European Community's Seventh Framework
   Programme (FP7) [309962]; European Research Council [647426]; ReumaFonds
   [LLP-12]
FX The authors' research work is supported by the Dutch Arthritis
   Foundation; the European Community's Seventh Framework Programme
   (FP7/2007-2013) under grant agreement 309962 (HydroZONES); and the
   European Research Council under grant agreement 647426 (3D-JOINT).
CR Amini AA, 2012, J BIOACT COMPAT POL, V27, P342, DOI 10.1177/0883911512444713
   Babin H, 2001, FOOD HYDROCOLLOID, V15, P271, DOI 10.1016/S0268-005X(01)00025-X
   Benton JA, 2009, TISSUE ENG PT A, V15, P3221, DOI [10.1089/ten.tea.2008.0545, 10.1089/ten.TEA.2008.0545]
   Bertassoni LE, 2014, LAB CHIP, V14, P2202, DOI 10.1039/c4lc00030g
   Bertassoni LE, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/2/024105
   Bigi A, 2001, BIOMATERIALS, V22, P763, DOI 10.1016/S0142-9612(00)00236-2
   Billiet T, 2013, MACROMOL BIOSCI, V13, P1531, DOI 10.1002/mabi.201300143
   Billiet T, 2014, BIOMATERIALS, V35, P49, DOI 10.1016/j.biomaterials.2013.09.078
   Boere KWM, 2014, ACTA BIOMATER, V10, P2602, DOI 10.1016/j.actbio.2014.02.041
   Bryant SJ, 2000, J BIOMAT SCI-POLYM E, V11, P439, DOI 10.1163/156856200743805
   Cha CY, 2014, BIOMATER SCI-UK, V2, P703, DOI 10.1039/c3bm60210a
   Chen PY, 2014, ACTA BIOMATER, V10, P912, DOI 10.1016/j.actbio.2013.11.009
   Chen YC, 2012, ADV FUNCT MATER, V22, P2027, DOI 10.1002/adfm.201101662
   Chuang CH, 2015, ACTA BIOMATER, V19, P85, DOI 10.1016/j.actbio.2015.02.024
   Croes M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132781
   Daniele MA, 2014, BIOMATERIALS, V35, P1845, DOI 10.1016/j.biomaterials.2013.11.009
   Das S, 2015, ACTA BIOMATER, V11, P233, DOI 10.1016/j.actbio.2014.09.023
   Djagny KB, 2001, CRIT REV FOOD SCI, V41, P481, DOI 10.1080/20014091091904
   Ehrbar M, 2007, BIOMATERIALS, V28, P3856, DOI 10.1016/j.biomaterials.2007.03.027
   Elzoghby AO, 2013, J CONTROL RELEASE, V172, P1075, DOI 10.1016/j.jconrel.2013.09.019
   Evans CH, 2011, TISSUE ENG PART B-RE, V17, P437, DOI [10.1089/ten.teb.2011.0228, 10.1089/ten.TEB.2011.0228]
   Farris S, 2009, TRENDS FOOD SCI TECH, V20, P316, DOI 10.1016/j.tifs.2009.04.003
   Fedorovich NE, 2009, BIOMATERIALS, V30, P344, DOI 10.1016/j.biomaterials.2008.09.037
   Gevaert E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105171
   Gevaert E, 2014, MACROMOL BIOSCI, V14, P419, DOI 10.1002/mabi.201300320
   Gomez-Guillen MC, 2011, FOOD HYDROCOLLOID, V25, P1813, DOI 10.1016/j.foodhyd.2011.02.007
   Gorgleva S., 2011, COLLAGEN VS GELATINE
   Groll J, 2016, BIOFABRICATION, V8, DOI 10.1088/1758-5090/8/1/013001
   HABEEB AFS, 1966, ANAL BIOCHEM, V14, P328, DOI 10.1016/0003-2697(66)90275-2
   Heino J, 2009, INT J BIOCHEM CELL B, V41, P341, DOI 10.1016/j.biocel.2008.08.021
   Henrikson K. J., 2014, SPINE J, V14, pS173
   Hoch E, 2013, J MATER CHEM B, V1, P5675, DOI 10.1039/c3tb20745e
   Hoshikawa A, 2006, TISSUE ENG, V12, P2333, DOI 10.1089/ten.2006.12.2333
   Huber B, 2016, J BIOMATER APPL, V30, P699, DOI 10.1177/0885328215587450
   Hutson CB, 2011, TISSUE ENG PT A, V17, P1713, DOI [10.1089/ten.TEA.2010.0666, 10.1089/ten.tea.2010.0666]
   Jung J., 2014, E-POLYMERS, V14, P161
   Jung J, 2014, BIOMICROFLUIDICS, V8, DOI 10.1063/1.4880375
   Kolesky DB, 2014, ADV MATER, V26, P3124, DOI 10.1002/adma.201305506
   Koshy ST, 2014, BIOMATERIALS, V35, P2477, DOI 10.1016/j.biomaterials.2013.11.044
   Lai JY, 2010, BIOMACROMOLECULES, V11, P1387, DOI 10.1021/bm100213f
   Lee SH, 2014, ADV FUNCT MATER, V24, P6771, DOI 10.1002/adfm.201401110
   Lee Y, 2014, J MATER CHEM B, V2, P7712, DOI 10.1039/c4tb01111b
   Lee Y, 2013, J MATER CHEM B, V1, P2407, DOI [10.1039/c3tb00578j, 10.1039/C3TB00578J]
   Leijten J, 2015, ADV DRUG DELIVER REV, V84, P30, DOI 10.1016/j.addr.2014.10.025
   Levato R, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/3/035020
   Levett PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113216
   Levett PA, 2014, J BIOMED MATER RES A, V102, P2544, DOI 10.1002/jbm.a.34924
   Levett PA, 2014, ACTA BIOMATER, V10, P214, DOI 10.1016/j.actbio.2013.10.005
   Li YH, 2015, ADV FUNCT MATER, V25, P5999, DOI 10.1002/adfm.201502018
   Li Z, 2015, ACTA BIOMATER, V13, P88, DOI 10.1016/j.actbio.2014.11.002
   Lin H, 2014, TISSUE ENG PT A, V20, P2402, DOI [10.1089/ten.tea.2013.0642, 10.1089/ten.TEA.2013.0642]
   Lin RZ, 2013, BIOMATERIALS, V34, P6785, DOI 10.1016/j.biomaterials.2013.05.060
   Liu MY, 2014, J PHYS CHEM A, V118, P8701, DOI 10.1021/jp506099n
   Malda J, 2013, ADV MATER, V25, P5011, DOI 10.1002/adma.201302042
   Mazaki T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04457
   Melchels FPW, 2014, J MATER CHEM B, V2, P2282, DOI 10.1039/c3tb21280g
   Mironi-Harpaz I, 2012, ACTA BIOMATER, V8, P1838, DOI 10.1016/j.actbio.2011.12.034
   Munoz Z, 2014, BIOMATER SCI-UK, V2, P1063, DOI 10.1039/c4bm00070f
   Nguyen AH, 2015, ACTA BIOMATER, V13, P101, DOI 10.1016/j.actbio.2014.11.028
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   Nichol JW, 2010, BIOMATERIALS, V31, P5536, DOI 10.1016/j.biomaterials.2010.03.064
   Novosel EC, 2011, ADV DRUG DELIVER REV, V63, P300, DOI 10.1016/j.addr.2011.03.004
   Occhetta P., 2014, J BIOMED MATER RES A, V103, P2109
   Ovsianikov A, 2014, LANGMUIR, V30, P3787, DOI 10.1021/la402346z
   Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236
   Park KM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5075
   Reddy N, 2015, TRENDS BIOTECHNOL, V33, P362, DOI 10.1016/j.tibtech.2015.03.008
   Santoro M, 2014, J CONTROL RELEASE, V190, P210, DOI 10.1016/j.jconrel.2014.04.014
   Schuurman W, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/2/021001
   Schuurman W, 2013, MACROMOL BIOSCI, V13, P551, DOI 10.1002/mabi.201200471
   Shi XT, 2015, ADV FUNCT MATER, V25, P2250, DOI 10.1002/adfm.201404531
   Shin SR, 2011, ACS NANO, V6, P362
   Shin SR, 2013, ADV MATER, V25, P6385, DOI 10.1002/adma.201301082
   Shin SR, 2013, ACS NANO, V7, P2369, DOI 10.1021/nn305559j
   Sirova M, 2014, J BIOMED MATER RES A, V102, P1982, DOI 10.1002/jbm.a.34873
   Sisson K, 2009, BIOMACROMOLECULES, V10, P1675, DOI 10.1021/bm900036s
   Soman P, 2013, BIOTECHNOL BIOENG, V110, P3038, DOI 10.1002/bit.24957
   SPEER DP, 1980, J BIOMED MATER RES, V14, P753, DOI 10.1002/jbm.820140607
   Van den Bulcke AI, 2000, BIOMACROMOLECULES, V1, P31, DOI 10.1021/bm990017d
   Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546
   Visser J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7933
   Visser J, 2015, BIOMATERIALS, V37, P174, DOI 10.1016/j.biomaterials.2014.10.020
   Visser J, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/3/035007
   Wang CM, 2011, J BIOMED MATER RES B, V97B, P58, DOI 10.1002/jbm.b.31786
   Wang H, 2014, J MATER SCI-MATER M, V25, P2173, DOI 10.1007/s10856-014-5261-x
   Wang LS, 2012, ACTA BIOMATER, V8, P1826, DOI 10.1016/j.actbio.2012.02.002
   Williams CG, 2005, BIOMATERIALS, V26, P1211, DOI 10.1016/j.biomaterials.2004.04.024
   Xiao WQ, 2011, ACTA BIOMATER, V7, P2384, DOI 10.1016/j.actbio.2011.01.016
   Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023
   Yue K, 2015, BIOMATERIALS, V73, P254, DOI 10.1016/j.biomaterials.2015.08.045
   Zhou L, 2014, RSC ADV, V4, P21997, DOI 10.1039/c4ra02271h
   Zuo YC, 2015, ACS APPL MATER INTER, V7, P10386, DOI 10.1021/acsami.5b01433
   Zuo YC, 2012, CHEM COMMUN, V48, P3170, DOI 10.1039/c2cc16744a
NR 93
TC 72
Z9 72
U1 41
U2 154
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0167-7799
J9 TRENDS BIOTECHNOL
JI Trends Biotechnol.
PD MAY
PY 2016
VL 34
IS 5
BP 394
EP 407
DI 10.1016/j.tibtech.2016.01.002
PG 14
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA DL7HD
UT WOS:000375810800008
PM 26867787
OA Green Accepted
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Skwarek, E
   Janusz, W
   Gun'ko, VM
   Pakhlov, EM
   Zarko, VI
   Gdula, K
AF Skwarek, E.
   Janusz, W.
   Gun'ko, V. M.
   Pakhlov, E. M.
   Zarko, V. I.
   Gdula, K.
TI Characteristics of surface and electrochemical properties of composites
   with fumed metal oxides and hydroxyapatite
SO ADSORPTION-JOURNAL OF THE INTERNATIONAL ADSORPTION SOCIETY
LA English
DT Article; Proceedings Paper
CT 9th International Symposium on Surface Heterogeneity Effects in
   Adsorption and Catalysis on Solids (ISSHAC)
CY JUL 17-23, 2015
CL Wroclaw, POLAND
DE Surface; Hydroxyapatite; Fumed oxides; Composites; pH(p0zc) i pH(IEP)
ID ZERO CHARGE; PHOTOCATALYST; ALUMINA; POINT; IONS
AB Hydroxyapatite composite is a very important biomaterial, which can be applied in various life areas. Hydroxyapatite and its composites with fumed oxides ST20, AST1, Al2O3, A90, and A300 were prepared and studied using X-ray diffraction, Fourier transform infrared spectroscopy (FTIR), scanning electron microscopy adsorption, potentiometric titration, quasi-elastic light scattering and zeta potential measurements. The values of pH(pzc) (the point of zero charge) and pH(IEP) (the isoelectric point) characteristic of the electrical double layer depend on the type of the fumed oxide matrix. Comparative studies of hydroxyapatite, fumed oxides and composites by adsorption and desorption of nitrogen, scanning electron microscopy and FTIR showed that in most cases composites have properties intermediate between hydroxyapatite and the oxides taken for the synthesis.
C1 [Skwarek, E.; Janusz, W.; Gdula, K.] Marie Curie Sklodowska Univ, Fac Chem, Maria Curie Sklodowska Sq 5, PL-20031 Lublin, Poland.
   [Gun'ko, V. M.; Pakhlov, E. M.; Zarko, V. I.] Chuiko Inst Surface Chem, Kiev 17 Naumov Str, UA-03164 Kiev, Ukraine.
RP Skwarek, E (reprint author), Marie Curie Sklodowska Univ, Fac Chem, Maria Curie Sklodowska Sq 5, PL-20031 Lublin, Poland.
EM ewunias@hektor.umcs.lublin.pl
OI Gun'ko, Vladimir/0000-0001-6333-3441; Pakhlov,
   Evgeniy/0000-0002-3103-0742
CR BELL LC, 1973, J COLLOID INTERF SCI, V42, P250, DOI 10.1016/0021-9797(73)90288-9
   Champion E, 1996, J MATER SCI-MATER M, V7, P125, DOI 10.1007/BF00058724
   Chen Y, 2006, CARBON, V44, P37, DOI 10.1016/j.carbon.2005.07.011
   Gregg S. J, 1982, ADSORPTION SURFACE A
   Gun'ko VM, 2007, APPL SURF SCI, V253, P3215, DOI 10.1016/j.apsusc.2006.07.013
   Gun'ko VM, 2009, POWDER TECHNOL, V195, P245, DOI 10.1016/j.powtec.2009.06.005
   Gun'ko V. M., 2013, NUCL MAGNETIC RESONA
   Gun'ko VM, 2014, APPL SURF SCI, V307, P444, DOI [10.1016/j.apsusc.2014.04.055, 10.1016/j.apsusc.2014.04.55]
   Hench L. L., 1993, INTRO BIOCERAMICS, P139
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Holst JR, 2010, ADV MATER, V22, P5212, DOI 10.1002/adma.201002440
   Hu AM, 2007, J MOL CATAL A-CHEM, V267, P79, DOI 10.1016/j.molcata.2006.11.038
   Janusz W, 2008, POL J CHEM, V82, P57
   Kim S, 2002, J MATER SCI-MATER M, V13, P307, DOI 10.1023/A:1014019103240
   Kiselev AV, 1975, INFRARED SPECTRA SUR
   Narasaraju TSB, 1996, J MATER SCI, V31, P1, DOI 10.1007/BF00355120
   NISHIKAWA H, 1994, B CHEM SOC JPN, V67, P2454, DOI 10.1246/bcsj.67.2454
   Nonami T, 2004, CATAL TODAY, V96, P113, DOI 10.1016/j.cattod.2004.06.112
   Skwarek E, 2014, J RADIOANAL NUCL CH, V299, P2027, DOI 10.1007/s10967-013-2825-z
   Smiciklas ID, 2000, SEP PURIF TECHNOL, V18, P185, DOI 10.1016/S1383-5866(99)00066-0
   Suzuki S, 1998, J MATER SCI LETT, V17, P381, DOI 10.1023/A:1006526915828
NR 21
TC 2
Z9 2
U1 0
U2 9
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0929-5607
EI 1572-8757
J9 ADSORPTION
JI Adsorpt.-J. Int. Adsorpt. Soc.
PD MAY
PY 2016
VL 22
IS 4-6
BP 725
EP 734
DI 10.1007/s10450-016-9770-4
PG 10
WC Chemistry, Physical; Engineering, Chemical
SC Chemistry; Engineering
GA DJ7EP
UT WOS:000374375000034
OA Other Gold
DA 2018-10-20
ER

PT J
AU Bruzauskaite, I
   Bironaite, D
   Bagdonas, E
   Bernotiene, E
AF Bruzauskaite, Ieva
   Bironaite, Daiva
   Bagdonas, Edvardas
   Bernotiene, Eiva
TI Scaffolds and cells for tissue regeneration: different scaffold pore
   sizes-different cell effects
SO CYTOTECHNOLOGY
LA English
DT Review
DE Scaffold; Pore size; Tissue regeneration; Stem cells
ID MESENCHYMAL STEM-CELLS; IN-VITRO; POLY(L-LACTIC ACID); NANOFIBROUS
   SCAFFOLDS; POLYMERIC SCAFFOLDS; MATRIX DEPOSITION; HUMAN FIBROBLASTS;
   POROUS MEMBRANES; BONE-FORMATION; GROWTH
AB During the last decade biomaterial sciences and tissue engineering have become new scientific fields supplying rising demand of regenerative therapy. Tissue engineering requires consolidation of a broad knowledge of cell biology and modern biotechnology investigating biocompatibility of materials and their application for the reconstruction of damaged organs and tissues. Stem cell-based tissue regeneration started from the direct cell transplantation into damaged tissues or blood vessels. However, it is difficult to track transplanted cells and keep them in one particular place of diseased organ. Recently, new technologies such as cultivation of stem cell on the scaffolds and subsequently their implantation into injured tissue have been extensively developed. Successful tissue regeneration requires scaffolds with particular mechanical stability or biodegradability, appropriate size, surface roughness and porosity to provide a suitable microenvironment for the sufficient cell-cell interaction, cell migration, proliferation and differentiation. Further functioning of implanted cells highly depends on the scaffold pore sizes that play an essential role in nutrient and oxygen diffusion and waste removal. In addition, pore sizes strongly influence cell adhesion, cell-cell interaction and cell transmigration across the membrane depending on the various purposes of tissue regeneration. Therefore, this review will highlight contemporary tendencies in application of non-degradable scaffolds and stem cells in regenerative medicine with a particular focus on the pore sizes significantly affecting final recover of diseased organs.
C1 [Bruzauskaite, Ieva; Bagdonas, Edvardas; Bernotiene, Eiva] State Res Inst, Ctr Innovat Med, Dept Regenerat Med, Zygimantu 9, LT-01102 Vilnius, Lithuania.
   [Bironaite, Daiva] State Res Inst, Ctr Innovat Med, Dept Stem Cell Biol, Zygimantu 9, LT-01102 Vilnius, Lithuania.
RP Bironaite, D (reprint author), State Res Inst, Ctr Innovat Med, Dept Stem Cell Biol, Zygimantu 9, LT-01102 Vilnius, Lithuania.
EM daibironai@gmail.com
FU EU project "Biocardiostim" [VP1-3.1-SMM-10-V-02-029]
FX This work was supported by EU project "Biocardiostim" (No.
   VP1-3.1-SMM-10-V-02-029).
CR Aarvold A, 2013, J BIOMED MATER RES A, V101, P3431, DOI 10.1002/jbm.a.34646
   Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A
   Akay G, 2004, BIOMATERIALS, V25, P3991, DOI 10.1016/j.biomaterials.2003.10.086
   Akino K, 2008, INT J DERMATOL, V47, P1112, DOI 10.1111/j.1365-4632.2008.03380.x
   Akram KM, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-9
   ASHMAN A, 1977, J PROSTHET DENT, V37, P657, DOI 10.1016/0022-3913(77)90216-5
   Atala A, 2012, J PEDIATR SURG, V47, P17, DOI 10.1016/j.jpedsurg.2011.10.013
   BECKER AJ, 1963, NATURE, V197, P452, DOI 10.1038/197452a0
   Blakeney BA, 2011, BIOMATERIALS, V32, P1583, DOI 10.1016/j.biomaterials.2010.10.056
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Boyd AS, 2012, STEM CELLS, V30, P797, DOI 10.1002/stem.1066
   Bozkurt A, 2009, BIOMATERIALS, V30, P169, DOI 10.1016/j.biomaterials.2008.09.017
   BRAUNWALD E, 1991, AM J CARDIOL, V68, pD1
   Chang HI, 2011, REGENERATIVE MEDICINE AND TISSUE ENGINEERING - CELLS AND BIOMATERIALS, P569
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274
   de Sousa EB, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt501
   Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x
   Fitton JH, 1998, J BIOMED MATER RES, V42, P245
   Fukano Y, 2010, J BIOMED MATER RES A, V94A, P1172, DOI 10.1002/jbm.a.32798
   Goldner JS, 2006, BIOMATERIALS, V27, P460, DOI 10.1016/j.biomaterials.2005.06.035
   GRINNELL F, 1982, METHOD ENZYMOL, V82, P499
   Haniffa MA, 2007, J IMMUNOL, V179, P1595, DOI 10.4049/jimmunol.179.3.1595
   Harley BAC, 2008, BIOPHYS J, V95, P4013, DOI 10.1529/biophysj.107.122598
   Hatano K, 1999, BONE, V25, P439, DOI 10.1016/S8756-3282(99)00192-1
   Hausner T, 2007, ACTA NEUROCHIR SUPPL, V100, P69
   Hong JK, 2015, INT J NANOMED, V10, DOI 10.2147/IJN.S73096
   Huang GTJ, 2009, J DENT RES, V88, P792, DOI 10.1177/0022034509340867
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   Isenberg BC, 2006, CIRC RES, V98, P25, DOI 10.1161/01.RES.0000196867.12470.84
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Jurga M, 2011, BIOMATERIALS, V32, P3423, DOI 10.1016/j.biomaterials.2011.01.049
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kawaguchi N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014297
   Kim MY, 2014, J MEMBRANE SCI, V452, P460, DOI 10.1016/j.memsci.2013.11.034
   Kim S, 2007, STEM CELLS, V25, P2601, DOI 10.1634/stemcells.2006-0814
   Koo Min-Ah, 2014, Biomater Res, V18, P7, DOI 10.1186/2055-7124-18-7
   Kumbar SG, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034002
   Lee IC, 2009, J BIOMED MATER RES A, V91A, P929, DOI 10.1002/jbm.a.32309
   Lee M, 2008, J BIOMED MATER RES A, V87A, P1010, DOI 10.1002/jbm.a.31816
   Lee SJ, 2004, BIOMATERIALS, V25, P4699, DOI 10.1016/j.biomaterials.2003.11.034
   Li Dong-jie, 2011, Zhonghua Yi Xue Za Zhi, V91, P699
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Li WJ, 2003, J BIOMED MATER RES A, V67A, P1105, DOI 10.1002/jbm.a.10101
   Liang D, 2007, ADV DRUG DELIVER REV, V59, P1392, DOI 10.1016/j.addr.2007.04.021
   Lim SH, 2009, ADV DRUG DELIVER REV, V61, P1084, DOI 10.1016/j.addr.2009.07.011
   Liu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111566
   Liu WH, 2000, IN VITRO CELL DEV-AN, V36, P476
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   Liu XH, 2005, J BIOMED NANOTECHNOL, V1, P54, DOI 10.1166/jbn.2005.013
   Lu QJ, 2004, BIOMATERIALS, V25, P5227, DOI 10.1016/j.biomaterials.2003.12.019
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   Mahoney MJ, 2005, BIOMATERIALS, V26, P771, DOI 10.1016/j.biomaterials.2004.03.015
   Marshall A. J., 2004, ACS POLYM PREPR, V45, P100
   Matsiko A, 2015, TISSUE ENG PT A, V21, P486, DOI [10.1089/ten.tea.2013.0545, 10.1089/ten.TEA.2013.0545]
   McHugh KJ, 2013, J MATER SCI-MATER M, V24, P1659, DOI 10.1007/s10856-013-4934-1
   Muller-Ehmsen J, 2002, J MOL CELL CARDIOL, V34, P107, DOI 10.1006/jmcc.2001.1491
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Nain AS, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2372694
   Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   O'Brien Fergal J, 2007, Technol Health Care, V15, P3
   O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X
   Owen SC, 2010, J BIOMED MATER RES A, V94A, P1321, DOI 10.1002/jbm.a.32834
   Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0
   Pankov R, 2000, J CELL BIOL, V148, P1075, DOI 10.1083/jcb.148.5.1075
   Paramonov SE, 2006, J AM CHEM SOC, V128, P7291, DOI 10.1021/ja060573x
   Pawar K, 2011, ACTA BIOMATER, V7, P2826, DOI 10.1016/j.actbio.2011.04.006
   Peter SJ, 1998, J BIOMED MATER RES, V43, P422, DOI 10.1002/(SICI)1097-4636(199824)43:4<422::AID-JBM9>3.3.CO;2-T
   Peyton SR, 2011, BIOTECHNOL BIOENG, V108, P1181, DOI 10.1002/bit.23027
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558
   Rosen MR, 2004, CARDIOVASC RES, V64, P12, DOI 10.1016/j.cardiores.2004.05.012
   Roufosse CA, 2004, INT J BIOCHEM CELL B, V36, P585, DOI 10.1016/j.biocel.2003.10.007
   SAUNDERS KB, 1992, IN VITRO CELL DEV-AN, V28A, P521
   Seale P, 2000, DEV BIOL, V218, P115, DOI 10.1006/dbio.1999.9565
   Sha'ban Munirah, 2008, J Orthop Surg Res, V3, P17, DOI 10.1186/1749-799X-3-17
   Smith IO, 2009, WIRES NANOMED NANOBI, V1, P226, DOI 10.1002/wnan.026
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Tao SL, 2007, NANO LETT, V7, P1463, DOI 10.1021/nl0700346
   Tienen TG, 2006, AM J SPORT MED, V34, P64, DOI 10.1177/0363546505280905
   TUCKER SP, 1992, EUR J CELL BIOL, V58, P280
   Vagaska B, 2010, PHYSIOL RES, V59, P309
   VERFAILLIE CM, 1992, BLOOD, V79, P2821
   Wang HJ, 2005, J BIOMED MATER RES A, V74A, P523, DOI 10.1002/jbm.a.30232
   Wang YW, 2007, BIOMATERIALS, V28, P4619, DOI 10.1016/j.biomaterials.2007.07.006
   Wang YW, 2009, EUR J PHARM SCI, V37, P387, DOI 10.1016/j.ejps.2009.03.010
   Wang YY, 2014, BIOMATERIALS, V35, P8960, DOI 10.1016/j.biomaterials.2014.07.011
   Wenceslau CV, 2013, PLURIPOTENT STEM CEL, P39, DOI [10.5772/54372, DOI 10.5772/54372]
   Wolf K, 2013, J CELL BIOL, V201, P1069, DOI 10.1083/jcb.201210152
   Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098
   Woo KM, 2007, BIOMATERIALS, V28, P335, DOI 10.1016/j.biomaterials.2006.06.013
   Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007
   Xi JY, 2010, FASEB J, V24, P2739, DOI 10.1096/fj.09-145177
   Yan XL, 2012, BREAST CANCER RES TR, V132, P153, DOI 10.1007/s10549-011-1577-0
   Yang F, 2004, J BIOMAT SCI-POLYM E, V15, P1483, DOI 10.1163/1568562042459733
   Yang J, 2002, J BIOMED MATER RES, V62, P438, DOI 10.1002/jbm.10318
   Yang YL, 2010, BIOMATERIALS, V31, P5678, DOI 10.1016/j.biomaterials.2010.03.039
   YANNAS I V, 1992, Clinical Materials, V9, P179, DOI 10.1016/0267-6605(92)90098-E
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526
   Yuan N, 2014, NEURAL REGEN RES, V9, P1014, DOI 10.4103/1673-5374.133160
   Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183
   Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367
   Zhang YF, 2010, ACTA BIOMATER, V6, P3021, DOI 10.1016/j.actbio.2010.02.030
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 105
TC 23
Z9 23
U1 3
U2 81
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0920-9069
EI 1573-0778
J9 CYTOTECHNOLOGY
JI Cytotechnology
PD MAY
PY 2016
VL 68
IS 3
BP 355
EP 369
DI 10.1007/s10616-015-9895-4
PG 15
WC Biotechnology & Applied Microbiology; Cell Biology
SC Biotechnology & Applied Microbiology; Cell Biology
GA DK5QC
UT WOS:000374973700001
PM 26091616
OA Green Published
DA 2018-10-20
ER

PT J
AU Gong, Y
   Han, GT
   Zhang, YM
   Zhang, JF
   Jiang, W
   Tao, XW
   Gao, SC
AF Gong, Ying
   Han, Guang Ting
   Zhang, Yuan Ming
   Zhang, Jin Feng
   Jiang, Wei
   Tao, Xiao Wei
   Gao, Sheng Chuan
TI Preparation of alginate membrane for tissue engineering
SO JOURNAL OF POLYMER ENGINEERING
LA English
DT Article
DE alginate; freeze drying; membrane; tissue engineering
ID BIOMATERIAL SCAFFOLDS; TECHNOLOGY; CHITOSAN; FILMS
AB Sodium alginate was provided with good processibility according to physical and chemical characterization of itself. Alginate scaffold has been used for preparation of soft or hard tissue engineering, but the structure of the scaffold needs to be improved for better performance for skin tissue engineering. In this study, highly porous alginate membrane was formed with ionic crosslinking. High molecular weight (M-w = 3.0 x 10(5)) alginate showed the best film-forming property. Therefore, the appropriate molecular weight should be selected for improving its performance. With freeze-drying technology and pre-freezing at -10 degrees C, we have built the honeycomb materials (porosity = 92.06%). Changing the pre-freezing temperature can regulate pore structure to some extent. With the increased dosage of sodium alginate, the porosity and the pore size of the materials were reduced, whereas tensile strength and elongation at break increased. Water absorption performance of the materials was good. The above studies lay a foundation for construction of skin tissue engineering scaffold.
C1 [Gong, Ying; Han, Guang Ting; Zhang, Yuan Ming; Tao, Xiao Wei; Gao, Sheng Chuan] Qingdao Univ, Lab New Fiber Mat & Modern Text, Growing Base State Key Lab, Qingdao 266071, Peoples R China.
   [Gong, Ying] Qingdao Univ, Coll Med, Inst Translat Med, Qingdao 266071, Peoples R China.
   [Zhang, Jin Feng] Qingdao Univ, Songshan Hosp, Dept Surg, Qingdao 266071, Peoples R China.
   [Jiang, Wei] Qingdao Univ, Coll Text, Qingdao 266071, Peoples R China.
RP Han, GT (reprint author), Qingdao Univ, Lab New Fiber Mat & Modern Text, Growing Base State Key Lab, Qingdao 266071, Peoples R China.
EM kychgt@qdu.edu.cn
FU National Natural Science Foundation of China [51373083]; Natural Science
   Foundation of Shandong Province, China [ZR2012EMZ002]
FX The work was funded by a grant from the National Natural Science
   Foundation of China (51373083) and the Natural Science Foundation of
   Shandong Province, China (ZR2012EMZ002).
CR ALSHAMKHANI A, 1995, J BIOACT COMPAT POL, V10, P4, DOI 10.1177/088391159501000102
   [Anonymous], 1995, PLAST DET TENS PRO 3
   BERSTED BH, 1990, J APPL POLYM SCI, V39, P499, DOI 10.1002/app.1990.070390302
   Butler MF, 2002, CRYST GROWTH DES, V2, P541, DOI 10.1021/cg02559le
   Chhatbar MU, 2012, SOFT MATTER, V8, P1837, DOI 10.1039/c2sm06947d
   Gaserod O, 1998, BIOMATERIALS, V19, P1815, DOI 10.1016/S0142-9612(98)00073-8
   Goh CH, 2012, CARBOHYD POLYM, V88, P1, DOI 10.1016/j.carbpol.2011.11.012
   Kang HW, 1999, BIOMATERIALS, V20, P1339, DOI 10.1016/S0142-9612(99)00036-8
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Khan F, 2013, MACROMOL BIOSCI, V13, P395, DOI 10.1002/mabi.201200409
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   KLAWITTER JJ, 1971, J BIOMED MATER RES S, V2, P161, DOI DOI 10.1002/JBM.820050613
   Ma GP, 2014, NEW J CHEM, V38, P1211, DOI 10.1039/c3nj00701d
   Pereira RF, 2013, CARBOHYD POLYM, V98, P311, DOI 10.1016/j.carbpol.2013.05.076
   Ribeiro CC, 2004, BIOMATERIALS, V25, P4363, DOI 10.1016/j.biomaterials.2003.11.028
   Speakman J. B., 1944, J SOC DYERS COLOUR, V60, P264
   Tong QY, 2013, INT J FOOD SCI TECH, V48, P870, DOI 10.1111/ijfs.12039
   Wang CC, 2011, BIOMATERIALS, V32, P7118, DOI 10.1016/j.biomaterials.2011.06.018
   Weng SY, 2013, J THERM ANAL CALORIM, V113, P1603, DOI 10.1007/s10973-013-3092-5
NR 19
TC 4
Z9 4
U1 3
U2 20
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0334-6447
EI 2191-0340
J9 J POLYM ENG
JI J. Polym. Eng.
PD MAY
PY 2016
VL 36
IS 4
BP 363
EP 370
DI 10.1515/polyeng-2015-0065
PG 8
WC Polymer Science
SC Polymer Science
GA DK8WX
UT WOS:000375210600002
OA Bronze
DA 2018-10-20
ER

PT J
AU Sealy, C
AF Sealy, Cordelia
TI Seaweed makes super-tough biomaterial
SO MATERIALS TODAY
LA English
DT News Item
CR Daemi H, 2016, BIOMATERIALS, V84, P54, DOI 10.1016/j.biomaterials.2016.01.025
NR 1
TC 1
Z9 1
U1 1
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1369-7021
EI 1873-4103
J9 MATER TODAY
JI Mater. Today
PD MAY
PY 2016
VL 19
IS 4
BP 187
EP 187
PG 1
WC Materials Science, Multidisciplinary
SC Materials Science
GA DK8PF
UT WOS:000375188500008
OA Other Gold
DA 2018-10-20
ER

PT J
AU Glass, KA
   Rowland, CR
   Ettyreddy, AR
   Brunger, JM
   Huynh, NPT
   Gersbach, CA
   Guilak, F
AF Glass, Katherine A.
   Rowland, Christopher R.
   Ettyreddy, Adarsh R.
   Brunger, Jonathan M.
   Huynh, Nguyen P. T.
   Gersbach, Charles A.
   Guilak, Farshid
TI Biomaterial-Mediated Lentiviral Delivery of Anti-Inflammatory Genes in
   Cartilage-Derived Matrix Hemispheres
SO MOLECULAR THERAPY
LA English
DT Meeting Abstract
CT 19th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy
   (ASGCT)
CY MAY 04-07, 2016
CL Washington, DC
SP Amer Soc Gene & Cell Therapy
C1 [Glass, Katherine A.; Ettyreddy, Adarsh R.; Brunger, Jonathan M.; Huynh, Nguyen P. T.; Gersbach, Charles A.; Guilak, Farshid] Duke Univ, Biomed Engn, Durham, NC USA.
   [Rowland, Christopher R.; Guilak, Farshid] Washington Univ, Shriners Hosp, Orthopaed Res, St Louis, MO USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1525-0016
EI 1525-0024
J9 MOL THER
JI Mol. Ther.
PD MAY
PY 2016
VL 24
SU 1
MA 502
BP S199
EP S200
DI 10.1016/S1525-0016(16)33311-1
PG 2
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine,
   Research & Experimental
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Research &
   Experimental Medicine
GA DK9PT
UT WOS:000375264200496
OA Other Gold
DA 2018-10-20
ER

PT J
AU Koolen, PGL
   Haas, D
   Kim, K
   Fox, S
   Ibrahim, AMS
   Kim, P
   Kaplan, DL
   Lin, SJ
AF Koolen, Pieter G. L.
   Haas, Dylan
   Kim, Kuylhee
   Fox, Sharon
   Ibrahim, Ahmed M. S.
   Kim, Peter
   Kaplan, David L.
   Lin, Samuel J.
TI Increased Osteoid Formation in BMP-2-Loaded Silk-Based Screws
SO PLASTIC AND RECONSTRUCTIVE SURGERY
LA English
DT Article
ID BONE MORPHOGENETIC PROTEIN-2; INTERNAL-FIXATION; BIOMATERIAL SCAFFOLDS;
   BIOABSORBABLE PLATES; MANDIBULAR FRACTURES; ABSORBABLE PLATES;
   RESORBABLE PLATES; BOMBYX-MORI; IN-VITRO; FIBROIN
AB Background: Resorbable osteosynthesis systems are used to treat craniofacial fractures. However, conventional synthetic polyester materials are potentially associated with inflammatory reaction and negative host response and may result in incomplete bone remodeling. The authors have developed a resorbable silk fibroin-based osteosynthesis system and propose that silk screws loaded with bone morphogenetic protein-2 (BMP-2) may exhibit biocompatibility and promote bone remodeling.
   Methods: Resorbable silk screws were prepared and loaded with BMP-2. The BMP-2-loaded and nonloaded silk screws were inserted into the distal femora in 15 Sprague-Dawley rats by self-tapping, similar to conventional metal systems. Animals were euthanized after 1, 3, and 6 months. The femora were explanted at the designated time points, dissected for histologic evaluation, and compared regarding osteoid formation and inflammatory response.
   Results: Increasing organization of newly formed bone tissue was observed over time in both groups. No appreciable difference in inflammation was noted between the BMP-2-loaded and nonloaded silk screws. Notably, mineralized collagen around the periphery of the screw appears to be greatest and more organized in the BMP-2-loaded samples. There was greater recruitment of osteoclasts and osteoblasts around the perimeter of the BMP-2-loaded screws at 3 and 6 months.
   Conclusions: The BMP-2-loaded silk-based fixation device in this study exhibited characteristics comparable to the current nonloaded silk screws with regard to integration and biocompatibility. However, functionalization of silk screws with BMP-2 appeared to allow for more organized collagen and osteoid deposition after 3 and 6 months and may increase the potential of successful remodeling.
C1 Harvard Univ, Sch Med, Div Plast Surg, Boston, MA 02115 USA.
   Harvard Univ, Sch Med, Dept Pathol, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.
   Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Lin, SJ (reprint author), 110 Francis St,Suite 5A, Boston, MA 02215 USA.; Kaplan, DL (reprint author), 4 Colby St,Room 251, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu; sjlin@bidmc.harvard.edu
RI Chen, Austin/N-3879-2017
FU National Institutes of Health/National Institute of Arthritis and
   Musculoskeletal and Skin Diseases [1R01AR068048-01]; Plastic Surgery
   Foundation National Endowment Research Grant
FX This study is supported in part by National Institutes of
   Health/National Institute of Arthritis and Musculoskeletal and Skin
   Diseases grant 1R01AR068048-01 and a Plastic Surgery Foundation National
   Endowment Research Grant. The authors thank Chunmei Li for her
   assistance with Figure 1.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   American Society of Plastic Surgeons, 2013 REC PLAST SURG
   Bonewald LF, 2003, CALCIFIED TISSUE INT, V72, P537, DOI 10.1007/s00223-002-1057-y
   BOS RRM, 1991, BIOMATERIALS, V12, P32, DOI 10.1016/0142-9612(91)90128-W
   BOS RRM, 1987, J ORAL MAXIL SURG, V45, P751, DOI 10.1016/0278-2391(87)90194-7
   BOS RRM, 1989, INT J ORAL MAX SURG, V18, P365, DOI 10.1016/S0901-5027(89)80035-9
   Bostman OM, 2005, J BONE JOINT SURG BR, V87B, P1575, DOI 10.1302/0301-620X.87B11.16520
   BOSTMAN OM, 1991, J BONE JOINT SURG AM, V73A, P148
   Bozic KJ, 2001, J HAND SURG-AM, V26A, P755, DOI 10.1053/jhsu.2001.24145
   Cao Y, 2009, INT J MOL SCI, V10, P1514, DOI 10.3390/ijms10041514
   Cordewener FW, 2000, TISSUE ENG, V6, P413, DOI 10.1089/107632700418119
   Dumont C, 2007, J HAND SURG-AM, V32A, P491, DOI 10.1016/j.jhsa.2007.02.005
   Eppley BL, 2005, J ORAL MAXIL SURG, V63, P385, DOI 10.1016/j.joms.2004.11.011
   Fedorowicz Z, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006204.pub2
   Gerlach K L, 2000, Mund Kiefer Gesichtschir, V4 Suppl 1, pS91
   Gilardino MS, 2009, CRANIOMAX TRAUM REC, V2, P49, DOI [10.1055/s-0029-1202591.ISSN1943-3875, 10.1055/s-0029-1202591]
   Goriainov V, 2014, ACTA BIOMATER, V10, P4043, DOI 10.1016/j.actbio.2014.06.004
   IIZUKA T, 1992, INT J ORAL MAX SURG, V21, P65, DOI 10.1016/S0901-5027(05)80533-8
   Imola M J, 2001, Arch Facial Plast Surg, V3, P79, DOI 10.1001/archfaci.3.2.79
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Kakudo N, 2006, WOUND REPAIR REGEN, V14, P336, DOI 10.1111/j.1743-6109.2006.00129.x
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Karageorgiou V, 2006, J BIOMED MATER RES A, V78A, P324, DOI 10.1002/jbm.a.30728
   Kim KH, 2005, J BIOTECHNOL, V120, P327, DOI 10.1016/j.jbiotec.2005.06.033
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kim YK, 2002, PLAST RECONSTR SURG, V110, P25, DOI 10.1097/00006534-200207000-00006
   Kirker-Head C, 2007, BONE, V41, P247, DOI 10.1016/j.bone.2007.04.186
   Kosaka M, 2003, J CRANIO MAXILL SURG, V31, P15, DOI 10.1016/S1010-5182(02)00162-2
   Kumar AV, 1997, J CRANIOFAC SURG, V8, P97, DOI 10.1097/00001665-199703000-00006
   Larsen MW, 2005, AM J SPORT MED, V33, P68, DOI 10.1177/0363546504265927
   Lee JM, 2013, JAMA OTOLARYNGOL, V139, P629, DOI 10.1001/jamaoto.2013.3044
   LEENSLAG JW, 1987, BIOMATERIALS, V8, P311, DOI 10.1016/0142-9612(87)90121-9
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Lionelli GT, 2002, ANN PLAS SURG, V49, P202, DOI 10.1097/00000637-200208000-00015
   Lu Q, 2010, MACROMOL BIOSCI, V10, P359, DOI 10.1002/mabi.200900388
   Lu SZ, 2009, BIOMACROMOLECULES, V10, P1032, DOI 10.1021/bm800956n
   Mohamed-Hashem I K, 2000, J Orthod, V27, P198, DOI 10.1093/ortho/27.2.198
   Neumann A, 2009, Laryngorhinootologie, V88 Suppl 1, pS48, DOI 10.1055/s-0028-1119515
   Numata K, 2010, BIOMATERIALS, V31, P2926, DOI 10.1016/j.biomaterials.2009.12.026
   Park CH, 2011, ARCH OTOLARYNGOL, V137, P125, DOI 10.1001/archoto.2010.241
   Perrone GS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4385
   Pietrzak William S, 2002, J Foot Ankle Surg, V41, P379
   Pritchard EM, 2011, BIOMATERIALS, V32, P909, DOI 10.1016/j.biomaterials.2010.09.055
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Rokkanen PU, 2000, BIOMATERIALS, V21, P2607, DOI 10.1016/S0142-9612(00)00128-9
   Rovati LC, 1997, J CRANIOFAC SURG, V8, P323, DOI 10.1097/00001665-199707000-00016
   ROZEMA FR, 1990, INT J ORAL MAX SURG, V19, P374, DOI 10.1016/S0901-5027(05)80086-4
   Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004
   Schmidt BL, 1998, J ORAL MAXIL SURG, V56, P184, DOI 10.1016/S0278-2391(98)90865-5
   Schubert R, FRACTURE HEALING
   Shen Y, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/1/015015
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Stuck BA, 2011, HNO, V59, P1088, DOI 10.1007/s00106-011-2386-9
   Suuronen R, 2000, J Craniomaxillofac Trauma, V6, P19
   Tripathi Nalini, 2013, Natl J Maxillofac Surg, V4, P181, DOI 10.4103/0975-5950.127648
   van Bakelen NB, 2013, J DENT RES, V92, P1100, DOI 10.1177/0022034513508953
   Varghai D, 2011, J CRANIOFAC SURG, V22, P543, DOI 10.1097/SCS.0b013e318208ba49
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang XQ, 2009, J CONTROL RELEASE, V134, P81, DOI 10.1016/j.jconrel.2008.10.021
   Waris E, 2003, CLIN ORTHOP RELAT R, P310, DOI 10.1097/01.blo.0000063789.32430.c6
   Yang LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067449
   Zhang JE, 2012, P NATL ACAD SCI USA, V109, P11981, DOI 10.1073/pnas.1206210109
   Zhang JW, 2012, J TRAUMA ACUTE CARE, V72, pE106, DOI 10.1097/TA.0b013e3182231811
   Zhou L, 2005, J PHYS CHEM B, V109, P16937, DOI 10.1021/jp050883m
NR 65
TC 0
Z9 0
U1 5
U2 21
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0032-1052
EI 1529-4242
J9 PLAST RECONSTR SURG
JI Plast. Reconstr. Surg.
PD MAY
PY 2016
VL 137
IS 5
BP 808E
EP 817E
DI 10.1097/PRS.0000000000002080
PG 10
WC Surgery
SC Surgery
GA DK8OL
UT WOS:000375186400006
PM 27119943
DA 2018-10-20
ER

PT J
AU Eghtedari, Y
   Richardson, A
   Mai, K
   Heng, B
   Guillemin, GJ
   Wakefield, D
   Di Girolamo, N
AF Eghtedari, Yas
   Richardson, Alexander
   Mai, Kelly
   Heng, Benjamin
   Guillemin, Gilles J.
   Wakefield, Denis
   Di Girolamo, Nick
TI Keratin 14 Expression in Epithelial Progenitor Cells of the Developing
   Human Cornea
SO STEM CELLS AND DEVELOPMENT
LA English
DT Article
ID ALPHA-V-INTEGRINS; STEM-CELLS; OCULAR SURFACE; LIMBAL EPITHELIUM;
   SELF-RENEWAL; TRANSPLANTATION; NICHE; ABSENCE; DIFFERENTIATION;
   PARKINSONS
AB A healthy and transparent cornea is essential for exquisite vision. During adulthood, its epithelium is constantly replenished through the activity of its stem cells (SCs). Precisely when these cells develop and their distribution across the ocular surface remain incompletely characterized in man. We postulated that the human fetal cornea harbors SCs that can be identified with keratin (K) 14 and v-integrin, two markers we and others previously used to identify their adult counterparts. Immunofluorescence, cell culture, quantitative real-time polymerase chain reaction (qRT-PCR), and colony-forming assays were performed on fetal and adult biomaterial to locate progenitors and establish their phenotypic and functional properties. K14 was used to map the spatiotemporal distribution of precursor cell activity across the developing cornea, divulging a dynamic pattern of vertical and horizontal consolidated expression with increasing gestational age. K14 was coexpressed with v-integrin in fetal and adult corneas and cultured corneolimbal epithelium, and colony-forming efficiency (an indicator of SC activity) was similar in cells from both sources. Finally, fetal cells were adherent, grew well, and maintained a K14 phenotype on contact lenses, a substrate we previously used to deliver cells to patients with blinding corneal disease. This study provides valuable insights into the development of the cornea, including the formation of the SC repository, the distribution of these cells across the ocular surface, and a preliminary attempt at harnessing, phenotyping, and functionally characterizing these cells. Future studies will focus on isolating fetal SCs to determine their utility as an alternative cell therapy for patients suffering from corneal blindness.
C1 [Eghtedari, Yas; Richardson, Alexander; Mai, Kelly; Wakefield, Denis; Di Girolamo, Nick] Univ New S Wales, Sch Med Sci, Ocular Dis Res Grp, Sydney, NSW 2052, Australia.
   [Heng, Benjamin; Guillemin, Gilles J.] Macquarie Univ, Neuroinflammat Grp, Fac Med & Hlth Sci, Sydney, NSW 2109, Australia.
RP Di Girolamo, N (reprint author), Univ New S Wales, Sch Med Sci, Sydney, NSW 2052, Australia.
EM n.digirolamo@unsw.edu.au
OI Guillemin, Gilles/0000-0001-8105-4470; Heng, Ruiwen
   Benjamin/0000-0002-0247-2920
FU University of New South Wales
FX Grant sponsorship: University of New South Wales. The authors thank Mr.
   Raj Devasahayam at the Lions NSW Eye Bank for providing the donor human
   adult corneas.
CR Abbott A, 2014, NATURE, V510, P195, DOI 10.1038/510195a
   Banting FG, 1922, CAN MED ASSOC J, V7, P141
   Barnard Z, 2001, CLIN EXP OPHTHALMOL, V29, P138, DOI 10.1046/j.1442-9071.2001.00394.x
   Baylis O, 2011, J CELL BIOCHEM, V112, P993, DOI 10.1002/jcb.23028
   Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012
   Bobba S, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0009-1
   Cattavarayane S, 2015, BMC CELL BIOL, V16, DOI 10.1186/s12860-015-0051-y
   CHUNG EH, 1992, INVEST OPHTH VIS SCI, V33, P2199
   CINTRON C, 1983, INVEST OPHTH VIS SCI, V24, P543
   Collinson JM, 2002, DEV DYNAM, V224, P432, DOI 10.1002/dvdy.10124
   DAVANGER M, 1971, NATURE, V229, P560, DOI 10.1038/229560a0
   Davies SB, 2009, STEM CELLS, V27, P2781, DOI 10.1002/stem.209
   Di Girolamo N, 2015, STEM CELLS, V33, P157, DOI 10.1002/stem.1769
   Girolamo N, 2015, PROG RETIN EYE RES, V48, P203, DOI 10.1016/j.preteyeres.2015.04.002
   Di Girolamo N, 2009, TRANSPLANTATION, V87, P1571, DOI 10.1097/TP.0b013e3181a4bbf2
   Dua HS, 2005, BRIT J OPHTHALMOL, V89, P529, DOI 10.1136/bjo.2004.049742
   Duke-Elder S, 1963, SYSTEM OPHTHALMOLO 1, P137
   EBATO B, 1988, INVEST OPHTH VIS SCI, V29, P1533
   Echevarria TJ, 2011, INVEST OPHTH VIS SCI, V52, P8138, DOI 10.1167/iovs.11-8140
   Graw J, 2010, CURR TOP DEV BIOL, V90, P343, DOI 10.1016/S0070-2153(10)90010-0
   Hay ED, 1980, DEV VERTEBRATE CORNE
   Hayashi R, 2008, BIOCHEM BIOPH RES CO, V367, P256, DOI 10.1016/j.bbrc.2007.12.077
   HUANG AJW, 1991, INVEST OPHTH VIS SCI, V32, P96
   Hunt JS, 2005, FASEB J, V19, P681, DOI 10.1096/fj.04-2078rev
   KURPAKUS MA, 1994, CURR EYE RES, V13, P805, DOI 10.3109/02713689409025135
   Li W, 2007, CELL RES, V17, P26, DOI 10.1038/sj.cr.7310137
   LLOYD C, 1995, J CELL BIOL, V129, P1329, DOI 10.1083/jcb.129.5.1329
   Mai K, 2014, J INFLAMM-LOND, V11, DOI 10.1186/1476-9255-11-20
   Mann I, 1964, DEV HUMAN EYE
   McCarty JH, 2008, AM J PATHOL, V172, P1740, DOI 10.2353/ajpath.2008.070700
   Molvaer RK, 2013, ACTA OPHTHALMOL, V91, P457, DOI 10.1111/j.1755-3768.2012.02446.x
   Moore KL, 2010, CLIN ORIENTED ANATOM, P889
   Nandrot EE, 2004, J EXP MED, V200, P1539, DOI 10.1084/jem.20041447
   Nieto-Miguel T, 2011, MOL VIS, V17, P2102
   Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720
   Ordonez P, 2013, STEM CELL RES, V11, P888, DOI 10.1016/j.scr.2013.05.013
   Pajoohesh-Ganji A, 2004, DEV DYNAM, V230, P518, DOI 10.1002/dvdy.20050
   Pajoohesh-Ganji A, 2016, DEV DYNAM, V245, P132, DOI [10.1002/DVDY.24365, 10.1002/dvdy.24365]
   Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955
   RODRIGUES M, 1987, DIFFERENTIATION, V34, P60, DOI 10.1111/j.1432-0436.1987.tb00051.x
   Sangwan VS, 2011, BRIT J OPHTHALMOL, V95, P1525, DOI 10.1136/bjophthalmol-2011-300352
   SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49
   Sehic A, 2015, J FUNCT BIOMATER, V6, P863, DOI 10.3390/jfb6030863
   Sevel D, 1988, Trans Am Ophthalmol Soc, V86, P178
   Shortt AJ, 2007, STEM CELLS, V25, P1402, DOI 10.1634/stemcells.2006-0580
   Shortt AJ, 2011, BRIT MED BULL, V100, P209, DOI 10.1093/bmb/ldr041
   Singh P, 2009, J INVEST DERMATOL, V129, P217, DOI 10.1038/jid.2008.201
   Tadeu AMB, 2013, DEVELOPMENT, V140, P3777, DOI 10.1242/dev.093948
   Thomas PB, 2007, MOL VIS, V13, P337
   Townsend W M, 1991, Trans Am Ophthalmol Soc, V89, P721
   Utheim TP, 2009, BRIT J OPHTHALMOL, V93, P980, DOI 10.1136/bjo.2008.149591
   Utheim Tor Paaske, 2013, Methods Mol Biol, V1014, P3, DOI 10.1007/978-1-62703-432-6_1
   Weis SM, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006478
   Yeung AM, 2009, EXP EYE RES, V88, P1161, DOI 10.1016/j.exer.2008.12.014
   Zhang H, 2005, JPN J OPHTHALMOL, V49, P195, DOI 10.1007/s10384-004-0189-1
   Zhao XPC, 2006, INVEST OPHTH VIS SCI, V47, P4341, DOI 10.1167/iovs.05-1611
   ZIESKE JD, 1993, J CELL SCI, V106, P145
NR 57
TC 4
Z9 5
U1 0
U2 4
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1547-3287
EI 1557-8534
J9 STEM CELLS DEV
JI Stem Cells Dev.
PD MAY 1
PY 2016
VL 25
IS 9
BP 699
EP 711
DI 10.1089/scd.2016.0039
PG 13
WC Cell & Tissue Engineering; Hematology; Medicine, Research &
   Experimental; Transplantation
SC Cell Biology; Hematology; Research & Experimental Medicine;
   Transplantation
GA DK3YT
UT WOS:000374854000004
PM 26956898
DA 2018-10-20
ER

PT J
AU Altman, D
   Hjern, F
   Zetterstrom, J
AF Altman, Daniel
   Hjern, Fredrik
   Zetterstrom, Jan
TI Transanal submucosal polyacrylamide gel injection treatment of anal
   incontinence: a randomized controlled trial
SO ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
LA English
DT Article
DE Anal incontinence; injection; polyacrylamide; randomized trial
ID PASSIVE FECAL INCONTINENCE; INJECTABLE BULKING AGENTS; FEMALE STRESS;
   MULTICENTER; HYDROGEL; EFFICACY; SAFETY
AB Introduction. The efficacious and safe use of transurethral injections of polyacrylamide hydrogel (Bulkamid (R)) in women with stress urinary incontinence suggests that it may be suitable also for treatment of anal incontinence. We aimed to determine the effectiveness and safety of polyacrylamide hydrogel when used as a transanal submucosal bulking agent in women with anal incontinence. Materials and methods. Thirty women with a diagnosis of anal incontinence and a Cleveland Clinic Incontinence Score (CCIS) > 10 were randomized to three different techniques of transanal submucosal injections using polyacrylamide hydrogel. Follow up was performed at 2, 6 and 12 months using CCIS and the Fecal Incontinence Quality of Life scale (FIQL). Results. In all, 29 of the 30 women completed the follow up. Approximately half of the women requested a re-injection at the 6-month visit. The overall CCIS improved significantly from baseline (14.7. SD 2.5) to 1 year (12.4. SD 3.1) (p = 0.003). There was a significant improvement with regard to the occurrence of loose fecal incontinence (p = 0.014) but not for solid fecal incontinence (p = 0.28). At 1 year the FIQL domains of coping-behavior, depression, and embarrassment showed significant improvements (p = 0.012, p = 0.007 and p = 0.007, respectively). We recorded no adverse events related either to the injection technique or the biomaterial. There were no significant differences between the treatment groups in either CCIS or FIQL scores. Conclusion. Transanal submucosal injection of polyacrylamide hydrogel resulted in a modest although significant overall improvement in anal incontinence symptom scores with corresponding improvements in several domains of quality of life, regardless of injection volume.
C1 [Altman, Daniel] Stockholm Urogynecol Clin, Kommendorsgatan 5, S-11448 Stockholm, Sweden.
   [Altman, Daniel; Zetterstrom, Jan] Karolinska Inst, Danderyd Hosp, Dept Clin Sci, S-18288 Danderyd, Sweden.
   [Altman, Daniel] Univ Milano Bicocca, Dept Stat & Quantitat Methods, Milan, Italy.
   [Hjern, Fredrik] Karolinska Inst, Danderyd Hosp, Dept Clin Sci, Div Surg, S-18288 Danderyd, Sweden.
   [Zetterstrom, Jan] Sophiahemmet Hosp, Gynecol Clin, Stockholm, Sweden.
RP Altman, D (reprint author), Stockholm Urogynecol Clin, Kommendorsgatan 5, S-11448 Stockholm, Sweden.
EM daniel.altman@ki.se
FU Swedish Society of Medicine; Stockholm county council; Karolinska
   Institute
FX Grant from the Swedish Society of Medicine and the regional agreement on
   medical training and clinical research (ALF) between Stockholm county
   council and Karolinska Institute.
CR Abramov Y, 2005, OBSTET GYNECOL, V106, P726, DOI 10.1097/01.AOG.0000161367.65261.16
   Brown SR, 2013, COCHRANE DB SYST REV, V7
   Graf W, 2011, LANCET, V377, P997, DOI 10.1016/S0140-6736(10)62297-0
   HAADEM K, 1991, OBSTET GYNECOL, V78, P823
   Koh CE, 2013, TECH COLOPROCTOL, V17, P343, DOI 10.1007/s10151-013-1018-7
   Maeda Y, 2008, COLORECTAL DIS, V10, P268, DOI 10.1111/j.1463-1318.2007.01318.x
   Maeda Y, 2013, COCHRANE DB SYST REV, V28, P2
   MARCIO J, 1993, DIS COLON RECTUM, V36, P77
   Morris OJ, 2013, TECH COLOPROCTOL, V17, P517, DOI 10.1007/s10151-013-1000-4
   Omar M.I., 2013, COCHRANE DATE BASE S, P11, DOI DOI 10.1002/14651858.CD002116.PUB2]
   Pallua N, 2010, PLAST RECONSTR SURG, V125, P1797, DOI 10.1097/PRS.0b013e3181d18158
   Rockwood TH, 2000, DIS COLON RECTUM, V43, P9, DOI 10.1007/BF02237236
   Sokol ER, 2014, J UROLOGY, V192, P843, DOI 10.1016/j.juro.2014.03.109
   Tjandra JJ, 2009, COLORECTAL DIS, V11, P382, DOI 10.1111/j.1463-1318.2008.01634.x
   Toozs-Hobson P, 2012, INT UROGYNECOL J, V23, P1373, DOI 10.1007/s00192-012-1761-8
   *WHO, 1992, INT CLASS DIS HLTH R
NR 16
TC 3
Z9 3
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0001-6349
EI 1600-0412
J9 ACTA OBSTET GYN SCAN
JI Acta Obstet. Gynecol. Scand.
PD MAY
PY 2016
VL 95
IS 5
BP 528
EP 533
DI 10.1111/aogs.12866
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DJ6UT
UT WOS:000374349400007
PM 26866933
DA 2018-10-20
ER

PT J
AU Zhou, HY
   Goss, M
   Hernandez, C
   Mansour, JM
   Exner, A
AF Zhou, Haoyan
   Goss, Monika
   Hernandez, Christopher
   Mansour, Joseph M.
   Exner, Agata
TI Validation of Ultrasound Elastography Imaging for Nondestructive
   Characterization of Stiffer Biomaterials
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Ultrasound elastography; Mechanical; Biomaterial characterization;
   Nondestructive; Noninvasive; Elasticity
ID ELASTIC PROPERTIES; BIOLOGICAL TISSUES; PLAQUE COMPONENTS;
   PROSTATE-CANCER; GOLD STANDARD; STIFFNESS; ADHESION; SOFT; PEPTIDE;
   SYSTEMS
AB Ultrasound elastography (UE) has been widely used as a "digital palpation" tool to characterize tissue mechanical properties in the clinic. UE benefits from the capability of noninvasively generating 2-D elasticity encoded maps. This spatial distribution of elasticity can be especially useful in the in vivo assessment of tissue engineering scaffolds and implantable drug delivery platforms. However, the detection limitations have not been fully characterized and thus its true potential has not been completely discovered. Characterization studies have focused primarily on the range of moduli corresponding to soft tissues, 20-600 kPa. However, polymeric biomaterials used in biomedical applications such as tissue scaffolds, stents, and implantable drug delivery devices can be much stiffer. In order to explore UE's potential to assess mechanical properties of biomaterials in a broader range of applications, this work investigated the detection limit of UE strain imaging beyond soft tissue range. To determine the detection limit, measurements using standard mechanical testing and UE on the same polydimethylsiloxane samples were compared and statistically evaluated. The broadest detection range found based on the current optimized setup is between 47 kPa and 4 MPa which exceeds the modulus of normal soft tissue suggesting the possibility of using this technique for stiffer materials' mechanical characterization. The detectable difference was found to be as low as 157 kPa depending on sample stiffness and experimental setup.
C1 [Zhou, Haoyan; Goss, Monika; Hernandez, Christopher] Case Western Reserve Univ, Dept Biomed Engn, 11100 Euclid Ave, Cleveland, OH 44106 USA.
   [Mansour, Joseph M.] Case Western Reserve Univ, Dept Mech & Aerosp Engn, 11100 Euclid Ave, Cleveland, OH 44106 USA.
   [Exner, Agata] Case Western Reserve Univ, Dept Radiol, 11100 Euclid Ave, Cleveland, OH 44106 USA.
RP Exner, A (reprint author), Case Western Reserve Univ, Dept Radiol, 11100 Euclid Ave, Cleveland, OH 44106 USA.
EM hxz143@case.edu; mag150@case.edu; cxh404@case.edu; Jmm12@case.edu;
   Agata.exner@case.edu
OI Exner, Agata/0000-0003-3913-7066; Hernandez,
   Christopher/0000-0003-0380-7136
FU National Institute of Biomedical Imaging and Bioengineering of the
   National Institutes of Health [R01EB016960, T32-EB007509]
FX This work was supported by the National Institute of Biomedical Imaging
   and Bioengineering of the National Institutes of Health under award
   numbers R01EB016960 and T32-EB007509. Views and opinions of, and
   endorsements by the author(s) do not reflect those of the National
   Institutes of Health. The authors would like to thank Dr. Bo Hu and Dr.
   Chen-yuan Chung for their help with statistical analysis and mechanical
   analysis respectively in this paper.
CR Ali MY, 2014, SOFT MATTER, V10, P8829, DOI 10.1039/c4sm01602e
   Ataollahi F, 2015, J BIOMED MATER RES A, V103, P2203, DOI 10.1002/jbm.a.35186
   de Korte CL, 2000, PHYS MED BIOL, V45, P1465, DOI 10.1088/0031-9155/45/6/305
   de Korte CL, 2000, CIRCULATION, V102, P617, DOI 10.1161/01.CIR.102.6.617
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   Fromageau J, 2007, IEEE T ULTRASON FERR, V54, P498, DOI 10.1109/TUFFC.2007.273
   Fung Y.C., 1993, BIOMECHANICS MECH PR
   Giovannini M, 2006, ENDOSCOPY, V38, P344, DOI 10.1055/s-2006-925158
   Greenleaf JF, 2003, ANNU REV BIOMED ENG, V5, P57, DOI 10.1146/annurev.bioeng.5.040202.121623
   Griffin MA, 2004, J CELL SCI, V117, P5855, DOI 10.1242/jcs.01496
   Han Z, 2015, BIOCONJUGATE CHEM, V26, P830, DOI 10.1021/acs.bioconjchem.5b00178
   HATAKEYAMA T, 1995, THERMOCHIM ACTA, V253, P137, DOI 10.1016/0040-6031(94)02087-5
   Hoyt K, 2008, CANCER BIOMARK, V4, P213, DOI 10.3233/CBM-2008-44-505
   Huang S, 2005, CANCER CELL, V8, P175, DOI 10.1016/j.ccr.2005.08.009
   Kim K, 2008, ACTA BIOMATER, V4, P783, DOI 10.1016/j.actbio.2008.02.010
   Kong HJ, 2005, NAT MATER, V4, P460, DOI 10.1038/nmat1392
   Krouskop TA, 1998, ULTRASONIC IMAGING, V20, P260, DOI 10.1177/016173469802000403
   LERNER RM, 1990, ULTRASOUND MED BIOL, V16, P231, DOI 10.1016/0301-5629(90)90002-T
   Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j
   Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/nmat2344, 10.1038/NMAT2344]
   Ophir J, 1999, P I MECH ENG H, V213, P203, DOI 10.1243/0954411991534933
   OPHIR J, 1991, ULTRASONIC IMAGING, V13, P111, DOI 10.1016/0161-7346(91)90079-W
   Oudry J, 2014, PHYS MED BIOL, V59, P5775, DOI 10.1088/0031-9155/59/19/5775
   Parker KJ, 2011, PHYS MED BIOL, V56, pR1, DOI 10.1088/0031-9155/56/1/R01
   Sarvazyan A, 2011, CURR MED IMAGING REV, V7, P255, DOI 10.2174/157340511798038684
   Sarvestani AS, 2007, BIOPOLYMERS, V85, P370, DOI 10.1002/bip.20659
   Selzer RH, 2001, ATHEROSCLEROSIS, V154, P185, DOI 10.1016/S0021-9150(00)00461-5
   Weber N, 2007, LANGMUIR, V23, P3298, DOI 10.1021/la060500r
   Yeh WC, 2002, ULTRASOUND MED BIOL, V28, P467, DOI 10.1016/S0301-5629(02)00489-1
   Yu J, 2013, BIOMATERIALS, V34, P2701, DOI 10.1016/j.biomaterials.2013.01.036
   Zhi H, 2007, J ULTRAS MED, V26, P807, DOI 10.7863/jum.2007.26.6.807
   Zhou HY, 2015, CURR DRUG TARGETS, V16, P672, DOI 10.2174/1389450115666141122211920
NR 33
TC 1
Z9 1
U1 0
U2 9
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD MAY
PY 2016
VL 44
IS 5
BP 1515
EP 1523
DI 10.1007/s10439-015-1448-7
PG 9
WC Engineering, Biomedical
SC Engineering
GA DK1IO
UT WOS:000374665900014
PM 26369634
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Batoni, G
   Maisetta, G
   Esin, S
AF Batoni, Giovanna
   Maisetta, Giuseppantonio
   Esin, Semih
TI Antimicrobial peptides and their interaction with biofilms of medically
   relevant bacteria
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
LA English
DT Review
DE Biofilm; Antimicrobial peptides; Extracellular DNA; Antibiofilm drugs;
   Biofilm matrix; Biofilm exopolysaccharides; Biofilm proteins
ID POLYSACCHARIDE INTERCELLULAR ADHESIN; BIOMATERIAL-ASSOCIATED INFECTION;
   RESISTANT STAPHYLOCOCCUS-AUREUS; RECOMBINANT HUMAN DNASE;
   PSEUDOMONAS-AERUGINOSA BIOFILMS; QUORUM-SENSING INHIBITORS;
   EXTRACELLULAR DNA; CYSTIC-FIBROSIS; HEPCIDIN 20; IN-VITRO
AB Biofilm-associated infections represent one of the major threats of modern medicine. Biofilm-forming bacteria are encased in a complex mixture of extracellular polymeric substances (EPS) and acquire properties that render them highly tolerant to conventional antibiotics and host immune response. Therefore, there is a pressing demand of new drugs active against microbial biofilms. In this regard, antimicrobial peptides (AMPs) represent an option taken increasingly in consideration. After dissecting the peculiar biofilm features that may greatly affect the development of new antibiofilm drugs, the present article provides a general overview of the rationale behind the use of AMPs against biofilms of medically relevant bacteria and on the possible mechanisms of AMP-antibiofilm activity. An analysis of the interactions of AMPs with biofilm components, especially those constituting the EPS, and the obstacles and/or opportunities that may arise from such interactions in the development of new AMP-based antibiofilm strategies is also presented and discussed. This article is part of a Special Issue entitled: Antimicrobial Peptides edited by Karl Lohner and Kai Hilpert. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Batoni, Giovanna; Maisetta, Giuseppantonio; Esin, Semih] Univ Pisa, Dept Translat Res & New Technol Med & Surg, Pisa, Italy.
RP Batoni, G (reprint author), Univ Pisa, Dept Translat Res & New Technol Med & Surg, Pisa, Italy.
EM giovanna.batoni@med.unipi.it
OI Batoni, Giovanna/0000-0002-4448-2385
FU University of Pisa
FX This work was supported by funds from the University of Pisa. We would
   like to thank Mariagrazia Di Luca for critical reading of the
   manuscript. This article is dedicated to the memory of our "Maestro"
   Professor Mario Campa who passed away in July 2014. We are very grateful
   to him for his teaching and constant support in science and everyday
   life.
CR Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x
   Alves D, 2014, BIOFOULING, V30, P483, DOI 10.1080/08927014.2014.889120
   Anderson J. M., 2013, BIOMATERIALS ASS INF, P119
   Anderson MJ, 2013, J MICROBIOL METH, V92, P201, DOI 10.1016/j.mimet.2012.12.003
   Arciola CR, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00007
   Baelo A, 2015, J CONTROL RELEASE, V209, P150, DOI 10.1016/j.jconrel.2015.04.028
   Barraud N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084220
   Batoni G, 2011, CURR MED CHEM, V18, P256, DOI 10.2174/092986711794088399
   Beloin C, 2014, CURR OPIN PHARMACOL, V18, P61, DOI 10.1016/j.coph.2014.09.005
   Benincasa M, 2009, J PEPT SCI, V15, P595, DOI 10.1002/psc.1142
   Bjarnsholt T, 2013, TRENDS MICROBIOL, V21, P466, DOI 10.1016/j.tim.2013.06.002
   Bjarnsholt T, 2009, PEDIATR PULM, V44, P547, DOI 10.1002/ppul.21011
   Boles BR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000052
   Brackman G, 2015, CURR PHARM DESIGN, V21, P5
   Brancatisano FL, 2011, J DENT RES, V90, P241, DOI 10.1177/0022034510385686
   Brancatisano FL, 2014, BIOFOULING, V30, P435, DOI 10.1080/08927014.2014.888062
   Brandelli A, 2012, MINI-REV MED CHEM, V12, P731, DOI 10.2174/138955712801264774
   BRANDT T, 1995, THORAX, V50, P880, DOI 10.1136/thx.50.8.880
   Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385
   Broekhuizen CAN, 2010, INFECT IMMUN, V78, P954, DOI 10.1128/IAI.00849-09
   Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098
   Brooks JL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004292
   Bucki R, 2008, J ANTIMICROB CHEMOTH, V62, P329, DOI 10.1093/jac/dkn176
   Chan C, 2005, J PEPT RES, V65, P343, DOI 10.1111/j.1399-3011.2005.0217.X
   Chan C, 2004, J BIOL CHEM, V279, P38749, DOI 10.1074/jbc.M406044200
   Chauhan A, 2012, ANTIMICROB AGENTS CH, V56, P6310, DOI 10.1128/AAC.01606-12
   Chen X, 2011, APPL ENVIRON MICROB, V77, P4878, DOI 10.1128/AEM.02440-10
   Chennupati SK, 2009, AMJ RHINOL ALLERGY, V23, P46, DOI 10.2500/ajra.2009.23.3261
   Christensen LD, 2012, J ANTIMICROB CHEMOTH, V67, P1198, DOI 10.1093/jac/dks002
   Ciofu O, 2015, ADV DRUG DELIVER REV, V85, P7, DOI 10.1016/j.addr.2014.11.017
   Cirioni O, 2006, PEPTIDES, V27, P1210, DOI 10.1016/j.peptides.2005.10.007
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Costerton W, 2003, J CLIN INVEST, V112, P1466, DOI 10.1172/JCI20365
   Cramton SE, 1999, INFECT IMMUN, V67, P5427
   Cramton SE, 2001, INFECT IMMUN, V69, P4079, DOI 10.1128/IAI.69.6.4079-4085.2001
   de Breij A, 2009, RES MICROBIOL, V160, P213, DOI 10.1016/j.resmic.2009.01.002
   de la Fuente-Nunez C, 2015, CHEM BIOL, V22, P196, DOI 10.1016/j.chembiol.2015.01.002
   de la Fuente-Nunez C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004152
   de la Fuente-Nunez C, 2012, ANTIMICROB AGENTS CH, V56, P2696, DOI 10.1128/AAC.00064-12
   Del Gaudio G, 2013, ANTIMICROB AGENTS CH, V57, P4314, DOI 10.1128/AAC.00904-13
   Di Luca M, 2015, BIOFOULING, V31, P193, DOI 10.1080/08927014.2015.1021340
   Di Luca M, 2014, PATHOG DIS, V70, P257, DOI 10.1111/2049-632X.12151
   Donelli G, 2007, ANTIMICROB AGENTS CH, V51, P2733, DOI 10.1128/AAC.01249-06
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002
   Doroshenko N, 2014, ANTIMICROB AGENTS CH, V58, P7273, DOI 10.1128/AAC.03132-14
   Dunne WM, 2002, CLIN MICROBIOL REV, V15, P155, DOI 10.1128/CMR.15.2.155-166.2002
   DUNNE WM, 1990, ANTIMICROB AGENTS CH, V34, P390, DOI 10.1128/AAC.34.3.390
   Duperthuy M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003620
   Ehlers S, 1999, FEMS IMMUNOL MED MIC, V23, P149, DOI 10.1111/j.1574-695X.1999.tb01234.x
   Esin S, 2015, J INNATE IMMUN, V7, P11, DOI 10.1159/000363321
   Feng XR, 2013, PEPTIDES, V49, P131, DOI 10.1016/j.peptides.2013.09.007
   Fey PD, 2010, FUTURE MICROBIOL, V5, P917, DOI 10.2217/FMB.10.56
   Finkel SE, 2001, J BACTERIOL, V183, P6288, DOI 10.1128/JB.183.21.6288-6293.2001
   Flemming HC, 2007, J BACTERIOL, V189, P7945, DOI 10.1128/JB.00858-07
   Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415
   Foschiatti M, 2009, MOL MICROBIOL, V72, P1137, DOI 10.1111/j.1365-2958.2009.06707.x
   Francolini I, 2010, FEMS IMMUNOL MED MIC, V59, P227, DOI 10.1111/j.1574-695X.2010.00665.x
   Franklin MJ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00167
   FUCHS HJ, 1994, NEW ENGL J MED, V331, P637, DOI 10.1056/NEJM199409083311003
   Gao GZ, 2011, BIOMATERIALS, V32, P3899, DOI 10.1016/j.biomaterials.2011.02.013
   Gil C, 2014, INFECT IMMUN, V82, P1017, DOI 10.1128/IAI.01419-13
   Gloag ES, 2013, P NATL ACAD SCI USA, V110, P11541, DOI 10.1073/pnas.1218898110
   Gomes F, 2014, BIOFOULING, V30, P131, DOI 10.1080/08927014.2013.848858
   Haisma EM, 2014, ANTIMICROB AGENTS CH, V58, P4411, DOI 10.1128/AAC.02554-14
   Hall-Stoodley L, 2012, FEMS IMMUNOL MED MIC, V65, P127, DOI 10.1111/j.1574-695X.2012.00968.x
   Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x
   Haney EF, 2015, PEPTIDES, V71, P276, DOI 10.1016/j.peptides.2015.03.015
   Hanke ML, 2013, J IMMUNOL, V190, P2159, DOI 10.4049/jimmunol.1202348
   Hanke ML, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00062
   Hansen CR, 2008, J CYST FIBROS, V7, P523, DOI 10.1016/j.jcf.2008.06.009
   Herasimenka Y, 2005, PEPTIDES, V26, P1127, DOI 10.1016/j.peptides.2005.01.020
   Hocquellet A, 2012, PEPTIDES, V36, P303, DOI 10.1016/j.peptides.2012.06.001
   Hoiby N, 2015, CLIN MICROBIOL INFEC, V21, pS1, DOI 10.1016/j.cmi.2014.10.024
   Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011
   Jesaitis AJ, 2003, J IMMUNOL, V171, P4329, DOI 10.4049/jimmunol.171.8.4329
   Johnson L, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-115
   Jones EA, 2013, J INNATE IMMUN, V5, P24, DOI 10.1159/000339961
   Jorge P, 2012, BIOFOULING, V28, P1033, DOI 10.1080/08927014.2012.728210
   Kaplan JB, 2012, MBIO, V3, DOI 10.1128/mBio.00198-12
   Kaplan JB, 2012, J ANTIBIOT, V65, P73, DOI 10.1038/ja.2011.113
   Kazemzadeh-Narbat M, 2013, BIOMATERIALS, V34, P5969, DOI 10.1016/j.biomaterials.2013.04.036
   Kogan G, 2006, FEMS MICROBIOL LETT, V255, P11, DOI 10.1111/j.1574-6968.2005.00043.x
   Kuo HH, 2007, CHEM BIOL DRUG DES, V69, P405, DOI 10.1111/j.1747-0285.2007.00518.x
   Kwakman PHS, 2006, ANTIMICROB AGENTS CH, V50, P3977, DOI 10.1128/AAC.00575-06
   Lebeaux D, 2014, J INFECT DIS, V210, P1357, DOI 10.1093/infdis/jiu286
   Lebeaux D, 2014, MICROBIOL MOL BIOL R, V78, P510, DOI 10.1128/MMBR.00013-14
   Leid JG, 2002, INFECT IMMUN, V70, P6339, DOI 10.1128/IAI.70.11.6339-6345.2002
   Lewenza S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00021
   Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557
   Lombardi L, 2015, MOLECULES, V20, P6319, DOI 10.3390/molecules20046319
   Lourenco A, 2014, PATHOG DIS, V70, P250, DOI 10.1111/2049-632X.12146
   Maccari G, 2015, METHODS MOL BIOL, V1268, P195, DOI 10.1007/978-1-4939-2285-7_9
   Maccari G, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003212
   Maisetta G, 2006, ANTIMICROB AGENTS CH, V50, P806, DOI 10.1128/AAC.50.2.806.809.2006
   Maisetta G, 2008, PEPTIDES, V29, P1, DOI 10.1016/j.peptides.2007.10.013
   Maisetta G, 2013, FEBS J, V280, P2842, DOI 10.1111/febs.12288
   Maisetta G, 2011, PEPTIDES, V32, P1073, DOI 10.1016/j.peptides.2011.02.003
   Maisetta G, 2010, PEPTIDES, V31, P1995, DOI 10.1016/j.peptides.2010.08.007
   Maisetta G, 2009, PEPTIDES, V30, P1622, DOI 10.1016/j.peptides.2009.06.004
   Mangoni ML, 2008, ANTIMICROB AGENTS CH, V52, P85, DOI 10.1128/AAC.00796-07
   Mangoni ML, 2009, BBA-BIOMEMBRANES, V1788, P1610, DOI 10.1016/j.bbamem.2009.04.021
   Mansour SC, 2015, J PEPT SCI, V21, P323, DOI 10.1002/psc.2708
   Mansour SC, 2014, TRENDS IMMUNOL, V35, P443, DOI 10.1016/j.it.2014.07.004
   Marr AK, 2006, CURR OPIN PHARMACOL, V6, P468, DOI 10.1016/j.coph.2006.04.006
   Menousek J, 2012, INT J ANTIMICROB AG, V39, P402, DOI 10.1016/j.ijantimicag.2012.02.003
   Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165
   Montanaro L, 2011, INT J ARTIF ORGANS, V34, P824, DOI 10.5301/ijao.5000051
   Mu HB, 2014, INT J MOL SCI, V15, P22296, DOI 10.3390/ijms151222296
   Mulcahy H, 2010, ENVIRON MICROBIOL, V12, P1621, DOI 10.1111/j.1462-2920.2010.02208.x
   Mulcahy H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000213
   Nagant C, 2012, ANTIMICROB AGENTS CH, V56, P5698, DOI 10.1128/AAC.00918-12
   Naves P, 2010, J HOSP INFECT, V76, P165, DOI 10.1016/j.jhin.2010.05.011
   Okshevsky M, 2015, CURR OPIN BIOTECH, V33, P73, DOI 10.1016/j.copbio.2014.12.002
   Otto M, 2008, CURR TOP MICROBIOL, V322, P207
   Otto M, 2006, CURR TOP MICROBIOL, V306, P251
   Overhage J, 2008, INFECT IMMUN, V76, P4176, DOI 10.1128/IAI.00318-08
   Pamp S. J., 2007, BIOFILM MODE LIFE MA, P37
   Pamp SJ, 2008, MOL MICROBIOL, V68, P223, DOI 10.1111/j.1365-2958.2008.06152.x
   Parkins MD, 2015, J CYST FIBROS, V14, P293, DOI 10.1016/j.jcf.2015.03.012
   Pavithra D, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034003
   Peschel A, 2013, NAT REV MICROBIOL, V11, P667, DOI 10.1038/nrmicro3110
   Pimentel ND, 2014, INT J FOOD MICROBIOL, V190, P1, DOI 10.1016/j.ijfoodmicro.2014.08.004
   Piras AM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00372
   Pompilio A, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-145
   Prabhakara R, 2011, INFECT IMMUN, V79, P5010, DOI 10.1128/IAI.05571-11
   Rabin N, 2015, FUTURE MED CHEM, V7, P493, DOI [10.4155/FMC.15.6, 10.4155/fmc.15.6]
   Reffuveille F, 2014, ANTIMICROB AGENTS CH, V58, P5363, DOI 10.1128/AAC.03163-14
   Ribeiro SM, 2015, ANTIMICROB AGENTS CH, V59, P3906, DOI 10.1128/AAC.00092-15
   Rohde H, 2007, BIOMATERIALS, V28, P1711, DOI 10.1016/j.biomaterials.2006.11.046
   Romling U, 2014, J INTERN MED, V276, P98, DOI 10.1111/joim.12242
   Morones-Ramirez JR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006276
   Sakuragi Y, 2007, J BACTERIOL, V189, P5383, DOI 10.1128/JB.00137-07
   Scherr TD, 2015, MBIO, V6, DOI 10.1128/mBio.01021-15
   SCHLESSINGER D, 1988, Clinical Microbiology Reviews, V1, P54
   Segev-Zarko L, 2015, BIOCHEM J, V468, P259, DOI 10.1042/BJ20141251
   Song ZJ, 2005, ANTIMICROB AGENTS CH, V49, P3868, DOI 10.1128/AAC.49.9.3868-3874.2005
   Speziale P, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00171
   Stark M, 2002, ANTIMICROB AGENTS CH, V46, P3585, DOI 10.1128/AAC.46.11.3585.3590.2002
   Steinstraesser L, 2002, ANTIMICROB AGENTS CH, V46, P1837, DOI 10.1128/AAC.46.6.1837-1844.2002
   Tavanti A, 2011, PEPTIDES, V32, P2484, DOI 10.1016/j.peptides.2011.10.012
   Tong SYC, 2015, CLIN MICROBIOL REV, V28, P603, DOI 10.1128/CMR.00134-14
   Vuong C, 2004, J BIOL CHEM, V279, P54881, DOI 10.1074/jbc.M411374200
   Vuong C, 2004, CELL MICROBIOL, V6, P269, DOI 10.1111/j.1462-5822.2004.00367.x
   Vuotto C, 2014, PATHOGENS, V3, P743, DOI 10.3390/pathogens3030743
   Wang R, 2011, J CLIN INVEST, V121, P238, DOI 10.1172/JCI42520
   Wang X, 2004, J BACTERIOL, V186, P2724, DOI 10.1128/JB.186.9.2724-2734.2004
   Weiner DJ, 2003, AM J RESP CELL MOL, V28, P738, DOI 10.1165/rcmb.2002-0191OC
   Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487
   Wickstrom C, 2008, ORAL MICROBIOL IMMUN, V23, P177, DOI 10.1111/j.1399-302X.2007.00407.x
   Wiens JR, 2014, MBIO, V5, DOI 10.1128/mBio.01010-13
   Wood LF, 2006, MOL MICROBIOL, V62, P412, DOI 10.1111/j.1365-2958.2006.05390.x
   Xu W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098935
   Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2
   Yin LM, 2013, PROTEIN PEPTIDE LETT, V20, P843, DOI 10.2174/0929866511320080001
   Zaat SAJ, 2010, FUTURE MICROBIOL, V5, P1149, DOI [10.2217/fmb.10.89, 10.2217/FMB.10.89]
   Zhang A, 2013, SCI REP-UK, V3, DOI 10.1038/srep03364
   Zhu C, 2013, J SURG RES, V183, P204, DOI 10.1016/j.jss.2012.11.048
NR 157
TC 38
Z9 43
U1 8
U2 75
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0005-2736
EI 0006-3002
J9 BBA-BIOMEMBRANES
JI Biochim. Biophys. Acta-Biomembr.
PD MAY
PY 2016
VL 1858
IS 5
SI SI
BP 1044
EP 1060
DI 10.1016/j.bbamem.2015.10.013
PG 17
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA DK0LF
UT WOS:000374603600015
PM 26525663
OA Bronze
DA 2018-10-20
ER

PT J
AU Reich, KM
   Huber, CD
   Heimel, P
   Ulm, C
   Redl, H
   Tangl, S
AF Reich, Karoline Maria
   Huber, Christian Domitian
   Heimel, Patrick
   Ulm, Christian
   Redl, Heinz
   Tangl, Stefan
TI A quantification of regenerated bone tissue in human sinus biopsies:
   influences of anatomical region, age and sex
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE age- and sex-dependency; bone quality; bone regeneration potential; bone
   substitute material; maxillary region; sinus augmentation
ID AUGMENTATION PROCEDURES; DENTAL IMPLANTS; OSTEOPOROSIS; GRAFTS; FLOOR;
   RIDGE; BIOMATERIALS; REDUCTION; FRACTURES; OUTCOMES
AB ObjectivesSinus augmentation is a standard procedure to increase vertical bone supply for dental implants in the atrophic posterior maxilla. Despite the longstanding application of this method, information about some basic factors that could potentially influence bone regeneration after sinus augmentation is rare. The objective of this study was therefore to quantify the impact of the maxillary region (premolar/molar) and patients' age and sex on bone regeneration after sinus grafting.
   Material and methodsSinus augmentation procedures were performed in 107 patients (66 female: 52.811.0years, 41 male: 50.611.3years). After 6 +/- 1months, 201 sinus biopsies were harvested and histomorphometrically analysed. Height (oldHt) and bone volume fraction of pristine bone (oldBV/TV), as well as the amount of new bone (newBV/TV) and bone-to-bone substitute contact (BBSC) in the augmentation area, were assessed.
   ResultsIn women, newBV/TV in the augmented sinus decreased significantly by 0.22 +/- 0.08% per year. In men, no similar trend was observed. There were strong influences of the maxillary region and the dimensions of the host bone. In the premolar region, newBV/TV was 23.1 +/- 7.9% and 25.1 +/- 10.1%; in the molar region, newBV/TV averaged 20.4 +/- 9.4% and 17.8 +/- 8.8% for women and men, respectively. The greater the thickness of the wall of the sinus floor (mainly in the former premolar region), the greater was the amount of new bone tissue formed in the spaces in-between bone substitute particles.
   ConclusionsThese empirical results derived from a large human sample, link factors that influence the quality of biomaterial integration to the known clinical risks for the success of dental implants.
C1 [Reich, Karoline Maria; Huber, Christian Domitian; Heimel, Patrick; Tangl, Stefan] Med Univ Vienna, Karl Donath Lab Hard Tissue & Biomat Res, Dept Oral Surg, Sensengasse 2a, A-1090 Vienna, Austria.
   [Reich, Karoline Maria; Huber, Christian Domitian; Redl, Heinz; Tangl, Stefan] Austrian Cluster Tissue Regenerat, Vienna, Austria.
   [Heimel, Patrick; Redl, Heinz] Trauma Res Ctr AUVA, Ludwig Boltzmann Inst Expt & Clin Traumatol, Vienna, Austria.
   [Ulm, Christian] Med Univ Vienna, Dept Oral Surg, A-1090 Vienna, Austria.
RP Tangl, S (reprint author), Med Univ Vienna, Karl Donath Lab Hard Tissue & Biomat Res, Dept Oral Surg, Sensengasse 2a, A-1090 Vienna, Austria.
EM stefan.tangl@meduniwien.ac.at
OI Tangl, Stefan/0000-0002-9023-4745
FU Baxter AG; Department of Oral Surgery, Medical University of Vienna
FX Histological specimens were collected from studies partially funded by
   Baxter AG.; The study was supported by the authors' institution
   (Department of Oral Surgery, Medical University of Vienna). No other
   external funding, apart from the support of the authors' institution,
   was available for this study.
CR Alsaadi G, 2007, J CLIN PERIODONTOL, V34, P610, DOI 10.1111/j.1600-051X.2007.01077.x
   ATWOOD DA, 1971, J PROSTHET DENT, V26, P266, DOI 10.1016/0022-3913(71)90069-2
   Avila-Ortiz G, 2012, CLIN ORAL IMPLAN RES, V23, P1082, DOI 10.1111/j.1600-0501.2011.02270.x
   Becktor JP, 2008, J ORAL MAXIL SURG, V66, P780, DOI 10.1016/j.joms.2007.11.008
   BOYNE PJ, 1980, J ORAL SURG, V38, P613
   Browaeys H, 2007, CLIN IMPLANT DENT R, V9, P166, DOI 10.1111/j.1708-8208.2007.00050
   CAWOOD JI, 1988, INT J ORAL MAX SURG, V17, P232, DOI 10.1016/S0901-5027(88)80047-X
   Coulthard P, 2002, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003604
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   Degidi M, 2007, IMPLANT DENT, V16, P317, DOI 10.1097/ID.0b013e3180de4c5f
   Donath K., 1988, PRAPARATOR, V34, P197
   Doundoulakis JH, 2003, J AM DENT ASSOC, V134, P1455, DOI 10.14219/jada.archive.2003.0073
   Erdogan O, 2007, ORAL SURG ORAL MED O, V104, P738, DOI 10.1016/j.tripleo.2007.04.008
   Esposito M, 2010, COCHRANE DB SYST REV, V3
   Esposito M, 2006, INT J ORAL MAX IMPL, V21, P696
   Farhat F. F., 2008, COMPENDIUM CONTINUIN, V29, P398
   FARHAT FF, 2008, COMPEND CONTIN ED DE, V29, P394
   Farhat Fred F, 2008, Compend Contin Educ Dent, V29, P388
   Fini M, 2004, BIOMED PHARMACOTHER, V58, P487, DOI 10.1016/j.biopha.2004.08.016
   Fini M, 1997, INT J ARTIF ORGANS, V20, P291
   Fuerst G, 2009, CLIN ORAL IMPLAN RES, V20, P135, DOI 10.1111/j.1600-0501.2008.01624.x
   Giannoudis P, 2007, INJURY, V38, pS90, DOI 10.1016/j.injury.2007.02.014
   GOLDMAN MJ, 1986, J PERIODONTOL, V57, P347, DOI 10.1902/jop.1986.57.6.347
   Grecchi F, 2009, J CRANIOFAC SURG, V20, P2205, DOI 10.1097/SCS.0b013e3181bf8487
   Gruber R, 2006, EXP GERONTOL, V41, P1080, DOI 10.1016/j.exger.2006.09.008
   Hildebrand H, 1994, Fortschr Kiefer Gesichtschir, V39, P34
   HIRAI T, 1993, J PROSTHET DENT, V69, P49, DOI 10.1016/0022-3913(93)90240-O
   HIRSCHFELD L, 1978, J PERIODONTOL, V49, P225, DOI 10.1902/jop.1978.49.5.225
   Johansson B, 2001, DENTOMAXILLOFAC RAD, V30, P157, DOI 10.1038/sj.dmfr.4600601
   Jokstad A., 2009, COCHRANE DATABASE SY
   Katz MH, 2011, MULTIVARIABLE ANAL P
   Kaufman Eliaz, 2003, J Esthet Restor Dent, V15, P272, DOI 10.1111/j.1708-8240.2003.tb00298.x
   McAllister BS, 2007, J PERIODONTOL, V78, P377, DOI 10.1902/jop.2007.060048
   McNamee R, 2005, OCCUP ENVIRON MED, V62, P500, DOI 10.1136/oem.2002.001115
   Nikolaou VS, 2009, INJURY, V40, P663, DOI 10.1016/j.injury.2008.10.035
   Parker MJ, 2007, CLIN ORTHOP RELAT R, P175, DOI 10.1097/BLO.0b013e3180325a42
   Pinherio J. C., 2000, MIXED EFFECTS MODELS
   Rosner B., 2010, FUNDAMENTALS BIOSTAT
   Scarano A, 2007, IMPLANT DENT, V16, P195, DOI 10.1097/ID.0b013e3180587ad8
   Schliephake H, 1997, J ORAL MAXIL SURG, V55, P1227, DOI 10.1016/S0278-2391(97)90173-7
   Sharan A, 2008, INT J ORAL MAX IMPL, V23, P48
   SILVER JJ, 1995, CLIN ORTHOP RELAT R, P10
   Solar P, 1998, Schweiz Monatsschr Zahnmed, V108, P871
   Strube P, 2008, BONE, V42, P758, DOI 10.1016/j.bone.2007.12.223
   Tsolaki IN, 2009, J PROSTHODONT, V18, P309, DOI 10.1111/j.1532-849X.2008.00433.x
   van den Bergh JPA, 2000, CLIN ORAL IMPLAN RES, V11, P256, DOI 10.1034/j.1600-0501.2000.011003256.x
   VONWOWERN N, 1992, J PROSTHET DENT, V67, P656, DOI 10.1016/0022-3913(92)90165-7
   Voss R, 1972, Dtsch Zahnarztl Z, V27, P377
   Yildirim M, 2001, INT J ORAL MAX IMPL, V16, P23
NR 49
TC 4
Z9 4
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD MAY
PY 2016
VL 27
IS 5
BP 583
EP 590
DI 10.1111/clr.12627
PG 8
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA DK1UF
UT WOS:000374699200010
PM 26037688
DA 2018-10-20
ER

PT J
AU Lee, IK
   Lim, HC
   Lee, JS
   Hong, JY
   Choi, SH
   Jung, UW
AF Lee, In-Kyeong
   Lim, Hyun-Chang
   Lee, Jung-Seok
   Hong, Ji-Youn
   Choi, Seong-Ho
   Jung, Ui-Won
TI Layered approach with autogenous bone and bone substitute for ridge
   augmentation on implant dehiscence defects in dogs
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE animal study; autogenous bone graft; bone substitutes; dental implants;
   guided bone regeneration
ID PARTIALLY EDENTULOUS PATIENTS; BARRIER MEMBRANES; CLINICAL-TRIAL; BOVINE
   BONE; MAXILLA; REGENERATION; EXTRACTION; PLACEMENT; GRAFTS; SITES
AB ObjectivesThis study compared the efficacies of different layered approaches using autogenous bone and synthetic bone substitute for ridge augmentation on implant dehiscence defects in dogs.
   Materials and methodsRight mandibular second, third, and fourth premolars and the first molar were extracted, followed by standardized one-wall defect preparation in five dogs. After a healing period of 12weeks, three implants (Implantium((R))) were installed. Each of the three implant dehiscence defects was grafted with a different material as follows: (i) synthetic bone substitute combined with collagen (SBC; SBC group), (ii) inner autogenous bone layer and outer SBC layer (IAB group), and (iii) inner SBC layer and outer autogenous bone layer (OAB group). The grafted sites were covered with a resorbable collagen membrane. Quantitative and qualitative analyses of the subsequent bone regeneration were performed at 12weeks postoperatively.
   ResultsThe dome-like augmented shape was relatively well maintained in the IAB and OAB groups, while the graft particles in the SBC group were dispersed. The bone-to-implant contact values tended to be significantly higher in the OAB group (49.51%) than in the SBC (36.58%) group. The amounts of newly formed bone within an area designated as 1x3mm (widthxheight) from the implant platform in the IAB, OAB, and SBC groups were 35.59%, 28.10%, and 16.71%, respectively.
   ConclusionApplication of the layered approach using autogenous bone and synthetic biomaterial resulted in substantial new bone formation and volume maintenance on implant dehiscence defects, irrespective of the position of the autogenous bone layer.
C1 [Lee, In-Kyeong; Lee, Jung-Seok; Choi, Seong-Ho; Jung, Ui-Won] Yonsei Univ, Dept Periodontol, Res Inst Periodontal Regenerat, Coll Dent, 50-1 Yonsei Ro, Seoul 120752, South Korea.
   [Lim, Hyun-Chang; Hong, Ji-Youn] Kyung Hee Univ, Dept Periodontol, Sch Dent, Seoul, South Korea.
RP Jung, UW (reprint author), Yonsei Univ, Dept Periodontol, Res Inst Periodontal Regenerat, Coll Dent, 50-1 Yonsei Ro, Seoul 120752, South Korea.
EM drjew@yuhs.ac
OI Hong, Ji-Youn/0000-0003-1040-7077
FU Korea Health technology R&D Project, Ministry of Health & Welfare,
   Republic of Korea [A120822]
FX This study was supported by a grant from the Korea Health technology R&D
   Project, Ministry of Health & Welfare, Republic of Korea (A120822).
CR Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P645, DOI 10.1111/j.1600-051X.2005.00726.x
   Bashutski JD, 2007, IMPLANT DENT, V16, P340, DOI 10.1097/ID.0b013e318159ca05
   Brunner E, 2000, BIOMETRICAL J, V42, P663, DOI 10.1002/1521-4036(200010)42:6<663::AID-BIMJ663>3.0.CO;2-7
   Buser D, 2004, INT J ORAL MAX IMPL, V19, P43
   Buser D, 1995, Int J Periodontics Restorative Dent, V15, P10
   Buser D, 1998, CLIN ORAL IMPLAN RES, V9, P137, DOI 10.1034/j.1600-0501.1998.090301.x
   Buser D, 1996, J ORAL MAXIL SURG, V54, P420, DOI 10.1016/S0278-2391(96)90113-5
   Chae SW, 2015, J PERIODONTAL IMPLAN, V45, P23, DOI 10.5051/jpis.2015.45.1.23
   Choi JY, 2011, CLIN ORAL IMPLAN RES, V22, P343, DOI 10.1111/j.1600-0501.2010.01978.x
   Dasmah A, 2012, J CRANIO MAXILL SURG, V40, P654, DOI 10.1016/j.jcms.2011.10.032
   Davies John E, 2003, J Dent Educ, V67, P932
   DesSantis E., 2013, CLIN ORAL IMPLAN RES, V24, P77
   Donos N, 2008, J CLIN PERIODONTOL, V35, P173, DOI 10.1111/j.1600-051X.2008.01269.x
   Fu J. H., 2014, CLIN ORAL IMPLAN RES, V26, P1150
   Fu JH, 2014, CLIN ORAL IMPLAN RES, V25, P458, DOI 10.1111/clr.12171
   Fu JH, 2012, EUR J ORAL IMPLANTOL, V5, pS91
   Fugazzotto PA, 1997, INT J PERIODONT REST, V17, P293
   Hammerle CHF, 2002, J CLIN PERIODONTOL, V29, P226, DOI 10.1034/j.1600-051X.29.s3.14.x
   Jang HY, 2010, J ORAL MAXIL SURG, V68, P1859, DOI 10.1016/j.joms.2009.09.093
   Jensen SS, 2006, CLIN ORAL IMPLAN RES, V17, P237, DOI 10.1111/j.1600-0501.2005.01257.x
   Jung UW, 2007, CLIN ORAL IMPLAN RES, V18, P171, DOI 10.1111/j.1600-0501.2006.01310.x
   Mordenfeld A, 2014, CLIN ORAL IMPLAN RES, V25, P310, DOI 10.1111/clr.12143
   Oginuma T, 2012, OR SURG OR MED OR PA, V114, pS107, DOI 10.1016/j.oooo.2011.08.004
   VansAssche N., 2013, CLIN IMPLANT DENT R, V15, P558
   von See C, 2010, BRIT J ORAL MAX SURG, V48, P607, DOI 10.1016/j.bjoms.2009.09.012
   vonsArx T., 2006, CLIN ORAL IMPLAN RES, V17, P359
   Wang Hom-Lay, 2004, Int J Periodontics Restorative Dent, V24, P232
   Zerbo IR, 2003, CLIN ORAL IMPLAN RES, V14, P759, DOI 10.1046/j.0905-7161.2003.00967.x
NR 29
TC 5
Z9 5
U1 1
U2 3
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD MAY
PY 2016
VL 27
IS 5
BP 622
EP 628
DI 10.1111/clr.12649
PG 7
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA DK1UF
UT WOS:000374699200016
PM 26109377
DA 2018-10-20
ER

PT J
AU Vaikkath, D
   Anitha, R
   Sumathy, B
   Nair, PD
AF Vaikkath, Dhanesh
   Anitha, Rakhi
   Sumathy, Babitha
   Nair, Prabha D.
TI A simple and effective method for making multipotent/multilineage
   scaffolds with hydrophilic nature without any postmodification/treatment
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Electrospinning; Blending; Scaffold modification; Tissue engineering;
   Hydrophilicity
ID CELL-ADHESION; SURFACE MODIFICATION; ENDOTHELIAL-CELLS;
   BLOCK-COPOLYMERS; NANOFIBER MESHES; STEM-CELLS; ELECTROSPUN; FIBERS;
   MEMBRANES; SILK
AB A number of biodegradable and bioresorbable materials, as well as scaffold designs, have been experimentally and/or clinically studied for tissue engineering of diverse tissue types. Cell material responses are strongly dependent on the properties of the scaffold material. In this study, scaffolds based on polycaprolactone (PCL) and PCL blended with a triblock copolymer, Polycaprolactone-polytetrahydrofuran-polycaprolactone (PCL-PTHF-PCL) at different ratios were fabricated by electrospinning. Blending and electrospinning of the triblock copolymer with PCL generated a super hydrophilic scaffold, the mechanical and biological properties of which varied with the concentration of the triblock copolymer. The hydrophilicity of the electrospun scaffolds was determined by measurement of water-air contact angle. Cellular response to the electrospun scaffolds was studied by seeding two types of cells, L929 fibroblast cell line and rat mesenchymal stem cells (RMSC). We observed that the super hydrophilicity of the material did not prevent cell adhesion, while the cell proliferation was low or negligible for scaffolds containing higher amount of PCL-PTHF-PCL. Chondrogenic differentiation of RMSC was found to be better on the PCL blend containing 10% (w/v) of PCL-PTHF-PCL than the bare PCL. Our studies indicate that the cellular response is dependent on the biomaterial composition and highlight the importance of tailoring the scaffold properties for applications in tissue engineering and regenerative medicine. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Vaikkath, Dhanesh; Anitha, Rakhi; Sumathy, Babitha; Nair, Prabha D.] Sree Chitra Tirunal Inst Med Sci & Technol, Div Tissue Engn & Regenerat Technol, Trivandrum, Kerala, India.
RP Nair, PD (reprint author), Sree Chitra Tirunal Inst Med Sci & Technol, Div Tissue Engn & Regenerat Technol, Trivandrum, Kerala, India.
EM dhaneshvaikkath@gmail.com; a.rakhi86@gmail.com; babisp2005@gmail.com;
   prabha@sctimst.ac.in
FU Department of Biotechnology, India (Indo-Danish grant); CSIR India
FX The authors acknowledge funding from Department of Biotechnology, India
   (Indo-Danish grant), RA acknowledges fellowship from CSIR India. The
   authors are grateful to the Director, Sree Chitra Tirunal Institute for
   Medical Sciences and Technology (SCTIMST), India for support and
   facilities.
CR Aloysious N, 2013, TISSUE ENG PART A, V20, P1508
   da Silva MLA, 2010, BIOMACROMOLECULES, V11, P3228, DOI 10.1021/bm100476r
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Bacakova L, 1996, BIOMATERIALS, V17, P1121
   Baek HS, 2008, SURF COAT TECH, V202, P5794, DOI 10.1016/j.surfcoat.2008.06.154
   Bhattarai N, 2005, BIOMATERIALS, V26, P6176, DOI 10.1016/j.biomaterials.2005.03.027
   Chen F, 2007, MAT SCI ENG C-BIO S, V27, P325, DOI 10.1016/j.msec.2006.05.004
   Cipitria A, 2011, J MATER CHEM, V21, P9419, DOI 10.1039/c0jm04502k
   Ding B, 2002, J POLYM SCI POL PHYS, V40, P1261, DOI 10.1002/polb.10191
   Greiner A, 2007, ANGEW CHEM INT EDIT, V46, P5670, DOI 10.1002/anie.200604646
   Guarino V, 2011, J BIOACT COMPAT POL, V26, P144, DOI 10.1177/0883911511399410
   Hamid Q, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/3/034109
   Hardy JG, 2014, MACROMOL BIOSCI, V14, P936, DOI 10.1002/mabi.201400020
   He W, 2005, BIOMATERIALS, V26, P7606, DOI 10.1016/j.biomaterials.2005.05.049
   Huang ZM, 2004, POLYMER, V45, P5361, DOI 10.1016/j.polymer.2004.04.005
   Jacobsen S, 1999, POLYM ENG SCI, V39, P1303, DOI 10.1002/pen.11517
   Jia YT, 2006, J APPL POLYM SCI, V99, P1462, DOI 10.1002/app.22633
   Kim HS, 2005, MACROMOL SYMP, V224, P145, DOI 10.1002/masy.200550613
   Kim K, 2003, BIOMATERIALS, V24, P4977, DOI 10.1016/S0142-9612(03)00407-1
   Kunzler TP, 2007, BIOMATERIALS, V28, P2175, DOI 10.1016/j.biomaterials.2007.01.019
   Lee JH, 1998, J COLLOID INTERF SCI, V205, P323, DOI 10.1006/jcis.1998.5688
   Liu S, 2012, BIOMACROMOLECULES, V13, P3611, DOI 10.1021/bm301022p
   Luu YK, 2003, J CONTROL RELEASE, V89, P341, DOI 10.1016/S0168-3659(03)00097-X
   Ma ML, 2005, LANGMUIR, V21, P5549, DOI 10.1021/la047064y
   Ma ZW, 2005, TISSUE ENG, V11, P1149, DOI 10.1089/ten.2005.11.1149
   Martins A, 2009, SMALL, V5, P1195, DOI 10.1002/smll.200801648
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   Mohan N, 2015, J BIOMED MATER RES A, V103, P3896, DOI 10.1002/jbm.a.35506
   Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269
   Singh N, 2013, BIOMACROMOLECULES, V14, P1287, DOI 10.1021/bm301762p
   Smith LA, 2004, COLLOID SURFACE B, V39, P125, DOI [10.1016/j.colsurfb.2003.12.004, 10.1016/j.colsurfb.2003.l2.004]
   Son WK, 2004, POLYMER, V45, P2959, DOI 10.1016/j.polymer.2004.02.006
   SVORCIK V, 1995, J MATER CHEM, V5, P27, DOI 10.1039/jm9950500027
   Teng PT, 2013, POLYM ENG SCI, V53, P762, DOI 10.1002/pen.23317
   Tsai HA, 2012, BIOMACROMOLECULES, V13, P3483, DOI 10.1021/bm301074j
   Viswanathan P, 2015, BIOMACROMOLECULES, V16, P66, DOI 10.1021/bm500671j
   Wang SD, 2009, BIOMACROMOLECULES, V10, P2240, DOI 10.1021/bm900416b
   Winer JP, 2009, TISSUE ENG PT A, V15, P147, DOI 10.1089/ten.tea.2007.0388
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Zhang D, 2013, BIOMATERIALS, V34, P3962, DOI 10.1016/j.biomaterials.2013.02.029
   Zhu YB, 2002, BIOMACROMOLECULES, V3, P1312, DOI 10.1021/bm020074y
   Zong XH, 2003, POLYMER, V44, P4959, DOI 10.1016/S0032-3861(03)00464-6
NR 42
TC 5
Z9 5
U1 5
U2 41
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD MAY 1
PY 2016
VL 141
BP 112
EP 119
DI 10.1016/j.colsurfb.2015.12.041
PG 8
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA DJ4SH
UT WOS:000374197700014
PM 26848946
DA 2018-10-20
ER

PT J
AU Kim, J
AF Kim, Jinku
TI Study of the conformational change of adsorbed proteins on biomaterial
   surfaces using hydrogen-deuterium exchange with mass spectroscopy
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Protein adsorption; Conformational change; Biomaterials;
   Hydrogen/deuterium exchange; Mass spectrometry
ID SOLID-SURFACES; BIOMEDICAL POLYMERS; ADSORPTION; SPECTROMETRY;
   ACTIVATION; FIBRINOGEN; NANOPARTICLES; DESORPTION; STABILITY; FTIR/ATR
AB There is no doubt that protein adsorption plays a crucial role in determining biocompatibility of biomaterials. Despite the information of the identity and composition of blood plasma/serum proteins adsorbed on surfaces of biomaterials to understand which proteins are involved in blood/biomaterial interactions, it still does not provide information about the conformations and orientations of adsorbed protein, which are very important in determining biological responses to biomaterials. Therefore, our laboratory has developed an experimental technology to probe protein conformations on materials that is applicable to mixtures of proteins. Herein, the new application of hydrogen/deuterium (H/D) exchange combined with mass spectrometry was applied to determine conformational changes of adsorbed proteins at biomaterial surfaces. The results suggest that there may be a significant conformational change in adsorbed proteins at 'low' bulk concentrations that leads to a large change in the kinetics of H/D exchange as compared to 'high' bulk concentrations. This technique may eventually be useful for the study of the kinetics of protein conformational changes. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Kim, Jinku] Hongik Univ, Dept Bio & Chem Engn, 2639 Sejong Ro, Jochiwon Eup 339701, Sejong, South Korea.
RP Kim, J (reprint author), Hongik Univ, Dept Bio & Chem Engn, 2639 Sejong Ro, Jochiwon Eup 339701, Sejong, South Korea.
EM jinkukim@hongik.ac.kr
FU Basic Science Research Program through the National Research Foundation
   of Korea (NRF) - Ministry of Education [2013R1A1A4A01011185]; Hongik
   University Research Fund
FX This research was supported by Basic Science Research Program through
   the National Research Foundation of Korea (NRF) funded by the Ministry
   of Education (2013R1A1A4A01011185). This work was supported by 2014
   Hongik University Research Fund. The author acknowledges Dr. Donald L.
   Elbert of the Biomedical Engineering Department at Washington University
   in St. Louis for his helpful discussion.
CR Anand G, 2010, LANGMUIR, V26, P10803, DOI 10.1021/la1006132
   ANDERSON JM, 1995, J BIOMAT SCI-POLYM E, V7, P159, DOI 10.1163/156856295X00670
   ANDERSON JM, 1990, INT J ARTIF ORGANS, V13, P375
   ANDRADE JD, 1985, J BIOMED MATER RES, V19, P981, DOI 10.1002/jbm.820190910
   BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110
   BAI YW, 1995, SCIENCE, V269, P192, DOI 10.1126/science.7618079
   Beavis RC, 1996, METHOD ENZYMOL, V270, P519
   BONFIELD TL, 1989, J BIOMED MATER RES, V23, P535, DOI 10.1002/jbm.820230602
   Brash JL, 1991, BLOOD COMPATIBLE MAT, P3
   Chen H, 2008, PROG POLYM SCI, V33, P1059, DOI 10.1016/j.progpolymsci.2008.07.006
   CHENG SS, 1994, J COLLOID INTERF SCI, V162, P135, DOI 10.1006/jcis.1994.1018
   Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   Clague MJ, 1998, BIOCHEM J, V336, P271, DOI 10.1042/bj3360271
   Cole MA, 2009, BIOMATERIALS, V30, P1827, DOI 10.1016/j.biomaterials.2008.12.026
   COURTNEY JM, 1993, IMMOBILISED MACROMOL, P175
   DEJARDIN P, 1995, LANGMUIR, V11, P4001, DOI 10.1021/la00010a061
   Englander SW, 1996, CURR OPIN STRUC BIOL, V6, P18, DOI 10.1016/S0959-440X(96)80090-X
   Feng L., 1995, J BIOMAT SCI-POLYM E, V7, P14
   Ferentz AE, 2000, Q REV BIOPHYS, V33, P29, DOI 10.1017/S0033583500003589
   Forbes C. D., 1995, HAEMOSTASIS THROMBOS, P1301
   Ghaemmaghami S, 2000, P NATL ACAD SCI USA, V97, P8296, DOI 10.1073/pnas.140111397
   Ghaemmaghami S, 2001, NAT STRUCT BIOL, V8, P879, DOI 10.1038/nsb1001-879
   Hlady V, 1996, CURR OPIN BIOTECH, V7, P72, DOI 10.1016/S0958-1669(96)80098-X
   Hook F, 2008, ACS NANO, V2, P2428, DOI 10.1021/nn800800v
   Horbett TA, 1995, ACS SYM SER, V602, P1
   Hu WB, 2013, P NATL ACAD SCI USA, V110, P7684, DOI 10.1073/pnas.1305887110
   LU CF, 1994, J COLLOID INTERF SCI, V168, P152, DOI 10.1006/jcis.1994.1404
   LUNDSTROM I, 1985, PROG COLL POL SCI S, V70, P76
   Nadarajah A., 1995, ACS SYM SER, V602, P14
   NORDE W, 1992, COLLOID SURFACE, V66, P73, DOI 10.1016/0166-6622(92)80122-I
   Powell KD, 2002, J AM CHEM SOC, V124, P10256, DOI 10.1021/ja026574g
   Rabe M, 2011, ADV COLLOID INTERFAC, V162, P87, DOI 10.1016/j.cis.2010.12.007
   RATNER BD, 1993, J BIOMED MATER RES, V27, P283, DOI 10.1002/jbm.820270302
   Roach P, 2007, J MATER SCI-MATER M, V18, P1263, DOI 10.1007/s10856-006-0064-3
   Salzman E W, 1969, J Biomed Mater Res, V3, P69
   SCOTT C F, 1991, Journal of Biomaterials Science Polymer Edition, V2, P173
   Shrivastava S, 2012, NANO LETT, V12, P1583, DOI 10.1021/nl2044524
   SLACK SM, 1989, J COLLOID INTERF SCI, V133, P148, DOI 10.1016/0021-9797(89)90288-9
   Slack SM, 1995, ACS SYM SER, V602, P112
   Wang AL, 2014, J PHYS CHEM B, V118, P14148, DOI 10.1021/jp506506p
   WOJCIECHOWSKI P, 1986, J COLLOID INTERF SCI, V111, P455, DOI 10.1016/0021-9797(86)90048-2
   WOJCIECHOWSKI PW, 1990, J COLLOID INTERF SCI, V140, P239, DOI 10.1016/0021-9797(90)90339-P
   Xiao YM, 2015, PROTEIN SCI, V24, P1247, DOI 10.1002/pro.2680
   Yan XG, 2004, MOL CELL PROTEOMICS, V3, P10, DOI 10.1074/mcp.R300010-MCP200
   Zhu MM, 2003, J AM CHEM SOC, V125, P5252, DOI 10.1021/ja029460d
NR 45
TC 3
Z9 3
U1 1
U2 17
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD MAY 1
PY 2016
VL 141
BP 513
EP 518
DI 10.1016/j.colsurfb.2016.02.023
PG 6
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA DJ4SH
UT WOS:000374197700060
PM 26896658
DA 2018-10-20
ER

PT J
AU Santamala, H
   Livingston, R
   Sixta, H
   Hummel, M
   Skrifvars, M
   Saarela, O
AF Santamala, H.
   Livingston, R.
   Sixta, H.
   Hummel, M.
   Skrifvars, M.
   Saarela, O.
TI Advantages of regenerated cellulose fibres as compared to flax fibres in
   the processability and mechanical performance of thermoset composites
SO COMPOSITES PART A-APPLIED SCIENCE AND MANUFACTURING
LA English
DT Article
DE Biocomposite; Cellulose; Interface/interphase; Electron microscopy
ID TENSILE PROPERTIES; EPOXY COMPOSITES; DEFORMATION; BEHAVIOR; WATER
AB Man-made cellulosic fibres (MMCFs) have attracted widespread interest as the next generation of fibre reinforced composite. However, most studies focused entirely on their performance on single fibre level and little attention has been paid to their behaviour on a larger application scale. In this study, MMCFs were utilized as reinforcement in unidirectionally (UD) manufactured thermoset composites and compared to several commercial UD flax fibre products. Specimens were prepared using a vacuum bag based resin infusion technique and the respective laminates characterized in terms of void fraction and mechanical properties. MMCF laminates had comparable or better mechanical performance when compared to flax fibre laminates. Failure mechanisms of MMCF laminates were noted to differ from those of flax-reinforced laminates. The results demonstrate the potential of MMCFs as a viable alternative to glass fibre for reinforcement on a larger scale of UD laminates. These results were utilized in the Biofore biomaterial demonstration vehicle. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Santamala, H.; Livingston, R.; Saarela, O.] Aalto Univ, Sch Engn, Dept Appl Mech, POB 14300, FI-00076 Aalto, Finland.
   [Sixta, H.; Hummel, M.] Aalto Univ, Sch Chem, Dept Forest Prod Technol, POB 16300, FI-00076 Aalto, Finland.
   [Skrifvars, M.] Univ Boras, Sch Engn, Allegatan 1, S-50190 Boras, Sweden.
RP Santamala, H (reprint author), Aalto Univ, Sch Engn, Dept Appl Mech, POB 14300, FI-00076 Aalto, Finland.
EM harri.santamala@aalto.fi
RI Sixta, Herbert/A-8071-2013; Saarela, Olli/G-2406-2013; Hummel,
   Michael/O-1526-2014
FU Finnish Funding Agency for Technology and Innovation, TEKES
   [392/31/2011]
FX This project was supported by the Finnish Funding Agency for Technology
   and Innovation, TEKES [project number 392/31/2011]. In addition, the
   following companies were involved in this project: AGCO Sisu Power Oy,
   AGCO Suomi Oy, BRP Finland Oy, Componeering Oy, Helsinki Metropolia
   University of Applied Sciences, Kemin Digipolis Oy, Kemi-Tornionlaakso
   Municipal Education and Training Consortium Lappia, Outokumpu Stainless
   Oy, Oy All-Plast Ab, Randax Oy, Rovaniemen Kehitys Oy, Ruukki Metals Oy,
   Sandvik Mining and Construction Oy, Tampere University of Technology,
   and UPM Oy.
CR Abdel-Halim ES, 2008, POLYM-PLAST TECHNOL, V47, P58, DOI 10.1080/03602550701580912
   Adusumalli R-B, 2010, J COMPOS MATER, V46, P359
   Alix S, 2009, BIORESOURCE TECHNOL, V100, P4742, DOI 10.1016/j.biortech.2009.04.067
   Baley C, 2006, MATER LETT, V60, P2984, DOI 10.1016/j.matlet.2006.02.028
   Bledzki AK, 1999, PROG POLYM SCI, V24, P221, DOI 10.1016/S0079-6700(98)00018-5
   Bourmaud A, 2013, IND CROP PROD, V44, P343, DOI 10.1016/j.indcrop.2012.11.031
   Charlet K, 2010, IND CROP PROD, V32, P220, DOI 10.1016/j.indcrop.2010.04.015
   Coroller G, 2013, COMPOS PART A-APPL S, V51, P62, DOI 10.1016/j.compositesa.2013.03.018
   de Weyenberg IV, 2006, COMPOS PART A-APPL S, V37, P1368, DOI DOI 10.1016/J.COMPOSITESA.2005.08.016
   Dittenber DB, 2012, COMPOS PART A-APPL S, V43, P1419, DOI 10.1016/j.compositesa.2011.11.019
   Duigou A. L., 2014, COMPOS PART A-APPL S, V65, P161
   Eichhorn SJ, 2003, POLYMER, V44, P5901, DOI 10.1016/S0032-3861(03)00540-8
   El Messiry M., 2013, ALEXANDRIA ENG J, V52, P301
   Faruk O, 2014, MACROMOL MATER ENG, V299, P9, DOI 10.1002/mame.201300008
   Gindl W, 2006, COMPOS SCI TECHNOL, V66, P2049, DOI 10.1016/j.compscitech.2005.12.019
   Gindl-Altmutter W, 2012, COMPOS SCI TECHNOL, V72, P1304, DOI 10.1016/j.compscitech.2012.05.011
   Graupner N, 2014, COMPOS PART A-APPL S, V63, P133, DOI 10.1016/j.compositesa.2014.04.011
   Gu H, 2009, MATER DESIGN, V30, P3931, DOI 10.1016/j.matdes.2009.01.035
   Gurit, 2016, PRIM 20 LV TECHN DAT
   Jiang GS, 2012, CARBOHYD POLYM, V87, P2012, DOI 10.1016/j.carbpol.2011.10.022
   Lee KY, 2012, COMPOS SCI TECHNOL, V72, P1479, DOI 10.1016/j.compscitech.2012.06.014
   Lefeuvre A, 2014, IND CROP PROD, V52, P762, DOI 10.1016/j.indcrop.2013.11.043
   Lefeuvre A, 2013, IND CROP PROD, V50, P400, DOI 10.1016/j.indcrop.2013.07.035
   Li Y, 2015, COMPOS PART A-APPL S, V72, P40, DOI 10.1016/j.compositesa.2015.01.029
   Livingston R, 2013, P SAMPE STUD C PAR
   Mishra HK, 2000, POLYM-PLAST TECHNOL, V39, P187, DOI 10.1081/PPT-100100023
   Morrison WH, 2000, IND CROP PROD, V12, P39, DOI 10.1016/S0926-6690(99)00044-8
   Northolt MG, 1985, LENZINGER BER, V59, P71
   Oksman K, 2001, J REINF PLAST COMP, V20, P621, DOI 10.1106/CA5A-6FAX-VJRB-80P0
   PAN N, 1993, TEXT RES J, V63, P565
   Pizzi A, 2009, IND CROP PROD, V30, P235, DOI 10.1016/j.indcrop.2009.03.013
   Porcher, 2013, GREENL MAT BROCH
   Roder T, 2009, LENZINGER BER, V87, P98
   Santamala H, 2013, P EC C BIRM
   Santamala H, 2016, CHEM COMPOSITI UNPUB
   Sgriccia N, 2008, COMPOS PART A-APPL S, V39, P1632, DOI 10.1016/j.compositesa.2008.07.007
   Shah DU, 2012, COMPOS SCI TECHNOL, V72, P1909, DOI 10.1016/j.compscitech.2012.08.005
   Doan TTL, 2012, COMPOS SCI TECHNOL, V72, P1160, DOI 10.1016/j.compscitech.2012.03.025
   Tsai SW, 1988, COMPOSITE DESIGN, P11
   Weyenberg IVde, 2003, COMPOS SCI TECHNOL, V63, P1241
   Zaman HU, 2010, FIBER POLYM, V11, P258, DOI 10.1007/s12221-010-0258-7
   Zhang W, 2005, CARBOHYD POLYM, V59, P173, DOI 10.1016/j.carbpol.2004.09.007
NR 42
TC 5
Z9 5
U1 0
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1359-835X
EI 1878-5840
J9 COMPOS PART A-APPL S
JI Compos. Pt. A-Appl. Sci. Manuf.
PD MAY
PY 2016
VL 84
BP 377
EP 385
DI 10.1016/j.compositesa.2016.02.011
PG 9
WC Engineering, Manufacturing; Materials Science, Composites
SC Engineering; Materials Science
GA DJ4SN
UT WOS:000374198400039
DA 2018-10-20
ER

PT J
AU Bezerra, RDS
   Morais, AIS
   Osajima, JA
   Nunes, LCC
   Silva, EC
AF Bezerra, Roosevelt D. S.
   Morais, Alan I. S.
   Osajima, Josy A.
   Nunes, Livio C. C.
   Silva Filho, Edson C.
TI Development of new phosphated cellulose for application as an efficient
   biomaterial for the incorporation/release of amitriptyline
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Phosphated cellulose; Amitriptyline; Adsorption; Desorption
ID AQUEOUS-SOLUTION; PHOSPHORYLATED CELLULOSE; BIOMEDICAL APPLICATIONS;
   BACTERIAL CELLULOSE; ACTIVATED CARBON; EQUILIBRIUM DATA; DYE ADSORPTION;
   REMOVAL; SORPTION; KINETICS
AB In the last years has increased the study about the using of natural biopolymers and theirs derivatives in the removal (adsorption/incorporation) of contaminats of medium aqueous, and theirs utilization in the desorption (release) de drugs. However, there not in the literature studies about the utilization of the cellulose and cellulose phosphate in the adsorption (incorporation)/desorption (release) of the drug amitriptyline (AMI). Therefore, in this study was accomplished the synthesized of the phosphated cellulose (PC) through the reaction of pure cellulose (C) with sodium trimetaphosphate (P) under-reflux, for 4 h and at 393 K. The efficiency of the reaction was observed by XRD, TG/DTG, P-31 NMR and EDS. The adsorption study for the AMI in aqueous medium was carried out by varying the time, pH, concentration, temperature and ionic strength. The results showed that the PC showed a greater adsorption capacity of AMI than pure cellulose, presenting an increase of about 102.72% in the adsorption capacity of the drug by cellulose after the phosphating reaction. In desorption of drug from the surface of biomaterials was performed by varying the pH and time, where it was observed that PC showed a maximum release of 40.98%+/- 0.31% at pH 7. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Bezerra, Roosevelt D. S.] Fed Inst Educ Sci & Technol Piaui, Teresina Cent Campus, BR-64000040 Teresina, PI, Brazil.
   [Morais, Alan I. S.; Osajima, Josy A.; Nunes, Livio C. C.; Silva Filho, Edson C.] Univ Fed Piaui, Interdisciplinary Lab Adv Mat LIMAV, BR-64049550 Teresina, PI, Brazil.
RP Silva, EC (reprint author), Univ Fed Piaui, Interdisciplinary Lab Adv Mat LIMAV, BR-64049550 Teresina, PI, Brazil.
EM edsonfilho@ufpi.edu.br
OI Nunes, Livio/0000-0002-1178-7940; Morais, Alan/0000-0002-6974-6455;
   Silva Filho, Edson/0000-0003-0988-2970
FU Coordination Support in Higher Education (CAPES); National Council for
   Scientific and Technological Development (CNPq); Foundation of Support
   to Research of Piaui (FAPEPI)
FX The authors thank to Coordination Support in Higher Education (CAPES),
   National Council for Scientific and Technological Development (CNPq) and
   the Foundation of Support to Research of Piaui (FAPEPI) for financial
   support. The Federal University of Piaui (UFPI) and Federal Institute of
   Piaui (IFPI), to provide work research conditions.
CR Ahmad MA, 2011, CHEM ENG J, V171, P510, DOI 10.1016/j.cej.2011.04.018
   Ahmad MA, 2011, CHEM ENG J, V170, P154, DOI 10.1016/j.cej.2011.03.045
   Alencar JM, 2014, CHEM ENG J, V236, P332, DOI 10.1016/j.cej.2013.09.091
   Alshehri SM, 2014, CHEM ENG J, V254, P181, DOI 10.1016/j.cej.2014.05.100
   Barud HS, 2007, J THERM ANAL CALORIM, V87, P815, DOI 10.1007/s10973-006-8170-5
   Bezerra RDS, 2014, J ENVIRON CHEM ENG, V2, P605, DOI 10.1016/j.jece.2013.10.016
   Bezerra RDS, 2014, MATERIALS, V7, P7907, DOI 10.3390/ma7127907
   Bhattacharyya KG, 2004, J HAZARD MATER, V113, P97, DOI 10.1016/j.jhazmat.2004.05.034
   Chang PH, 2014, J HAZARD MATER, V277, P44, DOI 10.1016/j.jhazmat.2013.12.004
   Chang YK, 2006, PROCESS BIOCHEM, V41, P1864, DOI 10.1016/j.procbio.2006.03.039
   Cheng L, 2015, CHEM ENG J, V264, P672, DOI 10.1016/j.cej.2014.12.003
   Cury BSF, 2008, REACT FUNCT POLYM, V68, P1200, DOI 10.1016/j.reactfunctpolym.2008.04.003
   Daud WRW, 2011, BIORESOURCES, V6, P1719
   Fathi MR, 2015, SPECTROCHIM ACTA A, V135, P364, DOI 10.1016/j.saa.2014.07.008
   Freundlich H M F, 1906, J PHYS CHEM, V57, P385
   Granja PL, 2001, J APPL POLYM SCI, V82, P3341
   Ho YS, 1998, PROCESS SAF ENVIRON, V76, P183, DOI 10.1205/095758298529326
   Jayakumar R, 2009, POLYM ENG SCI, V49, P844, DOI 10.1002/pen.21306
   Kyzas GZ, 2015, CHEM ENG J, V259, P438, DOI 10.1016/j.cej.2014.08.019
   Lack S, 2007, CARBOHYD RES, V342, P943, DOI 10.1016/j.carres.2007.01.011
   Lagergren S, 1898, KUNGLIGA SVENSKA VET, V24, P1, DOI DOI 10.1007/BF01501332
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   Lv GC, 2013, J COLLOID INTERF SCI, V411, P198, DOI 10.1016/j.jcis.2013.08.026
   Manoi K, 2010, CARBOHYD POLYM, V81, P687, DOI 10.1016/j.carbpol.2010.03.042
   Monier M, 2014, INT J BIOL MACROMOL, V66, P125, DOI 10.1016/j.ijbiomac.2014.01.068
   Mucalo MR, 2009, COLLOID SURFACE B, V71, P52, DOI 10.1016/j.colsurfb.2009.01.004
   Nabais JMV, 2012, ADSORPT SCI TECHNOL, V30, P255, DOI 10.1260/0263-6174.30.3.255
   Oshima T, 2011, CARBOHYD POLYM, V83, P953, DOI 10.1016/j.carbpol.2010.09.005
   Real FJ, 2012, IND ENG CHEM RES, V51, P16209, DOI 10.1021/ie302470g
   Rungrodnimitchai S., 2014, J SCI WORLD, V2014, P1
   Saleh TA, 2015, CHEM ENG J, V269, P9, DOI 10.1016/j.cej.2015.01.083
   Sang Y, 2007, CARBOHYD POLYM, V67, P201, DOI 10.1016/j.carbpol.2006.05.009
   Santana S. A. A., 2010, J THERM ANAL CALORIM, V100, P315
   Sari A, 2007, J HAZARD MATER, V149, P283, DOI 10.1016/j.jhazmat.2007.03.078
   Silva LS, 2015, OPEN CHEM, V13, P801, DOI 10.1515/chem-2015-0079
   Silva LS, 2013, CHEM ENG J, V218, P89, DOI 10.1016/j.cej.2012.11.118
   Silva MMF, 2012, CHEM ENG J, V203, P259, DOI 10.1016/j.cej.2012.07.009
   Suflet DM, 2006, REACT FUNCT POLYM, V66, P1240, DOI 10.1016/j.reactfunctpolym.2006.03.006
   Temkin MI, 1940, ACTA PHYSIOCHIM USSR, V12, P217
   Vieira AP, 2011, CHEM ENG J, V173, P334, DOI 10.1016/j.cej.2011.07.043
   Vieira AP, 2009, J HAZARD MATER, V166, P1272, DOI 10.1016/j.jhazmat.2008.12.043
   Wan Z, 2015, J COLLOID INTERF SCI, V443, P115, DOI 10.1016/j.jcis.2014.12.012
   Wanrosli WD, 2011, CARBOHYD POLYM, V84, P262, DOI 10.1016/j.carbpol.2010.11.032
   Weber WJ, 1963, J SANITARY ENGINEERI, V89, P31, DOI DOI 10.1016/J.DESAL.2010.08.036
   Wijekoon KC, 2014, J MEMBRANE SCI, V453, P636, DOI 10.1016/j.memsci.2013.12.002
   Wijekoon KC, 2013, BIORESOURCE TECHNOL, V144, P247, DOI 10.1016/j.biortech.2013.06.097
   Yang M, 2014, AQUAT TOXICOL, V151, P68, DOI 10.1016/j.aquatox.2013.12.029
   Yilmaz MS, 2015, RES CHEM INTERMEDIAT, V41, P199, DOI 10.1007/s11164-013-1182-4
NR 48
TC 7
Z9 7
U1 5
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD MAY
PY 2016
VL 86
BP 362
EP 375
DI 10.1016/j.ijbiomac.2016.01.063
PG 14
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA DJ4RT
UT WOS:000374196100045
PM 26812113
DA 2018-10-20
ER

PT J
AU Moore, LB
   Sawyer, AJ
   Saucier-Sawyer, J
   Saltzman, WM
   Kyriakides, TR
AF Moore, Laura Beth
   Sawyer, Andrew J.
   Saucier-Sawyer, Jennifer
   Saltzman, W. Mark
   Kyriakides, Themis R.
TI Nanoparticle delivery of miR-223 to attenuate macrophage fusion
SO BIOMATERIALS
LA English
DT Article
DE Nanoparticle; microRNA; Biomaterial; Macrophage fusion; Foreign body
   giant cell
ID FOREIGN-BODY RESPONSE; GIANT-CELL FORMATION; IN-VIVO; OSTEOCLAST
   DIFFERENTIATION; TARGETING RAC1; E-CADHERIN; MICRORNA; EXPRESSION;
   ACTIVATION; INHIBITION
AB The foreign body response (FBR) begins with injury acquired during implantation of a biomaterial (BM) and is detrimental due to the eventual encapsulation of the implant. Fusion of macrophages to form foreign body giant cells (FBGC), a hallmark of the FBR, is the consequence of a multistep mechanism induced by interleukin (IL)-4 that includes the acquisition of a fusion competent state and subsequent cytoskeletal rearrangements. However, the precise mechanism, regulation, and interplay among molecular mediators to generate FBGCs are insufficiently understood. Seeking novel mediators of fusion that might be regulated at the post-transcriptional level, we examined the role of microRNAs (miRs) in this process. A miR microarray was screened and identified miR-223 as a negative regulator of macrophage fusion. In addition, transfection of primary macrophages with a mir-223 mimic attenuated IL-4 induced fusion. Furthermore, miR-223 KO mice and mir-223 deficient cells displayed increased fusion in vivo and in vitro, respectively. Finally, we developed a method for in vivo delivery of miR-223 mimic utilizing PLGA nanoparticles, which inhibited FBGC formation in a biomaterial implant model. Our results identify miR-223 as a negative regulator of fusion and demonstrate miR-223 mimic-loaded nanoparticles as a therapeutic inhibitor of macrophage fusion. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Moore, Laura Beth] Yale Univ, Dept Genet, New Haven, CT 06520 USA.
   [Sawyer, Andrew J.; Kyriakides, Themis R.] Yale Univ, Dept Pathol, 10 Amistad Str 3010, New Haven, CT 06520 USA.
   [Saucier-Sawyer, Jennifer; Saltzman, W. Mark; Kyriakides, Themis R.] Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA.
   [Moore, Laura Beth; Sawyer, Andrew J.; Kyriakides, Themis R.] Yale Univ, Interdept Program Vasc Biol & Therapeut, New Haven, CT 06520 USA.
RP Kyriakides, TR (reprint author), Yale Univ, Dept Pathol, 10 Amistad Str 3010, New Haven, CT 06520 USA.
EM themis.kyriakides@yale.edu
FU National Institutes of Health [GM-072194, T32HL007950-12, T32GM007223];
   CRISP [NSF MRSEC DMR 1119826]; NSF-GRFP [DGE-1122492]
FX This work was funded by National Institutes of Health Grants
   (GM-072194), CRISP (NSF MRSEC DMR 1119826), NSF-GRFP (L.B.M
   DGE-1122492), and National Institutes of Health Vascular Research
   Training Grants (T32HL007950-12; AJ.S) and (T32GM007223; L.B.M).
CR Agatheeswaran S, 2013, LEUKEMIA, V27, P1578, DOI 10.1038/leu.2012.339
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008
   Arner E, 2012, DIABETES, V61, P1986, DOI 10.2337/db11-1508
   Avula MN, 2013, BIOMATERIALS, V34, P9737, DOI 10.1016/j.biomaterials.2013.08.090
   Babar IA, 2012, P NATL ACAD SCI USA, V109, pE1695, DOI 10.1073/pnas.1201516109
   Brodbeck WG, 2009, CURR OPIN HEMATOL, V16, P53, DOI 10.1097/MOH.0b013e32831ac52e
   Chandorkar Y, 2015, BIOMACROMOLECULES, V16, P636, DOI 10.1021/bm5017282
   Cheng CJ, 2012, MOL PHARMACEUT, V9, P1481, DOI 10.1021/mp300081s
   Dadsetan M, 2003, J CONTROL RELEASE, V93, P259, DOI 10.1016/j.jconrel.2003.08.010
   Devalliere J, 2014, FASEB J, V28, P908, DOI 10.1096/fj.13-238527
   Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783
   Esau CC, 2008, METHODS, V44, P55, DOI 10.1016/j.ymeth.2007.11.001
   Helming L, 2007, IMMUNOBIOLOGY, V212, P785, DOI 10.1016/j.imbio.2007.09.012
   Helming L, 2009, TRENDS CELL BIOL, V19, P514, DOI 10.1016/j.tcb.2009.07.005
   Helming L, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159665
   Jay SM, 2007, AM J PATHOL, V171, P632, DOI 10.2353/ajpath.2007.061213
   Jay SM, 2010, J BIOMED MATER RES A, V93A, P189, DOI 10.1002/jbm.a.32513
   Kagiya T, 2013, J PERIODONTAL RES, V48, P373, DOI 10.1111/jre.12017
   Kawano S, 2011, ANN RHEUM DIS, V70, pI88, DOI 10.1136/ard.2010.138669
   Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303
   Kyriakides TR, 2004, AM J PATHOL, V165, P2157, DOI 10.1016/S0002-9440(10)63265-8
   Kyriakides TR, 2003, THROMB HAEMOSTASIS, V90, P986, DOI 10.1160/TH03-06-0399
   Li T, 2010, NAT IMMUNOL, V11, P799, DOI 10.1038/ni.1918
   Lin XJ, 2014, BIOMED REP, V2, P122, DOI 10.3892/br.2013.192
   Liu D, 2015, THROMB RES, V135, P146, DOI 10.1016/j.thromres.2014.10.027
   Look M, 2014, BIOMATERIALS, V35, P1089, DOI 10.1016/j.biomaterials.2013.10.046
   MacLauchlan S, 2009, J LEUKOCYTE BIOL, V85, P617, DOI 10.1189/jlb.1008588
   McNally AK, 2002, AM J PATHOL, V160, P621, DOI 10.1016/S0002-9440(10)64882-1
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   McNally AK, 2011, ADV EXP MED BIOL, V713, P97, DOI 10.1007/978-94-007-0763-4_7
   Moore LB, 2015, ACTA BIOMATER, V11, P37, DOI 10.1016/j.actbio.2014.09.022
   Moreno JL, 2007, J LEUKOCYTE BIOL, V82, P1542, DOI 10.1189/jlb.0107058
   Murchison EP, 2004, CURR OPIN CELL BIOL, V16, P223, DOI 10.1016/j.ceb.2004.04.003
   Ratner BD, 2002, J CONTROL RELEASE, V78, P211, DOI 10.1016/S0168-3659(01)00502-8
   Roy S, 2011, PHYSIOL GENOMICS, V43, P557, DOI 10.1152/physiolgenomics.00160.2010
   Rutnam ZJ, 2013, MATRIX BIOL, V32, P74, DOI 10.1016/j.matbio.2012.11.003
   Sazani P, 2002, NAT BIOTECHNOL, V20, P1228, DOI 10.1038/nbt759
   Sissons JR, 2012, J IMMUNOL, V189, P23, DOI 10.4049/jimmunol.1102477
   Skokos EA, 2011, AM J PATHOL, V178, P2311, DOI 10.1016/j.ajpath.2011.01.045
   Steinbach JM, 2012, J CONTROL RELEASE, V162, P102, DOI 10.1016/j.jconrel.2012.06.008
   Su SC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9523
   Sugatani T, 2007, J CELL BIOCHEM, V101, P996, DOI 10.1002/jcb.21335
   Sun G, 2013, CANCER BIOTHER RADIO, V28, P327, DOI 10.1089/cbr.2012.1380
   Sun Q, 2014, PROSTATE, V74, P1613, DOI 10.1002/pros.22878
   Udpa N, 2013, TISSUE ENG PT A, V19, P2713, DOI [10.1089/ten.tea.2012.0739, 10.1089/ten.TEA.2012.0739]
   Van den Bossche J, 2009, BLOOD, V114, P4664, DOI 10.1182/blood-2009-05-221598
   Wang Y, 2013, J CONTROL RELEASE, V169, P341, DOI 10.1016/j.jconrel.2012.12.028
   Wu LF, 2011, FEBS LETT, V585, P1322, DOI 10.1016/j.febslet.2011.03.067
   Zhang Y, 2013, J CONTROL RELEASE, V172, P962, DOI 10.1016/j.jconrel.2013.09.015
NR 50
TC 7
Z9 8
U1 0
U2 28
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2016
VL 89
BP 127
EP 135
DI 10.1016/j.biomaterials.2016.02.036
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DJ2YY
UT WOS:000374072500011
PM 26967647
OA Green Accepted, Other Gold
DA 2018-10-20
ER

PT J
AU Yigit, S
   Dinjaski, N
   Kaplan, DL
AF Yigit, Sezin
   Dinjaski, Nina
   Kaplan, David L.
TI Fibrous proteins: At the crossroads of genetic engineering and
   biotechnological applications
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Review
DE silk; elastin; collagen; recombinant proteins; fibrous proteins
ID ELASTIN-LIKE POLYPEPTIDE; SPIDER-SILK PROTEINS; RECOMBINANT HUMAN
   TROPOELASTIN; COLLAGEN-LIKE PROTEINS; YEAST PICHIA-PASTORIS; BOMBYX-MORI
   SILK; RECURSIVE DIRECTIONAL LIGATION; HUMAN PROLYL 4-HYDROXYLASE;
   EXPRESSED HUMAN ELASTIN; CLAVIPES DRAGLINE SILK
AB Fibrous proteins, such as silk, elastin and collagen are finding broad impact in biomaterial systems for a range of biomedical and industrial applications. Some of the key advantages of biosynthetic fibrous proteins compared to synthetic polymers include the tailorability of sequence, protein size, degradation pattern, and mechanical properties. Recombinant DNA production and precise control over genetic sequence of these proteins allows expansion and fine tuning of material properties to meet the needs for specific applications. We review current approaches in the design, cloning, and expression of fibrous proteins, with a focus on strategies utilized to meet the challenges of repetitive fibrous protein production. We discuss recent advances in understanding the fundamental basis of structure-function relationships and the designs that foster fibrous protein self-assembly towards predictable architectures and properties for a range of applications. We highlight the potential of functionalization through genetic engineering to design fibrous protein systems for biotechnological and biomedical applications. Biotechnol. Bioeng. 2016;113: 913-929. (c) 2015 Wiley Periodicals, Inc.
C1 [Yigit, Sezin; Dinjaski, Nina; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Yigit, Sezin] Tufts Univ, Dept Chem, Somerville, MA 02145 USA.
   [Dinjaski, Nina] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
EM David.Kaplan@Tufts.edu
FU NIH [P41 EB002520]; AFOSR; NSF IGERT
FX Contract grant sponsor: NIH; Contract grant number: P41 EB002520;
   Contract grant sponsor: AFOSR; Contract grant sponsor: NSF IGERT
CR Allmeling C, 2006, J CELL MOL MED, V10, P770, DOI 10.2755/jcmm010.003.18
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Amiram M, 2011, NAT MATER, V10, P141, DOI [10.1038/nmat2942, 10.1038/NMAT2942]
   Amruthwar SS, 2012, J MATER SCI-MATER M, V23, P2903, DOI 10.1007/s10856-012-4749-5
   An B, 2014, J BIOL CHEM, V289, P4941, DOI 10.1074/jbc.M113.530808
   An B, 2013, BIOMATERIALS, V34, P402, DOI 10.1016/j.biomaterials.2012.09.085
   Arai T, 2001, J APPL POLYM SCI, V80, P297, DOI 10.1002/1097-4628(20010411)80:2<297::AID-APP1099>3.3.CO;2-Q
   Arcidiacono S, 2002, MACROMOLECULES, V35, P1262, DOI 10.1021/ma011471o
   Arcidiacono S, 1998, APPL MICROBIOL BIOT, V49, P31, DOI 10.1007/s002530051133
   Asai D, 2012, BIOMATERIALS, V33, P5451, DOI 10.1016/j.biomaterials.2012.03.083
   Assal Y, 2013, BIOMATERIALS, V34, P3315, DOI 10.1016/j.biomaterials.2013.01.067
   Baek DH, 2007, FIBER POLYM, V8, P271, DOI 10.1007/BF02877269
   Bai LQ, 2008, APPL SURF SCI, V254, P2988, DOI 10.1016/j.apsusc.2007.10.049
   Bandiera A, 2014, BIOMACROMOLECULES, V15, P416, DOI 10.1021/bm401677n
   Baneyx F, 1999, CURR OPIN BIOTECH, V10, P411, DOI 10.1016/S0958-1669(99)00003-8
   Beck K, 2000, P NATL ACAD SCI USA, V97, P4273, DOI 10.1073/pnas.070050097
   BEDELLHOGAN D, 1993, J BIOL CHEM, V268, P10345
   BELLA J, 1995, STRUCTURE, V3, P893, DOI 10.1016/S0969-2126(01)00224-6
   Bellas E, 2012, MACROMOL BIOSCI, V12, P1627, DOI 10.1002/mabi.201200262
   Bellingham CM, 2001, BBA-PROTEIN STRUCT M, V1550, P6, DOI 10.1016/S0167-4838(01)00262-X
   BELLOWS CG, 1986, CALCIFIED TISSUE INT, V38, P143, DOI 10.1007/BF02556874
   Bessa PC, 2010, J TISSUE ENG REGEN M, V4, P349, DOI 10.1002/term.245
   Betre H, 2006, J CONTROL RELEASE, V115, P175, DOI 10.1016/j.jconrel.2006.07.022
   Bhardwaj N, 2011, CARBOHYD POLYM, V85, P325, DOI 10.1016/j.carbpol.2011.02.027
   Boydston JA, 2005, J BACTERIOL, V187, P5310, DOI 10.1128/JB.187.15.5310-5317.2005
   Bozzini S, 2011, J MATER SCI-MATER M, V22, P2641, DOI 10.1007/s10856-011-4451-z
   Bracalello A, 2011, BIOMACROMOLECULES, V12, P2957, DOI 10.1021/bm2005388
   Bretscher LE, 2001, J AM CHEM SOC, V123, P777, DOI 10.1021/ja005542v
   Briggs AW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks624
   Brodsky B, 2005, ADV PROTEIN CHEM, V70, P301, DOI 10.1016/S0065-3233(05)70009-7
   Cai L, 2014, BIOMATER SCI-UK, V2, P757, DOI 10.1039/c3bm60293a
   Cai ZX, 2010, INT J MOL SCI, V11, P3529, DOI 10.3390/ijms11093529
   CANDELAS GC, 1990, DEV BIOL, V140, P215, DOI 10.1016/0012-1606(90)90069-U
   Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731
   Cappello J, 1998, J CONTROL RELEASE, V53, P105, DOI 10.1016/S0168-3659(97)00243-5
   CAPPELLO J, 1990, TRENDS BIOTECHNOL, V8, P309, DOI 10.1016/0167-7799(90)90207-E
   Caves JM, 2010, BIOMATERIALS, V31, P7175, DOI 10.1016/j.biomaterials.2010.05.014
   Chen GQ, 2009, CHEM SOC REV, V38, P2434, DOI 10.1039/b812677c
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   Chiarini A, 2003, BIOMATERIALS, V24, P789, DOI 10.1016/S0142-9612(02)00417-9
   Chow D, 2008, MAT SCI ENG R, V62, P125, DOI 10.1016/j.mser.2008.04.004
   Ciofani G, 2014, MACROMOL BIOSCI, V14, P632, DOI 10.1002/mabi.201300361
   Costa RR, 2013, NANOMED-NANOTECHNOL, V9, P895, DOI 10.1016/j.nano.2013.01.013
   Costa RR, 2013, J PHYS CHEM B, V117, P6839, DOI 10.1021/jp4028518
   Cranford SW, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0148
   Dams-Kozlowska H, 2013, J BIOMED MATER RES A, V101, P456, DOI 10.1002/jbm.a.34353
   Dash BC, 2011, J CONTROL RELEASE, V152, P382, DOI 10.1016/j.jconrel.2011.03.006
   Dreher MR, 2008, J AM CHEM SOC, V130, P687, DOI 10.1021/ja0764862
   Eles PT, 2004, BIOMACROMOLECULES, V5, P661, DOI 10.1021/bm0342685
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P23, DOI 10.1007/s002530050883
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P33, DOI 10.1007/s002530050884
   FAZIO MJ, 1988, J INVEST DERMATOL, V91, P458, DOI 10.1111/1523-1747.ep12476591
   Fukushima Y, 1998, BIOPOLYMERS, V45, P269, DOI 10.1002/(SICI)1097-0282(19980405)45:4<269::AID-BIP1>3.0.CO;2-J
   Gagner JE, 2014, ACTA BIOMATER, V10, P1542, DOI 10.1016/j.actbio.2013.10.001
   Garcia Y, 2009, TISSUE ENG PT A, V15, P887, DOI 10.1089/ten.tea.2008.0104
   Gasser B, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-11
   Gebauer M, 2009, CURR OPIN CHEM BIOL, V13, P245, DOI 10.1016/j.cbpa.2009.04.627
   GEDDIS AE, 1993, MATRIX, V13, P399, DOI 10.1016/S0934-8832(11)80045-4
   Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010
   Girotti A, 2011, BIOTECHNOL J, V6, P1174, DOI 10.1002/biot.201100116
   GOLDBERG I, 1989, GENE, V80, P305, DOI 10.1016/0378-1119(89)90294-1
   Gomes SC, 2011, BIOMATERIALS, V32, P4255, DOI 10.1016/j.biomaterials.2011.02.040
   GRAY WR, 1973, NATURE, V246, P461, DOI 10.1038/246461a0
   Gronau G, 2012, BIOMATERIALS, V33, P8240, DOI 10.1016/j.biomaterials.2012.06.054
   Hayashi CY, 1998, J MOL BIOL, V275, P773, DOI 10.1006/jmbi.1997.1478
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   HINMAN MB, 1992, J BIOL CHEM, V267, P19320
   Hiob MA, 2013, BIOMATERIALS, V34, P7584, DOI 10.1016/j.biomaterials.2013.06.036
   Hsueh YS, 2014, MAT SCI ENG C-MATER, V38, P119, DOI 10.1016/j.msec.2014.01.058
   Hu F, 2010, APPL BIOCHEM BIOTECH, V160, P2377, DOI 10.1007/s12010-009-8850-2
   Hu X, 2006, CELL MOL LIFE SCI, V63, P1986, DOI 10.1007/s00018-006-6090-y
   Hu XA, 2010, BIOMATERIALS, V31, P8121, DOI 10.1016/j.biomaterials.2010.07.044
   Huang L, 2000, MACROMOLECULES, V33, P2989, DOI 10.1021/ma991858f
   Huemmerich D, 2004, CURR BIOL, V14, P2070, DOI 10.1016/j.cub.2004.11.005
   Huemmerich D, 2004, BIOCHEMISTRY-US, V43, P13604, DOI 10.1021/bi048983q
   INDIK Z, 1990, ARCH BIOCHEM BIOPHYS, V280, P80, DOI 10.1016/0003-9861(90)90521-Y
   Islam MM, 2015, ACTA BIOMATER, V12, P70, DOI 10.1016/j.actbio.2014.10.035
   Ito H, 2006, J BIOMED MATER RES A, V76A, P551, DOI 10.1002/jbm.a.30551
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   John DCA, 1999, NAT BIOTECHNOL, V17, P385, DOI 10.1038/7945
   Jordan SW, 2007, BIOMATERIALS, V28, P1191, DOI 10.1016/j.biomaterials.2006.09.048
   Kaplan DL, 1998, POLYM DEGRAD STABIL, V59, P25, DOI 10.1016/S0141-3910(97)00000-1
   Kaufmann D, 2008, MACROMOL BIOSCI, V8, P577, DOI 10.1002/mabi.200700234
   Keane MA, 2009, CHEMSUSCHEM, V2, P207, DOI 10.1002/cssc.200900001
   Keeley FW, 2002, PHILOS T R SOC B, V357, P185, DOI 10.1098/rstb.2001.1027
   Keten S, 2010, NAT MATER, V9, P359, DOI [10.1038/NMAT2704, 10.1038/nmat2704]
   Khadka DB, 2014, POLYMER, V55, P2163, DOI 10.1016/j.polymer.2014.03.012
   Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775
   Kim S, 2014, NAT NANOTECHNOL, V9, P306, DOI [10.1038/nnano.2014.47, 10.1038/NNANO.2014.47]
   Kim W, 2012, ACTA BIOMATER, V8, P2476, DOI 10.1016/j.actbio.2012.04.011
   KING RD, 1994, PROTEIN ENG, V7, P1295, DOI 10.1093/protein/7.11.1295
   Kinikoglu B, 2011, J MATER SCI-MATER M, V22, P1541, DOI 10.1007/s10856-011-4315-6
   Kolbe A, 2011, MACROMOL RAPID COMM, V32, P186, DOI 10.1002/marc.201000491
   Koria P, 2011, P NATL ACAD SCI USA, V108, P1034, DOI 10.1073/pnas.1009881108
   Krishna UM, 2012, ACTA BIOMATER, V8, P988, DOI 10.1016/j.actbio.2011.11.024
   Kumar VA, 2014, BIOMED MATER, V9, P1
   Kurihara H, 2005, BIOTECHNOL LETT, V27, P665, DOI 10.1007/s10529-005-4477-8
   Kweon H, 2001, J APPL POLYM SCI, V80, P928, DOI 10.1002/app.1172
   Lao UL, 2007, BIOMACROMOLECULES, V8, P3736, DOI 10.1021/bm700662n
   LAPIERE CM, 1971, P NATL ACAD SCI USA, V68, P3054, DOI 10.1073/pnas.68.12.3054
   Laurencin CT, 1996, BONE, V19, P93
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lee KH, 2007, INT J BIOL MACROMOL, V41, P168, DOI 10.1016/j.ijbiomac.2007.01.011
   Lee S, 2011, ACTA BIOMATER, V7, P3868, DOI 10.1016/j.actbio.2011.06.035
   Lee TAT, 2000, ADV MATER, V12, P1105, DOI 10.1002/1521-4095(200008)12:15<1105::AID-ADMA1105>3.0.CO;2-1
   Lefevre T, 2007, BIOPHYS J, V92, P2885, DOI 10.1529/biophysj.106.100339
   LEHRACH H, 1978, P NATL ACAD SCI USA, V75, P5417, DOI 10.1073/pnas.75.11.5417
   Leong YK, 2014, J BIOTECHNOL, V180, P52, DOI 10.1016/j.jbiotec.2014.03.020
   Lewis RV, 1996, PROTEIN EXPRES PURIF, V7, P400, DOI 10.1006/prep.1996.0060
   Li L, 2013, ACS MACRO LETT, V2, P635, DOI 10.1021/mz4002194
   Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030
   Li MZ, 2002, INT J BIOL MACROMOL, V30, P89, DOI 10.1016/S0141-8130(02)00007-7
   Liu HT, 2008, MATER LETT, V62, P1949, DOI 10.1016/j.matlet.2007.10.061
   Lu Q, 2012, BIOMACROMOLECULES, V13, P826, DOI 10.1021/bm201731e
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Mamat U, 2008, MOL MICROBIOL, V67, P633, DOI 10.1111/j.1365-2958.2007.06074.x
   Mandal BB, 2012, P NATL ACAD SCI USA, V109, P7699, DOI 10.1073/pnas.1119474109
   Marsano E, 2008, INT J BIOL MACROMOL, V43, P106, DOI 10.1016/j.ijbiomac.2008.03.009
   Martin L, 2010, SOFT MATTER, V6, P1121, DOI 10.1039/b923684h
   Martin L, 2009, BIOMACROMOLECULES, V10, P3015, DOI 10.1021/bm900560a
   MARTIN SL, 1995, GENE, V154, P159, DOI 10.1016/0378-1119(94)00848-M
   Massodi I, 2005, J CONTROL RELEASE, V108, P396, DOI 10.1016/j.jcornel.2005.08.007
   Massodi I, 2007, J DRUG TARGET, V15, P611, DOI 10.1080/10611860701502780
   Mayne R, 1993, CURR OPIN CELL BIOL, V5, P883, DOI 10.1016/0955-0674(93)90039-S
   McDaniel JR, 2013, ANGEW CHEM INT EDIT, V52, P1683, DOI 10.1002/anie.201200899
   McDaniel JR, 2010, BIOMACROMOLECULES, V11, P944, DOI 10.1021/bm901387t
   McGrath K. P., 1997, PROTEIN BASED MAT
   McHale MK, 2005, TISSUE ENG, V11, P1768, DOI 10.1089/ten.2005.11.1768
   MCPHERSON DT, 1992, BIOTECHNOL PROGR, V8, P347, DOI 10.1021/bp00016a012
   McPherson DT, 1996, PROTEIN EXPRES PURIF, V7, P51, DOI 10.1006/prep.1996.0008
   MCPHERSON JM, 1985, COLLAGEN REL RES, V5, P119
   Megeed Z, 2004, J CONTROL RELEASE, V94, P433, DOI 10.1016/j.jconrel.2003.10.027
   Mello CM, 2004, BIOMACROMOLECULES, V5, P1849, DOI 10.1021/bm049815g
   Meyer DE, 2002, BIOMACROMOLECULES, V3, P357, DOI 10.1021/bm015630n
   Meyer DE, 1999, NAT BIOTECHNOL, V17, P1112, DOI 10.1038/15100
   Miao M, 2005, BIOCHEMISTRY-US, V44, P14367, DOI 10.1021/bi0510173
   Miao M, 2003, J BIOL CHEM, V278, P48553, DOI 10.1074/jbc.M308465200
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   Mohs A, 2007, J BIOL CHEM, V282, P29757, DOI 10.1074/jbc.M703991200
   Motriuk-Smith D, 2005, BIOMACROMOLECULES, V6, P3152, DOI 10.1021/bm050472b
   Myllyharju J, 2000, BIOCHEM SOC T, V28, P353, DOI 10.1042/0300-5127:0280353
   Nagae M, 2007, TISSUE ENG, V13, P147, DOI 10.1089/ten.2006.0042
   Nath N, 2003, ANAL CHEM, V75, P709, DOI 10.1021/ac0261855
   NICOL A, 1991, J VASC SURG, V13, P746, DOI 10.1016/0741-5214(91)90373-3
   Nivison-Smith L, 2010, ACTA BIOMATER, V6, P354, DOI 10.1016/j.actbio.2009.08.011
   Nokelainen M, 1998, MATRIX BIOL, V16, P329, DOI 10.1016/S0945-053X(98)90004-X
   Nokelainen M, 2001, YEAST, V18, P797, DOI 10.1002/yea.730
   Notbohm H, 1999, J BIOL CHEM, V274, P8988, DOI 10.1074/jbc.274.13.8988
   Nuhn H, 2008, BIOMACROMOLECULES, V9, P2755, DOI 10.1021/bm800784y
   Numata K, 2011, BIOCONJUGATE CHEM, V22, P1605, DOI 10.1021/bc200170u
   Numata K, 2010, ADV DRUG DELIVER REV, V62, P1497, DOI 10.1016/j.addr.2010.03.009
   Numata K, 2009, BIOMATERIALS, V30, P5775, DOI 10.1016/j.biomaterials.2009.06.028
   Olsen D, 2003, ADV DRUG DELIVER REV, V55, P1547, DOI 10.1016/j.addr.2003.08.008
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Osborne JL, 2008, ACTA BIOMATER, V4, P49, DOI 10.1016/j.actbio.2007.07.007
   Otero JM, 2010, BIOTECHNOL BIOENG, V105, P439, DOI 10.1002/bit.22592
   Park KE, 2006, INT J BIOL MACROMOL, V38, P165, DOI 10.1016/j.ijbiomac.2006.03.003
   Perret S, 2001, J BIOL CHEM, V276, P43693, DOI 10.1074/jbc.M105507200
   PIEZ KA, 1960, J BIOL CHEM, V235, P995
   Pinkas DM, 2011, ACS CHEM BIOL, V6, P320, DOI 10.1021/cb100298r
   PRINCE JT, 1995, BIOCHEMISTRY-US, V34, P10879, DOI 10.1021/bi00034a022
   Qiu WG, 2010, BIOMACROMOLECULES, V11, P3219, DOI 10.1021/bm100469w
   Rabotyagova OS, 2009, BIOMACROMOLECULES, V10, P229, DOI 10.1021/bm800930x
   Rammensee S, 2008, P NATL ACAD SCI USA, V105, P6590, DOI 10.1073/pnas.0709246105
   Rasmussen M, 2003, J BIOL CHEM, V278, P32313, DOI 10.1074/jbc.M304709200
   Ricci G, 2006, DERMATOLOGY, V213, P224, DOI 10.1159/000095040
   Rising A, 2006, BIOMACROMOLECULES, V7, P3120, DOI 10.1021/bm060693x
   Rodgers UR, 2004, BIOCHIMIE, V86, P173, DOI 10.1016/j.biochi.2004.03.002
   Rueda F, 2014, APPL MICROBIOL BIOT, V98, P9229, DOI 10.1007/s00253-014-6008-9
   Sarangthem V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081891
   Sato F, 2006, CLIN BIOCHEM, V39, P746, DOI 10.1016/j.clinbiochem.2006.02.017
   Scheibel T, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-14
   Scheller J, 2004, TRANSGENIC RES, V13, P51, DOI 10.1023/B:TRAG.0000017175.78809.7a
   Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335
   Seib FP, 2012, BIOMATERIALS, V33, P8442, DOI 10.1016/j.biomaterials.2012.08.004
   Sionkowska A, 2011, PROG POLYM SCI, V36, P1254, DOI 10.1016/j.progpolymsci.2011.05.003
   SOBEL ME, 1978, P NATL ACAD SCI USA, V75, P5846, DOI 10.1073/pnas.75.12.5846
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Srokowski EM, 2014, J BIOMED MATER RES A, V102, P540, DOI 10.1002/jbm.a.34699
   Stark M, 2007, BIOMACROMOLECULES, V8, P1695, DOI 10.1021/bm070049y
   STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4
   STERNBERG MJE, 1977, J MOL BIOL, V115, P1, DOI 10.1016/0022-2836(77)90242-X
   Stone PJ, 2001, AM J RESP CELL MOL, V24, P733, DOI 10.1165/ajrcmb.24.6.4304
   Szela S, 2000, BIOMACROMOLECULES, V1, P534, DOI 10.1021/bm0055697
   Tang-Schomer MD, 2014, P NATL ACAD SCI USA, V111, P13811, DOI 10.1073/pnas.1324214111
   Tao H, 2014, P NATL ACAD SCI USA, V111, P17385, DOI 10.1073/pnas.1407743111
   Tejeda-Montes E, 2014, ACTA BIOMATER, V10, P134, DOI 10.1016/j.actbio.2013.09.001
   TILLET E, 1994, EUR J BIOCHEM, V221, P177, DOI 10.1111/j.1432-1033.1994.tb18727.x
   Tokareva O, 2013, MICROB BIOTECHNOL, V6, P651, DOI 10.1111/1751-7915.12081
   Toman PD, 2000, J BIOL CHEM, V275, P23303, DOI 10.1074/jbc.M002284200
   Trabbic-Carlson K, 2004, PROTEIN SCI, V13, P3274, DOI 10.1110/ps.04931604
   Traub W, 1971, Adv Protein Chem, V25, P243, DOI 10.1016/S0065-3233(08)60281-8
   Tsukada M, 2003, J APPL POLYM SCI, V89, P638, DOI 10.1002/app.11911
   URRY DW, 1992, PROG BIOPHYS MOL BIO, V57, P23, DOI 10.1016/0079-6107(92)90003-O
   URRY DW, 1974, BIOCHIM BIOPHYS ACTA, V371, P597, DOI 10.1016/0005-2795(74)90057-9
   Valluzzi R, 1999, J PHYS CHEM B, V103, P11382, DOI 10.1021/jp991363s
   Vendrely C, 2007, MACROMOL BIOSCI, V7, P401, DOI 10.1002/mabi.200600255
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vuorela A, 1997, EMBO J, V16, P6702, DOI 10.1093/emboj/16.22.6702
   Wagenseil Jessica E., 2007, Birth Defects Research, V81, P229, DOI 10.1002/bdrc.20111
   Wang E, 2013, NANO LETT, V13, P2826, DOI 10.1021/nl401088b
   Wang XY, 2006, MATER TODAY, V9, P44, DOI 10.1016/S1369-7021(06)71742-4
   Wang Y, 2014, CURR OPIN BIOTECH, V30, P59, DOI 10.1016/j.copbio.2014.06.001
   Waterhouse A, 2010, BIOMATERIALS, V31, P8332, DOI 10.1016/j.biomaterials.2010.07.062
   Wenk E, 2008, J CONTROL RELEASE, V132, P26, DOI 10.1016/j.jconrel.2008.08.005
   Werkmeister JA, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/1/012002
   WHITESIDES GM, 1991, SCIENCE, V254, P1312, DOI 10.1126/science.1962191
   Widmaier DM, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.62
   Winkler S, 2000, BIOCHEMISTRY-US, V39, P12739, DOI 10.1021/bi001335w
   Wise SG, 2014, ACTA BIOMATER, V10, P1532, DOI 10.1016/j.actbio.2013.08.003
   Wise SG, 2011, ACTA BIOMATER, V7, P295, DOI 10.1016/j.actbio.2010.07.022
   Wise SG, 2009, INT J BIOCHEM CELL B, V41, P494, DOI 10.1016/j.biocel.2008.03.017
   Wong Foo Po C, 2002, ADV DRUG DELIV REV, V54, P1131
   Wong Po Foo C, 2006, P NATL ACAD SCI USA, V103, P9428
   Wu WY, 2006, NAT PROTOC, V1, P2257, DOI 10.1038/nprot.2006.314
   Wu WJ, 1999, J BIOL CHEM, V274, P21719, DOI 10.1074/jbc.274.31.21719
   Xia XX, 2011, BIOMACROMOLECULES, V12, P3844, DOI 10.1021/bm201165h
   Xia XX, 2010, P NATL ACAD SCI USA, V107, P14059, DOI 10.1073/pnas.1003366107
   Xiong AS, 2008, FEMS MICROBIOL REV, V32, P522, DOI 10.1111/j.1574-6976.2008.00109.x
   Xu CY, 2010, BIOMACROMOLECULES, V11, P348, DOI 10.1021/bm900894b
   Xu LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050227
   XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120
   Xu X, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-69
   Yamauchi M, 2012, ESSAYS BIOCHEM, V52, P113, DOI [10.1042/BSE0520113, 10.1042/bse0520113]
   Yang CL, 2004, BIODRUGS, V18, P103, DOI 10.2165/00063030-200418020-00004
   Yang G, 2002, J MEMBRANE SCI, V210, P379, DOI 10.1016/S0376-7388(02)00419-2
   Yao JM, 2004, J BIOCHEM, V136, P643, DOI 10.1093/jb/mvh172
   Yigit S, 2014, MACROMOL BIOSCI, V14, P1291, DOI 10.1002/mabi.201400113
   Yoo CR, 2008, INT J BIOL MACROMOL, V42, P324, DOI 10.1016/j.ijbiomac.2007.12.004
   Yoo MK, 2004, INT J BIOL MACROMOL, V34, P263, DOI 10.1016/j.ijbiomac.2004.06.002
   Yoshizumi A, 2009, PROTEIN SCI, V18, P1241, DOI 10.1002/pro.134
   Yu ZX, 2014, J STRUCT BIOL, V186, P451, DOI 10.1016/j.jsb.2014.01.003
   Zhang YS, 2008, MOL BIOL REP, V35, P329, DOI 10.1007/s11033-007-9090-6
   Zhou YT, 2001, BIOMACROMOLECULES, V2, P111, DOI 10.1021/bm005598h
   Zhu ZH, 2008, J APPL POLYM SCI, V109, P2956, DOI 10.1002/app.28460
NR 237
TC 8
Z9 8
U1 4
U2 73
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3592
EI 1097-0290
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD MAY
PY 2016
VL 113
IS 5
BP 913
EP 929
DI 10.1002/bit.25820
PG 17
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA DI4NN
UT WOS:000373476700001
PM 26332660
DA 2018-10-20
ER

PT J
AU Sharma, LA
   Ali, MA
   Love, RM
   Wilson, MJ
   Dias, GJ
AF Sharma, L. Ajay
   Ali, M. A.
   Love, R. M.
   Wilson, M. J.
   Dias, G. J.
TI Novel keratin preparation supports growth and differentiation of
   odontoblast-like cells
SO INTERNATIONAL ENDODONTIC JOURNAL
LA English
DT Article
DE bioactivity; hydrogel; odontoblasts; polymers; scaffold
ID PULP STEM-CELLS; DENTIN MATRIX PROTEIN-1; IN-VITRO; ODONTOGENIC
   DIFFERENTIATION; TOOTH-TISSUE; OVINE MODEL; SCAFFOLDS; PROLIFERATION;
   SPONGE; OSSEOINTEGRATION
AB AimTo fabricate a keratin hydrogel, characterize its functionality as a biomaterial and investigate the effects of keratin on growth and differentiation of odontoblast-like cells.
   MethodologyKeratins were extracted from sheep wool using a well-established technique. The extracted proteins were purified by dialysis, quantified by gel electrophoresis, mass spectrometry, amino acid analysis and inductively coupled mass spectrometry. The microstructure of the fabricated keratin hydrogels was studied by scanning electron microscopy, flow characteristics by rheometer, hydrolytic stability and cytocompatibility by Live/Dead((R)) cell assay. Furthermore, the influence of keratin on odontoblast-like cells (MDPC-23) was assessed to confirm their bioactivity at different dilutions. Cell proliferation was studied using alamarBlue((R)) assay and differentiation by alkaline phosphatase enzyme activity, alizarin red staining and calcium quantification, reverse transcription polymerase chain reaction (rt-PCR) and immunocytochemical staining for dentine matrix protein- 1 (DMP-1) expression. anova with Tukey's tests was performed for statistical comparison.
   ResultsThe characterized hydrogel was injectable with a highly porous architecture that underwent slow degradation, and its cytocompatibility was statistically equivalent to collagen hydrogel (P>0.05). Cell proliferation and differentiation were enhanced at the optimal keratin concentration of 0.1mgmL(-1). At this concentration, the influence of keratin on cell differentiation was demonstrated by marked elevation in alkaline phosphatase activity (P<0.05), calcium deposition (P<0.01), gene expression (P<0.01) and positive immunostaining for DMP-1.
   ConclusionThe presence of keratin enhanced odontoblast cell behaviour. Keratin hydrogels may be a potential scaffold for pulp-dentine regen-eration.
C1 [Sharma, L. Ajay; Wilson, M. J.; Dias, G. J.] Univ Otago, Dept Anat, Dunedin, New Zealand.
   [Ali, M. A.] Univ Otago, Dept Appl Sci, Dunedin, New Zealand.
   [Love, R. M.] Univ Otago, Dept Oral Rehabil, Dunedin, New Zealand.
RP Sharma, LA (reprint author), Univ Otago, Otago Sch Med Sci, Dept Anat, Dunedin, New Zealand.
EM ajala685@student.otago.ac.nz
OI Love, Robert/0000-0001-7262-2990; Wilson, Megan/0000-0003-3425-5071
FU New Zealand Dental association Research Fund; Maurice and Phyllis Paykel
   Trust
FX This research is supported by New Zealand Dental association Research
   Fund and The Maurice and Phyllis Paykel Trust. We wish to acknowledge
   the assistance of Dr Aladin Beckitt, Department of food Science,
   University of Otago, for his guidance during sample preparation. Our
   thanks to Professor Jacques E. Nor, University of Michigan, USA, for
   providing us with MDPC-23 cells. We like to thank Mr Andrew McNaughton,
   Otago Center for Confocal Microscopy, and Ms Liz Girwan, Otago Center
   for Electron Microscopy for their assistance in microscopy. Finally, Mr
   Robbie McPhee for his help with Fig. 1. We the authors of this
   manuscript declare that there is no potential conflict of interest with
   respect to the authorship and/or publication of this article.
CR Albuquerque MTP, 2014, J DENT RES, V93, P1222, DOI 10.1177/0022034514549809
   Alsanea R, 2011, J ENDODONT, V37, P1092, DOI 10.1016/j.joen.2011.05.019
   Baba O, 2004, MATRIX BIOL, V23, P371, DOI 10.1016/j.matnio.2004.07.008
   Dias GJ, 2010, J BIOMED MATER RES A, V95A, P1084, DOI 10.1002/jbm.a.32908
   Dias GJ, 2010, J BIOMED MATER RES A, V92A, P513, DOI 10.1002/jbm.a.32394
   Feng JQ, 2003, J DENT RES, V82, P776, DOI 10.1177/154405910308201003
   Galler K M, 2011, Adv Dent Res, V23, P333, DOI 10.1177/0022034511405326
   Galler KM, 2012, TISSUE ENG PT A, V18, P176, DOI [10.1089/ten.tea.2011.0222, 10.1089/ten.TEA.2011.0222]
   Goldberg M, 2011, Adv Dent Res, V23, P270, DOI 10.1177/0022034511405385
   Hanks CT, 1998, CONNECT TISSUE RES, V37, P233, DOI 10.3109/03008209809002442
   Hesse M, 2004, EUR J CELL BIOL, V83, P19, DOI 10.1078/0171-9335-00354
   Hill P, 2010, BIOMATERIALS, V31, P585, DOI 10.1016/j.biomaterials.2009.09.076
   Hill PS, 2011, TISSUE ENG PT A, V17, P1499, DOI 10.1089/ten.tea.2010.0184
   Huang George T-J, 2011, Front Biosci (Elite Ed), V3, P788, DOI 10.2741/e286
   Iohara K, 2009, REGEN MED, V4, P377, DOI 10.2217/RME.09.5
   Kelly RJ, 2012, United States patent US, Patent No. [8142807 B2, 8142807]
   Koehn H, 2010, J PROTEOME RES, V9, P2920, DOI 10.1021/pr901106m
   Kumar GS, 2014, ORBANS ORAL HISTOLOG, P93
   Nakashima M, 2011, Adv Dent Res, V23, P313, DOI 10.1177/0022034511405323
   Narayanan K, 2003, J BIOL CHEM, V278, P17500, DOI 10.1074/jbc.M212700200
   NOISHIKI Y, 1982, KOBUNSHI RONBUNSHU, V39, P221, DOI 10.1295/koron.39.221
   Orsini G, 2008, EUR J HISTOCHEM, V52, P215
   Plowman JE, 2003, J CHROMATOGR B, V787, P63, DOI 10.1016/S1570-0232(02)00211-8
   Prescott RS, 2008, J ENDODONT, V34, P421, DOI 10.1016/j.joen.2008.02.005
   Rouse JG, 2010, MATERIALS, V3, P999, DOI 10.3390/ma3020999
   Sando L, 2010, J BIOMED MATER RES A, V95A, P901, DOI 10.1002/jbm.a.32913
   Shui CX, 2001, J BONE MINER RES, V16, P731, DOI 10.1359/jbmr.2001.16.4.731
   Sierpinski P, 2008, BIOMATERIALS, V29, P118, DOI 10.1016/j.biomaterials.2007.08.023
   Sumita Y, 2006, BIOMATERIALS, V27, P3238, DOI 10.1016/j.biomaterials.2006.01.055
   Tachibana A, 2002, J BIOTECHNOL, V93, P165, DOI 10.1016/S0168-1656(01)00395-9
   Tachibana A, 2006, J BIOSCI BIOENG, V102, P425, DOI 10.1263/jbb.102.425
   THOMAS H, 1986, INT J BIOL MACROMOL, V8, P258, DOI 10.1016/0141-8130(86)90038-3
   Verma V, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/2/025007
   Wang J, 2011, BIOMATERIALS, V32, P7822, DOI 10.1016/j.biomaterials.2011.04.034
   Wang J, 2010, ACTA BIOMATER, V6, P3856, DOI 10.1016/j.actbio.2010.04.009
   Wang S, 2012, CELL TISSUE RES, V347, P795, DOI 10.1007/s00441-011-1295-2
   Yamauchi K, 1996, J BIOMED MATER RES, V31, P439, DOI 10.1002/(SICI)1097-4636(199608)31:4<439::AID-JBM1>3.0.CO;2-M
   Ye L, 2004, J BIOL CHEM, V279, P19141, DOI 10.1074/jbc.M400490200
   Zhang HM, 2012, TISSUE ENG PT A, V18, P677, DOI [10.1089/ten.tea.2011.0269, 10.1089/ten.TEA.2011.0269]
   Zhang WB, 2006, BIOMATERIALS, V27, P5658, DOI 10.1016/j.biomaterials.2006.07.013
   Zheng LQ, 2011, BIOMATERIALS, V32, P7053, DOI [10.1016/j.biomaterials.2011.06.094, 10.1016/j.biomaterials.2011.06.004]
NR 41
TC 6
Z9 6
U1 3
U2 17
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0143-2885
EI 1365-2591
J9 INT ENDOD J
JI Int. Endod. J.
PD MAY
PY 2016
VL 49
IS 5
BP 471
EP 482
DI 10.1111/iej.12476
PG 12
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA DJ0PS
UT WOS:000373907000007
PM 26016886
DA 2018-10-20
ER

PT J
AU Yuan, F
   Lin, LX
   Zhang, HH
   Huang, D
   Sun, YL
AF Yuan, Fang
   Lin, Long-Xiang
   Zhang, Hui-Hui
   Huang, Dan
   Sun, Yu-Long
TI Effect of carbodiimide-derivatized hyaluronic acid gelatin on preventing
   postsurgical intra-abdominal adhesion formation and promoting healing in
   a rat model
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE postsurgical intra-abdominal adhesion; hyaluronic acid; hydrogel;
   healing
ID CANINE MODEL; PERITONEAL ADHESIONS; EXTRASYNOVIAL TENDON; SODIUM
   HYALURONATE; RABBIT MODEL; IN-VIVO; REDUCTION; SURFACE; GEL;
   CARBOXYMETHYLCELLULOSE
AB Adhesions often occur after abdominal surgery. It could cause chronic pelvic pain, intestinal obstruction, and infertility. A hydrogel biomaterial, carbodiimide-derivatized hyaluronic acid gelatin (cd-HA gelatin), has been successfully used to reduce adhesion formation after flexor tendon grafting. This study investigated the efficacy of cd-HA gelatin in preventing postsurgical peritoneal adhesions in a rat model. The surgical traumas were created on the underlying muscle of the abdominal wall and the serosal layer of the cecum. The wounds were covered with or without cd-HA gelatin. Animals were euthanized at day 14 after surgery. Adhesion formation was assessed with adhesion degree and adhesion breaking strength. The healing of abdominal wall was evaluated with biomechanical testing and histological analysis. The adhesions occurred in all rats (n=12) without cd-HA gelatin treatment. The application of cd-HA gelatin significantly reduced the adhesion rate from 100% to 58%. The decrease of adhesion breaking strength also manifested that cd-HA gelatin could reduce postsurgical intra-abdominal adhesion formation. Moreover, it was found that cd-HA gelatin was a safe material and could promote tissue healing. The cd-HA gelatin hydrogel could reduce the formation of intra-abdominal adhesions without adversely effects on wound healing. (c) 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 104A: 1175-1181, 2016.
C1 [Yuan, Fang; Lin, Long-Xiang; Zhang, Hui-Hui; Huang, Dan; Sun, Yu-Long] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen 518055, Guangdong, Peoples R China.
RP Sun, YL (reprint author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen 518055, Guangdong, Peoples R China.
EM yl.sun@siat.ac.cn
FU Chinese Academy of Sciences and Shenzhen Research Programs
   [JCYJ20140417113430613, KQCX2015033117354153]
FX Contract grant sponsor: Chinese Academy of Sciences and Shenzhen
   Research Programs; contract grant numbers: JCYJ20140417113430613,
   KQCX2015033117354153
CR Attard JAP, 2007, CAN J SURG, V50, P291
   Becker JM, 1996, J AM COLL SURGEONS, V183, P297
   Belluco C, 2001, J SURG RES, V100, P217, DOI 10.1006/jsre.2001.6248
   Brunelli G, 2005, J ORTHOP RES, V23, P1377, DOI 10.1016/j.orthres.2005.05.001
   Buckenmaier CC, 1999, AM SURGEON, V65, P274
   Dijkstra FR, 2000, SCAND J GASTROENTERO, V35, P52
   Ergul Emre, 2008, Int J Surg, V6, P253, DOI 10.1016/j.ijsu.2007.05.010
   Gaffney J, 2010, MOL BIOSYST, V6, P437, DOI 10.1039/b910552m
   Hayashi M, 2004, KNEE SURG SPORT TR A, V12, P545, DOI 10.1007/s00167-004-0512-x
   Holmdahl L, 1999, LANCET, V353, P1456, DOI 10.1016/S0140-6736(99)90061-2
   Irkorucu O, 2009, CLINICS, V64, P143, DOI 10.1590/S1807-59322009000200012
   Johns DB, 1997, FERTIL STERIL, V68, P37, DOI 10.1016/S0015-0282(97)81472-0
   Lauder CIW, 2011, J SURG RES, V171, P877, DOI 10.1016/j.jss.2010.06.028
   Liakakos T, 2001, DIGEST SURG, V18, P260, DOI 10.1159/000050149
   Marana R, 1997, HUM REPROD, V12, P1935, DOI 10.1093/humrep/12.9.1935
   MAZUJI MK, 1964, ARCH SURG-CHICAGO, V89, P1011
   Morey-Mas MA, 2010, J ORAL MAXIL SURG, V68, P1069, DOI 10.1016/j.joms.2009.09.039
   Oh CH, 2011, CLIN ORTHOP SURG, V3, P55, DOI 10.4055/cios.2011.3.1.55
   Oncel M, 2003, DIS COLON RECTUM, V46, P187, DOI 10.1097/01.DCR.0000049342.17762.16
   Rao CM, 1996, BIOCHEM MOL BIOL INT, V40, P327
   Reijnen MMPJ, 2003, BRIT J SURG, V90, P533, DOI 10.1002/bjs.4141
   Riccio M, 2010, J HAND SURG-EUR VOL, V35E, P130, DOI 10.1177/1753193409342044
   ROONEY P, 1995, INT J CANCER, V60, P632, DOI 10.1002/ijc.2910600511
   Slevin M, 2007, MATRIX BIOL, V26, P58, DOI 10.1016/j.matbio.2006.08.261
   Sun YL, 2004, J ORTHOP RES, V22, P984, DOI 10.1016/j.orthres.2004.02.005
   Takagi K, 2013, INT J MED SCI, V10, P467, DOI 10.7150/ijms.5607
   Tanaka T, 2007, J HAND SURG-AM, V32A, P876, DOI 10.1016/j.jhsa.2007.03.007
   Tanaka T, 2006, J ORTHOP RES, V24, P1555, DOI 10.1002/jor.20205
   Toole BP, 2008, SEMIN CANCER BIOL, V18, P244, DOI 10.1016/j.semcancer.2008.03.009
   URMAN B, 1991, FERTIL STERIL, V56, P563
   Ward BC, 2011, J SURG RES, V165, P91, DOI 10.1016/j.jss.2009.09.015
   West DC, 1997, INT J BIOCHEM CELL B, V29, P201, DOI 10.1016/S1357-2725(96)00133-1
   Yoldemir T, 2002, FERTIL STERIL, V78, P335, DOI 10.1016/S0015-0282(02)03224-7
   Zhao C, 2006, J BONE JOINT SURG AM, V88A, P2181, DOI 10.2106/JBJS.E.00871
   Zhao CF, 2010, J BONE JOINT SURG AM, V92A, P2817, DOI 10.2106/JBJS.I.01148
NR 35
TC 9
Z9 9
U1 1
U2 26
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY
PY 2016
VL 104
IS 5
BP 1175
EP 1181
DI 10.1002/jbm.a.35653
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DI7YQ
UT WOS:000373718300013
PM 26749008
DA 2018-10-20
ER

PT J
AU Qi, FF
   Yoshida, T
   Koike, T
   Aizawa, H
   Shimane, T
   Li, YH
   Yamada, S
   Okabe, M
   Nikaido, T
   Kurita, H
AF Qi, Fangfang
   Yoshida, Toshiko
   Koike, Takeshi
   Aizawa, Hitoshi
   Shimane, Tetsu
   Li, Yinghui
   Yamada, Shinichi
   Okabe, Motonori
   Nikaido, Toshio
   Kurita, Hiroshi
TI Construction and characterization of human oral mucosa equivalent using
   hyper-dry amniotic membrane as a matrix
SO ARCHIVES OF ORAL BIOLOGY
LA English
DT Article
DE Oral keratinocytes; Hyper-dry amniotic membrane; Matrix; Oral mucosal
   equivalent; Reconstruction
ID EPITHELIAL-CELLS; STEM-CELLS; CULTURE; TRANSPLANTATION; REGENERATION;
   DIFFERENTIATION; RECONSTRUCTION; DEFECTS; SERUM; MODEL
AB Background: Human amniotic membrane(HAM) as a graft material has been used in various fields. Hyper dry amniotic membrane (HD-AM) is a novel dried amniotic membrane that is easy to handle and can be preserved at room temperature without time limitation. The purpose of this study was to investigate the useful properties of HD-AM in reconstruction of the oral mucosa.
   Methods: Human oral keratinocytes were isolated and seeded on HD-AM in serum-free culture system. Oral mucosa equivalent (OME) was developed and transplanted onto full-thickness wound on athymic mice. The wound healing was analyzed and the OME both before and after transplantation was analyzed with hematoxylin-eosin staining and immunohistochemicial staining for Cytokines 10 (CK10), Cytokines 16 (CK16), and Ivolucrin (IVL).
   Results: Oral keratinocytes spread and proliferated well on HD-AM. Two weeks after air-lifting, OME had formed with good differentiation and morphology. We confirmed immunohistochemically that the expression of CK10 was positive in all suprabasal layers, as was CK16 in the upper layers, while IVL was present in all cell layers. Three weeks after transplantation to athymic mice, the newly generated tissue had survived well with the smallest contraction. The epithelial cells of newly generated tissue expressed CK10 throughout in all suprabasal layers, IVL was mainly in the granular layer, and CK16 positive cells were observed in all spinous layer and granular layer but were not expressed in the mouse skin, all of which were similar to native gingival mucosa.
   Conclusions: The OME with HD-AM as a matrix revealed a good morphology and stable wound healing. This study demonstrates that HD-AM is a useful and feasible biomaterial for oral mucosa reconstruction. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Qi, Fangfang; Aizawa, Hitoshi; Shimane, Tetsu; Li, Yinghui; Yamada, Shinichi; Kurita, Hiroshi] Shinshu Univ, Dept Dent & Oral Surg, Sch Med, 3-1-1 Asahi, Matsumato 3908621, Japan.
   [Yoshida, Toshiko; Okabe, Motonori; Nikaido, Toshio] Toyama Univ, Dept Regenerat Med, Grad Sch Med & Pharmaceut Sci, 2630 Sugitani, Toyama 9300194, Japan.
   [Koike, Takeshi] Ina Cent Hosp, Dept Dent & Oral Surg, 1313-1 Koshiroukubo, Ina, Nagano 3968555, Japan.
RP Kurita, H (reprint author), Shinshu Univ, Dept Dent & Oral Surg, Sch Med, 3-1-1 Asahi, Matsumato 3908621, Japan.
EM hkurita@shinshu-u.ac.jp
CR Ahn KM, 2006, ARTIF ORGANS, V30, P411, DOI 10.1111/j.1525-1594.2006.00236.x
   AKLE CA, 1981, LANCET, V2, P1003
   Alaminos M, 2007, J TISSUE ENG REGEN M, V1, P350, DOI 10.1002/term.38
   Amemiya T, 2010, BIO-MED MATER ENG, V20, P37, DOI 10.3233/BME-2010-0613
   Arai N, 2012, J ORAL MAXIL SURG, V70, P2221, DOI 10.1016/j.joms.2011.09.033
   Atala A, 2003, CLIN PLAST SURG, V30, P649, DOI 10.1016/S0094-1298(03)00094-4
   DALE B A, 1990, Critical Reviews in Oral Biology and Medicine, V1, P167
   Gasparoni A, 2004, ARCH ORAL BIOL, V49, P653, DOI 10.1016/j.archoralbio.2004.02.010
   Gower RM, 2013, ADV WOUND CARE, V2, P100, DOI 10.1089/wound.2011.0325
   Horst M, 2013, BIOMATERIALS, V34, P1537, DOI 10.1016/j.biomaterials.2012.10.075
   Izumi K, 1999, J ORAL MAXIL SURG, V57, P571, DOI 10.1016/S0278-2391(99)90077-0
   Izumi K, 2000, J DENT RES, V79, P798, DOI 10.1177/00220345000790030301
   Ji SZ, 2011, BIOMATERIALS, V32, P7801, DOI 10.1016/j.biomaterials.2011.06.076
   Jin CZ, 2007, TISSUE ENG, V13, P693, DOI 10.1089/ten.2006.0184
   Kamiya K, 2005, EXP EYE RES, V80, P671, DOI 10.1016/j.exer.2004.11.018
   Kesting MR, 2009, J BIOMED MATER RES B, V90B, P930, DOI 10.1002/jbm.b.31365
   KIKKAWA Y, 1994, J BIOCHEM-TOKYO, V116, P862, DOI 10.1093/oxfordjournals.jbchem.a124608
   Koike T, 2011, ARCH ORAL BIOL, V56, P1170, DOI 10.1016/j.archoralbio.2011.04.009
   Koizumi N, 2000, CURR EYE RES, V20, P173, DOI 10.1076/0271-3683(200003)20:3;1-9;FT173
   Lee SH, 1997, AM J OPHTHALMOL, V123, P303, DOI 10.1016/S0002-9394(14)70125-4
   Lo V, 2009, INT J DERMATOL, V48, P935, DOI 10.1111/j.1365-4632.2009.04173.x
   Loeffelbein DJ, 2012, J BIOMED MATER RES B, V100B, P1245, DOI 10.1002/jbm.b.32689
   Mamede AC, 2012, CELL TISSUE RES, V349, P447, DOI 10.1007/s00441-012-1424-6
   Meller D, 1999, INVEST OPHTH VIS SCI, V40, P878
   Nikenjad H., 2008, EUROPEAN CELLS MAT, V29, P88
   Okabe M, 2014, J BIOMED MATER RES A, V102, P862, DOI 10.1002/jbm.a.34753
   Presland RB, 2000, CRIT REV ORAL BIOL M, V11, P383, DOI 10.1177/10454411000110040101
   Robinson WP, 2002, PRENATAL DIAG, V22, P1076, DOI 10.1002/pd.483
   Rohaina CM, 2014, TRANSL RES, V163, P200, DOI 10.1016/j.trsl.2013.11.004
   Rouabhia M, 2010, BIOMATERIALS, V31, P5798, DOI 10.1016/j.biomaterials.2010.04.004
   Shandadfar A, 2012, EXP EYE RES, V97, P1, DOI 10.1016/j.exer.2012.01.013
   Shi HF, 2014, J MECH BEHAV BIOMED, V29, P114, DOI 10.1016/j.jmbbm.2013.08.031
   Shimazaki J, 1998, BRIT J OPHTHALMOL, V82, P235, DOI 10.1136/bjo.82.3.235
   Terada M, 2012, J BIOMED MATER RES B, V100B, P1792, DOI 10.1002/jbm.b.32746
   Tesavibul N, 2001, CELL TISSUE BANK, V2, P31
   Toda A, 2007, J PHARMACOL SCI, V105, P215, DOI 10.1254/jphs.CP0070034
   Tsuno T., 2014, ORAL SURG ORAL MED O, V117, P83
   VANBAARE J, 1994, BURNS, V20, pS77, DOI 10.1016/0305-4179(94)90096-5
   von Versen-Hoeynck F, 2008, BIOLOGICALS, V36, P248, DOI 10.1016/j.biologicals.2008.02.001
   Wolbank S, 2009, J TISSUE ENG REGEN M, V3, P651, DOI 10.1002/term.207
   Yang LJ, 2009, J DERMATOL SCI, V56, P188, DOI 10.1016/j.jdermsci.2009.09.009
   Zhang YY, 2009, BIOMATERIALS, V30, P4021, DOI 10.1016/j.biomaterials.2009.04.005
NR 42
TC 1
Z9 3
U1 0
U2 9
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0003-9969
EI 1879-1506
J9 ARCH ORAL BIOL
JI Arch. Oral Biol.
PD MAY
PY 2016
VL 65
BP 26
EP 34
DI 10.1016/j.archoralbio.2016.01.011
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA DH4MH
UT WOS:000372759600004
PM 26845199
DA 2018-10-20
ER

PT J
AU Park, JH
   Jeong, J
   Moon, H
   Kim, C
   Kim, SJ
AF Park, Jeong Hoan
   Jeong, Joonsoo
   Moon, Hyowon
   Kim, Chaebin
   Kim, Sung June
TI Feasibility of LCP as an Encapsulating Material for Photodiode-Based
   Retinal Implants
SO IEEE PHOTONICS TECHNOLOGY LETTERS
LA English
DT Article
DE Photodiodes; microphotodiodes; long-term implantable transparent
   packaging; retinal implant; liquid crystal polymer (LCP)
ID CRYSTAL POLYMER LCP; PROSTHESIS; DEVICES
AB While retinal implants based on microphotodiode array (MPDA) could achieve great number of channels without an external camera, the absence of proper packaging technology of MPDA has limited their use in chronic implantation. Liquid crystal polymer (LCP) has gained increasing attention as a biomaterial for implantable devices due to its low water absorption rate and low permeability. In this letter, feasibility of LCP film as an encapsulation material of photodiode-based retinal prosthesis was explored. Optical property of LCP was measured to find the film thickness that can guarantee the light transmittance greater than 20%, which was achieved by developing the dry etching process of commercial LCP films to be less than 10 mu m. The minimum distinguishable line pitch of the thin LCP encapsulation evaluated by a custom setup with projected grating patterns on CMOS image sensor was 90 mu m, which could be equivalent to ideally 1200 channels in macular area of 10 mm(2).
C1 [Park, Jeong Hoan; Jeong, Joonsoo; Moon, Hyowon; Kim, Chaebin; Kim, Sung June] Seoul Natl Univ, Dept Elect & Comp Engn, Seoul 08826, South Korea.
   [Moon, Hyowon] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA.
RP Kim, SJ (reprint author), Seoul Natl Univ, Dept Elect & Comp Engn, Seoul 08826, South Korea.
EM tteem920@snu.ac.kr; joonsoo.jeong@gmail.com; hwmoon88@gmail.com;
   chae.b.kim@gmail.com; kimsj@snu.ac.kr
FU National Research Foundation of Korea within the Ministry of Education,
   Science and Technology through the Public Welfare and Safety Research
   Program [NRF-2010-0020851]; Defense Acquisition Program Administration
   [UD140069ID]; College of Engineering and College of Dentistry Seoul
   National University; Inter-university Semiconductor Research Center at
   Seoul National University; Department of Electrical and Computer
   Engineering at Seoul National University through the Brain Korea 21 plus
   Project
FX This work was supported in part by the National Research Foundation of
   Korea within the Ministry of Education, Science and Technology through
   the Public Welfare and Safety Research Program under Grant
   NRF-2010-0020851, in part by the Defense Acquisition Program
   Administration through the Project entitled Control of Animal Brain
   using MEMS Chip under Grant UD140069ID, in part by College of
   Engineering and College of Dentistry Seoul National University through
   the engineering dentistry interdisciplinary research grant, in part by
   the Inter-university Semiconductor Research Center at Seoul National
   University, and in part by the Department of Electrical and Computer
   Engineering at Seoul National University through the Brain Korea 21 plus
   Project in 2015. (Corresponding author: Sung June Kim.)
CR [Anonymous], 2015, 883J MIL
   Bae SH, 2012, INVEST OPHTH VIS SCI, V53, P2653, DOI 10.1167/iovs.11-9341
   Boreman G. D., 2001, MODULATION TRANSFER, V4
   Borton DA, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026010
   Chen MJ, 2006, IEEE T MICROW THEORY, V54, P4009, DOI 10.1109/TMTT.2006.884639
   Chow AY, 2004, ARCH OPHTHALMOL-CHIC, V122, P460, DOI 10.1001/archopht.122.4.460
   Ge J, 2003, J POLYM SCI POL PHYS, V41, P623, DOI 10.1002/polb.10407
   Ghezzi D, 2013, NAT PHOTONICS, V7, P400, DOI [10.1038/nphoton.2013.34, 10.1038/NPHOTON.2013.34]
   Greenhouse H, 2011, HERMETICITY ELECT PA
   Humayun MS, 2012, OPHTHALMOLOGY, V119, P779, DOI 10.1016/j.ophtha.2011.09.028
   Jenkins F. A., 1957, FUNDAMENTALS OPTICS
   Jeong J., 2016, J NEURAL ENG, V13
   Jeong J, 2015, IEEE T BIO-MED ENG, V62, P982, DOI 10.1109/TBME.2014.2377197
   Jeong J, 2012, SENSOR MATER, V24, P189
   Jiang GQ, 2010, BIOL MED PHYS BIOMED, P27, DOI 10.1007/978-0-387-98120-8_2
   Kumar V., 2011, ADV APPL SCI RES, V2, P79
   Lee SW, 2011, IEEE T BIO-MED ENG, V58, DOI 10.1109/TBME.2011.2136341
   Peacock AJ, 2006, POLYM CHEM PROPERTIE
   Stingl K, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0077
   Zhou DC, 2013, ADV INTEL SYS RES, V44, P1
   Zrenner E, 1999, VISION RES, V39, P2555, DOI 10.1016/S0042-6989(98)00312-5
   Zrenner E., 2010, P ROY SOC LOND B BIO, V283, P1489
NR 22
TC 2
Z9 2
U1 0
U2 7
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 1041-1135
EI 1941-0174
J9 IEEE PHOTONIC TECH L
JI IEEE Photonics Technol. Lett.
PD MAY 1
PY 2016
VL 28
IS 9
BP 1018
EP 1021
DI 10.1109/LPT.2016.2523561
PG 4
WC Engineering, Electrical & Electronic; Optics; Physics, Applied
SC Engineering; Optics; Physics
GA DH9IL
UT WOS:000373109600022
DA 2018-10-20
ER

PT J
AU Lu, JW
   Zhao, YQ
   Niu, HZ
   Zhang, YS
   Du, YZ
   Zhang, W
   Huo, WT
AF Lu, Jinwen
   Zhao, Yongqing
   Niu, Hongzhi
   Zhang, Yusheng
   Du, Yuzhou
   Zhang, Wei
   Huo, Wangtu
TI Electrochemical corrosion behavior and elasticity properties of
   Ti-6Al-xFe alloys for biomedical applications
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Ti-6Al-xFe alloys; Microstructure; Corrosion resistance; Elasticity;
   Biomaterial application
ID TI-MO ALLOYS; SIMULATED PHYSIOLOGICAL ENVIRONMENT; FREE TITANIUM-ALLOYS;
   IMPEDANCE SPECTROSCOPY; MECHANICAL-PROPERTIES; IMPLANT MATERIALS;
   TI-24NB-4ZR-8SN ALLOY; TI-5CR-XFE ALLOYS; SALINE SOLUTION; BODY
   SOLUTIONS
AB The present study is to investigate the microstructural characteristics, electrochemical corrosion behavior and elasticity properties of Ti-6Al-xFe alloys with Fe addition for biomedical application, and Ti-6Al-4V alloy with two-phase (alpha + beta) microstructure is also studied as a comparison. Microstructural characterization reveals that the phase and crystal structure are sensitive to the Fe content. Ti-6Al alloy displays feather-like hexagonal a phase, and Ti-6Al-1Fe exhibits coarse lath structure of hexagonal alpha phase and a small amount of beta phase. Ti-6Al-2Fe and Ti-6Al-4Fe alloys are dominated by elongated, equiaxed alpha phase and retained beta phase, but the size of alpha phase particle in Ti-6Al-4Fe alloy is much smaller than that in Ti-6Al-2Fe alloy. The corrosion resistance of these alloys is determined in SBF solution at 37 degrees C. It is found that the alloys spontaneously form a passive oxide film on their surface after immersion for 500 s, and then they are stable for polarizations up to 0 V-SCE. In comparison with Ti-6Al and Ti-6Al-4V alloys, Ti-6Al-xFe alloys exhibit better corrosion resistance with lower anodic current densities, larger polarization resistances and higher open-circuit potentials. The passive layers show stable characteristics, and the wide frequency ranges displaying capacitive characteristics occur for high iron contents. Elasticity experiments are performed to evaluate the elasticity property at room temperature. Ti-6Al-4Fe alloy has the lowest Young's modulus (112 GPa) and exhibits the highest strength/modulus ratios as large as 8.6, which is similar to that of c.p. Ti (8.5). These characteristics of Ti-6Al-xFe alloys form the basis of a great potential to be used as biomedical implantation materials. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Lu, Jinwen; Zhao, Yongqing; Niu, Hongzhi; Zhang, Yusheng; Du, Yuzhou; Zhang, Wei; Huo, Wangtu] Northwest Inst Nonferrous Met Res, Adv Mat Res Cent, Xian 710016, Peoples R China.
RP Lu, JW; Zhao, YQ (reprint author), Northwest Inst Nonferrous Met Res, Adv Mat Res Cent, Xian 710016, Peoples R China.
EM lujwen@163.com; trc@c-nin.com
FU National Natural Science Foundation of China [51471136, 51301140,
   51271152]
FX This work was performed partially under the support of the National
   Natural Science Foundation of China (Grant Nos. 51471136, 51301140 and
   51271152).
CR Alves VA, 2009, CORROS SCI, V51, P2473, DOI 10.1016/j.corsci.2009.06.035
   Arrazola PJ, 2009, J MATER PROCESS TECH, V209, P2223, DOI 10.1016/j.jmatprotec.2008.06.020
   Assis S.L.d., 2006, ELECTROCHIM ACTA, V51, P1815, DOI DOI 10.1016/J.ELECTACTA.2005.02.121
   Atapour M, 2011, MAT SCI ENG C-MATER, V31, P885, DOI 10.1016/j.msec.2011.02.005
   Aziz-Kerrzo M, 2001, BIOMATERIALS, V22, P1531, DOI 10.1016/S0142-9612(00)00309-4
   Bai Y, 2013, MAT SCI ENG C-MATER, V33, P2159, DOI 10.1016/j.msec.2013.01.036
   Bai Y, 2012, APPL SURF SCI, V258, P4035, DOI 10.1016/j.apsusc.2011.12.096
   Biesiekierski A, 2014, MATER DESIGN, V59, P303, DOI 10.1016/j.matdes.2014.02.058
   Bolat G, 2013, ELECTROCHIM ACTA, V113, P470, DOI 10.1016/j.electacta.2013.09.116
   Buenconsejo PJS, 2009, ACTA MATER, V57, P2509, DOI 10.1016/j.actamat.2009.02.007
   Chelariu R, 2014, ELECTROCHIM ACTA, V137, P280, DOI 10.1016/j.electacta.2014.06.021
   Choubey A, 2004, J ALLOY COMPD, V381, P288, DOI 10.1016/j.jallcom.2004.03.096
   Cremasco A, 2008, ELECTROCHIM ACTA, V53, P4867, DOI 10.1016/j.electacta.2008.02.011
   Fekry AM, 2009, ELECTROCHIM ACTA, V54, P3480, DOI 10.1016/j.electacta.2008.12.060
   Fonseca C, 2001, CORROS SCI, V43, P547, DOI 10.1016/S0010-938X(00)00107-4
   Geetha M, 2004, CORROS SCI, V46, P877, DOI 10.1016/S0010-938X(03)00186-0
   Ho WF, 2009, J ALLOY COMPD, V472, P546, DOI 10.1016/j.jallcom.2008.05.015
   Ho WF, 2009, MAT SCI ENG C-BIO S, V29, P36, DOI 10.1016/j.msec.2008.05.004
   Hsu HC, 2010, MATER CHARACT, V61, P851, DOI 10.1016/j.matchar.2010.05.003
   Hsu HC, 2009, J ALLOY COMPD, V474, P578, DOI 10.1016/j.jallcom.2008.07.003
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kotoka R, 2015, J MATER SCI TECHNOL, V31, P873, DOI 10.1016/j.jmst.2015.07.020
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Leyens C, 2003, TITANIUM TITANIUM AL
   Lin DJ, 2002, BIOMATERIALS, V23, P1723, DOI 10.1016/S0142-9612(01)00233-2
   Lopez MF, 2003, ELECTROCHIM ACTA, V48, P1395, DOI 10.1016/S0013-4686(03)00006-9
   Mareci D, 2013, EUR J SCI THEOL, V9, P189
   Marino CE, 2001, CORROS SCI, V43, P1465, DOI 10.1016/S0010-938X(00)00162-1
   Milosev I, 2008, ELECTROCHIM ACTA, V53, P3547, DOI 10.1016/j.electacta.2007.12.041
   Milosev I, 2013, ELECTROCHIM ACTA, V99, P176, DOI 10.1016/j.electacta.2013.03.086
   Min XH, 2010, MAT SCI ENG A-STRUCT, V527, P5499, DOI 10.1016/j.msea.2010.06.016
   Min XH, 2008, MAT SCI ENG A-STRUCT, V497, P74, DOI 10.1016/j.msea.2008.06.018
   Mohan L, 2013, APPL SURF SCI, V282, P281, DOI 10.1016/j.apsusc.2013.05.120
   Okazaki Y, 2002, BIOMATERIALS, V23, P2071, DOI 10.1016/S0142-9612(01)00337-4
   Oliveira NTC, 2007, MAT SCI ENG A-STRUCT, V452, P727, DOI 10.1016/j.msea.2006.11.061
   Park YJ, 2013, J DENT, V41, P1251, DOI 10.1016/j.jdent.2013.09.003
   Pimenova NV, 2006, ELECTROCHIM ACTA, V51, P2042, DOI 10.1016/j.electacta.2005.07.024
   Popa MV, 2004, ELECTROCHIM ACTA, V49, P2113, DOI 10.1016/j.electacta.2003.12.036
   Pouilleau J, 1997, MAT SCI ENG B-SOLID, V47, P235, DOI 10.1016/S0921-5107(97)00043-3
   Shan DB, 2009, J MATER PROCESS TECH, V209, P5713, DOI 10.1016/j.jmatprotec.2009.05.034
   Silva HM, 2004, MAT SCI ENG C-BIO S, V24, P679, DOI 10.1016/j.msec.2004.08.051
   Tamilselvi S, 2007, MATER CORROS, V58, P113, DOI 10.1002/maco.200603979
   Tamilselvi S, 2006, ELECTROCHIM ACTA, V52, P839, DOI 10.1016/j.electacta.2006.06.018
   Tsao LC, 2015, MAT SCI ENG C-MATER, V46, P246, DOI 10.1016/j.msec.2014.10.037
   Tsao LC, 2012, CORROS SCI, V63, P393, DOI 10.1016/j.corsci.2012.06.015
   Wang BL, 2009, MATER CORROS, V60, P330, DOI 10.1002/maco.200805120
   Zheng YF, 2006, MAT SCI ENG A-STRUCT, V438, P891, DOI 10.1016/j.msea.2006.01.131
   Zhou YL, 2011, J ALLOY COMPD, V509, P6267, DOI 10.1016/j.jallcom.2011.03.045
NR 48
TC 13
Z9 13
U1 1
U2 24
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAY 1
PY 2016
VL 62
BP 36
EP 44
DI 10.1016/j.msec.2016.01.019
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA DH4MC
UT WOS:000372759100005
PM 26952395
DA 2018-10-20
ER

PT J
AU Yin, RX
   Zhang, N
   Wu, WT
   Wang, KM
AF Yin, Ruixue
   Zhang, Nan
   Wu, Wentao
   Wang, Kemin
TI Poly(ethylene glycol)-grafted cyclic acetals based polymer networks with
   non-water-swellable, biodegradable and surface hydrophilic properties
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Cyclic acetals; Photopolymerization; Non-water-swellable; Pendent PEG
   chains
ID CELL ENCAPSULATION; DRUG-DELIVERY; HYDROGELS; BONE; PHOTOPOLYMERIZATION;
   SPECTROSCOPY; INITIATORS; CONVERSION
AB Cyclic acetals based biomaterial without acidic products during hydrolytic degradation is a promising candidate for tissue engineering applications; however, low hydrophilicity is still one limitation for its biomedical application. In this work, we aim to achieve non-water-swellable cyclic acetal networks with improved hydrophilicity and surface wettability by copolymerization of cyclic acetal units based monomer, 5-ethyl-5-(hydroxymethyl)-beta,beta-dimethyl-1, 3-dioxane-2-ethanol diacrylate (EHD) and methoxy poly(ethylene glycol) monoacrylate (mPEGA) under UV irradiation, to avoid swelling of conventional hydrogels which could limit their applicability in particular of the mechanical properties and geometry integrity. Various EHD/mPEGA networks were fabricated with different concentrations of mPEGA from 0 to 30%, and the results showed photopolymerization behavior, mechanical property and thermal stability could not be significantly affected by addition of mPEGA, while the surface hydrophilicity was dramatically improved with the increase of mPEGA and could achieve a water contact angle of 37 degrees with 30% mPEGA concentration. The obtained EHD/mPEGA network had comparative degradation rate to the PECA hydrogels reported previously, and WIT assay indicated it was biocompatible to L929 cells. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Yin, Ruixue] E China Univ Sci & Technol, Sch Mech & Power Engn, Complex & Intelligent Res Ctr, Shanghai 200237, Peoples R China.
   [Zhang, Nan; Wu, Wentao; Wang, Kemin] Changzhou Univ, Sch Mat Sci & Engn, Changzhou 213164, Peoples R China.
RP Yin, RX (reprint author), E China Univ Sci & Technol, Sch Mech & Power Engn, Complex & Intelligent Res Ctr, Shanghai 200237, Peoples R China.; Wang, KM (reprint author), Changzhou Univ, Sch Mat Sci & Engn, Changzhou 213164, Peoples R China.
EM qdruinyan@hotmail.com; kemin-wang@hotmail.com
FU National Natural Science Foundation of China [21304011]; priority
   academic program development of Jiangsu Higher Education Institutions;
   Fundamental Research Funds for the Central Universities [22A201514029]
FX The authors would like to thank the National Natural Science Foundation
   of China (21304011) and a project funded by the priority academic
   program development of Jiangsu Higher Education Institutions for its
   financial support, as well as the support of the Fundamental Research
   Funds for the Central Universities (22A201514029).
CR Balci M, 2010, POLYM BULL, V64, P691, DOI 10.1007/s00289-009-0211-3
   Betz MW, 2008, J BIOMED MATER RES A, V86A, P662, DOI 10.1002/jbm.a.31640
   Cai L, 2010, BIOMATERIALS, V31, P4457, DOI 10.1016/j.biomaterials.2010.02.020
   DECKER C, 1989, MACROMOLECULES, V22, P4455, DOI 10.1021/ma00202a013
   Dev A, 2010, CARBOHYD POLYM, V80, P833, DOI 10.1016/j.carbpol.2009.12.040
   Duncan R, 2006, ADV POLYM SCI, V192, P1, DOI 10.1007/12_037
   Erin E., 2008, PHARM RES, V25, P2348
   Falco E. E., 2007, J SURG RES, V149, P76
   Finne-Wistrand A, 2006, ANNU REV MATER RES, V36, P369, DOI 10.1146/annurev.matsci.36.032905.091005
   HAZER B, 1992, MAKROMOL CHEM, V193, P1081
   HAZER B, 1995, MACROMOL CHEM PHYSIC, V196, P1945, DOI 10.1002/macp.1995.021960614
   Hazer B, 2015, POLYM DEGRAD STABIL, V119, P159, DOI 10.1016/j.polymdegradstab.2015.04.024
   Hwang DK, 2009, J AM CHEM SOC, V131, P4499, DOI 10.1021/ja809256d
   JANMEY PA, 1994, J BIOL CHEM, V269, P32503
   Kaihara S, 2008, EUR J PHARM BIOPHARM, V68, P67, DOI 10.1016/j.ejpb.2007.05.019
   Kaihara S, 2007, MACROMOLECULES, V40, P7625, DOI 10.1021/ma071297p
   Kamata H, 2014, SCIENCE, V343, P873, DOI 10.1126/science.1247811
   Kutikov AB, 2013, ACTA BIOMATER, V9, P8354, DOI 10.1016/j.actbio.2013.06.013
   Lee S, 2015, ORG BIOMOL CHEM, V13, P8445, DOI 10.1039/c5ob01056j
   Mithieux SM, 2004, BIOMATERIALS, V25, P4921, DOI 10.1016/j.biomaterials.2004.01.055
   Moreau JL, 2007, J BIOMED MATER RES A, V81A, P594, DOI 10.1002/jbm.a.31104
   Rao BS, 2008, PROG ORG COAT, V63, P416, DOI 10.1016/j.porgcoat.2008.07.001
   Scherzer T, 2005, POLYMER, V46, P7072, DOI 10.1016/j.polymer.2005.05.142
   Schlosser M, 2005, J BIOMED MATER RES A, V72A, P317, DOI 10.1002/jbm.a.30240
   Stansbury JW, 2001, DENT MATER, V17, P71, DOI 10.1016/S0109-5641(00)00062-2
   Starr B, 2001, POLYMER, V42, P8727, DOI 10.1016/S0032-3861(01)00300-7
   Tang MJ, 2015, POLYM CHEM-UK, V6, P6671, DOI 10.1039/c5py00734h
   Wang KM, 2013, MAT SCI ENG C-MATER, V33, P1261, DOI 10.1016/j.msec.2012.12.024
   Wang SF, 2015, ADV FUNCT MATER, V25, P2715, DOI 10.1002/adfm.201500105
   Williams CG, 2005, BIOMATERIALS, V26, P1211, DOI 10.1016/j.biomaterials.2004.04.024
   Wolf MT, 2015, ADV DRUG DELIVER REV, V84, P208, DOI 10.1016/j.addr.2014.08.011
   Yin RX, 2015, MAT SCI ENG C-MATER, V46, P239, DOI 10.1016/j.msec.2014.10.040
   Zhang H.B., 2014, TISSUE ENG PART B-RE, V5, P492
NR 33
TC 1
Z9 1
U1 5
U2 33
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAY 1
PY 2016
VL 62
BP 137
EP 143
DI 10.1016/j.msec.2016.01.038
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA DH4MC
UT WOS:000372759100017
PM 26952407
DA 2018-10-20
ER

PT J
AU Nakamura, M
   Hori, N
   Ando, H
   Namba, S
   Toyama, T
   Nishimiya, N
   Yamashita, K
AF Nakamura, Miho
   Hori, Naoko
   Ando, Hiroshi
   Namba, Saki
   Toyama, Takeshi
   Nishimiya, Nobuyuki
   Yamashita, Kimihiro
TI Surface free energy predominates in cell adhesion to hydroxyapatite
   through wettability
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Cell adhesion; Wettability; Surface free energy; Surface
   characteristics; Hydroxyapatite
ID ELECTRICALLY POLARIZED HYDROXYAPATITE; HUMAN OSTEOBLASTIC CELLS; INITIAL
   ATTACHMENT; CALCIUM-PHOSPHATE; BEHAVIOR; MINERALIZATION; CYTOSKELETAL;
   EXPRESSION; RESPONSES; COATINGS
AB The initial adhesion of cells to biomaterials is critical in the regulation of subsequent cell behaviors. The purpose of this study was to investigate a mechanism through which the surface wettability of biomaterials can be improved and determine the effects of biomaterial surface characteristics on cellular behaviors. We investigated the surface characteristics of various types of hydroxyapatite after sintering in different atmospheres and examined the effects of various surface characteristics on cell adhesion to study cell-biomaterial interactions. Sintering atmosphere affects the polarization capacity of hydroxyapatite by changing hydroxide ion content and grain size. Compared with hydroxyapatite sintered in air, hydroxyapatite sintered in saturated water vapor had a higher polarization capacity that increased surface free energy and improved wettability, which in turn accelerated cell adhesion. We determined the optimal conditions of hydroxyapatite polarization for the improvement of surface wettability and acceleration of cell adhesion. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Nakamura, Miho; Hori, Naoko; Namba, Saki; Yamashita, Kimihiro] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, 2-3-10 Kanda Surugadai, Tokyo 1010062, Japan.
   [Ando, Hiroshi; Namba, Saki; Toyama, Takeshi; Nishimiya, Nobuyuki] Nihon Univ, Dept Mat & Appl Chem, Chiyoda Ku, 1-5-1 Kanda Surugadai, Tokyo 1018308, Japan.
RP Nakamura, M (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, 2-3-10 Kanda Surugadai, Tokyo 1010062, Japan.
EM miho.bcr@tmd.ac.jp
RI Nakamura, Miho/T-3166-2017
FU Sumitomo Foundation [15K20472, 26670847]; Shiseido Female Researcher
   Science Grant; Murata Foundation
FX This study was supported in part by Grants-in-Aid for Young Scientists
   (B) (15K20472) and for Exploratory Research (26670847), Grant for Basic
   Science Research Projects from the Sumitomo Foundation, the Shiseido
   Female Researcher Science Grant and the Murata Foundation.
CR Advincula MC, 2006, BIOMATERIALS, V27, P2201, DOI 10.1016/j.biomaterials.2005.11.014
   Aronov D, 2007, J EUR CERAM SOC, V27, P4181, DOI 10.1016/j.jeurceramsoc.2007.02.121
   Bodhak S, 2009, ACTA BIOMATER, V5, P2178, DOI 10.1016/j.actbio.2009.02.023
   Champion E, 2013, ACTA BIOMATER, V9, P5855, DOI 10.1016/j.actbio.2012.11.029
   CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514
   Costa DO, 2013, BIOMATERIALS, V34, P7215, DOI 10.1016/j.biomaterials.2013.06.014
   Dasgupta S, 2013, MAT SCI ENG C-MATER, V33, P2846, DOI 10.1016/j.msec.2013.03.004
   FOWKES FM, 1963, J PHYS CHEM-US, V67, P2538, DOI 10.1021/j100806a008
   Goldstein C, 2010, J ORTHOP TRAUMA, V24, pS62, DOI 10.1097/BOT.0b013e3181cdde1b
   Hao L, 2005, J MATER SCI-MATER M, V16, P719, DOI 10.1007/s10856-005-2608-3
   Horiuchi N, 2012, J APPL PHYS, V112, DOI 10.1063/1.4754298
   Kim MS, 2007, TISSUE ENG, V13, P2095, DOI 10.1089/ten.2006.0062
   Kim SH, 2007, J BIOMAT SCI-POLYM E, V18, P609, DOI 10.1163/156856207780852514
   Kobayashi T, 2001, J BIOMED MATER RES, V57, P477, DOI 10.1002/1097-4636(20011215)57:4<477::AID-JBM1193>3.0.CO;2-5
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791
   Nakamura M, 2006, J BIOMED MATER RES A, V79A, P627, DOI 10.1002/jbm.a.30827
   Nakamura M, 2009, ACS APPL MATER INTER, V1, P2181, DOI 10.1021/am900341v
   Nakamura M, 2015, BIOMED MATER, V10, DOI 10.1088/1748-6041/10/1/011001
   Nakamura M, 2010, J BIOMED MATER RES A, V92A, P783, DOI 10.1002/jbm.a.32404
   Nakamura S, 2001, J APPL PHYS, V89, P5386, DOI 10.1063/1.1357783
   Nakamura S, 2009, J MATER SCI-MATER M, V20, P99, DOI 10.1007/s10856-008-3546-7
   Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452
   Okumura A, 2001, BIOMATERIALS, V22, P2263, DOI 10.1016/S0142-9612(00)00415-4
   Redey SA, 2000, J BIOMED MATER RES, V50, P353, DOI 10.1002/(SICI)1097-4636(20000605)50:3<353::AID-JBM9>3.0.CO;2-C
   Rouahi M, 2006, BIOMATERIALS, V27, P2829, DOI 10.1016/j.biomaterials.2006.01.001
   SCHWARTZ Z, 1994, J CELL BIOCHEM, V56, P340, DOI 10.1002/jcb.240560310
   Thian ES, 2010, ACTA BIOMATER, V6, P750, DOI 10.1016/j.actbio.2009.08.012
   Wang YS, 2008, J BIOMED MATER RES A, V84A, P769, DOI 10.1002/jbm.a.31289
   Webb K, 1998, J BIOMED MATER RES, V41, P422, DOI 10.1002/(SICI)1097-4636(19980905)41:3<422::AID-JBM12>3.0.CO;2-K
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
   YAMASHITA K, 1995, J AM CERAM SOC, V78, P1191, DOI 10.1111/j.1151-2916.1995.tb08468.x
   Yang L, 2010, BIOMATERIALS, V31, P2976, DOI 10.1016/j.biomaterials.2010.01.002
NR 33
TC 9
Z9 9
U1 3
U2 24
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAY 1
PY 2016
VL 62
BP 283
EP 292
DI 10.1016/j.msec.2016.01.037
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA DH4MC
UT WOS:000372759100035
PM 26952425
DA 2018-10-20
ER

PT J
AU Chen, YH
   Cheng, CH
   Chang, WJ
   Lin, YC
   Lin, FH
   Lin, JC
AF Chen, Yen-Hsuan
   Cheng, Chi-Hui
   Chang, Wan-Ju
   Lin, Yi-Ching
   Lin, Feng-Huei
   Lin, Jui-Che
TI Studies of magnetic alginate-based electrospun matrices crosslinked with
   different methods for potential hyperthermia treatment
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Alginate; Electrospinning; Magnetic electrospun mats; Hyperthermia;
   Magnetic nanoparticles
ID CHITOSAN NANOFIBER COMPOSITE; FE3O4 NANOPARTICLES; FIBERS; FABRICATION;
   ADHESION
AB The magnetic electrospun mats were lately established as an innovative biomaterial for hyperthermic cancer treatment. Unlike those surface-modified magnetic nanoparticles that may not firmly adhere onto the tumor for long-term duration, the magnetic mats with nanofibrous structure can promote cell adhesion and kill the tumor directly within an alternating magnetic field. However, most magnetic electrospun mats were fabricated using non-biodegradable polymers and organic solvents, causing the problems of removal after therapy and the suspected biotoxicity associated with residual solvent. Alginate (SA) was utilized in this investigation as the main material for electrospinning because of being biodegradable and water-soluble. The alginate-based electrospun mats were then treated by an ionic or a covalent crosslinking method, and then followed by chelation with Fe2+/Fe3+ for chemical coprecipitation of Fe3O4 magnetic nanoparticles. Significant less cytotoxicity was noted on both liquid extracts from the ionic-crosslinked (Fe3O4-SA/PEO) and covalent-crosslinked (Fe3O4-SA/PVA) magnetic electrospun mats as well as the surface of Fe3O4-SA/PVA. In vitro hyperthermia assay indicated that the covalent-crosslinked magnetic alginate-based mats reduced tumor cell viability greater than Fe3O4 nanoparticles. Such magnetic electrospun mats are of potential for hyperthermia treatment by endoscopic/surgical delivery as well as serving as a supplementary debridement treatment after surgical tumor removal. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Chen, Yen-Hsuan; Chang, Wan-Ju; Lin, Jui-Che] Natl Cheng Kung Univ, Dept Chem Engn, Tainan 70101, Taiwan.
   [Cheng, Chi-Hui] Chang Gung Mem Hosp, Div Pediat Nephrol, Dept Pediat, Taoyuan 33305, Taiwan.
   [Cheng, Chi-Hui] Chang Gung Univ, Coll Med, Taoyuan 33302, Taiwan.
   [Lin, Yi-Ching] Fooyin Univ, Gen Educ Ctr, Kaohsiung 83102, Taiwan.
   [Lin, Yi-Ching] Fooyin Univ, Dept Phys Therapy, Kaohsiung 83102, Taiwan.
   [Lin, Feng-Huei] Natl Taiwan Univ, Inst Biomed Engn, Taipei 10051, Taiwan.
   [Lin, Jui-Che] Natl Cheng Kung Univ, Inst Oral Med, Coll Med, Tainan 70101, Taiwan.
RP Lin, JC (reprint author), Natl Cheng Kung Univ, Dept Chem Engn, Tainan 70101, Taiwan.
EM jclin@mail.ncku.edu.tw
FU Ministry of Science and Technology, Taiwan [NSC 98-2221-E-006-054-MY3,
   NSC 100-2221-E-006-128-MY2, NSC 102-2221-E-006-184-MY3, MOST
   103-2314-B-182-022-MY3]
FX The financial support from the Ministry of Science and Technology
   (formerly known as National Science Council), Taiwan under Grant NSC
   98-2221-E-006-054-MY3, NSC 100-2221-E-006-128-MY2, NSC
   102-2221-E-006-184-MY3, and MOST 103-2314-B-182-022-MY3 is gratefully
   appreciated.
CR Amarjargal A, 2013, EUR POLYM J, V49, P3796, DOI 10.1016/j.eurpolymj.2013.08.026
   Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Bhattarai N, 2006, ADV MATER, V18, P1463, DOI 10.1002/adma.200502537
   Bhattarai N, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/45/455601
   Bonino CA, 2011, CARBOHYD POLYM, V85, P111, DOI 10.1016/j.carbpol.2011.02.002
   Chen L, 2011, J BIOMED MATER RES A, V99A, P395, DOI 10.1002/jbm.a.33202
   Durmus Z, 2011, POLYHEDRON, V30, P322, DOI 10.1016/j.poly.2010.10.028
   Fang N, 2005, COLLOID SURFACE B, V42, P245, DOI 10.1016/j.colsurfb.2004.11.002
   Fouda MMG, 2013, CARBOHYD POLYM, V92, P1012, DOI 10.1016/j.carbpol.2012.10.047
   Ho YC, 2009, INT J PHARMACEUT, V376, P69, DOI 10.1016/j.ijpharm.2009.04.048
   Huang CB, 2012, ADV FUNCT MATER, V22, P2479, DOI 10.1002/adfm.201102171
   Jeong SI, 2010, MACROMOL BIOSCI, V10, P934, DOI 10.1002/mabi.201000046
   Kim YJ, 2013, ADV FUNCT MATER, V23, P5753, DOI 10.1002/adfm.201300746
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Lin TC, 2013, J BIOMAT SCI-POLYM E, V24, P1152, DOI 10.1080/09205063.2012.743061
   Lin TC, 2012, ACTA BIOMATER, V8, P2704, DOI 10.1016/j.actbio.2012.03.045
   Mansur HS, 2008, MAT SCI ENG C-BIO S, V28, P539, DOI 10.1016/j.msec.2007.10.088
   Mincheva R, 2008, EUR POLYM J, V44, P615, DOI 10.1016/j.eurpolymj.2007.11.001
   Miraftab M, 2003, CARBOHYD POLYM, V53, P225, DOI 10.1016/S0144-8617(03)00108-5
   Morimune S, 2012, POLYM J, V44, P1056, DOI 10.1038/pj.2012.58
   Nie HR, 2008, BIOMACROMOLECULES, V9, P1362, DOI 10.1021/bm701349j
   Papageorgiou SK, 2010, CARBOHYD RES, V345, P469, DOI 10.1016/j.carres.2009.12.010
   Park CH, 2013, CERAM INT, V39, P9785, DOI 10.1016/j.ceramint.2013.05.042
   Pawar SN, 2012, BIOMATERIALS, V33, P3279, DOI 10.1016/j.biomaterials.2012.01.007
   Qi HX, 2006, BIOMACROMOLECULES, V7, P2327, DOI 10.1021/bm060264z
   Qin YM, 2008, POLYM INT, V57, P171, DOI 10.1002/pi.2296
   Savva I., 2013, BIOMACROMOLECULES, V14, P4436
   Sharma N, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/8/085707
   Sharma S, 2012, RSC ADV, V2, P5837, DOI 10.1039/c2ra00006g
   Song HH, 2014, MATER RES BULL, V53, P280, DOI 10.1016/j.materresbull.2014.02.026
   Stone R, 2013, J APPL POLYM SCI, V130, P1975, DOI 10.1002/app.39408
   Sun J, 2007, J BIOMED MATER RES A, V80A, P333, DOI 10.1002/jbm.a.30909
   Uyar T, 2009, EUR POLYM J, V45, P1032, DOI 10.1016/j.eurpolymj.2008.12.024
   Wang A, 2004, POLYMER, V45, P5505, DOI 10.1016/j.polymer.2004.06.013
   Wang B, 2010, J APPL POLYM SCI, V115, P1781, DOI 10.1002/app.31288
   Wang SH, 2010, MATER LETT, V64, P9, DOI 10.1016/j.matlet.2009.09.043
   Xin Y, 2009, J APPL PHYS, V105, DOI 10.1063/1.3116552
   Yang DZ, 2010, PLAST RUBBER COMPOS, V39, P6, DOI 10.1179/146580109X12540995045363
   Zhang CC, 2009, APPL PHYS A-MATER, V97, P281, DOI [10.1007/s00339-009-53789, 10.1007/s00339-009-5378-9]
   Zhang D, 2009, POLYMER, V50, P4189, DOI 10.1016/j.polymer.2009.06.062
   Zhong Y, 2015, J MAGN MAGN MATER, V380, P330, DOI 10.1016/j.jmmm.2014.09.069
NR 41
TC 4
Z9 4
U1 9
U2 75
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAY 1
PY 2016
VL 62
BP 338
EP 349
DI 10.1016/j.msec.2016.01.070
PG 12
WC Materials Science, Biomaterials
SC Materials Science
GA DH4MC
UT WOS:000372759100042
PM 26952432
DA 2018-10-20
ER

PT J
AU Ma, FC
   Chen, S
   Liu, P
   Geng, F
   Li, W
   Liu, XK
   He, DH
   Pan, D
AF Ma, Fengcang
   Chen, Sai
   Liu, Ping
   Geng, Fang
   Li, Wei
   Liu, Xinkuan
   He, Daihua
   Pan, Deng
TI Improvement of beta-TCP/PLLA biodegradable material by surface
   modification with stearic acid
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Tricalcium phosphate; Interfacial compatibility; Surface modification;
   Hydrophilicity; Mechanical properties
ID COMPOSITE FILMS; IN-VITRO; HYDROXYAPATITE; FILLER; WETTABILITY;
   SCAFFOLDS; RESPONSES
AB Poly-L-lactide (PLLA) is a biodegradable polymer and used widely. Incorporation of beta tricalcium phosphate (beta-TCP) into PLLA can enhance its osteoinductive properties. But the interfacial layer between beta-TCP particles with PLLA matrix is easy to be destroyed due to inferior interfacial compatibility of the organic/inorganic material. In this work, a method of beta-TCP surface modification with stearic acid was investigated to improve the beta-TCP/PLLA biomaterial. The effects of surface modification on the beta-TCP were investigated by FTIR, XPS, TGA and CA. It was found that the stearic acid reacted with beta-TCP and oxhydryl was formed during the surface modification. Hydrophilicity of untreated or modified beta-TCP/PLLA composite was increased by the addition of 10 wt% beta-TCP, but it decreased as the addition amount increased from 10 wt.% to 20 wt.%. Two models were suggested to describe the effect of beta-TCP concentration on CA of the composites. Mechanical properties of beta-TCP/PLLA composites were tested by bending and tensile tests. Fractures of the composites after mechanical test were observed by SEM. It was found that surface modification with stearic acid improved bending and tensile strengths of the beta-TCP/PLLA composites obviously. The SEM results indicated that surface modification decreased the probability of interface debonding between fillers and matrix under load. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Ma, Fengcang; Liu, Ping; Li, Wei; Liu, Xinkuan; He, Daihua; Pan, Deng] Univ Shanghai Sci & Technol, Sch Mat Sci & Engn, Shanghai 200093, Peoples R China.
   [Chen, Sai] Univ Shanghai Sci & Technol, Sch Mech Engn, Shanghai 200093, Peoples R China.
   [Geng, Fang] Shanghai MicroPort Orthoped Co Ltd Liabil, Shanghai 201318, Peoples R China.
RP Ma, FC (reprint author), Univ Shanghai Sci & Technol, Sch Mat Sci & Engn, Shanghai 200093, Peoples R China.
EM mafengcang@163.com
RI Pan, Deng/A-1090-2018
FU National Research Fund of Science and Technology Commission of Shanghai
   Municipality [09ZR1422100]; Fund of Science and Technology Commission of
   Shanghai Municipality [11441900501]; Innovation Research Fund of
   Shanghai Municipal Commission of Education [10YZ94]; Key Laboratory of
   Advanced Metal-based Electrical Power Materials
FX The authors would like to acknowledge the financial support provided by
   the National Research Fund of Science and Technology Commission of
   Shanghai Municipality under Grant No. 09ZR1422100, the Fund of Science
   and Technology Commission of Shanghai Municipality under Grant No.
   11441900501, the Innovation Research Fund of Shanghai Municipal
   Commission of Education under Grant No. 10YZ94 and Key Laboratory of
   Advanced Metal-based Electrical Power Materials.
CR Carmen K., 2003, BIOMATERIALS, V24, P967
   Cerrai P, 1999, J MATER SCI-MATER M, V10, P283, DOI 10.1023/A:1008905529461
   Daculsi G, 2011, BIOMATERIALS, V32, P3166, DOI 10.1016/j.biomaterials.2011.01.033
   Deb S, 1996, J MATER SCI-MATER M, V7, P191, DOI 10.1007/BF00119729
   DOYLE C, 1991, BIOMATERIALS, V12, P841, DOI 10.1016/0142-9612(91)90072-I
   Dupraz AMP, 1996, J MATER SCI-MATER M, V7, P731, DOI 10.1007/BF00121408
   Hu K, 2007, J BIOACT COMPAT POL, V22, P395, DOI 10.1177/0883911507079893
   Huang HH, 2008, J APPL POLYM SCI, V107, P3325, DOI 10.1002/app.24894
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Karnnet S, 2005, POLYM DEGRAD STABIL, V90, P106, DOI 10.1016/j.polymdegradstab.2005.02.016
   Kikuchi M, 2002, J BIOMED MATER RES, V62, P265, DOI 10.1002/jbm.10248
   Kobayashi S, 2010, COMPOS SCI TECHNOL, V70, P1820, DOI 10.1016/j.compscitech.2010.06.008
   Liao JG, 2009, CHINESE J INORG CHEM, V25, P1267
   Liao JG, 2015, PROG CHEM, V27, P220, DOI 10.7536/PC140810
   Liu Q, 1998, J BIOMED MATER RES, V40, P490, DOI 10.1002/(SICI)1097-4636(19980605)40:3<490::AID-JBM20>3.0.CO;2-M
   Liu Q, 1998, J MATER SCI-MATER M, V9, P23, DOI 10.1023/A:1008826410395
   Liu Q., 1996, J MATER SCI-MATER M, V7, P51
   Liu XM, 2007, BIOMATERIALS, V28, P4535, DOI 10.1016/j.biomaterials.2007.06.016
   [Ma Ming 马铭], 2012, [影像科学与光化学, Imaging Science and Photochemistry], V30, P269
   Manoudis N.P., 2014, PROG ORG COAT, V77, P331
   Manoudis PN, 2008, LANGMUIR, V24, P11225, DOI 10.1021/la801817e
   Nie T.C., 2008, CHINA SURFACTANT DET, V8, P16
   Quan D.P., 2001, ACTA MAT COMPOS SIN, V18, P22
   Schutzius TM, 2012, NANOSCALE, V4, P5378, DOI 10.1039/c2nr30979c
   Setzer B, 2009, BIOMATERIALS, V30, P979, DOI 10.1016/j.biomaterials.2008.10.054
   Teo WE, 2011, ACTA BIOMATER, V7, P193, DOI 10.1016/j.actbio.2010.07.041
   Tiwari MK, 2010, ACS APPL MATER INTER, V2, P1114, DOI 10.1021/am900894n
   Vivet L, 2013, APPL SURF SCI, V287, P13, DOI 10.1016/j.apsusc.2013.09.042
   Yang MJ, 2012, J COLLOID INTERF SCI, V368, P603, DOI 10.1016/j.jcis.2011.11.037
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yu HX, 2003, J APPL POLYM SCI, V88, P2557, DOI 10.1002/app.12093
   Zhou JL, 1990, ACTA PHYS-CHIM SIN, V6, P629, DOI 10.3866/PKU.WHXB19900522
NR 32
TC 7
Z9 7
U1 2
U2 20
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAY 1
PY 2016
VL 62
BP 407
EP 413
DI 10.1016/j.msec.2016.01.087
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA DH4MC
UT WOS:000372759100050
DA 2018-10-20
ER

PT J
AU Singh, AK
   Gajiwala, AL
   Rai, RK
   Khan, MP
   Singh, C
   Barbhuyan, T
   Vijayalakshmi, S
   Chattopadhyay, N
   Sinha, N
   Kumar, A
   Bellare, JR
AF Singh, Atul Kumar
   Gajiwala, Astrid Lobo
   Rai, Ratan Kumar
   Khan, Mohd. Parvez
   Singh, Chandan
   Barbhuyan, Tarun
   Vijayalakshmi, S.
   Chattopadhyay, Naibedya
   Sinha, Neeraj
   Kumar, Ashutosh
   Bellare, Jayesh R.
TI Cross-correlative 3D micro-structural investigation of human bone
   processed into bone allografts
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Human bone; Allograft; Solid state NMR; Scanning electron microscopy;
   Bone; Processing; MIMICS
ID CORTICAL BONE; GAMMA-IRRADIATION; OSTEOPROTEGERIN; OSTEOPOROSIS;
   SUBSTITUTE; INTERFACE; COLLAGEN; RANKL; CELLS; WATER
AB Bone allografts (BA) are a cost-effective and sustainable alternative in orthopedic practice as they provide a permanent solution for preserving skeletal architecture and function. Such BA however, must be processed to be disease free and immunologically safe as well as biologically and clinically useful. Here, we have demonstrated a processing protocol for bone allografts and investigated the micro-structural properties of bone collected from osteoporotic and normal human donor samples. In order to characterize BA at different microscopic levels, a combination of techniques such as Solid State Nuclear Magnetic Resonance (ssNMR), Scanning Electron Microscope (SEM), micro-computed tomography (mu CT) and Thermal Gravimetric Analysis (TGA) were used for delineating the ultra-structural property of bone. ssNMR revealed the extent of water, collagen fine structure and crystalline order in the bone. These were greatly perturbed in the bone taken from osteoporotic bone donor. Among the processing methods analyzed, pasteurization at 60 degrees C and radiation treatment appeared to substantially alter the bone integrity. SEM study showed a reduction in Ca/P ratio and non-uniform distribution of elements in osteoporotic bones. mu-CT and MIMICS (R) (Materialize Interactive Medical Image Control System) demonstrated that pasteurization and radiation treatment affects the BA morphology and cause a shift in the HU unit. However, the combination of all these processes restored all-important parameters that are critical for BA integrity and sustain ability. Cross-correlation between the various probes we used quantitatively demonstrated differences in morphological and micro-structural properties between BA taken from normal and osteoporotic human donor. Such details could also be instrumental in designing an appropriate bone scaffold. For the best restoration of bone microstructure and to be used as a biomaterial allograft, a step-wise processing method is recommended that preserves all critical parameters of bone, showing a significant advancements over currently existing methods. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Singh, Atul Kumar; Vijayalakshmi, S.; Bellare, Jayesh R.] Indian Inst Technol, Ctr Res Nanotechnol & Sci, Bombay 400076, Maharashtra, India.
   [Gajiwala, Astrid Lobo] Tata Mem Hosp, Tissue Bank, Bombay 400012, Maharashtra, India.
   [Rai, Ratan Kumar; Singh, Chandan; Sinha, Neeraj] Ctr Biomed Res, SGPGIMS Campus, Lucknow 226014, Uttar Pradesh, India.
   [Khan, Mohd. Parvez; Barbhuyan, Tarun; Chattopadhyay, Naibedya] CSIR Cent Drug Res Inst, Ctr Res Anabol Skeletal Targets Hlth & Illness AS, Div Endocrinol, Lucknow 226031, Uttar Pradesh, India.
   [Kumar, Ashutosh] Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.
   [Bellare, Jayesh R.] Indian Inst Technol, Dept Chem Engn, Bombay 400076, Maharashtra, India.
RP Sinha, N (reprint author), Ctr Biomed Res, SGPGIMS Campus, Lucknow 226014, Uttar Pradesh, India.; Kumar, A (reprint author), Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.; Bellare, JR (reprint author), Indian Inst Technol, Dept Chem Engn, Bombay 400076, Maharashtra, India.
EM neerajcbmr@gmail.com; ashutoshk@iitb.ac.in; jb@iitb.ac.in
RI Rai, Ratan/N-6344-2018
OI Rai, Ratan/0000-0001-6015-5539; Singh, Chandan/0000-0001-8006-1329
FU Department of Science & Technology (DST), Government of India; CSIR
   [BSC0201]; DBT, India [BT/PR12700/BRB/10/719/2009,
   BT/PR3138/NNT/28/550/2011]; DST, India [SR/SO/BB/022/2012]; CSIR, India
   [37(1509)/11/EMRII]
FX The authors are grateful for the technical assistance provided by Ms.
   Urmila Samant and Ms. Cynthia D'Lima at the Tissue Bank, TMH, Mumbai,
   for processing the human bone samples according to the various
   protocols. The authors are also thankful to Sophisticated Analytical
   Instrument Facility (SAIF) and Centre for Research in Nanotechnology and
   Science (CRNTS), Indian Institute of Technology Bombay, Mumbai for the
   SEM and TGA Facility. We thank Rajan Singh, Nitin Sagar, Mayur Temgire
   and Rohit Teotia for helping in characterization. Atul Kumar Singh is
   supported by a fellowship DST-INSPIRE from the Department of Science &
   Technology (DST), Government of India. NC acknowledges funding from CSIR
   (BSC0201). NS acknowledge funding from DBT, India
   (BT/PR12700/BRB/10/719/2009). AK acknowledges funding from DST, India
   (SR/SO/BB/022/2012) and CSIR, India (37(1509)/11/EMRII). JRB
   acknowledges funding from DBT, India (BT/PR3138/NNT/28/550/2011).
CR [Anonymous], 2004, WHO TECHN REP SER, V924
   Baharuddin MY, 2014, BIOMED RES INT, DOI 10.1155/2014/692328
   Bezerra MC, 2005, BRAZ J MED BIOL RES, V38, P161, DOI 10.1590/S0100-879X2005000200004
   Board TN, 2006, J BONE JOINT SURG BR, V88B, P852, DOI 10.1302/0301-620X.88B7.17425
   Boskey AL, 2010, J DENT RES, V89, P1333, DOI 10.1177/0022034510377791
   Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141
   Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260
   CASSELLA JP, 1995, CALCIFIED TISSUE INT, V56, P118, DOI 10.1007/BF00296342
   Catanese J, 1999, J BIOMED MATER RES, V45, P327, DOI 10.1002/(SICI)1097-4636(19990615)45:4<327::AID-JBM7>3.0.CO;2-L
   Centers for Disease Control and Prevention, 2003, MMWR-MORBID MORTAL W, V52, p[273, 276]
   Cornu O, 2000, J ORTHOPAED RES, V18, P426, DOI 10.1002/jor.1100180314
   DANIELSEN CC, 1994, BONE, V15, P91, DOI 10.1016/8756-3282(94)90897-4
   Eastlund T, 2010, ESSENTIALS OF TISSUE BANKING, P167, DOI 10.1007/978-90-481-9142-0_11
   Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896
   Gajiwala A. Lobo, 2003, Cell and Tissue Banking, V4, P125
   Gardin C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132344
   Ireland Lyn, 2005, Cell and Tissue Banking, V6, P181, DOI 10.1007/s10561-005-7365-5
   Janicki P, 2011, INJURY, V42, pS77, DOI 10.1016/j.injury.2011.06.014
   Jones DH, 2002, ANN RHEUM DIS, V61, P32
   Kaflak-Hachulska A, 2003, CALCIFIED TISSUE INT, V73, P476, DOI 10.1007/s00223-002-2111-5
   Kaminski A, 2012, CELL TISSUE BANK, V13, P363, DOI 10.1007/s10561-012-9308-2
   Kothiwale SV, 2009, CELL TISSUE BANK, V10, P317, DOI 10.1007/s10561-009-9126-3
   LANDIS WJ, 1978, J ULTRA MOL STRUCT R, V63, P188, DOI 10.1016/S0022-5320(78)80074-4
   Lau ML, 2013, COMPOS PART B-ENG, V55, P447, DOI 10.1016/j.compositesb.2013.06.027
   Levitt M.H., 1990, ADV MAGN RESON, V14, P111
   McGilvray KC, 2011, CELL TISSUE BANK, V12, P89, DOI 10.1007/s10561-010-9170-z
   Moreau MF, 2000, BIOMATERIALS, V21, P369, DOI 10.1016/S0142-9612(99)00193-3
   Nguyen Huynh, 2007, Cell and Tissue Banking, V8, P93, DOI 10.1007/s10561-006-9020-1
   Nguyen H, 2011, J ARTHROPLASTY, V26, P303, DOI 10.1016/j.arth.2010.03.032
   Nyman JS, 2013, J MECH BEHAV BIOMED, V22, P136, DOI 10.1016/j.jmbbm.2012.08.013
   Oryan A, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/1749-799X-9-18
   Rai RK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083478
   Rai RK, 2011, J PHYS CHEM C, V115, P14219, DOI 10.1021/jp2025768
   Rutala WA, 2008, GUIDELINE DISINFECTI
   Sastry TP, 2007, CLIN BIOCHEM, V40, P907, DOI 10.1016/j.clinbiochem.2007.04.011
   Seeman E, 1997, J BONE MINER RES, V12, P509, DOI 10.1359/jbmr.1997.12.4.509
   Shah M., 2014, CELL TISSUE BANK, P1
   Singh C, 2013, SOLID STATE NUCL MAG, V54, P18, DOI 10.1016/j.ssnmr.2013.05.003
   Trivedi R, 2010, EXPERT OPIN INV DRUG, V19, P995, DOI 10.1517/13543784.2010.501077
   Tuan HS, 2005, COMPUT AIDED DESIGN, V37, P1151, DOI 10.1016/j.cad.2005.02.006
   Zhao WL, 2014, LANGMUIR, V30, P13283, DOI 10.1021/la503158p
   Zhu PZ, 2009, J AM CHEM SOC, V131, P17064, DOI 10.1021/ja9081028
   Zoricic S, 2002, ACTA MED OKAYAMA, V56, P121
NR 43
TC 3
Z9 4
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAY 1
PY 2016
VL 62
BP 574
EP 584
DI 10.1016/j.msec.2016.02.002
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA DH4MC
UT WOS:000372759100071
PM 26952461
DA 2018-10-20
ER

PT J
AU Kandimalla, R
   Kalita, S
   Choudhury, B
   Devi, D
   Kalita, D
   Kalita, K
   Dash, S
   Kotoky, J
AF Kandimalla, Raghuram
   Kalita, Sanjeeb
   Choudhury, Bhaswati
   Devi, Dipali
   Kalita, Dhaneswar
   Kalita, Kasturi
   Dash, Suvakanta
   Kotoky, Jibon
TI Fiber from ramie plant (Boehmeria nivea): A novel suture biomaterial
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Ramie plant fiber; Suture biomaterial; Biocompatible; Superficial
   wounds; BMSF
ID ASSAMA SILK FIBROIN; HEMOCOMPATIBILITY; BIOCOMPATIBILITY; NANOPARTICLES;
   MECHANISMS; RESISTANCE; CELLULOSE
AB The quest for developing an ideal suture material prompted our interest to develop a novel suture with advantageous characters to market available ones. From natural origin only silk, cotton and linen fibers are presently available in market as non-absorbable suture biomaterials. In this study, we have developed a novel, cost-effective, and biocompatible suture biomaterial from ramie plant, Boehmeria nivea fiber. Field emission scanning electron microscopy (FE-SEM), energy-dispersive X-ray spectroscopy (EDX), attenuated total reflection Fourier transform infrared spectroscopy (ATR-FTIR) and thermo gravimetric analysis (TGA) results revealed the physicochemical properties of raw and degummed ramie fiber, where the former one showed desirable characteristics for suture preparation. The braided multifilament ramie suture prepared from degummed fiber exhibited excellent tensile strength. The suture found to be biocompatible towards human erythrocytes and nontoxic to mammalian cells. The fabricated ramie suture exhibited significant antibacterial activity against Escherichia coli, Bacillus subtilis and Staphylococcus aureus; which can be attributed to the inherent bacteriostatic ability of ramie plant fiber. In vivo wound closure efficacy was evaluated in adult male wister rats by suturing the superficial wound incisions. Within seven days of surgery the wound got completely healed leaving no rash and scar. The role of the ramie suture in complete wound healing was supported by the reduced levels of serum inflammatory mediators. Histopathology studies confirmed the wound healing ability of ramie suture, as rapid synthesis of collagen, connective tissue and other skin adnexal structures were observed within seven days of surgery. Tensile properties, biocompatibility and wound closure efficacy of the ramie suture were comparable with market available BMSF suture. The outcome of this study can drive tremendous possibility for the utilization of ramie plant fiber for various biomedical applications. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Kandimalla, Raghuram; Kalita, Sanjeeb; Choudhury, Bhaswati; Kotoky, Jibon] Inst Adv Study Sci & Technol, Drug Discovery Lab, Gauhati 781035, Assam, India.
   [Devi, Dipali] Inst Adv Study Sci & Technol, Seri Biotech Lab, Gauhati 781035, Assam, India.
   [Kalita, Dhaneswar] Govt Ayurved Coll & Hosp, Gauhati 781014, Assam, India.
   [Kalita, Kasturi] Hayat Hosp, Dept Pathol, Gauhati 781034, Assam, India.
   [Dash, Suvakanta] Girijananda Chowdhury Inst Pharmaceut Sci, Gauhati 781017, Assam, India.
RP Kotoky, J (reprint author), Inst Adv Study Sci & Technol, Drug Discovery Lab, Gauhati 781035, Assam, India.
EM jkotoky@gmail.com
OI Kandimalla, Raghuram/0000-0002-9202-4071
CR Achrai B, 2015, MAT SCI ENG C-MATER, V53, P128, DOI 10.1016/j.msec.2015.04.040
   [Anonymous], 2015, GLOB IND AN SIZ SHAR, P2015
   Brigida AIS, 2010, CARBOHYD POLYM, V79, P832, DOI 10.1016/j.carbpol.2009.10.005
   Celeste C., 2008, SELECTION SUTURE MAT, P194
   Chellamani K. P., 2013, J ACAD IND RES, V1, P778
   Choudhury AJ, 2016, SURGERY, V159, P539, DOI 10.1016/j.surg.2015.07.022
   Choudhury AJ, 2016, MAT SCI ENG C-MATER, V60, P475, DOI 10.1016/j.msec.2015.11.070
   Choudhury B., 2016, FRONT PHARM
   Gogoi D., 2013, BIOPOLYMERS, V101, P355
   Justinger C, 2009, SURGERY, V145, P330, DOI 10.1016/j.surg.2008.11.007
   Kalita S, 2016, MAT SCI ENG C-MATER, V61, P720, DOI 10.1016/j.msec.2015.12.078
   Kalita S, 2015, INT J NANOMED, V10, P2971, DOI 10.2147/IJN.S75023
   Kruger T. F., 2007, CLIN GYNAECOLOGY, P554
   Liu TM, 2015, GENE, V558, P131, DOI 10.1016/j.gene.2014.12.057
   Madbouly S., 2015, BIOBASED PLANT OIL P
   MANOR A, 1982, J PERIODONTOL, V53, P86, DOI 10.1902/jop.1982.53.2.86
   Poletto M, 2014, MATERIALS, V7, P6105, DOI 10.3390/ma7096105
   POSTLETHWAIT RW, 1975, ANN SURG, V181, P144
   Pudner R., 2005, WOUND HEALING SURG P, P53
   Reddy KO, 2009, MATER LETT, V63, P2390, DOI 10.1016/j.matlet.2009.08.035
   Rihova B, 1996, ADV DRUG DELIVER REV, V21, P157
   Rosa IM, 2010, COMPOS SCI TECHNOL, V71, P246
   Sen T, 2011, INT J INNOVATION MAN, V2, P192, DOI [DOI 10.7763/IJIMT.2011.V2.130, 10.7763/IJIMT.2011.V2.130]
   Seyfert UT, 2002, BIOMOL ENG, V19, P91, DOI 10.1016/S1389-0344(02)00015-1
   Singhal JP, 2002, BIOMATERIALS, V23, P1139, DOI 10.1016/S0142-9612(01)00228-9
   van Heerden J, 2005, SAMJ S AFR MED J, V95, P972
   Velnar T, 2009, J INT MED RES, V37, P1528, DOI 10.1177/147323000903700531
   WALLACE WR, 1970, J ORAL SURG, V28, P739
   Wambua P, 2003, COMPOS SCI TECHNOL, V63, P1259, DOI 10.1016/S0266-3538(03)00096-4
   Wang JN, 2014, MAT SCI ENG C-MATER, V34, P429, DOI 10.1016/j.msec.2013.09.039
   Werner K, 2014, J ANAL APPL PYROL, V110, P130, DOI 10.1016/j.jaap.2014.08.013
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Xi LX, 2013, BIORESOURCES, V8, P6501
   Yang HP, 2006, ENERG FUEL, V20, P388, DOI 10.1021/ef0580117
NR 34
TC 15
Z9 16
U1 3
U2 41
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAY 1
PY 2016
VL 62
BP 816
EP 822
DI 10.1016/j.msec.2016.02.040
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA DH4MC
UT WOS:000372759100098
PM 26952488
DA 2018-10-20
ER

PT J
AU Krukiewicz, K
   Zak, JK
AF Krukiewicz, Katarzyna
   Zak, Jerzy K.
TI Biomaterial-based regional chemotherapy: Local anticancer drug delivery
   to enhance chemotherapy and minimize its side-effects
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Review
DE Regional chemotherapy; Local drug delivery; Anticancer implants; Drug
   carriers; Biomaterials
ID ELECTROCHEMICALLY CONTROLLED-RELEASE; POROUS SILICON NANOPARTICLES;
   RESPONSIVE DEXTRIN NANOGELS; REDUCED GRAPHENE OXIDE; IN-VITRO;
   CANCER-THERAPY; BREAST-CANCER; COLORECTAL-CANCER; SILK FILMS; BIOMEDICAL
   APPLICATIONS
AB Since the majority of anticancer pharmacological agents affect not only cancer tissue but also normal cells, chemotherapy is usually accompanied with severe side effects. Regional chemotherapy, as the alternative version of conventional treatment, leads to the enhancement of the therapeutic efficiency of anticancer drugs and, simultaneously, reduction of toxic effects to healthy tissues. This paper provides an insight into different approaches of local delivery of chemotherapeutics, such as the injection of anticancer agents directly into tumor tissue, the use of injectable in situ forming drug carriers or injectable platforms in a form of implants. The wide range of biomaterials used as reservoirs of anticancer drugs is described, i.e. poly(ethylene glycol) and its copolymers, polyurethanes, poly(lactic acid) and its copolymers, poly(epsilon-caprolactone), polyanhydrides, chitosan, cellulose, cyclodextrins, silk, conducting polymers, modified titanium surfaces, calcium phosphate based biomaterials, silicone and silica implants, as well as carbon nanotubes and graphene. To emphasize the applicability of regional chemotherapy in cancer treatment, the commercially available products approved by the relevant health agencies are presented. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Krukiewicz, Katarzyna; Zak, Jerzy K.] Silesian Tech Univ, Dept Phys Chem & Technol Polymers, M Strzody 9, PL-44100 Gliwice, Poland.
RP Krukiewicz, K (reprint author), Silesian Tech Univ, Dept Phys Chem & Technol Polymers, M Strzody 9, PL-44100 Gliwice, Poland.
EM katarzyna.krukiewicz@polsl.pl; jerzy.zak@polsl.pl
OI Krukiewicz, Katarzyna/0000-0003-0503-0906
CR Agarwal P, 2013, DRUG DISCOV TODAY, V18, P337, DOI 10.1016/j.drudis.2013.01.013
   Ahmed KK, 2014, IMMUNOL RES, V59, P220, DOI 10.1007/s12026-014-8537-9
   Aigner KR, 2011, INDUCTION CHEMOTHERAPY: INTEGRATED TREATMENT PROGRAMS FOR LOCALLY ADVANCED CANCERS, P1, DOI 10.1007/978-3-642-18173-3
   Akhavan O, 2014, J MATER CHEM B, V2, P3306, DOI 10.1039/c3tb21834a
   Akhavan O, 2013, SMALL, V9, P3593, DOI 10.1002/smll.201203106
   Akhavan O, 2012, BIOMATERIALS, V33, P8017, DOI 10.1016/j.biomaterials.2012.07.040
   Akhavan O, 2012, J MATER CHEM, V22, P13773, DOI 10.1039/c2jm31396k
   Alhmoud H, 2015, ADV FUNCT MATER, V25, P1137, DOI 10.1002/adfm.201403414
   Alizadeh N, 2014, ELECTROCHIM ACTA, V130, P488, DOI 10.1016/j.electacta.2014.03.055
   Ampollini L, 2010, EUR J CARDIO-THORAC, V37, P557, DOI 10.1016/j.ejcts.2009.08.012
   Anglin EJ, 2004, LANGMUIR, V20, P11264, DOI 10.1021/la048105t
   Anglin EJ, 2008, ADV DRUG DELIVER REV, V60, P1266, DOI 10.1016/j.addr.2008.03.017
   Aoki H., 1993, REP I MED DENT ENG, V27, P39
   Atta W, 2009, BIOMATERIALS, V30, P5352, DOI 10.1016/j.biomaterials.2009.06.040
   Attarwala Husain, 2010, J Nat Sci Biol Med, V1, P53, DOI 10.4103/0976-9668.71675
   Aw MS, 2012, POWDER TECHNOL, V223, P52, DOI 10.1016/j.powtec.2011.04.023
   Bai S, 2012, RSC ADV, V2, P64, DOI 10.1039/c1ra00260k
   Balint R, 2014, ACTA BIOMATER, V10, P2341, DOI 10.1016/j.actbio.2014.02.015
   Barrioni BR, 2015, MAT SCI ENG C-MATER, V52, P22, DOI 10.1016/j.msec.2015.03.027
   Barton-Burke M., 2002, CANC CHEMOTHERAPY CA
   Bhala N, 2013, LANCET, V382, P769, DOI 10.1016/S0140-6736(13)60900-9
   Bhattarai N, 2005, J CONTROL RELEASE, V103, P609, DOI 10.1016/j.jconrel.2004.12.019
   Bogaerts W, 2012, LASER PHOTONICS REV, V6, P47, DOI 10.1002/lpor.201100017
   Boncel S, 2013, J CONTROL RELEASE, V169, P126, DOI 10.1016/j.jconrel.2013.04.009
   Bos GW, 2004, EUR J PHARM SCI, V21, P561, DOI 10.1016/j.ejps.2003.12.007
   Byrne JD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3009951
   Cancer Research UK, 2014, WORLDW CANC INC STAT
   Celikoglu F, 2003, J PHARM PHARMACOL, V55, P1441, DOI 10.1211/0022357021936
   Celikoglu F, 2008, CANC THER, V6, P545
   Chai F, 2014, J BIOMED MATER RES B, V102, P1130, DOI 10.1002/jbm.b.33094
   Chang GT, 2011, J CONTROL RELEASE, V156, P21, DOI 10.1016/j.jconrel.2011.07.008
   Chau N. D. Quyen, 2015, BIOCH BIOPHYS RES CO
   Chen DQ, 2015, J CONTROL RELEASE, V210, P230, DOI 10.1016/j.jconrel.2015.04.021
   Chen H, 2016, ANTI-CANCER DRUG, V27, P118, DOI 10.1097/CAD.0000000000000290
   Chen MW, 2012, INT J NANOMED, V7, P4285, DOI 10.2147/IJN.S33083
   Chen XY, 2013, COLLOID SURFACE B, V103, P149, DOI 10.1016/j.colsurfb.2012.10.022
   Chen Y, 2011, REACT FUNCT POLYM, V71, P525, DOI 10.1016/j.reactfunctpolym.2011.01.010
   Cheng YL, 2013, BIOMATERIALS, V34, P10338, DOI 10.1016/j.biomaterials.2013.09.064
   Chitkara D, 2006, MACROMOL BIOSCI, V6, P977, DOI 10.1002/mabi.200600129
   Chiu B, 2014, BRIT J CANCER, V111, P708, DOI 10.1038/bjc.2014.324
   Cirillo G, 2013, EUR J PHARM SCI, V49, P359, DOI 10.1016/j.ejps.2013.04.008
   Comeau TB, 2001, SUPPORT CARE CANCER, V9, P575, DOI 10.1007/s005200100279
   Corrie P. G., 2008, MEDICINE, V36, P24, DOI DOI 10.1016/J.MPMED.2007.10.012
   Costa D, 2012, COLLOID SURFACE B, V92, P106, DOI 10.1016/j.colsurfb.2011.11.038
   Croisier F, 2013, EUR POLYM J, V49, P780, DOI 10.1016/j.eurpolymj.2012.12.009
   da Silva GR, 2010, POLYM DEGRAD STABIL, V95, P491, DOI 10.1016/j.polymdegradstab.2010.01.001
   Dang WB, 1996, J CONTROL RELEASE, V42, P83, DOI 10.1016/0168-3659(96)01371-5
   Daubine F, 2009, BIOMATERIALS, V30, P6367, DOI 10.1016/j.biomaterials.2009.08.002
   Dave K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115712
   De Souza R, 2010, DRUG DELIV, V17, P365, DOI 10.3109/10717541003762854
   Denmeade SR, 2002, NAT REV CANCER, V2, P389, DOI 10.1038/nrc801
   DeVita VT, 2008, CANCER RES, V68, P8643, DOI 10.1158/0008-5472.CAN-07-6611
   Dhanikula AB, 2004, AAPS J, V6
   Erdogar N, 2014, INT J PHARMACEUT, V471, P1, DOI 10.1016/j.ijpharm.2014.05.014
   Esrafilzadeh D, 2013, J CONTROL RELEASE, V169, P313, DOI 10.1016/j.jconrel.2013.01.022
   Fesler Mark J, 2010, Pharmacotherapy, V30, P540, DOI 10.1592/phco.30.5.540
   Foraker AB, 2003, PHARMACEUT RES, V20, P110, DOI 10.1023/A:1022211127890
   Fowler JE, 2000, J UROLOGY, V164, P730, DOI 10.1016/S0022-5347(05)67291-6
   Fung LK, 1997, ADV DRUG DELIVER REV, V26, P209, DOI 10.1016/S0169-409X(97)00036-7
   Gabouze N, 2006, VACUUM, V80, P986, DOI 10.1016/j.vacuum.2006.01.004
   Gilert Ariel, 2010, J Angiogenes Res, V2, P20, DOI 10.1186/2040-2384-2-20
   Goncalves C, 2010, MATERIALS, V3, P1420, DOI 10.3390/ma3021420
   GOODMAN LS, 1946, JAMA-J AM MED ASSOC, V132, P126, DOI 10.1001/jama.1946.02870380008004
   Gou ML, 2011, NANOSCALE, V3, P1558, DOI 10.1039/c0nr00758g
   Gou ML, 2009, J PHYS CHEM B, V113, P12928, DOI 10.1021/jp905781g
   Gradmann C, 2011, DYNAMIS, V31, P305, DOI 10.4321/s0211-95362011000200003
   Gulati K, 2012, INT J NANOMED, V7, P2069, DOI 10.2147/IJN.S29917
   Gustavsson B, 2015, CLIN COLORECTAL CANC, V14, P1, DOI 10.1016/j.clcc.2014.11.002
   Haidary SM, 2012, J NANOMATER, DOI 10.1155/2012/830503
   Han HD, 2008, INT J PHARM, V350, P27, DOI 10.1016/j.ijpharm.2007.08.014
   Han S, 2003, MACROMOLECULES, V36, P8312, DOI 10.1021/ma0347971
   Haupt S, 2006, EUR J PHARM SCI, V28, P204, DOI 10.1016/j.ejps.2006.02.001
   Hendricks BK, 2015, NEUROSURG FOCUS, V38, DOI 10.3171/2015.1.FOCUS14767
   Herrlich S, 2012, ADV DRUG DELIVER REV, V64, P1617, DOI 10.1016/j.addr.2012.02.003
   Hines DJ, 2011, BIOMACROMOLECULES, V12, P804, DOI 10.1021/bm101421r
   Hoare TR, 2008, POLYMER, V49, P1993, DOI 10.1016/j.polymer.2008.01.027
   Hochhaus A, 2002, LEUKEMIA, V16, P1205, DOI 10.1038/sj.leu.2402575
   Hofmann S, 2006, J CONTROL RELEASE, V111, P219, DOI 10.1016/j.jconrel.205.12.009
   Hon NK, 2012, J BIOMED MATER RES A, V100A, P3416, DOI 10.1002/jbm.a.34294
   Hong YL, 2010, MAT SCI ENG R, V70, P225, DOI 10.1016/j.mser.2010.06.010
   Huggins C, 1941, ARCH SURG-CHICAGO, V43, P209, DOI 10.1001/archsurg.1941.01210140043004
   Huggins C., 1941, CANCER RES, P293
   Jain JP, 2008, J BIOMED MATER RES A, V84A, P740, DOI 10.1002/jbm.a.31456
   Jain JP, 2005, J CONTROL RELEASE, V103, P541, DOI 10.1016/j.jconrel.2004.12.021
   Jelonek K, 2013, POLIMERY-W, V58, P858
   Joshi VB, 2013, HUM VACC IMMUNOTHER, V9, P2584, DOI 10.4161/hv.26136
   Joshi VB, 2013, ACTA BIOMATER, V9, P5583, DOI 10.1016/j.actbio.2012.11.001
   Juratli TA, 2013, PHARMACOL THERAPEUT, V139, P341, DOI 10.1016/j.pharmthera.2013.05.003
   Kang SG, 2010, MACROMOL RES, V18, P680, DOI 10.1007/s13233-010-0715-6
   Katti DS, 2002, ADV DRUG DELIVER REV, V54, P933, DOI 10.1016/S0169-409X(02)00052-2
   Kazek-Kesik A, 2014, MAT SCI ENG C-MATER, V39, P259, DOI 10.1016/j.msec.2014.03.008
   Kempe S, 2012, J CONTROL RELEASE, V161, P668, DOI 10.1016/j.jconrel.2012.04.016
   Kemper EM, 2004, CANCER TREAT REV, V30, P415, DOI 10.1016/j.ctrv.2004.04.001
   Khang G, 2003, MACROMOL RES, V11, P207, DOI 10.1007/BF03218355
   Kim SH, 2011, BIOMATERIALS, V32, P5505, DOI 10.1016/j.biomaterials.2011.04.017
   Kim S, 2009, J BIOMED MATER RES B, V90B, P145, DOI 10.1002/jbm.b.31266
   KLEIN CPAT, 1983, J BIOMED MATER RES, V17, P769, DOI 10.1002/jbm.820170505
   Ko PJ, 2011, NANOSCI NANOTECH LET, V3, P612, DOI 10.1166/nnl.2011.1236
   Krasko MY, 2003, J POLYM SCI POL CHEM, V41, P1059, DOI 10.1002/pola.10651
   Krishnamurthy S, 2014, BIOMATERIALS, V35, P9177, DOI 10.1016/j.biomaterials.2014.07.018
   Krukiewicz K, 2015, MAT SCI ENG C-MATER, V54, P176, DOI 10.1016/j.msec.2015.05.017
   Krukiewicz K, 2015, ACTA BIOMATER, V19, P158, DOI 10.1016/j.actbio.2015.03.006
   Krukiewicz K, 2014, J MATER SCI, V49, P5738, DOI 10.1007/s10853-014-8292-2
   Krzakala A, 2013, ELECTROCHIM ACTA, V104, P407, DOI 10.1016/j.electacta.2012.07.075
   Kufe D. W., 2003, HOLLAND FREI CANC ME
   Kuwata Yoichiro, 1997, Kobe Journal of Medical Sciences, V43, P83
   Kyriakopoulou S, 2011, CURR NANOSCI, V7, P503, DOI 10.2174/157341311796196880
   Leal-Egana A, 2010, BIOTECHNOL APPL BIOC, V55, P155, DOI 10.1042/BA20090229
   Levitzki A, 2010, MOL ASPECTS MED, V31, P287, DOI 10.1016/j.mam.2010.04.001
   Lewis SL, 2013, MED SURG NURSING ASS
   Li MQ, 2015, ACTA BIOMATER, V18, P132, DOI 10.1016/j.actbio.2015.02.022
   Li RB, 2011, CARBON, V49, P1797, DOI 10.1016/j.carbon.2011.01.003
   Li X, 2000, BIOMED MICRODEVICES, V2, P265, DOI 10.1023/A:1009951121205
   Lipps B. V., 2010, PROGR CANC THERAPY T
   Liu DX, 2015, DRUG DELIV, V22, P136, DOI 10.3109/10717544.2013.870258
   Liu L, 2013, COLLOID SURFACE B, V106, P93, DOI 10.1016/j.colsurfb.2013.01.047
   Liu Mingsong, 2000, Zhonghua Jiehe He Huxi Zazhi, V23, P550
   Liu S, 2015, NANOMED-NANOTECHNOL, V11, P1047, DOI 10.1016/j.nano.2015.03.001
   Loftsson T, 2007, INT J PHARM, V329, P1, DOI 10.1016/j.ijpharm.2006.10.044
   Lohr M, 1998, GENE THER, V5, P1070, DOI 10.1038/sj.gt.3300671
   Lu Q, 2010, MACROMOL BIOSCI, V10, P359, DOI 10.1002/mabi.200900388
   Ma J, 2008, MOL CANCER THER, V7, P3670, DOI 10.1158/1535-7163.MCT-08-0715
   Manabe T, 2005, J BIOMED MATER RES B, V73B, P203, DOI 10.1002/jbm.b.30186
   Manchun S, 2015, CARBOHYD POLYM, V126, P222, DOI 10.1016/j.carbpol.2015.03.018
   Manchun S, 2014, CARBOHYD POLYM, V114, P78, DOI 10.1016/j.carbpol.2014.08.002
   McKnight JA, 2003, CLIN TECH SMALL AN P, V18, P67, DOI 10.1053/svms.2003.36617
   Mechnikov I., 1967, NOBEL PRIZE PHYSL ME
   Mkhabela V, 2015, INT J BIOL MACROMOL, V79, P186, DOI 10.1016/j.ijbiomac.2015.04.056
   Morrison WB, 2010, J VET INTERN MED, V24, P1249, DOI 10.1111/j.1939-1676.2010.0590.x
   Munoz S, 2015, MATER CHARACT, V108, P68, DOI 10.1016/j.matchar.2015.08.019
   Nalwa H. S., 2008, HDB ORGANIC ELECT PH
   Niemela E, 2015, EUR J PHARM BIOPHARM, V96, P11, DOI 10.1016/j.ejpb.2015.07.009
   NIMNI ME, 1972, BIOCHEM PHARMACOL, V21, P485, DOI 10.1016/0006-2952(72)90321-8
   Olbrich JM, 2012, J BIOMED MATER RES A, V100A, P2365, DOI 10.1002/jbm.a.34179
   Olson J. S., 2010, YALE J BIOL MED, V83, P50
   Olson J. S., 1989, HIST CANC ANNOTATED
   Onn A, 2014, LANCET ONCOL, V15, P124, DOI 10.1016/S1470-2045(14)70010-5
   Otani Y, 1996, JPN J CLIN ONCOL, V26, P476, DOI 10.1093/oxfordjournals.jjco.a023268
   Papac Rose J., 2001, Yale Journal of Biology and Medicine, V74, P391
   Pardun K, 2015, MAT SCI ENG C-MATER, V48, P337, DOI 10.1016/j.msec.2014.12.031
   Park JS, 2011, SMALL, V7, P2061, DOI 10.1002/smll.201100438
   Park JH, 2009, NAT MATER, V8, P331, DOI [10.1038/NMAT2398, 10.1038/nmat2398]
   Park SB, 2015, MAT SCI ENG C-MATER, V50, P64, DOI 10.1016/j.msec.2015.01.073
   Park YH, 2015, J IND ENG CHEM, V30, P190, DOI 10.1016/j.jiec.2015.05.021
   Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387
   Pereira AD, 2013, DRUG DELIV, V20, P168, DOI 10.3109/10717544.2013.801052
   Perla V, 2005, J BIOMED MATER RES A, V75A, P356, DOI 10.1002/jbm.a.30423
   Pourjavadi A, 2015, POLYMER, V76, P52, DOI 10.1016/j.polymer.2015.08.050
   Poursaid A, 2015, BIOMATERIALS, V57, P142, DOI 10.1016/j.biomaterials.2015.04.015
   Pradeepa M., 2011, P INT C BIOSC BIOCH
   Price P., 2008, TREATMENT CANC
   Qian W, 2015, BIOORG MED CHEM LETT, V25, P856, DOI 10.1016/j.bmcl.2014.12.072
   Radivojsa M, 2013, EUR J PHARM SCI, V50, P93, DOI 10.1016/j.ejps.2013.03.002
   Rahman R, 2014, THER DELIV, V5, P1243, DOI [10.4155/TDE.14.83c2014Future, 10.4155/tde.14.83]
   Renneberg Reinhard, 2007, Biotechnology Journal, V2, P1207, DOI 10.1002/biot.200790106
   Rivers TJ, 2002, ADV FUNCT MATER, V12, P33, DOI 10.1002/1616-3028(20020101)12:1<33::AID-ADFM33>3.0.CO;2-E
   Rockwell S, 1998, RADIAT RES, V150, pS157, DOI 10.2307/3579817
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Rokhade AP, 2006, CARBOHYD POLYM, V65, P243, DOI 10.1016/j.carbpol.2006.01.013
   Saboktakin MR, 2011, INT J BIOL MACROMOL, V48, P747, DOI 10.1016/j.ijbiomac.2011.02.020
   del Burgo LS, 2014, NANOMED-NANOTECHNOL, V10, P905, DOI 10.1016/j.nano.2013.10.001
   Salonen J, 2005, J CONTROL RELEASE, V108, P362, DOI 10.1016/j.jconrel.2005.08.017
   Sandler AB, 2000, J CLIN ONCOL, V18, P122, DOI 10.1200/JCO.2000.18.1.122
   Sartor O, 2003, UROLOGY, V61, P25, DOI 10.1016/S0090-4295(02)02396-8
   SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0
   Schmaljohann D, 2006, ADV DRUG DELIVER REV, V58, P1655, DOI 10.1016/j.addr.2006.09.020
   Schwartz AL, 2000, CANCER PRACT, V8, P16, DOI 10.1046/j.1523-5394.2000.81003.x
   Schwendeman SP, 2014, J CONTROL RELEASE, V190, P240, DOI 10.1016/j.jconrel.2014.05.057
   Seib FP, 2015, ACTA BIOMATER, V20, P32, DOI 10.1016/j.actbio.2015.04.003
   Seib FP, 2013, ADV FUNCT MATER, V23, P58, DOI 10.1002/adfm.201201238
   Seib FP, 2012, BIOMATERIALS, V33, P8442, DOI 10.1016/j.biomaterials.2012.08.004
   Sellers WR, 1999, J CLIN INVEST, V104, P1655, DOI 10.1172/JCI9053
   Selvam S, 2015, COLLOID SURFACE B, V126, P35, DOI 10.1016/j.colsurfb.2014.11.043
   Shamaeli E, 2013, ELECTROCHIM ACTA, V114, P409, DOI 10.1016/j.electacta.2013.10.119
   Sharifi S, 2009, ACTA BIOMATER, V5, P1966, DOI 10.1016/j.actbio.2009.02.004
   Sheleg SV, 2002, J NEURO-ONCOL, V60, P53, DOI 10.1023/A:1020288015457
   Shikanov A, 2004, J BIOMED MATER RES A, V69A, P47, DOI 10.1002/jbm.a.20101
   Shimpi Shyam, 2005, Acta Pharmaceutica (Zagreb), V55, P139
   Skeel RT, 2011, HDB CANC CHEMOTHERAP
   Sridhar R, 2014, J BIOMAT SCI-POLYM E, V25, P985, DOI 10.1080/09205063.2014.917039
   Storm PB, 2002, J NEURO-ONCOL, V56, P209, DOI 10.1023/A:1015003232713
   Sugihara S, 2005, MACROMOLECULES, V38, P1919, DOI 10.1021/ma048409m
   Sullivan M. A., 2000, CARDIOVASC REV REP, V21, P89
   Sun CC, 2005, SUPPORT CARE CANCER, V13, P219, DOI 10.1007/s00520-004-0710-6
   Svirskis D, 2010, J CONTROL RELEASE, V146, P6, DOI 10.1016/j.jconrel.2010.03.023
   Tahara Y, 2001, J Orthop Sci, V6, P556, DOI 10.1007/s007760100012
   TAKAHASHI T, 1976, CANCER, V38, P1507, DOI 10.1002/1097-0142(197610)38:4<1507::AID-CNCR2820380411>3.0.CO;2-V
   Talamonti C, 2011, NUCL INSTRUM METH A, V658, P84, DOI 10.1016/j.nima.2011.05.044
   Tanaka Fumihiro, 2000, Current Pharmaceutical Biotechnology, V1, P137, DOI 10.2174/1389201003378979
   Tanzawa Y, 2011, J ORTHOP SCI, V16, P77, DOI 10.1007/s00776-011-0045-3
   ten Hagen TLM, 2003, TECHNOL CANCER RES T, V2, P195
   Tohnai I, 1998, ORAL ONCOL, V34, P387, DOI 10.1016/S1368-8375(98)00018-9
   Tosti A, 2005, BRIT J DERMATOL, V152, P1056, DOI 10.1111/J.1365-2133.2005.06469.x
   Tran P. A., 2009, MRS P, V1209
   Tran P, 2008, INT J NANOMED, V3, P391
   Tran PA, 2010, J BIOMED MATER RES A, V93A, P1417, DOI 10.1002/jbm.a.32631
   Truong VX, 2013, J MATER CHEM B, V1, P221, DOI 10.1039/c2tb00148a
   Tyler B, 2010, J NEUROSURG, V113, P210, DOI 10.3171/2009.11.JNS08162
   Tzur-Balter A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7208
   Tzur-Balter A, 2013, ACTA BIOMATER, V9, P6208, DOI 10.1016/j.actbio.2012.12.010
   UCHIDA A, 1992, J ORTHOPAED RES, V10, P440, DOI 10.1002/jor.1100100317
   UENO N, 1982, J BIOMED MATER RES, V16, P669, DOI 10.1002/jbm.820160514
   UHLIR A, 1956, AT&T TECH J, V35, P333, DOI 10.1002/j.1538-7305.1956.tb02385.x
   Vanneman M, 2012, NAT REV CANCER, V12, P237, DOI 10.1038/nrc3237
   Varan C, 2014, J INCL PHENOM MACRO, V80, P9, DOI 10.1007/s10847-014-0422-6
   Vashist SK, 2011, CARBON, V49, P4077, DOI 10.1016/j.carbon.2011.05.049
   Vellimana AK, 2013, J NEURO-ONCOL, V111, P229, DOI 10.1007/s11060-012-1014-1
   Venuganti VVK, 2015, NANOSCALE, V7, P3903, DOI 10.1039/c4nr05241b
   Wadhwa R, 2006, J CONTROL RELEASE, V110, P531, DOI 10.1016/j.jconrel.2005.10.027
   Wang J, 2014, BIOMATERIALS, V35, P3080, DOI 10.1016/j.biomaterials.2013.12.025
   Wang PP, 2002, ADV DRUG DELIVER REV, V54, P987, DOI 10.1016/S0169-409X(02)00054-6
   Wang ZH, 2015, COLLOID SURFACE B, V134, P40, DOI 10.1016/j.colsurfb.2015.06.031
   Weng LH, 2013, ACTA BIOMATER, V9, P8182, DOI 10.1016/j.actbio.2013.06.020
   Weng LH, 2013, ACTA BIOMATER, V9, P6823, DOI 10.1016/j.actbio.2013.02.017
   Wong BS, 2012, DRUG DELIV TRANSL RE, V2, P272, DOI 10.1007/s13346-012-0096-9
   Wozniak Anna, 2012, Przegl Lek, V69, P1079
   Wu WQ, 2014, MOL PHARMACEUT, V11, P3378, DOI 10.1021/mp500019p
   Xia B, 2015, RSC ADV, V5, P44660, DOI 10.1039/c5ra04843e
   Xia Q, 1999, J Tongji Med Univ, V19, P219
   Yang F, 2008, MED HYPOTHESES, V70, P765, DOI 10.1016/j.mehy.2007.07.045
   Yang K, 2012, BIOMATERIALS, V33, P2206, DOI 10.1016/j.biomaterials.2011.11.064
   Yang K, 2010, NANO LETT, V10, P3318, DOI 10.1021/nl100996u
   Yang WE, 2015, NANOSCALE RES LETT, V10, P1, DOI 10.1186/s11671-015-0849-8
   Yang XQ, 2008, POLYMER, V49, P3477, DOI 10.1016/j.polymer.2008.06.005
   Yasin MN, 2014, J CONTROL RELEASE, V196, P208, DOI 10.1016/j.jconrel.2014.09.030
   Yi H, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-211
   Yoshida K, 2011, BIOCHEM PHARMACOL, V82, P1884, DOI 10.1016/j.bcp.2011.09.015
   Yu SY, 2014, RSC ADV, V4, P18171, DOI 10.1039/c4ra02113d
   Yuan HP, 1999, BIOMATERIALS, V20, P1799, DOI 10.1016/S0142-9612(99)00075-7
   Yucel T, 2014, J CONTROL RELEASE, V190, P381, DOI 10.1016/j.jconrel.2014.05.059
   Zaman MH, 2013, NAT REV CANCER, V13, P596, DOI 10.1038/nrc3564
   Zhao B, 2005, MACROMOLECULES, V38, P9509, DOI 10.1021/ma0514572
   Zhao HP, 2013, INT J PHARMACEUT, V450, P235, DOI 10.1016/j.ijpharm.2013.04.051
   Zia KM, 2015, INT J BIOL MACROMOL, V79, P377, DOI 10.1016/j.ijbiomac.2015.04.076
NR 234
TC 31
Z9 31
U1 9
U2 137
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAY 1
PY 2016
VL 62
BP 927
EP 942
DI 10.1016/j.msec.2016.01.063
PG 16
WC Materials Science, Biomaterials
SC Materials Science
GA DH4MC
UT WOS:000372759100110
PM 26952500
DA 2018-10-20
ER

PT J
AU Shah, FA
   Trobos, M
   Thomsen, P
   Palmquist, A
AF Shah, Furqan A.
   Trobos, Margarita
   Thomsen, Peter
   Palmquist, Anders
TI Commercially pure titanium (cp-Ti) versus titanium alloy (Ti6Al4V)
   materials as bone anchored implants - Is one truly better than the
   other?
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Review
DE Commercially pure titanium; Ti6Al4V; Bacterial adhesion;
   Osseointegration; Biomechanics; Bone; Implant
ID TRANSMISSION ELECTRON-MICROSCOPY; STAPHYLOCOCCUS-EPIDERMIDIS; DENTAL
   IMPLANTS; TISSUE INTEGRATION; METALLIC IMPLANTS; SURFACE-TREATMENT;
   ION-IMPLANTATION; CORTICAL BONE; OXIDE-FILMS; RABBIT
AB Commercially pure titanium (cp-Ti) and titanium alloys (typically Ti6Al4V) display excellent corrosion resistance and biocompatibility. Although the chemical composition and topography are considered important, the mechanical properties of the material and the loading conditions in the host have, conventionally, influenced material selection for different clinical applications: predominantly Ti6Al4V in orthopaedics while cp-Ti in dentistry. This paper attempts to address three important questions: (i) To what extent do the surface properties differ when cp-Ti and Ti6Al4V materials are manufactured with the same processing technique?, (ii) Does bone tissue respond differently to the two materials, and (iii) Do bacteria responsible for causing biomaterial-associated infections respond differently to the two materials? It is concluded that: (i) Machined cp-Ti and Ti6Al4V exhibit similar surface morphology, topography, phase composition and chemistry, (ii) Under experimental conditions, cp-Ti and Ti6Al4V demonstrate similar osseointegration and biomechanical anchorage, and (iii) Experiments in vitro fail to disclose differences between cp-Ti and Ti6Al4V to harbour Staphylococcus epidermidis growth. No clinical comparative studies exist which could determine if long-term, clinical differences exist between the two types of bulk materials. It is debatable whether cp-Ti or Ti6Al4V exhibit superiority over the other, and further comparative studies, particularly in a clinical setting, are required. (C) 2016 Elsevier B.V. All rights reserved.
C1 Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Biomat, Gothenburg, Sweden.
   BIOMATCELL VINN Excellence Ctr Biomat & Cell Ther, Gothenburg, Sweden.
RP Shah, FA (reprint author), Univ Gothenburg, Sahlgrenska Acad, Dept Biomat, Gothenburg, Sweden.
EM furqan.ali.shah@biomaterials.gu.se
RI Palmquist, Anders/D-2171-2014
OI Shah, Furqan Ali/0000-0002-9876-0467; Thomsen, Peter/0000-0003-3910-6665
FU Swedish Research Council [K2015-52X-09495-28-4]; BIOMATCELL VINN
   Excellence Center of Biomaterials and Cell Therapy; Region Vastra
   Gotaland, an ALF/LUA grant [ALFGBG-138721]; IngaBritt and Arne Lundberg
   Foundation; Dr. Felix Neubergh Foundation; Wilhelm and Martina Lundgren
   Foundation, Promobilia; Hjalmar Svensson Foundation; Materials Science
   Area of Advance at Chalmers and the Department of Biomaterials,
   University of Gothenburg
FX This study was supported by the Swedish Research Council (grant
   K2015-52X-09495-28-4), the BIOMATCELL VINN Excellence Center of
   Biomaterials and Cell Therapy, the Region Vastra Gotaland, an ALF/LUA
   grant (ALFGBG-138721), the IngaBritt and Arne Lundberg Foundation, the
   Dr. Felix Neubergh Foundation, the Wilhelm and Martina Lundgren
   Foundation, Promobilia, the Hjalmar Svensson Foundation, and the
   Materials Science Area of Advance at Chalmers and the Department of
   Biomaterials, University of Gothenburg. The sponsors were not involved
   in the study design, data acquisition, interpretation, writing and
   submission of the article. The authors declare no conflict of interest.
CR ADELL R, 1981, INT J ORAL MAXILLOF, V10, P387, DOI 10.1016/S0300-9785(81)80077-4
   Al-Nawas B, 2012, CLIN IMPLANT DENT R, V14, P896, DOI 10.1111/j.1708-8208.2010.00324.x
   [Anonymous], 2013, B26513AE1 ASTM
   ASK M, 1990, J MATER RES, V5, P1662, DOI 10.1557/JMR.1990.1662
   Barao VAR, 2014, J PERIODONTOL, V85, P1275, DOI 10.1902/jop.2014.130595
   BLUMENTHAL NC, 1989, J BIOMED MATER RES-A, V23, P13, DOI 10.1002/jbm.820231305
   Branemark P I, 1977, Scand J Plast Reconstr Surg Suppl, V16, P1
   Brunette D. M., 2001, TITANIUM MED
   Carr AB, 2001, J PROSTHET DENT, V85, P276, DOI 10.1067/mpr.2001.114821
   Challa VSA, 2013, J BIOMED MATER RES A, V101, P2083, DOI 10.1002/jbm.a.34492
   de Maeztu MA, 2003, CLIN ORAL IMPLAN RES, V14, P57, DOI 10.1034/j.1600-0501.2003.140108.x
   de Peppo GM, 2012, SCI WORLD J, DOI 10.1100/2012/646417
   Dhert WJA, 1998, J BIOMED MATER RES, V41, P574, DOI 10.1002/(SICI)1097-4636(19980915)41:4<574::AID-JBM9>3.0.CO;2-9
   Esposito M., 2014, COCHRANE DB SYST REV, V7, DOI DOI 10.1002/14651858.CD003815
   Forsgren J, 2007, ACTA BIOMATER, V3, P980, DOI 10.1016/j.actbio.2007.03.006
   GABRIEL BL, 1994, BIOMATERIALS, V15, P628, DOI 10.1016/0142-9612(94)90214-3
   Giordano C, 2011, COLLOID SURFACE B, V88, P648, DOI 10.1016/j.colsurfb.2011.07.054
   Gittens RA, 2014, ACTA BIOMATER, V10, P2907, DOI 10.1016/j.actbio.2014.03.032
   Grandfield K, 2013, ULTRAMICROSCOPY, V127, P48, DOI 10.1016/j.ultramic.2012.07.007
   Ha KY, 2005, SPINE, V30, P38, DOI 10.1097/01.brs.0000147801.63304.8a
   Han CH, 1998, CLIN ORAL IMPLAN RES, V9, P1, DOI 10.1034/j.1600-0501.1998.090101.x
   Jarmar T, 2008, J BIOMED MATER RES A, V87A, P1003, DOI 10.1002/jbm.a.31856
   Jimbo R, 2015, CLIN IMPLANT DENT R, V17, pE670, DOI 10.1111/cid.12305
   JOHANSSON C, 1989, J BIOMED ENG, V11, P3, DOI 10.1016/0141-5425(89)90158-1
   Johansson CB, 2012, CLIN IMPLANT DENT R, V14, P603, DOI 10.1111/j.1708-8208.2010.00296.x
   Johansson CB, 1998, INT J ORAL MAX IMPL, V13, P315
   JOHANSSON CB, 1993, J MATER SCI-MATER M, V4, P132, DOI 10.1007/BF00120382
   JOHANSSON CB, 1992, J MATER SCI-MATER M, V3, P126, DOI 10.1007/BF00705280
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   KATSIKERIS N, 1987, INT J ORAL MAX SURG, V16, P473, DOI 10.1016/S0901-5027(87)80087-5
   Kim HM, 1996, J BIOMED MATER RES, V32, P409, DOI 10.1002/(SICI)1097-4636(199611)32:3<409::AID-JBM14>3.0.CO;2-B
   Lin DJ, 2007, BIOMATERIALS, V28, P2582, DOI 10.1016/j.biomaterials.2007.02.005
   LINDER L, 1989, ACTA ORTHOP SCAND, V60, P129
   LINDER L, 1989, ACTA ORTHOP SCAND, V60, P135, DOI 10.3109/17453678909149240
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Mendes VC, 2007, BIOMATERIALS, V28, P4748, DOI 10.1016/j.biomaterials.2007.07.020
   Mendes VC, 2009, J BIOMED MATER RES A, V90A, P577, DOI 10.1002/jbm.a.32126
   Morais LS, 2007, ACTA BIOMATER, V3, P331, DOI 10.1016/j.actbio.2006.10.010
   Okazaki Y, 2001, BIOMATERIALS, V22, P599, DOI 10.1016/S0142-9612(00)00221-0
   Palmquist A, 2012, APPL SURF SCI, V258, P6485, DOI 10.1016/j.apsusc.2012.03.065
   Palmquist A, 2010, J BIOMED MATER RES A, V92A, P1476, DOI 10.1002/jbm.a.32439
   Palmquist A, 2009, J BIOMED MATER RES B, V91B, P309, DOI 10.1002/jbm.b.31404
   Ponsonnet L, 2003, MAT SCI ENG C-BIO S, V23, P551, DOI 10.1016/S0928-4931(03)00033-X
   Rupp F, 2004, BIOMATERIALS, V25, P1429, DOI 10.1016/j.biomaterials.2003.08.015
   Rupp F, 2006, J BIOMED MATER RES A, V76A, P323, DOI 10.1002/jbm.a.30518
   Saulacic N, 2012, EUR CELLS MATER, V23, P273, DOI 10.22203/eCM.v023a21
   Schildhauer TA, 2006, J ORTHOP TRAUMA, V20, P476, DOI 10.1097/00005131-200608000-00005
   Sela MN, 2007, CLIN ORAL IMPLAN RES, V18, P630, DOI 10.1111/j.1600-0501.2007.01373.x
   Shah FA, 2015, ACS BIOMATER SCI ENG, V1, P305, DOI 10.1021/ab500127y
   Shah FA, 2014, NANOMED-NANOTECHNOL, V10, P1729, DOI 10.1016/j.nano.2014.05.015
   Shida T, 2013, INT J NANOMED, V8, P3955, DOI 10.2147/IJN.S51994
   Stenlund P, 2015, ACTA BIOMATER, V20, P165, DOI 10.1016/j.actbio.2015.03.038
   Stenport VF, 2008, CLIN IMPLANT DENT R, V10, P191, DOI 10.1111/j.1708-8208.2007.00077.x
   Svetina M, 2001, ACTA MATER, V49, P2169, DOI 10.1016/S1359-6454(01)00136-7
   Tawse-Smith A, 2001, Clin Implant Dent Relat Res, V3, P185, DOI 10.1111/j.1708-8208.2001.tb00140.x
   Tawse-Smith Andrew, 2002, Clin Implant Dent Relat Res, V4, P33, DOI 10.1111/j.1708-8208.2002.tb00149.x
   Textor M, 2001, ENG MAT SER, P171
   Thoma DS, 2011, J PERIODONTOL, V82, P1453, DOI 10.1902/jop.2010.100737
   Welsch G., 1993, MAT PROPERTIES HDB T
   Yoda I, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0234-2
NR 60
TC 30
Z9 30
U1 8
U2 62
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAY 1
PY 2016
VL 62
BP 960
EP 966
DI 10.1016/j.msec.2016.01.032
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA DH4MC
UT WOS:000372759100112
PM 26952502
DA 2018-10-20
ER

PT J
AU Lewallen, EA
   Jones, DL
   Dudakovic, A
   Thaler, R
   Paradise, CR
   Kremers, HM
   Abdel, MP
   Kakar, S
   Dietz, AB
   Cohen, RC
   Lewallen, DG
   van Wijnen, AJ
AF Lewallen, Eric A.
   Jones, Dakota L.
   Dudakovic, Amel
   Thaler, Roman
   Paradise, Christopher R.
   Kremers, Hilal M.
   Abdel, Matthew P.
   Kakar, Sanjeev
   Dietz, Allan B.
   Cohen, Robert C.
   Lewallen, David G.
   van Wijnen, Andre J.
TI Osteogenic potential of human adipose-tissue-derived mesenchymal stromal
   cells cultured on 3D-printed porous structured titanium
SO GENE
LA English
DT Article
DE Mesenchymal stem cell; Biomaterial; Gene expression; Extracellular
   matrix; Scanning electron microscopy
ID STEM-CELLS; UNITED-STATES; TANTALUM BIOMATERIAL; HUMAN OSTEOBLASTS;
   DIFFERENTIATION; SCAFFOLDS; PROLIFERATION; ARTHROPLASTY; VALIDATION;
   SURFACES
AB Integration of porous metal prosthetics, which restore form and function of irreversibly damaged joints, into remaining healthy bone is critical for implant success. We investigated the biological properties of adipose tissue-derived mesenchymal stromal/stem cells (AMSCs) and addressed their potential to alter the in vitro microenvironment of implants. We employed human AMSCs as a practical source for musculoskeletal applications because these cells can be obtained in large quantities, are multipotent, and have trophic paracrine functions. AMSCs were cultured on surgical-grade porous titanium disks as a model for orthopedic implants. We monitored cell/substrate attachment, cell proliferation, multipotency, and differentiation phenotypes of AMSCs upon osteogenic induction. High-resolution scanning electron microscopy and histology revealed that AMSCs adhere to the porous metallic surface. Compared to standard tissue culture plastic, AMSCs grown in the porous titanium micro environment showed differences in temporal expression for genes involved in cell cycle progression (CCNB2, HIST2H4), extracellular matrix production (COL1A1, COL3A1), mesenchymal lineage identity (ACTA2, CD248, CD44), osteoblastic transcription factors (DLX3, DLX5,1D3), and epigenetic regulators (EZH1, EZH2). We conclude that metal orthopedic implants can be effectively seeded with clinical-grade stem/stromal cells to create a preconditioned implant. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Lewallen, Eric A.; Jones, Dakota L.; Dudakovic, Amel; Thaler, Roman; Paradise, Christopher R.; Abdel, Matthew P.; Kakar, Sanjeev; Lewallen, David G.; van Wijnen, Andre J.] Mayo Clin, Dept Orthoped Surg, 200 First St SW, Rochester, MN 55905 USA.
   [Jones, Dakota L.; van Wijnen, Andre J.] Mayo Clin, Dept Biomed Engn & Physiol, Mayo Grad Sch, 200 First St SW, Rochester, MN 55905 USA.
   [Kremers, Hilal M.] Mayo Clin, Dept Hlth Sci Res, Coll Med, 200 First St SW, Rochester, MN 55905 USA.
   [Dietz, Allan B.] Mayo Clin, Dept Lab Med & Pathol, 200 First St SW, Rochester, MN 55905 USA.
   [Cohen, Robert C.] Stryker Orthoped, 325 Corp Dr, Mahwah, NJ 07430 USA.
   [van Wijnen, Andre J.] Mayo Clin, Dept Biochem & Mol Biol, 200 First St SW, Rochester, MN 55905 USA.
RP Lewallen, DG; van Wijnen, AJ (reprint author), Mayo Clin, Dept Orthoped Surg, 200 First St SW, Rochester, MN 55905 USA.
EM lewallen.david@mayo.edu; vanwijnen.andre@mayo.edu
OI Dietz, Allan/0000-0003-3410-9621
FU National Institute of Arthritis and Musculoskeletal and Skin Diseases
   [R01 AR049069, T32 AR56950, F32 AR066508]; Stryker; Pipeline Biomedical;
   Zimmer; Ketai Medical Devices
FX We thank members of the van Wijnen and Dietz Laboratories, especially
   Matthew Getzlaf and Darcie Radel, as well as Scott Riester, Emily
   Camilleri, and Janet Denbeigh, for stimulating discussions and/or
   assistance with reagents and procedures. The Biomaterials
   Characterization and Quantitative Histomorphometry Core Laboratory
   facility performed histological analysis, particularly Bob Brown and Jim
   Herrick. We are grateful to Scott Gamb and the Electron Microscopy Core
   facility for their assistance with acquiring scanning electron
   microscopy images. We thank the Reconstructive Research and Development
   group at Stryker Orthopedics, particularly Brent Mitchell, Dale Swarts,
   and Mark Gruczynski, for manufacturing biomaterials used in this study.
   Financial support for this work came from the National Institute of
   Arthritis and Musculoskeletal and Skin Diseases (R01 AR049069 to Andre
   van Wijnen; T32 AR56950 to Eric Lewallen; and F32 AR066508 to Amel
   Dudakovic). We also appreciate the generous philanthropic support of
   William H. and Karen J. Eby, and the charitable foundation in their
   names. The following author disclosures are provided regarding
   affiliations that may be perceived to bias the presentation of this
   work: ABD has commercial interest in Mill Creek Life Sciences, which
   manufactures the clinical-grade commercial platelet lysate product used
   for maintaining adipose-tissue-derived mesenchymal stem cells. RCC
   serves as the vice president and general manager of Reconstructive
   Research and Development, Stryker Orthopedics, 325 Corporate Drive,
   Mahwah, NJ 07430. DGL reports personal fees and other from Stryker,
   Pipeline Biomedical, Zimmer, and Ketai Medical Devices. In addition, DGL
   has patents on selected hip and knee implants with royalties paid by
   Zimmer and is employed part time as the Medical Director for the
   American Joint Replacement registry.
CR Benazzo F., 2013, J BIOMED MAT RES A
   Blanco JF, 2011, EUR SPINE J, V20, P353, DOI 10.1007/s00586-011-1901-8
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733
   Catauro M, 2014, MAT SCI ENG C-MATER, V45, P395, DOI 10.1016/j.msec.2014.09.007
   Chan CW, 2014, MAT SCI ENG C-MATER, V42, P254, DOI 10.1016/j.msec.2014.05.022
   Cohen R., 2013, BONE JOINT J ORT S34, V95, P267
   Crespo-Diaz R, 2011, CELL TRANSPLANT, V20, P797, DOI 10.3727/096368910X543376
   de Peppo GM, 2012, SCI WORLD J, DOI 10.1100/2012/646417
   Di Puccio F, 2015, WORLD J ORTHOP, V6, P77, DOI 10.5312/wjo.v6.i1.77
   Dudakovic A, 2015, J BIOL CHEM, V290, P27604, DOI 10.1074/jbc.M115.672345
   Dudakovic A, 2015, J CELL PHYSIOL, V230, P52, DOI 10.1002/jcp.24680
   Dudakovic A, 2014, J CELL BIOCHEM, V115, P1816, DOI 10.1002/jcb.24852
   Eirin A, 2014, GENE, V551, P55, DOI 10.1016/j.gene.2014.08.041
   Ercan B, 2010, BIOMATERIALS, V31, P3684, DOI 10.1016/j.biomaterials.2010.01.078
   Findlay DM, 2004, BIOMATERIALS, V25, P2215, DOI 10.1016/j.biomaterials.2003.09.005
   Gastaldi G, 2010, J BIOMED MATER RES A, V94A, P790, DOI 10.1002/jbm.a.32721
   Getzlaf M.A., 2015, J ORTHOP RES
   Gotman I, 2013, ACTA BIOMATER, V9, P8440, DOI 10.1016/j.actbio.2013.05.030
   Guasconi V, 2010, EPIGENETICS-US, V5, P704, DOI 10.4161/epi.5.8.13025
   Hirota M, 2015, MAT SCI ENG C-MATER, V49, P623, DOI 10.1016/j.msec.2015.01.006
   Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222
   Kurtz SM, 2014, J BONE JOINT SURG AM, V96A, P624, DOI 10.2106/JBJS.M.00285
   Lehil MS, 2014, J ARTHROPLASTY, V29, P1915, DOI 10.1016/j.arth.2014.05.017
   Lewallen E. A., 2014, TISSUE ENG PART B-RE, V21, P218
   Lopa S, 2013, J BIOMED MATER RES A, V101, P3396, DOI 10.1002/jbm.a.34649
   Mader E. K., 2013, J TRANSL MED, V11, P1186
   Mahmoudifar N, 2013, BIOTECHNOL PROGR, V29, P176, DOI 10.1002/btpr.1663
   Murphy Matthew B, 2013, Exp Mol Med, V45, pe54, DOI 10.1038/emm.2013.94
   Nguyen L.C., 2014, J ARTHROPLAST
   Olivares-Navarrete R, 2015, BONE, V73, P208, DOI 10.1016/j.bone.2014.12.057
   Olivares-Navarrete R, 2010, BIOMATERIALS, V31, P2728, DOI 10.1016/j.biomaterials.2009.12.029
   Sagomonyants KB, 2011, J ORTHOP RES, V29, P609, DOI 10.1002/jor.21251
   Shen XK, 2015, COLLOID SURFACE B, V127, P221, DOI 10.1016/j.colsurfb.2015.01.048
   Welldon KJ, 2008, J BIOMED MATER RES A, V84A, P691, DOI 10.1002/jbm.a.31336
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
NR 37
TC 6
Z9 7
U1 2
U2 60
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-1119
EI 1879-0038
J9 GENE
JI Gene
PD MAY 1
PY 2016
VL 581
IS 2
BP 95
EP 106
DI 10.1016/j.gene.2016.01.015
PG 12
WC Genetics & Heredity
SC Genetics & Heredity
GA DG3DG
UT WOS:000371949100001
PM 26774799
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Sharma, A
   McQuillan, AJ
   Shibata, Y
   Sharma, LA
   Waddell, JN
   Duncan, WJ
AF Sharma, Ajay
   McQuillan, A. James
   Shibata, Yo
   Sharma, Lavanya A.
   Waddell, John Neil
   Duncan, Warwick John
TI Histomorphometric and histologic evaluation of titanium-zirconium
   (aTiZr) implants with anodized surfaces
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID OSTEOBLAST ADHESION; BONE RESPONSE; INTRABONY DEFECTS; DENTAL IMPLANTS;
   OXIDE-FILMS; OSSEOINTEGRATION; BIOMATERIAL; RESOLUTION; OXIDATION;
   TI6AL4V
AB The choice of implant surface has a significant influence on osseointegration. Modification of TiZr surface by anodization is reported to have the potential to modulate the osteoblast cell behaviour favouring more rapid bone formation. The aim of this study is to investigate the effect of anodizing the surface of TiZr discs with respect to osseointegration after four weeks implantation in sheep femurs. Titanium (Ti) and TiZr discs were anodized in an electrolyte containing DL-alpha-glycerophosphate and calcium acetate at 300 V. The surface characteristics were analyzed by scanning electron microscopy, electron dispersive spectroscopy, atomic force microscopy and goniometry. Forty implant discs with thickness of 1.5 and 10 mm diameter (10 of each-titanium, titanium-zirconium, anodized titanium and anodized titanium-zirconium) were placed in the femoral condyles of 10 sheep. Histomorphometric and histologic analysis were performed 4 weeks after implantation. The anodized implants displayed hydrophilic, porous, nano-to-micrometer scale roughened surfaces. Energy dispersive spectroscopy analysis revealed calcium and phosphorous incorporation into the surface of both titanium and titanium-zirconium after anodization. Histologically there was new bone apposition on all implanted discs, slightly more pronounced on anodised discs. The percentage bone-to-implant contact measurements of anodized implants were higher than machined/unmodified implants but there was no significant difference between the two groups with anodized surfaces (P > 0.05, n = 10). The present histomorphometric and histological findings confirm that surface modification of titanium-zirconium by anodization is similar to anodised titanium enhances early osseointegration compared to machined implant surfaces.
C1 [Sharma, Ajay; Waddell, John Neil; Duncan, Warwick John] Univ Otago, Sir John Walsh Res Inst, Fac Dent, 310 Great King St, Dunedin 9016, New Zealand.
   [McQuillan, A. James] Univ Otago, Dept Chem, POB 56, Dunedin, New Zealand.
   [Shibata, Yo] Showa Univ, Sch Dent, Dept Conservat Dent, Div Biomat & Engn, Tokyo 142, Japan.
   [Sharma, Lavanya A.] Univ Otago, Otago Sch Med Sci, Dunedin, New Zealand.
RP Sharma, A (reprint author), Univ Otago, Sir John Walsh Res Inst, Fac Dent, 310 Great King St, Dunedin 9016, New Zealand.
EM ajsharma.perio@gmail.com
RI Duncan, Warwick/S-2126-2016
OI Duncan, Warwick/0000-0002-5412-0089
FU Dentsply, Australia; Lottery Health Research Grant, New Zealand
FX This study was funded by Dentsply, Australia and Lottery Health Research
   Grant, New Zealand. We wish to acknowledge the assistance of Liz Girwan,
   Otago Centre for Electron Microscopy, University of Otago, for her
   assistance in the SEM. We wish to acknowledge the assistance of Andrew
   McNaughton, Otago Centre for Confocal Microscopy, University of Otago,
   for his assistance in the confocal microscopy. We acknowledge the
   assistance of Dave Mathews, Hercus Taieri Research Unit for his
   assistance in animal surgeries.
CR Barter S, 2012, CLIN ORAL IMPLAN RES, V23, P873, DOI 10.1111/j.1600-0501.2011.02231.x
   Berglundh T, 2003, CLIN ORAL IMPLAN RES, V14, P251, DOI 10.1034/j.1600-0501.2003.00972.x
   Bernhard N, 2009, FORUM IMPLANTOLOGICU, V5, P30
   Bornstein MM, 2008, CLIN ORAL IMPLAN RES, V19, P233, DOI 10.1111/j.1600-0501.2007.01473.x
   Botticelli D, 2004, J CLIN PERIODONTOL, V31, P309, DOI 10.1111/j.1600-051X.2004.00502.x
   Branemark P I, 1977, Scand J Plast Reconstr Surg Suppl, V16, P1
   Choi JY, 2011, CLIN ORAL IMPLAN RES, V22, P343, DOI 10.1111/j.1600-0501.2010.01978.x
   Colon G, 2006, J BIOMED MATER RES A, V78A, P595, DOI 10.1002/jbm.a.30789
   Davies John E, 2003, J Dent Educ, V67, P932
   Davies JE, 2007, BIOMATERIALS, V28, P5058, DOI 10.1016/j.biomaterials.2007.07.049
   Duncan Warwick J, 2008, Ann R Australas Coll Dent Surg, V19, P152
   Giavaresi G, 2003, BIOMATERIALS, V24, P1583, DOI 10.1016/S0142-9612(02)00548-3
   Gottlow J, 2012, CLIN IMPLANT DENT R, V14, P538, DOI 10.1111/j.1708-8208.2010.00289.x
   Gottlow J, 2012, CLIN IMPLANT DENT R, V14, pe204, DOI 10.1111/j.1708-8208.2012.00439.x
   Jokstad A, 2008, AUST DENT J, V53, pS89, DOI 10.1111/j.1834-7819.2008.00046.x
   Jung UW, 2005, CURR APPL PHYS, V5, P507, DOI 10.1016/j.cap.2005.01.021
   Kim CS, 2004, J PERIODONTOL, V75, P229, DOI 10.1902/jop.2004.75.2.229
   KOBAYASHI E, 1995, J BIOMED MATER RES, V29, P943, DOI 10.1002/jbm.820290805
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Littell RC, 1998, J ANIM SCI, V76, P1216
   Park IS, 2008, J BIOMED MATER RES B, V84B, P422, DOI 10.1002/jbm.b.30887
   Park IS, 2011, SURF INTERFACE ANAL, V43, P1030, DOI 10.1002/sia.3686
   Park JW, 2009, CLIN ORAL IMPLAN RES, V20, P684, DOI 10.1111/j.1600-0501.2009.01714.x
   Park KH, 2007, J ORAL REHABIL, V34, P517, DOI 10.1111/j.1365-2842.2006.01688.x
   Sharma A, 2015, J MATER SCI-MATER M, V26, P1
   Shibata Y, 2004, J DENT RES, V83, P115, DOI 10.1177/154405910408300206
   Sista S, 2011, J BIOMED MATER RES A, V97A, P27, DOI 10.1002/jbm.a.33013
   Suh JY, 2003, BIOMATERIALS, V24, P347, DOI 10.1016/S0142-9612(02)00325-3
   Sul YT, 2006, INT J PROSTHODONT, V19, P319
   Sul YT, 2005, BIOMATERIALS, V26, P6720, DOI 10.1016/j.biomaterials.2005.04.058
   Sul YT, 2003, BIOMATERIALS, V24, P3893, DOI 10.1016/S0142-9612(03)00261-8
   Webster TJ, 2004, BIOMATERIALS, V25, P4731, DOI 10.1016/j.biomaterials.2003.12.002
   Webster TJ, 2001, TISSUE ENG, V7, P291, DOI 10.1089/10763270152044152
   Yao C, 2005, J BIOMED NANOTECHNOL, V1, P68, DOI 10.1166/jbn.2005.008
   Zhu XL, 2004, BIOMATERIALS, V25, P4087, DOI 10.1016/j.biomaterials.2003.11.011
   Zhu XL, 2001, BIOMATERIALS, V22, P2199, DOI 10.1016/S0142-9612(00)00394-X
NR 36
TC 0
Z9 0
U1 1
U2 15
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAY
PY 2016
VL 27
IS 5
AR 86
DI 10.1007/s10856-016-5695-4
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DG7JT
UT WOS:000372261300005
PM 26970768
DA 2018-10-20
ER

PT J
AU Wang, HJ
   Huang, JC
   Hou, L
   Miyazawa, T
   Wang, JY
AF Wang, Hua-Jie
   Huang, Jing-Chun
   Hou, Li
   Miyazawa, Teruo
   Wang, Jin-Ye
TI Prolongation of the degradation period and improvement of the
   angiogenesis of zein porous scaffolds in vivo
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID MECHANICAL-PROPERTIES; LINOLEIC ACIDS; CORN PROTEIN; BIOCOMPATIBILITY;
   FILM
AB Zein porous scaffolds modified with fatty acids have shown great improvement in mechanical properties and good cell compatibility in vitro, indicating the potential application as a bone tissue engineering substitute. The present study was conducted to systematically investigate whether the addition of fatty acids affects the short-term (up to 12 weeks) and long-term (up to 1 year) behaviors of scaffolds in vivo, mainly focusing on changes in the degradation period and inflammatory responses. Throughout the implantation period, no abnormal signs occurred and zein porous scaffolds modified with oleic acid showed good tolerance in rabbits, characterized by the growth of relatively more blood vessels in the scaffolds and only a slight degree of fibrosis histology. Moreover, the degradation period was prolonged from 8 months to 1 year as compared to the control. These results affirmed further that zein could be used as a new kind of natural biomaterial suitable for bone tissue engineering.
C1 [Wang, Hua-Jie; Wang, Jin-Ye] Shanghai Jiao Tong Univ, Sch Biomed Engn, Dongchuan Rd, Shanghai 200240, Peoples R China.
   [Huang, Jing-Chun; Hou, Li] Shandong Qual Inspect Ctr Med Devices, Key Lab Biol Evaluat Med Devices, Jinan 250101, Shandong, Peoples R China.
   [Miyazawa, Teruo] Tohoku Univ, New Ind Creat Hatchery Ctr NICHe, Food Biotechnol Innovat Project, Sendai, Miyagi 9800845, Japan.
   [Wang, Hua-Jie] Zhongyuan Univ Technol, Ctr Adv Mat Res, Xinzheng Shuanghu Econ Dev Zone, 1 Huaihe Rd, Zhengzhou 451191, Peoples R China.
RP Wang, JY (reprint author), Shanghai Jiao Tong Univ, Sch Biomed Engn, Dongchuan Rd, Shanghai 200240, Peoples R China.
EM jinyewang@sjtu.edu.cn
RI Wang, Jin-Ye/H-1450-2011
OI Wang, Jin-Ye/0000-0002-0937-1508
FU International S&T Cooperation Program of China [2012DFA30270,
   2015DFG32730]; Shanghai Municipal Science and Technology Commission
   [12JC1403400, 15540723900]
FX The authors gratefully acknowledge the financial support provided by the
   International S&T Cooperation Program of China (2012DFA30270,
   2015DFG32730), the Shanghai Municipal Science and Technology Commission
   (12JC1403400, 15540723900).
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Burugapalli K, 2007, BIOMACROMOLECULES, V8, P3439, DOI 10.1021/bm700560k
   Chen GP, 2001, MAT SCI ENG C-BIO S, V17, P63, DOI 10.1016/S0928-4931(01)00338-1
   Chen PY, 2011, J MECH BEHAV BIOMED, V4, P961, DOI 10.1016/j.jmbbm.2011.02.006
   Cury-Boaventura MF, 2006, CLIN NUTR, V25, P1004, DOI 10.1016/j.clnu.2006.05.008
   Dong J, 2004, BIOMATERIALS, V25, P4691, DOI 10.1016/j.biomaterials.2003.10.084
   Gong SJ, 2006, BIOMATERIALS, V27, P3793, DOI 10.1016/j.biomaterials.2006.02.019
   Hatakeda K, 2008, INT J CHEM REACT ENG, V6, P65
   Jiang QR, 2010, ACTA BIOMATER, V6, P4042, DOI 10.1016/j.actbio.2010.04.024
   Lai HM, 1997, CEREAL CHEM, V74, P83, DOI 10.1094/CCHEM.1997.74.1.83
   Liu XM, 2005, BIOMATERIALS, V26, P109, DOI 10.1016/j.biomaterials.2004.02.013
   Santosa FXB, 1999, J AGR FOOD CHEM, V47, P2070, DOI 10.1021/jf981154p
   Shukla R, 2001, IND CROP PROD, V13, P171, DOI 10.1016/S0926-6690(00)00064-9
   Skotak M, 2008, BIOMACROMOLECULES, V9, P1902, DOI 10.1021/bm800158c
   Subramaniam S, 2016, BIOMATERIALS, V74, P99, DOI 10.1016/j.biomaterials.2015.09.044
   Taylor J, 2015, J BIOMED MATER RES A, V103, P2582, DOI 10.1002/jbm.a.35394
   Tu JW, 2009, BIOMATERIALS, V30, P4369, DOI 10.1016/j.biomaterials.2009.04.054
   Venkatesan J, 2015, INT J BIOL MACROMOL, V72, P269, DOI 10.1016/j.ijbiomac.2014.07.008
   Wang HJ, 2005, J CONTROL RELEASE, V105, P120, DOI 10.1016/j.jconrel.2005.03.014
   Wang HJ, 2007, BIOMATERIALS, V28, P3952, DOI 10.1016/j.biomaterials.2007.05.017
   Wang XJ, 2016, BIOMATERIALS, V83, P127, DOI 10.1016/j.biomaterials.2016.01.012
   Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057
NR 22
TC 1
Z9 1
U1 1
U2 22
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAY
PY 2016
VL 27
IS 5
AR 92
DI 10.1007/s10856-016-5697-2
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DG7JT
UT WOS:000372261300011
PM 26979976
DA 2018-10-20
ER

PT J
AU Muiznieks, LD
   Miao, M
   Sitarz, EE
   Keeley, FW
AF Muiznieks, Lisa D.
   Miao, Ming
   Sitarz, Eva E.
   Keeley, Fred W.
TI Contribution of Domain 30 of Tropoelastin to Elastic Fiber Formation and
   Material Elasticity
SO BIOPOLYMERS
LA English
DT Article
DE elastin; elastic fibers; beta-sheet; entropic elasticity; biomaterial
   design
ID MECHANICAL-PROPERTIES; TERMINAL DOMAIN; PROLINE; POLYPEPTIDES; PROTEIN;
   SEQUENCE; SILKS; AGGREGATION; TOUGHNESS; STRENGTH
AB Elastin is a fibrous structural protein of the extracellular matrix that provides reversible elastic recoil to vertebrate tissues such as arterial vessels, lung, and skin. The elastin monomer, tropoelastin, contains a large proportion of intrinsically disordered and flexible hydrophobic sequences that collectively are responsible for the initial phase separation of monomers during assembly, and are essential for driving elastic recoil. While structural disorder of hydrophobic sequences is controlled by a high proline and glycine residue composition, hydrophobic domain 30 of human tropoelastin is atypically proline-poor, and forms beta-sheet amyloid-like fibrils as an individual peptide. We explored the contribution of confined regions of secondary structure at the location of domain 30 in human tropoelastin to fiber assembly and mechanical properties using a set of mutations designed to inhibit or enhance the propensity of b-sheet formation at this location. Our data support a dual role for confined beta-sheet secondary structure in domain 30 of tropoelastin in guiding the formation of fibers, and as a determinant of stiffness and viscoelastic properties of cross-linked materials. Together, these results suggest a mechanism for specificity in fiber assembly, and elucidate structure-function relationships for the rational design of elastomeric biomaterials with defined mechanical properties. (C) 2016 Wiley Periodicals, Inc.
C1 [Muiznieks, Lisa D.; Miao, Ming; Sitarz, Eva E.; Keeley, Fred W.] Hosp Sick Children, Mol Struct & Funct Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.
   [Keeley, Fred W.] Univ Toronto, Dept Biochem, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.
   [Keeley, Fred W.] Univ Toronto, Dept Pathol & Lab Med, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.
RP Keeley, FW (reprint author), Hosp Sick Children, Mol Struct & Funct Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.; Keeley, FW (reprint author), Univ Toronto, Dept Biochem, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.; Keeley, FW (reprint author), Univ Toronto, Dept Pathol & Lab Med, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.
EM fwk@sickkids.ca
FU Heart and Stroke Foundation of Canada [T6725]
FX Contract grant sponsor: Heart and Stroke Foundation of Canada,; Contract
   grant number: T6725 (to F.W.K.)
CR ANDERSEN SO, 1995, INSECT BIOCHEM MOLEC, V25, P153, DOI 10.1016/0965-1748(94)00052-J
   Baldock C, 2011, P NATL ACAD SCI USA, V108, P4322, DOI 10.1073/pnas.1014280108
   Bax DV, 2009, J BIOL CHEM, V284, P28616, DOI 10.1074/jbc.M109.017525
   Broekelmann TJ, 2008, MATRIX BIOL, V27, P631, DOI 10.1016/j.matbio.2008.06.001
   Broekelmann TJ, 2005, J BIOL CHEM, V280, P40939, DOI 10.1074/jbc.M507309200
   BrownAugsburger P, 1996, BIOCHEM J, V318, P149, DOI 10.1042/bj3180149
   BROWNAUGSBURGER P, 1995, J BIOL CHEM, V270, P17778, DOI 10.1074/jbc.270.30.17778
   Dicko C, 2006, ADV PROTEIN CHEM, V73, P17, DOI 10.1016/S0065-3233(06)73002-9
   Gosline J, 2002, PHILOS T ROY SOC B, V357, P121, DOI 10.1098/rstb.2001.1022
   Green E. M., 2014, BIOPOLYMERS, V103, P187
   Guerette PA, 2014, ACS NANO, V8, P7170, DOI 10.1021/nn502149u
   Holland GP, 2008, J AM CHEM SOC, V130, P9871, DOI 10.1021/ja8021208
   Keeley F. W, 2013, EVOLUTION EXTRACELLU, P73
   Keten S, 2010, NAT MATER, V9, P359, DOI [10.1038/NMAT2704, 10.1038/nmat2704]
   Kozel BA, 2006, J CELL PHYSIOL, V207, P87, DOI 10.1002/jcp.20546
   Kozel BA, 2003, J BIOL CHEM, V278, P18491, DOI 10.1074/jbc.M212715200
   Le DHT, 2013, BIOMACROMOLECULES, V14, P1028, DOI 10.1021/bm301887m
   Liu Y, 2008, BIOMACROMOLECULES, V9, P116, DOI 10.1021/bm700877g
   Miao M, 2003, J BIOL CHEM, V278, P48553, DOI 10.1074/jbc.M308465200
   Miao M, 2013, BIOPOLYMERS, V99, P392, DOI 10.1002/bip.22192
   Miao M, 2009, MATRIX BIOL, V28, P432, DOI 10.1016/j.matbio.2009.07.003
   Muiznieks LD, 2015, BIOPOLYMERS, V103, P563, DOI 10.1002/bip.22663
   Muiznieks LD, 2014, MATRIX BIOL, V36, P39, DOI 10.1016/j.matbio.2014.03.008
   Muiznieks LD, 2010, J BIOL CHEM, V285, P39779, DOI 10.1074/jbc.M110.164467
   Nonaka R, 2014, BIOL PHARM BULL, V37, P698, DOI 10.1248/bpb.b13-00933
   Nova A, 2010, NANO LETT, V10, P2626, DOI 10.1021/nl101341w
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Rauscher S, 2006, STRUCTURE, V14, P1667, DOI 10.1016/j.str.2006.09.008
   Rauscher S, 2012, ADV EXP MED BIOL, V725, P159, DOI 10.1007/978-1-4614-0659-4_10
   Reichheld SE, 2014, J BIOL CHEM, V289, P10057, DOI 10.1074/jbc.M113.533893
   ROBSON P, 1993, J BIOL CHEM, V268, P1440
   Savage KN, 2008, J EXP BIOL, V211, P1937, DOI 10.1242/jeb.014217
   Tamburro AM, 2005, J BIOL CHEM, V280, P2682, DOI 10.1074/jbc.M411617200
   Vieth S, 2007, BIOPOLYMERS, V85, P199, DOI 10.1002/bip.20619
   Wise SG, 2005, J STRUCT BIOL, V149, P273, DOI 10.1016/j.jsb.2004.11.006
   Yeo GC, 2014, J BIOL CHEM, V289, P34815, DOI 10.1074/jbc.M114.606772
   Yeo GC, 2012, P NATL ACAD SCI USA, V109, P2878, DOI 10.1073/pnas.1111615108
NR 37
TC 4
Z9 5
U1 1
U2 39
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3525
EI 1097-0282
J9 BIOPOLYMERS
JI Biopolymers
PD MAY
PY 2016
VL 105
IS 5
BP 267
EP 275
DI 10.1002/bip.22804
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA DF9OG
UT WOS:000371690100003
PM 26763595
DA 2018-10-20
ER

PT J
AU Gregoric, M
   Suen, K
   Cheng, RC
   Kralj-Fiser, S
   Kuntner, M
AF Gregoric, Matjaz
   Suen, Klavdija
   Cheng, Ren-Chung
   Kralj-Fiser, Simona
   Kuntner, Matjaz
TI Spider behaviors include oral sexual encounters
SO SCIENTIFIC REPORTS
LA English
DT Article
ID SPERM COMPETITION; ARANEAE ARANEIDAE; NEPHILID SPIDERS; DROSOPHILA;
   EMASCULATION; COEVOLUTION; COPULATION; CAEROSTRIS; DIMORPHISM; EVOLUTION
AB Several clades of spiders whose females evolved giant sizes are known for extreme sexual behaviors such as sexual cannibalism, opportunistic mating, mate-binding, genital mutilation, plugging, and emasculation. However, these behaviors have only been tested in a handful of size dimorphic spiders. Here, we bring another lineage into the picture by reporting on sexual behavior of Darwin's bark spider, Caerostris darwini. This sexually size dimorphic Madagascan species is known for extreme web gigantism and for producing the world's toughest biomaterial. Our field and laboratory study uncovers a rich sexual repertoire that predictably involves cannibalism, genital mutilation, male preference for teneral females, and emasculation. Surprisingly, C. darwini males engage in oral sexual encounters, rarely reported outside mammals. Irrespective of female's age or mating status males salivate onto female genitalia pre-, during, and post-copulation. While its adaptive significance is elusive, oral sexual contact in spiders may signal male quality or reduce sperm competition.
C1 [Gregoric, Matjaz; Suen, Klavdija; Cheng, Ren-Chung; Kralj-Fiser, Simona; Kuntner, Matjaz] Slovenian Acad Sci & Arts, Inst Biol, Ctr Sci Res, Ljubljana, Slovenia.
   [Kuntner, Matjaz] Smithsonian Inst, Natl Museum Nat Hist, Dept Entomol, Washington, DC 20560 USA.
RP Gregoric, M (reprint author), Slovenian Acad Sci & Arts, Inst Biol, Ctr Sci Res, Ljubljana, Slovenia.
EM matjaz.gregoric@gmail.com
FU Slovenian Research Agency; Explorers Club
FX This work was funded by the Slovenian Research Agency and the Explorers
   Club. We thank the MICET crew in Antananarivo, S. L. Rahanitriniaina and
   H. Nono Rabarison for help in the field, and T. Celik and T. Lokovsek
   for analytical and lab help.
CR Agnarsson I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011234
   Andrade MCB, 1996, SCIENCE, V271, P70, DOI 10.1126/science.271.5245.70
   Arnqvist G, 2002, NATURE, V415, P787
   Arnqvist G, 2005, SEXUAL CONFLICT, P330
   Berendock B., 2003, THESIS HEINRICH HEIN
   Blanckenhorn WU, 2005, ETHOLOGY, V111, P977, DOI 10.1111/j.1439-0310.2005.01147.x
   CHAPMAN T, 1995, NATURE, V373, P241, DOI 10.1038/373241a0
   Cheng RC, 2015, EVOL BIOL, V42, P223, DOI 10.1007/s11692-015-9313-z
   DAVIES NB, 1983, NATURE, V302, P334, DOI 10.1038/302334a0
   Eberhard WG, 1996, FEMALE CONTROL SEXUA, P472
   Elgar MA, 2003, ANIM BEHAV, V66, P211, DOI 10.1006/anbe.2003.2189
   Elgar MA, 2000, P ROY SOC B-BIOL SCI, V267, P2439, DOI 10.1098/rspb.2000.1303
   Fairbairn D.J., 2007, SEX SIZE GENDER ROLE
   Foellmer Matthias W., 2007, P71
   Forster Lyn, 1995, Records of the Western Australian Museum Supplement, V52, P13
   Fromhage L, 2005, EVOLUTION, V59, P1400
   Gregoric M, 2015, J ARACHNOL, V43, P293, DOI 10.1636/0161-8202-43.3.293
   Gregoric M, 2015, ZOOL J LINN SOC-LOND, V175, P225, DOI 10.1111/zoj.12281
   Gregoric M, 2011, J ARACHNOL, V39, P287, DOI 10.1636/CB10-95.1
   HALL JC, 1979, GENETICS, V92, P437
   Higgins L, 2011, EVOL ECOL, V25, P1289, DOI 10.1007/s10682-011-9475-9
   Knoflach B, 2000, J NAT HIST, V34, P1639, DOI 10.1080/00222930050117530
   Kuntner M, 2009, J ZOOL, V277, P257, DOI 10.1111/j.1469-7998.2008.00533.x
   Kuntner M., 2014, FRONT ECOL EVOL, V2, P26, DOI [10.3389/fevo.2014.00026, DOI 10.3389/FEVO.2014.00026]
   Kuntner M, 2015, BEHAV ECOL SOCIOBIOL, V69, P117, DOI 10.1007/s00265-014-1824-6
   Kuntner M, 2015, BIOL REV, V90, P279, DOI 10.1111/brv.12109
   Kuntner M, 2012, J ARACHNOL, V40, P345, DOI 10.1636/B12-03.1
   Kuntner M, 2009, EVOLUTION, V63, P1451, DOI 10.1111/j.1558-5646.2009.00634.x
   Lee QQ, 2012, BIOL LETTERS, V8, P733, DOI 10.1098/rsbl.2012.0285
   Maruthupandian J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059743
   Rivera M. J., 1901, REV CHIL HIST NAT, V8, P161
   Robinson M.H., 1980, Pacific Insects Monograph, V36, P1
   Robinson M.H., 1973, Smithsonian Contributions to Zoology, VNo. 149, P1
   Schneider J. M., 2015, CRYPTIC FEMALE CHOIC
   Sergiel A, 2014, ZOO BIOL, V33, P349, DOI 10.1002/zoo.21137
   Tan M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007595
   WELBERGEN P, 1992, BEHAV GENET, V22, P113, DOI 10.1007/BF01066796
   Wilder SM, 2009, ANNU REV ECOL EVOL S, V40, P21, DOI 10.1146/annurev.ecolsys.110308.120238
   Yamamoto D, 2013, NAT REV NEUROSCI, V14, P681, DOI 10.1038/nrn3567
   Zhang SC, 2011, ANIM BEHAV, V82, P1299, DOI 10.1016/j.anbehav.2011.09.010
NR 40
TC 2
Z9 2
U1 0
U2 21
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD APR 29
PY 2016
VL 6
AR 25128
DI 10.1038/srep25128
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DK8MI
UT WOS:000375180400001
PM 27126507
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Sun, J
   Deng, Y
   Li, JP
   Wang, G
   He, P
   Tian, SY
   Bu, XM
   Di, ZF
   Yang, SW
   Ding, GQ
   Xie, XM
AF Sun, Jing
   Deng, Yuan
   Li, Jipeng
   Wang, Gang
   He, Peng
   Tian, Suyun
   Bu, Xiuming
   Di, Zengfeng
   Yang, Siwei
   Ding, Guqiao
   Xie, Xiaoming
TI A New Graphene Derivative: Hydroxylated Graphene with Excellent
   Biocompatibility
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE graphene derivative; hydroxylated graphene; biomaterial; reversible;
   regeneration
ID QUANTUM DOTS; FUNCTIONALIZED GRAPHENE; GRAPHITE OXIDE;
   PHOTOLUMINESCENCE; DISPERSIONS; GRAPHANE
AB Graphene derivatives (such as graphene oxide and hydrogenated graphene) have been widely investigated because of their excellent properties. Here, we report large-scale (kilogram scale) synthesis of a new unique graphene derivative: hydroxylated graphene (G-OH). The exclusive existence form of oxygen-containing groups in G-OH is hydroxyl, which was verified by spectral characterization and quantitative halogenating reaction. It is very interesting that both the wettability and electrical conductivity show reversible change in halogenating and hydrolysis reaction cycles, which demonstrates the versatility of G-OH. Most importantly, the hydrophilicity and weak inductive nature of G-OH provides a well microenvironment for the cells adhesion and proliferation. On G-OH paper, rat adipose tissue-derived stromal cells exhibited a typical fibroblast-like shape with high rate of increase and survival after 3 day of incubation. This G-OH paper with good mechanical property is expected to be a new biomaterial for bone, vessel and skin regeneration.
C1 [Sun, Jing; Li, Jipeng; Wang, Gang; He, Peng; Tian, Suyun; Bu, Xiuming; Di, Zengfeng; Yang, Siwei; Ding, Guqiao; Xie, Xiaoming] Chinese Acad Sci, Shanghai Inst Microsyst & Informat Technol, State Key Lab Funct Mat Informat, Shanghai 20050, Peoples R China.
   [Deng, Yuan; Li, Jipeng] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Ophthalmol, Shanghai 20011, Peoples R China.
   [Tian, Suyun; Xie, Xiaoming] ShanghaiTech Univ, Sch Phys Sci & Technol, Shanghai 200031, Peoples R China.
   [Ding, Guqiao] Shanghai SIMBATT Energy Co, Shanghai 201821, Peoples R China.
RP Yang, SW; Ding, GQ (reprint author), Chinese Acad Sci, Shanghai Inst Microsyst & Informat Technol, State Key Lab Funct Mat Informat, Shanghai 20050, Peoples R China.; Ding, GQ (reprint author), Shanghai SIMBATT Energy Co, Shanghai 201821, Peoples R China.
EM yangsiwei@mail.sim.ac.cn; gqding@mail.sim.ac.cn
OI He, Peng/0000-0003-0606-8762; Yuan, Deng/0000-0001-8585-1178
FU National Science and Technology Major Project Fund [2011ZX02707];
   Chinese Academy of Sciences [XDA02040000]; Science and Technology
   Commission of Shanghai Municipality The Sailing Program [15YF1406800];
   National Natural Science Foundation of China [81501605]
FX This work was supported by The National Science and Technology Major
   Project Fund (2011ZX02707), The Chinese Academy of Sciences
   (XDA02040000), Science and Technology Commission of Shanghai
   Municipality The Sailing Program (15YF1406800), and The National Natural
   Science Foundation of China (81501605).
CR Dikin DA, 2007, NATURE, V448, P457, DOI 10.1038/nature06016
   Dreyer DR, 2010, CHEM SOC REV, V39, P228, DOI 10.1039/b917103g
   Elias DC, 2009, SCIENCE, V323, P610, DOI 10.1126/science.1167130
   He P, 2015, CHEM MATER, V27, P218, DOI 10.1021/cm503782p
   KIM KS, 1974, ANAL CHEM, V46, P197, DOI 10.1021/ac60338a037
   Li JH, 2015, J MATER CHEM B, V3, P1544, DOI 10.1039/c4tb01510j
   Li XB, 2014, CARBON, V78, P38, DOI 10.1016/j.carbon.2014.06.034
   Liao F, 2015, J MATER CHEM A, V3, P7568, DOI 10.1039/c5ta00675a
   Lin MM, 2015, MAT SCI ENG C-MATER, V50, P300, DOI 10.1016/j.msec.2015.01.086
   Lotya M, 2010, ACS NANO, V4, P3155, DOI 10.1021/nn1005304
   Pan HL, 2003, NANO LETT, V3, P29, DOI 10.1021/nl025856b
   Pumera M, 2013, CHEM SOC REV, V42, P5987, DOI 10.1039/c3cs60132c
   Stankovich S, 2007, CARBON, V45, P1558, DOI 10.1016/j.carbon.2007.02.034
   Sun J, 2015, PART PART SYST CHAR, V32, P434, DOI 10.1002/ppsc.201400189
   Taherian F, 2013, LANGMUIR, V29, P1457, DOI 10.1021/la304645w
   Tian SY, 2015, RSC ADV, V5, P69854, DOI 10.1039/c5ra09388k
   Wang JZ, 2011, J AM CHEM SOC, V133, P8888, DOI 10.1021/ja203725d
   Yan L, 2012, J MATER CHEM, V22, P8367, DOI 10.1039/c2jm30961k
   Yang D, 2008, J MATER CHEM, V18, P350, DOI 10.1039/b713467c
   Yang SW, 2016, ANALYST, V141, P1052, DOI 10.1039/c5an02270c
   Yang SW, 2015, CHEM MATER, V27, P2004, DOI 10.1021/acs.chemmater.5b00112
   Yang SW, 2014, J MATER CHEM A, V2, P8660, DOI 10.1039/c4ta00860j
   Zhang P, 2003, SYNTHETIC COMMUN, V33, P2469, DOI 10.1081/SCC-120021836
   Zhou J, 2009, NANO LETT, V9, P3867, DOI 10.1021/nl9020733
   Zhu C, 2015, J MATER CHEM B, V3, P6871, DOI 10.1039/c5tb01093d
   Zhu C, 2015, J MATER CHEM C, V3, P8810, DOI 10.1039/c5tc01933h
   Zhu YW, 2010, ADV MATER, V22, P3906, DOI 10.1002/adma.201001068
NR 27
TC 16
Z9 16
U1 11
U2 104
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD APR 27
PY 2016
VL 8
IS 16
BP 10226
EP 10233
DI 10.1021/acsami.6b02032
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA DK9IW
UT WOS:000375245100020
PM 27052945
DA 2018-10-20
ER

PT J
AU Mo, F
   Lin, BF
   Lai, FJ
   Xu, CH
   Zou, HZ
AF Mo, Fang
   Lin, Baofeng
   Lai, Fengjiao
   Xu, Chuanhui
   Zou, Haizhong
TI A Green Modified Microsphere of Chitosan Encapsulating Dimethyl Fumarate
   and Cross-Linked by Vanillin and Its Application for Litchi Preservation
SO INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH
LA English
DT Article
ID CONTROLLED-RELEASE; ANTIBACTERIAL ACTIVITY; AMBIENT-TEMPERATURE;
   BETA-CYCLODEXTRIN; DRUG-RELEASE; SHELF-LIFE; GEL BEADS; IN-VITRO;
   NANOPARTICLES; ANTIOXIDANT
AB A green sustained delivery biomaterial was prepared to encapsulate dimethyl fiimarate (DMF) by an emulsion cross-linking method for sustained release. The average size of the microspheres was 20-150 mu m. The highest encapsulation efficiency and loading efficiency were 85.7 and 13.2%, respectively. The release of DMF in phosphate buffer saline followed a Fickian diffusion. In addition, the results of inhibition zone showed that DMF-loaded microspheres exhibited antimicrobial and antifungal properties much better than those of CS microspheres. Furthermore, weight loss of treated fruit was reduced insignificantly, and storage time was extended with the stable quality of litchi as compared with that of the control group. Thus, the microspheres were synthesized successfully as a sustained delivery system for DMF, which might have broad prospect and development value in preservation of fruits and vegetables.
C1 [Mo, Fang; Lin, Baofeng; Lai, Fengjiao; Xu, Chuanhui; Zou, Haizhong] Guangxi Univ, Coll Chem & Chem Engn, Nanning 530004, Peoples R China.
RP Lin, BF (reprint author), Guangxi Univ, Coll Chem & Chem Engn, Nanning 530004, Peoples R China.
EM linbf941@gxu.edu.cn
FU National Natural Science Foundation of China [51263001]; Scientific
   Research Foundation of Guangxi University of China [XTZ140787]
FX This work was financially supported by National Natural Science
   Foundation of China under Grant No. 51263001 (to B.L.) and Scientific
   Research Foundation of Guangxi University of China. Contract grant
   sponsor: XTZ140787.
CR Dash M, 2011, PROG POLYM SCI, V36, P981, DOI 10.1016/j.progpolymsci.2011.02.001
   Ding P, 2007, INT J BIOL MACROMOL, V41, P125, DOI 10.1016/j.ijbiomac.2006.12.008
   Ducamp-Collin MN, 2008, POSTHARVEST BIOL TEC, V49, P241, DOI 10.1016/j.postharvbio.2008.01.009
   Esmaeili F, 2007, NANOMED-NANOTECHNOL, V3, P161, DOI 10.1016/j.nano.2007.03.003
   Furst W, 2005, ANN THORAC SURG, V79, P1522, DOI 10.1016/j.athoracsur.2004.11.054
   Gandhi A, 2014, INT J BIOL MACROMOL, V67, P478, DOI 10.1016/j.ijbiomac.2014.04.019
   Gupta KC, 2006, CARBOHYD RES, V341, P744, DOI 10.1016/j.carres.2006.02.003
   Huang XM, 2005, POSTHARVEST BIOL TEC, V36, P177, DOI 10.1016/j.postharvbio.2004.12.005
   Hundre SY, 2015, FOOD CHEM, V174, P16, DOI 10.1016/j.foodchem.2014.11.016
   Jiang YM, 2003, J HORTIC SCI BIOTECH, V78, P437, DOI 10.1080/14620316.2003.11511645
   Kai YM, 2013, FLUID PHASE EQUILIBR, V344, P19, DOI 10.1016/j.fluid.2012.12.031
   Kalinin S, 2013, J NEUROIMMUNOL, V263, P13, DOI 10.1016/j.jneuroim.2013.07.007
   Karathanos VT, 2007, FOOD CHEM, V101, P652, DOI 10.1016/j.foodchem.2006.01.053
   Kong XY, 2010, CARBOHYD POLYM, V79, P170, DOI 10.1016/j.carbpol.2009.07.037
   Kooijman H, 2004, ACTA CRYSTALLOGR E, V60, pO917, DOI 10.1107/S1600536804010177
   Liang YS, 2012, POSTHARVEST BIOL TEC, V68, P72, DOI 10.1016/j.postharvbio.2012.02.005
   Lin BF, 2011, J FOOD ENG, V102, P94, DOI 10.1016/j.jfoodeng.2010.08.009
   Lopes SB, 2002, PHYS CHEM CHEM PHYS, V4, P1014, DOI 10.1039/b107232n
   Mangaraj S, 2012, POSTHARVEST BIOL TEC, V71, P1, DOI 10.1016/j.postharvbio.2012.04.007
   Mi FL, 1999, J APPL POLYM SCI, V74, P1868, DOI 10.1002/(SICI)1097-4628(19991114)74:7<1868::AID-APP32>3.0.CO;2-N
   Misra R, 2009, NANOMEDICINE-UK, V4, P519, DOI [10.2217/nnm.09.28, 10.2217/NNM.09.28]
   Mohamed Nadia Hussein, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P876
   Mourtzinos I, 2009, FOOD CHEM, V114, P791, DOI 10.1016/j.foodchem.2008.10.014
   Olesen T, 2004, POSTHARVEST BIOL TEC, V32, P135, DOI 10.1016/j.postharvbio.2003.10.009
   Prakash B, 2012, FOOD RES INT, V49, P201, DOI 10.1016/j.foodres.2012.08.020
   Rathna GVN, 2008, J MATER SCI-MATER M, V19, P2351, DOI 10.1007/s10856-007-3334-9
   RITGER P L, 1987, Journal of Controlled Release, V5, P37, DOI 10.1016/0168-3659(87)90035-6
   Rokhade AP, 2007, CARBOHYD POLYM, V69, P678, DOI 10.1016/j.carbpol.2007.02.008
   Sashikala S., 2014, SCHOLARS RES LIB PHA, V6, P90
   Siepmann J, 2001, ADV DRUG DELIVER REV, V48, P139, DOI 10.1016/S0169-409X(01)00112-0
   Silva MD, 2010, QUIM NOVA, V33, P1868, DOI 10.1590/S0100-40422010000900009
   Sinha AK, 2008, INT J FOOD SCI NUTR, V59, P299, DOI 10.1080/09687630701539350
   Sivakami MS, 2013, INT J BIOL MACROMOL, V57, P204, DOI 10.1016/j.ijbiomac.2013.03.005
   Takka S, 1998, EUR J PHARM SCI, V6, P241, DOI 10.1016/S0928-0987(97)10005-7
   Tanuma H, 2010, CARBOHYD POLYM, V80, P260, DOI 10.1016/j.carbpol.2009.11.022
   Wang HC, 2010, PHYTOPATHOLOGY, V100, P522, DOI 10.1094/PHYTO-100-5-0522
   Wu H, 2015, FOOD CHEM, V175, P344, DOI 10.1016/j.foodchem.2014.11.149
   Zhang SY, 2014, LWT-FOOD SCI TECHNOL, V57, P749, DOI 10.1016/j.lwt.2014.02.046
NR 38
TC 3
Z9 3
U1 14
U2 51
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0888-5885
J9 IND ENG CHEM RES
JI Ind. Eng. Chem. Res.
PD APR 27
PY 2016
VL 55
IS 16
BP 4490
EP 4498
DI 10.1021/acs.iecr.6b00028
PG 9
WC Engineering, Chemical
SC Engineering
GA DK9IU
UT WOS:000375244900012
DA 2018-10-20
ER

PT J
AU Zhao, M
   Shi, Y
   He, MX
   Huang, XD
   Wang, Q
AF Zhao, Mi
   Shi, Yu
   He, Maoxian
   Huang, Xiande
   Wang, Qi
TI PfSMAD4 plays a role in biomineralization and can transduce bone
   morphogenetic protein-2 signals in the pearl oyster Pinctada fucata
SO BMC DEVELOPMENTAL BIOLOGY
LA English
DT Article
DE SMAD4; Biomineralization; BMP signaling pathway; Pinctada fucata
ID TGF-BETA; NACRE FORMATION; MATRIX PROTEIN; CELL-MEMBRANE; SMAD4;
   EXPRESSION; GENE; DPP; NUCLEUS; PATHWAY
AB Background: Mollusca is the second largest phylum in nature. The shell of molluscs is a remarkable example of a natural composite biomaterial. Biomineralization and how it affects mollusks is a popular research topic. The BMP-2 signaling pathway plays a canonical role in biomineralization. SMAD4 is an intracellular transmitter in the BMP signaling pathway in mammals, and some genomic data show SMAD4's involvment in BMP signaling in invertbrates, but whether SMAD4 plays a conservative role in pearl oyster, Pinctada fucata, still need to be tested.
   Results: In this study, we identified a SMAD4 gene (hereafter designated PfSMAD4) in pearl oyster Pinctada fucata. Bioinformatics analysis of PfSMAD4 showed high identity with its orthologs. PfSMAD4 was located in the cytoplasm in immunofluorescence assays and analyses of PfSMAD4 mRNA in tissues and developmental stages showed high expression in ovaries and D-shaped larvae. An RNA interference experiment, performed by PfSMAD4 double-stranded RNA (dsRNA) injection, demonstrated inhibition not only of nacre growth but also organic sheet formation with a decrease in PfSMAD4 expression. A knockdown experiment using PfBMP2 dsRNA showed decreased PfBMP2 and PfSMAD4 mRNA and irregular crystallization of the nacreous layer using scanning electron microscopy. In co-transfection experiments, PfBMP2-transactivated reporter constructs contained PfSMAD4 promoter sequences.
   Conclusions: Our results suggest that PfSMAD4 plays a role in biomineralization and can transduce BMP signals in P. fucata. Our data provides important clues about the molecular mechanisms that regulate biomineralization in pearl oyster.
C1 [Zhao, Mi; Shi, Yu; He, Maoxian; Huang, Xiande; Wang, Qi] Chinese Acad Sci, South China Sea Inst Oceanol, CAS Key Lab Trop Marine Bioresources & Ecol, Guangzhou 510301, Guangdong, Peoples R China.
   [Zhao, Mi; Wang, Qi] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
RP He, MX (reprint author), Chinese Acad Sci, South China Sea Inst Oceanol, CAS Key Lab Trop Marine Bioresources & Ecol, Guangzhou 510301, Guangdong, Peoples R China.
EM hmx@scsio.ac.cn
FU National Natural Science Foundation of China [41376159]; National
   Science and technology program of China [2012AA10A410]; Marine Fishery
   Science and Technology Promotion Program of Guangdong Province, China
   [A201201A05, A201301A03]
FX This work was supported by the National Natural Science Foundation of
   China (41376159), the National Science and technology program of China
   (2012AA10A410) and the Marine Fishery Science and Technology Promotion
   Program of Guangdong Province, China (A201201A05, A201301A03).
CR Addadi L, 1997, NATURE, V389, P912, DOI 10.1038/40010
   Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809
   Attisano L, 2001, GENOME BIOL, V2
   Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023
   Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929
   Cho YD, 2010, J BIOL CHEM, V285, P36369, DOI 10.1074/jbc.M110.103093
   Das P, 1998, DEVELOPMENT, V125, P1519
   De Robertis EM, 2008, CELL, V132, P185, DOI 10.1016/j.cell.2008.01.003
   Eivers E, 2009, CYTOKINE GROWTH F R, V20, P357, DOI 10.1016/j.cytogfr.2009.10.017
   Evans AG, 2001, J MATER RES, V16, P2475, DOI 10.1557/JMR.2001.0339
   Fang D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021860
   Funabara D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084706
   Gong NP, 2008, J STRUCT BIOL, V164, P33, DOI 10.1016/j.jsb.2008.05.009
   Hashimoto N, 2012, DEV BIOL, V366, P367, DOI 10.1016/j.ydbio.2012.04.010
   Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284
   Hohenstein P, 2003, GENE CHROMOSOME CANC, V36, P273, DOI 10.1002/gcc.10169
   Inman GJ, 2002, MOL CELL, V10, P283, DOI 10.1016/S1097-2765(02)00585-3
   Jiao Y, 2012, BIOCHEM BIOPH RES CO, V425, P679, DOI 10.1016/j.bbrc.2012.07.099
   Kin K, 2009, DEV BIOL, V329, P152, DOI 10.1016/j.ydbio.2009.01.021
   Kobayashi A, 1999, DEV GROWTH DIFFER, V41, P419
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Lazzereschi D, 2005, ONCOGENE, V24, P5344, DOI 10.1038/sj.onc.1208603
   Le Goff C, 2012, NAT GENET, V44, P85, DOI 10.1038/ng.1016
   Liu G, 2014, CHIN J OCEANOL LIMN, V32, P1224, DOI 10.1007/s00343-014-3360-7
   Luo YJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9301
   Maru D, 2004, ONCOGENE, V23, P859, DOI 10.1038/sj.onc.1207194
   Miyashita T., 2013, INT J ZOOLOGY, V2013
   Miyashita T, 2008, BIOSCI BIOTECH BIOCH, V72, P37, DOI 10.1271/bbb.70302
   Nederbragt AJ, 2002, DEV BIOL, V246, P341, DOI 10.1006/dbio.2002.0653
   Nohe A, 2004, CELL SIGNAL, V16, P291, DOI 10.1016/j.cellsig.2003.08.011
   PADGETT RW, 1993, P NATL ACAD SCI USA, V90, P2905, DOI 10.1073/pnas.90.7.2905
   Pierreux CE, 2000, MOL CELL BIOL, V20, P9041, DOI 10.1128/MCB.20.23.9041-9054.2000
   Retting KN, 2009, DEVELOPMENT, V136, P1093, DOI 10.1242/dev.029926
   Samuel G, 2001, EVOL DEV, V3, P241, DOI 10.1046/j.1525-142x.2001.003004241.x
   Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X
   Shimizu K, 2013, EVODEVO, V4, DOI 10.1186/2041-9139-4-15
   Shimizu K, 2011, DEV GENES EVOL, V221, P59, DOI 10.1007/s00427-011-0358-4
   Shioda T, 1998, P NATL ACAD SCI USA, V95, P9785, DOI 10.1073/pnas.95.17.9785
   Shrey K, 2009, BIOCHEM BIOPH RES CO, V386, P273, DOI 10.1016/j.bbrc.2009.06.018
   Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Tan XH, 2007, J CELL SCI, V120, P2162, DOI 10.1242/jcs.003466
   Tao SJ, 2010, DEV GROWTH DIFFER, V52, P335, DOI 10.1111/j.1440-169X.2009.01163.x
   WADA K., 1972, BIOMINERALISATION, V6, P141
   Wang RZ, 2001, J MATER RES, V16, P2485, DOI 10.1557/JMR.2001.0340
   Warmflash A, 2012, P NATL ACAD SCI USA, V109, pE1947, DOI 10.1073/pnas.1207607109
   Westbroek P, 1998, NATURE, V392, P861, DOI 10.1038/31798
   Xiao YT, 2007, BIOCHEM BIOPH RES CO, V362, P550, DOI 10.1016/j.bbrc.2007.08.045
   Xu C, 2005, GENE, V357, P1, DOI 10.1016/j.gene.2005.06.017
   Yu XS, 2011, SCI CHINA LIFE SCI, V54, P220, DOI 10.1007/s11427-011-4136-3
   Zaidi SK, 2002, P NATL ACAD SCI USA, V99, P8048, DOI 10.1073/pnas.112664499
   Zentz F, 2001, MAR BIOTECHNOL, V3, P36, DOI 10.1007/s101260000042
   Zhang Y, 1997, CURR BIOL, V7, P270, DOI 10.1016/S0960-9822(06)00123-0
NR 53
TC 5
Z9 5
U1 0
U2 21
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-213X
J9 BMC DEV BIOL
JI BMC Dev. Biol.
PD APR 26
PY 2016
VL 16
AR 9
DI 10.1186/s12861-016-0110-4
PG 9
WC Developmental Biology
SC Developmental Biology
GA DK2IQ
UT WOS:000374738300001
PM 27113217
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Zhao, TF
   Chen, CQ
   Deng, ZC
AF Zhao, T. F.
   Chen, C. Q.
   Deng, Z. C.
TI Elastoplastic properties of transversely isotropic sintered metal fiber
   sheets
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE Metal fiber networks; Transversely isotropic; Elastoplastic properties;
   Uniaxial test; Tomography
ID X-RAY TOMOGRAPHY; MECHANICAL-BEHAVIOR; CELLULAR METALS; NETWORK;
   DEFORMATION; MODEL; ENHANCEMENT; PREDICTION
AB Sintering of layered metal fiber sheets produces a structured, tunable, paper-like material that holds promise for thermal and biomaterial applications. Particularly promising for these areas is a material system synthesized by the sequential-overlap method, which produces a networked, transversely isotropic open cell porous material. Engineering application of these materials has been limited due in part to uncertainty about their mechanical responses. Here, we present a comprehensive structural and mechanical characterization of these materials, and define a modeling framework suitable for engineering design. X-ray tomography revealed a layered structure with an isotropic fiber distribution within each layer. In-plane uniaxial compression and tension tests revealed a linear dependence of Young's modulus and yield strength upon relative fiber density. Out-of-plane tests, however, revealed much lower Young's modulus and strength, with quartic and cubic dependence upon relative density, respectively. Fiber fracture was the dominant mode of failure for tension within the "in-plane" directions of the fiber layers, and fiber decohesion was the dominant mode of failure for tension applied in the "out-of-plane" direction, normal to the layers. Models based upon dispersions of beams predicted both in plane and out-of-plane elastoplastic properties as a function of the relative density of fibers. These models provide a foundation for mechanical design with and optimization of these materials for a broad range of potential applications. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Zhao, T. F.; Deng, Z. C.] Northwestern Polytech Univ, Sch Mech Civil Engn & Architecture, Xian 710072, Peoples R China.
   [Chen, C. Q.] Tsinghua Univ, AML, Dept Engn Mech, Beijing 100084, Peoples R China.
   [Chen, C. Q.] Tsinghua Univ, AML, Ctr Nano & Micro Mech, Beijing 100084, Peoples R China.
   [Deng, Z. C.] Dalian Univ Technol, State Key Lab Struct Anal Ind Equipment, Dalian 116024, Peoples R China.
RP Chen, CQ (reprint author), Tsinghua Univ, AML, Dept Engn Mech, Beijing 100084, Peoples R China.; Chen, CQ (reprint author), Tsinghua Univ, AML, Ctr Nano & Micro Mech, Beijing 100084, Peoples R China.
EM chencq@tsinghua.edu.cn
RI Chen, Changqing/A-4380-2009
OI Chen, Changqing/0000-0002-1561-0798
FU National Natural Science Foundation of China [11402201, 11172239,
   11372252]; National Basic Research Program of China [2015CB351900];
   Fundamental Research Funds for the Central Universities
   [3102014JCQ01037]
FX This work is supported by the National Natural Science Foundation of
   China (Nos. 11402201, 11172239 and 11372252), the National Basic
   Research Program of China (No. 2015CB351900), and the Fundamental
   Research Funds for the Central Universities (No. 3102014JCQ01037). The
   authors are grateful to Prof. Guy Genin at Washington University at St.
   Louis for his insightful comments and help on re-shaping this paper.
CR Ashby M.F., 2000, METAL FOAMS DESIGN G
   Banhart J, 2001, PROG MATER SCI, V46, P559, DOI 10.1016/S0079-6425(00)00002-5
   Budynas RG, 1998, ADV STRENGTH APPL ST
   Chadwick C, 2010, FILTR SEPARAT, V47, P18, DOI 10.1016/S0015-1882(10)70260-3
   CHEN YL, 2015, J MECH PHYS SOLIDS, V84, P395
   Clyne TW, 2005, COMPOS SCI TECHNOL, V65, P2492, DOI 10.1016/j.compscitech.2005.05.037
   Delince M, 2004, ACTA MATER, V52, P1013, DOI 10.1016/j.actamat.2003.10.035
   Deshpande VS, 2001, J MECH PHYS SOLIDS, V49, P1747, DOI 10.1016/S0022-5096(01)00010-2
   DUCHEYNE P, 1978, J MATER SCI, V13, P2650, DOI 10.1007/BF00552695
   Franco A, 2006, EXP THERM FLUID SCI, V30, P263, DOI 10.1016/j.expthermflusci.2005.07.002
   Gibson LJ, 2011, INTEGR COMP BIOL, V51, pE47
   Gibson L. J, 1997, CELLULAR SOLIDS STRU
   Huang X, 2013, MAT SCI ENG A-STRUCT, V585, P297, DOI 10.1016/j.msea.2013.07.052
   JANSEN JA, 1992, BIOMATERIALS, V13, P959, DOI 10.1016/0142-9612(92)90121-4
   Jayanty S, 2011, PHYS STATUS SOLIDI B, V248, P73, DOI 10.1002/pssb.201083973
   Jiang GF, 2014, MATER DESIGN, V56, P241, DOI 10.1016/j.matdes.2013.11.019
   Jin MZ, 2013, J MECH PHYS SOLIDS, V61, P161, DOI 10.1016/j.jmps.2012.08.006
   Liu JG, 2004, J POWER SOURCES, V133, P175, DOI 10.1016/j.jpowsour.2004.02.009
   Liu P, 2009, MATER DESIGN, V30, P2264, DOI 10.1016/j.matdes.2008.09.007
   Liu Q, 2013, MAT SCI ENG A-STRUCT, V587, P36, DOI 10.1016/j.msea.2013.07.087
   Markaki AE, 2003, ACTA MATER, V51, P1351, DOI 10.1016/S1359-6454(02)00529-3
   Neelakantan S, 2014, ACTA MATER, V66, P326, DOI 10.1016/j.actamat.2013.11.020
   Neelakantan S, 2015, SCRIPTA MATER, V106, P30, DOI 10.1016/j.scriptamat.2015.04.028
   Peukert W, 1998, FILTR SEPARAT, V35, P461, DOI 10.1016/S0015-1882(98)80015-3
   Tan J. C., 2006, ADV ENG MATER, V8, P455
   Tatlier M, 2009, PHYS STATUS SOLIDI B, V246, P2018, DOI 10.1002/pssb.200982032
   Tsarouchas D, 2011, ACTA MATER, V59, P6989, DOI 10.1016/j.actamat.2011.07.051
   Veyhl C, 2012, INT J HEAT MASS TRAN, V55, P2440, DOI 10.1016/j.ijheatmasstransfer.2012.01.016
   Wadley HNG, 2006, PHILOS T ROY SOC A, V364, P31, DOI 10.1098/rsta.2005.1697
   Wan ZP, 2012, MAT SCI ENG A-STRUCT, V544, P33, DOI 10.1016/j.msea.2012.02.070
   Yuranov I, 2003, APPL CATAL B-ENVIRON, V43, P217, DOI 10.1016/S0926-3373(02)00304-1
   Zhao TF, 2014, MECH MATER, V70, P33, DOI 10.1016/j.mechmat.2013.11.007
   Zhou DW, 2005, INT J MECH SCI, V47, P775, DOI 10.1016/j.ijmensci.2004.10.013
   Zou C., 2007, J MATER SCI-MATER M, V19, P401
NR 34
TC 5
Z9 5
U1 2
U2 14
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
EI 1873-4936
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD APR 26
PY 2016
VL 662
BP 308
EP 319
DI 10.1016/j.msea.2016.03.085
PG 12
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA DK8GD
UT WOS:000375164300036
DA 2018-10-20
ER

PT J
AU Chahal, S
   Hussain, FSJ
   Kumar, A
   Rasad, MSBA
   Yusoff, MM
AF Chahal, Sugandha
   Hussain, Fathima Shahitha Jahir
   Kumar, Anuj
   Rasad, Mohammad Syaiful Bahari Abdull
   Yusoff, Mashitah Mohd
TI Fabrication, characterization and in vitro biocompatibility of
   electrospun hydroxyethyl cellulose poly (vinyl) alcohol nanofibrous
   composite biomaterial for bone tissue engineering
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Hydroxyethyl cellulose; Electrospinning; Thermo-mechanical properties;
   Bone tissue engineering
ID POLY(VINYL ALCOHOL); SCAFFOLDS; HYDROGELS; COLLAGEN; FIBERS;
   NANOCOMPOSITES; DESIGN; FILMS; WATER; PVA
AB Development of novel scaffold materials that mimic the extracellular matrix, architecturally and functionally, is becoming highly important to meet the demands of the advances in bone tissue engineering. This paper reports, the fabrication of natural polymer cellulose derived hydroxyethyl cellulose (HEC) based nanostructured scaffolds with uniform fiber morphology through electrospinning. Poly (vinyl alcohol) (PVA) was used as an ionic solvent for supporting the electrospinning of HEC. Scanning electron microscopy and ImageJ analysis revealed the formation of non-woven nanofibers with well-defined porous architecture. The interactions between HEC and PVA in the electrospun nanofibers were studied by differential scanning calorimetry, X-ray diffraction, dynamic mechanical analysis thermo-gravimetric analysis; Fourier transform-infrared spectroscopy, X-ray photoelectron spectroscopy and tensile test. The mechanical properties of scaffolds were significantly altered with different ratios of HEC/PVA. Further, the biocompatibility of HEC/PVA scaffolds was evaluated using human osteosarcoma cells. The SEM images revealed favorable cells attachment and spreading on the nanofibrous scaffolds and MTS assay showed increased cell proliferation after different time periods. Thus, these results indicate that HEC based nanofibrous scaffolds will be a promising candidate for bone tissue engineering. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Chahal, Sugandha; Hussain, Fathima Shahitha Jahir; Yusoff, Mashitah Mohd] Univ Malaysia Pahang, Fac Ind Sci & Technol, Kuantan 26070, Pahang, Malaysia.
   [Kumar, Anuj] Czech Tech Univ, Dept Bldg Struct, Fac Civil Engn, Thakurova 7, Prague 16629 6, Czech Republic.
   [Rasad, Mohammad Syaiful Bahari Abdull] IIUM, Kulliyyah Allied Hlth Sci, Dept Biomed Sci, Kuantan 25200, Pahang, Malaysia.
RP Chahal, S (reprint author), Univ Malaysia Pahang, Fac Ind Sci & Technol, Kuantan 26070, Pahang, Malaysia.
EM mlt.mony@gmail.com
OI Kumar, Anuj/0000-0001-6940-3850; Yusoff, Mashitah/0000-0003-4118-5307
FU Fundamental Research Grant Scheme (FRGS) [RDU100106]; Ministry of Higher
   Education, Malaysia
FX This work was supported by Fundamental Research Grant Scheme (FRGS)
   RDU100106, by Ministry of Higher Education, Malaysia. Authors
   acknowledge the support of Dr. Janez Kovac from Jozef Stefan Institute,
   Ljubljana, Slovenia for conducted the XPS analysis of prepared samples.
CR Abd El-Kader FH, 1999, J APPL POLYM SCI, V72, P1395, DOI 10.1002/(SICI)1097-4628(19990613)72:11<1395::AID-APP3>3.0.CO;2-8
   Agarwal S, 2009, ADV MATER, V21, P3343, DOI 10.1002/adma.200803092
   Ali IO, 2013, COLLOID SURFACE A, V436, P922, DOI 10.1016/j.colsurfa.2013.08.032
   Andrade G, 2006, BIOMED MATER, V1, P221, DOI 10.1088/1748-6041/1/4/008
   Asran AS, 2010, POLYMER, V51, P868, DOI 10.1016/j.polymer.2009.12.046
   Attia A., 2013, INT J ELECTROCHEM SC, V8, P5672
   Azizi Samir M.A.S., 2005, BIOMACROMOLECULES, V6, P612, DOI DOI 10.1021/BM0493685
   Barazzouk S, 2011, CELLULOSE, V18, P643, DOI 10.1007/s10570-011-9503-5
   Cen L, 2008, PEDIATR RES, V63, P492, DOI 10.1203/PDR.0b013e31816c5bc3
   Chahal S, 2015, RSC ADV, V5, P29497, DOI 10.1039/c4ra17087c
   Chahal S, 2014, BIO-MED MATER ENG, V24, P1537, DOI 10.3233/BME-140957
   Chen R, 2010, CARBOHYD POLYM, V81, P188, DOI 10.1016/j.carbpol.2010.02.012
   Coates J., 2000, INTERPRETATION INFRA, P10815
   Ding FY, 2014, NANOSCALE, V6, P9477, DOI 10.1039/c4nr02814g
   Domingues RMA, 2014, BIOMACROMOLECULES, V15, P2327, DOI 10.1021/bm500524s
   Elashmawi I.S., 2014, BR J APPL SCI TECHNO, V4, P4263
   Fratzl P, 2003, CURR OPIN COLLOID IN, V8, P32, DOI 10.1016/S1359-0294(03)00011-6
   Goonoo N, 2013, POLYM INT, V62, P523, DOI 10.1002/pi.4474
   Guirguis OW, 2012, NAT SCI, V4, P57, DOI DOI 10.4236/NS.2012.41009
   Habibovic P, 2005, BIOMATERIALS, V26, P3565, DOI 10.1016/j.biomaterials.2004.09.056
   Hadano S, 2003, J APPL POLYM SCI, V90, P2059, DOI 10.1002/app.12807
   Heydarkhan-Hagvall S, 2008, BIOMATERIALS, V29, P2907, DOI 10.1016/j.biomaterials.2008.03.034
   Hing KA, 2005, J MATER SCI-MATER M, V16, P467, DOI 10.1007/s10856-005-6988-1
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Jianga T., 2015, PROG POLYM SCI
   Kanungo BP, 2008, ACTA BIOMATER, V4, P490, DOI 10.1016/j.actbio.2008.01.003
   Kmmerer K., 2011, CHEMOSPHERE, V82, P1387
   Kovacs T, 2010, NANOTOXICOLOGY, V4, P255, DOI 10.3109/17435391003628713
   Krumova M, 2000, POLYMER, V41, P9265, DOI 10.1016/S0032-3861(00)00287-1
   Lee JS, 2004, J APPL POLYM SCI, V93, P1638, DOI 10.1002/app.20602
   Li J, 1997, J APPL POLYM SCI, V65, P373
   Lin F, 2013, J POLYM ENVIRON, V21, P343, DOI 10.1007/s10924-012-0453-2
   Linde L., 1989, J BIOMECH, V22, P485
   Lu WJ, 2014, J MATER CHEM B, V2, P2369, DOI 10.1039/c3tb21478h
   Mallapragada SK, 1996, J POLYM SCI POL PHYS, V34, P1339, DOI 10.1002/(SICI)1099-0488(199605)34:7<1339::AID-POLB15>3.0.CO;2-B
   Martins A, 2007, NANOMEDICINE-UK, V2, P929, DOI 10.2217/17435889.2.6.929
   MORRILL T. C., 1994, IDENTIFICACAO ESPECT
   Nayar S, 2008, J MATER SCI-MATER M, V19, P301, DOI 10.1007/s10856-007-3129-z
   Park JC, 2010, POLYM J, V42, P273, DOI 10.1038/pj.2009.340
   PEPPAS NA, 1976, J APPL POLYM SCI, V20, P1457, DOI 10.1002/app.1976.070200604
   Poinern GE, 2009, ULTRASON SONOCHEM, V16, P469, DOI 10.1016/j.ultsonch.2009.01.007
   Qua EH, 2009, J APPL POLYM SCI, V113, P2238, DOI 10.1002/app.30116
   Rathna GVN, 2011, POLYM J, V43, P654, DOI 10.1038/pj.2011.34
   Reneker DH, 1996, NANOTECHNOLOGY, V7, P216, DOI 10.1088/0957-4484/7/3/009
   Ricciardi R, 2004, MACROMOLECULES, V37, P1921, DOI 10.1021/ma035663q
   Rodriguez K, 2011, ACS APPL MATER INTER, V3, P681, DOI 10.1021/am100972r
   ROHLMANN A, 1980, ARCH ORTHOP TRAUM SU, V97, P95, DOI 10.1007/BF00450930
   Rong C., 2010, CARBOHYD POLYM, V81, P188
   Rosic R, 2011, J DRUG DELIV SCI TEC, V21, P229, DOI 10.1016/S1773-2247(11)50031-0
   ROSKELLEY CD, 1995, CURR OPIN CELL BIOL, V7, P736, DOI 10.1016/0955-0674(95)80117-0
   Russo R, 2010, CARBOHYD POLYM, V82, P1061, DOI 10.1016/j.carbpol.2010.06.037
   Salamone J. C., 1998, CONCISE POLYM MAT EN, V1
   Sannino A, 2009, MATERIALS, V2, P353, DOI 10.3390/ma2020353
   Seliktar D, 2005, ANN NY ACAD SCI, V1047, P386, DOI 10.1196/annals.1341.034
   SELIM IZ, 1994, POLYM-PLAST TECHNOL, V33, P161, DOI 10.1080/03602559408015293
   Shakesheff KM, 1997, J COLLOID INTERF SCI, V185, P538, DOI 10.1006/jcis.1996.4637
   Sheeny K., 2014, J MATER CHEM B, V2, P3161
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Wallner EI, 1998, AM J PHYSIOL-RENAL, V275, pF467, DOI 10.1152/ajprenal.1998.275.4.F467
   Wenjing L., 2014, J MATER CHEM B, V2, P2369
   Wignall G.D., 1993, SCATTERING TECHNIQUE
   Woodard JR, 2007, BIOMATERIALS, V28, P45, DOI 10.1016/j.biomaterials.2006.08.021
   Yang C., 2008, BIODRUGS, V18, P490
   Zhang L, 2012, SOFT MATTER, V8, P10439, DOI 10.1039/c2sm26102b
   Zhang YZ, 2005, BIOMACROMOLECULES, V6, P2583, DOI 10.1021/bm050314k
   Zhang YZ, 2006, BIOMACROMOLECULES, V7, P1049, DOI 10.1021/bm050743i
   Zhang YZ, 2005, J BIOMED MATER RES B, V72B, P156, DOI 10.1002/jbm.b.30128
   Zohuriaan MJ, 2004, POLYM TEST, V23, P575, DOI 10.1016/j.polymertesting.2003.11.001
   Zulkifli FH, 2014, CARBOHYD POLYM, V114, P238, DOI 10.1016/j.carbpol.2014.08.019
NR 69
TC 16
Z9 17
U1 4
U2 86
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD APR 22
PY 2016
VL 144
BP 17
EP 29
DI 10.1016/j.ces.2015.12.030
PG 13
WC Engineering, Chemical
SC Engineering
GA DF6NO
UT WOS:000371472700003
DA 2018-10-20
ER

PT J
AU Kalman, S
   Garbett, KA
   Janka, Z
   Mirnics, K
AF Kalman, S.
   Garbett, K. A.
   Janka, Z.
   Mirnics, K.
TI HUMAN DERMAL FIBROBLASTS IN PSYCHIATRY RESEARCH
SO NEUROSCIENCE
LA English
DT Review
DE dermal fibroblasts; schizophrenia; major depression; bipolar disorder;
   in vitro model; gene*environment interaction
ID PLURIPOTENT STEM-CELLS; MAJOR DEPRESSIVE DISORDER; CULTURED SKIN
   FIBROBLASTS; NAIVE 1ST-EPISODE SCHIZOPHRENIA; IMPAIRED GLUTATHIONE
   SYNTHESIS; DECREASED TYROSINE TRANSPORT; CATECHOL-O-METHYLTRANSFERASE;
   CIRCADIAN GENE-EXPRESSION; DEPENDENT PROTEIN-KINASE;
   AMINO-ACID-TRANSPORT
AB In order to decipher the disease etiology, progression and treatment of multifactorial human brain diseases we utilize a host of different experimental models. Recently, patient-derived human dermal fibroblast (HDF) cultures have re-emerged as promising in vitro functional system for examining various cellular, molecular, metabolic and (patho) physiological states and traits of psychiatric disorders. HDF studies serve as a powerful complement to postmortem and animal studies, and often appear to be informative about the altered homeostasis in neural tissue. Studies of HDFs from patients with schizophrenia (SZ), depression, bipolar disorder (BD), autism, attention deficit and hyperactivity disorder and other psychiatric disorders have significantly advanced our understanding of these devastating diseases. These reports unequivocally prove that signal transduction, redox homeostasis, circadian rhythms and gene*environment (G*E) interactions are all amenable for assessment by the HDF model. Furthermore, the reported findings suggest that this underutilized patient biomaterial, combined with modern molecular biology techniques, may have both diagnostic and prognostic value, including prediction of response to therapeutic agents. (C) 2016 IBRO. Published by Elsevier Ltd. All rights reserved.
C1 [Kalman, S.; Janka, Z.; Mirnics, K.] Univ Szeged, Dept Psychiat, 57 Kalvaria Sgt, H-6725 Szeged, Hungary.
   [Garbett, K. A.; Mirnics, K.] Vanderbilt Univ, Dept Psychiat, 8128 MRB 3,465 21st Ave, Nashville, TN 37232 USA.
RP Mirnics, K (reprint author), Vanderbilt Univ, Dept Psychiat, 8128 MRB 3,465 21st Ave, Nashville, TN 37232 USA.
EM kalmansara@gmail.com; krassimira.garbett@vanderbilt.edu;
   janka.zoltan@med.u-szeged.hu; karoly.mirnics@vanderbilt.edu
OI Mirnics, Karoly/0000-0002-5521-0254
FU NIMH [R01 MH079299]; Vanderbilt International Summer Research Academy
   (VISRA) scholarship; Vanderbilt International Scholar Short-Term Visit
   Fellowship
FX K.M.'s work was partially supported by R01 MH079299 (NIMH). S.K.'s work
   was partially supported by the Vanderbilt International Summer Research
   Academy (VISRA) scholarship and the Vanderbilt International Scholar
   Short-Term Visit Fellowship. We are grateful to Ms. Kelli Money for
   editing and providing insightful comments on the manuscript.
CR Akin D, 2004, NEUROPSYCHOPHARMACOL, V29, P2081, DOI 10.1038/sj.npp.1300505
   Akin D, 2005, INT J NEUROPSYCHOPH, V8, P5, DOI 10.1017/S146114570400478X
   ANTEQUERA F, 1990, CELL, V62, P503, DOI 10.1016/0092-8674(90)90015-7
   Auburger G, 2012, MOL NEUROBIOL, V46, P20, DOI 10.1007/s12035-012-8245-1
   Bae S, 2015, ACTA PHARMACEUT, V65, P331, DOI 10.1515/acph-2015-0025
   Bajpai A, 2014, J CLIN DIAGN RES, V8, pCC4, DOI 10.7860/JCDR/2014/10258.5292
   Bamne MN, 2013, BIPOLAR DISORD, V15, P694, DOI 10.1111/bdi.12095
   Batalla A, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.122
   BAYREUTHER K, 1991, MUTAT RES, V256, P233, DOI 10.1016/0921-8734(91)90014-3
   Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016
   Belinsky GS, 2014, STEM CELL RES, V12, P101, DOI 10.1016/j.scr.2013.09.014
   Benedetti F, 2008, NEUROSCI LETT, V445, P184, DOI 10.1016/j.neulet.2008.09.002
   Benito E, 2015, MOL NEUROBIOL, V51, P1071, DOI 10.1007/s12035-014-8772-z
   Berretta S, 2015, SCHIZOPHR RES, V167, P18, DOI 10.1016/j.schres.2014.12.040
   BERRETTINI WH, 1987, BIOL PSYCHIAT, V22, P1439, DOI 10.1016/0006-3223(87)90101-6
   Biran R, 1999, J BIOMED MATER RES, V46, P150, DOI 10.1002/(SICI)1097-4636(199908)46:2<150::AID-JBM3>3.3.CO;2-K
   Bongiovanni R, 2013, SCHIZOPHR RES, V150, P386, DOI 10.1016/j.schres.2013.08.041
   Borgmann-Winter K, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2014.141
   BREAKEFIELD XO, 1980, PSYCHIAT RES, V2, P307, DOI 10.1016/0165-1781(80)90022-0
   Brennand KJ, 2012, MOL PSYCHIATR, V17, P1239, DOI 10.1038/mp.2012.20
   Brennand KJ, 2014, BIOL PSYCHIAT, V75, P936, DOI 10.1016/j.biopsych.2013.10.025
   BRESLOW RE, 1985, BIOL PSYCHIAT, V20, P58, DOI 10.1016/0006-3223(85)90135-0
   Brown JA, 2015, MOL PSYCHIAT
   Brown JA, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0183-6
   Brown SA, 2005, PLOS BIOL, V3, P1813, DOI 10.1371/journal.pbio.0030338
   BRUINVELS J, 1988, PHARMACOPSYCHIATRY, V21, P28, DOI 10.1055/s-2007-1014642
   Cataldo AM, 2010, AM J PATHOL, V177, P575, DOI 10.2353/ajpath.2010.081068
   Cattane N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116686
   Catts VS, 2006, SCHIZOPHR RES, V84, P20, DOI 10.1016/j.schres.2006.03.016
   Chanda S, 2014, STEM CELL REP, V3, P282, DOI 10.1016/j.stemcr.2014.05.020
   Chen YW, 2015, NEUROPSYCH DIS TREAT, V11, DOI 10.2147/NDT.S81432
   Coffey EE, 2014, NEUROSCIENCE, V263, P111, DOI 10.1016/j.neuroscience.2014.01.001
   COHEN MR, 1987, PSYCHIAT RES, V21, P43, DOI 10.1016/0165-1781(87)90060-6
   COHEN MR, 1989, BIOL PSYCHIAT, V25, P239, DOI 10.1016/0006-3223(89)90170-4
   COHEN MR, 1986, BIOL PSYCHIAT, V21, P322, DOI 10.1016/0006-3223(86)90055-7
   Connolly GP, 1998, TRENDS PHARMACOL SCI, V19, P171, DOI 10.1016/S0165-6147(98)01202-4
   Cordero MD, 2009, TOXICOL APPL PHARM, V235, P329, DOI 10.1016/j.taap.2008.12.026
   Dage JL, 2014, PSYCHOPHARMACOLOGY, V231, P1105, DOI 10.1007/s00213-013-3384-2
   De Filippi L, 2007, CURR GENET, V52, P171, DOI 10.1007/s00294-007-0151-0
   Dietschy JM, 2004, J LIPID RES, V45, P1375, DOI [10.1194/jlr.r400004-JLR200, 10.1194/jlr.r400004]
   Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799
   Do KQ, 2000, EUR J NEUROSCI, V12, P3721, DOI 10.1046/j.1460-9568.2000.00229.x
   Druzd D, 2014, SEMIN IMMUNOPATHOL, V36, P149, DOI 10.1007/s00281-013-0414-4
   Dwivedi Y, 2002, AM J PSYCHIAT, V159, P66, DOI 10.1176/appi.ajp.159.1.66
   Dwivedi Yogesh, 2008, Neuropsychiatr Dis Treat, V4, P161
   Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677
   Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612
   Evangelisti E, 2014, J ALZHEIMERS DIS, V41, P289, DOI 10.3233/JAD-131406
   Faissner A, 2010, BRAIN RES REV, V63, P26, DOI 10.1016/j.brainresrev.2010.01.001
   Fathi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022856
   FEKKES D, 1986, BIOL PSYCHIAT, V21, P951, DOI 10.1016/0006-3223(86)90269-6
   Fernell E, 2007, NEUROSCI LETT, V418, P82, DOI 10.1016/j.neulet.2007.03.004
   Feron F, 2013, METHODS MOL BIOL, V1059, P107, DOI 10.1007/978-1-62703-574-3_10
   Flyckt L, 2001, ARCH GEN PSYCHIAT, V58, P953, DOI 10.1001/archpsyc.58.10.953
   Forrest MP, 2014, TRENDS MOL MED, V20, P322, DOI 10.1016/j.molmed.2014.01.010
   Fournier M, 2014, SCHIZOPHRENIA BULL, V40, P973, DOI 10.1093/schbul/sbu053
   Fridman AL, 2008, ONCOGENE, V27, P5975, DOI 10.1038/onc.2008.213
   Fullar A, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1272-3
   Garbett KA, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.14
   Garbett KA, 2015, BIOL PSYCHIAT, V77, P256, DOI 10.1016/j.biopsych.2014.05.015
   Garriock HA, 2010, BIOL PSYCHIAT, V67, P133, DOI 10.1016/j.biopsych.2009.08.029
   Gaspar L, 2014, EUR J NEUROSCI, V40, P2206, DOI 10.1111/ejn.12602
   Gasso P, 2014, J PSYCHIATR RES, V48, P94, DOI 10.1016/j.jpsychires.2013.09.017
   Gibson SA, 2012, J PSYCHIATR RES, V46, P1326, DOI 10.1016/j.jpsychires.2012.06.008
   GILLER E, 1984, PSYCHIAT RES, V12, P339, DOI 10.1016/0165-1781(84)90050-7
   GILLER EL, 1980, PSYCHIAT RES, V2, P187, DOI 10.1016/0165-1781(80)90076-1
   Gladkevich A, 2004, PROG NEURO-PSYCHOPH, V28, P559, DOI 10.1016/j.pnpbo.2004.01.009
   Glaros T, 2009, FRONT BIOSCI, V14, P3988, DOI 10.2735/3506
   Gomez G, 2000, J NEUROSCI RES, V62, P737, DOI 10.1002/1097-4547(20001201)62:5<737::AID-JNR14>3.0.CO;2-A
   Gong QY, 2015, BIOL PSYCHIAT, V77, P223, DOI 10.1016/j.biopsych.2014.08.009
   Greiner J F W, 2011, Eur Cell Mater, V22, P403
   GROSHONG R, 1978, ARCH GEN PSYCHIAT, V35, P1198
   Gundelfinger ED, 2010, EUR J NEUROSCI, V31, P2156, DOI 10.1111/j.1460-9568.2010.07253.x
   Gurung R, 2015, PSYCHOL MED, V45, P2461, DOI 10.1017/S0033291715000537
   Gysin R, 2007, P NATL ACAD SCI USA, V104, P16621, DOI 10.1073/pnas.0706778104
   Gysin R, 2011, ANTIOXID REDOX SIGN, V15, P2003, DOI 10.1089/ars.2010.3463
   Gysin R, 2009, BRAIN RES BULL, V79, P46, DOI 10.1016/j.brainresbull.2008.10.015
   Hanzelmann S, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0057-5
   HAGENFELDT L, 1987, LIFE SCI, V41, P2749, DOI 10.1016/0024-3205(87)90468-1
   Hayashi-Takagi A, 2014, BIOL PSYCHIAT, V75, P920, DOI 10.1016/j.biopsych.2013.09.035
   HITZEMANN R, 1988, PSYCHIAT RES, V24, P337, DOI 10.1016/0165-1781(88)90114-X
   Horvath S, 2015, BIOL PSYCHIAT, V77, P22, DOI 10.1016/j.biopsych.2014.01.001
   Horvath S, 2011, BIOL PSYCHIAT, V69, P157, DOI 10.1016/j.biopsych.2010.07.017
   Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107
   Huang HM, 2005, NEUROBIOL AGING, V26, P839, DOI 10.1016/j.neurobiolaging.2004.07.012
   Huard JMT, 1998, J COMP NEUROL, V400, P469
   Hung YY, 2014, PSYCHIAT RES, V220, P283, DOI 10.1016/j.psychres.2014.07.074
   Iafrati J, 2014, MOL PSYCHIATR, V19, P417, DOI 10.1038/mp.2013.66
   Iga JI, 2008, ANN MED, V40, P336, DOI 10.1080/07853890802082088
   Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821
   Jagannath A, 2013, CURR OPIN NEUROBIOL, V23, P888, DOI 10.1016/j.conb.2013.03.008
   Johansson AS, 2013, J PSYCHIATR RES, V47, P1815, DOI 10.1016/j.jpsychires.2013.08.008
   Johansson AS, 2011, J BIOL RHYTHM, V26, P541, DOI 10.1177/0748730411419775
   Johansson J, 2013, ADHD-ATTEND DEFICIT, V5, P267, DOI 10.1007/s12402-013-0103-0
   Johansson J, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-40
   Kaiser T, 2015, NAT MED, V21, P979, DOI 10.1038/nm.3935
   Kalman S, 2014, EXP CELL RES, V320, P343, DOI 10.1016/j.yexcr.2013.10.019
   Khandaker G. M., 2015, PSYCHOPHARMACOLOGY
   Kim DS, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00109
   Kirkpatrick B, 2008, SCHIZOPHRENIA BULL, V34, P1024, DOI 10.1093/schbul/sbm140
   Koch CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016679
   Krieger K, 1998, PHARMACOPSYCHIATRY, V31, P193, DOI 10.1055/s-2007-979326
   Kubben N, 2015, METHODS
   Kumari D, 2014, HUM MUTAT, V35, P1485, DOI 10.1002/humu.22699
   Kurian SM, 2011, MOL PSYCHIATR, V16, P37, DOI 10.1038/mp.2009.117
   Kyosseva SV, 2004, PROG NEURO-PSYCHOPH, V28, P997, DOI 10.1016/j.pnpbp.2004.05.017
   Lauth M, 2010, MOL PHARMACOL, V78, P486, DOI 10.1124/mol.110.066431
   Lee Kim Mai, 2015, World J Virol, V4, P42, DOI 10.5501/wjv.v4.i2.42
   Leeb C, 2014, J BIOL CHEM, V289, P4161, DOI 10.1074/jbc.M113.529271
   Lemons JM, 2010, PLOS BIOL, V8
   Leonard BE, 2007, NEUROCHEM RES, V32, P1749, DOI 10.1007/s11064-007-9385-y
   Liu JP, 2014, CLIN EXP PHARMACOL P, V41, P445, DOI 10.1111/1440-1681.12247
   Liu Y, 2013, NAT PROTOC, V8, P1670, DOI 10.1038/nprot.2013.106
   Logue MW, 2013, MOL PSYCHIATR, V18, P937, DOI 10.1038/mp.2012.113
   Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0
   Corrales NLL, 2012, GENE, V506, P377, DOI 10.1016/j.gene.2012.07.005
   Lu Pengfei, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a005058
   Lubbers BR, 2014, PROG BRAIN RES, V214, P263, DOI 10.1016/B978-0-444-63486-3.00012-8
   Lundgaard I, 2014, NEUROSCIENCE, V276, P161, DOI 10.1016/j.neuroscience.2013.10.050
   MAHADIK SP, 1994, SCHIZOPHR RES, V13, P239, DOI 10.1016/0920-9964(94)90048-5
   Mahadik SP, 1996, PROSTAG LEUKOTR ESS, V55, P65, DOI 10.1016/S0952-3278(96)90147-7
   MAHADIK SP, 1991, PSYCHIAT RES, V37, P309, DOI 10.1016/0165-1781(91)90066-X
   MAHADIK SP, 1994, PSYCHIAT RES, V53, P87, DOI 10.1016/0165-1781(94)90097-3
   Mahadik SP, 1996, PSYCHIAT RES, V63, P133, DOI 10.1016/0165-1781(96)02899-5
   Maier AB, 2007, AGING CELL, V6, P27, DOI 10.1111/j.1474-9726.2006.00263.x
   Manier DH, 2001, J AFFECT DISORDERS, V65, P275, DOI 10.1016/S0165-0327(00)00278-0
   Manier DH, 2000, J AFFECT DISORDERS, V61, P51, DOI 10.1016/S0165-0327(99)00190-1
   Martins-Taylor K, 2012, STEM CELLS, V30, P22, DOI 10.1002/stem.705
   Matigian NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002412
   McCarthy MJ, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.90
   McCarthy MJ, 2016, NEUROPHARMACOLOGY, V101, P439, DOI 10.1016/j.neuropharm.2015.10.017
   McCarthy MJ, 2013, ALCOHOL CLIN EXP RES, V37, P1304, DOI 10.1111/acer.12106
   McGlashan TH, 2011, SCHIZOPHRENIA BULL, V37, P1101, DOI 10.1093/schbul/sbr130
   MEISTER A, 1995, METHOD ENZYMOL, V252, P26
   Mertens J, 2015, CELL STEM CELL, pS1934
   Mirnics K, 2006, BIOL PSYCHIAT, V60, P163, DOI 10.1016/j.biopsych.2006.02.003
   Moore NH, 2009, J NEUROCHEM, V108, P891, DOI 10.1111/j.1471-4159.2008.05836.x
   Moreira PI, 2007, J ALZHEIMERS DIS, V12, P195
   Mossner R, 2000, NEUROCHEM INT, V36, P197, DOI 10.1016/S0197-0186(99)00122-9
   Muller N, 2012, ADV PROTEIN CHEM STR, V88, P49, DOI 10.1016/B978-0-12-398314-5.00003-9
   MUKHERJEE AB, 1987, J CLIN INVEST, V79, P1039, DOI 10.1172/JCI112916
   Munzer A, 2013, TOXINS, V5, P2227, DOI 10.3390/toxins5112227
   Musliner KL, 2015, PSYCHOL MED, V45, P1709, DOI 10.1017/S0033291714002839
   Naba A, 2015, MATRIX BIOL
   Naderi W, 2006, MECH AGEING DEV, V127, P25, DOI 10.1016/j.mad.2005.08.006
   NADI NS, 1984, NEW ENGL J MED, V311, P225, DOI 10.1056/NEJM198407263110404
   Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015
   Naydenov AV, 2007, ARCH GEN PSYCHIAT, V64, P555, DOI 10.1001/archpsyc.64.5.555
   Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647
   Nestor CE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0576-y
   Olsson E, 2006, NEUROSCI LETT, V393, P211, DOI 10.1016/j.neulet.2005.09.070
   Ovadia G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019955
   Pagani L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013376
   Palazzo E, 2012, J CELL PHYSIOL, V227, P1017, DOI 10.1002/jcp.22811
   Palotas A, 2002, PROG NEURO-PSYCHOPH, V26, P971, DOI 10.1016/S0278-5846(02)00214-2
   Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202
   Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041
   Penninx BWJH, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-129
   Persson ML, 2009, NEUROSCI LETT, V457, P49, DOI 10.1016/j.neulet.2009.03.095
   PETERSON C, 1986, P NATL ACAD SCI USA, V83, P2758, DOI 10.1073/pnas.83.8.2758
   Przybyla LM, 2013, STEM CELLS, V31, P1097, DOI 10.1002/stem.1360
   RAMCHAND CN, 1994, SCHIZOPHR RES, V13, P249, DOI 10.1016/0920-9964(94)90049-3
   Ramchand CN, 1996, PROSTAG LEUKOTR ESS, V55, P59, DOI 10.1016/S0952-3278(96)90146-5
   RAMCHAND CN, 1995, LIFE SCI, V56, P1639, DOI 10.1016/0024-3205(95)00131-O
   Ranjekar PK, 2003, PSYCHIAT RES, V121, P109, DOI 10.1016/S0165-1781(03)00220-8
   Reyazuddin M, 2014, INDIAN J PSYCHIAT, V56, P344, DOI 10.4103/0019-5545.146516
   Rieske P, 2005, DIFFERENTIATION, V73, P474, DOI 10.1111/j.1432-0436.2005.00050.x
   Rohani L, 2014, AGING CELL, V13, P2, DOI 10.1111/acel.12182
   Saini C, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00095
   Sanacora G, 2013, BIOL PSYCHIAT, V73, P1172, DOI 10.1016/j.biopsych.2013.03.032
   Santarelli S, 2014, EUR NEUROPSYCHOPHARM, V24, P907, DOI 10.1016/j.euroneuro.2014.02.002
   Sarnyai Z, 2011, INT REV NEUROBIOL, V101, P203, DOI 10.1016/B978-0-12-387718-5.00008-0
   Schmidt MJ, 2014, MOL PSYCHIATR, V19, P580, DOI 10.1038/mp.2013.167
   Schmidt MJ, 2012, DEV NEUROSCI-BASEL, V34, P152, DOI 10.1159/000336731
   Schmitt A, 2008, CLINICS, V63, P255, DOI 10.1590/S1807-59322008000200015
   Schmitt A, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00019
   Shahpasand K, 2012, J NEUROSCI, V32, P2430, DOI 10.1523/JNEUROSCI.5927-11.2012
   Shelton RC, 2011, MOL PSYCHIATR, V16, P751, DOI 10.1038/mp.2010.52
   Shelton RC, 1999, INT J NEUROPSYCHOPH, V2, P187, DOI 10.1017/S1461145799001509
   Shelton RC, 1996, AM J PSYCHIAT, V153, P1037
   Shivakumar V, 2014, ASIAN J PSYCHIATR, V10, P3, DOI 10.1016/j.ajp.2014.02.007
   Singh Vimal K, 2015, Front Cell Dev Biol, V3, P2, DOI 10.3389/fcell.2015.00002
   Smith EN, 2009, MOL PSYCHIATR, V14, P755, DOI 10.1038/mp.2009.43
   Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019
   Song MK, 2013, STEM CELLS DEV, V22, P1551, DOI 10.1089/scd.2012.0556
   Sprenger A, 2010, MOL BIOSYST, V6, P1579, DOI 10.1039/c003962d
   Sugden K, 2010, J PSYCHOPHARMACOL, V24, P1253, DOI 10.1177/0269881108099690
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Tang S, 2015, J MED CHEM
   Tatullo M, 2015, INT J IMMUNOPATHOL P
   Tigges J, 2014, MECH AGEING DEV, V138, P26, DOI 10.1016/j.mad.2014.03.004
   Toll A, 2015, WORLD J PSYCHIATR, V5, P154, DOI 10.5498/wjp.v5.i1.154
   Toouli CD, 2002, ONCOGENE, V21, P128, DOI 10.1038/sj.onc.1205014
   Tosic M, 2006, AM J HUM GENET, V79, P586, DOI 10.1086/507566
   Tourjman V, 2013, SCHIZOPHR RES, V151, P43, DOI 10.1016/j.schres.2013.10.011
   van Scheltinga AFT, 2013, NEUROSCIENTIST, V19, P479, DOI 10.1177/1073858412472399
   Vangipuram M, 2013, JOVE-J VIS EXP, DOI 10.3791/3779
   Waldera-Lupa DM, 2014, AGING-US, V6, P856, DOI 10.18632/aging.100698
   Walker E, 2008, ANNU REV CLIN PSYCHO, V4, P189, DOI 10.1146/annurev.clinpsy.4.022007.141248
   Wang L, 2010, J PROTEOME RES, V9, P521, DOI 10.1021/pr900867x
   WASSEF AA, 1992, PROG NEURO-PSYCHOPH, V16, P65, DOI 10.1016/0278-5846(92)90009-4
   Wolkowitz OM, 2010, DEPRESS ANXIETY, V27, P327, DOI 10.1002/da.20686
   Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542
   Yang S, 2009, MOL PSYCHIATR, V14, P143, DOI 10.1038/mp.2008.10
   Yao JK, 2006, DIS MARKERS, V22, P83, DOI 10.1155/2006/248387
   Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323
   Zeng H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011853
   Zhan L, 2011, NEUROPATH APPL NEURO, V37, P206, DOI 10.1111/j.1365-2990.2010.01128.x
NR 208
TC 6
Z9 6
U1 0
U2 18
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0306-4522
EI 1873-7544
J9 NEUROSCIENCE
JI Neuroscience
PD APR 21
PY 2016
VL 320
BP 105
EP 121
DI 10.1016/j.neuroscience.2016.01.067
PG 17
WC Neurosciences
SC Neurosciences & Neurology
GA DG1NJ
UT WOS:000371834500010
PM 26855193
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Krasnov, GS
   Dmitriev, AA
   Melnikova, NV
   Zaretsky, AR
   Nasedkina, TV
   Zasedatelev, AS
   Senchenko, VN
   Kudryavtseva, AV
AF Krasnov, George S.
   Dmitriev, Alexey A.
   Melnikova, Nataliya V.
   Zaretsky, Andrew R.
   Nasedkina, Tatiana V.
   Zasedatelev, Alexander S.
   Senchenko, Vera N.
   Kudryavtseva, Anna V.
TI CrossHub: a tool for multi-way analysis of The Cancer Genome Atlas
   (TCGA) in the context of gene expression regulation mechanisms
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID CELL LUNG-CANCER; MICRORNA TARGET PREDICTION; FACTOR-BINDING SITES;
   TRANSCRIPTION FACTOR; MESSENGER-RNA; PROSTATE-CANCER; WIDE
   IDENTIFICATION; SIGNALING PATHWAY; NOTI-MICROARRAYS; GASTRIC-CANCER
AB The contribution of different mechanisms to the regulation of gene expression varies for different tissues and tumors. Complementation of predicted mRNA-miRNA and gene-transcription factor (TF) relationships with the results of expression correlation analyses derived for specific tumor types outlines the interactions with functional impact in the current biomaterial. We developed CrossHub software, which enables two-way identification of most possible TF-gene interactions: on the basis of ENCODE ChIP-Seq binding evidence or Jaspar prediction and co-expression according to the data of The Cancer Genome Atlas (TCGA) project, the largest cancer omics resource. Similarly, CrossHub identifies mRNA-miRNA pairs with predicted or validated binding sites (TargetScan, mirSVR, PicTar, DI-ANA microT, miRTarBase) and strong negative expression correlations. We observed partial consistency between ChIP-Seq or miRNA target predictions and gene-TF/miRNA co-expression, demonstrating a link between these indicators. Additionally, CrossHub expression-methylation correlation analysis can be used to identify hypermethylated CpG sites or regions with the greatest potential impact on gene expression. Thus, CrossHub is capable of outlining molecular portraits of a specific gene and determining the three most common sources of expression regulation: promoter/enhancer methylation, miRNA interference and TF-mediated activation or repression. CrossHub generates formatted Excel workbooks with the detailed results. CrossHub is freely available at https://sourceforge.net/projects/crosshub/.
C1 [Krasnov, George S.; Dmitriev, Alexey A.; Melnikova, Nataliya V.; Nasedkina, Tatiana V.; Zasedatelev, Alexander S.; Senchenko, Vera N.; Kudryavtseva, Anna V.] Russian Acad Sci, VA Engelhardt Mol Biol Inst, Moscow 119991, Russia.
   [Krasnov, George S.; Nasedkina, Tatiana V.; Zasedatelev, Alexander S.; Kudryavtseva, Anna V.] NN Blokhin Russian Canc Res Ctr, Moscow 115478, Russia.
   [Krasnov, George S.] Russian Acad Med Sci, Orekhovich Inst Biomed Chem, Moscow 119121, Russia.
   [Zaretsky, Andrew R.] Russian Acad Sci, MM Shemyakin Yu Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia.
RP Dmitriev, AA (reprint author), Russian Acad Sci, VA Engelhardt Mol Biol Inst, Moscow 119991, Russia.
EM Alex_245@mail.ru
RI Kudryavtseva, Anna/C-9032-2014; Senchenko, Vera/C-8992-2014; Dmitriev,
   Alexey/D-6109-2011; Melnikova, Nataliya/E-5894-2014
OI Kudryavtseva, Anna/0000-0002-3722-8207; Senchenko,
   Vera/0000-0002-3119-515X; Dmitriev, Alexey/0000-0002-6827-9584;
   Melnikova, Nataliya/0000-0001-8083-3018
FU Russian Science Foundation [14-35-00107, 14-15-01083]
FX Development and testing of the modules related to DE, TF target
   predictions and correlation analysis was supported by the Russian
   Science Foundation grant no. 14-35-00107; Development and testing of
   miRNA target prediction and methylation modules was supported by the
   Russian Science Foundation grant no. 14-15-01083. Funding for open
   access charge: Funds of authors.
CR Beitzinger M, 2007, RNA BIOL, V4, P76, DOI 10.4161/rna.4.2.4640
   Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90
   Bockmuhl Y, 2015, EPIGENETICS-US, V10, P247, DOI 10.1080/15592294.2015.1017199
   Braun R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055037
   Brodie SA, 2015, RESP MED, V109, P131, DOI 10.1016/j.rmed.2014.11.004
   Campa VM, 2014, ONCOTARGET, V5, P8173, DOI 10.18632/oncotarget.2303
   Cao LL, 2014, INT J CLIN EXP PATHO, V7, P5582
   Chen Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098293
   Cho S, 2013, NUCLEIC ACIDS RES, V41, pD252, DOI 10.1093/nar/gks1168
   Claus R, 2012, J CLIN ONCOL, V30, P2483, DOI 10.1200/JCO.2011.39.3090
   Cole C, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-28
   Consortium E. P, 2011, PLOS BIOL, V9, DOI DOI 10.1371/JOURNAL.PBIO.1001046
   Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003
   Dang CV, 2009, CLIN CANCER RES, V15, P6479, DOI 10.1158/1078-0432.CCR-09-0889
   Dellinger AE, 2014, CANCER INFORM, V13, P1, DOI 10.4137/CIN.S13634
   Dmitriev AA, 2012, EPIGENETICS-US, V7, P502, DOI 10.4161/epi.19801
   Dong YJ, 2014, CANCER MANAG RES, V6, P405, DOI 10.2147/CMAR.S35164
   Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247
   Dweep H, 2014, METHODS MOL BIOL, V1182, P289, DOI 10.1007/978-1-4939-1062-5_25
   Dweep H, 2013, CURR GENOMICS, V14, P127, DOI 10.2174/1389202911314020005
   Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002
   Easow G, 2007, RNA, V13, P1198, DOI 10.1261/rna.563707
   Ekimler S, 2014, GENES-BASEL, V5, P671, DOI 10.3390/genes5030671
   Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906
   Everett LJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-337
   Fedorova MS, 2015, MOL BIOL+, V49, P608, DOI [10.1134/S0026893315040044, 10.7868/S0026898415040047]
   Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108
   Gnad F, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S8-S5
   Gore J, 2015, ONCOTARGET, V6, P7504, DOI 10.18632/oncotarget.3233
   Gunaratne PH, 2010, METHODS MOL BIOL, V667, P297, DOI 10.1007/978-1-60761-811-9_20
   Guo Y, 2015, APOPTOSIS, V20, P1109, DOI 10.1007/s10495-015-1138-9
   Guo Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071462
   Hafner M, 2012, METHODS, V58, P94, DOI 10.1016/j.ymeth.2012.08.006
   Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009
   Han SS, 2014, LUNG CANCER, V84, P229, DOI 10.1016/j.lungcan.2014.03.018
   Haoues M, 2014, CELL MICROBIOL, V16, P1378, DOI 10.1111/cmi.12298
   Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043
   Hoeth M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030982
   Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266
   Hu ZH, 2015, BIOCHIMIE, V109, P42, DOI 10.1016/j.biochi.2014.12.001
   Huhn D, 2015, ONCOGENE, V34, P3977, DOI 10.1038/onc.2014.329
   Kim YW, 2013, NEURO-ONCOLOGY, V15, P829, DOI 10.1093/neuonc/not024
   Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412
   Krasnov GS, 2013, EXPERT OPIN THER TAR, V17, P1221, DOI 10.1517/14728222.2013.833607
   Krasnov GS, 2013, EXPERT OPIN THER TAR, V17, P681, DOI 10.1517/14728222.2013.775253
   Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536
   Kudla G, 2011, P NATL ACAD SCI USA, V108, P10010, DOI 10.1073/pnas.1017386108
   Li J, 2015, LAB INVEST, V95, P1056, DOI 10.1038/labinvest.2015.76
   Li P, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0473-z
   Li ZG, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1516-2
   Lin SL, 2009, BIOMETRICS, V65, P9, DOI 10.1111/j.1541-0420.2008.01044.x
   Loginov VI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123369
   Mahdevar G, 2013, GENES GENET SYST, V88, P301, DOI 10.1266/ggs.88.301
   Maiese K, 2015, WORLD J DIABETES, V6, P217, DOI 10.4239/wjd.v6.i2.217
   Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292
   Marco A, 2009, BIOINFORMATICS, V25, P2473, DOI 10.1093/bioinformatics/btp462
   Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997
   Migliardi G, 2012, CLIN CANCER RES, V18, P2515, DOI 10.1158/1078-0432.CCR-11-2683
   Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252
   Nam S, 2008, NUCLEIC ACIDS RES, V36, pD159, DOI 10.1093/nar/gkm829
   Nile CJ, 2008, ARTHRITIS RHEUM, V58, P2686, DOI 10.1002/art.23758
   Pal B, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0585-0
   Peterson SM, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00023
   Qin J, 2011, NUCLEIC ACIDS RES, V39, pW430, DOI 10.1093/nar/gkr332
   Qu Hongzhu, 2013, Genomics Proteomics & Bioinformatics, V11, P135, DOI 10.1016/j.gpb.2013.05.001
   Rao X, 2013, ONCOGENE, V32, P4519, DOI 10.1038/onc.2012.474
   Ricketts CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085621
   Saini V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041401
   Salgado MC, 2014, BBA-GENE REGUL MECH, V1839, P288, DOI 10.1016/j.bbagrm.2014.01.005
   Senchenko VN, 2013, EPIGENETICS-US, V8, P409, DOI 10.4161/epi.24233
   Slezak J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-148
   Smallwood A, 2012, GENOME RES, V22, P1426, DOI 10.1101/gr.124818.111
   Sridharan R, 2013, NAT CELL BIOL, V15, P872, DOI 10.1038/ncb2768
   Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577
   Tomczak Katarzyna, 2015, Contemp Oncol (Pozn), V19, pA68, DOI 10.5114/wo.2014.47136
   Tsang JS, 2010, MOL CELL, V38, P140, DOI 10.1016/j.molcel.2010.03.007
   Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182
   Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403
   Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pD153, DOI 10.1093/nar/gku1215
   Wang ZM, 2015, HUM MUTAT, V36, P684, DOI 10.1002/humu.22799
   Wang ZQ, 2014, MED SCI MONITOR, V20, P1668, DOI 10.12659/MSM.892096
   Wilentzik R, 2015, NUCLEIC ACIDS RES, V43, pE74, DOI 10.1093/nar/gkv203
   Wong HKA, 2015, MOL THER, V23, P1234, DOI 10.1038/mt.2015.72
   Woo S, 2014, PROTEOMICS, V14, P2719, DOI 10.1002/pmic.201400206
   Xu XF, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0218-4
   Yamamizu K, 2013, STEM CELL REP, V1, P545, DOI 10.1016/j.stemcr.2013.10.006
   Zhang B, 2014, NATURE, V513, P382, DOI 10.1038/nature13438
   Zhang X, 2010, PROSTATE, V70, P765, DOI 10.1002/pros.21109
   Zhao Q, 2015, BRIEF BIOINFORM, V16, P291, DOI 10.1093/bib/bbu003
   Zhu YT, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv129
NR 90
TC 14
Z9 15
U1 0
U2 14
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD APR 20
PY 2016
VL 44
IS 7
AR e62
DI 10.1093/nar/gkv1478
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA DL7DM
UT WOS:000375800200002
PM 26773058
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Su, DH
   Jiang, LB
   Chen, X
   Dong, J
   Shao, ZZ
AF Su, Dihan
   Jiang, Libo
   Chen, Xin
   Dong, Jian
   Shao, Zhengzhong
TI Enhancing the Gelation and Bioactivity of Injectable Silk Fibroin
   Hydrogel with Laponite Nanoplatelets
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE reconstitute silk fibroin; clay; hybrid hydrogel; thixotropy; primary
   osteoblasts
ID MESENCHYMAL STEM-CELLS; TISSUE REGENERATION; BIOMATERIALS; CLAY;
   DIFFERENTIATION; SPECTROSCOPY; SCAFFOLD; PROTEIN; FTIR; MECHANISMS
AB Regenerated silk fibroin (RSF) of Bombyx mori silk fiber is a promising natural material for bone defect repair. However, a lack of specific integrin and growth factor for osteoinduction significantly hinders its application in this area. In this study, the role of Laponite nanoplatelet (LAP), a bioactive clay that can promote osteoblast growth, in the formation of RSF hydrogel, as well as the various properties of RSF/LAP hybrid hydrogel, was closely investigated. The results indicate that LAP could serve as a medium to accelerate hydrophobic interaction among the RSF molecules and a disruptor to limit the growth of beta-sheet domain during the gelation of RSF. Rheological measurement suggests that the RSF/LAP hydrogel is injectable as it displays thixotropy in the room temperature. Proliferation and differentiation results of the primary osteoblasts encapsulated in hydrogel show that RSF/LAP hydrogel can promote the cell proliferation and enhance the osteogenic differentiation. The transcript levels for alkaline phosphatase, osteocalcin, osteopontin, and collagen type I osteogenic markers obviously improve with RSF/LAP hydrogel compared to the controls at 14 days, especially with the higher contents of LAP. Overall, the results suggest that the RSF/LAP hydrogel have great potential to be utilized as an injectable biomaterial for irregular bone defect repair.
C1 [Su, Dihan; Chen, Xin; Shao, Zhengzhong] Fudan Univ, State Key Lab Mol Engn Polymers, Dept Macromol Sci, Shanghai 200433, Peoples R China.
   [Su, Dihan; Chen, Xin; Shao, Zhengzhong] Fudan Univ, Adv Mat Lab, Shanghai 200433, Peoples R China.
   [Jiang, Libo; Dong, Jian] Fudan Univ, Dept Orthopaed Surg, Zhongshan Hosp, State Key Lab Mol Engn Polymers, Shanghai 200032, Peoples R China.
RP Shao, ZZ (reprint author), Fudan Univ, State Key Lab Mol Engn Polymers, Dept Macromol Sci, Shanghai 200433, Peoples R China.; Shao, ZZ (reprint author), Fudan Univ, Adv Mat Lab, Shanghai 200433, Peoples R China.; Dong, J (reprint author), Fudan Univ, Dept Orthopaed Surg, Zhongshan Hosp, State Key Lab Mol Engn Polymers, Shanghai 200032, Peoples R China.
EM dong.jian@zs-hospital.sh.cn; zzshao@fudan.edu.cn
RI Chen, Xin/F-6802-2015
OI Chen, Xin/0000-0001-7706-4166
FU National Natural Science Foundation of China [21574024, 21274028,
   21574023, 81572629, 81372002]; National High Technology Research and
   Development Program of China (863 program) [2015AA033703]
FX This work was supported by the National Natural Science Foundation of
   China (No. 21574024, 21274028, 21574023, 81572629 and 81372002) and
   National High Technology Research and Development Program of China (863
   program) (2015AA033703). We thank Dr. Yuhong Yang and Dr. Jingrong Yao
   at Fudan University for their valuable suggestions and discussion and
   Ms. Yiming Zhong (Curtin University, Australia) for critical reading and
   editing the English.
CR Balnois E, 2003, LANGMUIR, V19, P6633, DOI 10.1021/la0340908
   Bhattacharjee P, 2015, BIOPOLYMERS, V103, P271, DOI 10.1002/bip.22594
   Bombonato-Prado KF, 2009, J BIOMED MATER RES A, V88A, P401, DOI 10.1002/jbm.a.31701
   Braux J, 2011, ACTA BIOMATER, V7, P2593, DOI 10.1016/j.actbio.2011.02.013
   Chen X, 2001, POLYMER, V42, P9969, DOI 10.1016/S0032-3861(01)00541-9
   Chen X, 2007, PROTEINS, V68, P223, DOI 10.1002/prot.21414
   Cheng C, 2008, ADV FUNCT MATER, V18, P2172, DOI 10.1002/adfm.200701130
   Chimene D, 2015, ADV MATER, V27, P7261, DOI 10.1002/adma.201502422
   Dang QQ, 2010, BIOMACROMOLECULES, V11, P1796, DOI 10.1021/bm1002398
   Dawson JI, 2013, ADV MATER, V25, P4069, DOI 10.1002/adma.201301034
   Gaharwar AK, 2013, ADV MATER, V25, P3329, DOI 10.1002/adma.201300584
   Gaharwar AK, 2011, ACTA BIOMATER, V7, P568, DOI 10.1016/j.actbio.2010.09.015
   Gaharwar AK, 2010, ADV FUNCT MATER, V20, P429, DOI 10.1002/adfm.200901606
   Guerette PA, 2014, ACS NANO, V8, P7170, DOI 10.1021/nn502149u
   Guo P, 2014, ORTHOP SURG, V6, P280, DOI 10.1111/os.12135
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Kim JH, 2014, INT J BIOL MACROMOL, V68, P158, DOI 10.1016/j.ijbiomac.2014.04.045
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Kodama N, 2009, BONE, V44, P699, DOI 10.1016/j.bone.2008.12.017
   Li GY, 2001, EUR J BIOCHEM, V268, P6600, DOI 10.1046/j.0014-2956.2001.02614.x
   Li JJ, 2015, J MATER CHEM B, V3, P5361, DOI 10.1039/c5tb00353a
   Liff SM, 2007, NAT MATER, V6, P76, DOI 10.1038/nmat1798
   Ling SJ, 2011, BIOMACROMOLECULES, V12, P3344, DOI 10.1021/bm2006032
   Liu YX, 2014, BIOMATER SCI-UK, V2, P1338, DOI 10.1039/c4bm00214h
   MANDAIR APS, 1990, POLYHEDRON, V9, P517, DOI 10.1016/S0277-5387(00)86228-2
   Martel A, 2008, J AM CHEM SOC, V130, P17070, DOI 10.1021/ja806654t
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   Mieszawska AJ, 2011, ACTA BIOMATER, V7, P3036, DOI 10.1016/j.actbio.2011.04.016
   Mieszawska AJ, 2010, BIOMATERIALS, V31, P8902, DOI 10.1016/j.biomaterials.2010.07.109
   Monti P, 2005, J MOL STRUCT, V744, P685, DOI 10.1016/j.molstruc.2004.10.083
   Negrete, 2004, LANGMUIR, V20, P1564
   Paulusse JMJ, 2006, J POLYM SCI POL CHEM, V44, P5445, DOI 10.1002/pola.21646
   Shalumon KT, 2015, ACS APPL MATER INTER, V7, P21170, DOI 10.1021/acsami.5b04962
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Taddei P, 2005, BIOPOLYMERS, V78, P249, DOI 10.1002/bip.20275
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang CM, 2010, ADV DRUG DELIVER REV, V62, P699, DOI 10.1016/j.addr.2010.02.001
   WANG FC, 1994, J POLYM SCI POL PHYS, V32, P1305, DOI 10.1002/polb.1994.090320801
   Wang Q, 2010, NATURE, V463, P339, DOI 10.1038/nature08693
   Wang XQ, 2008, BIOMATERIALS, V29, P1054, DOI 10.1016/j.biomaterials.2007.11.003
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wray LS, 2011, J BIOMED MATER RES B, V99B, P89, DOI 10.1002/jbm.b.31875
   Yang Y., 2006, ACTA CHIM SINICA, V16, P1730
   Yang YH, 2004, BIOMACROMOLECULES, V5, P773, DOI 10.1021/bm0343848
   Zhu HL, 2012, MAT SCI ENG C-MATER, V32, P822, DOI 10.1016/j.msec.2012.01.033
   Zhu ZH, 2009, MATER CHEM PHYS, V117, P430, DOI 10.1016/j.matchemphys.2009.06.028
   Zreiqat H, 2002, J BIOMED MATER RES, V62, P175, DOI 10.1002/jbm.10270
NR 48
TC 20
Z9 21
U1 13
U2 157
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD APR 20
PY 2016
VL 8
IS 15
BP 9619
EP 9628
DI 10.1021/acsami.6b00891
PG 10
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA DK3JD
UT WOS:000374812000011
PM 26989907
DA 2018-10-20
ER

PT J
AU Zeng, RC
   Cui, LY
   Jiang, K
   Liu, R
   Zhao, BD
   Zheng, YF
AF Zeng, Rong-Chang
   Cui, Lan-yue
   Jiang, Ke
   Liu, Rui
   Zhao, Bao-Dong
   Zheng, Yu-Feng
TI In Vitro Corrosion and Cytocompatibility of a Microarc Oxidation Coating
   and Poly(L-lactic acid) Composite Coating on Mg-1Li-1Ca Alloy for
   Orthopedic Implants
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE magnesium alloy; degradation; microarc oxidation; poly(L-lactic acid);
   biomaterial
ID PLASMA ELECTROLYTIC OXIDATION; MAGNESIUM ALLOYS; HYDROLYTIC DEGRADATION;
   POLY(LACTIC ACID); COATED MAGNESIUM; TISSUE-RESPONSE; MG ALLOY; FILM;
   RESISTANCE; BEHAVIOR
AB Manipulating the degradation rate of biomedical magnesium alloys poses a challenge. The characteristics of a microarc oxidation (MAO), prepared in phytic acid, and poly(L-lactic acid) (PLLA) composite coating, fabricated on a novel Mg-1Li-1Ca alloy, were studied through field emission scanning electron microscopy (FE-SEM), electron probe X-ray microanalysis (EPMA), energy dispersive X-ray spectroscopy (EDS) and X-ray diffraction (XRD). The corrosion behaviors of the samples were evaluated via hydrogen evolution, potentiodynamic polarization and electrochemical impedance spectroscopy in Hanks' solution. The results indicated that the MAO/PLLA composite coatings significantly enhanced the corrosion resistance of the Mg-1Li-1Ca alloy. MTT and ALP assays using MC3T3 osteoblasts indicated that the MAO/PLLA coatings greatly improved the cytocompatibility, and the morphology of the cells cultured on different samples exhibited good adhesion. Hemolysis tests showed that the composite coatings endowed the Mg-1Li-1Ca alloys with a low hemolysis ratio. The increased solution pH resulting from the corrosion of magnesium could be tailored by the degradation of PLLA. The degradation mechanism of the composite coatings was discussed. The MAO/PLLA composite coating may be appropriate for applications on degradable Mg-based orthopedic implants.
C1 [Zeng, Rong-Chang; Cui, Lan-yue; Jiang, Ke] Shandong Univ Sci & Technol, Coll Mat Sci & Engn, Qingdao 266590, Peoples R China.
   [Zeng, Rong-Chang; Cui, Lan-yue; Jiang, Ke] Shandong Univ Sci & Technol, State Key Lab Min Disaster Prevent & Control Shan, Qingdao 266590, Peoples R China.
   [Zeng, Rong-Chang; Cui, Lan-yue; Jiang, Ke] Shandong Univ Sci & Technol, Minist Sci & Technol, Qingdao 266590, Peoples R China.
   [Liu, Rui; Zhao, Bao-Dong] Qingdao Univ, Affiliated Hosp, Qingdao 266590, Peoples R China.
   [Zheng, Yu-Feng] Peking Univ, State Key Lab Turbulence & Complex Syst, Beijing 100871, Peoples R China.
   [Zheng, Yu-Feng] Peking Univ, Dept Mat Sci & Engn, Coll Engn, Beijing 100871, Peoples R China.
RP Zeng, RC (reprint author), Shandong Univ Sci & Technol, Coll Mat Sci & Engn, Qingdao 266590, Peoples R China.; Zeng, RC (reprint author), Shandong Univ Sci & Technol, State Key Lab Min Disaster Prevent & Control Shan, Qingdao 266590, Peoples R China.; Zeng, RC (reprint author), Shandong Univ Sci & Technol, Minist Sci & Technol, Qingdao 266590, Peoples R China.; Zhao, BD (reprint author), Qingdao Univ, Affiliated Hosp, Qingdao 266590, Peoples R China.
EM rczeng@foxmail.com; zbd315@sina.com
RI Zheng, Yufeng/A-4146-2010; Zeng, Rong-Chang/H-4154-2011
OI Zheng, Yufeng/0000-0002-7402-9979; Zeng, Rong-Chang/0000-0002-5945-3851
FU National Natural Science Foundation of China [51571134]; SDUST (Shandong
   University of Science and Technology) Research Fund [2014TDJH104]; Joint
   Innovative Centre for Safe and Effective Mining Technology and Equipment
   of Coal Resources, Shandong Province
FX This work was supported by the National Natural Science Foundation of
   China (51571134), SDUST (Shandong University of Science and Technology)
   Research Fund (2014TDJH104), Joint Innovative Centre for Safe and
   Effective Mining Technology and Equipment of Coal Resources, Shandong
   Province.
CR Abdal-hay A, 2013, COLLOID SURFACE A, V420, P37, DOI 10.1016/j.colsurfa.2012.12.009
   Abdal-hay A, 2013, CERAM INT, V39, P183, DOI 10.1016/j.ceramint.2012.06.008
   Anderson JM, 1997, ADV DRUG DELIVER REV, V28, P5, DOI 10.1016/S0169-409X(97)00048-3
   Badar M, 2013, ACTA BIOMATER, V9, P7580, DOI 10.1016/j.actbio.2013.03.012
   Baino F, 2011, ACTA BIOMATER, V7, P3248, DOI 10.1016/j.actbio.2011.05.016
   BERGSMA JE, 1995, BIOMATERIALS, V16, P25, DOI 10.1016/0142-9612(95)91092-D
   BURKERSRODA F, 2002, BIOMATERIALS, V23, P4221, DOI DOI 10.1016/S0142-9612(02)00170-9
   Chen Y, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/2/025005
   de Jong SJ, 2001, POLYMER, V42, P2795, DOI 10.1016/S0032-3861(00)00646-7
   Ding YF, 2014, J MATER CHEM B, V2, P1912, DOI 10.1039/c3tb21746a
   Fischerauer S.F., 2012, ACTA BIOMATER, V9, P5411
   Gao JC, 2006, T NONFERR METAL SOC, V16, P539, DOI 10.1016/S1003-6326(06)60094-0
   Gao Y, 2013, SURF COAT TECH, V234, P132, DOI 10.1016/j.surfcoat.2012.11.035
   Garlotta D, 2001, J POLYM ENVIRON, V9, P63, DOI 10.1023/A:1020200822435
   Gu XN, 2011, ACTA BIOMATER, V7, P1880, DOI 10.1016/j.actbio.2010.11.034
   Gu XN, 2014, FRONT MATER SCI, V8, P200, DOI 10.1007/s11706-014-0253-9
   Gu XN, 2010, BIOMATERIALS, V31, P1093, DOI 10.1016/j.biomaterials.2009.11.015
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Guo MQ, 2011, J MATER SCI-MATER M, V22, P1735, DOI 10.1007/s10856-011-4354-z
   Han XG, 2013, SURF COAT TECH, V228, pS164, DOI 10.1016/j.surfcoat.2012.06.053
   Ivanou DK, 2013, CORROS SCI, V73, P300, DOI 10.1016/j.corsci.2013.04.019
   Liang J, 2014, FRONT MATER SCI, V8, P307, DOI 10.1007/s11706-014-0250-z
   Liu GY, 2011, APPL SURF SCI, V257, P2051, DOI 10.1016/j.apsusc.2010.09.050
   Liu X, 2013, ACTA BIOMATER, V9, P8671, DOI 10.1016/j.actbio.2012.12.025
   Lu L, 1999, J BIOMED MATER RES, V46, P236, DOI 10.1002/(SICI)1097-4636(199908)46:2<236::AID-JBM13>3.0.CO;2-F
   Lu P, 2011, J BIOMED MATER RES B, V96B, P101, DOI 10.1002/jbm.b.31744
   Narayanan TSNS, 2014, PROG MATER SCI, V60, P1, DOI 10.1016/j.pmatsci.2013.08.002
   Nemcova A, 2013, SURF COAT TECH, V232, P827, DOI 10.1016/j.surfcoat.2013.06.107
   Piemonte V, 2013, J POLYM ENVIRON, V21, P313, DOI 10.1007/s10924-012-0547-x
   Shu Y, 2011, J NANOMATER, DOI 10.1155/2011/423686
   Song GL, 1999, ADV ENG MATER, V1, P11, DOI 10.1002/(SICI)1527-2648(199909)1:1<11::AID-ADEM11>3.0.CO;2-N
   Song YW, 2012, CORROS SCI, V65, P322, DOI 10.1016/j.corsci.2012.08.037
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Takagishi Y, 2006, TISSUE ENG, V12, P927, DOI 10.1089/ten.2006.12.927
   Tokiwa Y, 2006, APPL MICROBIOL BIOT, V72, P244, DOI 10.1007/s00253-006-0488-1
   Tomihata K, 2001, J BIOMED MATER RES, V58, P511, DOI 10.1002/jbm.1048
   van der Elst M, 1999, BIOMATERIALS, V20, P121, DOI 10.1016/S0142-9612(98)00117-3
   van Nostrum CF, 2004, POLYMER, V45, P6779, DOI 10.1016/j.polymer.2004.08.001
   Vogt C, 2010, P 8 INT C MAGN ALL T, P1162
   Wei ZL, 2015, J BIOMED MATER RES B, V103, P342, DOI 10.1002/jbm.b.33208
   Witte F, 2007, J BIOMED MATER RES A, V81A, P748, DOI 10.1002/jbm.a.31170
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Witte F, 2007, BIOMATERIALS, V28, P2163, DOI 10.1016/j.biomaterials.2006.12.027
   Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028
   Witte F, 2008, CURR OPIN SOLID ST M, V12, P63, DOI 10.1016/j.cossms.2009.04.001
   Wong HM, 2010, BIOMATERIALS, V31, P2084, DOI 10.1016/j.biomaterials.2009.11.111
   Xu LP, 2012, APPL SURF SCI, V258, P6353, DOI 10.1016/j.apsusc.2012.03.036
   Xu LP, 2012, COLLOID SURFACE B, V93, P67, DOI 10.1016/j.colsurfb.2011.12.009
   Yuan XY, 2001, J APPL POLYM SCI, V81, P251, DOI 10.1002/app.1436
   Zeng RC, 2006, T NONFERR METAL SOC, V16, pS763, DOI 10.1016/S1003-6326(06)60297-5
   Zeng RC, 2015, ACTA METALL SIN-ENGL, V28, P373, DOI 10.1007/s40195-015-0208-x
   Zeng RC, 2014, FRONT MATER SCI, V8, P343, DOI 10.1007/s11706-014-0264-6
   Zeng RC, 2014, CORROS SCI, V88, P452, DOI 10.1016/j.corsci.2014.08.007
   Zeng RC, 2014, FRONT MATER SCI, V8, P230, DOI 10.1007/s11706-014-0256-6
   Zeng RC, 2014, J MATER CHEM A, V2, P13049, DOI 10.1039/c4ta01341g
   Zeng RC, 2014, CORROS SCI, V79, P69, DOI 10.1016/j.corsci.2013.10.028
   Zeng RC, 2008, ADV ENG MATER, V10, pB3, DOI 10.1002/adem.200800035
   Zeng RC, 2013, ACTA METALL SIN-ENGL, V26, P681, DOI 10.1007/S40195-013-0397-0
   Zeng RC, 2011, ACTA METALL SIN, V47, P1477, DOI 10.3724/SP.J.1037.2011.00325
   Zeng RC, 2011, SURF COAT TECH, V205, P3347, DOI 10.1016/j.surfcoat.2010.11.027
   Zhang F, 2014, SURF COAT TECH, V258, P1152, DOI 10.1016/j.surfcoat.2014.07.017
   Zhang J, 2013, COLLOID SURFACE B, V111, P179, DOI 10.1016/j.colsurfb.2013.05.040
   Zhang RF, 2010, CURR APPL PHYS, V10, P255, DOI 10.1016/j.cap.2009.06.008
   Zhang RF, 2009, APPL SURF SCI, V255, P7893, DOI 10.1016/j.apsusc.2009.04.145
   Zheng YF, 2014, MAT SCI ENG R, V77, P1, DOI 10.1016/j.mser.2014.01.001
   Zhou H, 2012, ACTA BIOMATER, V8, P1999, DOI 10.1016/j.actbio.2012.01.031
NR 66
TC 51
Z9 52
U1 14
U2 84
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD APR 20
PY 2016
VL 8
IS 15
BP 10014
EP 10028
DI 10.1021/acsami.6b00527
PG 15
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA DK3JD
UT WOS:000374812000055
PM 27022831
DA 2018-10-20
ER

PT J
AU Deen, GR
   Mah, CH
AF Deen, G. Roshan
   Mah, Chin Hao
TI Influence of external stimuli on the network properties of cationic
   poly(N-acryloyl-N '-propyl piperazine) hydrogels
SO POLYMER
LA English
DT Article
DE Poly(amido-amine)s; Stimuli-responsive hydrogels; Dynamic swelling;
   State of water
ID N'-ETHYL PIPERAZINE; SWELLING BEHAVIOR; ACID) HYDROGELS; 2-HYDROXYETHYL
   METHACRYLATE; RESPONSIVE POLYMERS; DRUG-RELEASE; POLYVINYL-ALCOHOL)
   HYDROGELS; BIOMEDICAL APPLICATIONS; COPOLYMER HYDROGELS; SENSITIVE
   HYDROGELS
AB Stimuli-responsive cationic hydrogels based on N-acryloyl-N'-propyl piperazine (AcrNPP) crosslinked with N,N'-methylenebisacrylamide (Mba) and 1,4-butanedioldiacrylate (Bda) were prepared by UV lightinitiated free-radical polymerization in bulk. The effect of external stimuli and type of crosslinker on the equilibrium swelling behavior and dynamic swelling was investigated in detail in buffer solution of various pH and temperatures. The equilibrium swelling capacity of the gels was large in swelling medium at pH 3.0 than at pH 10.0 due to ionization of polymer network under acidic conditions. With increase in temperature from 25 degrees C to 45 degrees C, the gels exhibited negative temperature-responsive (thermo-shrinking/ thermophobic) behavior with negative activation energy for diffusion of water. The thermodynamic parameters such as Gibbs' free energy (Delta G), enthalpy (Delta H), and entropy (Delta S) for the swelling of gels as function of temperature were negative indicating an exothermic swelling process. Water (media) transport mechanism and diffusion process in thin rectangular gels was studied. At pH 3.0, the diffusion process was non-Fickian (anomalous) while at pH 10.0 it was quasi-Fickian. The transport mechanism was partly influenced by the type of crosslinker in the gel. The dynamic swelling data was analyzed using early-time, late-time and Etters diffusion models. From the equilibrium swelling studies the average molecular weight between crosslinks (M-c), the crosslink density (rho(c)), and the mesh size (xi) were determined. The Mc was large at pH 3.0 due to ionization of polymer and chain expansion. The experimental Mc was much larger than the theoretical Mc which implied that the gels were loosely crosslinked real networks. The mesh size of gels were between 447 and 786 angstrom in the swollen (ionized) state (pH 3.0), and between 100 and 231 angstrom in the collapsed (non-ionized) state (pH 10.0). The mesh size increased between three to four times during the pH-dependent swelling transition. The state of water in fully swollen hydrogels which influences many important biomaterial properties was determined by differential scanning calorimetry. The bound water content of gels increased linearly with increase in pH of the swelling medium while the unbound water decreased. These hydrogels have potential to be used as controlled drug delivery systems and sorbents for removal of pollutants from water. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Deen, G. Roshan; Mah, Chin Hao] Nanyang Technol Univ, Natl Inst Educ, Soft Mat Lab, Nat Sci & Sci Educ, 1 Nanyang Walk, Singapore 637616, Singapore.
RP Deen, GR (reprint author), Nanyang Technol Univ, Natl Inst Educ, Soft Mat Lab, Nat Sci & Sci Educ, 1 Nanyang Walk, Singapore 637616, Singapore.
EM Roshan.gulam@nie.edu.sg
RI GR, Roshan Deen/I-2625-2017
OI GR, Roshan Deen/0000-0001-8329-0880
FU Nanyang Technological University (NTU), National Institute of Education
   (NIE) [NIEAcRF RI6/12GRD]
FX GRD and MCH thank the Nanyang Technological University (NTU), National
   Institute of Education (NIE) for financial support under research grant
   NIEAcRF RI6/12GRD, and for the NTU higher degree research scholarship,
   respectively. Bo Ouyang is thanked for his help with the SEM.
CR Alarcon CDH, 2005, CHEM SOC REV, V34, P276, DOI 10.1039/b406727d
   Awasthi S, 2012, J APPL POLYM SCI, V124, P2348, DOI 10.1002/app.35288
   Bajpai SK, 2006, REACT FUNCT POLYM, V66, P431, DOI 10.1016/j.reactfunctpolym.2005.09.003
   Bangbose J.T., 2012, J CHEM CHEM ENG, V6, P272
   BRAZEL CS, 1995, MACROMOLECULES, V28, P8016, DOI 10.1021/ma00128a007
   Bueno VB, 2013, CARBOHYD POLYM, V92, P1091, DOI 10.1016/j.carbpol.2012.10.062
   Bulmus V, 2000, BIOCONJUGATE CHEM, V11, P78, DOI 10.1021/bc9901043
   Burmistrova A, 2011, POLYMERS-BASEL, V3, P1575, DOI 10.3390/polym3041575
   Cakal E, 2010, IND ENG CHEM RES, V49, P11741, DOI 10.1021/ie1007097
   Chang CH, 2010, BIOMACROMOLECULES, V11, P133, DOI 10.1021/bm900985h
   CHEN CM, 1992, ANGEW MAKROMOL CHEM, V196, P49, DOI 10.1002/apmc.1992.051960104
   Chen KS, 2005, MATER CHEM PHYS, V91, P484, DOI 10.1016/j.matchemphys.2004.12.037
   Crank J., 1975, MATH DIFFUSION
   Deen GR, 2008, J APPL POLYM SCI, V107, P1449, DOI 10.1002/app.27126
   Deen GR, 2006, POLYMER, V47, P5025, DOI 10.1016/j.polymer.2006.05.003
   Deen GR, 2012, IND ENG CHEM RES, V51, P13354, DOI 10.1021/ie301987m
   Deen GR, 2012, J POLYM SCI POL CHEM, V50, P3363, DOI 10.1002/pola.26124
   Deen GR, 2011, POLYM BULL, V66, P301, DOI 10.1007/s00289-010-0277-y
   Desai PN, 2010, BIOMACROMOLECULES, V11, P666, DOI 10.1021/bm901240g
   Ende M., 1995, REACT POLYM, V25, P127
   Etters J. N., 1980, TEXT CHEM COLOR, V12, P140
   Ferruti P, 2000, MACROMOLECULES, V33, P7793, DOI 10.1021/ma000378h
   Ferruti P, 2006, J POLYM SCI POL CHEM, V44, P2316, DOI 10.1002/pola.21349
   Ferruti P, 2002, MACROMOL RAPID COMM, V23, P332, DOI 10.1002/1521-3927(20020401)23:5/6<332::AID-MARC332>3.0.CO;2-I
   Ferruti P, 1998, MACROMOL CHEM PHYSIC, V199, P2565, DOI 10.1002/(SICI)1521-3935(19981101)199:11<2565::AID-MACP2565>3.0.CO;2-G
   FIRESTONE BA, 1988, POLYM COMMUN, V29, P204
   FLORY PJ, 1953, PRINCIPLES POLYM CHE
   FRANK S, 1993, NATURE, V363, P334, DOI 10.1038/363334a0
   FRANSON NM, 1983, J APPL POLYM SCI, V28, P1299, DOI 10.1002/app.1983.070280404
   Galaev IY, 1999, TRENDS BIOTECHNOL, V17, P335, DOI 10.1016/S0167-7799(99)01345-1
   Galperin A, 2013, J BIOMED MATER RES A, V101, P775, DOI 10.1002/jbm.a.34380
   Gan LH, 2000, MACROMOLECULES, V33, P7893, DOI 10.1021/ma000928b
   Garg G, 2012, J APPL POLYM SCI, V124, P3721, DOI 10.1002/app.35369
   Geever LM, 2006, EUR POLYM J, V42, P69, DOI 10.1016/j.eurpolymj.2005.09.027
   Goda T, 2006, POLYMER, V47, P1390, DOI 10.1016/j.polymer.2005.12.043
   Gonzalez N, 2005, MACROMOLECULES, V38, P9298, DOI 10.1021/ma050939a
   GUDEMAN LF, 1995, J APPL POLYM SCI, V55, P919, DOI 10.1002/app.1995.070550610
   Gurdag G., 1010, IND ENG CHEM RES, V49, P12675
   Hill DJT, 2000, POLYMER, V41, P1287, DOI 10.1016/S0032-3861(99)00279-7
   Hoffman A. S., 2002, ADV DRUG DELIVERY RE, V43, P3, DOI DOI 10.1016/S0169-409X(01)00239-3
   Hoffman A.S., 1990, J CONTROL RELEASE, V13, P153
   Hoffmann J, 1999, SENSOR ACTUAT A-PHYS, V77, P139, DOI 10.1016/S0924-4247(99)00080-1
   Ikeda-Fukazawa T, 2013, J POLYM SCI POL PHYS, V51, P1017, DOI 10.1002/polb.23305
   Kakinoki S, 2003, RADIAT PHYS CHEM, V67, P685, DOI 10.1016/S0969-806X(02)00401-2
   Karadag E, 2002, TURK J CHEM, V26, P863
   Karadag E, 1997, TURK J CHEM, V21, P151
   Kim W., 2002, J BIOMAT SCI-POLYM E, V13, P1271
   Kong SD, 2013, ACTA BIOMATER, V9, P5447, DOI 10.1016/j.actbio.2012.11.006
   Kurata K, 2004, J MACROMOL SCI PURE, VA41, P143, DOI 10.1081/MA-120027300
   LI Y, 1990, J CHEM PHYS, V92, P1365, DOI 10.1063/1.458148
   Maeda T, 2006, BIOMACROMOLECULES, V7, P545, DOI 10.1021/bm050829b
   Mansor B.A., 1994, POLYM INT, V33, P2732
   Mao ZW, 2007, BIOMATERIALS, V28, P4488, DOI 10.1016/j.biomaterials.2007.06.033
   Mathur AM, 1996, J MACROMOL SCI R M C, VC36, P405
   MATSUO ES, 1992, NATURE, V358, P482, DOI 10.1038/358482a0
   MAZICH KA, 1992, MACROMOLECULES, V25, P6929, DOI 10.1021/ma00051a032
   Mullarney MP, 2006, POLYMER, V47, P3845, DOI 10.1016/j.polymer.2006.03.096
   Okay O, 1999, POLYMER, V40, P4117, DOI 10.1016/S0032-3861(98)00640-5
   Peniche C, 1997, POLYMER, V38, P5977, DOI 10.1016/S0032-3861(96)01058-0
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   PEPPAS NA, 1977, J APPL POLYM SCI, V21, P1763, DOI 10.1002/app.1977.070210704
   PEPPAS NA, 1976, J POLYM SCI POL CHEM, V14, P441, DOI 10.1002/pol.1976.170140215
   Plunkett KN, 2004, LANGMUIR, V20, P6535, DOI 10.1021/la049453y
   Quintana JR, 1999, LANGMUIR, V15, P4728, DOI 10.1021/la980982+
   Richardson SCW, 2001, BIOMACROMOLECULES, V2, P1023, DOI 10.1021/bm010079f
   RITGER P L, 1987, Journal of Controlled Release, V5, P37, DOI 10.1016/0168-3659(87)90035-6
   RITGER P L, 1987, Journal of Controlled Release, V5, P23, DOI 10.1016/0168-3659(87)90034-4
   Roshan Deen G., 2015, ENCY BIOMEDICAL POLY, V2
   RUSCONI L, 1982, POLYMER, V23, P1233, DOI 10.1016/0032-3861(82)90385-8
   Schexnailder P, 2009, COLLOID POLYM SCI, V287, P1, DOI 10.1007/s00396-008-1949-0
   SCHILD HG, 1992, PROG POLYM SCI, V17, P163, DOI 10.1016/0079-6700(92)90023-R
   Shiaw G., 1994, POLYMER, V35, P4416
   Sperling L. H., 1981, INTERPENETRATING POL
   Suzuki A, 2001, J CHEM PHYS, V114, P5012, DOI 10.1063/1.1350576
   Takafuji M, 2004, CHEM MATER, V16, P1977, DOI 10.1021/cm030334y
   TANAKA T, 1981, SCI AM, V244, P124, DOI 10.1038/scientificamerican0181-124
   Thakur A, 2011, CHEM BIOCHEM ENG Q, V25, P181
   Unnikrishnan G, 1997, J POLYM SCI POL PHYS, V35, P725, DOI 10.1002/(SICI)1099-0488(19970415)35:5<725::AID-POLB1>3.0.CO;2-L
   Varghese S, 2001, J PHYS CHEM B, V105, P5368, DOI 10.1021/jp002310+
   Velasco D, 2008, J MATER SCI-MATER M, V19, P1453, DOI 10.1007/s10856-007-3315-z
   Verestiuc L, 2004, INT J PHARM, V269, P185, DOI 10.1016/j.ijpharm.2003.09.031
   Wang B, 2008, COLLOID SURFACE B, V64, P34, DOI 10.1016/j.colsurfb.2008.01.001
   Wilson AN, 2014, POLYMERS-BASEL, V6, P2451, DOI 10.3390/polym6092451
   Xu ZH, 1997, APPL SURF SCI, V120, P269, DOI 10.1016/S0169-4332(97)00234-1
   Yan X., 2014, CARB POLYM, V114, P530
   YAO KJ, 1994, J APPL POLYM SCI, V53, P1533, DOI 10.1002/app.1994.070531115
   YOSHIDA H, 1990, POLYMER, V31, P693, DOI 10.1016/0032-3861(90)90291-6
   YOSHIDA R, 1992, IND ENG CHEM RES, V31, P2339, DOI 10.1021/ie00010a013
   Zhang QM, 2002, NATURE, V419, P284, DOI 10.1038/nature01021
   Zhang XZ, 2004, BIOMATERIALS, V25, P3793, DOI 10.1016/j.biomaterials.2003.10.065
   Zhao YB, 2006, J APPL POLYM SCI, V102, P3857, DOI 10.1002/app.24877
NR 91
TC 5
Z9 5
U1 3
U2 32
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
EI 1873-2291
J9 POLYMER
JI Polymer
PD APR 20
PY 2016
VL 89
BP 55
EP 68
DI 10.1016/j.polymer.2016.02.027
PG 14
WC Polymer Science
SC Polymer Science
GA DH0SD
UT WOS:000372493500007
DA 2018-10-20
ER

PT J
AU Yan, W
   Chen, C
   Wang, L
   Zhang, D
   Li, AJ
   Yao, Z
   Shi, LY
AF Yan, Wei
   Chen, Chang
   Wang, Ling
   Zhang, Dan
   Li, Ai-Jun
   Yao, Zheng
   Shi, Li-Yi
TI Facile and green synthesis of cellulose nanocrystal-supported gold
   nanoparticles with superior catalytic activity
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE One-pot; Green synthesis; Cellulose nanocrystals; Polyethylene glycol;
   Gold nanoparticles; 4-Nitrophenol
ID ACID-HYDROLYSIS; SURFACE; NANOCOMPOSITES; PERFORMANCE; REDUCTION;
   OXIDATION; PLATINUM; SILVER; OXIDE
AB The emphasis of science and technology shifts toward environmentally friendly and sustainable resources and processes. Herein, we report a facile, one-pot and green synthesis of biomaterial-supported gold nanoparticles (AuNPs) with superior catalytic activity. Cellulose nanocrystal (CNC)-supported AuNPs were prepared by heating the aqueous mixture of HAuC14, CNCs and polyethylene glycol, avoiding toxic chemicals, extreme condition and complicated procedure. The resultant CNC-supported AuNPs exhibited catalytic activities for the reduction of 4-nitrophenol by sodium borohydride. The maximum apparent rate constant reached 1.47 x 10(-2) s(-1), and the turnover frequency reached 641 h(-1). The superior catalytic performance can be ascribed to the large amount of highly dispersed AuNPs with few nanometers in size which are loaded on CNCs. About 90% of the AuNPs are smaller than 10 nm, and nearly 60% of the AuNPs are smaller than 5 nm. The synthesis is eco-friendly, facile and low-cost, thus has great potential for industrial and medical applications. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Yan, Wei; Chen, Chang; Wang, Ling; Yao, Zheng; Shi, Li-Yi] Shanghai Univ, Nano Sci & Technol Res Ctr, Shanghai 200444, Peoples R China.
   [Zhang, Dan] Shanghai Univ, Shanghai Inst Appl Math & Mech, Shanghai 200444, Peoples R China.
   [Zhang, Dan] Shanghai Key Lab Mech Energy Engn, Shanghai 200072, Peoples R China.
   [Li, Ai-Jun] Shanghai Univ, Res Ctr Composite Mat, Shanghai 200444, Peoples R China.
RP Shi, LY (reprint author), Shanghai Univ, Nano Sci & Technol Res Ctr, Shanghai 200444, Peoples R China.; Li, AJ (reprint author), Shanghai Univ, Res Ctr Composite Mat, Shanghai 200444, Peoples R China.
EM aljun.li@shu.edu.cn; shiliyi@shu.edu.cn
FU National Natural Science Foundation of China [11202124]; Doctoral Fund
   of Ministry of Education [20113108120019]; Shanghai Municipal Science
   and Technology Commission [13DZ229210-0]; Baoshan District Science and
   Technology Commission of Shanghai [bkw2013142]; Program for Professor of
   Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher
   Learning
FX The authors acknowledge the support of the National Natural Science
   Foundation of China (11202124); Doctoral Fund of Ministry of Education
   (20113108120019); Shanghai Municipal Science and Technology Commission
   with the funded project No.13DZ229210-0; Baoshan District Science and
   Technology Commission of Shanghai with the funded project No.bkw2013142;
   The Program for Professor of Special Appointment (Eastern Scholar) at
   Shanghai Institutions of Higher Learning.
CR Ahmad A, 2003, LANGMUIR, V19, P3550, DOI 10.1021/la026772l
   Bai W, 2009, CELLULOSE, V16, P455, DOI 10.1007/s10570-009-9277-1
   Barton DG, 2005, J PHYS CHEM B, V109, P2262, DOI 10.1021/jp048837u
   Bondeson D, 2006, CELLULOSE, V13, P171, DOI 10.1007/s10570-006-9061-4
   Campbell CT, 2011, FARADAY DISCUSS, V152, P227, DOI 10.1039/c1fd00033k
   Chang YC, 2009, J HAZARD MATER, V165, P664, DOI 10.1016/j.jhazmat.2008.10.034
   Chen L, 2015, ACS SUSTAIN CHEM ENG, V3, P978, DOI 10.1021/acssuschemeng.5b00110
   Corma A, 2008, CHEM SOC REV, V37, P2096, DOI 10.1039/b707314n
   Esumi K, 2000, LANGMUIR, V16, P2604, DOI 10.1021/1a991291w
   Goy-Lopez S., 2009, J PHYS CHEM B, V114, P66
   Habibi Y, 2010, CHEM REV, V110, P3479, DOI 10.1021/cr900339w
   Haruta M, 2002, CATTECH, V6, P102, DOI 10.1023/A:1020181423055
   Hu J, 2014, CHEM ENG J, V236, P1, DOI 10.1016/j.cej.2013.09.080
   Huang T, 2009, J PHYS CHEM C, V113, P13636, DOI 10.1021/jp903405y
   Jaramillo TF, 2003, J AM CHEM SOC, V125, P7148, DOI 10.1021/ja029800v
   Kim KS, 2006, J MATER CHEM, V16, P1315, DOI 10.1039/b601478j
   Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587
   Koga H, 2010, CHEM COMMUN, V46, P8567, DOI 10.1039/c0cc02754e
   Kuroda K., 2009, J MOL CATAL-A CHEM, V298, P7
   Lam E, 2012, NANOSCALE, V4, P997, DOI 10.1039/c2nr11558a
   Li J, 2012, J MATER CHEM, V22, P8426, DOI 10.1039/c2jm16386a
   Liu Q, 2014, ADV MATER, V26, P7178, DOI 10.1002/adma.201402699
   Lukach A, 2015, LANGMUIR, V31, P5033, DOI 10.1021/acs.langmuir.5b00728
   Luo CC, 2005, J COLLOID INTERF SCI, V288, P444, DOI 10.1016/j.jcis.2005.03.005
   Ma CY, 2013, GREEN CHEM, V15, P1035, DOI 10.1039/c3gc36891b
   Mahmoud KA, 2013, ACS APPL MATER INTER, V5, P4978, DOI 10.1021/am4007534
   Mahmoud KA, 2009, ACS APPL MATER INTER, V1, P1383, DOI 10.1021/am900331d
   Maji SK, 2014, ACS APPL MATER INTER, V6, P13648, DOI 10.1021/am503110s
   Mitsudome T, 2013, GREEN CHEM, V15, P2636, DOI 10.1039/c3gc41360h
   Moon RJ, 2011, CHEM SOC REV, V40, P3941, DOI 10.1039/c0cs00108b
   Nadagouda MN, 2007, BIOMACROMOLECULES, V8, P2762, DOI 10.1021/bm700446p
   Nadagouda MN, 2014, ACS SUSTAIN CHEM ENG, V2, P1717, DOI 10.1021/sc500237k
   Otsuka H, 2012, ADV DRUG DELIVER REV, V64, P246, DOI 10.1016/j.addr.2012.09.022
   Pandey S, 2014, CARBOHYD POLYM, V113, P525, DOI 10.1016/j.carbpol.2014.07.047
   Peng BL, 2011, CAN J CHEM ENG, V89, P1191, DOI 10.1002/cjce.20554
   Primo A, 2011, PHYS CHEM CHEM PHYS, V13, P886, DOI 10.1039/c0cp00917b
   Raveendran P, 2003, J AM CHEM SOC, V125, P13940, DOI 10.1021/ja029267j
   Saha S, 2009, LANGMUIR, V26, P2885
   Sen IK, 2013, CARBOHYD POLYM, V91, P518, DOI 10.1016/j.carbpol.2012.08.058
   Seol S. K., 2013, J NANOMATERIALS
   Sharma NC, 2007, ENVIRON SCI TECHNOL, V41, P5137, DOI 10.1021/es062929a
   Stratakis M, 2012, CHEM REV, V112, P4469, DOI 10.1021/cr3000785
   Wang HT, 2013, ACS SUSTAIN CHEM ENG, V1, P746, DOI 10.1021/sc400048m
   Wang LC, 2008, J PHYS CHEM C, V112, P6981, DOI 10.1021/jp711333t
   Wu XD, 2014, ENVIRON-SCI NANO, V1, P71, DOI 10.1039/c3en00066d
   Zhang MM, 2007, POLYMER, V48, P1989, DOI 10.1016/j.polymer.2007.01.069
   Zhang N, 2011, J MATER CHEM, V21, P11080, DOI 10.1039/c1jm12539g
   Zhao HB, 2007, CARBOHYD POLYM, V68, P235, DOI 10.1016/j.carbpol.2006.12.013
NR 48
TC 14
Z9 14
U1 4
U2 97
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD APR 20
PY 2016
VL 140
BP 66
EP 73
DI 10.1016/j.carbpol.2015.12.049
PG 8
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA DD5JA
UT WOS:000369958300010
PM 26876829
DA 2018-10-20
ER

PT J
AU Zhao, MX
   Zhu, BJ
AF Zhao, Mei-Xia
   Zhu, Bing-Jie
TI The Research and Applications of Quantum Dots as Nano-Carriers for
   Targeted Drug Delivery and Cancer Therapy
SO NANOSCALE RESEARCH LETTERS
LA English
DT Review
DE Quantum dots; Nano-medicine; Targeted drug delivery; Biomaterial
ID DOUBLE-STRANDED-RNA; GENE-FUNCTION; NANOPARTICLES; FOLATE; INTERFERENCE;
   THERAPEUTICS; NANOCARRIERS; DOXORUBICIN; DROSOPHILA; LIPOSOMES
AB Quantum dots (QDs), nano-carriers for drugs, can help realize the targeting of drugs, and improve the bioavailability of drugs in biological fields. And, a QD nano-carrier system for drugs has the potential to realize early detection, monitoring, and localized treatments of specific disease sites. In addition, QD nano-carrier systems for drugs can improve stability of drugs, lengthen circulation time in vivo, enhance targeted absorption, and improve the distribution and metabolism process of drugs in organization. So, the development of QD nano-carriers for drugs has become a hotspot in the fields of nano-drug research in recent years. In this paper, we review the advantages and applications of the QD nano-carriers for drugs in biological fields.
C1 [Zhao, Mei-Xia; Zhu, Bing-Jie] Henan Univ, Key Lab Nat Med & Immune Engn, Kaifeng 475004, Peoples R China.
RP Zhao, MX (reprint author), Henan Univ, Key Lab Nat Med & Immune Engn, Kaifeng 475004, Peoples R China.
EM zhaomeixia2011@henu.edu.cn
FU National Natural Science Foundation of China [U1204201, 21501044];
   Postdoctoral Science Foundation Funded Project of China [2012M511570];
   Department of Education Science and Technology Research Key Projects of
   Henan [13A150063, 16A150004]
FX This work was supported by the National Natural Science Foundation of
   China (Nos. U1204201, 21501044), the Postdoctoral Science Foundation
   Funded Project of China (No. 2012M511570), and the Department of
   Education Science and Technology Research Key Projects of Henan (No.
   13A150063, 16A150004).
CR Abbaspourrad A, 2013, LANGMUIR, V29, P12697, DOI 10.1021/la403064f
   Bagalkot V, 2007, NANO LETT, V7, P3065, DOI 10.1021/nl071546n
   Bagalkot V, 2011, ACS NANO, V5, P8131, DOI 10.1021/nn202772p
   Balaure PC, 2015, CURR TOP MED CHEM, V15, P1424
   Bartosova L, 2012, CURR MED CHEM, V19, P4671, DOI 10.2174/092986712803306358
   Biju V, 2010, BIOTECHNOL ADV, V28, P199, DOI 10.1016/j.biotechadv.2009.11.007
   Brigger I, 2002, ADV DRUG DELIVER REV, V54, P631, DOI 10.1016/S0169-409X(02)00044-3
   Briguglio I, 2015, EUR J MED CHEM, V97, P612, DOI 10.1016/j.ejmech.2014.09.089
   Chaudhury A, 2015, CURR PHARM BIOTECHNO, V16, P333, DOI 10.2174/1389201016666150118135107
   Cho KJ, 2008, CLIN CANCER RES, V14, P1310, DOI 10.1158/1078-0432.CCR-07-1441
   Cukierman E, 2010, BIOCHEM PHARMACOL, V80, P762, DOI 10.1016/j.bcp.2010.04.020
   de Bono JS, 2010, NATURE, V467, P543, DOI 10.1038/nature09339
   Dhyani H, 2015, RSC ADV, V5, P45928, DOI 10.1039/c5ra07012k
   Gui RJ, 2014, ANAL CHEM, V86, P5211, DOI 10.1021/ac501293e
   Han JH, 2015, ANAL BIOANAL CHEM, V407, P5243, DOI 10.1007/s00216-015-8708-0
   Lee SJ, 2015, NANOSCALE RES LETT, V10, P1, DOI 10.1186/s11671-014-0706-1
   Li C, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-244
   Li X, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-401
   Loretz B, 2013, SAFETY ASPECTS ENG N, P279
   Lyashchova A, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-88
   Malhotra A, 2014, PHARMACOGENET GENOM, V24, P582, DOI 10.1097/FPC.0000000000000094
   Mansur AAP, 2015, NANOSCALE RES LETT, V10, DOI 10.1186/s11671-015-0879-2
   Merkx M, 2013, BIOCHEM SOC T, V41, P1201, DOI 10.1042/BST20130128
   Misquitta L, 1999, P NATL ACAD SCI USA, V96, P1451, DOI 10.1073/pnas.96.4.1451
   Bustos ARM, 2015, ANAL CHIM ACTA, V879, P77, DOI 10.1016/j.aca.2015.03.015
   Oluwole DO, 2015, POLYHEDRON, V87, P8, DOI 10.1016/j.poly.2014.10.024
   Ozcan G, 2015, ADV DRUG DELIVER REV, V87, P108, DOI 10.1016/j.addr.2015.01.007
   Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653
   Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387
   ROMANO N, 1992, MOL MICROBIOL, V6, P3343, DOI 10.1111/j.1365-2958.1992.tb02202.x
   Rosenkranz D, 2015, RNA, V21, P911, DOI 10.1261/rna.048603.114
   Savva YA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3745
   Schneider RL, 2005, BIOORGAN MED CHEM, V13, P2799, DOI 10.1016/j.bmc.2005.02.025
   Shao D, 2015, BIOMATER SCI-UK, V3, P833, DOI 10.1039/c5bm00077g
   Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686
   Wang YC, 2015, BIOMATER SCI-UK, V3, P192, DOI 10.1039/c4bm00306c
   Wargelius A, 1999, BIOCHEM BIOPH RES CO, V263, P156, DOI 10.1006/bbrc.1999.1343
   Wianny F, 2000, NAT CELL BIOL, V2, P70, DOI 10.1038/35000016
   Win KY, 2015, SMALL, V11, P1197, DOI 10.1002/smll.201402073
   Wolfbeis OS, 2015, CHEM SOC REV, V44, P4743, DOI 10.1039/c4cs00392f
   Yoo HS, 2004, J CONTROL RELEASE, V100, P247, DOI 10.1016/j.jconrel.2004.08.017
   Yuan Y, 2014, BIOMATERIALS, V35, P7881, DOI 10.1016/j.biomaterials.2014.05.071
   Zhang G, 2015, ACS APPL MATER INTER, V7, P14192
   Zrazhevskiy P, 2010, CHEM SOC REV, V39, P4326, DOI 10.1039/b915139g
   Zrazhevskiy P, 2009, NANO TODAY, V4, P414, DOI 10.1016/j.nantod.2009.07.004
NR 45
TC 18
Z9 18
U1 5
U2 256
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1556-276X
J9 NANOSCALE RES LETT
JI Nanoscale Res. Lett.
PD APR 18
PY 2016
VL 11
AR 207
DI 10.1186/s11671-016-1394-9
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA DJ8PP
UT WOS:000374474700001
PM 27090658
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Bernhard, JC
   Vunjak-Novakovic, G
AF Bernhard, Jonathan C.
   Vunjak-Novakovic, Gordana
TI Should we use cells, biomaterials, or tissue engineering for cartilage
   regeneration?
SO STEM CELL RESEARCH & THERAPY
LA English
DT Review
DE Cartilage; Tissue engineering; Chondrocytes; Mesenchymal stem cells;
   Biomaterial; Bioreactor; Hydrogel; Implantation
ID PLURIPOTENT STEM-CELLS; AUTOLOGOUS CHONDROCYTE IMPLANTATION; IN-VITRO
   CHONDROGENESIS; ARTICULAR-CARTILAGE; HYDROSTATIC-PRESSURE; STROMAL
   CELLS; REPAIR; DIFFERENTIATION; COLLAGEN; SCAFFOLDS
AB For a long time, cartilage has been a major focus of the whole field of tissue engineering, both because of the constantly growing need for more effective options for joint repair and the expectation that this apparently simple tissue will be easy to engineer. After several decades, cartilage regeneration has proven to be anything but easy. With gratifying progress in our understanding of the factors governing cartilage development and function, and cell therapy being successfully used for several decades, there is still a lot to do. We lack reliable methods to generate durable articular cartilage that would resemble the original tissue lost to injury or disease. The question posed here is whether the answer would come from the methods using cells, biomaterials, or tissue engineering. We present a concise review of some of the most meritorious efforts in each area, and propose that the solution will most likely emerge from the ongoing attempts to recapitulate certain aspects of native cartilage development. While an ideal recipe for cartilage regeneration is yet to be formulated, we believe that it will contain cell, biomaterial, and tissue engineering approaches, blended into an effective method for seamless repair of articular cartilage.
C1 [Bernhard, Jonathan C.; Vunjak-Novakovic, Gordana] Columbia Univ, Dept Biomed Engn, 622 West 168th St,VC12-234, New York, NY 10032 USA.
   [Vunjak-Novakovic, Gordana] Columbia Univ, Dept Med, 622 West 168th St,VC12-234, New York, NY 10032 USA.
RP Vunjak-Novakovic, G (reprint author), Columbia Univ, Dept Biomed Engn, 622 West 168th St,VC12-234, New York, NY 10032 USA.; Vunjak-Novakovic, G (reprint author), Columbia Univ, Dept Med, 622 West 168th St,VC12-234, New York, NY 10032 USA.
EM gv2131@columbia.edu
FU NIDCR [DE016525]; NIBIB [EB002520]; NIAMS [AR061988, AR060361]; NSF
   (GRF)
FX The authors gratefully acknowledge the funding support of their work by
   NIDCR (grant DE016525), NIBIB (grant EB002520), NIAMS (grants AR061988
   and AR060361) and the NSF (GRF for JCB).
CR Allan KS, 2007, TISSUE ENG, V13, P167, DOI 10.1089/ten.2006.0081
   Arokoski JPA, 2000, SCAND J MED SCI SPOR, V10, P186, DOI 10.1034/j.1600-0838.2000.010004186.x
   Bae SE, 2010, J CONTROL RELEASE, V143, P23, DOI 10.1016/j.jconrel.2009.12.024
   Bhardwaj N, 2015, MACROMOL BIOSCI, V15, P153, DOI 10.1002/mabi.201400335
   Bhumiratana S, 2014, P NATL ACAD SCI USA, V111, P6940, DOI 10.1073/pnas.1324050111
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Caldwell KL, 2015, OSTEOARTHR CARTILAGE, V23, P351, DOI 10.1016/j.joca.2014.11.004
   Cohen DL, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/3/035004
   Craft AM, 2013, DEVELOPMENT, V140, P2597, DOI 10.1242/dev.087890
   Cucchiarini M, 2014, Eur Cell Mater, V27, P12
   Cui XF, 2012, TISSUE ENG PT A, V18, P1304, DOI [10.1089/ten.tea.2011.0543, 10.1089/ten.TEA.2011.0543]
   Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200
   Diekman BO, 2012, P NATL ACAD SCI USA, V109, P19172, DOI 10.1073/pnas.1210422109
   Elder BD, 2009, TISSUE ENG PART B-RE, V15, P43, DOI 10.1089/ten.teb.2008.0435
   Elisseeff J, 2005, Orthod Craniofac Res, V8, P150, DOI 10.1111/j.1601-6343.2005.00335.x
   Elisseeff J, 1999, P NATL ACAD SCI USA, V96, P3104, DOI 10.1073/pnas.96.6.3104
   Fedorovich NE, 2012, TISSUE ENG PART C-ME, V18, P33, DOI [10.1089/ten.tec.2011.0060, 10.1089/ten.TEC.2011.0060]
   Foss C, 2013, BIOMACROMOLECULES, V14, P38, DOI 10.1021/bm301174x
   Garg T, 2014, EXPERT OPIN DRUG DEL, V11, P767, DOI 10.1517/17425247.2014.891014
   Gawlitta D, 2012, TISSUE ENG PT A, V18, P1957, DOI [10.1089/ten.TEA.2011.0657, 10.1089/ten.tea.2011.0657]
   Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652
   GRANDE DA, 1989, J ORTHOP RES, V7, P208, DOI 10.1002/jor.1100070208
   Guilak F, 2006, ANN NY ACAD SCI, P498, DOI [10.1196/annals.1346.011, DOI 10.1196/ANNALS.1346.011]
   Hambly K, 2006, AM J SPORT MED, V34, P1020, DOI 10.1177/0363546505281918
   Hansen U, 2001, J BIOMECH, V34, P941, DOI 10.1016/S0021-9290(01)00050-1
   Hayes AJ, 2001, ANAT EMBRYOL, V203, P469, DOI 10.1007/s004290100178
   Heng BC, 2004, STEM CELLS, V22, P1152, DOI 10.1634/stemcells.2004-0062
   Hou QP, 2004, J MATER CHEM, V14, P1915, DOI 10.1039/b401791a
   Hu JC, 2006, TISSUE ENG, V12, P969, DOI 10.1089/ten.2006.12.969
   Huey DJ, 2012, SCIENCE, V338, P917, DOI 10.1126/science.1222454
   Klein TJ, 2009, TISSUE ENG PART B-RE, V15, P143, DOI [10.1089/ten.teb.2008.0563, 10.1089/ten.TEB.2008.0563]
   Knutsen G, 2007, J BONE JOINT SURG AM, V89A, P2105, DOI 10.2106/JBJS.G.00003
   Ko JY, 2014, BIOMATERIALS, V35, P3571, DOI 10.1016/j.biomaterials.2014.01.009
   Kyurkchiev Dobroslav, 2014, World J Stem Cells, V6, P552, DOI 10.4252/wjsc.v6.i5.552
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee CH, 2010, LANCET, V376, P440, DOI 10.1016/S0140-6736(10)60668-X
   Lee CR, 2001, BIOMATERIALS, V22, P3145, DOI 10.1016/S0142-9612(01)00067-9
   Li CH, 2011, TISSUE ENG PT A, V17, P777, DOI [10.1089/ten.tea.2010.0078, 10.1089/ten.TEA.2010.0078]
   Mabvuure N, 2012, CURR STEM CELL RES T, V7, P287, DOI 10.2174/157488812800793018
   Madry H, 2011, DTSCH ARZTEBL INT, V108, P669, DOI 10.3238/arztebl.2011.0669
   Mardones R, 2015, INT J STEM CELLS, V8, P48, DOI 10.15283/ijsc.2015.8.1.48
   Mauck RL, 2006, OSTEOARTHR CARTILAGE, V14, P179, DOI 10.1016/j.joca.2005.09.002
   Mauck RL, 2000, J BIOMECH ENG-T ASME, V122, P252, DOI 10.1115/1.429656
   McMahon LA, 2008, ANN BIOMED ENG, V36, P185, DOI 10.1007/s10439-007-9416-5
   Melchels FPW, 2012, PROG POLYM SCI, V37, P1079, DOI 10.1016/j.progpolymsci.2011.11.007
   Mollon B, 2013, OSTEOARTHR CARTILAGE, V21, P1824, DOI 10.1016/j.joca.2013.08.024
   MUIR H, 1995, BIOESSAYS, V17, P1039, DOI 10.1002/bies.950171208
   Munarin F, 2012, J APPL BIOMATER FUNC, V10, P67, DOI 10.5301/JABFM.2012.9418
   Nagaya H, 1999, ANN RHEUM DIS, V58, P186, DOI 10.1136/ard.58.3.186
   Nejadnik H, 2010, AM J SPORT MED, V38, P1110, DOI 10.1177/0363546509359067
   Ogawa R, 2009, TISSUE ENG PT A, V15, P2937, DOI [10.1089/ten.tea.2008.0672, 10.1089/ten.TEA.2008.0672]
   PACIFICI M, 1991, EXP CELL RES, V192, P266, DOI 10.1016/0014-4827(91)90185-W
   Park H, 2005, BIOMATERIALS, V26, P7095, DOI 10.1016/j.biomaterials.2005.05.083
   Pelttari K, 2006, ARTHRITIS RHEUM-US, V54, P3254, DOI 10.1002/art.22136
   Portner R, 2009, ADV BIOCHEM ENG BIOT, V112, P145, DOI [10.1007/10_2008_4, 10.1007/978-3-540-69357-4_7]
   Quarto N, 2012, P NATL ACAD SCI USA, V109, P215, DOI 10.1073/pnas.1113442109
   Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587
   Saito T, 2015, BIOMED RES-TOKYO, V36, P179, DOI 10.2220/biomedres.36.179
   Schulz RM, 2007, EUR BIOPHYS J BIOPHY, V36, P539, DOI 10.1007/s00249-007-0139-1
   Schuurman W, 2015, J TISSUE ENG REGEN M, V9, P669, DOI 10.1002/term.1638
   Shen Y, 2014, CURR STEM CELL RES T, V9, P254, DOI 10.2174/1574888X09666140213202700
   Shin H, 2004, J BIOMED MATER RES A, V69A, P535, DOI 10.1002/jbm.a.30027
   Spiller KL, 2011, TISSUE ENG PART B-RE, V17, P281, DOI [10.1089/ten.teb.2011.0077, 10.1089/ten.TEB.2011.0077]
   Steinert AF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2195
   Stoop R, 2008, INJURY, V39, pS77, DOI 10.1016/j.injury.2008.01.036
   Tognana E, 2005, OSTEOARTHR CARTILAGE, V13, P896, DOI 10.1016/j.joca.2005.05.003
   Toh WS, 2007, STEM CELLS, V25, P950, DOI 10.1634/stemcells.2006-0326
   Toh WS, 2010, BIOMATERIALS, V31, P6968, DOI 10.1016/j.biomaterials.2010.05.064
   Tuli R, 2004, TISSUE ENG, V10, P1169, DOI 10.1089/ten.2004.10.1169
   Vinatier C, 2009, TRENDS BIOTECHNOL, V27, P307, DOI 10.1016/j.tibtech.2009.02.005
   Vonk LA, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0086-1
   Wakitani S, 1998, TISSUE ENG, V4, P429, DOI 10.1089/ten.1998.4.429
   Wakitani S, 2007, J TISSUE ENG REGEN M, V1, P74, DOI 10.1002/term.8
   Webber MJ, 2015, ANN BIOMED ENG, V43, P641, DOI 10.1007/s10439-014-1104-7
   Wei YY, 2012, EUR CELLS MATER, V23, P1
   Zscharnack M, 2009, CELLS TISSUES ORGANS, V190, P81, DOI 10.1159/000178024
NR 76
TC 42
Z9 44
U1 3
U2 61
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1757-6512
J9 STEM CELL RES THER
JI Stem Cell Res. Ther.
PD APR 18
PY 2016
VL 7
AR 56
DI 10.1186/s13287-016-0314-3
PG 9
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA DK1AZ
UT WOS:000374645600001
PM 27089917
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Huang, Y
   Qiao, HX
   Nian, XF
   Zhang, XJ
   Zhang, XY
   Song, GQ
   Xu, ZW
   Zhang, HL
   Han, SG
AF Huang, Yong
   Qiao, Haixia
   Nian, Xiaofeng
   Zhang, Xuejiao
   Zhang, Xiaoyun
   Song, Guiqin
   Xu, Zhiwei
   Zhang, Honglei
   Han, Shuguang
TI Improving the bioactivity and corrosion resistance properties of
   electrodeposited hydroxyapatite coating by dual doping of bivalent
   strontium and manganese ion
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE Hydroxyapatite coating; Strontium; Manganese; Corrosion resistance;
   Biocompatibility
ID CALCIUM-PHOSPHATE COATINGS; PULSED-LASER DEPOSITION; IN-VITRO;
   CARBON/CARBON COMPOSITES; SUBSTITUTED HYDROXYAPATITES; IMPLANT
   APPLICATIONS; BIOLOGICAL-PROPERTY; TIN COATINGS; TITANIUM;
   BIOCOMPATIBILITY
AB The key property in the preparation of a biomaterial is to facilitate the regeneration and/or replacement of injured organs and tissues. To obtain such a biomaterial, strontium and manganese co-substituted hydroxyapatite (SrMnHA) ceramic coatings on commercially pure titanium (CP-Ti) were successfully prepared by a cathodic electrodeposition method. The formation of SrMnHA coating was investigated using Fourier transform infrared spectroscopy, X-ray diffraction, scanning electron microscopy, energy dispersive X-ray analysis and inductively coupled plasma. Co-doping of Sr2+ and Mn2+ ions decreased hydroxyapatite unit cell volume and grain sizes. Obtained coatings were crack-free and dense, which led to the decrease in the corrosion current densities of CP-Ti in physiological solutions. The dissolution tests performed on SrMnHA resulted in the leaching of Sr2+ and Mn2+ at low levels. SrMnHAs have moderately hydrophilic surfaces with a contact angle of 23.8 degrees.Additionally, the MC3T3-E1 cells show better cell morphology, adhesion, spreading, proliferation and expression of alkaline phosphatase on SrMnHA than on HA. The excellent biocompatibility of SrMnHA is mainly attributed to a probable effect of a combination of good surface wettability and ion release (Sr2+ and Mn2+). Results suggest that SrMnHA composite-coated CP-Ti can be a potential candidate for orthopaedic applications. (C) 2016 Elsevier" B.V. All rights reserved,
C1 [Huang, Yong; Qiao, Haixia; Nian, Xiaofeng; Zhang, Xuejiao; Zhang, Xiaoyun; Song, Guiqin; Xu, Zhiwei] Hebei North Univ, Coll Lab Med, Zhangjiakou 075000, Peoples R China.
   [Huang, Yong; Han, Shuguang] Univ Elect Sci & Technol China, Inst Life Sci & Technol, Chengdu 610054, Peoples R China.
   [Zhang, Honglei] Hebei Univ, Coll Chem Environm Sci, Baoding 071000, Peoples R China.
RP Huang, Y; Zhang, XJ (reprint author), Hebei North Univ, Coll Lab Med, Zhangjiakou 075000, Peoples R China.
EM xfpang@aliyun.com; 527238610@qq.com
FU Key Project of Science and Technology of Hebei Colleges [ZD2015124];
   Natural Science Foundation of Hebei North University; High-level
   Scientific Research Foundation of Hebei North University
FX This work was supported by the Key Project of Science and Technology of
   Hebei Colleges (No. ZD2015124), the Natural Science Foundation of Hebei
   North University, and the High-level Scientific Research Foundation of
   Hebei North University.
CR Bae YJ, 2008, BIOL TRACE ELEM RES, V124, P28, DOI 10.1007/s12011-008-8119-6
   Bigi A, 2005, BIOMATERIALS, V26, P2381, DOI 10.1016/j.biomaterials.2004.07.057
   Bir F, 2012, APPL SURF SCI, V258, P7021, DOI 10.1016/j.apsusc.2012.03.158
   Boanini E, 2015, J COLLOID INTERF SCI, V448, P1, DOI 10.1016/j.jcis.2015.01.088
   Boyd AR, 2015, MAT SCI ENG C-MATER, V46, P290, DOI 10.1016/j.msec.2014.10.046
   Bracci B, 2009, J INORG BIOCHEM, V103, P1666, DOI 10.1016/j.jinorgbio.2009.09.009
   Brown EM, 2007, NAT CLIN PRACT ENDOC, V3, P122, DOI 10.1038/ncpendmet0388
   Brown EM, 2003, OSTEOPOROSIS INT, V14, pS25, DOI 10.1007/s00198-002-1343-6
   Capuccini C, 2009, J BIOMED MATER RES A, V89A, P594, DOI 10.1002/jbm.a.31975
   Chen HT, 2015, SURF COAT TECH, V276, P168, DOI 10.1016/j.surfcoat.2015.06.056
   Diesselberg M, 2004, SURF COAT TECH, V177, P399, DOI 10.1016/j.surfcoat.2003.09.015
   Eliaz N, 2011, J MATER SCI-MATER M, V22, P1741, DOI 10.1007/s10856-011-4355-y
   Eliaz N, 2009, ACTA BIOMATER, V5, P3178, DOI 10.1016/j.actbio.2009.04.005
   Gopi D, 2015, RSC ADV, V5, P36766, DOI 10.1039/c5ra04382d
   Gopi D, 2015, RSC ADV, V5, P27402, DOI 10.1039/c5ra03432a
   Gopi D, 2015, CERAM INT, V41, P5454, DOI 10.1016/j.ceramint.2014.12.114
   Gopi D, 2014, RSC ADV, V4, P34751, DOI 10.1039/c4ra04484c
   Gyorgy E, 2004, J BIOMED MATER RES A, V71A, P353, DOI 10.1002/jbm.a.30172
   Huang Y, 2015, RSC ADV, V5, P17076, DOI 10.1039/c4ra12118j
   Huang Y, 2013, APPL SURF SCI, V282, P456, DOI 10.1016/j.apsusc.2013.05.152
   Huang Y, 2013, APPL SURF SCI, V282, P583, DOI 10.1016/j.apsusc.2013.06.015
   Huang Y, 2013, J MATER SCI-MATER M, V24, P1853, DOI 10.1007/s10856-013-4955-9
   Kaygili O, 2015, MAT SCI ENG C-MATER, V55, P538, DOI 10.1016/j.msec.2015.05.081
   Kim HW, 2007, TISSUE ENG, V13, P965, DOI 10.1089/ten.2006.0299
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kulanthaivel S, 2015, CERAM INT, V41, P11323, DOI 10.1016/j.ceramint.2015.05.090
   Liu B., 2015, MAT SCI ENG C, V53, P322
   Liu B, 2015, MAT SCI ENG C-MATER, V47, P97, DOI 10.1016/j.msec.2014.11.038
   Malakauskaite-Petruleviciene M, 2015, CERAM INT, V41, P7421, DOI 10.1016/j.ceramint.2015.02.055
   Mayrhofer PH, 2002, THIN SOLID FILMS, V415, P151, DOI 10.1016/S0040-6090(02)00511-4
   McGehee DS, 1997, J PHYSIOL-LONDON, V502, P31, DOI 10.1111/j.1469-7793.1997.031bl.x
   Miola M, 2014, MAT SCI ENG C-MATER, V38, P107, DOI 10.1016/j.msec.2014.01.045
   Mohseni E, 2015, CERAM INT, V41, P14447, DOI 10.1016/j.ceramint.2015.07.081
   Mohseni E, 2014, INT J ADHES ADHES, V48, P238, DOI 10.1016/j.ijadhadh.2013.09.030
   Narayanan R, 2008, J BIOMED MATER RES B, V85B, P279, DOI 10.1002/jbm.b.30932
   Paluszkiewicz C, 2010, J MOL STRUCT, V976, P301, DOI 10.1016/j.molstruc.2010.04.001
   Park JW, 2011, APPL SURF SCI, V258, P977, DOI 10.1016/j.apsusc.2011.09.053
   Pei XB, 2014, APPL SURF SCI, V295, P71, DOI 10.1016/j.apsusc.2014.01.009
   Sima F, 2007, APPL SURF SCI, V254, P1155, DOI 10.1016/j.apsuse.2007.08.053
   Sumathi S, 2015, J CRYST GROWTH, V422, P36, DOI 10.1016/j.jcrysgro.2015.04.022
   Supova M, 2015, CERAM INT, V41, P9203, DOI 10.1016/j.ceramint.2015.03.316
   Surmenev RA, 2014, ACTA BIOMATER, V10, P557, DOI 10.1016/j.actbio.2013.10.036
   Surmeneva M. A., 2015, COLLOIDS SURF B
   Tang S, 2014, SURF COAT TECH, V251, P210, DOI 10.1016/j.surfcoat.2014.04.028
   Vahabzadeh S, 2015, ACTA BIOMATER, V17, P47, DOI 10.1016/j.actbio.2015.01.022
   Vasilescu C, 2011, CORROS SCI, V53, P992, DOI 10.1016/j.corsci.2010.11.033
   Wang Y, 2015, MATER DESIGN, V85, P640, DOI 10.1016/j.matdes.2015.07.086
   Yang SP, 2015, APPL SURF SCI, V346, P554, DOI 10.1016/j.apsusc.2015.03.190
   Zalnezhad E, 2012, INT J PRECIS ENG MAN, V13, P1453, DOI 10.1007/s12541-012-0191-3
   Zhang LL, 2014, CERAM INT, V40, P13123, DOI 10.1016/j.ceramint.2014.05.015
   Zhang LL, 2014, APPL SURF SCI, V313, P85, DOI 10.1016/j.apsusc.2014.05.144
   Zhao XN, 2012, APPL SURF SCI, V258, P5117, DOI 10.1016/j.apsusc.2012.01.144
   Zhou H, 2015, MAT SCI ENG C-MATER, V56, P174, DOI 10.1016/j.msec.2015.06.032
NR 53
TC 14
Z9 14
U1 8
U2 59
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD APR 15
PY 2016
VL 291
BP 205
EP 215
DI 10.1016/j.surfcoat.2016.02.042
PG 11
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA EE5ZH
UT WOS:000389687600023
DA 2018-10-20
ER

PT J
AU Barros, SM
   Whitaker, SK
   Sukthankar, P
   Avila, LA
   Gudlur, S
   Warner, M
   Beltrao, EIC
   Tomich, JM
AF Barros, Sheila M.
   Whitaker, Susan K.
   Sukthankar, Pinakin
   Avila, L. Adriana
   Gudlur, Sushanth
   Warner, Matt
   Beltrao, Eduardo I. C.
   Tomich, John M.
TI A review of solute encapsulating nanoparticles used as delivery systems
   with emphasis on branched amphipathic peptide capsules
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE BAPCs; Nanoparticle; Drug delivery; Self-assembly; Peptide bilayer
ID SOLID LIPID NANOPARTICLES; SURFACTANT-LIKE PEPTIDES; CONTROLLED
   DRUG-DELIVERY; ALPHA-PARTICLE THERAPY; CROSS-LINKED MICELLES;
   BLOCK-COPOLYMERS; DIBLOCK COPOLYMERS; POLYMERIC MICELLES; PHASE-I;
   CLINICAL-APPLICATIONS
AB Various strategies are being developed to improve delivery and increase the biological half-lives of pharmacological agents. To address these issues, drug delivery technologies rely on different nano-sized molecules including: lipid vesicles, viral capsids and nano-particles. Peptides are a constituent of many of these nanomaterials and overcome some limitations associated with lipid-based or viral delivery systems, such as tune-ability, stability, specificity, inflammation, and antigenicity. This review focuses on the evolution of bio-based drug delivery nanomaterials that self-assemble forming vesicles/capsules. While lipid vesicles are preeminent among the structures; peptide-based constructs are emerging, in particular peptide bilayer delimited capsules.
   The novel biomaterial-Branched Amphiphilic Peptide Capsules (BAPCs) display many desirable properties. These nano-spheres are comprised of two branched peptides-bis(FLIVI)-K-KKKK and bis(FLIVIGSII)-K-KKKK, designed to mimic diacyl-phosphoglycerides in molecular architecture. They undergo supramolecular self-assembly and form solvent-filled, bilayer delineated capsules with sizes ranging from 20 nm to 2 mu m depending on annealing temperatures and time. They are able to encapsulate different fluorescent dyes, therapeutic drugs, radionuclides and even small proteins. While sharing many properties with lipid vesicles, the BAPCs are much more robust. They have been analyzed for stability, size, cellular uptake and localization, intra-cellular retention and, bio-distribution both in culture and in vivo. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Barros, Sheila M.; Whitaker, Susan K.; Sukthankar, Pinakin; Avila, L. Adriana; Gudlur, Sushanth; Warner, Matt; Tomich, John M.] Kansas State Univ, Dept Biochem & Mol Biophys, 141 Chalmers Hall, Manhattan, KS 66506 USA.
   [Barros, Sheila M.; Beltrao, Eduardo I. C.] Fed Univ Pernambuco UFPE, Dept Biochem, BR-50670901 Recife, PE, Brazil.
   [Sukthankar, Pinakin] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA.
   [Avila, L. Adriana] Auburn Univ, Dept Chem & Biochem, Auburn, AL 36849 USA.
   [Gudlur, Sushanth] Nanyang Technol Univ, CBSS, Singapore 637553, Singapore.
RP Tomich, JM (reprint author), Kansas State Univ, Dept Biochem & Mol Biophys, 141 Chalmers Hall, Manhattan, KS 66506 USA.
EM jtomich@ksu.edu
RI bagheri, amir/C-3274-2017
OI TOMICH, JOHN/0000-0001-7848-8307; Sukthankar,
   Pinakin/0000-0002-9043-5846
FU PHS-NIH grant [GM074096]; Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES) [PDSE - 99999.007690/2014-02]; Terry Johnson
   Cancer Center Innovation Award; Affilation: CAPES Foundation; Ministry
   of Education, Brasilia, Brazil [DF 70.040-020]
FX We thank Professor Jianhan Chen for carrying out the computer simulation
   that generated Fig. 16. This is publication 16-158-J from the Kansas
   Agricultural Experiment Station. Partial support for this project was
   provided by PHS-NIH grant # GM074096 and a Terry Johnson Cancer Center
   Innovation Award (to J.M.T), Scholarship award (to S. B.) from the
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)
   Process number: PDSE - 99999.007690/2014-02, Affilation: CAPES
   Foundation, Ministry of Education, Brasilia-DF 70.040-020, Brazil and
   the Terry Johnson Cancer Center at Kansas State University for summer
   support (for P.S. and S.G.).
CR Adams DJ, 2008, BIOMACROMOLECULES, V9, P2997, DOI 10.1021/bm8006693
   Alexis F, 2008, UROL ONCOL-SEMIN ORI, V26, P74, DOI 10.1016/j.urolonc.2007.03.017
   Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833
   ALLEN TM, 1980, BIOCHIM BIOPHYS ACTA, V597, P418, DOI 10.1016/0005-2736(80)90118-2
   ALLEN TM, 1987, FEBS LETT, V223, P42, DOI 10.1016/0014-5793(87)80506-9
   Antunes FE, 2009, ADV COLLOID INTERFAC, V147-48, P18, DOI 10.1016/j.cis.2008.10.001
   Arnedo A, 2004, J CONTROL RELEASE, V94, P217, DOI 10.1016/j.jconrel.2003.10.009
   Au JLS, 2001, J CONTROL RELEASE, V74, P31, DOI 10.1016/S0168-3659(01)00308-X
   Bae Y, 2005, BIOCONJUGATE CHEM, V16, P122, DOI 10.1021/bc0498166
   Basel MT, 2011, ACS NANO, V5, P2162, DOI 10.1021/nn103362n
   BILTONEN RL, 1993, CHEM PHYS LIPIDS, V64, P129, DOI 10.1016/0009-3084(93)90062-8
   Blasi P, 2007, ADV DRUG DELIVER REV, V59, P454, DOI 10.1016/j.addr.2007.04.011
   Boas U, 2004, CHEM SOC REV, V33, P43, DOI 10.1039/b309043b
   Brayden David J., 2003, Drug Discovery Today, V8, P976, DOI 10.1016/S1359-6446(03)02874-5
   Butun V, 2006, REACT FUNCT POLYM, V66, P157, DOI 10.1016/j.reactfunctpolym.2005.07.021
   Cai GQ, 2011, ACTA BIOMATER, V7, P3729, DOI 10.1016/j.actbio.2011.06.027
   Carafa M, 2009, J LIPOSOME RES, V19, P332, DOI 10.3109/08982100903014994
   Carlmark A, 2009, CHEM SOC REV, V38, P352, DOI 10.1039/b711745k
   Chauhan AS, 2004, J DRUG TARGET, V12, P575, DOI 10.1080/10611860400010655
   Choucair A, 2003, J AM CHEM SOC, V125, P11993, DOI 10.1021/ja036667d
   Choucair A, 2003, EUR PHYS J E, V10, P37, DOI 10.1140/epje/e2003-00002-5
   Chuanoi S, 2014, BIOMACROMOLECULES, V15, P2389, DOI 10.1021/bm500127g
   Cloninger MJ, 2002, CURR OPIN CHEM BIOL, V6, P742, DOI 10.1016/S1367-5931(02)00400-3
   Couturier O, 2005, EUR J NUCL MED MOL I, V32, P601, DOI 10.1007/s00259-005-1803-2
   Cui H, 2007, SOFT MATTER, V3, P945, DOI 10.1039/b704194b
   Cullis P.R., 1992, J LIPOSOME RES, V2, P397
   Daful AG, 2012, LANGMUIR, V28, P3730, DOI 10.1021/la204132c
   Davis ME, 2009, MOL PHARMACEUT, V6, P659, DOI 10.1021/mp900015y
   Decuzzi P, 2009, PHARM RES-DORD, V26, P235, DOI 10.1007/s11095-008-9697-x
   Devalapally H, 2007, CANCER CHEMOTH PHARM, V59, P477, DOI 10.1007/s00280-006-0287-5
   dos Santos S., 2013, DRUG DELIVERY SYSTEM, P35
   Drummond CJ, 1999, CURR OPIN COLLOID IN, V4, P449, DOI 10.1016/S1359-0294(00)00020-0
   El-Sayed M, 2001, PHARM RES-DORDR, V18, P23, DOI 10.1023/A:1011066408283
   Elgqvist J., 2014, FRONT ONCOL, V3, P1
   ENGIN K, 1995, INT J HYPERTHER, V11, P211, DOI 10.3109/02656739509022457
   Erhardt R, 2003, J AM CHEM SOC, V125, P3260, DOI 10.1021/ja028982q
   Erhardt R, 2001, MACROMOLECULES, V34, P1069, DOI 10.1021/ma000670p
   Etheridge ML, 2013, NANOMED-NANOTECHNOL, V9, P1, DOI 10.1016/j.nano.2012.05.013
   Ewert K, 2005, ADV GENET, V53, P119, DOI 10.1016/S0065-2660(05)53005-0
   Fang JY, 2001, INT J PHARM, V219, P61, DOI 10.1016/S0378-5173(01)00627-5
   FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664
   Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566
   Fetterly GJ, 2003, AAPS PHARMSCI, V5
   FUHRHOP JH, 1993, J AM CHEM SOC, V115, P11036, DOI 10.1021/ja00076a090
   Gabizon AA, 2006, J LIPOSOME RES, V16, P175, DOI 10.1080/08982100600848769
   Gebhardt KE, 2008, J COLLOID INTERF SCI, V317, P70, DOI 10.1016/j.jcis.2007.09.048
   Gelderblom H, 2001, EUR J CANCER, V37, P1590, DOI 10.1016/S0959-8049(01)00171-X
   Gharpure KM, 2015, CLIN CANCER RES, V21, P3121, DOI 10.1158/1078-0432.CCR-14-1189
   Gmeiner WH, 2014, NANOTECHNOL REV, V3, P111, DOI 10.1515/ntrev-2013-0013
   Goldstein AS, 1997, CHEM PHYS LIPIDS, V88, P21, DOI 10.1016/S0009-3084(97)00042-X
   GRACIAA A, 1989, J PHYS CHEM-US, V93, P4167, DOI 10.1021/j100347a055
   Gratton SEA, 2008, P NATL ACAD SCI USA, V105, P11613, DOI 10.1073/pnas.0801763105
   GROVE A, 1993, PROTEIN SCI, V2, P1918, DOI 10.1002/pro.5560021113
   Gudlur S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045374
   Guy V., 1975, French Patent, Patent No. [2315991-A1, 2315991]
   Hajduk DA, 1998, J PHYS CHEM B, V102, P4269, DOI 10.1021/jp973323z
   Hamman JH, 2005, BIODRUGS, V19, P165, DOI 10.2165/00063030-200519030-00003
   Hamoudeh M, 2008, ADV DRUG DELIVER REV, V60, P1329, DOI 10.1016/j.addr.2008.04.013
   Handjani R, 1989, U.S. Patent, Patent No. [4830857, US4830857A]
   HANDJANIVILA RM, 1979, INT J COSMETIC SCI, V1, P303, DOI 10.1111/j.1467-2494.1979.tb00224.x
   Hart Stephen L., 2005, Current Drug Delivery, V2, P423, DOI 10.2174/156720105774370230
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   Henriksen G, 2004, NUCL MED BIOL, V31, P441, DOI 10.1016/j.nucmedbio.2003.11.004
   Hoarau D, 2004, PHARM RES, V21, P1783, DOI 10.1023/B:PHAM.0000045229.87844.21
   Holder SJ, 2011, POLYM CHEM-UK, V2, P1018, DOI 10.1039/c0py00379d
   Holowka EP, 2005, J AM CHEM SOC, V127, P12423, DOI 10.1021/ja053557t
   Hsiao MS, 2014, MACROMOLECULES, V47, P2361, DOI 10.1021/ma402429d
   Hu CJ, 1999, INT J PHARM, V185, P23, DOI 10.1016/S0378-5173(99)00122-2
   Hu HQ, 2014, SOFT MATTER, V10, P3867, DOI 10.1039/c3sm52607k
   Iatrou H, 2007, BIOMACROMOLECULES, V8, P2173, DOI 10.1021/bm070360f
   Ibrahim NK, 2002, CLIN CANCER RES, V8, P1038
   Immordino ML, 2006, INT J NANOMED, V1, P297
   ISHIKAWA M, 1991, J COLLOID INTERF SCI, V141, P10, DOI 10.1016/0021-9797(91)90297-L
   Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P1
   IWAMOTO T, 1994, INT J PEPT PROT RES, V43, P597, DOI 10.1111/j.1399-3011.1994.tb00562.x
   Jeong WJ, 2014, BIOCONJUGATE CHEM, V25, P1996, DOI 10.1021/bc500367z
   Jevprasesphant R, 2003, INT J PHARM, V252, P263, DOI 10.1016/S0378-5173(02)00623-3
   Jiao DZ, 2012, ANGEW CHEM INT EDIT, V51, P9633, DOI 10.1002/anie.201202947
   Johnsson M, 2003, BIOPHYS J, V85, P3839, DOI 10.1016/S0006-3495(03)74798-5
   JOKELA P, 1987, J PHYS CHEM-US, V91, P3291, DOI 10.1021/j100296a037
   Jung SH, 2009, INT J PHARMACEUT, V382, P254, DOI 10.1016/j.ijpharm.2009.08.002
   KALER EW, 1989, SCIENCE, V245, P1371, DOI 10.1126/science.2781283
   Kar S, 2011, PROTEIN PEPTIDE LETT, V18, P886, DOI 10.2174/092986611796011428
   Karim KM, 2010, J ADV PHARM TECHNOL, V1, P374, DOI 10.4103/0110-5558.76435
   Kaur IP, 2008, J CONTROL RELEASE, V127, P97, DOI 10.1016/j.jconrel.2007.12.018
   Kayser O, 2005, CURR PHARM BIOTECHNO, V6, P3
   Kim BS, 2008, ACS NANO, V2, P386, DOI 10.1021/nn700408z
   Kim JK, 2014, ARCH PHARM RES, V37, P60, DOI 10.1007/s12272-013-0280-6
   Kim JS, 1995, J BIOL CHEM, V270, P31097, DOI 10.1074/jbc.270.52.31097
   Kim TY, 2004, CLIN CANCER RES, V10, P3708, DOI 10.1158/1078-0432.CCR-03-0655
   Kim YS, 2012, TUMOR BIOL, V33, P573, DOI 10.1007/s13277-011-0286-y
   Kirpotin DB, 2006, CANCER RES, V66, P6732, DOI 10.1158/0008-5472.CAN-05-4199
   Koo OM, 2005, NANOMED-NANOTECHNOL, V1, P193, DOI 10.1016/j.nano.2005.06.004
   Koo OM, 2005, NANOMED-NANOTECHNOL, V1, P77, DOI 10.1016/j.nano.2004.11.002
   Krishnadas A, 2003, PHARMACEUT RES, V20, P297, DOI 10.1023/A:1022243709003
   Kristl J, 2003, EUR J PHARM SCI, V19, P181, DOI 10.1016/S0928-0987(03)00104-0
   Kubik T, 2005, CURR PHARM BIOTECHNO, V6, P17
   Kwon GS, 2003, CRIT REV THER DRUG, V20, P357, DOI 10.1615/CritRevTherDrugCarrierSyst.v20.i5.20
   LANGER R, 1990, SCIENCE, V249, P1527, DOI 10.1126/science.2218494
   LaVan DA, 2003, NAT BIOTECHNOL, V21, P1184, DOI 10.1038/nbt876
   Lavasanifar A, 2002, ADV DRUG DELIVER REV, V54, P169, DOI 10.1016/S0169-409X(02)00015-7
   Le Garrec D., 2004, AM J DRUG DELIV, V2, P15, DOI DOI 10.1175/9038(04)0002-1
   Le Meins JF, 2011, EUR PHYS J E, V34, DOI 10.1140/epje/i2011-11014-y
   Lee ES, 2005, J CONTROL RELEASE, V103, P405, DOI 10.1016/j.jconrel.2004.12.018
   Lee ES, 2003, J CONTROL RELEASE, V91, P103, DOI 10.1016/S0168-3659(03)00239-6
   Letchford K, 2007, EUR J PHARM BIOPHARM, V65, P259, DOI 10.1016/j.ejpb.2006.11.009
   Levine DH, 2008, METHODS, V46, P25, DOI 10.1016/j.ymeth.2008.05.006
   Li Y, 2000, PHARMACEUT RES, V17, P607, DOI 10.1023/A:1007529218802
   Li ZB, 2006, MACROMOLECULES, V39, P765, DOI 10.1021/ma052199b
   Loh XJ, 2014, CHEM COMMUN, V50, P3033, DOI 10.1039/c3cc49074b
   Mai YY, 2012, CHEM SOC REV, V41, P5969, DOI 10.1039/c2cs35115c
   Mainardes RM, 2004, CURR DRUG TARGETS, V5, P449, DOI 10.2174/1389450043345407
   Manconi M, 2006, INT J PHARM, V311, P11, DOI 10.1016/j.ijpharm.2005.11.045
   Marianecci C, 2014, ADV COLLOID INTERFAC, V205, P187, DOI 10.1016/j.cis.2013.11.018
   Marsden HR, 2011, CHEM SOC REV, V40, P1572, DOI 10.1039/c0cs00115e
   Matsumura Y, 2004, BRIT J CANCER, V91, P1775, DOI 10.1038/sj.bjc.6602204
   McDevitt MR, 1999, APPL RADIAT ISOTOPES, V50, P895, DOI 10.1016/S0969-8043(98)00151-1
   Meng FH, 2009, BIOMACROMOLECULES, V10, P197, DOI 10.1021/bm801127d
   Miederer M, 2008, ADV DRUG DELIVER REV, V60, P1371, DOI 10.1016/j.addr.2008.04.009
   Min KH, 2008, J CONTROL RELEASE, V127, P208, DOI 10.1016/j.jconrel.2008.01.013
   Mishra B, 2010, NANOMED-NANOTECHNOL, V6, P9, DOI 10.1016/j.nano.2009.04.008
   Mo XQ, 2008, BIOPHYS J, V94, P1807, DOI [10.1529/biophysj.107.118299, 10.1529/hiophysj.107.118299]
   Moghimi SM, 2003, PROG LIPID RES, V42, P463, DOI 10.1016/S0163-7827(03)00033-X
   Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173
   Moses MA, 2003, CANCER CELL, V4, P337, DOI 10.1016/S1535-6108(03)00276-9
   Mourya VK, 2009, J MATER SCI-MATER M, V20, P1057, DOI 10.1007/s10856-008-3659-z
   Muller RH, 2000, EUR J PHARM BIOPHARM, V50, P161, DOI 10.1016/S0939-6411(00)00087-4
   Nagai A, 2007, J NANOSCI NANOTECHNO, V7, P2246, DOI 10.1166/jnn.2007.647
   Needham D., 2000, MECHANOCHEMISTRY LIP
   Nigavekar SS, 2004, PHARM RES, V21, P476, DOI 10.1023/B:PHAM.0000019302.26097.cc
   Ning SH, 2011, SOFT MATTER, V7, P9394, DOI 10.1039/c1sm05814b
   Ojugo ASE, 1999, NMR BIOMED, V12, P495, DOI 10.1002/(SICI)1099-1492(199912)12:8<495::AID-NBM594>3.0.CO;2-K
   Patil YB, 2009, BIOMATERIALS, V30, P859, DOI 10.1016/j.biomaterials.2008.09.056
   Pawar R, 2004, EXPERT OPIN BIOL TH, V4, P1203, DOI 10.1517/14712598.4.8.1203
   Percec V, 2010, SCIENCE, V328, P1009, DOI 10.1126/science.1185547
   Pollock S, 2010, FASEB J, V24, P1866, DOI 10.1096/fj.09-145755
   PORTE G, 1983, J PHYS CHEM-US, V87, P3541, DOI 10.1021/j100241a036
   Pramod PS, 2015, NANOSCALE, V7, P6636, DOI 10.1039/c5nr00799b
   Pramod PS, 2014, NANOSCALE, V6, P11841, DOI 10.1039/c4nr03514c
   Prasad V, 2007, DRUG DELIV, V14, P75, DOI 10.1080/10717540600642431
   Quintana A, 2002, PHARM RES-DORDR, V19, P1310, DOI 10.1023/A:1020398624602
   Rad-Malekshahi M, 2015, J AM CHEM SOC, V137, P7775, DOI 10.1021/jacs.5b02919
   Rajagopal K, 2004, CURR OPIN STRUC BIOL, V14, P480, DOI 10.1016/j.sbi.2004.06.006
   Read ES, 2007, CHEM COMMUN, P3021, DOI 10.1039/b701217a
   Ropponen J, 2004, ORG LETT, V6, P2495, DOI 10.1021/ol049555f
   Rosen BM, 2009, CHEM REV, V109, P6275, DOI 10.1021/cr900157q
   Rughani RV, 2008, MRS BULL, V33, P530, DOI 10.1557/mrs2008.106
   Sagar GH, 2007, INDIAN J EXP BIOL, V45, P133
   Sahoo SK, 2007, NANOMED-NANOTECHNOL, V3, P20, DOI 10.1016/j.nano.2006.11.008
   Sallach RE, 2006, J AM CHEM SOC, V128, P12014, DOI 10.1021/ja0638509
   Samad Abdus, 2007, Current Drug Delivery, V4, P297, DOI 10.2174/156720107782151269
   Santoso S, 2002, NANO LETT, V2, P687, DOI [10.1021/nl025563i, 10.1021/n1025563i]
   Sartor Oliver, 2003, Curr Oncol Rep, V5, P258, DOI 10.1007/s11912-003-0119-2
   Shen HW, 1999, J AM CHEM SOC, V121, P2728, DOI 10.1021/ja983712m
   Shen XC, 2006, J NANOSCI NANOTECHNO, V6, P837, DOI 10.1166/jnn.2006.126
   Shi JJ, 2010, NANO LETT, V10, P3223, DOI 10.1021/nl102184c
   Sinaga A, 2007, BIOMACROMOLECULES, V8, P2801, DOI 10.1021/bm700491q
   Sofou S, 2004, J NUCL MED, V45, P253
   Sofou S, 2007, BIOCONJUGATE CHEM, V18, P2061, DOI 10.1021/bc070075t
   Srinivas G, 2004, NAT MATER, V3, P638, DOI 10.1038/nmat1185
   Sukthankar P, 2015, LANGMUIR, V31, P2946, DOI 10.1021/la504381y
   Sukthankar P, 2013, LANGMUIR, V29, P14648, DOI 10.1021/la403492n
   Sukthankar P, 2014, BBA-BIOMEMBRANES, V1838, P2296, DOI 10.1016/j.bbamem.2014.02.005
   Sun J, 2008, LANGMUIR, V24, P10099, DOI 10.1021/la8013877
   Takeuchi H, 1998, INT J PHARM, V164, P103, DOI 10.1016/S0378-5173(97)00404-3
   Takeuchi H, 2001, J CONTROL RELEASE, V75, P83, DOI 10.1016/S0168-3659(01)00368-6
   TANFORD C, 1980, HYDROPHOBIC EFFECT F
   Tanisaka H, 2008, BIOCONJUGATE CHEM, V19, P109, DOI 10.1021/bc7001665
   ten Tije AJ, 2003, CLIN PHARMACOKINET, V42, P665, DOI 10.2165/00003088-200342070-00005
   Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632
   Torchilin VP, 2001, BIOMATERIALS, V22, P3035, DOI 10.1016/S0142-9612(01)00050-3
   Trent A, 2011, SOFT MATTER, V7, P9572, DOI 10.1039/c1sm05862b
   Tripathi PK, 2002, PHARMAZIE, V57, P261
   Tsonchev S, 2004, NANO LETT, V4, P427, DOI 10.1021/nl0351439
   Tu RS, 2004, ADV DRUG DELIVER REV, V56, P1537, DOI 10.1016/j.addr.2003.10.047
   Uchegbu IF, 1998, INT J PHARM, V172, P33, DOI 10.1016/S0378-5173(98)00169-0
   van Hell AJ, 2007, BIOMACROMOLECULES, V8, P2753, DOI 10.1021/bm0704267
   van Hell AJ, 2010, J CONTROL RELEASE, V141, P347, DOI 10.1016/j.jconrel.2009.09.012
   Vanlerberghe G., 1978, PHYSICOCHIMIE COMPOS, P303
   Vauthey S, 2002, P NATL ACAD SCI USA, V99, P5355, DOI 10.1073/pnas.072089599
   Velichko YS, 2008, J PHYS CHEM B, V112, P2326, DOI 10.1021/jp074420n
   Verma A, 2008, NAT MATER, V7, P588, DOI 10.1038/nmat2202
   Voets IK, 2006, ANGEW CHEM INT EDIT, V45, P6673, DOI 10.1002/anie.200601000
   von Maltzahn G, 2003, LANGMUIR, V19, P4332, DOI 10.1021/la026526+
   Vonarbourg A, 2006, BIOMATERIALS, V27, P4356, DOI 10.1016/j.biomaterials.2006.03.039
   Wang L, 2009, COLLOID SURFACE B, V74, P284, DOI 10.1016/j.colsurfb.2009.07.032
   Warriner HE, 1996, SCIENCE, V271, P969, DOI 10.1126/science.271.5251.969
   Wissing SA, 2004, ADV DRUG DELIVER REV, V56, P1257, DOI 10.1016/j.addr.2003.12.002
   Wu H, 2013, BIOMATERIALS, V34, P1213, DOI 10.1016/j.biomaterials.2012.08.072
   Xu H, 2009, LANGMUIR, V25, P4115, DOI 10.1021/la802499n
   Yang SJ, 2006, SUPRAMOL CHEM, V18, P389, DOI 10.1080/10615800600658586
   Yasam VR, 2014, DRUG DELIV, V21, P243, DOI 10.3109/10717544.2013.841783
   YOSHIOKA T, 1994, INT J PHARM, V105, P1, DOI 10.1016/0378-5173(94)90228-3
   Yu K, 1998, MACROMOLECULES, V31, P3509, DOI 10.1021/ma971419l
   YU ZJ, 1993, J COLLOID INTERF SCI, V156, P325, DOI 10.1006/jcis.1993.1119
   Zara GP, 2002, J DRUG TARGET, V10, P327, DOI 10.1080/10611860290031868
   Zhang JA, 2005, EUR J PHARM BIOPHARM, V59, P177, DOI 10.1016/j.ejpb.2004.06.009
   Zhang L, 2008, CLIN PHARMACOL THER, V83, P761, DOI 10.1038/sj.clpt.6100400
   Zhang SG, 2002, BIOTECHNOL ADV, V20, P321, DOI 10.1016/S0734-9750(02)00026-5
   Zhao XB, 2010, CHEM SOC REV, V39, P3480, DOI 10.1039/b915923c
   Zhao XB, 2009, SOFT MATTER, V5, P1630, DOI 10.1039/b807149g
   Zhivotovsky B, 1998, NATURE, V391, P449, DOI 10.1038/35060
NR 202
TC 7
Z9 7
U1 3
U2 52
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 15
PY 2016
VL 596
BP 22
EP 42
DI 10.1016/j.abb.2016.02.027
PG 21
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA DK0UE
UT WOS:000374626900003
PM 26926258
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Kobolak, J
   Dinnyes, A
   Memic, A
   Khademhosseini, A
   Mobasheri, A
AF Kobolak, Julianna
   Dinnyes, Andras
   Memic, Adnan
   Khademhosseini, Ali
   Mobasheri, Ali
TI Mesenchymal stem cells: Identification, phenotypic characterization,
   biological properties and potential for regenerative medicine through
   biomaterial micro-engineering of their niche
SO METHODS
LA English
DT Article
DE Mesenchymal stem cell (MSC); Regenerative medicine; CD markers;
   Micro-engineering; Stem cell niche; Biomaterials
ID MARROW STROMAL CELLS; HUMAN UMBILICAL-CORD; 3D CULTURE-SYSTEMS;
   BONE-MARROW; IN-VITRO; PROGENITOR CELLS; STEM/PROGENITOR CELLS;
   CLINICAL-APPLICATIONS; SELF-RENEWAL; DIFFERENTIATION
AB Mesenchymal stem cells (MSCs) are multipotent stem cells. Although they were originally identified in bone marrow and described as 'marrow stromal cells', they have since been identified in many other anatomical locations in the body. MSCs can be isolated from bone marrow, adipose tissue, umbilical cord and other tissues but the richest tissue source of MSCs is fat. Since they are adherent to plastic, they may be expanded in vitro. MSCs have a distinct morphology and express a specific set of CD (cluster of differentiation) molecules. The phenotypic pattern for the identification of MSCs cells requires expression of CD73, CD90, and CD105 and lack of CD34, CD45, and HLA-DR antigens. Under appropriate micro-environmental conditions MSCs can proliferate and give rise to other cell types. Therefore, they are ideally suited for the treatment of systemic inflammatory and autoimmune conditions. They have also been implicated as key players in regenerating injured tissue following injury and trauma. MSC populations isolated from adipose tissue may also contain regulatory T (Treg) cells, which have the capacity for modulating the immune system. The immunoregulatory and regenerative properties of MSCs make them ideal for use as therapeutic agents in vivo. In this paper we review the literature on the identification, phenotypic characterization and biological properties of MSCs and discuss their potential for applications in cell therapy and regenerative medicine. We also discuss strategies for biomaterial micro-engineering of the stem cell niche. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Kobolak, Julianna; Dinnyes, Andras] Biotalentum Ltd, H-2100 Godollo, Hungary.
   [Dinnyes, Andras] Szent Istvan Univ, H-2100 Godollo, Hungary.
   [Dinnyes, Andras] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, NL-3584 CL Utrecht, Netherlands.
   [Memic, Adnan] King Abdulaziz Univ, Ctr Nanotechnol, Jeddah 21589, Saudi Arabia.
   [Khademhosseini, Ali] Harvard Univ, Ctr Biomed Engn, Dept Med, Brigham & Womens Hosp,Med Sch, Cambridge, MA 02139 USA.
   [Khademhosseini, Ali] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
   [Khademhosseini, Ali] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.
   [Khademhosseini, Ali] Tohoku Univ, WPI Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan.
   [Mobasheri, Ali] Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 7XH, Surrey, England.
   [Mobasheri, Ali] Univ Nottingham, Arthrit Res UK Ctr Sport Exercise & Osteoarthrit, MRC, Arthrit Res UK Pain Ctr,Queens Med Ctr, Nottingham NG7 2UH, England.
   [Mobasheri, Ali] Univ Nottingham, Arthrit Res UK Ctr Musculoskeletal Ageing Res, Queens Med Ctr, Nottingham NG7 2UH, England.
   [Mobasheri, Ali] King Abdulaziz Univ, CEGMR, KFMRC, Fac Appl Med Sci, Jeddah 21589, Saudi Arabia.
RP Mobasheri, A (reprint author), Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 7XH, Surrey, England.
EM julianna.kobolak@biotalentum.hu; andras.dinnyes@biotalentum.hu;
   amemic@kau.edu.sa; akhademhosseini@rics.bwh.harvard.edu;
   a.mobasheri@surrey.ac.uk
RI Mobasheri, Ali/D-5770-2011; Memic, Adnan/I-6138-2013
OI Mobasheri, Ali/0000-0001-6261-1286; Memic, Adnan/0000-0003-4639-8168;
   Khademhosseini, Ali/0000-0001-6322-8852; Kobolak,
   Julianna/0000-0002-0986-9517; Dinnyes, Andras/0000-0003-3791-2583
CR Agarwal P, 2013, LAB CHIP, V13, P4525, DOI 10.1039/c3lc50678a
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Andreeva ER, 1998, TISSUE CELL, V30, P127, DOI 10.1016/S0040-8166(98)80014-1
   Arnhold S, 2007, GRAEF ARCH CLIN EXP, V245, P414, DOI 10.1007/s00417-006-0382-7
   Baharvand H, 2006, INT J DEV BIOL, V50, P645, DOI 10.1387/ijdb.052072hb
   Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180
   Bruno S., 2015, IMMUNOL LETT
   Burdick JA, 2009, TISSUE ENG PT A, V15, P205, DOI 10.1089/ten.tea.2008.0131
   Campagnoli C, 2001, BLOOD, V98, P2396, DOI 10.1182/blood.V98.8.2396
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886
   Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003
   Chen YS, 2012, STEM CELL TRANSL MED, V1, P83, DOI 10.5966/sctm.2011-0022
   Cook D, 2013, ADV EXP MED BIOL, V786, P213, DOI 10.1007/978-94-007-6621-1_12
   Cosson S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04462
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   De Bari C, 2001, ARTHRITIS RHEUM, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P
   Dennis JE, 1999, J BONE MINER RES, V14, P700, DOI 10.1359/jbmr.1999.14.5.700
   Dolatshahi-Pirouz A, 2014, SCI REP-UK, V4, DOI 10.1038/srep03896
   Dolatshahi-Pirouz A, 2011, J FUNCT BIOMATER, V2, P88, DOI 10.3390/jfb2030088
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Duffy MM, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt75
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x
   Fan CG, 2005, CELL TRANSPLANT, V14, P311, DOI 10.3727/000000005783983070
   Feng JF, 2011, P NATL ACAD SCI USA, V108, P6503, DOI 10.1073/pnas.1015449108
   FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009
   Fu XB, 2006, WOUND REPAIR REGEN, V14, P325, DOI 10.1111/j.1743-6109.2006.00128.x
   Gerecht S, 2007, P NATL ACAD SCI USA, V104, P11298, DOI 10.1073/pnas.0703723104
   Gobaa S, 2011, NAT METHODS, V8, P949, DOI [10.1038/NMETH.1732, 10.1038/nmeth.1732]
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   Hass R, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-12
   HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3
   Haynesworth SE, 1996, J CELL PHYSIOL, V166, P585, DOI 10.1002/(SICI)1097-4652(199603)166:3<585::AID-JCP13>3.3.CO;2-7
   Hwang YS, 2009, P NATL ACAD SCI USA, V106, P16978, DOI 10.1073/pnas.0905550106
   Hynes K, 2014, STEM CELLS DEV, V23, P1084, DOI 10.1089/scd.2013.0111
   in 'tAnker PS, 2003, BLOOD, V102, P1548, DOI 10.1182/blood-2003-04-1291
   Karp JM, 2007, LAB CHIP, V7, P786, DOI 10.1039/b705085m
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Kierszenbaum A, HISTOLOGY CELL BIOL
   Kolf CM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2116
   Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711
   Kuznetsov SA, 2001, J CELL BIOL, V153, P1133, DOI 10.1083/jcb.153.5.1133
   Lindroos B, 2011, STEM CELL REV REP, V7, P269, DOI 10.1007/s12015-010-9193-7
   Lund AW, 2009, TISSUE ENG PART B-RE, V15, P371, DOI [10.1089/ten.teb.2009.0270, 10.1089/ten.TEB.2009.0270]
   Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298
   Markert LD, 2009, STEM CELLS DEV, V18, P1331, DOI 10.1089/scd.2009.0114
   McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66
   Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932
   Memic A, 2014, ORGANOGENESIS, V10, P299, DOI 10.4161/org.29646
   Morigi M, 2004, J AM SOC NEPHROL, V15, P1794, DOI 10.1097/01.ASN.0000128974.07460.34
   Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046
   Munoz-Elias G, 2004, J NEUROSCI, V24, P4585, DOI 10.1523/JNEUROSCI.5060-03.2004
   Nakagawa H, 2005, BRIT J DERMATOL, V153, P29, DOI 10.1111/j.1365-2133.2005.06554.x
   Nakashima M., 2013, ENDODONTIC TOPICS, V28, P38
   Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716
   Nery AA, 2013, CYTOM PART A, V83A, P48, DOI 10.1002/cyto.a.22205
   Nichol JW, 2009, SOFT MATTER, V5, P1312, DOI 10.1039/b814285h
   Noort WA, 2002, EXP HEMATOL, V30, P870, DOI 10.1016/S0301-472X(02)00820-2
   Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100
   Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Prasad VK, 2011, BIOL BLOOD MARROW TR, V17, P534, DOI 10.1016/j.bbmt.2010.04.014
   Prockop DJ, 2009, MOL THER, V17, P939, DOI 10.1038/mt.2009.62
   Rasmusson I, 2006, EXP CELL RES, V312, P2169, DOI 10.1016/j.yexcr.2006.03.019
   Ratajczak MZ, 2015, LEUKEMIA, V29, P776, DOI 10.1038/leu.2014.346
   Riordan NH, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-29
   Sato Y, 2005, BLOOD, V106, P756, DOI 10.1182/blood-2005-02-0572
   Schuldiner M, 2000, P NATL ACAD SCI USA, V97, P11307, DOI 10.1073/pnas.97.21.11307
   Schwartz RE, 2002, J CLIN INVEST, V109, P1291, DOI 10.1172/JCI200215182
   Slack JMW, 2000, SCIENCE, V287, P1431, DOI 10.1126/science.287.5457.1431
   Sommer L., 2006, ADV EXP MED BIOL, V589, P197
   Takahashi N, 1999, BIOCHEM BIOPH RES CO, V256, P449, DOI 10.1006/bbrc.1999.0252
   Tang DQ, 2004, DIABETES, V53, P1721, DOI 10.2337/diabetes.53.7.1721
   Tay CY, 2010, EXP CELL RES, V316, P1159, DOI 10.1016/j.yexcr.2010.02.010
   Tian XF, 2008, SCAND J CLIN LAB INV, V68, P58, DOI 10.1080/00365510701466416
   WAKITANI S, 1995, MUSCLE NERVE, V18, P1417, DOI 10.1002/mus.880181212
   Wang HS, 2004, STEM CELLS, V22, P1330, DOI 10.1634/stemcells.2004-0013
   Wang SH, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-19
   Wang Y, 2007, J TISSUE ENG REGEN M, V1, P39, DOI 10.1002/term.6
   Williams JT, 1999, AM SURGEON, V65, P22
   Yang F, 2010, BIOMACROMOLECULES, V11, P1909, DOI 10.1021/bm100357t
   Ye Z, 2008, HEPATOB PANCREAT DIS, V7, P608
   Yoo JU, 1998, J BONE JOINT SURG AM, V80A, P1745, DOI 10.2106/00004623-199812000-00004
   Young RG, 1998, J ORTHOPAED RES, V16, P406, DOI 10.1002/jor.1100160403
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 87
TC 34
Z9 36
U1 1
U2 41
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1046-2023
EI 1095-9130
J9 METHODS
JI Methods
PD APR 15
PY 2016
VL 99
BP 62
EP 68
DI 10.1016/j.ymeth.2015.09.016
PG 7
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA DJ8AX
UT WOS:000374435600008
PM 26384580
DA 2018-10-20
ER

PT J
AU Hu, JJ
   Hu, K
   Cheng, YY
AF Hu, Jingjing
   Hu, Ke
   Cheng, Yiyun
TI Tailoring the dendrimer core for efficient gene delivery
SO ACTA BIOMATERIALIA
LA English
DT Review
DE Dendrimer; Core effect; Gene delivery; Flexibility; Hydrophobicity
ID DENDRON-BEARING LIPIDS; SMALL INTERFERING RNA; SURFACE-ENGINEERED
   DENDRIMERS; STAR-SHAPED POLYMER; SIRNA DELIVERY; IN-VITRO; PAMAM
   DENDRIMERS; DRUG-DELIVERY; POLYAMIDOAMINE DENDRIMERS; BIOMEDICAL
   APPLICATIONS
AB Dendrimers have been widely used as non-viral gene vectors due to well-defined chemical structures, high density of cationic charges and ease of surface modification. Although a large number of studies have reported the important roles of dendrimer architecture, component, generation and surface functionality in gene delivery, the effect of dendrimer core on this issue still remains unclear. Recent literatures suggest that a slight alternation in dendrimer core has a profound effect in the transfection efficacy and biocompatibility. In this review, we will discuss the transfection mechanism of dendrimers with different types of cores in respect of flexibility, hydrophobicity and functionality. We hope to open a possibility of designing efficient dendrimers for gene delivery by choosing a proper dendrimer core.
   Statement of Significance
   As a branch of researches on dendrimers and dendritic polymers, the design of biocompatible and high efficient polymeric gene carriers has attracted increasing attentions during these years. Although the effect of dendrimer generation, species, architecture and surface functionality on gene delivery have been widely reported, the effect of dendrimer core on this issue still remains unclear. Recent literatures suggest that a minor variation on the dendrimer core has a profound effect in the transfection efficacy and biocompatibility. This critical review summarized the dendrimers with different types of cores and discussed the transfection mechanism with particular focus on the flexibility, hydrophobicity, and functionality. It is hoped to provide a new insight to design efficient and safe dendrimer-based gene vectors by choosing a proper core.
   To the best of our knowledge, this is the first review on the effect of dendrimer core on gene delivery. The findings obtained in this filed are of central importance in the design of efficient polymeric gene vectors. This article will appeal a wide readership such as physical chemist, dendrimer chemist, biological chemist, pharmaceutical scientist, and biomaterial researchers. We hope that this review article can be published by Acta Biomaterialia, a top journal that publishes important reviews in the field of biomaterials science. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Hu, Jingjing; Cheng, Yiyun] E China Normal Univ, Shanghai Key Lab Regulatory Biol, Sch Life Sci, Shanghai 200241, Peoples R China.
   [Hu, Ke] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Gynecol & Obstet, Shanghai 200127, Peoples R China.
RP Cheng, YY (reprint author), E China Normal Univ, Shanghai Key Lab Regulatory Biol, Sch Life Sci, Shanghai 200241, Peoples R China.
EM yycheng@mail.ustc.edu.cn
FU National Natural Science Foundation of China [21322405, 21474030,
   21404020]; Shanghai Municipal Science and Technology Commission
   [148014518]
FX We take financial supports from the National Natural Science Foundation
   of China (No. 21322405, No. 21474030 and No. 21404020) and the Shanghai
   Municipal Science and Technology Commission (148014518) on this work.
CR Albertazzi L, 2012, BIOMACROMOLECULES, V13, P4089, DOI 10.1021/bm301384y
   Arima H, 2014, CURR TOP MED CHEM, V14, P465, DOI 10.2174/1568026613666131219123610
   Arima H, 2013, ADV DRUG DELIVER REV, V65, P1204, DOI 10.1016/j.addr.2013.04.001
   Auwarter W, 2015, NAT CHEM, V7, P105, DOI 10.1038/nchem.2159
   Bonnet V, 2015, DRUG DISCOV TODAY, V20, P1120, DOI 10.1016/j.drudis.2015.05.008
   Carter KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4546
   Chang H, 2014, BIOCONJUGATE CHEM, V25, P342, DOI 10.1021/bc400496u
   Cheng HH, 2000, GENETICA, V108, P53, DOI 10.1023/A:1004047902652
   Cheng YY, 2014, SOFT MATTER, V10, P2714, DOI 10.1039/c3sm53180e
   Cheng YY, 2011, CHEM SOC REV, V40, P2673, DOI 10.1039/c0cs00097c
   Deng JJ, 2011, J MATER CHEM, V21, P5273, DOI 10.1039/c0jm03030a
   Dufes C, 2005, ADV DRUG DELIVER REV, V57, P2177, DOI 10.1016/j.addr.2005.09.017
   Fan JQ, 2013, SMALL, V9, P613, DOI 10.1002/smll.201201456
   Ghobril C, 2013, ANGEW CHEM INT EDIT, V52, P14070, DOI 10.1002/anie.201308007
   Gray WD, 2013, BIOMACROMOLECULES, V14, P101, DOI 10.1021/bm301393z
   HAENSLER J, 1993, BIOCONJUGATE CHEM, V4, P372, DOI 10.1021/bc00023a012
   Hayashi Y, 2012, MOL PHARMACEUT, V9, P1645, DOI 10.1021/mp200654g
   He DS, 2015, MACROMOL BIOSCI, V15, P600, DOI 10.1002/mabi.201400524
   Hu JJ, 2012, CHEM REV, V112, P3856, DOI 10.1021/cr200333h
   Hung CH, 2015, J BIOMED MATER RES A, V103, P1595, DOI 10.1002/jbm.a.35299
   Jones SP, 2008, CHEM COMMUN, P4700, DOI 10.1039/b811852c
   Jones SP, 2011, MOL PHARMACEUT, V8, P416, DOI 10.1021/mp100260c
   Kala S, 2014, J MED CHEM, V57, P2634, DOI 10.1021/jm401907z
   Kanasty R, 2013, NAT MATER, V12, P967, DOI [10.1038/NMAT3765, 10.1038/nmat3765]
   Kaneshiro TL, 2007, MOL PHARM, V4, P759, DOI 10.1021/mp070036z
   Kannan RM, 2014, J INTERN MED, V276, P579, DOI 10.1111/joim.12280
   Kesharwani P, 2015, DRUG DISCOV TODAY, V20, P536, DOI 10.1016/j.drudis.2014.12.012
   Khan OF, 2014, ANGEW CHEM INT EDIT, V53, P14397, DOI 10.1002/anie.201408221
   Kim T, 2004, BIOMACROMOLECULES, V5, P2487, DOI 10.1021/bm049563j
   Kono K, 2012, BIOCONJUGATE CHEM, V23, P871, DOI 10.1021/bc200368b
   Lachelt U, 2015, CHEM REV, V115, P11043, DOI 10.1021/cr5006793
   Lee CC, 2005, NAT BIOTECHNOL, V23, P1517, DOI 10.1038/nbt1171
   Liang B, 2013, CARBOHYD POLYM, V94, P185, DOI 10.1016/j.carbpol.2012.12.070
   Lim J, 2012, ADV DRUG DELIVER REV, V64, P826, DOI 10.1016/j.addr.2012.03.008
   Liu HM, 2012, J AM CHEM SOC, V134, P17680, DOI 10.1021/ja307290j
   Liu QL, 2012, SMALL, V8, P2070, DOI 10.1002/smll.201200158
   Liu XX, 2009, CHEMMEDCHEM, V4, P1302, DOI 10.1002/cmdc.200900076
   Liu XX, 2014, BIOTECHNOL ADV, V32, P844, DOI 10.1016/j.biotechadv.2013.08.001
   Liu XX, 2012, MOL PHARMACEUT, V9, P470, DOI 10.1021/mp2006104
   Liu XX, 2011, BIOCONJUGATE CHEM, V22, P2461, DOI 10.1021/bc200275g
   Liu ZH, 2010, PROG POLYM SCI, V35, P1144, DOI 10.1016/j.progpolymsci.2010.04.007
   Luo K, 2014, BIOTECHNOL ADV, V32, P818, DOI 10.1016/j.biotechadv.2013.12.008
   Ma D, 2014, BIOMATERIALS, V35, P4357, DOI 10.1016/j.biomaterials.2014.01.070
   Ma D, 2013, MACROMOL BIOSCI, V13, P1221, DOI 10.1002/mabi.201300139
   Ma XP, 2009, J AM CHEM SOC, V131, P14795, DOI 10.1021/ja9037406
   Merkel OM, 2010, MOL PHARMACEUT, V7, P969, DOI 10.1021/mp100101s
   Merkel OM, 2009, BIOCONJUGATE CHEM, V20, P1799, DOI 10.1021/bc900243r
   NEWKOME GR, 1985, J ORG CHEM, V50, P2003, DOI 10.1021/jo00211a052
   Nishiyama N, 2005, NAT MATER, V4, P934, DOI 10.1038/nmat1524
   Nomoto T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4545
   Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775
   Posocco P, 2013, MOL PHARMACEUT, V10, P3262, DOI 10.1021/mp400329g
   Rodrigo AC, 2011, BIOMACROMOLECULES, V12, P1205, DOI 10.1021/bm1014987
   Somani S, 2014, NANOMEDICINE-UK, V9, P2403, DOI [10.2217/NNM.14.130, 10.2217/nnm.14.130]
   Stanwix H, 2012, NANOMEDICINE-UK, V7, P953, DOI [10.2217/nnm.12.81, 10.2217/NNM.12.81]
   Sun QH, 2014, ADV MATER, V26, P7615, DOI 10.1002/adma.201401554
   Svenson S, 2005, ADV DRUG DELIVER REV, V57, P2106, DOI 10.1016/j.addr.2005.09.018
   Takahashi T, 2005, BIOCONJUGATE CHEM, V16, P1160, DOI 10.1021/bc050012f
   Takahashi T, 2003, BIOCONJUGATE CHEM, V14, P764, DOI 10.1021/bc025663f
   Takahashi T, 2007, BIOCONJUGATE CHEM, V18, P1349, DOI 10.1021/bc060311k
   Tang JB, 2011, J CONTROL RELEASE, V152, pE89, DOI 10.1016/j.jconrel.2011.08.142
   Tang MX, 1996, BIOCONJUGATE CHEM, V7, P703, DOI 10.1021/bc9600630
   Tian WD, 2013, CHEM SOC REV, V42, P705, DOI 10.1039/c2cs35306g
   Tomalia DA, 2005, PROG POLYM SCI, V30, P294, DOI 10.1016/j.progpolymsci.2005.01.007
   Tomalia DA, 2012, DENDRIMERS, DENDRONS, AND DENDRITIC POLYMERS: DISCOVERY, APPLICATIONS, AND THE FUTURE, P1, DOI 10.1017/CBO9781139048859
   van Vlerken LE, 2007, PHARM RES, V24, P1405, DOI 10.1007/s11095-007-9284-6
   Wagner E., 2014, ADV GENET, P231
   Wang H, 2015, ANGEW CHEM INT EDIT, V54, P11647, DOI 10.1002/anie.201501461
   Wang H, 2012, J PHYS CHEM B, V116, P11217, DOI 10.1021/jp3062916
   Wang MM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4053
   Wang Y, 2014, ADV MATER, V26, P4163, DOI 10.1002/adma.201400323
   Watkins DM, 1997, LANGMUIR, V13, P3136, DOI 10.1021/la9620263
   Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742
   Yang JP, 2015, CHEM REV, V115, P5274, DOI 10.1021/cr500542t
   Ye MZ, 2013, J CONTROL RELEASE, V169, P239, DOI 10.1016/j.jconrel.2013.01.034
   Yin R, 2014, NANOMED-NANOTECHNOL, V10, P795, DOI 10.1016/j.nano.2013.11.014
   Yu TZ, 2012, ANGEW CHEM INT EDIT, V51, P8478, DOI 10.1002/anie.201203920
   Yuba E, 2012, J CONTROL RELEASE, V160, P552, DOI 10.1016/j.jconrel.2012.04.002
   Zhang XQ, 2005, BIOMACROMOLECULES, V6, P341, DOI 10.1021/bm040060n
   Zhang Y, 2013, BIOMACROMOLECULES, V14, P4289, DOI 10.1021/bm4011563
   Zhou JH, 2006, CHEM COMMUN, P2362, DOI 10.1039/b601381c
   Zhou JH, 2011, MOL THER, V19, P2228, DOI 10.1038/mt.2011.207
   Zhou ZX, 2014, NANOMEDICINE-UK, V9, P2387, DOI [10.2217/NNM.14.133, 10.2217/nnm.14.133]
   Zhou ZX, 2014, ANGEW CHEM INT EDIT, V53, P10949, DOI 10.1002/anie.201406442
NR 84
TC 22
Z9 23
U1 9
U2 131
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR 15
PY 2016
VL 35
BP 1
EP 11
DI 10.1016/j.actbio.2016.02.031
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DK8FI
UT WOS:000375162200001
PM 26923528
DA 2018-10-20
ER

PT J
AU Sanchez-Rodriguez, SP
   Moran-Garcia, AD
   Bolonduro, O
   Dordick, JS
   Bustos-Jaimes, I
AF Paola Sanchez-Rodriguez, Sandra
   del Carmen Moran-Garcia, Areli
   Bolonduro, Olurotimi
   Dordick, Jonathan S.
   Bustos-Jaimes, Ismael
TI Enhanced assembly and colloidal stabilization of primate
   erythroparvovirus 1 virus-like particles for improved surface
   engineering
SO ACTA BIOMATERIALIA
LA English
DT Article
DE In vitro assembly; Virus-like particles; Nanobiotechnology; Fluorescent
   labeling; Nanoparticle stabilization; Parvovirus B19
ID HUMAN PARVOVIRUS B19; DRUG-DELIVERY; EMPTY CAPSIDS; PROTEIN;
   NANOPARTICLES; PLATFORM; DISPLAY; CELLS
AB Virus-like particles (VLPs) are the product of the self-assembly, either in vivo or in vitro, of structural components of viral capsids. These particles are excellent scaffolds for surface display of biomolecules that can be used in vaccine development and tissue-specific drug delivery. Surface engineering of VLPs requires structural stability and chemical reactivity. Herein, we report the enhanced assembly, colloidal stabilization and fluorescent labeling of primate erythroparvovirus 1 (PE1V), generally referred to as parvovirus B19. In vitro assembly of the VP2 protein of PE1V produces VLPs, which are prone to flocculate and hence undergo limited chemical modification by thiol-specific reagents like the fluorogenic monobromobimane (mBBr). We determined that the addition of 0.2 M L-arginine during the assembly process produced an increased yield of soluble VLPs with good dispersion stability. Fluorescent labeling of VLPs suspended in phosphate buffered saline (PBS) added with 0.2 M L-Arg was achieved in significantly shorter times than the flocculated VLPs assembled in only PBS buffer. Finally, to demonstrate the potential application of this approach, mBBr-labeled VLPs were successfully used to tag human hepatoma HepG2 cells. This new method for assembly and labeling PE1V VLPs eases its applications and provides insights on the manipulation of this biomaterial for further developments.
   Statement of Significance
   Application of virus-derived biomaterials sometimes requires surface modification for diverse purposes, including enhanced cell-specific interaction, the inclusion of luminescent probes for bioimaging, or the incorporation of catalytic properties for the production of enzyme nanocarriers. In this research, we reported for the first time the colloidal stabilization of the primate erythroparvovirus 1 (PE1V) virus like particles (VLPs). Also, we report the chemical modification of the natural Cys residues located on the surface of these VLPs with a fluorescent probe, as well as its application for tagging hepatoma cells in vitro. Keeping in mind that PE1V is a human pathogen, virus-host interactions already exist in human cells, and they can be exploited for therapeutic and research aims. This study will impact on the speed in which the scientific community will be able to manipulate PEIV VLPs for diverse purposes. Additionally, this study may provide insights on the colloidal properties of these VLPs as well as in the effect of different protein additives used for protein stabilization. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Paola Sanchez-Rodriguez, Sandra; Bolonduro, Olurotimi; Dordick, Jonathan S.] Rensselaer Polytech Inst, Dept Chem & Biol Engn, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY USA.
   [Paola Sanchez-Rodriguez, Sandra; del Carmen Moran-Garcia, Areli; Bustos-Jaimes, Ismael] Univ Nacl Autonoma Mexico, Fac Med, Dept Biochem, Mexico City 04510, DF, Mexico.
   [Dordick, Jonathan S.] Rensselaer Polytech Inst, Dept Biomed Engn, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.
   [Dordick, Jonathan S.] Rensselaer Polytech Inst, Dept Biol, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.
RP Bustos-Jaimes, I (reprint author), Univ Nacl Autonoma Mexico, Fac Med, Dept Biochem, Mexico City 04510, DF, Mexico.
EM ismaelb@unam.mx
OI Bustos-Jaimes, Ismael/0000-0003-3038-8141; Bolonduro,
   Olurotimi/0000-0002-3210-0650
FU Consejo Nacional de Ciencia y Tecnologia (CONACyT), Mexico
   [CB-2010-01-151189]; Programa de Apoyo a Proyectos de Investigacion e
   Innovacion Tecnologica (PAPIIT), UNAM [IN215613]
FX This work was funded by Consejo Nacional de Ciencia y Tecnologia
   (CONACyT), Mexico (grant CB-2010-01-151189) and Programa de Apoyo a
   Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT), UNAM
   (grant IN215613). The authors acknowledge technical support of Laura
   Alvarez-Anorve.
CR Anderson L.J., 1997, MONOGR VIROL, V20, P153
   BROWN CS, 1991, J VIROL, V65, P2702
   Gallinella G., 2013, ISRN VIROL, V2013
   GERSTEIN M, 1992, ACTA CRYSTALLOGR A, V48, P271, DOI 10.1107/S0108767391012680
   Gilbert L, 2005, BIOCHEM BIOPH RES CO, V331, P527, DOI 10.1016/j.bbrc.2005.03.208
   Huang RK, 2011, NANOMEDICINE-UK, V6, P55, DOI 10.2217/NNM.10.99
   ICTV, 2015, VIR TAX 2014 REL
   KAJIGAYA S, 1991, P NATL ACAD SCI USA, V88, P4646, DOI 10.1073/pnas.88.11.4646
   KAJIGAYA S, 1989, P NATL ACAD SCI USA, V86, P7601, DOI 10.1073/pnas.86.19.7601
   Kamerzell TJ, 2011, ADV DRUG DELIVER REV, V63, P1118, DOI 10.1016/j.addr.2011.07.006
   Kaufmann B, 2004, P NATL ACAD SCI USA, V101, P11628, DOI 10.1073/pnas.0402992101
   Klem MT, 2008, J MATER CHEM, V18, P3821, DOI 10.1039/b805778h
   KOSOWER NS, 1987, METHOD ENZYMOL, V143, P76
   Manchester M, 2006, ADV DRUG DELIVER REV, V58, P1505, DOI 10.1016/j.addr.2006.09.014
   Mead G, 2014, BIOCONJUGATE CHEM, V25, P1444, DOI 10.1021/bc500200t
   NELSON CA, 1971, J BIOL CHEM, V246, P3895
   Ohtake S, 2011, ADV DRUG DELIVER REV, V63, P1053, DOI 10.1016/j.addr.2011.06.011
   Sanchez-Rodriguez SP, 2015, MOL BIOTECHNOL, V57, P309, DOI 10.1007/s12033-014-9823-4
   Prasuhn DE, 2008, CHEM BIOL, V15, P513, DOI 10.1616/j.chembiol.2008.03.018
   Ratha A, 2008, PNAS, V106, P1760
   Ren Y, 2007, BIOCONJUGATE CHEM, V18, P836, DOI 10.1021/bc060361p
   RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49
   Sanchez-Rodriguez S. P., 2010, CURRENT CHEM BIOL, V4, P231
   Sanchez-Rodriguez SP, 2012, BIOCHIMIE, V94, P870, DOI 10.1016/j.biochi.2011.12.006
   Santillan-Uribe JS, 2015, VIRUS RES, V201, P1, DOI 10.1016/j.virusres.2015.02.011
   Stephanopoulos N, 2009, ANGEW CHEM INT EDIT, V48, P9498, DOI 10.1002/anie.200902727
   Tsumoto K, 2004, BIOTECHNOL PROGR, V20, P1301, DOI 10.1021/bp0498793
   Tsumoto K, 2003, PROTEIN EXPRES PURIF, V28, P1, DOI 10.1016/S1046-5928(02)00641-1
   Udit AK, 2010, CHEMBIOCHEM, V11, P481, DOI 10.1002/cbic.201000001
   Yoo JW, 2011, NAT REV DRUG DISCOV, V10, P521, DOI 10.1038/nrd3499
   Yuan W, 2001, VIROLOGY, V279, P546, DOI 10.1006/viro.2000.0734
   Zeltins A, 2013, MOL BIOTECHNOL, V53, P92, DOI 10.1007/s12033-012-9598-4
NR 32
TC 5
Z9 5
U1 1
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR 15
PY 2016
VL 35
BP 206
EP 214
DI 10.1016/j.actbio.2016.02.024
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DK8FI
UT WOS:000375162200019
PM 26911883
DA 2018-10-20
ER

PT J
AU Shimizu, T
   Fujibayashi, S
   Yamaguchi, S
   Yamamoto, K
   Otsuki, B
   Takemoto, M
   Tsukanaka, M
   Kizuki, T
   Matsushita, T
   Kokubo, T
   Matsuda, S
AF Shimizu, Takayoshi
   Fujibayashi, Shunsuke
   Yamaguchi, Seiji
   Yamamoto, Koji
   Otsuki, Bungo
   Takemoto, Mitsuru
   Tsukanaka, Masako
   Kizuki, Takashi
   Matsushita, Tomiharu
   Kokubo, Tadashi
   Matsuda, Shuichi
TI Bioactivity of sol-gel-derived TiO2 coating on polyetheretherketone: In
   vitro and in vivo studies
SO ACTA BIOMATERIALIA
LA English
DT Article
DE PEEK; Bioactivity; TiO2; Sol-gel; Sandblast; O-2 plasma
ID TISSUE-REACTIONS; ACETABULAR CUPS; PEEK IMPLANTS; CELL-ADHESION;
   ETHER-KETONE; BONE; TITANIUM; SURFACE; FIXATION; OXIDE
AB A polyetheretherketone (PEEK) surface was modified using a sol-gel-derived TiO2 coating in order to confer bone-bonding ability. To enhance the bonding strength of the coating layer, pretreatment with either O-2 plasma or sandblasting was performed prior to sol-gel coating. Additionally, post-treatment with acid was carried out to confer apatite (calcium phosphate)-forming ability to the surface. Biomechanical and histological analyses performed using an in vivo rabbit tibia model showed that PEEK surfaces modified with sol-gel-derived TiO2 and acid post-treatment had better bone-bonding properties than uncoated PEEK surfaces. These modified surfaces also performed well in terms of their in vitro cell responses due to their modified surface chemistries and topographies. Although O-2 plasma or sandblasting treatment were, for the most part, equivocal in terms of performance, we conclude that sol-gel-derived TiO2 coating followed by acid post-treatment significantly improves the bone bonding ability of PEEK surfaces, thus rendering them optimal for their use in surgical implants.
   Statement of Significance
   The role of polyetheretherketone (PEEK) as an alternative biomaterial to conventional metallic implant materials has become increasingly important. However, its low bone bonding ability is yet to be resolved. This in vivo and in vitro investigation on the functionalization of PEEK surfaces highlights the utility of this material in clinical interventions that require implants, and may extend range of applications of PEEK. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Shimizu, Takayoshi; Fujibayashi, Shunsuke; Otsuki, Bungo; Takemoto, Mitsuru; Tsukanaka, Masako; Matsuda, Shuichi] Kyoto Univ, Grad Sch Med, Dept Orthoped Surg, Kyoto 6068507, Japan.
   [Yamaguchi, Seiji; Kizuki, Takashi; Matsushita, Tomiharu; Kokubo, Tadashi] Chubu Univ, Dept Biomed Sci, Coll Life & Hlth Sci, 1200 Matsumoto, Kasugai, Aichi 4878501, Japan.
   [Yamamoto, Koji] Kyoto Univ, Res & Educ Unit Leaders Integrated Med Syst, Ctr Promot Interdisciplinary Educ & Res, Kyoto 6068507, Japan.
RP Shimizu, T (reprint author), Kyoto Univ, Dept Orthoped Surg, Grad Sch Med, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.
EM takayosh@kuhp.kyoto-u.ac.jp
OI Otsuki, Bungo/0000-0002-4749-7830; Matsuda, Shuichi/0000-0003-0802-1255
CR [Anonymous], 2014, 233172014 ISO
   [Anonymous], 1994, GUID DOC TEST ORTH I
   Areva S, 2004, J BIOMED MATER RES A, V70A, P169, DOI 10.1002/jbm.a.20120
   Bacakova L, 2004, PHYSIOL RES, V53, pS35
   Bacakova L, 2011, BIOTECHNOL ADV, V29, P739, DOI 10.1016/j.biotechadv.2011.06.004
   Barkarmo S, 2013, J BIOMED MATER RES A, V101, P465, DOI 10.1002/jbm.a.34358
   BUMA P, 1995, J ARTHROPLASTY, V10, P389, DOI 10.1016/S0883-5403(05)80190-1
   Devine DM, 2013, J BIOMED MATER RES B, V101B, P591, DOI 10.1002/jbm.b.32861
   FURLONG RJ, 1991, J BONE JOINT SURG BR, V73, P741
   Johansson P, 2014, INT J NANOMED, V9, P3903, DOI 10.2147/IJN.S60387
   Jones FH, 2001, SURF SCI REP, V42, P79
   Kato H, 2000, J BIOMED MATER RES, V53, P28, DOI 10.1002/(SICI)1097-4636(2000)53:1<28::AID-JBM4>3.3.CO;2-6
   Kizuki T, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-014-5359-1
   KOKUBO T, 1991, BIOMATERIALS, V12, P155, DOI 10.1016/0142-9612(91)90194-F
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kokubo T, 2000, KEY ENG MAT, V192-1, P3
   Kokubo T, 2008, J MATER SCI-MATER M, V19, P695, DOI 10.1007/s10856-007-3103-9
   Krzak-Ros J, 2009, ACTA BIOENG BIOMECH, V11, P21
   Kurtz SM, 2007, BIOMATERIALS, V28, P4845, DOI 10.1016/j.biomaterials.2007.07.013
   Lau D., 2015, J NEUROSURG, P1
   Lau D, 2013, NEUROSURGERY, V72, P529, DOI 10.1227/NEU.0b013e318282a558
   Lee JH, 2013, ACTA BIOMATER, V9, P6177, DOI 10.1016/j.actbio.2012.11.030
   Lee TC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111390
   Manley MT, 1998, J BONE JOINT SURG AM, V80A, P1175, DOI 10.2106/00004623-199808000-00011
   NAKAMURA T, 1985, J BIOMED MATER RES, V19, P685, DOI 10.1002/jbm.820190608
   Nemoto O, 2014, EUR SPINE J, V23, P2150, DOI 10.1007/s00586-014-3466-9
   NEO M, 1992, J BIOMED MATER RES, V26, P1419, DOI 10.1002/jbm.820261103
   Nishiguchi S, 2003, J BIOMED MATER RES A, V67A, P26, DOI 10.1002/jbm.a.10540
   Ochsenbein A, 2008, ACTA BIOMATER, V4, P1506, DOI 10.1016/j.actbio.2008.03.012
   Olivares-Navarrete R, 2015, SPINE, V40, P399, DOI 10.1097/BRS.0000000000000778
   Olivares-Navarrete R, 2012, SPINE J, V12, P265, DOI 10.1016/j.spinee.2012.02.002
   Patsi ME, 1998, J SOL-GEL SCI TECHN, V11, P55, DOI 10.1023/A:1008684815735
   Pattanayak DK, 2011, J MATER SCI-MATER M, V22, P1803, DOI 10.1007/s10856-011-4372-x
   Rokkum M, 2003, J BONE JOINT SURG BR, V85B, P440, DOI 10.1302/0301-620X.85B3.12834
   Saito T, 2011, ACTA BIOMATER, V7, P1558, DOI 10.1016/j.actbio.2010.11.018
   Schimmel J. J., 2012, J SPINAL DISORDERS T
   Toth JM, 2006, BIOMATERIALS, V27, P324, DOI 10.1016/j.biomaterials.2005.07.011
   Vadapalli S, 2006, SPINE, V31, P2189, DOI 10.1097/01.brs.0000232720.23748.ce
   Wu GM, 2009, SURF COAT TECH, V203, P2755, DOI 10.1016/j.surfcoat.2009.02.115
   Wu WJ, 2012, EUR SPINE J, V21, P1374, DOI 10.1007/s00586-011-2131-9
   Wu XM, 2012, INT J NANOMED, V7, P1215, DOI 10.2147/IJN.S28101
NR 41
TC 13
Z9 13
U1 5
U2 50
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR 15
PY 2016
VL 35
BP 305
EP 317
DI 10.1016/j.actbio.2016.02.007
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DK8FI
UT WOS:000375162200028
PM 26861855
DA 2018-10-20
ER

PT J
AU Wetteland, CL
   Nguyen, NYT
   Liu, HN
AF Wetteland, Cheyann Lee
   Nhu-Y Thi Nguyen
   Liu, Huinan
TI Concentration-dependent behaviors of bone marrow derived mesenchymal
   stem cells and infectious bacteria toward magnesium oxide nanoparticles
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Magnesium oxide (MgO) nanoparticles; Bone marrow derived mesenchymal
   stem cells (BMSCs); Cytocompatibility; Viability; Bacteria; Escherichia
   coli (E. coli); Staphylococcus epidermidis (S. epidermidis)
ID ANTIBACTERIAL PROPERTIES; TRICALCIUM PHOSPHATE; MGO NANOPARTICLES;
   ESCHERICHIA-COLI; STROMAL CELLS; IN-VITRO; DEGRADATION; HYDROXYAPATITE;
   ALLOYS; DIFFERENTIATION
AB This article reports the quantitative relationship between the concentration of magnesium oxide (MgO) nanoparticles and its distinct biological activities towards mammalian cells and infectious bacteria for the first time. The effects of MgO nanoparticles on the viability of bone marrow derived mesenchymal stem cells (BMSCs) and infectious bacteria (both gram-negative Escherichia coli and gram-positive Staphylococcus epidermidis) showed a concentration-dependent behavior in vitro. The critical concentrations of MgO nanoparticles identified in this study provided valuable guidelines for biomaterial design toward potential clinical translation. BMSCs density increased significantly when cultured in 200 mu g/mL of MgO in comparison to the Cells Only control without MgO. The density of BMSCs decreased significantly after culture in the media with 500 mu g/mL or more of MgO. Concentrations at or above 1000 mu g mL of MgO resulted in complete BMSCs death. Quantification of colony forming units (CFU) revealed that the minimum bactericidal concentration (MBC) of MgO for E. coli and S. epidermidis was 1200 mu g/mL. The addition of MgO nanoparticles into the cultures increased the pH and Mg2+ ion concentration in the respective culture media, which might have played a role in the observed cell responses but not the main factors. E. coli and S. epidermidis still proliferated significantly at alkaline pH up to 10 or with supplemental Mg2+ dosages up to 50 mM, indicating bactericidal properties of MgO are beyond the effects of increased media pH and me ion concentrations. MgO nanoparticles at a concentration of 200 mu g/mL provided dual benefits of promoting BMSC proliferation while reducing bacterial adhesion, which should be further studied for potential medical implant applications. The use of free MgO nanoparticles yielded detrimental effects to BMSCs in concentrations above 300 mu g/mL. We recommend further study into MgO nanoparticle as a coating material or as a part of a composite.
   Statement of Significance
   This article reports the quantitative relationship between the concentration of magnesium oxide (MgO) nanoparticles and its distinct biological activities towards mammalian cells and infectious bacteria for the first time. The effects of MgO nanoparticles on the viability of bone marrow derived mesenchymal stem cells (BMSCs) and infectious bacteria (both gram-negative Escherichia coli and gram-positive Staphylococcus epidermidis) showed a concentration-dependent behavior in vitro. The critical concentrations of MgO nanoparticles identified in this study provided valuable guidelines for biomaterial design toward potential clinical translation. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Wetteland, Cheyann Lee; Liu, Huinan] Univ Calif Riverside, Dept Bioengn, 900 Univ Ave, Riverside, CA 92521 USA.
   [Nhu-Y Thi Nguyen; Liu, Huinan] Univ Calif Riverside, Dept Microbiol, Riverside, CA 92521 USA.
   [Liu, Huinan] Univ Calif Riverside, Mat Sci & Engn Program, Riverside, CA 92521 USA.
   [Liu, Huinan] Univ Calif Riverside, Stem Cell Ctr, Riverside, CA 92521 USA.
RP Liu, HN (reprint author), Univ Calif Riverside, Dept Bioengn, 900 Univ Ave, Riverside, CA 92521 USA.
EM huinan.liu@ucr.edu
FU U.S. National Science Foundation (NSF) [CBET 1512764]; Burroughs
   Wellcome Fund [1011235]; Hellman Faculty Fellowship; NIH SBIR program
   [6R43DE023287]; University of California (UC) Regents Faculty Fellowship
FX The authors thank the support from the U.S. National Science Foundation
   (NSF award CBET 1512764), the Burroughs Wellcome Fund (1011235), the
   Hellman Faculty Fellowship (HL), NIH SBIR program (6R43DE023287), and
   the University of California (UC) Regents Faculty Fellowship (HL). The
   authors appreciate the Central Facility for Advanced Microscopy and
   Microanalysis (CFAMM) for the use of SEM FEI XL30 and TEM at the
   University of California at Riverside. The authors also thank the
   undergraduate student researchers (Vannessa Guzman, Hakikat Gill, and
   Jimmy Tran) for their assistance with pH measurements and ImageJ
   analysis.
CR Al-Hazmi F, 2012, SUPERLATTICE MICROST, V52, P200, DOI 10.1016/j.spmi.2012.04.013
   Carpenter TO, 2006, J CLIN ENDOCR METAB, V91, P4866, DOI 10.1210/jc.2006-1391
   Cipriano A., 2014, ACTA BIOMATER
   Cipriano AF, 2015, ACTA BIOMATER, V12, P298, DOI 10.1016/j.actbio.2014.10.018
   Cremet L, 2012, J INFECTION, V64, P169, DOI 10.1016/j.jinf.2011.11.010
   Dong CX, 2011, MATER RES BULL, V46, P576, DOI 10.1016/j.materresbull.2010.12.023
   Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063
   Fielding GA, 2014, J BIOMED MATER RES A, V102, P2417, DOI 10.1002/jbm.a.34909
   FRUHWIRTH O, 1985, SURF TECHNOL, V24, P301, DOI 10.1016/0376-4583(85)90080-9
   Goldstein DA, 1990, CLIN METHODS HIST PH
   Grayson WL, 2015, NAT REV ENDOCRINOL, V11, P140, DOI 10.1038/nrendo.2014.234
   Hickey DJ, 2015, ACTA BIOMATER, V14, P175, DOI 10.1016/j.actbio.2014.12.004
   Honda MJ, 2007, BIOMATERIALS, V28, P680, DOI 10.1016/j.biomaterials.2006.09.039
   Iskandar ME, 2013, J BIOMED MATER RES A, V101, P2340, DOI 10.1002/jbm.a.34530
   Ito T., 1985, J CHEM SOC F1, V81, P10
   Jahnen-Dechent W, 2012, CLIN KIDNEY J, V5, P3, DOI 10.1093/ndtplus/sfr163
   Khandaker M, 2013, J BIOMECH, V46, P1035, DOI 10.1016/j.jbiomech.2012.12.006
   Krishnamoorthy K, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-1063-6
   Kum CH, 2014, SMALL, V10, P3783, DOI 10.1002/smll.201302880
   Lee JY, 2009, INTEGR BIOL, V1, P460, DOI 10.1039/b905757a
   Leung YH, 2014, SMALL, V10, P1171, DOI 10.1002/smll.201302434
   Lew DP, 1997, NEW ENGL J MED, V336, P999, DOI 10.1056/NEJM199704033361406
   Liao JH, 2011, J ORTHOP RES, V29, P1544, DOI 10.1002/jor.21436
   Liu H, 2007, BIOMATERIALS, V28, P354, DOI 10.1016/j.biomaterials.2006.08.049
   Liu HN, 2011, J BIOMED MATER RES A, V99A, P249, DOI 10.1002/jbm.a.33188
   Lock JY, 2014, J BIOMED MATER RES A, V102, P781, DOI 10.1002/jbm.a.34741
   Mejias JA, 1999, CHEM PHYS LETT, V314, P558, DOI 10.1016/S0009-2614(99)00909-4
   Montero M, 2009, BIOCHEM J, V424, P129, DOI 10.1042/BJ20090980
   Mueller WD, 2009, J BIOMED MATER RES A, V90A, P487, DOI 10.1002/jbm.a.32106
   Nygren H, 2014, J FUNCT BIOMATER, V5, P158, DOI 10.3390/jfb5030158
   Patel MK, 2013, BIOSENS BIOELECTRON, V45, P181, DOI 10.1016/j.bios.2012.12.055
   Pourdanesh F, 2014, MAT SCI ENG C-MATER, V40, P382, DOI 10.1016/j.msec.2014.04.018
   Rude R, 1996, FLUIDS ELECTROLYTES, P421
   Sales VL, 2007, TISSUE ENG, V13, P525, DOI 10.1089/ten.2006.0128
   Sawai J, 2003, J MICROBIOL METH, V54, P177, DOI 10.1016/S0167-7012(03)00037-X
   Sawai J, 2000, WORLD J MICROB BIOT, V16, P187, DOI 10.1023/A:1008916209784
   Simchi A, 2011, NANOMED-NANOTECHNOL, V7, P22, DOI 10.1016/j.nano.2010.10.005
   Tarafder S., 2014, J BIOMED MAT RES B
   Tarafder S, 2013, J TISSUE ENG REGEN M, V7, P631, DOI 10.1002/term.555
   US Nanomaterials Research Inc., 2015, MAGN OX MGO NAN
   Vallet-Regi M., 1998, J MATER CHEM, V9, P4
   Xia T, 2006, NANO LETT, V6, P1794, DOI 10.1021/nl061025k
   Yamamoto O., 2000, NANO LETT, V6, P1794
   YANAGISAWA Y, 1981, J PHYS SOC JPN, V50, P209, DOI 10.1143/JPSJ.50.209
   Yoshizawa S, 2014, ACTA BIOMATER, V10, P2834, DOI 10.1016/j.actbio.2014.02.002
   Zheng YF, 2014, MAT SCI ENG R, V77, P1, DOI 10.1016/j.mser.2014.01.001
NR 46
TC 12
Z9 12
U1 2
U2 38
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR 15
PY 2016
VL 35
BP 341
EP 356
DI 10.1016/j.actbio.2016.02.032
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DK8FI
UT WOS:000375162200031
PM 26923529
OA Other Gold
DA 2018-10-20
ER

PT J
AU Sadtler, K
   Estrellas, K
   Allen, BW
   Wolf, MT
   Fan, HN
   Tam, AJ
   Patel, CH
   Luber, BS
   Wang, H
   Wagner, KR
   Powell, JD
   Housseau, F
   Pardoll, DM
   Elisseeff, JH
AF Sadtler, Kaitlyn
   Estrellas, Kenneth
   Allen, Brian W.
   Wolf, Matthew T.
   Fan, Hongni
   Tam, Ada J.
   Patel, Chirag H.
   Luber, Brandon S.
   Wang, Hao
   Wagner, Kathryn R.
   Powell, Jonathan D.
   Housseau, Franck
   Pardoll, Drew M.
   Elisseeff, Jennifer H.
TI Developing a pro-regenerative biomaterial scaffold microenvironment
   requires T helper 2 cells
SO SCIENCE
LA English
DT Article
ID TH2-RESTRICTED IMMUNE-RESPONSE; MUSCLE REGENERATION; SKELETAL-MUSCLE;
   EXTRACELLULAR-MATRIX; IN-VIVO; MACROPHAGE; EXPRESSION; VACCINES; INNATE;
   GROWTH
AB Immune-mediated tissue regeneration driven by a biomaterial scaffold is emerging as an innovative regenerative strategy to repair damaged tissues. We investigated how biomaterial scaffolds shape the immune microenvironment in traumatic muscle wounds to improve tissue regeneration. The scaffolds induced a pro-regenerative response, characterized by an mTOR/Rictor-dependent T helper 2 pathway that guides interleukin-4-dependent macrophage polarization, which is critical for functional muscle recovery. Manipulating the adaptive immune system using biomaterials engineering may support the development of therapies that promote both systemic and local pro-regenerative immune responses, ultimately stimulating tissue repair.
C1 [Sadtler, Kaitlyn; Estrellas, Kenneth; Allen, Brian W.; Wolf, Matthew T.; Elisseeff, Jennifer H.] Johns Hopkins Univ, Translat Tissue Engn Ctr, Wilmer Eye Inst, Baltimore, MD 21287 USA.
   [Sadtler, Kaitlyn; Estrellas, Kenneth; Allen, Brian W.; Wolf, Matthew T.; Elisseeff, Jennifer H.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21287 USA.
   [Fan, Hongni; Tam, Ada J.; Patel, Chirag H.; Powell, Jonathan D.; Housseau, Franck; Pardoll, Drew M.] Johns Hopkins Univ, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Sch Med, Baltimore, MD 21231 USA.
   [Luber, Brandon S.; Wang, Hao] Johns Hopkins Univ, Div Biostat & Bioinformat, Sidney Kimmel Comprehens Canc Ctr, Sch Med, Baltimore, MD 21231 USA.
   [Wagner, Kathryn R.] Kennedy Krieger Inst, Hugo W Moser Res Inst, Baltimore, MD 21205 USA.
   [Wagner, Kathryn R.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.
   [Wagner, Kathryn R.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.
   [Sadtler, Kaitlyn; Estrellas, Kenneth; Allen, Brian W.; Wolf, Matthew T.; Fan, Hongni; Tam, Ada J.; Patel, Chirag H.; Luber, Brandon S.; Wang, Hao; Powell, Jonathan D.; Housseau, Franck; Pardoll, Drew M.; Elisseeff, Jennifer H.] Johns Hopkins Univ, Sch Med, Bloomberg Kimmel Inst Canc Immunotherapy, Baltimore, MD USA.
RP Elisseeff, JH (reprint author), Johns Hopkins Univ, Translat Tissue Engn Ctr, Wilmer Eye Inst, Baltimore, MD 21287 USA.; Elisseeff, JH (reprint author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21287 USA.
EM jhe@jhu.edu
FU Maryland Stem Cell Research Fund (MSCRF) [113345]; Armed Forces
   Institute for Regenerative Medicine; U.S. Department of Defense
   [W81XWH-11-2-0022]; Jules Stein Professorship from the Research to
   Prevent Blindness Foundation; Hartwell Foundation; Cancer Center Core
   grant [P30CA006973]; National Institutes of Health [R01AI077610];
   Bloomberg-Kimmel Institute for Cancer Immunotherapy
FX The authors acknowledge the Sidney Kimmel Comprehensive Cancer Center
   Flow Cytometry Research Core and L. Blosser for their help on flow
   cytometric studies; A. Anderson for assistance with adipogenesis
   studies; S. Sommerfeld and X. Wang for assistance with the clinical
   product testing; A. Rittenbach for assistance with computed tomography
   imaging; M. de Palma for generous donation of the iBMM macrophage cell
   line; M. Swartz and the Swartz lab for assistance in the pilot studies
   and J.H.E. sabbatical hosting; A. Ewald for helpful discussions; and J.
   Schneck for critical review. The data presented in this manuscript are
   tabulated in the main paper and in the supplementary materials. K.S.,
   F.H., D.P., and J.H.E. are inventors on provisional patent application
   no. 48317-502P01US, filed by Johns Hopkins University (JHU) related to
   regenerative immunology. J.H.E. holds equity in Aegeria Soft Tissue, a
   company that has licensed JHU intellectual property not directly related
   to the materials used in this study but similar enough that it may
   benefit from the results. The conflict is being managed by the Johns
   Hopkins Office of Policy Coordination. This work was funded by the
   Maryland Stem Cell Research Fund (MSCRF), grant 113345; the Armed Forces
   Institute for Regenerative Medicine; and U.S. Department of Defense
   grant W81XWH-11-2-0022 (awarded to J.H.E.) and the Jules Stein
   Professorship from the Research to Prevent Blindness Foundation. M.T.W.
   was supported by a postdoctoral fellowship from the Hartwell Foundation.
   D.M.P., J.D.P., B.S.L. and H.W. were supported by Cancer Center Core
   grant P30CA006973. J.D.P. was supported by a grant from the National
   Institutes of Health, R01AI077610. J.D.P, J.H.E., and D.M.P acknowledge
   support from the Bloomberg-Kimmel Institute for Cancer Immunotherapy.
CR Ali OA, 2014, CANCER RES, V74, P1670, DOI 10.1158/0008-5472.CAN-13-0777
   Ali OA, 2013, ADV FUNCT MATER, V23, P4621, DOI 10.1002/adfm.201203859
   Allman AJ, 2002, TISSUE ENG, V8, P53, DOI 10.1089/107632702753503054
   Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024
   Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   Arsic N, 2004, MOL THER, V10, P844, DOI 10.1016/j.ymthe.2004.08.007
   Beachley VZ, 2015, NAT METHODS, V12, P1197, DOI 10.1038/nmeth.3619
   Blackwell J, 2015, J PHYSIOL SCI, V65, P145, DOI 10.1007/s12576-014-0350-7
   Brown BN, 2012, ACTA BIOMATER, V8, P978, DOI 10.1016/j.actbio.2011.11.031
   Davis ME, 2013, J APPL PHYSIOL, V115, P884, DOI 10.1152/japplphysiol.00137.2013
   Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005
   Fang TC, 2007, IMMUNITY, V27, P100, DOI 10.1016/j.immuni.2007.04.018
   Frantz S, 2005, CIRC RES, V96, P15, DOI 10.1161/01.RES.0000153188.68898.ac
   Gause WC, 2013, NAT REV IMMUNOL, V13, P607, DOI 10.1038/nri3476
   Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053
   Horsley V, 2003, CELL, V113, P483, DOI 10.1016/S0092-8674(03)00319-2
   Kim J, 2011, NANO TODAY, V6, P466, DOI 10.1016/j.nantod.2011.08.005
   LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4
   Mase Vincent J Jr, 2010, Orthopedics, V33, P511, DOI 10.3928/01477447-20100526-24
   Matzinger P, 2011, NAT REV IMMUNOL, V11, P221, DOI 10.1038/nri2940
   Mourkioti F, 2005, TRENDS IMMUNOL, V26, P535, DOI 10.1016/j.it.2005.08.002
   Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008
   Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839
   Otis JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092363
   Peng Y, 2007, J AUTOIMMUN, V29, P303, DOI 10.1016/j.jaut.2007.07.017
   Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100
   Ruffell D, 2009, P NATL ACAD SCI USA, V106, P17475, DOI 10.1073/pnas.0908641106
   Salmon-Ehr V, 2000, LAB INVEST, V80, P1337, DOI 10.1038/labinvest.3780141
   Sicari BM, 2014, SCI TRANSL MED, V6, P234, DOI DOI 10.1126/SCITRANSLMED.3008085
   Sicari BM, 2012, TISSUE ENG PT A, V18, P1941, DOI [10.1089/ten.TEA.2012.0475, 10.1089/ten.tea.2012.0475]
   Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034
NR 33
TC 88
Z9 91
U1 11
U2 99
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD APR 15
PY 2016
VL 352
IS 6283
BP 366
EP 370
DI 10.1126/science.aad9272
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DJ1UK
UT WOS:000373990100046
PM 27081073
OA Green Accepted
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Sun, F
   Jiang, Y
   Xu, YF
   Shi, HC
   Zhang, SQ
   Liu, XC
   Pan, S
   Ye, G
   Zhang, WD
   Zhang, FB
   Zhong, CH
AF Sun, Fei
   Jiang, Yuan
   Xu, Yanfei
   Shi, Hongcan
   Zhang, Siquan
   Liu, Xingchen
   Pan, Shu
   Ye, Gang
   Zhang, Weidong
   Zhang, Fangbiao
   Zhong, Chonghao
TI Genipin cross-linked decellularized tracheal tubular matrix for tracheal
   tissue engineering applications
SO SCIENTIFIC REPORTS
LA English
DT Article
ID LINKING AGENT GENIPIN; IN-VIVO; BIOLOGICAL TISSUES; NITRIC-OXIDE; CELLS;
   REPLACEMENT; SCAFFOLD; AIRWAY; VITRO; BIOMATERIAL
AB Decellularization techniques have been widely used as an alternative strategy for organ reconstruction. This study investigated the mechanical, pro-angiogenic and in vivo biocompatibility properties of decellularized airway matrices cross-linked with genipin. New Zealand rabbit tracheae were decellularized and cross-linked with genipin, a naturally derived agent. The results demonstrated that, a significant (p < 0.05) increase in the secant modulus was computed for the cross-linked tracheae, compared to the decellularized samples. Angiogenic assays demonstrated that decellularized tracheal scaffolds and cross-linked tracheae treated with 1% genipin induce strong in vivo angiogenic responses (CAM analysis). Seven, 15 and 30 days after implantation, decreased (p < 0.01) inflammatory reactions were observed in the xenograft models for the genipin cross-linked tracheae matrices compared with control tracheae, and no increase in the IgM or IgG content was observed in rats. In conclusion, treatment with genipin improves the mechanical properties of decellularized airway matrices without altering the pro-angiogenic properties or eliciting an in vivo inflammatory response.
C1 [Sun, Fei; Shi, Hongcan; Zhang, Siquan; Liu, Xingchen; Pan, Shu; Ye, Gang; Zhang, Weidong; Zhang, Fangbiao; Zhong, Chonghao] Yangzhou Univ, Dept Cardiothorac Surg, Coll Clin Med, Yangzhou 225001, Jiangsu, Peoples R China.
   [Sun, Fei; Jiang, Yuan; Xu, Yanfei; Shi, Hongcan; Zhang, Siquan; Liu, Xingchen; Pan, Shu; Ye, Gang; Zhang, Weidong; Zhang, Fangbiao; Zhong, Chonghao] Yangzhou Univ, Coll Med, Yangzhou 225001, Jiangsu, Peoples R China.
   [Jiang, Yuan; Xu, Yanfei; Shi, Hongcan; Zhang, Siquan; Zhong, Chonghao] Jiangsu Key Lab Integrated Tradit Chinese & Weste, Yangzhou 225001, Jiangsu, Peoples R China.
RP Shi, HC (reprint author), Yangzhou Univ, Dept Cardiothorac Surg, Coll Clin Med, Yangzhou 225001, Jiangsu, Peoples R China.; Shi, HC (reprint author), Yangzhou Univ, Coll Med, Yangzhou 225001, Jiangsu, Peoples R China.; Shi, HC (reprint author), Jiangsu Key Lab Integrated Tradit Chinese & Weste, Yangzhou 225001, Jiangsu, Peoples R China.
EM shihongcan@hotmail.com
FU National Natural Science Foundation of China [81170014, 81370118]; Top
   Talent Support Program of Yangzhou University [201431]; Jiangsu
   Students' Innovation Training Program [201511117033Z]
FX This study was supported by the National Natural Science Foundation of
   China (no. 81170014, 81370118), the Top Talent Support Program of
   Yangzhou University (no. 201431) and Jiangsu Students' Innovation
   Training Program (201511117033Z).
CR Baiguera S, 2014, BIOMATERIALS, V35, P6344, DOI 10.1016/j.biomaterials.2014.04.070
   Baiguera S, 2012, J BIOMED MATER RES B, V100B, P1425, DOI 10.1002/jbm.b.32653
   Baiguera S, 2012, BIOMATERIALS, V33, P3662, DOI 10.1016/j.biomaterials.2012.01.064
   Baiguera S, 2011, EXPERT REV RESP MED, V5, P487, DOI [10.1586/ers.11.42, 10.1586/ERS.11.42]
   Baiguera S, 2010, BIOMATERIALS, V31, P8931, DOI 10.1016/j.biomaterials.2010.08.005
   Bhrany AD, 2008, J TISSUE ENG REGEN M, V2, P365, DOI 10.1002/term.105
   Chang Y, 2002, BIOMATERIALS, V23, P2447, DOI 10.1016/S0142-9612(01)00379-9
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Elliott MJ, 2012, LANCET, V380, P994, DOI 10.1016/S0140-6736(12)60737-5
   Englert C, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2202
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Go T, 2010, J THORAC CARDIOV SUR, V139, P437, DOI 10.1016/j.jtcvs.2009.10.002
   Gonfiotti A, 2014, LANCET, V383, P238, DOI 10.1016/S0140-6736(13)62033-4
   Haag J, 2012, BIOMATERIALS, V33, P780, DOI 10.1016/j.biomaterials.2011.10.008
   Hamilton NJ, 2015, AM J TRANSPLANT, V15, P2750, DOI 10.1111/ajt.13318
   Hoshiba T, 2010, EXPERT OPIN BIOL TH, V10, P1717, DOI 10.1517/14712598.2010.534079
   Jungebluth P, 2012, CLIN PHARMACOL THER, V91, P81, DOI 10.1038/clpt.2011.270
   Jungebluth P, 2009, J THORAC CARDIOV SUR, V138, P586, DOI 10.1016/j.jtcvs.2008.09.085
   Koo HJ, 2006, J ETHNOPHARMACOL, V103, P496, DOI 10.1016/j.jep.2005.08.011
   Laurance J, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1633
   Liang HC, 2003, J BIOMED MATER RES A, V65A, P271, DOI 10.1002/jbm.a.10476
   Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6
   Ott LM, 2011, ANN BIOMED ENG, V39, P2091, DOI 10.1007/s10439-011-0318-1
   Partington L, 2013, ACTA BIOMATER, V9, P5251, DOI 10.1016/j.actbio.2012.10.004
   Reich MS, 2013, CELL TISSUE BANK, V14, P381, DOI 10.1007/s10561-012-9335-z
   Sun F, 2015, J BIOMED MATER RES A, V103, P1509, DOI 10.1002/jbm.a.35273
   Sung HW, 2003, J BIOMED MATER RES A, V64A, P427, DOI 10.1002/jbm.a.10346
   Sung HW, 2001, J BIOMED MATER RES, V55, P538, DOI 10.1002/1097-4636(20010615)55:4<538::AID-JBM1047>3.3.CO;2-U
   Valentin JE, 2006, J BONE JOINT SURG AM, V88A, P2673, DOI 10.2106/JBJS.E.01008
   Vogel G, 2013, SCIENCE, V340, P266, DOI 10.1126/science.340.6130.266
   Wang CM, 2011, J BIOMED MATER RES B, V97B, P58, DOI 10.1002/jbm.b.31786
   Wang GF, 2009, ACTA PHARMACOL SIN, V30, P589, DOI 10.1038/aps.2009.31
   Yamazaki M, 2008, EUR J PHARMACOL, V581, P255, DOI 10.1016/j.ejphar.2007.12.001
   Yao C, 2008, BIOMATERIALS, V29, P66, DOI 10.1016/j.biomaterials.2007.08.049
   Yu XX, 2010, J MATER SCI-MATER M, V21, P777, DOI 10.1007/s10856-009-3933-8
   Zang MQ, 2013, PLAST RECONSTR SURG, V132, p549E, DOI 10.1097/PRS.0b013e3182a013fc
   Zang MQ, 2012, PLAST RECONSTR SURG, V130, P532, DOI 10.1097/PRS.0b013e31825dc084
   Zhang CY, 2006, CELL METAB, V3, P417, DOI 10.1016/j.cmet.2006.04.010
NR 38
TC 5
Z9 4
U1 0
U2 18
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD APR 15
PY 2016
VL 6
AR 24429
DI 10.1038/srep24429
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DJ4HR
UT WOS:000374166500001
PM 27080716
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Lee, S
   Maeda, H
   Obata, A
   Ueda, K
   Narushima, T
   Kasuga, T
AF Lee, Sungho
   Maeda, Hirotaka
   Obata, Akiko
   Ueda, Kyosuke
   Narushima, Takayuki
   Kasuga, Toshihiro
TI Structures and dissolution behaviors of MgO-CaO-P2O5-Nb2O5 glasses
SO JOURNAL OF NON-CRYSTALLINE SOLIDS
LA English
DT Article
DE Biomaterial; Phosphate invert glass; Magnesium; Calcium; Structure;
   Dissolution
ID PHOSPHATE INVERT GLASSES; BIOMEDICAL APPLICATIONS; OPTICAL-PROPERTIES;
   MAGNESIUM CONTENT; SYSTEM; ZINC; CRYSTALLIZATION; IONS; SOLUBILITY;
   CERAMICS
AB MgO-CaO-P2O5-Nb2O5 glasses with the substitution of MgO for CaO consisting predominantly of meta-, pyro-, and orthophosphate groups were prepared using a melt-quenching method, and their structures and dissolution behaviors were investigated. Magnesium in the metaphosphate compositions was shown to act as a modifier oxide and coordinate phosphate groups. Magnesium in the pyro- and/or orthophosphate compositions was shown to act as a network former and to form P-O-Mg bonds, which crosslink short phosphate groups. The chemical durability of the metaphosphate glasses increased with increasing the substitution of MgO for CaO because magnesium exhibits a larger field strength than calcium. However, the durability of the pyro- and/or orthophosphate glasses decreased with increasing the MgO content: P-O-Mg bonds weakened the glass network structure and induced hydrolysis. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Lee, Sungho; Maeda, Hirotaka; Obata, Akiko; Kasuga, Toshihiro] Nagoya Inst Technol, Grad Sch Engn, Dept Frontier Mat, Showa Ku, Gokiso Cho, Nagoya, Aichi 4668555, Japan.
   [Ueda, Kyosuke; Narushima, Takayuki] Tohoku Univ, Grad Sch Engn, Dept Met Mat Sci & Mat Proc, Aoba Ku, 6-6-02 Aoba, Sendai, Miyagi 9808579, Japan.
RP Kasuga, T (reprint author), Nagoya Inst Technol, Grad Sch Engn, Dept Frontier Mat, Showa Ku, Gokiso Cho, Nagoya, Aichi 4668555, Japan.
EM kasuga.toshihiro@nitech.ac.jp
RI Lee, Sungho/T-1734-2017
OI Lee, Sungho/0000-0002-4367-9573
FU JSPS KAKENHI [25249094, 26289238, 267992]
FX This work was supported in part by JSPS KAKENHI Grant Numbers 25249094,
   26289238, and 267992.
CR ABE Y, 1976, J AM CERAM SOC, V59, P487, DOI 10.1111/j.1151-2916.1976.tb09414.x
   Brauer DS, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0647
   Brauer DS, 2010, J NON-CRYST SOLIDS, V356, P2626, DOI 10.1016/j.jnoncrysol.2010.03.022
   BROW RK, 1995, J NON-CRYST SOLIDS, V191, P45, DOI 10.1016/0022-3093(95)00289-8
   Brow RK, 2000, J NON-CRYST SOLIDS, V263, P1, DOI 10.1016/S0022-3093(99)00620-1
   DAY DE, 1976, J NON-CRYST SOLIDS, V21, P343, DOI 10.1016/0022-3093(76)90026-0
   Diba M, 2012, INT J APPL GLASS SCI, V3, P221, DOI 10.1111/j.2041-1294.2012.00095.x
   Dietzel A., 1942, Z ELEKTROCHEM, V48, P9, DOI DOI 10.1007/BF01519713
   DILMORE MF, 1978, J AM CERAM SOC, V61, P439, DOI 10.1111/j.1151-2916.1978.tb09355.x
   ELJAZOULI A, 1988, J SOLID STATE CHEM, V73, P433, DOI 10.1016/0022-4596(88)90129-6
   Fayon F, 2001, J NON-CRYST SOLIDS, V283, P88, DOI 10.1016/S0022-3093(01)00357-X
   Flambard A, 2008, J NON-CRYST SOLIDS, V354, P3540, DOI 10.1016/j.jnoncrysol.2008.03.017
   Franks K, 2002, J MATER SCI-MATER M, V13, P549, DOI 10.1023/A:1015122709576
   Hsu SM, 2012, J NON-CRYST SOLIDS, V358, P14, DOI 10.1016/j.jnoncrysol.2011.08.006
   Isard J. O., 1969, Journal of Non-Crystalline Solids, V1, P235, DOI 10.1016/0022-3093(69)90003-9
   JEHNG JM, 1991, CHEM MATER, V3, P100, DOI 10.1021/cm00013a025
   Karakassides MA, 2004, J NON-CRYST SOLIDS, V347, P69, DOI 10.1016/j.jnoncrysol.2004.08.111
   Kasuga Toshihiro, 2012, Phosphorus Research Bulletin, V26, P8
   Kasuga T, 2003, J AM CERAM SOC, V86, P1031, DOI 10.1111/j.1151-2916.2003.tb03415.x
   Kasuga T, 2003, BIOMATERIALS, V24, P283, DOI 10.1016/S0142-9612(02)00316-2
   Kasuga T, 2001, J AM CERAM SOC, V84, P450
   Kasuga T, 1999, J NON-CRYST SOLIDS, V243, P70, DOI 10.1016/S0022-3093(98)00820-5
   Khor SF, 2013, OPT MATER, V35, P629, DOI 10.1016/j.optmat.2012.10.013
   Lee IH, 2013, J NON-CRYST SOLIDS, V363, P57, DOI 10.1016/j.jnoncrysol.2012.11.036
   Lee S., 2010, BIOCERAM DEV APPL, V1
   Lee S., 2015, J NONCRYST SOLIDS A, V432A, P60
   Lee S, 2015, J CERAM SOC JPN, V123, P942, DOI 10.2109/jcersj2.123.942
   Lee S, 2015, J NON-CRYST SOLIDS, V426, P35, DOI 10.1016/j.jnoncrysol.2015.06.024
   Lee S, 2009, J CERAM SOC JPN, V117, P935, DOI 10.2109/jcersj2.117.935
   Maeda H, 2014, J CERAM SOC JPN, V122, P122, DOI 10.2109/jcersj2.122.122
   Mandlule A, 2014, J NON-CRYST SOLIDS, V392, P31, DOI 10.1016/j.jnoncrysol.2014.04.002
   Mazali IO, 2004, J MATER SCI, V39, P1987, DOI 10.1023/B:JMSC.0000017760.85512.60
   Morikawa H, 2013, J NON-CRYST SOLIDS, V380, P53, DOI 10.1016/j.jnoncrysol.2013.08.029
   Obata A, 2012, ACS APPL MATER INTER, V4, P5684, DOI 10.1021/am301614a
   Okuma T, 2001, NUTRITION, V17, P679, DOI 10.1016/S0899-9007(01)00551-2
   OUCHETTO M, 1991, PHYS CHEM GLASSES, V32, P22
   Saboori A, 2009, MAT SCI ENG C-BIO S, V29, P335, DOI 10.1016/j.msec.2008.07.004
   SALTZBERG MA, 1990, J AM CERAM SOC, V73, P2970, DOI 10.1111/j.1151-2916.1990.tb06703.x
   Smith CE, 2014, J NON-CRYST SOLIDS, V390, P51, DOI 10.1016/j.jnoncrysol.2014.02.010
   Swenson J, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.155507
   TAKEICHI M, 1972, EXP CELL RES, V74, P51, DOI 10.1016/0014-4827(72)90480-6
   Tylkowski M, 2013, J NON-CRYST SOLIDS, V376, P175, DOI 10.1016/j.jnoncrysol.2013.05.039
   Watts SJ, 2010, J NON-CRYST SOLIDS, V356, P517, DOI 10.1016/j.jnoncrysol.2009.04.074
   Wolf Federica I., 1999, Frontiers in Bioscience, V4, pd607, DOI 10.2741/Wolf
   Yamasaki Y, 2002, J BIOMED MATER RES, V62, P99, DOI 10.1002/jbm.10220
   Zhifang W., 1986, J NONCRYST SOLIDS, V84, P468
NR 46
TC 4
Z9 4
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-3093
EI 1873-4812
J9 J NON-CRYST SOLIDS
JI J. Non-Cryst. Solids
PD APR 15
PY 2016
VL 438
BP 18
EP 25
DI 10.1016/j.jnoncrysol.2016.02.006
PG 8
WC Materials Science, Ceramics; Materials Science, Multidisciplinary
SC Materials Science
GA DI5NG
UT WOS:000373545300004
DA 2018-10-20
ER

PT J
AU Afroze, JD
   Abden, MJ
   Alam, MS
   Bahadur, NM
   Gafur, MA
AF Afroze, J. D.
   Abden, M. J.
   Alam, M. S.
   Bahadur, N. M.
   Gafur, M. A.
TI Development of functionalized carbon nanotube reinforced hydroxyapatite
   magnetic nanocomposites
SO MATERIALS LETTERS
LA English
DT Article
DE Hydroxyapatite; Carbon nanotubes; In-situ fabrication; Nanocomposites;
   Magnetic properties
ID CALCIUM PHOSPHATES; DRUG; NANOPARTICLES; DELIVERY; MATRIX
AB An innovative and effective approach is introduced to functionalize multi-walled carbon nanotubes (f-MWCNTs) by in-situ chemical precipitation of hydroxyapatite (HA) to improve their magnetic properties. The HA/f-MWCNTs nanocomposites are obtained by pressureless sintering in vacuum atmosphere. The carboxyl functional group (-COOH) is introduced by an acid treatment on the MWCNT surface. Magnetic hysteresis measurement reveals that HA/f-MWCNTs nanocomposites exhibit excellent hard ferromagnetic properties with saturation magnetization (M-s) of 0.233 emu/g and coercivity (H-C) of 2985.53 Oe at room temperature. The maximum magnetic hysteresis loss of 0.44 kJ/m(3) induces an expected heat generation and it is expected that this nanocomposite has potential to be used as a biomaterial for hyperthermia treatment of bone cancer and other biomedical applications. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Afroze, J. D.; Alam, M. S.; Bahadur, N. M.] Noakhali Sci & Technol Univ, Dept Appl Chem & Chem Engn, Noakhali 3814, Bangladesh.
   [Abden, M. J.] Int Islamic Univ Chittagong, Dept Elect & Elect Engn, Chittagong 4203, Bangladesh.
   [Abden, M. J.; Gafur, M. A.] Bangladesh Council Sci & Ind Res, Dev Mat Tools & Biometall Implant, Dhaka 1205, Bangladesh.
RP Abden, MJ (reprint author), Int Islamic Univ Chittagong, Dept Elect & Elect Engn, Chittagong 4203, Bangladesh.
EM mjaynul@gmail.com
OI Abden, M./0000-0002-7724-3663
CR Ashokan A, 2010, BIOMATERIALS, V31, P2606, DOI 10.1016/j.biomaterials.2009.11.113
   Balani K, 2007, BIOMATERIALS, V28, P618, DOI 10.1016/j.biomaterials.2006.09.013
   Chen F, 2012, BIOMATERIALS, V33, P6447, DOI 10.1016/j.biomaterials.2012.05.059
   Cheng FY, 2010, CHEM COMMUN, V46, P3167, DOI 10.1039/b919172k
   Freitag R, 2012, BIOTECHNOL J, V7, P90, DOI 10.1002/biot.201100015
   Heidari F, 2015, CERAM INT, V41, P3094, DOI 10.1016/j.ceramint.2014.10.153
   Kozlova D, 2012, J MATER CHEM, V22, P396, DOI 10.1039/c1jm14683a
   Li AM, 2007, MATER LETT, V61, P1839, DOI 10.1016/j.matlet.2006.07.159
   Liu TY, 2005, J CONTROL RELEASE, V107, P112, DOI 10.1016/j.jconrel.2005.05.025
   Lu XY, 2012, APPL SURF SCI, V262, P110, DOI 10.1016/j.apsusc.2012.02.139
   Lu XF, 2015, MATER LETT, V161, P128, DOI 10.1016/j.matlet.2015.07.102
   Mohammad F., 2011, ADV DRUG DELIV REV, V63, P789
   Morrison CJ, 2011, BIOTECHNOL BIOENG, V108, P813, DOI 10.1002/bit.22971
   Neelgund GM, 2011, MAT SCI ENG C-MATER, V31, P1477, DOI 10.1016/j.msec.2011.06.001
   Padilla S, 2008, CHEM MATER, V20, P5942, DOI 10.1021/cm801626k
   Prato M, 2008, ACCOUNTS CHEM RES, V41, P60, DOI 10.1021/ar700089b
   Rege K, 2003, NANO LETT, V3, P829, DOI 10.1021/nl034131k
   Ruiz-Hernandez E, 2007, CHEM MATER, V19, P3455, DOI 10.1021/cm0705789
   Sahoo NG, 2010, PROG POLYM SCI, V35, P837, DOI 10.1016/j.progpolymsci.2010.03.002
   Singh RK, 2012, MATER LETT, V75, P130, DOI 10.1016/j.matlet.2012.01.129
   Son KD, 2012, MATER CHEM PHYS, V132, P1041, DOI 10.1016/j.matchemphys.2011.12.062
   Tseng CL, 2014, CERAM INT, V40, P5117, DOI 10.1016/j.ceramint.2013.09.137
   Uskokovic V, 2011, J BIOMED MATER RES B, V96B, P152, DOI 10.1002/jbm.b.31746
   Usui Y, 2008, SMALL, V4, P240, DOI 10.1002/smll.200700670
   Vallet-Regi M, 2004, PROG SOLID STATE CH, V32, P1, DOI 10.1016/j.progsolidstchem.2004.07.001
   Wu MY, 2013, CARBON, V51, P335, DOI 10.1016/j.carbon.2012.08.061
   Zhang HF, 2012, MATER LETT, V75, P26, DOI 10.1016/j.matlet.2012.01.110
   Zhou H, 2011, ACTA BIOMATER, V7, P2769, DOI 10.1016/j.actbio.2011.03.019
NR 28
TC 5
Z9 5
U1 1
U2 46
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD APR 15
PY 2016
VL 169
BP 24
EP 27
DI 10.1016/j.matlet.2016.01.060
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA DE3MK
UT WOS:000370533300007
DA 2018-10-20
ER

PT J
AU Zhu, YQ
   Meng, QK
   Guo, S
   Qi, LC
   Xiao, WL
   Ping, DH
   Zhao, XQ
AF Zhu, Yongqi
   Meng, Qingkun
   Guo, Shun
   Qi, Lichun
   Xiao, Wenlong
   Ping, Dehai
   Zhao, Xinqing
TI Anomalous phase stability of surface and interior in a metastable
   Ti-Nb-Zr alloy
SO MATERIALS LETTERS
LA English
DT Article
DE Biomaterial; Metals and alloys; Phase transformation; Metastable phase
ID BETA-TITANIUM ALLOY; MARTENSITIC-TRANSFORMATION; OMEGA; SUPERELASTICITY;
   PRESSURE
AB The structural stability of beta phase is a key factor to determine the mechanical properties, such as strength and elastic modulus, of metastable beta-type titanium alloys. In the present study, we reported an anomalous phenomenon that the surface and the interior of quenched Ti-22Nb-9Zr (wt%) alloy exhibit quite different phase constitutions. It is indicated that abundant alpha '' martensite phase forms in the surficial region of less than 200 mu m in the specimen, while the interior consists of dominant beta phase together with a few omega phase. This interesting result might be of great significance for research and development of metastable beta titanium alloys with superior mechanical properties. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Zhu, Yongqi; Meng, Qingkun; Qi, Lichun; Xiao, Wenlong; Zhao, Xinqing] Beihang Univ, Sch Mat Sci & Engn, Beijing 100191, Peoples R China.
   [Guo, Shun] Jiangsu Univ, Inst Adv Mat, Zhenjiang 212013, Peoples R China.
   [Ping, Dehai] Dalian Jiaotong Univ, Sch Mat Sci & Engn, Dalian 116028, Peoples R China.
RP Xiao, WL; Zhao, XQ (reprint author), Beihang Univ, Sch Mat Sci & Engn, Beijing 100191, Peoples R China.
EM wlxiao@buaa.edu.cn; xinqing@buaa.edu.cn
RI Xiao, Wenlong/B-4765-2008; 赵, 新青/I-3313-2016
FU National Natural Science Foundation of China [51271010, 51471017,
   51431007]; National 973 Program of China [2012CB619403]
FX This work was supported by the National Natural Science Foundation of
   China (Grant nos. 51271010, 51471017 and 51431007) and the National 973
   Program of China (Grant no. 2012CB619403).
CR An YB, 2005, MATER LETT, V59, P2178, DOI 10.1016/j.matlet.2005.02.059
   Banerjee D, 2013, ACTA MATER, V61, P844, DOI 10.1016/j.actamat.2012.10.043
   Duerig T., 1980, TITANIUM 80 SCI TECH, P1503
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Guo S, 2014, MATER LETT, V133, P236, DOI 10.1016/j.matlet.2014.07.044
   Hennig RG, 2005, NAT MATER, V4, P129, DOI 10.1038/nmat1292
   KAUFMAN L, 1960, ACTA METALL MATER, V8, P270, DOI 10.1016/0001-6160(60)90193-0
   Kim HS, 2007, MAT SCI ENG A-STRUCT, V449, P322, DOI 10.1016/j.msea.2006.02.329
   Kim HY, 2006, ACTA MATER, V54, P2419, DOI 10.1016/j.actamat.2006.01.019
   KLOSTERMANN JA, 1964, ACTA METALL MATER, V12, P355, DOI 10.1016/0001-6160(64)90004-5
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   MOFFAT DL, 1988, METALL TRANS A, V19, P1677, DOI 10.1007/BF02645135
   Odegard B. C., 1974, Metallography, V7, P129, DOI 10.1016/0026-0800(74)90002-0
   Ohmori Y, 2001, MAT SCI ENG A-STRUCT, V312, P182, DOI 10.1016/S0921-5093(00)01891-8
   Ping D., 2008, APPL PHYS LETT, V93
   Ping DH, 2006, SCRIPTA MATER, V54, P1305, DOI 10.1016/j.scriptamat.2005.12.022
   Saito T, 2003, SCIENCE, V300, P464, DOI 10.1126/science.1081957
   Straumal B, 2014, ARCH CIV MECH ENG, V14, P242, DOI 10.1016/j.acme.2013.07.002
   Straumal BB, 2015, ADV ENG MATER, V17, P1835, DOI 10.1002/adem.201500143
   Straumal BB, 2012, MATER LETT, V81, P225, DOI 10.1016/j.matlet.2012.04.153
   Sun F, 2011, J MECH BEHAV BIOMED, V4, P1864, DOI 10.1016/j.jmbbm.2011.06.003
   Sun F, 2010, SCRIPTA MATER, V63, P1053, DOI 10.1016/j.scriptamat.2010.07.042
   Tian YX, 2015, MATER LETT, V145, P283, DOI 10.1016/j.matlet.2015.01.126
   Wu SQ, 2013, J ALLOY COMPD, V577, pS423, DOI 10.1016/j.jallcom.2011.12.152
   Wu SQ, 2014, ACTA MATER, V62, P122, DOI 10.1016/j.actamat.2013.09.040
   Zhang DC, 2012, J MECH BEHAV BIOMED, V13, P156, DOI 10.1016/j.jmbbm.2012.04.017
NR 26
TC 1
Z9 1
U1 1
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD APR 15
PY 2016
VL 169
BP 210
EP 213
DI 10.1016/j.matlet.2016.01.145
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA DE3MK
UT WOS:000370533300053
DA 2018-10-20
ER

PT J
AU Huang, BL
   Yuan, Y
   Li, T
   Ding, S
   Zhang, WJ
   Gu, YT
   Liu, CS
AF Huang, Baolin
   Yuan, Yuan
   Li, Tong
   Ding, Sai
   Zhang, Wenjing
   Gu, Yuantong
   Liu, Changsheng
TI Facilitated receptor-recognition and enhanced bioactivity of bone
   morphogenetic protein-2 on magnesium-substituted hydroxyapatite surface
SO SCIENTIFIC REPORTS
LA English
DT Article
ID MOLECULAR-DYNAMICS SIMULATION; BMP-2 DELIVERY; ADSORPTION; REGENERATION;
   SCAFFOLDS; RHBMP-2; DIFFERENTIATION; NANOPARTICLES; DESORPTION;
   CHEMISTRY
AB Biomaterial surface functionalized with bone morphogenetic protein-2 (BMP-2) is a promising approach to fabricating successful orthopedic implants/scaffolds. However, the bioactivity of BMP-2 on material surfaces is still far from satisfactory and the mechanism of related protein-surface interaction remains elusive. Based on the most widely used bone-implants/scaffolds material, hydroxyapatite (HAP), we developed a matrix of magnesium-substituted HAP (Mg-HAP, 2.2 at% substitution) to address these issues. Further, we investigated the adsorption dynamics, BMPRs-recruitment, and bioactivity of recombinant human BMP-2 (rhBMP-2) on the HAP and Mg-HAP surfaces. To elucidate the mechanism, molecular dynamic simulations were performed to calculate the preferred orientations, conformation changes, and cysteine-knot stabilities of adsorbed BMP-2 molecules. The results showed that rhBMP-2 on the Mg-HAP surface exhibited greater bioactivity, evidenced by more facilitated BMPRs-recognition and higher ALP activity than on the HAP surface. Moreover, molecular simulations indicated that BMP-2 favoured distinct side-on orientations on the HAP and Mg-HAP surfaces. Intriguingly, BMP-2 on the Mg-HAP surface largely preserved the active protein structure evidenced by more stable cysteine-knots than on the HAP surface. These findings explicitly clarify the mechanism of BMP-2-HAP/Mg-HAP interactions and highlight the promising application of Mg-HAP/BMP-2 matrixes in bone regeneration implants/scaffolds.
C1 [Huang, Baolin; Yuan, Yuan; Zhang, Wenjing; Liu, Changsheng] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China.
   [Huang, Baolin; Yuan, Yuan; Ding, Sai; Liu, Changsheng] E China Univ Sci & Technol, Key Lab Ultrafine Mat, Minist Educ, Shanghai 200237, Peoples R China.
   [Huang, Baolin; Li, Tong; Gu, Yuantong] Queensland Univ Technol, Sch Chem Phys & Mech Engn, 2 George St, Brisbane, Qld 4001, Australia.
   [Yuan, Yuan; Ding, Sai; Zhang, Wenjing; Liu, Changsheng] E China Univ Sci & Technol, Minist Educ, Engn Res Ctr Biomed Mat, Shanghai 200237, Peoples R China.
RP Yuan, Y; Liu, CS (reprint author), E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China.; Yuan, Y; Liu, CS (reprint author), E China Univ Sci & Technol, Key Lab Ultrafine Mat, Minist Educ, Shanghai 200237, Peoples R China.; Gu, YT (reprint author), Queensland Univ Technol, Sch Chem Phys & Mech Engn, 2 George St, Brisbane, Qld 4001, Australia.; Yuan, Y; Liu, CS (reprint author), E China Univ Sci & Technol, Minist Educ, Engn Res Ctr Biomed Mat, Shanghai 200237, Peoples R China.
EM yyuan@eucst.eud.cn; yuantong.gu@qut.edu.au; liucs@ecust.edu.cn
RI GU, Yuantong/C-5033-2009
OI GU, Yuantong/0000-0002-2770-5014
FU National Basic Research Program of China (973 Program) [2012CB933600];
   National Natural Science Foundation of China [31070850, 31330028,
   31470924]; Program for New Century Excellent Talents in University
   [NCET-11-0640]; 111 project [B14018]; China Scholarship Council
   [201406740036]
FX The authors wish to express their gratitude for the financial support
   received from the National Basic Research Program of China (973 Program,
   No. 2012CB933600) and the National Natural Science Foundation of China
   (No. 31070850, 31330028 and 31470924). This study was also supported by
   the Program for New Century Excellent Talents in University (No.
   NCET-11-0640), 111 project (B14018), and China Scholarship Council (No.
   201406740036). The authors are grateful to the High Performance Computer
   resources provided by the Queensland University of Technology.
CR Axelrad TW, 2009, CYTOKINE GROWTH F R, V20, P481, DOI 10.1016/j.cytogfr.2009.10.003
   Boix T, 2005, J INORG BIOCHEM, V99, P1043, DOI 10.1016/j.jinorgbio.2005.01.011
   Cox SC, 2014, MAT SCI ENG C-MATER, V35, P106, DOI 10.1016/j.msec.2013.10.015
   Crouzier T, 2011, ADV MATER, V23, pH111, DOI 10.1002/adma.201004637
   Crouzier T, 2010, SMALL, V6, P651, DOI 10.1002/smll.200901728
   Ding HM, 2014, BIOMATERIALS, V35, P8703, DOI 10.1016/j.biomaterials.2014.06.033
   Dolatshahi-Pirouz A, 2009, LANGMUIR, V25, P2971, DOI 10.1021/la803142u
   Dong XL, 2011, MOL SIMULAT, V37, P1097, DOI 10.1080/08927022.2011.582108
   Dong XL, 2007, BIOPHYS J, V93, P750, DOI 10.1529/biophysj.106.103168
   Farzadi A, 2014, CERAM INT, V40, P6021, DOI 10.1016/j.ceramint.2013.11.051
   Guan JJ, 2015, RSC ADV, V5, P36175, DOI 10.1039/c5ra01487e
   Hartvig RA, 2011, LANGMUIR, V27, P2634, DOI 10.1021/la104720n
   Hernandez A, 2012, ACTA BIOMATER, V8, P781, DOI 10.1016/j.actbio.2011.10.008
   Hettiaratchi MH, 2014, BIOMATERIALS, V35, P7228, DOI 10.1016/j.biomaterials.2014.05.011
   Hu JL, 2010, BIOCONJUGATE CHEM, V21, P1762, DOI 10.1021/bc9005706
   Huang BL, 2015, ACTA BIOMATER, V27, P275, DOI 10.1016/j.actbio.2015.09.007
   Kashiwagi K, 2009, BIOMATERIALS, V30, P1166, DOI 10.1016/j.biomaterials.2008.10.040
   Keller S, 2004, NAT STRUCT MOL BIOL, V11, P481, DOI 10.1038/nsmb756
   Kim MJ, 2013, BIOMATERIALS, V34, P7236, DOI 10.1016/j.biomaterials.2013.06.019
   La WG, 2013, SMALL, V9, DOI 10.1002/smll.201300571
   Lai ZB, 2014, J MECH BEHAV BIOMED, V36, P12, DOI 10.1016/j.jmbbm.2014.04.002
   Laurencin D, 2011, BIOMATERIALS, V32, P1826, DOI 10.1016/j.biomaterials.2010.11.017
   Lee SS, 2013, BIOMATERIALS, V34, P452, DOI 10.1016/j.biomaterials.2012.10.005
   Lee WH, 2014, COLLOID SURFACE B, V122, P823, DOI 10.1016/j.colsurfb.2014.07.029
   Luca L, 2010, J CONTROL RELEASE, V147, P38, DOI 10.1016/j.jconrel.2010.06.011
   Mehta M, 2012, ADV DRUG DELIVER REV, V64, P1257, DOI 10.1016/j.addr.2012.05.006
   Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200
   Park J, 2012, SMALL, V8, P98, DOI 10.1002/smll.201100790
   Roach P, 2006, J AM CHEM SOC, V128, P3939, DOI 10.1021/ja056278e
   Rude RK, 2004, J NUTR BIOCHEM, V15, P710, DOI 10.1016/j.jnutbio.2004.08.001
   Sawyer AA, 2009, BIOMATERIALS, V30, P2479, DOI 10.1016/j.biomaterials.2008.12.055
   Scheufler C, 1999, J MOL BIOL, V287, P103, DOI 10.1006/jmbi.1999.2590
   Schwab EH, 2015, NANO LETT, V15, P1526, DOI 10.1021/acs.nanolett.5b00315
   Shen JW, 2008, BIOMATERIALS, V29, P513, DOI 10.1016/j.biomaterials.2007.10.016
   Shepherd JH, 2012, J MATER SCI-MATER M, V23, P2335, DOI 10.1007/s10856-012-4598-2
   Shi PJ, 2013, ADV HEALTHC MATER, V2, P934, DOI 10.1002/adhm.201200281
   Shiels SM, 2012, J BIOMED MATER RES A, V100A, P3117, DOI 10.1002/jbm.a.34241
   Supova M, 2015, CERAM INT, V41, P9203, DOI 10.1016/j.ceramint.2015.03.316
   Tagaya M, 2011, LANGMUIR, V27, P7645, DOI 10.1021/la200621p
   Utesch T, 2011, LANGMUIR, V27, P13144, DOI 10.1021/la202489w
   Visser R, 2009, BIOMATERIALS, V30, P2032, DOI 10.1016/j.biomaterials.2008.12.046
   Wang KF, 2014, MATER LETT, V123, P191, DOI 10.1016/j.matlet.2014.02.089
   Wang XW, 2012, LANGMUIR, V28, P14642, DOI 10.1021/la303001j
   Zhang J, 2015, BIOMATERIALS, V53, P251, DOI 10.1016/j.biomaterials.2015.02.097
NR 44
TC 11
Z9 11
U1 2
U2 43
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD APR 14
PY 2016
VL 6
AR 24323
DI 10.1038/srep24323
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DJ2PQ
UT WOS:000374047500001
PM 27075233
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Govindarajan, SR
   Xu, Y
   Swanson, JP
   Jain, T
   Lu, YF
   Choi, JW
   Joy, A
AF Govindarajan, Sudhanva R.
   Xu, Ying
   Swanson, John P.
   Jain, Tanmay
   Lu, Yanfeng
   Choi, Jae-Won
   Joy, Abraham
TI A Solvent and Initiator Free, Low-Modulus, Degradable Polyester Platform
   with Modular Functionality for Ambient-Temperature 3D Printing
SO MACROMOLECULES
LA English
DT Article
ID IN-VITRO; BIOMATERIALS; FABRICATION; SCAFFOLDS; HYDROGELS; POLYMERS;
   TISSUES; CONSTRUCTS; LIBRARY
AB 3D printing has enabled the design of biomaterials into intricate and customized scaffolds. However, current 3D printed biomaterial scaffolds have potential drawbacks due to residual monomers, free-radical initiators, solvents, or printing at elevated temperatures. This work describes a solvent, initiator, and monomer-free degradable polyester platform for room temperature 3D printing. Linoleic acid side chains derived from soybean oil lowers the T-g and prevents packing and entanglement, ensuring that G '' > G' during room temperature printing. Upon printing, cross-linking of pendant functionalized coumarin moieties fixes the-viscous filaments to elastomeric solids. Furthermore, the modular design of the polyester platform enables conjugation of ligands, as demonstrated by the conjugation of FITC to surface amines on the 3D printed scaffolds. This low modulus, printable polyester platform addresses several design challenges in 3D printing of functional biomaterials and could potentially be useful in many tissue engineering applications.
C1 [Govindarajan, Sudhanva R.; Xu, Ying; Swanson, John P.; Jain, Tanmay; Joy, Abraham] Univ Akron, Dept Polymer Sci, Akron, OH 44325 USA.
   [Lu, Yanfeng; Choi, Jae-Won] Univ Akron, Dept Mech Engn, Akron, OH 44325 USA.
RP Joy, A (reprint author), Univ Akron, Dept Polymer Sci, Akron, OH 44325 USA.
EM abraham@uakron.edu
OI Swanson, John/0000-0001-8820-7273
FU NSF [1352485]; Univ. Akron; ABIA
FX Part of this work was funded by an NSF grant (#1352485) to A.J. The
   authors thank the Univ. Akron and ABIA for a fellowship to ,S.R.G. We
   thank Steven Mankoci (Univ. of Akron, Polymer Science) for guidance with
   optical microscopy images and cell adhesion data. We also thank Erik
   Willett (Univ. of Akron, Polymer Science) for assistance with infrared
   spectroscopy.
CR Billiet T, 2014, BIOMATERIALS, V35, P49, DOI 10.1016/j.biomaterials.2013.09.078
   Bose S, 2013, MATER TODAY, V16, P496, DOI 10.1016/j.mattod.2013.11.017
   Cao Y, 2006, BIOMATERIALS, V27, P2854, DOI 10.1016/j.biomaterials.2005.12.015
   Choi JW, 2009, J MATER PROCESS TECH, V209, P5494, DOI 10.1016/j.jmatprotec.2009.05.004
   de Espinosa LM, 2011, EUR POLYM J, V47, P837, DOI 10.1016/j.eurpolymj.2010.11.020
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Duan B, 2013, J BIOMED MATER RES A, V101, P1255, DOI 10.1002/jbm.a.34420
   Fertier L, 2013, PROG POLYM SCI, V38, P932, DOI 10.1016/j.progpolymsci.2012.12.002
   Gokhale S, 2013, BIOMACROMOLECULES, V14, P2489, DOI 10.1021/bm400697u
   Highley CB, 2015, ADV MATER, V27, P5075, DOI 10.1002/adma.201501234
   Horvath L, 2015, SCI REP-UK, V5, DOI 10.1038/srep07974
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Huyck R H., 2007, J MACROMOL SCI CHEM, V45, P9
   Kolesky DB, 2014, ADV MATER, V26, P3124, DOI 10.1002/adma.201305506
   Kuznetsova N. A., 1992, RUSS CHEM REV, V61, P683
   Lu Y., 2015, BIOFABRICATION, V7
   Lu YF, 2015, J MECH SCI TECHNOL, V29, P5377, DOI 10.1007/s12206-015-1139-1
   Lu YF, 2013, J MECH SCI TECHNOL, V27, P2929, DOI 10.1007/s12206-013-0805-4
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Maddipatla MVSN, 2013, MACROMOLECULES, V46, P5133, DOI 10.1021/ma400584y
   Melchels FPW, 2010, BIOMATERIALS, V31, P6121, DOI 10.1016/j.biomaterials.2010.04.050
   Messmore BW, 2004, J AM CHEM SOC, V126, P14452, DOI 10.1021/ja049325w
   Miller JS, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001882
   Miller JS, 2012, NAT MATER, V11, P768, DOI [10.1038/NMAT3357, 10.1038/nmat3357]
   Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Norotte C, 2009, BIOMATERIALS, V30, P5910, DOI 10.1016/j.biomaterials.2009.06.034
   Rutz AL, 2015, ADV MATER, V27, P1607, DOI 10.1002/adma.201405076
   Sato E, 2013, PROG ORG COAT, V76, P1747, DOI 10.1016/j.porgcoat.2013.05.010
   Schacht K, 2015, ANGEW CHEM INT EDIT, V54, P2816, DOI 10.1002/anie.201409846
   Skardal A, 2015, ANN BIOMED ENG, V43, P730, DOI 10.1007/s10439-014-1207-1
   Song SJ, 2011, ARTIF ORGANS, V35, P1132, DOI 10.1111/j.1525-1594.2011.01377.x
   Swanson JP, 2015, MACROMOLECULES, V48, P3834, DOI 10.1021/acs.macromol.5b00585
   Wang MO, 2015, ADV MATER, V27, P138, DOI 10.1002/adma.201403943
   Wust S, 2011, J FUNCT BIOMATER, V2, P119, DOI 10.3390/jfb2030119
   Zopf DA, 2013, NEW ENGL J MED, V368, P2043, DOI 10.1056/NEJMc1206319
NR 36
TC 6
Z9 6
U1 4
U2 55
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
EI 1520-5835
J9 MACROMOLECULES
JI Macromolecules
PD APR 12
PY 2016
VL 49
IS 7
BP 2429
EP 2437
DI 10.1021/acs.macromol.5b02399
PG 9
WC Polymer Science
SC Polymer Science
GA DJ4RO
UT WOS:000374195600003
DA 2018-10-20
ER

PT J
AU Chang, CW
   Petrie, T
   Clark, A
   Lin, X
   Sondergaard, CS
   Griffiths, LG
AF Chang, Chia Wei
   Petrie, Tye
   Clark, Alycia
   Lin, Xin
   Sondergaard, Claus S.
   Griffiths, Leigh G.
TI Mesenchymal Stem Cell Seeding of Porcine Small Intestinal Submucosal
   Extracellular Matrix for Cardiovascular Applications
SO PLOS ONE
LA English
DT Article
ID MYOCARDIAL-INFARCTION; PARACRINE MECHANISMS; CLINICAL-TRIAL; REPAIR;
   HEART; TRANSPLANTATION; REGENERATION; SURGERY; GRAFTS; TISSUE
AB In this study, we investigate the translational potential of a novel combined construct using an FDA-approved decellularized porcine small intestinal submucosa extracellular matrix (SIS-ECM) seeded with human or porcine mesenchymal stem cells (MSCs) for cardiovascular indications. With the emerging success of individual component in various clinical applications, the combination of SIS-ECM with MSCs could provide additional therapeutic potential compared to individual components alone for cardiovascular repair. We tested the in vitro effects of MSC-seeding on SIS-ECM on resultant construct structure/function properties and MSC phenotypes. Additionally, we evaluated the ability of porcine MSCs to modulate recipient graft-specific response towards SIS-ECM in a porcine cardiac patch in vivo model. Specifically, we determined: 1) in vitro loading-capacity of human MSCs on SIS-ECM, 2) effect of cell seeding on SIS-ECM structure, compositions and mechanical properties, 3) effect of SIS-ECM seeding on human MSC phenotypes and differentiation potential, and 4) optimal orientation and dose of porcine MSCs seeded SIS-ECM for an in vivo cardiac application. In this study, histological structure, biochemical compositions and mechanical properties of the FDA-approved SIS-ECM biomaterial were retained following MSCs re-population in vitro. Similarly, the cellular phenotypes and differentiation potential of MSCs were preserved following seeding on SIS-ECM. In a porcine in vivo patch study, the presence of porcine MSCs on SIS-ECM significantly reduced adaptive T cell response regardless of cell dose and orientation compared to SIS-ECM alone. These findings substantiate the clinical translational potential of combined SIS-ECM seeded with MSCs as a promising therapeutic candidate for cardiac applications.
C1 [Chang, Chia Wei; Clark, Alycia; Griffiths, Leigh G.] Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Davis, CA 95616 USA.
   [Petrie, Tye; Lin, Xin; Sondergaard, Claus S.] Univ Calif Davis, Sch Med, Dept Surg, Sacramento, CA 95817 USA.
RP Griffiths, LG (reprint author), Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Davis, CA 95616 USA.
EM lggriffiths@ucdavis.edu
FU California Institute for Regenerative Medicine (CIRM) [TR3-05626,
   TG2-01163]
FX This work was supported by funding from California Institute for
   Regenerative Medicine (CIRM): TR3-05626 (LGG and CSS) and TG2-01163
   (CWC).
CR Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024
   Bank RA, 1997, J CHROMATOGR B, V703, P37, DOI 10.1016/S0378-4347(97)00391-5
   Boyd WD, 2010, HEART SURG FORUM, V13, pE311, DOI 10.1532/HSF98.20091184
   Caione P, 2006, PEDIATR SURG INT, V22, P593, DOI 10.1007/s00383-006-1705-9
   Caione P, 2012, PEDIATR SURG INT, V28, P421, DOI 10.1007/s00383-012-3063-0
   Chalajour F, 2012, ANN THORAC SURG, V93, P1311, DOI 10.1016/j.athoracsur.2011.08.055
   Du XF, 2012, INT J PEDIATR OTORHI, V76, P345, DOI DOI 10.1016/J.IJP0RL.2011.12.005
   Engelmayr GC, 2006, BIOMATERIALS, V27, P6083, DOI 10.1016/j.biomaterials.2006.07.045
   Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826
   Hodde J P, 2005, J Wound Care, V14, P23
   Hodde JP, 2001, ENDOTHELIUM-NEW YORK, V8, P11, DOI 10.3109/10623320109063154
   Hodonsky C, 2015, ANN THORAC SURG, V99, P605, DOI 10.1016/j.athoracsur.2014.08.071
   Janis AD, 2012, J BIOMATER APPL, V26, P1013, DOI 10.1177/0885328210391688
   Katritsis DG, 2005, CATHETER CARDIO INTE, V65, P321, DOI 10.1002/ccd.20406
   Kini S, 2001, OBES SURG, V11, P469, DOI 10.1381/096089201321209350
   Lam MT, 2013, TISSUE ENG PT A, V19, P738, DOI [10.1089/ten.tea.2012.0480, 10.1089/ten.TEA.2012.0480]
   Li AH, 2014, CIRC RES, V114, P916, DOI 10.1161/CIRCRESAHA.114.302819
   Lin HK, 2014, TISSUE ENG PART B-RE, V20, P73, DOI 10.1089/ten.TEB.2013.0126
   Lin X, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0165-3
   Lopes MF, 2006, DIS ESOPHAGUS, V19, P254, DOI 10.1111/j.1442-2050.2006.00574.x
   Lopes MF, 2006, J INVEST SURG, V19, P105, DOI 10.1080/08941930600569621
   Makris EA, 2013, OSTEOARTHR CARTILAGE, V21, P634, DOI 10.1016/j.joca.2013.01.007
   McCready RA, 2005, J VASC SURG, V41, P782, DOI 10.1016/j.jvs.2005.02.035
   Mirotsou M, 2011, J MOL CELL CARDIOL, V50, P280, DOI 10.1016/j.yjmcc.2010.08.005
   Mostow EN, 2005, J VASC SURG, V41, P837, DOI 10.1016/j.jvs.2005.01.042
   Murphy KD, 2008, J HAND SURG-AM, V33A, P1168, DOI 10.1016/j.jhsa.2008.02.003
   National Research Council, 1996, GUID CAR US LAB AN
   Niezgoda Jeffrey A, 2005, Adv Skin Wound Care, V18, P258, DOI 10.1097/00129334-200506000-00012
   Nihsen Edith S, 2008, Adv Skin Wound Care, V21, P479, DOI 10.1097/01.ASW.0000323561.14144.19
   Nihsen Edith S, 2007, Adv Skin Wound Care, V20, P541, DOI 10.1097/01.ASW.0000294756.97425.c9
   Palmer EM, 2002, TISSUE ENG, V8, P893, DOI 10.1089/10763270260424259
   Perin EC, 2003, CIRCULATION, V107, P2294, DOI 10.1161/01.CIR.0000070596.30552.8B
   PREVEL CD, 1995, ANN PLAS SURG, V35, P381, DOI 10.1097/00000637-199510000-00009
   Quarti A, 2011, INTERACT CARDIOV TH, V13, P569, DOI 10.1510/icvts.2011.280016
   Ramaswamy S, 2010, BIOMATERIALS, V31, P1114, DOI 10.1016/j.biomaterials.2009.10.019
   Ranganath SH, 2012, CELL STEM CELL, V10, P244, DOI 10.1016/j.stem.2012.02.005
   Rossetto VJV, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-39
   Scholl FG, 2010, WORLD J PEDIATR CONG, V1, P132, DOI 10.1177/2150135110362092
   Sharma AK, 2011, STEM CELLS, V29, P241, DOI 10.1002/stem.568
   Slachman FN, 2014, ANN THORAC SURG, V97, pE129, DOI 10.1016/j.athoracsur.2013.10.103
   Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C
   Taljaard M, 2010, AM HEART J, V159, P354, DOI 10.1016/j.ahj.2009.12.021
   Tang YL, 2005, ANN THORAC SURG, V80, P229, DOI 10.1016/j.athoracsur.2005.02.072
   Williams AR, 2011, CIRC RES, V108, P792, DOI 10.1161/CIRCRESAHA.111.242610
   Witt RG, 2013, EUR J CARDIO-THORAC, V44, P72, DOI 10.1093/ejcts/ezs638
   Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9
   Wong ML, 2011, BIOMATERIALS, V32, P8129, DOI 10.1016/j.biomaterials.2011.07.030
   Yanagawa B, 2013, INNOVATIONS, V8, P348, DOI 10.1097/IMI.0000000000000014
NR 48
TC 12
Z9 12
U1 2
U2 17
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 12
PY 2016
VL 11
IS 4
AR e0153412
DI 10.1371/journal.pone.0153412
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DJ0NI
UT WOS:000373900700062
PM 27070546
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Fischer, KM
   Morgan, KY
   Hearon, K
   Sklaviadis, D
   Tochka, ZL
   Fenton, OS
   Anderson, DG
   Langer, R
   Freed, LE
AF Fischer, Kristin M.
   Morgan, Kathy Ye
   Hearon, Keith
   Sklaviadis, Demetra
   Tochka, Zachary L.
   Fenton, Owen S.
   Anderson, Daniel G.
   Langer, Robert
   Freed, Lisa E.
TI Poly(Limonene Thioether) Scaffold for Tissue Engineering
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
ID THIOL-ACRYLATE PHOTOPOLYMERS; POLY(GLYCEROL SEBACATE) PGS; CARDIAC
   TISSUE; BIOMEDICAL APPLICATIONS; DEGRADATION BEHAVIOR; D-LIMONENE;
   IN-VIVO; BIOMATERIALS; SUPPORT; BIOCOMPATIBILITY
AB A photocurable thiol-ene network polymer, poly(limonene thioether) (PLT32o), is synthesized, characterized, fabricated into tissue engineering scaffolds, and demonstrated in vitro and in vivo. Micromolded PLT32o grids exhibit compliant, elastomeric mechanical behavior similar to grids made of poly(glycerol sebacate) (PGS), an established biomaterial. Multilayered PL32o scaffolds with regular, geometrically defined pore architectures support heart cell seeding and culture in a manner similar to multilayered PGS scaffolds. Subcutaneous implantation of multilayered PLT32o scaffolds with cultured heart cells provides long-term 3D structural support and retains the exogenous cells, whereas PGS scaffolds lose both their structural integrity and the exogenous cells over 31 d in vivo. PLT32o membrane implants retain their dry mass, whereas PGS implants lose 70 percent of their dry mass by day 31. Macrophages are initially recruited to PLT32o and PGS membrane implants but are no longer present by day 31. Facile synthesis and processing in combination with the capability to support heart cells in vitro and in vivo suggest that PLT32o can offer advantages for tissue engineering applications where prolonged in vivo maintenance of 3D structural integrity and elastomeric mechanical behavior are required.
C1 [Fischer, Kristin M.; Morgan, Kathy Ye; Hearon, Keith; Sklaviadis, Demetra; Tochka, Zachary L.; Fenton, Owen S.; Anderson, Daniel G.; Langer, Robert; Freed, Lisa E.] MIT, Harvard Mit Div Hlth Sci & Technol, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.
   [Fischer, Kristin M.; Morgan, Kathy Ye; Hearon, Keith; Sklaviadis, Demetra; Tochka, Zachary L.; Fenton, Owen S.; Anderson, Daniel G.; Langer, Robert; Freed, Lisa E.] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA.
   [Freed, Lisa E.] Mat Engn Div, Draper Cambridge, MA 02139 USA.
RP Freed, LE (reprint author), MIT, Harvard Mit Div Hlth Sci & Technol, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.; Freed, LE (reprint author), Mat Engn Div, Draper Cambridge, MA 02139 USA.
EM Lfreed@mit.edu
OI Freed, Lisa/0000-0002-0720-8432
FU NIH/NHLBI [R01-HL107503]; Chick fil-A, Inc.
FX This work was funded by NIH/NHLBI Grant R01-HL107503 (to L.E.F.) and a
   fellowship from Chick fil-A, Inc. (to K.H.). We are grateful to J. Yu
   and C. van der Ven for help with polymer synthesis, J. Coppeta for help
   with embossed molds, A. Spencer and D. Stone for help with laser
   cutting, A. Anselmo for help with contact angle studies, J. Haupt and M.
   Jamiel for help with in vivo studies, N. Watson at the Whitehead
   Institute for help with imaging, and R. T. Bronson and the Koch
   Institute Core Facility for help with histology.
CR Ameer GA, 2002, J ORTHOPAED RES, V20, P16, DOI 10.1016/S0736-0266(01)00074-2
   Artzi N, 2011, NAT MATER, V10, P704, DOI [10.1038/nmat3095, 10.1038/NMAT3095]
   Atluri P, 2013, HEART FAIL REV, V18, P55, DOI 10.1007/s10741-012-9312-4
   Bettinger CJ, 2009, J BIOMED MATER RES A, V91A, P1077, DOI 10.1002/jbm.a.32306
   Bian W., 2012, TISSUE ENG PART A, V18, P957
   Chen QZ, 2010, BIOMATERIALS, V31, P3885, DOI 10.1016/j.biomaterials.2010.01.108
   Chen QZ, 2013, PROG POLYM SCI, V38, P584, DOI 10.1016/j.progpolymsci.2012.05.003
   Christoforou N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065963
   Claudino M, 2014, POLYM CHEM-UK, V5, P3245, DOI 10.1039/c3py01302b
   Engelmayr GC, 2006, J BIOMECH, V39, P1819, DOI 10.1016/j.jbiomech.2005.05.020
   Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316
   Freed LE, 2009, ADV MATER, V21, P3410, DOI 10.1002/adma.200900303
   Fulmer GR, 2010, ORGANOMETALLICS, V29, P2176, DOI 10.1021/om100106e
   Gilboa SM, 2010, CIRCULATION, V122, P2254, DOI 10.1161/CIRCULATIONAHA.110.947002
   Goodpaster T, 2008, J HISTOCHEM CYTOCHEM, V56, P347, DOI 10.1369/jhc.7A7287.2007
   Hearon K, 2015, ADV HEALTHC MATER, V4, P1386, DOI 10.1002/adhm.201500156
   Hearon K, 2014, ADV MATER, V26, P1552, DOI 10.1002/adma.201304370
   Holmes JW, 2005, ANNU REV BIOMED ENG, V7, P223, DOI 10.1146/annurev.bioeng.7.060804.100453
   Huyer LD, 2015, BIOMED MATER, V10, DOI 10.1088/1748-6041/10/3/034004
   Ifkovits JL, 2009, ACS APPL MATER INTER, V1, P1878, DOI 10.1021/am900403k
   Jiang JY, 2015, RSC ADV, V5, P36036, DOI 10.1039/c5ra02220g
   Kerativitayanan P, 2015, ACTA BIOMATER, V26, P34, DOI 10.1016/j.actbio.2015.08.025
   Kolewe ME, 2013, ADV MATER, V25, P4459, DOI 10.1002/adma.201301016
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   Mann DL, 2012, J THORAC CARDIOV SUR, V143, P1036, DOI 10.1016/j.jtcvs.2011.06.014
   Morgan KY, 2014, TISSUE ENG PT A, V20, P1654, DOI [10.1089/ten.tea.2013.0355, 10.1089/ten.TEA.2013.0355]
   Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152
   Neal RA, 2013, TISSUE ENG PT A, V19, P793, DOI 10.1089/ten.tea.2012.0330
   Nichol JW, 2010, BIOMATERIALS, V31, P5536, DOI 10.1016/j.biomaterials.2010.03.064
   Nijst CLE, 2007, BIOMACROMOLECULES, V8, P3067, DOI 10.1021/bm070423u
   Oliva N, 2015, ADV HEALTHC MATER, V4, P1584, DOI 10.1002/adhm.201400778
   Papadaki M, 2001, AM J PHYSIOL-HEART C, V280, pH168
   Park H, 2011, BIOMATERIALS, V32, P1856, DOI 10.1016/j.biomaterials.2010.11.032
   Pomerantseva I, 2009, J BIOMED MATER RES A, V91A, P1038, DOI 10.1002/jbm.a.32327
   Radisic M, 2006, TISSUE ENG, V12, P2077, DOI 10.1089/ten.2006.12.2077
   Rai R, 2013, MAT SCI ENG C-MATER, V33, P3677, DOI 10.1016/j.msec.2013.04.058
   Rai R, 2012, PROG POLYM SCI, V37, P1051, DOI 10.1016/j.progpolymsci.2012.02.001
   Rydholm AE, 2005, BIOMATERIALS, V26, P4495, DOI 10.1016/j.biomaterials.2004.11.046
   Rydholm AE, 2008, J BIOMED MATER RES A, V86A, P23, DOI 10.1002/jbm.a.31526
   Sales VL, 2007, CIRCULATION, V116, pI55, DOI 10.1161/CIRCULATIONAHA.106.6806637
   SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005
   Shamsi A, 2014, MICROSYST TECHNOL, V20, P1925, DOI 10.1007/s00542-013-2000-z
   Stuckey DJ, 2010, TISSUE ENG PT A, V16, P3395, DOI 10.1089/ten.TEA.2010.0213
   Sundback CA, 2005, BIOMATERIALS, V26, P5454, DOI 10.1016/j.biomaterials.2005.02.004
   Vunjak-Noyakovic G, 2011, ANNU REV BIOMED ENG, V13, P245, DOI 10.1146/annurev-bioeng-071910-124701
   Wang YD, 2003, J BIOMED MATER RES A, V66A, P192, DOI 10.1002/jbm.a.10534
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Wang YX, 2004, PHARM RES, V21, P1362, DOI 10.1023/B:PHAM.0000036909.41843.18
   Williams DF, 2014, TISSUE ENG PT A, V20, P1129, DOI 10.1089/ten.tea.2013.0769
   Ye K. Yuan, 2011, JOVE-J VIS EXP, V55, P3251
   Ye XF, 2014, ADV MATER, V26, P7202, DOI 10.1002/adma.201403074
   Ye XF, 2013, BIOMATERIALS, V34, P10007, DOI 10.1016/j.biomaterials.2013.09.039
   Zhang BY, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500423
NR 53
TC 7
Z9 7
U1 3
U2 47
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD APR 6
PY 2016
VL 5
IS 7
BP 813
EP 821
DI 10.1002/adhm.201500892
PG 9
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA DJ3IL
UT WOS:000374098000008
PM 26890480
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Xiao, X
   Zhang, CB
   Liu, DJ
   Bai, WB
   Zhang, QH
   Xiang, Q
   Huang, YD
   Su, ZJ
AF Xiao, Xue di
   Zhang, Changbin
   Liu, Dajun
   Bai, Weibin
   Zhang, Qihao
   Xiang, Qi
   Huang, Yadong
   Su, Zhijian
TI Prevention of gastrointestinal lead poisoning using recombinant
   Lactococcus lactis expressing human metallothionein-I fusion protein
SO SCIENTIFIC REPORTS
LA English
DT Article
ID GLUTATHIONE-S-TRANSFERASE; LEYDIG TUMOR-CELLS; CHELATION-THERAPY; ACID
   BACTERIA; GROWTH-FACTOR; PURIFICATION; TOXICITY; CHILDREN; DELIVERY;
   STEROIDOGENESIS
AB Low-level lead poisoning is an insidious disease that affects millions of children worldwide, leading to biochemical and neurological dysfunctions. Blocking lead uptake via the gastrointestinal tract is an important prevention strategy. With this in mind, we constructed the recombinant Lactococcus lactis strain pGSMT/MG1363, which constitutively expressed the fusion protein glutathione S-transferase (GST)-small molecule ubiquitin-like modifier protein (SUMO)-metallothionein-I (GST-SUMO-MT). The thermodynamic data indicated that the average number of lead bound to a GST-SUMO-MT molecule was 3.655 and this binding reaction was a spontaneous, exothermic and entropy-increasing process. The total lead-binding capacity of pGSMT/MG1363 was 4.11 +/- 0.15 mg/g dry mass. Oral administration of pGSMT/MG1363 (1 x 10(10) Colony-Forming Units) to pubertal male rats that were also treated with 5 mg/kg of lead acetate daily significantly inhibited the increase of blood lead levels, the impairment of hepatic function and the decrease of testosterone concentration in the serum, which were all impaired in rats treated by lead acetate alone. Moreover, the administration of pGSMT/MG1363 for 6 weeks did not affect the serum concentration of calcium, magnesium, potassium or sodium ions. This study provides a convenient and economical biomaterial for preventing lead poisoning via the digestive tract.
C1 [Xiao, Xue di; Zhang, Changbin; Liu, Dajun; Huang, Yadong; Su, Zhijian] Jinan Univ, Dept Cell Biol, Coll Life Sci & Technol, Guangzhou 510632, Guangdong, Peoples R China.
   [Zhang, Qihao; Xiang, Qi; Su, Zhijian] Jinan Univ, Inst Biomed, Guangdong Prov Key Lab Bioengn Med, Guangzhou 510632, Guangdong, Peoples R China.
   [Zhang, Changbin] Guangdong Women & Children Hosp, Dept Clin Mol Diag, Guangzhou 510010, Guangdong, Peoples R China.
   [Bai, Weibin] Jinan Univ, Dept Food Sci & Engieering, Guangzhou 510632, Guangdong, Peoples R China.
RP Huang, YD; Su, ZJ (reprint author), Jinan Univ, Dept Cell Biol, Coll Life Sci & Technol, Guangzhou 510632, Guangdong, Peoples R China.; Su, ZJ (reprint author), Jinan Univ, Inst Biomed, Guangdong Prov Key Lab Bioengn Med, Guangzhou 510632, Guangdong, Peoples R China.
EM tydhuang@jnu.edu.cn; tjnuszj@jnu.edu.cn
FU Guangdong Provincial Department of Science and Technology
   [2009B080701090, 2012B091100168]; Science Foundation of Wenzhou in China
   [Y20090252]; Major Scientific and Technological Special Project of
   Administration of Ocean and Fisheries of Guangdong Province
   [A201301B09]; National High-tech R&D Program of China [2011AA100901];
   Guangdong Province Higher Vocational Colleges & Schools Pearl River
   Scholar Funded Scheme
FX This work was partially supported by grant of Guangdong Provincial
   Department of Science and Technology (No. 2009B080701090,
   2012B091100168), grant of the Science Foundation of Wenzhou in China
   (No. Y20090252), Major Scientific and Technological Special Project of
   Administration of Ocean and Fisheries of Guangdong Province
   (A201301B09), National High-tech R&D Program of China (2011AA100901) and
   Project Supported by Guangdong Province Higher Vocational Colleges &
   Schools Pearl River Scholar Funded Scheme (2012).
CR Canfield RL, 2003, NEW ENGL J MED, V348, P1517, DOI 10.1056/NEJMoa022848
   CDC, 2010, GUID ID MAN LEAD EXP
   Centers for Disease Control and Prevention, 2015, NAT REP HUM EXP ENV
   Chu DY, 2000, THERMOCHIM ACTA, V352, P205, DOI 10.1016/S0040-6031(99)00468-2
   Dietrich KN, 2004, PEDIATRICS, V114, P19, DOI 10.1542/peds.114.1.19
   Flora Gagan, 2012, Interdiscip Toxicol, V5, P47, DOI 10.2478/v10102-012-0009-2
   Garcia-Leston J, 2010, ENVIRON INT, V36, P623, DOI 10.1016/j.envint.2010.04.011
   Ge R., 2007, LEYDIG CELL HLTH DIS, P55
   Ge RS, 2006, P NATL ACAD SCI USA, V103, P2719, DOI 10.1073/pnas.0507692103
   Ge RS, 1998, ENDOCRINOLOGY, V139, P3787, DOI 10.1210/en.139.9.3787
   Grandjean P, 2014, LANCET NEUROL, V13, P330, DOI 10.1016/S1474-4422(13)70278-3
   Guo JJ, 2013, REPRODUCTION, V145, P371, DOI 10.1530/REP-12-0465
   Halttunen T, 2007, INT J FOOD MICROBIOL, V114, P30, DOI 10.1016/j.ijfoodmicro.2006.10.040
   HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119
   Hong SH, 2001, PROTEIN EXPRES PURIF, V21, P243, DOI 10.1006/prep.2000.1372
   Huang YD, 2009, J PHARMACOL EXP THER, V329, P469, DOI 10.1124/jpet.108.149401
   Hunaiti AA, 2000, SCI TOTAL ENVIRON, V248, P45, DOI 10.1016/S0048-9697(99)00548-3
   Ignacak J., 1990, FOLIA MED CRACOV, V32, P111
   Jaroslawiecka A, 2014, MICROBIOL-SGM, V160, P12, DOI 10.1099/mic.0.070284-0
   KOPP SJ, 1988, ENVIRON HEALTH PERSP, V78, P91, DOI 10.2307/3430507
   Kosik-Bogacka DI, 2011, MED SCI MONITOR, V17, pBR16, DOI 10.12659/MSM.881323
   Liu H, 2014, J STEROID BIOCHEM, V144, P483, DOI 10.1016/j.jsbmb.2014.09.016
   LIU J, 1991, TOXICOL APPL PHARM, V107, P27, DOI 10.1016/0041-008X(91)90327-B
   Liu MY, 2003, ARCH ANDROLOGY, V49, P29, DOI 10.1080/01485010390129151
   Liu MY, 2001, LIFE SCI, V68, P849, DOI 10.1016/S0024-3205(00)00983-8
   MAIORINO RM, 1989, TOXICOL APPL PHARM, V97, P338, DOI 10.1016/0041-008X(89)90338-4
   McMichael AJ, 2000, B WORLD HEALTH ORGAN, V78, P1117
   Medina M, 2008, MICROBIOL IMMUNOL, V52, P399, DOI [10.1111/j.1348-0421.2008.00050.x, 10.1111/j.1348.0421.2008.00050.x]
   Meyer PA, 2003, INT J HYG ENVIR HEAL, V206, P363, DOI 10.1078/1438-4639-00232
   Miller A L, 1998, Altern Med Rev, V3, P199
   Muller Halima, 2013, F1000Res, V2, P250, DOI 10.12688/f1000research.2-250.v1
   Needleman H, 2004, ANNU REV MED, V55, P209, DOI 10.1146/annurev.med.55.091902.103653
   Ngu TT, 2009, IUBMB LIFE, V61, P438, DOI 10.1002/iub.182
   Nouaille Sebastien, 2003, Genet Mol Res, V2, P102
   Qu W, 2002, AM J PATHOL, V160, P1047, DOI 10.1016/S0002-9440(10)64925-5
   Rogan WJ, 2001, NEW ENGL J MED, V344, P1421, DOI 10.1056/NEJM200105103441902
   Rossi Enrico, 2008, Clin Biochem Rev, V29, P63
   Steidler L, 2003, NAT BIOTECHNOL, V21, P785, DOI 10.1038/nbt840
   Steidler L, 2006, ANN NY ACAD SCI, V1072, P176, DOI 10.1196/annals.1326.031
   Su ZJ, 2006, PROTEIN PEPTIDE LETT, V13, P785, DOI 10.2174/092986606777841280
   Terpe K, 2006, APPL MICROBIOL BIOT, V72, P211, DOI 10.1007/s00253-006-0465-8
   Vasak M, 2005, J TRACE ELEM MED BIO, V19, P13, DOI 10.1016/j.jtemb.2005.03.003
   Waalkes MP, 2004, CANCER RES, V64, P7766, DOI 10.1158/0008-5472.CAN-04-2220
   Wells JM, 2008, NAT REV MICROBIOL, V6, P349, DOI 10.1038/nrmicro1840
   WHO (World Health Organization), 2010, CHILDH LEAD POIS
   Wright LS, 1998, TOXICOL SCI, V46, P254, DOI 10.1006/toxs.1998.2543
   Zhou YJ, 2000, BBA-GEN SUBJECTS, V1524, P87, DOI 10.1016/S0304-4165(00)00072-6
NR 47
TC 2
Z9 2
U1 1
U2 23
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD APR 5
PY 2016
VL 6
AR 23716
DI 10.1038/srep23716
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DI3KC
UT WOS:000373396500001
PM 27045906
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Sharma, N
   Raj, T
   Jangra, KK
AF Sharma, Neeraj
   Raj, Tilak
   Jangra, Kamal Kumar
TI Microstructural Evaluation of NiTi-powder, Steatite, and Steel Balls
   After Different Milling Conditions
SO MATERIALS AND MANUFACTURING PROCESSES
LA English
DT Article
DE Biomaterial; Intermetallics; Microscopy; NiTi; Scanning; Steatite; XRD
ID SHAPE-MEMORY ALLOY; PROCESS PARAMETERS; TI; FABRICATION; IMPLANTS
AB The present research deals with the investigation of morphological characteristics after mechanical alloying of Ni-50 at. %Ti in a high-energy planetary ball mill at various milling times (i.e., 4, 8, 30, 40, 50, and 60h). Crystallite size was observed to be decreased with the increase of milling time, entire titanium fused in the nickel trellis, and results of intermetallic NiTi. The shape of particle also changed from lamella to globular. Steatite-ceramic and hardened balls were separately used for the ball milling. The observations of morphologies revealed that steatite balls are more durable and wear resistant as compared to steel ball. This research shows that ball milling with steatite-ceramic balls is a cost-effective, high purity, and productive step toward the formation of NiTi intermetallic compound with homogeneous composition and desired particle size.
C1 [Sharma, Neeraj; Raj, Tilak] YMCA Univ Sci & Technol, Dept Mech Engn, Faridabad 121006, India.
   [Jangra, Kamal Kumar] PEC Univ Technol, Dept Mech Engn, Chandigarh, India.
RP Sharma, N (reprint author), YMCA Univ Sci & Technol, Dept Mech Engn, Faridabad 121006, India.
EM neeraj.sharma@live.com
OI Sharma, Neeraj/0000-0002-6719-8379; Kumar, Kamal/0000-0002-4293-0068
CR Aghili SE, 2012, MATER MANUF PROCESS, V27, P467, DOI 10.1080/10426914.2011.585501
   Ashokkumar T, 2013, MATER MANUF PROCESS, V28, P670, DOI 10.1080/10426914.2012.727121
   Bormann T, 2012, J MATER ENG PERFORM, V21, P2519, DOI 10.1007/s11665-012-0318-9
   Da Silva EP, 1999, MATER LETT, V38, P341, DOI 10.1016/S0167-577X(98)00186-4
   Dashtbayazi M. R., 2007, MAT MANUFACTURING PR, V23, P37, DOI [10.1080/104269107001524485, DOI 10.1080/104269107001524485]
   Frenzel J, 2004, J ALLOY COMPD, V385, P214, DOI 10.1016/j.jallcom.2004.05.002
   Gibson I, 2010, ADDITIVE MANUFACTURING TECHNOLOGIES: RAPID PROTOTYPING TO DIRECT DIGITAL MANUFACTURING, P1, DOI 10.1007/978-1-4419-1120-9
   Koike M, 2011, J MATER PROCESS TECH, V211, P1400, DOI 10.1016/j.jmatprotec.2011.03.013
   Krishna BV, 2009, J BIOMED MATER RES B, V89B, P481, DOI 10.1002/jbm.b.31238
   McNaney JM, 2003, MECH MATER, V35, P969, DOI 10.1016/S0167-6636(02)00310-1
   Nazarian-Samani M, 2010, MATER LETT, V64, P309, DOI 10.1016/j.matlet.2009.10.070
   Otsuka K, 2005, PROG MATER SCI, V50, P511, DOI 10.1016/j.pmatsci.2004.10.001
   Sadrnezhaad SK, 2006, MATER MANUF PROCESS, V21, P727, DOI 10.1080/10426910600727882
   Shariat BS, 2013, ACTA MATER, V61, P3411, DOI 10.1016/j.actamat.2013.02.032
   Starosvetsky D, 2001, BIOMATERIALS, V22, P1853, DOI 10.1016/S0142-9612(00)00368-9
   Suryanarayana C, 2004, MECH ALLOYING MILLIN
   Tadeja K., 2014, APPL SURF SCI, V288, P727, DOI [10.1016/j.apsusc.2013.10.116, DOI 10.1016/J.APSUSC.2013.10.116]
   Tosun G, 2012, MATER MANUF PROCESS, V27, P1184, DOI 10.1080/10426914.2011.648692
   Wen CE, 2001, SCRIPTA MATER, V45, P1147, DOI 10.1016/S1359-6462(01)01132-0
NR 19
TC 9
Z9 9
U1 0
U2 26
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1042-6914
EI 1532-2475
J9 MATER MANUF PROCESS
JI Mater. Manuf. Process.
PD APR 3
PY 2016
VL 31
IS 5
BP 628
EP 632
DI 10.1080/10426914.2015.1004710
PG 5
WC Engineering, Manufacturing; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA CZ8GM
UT WOS:000367338200010
DA 2018-10-20
ER

PT J
AU Hathout, RM
   Omran, MK
AF Hathout, Rania M.
   Omran, Mohamed K.
TI Gelatin-based particulate systems in ocular drug delivery
SO PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
LA English
DT Review
DE Biomaterial; drug delivery; gelatin; ocular; particles
ID SITU GELLING SYSTEMS; TUMOR-BEARING MICE; IN-VITRO; BIODEGRADABLE
   NANOPARTICLES; INTRAARTICULAR DELIVERY; PENETRATION ENHANCERS;
   CATIONIZED GELATIN; 2-STEP DESOLVATION; CELL UPTAKE; MICROSPHERES
AB Despite all scientists efforts exerted over the past years, the ocular delivery of drugs remains a great challenge due to several barriers and hurdles faced by this kind of administration. The exploitation of gelatin that has a long history of safe use in pharmaceuticals and which is considered as a GRAS (Generally Regarded As Safe) material by the FDA was not fully achieved in this field. This review summarizes the recent studies and findings where gelatin-based micro- and nanoparticles were used for successful ocular delivery aiming at drawing the attention of researchers and scientists to this valuable biomaterial that has not been fully explored.
C1 [Hathout, Rania M.; Omran, Mohamed K.] Ain Shams Univ, Fac Pharm, Dept Pharmaceut & Ind Pharm, African Union St, Cairo 11566, Egypt.
RP Hathout, RM (reprint author), Ain Shams Univ, Fac Pharm, Dept Pharmaceut & Ind Pharm, African Union St, Cairo 11566, Egypt.
EM r_hathout@yahoo.com
OI Hathout, Rania/0000-0001-9153-4355
CR Abdel-Hafez SM, 2014, INT J BIOL MACROMOL, V64, P334, DOI 10.1016/j.ijbiomac.2013.11.041
   Abdelkader H, 2014, DRUG DELIV, V21, P87, DOI 10.3109/10717544.2013.838077
   Abdelkader H, 2012, INT J PHARMACEUT, V433, P142, DOI 10.1016/j.ijpharm.2012.05.011
   Abdelkader H, 2011, J PHARM SCI-US, V100, P1833, DOI 10.1002/jps.22422
   Achouri D, 2013, DRUG DEV IND PHARM, V39, P1599, DOI 10.3109/03639045.2012.736515
   Agarwal R, 2014, DRUG DELIV IN PRESS
   Akhter KF, 2012, J PHYS CHEM BIOPHY S, VS11
   Ali J, 2014, DRUG DELIV IN PRESS
   Araujo J, 2009, NANOMED-NANOTECHNOL, V5, P394, DOI 10.1016/j.nano.2009.02.003
   Azarmi S, 2006, J PHARM PHARM SCI, V9, P124
   Azimi Bahareh, 2014, Iranian Biomedical Journal, V18, P34, DOI 10.6091/ibj.12422.2013
   Balthasar S, 2005, BIOMATERIALS, V26, P2723, DOI 10.1016/j.biomaterials.2004.07.047
   Barbu E, 2006, J MATER CHEM, V16, P3439, DOI 10.1039/b605640g
   Bourges JL, 2006, ADV DRUG DELIVER REV, V58, P1182, DOI 10.1016/j.addr.2006.07.026
   Bourlais C L, 1998, Prog Retin Eye Res, V17, P33
   Bourquin C, 2008, J IMMUNOL, V181, P2990, DOI 10.4049/jimmunol.181.5.2990
   Bourquin C, 2010, J IMMUNOTHER, V33, P935, DOI 10.1097/CJI.0b013e3181f5dfa7
   Bucolo C, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00188
   Calvo P, 1996, J PHARM PHARMACOL, V48, P1147, DOI 10.1111/j.2042-7158.1996.tb03911.x
   Cascone MG, 2002, J MATER SCI-MATER M, V13, P523, DOI 10.1023/A:1014791327253
   Chan J, 2007, INT J PHARM, V328, P65, DOI 10.1016/j.ijpharm.2006.10.004
   Chan J, 2008, CLIN OPHTHALMOL, V2, P129
   Chi JL, 2014, RADIAT RES, V181, P416, DOI 10.1667/RR13539.1
   Coester C, 2006, EUR J PHARM BIOPHARM, V62, P306, DOI 10.1016/j.ejpb.2005.09.009
   Coester C, 2000, INT J PHARM, V196, P147, DOI 10.1016/S0378-5173(99)00409-3
   Coester CJ, 2000, J MICROENCAPSUL, V17, P187
   Contreras-Ruiz L, 2013, GENE THER, V20, P467, DOI 10.1038/gt.2012.56
   Dwivedi P, 2012, J DRUG TARGET, V20, P883, DOI 10.3109/1061186X.2012.725169
   Elbialy NS, 2013, J BIOMED NANOTECHNOL, V9, P2105, DOI 10.1166/jbn.2013.1711
   Elzoghby AO, 2013, J CONTROL RELEASE, V172, P1075, DOI 10.1016/j.jconrel.2013.09.019
   Elzoghby AO, 2012, J CONTROL RELEASE, V161, P38, DOI 10.1016/j.jconrel.2012.04.036
   Ethirajan A, 2008, BIOMACROMOLECULES, V9, P2383, DOI 10.1021/bm800377w
   Fraunhofer W, 2004, ANAL CHEM, V76, P1909, DOI 10.1021/ac0353031
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Fuchs S, 2012, J MICROENCAPSUL, V29, P615, DOI 10.3109/02652048.2012.668962
   Gan L, 2013, DRUG DISCOV TODAY, V18, P290, DOI 10.1016/j.drudis.2012.10.005
   Gratieri T, 2011, EUR J PHARM BIOPHARM, V79, P320, DOI 10.1016/j.ejpb.2011.05.006
   Gratieri T, 2010, EUR J PHARM BIOPHARM, V75, P186, DOI 10.1016/j.ejpb.2010.02.011
   Gregoriadis G, 2000, METHODS MOL MED, P137
   Guinedi AS, 2005, INT J PHARM, V306, P71, DOI 10.1016/j.ijpharm.2005.09.023
   Gunji S, 2013, SURGERY, V154, P991, DOI 10.1016/j.surg.2013.04.054
   Gupta AK, 2004, J CONTROL RELEASE, V95, P197, DOI 10.1016/j.jconrel.2003.11.006
   Hallaj-Nezhadi S, 2013, FUTURE ONCOL, V9, P1195, DOI [10.2217/fon.13.82, 10.2217/FON.13.82]
   Hathout RM, 2007, AAPS PHARMSCITECH, V8
   Ishikawa H, 2012, BIOMATERIALS, V33, P9097, DOI 10.1016/j.biomaterials.2012.08.032
   Januleviciene Ingrida, 2012, Pharmaceutics, V4, P243, DOI 10.3390/pharmaceutics4010243
   Jin Y, 2014, ACTA BIOMATER, V10, P3126, DOI 10.1016/j.actbio.2014.02.045
   Karthikeyan S., 2013, Biomedicine & Preventive Nutrition, V3, P64
   Kaur IP, 2002, DRUG DEV IND PHARM, V28, P353, DOI 10.1081/DDC-120002997
   Kawadkar J, 2013, J DRUG TARGET, V21, P200, DOI 10.3109/1061186X.2012.745549
   Kawadkar J, 2012, EUR J PHARM BIOPHARM, V81, P563, DOI 10.1016/j.ejpb.2012.04.018
   Khan SA, 2013, MACROMOL BIOSCI, V13, P455, DOI 10.1002/mabi.201200382
   Kim HW, 2005, J MATER SCI-MATER M, V16, P1105, DOI 10.1007/s10856-005-4714-7
   Klier J, 2012, PHARM RES-DORDR, V29, P1650, DOI 10.1007/s11095-012-0686-8
   Kommareddy S, 2007, J PHARM SCI-US, V96, P397, DOI 10.1002/jps.20813
   Zorzi GK, 2011, MOL PHARMACEUT, V8, P1783, DOI 10.1021/mp200155t
   Zorzi GK, 2011, MACROMOL BIOSCI, V11, P905, DOI 10.1002/mabi.201100005
   Kumari A, 2010, COLLOID SURFACE B, V75, P1, DOI 10.1016/j.colsurfb.2009.09.001
   Kuno N, 2011, POLYMERS-BASEL, V3, P193, DOI 10.3390/polym3010193
   Kuntworbe N, 2012, AAPS PHARMSCITECH, V13, P568, DOI 10.1208/s12249-012-9775-6
   Kuo WT, 2011, J NANOMATER, DOI 10.1155/2011/646538
   Lee EJ, 2011, J BIOMAT SCI-POLYM E, V22, P753, DOI 10.1163/092050610X492093
   Lee SJ, 2013, J CONTROL RELEASE, V172, P358, DOI 10.1016/j.jconrel.2013.09.002
   Leeuwenburgh SCG, 2010, BIOMACROMOLECULES, V11, P2653, DOI 10.1021/bm1006344
   LEUCUTA SE, 1989, INT J PHARM, V54, P71, DOI 10.1016/0378-5173(89)90167-1
   Li JK, 1997, J PHARM SCI-US, V86, P891, DOI 10.1021/js970084i
   Li JK, 1998, J MICROENCAPSUL, V15, P163, DOI 10.3109/02652049809006846
   Li LL, 2014, ACS NANO, V8, P4975, DOI 10.1021/nn501040h
   Loftssona T, 1999, ADV DRUG DELIVER REV, V36, P59, DOI 10.1016/S0169-409X(98)00055-6
   Lu Z, 2004, CLIN CANCER RES, V10, P7677, DOI 10.1158/1078-0432.CCR-04-1443
   Mahapatro A, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-55
   Manca ML, 2013, J PHARM PHARMACOL, V65, P1302, DOI 10.1111/jphp.12094
   Mansour M, 2008, DRUG DEV IND PHARM, V34, P744, DOI [10.1080/03639040801926030, 10.1080/03639040801926030 ]
   Mladenovska K, 2002, INT J PHARM, V242, P247, DOI 10.1016/S0378-5173(02)00167-9
   Mladenovska K, 2002, INT J PHARM, V242, P251, DOI 10.1016/S0378-5173(02)00168-0
   Mladenovska Kristina, 2003, Acta Pharmaceutica (Zagreb), V53, P187
   Mladenovskat K, 2002, MACEDONIAN PHARM B, V48, P9
   Mohanty B, 2005, J SURF SCI TECHNOL, V21, P149, DOI 10.18311/isst/2005/1995
   Morimoto K, 2000, J PHARM PHARMACOL, V52, P611, DOI 10.1211/0022357001774444
   Nahar M, 2008, NANOMED-NANOTECHNOL, V4, P252, DOI 10.1016/j.nano.2008.03.007
   Ofokansi K, 2010, EUR J PHARM BIOPHARM, V76, P1, DOI 10.1016/j.ejpb.2010.04.008
   Patel M, 2006, DRUG DELIV, V13, P323, DOI 10.1080/10717540500398175
   Patel M, 2013, EXPERT OPIN DRUG DEL, V10, P889, DOI 10.1517/17425247.2013.784742
   Peptu CA, 2010, J BIOACT COMPAT POL, V25, P98, DOI 10.1177/0883911509350262
   ROMANELLI L, 1994, LIFE SCI, V54, P877, DOI 10.1016/0024-3205(94)00624-5
   Rupenthal ID, 2011, MOL PHARMACEUT, V8, P2282, DOI 10.1021/mp200140e
   Rupenthal ID, 2011, INT J PHARMACEUT, V411, P69, DOI 10.1016/j.ijpharm.2011.03.042
   Sahoo SK, 2008, DRUG DISCOV TODAY, V13, P144, DOI 10.1016/j.drudis.2007.10.021
   Saravanan M, 2011, J DRUG TARGET, V19, P96, DOI 10.3109/10611861003733979
   Solorio L, 2010, J TISSUE ENG REGEN M, V4, P514, DOI 10.1002/term.267
   Sudheesh MS, 2011, DRUG DELIV, V18, P320, DOI 10.3109/10717544.2010.549525
   TANGLIU DDS, 1994, J PHARM SCI, V83, P85, DOI 10.1002/jps.2600830120
   Tseng CL, 2007, BIOMATERIALS, V28, P3996, DOI 10.1016/j.biomaterials.2007.05.006
   Tseng CL, 2013, J NANOMATER, V2013, P1
   Vandelli MA, 2001, INT J PHARM, V215, P175, DOI 10.1016/S0378-5173(00)00681-5
   Vandervoort J, 2004, EUR J PHARM BIOPHARM, V57, P251, DOI 10.1016/s0939-6411(03)00187-5
   Vega E, 2006, J PHARM SCI-US, V95, P2393, DOI 10.1002/jps.20685
   Vyas SP, 1998, PHARMAZIE, V53, P466
   Wang J, 2001, J CONTROL RELEASE, V73, P223, DOI 10.1016/S0168-3659(01)00288-7
   Won YW, 2008, J CONTROL RELEASE, V127, P154, DOI 10.1016/j.jconrel.2008.01.010
   Xu J, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-75
   Xu J, 2013, MOL PHARMACEUT, V10, P2031, DOI 10.1021/mp400054e
   Yasukawa T, 2004, PROG RETIN EYE RES, V23, P253, DOI 10.1016/j.preteyeres.2004.02.003
   Yewale C, 2013, EXPERT OPIN DRUG DEL, V10, P1429, DOI 10.1517/17425247.2013.805200
   Youngren SR, 2013, BIOMED RES INT, DOI 10.1155/2013/858946
   Youshia J, 2012, INT J NANOMED, V7, P2483, DOI 10.2147/IJN.S28307
   Zhang J, 2013, J MATER CHEM B, V1, P4388, DOI 10.1039/c3tb20391c
NR 107
TC 7
Z9 7
U1 3
U2 46
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1083-7450
EI 1097-9867
J9 PHARM DEV TECHNOL
JI Pharm. Dev. Technol.
PD APR 2
PY 2016
VL 21
IS 3
BP 379
EP 386
DI 10.3109/10837450.2014.999786
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA DC5WF
UT WOS:000369290600015
PM 25567143
DA 2018-10-20
ER

PT J
AU Go, YY
   Kim, SE
   Cho, GJ
   Chae, SW
   Song, JJ
AF Go, Yoon Young
   Kim, Sung Eun
   Cho, Geum Joon
   Chae, Sung-Won
   Song, Jae-Jun
TI Promotion of osteogenic differentiation by amnion/chorion membrane
   extracts
SO JOURNAL OF APPLIED BIOMATERIALS & FUNCTIONAL MATERIALS
LA English
DT Article
DE Amnion/chorion membrane extracts; Amnion membrane extracts; Growth
   factors; Osteogenesis
ID HUMAN AMNIOTIC MEMBRANE; OSTEOBLAST DIFFERENTIATION; CELLS;
   OPHTHALMOLOGY; CYTOKINES; PROTEINS; MATRIX; REPAIR; MODEL; BURNS
AB Background: The amniotic membrane is a favorable biomaterial to apply in the field of tissue engineering because of its unique biological properties. Human amniotic membranes consist of 2-layered sheets containing numerous growth factors, cytokines and other bioactive substances.
   Methods: In this study, we explored the potential of amnion membrane extracts (AME) and amnion/chorion membrane extracts (A/CME) to promote osteogenic differentiation of osteoblast-like (MG-63) cells. MG-63 cells were cultured in osteogenic induction medium (OIM) with or without 100 mu g/mL of AME or A/CME. To determine the early and late differentiation of osteogenesis, alkaline phosphatase (ALP) activity and calcium deposition were measured at 3, 7, 10 and 24 days. Expression of specific genes associated with osteogenic differentiation, including osteocalcin (OCN), osteopontin (OPN), runt domain-containing transcription factor (Runx2) and osterix (OSX) was also determined.
   Results: In vitro experiments demonstrated that A/CME increased ALP activity, osteogenic gene expression and mineralization under osteogenic-inducing conditions. Notably, we found that A/CME contained growth factors related to osteogenesis, including fibroblast growth factors and transforming growth factors, which potentially promoted osteogenic differentiation of MG-63 cells to a greater extent than AME.
   Conclusions: These results indicate that A/CME is capable of providing growth factors and other substrates for osteogenic differentiation, which significantly increased the efficacy of osteogenesis in MG-63 cells. Taken together, the results of this study suggest that human A/CME is a promising biomaterial with therapeutic potential in bone regeneration applications.
C1 [Go, Yoon Young; Chae, Sung-Won; Song, Jae-Jun] Korea Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea.
   [Kim, Sung Eun] Korea Univ, Coll Med, Dept Orthoped Surg, Seoul, South Korea.
   [Kim, Sung Eun] Korea Univ, Coll Med, Rare Dis Inst, Seoul, South Korea.
   [Cho, Geum Joon] Korea Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea.
RP Song, JJ (reprint author), Korea Univ, Guro Hosp, Dept Otorhinolaryngol Head & Neck Surg, 80 Guro Dong, Seoul 152703, South Korea.
EM jjsong23@gmail.com
FU National Research Foundation of Korea (NRF) grant - Korea government
   (MSIP) [2012M2A2A6035679]
FX This work was supported by a National Research Foundation of Korea (NRF)
   grant funded by the Korea government (MSIP) (No. 2012M2A2A6035679).
CR AKLE CA, 1981, LANCET, V2, P1003
   Boc S F, 1985, J Foot Surg, V24, P236
   Branski LK, 2008, BURNS, V34, P393, DOI 10.1016/j.burns.2007.06.007
   Bruderer M, 2014, EUR CELLS MATER, V28, P269, DOI 10.22203/eCM.v028a19
   Cecen B, 2015, J APPL BIOMATER FUNC, V13, P10, DOI 10.5301/jabfm.5000182
   Chen YJ, 2012, BIOMATERIALS, V33, P455, DOI 10.1016/j.biomaterials.2011.09.065
   Cowles EA, 1998, CALCIFIED TISSUE INT, V62, P74, DOI 10.1007/s002239900397
   Dahinterova J, 1969, SB VED PR LEK FAK S, P513
   Dua HS, 2004, SURV OPHTHALMOL, V49, P51, DOI 10.1016/j.survophthal.2003.10.004
   Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3
   Farea M, 2014, ARCH ORAL BIOL, V59, P1400, DOI 10.1016/j.archoralbio.2014.08.015
   FAULK WP, 1980, LANCET, V1, P1156
   Feng XM, 2014, DEV GROWTH DIFFER, V56, P615, DOI 10.1111/dgd.12179
   Fritsche A, 2013, J APPL BIOMATER FUNC, V11, P1, DOI 10.5301/JABFM.2012.9263
   Hao YX, 2000, CORNEA, V19, P348, DOI 10.1097/00003226-200005000-00018
   He H, 2008, INVEST OPHTH VIS SCI, V49, P4468, DOI 10.1167/iovs.08-1781
   Hughes FJ, 2006, PERIODONTOL 2000, V41, P48, DOI 10.1111/j.1600-0757.2006.00161.x
   Kimura A, 2014, J ORAL MAXIL SURG, V72, P2015, DOI 10.1016/j.joms.2014.03.014
   Koob TJ, 2015, J BIOMED MATER RES B, V103, P1133, DOI 10.1002/jbm.b.33265
   Kruse FE, 2007, BRIT J OPHTHALMOL, V91, P841, DOI 10.1136/bjo.2006.108134
   Lim S., 2015, CELL TISSUE RES, P1
   Lindenmair A, 2010, BIOMATERIALS, V31, P8659, DOI 10.1016/j.biomaterials.2010.07.090
   Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254
   Lopez-Valladares MJ, 2010, ACTA OPHTHALMOL, V88, pe211, DOI 10.1111/j.1755-3768.2010.01908.x
   Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200
   Mohammadi AA, 2013, BURNS, V39, P349, DOI 10.1016/j.burns.2012.07.010
   Moore EE, 2005, OSTEOARTHR CARTILAGE, V13, P623, DOI 10.1016/j.joca.2005.03.003
   Ornitz DM, 2015, GENE DEV, V29, P1463, DOI 10.1101/gad.266551.115
   Rahman I, 2009, EYE, V23, P1954, DOI 10.1038/eye.2008.410
   Russo A, 2012, CELL TISSUE BANK, V13, P353, DOI 10.1007/s10561-011-9261-5
   Sheridan RL, 2001, BURNS, V27, P92, DOI 10.1016/S0305-4179(00)00076-0
   SORSBY A, 1947, BRIT J OPHTHALMOL, V31, P409, DOI 10.1136/bjo.31.7.409
   Suzuki E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112566
   Woo HM, 2001, BRIT J OPHTHALMOL, V85, P345, DOI 10.1136/bjo.85.3.345
   Xiao XY, 2013, EXP EYE RES, V115, P31, DOI 10.1016/j.exer.2013.06.005
   Zelen CM, 2015, CLIN PODIATR MED SUR, V32, P135, DOI 10.1016/j.cpm.2014.09.002
NR 36
TC 7
Z9 7
U1 4
U2 7
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 2280-8000
J9 J APPL BIOMATER FUNC
JI J. Appl. Biomater. Funct. Mater.
PD APR-JUN
PY 2016
VL 14
IS 2
BP E171
EP E180
DI 10.5301/jabfm.5000264
PG 10
WC Biophysics; Engineering, Biomedical; Materials Science, Biomaterials
SC Biophysics; Engineering; Materials Science
GA EC8IS
UT WOS:000388385600006
PM 27056480
DA 2018-10-20
ER

PT J
AU Drira, N
   Piras, A
   Rosa, A
   Porcedda, S
   Dhaouadia, H
AF Drira, Neila
   Piras, Alessandra
   Rosa, Antonella
   Porcedda, Silvia
   Dhaouadia, Hatem
TI Microalgae from domestic wastewater facilitys high rate algal pond:
   Lipids extraction, characterization and biodiesel production
SO BIORESOURCE TECHNOLOGY
LA English
DT Article
DE wastewater; biomass flocculation/coagulation; lipid extraction;
   biodiesel
ID CHEMICAL-COMPOSITION; MICROWAVE IRRADIATION; HARVESTING MICROALGAE;
   CHLORELLA-VULGARIS; WET MICROALGAE; FLOCCULATION; PH;
   TRANSESTERIFICATION; MAGNESIUM; TISSUES
AB In this study, the harvesting of a biomass from a high rate algal pond (HRAP) of a real-scale domestic wastewater treatment facility and its potential as a biomaterial for the production of biodiesel were investigated. Increasing the medium pH to 12 induced high flocculation efficiency of up to 96% of the biomass through both sweep flocculation and charge neutralization. Lipids extracted by ultrasounds from this biomass contained around 70% of fatty acids, with palmitic and stearic acids being the most abundant. The extract obtained by supercritical CO2 contained 86% of fatty acids. Both conventional solvents extracts contained only around 10% of unsaturated fats, whereas supercritical CO2 extract contained more than 40% of unsaturated fatty acids. This same biomass was also subject to direct extractive-transesterification in a microwave reactor to produce fatty acid methyl ester, also known as, raw biodiesel.
C1 [Drira, Neila; Dhaouadia, Hatem] Univ Monastir, Fac Sci, Dept Chim, UR Chim Appl & Environm, Bvd Environm, Monastir 5000, Tunisia.
   [Piras, Alessandra; Porcedda, Silvia] Univ Cagliari, Dipartimento Sci Chim & Geol, Citadella Univ Monserrato,SP 8 Monserrato,Sestu k, I-09042 Monserrato, CA, Italy.
   [Rosa, Antonella] Univ Cagliari, Dipartimento Sci Biomed, Citadella Univ Monserrato,SP 8 Monserrato,Sestu k, I-09042 Monserrato, CA, Italy.
RP Dhaouadia, H (reprint author), Univ Monastir, Fac Sci, Dept Chim, UR Chim Appl & Environm, Bvd Environm, Monastir 5000, Tunisia.
EM neiladrira@yahoo.fr; apiras@unica.it; anrosa@unica.it;
   porcedda@unica.it; hatem.dhaouadi@fsm.rnu.tn
OI PORCEDDA, SILVIA/0000-0002-1441-3979; Rosa,
   Antonella/0000-0003-0939-9364; PIRAS, Alessandra/0000-0002-7232-4966
CR Andrich G, 2005, EUR J LIPID SCI TECH, V107, P381, DOI 10.1002/ejlt.200501130
   Araujo GS, 2013, ULTRASON SONOCHEM, V20, P95, DOI 10.1016/j.ultsonch.2012.07.027
   Aresta M, 2005, ENVIRON CHEM LETT, V3, P136, DOI 10.1007/s10311-005-0020-3
   Baananou S, 2015, NAT PROD RES, V29, P999, DOI 10.1080/14786419.2014.965167
   Chen CY, 2011, BIORESOURCE TECHNOL, V102, P71, DOI 10.1016/j.biortech.2010.06.159
   Cheng J, 2014, BIORESOURCE TECHNOL, V170, P69, DOI 10.1016/j.biortech.2014.07.089
   Christenson L, 2011, BIOTECHNOL ADV, V29, P686, DOI 10.1016/j.biotechadv.2011.05.015
   DRIRA N, 2015, DESALIN WATER TREAT
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5
   Martinez-Guerra E, 2014, APPL ENERG, V129, P354, DOI 10.1016/j.apenergy.2014.04.112
   Matthieu V, 2008, J CHROMATOGR A, V57, P1196
   Maxia A, 2012, MYCOPATHOLOGIA, V174, P61, DOI 10.1007/s11046-011-9519-2
   McMillan JR, 2013, APPL ENERG, V103, P128, DOI 10.1016/j.apenergy.2012.09.020
   Metchafe L.D., 1966, ANAL CHEM, V38, P524
   Mnari A, 2007, FOOD CHEM, V100, P1393, DOI 10.1016/j.foodchem.2005.11.030
   Mubarak M, 2015, ALGAL RES, V7, P117, DOI 10.1016/j.algal.2014.10.008
   Patil PD, 2011, BIORESOURCE TECHNOL, V102, P118, DOI 10.1016/j.biortech.2010.06.031
   Piras A, 2013, IND CROP PROD, V46, P317, DOI 10.1016/j.indcrop.2013.02.013
   Pittman JK, 2011, BIORESOURCE TECHNOL, V102, P17, DOI 10.1016/j.biortech.2010.06.035
   Prescott G. W., 1964, KNOW FRESHWATER ALGA
   RODIER J, 1996, ANALYSE EAU
   Rosa A, 2012, FOOD CHEM TOXICOL, V50, P3799, DOI 10.1016/j.fct.2012.07.003
   Garcia-Perez JS, 2014, ALGAL RES, V3, P24, DOI 10.1016/j.algal.2013.11.016
   Schlesinger A, 2012, BIOTECHNOL ADV, V30, P1023, DOI 10.1016/j.biotechadv.2012.01.011
   Teo CL, 2014, BIORESOURCE TECHNOL, V171, P477, DOI 10.1016/j.biortech.2014.08.024
   TGOBANOGLOUS G, 2003, WASTEWATER ENG OVERV
   Vandamme D, 2013, TRENDS BIOTECHNOL, V31, P233, DOI 10.1016/j.tibtech.2012.12.005
   Vandamme D, 2012, BIORESOURCE TECHNOL, V105, P114, DOI 10.1016/j.biortech.2011.11.105
   Vandamme D, 2010, J APPL PHYCOL, V22, P525, DOI 10.1007/s10811-009-9488-8
   Wahidin S, 2014, ENERG CONVERS MANAGE, V84, P227, DOI 10.1016/j.enconman.2014.04.034
   Wahlen BD, 2011, BIORESOURCE TECHNOL, V102, P2724, DOI 10.1016/j.biortech.2010.11.026
   Wileman A, 2012, BIORESOURCE TECHNOL, V104, P432, DOI 10.1016/j.biortech.2011.11.027
   Wu JH, 2015, BIORESOURCE TECHNOL, V197, P495, DOI 10.1016/j.biortech.2015.08.094
   Wu ZC, 2012, BIORESOURCE TECHNOL, V110, P496, DOI 10.1016/j.biortech.2012.01.101
NR 35
TC 19
Z9 19
U1 4
U2 47
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0960-8524
EI 1873-2976
J9 BIORESOURCE TECHNOL
JI Bioresour. Technol.
PD APR
PY 2016
VL 206
BP 239
EP 244
DI 10.1016/j.biortech.2016.01.082
PG 6
WC Agricultural Engineering; Biotechnology & Applied Microbiology; Energy &
   Fuels
SC Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels
GA DF3RB
UT WOS:000371262100038
PM 26866759
DA 2018-10-20
ER

PT J
AU de Leon, CC
   Rios, MJS
   Alamo, NF
   Berriel, CH
   Robles, OJ
AF Carreno de Leon, Carmen
   Solache Rios, Marcos Jose
   Flores Alamo, Nicolas
   Hernandez Berriel, Consuelo
   Juarez Robles, Olivia
TI Biosorption of lead (II) and chromium with zea mays rachis in aqueous
   solutions: characterization studies
SO AFINIDAD
LA English
DT Article
DE Biosorption; heavy metals; Zea mays
ID HEAVY-METAL IONS; ORANGE PEEL; WASTE; ADSORPTION; REMOVAL; CR(III);
   BIOSORBENT; SORPTION; BIOMASS; SYSTEMS
AB The aim of this study was to evaluate the adsorption of lead (II) and chromium from aqueous solutions by Zea mays rachis (ZMR). Experiments were performed in a batch system in triplicate, metals content was evaluated by atomic absorption. According to the characterization studies, the biomaterial was classified as mesoporous, with an average pore size of 6.16 nm and is stable up to 220 degrees C, it is composed mainly by lignocellulose. It was found that the adsorption of lead (II) and chromium on ZMR at pH of 5.0 is a process of chemisorption with removal percentages of 100 and 64.8 % respectively, Freundlich isotherm described the process for lead (II) (R-2 = 0.999) and the Langmuir isotherm for chromium (R-2 = 0.989). The results show that the ZMR is suitable for the removal of these two metals, although it is more favorable for Lead (II).
C1 [Carreno de Leon, Carmen; Flores Alamo, Nicolas; Hernandez Berriel, Consuelo; Juarez Robles, Olivia] Inst Tecnol Toluca, Div Estudios Posgrad & Invest, Ave Tecnol S-N Col Agr Buenavista, Metepec 52149, Mex, Mexico.
   [Solache Rios, Marcos Jose] Inst Nacl Invest Nucl, Dept Quim, Apdo Postal 18-1027, Mexico City 11801, DF, Mexico.
RP de Leon, CC (reprint author), Inst Tecnol Toluca, Div Estudios Posgrad & Invest, Ave Tecnol S-N Col Agr Buenavista, Metepec 52149, Mex, Mexico.
EM mcarcarleon@yahoo.com.mx
FU Professor Improvement Program (PRO-MEP) [ITTOL-PTC-006]
FX The authors thank Professor Improvement Program (PRO-MEP) for supporting
   this research with the Project: ITTOL-PTC-006 and ITToluca for the
   facilities provided to complete this work.
CR Acosta I, 2012, AV CIENC ING, V3, P1
   Ahmad H-B., 2010, CHEM ENG J, V160, P190, DOI DOI 10.1016/J.CEJ.2010.03.040
   Altun R. A., 2009, CHEM ENG J, V151, P255
   Aman T, 2008, COLLOID SURFACE B, V63, P116, DOI 10.1016/j.colsurfb.2007.11.013
   Bedoya M., 2010, BISTUA REV FACULTAD, V8, P21
   Garcia-Reyes RB, 2010, BIORESOURCE TECHNOL, V101, P8099, DOI 10.1016/j.biortech.2010.06.020
   Bertagnolli C, 2014, CHEM ENG J, V237, P362, DOI 10.1016/j.cej.2013.10.024
   Bhatnagar A, 2010, ADV COLLOID INTERFAC, V160, P1, DOI 10.1016/j.cis.2010.06.011
   Cimino G, 2000, WATER RES, V34, P2955, DOI 10.1016/S0043-1354(00)00048-8
   Febrianto J, 2009, J HAZARD MATER, V162, P616, DOI 10.1016/j.jhazmat.2008.06.042
   Fu FL, 2011, J ENVIRON MANAGE, V92, P407, DOI 10.1016/j.jenvman.2010.11.011
   Garcia-Mendieta A, 2012, DESALINATION, V284, P167, DOI 10.1016/j.desal.2011.08.052
   Garcia-Rosales G, 2010, J ENVIRON MANAGE, V91, P2079, DOI 10.1016/j.jenvman.2010.06.004
   Gregg S.J., 1982, ADSORPTION SURFACE A, P111
   Gun'ko VM, 2013, ADV COLLOID INTERFAC, V187, P1, DOI 10.1016/j.cis.2012.11.001
   Gupta S, 2009, CHEM ENG J, V150, P352, DOI 10.1016/j.cej.2009.01.013
   Ho YS, 2006, WATER RES, V40, P119, DOI 10.1016/j.watres.2005.10.040
   Ho YS, 2004, SCIENTOMETRICS, V59, P171
   Ho YS, 2000, SEPAR PURIF METHOD, V29, P189, DOI 10.1081/SPM-100100009
   Ho YS, 2006, J HAZARD MATER, V136, P681, DOI 10.1016/j.jhazmat.2005.12.043
   Inoue K, 2010, HYDROMETALLURGY, V104, P123, DOI 10.1016/j.hydromet.2010.05.005
   Iqbal MJ, 2013, ASIAN J CHEM, V25, P2099
   Jacques RA, 2007, SEP PURIF TECHNOL, V57, P193, DOI 10.1016/j.seppur.2007.01.018
   Jain M, 2009, J HAZARD MATER, V162, P365, DOI 10.1016/j.jhazmat.2008.05.048
   Kaczala F, 2009, BIORESOURCE TECHNOL, V100, P235, DOI 10.1016/j.biortech.2008.05.055
   Li X, 2008, COLLOID SURFACE A, V317, P512, DOI 10.1016/j.colsurfa.2007.11.031
   Lopez-Mesas M, 2011, CHEM ENG J, V174, P9, DOI 10.1016/j.cej.2011.07.026
   Pinzon-Bedoya ML, 2009, DYNA-COLOMBIA, V76, P95
   Lugo-Lugo V, 2012, J ENVIRON MANAGE, V112, P120, DOI 10.1016/j.jenvman.2012.07.009
   Malkoc E, 2007, SEP PURIF TECHNOL, V54, P291, DOI 10.1016/j.seppur.2006.09.017
   Martin-Lara M. A., 2008, THESIS
   Miretzky P, 2008, BIORESOURCE TECHNOL, V99, P1211, DOI 10.1016/j.biortech.2007.02.045
   Moore W.J., 1986, FISICOQUIMICA BASICA, P284
   Navarro B. S., 2013, QUIMICA AGRICOLA SUE, P15
   Paliwal R.L., 2001, MAIZ TROPICOS MEJORA, P1
   Park D, 2010, BIOTECHNOL BIOPROC E, V15, P86, DOI 10.1007/s12257-009-0199-4
   Perez M.A.B., 2010, BIOCH ENG J, V53, P2
   Qaiser S., 2007, JAL BIOTECH, V10, P1
   Saha BC, 1999, APPL BIOCHEM BIOTECH, V76, P65, DOI 10.1385/ABAB:76:2:65
   Sari A, 2008, CHEM ENG J, V144, P1, DOI 10.1016/j.cej.2007.12.020
   Slejko F. L., 1985, ADSORPTION TECHNOLOG, P23
   Smith J.M., 1990, INGENIERIA CINETICA, P385
   Sud D, 2008, BIORESOURCE TECHNOL, V99, P6017, DOI 10.1016/j.biortech.2007.11.064
   Tan GQ, 2010, J HAZARD MATER, V174, P740, DOI 10.1016/j.jhazmat.2009.09.114
   Tejeda-Tovar C., 2014, EDUCACION INGENIERIA, V9, P86
   Ullah I, 2013, ECOL ENG, V60, P99, DOI 10.1016/j.ecoleng.2013.07.028
   Uluozlu OD, 2008, BIORESOURCE TECHNOL, V99, P2972, DOI 10.1016/j.biortech.2007.06.052
   Venugopal V, 2011, CHEM ENG J, V174, P151, DOI 10.1016/j.cej.2011.08.068
   Wang JL, 2009, BIOTECHNOL ADV, V27, P195, DOI 10.1016/j.biotechadv.2008.11.002
   Yamakake K.T.A., 2010, MEMORIAS INVESTIGACI, P1
   Yong Liu, 2010, Carbohydrate Polymers, V81, P335
   Zezzi M.A., 2004, CHEMOSPHERE, V54, P987
   Zvinowanda CM, 2009, INT J ENVIRON SCI TE, V6, P425, DOI 10.1007/BF03326081
NR 53
TC 1
Z9 1
U1 0
U2 2
PU ASOC QUIMICOS
PI BARCELONA
PA INST QUIMICO SARRIA, VIA AUGUSTA, 390, 08017 BARCELONA, SPAIN
SN 0001-9704
J9 AFINIDAD
JI Afinidad
PD APR-JUN
PY 2016
VL 73
IS 574
BP 140
EP 147
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA DT1HQ
UT WOS:000381232700009
DA 2018-10-20
ER

PT J
AU Wang, G
   Wang, JJ
   Li, F
   To, SST
AF Wang, Gang
   Wang, Jun-Jie
   Li, Fei
   To, Shing-Shun Tony
TI Development and Evaluation of a Novel Drug Delivery: Pluronics/SDS Mixed
   Micelle Loaded With Myricetin In Vitro and In Vivo
SO JOURNAL OF PHARMACEUTICAL SCIENCES
LA English
DT Article
DE myricetin (MYR); F68/SDS; lipid-based micelles; Labrasol; brain tumor;
   bioavailability
ID SODIUM DODECYL-SULFATE; WATER-SOLUBLE DRUGS; BLOCK-COPOLYMER;
   INTESTINAL-ABSORPTION; MASS-SPECTROMETRY; GENE DELIVERY; ACIDIC PH;
   LABRASOL; RATS; PHOSPHATIDYLCHOLINE
AB This study is to prepare and evaluate Pluronics-modified mixed micelle (MM) to deliver polyphenolic myricetin (MYR) across the blood-brain barrier. MYR has been proven to be an effective anticancer agent against glioblastoma cells in our previous studies. However, the poor solubility of MYR limits its access to the brain. In this study, the feasibility of preparing lipid-based MM that combined sodium dodecyl sulphate (SDS) with Pluronic F68 (F68) and Labrasol was investigated. Furthermore, the nonionic surfactant coating technology for the protection of MYR against oxidation, and its attainment in oral bioavailability, was examined. On account of the altered biomaterial properties of F68/SDS-modified lipid-based micelles, myricetin-loaded mixed micelles (MYR-MMs) were prepared by solvent-vaporation method to self-assembly into MMs. The average size of MYR-MMs was 96.3 nm, with negatively charged potential and spherical in shape. The drug loading of MYR-MMs was high with the increased grafting ratio, the more prolonged drug release profile, and more effective killing glioblastoma cells in vitro. Moreover, MYR-MMs showed a higher preference for the brain than free MYR alone, suggesting the novel MMs loaded with MYR could promote absorption and increase relative bioavailability. Taken together, the F68/SDS-modified and Labrasol-modified lipid-based micelles may provide a promising method to deliver polyphenolic compounds across the brain to treat brain tumor. (C) 2016 American Pharmacists Association(R). Published by Elsevier Inc. All rights reserved.
C1 [Wang, Gang; Wang, Jun-Jie; Li, Fei] Jiangsu Univ, Shanghai Peoples Hosp 8, Dept Pharmaceut, Shanghai 200235, Peoples R China.
   [Wang, Jun-Jie] Hubei Univ Med, Coll Pharm, Shiyan City 442000, Hubei, Peoples R China.
   [To, Shing-Shun Tony] Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Hong Kong, Hong Kong, Peoples R China.
RP Wang, G (reprint author), Jiangsu Univ, Shanghai Peoples Hosp 8, Dept Pharmaceut, Shanghai 200235, Peoples R China.
EM wangan139@163.com
OI Tony, TO/0000-0003-1244-439X
CR Anderson BC, 2001, J CONTROL RELEASE, V70, P157, DOI 10.1016/S0168-3659(00)00341-2
   Batrakova EV, 2008, J CONTROL RELEASE, V130, P98, DOI 10.1016/j.jconrel.2008.04.013
   Chiu WT, 2010, NEUROBIOL DIS, V37, P118, DOI 10.1016/j.nbd.2009.09.015
   Contal E., 2010, THESIS
   Dang Y, 2014, Drug Res (Stuttg), V64, P516, DOI 10.1055/s-0033-1363220
   de Vos P, 2009, BIOMATERIALS, V30, P2559, DOI 10.1016/j.biomaterials.2009.01.014
   Du LY, 2014, EXPERT OPIN DRUG MET, V10, P921, DOI 10.1517/17425255.2014.918954
   Duan RL, 2011, ACTA PHARMACOL SIN, V32, P108, DOI 10.1038/aps.2010.192
   Eaimtrakarn S, 2002, J DRUG TARGET, V10, P255, DOI 10.1080/10611860290022688
   Fueyo J, 1998, NEUROLOGY, V51, P1250, DOI 10.1212/WNL.51.5.1250
   Fusco S, 2006, J BIOACT COMPAT POL, V21, P149, DOI 10.1177/0883911506063207
   Ganta S, 2008, J CONTROL RELEASE, V126, P187, DOI 10.1016/j.jconrel.2007.12.017
   Gill KK, 2014, J DRUG TARGET, V30, P1
   GRIFFITHS LA, 1972, BIOCHEM J, V130, P141, DOI 10.1042/bj1300141
   GUZMAN M, 1992, INT J PHARM, V80, P119, DOI 10.1016/0378-5173(92)90269-8
   Hu ZP, 2001, LIFE SCI, V69, P2899, DOI 10.1016/S0024-3205(01)01375-3
   Itoh K, 2003, CHEM PHARM BULL, V51, P171, DOI 10.1248/cpb.51.171
   Jang JH, 2014, CHEM PHARM BULL, V62, P328, DOI 10.1248/cpb.c13-00814
   Kabanov AV, 2002, J CONTROL RELEASE, V82, P189, DOI 10.1016/S0168-3659(02)00009-3
   Ko CH, 2005, MOL CANCER THER, V4, P281
   Lapenna S, 2009, J PHARM SCI-US, V98, P3666, DOI 10.1002/jps.21685
   Lee Y, 2010, SOFT MATTER, V6, P977, DOI 10.1039/b919944f
   Li M, 2005, J BIOMED NANOTECHNOL, V1, P190
   Licciardi M, 2010, INT J PHARMACEUT, V396, P219, DOI 10.1016/j.ijpharm.2010.06.021
   Lin YL, 2007, BIOL PHARM BULL, V30, P1301, DOI 10.1248/bpb.30.1301
   Liu M, 2010, INT J PHARMACEUT, V391, P292, DOI 10.1016/j.ijpharm.2010.03.001
   Liu SQ, 2007, BIOMATERIALS, V28, P1423, DOI 10.1016/j.biomaterials.2006.11.013
   Lucas-Abellan C, 2008, J AGR FOOD CHEM, V56, P255, DOI 10.1021/jf0720640
   Maronpot RR, 2015, FOOD ADDIT CONTAM A, V32, P1799, DOI 10.1080/19440049.2015.1084653
   Min KH, 2010, J CONTROL RELEASE, V144, P259, DOI 10.1016/j.jconrel.2010.02.024
   Nduom EK, 2012, NEUROSURG CLIN N AM, V23, P439, DOI 10.1016/j.nec.2012.04.006
   Pazos M, 2009, J AGR FOOD CHEM, V57, P5042, DOI 10.1021/jf900437m
   Prasad YVR, 2003, INT J PHARM, V250, P181, DOI 10.1016/S0378-5173(02)00544-6
   Ranganathan R, 2005, CHEM PHYS LIPIDS, V135, P93, DOI 10.1016/j.chemphyslip.2005.02.004
   Rupp C, 2010, INT J PHARMACEUT, V395, P272, DOI 10.1016/j.ijpharm.2010.05.025
   Sharma PK, 2008, COLLOID SURFACE B, V61, P53, DOI 10.1016/j.colsurfb.2007.07.002
   Shih YW, 2009, J AGR FOOD CHEM, V57, P3490, DOI 10.1021/jf900124r
   Siegelin MD, 2009, CANCER LETT, V283, P230, DOI 10.1016/j.canlet.2009.04.002
   Strickley RG, 2004, PHARM RES, V21, P201, DOI 10.1023/B:PHAM.0000016235.32639.23
   Varshosaz J, 2014, J LIPOSOME RES, V24, P191, DOI 10.3109/08982104.2013.868476
   Wang YJ, 2012, INT J PHARMACEUT, V434, P1, DOI 10.1016/j.ijpharm.2012.05.015
   Weng CJ, 2012, CANCER METAST REV, V31, P323, DOI 10.1007/s10555-012-9347-y
   Xu RR, 2013, FOOD CHEM, V138, P48, DOI 10.1016/j.foodchem.2012.09.102
   Yang CY, 2001, J MICROENCAPSUL, V18, P223
   Yang T, 2007, INT J PHARM, V338, P317, DOI 10.1016/j.ijpharm.2007.02.011
   Yao YS, 2014, PHARMAZIE, V69, P19
   Zhu YA, 2010, ARCH PHARM RES, V33, P911, DOI 10.1007/s12272-010-0614-6
NR 47
TC 12
Z9 13
U1 6
U2 31
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3549
EI 1520-6017
J9 J PHARM SCI-US
JI J. Pharm. Sci.
PD APR
PY 2016
VL 105
IS 4
BP 1535
EP 1543
DI 10.1016/j.xphs.2016.01.016
PG 9
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology &
   Pharmacy
SC Pharmacology & Pharmacy; Chemistry
GA DT8TX
UT WOS:000381769600023
PM 26947760
DA 2018-10-20
ER

PT J
AU Cavallo, C
   Desando, G
   Ferrari, A
   Zini, N
   Mariani, E
   Grigolo, B
AF Cavallo, C.
   Desando, G.
   Ferrari, A.
   Zini, N.
   Mariani, E.
   Grigolo, B.
TI HYALURONAN SCAFFOLD SUPPORTS OSTEOGENIC DIFFERENTIATION OF BONE MARROW
   CONCENTRATE CELLS
SO JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS
LA English
DT Article
DE orthopaedics; bone; transplantation; biomaterial; cells; histochemistry
ID MESENCHYMAL STEM-CELLS; ARTICULAR-CARTILAGE REPAIR; CHONDRAL DEFECTS;
   MICROFRACTURE; TRANSPLANTATION; PROLIFERATION; REGENERATION;
   OSTEOBLASTS; INJECTION; LESIONS
AB Osteochondral lesions are considered a challenge for orthopedic surgeons. Currently, the treatments available are often unsatisfactory and unable to stimulate tissue regeneration. Tissue engineering offers a new therapeutic strategy, taking into account the role exerted by cells, biomaterial and growth factors in restoring tissue damage. In this light, Mesenchymal Stem Cells (MSCs) have been indicated as a fascinating tool for regenerative medicine thanks to their ability to differentiate into bone, cartilage and adipose tissue. However, in vitro-cultivation of MSCs could be associated with some risks such as de-differentiation/reprogramming, infection and contaminations of the cells. To overcome these shortcomings, a new approach is represented by the use of Bone Marrow Concentrate (BMC), that could allow the delivery of cells surrounded by their microenvironment in injured tissue. For this purpose, cells require a tridimensional scaffold that can support their adhesion, proliferation and differentiation. This study is focused on the potentiality of BMC seeded onto a hyaluronan-based scaffold (Hyaff-11) to differentiate into osteogenic lineage. This process depends on the specific interaction between cells derived from bone marrow (surrounded by their niche) and scaffold, that create an environment able to support the regeneration of damaged tissue. The data obtained from the present study demonstrate that BMC grown onto Hyaff-11 are able to differentiate toward osteogenic sense, producing specific osteogenic genes and matrix proteins.
C1 [Cavallo, C.; Desando, G.; Mariani, E.; Grigolo, B.] Rizzoli Orthoped Inst, SSD Lab RAMSES, Bologna, Italy.
   [Ferrari, A.] Rizzoli Orthoped Inst, Lab Musculoskeletal Cell Biol, Bologna, Italy.
   [Zini, N.] IGM CNR, Rizzoli Orthoped Inst, Bologna, Italy.
   [Mariani, E.; Grigolo, B.] Rizzoli Orthopaed Inst, SC Lab Immunorheumatol & Tissue Regenerat, Bologna, Italy.
   [Mariani, E.] Univ Bologna, Dept Med & Surg Sci, Bologna, Italy.
RP Grigolo, B (reprint author), Rizzoli Orthoped Inst, SSD Lab RAMSES, SC Lab Immunorheumatol & Tissue Regenerat, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM brunella.grigolo@ior.it
OI Cavallo, Carola/0000-0002-2913-856X
FU Progetto Regione Emilia-Romagna University
FX We thank Patrizia Rappini and Graziella Salmi for their assistance in
   the preparation of the manuscript and Luciano Pizzi for his technical
   assistance. We also thank Dr Elettra Pignotti for statistical analysis.
   This work was partially supported by grants from Progetto Regione
   Emilia-Romagna University 2010-2012 "Regenerative medicine of cartilage
   and bone".
CR AHMED SA, 1994, J IMMUNOL METHODS, V170, P211
   Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180
   Blair H, 2007, ANN NY ACAD SCI, V116, P165
   BLANCO FJ, 1995, J IMMUNOL, V154, P4018
   Block JE, 2005, MED HYPOTHESES, V65, P740, DOI 10.1016/j.mehy.2005.04.026
   Brittberg M, 1999, CLIN ORTHOP RELAT R, pS147
   Buckwalter JA, 1998, ARTHRITIS RHEUM-US, V41, P1331, DOI 10.1002/1529-0131(199808)41:8<1331::AID-ART2>3.0.CO;2-J
   Cavallo C, 2013, J BIOMED MATER RES A, V101, P1559, DOI 10.1002/jbm.a.34460
   Gan YK, 2008, BIOMATERIALS, V29, P3973, DOI 10.1016/j.biomaterials.2008.06.026
   Giannini S, 2009, CLIN ORTHOP RELAT R, V467, P3307, DOI 10.1007/s11999-009-0885-8
   Giannoudis PV, 2007, INJURY, V38, pS3, DOI 10.1016/S0020-1383(08)70003-2
   Herberts CA, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-29
   Hernigou P, 2015, INT ORTHOP, V39, P1639, DOI 10.1007/s00264-015-2738-2
   Hisatome T, 2005, BIOMATERIALS, V26, P4550, DOI 10.1016/j.biomaterials.2004.11.032
   Hosseinkhani M, 2014, WORLD J PLAST SURG, V3, P3
   Jager M, 2009, CURR STEM CELL RES T, V4, P34, DOI 10.2174/157488809787169039
   Kacena MA, 2006, BONE, V39, P978, DOI 10.1016/j.bone.2006.05.019
   Kreuz PC, 2006, OSTEOARTHR CARTILAGE, V14, P1119, DOI 10.1016/j.joca.2006.05.003
   Lisignoli G, 2002, BIOMATERIALS, V23, P1043, DOI 10.1016/S0142-9612(01)00216-2
   MANKIN HJ, 1982, J BONE JOINT SURG AM, V64, P460, DOI 10.2106/00004623-198264030-00022
   Marcacci M, 2007, TISSUE ENG, V13, P947, DOI 10.1089/ten.2006.0271
   Marijanovic I, 2003, CROAT MED J, V44, P412
   Martin I, 2007, J BIOMECH, V40, P750, DOI 10.1016/j.jbiomech.2006.03.008
   Matsumoto T, 2010, J CELL PHYSIOL, V225, P291, DOI 10.1002/jcp.22223
   Murphy MB, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.94
   Ochi M, 2001, ARTIF ORGANS, V25, P172, DOI 10.1046/j.1525-1594.2001.025003172.x
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Rozen S, 2000, Methods Mol Biol, V132, P365
   Schroeder Tania M., 2005, Birth Defects Research, V75, P213, DOI 10.1002/bdrc.20043
   Shang XL, 2016, KNEE SURG SPORT TR A, V24, P1243, DOI 10.1007/s00167-015-3575-y
   Sharma L, 2016, OSTEOARTHR CARTILAGE, V24, P36, DOI 10.1016/j.joca.2015.07.026
   Solchaga LA, 2000, J ORTHOP RES, V18, P773, DOI 10.1002/jor.1100180515
   Steadman JR, 2001, CLIN ORTHOP RELAT R, pS362, DOI 10.1097/00003086-200110001-00033
   Velazquez OC, 2007, J VASC SURG, V45, p39A, DOI 10.1016/j.jvs.2007.02.068
   Yoo HS, 2005, BIOMATERIALS, V26, P1925, DOI 10.1016/j.biomaterials.2004.06.021
NR 35
TC 2
Z9 2
U1 0
U2 6
PU BIOLIFE SAS
PI SILVA MARINA (TE)
PA VIA S STEFANO 39 BIS, 64029 SILVA MARINA (TE), ITALY
SN 0393-974X
EI 1724-6083
J9 J BIOL REG HOMEOS AG
JI J. Biol. Regul. Homeost. Agents
PD APR-JUN
PY 2016
VL 30
IS 2
BP 409
EP 420
PG 12
WC Endocrinology & Metabolism; Immunology; Medicine, Research &
   Experimental; Physiology
SC Endocrinology & Metabolism; Immunology; Research & Experimental
   Medicine; Physiology
GA DR3IB
UT WOS:000379795800012
PM 27358127
DA 2018-10-20
ER

PT J
AU Garcia, JR
   Garcia, AJ
AF Garcia, Jose R.
   Garcia, Andres J.
TI Biomaterial-mediated strategies targeting vascularization for bone
   repair
SO DRUG DELIVERY AND TRANSLATIONAL RESEARCH
LA English
DT Article
DE Vascularization; Bone regeneration; Growth factor; Cell therapy; Tissue
   engineering
ID MESENCHYMAL STEM-CELLS; ENDOTHELIAL GROWTH-FACTOR; PLATELET-RICH PLASMA;
   TISSUE-ENGINEERED CONSTRUCTS; SIZED CALVARIAL DEFECTS; MARROW STROMAL
   CELLS; MORPHOGENETIC PROTEIN-2; PROGENITOR CELLS; IN-VITRO; GENE-THERAPY
AB Repair of non-healing bone defects through tissue engineering strategies remains a challenging feat in the clinic due to the aversive microenvironment surrounding the injured tissue. The vascular damage that occurs following a bone injury causes extreme ischemia and a loss of circulating cells that contribute to regeneration. Tissue-engineered constructs aimed at regenerating the injured bone suffer from complications based on the slow progression of endogenous vascular repair and often fail at bridging the bone defect. To that end, various strategies have been explored to increase blood vessel regeneration within defects to facilitate both tissue-engineered and natural repair processes. Developments that induce robust vascularization will need to consolidate various parameters including optimization of embedded therapeutics, scaffold characteristics, and successful integration between the construct and the biological tissue. This review provides an overview of current strategies as well as new developments in engineering biomaterials to induce reparation of a functional vascular supply in the context of bone repair.
C1 [Garcia, Jose R.; Garcia, Andres J.] Georgia Inst Technol, Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
   [Garcia, Jose R.; Garcia, Andres J.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
RP Garcia, AJ (reprint author), Georgia Inst Technol, Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.; Garcia, AJ (reprint author), Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
EM andres.garcia@me.gatech.edu
FU National Institutes of Health (NIH) [R01-AR062368, R01-AR062920]; Cell
   and Tissue Engineering NIH Biotechnology Training Grant [T32-GM008433]
FX This work was supported by the National Institutes of Health (NIH)
   grants R01-AR062368 and R01-AR062920 (AJG). JRG was supported by the
   Cell and Tissue Engineering NIH Biotechnology Training Grant
   (T32-GM008433).
CR Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802
   Aronin CEP, 2010, BIOMATERIALS, V31, P6417, DOI 10.1016/j.biomaterials.2010.04.061
   Asahara T, 2011, STEM CELLS, V29, P1650, DOI 10.1002/stem.745
   Asahina Izumi, 1997, Journal of Medical and Dental Sciences, V44, P63
   Awojoodu AO, 2013, P NATL ACAD SCI USA, V110, P13785, DOI 10.1073/pnas.1221309110
   Baek WY, 2009, J BONE MINER RES, V24, P1055, DOI [10.1359/JBMR.081248, 10.1359/jbmr.081248]
   Bai K, 2010, J BIOMECH, V43, P1176, DOI 10.1016/j.jbiomech.2009.11.030
   Bai Y, 2013, INT IMMUNOPHARMACOL, V16, P214, DOI 10.1016/j.intimp.2013.04.001
   Baltzer AWA, 2000, GENE THER, V7, P734, DOI 10.1038/sj.gt.3301166
   Baltzer AWA, 1999, KNEE SURG SPORT TR A, V7, P197, DOI 10.1007/s001670050147
   Bao P, 2009, J SURG RES, V153, P347, DOI 10.1016/j.jss.2008.04.023
   Becquart P, 2012, TISSUE ENG PT A, V18, P2084, DOI [10.1089/ten.tea.2011.0690, 10.1089/ten.TEA.2011.0690]
   Berner A, 2012, CELL TISSUE RES, V347, P501, DOI 10.1007/s00441-011-1184-8
   Bleich NK, 2012, ADV DRUG DELIVER REV, V64, P1320, DOI 10.1016/j.addr.2012.03.007
   Boerckel JD, 2011, P NATL ACAD SCI USA, V108, pE674, DOI 10.1073/pnas.1107019108
   Bulnheim U, 2014, J TISSUE ENG REGEN M, V8, P831, DOI 10.1002/term.1590
   Byers BA, 2006, J BIOMED MATER RES A, V76A, P646, DOI 10.1002/jbm.a.30549
   Byers BA, 2002, J BONE MINER RES, V17, P1931, DOI 10.1359/jbmr.2002.17.11.1931
   Camci-Unal G, 2013, POLYM INT, V62, P843, DOI 10.1002/pi.4502
   Cao L, 2012, J BIOMED MATER RES B, V100B, P1229, DOI 10.1002/jbm.b.32687
   Carlevaro MF, 2000, J CELL SCI, V113, P59
   Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023
   Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075
   Chen D, 2004, FRONT BIOSCI, V9, P349, DOI 10.2741/1090
   Chen XF, 2010, TISSUE ENG PT A, V16, P585, DOI [10.1089/ten.tea.2009.0491, 10.1089/ten.TEA.2009.0491]
   Chen XF, 2009, TISSUE ENG PT A, V15, P1363, DOI 10.1089/ten.tea.2008.0314
   Cheng G, 2011, BLOOD, V118, P4740, DOI 10.1182/blood-2011-02-338426
   Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017
   Chevrier A, 2007, OSTEOARTHR CARTILAGE, V15, P316, DOI 10.1016/j.joca.2006.08.007
   Clarke B, 2008, CLIN J AM SOC NEPHRO, V3, pS131, DOI 10.2215/CJN.04151206
   Cornejo A, 2012, TISSUE ENG PT A, V18, P1552, DOI [10.1089/ten.tea.2011.0515, 10.1089/ten.TEA.2011.0515]
   Dalby MJ, 2014, NAT MATER, V13, P558, DOI [10.1038/NMAT3980, 10.1038/nmat3980]
   Das A, 2014, J BIOMED MATER RES A, V102, P1210, DOI 10.1002/jbm.a.34779
   De la Riva B, 2010, J CONTROL RELEASE, V143, P45, DOI 10.1016/j.jconrel.2009.11.026
   Deckers MML, 2002, ENDOCRINOLOGY, V143, P1545, DOI 10.1210/en.143.4.1545
   Degano IR, 2008, BIOMATERIALS, V29, P427, DOI 10.1016/j.biomaterials.2007.10.006
   Derubeis AR, 2004, ANN BIOMED ENG, V32, P160, DOI 10.1023/B:ABME.0000007800.89194.95
   Deschepper M, 2011, J CELL MOL MED, V15, P1505, DOI 10.1111/j.1582-4934.2010.01138.x
   Dong JD, 2009, ACTA PHARMACOL SIN, V30, P530, DOI 10.1038/aps.2009.40
   Duan CG, 2014, ARCH MED SCI, V10, P174, DOI 10.5114/aoms.2012.30950
   Dupont KM, 2010, P NATL ACAD SCI USA, V107, P3305, DOI 10.1073/pnas.0905444107
   Eman RM, 2014, STEM CELLS DEV
   Feng L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082945
   Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669
   Fiedler J, 2002, J CELL BIOCHEM, V87, P305, DOI 10.1002/jcb.10309
   Finkemeier CG, 2002, J BONE JOINT SURG AM, V84A, P454, DOI 10.2106/00004623-200203000-00020
   Fittkau MH, 2005, BIOMATERIALS, V26, P167, DOI 10.1016/j.biomaterials.2004.02.012
   Forsythe JA, 1996, MOL CELL BIOL, V16, P4604
   Freeman I, 2008, BIOMATERIALS, V29, P3260, DOI 10.1016/j.biomaterials.2008.04.025
   Fujita M, 2004, BIOMATERIALS, V25, P699, DOI 10.1016/S0142-9612(03)00557-X
   Galas RJ, 2014, J CELL PHYSIOL, V229, P90, DOI 10.1002/jcp.24421
   Gao C, 2013, EUR CELLS MATER, V26, P195, DOI 10.22203/eCM.v026a14
   Garcia JR, 2014, NAT MATER, V13, P539, DOI 10.1038/nmat3996
   Geesink RGT, 1999, J BONE JOINT SURG BR, V81B, P710, DOI 10.1302/0301-620X.81B4.9311
   Geiger F, 2005, J BONE MINER RES, V20, P2028, DOI 10.1359/JBMR.050701
   Gerber HP, 1999, NAT MED, V5, P623
   Gershovich JG, 2013, TISSUE ENG PT A, V19, P2565, DOI [10.1089/ten.tea.2013.0256, 10.1089/ten.TEA.2013.0256]
   Geuze RE, 2010, TISSUE ENG PT A, V16, P3343, DOI [10.1089/ten.tea.2009.0774, 10.1089/ten.TEA.2009.0774]
   Geuze RE, 2012, TISSUE ENG PT A, V18, P2052, DOI [10.1089/ten.tea.2011.0560, 10.1089/ten.TEA.2011.0560]
   Ghajar CM, 2006, TISSUE ENG, V12, P2875, DOI 10.1089/ten.2006.12.2875
   Grainger SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022086
   Groeneveld EHJ, 2000, EUR J ENDOCRINOL, V142, P9, DOI 10.1530/eje.0.1420009
   Harrison BS, 2007, BIOMATERIALS, V28, P4628, DOI 10.1016/j.biomaterials.2007.07.003
   He X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104323
   Hendrich C, 2009, ORTHOP REV, V1, P99, DOI 10.4081/or.2009.e32
   Hernandez A, 2012, J BIOMED MATER RES A, V100A, P2382, DOI 10.1002/jbm.a.34183
   Hettiaratchi MH, 2014, BIOMATERIALS, V35, P7228, DOI 10.1016/j.biomaterials.2014.05.011
   Hollinger JO, 1998, J BIOMED MATER RES, V43, P356, DOI 10.1002/(SICI)1097-4636(199824)43:4<356::AID-JBM3>3.0.CO;2-7
   Hu N, 2013, J CELL SCI, V126, P532, DOI 10.1242/jcs.114231
   Huang YC, 2005, GENE THER, V12, P418, DOI 10.1038/sj.gt.3302439
   HUBBELL JA, 1991, BIO-TECHNOL, V9, P568, DOI 10.1038/nbt0691-568
   Hutmacher DW, 2005, GENE, V347, P1, DOI 10.1016/j.gene.2004.12.040
   Jacobs SA, 2013, IMMUNOL CELL BIOL, V91, P32, DOI 10.1038/icb.2012.64
   Jager M, 2011, J ORTHOP RES, V29, P173, DOI 10.1002/jor.21230
   Jo S, 2013, J BIOMED MATER RES A, V101, P892, DOI 10.1002/jbm.a.34354
   Kang Q, 2009, STEM CELLS DEV, V18, P545, DOI 10.1089/scd.2008.0130
   Kang SH, 2014, CELL TISSUE RES, V355, P81, DOI 10.1007/s00441-013-1738-z
   Kang YQ, 2013, ACTA BIOMATER, V9, P4906, DOI 10.1016/j.actbio.2012.08.008
   Karageorgiou V, 2006, J BIOMED MATER RES A, V78A, P324, DOI 10.1002/jbm.a.30728
   Karsenty G, 2012, NATURE, V481, P314, DOI 10.1038/nature10763
   Karvinen H, 2011, GENE THER, V18, P1166, DOI 10.1038/gt.2011.66
   Kempen DHR, 2009, BIOMATERIALS, V30, P2816, DOI 10.1016/j.biomaterials.2009.01.031
   Khan OF, 2011, TRENDS BIOTECHNOL, V29, P379, DOI 10.1016/j.tibtech.2011.03.004
   Kim J, 2007, BIOMATERIALS, V28, P1830, DOI 10.1016/j.biomaterials.2006.11.050
   Kim YH, 2014, BIOMATERIALS, V35, P214, DOI 10.1016/j.biomaterials.2013.09.103
   Kirker-Head C, 2007, BONE, V41, P247, DOI 10.1016/j.bone.2007.04.186
   Kitaori T, 2009, ARTHRITIS RHEUM-US, V60, P813, DOI 10.1002/art.24330
   Kitoh H, 2007, J PEDIATR ORTHOPED, V27, P629, DOI 10.1097/BPO.0b013e318093f523
   Kitoh H, 2007, BONE, V40, P522, DOI 10.1016/j.bone.2006.09.019
   Koob S, 2011, TISSUE ENG PT A, V17, P311, DOI 10.1089/ten.TEA.2010.0338
   Langenfeld EM, 2004, MOL CANCER RES, V2, P141
   Laranjeira MS, 2012, CELL PROLIFERAT, V45, P320, DOI 10.1111/j.1365-2184.2012.00822.x
   Leach JK, 2006, BIOMATERIALS, V27, P3249, DOI 10.1016/j.biomaterials.2006.01.033
   Lee JY, 2001, J BONE JOINT SURG AM, V83A, P1032, DOI 10.2106/00004623-200107000-00008
   Lee TT, 2014, NAT MAT
   Leslie-Barbick JE, 2009, J BIOMAT SCI-POLYM E, V20, P1763, DOI 10.1163/156856208X386381
   Levi B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011177
   Li Q, 2013, ARCH MED RES, V44, P504, DOI 10.1016/j.arcmed.2013.09.009
   Li R, 2009, J ORTHOP RES, V27, P8, DOI 10.1002/jor.20658
   Lin GL, 2011, J CELL BIOCHEM, V112, P3491, DOI 10.1002/jcb.23287
   Liu SY, 2011, TISSUE ENG PT A, V17, P725, DOI [10.1089/ten.tea.2010.0331, 10.1089/ten.TEA.2010.0331]
   Liu ZH, 2002, GENE DEV, V16, P859, DOI 10.1101/gad.965602
   Logeart-Avramoglou D, 2005, J CELL MOL MED, V9, P72, DOI 10.1111/j.1582-4934.2005.tb00338.x
   Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Ma JL, 2014, J BIOMED MATER RES A, V102, P1026, DOI 10.1002/jbm.a.34775
   Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009
   MAEDA T, 1994, J BIOCHEM, V115, P182, DOI 10.1093/oxfordjournals.jbchem.a124315
   Majumdar MK, 2001, J CELL PHYSIOL, V189, P275, DOI 10.1002/jcp.10025
   Mariner PD, 2013, J ORTHOP RES, V31, P401, DOI 10.1002/jor.22243
   Martino MM, 2014, SCIENCE, V343, P885, DOI 10.1126/science.1247663
   Martino MM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002614
   MASSIA SP, 1992, J BIOL CHEM, V267, P14019
   McCall JD, 2012, DRUG DELIV TRANSL RE, V2, P305, DOI 10.1007/s13346-012-0090-2
   McCarthy I, 2006, J BONE JOINT SURG AM, V88A, P4, DOI 10.2106/JBJS.F.00890
   Mckay WF, 2007, INT ORTHOP, V31, P729, DOI 10.1007/s00264-007-0418-6
   Moon JJ, 2010, BIOMATERIALS, V31, P3840, DOI 10.1016/j.biomaterials.2010.01.104
   Moutsatsos IK, 2001, MOL THER, V3, P449, DOI 10.1006/mthe.2001.0291
   Nguyen EH, 2014, BIOMATERIALS, V35, P2149, DOI 10.1016/j.biomaterials.2013.11.054
   Nguyen TH, 2013, NAT CHEM, V5, P221, DOI [10.1038/nchem.1573, 10.1038/NCHEM.1573]
   Novosel EC, 2011, ADV DRUG DELIVER REV, V63, P300, DOI 10.1016/j.addr.2011.03.004
   Oh SH, 2009, BIOMATERIALS, V30, P757, DOI 10.1016/j.biomaterials.2008.09.065
   Ohbayashi N, 2002, GENE DEV, V16, P870, DOI 10.1101/gad.965702
   Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191
   Ono I, 2004, BIOMATERIALS, V25, P4709, DOI 10.1016/j.biomaterials.2003.11.038
   Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702
   Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377
   Ozawa CR, 2004, J CLIN INVEST, V113, P516, DOI 10.1172/JCI200418420
   Pang H, 2013, INT ORTHOP, V37, P753, DOI 10.1007/s00264-012-1751-y
   Patel ZS, 2008, BONE, V43, P931, DOI 10.1016/j.bone.2008.06.019
   Patterson J, 2010, BIOMATERIALS, V31, P6772, DOI 10.1016/j.biomaterials.2010.05.047
   Pedraza E, 2012, P NATL ACAD SCI USA, V109, P4245, DOI 10.1073/pnas.1113560109
   Percival CJ, 2013, DEV DYNAM, V242, P909, DOI 10.1002/dvdy.23992
   Phelps EA, 2013, BIOMATERIALS, V34, P4602, DOI 10.1016/j.biomaterials.2013.03.012
   Phelps EA, 2010, P NATL ACAD SCI USA, V107, P3323, DOI 10.1073/pnas.0905447107
   Ramirez-Fernandez MP, 2013, CLIN ORAL INVEST, V17, P147, DOI 10.1007/s00784-012-0684-6
   Portalska KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046842
   Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516
   Raida M, 2005, J CANCER RES CLIN, V131, P741, DOI 10.1007/s00432-005-0024-1
   Rao RR, 2014, ACTA BIOMATER, V10, P3091, DOI 10.1016/j.actbio.2014.03.010
   Rao RR, 2013, CYTOTHERAPY, V15, P1309, DOI 10.1016/j.jcyt.2013.06.005
   Rao RR, 2012, ANGIOGENESIS, V15, P253, DOI 10.1007/s10456-012-9257-1
   Ravanti L, 2000, INT J MOL MED, V6, P391
   Ren LL, 2014, BONE, V64, P173, DOI 10.1016/j.bone.2014.04.011
   Resch T, 2012, STEM CELL REV REP, V8, P926, DOI 10.1007/s12015-011-9332-9
   Rihn JA, 2009, SPINE J, V9, P623, DOI 10.1016/j.spinee.2009.04.004
   Ross TD, 2013, CURR OPIN CELL BIOL, V25, P613, DOI 10.1016/j.ceb.2013.05.006
   Salimath AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050980
   Santos MI, 2010, MACROMOL BIOSCI, V10, P12, DOI 10.1002/mabi.200900107
   Santos MI, 2009, BIOMATERIALS, V30, P4407, DOI 10.1016/j.biomaterials.2009.05.004
   Seebach C, 2012, CELL TRANSPLANT, V21, P1667, DOI 10.3727/096368912X638937
   Seebach C, 2010, TISSUE ENG PT A, V16, P1961, DOI [10.1089/ten.tea.2009.0715, 10.1089/ten.TEA.2009.0715]
   Seebach E, 2014, ACTA BIOMATER, V10, P4730, DOI 10.1016/j.actbio.2014.07.017
   Sefcik LS, 2008, BIOMATERIALS, V29, P2869, DOI 10.1016/j.biomaterials.2008.03.017
   Sensebe L, 2010, VOX SANG, V98, P93, DOI 10.1111/j.1423-0410.2009.01227.x
   Shantsila E, 2007, J AM COLL CARDIOL, V49, P741, DOI 10.1016/j.jacc.2006.09.050
   Shekaran A, 2014, BIOMATERIALS, V35, P5453, DOI 10.1016/j.biomaterials.2014.03.055
   Shen YH, 2008, ACTA BIOMATER, V4, P477, DOI 10.1016/j.actbio.2007.12.011
   Shi YF, 2010, CELL RES, V20, P510, DOI 10.1038/cr.2010.44
   SORRELL JM, 1988, ANAT REC, V221, P730
   Steiner D, 2012, J ORTHOP RES, V30, P1682, DOI 10.1002/jor.22130
   Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099
   Sun HC, 2007, BIOMED ENG ONLINE, V6, DOI 10.1186/1475-925X-6-41
   Taite LJ, 2008, J BIOMED MATER RES B, V84B, P108, DOI 10.1002/jbm.b.30850
   Tayalia P, 2009, ADV MATER, V21, P3269, DOI 10.1002/adma.200900241
   Tsigkou O, 2010, P NATL ACAD SCI USA, V107, P3311, DOI 10.1073/pnas.0905445107
   Tsumaki N, 2002, J BONE MINER RES, V17, P898, DOI 10.1359/jbmr.2002.17.5.898
   Usami K, 2009, J BIOMED MATER RES A, V90A, P730, DOI 10.1002/jbm.a.32142
   Valimaki VV, 2005, TISSUE ENG, V11, P387, DOI 10.1089/ten.2005.11.387
   Vila OF, 2014, ACTA BIOMATER, V10, P4377, DOI 10.1016/j.actbio.2014.05.028
   Wang H, 2005, ARTERIOSCL THROM VAS, V25, P1817, DOI 10.1161/01.ATV.0000175840.90510.a8
   Wang J, 2011, BIOCHEM BIOPH RES CO, V412, P143, DOI 10.1016/j.bbrc.2011.07.062
   Wernike E, 2010, EUR CELLS MATER, V19, P30
   Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215
   Yang SY, 2003, J BONE MINER RES, V18, P705, DOI 10.1359/jbmr.2003.18.4.705
   Ye F, 2012, BLOOD, V119, P26, DOI 10.1182/blood-2011-04-292128
   Yoneda M, 2005, BIOMATERIALS, V26, P5145, DOI 10.1016/j.biomaterials.2005.01.054
   Young S, 2009, TISSUE ENG PT A, V15, P2347, DOI 10.1089/ten.tea.2008.0510
   Yourek G, 2010, REGEN MED, V5, P713, DOI [10.2217/rme.10.60, 10.2217/RME.10.60]
   Yu HY, 2008, J ORTHOP RES, V26, P1147, DOI 10.1002/jor.20609
   Zelzer E, 2004, DEVELOPMENT, V131, P2161, DOI 10.1242/dev.01053
   Zhang ZY, 2010, BIOMATERIALS, V31, P608, DOI 10.1016/j.biomaterials.2009.09.078
   Zieris A, 2010, BIOMATERIALS, V31, P7985, DOI 10.1016/j.biomaterials.2010.07.021
   Zisch AH, 2003, FASEB J, V17, P2260, DOI 10.1096/fj.02-1041fje
   Zou DH, 2011, STEM CELLS, V29, P1380, DOI 10.1002/stem.693
NR 185
TC 11
Z9 11
U1 3
U2 36
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 2190-393X
EI 2190-3948
J9 DRUG DELIV TRANSL RE
JI Drug Deliv. Transl. Res.
PD APR
PY 2016
VL 6
IS 2
BP 77
EP 95
DI 10.1007/s13346-015-0236-0
PG 19
WC Instruments & Instrumentation; Medicine, Research & Experimental;
   Pharmacology & Pharmacy
SC Instruments & Instrumentation; Research & Experimental Medicine;
   Pharmacology & Pharmacy
GA DO9YX
UT WOS:000378145200002
PM 26014967
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Jeon, OH
   Elisseeff, J
AF Jeon, Ok Hee
   Elisseeff, Jennifer
TI Orthopedic tissue regeneration: cells, scaffolds, and small molecules
SO DRUG DELIVERY AND TRANSLATIONAL RESEARCH
LA English
DT Review
DE Osteoporosis; Osteoarthritis; Bone; Cartilage; Stemcells; Scaffolds;
   Small molecules
ID MESENCHYMAL STEM-CELLS; OSTEOARTHRITIS STRUCTURAL ARTHRITIS;
   DEGENERATIVE JOINT DISEASE; ENHANCES BONE REGENERATION;
   ARTICULAR-CARTILAGE DEFECT; IN-VITRO CHONDROGENESIS; PLATELET-RICH
   PLASMA; SUBCHONDRAL BONE; KNEE OSTEOARTHRITIS; STRONTIUM RANELATE
AB Orthopedic tissue regeneration would benefit the aging population or patients with degenerative bone and cartilage diseases, especially osteoporosis and osteoarthritis. Despite progress in surgical and pharmacological interventions, new regenerative approaches are needed to meet the challenge of creating bone and articular cartilage tissues that are not only structurally sound but also functional, primarily to maintain mechanical integrity in their high load-bearing environments. In this review, we discuss new advances made in exploiting the three classes of materials in bone and cartilage regenerative medicine-cells, biomaterial-based scaffolds, and small molecules-and their successes and challenges reported in the clinic. In particular, the focus will be on the development of tissue-engineered bone and cartilage ex vivo by combining stem cells with biomaterials, providing appropriate structural, compositional, and mechanical cues to restore damaged tissue function. In addition, using small molecules to locally promote regeneration will be discussed, with potential approaches that combine bone and cartilage targeted therapeutics for the orthopedic-related disease, especially osteoporosis and osteoarthritis.
C1 [Elisseeff, Jennifer] Johns Hopkins Univ, Translat Tissue Engn Ctr, Wilmer Eye Inst, 5031 Smith Bldg,400N Broadway, Baltimore, MD 21231 USA.
   Johns Hopkins Univ, Dept Biomed Engn, 5031 Smith Bldg,400N Broadway, Baltimore, MD 21231 USA.
RP Elisseeff, J (reprint author), Johns Hopkins Univ, Translat Tissue Engn Ctr, Wilmer Eye Inst, 5031 Smith Bldg,400N Broadway, Baltimore, MD 21231 USA.
EM jhe@jhu.edu
CR Amini Ami R., 2012, Critical Reviews in Biomedical Engineering, V40, P363
   AMIR G, 1992, J CLIN PATHOL, V45, P990, DOI 10.1136/jcp.45.11.990
   Arrigoni E, 2013, J ORTHOP SCI, V18, P331, DOI 10.1007/s00776-012-0349-y
   Ashhurst DE, 2004, MATRIX BIOL, V23, P15, DOI 10.1016/j.mathbio.2004.02.001
   Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   Barry F, 2001, EXP CELL RES, V268, P189, DOI 10.1006/excr.2001.5278
   Bay-Jensen AC, 2010, RHEUMATOL INT, V30, P435, DOI 10.1007/s00296-009-1183-1
   Bellido M, 2011, OSTEOARTHR CARTILAGE, V19, P1228, DOI 10.1016/j.joca.2011.07.003
   Bellido M, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3103
   Bhumiratana S, 2011, BIOMATERIALS, V32, P2812, DOI 10.1016/j.biomaterials.2010.12.058
   Bingham CO, 2006, ARTHRITIS RHEUM, V54, P3494, DOI 10.1002/art.22160
   Bone HG, 2015, OSTEOPOROSIS INT, V26, P699, DOI 10.1007/s00198-014-2944-6
   Boonen S, 2012, CURR OSTEOPOROS REP, V10, P73, DOI 10.1007/s11914-011-0085-9
   Boyce BF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2165
   Buckland-Wright JC, 2007, RHEUMATOLOGY, V46, P257, DOI 10.1093/rheumatology/kel213
   Burr DB, 2012, NAT REV RHEUMATOL, V8, P665, DOI 10.1038/nrrheum.2012.130
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Carbone LD, 2004, ARTHRITIS RHEUM, V50, P3516, DOI 10.1002/art.20627
   Centeno CJ, 2008, PAIN PHYSICIAN, V11, P343
   Chang JK, 2009, ARTHRITIS RHEUM, V60, P3049, DOI 10.1002/art.24843
   Chen GP, 2004, BIOCHEM BIOPH RES CO, V322, P50, DOI 10.1016/j.bbrc.2004.07.071
   Coleman RM, 2007, BIOMATERIALS, V28, P2077, DOI 10.1016/j.biomaterials.2007.01.010
   Connor JR, 2009, OSTEOARTHR CARTILAGE, V17, P1236, DOI 10.1016/j.joca.2009.03.015
   Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958
   de Peppo GM, 2013, P NATL ACAD SCI USA, V110, P8680, DOI 10.1073/pnas.1301190110
   Debnath T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120803
   Diekman BO, 2012, P NATL ACAD SCI USA, V109, P19172, DOI 10.1073/pnas.1210422109
   Dragoo JL, 2007, TISSUE ENG, V13, P1615, DOI 10.1089/ten.2006.0249
   Duan XJ, 2011, J CELL PHYSIOL, V226, P150, DOI 10.1002/jcp.22316
   Estes BT, 2006, ARTHRITIS RHEUM, V54, P1222, DOI 10.1002/art.21779
   Eswaramoorthy R, 2012, ACTA BIOMATER, V8, P2254, DOI 10.1016/j.actbio.2012.03.015
   Fan HB, 2006, J BIOMED MATER RES A, V77A, P785, DOI 10.1002/jbm.a.30647
   Favi PM, 2013, MAT SCI ENG C-MATER, V33, P1935, DOI 10.1016/j.msec.2012.12.100
   FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381
   Frohlich M, 2010, TISSUE ENG PT A, V16, P179, DOI [10.1089/ten.tea.2009.0164, 10.1089/ten.TEA.2009.0164]
   Fu SZ, 2012, BIOMATERIALS, V33, P4801, DOI 10.1016/j.biomaterials.2012.03.040
   Fukunaga N, 2010, CELL REPROGRAM, V12, P369, DOI [10.1089/cell.2009.0097, 10.1089/cell.2009.0086]
   Gabbay JS, 2006, ANN PLAS SURG, V57, P89, DOI 10.1097/01.sap.0000205378.89052.d3
   Garnero P, 2008, OSTEOARTHR CARTILAGE, V16, P660, DOI 10.1016/j.joca.2007.10.002
   Gellynck K, 2013, BONE, V57, P405, DOI 10.1016/j.bone.2013.09.012
   Gentleman E, 2010, BIOMATERIALS, V31, P3949, DOI 10.1016/j.biomaterials.2010.01.121
   Giuliani N, 2013, STEM CELLS INT, DOI 10.1155/2013/312501
   Goldring MB, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2592
   Grayson WL, 2015, NAT REV ENDOCRINOL, V11, P140, DOI 10.1038/nrendo.2014.234
   Grayson WL, 2011, BIOTECHNOL BIOENG, V108, P1159, DOI 10.1002/bit.23024
   Guzzo RM, 2013, J CELL BIOCHEM, V114, P480, DOI 10.1002/jcb.24388
   Hashemibeni B, 2014, IRAN J BASIC MED SCI, V17, P854
   Hayami T, 2004, ARTHRITIS RHEUM, V50, P1193, DOI 10.1002/art.20124
   Hayami T, 2012, BONE, V50, P1250, DOI 10.1016/j.bone.2012.03.025
   Henrotin Y, 2001, J BONE MINER RES, V16, P299, DOI 10.1359/jbmr.2001.16.2.299
   Hicok KC, 2004, TISSUE ENG, V10, P371, DOI 10.1089/107632704323061735
   Huang CYC, 2004, ANAT REC PART A, V278A, P428, DOI 10.1002/ar.a.20010
   Huebsch N, 2015, NAT MATER, V14, P1269, DOI [10.1038/NMAT4407, 10.1038/nmat4407]
   Huey DJ, 2012, SCIENCE, V338, P917, DOI 10.1126/science.1222454
   HUGHES DE, 1995, J BONE MINER RES, V10, P1478
   Hutton DL, 2014, CURR OPIN CHEM ENG, V3, P75, DOI 10.1016/j.coche.2013.12.002
   Hwang NS, 2007, J CELL PHYSIOL, V212, P281, DOI 10.1002/jcp.21052
   Hwang NS, 2006, TISSUE ENG, V12, P2695, DOI 10.1089/ten.2006.12.2695
   Hwang NS, 2006, STEM CELLS, V24, P284, DOI 10.1634/stemcells.2005-0024
   Hwang NS, 2008, P NATL ACAD SCI USA, V105, P20641, DOI 10.1073/pnas.0809680106
   Ignjatovic N, 2005, J MATER SCI-MATER M, V16, P621, DOI 10.1007/s10856-005-2532-6
   Im GI, 2005, OSTEOARTHR CARTILAGE, V13, P845, DOI 10.1016/j.joca.2005.05.005
   Indrawattana N, 2004, BIOCHEM BIOPH RES CO, V320, P914, DOI 10.1016/j.bbre.2004.06.029
   Ishii I, 2007, J BONE JOINT SURG BR, V89B, P693, DOI 10.1302/0301-620X.89B5.18450
   Ito T, 2013, J PHARM PHARMACOL, V65, P494, DOI 10.1111/jphp.12008
   Jin XB, 2007, BIOMATERIALS, V28, P2994, DOI 10.1016/j.biomaterials.2007.03.002
   Jo CH, 2014, STEM CELLS, V32, P1254, DOI 10.1002/stem.1634
   Johnson K, 2012, SCIENCE, V336, P717, DOI 10.1126/science.1215157
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Kadri A, 2008, ARTHRITIS RHEUM, V58, P2379, DOI 10.1002/art.23638
   Kao CL, 2010, STEM CELLS DEV, V19, P247, DOI 10.1089/scd.2009.0186
   Kassem M, 1997, OSTEOPOROSIS INT, V7, P514, DOI 10.1007/BF02652556
   Kawate K, 2006, ARTIF ORGANS, V30, P960, DOI 10.1111/j.1525-1594.2006.00333.x
   Kim H. J., 2012, J TISSUE ENG, V3
   Kim HJ, 2009, J ORTHOP RES, V27, P612, DOI 10.1002/jor.20766
   Kim MJ, 2011, ARTHRITIS RHEUM-US, V63, P3010, DOI 10.1002/art.30488
   Kim YS, 2015, AM J SPORT MED, V43, P176, DOI 10.1177/0363546514554190
   Knippenberg M, 2006, BIOCHEM BIOPH RES CO, V342, P902, DOI 10.1016/j.bbrc.2006.02.052
   Ko JY, 2014, BIOMATERIALS, V35, P3571, DOI 10.1016/j.biomaterials.2014.01.009
   Koh YG, 2013, KNEE SURG SPORT TR A, V23, P1308
   Koh YG, 2014, AM J SPORT MED, V42, P1628, DOI 10.1177/0363546514529641
   Koh YG, 2014, ARTHROSCOPY, V30, P1453, DOI 10.1016/j.arthro.2014.05.036
   Koh YG, 2012, KNEE, V19, P902, DOI 10.1016/j.knee.2012.04.001
   Kramer J, 2000, MECH DEVELOP, V92, P193, DOI 10.1016/S0925-4773(99)00339-1
   Krampera M, 2006, STEM CELLS, V24, P386, DOI 10.1634/stemcells.2005-0008
   Kreuz PC, 2006, OSTEOARTHR CARTILAGE, V14, P1119, DOI 10.1016/j.joca.2006.05.003
   Kuroda R, 2007, OSTEOARTHR CARTILAGE, V15, P226, DOI 10.1016/j.joca.2006.08.008
   Langle D, 2014, ACS CHEM BIOL, V9, P57, DOI 10.1021/cb4008277
   Lampropoulou-Adamidou K, 2014, J ORTHOP RES, V32, P1646, DOI 10.1002/jor.22712
   Lee SH, 2007, ADV DRUG DELIVER REV, V59, P339, DOI 10.1016/j.addr.2007.03.016
   Levi B, 2012, P NATL ACAD SCI USA, V109, P20379, DOI 10.1073/pnas.1218052109
   Li F, 2010, J CELL BIOCHEM, V109, P643, DOI 10.1002/jcb.22440
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Liao HT, 2016, J TISSUE ENG REGEN M, V10, pE337, DOI 10.1002/term.1811
   Liechty WB, 2010, ANNU REV CHEM BIOMOL, V1, P149, DOI 10.1146/annurev-chembioeng-073009-100847
   Lock J, 2011, INT J NANOMED, V6, P2769, DOI 10.2147/IJN.S24493
   Lv Y, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-370
   Maas M, 2011, NANO LETT, V11, P1383, DOI 10.1021/nl200116d
   Mahmoudifar N, 2010, BIOMATERIALS, V31, P3858, DOI 10.1016/j.biomaterials.2010.01.090
   Makris EA, 2015, NAT REV RHEUMATOL, V11, P21, DOI 10.1038/nrrheum.2014.157
   Marino G, 2010, J MATER SCI-MATER M, V21, P353, DOI 10.1007/s10856-009-3840-z
   McDougall JJ, 2010, OSTEOARTHR CARTILAGE, V18, P1355, DOI 10.1016/j.joca.2010.07.014
   Merceron C, 2011, CELL TRANSPLANT, V20, P1575, DOI 10.3727/096368910X557191
   Mesimaki K, 2009, INT J ORAL MAX SURG, V38, P201, DOI 10.1016/j.ijom.2009.01.001
   Mwale F, 2010, TISSUE ENG PT A, V16, P3449, DOI 10.1089/ten.TEA.2010.0091
   Nakagawa T, 2009, ARTHRITIS RHEUM-US, V60, P3686, DOI 10.1002/art.27229
   Nejadnik H, 2015, STEM CELL REV REP, V11, P242, DOI 10.1007/s12015-014-9581-5
   Nejadnik H, 2010, AM J SPORT MED, V38, P1110, DOI 10.1177/0363546509359067
   Neogi T, 2009, ARTHRIT RHEUM-ARTHR, V61, P1539, DOI 10.1002/art.24824
   Nishii T, 2013, CLIN RHEUMATOL, V32, P1759, DOI 10.1007/s10067-013-2338-8
   Ogawa R, 2015, TISSUE ENG PT A, V21, P257, DOI [10.1089/ten.TEA.2013.0525, 10.1089/ten.tea.2013.0525]
   Orth P, 2014, OSTEOARTHR CARTILAGE, V22, P813, DOI 10.1016/j.joca.2014.03.010
   Pang YG, 2005, ARCH FACIAL PLAST S, V7, P7, DOI 10.1001/archfaci.7.1.7
   Parker AM, 2006, EXPERT OPIN BIOL TH, V6, P567, DOI 10.1517/14712598.6.6.567
   Pasquinelli G, 2008, J ANAT, V213, P520, DOI 10.1111/j.1469-7580.2008.00974.x
   Pelletier JP, 2013, ANN RHEUM DIS, V72, P250, DOI 10.1136/annrheumdis-2012-201710
   Petrie A.C.E., 2010, BIOMATERIALS, V31, P6417
   Van Pham P, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt277
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Qu ZW, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/6/065001
   Ragetly GR, 2010, ACTA BIOMATER, V6, P1430, DOI 10.1016/j.actbio.2009.10.040
   Ranganath SH, 2012, CELL STEM CELL, V10, P244, DOI 10.1016/j.stem.2012.02.005
   Reginster JY, 2014, ANN RHEUM DIS, V73, pE8, DOI 10.1136/annrheumdis-2013-204194
   Reginster JY, 2012, OSTEOPOROSIS INT, V23, P1115, DOI 10.1007/s00198-011-1847-z
   Reichert JC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003720
   Rudnicki JA, 1997, DEV BIOL, V185, P104, DOI 10.1006/dbio.1997.8536
   Saito T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074137
   Sampson ER, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002214
   Schmitt B, 2003, DIFFERENTIATION, V71, P567, DOI 10.1111/j.1432-0436.2003.07109003.x
   Schurigt U, 2008, ARTHRITIS RHEUM, V58, P422, DOI 10.1002/art.23224
   Shamsul BS, 2014, TISSUE CELL, V46, P152, DOI 10.1016/j.tice.2014.02.001
   Sharma B, 2007, PLAST RECONSTR SURG, V119, P112, DOI 10.1097/01.prs.0000236896.22479.52
   Shimizu S, 2007, ARTHRITIS RHEUM-US, V56, P3358, DOI 10.1002/art.22941
   Sinha S, 2006, NAT CHEM BIOL, V2, P29, DOI 10.1038/nchembio.753
   Spector TD, 2005, ARTHRITIS RES THER, V7, pR625, DOI 10.1186/ar1716
   Srinivasan S, 2012, AGEING RES REV, V11, P353, DOI 10.1016/j.arr.2011.12.007
   Stadelmann VA, 2008, EUR CELLS MATER, V16, P10, DOI 10.22203/eCM.v016a02
   Strassle BW, 2010, OSTEOARTHR CARTILAGE, V18, P1319, DOI 10.1016/j.joca.2010.06.007
   Sumanasinghe RD, 2006, TISSUE ENG, V12, P3459, DOI 10.1089/ten.2006.12.3459
   Sun N, 2010, CELL CYCLE, V9, P880, DOI 10.4161/cc.9.5.10827
   Takahashi D, 2009, ARTHRITIS RHEUM, V60, P2372, DOI 10.1002/art.24718
   Tang MH, 2014, TISSUE ENG PT A, V20, P1295, DOI [10.1089/ten.tea.2013.0211, 10.1089/ten.TEA.2013.0211]
   Tat SK, 2011, BONE, V49, P559, DOI 10.1016/j.bone.2011.06.005
   TheinHan WW, 2013, BONE RES, V1, P371, DOI 10.4248/BR201304008
   Uebersax L, 2008, J CONTROL RELEASE, V127, P12, DOI 10.1016/j.jconrel.2007.11.006
   Vicente LM, 2011, STEM CELLS DEV, V20, P1011, DOI DOI 10.1089/SCD.2010.0355
   Wakitani S, 2002, OSTEOARTHR CARTILAGE, V10, P199, DOI 10.1053/joca.2001.0504
   Wakitani S, 2004, CELL TRANSPLANT, V13, P595, DOI 10.3727/000000004783983747
   Wang HA, 2014, ACTA BIOMATER, V10, P508, DOI 10.1016/j.actbio.2013.08.036
   Wang X, 2013, INT ORTHOP, V37, P2491, DOI 10.1007/s00264-013-2059-2
   Warzecha J, 2006, J ORTHOP SCI, V11, P491, DOI 10.1007/s00776-006-1058-1
   Wei YY, 2012, EUR CELLS MATER, V23, P1
   Weir MD, 2010, ACTA BIOMATER, V6, P4118, DOI 10.1016/j.actbio.2010.04.029
   Wilke MM, 2007, J ORTHOP RES, V25, P913, DOI 10.1002/jor.20382
   Wu X, 2004, CHEM BIOL, V11, P1229, DOI 10.1016/j.chembiol.2004.06.010
   Wu X, 2002, J AM CHEM SOC, V124, P14520, DOI 10.1021/ja0283908
   Xu JP, 2008, TISSUE ENG PT A, V14, P667, DOI 10.1089/tea.2007.0272
   Xu Y, 2007, BIOCHEM BIOPH RES CO, V359, P311, DOI 10.1016/j.bbrc.2007.05.098
   Yamashita A, 2014, NATURE, V513, P507, DOI 10.1038/nature13775
   Yang F, 2009, ACTA BIOMATER, V5, P3295, DOI 10.1016/j.actbio.2009.05.023
   Yeon B, 2013, BIOMACROMOLECULES, V14, P3256, DOI 10.1021/bm400868j
   Yoon HH, 2012, TISSUE ENG PT A, V18, P1949, DOI [10.1089/ten.tea.2011.0647, 10.1089/ten.TEA.2011.0647]
   Yoon IS, 2011, J BIOSCI BIOENG, V112, P402, DOI 10.1016/j.jbiosc.2011.06.018
   Yoon YM, 2002, J BIOL CHEM, V277, P8412, DOI 10.1074/jbc.M110608200
   Yoshii T, 2014, J TISSUE ENG REGEN M, V8, P589, DOI 10.1002/term.1547
   Zaky SH, 2009, J DENT RES, V88, P1077, DOI 10.1177/0022034509349926
   Zhang KX, 2013, ACTA BIOMATER, V9, P7276, DOI 10.1016/j.actbio.2013.03.025
   Zhang ZY, 2009, STEM CELLS, V27, P126, DOI 10.1634/stemcells.2008-0456
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 169
TC 9
Z9 9
U1 4
U2 42
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 2190-393X
EI 2190-3948
J9 DRUG DELIV TRANSL RE
JI Drug Deliv. Transl. Res.
PD APR
PY 2016
VL 6
IS 2
BP 105
EP 120
DI 10.1007/s13346-015-0266-7
PG 16
WC Instruments & Instrumentation; Medicine, Research & Experimental;
   Pharmacology & Pharmacy
SC Instruments & Instrumentation; Research & Experimental Medicine;
   Pharmacology & Pharmacy
GA DO9YX
UT WOS:000378145200004
PM 26625850
DA 2018-10-20
ER

PT J
AU Wen, C
   Kang, HM
   Shih, YRV
   Hwang, Y
   Varghese, S
AF Wen, Cai
   Kang, Heemin
   Shih, Yu-Ru V.
   Hwang, YongSung
   Varghese, Shyni
TI In vivo comparison of biomineralized scaffold-directed osteogenic
   differentiation of human embryonic and mesenchymal stem cells
SO DRUG DELIVERY AND TRANSLATIONAL RESEARCH
LA English
DT Article
DE Embryonic stem cells; Mesenchymal stem cells; In vivo osteogenic
   differentiation; Biomineralized scaffold; Bone tissue engineering;
   Calcium phosphate
ID BONE MORPHOGENETIC PROTEIN; CALCIUM-PHOSPHATE; MINERAL COATINGS;
   MATRICES; TISSUE; ANGIOGENESIS; REGENERATION; MECHANISMS; MORPHOLOGY;
   HYDROGELS
AB Human pluripotent stem cells such as embryonic stem cells (hESCs) and multipotent stem cells like mesenchymal stem cells (hMSCs) hold great promise as potential cell sources for bone tissue regeneration. Comparing the in vivo osteogenesis of hESCs and hMSCs by biomaterial-based cues provides insight into the differentiation kinetics of these cells as well as their potential to contribute to bone tissue repair in vivo. Here, we compared in vivo osteogenic differentiation of hESCs and hMSCs within osteoinductive calcium phosphate (CaP)-bearing biomineralized scaffolds that recapitulate a bone-specific mineral microenvironment. Both hESCs and hMSCs underwent osteogenic differentiation responding to the biomaterial-based instructive cues. Furthermore, hMSCs underwent earlier in vivo osteogenesis compared to hESCs, but both stem cell types acquired a similar osteogenic maturation by 8 weeks of implantation.
C1 [Wen, Cai] Southeast Univ, Sch Chem & Chem Engn, Sipailou 2, Nanjing 210096, Jiangsu, Peoples R China.
   [Kang, Heemin; Shih, Yu-Ru V.; Hwang, YongSung; Varghese, Shyni] Univ Calif San Diego, Dept Bioengn, 9500 Gilman Dr, La Jolla, CA 92093 USA.
RP Varghese, S (reprint author), Univ Calif San Diego, Dept Bioengn, 9500 Gilman Dr, La Jolla, CA 92093 USA.
EM svarghese@ucsd.edu
FU National Institutes of Health (NIH) [1 R01 AR063184-01A1]; Texas A&M
   University from the NIH [P40RR017447]
FX This work was supported by National Institutes of Health (NIH; Grant 1
   R01 AR063184-01A1). The hMSCs used in this study were provided by Texas
   A&M University from the NIH (Grant P40RR017447).
CR Ahn SE, 2006, BIOCHEM BIOPH RES CO, V340, P403, DOI 10.1016/j.bbrc.2005.12.020
   Ayala R, 2011, BIOMATERIALS, V32, P3700, DOI 10.1016/j.biomaterials.2011.02.004
   Barradas AMC, 2012, BIOMATERIALS, V33, P3205, DOI 10.1016/j.biomaterials.2012.01.020
   Barradas AMC, 2011, EUR CELLS MATER, V21, P407, DOI 10.22203/eCM.v021a31
   Bilousova G, 2011, STEM CELLS, V29, P206, DOI 10.1002/stem.566
   Both SK, 2011, J TISSUE ENG REGEN M, V5, P180, DOI 10.1002/term.303
   Brey DM, 2011, BIOTECHNOL BIOENG, V108, P163, DOI 10.1002/bit.22925
   Cameron K, 2013, J BIOMED MATER RES A, V101, P13, DOI 10.1002/jbm.a.34261
   Chai YC, 2012, BIOMATERIALS, V33, P3127, DOI 10.1016/j.biomaterials.2012.01.015
   Chang CW, 2013, BIOMATERIALS, V34, P912, DOI 10.1016/j.biomaterials.2012.10.020
   Choi S, 2013, BIOTECHNOL J, V8, P496, DOI 10.1002/biot.201200204
   de Peppo GM, 2013, P NATL ACAD SCI USA, V110, P8680, DOI 10.1073/pnas.1301190110
   Deans RJ, 2000, EXP HEMATOL, V28, P875, DOI 10.1016/S0301-472X(00)00482-3
   Friedman MS, 2006, J CELL BIOCHEM, V98, P538, DOI 10.1002/jcb.20719
   Gamie Z, 2014, EXPERT OPIN BIOL TH, V14, P1611, DOI 10.1517/14712598.2014.945414
   Hwang NS, 2013, TISSUE ENG PT A, V19, P1723, DOI [10.1089/ten.TEA.2013.0064, 10.1089/ten.tea.2013.0064]
   Hwang NS, 2009, WIRES SYST BIOL MED, V1, P97, DOI [10.1002/wsbm.026, 10.1002/wsbm.26]
   Kaigler D, 2006, J BONE MINER RES, V21, P735, DOI 10.1359/JBMR.060120
   Kang H, 2015, BIOMACROMOLECULES, V16, P1050, DOI 10.1021/acs.biomac.5b00099
   Kang HM, 2014, ACTA BIOMATER, V10, P4961, DOI 10.1016/j.actbio.2014.08.010
   Kang HM, 2014, J MATER CHEM B, V2, P5676, DOI 10.1039/c4tb00714j
   Karp JM, 2006, STEM CELLS, V24, P835, DOI 10.1634/stemcells.2005-0383
   Kawaguchi J, 2005, BONE, V36, P758, DOI 10.1016/j.bone.2004.07.019
   LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g
   Levi B, 2012, P NATL ACAD SCI USA, V109, P20379, DOI 10.1073/pnas.1218052109
   Lin S, 2011, PHARM RES-DORDR, V28, P1422, DOI 10.1007/s11095-011-0378-9
   Liu YL, 2004, TISSUE ENG, V10, P101, DOI 10.1089/107632704322791745
   Madl CM, 2014, BIOMACROMOLECULES, V15, P445, DOI 10.1021/bm401726u
   Marolt D, 2010, STEM CELL RES THER, V1, P1
   Marolt D, 2012, P NATL ACAD SCI USA, V109, P8705, DOI 10.1073/pnas.1201830109
   Muller P, 2008, J CELL MOL MED, V12, P281, DOI 10.1111/j.1582-4934.2007.00103.x
   Murphy WL, 2004, J DENT RES, V83, P204, DOI 10.1177/154405910408300304
   Oyane A, 2003, J BIOMED MATER RES A, V65A, P188, DOI 10.1002/jbm.a.10482
   Peng Y, 2004, J BIOL CHEM, V279, P32941, DOI 10.1074/jbc.M403344200
   Petrie TA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001002
   Phadke A, 2013, EUR CELLS MATER, V25, P114, DOI 10.22203/eCM.v025a08
   Phadke A, 2012, MACROMOL BIOSCI, V12, P1022, DOI 10.1002/mabi.201100289
   Phadke A, 2010, BIOMACROMOLECULES, V11, P2060, DOI 10.1021/bm100425p
   Seong JM, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/6/062001
   Shih YR, 2015, ACTA BIOMATER, V19, P1, DOI 10.1016/j.actbio.2015.03.017
   Shih YRV, 2014, P NATL ACAD SCI USA, V111, P990, DOI 10.1073/pnas.1321717111
   Shimko DA, 2004, TISSUE ENG, V10, P1386, DOI 10.1089/ten.2004.10.1386
   Suarez-Gonzalez D, 2012, ACTA BIOMATER, V8, P1117, DOI 10.1016/j.actbio.2011.11.028
   Suarez-Gonzalez D, 2012, BIOMATERIALS, V33, P713, DOI 10.1016/j.biomaterials.2011.09.095
   Varghese S, 2010, STEM CELLS, V28, P765, DOI 10.1002/stem.325
   Wen L, 2012, BIOCHEM BIOPH RES CO, V424, P439, DOI 10.1016/j.bbrc.2012.06.128
   Xiao X, 2015, SCI REP-UK, V5, DOI 10.1038/srep09409
   Yang C, 2014, NAT MATER, V13, P645, DOI [10.1038/NMAT3889, 10.1038/nmat3889]
   Yang H, 2014, J MATER CHEM B, V2, P4703, DOI 10.1039/c4tb00424h
   Yuan HP, 1998, J MATER SCI-MATER M, V9, P717, DOI 10.1023/A:1008998817977
   Yuan HP, 2010, P NATL ACAD SCI USA, V107, P13614, DOI 10.1073/pnas.1003600107
   Zhang C, 2009, SOFT MATTER, V5, P3831, DOI 10.1039/b912102a
NR 52
TC 6
Z9 6
U1 2
U2 13
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 2190-393X
EI 2190-3948
J9 DRUG DELIV TRANSL RE
JI Drug Deliv. Transl. Res.
PD APR
PY 2016
VL 6
IS 2
BP 121
EP 131
DI 10.1007/s13346-015-0242-2
PG 11
WC Instruments & Instrumentation; Medicine, Research & Experimental;
   Pharmacology & Pharmacy
SC Instruments & Instrumentation; Research & Experimental Medicine;
   Pharmacology & Pharmacy
GA DO9YX
UT WOS:000378145200005
PM 26105532
DA 2018-10-20
ER

PT J
AU Cruz, RDAL
   Diniz, LGM
   Lisboa, HM
   Fook, MVL
AF Alves Leal Cruz, Rita de Cassia
   Marques Diniz, Luana Geovanna
   Lisboa, Hugo Miguel
   Lia Fook, Marcus Vinicius
TI Effect of different carboxylic acids as solvent on chitosan fibers
   production by wet spinning
SO MATERIA-RIO DE JANEIRO
LA English
DT Article
DE Biopolymers; Swelling; Mechanical Properties; Medical devices
AB Over the past decades, chitosan has been extensively investigated and used as a biomaterial due to a set of properties, such as biocompatibility, biodegradability and bioactivity. In the present work to produce the chitosan fibers was used the wet spinning technique and Two parameters, solvent and polymers concentration, were chosen as variables. For polymer concentration two concentrations were applied: 2%, 2.5%; and for solvents, three different acids were used: acetic, malic and lactic. Characterizations were carried out, using FTIR, Swelling Degree measurements, SEM and mechanical tests in terms of Traction. From the dimensional analysis of the fiber, different diameters where detected possibly due to steric effects cause by the presence of the acid. Other properties were also affected, revealing that as denser fibers are tend they have higher mechanical properties, and lesser tendency to swell. The fibers showed good potential for application as sutures.
C1 [Alves Leal Cruz, Rita de Cassia; Marques Diniz, Luana Geovanna; Lisboa, Hugo Miguel; Lia Fook, Marcus Vinicius] Univ Fed Campina Grande, Dept Mat Engn, CERTBIO, BR-58109970 Campina Grande, PB, Brazil.
RP Cruz, RDAL (reprint author), Univ Fed Campina Grande, Dept Mat Engn, CERTBIO, BR-58109970 Campina Grande, PB, Brazil.
EM ritaalvesleal@hotmail.com; luanamdiniz@gmail.com;
   hugom.lisboa80@gmail.com; marcus.fook@pq.cnpq.br
OI Vinicius Lia Fook, Marcus/0000-0002-8566-920X; Lisboa,
   Hugo/0000-0002-4722-0364
FU CAPES
FX The authors acknowledged the financial support given by CAPES.
CR ABNT. Associacao Brasileira de Normas Tecnicas, 2003, 13904 NBR ABNT
   [Anonymous], 2010, ANN BOOK ASTM STAND
   BENNETT RG, 1988, J AM ACAD DERMATOL, V18, P619, DOI 10.1016/S0190-9622(88)70083-3
   Ellis MJ, 2007, BIOTECHNOL BIOENG, V96, P177, DOI 10.1002/bit.21093
   Fambri L, 2006, MACROMOL SYMP, V234, P20, DOI 10.1002/masy.200650204
   FERREIRA M. L. G., 2005, REV BRASILEIRA CIENC, V12, P84
   HUAIZAN L. N., 2013, THESIS
   Jayakumar R, 2010, BIOTECHNOL ADV, V28, P142, DOI 10.1016/j.biotechadv.2009.11.001
   Knaul J, 1998, J APPL POLYM SCI, V69, P1435, DOI 10.1002/(SICI)1097-4628(19980815)69:7<1435::AID-APP19>3.0.CO;2-S
   Knaul JZ, 1999, J APPL POLYM SCI, V72, P1721, DOI 10.1002/(SICI)1097-4628(19990624)72:13<1721::AID-APP8>3.0.CO;2-V
   MELO K. G. P. C., 2009, THESIS
   Moncrieff RW, 1970, MAN MADE FIBRES, V5th
   Nwe N, 2009, MATERIALS, V2, P374, DOI 10.3390/ma2020374
   PAUL DR, 1968, J APPL POLYM SCI, V12, P383, DOI 10.1002/app.1968.070120301
   Ravi Kumar M. N. V., 1999, B MATER SCI, V22, P905
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Sardenberg Trajano, 2003, Acta ortop. bras., V11, P88, DOI 10.1590/S1413-78522003000200004
   TUZLAKOGLU K., 2007, THESIS
   Zheng H, 2001, J APPL POLYM SCI, V80, P2558, DOI 10.1002/app.1365
   ZIABICKI A, 1985, HIGH SPEED FIBER SPI
NR 20
TC 0
Z9 0
U1 2
U2 21
PU UNIV FED RIO DE JANEIRO, LAB HIDROGENIO
PI RIO DE JANEIRO RJ
PA CIDADE UNIV, ILHA DO FUNDAO, BLOCO I 2000, S L I 146, RIO DE JANEIRO RJ,
   CEP21941-972, BRAZIL
SN 1517-7076
J9 MATERIA-BRAZIL
JI Materia
PD APR-JUN
PY 2016
VL 21
IS 2
BP 525
EP 531
DI 10.1590/S1517-707620160002.0049
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA DO2IZ
UT WOS:000377604600024
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Lv, XM
   Liu, Y
   Wu, F
   Yuan, Y
   Luo, M
AF Lv, Xue-man
   Liu, Yan
   Wu, Fei
   Yuan, Yi
   Luo, Min
TI Human umbilical cord blood-derived stem cells and brain-derived
   neurotrophic factor protect injured optic nerve: viscoelasticity
   characterization
SO NEURAL REGENERATION RESEARCH
LA English
DT Article
DE nerve regeneration; optic nerve injury; human umbilical cord
   blood-derived stem cells; brain-derived neurotrophic factors; creep;
   histomorphology; stress relaxation; viscoelasticity; neural regeneration
ID REGENERATION
AB The optic nerve is a viscoelastic solid-like biomaterial. Its normal stress relaxation and creep properties enable the nerve to resist constant strain and protect it from injury. We hypothesized that stress relaxation and creep properties of the optic nerve change after injury. Moreover, human brain-derived neurotrophic factor or umbilical cord blood-derived stem cells may restore these changes to normal. To validate this hypothesis, a rabbit model of optic nerve injury was established using a clamp approach. At 7 days after injury, the vitreous body received a one-time injection of 50 mu g human brain-derived neurotrophic factor or 1 x 10(6) human umbilical cord blood-derived stem cells. At 30 days after injury, stress relaxation and creep properties of the optic nerve that received treatment had recovered greatly, with pathological changes in the injured optic nerve also noticeably improved. These results suggest that human brain-derived neurotrophic factor or umbilical cord blood-derived stem cell intervention promotes viscoelasticity recovery of injured optic nerves, and thereby contributes to nerve recovery.
C1 [Lv, Xue-man; Yuan, Yi] Jilin Univ, China Japan Union Hosp, Dept Ophthalmol, Changchun 130023, Jilin Province, Peoples R China.
   [Liu, Yan] Jilin Univ, China Japan Union Hosp, Dept Hand Surg, Changchun 130023, Jilin Province, Peoples R China.
   [Wu, Fei] Jilin Univ, Hosp 2, Dept Obstet & Gynaecol, Changchun 130023, Jilin Province, Peoples R China.
   [Luo, Min] Jilin Univ, China Japan Union Hosp, Dept Pain Management, Changchun 130023, Jilin Province, Peoples R China.
RP Yuan, Y (reprint author), Jilin Univ, China Japan Union Hosp, Dept Ophthalmol, Changchun 130023, Jilin Province, Peoples R China.
EM yuany@jlu.edu.cn
OI Yuan, Yi/0000-0002-7007-2857
FU High-Tech Research and Development Program of Jilin Province of China
   [20110492]
FX This study was supported by a grant from High-Tech Research and
   Development Program of Jilin Province of China, No. 20110492.
CR Bi YY, 2009, NEUROSCI RES, V65, P215, DOI 10.1016/j.neures.2009.07.008
   Bodanapally UK, 2013, J NEURO-OPHTHALMOL, V33, P128, DOI 10.1097/WNO.0b013e3182842553
   Chakraborty S K, 2014, Mymensingh Med J, V23, P614
   Chiu CT, 2013, PHARMACOL REV, V65, P105, DOI 10.1124/pr.111.005512
   Dagnelie G, 2012, CURR OPIN NEUROL, V25, P67, DOI 10.1097/WCO.0b013e32834f02c3
   Dahlmann-Noor A, 2010, CAN J OPHTHALMOL, V45, P333, DOI 10.3129/i10-077
   GLUCKMAN E, 1989, NEW ENGL J MED, V321, P1174, DOI 10.1056/NEJM198910263211707
   Hollander A, 2012, INVEST OPHTH VIS SCI, V53, P3973, DOI 10.1167/iovs.11-8350
   Hou X, 2004, YANKE XINJINZHAN, V24, P247
   Hunsberger JG, 2013, AM J TRANSL RES, V5, P450
   Li YQ, 2015, YANKE XINJINZHAN, V35, P125
   Liu Y, 2009, ZHONGHUA CHUANGSHANG, V25, P456
   Lv Q, 2013, SHENJING SUNSHANG YU, V8, P414
   Ma HS, 2004, ZHONGGUO SHENGWU YIX, V23, P274
   Ma HS, 2000, YIYONG SHENGWU LIXUE, V15, P125
   Mar FM, 2014, EMBO REP, V15, P254, DOI 10.1002/embr.201337723
   Munemasa Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034810
   Schwartz M, 2004, BRAIN RES BULL, V62, P467, DOI 10.1016/S0361-9230(03)00076-5
   Yi JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054792
   Zhao TT, 2011, GRAEF ARCH CLIN EXP, V249, P1021, DOI 10.1007/s00417-011-1635-7
   Zrenner E, 2011, P ROY SOC B-BIOL SCI, V278, P1489, DOI 10.1098/rspb.2010.1747
NR 21
TC 1
Z9 1
U1 0
U2 1
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1673-5374
EI 1876-7958
J9 NEURAL REGEN RES
JI Neural Regen. Res.
PD APR
PY 2016
VL 11
IS 4
BP 652
EP 656
DI 10.4103/1673-5374.180753
PG 5
WC Cell Biology; Neurosciences
SC Cell Biology; Neurosciences & Neurology
GA DO1XF
UT WOS:000377572700033
PM 27212930
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Ma, HC
   Yang, GL
   Fu, YH
   Ma, C
   Dong, XL
   Zhang, XF
AF Ma, Hongchao
   Yang, Guoliang
   Fu, Yinghuan
   Ma, Chun
   Dong, Xiaoli
   Zhang, Xiufang
TI Preparation, Characterization and Photocatalytic Properties of BiPO4
   Decorated with Ag/AgBr
SO JOURNAL OF CHEMICAL ENGINEERING OF JAPAN
LA English
DT Article
DE Photodegradation; KN-R; Ag/AgBr Modification; BiPO4
ID VISIBLE-LIGHT PHOTOCATALYST; OH-RELATED DEFECTS; COMPOSITE
   NANOPARTICLES; MAGNETIC CORE; ANTIMICROBIAL ACTIVITY; BIOMATERIAL
   SYSTEM; DEGRADATION; ANATASE; SHELL; ZNO
AB The present study investigates rod-like BiPO4 prepared by a hydrothermal process using bismuth nitrate and sodium dihydrogen phosphate as raw materials. Herein, Ag-AgBr was deposited onto the surface of BiPO4 via a facile precipitation-photoreduction technique. The structure, morphology, composition and optical property of as-synthesized samples were characterized by XRD, SEM, TEM, XPS, DRS and PL techniques. The results showed that introduction of Ag-AgBr did not change the structure and morphology of BiPO4, but extended its optical absorption to visible region. Moreover, the introduction of Ag-AgBr shifted binding energy of elements of BiPO4 to lower values, which implied that a strong interaction exists between Ag-AgBr and BiPO4. The photocatalytic tests showed that the Ag/AgBr/BiPO4 composites possess higher photocatalytic activity for degradation of anthraquinone dye (reactive brilliant blue KN-R) under simulated sunlight, as compared to that of pure BiPO4. The improvement of photocatalytic activity for Ag/AgBr/BiPO4 composites could be ascribed to their good optical absorption and the synergistic action between Ag-AgBr and BiPO4 substrate (the synergistic action effectively retarded recombination of photogenerated carriers in hetero-structured Ag/AgBr/BiPO4).
C1 [Ma, Hongchao; Yang, Guoliang; Fu, Yinghuan; Ma, Chun; Dong, Xiaoli; Zhang, Xiufang] Dalian Polytech Univ, Sch Chem Engn & Mat, 1 Qinggongyuan, Dalian 116034, Peoples R China.
RP Dong, XL; Zhang, XF (reprint author), Dalian Polytech Univ, Sch Chem Engn & Mat, 1 Qinggongyuan, Dalian 116034, Peoples R China.
EM 345961232@qq.com; fuyinghuan@sina.com
FU National Natural Science Foundation of China [21476033]; Program for
   Liaoning Excellent Talents in University [LR2014013]; Cultivation
   Program for Excellent Talents of Science and Technology Department of
   Liaoning Province [201402610]
FX This work was supported by The National Natural Science Foundation of
   China (21476033), Program for Liaoning Excellent Talents in University
   (LR2014013) and Cultivation Program for Excellent Talents of Science and
   Technology Department of Liaoning Province (No. 201402610).
CR Afzal S, 2013, ACS APPL MATER INTER, V5, P4753, DOI 10.1021/am400002k
   Cao J, 2013, CHEM ENG J, V228, P482, DOI 10.1016/j.cej.2013.05.008
   Chekroun M. Z., 2012, J MOD PHYS, V3, P102
   Deng ZW, 2008, J PHYS CHEM B, V112, P16, DOI 10.1021/jp077662w
   Fulekar MH, 2014, RSC ADV, V4, P10097, DOI 10.1039/c3ra44488k
   Gao EP, 2013, NANOSCALE, V5, P11248, DOI 10.1039/c3nr03370h
   Hernandez-Alonso MD, 2009, ENERG ENVIRON SCI, V2, P1231, DOI 10.1039/b907933e
   Hu C, 2006, J PHYS CHEM B, V110, P4066, DOI 10.1021/jp0564400
   Hu C, 2010, J AM CHEM SOC, V132, P857, DOI 10.1021/ja907792d
   Ibhadon AO, 2013, CATALYSTS, V3, P189, DOI 10.3390/catal3010189
   Keane DA, 2014, CATAL SCI TECHNOL, V4, P1211, DOI 10.1039/c4cy00006d
   Kim HG, 2005, ANGEW CHEM INT EDIT, V44, P4585, DOI 10.1002/anie.200500064
   Ko SH, 2011, NANO LETT, V11, P666, DOI 10.1021/nl1037962
   Li KB, 2014, APPL SURF SCI, V320, P1, DOI 10.1016/j.apsusc.2014.09.060
   Liang CH, 2001, APPL PHYS LETT, V78, P3202, DOI 10.1063/1.1374498
   Liu YF, 2014, APPL CATAL B-ENVIRON, V147, P851, DOI 10.1016/j.apcatb.2013.09.050
   Lv YH, 2014, J MATER CHEM A, V2, P1174, DOI 10.1039/c3ta13841k
   Pan CS, 2012, APPL CATAL B-ENVIRON, V115, P314, DOI 10.1016/j.apcatb.2011.12.030
   Pan CS, 2012, ADV FUNCT MATER, V22, P1518, DOI 10.1002/adfm.201102306
   Pan CS, 2010, ENVIRON SCI TECHNOL, V44, P5570, DOI 10.1021/es101223n
   PAPP J, 1993, CHEM MATER, V5, P284, DOI 10.1021/cm00027a009
   Pawinrat P, 2009, CATAL COMMUN, V10, P1380, DOI 10.1016/j.catcom.2009.03.002
   Qi B, 2012, MATER CHEM PHYS, V135, P549, DOI 10.1016/j.matchemphys.2012.05.023
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rana S, 2005, MAT SCI ENG B-SOLID, V119, P144, DOI 10.1016/j.mseb.2005.02.043
   Rawat J, 2007, MATER SCI TECH-LOND, V23, P97, DOI 10.1179/174328407X158488
   Rawat J, 2007, MAT SCI ENG C-BIO S, V27, P540, DOI 10.1016/j.msec.2006.05.021
   Sclafani A, 1998, J PHOTOCH PHOTOBIO A, V113, P181, DOI 10.1016/S1010-6030(97)00319-5
   Venkatasubramanian R, 2008, MATER SCI TECH-LOND, V24, P589, DOI 10.1179/174328408X282065
   Wang DS, 2012, J MATER CHEM, V22, P4847, DOI 10.1039/c2jm14628b
   Wang DS, 2011, DESALINATION, V270, P174, DOI 10.1016/j.desal.2010.11.042
   Wang H, 2011, COMM COM INF SC, V136, P1
   Xu YG, 2013, COLLOID SURFACE A, V436, P474, DOI 10.1016/j.colsurfa.2013.06.005
   Yan TJ, 2013, CHEM ENG J, V232, P564, DOI 10.1016/j.cej.2013.08.021
   Yan X, 2015, APPL CATAL B-ENVIRON, V164, P297, DOI 10.1016/j.apcatb.2014.09.046
   Yu JH, 2003, ACCOUNTS CHEM RES, V36, P481, DOI 10.1021/ar0201557
   Zhang J, 2015, CATAL COMMUN, V59, P30, DOI 10.1016/j.catcom.2014.09.041
   Zhang SB, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.075205
NR 39
TC 2
Z9 2
U1 2
U2 62
PU SOC CHEMICAL ENG JAPAN
PI BUNKYO KU TOKYO
PA KYORITSU BUILDING 4-16-19 KOHINATA, BUNKYO KU TOKYO, 112, JAPAN
SN 0021-9592
J9 J CHEM ENG JPN
JI J. Chem. Eng. Jpn.
PD APR
PY 2016
VL 49
IS 4
BP 366
EP 371
DI 10.1252/jcej.15we064
PG 6
WC Engineering, Chemical
SC Engineering
GA DO1MB
UT WOS:000377541200008
DA 2018-10-20
ER

PT J
AU Christensen, BB
AF Christensen, Bjorn Borsoe
TI Autologous tissue transplantations for osteochondral repair
SO DANISH MEDICAL JOURNAL
LA English
DT Article
ID ARTICULAR-CARTILAGE REPAIR; 2-YEAR FOLLOW-UP; FULL-THICKNESS DEFECTS;
   CHARACTERIZED CHONDROCYTE IMPLANTATION; COMPOSITE MULTILAYERED
   BIOMATERIAL; PARTICULATED JUVENILE CARTILAGE; CONTINUOUS PASSIVE MOTION;
   CRUCIATE LIGAMENT INJURY; LARGE-VOLUME DEFECTS; QUALITY-OF-LIFE
C1 [Christensen, Bjorn Borsoe] Aarhus Univ Hosp, Orthoped Res Lab, Norrebrogade 44,Build 1A,1 Floor, Aarhus, Denmark.
RP Christensen, BB (reprint author), Aarhus Univ Hosp, Orthoped Res Lab, Norrebrogade 44,Build 1A,1 Floor, Aarhus, Denmark.
EM bjornbc@gmail.com
FU Novo Nordisk Foundation; Gigtforeningen; Danish Orthopaedic Society
   Foundation; Aarhus University
FX I would like to acknowledge The Novo Nordisk Foundation for providing
   financial support for study 1 and study 4, Gigtforeningen for the
   financial support of study 1, Danish Orthopaedic Society Foundation for
   sponsoring a number of international conferences and Aarhus University
   for general financial support.
CR Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716
   Adams SB, 2014, ARTHROSC TEC, V3, pE533, DOI 10.1016/j.eats.2014.06.004
   Adkisson HD, 2010, AM J SPORT MED, V38, P1324, DOI 10.1177/0363546510361950
   ALBRECHT FH, 1983, FORTSCHR MED, V101, P1650
   Anders S., 2008, MATRIX ASS AUTOLOGOU
   [Anonymous], 2015, ELLEGAARD GOTTINGEN
   Archer CW, 2003, INT J BIOCHEM CELL B, V35, P401, DOI 10.1016/S1357-2725(02)00301-1
   Aroen A, 2004, AM J SPORT MED, V32, P211, DOI 10.1177/0363546503259345
   Barber FA, 2011, ARTHROSCOPY, V27, P60, DOI 10.1016/j.arthro.2010.06.023
   Bartlett W, 2005, J BONE JOINT SURG BR, V87B, P640, DOI 10.1302/0301-620X.87B5.15905
   Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a
   Bekkers JEJ, 2009, OSTEOARTHR CARTILAGE, V17, P1434, DOI 10.1016/j.joca.2009.04.019
   Bekkers JEJ, 2013, AM J SPORT MED, V41, P1290, DOI 10.1177/0363546513483536
   Benthien JP, 2011, KNEE SURG SPORT TR A, V19, P543, DOI 10.1007/s00167-010-1271-5
   Bentley G, 2012, J BONE JOINT SURG BR, V94B, P504, DOI 10.1302/0301-620X.94B4.27495
   Berruto M, 2014, AM J SPORT MED, V42, P1607, DOI 10.1177/0363546514530292
   BODEN BP, 1997, J AM ACAD ORTHOP SUR, V5, P47, DOI DOI 10.5435/00124635-199701000-00006
   Boenisch T., 2001, IMMUNOCHEMICAL STAIN
   Bonal D, 2016, ANN FOREST SCI, V73, P27, DOI 10.1007/s13595-015-0522-5
   Bonasia D. E., 2015, KNEE SURG SPORT TRAU
   Bonasia DE, 2011, AM J SPORT MED, V39, P2355, DOI 10.1177/0363546511417172
   Bonner Kevin F, 2010, J Knee Surg, V23, P109
   Boughanem J, 2011, AM J SPORT MED, V39, P2212, DOI 10.1177/0363546511416594
   Brandt KD, 2006, ANN RHEUM DIS, V65, P1261, DOI 10.1136/ard.2006.058347
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Brittberg M, 2000, ICRS CARTILAGE INJUR
   Brittberg M., 2000, OSTEOLOGIE, V9, P17
   Brown TD, 2006, J ORTHOP TRAUMA, V20, P739, DOI 10.1097/01.bot.0000246468.80635.ef
   Buckwalter J A, 2014, Iowa Orthop J, V34, P44
   Burr DB, 2003, RHEUM DIS CLIN N AM, V29, P675, DOI 10.1016/S0889-857X(03)00061-9
   Cahill BR, 1995, J AM ACAD ORTHOP SUR, V3, P237
   Carmont MR, 2009, ARTHROSCOPY, V25, P810, DOI 10.1016/j.arthro.2009.01.023
   Chahal J, 2013, ARTHROSCOPY, V29, P575, DOI 10.1016/j.arthro.2012.12.002
   Christensen B. B., 2015, KNEE SURG SPORT TRAU
   Christensen Bjorn Borsoe, 2015, J Exp Orthop, V2, P13, DOI 10.1186/s40634-015-0031-3
   Christensen BB, 2015, CARTILAGE, V6, P166, DOI 10.1177/1947603515580983
   Chu CR, 2010, TISSUE ENG PART B-RE, V16, P105, DOI [10.1089/ten.teb.2009.0452, 10.1089/ten.TEB.2009.0452]
   Coetzee JC, 2013, FOOT ANKLE INT, V34, P1205, DOI 10.1177/1071100713485739
   Cole BJ, 2011, AM J SPORT MED, V39, P1170, DOI 10.1177/0363546511399382
   CRAWFURD EJP, 1990, J BONE JOINT SURG BR, V72, P320
   Curl WW, 1997, ARTHROSCOPY, V13, P456, DOI 10.1016/S0749-8063(97)90124-9
   Dai Z, 2013, J INT MED RES, V41, P688, DOI 10.1177/0300060513476591
   DAINER R D, 1988, Arthroscopy, V4, P267, DOI 10.1016/S0749-8063(88)80042-2
   Davidson P. A., 2007, ARTHROSCOPY S, V23, pe22
   de Matos LL, 2010, BIOMARK INSIGHTS, V5, P9
   de Windt TS, 2013, AM J SPORT MED, V41, P1695, DOI 10.1177/0363546512473258
   DeGroot J, 1999, ARTHRITIS RHEUM, V42, P1003, DOI 10.1002/1529-0131(199905)42:5<1003::AID-ANR20>3.0.CO;2-K
   Delcogliano Marco, 2014, Joints, V2, P102
   Delcogliano M, 2014, KNEE SURG SPORT TR A, V22, P1260, DOI 10.1007/s00167-013-2717-3
   Dhollander AAM, 2012, ARTHROSCOPY, V28, P225, DOI 10.1016/j.arthro.2011.07.017
   Dillon CF, 2006, J RHEUMATOL, V33, P2271
   Dines JS, 2008, ARTHROSCOPY, V24, P62, DOI 10.1016/j.arthro.2007.07.025
   Eckstein F, 2006, J ANAT, V208, P491, DOI 10.1111/j.1469-7580.2006.00546.x
   Gelber PE, 2014, KNEE, V21, P827, DOI 10.1016/j.knee.2014.04.013
   England T. N., 2002, CONTROLLED TRIAL ART
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Eyre D, 2002, ARTHRITIS RES, V4, P30, DOI 10.1186/ar380
   Farr J., 2014, PRACT CLIN APPL, V14, P9
   Farr J, 2014, AM J SPORT MED, V42, P1417, DOI 10.1177/0363546514528671
   Farr J, 2011, CARTILAGE, V2, P346, DOI 10.1177/1947603511405838
   Farr J, 2012, J KNEE SURG, V25, P23, DOI 10.1055/s-0031-1299652
   Filardo G, 2014, OSTEOARTHR CARTILAGE, V22, P557, DOI 10.1016/j.joca.2014.01.004
   Filardo G, 2013, KNEE, V20, P570, DOI 10.1016/j.knee.2013.05.007
   Filardo G, 2014, INT ORTHOP, V38, P1905, DOI 10.1007/s00264-014-2322-1
   Filardo G, 2013, AM J SPORT MED, V41, P1786, DOI 10.1177/0363546513490658
   Foldager CB, 2015, CARTILAGE, V6, P123, DOI 10.1177/1947603514560655
   Foldager CB, 2014, CARTILAGE, V5, P123, DOI 10.1177/1947603513518217
   Foldager CB, 2013, DAN MED J, V60
   Fowler Donald E 3rd, 2009, J Knee Surg, V22, P372
   Fox AJS, 2009, SPORTS HEALTH, V1, P461, DOI 10.1177/1941738109350438
   Frisbie DD, 2006, VET COMP ORTHOPAED, V19, P142
   Frisbie DD, 2009, AM J SPORT MED, V37, p71S, DOI 10.1177/0363546509348478
   Gao Y., 2014, BIOMED RES INT, V2014
   Garcia EJ, 2010, J BONE JOINT SURG AM, V92A, P1774, DOI 10.2106/JBJS.I.01470
   Giza E, 2014, FOOT ANKLE INT, V35, P1087, DOI 10.1177/1071100714548704
   Gobbi A, 2005, KNEE SURG SPORT TR A, V13, P213, DOI 10.1007/s00167-004-0499-3
   Gobbi A., 2013, KNEE SURG SPORT TR A, P1986
   Goldring MB, 2006, BEST PRACT RES CL RH, V20, P1003, DOI 10.1016/j.berh.2006.06.003
   Gomoll AH, 2007, ORTHOPEDICS, V30, P487
   Gomoll AH, 2010, KNEE SURG SPORT TR A, V18, P434, DOI 10.1007/s00167-010-1072-x
   Gooding CR, 2006, KNEE, V13, P203, DOI 10.1016/j.knee.2006.02.011
   Goodman S, 2007, PLOS MED, V4, P773, DOI 10.1371/journal.pmed.0040168
   Gotterbarm T., 2008, MINIPIG MODEL EXPT C, P71
   Goyal D, 2013, ARTHROSCOPY, V29, P1579, DOI 10.1016/j.arthro.2013.05.027
   Grimm NL, 2014, CLIN SPORT MED, V33, P181, DOI 10.1016/j.csm.2013.11.006
   Gudas R, 2005, ARTHROSCOPY, V21, P1066, DOI 10.1016/j.arthro.2005.06.018
   Gudas R, 2012, AM J SPORT MED, V40, P2499, DOI 10.1177/0363546512458763
   Hambly K, 2008, AM J SPORT MED, V36, P1695, DOI 10.1177/0363546508317718
   Hangody L, 1998, ORTHOPEDICS, V21, P751
   Hangody L, 2003, J BONE JOINT SURG AM, V85A, P25, DOI 10.2106/00004623-200300002-00004
   Harman BD, 2006, AM J SPORT MED, V34, P913, DOI 10.1177/0363546505283257
   HART DJ, 1993, J RHEUMATOL, V20, P331
   Heir S, 2010, AM J SPORT MED, V38, P231, DOI 10.1177/0363546509352157
   Herberhold C, 1998, MAGNET RESON MED, V39, P843, DOI 10.1002/mrm.1910390522
   Higgins LD, 2007, JOINT BONE SPINE, V74, P594, DOI 10.1016/j.jbspin.2007.01.036
   Hindle P, 2014, KNEE SURG SPORT TR A, V22, P1235, DOI 10.1007/s00167-013-2493-0
   Hjelle K, 2002, ARTHROSCOPY, V18, P730, DOI 10.1053/jars.2002.32839
   Hoemann C, 2011, CARTILAGE, V2, P153, DOI 10.1177/1947603510397535
   Hootman JM, 2006, ARTHRITIS RHEUM, V54, P226, DOI 10.1002/art.21562
   HUGHSTON JC, 1984, J BONE JOINT SURG AM, V66A, P1340, DOI 10.2106/00004623-198466090-00003
   HUNTER W, 1743, PHILOS T R SOC LOND, V42, P514, DOI DOI 10.1098/RSTL.1742.0079)
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Imhof H, 2000, INVEST RADIOL, V35, P581, DOI 10.1097/00004424-200010000-00004
   INDELICATO PA, 1985, CLIN ORTHOP RELAT R, P77
   Ioannidis J. P. a, 2005, PLOS MED, V2, P0696
   Jackson DW, 2001, J BONE JOINT SURG AM, V83A, P53, DOI 10.2106/00004623-200101000-00008
   Jacobs TW, 1996, J NATL CANCER I, V88, P1054, DOI 10.1093/jnci/88.15.1054
   Jay GD, 2014, MATRIX BIOL, V39, P17, DOI 10.1016/j.matbio.2014.08.008
   Jiang C., 2007, REPAIR PORCINE ARTIC, P1277
   JOHNSON L L, 1990, Arthroscopy, V6, P179, DOI 10.1016/0749-8063(90)90073-M
   Johnson LL, 2012, CARTILAGE, V3, P86, DOI 10.1177/1947603511413568
   Johnson LL, 2014, CARTILAGE, V5, P86, DOI 10.1177/1947603513518216
   JONES GM, 1971, J PHYSIOL-LONDON, V219, P729, DOI 10.1113/jphysiol.1971.sp009685
   Joshi N, 2012, AM J SPORT MED, V40, P1289, DOI 10.1177/0363546512441585
   Jurgensen I, 2002, ARTHROSCOPY, V18, P378, DOI 10.1053/jars.2002.32237
   Kaab MJ, 1998, J ANAT, V193, P23, DOI 10.1046/j.1469-7580.1998.19310023.x
   Kao YJ, 2011, PHYSICIAN SPORTSMED, V39, P60, DOI 10.3810/psm.2011.11.1940
   Karthikeyan S, 2012, AM J SPORT MED, V40, P2725, DOI 10.1177/0363546512465400
   Kessler JI, 2014, AM J SPORT MED, V42, P320, DOI 10.1177/0363546513510390
   Kilborn SH, 2002, CONTEMP TOP LAB ANIM, V41, P21
   Knutsen G, 2007, J BONE JOINT SURG AM, V89A, P2105, DOI 10.2106/JBJS.G.00003
   Kocher MS, 2006, AM J SPORT MED, V34, P1181, DOI 10.1177/0363546506290127
   Kocher MS, 2001, AM J SPORT MED, V29, P562, DOI 10.1177/03635465010290050701
   Kock NB, 2008, KNEE SURG SPORT TR A, V16, P461, DOI 10.1007/s00167-008-0494-1
   Kon E, 2014, KNEE SURG SPORT TR A, V22, P1452, DOI 10.1007/s00167-013-2467-2
   Kon E, 2010, INJURY, V41, P693, DOI 10.1016/j.injury.2009.11.014
   Kon E., 2012, TREAT OSTEOCHONDRITI, V1, P1
   Kon E, 2014, J MATER SCI-MATER M, V25, P2437, DOI 10.1007/s10856-014-5188-2
   Kon E, 2014, J SPORT REHABIL, V23, P270, DOI [10.1123/JSR.2013-0054, 10.1123/jsr.2013-0054]
   Kon E, 2014, AM J SPORT MED, V42, P158, DOI 10.1177/0363546513505434
   Kon E, 2011, AM J SPORT MED, V39, P1180, DOI 10.1177/0363546510392711
   Kon E, 2009, KNEE SURG SPORT TR A, V17, P1312, DOI 10.1007/s00167-009-0819-8
   Kruse DL, 2012, J FOOT ANKLE SURG, V51, P218, DOI 10.1053/j.jfas.2011.10.027
   Krych AJ, 2012, J BONE JOINT SURG AM, V94A, P971, DOI 10.2106/JBJS.K.00815
   LEFKOE TP, 1993, J ORTHOP TRAUMA, V7, P458, DOI 10.1097/00005131-199310000-00009
   Lexer E, 1908, SURG GYNECOL OBSTET, V6, P601
   Leyh M, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0453-9
   Lim H. C., 2012, CLIN ORTHOP RELAT RE
   Lind M, 2008, CONNECT TISSUE RES, V49, P437, DOI 10.1080/03008200802325037
   LINDEN B, 1976, ACTA ORTHOP SCAND, V47, P664, DOI 10.3109/17453677608988756
   LINDEN B, 1977, J BONE JOINT SURG AM, V59, P769, DOI 10.2106/00004623-197759060-00010
   Liu H, 2013, AM J SPORT MED, V41, P2658, DOI 10.1177/0363546513502945
   Louisia S, 2003, KNEE SURG SPORT TR A, V11, P33, DOI 10.1007/s00167-002-0320-0
   Lu YL, 2006, J ORTHOP RES, V24, P1261, DOI 10.1002/jor.20135
   Magnuson PB, 1941, SURG GYNECOL OBSTET, V73, P1
   Mainil-Varlet P, 2001, OSTEOARTHR CARTILAGE, V9, pS6, DOI 10.1053/joca.2001.0438
   Mainil-Varlet P, 2010, AM J SPORT MED, V38, P880, DOI 10.1177/0363546509359068
   Makino A, 2005, AM J SPORT MED, V33, P1499, DOI 10.1177/0363546505274717
   Malinin T, 2000, OSTEOARTHR CARTILAGE, V8, P483, DOI 10.1053/joca.2000.0324
   Marlovits S, 2006, EUR J RADIOL, V57, P16, DOI 10.1016/j.ejrad.2005.08.007
   Marlovits S, 2004, EUR J RADIOL, V52, P310, DOI 10.1016/j.ejrad.2004.03.014
   Marmotti A, 2013, KNEE SURG SPORT TR A, V21, P1819, DOI 10.1007/s00167-012-2244-7
   Marmotti A, 2012, KNEE SURG SPORT TR A, V20, P2590, DOI 10.1007/s00167-012-1920-y
   Marmotti A, 2013, EUR CELLS MATER, V26, P15, DOI 10.22203/eCM.v026a02
   MARSHALL M, 1972, RES EXP MED, V157, P300, DOI 10.1007/BF01852074
   Matricali GA, 2010, ACTA ORTHOP BELG, V76, P669
   McCarthy H. S., 2015, CARTILAGE
   Messner K, 1996, ACTA ORTHOP SCAND, V67, P165, DOI 10.3109/17453679608994664
   Minas T, 2009, AM J SPORT MED, V37, P902, DOI 10.1177/0363546508330137
   Mitsuyama H, 2007, OSTEOARTHR CARTILAGE, V15, P559, DOI 10.1016/j.joca.2006.10.017
   MOW VC, 1992, BIOMATERIALS, V13, P67, DOI 10.1016/0142-9612(92)90001-5
   Nordenvall R, 2012, AM J SPORT MED, V40, P1808, DOI 10.1177/0363546512449306
   Nover A. B., 2015, LONG TERM STORAGE PR
   ODRISCOLL SW, 1988, J BONE JOINT SURG AM, V70A, P595, DOI 10.2106/00004623-198870040-00017
   Pace JM, 2003, MATRIX BIOL, V22, P3, DOI 10.1016/S0945-053X(03)00007-6
   Paget J., 1851, MON J MED SCI    SEP
   Pallante AL, 2012, AM J SPORT MED, V40, P1814, DOI 10.1177/0363546512449321
   Parkkari J, 2008, BRIT J SPORT MED, V42, P422, DOI 10.1136/bjsm.2008.046185
   Pascual-Garrido C, 2009, SPORTS HEALTH, V1, P326, DOI 10.1177/1941738109334216
   Pena E, 2007, COMPUT BIOL MED, V37, P376, DOI 10.1016/j.compbiomed.2006.04.004
   Pestka JM, 2012, AM J SPORT MED, V40, P325, DOI 10.1177/0363546511425651
   Petersen JP, 2008, J MATER SCI-MATER M, V19, P2029, DOI 10.1007/s10856-007-3291-3
   Peterson L, 2003, J BONE JOINT SURG AM, V85A, P17, DOI 10.2106/00004623-200300002-00003
   Peterson L, 2000, CLIN ORTHOP RELAT R, P212
   PINEDA S, 1992, ACTA ANAT, V143, P335
   PRIDIE KH, 1959, J BONE JOINT SURG BR, V41, P618
   Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1
   Prodromos CC, 2007, ARTHROSCOPY, V23, P1320, DOI 10.1016/j.arthro.2007.07.003
   Pufe T, 2004, MATRIX BIOL, V23, P267, DOI 10.1016/j.matbio.2004.06.003
   RADIN EL, 1986, CLIN ORTHOP RELAT R, P34
   Redman SN, 2004, OSTEOARTHR CARTILAGE, V12, P106, DOI 10.1016/j.joca.2002.12.001
   Rhee DK, 2005, J CLIN INVEST, V115, P622, DOI 10.1172/JCI200522263
   Riboh J. C., 2015, CURR REV MUSCULOSKEL
   RISPAT G, 1993, LAB ANIM, V27, P368, DOI 10.1258/002367793780745561
   Roos EM, 2009, AM J SPORT MED, V37, P1042, DOI 10.1177/0363546509334226
   Russell WMS B. K., 1992, PRINCIPLES HUMANE EX
   Sage A, 2009, AMJ RHINOL ALLERGY, V23, P486, DOI 10.2500/ajra.2009.23.3347
   Saithna A., 2008, BRIT ORTH ASS C
   Saris D, 2014, AM J SPORT MED, V42, P1384, DOI 10.1177/0363546514528093
   Saris DBF, 2008, AM J SPORT MED, V36, P235, DOI 10.1177/0363546507311095
   Saris DBF, 2009, AM J SPORT MED, V37, p10S, DOI 10.1177/0363546509350694
   Sasaki K, 2012, INT ORTHOP, V36, P2243, DOI 10.1007/s00264-012-1648-9
   Schlichting K, 2008, AM J SPORT MED, V36, P2379, DOI 10.1177/0363546508322899
   SCHUMACHER BL, 1994, ARCH BIOCHEM BIOPHYS, V311, P144, DOI 10.1006/abbi.1994.1219
   Sgaglione NA, 2009, ARTHROSCOPY, V25, P815, DOI 10.1016/j.arthro.2009.04.067
   Shortkroff S, 1996, BIOMATERIALS, V17, P147, DOI 10.1016/0142-9612(96)85759-0
   Simianer H, 2010, J PHARMACOL TOX MET, V62, P221, DOI 10.1016/j.vascn.2010.05.004
   Simonian PT, 1998, AM J SPORT MED, V26, P491, DOI 10.1177/03635465980260040201
   Skagen P. S., 2014, MICROSC RESEACH, V2, P67
   Smith GD, 2005, ARTHROSCOPY, V21, P1462, DOI 10.1016/j.arthro.2005.09.007
   Smolders JMN, 2010, ACTA ORTHOP BELG, V76, P208
   Solheim E., 2014, KNEE SURG SPORT TRAU
   Steadman JR, 2001, CLIN ORTHOP RELAT R, pS362, DOI 10.1097/00003086-200110001-00033
   Stevens HY, 2014, CARTILAGE, V5, P74, DOI 10.1177/1947603513515483
   Stone KR, 2014, KNEE, V21, P1145, DOI 10.1016/j.knee.2014.09.003
   Stone KR, 2006, ARTHROSCOPY, V22, P291, DOI 10.1016/j.arthro.2005.12.051
   Tampieri A, 2003, J BIOMED MATER RES A, V67A, P618, DOI 10.1002/jbm.a.10039
   Tampieri A, 2008, BIOMATERIALS, V29, P3539, DOI 10.1016/j.biomaterials.2008.05.008
   Tanner SM, 2007, AM J SPORT MED, V35, P1450, DOI 10.1177/0363546507301883
   Tew SR, 2000, ARTHRITIS RHEUM-US, V43, P215, DOI 10.1002/1529-0131(200001)43:1<215::AID-ANR26>3.0.CO;2-X
   Tompkins M, 2013, ARTHROSCOPY, V29, P1661, DOI 10.1016/j.arthro.2013.05.021
   Tower D. E., 2015, J FOOT ANKLE SURG
   Van den Borne MPJ, 2007, OSTEOARTHR CARTILAGE, V15, P1397, DOI 10.1016/j.joca.2007.05.005
   van Osch GJVM, 2009, J CELL MOL MED, V13, P792, DOI 10.1111/j.1582-4934.2009.00789.x
   Vanlauwe J, 2011, AM J SPORT MED, V39, P2566, DOI 10.1177/0363546511422220
   Vasara AI, 2005, CLIN ORTHOP RELAT R, P233, DOI 10.1097/01.blo.0000150567.00022.2e
   Verdonk P., 2015, BONE JOINT J B, V97-B, P318
   W. Zimmer Biomet, ZIMMER COM
   Widuchowski W, 2008, ACTA CHIR ORTHOP TR, V75, P382
   Widuchowski W, 2007, KNEE, V14, P177, DOI 10.1016/j.knee.2007.02.001
   Williams J S Jr, 1998, Am J Knee Surg, V11, P221
   Williams Riley J, 2008, Instr Course Lect, V57, P563
   Yaziji H, 2006, ADV ANAT PATHOL, V13, P238, DOI 10.1097/01.pap.0000213041.39070.2f
   Yoshida S, 1998, CLIN ORTHOP RELAT R, P162
   Zheng M.-H., 2007, MATRIX INDUCED AUTOL
   Zhou SD, 2004, ARTHRITIS RHEUM, V50, P3915, DOI 10.1002/art.20675
   Zimmer, DENOVO NT LONG DAT C
   Zingler C., 2015, OSTEOARTHR CARTILAGE, P5
NR 228
TC 4
Z9 4
U1 1
U2 2
PU DANISH MEDICAL ASSOC
PI COPENHAGEN
PA TRONDHJEMSGADE 9, DK-2100 COPENHAGEN, DENMARK
SN 2245-1919
J9 DAN MED J
JI Dan. Med. J.
PD APR
PY 2016
VL 63
IS 4
AR B5236
PG 27
WC Medicine, General & Internal
SC General & Internal Medicine
GA DN2TQ
UT WOS:000376916300012
DA 2018-10-20
ER

PT J
AU Lv, XG
   Li, Z
   Wang, HP
   Xu, YM
   Feng, C
AF Lv, XiangGuo
   Li, Zhe
   Wang, HuaPing
   Xu, YueMin
   Feng, Chao
TI The Application of Oxygen Generating Keratin/Silk Fibroin for Urethral
   Reconstruction: A Preliminary Study
SO JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING
LA English
DT Article
DE Keratin; Silk Fibroin; Oxygen Generating; Urethral Stricture; Tissue
   Engineering
ID TISSUE REGENERATION; CALCIUM PEROXIDE; SCAFFOLDS
AB The aim of this study is to assess the efficacy and feasibility of using oxygen generating keratin/silk fibroin for the urethroplasty in animal model. The scaffold were manufactured by blending the keratin, silk fibroin, gelatin and calcium peroxide (CPO) in certain concentration. The scanning electronic microscopy (SEM), MTT assay, oxygen releasing test were performed in order to evaluate the characters of scaffold in vitro. Then, the scaffold was used for repairing the urethral defection in rabbit model. The SEM showed typical core shell particles, embedded into the scaffold. The cytotoxicity assessments showed non-cytotoxicity of scaffold. The oxygen releasing test exhibited that scaffold could release oxygen for at least 2 weeks. Three months after implantation, the study group showed the patent urethra lumen by urthrography, while obvious fistula was noticed in the control group. In histological examination, intact epithelial layers, organized muscle bundles could be observed in the study group. However, only discontinuous epithelial layer was seen near the implanted area and no muscle bundles were revealed in the control group. At the end of 6 months, similar results were found in those groups. Our study demonstrated that oxygen generating keratin/silk fibroin scaffold could be a potential biomaterial for urethral reconstruction.
C1 [Lv, XiangGuo; Xu, YueMin; Feng, Chao] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Urol, Shanghai 200233, Peoples R China.
   [Li, Zhe; Wang, HuaPing] Donghua Univ, Coll Mat Sci & Engn, State Key Lab Modificat Chem Fibers & Polymer Mat, Shanghai 210620, Peoples R China.
   [Xu, YueMin] Shanghai Eastern Urol Reconstruct & Repair Inst, Shanghai 200233, Peoples R China.
RP Feng, C (reprint author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Urol, Shanghai 200233, Peoples R China.
FU National Natural Science Foundation of China [81100488]
FX There is no direct financial interest. Supproted by National Natural
   Science Foundation of China (81100488).
CR Agrawal CM, 1997, J BIOMED MATER RES, V38, P105, DOI 10.1002/(SICI)1097-4636(199722)38:2<105::AID-JBM4>3.0.CO;2-U
   Atala A, 2002, UROL CLIN N AM, V29, P485, DOI 10.1016/S0094-0143(02)00033-2
   BAKER AM, 1987, PLANT SOIL, V99, P357, DOI 10.1007/BF02370881
   Chandrasekharam V V S, 2013, Indian J Urol, V29, P48, DOI 10.4103/0970-1591.109984
   El-Kassaby AW, 2003, J UROLOGY, V169, P170, DOI 10.1016/S0022-5347(05)64060-8
   Hanh DN, 2005, ENVIRON TECHNOL, V26, P581, DOI 10.1080/09593332608618543
   Harrison BS, 2007, BIOMATERIALS, V28, P4628, DOI 10.1016/j.biomaterials.2007.07.003
   Jia WS, 2015, BIOMATERIALS, V69, P45, DOI 10.1016/j.biomaterials.2015.08.009
   Li C, 2013, UROLOGY, V81, P1075, DOI 10.1016/j.urology.2013.01.041
   Macedo A, 2012, CURR OPIN UROL, V22, P447, DOI 10.1097/MOU.0b013e328357bc62
   Villoldo GM, 2013, UROLOGY, V81, DOI 10.1016/j.urology.2013.02.023
   Nomi M, 2002, MOL ASPECTS MED, V23, P463, DOI 10.1016/S0098-2997(02)00008-0
   Oh SH, 2009, BIOMATERIALS, V30, P757, DOI 10.1016/j.biomaterials.2008.09.065
   Orabi H, 2013, SCI WORLD J, DOI 10.1155/2013/154564
   Palminteri E, 2007, EUR UROL, V51, P1695, DOI 10.1016/j.eururo.2006.12.016
   Radisic M, 2006, TISSUE ENG, V12, P2077, DOI 10.1089/ten.2006.12.2077
   Sahoo S, 2010, J BIOMED MATER RES B, V95B, P19, DOI 10.1002/jbm.b.31678
   Simaioforidis V, 2013, TISSUE ENG PART B-RE, V19, P413, DOI [10.1089/ten.teb.2012.0737, 10.1089/ten.TEB.2012.0737]
   Tanabe T, 2002, BIOMATERIALS, V23, P817, DOI 10.1016/S0142-9612(01)00187-9
   Vasconcelos A, 2008, BIOMACROMOLECULES, V9, P1299, DOI 10.1021/bm7012789
   Wang D, 2015, SPR GEOL, P1, DOI 10.1007/978-3-662-46557-8
NR 21
TC 1
Z9 1
U1 3
U2 17
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2157-9083
EI 2157-9091
J9 J BIOMATER TISS ENG
JI J. Biomater. Tissue Eng.
PD APR
PY 2016
VL 6
IS 4
BP 295
EP 300
DI 10.1166/jbt.2016.1444
PG 6
WC Cell & Tissue Engineering
SC Cell Biology
GA DM5WH
UT WOS:000376420600006
DA 2018-10-20
ER

PT J
AU Zhou, CX
   Lei, FY
   Chodosh, J
   Paschalis, EI
AF Zhou, Chengxin
   Lei, Fengyang
   Chodosh, James
   Paschalis, Eleftherios I.
TI The Role of Titanium Surface Microtopography on Adhesion, Proliferation,
   Transformation, and Matrix Deposition of Corneal Cells
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Article
DE titanium; biocompatibility; implants; cornea; surface roughness;
   alpha-smooth muscle actin; collagen deposition
ID BOSTON TYPE-1 KERATOPROSTHESIS; IN-VITRO; DIFFERENTIATION; FIBROBLASTS;
   EXPRESSION; OUTCOMES; KINASE; MYOFIBROBLASTS; ENDOTHELIUM; TOPOGRAPHY
AB PURPOSE. Titanium (Ti) is an excellent implantable biomaterial that can be further enhanced by surface topography optimization. Despite numerous data from orthopedics and dentistry, the effect of Ti surface topography on ocular cells is still poorly understood. In light of the recent adaptation of Ti in the Boston Keratoprosthesis artificial cornea, we attempted to perform an extended evaluation of the effect of Ti surface topography on corneal cell adhesion, proliferation, cytotoxicity, transformation, and matrix deposition.
   METHODS. Different surface topographies were generated on medical grade Ti-6Al-4V-ELI (extra-low interstitial), with linearly increased roughness (polished to grit blasted). Biological response was evaluated in vitro using human corneal limbal epithelial (HCLE) cells, stromal fibroblasts (HCF), and endothelial cells (HCEnC).
   RESULTS. None of the Ti surface topographies caused cytotoxicity to any of the three corneal cell types. However, rough Ti surface inhibited HCLE and HCF cell adhesion and proliferation, while HCEnC proliferation was unaffected. Long-term experiments with HCF revealed that rough Ti surface with R-a (the arithmetic average of the profile height from the mean line) >= 1.15 mu m suppressed HCF focal adhesion kinase phosphorylation, changed fibroblast morphology, and caused less aligned and reduced deposition of collagen matrix as compared to smooth Ti (R-a <= 0.08 mu m). In the presence of transforming growth factor beta 1 (TGF beta 1) stimulation, rough Ti inhibited alpha-smooth muscle actin (alpha-SMA) expression and collagen deposition, leading to decreased myofibroblast transformation and disorganization of the collagen fibrils as compared to smooth Ti.
   CONCLUSIONS. This study suggests that Ti surface topography regulates corneal cell behavior in a tissue-dependent manner that varies across the corneal strata. Contrary to the accepted paradigm, smooth surface topography can enhance cell adhesion and proliferation and increase matrix deposition by corneal cells.
C1 [Paschalis, Eleftherios I.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol,Boston Keratoprosthesis Lab, 243 Charles St, Boston, MA 02114 USA.
   [Paschalis, Eleftherios I.] Harvard Univ, Sch Med, Schepens Eye Res Inst, 243 Charles St, Boston, MA 02114 USA.
   [Chodosh, James] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, 243 Charles St, Boston, MA 02114 USA.
RP Paschalis, EI (reprint author), Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol,Boston Keratoprosthesis Lab, 243 Charles St, Boston, MA 02114 USA.; Paschalis, EI (reprint author), Harvard Univ, Sch Med, Schepens Eye Res Inst, 243 Charles St, Boston, MA 02114 USA.; Chodosh, J (reprint author), Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, 243 Charles St, Boston, MA 02114 USA.
EM James_Chodosh@meei.harvard.edu; eleftherios_paschalis@meei.harvard.edu
OI Paschalis, Eleftherios/0000-0002-4544-4452
FU Boston Keratoprosthesis Research Fund; Massachusetts Eye and Ear;
   Eleanor and Miles Shore Fund
FX Supported by the Boston Keratoprosthesis Research Fund, Massachusetts
   Eye and Ear, and the Eleanor and Miles Shore Fund. All authors are
   full-time employees of Massachusetts Eye and Ear Infirmary, a nonprofit
   organization that is the manufacturer of the Boston Keratoprosthesis.
   The authors alone are responsible for the content and writing of the
   paper.
CR Aldave AJ, 2012, OPHTHALMOLOGY, V119, P1530, DOI 10.1016/j.ophtha.2012.02.015
   Ament JD, 2009, CORNEA, V28, P808, DOI 10.1097/ICO.0b013e31819670ac
   Anselme K, 2000, BIOMATERIALS, V21, P1567, DOI 10.1016/S0142-9612(00)00042-9
   Bachle M, 2004, CLIN ORAL IMPLAN RES, V15, P683, DOI 10.1111/j.1600-0501.2004.01054.x
   BIRK DE, 1990, J CELL SCI, V95, P649
   Bourne WM, 2003, EYE, V17, P912, DOI 10.1038/sj.eye.6700559
   Cheung JWC, 2014, BIOMATERIALS, V35, P10025, DOI 10.1016/j.biomaterials.2014.09.001
   Chew HF, 2009, CORNEA, V28, P989, DOI 10.1097/ICO.0b013e3181a186dc
   Ciralsky J, 2010, OCUL IMMUNOL INFLAMM, V18, P275, DOI 10.3109/09273941003682300
   Estevez M, 2015, J BIOMED MATER RES A, V103, P1659, DOI 10.1002/jbm.a.35293
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Gipson IK, 2003, INVEST OPHTH VIS SCI, V44, P2496, DOI 10.1167/iovs.02-0851
   Guo XQ, 2007, INVEST OPHTH VIS SCI, V48, P4050, DOI 10.1167/iovs.06-1216
   Hou JH, 2014, JAMA OPHTHALMOL, V132, P1133, DOI 10.1001/jamaophthalmol.2014.1959
   Jester JV, 1996, CORNEA, V15, P505
   Jester JV, 1997, CORNEA, V16, P177
   Jester JV, 1999, PROG RETIN EYE RES, V18, P311, DOI 10.1016/S1350-9462(98)00021-4
   Joyce NC, 1996, INVEST OPHTH VIS SCI, V37, P645
   Karamichos D, 2010, INVEST OPHTH VIS SCI, V51, P1382, DOI 10.1167/iovs.09-3860
   Kim A, 2010, INVEST OPHTH VIS SCI, V51, P864, DOI 10.1167/iovs.09-4200
   Kubo K, 2009, BIOMATERIALS, V30, P5319, DOI 10.1016/j.biomaterials.2009.06.021
   Lauer G, 2001, BIOMATERIALS, V22, P2799, DOI 10.1016/S0142-9612(01)00024-2
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Leask A, 2013, ADV WOUND CARE, V2, P247, DOI 10.1089/wound.2012.0363
   Liliensiek SJ, 2006, J BIOMED MATER RES A, V79A, P185, DOI 10.1002/jbm.a.30744
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Masur SK, 1999, INVEST OPHTH VIS SCI, V40, P904
   Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011
   Mol A, 2005, BIOMATERIALS, V26, P3113, DOI 10.1016/j.biomaterials.2004.08.007
   Mustafa K, 2001, CLIN ORAL IMPLAN RES, V12, P515, DOI 10.1034/j.1600-0501.2001.120513.x
   Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373
   Paschalis EI, 2014, TRANSL VIS SCI TECHN, V3, DOI 10.1167/tvst.3.5.4
   Paschalis EI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067404
   Paschalis EI, 2013, INVEST OPHTH VIS SCI, V54, P3863, DOI 10.1167/iovs.13-11714
   Phillips DL, 2014, CORNEA, V33, P905, DOI 10.1097/ICO.0000000000000204
   POSTLETHWAITE AE, 1978, P NATL ACAD SCI USA, V75, P871, DOI 10.1073/pnas.75.2.871
   Rani WD, 2012, ACTA BIOMATER, V8, P1976
   RATNER BD, 2001, ENG MAT SER, P1
   Rheinwald JG, 2002, MOL CELL BIOL, V22, P5157, DOI 10.1128/MCB.22.14.5157-5172.2002
   Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2
   Schmedt T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051427
   Srikumaran D, 2014, OPHTHALMOLOGY, V121, P2159, DOI 10.1016/j.ophtha.2014.05.030
   Stacy RC, 2011, ARCH OPHTHALMOL-CHIC, V129, P310, DOI 10.1001/archophthalmol.2011.26
   Todani A, 2011, GRAEF ARCH CLIN EXP, V249, P1515, DOI 10.1007/s00417-011-1684-y
   Torricelli AAM, 2014, EXP EYE RES, V129, P151, DOI 10.1016/j.exer.2014.09.013
   Toutant M, 2002, MOL CELL BIOL, V22, P7731, DOI 10.1128/MCB.22.22.7731-7743.2002
   Tsukimura N, 2011, BIOMATERIALS, V32, P4358, DOI 10.1016/j.biomaterials.2011.03.001
   WARING GO, 1982, OPHTHALMOLOGY, V89, P531
   Wenstrup RJ, 2004, J BIOL CHEM, V279, P53331, DOI 10.1074/jbc.M409622200
   Zambuzzi WF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095662
   Zimerman B, 2004, CELL MOTIL CYTOSKEL, V58, P143, DOI 10.1002/cm.20005
NR 51
TC 8
Z9 8
U1 5
U2 13
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD APR
PY 2016
VL 57
IS 4
BP 1927
EP 1938
DI 10.1167/iovs.15-18406
PG 12
WC Ophthalmology
SC Ophthalmology
GA DL8XY
UT WOS:000375926700053
PM 27092719
OA Other Gold
DA 2018-10-20
ER

PT J
AU Gholami, M
   Mhaede, M
   Pastorek, F
   Altenberger, I
   Hadzima, B
   Wollmann, M
   Wagner, L
AF Gholami, Mozghan
   Mhaede, Mansour
   Pastorek, Filip
   Altenberger, Igor
   Hadzima, Branislav
   Wollmann, Manfred
   Wagner, Lothar
TI Corrosion Behavior and Mechanical Properties of Ultrafine-Grained Pure
   Copper with Potential as a Biomaterial
SO ADVANCED ENGINEERING MATERIALS
LA English
DT Article
ID SEVERE PLASTIC-DEFORMATION; SIMULATED UTERINE FLUID; ELECTROCHEMICAL
   IMPEDANCE SPECTROSCOPY; DENSITY POLYETHYLENE NANOCOMPOSITE;
   INTRAUTERINE-DEVICE; RELEASE BEHAVIOR; WORK FUNCTION; CUPRIC ION; BULK;
   MICROSTRUCTURE
AB This study aims to evaluate and compare the mechanical and corrosion resistance properties of ultrafine-grained (UFG) copper with that of coarse-grained (CG) copper microstructures. Ultrafine-grained microstructures are produced through severe plastic deformation using rotary swaging. Potentiodynamic polarization and electrochemical impedance tests are performed at 37 degrees C in Hank's solution as the simulated body fluid. The results reveal that the highly deformed UFG-materials not only show marked enhancement of the mechanical properties but also remarkable enhancement of corrosion resistance compared with that of the CG counterpart.
C1 [Gholami, Mozghan; Mhaede, Mansour; Wollmann, Manfred; Wagner, Lothar] Tech Univ Clausthal, Inst Mat Sci & Engn, D-38678 Clausthal Zellerfeld, Germany.
   [Mhaede, Mansour] Zagazig Univ, Fac Engn, Zagazig, Egypt.
   [Pastorek, Filip; Hadzima, Branislav] Univ Zilina, Fac Mech Engn, Dept Mat Engn, Zilina 01026, Slovakia.
   [Altenberger, Igor] Wieland Werke AG, Cent Lab, D-89079 Ulm, Germany.
RP Mhaede, M (reprint author), Tech Univ Clausthal, Inst Mat Sci & Engn, D-38678 Clausthal Zellerfeld, Germany.; Mhaede, M (reprint author), Zagazig Univ, Fac Engn, Zagazig, Egypt.
EM mansour.mhaede@yahoo.com
FU European Regional Development Fund; Slovak state budget by the project
   "Research Centre of the University of Zilina" [ITMS 26220220183]
FX We would like to acknowledge the financial support of European Regional
   Development Fund and Slovak state budget by the project "Research Centre
   of the University of Zilina," ITMS 26220220183 granted to F. Pastorek
   and B. Hadzima. We would also like to thank E. Mawaad for performing the
   X-Ray texture measurements.
CR Abdulstaar M, 2014, SURF COAT TECH, V254, P244, DOI 10.1016/j.surfcoat.2014.06.026
   Abdulstaar M, 2014, MATER DESIGN, V57, P325, DOI 10.1016/j.matdes.2014.01.005
   Abdulstaar MA, 2014, J MATER SCI, V49, P1138, DOI 10.1007/s10853-013-7792-9
   Abdulstaar MA, 2013, MAT SCI ENG A-STRUCT, V565, P351, DOI 10.1016/j.msea.2012.12.046
   Acciari HA, 2005, CORROS SCI, V47, P635, DOI 10.1016/j.corsci.2004.07.004
   Alexandrov IV, 1998, METALL MATER TRANS A, V29, P2253, DOI 10.1007/s11661-998-0103-4
   Altenberger I, 2014, IOP CONF SER-MAT SCI, V63, DOI 10.1088/1757-899X/63/1/012135
   Balakrishnan A, 2008, TRENDS BIOMATER ARTI, V22, P58
   Barbucci A, 2001, J ALLOY COMPD, V317, P607, DOI 10.1016/S0925-8388(00)01396-7
   Bastidas JM, 2000, CONTRACEPTION, V61, P395, DOI 10.1016/S0010-7824(00)00124-4
   Bastidas JM, 1997, BIOMATERIALS, V18, P247, DOI 10.1016/S0142-9612(96)00136-6
   BEAUNIER L, 1980, ELECTROCHIM ACTA, V25, P1239, DOI 10.1016/0013-4686(80)87127-1
   Beaunier L., 1982, J PHYS, V43, pC6
   Brandao L, 1998, SCRIPTA MATER, V39, P27, DOI 10.1016/S1359-6462(98)00123-7
   Cai SZ, 2007, J BIOMED MATER RES B, V80B, P220, DOI 10.1002/jbm.b.30587
   Cai SZ, 2005, BIOMATERIALS, V26, P2671, DOI 10.1016/j.biomaterials.2004.08.003
   Chiou CF, 2003, CONTRACEPTION, V68, P3, DOI 10.1016/S0010-7824(03)00078-7
   d'Arcangues C, 2007, CONTRACEPTION, V75, P2
   Gabrielli C., 1983, 00483 SOL INSTR
   Gao J., 2007, J REPROD CONTRACEPT, V18, P33
   Ghosh SK, 2006, J ALLOY COMPD, V426, P235, DOI 10.1016/j.jallcom.2005.12.094
   Gollapudi R., 2012, CORROS SCI, V62, P90
   Gollapudi S, 2012, CORROS SCI, V62, P90, DOI 10.1016/j.corsci.2012.04.040
   Gubicza J., 2007, MATER SCI FORUM, V567-568, P181
   Guo WY, 2009, MATER CHARACT, V60, P173, DOI 10.1016/j.matchar.2008.08.006
   Gutman E. M., 1994, MECHANOCHEMISTRY SOL
   Haanappel VAC, 2001, CORROSION, V57, P557, DOI 10.5006/1.3290382
   HALL EO, 1951, P PHYS SOC LOND B, V64, P747, DOI 10.1088/0370-1301/64/9/303
   Hughes DA, 2000, ACTA MATER, V48, P2985, DOI 10.1016/S1359-6454(00)00082-3
   Kang Y. C., 2008, CORROSION 2008
   Li W, 2005, APPL SURF SCI, V240, P388, DOI 10.1016/j.apsusc.2004.07.017
   Liang JY, 2008, CONTRACEPTION, V77, P299, DOI 10.1016/j.contraception.2007.12.005
   MANSFELD F, 1985, CORROSION, V41, P490, DOI 10.5006/1.3583832
   Miyamoto H, 2008, CORROS SCI, V50, P1215, DOI 10.1016/j.corsci.2008.01.024
   Mohamed MA, 2011, LONG TERM CONTRACEPT
   Mora N, 2002, BIOMATERIALS, V23, P667, DOI 10.1016/S0142-9612(01)00154-5
   O'Brien PA, 2008, CONTRACEPTION, V77, P318, DOI 10.1016/j.contraception.2007.12.011
   Palumbo G, 1999, MRS BULL, V24, P27
   PETCH NJ, 1953, J IRON STEEL I, V174, P25
   Ralston KD, 2010, CORROSION-US, V66, DOI 10.5006/1.3462912
   Saldana L, 2007, BIOMATERIALS, V28, P4343, DOI 10.1016/j.biomaterials.2007.06.015
   Scully J. C, 1990, FUNDAMENTALS CORROSI
   Song D, 2011, CORROS SCI, V53, P362, DOI 10.1016/j.corsci.2010.09.044
   Tamilselvi S, 2006, ELECTROCHIM ACTA, V52, P839, DOI 10.1016/j.electacta.2006.06.018
   Tao S, 2008, PHIL MAG LETT, V88, P137, DOI 10.1080/09500830701771939
   Torre F. D., 2004, ACTA MAT, V52, P4819, DOI DOI 10.1016/J.ACTAMAT.2004.06.040
   Trdan U, 2012, CORROS SCI, V59, P324, DOI 10.1016/j.corsci.2012.03.019
   Trussell J, 2007, CONTRACEPTIVE TECHNO, P747
   Trussell J, 2011, CONTRACEPTION, V83, P397, DOI 10.1016/j.contraception.2011.01.021
   Valiev RZ, 2002, J MATER RES, V17, P5, DOI 10.1557/JMR.2002.0002
   Valiev RZ, 2000, PROG MATER SCI, V45, P103, DOI 10.1016/S0079-6425(99)00007-9
   Vinogradov A, 1999, SCRIPTA MATER, V41, P319, DOI 10.1016/S1359-6462(99)00170-0
   Wang LP, 2007, ELECTROCHIM ACTA, V52, P4342, DOI 10.1016/j.electacta.2006.12.009
   Xia XP, 2011, J MATER SCI-MATER M, V22, P1773, DOI 10.1007/s10856-011-4347-y
   Xia XP, 2006, MATER CHEM PHYS, V95, P122, DOI 10.1016/j.matchemphys.2005.05.010
   Xu XX, 2013, J BIOMED MATER RES B, V101, P1428, DOI 10.1002/jbm.b.32962
   Xu XX, 2012, ACTA BIOMATER, V8, P886, DOI 10.1016/j.actbio.2011.10.018
   Xu XX, 2010, MATER LETT, V64, P524, DOI 10.1016/j.matlet.2009.11.065
   Yamasaki T, 2001, MAT SCI ENG A-STRUCT, V318, P122, DOI 10.1016/S0921-5093(01)01332-6
   Yin SB, 2005, MAT SCI ENG A-STRUCT, V394, P266, DOI 10.1016/j.msea.2004.11.054
   Yu J, 2008, CONTRACEPTION, V78, P319, DOI 10.1016/j.contraception.2008.05.008
   Zhang WW, 2012, ACTA BIOMATER, V8, P897, DOI 10.1016/j.actbio.2011.09.024
   Zhu JJ, 1999, ADV CONTRACEPT, V15, P179, DOI 10.1023/A:1006793231274
NR 63
TC 4
Z9 4
U1 3
U2 19
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1438-1656
EI 1527-2648
J9 ADV ENG MATER
JI Adv. Eng. Mater.
PD APR
PY 2016
VL 18
IS 4
BP 615
EP 623
DI 10.1002/adem.201500269
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA DJ9SL
UT WOS:000374553100020
DA 2018-10-20
ER

PT J
AU Hong, YQ
   Zhu, XK
   Wang, P
   Fu, HT
   Deng, C
   Cui, L
   Wang, Q
   Fan, XR
AF Hong, Yanqing
   Zhu, Xueke
   Wang, Ping
   Fu, Haitian
   Deng, Chao
   Cui, Li
   Wang, Qiang
   Fan, Xuerong
TI Tyrosinase-Mediated Construction of a Silk Fibroin/Elastin Nanofiber
   Bioscaffold
SO APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
LA English
DT Article
DE Tyrosinase; Silk fibroin; Elastin; Bioscaffold; Biocompatibility
ID CROSS-LINKING; FIBROIN FILMS; ELASTIN; CHITOSAN; DIFFERENTIATION;
   BIOMATERIAL; MOLECULES; SCAFFOLDS; HYDROGELS; COLLAGEN
AB Elastin has characteristics of elasticity, biological activity, and mechanical stability. In the present work, tyrosinase-mediated construction of a bioscaffold with silk fibroin and elastin was carried out, aiming at developing a novel medical biomaterial. The efficiency of enzymatic oxidation of silk fibroin and the covalent reaction between fibroin and elastin were examined by spectrophotometry, sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), and size exclusion chromatography (SEC). The properties of composite air-dried and nanofiber scaffolds were investigated. The results reveal that elastin was successfully bonded to silk fibroins, resulting in an increase in molecular weight of fibroin proteins. ATR-FTIR spectra indicated that tyrosinase treatment impacted the conformational structure of fibroin-based membrane. The thermal behaviors and mechanical properties of the tyrosinase-treated scaffolds were also improved compared with the untreated group. NIH/3T3 cells exhibited optimum densities when grown on the nanofiber scaffold, implying that the nanofiber scaffold has enhanced biocompatibility compared to the air-dried scaffold. A biological nanofiber scaffold constructed from tyrosinase-treated fibroin and elastin could potentially be utilized in biomedical applications.
C1 [Hong, Yanqing; Zhu, Xueke; Wang, Ping; Cui, Li; Wang, Qiang; Fan, Xuerong] Jiangnan Univ, Key Lab Sci & Technol Ecotext, Minist Educ, Wuxi 214122, Peoples R China.
   [Fu, Haitian] Jiangnan Univ, Sch Pharmaceut Sci, Wuxi 214122, Peoples R China.
   [Deng, Chao] Jiangnan Univ, Wuxi Med Sch, Wuxi 214122, Peoples R China.
RP Wang, P (reprint author), Jiangnan Univ, Key Lab Sci & Technol Ecotext, Minist Educ, Wuxi 214122, Peoples R China.
EM pwang@jiangnan.edu.cn
FU National Natural Science Foundation of China [51373071]; Program for New
   Century Excellent Talents in University [NCET-12-0883]
FX This work was financially supported by the National Natural Science
   Foundation of China (51373071) and Program for New Century Excellent
   Talents in University (NCET-12-0883).
CR Annabi N, 2009, BIOMATERIALS, V30, P1, DOI 10.1016/j.biomaterials.2008.09.031
   Daamen WF, 2007, BIOMATERIALS, V28, P4378, DOI 10.1016/j.biomaterials.2007.06.025
   Debelle L, 1999, BIOCHIMIE, V81, P981, DOI 10.1016/S0300-9084(99)00221-7
   Du XJ, 2014, COLLOID SURFACE B, V122, P79, DOI 10.1016/j.colsurfb.2014.06.049
   Faccio G, 2012, PROCESS BIOCHEM, V47, P1749, DOI 10.1016/j.procbio.2012.08.018
   Fan SN, 2013, INT J BIOL MACROMOL, V56, P83, DOI 10.1016/j.ijbiomac.2013.01.033
   Freddi G, 2003, J BIOTECHNOL, V106, P101, DOI 10.1016/j.jbiotec.2003.09.006
   Freddi G, 2006, J BIOTECHNOL, V125, P281, DOI 10.1016/j.jbiotec.2006.03.003
   Hashimoto T, 2015, POLYM DEGRAD STABIL, V112, P20, DOI 10.1016/j.polymdegradstab.2014.12.007
   Hu X, 2007, THERMOCHIM ACTA, V461, P137, DOI 10.1016/j.tca.2006.12.011
   Imsombut T, 2010, POWDER TECHNOL, V203, P603, DOI 10.1016/j.powtec.2010.06.027
   ITO S, 1977, BIOCHEM J, V161, P499, DOI 10.1042/bj1610499
   Jus S, 2011, MAT SCI ENG C-MATER, V31, P1068, DOI 10.1016/j.msec.2011.03.007
   Jus S, 2008, ENZYME MICROB TECH, V42, P535, DOI 10.1016/j.enzmictec.2008.02.012
   Kang GD, 2004, FIBER POLYM, V5, P234, DOI 10.1007/BF02903006
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Kundu J, 2012, ACTA BIOMATER, V8, P1720, DOI 10.1016/j.actbio.2012.01.004
   Li XQ, 2015, J COLLOID INTERF SCI, V445, P312, DOI 10.1016/j.jcis.2014.12.084
   Meinel AJ, 2009, BIOMATERIALS, V30, P3058, DOI 10.1016/j.biomaterials.2009.01.054
   Miyamoto K, 2009, INT J BIOL MACROMOL, V45, P33, DOI 10.1016/j.ijbiomac.2009.03.014
   Monogioudi E, 2009, FOOD HYDROCOLLOID, V23, P2008, DOI 10.1016/j.foodhyd.2009.03.011
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Sampaio S, 2005, J BIOTECHNOL, V116, P21, DOI 10.1016/j.jbiotec.2004.10.003
   Sionkowska A, 2013, J MOL LIQ, V178, P5, DOI 10.1016/j.molliq.2012.10.042
   Sousa F., 2009, PROCESS BIOCHEM, V44, P309
   Vasconcelos A., 2012, ACTA BIOMAERIALIA, V18, P3049
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang JL, 2011, COLLOID SURFACE B, V85, P241, DOI 10.1016/j.colsurfb.2011.02.035
   Wang JN, 2014, MAT SCI ENG C-MATER, V34, P429, DOI 10.1016/j.msec.2013.09.039
   Wang P, 2014, ENG LIFE SCI, V14, P211, DOI 10.1002/elsc.201300008
   Wise SG, 2009, ADV PROTEIN CHEM STR, V78, P1, DOI [10.1016/S1876-1623(08)78001-5, 10.1016/S1876-1623(09)78001-5]
   Zhang YQ, 2005, J BIOTECHNOL, V120, P315, DOI 10.1016/j.jbiotec.2005.06.027
NR 33
TC 6
Z9 7
U1 5
U2 37
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 0273-2289
EI 1559-0291
J9 APPL BIOCHEM BIOTECH
JI Appl. Biochem. Biotechnol.
PD APR
PY 2016
VL 178
IS 7
BP 1363
EP 1376
DI 10.1007/s12010-015-1952-0
PG 14
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA DL4NN
UT WOS:000375614500008
PM 26679706
DA 2018-10-20
ER

PT J
AU Cross, MC
   Toomey, RG
   Gallant, ND
AF Cross, Michael C.
   Toomey, Ryan G.
   Gallant, Nathan D.
TI Protein-surface interactions on stimuli-responsive polymeric
   biomaterials
SO BIOMEDICAL MATERIALS
LA English
DT Review
DE stimulus responsive materials; smart materials; protein adsorption; cell
   adhesion; poly(N-isopropylacrylamide) or PNIPAAm
ID POLY-N-ISOPROPYLACRYLAMIDE; SELF-ASSEMBLED MONOLAYERS; BOVINE
   SERUM-ALBUMIN; BIOMEDICAL APPLICATIONS; GRAFTING DENSITY;
   THERMOSENSITIVE-POLYMER; CONFORMATIONAL-CHANGES; ADSORPTION BEHAVIORS;
   CHAIN COLLAPSE; IN-VIVO
AB Responsive surfaces: a review of the dependence of protein adsorption on the reversible volume phase transition in stimuli-responsive polymers. Specifically addressed are a widely studied subset: thermoresponsive polymers. Findings are also generalizable to other materials which undergo a similarly reversible volume phase transition. As of 2015, over 100 000 articles have been published on stimuli-responsive polymers and many more on protein-biomaterial interactions. Significantly, fewer than 100 of these have focused specifically on protein interactions with stimuli-responsive polymers. These report a clear trend of increased protein adsorption in the collapsed state compared to the swollen state. This control over protein interactions makes stimuli-responsive polymers highly useful in biomedical applications such as wound repair scaffolds, on-demand drug delivery, and antifouling surfaces. Outstanding questions are whether the protein adsorption is reversible with the volume phase transition and whether there is a time-dependence. A clear understanding of protein interactions with stimuli-responsive polymers will advance theoretical models, experimental results, and biomedical applications.
C1 [Cross, Michael C.] Univ S Florida, Dept Phys, Tampa, FL 33620 USA.
   [Toomey, Ryan G.] Univ S Florida, Dept Chem & Biomed Engn, Tampa, FL 33620 USA.
   [Gallant, Nathan D.] Univ S Florida, Dept Mech Engn, 4202 East Fowler Ave,ENB118, Tampa, FL 33620 USA.
RP Gallant, ND (reprint author), Univ S Florida, Dept Mech Engn, 4202 East Fowler Ave,ENB118, Tampa, FL 33620 USA.
EM ngallant@usf.edu
OI Gallant, Nathan/0000-0001-6454-7660
CR Ahn SK, 2008, SOFT MATTER, V4, P1151, DOI 10.1039/b714376a
   Akintewe OO, 2015, ACTA BIOMATER, V11, P96, DOI 10.1016/j.actbio.2014.09.040
   Alarcon CDH, 2005, J MATER CHEM, V15, P2089, DOI 10.1039/b419142k
   Alarcon CDL, 2005, INT J PHARMACEUT, V295, P77, DOI 10.1016/j.ijpharm.2005.01.037
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Balamurugan S, 2005, J AM CHEM SOC, V127, P14548, DOI 10.1021/ja054156g
   Bostrom M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.168103
   Brouette N, 2012, EUR PHYS J-SPEC TOP, V213, P343, DOI 10.1140/epjst/e2012-01681-4
   Burkert S, 2010, LANGMUIR, V26, P1786, DOI 10.1021/la902505q
   Cao B, 2013, ADV HEALTHC MATER, V2, P1096, DOI 10.1002/adhm.201200359
   Carman ML, 2006, BIOFOULING, V22, P11, DOI 10.1080/08927010500484854
   Castellanos A, 2007, LANGMUIR, V23, P6391, DOI 10.1021/la700338p
   Cheney SM, 2014, UROLOGY, V83, P489, DOI 10.1016/j.urology.2013.10.005
   Cho EC, 2004, POLYMER, V45, P3195, DOI 10.1016/j.polymer.2004.02.052
   Choi S, 2013, BIOMACROMOLECULES, V14, P92, DOI 10.1021/bm301390q
   Cole MA, 2009, BIOMATERIALS, V30, P1827, DOI 10.1016/j.biomaterials.2008.12.026
   Costa D, 2013, J BIOMED MATER RES A, V101, P1210, DOI 10.1002/jbm.a.34416
   Demirel G, 2007, J POLYM RES, V14, P23, DOI 10.1007/s10965-006-9076-4
   Der A, 2007, J PHYS CHEM B, V111, P5344, DOI 10.1021/jp066206p
   Ding XB, 2000, J APPL POLYM SCI, V77, P2915, DOI 10.1002/1097-4628(20000923)77:13<2915::AID-APP14>3.3.CO;2-U
   DuPont SJ, 2010, SOFT MATTER, V6, P3876, DOI 10.1039/c0sm00021c
   Duracher D, 2000, LANGMUIR, V16, P9002, DOI 10.1021/la0004045
   Duracher D, 2004, POLYM INT, V53, P618, DOI 10.1002/pi.1441
   Ekici S, 2011, J MATER SCI, V46, P2843, DOI 10.1007/s10853-010-5158-0
   Elaissari A, 2001, J MAGN MAGN MATER, V225, P151, DOI 10.1016/S0304-8853(00)01244-0
   Ercole F, 2010, POLYM CHEM-UK, V1, P37, DOI 10.1039/b9py00300b
   Federici S, 2012, J COLLOID INTERF SCI, V375, P1, DOI 10.1016/j.jcis.2012.02.013
   Finch C, 2013, J COMPUT PHYS, V244, P212, DOI 10.1016/j.jcp.2012.07.034
   Fu Q, 2004, J AM CHEM SOC, V126, P8904, DOI 10.1021/ja047895q
   Gan DJ, 2002, MACROMOLECULES, V35, P9634, DOI 10.1021/ma021186k
   Ge X, 2009, J APPL POLYM SCI, V114, P1270, DOI 10.1002/app.30545
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   Halperin A, 2011, MACROMOLECULES, V44, P6986, DOI 10.1021/ma201006h
   Halperin A, 2009, LANGMUIR, V25, P11621, DOI 10.1021/la9008569
   Hoffman AS, 2013, ADV DRUG DELIVER REV, V65, P10, DOI 10.1016/j.addr.2012.11.004
   HORBETT TA, 1993, CARDIOVASC PATHOL, V2, pS137
   Huang QL, 2013, BIOMATERIALS, V34, P434, DOI 10.1016/j.biomaterials.2012.09.073
   Huber DL, 2003, SCIENCE, V301, P352, DOI 10.1126/science.1080759
   Ivanov AE, 2006, J COLLOID INTERF SCI, V296, P538, DOI 10.1016/j.jcis.2005.09.064
   Janzen J, 2004, J BIOMAT SCI-POLYM E, V15, P1121, DOI 10.1163/1568562041753043
   Jeong B, 2002, ADV DRUG DELIVER REV, V54, P37, DOI 10.1016/S0169-409X(01)00242-3
   Kanazawa R, 2012, SEP PURIF TECHNOL, V96, P26, DOI 10.1016/j.seppur.2012.05.016
   KAWAGUCHI H, 1992, COLLOID POLYM SCI, V270, P53, DOI 10.1007/BF00656929
   Kayitmazer AB, 2013, SOFT MATTER, V9, P2553, DOI 10.1039/c2sm27002a
   Kidoaki S, 2001, LANGMUIR, V17, P2402, DOI 10.1021/la001522v
   Kim J, 2012, TRENDS BIOTECHNOL, V30, P426, DOI 10.1016/j.tibtech.2012.04.003
   Kim J, 2010, NAT MATER, V9, P159, DOI [10.1038/NMAT2606, 10.1038/nmat2606]
   Klouda L, 2008, EUR J PHARM BIOPHARM, V68, P34, DOI 10.1016/j.ejpb.2007.02.025
   Koetting MC, 2015, MAT SCI ENG R, V93, P1, DOI 10.1016/j.mser.2015.04.001
   Laird D, 2015, J BIOACT COMPAT POL, V30, P319, DOI 10.1177/0883911515570370
   Lee SC, 2013, ADV DRUG DELIVER REV, V65, P17, DOI 10.1016/j.addr.2012.07.015
   Li LY, 2005, J PHYS CHEM B, V109, P2934, DOI 10.1021/jp0473321
   Liu XJ, 2011, SOFT MATTER, V7, P515, DOI 10.1039/c0sm00682c
   Lo Nostro P, 2012, CHEM REV, V112, P2286, DOI 10.1021/cr200271j
   London N, 2014, J STRUCT BIOL, V185, P136, DOI 10.1016/j.jsb.2013.03.012
   Mano JF, 2008, ADV ENG MATER, V10, P515, DOI 10.1002/adem.200700355
   Meng J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02655
   Morisada S, 2011, IND ENG CHEM RES, V50, P12358, DOI 10.1021/ie200779w
   Mueller TKH, 2013, J CHROMATOGR A, V1285, P97, DOI 10.1016/j.chroma.2013.02.025
   Nagase K, 2011, J MATER CHEM, V21, P2590, DOI 10.1039/c0jm03453c
   Nagase K, 2011, BIOMATERIALS, V32, P619, DOI 10.1016/j.biomaterials.2010.09.012
   Noh H, 2007, BIOMATERIALS, V28, P405, DOI 10.1016/j.biomaterials.2006.09.006
   Nolan CM, 2005, BIOMACROMOLECULES, V6, P2032, DOI 10.1021/bm0500087
   Okamura A, 2008, J BIOSCI BIOENG, V105, P221, DOI 10.1263/jbb.105.221
   Okubo M, 1996, COLLOID POLYM SCI, V274, P112, DOI 10.1007/BF00663443
   Ozdural AR, 2004, J CHROMATOGR A, V1041, P77, DOI 10.1016/j.chroma.2004.05.009
   Penna MJ, 2014, J AM CHEM SOC, V136, P5323, DOI 10.1021/ja411796e
   Plunkett KN, 2006, LANGMUIR, V22, P4259, DOI 10.1021/la0531502
   Poplewska I, 2014, J CHROMATOGR A, V1324, P181, DOI 10.1016/j.chroma.2013.11.040
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   Rabe M, 2011, ADV COLLOID INTERFAC, V162, P87, DOI 10.1016/j.cis.2010.12.007
   Rane A, 2010, J UROLOGY, V183, P1417, DOI 10.1016/j.juro.2009.12.023
   Reinicke S, 2010, SOFT MATTER, V6, P2760, DOI 10.1039/c000943a
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Sang LC, 2011, LANGMUIR, V27, P13828, DOI 10.1021/la202907f
   SCHILD HG, 1992, PROG POLYM SCI, V17, P163, DOI 10.1016/0079-6700(92)90023-R
   Sethuraman A, 2004, LANGMUIR, V20, P7779, DOI 10.1021/la049454q
   Shamim N, 2008, J COLLOID INTERF SCI, V320, P15, DOI 10.1016/j.jcis.2007.08.012
   Shamim N, 2006, J COLLOID INTERF SCI, V304, P1, DOI 10.1016/j.jcis.2006.08.047
   Shi XN, 2015, RSC ADV, V5, P41820, DOI 10.1039/c5ra04897d
   Sigal GB, 1998, J AM CHEM SOC, V120, P3464, DOI 10.1021/ja970819l
   Silva CSO, 2006, BIOTECHNOL LETT, V28, P2019, DOI 10.1007/s10529-006-9188-2
   Sinha SR, 2015, GASTROENTEROLOGY, V149, P52, DOI 10.1053/j.gastro.2015.04.002
   Sofia SJ, 1998, MACROMOLECULES, V31, P5059, DOI 10.1021/ma971016l
   Song MM, 2011, COLLOID SURFACE B, V84, P477, DOI 10.1016/j.colsurfb.2011.02.002
   Stuart MAC, 2010, NAT MATER, V9, P101, DOI [10.1038/NMAT2614, 10.1038/nmat2614]
   Sugiura S, 2009, BIOSENS BIOELECTRON, V24, P1135, DOI 10.1016/j.bios.2008.06.038
   Sun TL, 2004, ANGEW CHEM INT EDIT, V43, P357, DOI 10.1002/anie.200352565
   Tomatsu I, 2011, ADV DRUG DELIVER REV, V63, P1257, DOI 10.1016/j.addr.2011.06.009
   Trongsatitkul T, 2013, COLLOID SURFACE B, V103, P244, DOI 10.1016/j.colsurfb.2012.10.053
   Tziveleka LA, 2014, MACROMOL BIOSCI, V14, P131, DOI 10.1002/mabi.201300212
   Ulijn RV, 2006, J MATER CHEM, V16, P2217, DOI 10.1039/b601776m
   Vogler EA, 2012, BIOMATERIALS, V33, P1201, DOI 10.1016/j.biomaterials.2011.10.059
   Vogler EA, 2009, BIOMATERIALS, V30, P1857, DOI 10.1016/j.biomaterials.2008.12.041
   Wang KF, 2012, INTERFACE FOCUS, V2, P259, DOI 10.1098/rsfs.2012.0012
   Wang ZM, 2013, BBA-GEN SUBJECTS, V1830, P5356, DOI 10.1016/j.bbagen.2013.06.032
   Ward MA, 2011, POLYMERS-BASEL, V3, P1215, DOI 10.3390/polym3031215
   Wertz CF, 2001, LANGMUIR, V17, P3006, DOI 10.1021/la0017781
   White EM, 2013, J POLYM SCI POL PHYS, V51, P1084, DOI 10.1002/polb.23312
   Wu JY, 2005, J CONTROL RELEASE, V102, P361, DOI 10.1016/j.jconrel.2004.10.008
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
   Xue CY, 2012, ADV FUNCT MATER, V22, P2394, DOI 10.1002/adfm.201103056
   Xue CY, 2011, LANGMUIR, V27, P8810, DOI 10.1021/la2001909
   Yamazaki A, 1999, BBA-BIOMEMBRANES, V1421, P103, DOI 10.1016/S0005-2736(99)00117-0
   Yang WK, 2014, ACS APPL MATER INTER, V6, P10146, DOI 10.1021/am501193b
   Yigit C, 2012, LANGMUIR, V28, P14373, DOI 10.1021/la303292z
   YOSHIDA R, 1995, NATURE, V374, P240, DOI 10.1038/374240a0
   You JO, 2015, BIOMATERIALS, V57, P22, DOI 10.1016/j.biomaterials.2015.04.011
   Yu Q, 2013, ACS APPL MATER INTER, V5, P9295, DOI 10.1021/am4022279
   Yu Q, 2011, RSC ADV, V1, P262, DOI 10.1039/c1ra00201e
   Yu Q, 2010, LANGMUIR, V26, P8582, DOI 10.1021/la904663m
   Yu Q, 2010, COLLOID SURFACE B, V76, P468, DOI 10.1016/j.colsurfb.2009.12.006
   Yuan L, 2011, MACROMOL BIOSCI, V11, P1031, DOI 10.1002/mabi.201000464
   Zagar TM, 2014, INT J HYPERTHER, V30, P285, DOI 10.3109/02656736.2014.936049
   Zhao TL, 2011, COLLOID SURFACE B, V85, P26, DOI 10.1016/j.colsurfb.2010.10.047
   Zhou SY, 2014, J MEMBRANE SCI, V450, P351, DOI 10.1016/j.memsci.2013.09.011
   Zhu MQ, 2006, J AM CHEM SOC, V128, P4303, DOI 10.1021/ja0567642
   Zhu X, 2012, NANOSCALE RES LETT, V7, P1
   Zhu Y., 2005, ANGEW CHEM, V117, P5213, DOI DOI 10.1002/ANGE.200501500
NR 120
TC 9
Z9 9
U1 5
U2 94
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD APR
PY 2016
VL 11
IS 2
AR 022002
DI 10.1088/1748-6041/11/2/022002
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DL3GY
UT WOS:000375523400004
PM 26942693
OA Other Gold
DA 2018-10-20
ER

PT J
AU Magin, CM
   Alge, DL
   Anseth, KS
AF Magin, Chelsea M.
   Alge, Daniel L.
   Anseth, Kristi S.
TI Bio-inspired 3D microenvironments: a new dimension in tissue engineering
SO BIOMEDICAL MATERIALS
LA English
DT Review
DE bio-inspired; 3D; tissue engineering; biomaterials; microfabrication
ID STEM-CELL FATE; POLY(ETHYLENE GLYCOL) HYDROGELS; TETRAZINE-NORBORNENE
   CHEMISTRY; CLICK-BASED HYDROGELS; INK-JET METHOD; EXTRACELLULAR-MATRIX;
   REGENERATIVE MEDICINE; GROWTH-FACTORS; PROJECTION STEREOLITHOGRAPHY;
   PHOTODEGRADABLE HYDROGELS
AB Biomaterial scaffolds have been a foundational element of the tissue engineering paradigm since the inception of the field. Over the years there has been a progressive move toward the rational design and fabrication of bio-inspired materials that mimic the composition as well as the architecture and 3D structure of tissues. In this review, we chronicle advances in the field that address key challenges in tissue engineering as well as some emerging applications. Specifically, a summary of the materials and chemistries used to engineer bio-inspired 3D matrices that mimic numerous aspects of the extracellular matrix is provided, along with an overview of bioprinting, an additive manufacturing approach, for the fabrication of engineered tissues with precisely controlled 3D structures and architectures. To emphasize the potential clinical impact of the bio-inspired paradigm in biomaterials engineering, some applications of bio-inspired matrices are discussed in the context of translational tissue engineering. However, focus is also given to recent advances in the use of engineered 3D cellular microenvironments for fundamental studies in cell biology, including photoresponsive systems that are shedding new light on how matrix properties influence cell phenotype and function. In an outlook for future work, the need for high-throughput methods both for screening and fabrication is highlighted. Finally, microscale organ-on-a-chip technologies are highlighted as a promising area for future investment in the application of bio-inspired microenvironments.
C1 [Magin, Chelsea M.] Sharklet Technol Inc, Aurora, CO USA.
   [Alge, Daniel L.] Texas A&M Univ, Dept Biomed Engn, College Stn, TX USA.
   [Alge, Daniel L.] Texas A&M Univ, Dept Mat Sci & Engn, College Stn, TX USA.
   [Anseth, Kristi S.] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA.
   [Anseth, Kristi S.] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA.
   [Anseth, Kristi S.] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA.
RP Magin, CM (reprint author), Sharklet Technol Inc, Aurora, CO USA.
EM cmagin@sharklet.com
OI Magin, Chelsea/0000-0002-6988-8584
FU National Science Foundation [DMR 1408955]; National Institutes of Health
   [R01 DE016523]
FX The authors acknowledge financial support to KSA from the National
   Science Foundation (DMR 1408955) and the National Institutes of Health
   (R01 DE016523).
CR Alge DL, 2013, BIOMACROMOLECULES, V14, P949, DOI 10.1021/bm4000508
   Anderson JM, 2011, ACS NANO, V5, P9463, DOI 10.1021/nn203247m
   Anderson SB, 2011, BIOMATERIALS, V32, P3564, DOI 10.1016/j.biomaterials.2011.01.064
   Andukuri A, 2013, TISSUE ENG PART C-ME, V19, P375, DOI [10.1089/ten.tec.2012.0312, 10.1089/ten.TEC.2012.0312]
   Atala A, 2004, REJUV RES, V7, P15, DOI 10.1089/154916804323105053
   Atala A, 2012, SCI TRANSL MED, V4
   Azagarsamy MA, 2013, ANGEW CHEM INT EDIT, V52, P13803, DOI 10.1002/anie.201308174
   Azagarsamy MA, 2013, ACS MACRO LETT, V2, P5, DOI 10.1021/mz300585q
   Baier Leach J., 2003, BIOTECHNOL BIOENG, V82, P578, DOI DOI 10.1002/BIT.10605
   Bajaj P, 2014, ANNU REV BIOMED ENG, V16, P247, DOI 10.1146/annurev-bioeng-071813-105155
   Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509
   Benton G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123312
   Bhattacharjee T, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500655
   Bian LM, 2013, P NATL ACAD SCI USA, V110, P10117, DOI 10.1073/pnas.1214100110
   Boekhoven J, 2014, ADV MATER, V26, P1642, DOI 10.1002/adma.201304606
   BRAUKER JH, 1995, J BIOMED MATER RES, V29, P1517, DOI 10.1002/jbm.820291208
   Bury MI, 2014, BIOMATERIALS, V35, P9311, DOI 10.1016/j.biomaterials.2014.07.057
   Caplan AI, 2013, MESENCHYMAL STROMAL, P79
   Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008
   Chaudhuri O, 2014, NAT MATER, V13, P970, DOI [10.1038/NMAT4009, 10.1038/nmat4009]
   Choi NY, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-103
   Choi SH, 2014, NATURE, V515, P274, DOI 10.1038/nature13800
   Clark ER, 1939, AM J ANAT, V64, P251, DOI 10.1002/aja.1000640203
   Collier JH, 2010, CHEM SOC REV, V39, P3413, DOI 10.1039/b914337h
   Conda-Sheridan M, 2014, CHEM COMMUN, V50, P13757, DOI 10.1039/c4cc06340f
   Cordeiro JV, 2013, NAT REV MOL CELL BIO, V14, P249, DOI 10.1038/nrm3541
   Cui XF, 2012, TISSUE ENG PT A, V18, P1304, DOI [10.1089/ten.tea.2011.0543, 10.1089/ten.TEA.2011.0543]
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Cushing MC, 2007, SCIENCE, V316, P1133, DOI 10.1126/science.1140171
   D'haeseleer P, 2013, INSTRUCTABLES
   Dave PC, 2014, NAT MATER, V13, P532, DOI 10.1038/nmat3997
   DeForest CA, 2015, NAT MATER, V14, P523, DOI [10.1038/nmat4219, 10.1038/NMAT4219]
   DeForest CA, 2012, ANGEW CHEM INT EDIT, V51, P1816, DOI 10.1002/anie.201106463
   DeForest CA, 2011, NAT CHEM, V3, P925, DOI [10.1038/nchem.1174, 10.1038/NCHEM.1174]
   DeForest CA, 2010, CHEM MATER, V22, P4783, DOI 10.1021/cm101391y
   DeForest CA, 2009, NAT MATER, V8, P659, DOI [10.1038/NMAT2473, 10.1038/nmat2473]
   Demirci U, 2007, LAB CHIP, V7, P1139, DOI 10.1039/b704965j
   Desai RM, 2015, BIOMATERIALS, V50, P30, DOI 10.1016/j.biomaterials.2015.01.048
   Dolatshahi-Pirouz A, 2014, SCI REP-UK, V4, DOI 10.1038/srep03896
   Duan B, 2013, J BIOMED MATER RES A, V101, P1255, DOI 10.1002/jbm.a.34420
   Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI [10.1038/nnano.2010.246, 10.1038/NNANO.2010.246]
   Elisseeff J, 2000, J BIOMED MATER RES, V51, P164, DOI 10.1002/(SICI)1097-4636(200008)51:2<164::AID-JBM4>3.0.CO;2-W
   Eng G, 2013, P NATL ACAD SCI USA, V110, P4551, DOI 10.1073/pnas.1300569110
   Fairbanks BD, 2009, ADV MATER, V21, P5005, DOI 10.1002/adma.200901808
   Fang XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075187
   Fedorovich NE, 2012, TISSUE ENG PART C-ME, V18, P33, DOI [10.1089/ten.tec.2011.0060, 10.1089/ten.TEC.2011.0060]
   Flaherty J, 2013, WIRED CONDE NAST
   Galler KM, 2012, TISSUE ENG PT A, V18, P176, DOI [10.1089/ten.tea.2011.0222, 10.1089/ten.TEA.2011.0222]
   Giannitelli SM, 2014, ACTA BIOMATER, V10, P580, DOI 10.1016/j.actbio.2013.10.024
   Griffin DR, 2013, BIOMACROMOLECULES, V14, P1199, DOI 10.1021/bm400169d
   Grover GN, 2012, BIOMACROMOLECULES, V13, P3013, DOI 10.1021/bm301346e
   Gutierrez JMP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6571
   Guvendiren M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1792
   Hanjaya-Putra D, 2012, BIOMATERIALS, V33, P6123, DOI 10.1016/j.biomaterials.2012.05.027
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   Hauser CAE, 2010, CHEM SOC REV, V39, P2780, DOI 10.1039/b921448h
   Highley CB, 2015, ADV MATER, V27, P5075, DOI 10.1002/adma.201501234
   Hockaday LA, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/3/035005
   Holland JD, 2013, CURR OPIN CELL BIOL, V25, P254, DOI 10.1016/j.ceb.2013.01.004
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Holloway JL, 2014, J CONTROL RELEASE, V191, P63, DOI 10.1016/j.jconrel.2014.05.053
   Hribar KC, 2015, LAB CHIP, V15, P2412, DOI 10.1039/c5lc00159e
   Hudalla GA, 2014, NAT MATER, V13, P829, DOI [10.1038/NMAT3998, 10.1038/nmat3998]
   Imamura Y, 2015, ONCOL REP, V33, P1837, DOI 10.3892/or.2015.3767
   Janson IA, 2015, J BIOMED MATER RES A, V103, P1246, DOI 10.1002/jbm.a.35254
   Jeon O, 2013, TISSUE ENG PT A, V19, P1424, DOI [10.1089/ten.tea.2012.0581, 10.1089/ten.TEA.2012.0581]
   Jha AK, 2015, BIOMATERIALS, V47, P1, DOI 10.1016/j.biomaterials.2014.12.043
   Joly Y, 2010, NAT BIOTECHNOL, V28, P417, DOI 10.1038/nbt0510-417
   Jung JP, 2008, BIOMATERIALS, V29, P2143, DOI 10.1016/j.biomaterials.2008.01.008
   Jung JP, 2010, BIOPOLYMERS, V94, P49, DOI 10.1002/bip.21326
   Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Kinney MA, 2013, TRENDS BIOTECHNOL, V31, P78, DOI 10.1016/j.tibtech.2012.11.001
   Kirschner CM, 2014, WILEY-SOC BIOMAT SER, P77
   Kirschner CM, 2014, ADV HEALTHC MATER, V3, P649, DOI 10.1002/adhm.201300288
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Kolesky DB, 2014, ADV MATER, V26, P3124, DOI 10.1002/adma.201305506
   Krupinski P, 2012, CURR OPIN GENET DEV, V22, P613, DOI 10.1016/j.gde.2012.08.006
   Kwak B, 2014, J CONTROL RELEASE, V194, P157, DOI 10.1016/j.jconrel.2014.08.027
   Lee HJ, 2015, ADV HEALTHC MATER, V4, P1359, DOI 10.1002/adhm.201500193
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lee MP, 2015, SCI REP-UK, V5, DOI 10.1038/srep09875
   Lee SS, 2013, BIOMATERIALS, V34, P452, DOI 10.1016/j.biomaterials.2012.10.005
   Leight JL, 2015, P NATL ACAD SCI USA, V112, P5366, DOI 10.1073/pnas.1505662112
   Lin CC, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.41563
   Lin CC, 2011, BIOMATERIALS, V32, P9685, DOI 10.1016/j.biomaterials.2011.08.083
   Lin F, 2013, BIOMACROMOLECULES, V14, P3749, DOI 10.1021/bm401133r
   Luo Y, 2004, NAT MATER, V3, P249, DOI 10.1038/nmat1092
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Malda J, 2013, ADV MATER, V25, P5011, DOI 10.1002/adma.201302042
   Mariner PD, 2013, J ORTHOP RES, V31, P401, DOI 10.1002/jor.22243
   Marklein RA, 2010, SOFT MATTER, V6, P136, DOI 10.1039/b916933d
   Martino MM, 2014, SCIENCE, V343, P885, DOI 10.1126/science.1247663
   Masket S, J CATARACT REFRACT S, V40, P2057
   Matson JB, 2012, CHEM COMMUN, V48, P26, DOI 10.1039/c1cc15551b
   McCall JD, 2012, BIOMACROMOLECULES, V13, P2410, DOI 10.1021/bm300671s
   McKinnon DD, 2014, SOFT MATTER, V10, P9230, DOI 10.1039/c4sm01365d
   McKinnon DD, 2014, ADV MATER, V26, P865, DOI 10.1002/adma.201303680
   McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]
   Miller JS, 2012, NAT MATER, V11, P768, DOI [10.1038/NMAT3357, 10.1038/nmat3357]
   Mohammed JS, 2009, ADV MATER, V21, P2361, DOI 10.1002/adma.200803785
   Mosiewicz KA, 2013, NAT MATER, V12, P1071, DOI 10.1038/NMAT3766
   Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958
   Nam KH, 2015, JALA-J LAB AUTOM, V20, P201, DOI 10.1177/2211068214557813
   Nichol JW, 2010, BIOMATERIALS, V31, P5536, DOI 10.1016/j.biomaterials.2010.03.064
   Nimmo CM, 2011, BIOCONJUGATE CHEM, V22, P2199, DOI 10.1021/bc200281k
   Nimmo CM, 2011, BIOMACROMOLECULES, V12, P824, DOI 10.1021/bm101446k
   O'Leary LER, 2011, NAT CHEM, V3, P821, DOI [10.1038/NCHEM.1123, 10.1038/nchem.1123]
   Oliveira MB, 2014, TRENDS BIOTECHNOL, V32, P627, DOI 10.1016/j.tibtech.2014.09.009
   Owen SC, 2013, LANGMUIR, V29, P7393, DOI 10.1021/la305000w
   Pardo L, 2003, LANGMUIR, V19, P1462, DOI 10.1021/la026171u
   PATHAK CP, 1992, J AM CHEM SOC, V114, P8311, DOI 10.1021/ja00047a065
   Pati F, 2015, NAT COMMUN, V5, P3935
   Pearce JM, 2012, SCIENCE, V337, P1303, DOI 10.1126/science.1228183
   Polizzotti BD, 2008, BIOMACROMOLECULES, V9, P1084, DOI 10.1021/bm7012636
   Qin X. -H., 2014, BIONANOMATERIALS, V15, P49, DOI [10.1515/bnm-2014-0008, DOI 10.1515/BNM-2014-0008]
   Ranga A, 2012, CURR OPIN CELL BIOL, V24, P236, DOI 10.1016/j.ceb.2012.01.006
   Ratner B. D., 2004, BIOMATERIALS SCI INT
   Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009
   Rutz AL, 2015, ADV MATER, V27, P1607, DOI 10.1002/adma.201405076
   Schuurman W, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/2/021001
   Scott CM, 2015, LANGMUIR, V31, P6122, DOI 10.1021/acs.langmuir.5b00196
   Sharma B, 2013, SCI TRANSL MED, V5
   Shubin AD, 2015, TISSUE ENG PT A, V21, P1733, DOI [10.1089/ten.TEA.2014.0674, 10.1089/ten.tea.2014.0674]
   Siew CK, 2005, BIOMACROMOLECULES, V6, P963, DOI 10.1021/bm049341l
   Singh M, 2010, ADV MATER, V22, P673, DOI 10.1002/adma.200901141
   Skardal A, 2015, ACTA BIOMATER, V25, P24, DOI 10.1016/j.actbio.2015.07.030
   Skardal A, 2012, STEM CELL TRANSL MED, V1, P792, DOI 10.5966/sctm.2012-0088
   Smeds KA, 2001, J BIOMED MATER RES, V54, P115, DOI 10.1002/1097-4636(200101)54:1<115::AID-JBM14>3.0.CO;2-Q
   Sridhar BV, 2015, ADV HEALTHC MATER, V4, P702, DOI 10.1002/adhm.201400695
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Taipale J, 1997, FASEB J, V11, P51
   Tao X., 2013, BIOFABRICATION, V5
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Tokuda EY, 2014, BIOMATERIALS, V35, P4310, DOI 10.1016/j.biomaterials.2014.01.063
   Tyler K. M., 2015, BIOFABRICATION, V7, DOI DOI 10.1088/1758-5090/7/3/035003
   Van Vlierberghe S, 2011, BIOMACROMOLECULES, V12, P1387, DOI 10.1021/bm200083n
   Vila OF, 2014, ACTA BIOMATER, V10, P4377, DOI 10.1016/j.actbio.2014.05.028
   Vunjak-Novakovic G, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt369
   Wade RJ, 2012, MATER TODAY, V15, P454, DOI 10.1016/S1369-7021(12)70197-9
   Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231
   Wei SC, 2015, NAT CELL BIOL, V17, P678, DOI 10.1038/ncb3157
   Weigelt B, 2014, ADV DRUG DELIVER REV, V69, P42, DOI 10.1016/j.addr.2014.01.001
   West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k
   Wu PH, 2014, P NATL ACAD SCI USA, V111, P3949, DOI 10.1073/pnas.1318967111
   Wylie RG, 2011, NAT MATER, V10, P799, DOI [10.1038/NMAT3101, 10.1038/nmat3101]
   Wylie RG, 2011, BIOMACROMOLECULES, V12, P3789, DOI 10.1021/bm201037j
   Xu T, 2005, BIOMATERIALS, V26, P93, DOI 10.1016/j.biomaterials.2004.04.011
   Xu T, 2004, BIOTECHNOL BIOENG, V85, P29, DOI 10.1002/bit.10768
   Xu T, 2013, BIOMATERIALS, V34, P130, DOI 10.1016/j.biomaterials.2012.09.035
   Xu T, 2008, J MANUF SCI E-T ASME, V130, DOI 10.1115/1.2902857
   Yang C, 2014, NAT MATER, V13, P645, DOI [10.1038/NMAT3889, 10.1038/nmat3889]
   Zhang AP, 2012, ADV MATER, V24, P4266, DOI 10.1002/adma.201202024
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
   Zopf DA, 2013, NEW ENGL J MED, V368, P2043, DOI 10.1056/NEJMc1206319
NR 156
TC 25
Z9 25
U1 14
U2 170
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD APR
PY 2016
VL 11
IS 2
AR 022001
DI 10.1088/1748-6041/11/2/022001
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DL3GY
UT WOS:000375523400003
PM 26942469
OA Other Gold
DA 2018-10-20
ER

PT J
AU Parmaksiz, M
   Dogan, A
   Odabas, S
   Elcin, AE
   Elcin, YM
AF Parmaksiz, Mahmut
   Dogan, Arin
   Odabas, Sedat
   Elcin, A. Eser
   Elcin, Y. Murat
TI Clinical applications of decellularized extracellular matrices for
   tissue engineering and regenerative medicine
SO BIOMEDICAL MATERIALS
LA English
DT Review
DE decellularization; extracellular matrix (ECM); clinical applications;
   biomaterials; tissue engineering; regenerative medicine
ID ACELLULAR DERMAL MATRIX; SMALL-INTESTINAL SUBMUCOSA; TENDON AUGMENTATION
   GRAFTS; DEMINERALIZED BONE-MATRIX; STEM-CELL DIFFERENTIATION; PORCINE
   MEDIAL MENISCUS; ABDOMINAL-WALL DEFECTS; VOLUMETRIC MUSCLE LOSS; VENTRAL
   HERNIA REPAIR; ROTATOR-CUFF TEARS
AB Decellularization is the process of removing the cellular components from tissues or organs. It is a promising technology for obtaining a biomaterial with a highly preserved extracellular matrix (ECM), which may also act as a biological scaffold for tissue engineering and regenerative therapies. Decellularized products are gaining clinical importance and market space due to their ease of standardized production, constant availability for grafting and mechanical or biochemical superiority against competing clinical options, yielding clinical results ahead of the ones with autografts in some applications. Current drawbacks and limitations of traditional treatments and clinical applications can be overcome by using decellularized or acellular matrices. Several companies are leading the market with versatile acellular products designed for diverse use in the reconstruction of tissues and organs. This review describes ECM-based decellularized and acellular products that are currently in use for different branches of clinic.
C1 [Parmaksiz, Mahmut; Dogan, Arin; Odabas, Sedat; Elcin, A. Eser; Elcin, Y. Murat] Ankara Univ, Fac Sci, TR-06100 Ankara, Turkey.
   [Parmaksiz, Mahmut; Dogan, Arin; Odabas, Sedat; Elcin, A. Eser; Elcin, Y. Murat] Ankara Univ, Stem Cell Inst, Tissue Engn Biomat & Nanobiotechnol Lab, TR-06100 Ankara, Turkey.
   [Elcin, Y. Murat] Biovalda Hlth Technol Inc, Ankara, Turkey.
RP Elcin, AE; Elcin, YM (reprint author), Ankara Univ, Fac Sci, TR-06100 Ankara, Turkey.; Elcin, AE; Elcin, YM (reprint author), Ankara Univ, Stem Cell Inst, Tissue Engn Biomat & Nanobiotechnol Lab, TR-06100 Ankara, Turkey.; Elcin, YM (reprint author), Biovalda Hlth Technol Inc, Ankara, Turkey.
EM elcin@ankara.edu.tr; elcin@ankara.edu.tr
RI Dogan, Arin/L-6443-2015
OI Dogan, Arin/0000-0002-5362-5501; Elcin, Yasar Murat/0000-0003-1037-0825
CR Agarwal Chitra, 2015, J Indian Soc Periodontol, V19, P216, DOI 10.4103/0972-124X.149938
   Agrawal V, 2012, INT J SHOULDER SURG, V6, P36, DOI 10.4103/0973-6042.96992
   Akhyari P, 2011, TISSUE ENG PART C-ME, V17, P915, DOI [10.1089/ten.tec.2011.0210, 10.1089/ten.TEC.2011.0210]
   Albornoz CR, 2013, PLAST RECONSTR SURG, V131, P15, DOI 10.1097/PRS.0b013e3182729cde
   [Anonymous], 2010, A426 MEDTECH INS
   Ariganello MB, 2011, BIOMATERIALS, V32, P439, DOI 10.1016/j.biomaterials.2010.09.004
   Armitage S, 2012, OBSTET GYNECOL INT, V2012, DOI 10.1155/2012/376251
   Arunkalaivanan AS, 2003, INT UROGYNECOL J, V14, P17, DOI 10.1007/s00192-002-1000-9
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Atala A, 2006, CURR OPIN PEDIATR, V18, P167, DOI 10.1097/01.mop.0000193294.94646.be
   Aurora A, 2007, J SHOULDER ELB SURG, V16, p171S, DOI 10.1016/j.jse.2007.03.008
   BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   Badylak SF, 1998, J BIOMAT SCI-POLYM E, V9, P863, DOI 10.1163/156856298X00208
   Badylak SF, 2014, ANN BIOMED ENG, V42, P1517, DOI 10.1007/s10439-013-0963-7
   Badylak SF, 2012, LANCET, V379, P943, DOI 10.1016/S0140-6736(12)60073-7
   Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Baiguera S, 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/398069
   Baptista PM, 2011, HEPATOLOGY, V53, P604, DOI 10.1002/hep.24067
   Barakat O, 2012, J SURG RES, V173, pE11, DOI 10.1016/j.jss.2011.09.033
   Barber FA, 2012, ARTHROSCOPY, V28, P8, DOI 10.1016/j.arthro.2011.06.038
   Barber FA, 2006, ARTHROSCOPY, V22, P534, DOI 10.1016/j.arthro.2005.12.021
   Bellows CF, 2007, AM J SURG, V194, P192, DOI 10.1016/j.amjsurg.2006.11.012
   Berg M, 2014, TISSUE ENG PT A, V20, P389, DOI [10.1089/ten.tea.2012.0514, 10.1089/ten.TEA.2012.0514]
   Bissell M J, 1987, Prog Clin Biol Res, V249, P251
   Breuing K, 2010, SURGERY, V148, P544, DOI 10.1016/j.surg.2010.01.008
   Bringman S, 2010, HERNIA, V14, P81, DOI 10.1007/s10029-009-0587-x
   Brown CN, 2010, ANN ROY COLL SURG, V92, P272, DOI 10.1308/003588410X12664192076296
   Brown JW, 2011, ANN THORAC SURG, V91, P416, DOI 10.1016/j.athoracsur.2010.10.069
   Burkhead WZ, 2007, SEMIN ARTHROPLASTY, V18, P11, DOI DOI 10.1053/J.SART.2006.11.017
   Byrne GW, 2012, CURR OPIN ORGAN TRAN, V17, P148, DOI 10.1097/MOT.0b013e3283509120
   Cartmell JS, 2000, J BIOMED MATER RES, V49, P134, DOI 10.1002/(SICI)1097-4636(200001)49:1<134::AID-JBM17>3.3.CO;2-4
   Chen F, 1999, UROLOGY, V54, P407, DOI 10.1016/S0090-4295(99)00179-X
   Chen RN, 2004, BIOMATERIALS, V25, P2679, DOI 10.1016/j.biomaterials.2003.09.070
   Cheng A, 2012, CLIN PLAST SURG, V39, P167, DOI 10.1016/j.cps.2012.02.004
   Cheng CW, 2014, BIOTECHNOL ADV, V32, P462, DOI 10.1016/j.biotechadv.2013.12.012
   Choe JM, 2001, UROLOGY, V58, P482, DOI 10.1016/S0090-4295(01)01205-5
   Choi JS, 2010, BIOMATERIALS, V31, P6738, DOI 10.1016/j.biomaterials.2010.05.020
   Cornwell Kevin G, 2009, Clin Podiatr Med Surg, V26, P507, DOI 10.1016/j.cpm.2009.08.001
   Corona BT, 2014, TISSUE ENG PT A, V20, P705, DOI 10.1089/ten.TEA.2012.0761
   Cortiella J, 2010, TISSUE ENG PT A, V16, P2565, DOI 10.1089/ten.tea.2009.0730
   Dallenbach P, 2015, IN J WOMENS HEALTH, V7, P331, DOI 10.2147/IJWH.S71236
   Demirdogen B, 2010, GROWTH FACTORS, V28, P426, DOI 10.3109/08977194.2010.508456
   Dieterich M, 2013, GEBURTSH FRAUENHEILK, V73, P1100, DOI 10.1055/s-0033-1350930
   Dogan A, 2016, STEM CELL REV REP, V12, P202, DOI 10.1007/s12015-015-9641-5
   Edmunds D, 2014, MEDTECH, V360
   Eker HH, 2013, JAMA SURG, V148, P259, DOI 10.1001/jamasurg.2013.1466
   Elcin AE, 2006, TISSUE ENG, V12, P959, DOI 10.1089/ten.2006.12.959
   Elcin YM, 1999, ARTIF ORGANS, V23, P146, DOI 10.1046/j.1525-1594.1999.06222.x
   Elsalanty ME, 2009, CRANIOMAX TRAUM REC, V2, P125, DOI [10.1055/s-0029-1215875.ISSN1943-3875, 10.1055/s-0029-1215875]
   Emmert MY, 2014, ADV DRUG DELIVER REV, V69, P254, DOI 10.1016/j.addr.2013.12.004
   Ferzoco SJ, 2013, INT SURG, V98, P399, DOI 10.9738/INTSURG-D-12-00002.1
   Flynn LE, 2010, BIOMATERIALS, V31, P4715, DOI 10.1016/j.biomaterials.2010.02.046
   Frazer M, 2009, PELVIPERINEOLOGY, V28, P82
   Freytes DO, 2004, BIOMATERIALS, V25, P2353, DOI 10.1016/j.biomaterials.2003.09.015
   Frishman WH, 2013, J CARDIOVASC PHARM T, V18, P310, DOI 10.1177/1074248413484986
   Frohlich M, 2010, TISSUE ENG PT A, V16, P179, DOI [10.1089/ten.tea.2009.0164, 10.1089/ten.TEA.2009.0164]
   Galvez-Monton C, 2013, REV ESP CARDIOL, V66, P391, DOI 10.1016/j.rec.2012.11.012
   Gerber B, 2009, ANN SURG, V249, P461, DOI 10.1097/SLA.0b013e31819a044f
   Ghazi B, 2011, ANN PLAS SURG, V66, P488, DOI 10.1097/SAP.0b013e31820d18db
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Golla D, 2014, INT SURG, V99, P235, DOI 10.9738/INTSURG-D-13-00170.1
   Grandi C, 2011, INT J MOL MED, V28, P315, DOI 10.3892/ijmm.2011.720
   Gruskin E, 2012, ADV DRUG DELIVER REV, V64, P1063, DOI 10.1016/j.addr.2012.06.008
   Hara H, 2011, CORNEA, V30, P371, DOI 10.1097/ICO.0b013e3181f237ef
   HAWKINS RJ, 1985, J BONE JOINT SURG AM, V67A, P1349, DOI 10.2106/00004623-198567090-00007
   Heinemeier KM, 2011, J MUSCULOSKEL NEURON, V11, P115
   Hodde J P, 2005, J Wound Care, V14, P23
   Holubec T, 2015, J CARDIAC SURG, V30, P145, DOI 10.1111/jocs.12494
   Hulsmann J, 2012, XENOTRANSPLANTATION, V19, P286, DOI 10.1111/j.1399-3089.2012.00719.x
   Inanc B, 2008, TISSUE ENG PT A, V14, P955, DOI [10.1089/ten.tea.2007.0213, 10.1089/tea.2007.0213]
   Inanc B, 2009, TISSUE ENG PT A, V15, P3427, DOI [10.1089/ten.tea.2008.0380, 10.1089/ten.TEA.2008.0380]
   Jeon MJ, 2007, YONSEI MED J, V48, P147, DOI 10.3349/ymj.2007.48.2.147
   Dalmau MJ, 2011, EUR J CARDIO-THORAC, V39, P844, DOI 10.1016/j.ejcts.2010.11.015
   Juhasz I, 2010, DERMATOL RES PRACT, V2010
   Keenan TDL, 2011, BRIT J OPHTHALMOL, V95, P468, DOI 10.1136/bjo.2010.182329
   Kim BS, 2004, J BIOMED MATER RES A, V68A, P201, DOI 10.1002/jbm.a.10045
   Kim H, 2006, AM J SURG, V192, P705, DOI 10.1016/j.amjsurg.2006.09.003
   Kobashi KC, 2003, J UROLOGY, V169, P2242, DOI 10.1097/01.ju.0000060119.43064.f6
   Kochupura PV, 2005, CIRCULATION, V112, pI144, DOI 10.1161/CIRCULATIONAHA.104.524355
   Lam MT, 2012, EXPERT REV CARDIOVAS, V10, P1039, DOI [10.1586/erc.12.99, 10.1586/ERC.12.99]
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee W, 2014, INT J OPHTHALMOL-CHI, V7, P587, DOI 10.3980/j.issn.2222-3959.2014.04.01
   Lepow BD, 2011, EXPERT REV DERMATOL, V6, P255
   Levenda AC, 2015, ADV ORTHOP SURG, V2015, DOI DOI 10.1155/2015/423949
   Liao JH, 2010, BIOMATERIALS, V31, P8911, DOI 10.1016/j.biomaterials.2010.07.110
   Lin CH, 2014, INT J ARTIF ORGANS, V37, P546, DOI 10.5301/ijao.5000344
   Liu LB, 2011, INT UROGYNECOL J, V22, P221, DOI 10.1007/s00192-010-1288-9
   Longo UG, 2010, BRIT MED BULL, V94, P165, DOI 10.1093/bmb/ldp051
   Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6
   Makris EA, 2011, BIOMATERIALS, V32, P7411, DOI 10.1016/j.biomaterials.2011.06.037
   Mamaril Myrna Eileen, 2007, J Perianesth Nurs, V22, P184
   Mantovani F, 2003, EUR UROL, V44, P600, DOI 10.1016/S0302-2838(03)00212-4
   Marcos-Campos I, 2012, BIOMATERIALS, V33, P8329, DOI 10.1016/j.biomaterials.2012.08.013
   Markeson D, 2015, J TISSUE ENG REGEN M, V9, P649, DOI 10.1002/term.1841
   Mase Vincent J Jr, 2010, Orthopedics, V33, P511, DOI 10.3928/01477447-20100526-24
   McDevitt CA, 2003, J BIOMED MATER RES A, V67A, P637, DOI 10.1002/jbm.a.10144
   McGregor CGA, 2011, J THORAC CARDIOV SUR, V141, P269, DOI 10.1016/j.jtcvs.2010.08.064
   Moroni F, 2014, AM J STEM CELLS, V3, P1
   Morticelli L, 2013, J HEART VALVE DIS, V22, P340
   Mostow EN, 2005, J VASC SURG, V41, P837, DOI 10.1016/j.jvs.2005.01.042
   Nazemi TM, 2007, INDIAN J UROL, V23, P153, DOI 10.4103/0970-1591.32067
   Nelson DM, 2011, ACTA BIOMATER, V7, P1, DOI 10.1016/j.actbio.2010.06.039
   Olausson M, 2014, EBIOMEDICINE, V1, P72, DOI 10.1016/j.ebiom.2014.09.001
   Oryan A, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/1749-799X-9-18
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193
   Parmaksiz M, 2017, J TISSUE ENG REGEN M, V11, P1754, DOI 10.1002/term.2071
   Pereira T., 2013, ADV BIOMATERIALS SCI
   Perri G, 2012, EUR J CARDIO-THORAC, V41, P1320, DOI 10.1093/ejcts/ezr221
   Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345
   Raghavan SS, 2012, TISSUE ENG PT A, V18, P796, DOI [10.1089/ten.tea.2011.0422, 10.1089/ten.TEA.2011.0422]
   Roth JS, 2015, HERNIA, V19, P247, DOI 10.1007/s10029-014-1245-5
   Rutkow IM, 2003, SURG CLIN N AM, V83, P1045, DOI 10.1016/S0039-6109(03)00132-4
   Sanchez PL, 2015, BIOMATERIALS, V61, P279, DOI 10.1016/j.biomaterials.2015.04.056
   Sarig U, 2012, TISSUE ENG PT A, V18, P2125, DOI [10.1089/ten.tea.2011.0586, 10.1089/ten.TEA.2011.0586]
   Sawkins MJ, 2013, ACTA BIOMATER, V9, P7865, DOI 10.1016/j.actbio.2013.04.029
   Schenke-Layland K, 2011, ADV DRUG DELIVER REV, V63, P195, DOI 10.1016/j.addr.2011.05.001
   Scholl FG, 2010, WORLD J PEDIATR CONG, V1, P132, DOI 10.1177/2150135110362092
   Sicari BM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008085
   Sicari BM, 2012, TISSUE ENG PT A, V18, P1941, DOI [10.1089/ten.TEA.2012.0475, 10.1089/ten.tea.2012.0475]
   Siddiqui NY, 2014, IN J WOMENS HEALTH, V6, P83, DOI 10.2147/IJWH.S54845
   Silverman R P, 2004, Hernia, V8, P336, DOI 10.1007/s10029-004-0241-6
   Simon P, 2003, EUR J CARDIO-THORAC, V23, P1002, DOI 10.1016/S1010-7940(03)00094-0
   Smart NJ, 2014, BIOL-TARGETS THER, V8, P83, DOI 10.2147/BTT.S46469
   Song JJ, 2011, TRENDS MOL MED, V17, P424, DOI 10.1016/j.molmed.2011.03.005
   Soto-Gutierrez A, 2011, TISSUE ENG PART C-ME, V17, P677, DOI 10.1089/ten.tec.2010.0698
   Stapleton TW, 2008, TISSUE ENG PT A, V14, P505, DOI 10.1089/tea.2007.0233
   Stapleton TW, 2011, TISSUE ENG PT A, V17, P231, DOI 10.1089/ten.TEA.2009.0807
   Stelly M, 2013, ANN THORAC SURG, V96, pE127, DOI 10.1016/j.athoracsur.2013.06.114
   Sundermann SH, 2015, INTERACT CARDIOV TH, V20, P10, DOI 10.1093/icvts/ivu310
   Taylor JB, 2010, INT J PERIODONT REST, V30, P513
   Tidball JG, 2011, COMPR PHYSIOL, V1, P2029, DOI 10.1002/cphy.c100092
   Tilkeridis K, 2014, WORLD J ORTHOP, V5, P30, DOI 10.5312/wjo.v5.i1.30
   Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170
   Valdatta L, 2014, PLAST SURG INT, V2014
   Valentin JE, 2009, TISSUE ENG PT A, V15, P1687, DOI 10.1089/ten.tea.2008.0419
   van den Heever JJ, 2013, CELL TISSUE BANK, V14, P53, DOI 10.1007/s10561-012-9299-z
   Vashi A V, 2014, J BIOMED MATER RES A, DOI [10.1002/jbma.35335, DOI 10.1002/JBMA.35335]
   Vekris MD, 2008, INJURY, V39, pS15, DOI 10.1016/j.injury.2008.06.008
   Vindigni V, 2004, PLAST RECONSTR SURG, V114, P1509, DOI 10.1097/01.PRS.0000138253.96709.E5
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   Wainwright JM, 2010, THESIS U PITTSBURGH
   Wang JC, 2007, EUR SPINE J, V16, P1233, DOI 10.1007/s00586-006-0282-x
   Weichman KE, 2013, PLAST RECONSTR SURG, V132, P725, DOI 10.1097/PRS.0b013e31829fe35b
   Wilson SL, 2013, J FUNCT BIOMATER, V4, P114, DOI 10.3390/jfb4030114
   Wolf MT, 2012, BIOMATERIALS, V33, P2916, DOI 10.1016/j.biomaterials.2011.12.055
   Woods T, 2005, BIOMATERIALS, V26, P7339, DOI 10.1016/j.biomaterials.2005.05.066
   World Health Organization, 2012, WORLD HLTH STAT
   Wu I, 2012, PLAST RECONSTR SURG, V129, P1247, DOI 10.1097/PRS.0b013e31824ec3dc
   Yanagawa B, 2013, INNOVATIONS, V8, P348, DOI 10.1097/IMI.0000000000000014
   Yoo JJ, 1998, UROLOGY, V51, P221, DOI 10.1016/S0090-4295(97)00644-4
   Youngstrom DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064151
NR 154
TC 22
Z9 23
U1 8
U2 55
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD APR
PY 2016
VL 11
IS 2
AR 022003
DI 10.1088/1748-6041/11/2/022003
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DL3GY
UT WOS:000375523400005
PM 26989100
DA 2018-10-20
ER

PT J
AU Varoni, EM
   Altomare, L
   Cochis, A
   GhalayaniEsfahani, A
   Cigada, A
   Rimondini, L
   De Nardo, L
AF Varoni, Elena Maria
   Altomare, Lina
   Cochis, Andrea
   GhalayaniEsfahani, Arash
   Cigada, Alberto
   Rimondini, Lia
   De Nardo, Luigi
TI Hierarchic micro-patterned porous scaffolds via electrochemical
   replica-deposition enhance neo-vascularization
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE neovascularization; electrochemical deposition; chitosan; tissue
   engineering
ID IN-VITRO; BIOMATERIAL SCAFFOLDS; TISSUE; CHITOSAN; CELLS; ANGIOGENESIS
AB Neo-vascularization is a key factor in tissue regeneration within porous scaffolds. Here, we tested the hypothesis that micro-patterned scaffolds, with precisely-designed, open micro-channels, might help endothelial cells to produce int ra-scaffold vascular networks. Three series of micro-patterned scaffolds were produced via electrochemical replica-deposition of chitosan and cross-linking. All had regularly-oriented micro-channels (0 500 pm), which differed for the inter-channel spacing, at 600, 700, or 900 pm, respectively. Random-pore scaffolds, using the same technique, were taken as controls. Physical-mechanical characterization revealed high water uptake and favorable elastic mechanical behavior for all scaffolds, slightly reduced in the presence of cross-linking and enhanced with the 700 pm-spaced micro-pattern. At MTT assay, mouse endothelial cell viability was >90% at day 1,3 and 7, confirmed by visual examination with scanning electron microscopy (SEM). Intrascaffold cell density, at fluorescence analysis, was higher for the 600 Am-spaced and the 700 pm-spaced micro-patterns over the others. The 700 Am-spaced scaffold was selected for the in vivo testing, to be compared to the random-pore one. Neither type produced an inflammatory reaction; both showed excellent tissue ingrowth. Micro-patterned scaffolds enhanced neo-vascularization, demonstrated by immu nofluorescent, semi-quantitative analyses. These findings support the use of micro-patterned porous scaffolds, with adequately spaced micro-channels, to promote neo-vascularization.
C1 [Varoni, Elena Maria; Cochis, Andrea] Univ Milan, Dept Biomed Surg & Dent Sci, Via Beldiletto 1, Milan, MI, Italy.
   [Altomare, Lina; GhalayaniEsfahani, Arash; Cigada, Alberto; De Nardo, Luigi] Politecn Milan, Dept Chem Mat & Chem Engn G Natta, Piazza Leonardo da Vinci 32, I-20133 Milan, MI, Italy.
   [Altomare, Lina; Cigada, Alberto; De Nardo, Luigi] Politecn Milan, Consorzio Interuniv Nazl Sci & Tecnol Mat INSTM, Local Unit, Via Giusti 9, I-50121 Florence, FI, Italy.
   [Cochis, Andrea; Rimondini, Lia] Univ Piemonte Orientale, Dept Hlth Sci, Via Solaroli 17, Novara, NO, Italy.
   [Cochis, Andrea; Rimondini, Lia] Univ Piemonte Orientale, Local Unit, Consorzio Interuniv Nazl Sci & Tecnol Mat INSTM, Via Giusti 9, I-50121 Florence, FI, Italy.
RP Varoni, EM (reprint author), Univ Milan, Dept Biomed Surg & Dent Sci, Via Beldiletto 1, Milan, MI, Italy.
EM elena.varoni@unimi.it
OI Cochis, Andrea/0000-0003-2455-8239; ALTOMARE, LINA/0000-0001-9555-1291
FU MIUR through FIRB Futuro in Ricerca (Surface-associated selective
   transfection-SAST) [RBFR08XH0H]; Ministry of Education, University and
   Research (M.I.U.R., Rome, Italy) [PRIN 20102ZLNJ5_006]
FX LA and LDN thank MIUR for economic support through FIRB Futuro in
   Ricerca (Surface-associated selective transfection-SAST, RBFR08XH0H). AC
   thanks PRIN 2010-2011 (PRIN 20102ZLNJ5_006), by the Ministry of
   Education, University and Research (M.I.U.R., Rome, Italy) for financial
   support.
CR Altomare L, 2008, J APPL BIOMATER BIOM, V6, P132
   Altomare Lina, 2014, Biomatter, V4, DOI 10.4161/biom.29506
   Altomare L, 2012, MATER LETT, V78, P18, DOI 10.1016/j.matlet.2012.03.035
   Anitua E, 2010, ADV DRUG DELIVER REV, V62, P741, DOI 10.1016/j.addr.2010.01.001
   Bi L, 2011, J MATER SCI-MATER M, V22, P51, DOI 10.1007/s10856-010-4177-3
   Bloch K, 2010, ACTA BIOMATER, V6, P1200, DOI 10.1016/j.actbio.2009.08.022
   Cao Y, 2006, BIOMATERIALS, V27, P2854, DOI 10.1016/j.biomaterials.2005.12.015
   Chiu YC, 2011, BIOMATERIALS, V32, P6045, DOI 10.1016/j.biomaterials.2011.04.066
   Chrobak KM, 2006, MICROVASC RES, V71, P185, DOI 10.1016/j.mvr.2006.02.005
   De Nardo L, 2012, COATINGS FOR BIOMEDICAL APPLICATIONS, P106
   Dutta RC, 2009, BIOTECHNOL ADV, V27, P334, DOI 10.1016/j.biotechadv.2009.02.002
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Ju YM, 2010, BIOMATERIALS, V31, P4313, DOI 10.1016/j.biomaterials.2010.02.002
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kaully T, 2009, TISSUE ENG PART B-RE, V15, P159, DOI 10.1089/ten.teb.2008.0193
   Luo YX, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/1/015005
   Mehdizadeh H, 2013, BIOMATERIALS, V34, P2875, DOI 10.1016/j.biomaterials.2012.12.047
   Nardo L. D., 2011, SMART MATER STRUCT, V20
   Norotte C, 2009, BIOMATERIALS, V30, P5910, DOI 10.1016/j.biomaterials.2009.06.034
   Novosel EC, 2011, ADV DRUG DELIVER REV, V63, P300, DOI 10.1016/j.addr.2011.03.004
   Obokata H, 2011, NAT PROTOC, V6, P1053, DOI 10.1038/nprot.2011.356
   Perets A, 2003, J BIOMED MATER RES A, V65A, P489, DOI 10.1002/jbm.a.10542
   Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729
   Phelps EA, 2010, CURR OPIN BIOTECH, V21, P704, DOI 10.1016/j.copbio.2010.06.005
   Rorth P, 2009, ANNU REV CELL DEV BI, V25, P407, DOI 10.1146/annurev.cellbio.042308.113231
   Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009
   Shen YH, 2008, ACTA BIOMATER, V4, P477, DOI 10.1016/j.actbio.2007.12.011
   Simchi A, 2009, MATER LETT, V63, P2253, DOI 10.1016/j.matlet.2009.07.046
   Snyder JE, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/1/015007
   Stegen S, 2015, BONE, V70, P19, DOI 10.1016/j.bone.2014.09.017
   Sukmana I, 2012, SCI WORLD J, DOI 10.1100/2012/201352
   Sun CH, 2012, MACROMOL BIOSCI, V12, P761, DOI 10.1002/mabi.201200004
   Tan JY, 2013, BIOMED MICRODEVICES, V15, P83, DOI 10.1007/s10544-012-9690-3
   Unger RE, 2010, BIOMATERIALS, V31, P6959, DOI 10.1016/j.biomaterials.2010.05.057
   VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270
NR 35
TC 4
Z9 4
U1 3
U2 15
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD APR
PY 2016
VL 11
IS 2
AR 025018
DI 10.1088/1748-6041/11/2/025018
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DL3GY
UT WOS:000375523400023
PM 27099204
DA 2018-10-20
ER

PT J
AU DeHoog, E
   Doraiswamy, A
AF DeHoog, Edward
   Doraiswamy, Anand
TI Evaluation of loss in optical quality of multifocal intraocular lenses
   with glistenings
SO JOURNAL OF CATARACT AND REFRACTIVE SURGERY
LA English
DT Article
ID SURFACE LIGHT-SCATTERING; VISUAL FUNCTION; SCHEIMPFLUG PHOTOGRAPHY;
   LONG-TERM; EYES; PERFORMANCE; CATARACT; IMPACT; ACUITY; MODEL
AB PURPOSE: To study the impact of loss in optical quality from glistenings in diffractive multifocal intraocular lenses (IOLs) using ray tracing in a model eye.
   SETTING: Independent research laboratory, Irvine, California, USA.
   DESIGN: Experimental study.
   METHODS: A pseudophakic eye model was constructed in Zemax, an optical ray-tracing program, using the Arizona eye model as the basis. The Mie scattering theory was used to describe the intensity and direction of light as it scattered for a spherical particle immersed in a diffractive multifocal IOL. To evaluate the impact of glistening scatter, a more advanced eye model was constructed in Fred, a nonsequential optical ray-tracing software. An evaluation of scatter and modulation transfer function (MTF) was performed for a hydrophobic biomaterial with a refractive index of 1.54 for various sizes and densities of glistenings under mesopic conditions.
   RESULTS: As predicted by the Mie theory, the amount of scatter was a function of the change in the refractive index, size of the scatterer, and volume fraction of the scatterers. This modeling showed that an increase in density of glistenings can lead to a significant drop of MTF of the IOL. This effect was more pronounced in multifocal IOLs than in monofocal IOLs.
   CONCLUSIONS: Mathematical modeling showed that glistenings in multifocal IOLs lead to a reduction in MTF of the IOL and the pseudophakic eye. The relative loss of MTF in multifocal IOLs was more significant than in monofocal IOLs because of the nature of the design.
C1 [DeHoog, Edward] Opt Engn & Anal LLC, Irvine, CA USA.
RP Doraiswamy, A (reprint author), 508 Natoma St, San Francisco, CA 94103 USA.
EM andyswamy@gmail.com
CR Agbessi L, 2014, ANN M ASS RES VIS OP
   Auffarth GU, 2001, OPHTHALMOLOGE, V98, P127, DOI 10.1007/s003470170172
   Beheregaray S, 2014, J CATARACT REFR SURG, V40, P1147, DOI 10.1016/j.jcrs.2013.10.047
   Behndig A, 2009, J CATARACT REFR SURG, V35, P14, DOI 10.1016/j.jcrs.2008.08.040
   Bellucci Roberto, 2005, Curr Opin Ophthalmol, V16, P33, DOI 10.1097/00055735-200502000-00006
   Christiansen G, 2001, J CATARACT REFR SURG, V27, P728, DOI 10.1016/S0886-3350(00)00700-8
   Colin J, 2012, J CATARACT REFR SURG, V38, P1140, DOI 10.1016/j.jcrs.2012.01.031
   Costello MJ, 2007, INVEST OPHTH VIS SCI, V48, P303, DOI 10.1167/iovs.06-0480
   De Hoog E, 2014, J CATARACT REFR SURG, V40, P95, DOI 10.1016/j.jcrs.2013.10.018
   de Vries NE, 2013, J CATARACT REFR SURG, V39, P268, DOI 10.1016/j.jcrs.2012.12.002
   Dhaliwal DK, 1996, J CATARACT REFR SURG, V22, P452, DOI 10.1016/S0886-3350(96)80041-1
   Dogru M, 2000, J CATARACT REFR SURG, V26, P571, DOI 10.1016/S0886-3350(99)00342-9
   Gilliland KO, 2008, MOL VIS, V14, P572
   Goodman JW, 1996, INTRO FOURIER OPTICS, P267
   Goodman T, 2007, LIGHTING RES TECHNOL, V39, P365, DOI 10.1177/1477153507080930
   GREIVENKAMP JE, 1995, AM J OPHTHALMOL, V120, P227, DOI 10.1016/S0002-9394(14)72611-X
   Gunenc U, 2001, J CATARACT REFR SURG, V27, P1611, DOI 10.1016/S0886-3350(01)00995-6
   Harvey JE, 2013, OPT ENG, V52, DOI 10.1117/1.OE.52.7.073110
   Hayashi K, 2012, AM J OPHTHALMOL, V154, P240, DOI 10.1016/j.ajo.2012.03.011
   Henriksen BS, 2015, J CATARACT REFR SURG, V41, P1190, DOI 10.1016/j.jcrs.2014.09.051
   Iskander DR, 2006, OPTOMETRY VISION SCI, V83, P57, DOI 10.1097/01.opx.0000195563.82891.3b
   Klos KM, 1999, OPHTHALMIC RES, V31, P130, DOI 10.1159/000055524
   LANG A, 1993, J CATARACT REFR SURG, V19, P505, DOI 10.1016/S0886-3350(13)80615-3
   LANG AJ, 1993, J OPT SOC AM A, V10, P1600, DOI 10.1364/JOSAA.10.001600
   Marsack JD, 2004, J VISION, V4, P322, DOI 10.1167/4.4.8
   Matsushima H, 2009, J CATARACT REFR SURG, V35, P1927, DOI 10.1016/j.jcrs.2009.07.004
   Mitooka K, 1998, GANKA, V40, P1501
   Miyata A, 2004, J CATARACT REFR SURG, V30, P1768, DOI 10.1016/j.jcrs.2003.12.038
   Miyata Akira, 1997, Rinsho Ganka, V51, P729
   Miyata K, 2012, J CATARACT REFR SURG, V38, P221, DOI 10.1016/j.jcrs.2011.08.042
   Monestam E, 2011, ACTA OPHTHALMOL, V89, P724, DOI 10.1111/j.1755-3768.2009.01833.x
   Moreno-Montanes J, 2003, J CATARACT REFR SURG, V29, P1980, DOI 10.1016/S0886-3350(03)00136-6
   Nagata M, 2010, J CATARACT REFR SURG, V36, P2056, DOI 10.1016/j.jcrs.2010.06.064
   Nishihara H, 2003, J CATARACT REFR SURG, V29, P1385, DOI 10.1016/S0886-3350(02)01994-6
   Omar O, 1998, J CATARACT REFR SURG, V24, P107, DOI 10.1016/S0886-3350(98)80082-5
   Ong MD, 2012, J CATARACT REFR SURG, V38, P1833, DOI 10.1016/j.jcrs.2012.05.043
   Oshika T, 2001, BRIT J OPHTHALMOL, V85, P1034, DOI 10.1136/bjo.85.9.1034
   Schwiegerling J, 2004, FIELD GUIDE VISUAL O, P19
   Shiokawa Y, 2000, SHIKAKU NO KAGAKU, V21, P18
   STOVER JC, 1995, OPTICAL SCATTERING, P4
   Takahashi Y, 2015, J CATARACT REFR SURG, V41, P193, DOI 10.1016/j.jcrs.2014.10.021
   Tognetto D, 2002, J CATARACT REFR SURG, V28, P1211, DOI 10.1016/S0886-3350(02)01353-6
   Waite A, 2007, AM J OPHTHALMOL, V144, P143, DOI 10.1016/j.ajo.2007.03.015
   [王磊 WANG Lei], 2007, [测绘通报, Bulletin of Surveying and Mapping], P7
   Werner L, 2007, J CATARACT REFR SURG, V33, P713, DOI 10.1016/j.jcrs.2007.01.015
   Werner L, 2010, J CATARACT REFR SURG, V36, P1398, DOI 10.1016/j.jcrs.2010.06.003
   Xi L, 2014, INT J OPHTHALMOL-CHI, V7, P446, DOI 10.3980/j.issn.2222-3959.2014.03.11
   Yaguchi Shigeo, 2002, Nippon Ganka Gakkai Zasshi, V106, P109
   Yoshida S, 2000, NIHON GANNAI RENZU K, V14, P289
NR 49
TC 2
Z9 2
U1 0
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0886-3350
EI 1873-4502
J9 J CATARACT REFR SURG
JI J. Cataract. Refract. Surg.
PD APR
PY 2016
VL 42
IS 4
BP 606
EP 612
DI 10.1016/j.jcrs.2015.10.071
PG 7
WC Ophthalmology; Surgery
SC Ophthalmology; Surgery
GA DL3DW
UT WOS:000375515400016
PM 27113885
DA 2018-10-20
ER

PT J
AU Du, JK
   Chao, CY
   Jhong, YT
   Wu, CH
   Wu, JH
AF Du, Je-Kang
   Chao, Chih-Yeh
   Jhong, Yu-Ting
   Wu, Chung-Hao
   Wu, Ju-Hui
TI Effects of Cr2N Precipitation on the Antibacterial Properties of AISI
   430 Stainless Steel
SO METALS
LA English
DT Article
DE Cr2N precipitation; antibacterial behavior; ferritic type stainless
   steel; Escherichia coli
ID BIOMATERIALS; TEMPERATURE
AB Based on their mechanical properties and good corrosion resistance, some commercial Ni-Cr stainless steels have been widely applied as biomaterials, including the austenitic 304 stainless steel, the austenitic 316 stainless steel, the duplex 2205 stainless steel, and the ferritic 430 stainless steel. In order to reduce the occurrence of infections resulting from biomaterial implants, instruments, and medical devices, Cu2+ and Ag2+ ions have been added onto biomaterials for increasing the antibacterial properties, but they are known to damage biofilm. The occurrence of nanoparticles can also improve the antibacterial properties of biomaterials through various methods. In this study, we used Escherichia coli and analyzed the microstructures of American Iron and Steel Institute (AISI) 430 stainless steel with a 0.18 mass % N alloy element. During a lower temperature aging, the microstructure of the as-quenched specimen is essentially a ferrite and martensite duplex matrix with some Cr2N precipitates formed. Additionally, the antibacterial properties of the alloy for E. coli ranged from 3% to 60%, consistent with the presence of Cr2N precipitates. When aged at a lower temperature, which resulted in nano-Cr2N precipitation, the specimen possessed the highest antibacterial activity.
C1 [Du, Je-Kang] Kaohsiung Med Univ, Coll Dent Med, Sch Dent, Kaohsiung 80708, Taiwan.
   [Du, Je-Kang; Wu, Ju-Hui] Kaohsiung Med Univ Hosp, Dept Dent, Kaohsiung 80708, Taiwan.
   [Du, Je-Kang] Kaohsiung Med Univ, Coll Dent Med, Sch Dent, PhD Program, Kaohsiung 80708, Taiwan.
   [Chao, Chih-Yeh; Wu, Chung-Hao] Natl Pingtung Univ Sci & Technol, Dept Mech Engn, Pingtung 91201, Taiwan.
   [Jhong, Yu-Ting; Wu, Ju-Hui] Kaohsiung Med Univ, Coll Dent Med, Grad Inst Oral Hyg, Kaohsiung 80708, Taiwan.
   [Wu, Ju-Hui] Kaohsiung Med Univ, Coll Dent Med, Dept Oral Hyg, 100 Shih Chuan 1st Rd, Kaohsiung 80708, Taiwan.
RP Wu, JH (reprint author), Kaohsiung Med Univ Hosp, Dept Dent, Kaohsiung 80708, Taiwan.; Wu, JH (reprint author), Kaohsiung Med Univ, Coll Dent Med, Grad Inst Oral Hyg, Kaohsiung 80708, Taiwan.; Wu, JH (reprint author), Kaohsiung Med Univ, Coll Dent Med, Dept Oral Hyg, 100 Shih Chuan 1st Rd, Kaohsiung 80708, Taiwan.
EM dujekang@gmail.com; cychao@mail.npust.edu.tw;
   steelwillpower0130@gmail.com; richman720423@gmail.com;
   wujuhui1020@gmail.com
FU Ministry of Science and Technology, ROC [104-2314-B-037-057-MY2]
FX This work was partially funded by a grant from the Ministry of Science
   and Technology, ROC (104-2314-B-037-057-MY2).
CR Barrere F, 2008, MAT SCI ENG R, V59, P38, DOI 10.1016/j.mser.2007.12.001
   Chen QZ, 2015, MAT SCI ENG R, V87, P1, DOI 10.1016/j.mser.2014.10.001
   Chieh L.W., 2000, STUDY ANTIBACTERIAL
   Chin-Min C., 2010, STUDY ANTIBACTERIAL
   Chu PK, 2007, SURF COAT TECH, V201, P8076, DOI 10.1016/j.surfcoat.2005.12.053
   Diaz-Visurraga J, 2011, SCI MICROBIAL PATHOG, V3, P210
   Dong J., 2004, MAT REV, V18, P41
   Dunnill CWH, 2009, J PHOTOCH PHOTOBIO A, V207, P244, DOI 10.1016/j.jphotochem.2009.07.024
   Erneman J, 2004, ACTA MATER, V52, P4337, DOI 10.1016/j.actamat.2004.06.001
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Gehrig LMB, 2011, AM J SURG, V202, P364, DOI 10.1016/j.amjsurg.2011.06.007
   Hajipour MJ, 2012, TRENDS BIOTECHNOL, V30, P499, DOI 10.1016/j.tibtech.2012.06.004
   Ju L.T., 2004, ANTIBACTERIAL INFLUE, P707
   Li MJ, 2015, J MATER SCI TECHNOL, V31, P243, DOI 10.1016/j.jmst.2014.11.016
   Lin Z.D., 2010, STUDY ANTIBACTERIAL
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Lu M.Q., 2005, METALL FUNCT MAT, V12, P10
   Lyndon JA, 2014, J CONTROL RELEASE, V179, P63, DOI 10.1016/j.jconrel.2014.01.026
   Mahapatro A, 2015, MAT SCI ENG C-MATER, V55, P227, DOI 10.1016/j.msec.2015.05.018
   Mola J, 2011, SCRIPTA MATER, V65, P834, DOI 10.1016/j.scriptamat.2011.07.041
   Nan L, 2008, J MATER SCI TECHNOL, V24, P197
   Newson T., 2003, STAINLESS STEEL HYGI
   Prasongsook Sombat, 2015, Journal of Animal Science and Technology, V57, P31, DOI 10.1186/s40781-015-0063-3
   Rana S., 2011, ADV BIOTECHNOL, V11, P21
   Ren L, 2013, J MATER SCI TECHNOL, V29, P1005, DOI 10.1016/j.jmst.2013.09.008
   Shen YZ, 2010, J NUCL MATER, V400, P94, DOI 10.1016/j.jnucmat.2010.02.016
   Shi F, 2008, J IRON STEEL RES INT, V15, P72, DOI 10.1016/S1006-706X(08)60270-8
   Society T.M.I., 1992, ASM HDB
   Sung JH, 2008, MAT SCI ENG A-STRUCT, V489, P38, DOI 10.1016/j.msea.2007.11.078
   Van Landeghem HP, 2012, J CRYST GROWTH, V341, P53, DOI 10.1016/j.jcrysgro.2011.12.056
   Yan Y., 2001, CHEM PROCESS, V7, P5
   Yang K., 2005, METALL FUNCT MAT, V12, P6
   Yang K, 2007, J MATER SCI TECHNOL, V23, P333
   Zeng Y.S., 2008, STUDY PROPERTIES ANT
   Zhang D, 2013, COLLOID SURFACE B, V105, P51, DOI 10.1016/j.colsurfb.2012.12.025
   Zhang W, 2015, APPL SURF SCI, V349, P327, DOI 10.1016/j.apsusc.2015.05.012
   Zou D.N., 2005, FOUNDRY TECHNOL, V26, P1009
NR 37
TC 2
Z9 2
U1 1
U2 14
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2075-4701
J9 METALS-BASEL
JI Metals
PD APR
PY 2016
VL 6
IS 4
AR 73
DI 10.3390/met6040073
PG 9
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA DL8AG
UT WOS:000375861100003
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Nogami, M
   Kimura, T
   Seki, S
   Matsui, Y
   Yoshida, T
   Koike-Soko, C
   Okabe, M
   Motomura, H
   Gejo, R
   Nikaido, T
AF Nogami, Makiko
   Kimura, Tomoatsu
   Seki, Shoji
   Matsui, Yoshito
   Yoshida, Toshiko
   Koike-Soko, Chika
   Okabe, Motonori
   Motomura, Hiraku
   Gejo, Ryuichi
   Nikaido, Toshio
TI A Human Amnion-Derived Extracellular Matrix-Coated Cell-Free Scaffold
   for Cartilage Repair: In Vitro and In Vivo Studies
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; HUMAN FETAL MEMBRANES; ARTICULAR-CARTILAGE;
   BONE-MARROW; FOLLOW-UP; DEFECTS; COLLAGEN; TISSUE; KNEE; TRANSPLANTATION
AB Objective: Extracellular matrix (ECM) derived from human amniotic mesenchymal cells (HAMs) has various biological activities. In this study, we developed a novel HAM-derived ECM-coated polylactic-co-glycolic acid (ECM-PLGA) scaffold, examined its property on mesenchymal cells, and investigated its potential as a cell-free scaffold for cartilage repair.
   Materials and Methods: ECM-PLGA scaffolds were developed by inoculating HAM on a PLGA. After decellularization by irradiation, accumulated ECM was examined. Exogenous cell growth and differentiation of rat mesenchymal stem cells (MSCs) on the ECM-PLGA were analyzed in vitro by cell attachment/proliferation assay and reverse transcription-polymerase chain reaction. The cell-free ECM-PLGA scaffolds were implanted into osteochondral defects in the trochlear groove of rat knees. After 4, 12, or 24 weeks, the animals were sacrificed and the harvested tissues were examined histologically.
   Results: The ECM-PLGA contained ECM that mimicked natural amniotic stroma that contains type I collagen, fibronectin, hyaluronic acid, and chondroitin sulfates. The ECM-PLGA showed excellent properties of cell attachment and proliferation. MSCs inoculated on the ECM-PLGA scaffold showed accelerated type II collagen mRNA expression after 3 weeks in culture. The ECM-PLGA implanted into an osteochondral defect in rat knees induced gradual tissue regeneration and resulted in hyaline cartilage repair, which was better than that in the empty control group.
   Conclusion: These in vitro and in vivo experiments show that the cell-free scaffold composed of HAM-derived ECM and PLGA provides a favorable growth environment for MSCs and facilitates the cartilage repair process. The ECM-PLGA may become a "ready-made" biomaterial for cartilage repair therapy.
C1 [Nogami, Makiko; Kimura, Tomoatsu; Seki, Shoji; Matsui, Yoshito; Motomura, Hiraku; Gejo, Ryuichi] Toyama Univ, Fac Med & Pharmaceut Sci, Dept Orthopaed Surg, Sugitani 2630, Toyama 9300194, Japan.
   [Yoshida, Toshiko; Koike-Soko, Chika; Okabe, Motonori; Nikaido, Toshio] Toyama Univ, Fac Med & Pharmaceut Sci, Dept Regenerat Med, Toyama 930, Japan.
RP Nogami, M (reprint author), Toyama Univ, Fac Med & Pharmaceut Sci, Dept Orthopaed Surg, Sugitani 2630, Toyama 9300194, Japan.
EM makohna@hotmail.com
FU JSPS KAKENHI Grant [24390350]
FX We thank Etsuko Furuichi for sectioning the paraffin-embedded cartilage
   tissue. This work was supported by JSPS KAKENHI Grant Number 24390350.
CR Amer MI, 2010, J MINIM INVAS GYN, V17, P605, DOI 10.1016/j.jmig.2010.03.019
   Andrade AL, 2010, EUR J OPHTHALMOL, V20, P290
   Behrens P, 2006, KNEE, V13, P194, DOI 10.1016/j.knee.2006.02.012
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Derfoul A, 2007, OSTEOARTHR CARTILAGE, V15, P646, DOI 10.1016/j.joca.2007.01.014
   Diaz-Prado S, 2010, CELL TISSUE BANK, V11, P183, DOI 10.1007/s10561-009-9144-1
   Erggelet C, 2007, BIOMATERIALS, V28, P5570, DOI 10.1016/j.biomaterials.2007.09.005
   Garfias Y, 2011, IMMUNOL INVEST, V40, P183, DOI 10.3109/08820139.2010.532266
   Gobbi A, 2005, KNEE SURG SPORT TR A, V13, P213, DOI 10.1007/s00167-004-0499-3
   Guo QC, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/306083
   Hollander AP, 2006, TISSUE ENG, V12, P1787, DOI 10.1089/ten.2006.12.1787
   Katayama R, 2004, RHEUMATOLOGY, V43, P980, DOI 10.1093/rheumatology/keh240
   Kon E, 2015, ARTHROSCOPY, V31, P767, DOI 10.1016/j.arthro.2014.11.017
   Kon E, 2014, AM J SPORT MED, V42, P158, DOI 10.1177/0363546513505434
   Lisignoli G, 2005, BIOMATERIALS, V26, P5677, DOI 10.1016/j.biomaterials.2005.02.031
   Ma DHK, 2010, BIOMATERIALS, V31, P6647, DOI 10.1016/j.biomaterials.2010.05.034
   Ma ZW, 2005, BIOMATERIALS, V26, P1253, DOI 10.1016/j.biomaterials.2004.04.031
   MALAK TM, 1993, PLACENTA, V14, P385, DOI 10.1016/S0143-4004(05)80460-6
   Meinert M, 2001, AM J OBSTET GYNECOL, V184, P679, DOI 10.1067/mob.2001.110294
   Mimura T, 2008, OSTEOARTHR CARTILAGE, V16, P1083, DOI 10.1016/j.joca.2008.02.003
   Niknejad H, 2008, EUR CELLS MATER, V15, P88
   Nogami M, 2012, TRANSPLANTATION, V93, P1221, DOI 10.1097/TP.0b013e3182529b76
   Ochi M, 2002, J BONE JOINT SURG BR, V84B, P571, DOI 10.1302/0301-620X.84B4.11947
   Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059
   Parenteau-Bareil R, 2010, MATERIALS, V3, P1863, DOI 10.3390/ma3031863
   Peng YY, 2010, J BIOMED MATER RES A, V93A, P1235, DOI 10.1002/jbm.a.32616
   PINEDA S, 1992, ACTA ANAT, V143, P335
   Schneider U, 2011, KNEE SURG SPORT TR A, V19, P2145, DOI 10.1007/s00167-011-1460-x
   Shi JJ, 2012, ORTHOPEDICS, V35, pE665, DOI 10.3928/01477447-20120426-20
   Siclari A, 2012, CLIN ORTHOP RELAT R, V470, P910, DOI 10.1007/s11999-011-2107-4
   Silini A, 2013, CURR STEM CELL RES T, V8, P6, DOI 10.2174/1574888X11308010003
   Stanish WD, 2013, J BONE JOINT SURG AM, V95A, P1640, DOI 10.2106/JBJS.L.01345
   Steadman JR, 2003, ARTHROSCOPY, V19, P477, DOI 10.1053/jars.2003.50112
   Teng Z, 2013, CELL TRANSPLANT, V22, P267, DOI 10.3727/096368912X655055
   Toda A, 2007, J PHARMACOL SCI, V105, P215, DOI 10.1254/jphs.CP0070034
   Wakitani S, 2002, OSTEOARTHR CARTILAGE, V10, P199, DOI 10.1053/joca.2001.0504
   WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013
   Wei JP, 2003, CELL TRANSPLANT, V12, P545, DOI 10.3727/000000003108747000
   Wylie JD, 2016, ARTHROSCOPY, V32, P386, DOI 10.1016/j.arthro.2015.07.025
   Yamanaka K, 2015, DENT MATER J, V34, P78, DOI 10.4012/dmj.2013-330
   Zantop T, 2009, ARTHROSCOPY, V25, P1354, DOI 10.1016/j.arthro.2009.04.077
NR 41
TC 6
Z9 7
U1 0
U2 11
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD APR
PY 2016
VL 22
IS 7-8
BP 680
EP 688
DI 10.1089/ten.tea.2015.0285
PG 9
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA DK2RH
UT WOS:000374761600010
PM 27019057
DA 2018-10-20
ER

PT J
AU Duffy, C
   Venturato, A
   Callanan, A
   Lilienkampf, A
   Bradley, M
AF Duffy, Caiman
   Venturato, Andrea
   Callanan, Anthony
   Lilienkampf, Annamaria
   Bradley, Mark
TI Arrays of 3D double-network hydrogels for the high-throughput discovery
   of materials with enhanced physical and biological properties
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Hydrogel; Biomaterial; Microarray; High-throughput screening;
   Double-network; Polymer
ID EMBRYONIC STEM-CELLS; POLYMERS; CULTURE; BIOMATERIALS; SCAFFOLDS;
   SUBSTRATE; SURFACES; GROWTH; FATE
AB Synthetic hydrogels are attractive biomaterials due to their similarity to natural tissues and their chemical tunability, which can impart abilities to respond to environmental cues, e.g. temperature, pH and light. The mechanical properties of hydrogels can be enhanced by the generation of a double-network. Here, we report the development of an array platform that allows the macroscopic synthesis of up to 80 single- and double-network hydrogels on a single microscope slide. This new platform allows for the screening of hydrogels as 3D features in a high-throughput format with the added dimension of significant control over the compressive and tensile properties of the materials, thus widening their potential application. The platform is adaptable to allow different hydrogels to be generated, with the potential ability to tune and alter the first and second network, and represents an exciting tool in material and biomaterial discovery. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Duffy, Caiman; Venturato, Andrea; Lilienkampf, Annamaria; Bradley, Mark] Univ Edinburgh, EaStCHEM, Sch Chem, Joseph Black Bldg,West Mains Rd, Edinburgh EH9 3FJ, Midlothian, Scotland.
   [Callanan, Anthony] Univ Edinburgh, Inst Bioengn, Sch Engn, Faraday Bldg,Kings Bldg, Edinburgh EH9 3JL, Midlothian, Scotland.
RP Bradley, M (reprint author), Univ Edinburgh, EaStCHEM, Sch Chem, Joseph Black Bldg,West Mains Rd, Edinburgh EH9 3FJ, Midlothian, Scotland.
EM mark.bradley@ed.ac.uk
FU ERC [ERC-2013-ADG 340469 ADREEM]; HumEn project [FP7/2007-2013 -
   HEALTH-F4-2013-602889]
FX We thank the ERC (ERC-2013-ADG 340469 ADREEM) and the HumEn project
   (FP7/2007-2013 - HEALTH-F4-2013-602889) for funding, Dr Logan MacKay for
   helpful discussions on 3D printing, and PolyPico (Ireland) for their
   technical support and helpful advice.
CR Accardi MA, 2013, TISSUE ENG PT A, V19, P2300, DOI [10.1089/ten.tea.2012.0580, 10.1089/ten.TEA.2012.0580]
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Callanan A, 2014, J BIOMECH, V47, P1885, DOI 10.1016/j.jbiomech.2014.02.037
   Duffy CRE, 2014, BIOMATERIALS, V35, P5998, DOI 10.1016/j.biomaterials.2014.04.013
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035
   Gong JP, 2003, ADV MATER, V15, P1155, DOI 10.1002/adma.200304907
   Hague M. A., 2012, POLYMER, V53, P1805, DOI DOI 10.1016/J.BIOMATERIALS.2014.03.035
   Hansen A, 2014, ADV HEALTHC MATER, V3, P848, DOI 10.1002/adhm.201300489
   Hansen A, 2011, BIOMATERIALS, V32, P7034, DOI 10.1016/j.biomaterials.2011.06.001
   Hay DC, 2011, STEM CELL RES, V6, P92, DOI 10.1016/j.scr.2010.12.002
   Hook AL, 2012, NAT BIOTECHNOL, V30, P868, DOI 10.1038/nbt.2316
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Mangani C., 2015, BIOMATER SCI, P1371
   Mann BK, 2002, J BIOMED MATER RES, V60, P86, DOI 10.1002/jbm.10042
   McCullen SD, 2012, TISSUE ENG PT A, V18, P2073, DOI [10.1089/ten.tea.2011.0606, 10.1089/ten.TEA.2011.0606]
   Mizomoto H., 2004, SYNTHESIS SCREENING
   Myung D, 2007, POLYMER, V48, P5376, DOI 10.1016/j.polymer.2007.06.070
   Pernagallo S, 2011, J MATER CHEM, V21, P96, DOI 10.1039/c0jm01987a
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Ronken S, 2013, BIOMECH MODEL MECHAN, V12, P243, DOI 10.1007/s10237-012-0395-6
   Steele JAM, 2014, ACTA BIOMATER, V10, P2065, DOI 10.1016/j.actbio.2013.12.030
   Sun JY, 2012, NATURE, V489, P133, DOI 10.1038/nature11409
   Tare RS, 2009, BIOMATERIALS, V30, P1045, DOI 10.1016/j.biomaterials.2008.10.038
   Venkateswaran S, 2014, J MATER CHEM B, V2, P6723, DOI 10.1039/c4tb01129e
   Wu M, 2012, WATER RES, V46, P1715, DOI 10.1016/j.watres.2011.12.041
   Yang C, 2014, NAT MATER, V13, P645, DOI [10.1038/NMAT3889, 10.1038/nmat3889]
   Zhang R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2341
NR 28
TC 3
Z9 3
U1 4
U2 38
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR 1
PY 2016
VL 34
SI SI
BP 104
EP 112
DI 10.1016/j.actbio.2015.12.030
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DJ6YN
UT WOS:000374359200011
PM 26712601
DA 2018-10-20
ER

PT J
AU Liu, HJ
   Usprech, J
   Sun, Y
   Simmons, CA
AF Liu, Haijiao
   Usprech, Jenna
   Sun, Yu
   Simmons, Craig A.
TI A microfabricated platform with hydrogel arrays for 3D mechanical
   stimulation of cells
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Microdevice; Mechanical stimulation; Three-dimensional; Hydrogel;
   Mesenchymal stromal cell
ID VALVE INTERSTITIAL-CELLS; MESENCHYMAL STEM-CELLS; CONNECTIVE-TISSUE;
   CYCLIC STRETCH; STRAIN; GROWTH; DIFFERENTIATION; MECHANOBIOLOGY;
   CONSTRUCTS; MICROARRAY
AB Cellular microenvironments present cells with multiple stimuli, including not only soluble biochemical and insoluble matrix cues but also mechanical factors. Biomaterial array platforms have been used to combinatorially and efficiently probe and define two-dimensional (2D) and 3D microenvironmental cues to guide cell functions for tissue engineering applications. However, there are few examples of array platforms that include dynamic mechanical forces, particularly to enable stretching of 3D cell-seeded biomaterials, which is relevant to engineering connective and cardiovascular tissues. Here we present a deformable membrane platform that enables 3D dynamic mechanical stretch of arrayed biomaterial constructs. Cell-seeded polyethylene glycol norbornene (PEG-NB) hydrogels were bound to miniaturized deformable membranes via a thiol-ene reaction with off-stoichiometry thiol-ene based polydimethylsiloxane (OSTE-PDMS) as the membrane material. Bonding to OSTE-PDMS enabled the 3D hydrogel microconstructs to be cyclically deformed and stretched by the membrane. As a first demonstration, human mesenchymal stromal cells (MSCs) embedded in PEG-NB were stretched for several days. They were found to be viable, spread in the 3D hydrogels, and exhibited a contractile myofibroblast phenotype when exposed to dynamic 3D mechanical deformation. This platform, which is readily scalable to larger arrays, enables systematic interrogation of the relationships between combinations of 3D mechanobiological cues and cellular responses, and thus has the potential to identify strategies to predictably control the construction of functional engineered tissues.
   Statement of significance
   Current high-throughput biomaterial screening approaches fail to consider the effects of dynamic mechanical stimulation, despite its importance in a wide variety of regenerative medicine applications. To meet this need, we developed a deformable membrane platform that enables 3D dynamic stretch of arrayed biomaterial constructs. Our approach combines microtechnologies fabricated with offstoichiometry thiol-ene based polydimethylsiloxane membranes that can covalently bond cell-seeded polyethylene glycol norbornene 3D hydrogels, a model biomaterial with tunable adhesive, elastic and degradation characteristics. As a first demonstration, we show that human mesenchymal stromal cells embedded in hydrogels and subjected to dynamic mechanical stimulation undergo myofibroblast differentiation. This system is readily scaled up to larger arrays, and will enable systematic and efficient screening of combinations of 3D mechanobiological and biomaterial cues on cell fate and function. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Liu, Haijiao; Sun, Yu; Simmons, Craig A.] Univ Toronto, Dept Mech & Ind Engn, Toronto, ON M5S 3G8, Canada.
   [Liu, Haijiao; Usprech, Jenna; Sun, Yu; Simmons, Craig A.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada.
RP Sun, Y; Simmons, CA (reprint author), Univ Toronto, Dept Mech & Ind Engn, Toronto, ON M5S 3G8, Canada.
EM sun@mie.utoronto.ca; simmons@mie.utoronto.ca
RI Liu, Haijiao/O-1561-2015
OI Liu, Haijiao/0000-0003-2529-516X; Sun, Yu/0000-0001-7895-0741; Simmons,
   Craig/0000-0001-7729-1772
FU NSERC CREATE Program in Microfluidic Applications and Training in
   Cardiovascular Health (MATCH); Canadian Institutes of Health Research
   [MOP-130481]; Canada Research Chair in Mechanobiology; Canada Research
   Chair in Micro and Nanoengineering Systems
FX The authors thank Oleg Chebotarev for helpful suggestions and
   acknowledge financial support from the NSERC CREATE Program in
   Microfluidic Applications and Training in Cardiovascular Health (MATCH)
   (H.L.), the Canadian Institutes of Health Research (MOP-130481), and the
   Canada Research Chairs in Mechanobiology (C.S.) and Micro and
   Nanoengineering Systems (Y.S.).
CR Atala A, 2011, BRIT MED BULL, V97, P81, DOI 10.1093/bmb/ldr003
   Burdick J. A., 2009, TISSUE ENG, V15
   Cardwell R. D., 2015, J BIOMECH ENG, V137, P1
   Chen JH, 2011, ARTERIOSCL THROM VAS, V31, P590, DOI 10.1161/ATVBAHA.110.220061
   Chen WLK, 2010, BIOMATERIALS, V31, P2489, DOI 10.1016/j.biomaterials.2009.12.002
   Cui YD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7333
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Dolatshahi-Pirouz A, 2014, SCI REP-UK, V4, DOI 10.1038/srep03896
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fairbanks BD, 2009, ADV MATER, V21, P5005, DOI 10.1002/adma.200901808
   Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736
   Hansen TD, 2014, BIOMATER SCI-UK, V2, P745, DOI [10.1039/C3BM60278H, 10.1039/c3bm60278h]
   Hoyle CE, 2004, J POLYM SCI POL CHEM, V42, P5301, DOI 10.1002/pola.20366
   Huang GY, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/4/042001
   Huang HYS, 2007, J BIOMECH ENG-T ASME, V129, P880, DOI 10.1115/1.2801670
   Ingber D., 2006, FASEB J, P811
   Ingber DE, 2006, INT J DEV BIOL, V50, P255, DOI 10.1387/ijdb.052044di
   Ireland R.G., 2015, STEM CELLS
   Kamotani Y, 2008, BIOMATERIALS, V29, P2646, DOI 10.1016/j.biomaterials.2008.02.019
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Kluge JA, 2011, ANN BIOMED ENG, V39, P1390, DOI 10.1007/s10439-010-0243-8
   Lau K, 2015, NAT CELL BIOL, V17, P569, DOI 10.1038/ncb3156
   Liu HJ, 2014, ACS NANO, V8, P3821, DOI 10.1021/nn500553z
   Liu HJ, 2014, CELL BIOCHEM BIOPHYS, V68, P241, DOI 10.1007/s12013-013-9702-9
   Liu HJ, 2013, J BIOMECH, V46, P1967, DOI 10.1016/j.jbiomech.2013.05.001
   MacQueen L, 2012, LAB CHIP, V12, P4178, DOI [10.1039/c21c40670e, 10.1039/c2lc40670e]
   Maul TM, 2011, BIOMECH MODEL MECHAN, V10, P939, DOI 10.1007/s10237-010-0285-8
   McCall JD, 2012, BIOMACROMOLECULES, V13, P2410, DOI 10.1021/bm300671s
   Mihic A, 2014, BIOMATERIALS, V35, P2798, DOI 10.1016/j.biomaterials.2013.12.052
   Moraes C, 2013, INTEGR BIOL-UK, V5, P673, DOI 10.1039/c3ib20254b
   Moraes C, 2011, INTEGR BIOL-UK, V3, P959, DOI 10.1039/c1ib00056j
   Moraes C, 2010, BIOMATERIALS, V31, P577, DOI 10.1016/j.biomaterials.2009.09.068
   Nagai Y, 2012, BIOMATERIALS, V33, P1044, DOI 10.1016/j.biomaterials.2011.10.049
   Nguyen EH, 2014, BIOMATERIALS, V35, P2149, DOI 10.1016/j.biomaterials.2013.11.054
   O'Cearbhaill ED, 2008, BIOMATERIALS, V29, P1610, DOI 10.1016/j.biomaterials.2007.11.042
   Pedersen JA, 2005, ANN BIOMED ENG, V33, P1469, DOI 10.1007/s10439-005-8159-4
   Quinlan A. M., 2011, PLOS ONE, V6
   Riehl BD, 2012, TISSUE ENG PART B-RE, V18, P288, DOI [10.1089/ten.teb.2011.0465, 10.1089/ten.TEB.2011.0465]
   Sacks MS, 2009, ANNU REV BIOMED ENG, V11, P289, DOI 10.1146/annurev-bioeng-061008-124903
   Simmons CS, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/5/054016
   Simmons CS, 2013, LAB CHIP, V13, P646, DOI 10.1039/c2lc41110e
   Sridhar BV, 2015, ADV HEALTHC MATER, V4, P702, DOI 10.1002/adhm.201400695
   Sui GD, 2006, ANAL CHEM, V78, P5543, DOI 10.1021/ac060605z
   Syedain ZH, 2008, P NATL ACAD SCI USA, V105, P6537, DOI 10.1073/pnas.0711217105
   Syedain ZH, 2009, BIOMATERIALS, V30, P4078, DOI 10.1016/j.biomaterials.2009.04.027
   Tobita K, 2006, AM J PHYSIOL-HEART C, V291, pH1829, DOI 10.1152/ajpheart.00205.2006
   Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809
   Wang JHC, 2006, BIOMECH MODEL MECHAN, V5, P1, DOI 10.1007/s10237-005-0012-z
   WILSON E, 1995, J CLIN INVEST, V96, P2364, DOI 10.1172/JCI118293
   Yarmush ML, 2009, ANNU REV BIOMED ENG, V11, P235, DOI 10.1146/annurev.bioeng.10.061807.160502
   Zimmermann WH, 2002, CIRC RES, V90, P223, DOI 10.1161/hh0202.103644
NR 51
TC 9
Z9 9
U1 10
U2 60
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR 1
PY 2016
VL 34
SI SI
BP 113
EP 124
DI 10.1016/j.actbio.2015.11.054
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DJ6YN
UT WOS:000374359200012
PM 26646540
DA 2018-10-20
ER

PT J
AU Groen, N
   Guvendiren, M
   Rabitz, H
   Welsh, WJ
   Kohn, J
   de Boer, J
AF Groen, Nathalie
   Guvendiren, Murat
   Rabitz, Herschel
   Welsh, William J.
   Kohn, Joachim
   de Boer, Jan
TI Stepping into the omics era: Opportunities and challenges for
   biomaterials science and engineering
SO ACTA BIOMATERIALIA
LA English
DT Review
DE Materiomics; Transcriptomics; Genomics; Combinatorial screening;
   Computational modeling; High-throughput experimentation; Converging
   omics fields
ID TYROSINE-DERIVED POLYCARBONATES; DIMENSIONAL MODEL REPRESENTATIONS;
   SINGLE-CELL TRANSCRIPTOMICS; MESENCHYMAL STROMAL CELLS; DIP-PEN
   NANOLITHOGRAPHY; IN-VITRO; BONE-FORMATION; STEM-CELLS; FIBRINOGEN
   ADSORPTION; GENE DELIVERY
AB The research paradigm in biomaterials science and engineering is evolving from using low-throughput and iterative experimental designs towards high-throughput experimental designs for materials optimization and the evaluation of materials properties. Computational science plays an important role in this transition. With the emergence of the omics approach in the biomaterials field, referred to as materiomics, high-throughput approaches hold the promise of tackling the complexity of materials and understanding correlations between material properties and their effects on complex biological systems. The intrinsic complexity of biological systems is an important factor that is often oversimplified when characterizing biological responses to materials and establishing property-activity relationships. Indeed, in vitro tests designed to predict in vivo performance of a given biomaterial are largely lacking as we are not able to capture the biological complexity of whole tissues in an in vitro model. In this opinion paper, we explain how we reached our opinion that converging genomics and materiomics into a new field would enable a significant acceleration of the development of new and improved medical devices. The use of computational modeling to correlate high-throughput gene expression profiling with high throughput combinatorial material design strategies would add power to the analysis of biological effects induced by material properties. We believe that this extra layer of complexity on top of high-throughput material experimentation is necessary to tackle the biological complexity and further advance the biomaterials field.
   Statement of Significance
   In this opinion paper, we postulate that converging genomics and materiomics into a new field would enable a significant acceleration of the development of new and improved medical devices. The use of computational modeling to correlate high-throughput gene expression profiling with high throughput combinatorial material design strategies would add power to the analysis of biological effects induced by material properties. We believe that this extra layer of complexity on top of high-throughput material experimentation is necessary to tackle the biological complexity and further advance the biomaterials field. (C) 2016 Published by Elsevier Ltd. on behalf of Acta Materialia Inc.
C1 [Groen, Nathalie; de Boer, Jan] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Tissue Regenerat, POB 217, NL-7500 AE Enschede, Netherlands.
   [Guvendiren, Murat; Kohn, Joachim] Rutgers State Univ, New Jersey Ctr Biomat, Piscataway, NJ USA.
   [Rabitz, Herschel] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.
   [Welsh, William J.] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA.
   [Kohn, Joachim] Rutgers State Univ, New Jersey Ctr Biomat, Dept Chem & Chem Biol, Piscataway, NJ USA.
   [de Boer, Jan] Maastricht Univ, cBITE Lab, Merin Inst Technol Inspired Regenerat Med, NL-6200 MD Maastricht, Netherlands.
   [Groen, Nathalie] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands.
RP de Boer, J (reprint author), Maastricht Univ, cBITE Lab, Merin Inst Technol Inspired Regenerat Med, NL-6200 MD Maastricht, Netherlands.
EM n.groen@utwente.nl
FU BioMedical Materials Institute [P2.04 BONE-IP]; Dutch Ministry of
   Economic Affairs; National Institute of Biomedical Imaging and
   Bio-engineering [P41 EB001046]; Province of Limburg
FX This research forms part of the Project P2.04 BONE-IP of the research
   program of the BioMedical Materials Institute, co-funded by the Dutch
   Ministry of Economic Affairs (NG). JK was supported by the National
   Institute of Biomedical Imaging and Bio-engineering under the P41
   EB001046 program. JdB acknowledges the financial contribution of the
   Province of Limburg.
CR Algahtani M.S., 2014, J CONTROL RELEASE, V30, P00454
   Anderson DG, 2003, ANGEW CHEM INT EDIT, V42, P3153, DOI 10.1002/anie.200351244
   Autefage H, 2015, P NATL ACAD SCI USA, V112, P4280, DOI 10.1073/pnas.1419799112
   Bakal C, 2007, SCIENCE, V316, P1753, DOI 10.1126/science.1140324
   Baker BA, 2014, BIOMATERIALS, V35, P6716, DOI 10.1016/j.biomaterials.2014.04.075
   Barbieri D, 2010, EUR CELLS MATER, V19, P252, DOI 10.22203/eCM.v019a24
   Barradas AMC, 2013, INTEGR BIOL-UK, V5, P920, DOI 10.1039/c3ib40027a
   Barradas AMC, 2012, BIOMATERIALS, V33, P3205, DOI 10.1016/j.biomaterials.2012.01.020
   Boyan B. D., 2003, European Cells & Materials, V6, P22
   Brocchini S, 1998, J BIOMED MATER RES, V42, P66, DOI 10.1002/(SICI)1097-4636(199810)42:1<66::AID-JBM9>3.0.CO;2-M
   Brocchini S, 1997, J AM CHEM SOC, V119, P4553, DOI 10.1021/ja970389z
   Carlier A, 2011, ACTA BIOMATER, V7, P3573, DOI 10.1016/j.actbio.2011.06.021
   Chen K.H., 2015, SCIENCE, V348, P9
   Dalby MJ, 2008, J R SOC INTERFACE, V5, P1055, DOI 10.1098/rsif.2008.0016
   Davison NL, 2014, EUR CELLS MATER, V27, P281, DOI 10.22203/eCM.v027a20
   Delawi D, 2013, TISSUE ENG PART C-ME, V19, P821, DOI [10.1089/ten.tec.2012.0576, 10.1089/ten.TEC.2012.0576]
   Doom J, 2013, BIOMATERIALS, V34, P3053, DOI DOI 10.1016/J.BI0MATERIALS.2012.12.037
   Eyckmans J, 2013, BIOMATERIALS, V34, P4612, DOI 10.1016/j.biomaterials.2013.03.011
   Green JJ, 2008, ACCOUNTS CHEM RES, V41, P749, DOI 10.1021/ar7002336
   Groen N, 2015, ADV HEALTHC MATER, V4, P1691, DOI 10.1002/adhm.201500171
   Grun D, 2014, NAT METHODS, V11, P637, DOI [10.1038/nmeth.2930, 10.1038/NMETH.2930]
   Gubskaya AV, 2007, POLYMER, V48, P5788, DOI 10.1016/j.polymer.2007.07.007
   Gubskaya AV, 2011, MACROMOL THEOR SIMUL, V20, P275, DOI 10.1002/mats.201000087
   Habibovic P, 2005, BIOMATERIALS, V26, P3565, DOI 10.1016/j.biomaterials.2004.09.056
   Habibovic P, 2008, J ORTHOP RES, V26, P1363, DOI 10.1002/jor.20648
   Habibovic P, 2006, ADV EXP MED BIOL, V585, P327
   Harris N.K., 2006, BIOMATERIALS INFORM, P163
   Hayes MY, 2006, J PHYS CHEM A, V110, P264, DOI 10.1021/jp053197w
   Hulsman M, 2015, ACTA BIOMATER, V15, P29, DOI 10.1016/j.actbio.2014.12.019
   Johnson PA, 2010, J BIOMED MATER RES A, V93A, P505, DOI 10.1002/jbm.a.32544
   Jukes JM, 2008, P NATL ACAD SCI USA, V105, P6840, DOI 10.1073/pnas.0711662105
   Junker JP, 2015, MOL CELL, V58, P563, DOI 10.1016/j.molcel.2015.05.019
   Ke RQ, 2013, NAT METHODS, V10, P857, DOI 10.1038/nmeth.2563
   Kholodovych V, 2004, POLYMER, V45, P7367, DOI 10.1016/j.polymer.2004.09.002
   Kholodovych V, 2008, POLYMER, V49, P2435, DOI 10.1016/j.polymer.2008.03.032
   Kohn J, 2004, NAT MATER, V3, P745, DOI 10.1038/nmat1249
   Kohn J, 2007, BIOMATERIALS, V28, P4171, DOI 10.1016/j.biomaterials.2007.06.022
   Kumar G, 2011, BIOMATERIALS, V32, P9188, DOI 10.1016/j.biomaterials.2011.08.054
   Lamb J, 2007, NAT REV CANCER, V7, P54, DOI 10.1038/nrc2044
   Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939
   Le Nihouannen D, 2005, BONE, V36, P1086, DOI 10.1016/j.bone.2005.02.017
   Le T, 2012, CHEM REV, V112, P2889, DOI 10.1021/cr200066h
   Lewitus D, 2011, ACTA BIOMATER, V7, P2483, DOI 10.1016/j.actbio.2011.02.027
   Li GY, 2015, J PHYS CHEM A, V119, P8237, DOI 10.1021/acs.jpca.5b04911
   Li GY, 2001, J PHYS CHEM A, V105, P7765, DOI 10.1021/jp010450t
   Lin NJ, 2007, ACTA BIOMATER, V3, P163, DOI 10.1016/j.actbio.2006.10.001
   Liu E, 2009, COMB CHEM HIGH T SCR, V12, P646, DOI 10.2174/138620709788923737
   Lovmand J, 2009, BIOMATERIALS, V30, P2015, DOI 10.1016/j.biomaterials.2008.12.081
   LOWE G, 1995, CHEM SOC REV, V24, P309, DOI 10.1039/cs9952400309
   Lyubimova A, 2013, NAT PROTOC, V8, P1743, DOI 10.1038/nprot.2013.109
   Mei Y, 2010, NAT MATER, V9, P768, DOI [10.1038/NMAT2812, 10.1038/nmat2812]
   Mendes SC, 2004, J MATER SCI-MATER M, V15, P1123, DOI 10.1023/B:JMSM.0000046394.53153.21
   Mentink A, 2013, BIOMATERIALS, V34, P4592, DOI 10.1016/j.biomaterials.2013.03.001
   Meredith JC, 2003, J BIOMED MATER RES A, V66A, P483, DOI 10.1002/jbm.a.10004
   Mulari MTK, 2004, CALCIFIED TISSUE INT, V75, P253, DOI 10.1007/s00223-004-0172-3
   Murthy NS, 2010, POLYMER, V51, P3978, DOI 10.1016/j.polymer.2010.06.024
   Nur E. K. A., 2006, STEM CELLS, V24, P426, DOI DOI 10.1634/STEMCELLS.2005-0170)
   Piner RD, 1999, SCIENCE, V283, P661, DOI 10.1126/science.283.5402.661
   Rabitz H, 1999, J MATH CHEM, V25, P197, DOI 10.1023/A:1019188517934
   Ripamonti U, 2008, J CELL MOL MED, V12, P2609, DOI 10.1111/j.1582-4934.2008.00312.x
   Rohrer SP, 1998, SCIENCE, V282, P737, DOI 10.1126/science.282.5389.737
   Roth EA, 2004, BIOMATERIALS, V25, P3707, DOI 10.1016/j.biomaterials.2003.10.052
   Ryan PL, 2001, P NATL ACAD SCI USA, V98, P4323, DOI 10.1073/pnas.071615398
   Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439
   Siddappa R, 2008, P NATL ACAD SCI USA, V105, P7281, DOI 10.1073/pnas.0711190105
   Simon CG, 2011, ADV MATER, V23, P369, DOI 10.1002/adma.201001763
   Simon CG, 2005, BIOMATERIALS, V26, P6906, DOI 10.1016/j.biomaterials.2005.04.050
   Smith JR, 2005, POLYMER, V46, P4296, DOI 10.1016/j.polymer.2005.03.012
   Smith JR, 2004, J CHEM INF COMP SCI, V44, P1088, DOI 10.1021/ci0499774
   Sung HJ, 2009, J CELL PHYSIOL, V218, P549, DOI 10.1002/jcp.21629
   Tan W, 2003, TISSUE ENG, V9, P255, DOI 10.1089/107632703764664729
   Tangpasuthadol V, 2000, BIOMATERIALS, V21, P2371, DOI 10.1016/S0142-9612(00)00104-6
   Taylor M, 2009, SURF INTERFACE ANAL, V41, P127, DOI 10.1002/sia.2969
   Treiser MD, 2010, P NATL ACAD SCI USA, V107, P610, DOI 10.1073/pnas.0909597107
   Tsimbouri PM, 2013, BIOMATERIALS, V34, P2177, DOI 10.1016/j.biomaterials.2012.12.019
   Tziampazis E, 2000, BIOMATERIALS, V21, P511, DOI 10.1016/S0142-9612(99)00212-4
   Unadkat HV, 2011, P NATL ACAD SCI USA, V108, P16565, DOI 10.1073/pnas.1109861108
   Urquhart AJ, 2008, ANAL CHEM, V80, P135, DOI 10.1021/ac071560k
   Van der Stok J, 2011, ACTA BIOMATER, V7, P739, DOI 10.1016/j.actbio.2010.07.035
   Wang WJ, 2013, LANGMUIR, V29, P11420, DOI 10.1021/la401268s
   Wilson DL, 2001, P NATL ACAD SCI USA, V98, P13660, DOI 10.1073/pnas.241323198
   Yang J, 2009, ADV MATER, V21, P300, DOI 10.1002/adma.200801942
   Yang Y, 2008, ADV MATER, V20, P2037, DOI 10.1002/adma.200702088
   Yin Z, 2013, NAT CELL BIOL, V15, P860, DOI 10.1038/ncb2764
   Zhang SG, 1999, BIOMATERIALS, V20, P1213, DOI 10.1016/S0142-9612(99)00014-9
NR 85
TC 9
Z9 9
U1 1
U2 34
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR 1
PY 2016
VL 34
SI SI
BP 133
EP 142
DI 10.1016/j.actbio.2016.02.015
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DJ6YN
UT WOS:000374359200014
PM 26876875
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Aperador, W
   Duque, J
   Delgado, E
AF Aperador, W.
   Duque, J.
   Delgado, E.
TI Synthesis and Electrochemical Characterization a Coating of
   beta-Tricalcium Phosphate Deposited on Steel 316LVM
SO INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE
LA English
DT Article
DE tricalcium phosphate; Physical vapor deposition; Corrosion; Biomaterials
ID BONE-GRAFTS; TCP; BIOCERAMICS; BIOMATERIAL; SILICATE
AB Beta tricalcium phosphate thin films they were deposited on austenitic steel by means of a magnetron sputtering with r.f. (13.56 MHz) from tricalcium phosphate (TCP) which it was used as a sputtering target. In order to study the effect of the content of the coating; in the corrosion rate and electrochemical response function of time (0, 24, 196 and 720 hours) of the coated steels, corrosion rate is studied by polarization curves Tafel and the electrochemical response by electrochemical impedance spectroscopy, microstructural characterization was performed using scanning electron microscopy (SEM). Finding himself a decrease of 32% in the corrosion rate for the system evaluated to 720 hours. The ion exchange capacity indicates an increase in corrosion resistance.
C1 [Aperador, W.; Duque, J.; Delgado, E.] Univ Mil Nueva Granada, Sch Engn, Bogota, Colombia.
RP Aperador, W (reprint author), Univ Mil Nueva Granada, Sch Engn, Bogota, Colombia.
EM g.ing.materiales@gmail.com
FU Universidad Militar Nueva Granada [ING-1903-2015]
FX Thanks the financial support from the Universidad Militar Nueva Granada,
   contract number ING-1903-2015
CR Barber FA, 2013, ARTHROSCOPY, V29, P1834, DOI 10.1016/j.arthro.2013.08.004
   Bohner M, 2000, INJURY, V31, pS37
   Cabanas MV, 2009, EUR J PHARM SCI, V37, P249, DOI 10.1016/j.ejps.2009.02.011
   Carbajal L, 2012, J EUR CERAM SOC, V32, P569, DOI 10.1016/j.jeurceramsoc.2011.09.025
   Cattalini JP, 2013, PROCEDIA ENGINEER, V59, P78, DOI 10.1016/j.proeng.2013.05.096
   Clarke SA, 2007, BONE, V40, P939, DOI 10.1016/j.bone.2006.11.004
   Duncan J, 2014, ACTA BIOMATER, V10, P1443, DOI 10.1016/j.actbio.2013.11.014
   Elayaraja K, 2013, APPL SURF SCI, V274, P203, DOI 10.1016/j.apsusc.2013.03.016
   Kazek-Kesik A, 2014, ARCH CIV MECH ENG, V14, P671, DOI 10.1016/j.acme.2013.10.008
   Kurtulus G., 2011, MATER LETT, P2883
   Leadley S.R., 1997, BIOMATER SCI, P311
   Marques CF, 2016, CERAM INT, V42, P2706, DOI 10.1016/j.ceramint.2015.11.001
   Martinez IM, 2012, MATER CHARACT, V63, P47, DOI 10.1016/j.matchar.2011.10.013
   McEntire BJ, 2015, J EUR CERAM SOC, V35, P4327, DOI 10.1016/j.jeurceramsoc.2015.07.034
   Mina A, 2015, MATER CHEM PHYS, V160, P296, DOI 10.1016/j.matchemphys.2015.04.041
   Montazerolghaem M, 2015, MAT SCI ENG C-MATER, V52, P212, DOI 10.1016/j.msec.2015.03.038
   Nejadnik MR, 2014, BIOMATERIALS, V35, P6918, DOI 10.1016/j.biomaterials.2014.05.003
   Nolff MC, 2010, J CRANIO MAXILL SURG, V38, P38, DOI 10.1016/j.jcms.2009.07.010
   Piccirillo C, 2013, MAT SCI ENG C-MATER, V33, P103, DOI 10.1016/j.msec.2012.08.014
   Sanosh KP, 2010, CURR APPL PHYS, V10, P68, DOI 10.1016/j.cap.2009.04.014
   Shamsul BS, 2014, TISSUE CELL, V46, P152, DOI 10.1016/j.tice.2014.02.001
   Sowmya S, 2013, PROG POLYM SCI, V38, P1748, DOI 10.1016/j.progpolymsci.2013.05.005
   Vandecandelaere N, 2014, POWDER TECHNOL, V255, P3, DOI 10.1016/j.powtec.2013.09.015
   Varma HK, 2005, CERAM INT, V31, P109, DOI 10.1016/j.ceramint.2004.03.041
   Volkmer TM, 2013, POWDER TECHNOL, V235, P599, DOI 10.1016/j.powtec.2012.10.025
   Weijs WLJ, 2010, INT J ORAL MAX SURG, V39, P424, DOI 10.1016/j.ijom.2010.02.004
NR 26
TC 0
Z9 0
U1 0
U2 5
PU ESG
PI BELGRADE
PA BORIVOJA STEVANOVICA 25-7, BELGRADE, 11000, SERBIA
SN 1452-3981
J9 INT J ELECTROCHEM SC
JI Int. J. Electrochem. Sci.
PD APR
PY 2016
VL 11
IS 4
BP 2945
EP 2953
PG 9
WC Electrochemistry
SC Electrochemistry
GA DL1LP
UT WOS:000375393900035
DA 2018-10-20
ER

PT J
AU Liu, SP
   Lin, CH
   Lin, SJ
   Fu, RH
   Huang, YC
   Chen, SY
   Lin, SZ
   Hsu, CY
   Shyu, WC
AF Liu, Shih-Ping
   Lin, Chen-Huan
   Lin, Shao-Ji
   Fu, Ru-Huei
   Huang, Yu-Chuen
   Chen, Shih-Yin
   Lin, Shinn-Zong
   Hsu, Chung Y.
   Shyu, Woei-Cherng
TI Electrospun Polyacrylonitrile-Based Nanofibers Maintain Embryonic Stem
   Cell Sternness via TGF-Beta Signaling
SO JOURNAL OF BIOMEDICAL NANOTECHNOLOGY
LA English
DT Article
DE Electrospun; PAN; Pluripotenct Stem Cells; Stemness; TGF-Beta
ID SILICATE COMPOSITES; MATS; CULTURE; SCAFFOLDS; MEMBRANES; NANOPARTICLES;
   PLURIPOTENCY; REGENERATION; SUPPORT
AB Embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) are capable of self-renewal and differentiation into any cell type, thus making them the focus of many clinical application studies. Culturing ESCs on mouse embryonic fibroblast-derived and cell-based feeder layers to maintain pluripotency is a standard laboratory procedure. However, xenogeneic contamination and the large amount of time required for feeder cell preparation are two challenges that encourage the use of a murine-based feeder layer. A novel biomaterial is required to replace the current cell-based feeder system. Toward this goal, we applied a combination of biocompatible polyacrylonitrile (PAN) and electrospinning technology to establish a non-cell-based feeder layer. According to results from stem cell marker staining, scanning electron microscopy, and embryoid body formation tests, optimal ESC stemness and pluripotency were noted in three electrospun groups (2, 4, and 8 minutes), with the longer electrospinning times producing higher feeder-layer densities. KEGG pathway microarray results identified TGF-beta signaling as one of the major deregulatory pathways on electrospun-based feeder layers. Western blot data indicate significant increases in TGF-beta receptor II, phosphorylated Smad3, and Nanog protein levels in the 4- and 8-minute electrospun-based feeder layer groups compared to the non-feeder layer group. Combined, the data suggest that electrospun-based feeder layers are good candidates for maintaining ESC and iPSC pluripotency in clinical applications.
C1 [Liu, Shih-Ping; Lin, Chen-Huan; Fu, Ru-Huei; Lin, Shinn-Zong; Shyu, Woei-Cherng] China Med Univ Hosp, Ctr Neuropsychiat, Taichung 40402, Taiwan.
   [Liu, Shih-Ping; Lin, Shao-Ji] China Med Univ, Grad Inst Basic Med Sci, Taichung 40402, Taiwan.
   [Liu, Shih-Ping] Asia Univ, Dept Social Work, Taichung 41354, Taiwan.
   [Fu, Ru-Huei; Lin, Shinn-Zong; Shyu, Woei-Cherng] China Med Univ, Grad Inst Immunol, Taichung 40402, Taiwan.
   [Huang, Yu-Chuen; Chen, Shih-Yin] China Med Univ Hosp, Dept Med Res, Genet Ctr, Taichung 40402, Taiwan.
   [Huang, Yu-Chuen; Chen, Shih-Yin] China Med Univ, Grad Inst Chinese Med Sci, Coll Chinese Med, Taichung 40402, Taiwan.
   [Lin, Shinn-Zong] China Med Univ, Beigan Hosp, Dept Neurosurg, Yunlin 65152, Taiwan.
   [Hsu, Chung Y.] China Med Univ, Grad Inst Clin Med Sci, Taichung 40402, Taiwan.
RP Liu, SP; Shyu, WC (reprint author), China Med Univ Hosp, Ctr Neuropsychiat, Taichung 40402, Taiwan.; Liu, SP (reprint author), China Med Univ, Grad Inst Basic Med Sci, Taichung 40402, Taiwan.; Liu, SP (reprint author), Asia Univ, Dept Social Work, Taichung 41354, Taiwan.; Shyu, WC (reprint author), China Med Univ, Grad Inst Immunol, Taichung 40402, Taiwan.
EM spliu@mail.cmu.edu.tw; shyu9423@gmail.com
OI Hsu, Chung Y./0000-0002-5632-2733
FU Taiwan Ministry of Health and Welfare Clinical Trial and Research Center
   of Excellence [MOHW104-TDU-B-212-113002]; China Medical University
   Hospital [DMR-104-050]
FX This study is supported in part by Taiwan Ministry of Health and Welfare
   Clinical Trial and Research Center of Excellence
   (MOHW104-TDU-B-212-113002) and China Medical University Hospital
   (DMR-104-050).
CR Abbasi N, 2014, CELL J, V16, P245
   Chen M, 2013, LANGMUIR, V29, P11858, DOI 10.1021/la4017799
   Ding FY, 2014, NANOSCALE, V6, P9477, DOI 10.1039/c4nr02814g
   Gauthaman K, 2009, J CELL MOL MED, V13, P3475, DOI 10.1111/j.1582-4934.2009.00699.x
   Han B, 2014, J BIOMAT SCI-POLYM E, V25, P341, DOI 10.1080/09205063.2013.861169
   Hashemi SM, 2011, BIOMATERIALS, V32, P7363, DOI 10.1016/j.biomaterials.2011.06.048
   Heng BC, 2004, IN VITRO CELL DEV-AN, V40, P255
   Huang R, 2014, J BIOMED NANOTECHNOL, V10, P1346, DOI 10.1166/jbn.2014.1802
   Huang R, 2014, J BIOMED NANOTECHNOL, V10, P485, DOI 10.1166/jbn.2014.1716
   James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706
   Li W, 2014, CARBOHYD POLYM, V99, P218, DOI 10.1016/j.carbpol.2013.07.055
   Liu SP, 2014, STEM CELLS DEV, V23, P421, DOI 10.1089/scd.2013.0182
   Liu SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044024
   Lou T, 2014, J BIOMED NANOTECHNOL, V10, P1105, DOI 10.1166/jbn.2014.1793
   Ma ZW, 2005, TISSUE ENG, V11, P101, DOI 10.1089/ten.2005.11.101
   Manuel J, 2015, J BIOMED NANOTECHNOL, V11, P143, DOI 10.1166/jbn.2015.2028
   Mege JL, 1996, AM J KIDNEY DIS, V28, P395, DOI 10.1016/S0272-6386(96)90497-7
   Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353
   Nirmala R, 2013, J COLLOID INTERF SCI, V397, P65, DOI 10.1016/j.jcis.2013.01.057
   OUHIBI N, 1995, MOL REPROD DEV, V40, P311, DOI 10.1002/mrd.1080400307
   Park Kyung-Soon, 2011, Int J Stem Cells, V4, P18
   Peng HS, 2014, J MATER CHEM B, V2, P6435, DOI 10.1039/c4tb00344f
   Ribba L, 2014, J BIOMED NANOTECHNOL, V10, P3508, DOI 10.1166/jbn.2014.2046
   Sakaki-Yumoto M, 2013, BBA-GEN SUBJECTS, V1830, P2280, DOI 10.1016/j.bbagen.2012.08.008
   Saxena S, 2008, MOL REPROD DEV, V75, P1523, DOI 10.1002/mrd.20895
   Schmidt J. V., 2001, CURR PROTOC TOXICOL
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Truong YB, 2012, BIOMATERIALS, V33, P9198, DOI 10.1016/j.biomaterials.2012.09.012
   Truong YB, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/2/025005
   Xin SJ, 2014, J BIOMED NANOTECHNOL, V10, P803, DOI 10.1166/jbn.2014.1748
   Yun YP, 2014, J BIOMED NANOTECHNOL, V10, P1080, DOI 10.1166/jbn.2014.1819
NR 32
TC 6
Z9 6
U1 0
U2 6
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1550-7033
EI 1550-7041
J9 J BIOMED NANOTECHNOL
JI J. Biomed. Nanotechnol.
PD APR
PY 2016
VL 12
IS 4
BP 732
EP 742
DI 10.1166/jbn.2016.2201
PG 11
WC Nanoscience & Nanotechnology; Materials Science, Biomaterials
SC Science & Technology - Other Topics; Materials Science
GA DK3HP
UT WOS:000374808000013
PM 27301199
DA 2018-10-20
ER

PT J
AU Khalifa, A
   Chapin, K
   Abdelgawad, O
   Al Kom, S
   Anderson, J
   Akkus, O
   Hijaz, A
AF Khalifa, Ahmad
   Chapin, Katherine
   Abdelgawad, Osama
   Al Kom, Shebin
   Anderson, James
   Akkus, Ozan
   Hijaz, Adonis
TI BIOCOMPATIBILITY OF WOVEN COLLAGEN MESH AS A NOVEL BIOMATERIAL FOR
   FUTURE SLINGS.
SO JOURNAL OF UROLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Urological-Association (AUA)
CY MAY 06-10, 2016
CL San Diego, CA
SP Amer Urol Assoc
OI Akkus, Ozan/0000-0003-3523-3421
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-5347
EI 1527-3792
J9 J UROLOGY
JI J. Urol.
PD APR
PY 2016
VL 195
IS 4
SU S
MA PD36-11
BP E853
EP E853
DI 10.1016/j.juro.2016.02.1116
PG 1
WC Urology & Nephrology
SC Urology & Nephrology
GA DL3NC
UT WOS:000375539500580
DA 2018-10-20
ER

PT J
AU Achatz, FP
   Kujat, R
   Pfeifer, CG
   Koch, M
   Nerlich, M
   Angele, P
   Zellner, J
AF Achatz, Felix P.
   Kujat, Richard
   Pfeifer, Christian G.
   Koch, Matthias
   Nerlich, Michael
   Angele, Peter
   Zellner, Johannes
TI In Vitro Testing of Scaffolds for Mesenchymal Stem Cell-Based Meniscus
   Tissue Engineering-Introducing a New Biocompatibility Scoring System
SO MATERIALS
LA English
DT Article
DE meniscus; polyurethane scaffold; composite scaffold; hyaluronic acid;
   collagen; gelatin; chondrogenesis; human mesenchymal stem cells;
   biocompatibility
ID POLYURETHANE SCAFFOLD; CLINICAL-OUTCOMES; FOLLOW-UP; REPAIR;
   MENISCECTOMY; KNEE; IMPLANT; DIFFERENTIATION; REGENERATION; PROGENITOR
AB A combination of mesenchymal stem cells (MSCs) and scaffolds seems to be a promising approach for meniscus repair. To facilitate the search for an appropriate scaffold material a reliable and objective in vitro testing system is essential. This paper introduces a new scoring for this purpose and analyzes a hyaluronic acid (HA) gelatin composite scaffold and a polyurethane scaffold in combination with MSCs for tissue engineering of meniscus. The pore quality and interconnectivity of pores of a HA gelatin composite scaffold and a polyurethane scaffold were analyzed by surface photography and Berliner-Blau-BSA-solution vacuum filling. Further the two scaffold materials were vacuum-filled with human MSCs and analyzed by histology and immunohistochemistry after 21 days in chondrogenic media to determine cell distribution and cell survival as well as proteoglycan production, collagen type I and II content. The polyurethane scaffold showed better results than the hyaluronic acid gelatin composite scaffold, with signs of central necrosis in the HA gelatin composite scaffolds. The polyurethane scaffold showed good porosity, excellent pore interconnectivity, good cell distribution and cell survival, as well as an extensive content of proteoglycans and collagen type II. The polyurethane scaffold seems to be a promising biomaterial for a mesenchymal stem cell-based tissue engineering approach for meniscal repair. The new score could be applied as a new standard for in vitro scaffold testing.
C1 [Achatz, Felix P.; Kujat, Richard; Pfeifer, Christian G.; Koch, Matthias; Nerlich, Michael; Angele, Peter; Zellner, Johannes] Univ Med Ctr Regensburg, Dept Trauma Surg, Franz Josef Str Allee 11, D-93053 Regensburg, Germany.
   [Angele, Peter] Sporthopaedicum Regensburg, Hildegard von Bingen Str 1, D-93053 Regensburg, Germany.
RP Zellner, J (reprint author), Univ Med Ctr Regensburg, Dept Trauma Surg, Franz Josef Str Allee 11, D-93053 Regensburg, Germany.
EM felix.achatz@googlemail.com; richard.kujat@ukr.de;
   christian.pfeifer@ukr.de; matthias.koch@ukr.de; michael.nerlich@ukr.de;
   peter.angele@ukr.de; johannes.zellner@ukr.de
OI Achatz, Felix Paul/0000-0001-6859-9070
FU Clinic and Policlinic for Trauma Surgery, University Medical Center
   Regensburg; Orteq
FX We want to highly acknowledge technical support of Daniela Drenkard.
   Further we want to thank Florian Zeman from the Center of clinical
   studies of the University of Regensburg for the evaluation of our score.
   This study was funded by intramural funding of the Clinic and Policlinic
   for Trauma Surgery, University Medical Center Regensburg and by Orteq.
CR Abrams GD, 2013, AM J SPORT MED, V41, P2333, DOI 10.1177/0363546513495641
   AHMED AM, 1983, J BIOMECH ENG-T ASME, V105, P216, DOI 10.1115/1.3138409
   Akgun U, 2008, KNEE SURG SPORT TR A, V16, P809, DOI 10.1007/s00167-008-0542-x
   Angele P, 1999, TISSUE ENG, V5, P545, DOI 10.1089/ten.1999.5.545
   Angele P., 2014, J EXP ORTOP, V1
   Angele P, 2008, J BIOMED MATER RES A, V85A, P445, DOI 10.1002/jbm.a.31480
   Bouyarmane H, 2014, ORTHOP TRAUMATOL-SUR, V100, P153, DOI 10.1016/j.otsr.2013.10.011
   Brindle T, 2001, J Athl Train, V36, P160
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886
   Di Matteo Berardo, 2015, Open Orthop J, V9, P143, DOI 10.2174/1874325001509010143
   Efe T, 2012, KNEE SURG SPORT TR A, V20, P1822, DOI 10.1007/s00167-011-1779-3
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Hernigou P, 2014, INT ORTHOP, V38, P1855, DOI 10.1007/s00264-014-2318-x
   Hoben GM, 2006, SPORTS MED ARTHROSC, V14, P129, DOI 10.1097/00132585-200609000-00004
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   KIMURA M, 1995, CLIN ORTHOP RELAT R, P185
   Krampera Mauro, 2007, Blood Transfus, V5, P120, DOI 10.2450/2007.0029-07
   KUROSAWA H, 1980, CLIN ORTHOP RELAT R, P283
   LEVY IM, 1989, J BONE JOINT SURG AM, V71A, P401, DOI 10.2106/00004623-198971030-00014
   Liu CX, 2013, ARCH ORTHOP TRAUM SU, V133, P95, DOI 10.1007/s00402-012-1624-2
   Longo UG, 2013, KNEE SURG SPORT TR A, V21, P1569, DOI 10.1007/s00167-012-2142-z
   Maher Suzanne A, 2011, HSS J, V7, P157, DOI 10.1007/s11420-010-9188-6
   Makris EA, 2011, BIOMATERIALS, V32, P7411, DOI 10.1016/j.biomaterials.2011.06.037
   Matsiko A, 2015, TISSUE ENG PT A, V21, P486, DOI [10.1089/ten.tea.2013.0545, 10.1089/ten.TEA.2013.0545]
   McDermott ID, 2006, J BONE JOINT SURG BR, V88B, P1549, DOI 10.1302/0301-620X.88B12.18140
   Petty CA, 2011, ARTHROSCOPY, V27, P419, DOI 10.1016/j.arthro.2010.08.016
   RENSTROM P, 1990, CLIN SPORT MED, V9, P523
   Rodkey WG, 2008, J BONE JOINT SURG AM, V90A, P1413, DOI 10.2106/JBJS.G.00656
   Shemesh M, 2014, J MECH BEHAV BIOMED, V29, P42, DOI 10.1016/j.jmbbm.2013.08.021
   Stone KR, 1997, J BONE JOINT SURG AM, V79A, P1770, DOI 10.2106/00004623-199712000-00002
   Verdonk P, 2012, AM J SPORT MED, V40, P844, DOI 10.1177/0363546511433032
   Verdonk R., 2013, MENISCAL TRANSPLANTA
   Vrancken ACT, 2013, INT ORTHOP, V37, P291, DOI 10.1007/s00264-012-1682-7
   Welsing RTC, 2008, AM J SPORT MED, V36, P1978, DOI 10.1177/0363546508319900
   Zellner J., 2006, THESIS U REGENSBURG
   Zellner J, 2013, J BIOMED MATER RES B, V101, P1133, DOI 10.1002/jbm.b.32922
   Zellner J, 2010, J BIOMED MATER RES A, V94A, P1150, DOI 10.1002/jbm.a.32796
NR 38
TC 3
Z9 3
U1 1
U2 33
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD APR
PY 2016
VL 9
IS 4
AR 276
DI 10.3390/ma9040276
PG 14
WC Materials Science, Multidisciplinary
SC Materials Science
GA DK8EB
UT WOS:000375158900062
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Tozzi, G
   De Mori, A
   Oliveira, A
   Roldo, M
AF Tozzi, Gianluca
   De Mori, Arianna
   Oliveira, Antero
   Roldo, Marta
TI Composite Hydrogels for Bone Regeneration
SO MATERIALS
LA English
DT Review
DE biomaterials; regenerative medicine; hydrogels; bone regeneration;
   tissue engineering; mechanical properties; growth factors; statins;
   bisphosphonates; hydroxyapatite
ID MESENCHYMAL STEM-CELLS; EXFOLIATED DECIDUOUS TEETH; PROMOTE OSTEOGENIC
   DIFFERENTIATION; CALCIUM-PHOSPHATE CEMENT; GROWTH-FACTOR DELIVERY;
   MARROW STROMAL CELLS; ACID-BASED HYDROGELS; OF-THE-ART; HYALURONIC-ACID;
   IN-VITRO
AB Over the past few decades, bone related disorders have constantly increased. Among all pathological conditions, osteoporosis is one of the most common and often leads to bone fractures. This is a massive burden and it affects an estimated 3 million people only in the UK. Furthermore, as the population ages, numbers are due to increase. In this context, novel biomaterials for bone fracture regeneration are constantly under development. Typically, these materials aim at favoring optimal bone integration in the scaffold, up to complete bone regeneration; this approach to regenerative medicine is also known as tissue engineering (TE). Hydrogels are among the most promising biomaterials in TE applications: they are very flexible materials that allow a number of different properties to be targeted for different applications, through appropriate chemical modifications. The present review will focus on the strategies that have been developed for formulating hydrogels with ideal properties for bone regeneration applications. In particular, aspects related to the improvement of hydrogels' mechanical competence, controlled delivery of drugs and growth factors are treated in detail. It is hoped that this review can provide an exhaustive compendium of the main aspects in hydrogel related research and, therefore, stimulate future biomaterial development and applications.
C1 [Tozzi, Gianluca] Univ Portsmouth, Sch Engn, Anglesea Bldg,Anglesea Rd, Portsmouth PO1 3DJ, Hants, England.
   [De Mori, Arianna; Oliveira, Antero; Roldo, Marta] Univ Portsmouth, Sch Pharm & Biomed Sci, St Michaels Bldg,White Swan Rd, Portsmouth PO1 2DT, Hants, England.
RP Roldo, M (reprint author), Univ Portsmouth, Sch Pharm & Biomed Sci, St Michaels Bldg,White Swan Rd, Portsmouth PO1 2DT, Hants, England.
EM gianluca.tozzi@port.ac.uk; arianna.demori@port.ac.uk;
   antero.oliveira@port.ac.uk; marta.roldo@port.ac.uk
OI Roldo, Marta/0000-0003-2242-7761; Tozzi, Gianluca/0000-0002-3172-5720
FU University of Portsmouth (UK); Institute of Biomedical and Biomolecular
   Science
FX The authors wish to thank the University of Portsmouth (UK) and in
   particular the Institute of Biomedical and Biomolecular Science for
   financial support. Owain McClelland is acknowledged for his contribution
   to Section 2.1.
CR Ahmed EM, 2015, J ADV RES, V6, P105, DOI 10.1016/j.jare.2013.07.006
   Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282
   Almeshaly H., 2015, J ORAL MAXILLOFAC SU
   Amini Ami R., 2012, Critical Reviews in Biomedical Engineering, V40, P363
   Baldini N, 2009, WOODHEAD PUBL MATER, P69, DOI 10.1533/9781845696610.1.69
   Banyard DA, 2015, J CELL MOL MED, V19, P21, DOI 10.1111/jcmm.12425
   Barba M., 2013, BIOMED RES INT, V2013
   Basha RY, 2015, MAT SCI ENG C-MATER, V57, P452, DOI 10.1016/j.msec.2015.07.016
   Bayer EA, 2015, J CONTROL RELEASE, V219, P129, DOI 10.1016/j.jconrel.2015.08.004
   Benoit DSW, 2006, BIOMATERIALS, V27, P6102, DOI 10.1016/j.biomaterials.2006.06.031
   Bhakta G, 2012, BIOMATERIALS, V33, P6113, DOI 10.1016/j.biomaterials.2012.05.030
   Bifulco M, 2014, EUR J INTERN MED, V25, pE95, DOI 10.1016/j.ejim.2014.08.006
   Blokhuis TJ, 2013, INJURY, V44, pS40, DOI 10.1016/S0020-1383(13)70009-3
   Braddock M., 2001, PHYSIOLOGY, V10, P208
   Bradley JD, 2007, J PERIODONTAL RES, V42, P267, DOI 10.1111/j.1600-0765.2006.00943.x
   Buckwalter J A, 1987, Instr Course Lect, V36, P27
   Byrne DP, 2007, BIOMATERIALS, V28, P5544, DOI 10.1016/j.biomaterials.2007.09.003
   Chang C, 2013, CARBOHYD POLYM, V91, P7, DOI 10.1016/j.carbpol.2012.07.070
   Chung YI, 2007, J CONTROL RELEASE, V121, P91, DOI 10.1016/j.jconrel.2007.05.029
   Chung YS, 2000, J CLIN ENDOCR METAB, V85, P1137, DOI 10.1210/jc.85.3.1137
   Costa-Pinto AR, 2011, TISSUE ENG PART B-RE, V17, P331, DOI 10.1089/ten.teb.2010.0704
   Coutinho DF, 2010, BIOMATERIALS, V31, P7494, DOI 10.1016/j.biomaterials.2010.06.035
   Crowder SW, 2013, NANOSCALE, V5, P4171, DOI 10.1039/c3nr00803g
   CURREY JD, 2002, BONES STRUCTURE MECH, P3
   D'Este M, 2013, ACTA BIOMATER, V9, P5421, DOI 10.1016/j.actbio.2012.11.022
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   Deligkaris K, 2010, SENSOR ACTUAT B-CHEM, V147, P765, DOI 10.1016/j.snb.2010.03.083
   Dreifke MB, 2013, J BIOMED MATER RES A, V101, P2436, DOI 10.1002/jbm.a.34521
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Dyondi D, 2013, INT J NANOMED, V8, P47, DOI 10.2147/IJN.S37953
   Elavarasu S, 2012, J PHARM BIOALLIED SC, V4, pS248, DOI 10.4103/0975-7406.100225
   Fathi MH, 2009, J MATER PROCESS TECH, V209, P1385, DOI 10.1016/j.jmatprotec.2008.03.051
   Fedorovich NE, 2007, TISSUE ENG, V13, P1905, DOI 10.1089/ten.2006.0175
   Gantar A, 2014, MAT SCI ENG C-MATER, V43, P27, DOI 10.1016/j.msec.2014.06.045
   Gao C, 2012, NANOSCALE, V4, P1948, DOI 10.1039/c2nr11757f
   Gao GF, 2015, BIOTECHNOL J, V10, P1568, DOI 10.1002/biot.201400635
   Gao NN, 2016, CHEM ENG J, V287, P20, DOI 10.1016/j.cej.2015.11.015
   Garcia-Gareta E, 2015, BONE, V81, P112, DOI 10.1016/j.bone.2015.07.007
   Gerecht S, 2007, P NATL ACAD SCI USA, V104, P11298, DOI 10.1073/pnas.0703723104
   Geris L, 2009, PHILOS T R SOC A, V367, P2031, DOI 10.1098/rsta.2008.0293
   Giannotti S, 2013, CLIN CASES MINER BON, V10, P116, DOI 10.11138/ccmbm/2013.10.2.116
   Gigante A, 2008, EUR J HISTOCHEM, V52, P169
   Gomez-Barrena E, 2011, J CELL MOL MED, V15, P1266, DOI 10.1111/j.1582-4934.2011.01265.x
   Hak DJ, 2014, INJURY, V45, pS3, DOI 10.1016/j.injury.2014.04.002
   Hayden RS, 2014, ACTA BIOMATER, V10, P486, DOI 10.1016/j.actbio.2013.09.028
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Heo DN, 2014, J MATER CHEM B, V2, P1584, DOI 10.1039/c3tb21246g
   Hesse E, 2010, J BIOMED MATER RES A, V94A, P442, DOI 10.1002/jbm.a.32696
   Hoare TR, 2008, POLYMER, V49, P1993, DOI 10.1016/j.polymer.2008.01.027
   Holzwarth JM, 2011, BIOMATERIALS, V32, P9622, DOI 10.1016/j.biomaterials.2011.09.009
   Homma Y, 2013, INJURY, V44, pS46, DOI 10.1016/S0020-1383(13)70011-1
   Hu JX, 2016, INT J BIOL MACROMOL, V82, P134, DOI 10.1016/j.ijbiomac.2015.09.077
   Hwang NS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002498
   Iolascon G, 2010, CLIN CASES MINER BON, V7, P19
   Jeon JH, 2008, J PERIODONTOL, V79, P1457, DOI [10.1902/jop.2008.080004, 10.1902/jop.2008.080004 ]
   Jimi E., 2012, INT J DENT, V2012
   Johnson AJW, 2011, ACTA BIOMATER, V7, P16, DOI 10.1016/j.actbio.2010.07.012
   Kettenberger U., 2015, J TISSUE ENG REGEN M, V37, P3428
   Khosla S, 2012, J CLIN ENDOCR METAB, V97, P2272, DOI 10.1210/jc.2012-1027
   Khoushab F, 2010, MAR DRUGS, V8, P1988, DOI 10.3390/md8071988
   Killion JA, 2013, MAT SCI ENG C-MATER, V33, P4203, DOI 10.1016/j.msec.2013.06.013
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   Kim J, 2007, BIOMATERIALS, V28, P1830, DOI 10.1016/j.biomaterials.2006.11.050
   Kraehenbuehl TP, 2011, NAT METHODS, V8, P731, DOI 10.1038/nmeth.1671
   Krishnan V, 2013, J ADV PHARM TECHNOL, V4, P78, DOI 10.4103/2231-4040.111523
   Kumar RA, 2015, ACS APPL MATER INTER, V7, P9399, DOI 10.1021/acsami.5b02685
   Lacroix J, 2014, CHEM ENG J, V256, P9, DOI 10.1016/j.cej.2014.06.022
   Lalwani G, 2013, BIOMACROMOLECULES, V14, P900, DOI 10.1021/bm301995s
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LANYON LE, 1993, CALCIFIED TISSUE INT, V53, pS102, DOI 10.1007/BF01673415
   Lee SSS, 2015, ADV HEALTHC MATER, V4, DOI 10.1002/adhm.201400129
   Levi B, 2011, STEM CELLS, V29, P576, DOI 10.1002/stem.612
   Li XM, 2013, J BIOMED MATER RES A, V101, P2424, DOI 10.1002/jbm.a.34539
   Li YF, 2010, OSTEOPOROSIS INT, V21, P1889, DOI 10.1007/s00198-009-1140-6
   Li YJ, 2006, J BIOMED MATER RES A, V79A, P1, DOI 10.1002/jbm.a.30732
   Li ZS, 2010, BIOMATERIALS, V31, P404, DOI 10.1016/j.biomaterials.2009.09.070
   Li ZY, 2014, COLLOID SURFACE B, V123, P959, DOI 10.1016/j.colsurfb.2014.10.050
   Liu DD, 2010, CHINESE SCI BULL, V55, P1013, DOI 10.1007/s11434-010-0046-1
   Lu HF, 2012, BIOMATERIALS, V33, P2419, DOI 10.1016/j.biomaterials.2011.11.077
   Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177
   Luo Y, 2015, ACS APPL MATER INTER, V7, P6331, DOI 10.1021/acsami.5b00862
   Lyu CQ, 2015, ACS APPL MATER INTER, V7, P20245, DOI 10.1021/acsami.5b05802
   Madl CM, 2014, BIOMACROMOLECULES, V15, P445, DOI 10.1021/bm401726u
   Marzona L, 2009, CLIN CASES MINER BON, V6, P159
   Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100
   Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946
   Renno ACM, 2010, HUM ANAT PHYSIOL, P93
   National Osteoporosis Society, 2014, LIF OST UNT STOR
   National Osteoporosis Society, 2011, 25 ANN REP FRAG FUT
   Nichol JW, 2010, BIOMATERIALS, V31, P5536, DOI 10.1016/j.biomaterials.2010.03.064
   Nuttelman CR, 2004, J BIOMED MATER RES A, V68A, P773, DOI 10.1002/jbm.a.20112
   Office of the Surgeon General (US), 2004, BON HLTH OST REP SUR
   Ohno K, 2011, CURR MED CHEM, V18, P220, DOI 10.2174/092986711794088335
   Park JB, 2011, MED ORAL PATOL ORAL, V16, pE115, DOI 10.4317/medoral.16.e115
   Park YD, 2003, BIOMATERIALS, V24, P893, DOI 10.1016/S0142-9612(02)00420-9
   Patrick AR, 2010, J CLIN ENDOCR METAB, V95, P3251, DOI 10.1210/jc.2009-2778
   Pietschmann P., 2003, RADIOLOGY OSTEOPOROS
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Posadowska U, 2015, INT J PHARMACEUT, V485, P31, DOI 10.1016/j.ijpharm.2015.03.003
   Prestwich GD, 1998, J CONTROL RELEASE, V53, P93, DOI 10.1016/S0168-3659(97)00242-3
   Rahaman MN, 2011, ACTA BIOMATER, V7, P2355, DOI 10.1016/j.actbio.2011.03.016
   Reichert J.C., 2009, BIOMED MAT, V4
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Ribeiro M, 2015, EUR POLYM J, V67, P66, DOI 10.1016/j.eurpolymj.2015.03.056
   Richards M, 2002, NAT BIOTECHNOL, V20, P933, DOI 10.1038/nbt726
   Roldo M, 2013, ANNU REP PROG CHEM C, V109, P10, DOI 10.1039/c3pc90010j
   Rosenbaum D, 2013, NUTR METAB CARDIOVAS, V23, P871, DOI 10.1016/j.numecd.2012.04.012
   Russell RGG, 1999, OSTEOPOROSIS INT, V9, P66
   Salamon A, 2014, MATERIALS, V7, P1342, DOI 10.3390/ma7021342
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Saravanan S., 2016, INT J BIOL MACROMOL
   Sarker A, 2015, INT J BIOL MACROMOL, V81, P898, DOI 10.1016/j.ijbiomac.2015.09.029
   SATO M, 1991, J CLIN INVEST, V88, P2095, DOI 10.1172/JCI115539
   Scanlon V C, 2011, ESSENTIALS ANATOMY P
   Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589
   Seebach E, 2014, ACTA BIOMATER, V10, P4730, DOI 10.1016/j.actbio.2014.07.017
   Seo BB, 2015, J CONTROL RELEASE, V209, P67, DOI 10.1016/j.jconrel.2015.04.023
   Seo SJ, 2014, COMPOS SCI TECHNOL, V96, P31, DOI 10.1016/j.compscitech.2014.03.004
   Seyednejad H, 2012, BIOMATERIALS, V33, P4309, DOI 10.1016/j.biomaterials.2012.03.002
   Seyednejad H, 2011, ACTA BIOMATER, V7, P1999, DOI 10.1016/j.actbio.2011.01.018
   Shadjou N, 2015, MAT SCI ENG C-MATER, V55, P401, DOI 10.1016/j.msec.2015.05.027
   Sheikh Z, 2015, MATERIALS, V8, P5744, DOI 10.3390/ma8095273
   Sitharaman B, 2007, J BIOMAT SCI-POLYM E, V18, P655, DOI 10.1163/156856207781034133
   Sivashanmugam A, 2015, EUR POLYM J, V72, P543, DOI 10.1016/j.eurpolymj.2015.05.014
   Smith AM, 2007, J BIOMATER APPL, V22, P241, DOI 10.1177/0885328207076522
   Song CL, 2003, BIOCHEM BIOPH RES CO, V308, P458, DOI 10.1016/S0006-291X(03)01408-6
   Steck E, 2009, STEM CELLS DEV, V18, P969, DOI 10.1089/scd.2008.0213
   Stevens MM, 2008, MATER TODAY, V11, P18, DOI 10.1016/S1369-7021(08)70086-5
   Su WT, 2015, MAT SCI ENG C-MATER, V52, P46, DOI 10.1016/j.msec.2015.03.025
   Su WT, 2015, MAT SCI ENG C-MATER, V46, P427, DOI 10.1016/j.msec.2014.10.076
   Sukul M, 2015, EUR POLYM J, V73, P308, DOI 10.1016/j.eurpolymj.2015.10.022
   Tanigo T, 2010, J CONTROL RELEASE, V143, P201, DOI 10.1016/j.jconrel.2009.12.027
   Tonelli FMP, 2012, INT J NANOMED, V7, P4511, DOI 10.2147/IJN.S33612
   Tousi NS, 2013, MAT SCI ENG C-MATER, V33, P2757, DOI 10.1016/j.msec.2013.02.044
   Ullah F, 2015, MAT SCI ENG C-MATER, V57, P414, DOI 10.1016/j.msec.2015.07.053
   Ulubayram K, 2002, J BIOMAT SCI-POLYM E, V13, P1203, DOI 10.1163/156856202320892966
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Verron E, 2010, BIOMATERIALS, V31, P7776, DOI 10.1016/j.biomaterials.2010.06.047
   Vieira H.P., 2013, INT ARCH MED, V6
   Wang JS, 2010, STEM CELLS DEV, V19, P1375, DOI 10.1089/scd.2009.0258
   Watanabe J, 2007, J BIOMED MATER RES A, V83A, P845, DOI 10.1002/jbm.a.31435
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   Wu Chengtie, 2009, BONE TISSUE REGENERA, V2, P25
   Yan Q, 2015, J BIOMED MATER RES A, V103, P3580, DOI 10.1002/jbm.a.35499
   Yang XW, 2011, ANGEW CHEM INT EDIT, V50, P7325, DOI 10.1002/anie.201100723
   Yasmeen S, 2014, LANGMUIR, V30, P12977, DOI 10.1021/la503057w
   Yi CQ, 2010, ACS NANO, V4, P6439, DOI 10.1021/nn101373r
   Zhang JT, 2016, ACTA BIOMATER, V31, P326, DOI 10.1016/j.actbio.2015.11.055
   Zhou H, 2011, ACTA BIOMATER, V7, P2769, DOI 10.1016/j.actbio.2011.03.019
   Zuo Y, 2010, ACTA BIOMATER, V6, P1238, DOI 10.1016/j.actbio.2009.10.036
   Zur Nieden N.I., 2015, ACS APPL MATER INTER, V7, P10599
NR 152
TC 17
Z9 18
U1 4
U2 84
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD APR
PY 2016
VL 9
IS 4
AR UNSP 267
DI 10.3390/ma9040267
PG 24
WC Materials Science, Multidisciplinary
SC Materials Science
GA DK8EB
UT WOS:000375158900053
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Yang, YW
   Wu, P
   Wang, QY
   Wu, H
   Liu, Y
   Deng, YW
   Zhou, YZ
   Shuai, CJ
AF Yang, Youwen
   Wu, Ping
   Wang, Qiyuan
   Wu, Hong
   Liu, Yong
   Deng, Youwen
   Zhou, Yuanzhuo
   Shuai, Cijun
TI The Enhancement of Mg Corrosion Resistance by Alloying Mn and
   Laser-Melting
SO MATERIALS
LA English
DT Article
DE corrosion resistance; Mg-Mn alloy; laser-melting; microstructure;
   mechanical properties
ID IN-VITRO CORROSION; MAGNESIUM ALLOYS; POWDER-METALLURGY; VIVO; BONE;
   SYSTEM; BIODEGRADATION; DEGRADATION; MANGANESE
AB Mg has been considered a promising biomaterial for bone implants. However, the poor corrosion resistance has become its main undesirable property. In this study, both alloying Mn and laser-melting were applied to enhance the Mg corrosion resistance. The corrosion resistance, mechanical properties, and microstructure of rapid laser-melted Mg-xMn (x = 0-3 wt %) alloys were investigated. The alloys were composed of dendrite grains, and the grains size decreased with increasing Mn. Moreover, Mn could dissolve and induce the crystal lattice distortion of the Mg matrix during the solidification process. Mn ranging from 0-2 wt % dissolved completely due to rapid laser solidification. As Mn contents further increased up to 3 wt %, a small amount of Mn was left undissolved. The compressive strength of Mg-Mn alloys increased first (up to 2 wt %) and then decreased with increasing Mn, while the hardness increased continuously. The refinement of grains and the increase in corrosion potential both made contributions to the enhancement of Mg corrosion resistance.
C1 [Yang, Youwen; Zhou, Yuanzhuo; Shuai, Cijun] Cent S Univ, State Key Lab High Performance Complex Mfg, Changsha 410083, Hunan, Peoples R China.
   [Wu, Ping] Xiangtan Univ, Coll Chem, Xiangtan 411105, Peoples R China.
   [Wang, Qiyuan; Deng, Youwen] Cent S Univ, Xiangya Hosp 2, Dept Emergency Med, Changsha 410083, Hunan, Peoples R China.
   [Wu, Hong; Liu, Yong; Shuai, Cijun] Cent S Univ, State Key Lab Powder Met, Changsha 410083, Hunan, Peoples R China.
RP Shuai, CJ (reprint author), Cent S Univ, State Key Lab High Performance Complex Mfg, Changsha 410083, Hunan, Peoples R China.; Shuai, CJ (reprint author), Cent S Univ, State Key Lab Powder Met, Changsha 410083, Hunan, Peoples R China.
EM yangyouwen@csu.edu.cn; pingwu@xtu.edu.cn; idletwo@gmail.com;
   hwucsu@csu.edu.cn; yonliu@csu.edu.cn; dengjunjiejj@csu.edu.cn;
   zyz420357155@csu.edu.cn; shuai@csu.edu.cn
FU Natural Science Foundation of China [51575537, 81572577, 81472058];
   Overseas, Hong Kong & Macao Scholars Collaborated Researching Fund of
   National Natural Science Foundation of China [81428018]; Hunan
   Provincial Natural Science Foundation of China [14JJ1006]; Open-End Fund
   for the Valuable and Precision Instruments of Central South University;
   Fundamental Research Funds for the Central Universities of Central South
   University
FX This work was supported by the following funds: (1) The Natural Science
   Foundation of China (51575537, 81572577, 81472058); (2) Overseas, Hong
   Kong & Macao Scholars Collaborated Researching Fund of National Natural
   Science Foundation of China (81428018); (3) the Hunan Provincial Natural
   Science Foundation of China (14JJ1006); (4) The Open-End Fund for the
   Valuable and Precision Instruments of Central South University; and (5)
   The Fundamental Research Funds for the Central Universities of Central
   South University.
CR [Anonymous], 2004, E804 ASTM
   Asgharzadeh H, 2014, J ALLOY COMPD, V586, pS95, DOI 10.1016/j.jallcom.2012.10.108
   Baker H., 1992, ASM HDB, V3
   Baril G, 2001, CORROS SCI, V43, P471, DOI 10.1016/S0010-938X(00)00095-0
   Chaya A, 2015, ACTA BIOMATER, V18, P262, DOI 10.1016/j.actbio.2015.02.010
   Gu XN, 2012, ACTA BIOMATER, V8, P2360, DOI 10.1016/j.actbio.2012.02.018
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Hornberger H, 2012, ACTA BIOMATER, V8, P2442, DOI 10.1016/j.actbio.2012.04.012
   Kraus T, 2012, ACTA BIOMATER, V8, P1230, DOI 10.1016/j.actbio.2011.11.008
   LEACH RM, 1969, ARCH BIOCHEM BIOPHYS, V133, P22, DOI 10.1016/0003-9861(69)90483-4
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Liu YZ, 2013, PHYSIOL MEAS, V34, P1593, DOI 10.1088/0967-3334/34/12/1593
   MAKAR GL, 1993, INT MATER REV, V38, P138, DOI 10.1179/imr.1993.38.3.138
   Mora E, 2009, SCRIPTA MATER, V60, P776, DOI 10.1016/j.scriptamat.2009.01.012
   Nayak S, 2016, J MECH BEHAV BIOMED, V59, P57, DOI 10.1016/j.jmbbm.2015.12.010
   Ng CC, 2011, APPL SURF SCI, V257, P7447, DOI 10.1016/j.apsusc.2011.03.004
   Orlov D, 2011, ACTA MATER, V59, P6176, DOI 10.1016/j.actamat.2011.06.033
   Salahshoor M, 2012, MATERIALS, V5, P135, DOI 10.3390/ma5010135
   Shuai CJ, 2010, J BIOMED NANOTECHNOL, V6, P370, DOI 10.1166/jbn.2010.1139
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Sun Y, 2012, MATER DESIGN, V34, P58, DOI 10.1016/j.matdes.2011.07.058
   Vilaro T, 2012, MAT SCI ENG A-STRUCT, V534, P446, DOI 10.1016/j.msea.2011.11.092
   Xie DQ, 2013, CHIN OPT LETT, V11, DOI 10.3788/COL201311.111401
   Yu K, 2012, ACTA BIOMATER, V8, P2845, DOI 10.1016/j.actbio.2012.04.009
   Zhang EL, 2009, MAT SCI ENG C-BIO S, V29, P987, DOI 10.1016/j.msec.2008.08.024
   Zhang SX, 2010, ACTA BIOMATER, V6, P626, DOI 10.1016/j.actbio.2009.06.028
   Zhou Y., 2007, ANAL METHODS MAT SCI
NR 27
TC 8
Z9 9
U1 6
U2 33
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD APR
PY 2016
VL 9
IS 4
AR 216
DI 10.3390/ma9040216
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA DK8EB
UT WOS:000375158900002
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Morena, F
   Argentati, C
   Calzoni, E
   Cordellini, M
   Emiliani, C
   D'Angelo, F
   Martino, S
AF Morena, Francesco
   Argentati, Chiara
   Calzoni, Eleonora
   Cordellini, Marino
   Emiliani, Carla
   D'Angelo, Francesco
   Martino, Sabata
TI Ex-Vivo Tissues Engineering Modeling for Reconstructive Surgery Using
   Human Adult Adipose Stem Cells and Polymeric Nanostructured Matrix
SO NANOMATERIALS
LA English
DT Article
DE adult mesenchymal stem cells isolation and culture; stem cells and
   biomaterial interaction; INTEGRA (R); regenerative medicine
ID REGENERATIVE MEDICINE; DIFFERENTIATION; FATE
AB The major challenge for stem cell translation regenerative medicine is the regeneration of damaged tissues by creating biological substitutes capable of recapitulating the missing function in the recipient host. Therefore, the current paradigm of tissue engineering strategies is the combination of a selected stem cell type, based on their capability to differentiate toward committed cell lineages, and a biomaterial, that, due to own characteristics (e.g., chemical, electric, mechanical property, nano-topography, and nanostructured molecular components), could serve as active scaffold to generate a bio-hybrid tissue/organ. Thus, effort has been made on the generation of in vitro tissue engineering modeling. Here, we present an in vitro model where human adipose stem cells isolated from lipoaspirate adipose tissue and breast adipose tissue, cultured on polymeric INTEGRA (R) Meshed Bilayer Wound Matrix (selected based on conventional clinical applications) are evaluated for their potential application for reconstructive surgery toward bone and adipose tissue. We demonstrated that human adipose stem cells isolated from lipoaspirate and breast tissue have similar stemness properties and are suitable for tissue engineering applications. Finally, the overall results highlighted lipoaspirate adipose tissue as a good source for the generation of adult adipose stem cells.
C1 [Morena, Francesco; Argentati, Chiara; Calzoni, Eleonora; Emiliani, Carla; D'Angelo, Francesco; Martino, Sabata] Univ Perugia, Dept Chem Biol & Biotechnol, Biochem & Mol Biol Unit, Via Giochetto, I-06122 Perugia, Italy.
   [Cordellini, Marino] ASL 1 Umbria, Unita Operat Chirurg Plast & Ricostrutt, I-06012 Citta Di Castello, Italy.
   [D'Angelo, Francesco] Angelantoni Life Sci, Localita Cimacolle 464, I-06056 Perugia, Italy.
RP Martino, S (reprint author), Univ Perugia, Dept Chem Biol & Biotechnol, Biochem & Mol Biol Unit, Via Giochetto, I-06122 Perugia, Italy.
EM effemorena@gmail.com; chiara.argentati89@gmail.com;
   eleonoracalzoni@gmail.com; marinocordellini@yahoo.it;
   carla.emiliani@unipg.it; francesco.dangelo@angelantoni.it;
   sabata.martino@unipg.it
RI Emiliani, Carla/G-3738-2010; bagheri, amir/C-3274-2017; Martino,
   Sabata/F-2309-2014
OI Emiliani, Carla/0000-0002-6368-1515; Martino, Sabata/0000-0002-3942-237X
CR Barba M, 2013, BIOMED RES INT, DOI 10.1155/2013/416391
   Chen LN, 2014, J CARDIOVASC TRANSL, V7, P651, DOI 10.1007/s12265-014-9585-1
   Chen WQ, 2014, NANO TODAY, V9, P759, DOI 10.1016/j.nantod.2014.12.002
   Childs P.G., 2015, ACTA BIOMATER
   D'Angelo F, 2010, EUR CELLS MATER, V20, P231
   D'Angelo F, 2012, BIOMACROMOLECULES, V13, P1350, DOI 10.1021/bm3000716
   D'Angelo F, 2011, J FUNCT BIOMATER, V2, P67, DOI 10.3390/jfb2020067
   De Francesco F, 2015, TISSUE ENG PART B-RE, V21, P572, DOI [10.1089/ten.TEB.2014.0608, 10.1089/ten.teb.2014.0608]
   DeFatta Robert J, 2008, Facial Plast Surg Clin North Am, V16, P383, DOI 10.1016/j.fsc.2008.05.006
   Eun SC, 2014, J KOREAN MED SCI, V29, pS167, DOI 10.3346/jkms.2014.29.S3.S167
   Farouz Y, 2015, STEM CELLS, V33, P1021, DOI 10.1002/stem.1929
   Hao J, 2015, ACTA BIOMATER, V20, P1, DOI 10.1016/j.actbio.2015.04.008
   Katzengold R, 2016, J TISSUE VIABILITY, V25, P32, DOI 10.1016/j.jtv.2015.12.003
   Lin CS, 2010, HISTOL HISTOPATHOL, V25, P807, DOI 10.14670/HH-25.807
   Lizundia E, 2012, MACROMOL BIOSCI, V12, P870, DOI 10.1002/mabi.201200008
   Mandrycky C, 2015, BIOTECHNOL ADV
   Martino S, 2014, CURR PROTEOMICS, V11, P193, DOI 10.2174/157016461103140922164050
   Martino S, 2009, TISSUE ENG PT A, V15, P3139, DOI [10.1089/ten.tea.2008.0552, 10.1089/ten.TEA.2008.0552]
   Martino S, 2012, BIOTECHNOL ADV, V30, P338, DOI 10.1016/j.biotechadv.2011.06.015
   Martino S, 2011, INT J BIOCHEM CELL B, V43, P775, DOI 10.1016/j.biocel.2011.02.001
   Mattar P, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00560
   McMurray RJ, 2015, J TISSUE ENG REGEN M, V9, P528, DOI 10.1002/term.1957
   Mizuno H, 2012, STEM CELLS, V30, P804, DOI 10.1002/stem.1076
   Montespan F, 2014, J IMMUNOL RES, DOI 10.1155/2014/230346
   Morena F, 2014, ANAL CHEM, V86, P473, DOI 10.1021/ac4023555
   Murphy WL, 2014, NAT MATER, V13, P547, DOI [10.1038/NMAT3937, 10.1038/nmat3937]
   Narins RS, 2006, PLAST RECONSTR SURG, V118, p77S, DOI 10.1097/01.prs.0000234919.25096.67
   Pecanha R, 2012, J BONE JOINT SURG AM, V94A, P609, DOI 10.2106/JBJS.K.00351
   Perbellini F, 2015, STEM CELL TRANSL MED, V4, P1403, DOI 10.5966/sctm.2015-0024
   Philips BJ, 2014, WOUND REPAIR REGEN, V22, P11, DOI 10.1111/wrr.12164
   Santos LJ, 2015, TRENDS BIOTECHNOL, V33, P471, DOI 10.1016/j.tibtech.2015.06.006
   Tiribuzi R, 2012, CELL BIOCHEM FUNCT, V30, P61, DOI 10.1002/cbf.1819
   Tsimbouri PM, 2015, J FUNCT BIOMATER, V6, P598, DOI 10.3390/jfb6030598
   Veronesi F, 2014, J BIOMED MATER RES A, V102, P2448, DOI 10.1002/jbm.a.34896
   Vunjak-Novakovic G., 2015, TISSUE ENG
   Xu Y, 2013, NAT MATER, V12, P1082, DOI 10.1038/nmat3821
   Yin XL, 2016, CELL STEM CELL, V18, P25, DOI 10.1016/j.stem.2015.12.005
   Yiou R., 2015, STEM CELLS, V34
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
NR 39
TC 4
Z9 4
U1 1
U2 11
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2079-4991
J9 NANOMATERIALS-BASEL
JI Nanomaterials
PD APR
PY 2016
VL 6
IS 4
AR 57
DI 10.3390/nano6040057
PG 13
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA DK8WH
UT WOS:000375208800003
PM 28335186
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Oshiro, JA
   Abucafy, MP
   Manaia, EB
   da Silva, BL
   Chiari-Andreo, BG
   Chiavacci, LA
AF Oshiro Junior, Joao Augusto
   Abucafy, Marina Paiva
   Manaia, Eloisa Berbel
   da Silva, Bruna Lallo
   Chiari-Andreo, Bruna Galdorfini
   Chiavacci, Leila Aparecida
TI Drug Delivery Systems Obtained from Silica Based Organic-Inorganic
   Hybrids
SO POLYMERS
LA English
DT Review
DE organic-inorganic materials; drug delivery systems; sol-gel process
ID SOL-GEL METHOD; MESOPOROUS SILICA; SYNTHETIC STRATEGIES;
   BLOCK-COPOLYMERS; NITRIC-OXIDE; IN-VITRO; RELEASE; MATRIX;
   NANOPARTICLES; BEHAVIOR
AB This is a review of hybrid materials based on silica as an inorganic phase used as drug delivery systems (DDS). Silica based DDS have shown effectivity when compared with traditional delivery systems. They present advantages such as: (a) ability to maintain the therapeutic range with minor variations; (b) prevention of local and systemic toxic effects; (c) plasma concentrations increase of substances with a short half-life; and (d) reduction of the number of daily doses, which may increase patient adherence to the treatment. These advantages occur due to the physical, chemical and optical properties of these materials. Therefore, we discuss the properties and characteristics of them and we present some applications, using different approaches of DDS to ensure therapeutic effectiveness and side effects reduction such as implantable biomaterial, film-forming materials, stimuli-responsive systems and others.
C1 [Oshiro Junior, Joao Augusto; Abucafy, Marina Paiva; Manaia, Eloisa Berbel; da Silva, Bruna Lallo; Chiari-Andreo, Bruna Galdorfini; Chiavacci, Leila Aparecida] Univ Estadual Paulista, UNESP, Fac Ciencias Farmaceut, Araraquara Jau Km 1, BR-14800903 Araraquara, Brazil.
   [Chiari-Andreo, Bruna Galdorfini] Ctr Univ Araraquara UNIARA, Dept Ciencias Biol & Saude, BR-14800903 Araraquara, Brazil.
RP Chiavacci, LA (reprint author), Univ Estadual Paulista, UNESP, Fac Ciencias Farmaceut, Araraquara Jau Km 1, BR-14800903 Araraquara, Brazil.
EM joaooshiro@yahoo.com.br; marina.abucafy@gmail.com;
   elobm_elo@yahoo.com.br; brunalallo@hotmail.com;
   brunagchiari@yahoo.com.br; leila@fcfar.unesp.br
RI Chiari-Andreo, Bruna/J-2648-2013; Manaia, Eloisa/I-7222-2017
OI Chiari-Andreo, Bruna/0000-0001-7959-0207; Manaia,
   Eloisa/0000-0001-6352-1602; Oshiro Junior, Joao
   Augusto/0000-0001-7247-1598
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Programa
   de Apoio ao Desenvolvimento Cientifico da Faculdade de Ciencias
   Farmaceuticas do Campus de Araraquara da UNESP (PADC/FCF-UNESP)
FX Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and
   Programa de Apoio ao Desenvolvimento Cientifico da Faculdade de Ciencias
   Farmaceuticas do Campus de Araraquara da UNESP (PADC/FCF-UNESP) for the
   financial support.
CR Allen C, 1999, COLLOID SURFACE B, V16, P3, DOI 10.1016/S0927-7765(99)00058-2
   Ariga K, 2007, COORDIN CHEM REV, V251, P2562, DOI 10.1016/j.ccr.2007.02.024
   Ariga K, 2016, ADV MATER, V28, P1251, DOI 10.1002/adma.201502545
   Ariga K, 2014, NEW J CHEM, V38, P5149, DOI 10.1039/c4nj00864b
   Belting M, 2005, ADV DRUG DELIVER REV, V57, P505, DOI 10.1016/j.addr.2004.10.004
   Benvenutti EV, 2009, QUIM NOVA, V32, P1926, DOI 10.1590/S0100-40422009000700039
   BRENNAN AB, 1991, POLYMER, V32, P733, DOI 10.1016/0032-3861(91)90488-5
   Bronich TK, 1999, COLLOID SURFACE B, V16, P243, DOI 10.1016/S0927-7765(99)00075-2
   Burkett CM, 2008, CHEM MATER, V20, P1312, DOI 10.1021/cm0716001
   Chavanpatil MD, 2006, INT J PHARM, V316, P86, DOI 10.1016/j.ijpharm.2006.02.038
   Colilla M, 2006, CHEM MATER, V18, P5676, DOI 10.1021/cm0612043
   Colilla M, 2010, MICROPOR MESOPOR MAT, V135, P51, DOI 10.1016/j.micromeso.2010.06.010
   Corma A, 2009, ANGEW CHEM INT EDIT, V48, P6247, DOI 10.1002/anie.200902208
   de Menezes EW, 2012, J COLLOID INTERF SCI, V378, P10, DOI 10.1016/j.jcis.2012.04.021
   Esteves ACC, 2004, QUIM NOVA, V27, P798, DOI 10.1590/S0100-40422004000500020
   Franken L, 2002, QUIM NOVA, V25, P563, DOI 10.1590/S0100-40422002000400010
   Franville AC, 2000, CHEM MATER, V12, P428, DOI 10.1021/cm9904739
   Gao CB, 2009, MICROPOR MESOPOR MAT, V122, P201, DOI 10.1016/j.micromeso.2009.03.002
   Gao SF, 2012, PLAST RUBBER COMPOS, V41, P13, DOI 10.1179/1743289811Y.0000000021
   Garcia O, 2008, ADV FUNCT MATER, V18, P2017, DOI 10.1002/adfm.200701395
   GIRARDREYDET E, 1994, MACROMOL CHEM PHYSIC, V195, P149, DOI 10.1002/macp.1994.021950112
   Gonzalez B, 2008, CHEM MATER, V20, P4826, DOI 10.1021/cm703568k
   Herculano R.D., 2013, MAT SCI APPL, V4, P683
   Herculano RD, 2011, MATER RES-IBERO-AM J, V14, P355, DOI 10.1590/S1516-14392011005000055
   Jose NM, 2005, QUIM NOVA, V28, P281, DOI 10.1590/S0100-40422005000200020
   Junior J.A.O., 2014, MATERIA, V19, P24
   Kabanov A. V., 2002, CRITICAL REV THERAPE, V19, P72
   Kabanov AV, 2002, J CONTROL RELEASE, V82, P189, DOI 10.1016/S0168-3659(02)00009-3
   Kwon GS, 2012, ADV DRUG DELIVER REV, V64, P237, DOI 10.1016/j.addr.2012.09.016
   Lin CX, 2009, MICROPOR MESOPOR MAT, V117, P213, DOI 10.1016/j.micromeso.2008.06.023
   Lin M, 2007, J PHARM SCI-US, V96, P1518, DOI 10.1002/jps.20809
   Lin ZQ, 2014, J CONTROL RELEASE, V174, P161, DOI 10.1016/j.jconrel.2013.10.026
   Loira-Pastoriza C, 2014, ADV DRUG DELIVER REV, V75, P81, DOI 10.1016/j.addr.2014.05.017
   Lopes L, 2012, RSC ADV, V2, P5629, DOI 10.1039/c2ra01216b
   Magdalena S., 2009, CURR NANOSCI, V5, P1
   Matejka L, 2004, POLYMER, V45, P3267, DOI 10.1016/j.polymer.2004.03.033
   Molina EF, 2014, J SOL-GEL SCI TECHN, V70, P317, DOI 10.1007/s10971-014-3300-1
   Molina EF, 2014, LANGMUIR, V30, P3857, DOI 10.1021/la404812e
   Molina EF, 2010, J PHYS CHEM B, V114, P3461, DOI 10.1021/jp9097638
   Munoz B, 2003, CHEM MATER, V15, P500, DOI 10.1021/cm021217q
   Nassar EJ, 2007, QUIM NOVA, V30, P1567, DOI 10.1590/S0100-40422007000700013
   NAVA E, 1995, J HYPERTENS, V13, pS39, DOI 10.1097/00004872-199508001-00007
   Nori A, 2005, ADV DRUG DELIVER REV, V57, P609, DOI 10.1016/j.addr.2004.10.006
   Ogoshi T, 2005, COMPOS INTERFACE, V11, P539, DOI 10.1163/1568554053148735
   Oh KT, 2004, J CONTROL RELEASE, V94, P411, DOI 10.1016/j.jcornel.2003.10.018
   Orilall MC, 2011, CHEM SOC REV, V40, P520, DOI 10.1039/c0cs00034e
   Oshiro-Junior J.A., 2015, INT J POLYM SCI
   Palm C, 2007, BBA-BIOMEMBRANES, V1768, P1769, DOI 10.1016/j.bbamem.2007.03.029
   Paredes M, 2014, J SOL-GEL SCI TECHN, V72, P233, DOI 10.1007/s10971-014-3314-8
   Patel NR, 2010, NANOMEDICINE-UK, V5, P1037, DOI 10.2217/NNM.10.68
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   PHILIPP G, 1984, J NON-CRYST SOLIDS, V63, P283, DOI 10.1016/0022-3093(84)90407-1
   Popat A, 2012, J MATER CHEM, V22, P11173, DOI 10.1039/c2jm30501a
   Radin S, 2002, BIOMATERIALS, V23, P3113, DOI 10.1016/S0142-9612(02)00051-0
   Rekondo A, 2007, POLYM DEGRAD STABIL, V92, P2173, DOI 10.1016/j.polymdegradstab.2007.01.034
   Russell RGG, 1999, BONE, V25, P97, DOI 10.1016/S8756-3282(99)00116-7
   Sanchez C, 2005, J MATER CHEM, V15, P3559, DOI 10.1039/b509097k
   Sanchez C., 2000, MOL CRYST LIQ CRYST, V354, P143
   Santilli CV, 2009, CHEM MATER, V21, P463, DOI 10.1021/cm801899u
   Scherer G.W., 1990, SOL GEL PHYS CHEMYST
   Schmolka I. R., 1991, POLYM CONTROLLED DRU, P189
   Schottner G, 2001, CHEM MATER, V13, P3422, DOI 10.1021/cm011060m
   Schroeder IZ, 2007, EUR J PHARM BIOPHARM, V65, P111, DOI 10.1016/j.ejpb.2006.07.015
   Soppimath KS, 2001, J CONTROL RELEASE, V70, P1, DOI 10.1016/S0168-3659(00)00339-4
   Souza LK, 2013, COLLOID SURFACE B, V101, P156, DOI 10.1016/j.colsurfb.2012.06.009
   Torchilin VP, 2001, J CONTROL RELEASE, V73, P137, DOI 10.1016/S0168-3659(01)00299-1
   Vallet-Regi M, 2001, CHEM MATER, V13, P308, DOI 10.1021/cm0011559
   Vallet-Regi M, 2011, CHEM SOC REV, V40, P596, DOI 10.1039/c0cs00025f
   VASTA V, 1995, BIOCHEM BIOPH RES CO, V206, P878, DOI 10.1006/bbrc.1995.1125
   Vendruscolo CW, 2005, INT J PHARMACEUT, V296, P1, DOI 10.1016/j.ijpharm.2005.02.007
   Wan XJ, 2010, LANGMUIR, V26, P15574, DOI 10.1021/la102148x
   Wu J, 2007, BIOMATERIALS, V28, P2220, DOI 10.1016/j.biomaterials.2006.12.024
   Wu N, 2005, J CONTROL RELEASE, V102, P569, DOI 10.1016/j.jconrel.2004.11.002
   Xue JM, 2004, J CONTROL RELEASE, V98, P209, DOI 10.1016/j.jconrel.2004.04.023
   Zhang F, 2013, ENERG ENVIRON SCI, V6, P1623, DOI 10.1039/c3ee40509e
   Zhao YJ, 2009, EUR J PHARM BIOPHARM, V72, P521, DOI 10.1016/j.ejpb.2009.03.002
NR 76
TC 8
Z9 8
U1 4
U2 44
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 2073-4360
J9 POLYMERS-BASEL
JI Polymers
PD APR
PY 2016
VL 8
IS 4
AR 91
DI 10.3390/polym8040091
PG 14
WC Polymer Science
SC Polymer Science
GA DK8EL
UT WOS:000375159900004
OA DOAJ Gold
DA 2018-10-20
ER

EF